id|nct_id|result_group_id|ctgov_group_code|period|reason|count
199717|NCT03072719|623623|P2|Overall Study|Adverse Event|1
199718|NCT03072719|623624|P1|Overall Study|Adverse Event|1
199719|NCT03065933|623770|P1|Overall Study|study terminated|5
199720|NCT03023137|623912|P2|Overall Study|Lost the baby in a car accident|0
199721|NCT03023137|623913|P1|Overall Study|Lost the baby in a car accident|1
199722|NCT03023137|623912|P2|Overall Study|Protocol Violation|4
199723|NCT03023137|623913|P1|Overall Study|Protocol Violation|0
199724|NCT03023137|623912|P2|Overall Study|Lost to Follow-up|1
199725|NCT03023137|623913|P1|Overall Study|Lost to Follow-up|1
199726|NCT03023137|623912|P2|Overall Study|Multiple pregnancy|4
199727|NCT03023137|623913|P1|Overall Study|Multiple pregnancy|2
199728|NCT03022422|623971|P6|Overall Study|3 subjects consented but not vaccinated|0
199729|NCT03022422|623972|P5|Overall Study|3 subjects consented but not vaccinated|0
199730|NCT03022422|623973|P4|Overall Study|3 subjects consented but not vaccinated|0
199731|NCT03022422|623974|P3|Overall Study|3 subjects consented but not vaccinated|3
199732|NCT03022422|623975|P2|Overall Study|3 subjects consented but not vaccinated|0
199733|NCT03022422|623976|P1|Overall Study|3 subjects consented but not vaccinated|0
199734|NCT02988219|624073|P2|Overall Study|Withdrawal by Subject|2
199735|NCT02988219|624074|P1|Overall Study|Withdrawal by Subject|0
199736|NCT02988219|624073|P2|Overall Study|Lack of Efficacy|1
199737|NCT02988219|624074|P1|Overall Study|Lack of Efficacy|1
199738|NCT02974543|624089|P2|Overall Study|Withdrawal by Subject|0
199739|NCT02974543|624090|P1|Overall Study|Withdrawal by Subject|1
199740|NCT02971670|624114|P4|Overall Study|Withdrawal by Subject|2
199741|NCT02971670|624115|P3|Overall Study|Withdrawal by Subject|1
199742|NCT02971670|624116|P2|Overall Study|Withdrawal by Subject|1
199743|NCT02971670|624117|P1|Overall Study|Withdrawal by Subject|4
199744|NCT02961244|624137|P2|Overall Study|İnadequate data|2
199745|NCT02961244|624138|P1|Overall Study|İnadequate data|0
199746|NCT02961244|624137|P2|Overall Study|Lost to Follow-up|2
199747|NCT02961244|624138|P1|Overall Study|Lost to Follow-up|0
199748|NCT02961244|624137|P2|Overall Study|Surgery plan change after study approval|2
199749|NCT02961244|624138|P1|Overall Study|Surgery plan change after study approval|0
199750|NCT02961244|624137|P2|Overall Study|Withdrawal by Subject|2
199751|NCT02961244|624138|P1|Overall Study|Withdrawal by Subject|1
199752|NCT02961244|624137|P2|Overall Study|Protocol Violation|1
199753|NCT02961244|624138|P1|Overall Study|Protocol Violation|0
199754|NCT02951767|624173|P1|Overall Study|Death|46
199755|NCT02951767|624173|P1|Overall Study|Withdrawal by Subject|6
199756|NCT02951767|624173|P1|Overall Study|Ongoing at data cutoff 14 September 2015|67
199757|NCT02903238|624285|P1|Overall Study|Lost to Follow-up|4
199758|NCT02895347|624296|P2|Overall Study|Withdrawal by Subject|1
199759|NCT02895347|624297|P1|Overall Study|Withdrawal by Subject|3
199760|NCT02882152|624317|P2|Overall Study|Lost to Follow-up|0
199761|NCT02882152|624318|P1|Overall Study|Lost to Follow-up|1
199762|NCT02862106|624351|P2|Overall Study|Subjects moved to other city|0
199763|NCT02862106|624352|P1|Overall Study|Subjects moved to other city|1
199764|NCT02862106|624351|P2|Overall Study|Withdrawal by Subject|0
199765|NCT02862106|624352|P1|Overall Study|Withdrawal by Subject|2
199766|NCT02862106|624351|P2|Overall Study|Lost to Follow-up|5
199767|NCT02862106|624352|P1|Overall Study|Lost to Follow-up|15
199768|NCT02862106|624351|P2|Overall Study|Protocol Violation|1
199769|NCT02862106|624352|P1|Overall Study|Protocol Violation|16
199770|NCT02862106|624351|P2|Overall Study|Adverse Event|0
199771|NCT02862106|624352|P1|Overall Study|Adverse Event|4
199772|NCT02856880|624410|P1|Overall Study|Withdrawal of consent|1
199773|NCT02832375|624546|P2|Overall Study|Withdrawal of Consent|0
199774|NCT02832375|624547|P1|Overall Study|Withdrawal of Consent|1
199775|NCT02832375|624546|P2|Overall Study|Lost to Follow-up|0
199776|NCT02832375|624547|P1|Overall Study|Lost to Follow-up|1
199777|NCT02829775|624557|P1|Overall Study|Disease remission|1
199778|NCT02829775|624557|P1|Overall Study|Withdrawal by Subject|3
199779|NCT02829775|624557|P1|Overall Study|Death|1
199780|NCT02815735|624655|P2|Second Intervention (4 Weeks)|Protocol Violation|0
199781|NCT02815735|624656|P1|Second Intervention (4 Weeks)|Protocol Violation|1
199782|NCT02815735|624655|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
199783|NCT02815735|624656|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
199784|NCT02815735|624655|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
199785|NCT02815735|624656|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
199786|NCT02815735|624655|P2|First Intervention (4 Weeks)|Discomfort|0
199787|NCT02815735|624656|P1|First Intervention (4 Weeks)|Discomfort|1
199788|NCT02809833|624707|P1|Overall Study|Missing Information|52
199789|NCT02809833|624707|P1|Overall Study|Not Specified|5
199790|NCT02809833|624707|P1|Overall Study|Adverse Event (AE)|24
199791|NCT02809833|624707|P1|Overall Study|Lost to Follow-up|35
199792|NCT02809833|624707|P1|Overall Study|Withdrawal by Subject|34
199793|NCT02809833|624707|P1|Overall Study|Noncompliance|1
199794|NCT02809833|624707|P1|Overall Study|Remission/Treatment No Longer Needed|3
199795|NCT02809833|624707|P1|Overall Study|Lack of Efficacy|89
199796|NCT02809833|624707|P1|Overall Study|Intolerance|54
199797|NCT02809833|624707|P1|Overall Study|Death|3
199798|NCT02806505|624829|P2|Overall Study|Insufficient therapeutic response|4
199799|NCT02806505|624830|P1|Overall Study|Insufficient therapeutic response|2
199800|NCT02806505|624829|P2|Overall Study|Failure to return|1
199801|NCT02806505|624830|P1|Overall Study|Failure to return|0
199802|NCT02806505|624829|P2|Overall Study|Did not cooperate/refused treatment|3
199803|NCT02806505|624830|P1|Overall Study|Did not cooperate/refused treatment|3
199804|NCT02806505|624829|P2|Overall Study|Death|0
199805|NCT02806505|624830|P1|Overall Study|Death|4
199806|NCT02806505|624829|P2|Overall Study|Adverse event/intercurrent illness|3
199807|NCT02806505|624830|P1|Overall Study|Adverse event/intercurrent illness|1
199808|NCT02805907|624842|P2|Overall Study|Lost to Follow-up|3
199809|NCT02805907|624843|P1|Overall Study|Lost to Follow-up|3
199810|NCT02801396|624855|P6|Period 1|Withdrawal by Subject|0
199811|NCT02801396|624856|P5|Period 1|Withdrawal by Subject|1
199812|NCT02801396|624857|P4|Period 1|Withdrawal by Subject|0
199813|NCT02801396|624858|P3|Period 1|Withdrawal by Subject|0
199814|NCT02801396|624859|P2|Period 1|Withdrawal by Subject|0
199815|NCT02801396|624860|P1|Period 1|Withdrawal by Subject|0
199816|NCT02799082|624879|P2|Overall Study|Protocol Violation|1
199817|NCT02799082|624880|P1|Overall Study|Protocol Violation|0
199818|NCT02799082|624879|P2|Overall Study|Refused second PDT or withdraw consent|3
199819|NCT02799082|624880|P1|Overall Study|Refused second PDT or withdraw consent|4
199820|NCT02799069|624917|P3|Overall Study|Protocol Violation|2
199821|NCT02799069|624918|P2|Overall Study|Protocol Violation|0
199822|NCT02799069|624919|P1|Overall Study|Protocol Violation|1
199823|NCT02799069|624917|P3|Overall Study|Withdrawal by Subject|3
199824|NCT02799069|624918|P2|Overall Study|Withdrawal by Subject|4
199825|NCT02799069|624919|P1|Overall Study|Withdrawal by Subject|4
199826|NCT02799069|624917|P3|Overall Study|Lost to Follow-up|0
199827|NCT02799069|624918|P2|Overall Study|Lost to Follow-up|1
199828|NCT02799069|624919|P1|Overall Study|Lost to Follow-up|1
199829|NCT02799069|624917|P3|Overall Study|Lack of Efficacy|0
199830|NCT02799069|624918|P2|Overall Study|Lack of Efficacy|0
199831|NCT02799069|624919|P1|Overall Study|Lack of Efficacy|2
199832|NCT02799069|624917|P3|Overall Study|Adverse Event|2
199833|NCT02799069|624918|P2|Overall Study|Adverse Event|2
199834|NCT02799069|624919|P1|Overall Study|Adverse Event|0
199835|NCT02791659|625083|P2|Overall Study|Protocol Violation|1
199836|NCT02791659|625084|P1|Overall Study|Protocol Violation|0
199837|NCT02791269|625092|P2|Overall Study|Lost to Follow-up|1
199838|NCT02791269|625093|P1|Overall Study|Lost to Follow-up|0
199839|NCT02774278|625161|P1|Overall Study|Protocol Violation|2
199840|NCT02774278|625161|P1|Overall Study|Withdrawal by Subject|3
199841|NCT02774278|625161|P1|Overall Study|Administrative reasons|6
199842|NCT02774278|625161|P1|Overall Study|Refused treatment/did not cooperate|9
199843|NCT02774278|625161|P1|Overall Study|Adverse event/intercurrent illness|16
199844|NCT02774278|625161|P1|Overall Study|Death|29
199845|NCT02774278|625161|P1|Overall Study|Lack of Efficacy|199
199846|NCT02767765|625193|P1|Overall Study|Withdrawal by Subject|1
199847|NCT02767765|625193|P1|Overall Study|Non-Compliance|1
199848|NCT02767765|625193|P1|Overall Study|Investigator decision|1
199849|NCT02767765|625193|P1|Overall Study|Lost to Follow-up|2
199850|NCT02767765|625193|P1|Overall Study|Insufficient response|1
199851|NCT02767765|625193|P1|Overall Study|Death|1
199852|NCT02767765|625193|P1|Overall Study|Adverse Event|4
199853|NCT02766400|625204|P2|Overall Study|Withdrawal by Subject|0
199854|NCT02766400|625205|P1|Overall Study|Withdrawal by Subject|1
199855|NCT02766400|625204|P2|Overall Study|Death|2
199856|NCT02766400|625205|P1|Overall Study|Death|1
199857|NCT02763189|625237|P2|Overall Study|Device failure|2
199858|NCT02763189|625238|P1|Overall Study|Device failure|0
199859|NCT02761733|625250|P4|Overall Study|Cognitive Impairment|0
199860|NCT02761733|625251|P3|Overall Study|Cognitive Impairment|1
199861|NCT02761733|625252|P2|Overall Study|Cognitive Impairment|0
199862|NCT02761733|625253|P1|Overall Study|Cognitive Impairment|5
199863|NCT02761733|625250|P4|Overall Study|Discharged from Study Site|11
199864|NCT02761733|625251|P3|Overall Study|Discharged from Study Site|25
199865|NCT02761733|625252|P2|Overall Study|Discharged from Study Site|9
199866|NCT02761733|625253|P1|Overall Study|Discharged from Study Site|10
199867|NCT02761733|625250|P4|Overall Study|Withdrawal by Subject|0
199868|NCT02761733|625251|P3|Overall Study|Withdrawal by Subject|0
199869|NCT02761733|625252|P2|Overall Study|Withdrawal by Subject|0
199870|NCT02761733|625253|P1|Overall Study|Withdrawal by Subject|2
199871|NCT02761733|625250|P4|Overall Study|Physician Decision|0
199872|NCT02761733|625251|P3|Overall Study|Physician Decision|0
199873|NCT02761733|625252|P2|Overall Study|Physician Decision|0
199874|NCT02761733|625253|P1|Overall Study|Physician Decision|4
199875|NCT02761733|625250|P4|Overall Study|Lost to Follow-up|3
199876|NCT02761733|625251|P3|Overall Study|Lost to Follow-up|0
199877|NCT02761733|625252|P2|Overall Study|Lost to Follow-up|7
199878|NCT02761733|625253|P1|Overall Study|Lost to Follow-up|6
199879|NCT02761733|625250|P4|Overall Study|Death|1
199880|NCT02761733|625251|P3|Overall Study|Death|1
199881|NCT02761733|625252|P2|Overall Study|Death|5
199882|NCT02761733|625253|P1|Overall Study|Death|3
199883|NCT02761629|625285|P2|Overall Study|Randomized But Not Treated|4
199884|NCT02761629|625286|P1|Overall Study|Randomized But Not Treated|8
199885|NCT02761629|625285|P2|Overall Study|Lost to Follow-up|1
199886|NCT02761629|625286|P1|Overall Study|Lost to Follow-up|4
199887|NCT02761629|625285|P2|Overall Study|Unspecified|2
199888|NCT02761629|625286|P1|Overall Study|Unspecified|0
199889|NCT02761629|625285|P2|Overall Study|Withdrawal by Subject|3
199890|NCT02761629|625286|P1|Overall Study|Withdrawal by Subject|0
199891|NCT02761629|625285|P2|Overall Study|Protocol Violation|2
199892|NCT02761629|625286|P1|Overall Study|Protocol Violation|2
199893|NCT02761629|625285|P2|Overall Study|Did not Cooperate/Refused Treatment|4
199894|NCT02761629|625286|P1|Overall Study|Did not Cooperate/Refused Treatment|2
199895|NCT02761629|625285|P2|Overall Study|Failure to Return|4
199896|NCT02761629|625286|P1|Overall Study|Failure to Return|2
199897|NCT02761629|625285|P2|Overall Study|Insufficient Therapeutic Response|7
199898|NCT02761629|625286|P1|Overall Study|Insufficient Therapeutic Response|2
199899|NCT02761629|625285|P2|Overall Study|Adverse Event/Intercurrent Illness|5
199900|NCT02761629|625286|P1|Overall Study|Adverse Event/Intercurrent Illness|7
199901|NCT02760654|625308|P2|Overall Study|Withdrawal by Subject|3
199902|NCT02760654|625309|P1|Overall Study|Withdrawal by Subject|4
199903|NCT02760654|625308|P2|Overall Study|Lost to Follow-up|3
199904|NCT02760654|625309|P1|Overall Study|Lost to Follow-up|3
199905|NCT02759471|625333|P1|Overall Study|discomfort|2
199906|NCT02756637|625345|P2|Overall Study|Did not complete curative therapy|0
199907|NCT02756637|625346|P1|Overall Study|Did not complete curative therapy|33
199908|NCT02756637|625345|P2|Overall Study|No available NLR value|44
199909|NCT02756637|625346|P1|Overall Study|No available NLR value|44
199910|NCT02756637|625345|P2|Overall Study|Not eligible for initial SWOG study|10
199911|NCT02756637|625346|P1|Overall Study|Not eligible for initial SWOG study|10
199912|NCT02755805|625365|P2|Overall Study|Withdrawal by Subject|2
199913|NCT02755805|625366|P1|Overall Study|Withdrawal by Subject|0
199914|NCT02755805|625365|P2|Overall Study|Refused assessments|0
199915|NCT02755805|625366|P1|Overall Study|Refused assessments|1
199916|NCT02755805|625365|P2|Overall Study|Lost to Follow-up|2
199917|NCT02755805|625366|P1|Overall Study|Lost to Follow-up|1
199918|NCT02753075|625400|P3|Overall Study|Physician Decision|0
199919|NCT02753075|625401|P2|Overall Study|Physician Decision|1
199920|NCT02753075|625402|P1|Overall Study|Physician Decision|3
199921|NCT02753075|625400|P3|Overall Study|Withdrawal of Consent|3
199922|NCT02753075|625401|P2|Overall Study|Withdrawal of Consent|1
199923|NCT02753075|625402|P1|Overall Study|Withdrawal of Consent|1
199924|NCT02753075|625400|P3|Overall Study|Lost to Follow-up|0
199925|NCT02753075|625401|P2|Overall Study|Lost to Follow-up|0
199926|NCT02753075|625402|P1|Overall Study|Lost to Follow-up|2
199927|NCT02753075|625400|P3|Overall Study|Adverse Event|0
199928|NCT02753075|625401|P2|Overall Study|Adverse Event|1
199929|NCT02753075|625402|P1|Overall Study|Adverse Event|2
199930|NCT02752802|625429|P2|Overall Study|Contrast Volume Not Collected|0
199931|NCT02752802|625430|P1|Overall Study|Contrast Volume Not Collected|1
199932|NCT02751450|625441|P2|Overall Study|Adverse Event|0
199933|NCT02751450|625442|P1|Overall Study|Adverse Event|1
199934|NCT02750943|625456|P2|Overall Study|Withdrawal by Subject|7
199935|NCT02750943|625457|P1|Overall Study|Withdrawal by Subject|5
199936|NCT02750943|625456|P2|Overall Study|Lost to Follow-up|2
199937|NCT02750943|625457|P1|Overall Study|Lost to Follow-up|1
199938|NCT02750709|625471|P6|Treatment Period 1|Adverse Event|1
199939|NCT02750709|625472|P5|Treatment Period 1|Adverse Event|0
199940|NCT02750709|625473|P4|Treatment Period 1|Adverse Event|0
199941|NCT02750709|625474|P3|Treatment Period 1|Adverse Event|0
199942|NCT02750709|625475|P2|Treatment Period 1|Adverse Event|0
199943|NCT02750709|625476|P1|Treatment Period 1|Adverse Event|0
199944|NCT02750345|625502|P6|Intervention 1|Adverse Event|0
199945|NCT02750345|625503|P5|Intervention 1|Adverse Event|1
199946|NCT02750345|625504|P4|Intervention 1|Adverse Event|0
199947|NCT02750345|625505|P3|Intervention 1|Adverse Event|0
199948|NCT02750345|625506|P2|Intervention 1|Adverse Event|0
199949|NCT02750345|625507|P1|Intervention 1|Adverse Event|0
199950|NCT02750332|625533|P2|Treatment Period 1|Withdrawal by Subject|1
199951|NCT02750332|625534|P1|Treatment Period 1|Withdrawal by Subject|0
199952|NCT02748213|625554|P2|Overall Study|Not Specified|29
199953|NCT02748213|625555|P1|Overall Study|Not Specified|30
199954|NCT02748213|625554|P2|Overall Study|Failure to Return|0
199955|NCT02748213|625555|P1|Overall Study|Failure to Return|1
199956|NCT02748213|625554|P2|Overall Study|Refused Treatment*|6
199957|NCT02748213|625555|P1|Overall Study|Refused Treatment*|6
199958|NCT02748213|625554|P2|Overall Study|Protocol Violation|4
199959|NCT02748213|625555|P1|Overall Study|Protocol Violation|6
199960|NCT02748213|625554|P2|Overall Study|Violation of Selection Criteria|0
199961|NCT02748213|625555|P1|Overall Study|Violation of Selection Criteria|2
199962|NCT02748213|625554|P2|Overall Study|Insufficient Therapeutic Response|57
199963|NCT02748213|625555|P1|Overall Study|Insufficient Therapeutic Response|56
199964|NCT02748213|625554|P2|Overall Study|Death|3
199965|NCT02748213|625555|P1|Overall Study|Death|5
199966|NCT02748213|625554|P2|Overall Study|Adverse Event or Intercurrent Illness|11
199967|NCT02748213|625555|P1|Overall Study|Adverse Event or Intercurrent Illness|5
199968|NCT02748213|625554|P2|Overall Study|Abnormal Laboratory Test|0
199969|NCT02748213|625555|P1|Overall Study|Abnormal Laboratory Test|1
199970|NCT02748213|625554|P2|Overall Study|Withdrawal Prior to Treatment|2
199971|NCT02748213|625555|P1|Overall Study|Withdrawal Prior to Treatment|1
199972|NCT02746679|625573|P2|Overall Study|Lost to Follow-up|6
199973|NCT02746679|625574|P1|Overall Study|Lost to Follow-up|4
199974|NCT02739594|625676|P2|Overall Study|Not Specified|2
199975|NCT02739594|625677|P1|Overall Study|Not Specified|6
199976|NCT02739594|625676|P2|Overall Study|Elevated Serum Creatinine|1
199977|NCT02739594|625677|P1|Overall Study|Elevated Serum Creatinine|0
199978|NCT02739594|625676|P2|Overall Study|Lost to Follow-up|1
199979|NCT02739594|625677|P1|Overall Study|Lost to Follow-up|0
199980|NCT02739594|625676|P2|Overall Study|Withdrawal by Subject|1
199981|NCT02739594|625677|P1|Overall Study|Withdrawal by Subject|1
199982|NCT02739594|625676|P2|Overall Study|Administrative Reasons|3
199983|NCT02739594|625677|P1|Overall Study|Administrative Reasons|1
199984|NCT02739594|625676|P2|Overall Study|Renal Insufficiency|6
199985|NCT02739594|625677|P1|Overall Study|Renal Insufficiency|4
199986|NCT02739594|625676|P2|Overall Study|Death|2
199987|NCT02739594|625677|P1|Overall Study|Death|4
199988|NCT02739594|625676|P2|Overall Study|Protocol Violation|6
199989|NCT02739594|625677|P1|Overall Study|Protocol Violation|5
199990|NCT02739594|625676|P2|Overall Study|Violation of Eligibility Criteria|2
199991|NCT02739594|625677|P1|Overall Study|Violation of Eligibility Criteria|1
199992|NCT02739594|625676|P2|Overall Study|Undesired Event|4
199993|NCT02739594|625677|P1|Overall Study|Undesired Event|3
199994|NCT02737592|625707|P1|Overall Study|Withdrawal by Subject|1
199995|NCT02736721|625712|P1|Overall Study|Unspecified|5
199996|NCT02736721|625712|P1|Overall Study|Lost to Follow-up|3
199997|NCT02736721|625712|P1|Overall Study|Adverse Event|8
199998|NCT02735200|625723|P2|Overall Study|Withdrawal by Subject|0
199999|NCT02735200|625724|P1|Overall Study|Withdrawal by Subject|8
200000|NCT02735200|625723|P2|Overall Study|Lost to Follow-up|5
200001|NCT02735200|625724|P1|Overall Study|Lost to Follow-up|0
200002|NCT02732639|625772|P1|Overall Study|Lost to Follow-up|1
200003|NCT02732561|625785|P2|Overall Study|Withdrawal by Subject|0
200004|NCT02732561|625786|P1|Overall Study|Withdrawal by Subject|1
200005|NCT02732561|625785|P2|Overall Study|Lost to Follow-up|1
200006|NCT02732561|625786|P1|Overall Study|Lost to Follow-up|1
200007|NCT02732210|625796|P2|Overall Study|Missing|8
200008|NCT02732210|625797|P1|Overall Study|Missing|0
200009|NCT02732210|625796|P2|Overall Study|Other|103
200010|NCT02732210|625797|P1|Overall Study|Other|35
200011|NCT02732210|625796|P2|Overall Study|Death|15
200012|NCT02732210|625797|P1|Overall Study|Death|4
200013|NCT02732210|625796|P2|Overall Study|Lost to Follow-up|57
200014|NCT02732210|625797|P1|Overall Study|Lost to Follow-up|5
200015|NCT02732210|625796|P2|Overall Study|Withdrawal by Subject|87
200016|NCT02732210|625797|P1|Overall Study|Withdrawal by Subject|28
200017|NCT02732210|625796|P2|Overall Study|Study Ended|13
200018|NCT02732210|625797|P1|Overall Study|Study Ended|13
200019|NCT02732210|625796|P2|Overall Study|Site Closed|11
200020|NCT02732210|625797|P1|Overall Study|Site Closed|0
200021|NCT02731131|625849|P2|Overall Study|Refused Therapy|1
200022|NCT02731131|625850|P1|Overall Study|Refused Therapy|0
200023|NCT02731131|625849|P2|Overall Study|Psychiatric Disorder|1
200024|NCT02731131|625850|P1|Overall Study|Psychiatric Disorder|0
200025|NCT02726022|625897|P1|Overall Study|Treatment Failure and Poor Compliance|1
200026|NCT02726022|625897|P1|Overall Study|Poor Compliance|13
200027|NCT02726022|625897|P1|Overall Study|Treatment Failure|8
200028|NCT02726022|625897|P1|Overall Study|Adverse Event|14
200029|NCT02725788|625908|P2|Overall Study|Protocol Violation|1
200030|NCT02725788|625909|P1|Overall Study|Protocol Violation|0
200031|NCT02725788|625908|P2|Overall Study|Lost to Follow-up|1
200032|NCT02725788|625909|P1|Overall Study|Lost to Follow-up|1
200033|NCT02723188|625922|P3|Overall Study|Withdrawal by Subject|0
200034|NCT02723188|625923|P2|Overall Study|Withdrawal by Subject|0
200035|NCT02723188|625924|P1|Overall Study|Withdrawal by Subject|1
200036|NCT02717754|625989|P6|Overall Study|Incorrect Infusion Duration|20
200037|NCT02717754|625990|P5|Overall Study|Incorrect Infusion Duration|20
200038|NCT02717754|625991|P4|Overall Study|Incorrect Infusion Duration|10
200039|NCT02717754|625992|P3|Overall Study|Incorrect Infusion Duration|0
200040|NCT02717754|625993|P2|Overall Study|Incorrect Infusion Duration|0
200041|NCT02717754|625994|P1|Overall Study|Incorrect Infusion Duration|0
200042|NCT02716779|626025|P3|Combination Therapy|Adverse Event|1
200043|NCT02716779|626026|P2|Combination Therapy|Adverse Event|2
200044|NCT02716779|626027|P1|Combination Therapy|Adverse Event|0
200045|NCT02716779|626025|P3|Monotherapy|Adverse Event|1
200046|NCT02716779|626026|P2|Monotherapy|Adverse Event|1
200047|NCT02716779|626027|P1|Monotherapy|Adverse Event|0
200048|NCT02716298|626071|P2|First Intervention (1 Month)|Lens discomfort|1
200049|NCT02716298|626072|P1|First Intervention (1 Month)|Lens discomfort|1
200050|NCT02713594|626089|P2|Overall Study|Lost to Follow-up|374
200051|NCT02713594|626090|P1|Overall Study|Lost to Follow-up|358
200052|NCT02713594|626089|P2|Overall Study|Withdrawal by Subject|22
200053|NCT02713594|626090|P1|Overall Study|Withdrawal by Subject|32
200054|NCT02709577|626121|P4|Overall Study|Withdrawal by Subject|0
200055|NCT02709577|626122|P3|Overall Study|Withdrawal by Subject|2
200056|NCT02709577|626123|P2|Overall Study|Withdrawal by Subject|3
200057|NCT02709577|626124|P1|Overall Study|Withdrawal by Subject|2
200058|NCT02709577|626121|P4|Overall Study|procedural complication|0
200059|NCT02709577|626122|P3|Overall Study|procedural complication|0
200060|NCT02709577|626123|P2|Overall Study|procedural complication|1
200061|NCT02709577|626124|P1|Overall Study|procedural complication|0
200062|NCT02709577|626121|P4|Overall Study|non-accommodating anatomy|0
200063|NCT02709577|626122|P3|Overall Study|non-accommodating anatomy|0
200064|NCT02709577|626123|P2|Overall Study|non-accommodating anatomy|1
200065|NCT02709577|626124|P1|Overall Study|non-accommodating anatomy|0
200066|NCT02708524|626140|P4|Overall Study|Subject lost study lens|0
200067|NCT02708524|626141|P3|Overall Study|Subject lost study lens|0
200068|NCT02708524|626142|P2|Overall Study|Subject lost study lens|0
200069|NCT02708524|626143|P1|Overall Study|Subject lost study lens|1
200070|NCT02708524|626140|P4|Overall Study|Did not wear lens at final visit|0
200071|NCT02708524|626141|P3|Overall Study|Did not wear lens at final visit|0
200072|NCT02708524|626142|P2|Overall Study|Did not wear lens at final visit|1
200073|NCT02708524|626143|P1|Overall Study|Did not wear lens at final visit|0
200074|NCT02708524|626140|P4|Overall Study|Dispensed incorrect study lens|0
200075|NCT02708524|626141|P3|Overall Study|Dispensed incorrect study lens|1
200076|NCT02708524|626142|P2|Overall Study|Dispensed incorrect study lens|1
200077|NCT02708524|626143|P1|Overall Study|Dispensed incorrect study lens|0
200078|NCT02708524|626140|P4|Overall Study|Withdrawal by Subject|0
200079|NCT02708524|626141|P3|Overall Study|Withdrawal by Subject|0
200080|NCT02708524|626142|P2|Overall Study|Withdrawal by Subject|1
200081|NCT02708524|626143|P1|Overall Study|Withdrawal by Subject|1
200082|NCT02708524|626140|P4|Overall Study|Protocol Violation|0
200083|NCT02708524|626141|P3|Overall Study|Protocol Violation|0
200084|NCT02708524|626142|P2|Overall Study|Protocol Violation|1
200085|NCT02708524|626143|P1|Overall Study|Protocol Violation|0
200086|NCT02708524|626140|P4|Overall Study|Lost to Follow-up|0
200087|NCT02708524|626141|P3|Overall Study|Lost to Follow-up|1
200088|NCT02708524|626142|P2|Overall Study|Lost to Follow-up|1
200089|NCT02708524|626143|P1|Overall Study|Lost to Follow-up|1
200090|NCT02708524|626140|P4|Overall Study|Lens Discomfort|0
200091|NCT02708524|626141|P3|Overall Study|Lens Discomfort|1
200092|NCT02708524|626142|P2|Overall Study|Lens Discomfort|0
200093|NCT02708524|626143|P1|Overall Study|Lens Discomfort|1
200094|NCT02708524|626140|P4|Overall Study|Adverse Event|0
200095|NCT02708524|626141|P3|Overall Study|Adverse Event|0
200096|NCT02708524|626142|P2|Overall Study|Adverse Event|1
200097|NCT02708524|626143|P1|Overall Study|Adverse Event|0
200098|NCT02708355|626192|P3|Overall Study|Adverse Event|0
200099|NCT02708355|626193|P2|Overall Study|Adverse Event|0
200100|NCT02708355|626194|P1|Overall Study|Adverse Event|1
200101|NCT02708277|626207|P2|Overall Study|Lost to Follow-up|4
200102|NCT02708277|626208|P1|Overall Study|Lost to Follow-up|7
200103|NCT02707640|626251|P2|Overall Study|Sponsor Discretion|0
200104|NCT02707640|626252|P1|Overall Study|Sponsor Discretion|1
200105|NCT02707640|626251|P2|Overall Study|Participant's Personal Decision|2
200106|NCT02707640|626252|P1|Overall Study|Participant's Personal Decision|1
200107|NCT02707640|626251|P2|Overall Study|Withdrawal by Subject|1
200108|NCT02707640|626252|P1|Overall Study|Withdrawal by Subject|0
200109|NCT02707640|626251|P2|Overall Study|Physician Decision|0
200110|NCT02707640|626252|P1|Overall Study|Physician Decision|2
200111|NCT02707640|626251|P2|Overall Study|Death|2
200112|NCT02707640|626252|P1|Overall Study|Death|1
200113|NCT02707640|626251|P2|Overall Study|Adverse Event|2
200114|NCT02707640|626252|P1|Overall Study|Adverse Event|4
200115|NCT02705716|626307|P2|Overall Study|Withdrawal of Consent|1
200116|NCT02705716|626308|P1|Overall Study|Withdrawal of Consent|1
200117|NCT02705716|626307|P2|Overall Study|Protocol Violation|0
200118|NCT02705716|626308|P1|Overall Study|Protocol Violation|3
200119|NCT02705716|626307|P2|Overall Study|Adverse Event|1
200120|NCT02705716|626308|P1|Overall Study|Adverse Event|0
200121|NCT02701296|626334|P2|Overall Study|Incomplete Data|2
200122|NCT02701296|626335|P1|Overall Study|Incomplete Data|0
200123|NCT02699892|626368|P1|Overall Study|Unspecified|36
200124|NCT02699593|626373|P2|Period 2|Torn Contact Lens|0
200125|NCT02699593|626374|P1|Period 2|Torn Contact Lens|1
200126|NCT02699593|626373|P2|Period 2|Lost Contact Lens|1
200127|NCT02699593|626374|P1|Period 2|Lost Contact Lens|0
200128|NCT02699593|626373|P2|Period 2|Adverse Event|1
200129|NCT02699593|626374|P1|Period 2|Adverse Event|1
200130|NCT02699593|626373|P2|Period 1|Adverse Event|1
200131|NCT02699593|626374|P1|Period 1|Adverse Event|1
200132|NCT02699593|626373|P2|Period 1|Withdrawal by Subject|1
200133|NCT02699593|626374|P1|Period 1|Withdrawal by Subject|0
200134|NCT02699593|626373|P2|Period 1|Protocol Violation|1
200135|NCT02699593|626374|P1|Period 1|Protocol Violation|0
200136|NCT02699593|626373|P2|Period 1|Torn Contact Len|3
200137|NCT02699593|626374|P1|Period 1|Torn Contact Len|4
200138|NCT02699593|626373|P2|Period 1|Unsatisfactory Visual Response|1
200139|NCT02699593|626374|P1|Period 1|Unsatisfactory Visual Response|0
200140|NCT02694718|626397|P1|Overall Study|Withdrawal by Subject|1
200141|NCT02694718|626397|P1|Overall Study|Death|1
200142|NCT02694536|626407|P1|Overall Study|Not Specified|22
200143|NCT02694536|626407|P1|Overall Study|Death|8
200144|NCT02694536|626407|P1|Overall Study|Withdrawal by Subject|8
200145|NCT02694536|626407|P1|Overall Study|Study Drug-Related Adverse Event|1
200146|NCT02694536|626407|P1|Overall Study|Lost to Follow-up|1
200147|NCT02694536|626407|P1|Overall Study|Progressive Disease|40
200148|NCT02691507|626453|P2|Overall Study|Missed Visit 3|1
200149|NCT02691507|626454|P1|Overall Study|Missed Visit 3|0
200150|NCT02678676|626784|P2|Overall Study|Unconfirmed for lost to follow-up|67
200151|NCT02678676|626785|P1|Overall Study|Unconfirmed for lost to follow-up|85
200152|NCT02678676|626784|P2|Overall Study|Lost to Follow-up|151
200153|NCT02678676|626785|P1|Overall Study|Lost to Follow-up|171
200154|NCT02678676|626784|P2|Overall Study|Withdrawal by Subject|5
200155|NCT02678676|626785|P1|Overall Study|Withdrawal by Subject|13
200156|NCT02678676|626784|P2|Overall Study|Death|649
200157|NCT02678676|626785|P1|Overall Study|Death|619
200158|NCT02670473|626868|P1|Overall Study|Withdrawal by Subject|1
200159|NCT02669095|626923|P2|Overall Study|Visit 5 assessments not completed|1
200160|NCT02669095|626924|P1|Overall Study|Visit 5 assessments not completed|0
200161|NCT02669095|626923|P2|Overall Study|Torn Lens|1
200162|NCT02669095|626924|P1|Overall Study|Torn Lens|0
200163|NCT02669095|626923|P2|Overall Study|Unsatisfactory Lens Fitting|1
200164|NCT02669095|626924|P1|Overall Study|Unsatisfactory Lens Fitting|0
200165|NCT02669095|626923|P2|Overall Study|Adverse Event|0
200166|NCT02669095|626924|P1|Overall Study|Adverse Event|1
200167|NCT02669043|626932|P1|Overall Study|Didn't meet I/E criteria|4
200168|NCT02666222|626964|P1|Overall Study|Death|2
200169|NCT02663453|627032|P2|Overall Study|Withdrawal by Subject|0
200170|NCT02663453|627033|P1|Overall Study|Withdrawal by Subject|1
200171|NCT02663453|627032|P2|Overall Study|Death|4
200172|NCT02663453|627033|P1|Overall Study|Death|4
200173|NCT02662556|627080|P1|Overall Study|Lack of Efficacy|4
200174|NCT02662556|627080|P1|Overall Study|Adverse Event|4
200175|NCT02651467|627178|P3|Overall Study|Other (Not specified)|2
200176|NCT02651467|627179|P2|Overall Study|Other (Not specified)|0
200177|NCT02651467|627180|P1|Overall Study|Other (Not specified)|1
200178|NCT02651467|627178|P3|Overall Study|Withdrawal by Subject|2
200179|NCT02651467|627179|P2|Overall Study|Withdrawal by Subject|0
200180|NCT02651467|627180|P1|Overall Study|Withdrawal by Subject|0
200181|NCT02649634|627214|P2|Overall Study|Lost to Follow-up|1
200182|NCT02649634|627215|P1|Overall Study|Lost to Follow-up|0
200183|NCT02649634|627214|P2|Overall Study|Withdrawal by Subject|5
200184|NCT02649634|627215|P1|Overall Study|Withdrawal by Subject|3
200185|NCT02648438|627274|P3|Overall Study|Withdrawal by Subject|0
200186|NCT02648438|627275|P2|Overall Study|Withdrawal by Subject|1
200187|NCT02648438|627276|P1|Overall Study|Withdrawal by Subject|1
200188|NCT02648438|627274|P3|Overall Study|Protocol Violation|0
200189|NCT02648438|627275|P2|Overall Study|Protocol Violation|0
200190|NCT02648438|627276|P1|Overall Study|Protocol Violation|2
200191|NCT02648438|627274|P3|Overall Study|Eligibility criteria not fulfilled|0
200192|NCT02648438|627275|P2|Overall Study|Eligibility criteria not fulfilled|2
200193|NCT02648438|627276|P1|Overall Study|Eligibility criteria not fulfilled|0
200194|NCT02644356|627377|P1|Overall Study|Withdrawal by Subject|2
200195|NCT02644109|627389|P2|Overall Study|Adverse Event|4
200196|NCT02644109|627390|P1|Overall Study|Adverse Event|0
200197|NCT02644096|627398|P2|Overall Study|Withdrawal by Subject|25
200198|NCT02644096|627399|P1|Overall Study|Withdrawal by Subject|28
200199|NCT02641379|627554|P11|Overall Study|PCR positive|0
200200|NCT02641379|627555|P10|Overall Study|PCR positive|0
200201|NCT02641379|627556|P9|Overall Study|PCR positive|0
200202|NCT02641379|627557|P8|Overall Study|PCR positive|0
200203|NCT02641379|627558|P7|Overall Study|PCR positive|1
200204|NCT02641379|627559|P6|Overall Study|PCR positive|0
200205|NCT02641379|627560|P5|Overall Study|PCR positive|0
200206|NCT02641379|627561|P4|Overall Study|PCR positive|0
200207|NCT02641379|627562|P3|Overall Study|PCR positive|0
200208|NCT02641379|627563|P2|Overall Study|PCR positive|0
200209|NCT02641379|627564|P1|Overall Study|PCR positive|0
200210|NCT02641379|627554|P11|Overall Study|Missing PCR result at Week 8|0
200211|NCT02641379|627555|P10|Overall Study|Missing PCR result at Week 8|1
200212|NCT02641379|627556|P9|Overall Study|Missing PCR result at Week 8|0
200213|NCT02641379|627557|P8|Overall Study|Missing PCR result at Week 8|0
200214|NCT02641379|627558|P7|Overall Study|Missing PCR result at Week 8|0
200215|NCT02641379|627559|P6|Overall Study|Missing PCR result at Week 8|0
200216|NCT02641379|627560|P5|Overall Study|Missing PCR result at Week 8|0
200217|NCT02641379|627561|P4|Overall Study|Missing PCR result at Week 8|0
200218|NCT02641379|627562|P3|Overall Study|Missing PCR result at Week 8|0
200219|NCT02641379|627563|P2|Overall Study|Missing PCR result at Week 8|0
200220|NCT02641379|627564|P1|Overall Study|Missing PCR result at Week 8|0
200221|NCT02641379|627554|P11|Overall Study|Participant treated after Week 24|0
200222|NCT02641379|627555|P10|Overall Study|Participant treated after Week 24|0
200223|NCT02641379|627556|P9|Overall Study|Participant treated after Week 24|1
200224|NCT02641379|627557|P8|Overall Study|Participant treated after Week 24|0
200225|NCT02641379|627558|P7|Overall Study|Participant treated after Week 24|0
200226|NCT02641379|627559|P6|Overall Study|Participant treated after Week 24|0
200227|NCT02641379|627560|P5|Overall Study|Participant treated after Week 24|0
200228|NCT02641379|627561|P4|Overall Study|Participant treated after Week 24|0
200229|NCT02641379|627562|P3|Overall Study|Participant treated after Week 24|0
200230|NCT02641379|627563|P2|Overall Study|Participant treated after Week 24|0
200231|NCT02641379|627564|P1|Overall Study|Participant treated after Week 24|0
200232|NCT02641379|627554|P11|Overall Study|Participant’s PCR high|0
200233|NCT02641379|627555|P10|Overall Study|Participant’s PCR high|0
200234|NCT02641379|627556|P9|Overall Study|Participant’s PCR high|0
200235|NCT02641379|627557|P8|Overall Study|Participant’s PCR high|1
200236|NCT02641379|627558|P7|Overall Study|Participant’s PCR high|0
200237|NCT02641379|627559|P6|Overall Study|Participant’s PCR high|0
200238|NCT02641379|627560|P5|Overall Study|Participant’s PCR high|0
200239|NCT02641379|627561|P4|Overall Study|Participant’s PCR high|0
200240|NCT02641379|627562|P3|Overall Study|Participant’s PCR high|0
200241|NCT02641379|627563|P2|Overall Study|Participant’s PCR high|0
200242|NCT02641379|627564|P1|Overall Study|Participant’s PCR high|0
200243|NCT02641379|627554|P11|Overall Study|Negative PCR result|0
200244|NCT02641379|627555|P10|Overall Study|Negative PCR result|1
200245|NCT02641379|627556|P9|Overall Study|Negative PCR result|0
200246|NCT02641379|627557|P8|Overall Study|Negative PCR result|0
200247|NCT02641379|627558|P7|Overall Study|Negative PCR result|0
200248|NCT02641379|627559|P6|Overall Study|Negative PCR result|0
200249|NCT02641379|627560|P5|Overall Study|Negative PCR result|0
200250|NCT02641379|627561|P4|Overall Study|Negative PCR result|0
200251|NCT02641379|627562|P3|Overall Study|Negative PCR result|0
200252|NCT02641379|627563|P2|Overall Study|Negative PCR result|0
200253|NCT02641379|627564|P1|Overall Study|Negative PCR result|0
200254|NCT02641379|627554|P11|Overall Study|No 2 Log drop at Week 12|1
200255|NCT02641379|627555|P10|Overall Study|No 2 Log drop at Week 12|0
200256|NCT02641379|627556|P9|Overall Study|No 2 Log drop at Week 12|0
200257|NCT02641379|627557|P8|Overall Study|No 2 Log drop at Week 12|0
200258|NCT02641379|627558|P7|Overall Study|No 2 Log drop at Week 12|0
200259|NCT02641379|627559|P6|Overall Study|No 2 Log drop at Week 12|0
200260|NCT02641379|627560|P5|Overall Study|No 2 Log drop at Week 12|0
200261|NCT02641379|627561|P4|Overall Study|No 2 Log drop at Week 12|0
200262|NCT02641379|627562|P3|Overall Study|No 2 Log drop at Week 12|0
200263|NCT02641379|627563|P2|Overall Study|No 2 Log drop at Week 12|0
200264|NCT02641379|627564|P1|Overall Study|No 2 Log drop at Week 12|0
200265|NCT02641379|627554|P11|Overall Study|Non-response Week 12|0
200266|NCT02641379|627555|P10|Overall Study|Non-response Week 12|0
200267|NCT02641379|627556|P9|Overall Study|Non-response Week 12|0
200268|NCT02641379|627557|P8|Overall Study|Non-response Week 12|1
200269|NCT02641379|627558|P7|Overall Study|Non-response Week 12|0
200270|NCT02641379|627559|P6|Overall Study|Non-response Week 12|0
200271|NCT02641379|627560|P5|Overall Study|Non-response Week 12|0
200272|NCT02641379|627561|P4|Overall Study|Non-response Week 12|0
200273|NCT02641379|627562|P3|Overall Study|Non-response Week 12|0
200274|NCT02641379|627563|P2|Overall Study|Non-response Week 12|0
200275|NCT02641379|627564|P1|Overall Study|Non-response Week 12|0
200276|NCT02641379|627554|P11|Overall Study|Participant showed weight reduction|0
200277|NCT02641379|627555|P10|Overall Study|Participant showed weight reduction|0
200278|NCT02641379|627556|P9|Overall Study|Participant showed weight reduction|0
200279|NCT02641379|627557|P8|Overall Study|Participant showed weight reduction|1
200280|NCT02641379|627558|P7|Overall Study|Participant showed weight reduction|0
200281|NCT02641379|627559|P6|Overall Study|Participant showed weight reduction|0
200282|NCT02641379|627560|P5|Overall Study|Participant showed weight reduction|0
200283|NCT02641379|627561|P4|Overall Study|Participant showed weight reduction|0
200284|NCT02641379|627562|P3|Overall Study|Participant showed weight reduction|0
200285|NCT02641379|627563|P2|Overall Study|Participant showed weight reduction|0
200286|NCT02641379|627564|P1|Overall Study|Participant showed weight reduction|0
200287|NCT02641379|627554|P11|Overall Study|Source data not found|0
200288|NCT02641379|627555|P10|Overall Study|Source data not found|0
200289|NCT02641379|627556|P9|Overall Study|Source data not found|0
200290|NCT02641379|627557|P8|Overall Study|Source data not found|0
200291|NCT02641379|627558|P7|Overall Study|Source data not found|0
200292|NCT02641379|627559|P6|Overall Study|Source data not found|1
200293|NCT02641379|627560|P5|Overall Study|Source data not found|0
200294|NCT02641379|627561|P4|Overall Study|Source data not found|0
200295|NCT02641379|627562|P3|Overall Study|Source data not found|0
200296|NCT02641379|627563|P2|Overall Study|Source data not found|0
200297|NCT02641379|627564|P1|Overall Study|Source data not found|0
200298|NCT02641379|627554|P11|Overall Study|Lost to Follow-up|0
200299|NCT02641379|627555|P10|Overall Study|Lost to Follow-up|0
200300|NCT02641379|627556|P9|Overall Study|Lost to Follow-up|1
200301|NCT02641379|627557|P8|Overall Study|Lost to Follow-up|0
200302|NCT02641379|627558|P7|Overall Study|Lost to Follow-up|0
200303|NCT02641379|627559|P6|Overall Study|Lost to Follow-up|0
200304|NCT02641379|627560|P5|Overall Study|Lost to Follow-up|0
200305|NCT02641379|627561|P4|Overall Study|Lost to Follow-up|0
200306|NCT02641379|627562|P3|Overall Study|Lost to Follow-up|0
200307|NCT02641379|627563|P2|Overall Study|Lost to Follow-up|0
200308|NCT02641379|627564|P1|Overall Study|Lost to Follow-up|0
200309|NCT02641379|627554|P11|Overall Study|Participation in sili rescue study|0
200310|NCT02641379|627555|P10|Overall Study|Participation in sili rescue study|0
200311|NCT02641379|627556|P9|Overall Study|Participation in sili rescue study|0
200312|NCT02641379|627557|P8|Overall Study|Participation in sili rescue study|0
200313|NCT02641379|627558|P7|Overall Study|Participation in sili rescue study|0
200314|NCT02641379|627559|P6|Overall Study|Participation in sili rescue study|1
200315|NCT02641379|627560|P5|Overall Study|Participation in sili rescue study|0
200316|NCT02641379|627561|P4|Overall Study|Participation in sili rescue study|0
200317|NCT02641379|627562|P3|Overall Study|Participation in sili rescue study|0
200318|NCT02641379|627563|P2|Overall Study|Participation in sili rescue study|0
200319|NCT02641379|627564|P1|Overall Study|Participation in sili rescue study|0
200320|NCT02641379|627554|P11|Overall Study|Protocol Violation|0
200321|NCT02641379|627555|P10|Overall Study|Protocol Violation|0
200322|NCT02641379|627556|P9|Overall Study|Protocol Violation|1
200323|NCT02641379|627557|P8|Overall Study|Protocol Violation|0
200324|NCT02641379|627558|P7|Overall Study|Protocol Violation|0
200325|NCT02641379|627559|P6|Overall Study|Protocol Violation|0
200326|NCT02641379|627560|P5|Overall Study|Protocol Violation|2
200327|NCT02641379|627561|P4|Overall Study|Protocol Violation|0
200328|NCT02641379|627562|P3|Overall Study|Protocol Violation|0
200329|NCT02641379|627563|P2|Overall Study|Protocol Violation|0
200330|NCT02641379|627564|P1|Overall Study|Protocol Violation|0
200331|NCT02641379|627554|P11|Overall Study|Blood could not be drawn|0
200332|NCT02641379|627555|P10|Overall Study|Blood could not be drawn|0
200333|NCT02641379|627556|P9|Overall Study|Blood could not be drawn|0
200334|NCT02641379|627557|P8|Overall Study|Blood could not be drawn|0
200335|NCT02641379|627558|P7|Overall Study|Blood could not be drawn|0
200336|NCT02641379|627559|P6|Overall Study|Blood could not be drawn|0
200337|NCT02641379|627560|P5|Overall Study|Blood could not be drawn|1
200338|NCT02641379|627561|P4|Overall Study|Blood could not be drawn|0
200339|NCT02641379|627562|P3|Overall Study|Blood could not be drawn|0
200340|NCT02641379|627563|P2|Overall Study|Blood could not be drawn|0
200341|NCT02641379|627564|P1|Overall Study|Blood could not be drawn|0
200342|NCT02641379|627554|P11|Overall Study|Baseline viral load unavailable|0
200343|NCT02641379|627555|P10|Overall Study|Baseline viral load unavailable|0
200344|NCT02641379|627556|P9|Overall Study|Baseline viral load unavailable|0
200345|NCT02641379|627557|P8|Overall Study|Baseline viral load unavailable|0
200346|NCT02641379|627558|P7|Overall Study|Baseline viral load unavailable|0
200347|NCT02641379|627559|P6|Overall Study|Baseline viral load unavailable|0
200348|NCT02641379|627560|P5|Overall Study|Baseline viral load unavailable|0
200349|NCT02641379|627561|P4|Overall Study|Baseline viral load unavailable|1
200350|NCT02641379|627562|P3|Overall Study|Baseline viral load unavailable|0
200351|NCT02641379|627563|P2|Overall Study|Baseline viral load unavailable|0
200352|NCT02641379|627564|P1|Overall Study|Baseline viral load unavailable|0
200353|NCT02641379|627554|P11|Overall Study|Inclusion criteria not fulfilled|0
200354|NCT02641379|627555|P10|Overall Study|Inclusion criteria not fulfilled|0
200355|NCT02641379|627556|P9|Overall Study|Inclusion criteria not fulfilled|0
200356|NCT02641379|627557|P8|Overall Study|Inclusion criteria not fulfilled|0
200357|NCT02641379|627558|P7|Overall Study|Inclusion criteria not fulfilled|0
200358|NCT02641379|627559|P6|Overall Study|Inclusion criteria not fulfilled|0
200359|NCT02641379|627560|P5|Overall Study|Inclusion criteria not fulfilled|0
200360|NCT02641379|627561|P4|Overall Study|Inclusion criteria not fulfilled|1
200361|NCT02641379|627562|P3|Overall Study|Inclusion criteria not fulfilled|0
200362|NCT02641379|627563|P2|Overall Study|Inclusion criteria not fulfilled|0
200363|NCT02641379|627564|P1|Overall Study|Inclusion criteria not fulfilled|0
200364|NCT02641379|627554|P11|Overall Study|PCR sample for Week 4 not drawn|0
200365|NCT02641379|627555|P10|Overall Study|PCR sample for Week 4 not drawn|0
200366|NCT02641379|627556|P9|Overall Study|PCR sample for Week 4 not drawn|0
200367|NCT02641379|627557|P8|Overall Study|PCR sample for Week 4 not drawn|0
200368|NCT02641379|627558|P7|Overall Study|PCR sample for Week 4 not drawn|0
200369|NCT02641379|627559|P6|Overall Study|PCR sample for Week 4 not drawn|0
200370|NCT02641379|627560|P5|Overall Study|PCR sample for Week 4 not drawn|0
200371|NCT02641379|627561|P4|Overall Study|PCR sample for Week 4 not drawn|1
200372|NCT02641379|627562|P3|Overall Study|PCR sample for Week 4 not drawn|0
200373|NCT02641379|627563|P2|Overall Study|PCR sample for Week 4 not drawn|0
200374|NCT02641379|627564|P1|Overall Study|PCR sample for Week 4 not drawn|0
200375|NCT02641379|627554|P11|Overall Study|PCR positive at Week 28|0
200376|NCT02641379|627555|P10|Overall Study|PCR positive at Week 28|0
200377|NCT02641379|627556|P9|Overall Study|PCR positive at Week 28|0
200378|NCT02641379|627557|P8|Overall Study|PCR positive at Week 28|0
200379|NCT02641379|627558|P7|Overall Study|PCR positive at Week 28|0
200380|NCT02641379|627559|P6|Overall Study|PCR positive at Week 28|0
200381|NCT02641379|627560|P5|Overall Study|PCR positive at Week 28|0
200382|NCT02641379|627561|P4|Overall Study|PCR positive at Week 28|0
200383|NCT02641379|627562|P3|Overall Study|PCR positive at Week 28|1
200384|NCT02641379|627563|P2|Overall Study|PCR positive at Week 28|0
200385|NCT02641379|627564|P1|Overall Study|PCR positive at Week 28|0
200386|NCT02641379|627554|P11|Overall Study|No PCR at baseline|0
200387|NCT02641379|627555|P10|Overall Study|No PCR at baseline|0
200388|NCT02641379|627556|P9|Overall Study|No PCR at baseline|0
200389|NCT02641379|627557|P8|Overall Study|No PCR at baseline|0
200390|NCT02641379|627558|P7|Overall Study|No PCR at baseline|0
200391|NCT02641379|627559|P6|Overall Study|No PCR at baseline|0
200392|NCT02641379|627560|P5|Overall Study|No PCR at baseline|0
200393|NCT02641379|627561|P4|Overall Study|No PCR at baseline|0
200394|NCT02641379|627562|P3|Overall Study|No PCR at baseline|1
200395|NCT02641379|627563|P2|Overall Study|No PCR at baseline|0
200396|NCT02641379|627564|P1|Overall Study|No PCR at baseline|0
200397|NCT02641379|627554|P11|Overall Study|PCR not performed at Week 12|0
200398|NCT02641379|627555|P10|Overall Study|PCR not performed at Week 12|0
200399|NCT02641379|627556|P9|Overall Study|PCR not performed at Week 12|0
200400|NCT02641379|627557|P8|Overall Study|PCR not performed at Week 12|0
200401|NCT02641379|627558|P7|Overall Study|PCR not performed at Week 12|0
200402|NCT02641379|627559|P6|Overall Study|PCR not performed at Week 12|0
200403|NCT02641379|627560|P5|Overall Study|PCR not performed at Week 12|0
200404|NCT02641379|627561|P4|Overall Study|PCR not performed at Week 12|0
200405|NCT02641379|627562|P3|Overall Study|PCR not performed at Week 12|1
200406|NCT02641379|627563|P2|Overall Study|PCR not performed at Week 12|0
200407|NCT02641379|627564|P1|Overall Study|PCR not performed at Week 12|0
200408|NCT02641379|627554|P11|Overall Study|PCR positive at Week 48|0
200409|NCT02641379|627555|P10|Overall Study|PCR positive at Week 48|0
200410|NCT02641379|627556|P9|Overall Study|PCR positive at Week 48|0
200411|NCT02641379|627557|P8|Overall Study|PCR positive at Week 48|0
200412|NCT02641379|627558|P7|Overall Study|PCR positive at Week 48|0
200413|NCT02641379|627559|P6|Overall Study|PCR positive at Week 48|0
200414|NCT02641379|627560|P5|Overall Study|PCR positive at Week 48|0
200415|NCT02641379|627561|P4|Overall Study|PCR positive at Week 48|0
200416|NCT02641379|627562|P3|Overall Study|PCR positive at Week 48|0
200417|NCT02641379|627563|P2|Overall Study|PCR positive at Week 48|1
200418|NCT02641379|627564|P1|Overall Study|PCR positive at Week 48|0
200419|NCT02641379|627554|P11|Overall Study|PCR positive at Week 68|0
200420|NCT02641379|627555|P10|Overall Study|PCR positive at Week 68|0
200421|NCT02641379|627556|P9|Overall Study|PCR positive at Week 68|0
200422|NCT02641379|627557|P8|Overall Study|PCR positive at Week 68|0
200423|NCT02641379|627558|P7|Overall Study|PCR positive at Week 68|0
200424|NCT02641379|627559|P6|Overall Study|PCR positive at Week 68|0
200425|NCT02641379|627560|P5|Overall Study|PCR positive at Week 68|0
200426|NCT02641379|627561|P4|Overall Study|PCR positive at Week 68|0
200427|NCT02641379|627562|P3|Overall Study|PCR positive at Week 68|0
200428|NCT02641379|627563|P2|Overall Study|PCR positive at Week 68|1
200429|NCT02641379|627564|P1|Overall Study|PCR positive at Week 68|0
200430|NCT02641379|627554|P11|Overall Study|Financial problems|0
200431|NCT02641379|627555|P10|Overall Study|Financial problems|0
200432|NCT02641379|627556|P9|Overall Study|Financial problems|0
200433|NCT02641379|627557|P8|Overall Study|Financial problems|0
200434|NCT02641379|627558|P7|Overall Study|Financial problems|0
200435|NCT02641379|627559|P6|Overall Study|Financial problems|0
200436|NCT02641379|627560|P5|Overall Study|Financial problems|0
200437|NCT02641379|627561|P4|Overall Study|Financial problems|0
200438|NCT02641379|627562|P3|Overall Study|Financial problems|0
200439|NCT02641379|627563|P2|Overall Study|Financial problems|1
200440|NCT02641379|627564|P1|Overall Study|Financial problems|0
200441|NCT02641379|627554|P11|Overall Study|Therapy stopped due to misunderstanding|0
200442|NCT02641379|627555|P10|Overall Study|Therapy stopped due to misunderstanding|0
200443|NCT02641379|627556|P9|Overall Study|Therapy stopped due to misunderstanding|0
200444|NCT02641379|627557|P8|Overall Study|Therapy stopped due to misunderstanding|0
200445|NCT02641379|627558|P7|Overall Study|Therapy stopped due to misunderstanding|0
200446|NCT02641379|627559|P6|Overall Study|Therapy stopped due to misunderstanding|0
200447|NCT02641379|627560|P5|Overall Study|Therapy stopped due to misunderstanding|0
200448|NCT02641379|627561|P4|Overall Study|Therapy stopped due to misunderstanding|0
200449|NCT02641379|627562|P3|Overall Study|Therapy stopped due to misunderstanding|0
200450|NCT02641379|627563|P2|Overall Study|Therapy stopped due to misunderstanding|0
200451|NCT02641379|627564|P1|Overall Study|Therapy stopped due to misunderstanding|1
200452|NCT02641379|627554|P11|Overall Study|Participant stopped study/treatment|0
200453|NCT02641379|627555|P10|Overall Study|Participant stopped study/treatment|0
200454|NCT02641379|627556|P9|Overall Study|Participant stopped study/treatment|1
200455|NCT02641379|627557|P8|Overall Study|Participant stopped study/treatment|0
200456|NCT02641379|627558|P7|Overall Study|Participant stopped study/treatment|2
200457|NCT02641379|627559|P6|Overall Study|Participant stopped study/treatment|1
200458|NCT02641379|627560|P5|Overall Study|Participant stopped study/treatment|0
200459|NCT02641379|627561|P4|Overall Study|Participant stopped study/treatment|0
200460|NCT02641379|627562|P3|Overall Study|Participant stopped study/treatment|1
200461|NCT02641379|627563|P2|Overall Study|Participant stopped study/treatment|3
200462|NCT02641379|627564|P1|Overall Study|Participant stopped study/treatment|1
200463|NCT02641379|627554|P11|Overall Study|Participant showed relapse|0
200464|NCT02641379|627555|P10|Overall Study|Participant showed relapse|0
200465|NCT02641379|627556|P9|Overall Study|Participant showed relapse|0
200466|NCT02641379|627557|P8|Overall Study|Participant showed relapse|0
200467|NCT02641379|627558|P7|Overall Study|Participant showed relapse|1
200468|NCT02641379|627559|P6|Overall Study|Participant showed relapse|0
200469|NCT02641379|627560|P5|Overall Study|Participant showed relapse|0
200470|NCT02641379|627561|P4|Overall Study|Participant showed relapse|0
200471|NCT02641379|627562|P3|Overall Study|Participant showed relapse|0
200472|NCT02641379|627563|P2|Overall Study|Participant showed relapse|0
200473|NCT02641379|627564|P1|Overall Study|Participant showed relapse|1
200474|NCT02641379|627554|P11|Overall Study|PCR positive at follow up 2|0
200475|NCT02641379|627555|P10|Overall Study|PCR positive at follow up 2|0
200476|NCT02641379|627556|P9|Overall Study|PCR positive at follow up 2|0
200477|NCT02641379|627557|P8|Overall Study|PCR positive at follow up 2|0
200478|NCT02641379|627558|P7|Overall Study|PCR positive at follow up 2|0
200479|NCT02641379|627559|P6|Overall Study|PCR positive at follow up 2|0
200480|NCT02641379|627560|P5|Overall Study|PCR positive at follow up 2|0
200481|NCT02641379|627561|P4|Overall Study|PCR positive at follow up 2|0
200482|NCT02641379|627562|P3|Overall Study|PCR positive at follow up 2|0
200483|NCT02641379|627563|P2|Overall Study|PCR positive at follow up 2|0
200484|NCT02641379|627564|P1|Overall Study|PCR positive at follow up 2|1
200485|NCT02641379|627554|P11|Overall Study|PCR positive at Week 24|0
200486|NCT02641379|627555|P10|Overall Study|PCR positive at Week 24|1
200487|NCT02641379|627556|P9|Overall Study|PCR positive at Week 24|0
200488|NCT02641379|627557|P8|Overall Study|PCR positive at Week 24|8
200489|NCT02641379|627558|P7|Overall Study|PCR positive at Week 24|3
200490|NCT02641379|627559|P6|Overall Study|PCR positive at Week 24|6
200491|NCT02641379|627560|P5|Overall Study|PCR positive at Week 24|0
200492|NCT02641379|627561|P4|Overall Study|PCR positive at Week 24|0
200493|NCT02641379|627562|P3|Overall Study|PCR positive at Week 24|62
200494|NCT02641379|627563|P2|Overall Study|PCR positive at Week 24|21
200495|NCT02641379|627564|P1|Overall Study|PCR positive at Week 24|15
200496|NCT02641379|627554|P11|Overall Study|Participant cannot be reached|1
200497|NCT02641379|627555|P10|Overall Study|Participant cannot be reached|2
200498|NCT02641379|627556|P9|Overall Study|Participant cannot be reached|0
200499|NCT02641379|627557|P8|Overall Study|Participant cannot be reached|1
200500|NCT02641379|627558|P7|Overall Study|Participant cannot be reached|0
200501|NCT02641379|627559|P6|Overall Study|Participant cannot be reached|1
200502|NCT02641379|627560|P5|Overall Study|Participant cannot be reached|2
200503|NCT02641379|627561|P4|Overall Study|Participant cannot be reached|8
200504|NCT02641379|627562|P3|Overall Study|Participant cannot be reached|0
200505|NCT02641379|627563|P2|Overall Study|Participant cannot be reached|4
200506|NCT02641379|627564|P1|Overall Study|Participant cannot be reached|4
200507|NCT02641379|627554|P11|Overall Study|Participant’s compliance|1
200508|NCT02641379|627555|P10|Overall Study|Participant’s compliance|1
200509|NCT02641379|627556|P9|Overall Study|Participant’s compliance|1
200510|NCT02641379|627557|P8|Overall Study|Participant’s compliance|0
200511|NCT02641379|627558|P7|Overall Study|Participant’s compliance|0
200512|NCT02641379|627559|P6|Overall Study|Participant’s compliance|2
200513|NCT02641379|627560|P5|Overall Study|Participant’s compliance|0
200514|NCT02641379|627561|P4|Overall Study|Participant’s compliance|1
200515|NCT02641379|627562|P3|Overall Study|Participant’s compliance|0
200516|NCT02641379|627563|P2|Overall Study|Participant’s compliance|1
200517|NCT02641379|627564|P1|Overall Study|Participant’s compliance|0
200518|NCT02641379|627554|P11|Overall Study|Participant unable to attend study visit|0
200519|NCT02641379|627555|P10|Overall Study|Participant unable to attend study visit|2
200520|NCT02641379|627556|P9|Overall Study|Participant unable to attend study visit|0
200521|NCT02641379|627557|P8|Overall Study|Participant unable to attend study visit|1
200522|NCT02641379|627558|P7|Overall Study|Participant unable to attend study visit|1
200523|NCT02641379|627559|P6|Overall Study|Participant unable to attend study visit|1
200524|NCT02641379|627560|P5|Overall Study|Participant unable to attend study visit|5
200525|NCT02641379|627561|P4|Overall Study|Participant unable to attend study visit|2
200526|NCT02641379|627562|P3|Overall Study|Participant unable to attend study visit|1
200527|NCT02641379|627563|P2|Overall Study|Participant unable to attend study visit|10
200528|NCT02641379|627564|P1|Overall Study|Participant unable to attend study visit|4
200529|NCT02641379|627554|P11|Overall Study|Lack of Efficacy|0
200530|NCT02641379|627555|P10|Overall Study|Lack of Efficacy|0
200531|NCT02641379|627556|P9|Overall Study|Lack of Efficacy|0
200532|NCT02641379|627557|P8|Overall Study|Lack of Efficacy|5
200533|NCT02641379|627558|P7|Overall Study|Lack of Efficacy|0
200534|NCT02641379|627559|P6|Overall Study|Lack of Efficacy|2
200535|NCT02641379|627560|P5|Overall Study|Lack of Efficacy|0
200536|NCT02641379|627561|P4|Overall Study|Lack of Efficacy|0
200537|NCT02641379|627562|P3|Overall Study|Lack of Efficacy|2
200538|NCT02641379|627563|P2|Overall Study|Lack of Efficacy|0
200539|NCT02641379|627564|P1|Overall Study|Lack of Efficacy|0
200540|NCT02641379|627554|P11|Overall Study|Adverse Event|5
200541|NCT02641379|627555|P10|Overall Study|Adverse Event|1
200542|NCT02641379|627556|P9|Overall Study|Adverse Event|1
200543|NCT02641379|627557|P8|Overall Study|Adverse Event|0
200544|NCT02641379|627558|P7|Overall Study|Adverse Event|5
200545|NCT02641379|627559|P6|Overall Study|Adverse Event|1
200546|NCT02641379|627560|P5|Overall Study|Adverse Event|5
200547|NCT02641379|627561|P4|Overall Study|Adverse Event|2
200548|NCT02641379|627562|P3|Overall Study|Adverse Event|2
200549|NCT02641379|627563|P2|Overall Study|Adverse Event|8
200550|NCT02641379|627564|P1|Overall Study|Adverse Event|7
200551|NCT02641379|627554|P11|Overall Study|Withdrawal of informed consent|0
200552|NCT02641379|627555|P10|Overall Study|Withdrawal of informed consent|0
200553|NCT02641379|627556|P9|Overall Study|Withdrawal of informed consent|0
200554|NCT02641379|627557|P8|Overall Study|Withdrawal of informed consent|1
200555|NCT02641379|627558|P7|Overall Study|Withdrawal of informed consent|0
200556|NCT02641379|627559|P6|Overall Study|Withdrawal of informed consent|0
200557|NCT02641379|627560|P5|Overall Study|Withdrawal of informed consent|0
200558|NCT02641379|627561|P4|Overall Study|Withdrawal of informed consent|0
200559|NCT02641379|627562|P3|Overall Study|Withdrawal of informed consent|0
200560|NCT02641379|627563|P2|Overall Study|Withdrawal of informed consent|1
200561|NCT02641379|627564|P1|Overall Study|Withdrawal of informed consent|0
200562|NCT02641379|627554|P11|Overall Study|Exclusion criterion during screening|0
200563|NCT02641379|627555|P10|Overall Study|Exclusion criterion during screening|0
200564|NCT02641379|627556|P9|Overall Study|Exclusion criterion during screening|0
200565|NCT02641379|627557|P8|Overall Study|Exclusion criterion during screening|0
200566|NCT02641379|627558|P7|Overall Study|Exclusion criterion during screening|0
200567|NCT02641379|627559|P6|Overall Study|Exclusion criterion during screening|0
200568|NCT02641379|627560|P5|Overall Study|Exclusion criterion during screening|2
200569|NCT02641379|627561|P4|Overall Study|Exclusion criterion during screening|1
200570|NCT02641379|627562|P3|Overall Study|Exclusion criterion during screening|0
200571|NCT02641379|627563|P2|Overall Study|Exclusion criterion during screening|0
200572|NCT02641379|627564|P1|Overall Study|Exclusion criterion during screening|1
200573|NCT02639052|627638|P1|Overall Study|Lost to Follow-up|1
200574|NCT02638129|627654|P2|Overall Study|Study terminated|30
200575|NCT02638129|627655|P1|Overall Study|Study terminated|28
200576|NCT02637063|627683|P3|Overall Study|Withdrawal by Subject|3
200577|NCT02637063|627684|P2|Overall Study|Withdrawal by Subject|2
200578|NCT02637063|627685|P1|Overall Study|Withdrawal by Subject|2
200579|NCT02637063|627683|P3|Overall Study|Lost to Follow-up|3
200580|NCT02637063|627684|P2|Overall Study|Lost to Follow-up|2
200581|NCT02637063|627685|P1|Overall Study|Lost to Follow-up|3
200582|NCT02633787|627814|P1|Overall Study|Withdrawal by Subject|1
200583|NCT02630563|627841|P1|Overall Study|Administrative|1
200584|NCT02628938|627878|P3|Overall Study|Failure to comply with the instructions|3
200585|NCT02628938|627879|P2|Overall Study|Failure to comply with the instructions|0
200586|NCT02628938|627880|P1|Overall Study|Failure to comply with the instructions|3
200587|NCT02628938|627878|P3|Overall Study|Did not attend the follow up recall|1
200588|NCT02628938|627879|P2|Overall Study|Did not attend the follow up recall|2
200589|NCT02628938|627880|P1|Overall Study|Did not attend the follow up recall|2
200590|NCT02628418|627896|P2|Overall Study|Lost to Follow-up|2
200591|NCT02628418|627897|P1|Overall Study|Lost to Follow-up|1
200592|NCT02627144|627922|P1|Overall Study|Unspecified|17
200593|NCT02627144|627922|P1|Overall Study|Enrolled, not treated|6
200594|NCT02627144|627922|P1|Overall Study|Lost to Follow-up|8
200595|NCT02627144|627922|P1|Overall Study|Administrative reasons|65
200596|NCT02627144|627922|P1|Overall Study|Refusal of treatment / poor cooperation|38
200597|NCT02627144|627922|P1|Overall Study|Death from other cause|8
200598|NCT02627144|627922|P1|Overall Study|Death from cancer|20
200599|NCT02627144|627922|P1|Overall Study|Cancer progression|171
200600|NCT02627144|627922|P1|Overall Study|Serious adverse event|32
200601|NCT02625220|627943|P1|Overall Study|Study discontinued at site|2
200602|NCT02625220|627943|P1|Overall Study|Protocol Violation|1
200603|NCT02625220|627943|P1|Overall Study|Lost to Follow-up|2
200604|NCT02625220|627943|P1|Overall Study|Adverse Event|2
200605|NCT02624791|628043|P6|Overall Study|Withdrawal by Subject|0
200606|NCT02624791|628044|P5|Overall Study|Withdrawal by Subject|0
200607|NCT02624791|628045|P4|Overall Study|Withdrawal by Subject|0
200608|NCT02624791|628046|P3|Overall Study|Withdrawal by Subject|0
200609|NCT02624791|628047|P2|Overall Study|Withdrawal by Subject|0
200610|NCT02624791|628048|P1|Overall Study|Withdrawal by Subject|2
200611|NCT02621034|628056|P3|Overall Study|Lost to Follow-up|5
200612|NCT02621034|628057|P2|Overall Study|Lost to Follow-up|2
200613|NCT02621034|628058|P1|Overall Study|Lost to Follow-up|3
200614|NCT02619812|628075|P4|Overall Study|Withdrawal by Subject|2
200615|NCT02619812|628076|P3|Overall Study|Withdrawal by Subject|1
200616|NCT02619812|628077|P2|Overall Study|Withdrawal by Subject|0
200617|NCT02619812|628078|P1|Overall Study|Withdrawal by Subject|0
200618|NCT02613910|628318|P1|Overall Study|Termination of study|1
200619|NCT02612077|628367|P1|Overall Study|Unknown reason|2
200620|NCT02612077|628367|P1|Overall Study|Disease Progression|3
200621|NCT02612077|628367|P1|Overall Study|Enrollment in a Clinical Trial|1
200622|NCT02612077|628367|P1|Overall Study|Moved or Changed Medical Team|23
200623|NCT02612077|628367|P1|Overall Study|Death|377
200624|NCT02612077|628367|P1|Overall Study|Lost to Follow-up|20
200625|NCT02612077|628367|P1|Overall Study|Protocol Violation|28
200626|NCT02612077|628367|P1|Overall Study|Withdrawal by Subject|9
200627|NCT02612077|628367|P1|Overall Study|Adverse Event|3
200628|NCT02612064|628379|P2|Overall Study|Not Specified|2
200629|NCT02612064|628380|P1|Overall Study|Not Specified|0
200630|NCT02612064|628379|P2|Overall Study|Withdrawal by Subject|1
200631|NCT02612064|628380|P1|Overall Study|Withdrawal by Subject|1
200632|NCT02609672|628429|P2|Overall Study|Lost to Follow-up|1
200633|NCT02609672|628430|P1|Overall Study|Lost to Follow-up|3
200634|NCT02609178|628464|P6|First Crown|Withdrawal by Subject|0
200635|NCT02609178|628465|P5|First Crown|Withdrawal by Subject|0
200636|NCT02609178|628466|P4|First Crown|Withdrawal by Subject|1
200637|NCT02609178|628467|P3|First Crown|Withdrawal by Subject|1
200638|NCT02609178|628468|P2|First Crown|Withdrawal by Subject|0
200639|NCT02609178|628469|P1|First Crown|Withdrawal by Subject|0
200640|NCT02605928|628519|P1|Overall Study|Lack of Efficacy|5
200641|NCT02605928|628519|P1|Overall Study|Model tuning phase|28
200642|NCT02604589|628526|P3|Overall Study|catheter dislodgement|1
200643|NCT02604589|628527|P2|Overall Study|catheter dislodgement|0
200644|NCT02604589|628528|P1|Overall Study|catheter dislodgement|0
200645|NCT02604550|628556|P2|Overall Study|Incomplete data using paper journal|19
200646|NCT02604550|628557|P1|Overall Study|Incomplete data using paper journal|18
200647|NCT02604550|628556|P2|Overall Study|Withdrawal by Subject|1
200648|NCT02604550|628557|P1|Overall Study|Withdrawal by Subject|0
200649|NCT02604550|628556|P2|Overall Study|Lost to Follow-up|6
200650|NCT02604550|628557|P1|Overall Study|Lost to Follow-up|7
200651|NCT02604407|628584|P3|Overall Study|Unspecified|4
200652|NCT02604407|628585|P2|Overall Study|Unspecified|1
200653|NCT02604407|628586|P1|Overall Study|Unspecified|3
200654|NCT02604407|628584|P3|Overall Study|Lack of Efficacy|0
200655|NCT02604407|628585|P2|Overall Study|Lack of Efficacy|0
200656|NCT02604407|628586|P1|Overall Study|Lack of Efficacy|1
200657|NCT02604407|628584|P3|Overall Study|Lost to Follow-up|2
200658|NCT02604407|628585|P2|Overall Study|Lost to Follow-up|1
200659|NCT02604407|628586|P1|Overall Study|Lost to Follow-up|2
200660|NCT02604407|628584|P3|Overall Study|Withdrawal by Subject|5
200661|NCT02604407|628585|P2|Overall Study|Withdrawal by Subject|3
200662|NCT02604407|628586|P1|Overall Study|Withdrawal by Subject|3
200663|NCT02604407|628584|P3|Overall Study|Protocol Violation|0
200664|NCT02604407|628585|P2|Overall Study|Protocol Violation|0
200665|NCT02604407|628586|P1|Overall Study|Protocol Violation|2
200666|NCT02604407|628584|P3|Overall Study|Adverse Event|5
200667|NCT02604407|628585|P2|Overall Study|Adverse Event|7
200668|NCT02604407|628586|P1|Overall Study|Adverse Event|0
200669|NCT02604264|628599|P2|Overall Study|Had central venous catheter <21 days|242
200670|NCT02604264|628600|P1|Overall Study|Had central venous catheter <21 days|200
200671|NCT02598934|628628|P2|Overall Study|Protocol Violation|2
200672|NCT02598934|628629|P1|Overall Study|Protocol Violation|1
200673|NCT02598934|628628|P2|Overall Study|Administrative|1
200674|NCT02598934|628629|P1|Overall Study|Administrative|2
200675|NCT02598934|628628|P2|Overall Study|Withdrawal by Subject|3
200676|NCT02598934|628629|P1|Overall Study|Withdrawal by Subject|2
200677|NCT02598934|628628|P2|Overall Study|Failure to Return|3
200678|NCT02598934|628629|P1|Overall Study|Failure to Return|3
200679|NCT02598934|628628|P2|Overall Study|Adverse Event|13
200680|NCT02598934|628629|P1|Overall Study|Adverse Event|11
200681|NCT02598622|628641|P2|Overall Study|Physician Decision|0
200682|NCT02598622|628642|P1|Overall Study|Physician Decision|3
200683|NCT02598622|628641|P2|Overall Study|Withdrawal by Subject|0
200684|NCT02598622|628642|P1|Overall Study|Withdrawal by Subject|3
200685|NCT02598128|628648|P4|Period A: Days -7 to -1|Adverse Event|0
200686|NCT02598128|628649|P3|Period A: Days -7 to -1|Adverse Event|0
200687|NCT02598128|628650|P2|Period A: Days -7 to -1|Adverse Event|0
200688|NCT02598128|628651|P1|Period A: Days -7 to -1|Adverse Event|1
200689|NCT02597855|628674|P2|Overall Study|Lost to Follow-up|1
200690|NCT02597855|628675|P1|Overall Study|Lost to Follow-up|2
200691|NCT02596958|628702|P1|Overall Study|Excluded Due to Second Line Treatment|9
200692|NCT02596958|628702|P1|Overall Study|Missing|32
200693|NCT02596958|628702|P1|Overall Study|Lost to Follow-up|33
200694|NCT02596958|628702|P1|Overall Study|Administrative Reasons/Other|231
200695|NCT02596958|628702|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
200696|NCT02596958|628702|P1|Overall Study|Death From Other Cause|33
200697|NCT02596958|628702|P1|Overall Study|Death From Cancer|112
200698|NCT02596958|628702|P1|Overall Study|Cancer Progression|441
200699|NCT02596958|628702|P1|Overall Study|Serious Adverse Drug Reactions|44
200700|NCT02596945|628714|P1|Overall Study|Missing|1
200701|NCT02596945|628714|P1|Overall Study|Withdrawal by Subject|1
200702|NCT02596945|628714|P1|Overall Study|Other Erythropoietin stimulating agent|4
200703|NCT02596945|628714|P1|Overall Study|Change to hemodialysis|15
200704|NCT02596945|628714|P1|Overall Study|Unspecified|32
200705|NCT02596945|628714|P1|Overall Study|No documentation of study drug dosing|3
200706|NCT02596620|628722|P2|Overall Study|Lost to Follow-up|1
200707|NCT02596620|628723|P1|Overall Study|Lost to Follow-up|1
200708|NCT02595502|628729|P2|Period 3|Received Incorrect Treatment at period 3|1
200709|NCT02595502|628730|P1|Period 3|Received Incorrect Treatment at period 3|0
200710|NCT02595502|628729|P2|Period 3|Lost to Follow-up|0
200711|NCT02595502|628730|P1|Period 3|Lost to Follow-up|1
200712|NCT02595502|628729|P2|Period 3|Protocol Violation|1
200713|NCT02595502|628730|P1|Period 3|Protocol Violation|0
200714|NCT02595502|628729|P2|Period 2|Received incorrect lens at Period 1|1
200715|NCT02595502|628730|P1|Period 2|Received incorrect lens at Period 1|0
200716|NCT02595502|628729|P2|Period 2|Adverse Event|1
200717|NCT02595502|628730|P1|Period 2|Adverse Event|1
200718|NCT02595502|628729|P2|Period 1|Lost to Follow-up|1
200719|NCT02595502|628730|P1|Period 1|Lost to Follow-up|0
200720|NCT02595502|628729|P2|Period 1|Withdrawal by Subject|0
200721|NCT02595502|628730|P1|Period 1|Withdrawal by Subject|1
200722|NCT02595502|628729|P2|Period 1|Adverse Event|1
200723|NCT02595502|628730|P1|Period 1|Adverse Event|0
200724|NCT02595450|628736|P1|Overall Study|Enrolled, but not treated|8
200725|NCT02595450|628736|P1|Overall Study|Unspecified (only completed 1 cycle)|73
200726|NCT02591238|628755|P4|Overall Study|personal circumstances|0
200727|NCT02591238|628756|P3|Overall Study|personal circumstances|0
200728|NCT02591238|628757|P2|Overall Study|personal circumstances|1
200729|NCT02591238|628758|P1|Overall Study|personal circumstances|0
200730|NCT02591238|628755|P4|Overall Study|personal circumstances|1
200731|NCT02591238|628756|P3|Overall Study|personal circumstances|0
200732|NCT02591238|628757|P2|Overall Study|personal circumstances|0
200733|NCT02591238|628758|P1|Overall Study|personal circumstances|0
200734|NCT02591238|628755|P4|Overall Study|influenza|1
200735|NCT02591238|628756|P3|Overall Study|influenza|0
200736|NCT02591238|628757|P2|Overall Study|influenza|0
200737|NCT02591238|628758|P1|Overall Study|influenza|0
200738|NCT02591238|628755|P4|Overall Study|Withdrawal by Subject|1
200739|NCT02591238|628756|P3|Overall Study|Withdrawal by Subject|0
200740|NCT02591238|628757|P2|Overall Study|Withdrawal by Subject|0
200741|NCT02591238|628758|P1|Overall Study|Withdrawal by Subject|0
200742|NCT02591238|628755|P4|Overall Study|Pregnancy|0
200743|NCT02591238|628756|P3|Overall Study|Pregnancy|0
200744|NCT02591238|628757|P2|Overall Study|Pregnancy|0
200745|NCT02591238|628758|P1|Overall Study|Pregnancy|1
200746|NCT02590588|628792|P1|Overall Study|Adverse Event|1
200747|NCT02590562|628800|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
200748|NCT02587819|628879|P1|Overall Study|Lost to Follow-up|1
200749|NCT02587819|628879|P1|Overall Study|Adverse Event|1
200750|NCT02586506|628897|P1|Overall Study|Other Reason|2
200751|NCT02586506|628897|P1|Overall Study|Lost to Follow-up|1
200752|NCT02586506|628897|P1|Overall Study|Protocol Violation|6
200753|NCT02586493|628903|P1|Overall Study|Withdrawal by Subject|1
200754|NCT02586493|628903|P1|Overall Study|Lost to Follow-up|1
200755|NCT02586493|628903|P1|Overall Study|Protocol Violation|6
200756|NCT02586493|628903|P1|Overall Study|Adverse Event|4
200757|NCT02585999|628909|P1|Overall Study|Protocol Violation|1
200758|NCT02585999|628909|P1|Overall Study|Lost to Follow-up|1
200759|NCT02582983|628958|P1|Overall Study|Adverse Event|1
200760|NCT02582983|628958|P1|Overall Study|Withdrawal by Subject|2
200761|NCT02582983|628958|P1|Overall Study|Death|3
200762|NCT02580357|629013|P3|Overall Study|Protocol Violation|0
200763|NCT02580357|629014|P2|Overall Study|Protocol Violation|0
200764|NCT02580357|629015|P1|Overall Study|Protocol Violation|1
200765|NCT02580357|629013|P3|Overall Study|Lost to Follow-up|0
200766|NCT02580357|629014|P2|Overall Study|Lost to Follow-up|0
200767|NCT02580357|629015|P1|Overall Study|Lost to Follow-up|2
200768|NCT02578992|629028|P2|Overall Study|equipment not available or malfunction|3
200769|NCT02578992|629029|P1|Overall Study|equipment not available or malfunction|3
200770|NCT02578186|629041|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
200771|NCT02578186|629042|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
200772|NCT02578186|629041|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
200773|NCT02578186|629042|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
200774|NCT02577315|629064|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
200775|NCT02577315|629065|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
200776|NCT02576639|629086|P5|Overall Study|Physician Decision|1
200777|NCT02576639|629087|P4|Overall Study|Physician Decision|0
200778|NCT02576639|629088|P3|Overall Study|Physician Decision|0
200779|NCT02576639|629089|P2|Overall Study|Physician Decision|0
200780|NCT02576639|629090|P1|Overall Study|Physician Decision|0
200781|NCT02576639|629086|P5|Overall Study|Adverse Event|2
200782|NCT02576639|629087|P4|Overall Study|Adverse Event|1
200783|NCT02576639|629088|P3|Overall Study|Adverse Event|1
200784|NCT02576639|629089|P2|Overall Study|Adverse Event|0
200785|NCT02576639|629090|P1|Overall Study|Adverse Event|1
200786|NCT02576639|629086|P5|Overall Study|Withdrawal by Subject|1
200787|NCT02576639|629087|P4|Overall Study|Withdrawal by Subject|0
200788|NCT02576639|629088|P3|Overall Study|Withdrawal by Subject|1
200789|NCT02576639|629089|P2|Overall Study|Withdrawal by Subject|2
200790|NCT02576639|629090|P1|Overall Study|Withdrawal by Subject|1
200791|NCT02576535|629147|P1|Overall Study|Withdrawal by Subject|2
200792|NCT02576145|629158|P2|Overall Study|Tetanus Titers Decreased|1
200793|NCT02576145|629159|P1|Overall Study|Tetanus Titers Decreased|0
200794|NCT02576145|629158|P2|Overall Study|Acute rejection|0
200795|NCT02576145|629159|P1|Overall Study|Acute rejection|1
200796|NCT02576145|629158|P2|Overall Study|Withdrawal by Subject|0
200797|NCT02576145|629159|P1|Overall Study|Withdrawal by Subject|1
200798|NCT02576145|629158|P2|Overall Study|Adverse Event|0
200799|NCT02576145|629159|P1|Overall Study|Adverse Event|1
200800|NCT02575911|629201|P1|Overall Study|Lost to Follow-up|1
200801|NCT02574845|629225|P6|Overall Study|Adverse Event|1
200802|NCT02574845|629226|P5|Overall Study|Adverse Event|0
200803|NCT02574845|629227|P4|Overall Study|Adverse Event|0
200804|NCT02574845|629228|P3|Overall Study|Adverse Event|0
200805|NCT02574845|629229|P2|Overall Study|Adverse Event|1
200806|NCT02574845|629230|P1|Overall Study|Adverse Event|0
200807|NCT02574845|629225|P6|Overall Study|Consent withdrawn further participation|0
200808|NCT02574845|629226|P5|Overall Study|Consent withdrawn further participation|1
200809|NCT02574845|629227|P4|Overall Study|Consent withdrawn further participation|0
200810|NCT02574845|629228|P3|Overall Study|Consent withdrawn further participation|0
200811|NCT02574845|629229|P2|Overall Study|Consent withdrawn further participation|0
200812|NCT02574845|629230|P1|Overall Study|Consent withdrawn further participation|0
200813|NCT02574260|629256|P1|Overall Study|Disease Progression|1
200814|NCT02573870|629264|P2|Overall Study|Other: Fail to Meet Visit|2
200815|NCT02573870|629265|P1|Overall Study|Other: Fail to Meet Visit|0
200816|NCT02573870|629264|P2|Overall Study|Lost to Follow-up|1
200817|NCT02573870|629265|P1|Overall Study|Lost to Follow-up|0
200818|NCT02573870|629264|P2|Overall Study|Other: Reached defined stopping criteria|1
200819|NCT02573870|629265|P1|Overall Study|Other: Reached defined stopping criteria|0
200820|NCT02573870|629264|P2|Overall Study|Lack of Efficacy|1
200821|NCT02573870|629265|P1|Overall Study|Lack of Efficacy|0
200822|NCT02573870|629264|P2|Overall Study|Adverse Event|2
200823|NCT02573870|629265|P1|Overall Study|Adverse Event|0
200824|NCT02570165|629432|P7|Overall Study|Withdrawal Request by GSK|0
200825|NCT02570165|629433|P6|Overall Study|Withdrawal Request by GSK|0
200826|NCT02570165|629434|P5|Overall Study|Withdrawal Request by GSK|0
200827|NCT02570165|629435|P4|Overall Study|Withdrawal Request by GSK|0
200828|NCT02570165|629436|P3|Overall Study|Withdrawal Request by GSK|2
200829|NCT02570165|629437|P2|Overall Study|Withdrawal Request by GSK|0
200830|NCT02570165|629438|P1|Overall Study|Withdrawal Request by GSK|0
200831|NCT02570165|629432|P7|Overall Study|Par. did not Meet Continuation Criteria|0
200832|NCT02570165|629433|P6|Overall Study|Par. did not Meet Continuation Criteria|1
200833|NCT02570165|629434|P5|Overall Study|Par. did not Meet Continuation Criteria|0
200834|NCT02570165|629435|P4|Overall Study|Par. did not Meet Continuation Criteria|0
200835|NCT02570165|629436|P3|Overall Study|Par. did not Meet Continuation Criteria|0
200836|NCT02570165|629437|P2|Overall Study|Par. did not Meet Continuation Criteria|0
200837|NCT02570165|629438|P1|Overall Study|Par. did not Meet Continuation Criteria|0
200838|NCT02570165|629432|P7|Overall Study|Withdrawal by Subject|0
200839|NCT02570165|629433|P6|Overall Study|Withdrawal by Subject|0
200840|NCT02570165|629434|P5|Overall Study|Withdrawal by Subject|1
200841|NCT02570165|629435|P4|Overall Study|Withdrawal by Subject|2
200842|NCT02570165|629436|P3|Overall Study|Withdrawal by Subject|0
200843|NCT02570165|629437|P2|Overall Study|Withdrawal by Subject|0
200844|NCT02570165|629438|P1|Overall Study|Withdrawal by Subject|0
200845|NCT02570165|629432|P7|Overall Study|Physician Decision|0
200846|NCT02570165|629433|P6|Overall Study|Physician Decision|0
200847|NCT02570165|629434|P5|Overall Study|Physician Decision|0
200848|NCT02570165|629435|P4|Overall Study|Physician Decision|0
200849|NCT02570165|629436|P3|Overall Study|Physician Decision|0
200850|NCT02570165|629437|P2|Overall Study|Physician Decision|1
200851|NCT02570165|629438|P1|Overall Study|Physician Decision|0
200852|NCT02570165|629432|P7|Overall Study|Lost to Follow-up|0
200853|NCT02570165|629433|P6|Overall Study|Lost to Follow-up|0
200854|NCT02570165|629434|P5|Overall Study|Lost to Follow-up|0
200855|NCT02570165|629435|P4|Overall Study|Lost to Follow-up|1
200856|NCT02570165|629436|P3|Overall Study|Lost to Follow-up|1
200857|NCT02570165|629437|P2|Overall Study|Lost to Follow-up|0
200858|NCT02570165|629438|P1|Overall Study|Lost to Follow-up|0
200859|NCT02570165|629432|P7|Overall Study|Par. Reached Stopping Criteria|0
200860|NCT02570165|629433|P6|Overall Study|Par. Reached Stopping Criteria|1
200861|NCT02570165|629434|P5|Overall Study|Par. Reached Stopping Criteria|1
200862|NCT02570165|629435|P4|Overall Study|Par. Reached Stopping Criteria|2
200863|NCT02570165|629436|P3|Overall Study|Par. Reached Stopping Criteria|0
200864|NCT02570165|629437|P2|Overall Study|Par. Reached Stopping Criteria|1
200865|NCT02570165|629438|P1|Overall Study|Par. Reached Stopping Criteria|1
200866|NCT02570165|629432|P7|Overall Study|Lack of Efficacy|0
200867|NCT02570165|629433|P6|Overall Study|Lack of Efficacy|0
200868|NCT02570165|629434|P5|Overall Study|Lack of Efficacy|4
200869|NCT02570165|629435|P4|Overall Study|Lack of Efficacy|0
200870|NCT02570165|629436|P3|Overall Study|Lack of Efficacy|0
200871|NCT02570165|629437|P2|Overall Study|Lack of Efficacy|1
200872|NCT02570165|629438|P1|Overall Study|Lack of Efficacy|0
200873|NCT02570165|629432|P7|Overall Study|Adverse Event|0
200874|NCT02570165|629433|P6|Overall Study|Adverse Event|0
200875|NCT02570165|629434|P5|Overall Study|Adverse Event|0
200876|NCT02570165|629435|P4|Overall Study|Adverse Event|0
200877|NCT02570165|629436|P3|Overall Study|Adverse Event|2
200878|NCT02570165|629437|P2|Overall Study|Adverse Event|0
200879|NCT02570165|629438|P1|Overall Study|Adverse Event|1
200880|NCT02569996|629472|P1|Overall Study|Unknown reason|1
200881|NCT02569996|629472|P1|Overall Study|Complete remission|7
200882|NCT02569996|629472|P1|Overall Study|Lost to Follow-up|5
200883|NCT02569996|629472|P1|Overall Study|Withdrawal by Subject|5
200884|NCT02569996|629472|P1|Overall Study|Non-compliance|9
200885|NCT02569996|629472|P1|Overall Study|New anti-lymphoma treatment|1
200886|NCT02569996|629472|P1|Overall Study|Progression of the disease|18
200887|NCT02569996|629472|P1|Overall Study|Physician Decision|3
200888|NCT02569996|629472|P1|Overall Study|Adverse Event|6
200889|NCT02567188|629540|P1|Overall Study|Protocol Violation|5
200890|NCT02567188|629540|P1|Overall Study|Started Hemodialysis|2
200891|NCT02567188|629540|P1|Overall Study|Moved and Changed Clinic|1
200892|NCT02567188|629540|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
200893|NCT02567188|629540|P1|Overall Study|Withdrawal by Subject|1
200894|NCT02567188|629540|P1|Overall Study|Adverse Event|1
200895|NCT02567188|629540|P1|Overall Study|Lost to Follow-up|5
200896|NCT02567188|629540|P1|Overall Study|Terminated Mircera Treatment|9
200897|NCT02567188|629540|P1|Overall Study|Death|10
200898|NCT02561572|629627|P2|Overall Study|Protocol Violation|1
200899|NCT02561572|629628|P1|Overall Study|Protocol Violation|0
200900|NCT02561572|629627|P2|Overall Study|Inadequate time before surgery|1
200901|NCT02561572|629628|P1|Overall Study|Inadequate time before surgery|2
200902|NCT02557646|629711|P1|Overall Study|Unspecified|14
200903|NCT02557646|629711|P1|Overall Study|Lost to Follow-up|17
200904|NCT02557646|629711|P1|Overall Study|Withdrawal by Subject|18
200905|NCT02557646|629711|P1|Overall Study|Lack of Efficacy|186
200906|NCT02557646|629711|P1|Overall Study|Death|1
200907|NCT02557646|629711|P1|Overall Study|Adverse Event|40
200908|NCT02556307|629744|P1|Overall Study|Enrolled but not treated|2
200909|NCT02556307|629744|P1|Overall Study|Change to triple therapy|4
200910|NCT02556307|629744|P1|Overall Study|Lost to Follow-up|36
200911|NCT02556307|629744|P1|Overall Study|Premature treatment interruption|11
200912|NCT02555722|629756|P2|Month 2|Adverse Event|0
200913|NCT02555722|629757|P1|Month 2|Adverse Event|3
200914|NCT02555722|629756|P2|Month 1|Withdrawal by Subject|0
200915|NCT02555722|629757|P1|Month 1|Withdrawal by Subject|2
200916|NCT02555722|629756|P2|Week 2|Lens Discomfort|1
200917|NCT02555722|629757|P1|Week 2|Lens Discomfort|0
200918|NCT02555722|629756|P2|Week 1|Withdrawal by Subject|0
200919|NCT02555722|629757|P1|Week 1|Withdrawal by Subject|1
200920|NCT02555618|629917|P2|Overall Study|Sponsor's Circumstances|0
200921|NCT02555618|629918|P1|Overall Study|Sponsor's Circumstances|1
200922|NCT02554981|629960|P1|Overall Study|Other Miscellaneous Reasons|3
200923|NCT02554981|629960|P1|Overall Study|Administrative Reasons|1
200924|NCT02554981|629960|P1|Overall Study|Adverse Event|1
200925|NCT02553629|629986|P2|Overall Study|Logistic reasons|6
200926|NCT02553629|629987|P1|Overall Study|Logistic reasons|3
200927|NCT02553421|630011|P2|Overall Study|Improper Device Placement|0
200928|NCT02553421|630012|P1|Overall Study|Improper Device Placement|3
200929|NCT02553421|630011|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
200930|NCT02553421|630012|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
200931|NCT02553421|630011|P2|Overall Study|Lost to Follow-up|1
200932|NCT02553421|630012|P1|Overall Study|Lost to Follow-up|21
200933|NCT02549027|630107|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
200934|NCT02549027|630108|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
200935|NCT02549027|630109|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
200936|NCT02549027|630110|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
200937|NCT02549027|630111|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
200938|NCT02549027|630112|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
200939|NCT02549027|630107|P6|Washout After Period 4|Withdrawal by Subject|0
200940|NCT02549027|630108|P5|Washout After Period 4|Withdrawal by Subject|0
200941|NCT02549027|630109|P4|Washout After Period 4|Withdrawal by Subject|1
200942|NCT02549027|630110|P3|Washout After Period 4|Withdrawal by Subject|1
200943|NCT02549027|630111|P2|Washout After Period 4|Withdrawal by Subject|1
200944|NCT02549027|630112|P1|Washout After Period 4|Withdrawal by Subject|0
200945|NCT02548156|630240|P6|Washout Period 1|Lost to Follow-up|0
200946|NCT02548156|630241|P5|Washout Period 1|Lost to Follow-up|1
200947|NCT02548156|630242|P4|Washout Period 1|Lost to Follow-up|0
200948|NCT02548156|630243|P3|Washout Period 1|Lost to Follow-up|0
200949|NCT02548156|630244|P2|Washout Period 1|Lost to Follow-up|0
200950|NCT02548156|630245|P1|Washout Period 1|Lost to Follow-up|0
200951|NCT02547454|630262|P1|Overall Study|No data|11
200952|NCT02547454|630262|P1|Overall Study|Unspecified|39
200953|NCT02547454|630262|P1|Overall Study|Lost to Follow-up|26
200954|NCT02547454|630262|P1|Overall Study|Death|38
200955|NCT02547454|630262|P1|Overall Study|Due to no further need to treat|4
200956|NCT02547454|630262|P1|Overall Study|Due to transplantation|1
200957|NCT02547454|630262|P1|Overall Study|Due to hemodialysis|53
200958|NCT02545543|630321|P2|Overall Study|Enrolment of subject at >1 study site|1
200959|NCT02545543|630322|P1|Overall Study|Enrolment of subject at >1 study site|1
200960|NCT02545543|630321|P2|Overall Study|Noncomplaince|0
200961|NCT02545543|630322|P1|Overall Study|Noncomplaince|1
200962|NCT02545543|630321|P2|Overall Study|Withdrawal by Subject|8
200963|NCT02545543|630322|P1|Overall Study|Withdrawal by Subject|9
200964|NCT02545543|630321|P2|Overall Study|Physician Decision|0
200965|NCT02545543|630322|P1|Overall Study|Physician Decision|3
200966|NCT02545543|630321|P2|Overall Study|Lost to Follow-up|25
200967|NCT02545543|630322|P1|Overall Study|Lost to Follow-up|67
200968|NCT02545322|630346|P1|Overall Study|Withdrawal by Subject|3
200970|NCT02543918|630357|P2|Overall Study|Adverse Event|1
200971|NCT02543918|630358|P1|Overall Study|Adverse Event|1
200972|NCT02543918|630357|P2|Overall Study|Withdrawal by Subject|1
200973|NCT02543918|630358|P1|Overall Study|Withdrawal by Subject|1
200974|NCT02543918|630357|P2|Overall Study|Lost to Follow-up|1
200975|NCT02543918|630358|P1|Overall Study|Lost to Follow-up|1
200976|NCT02543918|630357|P2|Overall Study|Never treated|1
200977|NCT02543918|630358|P1|Overall Study|Never treated|0
200978|NCT02542943|630372|P3|Overall Study|Withdrawal by Subject|0
200979|NCT02542943|630373|P2|Overall Study|Withdrawal by Subject|1
200980|NCT02542943|630374|P1|Overall Study|Withdrawal by Subject|0
200981|NCT02542943|630372|P3|Overall Study|Lost to Follow-up|0
200982|NCT02542943|630373|P2|Overall Study|Lost to Follow-up|0
200983|NCT02542943|630374|P1|Overall Study|Lost to Follow-up|1
200984|NCT02542072|630410|P2|Second Intervention (1 Month)|Lens discomfort|0
200985|NCT02542072|630411|P1|Second Intervention (1 Month)|Lens discomfort|1
200986|NCT02542072|630410|P2|Second Intervention (1 Month)|Lost to Follow-up|0
200987|NCT02542072|630411|P1|Second Intervention (1 Month)|Lost to Follow-up|1
200988|NCT02542072|630410|P2|First Intervention (1 Month)|Protocol Violation|0
200989|NCT02542072|630411|P1|First Intervention (1 Month)|Protocol Violation|1
200990|NCT02542072|630410|P2|First Intervention (1 Month)|Lens discomfort|2
200991|NCT02542072|630411|P1|First Intervention (1 Month)|Lens discomfort|1
200992|NCT02542072|630410|P2|First Intervention (1 Month)|Lost to Follow-up|0
200993|NCT02542072|630411|P1|First Intervention (1 Month)|Lost to Follow-up|2
200994|NCT02542072|630410|P2|First Intervention (1 Month)|Adverse Event|1
200995|NCT02542072|630411|P1|First Intervention (1 Month)|Adverse Event|1
200996|NCT02540850|630514|P3|Overall Study|Lost to Follow-up|34
200997|NCT02540850|630515|P2|Overall Study|Lost to Follow-up|66
200998|NCT02540850|630516|P1|Overall Study|Lost to Follow-up|69
200999|NCT02540356|630587|P2|Overall Study|Terminated due to disease progression|0
201000|NCT02540356|630588|P1|Overall Study|Terminated due to disease progression|1
201001|NCT02540265|630622|P3|Overall Study|Lost to Follow-up|1
201002|NCT02540265|630623|P2|Overall Study|Lost to Follow-up|0
201003|NCT02540265|630624|P1|Overall Study|Lost to Follow-up|0
201004|NCT02540213|630644|P1|Overall Study|Enrolled but not treated|2
201005|NCT02540213|630644|P1|Overall Study|Consent withdrawn|7
201006|NCT02540213|630644|P1|Overall Study|Lack of Efficacy|6
201007|NCT02540213|630644|P1|Overall Study|Kidney transplant|3
201008|NCT02540213|630644|P1|Overall Study|Administrative reasons|3
201009|NCT02540213|630644|P1|Overall Study|Death/adverse event|18
201010|NCT02538107|630713|P1|Overall Study|Not recorded|7
201011|NCT02538107|630713|P1|Overall Study|Unspecified|7
201012|NCT02538107|630713|P1|Overall Study|Surgery|1
201013|NCT02538107|630713|P1|Overall Study|Adverse Event|4
201014|NCT02538107|630713|P1|Overall Study|Administrative reason|5
201015|NCT02538107|630713|P1|Overall Study|Death|4
201016|NCT02538107|630713|P1|Overall Study|Withdrawal by Subject|17
201017|NCT02538107|630713|P1|Overall Study|No further treatment necessary|18
201018|NCT02538107|630713|P1|Overall Study|Administration of other ESA|11
201019|NCT02538107|630713|P1|Overall Study|Necessity of dialysis|20
201020|NCT02538107|630713|P1|Overall Study|Missing|5
201021|NCT02538107|630713|P1|Overall Study|Did not receive any Mircera dose|11
201022|NCT02537522|630746|P4|Phase II - Period 1 Bilateral|Adverse Event|1
201023|NCT02537522|630747|P3|Phase II - Period 1 Bilateral|Adverse Event|0
201024|NCT02537522|630748|P2|Phase II - Period 1 Bilateral|Adverse Event|0
201025|NCT02537522|630749|P1|Phase II - Period 1 Bilateral|Adverse Event|0
201026|NCT02537522|630746|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
201027|NCT02537522|630747|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
201028|NCT02537522|630748|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
201029|NCT02537522|630749|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
201030|NCT02537522|630746|P4|Phase I - Contralateral|incorrect randomization|0
201031|NCT02537522|630747|P3|Phase I - Contralateral|incorrect randomization|0
201032|NCT02537522|630748|P2|Phase I - Contralateral|incorrect randomization|1
201033|NCT02537522|630749|P1|Phase I - Contralateral|incorrect randomization|0
201034|NCT02537522|630746|P4|Phase I - Contralateral|Withdrawal by Subject|0
201035|NCT02537522|630747|P3|Phase I - Contralateral|Withdrawal by Subject|0
201036|NCT02537522|630748|P2|Phase I - Contralateral|Withdrawal by Subject|1
201037|NCT02537522|630749|P1|Phase I - Contralateral|Withdrawal by Subject|0
201038|NCT02537522|630746|P4|Phase I - Contralateral|Subject no longer eligible|0
201039|NCT02537522|630747|P3|Phase I - Contralateral|Subject no longer eligible|0
201040|NCT02537522|630748|P2|Phase I - Contralateral|Subject no longer eligible|7
201041|NCT02537522|630749|P1|Phase I - Contralateral|Subject no longer eligible|15
201042|NCT02536664|630759|P2|Overall Study|Missing|20
201043|NCT02536664|630760|P1|Overall Study|Missing|53
201044|NCT02536664|630759|P2|Overall Study|Unspecified|24
201045|NCT02536664|630760|P1|Overall Study|Unspecified|18
201046|NCT02536664|630759|P2|Overall Study|Withdrawal by Subject|5
201047|NCT02536664|630760|P1|Overall Study|Withdrawal by Subject|8
201048|NCT02536664|630759|P2|Overall Study|Intolerability|6
201049|NCT02536664|630760|P1|Overall Study|Intolerability|8
201050|NCT02536664|630759|P2|Overall Study|Death due to other reason|2
201051|NCT02536664|630760|P1|Overall Study|Death due to other reason|3
201052|NCT02536664|630759|P2|Overall Study|Death due to lymphoma|1
201053|NCT02536664|630760|P1|Overall Study|Death due to lymphoma|2
201054|NCT02536664|630759|P2|Overall Study|Progression|18
201055|NCT02536664|630760|P1|Overall Study|Progression|13
201056|NCT02536664|630759|P2|Overall Study|Inadequate completion of documentation|4
201057|NCT02536664|630760|P1|Overall Study|Inadequate completion of documentation|2
201058|NCT02535741|630778|P1|Overall Study|Missing data|6
201059|NCT02535741|630778|P1|Overall Study|Exclusion criteria: Bilateral implant|4
201060|NCT02535741|630778|P1|Overall Study|Lost to Follow-up|10
201061|NCT02535741|630778|P1|Overall Study|Withdrawal by Subject|9
201062|NCT02535741|630778|P1|Overall Study|Adverse Event|3
201063|NCT02534324|630836|P2|Overall Study|Adverse Event|0
201064|NCT02534324|630837|P1|Overall Study|Adverse Event|1
201065|NCT02534324|630836|P2|Overall Study|Lost to Follow-up|7
201066|NCT02534324|630837|P1|Overall Study|Lost to Follow-up|20
201067|NCT02534324|630836|P2|Overall Study|Protocol Violation|1
201068|NCT02534324|630837|P1|Overall Study|Protocol Violation|4
201069|NCT02533401|630874|P1|Overall Study|Violation of Selection Criteria|1
201070|NCT02533401|630874|P1|Overall Study|Lost to Follow-up|1
201071|NCT02533401|630874|P1|Overall Study|Insufficient Response/Progressed Disease|1
201072|NCT02533401|630874|P1|Overall Study|Death|5
201073|NCT02533401|630874|P1|Overall Study|Adverse Event/Intercurrent Disease|3
201074|NCT02532374|630964|P1|Overall Study|Physician Decision|1
201075|NCT02532374|630964|P1|Overall Study|Withdrawal by Subject|1
201076|NCT02531646|630995|P3|Overall Study|equip. image processing issue|0
201077|NCT02531646|630996|P2|Overall Study|equip. image processing issue|1
201078|NCT02531646|630997|P1|Overall Study|equip. image processing issue|5
201079|NCT02530671|631017|P2|Overall Study|Withdrawal by Subject|0
201080|NCT02530671|631018|P1|Overall Study|Withdrawal by Subject|1
201081|NCT02530671|631017|P2|Overall Study|Lost to Follow-up|0
201082|NCT02530671|631018|P1|Overall Study|Lost to Follow-up|2
201083|NCT02529995|631045|P2|Part A|Discontinued Study|0
201084|NCT02529995|631046|P1|Part A|Discontinued Study|1
201085|NCT02529995|631045|P2|Part A|Ongoing Study at Data Cut-off|16
201086|NCT02529995|631046|P1|Part A|Ongoing Study at Data Cut-off|14
201087|NCT02528331|631093|P1|Overall Study|Withdrawal by Subject|2
201088|NCT02527161|631111|P1|Overall Study|Consent violation|4
201089|NCT02527161|631111|P1|Overall Study|MRI contraindication|2
201090|NCT02527161|631111|P1|Overall Study|Delay in or unfit for surgery|5
201091|NCT02527161|631111|P1|Overall Study|Exclusion RA diagnosis|1
201092|NCT02527161|631111|P1|Overall Study|Exclusion for excessive deformity|1
201093|NCT02527161|631111|P1|Overall Study|Exclusion for BMI|2
201094|NCT02527161|631111|P1|Overall Study|Shape Match not used in surgery|2
201095|NCT02527161|631111|P1|Overall Study|Withdrawal by Subject|6
201096|NCT02527161|631111|P1|Overall Study|Failed MRI|39
201097|NCT02527148|631130|P2|Overall Study|Did not receive study intervention|0
201098|NCT02527148|631131|P1|Overall Study|Did not receive study intervention|1
201099|NCT02526550|631149|P1|Overall Study|Lost to Follow-up|1
201100|NCT02524665|631231|P1|Overall Study|Lost to Follow-up|1
201101|NCT02522624|631284|P2|Overall Study|Technical failure|0
201102|NCT02522624|631285|P1|Overall Study|Technical failure|1
201103|NCT02519855|631307|P2|Overall Study|Lost to Follow-up|3
201104|NCT02519855|631308|P1|Overall Study|Lost to Follow-up|3
201105|NCT02519855|631307|P2|Overall Study|Adverse Event|1
201106|NCT02519855|631308|P1|Overall Study|Adverse Event|0
201107|NCT02519595|631327|P3|Overall Study|Protocol Violation|16
201108|NCT02519595|631328|P2|Overall Study|Protocol Violation|22
201109|NCT02519595|631329|P1|Overall Study|Protocol Violation|8
201110|NCT02518048|631360|P1|Overall Study|Withdrawal by Subject|1
201111|NCT02516306|631373|P2|Period 2: Day 8 - 91|Protocol Violation|2
201112|NCT02516306|631374|P1|Period 2: Day 8 - 91|Protocol Violation|1
201113|NCT02516163|631380|P1|Overall Study|MRI contraindication exclusion|6
201114|NCT02516163|631380|P1|Overall Study|Data not recorded|2
201115|NCT02516163|631380|P1|Overall Study|Use of incorrect measurement technique|5
201116|NCT02516163|631380|P1|Overall Study|Unfit/delay in surgery|3
201117|NCT02516163|631380|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
201118|NCT02516163|631380|P1|Overall Study|Withdrawal by Subject|1
201119|NCT02516098|631386|P2|Period 2|Withdrawal by Subject|1
201120|NCT02516098|631387|P1|Period 2|Withdrawal by Subject|0
201121|NCT02516098|631386|P2|Washout After Period 1|Adverse Event|1
201122|NCT02516098|631387|P1|Washout After Period 1|Adverse Event|0
201123|NCT02516098|631386|P2|Period 1|Protocol Violation|0
201124|NCT02516098|631387|P1|Period 1|Protocol Violation|1
201125|NCT02515994|631401|P2|Overall Study|Withdrawal by Subject|0
201126|NCT02515994|631402|P1|Overall Study|Withdrawal by Subject|2
201127|NCT02515994|631401|P2|Overall Study|Adverse Event|1
201128|NCT02515994|631402|P1|Overall Study|Adverse Event|3
201129|NCT02515994|631401|P2|Overall Study|No Longer Meets Eligibility Criteria|1
201130|NCT02515994|631402|P1|Overall Study|No Longer Meets Eligibility Criteria|2
201131|NCT02515994|631401|P2|Overall Study|Protocol Violation|5
201132|NCT02515994|631402|P1|Overall Study|Protocol Violation|3
201133|NCT02515279|631414|P1|Overall Study|Unspecified|22
201134|NCT02515279|631414|P1|Overall Study|End-of-treatment visit not attended|17
201135|NCT02515279|631414|P1|Overall Study|Withdrawal by Subject|18
201136|NCT02515279|631414|P1|Overall Study|Lost to Follow-up|9
201137|NCT02515279|631414|P1|Overall Study|Lack of Efficacy|31
201138|NCT02515279|631414|P1|Overall Study|Adverse Event|7
201139|NCT02513095|631422|P2|Overall Study|Stampede resulted in transfers out of ER|16
201140|NCT02513095|631423|P1|Overall Study|Stampede resulted in transfers out of ER|14
201141|NCT02511782|631505|P3|Overall Study|Withdrawal by Subject|0
201142|NCT02511782|631506|P2|Overall Study|Withdrawal by Subject|0
201143|NCT02511782|631507|P1|Overall Study|Withdrawal by Subject|1
201144|NCT02510820|631517|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
201145|NCT02510820|631518|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
201146|NCT02510820|631517|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
201147|NCT02510820|631518|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
201148|NCT02507752|631556|P1|Overall Study|Participant didn't perform visit Week 24|1
201149|NCT02507752|631556|P1|Overall Study|Participant didn't perform visit Week 12|1
201150|NCT02507752|631556|P1|Overall Study|Infusion reaction at first infusion|1
201151|NCT02507752|631556|P1|Overall Study|Lost to Follow-up|7
201152|NCT02507752|631556|P1|Overall Study|Protocol Violation|6
201153|NCT02507752|631556|P1|Overall Study|Adverse Event|1
201154|NCT02507375|631576|P2|Overall Study|Adverse Event|1
201155|NCT02507375|631577|P1|Overall Study|Adverse Event|0
201156|NCT02507375|631576|P2|Overall Study|Refused treatment|1
201157|NCT02507375|631577|P1|Overall Study|Refused treatment|0
201158|NCT02507375|631576|P2|Overall Study|Death|1
201159|NCT02507375|631577|P1|Overall Study|Death|0
201160|NCT02507375|631576|P2|Overall Study|Progressive Disease|5
201161|NCT02507375|631577|P1|Overall Study|Progressive Disease|4
201162|NCT02506881|631598|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
201246|NCT02496533|632094|P2|Overall Study|Lack of data on outcome|0
201163|NCT02506881|631599|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
201164|NCT02506881|631600|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
201165|NCT02506881|631601|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
201166|NCT02506881|631598|P4|First Intervention (Day 1)|Withdrawal by Subject|0
201167|NCT02506881|631599|P3|First Intervention (Day 1)|Withdrawal by Subject|0
201168|NCT02506881|631600|P2|First Intervention (Day 1)|Withdrawal by Subject|0
201169|NCT02506881|631601|P1|First Intervention (Day 1)|Withdrawal by Subject|1
201170|NCT02506881|631598|P4|First Intervention (Day 1)|Protocol Violation|0
201171|NCT02506881|631599|P3|First Intervention (Day 1)|Protocol Violation|1
201172|NCT02506881|631600|P2|First Intervention (Day 1)|Protocol Violation|0
201173|NCT02506881|631601|P1|First Intervention (Day 1)|Protocol Violation|0
201174|NCT02506257|631654|P4|Overall Study|Protocol Violation|0
201175|NCT02506257|631655|P3|Overall Study|Protocol Violation|1
201176|NCT02506257|631656|P2|Overall Study|Protocol Violation|0
201177|NCT02506257|631657|P1|Overall Study|Protocol Violation|0
201178|NCT02506257|631654|P4|Overall Study|Adverse Event|0
201179|NCT02506257|631655|P3|Overall Study|Adverse Event|3
201180|NCT02506257|631656|P2|Overall Study|Adverse Event|2
201181|NCT02506257|631657|P1|Overall Study|Adverse Event|0
201182|NCT02504502|631702|P2|Crossover to Enhanced Report|Lost to Follow-up|0
201183|NCT02504502|631703|P1|Crossover to Enhanced Report|Lost to Follow-up|5
201184|NCT02504502|631702|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
201185|NCT02504502|631703|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
201186|NCT02504320|631713|P4|Treatment Period 3|Adverse Event|0
201187|NCT02504320|631714|P3|Treatment Period 3|Adverse Event|1
201188|NCT02504320|631715|P2|Treatment Period 3|Adverse Event|0
201189|NCT02504320|631716|P1|Treatment Period 3|Adverse Event|0
201190|NCT02504320|631713|P4|Treatment Period 3|Positive Drug Screen|1
201191|NCT02504320|631714|P3|Treatment Period 3|Positive Drug Screen|0
201192|NCT02504320|631715|P2|Treatment Period 3|Positive Drug Screen|0
201193|NCT02504320|631716|P1|Treatment Period 3|Positive Drug Screen|0
201194|NCT02504320|631713|P4|Treatment Period 2|Positive Drug Screen|0
201195|NCT02504320|631714|P3|Treatment Period 2|Positive Drug Screen|0
201196|NCT02504320|631715|P2|Treatment Period 2|Positive Drug Screen|1
201197|NCT02504320|631716|P1|Treatment Period 2|Positive Drug Screen|0
201198|NCT02504320|631713|P4|Treatment Period 1|Positive Drug Screen|0
201199|NCT02504320|631714|P3|Treatment Period 1|Positive Drug Screen|1
201200|NCT02504320|631715|P2|Treatment Period 1|Positive Drug Screen|0
201201|NCT02504320|631716|P1|Treatment Period 1|Positive Drug Screen|0
201202|NCT02503865|631741|P3|Overall Study|Refused treatment|2
201203|NCT02503865|631742|P2|Overall Study|Refused treatment|39
201204|NCT02503865|631743|P1|Overall Study|Refused treatment|4
201205|NCT02503865|631741|P3|Overall Study|Moved out of area|0
201206|NCT02503865|631742|P2|Overall Study|Moved out of area|8
201207|NCT02503865|631743|P1|Overall Study|Moved out of area|1
201208|NCT02503215|631779|P1|Overall Study|Unable to use positive airway pressure|2
201209|NCT02503215|631779|P1|Overall Study|Unable to wear compression stockings|1
201210|NCT02502734|631858|P2|Washout Period|Adverse Event|0
201211|NCT02502734|631859|P1|Washout Period|Adverse Event|1
201212|NCT02502734|631858|P2|Double-blind Treatment Period 1|Adverse Event|0
201213|NCT02502734|631859|P1|Double-blind Treatment Period 1|Adverse Event|1
201214|NCT02500758|631883|P2|Second Intervention (2 Minutes)|Protocol Violation|1
201215|NCT02500758|631884|P1|Second Intervention (2 Minutes)|Protocol Violation|1
201216|NCT02500758|631883|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
201217|NCT02500758|631884|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
201218|NCT02500758|631883|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
201219|NCT02500758|631884|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
201220|NCT02500758|631883|P2|Washout (1 Week)|Lost to Follow-up|2
201221|NCT02500758|631884|P1|Washout (1 Week)|Lost to Follow-up|2
201222|NCT02500758|631883|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
201223|NCT02500758|631884|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
201224|NCT02500537|631894|P2|Overall Study|Withdrawal by Subject|0
201225|NCT02500537|631895|P1|Overall Study|Withdrawal by Subject|1
201226|NCT02500537|631894|P2|Overall Study|Lost to Follow-up|1
201227|NCT02500537|631895|P1|Overall Study|Lost to Follow-up|0
201228|NCT02500537|631894|P2|Overall Study|Death|0
201229|NCT02500537|631895|P1|Overall Study|Death|2
201230|NCT02500056|631964|P2|Overall Study|Death|1
201231|NCT02500056|631965|P1|Overall Study|Death|3
201232|NCT02500056|631964|P2|Overall Study|Recurrence|0
201233|NCT02500056|631965|P1|Overall Study|Recurrence|1
201234|NCT02500056|631964|P2|Overall Study|Lost to Follow-up|7
201235|NCT02500056|631965|P1|Overall Study|Lost to Follow-up|3
201236|NCT02499575|631986|P2|Overall Study|Protocol Violation|1
201237|NCT02499575|631987|P1|Overall Study|Protocol Violation|0
201238|NCT02498821|631999|P2|Overall Study|Screen failure|5
201239|NCT02498821|632000|P1|Overall Study|Screen failure|3
201240|NCT02498678|632029|P2|Overall Study|interference from the surgical team|2
201241|NCT02498678|632030|P1|Overall Study|interference from the surgical team|0
201242|NCT02496533|632094|P2|Overall Study|Late for radiologic testing|2
201243|NCT02496533|632095|P1|Overall Study|Late for radiologic testing|0
201244|NCT02496533|632094|P2|Overall Study|Patient did not complete all measures|4
201245|NCT02496533|632095|P1|Overall Study|Patient did not complete all measures|0
201247|NCT02496533|632095|P1|Overall Study|Lack of data on outcome|3
201248|NCT02496221|632107|P2|Treatment Period 2 - 4 Days|Physician Decision|0
201249|NCT02496221|632108|P1|Treatment Period 2 - 4 Days|Physician Decision|1
201250|NCT02496221|632107|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
201251|NCT02496221|632108|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
201252|NCT02496221|632107|P2|Treatment Period 2 - 4 Days|Adverse Event|1
201253|NCT02496221|632108|P1|Treatment Period 2 - 4 Days|Adverse Event|0
201254|NCT02496000|632145|P3|Overall Study|undetermined|0
201255|NCT02496000|632146|P2|Overall Study|undetermined|1
201256|NCT02496000|632147|P1|Overall Study|undetermined|0
201257|NCT02496000|632145|P3|Overall Study|Non-compliance or lack of cooperation|0
201258|NCT02496000|632146|P2|Overall Study|Non-compliance or lack of cooperation|2
201259|NCT02496000|632147|P1|Overall Study|Non-compliance or lack of cooperation|0
201260|NCT02496000|632145|P3|Overall Study|Protocol Violation|1
201261|NCT02496000|632146|P2|Overall Study|Protocol Violation|0
201262|NCT02496000|632147|P1|Overall Study|Protocol Violation|0
201263|NCT02496000|632145|P3|Overall Study|Lost to Follow-up|1
201264|NCT02496000|632146|P2|Overall Study|Lost to Follow-up|0
201265|NCT02496000|632147|P1|Overall Study|Lost to Follow-up|1
201266|NCT02496000|632145|P3|Overall Study|Withdrawal by Subject|0
201267|NCT02496000|632146|P2|Overall Study|Withdrawal by Subject|2
201268|NCT02496000|632147|P1|Overall Study|Withdrawal by Subject|1
201269|NCT02495948|632156|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
201270|NCT02495948|632157|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
201271|NCT02495948|632156|P2|Period 1, First 30 Days of Wear|Adverse Event|1
201272|NCT02495948|632157|P1|Period 1, First 30 Days of Wear|Adverse Event|0
201273|NCT02493855|632195|P3|Overall Study|Withdrawal by Subject|0
201274|NCT02493855|632196|P2|Overall Study|Withdrawal by Subject|0
201275|NCT02493855|632197|P1|Overall Study|Withdrawal by Subject|1
201276|NCT02493855|632195|P3|Overall Study|Adverse Event|0
201277|NCT02493855|632196|P2|Overall Study|Adverse Event|1
201278|NCT02493855|632197|P1|Overall Study|Adverse Event|0
201279|NCT02493855|632195|P3|Overall Study|Non-compliance|0
201280|NCT02493855|632196|P2|Overall Study|Non-compliance|0
201281|NCT02493855|632197|P1|Overall Study|Non-compliance|1
201282|NCT02494596|632205|P3|Overall Study|Refused Treatment|0
201283|NCT02494596|632206|P2|Overall Study|Refused Treatment|1
201284|NCT02494596|632207|P1|Overall Study|Refused Treatment|0
201285|NCT02494596|632205|P3|Overall Study|Adverse Event|0
201286|NCT02494596|632206|P2|Overall Study|Adverse Event|1
201287|NCT02494596|632207|P1|Overall Study|Adverse Event|0
201288|NCT02494596|632205|P3|Overall Study|Insufficient Therapeutic Response|1
201289|NCT02494596|632206|P2|Overall Study|Insufficient Therapeutic Response|3
201290|NCT02494596|632207|P1|Overall Study|Insufficient Therapeutic Response|3
201291|NCT02493127|632245|P2|Overall Study|Lost to Follow-up|1
201292|NCT02493127|632246|P1|Overall Study|Lost to Follow-up|1
201293|NCT02492984|632279|P2|Overall Study|Withdrawal by Subject|0
201294|NCT02492984|632280|P1|Overall Study|Withdrawal by Subject|1
201295|NCT02492984|632279|P2|Overall Study|Protocol Violation|0
201296|NCT02492984|632280|P1|Overall Study|Protocol Violation|1
201297|NCT02492984|632279|P2|Overall Study|Adverse Event|0
201298|NCT02492984|632280|P1|Overall Study|Adverse Event|1
201299|NCT02492165|632317|P4|Overall Study|Withdrawal by Subject|0
201300|NCT02492165|632318|P3|Overall Study|Withdrawal by Subject|0
201301|NCT02492165|632319|P2|Overall Study|Withdrawal by Subject|1
201302|NCT02492165|632320|P1|Overall Study|Withdrawal by Subject|0
201303|NCT02491892|632364|P2|Overall Study|Lost to Follow-up|0
201304|NCT02491892|632365|P1|Overall Study|Lost to Follow-up|1
201305|NCT02491892|632364|P2|Overall Study|Refused Treatment|0
201306|NCT02491892|632365|P1|Overall Study|Refused Treatment|1
201307|NCT02491892|632364|P2|Overall Study|Lack of Efficacy|36
201308|NCT02491892|632365|P1|Overall Study|Lack of Efficacy|37
201309|NCT02491892|632364|P2|Overall Study|Death|1
201310|NCT02491892|632365|P1|Overall Study|Death|1
201311|NCT02491892|632364|P2|Overall Study|Adverse Event|1
201312|NCT02491892|632365|P1|Overall Study|Adverse Event|1
201313|NCT02490475|632424|P4|Period 2: Extension Phase|Adverse Event|0
201314|NCT02490475|632425|P3|Period 2: Extension Phase|Adverse Event|1
201315|NCT02490475|632426|P2|Period 2: Extension Phase|Adverse Event|0
201316|NCT02490475|632427|P1|Period 2: Extension Phase|Adverse Event|0
201317|NCT02490475|632424|P4|Period 2: Extension Phase|Refused Treatment|1
201318|NCT02490475|632425|P3|Period 2: Extension Phase|Refused Treatment|0
201319|NCT02490475|632426|P2|Period 2: Extension Phase|Refused Treatment|0
201320|NCT02490475|632427|P1|Period 2: Extension Phase|Refused Treatment|0
201321|NCT02490475|632424|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
201322|NCT02490475|632425|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
201323|NCT02490475|632426|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
201324|NCT02490475|632427|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
201325|NCT02490475|632424|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
201326|NCT02490475|632425|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
201327|NCT02490475|632426|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
201328|NCT02490475|632427|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
201329|NCT02490475|632424|P4|Period 1: First 6 Cycles|Refused Treatment|0
201330|NCT02490475|632425|P3|Period 1: First 6 Cycles|Refused Treatment|0
201331|NCT02490475|632426|P2|Period 1: First 6 Cycles|Refused Treatment|0
201332|NCT02490475|632427|P1|Period 1: First 6 Cycles|Refused Treatment|1
201333|NCT02490475|632424|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
201334|NCT02490475|632425|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
201335|NCT02490475|632426|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
201336|NCT02490475|632427|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
201337|NCT02490475|632424|P4|Period 1: First 6 Cycles|Adverse Event|1
201338|NCT02490475|632425|P3|Period 1: First 6 Cycles|Adverse Event|0
201339|NCT02490475|632426|P2|Period 1: First 6 Cycles|Adverse Event|1
201340|NCT02490475|632427|P1|Period 1: First 6 Cycles|Adverse Event|2
201341|NCT02488980|632517|P3|Overall Study|Protocol Violation|2
201342|NCT02488980|632518|P2|Overall Study|Protocol Violation|2
201343|NCT02488980|632519|P1|Overall Study|Protocol Violation|2
201344|NCT02486952|632565|P1|Overall Study|Unspecified|2
201345|NCT02486952|632565|P1|Overall Study|Lost to Follow-up|26
201346|NCT02486952|632565|P1|Overall Study|Lack of Efficacy|3
201347|NCT02486952|632565|P1|Overall Study|Death|15
201348|NCT02486952|632565|P1|Overall Study|Adverse Event|1
201349|NCT02486952|632565|P1|Overall Study|Not Started Induction Therapy|3
201350|NCT02485483|632572|P2|Overall Study|Discontinued after baseline|0
201351|NCT02485483|632573|P1|Overall Study|Discontinued after baseline|39
201352|NCT02485483|632572|P2|Overall Study|Depression at baseline|0
201353|NCT02485483|632573|P1|Overall Study|Depression at baseline|15
201354|NCT02485158|632588|P1|Overall Study|expected drug side effect|1
201355|NCT02485158|632588|P1|Overall Study|Withdrawal by Subject|3
201356|NCT02484911|632677|P2|Overall Study|Protocol Violation|1
201357|NCT02484911|632678|P1|Overall Study|Protocol Violation|2
201358|NCT02484911|632677|P2|Overall Study|Withdrawal by Subject|1
201359|NCT02484911|632678|P1|Overall Study|Withdrawal by Subject|2
201360|NCT02484729|632720|P10|Overall Study|Failure of IntelliCap Error|1
201361|NCT02484729|632721|P9|Overall Study|Failure of IntelliCap Error|0
201362|NCT02484729|632722|P8|Overall Study|Failure of IntelliCap Error|0
201363|NCT02484729|632723|P7|Overall Study|Failure of IntelliCap Error|0
201364|NCT02484729|632724|P6|Overall Study|Failure of IntelliCap Error|0
201365|NCT02484729|632725|P5|Overall Study|Failure of IntelliCap Error|0
201366|NCT02484729|632726|P4|Overall Study|Failure of IntelliCap Error|0
201367|NCT02484729|632727|P3|Overall Study|Failure of IntelliCap Error|0
201368|NCT02484729|632728|P2|Overall Study|Failure of IntelliCap Error|0
201369|NCT02484729|632729|P1|Overall Study|Failure of IntelliCap Error|0
201370|NCT02483975|632927|P2|Overall Study|Physician Decision|0
201371|NCT02483975|632928|P1|Overall Study|Physician Decision|2
201372|NCT02483975|632927|P2|Overall Study|Lost to Follow-up|1
201373|NCT02483975|632928|P1|Overall Study|Lost to Follow-up|0
201374|NCT02483975|632927|P2|Overall Study|Adverse Event|1
201375|NCT02483975|632928|P1|Overall Study|Adverse Event|0
201376|NCT02483611|632945|P3|Overall Study|Protocol Violation|1
201377|NCT02483611|632946|P2|Overall Study|Protocol Violation|0
201378|NCT02483611|632947|P1|Overall Study|Protocol Violation|0
201379|NCT02481934|633042|P1|Overall Study|Death|2
201380|NCT02480712|633066|P1|Overall Study|Lack of Efficacy|1
201381|NCT02480712|633066|P1|Overall Study|Death|1
201382|NCT02480712|633066|P1|Overall Study|Withdrew Consent|3
201383|NCT02480712|633066|P1|Overall Study|Lost to Follow-up|5
201384|NCT02480712|633066|P1|Overall Study|Enrolled but Never Treated|1
201385|NCT02480010|633138|P2|Overall Study|Refused Treatment|3
201386|NCT02480010|633139|P1|Overall Study|Refused Treatment|0
201387|NCT02480010|633138|P2|Overall Study|Insufficient therapeutic response|29
201388|NCT02480010|633139|P1|Overall Study|Insufficient therapeutic response|31
201389|NCT02480010|633138|P2|Overall Study|Death|0
201390|NCT02480010|633139|P1|Overall Study|Death|1
201391|NCT02480010|633138|P2|Overall Study|Adverse Event|1
201392|NCT02480010|633139|P1|Overall Study|Adverse Event|3
201393|NCT02478372|633208|P2|Overall Study|Death|2
201394|NCT02478372|633209|P1|Overall Study|Death|0
201395|NCT02478372|633208|P2|Overall Study|Lost to Follow-up|4
201396|NCT02478372|633209|P1|Overall Study|Lost to Follow-up|1
201397|NCT02478372|633208|P2|Overall Study|Protocol Violation|8
201398|NCT02478372|633209|P1|Overall Study|Protocol Violation|12
201399|NCT02476422|633237|P2|Overall Study|Subject/guardian decision|1
201400|NCT02476422|633238|P1|Overall Study|Subject/guardian decision|0
201401|NCT02475980|633268|P1|Overall Study|Withdrawal by Subject|1
201402|NCT02475980|633268|P1|Overall Study|Lost to Follow-up|4
201403|NCT02475564|633279|P2|Overall Study|Intense Menstrual bleeding|0
201404|NCT02475564|633280|P1|Overall Study|Intense Menstrual bleeding|1
201405|NCT02475564|633279|P2|Overall Study|Lost to Follow-up|1
201406|NCT02475564|633280|P1|Overall Study|Lost to Follow-up|2
201407|NCT02475564|633279|P2|Overall Study|Withdrawal by Subject|0
201408|NCT02475564|633280|P1|Overall Study|Withdrawal by Subject|1
201409|NCT02475278|633290|P1|Overall Study|Reason Not Specified|1
201410|NCT02475278|633290|P1|Overall Study|Lost to Follow-up|1
201411|NCT02473523|633340|P1|Overall Study|Lost to Follow-up|1
201412|NCT02473523|633340|P1|Overall Study|Death|1
201413|NCT02473510|633361|P2|Overall Study|Lost to Follow-up|2
201414|NCT02473510|633362|P1|Overall Study|Lost to Follow-up|1
201415|NCT02473367|633376|P1|Period 4|Lost to Follow-up|1
201416|NCT02473367|633376|P1|Wait 1|Withdrawal by Subject|1
201417|NCT02472886|633397|P3|Overall Study|Lack of Efficacy|1
201418|NCT02472886|633398|P2|Overall Study|Lack of Efficacy|2
201419|NCT02472886|633399|P1|Overall Study|Lack of Efficacy|0
201420|NCT02472847|633427|P2|Overall Study|Withdrawal by Subject|5
201421|NCT02472847|633428|P1|Overall Study|Withdrawal by Subject|1
201422|NCT02472756|633434|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
201423|NCT02472756|633434|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
201424|NCT02472756|633434|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
201425|NCT02472756|633434|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
201426|NCT02472756|633434|P1|Induction (Approximately 6 Months)|Adverse Event|1
201427|NCT02472366|633475|P2|Overall Study|Lost to Follow-up|0
201428|NCT02472366|633476|P1|Overall Study|Lost to Follow-up|1
201429|NCT02471755|633492|P2|Overall Study|Lost to Follow-up|1
201430|NCT02471755|633493|P1|Overall Study|Lost to Follow-up|0
201431|NCT02471755|633492|P2|Overall Study|Withdrawal by Subject|0
201432|NCT02471755|633493|P1|Overall Study|Withdrawal by Subject|1
201433|NCT02471612|633509|P1|Overall Study|Lost to Follow-up|2
201434|NCT02470429|633539|P2|Overall Study|Withdrawal by Subject|0
201435|NCT02470429|633540|P1|Overall Study|Withdrawal by Subject|1
201436|NCT02470429|633539|P2|Overall Study|Adverse Event|0
201437|NCT02470429|633540|P1|Overall Study|Adverse Event|1
201438|NCT02470403|633556|P5|Overall Study|Subject/guardian decision|0
201439|NCT02470403|633557|P4|Overall Study|Subject/guardian decision|4
201440|NCT02470403|633558|P3|Overall Study|Subject/guardian decision|0
201441|NCT02470403|633559|P2|Overall Study|Subject/guardian decision|0
201442|NCT02470403|633560|P1|Overall Study|Subject/guardian decision|1
201443|NCT02470403|633556|P5|Overall Study|Lost to Follow-up|0
201444|NCT02470403|633557|P4|Overall Study|Lost to Follow-up|0
201445|NCT02470403|633558|P3|Overall Study|Lost to Follow-up|0
201446|NCT02470403|633559|P2|Overall Study|Lost to Follow-up|1
201447|NCT02470403|633560|P1|Overall Study|Lost to Follow-up|0
201448|NCT02470403|633556|P5|Overall Study|Adverse Event|0
201449|NCT02470403|633557|P4|Overall Study|Adverse Event|0
201450|NCT02470403|633558|P3|Overall Study|Adverse Event|0
201451|NCT02470403|633559|P2|Overall Study|Adverse Event|0
201452|NCT02470403|633560|P1|Overall Study|Adverse Event|1
201453|NCT02469961|633600|P2|Overall Study|Physician Decision|1
201454|NCT02469961|633601|P1|Overall Study|Physician Decision|4
201455|NCT02466425|633677|P2|Overall Study|Withdrawal by Parent/Guardian|0
201456|NCT02466425|633678|P1|Overall Study|Withdrawal by Parent/Guardian|2
201457|NCT02466425|633677|P2|Overall Study|Unspecified|3
201458|NCT02466425|633678|P1|Overall Study|Unspecified|1
201459|NCT02466425|633677|P2|Overall Study|Withdrawal by Subject|1
201460|NCT02466425|633678|P1|Overall Study|Withdrawal by Subject|0
201461|NCT02466425|633677|P2|Overall Study|Protocol Violation|0
201462|NCT02466425|633678|P1|Overall Study|Protocol Violation|1
201463|NCT02466425|633677|P2|Overall Study|Lost to Follow-up|0
201464|NCT02466425|633678|P1|Overall Study|Lost to Follow-up|3
201465|NCT02466425|633677|P2|Overall Study|Lack of Efficacy|1
201466|NCT02466425|633678|P1|Overall Study|Lack of Efficacy|4
201467|NCT02466425|633677|P2|Overall Study|Adverse Event|11
201468|NCT02466425|633678|P1|Overall Study|Adverse Event|3
201469|NCT02465866|633698|P4|Period 3|Withdrawal by Subject|0
201470|NCT02465866|633699|P3|Period 3|Withdrawal by Subject|0
201471|NCT02465866|633700|P2|Period 3|Withdrawal by Subject|1
201472|NCT02465866|633701|P1|Period 3|Withdrawal by Subject|0
201473|NCT02465489|633771|P1|Overall Study|Adverse Event|5
201474|NCT02463409|633811|P1|Overall Study|Screen failure|1
201475|NCT02463409|633811|P1|Overall Study|Withdrawal by Subject|1
201476|NCT02463331|633818|P2|Overall Study|Physician Decision|0
201477|NCT02463331|633819|P1|Overall Study|Physician Decision|3
201478|NCT02463331|633818|P2|Overall Study|Lack of Efficacy|0
201479|NCT02463331|633819|P1|Overall Study|Lack of Efficacy|6
201480|NCT02463331|633818|P2|Overall Study|Pregnancy|3
201481|NCT02463331|633819|P1|Overall Study|Pregnancy|2
201482|NCT02463331|633818|P2|Overall Study|Lost to Follow-up|1
201483|NCT02463331|633819|P1|Overall Study|Lost to Follow-up|1
201484|NCT02463331|633818|P2|Overall Study|Adverse Event|2
201485|NCT02463331|633819|P1|Overall Study|Adverse Event|4
201486|NCT02463097|633835|P1|Overall Study|Withdrawal by Subject|1
201487|NCT02462473|633841|P1|Overall Study|Unspecified|3
201488|NCT02462473|633841|P1|Overall Study|Death|1
201489|NCT02461290|633910|P1|Overall Study|Lost to Follow-up|3
201490|NCT02461290|633910|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
201491|NCT02460822|633917|P1|Overall Study|Withdrawal by Subject|1
201492|NCT02457611|633968|P1|Overall Study|Lost to Follow-up|3
201493|NCT02457247|633984|P4|Period 2|Voluntary Withdrawal|0
201494|NCT02457247|633985|P3|Period 2|Voluntary Withdrawal|0
201495|NCT02457247|633986|P2|Period 2|Voluntary Withdrawal|1
201496|NCT02457247|633987|P1|Period 2|Voluntary Withdrawal|1
201497|NCT02457247|633984|P4|Period 2|Lost to Follow-up|0
201498|NCT02457247|633985|P3|Period 2|Lost to Follow-up|0
201499|NCT02457247|633986|P2|Period 2|Lost to Follow-up|1
201500|NCT02457247|633987|P1|Period 2|Lost to Follow-up|0
201501|NCT02457247|633984|P4|Period 2|Significant Protocol Deviation|0
201502|NCT02457247|633985|P3|Period 2|Significant Protocol Deviation|0
201503|NCT02457247|633986|P2|Period 2|Significant Protocol Deviation|0
201504|NCT02457247|633987|P1|Period 2|Significant Protocol Deviation|1
201505|NCT02457247|633984|P4|Period 2|Pretreatment Event/Adverse Event|0
201506|NCT02457247|633985|P3|Period 2|Pretreatment Event/Adverse Event|0
201507|NCT02457247|633986|P2|Period 2|Pretreatment Event/Adverse Event|1
201508|NCT02457247|633987|P1|Period 2|Pretreatment Event/Adverse Event|0
201509|NCT02457247|633984|P4|Period 1|Voluntary Withdrawal|0
201510|NCT02457247|633985|P3|Period 1|Voluntary Withdrawal|0
201511|NCT02457247|633986|P2|Period 1|Voluntary Withdrawal|0
201512|NCT02457247|633987|P1|Period 1|Voluntary Withdrawal|1
201513|NCT02457247|633984|P4|Period 1|Significant Protocol Deviation|0
201514|NCT02457247|633985|P3|Period 1|Significant Protocol Deviation|0
201515|NCT02457247|633986|P2|Period 1|Significant Protocol Deviation|1
201516|NCT02457247|633987|P1|Period 1|Significant Protocol Deviation|1
201517|NCT02457247|633984|P4|Period 1|Pretreatment Event/Adverse Event|0
201518|NCT02457247|633985|P3|Period 1|Pretreatment Event/Adverse Event|0
201519|NCT02457247|633986|P2|Period 1|Pretreatment Event/Adverse Event|1
201520|NCT02457247|633987|P1|Period 1|Pretreatment Event/Adverse Event|0
201521|NCT02455050|634011|P4|Treatment Period 2|Lost to Follow-up|1
201522|NCT02455050|634012|P3|Treatment Period 2|Lost to Follow-up|2
201523|NCT02455050|634013|P2|Treatment Period 2|Lost to Follow-up|0
201524|NCT02455050|634014|P1|Treatment Period 2|Lost to Follow-up|1
201525|NCT02455050|634011|P4|Treatment Period 1|Lost to Follow-up|2
201526|NCT02455050|634012|P3|Treatment Period 1|Lost to Follow-up|1
201527|NCT02455050|634013|P2|Treatment Period 1|Lost to Follow-up|1
201528|NCT02455050|634014|P1|Treatment Period 1|Lost to Follow-up|1
201529|NCT02454959|634078|P1|Overall Study|Adverse Event|2
201530|NCT02454959|634078|P1|Overall Study|Withdrawal by Subject|3
201531|NCT02454959|634078|P1|Overall Study|Physician Decision|1
201532|NCT02454959|634078|P1|Overall Study|Protocol-Specified Criteria|3
201533|NCT02454608|634098|P2|Overall Study|Lack of Efficacy|2
201534|NCT02454608|634099|P1|Overall Study|Lack of Efficacy|0
201535|NCT02454101|634188|P2|Overall Study|Lost to Follow-up|4
201536|NCT02454101|634189|P1|Overall Study|Lost to Follow-up|3
201537|NCT02454101|634188|P2|Overall Study|Adverse Event|3
201538|NCT02454101|634189|P1|Overall Study|Adverse Event|2
201539|NCT02449902|634324|P2|Overall Study|Withdrawal by Subject|1
201540|NCT02449902|634325|P1|Overall Study|Withdrawal by Subject|0
201541|NCT02449902|634324|P2|Overall Study|Adverse Event|1
201542|NCT02449902|634325|P1|Overall Study|Adverse Event|0
201543|NCT02449044|634380|P1|Overall Study|Sponsor Discontinued Trial|3
201544|NCT02449044|634380|P1|Overall Study|Physician Decision|9
201545|NCT02449044|634380|P1|Overall Study|Met Withdrawal Criteria|7
201546|NCT02449044|634380|P1|Overall Study|Adverse Event|30
201547|NCT02449044|634380|P1|Overall Study|Withdrawal by Subject|13
201548|NCT02449044|634380|P1|Overall Study|Lost to Follow-up|2
201549|NCT02447458|634439|P6|Overall Study|Other|0
201550|NCT02447458|634440|P5|Overall Study|Other|0
201551|NCT02447458|634441|P4|Overall Study|Other|0
201552|NCT02447458|634442|P3|Overall Study|Other|1
201553|NCT02447458|634443|P2|Overall Study|Other|0
201554|NCT02447458|634444|P1|Overall Study|Other|0
201555|NCT02447432|634542|P2|Epoch 001|Lost to Follow-up|3
201556|NCT02447432|634543|P1|Epoch 001|Lost to Follow-up|1
201557|NCT02447432|634542|P2|Epoch 001|Migrated/moved from study area|5
201558|NCT02447432|634543|P1|Epoch 001|Migrated/moved from study area|3
201559|NCT02447432|634542|P2|Epoch 001|Withdrawal by Subject|4
201560|NCT02447432|634543|P1|Epoch 001|Withdrawal by Subject|0
201561|NCT02447432|634542|P2|Epoch 001|Adverse Event|1
201562|NCT02447432|634543|P1|Epoch 001|Adverse Event|1
201563|NCT02446990|634583|P2|Overall Study|Withdrawal by Subject|199
201564|NCT02446990|634584|P1|Overall Study|Withdrawal by Subject|231
201565|NCT02446990|634583|P2|Overall Study|Physician Decision|0
201566|NCT02446990|634584|P1|Overall Study|Physician Decision|1
201567|NCT02446990|634583|P2|Overall Study|Lost to Follow-up|1
201568|NCT02446990|634584|P1|Overall Study|Lost to Follow-up|3
201569|NCT02446990|634583|P2|Overall Study|Death|458
201570|NCT02446990|634584|P1|Overall Study|Death|485
201571|NCT02446171|634670|P4|Overall Study|Withdrawal by Subject|0
201572|NCT02446171|634671|P3|Overall Study|Withdrawal by Subject|2
201573|NCT02446171|634672|P2|Overall Study|Withdrawal by Subject|0
201574|NCT02446171|634673|P1|Overall Study|Withdrawal by Subject|0
201575|NCT02446015|634744|P2|Overall Study|Withdrawal by Subject|0
201576|NCT02446015|634745|P1|Overall Study|Withdrawal by Subject|1
201577|NCT02446015|634744|P2|Overall Study|Adverse Event|1
201578|NCT02446015|634745|P1|Overall Study|Adverse Event|0
201579|NCT02445755|634756|P1|Overall Study|Screen Failure|5
201580|NCT02445755|634756|P1|Overall Study|Protocol Violation|6
201581|NCT02445755|634756|P1|Overall Study|Withdrawal by Subject|2
201582|NCT02445573|634765|P2|Overall Study|Lost to Follow-up|1
201583|NCT02445573|634766|P1|Overall Study|Lost to Follow-up|0
201584|NCT02445573|634765|P2|Overall Study|Withdrawal by Subject|1
201585|NCT02445573|634766|P1|Overall Study|Withdrawal by Subject|1
201586|NCT02444182|634846|P2|Overall Study|Lost to Follow-up|4
201587|NCT02444182|634847|P1|Overall Study|Lost to Follow-up|0
201588|NCT02444182|634846|P2|Overall Study|non-compliance|1
201589|NCT02444182|634847|P1|Overall Study|non-compliance|2
201590|NCT02442349|634883|P1|Overall Study|On-going Study at Data Cut-off|149
201591|NCT02442349|634883|P1|Overall Study|Withdrawal by Subject|8
201592|NCT02442349|634883|P1|Overall Study|Death|14
201593|NCT02442310|634888|P1|Overall Study|Withdrawal by Subject|1
201594|NCT02442310|634888|P1|Overall Study|Adverse Event|2
201595|NCT02441218|634912|P2|Overall Study|Lost to Follow-up|1
201596|NCT02441218|634913|P1|Overall Study|Lost to Follow-up|2
201597|NCT02441218|634912|P2|Overall Study|Withdrawal by Subject|58
201598|NCT02441218|634913|P1|Overall Study|Withdrawal by Subject|73
201599|NCT02441218|634912|P2|Overall Study|Death|553
201600|NCT02441218|634913|P1|Overall Study|Death|503
201601|NCT02441179|634939|P2|Overall Study|Withdrawal by Subject|1
201602|NCT02441179|634940|P1|Overall Study|Withdrawal by Subject|1
201603|NCT02441114|634958|P1|Washout2|Withdrawal by Subject|4
201604|NCT02439138|634996|P1|Overall Study|PI decision to terminate the study|2
201605|NCT02439138|634996|P1|Overall Study|Adverse Event|1
201606|NCT02438137|635052|P2|Overall Study|Physician Decision|1
201607|NCT02438137|635053|P1|Overall Study|Physician Decision|0
201608|NCT02438137|635052|P2|Overall Study|Withdrawal by Subject|3
201609|NCT02438137|635053|P1|Overall Study|Withdrawal by Subject|4
201610|NCT02438137|635052|P2|Overall Study|Adverse Event|0
201611|NCT02438137|635053|P1|Overall Study|Adverse Event|1
201612|NCT02438137|635052|P2|Overall Study|Lost to Follow-up|2
201613|NCT02438137|635053|P1|Overall Study|Lost to Follow-up|3
201614|NCT02437903|635061|P1|Overall Study|Lost to Follow-up|3
201615|NCT02437903|635061|P1|Overall Study|Withdrawal by Subject|1
201616|NCT02437903|635061|P1|Overall Study|Adverse Event|1
201617|NCT02437409|635069|P1|Overall Study|Screening failure|9
201618|NCT02437409|635069|P1|Overall Study|Withdrawal by Subject|3
201619|NCT02437409|635069|P1|Overall Study|Protocol Violation|3
201620|NCT02437305|635082|P2|Overall Study|Lost to Follow-up|12
201621|NCT02437305|635083|P1|Overall Study|Lost to Follow-up|18
201622|NCT02436811|635094|P3|Overall Study|Lost to Follow-up|7
201623|NCT02436811|635095|P2|Overall Study|Lost to Follow-up|9
201624|NCT02436811|635096|P1|Overall Study|Lost to Follow-up|2
201625|NCT02436577|635110|P6|Overall Study|Protocol Deviation|0
201626|NCT02436577|635111|P5|Overall Study|Protocol Deviation|0
201627|NCT02436577|635112|P4|Overall Study|Protocol Deviation|0
201628|NCT02436577|635113|P3|Overall Study|Protocol Deviation|0
201629|NCT02436577|635114|P2|Overall Study|Protocol Deviation|1
201630|NCT02436577|635115|P1|Overall Study|Protocol Deviation|0
201631|NCT02436330|635170|P2|Cohort 6|Withdrawal by Subject|1
201632|NCT02436330|635171|P1|Cohort 6|Withdrawal by Subject|1
201633|NCT02436330|635170|P2|Cohort 6|Lost to Follow-up|0
201634|NCT02436330|635171|P1|Cohort 6|Lost to Follow-up|2
201635|NCT02436330|635170|P2|Cohort 5|Withdrawal by Subject|2
201636|NCT02436330|635171|P1|Cohort 5|Withdrawal by Subject|3
201637|NCT02436330|635170|P2|Cohort 5|Lost to Follow-up|2
201638|NCT02436330|635171|P1|Cohort 5|Lost to Follow-up|3
201639|NCT02436330|635170|P2|Cohort 4|Withdrawal by Subject|0
201640|NCT02436330|635171|P1|Cohort 4|Withdrawal by Subject|1
201641|NCT02436330|635170|P2|Cohort 4|Lost to Follow-up|0
201642|NCT02436330|635171|P1|Cohort 4|Lost to Follow-up|1
201643|NCT02436330|635170|P2|Cohort 3|Withdrawal by Subject|0
201644|NCT02436330|635171|P1|Cohort 3|Withdrawal by Subject|4
201645|NCT02436330|635170|P2|Cohort 3|Lost to Follow-up|0
201646|NCT02436330|635171|P1|Cohort 3|Lost to Follow-up|1
201647|NCT02436330|635170|P2|Cohort 2|Withdrawal by Subject|3
201648|NCT02436330|635171|P1|Cohort 2|Withdrawal by Subject|2
201649|NCT02436330|635170|P2|Cohort 2|Lost to Follow-up|0
201650|NCT02436330|635171|P1|Cohort 2|Lost to Follow-up|2
201651|NCT02436330|635170|P2|Cohort 1|Withdrawal by Subject|1
201652|NCT02436330|635171|P1|Cohort 1|Withdrawal by Subject|0
201653|NCT02436330|635170|P2|Cohort 1|Lost to Follow-up|2
201654|NCT02436330|635171|P1|Cohort 1|Lost to Follow-up|5
201655|NCT02435966|635227|P3|Overall Study|Withdrawal by Subject|0
201656|NCT02435966|635228|P2|Overall Study|Withdrawal by Subject|1
201657|NCT02435966|635229|P1|Overall Study|Withdrawal by Subject|0
201658|NCT02435836|635237|P1|Overall Study|AE of Worsening Schizophrenia|96
201659|NCT02435836|635237|P1|Overall Study|Met Withdrawal Criteria|7
201660|NCT02435836|635237|P1|Overall Study|Protocol Violation|6
201661|NCT02435836|635237|P1|Overall Study|Noncompliance|27
201662|NCT02435836|635237|P1|Overall Study|Sponsor discontinued trial|167
201663|NCT02435836|635237|P1|Overall Study|Adverse Event|44
201664|NCT02435836|635237|P1|Overall Study|Insufficient Clinical Response|26
201665|NCT02435836|635237|P1|Overall Study|Withdrawal by Subject|236
201666|NCT02435836|635237|P1|Overall Study|Lack of Efficacy|1
201667|NCT02435836|635237|P1|Overall Study|Lost to Follow-up|21
201668|NCT02434939|635255|P2|Overall Study|Adverse Event|1
201669|NCT02434939|635256|P1|Overall Study|Adverse Event|0
201670|NCT02434939|635255|P2|Overall Study|Withdrawal by Subject|0
201671|NCT02434939|635256|P1|Overall Study|Withdrawal by Subject|3
201672|NCT02434939|635255|P2|Overall Study|Lack of Efficacy|48
201673|NCT02434939|635256|P1|Overall Study|Lack of Efficacy|34
201674|NCT02432040|635308|P2|Overall Study|Physician Decision|1
201675|NCT02432040|635309|P1|Overall Study|Physician Decision|1
201676|NCT02432040|635308|P2|Overall Study|Lost to Follow-up|5
201677|NCT02432040|635309|P1|Overall Study|Lost to Follow-up|4
201678|NCT02432040|635308|P2|Overall Study|Lack of Efficacy|0
201679|NCT02432040|635309|P1|Overall Study|Lack of Efficacy|3
201680|NCT02430870|635422|P8|Part 2|Other Reason Not Specified|1
201681|NCT02430870|635423|P7|Part 2|Other Reason Not Specified|0
201682|NCT02430870|635424|P6|Part 2|Other Reason Not Specified|0
201683|NCT02430870|635425|P5|Part 2|Other Reason Not Specified|0
201684|NCT02430870|635426|P4|Part 2|Other Reason Not Specified|0
201685|NCT02430870|635427|P3|Part 2|Other Reason Not Specified|0
201686|NCT02430870|635428|P2|Part 2|Other Reason Not Specified|0
201687|NCT02430870|635429|P1|Part 2|Other Reason Not Specified|0
201688|NCT02430870|635422|P8|Part 2|Voluntary Withdrawal|0
201689|NCT02430870|635423|P7|Part 2|Voluntary Withdrawal|1
201690|NCT02430870|635424|P6|Part 2|Voluntary Withdrawal|0
201691|NCT02430870|635425|P5|Part 2|Voluntary Withdrawal|0
201692|NCT02430870|635426|P4|Part 2|Voluntary Withdrawal|0
201693|NCT02430870|635427|P3|Part 2|Voluntary Withdrawal|0
201694|NCT02430870|635428|P2|Part 2|Voluntary Withdrawal|0
201695|NCT02430870|635429|P1|Part 2|Voluntary Withdrawal|0
201696|NCT02430532|635503|P2|Overall Study|Adverse Event|1
201697|NCT02430532|635504|P1|Overall Study|Adverse Event|0
201698|NCT02430532|635503|P2|Overall Study|Consent Withdrawn|2
201699|NCT02430532|635504|P1|Overall Study|Consent Withdrawn|0
201700|NCT02430532|635503|P2|Overall Study|Sponsor Decision to Stop Study Early|25
201701|NCT02430532|635504|P1|Overall Study|Sponsor Decision to Stop Study Early|30
201702|NCT02429258|635544|P2|Overall Study|Protocol Violation|1
201703|NCT02429258|635545|P1|Overall Study|Protocol Violation|0
201704|NCT02429258|635544|P2|Overall Study|Withdrawal by Subject|0
201705|NCT02429258|635545|P1|Overall Study|Withdrawal by Subject|2
201706|NCT02428413|635582|P2|Overall Study|Nurse Refusal|0
201707|NCT02428413|635583|P1|Overall Study|Nurse Refusal|1
201708|NCT02428413|635582|P2|Overall Study|Missed Cases|2
201709|NCT02428413|635583|P1|Overall Study|Missed Cases|1
201710|NCT02428413|635582|P2|Overall Study|Case Cancelled|0
201711|NCT02428413|635583|P1|Overall Study|Case Cancelled|2
201712|NCT02428413|635582|P2|Overall Study|Protocol Violation|2
201713|NCT02428413|635583|P1|Overall Study|Protocol Violation|1
201714|NCT02428413|635582|P2|Overall Study|Device to measure WAG malfunctioned|5
201715|NCT02428413|635583|P1|Overall Study|Device to measure WAG malfunctioned|3
201716|NCT02428231|635597|P2|Overall Study|Adverse Event|0
201717|NCT02428231|635598|P1|Overall Study|Adverse Event|3
201718|NCT02428231|635597|P2|Overall Study|Required Symptomatic Therapy|1
201719|NCT02428231|635598|P1|Overall Study|Required Symptomatic Therapy|0
201720|NCT02428231|635597|P2|Overall Study|Not Specified|16
201721|NCT02428231|635598|P1|Overall Study|Not Specified|10
201722|NCT02427984|635615|P3|Overall Study|Lost to Follow-up|18
201723|NCT02427984|635616|P2|Overall Study|Lost to Follow-up|5
201724|NCT02427984|635617|P1|Overall Study|Lost to Follow-up|13
201725|NCT02427477|635659|P2|Period 1|Adverse Event|0
201726|NCT02427477|635660|P1|Period 1|Adverse Event|1
201727|NCT02425826|635670|P2|Overall Study|Unspecified|3
201728|NCT02425826|635671|P1|Overall Study|Unspecified|1
201729|NCT02425826|635670|P2|Overall Study|Lost to Follow-up|10
201730|NCT02425826|635671|P1|Overall Study|Lost to Follow-up|4
201731|NCT02425826|635670|P2|Overall Study|Withdrawal by Subject|9
201732|NCT02425826|635671|P1|Overall Study|Withdrawal by Subject|1
201733|NCT02425826|635670|P2|Overall Study|Lack of Efficacy|0
201734|NCT02425826|635671|P1|Overall Study|Lack of Efficacy|1
201735|NCT02425826|635670|P2|Overall Study|Adverse Event|5
201736|NCT02425826|635671|P1|Overall Study|Adverse Event|2
201737|NCT02424591|635751|P2|Overall Study|Protocol Violation|3
201738|NCT02424591|635752|P1|Overall Study|Protocol Violation|2
201739|NCT02424565|635762|P2|Period 1 (D0)|Protocol Violation|1
201740|NCT02424565|635763|P1|Period 1 (D0)|Protocol Violation|0
201741|NCT02424149|635771|P2|Overall Study|Withdrawal by Subject|1
201742|NCT02424149|635772|P1|Overall Study|Withdrawal by Subject|0
201743|NCT02424149|635771|P2|Overall Study|surgery cancelled|0
201744|NCT02424149|635772|P1|Overall Study|surgery cancelled|2
201745|NCT02421120|635882|P1|Overall Study|Adverse Event|1
201746|NCT02420093|635905|P2|Overall Study|Withdrawal by Subject|1
201747|NCT02420093|635906|P1|Overall Study|Withdrawal by Subject|1
201748|NCT02419313|635947|P2|Second Intervention|Lost to Follow-up|0
201749|NCT02419313|635948|P1|Second Intervention|Lost to Follow-up|1
201750|NCT02419313|635947|P2|First Intervention|Lost to Follow-up|0
201751|NCT02419313|635948|P1|First Intervention|Lost to Follow-up|2
201752|NCT02419001|635960|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
201753|NCT02419001|635961|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
201754|NCT02417961|636031|P1|Overall Study|Withdrawal by Subject|2
201755|NCT02417961|636031|P1|Overall Study|Lost to Follow-up|1
201756|NCT02417961|636031|P1|Overall Study|Adverse Event|1
201757|NCT02417753|636041|P1|Overall Study|Death|1
201758|NCT02417532|636051|P1|Overall Study|unable to complete exercises|4
201759|NCT02416180|636133|P1|Overall Study|Withdrawal by Subject|1
201760|NCT02415959|636145|P5|Overall Study|Protocol Violation|0
201761|NCT02415959|636146|P4|Overall Study|Protocol Violation|1
201762|NCT02415959|636147|P3|Overall Study|Protocol Violation|0
201763|NCT02415959|636148|P2|Overall Study|Protocol Violation|0
201764|NCT02415959|636149|P1|Overall Study|Protocol Violation|0
201765|NCT02415959|636145|P5|Overall Study|Adverse Event|0
201766|NCT02415959|636146|P4|Overall Study|Adverse Event|0
201767|NCT02415959|636147|P3|Overall Study|Adverse Event|0
201768|NCT02415959|636148|P2|Overall Study|Adverse Event|1
201769|NCT02415959|636149|P1|Overall Study|Adverse Event|0
201770|NCT02414828|636264|P4|Overall Study|Lost to Follow-up|2
201771|NCT02414828|636265|P3|Overall Study|Lost to Follow-up|1
201772|NCT02414828|636266|P2|Overall Study|Lost to Follow-up|1
201773|NCT02414828|636267|P1|Overall Study|Lost to Follow-up|0
201774|NCT02414152|636305|P1|Overall Study|Lack of Efficacy|1
201775|NCT02414152|636305|P1|Overall Study|Withdrawal by Subject|1
201776|NCT02413593|636309|P1|Overall Study|Adverse Event|1
201777|NCT02413593|636309|P1|Overall Study|Lost to Follow-up|3
201778|NCT02413333|636322|P2|Period 2|Protocol Deviation|0
201779|NCT02413333|636323|P1|Period 2|Protocol Deviation|1
201780|NCT02413333|636322|P2|Period 1|Reason Not Specified|1
201781|NCT02413333|636323|P1|Period 1|Reason Not Specified|0
201782|NCT02413333|636322|P2|Period 1|Adverse Event|0
201783|NCT02413333|636323|P1|Period 1|Adverse Event|1
201784|NCT02413294|636331|P1|Overall Study|Withdrawal by Subject|1
201785|NCT02412657|636386|P3|Overall Study|Protocol Violation|3
201786|NCT02412657|636387|P2|Overall Study|Protocol Violation|2
201787|NCT02412657|636388|P1|Overall Study|Protocol Violation|0
201788|NCT02412657|636386|P3|Overall Study|Lost to Follow-up|0
201789|NCT02412657|636387|P2|Overall Study|Lost to Follow-up|0
201790|NCT02412657|636388|P1|Overall Study|Lost to Follow-up|1
201791|NCT02411201|636396|P1|Overall Study|Age group completed|2
201792|NCT02411201|636396|P1|Overall Study|Withdrawal by Subject|2
201793|NCT02411201|636396|P1|Overall Study|Adverse Event|2
201794|NCT02411747|636439|P2|Overall Study|Protocol Violation|4
201795|NCT02411747|636440|P1|Overall Study|Protocol Violation|2
201796|NCT02411747|636439|P2|Overall Study|Withdrawal by Subject|0
201797|NCT02411747|636440|P1|Overall Study|Withdrawal by Subject|1
201798|NCT02410824|636446|P2|First Intervention (One Week)|Headache|1
201799|NCT02410824|636447|P1|First Intervention (One Week)|Headache|0
201800|NCT02410200|636488|P1|Overall Study|Adverse Event|2
201801|NCT02406586|636579|P3|Overall Study|Withdrawal by Subject|0
201802|NCT02406586|636580|P2|Overall Study|Withdrawal by Subject|0
201803|NCT02406586|636581|P1|Overall Study|Withdrawal by Subject|1
201804|NCT02406586|636579|P3|Overall Study|Lost to Follow-up|2
201805|NCT02406586|636580|P2|Overall Study|Lost to Follow-up|4
201806|NCT02406586|636581|P1|Overall Study|Lost to Follow-up|0
201807|NCT02404649|636694|P2|Overall Study|Adverse Event|2
201808|NCT02404649|636695|P1|Overall Study|Adverse Event|1
201809|NCT02404493|636703|P2|Overall Study|Adverse Event|1
201810|NCT02404493|636704|P1|Overall Study|Adverse Event|1
201811|NCT02403180|636957|P2|Period 2 (5 Days)|Withdrawal by Subject|1
201812|NCT02403180|636958|P1|Period 2 (5 Days)|Withdrawal by Subject|0
201813|NCT02403180|636957|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
201814|NCT02403180|636958|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
201815|NCT02402322|636977|P3|Follow-up|Withdrawal by Subject|24
201816|NCT02402322|636978|P2|Follow-up|Withdrawal by Subject|3
201817|NCT02402322|636979|P1|Follow-up|Withdrawal by Subject|6
201818|NCT02402322|636977|P3|Pretreatment|Withdrawal by Subject|1
201819|NCT02402322|636978|P2|Pretreatment|Withdrawal by Subject|1
201820|NCT02402322|636979|P1|Pretreatment|Withdrawal by Subject|3
201821|NCT02401529|637063|P2|Overall Study|Protocol Violation|0
201822|NCT02401529|637064|P1|Overall Study|Protocol Violation|5
201823|NCT02401529|637063|P2|Overall Study|Physician Decision|6
201824|NCT02401529|637064|P1|Overall Study|Physician Decision|2
201825|NCT02401529|637063|P2|Overall Study|Lost to Follow-up|1
201826|NCT02401529|637064|P1|Overall Study|Lost to Follow-up|2
201827|NCT02400333|637148|P4|Overall Study|Protocol Violation|1
201828|NCT02400333|637149|P3|Overall Study|Protocol Violation|2
201829|NCT02400333|637150|P2|Overall Study|Protocol Violation|0
201830|NCT02400333|637151|P1|Overall Study|Protocol Violation|1
201831|NCT02400333|637148|P4|Overall Study|Withdrawal by Subject|1
201832|NCT02400333|637149|P3|Overall Study|Withdrawal by Subject|0
201833|NCT02400333|637150|P2|Overall Study|Withdrawal by Subject|1
201834|NCT02400333|637151|P1|Overall Study|Withdrawal by Subject|0
201835|NCT02399163|637215|P1|Overall Study|Withdrawal by Participant|5
201836|NCT02399163|637215|P1|Overall Study|Protocol Deviation|2
201837|NCT02399163|637215|P1|Overall Study|Adverse Event|2
201838|NCT02397915|637260|P4|Period 1|Physician Decision|0
201839|NCT02397915|637261|P3|Period 1|Physician Decision|0
201840|NCT02397915|637262|P2|Period 1|Physician Decision|0
201841|NCT02397915|637263|P1|Period 1|Physician Decision|1
201842|NCT02397915|637260|P4|Period 1|Protocol Violation|0
201843|NCT02397915|637261|P3|Period 1|Protocol Violation|0
201844|NCT02397915|637262|P2|Period 1|Protocol Violation|1
201845|NCT02397915|637263|P1|Period 1|Protocol Violation|0
201846|NCT02397655|637313|P1|Overall Study|data not completed|1301
201847|NCT02396537|637319|P2|Overall Study|Protocol Violation|1
201848|NCT02396537|637320|P1|Overall Study|Protocol Violation|0
201849|NCT02395302|637414|P1|Overall Study|Physician Decision|2
201850|NCT02395302|637414|P1|Overall Study|Withdrawal by Subject|2
201851|NCT02395302|637414|P1|Overall Study|Run In Failure|7
201852|NCT02395302|637414|P1|Overall Study|Screen Failure|3
201853|NCT02395055|637420|P2|Overall Study|Withdrawal by Subject|3
201854|NCT02395055|637421|P1|Overall Study|Withdrawal by Subject|7
201855|NCT02394925|637431|P1|Overall Study|Unsatisfactory Visual Response|5
201856|NCT02394925|637431|P1|Overall Study|No longer meet eligibility criteria|1
201857|NCT02394925|637431|P1|Overall Study|Protocol Violation|5
201858|NCT02394925|637431|P1|Overall Study|Lost to Follow-up|9
201859|NCT02394925|637431|P1|Overall Study|Lens handling difficulities|5
201860|NCT02394925|637431|P1|Overall Study|Lens Discomfort|3
201861|NCT02394925|637431|P1|Overall Study|Adverse Event|1
201862|NCT02394756|637435|P6|Period 2|Unsatisfactory Visual Response|0
201863|NCT02394756|637436|P5|Period 2|Unsatisfactory Visual Response|1
201864|NCT02394756|637437|P4|Period 2|Unsatisfactory Visual Response|0
201865|NCT02394756|637438|P3|Period 2|Unsatisfactory Visual Response|0
201866|NCT02394756|637439|P2|Period 2|Unsatisfactory Visual Response|0
201867|NCT02394756|637440|P1|Period 2|Unsatisfactory Visual Response|0
201868|NCT02394756|637435|P6|Period 1|Withdrawal by Subject|0
201869|NCT02394756|637436|P5|Period 1|Withdrawal by Subject|0
201870|NCT02394756|637437|P4|Period 1|Withdrawal by Subject|1
201871|NCT02394756|637438|P3|Period 1|Withdrawal by Subject|1
201872|NCT02394756|637439|P2|Period 1|Withdrawal by Subject|1
201873|NCT02394756|637440|P1|Period 1|Withdrawal by Subject|0
201874|NCT02394756|637435|P6|Period 1|Lens Discomfort|1
201875|NCT02394756|637436|P5|Period 1|Lens Discomfort|0
201876|NCT02394756|637437|P4|Period 1|Lens Discomfort|0
201877|NCT02394756|637438|P3|Period 1|Lens Discomfort|0
201878|NCT02394756|637439|P2|Period 1|Lens Discomfort|0
201879|NCT02394756|637440|P1|Period 1|Lens Discomfort|0
201880|NCT02394665|637454|P3|Overall Study|Physician Decision|0
201881|NCT02394665|637455|P2|Overall Study|Physician Decision|0
201882|NCT02394665|637456|P1|Overall Study|Physician Decision|1
201883|NCT02393950|637497|P2|Overall Study|Withdrawal by Subject|1
201884|NCT02393950|637498|P1|Overall Study|Withdrawal by Subject|0
201885|NCT02393950|637497|P2|Overall Study|Adverse Event|0
201886|NCT02393950|637498|P1|Overall Study|Adverse Event|1
201887|NCT02393547|637572|P1|Overall Study|Lost to Follow-up|1
201888|NCT02393547|637572|P1|Overall Study|Withdrawal by Subject|3
201889|NCT02393547|637572|P1|Overall Study|Adverse Event|2
201890|NCT02392247|637598|P1|Overall Study|Surgery cancelled; no data|1
201891|NCT02392247|637598|P1|Overall Study|Withdrawal by Subject|1
201892|NCT02391311|637628|P2|Overall Study|deemed ineligible after baseline|1
201893|NCT02391311|637629|P1|Overall Study|deemed ineligible after baseline|1
201894|NCT02391311|637628|P2|Overall Study|Lost to Follow-up|1
201895|NCT02391311|637629|P1|Overall Study|Lost to Follow-up|2
201896|NCT02391038|637637|P3|Overall Study|Progressive disease|6
201897|NCT02391038|637638|P2|Overall Study|Progressive disease|3
201898|NCT02391038|637639|P1|Overall Study|Progressive disease|3
201899|NCT02390167|637753|P1|Overall Study|Lost to Follow-up|1
201900|NCT02389452|637834|P1|Overall Study|Enrolled but Not Eligible for Study|6
201901|NCT02389452|637834|P1|Overall Study|Withdrawal by Subject|5
201902|NCT02389452|637834|P1|Overall Study|Adverse Event|1
201903|NCT02389452|637834|P1|Overall Study|Lost to Follow-up|13
201904|NCT02388763|637909|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
201905|NCT02388763|637910|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
201906|NCT02388763|637909|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
201907|NCT02388763|637910|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
201908|NCT02388347|637926|P5|Overall Study|Withdrawal by Subject|0
201909|NCT02388347|637927|P4|Overall Study|Withdrawal by Subject|0
201910|NCT02388347|637928|P3|Overall Study|Withdrawal by Subject|1
201911|NCT02388347|637929|P2|Overall Study|Withdrawal by Subject|0
201912|NCT02388347|637930|P1|Overall Study|Withdrawal by Subject|0
201913|NCT02388074|637995|P1|Overall Study|Sample Not Returned|1
201914|NCT02388074|637995|P1|Overall Study|Lost in Transit|2
201915|NCT02387996|637999|P1|Overall Study|Poor/Non-Compliance|1
201916|NCT02387996|637999|P1|Overall Study|Lost to Follow-up|1
201917|NCT02387996|637999|P1|Overall Study|Subject Withdrew Consent|1
201918|NCT02387996|637999|P1|Overall Study|Subject Request to Discontinue Treatment|9
201919|NCT02387996|637999|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
201920|NCT02387996|637999|P1|Overall Study|Study Drug Toxicity|14
201921|NCT02387996|637999|P1|Overall Study|Disease Progression|144
201922|NCT02387580|638048|P6|Overall Study|Withdrawal by Subject|0
201923|NCT02387580|638049|P5|Overall Study|Withdrawal by Subject|0
201924|NCT02387580|638050|P4|Overall Study|Withdrawal by Subject|1
201925|NCT02387580|638051|P3|Overall Study|Withdrawal by Subject|0
201926|NCT02387580|638052|P2|Overall Study|Withdrawal by Subject|0
201927|NCT02387580|638053|P1|Overall Study|Withdrawal by Subject|0
201928|NCT02383862|638141|P2|3 Month Follow up|Lost to Follow-up|21
201929|NCT02383862|638142|P1|3 Month Follow up|Lost to Follow-up|23
201930|NCT02382640|638249|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
201931|NCT02382640|638250|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
201932|NCT02382640|638251|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
201933|NCT02382640|638252|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
201934|NCT02382133|638290|P1|Overall Study|pressure injury both sites|1
201935|NCT02382133|638290|P1|Overall Study|arterial catheter loss|4
201936|NCT02382133|638290|P1|Overall Study|Physician Decision|2
201937|NCT02382133|638290|P1|Overall Study|transfer out of ICU|4
201938|NCT02382133|638290|P1|Overall Study|Death|22
201939|NCT02380742|638345|P2|Overall Study|Withdrawal by Subject|0
201940|NCT02380742|638346|P1|Overall Study|Withdrawal by Subject|1
201941|NCT02380287|638366|P8|Overall Study|Adverse Event|0
201942|NCT02380287|638367|P7|Overall Study|Adverse Event|0
201943|NCT02380287|638368|P6|Overall Study|Adverse Event|0
201944|NCT02380287|638369|P5|Overall Study|Adverse Event|0
201945|NCT02380287|638370|P4|Overall Study|Adverse Event|0
201946|NCT02380287|638371|P3|Overall Study|Adverse Event|1
201947|NCT02380287|638372|P2|Overall Study|Adverse Event|0
201948|NCT02380287|638373|P1|Overall Study|Adverse Event|0
201949|NCT02380248|638389|P1|Overall Study|Withdrawal by Subject|3
201950|NCT02380248|638389|P1|Overall Study|Lost to Follow-up|11
201951|NCT02379637|638396|P2|Overall Study|Withdrawal by Subject|0
201952|NCT02379637|638397|P1|Overall Study|Withdrawal by Subject|1
201953|NCT02379637|638396|P2|Overall Study|Adverse Event|0
201954|NCT02379637|638397|P1|Overall Study|Adverse Event|1
201955|NCT02379637|638396|P2|Overall Study|Protocol Violation|1
201956|NCT02379637|638397|P1|Overall Study|Protocol Violation|0
201957|NCT02378506|638405|P1|Overall Study|Randomized But Not Treated|1
201958|NCT02378506|638405|P1|Overall Study|Adverse Event|14
201959|NCT02378506|638405|P1|Overall Study|Death|1
201960|NCT02378506|638405|P1|Overall Study|Protocol Violation|2
201961|NCT02378506|638405|P1|Overall Study|Withdrawal by Subject|4
201962|NCT02378506|638405|P1|Overall Study|Lack of Efficacy|3
201963|NCT02375724|638445|P2|Overall Study|Adverse Event|4
201964|NCT02375724|638446|P1|Overall Study|Adverse Event|2
201965|NCT02375724|638445|P2|Overall Study|Protocol Violation|0
201966|NCT02375724|638446|P1|Overall Study|Protocol Violation|1
201967|NCT02375724|638445|P2|Overall Study|Lost to Follow-up|0
201968|NCT02375724|638446|P1|Overall Study|Lost to Follow-up|1
201969|NCT02375724|638445|P2|Overall Study|Withdrawal by Subject|1
201970|NCT02375724|638446|P1|Overall Study|Withdrawal by Subject|1
201971|NCT02375724|638445|P2|Overall Study|Lack of Efficacy|1
201972|NCT02375724|638446|P1|Overall Study|Lack of Efficacy|1
201973|NCT02375373|638456|P1|Overall Study|Withdrawal by Subject|11
201974|NCT02375347|638460|P1|Overall Study|Protocol Violation|1
201975|NCT02374346|638497|P1|Overall Study|operated or discharged during weekend|48
201976|NCT02372071|638570|P1|Overall Study|Protocol Violation|18
201977|NCT02372058|638575|P1|Overall Study|Withdrawal by Subject|3
201978|NCT02371759|638599|P8|Overall Study|Withdrawal by Subject|1
201979|NCT02371759|638600|P7|Overall Study|Withdrawal by Subject|0
201980|NCT02371759|638601|P6|Overall Study|Withdrawal by Subject|0
201981|NCT02371759|638602|P5|Overall Study|Withdrawal by Subject|0
201982|NCT02371759|638603|P4|Overall Study|Withdrawal by Subject|0
201983|NCT02371759|638604|P3|Overall Study|Withdrawal by Subject|0
201984|NCT02371759|638605|P2|Overall Study|Withdrawal by Subject|0
201985|NCT02371759|638606|P1|Overall Study|Withdrawal by Subject|0
201986|NCT02371759|638599|P8|Overall Study|Protocol Violation|3
201987|NCT02371759|638600|P7|Overall Study|Protocol Violation|0
201988|NCT02371759|638601|P6|Overall Study|Protocol Violation|1
201989|NCT02371759|638602|P5|Overall Study|Protocol Violation|3
201990|NCT02371759|638603|P4|Overall Study|Protocol Violation|0
201991|NCT02371759|638604|P3|Overall Study|Protocol Violation|1
201992|NCT02371759|638605|P2|Overall Study|Protocol Violation|1
201993|NCT02371759|638606|P1|Overall Study|Protocol Violation|3
201994|NCT02370914|638816|P1|Overall Study|Protocol Violation|2
201995|NCT02370667|638823|P3|Overall Study|Lost to Follow-up|0
201996|NCT02370667|638824|P2|Overall Study|Lost to Follow-up|1
201997|NCT02370667|638825|P1|Overall Study|Lost to Follow-up|0
201998|NCT02370615|638889|P2|Overall Study|Adverse Event|0
201999|NCT02370615|638890|P1|Overall Study|Adverse Event|1
202000|NCT02370602|638933|P6|Overall Study|Pretreatment Event/Adverse Event|0
202001|NCT02370602|638934|P5|Overall Study|Pretreatment Event/Adverse Event|0
202002|NCT02370602|638935|P4|Overall Study|Pretreatment Event/Adverse Event|0
202003|NCT02370602|638936|P3|Overall Study|Pretreatment Event/Adverse Event|0
202004|NCT02370602|638937|P2|Overall Study|Pretreatment Event/Adverse Event|0
202005|NCT02370602|638938|P1|Overall Study|Pretreatment Event/Adverse Event|1
202006|NCT02370537|639032|P3|Part B|Withdrawal by Subject|0
202007|NCT02370537|639033|P2|Part B|Withdrawal by Subject|1
202008|NCT02370537|639034|P1|Part B|Withdrawal by Subject|0
202009|NCT02370537|639032|P3|Part B|Not randomised to receive treatment|259
202010|NCT02370537|639033|P2|Part B|Not randomised to receive treatment|2
202011|NCT02370537|639034|P1|Part B|Not randomised to receive treatment|1
202012|NCT02370537|639032|P3|Part A (Open-label Recruitment)|Adverse Event|1
202013|NCT02370537|639033|P2|Part A (Open-label Recruitment)|Adverse Event|0
202014|NCT02370537|639034|P1|Part A (Open-label Recruitment)|Adverse Event|0
202015|NCT02370537|639032|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
202016|NCT02370537|639033|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
202017|NCT02370537|639034|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
202018|NCT02370121|639083|P2|Overall Study|Lost to Follow-up|1
202019|NCT02370121|639084|P1|Overall Study|Lost to Follow-up|1
202020|NCT02369341|639172|P2|Overall Study|Migrated/moved from study area|0
202021|NCT02369341|639173|P1|Overall Study|Migrated/moved from study area|1
202022|NCT02368314|639240|P2|Overall Study|Adverse Event|2
202023|NCT02368314|639241|P1|Overall Study|Adverse Event|1
202024|NCT02368314|639240|P2|Overall Study|Withdrawal by Subject|1
202025|NCT02368314|639241|P1|Overall Study|Withdrawal by Subject|2
202026|NCT02367885|639263|P3|Overall Study|Withdrawal by Subject|0
202027|NCT02367885|639264|P2|Overall Study|Withdrawal by Subject|0
202028|NCT02367885|639265|P1|Overall Study|Withdrawal by Subject|1
202029|NCT02367885|639263|P3|Overall Study|Lost to Follow-up|0
202030|NCT02367885|639264|P2|Overall Study|Lost to Follow-up|0
202031|NCT02367885|639265|P1|Overall Study|Lost to Follow-up|1
202032|NCT02366936|639425|P1|Overall Study|Physician Decision|2
202033|NCT02366936|639425|P1|Overall Study|Lost to Follow-up|4
202034|NCT02366936|639425|P1|Overall Study|Withdrawal by Subject|2
202035|NCT02366923|639430|P1|Overall Study|High Astigmatism|3
202036|NCT02366923|639430|P1|Overall Study|Positive Slit Lamp Findings|2
202037|NCT02366923|639430|P1|Overall Study|Withdrawal by Subject|1
202038|NCT02366910|639443|P1|Overall Study|Screen Failure|3
202039|NCT02366910|639443|P1|Overall Study|Withdrawal by Subject|2
202040|NCT02366767|639457|P2|Overall Study|left for home after 1 day at camp|0
202041|NCT02366767|639458|P1|Overall Study|left for home after 1 day at camp|1
202042|NCT02366689|639471|P3|Overall Study|Pregnancy|1
202043|NCT02366689|639472|P2|Overall Study|Pregnancy|1
202044|NCT02366689|639473|P1|Overall Study|Pregnancy|0
202045|NCT02366689|639471|P3|Overall Study|Lost to Follow-up|0
202046|NCT02366689|639472|P2|Overall Study|Lost to Follow-up|2
202047|NCT02366689|639473|P1|Overall Study|Lost to Follow-up|3
202048|NCT02366689|639471|P3|Overall Study|Withdrawal by Subject|1
202049|NCT02366689|639472|P2|Overall Study|Withdrawal by Subject|0
202050|NCT02366689|639473|P1|Overall Study|Withdrawal by Subject|1
202051|NCT02366637|639496|P2|Second Intervention Period|Study Terminated by Sponsor|1
202052|NCT02366637|639497|P1|Second Intervention Period|Study Terminated by Sponsor|1
202053|NCT02366637|639496|P2|First Intervention Period|Study Terminated by Sponsor|4
202054|NCT02366637|639497|P1|First Intervention Period|Study Terminated by Sponsor|6
202055|NCT02366637|639496|P2|First Intervention Period|Adverse Event|1
202056|NCT02366637|639497|P1|First Intervention Period|Adverse Event|0
202057|NCT02364180|639552|P1|Overall Study|Screen Fail|1
202058|NCT02363478|639556|P1|Overall Study|Adverse Event|4
202059|NCT02363478|639556|P1|Overall Study|Lost to Follow-up|4
202060|NCT02362412|639563|P2|Treatment Period III|Lost to Follow-up|1
202061|NCT02362412|639564|P1|Treatment Period III|Lost to Follow-up|0
202062|NCT02362360|639598|P2|Period 1|Withdrawal by Subject|1
202063|NCT02362360|639599|P1|Period 1|Withdrawal by Subject|2
202064|NCT02362360|639598|P2|Period 1|Lack of Efficacy|0
202065|NCT02362360|639599|P1|Period 1|Lack of Efficacy|1
202066|NCT02361580|639637|P2|Overall Study|Lost to Follow-up|3
202067|NCT02361580|639638|P1|Overall Study|Lost to Follow-up|6
202068|NCT02360995|639651|P3|Overall Study|Withdrawal by Subject|0
202069|NCT02360995|639652|P2|Overall Study|Withdrawal by Subject|1
202070|NCT02360995|639653|P1|Overall Study|Withdrawal by Subject|0
202071|NCT02360995|639651|P3|Overall Study|Lost to Follow-up|2
202072|NCT02360995|639652|P2|Overall Study|Lost to Follow-up|0
202073|NCT02360995|639653|P1|Overall Study|Lost to Follow-up|2
202074|NCT02359903|639713|P2|Overall Study|Adverse Event|2
202075|NCT02359903|639714|P1|Overall Study|Adverse Event|0
202076|NCT02359877|639726|P4|Overall Study|Adverse Event|1
202077|NCT02359877|639727|P3|Overall Study|Adverse Event|0
202078|NCT02359877|639728|P2|Overall Study|Adverse Event|0
202079|NCT02359877|639729|P1|Overall Study|Adverse Event|0
202080|NCT02359877|639726|P4|Overall Study|Withdrawal by Subject|2
202081|NCT02359877|639727|P3|Overall Study|Withdrawal by Subject|0
202082|NCT02359877|639728|P2|Overall Study|Withdrawal by Subject|0
202083|NCT02359877|639729|P1|Overall Study|Withdrawal by Subject|1
202084|NCT02359435|639781|P2|Overall Study|Lost to Follow-up|4
202085|NCT02359435|639782|P1|Overall Study|Lost to Follow-up|4
202086|NCT02359045|639790|P2|Overall Study|Adverse Event|1
202087|NCT02359045|639791|P1|Overall Study|Adverse Event|0
202088|NCT02359045|639790|P2|Overall Study|Lost to Follow-up|1
202089|NCT02359045|639791|P1|Overall Study|Lost to Follow-up|1
202090|NCT02359045|639790|P2|Overall Study|Eligibility criteria not fulfilled|1
202091|NCT02359045|639791|P1|Overall Study|Eligibility criteria not fulfilled|3
202092|NCT02358668|640031|P3|Overall Study|Withdrawal by Subject|0
202093|NCT02358668|640032|P2|Overall Study|Withdrawal by Subject|1
202094|NCT02358668|640033|P1|Overall Study|Withdrawal by Subject|0
202095|NCT02358668|640031|P3|Overall Study|Adverse Event|0
202096|NCT02358668|640032|P2|Overall Study|Adverse Event|0
202097|NCT02358668|640033|P1|Overall Study|Adverse Event|2
202098|NCT02358044|640175|P2|Overall Study|Withdrawal by Subject|4
202099|NCT02358044|640176|P1|Overall Study|Withdrawal by Subject|0
202100|NCT02358044|640175|P2|Overall Study|Physician Decision|1
202101|NCT02358044|640176|P1|Overall Study|Physician Decision|0
202102|NCT02358044|640175|P2|Overall Study|Lost to Follow-up|1
202103|NCT02358044|640176|P1|Overall Study|Lost to Follow-up|2
202104|NCT02358044|640175|P2|Overall Study|Adverse Event|1
202105|NCT02358044|640176|P1|Overall Study|Adverse Event|0
202106|NCT02357940|640194|P2|Overall Study|Investigator's judgement|1
202107|NCT02357940|640195|P1|Overall Study|Investigator's judgement|0
202108|NCT02357940|640194|P2|Overall Study|Adverse Event|1
202109|NCT02357940|640195|P1|Overall Study|Adverse Event|0
202112|NCT02356588|640372|P2|Overall Study|Protocol Violation|1
202113|NCT02356588|640373|P1|Overall Study|Protocol Violation|0
202114|NCT02356588|640372|P2|Overall Study|Withdrawal by Subject|0
202115|NCT02356588|640373|P1|Overall Study|Withdrawal by Subject|1
202116|NCT02356588|640372|P2|Overall Study|Adverse Event|2
202117|NCT02356588|640373|P1|Overall Study|Adverse Event|0
202118|NCT02356588|640372|P2|Overall Study|Lack of Efficacy|10
202119|NCT02356588|640373|P1|Overall Study|Lack of Efficacy|4
202120|NCT02354599|640463|P6|Overall Study|Withdrawal by Subject|0
202121|NCT02354599|640464|P5|Overall Study|Withdrawal by Subject|0
202122|NCT02354599|640465|P4|Overall Study|Withdrawal by Subject|0
202123|NCT02354599|640466|P3|Overall Study|Withdrawal by Subject|0
202124|NCT02354599|640467|P2|Overall Study|Withdrawal by Subject|1
202125|NCT02354599|640468|P1|Overall Study|Withdrawal by Subject|1
202126|NCT02354599|640463|P6|Overall Study|Pretreatment Event/Adverse Event|1
202127|NCT02354599|640464|P5|Overall Study|Pretreatment Event/Adverse Event|0
202128|NCT02354599|640465|P4|Overall Study|Pretreatment Event/Adverse Event|0
202129|NCT02354599|640466|P3|Overall Study|Pretreatment Event/Adverse Event|0
202130|NCT02354599|640467|P2|Overall Study|Pretreatment Event/Adverse Event|0
202131|NCT02354599|640468|P1|Overall Study|Pretreatment Event/Adverse Event|0
202132|NCT02353572|640551|P1|Overall Study|Study terminated|2
202133|NCT02353572|640551|P1|Overall Study|Withdrawal by Subject|1
202134|NCT02353468|640555|P1|Overall Study|Study terminated|3
202135|NCT02353442|640561|P2|Overall Study|Withdrawal by Subject|4
202136|NCT02353442|640562|P1|Overall Study|Withdrawal by Subject|3
202137|NCT02351817|640581|P2|Period 2|Protocol Violation|0
202138|NCT02351817|640582|P1|Period 2|Protocol Violation|1
202139|NCT02351817|640581|P2|Period 2|Adverse Event|2
202140|NCT02351817|640582|P1|Period 2|Adverse Event|0
202141|NCT02351817|640581|P2|Period 1|Lack of Efficacy|1
202142|NCT02351817|640582|P1|Period 1|Lack of Efficacy|0
202143|NCT02351817|640581|P2|Period 1|Adverse Event|2
202144|NCT02351817|640582|P1|Period 1|Adverse Event|1
202145|NCT02349711|640640|P2|Overall Study|Lost to Follow-up|1
202146|NCT02349711|640641|P1|Overall Study|Lost to Follow-up|1
202147|NCT02349711|640640|P2|Overall Study|Withdrawal by Subject|1
202148|NCT02349711|640641|P1|Overall Study|Withdrawal by Subject|2
202149|NCT02349048|640682|P2|Overall Study|Lost to Follow-up|0
202150|NCT02349048|640683|P1|Overall Study|Lost to Follow-up|1
202151|NCT02349048|640682|P2|Overall Study|Withdrawal by Subject|0
202152|NCT02349048|640683|P1|Overall Study|Withdrawal by Subject|4
202153|NCT02347176|640752|P4|Overall Study|Unspecified|0
202154|NCT02347176|640753|P3|Overall Study|Unspecified|2
202155|NCT02347176|640754|P2|Overall Study|Unspecified|2
202156|NCT02347176|640755|P1|Overall Study|Unspecified|1
202157|NCT02347176|640752|P4|Overall Study|Withdrawal by Subject|3
202158|NCT02347176|640753|P3|Overall Study|Withdrawal by Subject|5
202159|NCT02347176|640754|P2|Overall Study|Withdrawal by Subject|5
202160|NCT02347176|640755|P1|Overall Study|Withdrawal by Subject|9
202161|NCT02347176|640752|P4|Overall Study|Lost to Follow-up|1
202162|NCT02347176|640753|P3|Overall Study|Lost to Follow-up|1
202163|NCT02347176|640754|P2|Overall Study|Lost to Follow-up|3
202164|NCT02347176|640755|P1|Overall Study|Lost to Follow-up|2
202165|NCT02347085|640801|P1|Overall Study|Protocol Criteria|2
202166|NCT02347085|640801|P1|Overall Study|Lost to Follow-up|1
202167|NCT02347085|640801|P1|Overall Study|Withdrawal by Subject|4
202168|NCT02347085|640801|P1|Overall Study|Lack of Efficacy|1
202169|NCT02347085|640801|P1|Overall Study|Adverse Event|2
202170|NCT02347072|640823|P1|Overall Study|Disc due to Protocol-specified Criteria|6
202171|NCT02347072|640823|P1|Overall Study|Protocol Violation|1
202172|NCT02347072|640823|P1|Overall Study|Lost to Follow-up|2
202173|NCT02347072|640823|P1|Overall Study|Physician Decision|1
202174|NCT02347072|640823|P1|Overall Study|Withdrawal by Subject|6
202175|NCT02347072|640823|P1|Overall Study|Adverse Event|2
202176|NCT02346877|640857|P2|Overall Study|Missing|0
202177|NCT02346877|640858|P1|Overall Study|Missing|5
202178|NCT02346877|640857|P2|Overall Study|Sponsor Decision|0
202179|NCT02346877|640858|P1|Overall Study|Sponsor Decision|12
202180|NCT02346877|640857|P2|Overall Study|Administrative Decision|0
202181|NCT02346877|640858|P1|Overall Study|Administrative Decision|1
202182|NCT02346877|640857|P2|Overall Study|Adverse Event|0
202183|NCT02346877|640858|P1|Overall Study|Adverse Event|1
202184|NCT02346721|640868|P1|Overall Study|Lack of Efficacy|1
202185|NCT02346721|640868|P1|Overall Study|Withdrew Consent|3
202186|NCT02344745|640885|P2|Overall Study|Data collection sheets were lost|0
202187|NCT02344745|640886|P1|Overall Study|Data collection sheets were lost|2
202188|NCT02344342|640902|P4|Overall Study|Industry partner dropped out|10
202189|NCT02344342|640903|P3|Overall Study|Industry partner dropped out|14
202190|NCT02344342|640904|P2|Overall Study|Industry partner dropped out|9
202191|NCT02344342|640905|P1|Overall Study|Industry partner dropped out|11
202192|NCT02343159|640943|P3|Overall Study|Enrollment Error|0
202193|NCT02343159|640944|P2|Overall Study|Enrollment Error|0
202194|NCT02343159|640945|P1|Overall Study|Enrollment Error|1
202195|NCT02343159|640943|P3|Overall Study|Sponsor Decision|0
202196|NCT02343159|640944|P2|Overall Study|Sponsor Decision|1
202197|NCT02343159|640945|P1|Overall Study|Sponsor Decision|0
202198|NCT02343159|640943|P3|Overall Study|Adverse Event|2
202199|NCT02343159|640944|P2|Overall Study|Adverse Event|4
202200|NCT02343159|640945|P1|Overall Study|Adverse Event|4
202201|NCT02343159|640943|P3|Overall Study|Lost to Follow-up|2
202202|NCT02343159|640944|P2|Overall Study|Lost to Follow-up|2
202203|NCT02343159|640945|P1|Overall Study|Lost to Follow-up|0
202204|NCT02343159|640943|P3|Overall Study|Withdrawal by Subject|2
202205|NCT02343159|640944|P2|Overall Study|Withdrawal by Subject|0
202206|NCT02343159|640945|P1|Overall Study|Withdrawal by Subject|3
202207|NCT02343159|640943|P3|Overall Study|Physician Decision|1
202208|NCT02343159|640944|P2|Overall Study|Physician Decision|0
202209|NCT02343159|640945|P1|Overall Study|Physician Decision|2
202210|NCT02343159|640943|P3|Overall Study|Early Study Termination|23
202211|NCT02343159|640944|P2|Overall Study|Early Study Termination|19
202212|NCT02343159|640945|P1|Overall Study|Early Study Termination|16
202213|NCT02342704|640989|P2|Overall Study|Adverse Event|3
202214|NCT02342704|640990|P1|Overall Study|Adverse Event|1
202215|NCT02342704|640989|P2|Overall Study|Lost to Follow-up|1
202216|NCT02342704|640990|P1|Overall Study|Lost to Follow-up|2
202217|NCT02342704|640989|P2|Overall Study|Withdrawal by Subject|0
202218|NCT02342704|640990|P1|Overall Study|Withdrawal by Subject|1
202219|NCT02342704|640989|P2|Overall Study|Not Specified|1
202220|NCT02342704|640990|P1|Overall Study|Not Specified|0
202221|NCT02342704|640989|P2|Overall Study|Sponsor Termination|43
202222|NCT02342704|640990|P1|Overall Study|Sponsor Termination|49
202223|NCT02342704|640989|P2|Overall Study|Physician Decision|3
202224|NCT02342704|640990|P1|Overall Study|Physician Decision|0
202225|NCT02342418|641026|P2|Overall Study|Adverse Event|1
202226|NCT02342418|641027|P1|Overall Study|Adverse Event|0
202227|NCT02342288|641037|P2|Overall Study|coordinator not available|2
202228|NCT02342288|641038|P1|Overall Study|coordinator not available|0
202229|NCT02342288|641037|P2|Overall Study|subject cannot tolerate numbing drops|1
202230|NCT02342288|641038|P1|Overall Study|subject cannot tolerate numbing drops|0
202231|NCT02342288|641037|P2|Overall Study|coordinator contaminated with blood|1
202232|NCT02342288|641038|P1|Overall Study|coordinator contaminated with blood|0
202233|NCT02342288|641037|P2|Overall Study|Withdrawal by Subject|0
202234|NCT02342288|641038|P1|Overall Study|Withdrawal by Subject|1
202235|NCT02342288|641037|P2|Overall Study|anesthesia leak in system|0
202236|NCT02342288|641038|P1|Overall Study|anesthesia leak in system|1
202237|NCT02342288|641037|P2|Overall Study|no protocol anesthesiologist available|2
202238|NCT02342288|641038|P1|Overall Study|no protocol anesthesiologist available|3
202239|NCT02342223|641044|P1|Overall Study|Lost to Follow-up|1
202240|NCT02341482|641216|P1|Overall Study|Adverse Event|1
202241|NCT02336607|641431|P4|Overall Study|Withdrawal by Subject|20
202242|NCT02336607|641432|P3|Overall Study|Withdrawal by Subject|0
202243|NCT02336607|641433|P2|Overall Study|Withdrawal by Subject|2
202244|NCT02336607|641434|P1|Overall Study|Withdrawal by Subject|0
202245|NCT02336607|641431|P4|Overall Study|Adverse Event|26
202246|NCT02336607|641432|P3|Overall Study|Adverse Event|2
202247|NCT02336607|641433|P2|Overall Study|Adverse Event|2
202248|NCT02336607|641434|P1|Overall Study|Adverse Event|0
202249|NCT02336607|641431|P4|Overall Study|Protocol Violation|3
202250|NCT02336607|641432|P3|Overall Study|Protocol Violation|1
202251|NCT02336607|641433|P2|Overall Study|Protocol Violation|1
202252|NCT02336607|641434|P1|Overall Study|Protocol Violation|0
202253|NCT02336607|641431|P4|Overall Study|Lost to Follow-up|21
202254|NCT02336607|641432|P3|Overall Study|Lost to Follow-up|0
202255|NCT02336607|641433|P2|Overall Study|Lost to Follow-up|1
202256|NCT02336607|641434|P1|Overall Study|Lost to Follow-up|2
202257|NCT02336607|641431|P4|Overall Study|Lack of Efficacy|2
202258|NCT02336607|641432|P3|Overall Study|Lack of Efficacy|0
202259|NCT02336607|641433|P2|Overall Study|Lack of Efficacy|0
202260|NCT02336607|641434|P1|Overall Study|Lack of Efficacy|1
202261|NCT02336607|641431|P4|Overall Study|Physician Decision|15
202262|NCT02336607|641432|P3|Overall Study|Physician Decision|3
202263|NCT02336607|641433|P2|Overall Study|Physician Decision|4
202264|NCT02336607|641434|P1|Overall Study|Physician Decision|1
202265|NCT02336425|641501|P4|Overall Study|Study terminated.|3
202266|NCT02336425|641502|P3|Overall Study|Study terminated.|3
202267|NCT02336425|641503|P2|Overall Study|Study terminated.|2
202268|NCT02336425|641504|P1|Overall Study|Study terminated.|2
202269|NCT02336178|641554|P1|Overall Study|Unspecified|1
202270|NCT02336178|641554|P1|Overall Study|Withdrawal by Subject|1
202271|NCT02336178|641554|P1|Overall Study|Protocol Violation|1
202272|NCT02336178|641554|P1|Overall Study|Lost to Follow-up|1
202273|NCT02332798|641841|P3|Overall Study|Abnormal laboratory findings|0
202274|NCT02332798|641842|P2|Overall Study|Abnormal laboratory findings|0
202275|NCT02332798|641843|P1|Overall Study|Abnormal laboratory findings|1
202276|NCT02332798|641841|P3|Overall Study|Positive urine drug test|0
202277|NCT02332798|641842|P2|Overall Study|Positive urine drug test|1
202278|NCT02332798|641843|P1|Overall Study|Positive urine drug test|0
202279|NCT02332798|641841|P3|Overall Study|Unwilling to participate in study|1
202280|NCT02332798|641842|P2|Overall Study|Unwilling to participate in study|1
202281|NCT02332798|641843|P1|Overall Study|Unwilling to participate in study|0
202282|NCT02331446|641927|P4|Overall Study|Lost before baseline analysis|0
202283|NCT02331446|641928|P3|Overall Study|Lost before baseline analysis|1
202284|NCT02331446|641929|P2|Overall Study|Lost before baseline analysis|1
202285|NCT02331446|641930|P1|Overall Study|Lost before baseline analysis|0
202286|NCT02331446|641927|P4|Overall Study|Physician Decision|1
202287|NCT02331446|641928|P3|Overall Study|Physician Decision|0
202288|NCT02331446|641929|P2|Overall Study|Physician Decision|1
202289|NCT02331446|641930|P1|Overall Study|Physician Decision|0
202290|NCT02331446|641927|P4|Overall Study|Disease|1
202291|NCT02331446|641928|P3|Overall Study|Disease|2
202292|NCT02331446|641929|P2|Overall Study|Disease|2
202293|NCT02331446|641930|P1|Overall Study|Disease|0
202294|NCT02331446|641927|P4|Overall Study|Personal Problem|0
202295|NCT02331446|641928|P3|Overall Study|Personal Problem|0
202296|NCT02331446|641929|P2|Overall Study|Personal Problem|0
202297|NCT02331446|641930|P1|Overall Study|Personal Problem|2
202298|NCT02331446|641927|P4|Overall Study|Lost to Follow-up|1
202299|NCT02331446|641928|P3|Overall Study|Lost to Follow-up|0
202300|NCT02331446|641929|P2|Overall Study|Lost to Follow-up|1
202301|NCT02331446|641930|P1|Overall Study|Lost to Follow-up|2
202302|NCT02329730|642145|P12|Overall Study|Withdrawal by Subject|0
202303|NCT02329730|642146|P11|Overall Study|Withdrawal by Subject|0
202304|NCT02329730|642147|P10|Overall Study|Withdrawal by Subject|1
202305|NCT02329730|642148|P9|Overall Study|Withdrawal by Subject|1
202306|NCT02329730|642149|P8|Overall Study|Withdrawal by Subject|1
202307|NCT02329730|642150|P7|Overall Study|Withdrawal by Subject|1
202308|NCT02329730|642151|P6|Overall Study|Withdrawal by Subject|0
202309|NCT02329730|642152|P5|Overall Study|Withdrawal by Subject|1
202310|NCT02329730|642153|P4|Overall Study|Withdrawal by Subject|0
202311|NCT02329730|642154|P3|Overall Study|Withdrawal by Subject|0
202312|NCT02329730|642155|P2|Overall Study|Withdrawal by Subject|0
202313|NCT02329730|642156|P1|Overall Study|Withdrawal by Subject|0
202314|NCT02329730|642145|P12|Overall Study|Protocol Violation|0
202315|NCT02329730|642146|P11|Overall Study|Protocol Violation|0
202316|NCT02329730|642147|P10|Overall Study|Protocol Violation|0
202317|NCT02329730|642148|P9|Overall Study|Protocol Violation|0
202318|NCT02329730|642149|P8|Overall Study|Protocol Violation|0
202319|NCT02329730|642150|P7|Overall Study|Protocol Violation|0
202320|NCT02329730|642151|P6|Overall Study|Protocol Violation|2
202321|NCT02329730|642152|P5|Overall Study|Protocol Violation|2
202322|NCT02329730|642153|P4|Overall Study|Protocol Violation|0
202323|NCT02329730|642154|P3|Overall Study|Protocol Violation|0
202324|NCT02329730|642155|P2|Overall Study|Protocol Violation|0
202325|NCT02329730|642156|P1|Overall Study|Protocol Violation|0
202326|NCT02329223|642249|P3|Overall Study|Adverse Event|0
202327|NCT02329223|642250|P2|Overall Study|Adverse Event|1
202328|NCT02329223|642251|P1|Overall Study|Adverse Event|0
202329|NCT02329223|642249|P3|Overall Study|Physician Decision|1
202330|NCT02329223|642250|P2|Overall Study|Physician Decision|0
202331|NCT02329223|642251|P1|Overall Study|Physician Decision|0
202332|NCT02329223|642249|P3|Overall Study|Withdrawal by Subject|5
202333|NCT02329223|642250|P2|Overall Study|Withdrawal by Subject|2
202334|NCT02329223|642251|P1|Overall Study|Withdrawal by Subject|1
202335|NCT02328937|642301|P6|Period 2|Adverse Event|0
202336|NCT02328937|642302|P5|Period 2|Adverse Event|0
202337|NCT02328937|642303|P4|Period 2|Adverse Event|0
202338|NCT02328937|642304|P3|Period 2|Adverse Event|1
202339|NCT02328937|642305|P2|Period 2|Adverse Event|0
202340|NCT02328937|642306|P1|Period 2|Adverse Event|0
202341|NCT02328937|642301|P6|Period 1|Lost to Follow-up|0
202342|NCT02328937|642302|P5|Period 1|Lost to Follow-up|0
202343|NCT02328937|642303|P4|Period 1|Lost to Follow-up|1
202344|NCT02328937|642304|P3|Period 1|Lost to Follow-up|0
202345|NCT02328937|642305|P2|Period 1|Lost to Follow-up|0
202346|NCT02328937|642306|P1|Period 1|Lost to Follow-up|0
202347|NCT02325713|642401|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202348|NCT02325713|642402|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202349|NCT02325713|642403|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202350|NCT02325713|642404|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202351|NCT02325713|642405|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202352|NCT02325713|642406|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202353|NCT02325713|642407|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
202354|NCT02325713|642408|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202355|NCT02325713|642409|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202356|NCT02325713|642410|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202357|NCT02325713|642411|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202358|NCT02325713|642412|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202359|NCT02325713|642413|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202360|NCT02325713|642414|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202361|NCT02325713|642415|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202362|NCT02325713|642416|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
202363|NCT02325713|642401|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202364|NCT02325713|642402|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202365|NCT02325713|642403|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202366|NCT02325713|642404|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202367|NCT02325713|642405|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202368|NCT02325713|642406|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202369|NCT02325713|642407|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202370|NCT02325713|642408|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202371|NCT02325713|642409|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202372|NCT02325713|642410|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202373|NCT02325713|642411|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202374|NCT02325713|642412|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202375|NCT02325713|642413|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202376|NCT02325713|642414|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202377|NCT02325713|642415|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
202378|NCT02325713|642416|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
202379|NCT02325713|642401|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202380|NCT02325713|642402|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202381|NCT02325713|642403|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202382|NCT02325713|642404|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202383|NCT02325713|642405|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202384|NCT02325713|642406|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
202385|NCT02325713|642407|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202386|NCT02325713|642408|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202387|NCT02325713|642409|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202388|NCT02325713|642410|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202389|NCT02325713|642411|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202390|NCT02325713|642412|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202391|NCT02325713|642413|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202392|NCT02325713|642414|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202393|NCT02325713|642415|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202394|NCT02325713|642416|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
202395|NCT02325518|642511|P2|Overall Study|Withdrawal by Subject|1
202396|NCT02325518|642512|P1|Overall Study|Withdrawal by Subject|0
202397|NCT02325518|642511|P2|Overall Study|Physician Decision|1
202398|NCT02325518|642512|P1|Overall Study|Physician Decision|0
202399|NCT02325518|642511|P2|Overall Study|Adverse Event|1
202400|NCT02325518|642512|P1|Overall Study|Adverse Event|4
202401|NCT02322892|642523|P2|Overall Study|Protocol Violation|0
202402|NCT02322892|642524|P1|Overall Study|Protocol Violation|1
202403|NCT02322892|642523|P2|Overall Study|Met exclusion criteria|1
202404|NCT02322892|642524|P1|Overall Study|Met exclusion criteria|0
202405|NCT02322892|642523|P2|Overall Study|Surgery cancelled|2
202406|NCT02322892|642524|P1|Overall Study|Surgery cancelled|1
202407|NCT02322775|642553|P2|Overall Study|Not willing to perform all FU visits|1
202408|NCT02322775|642554|P1|Overall Study|Not willing to perform all FU visits|0
202409|NCT02322775|642553|P2|Overall Study|Withdrawal by Subject|4
202410|NCT02322775|642554|P1|Overall Study|Withdrawal by Subject|3
202411|NCT02322775|642553|P2|Overall Study|Protocol Violation|0
202412|NCT02322775|642554|P1|Overall Study|Protocol Violation|1
202413|NCT02322775|642553|P2|Overall Study|Lost to Follow-up|1
202414|NCT02322775|642554|P1|Overall Study|Lost to Follow-up|0
202415|NCT02322775|642553|P2|Overall Study|Adverse Event|0
202416|NCT02322775|642554|P1|Overall Study|Adverse Event|1
202417|NCT02322749|642580|P6|Period 3|Withdrawal by Subject|0
202418|NCT02322749|642581|P5|Period 3|Withdrawal by Subject|0
202419|NCT02322749|642582|P4|Period 3|Withdrawal by Subject|0
202420|NCT02322749|642583|P3|Period 3|Withdrawal by Subject|1
202421|NCT02322749|642584|P2|Period 3|Withdrawal by Subject|0
202422|NCT02322749|642585|P1|Period 3|Withdrawal by Subject|0
202423|NCT02322749|642580|P6|Period 2|Withdrawal by Subject|0
202424|NCT02322749|642581|P5|Period 2|Withdrawal by Subject|0
202425|NCT02322749|642582|P4|Period 2|Withdrawal by Subject|1
202426|NCT02322749|642583|P3|Period 2|Withdrawal by Subject|0
202427|NCT02322749|642584|P2|Period 2|Withdrawal by Subject|0
202428|NCT02322749|642585|P1|Period 2|Withdrawal by Subject|0
202429|NCT02322749|642580|P6|Period 2|Adverse Event|0
202430|NCT02322749|642581|P5|Period 2|Adverse Event|0
202431|NCT02322749|642582|P4|Period 2|Adverse Event|1
202432|NCT02322749|642583|P3|Period 2|Adverse Event|0
202433|NCT02322749|642584|P2|Period 2|Adverse Event|0
202434|NCT02322749|642585|P1|Period 2|Adverse Event|0
202435|NCT02322216|642615|P2|Overall Study|Withdrawal by Subject|4
202436|NCT02322216|642616|P1|Overall Study|Withdrawal by Subject|1
202437|NCT02322216|642615|P2|Overall Study|Adverse Event|0
202438|NCT02322216|642616|P1|Overall Study|Adverse Event|1
202439|NCT02320396|642652|P2|Overall Study|Withdrawal by Subject|0
202440|NCT02320396|642653|P1|Overall Study|Withdrawal by Subject|2
202441|NCT02320396|642652|P2|Overall Study|Protocol Violation|1
202442|NCT02320396|642653|P1|Overall Study|Protocol Violation|0
202443|NCT02320396|642652|P2|Overall Study|Pregnancy|1
202444|NCT02320396|642653|P1|Overall Study|Pregnancy|0
202445|NCT02320396|642652|P2|Overall Study|Adverse Event|2
202446|NCT02320396|642653|P1|Overall Study|Adverse Event|2
202447|NCT02319668|642695|P2|Overall Study|Other (Not specified)|2
202448|NCT02319668|642696|P1|Overall Study|Other (Not specified)|0
202449|NCT02319525|642710|P2|Overall Study|Withdrawal by Subject|1
202450|NCT02319525|642711|P1|Overall Study|Withdrawal by Subject|2
202451|NCT02319148|642734|P4|Second Intervention Period|Unspecified|1
202452|NCT02319148|642735|P3|Second Intervention Period|Unspecified|0
202453|NCT02319148|642736|P2|Second Intervention Period|Unspecified|0
202454|NCT02319148|642737|P1|Second Intervention Period|Unspecified|0
202455|NCT02319148|642734|P4|Second Intervention Period|No longer willing to participate|0
202456|NCT02319148|642735|P3|Second Intervention Period|No longer willing to participate|0
202457|NCT02319148|642736|P2|Second Intervention Period|No longer willing to participate|1
202458|NCT02319148|642737|P1|Second Intervention Period|No longer willing to participate|0
202459|NCT02319148|642734|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
202460|NCT02319148|642735|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
202461|NCT02319148|642736|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
202462|NCT02319148|642737|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
202463|NCT02319031|642799|P2|Treatment Period|Death|0
202464|NCT02319031|642800|P1|Treatment Period|Death|1
202465|NCT02318940|642812|P2|Overall Study|lost the record|0
202466|NCT02318940|642813|P1|Overall Study|lost the record|1
202467|NCT02318693|642827|P2|Overall Study|Protocol Violation|1
202468|NCT02318693|642828|P1|Overall Study|Protocol Violation|0
202469|NCT02317809|642842|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
202470|NCT02317809|642843|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
202471|NCT02317809|642842|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
202472|NCT02317809|642843|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
202473|NCT02317510|642887|P2|Overall Study|Adverse Event|1
202474|NCT02317510|642888|P1|Overall Study|Adverse Event|0
202475|NCT02317016|642916|P1|Period 3|Death|1
202476|NCT02317016|642916|P1|Period 3|Condition under investigation worsened|1
202477|NCT02317016|642916|P1|Period 2|Adverse Event|1
202478|NCT02316769|642942|P2|Overall Study|Withdrawal by Subject|0
202479|NCT02316769|642943|P1|Overall Study|Withdrawal by Subject|1
202480|NCT02316769|642942|P2|Overall Study|Physician Decision|0
202481|NCT02316769|642943|P1|Overall Study|Physician Decision|1
202482|NCT02316613|642960|P1|Overall Study|Did not met selection criteria|14
202483|NCT02316613|642960|P1|Overall Study|No data and duplicate cases|5
202484|NCT02316613|642960|P1|Overall Study|Participant moved/changed medical team|11
202485|NCT02316613|642960|P1|Overall Study|Lymphoma transformation|2
202486|NCT02316613|642960|P1|Overall Study|Lost to Follow-up|9
202487|NCT02316613|642960|P1|Overall Study|Death|63
202488|NCT02314637|643161|P2|Overall Study|Other Reason|0
202489|NCT02314637|643162|P1|Overall Study|Other Reason|1
202490|NCT02314637|643161|P2|Overall Study|Withdrawal by Subject|4
202491|NCT02314637|643162|P1|Overall Study|Withdrawal by Subject|5
202492|NCT02314637|643161|P2|Overall Study|Physician Decision|2
202493|NCT02314637|643162|P1|Overall Study|Physician Decision|5
202494|NCT02314637|643161|P2|Overall Study|Lack of Efficacy|0
202495|NCT02314637|643162|P1|Overall Study|Lack of Efficacy|1
202496|NCT02314637|643161|P2|Overall Study|Adverse Event|8
202497|NCT02314637|643162|P1|Overall Study|Adverse Event|4
202498|NCT02313766|643238|P3|Overall Study|Adverse Event|0
202499|NCT02313766|643239|P2|Overall Study|Adverse Event|1
202500|NCT02313766|643240|P1|Overall Study|Adverse Event|0
202501|NCT02313766|643238|P3|Overall Study|Lost to Follow-up|0
202502|NCT02313766|643239|P2|Overall Study|Lost to Follow-up|2
202503|NCT02313766|643240|P1|Overall Study|Lost to Follow-up|0
202504|NCT02313766|643238|P3|Overall Study|surgery cancelled|0
202505|NCT02313766|643239|P2|Overall Study|surgery cancelled|0
202506|NCT02313766|643240|P1|Overall Study|surgery cancelled|1
202507|NCT02313558|643256|P2|Overall Study|Lost to Follow-up|4
202508|NCT02313558|643257|P1|Overall Study|Lost to Follow-up|4
202509|NCT02313558|643256|P2|Overall Study|Withdrawal by Subject|0
202510|NCT02313558|643257|P1|Overall Study|Withdrawal by Subject|2
202511|NCT02313233|643271|P2|Overall Study|Administrative reason|1
202512|NCT02313233|643272|P1|Overall Study|Administrative reason|1
202513|NCT02313233|643271|P2|Overall Study|Withdrawal by Subject|2
202514|NCT02313233|643272|P1|Overall Study|Withdrawal by Subject|1
202515|NCT02313155|643294|P2|Overall Study|Lost to Follow-up|1
202516|NCT02313155|643295|P1|Overall Study|Lost to Follow-up|0
202517|NCT02311881|643437|P3|Overall Study|Serious Adverse Event|0
202518|NCT02311881|643438|P2|Overall Study|Serious Adverse Event|1
202519|NCT02311881|643439|P1|Overall Study|Serious Adverse Event|0
202520|NCT02311881|643437|P3|Overall Study|Participant taking another medication|1
202521|NCT02311881|643438|P2|Overall Study|Participant taking another medication|0
202522|NCT02311881|643439|P1|Overall Study|Participant taking another medication|0
202523|NCT02311881|643437|P3|Overall Study|Medical Monitor Discretion|1
202524|NCT02311881|643438|P2|Overall Study|Medical Monitor Discretion|0
202525|NCT02311881|643439|P1|Overall Study|Medical Monitor Discretion|0
202526|NCT02311881|643437|P3|Overall Study|Physician Decision|1
202527|NCT02311881|643438|P2|Overall Study|Physician Decision|0
202528|NCT02311881|643439|P1|Overall Study|Physician Decision|0
202529|NCT02311881|643437|P3|Overall Study|Non-Compliance|2
202530|NCT02311881|643438|P2|Overall Study|Non-Compliance|0
202531|NCT02311881|643439|P1|Overall Study|Non-Compliance|1
202532|NCT02311881|643437|P3|Overall Study|Protocol Deviation|0
202533|NCT02311881|643438|P2|Overall Study|Protocol Deviation|0
202534|NCT02311881|643439|P1|Overall Study|Protocol Deviation|1
202535|NCT02311881|643437|P3|Overall Study|Sponsor Decision|1
202536|NCT02311881|643438|P2|Overall Study|Sponsor Decision|1
202537|NCT02311881|643439|P1|Overall Study|Sponsor Decision|1
202538|NCT02311881|643437|P3|Overall Study|Withdrawal by Subject|4
202539|NCT02311881|643438|P2|Overall Study|Withdrawal by Subject|1
202540|NCT02311881|643439|P1|Overall Study|Withdrawal by Subject|3
202541|NCT02311881|643437|P3|Overall Study|Subject has border line pregnancy test|0
202542|NCT02311881|643438|P2|Overall Study|Subject has border line pregnancy test|0
202543|NCT02311881|643439|P1|Overall Study|Subject has border line pregnancy test|1
202544|NCT02311881|643437|P3|Overall Study|Lack of Efficacy|0
202545|NCT02311881|643438|P2|Overall Study|Lack of Efficacy|2
202546|NCT02311881|643439|P1|Overall Study|Lack of Efficacy|1
202547|NCT02311881|643437|P3|Overall Study|Not Specified|1
202548|NCT02311881|643438|P2|Overall Study|Not Specified|0
202549|NCT02311881|643439|P1|Overall Study|Not Specified|0
202550|NCT02311881|643437|P3|Overall Study|Withdrawal of consent|17
202551|NCT02311881|643438|P2|Overall Study|Withdrawal of consent|16
202552|NCT02311881|643439|P1|Overall Study|Withdrawal of consent|14
202553|NCT02311881|643437|P3|Overall Study|Protocol Violation|3
202554|NCT02311881|643438|P2|Overall Study|Protocol Violation|2
202555|NCT02311881|643439|P1|Overall Study|Protocol Violation|1
202556|NCT02311881|643437|P3|Overall Study|Lost to Follow-up|2
202557|NCT02311881|643438|P2|Overall Study|Lost to Follow-up|3
202558|NCT02311881|643439|P1|Overall Study|Lost to Follow-up|3
202559|NCT02311881|643437|P3|Overall Study|Adverse Event|8
202560|NCT02311881|643438|P2|Overall Study|Adverse Event|15
202561|NCT02311881|643439|P1|Overall Study|Adverse Event|7
202562|NCT02311881|643437|P3|Overall Study|Did not meet the study criteria|0
202563|NCT02311881|643438|P2|Overall Study|Did not meet the study criteria|2
202564|NCT02311881|643439|P1|Overall Study|Did not meet the study criteria|2
202565|NCT02310750|643505|P16|HP Washout 2|Lost to Follow-up|0
202566|NCT02310750|643506|P15|HP Washout 2|Lost to Follow-up|0
202567|NCT02310750|643507|P14|HP Washout 2|Lost to Follow-up|0
202568|NCT02310750|643508|P13|HP Washout 2|Lost to Follow-up|0
202569|NCT02310750|643509|P12|HP Washout 2|Lost to Follow-up|0
202570|NCT02310750|643510|P11|HP Washout 2|Lost to Follow-up|0
202571|NCT02310750|643511|P10|HP Washout 2|Lost to Follow-up|0
202572|NCT02310750|643512|P9|HP Washout 2|Lost to Follow-up|0
202573|NCT02310750|643513|P8|HP Washout 2|Lost to Follow-up|0
202574|NCT02310750|643514|P7|HP Washout 2|Lost to Follow-up|7
202575|NCT02310750|643515|P6|HP Washout 2|Lost to Follow-up|0
202576|NCT02310750|643516|P5|HP Washout 2|Lost to Follow-up|1
202577|NCT02310750|643517|P4|HP Washout 2|Lost to Follow-up|0
202578|NCT02310750|643518|P3|HP Washout 2|Lost to Follow-up|0
202579|NCT02310750|643519|P2|HP Washout 2|Lost to Follow-up|0
202580|NCT02310750|643520|P1|HP Washout 2|Lost to Follow-up|0
202581|NCT02310750|643505|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202582|NCT02310750|643506|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202583|NCT02310750|643507|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202584|NCT02310750|643508|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202585|NCT02310750|643509|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202586|NCT02310750|643510|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202587|NCT02310750|643511|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202588|NCT02310750|643512|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
202589|NCT02310750|643513|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
202590|NCT02310750|643514|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202591|NCT02310750|643515|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202592|NCT02310750|643516|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202593|NCT02310750|643517|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202594|NCT02310750|643518|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202595|NCT02310750|643519|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202596|NCT02310750|643520|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
202597|NCT02310750|643505|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202598|NCT02310750|643506|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202599|NCT02310750|643507|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202600|NCT02310750|643508|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202601|NCT02310750|643509|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202602|NCT02310750|643510|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202603|NCT02310750|643511|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
202604|NCT02310750|643512|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
202605|NCT02310750|643513|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
202606|NCT02310750|643514|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202607|NCT02310750|643515|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202608|NCT02310750|643516|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202609|NCT02310750|643517|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202610|NCT02310750|643518|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202611|NCT02310750|643519|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202612|NCT02310750|643520|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
202613|NCT02310750|643505|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202614|NCT02310750|643506|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202615|NCT02310750|643507|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202616|NCT02310750|643508|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202617|NCT02310750|643509|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202618|NCT02310750|643510|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202619|NCT02310750|643511|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
202620|NCT02310750|643512|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202621|NCT02310750|643513|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202622|NCT02310750|643514|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202623|NCT02310750|643515|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202624|NCT02310750|643516|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202625|NCT02310750|643517|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202626|NCT02310750|643518|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202627|NCT02310750|643519|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202628|NCT02310750|643520|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
202629|NCT02310750|643505|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202630|NCT02310750|643506|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202631|NCT02310750|643507|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202632|NCT02310750|643508|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202633|NCT02310750|643509|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202634|NCT02310750|643510|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202635|NCT02310750|643511|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
202636|NCT02310750|643512|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
202637|NCT02310750|643513|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202638|NCT02310750|643514|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202639|NCT02310750|643515|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
202640|NCT02310750|643516|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202641|NCT02310750|643517|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
202642|NCT02310750|643518|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202643|NCT02310750|643519|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202644|NCT02310750|643520|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
202645|NCT02310750|643505|P16|HP Washout 1|Lost to Follow-up|0
202646|NCT02310750|643506|P15|HP Washout 1|Lost to Follow-up|0
202647|NCT02310750|643507|P14|HP Washout 1|Lost to Follow-up|0
202648|NCT02310750|643508|P13|HP Washout 1|Lost to Follow-up|0
202649|NCT02310750|643509|P12|HP Washout 1|Lost to Follow-up|0
202650|NCT02310750|643510|P11|HP Washout 1|Lost to Follow-up|0
202651|NCT02310750|643511|P10|HP Washout 1|Lost to Follow-up|0
202652|NCT02310750|643512|P9|HP Washout 1|Lost to Follow-up|0
202653|NCT02310750|643513|P8|HP Washout 1|Lost to Follow-up|0
202654|NCT02310750|643514|P7|HP Washout 1|Lost to Follow-up|3
202655|NCT02310750|643515|P6|HP Washout 1|Lost to Follow-up|2
202656|NCT02310750|643516|P5|HP Washout 1|Lost to Follow-up|2
202657|NCT02310750|643517|P4|HP Washout 1|Lost to Follow-up|1
202658|NCT02310750|643518|P3|HP Washout 1|Lost to Follow-up|1
202659|NCT02310750|643519|P2|HP Washout 1|Lost to Follow-up|0
202660|NCT02310750|643520|P1|HP Washout 1|Lost to Follow-up|0
202661|NCT02310750|643505|P16|HP Period 1|Withdrawal by Subject|0
202662|NCT02310750|643506|P15|HP Period 1|Withdrawal by Subject|0
202663|NCT02310750|643507|P14|HP Period 1|Withdrawal by Subject|0
202664|NCT02310750|643508|P13|HP Period 1|Withdrawal by Subject|0
202665|NCT02310750|643509|P12|HP Period 1|Withdrawal by Subject|0
202666|NCT02310750|643510|P11|HP Period 1|Withdrawal by Subject|0
202667|NCT02310750|643511|P10|HP Period 1|Withdrawal by Subject|0
202668|NCT02310750|643512|P9|HP Period 1|Withdrawal by Subject|0
202669|NCT02310750|643513|P8|HP Period 1|Withdrawal by Subject|0
202670|NCT02310750|643514|P7|HP Period 1|Withdrawal by Subject|0
202671|NCT02310750|643515|P6|HP Period 1|Withdrawal by Subject|0
202672|NCT02310750|643516|P5|HP Period 1|Withdrawal by Subject|0
202673|NCT02310750|643517|P4|HP Period 1|Withdrawal by Subject|1
202674|NCT02310750|643518|P3|HP Period 1|Withdrawal by Subject|0
202675|NCT02310750|643519|P2|HP Period 1|Withdrawal by Subject|0
202676|NCT02310750|643520|P1|HP Period 1|Withdrawal by Subject|1
202677|NCT02310750|643505|P16|HP Period 1|Lost to Follow-up|0
202678|NCT02310750|643506|P15|HP Period 1|Lost to Follow-up|0
202679|NCT02310750|643507|P14|HP Period 1|Lost to Follow-up|0
202680|NCT02310750|643508|P13|HP Period 1|Lost to Follow-up|0
202681|NCT02310750|643509|P12|HP Period 1|Lost to Follow-up|0
202682|NCT02310750|643510|P11|HP Period 1|Lost to Follow-up|0
202683|NCT02310750|643511|P10|HP Period 1|Lost to Follow-up|0
202684|NCT02310750|643512|P9|HP Period 1|Lost to Follow-up|0
202685|NCT02310750|643513|P8|HP Period 1|Lost to Follow-up|0
202686|NCT02310750|643514|P7|HP Period 1|Lost to Follow-up|1
202687|NCT02310750|643515|P6|HP Period 1|Lost to Follow-up|0
202688|NCT02310750|643516|P5|HP Period 1|Lost to Follow-up|0
202689|NCT02310750|643517|P4|HP Period 1|Lost to Follow-up|0
202690|NCT02310750|643518|P3|HP Period 1|Lost to Follow-up|0
202691|NCT02310750|643519|P2|HP Period 1|Lost to Follow-up|0
202692|NCT02310750|643520|P1|HP Period 1|Lost to Follow-up|0
202693|NCT02310646|643961|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
202694|NCT02310646|643962|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
202695|NCT02310646|643961|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
202696|NCT02310646|643962|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
202697|NCT02310568|643991|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
202698|NCT02310568|643992|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
202699|NCT02310568|643993|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
202700|NCT02310568|643994|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
202701|NCT02310568|643995|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
202702|NCT02310568|643991|P5|Stage 2 (4 Weeks)|Protocol Violation|0
202703|NCT02310568|643992|P4|Stage 2 (4 Weeks)|Protocol Violation|1
202704|NCT02310568|643993|P3|Stage 2 (4 Weeks)|Protocol Violation|0
202705|NCT02310568|643994|P2|Stage 2 (4 Weeks)|Protocol Violation|0
202706|NCT02310568|643995|P1|Stage 2 (4 Weeks)|Protocol Violation|0
202707|NCT02310568|643991|P5|Stage 2 (4 Weeks)|Adverse Event|1
202708|NCT02310568|643992|P4|Stage 2 (4 Weeks)|Adverse Event|1
202709|NCT02310568|643993|P3|Stage 2 (4 Weeks)|Adverse Event|0
202710|NCT02310568|643994|P2|Stage 2 (4 Weeks)|Adverse Event|0
202711|NCT02310568|643995|P1|Stage 2 (4 Weeks)|Adverse Event|0
202712|NCT02310568|643991|P5|Stage 2 (4 Weeks)|Unspecified|0
202713|NCT02310568|643992|P4|Stage 2 (4 Weeks)|Unspecified|0
202714|NCT02310568|643993|P3|Stage 2 (4 Weeks)|Unspecified|1
202715|NCT02310568|643994|P2|Stage 2 (4 Weeks)|Unspecified|1
202716|NCT02310568|643995|P1|Stage 2 (4 Weeks)|Unspecified|0
202717|NCT02310568|643991|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
202718|NCT02310568|643992|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
202719|NCT02310568|643993|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
202720|NCT02310568|643994|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
202721|NCT02310568|643995|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
202722|NCT02310568|643991|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
202723|NCT02310568|643992|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
202724|NCT02310568|643993|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
202725|NCT02310568|643994|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
202726|NCT02310568|643995|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
202727|NCT02310568|643991|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
202728|NCT02310568|643992|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
202729|NCT02310568|643993|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
202730|NCT02310568|643994|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
202731|NCT02310568|643995|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
202732|NCT02310568|643991|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
202733|NCT02310568|643992|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
202734|NCT02310568|643993|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
202735|NCT02310568|643994|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
202736|NCT02310568|643995|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
202737|NCT02310568|643991|P5|Stage 1 ( 4 Weeks)|Unspecified|0
202738|NCT02310568|643992|P4|Stage 1 ( 4 Weeks)|Unspecified|0
202739|NCT02310568|643993|P3|Stage 1 ( 4 Weeks)|Unspecified|0
202740|NCT02310568|643994|P2|Stage 1 ( 4 Weeks)|Unspecified|1
202741|NCT02310568|643995|P1|Stage 1 ( 4 Weeks)|Unspecified|1
202742|NCT02310568|643991|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
202743|NCT02310568|643992|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
202744|NCT02310568|643993|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
202745|NCT02310568|643994|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
202746|NCT02310568|643995|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
202747|NCT02310568|643991|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
202748|NCT02310568|643992|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
202749|NCT02310568|643993|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
202750|NCT02310568|643994|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
202751|NCT02310568|643995|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
202752|NCT02310126|644075|P2|Period 1|Protocol Violation|1
202753|NCT02310126|644076|P1|Period 1|Protocol Violation|0
202754|NCT02310126|644075|P2|Period 1|Lost to Follow-up|1
202755|NCT02310126|644076|P1|Period 1|Lost to Follow-up|0
202756|NCT02309723|644085|P3|Overall Study|Withdrawal by Subject|24
202757|NCT02309723|644086|P2|Overall Study|Withdrawal by Subject|23
202758|NCT02309723|644087|P1|Overall Study|Withdrawal by Subject|24
202759|NCT02309294|644101|P1|Overall Study|Withdrawal by Subject|2
202760|NCT02309112|644108|P3|Overall Study|Lost to Follow-up|0
202761|NCT02309112|644109|P2|Overall Study|Lost to Follow-up|1
202762|NCT02309112|644110|P1|Overall Study|Lost to Follow-up|0
202763|NCT02309112|644108|P3|Overall Study|Withdrawal by Subject|1
202764|NCT02309112|644109|P2|Overall Study|Withdrawal by Subject|0
202765|NCT02309112|644110|P1|Overall Study|Withdrawal by Subject|1
202766|NCT02308748|644146|P10|Period 5|Adverse Event|0
202767|NCT02308748|644147|P9|Period 5|Adverse Event|1
202768|NCT02308748|644148|P8|Period 5|Adverse Event|0
202769|NCT02308748|644149|P7|Period 5|Adverse Event|0
202770|NCT02308748|644150|P6|Period 5|Adverse Event|0
202771|NCT02308748|644151|P5|Period 5|Adverse Event|0
202772|NCT02308748|644152|P4|Period 5|Adverse Event|0
202773|NCT02308748|644153|P3|Period 5|Adverse Event|0
202774|NCT02308748|644154|P2|Period 5|Adverse Event|0
202775|NCT02308748|644155|P1|Period 5|Adverse Event|1
202776|NCT02308748|644146|P10|Period 3|Protocol Violation|1
202777|NCT02308748|644147|P9|Period 3|Protocol Violation|0
202778|NCT02308748|644148|P8|Period 3|Protocol Violation|0
202779|NCT02308748|644149|P7|Period 3|Protocol Violation|0
202780|NCT02308748|644150|P6|Period 3|Protocol Violation|0
202781|NCT02308748|644151|P5|Period 3|Protocol Violation|0
202782|NCT02308748|644152|P4|Period 3|Protocol Violation|0
202783|NCT02308748|644153|P3|Period 3|Protocol Violation|0
202784|NCT02308748|644154|P2|Period 3|Protocol Violation|0
202785|NCT02308748|644155|P1|Period 3|Protocol Violation|0
202786|NCT02308748|644146|P10|Period 2|Adverse Event|0
202787|NCT02308748|644147|P9|Period 2|Adverse Event|0
202788|NCT02308748|644148|P8|Period 2|Adverse Event|1
202789|NCT02308748|644149|P7|Period 2|Adverse Event|0
202790|NCT02308748|644150|P6|Period 2|Adverse Event|0
202791|NCT02308748|644151|P5|Period 2|Adverse Event|0
202792|NCT02308748|644152|P4|Period 2|Adverse Event|0
202793|NCT02308748|644153|P3|Period 2|Adverse Event|0
202794|NCT02308748|644154|P2|Period 2|Adverse Event|0
202795|NCT02308748|644155|P1|Period 2|Adverse Event|0
202796|NCT02308748|644146|P10|Period 1|Withdrawal by Subject|0
202797|NCT02308748|644147|P9|Period 1|Withdrawal by Subject|0
202798|NCT02308748|644148|P8|Period 1|Withdrawal by Subject|0
202799|NCT02308748|644149|P7|Period 1|Withdrawal by Subject|0
202800|NCT02308748|644150|P6|Period 1|Withdrawal by Subject|0
202801|NCT02308748|644151|P5|Period 1|Withdrawal by Subject|0
202802|NCT02308748|644152|P4|Period 1|Withdrawal by Subject|0
202803|NCT02308748|644153|P3|Period 1|Withdrawal by Subject|1
202804|NCT02308748|644154|P2|Period 1|Withdrawal by Subject|0
202805|NCT02308748|644155|P1|Period 1|Withdrawal by Subject|0
202806|NCT02308124|644187|P3|Overall Study|Adverse Event|2
202807|NCT02308124|644188|P2|Overall Study|Adverse Event|2
202808|NCT02308124|644189|P1|Overall Study|Adverse Event|0
202809|NCT02308124|644187|P3|Overall Study|Lost to Follow-up|6
202810|NCT02308124|644188|P2|Overall Study|Lost to Follow-up|6
202811|NCT02308124|644189|P1|Overall Study|Lost to Follow-up|6
202812|NCT02307266|644267|P3|Overall Study|Lost to Follow-up|0
202813|NCT02307266|644268|P2|Overall Study|Lost to Follow-up|0
202814|NCT02307266|644269|P1|Overall Study|Lost to Follow-up|3
202815|NCT02307266|644267|P3|Overall Study|Withdrawal by Subject|1
202816|NCT02307266|644268|P2|Overall Study|Withdrawal by Subject|0
202817|NCT02307266|644269|P1|Overall Study|Withdrawal by Subject|2
202818|NCT02307266|644267|P3|Overall Study|Adverse Event|5
202819|NCT02307266|644268|P2|Overall Study|Adverse Event|1
202820|NCT02307266|644269|P1|Overall Study|Adverse Event|3
202821|NCT02305446|644311|P1|Overall Study|Adverse Event|1
202822|NCT02304926|644414|P2|Overall Study|Lost to Follow-up|1
202823|NCT02304926|644415|P1|Overall Study|Lost to Follow-up|2
202824|NCT02303704|644472|P2|Overall Study|Protocol Violation|9
202825|NCT02303704|644473|P1|Overall Study|Protocol Violation|5
202826|NCT02301975|644508|P3|Overall Study|Withdrawal by Subject|11
202827|NCT02301975|644509|P2|Overall Study|Withdrawal by Subject|12
202828|NCT02301975|644510|P1|Overall Study|Withdrawal by Subject|15
202829|NCT02301975|644508|P3|Overall Study|Physician Decision|3
202830|NCT02301975|644509|P2|Overall Study|Physician Decision|2
202831|NCT02301975|644510|P1|Overall Study|Physician Decision|4
202832|NCT02301975|644508|P3|Overall Study|Lost to Follow-up|2
202833|NCT02301975|644509|P2|Overall Study|Lost to Follow-up|2
202834|NCT02301975|644510|P1|Overall Study|Lost to Follow-up|0
202835|NCT02301975|644508|P3|Overall Study|Protocol Violation|3
202836|NCT02301975|644509|P2|Overall Study|Protocol Violation|5
202837|NCT02301975|644510|P1|Overall Study|Protocol Violation|3
202838|NCT02301975|644508|P3|Overall Study|Lack of Efficacy|1
202839|NCT02301975|644509|P2|Overall Study|Lack of Efficacy|1
202840|NCT02301975|644510|P1|Overall Study|Lack of Efficacy|1
202841|NCT02301975|644508|P3|Overall Study|Adverse Event|2
202842|NCT02301975|644509|P2|Overall Study|Adverse Event|3
202843|NCT02301975|644510|P1|Overall Study|Adverse Event|8
202844|NCT02301936|644538|P2|Overall Study|Lost to Follow-up|0
202845|NCT02301936|644539|P1|Overall Study|Lost to Follow-up|1
202846|NCT02301429|644561|P1|Overall Study|not acceptable vascular anatomy|3
202847|NCT02301169|644580|P2|Overall Study|Adverse Event|0
202848|NCT02301169|644581|P1|Overall Study|Adverse Event|1
202849|NCT02300311|644597|P2|Overall Study|Refused to continue taking medication|0
202850|NCT02300311|644598|P1|Overall Study|Refused to continue taking medication|18
202851|NCT02300311|644597|P2|Overall Study|Other than the reason specified|0
202852|NCT02300311|644598|P1|Overall Study|Other than the reason specified|1
202853|NCT02300129|644610|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
202854|NCT02300129|644611|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
202855|NCT02300129|644612|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
202856|NCT02300129|644613|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
202857|NCT02300129|644610|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
202858|NCT02300129|644611|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
202859|NCT02300129|644612|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
202860|NCT02300129|644613|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
202861|NCT02300129|644610|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
202862|NCT02300129|644611|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
202863|NCT02300129|644612|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
202864|NCT02300129|644613|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
202865|NCT02299635|644702|P1|Overall Study|Unspecified|3
202866|NCT02299635|644702|P1|Overall Study|Withdrawal by Subject|2
202867|NCT02299635|644702|P1|Overall Study|Objective progression or relapse|10
202868|NCT02299635|644702|P1|Overall Study|Global deterioration of health status|1
202869|NCT02299635|644702|P1|Overall Study|Death|1
202870|NCT02299635|644702|P1|Overall Study|Adverse Event|2
202871|NCT02299427|644723|P2|Overall Study|not adherent to dog website use|0
202872|NCT02299427|644724|P1|Overall Study|not adherent to dog website use|21
202873|NCT02299427|644723|P2|Overall Study|Lost to Follow-up|3
202874|NCT02299427|644724|P1|Overall Study|Lost to Follow-up|1
202875|NCT02299427|644723|P2|Overall Study|Withdrawal by Subject|0
202876|NCT02299427|644724|P1|Overall Study|Withdrawal by Subject|1
202877|NCT02298868|644754|P1|Overall Study|Patient underwent transplant|1
202878|NCT02298868|644754|P1|Overall Study|Death|1
202879|NCT02298868|644754|P1|Overall Study|Adverse Event|1
202880|NCT02298192|644787|P2|Overall Study|Adverse Event|2
202881|NCT02298192|644788|P1|Overall Study|Adverse Event|6
202882|NCT02298192|644787|P2|Overall Study|Lost to Follow-up|1
202883|NCT02298192|644788|P1|Overall Study|Lost to Follow-up|2
202884|NCT02298192|644787|P2|Overall Study|Withdrawal by Subject|1
202885|NCT02298192|644788|P1|Overall Study|Withdrawal by Subject|6
202886|NCT02298192|644787|P2|Overall Study|Withdrawal criteria|0
202887|NCT02298192|644788|P1|Overall Study|Withdrawal criteria|2
202888|NCT02298192|644787|P2|Overall Study|Unclassified|2
202889|NCT02298192|644788|P1|Overall Study|Unclassified|3
202890|NCT02297841|644800|P1|Overall Study|Protocol Violation|7
202891|NCT02297841|644800|P1|Overall Study|Withdrawal by Subject|1
202892|NCT02296931|644811|P2|Overall Study|Protocol Violation|2
202893|NCT02296931|644812|P1|Overall Study|Protocol Violation|0
202894|NCT02295774|644818|P1|Overall Study|Withdrawal by Subject|2
202895|NCT02295774|644818|P1|Overall Study|Lost to Follow-up|1
202896|NCT02295020|644849|P2|Overall Study|Withdrawal by Subject|2
202897|NCT02295020|644850|P1|Overall Study|Withdrawal by Subject|3
202898|NCT02295020|644849|P2|Overall Study|Adverse Event|1
202899|NCT02295020|644850|P1|Overall Study|Adverse Event|0
202900|NCT02294773|644882|P2|Overall Study|Withdrawal by Subject|2
202901|NCT02294773|644883|P1|Overall Study|Withdrawal by Subject|0
202902|NCT02294734|644899|P2|Overall Study|Withdrawal by Subject|2
202903|NCT02294734|644900|P1|Overall Study|Withdrawal by Subject|4
202904|NCT02294734|644899|P2|Overall Study|Physician Decision|1
202905|NCT02294734|644900|P1|Overall Study|Physician Decision|2
202906|NCT02294734|644899|P2|Overall Study|Lost to Follow-up|0
202907|NCT02294734|644900|P1|Overall Study|Lost to Follow-up|2
202908|NCT02294734|644899|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
202909|NCT02294734|644900|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
202910|NCT02294734|644899|P2|Overall Study|Adverse Event|5
202911|NCT02294734|644900|P1|Overall Study|Adverse Event|5
202912|NCT02294682|644952|P2|Overall Study|Could not swallow pills|0
202913|NCT02294682|644953|P1|Overall Study|Could not swallow pills|1
202914|NCT02294604|644996|P3|Overall Study|Culture contamination|0
202915|NCT02294604|644997|P2|Overall Study|Culture contamination|2
202916|NCT02294604|644998|P1|Overall Study|Culture contamination|1
202917|NCT02294604|644996|P3|Overall Study|Did not provide samples for culture|0
202918|NCT02294604|644997|P2|Overall Study|Did not provide samples for culture|1
202919|NCT02294604|644998|P1|Overall Study|Did not provide samples for culture|0
202920|NCT02294461|645017|P2|Overall Study|Miscellaneous|34
202921|NCT02294461|645018|P1|Overall Study|Miscellaneous|13
202922|NCT02294461|645017|P2|Overall Study|Adverse Event|10
202923|NCT02294461|645018|P1|Overall Study|Adverse Event|12
202924|NCT02294461|645017|P2|Overall Study|Disease Progression|39
202925|NCT02294461|645018|P1|Overall Study|Disease Progression|23
202926|NCT02294461|645017|P2|Overall Study|Withdrawal by Subject|49
202927|NCT02294461|645018|P1|Overall Study|Withdrawal by Subject|14
202928|NCT02294461|645017|P2|Overall Study|Protocol Violation|2
202929|NCT02294461|645018|P1|Overall Study|Protocol Violation|0
202930|NCT02294461|645017|P2|Overall Study|Death|3
202931|NCT02294461|645018|P1|Overall Study|Death|3
202932|NCT02294019|645070|P1|Overall Study|Withdrawal by Subject|1
202933|NCT02294019|645070|P1|Overall Study|Unspecified|1
202934|NCT02294019|645070|P1|Overall Study|Lost to Follow-up|31
202935|NCT02294019|645070|P1|Overall Study|Protocol Violation|68
202936|NCT02294019|645070|P1|Overall Study|Adverse Event|2
202937|NCT02293538|645077|P2|Overall Study|Withdrawal by Subject|1
202938|NCT02293538|645078|P1|Overall Study|Withdrawal by Subject|0
202939|NCT02293538|645077|P2|Overall Study|Lost to Follow-up|0
202940|NCT02293538|645078|P1|Overall Study|Lost to Follow-up|1
202941|NCT02293538|645077|P2|Overall Study|Adverse Event|1
202942|NCT02293538|645078|P1|Overall Study|Adverse Event|0
202943|NCT02291679|645192|P3|Overall Study|Not Specified|2
202944|NCT02291679|645193|P2|Overall Study|Not Specified|4
202945|NCT02291679|645194|P1|Overall Study|Not Specified|2
202946|NCT02291679|645192|P3|Overall Study|Insufficient Therapeutic Response|7
202947|NCT02291679|645193|P2|Overall Study|Insufficient Therapeutic Response|5
202948|NCT02291679|645194|P1|Overall Study|Insufficient Therapeutic Response|5
202949|NCT02291679|645192|P3|Overall Study|Lost to Follow-up|9
202950|NCT02291679|645193|P2|Overall Study|Lost to Follow-up|10
202951|NCT02291679|645194|P1|Overall Study|Lost to Follow-up|12
202952|NCT02291679|645192|P3|Overall Study|Withdrew Consent|15
202953|NCT02291679|645193|P2|Overall Study|Withdrew Consent|10
202954|NCT02291679|645194|P1|Overall Study|Withdrew Consent|18
202955|NCT02291679|645192|P3|Overall Study|Protocol Violation|7
202956|NCT02291679|645193|P2|Overall Study|Protocol Violation|1
202957|NCT02291679|645194|P1|Overall Study|Protocol Violation|5
202958|NCT02291679|645192|P3|Overall Study|Adverse Event|19
202959|NCT02291679|645193|P2|Overall Study|Adverse Event|12
202960|NCT02291679|645194|P1|Overall Study|Adverse Event|2
202961|NCT02291510|645227|P4|Overall Study|Adverse Event|1
202962|NCT02291510|645228|P3|Overall Study|Adverse Event|0
202963|NCT02291510|645229|P2|Overall Study|Adverse Event|0
202964|NCT02291510|645230|P1|Overall Study|Adverse Event|0
202965|NCT02291419|645246|P2|Overall Study|Early study termination|5
202966|NCT02291419|645247|P1|Overall Study|Early study termination|1
202967|NCT02290821|645265|P2|Overall Study|Lost to Follow-up|2
202968|NCT02290821|645266|P1|Overall Study|Lost to Follow-up|3
202969|NCT02290821|645265|P2|Overall Study|Unable or unwilling to cooperate with|0
202970|NCT02290821|645266|P1|Overall Study|Unable or unwilling to cooperate with|2
202971|NCT02290821|645265|P2|Overall Study|Withdrawal by Subject|1
202972|NCT02290821|645266|P1|Overall Study|Withdrawal by Subject|1
202973|NCT02289742|645313|P4|Third Wear Period|Reason not given|1
202974|NCT02289742|645314|P3|Third Wear Period|Reason not given|0
202975|NCT02289742|645315|P2|Third Wear Period|Reason not given|0
202976|NCT02289742|645316|P1|Third Wear Period|Reason not given|0
202977|NCT02289742|645313|P4|Third Wear Period|Adverse Event|0
202978|NCT02289742|645314|P3|Third Wear Period|Adverse Event|0
202979|NCT02289742|645315|P2|Third Wear Period|Adverse Event|1
202980|NCT02289742|645316|P1|Third Wear Period|Adverse Event|0
202981|NCT02289742|645313|P4|First Wear Period|Other prior to treatment|1
202982|NCT02289742|645314|P3|First Wear Period|Other prior to treatment|0
202983|NCT02289742|645315|P2|First Wear Period|Other prior to treatment|0
202984|NCT02289742|645316|P1|First Wear Period|Other prior to treatment|0
202985|NCT02289742|645313|P4|First Wear Period|Adverse Event|0
202986|NCT02289742|645314|P3|First Wear Period|Adverse Event|1
202987|NCT02289742|645315|P2|First Wear Period|Adverse Event|0
202988|NCT02289742|645316|P1|First Wear Period|Adverse Event|0
202989|NCT02289742|645313|P4|First Wear Period|Adverse event prior to treatment|0
202990|NCT02289742|645314|P3|First Wear Period|Adverse event prior to treatment|0
202991|NCT02289742|645315|P2|First Wear Period|Adverse event prior to treatment|1
202992|NCT02289742|645316|P1|First Wear Period|Adverse event prior to treatment|0
202993|NCT02289079|645348|P2|Overall Study|Lost to Follow-up|1
202994|NCT02289079|645349|P1|Overall Study|Lost to Follow-up|0
202995|NCT02289079|645348|P2|Overall Study|Physician Decision|0
202996|NCT02289079|645349|P1|Overall Study|Physician Decision|2
202997|NCT02288312|645391|P3|Overall Study|Pregnancy|0
202998|NCT02288312|645392|P2|Overall Study|Pregnancy|0
202999|NCT02288312|645393|P1|Overall Study|Pregnancy|1
203000|NCT02287623|645586|P2|Overall Study|Protocol Violation|1
203001|NCT02287623|645587|P1|Overall Study|Protocol Violation|0
203002|NCT02287610|645603|P1|Overall Study|Excluded-investigator non-responsiveness|5
203003|NCT02287610|645603|P1|Overall Study|Withdrawal by Subject|8
203004|NCT02287610|645603|P1|Overall Study|Lost to Follow-up|3
203005|NCT02287402|645642|P1|Follow-up|Voluntary Withdrawal|2
203006|NCT02287402|645642|P1|Follow-up|Lost to Follow-up|1
203007|NCT02287402|645642|P1|Treatment Period|Voluntary Withdrawal|10
203008|NCT02287402|645642|P1|Treatment Period|Adverse Event|17
203009|NCT02286193|645824|P1|Overall Study|Referred: Declined service|38
203010|NCT02286193|645824|P1|Overall Study|Referred: unable to reach/resource sent|104
203011|NCT02286193|645824|P1|Overall Study|Referred: CRS unable to make contact|62
203012|NCT02285998|645831|P2|Overall Study|Other Reasons|10
203013|NCT02285998|645832|P1|Overall Study|Other Reasons|7
203014|NCT02285998|645831|P2|Overall Study|Withdrawal by Subject|61
203015|NCT02285998|645832|P1|Overall Study|Withdrawal by Subject|53
203016|NCT02285998|645831|P2|Overall Study|Lost to Follow-up|172
203017|NCT02285998|645832|P1|Overall Study|Lost to Follow-up|176
203018|NCT02285998|645831|P2|Overall Study|Physician Decision|2
203019|NCT02285998|645832|P1|Overall Study|Physician Decision|1
203020|NCT02285998|645831|P2|Overall Study|Adverse Event|8
203021|NCT02285998|645832|P1|Overall Study|Adverse Event|9
203022|NCT02285270|645856|P1|Overall Study|Determined to be ineligible|1
203023|NCT02285270|645856|P1|Overall Study|Physician Decision|3
203024|NCT02285270|645856|P1|Overall Study|Lost to Follow-up|1
203025|NCT02284347|645949|P1|Overall Study|Withdrawn prior to treatment|1
203026|NCT02284347|645949|P1|Overall Study|Lost to Follow-up|2
203027|NCT02284243|645957|P2|Overall Study|Adverse Event|0
203028|NCT02284243|645958|P1|Overall Study|Adverse Event|1
203029|NCT02284243|645957|P2|Overall Study|Lack of Efficacy|3
203030|NCT02284243|645958|P1|Overall Study|Lack of Efficacy|3
203031|NCT02283788|646054|P4|Overall Study|Withdrawal by Subject|1
203032|NCT02283788|646055|P3|Overall Study|Withdrawal by Subject|0
203033|NCT02283788|646056|P2|Overall Study|Withdrawal by Subject|1
203034|NCT02283788|646057|P1|Overall Study|Withdrawal by Subject|0
203035|NCT02283788|646054|P4|Overall Study|Adverse Event|1
203036|NCT02283788|646055|P3|Overall Study|Adverse Event|5
203037|NCT02283788|646056|P2|Overall Study|Adverse Event|3
203038|NCT02283788|646057|P1|Overall Study|Adverse Event|1
203039|NCT02282982|646067|P1|Overall Study|Other, not specified|18
203040|NCT02282982|646067|P1|Overall Study|Palivizumab is ended|11
203041|NCT02282982|646067|P1|Overall Study|Lack of product|156
203042|NCT02282982|646067|P1|Overall Study|Death|4
203043|NCT02282982|646067|P1|Overall Study|Withdrew consent|2
203044|NCT02282982|646067|P1|Overall Study|Lost to Follow-up|15
203045|NCT02282813|646085|P3|Overall Study|Administrative reasons|0
203046|NCT02282813|646086|P2|Overall Study|Administrative reasons|1
203047|NCT02282813|646087|P1|Overall Study|Administrative reasons|0
203048|NCT02282813|646085|P3|Overall Study|Lack of Efficacy|0
203049|NCT02282813|646086|P2|Overall Study|Lack of Efficacy|0
203050|NCT02282813|646087|P1|Overall Study|Lack of Efficacy|1
203051|NCT02282813|646085|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
203052|NCT02282813|646086|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
203053|NCT02282813|646087|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
203054|NCT02282813|646085|P3|Overall Study|Lost to Follow-up|1
203055|NCT02282813|646086|P2|Overall Study|Lost to Follow-up|0
203056|NCT02282813|646087|P1|Overall Study|Lost to Follow-up|2
203057|NCT02282813|646085|P3|Overall Study|Physician Decision|1
203058|NCT02282813|646086|P2|Overall Study|Physician Decision|3
203059|NCT02282813|646087|P1|Overall Study|Physician Decision|0
203060|NCT02282813|646085|P3|Overall Study|Subject non-compliance|0
203061|NCT02282813|646086|P2|Overall Study|Subject non-compliance|4
203062|NCT02282813|646087|P1|Overall Study|Subject non-compliance|1
203063|NCT02282813|646085|P3|Overall Study|Adverse Event|1
203064|NCT02282813|646086|P2|Overall Study|Adverse Event|10
203065|NCT02282813|646087|P1|Overall Study|Adverse Event|3
203066|NCT02282813|646085|P3|Overall Study|Withdrawal by Subject|0
203067|NCT02282813|646086|P2|Overall Study|Withdrawal by Subject|5
203068|NCT02282813|646087|P1|Overall Study|Withdrawal by Subject|4
203069|NCT02282631|646106|P2|Overall Study|Lost to Follow-up|0
203070|NCT02282631|646107|P1|Overall Study|Lost to Follow-up|2
203071|NCT02282605|646148|P3|Overall Study|negative SA result on Day -1|0
203072|NCT02282605|646149|P2|Overall Study|negative SA result on Day -1|0
203073|NCT02282605|646150|P1|Overall Study|negative SA result on Day -1|3
203074|NCT02282527|646172|P2|Overall Study|Lack of home health aid|0
203075|NCT02282527|646173|P1|Overall Study|Lack of home health aid|1
203076|NCT02282527|646172|P2|Overall Study|Lost to Follow-up|1
203077|NCT02282527|646173|P1|Overall Study|Lost to Follow-up|0
203078|NCT02281318|646267|P2|Overall Study|Withdrawal by Subject|2
203079|NCT02281318|646268|P1|Overall Study|Withdrawal by Subject|6
203080|NCT02281318|646267|P2|Overall Study|Physician Decision|0
203081|NCT02281318|646268|P1|Overall Study|Physician Decision|2
203082|NCT02281318|646267|P2|Overall Study|Lost to Follow-up|1
203083|NCT02281318|646268|P1|Overall Study|Lost to Follow-up|2
203084|NCT02281318|646267|P2|Overall Study|Lack of Efficacy|0
203085|NCT02281318|646268|P1|Overall Study|Lack of Efficacy|2
203086|NCT02281318|646267|P2|Overall Study|Adverse Event|2
203087|NCT02281318|646268|P1|Overall Study|Adverse Event|2
203088|NCT02280499|646323|P1|Overall Study|Adverse Event|5
203089|NCT02280499|646323|P1|Overall Study|Lost to Follow-up|42
203090|NCT02280499|646323|P1|Overall Study|Death|14
203091|NCT02280473|646331|P2|Overall Study|Lost to Follow-up|1
203092|NCT02280473|646332|P1|Overall Study|Lost to Follow-up|0
203093|NCT02280473|646331|P2|Overall Study|Lack of Efficacy|1
203094|NCT02280473|646332|P1|Overall Study|Lack of Efficacy|0
203095|NCT02280473|646331|P2|Overall Study|Adverse Event|1
203096|NCT02280473|646332|P1|Overall Study|Adverse Event|1
203097|NCT02280187|646346|P1|Overall Study|Lost to Follow-up|218
203098|NCT02279420|646395|P1|Overall Study|Lost to Follow-up|23
203099|NCT02279407|646403|P4|Overall Study|Adverse Event|0
203100|NCT02279407|646404|P3|Overall Study|Adverse Event|2
203101|NCT02279407|646405|P2|Overall Study|Adverse Event|1
203102|NCT02279407|646406|P1|Overall Study|Adverse Event|1
203103|NCT02279407|646403|P4|Overall Study|Withdrawal by Subject|1
203104|NCT02279407|646404|P3|Overall Study|Withdrawal by Subject|1
203105|NCT02279407|646405|P2|Overall Study|Withdrawal by Subject|0
203106|NCT02279407|646406|P1|Overall Study|Withdrawal by Subject|1
203107|NCT02279407|646403|P4|Overall Study|Couldn't swallow IP; noncompliance|0
203108|NCT02279407|646404|P3|Overall Study|Couldn't swallow IP; noncompliance|2
203109|NCT02279407|646405|P2|Overall Study|Couldn't swallow IP; noncompliance|0
203110|NCT02279407|646406|P1|Overall Study|Couldn't swallow IP; noncompliance|0
203111|NCT02278614|646433|P2|Overall Study|left eye was not eligible|0
203112|NCT02278614|646434|P1|Overall Study|left eye was not eligible|1
203113|NCT02278614|646433|P2|Overall Study|Adverse Event|0
203114|NCT02278614|646434|P1|Overall Study|Adverse Event|1
203115|NCT02278614|646433|P2|Overall Study|Withdrawal by Subject|5
203116|NCT02278614|646434|P1|Overall Study|Withdrawal by Subject|3
203117|NCT02277119|646487|P3|Overall Study|Protocol Violation|7
203118|NCT02277119|646488|P2|Overall Study|Protocol Violation|3
203119|NCT02277119|646489|P1|Overall Study|Protocol Violation|2
203120|NCT02277119|646487|P3|Overall Study|Lack of Efficacy|1
203121|NCT02277119|646488|P2|Overall Study|Lack of Efficacy|1
203122|NCT02277119|646489|P1|Overall Study|Lack of Efficacy|1
203123|NCT02276560|646517|P3|Overall Study|Adverse Event|0
203124|NCT02276560|646518|P2|Overall Study|Adverse Event|0
203125|NCT02276560|646519|P1|Overall Study|Adverse Event|1
203126|NCT02275611|646658|P4|Inpatient Withdrawal|Withdrawal by Subject|0
203127|NCT02275611|646659|P3|Inpatient Withdrawal|Withdrawal by Subject|0
203128|NCT02275611|646660|P2|Inpatient Withdrawal|Withdrawal by Subject|0
203129|NCT02275611|646661|P1|Inpatient Withdrawal|Withdrawal by Subject|1
203130|NCT02275546|646673|P2|Treatment Period 2|Protocol Violation|1
203131|NCT02275546|646674|P1|Treatment Period 2|Protocol Violation|0
203132|NCT02275546|646673|P2|Treatment Period 2|Withdrawal by Subject|1
203133|NCT02275546|646674|P1|Treatment Period 2|Withdrawal by Subject|2
203134|NCT02275364|646682|P2|Period 1|Other reason|0
203135|NCT02275364|646683|P1|Period 1|Other reason|1
203136|NCT02275364|646682|P2|Period 1|Withdrawal by Subject|0
203137|NCT02275364|646683|P1|Period 1|Withdrawal by Subject|1
203138|NCT02275052|646744|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
203139|NCT02275052|646745|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
203140|NCT02275052|646746|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
203141|NCT02275052|646747|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
203142|NCT02275052|646744|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
203143|NCT02275052|646745|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
203144|NCT02275052|646746|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
203145|NCT02275052|646747|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
203146|NCT02275052|646744|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
203147|NCT02275052|646745|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
203148|NCT02275052|646746|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
203313|NCT02260492|647607|P3|Overall Study|Withdrawal by Subject|2
203149|NCT02275052|646747|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
203150|NCT02275052|646744|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
203151|NCT02275052|646745|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
203152|NCT02275052|646746|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
203153|NCT02275052|646747|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
203154|NCT02275052|646744|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
203155|NCT02275052|646745|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
203156|NCT02275052|646746|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
203157|NCT02275052|646747|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
203158|NCT02275052|646744|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
203159|NCT02275052|646745|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
203160|NCT02275052|646746|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
203161|NCT02275052|646747|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
203162|NCT02275052|646744|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
203163|NCT02275052|646745|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
203164|NCT02275052|646746|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
203165|NCT02275052|646747|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
203166|NCT02275052|646744|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
203167|NCT02275052|646745|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
203168|NCT02275052|646746|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
203169|NCT02275052|646747|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
203170|NCT02275052|646744|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
203171|NCT02275052|646745|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
203172|NCT02275052|646746|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
203173|NCT02275052|646747|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
203174|NCT02275052|646744|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
203175|NCT02275052|646745|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
203176|NCT02275052|646746|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
203177|NCT02275052|646747|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
203178|NCT02275052|646744|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
203179|NCT02275052|646745|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
203180|NCT02275052|646746|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
203181|NCT02275052|646747|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
203182|NCT02274948|646761|P2|Overall Study|Left the area|3
203183|NCT02274948|646762|P1|Overall Study|Left the area|4
203184|NCT02274948|646761|P2|Overall Study|Stopped on family Practitioner advice|5
203185|NCT02274948|646762|P1|Overall Study|Stopped on family Practitioner advice|2
203186|NCT02274948|646761|P2|Overall Study|Withdrawal by Subject|58
203187|NCT02274948|646762|P1|Overall Study|Withdrawal by Subject|64
203188|NCT02274948|646761|P2|Overall Study|Lost to Follow-up|25
203189|NCT02274948|646762|P1|Overall Study|Lost to Follow-up|28
203190|NCT02274792|646776|P1|Overall Study|Sponsor Decision|2
203191|NCT02274792|646776|P1|Overall Study|Protocol Specified Criteria|2
203192|NCT02274792|646776|P1|Overall Study|Lost to Follow-up|8
203193|NCT02274792|646776|P1|Overall Study|Withdrawal by Subject|13
203194|NCT02273908|646796|P2|Overall Study|Withdrawal by Subject|2
203195|NCT02273908|646797|P1|Overall Study|Withdrawal by Subject|4
203196|NCT02273908|646796|P2|Overall Study|Did not meet entrance criteria|2
203197|NCT02273908|646797|P1|Overall Study|Did not meet entrance criteria|3
203198|NCT02273908|646796|P2|Overall Study|Lost to Follow-up|1
203199|NCT02273908|646797|P1|Overall Study|Lost to Follow-up|10
203200|NCT02273908|646796|P2|Overall Study|Adverse Event|0
203201|NCT02273908|646797|P1|Overall Study|Adverse Event|16
203202|NCT02273752|646819|P1|Overall Study|Trial was terminated early|2
203203|NCT02273167|646864|P3|Overall Study|Various|8
203204|NCT02273167|646865|P2|Overall Study|Various|9
203205|NCT02273167|646866|P1|Overall Study|Various|10
203206|NCT02273167|646864|P3|Overall Study|Withdrawal by Subject|11
203207|NCT02273167|646865|P2|Overall Study|Withdrawal by Subject|12
203208|NCT02273167|646866|P1|Overall Study|Withdrawal by Subject|10
203209|NCT02273167|646864|P3|Overall Study|Lost to Follow-up|1
203210|NCT02273167|646865|P2|Overall Study|Lost to Follow-up|1
203211|NCT02273167|646866|P1|Overall Study|Lost to Follow-up|0
203212|NCT02273167|646864|P3|Overall Study|Protocol Violation|1
203213|NCT02273167|646865|P2|Overall Study|Protocol Violation|1
203214|NCT02273167|646866|P1|Overall Study|Protocol Violation|3
203215|NCT02273167|646864|P3|Overall Study|Adverse Event|0
203216|NCT02273167|646865|P2|Overall Study|Adverse Event|0
203217|NCT02273167|646866|P1|Overall Study|Adverse Event|1
203218|NCT02273141|646891|P2|Overall Study|Various|6
203219|NCT02273141|646892|P1|Overall Study|Various|6
203220|NCT02273141|646891|P2|Overall Study|Withdrawal by Subject|15
203221|NCT02273141|646892|P1|Overall Study|Withdrawal by Subject|10
203222|NCT02273141|646891|P2|Overall Study|Lost to Follow-up|3
203223|NCT02273141|646892|P1|Overall Study|Lost to Follow-up|1
203224|NCT02273141|646891|P2|Overall Study|Adverse Event|1
203225|NCT02273141|646892|P1|Overall Study|Adverse Event|0
203226|NCT02272725|646959|P2|Overall Study|equipment malfunction|0
203227|NCT02272725|646960|P1|Overall Study|equipment malfunction|2
203228|NCT02271854|646970|P1|Overall Study|Lost to Follow-up|1
203229|NCT02271854|646970|P1|Overall Study|Unable or unwilling to cooperate with st|1
203230|NCT02271854|646970|P1|Overall Study|Withdrawal by Subject|2
203231|NCT02271529|646998|P1|Overall Study|Withdrawal by Subject|1
203232|NCT02270684|647019|P2|Overall Study|Study terminated|0
203233|NCT02270684|647020|P1|Overall Study|Study terminated|1
203234|NCT02270684|647019|P2|Overall Study|Lost to Follow-up|3
203235|NCT02270684|647020|P1|Overall Study|Lost to Follow-up|0
203236|NCT02270515|647026|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
203237|NCT02270515|647026|P1|Intervention Period 3: 12-18 Months|Death|3
203238|NCT02270515|647026|P1|Intervention Period 3: 12-18 Months|Received transplant|2
203239|NCT02270515|647026|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
203240|NCT02270515|647026|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
203241|NCT02270515|647026|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
203242|NCT02270515|647026|P1|Intervention Period 2: 6-12 Months|Death|5
203243|NCT02270515|647026|P1|Intervention Period 2: 6-12 Months|Received transplant|1
203244|NCT02270515|647026|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
203245|NCT02270515|647026|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
203246|NCT02270515|647026|P1|Intervention Period 1: 0-6 Months|Death|7
203247|NCT02270515|647026|P1|Intervention Period 1: 0-6 Months|Received transplant|3
203248|NCT02270515|647026|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
203249|NCT02270515|647026|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
203250|NCT02269657|647041|P1|Overall Study|Protocol Violation|3
203251|NCT02269475|647061|P2|Overall Study|Withdrawal by Subject|1
203252|NCT02269475|647062|P1|Overall Study|Withdrawal by Subject|0
203253|NCT02269475|647061|P2|Overall Study|Meet Exclusion Criteria No. 17|0
203254|NCT02269475|647062|P1|Overall Study|Meet Exclusion Criteria No. 17|3
203255|NCT02269098|647075|P2|Overall Study|Lost to Follow-up|9
203256|NCT02269098|647076|P1|Overall Study|Lost to Follow-up|14
203257|NCT02268864|647104|P3|Overall Study|Death|0
203258|NCT02268864|647105|P2|Overall Study|Death|1
203259|NCT02268864|647106|P1|Overall Study|Death|0
203260|NCT02268864|647104|P3|Overall Study|Withdrawal by Subject|0
203261|NCT02268864|647105|P2|Overall Study|Withdrawal by Subject|0
203262|NCT02268864|647106|P1|Overall Study|Withdrawal by Subject|2
203263|NCT02268396|647128|P1|Overall Study|2 Subjects no Day 29 Assessment|2
203264|NCT02268396|647128|P1|Overall Study|Protocol-Specified Criteria|2
203265|NCT02268396|647128|P1|Overall Study|Lost to Follow-up|2
203266|NCT02268396|647128|P1|Overall Study|Withdrawal by Subject|1
203267|NCT02268396|647128|P1|Overall Study|Administrative|2
203268|NCT02268396|647128|P1|Overall Study|Adverse Event|3
203269|NCT02268058|647141|P4|Overall Study|Protocol Violation|0
203270|NCT02268058|647142|P3|Overall Study|Protocol Violation|0
203271|NCT02268058|647143|P2|Overall Study|Protocol Violation|0
203272|NCT02268058|647144|P1|Overall Study|Protocol Violation|1
203273|NCT02267824|647177|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
203274|NCT02267824|647178|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
203275|NCT02267824|647177|P2|Overall Study|Protocol Violation|0
203276|NCT02267824|647178|P1|Overall Study|Protocol Violation|3
203277|NCT02267824|647177|P2|Overall Study|Lost to Follow-up|0
203278|NCT02267824|647178|P1|Overall Study|Lost to Follow-up|4
203279|NCT02267824|647177|P2|Overall Study|Pregnancy|1
203280|NCT02267824|647178|P1|Overall Study|Pregnancy|1
203281|NCT02266381|647230|P3|Overall Study|Physician Decision|4
203282|NCT02266381|647231|P2|Overall Study|Physician Decision|5
203283|NCT02266381|647232|P1|Overall Study|Physician Decision|3
203284|NCT02264821|647304|P3|Overall Study|Protocol Violation|6
203285|NCT02264821|647305|P2|Overall Study|Protocol Violation|3
203286|NCT02264821|647306|P1|Overall Study|Protocol Violation|1
203287|NCT02262754|647409|P3|Overall Study|Unspecified|2
203288|NCT02262754|647410|P2|Overall Study|Unspecified|0
203289|NCT02262754|647411|P1|Overall Study|Unspecified|4
203290|NCT02262754|647409|P3|Overall Study|Withdrawal by Subject|1
203291|NCT02262754|647410|P2|Overall Study|Withdrawal by Subject|0
203292|NCT02262754|647411|P1|Overall Study|Withdrawal by Subject|1
203293|NCT02262754|647409|P3|Overall Study|Protocol Violation|0
203294|NCT02262754|647410|P2|Overall Study|Protocol Violation|0
203295|NCT02262754|647411|P1|Overall Study|Protocol Violation|1
203296|NCT02262754|647409|P3|Overall Study|Study terminated by sponsor|4
203297|NCT02262754|647410|P2|Overall Study|Study terminated by sponsor|4
203298|NCT02262754|647411|P1|Overall Study|Study terminated by sponsor|5
203299|NCT02262754|647409|P3|Overall Study|No longer meets eligibility criteria|0
203300|NCT02262754|647410|P2|Overall Study|No longer meets eligibility criteria|1
203301|NCT02262754|647411|P1|Overall Study|No longer meets eligibility criteria|0
203302|NCT02262754|647409|P3|Overall Study|Lost to Follow-up|1
203303|NCT02262754|647410|P2|Overall Study|Lost to Follow-up|0
203304|NCT02262754|647411|P1|Overall Study|Lost to Follow-up|0
203305|NCT02262754|647409|P3|Overall Study|Lack of Efficacy|1
203306|NCT02262754|647410|P2|Overall Study|Lack of Efficacy|0
203307|NCT02262754|647411|P1|Overall Study|Lack of Efficacy|2
203308|NCT02262754|647409|P3|Overall Study|Adverse Event|0
203309|NCT02262754|647410|P2|Overall Study|Adverse Event|4
203310|NCT02262754|647411|P1|Overall Study|Adverse Event|3
203311|NCT02260882|647581|P2|Overall Study|Protocol Violation|1
203312|NCT02260882|647582|P1|Overall Study|Protocol Violation|0
203314|NCT02260492|647608|P2|Overall Study|Withdrawal by Subject|2
203315|NCT02260492|647609|P1|Overall Study|Withdrawal by Subject|3
203316|NCT02260492|647607|P3|Overall Study|Physician Decision|1
203317|NCT02260492|647608|P2|Overall Study|Physician Decision|0
203318|NCT02260492|647609|P1|Overall Study|Physician Decision|2
203319|NCT02260492|647607|P3|Overall Study|Lost to Follow-up|0
203320|NCT02260492|647608|P2|Overall Study|Lost to Follow-up|9
203321|NCT02260492|647609|P1|Overall Study|Lost to Follow-up|12
203322|NCT02260492|647607|P3|Overall Study|Death|0
203323|NCT02260492|647608|P2|Overall Study|Death|1
203324|NCT02260492|647609|P1|Overall Study|Death|0
203325|NCT02260492|647607|P3|Overall Study|Adverse Event|2
203326|NCT02260492|647608|P2|Overall Study|Adverse Event|1
203327|NCT02260492|647609|P1|Overall Study|Adverse Event|6
203328|NCT02259400|647645|P2|Overall Study|Death|2
203329|NCT02259400|647646|P1|Overall Study|Death|0
203330|NCT02259348|647678|P1|Overall Study|Death|4
203331|NCT02259348|647678|P1|Overall Study|Donors|6
203332|NCT02258529|647690|P1|Overall Study|Adverse Event|1
203333|NCT02258529|647690|P1|Overall Study|Study Terminated by Sponsor|9
203334|NCT02258334|647736|P4|Overall Study|Adverse Event|0
203335|NCT02258334|647737|P3|Overall Study|Adverse Event|0
203336|NCT02258334|647738|P2|Overall Study|Adverse Event|0
203337|NCT02258334|647739|P1|Overall Study|Adverse Event|1
203338|NCT02257918|647768|P3|Overall Study|Pregnancy|1
203339|NCT02257918|647769|P2|Overall Study|Pregnancy|0
203340|NCT02257918|647770|P1|Overall Study|Pregnancy|0
203341|NCT02257918|647768|P3|Overall Study|Withdrawal by Subject|1
203342|NCT02257918|647769|P2|Overall Study|Withdrawal by Subject|0
203343|NCT02257918|647770|P1|Overall Study|Withdrawal by Subject|0
203344|NCT02257918|647768|P3|Overall Study|Lost to Follow-up|0
203345|NCT02257918|647769|P2|Overall Study|Lost to Follow-up|1
203346|NCT02257918|647770|P1|Overall Study|Lost to Follow-up|4
203347|NCT02257684|647820|P1|Overall Study|Sponsor's Decision|1
203348|NCT02257684|647820|P1|Overall Study|Lack of Efficacy|1
203349|NCT02257684|647820|P1|Overall Study|Adverse Event|2
203350|NCT02257385|647830|P2|Overall Study|Withdrawal by Subject|4
203351|NCT02257385|647831|P1|Overall Study|Withdrawal by Subject|4
203352|NCT02257385|647830|P2|Overall Study|Lost to Follow-up|1
203353|NCT02257385|647831|P1|Overall Study|Lost to Follow-up|0
203354|NCT02257385|647830|P2|Overall Study|Protocol Violation|7
203355|NCT02257385|647831|P1|Overall Study|Protocol Violation|5
203356|NCT02257385|647830|P2|Overall Study|Lack of Efficacy|2
203357|NCT02257385|647831|P1|Overall Study|Lack of Efficacy|1
203358|NCT02257385|647830|P2|Overall Study|Adverse Event|8
203359|NCT02257385|647831|P1|Overall Study|Adverse Event|12
203360|NCT02257372|647841|P2|Overall Study|Withdrew consent|0
203361|NCT02257372|647842|P1|Overall Study|Withdrew consent|1
203362|NCT02257372|647841|P2|Overall Study|Lost to Follow-up|1
203363|NCT02257372|647842|P1|Overall Study|Lost to Follow-up|0
203364|NCT02257372|647841|P2|Overall Study|Protocol Violation|1
203365|NCT02257372|647842|P1|Overall Study|Protocol Violation|1
203366|NCT02257372|647841|P2|Overall Study|Lack of Efficacy|1
203367|NCT02257372|647842|P1|Overall Study|Lack of Efficacy|2
203368|NCT02257372|647841|P2|Overall Study|Adverse Event|7
203369|NCT02257372|647842|P1|Overall Study|Adverse Event|3
203370|NCT02256982|647852|P2|Overall Study|Disease Progression|1
203371|NCT02256982|647853|P1|Overall Study|Disease Progression|0
203372|NCT02256969|647862|P3|Overall Study|Screenfailed or withdrew|1
203373|NCT02256969|647863|P2|Overall Study|Screenfailed or withdrew|1
203374|NCT02256969|647864|P1|Overall Study|Screenfailed or withdrew|2
203375|NCT02256553|647881|P1|Period III|Adverse Event|3
203376|NCT02256553|647881|P1|Period II|Subject Moved|1
203377|NCT02256553|647881|P1|Period II|Adverse Event|1
203378|NCT02256553|647881|P1|Period I|Protocol Violation|1
203379|NCT02256553|647881|P1|Period I|Adverse Event|5
203380|NCT02256488|647894|P4|Overall Study|Withdrawal by Subject|2
203381|NCT02256488|647895|P3|Overall Study|Withdrawal by Subject|0
203382|NCT02256488|647896|P2|Overall Study|Withdrawal by Subject|0
203383|NCT02256488|647897|P1|Overall Study|Withdrawal by Subject|1
203384|NCT02256488|647894|P4|Overall Study|OTHER|1
203385|NCT02256488|647895|P3|Overall Study|OTHER|1
203386|NCT02256488|647896|P2|Overall Study|OTHER|0
203387|NCT02256488|647897|P1|Overall Study|OTHER|1
203388|NCT02256488|647894|P4|Overall Study|Lost to Follow-up|3
203389|NCT02256488|647895|P3|Overall Study|Lost to Follow-up|9
203390|NCT02256488|647896|P2|Overall Study|Lost to Follow-up|6
203391|NCT02256488|647897|P1|Overall Study|Lost to Follow-up|6
203392|NCT02255565|647940|P3|Overall Study|Withdrawal by Subject|0
203393|NCT02255565|647941|P2|Overall Study|Withdrawal by Subject|1
203394|NCT02255565|647942|P1|Overall Study|Withdrawal by Subject|0
203395|NCT02255279|648003|P2|Overall Study|Withdrawal by Subject|6
203396|NCT02255279|648004|P1|Overall Study|Withdrawal by Subject|3
203397|NCT02255279|648003|P2|Overall Study|Protocol Violation|1
203398|NCT02255279|648004|P1|Overall Study|Protocol Violation|0
203399|NCT02255279|648003|P2|Overall Study|Lost to Follow-up|2
203400|NCT02255279|648004|P1|Overall Study|Lost to Follow-up|2
203401|NCT02255149|648030|P1|Overall Study|Implant Failure|1
203402|NCT02255149|648030|P1|Overall Study|Withdrawal by PI|1
203403|NCT02255149|648030|P1|Overall Study|Withdrawal by Subject|1
203404|NCT02255149|648030|P1|Overall Study|Lost to Follow-up|2
203405|NCT02254551|648034|P1|Dose Escalation|Dose-limiting toxicity|2
203406|NCT02254551|648034|P1|Dose Escalation|Physician Decision|1
203407|NCT02254486|648044|P2|Overall Study|Various|12
203408|NCT02254486|648045|P1|Overall Study|Various|12
203409|NCT02254486|648044|P2|Overall Study|GFR<60mL/min|21
203410|NCT02254486|648045|P1|Overall Study|GFR<60mL/min|16
203411|NCT02254486|648044|P2|Overall Study|Withdrawal by Subject|15
203412|NCT02254486|648045|P1|Overall Study|Withdrawal by Subject|17
203413|NCT02254486|648044|P2|Overall Study|Protocol Violation|2
203414|NCT02254486|648045|P1|Overall Study|Protocol Violation|1
203415|NCT02254486|648044|P2|Overall Study|Lost to Follow-up|4
203416|NCT02254486|648045|P1|Overall Study|Lost to Follow-up|2
203417|NCT02254486|648044|P2|Overall Study|Lack of Efficacy|0
203418|NCT02254486|648045|P1|Overall Study|Lack of Efficacy|1
203419|NCT02254486|648044|P2|Overall Study|Adverse Event|1
203420|NCT02254486|648045|P1|Overall Study|Adverse Event|1
203421|NCT02254460|648061|P2|Overall Study|Adverse Event|0
203422|NCT02254460|648062|P1|Overall Study|Adverse Event|1
203423|NCT02253654|648083|P2|Overall Study|Did Not Receive Study Treatment|1
203424|NCT02253654|648084|P1|Overall Study|Did Not Receive Study Treatment|4
203425|NCT02253654|648083|P2|Overall Study|Death|7
203426|NCT02253654|648084|P1|Overall Study|Death|4
203427|NCT02253654|648083|P2|Overall Study|Lost to Follow-up|5
203428|NCT02253654|648084|P1|Overall Study|Lost to Follow-up|2
203429|NCT02253654|648083|P2|Overall Study|Decision by Sponsor|1
203430|NCT02253654|648084|P1|Overall Study|Decision by Sponsor|1
203431|NCT02253654|648083|P2|Overall Study|Withdrawal by Subject|4
203432|NCT02253654|648084|P1|Overall Study|Withdrawal by Subject|12
203433|NCT02252965|648348|P2|Overall Study|Unspecified|5
203434|NCT02252965|648349|P1|Overall Study|Unspecified|4
203435|NCT02252965|648348|P2|Overall Study|Withdrawal by Subject|9
203436|NCT02252965|648349|P1|Overall Study|Withdrawal by Subject|7
203437|NCT02252965|648348|P2|Overall Study|Lack of Efficacy|2
203438|NCT02252965|648349|P1|Overall Study|Lack of Efficacy|0
203439|NCT02252965|648348|P2|Overall Study|Protocol Violation|5
203440|NCT02252965|648349|P1|Overall Study|Protocol Violation|4
203441|NCT02252965|648348|P2|Overall Study|Lost to Follow-up|8
203442|NCT02252965|648349|P1|Overall Study|Lost to Follow-up|16
203443|NCT02252965|648348|P2|Overall Study|Adverse Event|14
203444|NCT02252965|648349|P1|Overall Study|Adverse Event|9
203445|NCT02252016|648468|P2|Safety Follow-Up|Ongoing in follow-up|50
203446|NCT02252016|648469|P1|Safety Follow-Up|Ongoing in follow-up|106
203447|NCT02252016|648468|P2|Treatment|Adverse Event|1
203448|NCT02252016|648469|P1|Treatment|Adverse Event|0
203449|NCT02252016|648468|P2|Treatment|Protocol Violation|0
203450|NCT02252016|648469|P1|Treatment|Protocol Violation|1
203451|NCT02252016|648468|P2|Treatment|Withdrawal by Subject|1
203452|NCT02252016|648469|P1|Treatment|Withdrawal by Subject|0
203453|NCT02251652|648498|P1|Overall Study|Withdrawal by Subject|1
203454|NCT02250274|648536|P2|Overall Study|Insufficient blood draw amount|6
203455|NCT02250274|648537|P1|Overall Study|Insufficient blood draw amount|7
203456|NCT02248818|648590|P9|Randomised Study|Administrative - randomization error|0
203457|NCT02248818|648591|P8|Randomised Study|Administrative - randomization error|0
203458|NCT02248818|648592|P7|Randomised Study|Administrative - randomization error|0
203459|NCT02248818|648593|P6|Randomised Study|Administrative - randomization error|8
203460|NCT02248818|648594|P5|Randomised Study|Administrative - randomization error|0
203461|NCT02248818|648595|P4|Randomised Study|Administrative - randomization error|0
203462|NCT02248818|648596|P3|Randomised Study|Administrative - randomization error|0
203463|NCT02248818|648597|P2|Randomised Study|Administrative - randomization error|0
203464|NCT02248818|648598|P1|Randomised Study|Administrative - randomization error|0
203465|NCT02248818|648590|P9|Screening|Lost to Follow-up|7
203466|NCT02248818|648591|P8|Screening|Lost to Follow-up|0
203467|NCT02248818|648592|P7|Screening|Lost to Follow-up|0
203468|NCT02248818|648593|P6|Screening|Lost to Follow-up|0
203469|NCT02248818|648594|P5|Screening|Lost to Follow-up|0
203470|NCT02248818|648595|P4|Screening|Lost to Follow-up|0
203471|NCT02248818|648596|P3|Screening|Lost to Follow-up|0
203472|NCT02248818|648597|P2|Screening|Lost to Follow-up|0
203473|NCT02248818|648598|P1|Screening|Lost to Follow-up|0
203474|NCT02248818|648590|P9|Screening|Withdrawal by Subject|6
203475|NCT02248818|648591|P8|Screening|Withdrawal by Subject|0
203476|NCT02248818|648592|P7|Screening|Withdrawal by Subject|0
203477|NCT02248818|648593|P6|Screening|Withdrawal by Subject|0
203478|NCT02248818|648594|P5|Screening|Withdrawal by Subject|0
203479|NCT02248818|648595|P4|Screening|Withdrawal by Subject|0
203480|NCT02248818|648596|P3|Screening|Withdrawal by Subject|0
203481|NCT02248818|648597|P2|Screening|Withdrawal by Subject|0
203482|NCT02248818|648598|P1|Screening|Withdrawal by Subject|0
203483|NCT02248818|648590|P9|Screening|Physician Decision|73
203484|NCT02248818|648591|P8|Screening|Physician Decision|0
203485|NCT02248818|648592|P7|Screening|Physician Decision|0
203486|NCT02248818|648593|P6|Screening|Physician Decision|0
203487|NCT02248818|648594|P5|Screening|Physician Decision|0
203488|NCT02248818|648595|P4|Screening|Physician Decision|0
203489|NCT02248818|648596|P3|Screening|Physician Decision|0
203490|NCT02248818|648597|P2|Screening|Physician Decision|0
203491|NCT02248818|648598|P1|Screening|Physician Decision|0
203492|NCT02248818|648590|P9|Screening|Study fully enrolled|14
203493|NCT02248818|648591|P8|Screening|Study fully enrolled|0
203494|NCT02248818|648592|P7|Screening|Study fully enrolled|0
203495|NCT02248818|648593|P6|Screening|Study fully enrolled|0
203496|NCT02248818|648594|P5|Screening|Study fully enrolled|0
203497|NCT02248818|648595|P4|Screening|Study fully enrolled|0
203498|NCT02248818|648596|P3|Screening|Study fully enrolled|0
203499|NCT02248818|648597|P2|Screening|Study fully enrolled|0
203500|NCT02248818|648598|P1|Screening|Study fully enrolled|0
203501|NCT02248818|648590|P9|Screening|Protocol Violation|7
203502|NCT02248818|648591|P8|Screening|Protocol Violation|0
203503|NCT02248818|648592|P7|Screening|Protocol Violation|0
203504|NCT02248818|648593|P6|Screening|Protocol Violation|0
203505|NCT02248818|648594|P5|Screening|Protocol Violation|0
203506|NCT02248818|648595|P4|Screening|Protocol Violation|0
203507|NCT02248818|648596|P3|Screening|Protocol Violation|0
203508|NCT02248818|648597|P2|Screening|Protocol Violation|0
203509|NCT02248818|648598|P1|Screening|Protocol Violation|0
203510|NCT02248675|648761|P2|Overall Study|Lost to Follow-up|1
203511|NCT02248675|648762|P1|Overall Study|Lost to Follow-up|3
203512|NCT02248480|648789|P2|Overall Study|Other:Physician Decision|1
203513|NCT02248480|648790|P1|Overall Study|Other:Physician Decision|0
203514|NCT02248480|648789|P2|Overall Study|Entry Criteria Not Met|1
203515|NCT02248480|648790|P1|Overall Study|Entry Criteria Not Met|0
203516|NCT02248480|648789|P2|Overall Study|Withdrawal by Subject|4
203517|NCT02248480|648790|P1|Overall Study|Withdrawal by Subject|2
203518|NCT02248480|648789|P2|Overall Study|Adverse Event|2
203519|NCT02248480|648790|P1|Overall Study|Adverse Event|11
203520|NCT02248480|648789|P2|Overall Study|Lack of Efficacy|6
203521|NCT02248480|648790|P1|Overall Study|Lack of Efficacy|4
203522|NCT02247960|648848|P2|Catheter Removed|Lost to Follow-up|10
203523|NCT02247960|648849|P1|Catheter Removed|Lost to Follow-up|7
203524|NCT02247960|648848|P2|Patient Consent and Randomization|Withdrawal by Subject|4
203525|NCT02247960|648849|P1|Patient Consent and Randomization|Withdrawal by Subject|0
203526|NCT02247960|648848|P2|Patient Consent and Randomization|Physician Decision|2
203527|NCT02247960|648849|P1|Patient Consent and Randomization|Physician Decision|2
203528|NCT02247011|648866|P1|Overall Study|Poor quality of radiological results|125
203529|NCT02246582|648883|P2|Overall Study|Withdrawal by Subject|4
203530|NCT02246582|648884|P1|Overall Study|Withdrawal by Subject|3
203531|NCT02246166|648892|P2|Overall Study|Protocol Violation|0
203532|NCT02246166|648893|P1|Overall Study|Protocol Violation|1
203533|NCT02246114|648929|P2|Overall Study|miscarriage|0
203534|NCT02246114|648930|P1|Overall Study|miscarriage|1
203535|NCT02244580|648976|P1|Overall Study|No cancer tissues available|241
203536|NCT02243280|649008|P11|Treated|Lost to Follow-up|2
203537|NCT02243280|649009|P10|Treated|Lost to Follow-up|0
203538|NCT02243280|649010|P9|Treated|Lost to Follow-up|1
203539|NCT02243280|649011|P8|Treated|Lost to Follow-up|0
203540|NCT02243280|649012|P7|Treated|Lost to Follow-up|0
203541|NCT02243280|649013|P6|Treated|Lost to Follow-up|0
203542|NCT02243280|649014|P5|Treated|Lost to Follow-up|0
203543|NCT02243280|649015|P4|Treated|Lost to Follow-up|0
203544|NCT02243280|649016|P3|Treated|Lost to Follow-up|0
203545|NCT02243280|649017|P2|Treated|Lost to Follow-up|0
203546|NCT02243280|649018|P1|Treated|Lost to Follow-up|0
203547|NCT02243280|649008|P11|Treated|Adverse Event|1
203548|NCT02243280|649009|P10|Treated|Adverse Event|0
203549|NCT02243280|649010|P9|Treated|Adverse Event|0
203550|NCT02243280|649011|P8|Treated|Adverse Event|0
203551|NCT02243280|649012|P7|Treated|Adverse Event|0
203552|NCT02243280|649013|P6|Treated|Adverse Event|0
203553|NCT02243280|649014|P5|Treated|Adverse Event|0
203554|NCT02243280|649015|P4|Treated|Adverse Event|0
203555|NCT02243280|649016|P3|Treated|Adverse Event|0
203556|NCT02243280|649017|P2|Treated|Adverse Event|0
203557|NCT02243280|649018|P1|Treated|Adverse Event|1
203558|NCT02243202|649073|P4|Overall Study|Randomized but not received treatment|1
203559|NCT02243202|649074|P3|Overall Study|Randomized but not received treatment|0
203560|NCT02243202|649075|P2|Overall Study|Randomized but not received treatment|0
203561|NCT02243202|649076|P1|Overall Study|Randomized but not received treatment|0
203562|NCT02243202|649073|P4|Overall Study|Unspecified|2
203563|NCT02243202|649074|P3|Overall Study|Unspecified|1
203564|NCT02243202|649075|P2|Overall Study|Unspecified|3
203565|NCT02243202|649076|P1|Overall Study|Unspecified|1
203566|NCT02243202|649073|P4|Overall Study|Withdrawal by Subject|4
203567|NCT02243202|649074|P3|Overall Study|Withdrawal by Subject|4
203568|NCT02243202|649075|P2|Overall Study|Withdrawal by Subject|6
203569|NCT02243202|649076|P1|Overall Study|Withdrawal by Subject|7
203570|NCT02243202|649073|P4|Overall Study|Protocol Violation|1
203571|NCT02243202|649074|P3|Overall Study|Protocol Violation|2
203572|NCT02243202|649075|P2|Overall Study|Protocol Violation|1
203573|NCT02243202|649076|P1|Overall Study|Protocol Violation|3
203574|NCT02243202|649073|P4|Overall Study|Lost to Follow-up|11
203575|NCT02243202|649074|P3|Overall Study|Lost to Follow-up|14
203576|NCT02243202|649075|P2|Overall Study|Lost to Follow-up|9
203577|NCT02243202|649076|P1|Overall Study|Lost to Follow-up|9
203578|NCT02243202|649073|P4|Overall Study|Adverse Event|4
203579|NCT02243202|649074|P3|Overall Study|Adverse Event|10
203580|NCT02243202|649075|P2|Overall Study|Adverse Event|6
203581|NCT02243202|649076|P1|Overall Study|Adverse Event|5
203582|NCT02243176|649112|P2|Overall Study|Adverse Event|2
203583|NCT02243176|649113|P1|Overall Study|Adverse Event|2
203584|NCT02243176|649112|P2|Overall Study|Withdrawal by Subject|7
203585|NCT02243176|649113|P1|Overall Study|Withdrawal by Subject|8
203586|NCT02243176|649112|P2|Overall Study|Protocol Violation|1
203587|NCT02243176|649113|P1|Overall Study|Protocol Violation|2
203588|NCT02243176|649112|P2|Overall Study|protocol specified withdrawal critera|3
203589|NCT02243176|649113|P1|Overall Study|protocol specified withdrawal critera|1
203590|NCT02243176|649112|P2|Overall Study|Other reason|2
203591|NCT02243176|649113|P1|Overall Study|Other reason|1
203592|NCT02243046|649138|P3|Overall Study|Lost to Follow-up|4
203593|NCT02243046|649139|P2|Overall Study|Lost to Follow-up|1
203594|NCT02243046|649140|P1|Overall Study|Lost to Follow-up|1
203595|NCT02242643|649195|P2|Overall Study|Withdrawal by subject at Visit 2|1
203596|NCT02242643|649196|P1|Overall Study|Withdrawal by subject at Visit 2|0
203597|NCT02242643|649195|P2|Overall Study|Language barrier|0
203598|NCT02242643|649196|P1|Overall Study|Language barrier|1
203599|NCT02242643|649195|P2|Overall Study|Protocol requirements not followed|0
203600|NCT02242643|649196|P1|Overall Study|Protocol requirements not followed|1
203601|NCT02242643|649195|P2|Overall Study|Consent withdrawal by parent|0
203602|NCT02242643|649196|P1|Overall Study|Consent withdrawal by parent|1
203603|NCT02242643|649195|P2|Overall Study|Non-compliance|0
203604|NCT02242643|649196|P1|Overall Study|Non-compliance|1
203605|NCT02242643|649195|P2|Overall Study|Child placed in foster care by family|1
203606|NCT02242643|649196|P1|Overall Study|Child placed in foster care by family|0
203607|NCT02242643|649195|P2|Overall Study|Lost to Follow-up|61
203608|NCT02242643|649196|P1|Overall Study|Lost to Follow-up|54
203609|NCT02242643|649195|P2|Overall Study|Migrated/moved from study area|3
203610|NCT02242643|649196|P1|Overall Study|Migrated/moved from study area|1
203611|NCT02242643|649195|P2|Overall Study|Withdrawal by Subject|10
203612|NCT02242643|649196|P1|Overall Study|Withdrawal by Subject|15
203613|NCT02242643|649195|P2|Overall Study|Protocol Violation|2
203614|NCT02242643|649196|P1|Overall Study|Protocol Violation|1
203615|NCT02241889|649255|P6|Overall Study|Withdrawal by Subject|1
203616|NCT02241889|649256|P5|Overall Study|Withdrawal by Subject|0
203617|NCT02241889|649257|P4|Overall Study|Withdrawal by Subject|0
203618|NCT02241889|649258|P3|Overall Study|Withdrawal by Subject|0
203619|NCT02241889|649259|P2|Overall Study|Withdrawal by Subject|0
203620|NCT02241889|649260|P1|Overall Study|Withdrawal by Subject|0
203621|NCT02241889|649255|P6|Overall Study|device issues|0
203622|NCT02241889|649256|P5|Overall Study|device issues|0
203623|NCT02241889|649257|P4|Overall Study|device issues|0
203624|NCT02241889|649258|P3|Overall Study|device issues|1
203625|NCT02241889|649259|P2|Overall Study|device issues|0
203626|NCT02241889|649260|P1|Overall Study|device issues|0
203627|NCT02241785|649295|P1|Overall Study|Adverse Event|1
203628|NCT02241785|649295|P1|Overall Study|Lost to Follow-up|2
203629|NCT02241785|649295|P1|Overall Study|Withdrawal by Subject|1
203630|NCT02241785|649295|P1|Overall Study|Sponsor Termination|43
203631|NCT02240628|649309|P2|Overall Study|Physician Decision|5
203632|NCT02240628|649310|P1|Overall Study|Physician Decision|6
203633|NCT02240368|649321|P3|Overall Study|Entropy failed to detect more than 50%|1
203634|NCT02240368|649322|P2|Overall Study|Entropy failed to detect more than 50%|0
203635|NCT02240368|649323|P1|Overall Study|Entropy failed to detect more than 50%|0
203636|NCT02240368|649321|P3|Overall Study|Surgery lasted less then 20 minutes|0
203637|NCT02240368|649322|P2|Overall Study|Surgery lasted less then 20 minutes|0
203638|NCT02240368|649323|P1|Overall Study|Surgery lasted less then 20 minutes|1
203639|NCT02239978|649347|P2|Overall Study|Withdrawal by Subject|0
203640|NCT02239978|649348|P1|Overall Study|Withdrawal by Subject|2
203641|NCT02239926|649365|P2|Overall Study|Withdrawal by Subject|1
203642|NCT02239926|649366|P1|Overall Study|Withdrawal by Subject|0
203643|NCT02239692|649391|P2|Overall Study|Other reason|0
203644|NCT02239692|649392|P1|Overall Study|Other reason|1
203645|NCT02239692|649391|P2|Overall Study|Withdrawal by Subject|5
203646|NCT02239692|649392|P1|Overall Study|Withdrawal by Subject|3
203647|NCT02239692|649391|P2|Overall Study|Lost to Follow-up|4
203648|NCT02239692|649392|P1|Overall Study|Lost to Follow-up|1
203649|NCT02239692|649391|P2|Overall Study|Physician Decision|1
203650|NCT02239692|649392|P1|Overall Study|Physician Decision|0
203651|NCT02239692|649391|P2|Overall Study|Adverse Event|1
203652|NCT02239692|649392|P1|Overall Study|Adverse Event|0
203653|NCT02239692|649391|P2|Overall Study|Incomplete colonoscopy|2
203654|NCT02239692|649392|P1|Overall Study|Incomplete colonoscopy|1
203655|NCT02238379|649433|P2|Overall Study|Lost to Follow-up|0
203656|NCT02238379|649434|P1|Overall Study|Lost to Follow-up|1
203657|NCT02238080|649460|P1|Overall Study|Unspecified|4
203658|NCT02238080|649460|P1|Overall Study|Withdrawal by Subject|2
203659|NCT02238080|649460|P1|Overall Study|Treatment interrupted|6
203660|NCT02238080|649460|P1|Overall Study|Death|13
203661|NCT02238067|649474|P1|Overall Study|Not completed survey at Month 6|45
203662|NCT02237118|649519|P2|Overall Study|consent withdrawn|0
203663|NCT02237118|649520|P1|Overall Study|consent withdrawn|1
203664|NCT02237118|649519|P2|Overall Study|Protocol Violation|1
203665|NCT02237118|649520|P1|Overall Study|Protocol Violation|0
203666|NCT02236611|649557|P2|Overall Study|Withdrew consent|4
203667|NCT02236611|649558|P1|Overall Study|Withdrew consent|9
203668|NCT02236611|649557|P2|Overall Study|Protocol deviation|5
203669|NCT02236611|649558|P1|Overall Study|Protocol deviation|3
203670|NCT02236611|649557|P2|Overall Study|Lost to Follow-up|2
203671|NCT02236611|649558|P1|Overall Study|Lost to Follow-up|0
203672|NCT02236611|649557|P2|Overall Study|Lack of Efficacy|7
203673|NCT02236611|649558|P1|Overall Study|Lack of Efficacy|4
203674|NCT02236611|649557|P2|Overall Study|Adverse Event|16
203675|NCT02236611|649558|P1|Overall Study|Adverse Event|10
203676|NCT02236598|649566|P2|Overall Study|Withdrawal by Subject|1
203677|NCT02236598|649567|P1|Overall Study|Withdrawal by Subject|0
203678|NCT02236598|649566|P2|Overall Study|Adverse Event|1
203679|NCT02236598|649567|P1|Overall Study|Adverse Event|0
203680|NCT02236130|649588|P2|Overall Study|Lost to Follow-up|12
203681|NCT02236130|649589|P1|Overall Study|Lost to Follow-up|7
203682|NCT02235077|649620|P2|Overall Study|Physician Decision|1
203683|NCT02235077|649621|P1|Overall Study|Physician Decision|0
203684|NCT02235077|649620|P2|Overall Study|Withdrawal by Subject|5
203685|NCT02235077|649621|P1|Overall Study|Withdrawal by Subject|8
203686|NCT02235077|649620|P2|Overall Study|Lost to Follow-up|6
203687|NCT02235077|649621|P1|Overall Study|Lost to Follow-up|5
203688|NCT02235077|649620|P2|Overall Study|Death|7
203689|NCT02235077|649621|P1|Overall Study|Death|5
203690|NCT02234479|649658|P2|Overall Study|Withdrawal by Subject|3
203691|NCT02234479|649659|P1|Overall Study|Withdrawal by Subject|1
203695|NCT02233647|649745|P1|Overall Study|Adverse Event|1
203696|NCT02233309|649774|P1|Overall Study|Physician Decision|5
203697|NCT02232880|649808|P1|Overall Study|study stopped prior to randomization|1
203698|NCT02232698|649817|P2|Overall Study|Withdrawal by Subject|11
203699|NCT02232698|649818|P1|Overall Study|Withdrawal by Subject|0
203700|NCT02232698|649817|P2|Overall Study|Allocated to control group|3
203701|NCT02232698|649818|P1|Overall Study|Allocated to control group|0
203702|NCT02232698|649817|P2|Overall Study|Non-compliance with study device|4
203703|NCT02232698|649818|P1|Overall Study|Non-compliance with study device|1
203704|NCT02232698|649817|P2|Overall Study|Had device-associated symptoms|0
203705|NCT02232698|649818|P1|Overall Study|Had device-associated symptoms|7
203706|NCT02232698|649817|P2|Overall Study|Met exclusion criteria|1
203707|NCT02232698|649818|P1|Overall Study|Met exclusion criteria|1
203708|NCT02232698|649817|P2|Overall Study|Pregnancy|1
203709|NCT02232698|649818|P1|Overall Study|Pregnancy|1
203710|NCT02231918|649853|P3|Overall Study|Adverse Event|1
203711|NCT02231918|649854|P2|Overall Study|Adverse Event|0
203712|NCT02231918|649855|P1|Overall Study|Adverse Event|0
203713|NCT02231918|649853|P3|Overall Study|Withdrawal by Subject|0
203714|NCT02231918|649854|P2|Overall Study|Withdrawal by Subject|1
203715|NCT02231918|649855|P1|Overall Study|Withdrawal by Subject|0
203716|NCT02231164|649978|P2|Overall Study|Withdrawal by Subject|2
203717|NCT02231164|649979|P1|Overall Study|Withdrawal by Subject|1
203718|NCT02231164|649978|P2|Overall Study|Lack of Efficacy|3
203719|NCT02231164|649979|P1|Overall Study|Lack of Efficacy|4
203720|NCT02231164|649978|P2|Overall Study|Adverse Event|1
203721|NCT02231164|649979|P1|Overall Study|Adverse Event|1
203722|NCT02230956|650007|P3|Overall Study|Other Miscellaneous Reason|2
203723|NCT02230956|650008|P2|Overall Study|Other Miscellaneous Reason|1
203724|NCT02230956|650009|P1|Overall Study|Other Miscellaneous Reason|0
203725|NCT02230956|650007|P3|Overall Study|Protocol Violation|1
203726|NCT02230956|650008|P2|Overall Study|Protocol Violation|1
203727|NCT02230956|650009|P1|Overall Study|Protocol Violation|0
203728|NCT02230956|650007|P3|Overall Study|Personal Reasons|1
203729|NCT02230956|650008|P2|Overall Study|Personal Reasons|1
203730|NCT02230956|650009|P1|Overall Study|Personal Reasons|2
203731|NCT02230956|650007|P3|Overall Study|Lost to Follow-up|2
203732|NCT02230956|650008|P2|Overall Study|Lost to Follow-up|1
203733|NCT02230956|650009|P1|Overall Study|Lost to Follow-up|1
203734|NCT02230956|650007|P3|Overall Study|Lack of Efficacy|1
203735|NCT02230956|650008|P2|Overall Study|Lack of Efficacy|1
203736|NCT02230956|650009|P1|Overall Study|Lack of Efficacy|1
203737|NCT02230956|650007|P3|Overall Study|Adverse Event|0
203738|NCT02230956|650008|P2|Overall Study|Adverse Event|1
203739|NCT02230956|650009|P1|Overall Study|Adverse Event|1
203740|NCT02230904|650031|P2|Overall Study|Safety follow up could not take place|1
203741|NCT02230904|650032|P1|Overall Study|Safety follow up could not take place|0
203742|NCT02230683|650065|P1|Overall Study|Adverse Event|1
203743|NCT02230085|650085|P1|Overall Study|Withdrawal by Subject|3
203744|NCT02230085|650085|P1|Overall Study|Physician Decision|1
203745|NCT02229864|650089|P1|1 - Year Visit|Missed Visits|1
203746|NCT02229539|650130|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
203747|NCT02229539|650131|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
203748|NCT02229539|650132|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
203749|NCT02229539|650130|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
203750|NCT02229539|650131|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
203751|NCT02229539|650132|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
203752|NCT02229539|650130|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
203753|NCT02229539|650131|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
203754|NCT02229539|650132|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
203755|NCT02229539|650130|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
203756|NCT02229539|650131|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
203757|NCT02229539|650132|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
203758|NCT02229539|650130|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
203759|NCT02229539|650131|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
203760|NCT02229539|650132|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
203761|NCT02229539|650130|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
203762|NCT02229539|650131|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
203763|NCT02229539|650132|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
203764|NCT02229539|650130|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
203765|NCT02229539|650131|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
203766|NCT02229539|650132|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
203767|NCT02229539|650130|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
203768|NCT02229539|650131|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
203769|NCT02229539|650132|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
203770|NCT02229539|650130|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
203771|NCT02229539|650131|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
203772|NCT02229539|650132|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
203773|NCT02229214|650229|P2|Overall Study|Withdrawal by Subject|0
203774|NCT02229214|650230|P1|Overall Study|Withdrawal by Subject|4
203775|NCT02229214|650229|P2|Overall Study|Adverse Event|0
203776|NCT02229214|650230|P1|Overall Study|Adverse Event|2
203777|NCT02228980|650254|P4|Overall Study|Withdrawal by Subject|3
203778|NCT02228980|650255|P3|Overall Study|Withdrawal by Subject|2
203779|NCT02228980|650256|P2|Overall Study|Withdrawal by Subject|3
203780|NCT02228980|650257|P1|Overall Study|Withdrawal by Subject|3
203781|NCT02228980|650254|P4|Overall Study|Protocol Violation|0
203782|NCT02228980|650255|P3|Overall Study|Protocol Violation|0
203783|NCT02228980|650256|P2|Overall Study|Protocol Violation|0
203784|NCT02228980|650257|P1|Overall Study|Protocol Violation|7
203785|NCT02228980|650254|P4|Overall Study|Adverse Event|0
203786|NCT02228980|650255|P3|Overall Study|Adverse Event|0
203787|NCT02228980|650256|P2|Overall Study|Adverse Event|0
203788|NCT02228980|650257|P1|Overall Study|Adverse Event|14
203789|NCT02228395|650279|P3|First Intervention Period|Unable to comply with study dates|1
203790|NCT02228395|650280|P2|First Intervention Period|Unable to comply with study dates|1
203791|NCT02228395|650281|P1|First Intervention Period|Unable to comply with study dates|0
203792|NCT02228395|650279|P3|First Intervention Period|No longer willing to participate|0
203793|NCT02228395|650280|P2|First Intervention Period|No longer willing to participate|0
203794|NCT02228395|650281|P1|First Intervention Period|No longer willing to participate|1
203795|NCT02227368|650381|P2|Overall Study|Adverse Event|0
203796|NCT02227368|650382|P1|Overall Study|Adverse Event|1
203797|NCT02227368|650381|P2|Overall Study|Lost to Follow-up|0
203798|NCT02227368|650382|P1|Overall Study|Lost to Follow-up|1
203799|NCT02227368|650381|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
203800|NCT02227368|650382|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
203801|NCT02227108|650394|P1|Overall Study|Adverse Event|6
203802|NCT02227108|650394|P1|Overall Study|Investigator discretion|1
203803|NCT02227108|650394|P1|Overall Study|Initiation of alternative therapy|2
203804|NCT02227108|650394|P1|Overall Study|Progressive disease|17
203805|NCT02227108|650394|P1|Overall Study|Unspecified|3
203806|NCT02227108|650394|P1|Overall Study|Did not receive treatment|2
203807|NCT02226562|650423|P2|Overall Study|Lost to Follow-up|1
203808|NCT02226562|650424|P1|Overall Study|Lost to Follow-up|0
203809|NCT02226549|650442|P2|Overall Study|Lost to Follow-up|1
203810|NCT02226549|650443|P1|Overall Study|Lost to Follow-up|0
203811|NCT02226549|650442|P2|Overall Study|Randomized but Never Treated|0
203812|NCT02226549|650443|P1|Overall Study|Randomized but Never Treated|1
203813|NCT02226198|650453|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
203814|NCT02226198|650454|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
203815|NCT02226198|650455|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
203816|NCT02226198|650453|P3|Lead-in Phase|Protocol Violation|0
203817|NCT02226198|650454|P2|Lead-in Phase|Protocol Violation|0
203818|NCT02226198|650455|P1|Lead-in Phase|Protocol Violation|1
203819|NCT02226003|650531|P3|Overall Study|Withdrawal by Subject|3
203820|NCT02226003|650532|P2|Overall Study|Withdrawal by Subject|0
203821|NCT02226003|650533|P1|Overall Study|Withdrawal by Subject|0
203822|NCT02226003|650531|P3|Overall Study|Lost to Follow-up|3
203823|NCT02226003|650532|P2|Overall Study|Lost to Follow-up|1
203824|NCT02226003|650533|P1|Overall Study|Lost to Follow-up|2
203825|NCT02224664|650586|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
203826|NCT02224664|650587|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
203827|NCT02224664|650588|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
203828|NCT02224664|650589|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
203829|NCT02224664|650590|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
203830|NCT02224664|650586|P5|Dose Escalation Period (21 Days)|Adverse Event|7
203831|NCT02224664|650587|P4|Dose Escalation Period (21 Days)|Adverse Event|2
203832|NCT02224664|650588|P3|Dose Escalation Period (21 Days)|Adverse Event|2
203833|NCT02224664|650589|P2|Dose Escalation Period (21 Days)|Adverse Event|0
203834|NCT02224664|650590|P1|Dose Escalation Period (21 Days)|Adverse Event|0
203835|NCT02224664|650586|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
203836|NCT02224664|650587|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
203837|NCT02224664|650588|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
203838|NCT02224664|650589|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
203839|NCT02224664|650590|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
203840|NCT02224625|650670|P1|Sensitization|Adverse Event|55
203841|NCT02224625|650670|P1|Irritation|Adverse Event|6
203842|NCT02224053|650700|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
203843|NCT02224053|650700|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
203844|NCT02224053|650700|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
203845|NCT02224053|650700|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
203846|NCT02224053|650700|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
203847|NCT02223754|650746|P2|Period 2|Test Article No Longer Available|1
203848|NCT02223754|650747|P1|Period 2|Test Article No Longer Available|0
203849|NCT02223754|650746|P2|Period 2|Lost to Follow-up|0
203850|NCT02223754|650747|P1|Period 2|Lost to Follow-up|1
203851|NCT02223754|650746|P2|Period 2|Lens Discomfort|1
203852|NCT02223754|650747|P1|Period 2|Lens Discomfort|1
203853|NCT02223754|650746|P2|Period 2|Protocol Violation|0
203854|NCT02223754|650747|P1|Period 2|Protocol Violation|1
203855|NCT02223754|650746|P2|Period 2|Adverse Event|1
203856|NCT02223754|650747|P1|Period 2|Adverse Event|0
203857|NCT02223754|650746|P2|Period 1|Unsatisfactory Visual Response|1
203858|NCT02223754|650747|P1|Period 1|Unsatisfactory Visual Response|0
203859|NCT02223754|650746|P2|Period 1|Test Article No Longer Available|5
203860|NCT02223754|650747|P1|Period 1|Test Article No Longer Available|1
203861|NCT02223754|650746|P2|Period 1|Withdrawal by Subject|4
203862|NCT02223754|650747|P1|Period 1|Withdrawal by Subject|0
203863|NCT02223754|650746|P2|Period 1|Protocol Violation|4
203864|NCT02223754|650747|P1|Period 1|Protocol Violation|2
203865|NCT02223754|650746|P2|Period 1|Lost to Follow-up|1
203866|NCT02223754|650747|P1|Period 1|Lost to Follow-up|0
203867|NCT02223754|650746|P2|Period 1|Adverse Event|0
203868|NCT02223754|650747|P1|Period 1|Adverse Event|1
203869|NCT02223715|650767|P1|Overall Study|Lost to Follow-up|73
203870|NCT02223715|650767|P1|Overall Study|Death|31
203871|NCT02222818|650896|P2|Period 1|Eligibility criteria not met|3
203872|NCT02222818|650897|P1|Period 1|Eligibility criteria not met|0
203873|NCT02222558|650904|P6|Period 3|Withdrawal by Subject|1
203874|NCT02222558|650905|P5|Period 3|Withdrawal by Subject|0
203875|NCT02222558|650906|P4|Period 3|Withdrawal by Subject|0
203876|NCT02222558|650907|P3|Period 3|Withdrawal by Subject|0
203877|NCT02222558|650908|P2|Period 3|Withdrawal by Subject|0
203878|NCT02222558|650909|P1|Period 3|Withdrawal by Subject|0
203879|NCT02222558|650904|P6|Period 1: Single Dose|Withdrawal by Subject|0
203880|NCT02222558|650905|P5|Period 1: Single Dose|Withdrawal by Subject|0
203881|NCT02222558|650906|P4|Period 1: Single Dose|Withdrawal by Subject|0
203882|NCT02222558|650907|P3|Period 1: Single Dose|Withdrawal by Subject|0
203883|NCT02222558|650908|P2|Period 1: Single Dose|Withdrawal by Subject|0
203884|NCT02222558|650909|P1|Period 1: Single Dose|Withdrawal by Subject|4
203885|NCT02222207|650923|P1|Overall Study|Adverse Event|1
203886|NCT02222207|650923|P1|Overall Study|Other reasons|2
203887|NCT02222207|650923|P1|Overall Study|Death|1
203888|NCT02221648|650960|P2|Overall Study|Withdrawal by Subject|3
203889|NCT02221648|650961|P1|Overall Study|Withdrawal by Subject|3
203890|NCT02220998|650973|P2|Overall Study|Lost to Follow-up|4
203891|NCT02220998|650974|P1|Overall Study|Lost to Follow-up|4
203892|NCT02220998|650973|P2|Overall Study|Lack of Efficacy|5
203893|NCT02220998|650974|P1|Overall Study|Lack of Efficacy|0
203894|NCT02220998|650973|P2|Overall Study|Death|0
203895|NCT02220998|650974|P1|Overall Study|Death|2
203896|NCT02220998|650973|P2|Overall Study|Randomized but Never Treated|2
203897|NCT02220998|650974|P1|Overall Study|Randomized but Never Treated|1
203898|NCT02220920|650992|P2|Overall Study|Conflict with the stopping criteria|2
203899|NCT02220920|650993|P1|Overall Study|Conflict with the stopping criteria|1
203900|NCT02220920|650992|P2|Overall Study|Withdrawal by Subject|0
203901|NCT02220920|650993|P1|Overall Study|Withdrawal by Subject|1
203902|NCT02220920|650992|P2|Overall Study|Lack of Efficacy|1
203903|NCT02220920|650993|P1|Overall Study|Lack of Efficacy|0
203904|NCT02220920|650992|P2|Overall Study|Adverse Event|0
203905|NCT02220920|650993|P1|Overall Study|Adverse Event|1
203906|NCT02220764|651009|P2|Overall Study|Death|0
203907|NCT02220764|651010|P1|Overall Study|Death|1
203908|NCT02220764|651009|P2|Overall Study|Lost to Follow-up|1
203909|NCT02220764|651010|P1|Overall Study|Lost to Follow-up|3
203910|NCT02220205|651022|P2|Overall Study|Withdrawal by Subject|0
203911|NCT02220205|651023|P1|Overall Study|Withdrawal by Subject|1
203912|NCT02219932|651048|P2|Overall Study|Adverse Event|21
203913|NCT02219932|651049|P1|Overall Study|Adverse Event|23
203914|NCT02219932|651048|P2|Overall Study|Lost to Follow-up|2
203915|NCT02219932|651049|P1|Overall Study|Lost to Follow-up|4
203916|NCT02219932|651048|P2|Overall Study|Pregnancy|0
203917|NCT02219932|651049|P1|Overall Study|Pregnancy|1
203918|NCT02219932|651048|P2|Overall Study|Protocol Violation|6
203919|NCT02219932|651049|P1|Overall Study|Protocol Violation|10
203920|NCT02219932|651048|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
203921|NCT02219932|651049|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
203922|NCT02219932|651048|P2|Overall Study|Consent Withdrawn|7
203923|NCT02219932|651049|P1|Overall Study|Consent Withdrawn|11
203924|NCT02219932|651048|P2|Overall Study|Investigator Decision|1
203925|NCT02219932|651049|P1|Overall Study|Investigator Decision|0
203926|NCT02219932|651048|P2|Overall Study|Death|1
203927|NCT02219932|651049|P1|Overall Study|Death|1
203928|NCT02219932|651048|P2|Overall Study|Not Specified|11
203929|NCT02219932|651049|P1|Overall Study|Not Specified|5
203930|NCT02219685|651065|P2|Blinded Treatment Phase|Withdrew Consent|0
203931|NCT02219685|651066|P1|Blinded Treatment Phase|Withdrew Consent|1
203932|NCT02219685|651065|P2|Blinded Treatment Phase|Lost to Follow-up|0
203933|NCT02219685|651066|P1|Blinded Treatment Phase|Lost to Follow-up|1
203934|NCT02219464|651171|P2|Overall Study|catheter malfunction|0
203935|NCT02219464|651172|P1|Overall Study|catheter malfunction|1
203936|NCT02219464|651171|P2|Overall Study|case cancelled|0
203937|NCT02219464|651172|P1|Overall Study|case cancelled|1
203938|NCT02219464|651171|P2|Overall Study|Withdrawal by Subject|0
203939|NCT02219464|651172|P1|Overall Study|Withdrawal by Subject|1
203940|NCT02218697|651315|P2|Overall Study|Withdrawal by Subject|3
203941|NCT02218697|651316|P1|Overall Study|Withdrawal by Subject|2
203942|NCT02218697|651315|P2|Overall Study|Unwilling to be vaccinated in left arm|1
203943|NCT02218697|651316|P1|Overall Study|Unwilling to be vaccinated in left arm|0
203944|NCT02218697|651315|P2|Overall Study|Adverse Event|2
203945|NCT02218697|651316|P1|Overall Study|Adverse Event|0
203946|NCT02218268|651365|P2|24 Hour Washout|Physician Decision|9
203947|NCT02218268|651366|P1|24 Hour Washout|Physician Decision|11
203948|NCT02217982|651374|P2|Overall Study|Adverse Event|1
203949|NCT02217982|651375|P1|Overall Study|Adverse Event|0
203950|NCT02217982|651374|P2|Overall Study|Trial discontinued|0
203951|NCT02217982|651375|P1|Overall Study|Trial discontinued|1
203952|NCT02217878|651385|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
203953|NCT02217878|651386|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
203954|NCT02217878|651385|P2|Overall Study|required morphine due to chest pain|2
203955|NCT02217878|651386|P1|Overall Study|required morphine due to chest pain|1
203956|NCT02216357|651483|P2|Overall Study|Inclusion or exclusion criteria not met|1
203957|NCT02216357|651484|P1|Overall Study|Inclusion or exclusion criteria not met|2
203958|NCT02215252|651536|P3|Overall Study|Unspecified|1
203959|NCT02215252|651537|P2|Overall Study|Unspecified|1
203960|NCT02215252|651538|P1|Overall Study|Unspecified|0
203961|NCT02215252|651536|P3|Overall Study|Withdrawal by Subject|0
203962|NCT02215252|651537|P2|Overall Study|Withdrawal by Subject|0
203963|NCT02215252|651538|P1|Overall Study|Withdrawal by Subject|1
203964|NCT02215252|651536|P3|Overall Study|Protocol Violation|0
203965|NCT02215252|651537|P2|Overall Study|Protocol Violation|1
203966|NCT02215252|651538|P1|Overall Study|Protocol Violation|0
203967|NCT02215252|651536|P3|Overall Study|Does not Meet Entrance Criteria|0
203968|NCT02215252|651537|P2|Overall Study|Does not Meet Entrance Criteria|1
203969|NCT02215252|651538|P1|Overall Study|Does not Meet Entrance Criteria|0
203970|NCT02215252|651536|P3|Overall Study|Lost to Follow-up|1
203971|NCT02215252|651537|P2|Overall Study|Lost to Follow-up|0
203972|NCT02215252|651538|P1|Overall Study|Lost to Follow-up|0
203973|NCT02215252|651536|P3|Overall Study|Adverse Event|2
203974|NCT02215252|651537|P2|Overall Study|Adverse Event|5
203975|NCT02215252|651538|P1|Overall Study|Adverse Event|1
203976|NCT02214225|651622|P3|Overall Study|randomized in error, not vaccinated|1
203977|NCT02214225|651623|P2|Overall Study|randomized in error, not vaccinated|1
203978|NCT02214225|651624|P1|Overall Study|randomized in error, not vaccinated|2
203979|NCT02214225|651622|P3|Overall Study|Death|1
203980|NCT02214225|651623|P2|Overall Study|Death|0
203981|NCT02214225|651624|P1|Overall Study|Death|5
203982|NCT02214225|651622|P3|Overall Study|Withdrawal by Subject|2
203983|NCT02214225|651623|P2|Overall Study|Withdrawal by Subject|0
203984|NCT02214225|651624|P1|Overall Study|Withdrawal by Subject|2
203985|NCT02214225|651622|P3|Overall Study|Lost to Follow-up|18
203986|NCT02214225|651623|P2|Overall Study|Lost to Follow-up|18
203987|NCT02214225|651624|P1|Overall Study|Lost to Follow-up|46
203988|NCT02214186|651683|P2|Overall Study|Protocol Violation|1
203989|NCT02214186|651684|P1|Overall Study|Protocol Violation|1
203990|NCT02214186|651683|P2|Overall Study|Lost to Follow-up|1
203991|NCT02214186|651684|P1|Overall Study|Lost to Follow-up|1
203992|NCT02213666|651721|P1|Overall Study|Withdrawal by Subject|1
203993|NCT02213510|651727|P2|Overall Study|Lost to Follow-up|0
203994|NCT02213510|651728|P1|Overall Study|Lost to Follow-up|1
203995|NCT02213510|651727|P2|Overall Study|Death|1
203996|NCT02213510|651728|P1|Overall Study|Death|0
203997|NCT02213198|651786|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
203998|NCT02213198|651787|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
203999|NCT02213198|651786|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
204000|NCT02213198|651787|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
204001|NCT02213198|651786|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
204002|NCT02213198|651787|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
204003|NCT02213198|651786|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
204004|NCT02213198|651787|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
204005|NCT02213198|651786|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
204006|NCT02213198|651787|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
204007|NCT02213198|651786|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
204008|NCT02213198|651787|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
204009|NCT02213198|651786|P2|Baseline|incarcerated,violent|1
204010|NCT02213198|651787|P1|Baseline|incarcerated,violent|0
204011|NCT02213198|651786|P2|Baseline|Lost to Follow-up|21
204012|NCT02213198|651787|P1|Baseline|Lost to Follow-up|40
204013|NCT02213198|651786|P2|Baseline|transferred out of clinic|9
204014|NCT02213198|651787|P1|Baseline|transferred out of clinic|7
204015|NCT02213198|651786|P2|Baseline|Withdrawal by Subject|11
204016|NCT02213198|651787|P1|Baseline|Withdrawal by Subject|34
204017|NCT02213198|651786|P2|Baseline|No show for intake|9
204018|NCT02213198|651787|P1|Baseline|No show for intake|7
204019|NCT02213055|651797|P2|Overall Study|Did not Return to School|0
204020|NCT02213055|651798|P1|Overall Study|Did not Return to School|5
204021|NCT02213055|651797|P2|Overall Study|Did not meet Inclusion Criteria|0
204022|NCT02213055|651798|P1|Overall Study|Did not meet Inclusion Criteria|6
204023|NCT02213055|651797|P2|Overall Study|Had another Treatment during the Study|0
204024|NCT02213055|651798|P1|Overall Study|Had another Treatment during the Study|3
204025|NCT02213055|651797|P2|Overall Study|Did not have Live Lice|0
204026|NCT02213055|651798|P1|Overall Study|Did not have Live Lice|8
204027|NCT02213055|651797|P2|Overall Study|Documentation Issue during Study|0
204028|NCT02213055|651798|P1|Overall Study|Documentation Issue during Study|10
204029|NCT02213055|651797|P2|Overall Study|Documentation Issue at Enrollment|0
204030|NCT02213055|651798|P1|Overall Study|Documentation Issue at Enrollment|1
204031|NCT02213055|651797|P2|Overall Study|Protocol was not Followed during Study|0
204032|NCT02213055|651798|P1|Overall Study|Protocol was not Followed during Study|1
204033|NCT02213055|651797|P2|Overall Study|Protocol was not Followed at Enrollment|0
204034|NCT02213055|651798|P1|Overall Study|Protocol was not Followed at Enrollment|5
204035|NCT02212301|651830|P2|Period 1|Lost to Follow-up|1
204036|NCT02212301|651831|P1|Period 1|Lost to Follow-up|0
204037|NCT02212197|651842|P3|Overall Study|Need for radiotherapy|0
204038|NCT02212197|651843|P2|Overall Study|Need for radiotherapy|0
204039|NCT02212197|651844|P1|Overall Study|Need for radiotherapy|1
204040|NCT02210091|651899|P2|Overall Study|Withdrawal by Sponsor|1
204041|NCT02210091|651900|P1|Overall Study|Withdrawal by Sponsor|0
204042|NCT02210091|651899|P2|Overall Study|Physician Decision|1
204043|NCT02210091|651900|P1|Overall Study|Physician Decision|0
204044|NCT02209766|651976|P5|Overall Study|Withdrawal by Subject|0
204045|NCT02209766|651977|P4|Overall Study|Withdrawal by Subject|1
204046|NCT02209766|651978|P3|Overall Study|Withdrawal by Subject|0
204047|NCT02209766|651979|P2|Overall Study|Withdrawal by Subject|0
204048|NCT02209766|651980|P1|Overall Study|Withdrawal by Subject|0
204049|NCT02209506|652031|P5|Overall Study|Withdrawal by Subject|1
204050|NCT02209506|652032|P4|Overall Study|Withdrawal by Subject|0
204051|NCT02209506|652033|P3|Overall Study|Withdrawal by Subject|0
204052|NCT02209506|652034|P2|Overall Study|Withdrawal by Subject|0
204053|NCT02209506|652035|P1|Overall Study|Withdrawal by Subject|0
204054|NCT02209454|652110|P2|Second Period|Adverse Event|0
204055|NCT02209454|652111|P1|Second Period|Adverse Event|1
204056|NCT02209181|652129|P4|Overall Study|Withdrawal by Subject|0
204057|NCT02209181|652130|P3|Overall Study|Withdrawal by Subject|0
204058|NCT02209181|652131|P2|Overall Study|Withdrawal by Subject|1
204059|NCT02209181|652132|P1|Overall Study|Withdrawal by Subject|0
204060|NCT02209181|652129|P4|Overall Study|Adverse Event|0
204061|NCT02209181|652130|P3|Overall Study|Adverse Event|1
204062|NCT02209181|652131|P2|Overall Study|Adverse Event|0
204063|NCT02209181|652132|P1|Overall Study|Adverse Event|1
204064|NCT02207907|652303|P2|Overall Study|Pregnancy|1
204065|NCT02207907|652304|P1|Overall Study|Pregnancy|0
204066|NCT02207907|652303|P2|Overall Study|Did not meet study criteria|0
204067|NCT02207907|652304|P1|Overall Study|Did not meet study criteria|3
204068|NCT02207907|652303|P2|Overall Study|Withdrawal by Subject|6
204069|NCT02207907|652304|P1|Overall Study|Withdrawal by Subject|5
204070|NCT02207907|652303|P2|Overall Study|Lost to Follow-up|1
204071|NCT02207907|652304|P1|Overall Study|Lost to Follow-up|3
204072|NCT02207829|652322|P2|Overall Study|Withdrew consent|14
204073|NCT02207829|652323|P1|Overall Study|Withdrew consent|18
204074|NCT02207829|652322|P2|Overall Study|Protocol deviation|4
204075|NCT02207829|652323|P1|Overall Study|Protocol deviation|5
204076|NCT02207829|652322|P2|Overall Study|Lost to Follow-up|2
204077|NCT02207829|652323|P1|Overall Study|Lost to Follow-up|2
204078|NCT02207829|652322|P2|Overall Study|Lack of Efficacy|5
204079|NCT02207829|652323|P1|Overall Study|Lack of Efficacy|7
204080|NCT02207829|652322|P2|Overall Study|Adverse Event|9
204081|NCT02207829|652323|P1|Overall Study|Adverse Event|10
204082|NCT02207608|652331|P2|Overall Study|Adverse Event|0
204083|NCT02207608|652332|P1|Overall Study|Adverse Event|1
204084|NCT02207413|652355|P6|Overall Study|Migrated/moved from study area|0
204085|NCT02207413|652356|P5|Overall Study|Migrated/moved from study area|1
204086|NCT02207413|652357|P4|Overall Study|Migrated/moved from study area|0
204087|NCT02207413|652358|P3|Overall Study|Migrated/moved from study area|0
204088|NCT02207413|652359|P2|Overall Study|Migrated/moved from study area|0
204089|NCT02207413|652360|P1|Overall Study|Migrated/moved from study area|0
204090|NCT02207413|652355|P6|Overall Study|Adverse Event|1
204091|NCT02207413|652356|P5|Overall Study|Adverse Event|2
204092|NCT02207413|652357|P4|Overall Study|Adverse Event|0
204093|NCT02207413|652358|P3|Overall Study|Adverse Event|0
204094|NCT02207413|652359|P2|Overall Study|Adverse Event|0
204095|NCT02207413|652360|P1|Overall Study|Adverse Event|0
204096|NCT02207413|652355|P6|Overall Study|Lost to Follow-up|5
204097|NCT02207413|652356|P5|Overall Study|Lost to Follow-up|1
204098|NCT02207413|652357|P4|Overall Study|Lost to Follow-up|1
204099|NCT02207413|652358|P3|Overall Study|Lost to Follow-up|0
204100|NCT02207413|652359|P2|Overall Study|Lost to Follow-up|0
204101|NCT02207413|652360|P1|Overall Study|Lost to Follow-up|0
204102|NCT02207413|652355|P6|Overall Study|Withdrawal by Subject|7
204103|NCT02207413|652356|P5|Overall Study|Withdrawal by Subject|3
204104|NCT02207413|652357|P4|Overall Study|Withdrawal by Subject|0
204105|NCT02207413|652358|P3|Overall Study|Withdrawal by Subject|0
204106|NCT02207413|652359|P2|Overall Study|Withdrawal by Subject|0
204107|NCT02207413|652360|P1|Overall Study|Withdrawal by Subject|1
204108|NCT02207400|652456|P2|Overall Study|Positive Urine Pregnancy Test|1
204109|NCT02207400|652457|P1|Overall Study|Positive Urine Pregnancy Test|0
204110|NCT02207400|652456|P2|Overall Study|Withdrawal by Subject|4
204111|NCT02207400|652457|P1|Overall Study|Withdrawal by Subject|8
204112|NCT02207400|652456|P2|Overall Study|Protocol Violation|1
204113|NCT02207400|652457|P1|Overall Study|Protocol Violation|1
204114|NCT02207400|652456|P2|Overall Study|Lost to Follow-up|7
204115|NCT02207400|652457|P1|Overall Study|Lost to Follow-up|6
204116|NCT02207400|652456|P2|Overall Study|Adverse Event|1
204117|NCT02207400|652457|P1|Overall Study|Adverse Event|1
204118|NCT02206607|652484|P5|Second Intervention Period|Insufficient Clinical Response|0
204119|NCT02206607|652485|P4|Second Intervention Period|Insufficient Clinical Response|1
204120|NCT02206607|652486|P3|Second Intervention Period|Insufficient Clinical Response|0
204121|NCT02206607|652487|P2|Second Intervention Period|Insufficient Clinical Response|0
204122|NCT02206607|652488|P1|Second Intervention Period|Insufficient Clinical Response|0
204123|NCT02206607|652484|P5|Open-Label Run-In|Withdrawal by Subject|0
204124|NCT02206607|652485|P4|Open-Label Run-In|Withdrawal by Subject|0
204125|NCT02206607|652486|P3|Open-Label Run-In|Withdrawal by Subject|0
204126|NCT02206607|652487|P2|Open-Label Run-In|Withdrawal by Subject|0
204127|NCT02206607|652488|P1|Open-Label Run-In|Withdrawal by Subject|3
204128|NCT02205814|652544|P4|Overall Study|not compliant with study procedures|0
204129|NCT02205814|652545|P3|Overall Study|not compliant with study procedures|1
204130|NCT02205814|652546|P2|Overall Study|not compliant with study procedures|0
204131|NCT02205814|652547|P1|Overall Study|not compliant with study procedures|0
204132|NCT02205814|652544|P4|Overall Study|Withdrawal by Subject|1
204133|NCT02205814|652545|P3|Overall Study|Withdrawal by Subject|2
204134|NCT02205814|652546|P2|Overall Study|Withdrawal by Subject|1
204135|NCT02205814|652547|P1|Overall Study|Withdrawal by Subject|0
204136|NCT02205814|652544|P4|Overall Study|Protocol Violation|1
204137|NCT02205814|652545|P3|Overall Study|Protocol Violation|0
204138|NCT02205814|652546|P2|Overall Study|Protocol Violation|0
204139|NCT02205814|652547|P1|Overall Study|Protocol Violation|1
204140|NCT02205814|652544|P4|Overall Study|Physician Decision|0
204141|NCT02205814|652545|P3|Overall Study|Physician Decision|1
204142|NCT02205814|652546|P2|Overall Study|Physician Decision|0
204143|NCT02205814|652547|P1|Overall Study|Physician Decision|0
204144|NCT02205814|652544|P4|Overall Study|Lack of Efficacy|1
204145|NCT02205814|652545|P3|Overall Study|Lack of Efficacy|1
204146|NCT02205814|652546|P2|Overall Study|Lack of Efficacy|0
204147|NCT02205814|652547|P1|Overall Study|Lack of Efficacy|1
204148|NCT02205814|652544|P4|Overall Study|Lost to Follow-up|1
204149|NCT02205814|652545|P3|Overall Study|Lost to Follow-up|0
204150|NCT02205814|652546|P2|Overall Study|Lost to Follow-up|0
204151|NCT02205814|652547|P1|Overall Study|Lost to Follow-up|0
204152|NCT02205476|652571|P2|Overall Study|Study termination by Sponsor|3
204153|NCT02205476|652572|P1|Overall Study|Study termination by Sponsor|7
204154|NCT02205333|652611|P9|Overall Study|Withdrawal by Subject|0
204155|NCT02205333|652612|P8|Overall Study|Withdrawal by Subject|0
204156|NCT02205333|652613|P7|Overall Study|Withdrawal by Subject|2
204157|NCT02205333|652614|P6|Overall Study|Withdrawal by Subject|0
204158|NCT02205333|652615|P5|Overall Study|Withdrawal by Subject|0
204159|NCT02205333|652616|P4|Overall Study|Withdrawal by Subject|1
204160|NCT02205333|652617|P3|Overall Study|Withdrawal by Subject|0
204161|NCT02205333|652618|P2|Overall Study|Withdrawal by Subject|0
204162|NCT02205333|652619|P1|Overall Study|Withdrawal by Subject|1
204163|NCT02205333|652611|P9|Overall Study|Death|0
204164|NCT02205333|652612|P8|Overall Study|Death|2
204165|NCT02205333|652613|P7|Overall Study|Death|3
204166|NCT02205333|652614|P6|Overall Study|Death|3
204167|NCT02205333|652615|P5|Overall Study|Death|5
204168|NCT02205333|652616|P4|Overall Study|Death|6
204169|NCT02205333|652617|P3|Overall Study|Death|2
204170|NCT02205333|652618|P2|Overall Study|Death|6
204171|NCT02205333|652619|P1|Overall Study|Death|5
204172|NCT02204579|652815|P1|Overall Study|Screen failures|2
204173|NCT02204449|652869|P2|Overall Study|Withdrawal by Subject|1
204174|NCT02204449|652870|P1|Overall Study|Withdrawal by Subject|0
204175|NCT02204449|652869|P2|Overall Study|Death|1
204176|NCT02204449|652870|P1|Overall Study|Death|0
204177|NCT02204449|652869|P2|Overall Study|Lost to Follow-up|9
204178|NCT02204449|652870|P1|Overall Study|Lost to Follow-up|7
204179|NCT02204007|652882|P2|Overall Study|Surgery Canceled|1
204180|NCT02204007|652883|P1|Overall Study|Surgery Canceled|1
204181|NCT02203916|652894|P3|Overall Study|Reason Not Specified|1
204182|NCT02203916|652895|P2|Overall Study|Reason Not Specified|2
204183|NCT02203916|652896|P1|Overall Study|Reason Not Specified|0
204184|NCT02203916|652894|P3|Overall Study|Lack of Efficacy|0
204185|NCT02203916|652895|P2|Overall Study|Lack of Efficacy|0
204186|NCT02203916|652896|P1|Overall Study|Lack of Efficacy|3
204187|NCT02203916|652894|P3|Overall Study|Voluntary Withdrawal|8
204188|NCT02203916|652895|P2|Overall Study|Voluntary Withdrawal|3
204189|NCT02203916|652896|P1|Overall Study|Voluntary Withdrawal|3
204190|NCT02203916|652894|P3|Overall Study|Lost to Follow-up|0
204191|NCT02203916|652895|P2|Overall Study|Lost to Follow-up|1
204192|NCT02203916|652896|P1|Overall Study|Lost to Follow-up|0
204193|NCT02203916|652894|P3|Overall Study|Major Protocol Deviation|0
204194|NCT02203916|652895|P2|Overall Study|Major Protocol Deviation|1
204195|NCT02203916|652896|P1|Overall Study|Major Protocol Deviation|1
204196|NCT02203916|652894|P3|Overall Study|Pretreatment Event/Adverse Event|2
204197|NCT02203916|652895|P2|Overall Study|Pretreatment Event/Adverse Event|3
204198|NCT02203916|652896|P1|Overall Study|Pretreatment Event/Adverse Event|1
204199|NCT02203721|652966|P2|Overall Study|Illness|1
204200|NCT02203721|652967|P1|Overall Study|Illness|0
204201|NCT02203721|652966|P2|Overall Study|Death|2
204202|NCT02203721|652967|P1|Overall Study|Death|0
204203|NCT02203721|652966|P2|Overall Study|Lost to Follow-up|0
204204|NCT02203721|652967|P1|Overall Study|Lost to Follow-up|1
204205|NCT02203149|652996|P5|Part 2|Adverse Event|1
204206|NCT02203149|652997|P4|Part 2|Adverse Event|1
204207|NCT02203149|652998|P3|Part 2|Adverse Event|0
204208|NCT02203149|652999|P2|Part 2|Adverse Event|0
204209|NCT02203149|653000|P1|Part 2|Adverse Event|0
204210|NCT02203149|652996|P5|Part 2|Withdrawal by Subject|0
204211|NCT02203149|652997|P4|Part 2|Withdrawal by Subject|1
204212|NCT02203149|652998|P3|Part 2|Withdrawal by Subject|0
204213|NCT02203149|652999|P2|Part 2|Withdrawal by Subject|0
204214|NCT02203149|653000|P1|Part 2|Withdrawal by Subject|0
204215|NCT02203149|652996|P5|Part 2|Death|0
204216|NCT02203149|652997|P4|Part 2|Death|1
204217|NCT02203149|652998|P3|Part 2|Death|1
204218|NCT02203149|652999|P2|Part 2|Death|0
204219|NCT02203149|653000|P1|Part 2|Death|0
204220|NCT02203149|652996|P5|Part 1|Adverse Event|0
204221|NCT02203149|652997|P4|Part 1|Adverse Event|0
204222|NCT02203149|652998|P3|Part 1|Adverse Event|0
204223|NCT02203149|652999|P2|Part 1|Adverse Event|1
204224|NCT02203149|653000|P1|Part 1|Adverse Event|0
204225|NCT02202785|653036|P3|Overall Study|Reason not Specified|13
204226|NCT02202785|653037|P2|Overall Study|Reason not Specified|7
204227|NCT02202785|653038|P1|Overall Study|Reason not Specified|10
204228|NCT02202785|653036|P3|Overall Study|Lost to Follow-up|0
204229|NCT02202785|653037|P2|Overall Study|Lost to Follow-up|1
204230|NCT02202785|653038|P1|Overall Study|Lost to Follow-up|0
204231|NCT02202785|653036|P3|Overall Study|Withdrawal by Subject|0
204232|NCT02202785|653037|P2|Overall Study|Withdrawal by Subject|1
204233|NCT02202785|653038|P1|Overall Study|Withdrawal by Subject|0
204234|NCT02202785|653036|P3|Overall Study|Study Terminated by Sponsor|4
204235|NCT02202785|653037|P2|Overall Study|Study Terminated by Sponsor|6
204236|NCT02202785|653038|P1|Overall Study|Study Terminated by Sponsor|1
204237|NCT02202759|653075|P3|Overall Study|Reason not Specified|10
204238|NCT02202759|653076|P2|Overall Study|Reason not Specified|11
204239|NCT02202759|653077|P1|Overall Study|Reason not Specified|4
204240|NCT02202759|653075|P3|Overall Study|Withdrawal by Subject|1
204241|NCT02202759|653076|P2|Overall Study|Withdrawal by Subject|1
204242|NCT02202759|653077|P1|Overall Study|Withdrawal by Subject|2
204243|NCT02202759|653075|P3|Overall Study|Study Terminated by Sponsor|3
204244|NCT02202759|653076|P2|Overall Study|Study Terminated by Sponsor|3
204245|NCT02202759|653077|P1|Overall Study|Study Terminated by Sponsor|3
204246|NCT02202538|653111|P1|Overall Study|Investigator Decision|1
204247|NCT02202538|653111|P1|Overall Study|Did not meet all inclusion criteria|2
204248|NCT02202538|653111|P1|Overall Study|Withdrawal by Subject|5
204249|NCT02201953|653141|P2|Overall Study|Death|3
204250|NCT02201953|653142|P1|Overall Study|Death|0
204251|NCT02201953|653141|P2|Overall Study|Adverse Event|5
204252|NCT02201953|653142|P1|Overall Study|Adverse Event|0
204253|NCT02201953|653141|P2|Overall Study|Withdrew Consent|5
204254|NCT02201953|653142|P1|Overall Study|Withdrew Consent|2
204255|NCT02201953|653141|P2|Overall Study|Lost to Follow-up|8
204256|NCT02201953|653142|P1|Overall Study|Lost to Follow-up|8
204257|NCT02201953|653141|P2|Overall Study|Lack of Efficacy|30
204258|NCT02201953|653142|P1|Overall Study|Lack of Efficacy|9
204259|NCT02201953|653141|P2|Overall Study|Randomized but Never Treated|5
204260|NCT02201953|653142|P1|Overall Study|Randomized but Never Treated|1
204261|NCT02201940|653160|P2|Overall Study|Adverse Event|1
204262|NCT02201940|653161|P1|Overall Study|Adverse Event|0
204263|NCT02201940|653160|P2|Overall Study|Death|0
204264|NCT02201940|653161|P1|Overall Study|Death|1
204265|NCT02201940|653160|P2|Overall Study|Investigator's Discretion|1
204266|NCT02201940|653161|P1|Overall Study|Investigator's Discretion|1
204267|NCT02201940|653160|P2|Overall Study|Withdrew Consent|1
204268|NCT02201940|653161|P1|Overall Study|Withdrew Consent|2
204269|NCT02201940|653160|P2|Overall Study|Lost to Follow-up|0
204270|NCT02201940|653161|P1|Overall Study|Lost to Follow-up|5
204271|NCT02201940|653160|P2|Overall Study|Lack of Efficacy|113
204272|NCT02201940|653161|P1|Overall Study|Lack of Efficacy|2
204273|NCT02201940|653160|P2|Overall Study|Randomized/Enrolled but Never Treated|0
204274|NCT02201940|653161|P1|Overall Study|Randomized/Enrolled but Never Treated|1
204275|NCT02201901|653180|P3|Overall Study|Adverse Event|0
204276|NCT02201901|653181|P2|Overall Study|Adverse Event|1
204277|NCT02201901|653182|P1|Overall Study|Adverse Event|1
204278|NCT02201901|653180|P3|Overall Study|Withdrew Consent|2
204279|NCT02201901|653181|P2|Overall Study|Withdrew Consent|0
204280|NCT02201901|653182|P1|Overall Study|Withdrew Consent|2
204281|NCT02201901|653180|P3|Overall Study|Lost to Follow-up|2
204282|NCT02201901|653181|P2|Overall Study|Lost to Follow-up|3
204283|NCT02201901|653182|P1|Overall Study|Lost to Follow-up|2
204284|NCT02201901|653180|P3|Overall Study|Death|3
204285|NCT02201901|653181|P2|Overall Study|Death|3
204286|NCT02201901|653182|P1|Overall Study|Death|3
204287|NCT02201901|653180|P3|Overall Study|Lack of Efficacy|6
204288|NCT02201901|653181|P2|Overall Study|Lack of Efficacy|1
204289|NCT02201901|653182|P1|Overall Study|Lack of Efficacy|7
204290|NCT02201901|653180|P3|Overall Study|Randomized but never treated|0
204291|NCT02201901|653181|P2|Overall Study|Randomized but never treated|1
204292|NCT02201901|653182|P1|Overall Study|Randomized but never treated|0
204293|NCT02201784|653213|P2|Overall Study|Failure to achieve adequate block|0
204294|NCT02201784|653214|P1|Overall Study|Failure to achieve adequate block|2
204295|NCT02201524|653232|P4|Overall Study|Unspecified|0
204296|NCT02201524|653233|P3|Overall Study|Unspecified|0
204297|NCT02201524|653234|P2|Overall Study|Unspecified|1
204298|NCT02201524|653235|P1|Overall Study|Unspecified|1
204299|NCT02201524|653232|P4|Overall Study|Withdrawal by Subject|1
204300|NCT02201524|653233|P3|Overall Study|Withdrawal by Subject|1
204301|NCT02201524|653234|P2|Overall Study|Withdrawal by Subject|0
204302|NCT02201524|653235|P1|Overall Study|Withdrawal by Subject|0
204303|NCT02201524|653232|P4|Overall Study|Protocol Violation|1
204304|NCT02201524|653233|P3|Overall Study|Protocol Violation|0
204305|NCT02201524|653234|P2|Overall Study|Protocol Violation|0
204306|NCT02201524|653235|P1|Overall Study|Protocol Violation|0
204307|NCT02201524|653232|P4|Overall Study|No longer meets eligibility criteria|2
204308|NCT02201524|653233|P3|Overall Study|No longer meets eligibility criteria|0
204309|NCT02201524|653234|P2|Overall Study|No longer meets eligibility criteria|0
204310|NCT02201524|653235|P1|Overall Study|No longer meets eligibility criteria|0
204311|NCT02201524|653232|P4|Overall Study|Lost to Follow-up|0
204312|NCT02201524|653233|P3|Overall Study|Lost to Follow-up|2
204313|NCT02201524|653234|P2|Overall Study|Lost to Follow-up|0
204314|NCT02201524|653235|P1|Overall Study|Lost to Follow-up|0
204315|NCT02201524|653232|P4|Overall Study|Insufficient clinical response|0
204316|NCT02201524|653233|P3|Overall Study|Insufficient clinical response|0
204317|NCT02201524|653234|P2|Overall Study|Insufficient clinical response|0
204318|NCT02201524|653235|P1|Overall Study|Insufficient clinical response|1
204319|NCT02201524|653232|P4|Overall Study|Adverse Event|0
204320|NCT02201524|653233|P3|Overall Study|Adverse Event|1
204321|NCT02201524|653234|P2|Overall Study|Adverse Event|2
204322|NCT02201524|653235|P1|Overall Study|Adverse Event|0
204323|NCT02198963|653468|P1|Overall Study|Withdrawal by Subject|6
204324|NCT02198963|653468|P1|Overall Study|Adverse Event|1
204325|NCT02198235|653510|P3|Overall Study|Lost to Follow-up|2
204326|NCT02198235|653511|P2|Overall Study|Lost to Follow-up|2
204327|NCT02198235|653512|P1|Overall Study|Lost to Follow-up|3
204328|NCT02198040|653532|P3|Overall Study|Withdrawal by Subject|1
204329|NCT02198040|653533|P2|Overall Study|Withdrawal by Subject|0
204330|NCT02198040|653534|P1|Overall Study|Withdrawal by Subject|0
204331|NCT02198040|653532|P3|Overall Study|Work reasons|0
204332|NCT02198040|653533|P2|Overall Study|Work reasons|1
204333|NCT02198040|653534|P1|Overall Study|Work reasons|0
204334|NCT02197806|653564|P4|Overall Study|Adverse Event|1
204335|NCT02197806|653565|P3|Overall Study|Adverse Event|0
204336|NCT02197806|653566|P2|Overall Study|Adverse Event|1
204337|NCT02197806|653567|P1|Overall Study|Adverse Event|0
204338|NCT02197247|653595|P1|Period 3|Condition under investigation worsened|5
204339|NCT02197247|653595|P1|Period 2|Condition under investigation worsened|2
204340|NCT02197247|653595|P1|Period 2|Adverse Event|2
204341|NCT02197234|653638|P1|Overall Study|Withdrawal by Subject|1
204342|NCT02197234|653638|P1|Overall Study|Adverse Event|1
204343|NCT02197234|653638|P1|Overall Study|Condition under investigation worsened|1
204344|NCT02196714|653675|P4|Overall Study|Protocol Violation|0
204345|NCT02196714|653676|P3|Overall Study|Protocol Violation|1
204346|NCT02196714|653677|P2|Overall Study|Protocol Violation|0
204347|NCT02196714|653678|P1|Overall Study|Protocol Violation|0
204348|NCT02196675|653801|P3|Overall Study|Death|1
204349|NCT02196675|653802|P2|Overall Study|Death|0
204350|NCT02196675|653803|P1|Overall Study|Death|0
204351|NCT02196675|653801|P3|Overall Study|Protocol Violation|0
204352|NCT02196675|653802|P2|Overall Study|Protocol Violation|1
204353|NCT02196675|653803|P1|Overall Study|Protocol Violation|0
204354|NCT02196675|653801|P3|Overall Study|Intra-operative surgical exclusion|0
204355|NCT02196675|653802|P2|Overall Study|Intra-operative surgical exclusion|1
204356|NCT02196675|653803|P1|Overall Study|Intra-operative surgical exclusion|1
204357|NCT02196675|653801|P3|Overall Study|Withdrawal by Subject|0
204358|NCT02196675|653802|P2|Overall Study|Withdrawal by Subject|0
204359|NCT02196675|653803|P1|Overall Study|Withdrawal by Subject|1
204360|NCT02196259|653826|P3|Overall Study|Partial data analysis|0
204361|NCT02196259|653827|P2|Overall Study|Partial data analysis|3
204362|NCT02196259|653828|P1|Overall Study|Partial data analysis|0
204363|NCT02196259|653826|P3|Overall Study|Researcher choice|1
204364|NCT02196259|653827|P2|Overall Study|Researcher choice|0
204365|NCT02196259|653828|P1|Overall Study|Researcher choice|0
204366|NCT02196077|653856|P1|Overall Study|Protocol Violation|24
204367|NCT02196077|653856|P1|Overall Study|Lost to Follow-up|3
204368|NCT02196077|653856|P1|Overall Study|Physician Decision|1
204369|NCT02196077|653856|P1|Overall Study|Withdrawal by Subject|14
204370|NCT02196077|653856|P1|Overall Study|Lack of Efficacy|1
204371|NCT02196077|653856|P1|Overall Study|Adverse Event|4
204372|NCT02195687|653914|P2|Overall Study|Lost to Follow-up|1
204373|NCT02195687|653915|P1|Overall Study|Lost to Follow-up|4
204374|NCT02195687|653914|P2|Overall Study|Personal Reasons|1
204375|NCT02195687|653915|P1|Overall Study|Personal Reasons|1
204376|NCT02195583|653931|P1|Overall Study|Other Reason|2
204377|NCT02195583|653931|P1|Overall Study|Adverse Event|2
204378|NCT02195583|653931|P1|Overall Study|Withdrawal by Subject|4
204379|NCT02195583|653931|P1|Overall Study|Lost to Follow-up|1
204380|NCT02194621|653973|P3|Overall Study|Withdrawal by Subject|7
204381|NCT02194621|653974|P2|Overall Study|Withdrawal by Subject|4
204382|NCT02194621|653975|P1|Overall Study|Withdrawal by Subject|4
204383|NCT02194621|653973|P3|Overall Study|6 withdrew prior to randomization|2
204384|NCT02194621|653974|P2|Overall Study|6 withdrew prior to randomization|2
204385|NCT02194621|653975|P1|Overall Study|6 withdrew prior to randomization|2
204386|NCT02194062|654008|P3|Overall Study|Lost to Follow-up|5
204387|NCT02194062|654009|P2|Overall Study|Lost to Follow-up|2
204388|NCT02194062|654010|P1|Overall Study|Lost to Follow-up|2
204389|NCT02193828|654025|P4|Overall Study|Withdrawal by Subject|1
204390|NCT02193828|654026|P3|Overall Study|Withdrawal by Subject|1
204391|NCT02193828|654027|P2|Overall Study|Withdrawal by Subject|0
204392|NCT02193828|654028|P1|Overall Study|Withdrawal by Subject|0
204393|NCT02193178|654101|P1|Overall Study|Dry eyes|1
204394|NCT02193178|654101|P1|Overall Study|Lost to Follow-up|1
204395|NCT02193165|654151|P3|6 Week Product Use|Lost to Follow-up|0
204396|NCT02193165|654152|P2|6 Week Product Use|Lost to Follow-up|1
204397|NCT02193165|654153|P1|6 Week Product Use|Lost to Follow-up|0
204398|NCT02193165|654151|P3|4 Week Product Use|Lost to Follow-up|1
204399|NCT02193165|654152|P2|4 Week Product Use|Lost to Follow-up|1
204400|NCT02193165|654153|P1|4 Week Product Use|Lost to Follow-up|1
204401|NCT02193087|654180|P4|Overall Study|Did Not Receive Any Vaccination|1
204402|NCT02193087|654181|P3|Overall Study|Did Not Receive Any Vaccination|0
204403|NCT02193087|654182|P2|Overall Study|Did Not Receive Any Vaccination|3
204404|NCT02193087|654183|P1|Overall Study|Did Not Receive Any Vaccination|2
204405|NCT02193087|654180|P4|Overall Study|Other Reason Not Specified|9
204406|NCT02193087|654181|P3|Overall Study|Other Reason Not Specified|1
204407|NCT02193087|654182|P2|Overall Study|Other Reason Not Specified|2
204408|NCT02193087|654183|P1|Overall Study|Other Reason Not Specified|7
204409|NCT02193087|654180|P4|Overall Study|Withdrawal by Subject|19
204410|NCT02193087|654181|P3|Overall Study|Withdrawal by Subject|1
204411|NCT02193087|654182|P2|Overall Study|Withdrawal by Subject|3
204412|NCT02193087|654183|P1|Overall Study|Withdrawal by Subject|10
204413|NCT02193087|654180|P4|Overall Study|Protocol Violation|2
204414|NCT02193087|654181|P3|Overall Study|Protocol Violation|1
204415|NCT02193087|654182|P2|Overall Study|Protocol Violation|0
204416|NCT02193087|654183|P1|Overall Study|Protocol Violation|2
204417|NCT02193087|654180|P4|Overall Study|Lost to Follow-up|37
204418|NCT02193087|654181|P3|Overall Study|Lost to Follow-up|4
204419|NCT02193087|654182|P2|Overall Study|Lost to Follow-up|6
204420|NCT02193087|654183|P1|Overall Study|Lost to Follow-up|14
204421|NCT02193087|654180|P4|Overall Study|Adverse Event|11
204422|NCT02193087|654181|P3|Overall Study|Adverse Event|0
204423|NCT02193087|654182|P2|Overall Study|Adverse Event|0
204424|NCT02193087|654183|P1|Overall Study|Adverse Event|2
204425|NCT02191046|654304|P2|Overall Study|low compliance|1
204426|NCT02191046|654305|P1|Overall Study|low compliance|5
204427|NCT02190591|654326|P2|Overall Study|face presentation so she was ineligible|1
204428|NCT02190591|654327|P1|Overall Study|face presentation so she was ineligible|0
204429|NCT02190591|654326|P2|Overall Study|did not use peanut ball as instructed|2
204430|NCT02190591|654327|P1|Overall Study|did not use peanut ball as instructed|0
204431|NCT02190591|654326|P2|Overall Study|Protocol Violation|0
204432|NCT02190591|654327|P1|Overall Study|Protocol Violation|1
204433|NCT02190591|654326|P2|Overall Study|Withdrawal by Subject|8
204434|NCT02190591|654327|P1|Overall Study|Withdrawal by Subject|1
204435|NCT02190435|654339|P2|Overall Study|3 consented screen fails|0
204436|NCT02190435|654340|P1|Overall Study|3 consented screen fails|3
204437|NCT02190435|654339|P2|Overall Study|First 12 patients were lead-ins|0
204438|NCT02190435|654340|P1|Overall Study|First 12 patients were lead-ins|12
204439|NCT02189941|654359|P3|Overall Study|Non-compliance|1
204440|NCT02189941|654360|P2|Overall Study|Non-compliance|0
204441|NCT02189941|654361|P1|Overall Study|Non-compliance|0
204442|NCT02189863|654389|P2|First 2 Weeks|Motion Sickness|2
204443|NCT02189863|654390|P1|First 2 Weeks|Motion Sickness|4
204444|NCT02189837|654405|P4|Overall Study|Sponsor Decision|1
204445|NCT02189837|654406|P3|Overall Study|Sponsor Decision|0
204446|NCT02189837|654407|P2|Overall Study|Sponsor Decision|0
204447|NCT02189837|654408|P1|Overall Study|Sponsor Decision|0
204448|NCT02189837|654405|P4|Overall Study|Withdrawal by Subject|1
204449|NCT02189837|654406|P3|Overall Study|Withdrawal by Subject|3
204450|NCT02189837|654407|P2|Overall Study|Withdrawal by Subject|1
204451|NCT02189837|654408|P1|Overall Study|Withdrawal by Subject|2
204452|NCT02189252|654451|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
204453|NCT02189252|654452|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
204454|NCT02189252|654453|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
204455|NCT02189252|654454|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
204456|NCT02189252|654451|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
204457|NCT02189252|654452|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
204458|NCT02189252|654453|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
204459|NCT02189252|654454|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
204460|NCT02188849|654513|P2|Overall Study|Lost to Follow-up|8
204461|NCT02188849|654514|P1|Overall Study|Lost to Follow-up|3
204462|NCT02188784|654528|P2|Overall Study|Physician Decision|3
204463|NCT02188784|654529|P1|Overall Study|Physician Decision|2
204464|NCT02188784|654528|P2|Overall Study|Withdrawal by Subject|9
204465|NCT02188784|654529|P1|Overall Study|Withdrawal by Subject|3
204466|NCT02188784|654528|P2|Overall Study|Lost to Follow-up|0
204467|NCT02188784|654529|P1|Overall Study|Lost to Follow-up|1
204468|NCT02188784|654528|P2|Overall Study|Death|1
204469|NCT02188784|654529|P1|Overall Study|Death|3
204470|NCT02187809|654550|P1|Overall Study|The study was terminated|3
204471|NCT02187744|654562|P2|Treatment|Participant refused continued treatment|1
204472|NCT02187744|654563|P1|Treatment|Participant refused continued treatment|1
204473|NCT02187744|654562|P2|Treatment|Not specified|0
204474|NCT02187744|654563|P1|Treatment|Not specified|2
204475|NCT02187744|654562|P2|Treatment|Lost to Follow-up|1
204476|NCT02187744|654563|P1|Treatment|Lost to Follow-up|0
204477|NCT02187744|654562|P2|Treatment|Related adverse event, not serious|2
204478|NCT02187744|654563|P1|Treatment|Related adverse event, not serious|0
204479|NCT02187744|654562|P2|Treatment|Related adverse event, serious non-fatal|1
204480|NCT02187744|654563|P1|Treatment|Related adverse event, serious non-fatal|0
204481|NCT02187744|654562|P2|Treatment|Death|0
204482|NCT02187744|654563|P1|Treatment|Death|1
204483|NCT02187744|654562|P2|Study|Related adverse event, serious non-fatal|1
204484|NCT02187744|654563|P1|Study|Related adverse event, serious non-fatal|0
204485|NCT02187744|654562|P2|Study|Death|0
204486|NCT02187744|654563|P1|Study|Death|1
204487|NCT02187744|654562|P2|Study|Related adverse event, not serious|2
204488|NCT02187744|654563|P1|Study|Related adverse event, not serious|0
204489|NCT02187744|654562|P2|Study|Lost to Follow-up|2
204490|NCT02187744|654563|P1|Study|Lost to Follow-up|0
204491|NCT02187744|654562|P2|Study|Not specified|1
204492|NCT02187744|654563|P1|Study|Not specified|2
204493|NCT02187744|654562|P2|Study|Participant refused further follow-up|0
204494|NCT02187744|654563|P1|Study|Participant refused further follow-up|1
204495|NCT02187029|654583|P4|Overall Study|Withdrawal by Subject|0
204496|NCT02187029|654584|P3|Overall Study|Withdrawal by Subject|0
204497|NCT02187029|654585|P2|Overall Study|Withdrawal by Subject|0
204498|NCT02187029|654586|P1|Overall Study|Withdrawal by Subject|1
204499|NCT02187029|654583|P4|Overall Study|Study Terminated by Sponsor|3
204500|NCT02187029|654584|P3|Overall Study|Study Terminated by Sponsor|10
204501|NCT02187029|654585|P2|Overall Study|Study Terminated by Sponsor|0
204502|NCT02187029|654586|P1|Overall Study|Study Terminated by Sponsor|0
204503|NCT02187029|654583|P4|Overall Study|Adverse Event|0
204504|NCT02187029|654584|P3|Overall Study|Adverse Event|1
204505|NCT02187029|654585|P2|Overall Study|Adverse Event|1
204506|NCT02187029|654586|P1|Overall Study|Adverse Event|0
204507|NCT02186223|654717|P1|Overall Study|Device in place less than 48 hours|9
204508|NCT02186223|654717|P1|Overall Study|Death|3
204509|NCT02186223|654717|P1|Overall Study|Unable to obtain femoral access|3
204510|NCT02186223|654717|P1|Overall Study|Not eligible for device placement|6
204511|NCT02185534|654747|P6|First Washout Period|Protocol Violation|1
204512|NCT02185534|654748|P5|First Washout Period|Protocol Violation|0
204513|NCT02185534|654749|P4|First Washout Period|Protocol Violation|0
204514|NCT02185534|654750|P3|First Washout Period|Protocol Violation|0
204515|NCT02185534|654751|P2|First Washout Period|Protocol Violation|0
204516|NCT02185534|654752|P1|First Washout Period|Protocol Violation|0
204517|NCT02185534|654747|P6|First Washout Period|Withdrawal by Subject|0
204518|NCT02185534|654748|P5|First Washout Period|Withdrawal by Subject|1
204519|NCT02185534|654749|P4|First Washout Period|Withdrawal by Subject|0
204520|NCT02185534|654750|P3|First Washout Period|Withdrawal by Subject|0
204521|NCT02185534|654751|P2|First Washout Period|Withdrawal by Subject|0
204522|NCT02185534|654752|P1|First Washout Period|Withdrawal by Subject|1
204523|NCT02185534|654747|P6|First Period|Withdrawal by Subject|0
204524|NCT02185534|654748|P5|First Period|Withdrawal by Subject|0
204525|NCT02185534|654749|P4|First Period|Withdrawal by Subject|1
204526|NCT02185534|654750|P3|First Period|Withdrawal by Subject|0
204527|NCT02185534|654751|P2|First Period|Withdrawal by Subject|0
204528|NCT02185534|654752|P1|First Period|Withdrawal by Subject|0
204529|NCT02183675|654932|P6|Treatment Period 2 (10 Days)|Adverse Event|2
204530|NCT02183675|654933|P5|Treatment Period 2 (10 Days)|Adverse Event|0
204531|NCT02183675|654934|P4|Treatment Period 2 (10 Days)|Adverse Event|0
204532|NCT02183675|654935|P3|Treatment Period 2 (10 Days)|Adverse Event|0
204533|NCT02183675|654936|P2|Treatment Period 2 (10 Days)|Adverse Event|0
204534|NCT02183675|654937|P1|Treatment Period 2 (10 Days)|Adverse Event|0
204535|NCT02183519|654961|P2|Overall Study|Did not respond to cough inducter|3
204628|NCT02176421|655570|P1|Overall Study|Adverse Event|1
204536|NCT02183519|654962|P1|Overall Study|Did not respond to cough inducter|0
204537|NCT02183519|654961|P2|Overall Study|computer error|0
204538|NCT02183519|654962|P1|Overall Study|computer error|3
204539|NCT02182895|654970|P2|Overall Study|Discharged from hospital within 24 hours|4
204540|NCT02182895|654971|P1|Overall Study|Discharged from hospital within 24 hours|2
204541|NCT02181790|654993|P2|Overall Study|study terminated|0
204542|NCT02181790|654994|P1|Overall Study|study terminated|2
204543|NCT02181504|655040|P3|Overall Study|Adverse Event|1
204544|NCT02181504|655041|P2|Overall Study|Adverse Event|1
204545|NCT02181504|655042|P1|Overall Study|Adverse Event|1
204546|NCT02180061|655133|P2|Overall Study|Continuing in Study|2
204547|NCT02180061|655134|P1|Overall Study|Continuing in Study|19
204548|NCT02180061|655133|P2|Overall Study|Progressive Disease|4
204549|NCT02180061|655134|P1|Overall Study|Progressive Disease|9
204550|NCT02180061|655133|P2|Overall Study|Clinical Progression|0
204551|NCT02180061|655134|P1|Overall Study|Clinical Progression|3
204552|NCT02180061|655133|P2|Overall Study|Adverse Event|2
204553|NCT02180061|655134|P1|Overall Study|Adverse Event|3
204554|NCT02179398|655172|P2|Overall Study|Lost to Follow-up|1
204555|NCT02179398|655173|P1|Overall Study|Lost to Follow-up|0
204556|NCT02179398|655172|P2|Overall Study|Lack of obligatory data|3
204557|NCT02179398|655173|P1|Overall Study|Lack of obligatory data|3
204558|NCT02178995|655193|P9|Open Label|Adverse Event|0
204559|NCT02178995|655194|P8|Open Label|Adverse Event|0
204560|NCT02178995|655195|P7|Open Label|Adverse Event|0
204561|NCT02178995|655196|P6|Open Label|Adverse Event|0
204562|NCT02178995|655197|P5|Open Label|Adverse Event|0
204563|NCT02178995|655198|P4|Open Label|Adverse Event|0
204564|NCT02178995|655199|P3|Open Label|Adverse Event|0
204565|NCT02178995|655200|P2|Open Label|Adverse Event|0
204566|NCT02178995|655201|P1|Open Label|Adverse Event|2
204567|NCT02178995|655193|P9|Double Blind|Lost to Follow-up|0
204568|NCT02178995|655194|P8|Double Blind|Lost to Follow-up|1
204569|NCT02178995|655195|P7|Double Blind|Lost to Follow-up|0
204570|NCT02178995|655196|P6|Double Blind|Lost to Follow-up|0
204571|NCT02178995|655197|P5|Double Blind|Lost to Follow-up|0
204572|NCT02178995|655198|P4|Double Blind|Lost to Follow-up|0
204573|NCT02178995|655199|P3|Double Blind|Lost to Follow-up|0
204574|NCT02178995|655200|P2|Double Blind|Lost to Follow-up|1
204575|NCT02178995|655201|P1|Double Blind|Lost to Follow-up|0
204576|NCT02178995|655193|P9|Double Blind|Adverse Event|1
204577|NCT02178995|655194|P8|Double Blind|Adverse Event|1
204578|NCT02178995|655195|P7|Double Blind|Adverse Event|0
204579|NCT02178995|655196|P6|Double Blind|Adverse Event|1
204580|NCT02178995|655197|P5|Double Blind|Adverse Event|0
204581|NCT02178995|655198|P4|Double Blind|Adverse Event|0
204582|NCT02178995|655199|P3|Double Blind|Adverse Event|0
204583|NCT02178995|655200|P2|Double Blind|Adverse Event|0
204584|NCT02178995|655201|P1|Double Blind|Adverse Event|0
204585|NCT02178787|655274|P2|Overall Study|Physician Decision|0
204586|NCT02178787|655275|P1|Overall Study|Physician Decision|1
204587|NCT02178787|655274|P2|Overall Study|No TCD window|7
204588|NCT02178787|655275|P1|Overall Study|No TCD window|3
204589|NCT02178787|655274|P2|Overall Study|Withdrawal by Subject|2
204590|NCT02178787|655275|P1|Overall Study|Withdrawal by Subject|0
204591|NCT02178787|655274|P2|Overall Study|Lost to Follow-up|0
204592|NCT02178787|655275|P1|Overall Study|Lost to Follow-up|1
204593|NCT02178059|655290|P2|Washout|Physician Decision|0
204594|NCT02178059|655291|P1|Washout|Physician Decision|1
204595|NCT02177032|655320|P4|Overall Study|Withdrawal by Subject|0
204596|NCT02177032|655321|P3|Overall Study|Withdrawal by Subject|1
204597|NCT02177032|655322|P2|Overall Study|Withdrawal by Subject|0
204598|NCT02177032|655323|P1|Overall Study|Withdrawal by Subject|1
204599|NCT02177032|655320|P4|Overall Study|OTHER|0
204600|NCT02177032|655321|P3|Overall Study|OTHER|1
204601|NCT02177032|655322|P2|Overall Study|OTHER|0
204602|NCT02177032|655323|P1|Overall Study|OTHER|2
204603|NCT02177032|655320|P4|Overall Study|Lost to Follow-up|0
204604|NCT02177032|655321|P3|Overall Study|Lost to Follow-up|0
204605|NCT02177032|655322|P2|Overall Study|Lost to Follow-up|2
204606|NCT02177032|655323|P1|Overall Study|Lost to Follow-up|0
204607|NCT02177032|655320|P4|Overall Study|ADMINISTRATIVE REASON|0
204608|NCT02177032|655321|P3|Overall Study|ADMINISTRATIVE REASON|1
204609|NCT02177032|655322|P2|Overall Study|ADMINISTRATIVE REASON|0
204610|NCT02177032|655323|P1|Overall Study|ADMINISTRATIVE REASON|2
204611|NCT02176655|655357|P1|Overall Study|Subjects did not treat|6
204612|NCT02176525|655386|P8|Overall Study|not treated|0
204613|NCT02176525|655387|P7|Overall Study|not treated|0
204614|NCT02176525|655388|P6|Overall Study|not treated|1
204615|NCT02176525|655389|P5|Overall Study|not treated|0
204616|NCT02176525|655390|P4|Overall Study|not treated|0
204617|NCT02176525|655391|P3|Overall Study|not treated|0
204618|NCT02176525|655392|P2|Overall Study|not treated|0
204619|NCT02176525|655393|P1|Overall Study|not treated|1
204620|NCT02176525|655386|P8|Overall Study|Adverse Event|0
204621|NCT02176525|655387|P7|Overall Study|Adverse Event|1
204622|NCT02176525|655388|P6|Overall Study|Adverse Event|0
204623|NCT02176525|655389|P5|Overall Study|Adverse Event|1
204624|NCT02176525|655390|P4|Overall Study|Adverse Event|1
204625|NCT02176525|655391|P3|Overall Study|Adverse Event|0
204626|NCT02176525|655392|P2|Overall Study|Adverse Event|0
204627|NCT02176525|655393|P1|Overall Study|Adverse Event|0
204629|NCT02176421|655570|P1|Overall Study|Lost to Follow-up|4
204630|NCT02176356|655579|P1|Overall Study|Other Miscellaneous Reasons|2
204631|NCT02176356|655579|P1|Overall Study|Personal Reasons|3
204632|NCT02176356|655579|P1|Overall Study|Lost to Follow-up|4
204633|NCT02176356|655579|P1|Overall Study|Screen Failure|14
204634|NCT02175771|655604|P9|Treatment Period|Not specified|0
204635|NCT02175771|655605|P8|Treatment Period|Not specified|2
204636|NCT02175771|655606|P7|Treatment Period|Not specified|0
204637|NCT02175771|655607|P6|Treatment Period|Not specified|0
204638|NCT02175771|655608|P5|Treatment Period|Not specified|1
204639|NCT02175771|655609|P4|Treatment Period|Not specified|3
204640|NCT02175771|655610|P3|Treatment Period|Not specified|0
204641|NCT02175771|655611|P2|Treatment Period|Not specified|1
204642|NCT02175771|655612|P1|Treatment Period|Not specified|0
204643|NCT02175771|655604|P9|Treatment Period|Lack of Efficacy|0
204644|NCT02175771|655605|P8|Treatment Period|Lack of Efficacy|1
204645|NCT02175771|655606|P7|Treatment Period|Lack of Efficacy|0
204646|NCT02175771|655607|P6|Treatment Period|Lack of Efficacy|1
204647|NCT02175771|655608|P5|Treatment Period|Lack of Efficacy|0
204648|NCT02175771|655609|P4|Treatment Period|Lack of Efficacy|0
204649|NCT02175771|655610|P3|Treatment Period|Lack of Efficacy|0
204650|NCT02175771|655611|P2|Treatment Period|Lack of Efficacy|0
204651|NCT02175771|655612|P1|Treatment Period|Lack of Efficacy|0
204652|NCT02175771|655604|P9|Treatment Period|Lost to Follow-up|2
204653|NCT02175771|655605|P8|Treatment Period|Lost to Follow-up|2
204654|NCT02175771|655606|P7|Treatment Period|Lost to Follow-up|1
204655|NCT02175771|655607|P6|Treatment Period|Lost to Follow-up|2
204656|NCT02175771|655608|P5|Treatment Period|Lost to Follow-up|1
204657|NCT02175771|655609|P4|Treatment Period|Lost to Follow-up|3
204658|NCT02175771|655610|P3|Treatment Period|Lost to Follow-up|1
204659|NCT02175771|655611|P2|Treatment Period|Lost to Follow-up|3
204660|NCT02175771|655612|P1|Treatment Period|Lost to Follow-up|0
204661|NCT02175771|655604|P9|Treatment Period|Disease progression|0
204662|NCT02175771|655605|P8|Treatment Period|Disease progression|2
204663|NCT02175771|655606|P7|Treatment Period|Disease progression|0
204664|NCT02175771|655607|P6|Treatment Period|Disease progression|0
204665|NCT02175771|655608|P5|Treatment Period|Disease progression|0
204666|NCT02175771|655609|P4|Treatment Period|Disease progression|0
204667|NCT02175771|655610|P3|Treatment Period|Disease progression|0
204668|NCT02175771|655611|P2|Treatment Period|Disease progression|0
204669|NCT02175771|655612|P1|Treatment Period|Disease progression|0
204670|NCT02175771|655604|P9|Treatment Period|Protocol Violation|0
204671|NCT02175771|655605|P8|Treatment Period|Protocol Violation|1
204672|NCT02175771|655606|P7|Treatment Period|Protocol Violation|0
204673|NCT02175771|655607|P6|Treatment Period|Protocol Violation|0
204674|NCT02175771|655608|P5|Treatment Period|Protocol Violation|0
204675|NCT02175771|655609|P4|Treatment Period|Protocol Violation|0
204676|NCT02175771|655610|P3|Treatment Period|Protocol Violation|0
204677|NCT02175771|655611|P2|Treatment Period|Protocol Violation|0
204678|NCT02175771|655612|P1|Treatment Period|Protocol Violation|0
204679|NCT02175771|655604|P9|Treatment Period|Noncompliance|1
204680|NCT02175771|655605|P8|Treatment Period|Noncompliance|0
204681|NCT02175771|655606|P7|Treatment Period|Noncompliance|0
204682|NCT02175771|655607|P6|Treatment Period|Noncompliance|0
204683|NCT02175771|655608|P5|Treatment Period|Noncompliance|0
204684|NCT02175771|655609|P4|Treatment Period|Noncompliance|0
204685|NCT02175771|655610|P3|Treatment Period|Noncompliance|2
204686|NCT02175771|655611|P2|Treatment Period|Noncompliance|1
204687|NCT02175771|655612|P1|Treatment Period|Noncompliance|0
204688|NCT02175771|655604|P9|Treatment Period|Withdrawal by Subject|2
204689|NCT02175771|655605|P8|Treatment Period|Withdrawal by Subject|9
204690|NCT02175771|655606|P7|Treatment Period|Withdrawal by Subject|2
204691|NCT02175771|655607|P6|Treatment Period|Withdrawal by Subject|4
204692|NCT02175771|655608|P5|Treatment Period|Withdrawal by Subject|2
204693|NCT02175771|655609|P4|Treatment Period|Withdrawal by Subject|6
204694|NCT02175771|655610|P3|Treatment Period|Withdrawal by Subject|3
204695|NCT02175771|655611|P2|Treatment Period|Withdrawal by Subject|9
204696|NCT02175771|655612|P1|Treatment Period|Withdrawal by Subject|0
204697|NCT02175771|655604|P9|Treatment Period|Adverse Event|1
204698|NCT02175771|655605|P8|Treatment Period|Adverse Event|0
204699|NCT02175771|655606|P7|Treatment Period|Adverse Event|2
204700|NCT02175771|655607|P6|Treatment Period|Adverse Event|3
204701|NCT02175771|655608|P5|Treatment Period|Adverse Event|1
204702|NCT02175771|655609|P4|Treatment Period|Adverse Event|1
204703|NCT02175771|655610|P3|Treatment Period|Adverse Event|1
204704|NCT02175771|655611|P2|Treatment Period|Adverse Event|2
204705|NCT02175771|655612|P1|Treatment Period|Adverse Event|0
204706|NCT02175771|655604|P9|Run-In Period (Pre-assignment)|Not specified|0
204707|NCT02175771|655605|P8|Run-In Period (Pre-assignment)|Not specified|0
204708|NCT02175771|655606|P7|Run-In Period (Pre-assignment)|Not specified|0
204709|NCT02175771|655607|P6|Run-In Period (Pre-assignment)|Not specified|0
204710|NCT02175771|655608|P5|Run-In Period (Pre-assignment)|Not specified|0
204711|NCT02175771|655609|P4|Run-In Period (Pre-assignment)|Not specified|0
204712|NCT02175771|655610|P3|Run-In Period (Pre-assignment)|Not specified|0
204713|NCT02175771|655611|P2|Run-In Period (Pre-assignment)|Not specified|0
204714|NCT02175771|655612|P1|Run-In Period (Pre-assignment)|Not specified|8
204715|NCT02175771|655604|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
204716|NCT02175771|655605|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
204717|NCT02175771|655606|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
204718|NCT02175771|655607|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
204719|NCT02175771|655608|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
204720|NCT02175771|655609|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
204721|NCT02175771|655610|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
204722|NCT02175771|655611|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
204723|NCT02175771|655612|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
204724|NCT02175771|655604|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
204725|NCT02175771|655605|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
204726|NCT02175771|655606|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
204727|NCT02175771|655607|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
204728|NCT02175771|655608|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
204729|NCT02175771|655609|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
204730|NCT02175771|655610|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
204731|NCT02175771|655611|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
204732|NCT02175771|655612|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
204733|NCT02175771|655604|P9|Run-In Period (Pre-assignment)|Adverse Event|0
204734|NCT02175771|655605|P8|Run-In Period (Pre-assignment)|Adverse Event|0
204735|NCT02175771|655606|P7|Run-In Period (Pre-assignment)|Adverse Event|0
204736|NCT02175771|655607|P6|Run-In Period (Pre-assignment)|Adverse Event|0
204737|NCT02175771|655608|P5|Run-In Period (Pre-assignment)|Adverse Event|0
204738|NCT02175771|655609|P4|Run-In Period (Pre-assignment)|Adverse Event|0
204739|NCT02175771|655610|P3|Run-In Period (Pre-assignment)|Adverse Event|0
204740|NCT02175771|655611|P2|Run-In Period (Pre-assignment)|Adverse Event|0
204741|NCT02175771|655612|P1|Run-In Period (Pre-assignment)|Adverse Event|9
204742|NCT02175771|655604|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
204743|NCT02175771|655605|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
204744|NCT02175771|655606|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
204745|NCT02175771|655607|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
204746|NCT02175771|655608|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
204747|NCT02175771|655609|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
204748|NCT02175771|655610|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
204749|NCT02175771|655611|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
204750|NCT02175771|655612|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
204751|NCT02175771|655604|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
204752|NCT02175771|655605|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
204753|NCT02175771|655606|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
204754|NCT02175771|655607|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
204755|NCT02175771|655608|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
204756|NCT02175771|655609|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
204757|NCT02175771|655610|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
204758|NCT02175771|655611|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
204759|NCT02175771|655612|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
204760|NCT02175771|655604|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
204761|NCT02175771|655605|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
204762|NCT02175771|655606|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
204763|NCT02175771|655607|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
204764|NCT02175771|655608|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
204765|NCT02175771|655609|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
204766|NCT02175771|655610|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
204767|NCT02175771|655611|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
204768|NCT02175771|655612|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
204769|NCT02175745|655670|P1|Overall Study|Not Eligible|1
204770|NCT02175199|655694|P2|Overall Study|Sponsor Decision|0
204771|NCT02175199|655695|P1|Overall Study|Sponsor Decision|1
204772|NCT02175199|655694|P2|Overall Study|Randomized in Error|0
204773|NCT02175199|655695|P1|Overall Study|Randomized in Error|1
204774|NCT02175199|655694|P2|Overall Study|Withdrawal by Subject|5
204775|NCT02175199|655695|P1|Overall Study|Withdrawal by Subject|1
204776|NCT02175121|655709|P5|Overall Study|Time issues|0
204777|NCT02175121|655710|P4|Overall Study|Time issues|0
204778|NCT02175121|655711|P3|Overall Study|Time issues|1
204779|NCT02175121|655712|P2|Overall Study|Time issues|0
204780|NCT02175121|655713|P1|Overall Study|Time issues|0
204781|NCT02175121|655709|P5|Overall Study|Schedule conflict|0
204782|NCT02175121|655710|P4|Overall Study|Schedule conflict|0
204783|NCT02175121|655711|P3|Overall Study|Schedule conflict|1
204784|NCT02175121|655712|P2|Overall Study|Schedule conflict|0
204785|NCT02175121|655713|P1|Overall Study|Schedule conflict|0
204786|NCT02175121|655709|P5|Overall Study|Personal emergency|1
204787|NCT02175121|655710|P4|Overall Study|Personal emergency|0
204788|NCT02175121|655711|P3|Overall Study|Personal emergency|0
204789|NCT02175121|655712|P2|Overall Study|Personal emergency|0
204790|NCT02175121|655713|P1|Overall Study|Personal emergency|0
204791|NCT02175121|655709|P5|Overall Study|Lost to Follow-up|0
204792|NCT02175121|655710|P4|Overall Study|Lost to Follow-up|1
204793|NCT02175121|655711|P3|Overall Study|Lost to Follow-up|0
204794|NCT02175121|655712|P2|Overall Study|Lost to Follow-up|1
204795|NCT02175121|655713|P1|Overall Study|Lost to Follow-up|0
204796|NCT02175121|655709|P5|Overall Study|Lack of Efficacy|0
204797|NCT02175121|655710|P4|Overall Study|Lack of Efficacy|0
204798|NCT02175121|655711|P3|Overall Study|Lack of Efficacy|0
204799|NCT02175121|655712|P2|Overall Study|Lack of Efficacy|0
204800|NCT02175121|655713|P1|Overall Study|Lack of Efficacy|1
204801|NCT02173769|655840|P1|Overall Study|Protocol Violation|4
204802|NCT02173054|655930|P3|Overall Study|Withdrawal by Subject|1
204803|NCT02173054|655931|P2|Overall Study|Withdrawal by Subject|0
204804|NCT02173054|655932|P1|Overall Study|Withdrawal by Subject|0
204805|NCT02173054|655930|P3|Overall Study|lack of compliance|0
204806|NCT02173054|655931|P2|Overall Study|lack of compliance|0
204807|NCT02173054|655932|P1|Overall Study|lack of compliance|1
204808|NCT02172625|655977|P2|Overall Study|car accident|1
204809|NCT02172625|655978|P1|Overall Study|car accident|0
204810|NCT02172625|655977|P2|Overall Study|Pregnancy|1
204811|NCT02172625|655978|P1|Overall Study|Pregnancy|0
204812|NCT02172625|655977|P2|Overall Study|Adverse Event|1
204813|NCT02172625|655978|P1|Overall Study|Adverse Event|0
204814|NCT02170779|656152|P2|Overall Study|Lost to Follow-up|1
204815|NCT02170779|656153|P1|Overall Study|Lost to Follow-up|0
204816|NCT02170779|656152|P2|Overall Study|Withdrawal by Subject|0
204817|NCT02170779|656153|P1|Overall Study|Withdrawal by Subject|1
204818|NCT02170688|656180|P5|Overall Study|Physician Decision|0
204819|NCT02170688|656181|P4|Overall Study|Physician Decision|0
204820|NCT02170688|656182|P3|Overall Study|Physician Decision|1
204821|NCT02170688|656183|P2|Overall Study|Physician Decision|0
204822|NCT02170688|656184|P1|Overall Study|Physician Decision|0
204823|NCT02170688|656180|P5|Overall Study|Full dose not received|0
204824|NCT02170688|656181|P4|Overall Study|Full dose not received|0
204825|NCT02170688|656182|P3|Overall Study|Full dose not received|0
204826|NCT02170688|656183|P2|Overall Study|Full dose not received|1
204827|NCT02170688|656184|P1|Overall Study|Full dose not received|0
204828|NCT02170688|656180|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
204829|NCT02170688|656181|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
204830|NCT02170688|656182|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
204831|NCT02170688|656183|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
204832|NCT02170688|656184|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
204833|NCT02170207|656345|P1|Overall Study|Case report forms unavailable|5
204834|NCT02170077|656356|P3|Overall Study|Exacerbation of seizures|1
204835|NCT02170077|656357|P2|Overall Study|Exacerbation of seizures|2
204836|NCT02170077|656358|P1|Overall Study|Exacerbation of seizures|0
204837|NCT02170077|656356|P3|Overall Study|Exclusion criteria|5
204838|NCT02170077|656357|P2|Overall Study|Exclusion criteria|2
204839|NCT02170077|656358|P1|Overall Study|Exclusion criteria|2
204840|NCT02170077|656356|P3|Overall Study|Lost to Follow-up|0
204841|NCT02170077|656357|P2|Overall Study|Lost to Follow-up|1
204842|NCT02170077|656358|P1|Overall Study|Lost to Follow-up|0
204843|NCT02170077|656356|P3|Overall Study|Adverse Event|4
204844|NCT02170077|656357|P2|Overall Study|Adverse Event|4
204845|NCT02170077|656358|P1|Overall Study|Adverse Event|4
204846|NCT02170077|656356|P3|Overall Study|Withdrawal by Subject|2
204847|NCT02170077|656357|P2|Overall Study|Withdrawal by Subject|4
204848|NCT02170077|656358|P1|Overall Study|Withdrawal by Subject|3
204849|NCT02170064|656369|P3|Overall Study|Physician Decision|0
204850|NCT02170064|656370|P2|Overall Study|Physician Decision|1
204851|NCT02170064|656371|P1|Overall Study|Physician Decision|1
204852|NCT02170064|656369|P3|Overall Study|Withdrawal by Subject|1
204853|NCT02170064|656370|P2|Overall Study|Withdrawal by Subject|1
204854|NCT02170064|656371|P1|Overall Study|Withdrawal by Subject|5
204855|NCT02169414|656527|P4|Overall Study|Adverse Event|0
204856|NCT02169414|656528|P3|Overall Study|Adverse Event|0
204857|NCT02169414|656529|P2|Overall Study|Adverse Event|1
204858|NCT02169414|656530|P1|Overall Study|Adverse Event|0
204859|NCT02169414|656527|P4|Overall Study|Withdrawal by Subject|0
204860|NCT02169414|656528|P3|Overall Study|Withdrawal by Subject|0
204861|NCT02169414|656529|P2|Overall Study|Withdrawal by Subject|0
204862|NCT02169414|656530|P1|Overall Study|Withdrawal by Subject|1
204863|NCT02169336|656571|P3|Overall Study|Subject declined to continue dosing|1
204864|NCT02169336|656572|P2|Overall Study|Subject declined to continue dosing|0
204865|NCT02169336|656573|P1|Overall Study|Subject declined to continue dosing|0
204866|NCT02169336|656571|P3|Overall Study|Physician Decision|1
204867|NCT02169336|656572|P2|Overall Study|Physician Decision|0
204868|NCT02169336|656573|P1|Overall Study|Physician Decision|0
204869|NCT02169336|656571|P3|Overall Study|Withdrawal by Subject|0
204870|NCT02169336|656572|P2|Overall Study|Withdrawal by Subject|0
204871|NCT02169336|656573|P1|Overall Study|Withdrawal by Subject|1
204872|NCT02169336|656571|P3|Overall Study|Adverse Event|1
204873|NCT02169336|656572|P2|Overall Study|Adverse Event|3
204874|NCT02169336|656573|P1|Overall Study|Adverse Event|2
204875|NCT02169336|656571|P3|Overall Study|Lack of Efficacy|0
204876|NCT02169336|656572|P2|Overall Study|Lack of Efficacy|1
204877|NCT02169336|656573|P1|Overall Study|Lack of Efficacy|1
204878|NCT02168491|656594|P1|Overall Study|Withdrawal by Subject|1
204879|NCT02168478|656600|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
204880|NCT02168478|656600|P1|Overall Study|Did Not Consent to Participation|2
204881|NCT02168478|656600|P1|Overall Study|Withdrawal by Subject|1
204882|NCT02168439|656606|P2|Overall Study|Protocol Violation|2
204883|NCT02168439|656607|P1|Overall Study|Protocol Violation|0
204884|NCT02168387|656625|P2|Overall Study|Death|0
204885|NCT02168387|656626|P1|Overall Study|Death|1
204886|NCT02168387|656625|P2|Overall Study|Planned exubation|3
204887|NCT02168387|656626|P1|Overall Study|Planned exubation|6
204888|NCT02167893|656647|P1|Overall Study|Case report forms not collected|68
204889|NCT02167893|656647|P1|Overall Study|Investigator health reasons|10
204890|NCT02167893|656647|P1|Overall Study|Investigator transferred|85
204891|NCT02166697|656656|P1|Overall Study|Protocol Violation|347
204892|NCT02167139|656690|P4|Transition-extension|Lost to Follow-up|0
204893|NCT02167139|656691|P3|Transition-extension|Lost to Follow-up|0
204894|NCT02167139|656692|P2|Transition-extension|Lost to Follow-up|0
204895|NCT02167139|656693|P1|Transition-extension|Lost to Follow-up|1
204896|NCT02167139|656690|P4|Transition-extension|Other|0
204897|NCT02167139|656691|P3|Transition-extension|Other|1
204898|NCT02167139|656692|P2|Transition-extension|Other|0
204899|NCT02167139|656693|P1|Transition-extension|Other|1
204900|NCT02167139|656690|P4|Transition-extension|Lack of Efficacy|1
204901|NCT02167139|656691|P3|Transition-extension|Lack of Efficacy|1
204902|NCT02167139|656692|P2|Transition-extension|Lack of Efficacy|0
204903|NCT02167139|656693|P1|Transition-extension|Lack of Efficacy|0
204904|NCT02167139|656690|P4|Transition-extension|Withdrawal by Subject|1
204905|NCT02167139|656691|P3|Transition-extension|Withdrawal by Subject|4
204906|NCT02167139|656692|P2|Transition-extension|Withdrawal by Subject|0
204907|NCT02167139|656693|P1|Transition-extension|Withdrawal by Subject|2
204908|NCT02167139|656690|P4|Transition-extension|Adverse Event|3
204909|NCT02167139|656691|P3|Transition-extension|Adverse Event|2
204910|NCT02167139|656692|P2|Transition-extension|Adverse Event|0
204911|NCT02167139|656693|P1|Transition-extension|Adverse Event|2
204912|NCT02167139|656690|P4|Randomised, Double-blind|Other|0
204913|NCT02167139|656691|P3|Randomised, Double-blind|Other|0
204914|NCT02167139|656692|P2|Randomised, Double-blind|Other|0
204915|NCT02167139|656693|P1|Randomised, Double-blind|Other|3
204916|NCT02167139|656690|P4|Randomised, Double-blind|Lack of Efficacy|0
204917|NCT02167139|656691|P3|Randomised, Double-blind|Lack of Efficacy|0
204918|NCT02167139|656692|P2|Randomised, Double-blind|Lack of Efficacy|2
204919|NCT02167139|656693|P1|Randomised, Double-blind|Lack of Efficacy|1
204920|NCT02167139|656690|P4|Randomised, Double-blind|Adverse Event|0
204921|NCT02167139|656691|P3|Randomised, Double-blind|Adverse Event|0
204922|NCT02167139|656692|P2|Randomised, Double-blind|Adverse Event|9
204923|NCT02167139|656693|P1|Randomised, Double-blind|Adverse Event|2
204924|NCT02167139|656690|P4|Randomised, Double-blind|Withdrawal by Subject|0
204925|NCT02167139|656691|P3|Randomised, Double-blind|Withdrawal by Subject|0
204926|NCT02167139|656692|P2|Randomised, Double-blind|Withdrawal by Subject|8
204927|NCT02167139|656693|P1|Randomised, Double-blind|Withdrawal by Subject|11
204928|NCT02165826|656710|P3|Down-Titration Period|Reason Not Specified|2
204929|NCT02165826|656711|P2|Down-Titration Period|Reason Not Specified|0
204930|NCT02165826|656712|P1|Down-Titration Period|Reason Not Specified|1
204931|NCT02165826|656710|P3|Down-Titration Period|Voluntary Withdrawal|2
204932|NCT02165826|656711|P2|Down-Titration Period|Voluntary Withdrawal|1
204933|NCT02165826|656712|P1|Down-Titration Period|Voluntary Withdrawal|2
204934|NCT02165826|656710|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
204935|NCT02165826|656711|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
204936|NCT02165826|656712|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
204937|NCT02165826|656710|P3|Main Treatment Period|Did Not Receive Study Drug|0
204938|NCT02165826|656711|P2|Main Treatment Period|Did Not Receive Study Drug|2
204939|NCT02165826|656712|P1|Main Treatment Period|Did Not Receive Study Drug|0
204940|NCT02165826|656710|P3|Main Treatment Period|Reason Not Specified|16
204941|NCT02165826|656711|P2|Main Treatment Period|Reason Not Specified|5
204942|NCT02165826|656712|P1|Main Treatment Period|Reason Not Specified|8
204943|NCT02165826|656710|P3|Main Treatment Period|Lack of Efficacy|0
204944|NCT02165826|656711|P2|Main Treatment Period|Lack of Efficacy|0
204945|NCT02165826|656712|P1|Main Treatment Period|Lack of Efficacy|2
204946|NCT02165826|656710|P3|Main Treatment Period|Voluntary Withdrawal|21
204947|NCT02165826|656711|P2|Main Treatment Period|Voluntary Withdrawal|23
204948|NCT02165826|656712|P1|Main Treatment Period|Voluntary Withdrawal|23
204949|NCT02165826|656710|P3|Main Treatment Period|Lost to Follow-up|1
204950|NCT02165826|656711|P2|Main Treatment Period|Lost to Follow-up|2
204951|NCT02165826|656712|P1|Main Treatment Period|Lost to Follow-up|4
204952|NCT02165826|656710|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
204953|NCT02165826|656711|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
204954|NCT02165826|656712|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
204955|NCT02165826|656710|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
204956|NCT02165826|656711|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
205039|NCT02161146|657080|P2|Overall Study|Lost to Follow-up|1
204957|NCT02165826|656712|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
204958|NCT02164539|656816|P7|Treatment Phase C (1 Week)|Physician Decision|1
204959|NCT02164539|656817|P6|Treatment Phase C (1 Week)|Physician Decision|0
204960|NCT02164539|656818|P5|Treatment Phase C (1 Week)|Physician Decision|0
204961|NCT02164539|656819|P4|Treatment Phase C (1 Week)|Physician Decision|0
204962|NCT02164539|656820|P3|Treatment Phase C (1 Week)|Physician Decision|0
204963|NCT02164539|656821|P2|Treatment Phase C (1 Week)|Physician Decision|0
204964|NCT02164539|656822|P1|Treatment Phase C (1 Week)|Physician Decision|0
204965|NCT02164539|656816|P7|Treatment Phase C (1 Week)|Adverse Event|1
204966|NCT02164539|656817|P6|Treatment Phase C (1 Week)|Adverse Event|0
204967|NCT02164539|656818|P5|Treatment Phase C (1 Week)|Adverse Event|0
204968|NCT02164539|656819|P4|Treatment Phase C (1 Week)|Adverse Event|0
204969|NCT02164539|656820|P3|Treatment Phase C (1 Week)|Adverse Event|0
204970|NCT02164539|656821|P2|Treatment Phase C (1 Week)|Adverse Event|0
204971|NCT02164539|656822|P1|Treatment Phase C (1 Week)|Adverse Event|0
204972|NCT02164539|656816|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
204973|NCT02164539|656817|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
204974|NCT02164539|656818|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
204975|NCT02164539|656819|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
204976|NCT02164539|656820|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
204977|NCT02164539|656821|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
204978|NCT02164539|656822|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
204979|NCT02164539|656816|P7|Treatment Phase B (1 Week)|Physician Decision|1
204980|NCT02164539|656817|P6|Treatment Phase B (1 Week)|Physician Decision|0
204981|NCT02164539|656818|P5|Treatment Phase B (1 Week)|Physician Decision|1
204982|NCT02164539|656819|P4|Treatment Phase B (1 Week)|Physician Decision|0
204983|NCT02164539|656820|P3|Treatment Phase B (1 Week)|Physician Decision|0
204984|NCT02164539|656821|P2|Treatment Phase B (1 Week)|Physician Decision|0
204985|NCT02164539|656822|P1|Treatment Phase B (1 Week)|Physician Decision|0
204986|NCT02164539|656816|P7|Treatment Phase B (1 Week)|Adverse Event|0
204987|NCT02164539|656817|P6|Treatment Phase B (1 Week)|Adverse Event|0
204988|NCT02164539|656818|P5|Treatment Phase B (1 Week)|Adverse Event|2
204989|NCT02164539|656819|P4|Treatment Phase B (1 Week)|Adverse Event|0
204990|NCT02164539|656820|P3|Treatment Phase B (1 Week)|Adverse Event|0
204991|NCT02164539|656821|P2|Treatment Phase B (1 Week)|Adverse Event|0
204992|NCT02164539|656822|P1|Treatment Phase B (1 Week)|Adverse Event|0
204993|NCT02164539|656816|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
204994|NCT02164539|656817|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
204995|NCT02164539|656818|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
204996|NCT02164539|656819|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
204997|NCT02164539|656820|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
204998|NCT02164539|656821|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
204999|NCT02164539|656822|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
205000|NCT02164318|656884|P4|Overall Study|Withdrawal by Subject|1
205001|NCT02164318|656885|P3|Overall Study|Withdrawal by Subject|0
205002|NCT02164318|656886|P2|Overall Study|Withdrawal by Subject|1
205003|NCT02164318|656887|P1|Overall Study|Withdrawal by Subject|0
205004|NCT02163915|656910|P5|Overall Study|Physician Decision|0
205005|NCT02163915|656911|P4|Overall Study|Physician Decision|1
205006|NCT02163915|656912|P3|Overall Study|Physician Decision|0
205007|NCT02163915|656913|P2|Overall Study|Physician Decision|0
205008|NCT02163915|656914|P1|Overall Study|Physician Decision|0
205009|NCT02163915|656910|P5|Overall Study|Study termination|2
205010|NCT02163915|656911|P4|Overall Study|Study termination|0
205011|NCT02163915|656912|P3|Overall Study|Study termination|0
205012|NCT02163915|656913|P2|Overall Study|Study termination|0
205013|NCT02163915|656914|P1|Overall Study|Study termination|1
205014|NCT02163915|656910|P5|Overall Study|Withdrawal by Subject|2
205015|NCT02163915|656911|P4|Overall Study|Withdrawal by Subject|2
205016|NCT02163915|656912|P3|Overall Study|Withdrawal by Subject|2
205017|NCT02163915|656913|P2|Overall Study|Withdrawal by Subject|0
205018|NCT02163915|656914|P1|Overall Study|Withdrawal by Subject|2
205019|NCT02163395|657019|P1|Overall Study|Adverse Event|1
205020|NCT02163395|657019|P1|Overall Study|Lost to Follow-up|3
205021|NCT02163395|657019|P1|Overall Study|Withdrawal by Subject|1
205022|NCT02162758|657037|P2|Overall Study|Study termination|1
205023|NCT02162758|657038|P1|Overall Study|Study termination|0
205024|NCT02161549|657065|P2|Overall Study|Physician Decision|2
205025|NCT02161549|657066|P1|Overall Study|Physician Decision|6
205026|NCT02161146|657077|P5|Overall Study|Other Miscellaneous Reasons|0
205027|NCT02161146|657078|P4|Overall Study|Other Miscellaneous Reasons|0
205028|NCT02161146|657079|P3|Overall Study|Other Miscellaneous Reasons|0
205029|NCT02161146|657080|P2|Overall Study|Other Miscellaneous Reasons|1
205030|NCT02161146|657081|P1|Overall Study|Other Miscellaneous Reasons|0
205031|NCT02161146|657077|P5|Overall Study|Personal Reasons|1
205032|NCT02161146|657078|P4|Overall Study|Personal Reasons|2
205033|NCT02161146|657079|P3|Overall Study|Personal Reasons|0
205034|NCT02161146|657080|P2|Overall Study|Personal Reasons|1
205035|NCT02161146|657081|P1|Overall Study|Personal Reasons|0
205036|NCT02161146|657077|P5|Overall Study|Lost to Follow-up|0
205037|NCT02161146|657078|P4|Overall Study|Lost to Follow-up|0
205038|NCT02161146|657079|P3|Overall Study|Lost to Follow-up|0
205040|NCT02161146|657081|P1|Overall Study|Lost to Follow-up|0
205041|NCT02161146|657077|P5|Overall Study|Adverse Event|0
205042|NCT02161146|657078|P4|Overall Study|Adverse Event|1
205043|NCT02161146|657079|P3|Overall Study|Adverse Event|0
205044|NCT02161146|657080|P2|Overall Study|Adverse Event|1
205045|NCT02161146|657081|P1|Overall Study|Adverse Event|1
205046|NCT02161016|657094|P1|Overall Study|withdrawn by IRB|1
205047|NCT02160977|657125|P2|Six Months After Surgery|Lost to Follow-up|1
205048|NCT02160977|657126|P1|Six Months After Surgery|Lost to Follow-up|2
205049|NCT02160977|657125|P2|Three Months After Surgery|Lost to Follow-up|2
205050|NCT02160977|657126|P1|Three Months After Surgery|Lost to Follow-up|0
205051|NCT02160977|657125|P2|Six Weeks After Surgery|Lost to Follow-up|0
205052|NCT02160977|657126|P1|Six Weeks After Surgery|Lost to Follow-up|1
205053|NCT02160314|657153|P2|Overall Study|Lost to Follow-up|1
205054|NCT02160314|657154|P1|Overall Study|Lost to Follow-up|0
205055|NCT02160314|657153|P2|Overall Study|Withdrawal by Subject|2
205056|NCT02160314|657154|P1|Overall Study|Withdrawal by Subject|1
205057|NCT02160314|657153|P2|Overall Study|Protocol Violation|4
205058|NCT02160314|657154|P1|Overall Study|Protocol Violation|0
205059|NCT02160314|657153|P2|Overall Study|Adverse Event|6
205060|NCT02160314|657154|P1|Overall Study|Adverse Event|0
205061|NCT02159950|657162|P2|Overall Study|Progression|1
205062|NCT02159950|657163|P1|Overall Study|Progression|0
205063|NCT02159950|657162|P2|Overall Study|Adverse Event|1
205064|NCT02159950|657163|P1|Overall Study|Adverse Event|0
205065|NCT02159482|657224|P1|Overall Study|Physician Decision|3
205066|NCT02159482|657224|P1|Overall Study|Withdrawal by Subject|2
205067|NCT02159365|657229|P1|Overall Study|Unspecified|1
205068|NCT02159365|657229|P1|Overall Study|Subject Withdrew Consent|1
205069|NCT02159365|657229|P1|Overall Study|Subject Request to Discontinue Treatment|1
205070|NCT02159365|657229|P1|Overall Study|Study Drug Toxicity|1
205071|NCT02159365|657229|P1|Overall Study|Lost to Follow-up|1
205072|NCT02159365|657229|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
205073|NCT02159365|657229|P1|Overall Study|Disease Progression|11
205074|NCT02159352|657235|P2|Overall Study|Withdrawal by Subject|1
205075|NCT02159352|657236|P1|Overall Study|Withdrawal by Subject|0
205076|NCT02159352|657235|P2|Overall Study|Adverse Event|1
205077|NCT02159352|657236|P1|Overall Study|Adverse Event|3
205078|NCT02159040|657311|P1|Overall Study|Death|1
205079|NCT02158728|657324|P1|Overall Study|no qualified dataset|24
205080|NCT02158728|657324|P1|Overall Study|no procedure according to CIP done|3
205081|NCT02158442|657330|P2|Overall Study|Perfusion staff not available|0
205082|NCT02158442|657331|P1|Overall Study|Perfusion staff not available|1
205083|NCT02158442|657330|P2|Overall Study|Withdrawal by Subject|0
205084|NCT02158442|657331|P1|Overall Study|Withdrawal by Subject|1
205085|NCT02158247|657350|P1|Overall Study|Invisible vocal cords|5
205086|NCT02158039|657366|P1|Overall Study|Screen Failure|9
205087|NCT02158039|657366|P1|Overall Study|Withdrawal by Subject|1
205088|NCT02157935|657373|P2|Overall Study|Adverse Event|5
205089|NCT02157935|657374|P1|Overall Study|Adverse Event|3
205090|NCT02157935|657373|P2|Overall Study|Death|4
205091|NCT02157935|657374|P1|Overall Study|Death|4
205092|NCT02157935|657373|P2|Overall Study|Lack of Efficacy|1
205093|NCT02157935|657374|P1|Overall Study|Lack of Efficacy|0
205094|NCT02157935|657373|P2|Overall Study|Other|12
205095|NCT02157935|657374|P1|Overall Study|Other|5
205096|NCT02157935|657373|P2|Overall Study|Progressive disease|2
205097|NCT02157935|657374|P1|Overall Study|Progressive disease|0
205098|NCT02157935|657373|P2|Overall Study|Protocol Violation|0
205099|NCT02157935|657374|P1|Overall Study|Protocol Violation|1
205100|NCT02157935|657373|P2|Overall Study|Screen failure|2
205101|NCT02157935|657374|P1|Overall Study|Screen failure|1
205102|NCT02157935|657373|P2|Overall Study|Withdrawal by Subject|39
205103|NCT02157935|657374|P1|Overall Study|Withdrawal by Subject|25
205104|NCT02157883|657400|P1|2: AZD9291+Itraconozole|Adverse Event|1
205105|NCT02157623|657431|P2|Overall Study|Physician Decision|3
205106|NCT02157623|657432|P1|Overall Study|Physician Decision|4
205107|NCT02157376|657440|P2|Overall Study|Investigator's misjudgement|2
205108|NCT02157376|657441|P1|Overall Study|Investigator's misjudgement|1
205109|NCT02157376|657440|P2|Overall Study|Not treated|3
205110|NCT02157376|657441|P1|Overall Study|Not treated|8
205111|NCT02157376|657440|P2|Overall Study|Withdrawal by Subject|8
205112|NCT02157376|657441|P1|Overall Study|Withdrawal by Subject|3
205113|NCT02157376|657440|P2|Overall Study|Eligibility criteria not fulfilled|1
205114|NCT02157376|657441|P1|Overall Study|Eligibility criteria not fulfilled|0
205115|NCT02157376|657440|P2|Overall Study|Death|4
205116|NCT02157376|657441|P1|Overall Study|Death|10
205117|NCT02157298|657451|P2|Overall Study|Withdrawal by Subject|0
205118|NCT02157298|657452|P1|Overall Study|Withdrawal by Subject|1
205119|NCT02157298|657451|P2|Overall Study|Poor/Non-compliance|0
205120|NCT02157298|657452|P1|Overall Study|Poor/Non-compliance|1
205121|NCT02157298|657451|P2|Overall Study|Subject no longer meets study criteria|2
205122|NCT02157298|657452|P1|Overall Study|Subject no longer meets study criteria|1
205123|NCT02157298|657451|P2|Overall Study|Adverse Event|0
205124|NCT02157298|657452|P1|Overall Study|Adverse Event|1
205125|NCT02157116|657466|P1|Overall Study|Failed Screening|2
205126|NCT02157116|657466|P1|Overall Study|Physician Decision|3
205127|NCT02157116|657466|P1|Overall Study|Withdrawal by Subject|4
205128|NCT02156466|657480|P5|Overall Study|Quantiferon Positivity|0
205129|NCT02156466|657481|P4|Overall Study|Quantiferon Positivity|1
205130|NCT02156466|657482|P3|Overall Study|Quantiferon Positivity|0
205131|NCT02156466|657483|P2|Overall Study|Quantiferon Positivity|0
205132|NCT02156466|657484|P1|Overall Study|Quantiferon Positivity|0
205133|NCT02156466|657480|P5|Overall Study|Adverse Event|0
205134|NCT02156466|657481|P4|Overall Study|Adverse Event|1
205135|NCT02156466|657482|P3|Overall Study|Adverse Event|1
205136|NCT02156466|657483|P2|Overall Study|Adverse Event|0
205137|NCT02156466|657484|P1|Overall Study|Adverse Event|0
205138|NCT02156271|657665|P2|Overall Study|Physician Decision|3
205139|NCT02156271|657666|P1|Overall Study|Physician Decision|4
205140|NCT02155985|657705|P3|Overall Study|Lost to Follow-up|0
205141|NCT02155985|657706|P2|Overall Study|Lost to Follow-up|0
205142|NCT02155985|657707|P1|Overall Study|Lost to Follow-up|1
205143|NCT02155985|657705|P3|Overall Study|Withdrawal by Subject|1
205144|NCT02155985|657706|P2|Overall Study|Withdrawal by Subject|0
205145|NCT02155985|657707|P1|Overall Study|Withdrawal by Subject|0
205146|NCT02155881|657774|P2|Overall Study|Inappropriately randomized|2
205147|NCT02155881|657775|P1|Overall Study|Inappropriately randomized|2
205148|NCT02155881|657774|P2|Overall Study|Withdrawal by Subject|2
205149|NCT02155881|657775|P1|Overall Study|Withdrawal by Subject|0
205150|NCT02155322|657827|P1|Overall Study|Withdrawal by Subject|4
205151|NCT02155322|657827|P1|Overall Study|Relapse/Recurrence|8
205152|NCT02155322|657827|P1|Overall Study|Physician Decision|1
205153|NCT02155322|657827|P1|Overall Study|Adverse Event|1
205154|NCT02155283|657832|P1|Overall Study|Protocol Violation|3
205155|NCT02155283|657832|P1|Overall Study|Withdrawal by Subject|1
205156|NCT02155283|657832|P1|Overall Study|Lost to Follow-up|3
205157|NCT02154425|657859|P1|Screening Period|Adverse Event|1
205158|NCT02154139|657902|P1|Overall Study|Investigator transferred|3
205159|NCT02154139|657902|P1|Overall Study|Other|2
205160|NCT02154139|657902|P1|Overall Study|Injection not administered|2
205161|NCT02154087|657910|P1|Overall Study|Study Termination|1
205162|NCT02153827|657929|P2|Overall Study|Lost to Follow-up|9
205163|NCT02153827|657930|P1|Overall Study|Lost to Follow-up|3
205164|NCT02153788|657946|P2|Overall Study|Physician Decision|1
205165|NCT02153788|657947|P1|Overall Study|Physician Decision|2
205166|NCT02153398|658009|P5|Overall Study|Adverse Event|0
205167|NCT02153398|658010|P4|Overall Study|Adverse Event|1
205168|NCT02153398|658011|P3|Overall Study|Adverse Event|1
205169|NCT02153398|658012|P2|Overall Study|Adverse Event|0
205170|NCT02153398|658013|P1|Overall Study|Adverse Event|0
205171|NCT02153398|658009|P5|Overall Study|Withdrawal by Subject|0
205172|NCT02153398|658010|P4|Overall Study|Withdrawal by Subject|0
205173|NCT02153398|658011|P3|Overall Study|Withdrawal by Subject|0
205174|NCT02153398|658012|P2|Overall Study|Withdrawal by Subject|0
205175|NCT02153398|658013|P1|Overall Study|Withdrawal by Subject|1
205176|NCT02153346|658135|P1|Overall Study|Lost to Follow-up|11
205177|NCT02153086|658209|P1|Overall Study|Other|2
205178|NCT02153086|658209|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
205179|NCT02152605|658225|P2|Overall Study|Withdrew consent|2
205180|NCT02152605|658226|P1|Overall Study|Withdrew consent|4
205181|NCT02152605|658225|P2|Overall Study|Lost to Follow-up|0
205182|NCT02152605|658226|P1|Overall Study|Lost to Follow-up|1
205183|NCT02152605|658225|P2|Overall Study|Protocol deviation|4
205184|NCT02152605|658226|P1|Overall Study|Protocol deviation|1
205185|NCT02152605|658225|P2|Overall Study|Lack of Efficacy|4
205186|NCT02152605|658226|P1|Overall Study|Lack of Efficacy|7
205187|NCT02152605|658225|P2|Overall Study|Adverse Event|8
205188|NCT02152605|658226|P1|Overall Study|Adverse Event|6
205189|NCT02152566|658236|P1|Overall Study|Withdrawal by Subject|2
205190|NCT02152566|658236|P1|Overall Study|Lost to Follow-up|1
205191|NCT02152371|658242|P2|Overall Study|Reason Not Given|1
205192|NCT02152371|658243|P1|Overall Study|Reason Not Given|0
205193|NCT02152371|658242|P2|Overall Study|Physician Decision|2
205194|NCT02152371|658243|P1|Overall Study|Physician Decision|0
205195|NCT02152371|658242|P2|Overall Study|Lack of Efficacy|1
205196|NCT02152371|658243|P1|Overall Study|Lack of Efficacy|0
205197|NCT02152371|658242|P2|Overall Study|Lost to Follow-up|0
205198|NCT02152371|658243|P1|Overall Study|Lost to Follow-up|1
205199|NCT02152371|658242|P2|Overall Study|Protocol Violation|3
205200|NCT02152371|658243|P1|Overall Study|Protocol Violation|2
205201|NCT02152371|658242|P2|Overall Study|Withdrawal by Subject|7
205202|NCT02152371|658243|P1|Overall Study|Withdrawal by Subject|3
205203|NCT02152371|658242|P2|Overall Study|Adverse Event|2
205204|NCT02152371|658243|P1|Overall Study|Adverse Event|6
205205|NCT02152007|658279|P1|Overall Study|Withdrawal by Subject|1
205206|NCT02151786|658338|P1|Overall Study|Unavailability of Information|8
205207|NCT02151786|658338|P1|Overall Study|Randomized, not Treated|1
205208|NCT02151786|658338|P1|Overall Study|Outside the Contract Period|1
205209|NCT02151786|658338|P1|Overall Study|Unavailability of Case Report Form|26
205210|NCT02151773|658349|P1|Overall Study|Protocol Deviation|64
205211|NCT02151058|658372|P3|Overall Study|Lost to Follow-up|2
205212|NCT02151058|658373|P2|Overall Study|Lost to Follow-up|0
205213|NCT02151058|658374|P1|Overall Study|Lost to Follow-up|1
205214|NCT02151058|658372|P3|Overall Study|Withdrawal by Subject|3
205215|NCT02151058|658373|P2|Overall Study|Withdrawal by Subject|1
205216|NCT02151058|658374|P1|Overall Study|Withdrawal by Subject|1
205217|NCT02150954|658408|P2|Overall Study|Protocol Violation|0
205218|NCT02150954|658409|P1|Overall Study|Protocol Violation|1
205219|NCT02150213|658481|P1|Overall Study|Withdrawal by Subject|1
205220|NCT02150213|658481|P1|Overall Study|Lost to Follow-up|1
205221|NCT02149875|658507|P3|Overall Study|Physician Decision|2
205222|NCT02149875|658508|P2|Overall Study|Physician Decision|2
205223|NCT02149875|658509|P1|Overall Study|Physician Decision|1
205224|NCT02149875|658507|P3|Overall Study|Withdrawal by Subject|2
205225|NCT02149875|658508|P2|Overall Study|Withdrawal by Subject|2
205226|NCT02149875|658509|P1|Overall Study|Withdrawal by Subject|3
205227|NCT02149875|658507|P3|Overall Study|Lost to Follow-up|5
205228|NCT02149875|658508|P2|Overall Study|Lost to Follow-up|4
205229|NCT02149875|658509|P1|Overall Study|Lost to Follow-up|3
205230|NCT02147691|658579|P2|Overall Study|Lost to Follow-up|1
205231|NCT02147691|658580|P1|Overall Study|Lost to Follow-up|0
205232|NCT02147691|658579|P2|Overall Study|Adverse Event|0
205233|NCT02147691|658580|P1|Overall Study|Adverse Event|2
205234|NCT02147691|658579|P2|Overall Study|Withdrawal by Subject|0
205235|NCT02147691|658580|P1|Overall Study|Withdrawal by Subject|2
205236|NCT02147561|658624|P1|Overall Study|Subjects who didn’t receive BOTOX|1
205237|NCT02147561|658624|P1|Overall Study|Lost to Follow-up|3
205238|NCT02147288|658632|P10|Overall Study|complications from concurrent hernia rep|0
205239|NCT02147288|658633|P9|Overall Study|complications from concurrent hernia rep|0
205240|NCT02147288|658634|P8|Overall Study|complications from concurrent hernia rep|0
205241|NCT02147288|658635|P7|Overall Study|complications from concurrent hernia rep|0
205242|NCT02147288|658636|P6|Overall Study|complications from concurrent hernia rep|0
205243|NCT02147288|658637|P5|Overall Study|complications from concurrent hernia rep|0
205244|NCT02147288|658638|P4|Overall Study|complications from concurrent hernia rep|0
205245|NCT02147288|658639|P3|Overall Study|complications from concurrent hernia rep|0
205246|NCT02147288|658640|P2|Overall Study|complications from concurrent hernia rep|1
205247|NCT02147288|658641|P1|Overall Study|complications from concurrent hernia rep|0
205248|NCT02147288|658632|P10|Overall Study|post-operative hematoma|0
205249|NCT02147288|658633|P9|Overall Study|post-operative hematoma|0
205250|NCT02147288|658634|P8|Overall Study|post-operative hematoma|0
205251|NCT02147288|658635|P7|Overall Study|post-operative hematoma|0
205252|NCT02147288|658636|P6|Overall Study|post-operative hematoma|0
205253|NCT02147288|658637|P5|Overall Study|post-operative hematoma|0
205254|NCT02147288|658638|P4|Overall Study|post-operative hematoma|0
205255|NCT02147288|658639|P3|Overall Study|post-operative hematoma|0
205256|NCT02147288|658640|P2|Overall Study|post-operative hematoma|1
205257|NCT02147288|658641|P1|Overall Study|post-operative hematoma|1
205258|NCT02147093|658649|P2|Period 2|Protocol Violation|0
205259|NCT02147093|658650|P1|Period 2|Protocol Violation|2
205260|NCT02147093|658649|P2|Period 1|Lost to Follow-up|1
205261|NCT02147093|658650|P1|Period 1|Lost to Follow-up|0
205262|NCT02146599|658658|P1|Overall Study|Failed to meet inclusion criteria|5
205263|NCT02146352|658671|P1|Overall Study|Patient entered hospice care|1
205264|NCT02146352|658671|P1|Overall Study|Death|1
205265|NCT02146326|658689|P4|Overall Study|Unable to complete interview|6
205266|NCT02146326|658690|P3|Overall Study|Unable to complete interview|10
205267|NCT02146326|658691|P2|Overall Study|Unable to complete interview|0
205268|NCT02146326|658692|P1|Overall Study|Unable to complete interview|0
205269|NCT02146326|658689|P4|Overall Study|Death|4
205270|NCT02146326|658690|P3|Overall Study|Death|4
205271|NCT02146326|658691|P2|Overall Study|Death|0
205272|NCT02146326|658692|P1|Overall Study|Death|0
205273|NCT02146326|658689|P4|Overall Study|Incarcerated|8
205274|NCT02146326|658690|P3|Overall Study|Incarcerated|3
205275|NCT02146326|658691|P2|Overall Study|Incarcerated|0
205276|NCT02146326|658692|P1|Overall Study|Incarcerated|0
205277|NCT02146326|658689|P4|Overall Study|Separated from mental health center|0
205278|NCT02146326|658690|P3|Overall Study|Separated from mental health center|0
205279|NCT02146326|658691|P2|Overall Study|Separated from mental health center|33
205280|NCT02146326|658692|P1|Overall Study|Separated from mental health center|23
205281|NCT02146326|658689|P4|Overall Study|Withdrawal by Subject|11
205282|NCT02146326|658690|P3|Overall Study|Withdrawal by Subject|15
205283|NCT02146326|658691|P2|Overall Study|Withdrawal by Subject|1
205284|NCT02146326|658692|P1|Overall Study|Withdrawal by Subject|2
205285|NCT02146326|658689|P4|Overall Study|Lost to Follow-up|19
205286|NCT02146326|658690|P3|Overall Study|Lost to Follow-up|11
205287|NCT02146326|658691|P2|Overall Study|Lost to Follow-up|3
205288|NCT02146326|658692|P1|Overall Study|Lost to Follow-up|3
205289|NCT02146248|658854|P1|Overall Study|Withdrawal by Subject|2
205290|NCT02146105|658862|P1|Overall Study|Withdrawal by Subject|5
205291|NCT02146105|658862|P1|Overall Study|Adverse Event|1
205292|NCT02145468|658913|P2|Overall Study|Withdrawal by Subject|8
205293|NCT02145468|658914|P1|Overall Study|Withdrawal by Subject|5
205294|NCT02145156|659002|P3|Overall Study|No match to vaccination records|37
205295|NCT02145156|659003|P2|Overall Study|No match to vaccination records|59
205296|NCT02145156|659004|P1|Overall Study|No match to vaccination records|52
205297|NCT02145156|659002|P3|Overall Study|Received all vaccines prior to baseline|45
205298|NCT02145156|659003|P2|Overall Study|Received all vaccines prior to baseline|61
205299|NCT02145156|659004|P1|Overall Study|Received all vaccines prior to baseline|41
205300|NCT02144337|659047|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
205301|NCT02144337|659048|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
205302|NCT02144337|659047|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
205303|NCT02144337|659048|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
205304|NCT02144337|659047|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
205305|NCT02144337|659048|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
205306|NCT02144337|659047|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
205307|NCT02144337|659048|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
205308|NCT02144337|659047|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
205309|NCT02144337|659048|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
205310|NCT02144220|659077|P1|Overall Study|Protocol Violation|1
205311|NCT02144220|659077|P1|Overall Study|Withdrawal by Subject|2
205312|NCT02144220|659077|P1|Overall Study|Physician Decision|3
205313|NCT02144220|659077|P1|Overall Study|Lack of Efficacy|4
205314|NCT02144220|659077|P1|Overall Study|technology incompatibility|9
205315|NCT02144012|659087|P2|Overall Study|Other|0
205316|NCT02144012|659088|P1|Overall Study|Other|3
205317|NCT02144012|659087|P2|Overall Study|Study Terminated by Sponsor|12
205318|NCT02144012|659088|P1|Overall Study|Study Terminated by Sponsor|18
205319|NCT02144012|659087|P2|Overall Study|Withdrawal by Subject|3
205320|NCT02144012|659088|P1|Overall Study|Withdrawal by Subject|11
205321|NCT02144012|659087|P2|Overall Study|Death|0
205322|NCT02144012|659088|P1|Overall Study|Death|1
205323|NCT02144012|659087|P2|Overall Study|Adverse Event|0
205324|NCT02144012|659088|P1|Overall Study|Adverse Event|1
205325|NCT02143947|659125|P2|Overall Study|Lost to Follow-up|2
205326|NCT02143947|659126|P1|Overall Study|Lost to Follow-up|4
205327|NCT02143583|659141|P3|Overall Study|husband illness|1
205328|NCT02143583|659142|P2|Overall Study|husband illness|0
205329|NCT02143583|659143|P1|Overall Study|husband illness|0
205330|NCT02143583|659141|P3|Overall Study|Withdrawal by Subject|1
205331|NCT02143583|659142|P2|Overall Study|Withdrawal by Subject|0
205332|NCT02143583|659143|P1|Overall Study|Withdrawal by Subject|1
205333|NCT02142712|659157|P4|Overall Study|Lost to Follow-up|0
205334|NCT02142712|659158|P3|Overall Study|Lost to Follow-up|1
205335|NCT02142712|659159|P2|Overall Study|Lost to Follow-up|1
205336|NCT02142712|659160|P1|Overall Study|Lost to Follow-up|1
205337|NCT02142504|659183|P3|Overall Study|Reason Not Specified|4
205338|NCT02142504|659184|P2|Overall Study|Reason Not Specified|5
205339|NCT02142504|659185|P1|Overall Study|Reason Not Specified|4
205340|NCT02142504|659183|P3|Overall Study|Physician Decision|3
205341|NCT02142504|659184|P2|Overall Study|Physician Decision|1
205342|NCT02142504|659185|P1|Overall Study|Physician Decision|0
205343|NCT02142504|659183|P3|Overall Study|Pregnancy|2
205344|NCT02142504|659184|P2|Overall Study|Pregnancy|4
205345|NCT02142504|659185|P1|Overall Study|Pregnancy|4
205346|NCT02142504|659183|P3|Overall Study|Withdrawal by Subject|11
205347|NCT02142504|659184|P2|Overall Study|Withdrawal by Subject|9
205348|NCT02142504|659185|P1|Overall Study|Withdrawal by Subject|7
205349|NCT02142504|659183|P3|Overall Study|Lost to Follow-up|17
205350|NCT02142504|659184|P2|Overall Study|Lost to Follow-up|19
205351|NCT02142504|659185|P1|Overall Study|Lost to Follow-up|12
205352|NCT02142504|659183|P3|Overall Study|Adverse Event|4
205353|NCT02142504|659184|P2|Overall Study|Adverse Event|3
205354|NCT02142504|659185|P1|Overall Study|Adverse Event|2
205355|NCT02142504|659183|P3|Overall Study|Protocol Violation|2
205356|NCT02142504|659184|P2|Overall Study|Protocol Violation|1
205357|NCT02142504|659185|P1|Overall Study|Protocol Violation|2
205358|NCT02141997|659427|P4|Overall Study|Not specified|0
205359|NCT02141997|659428|P3|Overall Study|Not specified|0
205360|NCT02141997|659429|P2|Overall Study|Not specified|4
205361|NCT02141997|659430|P1|Overall Study|Not specified|1
205362|NCT02141997|659427|P4|Overall Study|Withdrew consent|0
205363|NCT02141997|659428|P3|Overall Study|Withdrew consent|3
205364|NCT02141997|659429|P2|Overall Study|Withdrew consent|0
205365|NCT02141997|659430|P1|Overall Study|Withdrew consent|1
205366|NCT02141997|659427|P4|Overall Study|Participant noncompliance|0
205367|NCT02141997|659428|P3|Overall Study|Participant noncompliance|0
205368|NCT02141997|659429|P2|Overall Study|Participant noncompliance|0
205369|NCT02141997|659430|P1|Overall Study|Participant noncompliance|1
205370|NCT02141997|659427|P4|Overall Study|Adverse Event|1
205371|NCT02141997|659428|P3|Overall Study|Adverse Event|0
205372|NCT02141997|659429|P2|Overall Study|Adverse Event|2
205373|NCT02141997|659430|P1|Overall Study|Adverse Event|0
205374|NCT02141854|659480|P6|Treatment Period|Lost to Follow-up|1
205375|NCT02141854|659481|P5|Treatment Period|Lost to Follow-up|0
205376|NCT02141854|659482|P4|Treatment Period|Lost to Follow-up|1
205377|NCT02141854|659483|P3|Treatment Period|Lost to Follow-up|1
205378|NCT02141854|659484|P2|Treatment Period|Lost to Follow-up|1
205379|NCT02141854|659485|P1|Treatment Period|Lost to Follow-up|0
205380|NCT02141854|659480|P6|Treatment Period|Disease progression|18
205381|NCT02141854|659481|P5|Treatment Period|Disease progression|0
205382|NCT02141854|659482|P4|Treatment Period|Disease progression|3
205383|NCT02141854|659483|P3|Treatment Period|Disease progression|1
205384|NCT02141854|659484|P2|Treatment Period|Disease progression|2
205385|NCT02141854|659485|P1|Treatment Period|Disease progression|0
205386|NCT02141854|659480|P6|Treatment Period|Withdrawal by Subject|7
205387|NCT02141854|659481|P5|Treatment Period|Withdrawal by Subject|4
205388|NCT02141854|659482|P4|Treatment Period|Withdrawal by Subject|3
205389|NCT02141854|659483|P3|Treatment Period|Withdrawal by Subject|3
205390|NCT02141854|659484|P2|Treatment Period|Withdrawal by Subject|2
205391|NCT02141854|659485|P1|Treatment Period|Withdrawal by Subject|0
205392|NCT02141854|659480|P6|Treatment Period|Adverse Event|2
205393|NCT02141854|659481|P5|Treatment Period|Adverse Event|2
205394|NCT02141854|659482|P4|Treatment Period|Adverse Event|0
205395|NCT02141854|659483|P3|Treatment Period|Adverse Event|2
205396|NCT02141854|659484|P2|Treatment Period|Adverse Event|2
205397|NCT02141854|659485|P1|Treatment Period|Adverse Event|0
205398|NCT02141854|659480|P6|Treatment Period|Not specified|2
205399|NCT02141854|659481|P5|Treatment Period|Not specified|1
205400|NCT02141854|659482|P4|Treatment Period|Not specified|0
205401|NCT02141854|659483|P3|Treatment Period|Not specified|2
205402|NCT02141854|659484|P2|Treatment Period|Not specified|1
205403|NCT02141854|659485|P1|Treatment Period|Not specified|0
205404|NCT02141854|659480|P6|Treatment Period|Pregnancy|0
205405|NCT02141854|659481|P5|Treatment Period|Pregnancy|0
205406|NCT02141854|659482|P4|Treatment Period|Pregnancy|0
205407|NCT02141854|659483|P3|Treatment Period|Pregnancy|0
205408|NCT02141854|659484|P2|Treatment Period|Pregnancy|1
205409|NCT02141854|659485|P1|Treatment Period|Pregnancy|0
205410|NCT02141854|659480|P6|Treatment Period|Lack of Efficacy|7
205411|NCT02141854|659481|P5|Treatment Period|Lack of Efficacy|1
205412|NCT02141854|659482|P4|Treatment Period|Lack of Efficacy|1
205413|NCT02141854|659483|P3|Treatment Period|Lack of Efficacy|0
205414|NCT02141854|659484|P2|Treatment Period|Lack of Efficacy|0
205415|NCT02141854|659485|P1|Treatment Period|Lack of Efficacy|0
205416|NCT02141854|659480|P6|Treatment Period|Noncompliance|0
205417|NCT02141854|659481|P5|Treatment Period|Noncompliance|0
205418|NCT02141854|659482|P4|Treatment Period|Noncompliance|1
205419|NCT02141854|659483|P3|Treatment Period|Noncompliance|0
205420|NCT02141854|659484|P2|Treatment Period|Noncompliance|0
205421|NCT02141854|659485|P1|Treatment Period|Noncompliance|0
205422|NCT02141854|659480|P6|Treatment Period|Protocol Violation|1
205423|NCT02141854|659481|P5|Treatment Period|Protocol Violation|2
205424|NCT02141854|659482|P4|Treatment Period|Protocol Violation|2
205425|NCT02141854|659483|P3|Treatment Period|Protocol Violation|0
205426|NCT02141854|659484|P2|Treatment Period|Protocol Violation|1
205427|NCT02141854|659485|P1|Treatment Period|Protocol Violation|0
205428|NCT02141854|659480|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205429|NCT02141854|659481|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205430|NCT02141854|659482|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205431|NCT02141854|659483|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205432|NCT02141854|659484|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205433|NCT02141854|659485|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
205434|NCT02141854|659480|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205435|NCT02141854|659481|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205436|NCT02141854|659482|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205437|NCT02141854|659483|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205438|NCT02141854|659484|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205439|NCT02141854|659485|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
205440|NCT02141854|659480|P6|Run-In Period (Pre-assignment)|Adverse Event|0
205441|NCT02141854|659481|P5|Run-In Period (Pre-assignment)|Adverse Event|0
205442|NCT02141854|659482|P4|Run-In Period (Pre-assignment)|Adverse Event|0
205443|NCT02141854|659483|P3|Run-In Period (Pre-assignment)|Adverse Event|0
205444|NCT02141854|659484|P2|Run-In Period (Pre-assignment)|Adverse Event|0
205445|NCT02141854|659485|P1|Run-In Period (Pre-assignment)|Adverse Event|10
205446|NCT02141854|659480|P6|Run-In Period (Pre-assignment)|Not specified|0
205447|NCT02141854|659481|P5|Run-In Period (Pre-assignment)|Not specified|0
205448|NCT02141854|659482|P4|Run-In Period (Pre-assignment)|Not specified|0
205449|NCT02141854|659483|P3|Run-In Period (Pre-assignment)|Not specified|0
205450|NCT02141854|659484|P2|Run-In Period (Pre-assignment)|Not specified|0
205451|NCT02141854|659485|P1|Run-In Period (Pre-assignment)|Not specified|14
205452|NCT02141854|659480|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205453|NCT02141854|659481|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205454|NCT02141854|659482|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205455|NCT02141854|659483|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205456|NCT02141854|659484|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205457|NCT02141854|659485|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
205458|NCT02141854|659480|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205459|NCT02141854|659481|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205460|NCT02141854|659482|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205461|NCT02141854|659483|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205462|NCT02141854|659484|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205463|NCT02141854|659485|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
205464|NCT02141854|659480|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205465|NCT02141854|659481|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205466|NCT02141854|659482|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205467|NCT02141854|659483|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205557|NCT02139644|659987|P6|Treatment Period|Lost to Follow-up|1
205468|NCT02141854|659484|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205469|NCT02141854|659485|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
205470|NCT02141633|659539|P2|Overall Study|Physician Decision|0
205471|NCT02141633|659540|P1|Overall Study|Physician Decision|1
205472|NCT02141620|659548|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
205473|NCT02141620|659549|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
205474|NCT02141516|659626|P3|Overall Study|Other|0
205475|NCT02141516|659627|P2|Overall Study|Other|3
205476|NCT02141516|659628|P1|Overall Study|Other|0
205477|NCT02141516|659626|P3|Overall Study|Lost to Follow-up|0
205478|NCT02141516|659627|P2|Overall Study|Lost to Follow-up|1
205479|NCT02141516|659628|P1|Overall Study|Lost to Follow-up|0
205480|NCT02141516|659626|P3|Overall Study|Adverse Event|0
205481|NCT02141516|659627|P2|Overall Study|Adverse Event|1
205482|NCT02141516|659628|P1|Overall Study|Adverse Event|0
205483|NCT02141217|659678|P2|Overall Study|Surgical Intervention|1
205484|NCT02141217|659679|P1|Overall Study|Surgical Intervention|1
205485|NCT02141217|659678|P2|Overall Study|Physician Decision|0
205486|NCT02141217|659679|P1|Overall Study|Physician Decision|1
205487|NCT02141217|659678|P2|Overall Study|Lost to Follow-up|1
205488|NCT02141217|659679|P1|Overall Study|Lost to Follow-up|1
205489|NCT02141217|659678|P2|Overall Study|Withdrawal by Subject|0
205490|NCT02141217|659679|P1|Overall Study|Withdrawal by Subject|6
205491|NCT02141217|659678|P2|Overall Study|Protocol Violation|4
205492|NCT02141217|659679|P1|Overall Study|Protocol Violation|1
205493|NCT02141217|659678|P2|Overall Study|Adverse Event|2
205494|NCT02141217|659679|P1|Overall Study|Adverse Event|1
205495|NCT02140645|659745|P6|Overall Study|Not linked|70896
205496|NCT02140645|659746|P5|Overall Study|Not linked|3286
205497|NCT02140645|659747|P4|Overall Study|Not linked|13833
205498|NCT02140645|659748|P3|Overall Study|Not linked|4236
205499|NCT02140645|659749|P2|Overall Study|Not linked|61654
205500|NCT02140645|659750|P1|Overall Study|Not linked|5489
205501|NCT02140164|659859|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
205502|NCT02140060|659876|P6|Overall Study|Lack of Efficacy|0
205503|NCT02140060|659877|P5|Overall Study|Lack of Efficacy|0
205504|NCT02140060|659878|P4|Overall Study|Lack of Efficacy|1
205505|NCT02140060|659879|P3|Overall Study|Lack of Efficacy|0
205506|NCT02140060|659880|P2|Overall Study|Lack of Efficacy|0
205507|NCT02140060|659881|P1|Overall Study|Lack of Efficacy|0
205508|NCT02140060|659876|P6|Overall Study|Adverse Event|1
205509|NCT02140060|659877|P5|Overall Study|Adverse Event|1
205510|NCT02140060|659878|P4|Overall Study|Adverse Event|1
205511|NCT02140060|659879|P3|Overall Study|Adverse Event|0
205512|NCT02140060|659880|P2|Overall Study|Adverse Event|0
205513|NCT02140060|659881|P1|Overall Study|Adverse Event|0
205514|NCT02139982|659906|P10|Overall Study|Lack of Efficacy|0
205515|NCT02139982|659907|P9|Overall Study|Lack of Efficacy|0
205516|NCT02139982|659908|P8|Overall Study|Lack of Efficacy|0
205517|NCT02139982|659909|P7|Overall Study|Lack of Efficacy|0
205518|NCT02139982|659910|P6|Overall Study|Lack of Efficacy|0
205519|NCT02139982|659911|P5|Overall Study|Lack of Efficacy|0
205520|NCT02139982|659912|P4|Overall Study|Lack of Efficacy|1
205521|NCT02139982|659913|P3|Overall Study|Lack of Efficacy|0
205522|NCT02139982|659914|P2|Overall Study|Lack of Efficacy|1
205523|NCT02139982|659915|P1|Overall Study|Lack of Efficacy|0
205524|NCT02139943|659960|P3|Overall Study|eGFR Withdrawal Criteria|1
205525|NCT02139943|659961|P2|Overall Study|eGFR Withdrawal Criteria|0
205526|NCT02139943|659962|P1|Overall Study|eGFR Withdrawal Criteria|0
205527|NCT02139943|659960|P3|Overall Study|Participant in Poor Compliance|1
205528|NCT02139943|659961|P2|Overall Study|Participant in Poor Compliance|0
205529|NCT02139943|659962|P1|Overall Study|Participant in Poor Compliance|1
205530|NCT02139943|659960|P3|Overall Study|Participant wishes to discontinue|0
205531|NCT02139943|659961|P2|Overall Study|Participant wishes to discontinue|0
205532|NCT02139943|659962|P1|Overall Study|Participant wishes to discontinue|2
205533|NCT02139943|659960|P3|Overall Study|Unspecified|1
205534|NCT02139943|659961|P2|Overall Study|Unspecified|0
205535|NCT02139943|659962|P1|Overall Study|Unspecified|0
205536|NCT02139943|659960|P3|Overall Study|Withdrawal by Subject|0
205537|NCT02139943|659961|P2|Overall Study|Withdrawal by Subject|3
205538|NCT02139943|659962|P1|Overall Study|Withdrawal by Subject|4
205539|NCT02139943|659960|P3|Overall Study|Lost to Follow-up|2
205540|NCT02139943|659961|P2|Overall Study|Lost to Follow-up|2
205541|NCT02139943|659962|P1|Overall Study|Lost to Follow-up|3
205542|NCT02139943|659960|P3|Overall Study|Adverse Event|2
205543|NCT02139943|659961|P2|Overall Study|Adverse Event|1
205544|NCT02139943|659962|P1|Overall Study|Adverse Event|0
205545|NCT02139644|659987|P6|Treatment Period|Not specified|1
205546|NCT02139644|659988|P5|Treatment Period|Not specified|0
205547|NCT02139644|659989|P4|Treatment Period|Not specified|1
205548|NCT02139644|659990|P3|Treatment Period|Not specified|1
205549|NCT02139644|659991|P2|Treatment Period|Not specified|3
205550|NCT02139644|659992|P1|Treatment Period|Not specified|0
205551|NCT02139644|659987|P6|Treatment Period|Lack of Efficacy|4
205552|NCT02139644|659988|P5|Treatment Period|Lack of Efficacy|1
205553|NCT02139644|659989|P4|Treatment Period|Lack of Efficacy|0
205554|NCT02139644|659990|P3|Treatment Period|Lack of Efficacy|1
205555|NCT02139644|659991|P2|Treatment Period|Lack of Efficacy|0
205556|NCT02139644|659992|P1|Treatment Period|Lack of Efficacy|0
205558|NCT02139644|659988|P5|Treatment Period|Lost to Follow-up|1
205559|NCT02139644|659989|P4|Treatment Period|Lost to Follow-up|1
205560|NCT02139644|659990|P3|Treatment Period|Lost to Follow-up|1
205561|NCT02139644|659991|P2|Treatment Period|Lost to Follow-up|0
205562|NCT02139644|659992|P1|Treatment Period|Lost to Follow-up|0
205563|NCT02139644|659987|P6|Treatment Period|Disease progression|2
205564|NCT02139644|659988|P5|Treatment Period|Disease progression|1
205565|NCT02139644|659989|P4|Treatment Period|Disease progression|1
205566|NCT02139644|659990|P3|Treatment Period|Disease progression|0
205567|NCT02139644|659991|P2|Treatment Period|Disease progression|0
205568|NCT02139644|659992|P1|Treatment Period|Disease progression|0
205569|NCT02139644|659987|P6|Treatment Period|Protocol Violation|1
205570|NCT02139644|659988|P5|Treatment Period|Protocol Violation|1
205571|NCT02139644|659989|P4|Treatment Period|Protocol Violation|1
205572|NCT02139644|659990|P3|Treatment Period|Protocol Violation|0
205573|NCT02139644|659991|P2|Treatment Period|Protocol Violation|0
205574|NCT02139644|659992|P1|Treatment Period|Protocol Violation|0
205575|NCT02139644|659987|P6|Treatment Period|Non-compliance|0
205576|NCT02139644|659988|P5|Treatment Period|Non-compliance|0
205577|NCT02139644|659989|P4|Treatment Period|Non-compliance|1
205578|NCT02139644|659990|P3|Treatment Period|Non-compliance|0
205579|NCT02139644|659991|P2|Treatment Period|Non-compliance|0
205580|NCT02139644|659992|P1|Treatment Period|Non-compliance|0
205581|NCT02139644|659987|P6|Treatment Period|Withdrawal by Subject|2
205582|NCT02139644|659988|P5|Treatment Period|Withdrawal by Subject|3
205583|NCT02139644|659989|P4|Treatment Period|Withdrawal by Subject|2
205584|NCT02139644|659990|P3|Treatment Period|Withdrawal by Subject|2
205585|NCT02139644|659991|P2|Treatment Period|Withdrawal by Subject|0
205586|NCT02139644|659992|P1|Treatment Period|Withdrawal by Subject|0
205587|NCT02139644|659987|P6|Treatment Period|Adverse Event|6
205588|NCT02139644|659988|P5|Treatment Period|Adverse Event|1
205589|NCT02139644|659989|P4|Treatment Period|Adverse Event|2
205590|NCT02139644|659990|P3|Treatment Period|Adverse Event|3
205591|NCT02139644|659991|P2|Treatment Period|Adverse Event|0
205592|NCT02139644|659992|P1|Treatment Period|Adverse Event|0
205593|NCT02139644|659987|P6|Run-In Period (Pre-assignment)|Not specified|0
205594|NCT02139644|659988|P5|Run-In Period (Pre-assignment)|Not specified|0
205595|NCT02139644|659989|P4|Run-In Period (Pre-assignment)|Not specified|0
205596|NCT02139644|659990|P3|Run-In Period (Pre-assignment)|Not specified|0
205597|NCT02139644|659991|P2|Run-In Period (Pre-assignment)|Not specified|0
205598|NCT02139644|659992|P1|Run-In Period (Pre-assignment)|Not specified|6
205599|NCT02139644|659987|P6|Run-In Period (Pre-assignment)|Adverse Event|0
205600|NCT02139644|659988|P5|Run-In Period (Pre-assignment)|Adverse Event|0
205601|NCT02139644|659989|P4|Run-In Period (Pre-assignment)|Adverse Event|0
205602|NCT02139644|659990|P3|Run-In Period (Pre-assignment)|Adverse Event|0
205603|NCT02139644|659991|P2|Run-In Period (Pre-assignment)|Adverse Event|0
205604|NCT02139644|659992|P1|Run-In Period (Pre-assignment)|Adverse Event|3
205605|NCT02139644|659987|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205606|NCT02139644|659988|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205607|NCT02139644|659989|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205608|NCT02139644|659990|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205609|NCT02139644|659991|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
205610|NCT02139644|659992|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
205611|NCT02139644|659987|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205612|NCT02139644|659988|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205613|NCT02139644|659989|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205614|NCT02139644|659990|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205615|NCT02139644|659991|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
205616|NCT02139644|659992|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
205617|NCT02139644|659987|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205618|NCT02139644|659988|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205619|NCT02139644|659989|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205620|NCT02139644|659990|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205621|NCT02139644|659991|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
205622|NCT02139644|659992|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
205623|NCT02139644|659987|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205624|NCT02139644|659988|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205625|NCT02139644|659989|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205626|NCT02139644|659990|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205627|NCT02139644|659991|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
205628|NCT02139644|659992|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
205629|NCT02139644|659987|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205630|NCT02139644|659988|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205631|NCT02139644|659989|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205632|NCT02139644|659990|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205633|NCT02139644|659991|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
205634|NCT02139644|659992|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
205635|NCT02139046|660077|P5|Overall Study|Other Miscellaneous Reasons|12
205636|NCT02139046|660078|P4|Overall Study|Other Miscellaneous Reasons|9
205637|NCT02139046|660079|P3|Overall Study|Other Miscellaneous Reasons|4
205638|NCT02139046|660080|P2|Overall Study|Other Miscellaneous Reasons|9
205639|NCT02139046|660081|P1|Overall Study|Other Miscellaneous Reasons|10
205640|NCT02139046|660077|P5|Overall Study|Withdrawal due to a Gout Flare|1
205641|NCT02139046|660078|P4|Overall Study|Withdrawal due to a Gout Flare|0
205642|NCT02139046|660079|P3|Overall Study|Withdrawal due to a Gout Flare|1
205643|NCT02139046|660080|P2|Overall Study|Withdrawal due to a Gout Flare|1
205644|NCT02139046|660081|P1|Overall Study|Withdrawal due to a Gout Flare|1
205645|NCT02139046|660077|P5|Overall Study|Lack of Efficacy|2
205646|NCT02139046|660078|P4|Overall Study|Lack of Efficacy|1
205647|NCT02139046|660079|P3|Overall Study|Lack of Efficacy|2
205648|NCT02139046|660080|P2|Overall Study|Lack of Efficacy|1
205649|NCT02139046|660081|P1|Overall Study|Lack of Efficacy|0
205650|NCT02139046|660077|P5|Overall Study|Voluntary Withdrawal|16
205651|NCT02139046|660078|P4|Overall Study|Voluntary Withdrawal|15
205652|NCT02139046|660079|P3|Overall Study|Voluntary Withdrawal|10
205653|NCT02139046|660080|P2|Overall Study|Voluntary Withdrawal|8
205654|NCT02139046|660081|P1|Overall Study|Voluntary Withdrawal|20
205655|NCT02139046|660077|P5|Overall Study|Lost to Follow-up|13
205656|NCT02139046|660078|P4|Overall Study|Lost to Follow-up|18
205657|NCT02139046|660079|P3|Overall Study|Lost to Follow-up|16
205658|NCT02139046|660080|P2|Overall Study|Lost to Follow-up|16
205659|NCT02139046|660081|P1|Overall Study|Lost to Follow-up|13
205660|NCT02139046|660077|P5|Overall Study|Major Protocol Deviation|6
205661|NCT02139046|660078|P4|Overall Study|Major Protocol Deviation|12
205662|NCT02139046|660079|P3|Overall Study|Major Protocol Deviation|16
205663|NCT02139046|660080|P2|Overall Study|Major Protocol Deviation|10
205664|NCT02139046|660081|P1|Overall Study|Major Protocol Deviation|9
205665|NCT02139046|660077|P5|Overall Study|Pretreatment Event/Adverse Event|7
205666|NCT02139046|660078|P4|Overall Study|Pretreatment Event/Adverse Event|13
205667|NCT02139046|660079|P3|Overall Study|Pretreatment Event/Adverse Event|10
205668|NCT02139046|660080|P2|Overall Study|Pretreatment Event/Adverse Event|9
205669|NCT02139046|660081|P1|Overall Study|Pretreatment Event/Adverse Event|9
205670|NCT02138825|660121|P2|Main Study Treatment|Medical decision|0
205671|NCT02138825|660122|P1|Main Study Treatment|Medical decision|1
205672|NCT02138825|660121|P2|Main Study Treatment|Withdrawal by Subject|1
205673|NCT02138825|660122|P1|Main Study Treatment|Withdrawal by Subject|3
205674|NCT02138825|660121|P2|Main Study Treatment|Study terminated by sponsor|9
205675|NCT02138825|660122|P1|Main Study Treatment|Study terminated by sponsor|10
205676|NCT02138825|660121|P2|Main Study Treatment|Sponsor decision|18
205677|NCT02138825|660122|P1|Main Study Treatment|Sponsor decision|12
205678|NCT02138825|660121|P2|Main Study Treatment|Protocol Violation|2
205679|NCT02138825|660122|P1|Main Study Treatment|Protocol Violation|2
205680|NCT02138825|660121|P2|Main Study Treatment|Death|2
205681|NCT02138825|660122|P1|Main Study Treatment|Death|1
205682|NCT02138825|660121|P2|Main Study Treatment|Adverse Event|3
205683|NCT02138825|660122|P1|Main Study Treatment|Adverse Event|11
205684|NCT02138747|660134|P4|Treatment Period 2|Other - Miscellaneous|0
205685|NCT02138747|660135|P3|Treatment Period 2|Other - Miscellaneous|0
205686|NCT02138747|660136|P2|Treatment Period 2|Other - Miscellaneous|0
205687|NCT02138747|660137|P1|Treatment Period 2|Other - Miscellaneous|3
205688|NCT02138747|660134|P4|Treatment Period 2|Withdrawal by Subject|2
205689|NCT02138747|660135|P3|Treatment Period 2|Withdrawal by Subject|1
205690|NCT02138747|660136|P2|Treatment Period 2|Withdrawal by Subject|4
205691|NCT02138747|660137|P1|Treatment Period 2|Withdrawal by Subject|5
205692|NCT02138747|660134|P4|Treatment Period 2|Protocol Violation|0
205693|NCT02138747|660135|P3|Treatment Period 2|Protocol Violation|0
205694|NCT02138747|660136|P2|Treatment Period 2|Protocol Violation|0
205695|NCT02138747|660137|P1|Treatment Period 2|Protocol Violation|1
205696|NCT02138747|660134|P4|Treatment Period 2|Lost to Follow-up|0
205697|NCT02138747|660135|P3|Treatment Period 2|Lost to Follow-up|0
205698|NCT02138747|660136|P2|Treatment Period 2|Lost to Follow-up|0
205699|NCT02138747|660137|P1|Treatment Period 2|Lost to Follow-up|2
205700|NCT02138747|660134|P4|Treatment Period 2|Adverse Event|1
205701|NCT02138747|660135|P3|Treatment Period 2|Adverse Event|1
205702|NCT02138747|660136|P2|Treatment Period 2|Adverse Event|3
205703|NCT02138747|660137|P1|Treatment Period 2|Adverse Event|6
205704|NCT02138747|660134|P4|Treatment Period 1|Other - Miscellaneous|0
205705|NCT02138747|660135|P3|Treatment Period 1|Other - Miscellaneous|0
205706|NCT02138747|660136|P2|Treatment Period 1|Other - Miscellaneous|4
205707|NCT02138747|660137|P1|Treatment Period 1|Other - Miscellaneous|2
205708|NCT02138747|660134|P4|Treatment Period 1|Withdrawal by Subject|3
205709|NCT02138747|660135|P3|Treatment Period 1|Withdrawal by Subject|1
205710|NCT02138747|660136|P2|Treatment Period 1|Withdrawal by Subject|4
205711|NCT02138747|660137|P1|Treatment Period 1|Withdrawal by Subject|8
205712|NCT02138747|660134|P4|Treatment Period 1|Protocol Violation|0
205713|NCT02138747|660135|P3|Treatment Period 1|Protocol Violation|0
205714|NCT02138747|660136|P2|Treatment Period 1|Protocol Violation|2
205715|NCT02138747|660137|P1|Treatment Period 1|Protocol Violation|0
205716|NCT02138747|660134|P4|Treatment Period 1|Lost to Follow-up|0
205717|NCT02138747|660135|P3|Treatment Period 1|Lost to Follow-up|1
205718|NCT02138747|660136|P2|Treatment Period 1|Lost to Follow-up|1
205719|NCT02138747|660137|P1|Treatment Period 1|Lost to Follow-up|0
205720|NCT02138747|660134|P4|Treatment Period 1|Adverse Event|1
205721|NCT02138747|660135|P3|Treatment Period 1|Adverse Event|2
205722|NCT02138747|660136|P2|Treatment Period 1|Adverse Event|14
205723|NCT02138747|660137|P1|Treatment Period 1|Adverse Event|10
205724|NCT02137785|660400|P2|Overall Study|subject moved out of state|0
205725|NCT02137785|660401|P1|Overall Study|subject moved out of state|1
205726|NCT02137785|660400|P2|Overall Study|Withdrawal by Subject|4
205727|NCT02137785|660401|P1|Overall Study|Withdrawal by Subject|1
205728|NCT02137785|660400|P2|Overall Study|Lost to Follow-up|0
205729|NCT02137785|660401|P1|Overall Study|Lost to Follow-up|1
205730|NCT02136134|660586|P2|Overall Study|Subjects randomized but not treated|8
205731|NCT02136134|660587|P1|Overall Study|Subjects randomized but not treated|10
205732|NCT02136134|660586|P2|Overall Study|Ongoing|207
205733|NCT02136134|660587|P1|Overall Study|Ongoing|185
205734|NCT02136134|660586|P2|Overall Study|Unspecified|3
205735|NCT02136134|660587|P1|Overall Study|Unspecified|3
205736|NCT02136134|660586|P2|Overall Study|Withdrawal by Subject|4
205737|NCT02136134|660587|P1|Overall Study|Withdrawal by Subject|14
205738|NCT02136134|660586|P2|Overall Study|Death|29
205739|NCT02136134|660587|P1|Overall Study|Death|35
205740|NCT02135445|660625|P2|Overall Study|Withdrawal by Subject|0
205741|NCT02135445|660626|P1|Overall Study|Withdrawal by Subject|1
205742|NCT02135445|660625|P2|Overall Study|Lost to Follow-up|0
205743|NCT02135445|660626|P1|Overall Study|Lost to Follow-up|1
205744|NCT02134977|660715|P1|Overall Study|Protocol Deviation|102
205745|NCT02134587|660736|P1|Overall Study|Did not completed all meetings|30
205746|NCT02133664|660820|P2|Overall Study|Adverse Event|6
205747|NCT02133664|660821|P1|Overall Study|Adverse Event|3
205748|NCT02133664|660820|P2|Overall Study|Lost to Follow-up|1
205749|NCT02133664|660821|P1|Overall Study|Lost to Follow-up|2
205750|NCT02133352|660837|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
205751|NCT02133131|660868|P7|Overall Study|Protocol Violation|1
205752|NCT02133131|660869|P6|Overall Study|Protocol Violation|0
205753|NCT02133131|660870|P5|Overall Study|Protocol Violation|0
205754|NCT02133131|660871|P4|Overall Study|Protocol Violation|0
205755|NCT02133131|660872|P3|Overall Study|Protocol Violation|0
205756|NCT02133131|660873|P2|Overall Study|Protocol Violation|0
205757|NCT02133131|660874|P1|Overall Study|Protocol Violation|0
205758|NCT02133131|660868|P7|Overall Study|Ongoing in study|11
205759|NCT02133131|660869|P6|Overall Study|Ongoing in study|14
205760|NCT02133131|660870|P5|Overall Study|Ongoing in study|15
205761|NCT02133131|660871|P4|Overall Study|Ongoing in study|0
205762|NCT02133131|660872|P3|Overall Study|Ongoing in study|0
205763|NCT02133131|660873|P2|Overall Study|Ongoing in study|0
205764|NCT02133131|660874|P1|Overall Study|Ongoing in study|0
205765|NCT02133131|660868|P7|Overall Study|Status not recorded|0
205766|NCT02133131|660869|P6|Overall Study|Status not recorded|0
205767|NCT02133131|660870|P5|Overall Study|Status not recorded|0
205768|NCT02133131|660871|P4|Overall Study|Status not recorded|4
205769|NCT02133131|660872|P3|Overall Study|Status not recorded|1
205770|NCT02133131|660873|P2|Overall Study|Status not recorded|5
205771|NCT02133131|660874|P1|Overall Study|Status not recorded|4
205772|NCT02133131|660868|P7|Overall Study|Lost to Follow-up|0
205773|NCT02133131|660869|P6|Overall Study|Lost to Follow-up|0
205774|NCT02133131|660870|P5|Overall Study|Lost to Follow-up|0
205775|NCT02133131|660871|P4|Overall Study|Lost to Follow-up|1
205776|NCT02133131|660872|P3|Overall Study|Lost to Follow-up|0
205777|NCT02133131|660873|P2|Overall Study|Lost to Follow-up|0
205778|NCT02133131|660874|P1|Overall Study|Lost to Follow-up|1
205779|NCT02133131|660868|P7|Overall Study|Adverse Event|0
205780|NCT02133131|660869|P6|Overall Study|Adverse Event|0
205781|NCT02133131|660870|P5|Overall Study|Adverse Event|0
205782|NCT02133131|660871|P4|Overall Study|Adverse Event|1
205783|NCT02133131|660872|P3|Overall Study|Adverse Event|0
205784|NCT02133131|660873|P2|Overall Study|Adverse Event|0
205785|NCT02133131|660874|P1|Overall Study|Adverse Event|0
205786|NCT02132949|660913|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
205787|NCT02132949|660914|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
205788|NCT02132949|660913|P2|Adjuvant Treatment Period|Protocol Deviation|0
205789|NCT02132949|660914|P1|Adjuvant Treatment Period|Protocol Deviation|1
205790|NCT02132949|660913|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
205791|NCT02132949|660914|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
205792|NCT02132949|660913|P2|Adjuvant Treatment Period|Physician Decision|0
205793|NCT02132949|660914|P1|Adjuvant Treatment Period|Physician Decision|1
205794|NCT02132949|660913|P2|Adjuvant Treatment Period|Disease Relapse|1
205795|NCT02132949|660914|P1|Adjuvant Treatment Period|Disease Relapse|0
205796|NCT02132949|660913|P2|Adjuvant Treatment Period|Disease Progression|1
205797|NCT02132949|660914|P1|Adjuvant Treatment Period|Disease Progression|0
205798|NCT02132949|660913|P2|Adjuvant Treatment Period|Reason unspecified|1
205799|NCT02132949|660914|P1|Adjuvant Treatment Period|Reason unspecified|0
205800|NCT02132949|660913|P2|Adjuvant Treatment Period|Adverse Event|6
205801|NCT02132949|660914|P1|Adjuvant Treatment Period|Adverse Event|4
205802|NCT02132949|660913|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
205803|NCT02132949|660914|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
205804|NCT02132949|660913|P2|Neoadjuvant Treatment Period|Adverse Event|3
205805|NCT02132949|660914|P1|Neoadjuvant Treatment Period|Adverse Event|6
205806|NCT02132949|660913|P2|Neoadjuvant Treatment Period|Disease Progression|1
205807|NCT02132949|660914|P1|Neoadjuvant Treatment Period|Disease Progression|1
205808|NCT02132949|660913|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
205809|NCT02132949|660914|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
205810|NCT02132949|660913|P2|Neoadjuvant Treatment Period|Physician Decision|0
205811|NCT02132949|660914|P1|Neoadjuvant Treatment Period|Physician Decision|2
205812|NCT02132949|660913|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
205813|NCT02132949|660914|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
205814|NCT02132949|660913|P2|Neoadjuvant Treatment Period|Reason unspecified|1
205815|NCT02132949|660914|P1|Neoadjuvant Treatment Period|Reason unspecified|3
205816|NCT02132949|660913|P2|Neoadjuvant Treatment Period|Early surgery|3
205817|NCT02132949|660914|P1|Neoadjuvant Treatment Period|Early surgery|4
205818|NCT02132767|660998|P2|Overall Study|Lost to Follow-up|4
205819|NCT02132767|660999|P1|Overall Study|Lost to Follow-up|4
205820|NCT02132767|660998|P2|Overall Study|Withdrawal by Subject|9
205821|NCT02132767|660999|P1|Overall Study|Withdrawal by Subject|10
205822|NCT02132767|660998|P2|Overall Study|Death|2
205823|NCT02132767|660999|P1|Overall Study|Death|3
205824|NCT02132611|661019|P1|Overall Study|Death|2
205825|NCT02132117|661030|P2|Overall Study|Other Miscellaneous Reasons|0
205826|NCT02132117|661031|P1|Overall Study|Other Miscellaneous Reasons|2
205827|NCT02132117|661030|P2|Overall Study|Personal Reasons|2
205828|NCT02132117|661031|P1|Overall Study|Personal Reasons|1
205829|NCT02132117|661030|P2|Overall Study|Lost to Follow-up|2
205830|NCT02132117|661031|P1|Overall Study|Lost to Follow-up|2
205831|NCT02132117|661030|P2|Overall Study|Adverse Event|1
205832|NCT02132117|661031|P1|Overall Study|Adverse Event|6
205833|NCT02131636|661049|P2|Overall Study|Adverse Event|1
205834|NCT02131636|661050|P1|Overall Study|Adverse Event|4
205835|NCT02131636|661049|P2|Overall Study|Lost to Follow-up|0
205836|NCT02131636|661050|P1|Overall Study|Lost to Follow-up|4
205837|NCT02131636|661049|P2|Overall Study|Personal Reasons|4
205838|NCT02131636|661050|P1|Overall Study|Personal Reasons|4
205839|NCT02131532|661066|P1|Overall Study|Other health conditions|2
205840|NCT02131532|661066|P1|Overall Study|Physician Decision|1
205841|NCT02131532|661066|P1|Overall Study|Withdrawal by Subject|1
205842|NCT02131311|661156|P1|Overall Study|Lost to Follow-up|1
205843|NCT02131311|661156|P1|Overall Study|Protocol Violation|1
205844|NCT02131311|661156|P1|Overall Study|Adverse Event|2
205845|NCT02131233|661168|P2|Overall Study|Withdrawal by Subject|8
205846|NCT02131233|661169|P1|Overall Study|Withdrawal by Subject|12
205847|NCT02131233|661168|P2|Overall Study|Pregnancy|0
205848|NCT02131233|661169|P1|Overall Study|Pregnancy|2
205849|NCT02131233|661168|P2|Overall Study|Physician Decision|0
205850|NCT02131233|661169|P1|Overall Study|Physician Decision|4
205851|NCT02131233|661168|P2|Overall Study|Non-Compliance With Study Drug|4
205852|NCT02131233|661169|P1|Overall Study|Non-Compliance With Study Drug|5
205853|NCT02131233|661168|P2|Overall Study|Lost to Follow-up|4
205854|NCT02131233|661169|P1|Overall Study|Lost to Follow-up|8
205855|NCT02131233|661168|P2|Overall Study|Lack of Efficacy|1
205856|NCT02131233|661169|P1|Overall Study|Lack of Efficacy|4
205857|NCT02131233|661168|P2|Overall Study|Death|1
205858|NCT02131233|661169|P1|Overall Study|Death|0
205859|NCT02131233|661168|P2|Overall Study|Adverse Event|6
205860|NCT02131233|661169|P1|Overall Study|Adverse Event|6
205861|NCT02131233|661168|P2|Overall Study|Not Treated|3
205862|NCT02131233|661169|P1|Overall Study|Not Treated|2
205863|NCT02131064|661189|P2|Overall Study|Unspecified|0
205864|NCT02131064|661190|P1|Overall Study|Unspecified|1
205865|NCT02131064|661189|P2|Overall Study|Ongoing|207
205866|NCT02131064|661190|P1|Overall Study|Ongoing|214
205867|NCT02131064|661189|P2|Overall Study|Withdrawal by Subject|14
205868|NCT02131064|661190|P1|Overall Study|Withdrawal by Subject|6
205869|NCT02131064|661189|P2|Overall Study|Lost to Follow-up|1
205870|NCT02131064|661190|P1|Overall Study|Lost to Follow-up|0
205871|NCT02131064|661189|P2|Overall Study|Death|1
205872|NCT02131064|661190|P1|Overall Study|Death|0
205873|NCT02130284|661249|P1|Overall Study|Screen Failure|1
205874|NCT02130284|661249|P1|Overall Study|Subject was screened as backup for study|3
205875|NCT02130284|661249|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
205876|NCT02130284|661249|P1|Overall Study|Subject Withdrew Consent|1
205877|NCT02130284|661249|P1|Overall Study|Withdrawal by Subject|3
205878|NCT02130193|661262|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
205879|NCT02130193|661263|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
205880|NCT02130193|661264|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
205881|NCT02130193|661262|P3|Part B: 52-week Double-blind Period|Physician Decision|1
205882|NCT02130193|661263|P2|Part B: 52-week Double-blind Period|Physician Decision|0
205883|NCT02130193|661264|P1|Part B: 52-week Double-blind Period|Physician Decision|0
205884|NCT02130193|661262|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
205885|NCT02130193|661263|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
205886|NCT02130193|661264|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
205887|NCT02130193|661262|P3|Part B: 52-week Double-blind Period|Adverse Event|3
205888|NCT02130193|661263|P2|Part B: 52-week Double-blind Period|Adverse Event|5
205889|NCT02130193|661264|P1|Part B: 52-week Double-blind Period|Adverse Event|0
205890|NCT02129777|661333|P7|Open-Label Period|Study Termination|39
205891|NCT02129777|661334|P6|Open-Label Period|Study Termination|10
205892|NCT02129777|661335|P5|Open-Label Period|Study Termination|0
205893|NCT02129777|661336|P4|Open-Label Period|Study Termination|0
205894|NCT02129777|661337|P3|Open-Label Period|Study Termination|0
205895|NCT02129777|661338|P2|Open-Label Period|Study Termination|0
205896|NCT02129777|661339|P1|Open-Label Period|Study Termination|0
205897|NCT02129777|661333|P7|Open-Label Period|Withdrawal by Subject|3
205898|NCT02129777|661334|P6|Open-Label Period|Withdrawal by Subject|1
205899|NCT02129777|661335|P5|Open-Label Period|Withdrawal by Subject|0
205900|NCT02129777|661336|P4|Open-Label Period|Withdrawal by Subject|0
205901|NCT02129777|661337|P3|Open-Label Period|Withdrawal by Subject|0
205902|NCT02129777|661338|P2|Open-Label Period|Withdrawal by Subject|0
205903|NCT02129777|661339|P1|Open-Label Period|Withdrawal by Subject|0
205904|NCT02129777|661333|P7|Open-Label Period|Lost to Follow-up|1
205905|NCT02129777|661334|P6|Open-Label Period|Lost to Follow-up|1
205906|NCT02129777|661335|P5|Open-Label Period|Lost to Follow-up|0
205907|NCT02129777|661336|P4|Open-Label Period|Lost to Follow-up|0
205908|NCT02129777|661337|P3|Open-Label Period|Lost to Follow-up|0
205909|NCT02129777|661338|P2|Open-Label Period|Lost to Follow-up|0
205910|NCT02129777|661339|P1|Open-Label Period|Lost to Follow-up|0
205911|NCT02129777|661333|P7|Open-Label Period|Lack of Efficacy|5
205912|NCT02129777|661334|P6|Open-Label Period|Lack of Efficacy|0
205913|NCT02129777|661335|P5|Open-Label Period|Lack of Efficacy|0
205914|NCT02129777|661336|P4|Open-Label Period|Lack of Efficacy|0
205915|NCT02129777|661337|P3|Open-Label Period|Lack of Efficacy|0
205916|NCT02129777|661338|P2|Open-Label Period|Lack of Efficacy|0
205917|NCT02129777|661339|P1|Open-Label Period|Lack of Efficacy|0
205918|NCT02129777|661333|P7|Double-Blind Period|Other|0
205919|NCT02129777|661334|P6|Double-Blind Period|Other|0
205920|NCT02129777|661335|P5|Double-Blind Period|Other|0
205921|NCT02129777|661336|P4|Double-Blind Period|Other|0
205922|NCT02129777|661337|P3|Double-Blind Period|Other|0
205923|NCT02129777|661338|P2|Double-Blind Period|Other|2
205924|NCT02129777|661339|P1|Double-Blind Period|Other|1
205925|NCT02129777|661333|P7|Double-Blind Period|Lack of Efficacy|0
205926|NCT02129777|661334|P6|Double-Blind Period|Lack of Efficacy|0
205927|NCT02129777|661335|P5|Double-Blind Period|Lack of Efficacy|2
205928|NCT02129777|661336|P4|Double-Blind Period|Lack of Efficacy|3
205929|NCT02129777|661337|P3|Double-Blind Period|Lack of Efficacy|0
205930|NCT02129777|661338|P2|Double-Blind Period|Lack of Efficacy|1
205931|NCT02129777|661339|P1|Double-Blind Period|Lack of Efficacy|3
205932|NCT02129777|661333|P7|Double-Blind Period|Pregnancy|0
205933|NCT02129777|661334|P6|Double-Blind Period|Pregnancy|0
205934|NCT02129777|661335|P5|Double-Blind Period|Pregnancy|1
205935|NCT02129777|661336|P4|Double-Blind Period|Pregnancy|0
205936|NCT02129777|661337|P3|Double-Blind Period|Pregnancy|0
205937|NCT02129777|661338|P2|Double-Blind Period|Pregnancy|0
205938|NCT02129777|661339|P1|Double-Blind Period|Pregnancy|0
205939|NCT02129777|661333|P7|Double-Blind Period|Withdrawal by Subject|0
205940|NCT02129777|661334|P6|Double-Blind Period|Withdrawal by Subject|0
205941|NCT02129777|661335|P5|Double-Blind Period|Withdrawal by Subject|3
205942|NCT02129777|661336|P4|Double-Blind Period|Withdrawal by Subject|2
205943|NCT02129777|661337|P3|Double-Blind Period|Withdrawal by Subject|3
205944|NCT02129777|661338|P2|Double-Blind Period|Withdrawal by Subject|4
205945|NCT02129777|661339|P1|Double-Blind Period|Withdrawal by Subject|2
205946|NCT02129777|661333|P7|Double-Blind Period|Lost to Follow-up|0
205947|NCT02129777|661334|P6|Double-Blind Period|Lost to Follow-up|0
205948|NCT02129777|661335|P5|Double-Blind Period|Lost to Follow-up|0
205949|NCT02129777|661336|P4|Double-Blind Period|Lost to Follow-up|2
205950|NCT02129777|661337|P3|Double-Blind Period|Lost to Follow-up|1
205951|NCT02129777|661338|P2|Double-Blind Period|Lost to Follow-up|1
205952|NCT02129777|661339|P1|Double-Blind Period|Lost to Follow-up|1
205953|NCT02129777|661333|P7|Double-Blind Period|Adverse Event|0
205954|NCT02129777|661334|P6|Double-Blind Period|Adverse Event|0
205955|NCT02129777|661335|P5|Double-Blind Period|Adverse Event|1
205956|NCT02129777|661336|P4|Double-Blind Period|Adverse Event|0
205957|NCT02129777|661337|P3|Double-Blind Period|Adverse Event|0
205958|NCT02129777|661338|P2|Double-Blind Period|Adverse Event|0
205959|NCT02129777|661339|P1|Double-Blind Period|Adverse Event|0
205960|NCT02129608|661455|P3|Overall Study|Withdrawal by Subject|2
205961|NCT02129608|661456|P2|Overall Study|Withdrawal by Subject|0
205962|NCT02129608|661457|P1|Overall Study|Withdrawal by Subject|0
205963|NCT02129608|661455|P3|Overall Study|Lost to Follow-up|1
205964|NCT02129608|661456|P2|Overall Study|Lost to Follow-up|1
205965|NCT02129608|661457|P1|Overall Study|Lost to Follow-up|0
205966|NCT02129192|661470|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
205967|NCT02129192|661471|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
205968|NCT02129062|661488|P1|Overall Study|Disease Progression|2
205969|NCT02129062|661488|P1|Overall Study|Death|1
205970|NCT02128542|661508|P2|Overall Study|Withdrew Consent|0
205971|NCT02128542|661509|P1|Overall Study|Withdrew Consent|1
205972|NCT02128542|661508|P2|Overall Study|Lost to Follow-up|0
205973|NCT02128542|661509|P1|Overall Study|Lost to Follow-up|3
205974|NCT02128490|661527|P5|Overall Study|Other Miscellaneous Reasons|1
205975|NCT02128490|661528|P4|Overall Study|Other Miscellaneous Reasons|1
205976|NCT02128490|661529|P3|Overall Study|Other Miscellaneous Reasons|2
205977|NCT02128490|661530|P2|Overall Study|Other Miscellaneous Reasons|0
205978|NCT02128490|661531|P1|Overall Study|Other Miscellaneous Reasons|0
205979|NCT02128490|661527|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
205980|NCT02128490|661528|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
205981|NCT02128490|661529|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
205982|NCT02128490|661530|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
205983|NCT02128490|661531|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
205984|NCT02128490|661527|P5|Overall Study|Lack of Efficacy|0
205985|NCT02128490|661528|P4|Overall Study|Lack of Efficacy|0
205986|NCT02128490|661529|P3|Overall Study|Lack of Efficacy|0
205987|NCT02128490|661530|P2|Overall Study|Lack of Efficacy|1
205988|NCT02128490|661531|P1|Overall Study|Lack of Efficacy|0
205989|NCT02128490|661527|P5|Overall Study|Voluntary Withdrawal|2
205990|NCT02128490|661528|P4|Overall Study|Voluntary Withdrawal|1
205991|NCT02128490|661529|P3|Overall Study|Voluntary Withdrawal|1
205992|NCT02128490|661530|P2|Overall Study|Voluntary Withdrawal|3
205993|NCT02128490|661531|P1|Overall Study|Voluntary Withdrawal|3
205994|NCT02128490|661527|P5|Overall Study|Lost to Follow-up|1
205995|NCT02128490|661528|P4|Overall Study|Lost to Follow-up|1
205996|NCT02128490|661529|P3|Overall Study|Lost to Follow-up|1
205997|NCT02128490|661530|P2|Overall Study|Lost to Follow-up|0
205998|NCT02128490|661531|P1|Overall Study|Lost to Follow-up|0
205999|NCT02128490|661527|P5|Overall Study|Major Protocol Deviation|2
206000|NCT02128490|661528|P4|Overall Study|Major Protocol Deviation|2
206001|NCT02128490|661529|P3|Overall Study|Major Protocol Deviation|0
206002|NCT02128490|661530|P2|Overall Study|Major Protocol Deviation|2
206003|NCT02128490|661531|P1|Overall Study|Major Protocol Deviation|1
206004|NCT02128490|661527|P5|Overall Study|Pretreatment Event/Adverse Event|0
206005|NCT02128490|661528|P4|Overall Study|Pretreatment Event/Adverse Event|1
206006|NCT02128490|661529|P3|Overall Study|Pretreatment Event/Adverse Event|1
206007|NCT02128490|661530|P2|Overall Study|Pretreatment Event/Adverse Event|0
206008|NCT02128490|661531|P1|Overall Study|Pretreatment Event/Adverse Event|1
206009|NCT02127372|661575|P2|Overall Study|Withdrawal by Subject|0
206010|NCT02127372|661576|P1|Overall Study|Withdrawal by Subject|1
206011|NCT02127307|661586|P1|Overall Study|Other than specified above|169
206012|NCT02127307|661586|P1|Overall Study|Death|101
206013|NCT02127307|661586|P1|Overall Study|Lost to Follow-up|2
206014|NCT02127307|661586|P1|Overall Study|Protocol Violation|36
206015|NCT02126839|661592|P2|Overall Study|Not specified|5
206016|NCT02126839|661593|P1|Overall Study|Not specified|5
206017|NCT02126839|661592|P2|Overall Study|Lost to Follow-up|4
206018|NCT02126839|661593|P1|Overall Study|Lost to Follow-up|1
206019|NCT02126839|661592|P2|Overall Study|Sponsor request|1
206020|NCT02126839|661593|P1|Overall Study|Sponsor request|0
206021|NCT02126839|661592|P2|Overall Study|Protocol Violation|3
206022|NCT02126839|661593|P1|Overall Study|Protocol Violation|2
206023|NCT02126839|661592|P2|Overall Study|Withdrawal by parent/guardian|0
206024|NCT02126839|661593|P1|Overall Study|Withdrawal by parent/guardian|1
206025|NCT02126839|661592|P2|Overall Study|Withdrawal by Subject|0
206026|NCT02126839|661593|P1|Overall Study|Withdrawal by Subject|1
206027|NCT02126839|661592|P2|Overall Study|Adverse Event|1
206028|NCT02126839|661593|P1|Overall Study|Adverse Event|0
206029|NCT02126670|661620|P4|Overall Study|Withdrawal by Subject|1
206030|NCT02126670|661621|P3|Overall Study|Withdrawal by Subject|0
206031|NCT02126670|661622|P2|Overall Study|Withdrawal by Subject|0
206032|NCT02126670|661623|P1|Overall Study|Withdrawal by Subject|1
206033|NCT02125877|661675|P2|Overall Study|Adverse Event|4
206034|NCT02125877|661676|P1|Overall Study|Adverse Event|6
206035|NCT02125877|661675|P2|Overall Study|Protocol deviation|1
206036|NCT02125877|661676|P1|Overall Study|Protocol deviation|4
206037|NCT02125877|661675|P2|Overall Study|Withdrawal by Subject|1
206038|NCT02125877|661676|P1|Overall Study|Withdrawal by Subject|2
206039|NCT02125877|661675|P2|Overall Study|Participant/guardian decision|2
206040|NCT02125877|661676|P1|Overall Study|Participant/guardian decision|0
206041|NCT02125877|661675|P2|Overall Study|Administrative problems|1
206042|NCT02125877|661676|P1|Overall Study|Administrative problems|0
206043|NCT02125877|661675|P2|Overall Study|Death|1
206044|NCT02125877|661676|P1|Overall Study|Death|0
206045|NCT02125877|661675|P2|Overall Study|Physician Decision|0
206046|NCT02125877|661676|P1|Overall Study|Physician Decision|1
206047|NCT02125838|661706|P2|Overall Study|Lost to Follow-up|4
206048|NCT02125838|661707|P1|Overall Study|Lost to Follow-up|4
206049|NCT02125734|661725|P2|Period 2|Adverse Event|1
206050|NCT02125734|661726|P1|Period 2|Adverse Event|0
206051|NCT02125604|661736|P1|Overall Study|Adverse Event|20
206052|NCT02125604|661736|P1|Overall Study|Consent Withdrawn|4
206053|NCT02125604|661736|P1|Overall Study|Lost to Follow-up|2
206054|NCT02125604|661736|P1|Overall Study|Investigator Decision|1
206055|NCT02125604|661736|P1|Overall Study|Not Specified|4
206056|NCT02124798|661782|P1|Overall Study|Lost to Follow-up|1
206057|NCT02124798|661782|P1|Overall Study|Adverse Event|3
206058|NCT02124161|661840|P2|Overall Study|Lost to Follow-up|4
206059|NCT02124161|661841|P1|Overall Study|Lost to Follow-up|3
206060|NCT02124161|661840|P2|Overall Study|No longer meets eligibility criteria|4
206061|NCT02124161|661841|P1|Overall Study|No longer meets eligibility criteria|5
206062|NCT02124161|661840|P2|Overall Study|Does not meet entrance criteria|3
206063|NCT02124161|661841|P1|Overall Study|Does not meet entrance criteria|2
206064|NCT02124161|661840|P2|Overall Study|Adverse Event|0
206065|NCT02124161|661841|P1|Overall Study|Adverse Event|2
206066|NCT02124161|661840|P2|Overall Study|Withdrawal by Subject|2
206067|NCT02124161|661841|P1|Overall Study|Withdrawal by Subject|1
206068|NCT02124161|661840|P2|Overall Study|Protocol Violation|1
206069|NCT02124161|661841|P1|Overall Study|Protocol Violation|2
206070|NCT02124161|661840|P2|Overall Study|Death|0
206071|NCT02124161|661841|P1|Overall Study|Death|1
206072|NCT02124161|661840|P2|Overall Study|Other unspecified|1
206073|NCT02124161|661841|P1|Overall Study|Other unspecified|0
206074|NCT02123472|661899|P2|Period 2 (7 Days)|Withdrawal by Subject|1
206075|NCT02123472|661900|P1|Period 2 (7 Days)|Withdrawal by Subject|0
206076|NCT02123459|661910|P2|Washout Period (1 Day)|Adverse Event|0
206077|NCT02123459|661911|P1|Washout Period (1 Day)|Adverse Event|1
206078|NCT02123446|661921|P2|Washout Period (1 Day)|Physician Decision|0
206079|NCT02123446|661922|P1|Washout Period (1 Day)|Physician Decision|1
206080|NCT02121847|661993|P1|Overall Study|Adverse Event|2
206081|NCT02121847|661993|P1|Overall Study|Administrative Reasons|1
206082|NCT02121795|662014|P2|Overall Study|Still in Study up to the Data Cut Date|316
206083|NCT02121795|662015|P1|Overall Study|Still in Study up to the Data Cut Date|315
206084|NCT02121795|662014|P2|Overall Study|Lost to Follow-up|1
206085|NCT02121795|662015|P1|Overall Study|Lost to Follow-up|2
206086|NCT02121795|662014|P2|Overall Study|Withdrew Consent|10
206087|NCT02121795|662015|P1|Overall Study|Withdrew Consent|10
206088|NCT02121795|662014|P2|Overall Study|Protocol Violation|2
206089|NCT02121795|662015|P1|Overall Study|Protocol Violation|0
206090|NCT02121795|662014|P2|Overall Study|Non-Compliance with Study Drug|1
206091|NCT02121795|662015|P1|Overall Study|Non-Compliance with Study Drug|1
206092|NCT02121795|662014|P2|Overall Study|Investigator's Discretion|0
206093|NCT02121795|662015|P1|Overall Study|Investigator's Discretion|1
206094|NCT02121795|662014|P2|Overall Study|Adverse Event|0
206095|NCT02121795|662015|P1|Overall Study|Adverse Event|4
206096|NCT02121795|662014|P2|Overall Study|Randomized but Never Treated|4
206097|NCT02121795|662015|P1|Overall Study|Randomized but Never Treated|1
206098|NCT02121535|662031|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
206099|NCT02121535|662032|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
206100|NCT02121535|662031|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
206101|NCT02121535|662032|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
206102|NCT02121522|662055|P1|Overall Study|Adverse Event|1
206103|NCT02121509|662062|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
206104|NCT02121509|662063|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
206105|NCT02121509|662064|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
206106|NCT02121509|662065|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
206107|NCT02121509|662062|P4|Washout Period (35 Days)|Withdrawal by Subject|0
206108|NCT02121509|662063|P3|Washout Period (35 Days)|Withdrawal by Subject|0
206109|NCT02121509|662064|P2|Washout Period (35 Days)|Withdrawal by Subject|3
206110|NCT02121509|662065|P1|Washout Period (35 Days)|Withdrawal by Subject|0
206111|NCT02121509|662062|P4|Washout Period (35 Days)|Adverse Event|0
206112|NCT02121509|662063|P3|Washout Period (35 Days)|Adverse Event|0
206113|NCT02121509|662064|P2|Washout Period (35 Days)|Adverse Event|1
206114|NCT02121509|662065|P1|Washout Period (35 Days)|Adverse Event|1
206115|NCT02120833|662146|P2|Overall Study|Lost to Follow-up|1
206116|NCT02120833|662147|P1|Overall Study|Lost to Follow-up|1
206117|NCT02120833|662146|P2|Overall Study|Withdrawal by Subject|0
206118|NCT02120833|662147|P1|Overall Study|Withdrawal by Subject|2
206119|NCT02120833|662146|P2|Overall Study|Adverse Event|0
206120|NCT02120833|662147|P1|Overall Study|Adverse Event|1
206121|NCT02120664|662306|P5|Overall Study|Withdrawal by Subject|0
206122|NCT02120664|662307|P4|Overall Study|Withdrawal by Subject|1
206123|NCT02120664|662308|P3|Overall Study|Withdrawal by Subject|0
206124|NCT02120664|662309|P2|Overall Study|Withdrawal by Subject|0
206125|NCT02120664|662310|P1|Overall Study|Withdrawal by Subject|0
206126|NCT02120625|662328|P1|Overall Study|Physician Decision|2
206127|NCT02120300|662345|P4|Overall Study|Lost to Follow-up|0
206128|NCT02120300|662346|P3|Overall Study|Lost to Follow-up|0
206129|NCT02120300|662347|P2|Overall Study|Lost to Follow-up|0
206130|NCT02120300|662348|P1|Overall Study|Lost to Follow-up|1
206131|NCT02120300|662345|P4|Overall Study|Lack of Efficacy|1
206132|NCT02120300|662346|P3|Overall Study|Lack of Efficacy|0
206133|NCT02120300|662347|P2|Overall Study|Lack of Efficacy|0
206134|NCT02120300|662348|P1|Overall Study|Lack of Efficacy|0
206135|NCT02120300|662345|P4|Overall Study|Enrolled but Never Treated|0
206136|NCT02120300|662346|P3|Overall Study|Enrolled but Never Treated|0
206137|NCT02120300|662347|P2|Overall Study|Enrolled but Never Treated|0
206138|NCT02120300|662348|P1|Overall Study|Enrolled but Never Treated|2
206139|NCT02120027|662386|P2|Overall Study|Withdrawal by Subject|25
206140|NCT02120027|662387|P1|Overall Study|Withdrawal by Subject|33
206141|NCT02120027|662386|P2|Overall Study|Study terminated by Sponsor|47
206142|NCT02120027|662387|P1|Overall Study|Study terminated by Sponsor|45
206143|NCT02120027|662386|P2|Overall Study|Protocol Violation|21
206144|NCT02120027|662387|P1|Overall Study|Protocol Violation|18
206145|NCT02120027|662386|P2|Overall Study|Physician Decision|3
206146|NCT02120027|662387|P1|Overall Study|Physician Decision|4
206147|NCT02120027|662386|P2|Overall Study|Other|0
206148|NCT02120027|662387|P1|Overall Study|Other|4
206149|NCT02120027|662386|P2|Overall Study|Lost to Follow-up|13
206150|NCT02120027|662387|P1|Overall Study|Lost to Follow-up|5
206151|NCT02120027|662386|P2|Overall Study|Lack of Efficacy|5
206152|NCT02120027|662387|P1|Overall Study|Lack of Efficacy|3
206153|NCT02120027|662386|P2|Overall Study|Adverse Event|5
206154|NCT02120027|662387|P1|Overall Study|Adverse Event|4
206155|NCT02119676|662416|P4|Overall Study|Did not receive study med|5
206156|NCT02119676|662417|P3|Overall Study|Did not receive study med|4
206157|NCT02119676|662418|P2|Overall Study|Did not receive study med|2
206158|NCT02119676|662419|P1|Overall Study|Did not receive study med|2
206159|NCT02119676|662416|P4|Overall Study|Other, unspecified|4
206160|NCT02119676|662417|P3|Overall Study|Other, unspecified|3
206161|NCT02119676|662418|P2|Overall Study|Other, unspecified|1
206162|NCT02119676|662419|P1|Overall Study|Other, unspecified|2
206163|NCT02119676|662416|P4|Overall Study|Protocol deviation|0
206164|NCT02119676|662417|P3|Overall Study|Protocol deviation|1
206165|NCT02119676|662418|P2|Overall Study|Protocol deviation|0
206166|NCT02119676|662419|P1|Overall Study|Protocol deviation|0
206167|NCT02119676|662416|P4|Overall Study|Lost to Follow-up|0
206168|NCT02119676|662417|P3|Overall Study|Lost to Follow-up|1
206169|NCT02119676|662418|P2|Overall Study|Lost to Follow-up|0
206170|NCT02119676|662419|P1|Overall Study|Lost to Follow-up|0
206171|NCT02119676|662416|P4|Overall Study|Noncompliance|0
206172|NCT02119676|662417|P3|Overall Study|Noncompliance|0
206173|NCT02119676|662418|P2|Overall Study|Noncompliance|1
206174|NCT02119676|662419|P1|Overall Study|Noncompliance|0
206175|NCT02119676|662416|P4|Overall Study|Death|1
206176|NCT02119676|662417|P3|Overall Study|Death|2
206177|NCT02119676|662418|P2|Overall Study|Death|3
206178|NCT02119676|662419|P1|Overall Study|Death|9
206179|NCT02119676|662416|P4|Overall Study|Physician Decision|2
206180|NCT02119676|662417|P3|Overall Study|Physician Decision|3
206181|NCT02119676|662418|P2|Overall Study|Physician Decision|2
206182|NCT02119676|662419|P1|Overall Study|Physician Decision|4
206183|NCT02119676|662416|P4|Overall Study|Patient decision, inc. consent withdrawn|6
206184|NCT02119676|662417|P3|Overall Study|Patient decision, inc. consent withdrawn|5
206185|NCT02119676|662418|P2|Overall Study|Patient decision, inc. consent withdrawn|5
206186|NCT02119676|662419|P1|Overall Study|Patient decision, inc. consent withdrawn|4
206187|NCT02119676|662416|P4|Overall Study|Disease progression|73
206188|NCT02119676|662417|P3|Overall Study|Disease progression|68
206189|NCT02119676|662418|P2|Overall Study|Disease progression|55
206190|NCT02119676|662419|P1|Overall Study|Disease progression|53
206191|NCT02119676|662416|P4|Overall Study|Adverse Event|10
206192|NCT02119676|662417|P3|Overall Study|Adverse Event|10
206193|NCT02119676|662418|P2|Overall Study|Adverse Event|17
206194|NCT02119676|662419|P1|Overall Study|Adverse Event|9
206195|NCT02119663|662451|P2|Overall Study|Study Terminated by the Sponsor|4
206196|NCT02119663|662452|P1|Overall Study|Study Terminated by the Sponsor|3
206197|NCT02119663|662451|P2|Overall Study|Subject decision|1
206198|NCT02119663|662452|P1|Overall Study|Subject decision|0
206199|NCT02119663|662451|P2|Overall Study|Other unspecified|0
206200|NCT02119663|662452|P1|Overall Study|Other unspecified|2
206201|NCT02119663|662451|P2|Overall Study|Physician Decision|2
206202|NCT02119663|662452|P1|Overall Study|Physician Decision|1
206203|NCT02119663|662451|P2|Overall Study|Death|2
206204|NCT02119663|662452|P1|Overall Study|Death|3
206205|NCT02119663|662451|P2|Overall Study|Adverse Event|5
206206|NCT02119663|662452|P1|Overall Study|Adverse Event|5
206207|NCT02119663|662451|P2|Overall Study|Disease progression|27
206208|NCT02119663|662452|P1|Overall Study|Disease progression|26
206209|NCT02119650|662470|P2|Overall Study|Multiple reasons for termination|1
206210|NCT02119650|662471|P1|Overall Study|Multiple reasons for termination|2
206211|NCT02119650|662470|P2|Overall Study|Physician Decision|2
206212|NCT02119650|662471|P1|Overall Study|Physician Decision|0
206213|NCT02119650|662470|P2|Overall Study|Study terminated by the sponsor|0
206214|NCT02119650|662471|P1|Overall Study|Study terminated by the sponsor|1
206215|NCT02119650|662470|P2|Overall Study|Noncompliance with study treatment|1
206216|NCT02119650|662471|P1|Overall Study|Noncompliance with study treatment|1
206217|NCT02119650|662470|P2|Overall Study|Death|1
206218|NCT02119650|662471|P1|Overall Study|Death|5
206219|NCT02119650|662470|P2|Overall Study|Disease progression|14
206220|NCT02119650|662471|P1|Overall Study|Disease progression|11
206221|NCT02119650|662470|P2|Overall Study|Subject decision|3
206222|NCT02119650|662471|P1|Overall Study|Subject decision|2
206223|NCT02119650|662470|P2|Overall Study|Adverse Event|4
206224|NCT02119650|662471|P1|Overall Study|Adverse Event|3
206225|NCT02119325|662485|P2|Washout Period 1|Adverse Event|1
206226|NCT02119325|662486|P1|Washout Period 1|Adverse Event|0
206227|NCT02119286|662533|P3|Overall Study|Withdrawal by Subject|0
206228|NCT02119286|662534|P2|Overall Study|Withdrawal by Subject|1
206229|NCT02119286|662535|P1|Overall Study|Withdrawal by Subject|4
206230|NCT02119286|662533|P3|Overall Study|Lost to Follow-up|1
206231|NCT02119286|662534|P2|Overall Study|Lost to Follow-up|0
206232|NCT02119286|662535|P1|Overall Study|Lost to Follow-up|2
206233|NCT02119286|662533|P3|Overall Study|Lack of Efficacy|4
206234|NCT02119286|662534|P2|Overall Study|Lack of Efficacy|3
206235|NCT02119286|662535|P1|Overall Study|Lack of Efficacy|11
206236|NCT02119286|662533|P3|Overall Study|Adverse Event|2
206237|NCT02119286|662534|P2|Overall Study|Adverse Event|7
206238|NCT02119286|662535|P1|Overall Study|Adverse Event|9
206239|NCT02118961|662548|P2|Overall Study|Withdrawal by Subject|0
206240|NCT02118961|662549|P1|Overall Study|Withdrawal by Subject|1
206241|NCT02118896|662577|P10|Overall Study|Miscellaneous|0
206242|NCT02118896|662578|P9|Overall Study|Miscellaneous|0
206243|NCT02118896|662579|P8|Overall Study|Miscellaneous|0
206244|NCT02118896|662580|P7|Overall Study|Miscellaneous|0
206245|NCT02118896|662581|P6|Overall Study|Miscellaneous|4
206246|NCT02118896|662582|P5|Overall Study|Miscellaneous|0
206247|NCT02118896|662583|P4|Overall Study|Miscellaneous|2
206248|NCT02118896|662584|P3|Overall Study|Miscellaneous|0
206249|NCT02118896|662585|P2|Overall Study|Miscellaneous|2
206250|NCT02118896|662586|P1|Overall Study|Miscellaneous|1
206251|NCT02118896|662577|P10|Overall Study|Prohibited medication|0
206252|NCT02118896|662578|P9|Overall Study|Prohibited medication|0
206253|NCT02118896|662579|P8|Overall Study|Prohibited medication|0
206254|NCT02118896|662580|P7|Overall Study|Prohibited medication|0
206255|NCT02118896|662581|P6|Overall Study|Prohibited medication|3
206256|NCT02118896|662582|P5|Overall Study|Prohibited medication|1
206257|NCT02118896|662583|P4|Overall Study|Prohibited medication|0
206258|NCT02118896|662584|P3|Overall Study|Prohibited medication|0
206259|NCT02118896|662585|P2|Overall Study|Prohibited medication|0
206260|NCT02118896|662586|P1|Overall Study|Prohibited medication|0
206261|NCT02118896|662577|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
206262|NCT02118896|662578|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
206263|NCT02118896|662579|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
206264|NCT02118896|662580|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
206265|NCT02118896|662581|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
206266|NCT02118896|662582|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
206267|NCT02118896|662583|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
206268|NCT02118896|662584|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
206269|NCT02118896|662585|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
206270|NCT02118896|662586|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
206271|NCT02118896|662577|P10|Overall Study|Lost to Follow-up|0
206272|NCT02118896|662578|P9|Overall Study|Lost to Follow-up|0
206273|NCT02118896|662579|P8|Overall Study|Lost to Follow-up|0
206274|NCT02118896|662580|P7|Overall Study|Lost to Follow-up|0
206275|NCT02118896|662581|P6|Overall Study|Lost to Follow-up|1
206276|NCT02118896|662582|P5|Overall Study|Lost to Follow-up|2
206277|NCT02118896|662583|P4|Overall Study|Lost to Follow-up|0
206278|NCT02118896|662584|P3|Overall Study|Lost to Follow-up|1
206279|NCT02118896|662585|P2|Overall Study|Lost to Follow-up|2
206280|NCT02118896|662586|P1|Overall Study|Lost to Follow-up|1
206281|NCT02118896|662577|P10|Overall Study|Pregnancy|0
206282|NCT02118896|662578|P9|Overall Study|Pregnancy|0
206283|NCT02118896|662579|P8|Overall Study|Pregnancy|0
206284|NCT02118896|662580|P7|Overall Study|Pregnancy|1
206285|NCT02118896|662581|P6|Overall Study|Pregnancy|3
206286|NCT02118896|662582|P5|Overall Study|Pregnancy|1
206287|NCT02118896|662583|P4|Overall Study|Pregnancy|0
206288|NCT02118896|662584|P3|Overall Study|Pregnancy|0
206289|NCT02118896|662585|P2|Overall Study|Pregnancy|1
206290|NCT02118896|662586|P1|Overall Study|Pregnancy|1
206291|NCT02118896|662577|P10|Overall Study|Non-compliance|0
206292|NCT02118896|662578|P9|Overall Study|Non-compliance|0
206293|NCT02118896|662579|P8|Overall Study|Non-compliance|1
206294|NCT02118896|662580|P7|Overall Study|Non-compliance|0
206295|NCT02118896|662581|P6|Overall Study|Non-compliance|1
206296|NCT02118896|662582|P5|Overall Study|Non-compliance|0
206297|NCT02118896|662583|P4|Overall Study|Non-compliance|5
206298|NCT02118896|662584|P3|Overall Study|Non-compliance|1
206299|NCT02118896|662585|P2|Overall Study|Non-compliance|1
206300|NCT02118896|662586|P1|Overall Study|Non-compliance|2
206301|NCT02118896|662577|P10|Overall Study|Consent withdrawn|0
206302|NCT02118896|662578|P9|Overall Study|Consent withdrawn|0
206303|NCT02118896|662579|P8|Overall Study|Consent withdrawn|0
206304|NCT02118896|662580|P7|Overall Study|Consent withdrawn|0
206305|NCT02118896|662581|P6|Overall Study|Consent withdrawn|4
206306|NCT02118896|662582|P5|Overall Study|Consent withdrawn|1
206307|NCT02118896|662583|P4|Overall Study|Consent withdrawn|4
206308|NCT02118896|662584|P3|Overall Study|Consent withdrawn|3
206309|NCT02118896|662585|P2|Overall Study|Consent withdrawn|0
206310|NCT02118896|662586|P1|Overall Study|Consent withdrawn|2
206311|NCT02118896|662577|P10|Overall Study|Adverse Event|0
206312|NCT02118896|662578|P9|Overall Study|Adverse Event|4
206313|NCT02118896|662579|P8|Overall Study|Adverse Event|1
206314|NCT02118896|662580|P7|Overall Study|Adverse Event|1
206315|NCT02118896|662581|P6|Overall Study|Adverse Event|9
206316|NCT02118896|662582|P5|Overall Study|Adverse Event|5
206317|NCT02118896|662583|P4|Overall Study|Adverse Event|5
206318|NCT02118896|662584|P3|Overall Study|Adverse Event|4
206319|NCT02118896|662585|P2|Overall Study|Adverse Event|4
206320|NCT02118896|662586|P1|Overall Study|Adverse Event|5
206321|NCT02118896|662577|P10|Overall Study|Death|0
206322|NCT02118896|662578|P9|Overall Study|Death|0
206323|NCT02118896|662579|P8|Overall Study|Death|0
206324|NCT02118896|662580|P7|Overall Study|Death|0
206325|NCT02118896|662581|P6|Overall Study|Death|1
206326|NCT02118896|662582|P5|Overall Study|Death|3
206327|NCT02118896|662583|P4|Overall Study|Death|6
206328|NCT02118896|662584|P3|Overall Study|Death|4
206329|NCT02118896|662585|P2|Overall Study|Death|0
206330|NCT02118896|662586|P1|Overall Study|Death|4
206331|NCT02118792|662676|P2|Overall Study|Randomised but not treated|0
206332|NCT02118792|662677|P1|Overall Study|Randomised but not treated|1
206333|NCT02118792|662676|P2|Overall Study|Unspecified|6
206334|NCT02118792|662677|P1|Overall Study|Unspecified|1
206335|NCT02118792|662676|P2|Overall Study|Withdrawal by parent/guardian|20
206336|NCT02118792|662677|P1|Overall Study|Withdrawal by parent/guardian|14
206337|NCT02118792|662676|P2|Overall Study|Adverse Event|4
206338|NCT02118792|662677|P1|Overall Study|Adverse Event|5
206339|NCT02118792|662676|P2|Overall Study|Lost to Follow-up|4
206340|NCT02118792|662677|P1|Overall Study|Lost to Follow-up|4
206341|NCT02118792|662676|P2|Overall Study|Withdrawal by Subject|3
206342|NCT02118792|662677|P1|Overall Study|Withdrawal by Subject|6
206343|NCT02118766|662719|P2|Overall Study|Unspecified|1
206344|NCT02118766|662720|P1|Overall Study|Unspecified|3
206345|NCT02118766|662719|P2|Overall Study|Withdrawal by parent/guardian|18
206346|NCT02118766|662720|P1|Overall Study|Withdrawal by parent/guardian|12
206347|NCT02118766|662719|P2|Overall Study|Lost to Follow-up|4
206348|NCT02118766|662720|P1|Overall Study|Lost to Follow-up|5
206349|NCT02118766|662719|P2|Overall Study|Withdrawal by Subject|6
206350|NCT02118766|662720|P1|Overall Study|Withdrawal by Subject|3
206351|NCT02118766|662719|P2|Overall Study|Adverse Event|2
206352|NCT02118766|662720|P1|Overall Study|Adverse Event|7
206353|NCT02118597|662742|P1|Overall Study|Investigator's decision|1
206354|NCT02118597|662742|P1|Overall Study|Serious Adverse Event|1
206355|NCT02118597|662742|P1|Overall Study|Sponsor terminated the study|14
206356|NCT02117687|662773|P2|Overall Study|Other Reasons|1
206357|NCT02117687|662774|P1|Overall Study|Other Reasons|1
206358|NCT02117687|662773|P2|Overall Study|Adverse Event|2
206359|NCT02117687|662774|P1|Overall Study|Adverse Event|0
206360|NCT02117687|662773|P2|Overall Study|Lost to Follow-up|1
206361|NCT02117687|662774|P1|Overall Study|Lost to Follow-up|0
206362|NCT02117570|662809|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
206363|NCT02117570|662810|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
206364|NCT02117570|662811|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
206365|NCT02117570|662809|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
206366|NCT02117570|662810|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
206367|NCT02117570|662811|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
206368|NCT02117570|662809|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
206369|NCT02117570|662810|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
206370|NCT02117570|662811|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
206371|NCT02117570|662809|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
206372|NCT02117570|662810|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
206373|NCT02117570|662811|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
206374|NCT02117570|662809|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
206375|NCT02117570|662810|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
206376|NCT02117570|662811|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
206377|NCT02117570|662809|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
206378|NCT02117570|662810|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
206379|NCT02117570|662811|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
206380|NCT02117570|662809|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
206381|NCT02117570|662810|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
206382|NCT02117570|662811|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
206383|NCT02117544|662861|P2|Period 1|Lost to follow-up (prior to treatment)|0
206384|NCT02117544|662862|P1|Period 1|Lost to follow-up (prior to treatment)|2
206385|NCT02117414|662877|P2|Overall Study|Withdrawal by Subject|4
206386|NCT02117414|662878|P1|Overall Study|Withdrawal by Subject|10
206387|NCT02117414|662877|P2|Overall Study|Death|2
206388|NCT02117414|662878|P1|Overall Study|Death|5
206389|NCT02117050|662922|P1|Overall Study|Subject Enrolled but not Dosed|1
206390|NCT02116582|662934|P1|Overall Study|Other: Miscellaneous|9
206391|NCT02116582|662934|P1|Overall Study|Withdrawal by Subject|8
206392|NCT02116582|662934|P1|Overall Study|Protocol Violation|3
206393|NCT02116582|662934|P1|Overall Study|Progressive Disease|140
206394|NCT02116582|662934|P1|Overall Study|Death|7
206395|NCT02116582|662934|P1|Overall Study|Adverse Event|17
206396|NCT02116582|662934|P1|Overall Study|Enrolled but Never Received Study Drug|1
206397|NCT02116530|662944|P2|Overall Study|Other Medical Problems|2
206398|NCT02116530|662945|P1|Overall Study|Other Medical Problems|2
206399|NCT02116530|662944|P2|Overall Study|Lost to Follow-up|0
206400|NCT02116530|662945|P1|Overall Study|Lost to Follow-up|1
206401|NCT02116530|662944|P2|Overall Study|Physician Decision|0
206402|NCT02116530|662945|P1|Overall Study|Physician Decision|1
206403|NCT02116530|662944|P2|Overall Study|Adverse Event|0
206404|NCT02116530|662945|P1|Overall Study|Adverse Event|4
206405|NCT02116530|662944|P2|Overall Study|Withdrawal by Subject|2
206406|NCT02116530|662945|P1|Overall Study|Withdrawal by Subject|1
206407|NCT02115815|662975|P7|Overall Study|Missed appointment, randomized in error|0
206408|NCT02115815|662976|P6|Overall Study|Missed appointment, randomized in error|1
206409|NCT02115815|662977|P5|Overall Study|Missed appointment, randomized in error|0
206410|NCT02115815|662978|P4|Overall Study|Missed appointment, randomized in error|0
206411|NCT02115815|662979|P3|Overall Study|Missed appointment, randomized in error|0
206412|NCT02115815|662980|P2|Overall Study|Missed appointment, randomized in error|0
206413|NCT02115815|662981|P1|Overall Study|Missed appointment, randomized in error|0
206414|NCT02115815|662975|P7|Overall Study|Not enough drug to dose participant|0
206415|NCT02115815|662976|P6|Overall Study|Not enough drug to dose participant|1
206416|NCT02115815|662977|P5|Overall Study|Not enough drug to dose participant|0
206417|NCT02115815|662978|P4|Overall Study|Not enough drug to dose participant|0
206418|NCT02115815|662979|P3|Overall Study|Not enough drug to dose participant|0
206419|NCT02115815|662980|P2|Overall Study|Not enough drug to dose participant|0
206420|NCT02115815|662981|P1|Overall Study|Not enough drug to dose participant|0
206421|NCT02115815|662975|P7|Overall Study|Withdrawal by Subject|0
206422|NCT02115815|662976|P6|Overall Study|Withdrawal by Subject|0
206423|NCT02115815|662977|P5|Overall Study|Withdrawal by Subject|0
206424|NCT02115815|662978|P4|Overall Study|Withdrawal by Subject|0
206425|NCT02115815|662979|P3|Overall Study|Withdrawal by Subject|0
206426|NCT02115815|662980|P2|Overall Study|Withdrawal by Subject|0
206427|NCT02115815|662981|P1|Overall Study|Withdrawal by Subject|2
206428|NCT02115321|663089|P2|Overall Study|Death|0
206429|NCT02115321|663090|P1|Overall Study|Death|1
206430|NCT02115256|663112|P2|Overall Study|Withdrawal by Subject|1
206431|NCT02115256|663113|P1|Overall Study|Withdrawal by Subject|0
206432|NCT02114931|663127|P2|Overall Study|Other|1
206433|NCT02114931|663128|P1|Overall Study|Other|2
206434|NCT02114931|663127|P2|Overall Study|Physician Decision|2
206435|NCT02114931|663128|P1|Overall Study|Physician Decision|1
206436|NCT02114931|663127|P2|Overall Study|Lost to Follow-up|3
206437|NCT02114931|663128|P1|Overall Study|Lost to Follow-up|3
206438|NCT02114931|663127|P2|Overall Study|Adverse Event|6
206439|NCT02114931|663128|P1|Overall Study|Adverse Event|4
206440|NCT02114931|663127|P2|Overall Study|Withdrawal by Subject|18
206441|NCT02114931|663128|P1|Overall Study|Withdrawal by Subject|15
206442|NCT02114892|663144|P2|Overall Study|Lost to Follow-up|2
206443|NCT02114892|663145|P1|Overall Study|Lost to Follow-up|1
206444|NCT02114268|663185|P6|Overall Study|Withdrawn by site due to noncompliance|0
206445|NCT02114268|663186|P5|Overall Study|Withdrawn by site due to noncompliance|0
206446|NCT02114268|663187|P4|Overall Study|Withdrawn by site due to noncompliance|0
206447|NCT02114268|663188|P3|Overall Study|Withdrawn by site due to noncompliance|0
206448|NCT02114268|663189|P2|Overall Study|Withdrawn by site due to noncompliance|0
206449|NCT02114268|663190|P1|Overall Study|Withdrawn by site due to noncompliance|1
206450|NCT02114268|663185|P6|Overall Study|Withdrawal by Subject|1
206451|NCT02114268|663186|P5|Overall Study|Withdrawal by Subject|0
206452|NCT02114268|663187|P4|Overall Study|Withdrawal by Subject|0
206453|NCT02114268|663188|P3|Overall Study|Withdrawal by Subject|0
206454|NCT02114268|663189|P2|Overall Study|Withdrawal by Subject|0
206455|NCT02114268|663190|P1|Overall Study|Withdrawal by Subject|1
206456|NCT02114268|663185|P6|Overall Study|Lost to Follow-up|2
206457|NCT02114268|663186|P5|Overall Study|Lost to Follow-up|0
206458|NCT02114268|663187|P4|Overall Study|Lost to Follow-up|0
206459|NCT02114268|663188|P3|Overall Study|Lost to Follow-up|1
206460|NCT02114268|663189|P2|Overall Study|Lost to Follow-up|1
206461|NCT02114268|663190|P1|Overall Study|Lost to Follow-up|4
206462|NCT02114177|663258|P2|Overall Study|Unspecified|1
206463|NCT02114177|663259|P1|Overall Study|Unspecified|2
206464|NCT02114177|663258|P2|Overall Study|Withdrawal by Subject|1
206465|NCT02114177|663259|P1|Overall Study|Withdrawal by Subject|6
206466|NCT02114177|663258|P2|Overall Study|Lost to Follow-up|2
206467|NCT02114177|663259|P1|Overall Study|Lost to Follow-up|1
206468|NCT02114151|663283|P1|Overall Study|Withdrawal by Subject|5
206469|NCT02114151|663283|P1|Overall Study|Lost to Follow-up|1
206470|NCT02114151|663283|P1|Overall Study|Death|1
206471|NCT02113579|663300|P2|Overall Study|Lost to Follow-up|2
206472|NCT02113579|663301|P1|Overall Study|Lost to Follow-up|6
206473|NCT02113579|663300|P2|Overall Study|Withdrawal by Subject|2
206474|NCT02113579|663301|P1|Overall Study|Withdrawal by Subject|3
206475|NCT02113579|663300|P2|Overall Study|Adverse Event|0
206476|NCT02113579|663301|P1|Overall Study|Adverse Event|1
206477|NCT02113449|663325|P1|Overall Study|Adverse Event|4
206478|NCT02113436|663341|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
206479|NCT02113436|663342|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
206480|NCT02113436|663343|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
206481|NCT02113436|663344|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
206482|NCT02113436|663341|P4|Period 2: 16 Weeks|Physician Decision|0
206483|NCT02113436|663342|P3|Period 2: 16 Weeks|Physician Decision|2
206484|NCT02113436|663343|P2|Period 2: 16 Weeks|Physician Decision|0
206485|NCT02113436|663344|P1|Period 2: 16 Weeks|Physician Decision|0
206486|NCT02113436|663341|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
206487|NCT02113436|663342|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
206488|NCT02113436|663343|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
206489|NCT02113436|663344|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
206490|NCT02113436|663341|P4|Period 2: 16 Weeks|Adverse Event|5
206491|NCT02113436|663342|P3|Period 2: 16 Weeks|Adverse Event|4
206492|NCT02113436|663343|P2|Period 2: 16 Weeks|Adverse Event|0
206493|NCT02113436|663344|P1|Period 2: 16 Weeks|Adverse Event|0
206494|NCT02113436|663341|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
206495|NCT02113436|663342|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
206496|NCT02113436|663343|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
206497|NCT02113436|663344|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
206498|NCT02113436|663341|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
206499|NCT02113436|663342|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
206500|NCT02113436|663343|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
206584|NCT02107196|663652|P1|12-week Treatment Period|Reason Missing|11
206501|NCT02113436|663344|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
206502|NCT02113436|663341|P4|Period 1: 8 Weeks|Protocol Violation|0
206503|NCT02113436|663342|P3|Period 1: 8 Weeks|Protocol Violation|0
206504|NCT02113436|663343|P2|Period 1: 8 Weeks|Protocol Violation|0
206505|NCT02113436|663344|P1|Period 1: 8 Weeks|Protocol Violation|1
206506|NCT02113436|663341|P4|Period 1: 8 Weeks|Adverse Event|0
206507|NCT02113436|663342|P3|Period 1: 8 Weeks|Adverse Event|0
206508|NCT02113436|663343|P2|Period 1: 8 Weeks|Adverse Event|0
206509|NCT02113436|663344|P1|Period 1: 8 Weeks|Adverse Event|1
206510|NCT02113124|663367|P2|Overall Study|Unable to retrieve blood sample|1
206511|NCT02113124|663368|P1|Overall Study|Unable to retrieve blood sample|1
206512|NCT02113007|663374|P1|Overall Study|Progressive disease|2
206513|NCT02112448|663382|P2|Overall Study|required heparin so could not use ketoro|0
206514|NCT02112448|663383|P1|Overall Study|required heparin so could not use ketoro|1
206515|NCT02112448|663382|P2|Overall Study|Physician Decision|6
206516|NCT02112448|663383|P1|Overall Study|Physician Decision|4
206517|NCT02112448|663382|P2|Overall Study|Protocol Violation|2
206518|NCT02112448|663383|P1|Overall Study|Protocol Violation|1
206519|NCT02112448|663382|P2|Overall Study|lab values precluding use of ketorolac|2
206520|NCT02112448|663383|P1|Overall Study|lab values precluding use of ketorolac|2
206521|NCT02111603|663391|P1|Overall Study|Withdrawal by Subject|1
206522|NCT02111369|663400|P1|Overall Study|Withdrawal by Subject|1
206523|NCT02111369|663400|P1|Overall Study|Lost to Follow-up|2
206524|NCT02111083|663424|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
206525|NCT02111083|663425|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
206526|NCT02110238|663459|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
206527|NCT02110238|663460|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
206528|NCT02110238|663459|P2|14 Week Blinded Extension Phase|Protocol Violation|3
206529|NCT02110238|663460|P1|14 Week Blinded Extension Phase|Protocol Violation|2
206530|NCT02110238|663459|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
206531|NCT02110238|663460|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
206532|NCT02110238|663459|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
206533|NCT02110238|663460|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
206534|NCT02110238|663459|P2|14 Week Blinded Extension Phase|Adverse Event|1
206535|NCT02110238|663460|P1|14 Week Blinded Extension Phase|Adverse Event|1
206536|NCT02110238|663459|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
206537|NCT02110238|663460|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
206538|NCT02110238|663459|P2|12 Week Pivotal Phase|Protocol Violation|1
206539|NCT02110238|663460|P1|12 Week Pivotal Phase|Protocol Violation|0
206540|NCT02110238|663459|P2|12 Week Pivotal Phase|Physician Decision|2
206541|NCT02110238|663460|P1|12 Week Pivotal Phase|Physician Decision|0
206542|NCT02110238|663459|P2|12 Week Pivotal Phase|Lost to Follow-up|0
206543|NCT02110238|663460|P1|12 Week Pivotal Phase|Lost to Follow-up|2
206544|NCT02110238|663459|P2|12 Week Pivotal Phase|Lack of Efficacy|3
206545|NCT02110238|663460|P1|12 Week Pivotal Phase|Lack of Efficacy|2
206546|NCT02110238|663459|P2|12 Week Pivotal Phase|Adverse Event|0
206547|NCT02110238|663460|P1|12 Week Pivotal Phase|Adverse Event|3
206548|NCT02109445|663495|P1|Overall Study|Adverse Event|1
206549|NCT02109445|663495|P1|Overall Study|Symptomatic deterioration|2
206550|NCT02109172|663528|P6|Overall Study|Death|0
206551|NCT02109172|663529|P5|Overall Study|Death|1
206552|NCT02109172|663530|P4|Overall Study|Death|0
206553|NCT02109172|663531|P3|Overall Study|Death|0
206554|NCT02109172|663532|P2|Overall Study|Death|0
206555|NCT02109172|663533|P1|Overall Study|Death|0
206556|NCT02109172|663528|P6|Overall Study|Adverse Event|1
206557|NCT02109172|663529|P5|Overall Study|Adverse Event|0
206558|NCT02109172|663530|P4|Overall Study|Adverse Event|0
206559|NCT02109172|663531|P3|Overall Study|Adverse Event|1
206560|NCT02109172|663532|P2|Overall Study|Adverse Event|0
206561|NCT02109172|663533|P1|Overall Study|Adverse Event|0
206562|NCT02109172|663528|P6|Overall Study|Withdrawal by Subject|0
206563|NCT02109172|663529|P5|Overall Study|Withdrawal by Subject|0
206564|NCT02109172|663530|P4|Overall Study|Withdrawal by Subject|1
206565|NCT02109172|663531|P3|Overall Study|Withdrawal by Subject|0
206566|NCT02109172|663532|P2|Overall Study|Withdrawal by Subject|0
206567|NCT02109172|663533|P1|Overall Study|Withdrawal by Subject|1
206568|NCT02109133|663554|P2|Overall Study|Lost to Follow-up|0
206569|NCT02109133|663555|P1|Overall Study|Lost to Follow-up|1
206570|NCT02109107|663567|P1|Overall Study|Lost to Follow-up|2
206571|NCT02108652|663610|P1|Overall Study|Ongoing at data cutoff 14 September 2015|108
206572|NCT02108652|663610|P1|Overall Study|Withdrawal by Subject|8
206573|NCT02108652|663610|P1|Overall Study|Unspecified|1
206574|NCT02108652|663610|P1|Overall Study|Death|193
206575|NCT02107196|663651|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
206576|NCT02107196|663652|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
206577|NCT02107196|663651|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
206578|NCT02107196|663652|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
206579|NCT02107196|663651|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
206580|NCT02107196|663652|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
206581|NCT02107196|663651|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
206582|NCT02107196|663652|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
206583|NCT02107196|663651|P2|12-week Treatment Period|Reason Missing|8
206585|NCT02107196|663651|P2|12-week Treatment Period|Protocol Violation|8
206586|NCT02107196|663652|P1|12-week Treatment Period|Protocol Violation|7
206587|NCT02107196|663651|P2|12-week Treatment Period|Withdrawal by Subject|12
206588|NCT02107196|663652|P1|12-week Treatment Period|Withdrawal by Subject|15
206589|NCT02107196|663651|P2|12-week Treatment Period|Physician Decision|1
206590|NCT02107196|663652|P1|12-week Treatment Period|Physician Decision|0
206591|NCT02107196|663651|P2|12-week Treatment Period|Lost to Follow-up|6
206592|NCT02107196|663652|P1|12-week Treatment Period|Lost to Follow-up|3
206593|NCT02107196|663651|P2|12-week Treatment Period|Lack of Efficacy|1
206594|NCT02107196|663652|P1|12-week Treatment Period|Lack of Efficacy|2
206595|NCT02107196|663651|P2|12-week Treatment Period|Adverse Event|3
206596|NCT02107196|663652|P1|12-week Treatment Period|Adverse Event|6
206597|NCT02107898|663795|P2|Overall Study|Randomized but not treated|1
206598|NCT02107898|663796|P1|Overall Study|Randomized but not treated|0
206599|NCT02107898|663795|P2|Overall Study|Consent withdrawn by participant|1
206600|NCT02107898|663796|P1|Overall Study|Consent withdrawn by participant|2
206601|NCT02107898|663795|P2|Overall Study|Participant moved|2
206602|NCT02107898|663796|P1|Overall Study|Participant moved|0
206603|NCT02107898|663795|P2|Overall Study|Poor compliance to protocol|1
206604|NCT02107898|663796|P1|Overall Study|Poor compliance to protocol|0
206605|NCT02107898|663795|P2|Overall Study|Adverse Event|7
206606|NCT02107898|663796|P1|Overall Study|Adverse Event|4
206607|NCT02107482|663855|P1|Overall Study|Lack of Efficacy|1
206608|NCT02107482|663855|P1|Overall Study|Lost to Follow-up|1
206609|NCT02107482|663855|P1|Overall Study|inconveinence|2
206610|NCT02107313|663892|P2|Overall Study|One participant did not do the FED cohor|1
206611|NCT02107313|663893|P1|Overall Study|One participant did not do the FED cohor|0
206612|NCT02107274|663903|P2|Control Phase|Adverse Event|1
206613|NCT02107274|663904|P1|Control Phase|Adverse Event|0
206614|NCT02107274|663903|P2|Control Phase|Death|0
206615|NCT02107274|663904|P1|Control Phase|Death|2
206616|NCT02107274|663903|P2|Control Phase|Lost to Follow-up|1
206617|NCT02107274|663904|P1|Control Phase|Lost to Follow-up|1
206618|NCT02107274|663903|P2|Treatment vs. Placebo|Lost to Follow-up|2
206619|NCT02107274|663904|P1|Treatment vs. Placebo|Lost to Follow-up|0
206620|NCT02107274|663903|P2|Treatment vs. Placebo|Adverse Event|0
206621|NCT02107274|663904|P1|Treatment vs. Placebo|Adverse Event|3
206622|NCT02107014|663916|P1|Overall Study|Withdrew before drug: moving interstate|1
206623|NCT02106923|663987|P6|Overall Study|Protocol Violation|1
206624|NCT02106923|663988|P5|Overall Study|Protocol Violation|0
206625|NCT02106923|663989|P4|Overall Study|Protocol Violation|0
206626|NCT02106923|663990|P3|Overall Study|Protocol Violation|0
206627|NCT02106923|663991|P2|Overall Study|Protocol Violation|0
206628|NCT02106923|663992|P1|Overall Study|Protocol Violation|0
206629|NCT02106403|664070|P6|Follow-Up Visit 3|Other Reason|1
206630|NCT02106403|664071|P5|Follow-Up Visit 3|Other Reason|0
206631|NCT02106403|664072|P4|Follow-Up Visit 3|Other Reason|0
206632|NCT02106403|664073|P3|Follow-Up Visit 3|Other Reason|0
206633|NCT02106403|664074|P2|Follow-Up Visit 3|Other Reason|0
206634|NCT02106403|664075|P1|Follow-Up Visit 3|Other Reason|0
206635|NCT02106156|664098|P3|Overall Study|Relocation/Change of Physician|0
206636|NCT02106156|664099|P2|Overall Study|Relocation/Change of Physician|1
206637|NCT02106156|664100|P1|Overall Study|Relocation/Change of Physician|40
206638|NCT02106156|664098|P3|Overall Study|Hospitalization/Surgical Intervention|0
206639|NCT02106156|664099|P2|Overall Study|Hospitalization/Surgical Intervention|0
206640|NCT02106156|664100|P1|Overall Study|Hospitalization/Surgical Intervention|6
206641|NCT02106156|664098|P3|Overall Study|Change of Laboratory Parameter|0
206642|NCT02106156|664099|P2|Overall Study|Change of Laboratory Parameter|0
206643|NCT02106156|664100|P1|Overall Study|Change of Laboratory Parameter|10
206644|NCT02106156|664098|P3|Overall Study|Unplanned Event|0
206645|NCT02106156|664099|P2|Overall Study|Unplanned Event|2
206646|NCT02106156|664100|P1|Overall Study|Unplanned Event|82
206647|NCT02106156|664098|P3|Overall Study|Lost to Follow-up|0
206648|NCT02106156|664099|P2|Overall Study|Lost to Follow-up|8
206649|NCT02106156|664100|P1|Overall Study|Lost to Follow-up|451
206650|NCT02106156|664098|P3|Overall Study|Patients Request|0
206651|NCT02106156|664099|P2|Overall Study|Patients Request|9
206652|NCT02106156|664100|P1|Overall Study|Patients Request|307
206653|NCT02106156|664098|P3|Overall Study|Lack of Compliance|0
206654|NCT02106156|664099|P2|Overall Study|Lack of Compliance|7
206655|NCT02106156|664100|P1|Overall Study|Lack of Compliance|211
206656|NCT02106156|664098|P3|Overall Study|Concomitant Disease|0
206657|NCT02106156|664099|P2|Overall Study|Concomitant Disease|2
206658|NCT02106156|664100|P1|Overall Study|Concomitant Disease|74
206659|NCT02106156|664098|P3|Overall Study|Lack of Virological Response|0
206660|NCT02106156|664099|P2|Overall Study|Lack of Virological Response|8
206661|NCT02106156|664100|P1|Overall Study|Lack of Virological Response|1044
206662|NCT02106156|664098|P3|Overall Study|Lack of Tolerability|0
206663|NCT02106156|664099|P2|Overall Study|Lack of Tolerability|3
206664|NCT02106156|664100|P1|Overall Study|Lack of Tolerability|305
206665|NCT02106156|664098|P3|Overall Study|Patient Died|0
206666|NCT02106156|664099|P2|Overall Study|Patient Died|0
206667|NCT02106156|664100|P1|Overall Study|Patient Died|19
206668|NCT02105987|664124|P6|Continuation Phase|Protocol Violation|0
206669|NCT02105987|664125|P5|Continuation Phase|Protocol Violation|1
206670|NCT02105987|664126|P4|Continuation Phase|Protocol Violation|0
206671|NCT02105987|664127|P3|Continuation Phase|Protocol Violation|0
206672|NCT02105987|664128|P2|Continuation Phase|Protocol Violation|0
206673|NCT02105987|664129|P1|Continuation Phase|Protocol Violation|0
206674|NCT02105987|664124|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
206675|NCT02105987|664125|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
206676|NCT02105987|664126|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
206677|NCT02105987|664127|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
206678|NCT02105987|664128|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
206679|NCT02105987|664129|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
206680|NCT02105987|664124|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
206681|NCT02105987|664125|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
206682|NCT02105987|664126|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
206683|NCT02105987|664127|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
206684|NCT02105987|664128|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
206685|NCT02105987|664129|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
206686|NCT02105987|664124|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
206687|NCT02105987|664125|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
206688|NCT02105987|664126|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
206689|NCT02105987|664127|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
206690|NCT02105987|664128|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
206691|NCT02105987|664129|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
206692|NCT02105987|664124|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
206693|NCT02105987|664125|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
206694|NCT02105987|664126|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
206695|NCT02105987|664127|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
206696|NCT02105987|664128|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
206697|NCT02105987|664129|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
206698|NCT02105987|664124|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
206699|NCT02105987|664125|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
206700|NCT02105987|664126|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
206701|NCT02105987|664127|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
206702|NCT02105987|664128|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
206703|NCT02105987|664129|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
206704|NCT02105987|664124|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
206705|NCT02105987|664125|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
206706|NCT02105987|664126|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
206707|NCT02105987|664127|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
206708|NCT02105987|664128|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
206709|NCT02105987|664129|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
206710|NCT02105987|664124|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
206711|NCT02105987|664125|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
206712|NCT02105987|664126|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
206713|NCT02105987|664127|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
206714|NCT02105987|664128|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
206715|NCT02105987|664129|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
206716|NCT02105987|664124|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
206717|NCT02105987|664125|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
206718|NCT02105987|664126|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
206719|NCT02105987|664127|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
206720|NCT02105987|664128|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
206721|NCT02105987|664129|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
206722|NCT02105987|664124|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
206723|NCT02105987|664125|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
206724|NCT02105987|664126|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
206725|NCT02105987|664127|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
206726|NCT02105987|664128|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
206727|NCT02105987|664129|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
206728|NCT02105987|664124|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
206729|NCT02105987|664125|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
206730|NCT02105987|664126|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
206731|NCT02105987|664127|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
206732|NCT02105987|664128|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
206733|NCT02105987|664129|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
206734|NCT02105987|664124|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
206735|NCT02105987|664125|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
206736|NCT02105987|664126|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
206737|NCT02105987|664127|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
206738|NCT02105987|664128|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
206739|NCT02105987|664129|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
206740|NCT02105987|664124|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
206741|NCT02105987|664125|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
206742|NCT02105987|664126|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
206743|NCT02105987|664127|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
206744|NCT02105987|664128|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
206745|NCT02105987|664129|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
206746|NCT02105987|664124|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
206747|NCT02105987|664125|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
206748|NCT02105987|664126|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
206749|NCT02105987|664127|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
206750|NCT02105987|664128|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
206751|NCT02105987|664129|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
206752|NCT02105974|664183|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
206753|NCT02105974|664184|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
206754|NCT02105974|664185|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
206755|NCT02105974|664183|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
206756|NCT02105974|664184|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
206757|NCT02105974|664185|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
206758|NCT02105974|664183|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
206759|NCT02105974|664184|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
206760|NCT02105974|664185|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
206761|NCT02105974|664183|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
206762|NCT02105974|664184|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
206763|NCT02105974|664185|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
206764|NCT02105974|664183|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
206765|NCT02105974|664184|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
206766|NCT02105974|664185|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
206767|NCT02105974|664183|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
206768|NCT02105974|664184|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
206769|NCT02105974|664185|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
206770|NCT02105974|664183|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
206771|NCT02105974|664184|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
206772|NCT02105974|664185|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
206773|NCT02105974|664183|P3|2 Week Run-in Period|Investigator discretion|0
206774|NCT02105974|664184|P2|2 Week Run-in Period|Investigator discretion|0
206775|NCT02105974|664185|P1|2 Week Run-in Period|Investigator discretion|8
206776|NCT02105974|664183|P3|2 Week Run-in Period|Withdrew consent|0
206777|NCT02105974|664184|P2|2 Week Run-in Period|Withdrew consent|0
206778|NCT02105974|664185|P1|2 Week Run-in Period|Withdrew consent|23
206779|NCT02105974|664183|P3|2 Week Run-in Period|Lost to Follow-up|0
206780|NCT02105974|664184|P2|2 Week Run-in Period|Lost to Follow-up|0
206781|NCT02105974|664185|P1|2 Week Run-in Period|Lost to Follow-up|2
206782|NCT02105974|664183|P3|2 Week Run-in Period|Study closed/terminated|0
206783|NCT02105974|664184|P2|2 Week Run-in Period|Study closed/terminated|0
206784|NCT02105974|664185|P1|2 Week Run-in Period|Study closed/terminated|1
206785|NCT02105974|664183|P3|2 Week Run-in Period|Adverse Event|0
206786|NCT02105974|664184|P2|2 Week Run-in Period|Adverse Event|0
206787|NCT02105974|664185|P1|2 Week Run-in Period|Adverse Event|6
206788|NCT02105974|664183|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
206789|NCT02105974|664184|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
206790|NCT02105974|664185|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
206791|NCT02105974|664183|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
206792|NCT02105974|664184|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
206793|NCT02105974|664185|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
206794|NCT02105701|664210|P4|Overall Study|Death|0
206795|NCT02105701|664211|P3|Overall Study|Death|0
206796|NCT02105701|664212|P2|Overall Study|Death|0
206797|NCT02105701|664213|P1|Overall Study|Death|1
206798|NCT02105701|664210|P4|Overall Study|Withdrawal by Subject|1
206799|NCT02105701|664211|P3|Overall Study|Withdrawal by Subject|0
206800|NCT02105701|664212|P2|Overall Study|Withdrawal by Subject|1
206801|NCT02105701|664213|P1|Overall Study|Withdrawal by Subject|2
206802|NCT02105701|664210|P4|Overall Study|Protocol Violation|0
206803|NCT02105701|664211|P3|Overall Study|Protocol Violation|1
206804|NCT02105701|664212|P2|Overall Study|Protocol Violation|0
206805|NCT02105701|664213|P1|Overall Study|Protocol Violation|0
206806|NCT02105701|664210|P4|Overall Study|Lost to Follow-up|1
206807|NCT02105701|664211|P3|Overall Study|Lost to Follow-up|2
206808|NCT02105701|664212|P2|Overall Study|Lost to Follow-up|0
206809|NCT02105701|664213|P1|Overall Study|Lost to Follow-up|1
206810|NCT02105688|664237|P2|Overall Study|Withdrawal by Subject|2
206811|NCT02105688|664238|P1|Overall Study|Withdrawal by Subject|4
206812|NCT02105688|664237|P2|Overall Study|Protocol Violation|1
206813|NCT02105688|664238|P1|Overall Study|Protocol Violation|0
206814|NCT02105688|664237|P2|Overall Study|Physician Decision|1
206815|NCT02105688|664238|P1|Overall Study|Physician Decision|0
206816|NCT02105688|664237|P2|Overall Study|Lost to Follow-up|4
206817|NCT02105688|664238|P1|Overall Study|Lost to Follow-up|9
206818|NCT02105688|664237|P2|Overall Study|Adverse Event|1
206819|NCT02105688|664238|P1|Overall Study|Adverse Event|1
206820|NCT02105688|664237|P2|Overall Study|Ongoing|90
206821|NCT02105688|664238|P1|Overall Study|Ongoing|12
206822|NCT02105662|664248|P1|Overall Study|Withdrawal by Subject|1
206823|NCT02105662|664248|P1|Overall Study|Lost to Follow-up|5
206824|NCT02105636|664257|P2|Overall Study|Not Reported|0
206825|NCT02105636|664258|P1|Overall Study|Not Reported|3
206826|NCT02105636|664257|P2|Overall Study|Reason Not Specified|2
206827|NCT02105636|664258|P1|Overall Study|Reason Not Specified|0
206828|NCT02105636|664257|P2|Overall Study|Poor/Non-compliance|1
206829|NCT02105636|664258|P1|Overall Study|Poor/Non-compliance|0
206830|NCT02105636|664257|P2|Overall Study|Maximum Clinical Benefit|1
206831|NCT02105636|664258|P1|Overall Study|Maximum Clinical Benefit|1
206832|NCT02105636|664257|P2|Overall Study|Subject Withdrew Consent|1
206833|NCT02105636|664258|P1|Overall Study|Subject Withdrew Consent|4
206834|NCT02105636|664257|P2|Overall Study|Subject Request to Discontinue Treatment|6
206835|NCT02105636|664258|P1|Overall Study|Subject Request to Discontinue Treatment|4
206836|NCT02105636|664257|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
206837|NCT02105636|664258|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
206838|NCT02105636|664257|P2|Overall Study|Study Drug Toxicity|11
206839|NCT02105636|664258|P1|Overall Study|Study Drug Toxicity|9
206840|NCT02105636|664257|P2|Overall Study|Disease Progression|83
206841|NCT02105636|664258|P1|Overall Study|Disease Progression|162
206842|NCT02105467|664270|P2|Period 3|Lost to Follow-up|1
206843|NCT02105467|664271|P1|Period 3|Lost to Follow-up|0
206844|NCT02105467|664270|P2|Period 2|Withdrawal by Subject|2
206845|NCT02105467|664271|P1|Period 2|Withdrawal by Subject|0
206846|NCT02105467|664270|P2|Period 2|Death|0
206847|NCT02105467|664271|P1|Period 2|Death|1
206848|NCT02105467|664270|P2|Period 2|Lost to Follow-up|0
206849|NCT02105467|664271|P1|Period 2|Lost to Follow-up|1
206850|NCT02105467|664270|P2|Period 1|Death|0
206851|NCT02105467|664271|P1|Period 1|Death|1
206852|NCT02105467|664270|P2|Period 1|Lost to Follow-up|0
206853|NCT02105467|664271|P1|Period 1|Lost to Follow-up|1
206854|NCT02105454|664283|P1|Overall Study|Withdrawal by Subject|1
206855|NCT02105285|664293|P3|Overall Study|Withdrawal by Subject|0
206856|NCT02105285|664294|P2|Overall Study|Withdrawal by Subject|0
206857|NCT02105285|664295|P1|Overall Study|Withdrawal by Subject|1
206858|NCT02105285|664293|P3|Overall Study|Protocol Violation|0
206859|NCT02105285|664294|P2|Overall Study|Protocol Violation|1
206860|NCT02105285|664295|P1|Overall Study|Protocol Violation|0
206861|NCT02105285|664293|P3|Overall Study|Adverse Event|0
206862|NCT02105285|664294|P2|Overall Study|Adverse Event|1
206863|NCT02105285|664295|P1|Overall Study|Adverse Event|1
206864|NCT02105272|664314|P2|Overall Study|Withdrawal by Subject|0
206865|NCT02105272|664315|P1|Overall Study|Withdrawal by Subject|2
206866|NCT02105272|664314|P2|Overall Study|Protocol Violation|0
206867|NCT02105272|664315|P1|Overall Study|Protocol Violation|2
206868|NCT02105272|664314|P2|Overall Study|Physician Decision|1
206869|NCT02105272|664315|P1|Overall Study|Physician Decision|0
206870|NCT02105272|664314|P2|Overall Study|Adverse Event|2
206871|NCT02105272|664315|P1|Overall Study|Adverse Event|1
206872|NCT02105012|664331|P1|Overall Study|Lack of Efficacy|1
206873|NCT02105012|664331|P1|Overall Study|Adverse Event|1
206874|NCT02105012|664331|P1|Overall Study|Physician Decision|3
206875|NCT02105012|664331|P1|Overall Study|Protocol Violation|4
206876|NCT02105012|664331|P1|Overall Study|Lost to Follow-up|4
206877|NCT02105012|664331|P1|Overall Study|Protocol Specified Criteria|9
206878|NCT02105012|664331|P1|Overall Study|Withdrawal by Subject|11
206879|NCT02104895|664365|P2|Overall Study|Withdrawal by Subject|14
206880|NCT02104895|664366|P1|Overall Study|Withdrawal by Subject|0
206881|NCT02103439|664413|P2|Overall Study|Withdrawal by Subject|1
206882|NCT02103439|664414|P1|Overall Study|Withdrawal by Subject|3
206883|NCT02103439|664413|P2|Overall Study|Adverse Event|2
206884|NCT02103439|664414|P1|Overall Study|Adverse Event|0
206885|NCT02103062|664449|P2|Overall Study|Death|1
206886|NCT02103062|664450|P1|Overall Study|Death|0
206887|NCT02103062|664449|P2|Overall Study|Progressive Disease|20
206888|NCT02103062|664450|P1|Overall Study|Progressive Disease|17
206889|NCT02103062|664449|P2|Overall Study|Adverse Event|2
206890|NCT02103062|664450|P1|Overall Study|Adverse Event|1
206891|NCT02102399|664543|P2|Overall Study|Withdrawal by Subject|4
206892|NCT02102399|664544|P1|Overall Study|Withdrawal by Subject|6
206893|NCT02101359|664594|P2|Overall Study|Protocol Violation|2
206894|NCT02101359|664595|P1|Overall Study|Protocol Violation|0
206895|NCT02101359|664594|P2|Overall Study|Lost to Follow-up|0
206896|NCT02101359|664595|P1|Overall Study|Lost to Follow-up|1
206897|NCT02101359|664594|P2|Overall Study|Withdrawal by Subject|4
206898|NCT02101359|664595|P1|Overall Study|Withdrawal by Subject|5
206899|NCT02101359|664594|P2|Overall Study|Not included|13
206900|NCT02101359|664595|P1|Overall Study|Not included|23
206901|NCT02101294|664601|P1|Overall Study|Lost to Follow-up|6
206902|NCT02101294|664601|P1|Overall Study|Withdrawal by Subject|5
206903|NCT02101112|664621|P6|Overall Study|Withdrawal by Subject|0
206904|NCT02101112|664622|P5|Overall Study|Withdrawal by Subject|1
206905|NCT02101112|664623|P4|Overall Study|Withdrawal by Subject|0
206906|NCT02101112|664624|P3|Overall Study|Withdrawal by Subject|0
206907|NCT02101112|664625|P2|Overall Study|Withdrawal by Subject|0
206908|NCT02101112|664626|P1|Overall Study|Withdrawal by Subject|0
206909|NCT02101112|664621|P6|Overall Study|Adverse Event|0
206910|NCT02101112|664622|P5|Overall Study|Adverse Event|0
206911|NCT02101112|664623|P4|Overall Study|Adverse Event|0
206912|NCT02101112|664624|P3|Overall Study|Adverse Event|1
206913|NCT02101112|664625|P2|Overall Study|Adverse Event|0
206914|NCT02101112|664626|P1|Overall Study|Adverse Event|0
206915|NCT02100839|664658|P2|Multiple Ascending Dose|Withdrawal by Subject|0
206916|NCT02100839|664659|P1|Multiple Ascending Dose|Withdrawal by Subject|2
206917|NCT02100839|664658|P2|Multiple Ascending Dose|Adverse Event|0
206918|NCT02100839|664659|P1|Multiple Ascending Dose|Adverse Event|2
206919|NCT02100644|664682|P3|LTG Escalation Phase|Withdrawal by Subject|0
206920|NCT02100644|664683|P2|LTG Escalation Phase|Withdrawal by Subject|0
206921|NCT02100644|664684|P1|LTG Escalation Phase|Withdrawal by Subject|3
206922|NCT02100644|664682|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
206923|NCT02100644|664683|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
206924|NCT02100644|664684|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
206925|NCT02100644|664682|P3|LTG Escalation Phase|Adverse Event|0
206926|NCT02100644|664683|P2|LTG Escalation Phase|Adverse Event|0
206927|NCT02100644|664684|P1|LTG Escalation Phase|Adverse Event|9
206928|NCT02100475|664709|P2|Overall Study|Withdrawal criteria|0
206929|NCT02100475|664710|P1|Overall Study|Withdrawal criteria|1
206930|NCT02100475|664709|P2|Overall Study|Unclassified|2
206931|NCT02100475|664710|P1|Overall Study|Unclassified|1
206932|NCT02099838|664750|P2|Overall Study|Withdrawal by Subject|1
206933|NCT02099838|664751|P1|Overall Study|Withdrawal by Subject|0
206934|NCT02099838|664750|P2|Overall Study|Lost to Follow-up|1
206935|NCT02099838|664751|P1|Overall Study|Lost to Follow-up|3
206936|NCT02099838|664750|P2|Overall Study|Death|0
206937|NCT02099838|664751|P1|Overall Study|Death|1
206938|NCT02099708|664781|P1|Overall Study|Other|29
206939|NCT02099708|664781|P1|Overall Study|Lost to Follow-up|141
206940|NCT02099708|664781|P1|Overall Study|Data Not Available|30
206941|NCT02099682|664792|P1|Overall Study|Other|29
206942|NCT02099682|664792|P1|Overall Study|Lost to Follow-up|31
206943|NCT02099682|664792|P1|Overall Study|Data Not Available|51
206944|NCT02099344|664818|P2|Overall Study|Physician Decision|0
206945|NCT02099344|664819|P1|Overall Study|Physician Decision|1
206946|NCT02098746|664876|P1|Overall Study|Data Not Available After Treatment|1
206947|NCT02098746|664876|P1|Overall Study|Enrolled 15 Days After the First Dose|1
206948|NCT02098746|664876|P1|Overall Study|Other Miscellaneous Reasons|1
206949|NCT02098746|664876|P1|Overall Study|Changes of Investigator|2
206950|NCT02098733|664884|P1|Overall Study|Lost to Follow-up|5
206951|NCT02098733|664884|P1|Overall Study|Data Not Available|5
206952|NCT02098395|664898|P4|Overall Study|Unclassified|2
206953|NCT02098395|664899|P3|Overall Study|Unclassified|3
206954|NCT02098395|664900|P2|Overall Study|Unclassified|0
206955|NCT02098395|664901|P1|Overall Study|Unclassified|0
206956|NCT02098395|664898|P4|Overall Study|Lost to Follow-up|3
206957|NCT02098395|664899|P3|Overall Study|Lost to Follow-up|0
206958|NCT02098395|664900|P2|Overall Study|Lost to Follow-up|1
206959|NCT02098395|664901|P1|Overall Study|Lost to Follow-up|2
206960|NCT02098395|664898|P4|Overall Study|Adverse Event|2
206961|NCT02098395|664899|P3|Overall Study|Adverse Event|34
206962|NCT02098395|664900|P2|Overall Study|Adverse Event|19
206963|NCT02098395|664901|P1|Overall Study|Adverse Event|12
206964|NCT02098395|664898|P4|Overall Study|Withdrawal by Subject|13
206965|NCT02098395|664899|P3|Overall Study|Withdrawal by Subject|5
206966|NCT02098395|664900|P2|Overall Study|Withdrawal by Subject|10
206967|NCT02098395|664901|P1|Overall Study|Withdrawal by Subject|10
206968|NCT02098395|664898|P4|Overall Study|Protocol Violation|7
206969|NCT02098395|664899|P3|Overall Study|Protocol Violation|0
206970|NCT02098395|664900|P2|Overall Study|Protocol Violation|2
206971|NCT02098395|664901|P1|Overall Study|Protocol Violation|2
206972|NCT02097823|664967|P2|Overall Study|Withdrawal by Subject|1
206973|NCT02097823|664968|P1|Overall Study|Withdrawal by Subject|1
206974|NCT02097745|664983|P1|Overall Study|Reason Not Specified|96
206975|NCT02097745|664983|P1|Overall Study|Administrative/Other|27
206976|NCT02097745|664983|P1|Overall Study|Failure to Return|14
206977|NCT02097745|664983|P1|Overall Study|Death|16
206978|NCT02097745|664983|P1|Overall Study|Adverse Event|25
206979|NCT02097719|665007|P2|Overall Study|Adverse Event|0
206980|NCT02097719|665008|P1|Overall Study|Adverse Event|2
206981|NCT02097719|665007|P2|Overall Study|Lost to Follow-up|1
206982|NCT02097719|665008|P1|Overall Study|Lost to Follow-up|0
206983|NCT02097719|665007|P2|Overall Study|Subject Withdrew Consent|0
206984|NCT02097719|665008|P1|Overall Study|Subject Withdrew Consent|1
206985|NCT02097108|665020|P1|Overall Study|patient was abroad for 6 months|1
206986|NCT02097108|665020|P1|Overall Study|Adverse Event|1
206987|NCT02097056|665027|P1|Overall Study|Not specified|2
206988|NCT02097056|665027|P1|Overall Study|Adverse Event|37
206989|NCT02097056|665027|P1|Overall Study|Lost to Follow-up|2
206990|NCT02097056|665027|P1|Overall Study|Withdrawal by Subject|15
206991|NCT02097056|665027|P1|Overall Study|Protocol Violation|2
206992|NCT02097030|665035|P2|First Intervention (3 Days)|Visual Acuity|1
206993|NCT02097030|665036|P1|First Intervention (3 Days)|Visual Acuity|0
206994|NCT02097030|665035|P2|First Intervention (3 Days)|Lost to Follow-up|0
206995|NCT02097030|665036|P1|First Intervention (3 Days)|Lost to Follow-up|1
206996|NCT02096835|665100|P3|Overall Study|Lost to Follow-up|1
206997|NCT02096835|665101|P2|Overall Study|Lost to Follow-up|0
206998|NCT02096835|665102|P1|Overall Study|Lost to Follow-up|1
206999|NCT02096835|665100|P3|Overall Study|converted to open procedures|0
207000|NCT02096835|665101|P2|Overall Study|converted to open procedures|0
207001|NCT02096835|665102|P1|Overall Study|converted to open procedures|1
207002|NCT02096835|665100|P3|Overall Study|Withdrawal by Subject|0
207003|NCT02096835|665101|P2|Overall Study|Withdrawal by Subject|0
207004|NCT02096835|665102|P1|Overall Study|Withdrawal by Subject|1
207005|NCT02096744|665119|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
207006|NCT02096744|665120|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
207007|NCT02096744|665119|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
207008|NCT02096744|665120|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
207009|NCT02096744|665119|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
207010|NCT02096744|665120|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
207011|NCT02096705|665174|P2|Follow-up|Subjects not reporting status|2
207012|NCT02096705|665175|P1|Follow-up|Subjects not reporting status|1
207013|NCT02096705|665174|P2|Follow-up|Adverse Event|2
207014|NCT02096705|665175|P1|Follow-up|Adverse Event|2
207015|NCT02096705|665174|P2|Follow-up|Withdrawal by Subject|0
207016|NCT02096705|665175|P1|Follow-up|Withdrawal by Subject|1
207017|NCT02096705|665174|P2|Treatment|Unspecified|1
207018|NCT02096705|665175|P1|Treatment|Unspecified|1
207019|NCT02096705|665174|P2|Treatment|Withdrawal by Subject|0
207020|NCT02096705|665175|P1|Treatment|Withdrawal by Subject|1
207021|NCT02096705|665174|P2|Treatment|Subject request to discontinue treatment|1
207022|NCT02096705|665175|P1|Treatment|Subject request to discontinue treatment|1
207023|NCT02096705|665174|P2|Treatment|Adverse Event|3
207024|NCT02096705|665175|P1|Treatment|Adverse Event|6
207025|NCT02095873|665275|P2|Second Intervention (8 Weeks)|Protocol Violation|0
207026|NCT02095873|665276|P1|Second Intervention (8 Weeks)|Protocol Violation|1
207027|NCT02095873|665275|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
207028|NCT02095873|665276|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
207029|NCT02095873|665275|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
207030|NCT02095873|665276|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
207031|NCT02095691|665288|P1|Overall Study|Physician Decision|1
207032|NCT02095223|665322|P2|Overall Study|Withdrawal by Subject|0
207033|NCT02095223|665323|P1|Overall Study|Withdrawal by Subject|1
207034|NCT02095197|665333|P2|Overall Study|Lost to Follow-up|3
207035|NCT02095197|665334|P1|Overall Study|Lost to Follow-up|0
207036|NCT02095158|665346|P1|Overall Study|Other Miscellaneous Reasons|1
207037|NCT02095158|665346|P1|Overall Study|Protocol Violation|1
207038|NCT02095158|665346|P1|Overall Study|Personal Reasons|35
207039|NCT02095158|665346|P1|Overall Study|Lost to Follow-up|20
207040|NCT02095158|665346|P1|Overall Study|Pregnancy|1
207041|NCT02095158|665346|P1|Overall Study|Lack of Efficacy|3
207042|NCT02095158|665346|P1|Overall Study|Adverse Event|14
207043|NCT02094937|665351|P4|12 Weeks in Period 2|Randomized incorrectly|0
207044|NCT02094937|665352|P3|12 Weeks in Period 2|Randomized incorrectly|0
207045|NCT02094937|665353|P2|12 Weeks in Period 2|Randomized incorrectly|1
207046|NCT02094937|665354|P1|12 Weeks in Period 2|Randomized incorrectly|0
207047|NCT02094937|665351|P4|12 Weeks in Period 2|Withdrawal by Subject|0
207048|NCT02094937|665352|P3|12 Weeks in Period 2|Withdrawal by Subject|2
207049|NCT02094937|665353|P2|12 Weeks in Period 2|Withdrawal by Subject|2
207050|NCT02094937|665354|P1|12 Weeks in Period 2|Withdrawal by Subject|0
207051|NCT02094937|665351|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
207052|NCT02094937|665352|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
207053|NCT02094937|665353|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
207054|NCT02094937|665354|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
207055|NCT02094937|665351|P4|12 Weeks in Period 2|Lack of Efficacy|0
207056|NCT02094937|665352|P3|12 Weeks in Period 2|Lack of Efficacy|0
207057|NCT02094937|665353|P2|12 Weeks in Period 2|Lack of Efficacy|1
207058|NCT02094937|665354|P1|12 Weeks in Period 2|Lack of Efficacy|0
207059|NCT02094937|665351|P4|12 Weeks in Period 2|Adverse Event|1
207060|NCT02094937|665352|P3|12 Weeks in Period 2|Adverse Event|4
207061|NCT02094937|665353|P2|12 Weeks in Period 2|Adverse Event|2
207062|NCT02094937|665354|P1|12 Weeks in Period 2|Adverse Event|0
207063|NCT02094937|665351|P4|8 Weeks in Period 1|Withdrawal by Subject|0
207064|NCT02094937|665352|P3|8 Weeks in Period 1|Withdrawal by Subject|0
207065|NCT02094937|665353|P2|8 Weeks in Period 1|Withdrawal by Subject|0
207066|NCT02094937|665354|P1|8 Weeks in Period 1|Withdrawal by Subject|4
207067|NCT02094937|665351|P4|8 Weeks in Period 1|Physician Decision|0
207068|NCT02094937|665352|P3|8 Weeks in Period 1|Physician Decision|0
207069|NCT02094937|665353|P2|8 Weeks in Period 1|Physician Decision|0
207070|NCT02094937|665354|P1|8 Weeks in Period 1|Physician Decision|1
207071|NCT02094937|665351|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
207072|NCT02094937|665352|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
207073|NCT02094937|665353|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
207074|NCT02094937|665354|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
207075|NCT02094937|665351|P4|8 Weeks in Period 1|Protocol Violation|0
207076|NCT02094937|665352|P3|8 Weeks in Period 1|Protocol Violation|0
207077|NCT02094937|665353|P2|8 Weeks in Period 1|Protocol Violation|0
207078|NCT02094937|665354|P1|8 Weeks in Period 1|Protocol Violation|2
207079|NCT02094937|665351|P4|8 Weeks in Period 1|Lack of Efficacy|0
207080|NCT02094937|665352|P3|8 Weeks in Period 1|Lack of Efficacy|0
207081|NCT02094937|665353|P2|8 Weeks in Period 1|Lack of Efficacy|0
207082|NCT02094937|665354|P1|8 Weeks in Period 1|Lack of Efficacy|3
207083|NCT02094937|665351|P4|8 Weeks in Period 1|Adverse Event|0
207084|NCT02094937|665352|P3|8 Weeks in Period 1|Adverse Event|0
207085|NCT02094937|665353|P2|8 Weeks in Period 1|Adverse Event|0
207086|NCT02094937|665354|P1|8 Weeks in Period 1|Adverse Event|9
207087|NCT02094885|665386|P2|Overall Study|Withdrawn due to age|0
207088|NCT02094885|665387|P1|Overall Study|Withdrawn due to age|1
207089|NCT02094885|665386|P2|Overall Study|Death|5
207090|NCT02094885|665387|P1|Overall Study|Death|1
207091|NCT02094677|665401|P2|Overall Study|Screening|1
207092|NCT02094677|665402|P1|Overall Study|Screening|3
207093|NCT02094300|665503|P1|Overall Study|Still be eligible for follow-up|3
207094|NCT02094300|665503|P1|Overall Study|Lost to Follow-up|10
207095|NCT02094300|665503|P1|Overall Study|Death|7
207096|NCT02094261|665507|P1|Overall Study|Ongoing Study at Data Cut-off|181
207097|NCT02094261|665507|P1|Overall Study|Withdrawal by Subject|4
207098|NCT02094261|665507|P1|Overall Study|Lost to Follow-up|1
207099|NCT02094261|665507|P1|Overall Study|Death|24
207100|NCT02093923|665540|P5|Overall Study|Screen failure after randomization|0
207101|NCT02093923|665541|P4|Overall Study|Screen failure after randomization|1
207102|NCT02093923|665542|P3|Overall Study|Screen failure after randomization|0
207103|NCT02093923|665543|P2|Overall Study|Screen failure after randomization|0
207104|NCT02093923|665544|P1|Overall Study|Screen failure after randomization|0
207105|NCT02093923|665540|P5|Overall Study|Lost to Follow-up|0
207106|NCT02093923|665541|P4|Overall Study|Lost to Follow-up|1
207107|NCT02093923|665542|P3|Overall Study|Lost to Follow-up|0
207108|NCT02093923|665543|P2|Overall Study|Lost to Follow-up|0
207109|NCT02093923|665544|P1|Overall Study|Lost to Follow-up|0
207110|NCT02093897|665599|P1|Overall Study|Adverse event, non-fatal|1
207111|NCT02093897|665599|P1|Overall Study|Planned age group closure - no's reached|17
207112|NCT02093897|665599|P1|Overall Study|Physician Decision|1
207113|NCT02093390|665701|P2|Overall Study|Withdrawal by Subject|1
207114|NCT02093390|665702|P1|Overall Study|Withdrawal by Subject|0
207115|NCT02093351|665741|P3|Overall Study|Death|0
207116|NCT02093351|665742|P2|Overall Study|Death|1
207117|NCT02093351|665743|P1|Overall Study|Death|0
207118|NCT02093351|665741|P3|Overall Study|Condition under investigation worsened|2
207119|NCT02093351|665742|P2|Overall Study|Condition under investigation worsened|0
207120|NCT02093351|665743|P1|Overall Study|Condition under investigation worsened|2
207121|NCT02093351|665741|P3|Overall Study|Adverse Event|1
207122|NCT02093351|665742|P2|Overall Study|Adverse Event|1
207123|NCT02093351|665743|P1|Overall Study|Adverse Event|0
207124|NCT02093026|665794|P1|Overall Study|Unspecified|157
207125|NCT02093026|665794|P1|Overall Study|Death|10
207126|NCT02093026|665794|P1|Overall Study|Adverse Event|26
207127|NCT02092961|665816|P3|Overall Study|Adverse Event|0
207128|NCT02092961|665817|P2|Overall Study|Adverse Event|4
207129|NCT02092961|665818|P1|Overall Study|Adverse Event|2
207130|NCT02092961|665816|P3|Overall Study|Dev. of study specific discont. criteria|0
207131|NCT02092961|665817|P2|Overall Study|Dev. of study specific discont. criteria|0
207132|NCT02092961|665818|P1|Overall Study|Dev. of study specific discont. criteria|3
207133|NCT02092961|665816|P3|Overall Study|Lack of therapeutic response|3
207134|NCT02092961|665817|P2|Overall Study|Lack of therapeutic response|1
207135|NCT02092961|665818|P1|Overall Study|Lack of therapeutic response|2
207136|NCT02092961|665816|P3|Overall Study|Study stopped|12
207137|NCT02092961|665817|P2|Overall Study|Study stopped|9
207138|NCT02092961|665818|P1|Overall Study|Study stopped|13
207139|NCT02092961|665816|P3|Overall Study|Not reported|1
207140|NCT02092961|665817|P2|Overall Study|Not reported|0
207141|NCT02092961|665818|P1|Overall Study|Not reported|1
207142|NCT02092662|665854|P2|Overall Study|Lost to Follow-up|0
207143|NCT02092662|665855|P1|Overall Study|Lost to Follow-up|13
207144|NCT02092389|665914|P1|Overall Study|Not specified|5
207145|NCT02092389|665914|P1|Overall Study|Adverse Event|1
207146|NCT02092350|665926|P2|Overall Study|Withdrawal by Subject|2
207147|NCT02092350|665927|P1|Overall Study|Withdrawal by Subject|2
207148|NCT02092350|665926|P2|Overall Study|Screen Failure|0
207149|NCT02092350|665927|P1|Overall Study|Screen Failure|1
207150|NCT02092350|665926|P2|Overall Study|Physician Decision|1
207151|NCT02092350|665927|P1|Overall Study|Physician Decision|1
207152|NCT02092350|665926|P2|Overall Study|Protocol Violation|0
207153|NCT02092350|665927|P1|Overall Study|Protocol Violation|1
207154|NCT02092350|665926|P2|Overall Study|Lost to Follow-up|1
207155|NCT02092350|665927|P1|Overall Study|Lost to Follow-up|3
207156|NCT02092350|665926|P2|Overall Study|Death|5
207157|NCT02092350|665927|P1|Overall Study|Death|2
207158|NCT02092350|665926|P2|Overall Study|Adverse Event|3
207159|NCT02092350|665927|P1|Overall Study|Adverse Event|0
207160|NCT02092116|665970|P2|Overall Study|Adverse Event|1
207161|NCT02092116|665971|P1|Overall Study|Adverse Event|0
207162|NCT02092116|665970|P2|Overall Study|Withdrawal by Subject|3
207163|NCT02092116|665971|P1|Overall Study|Withdrawal by Subject|0
207164|NCT02091986|665983|P3|Overall Study|Adverse Event|2
207165|NCT02091986|665984|P2|Overall Study|Adverse Event|0
207166|NCT02091986|665985|P1|Overall Study|Adverse Event|0
207167|NCT02091986|665983|P3|Overall Study|Withdrawal by Subject|3
207168|NCT02091986|665984|P2|Overall Study|Withdrawal by Subject|8
207169|NCT02091986|665985|P1|Overall Study|Withdrawal by Subject|4
207170|NCT02091986|665983|P3|Overall Study|Lost to Follow-up|0
207171|NCT02091986|665984|P2|Overall Study|Lost to Follow-up|0
207172|NCT02091986|665985|P1|Overall Study|Lost to Follow-up|1
207173|NCT02091986|665983|P3|Overall Study|7 rand in error 1 patient decision|3
207174|NCT02091986|665984|P2|Overall Study|7 rand in error 1 patient decision|3
207175|NCT02091986|665985|P1|Overall Study|7 rand in error 1 patient decision|2
207176|NCT02091869|666034|P2|Overall Study|Withdrawal by Subject|3
207177|NCT02091869|666035|P1|Overall Study|Withdrawal by Subject|0
207178|NCT02091752|666076|P1|Overall Study|Adverse Event|1
207179|NCT02091752|666076|P1|Overall Study|Study terminated by Sponsor|2
207180|NCT02091726|666087|P1|Overall Study|Lost to Follow-up|6
207181|NCT02091414|666104|P1|Overall Study|Death|2
207182|NCT02091414|666104|P1|Overall Study|Withdrawal by Subject|2
207183|NCT02090855|666116|P1|Overall Study|no evaluable Standard of Truth results|2
207184|NCT02090764|666129|P2|Overall Study|Lost to Follow-up|2
207185|NCT02090764|666130|P1|Overall Study|Lost to Follow-up|2
207186|NCT02090764|666129|P2|Overall Study|Intercurrent illness and other|1
207187|NCT02090764|666130|P1|Overall Study|Intercurrent illness and other|1
207188|NCT02090764|666129|P2|Overall Study|Withdrawal by Subject|1
207189|NCT02090764|666130|P1|Overall Study|Withdrawal by Subject|2
207190|NCT02090764|666129|P2|Overall Study|Lack of Efficacy|13
207191|NCT02090764|666130|P1|Overall Study|Lack of Efficacy|0
207192|NCT02090764|666129|P2|Overall Study|Adverse Event|3
207193|NCT02090764|666130|P1|Overall Study|Adverse Event|1
207194|NCT02090413|666139|P3|Overall Study|Lost to Follow-up|0
207195|NCT02090413|666140|P2|Overall Study|Lost to Follow-up|1
207196|NCT02090413|666141|P1|Overall Study|Lost to Follow-up|1
207197|NCT02090413|666139|P3|Overall Study|Not Specified|0
207198|NCT02090413|666140|P2|Overall Study|Not Specified|1
207199|NCT02090413|666141|P1|Overall Study|Not Specified|2
207200|NCT02090413|666139|P3|Overall Study|Investigator Decision|0
207201|NCT02090413|666140|P2|Overall Study|Investigator Decision|1
207202|NCT02090413|666141|P1|Overall Study|Investigator Decision|1
207203|NCT02090413|666139|P3|Overall Study|Withdrawal by Subject|2
207204|NCT02090413|666140|P2|Overall Study|Withdrawal by Subject|2
207205|NCT02090413|666141|P1|Overall Study|Withdrawal by Subject|2
207206|NCT02090413|666139|P3|Overall Study|Flushing event|1
207207|NCT02090413|666140|P2|Overall Study|Flushing event|0
207208|NCT02090413|666141|P1|Overall Study|Flushing event|2
207209|NCT02090413|666139|P3|Overall Study|Adverse Event|20
207210|NCT02090413|666140|P2|Overall Study|Adverse Event|15
207211|NCT02090413|666141|P1|Overall Study|Adverse Event|11
207212|NCT02089737|666227|P1|Overall Study|Not treated|1
207213|NCT02089737|666227|P1|Overall Study|Survey form not completed|5
207214|NCT02089347|666236|P2|Overall Study|Protocol Violation|0
207215|NCT02089347|666237|P1|Overall Study|Protocol Violation|1
207216|NCT02088957|666277|P2|Overall Study|Lack of Efficacy|0
207217|NCT02088957|666278|P1|Overall Study|Lack of Efficacy|1
207218|NCT02087943|666297|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
207219|NCT02087943|666298|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
207220|NCT02087943|666299|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
207221|NCT02087943|666300|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
207222|NCT02087943|666301|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
207223|NCT02087943|666297|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
207224|NCT02087943|666298|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
207225|NCT02087943|666299|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
207226|NCT02087943|666300|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
207227|NCT02087943|666301|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
207228|NCT02087943|666297|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
207229|NCT02087943|666298|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
207230|NCT02087943|666299|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
207231|NCT02087943|666300|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
207232|NCT02087943|666301|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
207233|NCT02087943|666297|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
207234|NCT02087943|666298|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
207235|NCT02087943|666299|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
207236|NCT02087943|666300|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
207237|NCT02087943|666301|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
207238|NCT02087943|666297|P5|Active Treatment Phase Week 12-24|Adverse Event|1
207239|NCT02087943|666298|P4|Active Treatment Phase Week 12-24|Adverse Event|0
207240|NCT02087943|666299|P3|Active Treatment Phase Week 12-24|Adverse Event|2
207241|NCT02087943|666300|P2|Active Treatment Phase Week 12-24|Adverse Event|1
207242|NCT02087943|666301|P1|Active Treatment Phase Week 12-24|Adverse Event|0
207243|NCT02087943|666297|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
207244|NCT02087943|666298|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
207245|NCT02087943|666299|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
207246|NCT02087943|666300|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
207247|NCT02087943|666301|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
207248|NCT02087943|666297|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
207249|NCT02087943|666298|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
207250|NCT02087943|666299|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
207251|NCT02087943|666300|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
207252|NCT02087943|666301|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
207253|NCT02087943|666297|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
207254|NCT02087943|666298|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
207255|NCT02087943|666299|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
207256|NCT02087943|666300|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
207257|NCT02087943|666301|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
207258|NCT02087943|666297|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
207259|NCT02087943|666298|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
207260|NCT02087943|666299|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
207261|NCT02087943|666300|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
207262|NCT02087943|666301|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
207263|NCT02087943|666297|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
207264|NCT02087943|666298|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
207265|NCT02087943|666299|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
207266|NCT02087943|666300|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
207267|NCT02087943|666301|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
207268|NCT02087774|666327|P2|Overall Study|Were absent day of data collection|20
207269|NCT02087774|666328|P1|Overall Study|Were absent day of data collection|8
207270|NCT02087670|666348|P2|Overall Study|Withdrawal by Subject|2
207271|NCT02087670|666349|P1|Overall Study|Withdrawal by Subject|3
207272|NCT02087241|666361|P4|Overall Study|Study Terminated by Sponsor|4
207273|NCT02087241|666362|P3|Overall Study|Study Terminated by Sponsor|0
207274|NCT02087241|666363|P2|Overall Study|Study Terminated by Sponsor|2
207275|NCT02087241|666364|P1|Overall Study|Study Terminated by Sponsor|0
207276|NCT02087241|666361|P4|Overall Study|Progressive Disease|1
207277|NCT02087241|666362|P3|Overall Study|Progressive Disease|0
207278|NCT02087241|666363|P2|Overall Study|Progressive Disease|0
207279|NCT02087241|666364|P1|Overall Study|Progressive Disease|0
207280|NCT02087241|666361|P4|Overall Study|Withdrawal by Subject|1
207281|NCT02087241|666362|P3|Overall Study|Withdrawal by Subject|0
207282|NCT02087241|666363|P2|Overall Study|Withdrawal by Subject|0
207283|NCT02087241|666364|P1|Overall Study|Withdrawal by Subject|1
207284|NCT02087241|666361|P4|Overall Study|Death|1
207285|NCT02087241|666362|P3|Overall Study|Death|1
207286|NCT02087241|666363|P2|Overall Study|Death|1
207287|NCT02087241|666364|P1|Overall Study|Death|2
207288|NCT02087176|666390|P1|Overall Study|Study Terminated by Sponsor|2
207289|NCT02087176|666390|P1|Overall Study|Censored|19
207290|NCT02087176|666390|P1|Overall Study|Death|10
207291|NCT02087176|666390|P1|Overall Study|Withdrawal by Subject|1
207292|NCT02087059|666395|P1|Overall Study|Lost to Follow-up|1
207293|NCT02087059|666395|P1|Overall Study|Adverse Event|5
207294|NCT02087059|666395|P1|Overall Study|Disease Progression|1
207295|NCT02086591|666415|P1|Overall Study|protocol terminated|3
207296|NCT02086591|666415|P1|Overall Study|Withdrawal by Subject|1
207297|NCT02086591|666415|P1|Overall Study|Adverse Event|1
207298|NCT02085785|666423|P2|Overall Study|Lost to Follow-up|1
207299|NCT02085785|666424|P1|Overall Study|Lost to Follow-up|0
207300|NCT02085785|666423|P2|Overall Study|Withdrawal by Subject|1
207301|NCT02085785|666424|P1|Overall Study|Withdrawal by Subject|2
207302|NCT02085161|666448|P4|Overall Study|Other Reason|1
207303|NCT02085161|666449|P3|Overall Study|Other Reason|1
207304|NCT02085161|666450|P2|Overall Study|Other Reason|0
207305|NCT02085161|666451|P1|Overall Study|Other Reason|1
207306|NCT02085161|666448|P4|Overall Study|Withdrawal by Subject|3
207307|NCT02085161|666449|P3|Overall Study|Withdrawal by Subject|0
207308|NCT02085161|666450|P2|Overall Study|Withdrawal by Subject|4
207309|NCT02085161|666451|P1|Overall Study|Withdrawal by Subject|2
207310|NCT02085161|666448|P4|Overall Study|Protocol Violation|1
207311|NCT02085161|666449|P3|Overall Study|Protocol Violation|0
207312|NCT02085161|666450|P2|Overall Study|Protocol Violation|1
207313|NCT02085161|666451|P1|Overall Study|Protocol Violation|0
207314|NCT02085161|666448|P4|Overall Study|Adverse Event|5
207315|NCT02085161|666449|P3|Overall Study|Adverse Event|4
207316|NCT02085161|666450|P2|Overall Study|Adverse Event|5
207317|NCT02085161|666451|P1|Overall Study|Adverse Event|8
207318|NCT02085161|666448|P4|Overall Study|Not Treated|0
207319|NCT02085161|666449|P3|Overall Study|Not Treated|0
207320|NCT02085161|666450|P2|Overall Study|Not Treated|0
207321|NCT02085161|666451|P1|Overall Study|Not Treated|1
207322|NCT02084238|666519|P1|Overall Study|Lost to Follow-up|2
207323|NCT02084082|666532|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
207324|NCT02084082|666533|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
207325|NCT02084082|666534|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
207326|NCT02084082|666535|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
207327|NCT02084082|666532|P4|Washout Period 1 (35 Days)|Adverse Event|1
207328|NCT02084082|666533|P3|Washout Period 1 (35 Days)|Adverse Event|1
207329|NCT02084082|666534|P2|Washout Period 1 (35 Days)|Adverse Event|0
207330|NCT02084082|666535|P1|Washout Period 1 (35 Days)|Adverse Event|0
207331|NCT02084056|666576|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
207332|NCT02084056|666577|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
207333|NCT02084056|666578|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
207334|NCT02084056|666579|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
207335|NCT02084056|666576|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
207336|NCT02084056|666577|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
207337|NCT02084056|666578|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
207338|NCT02084056|666579|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
207339|NCT02083965|666611|P2|Overall Study|Not specified|0
207340|NCT02083965|666612|P1|Overall Study|Not specified|1
207341|NCT02083965|666611|P2|Overall Study|Withdrawal by Subject|1
207342|NCT02083965|666612|P1|Overall Study|Withdrawal by Subject|0
207343|NCT02083380|666714|P3|Overall Study|Other|6
207344|NCT02083380|666715|P2|Overall Study|Other|4
207345|NCT02083380|666716|P1|Overall Study|Other|8
207346|NCT02083380|666714|P3|Overall Study|Lost to Follow-up|3
207347|NCT02083380|666715|P2|Overall Study|Lost to Follow-up|3
207348|NCT02083380|666716|P1|Overall Study|Lost to Follow-up|5
207349|NCT02083380|666714|P3|Overall Study|Adverse Event|1
207350|NCT02083380|666715|P2|Overall Study|Adverse Event|0
207351|NCT02083380|666716|P1|Overall Study|Adverse Event|0
207352|NCT02083380|666714|P3|Overall Study|Physician Decision|3
207353|NCT02083380|666715|P2|Overall Study|Physician Decision|6
207354|NCT02083380|666716|P1|Overall Study|Physician Decision|1
207355|NCT02083380|666714|P3|Overall Study|Withdrawal by Subject|7
207356|NCT02083380|666715|P2|Overall Study|Withdrawal by Subject|3
207357|NCT02083380|666716|P1|Overall Study|Withdrawal by Subject|9
207358|NCT02083380|666714|P3|Overall Study|Lack of Efficacy|64
207359|NCT02083380|666715|P2|Overall Study|Lack of Efficacy|79
207360|NCT02083380|666716|P1|Overall Study|Lack of Efficacy|68
207361|NCT02082912|666860|P2|Overall Study|Physician Decision|1
207362|NCT02082912|666861|P1|Overall Study|Physician Decision|0
207363|NCT02082262|666890|P1|Overall Study|Adverse Event|48
207364|NCT02082262|666890|P1|Overall Study|Withdrawal by Subject|3
207365|NCT02082184|666896|P2|Overall Study|Subject non-compliance|1
207366|NCT02082184|666897|P1|Overall Study|Subject non-compliance|0
207367|NCT02082184|666896|P2|Overall Study|Lost to Follow-up|2
207368|NCT02082184|666897|P1|Overall Study|Lost to Follow-up|0
207369|NCT02082184|666896|P2|Overall Study|Protocol Violation|6
207370|NCT02082184|666897|P1|Overall Study|Protocol Violation|0
207371|NCT02082184|666896|P2|Overall Study|Withdrawal by Subject|2
207372|NCT02082184|666897|P1|Overall Study|Withdrawal by Subject|3
207373|NCT02082184|666896|P2|Overall Study|Device associated symptoms|0
207374|NCT02082184|666897|P1|Overall Study|Device associated symptoms|5
207375|NCT02082184|666896|P2|Overall Study|Medical diagnosis|2
207376|NCT02082184|666897|P1|Overall Study|Medical diagnosis|1
207377|NCT02082184|666896|P2|Overall Study|Adverse Event|0
207378|NCT02082184|666897|P1|Overall Study|Adverse Event|1
207379|NCT02082158|666922|P6|Overall Study|Failed Fit-testing|7
207380|NCT02082158|666923|P5|Overall Study|Failed Fit-testing|3
207381|NCT02082158|666924|P4|Overall Study|Failed Fit-testing|4
207382|NCT02082158|666925|P3|Overall Study|Failed Fit-testing|14
207383|NCT02082158|666926|P2|Overall Study|Failed Fit-testing|8
207384|NCT02082158|666927|P1|Overall Study|Failed Fit-testing|8
207385|NCT02082158|666922|P6|Overall Study|Withdrawal by Subject|0
207386|NCT02082158|666923|P5|Overall Study|Withdrawal by Subject|1
207387|NCT02082158|666924|P4|Overall Study|Withdrawal by Subject|0
207388|NCT02082158|666925|P3|Overall Study|Withdrawal by Subject|0
207389|NCT02082158|666926|P2|Overall Study|Withdrawal by Subject|0
207390|NCT02082158|666927|P1|Overall Study|Withdrawal by Subject|0
207391|NCT02081859|666949|P2|Overall Study|Other reasons|0
207392|NCT02081859|666950|P1|Overall Study|Other reasons|2
207393|NCT02081859|666949|P2|Overall Study|< 4 embryos|23
207394|NCT02081859|666950|P1|Overall Study|< 4 embryos|27
207395|NCT02081859|666949|P2|Overall Study|Unanticipated freeze all cycle|6
207396|NCT02081859|666950|P1|Overall Study|Unanticipated freeze all cycle|2
207397|NCT02081859|666949|P2|Overall Study|No sperm|0
207398|NCT02081859|666950|P1|Overall Study|No sperm|1
207399|NCT02081859|666949|P2|Overall Study|No fertilization|2
207400|NCT02081859|666950|P1|Overall Study|No fertilization|2
207401|NCT02081599|666960|P2|Period 2：Open-label Period|Withdrawal by Subject|0
207402|NCT02081599|666961|P1|Period 2：Open-label Period|Withdrawal by Subject|2
207403|NCT02081599|666960|P2|Period 2：Open-label Period|Physician Decision|0
207404|NCT02081599|666961|P1|Period 2：Open-label Period|Physician Decision|1
207405|NCT02081599|666960|P2|Period 2：Open-label Period|Lack of Efficacy|4
207406|NCT02081599|666961|P1|Period 2：Open-label Period|Lack of Efficacy|2
207407|NCT02081599|666960|P2|Period 2：Open-label Period|Adverse Event|0
207408|NCT02081599|666961|P1|Period 2：Open-label Period|Adverse Event|1
207409|NCT02081599|666960|P2|Period 1：Double-blind Period|stopping criteria|0
207410|NCT02081599|666961|P1|Period 1：Double-blind Period|stopping criteria|1
207411|NCT02081599|666960|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
207412|NCT02081599|666961|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
207413|NCT02081599|666960|P2|Period 1：Double-blind Period|Protocol Violation|1
207414|NCT02081599|666961|P1|Period 1：Double-blind Period|Protocol Violation|0
207415|NCT02081599|666960|P2|Period 1：Double-blind Period|Physician Decision|0
207416|NCT02081599|666961|P1|Period 1：Double-blind Period|Physician Decision|1
207417|NCT02081599|666960|P2|Period 1：Double-blind Period|Lack of Efficacy|1
207418|NCT02081599|666961|P1|Period 1：Double-blind Period|Lack of Efficacy|2
207419|NCT02081599|666960|P2|Period 1：Double-blind Period|Adverse Event|0
207420|NCT02081599|666961|P1|Period 1：Double-blind Period|Adverse Event|3
207421|NCT02081586|666979|P4|Overall Study|Head injury not related to study|0
207422|NCT02081586|666980|P3|Overall Study|Head injury not related to study|1
207423|NCT02081586|666981|P2|Overall Study|Head injury not related to study|0
207424|NCT02081586|666982|P1|Overall Study|Head injury not related to study|0
207425|NCT02081586|666979|P4|Overall Study|Lost to Follow-up|1
207426|NCT02081586|666980|P3|Overall Study|Lost to Follow-up|0
207427|NCT02081586|666981|P2|Overall Study|Lost to Follow-up|1
207428|NCT02081586|666982|P1|Overall Study|Lost to Follow-up|0
207429|NCT02081183|667039|P2|Overall Study|Not specified|3
207430|NCT02081183|667040|P1|Overall Study|Not specified|3
207431|NCT02081183|667039|P2|Overall Study|Protocol Violation|0
207432|NCT02081183|667040|P1|Overall Study|Protocol Violation|1
207433|NCT02081183|667039|P2|Overall Study|Lost to Follow-up|1
207434|NCT02081183|667040|P1|Overall Study|Lost to Follow-up|0
207435|NCT02081079|667056|P2|Overall Study|Lost to Follow-up|0
207436|NCT02081079|667057|P1|Overall Study|Lost to Follow-up|1
207437|NCT02081079|667056|P2|Overall Study|Lack of Efficacy|2
207438|NCT02081079|667057|P1|Overall Study|Lack of Efficacy|3
207439|NCT02081001|667130|P12|Overall Study|Adverse Event|0
207440|NCT02081001|667131|P11|Overall Study|Adverse Event|0
207441|NCT02081001|667132|P10|Overall Study|Adverse Event|0
207442|NCT02081001|667133|P9|Overall Study|Adverse Event|0
207443|NCT02081001|667134|P8|Overall Study|Adverse Event|0
207444|NCT02081001|667135|P7|Overall Study|Adverse Event|0
207445|NCT02081001|667136|P6|Overall Study|Adverse Event|0
207446|NCT02081001|667137|P5|Overall Study|Adverse Event|1
207447|NCT02081001|667138|P4|Overall Study|Adverse Event|0
207448|NCT02081001|667139|P3|Overall Study|Adverse Event|0
207449|NCT02081001|667140|P2|Overall Study|Adverse Event|0
207450|NCT02081001|667141|P1|Overall Study|Adverse Event|0
207451|NCT02080481|667236|P2|Overall Study|Never received a block.|0
207452|NCT02080481|667237|P1|Overall Study|Never received a block.|1
207453|NCT02080091|667255|P1|Overall Study|Other|1
207454|NCT02080091|667255|P1|Overall Study|Withdrawal by Subject|1
207455|NCT02080091|667255|P1|Overall Study|Death|1
207456|NCT02080091|667255|P1|Overall Study|Study Terminated|22
207457|NCT02079844|667264|P3|Treatment Period 2|Voluntary Withdrawal|0
207458|NCT02079844|667265|P2|Treatment Period 2|Voluntary Withdrawal|1
207459|NCT02079844|667266|P1|Treatment Period 2|Voluntary Withdrawal|0
207460|NCT02079844|667264|P3|Treatment Period 1|Voluntary Withdrawal|2
207461|NCT02079844|667265|P2|Treatment Period 1|Voluntary Withdrawal|0
207462|NCT02079844|667266|P1|Treatment Period 1|Voluntary Withdrawal|0
207463|NCT02079649|667326|P4|Overall Study|Randomization error (prior to treatment)|0
207464|NCT02079649|667327|P3|Overall Study|Randomization error (prior to treatment)|1
207465|NCT02079649|667328|P2|Overall Study|Randomization error (prior to treatment)|0
207466|NCT02079649|667329|P1|Overall Study|Randomization error (prior to treatment)|1
207467|NCT02079649|667326|P4|Overall Study|Withdrawal by Subject|1
207468|NCT02079649|667327|P3|Overall Study|Withdrawal by Subject|0
207469|NCT02079649|667328|P2|Overall Study|Withdrawal by Subject|0
207470|NCT02079649|667329|P1|Overall Study|Withdrawal by Subject|0
207471|NCT02079649|667326|P4|Overall Study|Lost to Follow-up|1
207472|NCT02079649|667327|P3|Overall Study|Lost to Follow-up|0
207473|NCT02079649|667328|P2|Overall Study|Lost to Follow-up|0
207474|NCT02079649|667329|P1|Overall Study|Lost to Follow-up|0
207475|NCT02079532|667344|P1|Overall Study|Not specified|3
207476|NCT02079532|667344|P1|Overall Study|Inclusion into ReFIRST|3
207477|NCT02079532|667344|P1|Overall Study|Administrative problems|1
207478|NCT02079532|667344|P1|Overall Study|Withdrawal by Subject|1
207479|NCT02079532|667344|P1|Overall Study|Protocol Violation|3
207480|NCT02079532|667344|P1|Overall Study|Lack of Efficacy|9
207481|NCT02079532|667344|P1|Overall Study|Additional or changed therapy|2
207482|NCT02079532|667344|P1|Overall Study|Adverse Event|7
207483|NCT02079519|667366|P1|Overall Study|Adverse Event|1
207484|NCT02079519|667366|P1|Overall Study|Disease Progression|9
207485|NCT02077374|667403|P2|Overall Study|Protocol Violation|1
207486|NCT02077374|667404|P1|Overall Study|Protocol Violation|0
207487|NCT02077374|667403|P2|Overall Study|Withdrawal by Subject|1
207488|NCT02077374|667404|P1|Overall Study|Withdrawal by Subject|0
207489|NCT02076009|667535|P2|Overall Study|Subjects randomized but not treated|3
207490|NCT02076009|667536|P1|Overall Study|Subjects randomized but not treated|2
207491|NCT02076009|667535|P2|Overall Study|Ongoing|249
207492|NCT02076009|667536|P1|Overall Study|Ongoing|226
207493|NCT02076009|667535|P2|Overall Study|Progressive disease|0
207494|NCT02076009|667536|P1|Overall Study|Progressive disease|1
207495|NCT02076009|667535|P2|Overall Study|Lost to Follow-up|1
207496|NCT02076009|667536|P1|Overall Study|Lost to Follow-up|1
207497|NCT02076009|667535|P2|Overall Study|Withdrawal by Subject|3
207498|NCT02076009|667536|P1|Overall Study|Withdrawal by Subject|9
207499|NCT02076009|667535|P2|Overall Study|Death|30
207500|NCT02076009|667536|P1|Overall Study|Death|44
207501|NCT02075632|667558|P2|Overall Study|Withdrawal by Subject|1
207502|NCT02075632|667559|P1|Overall Study|Withdrawal by Subject|0
207503|NCT02075632|667558|P2|Overall Study|Lost to Follow-up|3
207504|NCT02075632|667559|P1|Overall Study|Lost to Follow-up|0
207505|NCT02075632|667558|P2|Overall Study|Adverse Event|1
207506|NCT02075632|667559|P1|Overall Study|Adverse Event|1
207507|NCT02075515|667572|P3|Overall Study|Lost to Follow-up|6
207508|NCT02075515|667573|P2|Overall Study|Lost to Follow-up|3
207509|NCT02075515|667574|P1|Overall Study|Lost to Follow-up|1
207510|NCT02075515|667572|P3|Overall Study|Withdrawal by Subject|1
207511|NCT02075515|667573|P2|Overall Study|Withdrawal by Subject|0
207512|NCT02075515|667574|P1|Overall Study|Withdrawal by Subject|2
207513|NCT02075515|667572|P3|Overall Study|Non-Serious Adverse Event|0
207514|NCT02075515|667573|P2|Overall Study|Non-Serious Adverse Event|1
207515|NCT02075515|667574|P1|Overall Study|Non-Serious Adverse Event|0
207516|NCT02075515|667572|P3|Overall Study|Serious Adverse Event|1
207517|NCT02075515|667573|P2|Overall Study|Serious Adverse Event|1
207518|NCT02075515|667574|P1|Overall Study|Serious Adverse Event|1
207519|NCT02075073|667658|P3|Overall Study|Withdrawal by Subject|0
207520|NCT02075073|667659|P2|Overall Study|Withdrawal by Subject|1
207521|NCT02075073|667660|P1|Overall Study|Withdrawal by Subject|0
207522|NCT02075008|667677|P1|Overall Study|Study terminated by Sponsor|159
207523|NCT02075008|667677|P1|Overall Study|Withdrawal by Subject|6
207524|NCT02075008|667677|P1|Overall Study|Adverse Event|5
207525|NCT02075008|667677|P1|Overall Study|Death|1
207526|NCT02075008|667677|P1|Overall Study|Lack of Efficacy|1
207527|NCT02075008|667677|P1|Overall Study|Lost to Follow-up|1
207528|NCT02075008|667677|P1|Overall Study|Physician Decision|1
207529|NCT02075008|667677|P1|Overall Study|Pregnancy|1
207530|NCT02075008|667677|P1|Overall Study|Technical problems|1
207531|NCT02074553|667709|P8|Washout Period 3|Physician Decision|1
207532|NCT02074553|667710|P7|Washout Period 3|Physician Decision|0
207533|NCT02074553|667711|P6|Washout Period 3|Physician Decision|0
207534|NCT02074553|667712|P5|Washout Period 3|Physician Decision|0
207535|NCT02074553|667713|P4|Washout Period 3|Physician Decision|0
207536|NCT02074553|667714|P3|Washout Period 3|Physician Decision|0
207537|NCT02074553|667715|P2|Washout Period 3|Physician Decision|0
207538|NCT02074553|667716|P1|Washout Period 3|Physician Decision|0
207539|NCT02074553|667709|P8|Washout Period 2|Lost to Follow-up|0
207540|NCT02074553|667710|P7|Washout Period 2|Lost to Follow-up|0
207541|NCT02074553|667711|P6|Washout Period 2|Lost to Follow-up|0
207542|NCT02074553|667712|P5|Washout Period 2|Lost to Follow-up|0
207543|NCT02074553|667713|P4|Washout Period 2|Lost to Follow-up|0
207544|NCT02074553|667714|P3|Washout Period 2|Lost to Follow-up|1
207545|NCT02074553|667715|P2|Washout Period 2|Lost to Follow-up|0
207546|NCT02074553|667716|P1|Washout Period 2|Lost to Follow-up|0
207547|NCT02074553|667709|P8|Washout Period 2|Physician Decision|0
207548|NCT02074553|667710|P7|Washout Period 2|Physician Decision|0
207549|NCT02074553|667711|P6|Washout Period 2|Physician Decision|1
207550|NCT02074553|667712|P5|Washout Period 2|Physician Decision|0
207551|NCT02074553|667713|P4|Washout Period 2|Physician Decision|0
207552|NCT02074553|667714|P3|Washout Period 2|Physician Decision|0
207553|NCT02074553|667715|P2|Washout Period 2|Physician Decision|0
207554|NCT02074553|667716|P1|Washout Period 2|Physician Decision|0
207555|NCT02074553|667709|P8|Washout Period 2|Adverse Event|0
207556|NCT02074553|667710|P7|Washout Period 2|Adverse Event|1
207557|NCT02074553|667711|P6|Washout Period 2|Adverse Event|0
207558|NCT02074553|667712|P5|Washout Period 2|Adverse Event|0
207559|NCT02074553|667713|P4|Washout Period 2|Adverse Event|0
207560|NCT02074553|667714|P3|Washout Period 2|Adverse Event|0
207561|NCT02074553|667715|P2|Washout Period 2|Adverse Event|0
207562|NCT02074553|667716|P1|Washout Period 2|Adverse Event|0
207563|NCT02074553|667709|P8|Washout Period 1|Unspecified|0
207564|NCT02074553|667710|P7|Washout Period 1|Unspecified|0
207565|NCT02074553|667711|P6|Washout Period 1|Unspecified|1
207566|NCT02074553|667712|P5|Washout Period 1|Unspecified|0
207567|NCT02074553|667713|P4|Washout Period 1|Unspecified|0
207568|NCT02074553|667714|P3|Washout Period 1|Unspecified|0
207569|NCT02074553|667715|P2|Washout Period 1|Unspecified|0
207570|NCT02074553|667716|P1|Washout Period 1|Unspecified|0
207571|NCT02074553|667709|P8|Washout Period 1|Physician Decision|0
207572|NCT02074553|667710|P7|Washout Period 1|Physician Decision|0
207573|NCT02074553|667711|P6|Washout Period 1|Physician Decision|0
207574|NCT02074553|667712|P5|Washout Period 1|Physician Decision|0
207575|NCT02074553|667713|P4|Washout Period 1|Physician Decision|1
207576|NCT02074553|667714|P3|Washout Period 1|Physician Decision|0
207577|NCT02074553|667715|P2|Washout Period 1|Physician Decision|0
207578|NCT02074553|667716|P1|Washout Period 1|Physician Decision|0
207579|NCT02074553|667709|P8|Washout Period 1|Adverse Event|0
207580|NCT02074553|667710|P7|Washout Period 1|Adverse Event|0
207581|NCT02074553|667711|P6|Washout Period 1|Adverse Event|0
207582|NCT02074553|667712|P5|Washout Period 1|Adverse Event|0
207583|NCT02074553|667713|P4|Washout Period 1|Adverse Event|0
207584|NCT02074553|667714|P3|Washout Period 1|Adverse Event|0
207585|NCT02074553|667715|P2|Washout Period 1|Adverse Event|0
207586|NCT02074553|667716|P1|Washout Period 1|Adverse Event|1
207587|NCT02074553|667709|P8|Intervention Period 1|Family Emergency|0
207588|NCT02074553|667710|P7|Intervention Period 1|Family Emergency|0
207589|NCT02074553|667711|P6|Intervention Period 1|Family Emergency|0
207590|NCT02074553|667712|P5|Intervention Period 1|Family Emergency|0
207591|NCT02074553|667713|P4|Intervention Period 1|Family Emergency|1
207592|NCT02074553|667714|P3|Intervention Period 1|Family Emergency|0
207593|NCT02074553|667715|P2|Intervention Period 1|Family Emergency|0
207594|NCT02074553|667716|P1|Intervention Period 1|Family Emergency|0
207595|NCT02074514|667898|P2|Overall Study|Withdrew Consent|1
207596|NCT02074514|667899|P1|Overall Study|Withdrew Consent|0
207597|NCT02074514|667898|P2|Overall Study|Lost to Follow-up|1
207598|NCT02074514|667899|P1|Overall Study|Lost to Follow-up|0
207599|NCT02074514|667898|P2|Overall Study|Lack of Efficacy|2
207600|NCT02074514|667899|P1|Overall Study|Lack of Efficacy|3
207601|NCT02074059|668040|P6|Overall Study|Death|1
207602|NCT02074059|668041|P5|Overall Study|Death|1
207603|NCT02074059|668042|P4|Overall Study|Death|0
207604|NCT02074059|668043|P3|Overall Study|Death|0
207605|NCT02074059|668044|P2|Overall Study|Death|0
207606|NCT02074059|668045|P1|Overall Study|Death|0
207607|NCT02073656|668083|P1|Primary Study|Withdrew Consent|1
207608|NCT02073656|668083|P1|Primary Study|Death|1
207609|NCT02073656|668083|P1|Primary Study|Lost to Follow-up|6
207610|NCT02072980|668161|P2|Period 2, Second Wear|Adverse Event|1
207611|NCT02072980|668162|P1|Period 2, Second Wear|Adverse Event|0
207612|NCT02072096|668184|P2|Overall Study|Lost to Follow-up|0
207613|NCT02072096|668185|P1|Overall Study|Lost to Follow-up|1
207614|NCT02072096|668184|P2|Overall Study|Study Terminated by Sponsor|30
207615|NCT02072096|668185|P1|Overall Study|Study Terminated by Sponsor|43
207616|NCT02072096|668184|P2|Overall Study|Physician Decision|1
207617|NCT02072096|668185|P1|Overall Study|Physician Decision|0
207618|NCT02072096|668184|P2|Overall Study|Death|0
207619|NCT02072096|668185|P1|Overall Study|Death|2
207620|NCT02072096|668184|P2|Overall Study|No Reason Provided|2
207621|NCT02072096|668185|P1|Overall Study|No Reason Provided|4
207622|NCT02072096|668184|P2|Overall Study|Adverse Event|2
207623|NCT02072096|668185|P1|Overall Study|Adverse Event|5
207624|NCT02072096|668184|P2|Overall Study|Withdrawal by Subject|7
207625|NCT02072096|668185|P1|Overall Study|Withdrawal by Subject|5
207626|NCT02072096|668184|P2|Overall Study|Protocol Violation|7
207627|NCT02072096|668185|P1|Overall Study|Protocol Violation|7
207628|NCT02072096|668184|P2|Overall Study|Lack of Efficacy|29
207629|NCT02072096|668185|P1|Overall Study|Lack of Efficacy|18
207630|NCT02071849|668207|P1|2-year Extended Follow-up|Adverse Event|1
207631|NCT02071849|668207|P1|6-month Primary Endpoint|Adverse Event|1
207632|NCT02071849|668207|P1|6-month Primary Endpoint|Did not receive device|4
207633|NCT02071771|668273|P2|Period 1: First 10 Days|Unavailable lens power|0
207634|NCT02071771|668274|P1|Period 1: First 10 Days|Unavailable lens power|1
207635|NCT02071771|668273|P2|Period 1: First 10 Days|Unacceptable lens fit|0
207636|NCT02071771|668274|P1|Period 1: First 10 Days|Unacceptable lens fit|1
207637|NCT02071082|668303|P2|Overall Study|Participants Still on Study|68
207638|NCT02071082|668304|P1|Overall Study|Participants Still on Study|3
207639|NCT02071082|668303|P2|Overall Study|Lost to Follow-up|1
207640|NCT02071082|668304|P1|Overall Study|Lost to Follow-up|0
207641|NCT02071082|668303|P2|Overall Study|Withdrew Consent|3
207642|NCT02071082|668304|P1|Overall Study|Withdrew Consent|0
207643|NCT02071082|668303|P2|Overall Study|Non-Compliance with Study Drug|1
207644|NCT02071082|668304|P1|Overall Study|Non-Compliance with Study Drug|0
207645|NCT02071082|668303|P2|Overall Study|Adverse Event|1
207646|NCT02071082|668304|P1|Overall Study|Adverse Event|0
207647|NCT02071082|668303|P2|Overall Study|Enrolled and Never Treated|1
207648|NCT02071082|668304|P1|Overall Study|Enrolled and Never Treated|1
207649|NCT02070965|668335|P3|Overall Study|Subject moved|0
207650|NCT02070965|668336|P2|Overall Study|Subject moved|0
207651|NCT02070965|668337|P1|Overall Study|Subject moved|1
207652|NCT02070965|668335|P3|Overall Study|Withdrawal by Subject|1
207653|NCT02070965|668336|P2|Overall Study|Withdrawal by Subject|1
207654|NCT02070965|668337|P1|Overall Study|Withdrawal by Subject|1
207655|NCT02070965|668335|P3|Overall Study|Lost to Follow-up|0
207656|NCT02070965|668336|P2|Overall Study|Lost to Follow-up|1
207657|NCT02070965|668337|P1|Overall Study|Lost to Follow-up|0
207658|NCT02070380|668379|P4|Second Injection|Protocol Violation|5
207659|NCT02070380|668380|P3|Second Injection|Protocol Violation|1
207660|NCT02070380|668381|P2|Second Injection|Protocol Violation|1
207661|NCT02070380|668382|P1|Second Injection|Protocol Violation|0
207662|NCT02070380|668379|P4|Second Injection|Image sets missing or technically inadeq|0
207663|NCT02070380|668380|P3|Second Injection|Image sets missing or technically inadeq|0
207664|NCT02070380|668381|P2|Second Injection|Image sets missing or technically inadeq|1
207665|NCT02070380|668382|P1|Second Injection|Image sets missing or technically inadeq|0
207666|NCT02070380|668379|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
207667|NCT02070380|668380|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
207668|NCT02070380|668381|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
207669|NCT02070380|668382|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
207670|NCT02069093|668441|P1|Overall Study|Adverse Event|10
207671|NCT02069093|668441|P1|Overall Study|Abnormal laboratory values|1
207672|NCT02069093|668441|P1|Overall Study|Withdrawal by Subject|2
207673|NCT02069093|668441|P1|Overall Study|Administrative problems|1
207674|NCT02069093|668441|P1|Overall Study|Death|1
207675|NCT02069093|668441|P1|Overall Study|New cancer therapy|1
207676|NCT02069093|668441|P1|Overall Study|Disease progression|14
207677|NCT02068443|668453|P3|Overall Study|Other Reason Not Specified|0
207678|NCT02068443|668454|P2|Overall Study|Other Reason Not Specified|0
207679|NCT02068443|668455|P1|Overall Study|Other Reason Not Specified|1
207680|NCT02068443|668453|P3|Overall Study|Lack of Efficacy|0
207681|NCT02068443|668454|P2|Overall Study|Lack of Efficacy|1
207682|NCT02068443|668455|P1|Overall Study|Lack of Efficacy|2
207683|NCT02068443|668453|P3|Overall Study|Voluntary Withdrawal|1
207684|NCT02068443|668454|P2|Overall Study|Voluntary Withdrawal|0
207685|NCT02068443|668455|P1|Overall Study|Voluntary Withdrawal|4
207686|NCT02068443|668453|P3|Overall Study|Pretreatment Event/Adverse Event|2
207687|NCT02068443|668454|P2|Overall Study|Pretreatment Event/Adverse Event|5
207688|NCT02068443|668455|P1|Overall Study|Pretreatment Event/Adverse Event|0
207689|NCT02068222|668490|P1|Overall Study|Lost to Follow-up|1
207690|NCT02067728|668499|P2|6 Month Measurements|Unable to attend|97
207691|NCT02067728|668500|P1|6 Month Measurements|Unable to attend|114
207692|NCT02067728|668499|P2|6 Month Follow up Survey|Lost to Follow-up|60
207693|NCT02067728|668500|P1|6 Month Follow up Survey|Lost to Follow-up|48
207694|NCT02067728|668499|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
207695|NCT02067728|668500|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
207696|NCT02067533|668570|P2|Overall Study|Lost to Follow-up|2
207697|NCT02067533|668571|P1|Overall Study|Lost to Follow-up|4
207698|NCT02066922|668586|P1|Overall Study|Adverse Event|1
207699|NCT02066402|668627|P2|Overall Study|Protocol driven decision point|1
207700|NCT02066402|668628|P1|Overall Study|Protocol driven decision point|0
207701|NCT02066402|668627|P2|Overall Study|Progressive disease-clinical progression|1
207702|NCT02066402|668628|P1|Overall Study|Progressive disease-clinical progression|0
207703|NCT02066402|668627|P2|Overall Study|Withdrawal by Subject|11
207704|NCT02066402|668628|P1|Overall Study|Withdrawal by Subject|14
207705|NCT02066402|668627|P2|Overall Study|Lost to Follow-up|8
207706|NCT02066402|668628|P1|Overall Study|Lost to Follow-up|11
207707|NCT02066402|668627|P2|Overall Study|Adverse Event|2
207708|NCT02066402|668628|P1|Overall Study|Adverse Event|1
207709|NCT02066051|668654|P1|Overall Study|Subject developed active GVHD|1
207710|NCT02064231|668852|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
207711|NCT02064231|668853|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
207712|NCT02064231|668854|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
207713|NCT02064231|668855|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
207714|NCT02064231|668852|P4|First Test Period (Test A or Test C)|Adverse Event|0
207715|NCT02064231|668853|P3|First Test Period (Test A or Test C)|Adverse Event|1
207716|NCT02064231|668854|P2|First Test Period (Test A or Test C)|Adverse Event|0
207717|NCT02064231|668855|P1|First Test Period (Test A or Test C)|Adverse Event|1
207718|NCT02064231|668852|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
207719|NCT02064231|668853|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
207720|NCT02064231|668854|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
207721|NCT02064231|668855|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
207722|NCT02064231|668852|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
207723|NCT02064231|668853|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
207724|NCT02064231|668854|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
207725|NCT02064231|668855|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
207726|NCT02064205|668867|P1|Overall Study|Withdrawal by Subject|1
207727|NCT02063854|668890|P7|Overall Study|Did Not Receive Study Drug|0
207728|NCT02063854|668891|P6|Overall Study|Did Not Receive Study Drug|1
207729|NCT02063854|668892|P5|Overall Study|Did Not Receive Study Drug|0
207730|NCT02063854|668893|P4|Overall Study|Did Not Receive Study Drug|0
207731|NCT02063854|668894|P3|Overall Study|Did Not Receive Study Drug|0
207732|NCT02063854|668895|P2|Overall Study|Did Not Receive Study Drug|0
207733|NCT02063854|668896|P1|Overall Study|Did Not Receive Study Drug|0
207734|NCT02063854|668890|P7|Overall Study|Reason Not Specified|0
207735|NCT02063854|668891|P6|Overall Study|Reason Not Specified|0
207736|NCT02063854|668892|P5|Overall Study|Reason Not Specified|0
207737|NCT02063854|668893|P4|Overall Study|Reason Not Specified|0
207738|NCT02063854|668894|P3|Overall Study|Reason Not Specified|0
207739|NCT02063854|668895|P2|Overall Study|Reason Not Specified|0
207740|NCT02063854|668896|P1|Overall Study|Reason Not Specified|1
207741|NCT02063854|668890|P7|Overall Study|Surgical Dental Work Performed/Planned|1
207742|NCT02063854|668891|P6|Overall Study|Surgical Dental Work Performed/Planned|6
207743|NCT02063854|668892|P5|Overall Study|Surgical Dental Work Performed/Planned|1
207744|NCT02063854|668893|P4|Overall Study|Surgical Dental Work Performed/Planned|1
207745|NCT02063854|668894|P3|Overall Study|Surgical Dental Work Performed/Planned|6
207746|NCT02063854|668895|P2|Overall Study|Surgical Dental Work Performed/Planned|2
207747|NCT02063854|668896|P1|Overall Study|Surgical Dental Work Performed/Planned|5
207748|NCT02063854|668890|P7|Overall Study|Voluntary Withdrawal|1
207749|NCT02063854|668891|P6|Overall Study|Voluntary Withdrawal|6
207750|NCT02063854|668892|P5|Overall Study|Voluntary Withdrawal|3
207751|NCT02063854|668893|P4|Overall Study|Voluntary Withdrawal|1
207752|NCT02063854|668894|P3|Overall Study|Voluntary Withdrawal|8
207753|NCT02063854|668895|P2|Overall Study|Voluntary Withdrawal|0
207754|NCT02063854|668896|P1|Overall Study|Voluntary Withdrawal|2
207755|NCT02063854|668890|P7|Overall Study|Major Protocol Deviation|0
207756|NCT02063854|668891|P6|Overall Study|Major Protocol Deviation|0
207757|NCT02063854|668892|P5|Overall Study|Major Protocol Deviation|0
207758|NCT02063854|668893|P4|Overall Study|Major Protocol Deviation|0
207759|NCT02063854|668894|P3|Overall Study|Major Protocol Deviation|3
207760|NCT02063854|668895|P2|Overall Study|Major Protocol Deviation|0
207761|NCT02063854|668896|P1|Overall Study|Major Protocol Deviation|0
207762|NCT02063854|668890|P7|Overall Study|Pretreatment Event/Adverse Event|4
207763|NCT02063854|668891|P6|Overall Study|Pretreatment Event/Adverse Event|18
207764|NCT02063854|668892|P5|Overall Study|Pretreatment Event/Adverse Event|7
207765|NCT02063854|668893|P4|Overall Study|Pretreatment Event/Adverse Event|8
207766|NCT02063854|668894|P3|Overall Study|Pretreatment Event/Adverse Event|13
207767|NCT02063854|668895|P2|Overall Study|Pretreatment Event/Adverse Event|10
207858|NCT02059161|669706|P1|Overall Study|Non-compliance with study drug|6
207768|NCT02063854|668896|P1|Overall Study|Pretreatment Event/Adverse Event|13
207769|NCT02063737|668980|P2|Overall Study|Lost to Follow-up|4
207770|NCT02063737|668981|P1|Overall Study|Lost to Follow-up|11
207771|NCT02062658|669115|P1|Overall Study|Lack of Efficacy|1
207772|NCT02062658|669115|P1|Overall Study|Withdrawal by Subject|1
207773|NCT02062645|669119|P1|Overall Study|Lost to Follow-up|5
207774|NCT02062645|669119|P1|Overall Study|Protocol Violation|8
207775|NCT02062645|669119|P1|Overall Study|Adverse Event|2
207776|NCT02062450|669161|P1|Overall Study|No follow-up visit|124
207777|NCT02062437|669175|P1|Overall Study|Pt. couldn't come due to med. condition|1
207778|NCT02062437|669175|P1|Overall Study|Death|2
207779|NCT02062437|669175|P1|Overall Study|Patient not available for the 2y visit|18
207780|NCT02062437|669175|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
207781|NCT02062385|669188|P4|Overall Study|Lost to Follow-up|0
207782|NCT02062385|669189|P3|Overall Study|Lost to Follow-up|1
207783|NCT02062385|669190|P2|Overall Study|Lost to Follow-up|0
207784|NCT02062385|669191|P1|Overall Study|Lost to Follow-up|0
207785|NCT02062385|669188|P4|Overall Study|Death|1
207786|NCT02062385|669189|P3|Overall Study|Death|0
207787|NCT02062385|669190|P2|Overall Study|Death|0
207788|NCT02062385|669191|P1|Overall Study|Death|0
207789|NCT02062385|669188|P4|Overall Study|Withdrawn by parent/guardian|8
207790|NCT02062385|669189|P3|Overall Study|Withdrawn by parent/guardian|9
207791|NCT02062385|669190|P2|Overall Study|Withdrawn by parent/guardian|41
207792|NCT02062385|669191|P1|Overall Study|Withdrawn by parent/guardian|46
207793|NCT02062385|669188|P4|Overall Study|Moved|0
207794|NCT02062385|669189|P3|Overall Study|Moved|1
207795|NCT02062385|669190|P2|Overall Study|Moved|11
207796|NCT02062385|669191|P1|Overall Study|Moved|10
207797|NCT02062385|669188|P4|Overall Study|Incomplete EPI by database lock|0
207798|NCT02062385|669189|P3|Overall Study|Incomplete EPI by database lock|0
207799|NCT02062385|669190|P2|Overall Study|Incomplete EPI by database lock|0
207800|NCT02062385|669191|P1|Overall Study|Incomplete EPI by database lock|2
207801|NCT02062385|669188|P4|Overall Study|Protocol Violation|0
207802|NCT02062385|669189|P3|Overall Study|Protocol Violation|0
207803|NCT02062385|669190|P2|Overall Study|Protocol Violation|0
207804|NCT02062385|669191|P1|Overall Study|Protocol Violation|1
207805|NCT02062385|669188|P4|Overall Study|Adverse Event|0
207806|NCT02062385|669189|P3|Overall Study|Adverse Event|1
207807|NCT02062385|669190|P2|Overall Study|Adverse Event|13
207808|NCT02062385|669191|P1|Overall Study|Adverse Event|19
207809|NCT02061592|669317|P2|Period 2|Lost to Follow-up|1
207810|NCT02061592|669318|P1|Period 2|Lost to Follow-up|0
207811|NCT02061592|669317|P2|Period 1|Protocol Violation|0
207812|NCT02061592|669318|P1|Period 1|Protocol Violation|1
207813|NCT02061592|669317|P2|Period 1|Withdrawal by Subject|0
207814|NCT02061592|669318|P1|Period 1|Withdrawal by Subject|1
207815|NCT02061540|669330|P1|Overall Study|Withdrawal by Subject|2
207816|NCT02061540|669330|P1|Overall Study|Adverse Event|2
207817|NCT02059291|669632|P6|Overall Study|Withdrawal by Subject|1
207818|NCT02059291|669633|P5|Overall Study|Withdrawal by Subject|0
207819|NCT02059291|669634|P4|Overall Study|Withdrawal by Subject|0
207820|NCT02059291|669635|P3|Overall Study|Withdrawal by Subject|0
207821|NCT02059291|669636|P2|Overall Study|Withdrawal by Subject|1
207822|NCT02059291|669637|P1|Overall Study|Withdrawal by Subject|0
207823|NCT02059291|669632|P6|Overall Study|Adverse Event|0
207824|NCT02059291|669633|P5|Overall Study|Adverse Event|0
207825|NCT02059291|669634|P4|Overall Study|Adverse Event|1
207826|NCT02059291|669635|P3|Overall Study|Adverse Event|1
207827|NCT02059291|669636|P2|Overall Study|Adverse Event|0
207828|NCT02059291|669637|P1|Overall Study|Adverse Event|0
207829|NCT02059291|669632|P6|Overall Study|Lack of Efficacy|1
207830|NCT02059291|669633|P5|Overall Study|Lack of Efficacy|0
207831|NCT02059291|669634|P4|Overall Study|Lack of Efficacy|1
207832|NCT02059291|669635|P3|Overall Study|Lack of Efficacy|0
207833|NCT02059291|669636|P2|Overall Study|Lack of Efficacy|0
207834|NCT02059291|669637|P1|Overall Study|Lack of Efficacy|0
207835|NCT02059187|669653|P2|Overall Study|Withdrawal by Subject|8
207836|NCT02059187|669654|P1|Overall Study|Withdrawal by Subject|12
207837|NCT02059187|669653|P2|Overall Study|Protocol Violation|0
207838|NCT02059187|669654|P1|Overall Study|Protocol Violation|1
207839|NCT02059187|669653|P2|Overall Study|Physician Decision|2
207840|NCT02059187|669654|P1|Overall Study|Physician Decision|1
207841|NCT02059187|669653|P2|Overall Study|Non-compliance with study drug|0
207842|NCT02059187|669654|P1|Overall Study|Non-compliance with study drug|1
207843|NCT02059187|669653|P2|Overall Study|Lost to Follow-up|8
207844|NCT02059187|669654|P1|Overall Study|Lost to Follow-up|9
207845|NCT02059187|669653|P2|Overall Study|Death|1
207846|NCT02059187|669654|P1|Overall Study|Death|1
207847|NCT02059187|669653|P2|Overall Study|Adverse Event|3
207848|NCT02059187|669654|P1|Overall Study|Adverse Event|0
207849|NCT02059174|669680|P2|Period 3|Physician Decision|0
207850|NCT02059174|669681|P1|Period 3|Physician Decision|1
207851|NCT02059174|669680|P2|Period 2|Protocol Violation|0
207852|NCT02059174|669681|P1|Period 2|Protocol Violation|1
207853|NCT02059174|669680|P2|Period 2|Withdrawal by Subject|2
207854|NCT02059174|669681|P1|Period 2|Withdrawal by Subject|0
207855|NCT02059174|669680|P2|Period 1|Withdrawal by Subject|2
207856|NCT02059174|669681|P1|Period 1|Withdrawal by Subject|0
207857|NCT02059161|669705|P2|Overall Study|Non-compliance with study drug|2
207859|NCT02059161|669705|P2|Overall Study|Randomized in error, no study drug|1
207860|NCT02059161|669706|P1|Overall Study|Randomized in error, no study drug|0
207861|NCT02059161|669705|P2|Overall Study|Withdrawal by Subject|13
207862|NCT02059161|669706|P1|Overall Study|Withdrawal by Subject|16
207863|NCT02059161|669705|P2|Overall Study|Protocol Violation|1
207864|NCT02059161|669706|P1|Overall Study|Protocol Violation|1
207865|NCT02059161|669705|P2|Overall Study|Physician Decision|4
207866|NCT02059161|669706|P1|Overall Study|Physician Decision|4
207867|NCT02059161|669705|P2|Overall Study|Lost to Follow-up|12
207868|NCT02059161|669706|P1|Overall Study|Lost to Follow-up|20
207869|NCT02059161|669705|P2|Overall Study|Adverse Event|6
207870|NCT02059161|669706|P1|Overall Study|Adverse Event|2
207871|NCT02059161|669705|P2|Overall Study|Pregnancy|2
207872|NCT02059161|669706|P1|Overall Study|Pregnancy|0
207873|NCT02058992|669781|P1|Overall Study|CRF Uncollected|20
207874|NCT02058992|669781|P1|Overall Study|Protocol Violation|92
207875|NCT02058992|669781|P1|Overall Study|Lost to Follow-up|4
207876|NCT02058563|669792|P2|Overall Study|Other (patient incarcerated)|1
207877|NCT02058563|669793|P1|Overall Study|Other (patient incarcerated)|0
207878|NCT02058563|669792|P2|Overall Study|Consent Withdrawal|1
207879|NCT02058563|669793|P1|Overall Study|Consent Withdrawal|1
207880|NCT02058563|669792|P2|Overall Study|Other (vaccinated later as new subject)|0
207881|NCT02058563|669793|P1|Overall Study|Other (vaccinated later as new subject)|1
207882|NCT02058563|669792|P2|Overall Study|Lost to Follow-up|22
207883|NCT02058563|669793|P1|Overall Study|Lost to Follow-up|26
207884|NCT02058537|669829|P1|Overall Study|Withdrawal by Subject|1
207885|NCT02058498|669835|P1|Overall Study|Withdrawal by Subject|4
207886|NCT02058290|669843|P2|Overall Study|Withdrawal by Subject|1
207887|NCT02058290|669844|P1|Overall Study|Withdrawal by Subject|0
207888|NCT02058290|669843|P2|Overall Study|Didn't meet intraoperative criteria|7
207889|NCT02058290|669844|P1|Overall Study|Didn't meet intraoperative criteria|8
207890|NCT02058290|669843|P2|Overall Study|Physician Decision|0
207891|NCT02058290|669844|P1|Overall Study|Physician Decision|1
207892|NCT02058290|669843|P2|Overall Study|Protocol Violation|1
207893|NCT02058290|669844|P1|Overall Study|Protocol Violation|2
207894|NCT02058160|669860|P2|Overall Study|Other than specified above|6
207895|NCT02058160|669861|P1|Overall Study|Other than specified above|12
207896|NCT02058160|669860|P2|Overall Study|Lost to Follow-up|0
207897|NCT02058160|669861|P1|Overall Study|Lost to Follow-up|1
207898|NCT02058160|669860|P2|Overall Study|Adverse Event|3
207899|NCT02058160|669861|P1|Overall Study|Adverse Event|12
207900|NCT02058160|669860|P2|Overall Study|Poor compliance to protocol|1
207901|NCT02058160|669861|P1|Overall Study|Poor compliance to protocol|4
207902|NCT02058160|669860|P2|Overall Study|Randomized but not treated|4
207903|NCT02058160|669861|P1|Overall Study|Randomized but not treated|2
207904|NCT02058147|669898|P3|Overall Study|Other than specified|0
207905|NCT02058147|669899|P2|Overall Study|Other than specified|9
207906|NCT02058147|669900|P1|Overall Study|Other than specified|8
207907|NCT02058147|669898|P3|Overall Study|Poor compliance to protocol|4
207908|NCT02058147|669899|P2|Overall Study|Poor compliance to protocol|9
207909|NCT02058147|669900|P1|Overall Study|Poor compliance to protocol|8
207910|NCT02058147|669898|P3|Overall Study|Lack of Efficacy|3
207911|NCT02058147|669899|P2|Overall Study|Lack of Efficacy|0
207912|NCT02058147|669900|P1|Overall Study|Lack of Efficacy|1
207913|NCT02058147|669898|P3|Overall Study|Adverse Event|21
207914|NCT02058147|669899|P2|Overall Study|Adverse Event|9
207915|NCT02058147|669900|P1|Overall Study|Adverse Event|12
207916|NCT02058147|669898|P3|Overall Study|Randomized but not treated|1
207917|NCT02058147|669899|P2|Overall Study|Randomized but not treated|0
207918|NCT02058147|669900|P1|Overall Study|Randomized but not treated|0
207919|NCT02058069|669949|P1|Overall Study|Withdrawal by Subject|6
207920|NCT02058069|669949|P1|Overall Study|Exclusion due to implant size|5
207921|NCT02057835|669968|P10|Overall Study|Withdrawal by Subject|0
207922|NCT02057835|669969|P9|Overall Study|Withdrawal by Subject|0
207923|NCT02057835|669970|P8|Overall Study|Withdrawal by Subject|0
207924|NCT02057835|669971|P7|Overall Study|Withdrawal by Subject|0
207925|NCT02057835|669972|P6|Overall Study|Withdrawal by Subject|0
207926|NCT02057835|669973|P5|Overall Study|Withdrawal by Subject|0
207927|NCT02057835|669974|P4|Overall Study|Withdrawal by Subject|0
207928|NCT02057835|669975|P3|Overall Study|Withdrawal by Subject|0
207929|NCT02057835|669976|P2|Overall Study|Withdrawal by Subject|2
207930|NCT02057835|669977|P1|Overall Study|Withdrawal by Subject|0
207931|NCT02057406|670057|P3|Overall Study|Patient transportation issues|1
207932|NCT02057406|670058|P2|Overall Study|Patient transportation issues|0
207933|NCT02057406|670059|P1|Overall Study|Patient transportation issues|0
207934|NCT02057406|670057|P3|Overall Study|Protocol Violation|0
207935|NCT02057406|670058|P2|Overall Study|Protocol Violation|1
207936|NCT02057406|670059|P1|Overall Study|Protocol Violation|0
207937|NCT02057406|670057|P3|Overall Study|Death|0
207938|NCT02057406|670058|P2|Overall Study|Death|0
207939|NCT02057406|670059|P1|Overall Study|Death|1
207940|NCT02057406|670057|P3|Overall Study|Lost to Follow-up|1
207941|NCT02057406|670058|P2|Overall Study|Lost to Follow-up|0
207942|NCT02057406|670059|P1|Overall Study|Lost to Follow-up|0
207943|NCT02057406|670057|P3|Overall Study|Withdrawal by Subject|0
207944|NCT02057406|670058|P2|Overall Study|Withdrawal by Subject|2
207945|NCT02057406|670059|P1|Overall Study|Withdrawal by Subject|0
207946|NCT02057406|670057|P3|Overall Study|Physician Decision|2
207947|NCT02057406|670058|P2|Overall Study|Physician Decision|0
207948|NCT02057406|670059|P1|Overall Study|Physician Decision|0
207949|NCT02056834|670092|P1|Overall Study|Lost to Follow-up|7
207950|NCT02056392|670117|P6|Overall Study|Withdrawal by Subject|0
207951|NCT02056392|670118|P5|Overall Study|Withdrawal by Subject|1
207952|NCT02056392|670119|P4|Overall Study|Withdrawal by Subject|0
207953|NCT02056392|670120|P3|Overall Study|Withdrawal by Subject|0
207954|NCT02056392|670121|P2|Overall Study|Withdrawal by Subject|0
207955|NCT02056392|670122|P1|Overall Study|Withdrawal by Subject|1
207956|NCT02056392|670117|P6|Overall Study|Protocol Violation|0
207957|NCT02056392|670118|P5|Overall Study|Protocol Violation|0
207958|NCT02056392|670119|P4|Overall Study|Protocol Violation|0
207959|NCT02056392|670120|P3|Overall Study|Protocol Violation|1
207960|NCT02056392|670121|P2|Overall Study|Protocol Violation|0
207961|NCT02056392|670122|P1|Overall Study|Protocol Violation|1
207962|NCT02056392|670117|P6|Overall Study|Lost to Follow-up|0
207963|NCT02056392|670118|P5|Overall Study|Lost to Follow-up|0
207964|NCT02056392|670119|P4|Overall Study|Lost to Follow-up|0
207965|NCT02056392|670120|P3|Overall Study|Lost to Follow-up|2
207966|NCT02056392|670121|P2|Overall Study|Lost to Follow-up|1
207967|NCT02056392|670122|P1|Overall Study|Lost to Follow-up|0
207968|NCT02055352|670181|P2|Overall Study|Reason unknown|5
207969|NCT02055352|670182|P1|Overall Study|Reason unknown|1
207970|NCT02055352|670181|P2|Overall Study|Withdrawal of informed consent|0
207971|NCT02055352|670182|P1|Overall Study|Withdrawal of informed consent|1
207972|NCT02055352|670181|P2|Overall Study|AE, study drug would be detrimental|3
207973|NCT02055352|670182|P1|Overall Study|AE, study drug would be detrimental|1
207974|NCT02055352|670181|P2|Overall Study|Use of prohibited treatment|3
207975|NCT02055352|670182|P1|Overall Study|Use of prohibited treatment|0
207976|NCT02055352|670181|P2|Overall Study|Patient decision|1
207977|NCT02055352|670182|P1|Overall Study|Patient decision|1
207978|NCT02055352|670181|P2|Overall Study|Death|2
207979|NCT02055352|670182|P1|Overall Study|Death|1
207980|NCT02055352|670181|P2|Overall Study|Poor compliance|1
207981|NCT02055352|670182|P1|Overall Study|Poor compliance|1
207982|NCT02055352|670181|P2|Overall Study|Non-eligible|1
207983|NCT02055352|670182|P1|Overall Study|Non-eligible|0
207984|NCT02055352|670181|P2|Overall Study|Adverse Event|1
207985|NCT02055352|670182|P1|Overall Study|Adverse Event|0
207986|NCT02054910|670198|P2|Overall Study|Lost to Follow-up|1
207987|NCT02054910|670199|P1|Overall Study|Lost to Follow-up|4
207988|NCT02054702|670239|P2|Overall Study|Withdrawal by Subject|4
207989|NCT02054702|670240|P1|Overall Study|Withdrawal by Subject|14
207990|NCT02054702|670239|P2|Overall Study|Physician Decision|1
207991|NCT02054702|670240|P1|Overall Study|Physician Decision|0
207992|NCT02054702|670239|P2|Overall Study|Met Withdrawal Criteria|1
207993|NCT02054702|670240|P1|Overall Study|Met Withdrawal Criteria|4
207994|NCT02054702|670239|P2|Overall Study|Adverse Event|1
207995|NCT02054702|670240|P1|Overall Study|Adverse Event|3
207996|NCT02054702|670239|P2|Overall Study|Lost to Follow-up|5
207997|NCT02054702|670240|P1|Overall Study|Lost to Follow-up|3
207998|NCT02054481|670295|P4|Overall Study|Other reason|0
207999|NCT02054481|670296|P3|Overall Study|Other reason|2
208000|NCT02054481|670297|P2|Overall Study|Other reason|1
208001|NCT02054481|670298|P1|Overall Study|Other reason|2
208002|NCT02054481|670295|P4|Overall Study|Lost to Follow-up|0
208003|NCT02054481|670296|P3|Overall Study|Lost to Follow-up|0
208004|NCT02054481|670297|P2|Overall Study|Lost to Follow-up|0
208005|NCT02054481|670298|P1|Overall Study|Lost to Follow-up|1
208006|NCT02054481|670295|P4|Overall Study|Adverse Event|1
208007|NCT02054481|670296|P3|Overall Study|Adverse Event|0
208008|NCT02054481|670297|P2|Overall Study|Adverse Event|1
208009|NCT02054481|670298|P1|Overall Study|Adverse Event|1
208010|NCT02054325|670346|P2|Overall Study|Lost to Follow-up|5
208011|NCT02054325|670347|P1|Overall Study|Lost to Follow-up|8
208012|NCT02053610|670357|P2|Overall Study|Failure to Return|3
208013|NCT02053610|670358|P1|Overall Study|Failure to Return|4
208014|NCT02053610|670357|P2|Overall Study|Did not Receive Treatment|2
208015|NCT02053610|670358|P1|Overall Study|Did not Receive Treatment|0
208016|NCT02053610|670357|P2|Overall Study|Refused treatment/Did not cooperate|0
208017|NCT02053610|670358|P1|Overall Study|Refused treatment/Did not cooperate|3
208018|NCT02053610|670357|P2|Overall Study|Disease Progression|94
208019|NCT02053610|670358|P1|Overall Study|Disease Progression|148
208020|NCT02053610|670357|P2|Overall Study|Administrative/Other|27
208021|NCT02053610|670358|P1|Overall Study|Administrative/Other|34
208022|NCT02053610|670357|P2|Overall Study|Death|25
208023|NCT02053610|670358|P1|Overall Study|Death|31
208024|NCT02053610|670357|P2|Overall Study|Withdrew Consent|14
208025|NCT02053610|670358|P1|Overall Study|Withdrew Consent|12
208026|NCT02053610|670357|P2|Overall Study|Adverse Event/Intercurrent Illness|9
208027|NCT02053610|670358|P1|Overall Study|Adverse Event/Intercurrent Illness|3
208028|NCT02053493|670390|P2|Overall Study|Withdrawal by Subject|1
208029|NCT02053493|670391|P1|Overall Study|Withdrawal by Subject|1
208030|NCT02052466|670497|P1|Overall Study|Acromial fracture|1
208031|NCT02052466|670497|P1|Overall Study|Withdrawal by Subject|1
208032|NCT02052414|670512|P1|Overall Study|Withdrawal by Subject|3
208033|NCT02052414|670512|P1|Overall Study|Lack of Efficacy|2
208034|NCT02052414|670512|P1|Overall Study|Adverse Event|12
208035|NCT02052011|670522|P2|Overall Study|Withdrawal by Subject|2
208036|NCT02052011|670523|P1|Overall Study|Withdrawal by Subject|1
208037|NCT02052011|670522|P2|Overall Study|Lost to Follow-up|0
208038|NCT02052011|670523|P1|Overall Study|Lost to Follow-up|3
208039|NCT02050048|670669|P2|Overall Study|Ineligible after ERCP|1
208040|NCT02050048|670670|P1|Overall Study|Ineligible after ERCP|4
208041|NCT02050048|670669|P2|Overall Study|Death|0
208042|NCT02050048|670670|P1|Overall Study|Death|1
208043|NCT02050048|670669|P2|Overall Study|Lost to Follow-up|1
208044|NCT02050048|670670|P1|Overall Study|Lost to Follow-up|0
208045|NCT02049450|670689|P1|Overall Study|Patients/guardian decision|1
208046|NCT02049450|670689|P1|Overall Study|Withdrawal by Subject|1
208047|NCT02049450|670689|P1|Overall Study|Adverse Event|2
208048|NCT02048072|670729|P1|Overall Study|Lost to Follow-up|1
208049|NCT02048072|670729|P1|Overall Study|Adverse Event|3
208050|NCT02047227|670740|P2|Overall Study|Unspecified|9
208051|NCT02047227|670741|P1|Overall Study|Unspecified|10
208052|NCT02047227|670740|P2|Overall Study|All embryos discarded|11
208053|NCT02047227|670741|P1|Overall Study|All embryos discarded|12
208054|NCT02047227|670740|P2|Overall Study|Intention to freeze all embryos|0
208055|NCT02047227|670741|P1|Overall Study|Intention to freeze all embryos|1
208056|NCT02047227|670740|P2|Overall Study|No fertilization|51
208057|NCT02047227|670741|P1|Overall Study|No fertilization|61
208058|NCT02047227|670740|P2|Overall Study|No oocytes retrieved|20
208059|NCT02047227|670741|P1|Overall Study|No oocytes retrieved|21
208060|NCT02047227|670740|P2|Overall Study|Lack of ovarian response to stimulation|32
208061|NCT02047227|670741|P1|Overall Study|Lack of ovarian response to stimulation|35
208062|NCT02047227|670740|P2|Overall Study|Spontaneous pregnancy|0
208063|NCT02047227|670741|P1|Overall Study|Spontaneous pregnancy|1
208064|NCT02047227|670740|P2|Overall Study|Protocol Violation|0
208065|NCT02047227|670741|P1|Overall Study|Protocol Violation|1
208066|NCT02047227|670740|P2|Overall Study|Lost to Follow-up|3
208067|NCT02047227|670741|P1|Overall Study|Lost to Follow-up|0
208068|NCT02047227|670740|P2|Overall Study|Adverse Event|4
208069|NCT02047227|670741|P1|Overall Study|Adverse Event|2
208070|NCT02046993|670759|P2|Overall Study|Lost to Follow-up|1
208071|NCT02046993|670760|P1|Overall Study|Lost to Follow-up|1
208072|NCT02046993|670759|P2|Overall Study|Withdrawal by Subject|10
208073|NCT02046993|670760|P1|Overall Study|Withdrawal by Subject|2
208074|NCT02046226|670827|P1|Overall Study|Lost to Follow-up|7
208075|NCT02046148|670875|P2|Overall Study|Withdrawal by Subject|2
208076|NCT02046148|670876|P1|Overall Study|Withdrawal by Subject|0
208077|NCT02046148|670875|P2|Overall Study|Lost to Follow-up|1
208078|NCT02046148|670876|P1|Overall Study|Lost to Follow-up|1
208079|NCT02045732|670922|P2|Overall Study|At the discretion of the investigator|1
208080|NCT02045732|670923|P1|Overall Study|At the discretion of the investigator|1
208081|NCT02044848|670982|P2|Overall Study|Administrative Problems|3
208082|NCT02044848|670983|P1|Overall Study|Administrative Problems|2
208083|NCT02044822|670989|P1|Overall Study|Lost to Follow-up|1
208084|NCT02044822|670989|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
208085|NCT02044822|670989|P1|Overall Study|Withdrew Consent|3
208086|NCT02044822|670989|P1|Overall Study|Investigator's Discretion|10
208087|NCT02044822|670989|P1|Overall Study|Study Terminated by Sponsor|77
208088|NCT02044458|671001|P2|Overall Study|Protocol Violation|8
208089|NCT02044458|671002|P1|Overall Study|Protocol Violation|3
208090|NCT02044302|671060|P2|Overall Study|study terminated|0
208091|NCT02044302|671061|P1|Overall Study|study terminated|2
208092|NCT02043782|671108|P6|Period 1|Adverse Event|0
208093|NCT02043782|671109|P5|Period 1|Adverse Event|0
208094|NCT02043782|671110|P4|Period 1|Adverse Event|0
208095|NCT02043782|671111|P3|Period 1|Adverse Event|1
208096|NCT02043782|671112|P2|Period 1|Adverse Event|0
208097|NCT02043782|671113|P1|Period 1|Adverse Event|0
208098|NCT02043366|671186|P6|Overall Study|Lost to Follow-up|2
208099|NCT02043366|671187|P5|Overall Study|Lost to Follow-up|2
208100|NCT02043366|671188|P4|Overall Study|Lost to Follow-up|2
208101|NCT02043366|671189|P3|Overall Study|Lost to Follow-up|2
208102|NCT02043366|671190|P2|Overall Study|Lost to Follow-up|2
208103|NCT02043366|671191|P1|Overall Study|Lost to Follow-up|2
208104|NCT02042924|671227|P1|Overall Study|Early Death|1
208105|NCT02042404|671273|P2|Overall Study|Inability to meet time requirements|0
208106|NCT02042404|671274|P1|Overall Study|Inability to meet time requirements|1
208107|NCT02042404|671273|P2|Overall Study|Unrelated Adverse Event|0
208108|NCT02042404|671274|P1|Overall Study|Unrelated Adverse Event|3
208109|NCT02042404|671273|P2|Overall Study|Death|0
208110|NCT02042404|671274|P1|Overall Study|Death|1
208111|NCT02041520|671292|P2|Overall Study|Hypothiroidism identified during follow-|1
208112|NCT02041520|671293|P1|Overall Study|Hypothiroidism identified during follow-|0
208113|NCT02041520|671292|P2|Overall Study|Lost to Follow-up|1
208114|NCT02041520|671293|P1|Overall Study|Lost to Follow-up|0
208115|NCT02041520|671292|P2|Overall Study|Protocol Violation|0
208116|NCT02041520|671293|P1|Overall Study|Protocol Violation|1
208117|NCT02041520|671292|P2|Overall Study|Withdrawal by Subject|4
208118|NCT02041520|671293|P1|Overall Study|Withdrawal by Subject|3
208119|NCT02041520|671292|P2|Overall Study|Adverse Event|1
208120|NCT02041520|671293|P1|Overall Study|Adverse Event|2
208121|NCT02041286|671336|P1|Overall Study|Adverse Event|1
208122|NCT02040532|671403|P1|Overall Study|Withdrawal by Subject|3
208123|NCT02040532|671403|P1|Overall Study|Adverse Event|4
208124|NCT02040532|671403|P1|Overall Study|Physician Decision|4
208125|NCT02040532|671403|P1|Overall Study|Lost to Follow-up|1
208126|NCT02039778|671426|P1|Overall Study|Never started the protocol treatment|1
208127|NCT02039778|671426|P1|Overall Study|Withdrawal by Subject|1
208128|NCT02039778|671426|P1|Overall Study|Death|2
208129|NCT02039687|671438|P4|Overall Study|treatment assignment could not be confir|0
208130|NCT02039687|671439|P3|Overall Study|treatment assignment could not be confir|2
208131|NCT02039687|671440|P2|Overall Study|treatment assignment could not be confir|0
208132|NCT02039687|671441|P1|Overall Study|treatment assignment could not be confir|0
208133|NCT02039687|671438|P4|Overall Study|Withdrawal by Subject|0
208134|NCT02039687|671439|P3|Overall Study|Withdrawal by Subject|0
208135|NCT02039687|671440|P2|Overall Study|Withdrawal by Subject|1
208136|NCT02039687|671441|P1|Overall Study|Withdrawal by Subject|0
208137|NCT02039687|671438|P4|Overall Study|Adverse Event|0
208138|NCT02039687|671439|P3|Overall Study|Adverse Event|1
208139|NCT02039687|671440|P2|Overall Study|Adverse Event|0
208140|NCT02039687|671441|P1|Overall Study|Adverse Event|0
208141|NCT02039414|671469|P2|Overall Study|Protocol Violation|1
208142|NCT02039414|671470|P1|Overall Study|Protocol Violation|3
208143|NCT02039414|671469|P2|Overall Study|Lost to Follow-up|0
208144|NCT02039414|671470|P1|Overall Study|Lost to Follow-up|2
208145|NCT02039414|671469|P2|Overall Study|Delivered|1
208146|NCT02039414|671470|P1|Overall Study|Delivered|1
208147|NCT02038959|671484|P2|Overall Study|Withdrawal by Subject|8
208148|NCT02038959|671485|P1|Overall Study|Withdrawal by Subject|6
208149|NCT02038933|671513|P1|Follow-up|Disease Progression|2
208150|NCT02038933|671513|P1|Follow-up|Withdrawal by Subject|1
208151|NCT02038933|671513|P1|Follow-up|Lost to Follow-up|1
208152|NCT02038933|671513|P1|Follow-up|Adverse event unrelated to study drug|4
208153|NCT02038933|671513|P1|Follow-up|Death|11
208154|NCT02038933|671513|P1|Treatment|Withdrawal by Subject|1
208155|NCT02038933|671513|P1|Treatment|Disease Progression|101
208156|NCT02038933|671513|P1|Treatment|Study Drug Toxicity|4
208157|NCT02038933|671513|P1|Treatment|Adverse Event Unrelated to Study Drug|6
208158|NCT02038933|671513|P1|Treatment|Lost to Follow-up|1
208159|NCT02038933|671513|P1|Treatment|No longer meets study criteria|1
208160|NCT02038907|671546|P14|Overall Study|Withdrawal by Subject|0
208161|NCT02038907|671547|P13|Overall Study|Withdrawal by Subject|0
208162|NCT02038907|671548|P12|Overall Study|Withdrawal by Subject|0
208163|NCT02038907|671549|P11|Overall Study|Withdrawal by Subject|1
208164|NCT02038907|671550|P10|Overall Study|Withdrawal by Subject|0
208165|NCT02038907|671551|P9|Overall Study|Withdrawal by Subject|0
208166|NCT02038907|671552|P8|Overall Study|Withdrawal by Subject|0
208167|NCT02038907|671553|P7|Overall Study|Withdrawal by Subject|0
208168|NCT02038907|671554|P6|Overall Study|Withdrawal by Subject|0
208169|NCT02038907|671555|P5|Overall Study|Withdrawal by Subject|0
208170|NCT02038907|671556|P4|Overall Study|Withdrawal by Subject|0
208171|NCT02038907|671557|P3|Overall Study|Withdrawal by Subject|0
208172|NCT02038907|671558|P2|Overall Study|Withdrawal by Subject|0
208173|NCT02038907|671559|P1|Overall Study|Withdrawal by Subject|0
208174|NCT02038907|671546|P14|Overall Study|Protocol Violation|0
208175|NCT02038907|671547|P13|Overall Study|Protocol Violation|0
208176|NCT02038907|671548|P12|Overall Study|Protocol Violation|0
208177|NCT02038907|671549|P11|Overall Study|Protocol Violation|1
208178|NCT02038907|671550|P10|Overall Study|Protocol Violation|0
208179|NCT02038907|671551|P9|Overall Study|Protocol Violation|0
208180|NCT02038907|671552|P8|Overall Study|Protocol Violation|0
208181|NCT02038907|671553|P7|Overall Study|Protocol Violation|0
208182|NCT02038907|671554|P6|Overall Study|Protocol Violation|0
208183|NCT02038907|671555|P5|Overall Study|Protocol Violation|0
208184|NCT02038907|671556|P4|Overall Study|Protocol Violation|0
208185|NCT02038907|671557|P3|Overall Study|Protocol Violation|0
208186|NCT02038907|671558|P2|Overall Study|Protocol Violation|0
208187|NCT02038907|671559|P1|Overall Study|Protocol Violation|0
208188|NCT02038790|672087|P2|Day 0 - First Treatment|Withdrawal by Subject|1
208189|NCT02038790|672088|P1|Day 0 - First Treatment|Withdrawal by Subject|1
208190|NCT02038075|672121|P2|Overall Study|Withdrawal by Subject|0
208191|NCT02038075|672122|P1|Overall Study|Withdrawal by Subject|3
208192|NCT02037477|672136|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
208193|NCT02037477|672137|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
208194|NCT02037477|672138|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
208195|NCT02037477|672139|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
208196|NCT02036775|672217|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
208197|NCT02036775|672218|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
208198|NCT02036775|672219|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
208199|NCT02036775|672220|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
208200|NCT02036775|672221|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
208201|NCT02036775|672222|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
208202|NCT02036580|672263|P3|Overall Study|Adverse Event|0
208203|NCT02036580|672264|P2|Overall Study|Adverse Event|0
208204|NCT02036580|672265|P1|Overall Study|Adverse Event|1
208205|NCT02036580|672263|P3|Overall Study|Withdrawal by Subject|0
208206|NCT02036580|672264|P2|Overall Study|Withdrawal by Subject|1
208207|NCT02036580|672265|P1|Overall Study|Withdrawal by Subject|0
208208|NCT02035748|672305|P1|Overall Study|Progressive Disease|1
208209|NCT02035748|672305|P1|Overall Study|Withdrawal by Subject|6
208210|NCT02035748|672305|P1|Overall Study|Physician Decision|3
208211|NCT02035748|672305|P1|Overall Study|Lost to Follow-up|2
208212|NCT02035748|672305|P1|Overall Study|Death|3
208213|NCT02035748|672305|P1|Overall Study|Adverse Event|5
208214|NCT02035475|672315|P1|Overall Study|Equipment Error|1
208215|NCT02035475|672315|P1|Overall Study|Physician Decision|1
208216|NCT02035475|672315|P1|Overall Study|Withdrawal by Subject|4
208217|NCT02035332|672326|P1|Overall Study|Procedure Aborted due to Uterine Width|1
208218|NCT02034877|672334|P2|Overall Study|No Longer Willing to Participate|3
208219|NCT02034877|672335|P1|Overall Study|No Longer Willing to Participate|0
208220|NCT02034877|672334|P2|Overall Study|Lost to Follow-up|3
208221|NCT02034877|672335|P1|Overall Study|Lost to Follow-up|0
208222|NCT02034708|672353|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
208223|NCT02034708|672354|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
208224|NCT02034708|672353|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
208225|NCT02034708|672354|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
208226|NCT02034708|672353|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
208227|NCT02034708|672354|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
208228|NCT02034708|672353|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
208229|NCT02034708|672354|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
208230|NCT02034591|672365|P6|Overall Study|Withdrawal by Subject|0
208231|NCT02034591|672366|P5|Overall Study|Withdrawal by Subject|1
208232|NCT02034591|672367|P4|Overall Study|Withdrawal by Subject|0
208233|NCT02034591|672368|P3|Overall Study|Withdrawal by Subject|0
208234|NCT02034591|672369|P2|Overall Study|Withdrawal by Subject|0
208235|NCT02034591|672370|P1|Overall Study|Withdrawal by Subject|0
208236|NCT02034565|672425|P2|Overall Study|Adverse Event|0
208237|NCT02034565|672426|P1|Overall Study|Adverse Event|1
208238|NCT02034513|672442|P2|Overall Study|Unclassified|1
208239|NCT02034513|672443|P1|Overall Study|Unclassified|0
208240|NCT02034513|672442|P2|Overall Study|Withdrawal by Subject|25
208241|NCT02034513|672443|P1|Overall Study|Withdrawal by Subject|25
208242|NCT02034513|672442|P2|Overall Study|Protocol Violation|10
208243|NCT02034513|672443|P1|Overall Study|Protocol Violation|7
208244|NCT02034513|672442|P2|Overall Study|Pregnancy|3
208245|NCT02034513|672443|P1|Overall Study|Pregnancy|0
208246|NCT02034513|672442|P2|Overall Study|Lost to Follow-up|7
208247|NCT02034513|672443|P1|Overall Study|Lost to Follow-up|6
208248|NCT02034513|672442|P2|Overall Study|Lack of Efficacy|1
208249|NCT02034513|672443|P1|Overall Study|Lack of Efficacy|0
208250|NCT02034513|672442|P2|Overall Study|Adverse Event|10
208251|NCT02034513|672443|P1|Overall Study|Adverse Event|11
208252|NCT02034162|672461|P3|Double-blind|Withdrawal by Subject|0
208253|NCT02034162|672462|P2|Double-blind|Withdrawal by Subject|7
208254|NCT02034162|672463|P1|Double-blind|Withdrawal by Subject|5
208255|NCT02034162|672461|P3|Double-blind|Protocol Violation|0
208256|NCT02034162|672462|P2|Double-blind|Protocol Violation|1
208257|NCT02034162|672463|P1|Double-blind|Protocol Violation|0
208258|NCT02034162|672461|P3|Double-blind|Physician Decision|0
208259|NCT02034162|672462|P2|Double-blind|Physician Decision|0
208260|NCT02034162|672463|P1|Double-blind|Physician Decision|1
208261|NCT02034162|672461|P3|Double-blind|Lost to Follow-up|0
208262|NCT02034162|672462|P2|Double-blind|Lost to Follow-up|0
208263|NCT02034162|672463|P1|Double-blind|Lost to Follow-up|3
208264|NCT02032901|672547|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
208265|NCT02032901|672548|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
208266|NCT02032901|672547|P2|Treatment Period (12 Weeks)|Pregnancy|0
208267|NCT02032901|672548|P1|Treatment Period (12 Weeks)|Pregnancy|1
208268|NCT02032888|672572|P3|Follow-up Period|Not specified|0
208269|NCT02032888|672573|P2|Follow-up Period|Not specified|0
208270|NCT02032888|672574|P1|Follow-up Period|Not specified|1
208271|NCT02032888|672572|P3|Follow-up Period|Death|0
208272|NCT02032888|672573|P2|Follow-up Period|Death|1
208273|NCT02032888|672574|P1|Follow-up Period|Death|1
208274|NCT02032888|672572|P3|Follow-up Period|Lost to Follow-up|0
208275|NCT02032888|672573|P2|Follow-up Period|Lost to Follow-up|1
208276|NCT02032888|672574|P1|Follow-up Period|Lost to Follow-up|1
208277|NCT02032888|672572|P3|Treatment Period|Not specified|0
208278|NCT02032888|672573|P2|Treatment Period|Not specified|1
208279|NCT02032888|672574|P1|Treatment Period|Not specified|1
208280|NCT02032888|672572|P3|Treatment Period|Poor compliance/noncompliance|0
208281|NCT02032888|672573|P2|Treatment Period|Poor compliance/noncompliance|1
208282|NCT02032888|672574|P1|Treatment Period|Poor compliance/noncompliance|1
208283|NCT02032875|672605|P2|Follow-up Period|Virologic Relapse|10
208284|NCT02032875|672606|P1|Follow-up Period|Virologic Relapse|3
208285|NCT02032875|672605|P2|Follow-up Period|Death|1
208286|NCT02032875|672606|P1|Follow-up Period|Death|0
208287|NCT02032875|672605|P2|Treatment Period|Liver transplant, Treatment extension|3
208288|NCT02032875|672606|P1|Treatment Period|Liver transplant, Treatment extension|0
208289|NCT02032875|672605|P2|Treatment Period|Liver transplant, No extension needed|1
208290|NCT02032875|672606|P1|Treatment Period|Liver transplant, No extension needed|0
208291|NCT02032875|672605|P2|Treatment Period|Adverse Event|0
208292|NCT02032875|672606|P1|Treatment Period|Adverse Event|1
208293|NCT02032706|672635|P1|Overall Study|Protocol Violation|1
208294|NCT02032706|672635|P1|Overall Study|Did not qualify|5
208295|NCT02031471|672658|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
208296|NCT02031471|672658|P1|Long Term Extension (LTE) Period|Adverse Event|1
208297|NCT02031471|672658|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
208298|NCT02031471|672658|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
208299|NCT02031471|672658|P1|24 Week Treatment Period|Protocol Violation|1
208300|NCT02031471|672658|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
208301|NCT02031471|672658|P1|24 Week Treatment Period|Adverse Event|6
208302|NCT02031458|672691|P3|Overall Study|Lost to Follow-up|2
208303|NCT02031458|672692|P2|Overall Study|Lost to Follow-up|1
208304|NCT02031458|672693|P1|Overall Study|Lost to Follow-up|1
208305|NCT02031458|672691|P3|Overall Study|On Treatment|73
208306|NCT02031458|672692|P2|Overall Study|On Treatment|81
208307|NCT02031458|672693|P1|Overall Study|On Treatment|43
208308|NCT02031458|672691|P3|Overall Study|On Survival Follow-Up|73
208309|NCT02031458|672692|P2|Overall Study|On Survival Follow-Up|83
208310|NCT02031458|672693|P1|Overall Study|On Survival Follow-Up|46
208311|NCT02031458|672691|P3|Overall Study|Withdrawal by Subject|3
208312|NCT02031458|672692|P2|Overall Study|Withdrawal by Subject|9
208313|NCT02031458|672693|P1|Overall Study|Withdrawal by Subject|6
208314|NCT02031458|672691|P3|Overall Study|Unknown Reason|2
208315|NCT02031458|672692|P2|Overall Study|Unknown Reason|1
208316|NCT02031458|672693|P1|Overall Study|Unknown Reason|0
208317|NCT02031458|672691|P3|Overall Study|Physician Decision|0
208318|NCT02031458|672692|P2|Overall Study|Physician Decision|1
208319|NCT02031458|672693|P1|Overall Study|Physician Decision|0
208320|NCT02031458|672691|P3|Overall Study|Protocol Violation|0
208321|NCT02031458|672692|P2|Overall Study|Protocol Violation|4
208322|NCT02031458|672693|P1|Overall Study|Protocol Violation|7
208323|NCT02031458|672691|P3|Overall Study|Death|100
208324|NCT02031458|672692|P2|Overall Study|Death|87
208325|NCT02031458|672693|P1|Overall Study|Death|36
208326|NCT02032407|672802|P1|Overall Study|Other Miscellaneous Reasons|2
208327|NCT02032407|672802|P1|Overall Study|Pregnancy|1
208328|NCT02032407|672802|P1|Overall Study|Lost to Follow-up|2
208329|NCT02030600|672848|P2|Treatment Period 2|Unclassified|0
208330|NCT02030600|672849|P1|Treatment Period 2|Unclassified|1
208331|NCT02030600|672848|P2|Treatment Period 2|Withdrawal by Subject|9
208332|NCT02030600|672849|P1|Treatment Period 2|Withdrawal by Subject|13
208333|NCT02030600|672848|P2|Treatment Period 2|Protocol Violation|2
208334|NCT02030600|672849|P1|Treatment Period 2|Protocol Violation|1
208335|NCT02030600|672848|P2|Treatment Period 2|Lost to Follow-up|2
208336|NCT02030600|672849|P1|Treatment Period 2|Lost to Follow-up|4
208337|NCT02030600|672848|P2|Treatment Period 2|Lack of Efficacy|1
208338|NCT02030600|672849|P1|Treatment Period 2|Lack of Efficacy|2
208339|NCT02030600|672848|P2|Treatment Period 2|Adverse Event|4
208340|NCT02030600|672849|P1|Treatment Period 2|Adverse Event|4
208341|NCT02030600|672848|P2|Treatment Period 1|Unclassified|0
208342|NCT02030600|672849|P1|Treatment Period 1|Unclassified|1
208343|NCT02030600|672848|P2|Treatment Period 1|Casebook Unsigned|0
208344|NCT02030600|672849|P1|Treatment Period 1|Casebook Unsigned|1
208345|NCT02030600|672848|P2|Treatment Period 1|Withdrawal by Subject|17
208346|NCT02030600|672849|P1|Treatment Period 1|Withdrawal by Subject|13
208347|NCT02030600|672848|P2|Treatment Period 1|Protocol Violation|17
208348|NCT02030600|672849|P1|Treatment Period 1|Protocol Violation|22
208349|NCT02030600|672848|P2|Treatment Period 1|Lost to Follow-up|3
208350|NCT02030600|672849|P1|Treatment Period 1|Lost to Follow-up|11
208351|NCT02030600|672848|P2|Treatment Period 1|Lack of Efficacy|1
208352|NCT02030600|672849|P1|Treatment Period 1|Lack of Efficacy|0
208353|NCT02030600|672848|P2|Treatment Period 1|Adverse Event|7
208354|NCT02030600|672849|P1|Treatment Period 1|Adverse Event|5
208355|NCT02030535|672870|P1|Washout Period 1 (21 Days)|Adverse Event|1
208356|NCT02030405|672938|P1|Overall Study|Lost to Follow-up|1
208357|NCT02030405|672938|P1|Overall Study|Withdrawal by Subject|1
208358|NCT02030041|672946|P3|Overall Study|Withdrawal by Subject|1
208359|NCT02030041|672947|P2|Overall Study|Withdrawal by Subject|2
208360|NCT02030041|672948|P1|Overall Study|Withdrawal by Subject|2
208361|NCT02029989|672961|P2|Overall Study|Protocol Violation|0
208362|NCT02029989|672962|P1|Overall Study|Protocol Violation|1
208363|NCT02029989|672961|P2|Overall Study|Death|1
208364|NCT02029989|672962|P1|Overall Study|Death|0
208365|NCT02029989|672961|P2|Overall Study|Lost to Follow-up|7
208366|NCT02029989|672962|P1|Overall Study|Lost to Follow-up|9
208367|NCT02029989|672961|P2|Overall Study|Physician Decision|0
208368|NCT02029989|672962|P1|Overall Study|Physician Decision|2
208369|NCT02029989|672961|P2|Overall Study|Change of location|3
208370|NCT02029989|672962|P1|Overall Study|Change of location|2
208371|NCT02029989|672961|P2|Overall Study|Withdrawal: Fear of needles|0
208372|NCT02029989|672962|P1|Overall Study|Withdrawal: Fear of needles|1
208373|NCT02029989|672961|P2|Overall Study|Withdrawal by Subject|0
208374|NCT02029989|672962|P1|Overall Study|Withdrawal by Subject|1
208375|NCT02029521|673014|P2|Overall Study|Withdrawal by Subject|1
208376|NCT02029521|673015|P1|Overall Study|Withdrawal by Subject|1
208377|NCT02029521|673014|P2|Overall Study|Protocol Violation|0
208378|NCT02029521|673015|P1|Overall Study|Protocol Violation|1
208379|NCT02029417|673113|P1|Overall Study|Adverse Event|1
208380|NCT02029417|673113|P1|Overall Study|Death|1
208463|NCT02023879|673771|P1|Overall Study|Poor compliance to protocol|0
208381|NCT02028767|673217|P2|Treatment Period 2|Reason other than those specified above|0
208382|NCT02028767|673218|P1|Treatment Period 2|Reason other than those specified above|1
208383|NCT02028767|673217|P2|Treatment Period 2|Non compliant with protocol|0
208384|NCT02028767|673218|P1|Treatment Period 2|Non compliant with protocol|1
208385|NCT02028169|673443|P1|Overall Study|Concomitant Medication Usage|1
208386|NCT02028169|673443|P1|Overall Study|Cessation of Drug|1
208387|NCT02028169|673443|P1|Overall Study|Adverse Event|1
208388|NCT02028169|673443|P1|Overall Study|Withdrawal by Subject|2
208389|NCT02028169|673443|P1|Overall Study|Lack of Efficacy|2
208390|NCT02028169|673443|P1|Overall Study|Lost to Follow-up|21
208391|NCT02028065|673469|P3|Treatment Through Study Completion|Adverse Event|5
208392|NCT02028065|673470|P2|Treatment Through Study Completion|Adverse Event|3
208393|NCT02028065|673471|P1|Treatment Through Study Completion|Adverse Event|3
208394|NCT02028065|673469|P3|Treatment Through Study Completion|Withdrawal by Subject|3
208395|NCT02028065|673470|P2|Treatment Through Study Completion|Withdrawal by Subject|4
208396|NCT02028065|673471|P1|Treatment Through Study Completion|Withdrawal by Subject|5
208397|NCT02028065|673469|P3|Treatment Through Study Completion|Protocol Violation|0
208398|NCT02028065|673470|P2|Treatment Through Study Completion|Protocol Violation|4
208399|NCT02028065|673471|P1|Treatment Through Study Completion|Protocol Violation|1
208400|NCT02028065|673469|P3|Treatment Through Study Completion|Physician Decision|0
208401|NCT02028065|673470|P2|Treatment Through Study Completion|Physician Decision|0
208402|NCT02028065|673471|P1|Treatment Through Study Completion|Physician Decision|1
208403|NCT02028065|673469|P3|Treatment Through Study Completion|Lost to Follow-up|6
208404|NCT02028065|673470|P2|Treatment Through Study Completion|Lost to Follow-up|4
208405|NCT02028065|673471|P1|Treatment Through Study Completion|Lost to Follow-up|2
208406|NCT02028065|673469|P3|Randomization Through Start Treatment|Not treated|3
208407|NCT02028065|673470|P2|Randomization Through Start Treatment|Not treated|3
208408|NCT02028065|673471|P1|Randomization Through Start Treatment|Not treated|1
208409|NCT02027844|673498|P3|Overall Study|Incomlete data|0
208410|NCT02027844|673499|P2|Overall Study|Incomlete data|0
208411|NCT02027844|673500|P1|Overall Study|Incomlete data|2
208412|NCT02027844|673498|P3|Overall Study|Protocol Violation|0
208413|NCT02027844|673499|P2|Overall Study|Protocol Violation|2
208414|NCT02027844|673500|P1|Overall Study|Protocol Violation|0
208415|NCT02027844|673498|P3|Overall Study|Lost to Follow-up|1
208416|NCT02027844|673499|P2|Overall Study|Lost to Follow-up|2
208417|NCT02027844|673500|P1|Overall Study|Lost to Follow-up|0
208418|NCT02027844|673498|P3|Overall Study|Withdrawal by Subject|1
208419|NCT02027844|673499|P2|Overall Study|Withdrawal by Subject|2
208420|NCT02027844|673500|P1|Overall Study|Withdrawal by Subject|3
208421|NCT02027402|673519|P2|Overall Study|Withdrawal by Subject|1
208422|NCT02027402|673520|P1|Overall Study|Withdrawal by Subject|4
208423|NCT02027311|673534|P2|Overall Study|Protocol Violation|2
208424|NCT02027311|673535|P1|Overall Study|Protocol Violation|3
208425|NCT02026141|673574|P2|Overall Study|Protocol Violation|1
208426|NCT02026141|673575|P1|Overall Study|Protocol Violation|0
208427|NCT02025907|673583|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
208428|NCT02025907|673584|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
208429|NCT02025907|673583|P2|Overall Study|Adverse Event|1
208430|NCT02025907|673584|P1|Overall Study|Adverse Event|3
208431|NCT02025907|673583|P2|Overall Study|Lost to Follow-up|2
208432|NCT02025907|673584|P1|Overall Study|Lost to Follow-up|2
208433|NCT02025907|673583|P2|Overall Study|Physician Decision|0
208434|NCT02025907|673584|P1|Overall Study|Physician Decision|2
208435|NCT02025907|673583|P2|Overall Study|Protocol Violation|0
208436|NCT02025907|673584|P1|Overall Study|Protocol Violation|2
208437|NCT02025907|673583|P2|Overall Study|Withdrawal by Subject|8
208438|NCT02025907|673584|P1|Overall Study|Withdrawal by Subject|15
208439|NCT02025907|673583|P2|Overall Study|Lack of Efficacy|0
208440|NCT02025907|673584|P1|Overall Study|Lack of Efficacy|1
208441|NCT02024971|673666|P1|Overall Study|Lost to Follow-up|6
208442|NCT02024971|673666|P1|Overall Study|Data Not Available|30
208443|NCT02024867|673675|P2|Overall Study|Lost to Follow-up|4
208444|NCT02024867|673676|P1|Overall Study|Lost to Follow-up|6
208445|NCT02024867|673675|P2|Overall Study|Protocol Violation|3
208446|NCT02024867|673676|P1|Overall Study|Protocol Violation|3
208447|NCT02024698|673701|P2|First Intervention (7 Days)|Withdrawal by Subject|1
208448|NCT02024698|673702|P1|First Intervention (7 Days)|Withdrawal by Subject|0
208449|NCT02023879|673769|P3|Overall Study|Other than specified above|1
208450|NCT02023879|673770|P2|Overall Study|Other than specified above|3
208451|NCT02023879|673771|P1|Overall Study|Other than specified above|1
208452|NCT02023879|673769|P3|Overall Study|Randomized but not treated|1
208453|NCT02023879|673770|P2|Overall Study|Randomized but not treated|1
208454|NCT02023879|673771|P1|Overall Study|Randomized but not treated|0
208455|NCT02023879|673769|P3|Overall Study|Consent withdrawn by participant|1
208456|NCT02023879|673770|P2|Overall Study|Consent withdrawn by participant|0
208457|NCT02023879|673771|P1|Overall Study|Consent withdrawn by participant|1
208458|NCT02023879|673769|P3|Overall Study|Physician Decision|0
208459|NCT02023879|673770|P2|Overall Study|Physician Decision|1
208460|NCT02023879|673771|P1|Overall Study|Physician Decision|0
208461|NCT02023879|673769|P3|Overall Study|Poor compliance to protocol|1
208462|NCT02023879|673770|P2|Overall Study|Poor compliance to protocol|2
208464|NCT02023879|673769|P3|Overall Study|Adverse Event|5
208465|NCT02023879|673770|P2|Overall Study|Adverse Event|2
208466|NCT02023879|673771|P1|Overall Study|Adverse Event|2
208467|NCT02023268|673862|P2|Overall Study|Withdrawal by Subject|1
208468|NCT02023268|673863|P1|Overall Study|Withdrawal by Subject|0
208469|NCT02023268|673862|P2|Overall Study|Adverse Event|2
208470|NCT02023268|673863|P1|Overall Study|Adverse Event|0
208471|NCT02023268|673862|P2|Overall Study|Lack of Efficacy|1
208472|NCT02023268|673863|P1|Overall Study|Lack of Efficacy|0
208473|NCT02023112|673934|P2|Overall Study|Withdrawal by Subject|1
208474|NCT02023112|673935|P1|Overall Study|Withdrawal by Subject|2
208475|NCT02023099|673956|P3|Overall Study|Non-treatment-emergent Fatal AE|1
208476|NCT02023099|673957|P2|Overall Study|Non-treatment-emergent Fatal AE|0
208477|NCT02023099|673958|P1|Overall Study|Non-treatment-emergent Fatal AE|0
208478|NCT02023099|673956|P3|Overall Study|Withdrawn Consent|1
208479|NCT02023099|673957|P2|Overall Study|Withdrawn Consent|0
208480|NCT02023099|673958|P1|Overall Study|Withdrawn Consent|3
208481|NCT02023099|673956|P3|Overall Study|Non-fatal Adverse Event (AE)|1
208482|NCT02023099|673957|P2|Overall Study|Non-fatal Adverse Event (AE)|0
208483|NCT02023099|673958|P1|Overall Study|Non-fatal Adverse Event (AE)|0
208484|NCT02022670|673977|P3|Overall Study|Adverse Event|1
208485|NCT02022670|673978|P2|Overall Study|Adverse Event|0
208486|NCT02022670|673979|P1|Overall Study|Adverse Event|1
208487|NCT02021331|674028|P2|Overall Study|Adverse Event|2
208488|NCT02021331|674029|P1|Overall Study|Adverse Event|0
208489|NCT02020941|674049|P1|Overall Study|Disease Progression|4
208490|NCT02020941|674049|P1|Overall Study|Withdrawal by Subject|1
208491|NCT02020941|674049|P1|Overall Study|Physician Decision|2
208492|NCT02020941|674049|P1|Overall Study|Adverse Event|1
208493|NCT02020863|674058|P1|Overall Study|Team chose not to place an a line|1
208494|NCT02020863|674058|P1|Overall Study|Discovery of Metastatic disease|4
208495|NCT02020577|674064|P2|Overall Study|Withdrawal by Subject|1
208496|NCT02020577|674065|P1|Overall Study|Withdrawal by Subject|0
208497|NCT02020577|674064|P2|Overall Study|Other AE or clinical progression|15
208498|NCT02020577|674065|P1|Overall Study|Other AE or clinical progression|0
208499|NCT02020577|674064|P2|Overall Study|Progressive disease|36
208500|NCT02020577|674065|P1|Overall Study|Progressive disease|3
208501|NCT02020512|674075|P1|Overall Study|Protocol Violation|4
208502|NCT02020512|674075|P1|Overall Study|Lost to Follow-up|3
208503|NCT02020512|674075|P1|Overall Study|Adverse Event|1
208504|NCT02020031|674110|P2|Overall Study|Physician Decision|1
208505|NCT02020031|674111|P1|Overall Study|Physician Decision|1
208506|NCT02019550|674138|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
208507|NCT02019550|674139|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
208508|NCT02017015|674216|P1|Overall Study|Physician Decision|2
208509|NCT02017015|674216|P1|Overall Study|Non-compliance with study drug|2
208510|NCT02017015|674216|P1|Overall Study|Progressive Disease|31
208511|NCT02017015|674216|P1|Overall Study|Death|4
208512|NCT02017015|674216|P1|Overall Study|Withdrawal by Subject|21
208513|NCT02017015|674216|P1|Overall Study|Adverse Event|9
208514|NCT02016690|674239|P1|Overall Study|Hospitalized for RSV at study start|3
208515|NCT02016690|674239|P1|Overall Study|Did not meet inclusion criteria|13
208516|NCT02016690|674239|P1|Overall Study|Excluded from SAS: Ineligible for study|2
208517|NCT02016690|674239|P1|Overall Study|Excluded from SAS: Early treatment|2
208518|NCT02016690|674239|P1|Overall Study|Excluded from SAS: Duplication|2
208519|NCT02016690|674239|P1|Overall Study|Excluded from SAS: Enrollment violation|2
208520|NCT02016625|674252|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
208521|NCT02016625|674253|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
208522|NCT02016625|674252|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
208523|NCT02016625|674253|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
208524|NCT02016625|674252|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
208525|NCT02016625|674253|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
208526|NCT02016482|674287|P2|Period B|Required Alternative/Prohibited Therapy|2
208527|NCT02016482|674288|P1|Period B|Required Alternative/Prohibited Therapy|0
208528|NCT02016482|674287|P2|Period B|Not Specified|0
208529|NCT02016482|674288|P1|Period B|Not Specified|4
208530|NCT02016482|674287|P2|Period B|Lack of Efficacy|4
208531|NCT02016482|674288|P1|Period B|Lack of Efficacy|6
208532|NCT02016482|674287|P2|Period B|Lost to Follow-up|0
208533|NCT02016482|674288|P1|Period B|Lost to Follow-up|2
208534|NCT02016482|674287|P2|Period B|Withdrawal by Subject|1
208535|NCT02016482|674288|P1|Period B|Withdrawal by Subject|1
208536|NCT02016482|674287|P2|Period A|Required Alternative/Prohibited Therapy|1
208537|NCT02016482|674288|P1|Period A|Required Alternative/Prohibited Therapy|0
208538|NCT02016482|674287|P2|Period A|Protocol Violation|1
208539|NCT02016482|674288|P1|Period A|Protocol Violation|0
208540|NCT02016482|674287|P2|Period A|Not Specified|0
208541|NCT02016482|674288|P1|Period A|Not Specified|3
208542|NCT02016482|674287|P2|Period A|Lack of Efficacy|1
208543|NCT02016482|674288|P1|Period A|Lack of Efficacy|2
208544|NCT02016482|674287|P2|Period A|Lost to Follow-up|3
208545|NCT02016482|674288|P1|Period A|Lost to Follow-up|3
208546|NCT02016482|674287|P2|Period A|Withdrawal by Subject|4
208547|NCT02016482|674288|P1|Period A|Withdrawal by Subject|3
208548|NCT02016482|674287|P2|Period A|Adverse Event|5
208549|NCT02016482|674288|P1|Period A|Adverse Event|3
208550|NCT02016170|674379|P3|Overall Study|Protocol Violation|0
208551|NCT02016170|674380|P2|Overall Study|Protocol Violation|0
208552|NCT02016170|674381|P1|Overall Study|Protocol Violation|1
208553|NCT02016170|674379|P3|Overall Study|Adverse Event|0
208554|NCT02016170|674380|P2|Overall Study|Adverse Event|1
208555|NCT02016170|674381|P1|Overall Study|Adverse Event|1
208556|NCT02016105|674392|P6|EXTENSION PERIOD|Lost to Follow-up|2
208557|NCT02016105|674393|P5|EXTENSION PERIOD|Lost to Follow-up|0
208558|NCT02016105|674394|P4|EXTENSION PERIOD|Lost to Follow-up|0
208559|NCT02016105|674395|P3|EXTENSION PERIOD|Lost to Follow-up|0
208560|NCT02016105|674396|P2|EXTENSION PERIOD|Lost to Follow-up|0
208561|NCT02016105|674397|P1|EXTENSION PERIOD|Lost to Follow-up|0
208562|NCT02016105|674392|P6|EXTENSION PERIOD|Non-compliance with study indication|0
208563|NCT02016105|674393|P5|EXTENSION PERIOD|Non-compliance with study indication|1
208564|NCT02016105|674394|P4|EXTENSION PERIOD|Non-compliance with study indication|0
208565|NCT02016105|674395|P3|EXTENSION PERIOD|Non-compliance with study indication|0
208566|NCT02016105|674396|P2|EXTENSION PERIOD|Non-compliance with study indication|0
208567|NCT02016105|674397|P1|EXTENSION PERIOD|Non-compliance with study indication|0
208568|NCT02016105|674392|P6|EXTENSION PERIOD|Withdrawal by Subject|2
208569|NCT02016105|674393|P5|EXTENSION PERIOD|Withdrawal by Subject|2
208570|NCT02016105|674394|P4|EXTENSION PERIOD|Withdrawal by Subject|2
208571|NCT02016105|674395|P3|EXTENSION PERIOD|Withdrawal by Subject|2
208572|NCT02016105|674396|P2|EXTENSION PERIOD|Withdrawal by Subject|0
208573|NCT02016105|674397|P1|EXTENSION PERIOD|Withdrawal by Subject|0
208574|NCT02016105|674392|P6|EXTENSION PERIOD|Adverse Event|0
208575|NCT02016105|674393|P5|EXTENSION PERIOD|Adverse Event|1
208576|NCT02016105|674394|P4|EXTENSION PERIOD|Adverse Event|0
208577|NCT02016105|674395|P3|EXTENSION PERIOD|Adverse Event|2
208578|NCT02016105|674396|P2|EXTENSION PERIOD|Adverse Event|0
208579|NCT02016105|674397|P1|EXTENSION PERIOD|Adverse Event|0
208580|NCT02016105|674392|P6|EXTENSION PERIOD|Lack of Efficacy|1
208581|NCT02016105|674393|P5|EXTENSION PERIOD|Lack of Efficacy|1
208582|NCT02016105|674394|P4|EXTENSION PERIOD|Lack of Efficacy|3
208583|NCT02016105|674395|P3|EXTENSION PERIOD|Lack of Efficacy|1
208584|NCT02016105|674396|P2|EXTENSION PERIOD|Lack of Efficacy|0
208585|NCT02016105|674397|P1|EXTENSION PERIOD|Lack of Efficacy|0
208586|NCT02016105|674392|P6|EXTENSION PERIOD|New therapy for study indication|1
208587|NCT02016105|674393|P5|EXTENSION PERIOD|New therapy for study indication|1
208588|NCT02016105|674394|P4|EXTENSION PERIOD|New therapy for study indication|0
208589|NCT02016105|674395|P3|EXTENSION PERIOD|New therapy for study indication|0
208590|NCT02016105|674396|P2|EXTENSION PERIOD|New therapy for study indication|0
208591|NCT02016105|674397|P1|EXTENSION PERIOD|New therapy for study indication|0
208592|NCT02016105|674392|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
208593|NCT02016105|674393|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
208594|NCT02016105|674394|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
208595|NCT02016105|674395|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
208596|NCT02016105|674396|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
208597|NCT02016105|674397|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
208598|NCT02016105|674392|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
208599|NCT02016105|674393|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
208600|NCT02016105|674394|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
208601|NCT02016105|674395|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
208602|NCT02016105|674396|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
208603|NCT02016105|674397|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
208604|NCT02016105|674392|P6|TREATMENT PERIOD 2|Adverse Event|1
208605|NCT02016105|674393|P5|TREATMENT PERIOD 2|Adverse Event|0
208606|NCT02016105|674394|P4|TREATMENT PERIOD 2|Adverse Event|4
208607|NCT02016105|674395|P3|TREATMENT PERIOD 2|Adverse Event|0
208608|NCT02016105|674396|P2|TREATMENT PERIOD 2|Adverse Event|0
208609|NCT02016105|674397|P1|TREATMENT PERIOD 2|Adverse Event|0
208610|NCT02016105|674392|P6|TREATMENT PERIOD 2|Death|1
208611|NCT02016105|674393|P5|TREATMENT PERIOD 2|Death|0
208612|NCT02016105|674394|P4|TREATMENT PERIOD 2|Death|0
208613|NCT02016105|674395|P3|TREATMENT PERIOD 2|Death|0
208614|NCT02016105|674396|P2|TREATMENT PERIOD 2|Death|0
208615|NCT02016105|674397|P1|TREATMENT PERIOD 2|Death|0
208616|NCT02016105|674392|P6|TREATMENT PERIOD 2|Pregnancy|1
208617|NCT02016105|674393|P5|TREATMENT PERIOD 2|Pregnancy|0
208618|NCT02016105|674394|P4|TREATMENT PERIOD 2|Pregnancy|0
208619|NCT02016105|674395|P3|TREATMENT PERIOD 2|Pregnancy|0
208620|NCT02016105|674396|P2|TREATMENT PERIOD 2|Pregnancy|0
208621|NCT02016105|674397|P1|TREATMENT PERIOD 2|Pregnancy|0
208622|NCT02016105|674392|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
208623|NCT02016105|674393|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
208624|NCT02016105|674394|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
208625|NCT02016105|674395|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
208626|NCT02016105|674396|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
208627|NCT02016105|674397|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
208628|NCT02016105|674392|P6|TREATMENT PERIOD 2|Non compliance study medication|1
208629|NCT02016105|674393|P5|TREATMENT PERIOD 2|Non compliance study medication|0
208630|NCT02016105|674394|P4|TREATMENT PERIOD 2|Non compliance study medication|0
208631|NCT02016105|674395|P3|TREATMENT PERIOD 2|Non compliance study medication|0
208632|NCT02016105|674396|P2|TREATMENT PERIOD 2|Non compliance study medication|0
208633|NCT02016105|674397|P1|TREATMENT PERIOD 2|Non compliance study medication|0
208634|NCT02016105|674392|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
208635|NCT02016105|674393|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
208636|NCT02016105|674394|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
208637|NCT02016105|674395|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
208638|NCT02016105|674396|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
208639|NCT02016105|674397|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
208640|NCT02016105|674392|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
208641|NCT02016105|674393|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
208642|NCT02016105|674394|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
208643|NCT02016105|674395|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
208644|NCT02016105|674396|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
208645|NCT02016105|674397|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
208646|NCT02016105|674392|P6|TREATMENT PERIOD 1|Adverse Event|0
208647|NCT02016105|674393|P5|TREATMENT PERIOD 1|Adverse Event|0
208648|NCT02016105|674394|P4|TREATMENT PERIOD 1|Adverse Event|0
208649|NCT02016105|674395|P3|TREATMENT PERIOD 1|Adverse Event|0
208650|NCT02016105|674396|P2|TREATMENT PERIOD 1|Adverse Event|5
208651|NCT02016105|674397|P1|TREATMENT PERIOD 1|Adverse Event|3
208652|NCT02016105|674392|P6|TREATMENT PERIOD 1|Pregnancy|0
208653|NCT02016105|674393|P5|TREATMENT PERIOD 1|Pregnancy|0
208654|NCT02016105|674394|P4|TREATMENT PERIOD 1|Pregnancy|0
208655|NCT02016105|674395|P3|TREATMENT PERIOD 1|Pregnancy|0
208656|NCT02016105|674396|P2|TREATMENT PERIOD 1|Pregnancy|1
208657|NCT02016105|674397|P1|TREATMENT PERIOD 1|Pregnancy|0
208658|NCT02016105|674392|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
208659|NCT02016105|674393|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
208660|NCT02016105|674394|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
208661|NCT02016105|674395|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
208662|NCT02016105|674396|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
208663|NCT02016105|674397|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
208664|NCT02016105|674392|P6|TREATMENT PERIOD 1|Physician Decision|0
208665|NCT02016105|674393|P5|TREATMENT PERIOD 1|Physician Decision|0
208666|NCT02016105|674394|P4|TREATMENT PERIOD 1|Physician Decision|0
208667|NCT02016105|674395|P3|TREATMENT PERIOD 1|Physician Decision|0
208668|NCT02016105|674396|P2|TREATMENT PERIOD 1|Physician Decision|2
208669|NCT02016105|674397|P1|TREATMENT PERIOD 1|Physician Decision|0
208670|NCT02016105|674392|P6|TREATMENT PERIOD 1|Protocol Violation|0
208671|NCT02016105|674393|P5|TREATMENT PERIOD 1|Protocol Violation|0
208672|NCT02016105|674394|P4|TREATMENT PERIOD 1|Protocol Violation|0
208673|NCT02016105|674395|P3|TREATMENT PERIOD 1|Protocol Violation|0
208674|NCT02016105|674396|P2|TREATMENT PERIOD 1|Protocol Violation|8
208675|NCT02016105|674397|P1|TREATMENT PERIOD 1|Protocol Violation|2
208676|NCT02015793|674456|P2|Overall Study|Withdrawal by Subject|1
208677|NCT02015793|674457|P1|Overall Study|Withdrawal by Subject|1
208678|NCT02015793|674456|P2|Overall Study|Adverse Event|3
208679|NCT02015793|674457|P1|Overall Study|Adverse Event|3
208680|NCT02015676|674490|P3|Overall Study|Disease progression|1
208681|NCT02015676|674491|P2|Overall Study|Disease progression|1
208682|NCT02015676|674492|P1|Overall Study|Disease progression|3
208683|NCT02015676|674490|P3|Overall Study|Death|0
208684|NCT02015676|674491|P2|Overall Study|Death|1
208685|NCT02015676|674492|P1|Overall Study|Death|0
208686|NCT02015676|674490|P3|Overall Study|Administrative reasons|1
208687|NCT02015676|674491|P2|Overall Study|Administrative reasons|3
208688|NCT02015676|674492|P1|Overall Study|Administrative reasons|0
208689|NCT02015676|674490|P3|Overall Study|Withdrawal by Subject|1
208690|NCT02015676|674491|P2|Overall Study|Withdrawal by Subject|7
208691|NCT02015676|674492|P1|Overall Study|Withdrawal by Subject|1
208692|NCT02015676|674490|P3|Overall Study|Protocol Violation|0
208693|NCT02015676|674491|P2|Overall Study|Protocol Violation|0
208694|NCT02015676|674492|P1|Overall Study|Protocol Violation|1
208695|NCT02015676|674490|P3|Overall Study|Lack of Efficacy|0
208696|NCT02015676|674491|P2|Overall Study|Lack of Efficacy|4
208697|NCT02015676|674492|P1|Overall Study|Lack of Efficacy|2
208698|NCT02015676|674490|P3|Overall Study|Adverse Event|0
208699|NCT02015676|674491|P2|Overall Study|Adverse Event|18
208700|NCT02015676|674492|P1|Overall Study|Adverse Event|2
208701|NCT02015663|674508|P2|Overall Study|Administrative problems|11
208702|NCT02015663|674509|P1|Overall Study|Administrative problems|10
208703|NCT02015663|674508|P2|Overall Study|Adverse Event|0
208704|NCT02015663|674509|P1|Overall Study|Adverse Event|3
208705|NCT02015663|674508|P2|Overall Study|Protocol Violation|1
208706|NCT02015663|674509|P1|Overall Study|Protocol Violation|0
208707|NCT02015663|674508|P2|Overall Study|Withdrawal by Subject|0
208708|NCT02015663|674509|P1|Overall Study|Withdrawal by Subject|1
208709|NCT02015663|674508|P2|Overall Study|unsatisfactory therapeutic effect|0
208710|NCT02015663|674509|P1|Overall Study|unsatisfactory therapeutic effect|1
208711|NCT02015546|674541|P3|Overall Study|Screem Failure|3
208712|NCT02015546|674542|P2|Overall Study|Screem Failure|1
208713|NCT02015546|674543|P1|Overall Study|Screem Failure|2
208714|NCT02015546|674541|P3|Overall Study|Withdrawal by Subject|1
208715|NCT02015546|674542|P2|Overall Study|Withdrawal by Subject|1
208716|NCT02015546|674543|P1|Overall Study|Withdrawal by Subject|1
208717|NCT02015221|674577|P2|Overall Study|Lost to Follow-up|0
208718|NCT02015221|674578|P1|Overall Study|Lost to Follow-up|1
208719|NCT02015221|674577|P2|Overall Study|Withdrawal by Subject|6
208720|NCT02015221|674578|P1|Overall Study|Withdrawal by Subject|8
208721|NCT02015195|674591|P7|Overall Study|Adverse Event|0
208722|NCT02015195|674592|P6|Overall Study|Adverse Event|0
208723|NCT02015195|674593|P5|Overall Study|Adverse Event|0
208724|NCT02015195|674594|P4|Overall Study|Adverse Event|1
208725|NCT02015195|674595|P3|Overall Study|Adverse Event|0
208726|NCT02015195|674596|P2|Overall Study|Adverse Event|0
208727|NCT02015195|674597|P1|Overall Study|Adverse Event|0
208728|NCT02014584|674620|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
208729|NCT02014584|674621|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
208730|NCT02014584|674622|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
208731|NCT02014584|674623|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
208732|NCT02014584|674624|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
208733|NCT02014584|674625|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
208734|NCT02014584|674620|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
208735|NCT02014584|674621|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
208736|NCT02014584|674622|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
208737|NCT02014584|674623|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
208738|NCT02014584|674624|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
208739|NCT02014584|674625|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
208740|NCT02014584|674620|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
208741|NCT02014584|674621|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
208742|NCT02014584|674622|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
208743|NCT02014584|674623|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
208744|NCT02014584|674624|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
208745|NCT02014584|674625|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
208746|NCT02014584|674620|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
208747|NCT02014584|674621|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
208748|NCT02014584|674622|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
208749|NCT02014584|674623|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
208750|NCT02014584|674624|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
208751|NCT02014584|674625|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
208752|NCT02014584|674620|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
208753|NCT02014584|674621|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
208754|NCT02014584|674622|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
208755|NCT02014584|674623|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
208756|NCT02014584|674624|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
208757|NCT02014584|674625|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
208758|NCT02014480|674742|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
208759|NCT02014480|674743|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
208760|NCT02014480|674744|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
208761|NCT02014480|674745|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
208762|NCT02014480|674746|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
208763|NCT02014480|674747|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
208764|NCT02014480|674742|P6|Treatment Period 3 (14 Days)|Adverse Event|1
208765|NCT02014480|674743|P5|Treatment Period 3 (14 Days)|Adverse Event|0
208766|NCT02014480|674744|P4|Treatment Period 3 (14 Days)|Adverse Event|0
208767|NCT02014480|674745|P3|Treatment Period 3 (14 Days)|Adverse Event|1
208768|NCT02014480|674746|P2|Treatment Period 3 (14 Days)|Adverse Event|0
208769|NCT02014480|674747|P1|Treatment Period 3 (14 Days)|Adverse Event|0
208770|NCT02014480|674742|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
208771|NCT02014480|674743|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
208772|NCT02014480|674744|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
208773|NCT02014480|674745|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
208774|NCT02014480|674746|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
208775|NCT02014480|674747|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
208776|NCT02014480|674742|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
208777|NCT02014480|674743|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
208778|NCT02014480|674744|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
208779|NCT02014480|674745|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
208780|NCT02014480|674746|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
208781|NCT02014480|674747|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
208782|NCT02014480|674742|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
208783|NCT02014480|674743|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
208784|NCT02014480|674744|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
208785|NCT02014480|674745|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
208786|NCT02014480|674746|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
208787|NCT02014480|674747|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
208788|NCT02014480|674742|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
208789|NCT02014480|674743|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
208790|NCT02014480|674744|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
208791|NCT02014480|674745|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
208792|NCT02014480|674746|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
208793|NCT02014480|674747|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
208794|NCT02014480|674742|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
208795|NCT02014480|674743|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
208796|NCT02014480|674744|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
208797|NCT02014480|674745|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
208798|NCT02014480|674746|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
208799|NCT02014480|674747|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
208800|NCT02014467|674766|P2|Overall Study|Withdrawal by Subject|4
208801|NCT02014467|674767|P1|Overall Study|Withdrawal by Subject|16
208802|NCT02014467|674766|P2|Overall Study|Physician Decision|3
208803|NCT02014467|674767|P1|Overall Study|Physician Decision|2
208804|NCT02014467|674766|P2|Overall Study|Protocol Violation|0
208805|NCT02014467|674767|P1|Overall Study|Protocol Violation|3
208806|NCT02014467|674766|P2|Overall Study|Adverse Event|0
208807|NCT02014467|674767|P1|Overall Study|Adverse Event|4
208808|NCT02014441|674827|P1|Overall Study|Continuing in Study|21
208809|NCT02014441|674827|P1|Overall Study|Withdrawal by Subject|9
208810|NCT02014402|674923|P4|Overall Study|Lost to Follow-up|2
208811|NCT02014402|674924|P3|Overall Study|Lost to Follow-up|1
208812|NCT02014402|674925|P2|Overall Study|Lost to Follow-up|0
208813|NCT02014402|674926|P1|Overall Study|Lost to Follow-up|0
208814|NCT02014402|674923|P4|Overall Study|Subject did not have transportation|0
208815|NCT02014402|674924|P3|Overall Study|Subject did not have transportation|0
208816|NCT02014402|674925|P2|Overall Study|Subject did not have transportation|1
208817|NCT02014402|674926|P1|Overall Study|Subject did not have transportation|0
208818|NCT02014402|674923|P4|Overall Study|Withdrawal by Subject|1
208819|NCT02014402|674924|P3|Overall Study|Withdrawal by Subject|2
208820|NCT02014402|674925|P2|Overall Study|Withdrawal by Subject|2
208821|NCT02014402|674926|P1|Overall Study|Withdrawal by Subject|1
208822|NCT02014402|674923|P4|Overall Study|Adverse Event|0
208823|NCT02014402|674924|P3|Overall Study|Adverse Event|0
208824|NCT02014402|674925|P2|Overall Study|Adverse Event|0
208825|NCT02014402|674926|P1|Overall Study|Adverse Event|1
208826|NCT02014272|674966|P2|Intervention Period 1|Adverse Event|1
208827|NCT02014272|674967|P1|Intervention Period 1|Adverse Event|0
208828|NCT02014272|674966|P2|Intervention Period 1|Withdrawal by Subject|0
208829|NCT02014272|674967|P1|Intervention Period 1|Withdrawal by Subject|1
208830|NCT02013830|674999|P1|Overall Study|Refused treatment|1
208831|NCT02013830|674999|P1|Overall Study|Insufficient therapeutic response|25
208832|NCT02013830|674999|P1|Overall Study|Death|1
208833|NCT02013830|674999|P1|Overall Study|Adverse Event|3
208834|NCT02013817|675010|P1|Overall Study|Not specified|9
208835|NCT02013817|675010|P1|Overall Study|Death|2
208836|NCT02013817|675010|P1|Overall Study|Withdrawal by Subject|4
208837|NCT02013817|675010|P1|Overall Study|Adverse Event|12
208838|NCT02013765|675019|P1|Overall Study|Trial was terminated by sponsor|1
208839|NCT02013687|675033|P4|Overall Study|Missed visits due to patient travel|0
208840|NCT02013687|675034|P3|Overall Study|Missed visits due to patient travel|1
208841|NCT02013687|675035|P2|Overall Study|Missed visits due to patient travel|0
208842|NCT02013687|675036|P1|Overall Study|Missed visits due to patient travel|0
208843|NCT02013687|675033|P4|Overall Study|Withdrawal by Subject|1
208844|NCT02013687|675034|P3|Overall Study|Withdrawal by Subject|0
208845|NCT02013687|675035|P2|Overall Study|Withdrawal by Subject|0
208846|NCT02013687|675036|P1|Overall Study|Withdrawal by Subject|0
208847|NCT02013687|675033|P4|Overall Study|Protocol Violation|1
208848|NCT02013687|675034|P3|Overall Study|Protocol Violation|0
208849|NCT02013687|675035|P2|Overall Study|Protocol Violation|0
208850|NCT02013687|675036|P1|Overall Study|Protocol Violation|0
208851|NCT02013687|675033|P4|Overall Study|Lost to Follow-up|0
208852|NCT02013687|675034|P3|Overall Study|Lost to Follow-up|1
208853|NCT02013687|675035|P2|Overall Study|Lost to Follow-up|0
208854|NCT02013687|675036|P1|Overall Study|Lost to Follow-up|0
208855|NCT02013622|675066|P1|Overall Study|Lack of Efficacy|1
208856|NCT02013622|675066|P1|Overall Study|Protocol Deviation|1
208857|NCT02013622|675066|P1|Overall Study|Withdrawal by Subject|6
208858|NCT02013622|675066|P1|Overall Study|Met Withdrawal Criteria|3
208859|NCT02013622|675066|P1|Overall Study|Adverse Event|3
208860|NCT02013622|675066|P1|Overall Study|Lost to Follow-up|10
208861|NCT02013609|675086|P1|Overall Study|Met Withdrawal Criteria|3
208862|NCT02013609|675086|P1|Overall Study|Adverse Event|3
208863|NCT02013609|675086|P1|Overall Study|Lost to Follow-up|3
208864|NCT02013609|675086|P1|Overall Study|Withdrawal by Subject|9
208865|NCT02013544|675111|P2|Overall Study|Entry criteria not met/non-compliance|3
208866|NCT02013544|675112|P1|Overall Study|Entry criteria not met/non-compliance|2
208867|NCT02013544|675111|P2|Overall Study|Physician Decision|1
208868|NCT02013544|675112|P1|Overall Study|Physician Decision|0
208869|NCT02013544|675111|P2|Overall Study|Withdrawal by Subject|8
208870|NCT02013544|675112|P1|Overall Study|Withdrawal by Subject|2
208871|NCT02013544|675111|P2|Overall Study|Lost to Follow-up|3
208872|NCT02013544|675112|P1|Overall Study|Lost to Follow-up|2
208873|NCT02013544|675111|P2|Overall Study|Adverse Event|5
208874|NCT02013544|675112|P1|Overall Study|Adverse Event|5
208875|NCT02013531|675134|P1|Overall Study|Withdrawal by Subject|1
208876|NCT02013531|675134|P1|Overall Study|Met Withdrawal Criteria|1
208877|NCT02013531|675134|P1|Overall Study|Lost to Follow-up|3
208878|NCT02013388|675164|P8|Overall Study|work emergency|0
208879|NCT02013388|675165|P7|Overall Study|work emergency|0
208880|NCT02013388|675166|P6|Overall Study|work emergency|0
208881|NCT02013388|675167|P5|Overall Study|work emergency|1
208882|NCT02013388|675168|P4|Overall Study|work emergency|0
208883|NCT02013388|675169|P3|Overall Study|work emergency|0
208884|NCT02013388|675170|P2|Overall Study|work emergency|0
208885|NCT02013388|675171|P1|Overall Study|work emergency|1
208886|NCT02013206|675228|P2|Overall Study|Other reasons off treatment|2
208887|NCT02013206|675229|P1|Overall Study|Other reasons off treatment|5
208888|NCT02013206|675228|P2|Overall Study|Death|2
208889|NCT02013206|675229|P1|Overall Study|Death|1
208890|NCT02013206|675228|P2|Overall Study|Patient non-compliance|0
208891|NCT02013206|675229|P1|Overall Study|Patient non-compliance|1
208892|NCT02013206|675228|P2|Overall Study|Patient refusal|0
208893|NCT02013206|675229|P1|Overall Study|Patient refusal|2
208894|NCT02013206|675228|P2|Overall Study|Adverse Event|0
208895|NCT02013206|675229|P1|Overall Study|Adverse Event|1
208896|NCT02013206|675228|P2|Overall Study|Symptomatic deterioration|1
208897|NCT02013206|675229|P1|Overall Study|Symptomatic deterioration|3
208898|NCT02013206|675228|P2|Overall Study|Progressive disease (PD)|17
208899|NCT02013206|675229|P1|Overall Study|Progressive disease (PD)|14
208900|NCT02012686|675251|P2|Overall Study|electrocardiography monitoring noise|1
208901|NCT02012686|675252|P1|Overall Study|electrocardiography monitoring noise|0
208902|NCT02012686|675251|P2|Overall Study|muscle contraction|1
208903|NCT02012686|675252|P1|Overall Study|muscle contraction|0
208904|NCT02012452|675299|P2|Overall Study|Withdrawal by Subject|0
208905|NCT02012452|675300|P1|Overall Study|Withdrawal by Subject|4
208906|NCT02012452|675299|P2|Overall Study|Lost to Follow-up|1
208907|NCT02012452|675300|P1|Overall Study|Lost to Follow-up|2
208908|NCT02012218|675313|P5|Overall Study|Protocol Deviation|0
208909|NCT02012218|675314|P4|Overall Study|Protocol Deviation|0
208910|NCT02012218|675315|P3|Overall Study|Protocol Deviation|0
208911|NCT02012218|675316|P2|Overall Study|Protocol Deviation|0
208912|NCT02012218|675317|P1|Overall Study|Protocol Deviation|1
208913|NCT02012218|675313|P5|Overall Study|Protocol Specified|0
208914|NCT02012218|675314|P4|Overall Study|Protocol Specified|0
208915|NCT02012218|675315|P3|Overall Study|Protocol Specified|0
208916|NCT02012218|675316|P2|Overall Study|Protocol Specified|0
208917|NCT02012218|675317|P1|Overall Study|Protocol Specified|1
208918|NCT02012218|675313|P5|Overall Study|Lost to Follow-up|0
208919|NCT02012218|675314|P4|Overall Study|Lost to Follow-up|0
208920|NCT02012218|675315|P3|Overall Study|Lost to Follow-up|1
208921|NCT02012218|675316|P2|Overall Study|Lost to Follow-up|1
208922|NCT02012218|675317|P1|Overall Study|Lost to Follow-up|0
208923|NCT02012218|675313|P5|Overall Study|Adverse Event|0
208924|NCT02012218|675314|P4|Overall Study|Adverse Event|1
208925|NCT02012218|675315|P3|Overall Study|Adverse Event|0
208926|NCT02012218|675316|P2|Overall Study|Adverse Event|0
208927|NCT02012218|675317|P1|Overall Study|Adverse Event|1
208928|NCT02012218|675313|P5|Overall Study|Withdrawal by Subject|1
208929|NCT02012218|675314|P4|Overall Study|Withdrawal by Subject|1
208930|NCT02012218|675315|P3|Overall Study|Withdrawal by Subject|1
208931|NCT02012218|675316|P2|Overall Study|Withdrawal by Subject|0
208932|NCT02012218|675317|P1|Overall Study|Withdrawal by Subject|1
208933|NCT02011893|675329|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
208934|NCT02011893|675330|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
208935|NCT02011893|675331|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
208936|NCT02011893|675329|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
208937|NCT02011893|675330|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
208938|NCT02011893|675331|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
208939|NCT02011893|675329|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
208940|NCT02011893|675330|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
208941|NCT02011893|675331|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
208942|NCT02011893|675329|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
208943|NCT02011893|675330|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
208944|NCT02011893|675331|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
208945|NCT02011893|675329|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
208946|NCT02011893|675330|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
208947|NCT02011893|675331|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
208948|NCT02011893|675329|P3|Enrollment to Randomization|Screening Failure|0
208949|NCT02011893|675330|P2|Enrollment to Randomization|Screening Failure|0
208950|NCT02011893|675331|P1|Enrollment to Randomization|Screening Failure|29
208951|NCT02011893|675329|P3|Enrollment to Randomization|Withdrawal by Subject|0
208952|NCT02011893|675330|P2|Enrollment to Randomization|Withdrawal by Subject|0
208953|NCT02011893|675331|P1|Enrollment to Randomization|Withdrawal by Subject|21
208954|NCT02011893|675329|P3|Enrollment to Randomization|Physician Decision|0
208955|NCT02011893|675330|P2|Enrollment to Randomization|Physician Decision|0
208956|NCT02011893|675331|P1|Enrollment to Randomization|Physician Decision|10
208957|NCT02011893|675329|P3|Enrollment to Randomization|Adverse Event|0
208958|NCT02011893|675330|P2|Enrollment to Randomization|Adverse Event|0
208959|NCT02011893|675331|P1|Enrollment to Randomization|Adverse Event|2
208960|NCT02011113|675445|P1|Overall Study|Study terminated by sponsor|11
208961|NCT02011113|675445|P1|Overall Study|Investigator's judgement- DP|3
208962|NCT02011113|675445|P1|Overall Study|Insufficient effect of Pomalidomide|1
208963|NCT02011113|675445|P1|Overall Study|Death|1
208964|NCT02011113|675445|P1|Overall Study|Disease Progression (DP)|16
208965|NCT02011113|675445|P1|Overall Study|Adverse Event|4
208966|NCT02010684|675474|P2|Overall Study|Withdrawal by Subject|5
208967|NCT02010684|675475|P1|Overall Study|Withdrawal by Subject|4
208968|NCT02010684|675474|P2|Overall Study|Lost to Follow-up|18
208969|NCT02010684|675475|P1|Overall Study|Lost to Follow-up|8
208970|NCT02010632|675493|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
208971|NCT02010632|675494|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
208972|NCT02010255|675514|P14|Overall Study|Randomized but Not Treated|1
208973|NCT02010255|675515|P13|Overall Study|Randomized but Not Treated|0
208974|NCT02010255|675516|P12|Overall Study|Randomized but Not Treated|0
208975|NCT02010255|675517|P11|Overall Study|Randomized but Not Treated|0
208976|NCT02010255|675518|P10|Overall Study|Randomized but Not Treated|0
208977|NCT02010255|675519|P9|Overall Study|Randomized but Not Treated|0
208978|NCT02010255|675520|P8|Overall Study|Randomized but Not Treated|0
208979|NCT02010255|675521|P7|Overall Study|Randomized but Not Treated|0
208980|NCT02010255|675522|P6|Overall Study|Randomized but Not Treated|0
208981|NCT02010255|675523|P5|Overall Study|Randomized but Not Treated|0
208982|NCT02010255|675524|P4|Overall Study|Randomized but Not Treated|0
208983|NCT02010255|675525|P3|Overall Study|Randomized but Not Treated|0
208984|NCT02010255|675526|P2|Overall Study|Randomized but Not Treated|0
208985|NCT02010255|675527|P1|Overall Study|Randomized but Not Treated|0
208986|NCT02010255|675514|P14|Overall Study|Lost to Follow-up|0
208987|NCT02010255|675515|P13|Overall Study|Lost to Follow-up|0
208988|NCT02010255|675516|P12|Overall Study|Lost to Follow-up|0
208989|NCT02010255|675517|P11|Overall Study|Lost to Follow-up|0
208990|NCT02010255|675518|P10|Overall Study|Lost to Follow-up|0
208991|NCT02010255|675519|P9|Overall Study|Lost to Follow-up|0
208992|NCT02010255|675520|P8|Overall Study|Lost to Follow-up|0
208993|NCT02010255|675521|P7|Overall Study|Lost to Follow-up|0
208994|NCT02010255|675522|P6|Overall Study|Lost to Follow-up|0
208995|NCT02010255|675523|P5|Overall Study|Lost to Follow-up|1
208996|NCT02010255|675524|P4|Overall Study|Lost to Follow-up|0
208997|NCT02010255|675525|P3|Overall Study|Lost to Follow-up|1
208998|NCT02010255|675526|P2|Overall Study|Lost to Follow-up|0
208999|NCT02010255|675527|P1|Overall Study|Lost to Follow-up|0
209000|NCT02010255|675514|P14|Overall Study|Adverse Event|0
209001|NCT02010255|675515|P13|Overall Study|Adverse Event|0
209002|NCT02010255|675516|P12|Overall Study|Adverse Event|0
209003|NCT02010255|675517|P11|Overall Study|Adverse Event|0
209004|NCT02010255|675518|P10|Overall Study|Adverse Event|0
209005|NCT02010255|675519|P9|Overall Study|Adverse Event|0
209006|NCT02010255|675520|P8|Overall Study|Adverse Event|0
209007|NCT02010255|675521|P7|Overall Study|Adverse Event|0
209008|NCT02010255|675522|P6|Overall Study|Adverse Event|0
209009|NCT02010255|675523|P5|Overall Study|Adverse Event|0
209010|NCT02010255|675524|P4|Overall Study|Adverse Event|0
209011|NCT02010255|675525|P3|Overall Study|Adverse Event|0
209012|NCT02010255|675526|P2|Overall Study|Adverse Event|0
209013|NCT02010255|675527|P1|Overall Study|Adverse Event|1
209014|NCT02010255|675514|P14|Overall Study|Withdrew Consent|0
209015|NCT02010255|675515|P13|Overall Study|Withdrew Consent|0
209016|NCT02010255|675516|P12|Overall Study|Withdrew Consent|0
209017|NCT02010255|675517|P11|Overall Study|Withdrew Consent|0
209018|NCT02010255|675518|P10|Overall Study|Withdrew Consent|0
209019|NCT02010255|675519|P9|Overall Study|Withdrew Consent|0
209020|NCT02010255|675520|P8|Overall Study|Withdrew Consent|0
209021|NCT02010255|675521|P7|Overall Study|Withdrew Consent|0
209022|NCT02010255|675522|P6|Overall Study|Withdrew Consent|0
209023|NCT02010255|675523|P5|Overall Study|Withdrew Consent|0
209024|NCT02010255|675524|P4|Overall Study|Withdrew Consent|1
209025|NCT02010255|675525|P3|Overall Study|Withdrew Consent|0
209026|NCT02010255|675526|P2|Overall Study|Withdrew Consent|0
209027|NCT02010255|675527|P1|Overall Study|Withdrew Consent|1
209028|NCT02010255|675514|P14|Overall Study|Lack of Efficacy|0
209029|NCT02010255|675515|P13|Overall Study|Lack of Efficacy|0
209030|NCT02010255|675516|P12|Overall Study|Lack of Efficacy|0
209031|NCT02010255|675517|P11|Overall Study|Lack of Efficacy|1
209032|NCT02010255|675518|P10|Overall Study|Lack of Efficacy|0
209033|NCT02010255|675519|P9|Overall Study|Lack of Efficacy|0
209034|NCT02010255|675520|P8|Overall Study|Lack of Efficacy|0
209035|NCT02010255|675521|P7|Overall Study|Lack of Efficacy|0
209036|NCT02010255|675522|P6|Overall Study|Lack of Efficacy|0
209037|NCT02010255|675523|P5|Overall Study|Lack of Efficacy|1
209038|NCT02010255|675524|P4|Overall Study|Lack of Efficacy|1
209039|NCT02010255|675525|P3|Overall Study|Lack of Efficacy|2
209040|NCT02010255|675526|P2|Overall Study|Lack of Efficacy|1
209041|NCT02010255|675527|P1|Overall Study|Lack of Efficacy|4
209042|NCT02010255|675514|P14|Overall Study|Death|0
209043|NCT02010255|675515|P13|Overall Study|Death|0
209044|NCT02010255|675516|P12|Overall Study|Death|1
209045|NCT02010255|675517|P11|Overall Study|Death|1
209046|NCT02010255|675518|P10|Overall Study|Death|0
209047|NCT02010255|675519|P9|Overall Study|Death|1
209048|NCT02010255|675520|P8|Overall Study|Death|1
209049|NCT02010255|675521|P7|Overall Study|Death|1
209050|NCT02010255|675522|P6|Overall Study|Death|0
209051|NCT02010255|675523|P5|Overall Study|Death|2
209052|NCT02010255|675524|P4|Overall Study|Death|4
209053|NCT02010255|675525|P3|Overall Study|Death|4
209054|NCT02010255|675526|P2|Overall Study|Death|1
209055|NCT02010255|675527|P1|Overall Study|Death|0
209056|NCT02009878|675871|P3|Overall Study|Participant Met Withdrawal Criteria|0
209057|NCT02009878|675872|P2|Overall Study|Participant Met Withdrawal Criteria|1
209058|NCT02009878|675873|P1|Overall Study|Participant Met Withdrawal Criteria|0
209059|NCT02009865|675907|P2|Overall Study|Withdrawal by Subject|1
209060|NCT02009865|675908|P1|Overall Study|Withdrawal by Subject|1
209061|NCT02009865|675907|P2|Overall Study|Protocol Violation|2
209062|NCT02009865|675908|P1|Overall Study|Protocol Violation|0
209063|NCT02009865|675907|P2|Overall Study|Adverse Event|2
209064|NCT02009865|675908|P1|Overall Study|Adverse Event|0
209065|NCT02009722|675924|P2|Overall Study|Did not receive intervention|1
209066|NCT02009722|675925|P1|Overall Study|Did not receive intervention|0
209067|NCT02009722|675924|P2|Overall Study|Protocol Violation|2
209068|NCT02009722|675925|P1|Overall Study|Protocol Violation|1
209069|NCT02009696|675949|P1|Overall Study|Withdrawal by Subject|2
209070|NCT02009163|675957|P3|Randomized-withdrawal Period|Not specified|5
209071|NCT02009163|675958|P2|Randomized-withdrawal Period|Not specified|9
209072|NCT02009163|675959|P1|Randomized-withdrawal Period|Not specified|0
209073|NCT02009163|675957|P3|Randomized-withdrawal Period|Pregnancy|2
209074|NCT02009163|675958|P2|Randomized-withdrawal Period|Pregnancy|0
209075|NCT02009163|675959|P1|Randomized-withdrawal Period|Pregnancy|0
209076|NCT02009163|675957|P3|Randomized-withdrawal Period|Protocol Violation|2
209077|NCT02009163|675958|P2|Randomized-withdrawal Period|Protocol Violation|1
209078|NCT02009163|675959|P1|Randomized-withdrawal Period|Protocol Violation|0
209079|NCT02009163|675957|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
209080|NCT02009163|675958|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
209081|NCT02009163|675959|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
209082|NCT02009163|675957|P3|Randomized-withdrawal Period|Adverse Event|6
209083|NCT02009163|675958|P2|Randomized-withdrawal Period|Adverse Event|0
209084|NCT02009163|675959|P1|Randomized-withdrawal Period|Adverse Event|0
209085|NCT02009163|675957|P3|Randomized-withdrawal Period|Lost to Follow-up|6
209086|NCT02009163|675958|P2|Randomized-withdrawal Period|Lost to Follow-up|13
209087|NCT02009163|675959|P1|Randomized-withdrawal Period|Lost to Follow-up|0
209088|NCT02009163|675957|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
209089|NCT02009163|675958|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
209090|NCT02009163|675959|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
209091|NCT02009163|675957|P3|Open-label Period (Non-randomized)|Not specified|0
209092|NCT02009163|675958|P2|Open-label Period (Non-randomized)|Not specified|0
209093|NCT02009163|675959|P1|Open-label Period (Non-randomized)|Not specified|13
209094|NCT02009163|675957|P3|Open-label Period (Non-randomized)|Pregnancy|0
209095|NCT02009163|675958|P2|Open-label Period (Non-randomized)|Pregnancy|0
209096|NCT02009163|675959|P1|Open-label Period (Non-randomized)|Pregnancy|1
209097|NCT02009163|675957|P3|Open-label Period (Non-randomized)|Protocol Violation|0
209098|NCT02009163|675958|P2|Open-label Period (Non-randomized)|Protocol Violation|0
209099|NCT02009163|675959|P1|Open-label Period (Non-randomized)|Protocol Violation|10
209100|NCT02009163|675957|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
209101|NCT02009163|675958|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
209102|NCT02009163|675959|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
209103|NCT02009163|675957|P3|Open-label Period (Non-randomized)|Adverse Event|0
209104|NCT02009163|675958|P2|Open-label Period (Non-randomized)|Adverse Event|0
209105|NCT02009163|675959|P1|Open-label Period (Non-randomized)|Adverse Event|22
209106|NCT02009163|675957|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
209107|NCT02009163|675958|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
209108|NCT02009163|675959|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
209109|NCT02009163|675957|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
209110|NCT02009163|675958|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
209111|NCT02009163|675959|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
209112|NCT02007577|676039|P2|Overall Study|Withdrawal by Subject|1
209113|NCT02007577|676040|P1|Overall Study|Withdrawal by Subject|0
209114|NCT02007577|676039|P2|Overall Study|Adverse Event|0
209115|NCT02007577|676040|P1|Overall Study|Adverse Event|1
209116|NCT02007434|676056|P8|Overall Study|Non-compliance|0
209117|NCT02007434|676057|P7|Overall Study|Non-compliance|0
209118|NCT02007434|676058|P6|Overall Study|Non-compliance|0
209119|NCT02007434|676059|P5|Overall Study|Non-compliance|0
209120|NCT02007434|676060|P4|Overall Study|Non-compliance|0
209121|NCT02007434|676061|P3|Overall Study|Non-compliance|1
209122|NCT02007434|676062|P2|Overall Study|Non-compliance|0
209123|NCT02007434|676063|P1|Overall Study|Non-compliance|1
209124|NCT02007434|676056|P8|Overall Study|Lost to Follow-up|0
209125|NCT02007434|676057|P7|Overall Study|Lost to Follow-up|0
209126|NCT02007434|676058|P6|Overall Study|Lost to Follow-up|0
209127|NCT02007434|676059|P5|Overall Study|Lost to Follow-up|0
209128|NCT02007434|676060|P4|Overall Study|Lost to Follow-up|0
209129|NCT02007434|676061|P3|Overall Study|Lost to Follow-up|0
209130|NCT02007434|676062|P2|Overall Study|Lost to Follow-up|1
209131|NCT02007434|676063|P1|Overall Study|Lost to Follow-up|0
209132|NCT02007252|676185|P2|Overall Study|Adverse Event|4
209133|NCT02007252|676186|P1|Overall Study|Adverse Event|7
209134|NCT02007252|676185|P2|Overall Study|Abnormal laboratory value(s)|0
209135|NCT02007252|676186|P1|Overall Study|Abnormal laboratory value(s)|1
209136|NCT02007252|676185|P2|Overall Study|Administrative problems|7
209137|NCT02007252|676186|P1|Overall Study|Administrative problems|3
209138|NCT02007070|676199|P1|Overall Study|Continuing|9
209139|NCT02007070|676199|P1|Overall Study|Progressive Disease|18
209140|NCT02007070|676199|P1|Overall Study|Physician Decision|1
209141|NCT02007070|676199|P1|Overall Study|Protocol Violation|2
209142|NCT02007070|676199|P1|Overall Study|Death|1
209143|NCT02007070|676199|P1|Overall Study|Clinical Progression|4
209144|NCT02007070|676199|P1|Overall Study|Adverse Event|3
209145|NCT02006732|676233|P4|Overall Study|Withdrawal by Subject|1
209146|NCT02006732|676234|P3|Overall Study|Withdrawal by Subject|4
209147|NCT02006732|676235|P2|Overall Study|Withdrawal by Subject|0
209148|NCT02006732|676236|P1|Overall Study|Withdrawal by Subject|3
209149|NCT02006732|676233|P4|Overall Study|Lost to Follow-up|0
209150|NCT02006732|676234|P3|Overall Study|Lost to Follow-up|0
209151|NCT02006732|676235|P2|Overall Study|Lost to Follow-up|1
209152|NCT02006732|676236|P1|Overall Study|Lost to Follow-up|0
209153|NCT02006732|676233|P4|Overall Study|Protocol Violation|0
209154|NCT02006732|676234|P3|Overall Study|Protocol Violation|0
209155|NCT02006732|676235|P2|Overall Study|Protocol Violation|1
209156|NCT02006732|676236|P1|Overall Study|Protocol Violation|1
209157|NCT02006732|676233|P4|Overall Study|Lack of Efficacy|1
209158|NCT02006732|676234|P3|Overall Study|Lack of Efficacy|1
209159|NCT02006732|676235|P2|Overall Study|Lack of Efficacy|3
209160|NCT02006732|676236|P1|Overall Study|Lack of Efficacy|6
209161|NCT02006732|676233|P4|Overall Study|Adverse Event|2
209162|NCT02006732|676234|P3|Overall Study|Adverse Event|4
209163|NCT02006732|676235|P2|Overall Study|Adverse Event|7
209164|NCT02006732|676236|P1|Overall Study|Adverse Event|10
209165|NCT02006719|676276|P2|Overall Study|Other/Unknown|1
209166|NCT02006719|676277|P1|Overall Study|Other/Unknown|0
209167|NCT02006719|676276|P2|Overall Study|Adverse Event|1
209168|NCT02006719|676277|P1|Overall Study|Adverse Event|1
209169|NCT02006719|676276|P2|Overall Study|Protocol Violation|0
209170|NCT02006719|676277|P1|Overall Study|Protocol Violation|2
209171|NCT02006719|676276|P2|Overall Study|Lost to Follow-up|1
209172|NCT02006719|676277|P1|Overall Study|Lost to Follow-up|5
209173|NCT02006719|676276|P2|Overall Study|Withdrawal by Subject|2
209174|NCT02006719|676277|P1|Overall Study|Withdrawal by Subject|10
209175|NCT02006706|676307|P1|Overall Study|Lost to Follow-up|1
209176|NCT02006667|676312|P1|Overall Study|Withdrawal by Subject|1
209177|NCT02006667|676312|P1|Overall Study|Death|2
209178|NCT02006667|676312|P1|Overall Study|Adverse Event|3
209179|NCT02005692|676345|P1|Overall Study|Discharged earlier than anticipated|5
209180|NCT02005692|676345|P1|Overall Study|Withdrawal by Subject|1
209181|NCT02005692|676345|P1|Overall Study|Protocol Violation|1
209182|NCT02005562|676352|P2|Overall Study|Physician Decision|1
209183|NCT02005562|676353|P1|Overall Study|Physician Decision|0
209184|NCT02005562|676352|P2|Overall Study|No transplant|4
209185|NCT02005562|676353|P1|Overall Study|No transplant|1
209186|NCT02005562|676352|P2|Overall Study|Withdrawal by Subject|2
209187|NCT02005562|676353|P1|Overall Study|Withdrawal by Subject|2
209188|NCT02005562|676352|P2|Overall Study|Graft loss|6
209189|NCT02005562|676353|P1|Overall Study|Graft loss|7
209190|NCT02005562|676352|P2|Overall Study|Death|2
209191|NCT02005562|676353|P1|Overall Study|Death|2
209192|NCT02005484|676395|P1|Overall Study|Sponsor decision|1
209193|NCT02005484|676395|P1|Overall Study|Changed to a Different Study|1
209194|NCT02005484|676395|P1|Overall Study|Disease progression|1
209195|NCT02005484|676395|P1|Overall Study|Death|1
209196|NCT02005211|676416|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
209197|NCT02005211|676417|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
209198|NCT02005211|676418|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
209199|NCT02005211|676419|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
209200|NCT02005211|676420|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
209201|NCT02005211|676421|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
209202|NCT02005211|676422|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
209203|NCT02005029|676457|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
209204|NCT02005029|676458|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
209205|NCT02004886|676493|P4|Overall Study|Unable to attend future visits|0
209206|NCT02004886|676494|P3|Overall Study|Unable to attend future visits|0
209207|NCT02004886|676495|P2|Overall Study|Unable to attend future visits|0
209208|NCT02004886|676496|P1|Overall Study|Unable to attend future visits|1
209209|NCT02004886|676493|P4|Overall Study|Adverse Event|0
209210|NCT02004886|676494|P3|Overall Study|Adverse Event|0
209211|NCT02004886|676495|P2|Overall Study|Adverse Event|1
209212|NCT02004886|676496|P1|Overall Study|Adverse Event|0
209213|NCT02004873|676546|P1|Overall Study|Withdrawal by Subject|1
209214|NCT02004873|676546|P1|Overall Study|Death|23
209215|NCT02004873|676546|P1|Overall Study|Missed 6-month visit|4
209216|NCT02004873|676546|P1|Overall Study|Awaiting 6-month visit|390
209217|NCT02004873|676546|P1|Overall Study|Implant unsuccessful|6
209218|NCT02004847|676555|P2|Overall Study|Protocol Violation|1
209219|NCT02004847|676556|P1|Overall Study|Protocol Violation|1
209220|NCT02004236|676603|P3|Overall Study|Lack of Efficacy|16
209221|NCT02004236|676604|P2|Overall Study|Lack of Efficacy|0
209222|NCT02004236|676605|P1|Overall Study|Lack of Efficacy|0
209223|NCT02004093|676657|P2|Overall Study|Not specified|1
209224|NCT02004093|676658|P1|Overall Study|Not specified|3
209225|NCT02004093|676657|P2|Overall Study|Withdrawal by Subject|7
209226|NCT02004093|676658|P1|Overall Study|Withdrawal by Subject|3
209227|NCT02004093|676657|P2|Overall Study|Lost to Follow-up|1
209228|NCT02004093|676658|P1|Overall Study|Lost to Follow-up|0
209229|NCT02004093|676657|P2|Overall Study|Protocol Violation|1
209230|NCT02004093|676658|P1|Overall Study|Protocol Violation|0
209231|NCT02004093|676657|P2|Overall Study|Lack of Efficacy|62
209232|NCT02004093|676658|P1|Overall Study|Lack of Efficacy|66
209233|NCT02004093|676657|P2|Overall Study|Death|1
209234|NCT02004093|676658|P1|Overall Study|Death|2
209235|NCT02003963|676690|P2|Overall Study|Lost to Follow-up|1
209236|NCT02003963|676691|P1|Overall Study|Lost to Follow-up|2
209237|NCT02003638|676709|P2|Overall Study|Withdrawal by Subject|0
209238|NCT02003638|676710|P1|Overall Study|Withdrawal by Subject|1
209239|NCT02003534|676716|P1|Overall Study|Lost to Follow-up|47
209240|NCT02003391|676728|P2|Overall Study|Adverse Event|0
209241|NCT02003391|676729|P1|Overall Study|Adverse Event|1
209242|NCT02003391|676728|P2|Overall Study|Protocol Violation|1
209243|NCT02003391|676729|P1|Overall Study|Protocol Violation|0
209244|NCT02003391|676728|P2|Overall Study|Withdrawal by Subject|1
209245|NCT02003391|676729|P1|Overall Study|Withdrawal by Subject|2
209246|NCT02003014|676743|P1|Overall Study|Investigator's transfer|4
209247|NCT02003014|676743|P1|Overall Study|Patient did not visit the study site|5
209248|NCT02003014|676743|P1|Overall Study|Treatment started after contract period|1
209249|NCT02003014|676743|P1|Overall Study|Case report forms uncollected|9
209250|NCT02002689|676825|P1|Overall Study|Adverse Event|3
209251|NCT02002689|676825|P1|Overall Study|Disease Progression|7
209252|NCT02002221|676844|P2|Overall Study|Patient withdrew consent|1
209253|NCT02002221|676845|P1|Overall Study|Patient withdrew consent|0
209254|NCT02002221|676844|P2|Overall Study|Unsatisfactory therapeutic effect|1
209255|NCT02002221|676845|P1|Overall Study|Unsatisfactory therapeutic effect|0
209256|NCT02002221|676844|P2|Overall Study|Adverse Event|1
209257|NCT02002221|676845|P1|Overall Study|Adverse Event|2
209258|NCT02001181|676872|P2|Overall Study|Withdrawal by Subject|1
209259|NCT02001181|676873|P1|Overall Study|Withdrawal by Subject|0
209260|NCT02001181|676872|P2|Overall Study|Lost to Follow-up|0
209261|NCT02001181|676873|P1|Overall Study|Lost to Follow-up|1
209262|NCT02001181|676872|P2|Overall Study|Adverse Event|2
209263|NCT02001181|676873|P1|Overall Study|Adverse Event|0
209264|NCT02000921|676919|P3|Overall Study|Physician Decision|0
209265|NCT02000921|676920|P2|Overall Study|Physician Decision|2
209266|NCT02000921|676921|P1|Overall Study|Physician Decision|0
209267|NCT02000921|676919|P3|Overall Study|Lost to Follow-up|5
209268|NCT02000921|676920|P2|Overall Study|Lost to Follow-up|4
209269|NCT02000921|676921|P1|Overall Study|Lost to Follow-up|2
209270|NCT02000921|676919|P3|Overall Study|Withdrawal by Subject|5
209271|NCT02000921|676920|P2|Overall Study|Withdrawal by Subject|10
209272|NCT02000921|676921|P1|Overall Study|Withdrawal by Subject|3
209273|NCT02000752|676940|P2|Overall Study|Shift Changes|5
209274|NCT02000752|676941|P1|Overall Study|Shift Changes|12
209275|NCT02000752|676940|P2|Overall Study|Dystocic delivery|8
209276|NCT02000752|676941|P1|Overall Study|Dystocic delivery|19
209277|NCT02000531|676955|P2|Overall Study|Discontinued due to data cut-off|8
209278|NCT02000531|676956|P1|Overall Study|Discontinued due to data cut-off|3
209279|NCT02000531|676955|P2|Overall Study|Lost to Follow-up|0
209280|NCT02000531|676956|P1|Overall Study|Lost to Follow-up|1
209281|NCT02000440|676964|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
209282|NCT02000440|676964|P1|Overall Study|Adverse Event|3
209283|NCT01999894|676992|P1|Overall Study|Inclusion/exclusion criteria not met|1
209284|NCT01999894|676992|P1|Overall Study|Other Reason|3
209285|NCT01999894|676992|P1|Overall Study|Lost to Follow-up|10
209286|NCT01999894|676992|P1|Overall Study|Withdrawal by Subject|7
209287|NCT01999894|676992|P1|Overall Study|Protocol Violation|1
209288|NCT01999894|676992|P1|Overall Study|Lack of Efficacy|5
209289|NCT01999894|676992|P1|Overall Study|Adverse Event|9
209290|NCT01998919|677071|P2|Overall Study|Not specified|2
209291|NCT01998919|677072|P1|Overall Study|Not specified|5
209292|NCT01998919|677071|P2|Overall Study|Lost to Follow-up|0
209293|NCT01998919|677072|P1|Overall Study|Lost to Follow-up|2
209294|NCT01998919|677071|P2|Overall Study|Withdrawal by Subject|4
209295|NCT01998919|677072|P1|Overall Study|Withdrawal by Subject|2
209296|NCT01998919|677071|P2|Overall Study|Disease progression|22
209297|NCT01998919|677072|P1|Overall Study|Disease progression|31
209298|NCT01998919|677071|P2|Overall Study|Adverse Event|5
209299|NCT01998919|677072|P1|Overall Study|Adverse Event|0
209300|NCT01998919|677071|P2|Overall Study|Death|2
209301|NCT01998919|677072|P1|Overall Study|Death|2
209302|NCT01998906|677093|P3|Overall Study|Not specified|4
209303|NCT01998906|677094|P2|Overall Study|Not specified|8
209304|NCT01998906|677095|P1|Overall Study|Not specified|3
209305|NCT01998906|677093|P3|Overall Study|Administrative/Other|3
209306|NCT01998906|677094|P2|Overall Study|Administrative/Other|1
209307|NCT01998906|677095|P1|Overall Study|Administrative/Other|2
209308|NCT01998906|677093|P3|Overall Study|Withdrawal by Subject|3
209309|NCT01998906|677094|P2|Overall Study|Withdrawal by Subject|4
209310|NCT01998906|677095|P1|Overall Study|Withdrawal by Subject|1
209311|NCT01998906|677093|P3|Overall Study|Violation of Selection Criteria|1
209312|NCT01998906|677094|P2|Overall Study|Violation of Selection Criteria|0
209313|NCT01998906|677095|P1|Overall Study|Violation of Selection Criteria|0
209314|NCT01998906|677093|P3|Overall Study|Failure to return|4
209315|NCT01998906|677094|P2|Overall Study|Failure to return|2
209316|NCT01998906|677095|P1|Overall Study|Failure to return|0
209317|NCT01998906|677093|P3|Overall Study|Lack of Efficacy|8
209318|NCT01998906|677094|P2|Overall Study|Lack of Efficacy|9
209319|NCT01998906|677095|P1|Overall Study|Lack of Efficacy|10
209320|NCT01998906|677093|P3|Overall Study|Death|17
209321|NCT01998906|677094|P2|Overall Study|Death|30
209322|NCT01998906|677095|P1|Overall Study|Death|21
209323|NCT01998906|677093|P3|Overall Study|Participants ongoing in follow−up|58
209324|NCT01998906|677094|P2|Overall Study|Participants ongoing in follow−up|60
209325|NCT01998906|677095|P1|Overall Study|Participants ongoing in follow−up|77
209326|NCT01998893|677139|P1|Overall Study|Transformation to high-grade lymphoma|1
209327|NCT01998893|677139|P1|Overall Study|Withdrawal by Subject|1
209328|NCT01998893|677139|P1|Overall Study|Protocol Violation|2
209329|NCT01998893|677139|P1|Overall Study|Physician Decision|2
209330|NCT01998893|677139|P1|Overall Study|Lost to Follow-up|8
209331|NCT01998893|677139|P1|Overall Study|Death|1
209332|NCT01998893|677139|P1|Overall Study|Adverse Event|2
209333|NCT01998880|677151|P2|Overall Study|Violation of Selection Criteria at Entry|1
209334|NCT01998880|677152|P1|Overall Study|Violation of Selection Criteria at Entry|1
209335|NCT01998880|677151|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
209336|NCT01998880|677152|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
209337|NCT01998880|677151|P2|Overall Study|Other Protocol Violation|1
209338|NCT01998880|677152|P1|Overall Study|Other Protocol Violation|0
209339|NCT01998880|677151|P2|Overall Study|Administrative/Other|1
209340|NCT01998880|677152|P1|Overall Study|Administrative/Other|3
209341|NCT01998880|677151|P2|Overall Study|Insufficient Therapeutic Response|5
209342|NCT01998880|677152|P1|Overall Study|Insufficient Therapeutic Response|1
209343|NCT01998880|677151|P2|Overall Study|Death|6
209344|NCT01998880|677152|P1|Overall Study|Death|3
209345|NCT01998880|677151|P2|Overall Study|Withdrew Consent|2
209346|NCT01998880|677152|P1|Overall Study|Withdrew Consent|2
209347|NCT01998880|677151|P2|Overall Study|Progression of Disease|8
209348|NCT01998880|677152|P1|Overall Study|Progression of Disease|2
209349|NCT01998880|677151|P2|Overall Study|Adverse Events or Intercurrent Illness|16
209350|NCT01998880|677152|P1|Overall Study|Adverse Events or Intercurrent Illness|16
209351|NCT01998581|677170|P2|Overall Study|Randomized but withdrew before treatment|0
209352|NCT01998581|677171|P1|Overall Study|Randomized but withdrew before treatment|1
209353|NCT01998581|677170|P2|Overall Study|Other reasons|2
209354|NCT01998581|677171|P1|Overall Study|Other reasons|3
209355|NCT01998581|677170|P2|Overall Study|Adverse Event|1
209356|NCT01998581|677171|P1|Overall Study|Adverse Event|1
209357|NCT01998581|677170|P2|Overall Study|Lost to Follow-up|4
209358|NCT01998581|677171|P1|Overall Study|Lost to Follow-up|12
209359|NCT01998581|677170|P2|Overall Study|Withdrawal by Subject|1
209360|NCT01998581|677171|P1|Overall Study|Withdrawal by Subject|8
209361|NCT01998581|677170|P2|Overall Study|Protocol Violation|0
209362|NCT01998581|677171|P1|Overall Study|Protocol Violation|1
209363|NCT01998581|677170|P2|Overall Study|Refused repeat treatment|4
209364|NCT01998581|677171|P1|Overall Study|Refused repeat treatment|20
209365|NCT01998477|677183|P2|Overall Study|Withdrawal by Subject|0
209366|NCT01998477|677184|P1|Overall Study|Withdrawal by Subject|6
209367|NCT01998477|677183|P2|Overall Study|Lost to Follow-up|5
209368|NCT01998477|677184|P1|Overall Study|Lost to Follow-up|4
209369|NCT01998399|677230|P2|Overall Study|Withdrawal by Subject|1
209370|NCT01998399|677231|P1|Overall Study|Withdrawal by Subject|0
209371|NCT01998399|677230|P2|Overall Study|Study stopped before dosing completed|3
209372|NCT01998399|677231|P1|Overall Study|Study stopped before dosing completed|3
209373|NCT01998399|677230|P2|Overall Study|Death|2
209374|NCT01998399|677231|P1|Overall Study|Death|4
209375|NCT01998399|677230|P2|Overall Study|Lost to Follow-up|3
209376|NCT01998399|677231|P1|Overall Study|Lost to Follow-up|1
209377|NCT01997892|677267|P1|Overall Study|Study completion data not recorded|35
209378|NCT01997892|677267|P1|Overall Study|Other|3
209379|NCT01997892|677267|P1|Overall Study|Renal transplant|8
209380|NCT01997892|677267|P1|Overall Study|Death|14
209381|NCT01997892|677267|P1|Overall Study|Lost to Follow-up|6
209382|NCT01997892|677267|P1|Overall Study|Physician Decision|2
209383|NCT01996904|677425|P2|Overall Study|Lost to Follow-up|27
209384|NCT01996904|677426|P1|Overall Study|Lost to Follow-up|38
209385|NCT01996748|677439|P2|Overall Study|Lost to Follow-up|1
209386|NCT01996748|677440|P1|Overall Study|Lost to Follow-up|4
209387|NCT01996748|677439|P2|Overall Study|Withdrawal by Subject|1
209388|NCT01996748|677440|P1|Overall Study|Withdrawal by Subject|0
209389|NCT01996748|677439|P2|Overall Study|Adverse Event|4
209390|NCT01996748|677440|P1|Overall Study|Adverse Event|1
209391|NCT01996748|677439|P2|Overall Study|Physician Decision|0
209392|NCT01996748|677440|P1|Overall Study|Physician Decision|2
209393|NCT01996748|677439|P2|Overall Study|Personal reason|0
209394|NCT01996748|677440|P1|Overall Study|Personal reason|1
209395|NCT01996709|677454|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
209396|NCT01996709|677455|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
209397|NCT01996709|677454|P2|Overall Study|Subject Non-Compliant|0
209398|NCT01996709|677455|P1|Overall Study|Subject Non-Compliant|1
209399|NCT01996709|677454|P2|Overall Study|Lost to Follow-up|0
209400|NCT01996709|677455|P1|Overall Study|Lost to Follow-up|3
209401|NCT01996709|677454|P2|Overall Study|Withdrawal by Subject|0
209402|NCT01996709|677455|P1|Overall Study|Withdrawal by Subject|1
209403|NCT01996332|677496|P1|Overall Study|Lost to Follow-up|34
209404|NCT01996332|677496|P1|Overall Study|Physician Decision|17
209405|NCT01996332|677496|P1|Overall Study|Clinical Deterioration|28
209406|NCT01996332|677496|P1|Overall Study|Other|20
209407|NCT01996332|677496|P1|Overall Study|Withdrawal by Subject|71
209408|NCT01996332|677496|P1|Overall Study|Protocol Violation|9
209409|NCT01996332|677496|P1|Overall Study|Death|264
209410|NCT01996332|677496|P1|Overall Study|Lack of Efficacy|1245
209411|NCT01996332|677496|P1|Overall Study|Adverse Event|117
209412|NCT01996319|677504|P2|Overall Study|Adverse Event|2
209413|NCT01996319|677505|P1|Overall Study|Adverse Event|2
209414|NCT01996319|677504|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
209415|NCT01996319|677505|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
209416|NCT01996319|677504|P2|Overall Study|Protocol Violation|0
209417|NCT01996319|677505|P1|Overall Study|Protocol Violation|1
209418|NCT01995461|677525|P1|Overall Study|Withdrawal by Subject|2
209419|NCT01995461|677525|P1|Overall Study|Lost to Follow-up|2
209420|NCT01995461|677525|P1|Overall Study|Death|1
209421|NCT01995357|677531|P6|Period 5|Adverse Event|0
209422|NCT01995357|677532|P5|Period 5|Adverse Event|0
209423|NCT01995357|677533|P4|Period 5|Adverse Event|0
209424|NCT01995357|677534|P3|Period 5|Adverse Event|1
209425|NCT01995357|677535|P2|Period 5|Adverse Event|0
209426|NCT01995357|677536|P1|Period 5|Adverse Event|1
209427|NCT01995357|677531|P6|Period 5|Lack of Efficacy|0
209428|NCT01995357|677532|P5|Period 5|Lack of Efficacy|0
209429|NCT01995357|677533|P4|Period 5|Lack of Efficacy|0
209430|NCT01995357|677534|P3|Period 5|Lack of Efficacy|0
209431|NCT01995357|677535|P2|Period 5|Lack of Efficacy|0
209432|NCT01995357|677536|P1|Period 5|Lack of Efficacy|1
209433|NCT01995136|677552|P1|Overall Study|Change in residence|1
209434|NCT01994902|677571|P2|Test Period 2|not known|3
209435|NCT01994902|677572|P1|Test Period 2|not known|0
209436|NCT01994902|677571|P2|Test Period 2|Lack of Efficacy|1
209437|NCT01994902|677572|P1|Test Period 2|Lack of Efficacy|0
209438|NCT01994902|677571|P2|Test Period 2|Withdrawal by Subject|2
209439|NCT01994902|677572|P1|Test Period 2|Withdrawal by Subject|0
209440|NCT01994902|677571|P2|Test Period 1|bag too small|0
209441|NCT01994902|677572|P1|Test Period 1|bag too small|1
209442|NCT01994902|677571|P2|Test Period 1|Lack of Efficacy|1
209443|NCT01994902|677572|P1|Test Period 1|Lack of Efficacy|0
209444|NCT01994902|677571|P2|Test Period 1|Adverse Event|1
209445|NCT01994902|677572|P1|Test Period 1|Adverse Event|2
209446|NCT01994902|677571|P2|Test Period 1|device deficiency with adverse event|1
209447|NCT01994902|677572|P1|Test Period 1|device deficiency with adverse event|0
209448|NCT01994902|677571|P2|Test Period 1|Withdrawal by Subject|0
209449|NCT01994902|677572|P1|Test Period 1|Withdrawal by Subject|3
209450|NCT01994876|677578|P2|Test Period 2|Protocol Violation|1
209451|NCT01994876|677579|P1|Test Period 2|Protocol Violation|0
209452|NCT01994876|677578|P2|Test Period 2|Adverse Event|0
209453|NCT01994876|677579|P1|Test Period 2|Adverse Event|1
209454|NCT01994876|677578|P2|Test Period 1|Adverse Event|1
209455|NCT01994876|677579|P1|Test Period 1|Adverse Event|0
209456|NCT01994876|677578|P2|Test Period 1|Withdrawal by Subject|1
209457|NCT01994876|677579|P1|Test Period 1|Withdrawal by Subject|0
209458|NCT01994863|677587|P2|Period 2|Withdrawal by Subject|1
209459|NCT01994863|677588|P1|Period 2|Withdrawal by Subject|1
209460|NCT01994863|677587|P2|Period 2|Lack of Efficacy|2
209461|NCT01994863|677588|P1|Period 2|Lack of Efficacy|0
209462|NCT01994863|677587|P2|Period 2|Adverse Event|1
209463|NCT01994863|677588|P1|Period 2|Adverse Event|0
209464|NCT01994863|677587|P2|Period 1|Lack of Efficacy|0
209465|NCT01994863|677588|P1|Period 1|Lack of Efficacy|1
209466|NCT01994863|677587|P2|Period 1|Trial stopped by sponsor|3
209467|NCT01994863|677588|P1|Period 1|Trial stopped by sponsor|1
209468|NCT01994863|677587|P2|Period 1|Withdrawal by Subject|0
209469|NCT01994863|677588|P1|Period 1|Withdrawal by Subject|1
209470|NCT01994863|677587|P2|Period 1|Adverse Event|0
209471|NCT01994863|677588|P1|Period 1|Adverse Event|4
209472|NCT01994720|677603|P2|Overall Study|Withdrawal by Subject|56
209473|NCT01994720|677604|P1|Overall Study|Withdrawal by Subject|46
209474|NCT01994629|677646|P2|Overall Study|Lost to Follow-up|3
209475|NCT01994629|677647|P1|Overall Study|Lost to Follow-up|0
209476|NCT01994629|677646|P2|Overall Study|Withdrawal by Subject|0
209477|NCT01994629|677647|P1|Overall Study|Withdrawal by Subject|1
209478|NCT01994291|677683|P3|Overall Study|Unspecified|0
209479|NCT01994291|677684|P2|Overall Study|Unspecified|2
209480|NCT01994291|677685|P1|Overall Study|Unspecified|1
209481|NCT01994291|677683|P3|Overall Study|Withdrawal by Subject|5
209482|NCT01994291|677684|P2|Overall Study|Withdrawal by Subject|3
209483|NCT01994291|677685|P1|Overall Study|Withdrawal by Subject|6
209484|NCT01994291|677683|P3|Overall Study|Protocol Violation|0
209485|NCT01994291|677684|P2|Overall Study|Protocol Violation|0
209486|NCT01994291|677685|P1|Overall Study|Protocol Violation|1
209487|NCT01994291|677683|P3|Overall Study|Medication error without associated AE|1
209488|NCT01994291|677684|P2|Overall Study|Medication error without associated AE|0
209489|NCT01994291|677685|P1|Overall Study|Medication error without associated AE|1
209490|NCT01994291|677683|P3|Overall Study|Does not meet entrance criteria|0
209491|NCT01994291|677684|P2|Overall Study|Does not meet entrance criteria|0
209492|NCT01994291|677685|P1|Overall Study|Does not meet entrance criteria|1
209493|NCT01994291|677683|P3|Overall Study|Lost to Follow-up|0
209494|NCT01994291|677684|P2|Overall Study|Lost to Follow-up|1
209495|NCT01994291|677685|P1|Overall Study|Lost to Follow-up|1
209496|NCT01994291|677683|P3|Overall Study|Adverse Event|3
209497|NCT01994291|677684|P2|Overall Study|Adverse Event|1
209498|NCT01994291|677685|P1|Overall Study|Adverse Event|4
209499|NCT01993940|677741|P2|Overall Study|Other - Miscellaneous|1
209500|NCT01993940|677742|P1|Overall Study|Other - Miscellaneous|1
209501|NCT01993940|677741|P2|Overall Study|Death|0
209502|NCT01993940|677742|P1|Overall Study|Death|1
209503|NCT01993940|677741|P2|Overall Study|Protocol Violation|8
209504|NCT01993940|677742|P1|Overall Study|Protocol Violation|5
209505|NCT01993940|677741|P2|Overall Study|Lost to Follow-up|5
209506|NCT01993940|677742|P1|Overall Study|Lost to Follow-up|2
209507|NCT01993940|677741|P2|Overall Study|Withdrawal by Subject|19
209508|NCT01993940|677742|P1|Overall Study|Withdrawal by Subject|15
209509|NCT01993940|677741|P2|Overall Study|Adverse Event|11
209510|NCT01993940|677742|P1|Overall Study|Adverse Event|16
209511|NCT01993888|677758|P2|Overall Study|Withdrawal by Subject|1
209512|NCT01993888|677759|P1|Overall Study|Withdrawal by Subject|0
209513|NCT01993888|677758|P2|Overall Study|Lost to Follow-up|1
209514|NCT01993888|677759|P1|Overall Study|Lost to Follow-up|1
209515|NCT01993888|677758|P2|Overall Study|Death|1
209516|NCT01993888|677759|P1|Overall Study|Death|1
209517|NCT01993823|677777|P2|Overall Study|Lost to Follow-up|4
209518|NCT01993823|677778|P1|Overall Study|Lost to Follow-up|1
209519|NCT01993823|677777|P2|Overall Study|Protocol Violation|1
209520|NCT01993823|677778|P1|Overall Study|Protocol Violation|0
209521|NCT01993823|677777|P2|Overall Study|Requested by the patient|11
209522|NCT01993823|677778|P1|Overall Study|Requested by the patient|6
209523|NCT01993030|677793|P2|Overall Study|Adverse Event|4
209524|NCT01993030|677794|P1|Overall Study|Adverse Event|0
209525|NCT01992536|677848|P10|Overall Study|Withdrawal by Subject|0
209526|NCT01992536|677849|P9|Overall Study|Withdrawal by Subject|0
209527|NCT01992536|677850|P8|Overall Study|Withdrawal by Subject|0
209528|NCT01992536|677851|P7|Overall Study|Withdrawal by Subject|0
209529|NCT01992536|677852|P6|Overall Study|Withdrawal by Subject|0
209530|NCT01992536|677853|P5|Overall Study|Withdrawal by Subject|0
209531|NCT01992536|677854|P4|Overall Study|Withdrawal by Subject|2
209532|NCT01992536|677855|P3|Overall Study|Withdrawal by Subject|0
209533|NCT01992536|677856|P2|Overall Study|Withdrawal by Subject|1
209534|NCT01992536|677857|P1|Overall Study|Withdrawal by Subject|0
209535|NCT01992536|677848|P10|Overall Study|Lost to Follow-up|1
209536|NCT01992536|677849|P9|Overall Study|Lost to Follow-up|1
209537|NCT01992536|677850|P8|Overall Study|Lost to Follow-up|0
209538|NCT01992536|677851|P7|Overall Study|Lost to Follow-up|0
209539|NCT01992536|677852|P6|Overall Study|Lost to Follow-up|1
209540|NCT01992536|677853|P5|Overall Study|Lost to Follow-up|0
209541|NCT01992536|677854|P4|Overall Study|Lost to Follow-up|0
209542|NCT01992536|677855|P3|Overall Study|Lost to Follow-up|1
209543|NCT01992536|677856|P2|Overall Study|Lost to Follow-up|2
209544|NCT01992536|677857|P1|Overall Study|Lost to Follow-up|4
209545|NCT01992536|677848|P10|Overall Study|Administrative Reason|0
209546|NCT01992536|677849|P9|Overall Study|Administrative Reason|0
209547|NCT01992536|677850|P8|Overall Study|Administrative Reason|0
209548|NCT01992536|677851|P7|Overall Study|Administrative Reason|7
209549|NCT01992536|677852|P6|Overall Study|Administrative Reason|0
209550|NCT01992536|677853|P5|Overall Study|Administrative Reason|0
209551|NCT01992536|677854|P4|Overall Study|Administrative Reason|0
209552|NCT01992536|677855|P3|Overall Study|Administrative Reason|0
209553|NCT01992536|677856|P2|Overall Study|Administrative Reason|0
209554|NCT01992536|677857|P1|Overall Study|Administrative Reason|0
209555|NCT01992107|678108|P3|Overall Study|Withdrawal by Subject|8
209556|NCT01992107|678109|P2|Overall Study|Withdrawal by Subject|7
209557|NCT01992107|678110|P1|Overall Study|Withdrawal by Subject|13
209558|NCT01992107|678108|P3|Overall Study|noncompliance and were unavailable|2
209559|NCT01992107|678109|P2|Overall Study|noncompliance and were unavailable|3
209560|NCT01992107|678110|P1|Overall Study|noncompliance and were unavailable|7
209561|NCT01992107|678108|P3|Overall Study|Lost to Follow-up|26
209562|NCT01992107|678109|P2|Overall Study|Lost to Follow-up|22
209563|NCT01992107|678110|P1|Overall Study|Lost to Follow-up|46
209564|NCT01992107|678108|P3|Overall Study|Adverse Event|0
209565|NCT01992107|678109|P2|Overall Study|Adverse Event|1
209566|NCT01992107|678110|P1|Overall Study|Adverse Event|0
209567|NCT01992107|678108|P3|Overall Study|Administrative reasons|0
209568|NCT01992107|678109|P2|Overall Study|Administrative reasons|0
209569|NCT01992107|678110|P1|Overall Study|Administrative reasons|2
209570|NCT01992094|678166|P3|Overall Study|Withdrawal by Subject|4
209571|NCT01992094|678167|P2|Overall Study|Withdrawal by Subject|3
209572|NCT01992094|678168|P1|Overall Study|Withdrawal by Subject|7
209573|NCT01992094|678166|P3|Overall Study|Protocol Violation|1
209574|NCT01992094|678167|P2|Overall Study|Protocol Violation|0
209575|NCT01992094|678168|P1|Overall Study|Protocol Violation|1
209576|NCT01992094|678166|P3|Overall Study|OTHER|0
209577|NCT01992094|678167|P2|Overall Study|OTHER|0
209578|NCT01992094|678168|P1|Overall Study|OTHER|4
209579|NCT01992094|678166|P3|Overall Study|Lost to Follow-up|13
209580|NCT01992094|678167|P2|Overall Study|Lost to Follow-up|9
209581|NCT01992094|678168|P1|Overall Study|Lost to Follow-up|26
209582|NCT01992094|678166|P3|Overall Study|Death|2
209583|NCT01992094|678167|P2|Overall Study|Death|5
209584|NCT01992094|678168|P1|Overall Study|Death|5
209585|NCT01992094|678166|P3|Overall Study|Adverse Event|0
209586|NCT01992094|678167|P2|Overall Study|Adverse Event|0
209587|NCT01992094|678168|P1|Overall Study|Adverse Event|1
209588|NCT01992094|678166|P3|Overall Study|ADMINISTRATIVE REASON|1
209589|NCT01992094|678167|P2|Overall Study|ADMINISTRATIVE REASON|7
209590|NCT01992094|678168|P1|Overall Study|ADMINISTRATIVE REASON|6
209591|NCT01991314|678273|P2|Overall Study|Lost to Follow-up|10
209592|NCT01991314|678274|P1|Overall Study|Lost to Follow-up|6
209593|NCT01991314|678273|P2|Overall Study|Adverse Event|1
209594|NCT01991314|678274|P1|Overall Study|Adverse Event|5
209595|NCT01990859|678296|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
209596|NCT01990859|678296|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
209597|NCT01990664|678432|P2|Overall Study|Unsatisfactory Visual Response|1
209598|NCT01990664|678433|P1|Overall Study|Unsatisfactory Visual Response|0
209599|NCT01990664|678432|P2|Overall Study|Lens Handling Difficulties|0
209600|NCT01990664|678433|P1|Overall Study|Lens Handling Difficulties|1
209601|NCT01990664|678432|P2|Overall Study|Lens Discomfort|1
209602|NCT01990664|678433|P1|Overall Study|Lens Discomfort|1
209603|NCT01990664|678432|P2|Overall Study|Protocol Violation|0
209604|NCT01990664|678433|P1|Overall Study|Protocol Violation|1
209605|NCT01990664|678432|P2|Overall Study|Withdrawal by Subject|3
209606|NCT01990664|678433|P1|Overall Study|Withdrawal by Subject|2
209607|NCT01990664|678432|P2|Overall Study|Lost to Follow-up|6
209608|NCT01990664|678433|P1|Overall Study|Lost to Follow-up|2
209609|NCT01990534|678439|P1|Overall Study|Overall Survival Follow-up|25
209610|NCT01990534|678439|P1|Overall Study|Progression Free Survival Follow-up|11
209611|NCT01990534|678439|P1|Overall Study|Reason Not Specified|2
209612|NCT01990534|678439|P1|Overall Study|Withdrawal by Subject|3
209613|NCT01990534|678439|P1|Overall Study|Symptomatic Deterioration|1
209614|NCT01990534|678439|P1|Overall Study|Withdrawal of Informed Consent|2
209615|NCT01990534|678439|P1|Overall Study|Protocol Violation|1
209616|NCT01990534|678439|P1|Overall Study|Progressive disease|3
209617|NCT01990534|678439|P1|Overall Study|Death|12
209618|NCT01990339|678455|P1|Overall Study|Lost to Follow-up|861
209619|NCT01990339|678455|P1|Overall Study|Voluntary Withdrawal|1402
209620|NCT01990339|678455|P1|Overall Study|Data Not Available|49
209621|NCT01990261|678460|P1|Overall Study|Lost to Follow-up|2
209622|NCT01990261|678460|P1|Overall Study|Dossier not Approved|1
209623|NCT01990261|678460|P1|Overall Study|PD Before Treatment Start|1
209624|NCT01990261|678460|P1|Overall Study|Disease Progression (PD)|8
209625|NCT01990261|678460|P1|Overall Study|Death From other Causes|1
209626|NCT01990261|678460|P1|Overall Study|Death due to Disease Progression (PD)|10
209627|NCT01990261|678460|P1|Overall Study|Death Before Treatment Start|2
209628|NCT01989689|678472|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
209629|NCT01989689|678473|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
209630|NCT01989689|678472|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
209631|NCT01989689|678473|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
209632|NCT01989572|678489|P6|Overall Study|alternative therapy|3
209633|NCT01989572|678490|P5|Overall Study|alternative therapy|1
209634|NCT01989572|678491|P4|Overall Study|alternative therapy|0
209635|NCT01989572|678492|P3|Overall Study|alternative therapy|0
209636|NCT01989572|678493|P2|Overall Study|alternative therapy|0
209637|NCT01989572|678494|P1|Overall Study|alternative therapy|3
209638|NCT01989572|678489|P6|Overall Study|not start protocol therapy|18
209639|NCT01989572|678490|P5|Overall Study|not start protocol therapy|4
209640|NCT01989572|678491|P4|Overall Study|not start protocol therapy|3
209641|NCT01989572|678492|P3|Overall Study|not start protocol therapy|2
209642|NCT01989572|678493|P2|Overall Study|not start protocol therapy|1
209643|NCT01989572|678494|P1|Overall Study|not start protocol therapy|5
209644|NCT01989572|678489|P6|Overall Study|unknown/not specify|5
209645|NCT01989572|678490|P5|Overall Study|unknown/not specify|3
209646|NCT01989572|678491|P4|Overall Study|unknown/not specify|3
209647|NCT01989572|678492|P3|Overall Study|unknown/not specify|1
209648|NCT01989572|678493|P2|Overall Study|unknown/not specify|4
209649|NCT01989572|678494|P1|Overall Study|unknown/not specify|3
209650|NCT01989572|678489|P6|Overall Study|maximum dose reached|0
209651|NCT01989572|678490|P5|Overall Study|maximum dose reached|1
209652|NCT01989572|678491|P4|Overall Study|maximum dose reached|0
209653|NCT01989572|678492|P3|Overall Study|maximum dose reached|0
209654|NCT01989572|678493|P2|Overall Study|maximum dose reached|1
209655|NCT01989572|678494|P1|Overall Study|maximum dose reached|0
209656|NCT01989572|678489|P6|Overall Study|error|1
209657|NCT01989572|678490|P5|Overall Study|error|1
209658|NCT01989572|678491|P4|Overall Study|error|1
209659|NCT01989572|678492|P3|Overall Study|error|1
209660|NCT01989572|678493|P2|Overall Study|error|1
209661|NCT01989572|678494|P1|Overall Study|error|2
209662|NCT01989572|678489|P6|Overall Study|complicating disease|0
209663|NCT01989572|678490|P5|Overall Study|complicating disease|1
209664|NCT01989572|678491|P4|Overall Study|complicating disease|0
209665|NCT01989572|678492|P3|Overall Study|complicating disease|2
209666|NCT01989572|678493|P2|Overall Study|complicating disease|1
209667|NCT01989572|678494|P1|Overall Study|complicating disease|1
209668|NCT01989572|678489|P6|Overall Study|Withdrawal by Subject|4
209669|NCT01989572|678490|P5|Overall Study|Withdrawal by Subject|12
209670|NCT01989572|678491|P4|Overall Study|Withdrawal by Subject|1
209671|NCT01989572|678492|P3|Overall Study|Withdrawal by Subject|5
209672|NCT01989572|678493|P2|Overall Study|Withdrawal by Subject|1
209673|NCT01989572|678494|P1|Overall Study|Withdrawal by Subject|4
209674|NCT01989572|678489|P6|Overall Study|Death|0
209675|NCT01989572|678490|P5|Overall Study|Death|1
209676|NCT01989572|678491|P4|Overall Study|Death|0
209677|NCT01989572|678492|P3|Overall Study|Death|0
209678|NCT01989572|678493|P2|Overall Study|Death|0
209679|NCT01989572|678494|P1|Overall Study|Death|0
209680|NCT01989572|678489|P6|Overall Study|Adverse Event|0
209681|NCT01989572|678490|P5|Overall Study|Adverse Event|3
209682|NCT01989572|678491|P4|Overall Study|Adverse Event|0
209683|NCT01989572|678492|P3|Overall Study|Adverse Event|3
209684|NCT01989572|678493|P2|Overall Study|Adverse Event|1
209685|NCT01989572|678494|P1|Overall Study|Adverse Event|2
209686|NCT01989572|678489|P6|Overall Study|Lack of Efficacy|79
209687|NCT01989572|678490|P5|Overall Study|Lack of Efficacy|71
209688|NCT01989572|678491|P4|Overall Study|Lack of Efficacy|43
209689|NCT01989572|678492|P3|Overall Study|Lack of Efficacy|48
209690|NCT01989572|678493|P2|Overall Study|Lack of Efficacy|48
209691|NCT01989572|678494|P1|Overall Study|Lack of Efficacy|35
209692|NCT01989455|678527|P5|Overall Study|Technical problems with infusion|1
209693|NCT01989455|678528|P4|Overall Study|Technical problems with infusion|0
209694|NCT01989455|678529|P3|Overall Study|Technical problems with infusion|1
209695|NCT01989455|678530|P2|Overall Study|Technical problems with infusion|0
209696|NCT01989455|678531|P1|Overall Study|Technical problems with infusion|0
209697|NCT01989455|678527|P5|Overall Study|Withdrawal by Subject|0
209698|NCT01989455|678528|P4|Overall Study|Withdrawal by Subject|0
209699|NCT01989455|678529|P3|Overall Study|Withdrawal by Subject|0
209700|NCT01989455|678530|P2|Overall Study|Withdrawal by Subject|1
209701|NCT01989455|678531|P1|Overall Study|Withdrawal by Subject|0
209702|NCT01989455|678527|P5|Overall Study|Adverse Event|0
209703|NCT01989455|678528|P4|Overall Study|Adverse Event|0
209704|NCT01989455|678529|P3|Overall Study|Adverse Event|0
209705|NCT01989455|678530|P2|Overall Study|Adverse Event|1
209706|NCT01989455|678531|P1|Overall Study|Adverse Event|0
209707|NCT01988402|678575|P2|Overall Study|Withdrawal by Subject|0
209708|NCT01988402|678576|P1|Overall Study|Withdrawal by Subject|1
209709|NCT01988402|678575|P2|Overall Study|Adverse Event|2
209710|NCT01988402|678576|P1|Overall Study|Adverse Event|1
209711|NCT01989169|678594|P2|Period 2|Adverse Event|1
209712|NCT01989169|678595|P1|Period 2|Adverse Event|0
209713|NCT01989156|678608|P3|End of Study (Population at Day 90)|Employment Conflict|0
209714|NCT01989156|678609|P2|End of Study (Population at Day 90)|Employment Conflict|1
209715|NCT01989156|678610|P1|End of Study (Population at Day 90)|Employment Conflict|0
209716|NCT01989156|678608|P3|End of Study (Population at Day 90)|Moved out of state|0
209717|NCT01989156|678609|P2|End of Study (Population at Day 90)|Moved out of state|0
209718|NCT01989156|678610|P1|End of Study (Population at Day 90)|Moved out of state|1
209719|NCT01989156|678608|P3|End of Study (Population at Day 90)|Physician Decision|1
209720|NCT01989156|678609|P2|End of Study (Population at Day 90)|Physician Decision|0
209721|NCT01989156|678610|P1|End of Study (Population at Day 90)|Physician Decision|1
209722|NCT01989156|678608|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
209723|NCT01989156|678609|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
209724|NCT01989156|678610|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
209725|NCT01989156|678608|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
209726|NCT01989156|678609|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
209727|NCT01989156|678610|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
209728|NCT01989156|678608|P3|Confinement Period (Population at Day 5)|Adverse Event|1
209729|NCT01989156|678609|P2|Confinement Period (Population at Day 5)|Adverse Event|0
209730|NCT01989156|678610|P1|Confinement Period (Population at Day 5)|Adverse Event|0
209731|NCT01989156|678608|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
209732|NCT01989156|678609|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
209733|NCT01989156|678610|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
209734|NCT01989156|678608|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
209735|NCT01989156|678609|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
209736|NCT01989156|678610|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
209737|NCT01988662|678654|P2|Overall Study|Adverse Event|1
209738|NCT01988662|678655|P1|Overall Study|Adverse Event|3
209739|NCT01988662|678654|P2|Overall Study|Subject/guardian decision|1
209740|NCT01988662|678655|P1|Overall Study|Subject/guardian decision|1
209741|NCT01988012|678702|P1|Overall Study|Protocol Violation|1
209742|NCT01988012|678702|P1|Overall Study|Physician Decision|1
209743|NCT01988012|678702|P1|Overall Study|Lost to Follow-up|1
209744|NCT01988012|678702|P1|Overall Study|Patient Withdrawal of Consent|4
209745|NCT01988012|678702|P1|Overall Study|Insufficient Therapeutic Response|3
209746|NCT01988012|678702|P1|Overall Study|Adverse Event|5
209747|NCT01987960|678726|P4|Period 3|Administrative or other reason|43
209748|NCT01987960|678727|P3|Period 3|Administrative or other reason|0
209749|NCT01987960|678728|P2|Period 3|Administrative or other reason|0
209750|NCT01987960|678729|P1|Period 3|Administrative or other reason|0
209751|NCT01987960|678726|P4|Period 3|Lost to Follow-up|5
209752|NCT01987960|678727|P3|Period 3|Lost to Follow-up|0
209753|NCT01987960|678728|P2|Period 3|Lost to Follow-up|0
209754|NCT01987960|678729|P1|Period 3|Lost to Follow-up|0
209755|NCT01987960|678726|P4|Period 3|Withdrawal by Subject|9
209756|NCT01987960|678727|P3|Period 3|Withdrawal by Subject|0
209757|NCT01987960|678728|P2|Period 3|Withdrawal by Subject|0
209758|NCT01987960|678729|P1|Period 3|Withdrawal by Subject|0
209759|NCT01987960|678726|P4|Period 3|Protocol Violation|6
209760|NCT01987960|678727|P3|Period 3|Protocol Violation|0
209761|NCT01987960|678728|P2|Period 3|Protocol Violation|0
209762|NCT01987960|678729|P1|Period 3|Protocol Violation|0
209763|NCT01987960|678726|P4|Period 3|Non-compliance with IMP|1
209764|NCT01987960|678727|P3|Period 3|Non-compliance with IMP|0
209765|NCT01987960|678728|P2|Period 3|Non-compliance with IMP|0
209766|NCT01987960|678729|P1|Period 3|Non-compliance with IMP|0
209767|NCT01987960|678726|P4|Period 3|Adverse Event|7
209768|NCT01987960|678727|P3|Period 3|Adverse Event|0
209769|NCT01987960|678728|P2|Period 3|Adverse Event|0
209770|NCT01987960|678729|P1|Period 3|Adverse Event|0
209771|NCT01987960|678726|P4|Period 2|Administrative or other reason|0
209772|NCT01987960|678727|P3|Period 2|Administrative or other reason|7
209773|NCT01987960|678728|P2|Period 2|Administrative or other reason|5
209774|NCT01987960|678729|P1|Period 2|Administrative or other reason|0
209775|NCT01987960|678726|P4|Period 2|Withdrawal by Subject|0
209776|NCT01987960|678727|P3|Period 2|Withdrawal by Subject|1
209777|NCT01987960|678728|P2|Period 2|Withdrawal by Subject|0
209778|NCT01987960|678729|P1|Period 2|Withdrawal by Subject|0
209779|NCT01987960|678726|P4|Period 2|Adverse Event|0
209780|NCT01987960|678727|P3|Period 2|Adverse Event|1
209781|NCT01987960|678728|P2|Period 2|Adverse Event|0
209782|NCT01987960|678729|P1|Period 2|Adverse Event|0
209783|NCT01987960|678726|P4|Period 1|Withdrawal of consent before treatment|0
209784|NCT01987960|678727|P3|Period 1|Withdrawal of consent before treatment|0
209785|NCT01987960|678728|P2|Period 1|Withdrawal of consent before treatment|0
209786|NCT01987960|678729|P1|Period 1|Withdrawal of consent before treatment|4
209787|NCT01987960|678726|P4|Period 1|administrative or other reason|0
209788|NCT01987960|678727|P3|Period 1|administrative or other reason|0
209789|NCT01987960|678728|P2|Period 1|administrative or other reason|0
209790|NCT01987960|678729|P1|Period 1|administrative or other reason|75
209791|NCT01987960|678726|P4|Period 1|Lost to Follow-up|0
209792|NCT01987960|678727|P3|Period 1|Lost to Follow-up|0
209793|NCT01987960|678728|P2|Period 1|Lost to Follow-up|0
209794|NCT01987960|678729|P1|Period 1|Lost to Follow-up|40
209795|NCT01987960|678726|P4|Period 1|Withdrawal by Subject|0
209796|NCT01987960|678727|P3|Period 1|Withdrawal by Subject|0
209797|NCT01987960|678728|P2|Period 1|Withdrawal by Subject|0
209798|NCT01987960|678729|P1|Period 1|Withdrawal by Subject|21
209799|NCT01987960|678726|P4|Period 1|Protocol Violation|0
209800|NCT01987960|678727|P3|Period 1|Protocol Violation|0
209801|NCT01987960|678728|P2|Period 1|Protocol Violation|0
209802|NCT01987960|678729|P1|Period 1|Protocol Violation|12
209803|NCT01987960|678726|P4|Period 1|Non-compliance with IMP|0
209804|NCT01987960|678727|P3|Period 1|Non-compliance with IMP|0
209805|NCT01987960|678728|P2|Period 1|Non-compliance with IMP|0
209806|NCT01987960|678729|P1|Period 1|Non-compliance with IMP|6
209807|NCT01987960|678726|P4|Period 1|Lack of Efficacy|0
209808|NCT01987960|678727|P3|Period 1|Lack of Efficacy|0
209809|NCT01987960|678728|P2|Period 1|Lack of Efficacy|0
209810|NCT01987960|678729|P1|Period 1|Lack of Efficacy|4
209811|NCT01987960|678726|P4|Period 1|Adverse Event|0
209812|NCT01987960|678727|P3|Period 1|Adverse Event|0
209813|NCT01987960|678728|P2|Period 1|Adverse Event|0
209814|NCT01987960|678729|P1|Period 1|Adverse Event|24
209815|NCT01987908|678741|P3|Post-Treatment Observation Period|Other: Bad Veins|0
209816|NCT01987908|678742|P2|Post-Treatment Observation Period|Other: Bad Veins|1
209817|NCT01987908|678743|P1|Post-Treatment Observation Period|Other: Bad Veins|0
209818|NCT01987908|678741|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
209819|NCT01987908|678742|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
209820|NCT01987908|678743|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
209821|NCT01987908|678741|P3|Treatment Period|Adverse Event|1
209822|NCT01987908|678742|P2|Treatment Period|Adverse Event|1
209823|NCT01987908|678743|P1|Treatment Period|Adverse Event|0
209824|NCT01987908|678741|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
209825|NCT01987908|678742|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
209826|NCT01987908|678743|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
209827|NCT01987908|678741|P3|Placebo Lead-in Period|Withdrawal by Subject|0
209828|NCT01987908|678742|P2|Placebo Lead-in Period|Withdrawal by Subject|0
209829|NCT01987908|678743|P1|Placebo Lead-in Period|Withdrawal by Subject|1
209830|NCT01987908|678741|P3|Placebo Lead-in Period|Physician Decision|0
209831|NCT01987908|678742|P2|Placebo Lead-in Period|Physician Decision|0
209832|NCT01987908|678743|P1|Placebo Lead-in Period|Physician Decision|2
209833|NCT01987908|678741|P3|Placebo Lead-in Period|Adverse Event|0
209834|NCT01987908|678742|P2|Placebo Lead-in Period|Adverse Event|0
209835|NCT01987908|678743|P1|Placebo Lead-in Period|Adverse Event|2
209836|NCT01987765|678824|P1|Overall Study|Lost to Follow-up|37
209837|NCT01987765|678824|P1|Overall Study|Protocol Violation|65
209838|NCT01987557|678848|P3|Overall Study|Adverse Event|0
209839|NCT01987557|678849|P2|Overall Study|Adverse Event|2
209840|NCT01987557|678850|P1|Overall Study|Adverse Event|0
209841|NCT01987557|678848|P3|Overall Study|Withdrawal by Subject|2
209842|NCT01987557|678849|P2|Overall Study|Withdrawal by Subject|1
209843|NCT01987557|678850|P1|Overall Study|Withdrawal by Subject|2
209844|NCT01987557|678848|P3|Overall Study|Protocol Violation|1
209845|NCT01987557|678849|P2|Overall Study|Protocol Violation|0
209846|NCT01987557|678850|P1|Overall Study|Protocol Violation|1
209847|NCT01987453|678861|P3|Overall Study|Lack of Efficacy|0
209848|NCT01987453|678862|P2|Overall Study|Lack of Efficacy|12
209849|NCT01987453|678863|P1|Overall Study|Lack of Efficacy|1
209850|NCT01987453|678861|P3|Overall Study|Death|1
209851|NCT01987453|678862|P2|Overall Study|Death|0
209852|NCT01987453|678863|P1|Overall Study|Death|0
209853|NCT01986985|678955|P1|Overall Study|Scan not completed due to malfunction|3
209854|NCT01986985|678955|P1|Overall Study|Withdrawal by Subject|4
209855|NCT01986751|679013|P2|Overall Study|improperly consented|2
209856|NCT01986751|679014|P1|Overall Study|improperly consented|10
209857|NCT01986231|679034|P1|Overall Study|Adverse Event|1
209858|NCT01986062|679041|P2|Overall Study|Lost to Follow-up|1
209859|NCT01986062|679042|P1|Overall Study|Lost to Follow-up|1
209860|NCT01985321|679102|P2|Overall Study|Subject treated wrong type of sore|0
209861|NCT01985321|679103|P1|Overall Study|Subject treated wrong type of sore|1
209862|NCT01985321|679102|P2|Overall Study|Lost to Follow-up|2
209863|NCT01985321|679103|P1|Overall Study|Lost to Follow-up|5
209864|NCT01985321|679102|P2|Overall Study|Withdrawal by Subject|0
209865|NCT01985321|679103|P1|Overall Study|Withdrawal by Subject|1
209866|NCT01985321|679102|P2|Overall Study|Protocol Violation|3
209867|NCT01985321|679103|P1|Overall Study|Protocol Violation|4
209868|NCT01985126|679113|P2|Overall Study|Ongoing|67
209869|NCT01985126|679114|P1|Overall Study|Ongoing|9
209870|NCT01985126|679113|P2|Overall Study|Lost to Follow-up|3
209871|NCT01985126|679114|P1|Overall Study|Lost to Follow-up|0
209872|NCT01985126|679113|P2|Overall Study|Withdrawal by Subject|5
209873|NCT01985126|679114|P1|Overall Study|Withdrawal by Subject|2
209874|NCT01985126|679113|P2|Overall Study|Death|31
209875|NCT01985126|679114|P1|Overall Study|Death|7
209876|NCT01984697|679137|P5|Overall Study|Follow-up continues|308
209877|NCT01984697|679138|P4|Overall Study|Follow-up continues|290
209878|NCT01984697|679139|P3|Overall Study|Follow-up continues|292
209879|NCT01984697|679140|P2|Overall Study|Follow-up continues|294
209880|NCT01984697|679141|P1|Overall Study|Follow-up continues|290
209881|NCT01984697|679137|P5|Overall Study|Withdrawal by Subject|2
209882|NCT01984697|679138|P4|Overall Study|Withdrawal by Subject|7
209883|NCT01984697|679139|P3|Overall Study|Withdrawal by Subject|4
209884|NCT01984697|679140|P2|Overall Study|Withdrawal by Subject|5
209885|NCT01984697|679141|P1|Overall Study|Withdrawal by Subject|3
209886|NCT01984697|679137|P5|Overall Study|Protocol Violation|0
209887|NCT01984697|679138|P4|Overall Study|Protocol Violation|1
209888|NCT01984697|679139|P3|Overall Study|Protocol Violation|0
209889|NCT01984697|679140|P2|Overall Study|Protocol Violation|0
209890|NCT01984697|679141|P1|Overall Study|Protocol Violation|0
209891|NCT01984697|679137|P5|Overall Study|Physician Decision|0
209892|NCT01984697|679138|P4|Overall Study|Physician Decision|0
209893|NCT01984697|679139|P3|Overall Study|Physician Decision|0
209894|NCT01984697|679140|P2|Overall Study|Physician Decision|0
209895|NCT01984697|679141|P1|Overall Study|Physician Decision|1
209896|NCT01984697|679137|P5|Overall Study|Lost to Follow-up|4
209897|NCT01984697|679138|P4|Overall Study|Lost to Follow-up|3
209898|NCT01984697|679139|P3|Overall Study|Lost to Follow-up|4
209899|NCT01984697|679140|P2|Overall Study|Lost to Follow-up|2
209900|NCT01984697|679141|P1|Overall Study|Lost to Follow-up|7
209901|NCT01984697|679137|P5|Overall Study|Adverse Event|0
209902|NCT01984697|679138|P4|Overall Study|Adverse Event|0
209903|NCT01984697|679139|P3|Overall Study|Adverse Event|1
209904|NCT01984697|679140|P2|Overall Study|Adverse Event|0
209905|NCT01984697|679141|P1|Overall Study|Adverse Event|0
209906|NCT01984294|679247|P3|Overall Study|Adverse Event|0
209907|NCT01984294|679248|P2|Overall Study|Adverse Event|1
209908|NCT01984294|679249|P1|Overall Study|Adverse Event|0
209909|NCT01984294|679247|P3|Overall Study|Lack of Efficacy|6
209910|NCT01984294|679248|P2|Overall Study|Lack of Efficacy|2
209911|NCT01984294|679249|P1|Overall Study|Lack of Efficacy|4
209912|NCT01984294|679247|P3|Overall Study|Randomized but Never Treated|1
209913|NCT01984294|679248|P2|Overall Study|Randomized but Never Treated|0
209914|NCT01984294|679249|P1|Overall Study|Randomized but Never Treated|0
209915|NCT01984229|679271|P2|Safety Follow-up Period|Lost to Follow-up|0
209916|NCT01984229|679272|P1|Safety Follow-up Period|Lost to Follow-up|1
209917|NCT01984229|679271|P2|Safety Follow-up Period|Adverse Event|1
209918|NCT01984229|679272|P1|Safety Follow-up Period|Adverse Event|1
209919|NCT01983254|679389|P2|Overall Study|too ill|8
209920|NCT01983254|679390|P1|Overall Study|too ill|11
209921|NCT01983254|679389|P2|Overall Study|Lost to Follow-up|16
209922|NCT01983254|679390|P1|Overall Study|Lost to Follow-up|17
209923|NCT01983254|679389|P2|Overall Study|Death|6
209924|NCT01983254|679390|P1|Overall Study|Death|6
209925|NCT01983111|679402|P2|Overall Study|Protocol Violation|1
209926|NCT01983111|679403|P1|Overall Study|Protocol Violation|0
209927|NCT01983111|679402|P2|Overall Study|Adverse Event|0
209928|NCT01983111|679403|P1|Overall Study|Adverse Event|4
209929|NCT01983111|679402|P2|Overall Study|Withdrawal by Subject|6
209930|NCT01983111|679403|P1|Overall Study|Withdrawal by Subject|8
209931|NCT01982812|679438|P2|Overall Study|Adverse Event|5
209932|NCT01982812|679439|P1|Overall Study|Adverse Event|0
209933|NCT01982812|679438|P2|Overall Study|Death|5
209934|NCT01982812|679439|P1|Overall Study|Death|1
209935|NCT01982292|679466|P2|Overall Study|Technical Problems|0
209936|NCT01982292|679467|P1|Overall Study|Technical Problems|2
209937|NCT01982292|679466|P2|Overall Study|Patient/Guardian Decision|1
209938|NCT01982292|679467|P1|Overall Study|Patient/Guardian Decision|3
209939|NCT01982292|679466|P2|Overall Study|Protocol Deviation|0
209940|NCT01982292|679467|P1|Overall Study|Protocol Deviation|1
209941|NCT01982292|679466|P2|Overall Study|Non-Compliance With Study Treatment|0
209942|NCT01982292|679467|P1|Overall Study|Non-Compliance With Study Treatment|1
209943|NCT01982292|679466|P2|Overall Study|Lost to Follow-up|0
209944|NCT01982292|679467|P1|Overall Study|Lost to Follow-up|2
209945|NCT01982292|679466|P2|Overall Study|Death|0
209946|NCT01982292|679467|P1|Overall Study|Death|1
209947|NCT01982292|679466|P2|Overall Study|Adverse Event|0
209948|NCT01982292|679467|P1|Overall Study|Adverse Event|2
209949|NCT01982253|679488|P3|Overall Study|Study terminated by sponsor|4
209950|NCT01982253|679489|P2|Overall Study|Study terminated by sponsor|4
209951|NCT01982253|679490|P1|Overall Study|Study terminated by sponsor|1
209952|NCT01982253|679488|P3|Overall Study|Withdrawal by Subject|0
209953|NCT01982253|679489|P2|Overall Study|Withdrawal by Subject|0
209954|NCT01982253|679490|P1|Overall Study|Withdrawal by Subject|1
209955|NCT01981616|679529|P2|Overall Study|Protocol Violation|0
209956|NCT01981616|679530|P1|Overall Study|Protocol Violation|1
209957|NCT01981616|679529|P2|Overall Study|Adverse Event|1
209958|NCT01981616|679530|P1|Overall Study|Adverse Event|0
209959|NCT01981473|679545|P3|Overall Study|Received treatment for >24 months|6
209960|NCT01981473|679546|P2|Overall Study|Received treatment for >24 months|0
209961|NCT01981473|679547|P1|Overall Study|Received treatment for >24 months|2
209962|NCT01981473|679545|P3|Overall Study|Received treatment for < 6 months|1
209963|NCT01981473|679546|P2|Overall Study|Received treatment for < 6 months|0
209964|NCT01981473|679547|P1|Overall Study|Received treatment for < 6 months|0
209965|NCT01981473|679545|P3|Overall Study|Incorrect diagnosis of RA|1
209966|NCT01981473|679546|P2|Overall Study|Incorrect diagnosis of RA|0
209967|NCT01981473|679547|P1|Overall Study|Incorrect diagnosis of RA|0
209968|NCT01981356|679588|P2|Overall Study|Protocol Violation|0
209969|NCT01981356|679589|P1|Overall Study|Protocol Violation|2
209970|NCT01981356|679588|P2|Overall Study|Withdrawal by Subject|1
209971|NCT01981356|679589|P1|Overall Study|Withdrawal by Subject|1
209972|NCT01981356|679588|P2|Overall Study|Lost to Follow-up|1
209973|NCT01981356|679589|P1|Overall Study|Lost to Follow-up|4
209974|NCT01980992|679625|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
209975|NCT01980992|679626|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
209976|NCT01980992|679625|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
209977|NCT01980992|679626|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
209978|NCT01980992|679625|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
209979|NCT01980992|679626|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
209980|NCT01980992|679625|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
209981|NCT01980992|679626|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
209982|NCT01980992|679625|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
209983|NCT01980992|679626|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
209984|NCT01980992|679625|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
209985|NCT01980992|679626|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
209986|NCT01980940|679640|P8|Overall Study|Protocol Violation|0
209987|NCT01980940|679641|P7|Overall Study|Protocol Violation|0
209988|NCT01980940|679642|P6|Overall Study|Protocol Violation|2
209989|NCT01980940|679643|P5|Overall Study|Protocol Violation|0
209990|NCT01980940|679644|P4|Overall Study|Protocol Violation|0
209991|NCT01980940|679645|P3|Overall Study|Protocol Violation|0
209992|NCT01980940|679646|P2|Overall Study|Protocol Violation|0
209993|NCT01980940|679647|P1|Overall Study|Protocol Violation|0
209994|NCT01980095|679739|P2|Overall Study|Study drug discontinued|0
209995|NCT01980095|679740|P1|Overall Study|Study drug discontinued|1
209996|NCT01980095|679739|P2|Overall Study|Safety issue|1
209997|NCT01980095|679740|P1|Overall Study|Safety issue|0
209998|NCT01980095|679739|P2|Overall Study|Poor compliance|0
209999|NCT01980095|679740|P1|Overall Study|Poor compliance|5
210000|NCT01980095|679739|P2|Overall Study|Withdrawal by Subject|3
210001|NCT01980095|679740|P1|Overall Study|Withdrawal by Subject|2
210002|NCT01980095|679739|P2|Overall Study|Lost to Follow-up|7
210003|NCT01980095|679740|P1|Overall Study|Lost to Follow-up|6
210004|NCT01979185|679750|P2|Period 2|Not specified|1
210005|NCT01979185|679751|P1|Period 2|Not specified|0
210006|NCT01978145|679804|P2|Treatment Period 2|Par. reached defined stopping criteria|5
210007|NCT01978145|679805|P1|Treatment Period 2|Par. reached defined stopping criteria|8
210008|NCT01978145|679804|P2|Treatment Period 2|Withdrawal by Subject|4
210009|NCT01978145|679805|P1|Treatment Period 2|Withdrawal by Subject|7
210010|NCT01978145|679804|P2|Treatment Period 2|Lost to Follow-up|1
210011|NCT01978145|679805|P1|Treatment Period 2|Lost to Follow-up|1
210012|NCT01978145|679804|P2|Treatment Period 2|Protocol Violation|1
210013|NCT01978145|679805|P1|Treatment Period 2|Protocol Violation|0
210014|NCT01978145|679804|P2|Treatment Period 2|Adverse Event|3
210015|NCT01978145|679805|P1|Treatment Period 2|Adverse Event|3
210016|NCT01978145|679804|P2|Washout Period 1|Par. reached defined stopping criteria|1
210017|NCT01978145|679805|P1|Washout Period 1|Par. reached defined stopping criteria|0
210018|NCT01978145|679804|P2|Washout Period 1|Withdrawal by Subject|1
210019|NCT01978145|679805|P1|Washout Period 1|Withdrawal by Subject|1
210020|NCT01978145|679804|P2|Washout Period 1|Adverse Event|1
210021|NCT01978145|679805|P1|Washout Period 1|Adverse Event|0
210022|NCT01978145|679804|P2|Treatment Period 1|Par. reached defined stopping criteria|3
210023|NCT01978145|679805|P1|Treatment Period 1|Par. reached defined stopping criteria|2
210024|NCT01978145|679804|P2|Treatment Period 1|Withdrawal by Subject|4
210025|NCT01978145|679805|P1|Treatment Period 1|Withdrawal by Subject|5
210026|NCT01978145|679804|P2|Treatment Period 1|Physician Decision|0
210027|NCT01978145|679805|P1|Treatment Period 1|Physician Decision|1
210028|NCT01978145|679804|P2|Treatment Period 1|Adverse Event|9
210029|NCT01978145|679805|P1|Treatment Period 1|Adverse Event|1
210030|NCT01978119|679821|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
210031|NCT01978119|679822|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
210032|NCT01978119|679821|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
210033|NCT01978119|679822|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
210034|NCT01978119|679821|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
210035|NCT01978119|679822|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
210036|NCT01977820|679848|P2|Overall Study|Sponsor terminated the study|1
210037|NCT01977820|679849|P1|Overall Study|Sponsor terminated the study|1
210038|NCT01977794|679857|P2|Overall Study|Unspecified|1
210039|NCT01977794|679858|P1|Overall Study|Unspecified|0
210040|NCT01977794|679857|P2|Overall Study|Withdrew consent|1
210041|NCT01977794|679858|P1|Overall Study|Withdrew consent|2
210042|NCT01977794|679857|P2|Overall Study|Death|1
210043|NCT01977794|679858|P1|Overall Study|Death|1
210044|NCT01977794|679857|P2|Overall Study|Protocol Violation|0
210045|NCT01977794|679858|P1|Overall Study|Protocol Violation|1
210046|NCT01977794|679857|P2|Overall Study|Lost to Follow-up|1
210047|NCT01977794|679858|P1|Overall Study|Lost to Follow-up|2
210048|NCT01977794|679857|P2|Overall Study|Adverse Event|2
210049|NCT01977794|679858|P1|Overall Study|Adverse Event|2
210050|NCT01977729|679893|P1|Overall Study|Study terminated|1
210051|NCT01977573|679907|P4|Overall Study|Withdrawal by Subject|1
210052|NCT01977573|679908|P3|Overall Study|Withdrawal by Subject|1
210053|NCT01977573|679909|P2|Overall Study|Withdrawal by Subject|1
210054|NCT01977573|679910|P1|Overall Study|Withdrawal by Subject|6
210055|NCT01977573|679907|P4|Overall Study|Reached Defined Stopping Criteria|0
210056|NCT01977573|679908|P3|Overall Study|Reached Defined Stopping Criteria|1
210057|NCT01977573|679909|P2|Overall Study|Reached Defined Stopping Criteria|1
210058|NCT01977573|679910|P1|Overall Study|Reached Defined Stopping Criteria|2
210059|NCT01977573|679907|P4|Overall Study|Protocol Violation|0
210060|NCT01977573|679908|P3|Overall Study|Protocol Violation|0
210061|NCT01977573|679909|P2|Overall Study|Protocol Violation|1
210062|NCT01977573|679910|P1|Overall Study|Protocol Violation|3
210063|NCT01977573|679907|P4|Overall Study|Physician Decision|0
210064|NCT01977573|679908|P3|Overall Study|Physician Decision|0
210065|NCT01977573|679909|P2|Overall Study|Physician Decision|0
210066|NCT01977573|679910|P1|Overall Study|Physician Decision|1
210067|NCT01977573|679907|P4|Overall Study|Lost to Follow-up|1
210068|NCT01977573|679908|P3|Overall Study|Lost to Follow-up|0
210069|NCT01977573|679909|P2|Overall Study|Lost to Follow-up|0
210070|NCT01977573|679910|P1|Overall Study|Lost to Follow-up|1
210071|NCT01977573|679907|P4|Overall Study|Adverse Event|1
210072|NCT01977573|679908|P3|Overall Study|Adverse Event|2
210073|NCT01977573|679909|P2|Overall Study|Adverse Event|0
210074|NCT01977573|679910|P1|Overall Study|Adverse Event|7
210075|NCT01977482|680024|P6|Overall Study|Withdrawal by Subject|5
210076|NCT01977482|680025|P5|Overall Study|Withdrawal by Subject|1
210077|NCT01977482|680026|P4|Overall Study|Withdrawal by Subject|3
210078|NCT01977482|680027|P3|Overall Study|Withdrawal by Subject|1
210079|NCT01977482|680028|P2|Overall Study|Withdrawal by Subject|4
210080|NCT01977482|680029|P1|Overall Study|Withdrawal by Subject|2
210081|NCT01977482|680024|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
210082|NCT01977482|680025|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
210083|NCT01977482|680026|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
210084|NCT01977482|680027|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
210085|NCT01977482|680028|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
210086|NCT01977482|680029|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
210087|NCT01977482|680024|P6|Overall Study|Protocol Violation|0
210088|NCT01977482|680025|P5|Overall Study|Protocol Violation|0
210089|NCT01977482|680026|P4|Overall Study|Protocol Violation|0
210090|NCT01977482|680027|P3|Overall Study|Protocol Violation|1
210091|NCT01977482|680028|P2|Overall Study|Protocol Violation|0
210092|NCT01977482|680029|P1|Overall Study|Protocol Violation|0
210093|NCT01977482|680024|P6|Overall Study|Physician Decision|0
210094|NCT01977482|680025|P5|Overall Study|Physician Decision|0
210095|NCT01977482|680026|P4|Overall Study|Physician Decision|0
210096|NCT01977482|680027|P3|Overall Study|Physician Decision|0
210097|NCT01977482|680028|P2|Overall Study|Physician Decision|1
210098|NCT01977482|680029|P1|Overall Study|Physician Decision|0
210099|NCT01977482|680024|P6|Overall Study|Lost to Follow-up|0
210100|NCT01977482|680025|P5|Overall Study|Lost to Follow-up|0
210101|NCT01977482|680026|P4|Overall Study|Lost to Follow-up|0
210102|NCT01977482|680027|P3|Overall Study|Lost to Follow-up|0
210103|NCT01977482|680028|P2|Overall Study|Lost to Follow-up|0
210104|NCT01977482|680029|P1|Overall Study|Lost to Follow-up|1
210105|NCT01977482|680024|P6|Overall Study|Adverse Event|0
210106|NCT01977482|680025|P5|Overall Study|Adverse Event|2
210107|NCT01977482|680026|P4|Overall Study|Adverse Event|0
210108|NCT01977482|680027|P3|Overall Study|Adverse Event|1
210109|NCT01977482|680028|P2|Overall Study|Adverse Event|1
210110|NCT01977482|680029|P1|Overall Study|Adverse Event|0
210111|NCT01977456|680144|P1|Overall Study|Death|5
210112|NCT01976845|680182|P3|Overall Study|Physician Decision|3
210113|NCT01976845|680183|P2|Overall Study|Physician Decision|8
210114|NCT01976845|680184|P1|Overall Study|Physician Decision|8
210115|NCT01976806|680200|P2|Overall Study|Withdrawal by Subject|1
210116|NCT01976806|680201|P1|Overall Study|Withdrawal by Subject|1
210117|NCT01976806|680200|P2|Overall Study|Adverse Event|1
210118|NCT01976806|680201|P1|Overall Study|Adverse Event|1
210119|NCT01976806|680200|P2|Overall Study|Lost to Follow-up|4
210120|NCT01976806|680201|P1|Overall Study|Lost to Follow-up|1
210121|NCT01976663|680207|P1|Overall Study|Lost to Follow-up|3
210122|NCT01976663|680207|P1|Overall Study|Adverse Event|2
210123|NCT01976663|680207|P1|Overall Study|Screen Failure|3
210124|NCT01976663|680207|P1|Overall Study|Withdrawal by Subject|4
210125|NCT01976663|680207|P1|Overall Study|Personal Reasons|6
210126|NCT01976663|680207|P1|Overall Study|Completed 18 mos but no repeat treatment|24
210127|NCT01976624|680226|P1|Overall Study|Participants age less than 19 years|12
210128|NCT01976624|680226|P1|Overall Study|Participants contraindicated|2
210129|NCT01976338|680271|P2|Overall Study|Adverse Event|1
210130|NCT01976338|680272|P1|Overall Study|Adverse Event|5
210131|NCT01976338|680271|P2|Overall Study|Withdrawal by Subject|2
210132|NCT01976338|680272|P1|Overall Study|Withdrawal by Subject|5
210133|NCT01976338|680271|P2|Overall Study|Lost to Follow-up|0
210134|NCT01976338|680272|P1|Overall Study|Lost to Follow-up|3
210135|NCT01976338|680271|P2|Overall Study|Physician Decision|1
210136|NCT01976338|680272|P1|Overall Study|Physician Decision|0
210137|NCT01976312|680299|P2|Overall Study|Protocol Violation|0
210138|NCT01976312|680300|P1|Overall Study|Protocol Violation|2
210139|NCT01976312|680299|P2|Overall Study|Adverse Event|6
210140|NCT01976312|680300|P1|Overall Study|Adverse Event|6
210141|NCT01976312|680299|P2|Overall Study|Withdrawal by Subject|2
210142|NCT01976312|680300|P1|Overall Study|Withdrawal by Subject|7
210143|NCT01976312|680299|P2|Overall Study|Lost to Follow-up|0
210144|NCT01976312|680300|P1|Overall Study|Lost to Follow-up|2
210145|NCT01976312|680299|P2|Overall Study|Pregnancy|1
210146|NCT01976312|680300|P1|Overall Study|Pregnancy|0
210147|NCT01976299|680321|P2|Overall Study|See clarification above in comments|2
210148|NCT01976299|680322|P1|Overall Study|See clarification above in comments|9
210149|NCT01976299|680321|P2|Overall Study|Lost to Follow-up|1
210150|NCT01976299|680322|P1|Overall Study|Lost to Follow-up|7
210151|NCT01976299|680321|P2|Overall Study|Death|2
210152|NCT01976299|680322|P1|Overall Study|Death|4
210153|NCT01976299|680321|P2|Overall Study|Withdrawal by Subject|1
210154|NCT01976299|680322|P1|Overall Study|Withdrawal by Subject|3
210155|NCT01975675|680382|P4|Overall Study|Death|0
210156|NCT01975675|680383|P3|Overall Study|Death|0
210157|NCT01975675|680384|P2|Overall Study|Death|1
210158|NCT01975675|680385|P1|Overall Study|Death|0
210159|NCT01975285|680418|P2|Overall Study|Failed Block and follow up|2
210160|NCT01975285|680419|P1|Overall Study|Failed Block and follow up|2
210161|NCT01975246|680435|P2|Overall Study|Other than stated|1
210162|NCT01975246|680436|P1|Overall Study|Other than stated|0
210163|NCT01975246|680435|P2|Overall Study|Protocol Violation|0
210164|NCT01975246|680436|P1|Overall Study|Protocol Violation|1
210165|NCT01975246|680435|P2|Overall Study|Lack of Efficacy|0
210166|NCT01975246|680436|P1|Overall Study|Lack of Efficacy|1
210167|NCT01975246|680435|P2|Overall Study|Adverse Event|1
210168|NCT01975246|680436|P1|Overall Study|Adverse Event|2
210169|NCT01975220|680449|P6|Test Period 1|Not treated|0
210170|NCT01975220|680450|P5|Test Period 1|Not treated|0
210171|NCT01975220|680451|P4|Test Period 1|Not treated|0
210172|NCT01975220|680452|P3|Test Period 1|Not treated|0
210173|NCT01975220|680453|P2|Test Period 1|Not treated|1
210174|NCT01975220|680454|P1|Test Period 1|Not treated|0
210175|NCT01974895|680500|P2|Overall Study|Other (Reason unknown)|8
210176|NCT01974895|680501|P1|Overall Study|Other (Reason unknown)|9
210177|NCT01974895|680500|P2|Overall Study|Other (Missed Visit)|0
210178|NCT01974895|680501|P1|Overall Study|Other (Missed Visit)|1
210179|NCT01974895|680500|P2|Overall Study|Withdrawal by Subject|1
210180|NCT01974895|680501|P1|Overall Study|Withdrawal by Subject|0
210181|NCT01974895|680500|P2|Overall Study|Lost to Follow-up|6
210182|NCT01974895|680501|P1|Overall Study|Lost to Follow-up|4
210183|NCT01974895|680500|P2|Overall Study|Protocol Violation|0
210184|NCT01974895|680501|P1|Overall Study|Protocol Violation|1
210185|NCT01974817|680531|P1|Overall Study|Protocol Violation|2
210186|NCT01974817|680531|P1|Overall Study|Lost to Follow-up|2
210187|NCT01974817|680531|P1|Overall Study|Death|4
210188|NCT01974752|680537|P2|Overall Study|Other Eligibility Criteria|1
210189|NCT01974752|680538|P1|Overall Study|Other Eligibility Criteria|0
210190|NCT01974752|680537|P2|Overall Study|Withdrawal by Subject|3
210191|NCT01974752|680538|P1|Overall Study|Withdrawal by Subject|2
210192|NCT01974752|680537|P2|Overall Study|Lost to Follow-up|0
210193|NCT01974752|680538|P1|Overall Study|Lost to Follow-up|2
210194|NCT01974752|680537|P2|Overall Study|Death|11
210195|NCT01974752|680538|P1|Overall Study|Death|33
210196|NCT01974323|680565|P2|Overall Study|Adverse Event|2
210197|NCT01974323|680566|P1|Overall Study|Adverse Event|2
210198|NCT01974323|680565|P2|Overall Study|Lack of Efficacy|1
210199|NCT01974323|680566|P1|Overall Study|Lack of Efficacy|1
210200|NCT01974323|680565|P2|Overall Study|Pregnancy|1
210201|NCT01974323|680566|P1|Overall Study|Pregnancy|2
210202|NCT01974323|680565|P2|Overall Study|Lost to Follow-up|40
210203|NCT01974323|680566|P1|Overall Study|Lost to Follow-up|45
210204|NCT01974323|680565|P2|Overall Study|Personal Reasons|19
210205|NCT01974323|680566|P1|Overall Study|Personal Reasons|15
210206|NCT01974323|680565|P2|Overall Study|Protocol Violation|2
210207|NCT01974323|680566|P1|Overall Study|Protocol Violation|2
210208|NCT01974323|680565|P2|Overall Study|Other Reasons|28
210209|NCT01974323|680566|P1|Overall Study|Other Reasons|25
210210|NCT01974141|680599|P2|Overall Study|Adverse Event|5
210211|NCT01974141|680600|P1|Overall Study|Adverse Event|4
210212|NCT01974141|680599|P2|Overall Study|Lack of Efficacy|1
210213|NCT01974141|680600|P1|Overall Study|Lack of Efficacy|0
210214|NCT01974141|680599|P2|Overall Study|Pregnancy|3
210215|NCT01974141|680600|P1|Overall Study|Pregnancy|3
210216|NCT01974141|680599|P2|Overall Study|Lost to Follow-up|29
210217|NCT01974141|680600|P1|Overall Study|Lost to Follow-up|38
210218|NCT01974141|680599|P2|Overall Study|Personal Reasons|20
210219|NCT01974141|680600|P1|Overall Study|Personal Reasons|21
210220|NCT01974141|680599|P2|Overall Study|Protocol Violation|6
210221|NCT01974141|680600|P1|Overall Study|Protocol Violation|2
210222|NCT01974141|680599|P2|Overall Study|Other Reasons|18
210223|NCT01974141|680600|P1|Overall Study|Other Reasons|28
210224|NCT01973595|680657|P4|Washout|Withdrawal by Subject|0
210225|NCT01973595|680658|P3|Washout|Withdrawal by Subject|1
210226|NCT01973595|680659|P2|Washout|Withdrawal by Subject|0
210227|NCT01973595|680660|P1|Washout|Withdrawal by Subject|1
210228|NCT01973491|680674|P1|Treatment Period (16 Weeks)|Adverse Event|1
210229|NCT01973491|680674|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
210230|NCT01973491|680674|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
210231|NCT01973439|680690|P1|Overall Study|PK curve incomplete|2
210232|NCT01973439|680690|P1|Overall Study|Vomiting after commencing once daily|1
210233|NCT01973439|680690|P1|Overall Study|Lost samples from one PK Day|2
210234|NCT01973387|680712|P2|Overall Study|Did not receive study drug|2
210235|NCT01973387|680713|P1|Overall Study|Did not receive study drug|2
210236|NCT01973387|680712|P2|Overall Study|Ongoing|0
210237|NCT01973387|680713|P1|Overall Study|Ongoing|72
210238|NCT01973387|680712|P2|Overall Study|Adverse Event|4
210239|NCT01973387|680713|P1|Overall Study|Adverse Event|13
210240|NCT01973387|680712|P2|Overall Study|Progressive disease or relapse|5
210241|NCT01973387|680713|P1|Overall Study|Progressive disease or relapse|10
210242|NCT01973387|680712|P2|Overall Study|Death|3
210243|NCT01973387|680713|P1|Overall Study|Death|3
210244|NCT01973387|680712|P2|Overall Study|Withdrawal by Subject|4
210245|NCT01973387|680713|P1|Overall Study|Withdrawal by Subject|6
210246|NCT01973231|680725|P2|Overall Study|Withdrawal by Subject|9
210247|NCT01973231|680726|P1|Overall Study|Withdrawal by Subject|7
210248|NCT01973231|680725|P2|Overall Study|unclassified|1
210249|NCT01973231|680726|P1|Overall Study|unclassified|2
210250|NCT01973231|680725|P2|Overall Study|Lost to Follow-up|1
210251|NCT01973231|680726|P1|Overall Study|Lost to Follow-up|1
210252|NCT01973231|680725|P2|Overall Study|Protocol Violation|1
210253|NCT01973231|680726|P1|Overall Study|Protocol Violation|1
210254|NCT01973218|680746|P2|Overall Study|Withdrawal by Subject|0
210255|NCT01973218|680747|P1|Overall Study|Withdrawal by Subject|1
210256|NCT01973218|680746|P2|Overall Study|Adverse Event|0
210257|NCT01973218|680747|P1|Overall Study|Adverse Event|1
210258|NCT01972776|680789|P6|Part 2|Administrative problems|7
210259|NCT01972776|680790|P5|Part 2|Administrative problems|10
210260|NCT01972776|680791|P4|Part 2|Administrative problems|0
210261|NCT01972776|680792|P3|Part 2|Administrative problems|0
210262|NCT01972776|680793|P2|Part 2|Administrative problems|0
210263|NCT01972776|680794|P1|Part 2|Administrative problems|0
210264|NCT01972776|680789|P6|Part 2|Adverse Event|0
210265|NCT01972776|680790|P5|Part 2|Adverse Event|3
210266|NCT01972776|680791|P4|Part 2|Adverse Event|0
210267|NCT01972776|680792|P3|Part 2|Adverse Event|0
210268|NCT01972776|680793|P2|Part 2|Adverse Event|0
210269|NCT01972776|680794|P1|Part 2|Adverse Event|0
210270|NCT01972776|680789|P6|Part 1|Adverse Event|0
210271|NCT01972776|680790|P5|Part 1|Adverse Event|0
210272|NCT01972776|680791|P4|Part 1|Adverse Event|1
210273|NCT01972776|680792|P3|Part 1|Adverse Event|1
210274|NCT01972776|680793|P2|Part 1|Adverse Event|0
210275|NCT01972776|680794|P1|Part 1|Adverse Event|0
210276|NCT01972776|680789|P6|Part 1|Withdrawal by Subject|0
210277|NCT01972776|680790|P5|Part 1|Withdrawal by Subject|0
210278|NCT01972776|680791|P4|Part 1|Withdrawal by Subject|0
210279|NCT01972776|680792|P3|Part 1|Withdrawal by Subject|1
210280|NCT01972776|680793|P2|Part 1|Withdrawal by Subject|0
210281|NCT01972776|680794|P1|Part 1|Withdrawal by Subject|0
210282|NCT01972659|680864|P2|Overall Study|problems realted to acceleromyograph|1
210283|NCT01972659|680865|P1|Overall Study|problems realted to acceleromyograph|2
210284|NCT01972659|680864|P2|Overall Study|Protocol Violation|2
210285|NCT01972659|680865|P1|Overall Study|Protocol Violation|2
210286|NCT01972438|680890|P2|Post Month 12 Study Period|Early Study Closure|4
210287|NCT01972438|680891|P1|Post Month 12 Study Period|Early Study Closure|3
210288|NCT01972438|680890|P2|Months 6-12 Study Period|Early Study Closure|2
210289|NCT01972438|680891|P1|Months 6-12 Study Period|Early Study Closure|2
210290|NCT01972438|680890|P2|Months 6-12 Study Period|Death|0
210291|NCT01972438|680891|P1|Months 6-12 Study Period|Death|1
210292|NCT01972438|680890|P2|Months 3-6 Crossover Period|Early Study Closure|1
210293|NCT01972438|680891|P1|Months 3-6 Crossover Period|Early Study Closure|0
210294|NCT01972438|680890|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
210295|NCT01972438|680891|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
210296|NCT01972438|680890|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
210297|NCT01972438|680891|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
210298|NCT01972438|680890|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
210299|NCT01972438|680891|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
210300|NCT01972438|680890|P2|Baseline-Month 3 Crossover Period|Death|0
210301|NCT01972438|680891|P1|Baseline-Month 3 Crossover Period|Death|1
210302|NCT01972152|680943|P6|Second Treatment Visit|Protocol Violation|0
210303|NCT01972152|680944|P5|Second Treatment Visit|Protocol Violation|0
210304|NCT01972152|680945|P4|Second Treatment Visit|Protocol Violation|0
210305|NCT01972152|680946|P3|Second Treatment Visit|Protocol Violation|0
210306|NCT01972152|680947|P2|Second Treatment Visit|Protocol Violation|1
210307|NCT01972152|680948|P1|Second Treatment Visit|Protocol Violation|0
210308|NCT01972152|680943|P6|First Treatment Visit|Lost to Follow-up|0
210309|NCT01972152|680944|P5|First Treatment Visit|Lost to Follow-up|0
210310|NCT01972152|680945|P4|First Treatment Visit|Lost to Follow-up|0
210311|NCT01972152|680946|P3|First Treatment Visit|Lost to Follow-up|0
210312|NCT01972152|680947|P2|First Treatment Visit|Lost to Follow-up|1
210313|NCT01972152|680948|P1|First Treatment Visit|Lost to Follow-up|0
210314|NCT01971723|680985|P2|Overall Study|Protocol Violation|2
210315|NCT01971723|680986|P1|Overall Study|Protocol Violation|1
210316|NCT01971723|680985|P2|Overall Study|Withdrawal by Subject|1
210317|NCT01971723|680986|P1|Overall Study|Withdrawal by Subject|1
210318|NCT01971554|681020|P4|Overall Study|Lost to Follow-up|0
210319|NCT01971554|681021|P3|Overall Study|Lost to Follow-up|0
210320|NCT01971554|681022|P2|Overall Study|Lost to Follow-up|0
210321|NCT01971554|681023|P1|Overall Study|Lost to Follow-up|1
210322|NCT01970995|681091|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
210323|NCT01970995|681092|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
210324|NCT01970995|681093|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
210325|NCT01970995|681091|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
210326|NCT01970995|681092|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
210327|NCT01970995|681093|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
210328|NCT01970982|681116|P3|Overall Study|Withdrawal by Subject|2
210329|NCT01970982|681117|P2|Overall Study|Withdrawal by Subject|0
210330|NCT01970982|681118|P1|Overall Study|Withdrawal by Subject|0
210331|NCT01970878|681140|P4|Overall Study|No Completion Status|0
210332|NCT01970878|681141|P3|Overall Study|No Completion Status|0
210333|NCT01970878|681142|P2|Overall Study|No Completion Status|1
210334|NCT01970878|681143|P1|Overall Study|No Completion Status|0
210335|NCT01970878|681140|P4|Overall Study|Physician Decision|0
210336|NCT01970878|681141|P3|Overall Study|Physician Decision|1
210337|NCT01970878|681142|P2|Overall Study|Physician Decision|1
210338|NCT01970878|681143|P1|Overall Study|Physician Decision|0
210339|NCT01970878|681140|P4|Overall Study|Protocol Specified Criteria|6
210340|NCT01970878|681141|P3|Overall Study|Protocol Specified Criteria|3
210341|NCT01970878|681142|P2|Overall Study|Protocol Specified Criteria|4
210342|NCT01970878|681143|P1|Overall Study|Protocol Specified Criteria|10
210343|NCT01970878|681140|P4|Overall Study|Adverse Event|3
210344|NCT01970878|681141|P3|Overall Study|Adverse Event|4
210345|NCT01970878|681142|P2|Overall Study|Adverse Event|7
210346|NCT01970878|681143|P1|Overall Study|Adverse Event|12
210347|NCT01970878|681140|P4|Overall Study|Lack of Efficacy|0
210348|NCT01970878|681141|P3|Overall Study|Lack of Efficacy|2
210349|NCT01970878|681142|P2|Overall Study|Lack of Efficacy|1
210350|NCT01970878|681143|P1|Overall Study|Lack of Efficacy|2
210351|NCT01970878|681140|P4|Overall Study|Administrative Reasons|4
210352|NCT01970878|681141|P3|Overall Study|Administrative Reasons|0
210353|NCT01970878|681142|P2|Overall Study|Administrative Reasons|0
210354|NCT01970878|681143|P1|Overall Study|Administrative Reasons|1
210355|NCT01970878|681140|P4|Overall Study|Lost to Follow-up|4
210356|NCT01970878|681141|P3|Overall Study|Lost to Follow-up|2
210357|NCT01970878|681142|P2|Overall Study|Lost to Follow-up|3
210358|NCT01970878|681143|P1|Overall Study|Lost to Follow-up|1
210359|NCT01970878|681140|P4|Overall Study|Withdrawal by Subject|7
210360|NCT01970878|681141|P3|Overall Study|Withdrawal by Subject|14
210361|NCT01970878|681142|P2|Overall Study|Withdrawal by Subject|10
210362|NCT01970878|681143|P1|Overall Study|Withdrawal by Subject|11
210363|NCT01970488|681179|P5|Part 2: Post Week 16|Lost to Follow-up|2
210364|NCT01970488|681180|P4|Part 2: Post Week 16|Lost to Follow-up|1
210365|NCT01970488|681181|P3|Part 2: Post Week 16|Lost to Follow-up|1
210366|NCT01970488|681182|P2|Part 2: Post Week 16|Lost to Follow-up|0
210367|NCT01970488|681183|P1|Part 2: Post Week 16|Lost to Follow-up|0
210368|NCT01970488|681179|P5|Part 2: Post Week 16|Withdrawal by Subject|3
210369|NCT01970488|681180|P4|Part 2: Post Week 16|Withdrawal by Subject|3
210370|NCT01970488|681181|P3|Part 2: Post Week 16|Withdrawal by Subject|8
210371|NCT01970488|681182|P2|Part 2: Post Week 16|Withdrawal by Subject|0
210372|NCT01970488|681183|P1|Part 2: Post Week 16|Withdrawal by Subject|0
210373|NCT01970488|681179|P5|Part 2: Post Week 16|Adverse Event|1
210374|NCT01970488|681180|P4|Part 2: Post Week 16|Adverse Event|1
210375|NCT01970488|681181|P3|Part 2: Post Week 16|Adverse Event|5
210376|NCT01970488|681182|P2|Part 2: Post Week 16|Adverse Event|0
210377|NCT01970488|681183|P1|Part 2: Post Week 16|Adverse Event|0
210378|NCT01970488|681179|P5|Part 2: Post Week 16|Lack of Efficacy|1
210379|NCT01970488|681180|P4|Part 2: Post Week 16|Lack of Efficacy|3
210380|NCT01970488|681181|P3|Part 2: Post Week 16|Lack of Efficacy|2
210381|NCT01970488|681182|P2|Part 2: Post Week 16|Lack of Efficacy|0
210382|NCT01970488|681183|P1|Part 2: Post Week 16|Lack of Efficacy|0
210383|NCT01970488|681179|P5|Part 2: Post Week 16|Non-compliance|0
210384|NCT01970488|681180|P4|Part 2: Post Week 16|Non-compliance|0
210385|NCT01970488|681181|P3|Part 2: Post Week 16|Non-compliance|1
210386|NCT01970488|681182|P2|Part 2: Post Week 16|Non-compliance|0
210387|NCT01970488|681183|P1|Part 2: Post Week 16|Non-compliance|0
210388|NCT01970488|681179|P5|Part 2: Post Week 16|Physician Decision|1
210389|NCT01970488|681180|P4|Part 2: Post Week 16|Physician Decision|0
210390|NCT01970488|681181|P3|Part 2: Post Week 16|Physician Decision|0
210391|NCT01970488|681182|P2|Part 2: Post Week 16|Physician Decision|0
210392|NCT01970488|681183|P1|Part 2: Post Week 16|Physician Decision|0
210393|NCT01970488|681179|P5|Part 1: Through Week 16|Lost to Follow-up|0
210394|NCT01970488|681180|P4|Part 1: Through Week 16|Lost to Follow-up|0
210395|NCT01970488|681181|P3|Part 1: Through Week 16|Lost to Follow-up|0
210396|NCT01970488|681182|P2|Part 1: Through Week 16|Lost to Follow-up|2
210397|NCT01970488|681183|P1|Part 1: Through Week 16|Lost to Follow-up|0
210398|NCT01970488|681179|P5|Part 1: Through Week 16|Withdrawal by Subject|0
210399|NCT01970488|681180|P4|Part 1: Through Week 16|Withdrawal by Subject|0
210400|NCT01970488|681181|P3|Part 1: Through Week 16|Withdrawal by Subject|0
210401|NCT01970488|681182|P2|Part 1: Through Week 16|Withdrawal by Subject|2
210402|NCT01970488|681183|P1|Part 1: Through Week 16|Withdrawal by Subject|3
210403|NCT01970488|681179|P5|Part 1: Through Week 16|Adverse Event|0
210404|NCT01970488|681180|P4|Part 1: Through Week 16|Adverse Event|0
210405|NCT01970488|681181|P3|Part 1: Through Week 16|Adverse Event|0
210406|NCT01970488|681182|P2|Part 1: Through Week 16|Adverse Event|5
210407|NCT01970488|681183|P1|Part 1: Through Week 16|Adverse Event|6
210408|NCT01970488|681179|P5|Part 1: Through Week 16|Protocol Violation|0
210409|NCT01970488|681180|P4|Part 1: Through Week 16|Protocol Violation|0
210410|NCT01970488|681181|P3|Part 1: Through Week 16|Protocol Violation|0
210411|NCT01970488|681182|P2|Part 1: Through Week 16|Protocol Violation|2
210412|NCT01970488|681183|P1|Part 1: Through Week 16|Protocol Violation|1
210413|NCT01970488|681179|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
210414|NCT01970488|681180|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
210415|NCT01970488|681181|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
210416|NCT01970488|681182|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
210417|NCT01970488|681183|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
210418|NCT01970475|681250|P2|Overall Study|Protocol Violation|0
210419|NCT01970475|681251|P1|Overall Study|Protocol Violation|1
210420|NCT01970475|681250|P2|Overall Study|Lost to Follow-up|2
210421|NCT01970475|681251|P1|Overall Study|Lost to Follow-up|2
210422|NCT01970475|681250|P2|Overall Study|Adverse Event|3
210423|NCT01970475|681251|P1|Overall Study|Adverse Event|7
210424|NCT01970475|681250|P2|Overall Study|Withdrawal by Subject|6
210425|NCT01970475|681251|P1|Overall Study|Withdrawal by Subject|11
210426|NCT01970397|681271|P2|Overall Study|Protocol Violation|1
210427|NCT01970397|681272|P1|Overall Study|Protocol Violation|1
210428|NCT01970397|681271|P2|Overall Study|Personal Reasons|2
210429|NCT01970397|681272|P1|Overall Study|Personal Reasons|1
210430|NCT01970397|681271|P2|Overall Study|Lost to Follow-up|1
210431|NCT01970397|681272|P1|Overall Study|Lost to Follow-up|0
210432|NCT01970397|681271|P2|Overall Study|Adverse Event|1
210433|NCT01970397|681272|P1|Overall Study|Adverse Event|0
210434|NCT01969084|681284|P2|Overall Study|Adverse Event|1
210435|NCT01969084|681285|P1|Overall Study|Adverse Event|0
210436|NCT01968980|681301|P2|Overall Study|Other unspecified|2
210437|NCT01968980|681302|P1|Overall Study|Other unspecified|1
210438|NCT01968980|681301|P2|Overall Study|Withdrawal by Subject|5
210439|NCT01968980|681302|P1|Overall Study|Withdrawal by Subject|13
210440|NCT01968980|681301|P2|Overall Study|Does not meet entry criteria|3
210441|NCT01968980|681302|P1|Overall Study|Does not meet entry criteria|1
210442|NCT01968980|681301|P2|Overall Study|Adverse Event|3
210443|NCT01968980|681302|P1|Overall Study|Adverse Event|1
210444|NCT01968980|681301|P2|Overall Study|Death|1
210445|NCT01968980|681302|P1|Overall Study|Death|0
210446|NCT01968954|681364|P2|Overall Study|Did not met inclusion criteria|2
210447|NCT01968954|681365|P1|Overall Study|Did not met inclusion criteria|0
210448|NCT01968954|681364|P2|Overall Study|Protocol Violation|1
210449|NCT01968954|681365|P1|Overall Study|Protocol Violation|0
210450|NCT01968954|681364|P2|Overall Study|Unspecified|8
210451|NCT01968954|681365|P1|Overall Study|Unspecified|7
210452|NCT01968954|681364|P2|Overall Study|Withdrawal by Subject|23
210453|NCT01968954|681365|P1|Overall Study|Withdrawal by Subject|20
210454|NCT01968954|681364|P2|Overall Study|Lost to Follow-up|4
210455|NCT01968954|681365|P1|Overall Study|Lost to Follow-up|6
210456|NCT01968954|681364|P2|Overall Study|Death|2
210457|NCT01968954|681365|P1|Overall Study|Death|1
210458|NCT01968954|681364|P2|Overall Study|Adverse Event|3
210459|NCT01968954|681365|P1|Overall Study|Adverse Event|6
210460|NCT01969721|681446|P4|Overall Study|Discontinued during washout periods.|2
210461|NCT01969721|681447|P3|Overall Study|Discontinued during washout periods.|1
210462|NCT01969721|681448|P2|Overall Study|Discontinued during washout periods.|1
210463|NCT01969721|681449|P1|Overall Study|Discontinued during washout periods.|0
210464|NCT01969721|681446|P4|Overall Study|Other not defined above|0
210465|NCT01969721|681447|P3|Overall Study|Other not defined above|0
210466|NCT01969721|681448|P2|Overall Study|Other not defined above|2
210467|NCT01969721|681449|P1|Overall Study|Other not defined above|0
210468|NCT01969721|681446|P4|Overall Study|Non compliant with protocol|2
210469|NCT01969721|681447|P3|Overall Study|Non compliant with protocol|0
210470|NCT01969721|681448|P2|Overall Study|Non compliant with protocol|1
210471|NCT01969721|681449|P1|Overall Study|Non compliant with protocol|1
210472|NCT01969721|681446|P4|Overall Study|Lack of Efficacy|0
210473|NCT01969721|681447|P3|Overall Study|Lack of Efficacy|1
210474|NCT01969721|681448|P2|Overall Study|Lack of Efficacy|0
210475|NCT01969721|681449|P1|Overall Study|Lack of Efficacy|0
210476|NCT01969721|681446|P4|Overall Study|Adverse Event|2
210477|NCT01969721|681447|P3|Overall Study|Adverse Event|3
210478|NCT01969721|681448|P2|Overall Study|Adverse Event|8
210479|NCT01969721|681449|P1|Overall Study|Adverse Event|3
210480|NCT01969565|681475|P1|Overall Study|Withdrawal by Subject|1
210481|NCT01968811|681502|P1|Overall Study|post op.ref. of subject to other hospita|1
210482|NCT01968811|681502|P1|Overall Study|Protocol Violation|4
210483|NCT01968694|681509|P2|Washout (1 Month)|Lost to Follow-up|1
210484|NCT01968694|681510|P1|Washout (1 Month)|Lost to Follow-up|0
210485|NCT01968551|681527|P3|Extension Phase|Still on study|32
210486|NCT01968551|681528|P2|Extension Phase|Still on study|87
210487|NCT01968551|681529|P1|Extension Phase|Still on study|20
210488|NCT01968551|681527|P3|Extension Phase|Adverse Event|2
210489|NCT01968551|681528|P2|Extension Phase|Adverse Event|0
210490|NCT01968551|681529|P1|Extension Phase|Adverse Event|0
210491|NCT01968551|681527|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
210492|NCT01968551|681528|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
210493|NCT01968551|681529|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
210494|NCT01968551|681527|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
210495|NCT01968551|681528|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
210496|NCT01968551|681529|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
210497|NCT01968551|681527|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
210498|NCT01968551|681528|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
210499|NCT01968551|681529|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
210500|NCT01968551|681527|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
210501|NCT01968551|681528|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
210502|NCT01968551|681529|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
210503|NCT01968434|681545|P2|Overall Study|Lost to Follow-up|6
210504|NCT01968434|681546|P1|Overall Study|Lost to Follow-up|3
210505|NCT01967940|681584|P3|Part 2|Still on Study|14
210506|NCT01967940|681585|P2|Part 2|Still on Study|16
210507|NCT01967940|681586|P1|Part 2|Still on Study|8
210508|NCT01967732|681613|P4|First Intervention (Day 1)|Poor venous access|0
210509|NCT01967732|681614|P3|First Intervention (Day 1)|Poor venous access|0
210510|NCT01967732|681615|P2|First Intervention (Day 1)|Poor venous access|1
210511|NCT01967732|681616|P1|First Intervention (Day 1)|Poor venous access|0
210512|NCT01967732|681613|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
210513|NCT01967732|681614|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
210514|NCT01967732|681615|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
210515|NCT01967732|681616|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
210516|NCT01967719|681630|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
210517|NCT01967719|681631|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
210518|NCT01967719|681632|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
210519|NCT01967719|681633|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
210520|NCT01967719|681630|P4|First Intervention (Day 1)|Withdrawal by Subject|1
210521|NCT01967719|681631|P3|First Intervention (Day 1)|Withdrawal by Subject|0
210522|NCT01967719|681632|P2|First Intervention (Day 1)|Withdrawal by Subject|1
210523|NCT01967719|681633|P1|First Intervention (Day 1)|Withdrawal by Subject|0
210524|NCT01967706|681648|P4|First Intervention (Day 1)|Withdrawal by Subject|0
210525|NCT01967706|681649|P3|First Intervention (Day 1)|Withdrawal by Subject|0
210526|NCT01967706|681650|P2|First Intervention (Day 1)|Withdrawal by Subject|0
210527|NCT01967706|681651|P1|First Intervention (Day 1)|Withdrawal by Subject|1
210528|NCT01967550|681662|P2|Overall Study|Non Compliance|1
210529|NCT01967550|681663|P1|Overall Study|Non Compliance|0
210530|NCT01967550|681662|P2|Overall Study|Protocol Violation|1
210531|NCT01967550|681663|P1|Overall Study|Protocol Violation|2
210532|NCT01967550|681662|P2|Overall Study|Adverse Event|0
210533|NCT01967550|681663|P1|Overall Study|Adverse Event|2
210534|NCT01967550|681662|P2|Overall Study|Withdrawal by Subject|0
210535|NCT01967550|681663|P1|Overall Study|Withdrawal by Subject|1
210536|NCT01967277|681693|P2|Overall Study|Unrelated illness|1
210537|NCT01967277|681694|P1|Overall Study|Unrelated illness|0
210538|NCT01967277|681693|P2|Overall Study|Lost to Follow-up|2
210539|NCT01967277|681694|P1|Overall Study|Lost to Follow-up|1
210540|NCT01967147|681704|P2|Overall Study|Other|5
210541|NCT01967147|681705|P1|Overall Study|Other|4
210542|NCT01967147|681704|P2|Overall Study|Non-compliance with Study Drug|3
210543|NCT01967147|681705|P1|Overall Study|Non-compliance with Study Drug|0
210544|NCT01967147|681704|P2|Overall Study|Withdrawal by Subject|4
210545|NCT01967147|681705|P1|Overall Study|Withdrawal by Subject|2
210546|NCT01967147|681704|P2|Overall Study|Lost to Follow-up|2
210547|NCT01967147|681705|P1|Overall Study|Lost to Follow-up|1
210548|NCT01967147|681704|P2|Overall Study|Lack of Efficacy|4
210549|NCT01967147|681705|P1|Overall Study|Lack of Efficacy|1
210550|NCT01967147|681704|P2|Overall Study|Adverse Event|2
210551|NCT01967147|681705|P1|Overall Study|Adverse Event|5
210552|NCT01967069|681735|P2|Overall Study|Lack of Efficacy|1
210553|NCT01967069|681736|P1|Overall Study|Lack of Efficacy|0
210554|NCT01967069|681735|P2|Overall Study|Withdrawal by Subject|3
210555|NCT01967069|681736|P1|Overall Study|Withdrawal by Subject|1
210556|NCT01967069|681735|P2|Overall Study|Lost to Follow-up|2
210557|NCT01967069|681736|P1|Overall Study|Lost to Follow-up|5
210558|NCT01967069|681735|P2|Overall Study|Adverse Event|2
210559|NCT01967069|681736|P1|Overall Study|Adverse Event|2
210560|NCT01966120|681928|P2|Overall Study|Lost to Follow-up|1
210561|NCT01966120|681929|P1|Overall Study|Lost to Follow-up|1
210562|NCT01966120|681928|P2|Overall Study|Withdrawal by Subject|5
210563|NCT01966120|681929|P1|Overall Study|Withdrawal by Subject|0
210564|NCT01966068|681953|P1|Overall Study|Lost to Follow-up|81
210565|NCT01966068|681953|P1|Overall Study|Withdrawal by Subject|57
210566|NCT01966042|681958|P1|Overall Study|Death|2
210567|NCT01965938|681967|P2|Overall Study|Withdrawal by Subject|0
210568|NCT01965938|681968|P1|Overall Study|Withdrawal by Subject|1
210569|NCT01965834|681999|P1|Overall Study|Lack of Efficacy|4
210570|NCT01965652|682013|P2|Overall Study|Pregnancy|1
210571|NCT01965652|682014|P1|Overall Study|Pregnancy|0
210572|NCT01965652|682013|P2|Overall Study|Other - Miscellaneous|21
210573|NCT01965652|682014|P1|Overall Study|Other - Miscellaneous|18
210574|NCT01965652|682013|P2|Overall Study|Death|4
210575|NCT01965652|682014|P1|Overall Study|Death|3
210576|NCT01965652|682013|P2|Overall Study|Protocol Violation|38
210577|NCT01965652|682014|P1|Overall Study|Protocol Violation|34
210578|NCT01965652|682013|P2|Overall Study|Lost to Follow-up|40
210579|NCT01965652|682014|P1|Overall Study|Lost to Follow-up|53
210580|NCT01965652|682013|P2|Overall Study|Withdrawal by Subject|69
210581|NCT01965652|682014|P1|Overall Study|Withdrawal by Subject|62
210582|NCT01965652|682013|P2|Overall Study|Adverse Event|37
210583|NCT01965652|682014|P1|Overall Study|Adverse Event|40
210584|NCT01965600|682044|P4|Second Intervention|Study terminated by Sponsor|2
210585|NCT01965600|682045|P3|Second Intervention|Study terminated by Sponsor|2
210586|NCT01965600|682046|P2|Second Intervention|Study terminated by Sponsor|0
210587|NCT01965600|682047|P1|Second Intervention|Study terminated by Sponsor|0
210588|NCT01965600|682044|P4|Washout Period of Approximately 15 Days|Adverse Event|1
210589|NCT01965600|682045|P3|Washout Period of Approximately 15 Days|Adverse Event|0
210590|NCT01965600|682046|P2|Washout Period of Approximately 15 Days|Adverse Event|0
210591|NCT01965600|682047|P1|Washout Period of Approximately 15 Days|Adverse Event|0
210592|NCT01965600|682044|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
210593|NCT01965600|682045|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
210594|NCT01965600|682046|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
210595|NCT01965600|682047|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
210596|NCT01965600|682044|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
210597|NCT01965600|682045|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
210598|NCT01965600|682046|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
210599|NCT01965600|682047|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
210600|NCT01965600|682044|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
210601|NCT01965600|682045|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
210602|NCT01965600|682046|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
210603|NCT01965600|682047|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
210604|NCT01965535|682104|P2|Overall Study|Lack of Efficacy|1
210605|NCT01965535|682105|P1|Overall Study|Lack of Efficacy|2
210606|NCT01965431|682119|P6|Overall Study|Other than stated above|6
210607|NCT01965431|682120|P5|Overall Study|Other than stated above|6
210608|NCT01965431|682121|P4|Overall Study|Other than stated above|6
210609|NCT01965431|682122|P3|Overall Study|Other than stated above|6
210610|NCT01965431|682123|P2|Overall Study|Other than stated above|5
210611|NCT01965431|682124|P1|Overall Study|Other than stated above|6
210612|NCT01965431|682119|P6|Overall Study|Adverse Event|0
210613|NCT01965431|682120|P5|Overall Study|Adverse Event|0
210614|NCT01965431|682121|P4|Overall Study|Adverse Event|0
210615|NCT01965431|682122|P3|Overall Study|Adverse Event|0
210616|NCT01965431|682123|P2|Overall Study|Adverse Event|1
210617|NCT01965431|682124|P1|Overall Study|Adverse Event|0
210618|NCT01965327|682137|P1|Overall Study|Physician Decision|2
210619|NCT01965262|682351|P2|Second Intervention (7 Days)|Poor visual acuity|0
210620|NCT01965262|682352|P1|Second Intervention (7 Days)|Poor visual acuity|1
210621|NCT01965262|682351|P2|Second Intervention (7 Days)|Poor lens fit|9
210622|NCT01965262|682352|P1|Second Intervention (7 Days)|Poor lens fit|0
210623|NCT01965262|682351|P2|Second Intervention (7 Days)|Discontinued|1
210624|NCT01965262|682352|P1|Second Intervention (7 Days)|Discontinued|0
210625|NCT01965158|682416|P2|Overall Study|Other - Miscellaneous|0
210626|NCT01965158|682417|P1|Overall Study|Other - Miscellaneous|3
210627|NCT01965158|682416|P2|Overall Study|Protocol Violation|1
210628|NCT01965158|682417|P1|Overall Study|Protocol Violation|1
210629|NCT01965158|682416|P2|Overall Study|Lost to Follow-up|5
210630|NCT01965158|682417|P1|Overall Study|Lost to Follow-up|7
210631|NCT01965158|682416|P2|Overall Study|Withdrawal by Subject|24
210632|NCT01965158|682417|P1|Overall Study|Withdrawal by Subject|16
210633|NCT01965158|682416|P2|Overall Study|Adverse Event|5
210634|NCT01965158|682417|P1|Overall Study|Adverse Event|14
210635|NCT01964976|682452|P1|Overall Study|Protocol Violation|31
210636|NCT01964950|682466|P1|Overall Study|Protocol Violation|25
210637|NCT01964898|682480|P2|Overall Study|Withdrawal by Subject|0
210638|NCT01964898|682481|P1|Overall Study|Withdrawal by Subject|1
210639|NCT01964898|682480|P2|Overall Study|Lost to Follow-up|5
210640|NCT01964898|682481|P1|Overall Study|Lost to Follow-up|3
210641|NCT01964898|682480|P2|Overall Study|did not receive the allocated interventi|1
210642|NCT01964898|682481|P1|Overall Study|did not receive the allocated interventi|2
210643|NCT01964898|682480|P2|Overall Study|ineligible post-randomization|1
210644|NCT01964898|682481|P1|Overall Study|ineligible post-randomization|1
210645|NCT01964716|682503|P2|Overall Study|Death|0
210646|NCT01964716|682504|P1|Overall Study|Death|1
210647|NCT01964716|682503|P2|Overall Study|No longer met eligibility criteria|1
210648|NCT01964716|682504|P1|Overall Study|No longer met eligibility criteria|1
210649|NCT01964716|682503|P2|Overall Study|Lost to Follow-up|2
210650|NCT01964716|682504|P1|Overall Study|Lost to Follow-up|1
210651|NCT01964716|682503|P2|Overall Study|Withdrawal by Subject|3
210652|NCT01964716|682504|P1|Overall Study|Withdrawal by Subject|2
210653|NCT01964547|682542|P2|Overall Study|Withdrawal by Investigator|1
210654|NCT01964547|682543|P1|Overall Study|Withdrawal by Investigator|0
210655|NCT01964547|682542|P2|Overall Study|Lost to Follow-up|1
210656|NCT01964547|682543|P1|Overall Study|Lost to Follow-up|0
210657|NCT01964547|682542|P2|Overall Study|Withdrawal by Subject|7
210658|NCT01964547|682543|P1|Overall Study|Withdrawal by Subject|4
210659|NCT01964547|682542|P2|Overall Study|Adverse Event|2
210660|NCT01964547|682543|P1|Overall Study|Adverse Event|8
210661|NCT01964352|682571|P4|Overall Study|Other than stated above|2
210662|NCT01964352|682572|P3|Overall Study|Other than stated above|1
210663|NCT01964352|682573|P2|Overall Study|Other than stated above|2
210664|NCT01964352|682574|P1|Overall Study|Other than stated above|0
210665|NCT01964352|682571|P4|Overall Study|Withdrawal by Subject|0
210666|NCT01964352|682572|P3|Overall Study|Withdrawal by Subject|1
210667|NCT01964352|682573|P2|Overall Study|Withdrawal by Subject|2
210668|NCT01964352|682574|P1|Overall Study|Withdrawal by Subject|4
210669|NCT01964352|682571|P4|Overall Study|Lost to Follow-up|1
210670|NCT01964352|682572|P3|Overall Study|Lost to Follow-up|0
210671|NCT01964352|682573|P2|Overall Study|Lost to Follow-up|0
210672|NCT01964352|682574|P1|Overall Study|Lost to Follow-up|1
210673|NCT01964352|682571|P4|Overall Study|Protocol Violation|2
210674|NCT01964352|682572|P3|Overall Study|Protocol Violation|0
210675|NCT01964352|682573|P2|Overall Study|Protocol Violation|4
210676|NCT01964352|682574|P1|Overall Study|Protocol Violation|2
210677|NCT01964352|682571|P4|Overall Study|Lack of Efficacy|0
210678|NCT01964352|682572|P3|Overall Study|Lack of Efficacy|0
210679|NCT01964352|682573|P2|Overall Study|Lack of Efficacy|0
210680|NCT01964352|682574|P1|Overall Study|Lack of Efficacy|6
210681|NCT01964352|682571|P4|Overall Study|Adverse Event|3
210682|NCT01964352|682572|P3|Overall Study|Adverse Event|4
210683|NCT01964352|682573|P2|Overall Study|Adverse Event|3
210684|NCT01964352|682574|P1|Overall Study|Adverse Event|13
210685|NCT01964326|682604|P1|Overall Study|Did not meet eligibility criteria|1
210686|NCT01964326|682604|P1|Overall Study|Unspecified|9
210687|NCT01964326|682604|P1|Overall Study|Investigator Discretion|1
210688|NCT01964326|682604|P1|Overall Study|Physician Decision|55
210689|NCT01964326|682604|P1|Overall Study|No Longer Meets Eligibility Criteria|1
210690|NCT01964326|682604|P1|Overall Study|Pregnancy|1
210691|NCT01964326|682604|P1|Overall Study|Withdrawal by Subject|87
210692|NCT01964326|682604|P1|Overall Study|Lost to Follow-up|88
210693|NCT01964326|682604|P1|Overall Study|Protocol Violation|4
210694|NCT01964326|682604|P1|Overall Study|Death|2
210695|NCT01964326|682604|P1|Overall Study|Adverse Event|48
210696|NCT01964222|682613|P2|Overall Study|Screening Failure|0
210697|NCT01964222|682614|P1|Overall Study|Screening Failure|2
210698|NCT01964222|682613|P2|Overall Study|Withdrawal by Subject|6
210699|NCT01964222|682614|P1|Overall Study|Withdrawal by Subject|6
210700|NCT01964222|682613|P2|Overall Study|Lost to Follow-up|5
210701|NCT01964222|682614|P1|Overall Study|Lost to Follow-up|7
210702|NCT01963767|682647|P2|Overall Study|Adverse Event|0
210703|NCT01963767|682648|P1|Overall Study|Adverse Event|2
210704|NCT01963767|682647|P2|Overall Study|Withdrawal by Subject|2
210705|NCT01963767|682648|P1|Overall Study|Withdrawal by Subject|4
210706|NCT01963676|682658|P2|Overall Study|Withdrawal by Subject|0
210707|NCT01963676|682659|P1|Overall Study|Withdrawal by Subject|1
210708|NCT01963611|682672|P5|Overall Study|Unspecified|45
210709|NCT01963611|682673|P4|Overall Study|Unspecified|45
210710|NCT01963611|682674|P3|Overall Study|Unspecified|48
210711|NCT01963611|682675|P2|Overall Study|Unspecified|46
210712|NCT01963611|682676|P1|Overall Study|Unspecified|47
210713|NCT01963611|682672|P5|Overall Study|Withdrawal by Subject|3
210714|NCT01963611|682673|P4|Overall Study|Withdrawal by Subject|1
210715|NCT01963611|682674|P3|Overall Study|Withdrawal by Subject|1
210716|NCT01963611|682675|P2|Overall Study|Withdrawal by Subject|2
210717|NCT01963611|682676|P1|Overall Study|Withdrawal by Subject|3
210718|NCT01963611|682672|P5|Overall Study|Lack of Efficacy|0
210719|NCT01963611|682673|P4|Overall Study|Lack of Efficacy|1
210720|NCT01963611|682674|P3|Overall Study|Lack of Efficacy|0
210721|NCT01963611|682675|P2|Overall Study|Lack of Efficacy|0
210722|NCT01963611|682676|P1|Overall Study|Lack of Efficacy|0
210723|NCT01963611|682672|P5|Overall Study|Protocol Violation|0
210724|NCT01963611|682673|P4|Overall Study|Protocol Violation|1
210725|NCT01963611|682674|P3|Overall Study|Protocol Violation|0
210726|NCT01963611|682675|P2|Overall Study|Protocol Violation|0
210727|NCT01963611|682676|P1|Overall Study|Protocol Violation|0
210728|NCT01963611|682672|P5|Overall Study|Adverse Event|3
210729|NCT01963611|682673|P4|Overall Study|Adverse Event|4
210730|NCT01963611|682674|P3|Overall Study|Adverse Event|3
210731|NCT01963611|682675|P2|Overall Study|Adverse Event|1
210732|NCT01963611|682676|P1|Overall Study|Adverse Event|1
210733|NCT01963403|682735|P2|Overall Study|Implant removal|1
210734|NCT01963403|682736|P1|Overall Study|Implant removal|0
210735|NCT01963403|682735|P2|Overall Study|Lost to Follow-up|3
210736|NCT01963403|682736|P1|Overall Study|Lost to Follow-up|2
210737|NCT01963260|682758|P10|Overall Study|Withdrawal by Subject|0
210738|NCT01963260|682759|P9|Overall Study|Withdrawal by Subject|0
210739|NCT01963260|682760|P8|Overall Study|Withdrawal by Subject|0
210740|NCT01963260|682761|P7|Overall Study|Withdrawal by Subject|0
210741|NCT01963260|682762|P6|Overall Study|Withdrawal by Subject|0
210742|NCT01963260|682763|P5|Overall Study|Withdrawal by Subject|2
210743|NCT01963260|682764|P4|Overall Study|Withdrawal by Subject|1
210744|NCT01963260|682765|P3|Overall Study|Withdrawal by Subject|0
210745|NCT01963260|682766|P2|Overall Study|Withdrawal by Subject|0
210746|NCT01963260|682767|P1|Overall Study|Withdrawal by Subject|2
210747|NCT01962974|682847|P1|Overall Study|Study termination|7
210748|NCT01962922|682874|P2|Extendion Portion (up to Month 6)|Physician Decision|0
210749|NCT01962922|682875|P1|Extendion Portion (up to Month 6)|Physician Decision|1
210750|NCT01962922|682874|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
210751|NCT01962922|682875|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
210752|NCT01962922|682874|P2|PK Portion Day 7|non-compliance|0
210753|NCT01962922|682875|P1|PK Portion Day 7|non-compliance|1
210754|NCT01962922|682874|P2|PK Portion Day 7|Withdrawal by Subject|0
210755|NCT01962922|682875|P1|PK Portion Day 7|Withdrawal by Subject|3
210756|NCT01962493|682914|P2|Overall Study|Withdrawal by Subject|2
210757|NCT01962493|682915|P1|Overall Study|Withdrawal by Subject|4
210758|NCT01962493|682914|P2|Overall Study|Protocol Violation|1
210759|NCT01962493|682915|P1|Overall Study|Protocol Violation|0
210760|NCT01962493|682914|P2|Overall Study|Adverse Event|2
210761|NCT01962493|682915|P1|Overall Study|Adverse Event|1
210762|NCT01962441|682938|P3|Retreatment Substudy|Participant Still on Study|0
210763|NCT01962441|682939|P2|Retreatment Substudy|Participant Still on Study|10
210764|NCT01962441|682940|P1|Retreatment Substudy|Participant Still on Study|20
210765|NCT01962441|682938|P3|Randomized Period|Protocol Violation|0
210766|NCT01962441|682939|P2|Randomized Period|Protocol Violation|1
210767|NCT01962441|682940|P1|Randomized Period|Protocol Violation|0
210768|NCT01962441|682938|P3|Randomized Period|Death|2
210769|NCT01962441|682939|P2|Randomized Period|Death|0
210770|NCT01962441|682940|P1|Randomized Period|Death|0
210771|NCT01962441|682938|P3|Randomized Period|Adverse Event|0
210772|NCT01962441|682939|P2|Randomized Period|Adverse Event|1
210773|NCT01962441|682940|P1|Randomized Period|Adverse Event|1
210774|NCT01962441|682938|P3|Randomized Period|Withdrew Consent|2
210775|NCT01962441|682939|P2|Randomized Period|Withdrew Consent|3
210776|NCT01962441|682940|P1|Randomized Period|Withdrew Consent|3
210777|NCT01962441|682938|P3|Randomized Period|Lost to Follow-up|4
210778|NCT01962441|682939|P2|Randomized Period|Lost to Follow-up|4
210779|NCT01962441|682940|P1|Randomized Period|Lost to Follow-up|2
210780|NCT01962441|682938|P3|Randomized Period|Randomized but Never Treated|3
210781|NCT01962441|682939|P2|Randomized Period|Randomized but Never Treated|2
210782|NCT01962441|682940|P1|Randomized Period|Randomized but Never Treated|4
210783|NCT01961544|682978|P1|Overall Study|Aggravation of Steral Pain|1
210784|NCT01961544|682978|P1|Overall Study|Poor Tolerance|1
210785|NCT01961544|682978|P1|Overall Study|Physician Decision|2
210786|NCT01961544|682978|P1|Overall Study|Adverse Event|1
210787|NCT01961544|682978|P1|Overall Study|Withdrawal by Subject|7
210788|NCT01961544|682978|P1|Overall Study|Protocol Violation|1
210789|NCT01961349|682986|P3|Overall Study|registration error, personal reason etc|1
210790|NCT01961349|682987|P2|Overall Study|registration error, personal reason etc|2
210791|NCT01961349|682988|P1|Overall Study|registration error, personal reason etc|2
210792|NCT01961349|682986|P3|Overall Study|Adverse Event|1
210793|NCT01961349|682987|P2|Overall Study|Adverse Event|0
210794|NCT01961349|682988|P1|Overall Study|Adverse Event|0
210795|NCT01961349|682986|P3|Overall Study|Withdrawal by Subject|0
210796|NCT01961349|682987|P2|Overall Study|Withdrawal by Subject|4
210797|NCT01961349|682988|P1|Overall Study|Withdrawal by Subject|1
210798|NCT01960907|683010|P2|Overall Study|Withdrawal by Subject|42
210799|NCT01960907|683011|P1|Overall Study|Withdrawal by Subject|32
210800|NCT01960907|683010|P2|Overall Study|Death|3
210801|NCT01960907|683011|P1|Overall Study|Death|4
210802|NCT01960842|683021|P1|Overall Study|Withdrawal by Subject|2
210803|NCT01960842|683021|P1|Overall Study|Adverse Event|1
210804|NCT01960816|683044|P1|Overall Study|Lost to Follow-up|1
210805|NCT01960725|683052|P2|Overall Study|unable to obtain blood sample|2
210806|NCT01960725|683053|P1|Overall Study|unable to obtain blood sample|1
210807|NCT01960725|683052|P2|Overall Study|Withdrawal by Subject|0
210808|NCT01960725|683053|P1|Overall Study|Withdrawal by Subject|1
210809|NCT01960725|683052|P2|Overall Study|Lost to Follow-up|3
210810|NCT01960725|683053|P1|Overall Study|Lost to Follow-up|4
210811|NCT01960296|683132|P2|Overall Study|Received different procedure|3
210812|NCT01960296|683133|P1|Overall Study|Received different procedure|1
210813|NCT01960296|683132|P2|Overall Study|Postponed surgery|0
210814|NCT01960296|683133|P1|Overall Study|Postponed surgery|1
210815|NCT01960140|683153|P1|Period 2 (Days 3-18)|Adverse Event|2
210816|NCT01960114|683164|P2|Overall Study|Could not swallow study medication|1
210817|NCT01960114|683165|P1|Overall Study|Could not swallow study medication|0
210818|NCT01960114|683164|P2|Overall Study|Adverse Event|0
210819|NCT01960114|683165|P1|Overall Study|Adverse Event|1
210820|NCT01959932|683211|P3|Overall Study|Withdrawal by Subject|0
210821|NCT01959932|683212|P2|Overall Study|Withdrawal by Subject|0
210822|NCT01959932|683213|P1|Overall Study|Withdrawal by Subject|1
210823|NCT01959880|683235|P4|Overall Study|Study completed early-FDA approved|152
210824|NCT01959880|683236|P3|Overall Study|Study completed early-FDA approved|179
210825|NCT01959880|683237|P2|Overall Study|Study completed early-FDA approved|311
210826|NCT01959880|683238|P1|Overall Study|Study completed early-FDA approved|1003
210827|NCT01959880|683235|P4|Overall Study|Explantation w/o study device reimplant.|12
210828|NCT01959880|683236|P3|Overall Study|Explantation w/o study device reimplant.|5
210829|NCT01959880|683237|P2|Overall Study|Explantation w/o study device reimplant.|17
210830|NCT01959880|683238|P1|Overall Study|Explantation w/o study device reimplant.|22
210831|NCT01959880|683235|P4|Overall Study|Lost to Follow-up|8
210832|NCT01959880|683236|P3|Overall Study|Lost to Follow-up|15
210833|NCT01959880|683237|P2|Overall Study|Lost to Follow-up|18
210834|NCT01959880|683238|P1|Overall Study|Lost to Follow-up|95
210835|NCT01959880|683235|P4|Overall Study|Death|2
210836|NCT01959880|683236|P3|Overall Study|Death|1
210837|NCT01959880|683237|P2|Overall Study|Death|10
210838|NCT01959880|683238|P1|Overall Study|Death|1
210839|NCT01959880|683235|P4|Overall Study|Withdrawal by Subject|7
210840|NCT01959880|683236|P3|Overall Study|Withdrawal by Subject|8
210841|NCT01959880|683237|P2|Overall Study|Withdrawal by Subject|13
210842|NCT01959880|683238|P1|Overall Study|Withdrawal by Subject|11
210843|NCT01959607|683267|P4|First Intervention (Day 1)|Withdrawal by Subject|0
210844|NCT01959607|683268|P3|First Intervention (Day 1)|Withdrawal by Subject|0
210845|NCT01959607|683269|P2|First Intervention (Day 1)|Withdrawal by Subject|1
210846|NCT01959607|683270|P1|First Intervention (Day 1)|Withdrawal by Subject|1
210847|NCT01959516|683277|P2|Epoch 2|Moderate or severe COPD exacerbation|1
210848|NCT01959516|683278|P1|Epoch 2|Moderate or severe COPD exacerbation|0
210849|NCT01959516|683277|P2|Epoch 2|Subject withdrew consent|0
210850|NCT01959516|683278|P1|Epoch 2|Subject withdrew consent|1
210851|NCT01959516|683277|P2|Epoch 2|unsatisfactory therapeutic effect|0
210852|NCT01959516|683278|P1|Epoch 2|unsatisfactory therapeutic effect|1
210853|NCT01959516|683277|P2|Epoch 1|Protocol deviation|1
210854|NCT01959516|683278|P1|Epoch 1|Protocol deviation|0
210855|NCT01959516|683277|P2|Epoch 1|Moderate or severe COPD exacerbation|1
210856|NCT01959516|683278|P1|Epoch 1|Moderate or severe COPD exacerbation|0
210857|NCT01959516|683277|P2|Epoch 1|Use of prohibited treatment|0
210858|NCT01959516|683278|P1|Epoch 1|Use of prohibited treatment|1
210859|NCT01959516|683277|P2|Epoch 1|Administrative problems|0
210860|NCT01959516|683278|P1|Epoch 1|Administrative problems|1
210861|NCT01959516|683277|P2|Epoch 1|Subject withdrew consent|2
210862|NCT01959516|683278|P1|Epoch 1|Subject withdrew consent|3
210863|NCT01959516|683277|P2|Epoch 1|unsatisfactory therapeutic effect|0
210864|NCT01959516|683278|P1|Epoch 1|unsatisfactory therapeutic effect|1
210865|NCT01959516|683277|P2|Epoch 1|Adverse Event|1
210866|NCT01959516|683278|P1|Epoch 1|Adverse Event|4
210867|NCT01959503|683288|P2|Overall Study|Randomized but not treated|1
210868|NCT01959503|683289|P1|Overall Study|Randomized but not treated|1
210869|NCT01959503|683288|P2|Overall Study|Death|1
210870|NCT01959503|683289|P1|Overall Study|Death|2
210871|NCT01959412|683309|P6|Overall Study|Adverse Event|0
210872|NCT01959412|683310|P5|Overall Study|Adverse Event|0
210873|NCT01959412|683311|P4|Overall Study|Adverse Event|1
210874|NCT01959412|683312|P3|Overall Study|Adverse Event|0
210875|NCT01959412|683313|P2|Overall Study|Adverse Event|0
210876|NCT01959412|683314|P1|Overall Study|Adverse Event|0
210877|NCT01959412|683309|P6|Overall Study|Protocol deviation|0
210878|NCT01959412|683310|P5|Overall Study|Protocol deviation|3
210879|NCT01959412|683311|P4|Overall Study|Protocol deviation|1
210880|NCT01959412|683312|P3|Overall Study|Protocol deviation|0
210881|NCT01959412|683313|P2|Overall Study|Protocol deviation|1
210882|NCT01959412|683314|P1|Overall Study|Protocol deviation|1
210883|NCT01959035|683352|P1|Overall Study|Other (no primary reason given)|1
210884|NCT01959035|683352|P1|Overall Study|Lost to Follow-up|1
210885|NCT01959035|683352|P1|Overall Study|Withdrawal by Subject|4
210886|NCT01959035|683352|P1|Overall Study|Adverse Event|5
210887|NCT01958827|683378|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
210888|NCT01958827|683378|P1|Overall Study|Lack of Efficacy|6
210889|NCT01958827|683378|P1|Overall Study|Adverse Event|3
210890|NCT01958619|683439|P4|Overall Study|Protocol Violation|0
210891|NCT01958619|683440|P3|Overall Study|Protocol Violation|1
210892|NCT01958619|683441|P2|Overall Study|Protocol Violation|0
210893|NCT01958619|683442|P1|Overall Study|Protocol Violation|2
210894|NCT01958164|683516|P2|Overall Study|Lost to Follow-up|3
210895|NCT01958164|683517|P1|Overall Study|Lost to Follow-up|2
210896|NCT01958164|683516|P2|Overall Study|Adverse Event|2
210897|NCT01958164|683517|P1|Overall Study|Adverse Event|0
210898|NCT01958060|683536|P6|Overall Study|Not treated|0
210899|NCT01958060|683537|P5|Overall Study|Not treated|1
210900|NCT01958060|683538|P4|Overall Study|Not treated|0
210901|NCT01958060|683539|P3|Overall Study|Not treated|0
210902|NCT01958060|683540|P2|Overall Study|Not treated|0
210903|NCT01958060|683541|P1|Overall Study|Not treated|2
210904|NCT01958021|683566|P2|Overall Study|Death|0
210905|NCT01958021|683567|P1|Overall Study|Death|2
210906|NCT01958021|683566|P2|Overall Study|Protocol Violation|1
210907|NCT01958021|683567|P1|Overall Study|Protocol Violation|3
210908|NCT01958021|683566|P2|Overall Study|Physician Decision|13
210909|NCT01958021|683567|P1|Overall Study|Physician Decision|10
210910|NCT01958021|683566|P2|Overall Study|Subject/guardian decision|13
210911|NCT01958021|683567|P1|Overall Study|Subject/guardian decision|12
210912|NCT01958021|683566|P2|Overall Study|Adverse Event|7
210913|NCT01958021|683567|P1|Overall Study|Adverse Event|25
210914|NCT01958021|683566|P2|Overall Study|Progressive disease|146
210915|NCT01958021|683567|P1|Overall Study|Progressive disease|87
210916|NCT01958008|683579|P4|Overall Study|Other adverse event|0
210917|NCT01958008|683580|P3|Overall Study|Other adverse event|0
210918|NCT01958008|683581|P2|Overall Study|Other adverse event|0
210919|NCT01958008|683582|P1|Overall Study|Other adverse event|1
210920|NCT01958008|683579|P4|Overall Study|Worsening of disease under study|0
210921|NCT01958008|683580|P3|Overall Study|Worsening of disease under study|1
210922|NCT01958008|683581|P2|Overall Study|Worsening of disease under study|0
210923|NCT01958008|683582|P1|Overall Study|Worsening of disease under study|0
210924|NCT01957865|683622|P3|Overall Study|Lost to Follow-up|2
210925|NCT01957865|683623|P2|Overall Study|Lost to Follow-up|2
210926|NCT01957865|683624|P1|Overall Study|Lost to Follow-up|0
210927|NCT01957865|683622|P3|Overall Study|Found HIV negative|1
210928|NCT01957865|683623|P2|Overall Study|Found HIV negative|0
210929|NCT01957865|683624|P1|Overall Study|Found HIV negative|0
210930|NCT01957579|683657|P4|Overall Study|Death|0
210931|NCT01957579|683658|P3|Overall Study|Death|2
210932|NCT01957579|683659|P2|Overall Study|Death|0
210933|NCT01957579|683660|P1|Overall Study|Death|0
210934|NCT01957579|683657|P4|Overall Study|Withdrawal of concent|0
210935|NCT01957579|683658|P3|Overall Study|Withdrawal of concent|0
210936|NCT01957579|683659|P2|Overall Study|Withdrawal of concent|1
210937|NCT01957579|683660|P1|Overall Study|Withdrawal of concent|0
210938|NCT01957553|683727|P2|Test Period 2 (21 +- 1 Days)|Other|0
210939|NCT01957553|683728|P1|Test Period 2 (21 +- 1 Days)|Other|1
210940|NCT01957553|683727|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
210941|NCT01957553|683728|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
210942|NCT01957553|683727|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
210943|NCT01957553|683728|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
210944|NCT01957553|683727|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
210945|NCT01957553|683728|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
210946|NCT01957553|683727|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
210947|NCT01957553|683728|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
210948|NCT01957553|683727|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
210949|NCT01957553|683728|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
210950|NCT01957553|683727|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
210951|NCT01957553|683728|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
210952|NCT01957553|683727|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
210953|NCT01957553|683728|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
210954|NCT01957553|683727|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
210955|NCT01957553|683728|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
210956|NCT01957488|683734|P6|Test Period 3|Lack of Efficacy|0
210957|NCT01957488|683735|P5|Test Period 3|Lack of Efficacy|0
210958|NCT01957488|683736|P4|Test Period 3|Lack of Efficacy|0
210959|NCT01957488|683737|P3|Test Period 3|Lack of Efficacy|0
210960|NCT01957488|683738|P2|Test Period 3|Lack of Efficacy|1
210961|NCT01957488|683739|P1|Test Period 3|Lack of Efficacy|0
210962|NCT01957488|683734|P6|Test Period 3|Withdrawal by Subject|0
210963|NCT01957488|683735|P5|Test Period 3|Withdrawal by Subject|0
210964|NCT01957488|683736|P4|Test Period 3|Withdrawal by Subject|0
210965|NCT01957488|683737|P3|Test Period 3|Withdrawal by Subject|0
210966|NCT01957488|683738|P2|Test Period 3|Withdrawal by Subject|0
210967|NCT01957488|683739|P1|Test Period 3|Withdrawal by Subject|1
210968|NCT01957488|683734|P6|Test Period 2|Discontinue due to personal problems|1
210969|NCT01957488|683735|P5|Test Period 2|Discontinue due to personal problems|0
210970|NCT01957488|683736|P4|Test Period 2|Discontinue due to personal problems|0
210971|NCT01957488|683737|P3|Test Period 2|Discontinue due to personal problems|0
210972|NCT01957488|683738|P2|Test Period 2|Discontinue due to personal problems|0
210973|NCT01957488|683739|P1|Test Period 2|Discontinue due to personal problems|0
210974|NCT01957488|683734|P6|Test Period 2|Adverse Event|0
210975|NCT01957488|683735|P5|Test Period 2|Adverse Event|2
210976|NCT01957488|683736|P4|Test Period 2|Adverse Event|0
210977|NCT01957488|683737|P3|Test Period 2|Adverse Event|0
210978|NCT01957488|683738|P2|Test Period 2|Adverse Event|0
210979|NCT01957488|683739|P1|Test Period 2|Adverse Event|0
210980|NCT01957488|683734|P6|Test Period 2|Withdrawal by Subject|0
210981|NCT01957488|683735|P5|Test Period 2|Withdrawal by Subject|0
210982|NCT01957488|683736|P4|Test Period 2|Withdrawal by Subject|0
210983|NCT01957488|683737|P3|Test Period 2|Withdrawal by Subject|0
210984|NCT01957488|683738|P2|Test Period 2|Withdrawal by Subject|1
210985|NCT01957488|683739|P1|Test Period 2|Withdrawal by Subject|0
210986|NCT01957488|683734|P6|Test Period 2|not known|0
210987|NCT01957488|683735|P5|Test Period 2|not known|0
210988|NCT01957488|683736|P4|Test Period 2|not known|0
210989|NCT01957488|683737|P3|Test Period 2|not known|0
210990|NCT01957488|683738|P2|Test Period 2|not known|0
210991|NCT01957488|683739|P1|Test Period 2|not known|1
210992|NCT01957488|683734|P6|Test Period 2|Protocol Violation|0
210993|NCT01957488|683735|P5|Test Period 2|Protocol Violation|0
210994|NCT01957488|683736|P4|Test Period 2|Protocol Violation|1
210995|NCT01957488|683737|P3|Test Period 2|Protocol Violation|1
210996|NCT01957488|683738|P2|Test Period 2|Protocol Violation|0
210997|NCT01957488|683739|P1|Test Period 2|Protocol Violation|2
210998|NCT01957488|683734|P6|Test Period 1|screen failure|1
210999|NCT01957488|683735|P5|Test Period 1|screen failure|0
211000|NCT01957488|683736|P4|Test Period 1|screen failure|0
211001|NCT01957488|683737|P3|Test Period 1|screen failure|0
211002|NCT01957488|683738|P2|Test Period 1|screen failure|0
211003|NCT01957488|683739|P1|Test Period 1|screen failure|0
211004|NCT01957488|683734|P6|Test Period 1|subject did not want to wait for cut bag|0
211005|NCT01957488|683735|P5|Test Period 1|subject did not want to wait for cut bag|1
211006|NCT01957488|683736|P4|Test Period 1|subject did not want to wait for cut bag|0
211007|NCT01957488|683737|P3|Test Period 1|subject did not want to wait for cut bag|0
211008|NCT01957488|683738|P2|Test Period 1|subject did not want to wait for cut bag|0
211009|NCT01957488|683739|P1|Test Period 1|subject did not want to wait for cut bag|0
211010|NCT01957488|683734|P6|Test Period 1|Withdrawal by Subject|2
211011|NCT01957488|683735|P5|Test Period 1|Withdrawal by Subject|1
211012|NCT01957488|683736|P4|Test Period 1|Withdrawal by Subject|1
211013|NCT01957488|683737|P3|Test Period 1|Withdrawal by Subject|0
211014|NCT01957488|683738|P2|Test Period 1|Withdrawal by Subject|0
211015|NCT01957488|683739|P1|Test Period 1|Withdrawal by Subject|0
211016|NCT01957488|683734|P6|Test Period 1|Adverse Event|0
211017|NCT01957488|683735|P5|Test Period 1|Adverse Event|1
211018|NCT01957488|683736|P4|Test Period 1|Adverse Event|0
211019|NCT01957488|683737|P3|Test Period 1|Adverse Event|1
211020|NCT01957488|683738|P2|Test Period 1|Adverse Event|1
211021|NCT01957488|683739|P1|Test Period 1|Adverse Event|0
211022|NCT01957488|683734|P6|Test Period 1|Protocol Violation|3
211023|NCT01957488|683735|P5|Test Period 1|Protocol Violation|0
211024|NCT01957488|683736|P4|Test Period 1|Protocol Violation|1
211025|NCT01957488|683737|P3|Test Period 1|Protocol Violation|2
211026|NCT01957488|683738|P2|Test Period 1|Protocol Violation|2
211027|NCT01957488|683739|P1|Test Period 1|Protocol Violation|1
211028|NCT01957488|683734|P6|Test Period 1|Lost to Follow-up|0
211029|NCT01957488|683735|P5|Test Period 1|Lost to Follow-up|0
211030|NCT01957488|683736|P4|Test Period 1|Lost to Follow-up|1
211031|NCT01957488|683737|P3|Test Period 1|Lost to Follow-up|1
211032|NCT01957488|683738|P2|Test Period 1|Lost to Follow-up|0
211033|NCT01957488|683739|P1|Test Period 1|Lost to Follow-up|2
211034|NCT01957475|683747|P2|Test Period 2|Adverse Event|0
211035|NCT01957475|683748|P1|Test Period 2|Adverse Event|1
211036|NCT01957475|683747|P2|Test Period 1|Lack of Efficacy|1
211037|NCT01957475|683748|P1|Test Period 1|Lack of Efficacy|0
211038|NCT01957475|683747|P2|Test Period 1|Other|0
211039|NCT01957475|683748|P1|Test Period 1|Other|1
211040|NCT01957475|683747|P2|Test Period 1|Withdrawal by Subject|0
211041|NCT01957475|683748|P1|Test Period 1|Withdrawal by Subject|1
211042|NCT01957462|683754|P2|Test Period 1|Adverse Event|0
211043|NCT01957462|683755|P1|Test Period 1|Adverse Event|1
211044|NCT01957462|683754|P2|Test Period 1|Withdrawal by Subject|0
211045|NCT01957462|683755|P1|Test Period 1|Withdrawal by Subject|1
211046|NCT01957397|683766|P2|Test Period 3|the adhesive did not work|0
211047|NCT01957397|683767|P1|Test Period 3|the adhesive did not work|1
211048|NCT01957397|683766|P2|Test Period 3|Adverse Event|2
211049|NCT01957397|683767|P1|Test Period 3|Adverse Event|1
211050|NCT01957397|683766|P2|Test Period 2|Adverse Event|1
211051|NCT01957397|683767|P1|Test Period 2|Adverse Event|0
211052|NCT01957397|683766|P2|Test Period 1|Withdrawal by Subject|0
211053|NCT01957397|683767|P1|Test Period 1|Withdrawal by Subject|1
211054|NCT01957397|683766|P2|Test Period 1|sudden leakage/small bag|1
211055|NCT01957397|683767|P1|Test Period 1|sudden leakage/small bag|1
211056|NCT01957215|683792|P2|Overall Study|Withdrawal by Subject|5
211057|NCT01957215|683793|P1|Overall Study|Withdrawal by Subject|7
211058|NCT01957215|683792|P2|Overall Study|Protocol Violation|2
211059|NCT01957215|683793|P1|Overall Study|Protocol Violation|1
211060|NCT01957215|683792|P2|Overall Study|Lost to Follow-up|3
211061|NCT01957215|683793|P1|Overall Study|Lost to Follow-up|3
211062|NCT01957215|683792|P2|Overall Study|Adverse Event|2
211063|NCT01957215|683793|P1|Overall Study|Adverse Event|2
211064|NCT01957202|683821|P18|Treatment Period 3 (8 Days)|Adverse Event|0
211065|NCT01957202|683822|P17|Treatment Period 3 (8 Days)|Adverse Event|1
211066|NCT01957202|683823|P16|Treatment Period 3 (8 Days)|Adverse Event|0
211067|NCT01957202|683824|P15|Treatment Period 3 (8 Days)|Adverse Event|0
211068|NCT01957202|683825|P14|Treatment Period 3 (8 Days)|Adverse Event|0
211069|NCT01957202|683826|P13|Treatment Period 3 (8 Days)|Adverse Event|0
211070|NCT01957202|683827|P12|Treatment Period 3 (8 Days)|Adverse Event|0
211071|NCT01957202|683828|P11|Treatment Period 3 (8 Days)|Adverse Event|0
211072|NCT01957202|683829|P10|Treatment Period 3 (8 Days)|Adverse Event|0
211073|NCT01957202|683830|P9|Treatment Period 3 (8 Days)|Adverse Event|0
211074|NCT01957202|683831|P8|Treatment Period 3 (8 Days)|Adverse Event|0
211075|NCT01957202|683832|P7|Treatment Period 3 (8 Days)|Adverse Event|0
211076|NCT01957202|683833|P6|Treatment Period 3 (8 Days)|Adverse Event|0
211077|NCT01957202|683834|P5|Treatment Period 3 (8 Days)|Adverse Event|0
211078|NCT01957202|683835|P4|Treatment Period 3 (8 Days)|Adverse Event|0
211079|NCT01957202|683836|P3|Treatment Period 3 (8 Days)|Adverse Event|0
211080|NCT01957202|683837|P2|Treatment Period 3 (8 Days)|Adverse Event|0
211081|NCT01957202|683838|P1|Treatment Period 3 (8 Days)|Adverse Event|0
211082|NCT01957202|683821|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211083|NCT01957202|683822|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
211084|NCT01957202|683823|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211085|NCT01957202|683824|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211086|NCT01957202|683825|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211087|NCT01957202|683826|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211088|NCT01957202|683827|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211089|NCT01957202|683828|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211090|NCT01957202|683829|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211091|NCT01957202|683830|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211092|NCT01957202|683831|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211093|NCT01957202|683832|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211094|NCT01957202|683833|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211095|NCT01957202|683834|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211096|NCT01957202|683835|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211097|NCT01957202|683836|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211098|NCT01957202|683837|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
211099|NCT01957202|683838|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
211100|NCT01957163|683863|P3|Overall Study|Withdrawal by Subject|4
211101|NCT01957163|683864|P2|Overall Study|Withdrawal by Subject|2
211102|NCT01957163|683865|P1|Overall Study|Withdrawal by Subject|4
211103|NCT01957163|683863|P3|Overall Study|Lost to Follow-up|0
211104|NCT01957163|683864|P2|Overall Study|Lost to Follow-up|1
211105|NCT01957163|683865|P1|Overall Study|Lost to Follow-up|0
211106|NCT01957163|683863|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
211107|NCT01957163|683864|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
211108|NCT01957163|683865|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
211109|NCT01957163|683863|P3|Overall Study|Protocol Violation|0
211110|NCT01957163|683864|P2|Overall Study|Protocol Violation|2
211111|NCT01957163|683865|P1|Overall Study|Protocol Violation|1
211112|NCT01957163|683863|P3|Overall Study|Lack of Efficacy|9
211113|NCT01957163|683864|P2|Overall Study|Lack of Efficacy|4
211114|NCT01957163|683865|P1|Overall Study|Lack of Efficacy|5
211115|NCT01957163|683863|P3|Overall Study|Adverse Event|4
211116|NCT01957163|683864|P2|Overall Study|Adverse Event|2
211117|NCT01957163|683865|P1|Overall Study|Adverse Event|5
211118|NCT01957137|683876|P1|Randomized Portion|Withdrawal by Subject|1
211119|NCT01957137|683876|P1|Randomized Portion|Adverse Event|1
211120|NCT01957111|683906|P2|Overall Study|Withdrawal by Subject|1
211121|NCT01957111|683907|P1|Overall Study|Withdrawal by Subject|1
211122|NCT01956240|683917|P2|Overall Study|Adverse Event|4
211123|NCT01956240|683918|P1|Overall Study|Adverse Event|17
211124|NCT01956240|683917|P2|Overall Study|Lost to Follow-up|20
211125|NCT01956240|683918|P1|Overall Study|Lost to Follow-up|6
211126|NCT01955707|684068|P2|Overall Study|Not Specified|2
211127|NCT01955707|684069|P1|Overall Study|Not Specified|4
211128|NCT01955707|684068|P2|Overall Study|Death|14
211129|NCT01955707|684069|P1|Overall Study|Death|13
211130|NCT01955707|684068|P2|Overall Study|Withdrawal by Subject|3
211131|NCT01955707|684069|P1|Overall Study|Withdrawal by Subject|0
211132|NCT01955707|684068|P2|Overall Study|Lost to Follow-up|1
211133|NCT01955707|684069|P1|Overall Study|Lost to Follow-up|2
211134|NCT01955707|684068|P2|Overall Study|Adverse Event|2
211135|NCT01955707|684069|P1|Overall Study|Adverse Event|1
211136|NCT01955122|684276|P2|Overall Study|Physician Decision|5
211137|NCT01955122|684277|P1|Overall Study|Physician Decision|5
211138|NCT01955083|684297|P2|Overall Study|Lost to Follow-up|1
211139|NCT01955083|684298|P1|Overall Study|Lost to Follow-up|1
211140|NCT01955044|684331|P3|Overall Study|Death|0
211141|NCT01955044|684332|P2|Overall Study|Death|1
211142|NCT01955044|684333|P1|Overall Study|Death|1
211143|NCT01955005|684346|P2|Overall Study|Withdrawal by Subject|5
211144|NCT01955005|684347|P1|Overall Study|Withdrawal by Subject|3
211145|NCT01954745|684357|P1|Overall Study|Death|1
211146|NCT01954745|684357|P1|Overall Study|Adverse Event|2
211147|NCT01954745|684357|P1|Overall Study|Clinical Progression|5
211148|NCT01954745|684357|P1|Overall Study|Radiological Progression|11
211149|NCT01954251|684388|P2|Overall Study|Withdrawal by Subject|6
211150|NCT01954251|684389|P1|Overall Study|Withdrawal by Subject|2
211151|NCT01954251|684388|P2|Overall Study|Lost to Follow-up|6
211152|NCT01954251|684389|P1|Overall Study|Lost to Follow-up|6
211153|NCT01954251|684388|P2|Overall Study|Adverse Event|7
211154|NCT01954251|684389|P1|Overall Study|Adverse Event|5
211155|NCT01954121|684486|P2|Overall Study|Subject did not follow instructions|2
211156|NCT01954121|684487|P1|Overall Study|Subject did not follow instructions|0
211157|NCT01954121|684486|P2|Overall Study|Non-compliant patient|1
211158|NCT01954121|684487|P1|Overall Study|Non-compliant patient|1
211159|NCT01954121|684486|P2|Overall Study|Non-compliant with study procedures|0
211160|NCT01954121|684487|P1|Overall Study|Non-compliant with study procedures|1
211161|NCT01954121|684486|P2|Overall Study|SAE, non-fatal|4
211162|NCT01954121|684487|P1|Overall Study|SAE, non-fatal|1
211163|NCT01954121|684486|P2|Overall Study|AE, non-serious non-fatal|22
211164|NCT01954121|684487|P1|Overall Study|AE, non-serious non-fatal|5
211165|NCT01954121|684486|P2|Overall Study|AE, serious fatal|0
211166|NCT01954121|684487|P1|Overall Study|AE, serious fatal|1
211167|NCT01954121|684486|P2|Overall Study|Pregnancy|1
211168|NCT01954121|684487|P1|Overall Study|Pregnancy|1
211169|NCT01954121|684486|P2|Overall Study|Withdrawal by Subject|12
211170|NCT01954121|684487|P1|Overall Study|Withdrawal by Subject|18
211171|NCT01954121|684486|P2|Overall Study|Lost to Follow-up|6
211172|NCT01954121|684487|P1|Overall Study|Lost to Follow-up|5
211173|NCT01954121|684486|P2|Overall Study|Protocol Violation|2
211174|NCT01954121|684487|P1|Overall Study|Protocol Violation|0
211175|NCT01954121|684486|P2|Overall Study|Lack of Efficacy|41
211176|NCT01954121|684487|P1|Overall Study|Lack of Efficacy|94
211177|NCT01953354|684503|P2|Overall Study|Disease Exacerbation|0
211178|NCT01953354|684504|P1|Overall Study|Disease Exacerbation|1
211179|NCT01953354|684503|P2|Overall Study|Decision of Sponsor|1
211180|NCT01953354|684504|P1|Overall Study|Decision of Sponsor|0
211181|NCT01953354|684503|P2|Overall Study|Withdrawal by Subject|1
211182|NCT01953354|684504|P1|Overall Study|Withdrawal by Subject|0
211183|NCT01953328|684532|P8|Overall Study|Lost to Follow-up|0
211184|NCT01953328|684533|P7|Overall Study|Lost to Follow-up|0
211185|NCT01953328|684534|P6|Overall Study|Lost to Follow-up|0
211186|NCT01953328|684535|P5|Overall Study|Lost to Follow-up|1
211187|NCT01953328|684536|P4|Overall Study|Lost to Follow-up|0
211188|NCT01953328|684537|P3|Overall Study|Lost to Follow-up|0
211189|NCT01953328|684538|P2|Overall Study|Lost to Follow-up|0
211190|NCT01953328|684539|P1|Overall Study|Lost to Follow-up|0
211191|NCT01953328|684532|P8|Overall Study|Withdrawal by Subject|0
211192|NCT01953328|684533|P7|Overall Study|Withdrawal by Subject|0
211193|NCT01953328|684534|P6|Overall Study|Withdrawal by Subject|0
211194|NCT01953328|684535|P5|Overall Study|Withdrawal by Subject|1
211195|NCT01953328|684536|P4|Overall Study|Withdrawal by Subject|0
211196|NCT01953328|684537|P3|Overall Study|Withdrawal by Subject|0
211197|NCT01953328|684538|P2|Overall Study|Withdrawal by Subject|0
211198|NCT01953328|684539|P1|Overall Study|Withdrawal by Subject|0
211199|NCT01952834|684769|P1|Overall Study|Adverse Event|1
211200|NCT01952691|684776|P1|Overall Study|Lost to Follow-up|2
211201|NCT01952665|684784|P2|Overall Study|Protocol Violation|1
211202|NCT01952665|684785|P1|Overall Study|Protocol Violation|0
211203|NCT01952665|684784|P2|Overall Study|Adverse Event|1
211204|NCT01952665|684785|P1|Overall Study|Adverse Event|2
211205|NCT01952665|684784|P2|Overall Study|Lost to Follow-up|2
211206|NCT01952665|684785|P1|Overall Study|Lost to Follow-up|1
211207|NCT01952665|684784|P2|Overall Study|Physician Decision|2
211208|NCT01952665|684785|P1|Overall Study|Physician Decision|3
211209|NCT01952366|684951|P1|Overall Study|Withdrawal by Subject|9
211210|NCT01952366|684951|P1|Overall Study|Death|22
211211|NCT01952145|684965|P2|Overall Study|Unclassified|1
211212|NCT01952145|684966|P1|Overall Study|Unclassified|1
211213|NCT01952145|684965|P2|Overall Study|Withdrawal Criteria|11
211214|NCT01952145|684966|P1|Overall Study|Withdrawal Criteria|16
211215|NCT01952145|684965|P2|Overall Study|Adverse Event|0
211216|NCT01952145|684966|P1|Overall Study|Adverse Event|9
211217|NCT01952145|684965|P2|Overall Study|Death|1
211218|NCT01952145|684966|P1|Overall Study|Death|0
211219|NCT01952145|684965|P2|Overall Study|Protocol Violation|1
211220|NCT01952145|684966|P1|Overall Study|Protocol Violation|2
211221|NCT01952080|684980|P4|Overall Study|Protocol Non-compliance|0
211222|NCT01952080|684981|P3|Overall Study|Protocol Non-compliance|0
211223|NCT01952080|684982|P2|Overall Study|Protocol Non-compliance|1
211224|NCT01952080|684983|P1|Overall Study|Protocol Non-compliance|0
211225|NCT01952080|684980|P4|Overall Study|Withdrawal by Subject|1
211226|NCT01952080|684981|P3|Overall Study|Withdrawal by Subject|0
211227|NCT01952080|684982|P2|Overall Study|Withdrawal by Subject|0
211228|NCT01952080|684983|P1|Overall Study|Withdrawal by Subject|0
211229|NCT01951703|685049|P2|Second Intervention|Unsatisfactory Lens fitting|1
211230|NCT01951703|685050|P1|Second Intervention|Unsatisfactory Lens fitting|0
211231|NCT01951703|685049|P2|Second Intervention|Protocol Violation|1
211232|NCT01951703|685050|P1|Second Intervention|Protocol Violation|0
211233|NCT01951703|685049|P2|First Intervention|Physician Decision|0
211234|NCT01951703|685050|P1|First Intervention|Physician Decision|1
211235|NCT01951703|685049|P2|First Intervention|Subject was not compliant|1
211236|NCT01951703|685050|P1|First Intervention|Subject was not compliant|1
211237|NCT01951703|685049|P2|First Intervention|Withdrawal by Subject|0
211238|NCT01951703|685050|P1|First Intervention|Withdrawal by Subject|1
211239|NCT01951573|685073|P2|Washout Period|Adverse Event|1
211240|NCT01951573|685074|P1|Washout Period|Adverse Event|0
211241|NCT01951417|685084|P1|Overall Study|Lost to Follow-up|6
211242|NCT01951417|685084|P1|Overall Study|Protocol Violation|2
211243|NCT01951417|685084|P1|Overall Study|Withdrawal by Subject|1
211244|NCT01951170|685107|P1|Overall Study|Investigator decision|1
211245|NCT01951092|685130|P1|Overall Study|Transfer of Care|1
211246|NCT01951092|685130|P1|Overall Study|Incarceration|1
211247|NCT01951092|685130|P1|Overall Study|Lost to Follow-up|10
211248|NCT01950741|685141|P1|Overall Study|Withdrawal by Subject|1
211249|NCT01950741|685141|P1|Overall Study|Death|1
211250|NCT01950741|685141|P1|Overall Study|Lost to Follow-up|1
211251|NCT01950364|685156|P2|Overall Study|Protocol Violation|1
211252|NCT01950364|685157|P1|Overall Study|Protocol Violation|0
211253|NCT01950364|685156|P2|Overall Study|Withdrawal by Subject|1
211254|NCT01950364|685157|P1|Overall Study|Withdrawal by Subject|0
211255|NCT01950364|685156|P2|Overall Study|Disease Progression|2
211256|NCT01950364|685157|P1|Overall Study|Disease Progression|5
211257|NCT01950364|685156|P2|Overall Study|Stem Cell Transplant|6
211258|NCT01950364|685157|P1|Overall Study|Stem Cell Transplant|2
211259|NCT01950364|685156|P2|Overall Study|Adverse Event|0
211260|NCT01950364|685157|P1|Overall Study|Adverse Event|3
211261|NCT01949870|685266|P1|Overall Study|Eligibility requirements not fulfilled|2
211262|NCT01949870|685266|P1|Overall Study|Study termination|1
211263|NCT01949870|685266|P1|Overall Study|Adverse Event|1
211264|NCT01949870|685266|P1|Overall Study|Lack of Efficacy|2
211265|NCT01949532|685425|P2|Overall Study|On-study at the Data Cut-off Date|3
211266|NCT01949532|685426|P1|Overall Study|On-study at the Data Cut-off Date|3
211267|NCT01949155|685501|P2|Overall Study|Protocol Violation|0
211268|NCT01949155|685502|P1|Overall Study|Protocol Violation|1
211269|NCT01949155|685501|P2|Overall Study|Lost to Follow-up|0
211270|NCT01949155|685502|P1|Overall Study|Lost to Follow-up|1
211271|NCT01949142|685514|P2|Overall Study|Parent changed their mind|0
211272|NCT01949142|685515|P1|Overall Study|Parent changed their mind|1
211273|NCT01949142|685514|P2|Overall Study|Lost to Follow-up|1
211274|NCT01949142|685515|P1|Overall Study|Lost to Follow-up|1
211275|NCT01949142|685514|P2|Overall Study|Withdrawal of consent|0
211276|NCT01949142|685515|P1|Overall Study|Withdrawal of consent|1
211277|NCT01949051|685525|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
211278|NCT01949051|685526|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
211279|NCT01949051|685527|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
211280|NCT01949051|685528|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
211281|NCT01949051|685529|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
211282|NCT01949051|685530|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
211283|NCT01949051|685525|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
211284|NCT01949051|685526|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
211285|NCT01949051|685527|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
211286|NCT01949051|685528|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
211287|NCT01949051|685529|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
211288|NCT01949051|685530|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
211289|NCT01949051|685525|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
211290|NCT01949051|685526|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
211291|NCT01949051|685527|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
211292|NCT01949051|685528|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
211293|NCT01949051|685529|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
211294|NCT01949051|685530|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
211295|NCT01949051|685525|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
211296|NCT01949051|685526|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
211297|NCT01949051|685527|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
211298|NCT01949051|685528|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
211299|NCT01949051|685529|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
211300|NCT01949051|685530|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
211301|NCT01949051|685525|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
211302|NCT01949051|685526|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
211303|NCT01949051|685527|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
211304|NCT01949051|685528|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
211305|NCT01949051|685529|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
211306|NCT01949051|685530|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
211307|NCT01948908|685544|P3|Overall Study|Protocol Violation|2
211308|NCT01948908|685545|P2|Overall Study|Protocol Violation|0
211309|NCT01948908|685546|P1|Overall Study|Protocol Violation|1
211310|NCT01948830|685562|P2|Overall Study|Death|4
211311|NCT01948830|685563|P1|Overall Study|Death|3
211312|NCT01948830|685562|P2|Overall Study|Adverse Event|2
211313|NCT01948830|685563|P1|Overall Study|Adverse Event|9
211314|NCT01948830|685562|P2|Overall Study|Withdrawal by Subject|17
211315|NCT01948830|685563|P1|Overall Study|Withdrawal by Subject|14
211316|NCT01948830|685562|P2|Overall Study|Lost to Follow-up|4
211317|NCT01948830|685563|P1|Overall Study|Lost to Follow-up|5
211318|NCT01948830|685562|P2|Overall Study|Protocol deviation|2
211319|NCT01948830|685563|P1|Overall Study|Protocol deviation|1
211320|NCT01948830|685562|P2|Overall Study|Physician Decision|3
211321|NCT01948830|685563|P1|Overall Study|Physician Decision|1
211322|NCT01948791|685595|P1|Overall Study|Screening failure|35
211323|NCT01948791|685595|P1|Overall Study|Others|7
211324|NCT01948791|685595|P1|Overall Study|Management issues|1
211325|NCT01948791|685595|P1|Overall Study|Lost to Follow-up|6
211326|NCT01948791|685595|P1|Overall Study|Withdrawal by Subject|5
211327|NCT01948791|685595|P1|Overall Study|Protocol Violation|2
211328|NCT01948791|685595|P1|Overall Study|Lack of Efficacy|3
211329|NCT01948791|685595|P1|Overall Study|Adverse Event|12
211330|NCT01948193|685625|P1|Overall Study|Lost to Follow-up|7
211331|NCT01948193|685625|P1|Overall Study|Serious event|2
211332|NCT01948076|685647|P2|Overall Study|Withdrawal by Subject|1
211333|NCT01948076|685648|P1|Overall Study|Withdrawal by Subject|0
211334|NCT01948063|685658|P2|Overall Study|Blood samples were accidentally thawed|0
211335|NCT01948063|685659|P1|Overall Study|Blood samples were accidentally thawed|1
211336|NCT01948063|685658|P2|Overall Study|Discovered an enrollment in other study|1
211337|NCT01948063|685659|P1|Overall Study|Discovered an enrollment in other study|0
211338|NCT01948063|685658|P2|Overall Study|Boston MCI halted research protocol|1
211339|NCT01948063|685659|P1|Overall Study|Boston MCI halted research protocol|0
211340|NCT01948050|685667|P2|Overall Study|Withdrawal by Subject|1
211341|NCT01948050|685668|P1|Overall Study|Withdrawal by Subject|0
211342|NCT01947855|685736|P3|Overall Study|Withdrawal by Subject|0
211343|NCT01947855|685737|P2|Overall Study|Withdrawal by Subject|0
211344|NCT01947855|685738|P1|Overall Study|Withdrawal by Subject|1
211345|NCT01947582|685746|P1|Overall Study|Withdrawal by Subject|1
211346|NCT01947517|685755|P2|Overall Study|Withdrawal by Subject|1
211347|NCT01947517|685756|P1|Overall Study|Withdrawal by Subject|1
211348|NCT01947491|685774|P4|Overall Study|Adverse Event|2
211349|NCT01947491|685775|P3|Overall Study|Adverse Event|0
211350|NCT01947491|685776|P2|Overall Study|Adverse Event|1
211351|NCT01947491|685777|P1|Overall Study|Adverse Event|0
211352|NCT01947491|685774|P4|Overall Study|Worsening of condition|0
211353|NCT01947491|685775|P3|Overall Study|Worsening of condition|0
211354|NCT01947491|685776|P2|Overall Study|Worsening of condition|1
211355|NCT01947491|685777|P1|Overall Study|Worsening of condition|0
211356|NCT01947491|685774|P4|Overall Study|Withdrawal by Subject|0
211357|NCT01947491|685775|P3|Overall Study|Withdrawal by Subject|1
211358|NCT01947491|685776|P2|Overall Study|Withdrawal by Subject|1
211359|NCT01947491|685777|P1|Overall Study|Withdrawal by Subject|1
211360|NCT01947491|685774|P4|Overall Study|Protocol Violation|0
211361|NCT01947491|685775|P3|Overall Study|Protocol Violation|0
211362|NCT01947491|685776|P2|Overall Study|Protocol Violation|0
211363|NCT01947491|685777|P1|Overall Study|Protocol Violation|1
211364|NCT01947491|685774|P4|Overall Study|Lack of Efficacy|1
211365|NCT01947491|685775|P3|Overall Study|Lack of Efficacy|0
211366|NCT01947491|685776|P2|Overall Study|Lack of Efficacy|0
211367|NCT01947491|685777|P1|Overall Study|Lack of Efficacy|1
211368|NCT01947491|685774|P4|Overall Study|Lost to Follow-up|2
211369|NCT01947491|685775|P3|Overall Study|Lost to Follow-up|1
211370|NCT01947491|685776|P2|Overall Study|Lost to Follow-up|3
211371|NCT01947491|685777|P1|Overall Study|Lost to Follow-up|5
211372|NCT01947127|685821|P2|Overall Study|Data loss|4
211373|NCT01947127|685822|P1|Overall Study|Data loss|4
211374|NCT01947127|685821|P2|Overall Study|Withdrawal by Subject|1
211375|NCT01947127|685822|P1|Overall Study|Withdrawal by Subject|1
211376|NCT01947127|685821|P2|Overall Study|Protocol Violation|38
211377|NCT01947127|685822|P1|Overall Study|Protocol Violation|18
211378|NCT01946529|685846|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
211379|NCT01946529|685847|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
211380|NCT01946529|685848|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
211381|NCT01946529|685846|P3|End of Window Therapy (2 Courses)|Physician Decision|0
211382|NCT01946529|685847|P2|End of Window Therapy (2 Courses)|Physician Decision|1
211383|NCT01946529|685848|P1|End of Window Therapy (2 Courses)|Physician Decision|0
211384|NCT01946438|685859|P4|Overall Study|Withdrawal by Subject|0
211385|NCT01946438|685860|P3|Overall Study|Withdrawal by Subject|0
211386|NCT01946438|685861|P2|Overall Study|Withdrawal by Subject|0
211387|NCT01946438|685862|P1|Overall Study|Withdrawal by Subject|1
211388|NCT01946438|685859|P4|Overall Study|Protocol Violation|0
211389|NCT01946438|685860|P3|Overall Study|Protocol Violation|1
211390|NCT01946438|685861|P2|Overall Study|Protocol Violation|0
211391|NCT01946438|685862|P1|Overall Study|Protocol Violation|0
211392|NCT01946438|685859|P4|Overall Study|Serious Adverse event|0
211393|NCT01946438|685860|P3|Overall Study|Serious Adverse event|0
211394|NCT01946438|685861|P2|Overall Study|Serious Adverse event|0
211395|NCT01946438|685862|P1|Overall Study|Serious Adverse event|1
211396|NCT01946438|685859|P4|Overall Study|Adverse Event|1
211397|NCT01946438|685860|P3|Overall Study|Adverse Event|0
211398|NCT01946438|685861|P2|Overall Study|Adverse Event|0
211399|NCT01946438|685862|P1|Overall Study|Adverse Event|0
211400|NCT01946425|685890|P2|Overall Study|Withdrawal by Subject|0
211401|NCT01946425|685891|P1|Overall Study|Withdrawal by Subject|1
211402|NCT01946425|685890|P2|Overall Study|Protocol Violation|0
211403|NCT01946425|685891|P1|Overall Study|Protocol Violation|1
211404|NCT01946412|685905|P1|Overall Study|Difficulty in swallowing|1
211405|NCT01946412|685905|P1|Overall Study|Continued with commercial Kalydeco|2
211406|NCT01946412|685905|P1|Overall Study|Non-Compliance|1
211407|NCT01946412|685905|P1|Overall Study|Adverse Event|1
211408|NCT01946178|685948|P1|Overall Study|Lost to Follow-up|1
211409|NCT01946178|685948|P1|Overall Study|Pregnancy|1
211410|NCT01945944|686017|P2|Overall Study|Withdrawal by Subject|1
211411|NCT01945944|686018|P1|Overall Study|Withdrawal by Subject|0
211412|NCT01945944|686017|P2|Overall Study|Physician Decision|0
211413|NCT01945944|686018|P1|Overall Study|Physician Decision|1
211414|NCT01945944|686017|P2|Overall Study|Adverse Event|2
211415|NCT01945944|686018|P1|Overall Study|Adverse Event|0
211416|NCT01945242|686077|P2|Overall Study|Physician Decision|3
211417|NCT01945242|686078|P1|Overall Study|Physician Decision|3
211418|NCT01945086|686136|P3|Overall Study|Adverse Event|1
211419|NCT01945086|686137|P2|Overall Study|Adverse Event|0
211420|NCT01945086|686138|P1|Overall Study|Adverse Event|0
211421|NCT01945086|686136|P3|Overall Study|Withdrawal by Subject|1
211422|NCT01945086|686137|P2|Overall Study|Withdrawal by Subject|0
211423|NCT01945086|686138|P1|Overall Study|Withdrawal by Subject|1
211424|NCT01945034|686182|P3|Overall Study|Protocol Violation|1
211425|NCT01945034|686183|P2|Overall Study|Protocol Violation|0
211426|NCT01945034|686184|P1|Overall Study|Protocol Violation|1
211427|NCT01945034|686182|P3|Overall Study|Lost to Follow-up|2
211428|NCT01945034|686183|P2|Overall Study|Lost to Follow-up|0
211429|NCT01945034|686184|P1|Overall Study|Lost to Follow-up|0
211430|NCT01945034|686182|P3|Overall Study|Unspecified|3
211431|NCT01945034|686183|P2|Overall Study|Unspecified|1
211432|NCT01945034|686184|P1|Overall Study|Unspecified|0
211433|NCT01945034|686182|P3|Overall Study|Withdrawal by Subject|1
211434|NCT01945034|686183|P2|Overall Study|Withdrawal by Subject|3
211435|NCT01945034|686184|P1|Overall Study|Withdrawal by Subject|0
211436|NCT01945034|686182|P3|Overall Study|Medication Error|0
211437|NCT01945034|686183|P2|Overall Study|Medication Error|1
211438|NCT01945034|686184|P1|Overall Study|Medication Error|0
211439|NCT01945021|686234|P1|Overall Study|Non-RECIST disease progression|1
211440|NCT01945021|686234|P1|Overall Study|Withdrawal of consent|3
211441|NCT01945021|686234|P1|Overall Study|Withdrawal by Subject|2
211442|NCT01945021|686234|P1|Overall Study|Global deterioration of health-related s|1
211443|NCT01945021|686234|P1|Overall Study|Disease progression by RECIST v1.1|30
211444|NCT01945021|686234|P1|Overall Study|Pregnancy|1
211445|NCT01945021|686234|P1|Overall Study|Death|1
211446|NCT01945021|686234|P1|Overall Study|Adverse Event|8
211447|NCT01944969|686248|P1|Overall Study|Administrative or other reasons|23
211448|NCT01944969|686248|P1|Overall Study|Non-compliance with IMP|1
211449|NCT01944969|686248|P1|Overall Study|Lack of Efficacy|1
211450|NCT01944969|686248|P1|Overall Study|Adverse Event|1
211451|NCT01944774|686273|P3|Overall Study|Lost to Follow-up|0
211452|NCT01944774|686274|P2|Overall Study|Lost to Follow-up|1
211453|NCT01944774|686275|P1|Overall Study|Lost to Follow-up|0
211454|NCT01944774|686273|P3|Overall Study|Lack of Efficacy|2
211455|NCT01944774|686274|P2|Overall Study|Lack of Efficacy|2
211456|NCT01944774|686275|P1|Overall Study|Lack of Efficacy|1
211457|NCT01944774|686273|P3|Overall Study|Adverse Event|3
211458|NCT01944774|686274|P2|Overall Study|Adverse Event|2
211459|NCT01944774|686275|P1|Overall Study|Adverse Event|3
211460|NCT01944774|686273|P3|Overall Study|Withdrawal by Subject|3
211461|NCT01944774|686274|P2|Overall Study|Withdrawal by Subject|3
211462|NCT01944774|686275|P1|Overall Study|Withdrawal by Subject|2
211463|NCT01944670|686316|P1|Overall Study|Lost to Follow-up|2
211464|NCT01944631|686323|P2|Overall Study|Withdrawal by Subject|1
211465|NCT01944631|686324|P1|Overall Study|Withdrawal by Subject|0
211466|NCT01944631|686323|P2|Overall Study|Lost to Follow-up|1
211467|NCT01944631|686324|P1|Overall Study|Lost to Follow-up|3
211468|NCT01944631|686323|P2|Overall Study|Adverse Event|0
211469|NCT01944631|686324|P1|Overall Study|Adverse Event|1
211470|NCT01944059|686359|P1|Overall Study|Adverse Event|2
211471|NCT01944059|686359|P1|Overall Study|Withdrawal by Subject|1
211472|NCT01944059|686359|P1|Overall Study|Physician Decision|3
211473|NCT01944059|686359|P1|Overall Study|Lost to Follow-up|1
211474|NCT01943552|686398|P2|Overall Study|Other Reasons|17
211475|NCT01943552|686399|P1|Overall Study|Other Reasons|16
211476|NCT01943552|686398|P2|Overall Study|Withdrawal by Subject|6
211477|NCT01943552|686399|P1|Overall Study|Withdrawal by Subject|6
211478|NCT01943552|686398|P2|Overall Study|Adverse Event|2
211479|NCT01943552|686399|P1|Overall Study|Adverse Event|3
211480|NCT01943435|686442|P3|6 Month Follow up|Lost to Follow-up|15
211481|NCT01943435|686443|P2|6 Month Follow up|Lost to Follow-up|7
211482|NCT01943435|686444|P1|6 Month Follow up|Lost to Follow-up|12
211483|NCT01943435|686442|P3|2 Month Follow up|Lost to Follow-up|0
211484|NCT01943435|686443|P2|2 Month Follow up|Lost to Follow-up|3
211485|NCT01943435|686444|P1|2 Month Follow up|Lost to Follow-up|2
211486|NCT01943435|686442|P3|Intervention Period|Withdrawal by Subject|4
211487|NCT01943435|686443|P2|Intervention Period|Withdrawal by Subject|3
211488|NCT01943435|686444|P1|Intervention Period|Withdrawal by Subject|3
211489|NCT01943292|686465|P3|Overall Study|Withdrawal by Subject|0
211490|NCT01943292|686466|P2|Overall Study|Withdrawal by Subject|0
211491|NCT01943292|686467|P1|Overall Study|Withdrawal by Subject|1
211492|NCT01942785|686494|P1|Overall Study|Protocol Violation|1
211493|NCT01942785|686494|P1|Overall Study|Withdrawal by Subject|1
211494|NCT01942785|686494|P1|Overall Study|Adverse Event|2
211495|NCT01942733|686523|P1|Overall Study|Administrative|1
211496|NCT01942733|686523|P1|Overall Study|Non-compliance with IMP|1
211497|NCT01942733|686523|P1|Overall Study|Lost to Follow-up|1
211498|NCT01942135|686562|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
211499|NCT01942135|686563|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
211500|NCT01942135|686562|P2|Overall Study|Withdrawal by Subject|2
211501|NCT01942135|686563|P1|Overall Study|Withdrawal by Subject|4
211502|NCT01942135|686562|P2|Overall Study|Participant Refused toContinue Treatment|1
211503|NCT01942135|686563|P1|Overall Study|Participant Refused toContinue Treatment|1
211504|NCT01942135|686562|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
211505|NCT01942135|686563|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
211506|NCT01942135|686562|P2|Overall Study|Death|1
211507|NCT01942135|686563|P1|Overall Study|Death|0
211508|NCT01942135|686562|P2|Overall Study|Randomized Not Treated|2
211509|NCT01942135|686563|P1|Overall Study|Randomized Not Treated|2
211510|NCT01942135|686562|P2|Overall Study|Global deterioration of health status|3
211511|NCT01942135|686563|P1|Overall Study|Global deterioration of health status|8
211512|NCT01942135|686562|P2|Overall Study|Adverse Event|3
211513|NCT01942135|686563|P1|Overall Study|Adverse Event|9
211514|NCT01941940|686600|P1|Overall Study|Unspecified|6
211515|NCT01941940|686600|P1|Overall Study|Protocol Violation|1
211516|NCT01941940|686600|P1|Overall Study|Withdrawal by Subject|15
211517|NCT01941940|686600|P1|Overall Study|Physician Decision|8
211518|NCT01941940|686600|P1|Overall Study|Lost to Follow-up|1
211519|NCT01941940|686600|P1|Overall Study|Adverse Event|19
211520|NCT01941498|686619|P1|Overall Study|Relocated out of state|1
211521|NCT01941186|686737|P2|Follow-up|Lost to Follow-up|0
211522|NCT01941186|686738|P1|Follow-up|Lost to Follow-up|1
211523|NCT01940484|686806|P1|Overall Study|Adverse Event|1
211524|NCT01940484|686806|P1|Overall Study|Death|2
211525|NCT01940484|686806|P1|Overall Study|Underwent transplantation|4
211526|NCT01940484|686806|P1|Overall Study|Withdrawal by Subject|3
211527|NCT01940471|686826|P2|Open-Label Extension|Still on Open-Label Treatment|8
211528|NCT01940471|686827|P1|Open-Label Extension|Still on Open-Label Treatment|14
211529|NCT01940471|686826|P2|Double-Blind Phase|Still on Double-Blind Treatment|270
211530|NCT01940471|686827|P1|Double-Blind Phase|Still on Double-Blind Treatment|537
211531|NCT01940471|686826|P2|Double-Blind Phase|HBsAg Seroconversion|0
211532|NCT01940471|686827|P1|Double-Blind Phase|HBsAg Seroconversion|1
211533|NCT01940471|686826|P2|Double-Blind Phase|Protocol Violation|1
211534|NCT01940471|686827|P1|Double-Blind Phase|Protocol Violation|0
211535|NCT01940471|686826|P2|Double-Blind Phase|Lack of Efficacy|0
211536|NCT01940471|686827|P1|Double-Blind Phase|Lack of Efficacy|1
211537|NCT01940471|686826|P2|Double-Blind Phase|Death|0
211538|NCT01940471|686827|P1|Double-Blind Phase|Death|1
211539|NCT01940471|686826|P2|Double-Blind Phase|Protocol-Specified Criteria|0
211540|NCT01940471|686827|P1|Double-Blind Phase|Protocol-Specified Criteria|2
211541|NCT01940471|686826|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
211542|NCT01940471|686827|P1|Double-Blind Phase|Non-Compliance with Study Drug|2
211543|NCT01940471|686826|P2|Double-Blind Phase|Investigator's Discretion|1
211544|NCT01940471|686827|P1|Double-Blind Phase|Investigator's Discretion|2
211545|NCT01940471|686826|P2|Double-Blind Phase|Pregnancy|1
211546|NCT01940471|686827|P1|Double-Blind Phase|Pregnancy|2
211547|NCT01940471|686826|P2|Double-Blind Phase|Lost to Follow-up|2
211548|NCT01940471|686827|P1|Double-Blind Phase|Lost to Follow-up|2
211549|NCT01940471|686826|P2|Double-Blind Phase|Adverse Event|3
211550|NCT01940471|686827|P1|Double-Blind Phase|Adverse Event|6
211551|NCT01940471|686826|P2|Double-Blind Phase|Withdrew Consent|5
211552|NCT01940471|686827|P1|Double-Blind Phase|Withdrew Consent|11
211553|NCT01940471|686826|P2|Double-Blind Phase|Randomized but Never Treated|1
211554|NCT01940471|686827|P1|Double-Blind Phase|Randomized but Never Treated|1
211555|NCT01940341|686845|P2|Open-label Extension Phase|Still on Study|1
211556|NCT01940341|686846|P1|Open-label Extension Phase|Still on Study|4
211557|NCT01940341|686845|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
211558|NCT01940341|686846|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
211559|NCT01940341|686845|P2|Double-Blind Phase|Protocol Specified Criteria|0
211560|NCT01940341|686846|P1|Double-Blind Phase|Protocol Specified Criteria|1
211561|NCT01940341|686845|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
211562|NCT01940341|686846|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
211563|NCT01940341|686845|P2|Double-Blind Phase|Investigator's Discretion|0
211564|NCT01940341|686846|P1|Double-Blind Phase|Investigator's Discretion|1
211565|NCT01940341|686845|P2|Double-Blind Phase|Pregnancy|1
211566|NCT01940341|686846|P1|Double-Blind Phase|Pregnancy|0
211567|NCT01940341|686845|P2|Double-Blind Phase|Lost to Follow-up|1
211568|NCT01940341|686846|P1|Double-Blind Phase|Lost to Follow-up|4
211569|NCT01940341|686845|P2|Double-Blind Phase|Withdrew Consent|2
211570|NCT01940341|686846|P1|Double-Blind Phase|Withdrew Consent|3
211571|NCT01940341|686845|P2|Double-Blind Phase|Adverse Event|2
211572|NCT01940341|686846|P1|Double-Blind Phase|Adverse Event|3
211573|NCT01940341|686845|P2|Double-Blind Phase|Randomized but Never Treated|1
211574|NCT01940341|686846|P1|Double-Blind Phase|Randomized but Never Treated|0
211575|NCT01940120|686877|P1|Overall Study|Lost to Follow-up|4
211576|NCT01940120|686877|P1|Overall Study|Withdrawal by Subject|7
211577|NCT01940120|686877|P1|Overall Study|Death|33
211578|NCT01939548|687007|P3|Overall Study|Did not complete follow-up|0
211579|NCT01939548|687008|P2|Overall Study|Did not complete follow-up|1
211580|NCT01939548|687009|P1|Overall Study|Did not complete follow-up|0
211581|NCT01939548|687007|P3|Overall Study|Participant withdrew consent|0
211582|NCT01939548|687008|P2|Overall Study|Participant withdrew consent|2
211583|NCT01939548|687009|P1|Overall Study|Participant withdrew consent|0
211584|NCT01939548|687007|P3|Overall Study|Participant unwilling to continue|0
211585|NCT01939548|687008|P2|Overall Study|Participant unwilling to continue|1
211586|NCT01939548|687009|P1|Overall Study|Participant unwilling to continue|0
211587|NCT01939548|687007|P3|Overall Study|Participant dropped|1
211588|NCT01939548|687008|P2|Overall Study|Participant dropped|0
211589|NCT01939548|687009|P1|Overall Study|Participant dropped|0
211590|NCT01939548|687007|P3|Overall Study|Death|1
211591|NCT01939548|687008|P2|Overall Study|Death|0
211592|NCT01939548|687009|P1|Overall Study|Death|0
211593|NCT01939548|687007|P3|Overall Study|Adverse Event|7
211594|NCT01939548|687008|P2|Overall Study|Adverse Event|9
211595|NCT01939548|687009|P1|Overall Study|Adverse Event|2
211596|NCT01939548|687007|P3|Overall Study|Lost to Follow-up|3
211597|NCT01939548|687008|P2|Overall Study|Lost to Follow-up|5
211598|NCT01939548|687009|P1|Overall Study|Lost to Follow-up|5
211599|NCT01939548|687007|P3|Overall Study|Protocol Violation|5
211600|NCT01939548|687008|P2|Overall Study|Protocol Violation|6
211601|NCT01939548|687009|P1|Overall Study|Protocol Violation|7
211602|NCT01939548|687007|P3|Overall Study|Withdrawal by Subject|1
211603|NCT01939548|687008|P2|Overall Study|Withdrawal by Subject|4
211604|NCT01939548|687009|P1|Overall Study|Withdrawal by Subject|4
211605|NCT01939548|687007|P3|Overall Study|Did Not Meet Entrance Criteria|0
211606|NCT01939548|687008|P2|Overall Study|Did Not Meet Entrance Criteria|0
211607|NCT01939548|687009|P1|Overall Study|Did Not Meet Entrance Criteria|1
211608|NCT01939548|687007|P3|Overall Study|Insufficient Clinical Response|0
211609|NCT01939548|687008|P2|Overall Study|Insufficient Clinical Response|0
211610|NCT01939548|687009|P1|Overall Study|Insufficient Clinical Response|1
211611|NCT01939548|687007|P3|Overall Study|Study Terminated by Sponsor|12
211612|NCT01939548|687008|P2|Overall Study|Study Terminated by Sponsor|19
211613|NCT01939548|687009|P1|Overall Study|Study Terminated by Sponsor|17
211614|NCT01939548|687007|P3|Overall Study|Non compliance|0
211615|NCT01939548|687008|P2|Overall Study|Non compliance|2
211616|NCT01939548|687009|P1|Overall Study|Non compliance|0
211617|NCT01939496|687083|P3|Overall Study|Unspecified|1
211618|NCT01939496|687084|P2|Overall Study|Unspecified|0
211619|NCT01939496|687085|P1|Overall Study|Unspecified|2
211620|NCT01939496|687083|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
211621|NCT01939496|687084|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
211622|NCT01939496|687085|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
211623|NCT01939496|687083|P3|Overall Study|Withdrawal by Subject|1
211624|NCT01939496|687084|P2|Overall Study|Withdrawal by Subject|1
211625|NCT01939496|687085|P1|Overall Study|Withdrawal by Subject|0
211626|NCT01939496|687083|P3|Overall Study|Protocol Violation|0
211627|NCT01939496|687084|P2|Overall Study|Protocol Violation|0
211628|NCT01939496|687085|P1|Overall Study|Protocol Violation|3
211629|NCT01939496|687083|P3|Overall Study|Physician Decision|0
211630|NCT01939496|687084|P2|Overall Study|Physician Decision|0
211631|NCT01939496|687085|P1|Overall Study|Physician Decision|1
211632|NCT01939496|687083|P3|Overall Study|Lost to Follow-up|0
211633|NCT01939496|687084|P2|Overall Study|Lost to Follow-up|1
211634|NCT01939496|687085|P1|Overall Study|Lost to Follow-up|1
211635|NCT01939496|687083|P3|Overall Study|Adverse Event|0
211636|NCT01939496|687084|P2|Overall Study|Adverse Event|0
211637|NCT01939496|687085|P1|Overall Study|Adverse Event|2
211638|NCT01939314|687137|P2|Overall Study|Lost to Follow-up|6
211639|NCT01939314|687138|P1|Overall Study|Lost to Follow-up|5
211640|NCT01939314|687137|P2|Overall Study|Pregnancy|1
211641|NCT01939314|687138|P1|Overall Study|Pregnancy|0
211642|NCT01939314|687137|P2|Overall Study|Protocol Violation|0
211643|NCT01939314|687138|P1|Overall Study|Protocol Violation|1
211644|NCT01939314|687137|P2|Overall Study|Withdrawal by Subject|1
211645|NCT01939314|687138|P1|Overall Study|Withdrawal by Subject|3
211646|NCT01939002|687161|P2|Overall Study|Not Specified|2
211647|NCT01939002|687162|P1|Overall Study|Not Specified|1
211648|NCT01939002|687161|P2|Overall Study|Withdrawal by Subject|3
211649|NCT01939002|687162|P1|Overall Study|Withdrawal by Subject|5
211650|NCT01939002|687161|P2|Overall Study|Adverse Event|13
211651|NCT01939002|687162|P1|Overall Study|Adverse Event|13
211652|NCT01938430|687249|P14|Overall Study|Withdrew Consent|0
211653|NCT01938430|687250|P13|Overall Study|Withdrew Consent|0
211654|NCT01938430|687251|P12|Overall Study|Withdrew Consent|0
211655|NCT01938430|687252|P11|Overall Study|Withdrew Consent|0
211656|NCT01938430|687253|P10|Overall Study|Withdrew Consent|0
211657|NCT01938430|687254|P9|Overall Study|Withdrew Consent|1
211658|NCT01938430|687255|P8|Overall Study|Withdrew Consent|0
211659|NCT01938430|687256|P7|Overall Study|Withdrew Consent|0
211660|NCT01938430|687257|P6|Overall Study|Withdrew Consent|0
211661|NCT01938430|687258|P5|Overall Study|Withdrew Consent|0
211662|NCT01938430|687259|P4|Overall Study|Withdrew Consent|0
211663|NCT01938430|687260|P3|Overall Study|Withdrew Consent|0
211664|NCT01938430|687261|P2|Overall Study|Withdrew Consent|0
211665|NCT01938430|687262|P1|Overall Study|Withdrew Consent|0
211666|NCT01938430|687249|P14|Overall Study|Lost to Follow-up|0
211667|NCT01938430|687250|P13|Overall Study|Lost to Follow-up|0
211668|NCT01938430|687251|P12|Overall Study|Lost to Follow-up|0
211669|NCT01938430|687252|P11|Overall Study|Lost to Follow-up|0
211670|NCT01938430|687253|P10|Overall Study|Lost to Follow-up|0
211671|NCT01938430|687254|P9|Overall Study|Lost to Follow-up|0
211672|NCT01938430|687255|P8|Overall Study|Lost to Follow-up|0
211673|NCT01938430|687256|P7|Overall Study|Lost to Follow-up|0
211674|NCT01938430|687257|P6|Overall Study|Lost to Follow-up|1
211675|NCT01938430|687258|P5|Overall Study|Lost to Follow-up|0
211676|NCT01938430|687259|P4|Overall Study|Lost to Follow-up|0
211677|NCT01938430|687260|P3|Overall Study|Lost to Follow-up|1
211678|NCT01938430|687261|P2|Overall Study|Lost to Follow-up|0
211679|NCT01938430|687262|P1|Overall Study|Lost to Follow-up|0
211680|NCT01938430|687249|P14|Overall Study|Lack of Efficacy|0
211681|NCT01938430|687250|P13|Overall Study|Lack of Efficacy|0
211682|NCT01938430|687251|P12|Overall Study|Lack of Efficacy|1
211683|NCT01938430|687252|P11|Overall Study|Lack of Efficacy|2
211684|NCT01938430|687253|P10|Overall Study|Lack of Efficacy|0
211685|NCT01938430|687254|P9|Overall Study|Lack of Efficacy|1
211686|NCT01938430|687255|P8|Overall Study|Lack of Efficacy|0
211687|NCT01938430|687256|P7|Overall Study|Lack of Efficacy|0
211688|NCT01938430|687257|P6|Overall Study|Lack of Efficacy|0
211689|NCT01938430|687258|P5|Overall Study|Lack of Efficacy|0
211690|NCT01938430|687259|P4|Overall Study|Lack of Efficacy|1
211691|NCT01938430|687260|P3|Overall Study|Lack of Efficacy|1
211692|NCT01938430|687261|P2|Overall Study|Lack of Efficacy|1
211693|NCT01938430|687262|P1|Overall Study|Lack of Efficacy|3
211694|NCT01938430|687249|P14|Overall Study|Investigator's Discretion|0
211695|NCT01938430|687250|P13|Overall Study|Investigator's Discretion|0
211696|NCT01938430|687251|P12|Overall Study|Investigator's Discretion|0
211697|NCT01938430|687252|P11|Overall Study|Investigator's Discretion|0
211698|NCT01938430|687253|P10|Overall Study|Investigator's Discretion|0
211699|NCT01938430|687254|P9|Overall Study|Investigator's Discretion|0
211700|NCT01938430|687255|P8|Overall Study|Investigator's Discretion|0
211701|NCT01938430|687256|P7|Overall Study|Investigator's Discretion|0
211702|NCT01938430|687257|P6|Overall Study|Investigator's Discretion|0
211703|NCT01938430|687258|P5|Overall Study|Investigator's Discretion|0
211704|NCT01938430|687259|P4|Overall Study|Investigator's Discretion|0
211705|NCT01938430|687260|P3|Overall Study|Investigator's Discretion|1
211706|NCT01938430|687261|P2|Overall Study|Investigator's Discretion|0
211707|NCT01938430|687262|P1|Overall Study|Investigator's Discretion|0
211708|NCT01938430|687249|P14|Overall Study|Death|0
211709|NCT01938430|687250|P13|Overall Study|Death|0
211710|NCT01938430|687251|P12|Overall Study|Death|0
211711|NCT01938430|687252|P11|Overall Study|Death|0
211712|NCT01938430|687253|P10|Overall Study|Death|3
211713|NCT01938430|687254|P9|Overall Study|Death|2
211714|NCT01938430|687255|P8|Overall Study|Death|1
211715|NCT01938430|687256|P7|Overall Study|Death|1
211716|NCT01938430|687257|P6|Overall Study|Death|0
211717|NCT01938430|687258|P5|Overall Study|Death|0
211718|NCT01938430|687259|P4|Overall Study|Death|1
211719|NCT01938430|687260|P3|Overall Study|Death|2
211720|NCT01938430|687261|P2|Overall Study|Death|2
211721|NCT01938430|687262|P1|Overall Study|Death|1
211722|NCT01938430|687249|P14|Overall Study|Adverse Event|0
211723|NCT01938430|687250|P13|Overall Study|Adverse Event|0
211724|NCT01938430|687251|P12|Overall Study|Adverse Event|0
211725|NCT01938430|687252|P11|Overall Study|Adverse Event|0
211726|NCT01938430|687253|P10|Overall Study|Adverse Event|0
211727|NCT01938430|687254|P9|Overall Study|Adverse Event|0
211728|NCT01938430|687255|P8|Overall Study|Adverse Event|0
211729|NCT01938430|687256|P7|Overall Study|Adverse Event|1
211730|NCT01938430|687257|P6|Overall Study|Adverse Event|0
211731|NCT01938430|687258|P5|Overall Study|Adverse Event|0
211732|NCT01938430|687259|P4|Overall Study|Adverse Event|0
211733|NCT01938430|687260|P3|Overall Study|Adverse Event|0
211734|NCT01938430|687261|P2|Overall Study|Adverse Event|0
211735|NCT01938430|687262|P1|Overall Study|Adverse Event|0
211736|NCT01938430|687249|P14|Overall Study|Randomized but Not Treated|1
211737|NCT01938430|687250|P13|Overall Study|Randomized but Not Treated|0
211738|NCT01938430|687251|P12|Overall Study|Randomized but Not Treated|0
211739|NCT01938430|687252|P11|Overall Study|Randomized but Not Treated|1
211740|NCT01938430|687253|P10|Overall Study|Randomized but Not Treated|0
211741|NCT01938430|687254|P9|Overall Study|Randomized but Not Treated|0
211742|NCT01938430|687255|P8|Overall Study|Randomized but Not Treated|0
211743|NCT01938430|687256|P7|Overall Study|Randomized but Not Treated|0
211744|NCT01938430|687257|P6|Overall Study|Randomized but Not Treated|0
211745|NCT01938430|687258|P5|Overall Study|Randomized but Not Treated|0
211746|NCT01938430|687259|P4|Overall Study|Randomized but Not Treated|0
211747|NCT01938430|687260|P3|Overall Study|Randomized but Not Treated|0
211748|NCT01938430|687261|P2|Overall Study|Randomized but Not Treated|0
211749|NCT01938430|687262|P1|Overall Study|Randomized but Not Treated|0
211750|NCT01937871|687696|P3|Overall Study|Entry Criteria Not Met|1
211751|NCT01937871|687697|P2|Overall Study|Entry Criteria Not Met|2
211752|NCT01937871|687698|P1|Overall Study|Entry Criteria Not Met|1
211753|NCT01937871|687696|P3|Overall Study|Physician Decision|0
211754|NCT01937871|687697|P2|Overall Study|Physician Decision|1
211755|NCT01937871|687698|P1|Overall Study|Physician Decision|0
211756|NCT01937871|687696|P3|Overall Study|Withdrawal by Subject|4
211757|NCT01937871|687697|P2|Overall Study|Withdrawal by Subject|6
211758|NCT01937871|687698|P1|Overall Study|Withdrawal by Subject|9
211759|NCT01937871|687696|P3|Overall Study|Lost to Follow-up|4
211760|NCT01937871|687697|P2|Overall Study|Lost to Follow-up|2
211761|NCT01937871|687698|P1|Overall Study|Lost to Follow-up|8
211762|NCT01937871|687696|P3|Overall Study|Adverse Event|2
211763|NCT01937871|687697|P2|Overall Study|Adverse Event|6
211764|NCT01937871|687698|P1|Overall Study|Adverse Event|6
211765|NCT01937715|687774|P5|Overall Study|Unspecified|0
211766|NCT01937715|687775|P4|Overall Study|Unspecified|3
211767|NCT01937715|687776|P3|Overall Study|Unspecified|0
211768|NCT01937715|687777|P2|Overall Study|Unspecified|0
211769|NCT01937715|687778|P1|Overall Study|Unspecified|0
211770|NCT01937715|687774|P5|Overall Study|Withdrawal by Subject|2
211771|NCT01937715|687775|P4|Overall Study|Withdrawal by Subject|0
211772|NCT01937715|687776|P3|Overall Study|Withdrawal by Subject|0
211773|NCT01937715|687777|P2|Overall Study|Withdrawal by Subject|1
211774|NCT01937715|687778|P1|Overall Study|Withdrawal by Subject|0
211775|NCT01937715|687774|P5|Overall Study|Death|0
211776|NCT01937715|687775|P4|Overall Study|Death|1
211777|NCT01937715|687776|P3|Overall Study|Death|0
211778|NCT01937715|687777|P2|Overall Study|Death|0
211779|NCT01937715|687778|P1|Overall Study|Death|0
211780|NCT01937364|687964|P2|Overall Study|Adverse Event|1
211781|NCT01937364|687965|P1|Overall Study|Adverse Event|2
211782|NCT01937351|687977|P2|Overall Study|Not treated w device, per protocol fail|0
211783|NCT01937351|687978|P1|Overall Study|Not treated w device, per protocol fail|4
211784|NCT01937351|687977|P2|Overall Study|Death|0
211785|NCT01937351|687978|P1|Overall Study|Death|1
211786|NCT01937351|687977|P2|Overall Study|Withdrawal by Subject|2
211787|NCT01937351|687978|P1|Overall Study|Withdrawal by Subject|4
211788|NCT01937312|687986|P2|Overall Study|Withdrawal of subject prior to treatment|1
211789|NCT01937312|687987|P1|Overall Study|Withdrawal of subject prior to treatment|1
211790|NCT01937312|687986|P2|Overall Study|Lack of Efficacy|1
211791|NCT01937312|687987|P1|Overall Study|Lack of Efficacy|0
211792|NCT01937312|687986|P2|Overall Study|Adverse Event|1
211793|NCT01937312|687987|P1|Overall Study|Adverse Event|10
211794|NCT01937299|688002|P2|Overall Study|Withdrawal by Subject|0
211795|NCT01937299|688003|P1|Overall Study|Withdrawal by Subject|1
211796|NCT01937299|688002|P2|Overall Study|Lack of Efficacy|4
211797|NCT01937299|688003|P1|Overall Study|Lack of Efficacy|0
211798|NCT01937299|688002|P2|Overall Study|Adverse Event|0
211799|NCT01937299|688003|P1|Overall Study|Adverse Event|13
211800|NCT01937130|688038|P4|Overall Study|Patient lost to FU due to death|0
211801|NCT01937130|688039|P3|Overall Study|Patient lost to FU due to death|0
211802|NCT01937130|688040|P2|Overall Study|Patient lost to FU due to death|0
211803|NCT01937130|688041|P1|Overall Study|Patient lost to FU due to death|2
211804|NCT01937130|688038|P4|Overall Study|Patients unable to swallow|0
211805|NCT01937130|688039|P3|Overall Study|Patients unable to swallow|0
211806|NCT01937130|688040|P2|Overall Study|Patients unable to swallow|1
211807|NCT01937130|688041|P1|Overall Study|Patients unable to swallow|0
211808|NCT01937130|688038|P4|Overall Study|Physician Decision|0
211809|NCT01937130|688039|P3|Overall Study|Physician Decision|0
211810|NCT01937130|688040|P2|Overall Study|Physician Decision|1
211811|NCT01937130|688041|P1|Overall Study|Physician Decision|0
211812|NCT01937130|688038|P4|Overall Study|Lost to Follow-up|0
211813|NCT01937130|688039|P3|Overall Study|Lost to Follow-up|2
211814|NCT01937130|688040|P2|Overall Study|Lost to Follow-up|0
211815|NCT01937130|688041|P1|Overall Study|Lost to Follow-up|2
211816|NCT01937130|688038|P4|Overall Study|Death|0
211817|NCT01937130|688039|P3|Overall Study|Death|1
211818|NCT01937130|688040|P2|Overall Study|Death|1
211819|NCT01937130|688041|P1|Overall Study|Death|1
211820|NCT01937130|688038|P4|Overall Study|Adverse Event|1
211821|NCT01937130|688039|P3|Overall Study|Adverse Event|0
211822|NCT01937130|688040|P2|Overall Study|Adverse Event|1
211823|NCT01937130|688041|P1|Overall Study|Adverse Event|0
211824|NCT01937130|688038|P4|Overall Study|Withdrawal by Subject|1
211825|NCT01937130|688039|P3|Overall Study|Withdrawal by Subject|0
211826|NCT01937130|688040|P2|Overall Study|Withdrawal by Subject|0
211827|NCT01937130|688041|P1|Overall Study|Withdrawal by Subject|0
211828|NCT01936870|688082|P1|Overall Study|No Drug Administration|1
211829|NCT01936870|688082|P1|Overall Study|Protocol Violation|12
211830|NCT01936870|688082|P1|Overall Study|No Visit After Treatment|176
211831|NCT01936649|688119|P1|Overall Study|Other than specified above|5
211832|NCT01936649|688119|P1|Overall Study|Protocol Violation|2
211833|NCT01936649|688119|P1|Overall Study|Physician Decision|2
211834|NCT01936649|688119|P1|Overall Study|Withdrawal by Subject|4
211835|NCT01936363|688156|P2|Overall Study|Ongoing|5
211836|NCT01936363|688157|P1|Overall Study|Ongoing|7
211837|NCT01936181|688183|P4|Transition-extension|Withdrawal by Subject|1
211838|NCT01936181|688184|P3|Transition-extension|Withdrawal by Subject|2
211839|NCT01936181|688185|P2|Transition-extension|Withdrawal by Subject|0
211840|NCT01936181|688186|P1|Transition-extension|Withdrawal by Subject|7
211841|NCT01936181|688183|P4|Transition-extension|Physician Decision|1
211842|NCT01936181|688184|P3|Transition-extension|Physician Decision|0
211843|NCT01936181|688185|P2|Transition-extension|Physician Decision|0
211844|NCT01936181|688186|P1|Transition-extension|Physician Decision|2
211845|NCT01936181|688183|P4|Transition-extension|Lost to Follow-up|2
211846|NCT01936181|688184|P3|Transition-extension|Lost to Follow-up|1
211847|NCT01936181|688185|P2|Transition-extension|Lost to Follow-up|0
211848|NCT01936181|688186|P1|Transition-extension|Lost to Follow-up|3
211849|NCT01936181|688183|P4|Transition-extension|Adverse Event|1
211850|NCT01936181|688184|P3|Transition-extension|Adverse Event|3
211851|NCT01936181|688185|P2|Transition-extension|Adverse Event|0
211852|NCT01936181|688186|P1|Transition-extension|Adverse Event|3
211853|NCT01936181|688183|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
211854|NCT01936181|688184|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
211855|NCT01936181|688185|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
211856|NCT01936181|688186|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
211857|NCT01936181|688183|P4|Randomised, Double-blind|Withdrawal by Subject|0
211858|NCT01936181|688184|P3|Randomised, Double-blind|Withdrawal by Subject|0
211859|NCT01936181|688185|P2|Randomised, Double-blind|Withdrawal by Subject|26
211860|NCT01936181|688186|P1|Randomised, Double-blind|Withdrawal by Subject|23
211861|NCT01936181|688183|P4|Randomised, Double-blind|Physician Decision|0
211862|NCT01936181|688184|P3|Randomised, Double-blind|Physician Decision|0
211863|NCT01936181|688185|P2|Randomised, Double-blind|Physician Decision|4
211864|NCT01936181|688186|P1|Randomised, Double-blind|Physician Decision|4
211865|NCT01936181|688183|P4|Randomised, Double-blind|Pregnancy|0
211866|NCT01936181|688184|P3|Randomised, Double-blind|Pregnancy|0
211867|NCT01936181|688185|P2|Randomised, Double-blind|Pregnancy|1
211868|NCT01936181|688186|P1|Randomised, Double-blind|Pregnancy|0
211869|NCT01936181|688183|P4|Randomised, Double-blind|Lost to Follow-up|0
211870|NCT01936181|688184|P3|Randomised, Double-blind|Lost to Follow-up|0
211871|NCT01936181|688185|P2|Randomised, Double-blind|Lost to Follow-up|1
211872|NCT01936181|688186|P1|Randomised, Double-blind|Lost to Follow-up|0
211873|NCT01936181|688183|P4|Randomised, Double-blind|Lack of Efficacy|0
211874|NCT01936181|688184|P3|Randomised, Double-blind|Lack of Efficacy|0
211875|NCT01936181|688185|P2|Randomised, Double-blind|Lack of Efficacy|6
211876|NCT01936181|688186|P1|Randomised, Double-blind|Lack of Efficacy|5
211877|NCT01936181|688183|P4|Randomised, Double-blind|Protocol Violation|0
211878|NCT01936181|688184|P3|Randomised, Double-blind|Protocol Violation|0
211879|NCT01936181|688185|P2|Randomised, Double-blind|Protocol Violation|5
211880|NCT01936181|688186|P1|Randomised, Double-blind|Protocol Violation|1
211881|NCT01936181|688183|P4|Randomised, Double-blind|Adverse Event|0
211882|NCT01936181|688184|P3|Randomised, Double-blind|Adverse Event|0
211883|NCT01936181|688185|P2|Randomised, Double-blind|Adverse Event|21
211884|NCT01936181|688186|P1|Randomised, Double-blind|Adverse Event|27
211885|NCT01934894|688233|P2|Overall Study|Progressive Disease|2
211886|NCT01934894|688234|P1|Overall Study|Progressive Disease|3
211887|NCT01934894|688233|P2|Overall Study|Withdrawal by Subject|1
211888|NCT01934894|688234|P1|Overall Study|Withdrawal by Subject|0
211889|NCT01934894|688233|P2|Overall Study|Death|0
211890|NCT01934894|688234|P1|Overall Study|Death|2
211891|NCT01934894|688233|P2|Overall Study|Adverse Event|2
211892|NCT01934894|688234|P1|Overall Study|Adverse Event|1
211893|NCT01934790|688249|P1|Overall Study|Study drug never administered|1
211894|NCT01934790|688249|P1|Overall Study|Withdrawal by Subject|2
211895|NCT01934790|688249|P1|Overall Study|Radiological progression|4
211896|NCT01934790|688249|P1|Overall Study|Clinical progression|6
211897|NCT01934790|688249|P1|Overall Study|Adverse Event|3
211898|NCT01934504|688295|P4|Overall Study|Study Terminated by Sponsor|5
211899|NCT01934504|688296|P3|Overall Study|Study Terminated by Sponsor|5
211900|NCT01934504|688297|P2|Overall Study|Study Terminated by Sponsor|0
211901|NCT01934504|688298|P1|Overall Study|Study Terminated by Sponsor|1
211902|NCT01934504|688295|P4|Overall Study|Protocol Deviation|2
211903|NCT01934504|688296|P3|Overall Study|Protocol Deviation|0
211904|NCT01934504|688297|P2|Overall Study|Protocol Deviation|0
211905|NCT01934504|688298|P1|Overall Study|Protocol Deviation|0
211906|NCT01933880|688331|P2|Overall Study|Protocol Violation|0
211907|NCT01933880|688332|P1|Overall Study|Protocol Violation|1
211908|NCT01933880|688331|P2|Overall Study|Unspecified|0
211909|NCT01933880|688332|P1|Overall Study|Unspecified|4
211910|NCT01933880|688331|P2|Overall Study|Followup exceeded 4 days to visit window|0
211911|NCT01933880|688332|P1|Overall Study|Followup exceeded 4 days to visit window|19
211912|NCT01933880|688331|P2|Overall Study|Concomitant medication Interference|1
211913|NCT01933880|688332|P1|Overall Study|Concomitant medication Interference|0
211914|NCT01933880|688331|P2|Overall Study|Lack of Efficacy|0
211915|NCT01933880|688332|P1|Overall Study|Lack of Efficacy|1
211916|NCT01933880|688331|P2|Overall Study|Withdrawal by Subject|0
211917|NCT01933880|688332|P1|Overall Study|Withdrawal by Subject|5
211918|NCT01933672|688408|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
211919|NCT01933672|688409|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
211920|NCT01933672|688410|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
211921|NCT01933672|688411|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
211922|NCT01933672|688412|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
211923|NCT01933672|688413|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
211924|NCT01933672|688414|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
211925|NCT01933672|688408|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
211926|NCT01933672|688409|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
211927|NCT01933672|688410|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
211928|NCT01933672|688411|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
211929|NCT01933672|688412|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
211930|NCT01933672|688413|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
211931|NCT01933672|688414|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
211932|NCT01933672|688408|P7|Second Intervention Period (12-16 Days)|Unspecified|0
211933|NCT01933672|688409|P6|Second Intervention Period (12-16 Days)|Unspecified|0
211934|NCT01933672|688410|P5|Second Intervention Period (12-16 Days)|Unspecified|0
211935|NCT01933672|688411|P4|Second Intervention Period (12-16 Days)|Unspecified|0
211936|NCT01933672|688412|P3|Second Intervention Period (12-16 Days)|Unspecified|1
211937|NCT01933672|688413|P2|Second Intervention Period (12-16 Days)|Unspecified|1
211938|NCT01933672|688414|P1|Second Intervention Period (12-16 Days)|Unspecified|0
211939|NCT01933672|688408|P7|First Intervention Period (12-16 Days)|Unspecified|0
211940|NCT01933672|688409|P6|First Intervention Period (12-16 Days)|Unspecified|1
211941|NCT01933672|688410|P5|First Intervention Period (12-16 Days)|Unspecified|0
211942|NCT01933672|688411|P4|First Intervention Period (12-16 Days)|Unspecified|0
211943|NCT01933672|688412|P3|First Intervention Period (12-16 Days)|Unspecified|1
211944|NCT01933672|688413|P2|First Intervention Period (12-16 Days)|Unspecified|0
211945|NCT01933672|688414|P1|First Intervention Period (12-16 Days)|Unspecified|0
211946|NCT01933672|688408|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
211947|NCT01933672|688409|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
211948|NCT01933672|688410|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
211949|NCT01933672|688411|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
211950|NCT01933672|688412|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
211951|NCT01933672|688413|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
211952|NCT01933672|688414|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
211953|NCT01933672|688408|P7|Metformin Run-in Period|Unspecified|0
211954|NCT01933672|688409|P6|Metformin Run-in Period|Unspecified|0
211955|NCT01933672|688410|P5|Metformin Run-in Period|Unspecified|0
211956|NCT01933672|688411|P4|Metformin Run-in Period|Unspecified|0
211957|NCT01933672|688412|P3|Metformin Run-in Period|Unspecified|0
211958|NCT01933672|688413|P2|Metformin Run-in Period|Unspecified|0
211959|NCT01933672|688414|P1|Metformin Run-in Period|Unspecified|5
211960|NCT01933672|688408|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
211961|NCT01933672|688409|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
211962|NCT01933672|688410|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
211963|NCT01933672|688411|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
211964|NCT01933672|688412|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
211965|NCT01933672|688413|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
211966|NCT01933672|688414|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
211967|NCT01933672|688408|P7|Metformin Run-in Period|Adverse Event|0
211968|NCT01933672|688409|P6|Metformin Run-in Period|Adverse Event|0
211969|NCT01933672|688410|P5|Metformin Run-in Period|Adverse Event|0
211970|NCT01933672|688411|P4|Metformin Run-in Period|Adverse Event|0
211971|NCT01933672|688412|P3|Metformin Run-in Period|Adverse Event|0
211972|NCT01933672|688413|P2|Metformin Run-in Period|Adverse Event|0
211973|NCT01933672|688414|P1|Metformin Run-in Period|Adverse Event|1
211974|NCT01933334|688489|P2|Overall Study|Withdrawal by Subject|1
211975|NCT01933334|688490|P1|Overall Study|Withdrawal by Subject|0
211976|NCT01933334|688489|P2|Overall Study|Adverse Event|1
211977|NCT01933334|688490|P1|Overall Study|Adverse Event|5
211978|NCT01932970|688504|P1|Overall Study|Protocol Specified Criteria|10
211979|NCT01932970|688504|P1|Overall Study|Lost to Follow-up|2
211980|NCT01932970|688504|P1|Overall Study|Death|1
211981|NCT01932970|688504|P1|Overall Study|Withdrawal by Subject|5
211982|NCT01932762|688516|P4|Overall Study|Physician Decision|0
211983|NCT01932762|688517|P3|Overall Study|Physician Decision|0
211984|NCT01932762|688518|P2|Overall Study|Physician Decision|0
211985|NCT01932762|688519|P1|Overall Study|Physician Decision|1
211986|NCT01932762|688516|P4|Overall Study|Lost to Follow-up|1
211987|NCT01932762|688517|P3|Overall Study|Lost to Follow-up|0
211988|NCT01932762|688518|P2|Overall Study|Lost to Follow-up|0
211989|NCT01932762|688519|P1|Overall Study|Lost to Follow-up|4
211990|NCT01932762|688516|P4|Overall Study|Withdrawal by Subject|0
211991|NCT01932762|688517|P3|Overall Study|Withdrawal by Subject|0
211992|NCT01932762|688518|P2|Overall Study|Withdrawal by Subject|2
211993|NCT01932762|688519|P1|Overall Study|Withdrawal by Subject|1
211994|NCT01931865|688636|P1|Overall Study|Withdrawal by Subject|2
211995|NCT01931865|688636|P1|Overall Study|Lost to Follow-up|2
211996|NCT01931839|688649|P7|Overall Study|Unspecified|0
211997|NCT01931839|688650|P6|Overall Study|Unspecified|0
211998|NCT01931839|688651|P5|Overall Study|Unspecified|0
211999|NCT01931839|688652|P4|Overall Study|Unspecified|0
212000|NCT01931839|688653|P3|Overall Study|Unspecified|6
212001|NCT01931839|688654|P2|Overall Study|Unspecified|2
212002|NCT01931839|688655|P1|Overall Study|Unspecified|4
212003|NCT01931839|688649|P7|Overall Study|Lost to Follow-up|0
212004|NCT01931839|688650|P6|Overall Study|Lost to Follow-up|0
212005|NCT01931839|688651|P5|Overall Study|Lost to Follow-up|0
212006|NCT01931839|688652|P4|Overall Study|Lost to Follow-up|5
212007|NCT01931839|688653|P3|Overall Study|Lost to Follow-up|4
212008|NCT01931839|688654|P2|Overall Study|Lost to Follow-up|2
212009|NCT01931839|688655|P1|Overall Study|Lost to Follow-up|1
212010|NCT01931839|688649|P7|Overall Study|Other non-compliance|0
212011|NCT01931839|688650|P6|Overall Study|Other non-compliance|3
212012|NCT01931839|688651|P5|Overall Study|Other non-compliance|0
212013|NCT01931839|688652|P4|Overall Study|Other non-compliance|3
212014|NCT01931839|688653|P3|Overall Study|Other non-compliance|12
212015|NCT01931839|688654|P2|Overall Study|Other non-compliance|9
212016|NCT01931839|688655|P1|Overall Study|Other non-compliance|15
212017|NCT01931839|688649|P7|Overall Study|Withdrawal of consent (not due to AE)|2
212018|NCT01931839|688650|P6|Overall Study|Withdrawal of consent (not due to AE)|2
212019|NCT01931839|688651|P5|Overall Study|Withdrawal of consent (not due to AE)|0
212020|NCT01931839|688652|P4|Overall Study|Withdrawal of consent (not due to AE)|3
212021|NCT01931839|688653|P3|Overall Study|Withdrawal of consent (not due to AE)|13
212022|NCT01931839|688654|P2|Overall Study|Withdrawal of consent (not due to AE)|8
212023|NCT01931839|688655|P1|Overall Study|Withdrawal of consent (not due to AE)|11
212024|NCT01931839|688649|P7|Overall Study|Adverse Event|1
212025|NCT01931839|688650|P6|Overall Study|Adverse Event|0
212026|NCT01931839|688651|P5|Overall Study|Adverse Event|0
212027|NCT01931839|688652|P4|Overall Study|Adverse Event|3
212028|NCT01931839|688653|P3|Overall Study|Adverse Event|1
212029|NCT01931839|688654|P2|Overall Study|Adverse Event|4
212030|NCT01931839|688655|P1|Overall Study|Adverse Event|9
212031|NCT01931839|688649|P7|Overall Study|Withdrawal of consent|0
212032|NCT01931839|688650|P6|Overall Study|Withdrawal of consent|0
212033|NCT01931839|688651|P5|Overall Study|Withdrawal of consent|1
212034|NCT01931839|688652|P4|Overall Study|Withdrawal of consent|0
212035|NCT01931839|688653|P3|Overall Study|Withdrawal of consent|0
212036|NCT01931839|688654|P2|Overall Study|Withdrawal of consent|0
212037|NCT01931839|688655|P1|Overall Study|Withdrawal of consent|0
212038|NCT01931839|688649|P7|Overall Study|Physician Decision|1
212039|NCT01931839|688650|P6|Overall Study|Physician Decision|0
212040|NCT01931839|688651|P5|Overall Study|Physician Decision|0
212041|NCT01931839|688652|P4|Overall Study|Physician Decision|0
212042|NCT01931839|688653|P3|Overall Study|Physician Decision|1
212043|NCT01931839|688654|P2|Overall Study|Physician Decision|0
212044|NCT01931839|688655|P1|Overall Study|Physician Decision|1
212045|NCT01931839|688649|P7|Overall Study|Death|0
212046|NCT01931839|688650|P6|Overall Study|Death|0
212047|NCT01931839|688651|P5|Overall Study|Death|0
212048|NCT01931839|688652|P4|Overall Study|Death|0
212049|NCT01931839|688653|P3|Overall Study|Death|2
212050|NCT01931839|688654|P2|Overall Study|Death|1
212051|NCT01931839|688655|P1|Overall Study|Death|0
212052|NCT01931475|688746|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
212053|NCT01931475|688747|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
212054|NCT01931475|688746|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
212055|NCT01931475|688747|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
212056|NCT01931475|688746|P2|Period 2: Extension Treatment Phase|Physician Decision|1
212057|NCT01931475|688747|P1|Period 2: Extension Treatment Phase|Physician Decision|1
212058|NCT01931475|688746|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
212059|NCT01931475|688747|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
212060|NCT01931475|688746|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
212061|NCT01931475|688747|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
212062|NCT01931475|688746|P2|Period 2: Extension Treatment Phase|Adverse Event|8
212063|NCT01931475|688747|P1|Period 2: Extension Treatment Phase|Adverse Event|0
212064|NCT01931475|688746|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
212065|NCT01931475|688747|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
212066|NCT01931475|688746|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
212067|NCT01931475|688747|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
212068|NCT01931475|688746|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
212069|NCT01931475|688747|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
212070|NCT01931475|688746|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
212071|NCT01931475|688747|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
212072|NCT01931475|688746|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
212073|NCT01931475|688747|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
212074|NCT01931397|688774|P1|Overall Study|moved out of state|1
212075|NCT01931397|688774|P1|Overall Study|Withdrawal by Subject|8
212076|NCT01931397|688774|P1|Overall Study|Physician Decision|2
212077|NCT01931150|688785|P2|Overall Study|Withdrawal by Subject|2
212078|NCT01931150|688786|P1|Overall Study|Withdrawal by Subject|1
212079|NCT01930890|688796|P4|Overall Study|Adverse Event|0
212080|NCT01930890|688797|P3|Overall Study|Adverse Event|0
212081|NCT01930890|688798|P2|Overall Study|Adverse Event|1
212082|NCT01930890|688799|P1|Overall Study|Adverse Event|0
212083|NCT01930890|688796|P4|Overall Study|Consent Withdrawn|1
212084|NCT01930890|688797|P3|Overall Study|Consent Withdrawn|0
212085|NCT01930890|688798|P2|Overall Study|Consent Withdrawn|3
212086|NCT01930890|688799|P1|Overall Study|Consent Withdrawn|0
212087|NCT01930890|688796|P4|Overall Study|Investigator Decision|0
212088|NCT01930890|688797|P3|Overall Study|Investigator Decision|0
212089|NCT01930890|688798|P2|Overall Study|Investigator Decision|1
212090|NCT01930890|688799|P1|Overall Study|Investigator Decision|0
212091|NCT01930890|688796|P4|Overall Study|Death|1
212092|NCT01930890|688797|P3|Overall Study|Death|0
212093|NCT01930890|688798|P2|Overall Study|Death|0
212094|NCT01930890|688799|P1|Overall Study|Death|0
212095|NCT01930890|688796|P4|Overall Study|Study Termination|25
212096|NCT01930890|688797|P3|Overall Study|Study Termination|13
212097|NCT01930890|688798|P2|Overall Study|Study Termination|28
212098|NCT01930890|688799|P1|Overall Study|Study Termination|14
212099|NCT01930799|688813|P1|Overall Study|Lost to Follow-up|5
212100|NCT01930799|688813|P1|Overall Study|Withdrawal by Subject|3
212101|NCT01930045|688948|P6|Pause (up to 37 Days)|Protocol Violation|1
212102|NCT01930045|688949|P5|Pause (up to 37 Days)|Protocol Violation|0
212103|NCT01930045|688950|P4|Pause (up to 37 Days)|Protocol Violation|0
212104|NCT01930045|688951|P3|Pause (up to 37 Days)|Protocol Violation|0
212105|NCT01930045|688952|P2|Pause (up to 37 Days)|Protocol Violation|0
212106|NCT01930045|688953|P1|Pause (up to 37 Days)|Protocol Violation|0
212107|NCT01930045|688948|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
212108|NCT01930045|688949|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
212109|NCT01930045|688950|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
212110|NCT01930045|688951|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
212111|NCT01930045|688952|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
212112|NCT01930045|688953|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
212113|NCT01929993|688980|P2|Overall Study|Absent CIN, invasion present or artifact|22
212114|NCT01929993|688981|P1|Overall Study|Absent CIN, invasion present or artifact|26
212115|NCT01929993|688980|P2|Overall Study|Protocol Violation|6
212116|NCT01929993|688981|P1|Overall Study|Protocol Violation|4
212117|NCT01929980|688987|P1|Overall Study|Physician Decision|1
212118|NCT01929876|688995|P1|Period 2|Non-Compliance|1
212119|NCT01929317|689039|P2|Long-term Phase|Study Closed/Terminated|3
212120|NCT01929317|689040|P1|Long-term Phase|Study Closed/Terminated|5
212121|NCT01929317|689039|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
212122|NCT01929317|689040|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
212123|NCT01929317|689039|P2|Long-term Phase|Protocol Violation|0
212124|NCT01929317|689040|P1|Long-term Phase|Protocol Violation|1
212125|NCT01929317|689039|P2|Long-term Phase|Withdrawal by Subject|0
212126|NCT01929317|689040|P1|Long-term Phase|Withdrawal by Subject|4
212127|NCT01929317|689039|P2|Long-term Phase|Physician Decision|0
212128|NCT01929317|689040|P1|Long-term Phase|Physician Decision|3
212129|NCT01929317|689039|P2|Long-term Phase|Adverse Event|1
212130|NCT01929317|689040|P1|Long-term Phase|Adverse Event|5
212131|NCT01929317|689039|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
212132|NCT01929317|689040|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
212133|NCT01929317|689039|P2|Dose Increase Effect Verification Phase|Physician Decision|0
212134|NCT01929317|689040|P1|Dose Increase Effect Verification Phase|Physician Decision|1
212135|NCT01929317|689039|P2|Dose Increase Effect Verification Phase|Adverse Event|1
212136|NCT01929317|689040|P1|Dose Increase Effect Verification Phase|Adverse Event|5
212137|NCT01929135|689109|P2|Overall Study|Lost to Follow-up|1
212138|NCT01929135|689110|P1|Overall Study|Lost to Follow-up|1
212139|NCT01929083|689124|P2|Intervention 2|Adverse Event|1
212140|NCT01929083|689125|P1|Intervention 2|Adverse Event|0
212141|NCT01929083|689124|P2|Intervention 1|Nonadherent to study medications|0
212142|NCT01929083|689125|P1|Intervention 1|Nonadherent to study medications|1
212143|NCT01929083|689124|P2|Intervention 1|Lost to Follow-up|0
212144|NCT01929083|689125|P1|Intervention 1|Lost to Follow-up|2
212145|NCT01929044|689151|P2|Overall Study|Not Treated|3
212146|NCT01929044|689152|P1|Overall Study|Not Treated|1
212147|NCT01929044|689151|P2|Overall Study|Protocol Violation|14
212148|NCT01929044|689152|P1|Overall Study|Protocol Violation|9
212149|NCT01929044|689151|P2|Overall Study|Adverse Event|0
212150|NCT01929044|689152|P1|Overall Study|Adverse Event|1
212151|NCT01929031|689174|P6|Overall Study|Reason other than specified above|0
212152|NCT01929031|689175|P5|Overall Study|Reason other than specified above|1
212153|NCT01929031|689176|P4|Overall Study|Reason other than specified above|0
212154|NCT01929031|689177|P3|Overall Study|Reason other than specified above|0
212155|NCT01929031|689178|P2|Overall Study|Reason other than specified above|1
212156|NCT01929031|689179|P1|Overall Study|Reason other than specified above|0
212157|NCT01929031|689174|P6|Overall Study|Protocol Violation|1
212158|NCT01929031|689175|P5|Overall Study|Protocol Violation|0
212159|NCT01929031|689176|P4|Overall Study|Protocol Violation|0
212160|NCT01929031|689177|P3|Overall Study|Protocol Violation|0
212161|NCT01929031|689178|P2|Overall Study|Protocol Violation|0
212162|NCT01929031|689179|P1|Overall Study|Protocol Violation|1
212163|NCT01929031|689174|P6|Overall Study|Adverse Event|0
212164|NCT01929031|689175|P5|Overall Study|Adverse Event|0
212165|NCT01929031|689176|P4|Overall Study|Adverse Event|0
212166|NCT01929031|689177|P3|Overall Study|Adverse Event|1
212167|NCT01929031|689178|P2|Overall Study|Adverse Event|1
212168|NCT01929031|689179|P1|Overall Study|Adverse Event|3
212169|NCT01928940|689203|P2|Overall Study|Adverse Event|1
212170|NCT01928940|689204|P1|Overall Study|Adverse Event|0
212171|NCT01928927|689247|P2|Overall Study|Withdrawal by Subject|1
212172|NCT01928927|689248|P1|Overall Study|Withdrawal by Subject|1
212173|NCT01928927|689247|P2|Overall Study|Lost to Follow-up|0
212174|NCT01928927|689248|P1|Overall Study|Lost to Follow-up|1
212175|NCT01928771|689259|P3|Overall Study|Severe Non-Compliance to Protocol|2
212176|NCT01928771|689260|P2|Overall Study|Severe Non-Compliance to Protocol|2
212177|NCT01928771|689261|P1|Overall Study|Severe Non-Compliance to Protocol|4
212178|NCT01928771|689259|P3|Overall Study|Other Reasons|14
212179|NCT01928771|689260|P2|Overall Study|Other Reasons|9
212180|NCT01928771|689261|P1|Overall Study|Other Reasons|9
212181|NCT01928771|689259|P3|Overall Study|Study-Specific Withdrawal Criteria|1
212182|NCT01928771|689260|P2|Overall Study|Study-Specific Withdrawal Criteria|1
212183|NCT01928771|689261|P1|Overall Study|Study-Specific Withdrawal Criteria|0
212184|NCT01928771|689259|P3|Overall Study|Withdrawal by Subject|17
212185|NCT01928771|689260|P2|Overall Study|Withdrawal by Subject|15
212186|NCT01928771|689261|P1|Overall Study|Withdrawal by Subject|20
212187|NCT01928771|689259|P3|Overall Study|Lost to Follow-up|3
212188|NCT01928771|689260|P2|Overall Study|Lost to Follow-up|6
212189|NCT01928771|689261|P1|Overall Study|Lost to Follow-up|5
212190|NCT01928771|689259|P3|Overall Study|Death|2
212191|NCT01928771|689260|P2|Overall Study|Death|2
212192|NCT01928771|689261|P1|Overall Study|Death|2
212193|NCT01928771|689259|P3|Overall Study|Adverse Event|1
212194|NCT01928771|689260|P2|Overall Study|Adverse Event|5
212195|NCT01928771|689261|P1|Overall Study|Adverse Event|6
212196|NCT01928615|689373|P1|Overall Study|Study Terminated by Sponsor|2
212197|NCT01928472|689392|P4|Overall Study|Unclassified|0
212198|NCT01928472|689393|P3|Overall Study|Unclassified|1
212199|NCT01928472|689394|P2|Overall Study|Unclassified|0
212200|NCT01928472|689395|P1|Overall Study|Unclassified|0
212201|NCT01928472|689392|P4|Overall Study|Administrative Reason|0
212202|NCT01928472|689393|P3|Overall Study|Administrative Reason|0
212203|NCT01928472|689394|P2|Overall Study|Administrative Reason|1
212204|NCT01928472|689395|P1|Overall Study|Administrative Reason|2
212205|NCT01928472|689392|P4|Overall Study|Lost to Follow-up|0
212206|NCT01928472|689393|P3|Overall Study|Lost to Follow-up|4
212207|NCT01928472|689394|P2|Overall Study|Lost to Follow-up|3
212208|NCT01928472|689395|P1|Overall Study|Lost to Follow-up|2
212209|NCT01928472|689392|P4|Overall Study|Withdrawal by Subject|2
212210|NCT01928472|689393|P3|Overall Study|Withdrawal by Subject|1
212211|NCT01928472|689394|P2|Overall Study|Withdrawal by Subject|4
212212|NCT01928472|689395|P1|Overall Study|Withdrawal by Subject|4
212213|NCT01928472|689392|P4|Overall Study|Death|0
212214|NCT01928472|689393|P3|Overall Study|Death|1
212215|NCT01928472|689394|P2|Overall Study|Death|0
212216|NCT01928472|689395|P1|Overall Study|Death|0
212217|NCT01928381|689462|P7|Part 2 - Post Third Intervention|Protocol Violation|0
212218|NCT01928381|689463|P6|Part 2 - Post Third Intervention|Protocol Violation|0
212219|NCT01928381|689464|P5|Part 2 - Post Third Intervention|Protocol Violation|0
212220|NCT01928381|689465|P4|Part 2 - Post Third Intervention|Protocol Violation|0
212221|NCT01928381|689466|P3|Part 2 - Post Third Intervention|Protocol Violation|1
212222|NCT01928381|689467|P2|Part 2 - Post Third Intervention|Protocol Violation|0
212223|NCT01928381|689468|P1|Part 2 - Post Third Intervention|Protocol Violation|0
212224|NCT01928381|689462|P7|Part 2 - Second Intervention|Lost to Follow-up|0
212225|NCT01928381|689463|P6|Part 2 - Second Intervention|Lost to Follow-up|0
212226|NCT01928381|689464|P5|Part 2 - Second Intervention|Lost to Follow-up|0
212227|NCT01928381|689465|P4|Part 2 - Second Intervention|Lost to Follow-up|1
212228|NCT01928381|689466|P3|Part 2 - Second Intervention|Lost to Follow-up|0
212229|NCT01928381|689467|P2|Part 2 - Second Intervention|Lost to Follow-up|1
212230|NCT01928381|689468|P1|Part 2 - Second Intervention|Lost to Follow-up|0
212231|NCT01928381|689462|P7|Washout First Intervention|Protocol Violation|0
212232|NCT01928381|689463|P6|Washout First Intervention|Protocol Violation|0
212233|NCT01928381|689464|P5|Washout First Intervention|Protocol Violation|1
212234|NCT01928381|689465|P4|Washout First Intervention|Protocol Violation|0
212235|NCT01928381|689466|P3|Washout First Intervention|Protocol Violation|0
212236|NCT01928381|689467|P2|Washout First Intervention|Protocol Violation|0
212310|NCT01928381|689464|P5|Part 1 - Pain Training|Withdrawal by Subject|0
212237|NCT01928381|689468|P1|Washout First Intervention|Protocol Violation|0
212238|NCT01928381|689462|P7|Part 2 - First Intervention|Lost to Follow-up|0
212239|NCT01928381|689463|P6|Part 2 - First Intervention|Lost to Follow-up|0
212240|NCT01928381|689464|P5|Part 2 - First Intervention|Lost to Follow-up|0
212241|NCT01928381|689465|P4|Part 2 - First Intervention|Lost to Follow-up|1
212242|NCT01928381|689466|P3|Part 2 - First Intervention|Lost to Follow-up|0
212243|NCT01928381|689467|P2|Part 2 - First Intervention|Lost to Follow-up|0
212244|NCT01928381|689468|P1|Part 2 - First Intervention|Lost to Follow-up|0
212245|NCT01928381|689462|P7|Part 2 - First Intervention|Eligibility criterion not met|1
212405|NCT01926782|689569|P6|Overall Study|Adverse Event|14
212246|NCT01928381|689463|P6|Part 2 - First Intervention|Eligibility criterion not met|1
212247|NCT01928381|689464|P5|Part 2 - First Intervention|Eligibility criterion not met|0
212248|NCT01928381|689465|P4|Part 2 - First Intervention|Eligibility criterion not met|0
212249|NCT01928381|689466|P3|Part 2 - First Intervention|Eligibility criterion not met|0
212250|NCT01928381|689467|P2|Part 2 - First Intervention|Eligibility criterion not met|0
212251|NCT01928381|689468|P1|Part 2 - First Intervention|Eligibility criterion not met|0
212252|NCT01928381|689462|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
212253|NCT01928381|689463|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
212254|NCT01928381|689464|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
212255|NCT01928381|689465|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
212256|NCT01928381|689466|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
212257|NCT01928381|689467|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
212258|NCT01928381|689468|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
212259|NCT01928381|689462|P7|Part 2 - First Intervention|Withdrawal by Subject|0
212260|NCT01928381|689463|P6|Part 2 - First Intervention|Withdrawal by Subject|0
212261|NCT01928381|689464|P5|Part 2 - First Intervention|Withdrawal by Subject|0
212262|NCT01928381|689465|P4|Part 2 - First Intervention|Withdrawal by Subject|0
212263|NCT01928381|689466|P3|Part 2 - First Intervention|Withdrawal by Subject|1
212264|NCT01928381|689467|P2|Part 2 - First Intervention|Withdrawal by Subject|0
212265|NCT01928381|689468|P1|Part 2 - First Intervention|Withdrawal by Subject|0
212266|NCT01928381|689462|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
212267|NCT01928381|689463|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
212268|NCT01928381|689464|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
212269|NCT01928381|689465|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
212270|NCT01928381|689466|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
212271|NCT01928381|689467|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
212272|NCT01928381|689468|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
212273|NCT01928381|689462|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
212274|NCT01928381|689463|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
212275|NCT01928381|689464|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
212276|NCT01928381|689465|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
212277|NCT01928381|689466|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
212278|NCT01928381|689467|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
212279|NCT01928381|689468|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
212280|NCT01928381|689462|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
212281|NCT01928381|689463|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
212282|NCT01928381|689464|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
212283|NCT01928381|689465|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
212284|NCT01928381|689466|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
212285|NCT01928381|689467|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
212286|NCT01928381|689468|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
212287|NCT01928381|689462|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
212288|NCT01928381|689463|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
212289|NCT01928381|689464|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
212290|NCT01928381|689465|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
212291|NCT01928381|689466|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
212292|NCT01928381|689467|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
212293|NCT01928381|689468|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
212294|NCT01928381|689462|P7|Part 1 - Pain Training|Protocol Violation|0
212295|NCT01928381|689463|P6|Part 1 - Pain Training|Protocol Violation|0
212296|NCT01928381|689464|P5|Part 1 - Pain Training|Protocol Violation|0
212297|NCT01928381|689465|P4|Part 1 - Pain Training|Protocol Violation|0
212298|NCT01928381|689466|P3|Part 1 - Pain Training|Protocol Violation|0
212299|NCT01928381|689467|P2|Part 1 - Pain Training|Protocol Violation|0
212300|NCT01928381|689468|P1|Part 1 - Pain Training|Protocol Violation|1
212301|NCT01928381|689462|P7|Part 1 - Pain Training|Lost to Follow-up|0
212302|NCT01928381|689463|P6|Part 1 - Pain Training|Lost to Follow-up|0
212303|NCT01928381|689464|P5|Part 1 - Pain Training|Lost to Follow-up|0
212304|NCT01928381|689465|P4|Part 1 - Pain Training|Lost to Follow-up|0
212305|NCT01928381|689466|P3|Part 1 - Pain Training|Lost to Follow-up|0
212306|NCT01928381|689467|P2|Part 1 - Pain Training|Lost to Follow-up|0
212307|NCT01928381|689468|P1|Part 1 - Pain Training|Lost to Follow-up|4
212308|NCT01928381|689462|P7|Part 1 - Pain Training|Withdrawal by Subject|0
212309|NCT01928381|689463|P6|Part 1 - Pain Training|Withdrawal by Subject|0
212311|NCT01928381|689465|P4|Part 1 - Pain Training|Withdrawal by Subject|0
212312|NCT01928381|689466|P3|Part 1 - Pain Training|Withdrawal by Subject|0
212313|NCT01928381|689467|P2|Part 1 - Pain Training|Withdrawal by Subject|0
212314|NCT01928381|689468|P1|Part 1 - Pain Training|Withdrawal by Subject|1
212315|NCT01928381|689462|P7|Part 1 - Pain Training|Pain training criteria not met|0
212316|NCT01928381|689463|P6|Part 1 - Pain Training|Pain training criteria not met|0
212317|NCT01928381|689464|P5|Part 1 - Pain Training|Pain training criteria not met|0
212318|NCT01928381|689465|P4|Part 1 - Pain Training|Pain training criteria not met|0
212319|NCT01928381|689466|P3|Part 1 - Pain Training|Pain training criteria not met|0
212320|NCT01928381|689467|P2|Part 1 - Pain Training|Pain training criteria not met|0
212321|NCT01928381|689468|P1|Part 1 - Pain Training|Pain training criteria not met|29
212322|NCT01928381|689462|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
212323|NCT01928381|689463|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
212324|NCT01928381|689464|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
212325|NCT01928381|689465|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
212326|NCT01928381|689466|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
212327|NCT01928381|689467|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
212328|NCT01928381|689468|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
212329|NCT01927757|689495|P1|Overall Study|Ethical Reasons|4
212330|NCT01927757|689495|P1|Overall Study|Other|1
212331|NCT01927757|689495|P1|Overall Study|Decision by Sponsor|2
212332|NCT01927757|689495|P1|Overall Study|Lost to Follow-up|2
212333|NCT01927757|689495|P1|Overall Study|Withdrawal by Subject|14
212334|NCT01927419|689523|P2|Overall Study|Not reported|0
212335|NCT01927419|689524|P1|Overall Study|Not reported|1
212336|NCT01927419|689523|P2|Overall Study|Not specified|1
212337|NCT01927419|689524|P1|Overall Study|Not specified|2
212338|NCT01927419|689523|P2|Overall Study|Withdrawal by Subject|1
212339|NCT01927419|689524|P1|Overall Study|Withdrawal by Subject|3
212340|NCT01927419|689523|P2|Overall Study|Adverse event unrelated to study drug|1
212341|NCT01927419|689524|P1|Overall Study|Adverse event unrelated to study drug|6
212342|NCT01927419|689523|P2|Overall Study|Death|1
212343|NCT01927419|689524|P1|Overall Study|Death|0
212344|NCT01927419|689523|P2|Overall Study|Study drug toxicity|7
212345|NCT01927419|689524|P1|Overall Study|Study drug toxicity|43
212346|NCT01927419|689523|P2|Overall Study|Disease progression|17
212347|NCT01927419|689524|P1|Overall Study|Disease progression|15
212348|NCT01927055|689543|P3|Double-Blind|Extended Vacation|0
212349|NCT01927055|689544|P2|Double-Blind|Extended Vacation|1
212350|NCT01927055|689545|P1|Double-Blind|Extended Vacation|0
212351|NCT01927055|689543|P3|Double-Blind|Supine Hypertension|1
212352|NCT01927055|689544|P2|Double-Blind|Supine Hypertension|0
212353|NCT01927055|689545|P1|Double-Blind|Supine Hypertension|0
212354|NCT01927055|689543|P3|Double-Blind|Study Stopped|7
212355|NCT01927055|689544|P2|Double-Blind|Study Stopped|7
212356|NCT01927055|689545|P1|Double-Blind|Study Stopped|0
212357|NCT01927055|689543|P3|Double-Blind|Withdrawal by Subject|3
212358|NCT01927055|689544|P2|Double-Blind|Withdrawal by Subject|2
212359|NCT01927055|689545|P1|Double-Blind|Withdrawal by Subject|0
212360|NCT01927055|689543|P3|Double-Blind|Protocol Violation|1
212361|NCT01927055|689544|P2|Double-Blind|Protocol Violation|0
212362|NCT01927055|689545|P1|Double-Blind|Protocol Violation|0
212363|NCT01927055|689543|P3|Double-Blind|Adverse Event|1
212364|NCT01927055|689544|P2|Double-Blind|Adverse Event|1
212365|NCT01927055|689545|P1|Double-Blind|Adverse Event|0
212366|NCT01927055|689543|P3|Open-label|Difficulty attending study visits|0
212367|NCT01927055|689544|P2|Open-label|Difficulty attending study visits|0
212368|NCT01927055|689545|P1|Open-label|Difficulty attending study visits|1
212369|NCT01927055|689543|P3|Open-label|Supine Hypertension|0
212370|NCT01927055|689544|P2|Open-label|Supine Hypertension|0
212371|NCT01927055|689545|P1|Open-label|Supine Hypertension|4
212372|NCT01927055|689543|P3|Open-label|Study Stopped|0
212373|NCT01927055|689544|P2|Open-label|Study Stopped|0
212374|NCT01927055|689545|P1|Open-label|Study Stopped|4
212375|NCT01927055|689543|P3|Open-label|Withdrawal by Subject|0
212376|NCT01927055|689544|P2|Open-label|Withdrawal by Subject|0
212377|NCT01927055|689545|P1|Open-label|Withdrawal by Subject|1
212378|NCT01927055|689543|P3|Open-label|Adverse Event|0
212379|NCT01927055|689544|P2|Open-label|Adverse Event|0
212380|NCT01927055|689545|P1|Open-label|Adverse Event|6
212381|NCT01926782|689569|P6|Overall Study|Related to study drug administration|2
212382|NCT01926782|689570|P5|Overall Study|Related to study drug administration|0
212383|NCT01926782|689571|P4|Overall Study|Related to study drug administration|0
212384|NCT01926782|689572|P3|Overall Study|Related to study drug administration|0
212385|NCT01926782|689573|P2|Overall Study|Related to study drug administration|0
212386|NCT01926782|689574|P1|Overall Study|Related to study drug administration|0
212387|NCT01926782|689569|P6|Overall Study|Withdrawal by Subject|5
212388|NCT01926782|689570|P5|Overall Study|Withdrawal by Subject|0
212389|NCT01926782|689571|P4|Overall Study|Withdrawal by Subject|1
212390|NCT01926782|689572|P3|Overall Study|Withdrawal by Subject|8
212391|NCT01926782|689573|P2|Overall Study|Withdrawal by Subject|1
212392|NCT01926782|689574|P1|Overall Study|Withdrawal by Subject|6
212393|NCT01926782|689569|P6|Overall Study|Randomized and not treated|0
212394|NCT01926782|689570|P5|Overall Study|Randomized and not treated|0
212395|NCT01926782|689571|P4|Overall Study|Randomized and not treated|1
212396|NCT01926782|689572|P3|Overall Study|Randomized and not treated|0
212397|NCT01926782|689573|P2|Overall Study|Randomized and not treated|0
212398|NCT01926782|689574|P1|Overall Study|Randomized and not treated|0
212399|NCT01926782|689569|P6|Overall Study|Poor compliance to protocol|6
212400|NCT01926782|689570|P5|Overall Study|Poor compliance to protocol|1
212401|NCT01926782|689571|P4|Overall Study|Poor compliance to protocol|0
212402|NCT01926782|689572|P3|Overall Study|Poor compliance to protocol|8
212403|NCT01926782|689573|P2|Overall Study|Poor compliance to protocol|3
212404|NCT01926782|689574|P1|Overall Study|Poor compliance to protocol|5
212406|NCT01926782|689570|P5|Overall Study|Adverse Event|3
212407|NCT01926782|689571|P4|Overall Study|Adverse Event|4
212408|NCT01926782|689572|P3|Overall Study|Adverse Event|17
212409|NCT01926782|689573|P2|Overall Study|Adverse Event|4
212410|NCT01926782|689574|P1|Overall Study|Adverse Event|13
212411|NCT01926782|689569|P6|Overall Study|Other than specified|11
212412|NCT01926782|689570|P5|Overall Study|Other than specified|4
212413|NCT01926782|689571|P4|Overall Study|Other than specified|12
212414|NCT01926782|689572|P3|Overall Study|Other than specified|5
212415|NCT01926782|689573|P2|Overall Study|Other than specified|3
212416|NCT01926782|689574|P1|Overall Study|Other than specified|2
212417|NCT01926782|689569|P6|Overall Study|Physician Decision|0
212418|NCT01926782|689570|P5|Overall Study|Physician Decision|0
212419|NCT01926782|689571|P4|Overall Study|Physician Decision|1
212420|NCT01926782|689572|P3|Overall Study|Physician Decision|1
212421|NCT01926782|689573|P2|Overall Study|Physician Decision|2
212422|NCT01926782|689574|P1|Overall Study|Physician Decision|0
212423|NCT01926782|689569|P6|Overall Study|Participant moved|3
212424|NCT01926782|689570|P5|Overall Study|Participant moved|0
212425|NCT01926782|689571|P4|Overall Study|Participant moved|1
212426|NCT01926782|689572|P3|Overall Study|Participant moved|1
212427|NCT01926782|689573|P2|Overall Study|Participant moved|0
212428|NCT01926782|689574|P1|Overall Study|Participant moved|2
212429|NCT01926626|689723|P1|Overall Study|Lost to Follow-up|7
212430|NCT01926626|689723|P1|Overall Study|Withdrawal by Subject|15
212431|NCT01926119|689733|P1|Overall Study|Withdrawal by Subject|1
212432|NCT01926015|689745|P2|Overall Study|Randomized not treated|0
212433|NCT01926015|689746|P1|Overall Study|Randomized not treated|2
212434|NCT01926015|689745|P2|Overall Study|Withdrawal by parent/guardian|1
212435|NCT01926015|689746|P1|Overall Study|Withdrawal by parent/guardian|0
212436|NCT01925768|689789|P2|Overall Study|Non-compliance with study drug|1
212437|NCT01925768|689790|P1|Overall Study|Non-compliance with study drug|0
212438|NCT01925768|689789|P2|Overall Study|Withdrawal by Subject|4
212439|NCT01925768|689790|P1|Overall Study|Withdrawal by Subject|1
212440|NCT01925768|689789|P2|Overall Study|Lack of Efficacy|6
212441|NCT01925768|689790|P1|Overall Study|Lack of Efficacy|3
212442|NCT01925768|689789|P2|Overall Study|Adverse Event|10
212443|NCT01925768|689790|P1|Overall Study|Adverse Event|5
212444|NCT01925768|689789|P2|Overall Study|Protocol Violation|2
212445|NCT01925768|689790|P1|Overall Study|Protocol Violation|1
212446|NCT01925768|689789|P2|Overall Study|Lost to Follow-up|0
212447|NCT01925768|689790|P1|Overall Study|Lost to Follow-up|1
212448|NCT01925703|689798|P1|Overall Study|Discharge prior to full iron repletion|1
212449|NCT01925703|689798|P1|Overall Study|Lost to Follow-up|2
212450|NCT01925703|689798|P1|Overall Study|Physician Decision|1
212451|NCT01925417|689817|P1|Overall Study|Death|1
212452|NCT01925417|689817|P1|Overall Study|Withdrawal by Subject|2
212453|NCT01925274|689827|P3|Overall Study|Protocol amendment|6
212454|NCT01925274|689828|P2|Overall Study|Protocol amendment|3
212455|NCT01925274|689829|P1|Overall Study|Protocol amendment|1
212456|NCT01925274|689827|P3|Overall Study|Study terminated by sponsor|0
212457|NCT01925274|689828|P2|Overall Study|Study terminated by sponsor|0
212458|NCT01925274|689829|P1|Overall Study|Study terminated by sponsor|4
212459|NCT01925274|689827|P3|Overall Study|Withdrawal by Subject|0
212460|NCT01925274|689828|P2|Overall Study|Withdrawal by Subject|2
212461|NCT01925274|689829|P1|Overall Study|Withdrawal by Subject|1
212462|NCT01925274|689827|P3|Overall Study|Lost to Follow-up|0
212463|NCT01925274|689828|P2|Overall Study|Lost to Follow-up|1
212464|NCT01925274|689829|P1|Overall Study|Lost to Follow-up|0
212465|NCT01925274|689827|P3|Overall Study|Death|0
212466|NCT01925274|689828|P2|Overall Study|Death|0
212467|NCT01925274|689829|P1|Overall Study|Death|1
212468|NCT01925209|689910|P4|Follow-up|Withdrawal by Subject|2
212469|NCT01925209|689911|P3|Follow-up|Withdrawal by Subject|0
212470|NCT01925209|689912|P2|Follow-up|Withdrawal by Subject|2
212471|NCT01925209|689913|P1|Follow-up|Withdrawal by Subject|0
212472|NCT01925209|689910|P4|Follow-up|Non-compliance with study treatment|1
212473|NCT01925209|689911|P3|Follow-up|Non-compliance with study treatment|0
212474|NCT01925209|689912|P2|Follow-up|Non-compliance with study treatment|0
212475|NCT01925209|689913|P1|Follow-up|Non-compliance with study treatment|0
212476|NCT01925209|689910|P4|Follow-up|Physician Decision|0
212477|NCT01925209|689911|P3|Follow-up|Physician Decision|1
212478|NCT01925209|689912|P2|Follow-up|Physician Decision|0
212479|NCT01925209|689913|P1|Follow-up|Physician Decision|0
212480|NCT01925209|689910|P4|Follow-up|Adverse Event|1
212481|NCT01925209|689911|P3|Follow-up|Adverse Event|0
212482|NCT01925209|689912|P2|Follow-up|Adverse Event|4
212483|NCT01925209|689913|P1|Follow-up|Adverse Event|1
212484|NCT01925209|689910|P4|Maintenance Treatment Epoch|Adverse Event|0
212485|NCT01925209|689911|P3|Maintenance Treatment Epoch|Adverse Event|1
212486|NCT01925209|689912|P2|Maintenance Treatment Epoch|Adverse Event|0
212487|NCT01925209|689913|P1|Maintenance Treatment Epoch|Adverse Event|0
212488|NCT01925209|689910|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
212489|NCT01925209|689911|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
212490|NCT01925209|689912|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
212491|NCT01925209|689913|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
212492|NCT01925209|689910|P4|Treatment Epoch|Adverse Event|1
212493|NCT01925209|689911|P3|Treatment Epoch|Adverse Event|3
212494|NCT01925209|689912|P2|Treatment Epoch|Adverse Event|5
212495|NCT01925209|689913|P1|Treatment Epoch|Adverse Event|3
212496|NCT01925209|689910|P4|Treatment Epoch|Withdrawal by Subject|2
212497|NCT01925209|689911|P3|Treatment Epoch|Withdrawal by Subject|3
212498|NCT01925209|689912|P2|Treatment Epoch|Withdrawal by Subject|3
212499|NCT01925209|689913|P1|Treatment Epoch|Withdrawal by Subject|4
212500|NCT01925209|689910|P4|Treatment Epoch|Protocol deviation|1
212501|NCT01925209|689911|P3|Treatment Epoch|Protocol deviation|1
212502|NCT01925209|689912|P2|Treatment Epoch|Protocol deviation|0
212503|NCT01925209|689913|P1|Treatment Epoch|Protocol deviation|0
212504|NCT01925209|689910|P4|Treatment Epoch|Death|0
212505|NCT01925209|689911|P3|Treatment Epoch|Death|0
212506|NCT01925209|689912|P2|Treatment Epoch|Death|0
212507|NCT01925209|689913|P1|Treatment Epoch|Death|1
212508|NCT01925209|689910|P4|Treatment Epoch|Non-compliance with study treatment|1
212509|NCT01925209|689911|P3|Treatment Epoch|Non-compliance with study treatment|0
212510|NCT01925209|689912|P2|Treatment Epoch|Non-compliance with study treatment|0
212511|NCT01925209|689913|P1|Treatment Epoch|Non-compliance with study treatment|0
212512|NCT01925209|689910|P4|Treatment Epoch|Physician Decision|0
212513|NCT01925209|689911|P3|Treatment Epoch|Physician Decision|0
212514|NCT01925209|689912|P2|Treatment Epoch|Physician Decision|0
212515|NCT01925209|689913|P1|Treatment Epoch|Physician Decision|1
212516|NCT01925183|689945|P2|Overall Study|Adverse Event|0
212517|NCT01925183|689946|P1|Overall Study|Adverse Event|1
212518|NCT01925170|689954|P1|Overall Study|Unverified cancer status|53
212519|NCT01924767|690015|P5|Overall Study|Adverse Event|0
212520|NCT01924767|690016|P4|Overall Study|Adverse Event|0
212521|NCT01924767|690017|P3|Overall Study|Adverse Event|1
212522|NCT01924767|690018|P2|Overall Study|Adverse Event|0
212523|NCT01924767|690019|P1|Overall Study|Adverse Event|1
212524|NCT01924299|690148|P2|Period 2|Adverse Event|1
212525|NCT01924299|690149|P1|Period 2|Adverse Event|0
212526|NCT01924299|690148|P2|Period 2|Withdrawal by Subject|0
212527|NCT01924299|690149|P1|Period 2|Withdrawal by Subject|1
212528|NCT01924182|690171|P2|Overall Study|Withdrawal by Subject|0
212529|NCT01924182|690172|P1|Overall Study|Withdrawal by Subject|1
212530|NCT01923896|690180|P2|Overall Study|Adverse Event|0
212531|NCT01923896|690181|P1|Overall Study|Adverse Event|1
212532|NCT01923467|690365|P1|Overall Study|Subject non-interest|479
212533|NCT01923467|690365|P1|Overall Study|Lost to Follow-up|62
212534|NCT01923389|690371|P2|Overall Study|Protocol Violation|0
212535|NCT01923389|690372|P1|Overall Study|Protocol Violation|1
212536|NCT01922739|690409|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
212537|NCT01922739|690409|P1|Open-label Treatment Period|Physician Decision|1
212538|NCT01922739|690409|P1|Open-label Treatment Period|Lost to Follow-up|2
212539|NCT01922739|690409|P1|Open-label Treatment Period|Noncompliance to study procedures|1
212540|NCT01922739|690409|P1|Open-label Treatment Period|Pregnancy|1
212541|NCT01922739|690409|P1|Open-label Treatment Period|Protocol Violation|5
212542|NCT01922739|690409|P1|Open-label Treatment Period|Noncompliance to study medication|3
212543|NCT01922739|690409|P1|Open-label Treatment Period|Withdrawal by Subject|14
212544|NCT01922739|690409|P1|Open-label Treatment Period|Adverse Event|6
212545|NCT01922739|690409|P1|Titration/Adjustment Period|Lack of Efficacy|3
212546|NCT01922739|690409|P1|Titration/Adjustment Period|Lost to Follow-up|1
212547|NCT01922739|690409|P1|Titration/Adjustment Period|Withdrawal by Subject|5
212548|NCT01922739|690409|P1|Titration/Adjustment Period|Adverse Event|3
212549|NCT01922349|690446|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
212550|NCT01922349|690447|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
212551|NCT01922349|690448|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
212552|NCT01922349|690449|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
212553|NCT01922271|690556|P2|WASHOUT Period|Withdrawal by Subject|0
212554|NCT01922271|690557|P1|WASHOUT Period|Withdrawal by Subject|1
212555|NCT01922089|690596|P2|Overall Study|Lost to Follow-up|1
212556|NCT01922089|690597|P1|Overall Study|Lost to Follow-up|0
212557|NCT01922089|690596|P2|Overall Study|Death|1
212558|NCT01922089|690597|P1|Overall Study|Death|2
212559|NCT01922089|690596|P2|Overall Study|Physician Decision|3
212560|NCT01922089|690597|P1|Overall Study|Physician Decision|2
212561|NCT01922089|690596|P2|Overall Study|administrative problems|1
212562|NCT01922089|690597|P1|Overall Study|administrative problems|4
212563|NCT01922089|690596|P2|Overall Study|Withdrawal by Subject|4
212564|NCT01922089|690597|P1|Overall Study|Withdrawal by Subject|3
212565|NCT01922089|690596|P2|Overall Study|Protocol Deviation|7
212566|NCT01922089|690597|P1|Overall Study|Protocol Deviation|10
212567|NCT01922089|690596|P2|Overall Study|Adverse Event|13
212568|NCT01922089|690597|P1|Overall Study|Adverse Event|18
212569|NCT01921101|690639|P2|Overall Study|Death|6
212570|NCT01921101|690640|P1|Overall Study|Death|16
212571|NCT01920958|690648|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
212572|NCT01920893|690666|P2|Overall Study|Lack of Efficacy|0
212573|NCT01920893|690667|P1|Overall Study|Lack of Efficacy|2
212574|NCT01920893|690666|P2|Overall Study|Adverse Event|2
212575|NCT01920893|690667|P1|Overall Study|Adverse Event|5
212576|NCT01920854|690700|P7|Overall Study|Withdrawal by Subject|1
212577|NCT01920854|690701|P6|Overall Study|Withdrawal by Subject|0
212578|NCT01920854|690702|P5|Overall Study|Withdrawal by Subject|1
212579|NCT01920854|690703|P4|Overall Study|Withdrawal by Subject|0
212580|NCT01920854|690704|P3|Overall Study|Withdrawal by Subject|0
212581|NCT01920854|690705|P2|Overall Study|Withdrawal by Subject|0
212582|NCT01920854|690706|P1|Overall Study|Withdrawal by Subject|1
212583|NCT01920568|690866|P2|Overall Study|Death due to disease progression|12
212584|NCT01920568|690867|P1|Overall Study|Death due to disease progression|25
212585|NCT01920568|690866|P2|Overall Study|Withdrawal by Subject|55
212586|NCT01920568|690867|P1|Overall Study|Withdrawal by Subject|79
212587|NCT01920568|690866|P2|Overall Study|Physician Decision|4
212588|NCT01920568|690867|P1|Overall Study|Physician Decision|13
212589|NCT01920568|690866|P2|Overall Study|Lost to Follow-up|2
212590|NCT01920568|690867|P1|Overall Study|Lost to Follow-up|2
212591|NCT01920568|690866|P2|Overall Study|Protocol Violation|3
212592|NCT01920568|690867|P1|Overall Study|Protocol Violation|5
212593|NCT01920568|690866|P2|Overall Study|Adverse Event|8
212594|NCT01920568|690867|P1|Overall Study|Adverse Event|27
212595|NCT01920178|690906|P2|Overall Study|Lost to Follow-up|1
212596|NCT01920178|690907|P1|Overall Study|Lost to Follow-up|2
212597|NCT01919801|690925|P2|Overall Study|Unspecified|1
212598|NCT01919801|690926|P1|Overall Study|Unspecified|0
212599|NCT01919801|690925|P2|Overall Study|Lost to Follow-up|1
212600|NCT01919801|690926|P1|Overall Study|Lost to Follow-up|0
212601|NCT01919801|690925|P2|Overall Study|Physician Decision|1
212602|NCT01919801|690926|P1|Overall Study|Physician Decision|0
212603|NCT01919801|690925|P2|Overall Study|Withdrawal by Subject|0
212604|NCT01919801|690926|P1|Overall Study|Withdrawal by Subject|1
212605|NCT01919723|690952|P2|Overall Study|Blood Samples Hemolyzed|2
212606|NCT01919723|690953|P1|Overall Study|Blood Samples Hemolyzed|2
212607|NCT01919229|690996|P3|Overall Study|Subject/guardian decision|1
212608|NCT01919229|690997|P2|Overall Study|Subject/guardian decision|0
212609|NCT01919229|690998|P1|Overall Study|Subject/guardian decision|0
212610|NCT01918371|691050|P2|Overall Study|Missing Data|1
212611|NCT01918371|691051|P1|Overall Study|Missing Data|1
212612|NCT01918332|691129|P4|Overall Study|lipid result by central lab did not meet|0
212613|NCT01918332|691130|P3|Overall Study|lipid result by central lab did not meet|1
212614|NCT01918332|691131|P2|Overall Study|lipid result by central lab did not meet|0
212615|NCT01918332|691132|P1|Overall Study|lipid result by central lab did not meet|0
212616|NCT01918332|691129|P4|Overall Study|Protocol Violation|3
212617|NCT01918332|691130|P3|Overall Study|Protocol Violation|6
212618|NCT01918332|691131|P2|Overall Study|Protocol Violation|2
212619|NCT01918332|691132|P1|Overall Study|Protocol Violation|6
212620|NCT01918332|691129|P4|Overall Study|Withdrawal by Subject|3
212621|NCT01918332|691130|P3|Overall Study|Withdrawal by Subject|2
212622|NCT01918332|691131|P2|Overall Study|Withdrawal by Subject|3
212623|NCT01918332|691132|P1|Overall Study|Withdrawal by Subject|2
212624|NCT01918332|691129|P4|Overall Study|Adverse Event|1
212625|NCT01918332|691130|P3|Overall Study|Adverse Event|0
212626|NCT01918332|691131|P2|Overall Study|Adverse Event|0
212627|NCT01918332|691132|P1|Overall Study|Adverse Event|0
212628|NCT01918085|691144|P2|Test Period 1: Strata Strip|Adverse Event|1
212629|NCT01918085|691145|P1|Test Period 1: Strata Strip|Adverse Event|0
212630|NCT01918033|691156|P3|Overall Study|Withdrawal by Subject|0
212631|NCT01918033|691157|P2|Overall Study|Withdrawal by Subject|1
212632|NCT01918033|691158|P1|Overall Study|Withdrawal by Subject|2
212633|NCT01918033|691156|P3|Overall Study|Protocol Violation|1
212634|NCT01918033|691157|P2|Overall Study|Protocol Violation|0
212635|NCT01918033|691158|P1|Overall Study|Protocol Violation|2
212636|NCT01918033|691156|P3|Overall Study|Lost to Follow-up|0
212637|NCT01918033|691157|P2|Overall Study|Lost to Follow-up|1
212638|NCT01918033|691158|P1|Overall Study|Lost to Follow-up|0
212639|NCT01918033|691156|P3|Overall Study|Adverse Event|2
212640|NCT01918033|691157|P2|Overall Study|Adverse Event|0
212641|NCT01918033|691158|P1|Overall Study|Adverse Event|1
212642|NCT01917656|691229|P2|Overall Study|Lost to Follow-up|4
212643|NCT01917656|691230|P1|Overall Study|Lost to Follow-up|3
212644|NCT01917656|691229|P2|Overall Study|Withdrawal by Subject|3
212645|NCT01917656|691230|P1|Overall Study|Withdrawal by Subject|4
212646|NCT01917656|691229|P2|Overall Study|Unclassified|3
212647|NCT01917656|691230|P1|Overall Study|Unclassified|0
212648|NCT01917656|691229|P2|Overall Study|Withdrawal criteria|14
212649|NCT01917656|691230|P1|Overall Study|Withdrawal criteria|8
212650|NCT01917656|691229|P2|Overall Study|Adverse Event|0
212651|NCT01917656|691230|P1|Overall Study|Adverse Event|11
212652|NCT01917526|691256|P2|Overall Study|Protocol Violation|1
212653|NCT01917526|691257|P1|Overall Study|Protocol Violation|1
212654|NCT01917344|691265|P1|Overall Study|Withdrawal by Subject|1
212655|NCT01916980|691280|P2|Overall Study|Withdrawal by Subject|0
212656|NCT01916980|691281|P1|Overall Study|Withdrawal by Subject|1
212657|NCT01916980|691280|P2|Overall Study|Lack of Efficacy|2
212658|NCT01916980|691281|P1|Overall Study|Lack of Efficacy|2
212659|NCT01916980|691280|P2|Overall Study|Adverse Event|2
212660|NCT01916980|691281|P1|Overall Study|Adverse Event|4
212661|NCT01916967|691300|P3|Overall Study|Protocol Violation|0
212662|NCT01916967|691301|P2|Overall Study|Protocol Violation|1
212663|NCT01916967|691302|P1|Overall Study|Protocol Violation|0
212664|NCT01916967|691300|P3|Overall Study|Physician Decision|1
212665|NCT01916967|691301|P2|Overall Study|Physician Decision|0
212666|NCT01916967|691302|P1|Overall Study|Physician Decision|0
212667|NCT01916967|691300|P3|Overall Study|Lack of Efficacy|6
212668|NCT01916967|691301|P2|Overall Study|Lack of Efficacy|0
212669|NCT01916967|691302|P1|Overall Study|Lack of Efficacy|0
212670|NCT01916967|691300|P3|Overall Study|Adverse Event|2
212671|NCT01916967|691301|P2|Overall Study|Adverse Event|0
212672|NCT01916967|691302|P1|Overall Study|Adverse Event|0
212673|NCT01916304|691410|P1|Overall Study|Screening failure|17
212674|NCT01916226|691422|P4|Overall Study|Physician Decision|1
212675|NCT01916226|691423|P3|Overall Study|Physician Decision|0
212676|NCT01916226|691424|P2|Overall Study|Physician Decision|0
212677|NCT01916226|691425|P1|Overall Study|Physician Decision|0
212678|NCT01916226|691422|P4|Overall Study|Protocol Violation|1
212679|NCT01916226|691423|P3|Overall Study|Protocol Violation|0
212680|NCT01916226|691424|P2|Overall Study|Protocol Violation|1
212681|NCT01916226|691425|P1|Overall Study|Protocol Violation|0
212682|NCT01916226|691422|P4|Overall Study|Lack of Efficacy|1
212683|NCT01916226|691423|P3|Overall Study|Lack of Efficacy|2
212684|NCT01916226|691424|P2|Overall Study|Lack of Efficacy|0
212685|NCT01916226|691425|P1|Overall Study|Lack of Efficacy|0
212686|NCT01916226|691422|P4|Overall Study|Adverse Event|1
212687|NCT01916226|691423|P3|Overall Study|Adverse Event|1
212688|NCT01916226|691424|P2|Overall Study|Adverse Event|0
212689|NCT01916226|691425|P1|Overall Study|Adverse Event|1
212690|NCT01916109|691459|P1|Overall Study|Withdrawal by Subject|1
212691|NCT01915914|691463|P4|Follow-up Phase|Physician Decision|1
212692|NCT01915914|691464|P3|Follow-up Phase|Physician Decision|0
212693|NCT01915914|691465|P2|Follow-up Phase|Physician Decision|0
212694|NCT01915914|691466|P1|Follow-up Phase|Physician Decision|0
212695|NCT01915914|691463|P4|Follow-up Phase|Withdrawal by Subject|1
212696|NCT01915914|691464|P3|Follow-up Phase|Withdrawal by Subject|0
212697|NCT01915914|691465|P2|Follow-up Phase|Withdrawal by Subject|0
212698|NCT01915914|691466|P1|Follow-up Phase|Withdrawal by Subject|0
212699|NCT01915914|691463|P4|Maintenance Phase|Missing|0
212700|NCT01915914|691464|P3|Maintenance Phase|Missing|0
212701|NCT01915914|691465|P2|Maintenance Phase|Missing|1
212702|NCT01915914|691466|P1|Maintenance Phase|Missing|0
212703|NCT01915914|691463|P4|Maintenance Phase|Lost to Follow-up|0
212704|NCT01915914|691464|P3|Maintenance Phase|Lost to Follow-up|1
212705|NCT01915914|691465|P2|Maintenance Phase|Lost to Follow-up|4
212706|NCT01915914|691466|P1|Maintenance Phase|Lost to Follow-up|0
212707|NCT01915914|691463|P4|Maintenance Phase|Withdrawal by Subject|0
212708|NCT01915914|691464|P3|Maintenance Phase|Withdrawal by Subject|1
212709|NCT01915914|691465|P2|Maintenance Phase|Withdrawal by Subject|1
212710|NCT01915914|691466|P1|Maintenance Phase|Withdrawal by Subject|0
212711|NCT01915914|691463|P4|Acute Phase|Missing|0
212712|NCT01915914|691464|P3|Acute Phase|Missing|0
212713|NCT01915914|691465|P2|Acute Phase|Missing|0
212714|NCT01915914|691466|P1|Acute Phase|Missing|1
212715|NCT01915914|691463|P4|Acute Phase|"Not Achieved treatment success"|0
212716|NCT01915914|691464|P3|Acute Phase|"Not Achieved treatment success"|0
212717|NCT01915914|691465|P2|Acute Phase|"Not Achieved treatment success"|0
212718|NCT01915914|691466|P1|Acute Phase|"Not Achieved treatment success"|1
212719|NCT01915914|691463|P4|Acute Phase|Accepted Other Topic Therapies|0
212720|NCT01915914|691464|P3|Acute Phase|Accepted Other Topic Therapies|0
212721|NCT01915914|691465|P2|Acute Phase|Accepted Other Topic Therapies|0
212722|NCT01915914|691466|P1|Acute Phase|Accepted Other Topic Therapies|1
212723|NCT01915914|691463|P4|Acute Phase|Physician Decision|0
212724|NCT01915914|691464|P3|Acute Phase|Physician Decision|0
212725|NCT01915914|691465|P2|Acute Phase|Physician Decision|0
212726|NCT01915914|691466|P1|Acute Phase|Physician Decision|1
212727|NCT01915914|691463|P4|Acute Phase|Lost to Follow-up|0
212728|NCT01915914|691464|P3|Acute Phase|Lost to Follow-up|0
212729|NCT01915914|691465|P2|Acute Phase|Lost to Follow-up|0
212730|NCT01915914|691466|P1|Acute Phase|Lost to Follow-up|4
212731|NCT01915914|691463|P4|Acute Phase|Withdrawal by Subject|0
212732|NCT01915914|691464|P3|Acute Phase|Withdrawal by Subject|0
212733|NCT01915914|691465|P2|Acute Phase|Withdrawal by Subject|0
212734|NCT01915914|691466|P1|Acute Phase|Withdrawal by Subject|4
212735|NCT01915849|691498|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
212736|NCT01915849|691499|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
212737|NCT01915849|691500|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
212738|NCT01915849|691501|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
212739|NCT01915849|691498|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
212740|NCT01915849|691499|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
212741|NCT01915849|691500|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
212742|NCT01915849|691501|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
224387|NCT01667900|736131|P3|Part B|Death|0
212743|NCT01915732|691526|P2|Overall Study|Poor Conscious Effect|1
212744|NCT01915732|691527|P1|Overall Study|Poor Conscious Effect|0
212745|NCT01915732|691526|P2|Overall Study|Improper Facial Procedure|1
212746|NCT01915732|691527|P1|Overall Study|Improper Facial Procedure|0
212747|NCT01915732|691526|P2|Overall Study|Job Transfer|1
212748|NCT01915732|691527|P1|Overall Study|Job Transfer|0
212749|NCT01915732|691526|P2|Overall Study|Par. Refused to Hospital Visits|1
212750|NCT01915732|691527|P1|Overall Study|Par. Refused to Hospital Visits|0
212751|NCT01915732|691526|P2|Overall Study|Par. not Willing to Continue Treatment|1
212752|NCT01915732|691527|P1|Overall Study|Par. not Willing to Continue Treatment|0
212753|NCT01915732|691526|P2|Overall Study|Got Well|1
212754|NCT01915732|691527|P1|Overall Study|Got Well|0
212755|NCT01915732|691526|P2|Overall Study|Par. Unable to Come to the Hospital|1
212756|NCT01915732|691527|P1|Overall Study|Par. Unable to Come to the Hospital|0
212757|NCT01915732|691526|P2|Overall Study|Poor Perceived Efficacy|0
212758|NCT01915732|691527|P1|Overall Study|Poor Perceived Efficacy|1
212759|NCT01915732|691526|P2|Overall Study|Pregnancy|0
212760|NCT01915732|691527|P1|Overall Study|Pregnancy|1
212761|NCT01915732|691526|P2|Overall Study|Recovered|0
212762|NCT01915732|691527|P1|Overall Study|Recovered|1
212763|NCT01915732|691526|P2|Overall Study|Drug Release Error|0
212764|NCT01915732|691527|P1|Overall Study|Drug Release Error|1
212765|NCT01915732|691526|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
212766|NCT01915732|691527|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
212767|NCT01915732|691526|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
212768|NCT01915732|691527|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
212769|NCT01915732|691526|P2|Overall Study|Lost to Follow-up|26
212770|NCT01915732|691527|P1|Overall Study|Lost to Follow-up|22
212771|NCT01915732|691526|P2|Overall Study|Lack of Efficacy|11
212772|NCT01915732|691527|P1|Overall Study|Lack of Efficacy|6
212773|NCT01915732|691526|P2|Overall Study|Protocol Violation|5
212774|NCT01915732|691527|P1|Overall Study|Protocol Violation|5
212775|NCT01915732|691526|P2|Overall Study|Adverse Event|4
212776|NCT01915732|691527|P1|Overall Study|Adverse Event|12
212777|NCT01915732|691526|P2|Overall Study|Failure to Meet Randomization Criteria|0
212778|NCT01915732|691527|P1|Overall Study|Failure to Meet Randomization Criteria|1
212779|NCT01915732|691526|P2|Overall Study|Withdrawal by Subject|18
212780|NCT01915732|691527|P1|Overall Study|Withdrawal by Subject|18
212781|NCT01914926|691595|P2|Overall Study|uncooperative, agitated and removed|1
212782|NCT01914926|691596|P1|Overall Study|uncooperative, agitated and removed|0
212783|NCT01914926|691595|P2|Overall Study|Adverse Event|0
212784|NCT01914926|691596|P1|Overall Study|Adverse Event|1
212785|NCT01914757|691605|P3|Overall Study|Other reasons|4
212786|NCT01914757|691606|P2|Overall Study|Other reasons|9
212787|NCT01914757|691607|P1|Overall Study|Other reasons|5
212788|NCT01914757|691605|P3|Overall Study|Eligibility criteria not fulfilled|2
212789|NCT01914757|691606|P2|Overall Study|Eligibility criteria not fulfilled|0
212790|NCT01914757|691607|P1|Overall Study|Eligibility criteria not fulfilled|2
212791|NCT01914757|691605|P3|Overall Study|Study specific withdrawal criteria|0
212792|NCT01914757|691606|P2|Overall Study|Study specific withdrawal criteria|1
212793|NCT01914757|691607|P1|Overall Study|Study specific withdrawal criteria|0
212794|NCT01914757|691605|P3|Overall Study|Adverse Event|4
212795|NCT01914757|691606|P2|Overall Study|Adverse Event|3
212796|NCT01914757|691607|P1|Overall Study|Adverse Event|4
212797|NCT01914757|691605|P3|Overall Study|Death|1
212798|NCT01914757|691606|P2|Overall Study|Death|2
212799|NCT01914757|691607|P1|Overall Study|Death|2
212800|NCT01914757|691605|P3|Overall Study|Withdrawal by Subject|19
212801|NCT01914757|691606|P2|Overall Study|Withdrawal by Subject|27
212802|NCT01914757|691607|P1|Overall Study|Withdrawal by Subject|15
212803|NCT01914757|691605|P3|Overall Study|Lost to Follow-up|6
212804|NCT01914757|691606|P2|Overall Study|Lost to Follow-up|8
212805|NCT01914757|691607|P1|Overall Study|Lost to Follow-up|5
212806|NCT01914757|691605|P3|Overall Study|Severe non-compliance to protocol|2
212807|NCT01914757|691606|P2|Overall Study|Severe non-compliance to protocol|1
212808|NCT01914757|691607|P1|Overall Study|Severe non-compliance to protocol|3
212809|NCT01914679|691681|P1|Overall Study|Sponsor terminated study|4
212810|NCT01914679|691681|P1|Overall Study|Lack of Efficacy|1
212811|NCT01914666|691688|P3|Treatment Period|Physician Decision|2
212812|NCT01914666|691689|P2|Treatment Period|Physician Decision|0
212813|NCT01914666|691690|P1|Treatment Period|Physician Decision|0
212814|NCT01914666|691688|P3|Treatment Period|Withdrawal by Subject|2
212815|NCT01914666|691689|P2|Treatment Period|Withdrawal by Subject|2
212816|NCT01914666|691690|P1|Treatment Period|Withdrawal by Subject|3
212817|NCT01914666|691688|P3|Treatment Period|Adverse Event|2
212818|NCT01914666|691689|P2|Treatment Period|Adverse Event|4
212819|NCT01914666|691690|P1|Treatment Period|Adverse Event|10
212820|NCT01914666|691688|P3|Treatment Period|Lack of Efficacy|2
212821|NCT01914666|691689|P2|Treatment Period|Lack of Efficacy|0
212822|NCT01914666|691690|P1|Treatment Period|Lack of Efficacy|0
212823|NCT01913483|691755|P2|Overall Study|Death|17
212824|NCT01913483|691756|P1|Overall Study|Death|14
212825|NCT01913483|691755|P2|Overall Study|Lost to Follow-up|3
212826|NCT01913483|691756|P1|Overall Study|Lost to Follow-up|6
212827|NCT01913483|691755|P2|Overall Study|Withdrawal by Subject|2
212828|NCT01913483|691756|P1|Overall Study|Withdrawal by Subject|1
212829|NCT01913470|691768|P2|Overall Study|Withdrawal by Subject|1
212830|NCT01913470|691769|P1|Overall Study|Withdrawal by Subject|0
212831|NCT01913470|691768|P2|Overall Study|Physician Decision|1
212832|NCT01913470|691769|P1|Overall Study|Physician Decision|0
212833|NCT01913470|691768|P2|Overall Study|Lost to Follow-up|1
212834|NCT01913470|691769|P1|Overall Study|Lost to Follow-up|0
212835|NCT01913041|691787|P1|Overall Study|Physician Decision|1
212836|NCT01913041|691787|P1|Overall Study|Withdrawal by Subject|3
212837|NCT01913041|691787|P1|Overall Study|Protocol Violation|35
212838|NCT01912781|691793|P2|Overall Study|Withdrawal by Subject|0
212839|NCT01912781|691794|P1|Overall Study|Withdrawal by Subject|2
212840|NCT01912768|691825|P2|Overall Study|Randomized in error|0
212841|NCT01912768|691826|P1|Overall Study|Randomized in error|1
212842|NCT01912768|691825|P2|Overall Study|Withdrawal by Subject|3
212843|NCT01912768|691826|P1|Overall Study|Withdrawal by Subject|5
212844|NCT01912768|691825|P2|Overall Study|Lost to Follow-up|1
212845|NCT01912768|691826|P1|Overall Study|Lost to Follow-up|2
212846|NCT01912768|691825|P2|Overall Study|Adverse Event|0
212847|NCT01912768|691826|P1|Overall Study|Adverse Event|2
212848|NCT01912599|691857|P2|Overall Study|Withdrawal by Subject|1
212849|NCT01912599|691858|P1|Overall Study|Withdrawal by Subject|0
212850|NCT01912404|691883|P2|Overall Study|Due to personal reasons|0
212851|NCT01912404|691884|P1|Overall Study|Due to personal reasons|1
212852|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
212853|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
212854|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
212855|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
212856|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
212857|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
212858|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
212859|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
212860|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
212861|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
212862|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
212863|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
212864|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
212865|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
212866|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
212867|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
212868|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
212869|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
212870|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
212871|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
212872|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
212873|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
212874|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
212875|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
212876|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
212877|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
212878|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
212879|NCT01912339|691897|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
212880|NCT01912339|691898|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
212881|NCT01912339|691899|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
212882|NCT01912339|691897|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
212883|NCT01912339|691898|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
212884|NCT01912339|691899|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
212885|NCT01912339|691897|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
212886|NCT01912339|691898|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
212887|NCT01912339|691899|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
212888|NCT01912339|691897|P3|Blinded (0 to 3 Months)|Declined to participate|0
212889|NCT01912339|691898|P2|Blinded (0 to 3 Months)|Declined to participate|0
212890|NCT01912339|691899|P1|Blinded (0 to 3 Months)|Declined to participate|1
212891|NCT01912222|691916|P3|Part B: Treatment Period|Withdrawal by Subject|2
212892|NCT01912222|691917|P2|Part B: Treatment Period|Withdrawal by Subject|1
212893|NCT01912222|691918|P1|Part B: Treatment Period|Withdrawal by Subject|2
212894|NCT01912222|691916|P3|Part B: Treatment Period|Adverse Event|3
212895|NCT01912222|691917|P2|Part B: Treatment Period|Adverse Event|2
212896|NCT01912222|691918|P1|Part B: Treatment Period|Adverse Event|1
212897|NCT01912222|691916|P3|Part B: Treatment Period|Progressive disease|15
212898|NCT01912222|691917|P2|Part B: Treatment Period|Progressive disease|12
212899|NCT01912222|691918|P1|Part B: Treatment Period|Progressive disease|10
212900|NCT01912222|691916|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
212901|NCT01912222|691917|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
212902|NCT01912222|691918|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
212903|NCT01911845|691941|P1|Overall Study|Other (not specified)|3
212904|NCT01911845|691941|P1|Overall Study|Lost to Follow-up|1
212905|NCT01911845|691941|P1|Overall Study|Adverse Event|2
212906|NCT01911780|691957|P2|Extension Period (52 Weeks)|Personal reason|1
212907|NCT01911780|691958|P1|Extension Period (52 Weeks)|Personal reason|1
212908|NCT01911780|691957|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
212909|NCT01911780|691958|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
212910|NCT01911780|691957|P2|Extension Period (52 Weeks)|Adverse Event|0
212911|NCT01911780|691958|P1|Extension Period (52 Weeks)|Adverse Event|3
212912|NCT01911780|691957|P2|Double-blind Period (8 Weeks)|Personal reason|0
212913|NCT01911780|691958|P1|Double-blind Period (8 Weeks)|Personal reason|1
212914|NCT01911780|691957|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
212915|NCT01911780|691958|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
212916|NCT01911780|691957|P2|Double-blind Period (8 Weeks)|Adverse Event|2
212917|NCT01911780|691958|P1|Double-blind Period (8 Weeks)|Adverse Event|1
212918|NCT01911442|691995|P3|Overall Study|Mother's Work Schedule|0
212919|NCT01911442|691996|P2|Overall Study|Mother's Work Schedule|1
212920|NCT01911442|691997|P1|Overall Study|Mother's Work Schedule|0
212921|NCT01911442|691995|P3|Overall Study|Withdrawal by Subject|6
212922|NCT01911442|691996|P2|Overall Study|Withdrawal by Subject|0
212923|NCT01911442|691997|P1|Overall Study|Withdrawal by Subject|1
212924|NCT01911442|691995|P3|Overall Study|Lost to Follow-up|1
212925|NCT01911442|691996|P2|Overall Study|Lost to Follow-up|0
212926|NCT01911442|691997|P1|Overall Study|Lost to Follow-up|2
212927|NCT01911442|691995|P3|Overall Study|Lack of Efficacy|1
212928|NCT01911442|691996|P2|Overall Study|Lack of Efficacy|1
212929|NCT01911442|691997|P1|Overall Study|Lack of Efficacy|1
212930|NCT01911442|691995|P3|Overall Study|Adverse Event|4
212931|NCT01911442|691996|P2|Overall Study|Adverse Event|2
212932|NCT01911442|691997|P1|Overall Study|Adverse Event|2
212933|NCT01911429|692026|P3|Overall Study|subject left study|0
212934|NCT01911429|692027|P2|Overall Study|subject left study|0
212935|NCT01911429|692028|P1|Overall Study|subject left study|1
212936|NCT01911429|692026|P3|Overall Study|Accidental randomization|1
212937|NCT01911429|692027|P2|Overall Study|Accidental randomization|0
212938|NCT01911429|692028|P1|Overall Study|Accidental randomization|0
212939|NCT01911429|692026|P3|Overall Study|Withdrawal by Subject|4
212940|NCT01911429|692027|P2|Overall Study|Withdrawal by Subject|5
212941|NCT01911429|692028|P1|Overall Study|Withdrawal by Subject|5
212942|NCT01911429|692026|P3|Overall Study|Protocol Violation|1
212943|NCT01911429|692027|P2|Overall Study|Protocol Violation|0
212944|NCT01911429|692028|P1|Overall Study|Protocol Violation|0
212945|NCT01911429|692026|P3|Overall Study|Lost to Follow-up|1
212946|NCT01911429|692027|P2|Overall Study|Lost to Follow-up|0
212947|NCT01911429|692028|P1|Overall Study|Lost to Follow-up|0
212948|NCT01911429|692026|P3|Overall Study|Lack of Efficacy|4
212949|NCT01911429|692027|P2|Overall Study|Lack of Efficacy|2
212950|NCT01911429|692028|P1|Overall Study|Lack of Efficacy|1
212951|NCT01911429|692026|P3|Overall Study|Adverse Event|9
212952|NCT01911429|692027|P2|Overall Study|Adverse Event|3
212953|NCT01911429|692028|P1|Overall Study|Adverse Event|5
212954|NCT01911273|692120|P2|Overall Study|Withdrawal by Subject|2
212955|NCT01911273|692121|P1|Overall Study|Withdrawal by Subject|0
212956|NCT01911273|692120|P2|Overall Study|Progression of Disease|0
212957|NCT01911273|692121|P1|Overall Study|Progression of Disease|1
212958|NCT01911260|692155|P4|Follow-up Period|transference or evasion of school|12
212959|NCT01911260|692156|P3|Follow-up Period|transference or evasion of school|15
212960|NCT01911260|692157|P2|Follow-up Period|transference or evasion of school|20
212961|NCT01911260|692158|P1|Follow-up Period|transference or evasion of school|13
212962|NCT01911260|692155|P4|Supplementation Period|less than 12 weeks supplementation|2
212963|NCT01911260|692156|P3|Supplementation Period|less than 12 weeks supplementation|1
212964|NCT01911260|692157|P2|Supplementation Period|less than 12 weeks supplementation|3
212965|NCT01911260|692158|P1|Supplementation Period|less than 12 weeks supplementation|0
212966|NCT01911260|692155|P4|Supplementation Period|refused to receive supplement|0
212967|NCT01911260|692156|P3|Supplementation Period|refused to receive supplement|1
212968|NCT01911260|692157|P2|Supplementation Period|refused to receive supplement|0
212969|NCT01911260|692158|P1|Supplementation Period|refused to receive supplement|1
212970|NCT01911260|692155|P4|Supplementation Period|Adverse Event|0
212971|NCT01911260|692156|P3|Supplementation Period|Adverse Event|1
212972|NCT01911260|692157|P2|Supplementation Period|Adverse Event|0
212973|NCT01911260|692158|P1|Supplementation Period|Adverse Event|2
212974|NCT01911260|692155|P4|Supplementation Period|transference or evasion of school|6
212975|NCT01911260|692156|P3|Supplementation Period|transference or evasion of school|7
212976|NCT01911260|692157|P2|Supplementation Period|transference or evasion of school|9
212977|NCT01911260|692158|P1|Supplementation Period|transference or evasion of school|7
212978|NCT01910441|692233|P2|Overall Study|Physician Decision|1
212979|NCT01910441|692234|P1|Overall Study|Physician Decision|0
212980|NCT01910441|692233|P2|Overall Study|Adverse Event|0
212981|NCT01910441|692234|P1|Overall Study|Adverse Event|1
212982|NCT01910441|692233|P2|Overall Study|Non-compliance|1
212983|NCT01910441|692234|P1|Overall Study|Non-compliance|0
212984|NCT01910441|692233|P2|Overall Study|Withdrawal by Subject|1
212985|NCT01910441|692234|P1|Overall Study|Withdrawal by Subject|0
212986|NCT01910441|692233|P2|Overall Study|Lost to Follow-up|5
212987|NCT01910441|692234|P1|Overall Study|Lost to Follow-up|6
212988|NCT01910441|692233|P2|Overall Study|Sponsor decision|2
224388|NCT01667900|736132|P2|Part B|Death|0
212989|NCT01910441|692234|P1|Overall Study|Sponsor decision|0
212990|NCT01910402|692242|P2|Continuation Phase|Withdrawal by Subject|0
212991|NCT01910402|692243|P1|Continuation Phase|Withdrawal by Subject|2
212992|NCT01910402|692242|P2|Continuation Phase|Protocol Violation|0
212993|NCT01910402|692243|P1|Continuation Phase|Protocol Violation|3
212994|NCT01910402|692242|P2|Continuation Phase|Adverse Event|0
212995|NCT01910402|692243|P1|Continuation Phase|Adverse Event|1
212996|NCT01910402|692242|P2|Continuation Phase|Ongoing|0
212997|NCT01910402|692243|P1|Continuation Phase|Ongoing|84
212998|NCT01910402|692242|P2|Randomized Phase|Withdrawal by Subject|7
212999|NCT01910402|692243|P1|Randomized Phase|Withdrawal by Subject|5
213000|NCT01910402|692242|P2|Randomized Phase|Protocol Violation|13
213001|NCT01910402|692243|P1|Randomized Phase|Protocol Violation|10
213002|NCT01910402|692242|P2|Randomized Phase|Lost to Follow-up|13
213003|NCT01910402|692243|P1|Randomized Phase|Lost to Follow-up|11
213004|NCT01910402|692242|P2|Randomized Phase|Lack of Efficacy|4
213005|NCT01910402|692243|P1|Randomized Phase|Lack of Efficacy|5
213006|NCT01910402|692242|P2|Randomized Phase|Physician Decision|0
213007|NCT01910402|692243|P1|Randomized Phase|Physician Decision|1
213008|NCT01910402|692242|P2|Randomized Phase|Adverse Event|18
213009|NCT01910402|692243|P1|Randomized Phase|Adverse Event|10
213010|NCT01910389|692313|P2|Overall Study|Study Closed|8
213011|NCT01910389|692314|P1|Overall Study|Study Closed|13
213012|NCT01910389|692313|P2|Overall Study|Withdrawal by Subject|0
213013|NCT01910389|692314|P1|Overall Study|Withdrawal by Subject|2
213014|NCT01910181|692355|P1|Overall Study|Alive in Follow-Up|12
213015|NCT01910181|692355|P1|Overall Study|Alive on Treatment|14
213016|NCT01910181|692355|P1|Overall Study|Death|20
213017|NCT01910116|692382|P2|Overall Study|incomplete data|1
213018|NCT01910116|692383|P1|Overall Study|incomplete data|0
213019|NCT01910116|692382|P2|Overall Study|uncertain allocation|3
213020|NCT01910116|692383|P1|Overall Study|uncertain allocation|1
213021|NCT01910116|692382|P2|Overall Study|Withdrawal by Subject|3
213022|NCT01910116|692383|P1|Overall Study|Withdrawal by Subject|8
213023|NCT01910116|692382|P2|Overall Study|Protocol Violation|2
213024|NCT01910116|692383|P1|Overall Study|Protocol Violation|1
213025|NCT01910116|692382|P2|Overall Study|Lost to Follow-up|0
213026|NCT01910116|692383|P1|Overall Study|Lost to Follow-up|1
213027|NCT01910116|692382|P2|Overall Study|Lack of Efficacy|4
213028|NCT01910116|692383|P1|Overall Study|Lack of Efficacy|3
213029|NCT01910116|692382|P2|Overall Study|Adverse Event|3
213030|NCT01910116|692383|P1|Overall Study|Adverse Event|0
213031|NCT01909804|692480|P12|Overall Study|Protocol Violation|1
213032|NCT01909804|692481|P11|Overall Study|Protocol Violation|0
213033|NCT01909804|692482|P10|Overall Study|Protocol Violation|0
213034|NCT01909804|692483|P9|Overall Study|Protocol Violation|0
213035|NCT01909804|692484|P8|Overall Study|Protocol Violation|0
213036|NCT01909804|692485|P7|Overall Study|Protocol Violation|0
213037|NCT01909804|692486|P6|Overall Study|Protocol Violation|0
213038|NCT01909804|692487|P5|Overall Study|Protocol Violation|0
213039|NCT01909804|692488|P4|Overall Study|Protocol Violation|0
213040|NCT01909804|692489|P3|Overall Study|Protocol Violation|0
213041|NCT01909804|692490|P2|Overall Study|Protocol Violation|0
213042|NCT01909804|692491|P1|Overall Study|Protocol Violation|0
213043|NCT01909804|692480|P12|Overall Study|Withdrew Consent|0
213044|NCT01909804|692481|P11|Overall Study|Withdrew Consent|0
213045|NCT01909804|692482|P10|Overall Study|Withdrew Consent|0
213046|NCT01909804|692483|P9|Overall Study|Withdrew Consent|0
213047|NCT01909804|692484|P8|Overall Study|Withdrew Consent|0
213048|NCT01909804|692485|P7|Overall Study|Withdrew Consent|0
213049|NCT01909804|692486|P6|Overall Study|Withdrew Consent|1
213050|NCT01909804|692487|P5|Overall Study|Withdrew Consent|1
213051|NCT01909804|692488|P4|Overall Study|Withdrew Consent|0
213052|NCT01909804|692489|P3|Overall Study|Withdrew Consent|0
213053|NCT01909804|692490|P2|Overall Study|Withdrew Consent|0
213054|NCT01909804|692491|P1|Overall Study|Withdrew Consent|0
213055|NCT01909804|692480|P12|Overall Study|Lack of Efficacy|1
213056|NCT01909804|692481|P11|Overall Study|Lack of Efficacy|0
213057|NCT01909804|692482|P10|Overall Study|Lack of Efficacy|1
213058|NCT01909804|692483|P9|Overall Study|Lack of Efficacy|0
213059|NCT01909804|692484|P8|Overall Study|Lack of Efficacy|1
213060|NCT01909804|692485|P7|Overall Study|Lack of Efficacy|1
213061|NCT01909804|692486|P6|Overall Study|Lack of Efficacy|3
213062|NCT01909804|692487|P5|Overall Study|Lack of Efficacy|7
213063|NCT01909804|692488|P4|Overall Study|Lack of Efficacy|0
213064|NCT01909804|692489|P3|Overall Study|Lack of Efficacy|0
213065|NCT01909804|692490|P2|Overall Study|Lack of Efficacy|1
213066|NCT01909804|692491|P1|Overall Study|Lack of Efficacy|4
213067|NCT01909804|692480|P12|Overall Study|Death|0
213068|NCT01909804|692481|P11|Overall Study|Death|1
213069|NCT01909804|692482|P10|Overall Study|Death|0
213070|NCT01909804|692483|P9|Overall Study|Death|0
213071|NCT01909804|692484|P8|Overall Study|Death|0
213072|NCT01909804|692485|P7|Overall Study|Death|0
213073|NCT01909804|692486|P6|Overall Study|Death|0
213074|NCT01909804|692487|P5|Overall Study|Death|0
213075|NCT01909804|692488|P4|Overall Study|Death|0
213076|NCT01909804|692489|P3|Overall Study|Death|0
213077|NCT01909804|692490|P2|Overall Study|Death|0
213078|NCT01909804|692491|P1|Overall Study|Death|0
224389|NCT01667900|736133|P1|Part B|Death|0
213079|NCT01909804|692480|P12|Overall Study|Randomized but Never Treated|1
213080|NCT01909804|692481|P11|Overall Study|Randomized but Never Treated|0
213081|NCT01909804|692482|P10|Overall Study|Randomized but Never Treated|0
213082|NCT01909804|692483|P9|Overall Study|Randomized but Never Treated|0
213083|NCT01909804|692484|P8|Overall Study|Randomized but Never Treated|0
213084|NCT01909804|692485|P7|Overall Study|Randomized but Never Treated|1
213085|NCT01909804|692486|P6|Overall Study|Randomized but Never Treated|0
213086|NCT01909804|692487|P5|Overall Study|Randomized but Never Treated|0
213087|NCT01909804|692488|P4|Overall Study|Randomized but Never Treated|0
213088|NCT01909804|692489|P3|Overall Study|Randomized but Never Treated|0
213089|NCT01909804|692490|P2|Overall Study|Randomized but Never Treated|0
213090|NCT01909804|692491|P1|Overall Study|Randomized but Never Treated|0
213091|NCT01909778|692537|P1|Overall Study|failed screening|1
213092|NCT01909674|692616|P2|Overall Study|Withdrawal by Subject|2
213093|NCT01909674|692617|P1|Overall Study|Withdrawal by Subject|5
213094|NCT01909466|692636|P2|Overall Study|Lack of Efficacy|0
213095|NCT01909466|692637|P1|Overall Study|Lack of Efficacy|1
213096|NCT01909466|692636|P2|Overall Study|Withdrawal by Subject|9
213097|NCT01909466|692637|P1|Overall Study|Withdrawal by Subject|11
213098|NCT01909466|692636|P2|Overall Study|Physician Decision|0
213099|NCT01909466|692637|P1|Overall Study|Physician Decision|2
213100|NCT01909466|692636|P2|Overall Study|Met Withdrawal Criteria|3
213101|NCT01909466|692637|P1|Overall Study|Met Withdrawal Criteria|0
213102|NCT01909466|692636|P2|Overall Study|Adverse Event|4
213103|NCT01909466|692637|P1|Overall Study|Adverse Event|3
213104|NCT01909466|692636|P2|Overall Study|Lost to Follow-up|7
213105|NCT01909466|692637|P1|Overall Study|Lost to Follow-up|5
213106|NCT01909336|692660|P3|Overall Study|Physician Decision|1
213107|NCT01909336|692661|P2|Overall Study|Physician Decision|1
213108|NCT01909336|692662|P1|Overall Study|Physician Decision|0
213109|NCT01909336|692660|P3|Overall Study|Lost to Follow-up|2
213110|NCT01909336|692661|P2|Overall Study|Lost to Follow-up|2
213111|NCT01909336|692662|P1|Overall Study|Lost to Follow-up|4
213112|NCT01908803|692735|P2|Overall Study|Adverse Event (pre-treatment)|0
213113|NCT01908803|692736|P1|Overall Study|Adverse Event (pre-treatment)|1
213114|NCT01908803|692735|P2|Overall Study|Randomization Error|0
213115|NCT01908803|692736|P1|Overall Study|Randomization Error|1
213116|NCT01908803|692735|P2|Overall Study|Withdrawal by Subject|0
213117|NCT01908803|692736|P1|Overall Study|Withdrawal by Subject|1
213118|NCT01908803|692735|P2|Overall Study|Physician Decision|1
213119|NCT01908803|692736|P1|Overall Study|Physician Decision|0
213120|NCT01908803|692735|P2|Overall Study|Adverse Event|0
213121|NCT01908803|692736|P1|Overall Study|Adverse Event|1
213122|NCT01908140|692749|P2|Overall Study|Adverse Event|23
213123|NCT01908140|692750|P1|Overall Study|Adverse Event|22
213124|NCT01908140|692749|P2|Overall Study|Protocol Violation|9
213125|NCT01908140|692750|P1|Overall Study|Protocol Violation|8
213126|NCT01908140|692749|P2|Overall Study|Lost to Follow-up|6
213127|NCT01908140|692750|P1|Overall Study|Lost to Follow-up|1
213128|NCT01908140|692749|P2|Overall Study|Withdrawal by Subject|24
213129|NCT01908140|692750|P1|Overall Study|Withdrawal by Subject|23
213130|NCT01908140|692749|P2|Overall Study|Lack of Efficacy|5
213131|NCT01908140|692750|P1|Overall Study|Lack of Efficacy|7
213132|NCT01908140|692749|P2|Overall Study|Other or Progressive Disease|12
213133|NCT01908140|692750|P1|Overall Study|Other or Progressive Disease|5
213134|NCT01907906|692771|P2|Overall Study|Physician Decision|1
213135|NCT01907906|692772|P1|Overall Study|Physician Decision|3
213136|NCT01907906|692771|P2|Overall Study|Withdrawal by Subject|0
213137|NCT01907906|692772|P1|Overall Study|Withdrawal by Subject|1
213138|NCT01907854|692852|P2|Overall Study|Unclassified|3
213139|NCT01907854|692853|P1|Overall Study|Unclassified|4
213140|NCT01907854|692852|P2|Overall Study|Lost to Follow-up|2
213141|NCT01907854|692853|P1|Overall Study|Lost to Follow-up|2
213142|NCT01907854|692852|P2|Overall Study|Withdrawal by Subject|7
213143|NCT01907854|692853|P1|Overall Study|Withdrawal by Subject|9
213144|NCT01907854|692852|P2|Overall Study|Protocol Violation|1
213145|NCT01907854|692853|P1|Overall Study|Protocol Violation|1
213146|NCT01907516|692873|P2|First Intervention (3 Weeks)|Developed DKA during study|0
213147|NCT01907516|692874|P1|First Intervention (3 Weeks)|Developed DKA during study|1
213148|NCT01907516|692873|P2|First Intervention (3 Weeks)|Delivered before second arm|4
213149|NCT01907516|692874|P1|First Intervention (3 Weeks)|Delivered before second arm|3
213150|NCT01907516|692873|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
213151|NCT01907516|692874|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
213152|NCT01907516|692873|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
213153|NCT01907516|692874|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
213154|NCT01905657|693060|P3|Overall Study|Excluded from Efficacy Analysis|0
213155|NCT01905657|693061|P2|Overall Study|Excluded from Efficacy Analysis|0
213156|NCT01905657|693062|P1|Overall Study|Excluded from Efficacy Analysis|1
213157|NCT01905657|693060|P3|Overall Study|Continuing in Study|11
213158|NCT01905657|693061|P2|Overall Study|Continuing in Study|74
213159|NCT01905657|693062|P1|Overall Study|Continuing in Study|74
213160|NCT01905657|693060|P3|Overall Study|Withdrawal by Subject|45
213161|NCT01905657|693061|P2|Overall Study|Withdrawal by Subject|10
213162|NCT01905657|693062|P1|Overall Study|Withdrawal by Subject|5
213163|NCT01905657|693060|P3|Overall Study|Protocol Violation|1
213164|NCT01905657|693061|P2|Overall Study|Protocol Violation|1
213165|NCT01905657|693062|P1|Overall Study|Protocol Violation|2
213166|NCT01905657|693060|P3|Overall Study|Progressive Disease|89
213167|NCT01905657|693061|P2|Overall Study|Progressive Disease|126
213168|NCT01905657|693062|P1|Overall Study|Progressive Disease|124
213169|NCT01905657|693060|P3|Overall Study|Physician Decision|113
213170|NCT01905657|693061|P2|Overall Study|Physician Decision|74
213171|NCT01905657|693062|P1|Overall Study|Physician Decision|82
213172|NCT01905657|693060|P3|Overall Study|Unspecified|1
213173|NCT01905657|693061|P2|Overall Study|Unspecified|7
213174|NCT01905657|693062|P1|Overall Study|Unspecified|3
213175|NCT01905657|693060|P3|Overall Study|Death|21
213176|NCT01905657|693061|P2|Overall Study|Death|21
213177|NCT01905657|693062|P1|Overall Study|Death|21
213178|NCT01905657|693060|P3|Overall Study|Adverse Event|47
213179|NCT01905657|693061|P2|Overall Study|Adverse Event|32
213180|NCT01905657|693062|P1|Overall Study|Adverse Event|33
213181|NCT01905657|693060|P3|Overall Study|Not Treated|0
213182|NCT01905657|693061|P2|Overall Study|Not Treated|1
213183|NCT01905657|693062|P1|Overall Study|Not Treated|0
213184|NCT01904773|693085|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
213185|NCT01904773|693086|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
213186|NCT01904773|693087|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
213187|NCT01904773|693088|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
213188|NCT01904773|693089|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
213189|NCT01904773|693090|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
213190|NCT01904773|693091|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
213191|NCT01904773|693092|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
213192|NCT01904773|693093|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
213193|NCT01904773|693085|P9|Fifth Intervention|Adverse Event|0
213194|NCT01904773|693086|P8|Fifth Intervention|Adverse Event|1
213195|NCT01904773|693087|P7|Fifth Intervention|Adverse Event|0
213196|NCT01904773|693088|P6|Fifth Intervention|Adverse Event|0
213197|NCT01904773|693089|P5|Fifth Intervention|Adverse Event|0
213198|NCT01904773|693090|P4|Fifth Intervention|Adverse Event|0
213199|NCT01904773|693091|P3|Fifth Intervention|Adverse Event|0
213200|NCT01904773|693092|P2|Fifth Intervention|Adverse Event|0
213201|NCT01904773|693093|P1|Fifth Intervention|Adverse Event|0
213202|NCT01904773|693085|P9|Placebo Washout First Intervention|Condition worsened|0
213203|NCT01904773|693086|P8|Placebo Washout First Intervention|Condition worsened|0
213204|NCT01904773|693087|P7|Placebo Washout First Intervention|Condition worsened|0
213205|NCT01904773|693088|P6|Placebo Washout First Intervention|Condition worsened|0
213206|NCT01904773|693089|P5|Placebo Washout First Intervention|Condition worsened|0
213207|NCT01904773|693090|P4|Placebo Washout First Intervention|Condition worsened|0
213208|NCT01904773|693091|P3|Placebo Washout First Intervention|Condition worsened|0
213209|NCT01904773|693092|P2|Placebo Washout First Intervention|Condition worsened|1
213210|NCT01904773|693093|P1|Placebo Washout First Intervention|Condition worsened|0
213211|NCT01904773|693085|P9|First Intervention|Adverse Event|0
213212|NCT01904773|693086|P8|First Intervention|Adverse Event|0
213213|NCT01904773|693087|P7|First Intervention|Adverse Event|1
213214|NCT01904773|693088|P6|First Intervention|Adverse Event|0
213215|NCT01904773|693089|P5|First Intervention|Adverse Event|0
213216|NCT01904773|693090|P4|First Intervention|Adverse Event|0
213217|NCT01904773|693091|P3|First Intervention|Adverse Event|0
213218|NCT01904773|693092|P2|First Intervention|Adverse Event|0
213219|NCT01904773|693093|P1|First Intervention|Adverse Event|0
213220|NCT01904773|693085|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
213221|NCT01904773|693086|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
213222|NCT01904773|693087|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
213223|NCT01904773|693088|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
213224|NCT01904773|693089|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
213225|NCT01904773|693090|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
213226|NCT01904773|693091|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
213227|NCT01904773|693092|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
213228|NCT01904773|693093|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
213229|NCT01904773|693085|P9|Screen|Withdrawal by Subject|0
213230|NCT01904773|693086|P8|Screen|Withdrawal by Subject|0
213231|NCT01904773|693087|P7|Screen|Withdrawal by Subject|0
213232|NCT01904773|693088|P6|Screen|Withdrawal by Subject|0
213233|NCT01904773|693089|P5|Screen|Withdrawal by Subject|0
213234|NCT01904773|693090|P4|Screen|Withdrawal by Subject|0
213235|NCT01904773|693091|P3|Screen|Withdrawal by Subject|0
213236|NCT01904773|693092|P2|Screen|Withdrawal by Subject|0
213237|NCT01904773|693093|P1|Screen|Withdrawal by Subject|1
213238|NCT01904773|693085|P9|Screen|Screen failure|0
213239|NCT01904773|693086|P8|Screen|Screen failure|0
213240|NCT01904773|693087|P7|Screen|Screen failure|0
213241|NCT01904773|693088|P6|Screen|Screen failure|0
213242|NCT01904773|693089|P5|Screen|Screen failure|0
213243|NCT01904773|693090|P4|Screen|Screen failure|0
213244|NCT01904773|693091|P3|Screen|Screen failure|0
213245|NCT01904773|693092|P2|Screen|Screen failure|0
213246|NCT01904773|693093|P1|Screen|Screen failure|3
213247|NCT01904760|693110|P2|Overall Study|Protocol Violation|0
213248|NCT01904760|693111|P1|Overall Study|Protocol Violation|1
213249|NCT01904721|693126|P7|Overall Study|Adverse Event|0
213250|NCT01904721|693127|P6|Overall Study|Adverse Event|1
213251|NCT01904721|693128|P5|Overall Study|Adverse Event|3
213252|NCT01904721|693129|P4|Overall Study|Adverse Event|0
213253|NCT01904721|693130|P3|Overall Study|Adverse Event|0
213254|NCT01904721|693131|P2|Overall Study|Adverse Event|0
213255|NCT01904721|693132|P1|Overall Study|Adverse Event|0
213256|NCT01904721|693126|P7|Overall Study|Lack of Efficacy|1
213257|NCT01904721|693127|P6|Overall Study|Lack of Efficacy|0
213258|NCT01904721|693128|P5|Overall Study|Lack of Efficacy|0
213259|NCT01904721|693129|P4|Overall Study|Lack of Efficacy|0
213260|NCT01904721|693130|P3|Overall Study|Lack of Efficacy|0
213261|NCT01904721|693131|P2|Overall Study|Lack of Efficacy|0
213262|NCT01904721|693132|P1|Overall Study|Lack of Efficacy|0
213263|NCT01904721|693126|P7|Overall Study|Lost to Follow-up|1
213264|NCT01904721|693127|P6|Overall Study|Lost to Follow-up|3
213265|NCT01904721|693128|P5|Overall Study|Lost to Follow-up|1
213266|NCT01904721|693129|P4|Overall Study|Lost to Follow-up|0
213267|NCT01904721|693130|P3|Overall Study|Lost to Follow-up|0
213268|NCT01904721|693131|P2|Overall Study|Lost to Follow-up|0
213269|NCT01904721|693132|P1|Overall Study|Lost to Follow-up|0
213270|NCT01904721|693126|P7|Overall Study|Personal Reasons|3
213271|NCT01904721|693127|P6|Overall Study|Personal Reasons|3
213272|NCT01904721|693128|P5|Overall Study|Personal Reasons|2
213273|NCT01904721|693129|P4|Overall Study|Personal Reasons|0
213274|NCT01904721|693130|P3|Overall Study|Personal Reasons|0
213275|NCT01904721|693131|P2|Overall Study|Personal Reasons|0
213276|NCT01904721|693132|P1|Overall Study|Personal Reasons|0
213277|NCT01904721|693126|P7|Overall Study|Other Reasons|2
213278|NCT01904721|693127|P6|Overall Study|Other Reasons|2
213279|NCT01904721|693128|P5|Overall Study|Other Reasons|2
213280|NCT01904721|693129|P4|Overall Study|Other Reasons|1
213281|NCT01904721|693130|P3|Overall Study|Other Reasons|1
213282|NCT01904721|693131|P2|Overall Study|Other Reasons|0
213283|NCT01904721|693132|P1|Overall Study|Other Reasons|0
213284|NCT01905553|693161|P2|Period 2|Adverse Event|0
213285|NCT01905553|693162|P1|Period 2|Adverse Event|1
213286|NCT01905540|693176|P4|Period 3|Not specified|1
213287|NCT01905540|693177|P3|Period 3|Not specified|1
213288|NCT01905540|693178|P2|Period 3|Not specified|0
213289|NCT01905540|693179|P1|Period 3|Not specified|1
213290|NCT01904604|693204|P3|Overall Study|Unrelated illness|0
213291|NCT01904604|693205|P2|Overall Study|Unrelated illness|1
213292|NCT01904604|693206|P1|Overall Study|Unrelated illness|0
213293|NCT01904604|693204|P3|Overall Study|Increased syncope|0
213294|NCT01904604|693205|P2|Overall Study|Increased syncope|1
213295|NCT01904604|693206|P1|Overall Study|Increased syncope|0
213296|NCT01904604|693204|P3|Overall Study|Patch site reactions|0
213297|NCT01904604|693205|P2|Overall Study|Patch site reactions|1
213298|NCT01904604|693206|P1|Overall Study|Patch site reactions|0
213299|NCT01904604|693204|P3|Overall Study|Anxiety about OFC/Refused OFC|0
213300|NCT01904604|693205|P2|Overall Study|Anxiety about OFC/Refused OFC|0
213301|NCT01904604|693206|P1|Overall Study|Anxiety about OFC/Refused OFC|2
213302|NCT01904604|693204|P3|Overall Study|Non-compliance|0
213303|NCT01904604|693205|P2|Overall Study|Non-compliance|0
213304|NCT01904604|693206|P1|Overall Study|Non-compliance|1
213305|NCT01904604|693204|P3|Overall Study|Withdrew before receiving dosing|0
213306|NCT01904604|693205|P2|Overall Study|Withdrew before receiving dosing|1
213307|NCT01904604|693206|P1|Overall Study|Withdrew before receiving dosing|0
213308|NCT01904279|693224|P2|Overall Study|Withdrawal by Subject|0
213309|NCT01904279|693225|P1|Overall Study|Withdrawal by Subject|1
213310|NCT01904279|693224|P2|Overall Study|Lack of Efficacy|3
213311|NCT01904279|693225|P1|Overall Study|Lack of Efficacy|2
213312|NCT01904149|693251|P6|Overall Study|non compliance with study drug|0
213313|NCT01904149|693252|P5|Overall Study|non compliance with study drug|0
213314|NCT01904149|693253|P4|Overall Study|non compliance with study drug|0
213315|NCT01904149|693254|P3|Overall Study|non compliance with study drug|0
213316|NCT01904149|693255|P2|Overall Study|non compliance with study drug|0
213317|NCT01904149|693256|P1|Overall Study|non compliance with study drug|1
213318|NCT01904149|693251|P6|Overall Study|Protocol Violation|0
213319|NCT01904149|693252|P5|Overall Study|Protocol Violation|0
213320|NCT01904149|693253|P4|Overall Study|Protocol Violation|0
213321|NCT01904149|693254|P3|Overall Study|Protocol Violation|0
213322|NCT01904149|693255|P2|Overall Study|Protocol Violation|1
213323|NCT01904149|693256|P1|Overall Study|Protocol Violation|0
213324|NCT01904149|693251|P6|Overall Study|Withdrawal by Subject|0
213325|NCT01904149|693252|P5|Overall Study|Withdrawal by Subject|1
213326|NCT01904149|693253|P4|Overall Study|Withdrawal by Subject|0
213327|NCT01904149|693254|P3|Overall Study|Withdrawal by Subject|1
213328|NCT01904149|693255|P2|Overall Study|Withdrawal by Subject|3
213329|NCT01904149|693256|P1|Overall Study|Withdrawal by Subject|1
213330|NCT01904149|693251|P6|Overall Study|Lack of Efficacy|1
213331|NCT01904149|693252|P5|Overall Study|Lack of Efficacy|3
213332|NCT01904149|693253|P4|Overall Study|Lack of Efficacy|3
213333|NCT01904149|693254|P3|Overall Study|Lack of Efficacy|1
213334|NCT01904149|693255|P2|Overall Study|Lack of Efficacy|3
213335|NCT01904149|693256|P1|Overall Study|Lack of Efficacy|0
213336|NCT01904149|693251|P6|Overall Study|Adverse Event|2
213337|NCT01904149|693252|P5|Overall Study|Adverse Event|1
213338|NCT01904149|693253|P4|Overall Study|Adverse Event|1
213339|NCT01904149|693254|P3|Overall Study|Adverse Event|0
213340|NCT01904149|693255|P2|Overall Study|Adverse Event|4
213341|NCT01904149|693256|P1|Overall Study|Adverse Event|3
213342|NCT01904058|693307|P4|Overall Study|Pregnancy|1
213343|NCT01904058|693308|P3|Overall Study|Pregnancy|0
213344|NCT01904058|693309|P2|Overall Study|Pregnancy|0
213345|NCT01904058|693310|P1|Overall Study|Pregnancy|0
213346|NCT01904058|693307|P4|Overall Study|Withdrawal by Subject|0
213347|NCT01904058|693308|P3|Overall Study|Withdrawal by Subject|1
213348|NCT01904058|693309|P2|Overall Study|Withdrawal by Subject|0
213349|NCT01904058|693310|P1|Overall Study|Withdrawal by Subject|1
213350|NCT01904058|693307|P4|Overall Study|Adverse Event|0
213351|NCT01904058|693308|P3|Overall Study|Adverse Event|0
213352|NCT01904058|693309|P2|Overall Study|Adverse Event|0
213353|NCT01904058|693310|P1|Overall Study|Adverse Event|2
213354|NCT01903993|693350|P2|Overall Study|Lost to Follow-up|1
213355|NCT01903993|693351|P1|Overall Study|Lost to Follow-up|1
213356|NCT01903993|693350|P2|Overall Study|Ongoing on study treatment|24
213357|NCT01903993|693351|P1|Overall Study|Ongoing on study treatment|1
213358|NCT01903993|693350|P2|Overall Study|Withdrawal by Subject|5
213359|NCT01903993|693351|P1|Overall Study|Withdrawal by Subject|12
213360|NCT01903993|693350|P2|Overall Study|Ongoing survival follow-up|36
213361|NCT01903993|693351|P1|Overall Study|Ongoing survival follow-up|36
213362|NCT01903993|693350|P2|Overall Study|Death|78
213363|NCT01903993|693351|P1|Overall Study|Death|93
213364|NCT01903876|693368|P2|Six-Month Follow-up Period|Lost to Follow-up|145
213365|NCT01903876|693369|P1|Six-Month Follow-up Period|Lost to Follow-up|91
213366|NCT01903876|693368|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
213367|NCT01903876|693369|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
213368|NCT01903720|693377|P1|Overall Study|Treatment with alternative drug|1
213369|NCT01903720|693377|P1|Overall Study|Lost to Follow-up|2
213370|NCT01903720|693377|P1|Overall Study|Rescinding of informed consent|2
213371|NCT01903720|693377|P1|Overall Study|Adverse Event|1
213372|NCT01903720|693377|P1|Overall Study|Inclusion / exclusion criteria not met|6
213373|NCT01903460|693396|P4|Overall Study|Adverse Event|1
213374|NCT01903460|693397|P3|Overall Study|Adverse Event|0
213375|NCT01903460|693398|P2|Overall Study|Adverse Event|0
213376|NCT01903460|693399|P1|Overall Study|Adverse Event|0
213377|NCT01902888|693481|P1|Overall Study|Study Terminated|3
213378|NCT01902303|693497|P2|Overall Study|Did not develop a cold sore|19
213379|NCT01902303|693498|P1|Overall Study|Did not develop a cold sore|21
213380|NCT01902303|693497|P2|Overall Study|subject lost investigational product|1
213381|NCT01902303|693498|P1|Overall Study|subject lost investigational product|0
213382|NCT01902303|693497|P2|Overall Study|Protocol Violation|2
213383|NCT01902303|693498|P1|Overall Study|Protocol Violation|2
213384|NCT01902303|693497|P2|Overall Study|Lost to Follow-up|1
213385|NCT01902303|693498|P1|Overall Study|Lost to Follow-up|0
213386|NCT01902303|693497|P2|Overall Study|Adverse Event|1
213387|NCT01902303|693498|P1|Overall Study|Adverse Event|0
213388|NCT01902134|693512|P6|Overall Study|not specified|0
213389|NCT01902134|693513|P5|Overall Study|not specified|1
213390|NCT01902134|693514|P4|Overall Study|not specified|0
213391|NCT01902134|693515|P3|Overall Study|not specified|2
213392|NCT01902134|693516|P2|Overall Study|not specified|1
213393|NCT01902134|693517|P1|Overall Study|not specified|0
213394|NCT01902134|693512|P6|Overall Study|no compliance|0
213395|NCT01902134|693513|P5|Overall Study|no compliance|0
213396|NCT01902134|693514|P4|Overall Study|no compliance|0
213397|NCT01902134|693515|P3|Overall Study|no compliance|0
213398|NCT01902134|693516|P2|Overall Study|no compliance|0
213399|NCT01902134|693517|P1|Overall Study|no compliance|1
213400|NCT01902134|693512|P6|Overall Study|Withdrawal by Subject|4
213401|NCT01902134|693513|P5|Overall Study|Withdrawal by Subject|5
213402|NCT01902134|693514|P4|Overall Study|Withdrawal by Subject|1
213403|NCT01902134|693515|P3|Overall Study|Withdrawal by Subject|9
213404|NCT01902134|693516|P2|Overall Study|Withdrawal by Subject|8
213405|NCT01902134|693517|P1|Overall Study|Withdrawal by Subject|4
213406|NCT01902134|693512|P6|Overall Study|Protocol Violation|1
213407|NCT01902134|693513|P5|Overall Study|Protocol Violation|0
213408|NCT01902134|693514|P4|Overall Study|Protocol Violation|0
213409|NCT01902134|693515|P3|Overall Study|Protocol Violation|0
213410|NCT01902134|693516|P2|Overall Study|Protocol Violation|0
213411|NCT01902134|693517|P1|Overall Study|Protocol Violation|0
213412|NCT01902134|693512|P6|Overall Study|Physician Decision|0
213413|NCT01902134|693513|P5|Overall Study|Physician Decision|0
213414|NCT01902134|693514|P4|Overall Study|Physician Decision|0
213415|NCT01902134|693515|P3|Overall Study|Physician Decision|0
213416|NCT01902134|693516|P2|Overall Study|Physician Decision|1
213417|NCT01902134|693517|P1|Overall Study|Physician Decision|0
213418|NCT01902134|693512|P6|Overall Study|Lack of Efficacy|1
213419|NCT01902134|693513|P5|Overall Study|Lack of Efficacy|0
213420|NCT01902134|693514|P4|Overall Study|Lack of Efficacy|0
213421|NCT01902134|693515|P3|Overall Study|Lack of Efficacy|2
213422|NCT01902134|693516|P2|Overall Study|Lack of Efficacy|0
213423|NCT01902134|693517|P1|Overall Study|Lack of Efficacy|0
213424|NCT01902134|693512|P6|Overall Study|Adverse Event|3
213425|NCT01902134|693513|P5|Overall Study|Adverse Event|1
213426|NCT01902134|693514|P4|Overall Study|Adverse Event|1
213427|NCT01902134|693515|P3|Overall Study|Adverse Event|2
213428|NCT01902134|693516|P2|Overall Study|Adverse Event|1
213429|NCT01902134|693517|P1|Overall Study|Adverse Event|3
213430|NCT01901393|693564|P2|Overall Study|Adverse Event|0
213431|NCT01901393|693565|P1|Overall Study|Adverse Event|1
213432|NCT01901341|693583|P2|Overall Study|Withdrawal by Subject|1
213433|NCT01901341|693584|P1|Overall Study|Withdrawal by Subject|1
213434|NCT01901341|693583|P2|Overall Study|Study Terminated by Sponsor|15
213435|NCT01901341|693584|P1|Overall Study|Study Terminated by Sponsor|13
213436|NCT01901341|693583|P2|Overall Study|Protocol Violation|0
213437|NCT01901341|693584|P1|Overall Study|Protocol Violation|2
213438|NCT01901341|693583|P2|Overall Study|Lost to Follow-up|1
213439|NCT01901341|693584|P1|Overall Study|Lost to Follow-up|0
213440|NCT01901341|693583|P2|Overall Study|Lack of Efficacy|2
213441|NCT01901341|693584|P1|Overall Study|Lack of Efficacy|0
213442|NCT01901341|693583|P2|Overall Study|Adverse Event|2
213443|NCT01901341|693584|P1|Overall Study|Adverse Event|4
213444|NCT01901328|693598|P2|Overall Study|Lack of Efficacy|1
213445|NCT01901328|693599|P1|Overall Study|Lack of Efficacy|0
213446|NCT01901328|693598|P2|Overall Study|Withdrawal by Subject|2
213447|NCT01901328|693599|P1|Overall Study|Withdrawal by Subject|1
213448|NCT01901328|693598|P2|Overall Study|Study Terminated by Sponsor|16
213449|NCT01901328|693599|P1|Overall Study|Study Terminated by Sponsor|19
213450|NCT01901328|693598|P2|Overall Study|Protocol Violation|1
213451|NCT01901328|693599|P1|Overall Study|Protocol Violation|1
213452|NCT01901328|693598|P2|Overall Study|Physician Decision|1
213453|NCT01901328|693599|P1|Overall Study|Physician Decision|0
213454|NCT01901328|693598|P2|Overall Study|Lost to Follow-up|0
213455|NCT01901328|693599|P1|Overall Study|Lost to Follow-up|1
213456|NCT01901302|693613|P2|Overall Study|Withdrawal by Subject|0
213457|NCT01901302|693614|P1|Overall Study|Withdrawal by Subject|2
213458|NCT01901302|693613|P2|Overall Study|Study Terminated by Sponsor|20
213459|NCT01901302|693614|P1|Overall Study|Study Terminated by Sponsor|23
213460|NCT01901302|693613|P2|Overall Study|Lack of Efficacy|2
213461|NCT01901302|693614|P1|Overall Study|Lack of Efficacy|0
213462|NCT01901302|693613|P2|Overall Study|Adverse Event|1
213463|NCT01901302|693614|P1|Overall Study|Adverse Event|2
213464|NCT01901185|693644|P1|Overall Study|Withdrawal by Subject|2
213465|NCT01900314|693653|P2|Overall Study|Withdrawal by Subject|3
213466|NCT01900314|693654|P1|Overall Study|Withdrawal by Subject|3
213467|NCT01900314|693653|P2|Overall Study|Protocol Violation|1
213468|NCT01900314|693654|P1|Overall Study|Protocol Violation|0
213469|NCT01900314|693653|P2|Overall Study|Lost to Follow-up|0
213470|NCT01900314|693654|P1|Overall Study|Lost to Follow-up|1
213471|NCT01900054|693684|P1|Overall Study|Withdrawal by Subject|1
213472|NCT01900054|693684|P1|Overall Study|Physician Decision|1
213473|NCT01899768|693693|P1|Part B|Withdrawal by Subject|1
213474|NCT01899768|693693|P1|Part B|Adverse Event|1
213475|NCT01899768|693693|P1|Part A|Withdrawal by Subject|1
213476|NCT01899768|693693|P1|Part A|Adverse Event|2
213477|NCT01899742|693767|P2|Overall Study|Withdrawal by Subject|5
213478|NCT01899742|693768|P1|Overall Study|Withdrawal by Subject|9
213479|NCT01899742|693767|P2|Overall Study|Protocol Violation|2
213480|NCT01899742|693768|P1|Overall Study|Protocol Violation|2
213481|NCT01899742|693767|P2|Overall Study|Lack of Efficacy|5
213482|NCT01899742|693768|P1|Overall Study|Lack of Efficacy|1
213483|NCT01899742|693767|P2|Overall Study|Adverse Event|4
213484|NCT01899742|693768|P1|Overall Study|Adverse Event|5
213485|NCT01899144|693807|P1|Treatment Period 5|Not specified|1
213486|NCT01899144|693807|P1|Treatment Period 3|Not specified|2
213487|NCT01899144|693807|P1|Treatment Period 2|Not specified|1
213488|NCT01898884|693834|P9|Multiple Dose Period|Randomized Not Treated|1
213489|NCT01898884|693835|P8|Multiple Dose Period|Randomized Not Treated|0
213490|NCT01898884|693836|P7|Multiple Dose Period|Randomized Not Treated|0
213491|NCT01898884|693837|P6|Multiple Dose Period|Randomized Not Treated|0
213492|NCT01898884|693838|P5|Multiple Dose Period|Randomized Not Treated|0
213493|NCT01898884|693839|P4|Multiple Dose Period|Randomized Not Treated|0
213494|NCT01898884|693840|P3|Multiple Dose Period|Randomized Not Treated|0
213495|NCT01898884|693841|P2|Multiple Dose Period|Randomized Not Treated|0
213496|NCT01898884|693842|P1|Multiple Dose Period|Randomized Not Treated|0
213497|NCT01898884|693834|P9|Multiple Dose Period|Adverse Event|0
213498|NCT01898884|693835|P8|Multiple Dose Period|Adverse Event|0
213499|NCT01898884|693836|P7|Multiple Dose Period|Adverse Event|1
213500|NCT01898884|693837|P6|Multiple Dose Period|Adverse Event|0
213501|NCT01898884|693838|P5|Multiple Dose Period|Adverse Event|0
213502|NCT01898884|693839|P4|Multiple Dose Period|Adverse Event|0
213503|NCT01898884|693840|P3|Multiple Dose Period|Adverse Event|0
213504|NCT01898884|693841|P2|Multiple Dose Period|Adverse Event|0
213505|NCT01898884|693842|P1|Multiple Dose Period|Adverse Event|0
213506|NCT01898598|693994|P2|Overall Study|Unspecified|1
213507|NCT01898598|693995|P1|Overall Study|Unspecified|0
213508|NCT01898598|693994|P2|Overall Study|Lost to Follow-up|1
213509|NCT01898598|693995|P1|Overall Study|Lost to Follow-up|0
213510|NCT01898598|693994|P2|Overall Study|Withdrawal by Subject|0
213511|NCT01898598|693995|P1|Overall Study|Withdrawal by Subject|3
213512|NCT01898598|693994|P2|Overall Study|Adverse Event|0
213513|NCT01898598|693995|P1|Overall Study|Adverse Event|1
213514|NCT01898442|694014|P3|Overall Study|Patient vomited pills|1
213515|NCT01898442|694015|P2|Overall Study|Patient vomited pills|0
213516|NCT01898442|694016|P1|Overall Study|Patient vomited pills|0
213517|NCT01898442|694014|P3|Overall Study|Hemolysis/technical problems|2
213518|NCT01898442|694015|P2|Overall Study|Hemolysis/technical problems|2
213519|NCT01898442|694016|P1|Overall Study|Hemolysis/technical problems|1
213520|NCT01898286|694045|P1|Overall Study|Lost to Follow-up|1
213521|NCT01898286|694045|P1|Overall Study|Protocol Violation|1
213522|NCT01898286|694045|P1|Overall Study|Withdrawal by Subject|1
213523|NCT01898208|694055|P3|Overall Study|Lost to Follow-up|1
213524|NCT01898208|694056|P2|Overall Study|Lost to Follow-up|1
213525|NCT01898208|694057|P1|Overall Study|Lost to Follow-up|3
213526|NCT01898208|694055|P3|Overall Study|System/Technical Error|3
213527|NCT01898208|694056|P2|Overall Study|System/Technical Error|2
213528|NCT01898208|694057|P1|Overall Study|System/Technical Error|1
213529|NCT01898208|694055|P3|Overall Study|Non-Blood Specimens in Bottles|4
213530|NCT01898208|694056|P2|Overall Study|Non-Blood Specimens in Bottles|5
213531|NCT01898208|694057|P1|Overall Study|Non-Blood Specimens in Bottles|3
213532|NCT01898208|694055|P3|Overall Study|Negative Gram Stain|6
213533|NCT01898208|694056|P2|Overall Study|Negative Gram Stain|9
213534|NCT01898208|694057|P1|Overall Study|Negative Gram Stain|6
213535|NCT01898208|694055|P3|Overall Study|Death/comfort care within 24 hours|8
213536|NCT01898208|694056|P2|Overall Study|Death/comfort care within 24 hours|9
213537|NCT01898208|694057|P1|Overall Study|Death/comfort care within 24 hours|10
213538|NCT01898208|694055|P3|Overall Study|Positive blood culture|15
213539|NCT01898208|694056|P2|Overall Study|Positive blood culture|23
213540|NCT01898208|694057|P1|Overall Study|Positive blood culture|17
213541|NCT01898091|694103|P2|Overall Study|Withdrawal by Subject|5
213542|NCT01898091|694104|P1|Overall Study|Withdrawal by Subject|1
213543|NCT01898091|694103|P2|Overall Study|Lost to Follow-up|1
213544|NCT01898091|694104|P1|Overall Study|Lost to Follow-up|1
213545|NCT01897727|694139|P2|Overall Study|Exclusion: central sleep apnea|1
213546|NCT01897727|694140|P1|Overall Study|Exclusion: central sleep apnea|0
213547|NCT01897233|694169|P1|Part B (24 Weeks)|Physician Decision|1
213548|NCT01897233|694169|P1|Part B (24 Weeks)|Withdrawal by Subject|2
213549|NCT01897233|694169|P1|Part B (24 Weeks)|Adverse Event|1
213550|NCT01896986|694202|P2|Overall Study|samples lost|23
213551|NCT01896986|694203|P1|Overall Study|samples lost|14
213552|NCT01896726|694209|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
213553|NCT01896726|694209|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
213554|NCT01896557|694233|P2|Clopidogrel + GI Protector|Reading error|3
213555|NCT01896557|694234|P1|Clopidogrel + GI Protector|Reading error|1
213556|NCT01896557|694233|P2|Clopidogrel + GI Protector|low adherence|1
213557|NCT01896557|694234|P1|Clopidogrel + GI Protector|low adherence|1
213558|NCT01896557|694233|P2|Clopidogrel Alone|Adverse Event|0
213559|NCT01896557|694234|P1|Clopidogrel Alone|Adverse Event|1
213560|NCT01896297|694267|P1|Overall Study|Died in post treatment phase|1
213561|NCT01896232|694274|P2|Overall Study|Lost to Follow-up|12
213562|NCT01896232|694275|P1|Overall Study|Lost to Follow-up|9
213563|NCT01896232|694274|P2|Overall Study|Sponsor Decision|0
213564|NCT01896232|694275|P1|Overall Study|Sponsor Decision|2
213565|NCT01896232|694274|P2|Overall Study|Withdrawal by Subject|31
213566|NCT01896232|694275|P1|Overall Study|Withdrawal by Subject|32
213567|NCT01896232|694274|P2|Overall Study|Death|10
213568|NCT01896232|694275|P1|Overall Study|Death|6
213569|NCT01896193|694303|P2|Overall Study|Withdrew Consent|0
213570|NCT01896193|694304|P1|Overall Study|Withdrew Consent|1
213571|NCT01896193|694303|P2|Overall Study|Protocol Violation|1
213572|NCT01896193|694304|P1|Overall Study|Protocol Violation|0
213573|NCT01896193|694303|P2|Overall Study|Lack of Efficacy|11
213574|NCT01896193|694304|P1|Overall Study|Lack of Efficacy|20
213575|NCT01896050|694353|P2|Overall Study|Death|0
213576|NCT01896050|694354|P1|Overall Study|Death|1
213577|NCT01896050|694353|P2|Overall Study|Adverse Event|2
213578|NCT01896050|694354|P1|Overall Study|Adverse Event|37
213579|NCT01895543|694393|P1|Overall Study|Other (Not fulfilling above criteria)|24
213580|NCT01895543|694393|P1|Overall Study|Physician Decision|2
213581|NCT01895543|694393|P1|Overall Study|Protocol Violation|1
213582|NCT01895543|694393|P1|Overall Study|Subject's substantial non-compliance|6
213583|NCT01895543|694393|P1|Overall Study|Adverse Event|28
213584|NCT01895543|694393|P1|Overall Study|Lost to Follow-up|25
213585|NCT01895543|694393|P1|Overall Study|Withdrawal by Subject|43
213586|NCT01895335|694407|P1|Overall Study|Other than Specified Above|44
213587|NCT01895335|694407|P1|Overall Study|Included But Not treated|1
213588|NCT01895335|694407|P1|Overall Study|Poor Compliance to Protocol|11
213589|NCT01895335|694407|P1|Overall Study|Lack of Efficacy|53
213590|NCT01895335|694407|P1|Overall Study|Adverse Event|106
213591|NCT01895322|694424|P1|Overall Study|Protocol Violation|10
213592|NCT01895322|694424|P1|Overall Study|Withdrawal by Subject|2
213593|NCT01895322|694424|P1|Overall Study|Adverse Event|1
213594|NCT01895309|694433|P2|Overall Study|Withdrawal by Subject|18
213595|NCT01895309|694434|P1|Overall Study|Withdrawal by Subject|9
213596|NCT01895309|694433|P2|Overall Study|Physician Decision|10
213597|NCT01895309|694434|P1|Overall Study|Physician Decision|15
213598|NCT01895309|694433|P2|Overall Study|Lost to Follow-up|3
213599|NCT01895309|694434|P1|Overall Study|Lost to Follow-up|1
213600|NCT01895309|694433|P2|Overall Study|Lack of Efficacy|3
213601|NCT01895309|694434|P1|Overall Study|Lack of Efficacy|1
213602|NCT01895309|694433|P2|Overall Study|Protocol Violation|0
213603|NCT01895309|694434|P1|Overall Study|Protocol Violation|1
213604|NCT01895309|694433|P2|Overall Study|Adverse Event|17
213605|NCT01895309|694434|P1|Overall Study|Adverse Event|13
213606|NCT01895270|694448|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
213607|NCT01895270|694449|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
213608|NCT01895270|694448|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
213609|NCT01895270|694449|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
213610|NCT01895270|694448|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
213611|NCT01895270|694449|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
213612|NCT01895270|694448|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
213613|NCT01895270|694449|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
213614|NCT01895270|694448|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
213615|NCT01895270|694449|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
213616|NCT01895270|694448|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
213617|NCT01895270|694449|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
213618|NCT01895270|694448|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
213619|NCT01895270|694449|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
213620|NCT01895101|694458|P3|Overall Study|coagulation disorder|0
213621|NCT01895101|694459|P2|Overall Study|coagulation disorder|1
213622|NCT01895101|694460|P1|Overall Study|coagulation disorder|0
213623|NCT01895101|694458|P3|Overall Study|Death|0
213624|NCT01895101|694459|P2|Overall Study|Death|1
213625|NCT01895101|694460|P1|Overall Study|Death|0
213626|NCT01895101|694458|P3|Overall Study|another study, enrolled in other study|0
213627|NCT01895101|694459|P2|Overall Study|another study, enrolled in other study|1
213628|NCT01895101|694460|P1|Overall Study|another study, enrolled in other study|0
213629|NCT01895101|694458|P3|Overall Study|Withdrawal by Subject|2
213630|NCT01895101|694459|P2|Overall Study|Withdrawal by Subject|1
213631|NCT01895101|694460|P1|Overall Study|Withdrawal by Subject|0
213632|NCT01895101|694458|P3|Overall Study|OPCAB procedure|3
213633|NCT01895101|694459|P2|Overall Study|OPCAB procedure|1
213634|NCT01895101|694460|P1|Overall Study|OPCAB procedure|1
213635|NCT01894984|694487|P2|Overall Study|Unspecified|175
213636|NCT01894984|694488|P1|Overall Study|Unspecified|314
213637|NCT01894607|694537|P1|Overall Study|Ineligible|1
213638|NCT01894581|694544|P2|Overall Study|Screen Failure|4
213639|NCT01894581|694545|P1|Overall Study|Screen Failure|3
213640|NCT01894581|694544|P2|Overall Study|Withdrawal by Subject|3
213641|NCT01894581|694545|P1|Overall Study|Withdrawal by Subject|2
213642|NCT01894256|694558|P3|Part B|Lack of Efficacy|13
213643|NCT01894256|694559|P2|Part B|Lack of Efficacy|12
213644|NCT01894256|694560|P1|Part B|Lack of Efficacy|15
213645|NCT01894256|694558|P3|Part B|Withdrawal by Subject|0
213646|NCT01894256|694559|P2|Part B|Withdrawal by Subject|1
213647|NCT01894256|694560|P1|Part B|Withdrawal by Subject|0
213648|NCT01894256|694558|P3|Part B|Death|1
213649|NCT01894256|694559|P2|Part B|Death|1
213650|NCT01894256|694560|P1|Part B|Death|0
213651|NCT01894256|694558|P3|Part A|Adverse Event|0
213652|NCT01894256|694559|P2|Part A|Adverse Event|1
213653|NCT01894256|694560|P1|Part A|Adverse Event|0
213654|NCT01894100|694606|P2|Overall Study|Withdrawal by Subject|0
213655|NCT01894100|694607|P1|Overall Study|Withdrawal by Subject|3
213656|NCT01894100|694606|P2|Overall Study|Lost to Follow-up|1
213657|NCT01894100|694607|P1|Overall Study|Lost to Follow-up|0
213658|NCT01894022|694617|P2|Overall Study|Study Closed/terminated|10
213659|NCT01894022|694618|P1|Overall Study|Study Closed/terminated|7
213660|NCT01894022|694617|P2|Overall Study|Adverse Event, non-fatal|0
213661|NCT01894022|694618|P1|Overall Study|Adverse Event, non-fatal|1
213662|NCT01894022|694617|P2|Overall Study|Death|0
213663|NCT01894022|694618|P1|Overall Study|Death|1
213664|NCT01893411|694686|P3|Overall Study|Lost to Follow-up|1
213665|NCT01893411|694687|P2|Overall Study|Lost to Follow-up|0
213666|NCT01893411|694688|P1|Overall Study|Lost to Follow-up|2
213667|NCT01893411|694686|P3|Overall Study|Withdrawal by Subject|3
213668|NCT01893411|694687|P2|Overall Study|Withdrawal by Subject|4
213669|NCT01893411|694688|P1|Overall Study|Withdrawal by Subject|7
213670|NCT01893411|694686|P3|Overall Study|Adverse Event|0
213671|NCT01893411|694687|P2|Overall Study|Adverse Event|0
213672|NCT01893411|694688|P1|Overall Study|Adverse Event|1
213673|NCT01893411|694686|P3|Overall Study|Not Specified|3
213674|NCT01893411|694687|P2|Overall Study|Not Specified|1
213675|NCT01893411|694688|P1|Overall Study|Not Specified|3
213676|NCT01893411|694686|P3|Overall Study|Lack of Efficacy|0
213677|NCT01893411|694687|P2|Overall Study|Lack of Efficacy|1
213678|NCT01893411|694688|P1|Overall Study|Lack of Efficacy|2
213679|NCT01893411|694686|P3|Overall Study|Physician Decision|2
213680|NCT01893411|694687|P2|Overall Study|Physician Decision|1
213681|NCT01893411|694688|P1|Overall Study|Physician Decision|1
213682|NCT01893411|694686|P3|Overall Study|Protocol Violation|0
213683|NCT01893411|694687|P2|Overall Study|Protocol Violation|0
213684|NCT01893411|694688|P1|Overall Study|Protocol Violation|1
213685|NCT01893346|694770|P4|Overall Study|Withdrawal by Subject|0
213686|NCT01893346|694771|P3|Overall Study|Withdrawal by Subject|0
213687|NCT01893346|694772|P2|Overall Study|Withdrawal by Subject|0
213688|NCT01893346|694773|P1|Overall Study|Withdrawal by Subject|2
213689|NCT01893346|694770|P4|Overall Study|Protocol Violation|0
213690|NCT01893346|694771|P3|Overall Study|Protocol Violation|0
213691|NCT01893346|694772|P2|Overall Study|Protocol Violation|0
213692|NCT01893346|694773|P1|Overall Study|Protocol Violation|1
213693|NCT01893346|694770|P4|Overall Study|Lost to Follow-up|0
213694|NCT01893346|694771|P3|Overall Study|Lost to Follow-up|0
213695|NCT01893346|694772|P2|Overall Study|Lost to Follow-up|1
213696|NCT01893346|694773|P1|Overall Study|Lost to Follow-up|0
213697|NCT01893281|694787|P1|Overall Study|Withdrawal by Subject|1
213698|NCT01893281|694787|P1|Overall Study|Protocol Violation|1
213699|NCT01893281|694787|P1|Overall Study|Adverse Event|1
213700|NCT01893203|694794|P1|Overall Study|Withdrawal by Subject|1
213701|NCT01892657|694801|P1|Overall Study|Protocol Violation|12
213702|NCT01892657|694801|P1|Overall Study|Withdrawal by Subject|6
213703|NCT01892189|694878|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
213704|NCT01892189|694879|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
213705|NCT01892189|694880|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
213706|NCT01892189|694881|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
213707|NCT01892189|694882|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
213708|NCT01892189|694883|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
213709|NCT01892189|694884|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
213710|NCT01892189|694885|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
213711|NCT01892189|694886|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
213712|NCT01892189|694878|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
213713|NCT01892189|694879|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
213714|NCT01892189|694880|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
213715|NCT01892189|694881|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
213716|NCT01892189|694882|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
213717|NCT01892189|694883|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
213718|NCT01892189|694884|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
213719|NCT01892189|694885|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
213720|NCT01892189|694886|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
213721|NCT01892189|694878|P9|Washout Period 1 (7 Days)|Adverse Event|1
213722|NCT01892189|694879|P8|Washout Period 1 (7 Days)|Adverse Event|0
213723|NCT01892189|694880|P7|Washout Period 1 (7 Days)|Adverse Event|0
213724|NCT01892189|694881|P6|Washout Period 1 (7 Days)|Adverse Event|0
213725|NCT01892189|694882|P5|Washout Period 1 (7 Days)|Adverse Event|0
213726|NCT01892189|694883|P4|Washout Period 1 (7 Days)|Adverse Event|0
213727|NCT01892189|694884|P3|Washout Period 1 (7 Days)|Adverse Event|0
213728|NCT01892189|694885|P2|Washout Period 1 (7 Days)|Adverse Event|0
213729|NCT01892189|694886|P1|Washout Period 1 (7 Days)|Adverse Event|0
213730|NCT01892163|694928|P2|Overall Study|Lost to Follow-up|0
213731|NCT01892163|694929|P1|Overall Study|Lost to Follow-up|1
213732|NCT01892163|694928|P2|Overall Study|Death|1
213733|NCT01892163|694929|P1|Overall Study|Death|1
213734|NCT01892020|694941|P2|Period 2|Protocol Violation|0
213735|NCT01892020|694942|P1|Period 2|Protocol Violation|1
213736|NCT01892020|694941|P2|Period 1|Unclassified|1
213737|NCT01892020|694942|P1|Period 1|Unclassified|0
213738|NCT01892020|694941|P2|Period 1|Protocol Violation|4
213739|NCT01892020|694942|P1|Period 1|Protocol Violation|2
213740|NCT01892020|694941|P2|Period 1|Adverse Event|1
213741|NCT01892020|694942|P1|Period 1|Adverse Event|1
213742|NCT01891864|694962|P6|Extension Period|Lost to Follow-up|0
213743|NCT01891864|694963|P5|Extension Period|Lost to Follow-up|0
213744|NCT01891864|694964|P4|Extension Period|Lost to Follow-up|0
213745|NCT01891864|694965|P3|Extension Period|Lost to Follow-up|2
213746|NCT01891864|694966|P2|Extension Period|Lost to Follow-up|0
213747|NCT01891864|694967|P1|Extension Period|Lost to Follow-up|0
213748|NCT01891864|694962|P6|Extension Period|Withdrawal by Subject|0
213749|NCT01891864|694963|P5|Extension Period|Withdrawal by Subject|4
213750|NCT01891864|694964|P4|Extension Period|Withdrawal by Subject|2
213751|NCT01891864|694965|P3|Extension Period|Withdrawal by Subject|1
213752|NCT01891864|694966|P2|Extension Period|Withdrawal by Subject|0
213753|NCT01891864|694967|P1|Extension Period|Withdrawal by Subject|0
213754|NCT01891864|694962|P6|Extension Period|Adverse Event|0
213755|NCT01891864|694963|P5|Extension Period|Adverse Event|2
213756|NCT01891864|694964|P4|Extension Period|Adverse Event|2
213757|NCT01891864|694965|P3|Extension Period|Adverse Event|4
213758|NCT01891864|694966|P2|Extension Period|Adverse Event|0
213759|NCT01891864|694967|P1|Extension Period|Adverse Event|0
213760|NCT01891864|694962|P6|Extension Period|Pregnancy|0
213761|NCT01891864|694963|P5|Extension Period|Pregnancy|0
213762|NCT01891864|694964|P4|Extension Period|Pregnancy|0
213763|NCT01891864|694965|P3|Extension Period|Pregnancy|1
213764|NCT01891864|694966|P2|Extension Period|Pregnancy|0
213765|NCT01891864|694967|P1|Extension Period|Pregnancy|0
213766|NCT01891864|694962|P6|Extension Period|Lack of Efficacy|0
213767|NCT01891864|694963|P5|Extension Period|Lack of Efficacy|1
213768|NCT01891864|694964|P4|Extension Period|Lack of Efficacy|1
213769|NCT01891864|694965|P3|Extension Period|Lack of Efficacy|0
213770|NCT01891864|694966|P2|Extension Period|Lack of Efficacy|0
213771|NCT01891864|694967|P1|Extension Period|Lack of Efficacy|0
213772|NCT01891864|694962|P6|Treatment Period 2|Withdrawal by Subject|1
213773|NCT01891864|694963|P5|Treatment Period 2|Withdrawal by Subject|1
213774|NCT01891864|694964|P4|Treatment Period 2|Withdrawal by Subject|4
213775|NCT01891864|694965|P3|Treatment Period 2|Withdrawal by Subject|3
213776|NCT01891864|694966|P2|Treatment Period 2|Withdrawal by Subject|0
213777|NCT01891864|694967|P1|Treatment Period 2|Withdrawal by Subject|0
213778|NCT01891864|694962|P6|Treatment Period 2|Termination of Site|0
213779|NCT01891864|694963|P5|Treatment Period 2|Termination of Site|2
213780|NCT01891864|694964|P4|Treatment Period 2|Termination of Site|0
213781|NCT01891864|694965|P3|Treatment Period 2|Termination of Site|0
213782|NCT01891864|694966|P2|Treatment Period 2|Termination of Site|0
213783|NCT01891864|694967|P1|Treatment Period 2|Termination of Site|0
213784|NCT01891864|694962|P6|Treatment Period 2|Adverse Event|4
213785|NCT01891864|694963|P5|Treatment Period 2|Adverse Event|0
213786|NCT01891864|694964|P4|Treatment Period 2|Adverse Event|2
213787|NCT01891864|694965|P3|Treatment Period 2|Adverse Event|1
213788|NCT01891864|694966|P2|Treatment Period 2|Adverse Event|0
213789|NCT01891864|694967|P1|Treatment Period 2|Adverse Event|0
213790|NCT01891864|694962|P6|Treatment Period 2|Lack of Efficacy|0
213791|NCT01891864|694963|P5|Treatment Period 2|Lack of Efficacy|1
213792|NCT01891864|694964|P4|Treatment Period 2|Lack of Efficacy|0
213793|NCT01891864|694965|P3|Treatment Period 2|Lack of Efficacy|1
213794|NCT01891864|694966|P2|Treatment Period 2|Lack of Efficacy|0
213795|NCT01891864|694967|P1|Treatment Period 2|Lack of Efficacy|0
213796|NCT01891864|694962|P6|Treatment Period 2|Site Termination|0
213797|NCT01891864|694963|P5|Treatment Period 2|Site Termination|0
213798|NCT01891864|694964|P4|Treatment Period 2|Site Termination|2
213799|NCT01891864|694965|P3|Treatment Period 2|Site Termination|1
213800|NCT01891864|694966|P2|Treatment Period 2|Site Termination|0
213801|NCT01891864|694967|P1|Treatment Period 2|Site Termination|0
213802|NCT01891864|694962|P6|Treatment Period 2|Physician Decision|0
213803|NCT01891864|694963|P5|Treatment Period 2|Physician Decision|0
213804|NCT01891864|694964|P4|Treatment Period 2|Physician Decision|0
213805|NCT01891864|694965|P3|Treatment Period 2|Physician Decision|1
213806|NCT01891864|694966|P2|Treatment Period 2|Physician Decision|0
213807|NCT01891864|694967|P1|Treatment Period 2|Physician Decision|0
213808|NCT01891864|694962|P6|Treatment Period 2|Protocol Violation|0
213809|NCT01891864|694963|P5|Treatment Period 2|Protocol Violation|0
213810|NCT01891864|694964|P4|Treatment Period 2|Protocol Violation|1
213811|NCT01891864|694965|P3|Treatment Period 2|Protocol Violation|0
213812|NCT01891864|694966|P2|Treatment Period 2|Protocol Violation|0
213813|NCT01891864|694967|P1|Treatment Period 2|Protocol Violation|0
213814|NCT01891864|694962|P6|Treatment Period 1|Lost to Follow-up|0
213815|NCT01891864|694963|P5|Treatment Period 1|Lost to Follow-up|0
213816|NCT01891864|694964|P4|Treatment Period 1|Lost to Follow-up|0
213817|NCT01891864|694965|P3|Treatment Period 1|Lost to Follow-up|0
213818|NCT01891864|694966|P2|Treatment Period 1|Lost to Follow-up|0
213819|NCT01891864|694967|P1|Treatment Period 1|Lost to Follow-up|1
213820|NCT01891864|694962|P6|Treatment Period 1|Withdrawal by Subject|0
213821|NCT01891864|694963|P5|Treatment Period 1|Withdrawal by Subject|0
213822|NCT01891864|694964|P4|Treatment Period 1|Withdrawal by Subject|0
213823|NCT01891864|694965|P3|Treatment Period 1|Withdrawal by Subject|0
213824|NCT01891864|694966|P2|Treatment Period 1|Withdrawal by Subject|5
213825|NCT01891864|694967|P1|Treatment Period 1|Withdrawal by Subject|2
213826|NCT01891864|694962|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
213827|NCT01891864|694963|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
213828|NCT01891864|694964|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
213829|NCT01891864|694965|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
213830|NCT01891864|694966|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
213831|NCT01891864|694967|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
213832|NCT01891864|694962|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
213833|NCT01891864|694963|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
213834|NCT01891864|694964|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
213835|NCT01891864|694965|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
213836|NCT01891864|694966|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
213837|NCT01891864|694967|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
213838|NCT01891864|694962|P6|Treatment Period 1|Physician Decision|0
213839|NCT01891864|694963|P5|Treatment Period 1|Physician Decision|0
213840|NCT01891864|694964|P4|Treatment Period 1|Physician Decision|0
213841|NCT01891864|694965|P3|Treatment Period 1|Physician Decision|0
213842|NCT01891864|694966|P2|Treatment Period 1|Physician Decision|1
213843|NCT01891864|694967|P1|Treatment Period 1|Physician Decision|0
213844|NCT01891864|694962|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
213845|NCT01891864|694963|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
213846|NCT01891864|694964|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
213847|NCT01891864|694965|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
213848|NCT01891864|694966|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
213849|NCT01891864|694967|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
213850|NCT01891669|695010|P10|Overall Study|Unspecified|0
213851|NCT01891669|695011|P9|Overall Study|Unspecified|0
213852|NCT01891669|695012|P8|Overall Study|Unspecified|1
213853|NCT01891669|695013|P7|Overall Study|Unspecified|0
213854|NCT01891669|695014|P6|Overall Study|Unspecified|0
213855|NCT01891669|695015|P5|Overall Study|Unspecified|0
213856|NCT01891669|695016|P4|Overall Study|Unspecified|0
213857|NCT01891669|695017|P3|Overall Study|Unspecified|0
213858|NCT01891669|695018|P2|Overall Study|Unspecified|0
213859|NCT01891669|695019|P1|Overall Study|Unspecified|1
213860|NCT01891669|695010|P10|Overall Study|Withdrawal by Subject|1
213861|NCT01891669|695011|P9|Overall Study|Withdrawal by Subject|1
213862|NCT01891669|695012|P8|Overall Study|Withdrawal by Subject|2
213863|NCT01891669|695013|P7|Overall Study|Withdrawal by Subject|1
213864|NCT01891669|695014|P6|Overall Study|Withdrawal by Subject|0
213865|NCT01891669|695015|P5|Overall Study|Withdrawal by Subject|0
213866|NCT01891669|695016|P4|Overall Study|Withdrawal by Subject|0
213867|NCT01891669|695017|P3|Overall Study|Withdrawal by Subject|0
213868|NCT01891669|695018|P2|Overall Study|Withdrawal by Subject|1
213869|NCT01891669|695019|P1|Overall Study|Withdrawal by Subject|1
213870|NCT01891669|695010|P10|Overall Study|Death|1
213871|NCT01891669|695011|P9|Overall Study|Death|0
213872|NCT01891669|695012|P8|Overall Study|Death|1
213873|NCT01891669|695013|P7|Overall Study|Death|0
213874|NCT01891669|695014|P6|Overall Study|Death|0
213875|NCT01891669|695015|P5|Overall Study|Death|0
213876|NCT01891669|695016|P4|Overall Study|Death|0
213877|NCT01891669|695017|P3|Overall Study|Death|0
213878|NCT01891669|695018|P2|Overall Study|Death|0
213879|NCT01891669|695019|P1|Overall Study|Death|0
213880|NCT01890915|695181|P2|Overall Study|Equipment Malfunction|1
213881|NCT01890915|695182|P1|Overall Study|Equipment Malfunction|0
213882|NCT01890915|695181|P2|Overall Study|Protocol Violation|0
213883|NCT01890915|695182|P1|Overall Study|Protocol Violation|2
213884|NCT01890915|695181|P2|Overall Study|Adverse Event|0
213885|NCT01890915|695182|P1|Overall Study|Adverse Event|1
213886|NCT01890785|695198|P6|Third Intervention|Withdrawal by Subject|0
213887|NCT01890785|695199|P5|Third Intervention|Withdrawal by Subject|0
213888|NCT01890785|695200|P4|Third Intervention|Withdrawal by Subject|0
213889|NCT01890785|695201|P3|Third Intervention|Withdrawal by Subject|0
213890|NCT01890785|695202|P2|Third Intervention|Withdrawal by Subject|1
213891|NCT01890785|695203|P1|Third Intervention|Withdrawal by Subject|0
213892|NCT01890746|695222|P2|Overall Study|Ongoing|50
213893|NCT01890746|695223|P1|Overall Study|Ongoing|44
213894|NCT01890746|695222|P2|Overall Study|Death|14
213895|NCT01890746|695223|P1|Overall Study|Death|23
213896|NCT01890746|695222|P2|Overall Study|Withdrawal by Subject|8
213897|NCT01890746|695223|P1|Overall Study|Withdrawal by Subject|4
213898|NCT01890746|695222|P2|Overall Study|Physician Decision|2
213899|NCT01890746|695223|P1|Overall Study|Physician Decision|2
213900|NCT01890746|695222|P2|Overall Study|Adverse Event|0
213901|NCT01890746|695223|P1|Overall Study|Adverse Event|1
213902|NCT01890512|695295|P1|Overall Study|Protocol Violation|1
213903|NCT01890512|695295|P1|Overall Study|Withdrawal by Subject|1
213904|NCT01890512|695295|P1|Overall Study|Physician Decision|1
213905|NCT01890473|695301|P2|Overall Study|Poor/non-compliance|0
213906|NCT01890473|695302|P1|Overall Study|Poor/non-compliance|1
213907|NCT01890473|695301|P2|Overall Study|Lost to Follow-up|0
213908|NCT01890473|695302|P1|Overall Study|Lost to Follow-up|1
213909|NCT01890148|695344|P1|Overall Study|Adverse Event|1
213910|NCT01890122|695364|P4|Overall Study|Randomized but not Treated|0
213911|NCT01890122|695365|P3|Overall Study|Randomized but not Treated|0
213912|NCT01890122|695366|P2|Overall Study|Randomized but not Treated|1
213913|NCT01890122|695367|P1|Overall Study|Randomized but not Treated|1
213914|NCT01890122|695364|P4|Overall Study|Reason not Specified|2
213915|NCT01890122|695365|P3|Overall Study|Reason not Specified|1
213916|NCT01890122|695366|P2|Overall Study|Reason not Specified|1
213917|NCT01890122|695367|P1|Overall Study|Reason not Specified|0
213918|NCT01890122|695364|P4|Overall Study|Lack of Efficacy|41
213919|NCT01890122|695365|P3|Overall Study|Lack of Efficacy|7
213920|NCT01890122|695366|P2|Overall Study|Lack of Efficacy|24
213921|NCT01890122|695367|P1|Overall Study|Lack of Efficacy|14
213922|NCT01890122|695364|P4|Overall Study|Voluntary Withdrawal|11
213923|NCT01890122|695365|P3|Overall Study|Voluntary Withdrawal|2
213924|NCT01890122|695366|P2|Overall Study|Voluntary Withdrawal|8
213925|NCT01890122|695367|P1|Overall Study|Voluntary Withdrawal|8
213926|NCT01890122|695364|P4|Overall Study|Lost to Follow-up|2
213927|NCT01890122|695365|P3|Overall Study|Lost to Follow-up|2
213928|NCT01890122|695366|P2|Overall Study|Lost to Follow-up|1
213929|NCT01890122|695367|P1|Overall Study|Lost to Follow-up|0
213930|NCT01890122|695364|P4|Overall Study|Major Protocol Deviation|1
213931|NCT01890122|695365|P3|Overall Study|Major Protocol Deviation|0
213932|NCT01890122|695366|P2|Overall Study|Major Protocol Deviation|1
213933|NCT01890122|695367|P1|Overall Study|Major Protocol Deviation|3
213934|NCT01890122|695364|P4|Overall Study|Adverse Event|2
213935|NCT01890122|695365|P3|Overall Study|Adverse Event|1
213936|NCT01890122|695366|P2|Overall Study|Adverse Event|1
213937|NCT01890122|695367|P1|Overall Study|Adverse Event|1
213938|NCT01889251|695514|P2|Overall Study|Adverse Event|0
213939|NCT01889251|695515|P1|Overall Study|Adverse Event|1
213940|NCT01888965|695521|P1|Overall Study|Lack of Efficacy|4
213941|NCT01888965|695521|P1|Overall Study|Adverse Event|5
213942|NCT01888900|695533|P2|Overall Study|failed treatment|2
213943|NCT01888900|695534|P1|Overall Study|failed treatment|0
213944|NCT01888367|695557|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
213945|NCT01888367|695558|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
213946|NCT01888367|695559|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
213947|NCT01888367|695557|P3|Overall Study|Protocol Violation|1
213948|NCT01888367|695558|P2|Overall Study|Protocol Violation|0
213949|NCT01888367|695559|P1|Overall Study|Protocol Violation|0
213950|NCT01888367|695557|P3|Overall Study|Lost to Follow-up|0
213951|NCT01888367|695558|P2|Overall Study|Lost to Follow-up|1
213952|NCT01888367|695559|P1|Overall Study|Lost to Follow-up|1
213953|NCT01888367|695557|P3|Overall Study|Withdrawal by Subject|1
213954|NCT01888367|695558|P2|Overall Study|Withdrawal by Subject|0
213955|NCT01888367|695559|P1|Overall Study|Withdrawal by Subject|1
213956|NCT01888367|695557|P3|Overall Study|Death|1
213957|NCT01888367|695558|P2|Overall Study|Death|0
213958|NCT01888367|695559|P1|Overall Study|Death|2
213959|NCT01888367|695557|P3|Overall Study|Physician Decision|2
213960|NCT01888367|695558|P2|Overall Study|Physician Decision|4
213961|NCT01888367|695559|P1|Overall Study|Physician Decision|3
213962|NCT01888003|695579|P3|Overall Study|Study Terminated|40
213963|NCT01888003|695580|P2|Overall Study|Study Terminated|6
213964|NCT01888003|695581|P1|Overall Study|Study Terminated|5
213965|NCT01887678|695621|P2|Overall Study|Specified|2
213966|NCT01887678|695622|P1|Overall Study|Specified|1
213967|NCT01887678|695621|P2|Overall Study|Non-compliance|3
213968|NCT01887678|695622|P1|Overall Study|Non-compliance|0
213969|NCT01887678|695621|P2|Overall Study|Lack of Efficacy|2
213970|NCT01887678|695622|P1|Overall Study|Lack of Efficacy|1
213971|NCT01887678|695621|P2|Overall Study|Deterioration of clinical condition|4
213972|NCT01887678|695622|P1|Overall Study|Deterioration of clinical condition|0
213973|NCT01887678|695621|P2|Overall Study|Lost to Follow-up|2
213974|NCT01887678|695622|P1|Overall Study|Lost to Follow-up|4
213975|NCT01887678|695621|P2|Overall Study|Withdrawal of consent|4
213976|NCT01887678|695622|P1|Overall Study|Withdrawal of consent|3
213977|NCT01887678|695621|P2|Overall Study|Exceeded rescue medication dosage|5
213978|NCT01887678|695622|P1|Overall Study|Exceeded rescue medication dosage|4
213979|NCT01887678|695621|P2|Overall Study|Adverse Event|6
213980|NCT01887678|695622|P1|Overall Study|Adverse Event|4
213981|NCT01887418|695690|P3|Overall Study|Travelling difficulties|1
213982|NCT01887418|695691|P2|Overall Study|Travelling difficulties|0
213983|NCT01887418|695692|P1|Overall Study|Travelling difficulties|0
213984|NCT01887353|695711|P2|Overall Study|Study stopped early|3
213985|NCT01887353|695712|P1|Overall Study|Study stopped early|4
213986|NCT01886781|695751|P2|Overall Study|Worsening of symptoms|1
213987|NCT01886781|695752|P1|Overall Study|Worsening of symptoms|1
213988|NCT01886781|695751|P2|Overall Study|Withdrawal by Subject|1
213989|NCT01886781|695752|P1|Overall Study|Withdrawal by Subject|2
213990|NCT01886781|695751|P2|Overall Study|Lost to Follow-up|0
213991|NCT01886781|695752|P1|Overall Study|Lost to Follow-up|5
213992|NCT01886781|695751|P2|Overall Study|Adverse Event|0
213993|NCT01886781|695752|P1|Overall Study|Adverse Event|1
213994|NCT01886781|695751|P2|Overall Study|Protocol Violation|0
213995|NCT01886781|695752|P1|Overall Study|Protocol Violation|5
213996|NCT01886716|695762|P4|Week 3|Lost to Follow-up|1
213997|NCT01886716|695763|P3|Week 3|Lost to Follow-up|0
213998|NCT01886716|695764|P2|Week 3|Lost to Follow-up|1
213999|NCT01886716|695765|P1|Week 3|Lost to Follow-up|1
214000|NCT01886716|695762|P4|Week 2|Lost to Follow-up|3
214001|NCT01886716|695763|P3|Week 2|Lost to Follow-up|1
214002|NCT01886716|695764|P2|Week 2|Lost to Follow-up|2
214003|NCT01886716|695765|P1|Week 2|Lost to Follow-up|3
214004|NCT01886716|695762|P4|Week 1|Lost to Follow-up|2
214005|NCT01886716|695763|P3|Week 1|Lost to Follow-up|2
214006|NCT01886716|695764|P2|Week 1|Lost to Follow-up|0
214007|NCT01886716|695765|P1|Week 1|Lost to Follow-up|0
214008|NCT01886690|695781|P2|Overall Study|Personal Reasons|1
214009|NCT01886690|695782|P1|Overall Study|Personal Reasons|0
214010|NCT01886690|695781|P2|Overall Study|Protocol Violation|1
214011|NCT01886690|695782|P1|Overall Study|Protocol Violation|0
214012|NCT01886313|695798|P2|Overall Study|Adverse Event|1
214013|NCT01886313|695799|P1|Overall Study|Adverse Event|1
214014|NCT01886300|695805|P1|Overall Study|Trial terminated by sponsor|16
214015|NCT01886287|695816|P1|Overall Study|Clinical progression due to disease|1
214016|NCT01886287|695816|P1|Overall Study|Radiographic disease progression|1
214017|NCT01885559|695856|P2|Overall Study|Protocol Violation|1
214018|NCT01885559|695857|P1|Overall Study|Protocol Violation|0
214019|NCT01885559|695856|P2|Overall Study|Less than full participation|19
214020|NCT01885559|695857|P1|Overall Study|Less than full participation|9
214021|NCT01885559|695856|P2|Overall Study|Lost to Follow-up|16
214022|NCT01885559|695857|P1|Overall Study|Lost to Follow-up|15
214023|NCT01885104|695902|P2|Overall Study|Physician Decision|0
214024|NCT01885104|695903|P1|Overall Study|Physician Decision|1
214025|NCT01885104|695902|P2|Overall Study|Lost to Follow-up|1
214026|NCT01885104|695903|P1|Overall Study|Lost to Follow-up|0
214027|NCT01885104|695902|P2|Overall Study|Withdrawal of Consent|0
214028|NCT01885104|695903|P1|Overall Study|Withdrawal of Consent|1
214029|NCT01885000|695913|P2|Overall Study|Protocol Violation|1
214030|NCT01885000|695914|P1|Overall Study|Protocol Violation|0
214031|NCT01885000|695913|P2|Overall Study|Withdrawal by Subject|1
214032|NCT01885000|695914|P1|Overall Study|Withdrawal by Subject|1
214033|NCT01885000|695913|P2|Overall Study|Adverse Event|0
214034|NCT01885000|695914|P1|Overall Study|Adverse Event|1
214035|NCT01884688|695926|P1|Overall Study|Screen Failure|2
214036|NCT01884675|695932|P2|Overall Study|Study closed/terminated|2
214037|NCT01884675|695933|P1|Overall Study|Study closed/terminated|3
214038|NCT01883635|696061|P2|Overall Study|Withdrawal by Subject|0
214039|NCT01883635|696062|P1|Overall Study|Withdrawal by Subject|4
214040|NCT01883453|696076|P2|Overall Study|No episode of common cold|23
214041|NCT01883453|696077|P1|Overall Study|No episode of common cold|25
214042|NCT01882907|696105|P2|Overall Study|Withdrawal by Subject|6
214043|NCT01882907|696106|P1|Overall Study|Withdrawal by Subject|0
214044|NCT01882907|696105|P2|Overall Study|Protocol Violation|14
214045|NCT01882907|696106|P1|Overall Study|Protocol Violation|10
214046|NCT01882907|696105|P2|Overall Study|Lost to Follow-up|4
214047|NCT01882907|696106|P1|Overall Study|Lost to Follow-up|1
214048|NCT01882907|696105|P2|Overall Study|Lack of Efficacy|3
214049|NCT01882907|696106|P1|Overall Study|Lack of Efficacy|0
214050|NCT01882907|696105|P2|Overall Study|Adverse Event|1
214051|NCT01882907|696106|P1|Overall Study|Adverse Event|3
214052|NCT01882647|696149|P2|Overall Study|Withdrawal by Subject|4
214053|NCT01882647|696150|P1|Overall Study|Withdrawal by Subject|0
214054|NCT01882647|696149|P2|Overall Study|Lost to Follow-up|2
214055|NCT01882647|696150|P1|Overall Study|Lost to Follow-up|2
214056|NCT01882465|696166|P7|Period 2|Protocol Violation|0
214057|NCT01882465|696167|P6|Period 2|Protocol Violation|0
214058|NCT01882465|696168|P5|Period 2|Protocol Violation|1
214059|NCT01882465|696169|P4|Period 2|Protocol Violation|0
214060|NCT01882465|696170|P3|Period 2|Protocol Violation|0
214061|NCT01882465|696171|P2|Period 2|Protocol Violation|0
214062|NCT01882465|696172|P1|Period 2|Protocol Violation|0
214063|NCT01882465|696166|P7|Period 1|Withdrawal by Subject|1
214064|NCT01882465|696167|P6|Period 1|Withdrawal by Subject|0
214065|NCT01882465|696168|P5|Period 1|Withdrawal by Subject|0
214066|NCT01882465|696169|P4|Period 1|Withdrawal by Subject|0
214067|NCT01882465|696170|P3|Period 1|Withdrawal by Subject|0
214068|NCT01882465|696171|P2|Period 1|Withdrawal by Subject|0
214069|NCT01882465|696172|P1|Period 1|Withdrawal by Subject|0
214070|NCT01882465|696166|P7|Period 1|Lens Discomfort|0
214071|NCT01882465|696167|P6|Period 1|Lens Discomfort|0
214072|NCT01882465|696168|P5|Period 1|Lens Discomfort|0
214073|NCT01882465|696169|P4|Period 1|Lens Discomfort|1
214074|NCT01882465|696170|P3|Period 1|Lens Discomfort|0
214075|NCT01882465|696171|P2|Period 1|Lens Discomfort|0
214076|NCT01882465|696172|P1|Period 1|Lens Discomfort|0
214077|NCT01882257|696197|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
214078|NCT01882257|696198|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
214079|NCT01882257|696199|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
214080|NCT01882257|696197|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
214081|NCT01882257|696198|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
214082|NCT01882257|696199|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
214083|NCT01881776|696226|P3|Overall Study|Protocol Violation|1
214084|NCT01881776|696227|P2|Overall Study|Protocol Violation|2
214085|NCT01881776|696228|P1|Overall Study|Protocol Violation|0
214086|NCT01881776|696226|P3|Overall Study|Lost to Follow-up|1
214087|NCT01881776|696227|P2|Overall Study|Lost to Follow-up|2
214088|NCT01881776|696228|P1|Overall Study|Lost to Follow-up|1
214089|NCT01881737|696254|P1|Overall Study|Worsening of baseline behavior|1
214090|NCT01881737|696254|P1|Overall Study|Withdrawal by Subject|1
214091|NCT01881737|696254|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
214092|NCT01881126|696265|P2|Overall Study|Adverse Event|1
214093|NCT01881126|696266|P1|Overall Study|Adverse Event|0
214094|NCT01881126|696265|P2|Overall Study|Non-compliance|1
214095|NCT01881126|696266|P1|Overall Study|Non-compliance|1
214096|NCT01880736|696285|P4|Overall Study|Withdrawal Criteria|5
214097|NCT01880736|696286|P3|Overall Study|Withdrawal Criteria|1
214098|NCT01880736|696287|P2|Overall Study|Withdrawal Criteria|2
214099|NCT01880736|696288|P1|Overall Study|Withdrawal Criteria|1
214100|NCT01880736|696285|P4|Overall Study|Adverse Event|1
214101|NCT01880736|696286|P3|Overall Study|Adverse Event|0
214102|NCT01880736|696287|P2|Overall Study|Adverse Event|0
214103|NCT01880736|696288|P1|Overall Study|Adverse Event|0
214104|NCT01880515|696372|P2|Overall Study|Disease Progression|7
214105|NCT01880515|696373|P1|Overall Study|Disease Progression|5
214106|NCT01880515|696372|P2|Overall Study|Lost to Follow-up|2
214107|NCT01880515|696373|P1|Overall Study|Lost to Follow-up|3
214108|NCT01880437|696384|P3|Overall Study|Study terminated by Sponsor|2
214109|NCT01880437|696385|P2|Overall Study|Study terminated by Sponsor|0
214110|NCT01880437|696386|P1|Overall Study|Study terminated by Sponsor|3
214111|NCT01880437|696384|P3|Overall Study|Death|17
214112|NCT01880437|696385|P2|Overall Study|Death|4
214113|NCT01880437|696386|P1|Overall Study|Death|12
214114|NCT01880424|696412|P2|Overall Study|Not specified|0
214115|NCT01880424|696413|P1|Overall Study|Not specified|1
214116|NCT01880424|696412|P2|Overall Study|Withdrawal by Subject|30
214117|NCT01880424|696413|P1|Overall Study|Withdrawal by Subject|10
214118|NCT01880424|696412|P2|Overall Study|Protocol Violation|13
214119|NCT01880424|696413|P1|Overall Study|Protocol Violation|11
214120|NCT01880424|696412|P2|Overall Study|Lost to Follow-up|2
214121|NCT01880424|696413|P1|Overall Study|Lost to Follow-up|3
214122|NCT01880424|696412|P2|Overall Study|Lack of Efficacy|4
214123|NCT01880424|696413|P1|Overall Study|Lack of Efficacy|1
214124|NCT01880424|696412|P2|Overall Study|Adverse Event|6
214125|NCT01880424|696413|P1|Overall Study|Adverse Event|7
214126|NCT01880086|696456|P2|Overall Study|Lost to Follow-up|1
214127|NCT01880086|696457|P1|Overall Study|Lost to Follow-up|1
214128|NCT01879852|696477|P2|Overall Study|Withdrawal by Subject|0
214129|NCT01879852|696478|P1|Overall Study|Withdrawal by Subject|2
214130|NCT01879722|696522|P10|Overall Study|Voluntary Withdrawal|0
214131|NCT01879722|696523|P9|Overall Study|Voluntary Withdrawal|1
214132|NCT01879722|696524|P8|Overall Study|Voluntary Withdrawal|0
214133|NCT01879722|696525|P7|Overall Study|Voluntary Withdrawal|0
214134|NCT01879722|696526|P6|Overall Study|Voluntary Withdrawal|0
214135|NCT01879722|696527|P5|Overall Study|Voluntary Withdrawal|0
214136|NCT01879722|696528|P4|Overall Study|Voluntary Withdrawal|0
214137|NCT01879722|696529|P3|Overall Study|Voluntary Withdrawal|0
214138|NCT01879722|696530|P2|Overall Study|Voluntary Withdrawal|0
214139|NCT01879722|696531|P1|Overall Study|Voluntary Withdrawal|0
214140|NCT01879722|696522|P10|Overall Study|Pretreatment Event/Adverse Event|0
214141|NCT01879722|696523|P9|Overall Study|Pretreatment Event/Adverse Event|1
214142|NCT01879722|696524|P8|Overall Study|Pretreatment Event/Adverse Event|1
214143|NCT01879722|696525|P7|Overall Study|Pretreatment Event/Adverse Event|0
214144|NCT01879722|696526|P6|Overall Study|Pretreatment Event/Adverse Event|0
214145|NCT01879722|696527|P5|Overall Study|Pretreatment Event/Adverse Event|1
214146|NCT01879722|696528|P4|Overall Study|Pretreatment Event/Adverse Event|1
214147|NCT01879722|696529|P3|Overall Study|Pretreatment Event/Adverse Event|0
214148|NCT01879722|696530|P2|Overall Study|Pretreatment Event/Adverse Event|1
214149|NCT01879722|696531|P1|Overall Study|Pretreatment Event/Adverse Event|0
214150|NCT01879683|696679|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
214151|NCT01879618|696686|P1|Overall Study|Adverse Event|5
214152|NCT01879618|696686|P1|Overall Study|Protocol Violation|6
214153|NCT01879618|696686|P1|Overall Study|Surgery;changed schedule; not available|8
214154|NCT01879618|696686|P1|Overall Study|Withdrawal by Subject|1
214155|NCT01879618|696686|P1|Overall Study|Does not meet entrance criteria|1
214156|NCT01879579|696693|P2|Overall Study|Discontinued insulin - possible allergy|1
214157|NCT01879579|696694|P1|Overall Study|Discontinued insulin - possible allergy|0
214158|NCT01879579|696693|P2|Overall Study|Phenotypic type 1 diabetes|1
214159|NCT01879579|696694|P1|Overall Study|Phenotypic type 1 diabetes|0
214160|NCT01879579|696693|P2|Overall Study|Did not initiate insulin treatment|0
214161|NCT01879579|696694|P1|Overall Study|Did not initiate insulin treatment|1
214162|NCT01879579|696693|P2|Overall Study|Did not enroll in texting platform|0
214163|NCT01879579|696694|P1|Overall Study|Did not enroll in texting platform|1
214164|NCT01879579|696693|P2|Overall Study|Phone incompatible with texting platform|0
214165|NCT01879579|696694|P1|Overall Study|Phone incompatible with texting platform|3
214166|NCT01879553|696724|P2|Overall Study|Withdrawal by Subject|0
214167|NCT01879553|696725|P1|Overall Study|Withdrawal by Subject|1
214168|NCT01879410|696759|P2|Overall Study|Randomised in Error|2
214169|NCT01879410|696760|P1|Overall Study|Randomised in Error|1
214170|NCT01879410|696759|P2|Overall Study|Withdrawal by Subject|8
214171|NCT01879410|696760|P1|Overall Study|Withdrawal by Subject|7
214172|NCT01879410|696759|P2|Overall Study|Lost to Follow-up|1
214173|NCT01879410|696760|P1|Overall Study|Lost to Follow-up|2
214174|NCT01879410|696759|P2|Overall Study|Protocol Violation|7
214175|NCT01879410|696760|P1|Overall Study|Protocol Violation|1
214176|NCT01879410|696759|P2|Overall Study|Lack of Efficacy|6
214177|NCT01879410|696760|P1|Overall Study|Lack of Efficacy|4
214178|NCT01879410|696759|P2|Overall Study|Adverse Event|14
214179|NCT01879410|696760|P1|Overall Study|Adverse Event|9
214180|NCT01879319|696827|P2|Overall Study|Lost to Follow-up|5
214181|NCT01879319|696828|P1|Overall Study|Lost to Follow-up|1
214182|NCT01879319|696827|P2|Overall Study|Withdrawal by Subject|0
214183|NCT01879319|696828|P1|Overall Study|Withdrawal by Subject|1
214184|NCT01878214|696966|P2|Overall Study|Lost to Follow-up|36
214185|NCT01878214|696967|P1|Overall Study|Lost to Follow-up|35
214186|NCT01878214|696966|P2|Overall Study|Death|1
214187|NCT01878214|696967|P1|Overall Study|Death|0
214188|NCT01878214|696966|P2|Overall Study|Withdrawal by Subject|7
214189|NCT01878214|696967|P1|Overall Study|Withdrawal by Subject|18
214190|NCT01878175|696981|P1|Overall Study|Developed contraindicated health problem|2
214191|NCT01878149|697000|P2|Overall Study|Did Not Meet Eligibility Criteria|2
214192|NCT01878149|697001|P1|Overall Study|Did Not Meet Eligibility Criteria|2
214193|NCT01877720|697013|P2|Overall Study|Adverse Event|0
214194|NCT01877720|697014|P1|Overall Study|Adverse Event|1
214195|NCT01877408|697045|P2|Overall Study|Lost to Follow-up|2
214196|NCT01877408|697046|P1|Overall Study|Lost to Follow-up|0
214197|NCT01877278|697079|P2|Overall Study|Lost to Follow-up|3
214198|NCT01877278|697080|P1|Overall Study|Lost to Follow-up|3
214199|NCT01876823|697111|P1|Overall Study|Patients moved|2
214200|NCT01876823|697111|P1|Overall Study|Physician Decision|2
214201|NCT01876823|697111|P1|Overall Study|Withdrawal by Subject|5
214202|NCT01876810|697124|P2|Overall Study|Physician Decision|1
214203|NCT01876810|697125|P1|Overall Study|Physician Decision|0
214204|NCT01876784|697137|P2|Overall Study|Ongoing|40
214205|NCT01876784|697138|P1|Overall Study|Ongoing|41
214206|NCT01876784|697137|P2|Overall Study|Other than specified above|6
214207|NCT01876784|697138|P1|Overall Study|Other than specified above|5
214208|NCT01876784|697137|P2|Overall Study|Randomized but not treated|1
214209|NCT01876784|697138|P1|Overall Study|Randomized but not treated|2
214210|NCT01876784|697137|P2|Overall Study|Death|0
214211|NCT01876784|697138|P1|Overall Study|Death|1
214212|NCT01876784|697137|P2|Overall Study|Lost to Follow-up|1
214213|NCT01876784|697138|P1|Overall Study|Lost to Follow-up|0
214214|NCT01876784|697137|P2|Overall Study|Disease progression|67
214215|NCT01876784|697138|P1|Overall Study|Disease progression|37
214216|NCT01876784|697137|P2|Overall Study|Protocol Violation|0
214217|NCT01876784|697138|P1|Overall Study|Protocol Violation|1
214218|NCT01876784|697137|P2|Overall Study|Adverse Event|2
214219|NCT01876784|697138|P1|Overall Study|Adverse Event|15
214220|NCT01876784|697137|P2|Overall Study|Withdrawal by Subject|2
214221|NCT01876784|697138|P1|Overall Study|Withdrawal by Subject|17
214222|NCT01876732|697144|P1|Overall Study|MMA was not over 800mg/dL|75
214223|NCT01876706|697149|P1|Overall Study|Lost to Follow-up|2
214224|NCT01876706|697149|P1|Overall Study|BPH Intervention|2
214225|NCT01876368|697168|P2|Overall Study|Subject/guardian decision|1
214226|NCT01876368|697169|P1|Overall Study|Subject/guardian decision|3
214227|NCT01876368|697168|P2|Overall Study|Protocol deviation|3
214228|NCT01876368|697169|P1|Overall Study|Protocol deviation|3
214229|NCT01876368|697168|P2|Overall Study|Physician Decision|2
214230|NCT01876368|697169|P1|Overall Study|Physician Decision|0
214231|NCT01876368|697168|P2|Overall Study|Non-compliance with study treatment|1
214232|NCT01876368|697169|P1|Overall Study|Non-compliance with study treatment|0
214233|NCT01876368|697168|P2|Overall Study|Lost to Follow-up|1
214234|NCT01876368|697169|P1|Overall Study|Lost to Follow-up|0
214235|NCT01876368|697168|P2|Overall Study|Lack of Efficacy|0
214236|NCT01876368|697169|P1|Overall Study|Lack of Efficacy|1
214237|NCT01876368|697168|P2|Overall Study|Adverse Event|5
214238|NCT01876368|697169|P1|Overall Study|Adverse Event|2
214239|NCT01875991|697213|P2|Overall Study|Sponsor Decision|0
214240|NCT01875991|697214|P1|Overall Study|Sponsor Decision|1
214241|NCT01875991|697213|P2|Overall Study|Withdrawal by Subject|6
214242|NCT01875991|697214|P1|Overall Study|Withdrawal by Subject|6
214243|NCT01875848|697252|P2|Overall Study|Withdrawal by Subject|0
214244|NCT01875848|697253|P1|Overall Study|Withdrawal by Subject|2
214245|NCT01875731|697263|P2|Overall Study|Fail to obtain lab sample|0
214246|NCT01875731|697264|P1|Overall Study|Fail to obtain lab sample|1
214247|NCT01875471|697283|P2|Overall Study|Unsatisfactory Lens Fitting|0
214248|NCT01875471|697284|P1|Overall Study|Unsatisfactory Lens Fitting|1
214249|NCT01875471|697283|P2|Overall Study|Adverse Event|1
214250|NCT01875471|697284|P1|Overall Study|Adverse Event|0
214251|NCT01875445|697292|P2|Overall Study|Withdrawal by Subject|0
214252|NCT01875445|697293|P1|Overall Study|Withdrawal by Subject|2
214253|NCT01875445|697292|P2|Overall Study|Lost to Follow-up|0
214254|NCT01875445|697293|P1|Overall Study|Lost to Follow-up|5
214255|NCT01874665|697337|P2|Overall Study|Treatment Ongoing|2
214256|NCT01874665|697338|P1|Overall Study|Treatment Ongoing|4
214257|NCT01874340|697347|P4|Overall Study|Withdrawal by Subject|1
214258|NCT01874340|697348|P3|Overall Study|Withdrawal by Subject|0
214259|NCT01874340|697349|P2|Overall Study|Withdrawal by Subject|0
214260|NCT01874340|697350|P1|Overall Study|Withdrawal by Subject|0
214261|NCT01874340|697347|P4|Overall Study|Study terminated by Sponsor|4
214262|NCT01874340|697348|P3|Overall Study|Study terminated by Sponsor|8
214263|NCT01874340|697349|P2|Overall Study|Study terminated by Sponsor|8
214264|NCT01874340|697350|P1|Overall Study|Study terminated by Sponsor|6
214265|NCT01874275|697378|P2|Overall Study|Lost to Follow-up|0
214266|NCT01874275|697379|P1|Overall Study|Lost to Follow-up|1
214267|NCT01874145|697402|P2|Extension Period|Lost to Follow-up|1
214268|NCT01874145|697403|P1|Extension Period|Lost to Follow-up|1
214269|NCT01874145|697402|P2|Extension Period|Withdrawal by Subject|1
214270|NCT01874145|697403|P1|Extension Period|Withdrawal by Subject|2
214271|NCT01874145|697402|P2|Extension Period|Adverse Event|2
214272|NCT01874145|697403|P1|Extension Period|Adverse Event|3
214273|NCT01874145|697402|P2|Core Period|Withdrawal by Subject|4
214274|NCT01874145|697403|P1|Core Period|Withdrawal by Subject|0
214275|NCT01874145|697402|P2|Core Period|Adverse Event|1
214276|NCT01874145|697403|P1|Core Period|Adverse Event|0
214277|NCT01874145|697402|P2|Core Period|Physician Decision|1
214278|NCT01874145|697403|P1|Core Period|Physician Decision|1
214279|NCT01874145|697402|P2|Core Period|Protocol Violation|1
214280|NCT01874145|697403|P1|Core Period|Protocol Violation|1
214281|NCT01874145|697402|P2|Core Period|Non-compliance|0
214282|NCT01874145|697403|P1|Core Period|Non-compliance|1
214283|NCT01874054|697455|P1|Follow-up Period|Continuing in Follow-up|48
214284|NCT01874054|697455|P1|Follow-up Period|Withdrawal by Subject|1
214285|NCT01874054|697455|P1|Treatment Period|Non-AE related|2
214286|NCT01874054|697455|P1|Treatment Period|Withdrawal by Subject|6
214287|NCT01874054|697455|P1|Treatment Period|Physician Decision|3
214288|NCT01874054|697455|P1|Treatment Period|Adverse Event|20
214289|NCT01874054|697455|P1|Treatment Period|Progressive Disease|7
214290|NCT01873950|697477|P5|Period 5|Withdrawal by Subject|0
214291|NCT01873950|697478|P4|Period 5|Withdrawal by Subject|1
214292|NCT01873950|697479|P3|Period 5|Withdrawal by Subject|0
214293|NCT01873950|697480|P2|Period 5|Withdrawal by Subject|0
214294|NCT01873950|697481|P1|Period 5|Withdrawal by Subject|0
214295|NCT01873859|697502|P2|Overall Study|Withdrawal by Subject|4
214296|NCT01873859|697503|P1|Overall Study|Withdrawal by Subject|0
214297|NCT01873729|697511|P1|Overall Study|Withdrawal by Subject|1
214298|NCT01873417|697516|P1|Overall Study|Physician Decision|3
214299|NCT01873417|697516|P1|Overall Study|Withdrawal by Subject|2
214300|NCT01873417|697516|P1|Overall Study|Lost to Follow-up|2
214301|NCT01873417|697516|P1|Overall Study|Adverse Event|24
214302|NCT01873417|697516|P1|Overall Study|Did Not Receive Any Study Drug|4
214303|NCT01872819|697527|P1|Overall Study|Withdrawal by Subject|1
214304|NCT01872819|697527|P1|Overall Study|Physician Decision|1
214305|NCT01872715|697531|P1|Overall Study|Withdrawal by Subject|2
214306|NCT01872715|697531|P1|Overall Study|Protocol Violation|1
214307|NCT01872715|697531|P1|Overall Study|Adverse Event|1
214308|NCT01872611|697548|P2|Overall Study|Reason not provided|6
214309|NCT01872611|697549|P1|Overall Study|Reason not provided|6
214310|NCT01872611|697548|P2|Overall Study|Withdrawal by Subject|1
214311|NCT01872611|697549|P1|Overall Study|Withdrawal by Subject|6
214312|NCT01872611|697548|P2|Overall Study|Physician Decision|0
214313|NCT01872611|697549|P1|Overall Study|Physician Decision|1
214314|NCT01872611|697548|P2|Overall Study|Lost to Follow-up|1
214315|NCT01872611|697549|P1|Overall Study|Lost to Follow-up|8
214316|NCT01872611|697548|P2|Overall Study|Death, prior to treatment|1
214317|NCT01872611|697549|P1|Overall Study|Death, prior to treatment|0
214318|NCT01872611|697548|P2|Overall Study|Death|1
214319|NCT01872611|697549|P1|Overall Study|Death|0
214320|NCT01872611|697548|P2|Overall Study|Adverse Event, prior to treatment|1
214321|NCT01872611|697549|P1|Overall Study|Adverse Event, prior to treatment|0
214322|NCT01872611|697548|P2|Overall Study|Adverse Event|1
214323|NCT01872611|697549|P1|Overall Study|Adverse Event|3
214324|NCT01872078|697571|P4|Overall Study|Patient met exclusion criterion 16.|1
214325|NCT01872078|697572|P3|Overall Study|Patient met exclusion criterion 16.|0
214326|NCT01872078|697573|P2|Overall Study|Patient met exclusion criterion 16.|0
214327|NCT01872078|697574|P1|Overall Study|Patient met exclusion criterion 16.|0
214328|NCT01872078|697571|P4|Overall Study|Withdrawal by Subject|0
214329|NCT01872078|697572|P3|Overall Study|Withdrawal by Subject|1
214330|NCT01872078|697573|P2|Overall Study|Withdrawal by Subject|0
214331|NCT01872078|697574|P1|Overall Study|Withdrawal by Subject|0
214332|NCT01872078|697571|P4|Overall Study|Protocol Violation|0
214333|NCT01872078|697572|P3|Overall Study|Protocol Violation|1
214334|NCT01872078|697573|P2|Overall Study|Protocol Violation|0
214335|NCT01872078|697574|P1|Overall Study|Protocol Violation|0
214336|NCT01872078|697571|P4|Overall Study|Dose administration non-compliance|1
214337|NCT01872078|697572|P3|Overall Study|Dose administration non-compliance|0
214338|NCT01872078|697573|P2|Overall Study|Dose administration non-compliance|0
214339|NCT01872078|697574|P1|Overall Study|Dose administration non-compliance|0
214340|NCT01872078|697571|P4|Overall Study|Adverse Event|0
214341|NCT01872078|697572|P3|Overall Study|Adverse Event|1
214342|NCT01872078|697573|P2|Overall Study|Adverse Event|0
214343|NCT01872078|697574|P1|Overall Study|Adverse Event|0
214344|NCT01871870|697584|P1|Overall Study|hyperglycemia|2
214345|NCT01871870|697584|P1|Overall Study|Hardware issues|7
214346|NCT01871805|697595|P6|Phase II|Lost to Follow-up|2
214347|NCT01871805|697596|P5|Phase II|Lost to Follow-up|0
214348|NCT01871805|697597|P4|Phase II|Lost to Follow-up|0
214349|NCT01871805|697598|P3|Phase II|Lost to Follow-up|0
214350|NCT01871805|697599|P2|Phase II|Lost to Follow-up|0
214351|NCT01871805|697600|P1|Phase II|Lost to Follow-up|0
214352|NCT01871805|697595|P6|Phase II|Alive in Survival Follow-up|17
214353|NCT01871805|697596|P5|Phase II|Alive in Survival Follow-up|0
214354|NCT01871805|697597|P4|Phase II|Alive in Survival Follow-up|0
214355|NCT01871805|697598|P3|Phase II|Alive in Survival Follow-up|0
214356|NCT01871805|697599|P2|Phase II|Alive in Survival Follow-up|0
214357|NCT01871805|697600|P1|Phase II|Alive in Survival Follow-up|0
214358|NCT01871805|697595|P6|Phase II|Alive on Treatment|56
214359|NCT01871805|697596|P5|Phase II|Alive on Treatment|0
214360|NCT01871805|697597|P4|Phase II|Alive on Treatment|0
214361|NCT01871805|697598|P3|Phase II|Alive on Treatment|0
214362|NCT01871805|697599|P2|Phase II|Alive on Treatment|0
214363|NCT01871805|697600|P1|Phase II|Alive on Treatment|0
214364|NCT01871805|697595|P6|Phase II|Death|12
214365|NCT01871805|697596|P5|Phase II|Death|0
214366|NCT01871805|697597|P4|Phase II|Death|0
214367|NCT01871805|697598|P3|Phase II|Death|0
214368|NCT01871805|697599|P2|Phase II|Death|0
214369|NCT01871805|697600|P1|Phase II|Death|0
214370|NCT01871805|697595|P6|Phase I|Lost to Follow-up|0
214371|NCT01871805|697596|P5|Phase I|Lost to Follow-up|0
214372|NCT01871805|697597|P4|Phase I|Lost to Follow-up|0
214373|NCT01871805|697598|P3|Phase I|Lost to Follow-up|0
214374|NCT01871805|697599|P2|Phase I|Lost to Follow-up|1
214375|NCT01871805|697600|P1|Phase I|Lost to Follow-up|0
214376|NCT01871805|697595|P6|Phase I|Alive in Survival Follow-up|0
214377|NCT01871805|697596|P5|Phase I|Alive in Survival Follow-up|4
214378|NCT01871805|697597|P4|Phase I|Alive in Survival Follow-up|1
214379|NCT01871805|697598|P3|Phase I|Alive in Survival Follow-up|3
214380|NCT01871805|697599|P2|Phase I|Alive in Survival Follow-up|0
214381|NCT01871805|697600|P1|Phase I|Alive in Survival Follow-up|1
214382|NCT01871805|697595|P6|Phase I|Alive on Treatment|0
214383|NCT01871805|697596|P5|Phase I|Alive on Treatment|3
214384|NCT01871805|697597|P4|Phase I|Alive on Treatment|4
214385|NCT01871805|697598|P3|Phase I|Alive on Treatment|5
214386|NCT01871805|697599|P2|Phase I|Alive on Treatment|3
214387|NCT01871805|697600|P1|Phase I|Alive on Treatment|0
214388|NCT01871805|697595|P6|Phase I|Death|0
214389|NCT01871805|697596|P5|Phase I|Death|6
214390|NCT01871805|697597|P4|Phase I|Death|2
214391|NCT01871805|697598|P3|Phase I|Death|5
214392|NCT01871805|697599|P2|Phase I|Death|3
214393|NCT01871805|697600|P1|Phase I|Death|6
214394|NCT01871558|697668|P2|Overall Study|Withdrawal by Subject|0
214395|NCT01871558|697669|P1|Overall Study|Withdrawal by Subject|2
214480|NCT01869959|697983|P5|Randomization Period|Physician Decision|1
214396|NCT01871558|697668|P2|Overall Study|antidiabetic drug prematurely stopped|1
214397|NCT01871558|697669|P1|Overall Study|antidiabetic drug prematurely stopped|1
214398|NCT01871558|697668|P2|Overall Study|Other reason|1
214399|NCT01871558|697669|P1|Overall Study|Other reason|0
214400|NCT01871532|697689|P2|Overall Study|Withdrawal by Subject|2
214401|NCT01871532|697690|P1|Overall Study|Withdrawal by Subject|1
214402|NCT01871519|697724|P1|Overall Study|Withdrawal by Subject|49
214403|NCT01871519|697724|P1|Overall Study|Lost to Follow-up|15
214404|NCT01871519|697724|P1|Overall Study|Death|26
214405|NCT01871402|697747|P2|Overall Study|Non-compliance|1
214406|NCT01871402|697748|P1|Overall Study|Non-compliance|0
214407|NCT01871402|697747|P2|Overall Study|Withdrawal by Subject|2
214408|NCT01871402|697748|P1|Overall Study|Withdrawal by Subject|0
214409|NCT01871402|697747|P2|Overall Study|Lost to Follow-up|0
214410|NCT01871402|697748|P1|Overall Study|Lost to Follow-up|1
214411|NCT01871285|697766|P4|First Intervention (1 Day)|Lost to Follow-up|0
214412|NCT01871285|697767|P3|First Intervention (1 Day)|Lost to Follow-up|1
214413|NCT01871285|697768|P2|First Intervention (1 Day)|Lost to Follow-up|1
214414|NCT01871285|697769|P1|First Intervention (1 Day)|Lost to Follow-up|0
214415|NCT01871285|697766|P4|First Intervention (1 Day)|Adverse Event|0
214416|NCT01871285|697767|P3|First Intervention (1 Day)|Adverse Event|0
214417|NCT01871285|697768|P2|First Intervention (1 Day)|Adverse Event|0
214418|NCT01871285|697769|P1|First Intervention (1 Day)|Adverse Event|1
214419|NCT01871142|697795|P1|Overall Study|Adverse Event|1
214420|NCT01871090|697811|P2|Overall Study|Subject Non-Compliance|1
214421|NCT01871090|697812|P1|Overall Study|Subject Non-Compliance|0
214422|NCT01871090|697811|P2|Overall Study|Interrogation not completed correctly|0
214423|NCT01871090|697812|P1|Overall Study|Interrogation not completed correctly|1
214424|NCT01871090|697811|P2|Overall Study|Interrogation not done in Emergency Room|22
214425|NCT01871090|697812|P1|Overall Study|Interrogation not done in Emergency Room|1
214426|NCT01870999|697825|P3|Overall Study|Protocol Violation|1
214427|NCT01870999|697826|P2|Overall Study|Protocol Violation|0
214428|NCT01870999|697827|P1|Overall Study|Protocol Violation|0
214429|NCT01870999|697825|P3|Overall Study|Withdrawal by Subject|5
214430|NCT01870999|697826|P2|Overall Study|Withdrawal by Subject|2
214431|NCT01870999|697827|P1|Overall Study|Withdrawal by Subject|0
214432|NCT01870999|697825|P3|Overall Study|Subject withdrawn by Investigator|0
214433|NCT01870999|697826|P2|Overall Study|Subject withdrawn by Investigator|0
214434|NCT01870999|697827|P1|Overall Study|Subject withdrawn by Investigator|1
214435|NCT01870999|697825|P3|Overall Study|Subject met withdrawal criteria|0
214436|NCT01870999|697826|P2|Overall Study|Subject met withdrawal criteria|2
214437|NCT01870999|697827|P1|Overall Study|Subject met withdrawal criteria|3
214438|NCT01870999|697825|P3|Overall Study|Adverse Event|1
214439|NCT01870999|697826|P2|Overall Study|Adverse Event|4
214440|NCT01870999|697827|P1|Overall Study|Adverse Event|0
214441|NCT01870973|697885|P2|Overall Study|Lost to Follow-up|3
214442|NCT01870973|697886|P1|Overall Study|Lost to Follow-up|10
214443|NCT01870921|697892|P1|Overall Study|Other|1
214444|NCT01870921|697892|P1|Overall Study|Subject Lost to Follow up|2
214445|NCT01870921|697892|P1|Overall Study|Severe non-compliance to protocol|7
214446|NCT01870921|697892|P1|Overall Study|Subject decision|80
214447|NCT01870843|697911|P1|Overall Study|Withdrawal by Subject|18
214448|NCT01870843|697911|P1|Overall Study|Death|1
214449|NCT01870843|697911|P1|Overall Study|Lost to Follow-up|24
214450|NCT01870843|697911|P1|Overall Study|Adverse Event|10
214451|NCT01870739|697926|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
214452|NCT01870739|697927|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
214453|NCT01870739|697926|P2|Add-on Period (40 Weeks)|Protocol deviation|1
214454|NCT01870739|697927|P1|Add-on Period (40 Weeks)|Protocol deviation|1
214455|NCT01870739|697926|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
214456|NCT01870739|697927|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
214457|NCT01870739|697926|P2|Add-on Period (40 Weeks)|Adverse Event|1
214458|NCT01870739|697927|P1|Add-on Period (40 Weeks)|Adverse Event|0
214459|NCT01870739|697926|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
214460|NCT01870739|697927|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
214461|NCT01870739|697926|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
214462|NCT01870739|697927|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
214463|NCT01870739|697926|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
214464|NCT01870739|697927|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
214465|NCT01869959|697983|P5|Treatment Period|Withdrawal by Subject|0
214466|NCT01869959|697984|P4|Treatment Period|Withdrawal by Subject|0
214467|NCT01869959|697985|P3|Treatment Period|Withdrawal by Subject|0
214468|NCT01869959|697986|P2|Treatment Period|Withdrawal by Subject|1
214469|NCT01869959|697987|P1|Treatment Period|Withdrawal by Subject|0
214470|NCT01869959|697983|P5|Treatment Period|Sponsor decision|0
214471|NCT01869959|697984|P4|Treatment Period|Sponsor decision|1
214472|NCT01869959|697985|P3|Treatment Period|Sponsor decision|0
214473|NCT01869959|697986|P2|Treatment Period|Sponsor decision|1
214474|NCT01869959|697987|P1|Treatment Period|Sponsor decision|0
214475|NCT01869959|697983|P5|Treatment Period|Adverse Event|0
214476|NCT01869959|697984|P4|Treatment Period|Adverse Event|1
214477|NCT01869959|697985|P3|Treatment Period|Adverse Event|3
214478|NCT01869959|697986|P2|Treatment Period|Adverse Event|0
214479|NCT01869959|697987|P1|Treatment Period|Adverse Event|1
214481|NCT01869959|697984|P4|Randomization Period|Physician Decision|0
214482|NCT01869959|697985|P3|Randomization Period|Physician Decision|0
214483|NCT01869959|697986|P2|Randomization Period|Physician Decision|0
214484|NCT01869959|697987|P1|Randomization Period|Physician Decision|0
214485|NCT01868893|698119|P1|Overall Study|Neutropenia|1
214486|NCT01868893|698119|P1|Overall Study|Commercial availability of study drug|17
214487|NCT01868893|698119|P1|Overall Study|Adverse Event|2
214488|NCT01868542|698150|P2|Overall Study|Unclassified|1
214489|NCT01868542|698151|P1|Overall Study|Unclassified|0
214490|NCT01868542|698150|P2|Overall Study|Protocol Violation|1
214491|NCT01868542|698151|P1|Overall Study|Protocol Violation|0
214492|NCT01868503|698169|P1|Overall Study|Protocol Violation|1
214493|NCT01868503|698169|P1|Overall Study|Withdrawal by Subject|1
214494|NCT01868243|698175|P2|Overall Study|Death|1
214495|NCT01868243|698176|P1|Overall Study|Death|0
214496|NCT01868074|698186|P2|Overall Study|Withdrawal by Subject|2
214497|NCT01868074|698187|P1|Overall Study|Withdrawal by Subject|4
214498|NCT01868074|698186|P2|Overall Study|Lost to Follow-up|2
214499|NCT01868074|698187|P1|Overall Study|Lost to Follow-up|3
214500|NCT01868035|698197|P1|Overall Study|Non-compliance|1
214501|NCT01868035|698197|P1|Overall Study|Progressive Disease|2
214502|NCT01868035|698197|P1|Overall Study|Withdrawal by Subject|1
214503|NCT01868035|698197|P1|Overall Study|Lost to Follow-up|3
214504|NCT01868009|698213|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
214505|NCT01868009|698214|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
214506|NCT01868009|698213|P2|Period 2 (5-9 Days)|Adverse Event|0
214507|NCT01868009|698214|P1|Period 2 (5-9 Days)|Adverse Event|1
214508|NCT01868009|698213|P2|Period 1 (5-9 Days)|Adverse Event|2
214509|NCT01868009|698214|P1|Period 1 (5-9 Days)|Adverse Event|0
214510|NCT01867710|698228|P4|Overall Study|Unspecified|0
214511|NCT01867710|698229|P3|Overall Study|Unspecified|0
214512|NCT01867710|698230|P2|Overall Study|Unspecified|1
214513|NCT01867710|698231|P1|Overall Study|Unspecified|0
214514|NCT01867710|698228|P4|Overall Study|Eligible Criteria Not Met|0
214515|NCT01867710|698229|P3|Overall Study|Eligible Criteria Not Met|1
214516|NCT01867710|698230|P2|Overall Study|Eligible Criteria Not Met|0
214517|NCT01867710|698231|P1|Overall Study|Eligible Criteria Not Met|0
214518|NCT01867710|698228|P4|Overall Study|Withdrawal by Subject|0
214519|NCT01867710|698229|P3|Overall Study|Withdrawal by Subject|0
214520|NCT01867710|698230|P2|Overall Study|Withdrawal by Subject|1
214521|NCT01867710|698231|P1|Overall Study|Withdrawal by Subject|0
214522|NCT01867710|698228|P4|Overall Study|Protocol Violation|1
214523|NCT01867710|698229|P3|Overall Study|Protocol Violation|0
214524|NCT01867710|698230|P2|Overall Study|Protocol Violation|0
214525|NCT01867710|698231|P1|Overall Study|Protocol Violation|1
214526|NCT01867710|698228|P4|Overall Study|Physician Decision|0
214527|NCT01867710|698229|P3|Overall Study|Physician Decision|1
214528|NCT01867710|698230|P2|Overall Study|Physician Decision|0
214529|NCT01867710|698231|P1|Overall Study|Physician Decision|0
214530|NCT01867710|698228|P4|Overall Study|Death|0
214531|NCT01867710|698229|P3|Overall Study|Death|1
214532|NCT01867710|698230|P2|Overall Study|Death|1
214533|NCT01867710|698231|P1|Overall Study|Death|0
214534|NCT01867710|698228|P4|Overall Study|Other Adverse Events|3
214535|NCT01867710|698229|P3|Overall Study|Other Adverse Events|1
214536|NCT01867710|698230|P2|Overall Study|Other Adverse Events|0
214537|NCT01867710|698231|P1|Overall Study|Other Adverse Events|1
214538|NCT01867710|698228|P4|Overall Study|Palliative Radiation Required|1
214539|NCT01867710|698229|P3|Overall Study|Palliative Radiation Required|1
214540|NCT01867710|698230|P2|Overall Study|Palliative Radiation Required|0
214541|NCT01867710|698231|P1|Overall Study|Palliative Radiation Required|0
214542|NCT01867710|698228|P4|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
214543|NCT01867710|698229|P3|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
214544|NCT01867710|698230|P2|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
214545|NCT01867710|698231|P1|Overall Study|Adverse Event Sustained Toxicity>Grade 1|1
214546|NCT01867710|698228|P4|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
214547|NCT01867710|698229|P3|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
214548|NCT01867710|698230|P2|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|2
214549|NCT01867710|698231|P1|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
214550|NCT01867710|698228|P4|Overall Study|Disease Progression|2
214551|NCT01867710|698229|P3|Overall Study|Disease Progression|4
214552|NCT01867710|698230|P2|Overall Study|Disease Progression|2
214553|NCT01867710|698231|P1|Overall Study|Disease Progression|5
214554|NCT01867658|698245|P1|Overall Study|Subject could not be contacted|1
214555|NCT01867658|698245|P1|Overall Study|Death|2
214556|NCT01867658|698245|P1|Overall Study|Withdrawal by Subject|6
214557|NCT01867307|698263|P2|Overall Study|Other Adverse Event|3
214558|NCT01867307|698264|P1|Overall Study|Other Adverse Event|1
214559|NCT01867307|698263|P2|Overall Study|Protocol Violation|0
214560|NCT01867307|698264|P1|Overall Study|Protocol Violation|2
214561|NCT01867021|698289|P2|Overall Study|Withdrawal by Subject|6
214562|NCT01867021|698290|P1|Overall Study|Withdrawal by Subject|1
214563|NCT01867021|698289|P2|Overall Study|Lost to Follow-up|2
214564|NCT01867021|698290|P1|Overall Study|Lost to Follow-up|0
214565|NCT01867021|698289|P2|Overall Study|Death|0
214566|NCT01867021|698290|P1|Overall Study|Death|1
214567|NCT01867021|698289|P2|Overall Study|Not Eligible|1
214568|NCT01867021|698290|P1|Overall Study|Not Eligible|0
214569|NCT01867021|698289|P2|Overall Study|Adverse Event|1
214570|NCT01867021|698290|P1|Overall Study|Adverse Event|0
214571|NCT01866709|698311|P2|Overall Study|Adverse Event|0
214572|NCT01866709|698312|P1|Overall Study|Adverse Event|1
214573|NCT01866319|698323|P3|Overall Study|Remain on study|176
214574|NCT01866319|698324|P2|Overall Study|Remain on study|190
214575|NCT01866319|698325|P1|Overall Study|Remain on study|131
214576|NCT01866319|698323|P3|Overall Study|Withdrawal by Subject|6
214577|NCT01866319|698324|P2|Overall Study|Withdrawal by Subject|9
214578|NCT01866319|698325|P1|Overall Study|Withdrawal by Subject|31
214579|NCT01866319|698323|P3|Overall Study|Physician Decision|0
214580|NCT01866319|698324|P2|Overall Study|Physician Decision|0
214581|NCT01866319|698325|P1|Overall Study|Physician Decision|1
214582|NCT01866319|698323|P3|Overall Study|Lost to Follow-up|6
214583|NCT01866319|698324|P2|Overall Study|Lost to Follow-up|0
214584|NCT01866319|698325|P1|Overall Study|Lost to Follow-up|3
214585|NCT01866319|698323|P3|Overall Study|Death|77
214586|NCT01866319|698324|P2|Overall Study|Death|74
214587|NCT01866319|698325|P1|Overall Study|Death|97
214588|NCT01866319|698323|P3|Overall Study|Clinical progression|0
214589|NCT01866319|698324|P2|Overall Study|Clinical progression|0
214590|NCT01866319|698325|P1|Overall Study|Clinical progression|1
214591|NCT01866319|698323|P3|Overall Study|Adverse Event|12
214592|NCT01866319|698324|P2|Overall Study|Adverse Event|6
214593|NCT01866319|698325|P1|Overall Study|Adverse Event|13
214594|NCT01865812|698458|P1|Overall Study|Adverse Event|2
214595|NCT01865084|698467|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
214596|NCT01865084|698468|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
214597|NCT01865084|698469|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
214598|NCT01865084|698467|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
214599|NCT01865084|698468|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
214600|NCT01865084|698469|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
214601|NCT01865084|698467|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
214602|NCT01865084|698468|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
214603|NCT01865084|698469|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
214604|NCT01865084|698467|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
214605|NCT01865084|698468|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
214606|NCT01865084|698469|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
214607|NCT01865084|698467|P3|Open Label Extension (OLE) Period|Adverse Event|1
214608|NCT01865084|698468|P2|Open Label Extension (OLE) Period|Adverse Event|0
214609|NCT01865084|698469|P1|Open Label Extension (OLE) Period|Adverse Event|0
214610|NCT01865084|698467|P3|Double Blind Period (DB)|Withdrawal by Subject|0
214611|NCT01865084|698468|P2|Double Blind Period (DB)|Withdrawal by Subject|0
214612|NCT01865084|698469|P1|Double Blind Period (DB)|Withdrawal by Subject|1
214613|NCT01865084|698467|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
214614|NCT01865084|698468|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
214615|NCT01865084|698469|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
214616|NCT01865084|698467|P3|Double Blind Period (DB)|Protocol Violation|1
214617|NCT01865084|698468|P2|Double Blind Period (DB)|Protocol Violation|0
214618|NCT01865084|698469|P1|Double Blind Period (DB)|Protocol Violation|0
214619|NCT01865084|698467|P3|Double Blind Period (DB)|Adverse Event|1
214620|NCT01865084|698468|P2|Double Blind Period (DB)|Adverse Event|2
214621|NCT01865084|698469|P1|Double Blind Period (DB)|Adverse Event|2
214622|NCT01864148|698513|P5|Overall Study|Not Dosed|0
214623|NCT01864148|698514|P4|Overall Study|Not Dosed|1
214624|NCT01864148|698515|P3|Overall Study|Not Dosed|0
214625|NCT01864148|698516|P2|Overall Study|Not Dosed|0
214626|NCT01864148|698517|P1|Overall Study|Not Dosed|0
214627|NCT01864148|698513|P5|Overall Study|Adverse Event|7
214628|NCT01864148|698514|P4|Overall Study|Adverse Event|7
214629|NCT01864148|698515|P3|Overall Study|Adverse Event|4
214630|NCT01864148|698516|P2|Overall Study|Adverse Event|2
214631|NCT01864148|698517|P1|Overall Study|Adverse Event|4
214632|NCT01864148|698513|P5|Overall Study|Lost to Follow-up|1
214633|NCT01864148|698514|P4|Overall Study|Lost to Follow-up|2
214634|NCT01864148|698515|P3|Overall Study|Lost to Follow-up|0
214635|NCT01864148|698516|P2|Overall Study|Lost to Follow-up|0
214636|NCT01864148|698517|P1|Overall Study|Lost to Follow-up|0
214637|NCT01864148|698513|P5|Overall Study|Withdrawal by Subject|8
214638|NCT01864148|698514|P4|Overall Study|Withdrawal by Subject|8
214639|NCT01864148|698515|P3|Overall Study|Withdrawal by Subject|6
214640|NCT01864148|698516|P2|Overall Study|Withdrawal by Subject|2
214641|NCT01864148|698517|P1|Overall Study|Withdrawal by Subject|9
214642|NCT01864148|698513|P5|Overall Study|Investigator Decision|6
214643|NCT01864148|698514|P4|Overall Study|Investigator Decision|4
214644|NCT01864148|698515|P3|Overall Study|Investigator Decision|0
214645|NCT01864148|698516|P2|Overall Study|Investigator Decision|0
214646|NCT01864148|698517|P1|Overall Study|Investigator Decision|5
214647|NCT01864148|698513|P5|Overall Study|Death|0
214648|NCT01864148|698514|P4|Overall Study|Death|1
214649|NCT01864148|698515|P3|Overall Study|Death|0
214650|NCT01864148|698516|P2|Overall Study|Death|0
214651|NCT01864148|698517|P1|Overall Study|Death|0
214652|NCT01864148|698513|P5|Overall Study|Not Specified|1
214653|NCT01864148|698514|P4|Overall Study|Not Specified|3
214654|NCT01864148|698515|P3|Overall Study|Not Specified|1
214655|NCT01864148|698516|P2|Overall Study|Not Specified|1
214656|NCT01864148|698517|P1|Overall Study|Not Specified|2
214657|NCT01864005|698546|P2|Overall Study|Need GP IIb/IIIa|3
214658|NCT01864005|698547|P1|Overall Study|Need GP IIb/IIIa|1
214659|NCT01864005|698546|P2|Overall Study|Disease need|1
214660|NCT01864005|698547|P1|Overall Study|Disease need|1
214661|NCT01864005|698546|P2|Overall Study|Incorrect enrolment|0
214662|NCT01864005|698547|P1|Overall Study|Incorrect enrolment|1
214663|NCT01864005|698546|P2|Overall Study|Withdrawal by Subject|1
214664|NCT01864005|698547|P1|Overall Study|Withdrawal by Subject|0
214665|NCT01864005|698546|P2|Overall Study|Protocol Violation|1
214666|NCT01864005|698547|P1|Overall Study|Protocol Violation|0
214667|NCT01863953|698564|P3|Overall Study|Adverse Event|1
214668|NCT01863953|698565|P2|Overall Study|Adverse Event|0
214669|NCT01863953|698566|P1|Overall Study|Adverse Event|0
214670|NCT01863771|698580|P4|Maintenance Phase|Withdrawal by Subject|3
214671|NCT01863771|698581|P3|Maintenance Phase|Withdrawal by Subject|2
214672|NCT01863771|698582|P2|Maintenance Phase|Withdrawal by Subject|1
214673|NCT01863771|698583|P1|Maintenance Phase|Withdrawal by Subject|0
214674|NCT01863771|698580|P4|Maintenance Phase|Pregnancy|0
214675|NCT01863771|698581|P3|Maintenance Phase|Pregnancy|0
214676|NCT01863771|698582|P2|Maintenance Phase|Pregnancy|1
214677|NCT01863771|698583|P1|Maintenance Phase|Pregnancy|0
214678|NCT01863771|698580|P4|Maintenance Phase|Physician Decision|1
214679|NCT01863771|698581|P3|Maintenance Phase|Physician Decision|2
214680|NCT01863771|698582|P2|Maintenance Phase|Physician Decision|0
214681|NCT01863771|698583|P1|Maintenance Phase|Physician Decision|0
214682|NCT01863771|698580|P4|Maintenance Phase|Lack of Efficacy|38
214683|NCT01863771|698581|P3|Maintenance Phase|Lack of Efficacy|7
214684|NCT01863771|698582|P2|Maintenance Phase|Lack of Efficacy|3
214685|NCT01863771|698583|P1|Maintenance Phase|Lack of Efficacy|0
214686|NCT01863771|698580|P4|Maintenance Phase|Adverse Event|1
214687|NCT01863771|698581|P3|Maintenance Phase|Adverse Event|1
214688|NCT01863771|698582|P2|Maintenance Phase|Adverse Event|0
214689|NCT01863771|698583|P1|Maintenance Phase|Adverse Event|0
214690|NCT01863771|698580|P4|Induction Phase|Withdrawal by Subject|0
214691|NCT01863771|698581|P3|Induction Phase|Withdrawal by Subject|0
214692|NCT01863771|698582|P2|Induction Phase|Withdrawal by Subject|0
214693|NCT01863771|698583|P1|Induction Phase|Withdrawal by Subject|2
214694|NCT01863771|698580|P4|Induction Phase|Lack of Efficacy|0
214695|NCT01863771|698581|P3|Induction Phase|Lack of Efficacy|0
214696|NCT01863771|698582|P2|Induction Phase|Lack of Efficacy|0
214697|NCT01863771|698583|P1|Induction Phase|Lack of Efficacy|10
214698|NCT01863771|698580|P4|Induction Phase|Adverse Event|0
214699|NCT01863771|698581|P3|Induction Phase|Adverse Event|0
214700|NCT01863771|698582|P2|Induction Phase|Adverse Event|0
214701|NCT01863771|698583|P1|Induction Phase|Adverse Event|9
214702|NCT01863680|698595|P1|Overall Study|Unspecified|6
214703|NCT01863680|698595|P1|Overall Study|Did not undergo IVF/ET|14
214704|NCT01863680|698595|P1|Overall Study|Withdrawal by Subject|1
214705|NCT01863680|698595|P1|Overall Study|Spontaneous pregnancy|2
214706|NCT01863680|698595|P1|Overall Study|Risk of OHSS|17
214707|NCT01863680|698595|P1|Overall Study|Adverse Event|17
214708|NCT01863667|698603|P2|Overall Study|Withdrawal by Subject|2
214709|NCT01863667|698604|P1|Overall Study|Withdrawal by Subject|2
214710|NCT01863667|698603|P2|Overall Study|Study terminated by Sponsor|30
214711|NCT01863667|698604|P1|Overall Study|Study terminated by Sponsor|30
214712|NCT01863667|698603|P2|Overall Study|Adverse Event|0
214713|NCT01863667|698604|P1|Overall Study|Adverse Event|1
214714|NCT01863433|698624|P1|Overall Study|Protocol Violation|1
214715|NCT01863368|698634|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
214716|NCT01863368|698635|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
214717|NCT01863368|698634|P2|Phase II, Day 35 to Day 90|Adverse Event|0
214718|NCT01863368|698635|P1|Phase II, Day 35 to Day 90|Adverse Event|1
214719|NCT01863368|698634|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
214720|NCT01863368|698635|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
214721|NCT01863368|698634|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
214722|NCT01863368|698635|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
214723|NCT01863368|698634|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
214724|NCT01863368|698635|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
214725|NCT01863368|698634|P2|Phase I, Day 0 to Day 35|Adverse Event|4
214726|NCT01863368|698635|P1|Phase I, Day 0 to Day 35|Adverse Event|2
214727|NCT01862991|698660|P3|Overall Study|Protocol Violation|0
214728|NCT01862991|698661|P2|Overall Study|Protocol Violation|0
214729|NCT01862991|698662|P1|Overall Study|Protocol Violation|1
214730|NCT01862991|698660|P3|Overall Study|Lost to Follow-up|1
214731|NCT01862991|698661|P2|Overall Study|Lost to Follow-up|1
214732|NCT01862991|698662|P1|Overall Study|Lost to Follow-up|2
214733|NCT01862484|698675|P2|Overall Study|Withdrawal by Subject|3
214734|NCT01862484|698676|P1|Overall Study|Withdrawal by Subject|0
214735|NCT01862484|698675|P2|Overall Study|Protocol Violation|2
214736|NCT01862484|698676|P1|Overall Study|Protocol Violation|0
214737|NCT01862484|698675|P2|Overall Study|Lost to Follow-up|2
214738|NCT01862484|698676|P1|Overall Study|Lost to Follow-up|1
214739|NCT01862484|698675|P2|Overall Study|Lack of Efficacy|1
214740|NCT01862484|698676|P1|Overall Study|Lack of Efficacy|1
214741|NCT01861522|698748|P2|Overall Study|Withdrawal by Subject|0
214742|NCT01861522|698749|P1|Overall Study|Withdrawal by Subject|2
214743|NCT01861522|698748|P2|Overall Study|Adverse Event|0
214744|NCT01861522|698749|P1|Overall Study|Adverse Event|1
214745|NCT01860989|698773|P1|Overall Study|Unsatisfactory therapeutic|5
214746|NCT01860846|698777|P1|Overall Study|Lost to Follow-up|33
214747|NCT01860703|698788|P4|Overall Study|Personal reason|0
214748|NCT01860703|698789|P3|Overall Study|Personal reason|1
214749|NCT01860703|698790|P2|Overall Study|Personal reason|0
214750|NCT01860703|698791|P1|Overall Study|Personal reason|1
214751|NCT01860703|698788|P4|Overall Study|Withdrawal by Subject|0
214752|NCT01860703|698789|P3|Overall Study|Withdrawal by Subject|0
214753|NCT01860703|698790|P2|Overall Study|Withdrawal by Subject|1
214754|NCT01860703|698791|P1|Overall Study|Withdrawal by Subject|0
214755|NCT01860703|698788|P4|Overall Study|Adverse Event|2
214756|NCT01860703|698789|P3|Overall Study|Adverse Event|0
214757|NCT01860703|698790|P2|Overall Study|Adverse Event|4
214758|NCT01860703|698791|P1|Overall Study|Adverse Event|1
214759|NCT01860677|698823|P2|Second Intervention (1 Day)|Lost to Follow-up|0
214760|NCT01860677|698824|P1|Second Intervention (1 Day)|Lost to Follow-up|7
214761|NCT01860534|698862|P2|ROP #2|discharged prior to ROP #2|0
214762|NCT01860534|698863|P1|ROP #2|discharged prior to ROP #2|1
214763|NCT01860534|698862|P2|ROP #1|Needed treatment for ROP|1
214764|NCT01860534|698863|P1|ROP #1|Needed treatment for ROP|0
214765|NCT01860079|698911|P2|Overall Study|Physician Decision|22
214766|NCT01860079|698912|P1|Overall Study|Physician Decision|14
214767|NCT01859949|698920|P2|Overall Study|Adverse Event|1
214768|NCT01859949|698921|P1|Overall Study|Adverse Event|0
214769|NCT01859949|698920|P2|Overall Study|Protocol Violation|1
214770|NCT01859949|698921|P1|Overall Study|Protocol Violation|1
214771|NCT01859949|698920|P2|Overall Study|Withdrawal by Subject|10
214772|NCT01859949|698921|P1|Overall Study|Withdrawal by Subject|11
214773|NCT01859949|698920|P2|Overall Study|Physician Decision|4
214774|NCT01859949|698921|P1|Overall Study|Physician Decision|2
214775|NCT01859949|698920|P2|Overall Study|Family Matters|1
214776|NCT01859949|698921|P1|Overall Study|Family Matters|0
214777|NCT01859793|698939|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
214778|NCT01859793|698940|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
214779|NCT01859793|698939|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
214780|NCT01859793|698940|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
214781|NCT01859793|698939|P2|First Intervention (8 Weeks)|Adverse Event|0
214782|NCT01859793|698940|P1|First Intervention (8 Weeks)|Adverse Event|1
214783|NCT01859793|698939|P2|First Intervention (8 Weeks)|Protocol Violation|0
214784|NCT01859793|698940|P1|First Intervention (8 Weeks)|Protocol Violation|2
214785|NCT01859715|698953|P3|Overall Study|No 2nd VAS|23
214786|NCT01859715|698954|P2|Overall Study|No 2nd VAS|8
214787|NCT01859715|698955|P1|Overall Study|No 2nd VAS|16
214788|NCT01859702|698966|P1|Overall Study|Adverse Event|2
214789|NCT01859702|698966|P1|Overall Study|Protocol deviation|3
214790|NCT01859598|698980|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
214791|NCT01859507|698988|P1|Overall Study|left the country|4
214792|NCT01859494|698993|P1|Overall Study|Adverse Event|1
214793|NCT01859390|699004|P2|Overall Study|Shipment Error|1
214794|NCT01859390|699005|P1|Overall Study|Shipment Error|0
214795|NCT01859390|699004|P2|Overall Study|Tube Cracked|2
214796|NCT01859390|699005|P1|Overall Study|Tube Cracked|0
214797|NCT01859390|699004|P2|Overall Study|Sample Missing Collection Date|1
214798|NCT01859390|699005|P1|Overall Study|Sample Missing Collection Date|0
214799|NCT01859390|699004|P2|Overall Study|Insufficient Sputum Collected|3
214800|NCT01859390|699005|P1|Overall Study|Insufficient Sputum Collected|1
214801|NCT01859143|699069|P2|Overall Study|Lost to Follow-up|0
214802|NCT01859143|699070|P1|Overall Study|Lost to Follow-up|2
214803|NCT01858766|699117|P19|Overall Study|Withdrew Consent|0
214804|NCT01858766|699118|P18|Overall Study|Withdrew Consent|0
214805|NCT01858766|699119|P17|Overall Study|Withdrew Consent|0
214806|NCT01858766|699120|P16|Overall Study|Withdrew Consent|0
214807|NCT01858766|699121|P15|Overall Study|Withdrew Consent|0
214808|NCT01858766|699122|P14|Overall Study|Withdrew Consent|0
214809|NCT01858766|699123|P13|Overall Study|Withdrew Consent|0
214810|NCT01858766|699124|P12|Overall Study|Withdrew Consent|1
214811|NCT01858766|699125|P11|Overall Study|Withdrew Consent|0
214812|NCT01858766|699126|P10|Overall Study|Withdrew Consent|0
214813|NCT01858766|699127|P9|Overall Study|Withdrew Consent|0
214814|NCT01858766|699128|P8|Overall Study|Withdrew Consent|0
214815|NCT01858766|699129|P7|Overall Study|Withdrew Consent|0
214816|NCT01858766|699130|P6|Overall Study|Withdrew Consent|0
214817|NCT01858766|699131|P5|Overall Study|Withdrew Consent|0
214818|NCT01858766|699132|P4|Overall Study|Withdrew Consent|0
214819|NCT01858766|699133|P3|Overall Study|Withdrew Consent|0
214820|NCT01858766|699134|P2|Overall Study|Withdrew Consent|0
214821|NCT01858766|699135|P1|Overall Study|Withdrew Consent|0
214822|NCT01858766|699117|P19|Overall Study|Lost to Follow-up|1
214823|NCT01858766|699118|P18|Overall Study|Lost to Follow-up|0
214824|NCT01858766|699119|P17|Overall Study|Lost to Follow-up|1
214825|NCT01858766|699120|P16|Overall Study|Lost to Follow-up|1
214826|NCT01858766|699121|P15|Overall Study|Lost to Follow-up|3
214827|NCT01858766|699122|P14|Overall Study|Lost to Follow-up|0
214828|NCT01858766|699123|P13|Overall Study|Lost to Follow-up|0
214829|NCT01858766|699124|P12|Overall Study|Lost to Follow-up|1
214830|NCT01858766|699125|P11|Overall Study|Lost to Follow-up|0
214831|NCT01858766|699126|P10|Overall Study|Lost to Follow-up|0
214832|NCT01858766|699127|P9|Overall Study|Lost to Follow-up|0
214833|NCT01858766|699128|P8|Overall Study|Lost to Follow-up|2
214834|NCT01858766|699129|P7|Overall Study|Lost to Follow-up|0
214835|NCT01858766|699130|P6|Overall Study|Lost to Follow-up|1
214836|NCT01858766|699131|P5|Overall Study|Lost to Follow-up|0
214837|NCT01858766|699132|P4|Overall Study|Lost to Follow-up|0
214838|NCT01858766|699133|P3|Overall Study|Lost to Follow-up|0
214839|NCT01858766|699134|P2|Overall Study|Lost to Follow-up|0
214840|NCT01858766|699135|P1|Overall Study|Lost to Follow-up|0
214841|NCT01858766|699117|P19|Overall Study|Lack of Efficacy|3
214842|NCT01858766|699118|P18|Overall Study|Lack of Efficacy|3
214843|NCT01858766|699119|P17|Overall Study|Lack of Efficacy|2
214844|NCT01858766|699120|P16|Overall Study|Lack of Efficacy|5
214845|NCT01858766|699121|P15|Overall Study|Lack of Efficacy|5
214846|NCT01858766|699122|P14|Overall Study|Lack of Efficacy|3
214847|NCT01858766|699123|P13|Overall Study|Lack of Efficacy|5
214848|NCT01858766|699124|P12|Overall Study|Lack of Efficacy|3
214849|NCT01858766|699125|P11|Overall Study|Lack of Efficacy|0
214850|NCT01858766|699126|P10|Overall Study|Lack of Efficacy|0
214851|NCT01858766|699127|P9|Overall Study|Lack of Efficacy|0
214852|NCT01858766|699128|P8|Overall Study|Lack of Efficacy|0
214853|NCT01858766|699129|P7|Overall Study|Lack of Efficacy|0
214854|NCT01858766|699130|P6|Overall Study|Lack of Efficacy|2
214855|NCT01858766|699131|P5|Overall Study|Lack of Efficacy|1
214856|NCT01858766|699132|P4|Overall Study|Lack of Efficacy|0
214857|NCT01858766|699133|P3|Overall Study|Lack of Efficacy|0
214858|NCT01858766|699134|P2|Overall Study|Lack of Efficacy|0
214859|NCT01858766|699135|P1|Overall Study|Lack of Efficacy|1
214860|NCT01858766|699117|P19|Overall Study|Death|0
214861|NCT01858766|699118|P18|Overall Study|Death|0
214862|NCT01858766|699119|P17|Overall Study|Death|0
214863|NCT01858766|699120|P16|Overall Study|Death|0
214864|NCT01858766|699121|P15|Overall Study|Death|0
214865|NCT01858766|699122|P14|Overall Study|Death|0
214866|NCT01858766|699123|P13|Overall Study|Death|0
214867|NCT01858766|699124|P12|Overall Study|Death|0
214868|NCT01858766|699125|P11|Overall Study|Death|0
214869|NCT01858766|699126|P10|Overall Study|Death|0
214870|NCT01858766|699127|P9|Overall Study|Death|0
214871|NCT01858766|699128|P8|Overall Study|Death|0
214872|NCT01858766|699129|P7|Overall Study|Death|0
214873|NCT01858766|699130|P6|Overall Study|Death|0
214874|NCT01858766|699131|P5|Overall Study|Death|0
214875|NCT01858766|699132|P4|Overall Study|Death|0
214876|NCT01858766|699133|P3|Overall Study|Death|1
214877|NCT01858766|699134|P2|Overall Study|Death|0
214878|NCT01858766|699135|P1|Overall Study|Death|0
214879|NCT01858766|699117|P19|Overall Study|Randomized but Never Treated|0
214880|NCT01858766|699118|P18|Overall Study|Randomized but Never Treated|1
214881|NCT01858766|699119|P17|Overall Study|Randomized but Never Treated|0
214882|NCT01858766|699120|P16|Overall Study|Randomized but Never Treated|0
214883|NCT01858766|699121|P15|Overall Study|Randomized but Never Treated|0
214884|NCT01858766|699122|P14|Overall Study|Randomized but Never Treated|0
214885|NCT01858766|699123|P13|Overall Study|Randomized but Never Treated|0
214886|NCT01858766|699124|P12|Overall Study|Randomized but Never Treated|0
214887|NCT01858766|699125|P11|Overall Study|Randomized but Never Treated|0
214888|NCT01858766|699126|P10|Overall Study|Randomized but Never Treated|0
214889|NCT01858766|699127|P9|Overall Study|Randomized but Never Treated|0
214890|NCT01858766|699128|P8|Overall Study|Randomized but Never Treated|0
214891|NCT01858766|699129|P7|Overall Study|Randomized but Never Treated|0
214892|NCT01858766|699130|P6|Overall Study|Randomized but Never Treated|1
214893|NCT01858766|699131|P5|Overall Study|Randomized but Never Treated|0
214894|NCT01858766|699132|P4|Overall Study|Randomized but Never Treated|0
214895|NCT01858766|699133|P3|Overall Study|Randomized but Never Treated|0
214896|NCT01858766|699134|P2|Overall Study|Randomized but Never Treated|0
214897|NCT01858766|699135|P1|Overall Study|Randomized but Never Treated|0
214898|NCT01858701|699206|P2|Period 2, Second 30 Days of Wear|Comfort|1
214899|NCT01858701|699207|P1|Period 2, Second 30 Days of Wear|Comfort|0
214900|NCT01858701|699206|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
214901|NCT01858701|699207|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
214902|NCT01858701|699206|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
214903|NCT01858701|699207|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
214904|NCT01858701|699206|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
214905|NCT01858701|699207|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
214906|NCT01858636|699213|P1|Overall Study|Withdrawal by Subject|1
214907|NCT01858636|699213|P1|Overall Study|Lost to Follow-up|1
214908|NCT01858636|699213|P1|Overall Study|Death|1
214909|NCT01858636|699213|P1|Overall Study|Physician Decision|1
214910|NCT01858636|699213|P1|Overall Study|No Device Deployment Attempted|24
214911|NCT01858376|699218|P1|Overall Study|Dropped d/t lab work not fitting criter|4
214912|NCT01857622|699243|P3|Overall Study|Withdrawal by Subject|0
214913|NCT01857622|699244|P2|Overall Study|Withdrawal by Subject|0
214914|NCT01857622|699245|P1|Overall Study|Withdrawal by Subject|1
214915|NCT01857622|699243|P3|Overall Study|Protocol Violation|0
214916|NCT01857622|699244|P2|Overall Study|Protocol Violation|1
214917|NCT01857622|699245|P1|Overall Study|Protocol Violation|4
214918|NCT01857622|699243|P3|Overall Study|Physician Decision|0
214919|NCT01857622|699244|P2|Overall Study|Physician Decision|0
214920|NCT01857622|699245|P1|Overall Study|Physician Decision|1
214921|NCT01857622|699243|P3|Overall Study|Adverse Event|2
214922|NCT01857622|699244|P2|Overall Study|Adverse Event|0
214923|NCT01857622|699245|P1|Overall Study|Adverse Event|5
214924|NCT01857583|699257|P4|Overall Study|Withdrawal by Subject|2
214925|NCT01857583|699258|P3|Overall Study|Withdrawal by Subject|1
214926|NCT01857583|699259|P2|Overall Study|Withdrawal by Subject|0
214927|NCT01857583|699260|P1|Overall Study|Withdrawal by Subject|1
214928|NCT01857583|699257|P4|Overall Study|Physician Decision|1
214929|NCT01857583|699258|P3|Overall Study|Physician Decision|0
214930|NCT01857583|699259|P2|Overall Study|Physician Decision|0
214931|NCT01857583|699260|P1|Overall Study|Physician Decision|0
214932|NCT01857583|699257|P4|Overall Study|Death|0
214933|NCT01857583|699258|P3|Overall Study|Death|1
214934|NCT01857583|699259|P2|Overall Study|Death|1
214935|NCT01857583|699260|P1|Overall Study|Death|0
214936|NCT01857583|699257|P4|Overall Study|Adverse Event|1
214937|NCT01857583|699258|P3|Overall Study|Adverse Event|1
214938|NCT01857583|699259|P2|Overall Study|Adverse Event|0
214939|NCT01857583|699260|P1|Overall Study|Adverse Event|0
214940|NCT01857531|699270|P1|Overall Study|Withdrawal by Subject|4
214941|NCT01857323|699288|P1|Overall Study|Did not complete 180 doses|48
214942|NCT01857323|699288|P1|Overall Study|Not specified|4
214943|NCT01857323|699288|P1|Overall Study|Lost to Follow-up|1
214944|NCT01857323|699288|P1|Overall Study|Protocol Violation|6
214945|NCT01857323|699288|P1|Overall Study|Non-compliance|1
214946|NCT01857323|699288|P1|Overall Study|Withdrawal by Subject|3
214947|NCT01857323|699288|P1|Overall Study|Adverse Event|1
214948|NCT01857206|699337|P2|Overall Study|Withdrawal by Subject|0
214949|NCT01857206|699338|P1|Overall Study|Withdrawal by Subject|1
214950|NCT01857206|699337|P2|Overall Study|Unclassified|3
214951|NCT01857206|699338|P1|Overall Study|Unclassified|3
214952|NCT01857206|699337|P2|Overall Study|Lost to Follow-up|6
214953|NCT01857206|699338|P1|Overall Study|Lost to Follow-up|9
214954|NCT01857206|699337|P2|Overall Study|ADMINISTRATIVE REASON|1
214955|NCT01857206|699338|P1|Overall Study|ADMINISTRATIVE REASON|0
214956|NCT01857102|699356|P2|Period 2|Unsatisfactory Lens Fit|0
214957|NCT01857102|699357|P1|Period 2|Unsatisfactory Lens Fit|1
214958|NCT01857102|699356|P2|Period 2|Lens Discomfort|0
214959|NCT01857102|699357|P1|Period 2|Lens Discomfort|1
214960|NCT01857102|699356|P2|Period 1|Physician Decision|0
214961|NCT01857102|699357|P1|Period 1|Physician Decision|1
214962|NCT01857102|699356|P2|Period 1|Unsatisfactory Visual Response|0
214963|NCT01857102|699357|P1|Period 1|Unsatisfactory Visual Response|1
214964|NCT01857102|699356|P2|Period 1|Unsatisfactory Lens Fit|0
214965|NCT01857102|699357|P1|Period 1|Unsatisfactory Lens Fit|1
214966|NCT01857102|699356|P2|Period 1|Lost to Follow-up|3
214967|NCT01857102|699357|P1|Period 1|Lost to Follow-up|0
214968|NCT01857102|699356|P2|Period 1|No longer meets Eligibility Criteria|2
214969|NCT01857102|699357|P1|Period 1|No longer meets Eligibility Criteria|0
214970|NCT01857063|699367|P2|Period 2 (7 Days)|Withdrawal by Subject|0
214971|NCT01857063|699368|P1|Period 2 (7 Days)|Withdrawal by Subject|1
214972|NCT01857063|699367|P2|Period 2 (7 Days)|Physician Decision|1
214973|NCT01857063|699368|P1|Period 2 (7 Days)|Physician Decision|1
214974|NCT01857063|699367|P2|Period 2 (7 Days)|Adverse Event|1
214975|NCT01857063|699368|P1|Period 2 (7 Days)|Adverse Event|2
214976|NCT01857063|699367|P2|Period 1 (7 Days)|Withdrawal by Subject|3
214977|NCT01857063|699368|P1|Period 1 (7 Days)|Withdrawal by Subject|1
214978|NCT01857063|699367|P2|Period 1 (7 Days)|Physician Decision|0
214979|NCT01857063|699368|P1|Period 1 (7 Days)|Physician Decision|1
214980|NCT01857063|699367|P2|Period 1 (7 Days)|Adverse Event|1
214981|NCT01857063|699368|P1|Period 1 (7 Days)|Adverse Event|0
214982|NCT01856686|699413|P2|Overall Study|Lost to Follow-up|11
214983|NCT01856686|699414|P1|Overall Study|Lost to Follow-up|5
214984|NCT01856673|699457|P3|Overall Study|Protocol Violation|1
214985|NCT01856673|699458|P2|Overall Study|Protocol Violation|0
214986|NCT01856673|699459|P1|Overall Study|Protocol Violation|1
214987|NCT01856673|699457|P3|Overall Study|Death|0
214988|NCT01856673|699458|P2|Overall Study|Death|1
214989|NCT01856673|699459|P1|Overall Study|Death|2
214990|NCT01856673|699457|P3|Overall Study|Paperwork errors|0
214991|NCT01856673|699458|P2|Overall Study|Paperwork errors|0
214992|NCT01856673|699459|P1|Overall Study|Paperwork errors|4
214993|NCT01856673|699457|P3|Overall Study|Psychologist decision|0
214994|NCT01856673|699458|P2|Overall Study|Psychologist decision|0
214995|NCT01856673|699459|P1|Overall Study|Psychologist decision|3
214996|NCT01856673|699457|P3|Overall Study|Unknown reasons|0
214997|NCT01856673|699458|P2|Overall Study|Unknown reasons|0
214998|NCT01856673|699459|P1|Overall Study|Unknown reasons|20
214999|NCT01856673|699457|P3|Overall Study|Lost to Follow-up|0
215000|NCT01856673|699458|P2|Overall Study|Lost to Follow-up|34
215001|NCT01856673|699459|P1|Overall Study|Lost to Follow-up|22
215002|NCT01856673|699457|P3|Overall Study|Withdrawal by Subject|33
215003|NCT01856673|699458|P2|Overall Study|Withdrawal by Subject|50
215004|NCT01856673|699459|P1|Overall Study|Withdrawal by Subject|46
215005|NCT01856569|699470|P1|Overall Study|Did not met inclusion criteria|8
215006|NCT01856569|699470|P1|Overall Study|Lost to Follow-up|3
215007|NCT01856569|699470|P1|Overall Study|Changed Site/Structure|1
215008|NCT01856569|699470|P1|Overall Study|Unspecified|1
215009|NCT01856322|699518|P3|Overall Study|off study due to lack of accrual|3
215010|NCT01856322|699519|P2|Overall Study|off study due to lack of accrual|0
215011|NCT01856322|699520|P1|Overall Study|off study due to lack of accrual|0
215012|NCT01855958|699582|P2|Overall Study|Withdrawal by Subject|0
215013|NCT01855958|699583|P1|Overall Study|Withdrawal by Subject|1
215014|NCT01855945|699613|P12|Overall Study|Withdrawal by Subject|1
215015|NCT01855945|699614|P11|Overall Study|Withdrawal by Subject|4
215016|NCT01855945|699615|P10|Overall Study|Withdrawal by Subject|2
215017|NCT01855945|699616|P9|Overall Study|Withdrawal by Subject|0
215018|NCT01855945|699617|P8|Overall Study|Withdrawal by Subject|0
215019|NCT01855945|699618|P7|Overall Study|Withdrawal by Subject|1
215020|NCT01855945|699619|P6|Overall Study|Withdrawal by Subject|0
215021|NCT01855945|699620|P5|Overall Study|Withdrawal by Subject|1
215022|NCT01855945|699621|P4|Overall Study|Withdrawal by Subject|1
215023|NCT01855945|699622|P3|Overall Study|Withdrawal by Subject|4
215024|NCT01855945|699623|P2|Overall Study|Withdrawal by Subject|0
215025|NCT01855945|699624|P1|Overall Study|Withdrawal by Subject|4
215026|NCT01855945|699613|P12|Overall Study|Other - Unclassified|0
215027|NCT01855945|699614|P11|Overall Study|Other - Unclassified|1
215028|NCT01855945|699615|P10|Overall Study|Other - Unclassified|0
215029|NCT01855945|699616|P9|Overall Study|Other - Unclassified|0
215030|NCT01855945|699617|P8|Overall Study|Other - Unclassified|1
215031|NCT01855945|699618|P7|Overall Study|Other - Unclassified|2
215032|NCT01855945|699619|P6|Overall Study|Other - Unclassified|0
215033|NCT01855945|699620|P5|Overall Study|Other - Unclassified|0
215034|NCT01855945|699621|P4|Overall Study|Other - Unclassified|0
215035|NCT01855945|699622|P3|Overall Study|Other - Unclassified|1
215036|NCT01855945|699623|P2|Overall Study|Other - Unclassified|1
215037|NCT01855945|699624|P1|Overall Study|Other - Unclassified|1
215038|NCT01855945|699613|P12|Overall Study|Lost to Follow-up|2
215039|NCT01855945|699614|P11|Overall Study|Lost to Follow-up|0
215040|NCT01855945|699615|P10|Overall Study|Lost to Follow-up|0
215041|NCT01855945|699616|P9|Overall Study|Lost to Follow-up|2
215042|NCT01855945|699617|P8|Overall Study|Lost to Follow-up|7
215043|NCT01855945|699618|P7|Overall Study|Lost to Follow-up|4
215044|NCT01855945|699619|P6|Overall Study|Lost to Follow-up|3
215045|NCT01855945|699620|P5|Overall Study|Lost to Follow-up|0
215046|NCT01855945|699621|P4|Overall Study|Lost to Follow-up|3
215047|NCT01855945|699622|P3|Overall Study|Lost to Follow-up|7
215048|NCT01855945|699623|P2|Overall Study|Lost to Follow-up|10
215049|NCT01855945|699624|P1|Overall Study|Lost to Follow-up|11
215050|NCT01855945|699613|P12|Overall Study|Death|0
215051|NCT01855945|699614|P11|Overall Study|Death|0
215052|NCT01855945|699615|P10|Overall Study|Death|0
215053|NCT01855945|699616|P9|Overall Study|Death|0
215054|NCT01855945|699617|P8|Overall Study|Death|0
215055|NCT01855945|699618|P7|Overall Study|Death|2
215056|NCT01855945|699619|P6|Overall Study|Death|0
215057|NCT01855945|699620|P5|Overall Study|Death|0
215058|NCT01855945|699621|P4|Overall Study|Death|0
215059|NCT01855945|699622|P3|Overall Study|Death|0
215060|NCT01855945|699623|P2|Overall Study|Death|0
215061|NCT01855945|699624|P1|Overall Study|Death|0
215062|NCT01855945|699613|P12|Overall Study|Adverse Event|0
215063|NCT01855945|699614|P11|Overall Study|Adverse Event|0
215064|NCT01855945|699615|P10|Overall Study|Adverse Event|0
215065|NCT01855945|699616|P9|Overall Study|Adverse Event|0
215066|NCT01855945|699617|P8|Overall Study|Adverse Event|0
215067|NCT01855945|699618|P7|Overall Study|Adverse Event|1
215068|NCT01855945|699619|P6|Overall Study|Adverse Event|0
215069|NCT01855945|699620|P5|Overall Study|Adverse Event|0
215070|NCT01855945|699621|P4|Overall Study|Adverse Event|0
215071|NCT01855945|699622|P3|Overall Study|Adverse Event|0
215072|NCT01855945|699623|P2|Overall Study|Adverse Event|0
215073|NCT01855945|699624|P1|Overall Study|Adverse Event|0
215074|NCT01855919|699760|P2|Overall Study|Protocol Violation|4
215075|NCT01855919|699761|P1|Overall Study|Protocol Violation|1
215076|NCT01855919|699760|P2|Overall Study|Entry Criteria Not Met|1
215077|NCT01855919|699761|P1|Overall Study|Entry Criteria Not Met|1
215078|NCT01855919|699760|P2|Overall Study|Withdrawal by Subject|10
215079|NCT01855919|699761|P1|Overall Study|Withdrawal by Subject|4
215080|NCT01855919|699760|P2|Overall Study|Lack of Efficacy|3
215081|NCT01855919|699761|P1|Overall Study|Lack of Efficacy|1
215082|NCT01855919|699760|P2|Overall Study|Adverse Event|8
215083|NCT01855919|699761|P1|Overall Study|Adverse Event|16
215084|NCT01855074|699793|P1|Overall Study|Started but not treated|1
215085|NCT01855074|699793|P1|Overall Study|Withdrawal by Subject|8
215086|NCT01855074|699793|P1|Overall Study|Lost to Follow-up|4
215087|NCT01855074|699793|P1|Overall Study|Adverse Event|1
215088|NCT01854944|699805|P3|Overall Study|Withdrawal by Subject|1
215089|NCT01854944|699806|P2|Overall Study|Withdrawal by Subject|0
215090|NCT01854944|699807|P1|Overall Study|Withdrawal by Subject|0
215091|NCT01854697|699866|P5|Overall Study|Not Specified|0
215092|NCT01854697|699867|P4|Overall Study|Not Specified|0
215093|NCT01854697|699868|P3|Overall Study|Not Specified|1
215094|NCT01854697|699869|P2|Overall Study|Not Specified|1
215095|NCT01854697|699870|P1|Overall Study|Not Specified|0
215096|NCT01854697|699866|P5|Overall Study|Withdrew Consent|0
215097|NCT01854697|699867|P4|Overall Study|Withdrew Consent|1
215098|NCT01854697|699868|P3|Overall Study|Withdrew Consent|0
215099|NCT01854697|699869|P2|Overall Study|Withdrew Consent|1
215100|NCT01854697|699870|P1|Overall Study|Withdrew Consent|0
215101|NCT01854697|699866|P5|Overall Study|To enter another AbbVie study|1
215102|NCT01854697|699867|P4|Overall Study|To enter another AbbVie study|0
215103|NCT01854697|699868|P3|Overall Study|To enter another AbbVie study|0
215104|NCT01854697|699869|P2|Overall Study|To enter another AbbVie study|0
215105|NCT01854697|699870|P1|Overall Study|To enter another AbbVie study|1
215106|NCT01854697|699866|P5|Overall Study|Lost to Follow-up|0
215107|NCT01854697|699867|P4|Overall Study|Lost to Follow-up|2
215108|NCT01854697|699868|P3|Overall Study|Lost to Follow-up|1
215109|NCT01854697|699869|P2|Overall Study|Lost to Follow-up|1
215110|NCT01854697|699870|P1|Overall Study|Lost to Follow-up|4
215111|NCT01854697|699866|P5|Overall Study|Adverse Event|1
215112|NCT01854697|699867|P4|Overall Study|Adverse Event|0
215113|NCT01854697|699868|P3|Overall Study|Adverse Event|0
215114|NCT01854697|699869|P2|Overall Study|Adverse Event|0
215115|NCT01854697|699870|P1|Overall Study|Adverse Event|1
215116|NCT01854658|699914|P4|Overall Study|Administrative reasons|2
215117|NCT01854658|699915|P3|Overall Study|Administrative reasons|2
215118|NCT01854658|699916|P2|Overall Study|Administrative reasons|1
215119|NCT01854658|699917|P1|Overall Study|Administrative reasons|5
215120|NCT01854658|699914|P4|Overall Study|Adverse Event|19
215121|NCT01854658|699915|P3|Overall Study|Adverse Event|23
215122|NCT01854658|699916|P2|Overall Study|Adverse Event|14
215123|NCT01854658|699917|P1|Overall Study|Adverse Event|21
215124|NCT01854658|699914|P4|Overall Study|Lack of Efficacy|7
215125|NCT01854658|699915|P3|Overall Study|Lack of Efficacy|4
215126|NCT01854658|699916|P2|Overall Study|Lack of Efficacy|8
215127|NCT01854658|699917|P1|Overall Study|Lack of Efficacy|3
215128|NCT01854658|699914|P4|Overall Study|Protocol-specified criteria|7
215129|NCT01854658|699915|P3|Overall Study|Protocol-specified criteria|10
215130|NCT01854658|699916|P2|Overall Study|Protocol-specified criteria|15
215131|NCT01854658|699917|P1|Overall Study|Protocol-specified criteria|15
215132|NCT01854658|699914|P4|Overall Study|Withdrawal by Subject|15
215133|NCT01854658|699915|P3|Overall Study|Withdrawal by Subject|29
215134|NCT01854658|699916|P2|Overall Study|Withdrawal by Subject|21
215135|NCT01854658|699917|P1|Overall Study|Withdrawal by Subject|28
215136|NCT01854658|699914|P4|Overall Study|Lost to Follow-up|4
215137|NCT01854658|699915|P3|Overall Study|Lost to Follow-up|8
215138|NCT01854658|699916|P2|Overall Study|Lost to Follow-up|9
215139|NCT01854658|699917|P1|Overall Study|Lost to Follow-up|8
215140|NCT01854658|699914|P4|Overall Study|Physician Decision|4
215141|NCT01854658|699915|P3|Overall Study|Physician Decision|2
215142|NCT01854658|699916|P2|Overall Study|Physician Decision|5
215143|NCT01854658|699917|P1|Overall Study|Physician Decision|7
215144|NCT01854658|699914|P4|Overall Study|Protocol Violation|1
215145|NCT01854658|699915|P3|Overall Study|Protocol Violation|2
215146|NCT01854658|699916|P2|Overall Study|Protocol Violation|2
215147|NCT01854658|699917|P1|Overall Study|Protocol Violation|6
215148|NCT01854645|699952|P5|Overall Study|Adverse Event|11
215149|NCT01854645|699953|P4|Overall Study|Adverse Event|20
215150|NCT01854645|699954|P3|Overall Study|Adverse Event|19
215151|NCT01854645|699955|P2|Overall Study|Adverse Event|31
215152|NCT01854645|699956|P1|Overall Study|Adverse Event|33
215153|NCT01854645|699952|P5|Overall Study|Lack of Efficacy|9
215154|NCT01854645|699953|P4|Overall Study|Lack of Efficacy|3
215155|NCT01854645|699954|P3|Overall Study|Lack of Efficacy|9
215156|NCT01854645|699955|P2|Overall Study|Lack of Efficacy|12
215157|NCT01854645|699956|P1|Overall Study|Lack of Efficacy|7
215158|NCT01854645|699952|P5|Overall Study|Withdrawal by Subject|24
215159|NCT01854645|699953|P4|Overall Study|Withdrawal by Subject|21
215160|NCT01854645|699954|P3|Overall Study|Withdrawal by Subject|30
215161|NCT01854645|699955|P2|Overall Study|Withdrawal by Subject|41
215162|NCT01854645|699956|P1|Overall Study|Withdrawal by Subject|31
215163|NCT01854645|699952|P5|Overall Study|Physician Decision|7
215164|NCT01854645|699953|P4|Overall Study|Physician Decision|3
215165|NCT01854645|699954|P3|Overall Study|Physician Decision|3
215166|NCT01854645|699955|P2|Overall Study|Physician Decision|5
215167|NCT01854645|699956|P1|Overall Study|Physician Decision|1
215168|NCT01854645|699952|P5|Overall Study|Lost to Follow-up|0
215169|NCT01854645|699953|P4|Overall Study|Lost to Follow-up|5
215170|NCT01854645|699954|P3|Overall Study|Lost to Follow-up|8
215171|NCT01854645|699955|P2|Overall Study|Lost to Follow-up|7
215172|NCT01854645|699956|P1|Overall Study|Lost to Follow-up|10
215173|NCT01854645|699952|P5|Overall Study|Protocol Violation|1
215174|NCT01854645|699953|P4|Overall Study|Protocol Violation|4
215175|NCT01854645|699954|P3|Overall Study|Protocol Violation|5
215176|NCT01854645|699955|P2|Overall Study|Protocol Violation|0
215177|NCT01854645|699956|P1|Overall Study|Protocol Violation|3
215178|NCT01854645|699952|P5|Overall Study|Administrative Reasons / Missing|1
215179|NCT01854645|699953|P4|Overall Study|Administrative Reasons / Missing|1
215180|NCT01854645|699954|P3|Overall Study|Administrative Reasons / Missing|0
215181|NCT01854645|699955|P2|Overall Study|Administrative Reasons / Missing|0
215182|NCT01854645|699956|P1|Overall Study|Administrative Reasons / Missing|0
215183|NCT01854645|699952|P5|Overall Study|Protocol-Specified Criteria|7
215184|NCT01854645|699953|P4|Overall Study|Protocol-Specified Criteria|5
215185|NCT01854645|699954|P3|Overall Study|Protocol-Specified Criteria|8
215186|NCT01854645|699955|P2|Overall Study|Protocol-Specified Criteria|10
215187|NCT01854645|699956|P1|Overall Study|Protocol-Specified Criteria|13
215188|NCT01854528|700037|P2|Overall Study|Virologic Failure|9
215189|NCT01854528|700038|P1|Overall Study|Virologic Failure|0
215190|NCT01854528|700037|P2|Overall Study|Withdrawal by Subject|2
215191|NCT01854528|700038|P1|Overall Study|Withdrawal by Subject|0
215192|NCT01854528|700037|P2|Overall Study|Adverse Event|4
215193|NCT01854528|700038|P1|Overall Study|Adverse Event|0
215194|NCT01854047|700086|P5|Overall Study|Other than specified above|8
215195|NCT01854047|700087|P4|Overall Study|Other than specified above|5
215196|NCT01854047|700088|P3|Overall Study|Other than specified above|3
215197|NCT01854047|700089|P2|Overall Study|Other than specified above|3
215198|NCT01854047|700090|P1|Overall Study|Other than specified above|3
215199|NCT01854047|700086|P5|Overall Study|Randomized but not treated|4
215200|NCT01854047|700087|P4|Overall Study|Randomized but not treated|0
215201|NCT01854047|700088|P3|Overall Study|Randomized but not treated|2
215202|NCT01854047|700089|P2|Overall Study|Randomized but not treated|1
215203|NCT01854047|700090|P1|Overall Study|Randomized but not treated|0
215204|NCT01854047|700086|P5|Overall Study|Adverse Event|7
215205|NCT01854047|700087|P4|Overall Study|Adverse Event|10
215206|NCT01854047|700088|P3|Overall Study|Adverse Event|6
215207|NCT01854047|700089|P2|Overall Study|Adverse Event|4
215208|NCT01854047|700090|P1|Overall Study|Adverse Event|5
215209|NCT01854047|700086|P5|Overall Study|Poor compliance to protocol|0
215210|NCT01854047|700087|P4|Overall Study|Poor compliance to protocol|0
215211|NCT01854047|700088|P3|Overall Study|Poor compliance to protocol|2
215212|NCT01854047|700089|P2|Overall Study|Poor compliance to protocol|0
215213|NCT01854047|700090|P1|Overall Study|Poor compliance to protocol|3
215214|NCT01854047|700086|P5|Overall Study|Lack of Efficacy|0
215215|NCT01854047|700087|P4|Overall Study|Lack of Efficacy|0
215216|NCT01854047|700088|P3|Overall Study|Lack of Efficacy|0
215217|NCT01854047|700089|P2|Overall Study|Lack of Efficacy|0
215218|NCT01854047|700090|P1|Overall Study|Lack of Efficacy|1
215219|NCT01853982|700214|P2|Overall Study|Lost to Follow-up|1
215220|NCT01853982|700215|P1|Overall Study|Lost to Follow-up|0
215221|NCT01853982|700214|P2|Overall Study|Death|0
215222|NCT01853982|700215|P1|Overall Study|Death|1
215223|NCT01853982|700214|P2|Overall Study|Withdrawal by Subject|0
215224|NCT01853982|700215|P1|Overall Study|Withdrawal by Subject|1
215225|NCT01853839|700221|P1|Overall Study|Lost to follow-up or no valid BP measure|336
215226|NCT01853839|700221|P1|Overall Study|End of treatment visit too early|33
215227|NCT01853839|700221|P1|Overall Study|Not meet ITT population definition|58
215228|NCT01853839|700221|P1|Overall Study|Violated inclusion criteria|2
215229|NCT01853696|700243|P2|Overall Study|Lost to Follow-up|4
215230|NCT01853696|700244|P1|Overall Study|Lost to Follow-up|5
215231|NCT01853696|700243|P2|Overall Study|Withdrawal by Subject|1
215232|NCT01853696|700244|P1|Overall Study|Withdrawal by Subject|1
215233|NCT01853475|700280|P3|Overall Study|Withdrawal by Subject|0
215234|NCT01853475|700281|P2|Overall Study|Withdrawal by Subject|1
215235|NCT01853475|700282|P1|Overall Study|Withdrawal by Subject|0
215236|NCT01853397|700303|P4|Overall Study|Subject Noncompliance|1
215237|NCT01853397|700304|P3|Overall Study|Subject Noncompliance|0
215238|NCT01853397|700305|P2|Overall Study|Subject Noncompliance|0
215239|NCT01853397|700306|P1|Overall Study|Subject Noncompliance|0
215240|NCT01853397|700303|P4|Overall Study|Withdrawal by Subject|1
215241|NCT01853397|700304|P3|Overall Study|Withdrawal by Subject|0
215242|NCT01853397|700305|P2|Overall Study|Withdrawal by Subject|0
215243|NCT01853397|700306|P1|Overall Study|Withdrawal by Subject|0
215244|NCT01853384|700334|P2|Completed Follow up Visit 2|Lost to Follow-up|1
215245|NCT01853384|700335|P1|Completed Follow up Visit 2|Lost to Follow-up|0
215246|NCT01853384|700334|P2|Completed Follow up Visit 2|Death|0
215247|NCT01853384|700335|P1|Completed Follow up Visit 2|Death|1
215248|NCT01853384|700334|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
215249|NCT01853384|700335|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
215250|NCT01853384|700334|P2|Completed Follow up Visit 2|Adverse Event|0
215251|NCT01853384|700335|P1|Completed Follow up Visit 2|Adverse Event|1
215252|NCT01853384|700334|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
215253|NCT01853384|700335|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
215254|NCT01853384|700334|P2|Completed Follow up Visit 1|Early Termination|9
215255|NCT01853384|700335|P1|Completed Follow up Visit 1|Early Termination|13
215256|NCT01853384|700334|P2|Randomized|Other|3
215257|NCT01853384|700335|P1|Randomized|Other|3
215258|NCT01853384|700334|P2|Randomized|Sponsor Decision|34
215259|NCT01853384|700335|P1|Randomized|Sponsor Decision|47
215260|NCT01853384|700334|P2|Randomized|Withdrawal by Subject|3
215261|NCT01853384|700335|P1|Randomized|Withdrawal by Subject|5
215262|NCT01853384|700334|P2|Randomized|Lost to Follow-up|1
215263|NCT01853384|700335|P1|Randomized|Lost to Follow-up|1
215264|NCT01853384|700334|P2|Randomized|Death|2
215265|NCT01853384|700335|P1|Randomized|Death|1
215266|NCT01853384|700334|P2|Randomized|Adverse Event|3
215267|NCT01853384|700335|P1|Randomized|Adverse Event|5
215268|NCT01853254|700364|P1|Overall Study|Administrative/Other|16
215269|NCT01853254|700364|P1|Overall Study|Withdrawal of Consent|16
215270|NCT01853254|700364|P1|Overall Study|Other Protocol Violation|1
215271|NCT01853254|700364|P1|Overall Study|Refusal of Treatment|1
215272|NCT01853254|700364|P1|Overall Study|Insufficient Therapeutic Response|22
215273|NCT01853254|700364|P1|Overall Study|Failure to Return|43
215274|NCT01853254|700364|P1|Overall Study|Death|1
215275|NCT01853254|700364|P1|Overall Study|Adverse Event/Intercurrent Illness|3
215276|NCT01853254|700364|P1|Overall Study|Abnormal Laboratory Test|1
215277|NCT01853176|700381|P2|Overall Study|Study terminated|0
215278|NCT01853176|700382|P1|Overall Study|Study terminated|4
215279|NCT01853072|700401|P2|Overall Study|Reason not specified|6
215280|NCT01853072|700402|P1|Overall Study|Reason not specified|9
215281|NCT01853072|700401|P2|Overall Study|Withdrawal by Subject|2
215282|NCT01853072|700402|P1|Overall Study|Withdrawal by Subject|1
215283|NCT01853072|700401|P2|Overall Study|Physician Decision|1
215284|NCT01853072|700402|P1|Overall Study|Physician Decision|1
215285|NCT01853072|700401|P2|Overall Study|Non-compliance with study drug|1
215286|NCT01853072|700402|P1|Overall Study|Non-compliance with study drug|0
215287|NCT01853072|700401|P2|Overall Study|Lost to Follow-up|3
215288|NCT01853072|700402|P1|Overall Study|Lost to Follow-up|0
215289|NCT01853072|700401|P2|Overall Study|Death|4
215290|NCT01853072|700402|P1|Overall Study|Death|1
215291|NCT01853072|700401|P2|Overall Study|Adverse Event|3
215292|NCT01853072|700402|P1|Overall Study|Adverse Event|0
215293|NCT01853072|700401|P2|Overall Study|Adverse event prior to treatment|1
215294|NCT01853072|700402|P1|Overall Study|Adverse event prior to treatment|0
215295|NCT01853046|700422|P2|Overall Study|Disease progression|3
215296|NCT01853046|700423|P1|Overall Study|Disease progression|13
215297|NCT01853046|700422|P2|Overall Study|Adverse Event|2
215298|NCT01853046|700423|P1|Overall Study|Adverse Event|4
215299|NCT01853046|700422|P2|Overall Study|Withdrawal by Subject|1
215300|NCT01853046|700423|P1|Overall Study|Withdrawal by Subject|1
215301|NCT01852825|700491|P3|Overall Study|Withdrawal by Subject|0
215302|NCT01852825|700492|P2|Overall Study|Withdrawal by Subject|0
215303|NCT01852825|700493|P1|Overall Study|Withdrawal by Subject|2
215304|NCT01852812|700519|P3|Overall Study|Non-compliance With Study Drug|0
215305|NCT01852812|700520|P2|Overall Study|Non-compliance With Study Drug|1
215306|NCT01852812|700521|P1|Overall Study|Non-compliance With Study Drug|0
215307|NCT01852812|700519|P3|Overall Study|Adverse Event|1
215308|NCT01852812|700520|P2|Overall Study|Adverse Event|0
215309|NCT01852812|700521|P1|Overall Study|Adverse Event|0
215310|NCT01852591|700550|P1|Overall Study|Not Evaluable at Time of Analysis|1
215311|NCT01852591|700550|P1|Overall Study|Withdrawal by Subject|2
215312|NCT01852214|700564|P2|Washout Period|Withdrawal by Subject|1
215313|NCT01852214|700565|P1|Washout Period|Withdrawal by Subject|0
215314|NCT01852214|700564|P2|Period 1|Withdrawal by Subject|1
215315|NCT01852214|700565|P1|Period 1|Withdrawal by Subject|0
215316|NCT01852214|700564|P2|Period 1|Adverse Event|2
215317|NCT01852214|700565|P1|Period 1|Adverse Event|1
215318|NCT01852162|700592|P2|Overall Study|Withdrawal by Subject|1
215319|NCT01852162|700593|P1|Overall Study|Withdrawal by Subject|3
215320|NCT01852162|700592|P2|Overall Study|Adverse Event|0
215321|NCT01852162|700593|P1|Overall Study|Adverse Event|1
215322|NCT01851863|700645|P4|Overall Study|Lost to Follow-up|3
215323|NCT01851863|700646|P3|Overall Study|Lost to Follow-up|2
215324|NCT01851863|700647|P2|Overall Study|Lost to Follow-up|4
215325|NCT01851863|700648|P1|Overall Study|Lost to Follow-up|3
215326|NCT01851863|700645|P4|Overall Study|Did not receive study medication|0
215327|NCT01851863|700646|P3|Overall Study|Did not receive study medication|3
215328|NCT01851863|700647|P2|Overall Study|Did not receive study medication|5
215329|NCT01851863|700648|P1|Overall Study|Did not receive study medication|2
215330|NCT01851590|700699|P3|Overall Study|Lack of Efficacy|0
215331|NCT01851590|700700|P2|Overall Study|Lack of Efficacy|1
215332|NCT01851590|700701|P1|Overall Study|Lack of Efficacy|0
215333|NCT01851590|700699|P3|Overall Study|Adverse Event|2
215334|NCT01851590|700700|P2|Overall Study|Adverse Event|0
215335|NCT01851590|700701|P1|Overall Study|Adverse Event|0
215336|NCT01851590|700699|P3|Overall Study|Withdrawal by Subject|1
215337|NCT01851590|700700|P2|Overall Study|Withdrawal by Subject|0
215338|NCT01851590|700701|P1|Overall Study|Withdrawal by Subject|0
215339|NCT01851330|700724|P3|Overall Study|Investigator’s Discretion|1
215340|NCT01851330|700725|P2|Overall Study|Investigator’s Discretion|0
215341|NCT01851330|700726|P1|Overall Study|Investigator’s Discretion|0
215342|NCT01851330|700724|P3|Overall Study|Withdrew Consent|0
215343|NCT01851330|700725|P2|Overall Study|Withdrew Consent|1
215344|NCT01851330|700726|P1|Overall Study|Withdrew Consent|2
215345|NCT01851330|700724|P3|Overall Study|Lost to Follow-up|9
215346|NCT01851330|700725|P2|Overall Study|Lost to Follow-up|6
215347|NCT01851330|700726|P1|Overall Study|Lost to Follow-up|1
215348|NCT01851330|700724|P3|Overall Study|Lack of Efficacy|2
215349|NCT01851330|700725|P2|Overall Study|Lack of Efficacy|9
215350|NCT01851330|700726|P1|Overall Study|Lack of Efficacy|10
215351|NCT01849588|700761|P1|Overall Study|Lack of Efficacy|3
215352|NCT01849562|700771|P3|Overall Study|Non-compliance with Study Drug|0
215353|NCT01849562|700772|P2|Overall Study|Non-compliance with Study Drug|0
215354|NCT01849562|700773|P1|Overall Study|Non-compliance with Study Drug|1
215355|NCT01849562|700771|P3|Overall Study|Lost to Follow-up|0
215356|NCT01849562|700772|P2|Overall Study|Lost to Follow-up|0
215357|NCT01849562|700773|P1|Overall Study|Lost to Follow-up|1
215358|NCT01849497|700786|P2|Overall Study|Lost to Follow-up|1
215359|NCT01849497|700787|P1|Overall Study|Lost to Follow-up|0
215360|NCT01849497|700786|P2|Overall Study|Sponsor Decision|1
215361|NCT01849497|700787|P1|Overall Study|Sponsor Decision|0
215362|NCT01849497|700786|P2|Overall Study|Withdrawal by Subject|2
215363|NCT01849497|700787|P1|Overall Study|Withdrawal by Subject|1
215364|NCT01850589|700824|P2|Overall Study|Withdrawal by Subject|0
215365|NCT01850589|700825|P1|Overall Study|Withdrawal by Subject|8
215366|NCT01849848|700888|P1|Overall Study|Progression of the primary disease|3
215367|NCT01849848|700888|P1|Overall Study|Physician Decision|1
215368|NCT01849289|700988|P2|Overall Study|Unclassified|18
215369|NCT01849289|700989|P1|Overall Study|Unclassified|25
215370|NCT01849289|700988|P2|Overall Study|Withdrawal criteria|0
215371|NCT01849289|700989|P1|Overall Study|Withdrawal criteria|1
215372|NCT01849289|700988|P2|Overall Study|Protocol Violation|3
215373|NCT01849289|700989|P1|Overall Study|Protocol Violation|3
215374|NCT01849289|700988|P2|Overall Study|Adverse Event|3
215375|NCT01849289|700989|P1|Overall Study|Adverse Event|3
215376|NCT01848990|701023|P3|Overall Study|Death|0
215377|NCT01848990|701024|P2|Overall Study|Death|0
215378|NCT01848990|701025|P1|Overall Study|Death|1
215379|NCT01848990|701023|P3|Overall Study|Non Compliance|0
215380|NCT01848990|701024|P2|Overall Study|Non Compliance|0
215381|NCT01848990|701025|P1|Overall Study|Non Compliance|1
215382|NCT01848990|701023|P3|Overall Study|Physician Decision|0
215383|NCT01848990|701024|P2|Overall Study|Physician Decision|0
215384|NCT01848990|701025|P1|Overall Study|Physician Decision|1
215385|NCT01848990|701023|P3|Overall Study|Withdrawal by Subject|9
215386|NCT01848990|701024|P2|Overall Study|Withdrawal by Subject|6
215387|NCT01848990|701025|P1|Overall Study|Withdrawal by Subject|20
215388|NCT01848990|701023|P3|Overall Study|Protocol Violation|0
215389|NCT01848990|701024|P2|Overall Study|Protocol Violation|1
215390|NCT01848990|701025|P1|Overall Study|Protocol Violation|0
215391|NCT01848990|701023|P3|Overall Study|Lost to Follow-up|2
215392|NCT01848990|701024|P2|Overall Study|Lost to Follow-up|1
215393|NCT01848990|701025|P1|Overall Study|Lost to Follow-up|6
215394|NCT01848990|701023|P3|Overall Study|Adverse Event|0
215395|NCT01848990|701024|P2|Overall Study|Adverse Event|1
215396|NCT01848990|701025|P1|Overall Study|Adverse Event|4
215397|NCT01848938|701051|P2|Overall Study|Lost to Follow-up|1
215398|NCT01848938|701052|P1|Overall Study|Lost to Follow-up|1
215399|NCT01848756|701096|P1|Overall Study|Enrolled in Error|1
215400|NCT01848756|701096|P1|Overall Study|Withdrawal by Subject|1
215401|NCT01848756|701096|P1|Overall Study|Adverse Event|1
215402|NCT01848288|701110|P1|Overall Study|Withdrawal by Subject|1
215403|NCT01848288|701110|P1|Overall Study|Protocol Violation|1
215404|NCT01848288|701110|P1|Overall Study|Death|1
215405|NCT01848210|701121|P2|Overall Study|Administrative|0
215406|NCT01848210|701122|P1|Overall Study|Administrative|1
215407|NCT01848210|701121|P2|Overall Study|Chronic Venous Insufficiency Course|2
215408|NCT01848210|701122|P1|Overall Study|Chronic Venous Insufficiency Course|1
215409|NCT01848210|701121|P2|Overall Study|Hepatic Function Alteration|0
215410|NCT01848210|701122|P1|Overall Study|Hepatic Function Alteration|4
215411|NCT01848210|701121|P2|Overall Study|Hypesensitivity|0
215412|NCT01848210|701122|P1|Overall Study|Hypesensitivity|1
215413|NCT01848210|701121|P2|Overall Study|Discontinuation Criterion|7
215414|NCT01848210|701122|P1|Overall Study|Discontinuation Criterion|5
215415|NCT01848210|701121|P2|Overall Study|Adverse Event|9
215416|NCT01848210|701122|P1|Overall Study|Adverse Event|7
215417|NCT01848210|701121|P2|Overall Study|Impedition Condition|9
215418|NCT01848210|701122|P1|Overall Study|Impedition Condition|5
215419|NCT01848210|701121|P2|Overall Study|Use of Forbidden Drugs|10
215420|NCT01848210|701122|P1|Overall Study|Use of Forbidden Drugs|9
215421|NCT01848210|701121|P2|Overall Study|Protocol Violation|5
215422|NCT01848210|701122|P1|Overall Study|Protocol Violation|3
215423|NCT01848210|701121|P2|Overall Study|Lost to Follow-up|12
215424|NCT01848210|701122|P1|Overall Study|Lost to Follow-up|24
215425|NCT01848210|701121|P2|Overall Study|Informed Consent Form Withdrawal|24
215426|NCT01848210|701122|P1|Overall Study|Informed Consent Form Withdrawal|28
215427|NCT01848145|701134|P1|Subsequent Infusions: Weeks 3-8|Death|1
215428|NCT01848145|701134|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
215429|NCT01848145|701134|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
215430|NCT01848145|701134|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
215431|NCT01848145|701134|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
215432|NCT01848145|701134|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
215433|NCT01848145|701134|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
215434|NCT01847443|701211|P4|Washout Period Before Study Period 4|Positive alcohol test|0
215435|NCT01847443|701212|P3|Washout Period Before Study Period 4|Positive alcohol test|0
215436|NCT01847443|701213|P2|Washout Period Before Study Period 4|Positive alcohol test|0
215437|NCT01847443|701214|P1|Washout Period Before Study Period 4|Positive alcohol test|1
215438|NCT01847443|701211|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
215439|NCT01847443|701212|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
215440|NCT01847443|701213|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
215441|NCT01847443|701214|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
215442|NCT01847443|701211|P4|Washout Period Before Study Period 3|Other reason|0
215443|NCT01847443|701212|P3|Washout Period Before Study Period 3|Other reason|0
215444|NCT01847443|701213|P2|Washout Period Before Study Period 3|Other reason|0
215445|NCT01847443|701214|P1|Washout Period Before Study Period 3|Other reason|1
215446|NCT01847443|701211|P4|Washout Period Before Study Period 2|Other reason|0
215447|NCT01847443|701212|P3|Washout Period Before Study Period 2|Other reason|0
215448|NCT01847443|701213|P2|Washout Period Before Study Period 2|Other reason|0
215449|NCT01847443|701214|P1|Washout Period Before Study Period 2|Other reason|1
215450|NCT01847443|701211|P4|Washout Period Before Study Period 2|Adverse Event|0
215451|NCT01847443|701212|P3|Washout Period Before Study Period 2|Adverse Event|0
215452|NCT01847443|701213|P2|Washout Period Before Study Period 2|Adverse Event|1
215453|NCT01847443|701214|P1|Washout Period Before Study Period 2|Adverse Event|1
215454|NCT01847443|701211|P4|Study Period 1|Withdrawal by Subject|0
215455|NCT01847443|701212|P3|Study Period 1|Withdrawal by Subject|0
215456|NCT01847443|701213|P2|Study Period 1|Withdrawal by Subject|1
215457|NCT01847443|701214|P1|Study Period 1|Withdrawal by Subject|0
215458|NCT01846741|701271|P1|Baseline Visit|Subject did not meet entry criteria|2
215459|NCT01846442|701397|P4|Overall Study|Left the city/Lost medication|1
215460|NCT01846442|701398|P3|Overall Study|Left the city/Lost medication|1
215461|NCT01846442|701399|P2|Overall Study|Left the city/Lost medication|0
215462|NCT01846442|701400|P1|Overall Study|Left the city/Lost medication|1
215463|NCT01846442|701397|P4|Overall Study|Withdrawal by Subject|1
215464|NCT01846442|701398|P3|Overall Study|Withdrawal by Subject|0
215465|NCT01846442|701399|P2|Overall Study|Withdrawal by Subject|2
215466|NCT01846442|701400|P1|Overall Study|Withdrawal by Subject|3
215467|NCT01846442|701397|P4|Overall Study|Lost to Follow-up|0
215468|NCT01846442|701398|P3|Overall Study|Lost to Follow-up|1
215469|NCT01846442|701399|P2|Overall Study|Lost to Follow-up|0
215470|NCT01846442|701400|P1|Overall Study|Lost to Follow-up|0
215471|NCT01846442|701397|P4|Overall Study|Adverse Event|1
215472|NCT01846442|701398|P3|Overall Study|Adverse Event|2
215473|NCT01846442|701399|P2|Overall Study|Adverse Event|4
215474|NCT01846442|701400|P1|Overall Study|Adverse Event|2
215475|NCT01846416|701441|P3|Overall Study|Lost to Follow-up|1
215476|NCT01846416|701442|P2|Overall Study|Lost to Follow-up|2
215477|NCT01846416|701443|P1|Overall Study|Lost to Follow-up|0
215478|NCT01846416|701441|P3|Overall Study|Ongoing as of 7 January 2015|3
215479|NCT01846416|701442|P2|Overall Study|Ongoing as of 7 January 2015|41
215480|NCT01846416|701443|P1|Overall Study|Ongoing as of 7 January 2015|21
215481|NCT01846416|701441|P3|Overall Study|Unspecified|0
215482|NCT01846416|701442|P2|Overall Study|Unspecified|0
215483|NCT01846416|701443|P1|Overall Study|Unspecified|1
215484|NCT01846416|701441|P3|Overall Study|Withdrawal by Subject|0
215485|NCT01846416|701442|P2|Overall Study|Withdrawal by Subject|7
215486|NCT01846416|701443|P1|Overall Study|Withdrawal by Subject|1
215487|NCT01846416|701441|P3|Overall Study|Death|9
215488|NCT01846416|701442|P2|Overall Study|Death|43
215489|NCT01846416|701443|P1|Overall Study|Death|8
215490|NCT01846299|701488|P2|Overall Study|Adverse Event|0
215491|NCT01846299|701489|P1|Overall Study|Adverse Event|2
215492|NCT01846299|701488|P2|Overall Study|Withdrawal by Subject|6
215493|NCT01846299|701489|P1|Overall Study|Withdrawal by Subject|1
215494|NCT01846299|701488|P2|Overall Study|Lost to Follow-up|0
215495|NCT01846299|701489|P1|Overall Study|Lost to Follow-up|3
215496|NCT01846299|701488|P2|Overall Study|Death|2
215497|NCT01846299|701489|P1|Overall Study|Death|1
215498|NCT01846299|701488|P2|Overall Study|Protocol deviation|0
215499|NCT01846299|701489|P1|Overall Study|Protocol deviation|1
215500|NCT01846299|701488|P2|Overall Study|Physician Decision|2
215501|NCT01846299|701489|P1|Overall Study|Physician Decision|4
215502|NCT01846104|701525|P1|Overall Study|Withdrawal by Subject|1
215503|NCT01846039|701531|P1|Overall Study|Subject Withdrew Consent|1
215504|NCT01846039|701531|P1|Overall Study|Protocol Violation|1
215505|NCT01845831|701543|P5|Inpatient Phase|Withdrawal by Subject|0
215506|NCT01845831|701544|P4|Inpatient Phase|Withdrawal by Subject|0
215507|NCT01845831|701545|P3|Inpatient Phase|Withdrawal by Subject|0
215508|NCT01845831|701546|P2|Inpatient Phase|Withdrawal by Subject|1
215509|NCT01845831|701547|P1|Inpatient Phase|Withdrawal by Subject|1
215510|NCT01845077|701593|P6|Washout Period|Protocol Violation|0
215511|NCT01845077|701594|P5|Washout Period|Protocol Violation|1
215512|NCT01845077|701595|P4|Washout Period|Protocol Violation|1
215513|NCT01845077|701596|P3|Washout Period|Protocol Violation|0
215514|NCT01845077|701597|P2|Washout Period|Protocol Violation|0
215515|NCT01845077|701598|P1|Washout Period|Protocol Violation|0
215516|NCT01845077|701593|P6|Washout Period|elevated lab values (not clinic. sign.)|0
215517|NCT01845077|701594|P5|Washout Period|elevated lab values (not clinic. sign.)|0
215518|NCT01845077|701595|P4|Washout Period|elevated lab values (not clinic. sign.)|0
215519|NCT01845077|701596|P3|Washout Period|elevated lab values (not clinic. sign.)|1
215520|NCT01845077|701597|P2|Washout Period|elevated lab values (not clinic. sign.)|0
215521|NCT01845077|701598|P1|Washout Period|elevated lab values (not clinic. sign.)|0
215522|NCT01845077|701593|P6|Washout Period|Adverse Event|0
215523|NCT01845077|701594|P5|Washout Period|Adverse Event|0
215524|NCT01845077|701595|P4|Washout Period|Adverse Event|0
215525|NCT01845077|701596|P3|Washout Period|Adverse Event|0
215526|NCT01845077|701597|P2|Washout Period|Adverse Event|0
215527|NCT01845077|701598|P1|Washout Period|Adverse Event|1
215528|NCT01845077|701593|P6|Washout Period|Lost to Follow-up|1
215529|NCT01845077|701594|P5|Washout Period|Lost to Follow-up|0
215530|NCT01845077|701595|P4|Washout Period|Lost to Follow-up|1
215531|NCT01845077|701596|P3|Washout Period|Lost to Follow-up|0
215532|NCT01845077|701597|P2|Washout Period|Lost to Follow-up|1
215533|NCT01845077|701598|P1|Washout Period|Lost to Follow-up|0
215534|NCT01845025|701644|P2|Overall Study|Missing|1
215535|NCT01845025|701645|P1|Overall Study|Missing|1
215536|NCT01845025|701644|P2|Overall Study|Protocol deviation|6
215537|NCT01845025|701645|P1|Overall Study|Protocol deviation|3
215538|NCT01845025|701644|P2|Overall Study|Death|0
215539|NCT01845025|701645|P1|Overall Study|Death|2
215540|NCT01845025|701644|P2|Overall Study|Administrative problems|8
215541|NCT01845025|701645|P1|Overall Study|Administrative problems|8
215542|NCT01845025|701644|P2|Overall Study|Lost to Follow-up|13
215543|NCT01845025|701645|P1|Overall Study|Lost to Follow-up|13
215544|NCT01845025|701644|P2|Overall Study|Withdrawal by Subject|44
215545|NCT01845025|701645|P1|Overall Study|Withdrawal by Subject|48
215546|NCT01845025|701644|P2|Overall Study|Unsatisfactory therapeutic effect|2
215547|NCT01845025|701645|P1|Overall Study|Unsatisfactory therapeutic effect|4
215548|NCT01845025|701644|P2|Overall Study|Adverse Event|3
215549|NCT01845025|701645|P1|Overall Study|Adverse Event|6
215550|NCT01844895|701667|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
215551|NCT01844895|701667|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
215552|NCT01844895|701667|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
215553|NCT01844895|701667|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
215554|NCT01844895|701667|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
215555|NCT01844895|701667|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
215556|NCT01844895|701667|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
215557|NCT01844856|701685|P2|Overall Study|Randomized but was a Screen Failure|1
215558|NCT01844856|701686|P1|Overall Study|Randomized but was a Screen Failure|0
215559|NCT01844856|701685|P2|Overall Study|Inadvertently Not Scheduled|0
215560|NCT01844856|701686|P1|Overall Study|Inadvertently Not Scheduled|1
215561|NCT01844856|701685|P2|Overall Study|Enterococcus Resistant|1
215562|NCT01844856|701686|P1|Overall Study|Enterococcus Resistant|0
215563|NCT01844856|701685|P2|Overall Study|Noncompliance|3
215564|NCT01844856|701686|P1|Overall Study|Noncompliance|2
215565|NCT01844856|701685|P2|Overall Study|Withdrawal by Subject|2
215566|NCT01844856|701686|P1|Overall Study|Withdrawal by Subject|3
215567|NCT01844856|701685|P2|Overall Study|Adverse Event|6
215568|NCT01844856|701686|P1|Overall Study|Adverse Event|3
215569|NCT01844856|701685|P2|Overall Study|Lost to Follow-up|3
215570|NCT01844856|701686|P1|Overall Study|Lost to Follow-up|15
215571|NCT01844817|701698|P2|Treatment|Other|3
215572|NCT01844817|701699|P1|Treatment|Other|0
215573|NCT01844817|701698|P2|Treatment|Lost to Follow-up|1
215574|NCT01844817|701699|P1|Treatment|Lost to Follow-up|0
215575|NCT01844817|701698|P2|Treatment|Death|8
215576|NCT01844817|701699|P1|Treatment|Death|10
215577|NCT01844817|701698|P2|Treatment|Withdrawal by Subject|6
215578|NCT01844817|701699|P1|Treatment|Withdrawal by Subject|10
215579|NCT01844817|701698|P2|Treatment|Adverse Event|9
215580|NCT01844817|701699|P1|Treatment|Adverse Event|17
215581|NCT01844817|701698|P2|Treatment|Progressive Disease|36
215582|NCT01844817|701699|P1|Treatment|Progressive Disease|27
215583|NCT01844817|701698|P2|Enrolled and Randomized|Withdrawal by Subject|3
215584|NCT01844817|701699|P1|Enrolled and Randomized|Withdrawal by Subject|2
215585|NCT01844778|701712|P3|Overall Study|Adverse Event|2
215586|NCT01844778|701713|P2|Overall Study|Adverse Event|2
215587|NCT01844778|701714|P1|Overall Study|Adverse Event|0
215588|NCT01844778|701712|P3|Overall Study|Withdrawal by Subject|0
215589|NCT01844778|701713|P2|Overall Study|Withdrawal by Subject|0
215590|NCT01844778|701714|P1|Overall Study|Withdrawal by Subject|2
215591|NCT01844778|701712|P3|Overall Study|Protocol deviation|2
215592|NCT01844778|701713|P2|Overall Study|Protocol deviation|1
215593|NCT01844778|701714|P1|Overall Study|Protocol deviation|0
215594|NCT01844700|701740|P2|Overall Study|stopped taking meds|1
215595|NCT01844700|701741|P1|Overall Study|stopped taking meds|0
215596|NCT01844700|701740|P2|Overall Study|Withdrawal by Subject|0
215597|NCT01844700|701741|P1|Overall Study|Withdrawal by Subject|1
215598|NCT01844700|701740|P2|Overall Study|refused medication switch|0
215599|NCT01844700|701741|P1|Overall Study|refused medication switch|1
215600|NCT01844700|701740|P2|Overall Study|Lack of Efficacy|0
215601|NCT01844700|701741|P1|Overall Study|Lack of Efficacy|1
215602|NCT01844687|701753|P1|Visit 4|Withdrawal by Subject|2
215603|NCT01844687|701753|P1|Visit 4|Lost to Follow-up|1
215604|NCT01844687|701753|P1|Visit 4|Pregnancy|1
215605|NCT01844687|701753|P1|Visit 3|child care problems|1
215606|NCT01844687|701753|P1|Visit 3|Withdrawal by Subject|3
215607|NCT01844687|701753|P1|Visit 3|Lost to Follow-up|1
215608|NCT01844687|701753|P1|Visit 2|Protocol Violation|1
215609|NCT01844687|701753|P1|Visit 2|Withdrawal by Subject|1
215610|NCT01844687|701753|P1|Visit 1|Lost to Follow-up|5
215611|NCT01844687|701753|P1|Visit 1|Protocol Violation|3
215612|NCT01844531|701816|P4|Overall Study|Withdrawal by Subject|0
215613|NCT01844531|701817|P3|Overall Study|Withdrawal by Subject|0
215614|NCT01844531|701818|P2|Overall Study|Withdrawal by Subject|1
215615|NCT01844531|701819|P1|Overall Study|Withdrawal by Subject|0
215616|NCT01844518|701849|P1|Long-Term Extension|Still in On-Going Study|149
215617|NCT01844518|701849|P1|Long-Term Extension|No Longer Met Study Criteria|1
215618|NCT01844518|701849|P1|Long-Term Extension|Adverse Event|1
215619|NCT01844518|701849|P1|Long-Term Extension|Lack of Efficacy|6
215620|NCT01844518|701849|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
215621|NCT01844518|701849|P1|Short-Term (ST) Period|Withdrawal of Consent|2
215622|NCT01844518|701849|P1|Short-Term (ST) Period|Lack of Efficacy|3
215623|NCT01844518|701849|P1|Short-Term (ST) Period|Adverse Event|3
215624|NCT01843972|701924|P10|Overall Study|Withdrawal by Subject|0
215625|NCT01843972|701925|P9|Overall Study|Withdrawal by Subject|0
215626|NCT01843972|701926|P8|Overall Study|Withdrawal by Subject|0
215627|NCT01843972|701927|P7|Overall Study|Withdrawal by Subject|0
215628|NCT01843972|701928|P6|Overall Study|Withdrawal by Subject|0
215629|NCT01843972|701929|P5|Overall Study|Withdrawal by Subject|1
215630|NCT01843972|701930|P4|Overall Study|Withdrawal by Subject|0
215631|NCT01843972|701931|P3|Overall Study|Withdrawal by Subject|0
215632|NCT01843972|701932|P2|Overall Study|Withdrawal by Subject|0
215633|NCT01843972|701933|P1|Overall Study|Withdrawal by Subject|0
215634|NCT01843933|702003|P2|Overall Study|Data lost|4
215635|NCT01843933|702004|P1|Overall Study|Data lost|6
215636|NCT01843777|702021|P2|Overall Study|Withdrawal by Subject|0
215637|NCT01843777|702022|P1|Overall Study|Withdrawal by Subject|1
215638|NCT01843673|702030|P1|Overall Study|Withdrawal by Subject|4
215639|NCT01843673|702030|P1|Overall Study|Lack of Efficacy|2
215640|NCT01843660|702042|P1|Overall Study|Unspecified|30
215641|NCT01843348|702067|P3|Overall Study|Various reasons|6
215642|NCT01843348|702068|P2|Overall Study|Various reasons|9
215643|NCT01843348|702069|P1|Overall Study|Various reasons|4
215644|NCT01843348|702067|P3|Overall Study|Graft loss/retransplantation|11
215645|NCT01843348|702068|P2|Overall Study|Graft loss/retransplantation|8
215646|NCT01843348|702069|P1|Overall Study|Graft loss/retransplantation|5
215647|NCT01843348|702067|P3|Overall Study|Death|4
215648|NCT01843348|702068|P2|Overall Study|Death|3
215649|NCT01843348|702069|P1|Overall Study|Death|5
215650|NCT01843348|702067|P3|Overall Study|Lost to Follow-up|2
215651|NCT01843348|702068|P2|Overall Study|Lost to Follow-up|4
215652|NCT01843348|702069|P1|Overall Study|Lost to Follow-up|5
215653|NCT01843348|702067|P3|Overall Study|Withdrawal by Subject|18
215654|NCT01843348|702068|P2|Overall Study|Withdrawal by Subject|16
215655|NCT01843348|702069|P1|Overall Study|Withdrawal by Subject|4
215656|NCT01843192|702112|P3|Overall Study|Intra-operative exclusions per protocol|2
215657|NCT01843192|702113|P2|Overall Study|Intra-operative exclusions per protocol|6
215658|NCT01843192|702114|P1|Overall Study|Intra-operative exclusions per protocol|2
215659|NCT01842607|702183|P1|Overall Study|Withdrawal by Subject|14
215660|NCT01842607|702183|P1|Overall Study|Physician Decision|9
215661|NCT01842607|702183|P1|Overall Study|Lost to Follow-up|3
215662|NCT01842607|702183|P1|Overall Study|Protocol defined stopping criteria|2
215663|NCT01842607|702183|P1|Overall Study|Protocol Violation|8
215664|NCT01842607|702183|P1|Overall Study|Lack of Efficacy|19
215665|NCT01842607|702183|P1|Overall Study|Adverse Event|11
215666|NCT01842438|702215|P2|T2: 6month Follow-up|Death|1
215667|NCT01842438|702216|P1|T2: 6month Follow-up|Death|0
215668|NCT01842438|702215|P2|T2: 6month Follow-up|Withdrawal by Subject|3
215669|NCT01842438|702216|P1|T2: 6month Follow-up|Withdrawal by Subject|4
215670|NCT01842438|702215|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
215671|NCT01842438|702216|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
215672|NCT01841970|702228|P1|Overall Study|Lost to Follow-up|8
215673|NCT01841970|702228|P1|Overall Study|Physician Decision|2
215674|NCT01841970|702228|P1|Overall Study|Withdrawal by Subject|1
215675|NCT01841697|702246|P2|Overall Study|Withdrawal by Subject|16
215676|NCT01841697|702247|P1|Overall Study|Withdrawal by Subject|16
215677|NCT01841697|702246|P2|Overall Study|Lost to Follow-up|1
215678|NCT01841697|702247|P1|Overall Study|Lost to Follow-up|4
215679|NCT01841697|702246|P2|Overall Study|Death|1
215680|NCT01841697|702247|P1|Overall Study|Death|0
215681|NCT01841593|702273|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
215682|NCT01841593|702274|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
215683|NCT01841593|702273|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
215684|NCT01841593|702274|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
215685|NCT01841567|702290|P1|Overall Study|Adverse Event|3
215686|NCT01840943|702318|P2|Overall Study|Lost to Follow-up|4
215687|NCT01840943|702319|P1|Overall Study|Lost to Follow-up|4
215688|NCT01840943|702318|P2|Overall Study|Physician Decision|2
215689|NCT01840943|702319|P1|Overall Study|Physician Decision|4
215690|NCT01840943|702318|P2|Overall Study|Withdrawal by Subject|6
215691|NCT01840943|702319|P1|Overall Study|Withdrawal by Subject|5
215692|NCT01840605|702355|P2|Overall Study|Physician Decision|1
215693|NCT01840605|702356|P1|Overall Study|Physician Decision|2
215694|NCT01840605|702355|P2|Overall Study|Adverse Event|1
215695|NCT01840605|702356|P1|Overall Study|Adverse Event|0
215696|NCT01840410|702364|P2|Overall Study|Adverse Event|1
215697|NCT01840410|702365|P1|Overall Study|Adverse Event|1
215698|NCT01840410|702364|P2|Overall Study|Withdrawal by Subject|1
215699|NCT01840410|702365|P1|Overall Study|Withdrawal by Subject|2
215700|NCT01840410|702364|P2|Overall Study|Lost to Follow-up|0
215701|NCT01840410|702365|P1|Overall Study|Lost to Follow-up|1
215702|NCT01840410|702364|P2|Overall Study|Protocol deviation|0
215703|NCT01840410|702365|P1|Overall Study|Protocol deviation|1
215704|NCT01840410|702364|P2|Overall Study|Pregnancy|0
215705|NCT01840410|702365|P1|Overall Study|Pregnancy|1
215706|NCT01840410|702364|P2|Overall Study|Physician Decision|2
215707|NCT01840410|702365|P1|Overall Study|Physician Decision|1
215708|NCT01839279|702490|P3|Overall Study|Classified as 'Other'|0
215709|NCT01839279|702491|P2|Overall Study|Classified as 'Other'|0
215710|NCT01839279|702492|P1|Overall Study|Classified as 'Other'|5
215711|NCT01839279|702490|P3|Overall Study|Withdrawal by Subject|1
215712|NCT01839279|702491|P2|Overall Study|Withdrawal by Subject|1
215713|NCT01839279|702492|P1|Overall Study|Withdrawal by Subject|4
215714|NCT01839279|702490|P3|Overall Study|Adverse Event|1
215715|NCT01839279|702491|P2|Overall Study|Adverse Event|1
215716|NCT01839279|702492|P1|Overall Study|Adverse Event|4
215717|NCT01838941|702515|P1|Overall Study|Withdrawal by Subject|1
215718|NCT01838941|702515|P1|Overall Study|Adverse Event|1
215719|NCT01838694|702522|P2|Overall Study|Adverse Event|1
215720|NCT01838694|702523|P1|Overall Study|Adverse Event|0
215721|NCT01838642|702532|P1|Overall Study|Died on study|1
215722|NCT01838616|702545|P2|Pick-up Arm|Technical problems|0
215723|NCT01838616|702546|P1|Pick-up Arm|Technical problems|1
215724|NCT01838616|702545|P2|Pick-up Arm|Withdrawal by Subject|0
215725|NCT01838616|702546|P1|Pick-up Arm|Withdrawal by Subject|1
215726|NCT01838616|702545|P2|Pick-up Arm|Adverse Event|0
215727|NCT01838616|702546|P1|Pick-up Arm|Adverse Event|9
215728|NCT01838616|702545|P2|Pick-up Arm|Lack of Efficacy|0
215729|NCT01838616|702546|P1|Pick-up Arm|Lack of Efficacy|4
215730|NCT01838616|702545|P2|Continuation Period|Technical problems|1
215731|NCT01838616|702546|P1|Continuation Period|Technical problems|0
215732|NCT01838616|702545|P2|Continuation Period|Withdrawal by Subject|4
215733|NCT01838616|702546|P1|Continuation Period|Withdrawal by Subject|0
215734|NCT01838616|702545|P2|Continuation Period|Lost to Follow-up|0
215735|NCT01838616|702546|P1|Continuation Period|Lost to Follow-up|1
215736|NCT01838616|702545|P2|Continuation Period|Protocol Violation|0
215737|NCT01838616|702546|P1|Continuation Period|Protocol Violation|2
215738|NCT01838616|702545|P2|Continuation Period|Adverse Event|4
215739|NCT01838616|702546|P1|Continuation Period|Adverse Event|8
215740|NCT01838616|702545|P2|Continuation Period|Lack of Efficacy|5
215741|NCT01838616|702546|P1|Continuation Period|Lack of Efficacy|3
215742|NCT01838616|702545|P2|Titration Period|Protocol Violation|1
215743|NCT01838616|702546|P1|Titration Period|Protocol Violation|0
215744|NCT01838616|702545|P2|Titration Period|Not specified|0
215745|NCT01838616|702546|P1|Titration Period|Not specified|1
215746|NCT01838616|702545|P2|Titration Period|Technical problems|0
215747|NCT01838616|702546|P1|Titration Period|Technical problems|1
215748|NCT01838616|702545|P2|Titration Period|Withdrawal by Subject|5
215749|NCT01838616|702546|P1|Titration Period|Withdrawal by Subject|5
215750|NCT01838616|702545|P2|Titration Period|Lack of Efficacy|12
215751|NCT01838616|702546|P1|Titration Period|Lack of Efficacy|5
215752|NCT01838616|702545|P2|Titration Period|Adverse Event|48
215753|NCT01838616|702546|P1|Titration Period|Adverse Event|18
215754|NCT01838590|702617|P2|Overall Study|Lost to Follow-up|1
215755|NCT01838590|702618|P1|Overall Study|Lost to Follow-up|0
215756|NCT01838590|702617|P2|Overall Study|Lack of Efficacy|4
215757|NCT01838590|702618|P1|Overall Study|Lack of Efficacy|12
215758|NCT01838499|702642|P2|Overall Study|Withdrawal by Subject|9
215759|NCT01838499|702643|P1|Overall Study|Withdrawal by Subject|19
215760|NCT01838499|702642|P2|Overall Study|Adverse Event|1
215761|NCT01838499|702643|P1|Overall Study|Adverse Event|2
215762|NCT01838499|702642|P2|Overall Study|Lack of Efficacy|2
215763|NCT01838499|702643|P1|Overall Study|Lack of Efficacy|1
215764|NCT01838499|702642|P2|Overall Study|Lost to Follow-up|4
215765|NCT01838499|702643|P1|Overall Study|Lost to Follow-up|2
215766|NCT01838499|702642|P2|Overall Study|Protocol Violation|1
215767|NCT01838499|702643|P1|Overall Study|Protocol Violation|0
215768|NCT01838213|702655|P2|Overall Study|Ineligible|191
215769|NCT01838213|702656|P1|Overall Study|Ineligible|166
215770|NCT01838044|702664|P2|Overall Study|Lost to Follow-up|2
215771|NCT01838044|702665|P1|Overall Study|Lost to Follow-up|0
215772|NCT01838044|702664|P2|Overall Study|Medication error without associated AE|1
215773|NCT01838044|702665|P1|Overall Study|Medication error without associated AE|0
215774|NCT01838044|702664|P2|Overall Study|Insufficient clinical response|2
215775|NCT01838044|702665|P1|Overall Study|Insufficient clinical response|1
215776|NCT01838044|702664|P2|Overall Study|Withdrawal by Subject|2
215777|NCT01838044|702665|P1|Overall Study|Withdrawal by Subject|0
215778|NCT01838044|702664|P2|Overall Study|Protocol Violation|3
215779|NCT01838044|702665|P1|Overall Study|Protocol Violation|3
215780|NCT01838044|702664|P2|Overall Study|Adverse Event|6
215781|NCT01838044|702665|P1|Overall Study|Adverse Event|4
215782|NCT01837966|702698|P2|Overall Study|Withdrawal by Subject|1
215783|NCT01837966|702699|P1|Overall Study|Withdrawal by Subject|2
215784|NCT01837797|702708|P5|Period 3|Other|2
215785|NCT01837797|702709|P4|Period 3|Other|0
215786|NCT01837797|702710|P3|Period 3|Other|0
215787|NCT01837797|702711|P2|Period 3|Other|0
215788|NCT01837797|702712|P1|Period 3|Other|0
215789|NCT01837797|702708|P5|Period 3|Administrative reasons|20
215790|NCT01837797|702709|P4|Period 3|Administrative reasons|0
215791|NCT01837797|702710|P3|Period 3|Administrative reasons|0
215792|NCT01837797|702711|P2|Period 3|Administrative reasons|0
215793|NCT01837797|702712|P1|Period 3|Administrative reasons|0
215794|NCT01837797|702708|P5|Period 3|Adverse Event|1
215795|NCT01837797|702709|P4|Period 3|Adverse Event|0
215796|NCT01837797|702710|P3|Period 3|Adverse Event|0
215797|NCT01837797|702711|P2|Period 3|Adverse Event|0
215798|NCT01837797|702712|P1|Period 3|Adverse Event|0
215799|NCT01837797|702708|P5|Period 2|Adverse Event|0
215800|NCT01837797|702709|P4|Period 2|Adverse Event|1
215801|NCT01837797|702710|P3|Period 2|Adverse Event|0
215802|NCT01837797|702711|P2|Period 2|Adverse Event|0
215803|NCT01837797|702712|P1|Period 2|Adverse Event|0
215804|NCT01837797|702708|P5|Period 2|Administrative or other reasons|0
215805|NCT01837797|702709|P4|Period 2|Administrative or other reasons|4
215806|NCT01837797|702710|P3|Period 2|Administrative or other reasons|2
215807|NCT01837797|702711|P2|Period 2|Administrative or other reasons|5
215808|NCT01837797|702712|P1|Period 2|Administrative or other reasons|0
215809|NCT01837797|702708|P5|Period 1|Other|0
215810|NCT01837797|702709|P4|Period 1|Other|0
215811|NCT01837797|702710|P3|Period 1|Other|0
215812|NCT01837797|702711|P2|Period 1|Other|0
215813|NCT01837797|702712|P1|Period 1|Other|10
215814|NCT01837797|702708|P5|Period 1|Withdrawal of consent before treatment|0
215815|NCT01837797|702709|P4|Period 1|Withdrawal of consent before treatment|0
215816|NCT01837797|702710|P3|Period 1|Withdrawal of consent before treatment|0
215817|NCT01837797|702711|P2|Period 1|Withdrawal of consent before treatment|0
215818|NCT01837797|702712|P1|Period 1|Withdrawal of consent before treatment|1
215819|NCT01837797|702708|P5|Period 1|Administrative reasons|0
215820|NCT01837797|702709|P4|Period 1|Administrative reasons|0
215821|NCT01837797|702710|P3|Period 1|Administrative reasons|0
215822|NCT01837797|702711|P2|Period 1|Administrative reasons|0
215823|NCT01837797|702712|P1|Period 1|Administrative reasons|76
215824|NCT01837797|702708|P5|Period 1|Withdrawal by Subject|0
215825|NCT01837797|702709|P4|Period 1|Withdrawal by Subject|0
215826|NCT01837797|702710|P3|Period 1|Withdrawal by Subject|0
215827|NCT01837797|702711|P2|Period 1|Withdrawal by Subject|0
215828|NCT01837797|702712|P1|Period 1|Withdrawal by Subject|6
215829|NCT01837797|702708|P5|Period 1|Adverse Event|0
215830|NCT01837797|702709|P4|Period 1|Adverse Event|0
215831|NCT01837797|702710|P3|Period 1|Adverse Event|0
215832|NCT01837797|702711|P2|Period 1|Adverse Event|0
215833|NCT01837797|702712|P1|Period 1|Adverse Event|9
215834|NCT01837719|702747|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
215835|NCT01837719|702747|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
215836|NCT01837680|702816|P2|Overall Study|switched to oral hypoglycemic or diet|4
215837|NCT01837680|702817|P1|Overall Study|switched to oral hypoglycemic or diet|2
215838|NCT01837680|702816|P2|Overall Study|allergic reaction|0
215839|NCT01837680|702817|P1|Overall Study|allergic reaction|6
215840|NCT01837680|702816|P2|Overall Study|lack of insurance|2
215841|NCT01837680|702817|P1|Overall Study|lack of insurance|0
215842|NCT01837680|702816|P2|Overall Study|Lost to Follow-up|2
215843|NCT01837680|702817|P1|Overall Study|Lost to Follow-up|2
215844|NCT01836523|702923|P4|Overall Study|Unclassified|29
215845|NCT01836523|702924|P3|Overall Study|Unclassified|19
215846|NCT01836523|702925|P2|Overall Study|Unclassified|28
215847|NCT01836523|702926|P1|Overall Study|Unclassified|17
215848|NCT01836523|702923|P4|Overall Study|Met Withdrawal Criteria|27
215849|NCT01836523|702924|P3|Overall Study|Met Withdrawal Criteria|21
215850|NCT01836523|702925|P2|Overall Study|Met Withdrawal Criteria|13
215851|NCT01836523|702926|P1|Overall Study|Met Withdrawal Criteria|13
215852|NCT01836523|702923|P4|Overall Study|Protocol Violation|4
215853|NCT01836523|702924|P3|Overall Study|Protocol Violation|2
215854|NCT01836523|702925|P2|Overall Study|Protocol Violation|3
215855|NCT01836523|702926|P1|Overall Study|Protocol Violation|6
215856|NCT01836523|702923|P4|Overall Study|Adverse Event|14
215857|NCT01836523|702924|P3|Overall Study|Adverse Event|49
215858|NCT01836523|702925|P2|Overall Study|Adverse Event|41
215859|NCT01836523|702926|P1|Overall Study|Adverse Event|15
215860|NCT01836471|702953|P5|Overall Study|Non compliance with tx|0
215861|NCT01836471|702954|P4|Overall Study|Non compliance with tx|0
215862|NCT01836471|702955|P3|Overall Study|Non compliance with tx|0
215863|NCT01836471|702956|P2|Overall Study|Non compliance with tx|1
215864|NCT01836471|702957|P1|Overall Study|Non compliance with tx|1
215865|NCT01836471|702953|P5|Overall Study|Adverse Event|2
215866|NCT01836471|702954|P4|Overall Study|Adverse Event|1
215867|NCT01836471|702955|P3|Overall Study|Adverse Event|1
215868|NCT01836471|702956|P2|Overall Study|Adverse Event|3
215869|NCT01836471|702957|P1|Overall Study|Adverse Event|6
215870|NCT01836471|702953|P5|Overall Study|Lost to Follow-up|1
215871|NCT01836471|702954|P4|Overall Study|Lost to Follow-up|1
215872|NCT01836471|702955|P3|Overall Study|Lost to Follow-up|0
215873|NCT01836471|702956|P2|Overall Study|Lost to Follow-up|0
215874|NCT01836471|702957|P1|Overall Study|Lost to Follow-up|0
215875|NCT01836471|702953|P5|Overall Study|Physician Decision|0
215876|NCT01836471|702954|P4|Overall Study|Physician Decision|0
215877|NCT01836471|702955|P3|Overall Study|Physician Decision|0
215878|NCT01836471|702956|P2|Overall Study|Physician Decision|1
215879|NCT01836471|702957|P1|Overall Study|Physician Decision|0
215880|NCT01836471|702953|P5|Overall Study|Withdrawal by Subject|2
215881|NCT01836471|702954|P4|Overall Study|Withdrawal by Subject|0
215882|NCT01836471|702955|P3|Overall Study|Withdrawal by Subject|1
215883|NCT01836471|702956|P2|Overall Study|Withdrawal by Subject|4
215884|NCT01836471|702957|P1|Overall Study|Withdrawal by Subject|3
215885|NCT01836471|702953|P5|Overall Study|Pregnancy|0
215886|NCT01836471|702954|P4|Overall Study|Pregnancy|0
215887|NCT01836471|702955|P3|Overall Study|Pregnancy|0
215888|NCT01836471|702956|P2|Overall Study|Pregnancy|0
215889|NCT01836471|702957|P1|Overall Study|Pregnancy|1
215890|NCT01836458|702986|P4|Overall Study|Unsatisfactory therapeutic effect|6
215891|NCT01836458|702987|P3|Overall Study|Unsatisfactory therapeutic effect|5
215892|NCT01836458|702988|P2|Overall Study|Unsatisfactory therapeutic effect|2
215893|NCT01836458|702989|P1|Overall Study|Unsatisfactory therapeutic effect|3
215894|NCT01835899|703051|P3|Overall Study|Other than stated above|0
215895|NCT01835899|703052|P2|Overall Study|Other than stated above|1
215896|NCT01835899|703053|P1|Overall Study|Other than stated above|0
215897|NCT01835899|703051|P3|Overall Study|Adverse Event|1
215898|NCT01835899|703052|P2|Overall Study|Adverse Event|0
215899|NCT01835899|703053|P1|Overall Study|Adverse Event|0
215900|NCT01835470|703104|P1|Long Term Treatment Period|Lack of Efficacy|1
215901|NCT01835470|703104|P1|Long Term Treatment Period|Subject Request to Discontinue|1
215902|NCT01835431|703116|P2|Overall Study|Protocol Violation|0
215903|NCT01835431|703117|P1|Overall Study|Protocol Violation|1
215904|NCT01835431|703116|P2|Overall Study|Withdrawal by Subject|10
215905|NCT01835431|703117|P1|Overall Study|Withdrawal by Subject|6
215906|NCT01835431|703116|P2|Overall Study|other|2
215907|NCT01835431|703117|P1|Overall Study|other|0
215908|NCT01835431|703116|P2|Overall Study|Adverse Event|0
215909|NCT01835431|703117|P1|Overall Study|Adverse Event|1
215910|NCT01835132|703155|P1|Initial Phase|Insufficient Therapeutic Response|2
215911|NCT01835015|703199|P5|Overall Study|Adverse Event|0
215912|NCT01835015|703200|P4|Overall Study|Adverse Event|0
215913|NCT01835015|703201|P3|Overall Study|Adverse Event|1
215914|NCT01835015|703202|P2|Overall Study|Adverse Event|0
215915|NCT01835015|703203|P1|Overall Study|Adverse Event|0
215916|NCT01834274|703311|P2|Overall Study|Other|1
215917|NCT01834274|703312|P1|Overall Study|Other|2
215918|NCT01834274|703311|P2|Overall Study|Lost to Follow-up|1
215919|NCT01834274|703312|P1|Overall Study|Lost to Follow-up|3
215920|NCT01834274|703311|P2|Overall Study|Withdrawal by Subject|1
215921|NCT01834274|703312|P1|Overall Study|Withdrawal by Subject|1
215922|NCT01834274|703311|P2|Overall Study|Study Termination|38
215923|NCT01834274|703312|P1|Overall Study|Study Termination|41
215924|NCT01834222|703335|P1|Overall Study|Not meet inclusion/exclusion criteria|1
215925|NCT01833897|703357|P1|Overall Study|Lack of Efficacy|1
215926|NCT01833533|703384|P2|Overall Study|Not Specified|7
215927|NCT01833533|703385|P1|Overall Study|Not Specified|2
215928|NCT01833533|703384|P2|Overall Study|To Enter an Extension Study|4
215929|NCT01833533|703385|P1|Overall Study|To Enter an Extension Study|0
215930|NCT01833533|703384|P2|Overall Study|Lost to Follow-up|9
215931|NCT01833533|703385|P1|Overall Study|Lost to Follow-up|4
215932|NCT01833533|703384|P2|Overall Study|Adverse Event|1
215933|NCT01833533|703385|P1|Overall Study|Adverse Event|0
215934|NCT01833065|703487|P5|Overall Study|Others|4
215935|NCT01833065|703488|P4|Overall Study|Others|1
215936|NCT01833065|703489|P3|Overall Study|Others|1
215937|NCT01833065|703490|P2|Overall Study|Others|1
215938|NCT01833065|703491|P1|Overall Study|Others|2
215939|NCT01833065|703487|P5|Overall Study|Trial terminated by sponsor|13
215940|NCT01833065|703488|P4|Overall Study|Trial terminated by sponsor|3
215941|NCT01833065|703489|P3|Overall Study|Trial terminated by sponsor|7
215942|NCT01833065|703490|P2|Overall Study|Trial terminated by sponsor|8
215943|NCT01833065|703491|P1|Overall Study|Trial terminated by sponsor|8
215944|NCT01833065|703487|P5|Overall Study|Subject's substantial non-compliance|0
215945|NCT01833065|703488|P4|Overall Study|Subject's substantial non-compliance|0
215946|NCT01833065|703489|P3|Overall Study|Subject's substantial non-compliance|0
215947|NCT01833065|703490|P2|Overall Study|Subject's substantial non-compliance|1
215948|NCT01833065|703491|P1|Overall Study|Subject's substantial non-compliance|0
215949|NCT01833065|703487|P5|Overall Study|Withdrawal by Subject|11
215950|NCT01833065|703488|P4|Overall Study|Withdrawal by Subject|3
215951|NCT01833065|703489|P3|Overall Study|Withdrawal by Subject|4
215952|NCT01833065|703490|P2|Overall Study|Withdrawal by Subject|2
215953|NCT01833065|703491|P1|Overall Study|Withdrawal by Subject|6
215954|NCT01833065|703487|P5|Overall Study|Lost to Follow-up|3
215955|NCT01833065|703488|P4|Overall Study|Lost to Follow-up|0
215956|NCT01833065|703489|P3|Overall Study|Lost to Follow-up|0
215957|NCT01833065|703490|P2|Overall Study|Lost to Follow-up|0
215958|NCT01833065|703491|P1|Overall Study|Lost to Follow-up|1
215959|NCT01833065|703487|P5|Overall Study|Protocol Violation|2
215960|NCT01833065|703488|P4|Overall Study|Protocol Violation|0
215961|NCT01833065|703489|P3|Overall Study|Protocol Violation|0
215962|NCT01833065|703490|P2|Overall Study|Protocol Violation|0
215963|NCT01833065|703491|P1|Overall Study|Protocol Violation|1
215964|NCT01833065|703487|P5|Overall Study|Adverse Event|3
215965|NCT01833065|703488|P4|Overall Study|Adverse Event|2
215966|NCT01833065|703489|P3|Overall Study|Adverse Event|0
215967|NCT01833065|703490|P2|Overall Study|Adverse Event|1
215968|NCT01833065|703491|P1|Overall Study|Adverse Event|6
215969|NCT01832766|703522|P2|Washout|Lost to Follow-up|1
215970|NCT01832766|703523|P1|Washout|Lost to Follow-up|0
215971|NCT01832493|703589|P1|Overall Study|Unable to place LV lead|2
215972|NCT01832493|703589|P1|Overall Study|Protocol Violation|4
215973|NCT01832493|703589|P1|Overall Study|Physician Decision|2
215974|NCT01832155|703598|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
215975|NCT01832155|703599|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
215976|NCT01832155|703598|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
215977|NCT01832155|703599|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
215978|NCT01831817|703633|P4|Overall Study|Withdrawl of Consent|0
215979|NCT01831817|703634|P3|Overall Study|Withdrawl of Consent|0
215980|NCT01831817|703635|P2|Overall Study|Withdrawl of Consent|0
215981|NCT01831817|703636|P1|Overall Study|Withdrawl of Consent|3
215982|NCT01831817|703633|P4|Overall Study|Lost to Follow-up|0
215983|NCT01831817|703634|P3|Overall Study|Lost to Follow-up|0
215984|NCT01831817|703635|P2|Overall Study|Lost to Follow-up|0
215985|NCT01831817|703636|P1|Overall Study|Lost to Follow-up|1
215986|NCT01831791|703674|P1|Overall Study|Withdrawal by Subject|10
215987|NCT01831726|703700|P1|Overall Study|Subject/guardian decision|7
215988|NCT01831726|703700|P1|Overall Study|Physician Decision|1
215989|NCT01831726|703700|P1|Overall Study|Disease Progression|49
215990|NCT01831726|703700|P1|Overall Study|Death|7
215991|NCT01831726|703700|P1|Overall Study|Adverse Event|16
215992|NCT01831466|703719|P12|Overall Study|Adverse Event|2
215993|NCT01831466|703720|P11|Overall Study|Adverse Event|0
215994|NCT01831466|703721|P10|Overall Study|Adverse Event|1
215995|NCT01831466|703722|P9|Overall Study|Adverse Event|1
215996|NCT01831466|703723|P8|Overall Study|Adverse Event|1
215997|NCT01831466|703724|P7|Overall Study|Adverse Event|0
215998|NCT01831466|703725|P6|Overall Study|Adverse Event|7
215999|NCT01831466|703726|P5|Overall Study|Adverse Event|3
216000|NCT01831466|703727|P4|Overall Study|Adverse Event|6
216001|NCT01831466|703728|P3|Overall Study|Adverse Event|4
216002|NCT01831466|703729|P2|Overall Study|Adverse Event|0
216003|NCT01831466|703730|P1|Overall Study|Adverse Event|0
216004|NCT01831466|703719|P12|Overall Study|Lack of Efficacy|0
216005|NCT01831466|703720|P11|Overall Study|Lack of Efficacy|2
216006|NCT01831466|703721|P10|Overall Study|Lack of Efficacy|2
216007|NCT01831466|703722|P9|Overall Study|Lack of Efficacy|2
216008|NCT01831466|703723|P8|Overall Study|Lack of Efficacy|1
216009|NCT01831466|703724|P7|Overall Study|Lack of Efficacy|1
216010|NCT01831466|703725|P6|Overall Study|Lack of Efficacy|8
216011|NCT01831466|703726|P5|Overall Study|Lack of Efficacy|9
216012|NCT01831466|703727|P4|Overall Study|Lack of Efficacy|6
216013|NCT01831466|703728|P3|Overall Study|Lack of Efficacy|7
216014|NCT01831466|703729|P2|Overall Study|Lack of Efficacy|8
216015|NCT01831466|703730|P1|Overall Study|Lack of Efficacy|5
216016|NCT01831466|703719|P12|Overall Study|Lost to Follow-up|1
216017|NCT01831466|703720|P11|Overall Study|Lost to Follow-up|0
216018|NCT01831466|703721|P10|Overall Study|Lost to Follow-up|1
216019|NCT01831466|703722|P9|Overall Study|Lost to Follow-up|0
216020|NCT01831466|703723|P8|Overall Study|Lost to Follow-up|0
216021|NCT01831466|703724|P7|Overall Study|Lost to Follow-up|0
216022|NCT01831466|703725|P6|Overall Study|Lost to Follow-up|3
216023|NCT01831466|703726|P5|Overall Study|Lost to Follow-up|0
216024|NCT01831466|703727|P4|Overall Study|Lost to Follow-up|2
216025|NCT01831466|703728|P3|Overall Study|Lost to Follow-up|4
216026|NCT01831466|703729|P2|Overall Study|Lost to Follow-up|1
216027|NCT01831466|703730|P1|Overall Study|Lost to Follow-up|0
216028|NCT01831466|703719|P12|Overall Study|Withdrawal by Subject|1
216029|NCT01831466|703720|P11|Overall Study|Withdrawal by Subject|0
216030|NCT01831466|703721|P10|Overall Study|Withdrawal by Subject|1
216031|NCT01831466|703722|P9|Overall Study|Withdrawal by Subject|0
216032|NCT01831466|703723|P8|Overall Study|Withdrawal by Subject|0
216033|NCT01831466|703724|P7|Overall Study|Withdrawal by Subject|0
216034|NCT01831466|703725|P6|Overall Study|Withdrawal by Subject|5
216035|NCT01831466|703726|P5|Overall Study|Withdrawal by Subject|3
216036|NCT01831466|703727|P4|Overall Study|Withdrawal by Subject|3
216037|NCT01831466|703728|P3|Overall Study|Withdrawal by Subject|3
216038|NCT01831466|703729|P2|Overall Study|Withdrawal by Subject|3
216039|NCT01831466|703730|P1|Overall Study|Withdrawal by Subject|6
216040|NCT01831466|703719|P12|Overall Study|Death|0
216041|NCT01831466|703720|P11|Overall Study|Death|0
216042|NCT01831466|703721|P10|Overall Study|Death|0
216043|NCT01831466|703722|P9|Overall Study|Death|0
216044|NCT01831466|703723|P8|Overall Study|Death|0
216045|NCT01831466|703724|P7|Overall Study|Death|0
216046|NCT01831466|703725|P6|Overall Study|Death|0
216047|NCT01831466|703726|P5|Overall Study|Death|0
216048|NCT01831466|703727|P4|Overall Study|Death|0
216049|NCT01831466|703728|P3|Overall Study|Death|0
216050|NCT01831466|703729|P2|Overall Study|Death|1
216051|NCT01831466|703730|P1|Overall Study|Death|0
216052|NCT01831466|703719|P12|Overall Study|Non-compliance with study treatment|0
216053|NCT01831466|703720|P11|Overall Study|Non-compliance with study treatment|0
216054|NCT01831466|703721|P10|Overall Study|Non-compliance with study treatment|0
216055|NCT01831466|703722|P9|Overall Study|Non-compliance with study treatment|0
216056|NCT01831466|703723|P8|Overall Study|Non-compliance with study treatment|0
216057|NCT01831466|703724|P7|Overall Study|Non-compliance with study treatment|0
216058|NCT01831466|703725|P6|Overall Study|Non-compliance with study treatment|1
216059|NCT01831466|703726|P5|Overall Study|Non-compliance with study treatment|0
216060|NCT01831466|703727|P4|Overall Study|Non-compliance with study treatment|0
216061|NCT01831466|703728|P3|Overall Study|Non-compliance with study treatment|1
216062|NCT01831466|703729|P2|Overall Study|Non-compliance with study treatment|1
216063|NCT01831466|703730|P1|Overall Study|Non-compliance with study treatment|2
216064|NCT01831466|703719|P12|Overall Study|Not specified|0
216065|NCT01831466|703720|P11|Overall Study|Not specified|0
216066|NCT01831466|703721|P10|Overall Study|Not specified|0
216067|NCT01831466|703722|P9|Overall Study|Not specified|0
216068|NCT01831466|703723|P8|Overall Study|Not specified|0
216069|NCT01831466|703724|P7|Overall Study|Not specified|0
216070|NCT01831466|703725|P6|Overall Study|Not specified|1
216071|NCT01831466|703726|P5|Overall Study|Not specified|2
216072|NCT01831466|703727|P4|Overall Study|Not specified|2
216073|NCT01831466|703728|P3|Overall Study|Not specified|2
216074|NCT01831466|703729|P2|Overall Study|Not specified|3
216075|NCT01831466|703730|P1|Overall Study|Not specified|2
216076|NCT01831466|703719|P12|Overall Study|Protocol Violation|0
216077|NCT01831466|703720|P11|Overall Study|Protocol Violation|0
216078|NCT01831466|703721|P10|Overall Study|Protocol Violation|0
216079|NCT01831466|703722|P9|Overall Study|Protocol Violation|0
216080|NCT01831466|703723|P8|Overall Study|Protocol Violation|0
216081|NCT01831466|703724|P7|Overall Study|Protocol Violation|0
216082|NCT01831466|703725|P6|Overall Study|Protocol Violation|1
216083|NCT01831466|703726|P5|Overall Study|Protocol Violation|0
216084|NCT01831466|703727|P4|Overall Study|Protocol Violation|0
216085|NCT01831466|703728|P3|Overall Study|Protocol Violation|2
216086|NCT01831466|703729|P2|Overall Study|Protocol Violation|1
216087|NCT01831466|703730|P1|Overall Study|Protocol Violation|1
216088|NCT01830920|703921|P5|Overall Study|Not specified|3
216089|NCT01830920|703922|P4|Overall Study|Not specified|5
216090|NCT01830920|703923|P3|Overall Study|Not specified|1
216091|NCT01830920|703924|P2|Overall Study|Not specified|1
216092|NCT01830920|703925|P1|Overall Study|Not specified|15
216093|NCT01830920|703921|P5|Overall Study|Death|4
216094|NCT01830920|703922|P4|Overall Study|Death|4
216095|NCT01830920|703923|P3|Overall Study|Death|5
216096|NCT01830920|703924|P2|Overall Study|Death|3
216097|NCT01830920|703925|P1|Overall Study|Death|3
216098|NCT01830920|703921|P5|Overall Study|Withdrawal by Subject|1
216099|NCT01830920|703922|P4|Overall Study|Withdrawal by Subject|7
216100|NCT01830920|703923|P3|Overall Study|Withdrawal by Subject|1
216101|NCT01830920|703924|P2|Overall Study|Withdrawal by Subject|2
216102|NCT01830920|703925|P1|Overall Study|Withdrawal by Subject|2
216103|NCT01830920|703921|P5|Overall Study|Adverse Event|0
216104|NCT01830920|703922|P4|Overall Study|Adverse Event|0
216105|NCT01830920|703923|P3|Overall Study|Adverse Event|1
216106|NCT01830920|703924|P2|Overall Study|Adverse Event|0
216107|NCT01830920|703925|P1|Overall Study|Adverse Event|1
216108|NCT01830881|703964|P2|Overall Study|Changed decision to have an abortion|1
216109|NCT01830881|703965|P1|Overall Study|Changed decision to have an abortion|0
216110|NCT01830855|704009|P4|Overall Study|Lost to Follow-up|33
216111|NCT01830855|704010|P3|Overall Study|Lost to Follow-up|23
216112|NCT01830855|704011|P2|Overall Study|Lost to Follow-up|20
216113|NCT01830855|704012|P1|Overall Study|Lost to Follow-up|47
216114|NCT01830855|704009|P4|Overall Study|No longer willing to participate|17
216115|NCT01830855|704010|P3|Overall Study|No longer willing to participate|12
216116|NCT01830855|704011|P2|Overall Study|No longer willing to participate|13
216117|NCT01830855|704012|P1|Overall Study|No longer willing to participate|32
216118|NCT01830855|704009|P4|Overall Study|Withdrawal by Subject|12
216119|NCT01830855|704010|P3|Overall Study|Withdrawal by Subject|10
216120|NCT01830855|704011|P2|Overall Study|Withdrawal by Subject|14
216121|NCT01830855|704012|P1|Overall Study|Withdrawal by Subject|33
216122|NCT01830855|704009|P4|Overall Study|Protocol deviation|6
216123|NCT01830855|704010|P3|Overall Study|Protocol deviation|6
216124|NCT01830855|704011|P2|Overall Study|Protocol deviation|5
216125|NCT01830855|704012|P1|Overall Study|Protocol deviation|10
216126|NCT01830855|704009|P4|Overall Study|Adverse Event|3
216127|NCT01830855|704010|P3|Overall Study|Adverse Event|6
216128|NCT01830855|704011|P2|Overall Study|Adverse Event|5
216129|NCT01830855|704012|P1|Overall Study|Adverse Event|11
216130|NCT01830855|704009|P4|Overall Study|No longer meets eligibility criteria|5
216131|NCT01830855|704010|P3|Overall Study|No longer meets eligibility criteria|3
216132|NCT01830855|704011|P2|Overall Study|No longer meets eligibility criteria|2
216133|NCT01830855|704012|P1|Overall Study|No longer meets eligibility criteria|11
216134|NCT01830855|704009|P4|Overall Study|Pregnancy|1
216135|NCT01830855|704010|P3|Overall Study|Pregnancy|2
216136|NCT01830855|704011|P2|Overall Study|Pregnancy|1
216137|NCT01830855|704012|P1|Overall Study|Pregnancy|3
216138|NCT01830855|704009|P4|Overall Study|Medication error without associated AE|1
216139|NCT01830855|704010|P3|Overall Study|Medication error without associated AE|0
216140|NCT01830855|704011|P2|Overall Study|Medication error without associated AE|0
216141|NCT01830855|704012|P1|Overall Study|Medication error without associated AE|1
216142|NCT01830855|704009|P4|Overall Study|Unspecified|4
216143|NCT01830855|704010|P3|Overall Study|Unspecified|4
216144|NCT01830855|704011|P2|Overall Study|Unspecified|1
216145|NCT01830855|704012|P1|Overall Study|Unspecified|7
216146|NCT01830127|704240|P2|Overall Study|Other reason not defined above|2
216147|NCT01830127|704241|P1|Overall Study|Other reason not defined above|0
216148|NCT01830127|704240|P2|Overall Study|Withdrawal by Subject|1
216149|NCT01830127|704241|P1|Overall Study|Withdrawal by Subject|1
216150|NCT01830127|704240|P2|Overall Study|Lack of Efficacy|0
216151|NCT01830127|704241|P1|Overall Study|Lack of Efficacy|3
216152|NCT01830127|704240|P2|Overall Study|Adverse Event|6
216153|NCT01830127|704241|P1|Overall Study|Adverse Event|1
216154|NCT01829477|704276|P2|Overall Study|Withdrawal by Subject|0
216155|NCT01829477|704277|P1|Overall Study|Withdrawal by Subject|1
216156|NCT01829477|704276|P2|Overall Study|Study Terminated by Sponsor|15
216157|NCT01829477|704277|P1|Overall Study|Study Terminated by Sponsor|15
216158|NCT01829464|704290|P3|Overall Study|Lack of Efficacy|0
216159|NCT01829464|704291|P2|Overall Study|Lack of Efficacy|1
216160|NCT01829464|704292|P1|Overall Study|Lack of Efficacy|0
216161|NCT01829464|704290|P3|Overall Study|Study terminated by sponsor|25
216162|NCT01829464|704291|P2|Overall Study|Study terminated by sponsor|28
216163|NCT01829464|704292|P1|Overall Study|Study terminated by sponsor|25
216164|NCT01829464|704290|P3|Overall Study|Withdrawal by Subject|0
216165|NCT01829464|704291|P2|Overall Study|Withdrawal by Subject|0
216166|NCT01829464|704292|P1|Overall Study|Withdrawal by Subject|2
216167|NCT01829464|704290|P3|Overall Study|Lost to Follow-up|1
216168|NCT01829464|704291|P2|Overall Study|Lost to Follow-up|0
216169|NCT01829464|704292|P1|Overall Study|Lost to Follow-up|0
216170|NCT01829464|704290|P3|Overall Study|Adverse Event|0
216171|NCT01829464|704291|P2|Overall Study|Adverse Event|0
216172|NCT01829464|704292|P1|Overall Study|Adverse Event|1
216173|NCT01829243|704317|P2|First Intervention|Screen Failure|2
216174|NCT01829243|704318|P1|First Intervention|Screen Failure|4
216175|NCT01829230|704332|P2|Overall Study|Lost to Follow-up|1
216176|NCT01829230|704333|P1|Overall Study|Lost to Follow-up|1
216177|NCT01829230|704332|P2|Overall Study|Withdrawal by Subject|1
216178|NCT01829230|704333|P1|Overall Study|Withdrawal by Subject|0
216179|NCT01829230|704332|P2|Overall Study|Protocol Violation|2
216180|NCT01829230|704333|P1|Overall Study|Protocol Violation|0
216181|NCT01829191|704343|P2|Overall Study|Subject was fit for ortho - k|1
216182|NCT01829191|704344|P1|Overall Study|Subject was fit for ortho - k|0
216183|NCT01829191|704343|P2|Overall Study|Lost to Follow-up|1
216184|NCT01829191|704344|P1|Overall Study|Lost to Follow-up|0
216185|NCT01829191|704343|P2|Overall Study|Withdrawal by Subject|3
216186|NCT01829191|704344|P1|Overall Study|Withdrawal by Subject|2
216187|NCT01829191|704343|P2|Overall Study|Protocol Violation|1
216188|NCT01829191|704344|P1|Overall Study|Protocol Violation|4
216189|NCT01829191|704343|P2|Overall Study|Lens handling difficulty|4
216190|NCT01829191|704344|P1|Overall Study|Lens handling difficulty|1
216191|NCT01829191|704343|P2|Overall Study|Lens discomfort|3
216192|NCT01829191|704344|P1|Overall Study|Lens discomfort|0
216193|NCT01829191|704343|P2|Overall Study|Relocation|1
216194|NCT01829191|704344|P1|Overall Study|Relocation|0
216195|NCT01828281|704391|P2|Overall Study|Withdrawal by Subject|0
216196|NCT01828281|704392|P1|Overall Study|Withdrawal by Subject|1
216197|NCT01827839|704423|P1|Overall Study|Consent Withdrawal|2
216198|NCT01827839|704423|P1|Overall Study|Adverse Event|1
216199|NCT01827670|704447|P2|Overall Study|Lost to Follow-up|1
216200|NCT01827670|704448|P1|Overall Study|Lost to Follow-up|0
216201|NCT01827670|704447|P2|Overall Study|Withdrawal of Consent|2
216202|NCT01827670|704448|P1|Overall Study|Withdrawal of Consent|3
216203|NCT01827592|704467|P3|Overall Study|Others|3
216204|NCT01827592|704468|P2|Overall Study|Others|1
216205|NCT01827592|704469|P1|Overall Study|Others|0
216206|NCT01827592|704467|P3|Overall Study|Trial terminated by Sponsor|51
216207|NCT01827592|704468|P2|Overall Study|Trial terminated by Sponsor|53
216208|NCT01827592|704469|P1|Overall Study|Trial terminated by Sponsor|47
216209|NCT01827592|704467|P3|Overall Study|Patient's substantial non-compliance|6
216210|NCT01827592|704468|P2|Overall Study|Patient's substantial non-compliance|1
216211|NCT01827592|704469|P1|Overall Study|Patient's substantial non-compliance|1
216212|NCT01827592|704467|P3|Overall Study|Withdrawal by Subject|11
216213|NCT01827592|704468|P2|Overall Study|Withdrawal by Subject|11
216214|NCT01827592|704469|P1|Overall Study|Withdrawal by Subject|12
216215|NCT01827592|704467|P3|Overall Study|Lost to Follow-up|2
216216|NCT01827592|704468|P2|Overall Study|Lost to Follow-up|2
216217|NCT01827592|704469|P1|Overall Study|Lost to Follow-up|1
216218|NCT01827592|704467|P3|Overall Study|Protocol Violation|0
216219|NCT01827592|704468|P2|Overall Study|Protocol Violation|1
216220|NCT01827592|704469|P1|Overall Study|Protocol Violation|2
216221|NCT01827592|704467|P3|Overall Study|Physician Decision|1
216222|NCT01827592|704468|P2|Overall Study|Physician Decision|2
216223|NCT01827592|704469|P1|Overall Study|Physician Decision|0
216224|NCT01827592|704467|P3|Overall Study|Adverse Event|2
216225|NCT01827592|704468|P2|Overall Study|Adverse Event|9
216226|NCT01827592|704469|P1|Overall Study|Adverse Event|11
216227|NCT01827371|704534|P4|Overall Study|Temporary study halt to vaccinations|13
216228|NCT01827371|704535|P3|Overall Study|Temporary study halt to vaccinations|5
216229|NCT01827371|704536|P2|Overall Study|Temporary study halt to vaccinations|2
216230|NCT01827371|704537|P1|Overall Study|Temporary study halt to vaccinations|11
216231|NCT01827371|704534|P4|Overall Study|Physician Decision|1
216232|NCT01827371|704535|P3|Overall Study|Physician Decision|0
216233|NCT01827371|704536|P2|Overall Study|Physician Decision|1
216234|NCT01827371|704537|P1|Overall Study|Physician Decision|0
216235|NCT01827371|704534|P4|Overall Study|Withdrawal by Subject|3
216236|NCT01827371|704535|P3|Overall Study|Withdrawal by Subject|2
216237|NCT01827371|704536|P2|Overall Study|Withdrawal by Subject|2
216238|NCT01827371|704537|P1|Overall Study|Withdrawal by Subject|1
216239|NCT01827371|704534|P4|Overall Study|Protocol Violation|0
216240|NCT01827371|704535|P3|Overall Study|Protocol Violation|0
216241|NCT01827371|704536|P2|Overall Study|Protocol Violation|0
216242|NCT01827371|704537|P1|Overall Study|Protocol Violation|1
216243|NCT01827371|704534|P4|Overall Study|Lost to Follow-up|4
216244|NCT01827371|704535|P3|Overall Study|Lost to Follow-up|0
216245|NCT01827371|704536|P2|Overall Study|Lost to Follow-up|2
216246|NCT01827371|704537|P1|Overall Study|Lost to Follow-up|0
216247|NCT01827371|704534|P4|Overall Study|Adverse Event|2
216248|NCT01827371|704535|P3|Overall Study|Adverse Event|4
216249|NCT01827371|704536|P2|Overall Study|Adverse Event|0
216250|NCT01827371|704537|P1|Overall Study|Adverse Event|0
216251|NCT01827332|704561|P2|Overall Study|Lost to Follow-up|1
216252|NCT01827332|704562|P1|Overall Study|Lost to Follow-up|2
216253|NCT01827319|704570|P1|Overall Study|Lost to Follow-up|3
216254|NCT01827254|704591|P1|Overall Study|Intolerance to treatment|4
216255|NCT01827254|704591|P1|Overall Study|Disease progression|36
216256|NCT01827254|704591|P1|Overall Study|Did not complete re-challenge|1
216257|NCT01827254|704591|P1|Overall Study|Discontinued prior initiation: sunitinib|1
216258|NCT01827254|704591|P1|Overall Study|Invalidated centre|3
216259|NCT01827254|704591|P1|Overall Study|Case report form not completed|4
216260|NCT01827254|704591|P1|Overall Study|Death|10
216261|NCT01826981|704616|P15|Overall Study|Enrolled/Randomized but Not Treated|0
216262|NCT01826981|704617|P14|Overall Study|Enrolled/Randomized but Not Treated|0
216263|NCT01826981|704618|P13|Overall Study|Enrolled/Randomized but Not Treated|0
216264|NCT01826981|704619|P12|Overall Study|Enrolled/Randomized but Not Treated|0
216265|NCT01826981|704620|P11|Overall Study|Enrolled/Randomized but Not Treated|0
216266|NCT01826981|704621|P10|Overall Study|Enrolled/Randomized but Not Treated|0
216267|NCT01826981|704622|P9|Overall Study|Enrolled/Randomized but Not Treated|0
216268|NCT01826981|704623|P8|Overall Study|Enrolled/Randomized but Not Treated|1
216269|NCT01826981|704624|P7|Overall Study|Enrolled/Randomized but Not Treated|0
216270|NCT01826981|704625|P6|Overall Study|Enrolled/Randomized but Not Treated|0
216271|NCT01826981|704626|P5|Overall Study|Enrolled/Randomized but Not Treated|0
216272|NCT01826981|704627|P4|Overall Study|Enrolled/Randomized but Not Treated|0
216273|NCT01826981|704628|P3|Overall Study|Enrolled/Randomized but Not Treated|0
216274|NCT01826981|704629|P2|Overall Study|Enrolled/Randomized but Not Treated|0
216275|NCT01826981|704630|P1|Overall Study|Enrolled/Randomized but Not Treated|0
216276|NCT01826981|704616|P15|Overall Study|Upper G-I Haemorrhage|0
216277|NCT01826981|704617|P14|Overall Study|Upper G-I Haemorrhage|1
216278|NCT01826981|704618|P13|Overall Study|Upper G-I Haemorrhage|0
216279|NCT01826981|704619|P12|Overall Study|Upper G-I Haemorrhage|0
216280|NCT01826981|704620|P11|Overall Study|Upper G-I Haemorrhage|0
216281|NCT01826981|704621|P10|Overall Study|Upper G-I Haemorrhage|0
216282|NCT01826981|704622|P9|Overall Study|Upper G-I Haemorrhage|0
216283|NCT01826981|704623|P8|Overall Study|Upper G-I Haemorrhage|0
216284|NCT01826981|704624|P7|Overall Study|Upper G-I Haemorrhage|0
216285|NCT01826981|704625|P6|Overall Study|Upper G-I Haemorrhage|0
216286|NCT01826981|704626|P5|Overall Study|Upper G-I Haemorrhage|0
216287|NCT01826981|704627|P4|Overall Study|Upper G-I Haemorrhage|0
216288|NCT01826981|704628|P3|Overall Study|Upper G-I Haemorrhage|0
216289|NCT01826981|704629|P2|Overall Study|Upper G-I Haemorrhage|0
216290|NCT01826981|704630|P1|Overall Study|Upper G-I Haemorrhage|0
216291|NCT01826981|704616|P15|Overall Study|Adverse Event|0
216292|NCT01826981|704617|P14|Overall Study|Adverse Event|0
216293|NCT01826981|704618|P13|Overall Study|Adverse Event|0
216294|NCT01826981|704619|P12|Overall Study|Adverse Event|0
216295|NCT01826981|704620|P11|Overall Study|Adverse Event|0
216296|NCT01826981|704621|P10|Overall Study|Adverse Event|0
216297|NCT01826981|704622|P9|Overall Study|Adverse Event|0
216298|NCT01826981|704623|P8|Overall Study|Adverse Event|0
216299|NCT01826981|704624|P7|Overall Study|Adverse Event|0
216300|NCT01826981|704625|P6|Overall Study|Adverse Event|0
216301|NCT01826981|704626|P5|Overall Study|Adverse Event|1
216302|NCT01826981|704627|P4|Overall Study|Adverse Event|0
216303|NCT01826981|704628|P3|Overall Study|Adverse Event|0
216304|NCT01826981|704629|P2|Overall Study|Adverse Event|0
216305|NCT01826981|704630|P1|Overall Study|Adverse Event|0
216306|NCT01826981|704616|P15|Overall Study|Withdrew Consent|0
216307|NCT01826981|704617|P14|Overall Study|Withdrew Consent|1
216308|NCT01826981|704618|P13|Overall Study|Withdrew Consent|0
216309|NCT01826981|704619|P12|Overall Study|Withdrew Consent|1
216310|NCT01826981|704620|P11|Overall Study|Withdrew Consent|0
216311|NCT01826981|704621|P10|Overall Study|Withdrew Consent|0
216312|NCT01826981|704622|P9|Overall Study|Withdrew Consent|0
216313|NCT01826981|704623|P8|Overall Study|Withdrew Consent|1
216314|NCT01826981|704624|P7|Overall Study|Withdrew Consent|1
216315|NCT01826981|704625|P6|Overall Study|Withdrew Consent|0
216316|NCT01826981|704626|P5|Overall Study|Withdrew Consent|0
216317|NCT01826981|704627|P4|Overall Study|Withdrew Consent|0
216318|NCT01826981|704628|P3|Overall Study|Withdrew Consent|0
216319|NCT01826981|704629|P2|Overall Study|Withdrew Consent|0
216320|NCT01826981|704630|P1|Overall Study|Withdrew Consent|0
216321|NCT01826981|704616|P15|Overall Study|Lost to Follow-up|0
216322|NCT01826981|704617|P14|Overall Study|Lost to Follow-up|0
216323|NCT01826981|704618|P13|Overall Study|Lost to Follow-up|1
216324|NCT01826981|704619|P12|Overall Study|Lost to Follow-up|1
216325|NCT01826981|704620|P11|Overall Study|Lost to Follow-up|1
216326|NCT01826981|704621|P10|Overall Study|Lost to Follow-up|1
216327|NCT01826981|704622|P9|Overall Study|Lost to Follow-up|0
216328|NCT01826981|704623|P8|Overall Study|Lost to Follow-up|1
216329|NCT01826981|704624|P7|Overall Study|Lost to Follow-up|0
216330|NCT01826981|704625|P6|Overall Study|Lost to Follow-up|1
216331|NCT01826981|704626|P5|Overall Study|Lost to Follow-up|1
216332|NCT01826981|704627|P4|Overall Study|Lost to Follow-up|0
216333|NCT01826981|704628|P3|Overall Study|Lost to Follow-up|0
216334|NCT01826981|704629|P2|Overall Study|Lost to Follow-up|0
216335|NCT01826981|704630|P1|Overall Study|Lost to Follow-up|0
216336|NCT01826981|704616|P15|Overall Study|Lack of Efficacy|0
216337|NCT01826981|704617|P14|Overall Study|Lack of Efficacy|3
216338|NCT01826981|704618|P13|Overall Study|Lack of Efficacy|0
216339|NCT01826981|704619|P12|Overall Study|Lack of Efficacy|0
216340|NCT01826981|704620|P11|Overall Study|Lack of Efficacy|1
216341|NCT01826981|704621|P10|Overall Study|Lack of Efficacy|0
216342|NCT01826981|704622|P9|Overall Study|Lack of Efficacy|7
216343|NCT01826981|704623|P8|Overall Study|Lack of Efficacy|8
216344|NCT01826981|704624|P7|Overall Study|Lack of Efficacy|0
216345|NCT01826981|704625|P6|Overall Study|Lack of Efficacy|0
216346|NCT01826981|704626|P5|Overall Study|Lack of Efficacy|5
216347|NCT01826981|704627|P4|Overall Study|Lack of Efficacy|0
216348|NCT01826981|704628|P3|Overall Study|Lack of Efficacy|0
216349|NCT01826981|704629|P2|Overall Study|Lack of Efficacy|1
216350|NCT01826981|704630|P1|Overall Study|Lack of Efficacy|0
216351|NCT01826604|704793|P2|Overall Study|Lost to Follow-up|9
216352|NCT01826604|704794|P1|Overall Study|Lost to Follow-up|8
216353|NCT01826370|704836|P1|Overall Study|Other reason not defined above|2
216354|NCT01826370|704836|P1|Overall Study|Lost to Follow-up|12
216355|NCT01826370|704836|P1|Overall Study|Protocol Violation|6
216356|NCT01826214|704844|P2|Overall Study|Subject/guardian decision|3
216357|NCT01826214|704845|P1|Overall Study|Subject/guardian decision|2
216358|NCT01826214|704844|P2|Overall Study|Study terminated by Sponsor|1
216359|NCT01826214|704845|P1|Overall Study|Study terminated by Sponsor|0
216360|NCT01826214|704844|P2|Overall Study|Progressive disease|21
216361|NCT01826214|704845|P1|Overall Study|Progressive disease|22
216362|NCT01826214|704844|P2|Overall Study|Physician Decision|2
216363|NCT01826214|704845|P1|Overall Study|Physician Decision|0
216364|NCT01826214|704844|P2|Overall Study|Lost to Follow-up|0
216365|NCT01826214|704845|P1|Overall Study|Lost to Follow-up|1
216366|NCT01826214|704844|P2|Overall Study|Death|1
216367|NCT01826214|704845|P1|Overall Study|Death|3
216368|NCT01826214|704844|P2|Overall Study|Adverse Event|6
216369|NCT01826214|704845|P1|Overall Study|Adverse Event|7
216370|NCT01826201|704863|P1|Overall Study|Non compliance with protocol|4
216371|NCT01825837|704873|P4|PART II|reason unspecified|0
216372|NCT01825837|704874|P3|PART II|reason unspecified|2
216373|NCT01825837|704875|P2|PART II|reason unspecified|2
216374|NCT01825837|704876|P1|PART II|reason unspecified|2
216375|NCT01825837|704873|P4|PART II|Treatment failure|0
216376|NCT01825837|704874|P3|PART II|Treatment failure|5
216377|NCT01825837|704875|P2|PART II|Treatment failure|4
216378|NCT01825837|704876|P1|PART II|Treatment failure|6
216379|NCT01825837|704873|P4|PART II|Adverse Event|0
216380|NCT01825837|704874|P3|PART II|Adverse Event|1
216381|NCT01825837|704875|P2|PART II|Adverse Event|3
216382|NCT01825837|704876|P1|PART II|Adverse Event|3
216383|NCT01825837|704873|P4|PART II|Patient non-compliance|0
216384|NCT01825837|704874|P3|PART II|Patient non-compliance|4
216385|NCT01825837|704875|P2|PART II|Patient non-compliance|2
216386|NCT01825837|704876|P1|PART II|Patient non-compliance|5
216387|NCT01825837|704873|P4|PART II|Withdrawal by Subject|0
216388|NCT01825837|704874|P3|PART II|Withdrawal by Subject|7
216389|NCT01825837|704875|P2|PART II|Withdrawal by Subject|3
216390|NCT01825837|704876|P1|PART II|Withdrawal by Subject|3
216391|NCT01825837|704873|P4|PART I|reason unspecified|3
216392|NCT01825837|704874|P3|PART I|reason unspecified|0
216393|NCT01825837|704875|P2|PART I|reason unspecified|0
216394|NCT01825837|704876|P1|PART I|reason unspecified|0
216395|NCT01825837|704873|P4|PART I|Treatment failure|7
216396|NCT01825837|704874|P3|PART I|Treatment failure|0
216397|NCT01825837|704875|P2|PART I|Treatment failure|0
216398|NCT01825837|704876|P1|PART I|Treatment failure|0
216399|NCT01825837|704873|P4|PART I|Patient non-compliance|1
216400|NCT01825837|704874|P3|PART I|Patient non-compliance|0
216401|NCT01825837|704875|P2|PART I|Patient non-compliance|0
216402|NCT01825837|704876|P1|PART I|Patient non-compliance|0
216403|NCT01825837|704873|P4|PART I|Withdrawal by Subject|6
216404|NCT01825837|704874|P3|PART I|Withdrawal by Subject|0
216405|NCT01825837|704875|P2|PART I|Withdrawal by Subject|0
216406|NCT01825837|704876|P1|PART I|Withdrawal by Subject|0
216407|NCT01825577|704884|P1|Overall Study|Lack of Efficacy|3
216408|NCT01825577|704884|P1|Overall Study|Withdrawn by family members|2
216409|NCT01825577|704884|P1|Overall Study|Withdrawal by Subject|1
216410|NCT01825577|704884|P1|Overall Study|Physician Decision|2
216411|NCT01825200|704908|P2|Overall Study|Withdrawal by Subject|1
216412|NCT01825200|704909|P1|Overall Study|Withdrawal by Subject|0
216413|NCT01825200|704908|P2|Overall Study|Lost to Follow-up|6
216414|NCT01825200|704909|P1|Overall Study|Lost to Follow-up|5
216415|NCT01824823|704939|P2|Overall Study|Off-treatment reason not submitted|0
216416|NCT01824823|704940|P1|Overall Study|Off-treatment reason not submitted|1
216417|NCT01824823|704939|P2|Overall Study|Lack of Efficacy|1
216418|NCT01824823|704940|P1|Overall Study|Lack of Efficacy|1
216419|NCT01824602|704950|P4|Overall Study|Treatment failure|1
216420|NCT01824602|704951|P3|Overall Study|Treatment failure|0
216421|NCT01824602|704952|P2|Overall Study|Treatment failure|0
216422|NCT01824602|704953|P1|Overall Study|Treatment failure|0
216423|NCT01824602|704950|P4|Overall Study|Adverse Event|2
216424|NCT01824602|704951|P3|Overall Study|Adverse Event|2
216425|NCT01824602|704952|P2|Overall Study|Adverse Event|0
216426|NCT01824602|704953|P1|Overall Study|Adverse Event|1
216427|NCT01824602|704950|P4|Overall Study|Patient non-compliance|0
216428|NCT01824602|704951|P3|Overall Study|Patient non-compliance|1
216429|NCT01824602|704952|P2|Overall Study|Patient non-compliance|0
216430|NCT01824602|704953|P1|Overall Study|Patient non-compliance|0
216431|NCT01824602|704950|P4|Overall Study|Withdrawal by Subject|2
216432|NCT01824602|704951|P3|Overall Study|Withdrawal by Subject|1
216433|NCT01824602|704952|P2|Overall Study|Withdrawal by Subject|0
216434|NCT01824602|704953|P1|Overall Study|Withdrawal by Subject|0
216435|NCT01824498|704998|P6|Washout (8 Weeks)|Withdrawal by Subject|0
216436|NCT01824498|704999|P5|Washout (8 Weeks)|Withdrawal by Subject|1
216437|NCT01824498|705000|P4|Washout (8 Weeks)|Withdrawal by Subject|1
216438|NCT01824498|705001|P3|Washout (8 Weeks)|Withdrawal by Subject|2
216439|NCT01824498|705002|P2|Washout (8 Weeks)|Withdrawal by Subject|0
216440|NCT01824498|705003|P1|Washout (8 Weeks)|Withdrawal by Subject|2
216441|NCT01824355|705034|P1|Overall Study|unevaluable reference method results per|1
216442|NCT01824355|705034|P1|Overall Study|Adverse Event|2
216443|NCT01824342|705045|P2|Overall Study|Death|0
216444|NCT01824342|705046|P1|Overall Study|Death|2
216445|NCT01824342|705045|P2|Overall Study|Physician Decision|0
216446|NCT01824342|705046|P1|Overall Study|Physician Decision|5
216447|NCT01824342|705045|P2|Overall Study|Disease Progression|1
216448|NCT01824342|705046|P1|Overall Study|Disease Progression|1
216449|NCT01824342|705045|P2|Overall Study|Adverse Event|1
216450|NCT01824342|705046|P1|Overall Study|Adverse Event|1
216451|NCT01824342|705045|P2|Overall Study|Withdrawal by Subject|3
216452|NCT01824342|705046|P1|Overall Study|Withdrawal by Subject|0
216453|NCT01824303|705060|P2|Randomized Study|Other Miscellaneous Reasons|0
216454|NCT01824303|705061|P1|Randomized Study|Other Miscellaneous Reasons|1
216455|NCT01824303|705060|P2|Randomized Study|Withdrawal by Subject|1
216456|NCT01824303|705061|P1|Randomized Study|Withdrawal by Subject|1
216457|NCT01823679|705089|P1|Overall Study|Death|1
216458|NCT01823536|705142|P6|Overall Study|Subject moved out of the state|0
216459|NCT01823536|705143|P5|Overall Study|Subject moved out of the state|1
216460|NCT01823536|705144|P4|Overall Study|Subject moved out of the state|0
216461|NCT01823536|705145|P3|Overall Study|Subject moved out of the state|0
216462|NCT01823536|705146|P2|Overall Study|Subject moved out of the state|0
216463|NCT01823536|705147|P1|Overall Study|Subject moved out of the state|0
216464|NCT01823536|705142|P6|Overall Study|Met exclusion criterion No 6|0
216465|NCT01823536|705143|P5|Overall Study|Met exclusion criterion No 6|0
216466|NCT01823536|705144|P4|Overall Study|Met exclusion criterion No 6|1
216467|NCT01823536|705145|P3|Overall Study|Met exclusion criterion No 6|0
216468|NCT01823536|705146|P2|Overall Study|Met exclusion criterion No 6|0
216469|NCT01823536|705147|P1|Overall Study|Met exclusion criterion No 6|0
216470|NCT01823536|705142|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
216471|NCT01823536|705143|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
216472|NCT01823536|705144|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
216473|NCT01823536|705145|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
216474|NCT01823536|705146|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
216475|NCT01823536|705147|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
216476|NCT01823536|705142|P6|Overall Study|Withdrawal by Subject|0
216477|NCT01823536|705143|P5|Overall Study|Withdrawal by Subject|0
216478|NCT01823536|705144|P4|Overall Study|Withdrawal by Subject|0
216479|NCT01823536|705145|P3|Overall Study|Withdrawal by Subject|0
216480|NCT01823536|705146|P2|Overall Study|Withdrawal by Subject|1
216481|NCT01823536|705147|P1|Overall Study|Withdrawal by Subject|1
216482|NCT01823536|705142|P6|Overall Study|Protocol Violation|0
216483|NCT01823536|705143|P5|Overall Study|Protocol Violation|0
216484|NCT01823536|705144|P4|Overall Study|Protocol Violation|0
216485|NCT01823536|705145|P3|Overall Study|Protocol Violation|0
216486|NCT01823536|705146|P2|Overall Study|Protocol Violation|1
216487|NCT01823536|705147|P1|Overall Study|Protocol Violation|0
216488|NCT01823536|705142|P6|Overall Study|Lost to Follow-up|0
216489|NCT01823536|705143|P5|Overall Study|Lost to Follow-up|1
216490|NCT01823536|705144|P4|Overall Study|Lost to Follow-up|1
216491|NCT01823536|705145|P3|Overall Study|Lost to Follow-up|0
216492|NCT01823536|705146|P2|Overall Study|Lost to Follow-up|0
216493|NCT01823536|705147|P1|Overall Study|Lost to Follow-up|1
216494|NCT01823341|705185|P1|Overall Study|Adverse Event|1
216495|NCT01823341|705185|P1|Overall Study|Withdrawal by Subject|7
216496|NCT01823341|705185|P1|Overall Study|Failed run-in|7
216497|NCT01823289|705228|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
216498|NCT01823289|705228|P1|Overall Study|Drug affected efficacy and safety|1
216499|NCT01823289|705228|P1|Overall Study|Transaminase increased more than 3 times|1
216500|NCT01823289|705228|P1|Overall Study|Administered contraindicated medicine|1
216501|NCT01823289|705228|P1|Overall Study|Physician Decision|9
216502|NCT01823289|705228|P1|Overall Study|Lack of Efficacy|1
216503|NCT01823289|705228|P1|Overall Study|Adverse Event|5
216504|NCT01823289|705228|P1|Overall Study|Lost to Follow-up|5
216505|NCT01823224|705236|P2|Overall Study|Withdrawal by Subject|1
216506|NCT01823224|705237|P1|Overall Study|Withdrawal by Subject|0
216507|NCT01823224|705236|P2|Overall Study|missed med dose|1
216508|NCT01823224|705237|P1|Overall Study|missed med dose|0
216509|NCT01823224|705236|P2|Overall Study|pharmacy error|1
216510|NCT01823224|705237|P1|Overall Study|pharmacy error|0
216511|NCT01823224|705236|P2|Overall Study|didn't qualify|2
216512|NCT01823224|705237|P1|Overall Study|didn't qualify|1
216513|NCT01823224|705236|P2|Overall Study|Lost to Follow-up|6
216514|NCT01823224|705237|P1|Overall Study|Lost to Follow-up|5
216515|NCT01823146|705247|P2|Overall Study|Lost to Follow-up|1
216516|NCT01823146|705248|P1|Overall Study|Lost to Follow-up|2
216517|NCT01823146|705247|P2|Overall Study|Withdrawal by Subject|1
216518|NCT01823146|705248|P1|Overall Study|Withdrawal by Subject|0
216519|NCT01822899|705260|P2|Overall Study|Withdrawal by Subject|7
216520|NCT01822899|705261|P1|Overall Study|Withdrawal by Subject|5
216521|NCT01822899|705260|P2|Overall Study|Lost to Follow-up|0
216522|NCT01822899|705261|P1|Overall Study|Lost to Follow-up|1
216523|NCT01822899|705260|P2|Overall Study|Protocol Violation|3
216524|NCT01822899|705261|P1|Overall Study|Protocol Violation|6
216525|NCT01822899|705260|P2|Overall Study|Lack of Efficacy|3
216526|NCT01822899|705261|P1|Overall Study|Lack of Efficacy|6
216527|NCT01822899|705260|P2|Overall Study|Adverse Event|5
216528|NCT01822899|705261|P1|Overall Study|Adverse Event|6
216529|NCT01822821|705271|P2|Overall Study|Other reasons|0
216530|NCT01822821|705272|P1|Overall Study|Other reasons|1
216531|NCT01822821|705271|P2|Overall Study|Eligible surgery cancelled|1
216532|NCT01822821|705272|P1|Overall Study|Eligible surgery cancelled|1
216533|NCT01822756|705301|P5|Overall Study|disease progression & patient preference|0
216534|NCT01822756|705302|P4|Overall Study|disease progression & patient preference|0
216535|NCT01822756|705303|P3|Overall Study|disease progression & patient preference|1
216536|NCT01822756|705304|P2|Overall Study|disease progression & patient preference|0
216537|NCT01822756|705305|P1|Overall Study|disease progression & patient preference|2
216538|NCT01822756|705301|P5|Overall Study|Physician Decision|0
216539|NCT01822756|705302|P4|Overall Study|Physician Decision|0
216540|NCT01822756|705303|P3|Overall Study|Physician Decision|0
216541|NCT01822756|705304|P2|Overall Study|Physician Decision|1
216542|NCT01822756|705305|P1|Overall Study|Physician Decision|0
216543|NCT01822756|705301|P5|Overall Study|Lost to Follow-up|1
216544|NCT01822756|705302|P4|Overall Study|Lost to Follow-up|0
216545|NCT01822756|705303|P3|Overall Study|Lost to Follow-up|1
216546|NCT01822756|705304|P2|Overall Study|Lost to Follow-up|0
216547|NCT01822756|705305|P1|Overall Study|Lost to Follow-up|1
216548|NCT01822756|705301|P5|Overall Study|Death|0
216549|NCT01822756|705302|P4|Overall Study|Death|0
216550|NCT01822756|705303|P3|Overall Study|Death|1
216551|NCT01822756|705304|P2|Overall Study|Death|2
216552|NCT01822756|705305|P1|Overall Study|Death|2
216553|NCT01822756|705301|P5|Overall Study|Disease progression|6
216554|NCT01822756|705302|P4|Overall Study|Disease progression|2
216555|NCT01822756|705303|P3|Overall Study|Disease progression|7
216556|NCT01822756|705304|P2|Overall Study|Disease progression|1
216557|NCT01822756|705305|P1|Overall Study|Disease progression|11
216558|NCT01822756|705301|P5|Overall Study|Adverse Event|0
216559|NCT01822756|705302|P4|Overall Study|Adverse Event|2
216560|NCT01822756|705303|P3|Overall Study|Adverse Event|0
216561|NCT01822756|705304|P2|Overall Study|Adverse Event|0
216562|NCT01822756|705305|P1|Overall Study|Adverse Event|0
216563|NCT01822691|705347|P1|Overall Study|Withdrawal by Subject|2
216564|NCT01822678|705358|P3|Overall Study|Lost to Follow-up|1
216565|NCT01822678|705359|P2|Overall Study|Lost to Follow-up|2
216566|NCT01822678|705360|P1|Overall Study|Lost to Follow-up|0
216567|NCT01822678|705358|P3|Overall Study|Lack of Efficacy|5
216568|NCT01822678|705359|P2|Overall Study|Lack of Efficacy|6
216569|NCT01822678|705360|P1|Overall Study|Lack of Efficacy|3
216570|NCT01822678|705358|P3|Overall Study|Adverse Event|1
216571|NCT01822678|705359|P2|Overall Study|Adverse Event|3
216572|NCT01822678|705360|P1|Overall Study|Adverse Event|4
216573|NCT01822678|705358|P3|Overall Study|Withdrawal by Subject|4
216574|NCT01822678|705359|P2|Overall Study|Withdrawal by Subject|4
216575|NCT01822678|705360|P1|Overall Study|Withdrawal by Subject|5
216576|NCT01822665|705368|P1|Overall Study|Other Reason|5
216577|NCT01822665|705368|P1|Overall Study|Adverse Event|3
216578|NCT01822535|705413|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
216579|NCT01822535|705414|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
216580|NCT01822535|705413|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
216581|NCT01822535|705414|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
216582|NCT01822535|705413|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
216583|NCT01822535|705414|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
216584|NCT01822223|705438|P2|Overall Study|Death|1
216585|NCT01822223|705439|P1|Overall Study|Death|0
216586|NCT01821963|705484|P1|Overall Study|Adverse Event|1
216587|NCT01821937|705490|P2|Overall Study|Adverse Event|3
216588|NCT01821937|705491|P1|Overall Study|Adverse Event|0
216589|NCT01821807|705515|P2|Overall Study|Lost to Follow-up|1
216590|NCT01821807|705516|P1|Overall Study|Lost to Follow-up|3
216591|NCT01821118|705604|P2|Overall Study|Death|1
216592|NCT01821118|705605|P1|Overall Study|Death|0
216593|NCT01820585|705648|P4|Overall Study|Pregnancy|0
216594|NCT01820585|705649|P3|Overall Study|Pregnancy|0
216595|NCT01820585|705650|P2|Overall Study|Pregnancy|1
216596|NCT01820585|705651|P1|Overall Study|Pregnancy|0
216597|NCT01820585|705648|P4|Overall Study|at sponsor request|0
216598|NCT01820585|705649|P3|Overall Study|at sponsor request|1
216599|NCT01820585|705650|P2|Overall Study|at sponsor request|0
216600|NCT01820585|705651|P1|Overall Study|at sponsor request|0
216601|NCT01820585|705648|P4|Overall Study|Subject non-compliance|2
216602|NCT01820585|705649|P3|Overall Study|Subject non-compliance|1
216603|NCT01820585|705650|P2|Overall Study|Subject non-compliance|0
216604|NCT01820585|705651|P1|Overall Study|Subject non-compliance|0
216605|NCT01820585|705648|P4|Overall Study|Protocol Violation|1
216606|NCT01820585|705649|P3|Overall Study|Protocol Violation|1
216607|NCT01820585|705650|P2|Overall Study|Protocol Violation|1
216608|NCT01820585|705651|P1|Overall Study|Protocol Violation|3
216609|NCT01820585|705648|P4|Overall Study|Lost to Follow-up|3
216610|NCT01820585|705649|P3|Overall Study|Lost to Follow-up|0
216611|NCT01820585|705650|P2|Overall Study|Lost to Follow-up|3
216612|NCT01820585|705651|P1|Overall Study|Lost to Follow-up|3
216613|NCT01820585|705648|P4|Overall Study|Withdrawal by Subject|8
216614|NCT01820585|705649|P3|Overall Study|Withdrawal by Subject|3
216615|NCT01820585|705650|P2|Overall Study|Withdrawal by Subject|7
216616|NCT01820585|705651|P1|Overall Study|Withdrawal by Subject|3
216617|NCT01820585|705648|P4|Overall Study|Lack of Efficacy|1
216618|NCT01820585|705649|P3|Overall Study|Lack of Efficacy|5
216619|NCT01820585|705650|P2|Overall Study|Lack of Efficacy|7
216620|NCT01820585|705651|P1|Overall Study|Lack of Efficacy|9
216621|NCT01820585|705648|P4|Overall Study|Adverse Event|34
216622|NCT01820585|705649|P3|Overall Study|Adverse Event|23
216623|NCT01820585|705650|P2|Overall Study|Adverse Event|13
216624|NCT01820585|705651|P1|Overall Study|Adverse Event|9
216625|NCT01820559|705664|P3|Overall Study|Lack of Efficacy|3
216626|NCT01820559|705665|P2|Overall Study|Lack of Efficacy|2
216627|NCT01820559|705666|P1|Overall Study|Lack of Efficacy|3
216628|NCT01820559|705664|P3|Overall Study|At sponsor request|1
216629|NCT01820559|705665|P2|Overall Study|At sponsor request|0
216630|NCT01820559|705666|P1|Overall Study|At sponsor request|0
216631|NCT01820559|705664|P3|Overall Study|Lost to Follow-up|2
216632|NCT01820559|705665|P2|Overall Study|Lost to Follow-up|2
216633|NCT01820559|705666|P1|Overall Study|Lost to Follow-up|3
216634|NCT01820559|705664|P3|Overall Study|Subject's non-compliance|2
216635|NCT01820559|705665|P2|Overall Study|Subject's non-compliance|0
216636|NCT01820559|705666|P1|Overall Study|Subject's non-compliance|1
216637|NCT01820559|705664|P3|Overall Study|Protocol Violation|3
216638|NCT01820559|705665|P2|Overall Study|Protocol Violation|1
216639|NCT01820559|705666|P1|Overall Study|Protocol Violation|2
216640|NCT01820559|705664|P3|Overall Study|Withdrawal by Subject|5
216641|NCT01820559|705665|P2|Overall Study|Withdrawal by Subject|2
216642|NCT01820559|705666|P1|Overall Study|Withdrawal by Subject|1
216643|NCT01820559|705664|P3|Overall Study|Adverse Event|13
216644|NCT01820559|705665|P2|Overall Study|Adverse Event|6
216645|NCT01820559|705666|P1|Overall Study|Adverse Event|4
216646|NCT01820364|705687|P2|Part II: LGX818 + MEK162|Study Termination|1
216647|NCT01820364|705688|P1|Part II: LGX818 + MEK162|Study Termination|0
216648|NCT01820364|705687|P2|Part I: LGX818|Disease Progression|0
216649|NCT01820364|705688|P1|Part I: LGX818|Disease Progression|4
216650|NCT01820364|705687|P2|Part I: LGX818|Adverse Event|0
216651|NCT01820364|705688|P1|Part I: LGX818|Adverse Event|6
216652|NCT01820364|705687|P2|Part I: LGX818|Administrative Problems|0
216653|NCT01820364|705688|P1|Part I: LGX818|Administrative Problems|3
216654|NCT01820364|705687|P2|Part I: LGX818|Death|0
216655|NCT01820364|705688|P1|Part I: LGX818|Death|1
216656|NCT01819272|705831|P6|Overall Study|Loss of Glucose Control|0
216657|NCT01819272|705832|P5|Overall Study|Loss of Glucose Control|2
216658|NCT01819272|705833|P4|Overall Study|Loss of Glucose Control|1
216659|NCT01819272|705834|P3|Overall Study|Loss of Glucose Control|0
216660|NCT01819272|705835|P2|Overall Study|Loss of Glucose Control|1
216661|NCT01819272|705836|P1|Overall Study|Loss of Glucose Control|2
216662|NCT01819272|705831|P6|Overall Study|Withdrawal of Consent|1
216663|NCT01819272|705832|P5|Overall Study|Withdrawal of Consent|0
216664|NCT01819272|705833|P4|Overall Study|Withdrawal of Consent|1
216665|NCT01819272|705834|P3|Overall Study|Withdrawal of Consent|2
216666|NCT01819272|705835|P2|Overall Study|Withdrawal of Consent|1
216667|NCT01819272|705836|P1|Overall Study|Withdrawal of Consent|0
216668|NCT01819272|705831|P6|Overall Study|Physician Decision|0
216669|NCT01819272|705832|P5|Overall Study|Physician Decision|0
216670|NCT01819272|705833|P4|Overall Study|Physician Decision|0
216671|NCT01819272|705834|P3|Overall Study|Physician Decision|0
216672|NCT01819272|705835|P2|Overall Study|Physician Decision|1
216673|NCT01819272|705836|P1|Overall Study|Physician Decision|0
216674|NCT01819272|705831|P6|Overall Study|Protocol Violation|3
216675|NCT01819272|705832|P5|Overall Study|Protocol Violation|2
216676|NCT01819272|705833|P4|Overall Study|Protocol Violation|1
216677|NCT01819272|705834|P3|Overall Study|Protocol Violation|0
216678|NCT01819272|705835|P2|Overall Study|Protocol Violation|0
216679|NCT01819272|705836|P1|Overall Study|Protocol Violation|0
216680|NCT01819272|705831|P6|Overall Study|Lost to Follow-up|3
216681|NCT01819272|705832|P5|Overall Study|Lost to Follow-up|0
216682|NCT01819272|705833|P4|Overall Study|Lost to Follow-up|0
216683|NCT01819272|705834|P3|Overall Study|Lost to Follow-up|1
216684|NCT01819272|705835|P2|Overall Study|Lost to Follow-up|0
216685|NCT01819272|705836|P1|Overall Study|Lost to Follow-up|3
216686|NCT01819272|705831|P6|Overall Study|Adverse Event|0
216687|NCT01819272|705832|P5|Overall Study|Adverse Event|0
216688|NCT01819272|705833|P4|Overall Study|Adverse Event|2
216689|NCT01819272|705834|P3|Overall Study|Adverse Event|0
216690|NCT01819272|705835|P2|Overall Study|Adverse Event|0
216691|NCT01819272|705836|P1|Overall Study|Adverse Event|1
216692|NCT01819194|705862|P1|Overall Study|Loss of study articles|2
216693|NCT01818700|705867|P1|Overall Study|Other|1
216694|NCT01818700|705867|P1|Overall Study|Protocol Violation|2
216695|NCT01818700|705867|P1|Overall Study|Withdrawal by Subject|27
216696|NCT01818700|705867|P1|Overall Study|Lost to Follow-up|5
216697|NCT01818700|705867|P1|Overall Study|Lack of Efficacy|2
216698|NCT01818700|705867|P1|Overall Study|Adverse Event|67
216699|NCT01818596|705878|P2|Overall Study|Still on Study|6
216700|NCT01818596|705879|P1|Overall Study|Still on Study|232
216701|NCT01818596|705878|P2|Overall Study|Lost to Follow-up|0
216702|NCT01818596|705879|P1|Overall Study|Lost to Follow-up|2
216703|NCT01818596|705878|P2|Overall Study|Protocol Violation|0
216704|NCT01818596|705879|P1|Overall Study|Protocol Violation|1
216705|NCT01818596|705878|P2|Overall Study|Withdrew Consent|0
216706|NCT01818596|705879|P1|Overall Study|Withdrew Consent|3
216707|NCT01818596|705878|P2|Overall Study|Adverse Event|0
216708|NCT01818596|705879|P1|Overall Study|Adverse Event|4
216709|NCT01818596|705878|P2|Overall Study|Enrolled but Not Treated|0
216710|NCT01818596|705879|P1|Overall Study|Enrolled but Not Treated|4
216711|NCT01818336|705927|P2|Overall Study|Lost to Follow-up|1
216712|NCT01818336|705928|P1|Overall Study|Lost to Follow-up|0
216713|NCT01818336|705927|P2|Overall Study|Declined retest visit|11
216714|NCT01818336|705928|P1|Overall Study|Declined retest visit|0
216715|NCT01817790|705982|P2|Overall Study|Other: Could not attend appointment|1
216716|NCT01817790|705983|P1|Overall Study|Other: Could not attend appointment|1
216717|NCT01817790|705982|P2|Overall Study|Withdrawal by Subject|3
216718|NCT01817790|705983|P1|Overall Study|Withdrawal by Subject|1
216719|NCT01817790|705982|P2|Overall Study|Protocol Violation|1
216720|NCT01817790|705983|P1|Overall Study|Protocol Violation|2
216721|NCT01817790|705982|P2|Overall Study|Lost to Follow-up|1
216722|NCT01817790|705983|P1|Overall Study|Lost to Follow-up|0
216723|NCT01817790|705982|P2|Overall Study|Adverse Event|2
216724|NCT01817790|705983|P1|Overall Study|Adverse Event|0
216725|NCT01817777|706027|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
216726|NCT01817777|706028|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
216727|NCT01817777|706029|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
216728|NCT01817777|706027|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
216729|NCT01817777|706028|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
216730|NCT01817777|706029|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
216731|NCT01817777|706027|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
216732|NCT01817777|706028|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
216733|NCT01817777|706029|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
216734|NCT01817777|706027|P3|Observational Phase (8 Weeks)|Early Study Termination|0
216735|NCT01817777|706028|P2|Observational Phase (8 Weeks)|Early Study Termination|0
216736|NCT01817777|706029|P1|Observational Phase (8 Weeks)|Early Study Termination|2
216737|NCT01817777|706027|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
216738|NCT01817777|706028|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
216739|NCT01817777|706029|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
216740|NCT01817764|706053|P2|Overall Study|Withdrawal by Subject|12
216741|NCT01817764|706054|P1|Overall Study|Withdrawal by Subject|10
216742|NCT01817764|706053|P2|Overall Study|Lost to Follow-up|4
216743|NCT01817764|706054|P1|Overall Study|Lost to Follow-up|1
216744|NCT01817764|706053|P2|Overall Study|Protocol Violation|5
216745|NCT01817764|706054|P1|Overall Study|Protocol Violation|7
216746|NCT01817764|706053|P2|Overall Study|Lack of Efficacy|7
216747|NCT01817764|706054|P1|Overall Study|Lack of Efficacy|9
216748|NCT01817764|706053|P2|Overall Study|Adverse Event|10
216749|NCT01817764|706054|P1|Overall Study|Adverse Event|7
216750|NCT01817725|706062|P1|Overall Study|Withdrawal by Subject|1
216751|NCT01816685|706069|P2|Overall Study|Surgery Cancelled|2
216752|NCT01816685|706070|P1|Overall Study|Surgery Cancelled|3
216753|NCT01816685|706069|P2|Overall Study|Lost to Follow-up|9
216754|NCT01816685|706070|P1|Overall Study|Lost to Follow-up|7
216755|NCT01816477|706080|P2|Overall Study|Unable to tolerate catheter placement|0
216756|NCT01816477|706081|P1|Overall Study|Unable to tolerate catheter placement|3
216757|NCT01816477|706080|P2|Overall Study|Withdrawal by Subject|1
216758|NCT01816477|706081|P1|Overall Study|Withdrawal by Subject|13
216759|NCT01816295|706135|P2|OLE Phase|Lack of Efficacy|7
216760|NCT01816295|706136|P1|OLE Phase|Lack of Efficacy|3
216761|NCT01816295|706135|P2|OLE Phase|Withdrawal by Subject|10
216762|NCT01816295|706136|P1|OLE Phase|Withdrawal by Subject|10
216763|NCT01816295|706135|P2|OLE Phase|Sponsor Decision|9
216764|NCT01816295|706136|P1|OLE Phase|Sponsor Decision|7
216765|NCT01816295|706135|P2|OLE Phase|Protocol Violation|4
216766|NCT01816295|706136|P1|OLE Phase|Protocol Violation|4
216767|NCT01816295|706135|P2|OLE Phase|Physician Decision|1
216768|NCT01816295|706136|P1|OLE Phase|Physician Decision|3
216769|NCT01816295|706135|P2|OLE Phase|Lost to Follow-up|5
216770|NCT01816295|706136|P1|OLE Phase|Lost to Follow-up|5
216771|NCT01816295|706135|P2|OLE Phase|Entry Criteria Not Met|5
216772|NCT01816295|706136|P1|OLE Phase|Entry Criteria Not Met|3
216773|NCT01816295|706135|P2|OLE Phase|Death|0
216774|NCT01816295|706136|P1|OLE Phase|Death|1
216775|NCT01816295|706135|P2|OLE Phase|Adverse Event|15
216776|NCT01816295|706136|P1|OLE Phase|Adverse Event|17
216777|NCT01816295|706135|P2|Double Blind Phase|Withdrawal by Subject|20
216778|NCT01816295|706136|P1|Double Blind Phase|Withdrawal by Subject|22
216779|NCT01816295|706135|P2|Double Blind Phase|Sponsor Decision|8
216780|NCT01816295|706136|P1|Double Blind Phase|Sponsor Decision|8
216781|NCT01816295|706135|P2|Double Blind Phase|Protocol Violation|11
216782|NCT01816295|706136|P1|Double Blind Phase|Protocol Violation|17
216783|NCT01816295|706135|P2|Double Blind Phase|Physician Decision|2
216784|NCT01816295|706136|P1|Double Blind Phase|Physician Decision|2
216785|NCT01816295|706135|P2|Double Blind Phase|Lost to Follow-up|5
216786|NCT01816295|706136|P1|Double Blind Phase|Lost to Follow-up|3
216787|NCT01816295|706135|P2|Double Blind Phase|Entry Criteria Not Met|2
216788|NCT01816295|706136|P1|Double Blind Phase|Entry Criteria Not Met|0
216789|NCT01816295|706135|P2|Double Blind Phase|Adverse Event|8
216790|NCT01816295|706136|P1|Double Blind Phase|Adverse Event|11
216791|NCT01816243|706151|P1|Overall Study|Amputation|3
216792|NCT01816243|706151|P1|Overall Study|Not eligible for the study|1
216793|NCT01816243|706151|P1|Overall Study|Lack of Efficacy|1
216794|NCT01816243|706151|P1|Overall Study|Lost to Follow-up|1
216795|NCT01816243|706151|P1|Overall Study|Adverse Event|6
216796|NCT01815918|706160|P2|Overall Study|Lack of Efficacy|15
216797|NCT01815918|706161|P1|Overall Study|Lack of Efficacy|15
216798|NCT01815918|706160|P2|Overall Study|Patient samples not analyzable|4
216799|NCT01815918|706161|P1|Overall Study|Patient samples not analyzable|3
216800|NCT01815840|706177|P2|Overall Study|Still on Study|64
216801|NCT01815840|706178|P1|Overall Study|Still on Study|73
216802|NCT01815840|706177|P2|Overall Study|Missing|1
216803|NCT01815840|706178|P1|Overall Study|Missing|1
216804|NCT01815840|706177|P2|Overall Study|Withdrew Consent|26
216805|NCT01815840|706178|P1|Overall Study|Withdrew Consent|26
216806|NCT01815840|706177|P2|Overall Study|Refused Treatment|1
216807|NCT01815840|706178|P1|Overall Study|Refused Treatment|3
216808|NCT01815840|706177|P2|Overall Study|Lost to Follow-up|2
216809|NCT01815840|706178|P1|Overall Study|Lost to Follow-up|1
216810|NCT01815840|706177|P2|Overall Study|Investigator Decision|3
216811|NCT01815840|706178|P1|Overall Study|Investigator Decision|1
216812|NCT01815840|706177|P2|Overall Study|Disease Progression|0
216813|NCT01815840|706178|P1|Overall Study|Disease Progression|1
216814|NCT01815840|706177|P2|Overall Study|Death|2
216815|NCT01815840|706178|P1|Overall Study|Death|2
216816|NCT01815840|706177|P2|Overall Study|Adverse Event|14
216817|NCT01815840|706178|P1|Overall Study|Adverse Event|8
216818|NCT01815736|706208|P2|Overall Study|Still on Study|449
216819|NCT01815736|706209|P1|Overall Study|Still on Study|929
216820|NCT01815736|706208|P2|Overall Study|Lost to Follow-up|7
216821|NCT01815736|706209|P1|Overall Study|Lost to Follow-up|6
216822|NCT01815736|706208|P2|Overall Study|Withdrew Consent|15
216823|NCT01815736|706209|P1|Overall Study|Withdrew Consent|7
216824|NCT01815736|706208|P2|Overall Study|Investigator's Discretion|0
216825|NCT01815736|706209|P1|Overall Study|Investigator's Discretion|4
216826|NCT01815736|706208|P2|Overall Study|Death|0
216827|NCT01815736|706209|P1|Overall Study|Death|4
216828|NCT01815736|706208|P2|Overall Study|Adverse Event|4
216829|NCT01815736|706209|P1|Overall Study|Adverse Event|7
216830|NCT01815736|706208|P2|Overall Study|Randomized but Not Treated|3
216831|NCT01815736|706209|P1|Overall Study|Randomized but Not Treated|4
216832|NCT01815099|706236|P1|Overall Study|unable to attend study visits|1
216833|NCT01815099|706236|P1|Overall Study|Lack of Efficacy|1
216834|NCT01814878|706250|P2|Overall Study|Unspecified|0
216835|NCT01814878|706251|P1|Overall Study|Unspecified|2
216836|NCT01814878|706250|P2|Overall Study|Screening failure (drop-out)|3
216837|NCT01814878|706251|P1|Overall Study|Screening failure (drop-out)|0
216838|NCT01814878|706250|P2|Overall Study|Physician Decision|1
216839|NCT01814878|706251|P1|Overall Study|Physician Decision|3
216840|NCT01814878|706250|P2|Overall Study|Protocol Violation|5
216841|NCT01814878|706251|P1|Overall Study|Protocol Violation|5
216842|NCT01814878|706250|P2|Overall Study|Withdrawal by Subject|16
216843|NCT01814878|706251|P1|Overall Study|Withdrawal by Subject|20
216844|NCT01814878|706250|P2|Overall Study|Adverse Event|5
216845|NCT01814878|706251|P1|Overall Study|Adverse Event|16
216846|NCT01814800|706271|P1|Overall Study|Subject relocation|1
216847|NCT01814800|706271|P1|Overall Study|Sponsor decision|1
216848|NCT01814800|706271|P1|Overall Study|Pregnancy|1
216849|NCT01814800|706271|P1|Overall Study|Adverse Event|2
216850|NCT01814761|706331|P2|Overall Study|Lost to Follow-up|5
216851|NCT01814761|706332|P1|Overall Study|Lost to Follow-up|1
216852|NCT01814761|706331|P2|Overall Study|Ocular Adverse Event|15
216853|NCT01814761|706332|P1|Overall Study|Ocular Adverse Event|6
216854|NCT01814761|706331|P2|Overall Study|Other Reasons|10
216855|NCT01814761|706332|P1|Overall Study|Other Reasons|1
216856|NCT01814748|706346|P2|Overall Study|Withdrawal by Subject|4
216857|NCT01814748|706347|P1|Overall Study|Withdrawal by Subject|6
216858|NCT01814748|706346|P2|Overall Study|Study site terminated by sponsor|1
216859|NCT01814748|706347|P1|Overall Study|Study site terminated by sponsor|1
216860|NCT01814748|706346|P2|Overall Study|Lost to Follow-up|2
216861|NCT01814748|706347|P1|Overall Study|Lost to Follow-up|1
216862|NCT01814696|706391|P2|Overall Study|Randomized to wrong group|0
216863|NCT01814696|706392|P1|Overall Study|Randomized to wrong group|1
216864|NCT01814696|706391|P2|Overall Study|Withdrawal by Subject|0
216865|NCT01814696|706392|P1|Overall Study|Withdrawal by Subject|1
216866|NCT01814670|706410|P1|Overall Study|Protocol Violation|12
216867|NCT01814553|706420|P2|Overall Study|Other than stated|8
216868|NCT01814553|706421|P1|Overall Study|Other than stated|7
216869|NCT01814553|706420|P2|Overall Study|Withdrawal by Subject|1
216870|NCT01814553|706421|P1|Overall Study|Withdrawal by Subject|1
216871|NCT01814553|706420|P2|Overall Study|Other Adverse Event|5
216872|NCT01814553|706421|P1|Overall Study|Other Adverse Event|4
216873|NCT01814553|706420|P2|Overall Study|PD per clinical progression|8
216874|NCT01814553|706421|P1|Overall Study|PD per clinical progression|6
216875|NCT01814397|706435|P1|Overall Study|Withdrawal by Subject|7
216876|NCT01814397|706435|P1|Overall Study|Adverse Event|7
216877|NCT01814332|706444|P2|Overall Study|Lost to Follow-up|1
216878|NCT01814332|706445|P1|Overall Study|Lost to Follow-up|5
216879|NCT01814332|706444|P2|Overall Study|Protocol Violation|4
216880|NCT01814332|706445|P1|Overall Study|Protocol Violation|0
216881|NCT01814332|706444|P2|Overall Study|Withdrawal by Subject|8
216882|NCT01814332|706445|P1|Overall Study|Withdrawal by Subject|3
216883|NCT01814332|706444|P2|Overall Study|Adverse Event|3
216884|NCT01814332|706445|P1|Overall Study|Adverse Event|8
216885|NCT01814137|706465|P2|Overall Study|Unclassified|1
216886|NCT01814137|706466|P1|Overall Study|Unclassified|2
216887|NCT01814137|706465|P2|Overall Study|Physician Decision|1
216888|NCT01814137|706466|P1|Overall Study|Physician Decision|1
216889|NCT01814137|706465|P2|Overall Study|Withdrawal by Subject|2
216890|NCT01814137|706466|P1|Overall Study|Withdrawal by Subject|2
216891|NCT01814137|706465|P2|Overall Study|Adverse Event|1
216892|NCT01814137|706466|P1|Overall Study|Adverse Event|0
216893|NCT01813890|706483|P3|Overall Study|Lack of Efficacy|2
216894|NCT01813890|706484|P2|Overall Study|Lack of Efficacy|1
216895|NCT01813890|706485|P1|Overall Study|Lack of Efficacy|9
216896|NCT01813890|706483|P3|Overall Study|Adverse Event|4
216897|NCT01813890|706484|P2|Overall Study|Adverse Event|3
216898|NCT01813890|706485|P1|Overall Study|Adverse Event|0
216899|NCT01813721|706514|P1|Overall Study|Withdrawal by Subject|1
216900|NCT01813721|706514|P1|Overall Study|Ineligibility determined|63
216901|NCT01813019|706568|P2|Overall Study|Protocol Deviation|1
216902|NCT01813019|706569|P1|Overall Study|Protocol Deviation|2
216903|NCT01813019|706568|P2|Overall Study|administrative problems|0
216904|NCT01813019|706569|P1|Overall Study|administrative problems|2
216905|NCT01813019|706568|P2|Overall Study|Withdrawal by Subject|2
216906|NCT01813019|706569|P1|Overall Study|Withdrawal by Subject|3
216907|NCT01813019|706568|P2|Overall Study|Adverse Event|3
216908|NCT01813019|706569|P1|Overall Study|Adverse Event|0
216909|NCT01812837|706580|P3|Overall Study|Protocol Violation|0
216910|NCT01812837|706581|P2|Overall Study|Protocol Violation|0
216911|NCT01812837|706582|P1|Overall Study|Protocol Violation|1
216912|NCT01812837|706580|P3|Overall Study|Lost to Follow-up|0
216913|NCT01812837|706581|P2|Overall Study|Lost to Follow-up|1
216914|NCT01812837|706582|P1|Overall Study|Lost to Follow-up|1
216915|NCT01812707|706594|P4|Overall Study|Consent withdrawn by participant|0
216916|NCT01812707|706595|P3|Overall Study|Consent withdrawn by participant|0
216917|NCT01812707|706596|P2|Overall Study|Consent withdrawn by participant|0
216918|NCT01812707|706597|P1|Overall Study|Consent withdrawn by participant|1
216919|NCT01812707|706594|P4|Overall Study|Poor compliance to protocol|0
216920|NCT01812707|706595|P3|Overall Study|Poor compliance to protocol|0
216921|NCT01812707|706596|P2|Overall Study|Poor compliance to protocol|0
216922|NCT01812707|706597|P1|Overall Study|Poor compliance to protocol|1
216923|NCT01812707|706594|P4|Overall Study|Adverse Event|2
216924|NCT01812707|706595|P3|Overall Study|Adverse Event|0
216925|NCT01812707|706596|P2|Overall Study|Adverse Event|0
216926|NCT01812707|706597|P1|Overall Study|Adverse Event|0
216927|NCT01812655|706645|P3|Overall Study|Protocol Violation|0
216928|NCT01812655|706646|P2|Overall Study|Protocol Violation|1
216929|NCT01812655|706647|P1|Overall Study|Protocol Violation|1
216930|NCT01811953|706710|P6|Overall Study|Protocol Violation|0
216931|NCT01811953|706711|P5|Overall Study|Protocol Violation|1
216932|NCT01811953|706712|P4|Overall Study|Protocol Violation|0
216933|NCT01811953|706713|P3|Overall Study|Protocol Violation|0
216934|NCT01811953|706714|P2|Overall Study|Protocol Violation|0
216935|NCT01811953|706715|P1|Overall Study|Protocol Violation|0
216936|NCT01811953|706710|P6|Overall Study|Adverse Event|1
216937|NCT01811953|706711|P5|Overall Study|Adverse Event|0
216938|NCT01811953|706712|P4|Overall Study|Adverse Event|1
216939|NCT01811953|706713|P3|Overall Study|Adverse Event|0
216940|NCT01811953|706714|P2|Overall Study|Adverse Event|0
216941|NCT01811953|706715|P1|Overall Study|Adverse Event|0
216942|NCT01811706|706759|P2|First Intervention ( 4 Weeks)|Adverse Event|0
216943|NCT01811706|706760|P1|First Intervention ( 4 Weeks)|Adverse Event|1
216944|NCT01811563|706777|P2|Overall Study|Incorrect Randomization procedure|1
216945|NCT01811563|706778|P1|Overall Study|Incorrect Randomization procedure|0
216946|NCT01811563|706777|P2|Overall Study|Lost to Follow-up|2
216947|NCT01811563|706778|P1|Overall Study|Lost to Follow-up|5
216948|NCT01811485|706807|P3|Overall Study|Protocol Deviation|0
216949|NCT01811485|706808|P2|Overall Study|Protocol Deviation|1
216950|NCT01811485|706809|P1|Overall Study|Protocol Deviation|0
216951|NCT01811485|706807|P3|Overall Study|Administrative problems|0
216952|NCT01811485|706808|P2|Overall Study|Administrative problems|0
216953|NCT01811485|706809|P1|Overall Study|Administrative problems|1
216954|NCT01811485|706807|P3|Overall Study|Unsatisfactory therapeutic effect|3
216955|NCT01811485|706808|P2|Overall Study|Unsatisfactory therapeutic effect|0
216956|NCT01811485|706809|P1|Overall Study|Unsatisfactory therapeutic effect|0
216957|NCT01811485|706807|P3|Overall Study|Adverse Event|2
216958|NCT01811485|706808|P2|Overall Study|Adverse Event|3
216959|NCT01811485|706809|P1|Overall Study|Adverse Event|1
216960|NCT01811472|706829|P3|Overall Study|Subject/guardian decision|0
216961|NCT01811472|706830|P2|Overall Study|Subject/guardian decision|0
216962|NCT01811472|706831|P1|Overall Study|Subject/guardian decision|1
216963|NCT01811472|706829|P3|Overall Study|Lost to Follow-up|1
216964|NCT01811472|706830|P2|Overall Study|Lost to Follow-up|0
216965|NCT01811472|706831|P1|Overall Study|Lost to Follow-up|0
216966|NCT01811472|706829|P3|Overall Study|Adverse Event|4
216967|NCT01811472|706830|P2|Overall Study|Adverse Event|0
216968|NCT01811472|706831|P1|Overall Study|Adverse Event|1
216969|NCT01811238|706887|P1|Overall Study|subject refused study medication|6
216970|NCT01811238|706887|P1|Overall Study|Lack of Efficacy|4
216971|NCT01811238|706887|P1|Overall Study|Protocol Violation|4
216972|NCT01811238|706887|P1|Overall Study|Adverse Event|25
216973|NCT01811238|706887|P1|Overall Study|Withdrawal by Subject|42
216974|NCT01811186|706898|P2|Overall Study|Lost to Follow-up|2
216975|NCT01811186|706899|P1|Overall Study|Lost to Follow-up|4
216976|NCT01811186|706898|P2|Overall Study|Lack of Efficacy|6
216977|NCT01811186|706899|P1|Overall Study|Lack of Efficacy|3
216978|NCT01811186|706898|P2|Overall Study|Withdrawal by Subject|10
216979|NCT01811186|706899|P1|Overall Study|Withdrawal by Subject|5
216980|NCT01811186|706898|P2|Overall Study|Protocol Violation|6
216981|NCT01811186|706899|P1|Overall Study|Protocol Violation|5
216982|NCT01811186|706898|P2|Overall Study|Adverse Event|38
216983|NCT01811186|706899|P1|Overall Study|Adverse Event|54
216984|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
216985|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
216986|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
216987|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
216988|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
216989|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
216990|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
216991|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
216992|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
216993|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
216994|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
216995|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
216996|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
216997|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
216998|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
216999|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
217000|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
217001|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
217002|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Death|1
217003|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Death|0
217004|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Death|0
217005|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
217006|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
217007|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
217008|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
217009|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
217010|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
217011|NCT01810939|706932|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
217012|NCT01810939|706933|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
217013|NCT01810939|706934|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
217014|NCT01810939|706932|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
217015|NCT01810939|706933|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
217016|NCT01810939|706934|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
217017|NCT01810939|706932|P3|Part A Treatment Period|Protocol-specified (High K+)|0
217018|NCT01810939|706933|P2|Part A Treatment Period|Protocol-specified (High K+)|0
217019|NCT01810939|706934|P1|Part A Treatment Period|Protocol-specified (High K+)|3
217020|NCT01810939|706932|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
217021|NCT01810939|706933|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
217022|NCT01810939|706934|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
217023|NCT01810939|706932|P3|Part A Treatment Period|Withdrawal by Subject|0
217024|NCT01810939|706933|P2|Part A Treatment Period|Withdrawal by Subject|0
217025|NCT01810939|706934|P1|Part A Treatment Period|Withdrawal by Subject|5
217026|NCT01810939|706932|P3|Part A Treatment Period|Adverse Event|0
217027|NCT01810939|706933|P2|Part A Treatment Period|Adverse Event|0
217028|NCT01810939|706934|P1|Part A Treatment Period|Adverse Event|10
217029|NCT01810939|706932|P3|Part A Treatment Period|Protocol Violation|0
217030|NCT01810939|706933|P2|Part A Treatment Period|Protocol Violation|0
217031|NCT01810939|706934|P1|Part A Treatment Period|Protocol Violation|2
217032|NCT01810939|706932|P3|Part A Treatment Period|Non-compliance with Study Drug|0
217033|NCT01810939|706933|P2|Part A Treatment Period|Non-compliance with Study Drug|0
217034|NCT01810939|706934|P1|Part A Treatment Period|Non-compliance with Study Drug|1
217035|NCT01810783|706947|P1|Overall Study|Enrolled, not treated|1
217036|NCT01810783|706947|P1|Overall Study|Adminstrative or other reason(s)|23
217037|NCT01810783|706947|P1|Overall Study|Non-compliance with IMP|4
217038|NCT01810783|706947|P1|Overall Study|Protocol Violation|5
217039|NCT01810783|706947|P1|Overall Study|Lost to Follow-up|10
217040|NCT01810783|706947|P1|Overall Study|Lack of Efficacy|12
217041|NCT01810783|706947|P1|Overall Study|Withdrawal by Subject|22
217042|NCT01810783|706947|P1|Overall Study|Adverse Event|32
217043|NCT01810380|706975|P3|Overall Study|Administrative or other reasons|9
217044|NCT01810380|706976|P2|Overall Study|Administrative or other reasons|13
217045|NCT01810380|706977|P1|Overall Study|Administrative or other reasons|11
217046|NCT01810380|706975|P3|Overall Study|Withdrawal by Subject|6
217047|NCT01810380|706976|P2|Overall Study|Withdrawal by Subject|0
217048|NCT01810380|706977|P1|Overall Study|Withdrawal by Subject|6
217049|NCT01810380|706975|P3|Overall Study|Protocol Violation|1
217050|NCT01810380|706976|P2|Overall Study|Protocol Violation|0
217051|NCT01810380|706977|P1|Overall Study|Protocol Violation|1
217052|NCT01810380|706975|P3|Overall Study|Lack of Efficacy|11
217053|NCT01810380|706976|P2|Overall Study|Lack of Efficacy|10
217054|NCT01810380|706977|P1|Overall Study|Lack of Efficacy|24
217055|NCT01810380|706975|P3|Overall Study|Adverse Event|4
217056|NCT01810380|706976|P2|Overall Study|Adverse Event|14
217057|NCT01810380|706977|P1|Overall Study|Adverse Event|11
217058|NCT01810380|706975|P3|Overall Study|Randomised not treated|1
217059|NCT01810380|706976|P2|Overall Study|Randomised not treated|1
217060|NCT01810380|706977|P1|Overall Study|Randomised not treated|2
217061|NCT01810302|707038|P2|Overall Study|Physician Decision|1
217062|NCT01810302|707039|P1|Overall Study|Physician Decision|0
217063|NCT01810302|707038|P2|Overall Study|Death|0
217064|NCT01810302|707039|P1|Overall Study|Death|1
217065|NCT01810263|707058|P2|Overall Study|Lost to Follow-up|7
217066|NCT01810263|707059|P1|Overall Study|Lost to Follow-up|8
217067|NCT01810042|707065|P1|Overall Study|Lost to Follow-up|10
217068|NCT01809327|707120|P5|Overall Study|Unspecified|9
217069|NCT01809327|707121|P4|Overall Study|Unspecified|4
217070|NCT01809327|707122|P3|Overall Study|Unspecified|7
217071|NCT01809327|707123|P2|Overall Study|Unspecified|15
217072|NCT01809327|707124|P1|Overall Study|Unspecified|14
217073|NCT01809327|707120|P5|Overall Study|Pregnancy|0
217074|NCT01809327|707121|P4|Overall Study|Pregnancy|0
217075|NCT01809327|707122|P3|Overall Study|Pregnancy|0
217076|NCT01809327|707123|P2|Overall Study|Pregnancy|0
217077|NCT01809327|707124|P1|Overall Study|Pregnancy|1
217078|NCT01809327|707120|P5|Overall Study|Physician Decision|0
217079|NCT01809327|707121|P4|Overall Study|Physician Decision|0
217080|NCT01809327|707122|P3|Overall Study|Physician Decision|0
217081|NCT01809327|707123|P2|Overall Study|Physician Decision|1
217082|NCT01809327|707124|P1|Overall Study|Physician Decision|1
217083|NCT01809327|707120|P5|Overall Study|Protocol Violation|0
217084|NCT01809327|707121|P4|Overall Study|Protocol Violation|0
217085|NCT01809327|707122|P3|Overall Study|Protocol Violation|0
217086|NCT01809327|707123|P2|Overall Study|Protocol Violation|1
217087|NCT01809327|707124|P1|Overall Study|Protocol Violation|0
217088|NCT01809327|707120|P5|Overall Study|Death|0
217089|NCT01809327|707121|P4|Overall Study|Death|0
217090|NCT01809327|707122|P3|Overall Study|Death|0
217091|NCT01809327|707123|P2|Overall Study|Death|0
217092|NCT01809327|707124|P1|Overall Study|Death|1
217093|NCT01809327|707120|P5|Overall Study|Adverse Event|8
217094|NCT01809327|707121|P4|Overall Study|Adverse Event|4
217095|NCT01809327|707122|P3|Overall Study|Adverse Event|7
217096|NCT01809327|707123|P2|Overall Study|Adverse Event|3
217097|NCT01809327|707124|P1|Overall Study|Adverse Event|4
217098|NCT01809327|707120|P5|Overall Study|Withdrawal by Subject|5
217099|NCT01809327|707121|P4|Overall Study|Withdrawal by Subject|2
217100|NCT01809327|707122|P3|Overall Study|Withdrawal by Subject|4
217101|NCT01809327|707123|P2|Overall Study|Withdrawal by Subject|4
217102|NCT01809327|707124|P1|Overall Study|Withdrawal by Subject|6
217103|NCT01809327|707120|P5|Overall Study|Lost to Follow-up|3
217104|NCT01809327|707121|P4|Overall Study|Lost to Follow-up|2
217105|NCT01809327|707122|P3|Overall Study|Lost to Follow-up|4
217106|NCT01809327|707123|P2|Overall Study|Lost to Follow-up|2
217107|NCT01809327|707124|P1|Overall Study|Lost to Follow-up|5
217108|NCT01809314|707166|P1|Overall Study|Lost to Follow-up|724
217109|NCT01809314|707166|P1|Overall Study|Insufficient Therapeutic Response|14
217110|NCT01809314|707166|P1|Overall Study|Adverse Event|6
217111|NCT01809314|707166|P1|Overall Study|Withdrawal Prior to Treatment|1
217112|NCT01809262|707172|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
217113|NCT01809262|707173|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
217114|NCT01809262|707174|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
217115|NCT01809262|707175|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
217116|NCT01809262|707176|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
217117|NCT01809262|707177|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
217118|NCT01809262|707178|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
217119|NCT01809262|707179|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
217120|NCT01809262|707180|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
217121|NCT01809262|707181|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
217122|NCT01809262|707172|P10|Period 1 (First Dose + Washout)|Adverse Event|0
217123|NCT01809262|707173|P9|Period 1 (First Dose + Washout)|Adverse Event|0
217124|NCT01809262|707174|P8|Period 1 (First Dose + Washout)|Adverse Event|0
217125|NCT01809262|707175|P7|Period 1 (First Dose + Washout)|Adverse Event|0
217126|NCT01809262|707176|P6|Period 1 (First Dose + Washout)|Adverse Event|0
217127|NCT01809262|707177|P5|Period 1 (First Dose + Washout)|Adverse Event|1
217128|NCT01809262|707178|P4|Period 1 (First Dose + Washout)|Adverse Event|0
217129|NCT01809262|707179|P3|Period 1 (First Dose + Washout)|Adverse Event|0
217130|NCT01809262|707180|P2|Period 1 (First Dose + Washout)|Adverse Event|0
217131|NCT01809262|707181|P1|Period 1 (First Dose + Washout)|Adverse Event|0
217132|NCT01809197|707250|P2|Overall Study|Product not available|1
217133|NCT01809197|707251|P1|Overall Study|Product not available|0
217134|NCT01809197|707250|P2|Overall Study|Withdrawal by Subject|1
217135|NCT01809197|707251|P1|Overall Study|Withdrawal by Subject|1
217136|NCT01809197|707250|P2|Overall Study|Decision Unrelated to an Adverse Event|0
217137|NCT01809197|707251|P1|Overall Study|Decision Unrelated to an Adverse Event|1
217138|NCT01809197|707250|P2|Overall Study|Non-Compliance|1
217139|NCT01809197|707251|P1|Overall Study|Non-Compliance|1
217140|NCT01809197|707250|P2|Overall Study|Failed slit lamp exam|0
217141|NCT01809197|707251|P1|Overall Study|Failed slit lamp exam|1
217142|NCT01809197|707250|P2|Overall Study|Adverse Event|3
217143|NCT01809197|707251|P1|Overall Study|Adverse Event|2
217144|NCT01809197|707250|P2|Overall Study|Lost to Follow-up|2
217145|NCT01809197|707251|P1|Overall Study|Lost to Follow-up|4
217146|NCT01808651|707322|P3|Study Period 1|Participant Decision|3
217147|NCT01808651|707323|P2|Study Period 1|Participant Decision|7
217148|NCT01808651|707324|P1|Study Period 1|Participant Decision|9
217149|NCT01808651|707322|P3|Study Period 1|Adverse Event|1
217150|NCT01808651|707323|P2|Study Period 1|Adverse Event|4
217151|NCT01808651|707324|P1|Study Period 1|Adverse Event|10
217152|NCT01808651|707322|P3|Study Period 1|Lack of Efficacy|0
217153|NCT01808651|707323|P2|Study Period 1|Lack of Efficacy|1
217154|NCT01808651|707324|P1|Study Period 1|Lack of Efficacy|2
217155|NCT01808651|707322|P3|Study Period 1|Physician Decision|0
217156|NCT01808651|707323|P2|Study Period 1|Physician Decision|2
217157|NCT01808651|707324|P1|Study Period 1|Physician Decision|3
217158|NCT01808651|707322|P3|Study Period 1|Protocol Violation|1
217159|NCT01808651|707323|P2|Study Period 1|Protocol Violation|0
217160|NCT01808651|707324|P1|Study Period 1|Protocol Violation|1
217161|NCT01808651|707322|P3|Study Period 1|Lost to Follow-up|0
217162|NCT01808651|707323|P2|Study Period 1|Lost to Follow-up|3
217163|NCT01808651|707324|P1|Study Period 1|Lost to Follow-up|1
217164|NCT01808612|707359|P3|Discontinuation Period|Lost to Follow-up|0
217165|NCT01808612|707360|P2|Discontinuation Period|Lost to Follow-up|1
217166|NCT01808612|707361|P1|Discontinuation Period|Lost to Follow-up|0
217167|NCT01808612|707359|P3|Discontinuation Period|Physician Decision|0
217168|NCT01808612|707360|P2|Discontinuation Period|Physician Decision|0
217169|NCT01808612|707361|P1|Discontinuation Period|Physician Decision|1
217170|NCT01808612|707359|P3|Discontinuation Period|Adverse Event|0
217171|NCT01808612|707360|P2|Discontinuation Period|Adverse Event|0
217172|NCT01808612|707361|P1|Discontinuation Period|Adverse Event|1
217173|NCT01808612|707359|P3|Treatment Period|Lack of Efficacy|2
217174|NCT01808612|707360|P2|Treatment Period|Lack of Efficacy|1
217175|NCT01808612|707361|P1|Treatment Period|Lack of Efficacy|1
217176|NCT01808612|707359|P3|Treatment Period|Sponsor Decision|0
217177|NCT01808612|707360|P2|Treatment Period|Sponsor Decision|0
217178|NCT01808612|707361|P1|Treatment Period|Sponsor Decision|1
217179|NCT01808612|707359|P3|Treatment Period|Physician Decision|4
217180|NCT01808612|707360|P2|Treatment Period|Physician Decision|0
217181|NCT01808612|707361|P1|Treatment Period|Physician Decision|1
217182|NCT01808612|707359|P3|Treatment Period|Withdrawal by Subject|4
217183|NCT01808612|707360|P2|Treatment Period|Withdrawal by Subject|0
217184|NCT01808612|707361|P1|Treatment Period|Withdrawal by Subject|1
217185|NCT01808612|707359|P3|Treatment Period|Protocol Violation|0
217186|NCT01808612|707360|P2|Treatment Period|Protocol Violation|0
217187|NCT01808612|707361|P1|Treatment Period|Protocol Violation|1
217188|NCT01808612|707359|P3|Treatment Period|Lost to Follow-up|1
217189|NCT01808612|707360|P2|Treatment Period|Lost to Follow-up|2
217190|NCT01808612|707361|P1|Treatment Period|Lost to Follow-up|2
217191|NCT01808612|707359|P3|Treatment Period|Adverse Event|3
217192|NCT01808612|707360|P2|Treatment Period|Adverse Event|4
217193|NCT01808612|707361|P1|Treatment Period|Adverse Event|8
217194|NCT01808534|707399|P1|Overall Study|Physician Decision|1
217195|NCT01808534|707399|P1|Overall Study|Disease progression|3
217196|NCT01808508|707410|P3|Overall Study|Lost to Follow-up|0
217197|NCT01808508|707411|P2|Overall Study|Lost to Follow-up|0
217198|NCT01808508|707412|P1|Overall Study|Lost to Follow-up|1
217199|NCT01808339|707429|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
217200|NCT01808339|707430|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
217201|NCT01808339|707431|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
217202|NCT01808339|707432|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
217203|NCT01808339|707433|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
217204|NCT01808339|707434|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
217205|NCT01808339|707429|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
217206|NCT01808339|707430|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
217207|NCT01808339|707431|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
217208|NCT01808339|707432|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
217209|NCT01808339|707433|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
217210|NCT01808339|707434|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
217211|NCT01808339|707429|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
217212|NCT01808339|707430|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
217213|NCT01808339|707431|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
217214|NCT01808339|707432|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
217215|NCT01808339|707433|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
217216|NCT01808339|707434|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
217217|NCT01808313|707478|P1|Overall Study|Physician Decision|1
217218|NCT01808313|707478|P1|Overall Study|Lost to Follow-up|1
217219|NCT01808313|707478|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
217220|NCT01808313|707478|P1|Overall Study|Protocol Violation|2
217221|NCT01808313|707478|P1|Overall Study|Adverse Event|5
217222|NCT01808248|707508|P1|Overall Study|Lost to Follow-up|1
217223|NCT01808248|707508|P1|Overall Study|Withdrawal by Subject|1
217224|NCT01808248|707508|P1|Overall Study|Lack of Efficacy|3
217225|NCT01808209|707522|P2|Overall Study|Lost to Follow-up|1
217226|NCT01808209|707523|P1|Overall Study|Lost to Follow-up|0
217227|NCT01808092|707567|P2|Overall Study|Other Eligibility criteria|5
217228|NCT01808092|707568|P1|Overall Study|Other Eligibility criteria|3
217229|NCT01808092|707567|P2|Overall Study|Withdrawal by Subject|4
217230|NCT01808092|707568|P1|Overall Study|Withdrawal by Subject|9
217231|NCT01808092|707567|P2|Overall Study|Lost to Follow-up|7
217232|NCT01808092|707568|P1|Overall Study|Lost to Follow-up|3
217233|NCT01808092|707567|P2|Overall Study|Death|29
217234|NCT01808092|707568|P1|Overall Study|Death|39
217235|NCT01808066|707670|P1|Overall Study|Withdrawal by Subject|15
217236|NCT01807949|707677|P3|Overall Study|Randomized But Not Treated|2
217237|NCT01807949|707678|P2|Overall Study|Randomized But Not Treated|2
217238|NCT01807949|707679|P1|Overall Study|Randomized But Not Treated|0
217239|NCT01807949|707677|P3|Overall Study|Undefined|2
217240|NCT01807949|707678|P2|Overall Study|Undefined|1
217241|NCT01807949|707679|P1|Overall Study|Undefined|0
217242|NCT01807949|707677|P3|Overall Study|Non-Compliance|1
217243|NCT01807949|707678|P2|Overall Study|Non-Compliance|0
217244|NCT01807949|707679|P1|Overall Study|Non-Compliance|0
217245|NCT01807949|707677|P3|Overall Study|Withdrawal by Subject|2
217246|NCT01807949|707678|P2|Overall Study|Withdrawal by Subject|2
217247|NCT01807949|707679|P1|Overall Study|Withdrawal by Subject|1
217248|NCT01807949|707677|P3|Overall Study|Adverse Event|2
217249|NCT01807949|707678|P2|Overall Study|Adverse Event|2
217250|NCT01807949|707679|P1|Overall Study|Adverse Event|1
217251|NCT01807923|707731|P3|Overall Study|Randomized But Not Treated|5
217252|NCT01807923|707732|P2|Overall Study|Randomized But Not Treated|2
217253|NCT01807923|707733|P1|Overall Study|Randomized But Not Treated|3
217254|NCT01807923|707731|P3|Overall Study|Not Eligible (Genotype)|1
217255|NCT01807923|707732|P2|Overall Study|Not Eligible (Genotype)|0
217256|NCT01807923|707733|P1|Overall Study|Not Eligible (Genotype)|0
217257|NCT01807923|707731|P3|Overall Study|Physician Decision|1
217258|NCT01807923|707732|P2|Overall Study|Physician Decision|0
217259|NCT01807923|707733|P1|Overall Study|Physician Decision|0
217260|NCT01807923|707731|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
217261|NCT01807923|707732|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
217262|NCT01807923|707733|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
217263|NCT01807923|707731|P3|Overall Study|Adverse Event|2
217264|NCT01807923|707732|P2|Overall Study|Adverse Event|1
217265|NCT01807923|707733|P1|Overall Study|Adverse Event|2
217266|NCT01807234|707825|P6|Overall Study|Lack of Efficacy|1
217267|NCT01807234|707826|P5|Overall Study|Lack of Efficacy|1
217268|NCT01807234|707827|P4|Overall Study|Lack of Efficacy|0
217269|NCT01807234|707828|P3|Overall Study|Lack of Efficacy|0
217270|NCT01807234|707829|P2|Overall Study|Lack of Efficacy|0
217271|NCT01807234|707830|P1|Overall Study|Lack of Efficacy|0
217272|NCT01807234|707825|P6|Overall Study|Withdrawal by Subject|1
217273|NCT01807234|707826|P5|Overall Study|Withdrawal by Subject|2
217274|NCT01807234|707827|P4|Overall Study|Withdrawal by Subject|1
217275|NCT01807234|707828|P3|Overall Study|Withdrawal by Subject|1
217276|NCT01807234|707829|P2|Overall Study|Withdrawal by Subject|1
217277|NCT01807234|707830|P1|Overall Study|Withdrawal by Subject|3
217278|NCT01807234|707825|P6|Overall Study|Lost to Follow-up|2
217279|NCT01807234|707826|P5|Overall Study|Lost to Follow-up|1
217280|NCT01807234|707827|P4|Overall Study|Lost to Follow-up|1
217281|NCT01807234|707828|P3|Overall Study|Lost to Follow-up|1
217282|NCT01807234|707829|P2|Overall Study|Lost to Follow-up|5
217283|NCT01807234|707830|P1|Overall Study|Lost to Follow-up|2
217284|NCT01807156|707865|P1|Overall Study|Physician Decision|1
217285|NCT01806961|707889|P1|Overall Study|sponsor decision|16
217286|NCT01806779|707932|P3|Overall Study|Withdrawal by Subject|22
217287|NCT01806779|707933|P2|Overall Study|Withdrawal by Subject|23
217288|NCT01806779|707934|P1|Overall Study|Withdrawal by Subject|20
217289|NCT01806779|707932|P3|Overall Study|Lost to Follow-up|0
217290|NCT01806779|707933|P2|Overall Study|Lost to Follow-up|20
217291|NCT01806779|707934|P1|Overall Study|Lost to Follow-up|19
217292|NCT01806779|707932|P3|Overall Study|Lack of Efficacy|0
217293|NCT01806779|707933|P2|Overall Study|Lack of Efficacy|1
217294|NCT01806779|707934|P1|Overall Study|Lack of Efficacy|1
217295|NCT01806779|707932|P3|Overall Study|Physician Decision|1
217296|NCT01806779|707933|P2|Overall Study|Physician Decision|0
217297|NCT01806779|707934|P1|Overall Study|Physician Decision|2
217298|NCT01806623|707947|P1|Overall Study|Did not meet the inclusion criteria|56
217299|NCT01806623|707947|P1|Overall Study|Adverse Event|1
217300|NCT01806623|707947|P1|Overall Study|Withdrawal by Subject|1
217301|NCT01806584|707966|P2|Overall Study|Other unspecified|0
217302|NCT01806584|707967|P1|Overall Study|Other unspecified|1
217303|NCT01806584|707966|P2|Overall Study|Withdrawal by Subject|1
217304|NCT01806584|707967|P1|Overall Study|Withdrawal by Subject|1
217305|NCT01806584|707966|P2|Overall Study|Study terminated by sponsor|14
217306|NCT01806584|707967|P1|Overall Study|Study terminated by sponsor|9
217307|NCT01806584|707966|P2|Overall Study|Lost to Follow-up|2
217308|NCT01806584|707967|P1|Overall Study|Lost to Follow-up|0
217309|NCT01806584|707966|P2|Overall Study|Death|0
217310|NCT01806584|707967|P1|Overall Study|Death|1
217311|NCT01806584|707966|P2|Overall Study|Adverse Event|1
217312|NCT01806584|707967|P1|Overall Study|Adverse Event|2
217313|NCT01806545|707981|P2|Overall Study|Withdrawal by Subject|2
217314|NCT01806545|707982|P1|Overall Study|Withdrawal by Subject|3
217315|NCT01806545|707981|P2|Overall Study|Lost to Follow-up|0
217316|NCT01806545|707982|P1|Overall Study|Lost to Follow-up|1
217317|NCT01806545|707981|P2|Overall Study|Adverse Event|3
217318|NCT01806545|707982|P1|Overall Study|Adverse Event|2
217319|NCT01806389|708004|P1|Overall Study|Withdrawal by Subject|4
217320|NCT01806298|708018|P1|Overall Study|Other|5
217321|NCT01806298|708018|P1|Overall Study|Withdrawal by Subject|1
217322|NCT01806298|708018|P1|Overall Study|Protocol Non-compliance|1
217323|NCT01806298|708018|P1|Overall Study|Adverse Event|3
217324|NCT01806051|708028|P1|Overall Study|Withdrawal by Subject|6
217325|NCT01805180|708082|P3|Lead-in Donor Phase|screen failure|0
217326|NCT01805180|708083|P2|Lead-in Donor Phase|screen failure|0
217327|NCT01805180|708084|P1|Lead-in Donor Phase|screen failure|1
217328|NCT01804946|708122|P2|Overall Study|Do not meet inclusion criteria|2
217329|NCT01804946|708123|P1|Overall Study|Do not meet inclusion criteria|1
217330|NCT01804946|708122|P2|Overall Study|Insufficient data available|1
217331|NCT01804946|708123|P1|Overall Study|Insufficient data available|0
217332|NCT01804946|708122|P2|Overall Study|Adverse Event|1
217333|NCT01804946|708123|P1|Overall Study|Adverse Event|0
217334|NCT01804946|708122|P2|Overall Study|Protocol Violation|0
217335|NCT01804946|708123|P1|Overall Study|Protocol Violation|1
217336|NCT01804842|708161|P3|Overall Study|Personal Reason|1
217337|NCT01804842|708162|P2|Overall Study|Personal Reason|0
217338|NCT01804842|708163|P1|Overall Study|Personal Reason|0
217339|NCT01804842|708161|P3|Overall Study|Non-Compliance|0
217340|NCT01804842|708162|P2|Overall Study|Non-Compliance|1
217341|NCT01804842|708163|P1|Overall Study|Non-Compliance|1
217342|NCT01804842|708161|P3|Overall Study|Lost to Follow-up|0
217343|NCT01804842|708162|P2|Overall Study|Lost to Follow-up|0
217344|NCT01804842|708163|P1|Overall Study|Lost to Follow-up|1
217345|NCT01804842|708161|P3|Overall Study|Adverse Event|0
217346|NCT01804842|708162|P2|Overall Study|Adverse Event|1
217347|NCT01804842|708163|P1|Overall Study|Adverse Event|1
217348|NCT01804673|708180|P1|Overall Study|Unspecified|4
217349|NCT01804673|708180|P1|Overall Study|Use of Prohibited Medication|1
217350|NCT01804673|708180|P1|Overall Study|No Further Therapy Required|84
217351|NCT01804673|708180|P1|Overall Study|Change to Oral Therapy|37
217352|NCT01804673|708180|P1|Overall Study|Lack of Efficacy|9
217353|NCT01804673|708180|P1|Overall Study|Withdrawal by Subject|1
217354|NCT01804673|708180|P1|Overall Study|Adverse Event|4
217355|NCT01804140|708200|P1|Overall Study|No sampling or biopsy procedures done|114
217356|NCT01803737|708247|P2|Overall Study|Lost to Follow-up|2
217357|NCT01803737|708248|P1|Overall Study|Lost to Follow-up|0
217358|NCT01803737|708247|P2|Overall Study|Medical Reason|1
217359|NCT01803737|708248|P1|Overall Study|Medical Reason|0
217360|NCT01803737|708247|P2|Overall Study|Lack of Time|0
217361|NCT01803737|708248|P1|Overall Study|Lack of Time|1
217362|NCT01803607|708272|P2|Overall Study|Withdrawal by Subject|5
217363|NCT01803607|708273|P1|Overall Study|Withdrawal by Subject|6
217364|NCT01803607|708272|P2|Overall Study|Study terminated by sponsor|56
217365|NCT01803607|708273|P1|Overall Study|Study terminated by sponsor|54
217366|NCT01803607|708272|P2|Overall Study|Protocol Violation|2
217367|NCT01803607|708273|P1|Overall Study|Protocol Violation|3
217368|NCT01803607|708272|P2|Overall Study|Lack of Efficacy|1
217369|NCT01803607|708273|P1|Overall Study|Lack of Efficacy|0
217370|NCT01803607|708272|P2|Overall Study|Adverse Event|3
217371|NCT01803607|708273|P1|Overall Study|Adverse Event|5
217372|NCT01802632|708299|P6|Overall Study|Other (not specified)|1
217373|NCT01802632|708300|P5|Overall Study|Other (not specified)|0
217374|NCT01802632|708301|P4|Overall Study|Other (not specified)|1
217375|NCT01802632|708302|P3|Overall Study|Other (not specified)|7
217376|NCT01802632|708303|P2|Overall Study|Other (not specified)|0
217377|NCT01802632|708304|P1|Overall Study|Other (not specified)|0
217378|NCT01802632|708299|P6|Overall Study|Ongoing Study at Data Cut-off|22
217379|NCT01802632|708300|P5|Overall Study|Ongoing Study at Data Cut-off|6
217380|NCT01802632|708301|P4|Overall Study|Ongoing Study at Data Cut-off|50
217381|NCT01802632|708302|P3|Overall Study|Ongoing Study at Data Cut-off|115
217382|NCT01802632|708303|P2|Overall Study|Ongoing Study at Data Cut-off|16
217383|NCT01802632|708304|P1|Overall Study|Ongoing Study at Data Cut-off|168
217384|NCT01802632|708299|P6|Overall Study|Objective Disease Progression|4
217385|NCT01802632|708300|P5|Overall Study|Objective Disease Progression|4
217386|NCT01802632|708301|P4|Overall Study|Objective Disease Progression|6
217387|NCT01802632|708302|P3|Overall Study|Objective Disease Progression|104
217388|NCT01802632|708303|P2|Overall Study|Objective Disease Progression|12
217389|NCT01802632|708304|P1|Overall Study|Objective Disease Progression|1
217390|NCT01802632|708299|P6|Overall Study|Withdrawal by Subject|1
217391|NCT01802632|708300|P5|Overall Study|Withdrawal by Subject|0
217392|NCT01802632|708301|P4|Overall Study|Withdrawal by Subject|3
217393|NCT01802632|708302|P3|Overall Study|Withdrawal by Subject|7
217394|NCT01802632|708303|P2|Overall Study|Withdrawal by Subject|2
217395|NCT01802632|708304|P1|Overall Study|Withdrawal by Subject|4
217396|NCT01802632|708299|P6|Overall Study|Death|0
217397|NCT01802632|708300|P5|Overall Study|Death|2
217398|NCT01802632|708301|P4|Overall Study|Death|0
217399|NCT01802632|708302|P3|Overall Study|Death|38
217400|NCT01802632|708303|P2|Overall Study|Death|1
217401|NCT01802632|708304|P1|Overall Study|Death|28
217402|NCT01802515|708338|P3|Overall Study|Withdrawal by Subject|0
217403|NCT01802515|708339|P2|Overall Study|Withdrawal by Subject|0
217404|NCT01802515|708340|P1|Overall Study|Withdrawal by Subject|3
217405|NCT01802320|708351|P1|Overall Study|Withdrawal by Subject|1
217406|NCT01802320|708351|P1|Overall Study|Death|1
217407|NCT01801982|708424|P1|Overall Study|Lost to Follow-up|1
217408|NCT01801735|708434|P1|Overall Study|Other, including site closure|19
217409|NCT01801735|708434|P1|Overall Study|Death|1
217410|NCT01801735|708434|P1|Overall Study|Physician Decision|3
217411|NCT01801735|708434|P1|Overall Study|Non-compliance with Trial Drug|13
217412|NCT01801735|708434|P1|Overall Study|Lost to Follow-up|15
217413|NCT01801735|708434|P1|Overall Study|Protocol Violation|25
217414|NCT01801735|708434|P1|Overall Study|Withdrawal by Subject|27
217415|NCT01801735|708434|P1|Overall Study|Lack of Efficacy|28
217416|NCT01801735|708434|P1|Overall Study|Adverse Event|79
217417|NCT01801475|708441|P5|Overall Study|Withdrawal by Subject|1
217418|NCT01801475|708442|P4|Overall Study|Withdrawal by Subject|0
217419|NCT01801475|708443|P3|Overall Study|Withdrawal by Subject|0
217420|NCT01801475|708444|P2|Overall Study|Withdrawal by Subject|0
217421|NCT01801475|708445|P1|Overall Study|Withdrawal by Subject|0
217422|NCT01801436|708456|P1|Overall Study|Progressive disease|4
217423|NCT01801436|708456|P1|Overall Study|Adverse Event|2
217424|NCT01801436|708456|P1|Overall Study|Withdrawal by Subject|3
217425|NCT01801358|708494|P6|Overall Study|Withdrawal by Subject|2
217426|NCT01801358|708495|P5|Overall Study|Withdrawal by Subject|0
217427|NCT01801358|708496|P4|Overall Study|Withdrawal by Subject|1
217428|NCT01801358|708497|P3|Overall Study|Withdrawal by Subject|0
217429|NCT01801358|708498|P2|Overall Study|Withdrawal by Subject|0
217430|NCT01801358|708499|P1|Overall Study|Withdrawal by Subject|0
217431|NCT01801358|708494|P6|Overall Study|Progressive Disease|5
217432|NCT01801358|708495|P5|Overall Study|Progressive Disease|6
217433|NCT01801358|708496|P4|Overall Study|Progressive Disease|5
217434|NCT01801358|708497|P3|Overall Study|Progressive Disease|4
217435|NCT01801358|708498|P2|Overall Study|Progressive Disease|4
217436|NCT01801358|708499|P1|Overall Study|Progressive Disease|6
217437|NCT01801358|708494|P6|Overall Study|Physician Decision|0
217438|NCT01801358|708495|P5|Overall Study|Physician Decision|0
217439|NCT01801358|708496|P4|Overall Study|Physician Decision|0
217440|NCT01801358|708497|P3|Overall Study|Physician Decision|1
217441|NCT01801358|708498|P2|Overall Study|Physician Decision|0
217442|NCT01801358|708499|P1|Overall Study|Physician Decision|0
217443|NCT01801358|708494|P6|Overall Study|Adverse Event|1
217444|NCT01801358|708495|P5|Overall Study|Adverse Event|0
217445|NCT01801358|708496|P4|Overall Study|Adverse Event|0
217446|NCT01801358|708497|P3|Overall Study|Adverse Event|1
217447|NCT01801358|708498|P2|Overall Study|Adverse Event|2
217448|NCT01801358|708499|P1|Overall Study|Adverse Event|0
217449|NCT01801280|708621|P4|Period 4|Protocol Violation|0
217450|NCT01801280|708622|P3|Period 4|Protocol Violation|1
217451|NCT01801280|708623|P2|Period 4|Protocol Violation|0
217452|NCT01801280|708624|P1|Period 4|Protocol Violation|0
217453|NCT01801280|708621|P4|Period 2|Withdrawal by Subject|0
217454|NCT01801280|708622|P3|Period 2|Withdrawal by Subject|0
217455|NCT01801280|708623|P2|Period 2|Withdrawal by Subject|0
217456|NCT01801280|708624|P1|Period 2|Withdrawal by Subject|1
217457|NCT01801280|708621|P4|Period 1|Withdrawal by Subject|0
217458|NCT01801280|708622|P3|Period 1|Withdrawal by Subject|0
217459|NCT01801280|708623|P2|Period 1|Withdrawal by Subject|1
217460|NCT01801280|708624|P1|Period 1|Withdrawal by Subject|0
217461|NCT01801111|708639|P1|Overall Study|On-going Survival Follow up|25
217462|NCT01801111|708639|P1|Overall Study|Death|24
217463|NCT01801111|708639|P1|Overall Study|Treatment On-going|89
217464|NCT01800968|708664|P2|Overall Study|Physician Decision|0
217465|NCT01800968|708665|P1|Overall Study|Physician Decision|1
217466|NCT01800968|708664|P2|Overall Study|Withdrawal by Subject|9
217467|NCT01800968|708665|P1|Overall Study|Withdrawal by Subject|7
217468|NCT01800968|708664|P2|Overall Study|Lost to Follow-up|7
217469|NCT01800968|708665|P1|Overall Study|Lost to Follow-up|5
217470|NCT01800968|708664|P2|Overall Study|Death|16
217471|NCT01800968|708665|P1|Overall Study|Death|23
217472|NCT01800916|708707|P9|Test Period 1 (1 Week)|Adverse Event|0
217473|NCT01800916|708708|P8|Test Period 1 (1 Week)|Adverse Event|0
217474|NCT01800916|708709|P7|Test Period 1 (1 Week)|Adverse Event|0
217475|NCT01800916|708710|P6|Test Period 1 (1 Week)|Adverse Event|0
217476|NCT01800916|708711|P5|Test Period 1 (1 Week)|Adverse Event|1
217477|NCT01800916|708712|P4|Test Period 1 (1 Week)|Adverse Event|0
217478|NCT01800916|708713|P3|Test Period 1 (1 Week)|Adverse Event|0
217479|NCT01800916|708714|P2|Test Period 1 (1 Week)|Adverse Event|0
217480|NCT01800916|708715|P1|Test Period 1 (1 Week)|Adverse Event|0
217481|NCT01800916|708707|P9|Test Period 1 (1 Week)|Convex product user|0
217482|NCT01800916|708708|P8|Test Period 1 (1 Week)|Convex product user|0
217483|NCT01800916|708709|P7|Test Period 1 (1 Week)|Convex product user|0
217484|NCT01800916|708710|P6|Test Period 1 (1 Week)|Convex product user|0
217485|NCT01800916|708711|P5|Test Period 1 (1 Week)|Convex product user|0
217486|NCT01800916|708712|P4|Test Period 1 (1 Week)|Convex product user|1
217487|NCT01800916|708713|P3|Test Period 1 (1 Week)|Convex product user|0
217488|NCT01800916|708714|P2|Test Period 1 (1 Week)|Convex product user|0
217489|NCT01800916|708715|P1|Test Period 1 (1 Week)|Convex product user|0
217490|NCT01800903|708725|P6|Second Test Period|unable to catheterise|0
217491|NCT01800903|708726|P5|Second Test Period|unable to catheterise|0
217492|NCT01800903|708727|P4|Second Test Period|unable to catheterise|0
217493|NCT01800903|708728|P3|Second Test Period|unable to catheterise|0
217494|NCT01800903|708729|P2|Second Test Period|unable to catheterise|0
217495|NCT01800903|708730|P1|Second Test Period|unable to catheterise|1
217496|NCT01799941|708807|P1|Overall Study|Not Specified|15
217497|NCT01799941|708807|P1|Overall Study|Lost to Follow-up|17
217498|NCT01799941|708807|P1|Overall Study|Lack of Efficacy|3
217499|NCT01799941|708807|P1|Overall Study|Investigator Decision|4
217500|NCT01799941|708807|P1|Overall Study|Death|2
217501|NCT01799941|708807|P1|Overall Study|Withdrawal by Subject|21
217502|NCT01799941|708807|P1|Overall Study|Adverse Event|34
217503|NCT01799720|708864|P3|Overall Study|Pregnancy|1
217504|NCT01799720|708865|P2|Overall Study|Pregnancy|0
217505|NCT01799720|708866|P1|Overall Study|Pregnancy|0
217506|NCT01799720|708864|P3|Overall Study|Protocol Violation|0
217507|NCT01799720|708865|P2|Overall Study|Protocol Violation|1
217508|NCT01799720|708866|P1|Overall Study|Protocol Violation|0
217509|NCT01799720|708864|P3|Overall Study|Withdrawal by Subject|0
217510|NCT01799720|708865|P2|Overall Study|Withdrawal by Subject|0
217511|NCT01799720|708866|P1|Overall Study|Withdrawal by Subject|3
217512|NCT01799590|708904|P3|Overall Study|Unspecified|1
217513|NCT01799590|708905|P2|Overall Study|Unspecified|0
217514|NCT01799590|708906|P1|Overall Study|Unspecified|3
217515|NCT01799590|708904|P3|Overall Study|Use of prohibited concomitant drugs|0
217516|NCT01799590|708905|P2|Overall Study|Use of prohibited concomitant drugs|0
217517|NCT01799590|708906|P1|Overall Study|Use of prohibited concomitant drugs|1
217518|NCT01799590|708904|P3|Overall Study|Using drugs with restricted days of use|2
217519|NCT01799590|708905|P2|Overall Study|Using drugs with restricted days of use|3
217520|NCT01799590|708906|P1|Overall Study|Using drugs with restricted days of use|0
217521|NCT01799590|708904|P3|Overall Study|Aggravation of complications|1
217522|NCT01799590|708905|P2|Overall Study|Aggravation of complications|1
217523|NCT01799590|708906|P1|Overall Study|Aggravation of complications|0
217524|NCT01799590|708904|P3|Overall Study|Participants convenience|2
217525|NCT01799590|708905|P2|Overall Study|Participants convenience|4
217526|NCT01799590|708906|P1|Overall Study|Participants convenience|4
217527|NCT01799590|708904|P3|Overall Study|Lack of Efficacy|3
217528|NCT01799590|708905|P2|Overall Study|Lack of Efficacy|1
217529|NCT01799590|708906|P1|Overall Study|Lack of Efficacy|3
217530|NCT01799590|708904|P3|Overall Study|Pregnancy|0
217531|NCT01799590|708905|P2|Overall Study|Pregnancy|0
217532|NCT01799590|708906|P1|Overall Study|Pregnancy|2
217533|NCT01799590|708904|P3|Overall Study|Adverse Event|5
217534|NCT01799590|708905|P2|Overall Study|Adverse Event|7
217535|NCT01799590|708906|P1|Overall Study|Adverse Event|13
217536|NCT01799239|708941|P2|Period 2 (7 Days)|Protocol Violation|0
217537|NCT01799239|708942|P1|Period 2 (7 Days)|Protocol Violation|1
217538|NCT01799239|708941|P2|Period 2 (7 Days)|Withdrawal by Subject|1
217539|NCT01799239|708942|P1|Period 2 (7 Days)|Withdrawal by Subject|1
217540|NCT01799239|708941|P2|Period 1 (7 Days)|Protocol Violation|1
217541|NCT01799239|708942|P1|Period 1 (7 Days)|Protocol Violation|0
217542|NCT01799239|708941|P2|Period 1 (7 Days)|Withdrawal by Subject|0
217543|NCT01799239|708942|P1|Period 1 (7 Days)|Withdrawal by Subject|2
217544|NCT01799239|708941|P2|Period 1 (7 Days)|Lack of Efficacy|0
217545|NCT01799239|708942|P1|Period 1 (7 Days)|Lack of Efficacy|1
217546|NCT01799226|708950|P2|Overall Study|Disqualified at Day 14|0
217547|NCT01799226|708951|P1|Overall Study|Disqualified at Day 14|1
217548|NCT01799226|708950|P2|Overall Study|Withdrawal by Subject|0
217549|NCT01799226|708951|P1|Overall Study|Withdrawal by Subject|1
217550|NCT01798992|708963|P4|Overall Study|Insufficient biopsy tissue|0
217551|NCT01798992|708964|P3|Overall Study|Insufficient biopsy tissue|1
217552|NCT01798992|708965|P2|Overall Study|Insufficient biopsy tissue|0
217553|NCT01798992|708966|P1|Overall Study|Insufficient biopsy tissue|0
217554|NCT01798992|708963|P4|Overall Study|Lost to Follow-up|0
217555|NCT01798992|708964|P3|Overall Study|Lost to Follow-up|1
217556|NCT01798992|708965|P2|Overall Study|Lost to Follow-up|1
217557|NCT01798992|708966|P1|Overall Study|Lost to Follow-up|0
217558|NCT01798992|708963|P4|Overall Study|Administrative withdrawal|1
217559|NCT01798992|708964|P3|Overall Study|Administrative withdrawal|0
217560|NCT01798992|708965|P2|Overall Study|Administrative withdrawal|1
217561|NCT01798992|708966|P1|Overall Study|Administrative withdrawal|0
217562|NCT01798927|708986|P1|Overall Study|Withdrawal by Subject|1
217563|NCT01798706|708994|P2|Overall Study|Other than specified above|9
217564|NCT01798706|708995|P1|Overall Study|Other than specified above|5
217565|NCT01798706|708994|P2|Overall Study|Poor compliance to protocol|0
217566|NCT01798706|708995|P1|Overall Study|Poor compliance to protocol|1
217567|NCT01798706|708994|P2|Overall Study|Lack of Efficacy|2
217568|NCT01798706|708995|P1|Overall Study|Lack of Efficacy|0
217569|NCT01798706|708994|P2|Overall Study|Adverse Event|10
217570|NCT01798706|708995|P1|Overall Study|Adverse Event|15
217571|NCT01798485|709023|P2|Overall Study|Clinical Progression|24
217572|NCT01798485|709024|P1|Overall Study|Clinical Progression|35
217573|NCT01798485|709023|P2|Overall Study|Sponsor Decision|54
217574|NCT01798485|709024|P1|Overall Study|Sponsor Decision|61
217575|NCT01798485|709023|P2|Overall Study|Death|22
217576|NCT01798485|709024|P1|Overall Study|Death|25
217577|NCT01798485|709023|P2|Overall Study|Objective Disease Progression|106
217578|NCT01798485|709024|P1|Overall Study|Objective Disease Progression|152
217579|NCT01798485|709023|P2|Overall Study|Physician Decision|10
217580|NCT01798485|709024|P1|Overall Study|Physician Decision|14
217581|NCT01798485|709023|P2|Overall Study|Lost to Follow-up|3
217582|NCT01798485|709024|P1|Overall Study|Lost to Follow-up|0
217583|NCT01798485|709023|P2|Overall Study|Withdrawal by Subject|31
217584|NCT01798485|709024|P1|Overall Study|Withdrawal by Subject|27
217585|NCT01798485|709023|P2|Overall Study|Adverse Event|40
217586|NCT01798485|709024|P1|Overall Study|Adverse Event|32
217587|NCT01798134|709129|P1|Overall Study|Liver transplant/surgery|4
217588|NCT01798134|709129|P1|Overall Study|Physician Decision|3
217589|NCT01798134|709129|P1|Overall Study|Adverse Event|3
217590|NCT01798134|709129|P1|Overall Study|Death|2
217591|NCT01798134|709129|P1|Overall Study|Withdrawal by Subject|3
217592|NCT01798134|709129|P1|Overall Study|Lost to Follow-up|1
217593|NCT01798004|709136|P1|Overall Study|Enrollment another COG therapeutic trial|32
217594|NCT01798004|709136|P1|Overall Study|Initiation of other non-protocol therapy|5
217595|NCT01798004|709136|P1|Overall Study|Patient/parent refusal|7
217596|NCT01798004|709136|P1|Overall Study|Ineligible|4
217597|NCT01798004|709136|P1|Overall Study|Withdrawal by Subject|4
217598|NCT01798004|709136|P1|Overall Study|Physician Decision|25
217599|NCT01798004|709136|P1|Overall Study|Lack of Efficacy|8
217600|NCT01798004|709136|P1|Overall Study|Death|2
217601|NCT01797783|709142|P2|Overall Study|Withdrawal by Subject|0
217602|NCT01797783|709143|P1|Overall Study|Withdrawal by Subject|1
217603|NCT01797783|709142|P2|Overall Study|Adverse Event|1
217604|NCT01797783|709143|P1|Overall Study|Adverse Event|1
217605|NCT01797705|709165|P1|Overall Study|Withdrawal by Subject|1
217606|NCT01797705|709165|P1|Overall Study|Equipment anomalies during sleep studies|4
217607|NCT01797536|709173|P4|Overall Study|Adverse Event|0
217608|NCT01797536|709174|P3|Overall Study|Adverse Event|0
217609|NCT01797536|709175|P2|Overall Study|Adverse Event|1
217610|NCT01797536|709176|P1|Overall Study|Adverse Event|0
217611|NCT01797445|709208|P2|Overall Study|Still on Study|383
217612|NCT01797445|709209|P1|Overall Study|Still on Study|381
217613|NCT01797445|709208|P2|Overall Study|Lost to Follow-up|15
217614|NCT01797445|709209|P1|Overall Study|Lost to Follow-up|22
217615|NCT01797445|709208|P2|Overall Study|Withdrew Consent|19
217616|NCT01797445|709209|P1|Overall Study|Withdrew Consent|12
217617|NCT01797445|709208|P2|Overall Study|Protocol Violation|1
217618|NCT01797445|709209|P1|Overall Study|Protocol Violation|0
217619|NCT01797445|709208|P2|Overall Study|Noncompliance with Study Drug|1
217620|NCT01797445|709209|P1|Overall Study|Noncompliance with Study Drug|3
217621|NCT01797445|709208|P2|Overall Study|Investigator's Discretion|12
217622|NCT01797445|709209|P1|Overall Study|Investigator's Discretion|8
217623|NCT01797445|709208|P2|Overall Study|Lack of Efficacy|2
217624|NCT01797445|709209|P1|Overall Study|Lack of Efficacy|1
217625|NCT01797445|709208|P2|Overall Study|Death|2
217626|NCT01797445|709209|P1|Overall Study|Death|1
217627|NCT01797445|709208|P2|Overall Study|Adverse Event|0
217628|NCT01797445|709209|P1|Overall Study|Adverse Event|3
217629|NCT01797445|709208|P2|Overall Study|Randomized but Not Treated|2
217630|NCT01797445|709209|P1|Overall Study|Randomized but Not Treated|4
217631|NCT01797094|709267|P2|Overall Study|Other Miscellaneous Reasons|0
217632|NCT01797094|709268|P1|Overall Study|Other Miscellaneous Reasons|1
217633|NCT01797094|709267|P2|Overall Study|Protocol Violation|1
217634|NCT01797094|709268|P1|Overall Study|Protocol Violation|0
217635|NCT01797094|709267|P2|Overall Study|Personal Reasons|0
217636|NCT01797094|709268|P1|Overall Study|Personal Reasons|4
217637|NCT01797094|709267|P2|Overall Study|Adverse Event|1
217638|NCT01797094|709268|P1|Overall Study|Adverse Event|1
217639|NCT01797081|709290|P4|Overall Study|Protocol Violation|1
217640|NCT01797081|709291|P3|Overall Study|Protocol Violation|0
217641|NCT01797081|709292|P2|Overall Study|Protocol Violation|0
217642|NCT01797081|709293|P1|Overall Study|Protocol Violation|0
217643|NCT01797081|709290|P4|Overall Study|Personal Reasons|8
217644|NCT01797081|709291|P3|Overall Study|Personal Reasons|4
217645|NCT01797081|709292|P2|Overall Study|Personal Reasons|4
217646|NCT01797081|709293|P1|Overall Study|Personal Reasons|12
217647|NCT01797081|709290|P4|Overall Study|Pregnancy|0
217648|NCT01797081|709291|P3|Overall Study|Pregnancy|0
217649|NCT01797081|709292|P2|Overall Study|Pregnancy|0
217650|NCT01797081|709293|P1|Overall Study|Pregnancy|1
217651|NCT01797081|709290|P4|Overall Study|Adverse Event|0
217652|NCT01797081|709291|P3|Overall Study|Adverse Event|1
217653|NCT01797081|709292|P2|Overall Study|Adverse Event|0
217654|NCT01797081|709293|P1|Overall Study|Adverse Event|1
217655|NCT01796964|709334|P2|Overall Study|Withdrawal by Subject|1
217656|NCT01796964|709335|P1|Overall Study|Withdrawal by Subject|1
217657|NCT01796964|709334|P2|Overall Study|Protocol Violation|1
217658|NCT01796964|709335|P1|Overall Study|Protocol Violation|0
217659|NCT01796964|709334|P2|Overall Study|Death|0
217660|NCT01796964|709335|P1|Overall Study|Death|1
217661|NCT01796964|709334|P2|Overall Study|Adverse Event|1
217662|NCT01796964|709335|P1|Overall Study|Adverse Event|1
217663|NCT01796860|709357|P1|Overall Study|Withdrawal by Subject|3
217664|NCT01796548|709363|P1|Overall Study|unspecified|2
217665|NCT01796548|709363|P1|Overall Study|Lost to Follow-up|1
217666|NCT01795937|709397|P3|Overall Study|Physician Decision|0
217667|NCT01795937|709398|P2|Overall Study|Physician Decision|1
217668|NCT01795937|709399|P1|Overall Study|Physician Decision|0
217669|NCT01795937|709397|P3|Overall Study|Withdrawal by Subject|0
217670|NCT01795937|709398|P2|Overall Study|Withdrawal by Subject|0
217671|NCT01795937|709399|P1|Overall Study|Withdrawal by Subject|1
217672|NCT01795898|709428|P1|Overall Study|Physician Decision|1
217673|NCT01795898|709428|P1|Overall Study|Withdrew consent & had adverse events|3
217674|NCT01795898|709428|P1|Overall Study|Death|1
217675|NCT01795898|709428|P1|Overall Study|No pain|1
217676|NCT01795898|709428|P1|Overall Study|Diagnosed with metastasis|1
217677|NCT01795898|709428|P1|Overall Study|Withdrawal of consent|6
217678|NCT01795898|709428|P1|Overall Study|Lost to Follow-up|20
217679|NCT01795898|709428|P1|Overall Study|Adverse Event|27
217680|NCT01795547|709447|P2|Overall Study|Not stated|1
217681|NCT01795547|709448|P1|Overall Study|Not stated|0
217682|NCT01795547|709447|P2|Overall Study|Others|1
217683|NCT01795547|709448|P1|Overall Study|Others|4
217684|NCT01795547|709447|P2|Overall Study|Non-compliance with IMP|1
217685|NCT01795547|709448|P1|Overall Study|Non-compliance with IMP|1
217686|NCT01795547|709447|P2|Overall Study|Not Treated|10
217687|NCT01795547|709448|P1|Overall Study|Not Treated|4
217688|NCT01795547|709447|P2|Overall Study|Withdrawal of consent|12
217689|NCT01795547|709448|P1|Overall Study|Withdrawal of consent|7
217690|NCT01795547|709447|P2|Overall Study|Lost to Follow-up|5
217691|NCT01795547|709448|P1|Overall Study|Lost to Follow-up|2
217692|NCT01795547|709447|P2|Overall Study|Protocol Violation|4
217693|NCT01795547|709448|P1|Overall Study|Protocol Violation|6
217694|NCT01795547|709447|P2|Overall Study|Lack of Efficacy|3
217695|NCT01795547|709448|P1|Overall Study|Lack of Efficacy|8
217696|NCT01795547|709447|P2|Overall Study|Adverse Event|27
217697|NCT01795547|709448|P1|Overall Study|Adverse Event|16
217698|NCT01794949|709479|P2|Overall Study|Lost to Follow-up|0
217699|NCT01794949|709480|P1|Overall Study|Lost to Follow-up|1
217700|NCT01794845|709491|P1|Overall Study|Withdrawal by Subject|1
217701|NCT01794000|709528|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
217702|NCT01794000|709529|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
217703|NCT01794000|709528|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
217704|NCT01794000|709529|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
217705|NCT01794000|709528|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
217706|NCT01794000|709529|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
217707|NCT01794000|709528|P2|Double-Blind Phase (DBP)|Physician Decision|0
217708|NCT01794000|709529|P1|Double-Blind Phase (DBP)|Physician Decision|2
217709|NCT01794000|709528|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
217710|NCT01794000|709529|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
217711|NCT01794000|709528|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
217712|NCT01794000|709529|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
217713|NCT01794000|709528|P2|Double-Blind Phase (DBP)|Death|2
217714|NCT01794000|709529|P1|Double-Blind Phase (DBP)|Death|1
217715|NCT01794000|709528|P2|Double-Blind Phase (DBP)|Adverse Event|2
217716|NCT01794000|709529|P1|Double-Blind Phase (DBP)|Adverse Event|5
217717|NCT01793688|709560|P1|Overall Study|Protocol Violation|2
217718|NCT01792830|709602|P7|Overall Study|Adverse Event|0
217719|NCT01792830|709603|P6|Overall Study|Adverse Event|0
217720|NCT01792830|709604|P5|Overall Study|Adverse Event|1
217721|NCT01792830|709605|P4|Overall Study|Adverse Event|0
217722|NCT01792830|709606|P3|Overall Study|Adverse Event|0
217723|NCT01792830|709607|P2|Overall Study|Adverse Event|0
217724|NCT01792830|709608|P1|Overall Study|Adverse Event|0
217725|NCT01792830|709602|P7|Overall Study|Death|1
217726|NCT01792830|709603|P6|Overall Study|Death|0
217727|NCT01792830|709604|P5|Overall Study|Death|2
217728|NCT01792830|709605|P4|Overall Study|Death|1
217729|NCT01792830|709606|P3|Overall Study|Death|0
217730|NCT01792830|709607|P2|Overall Study|Death|0
217731|NCT01792830|709608|P1|Overall Study|Death|3
217732|NCT01792830|709602|P7|Overall Study|Withdrawal by Subject|2
217733|NCT01792830|709603|P6|Overall Study|Withdrawal by Subject|0
217734|NCT01792830|709604|P5|Overall Study|Withdrawal by Subject|9
217735|NCT01792830|709605|P4|Overall Study|Withdrawal by Subject|4
217736|NCT01792830|709606|P3|Overall Study|Withdrawal by Subject|0
217737|NCT01792830|709607|P2|Overall Study|Withdrawal by Subject|0
217738|NCT01792830|709608|P1|Overall Study|Withdrawal by Subject|22
217739|NCT01792635|709639|P3|Part B|Study terminated|3
217740|NCT01792635|709640|P2|Part B|Study terminated|4
217741|NCT01792635|709641|P1|Part B|Study terminated|0
217742|NCT01792635|709639|P3|Part B|Adverse Event|1
217743|NCT01792635|709640|P2|Part B|Adverse Event|0
217744|NCT01792635|709641|P1|Part B|Adverse Event|0
217745|NCT01792518|709669|P2|Overall Study|Other Reason|1
217746|NCT01792518|709670|P1|Overall Study|Other Reason|0
217747|NCT01792518|709669|P2|Overall Study|Withdrawal by Subject|0
217748|NCT01792518|709670|P1|Overall Study|Withdrawal by Subject|2
217749|NCT01792518|709669|P2|Overall Study|Lost to Follow-up|1
217750|NCT01792518|709670|P1|Overall Study|Lost to Follow-up|3
217751|NCT01792518|709669|P2|Overall Study|Protocol Violation|1
217752|NCT01792518|709670|P1|Overall Study|Protocol Violation|0
217753|NCT01792518|709669|P2|Overall Study|Adverse Event|4
217754|NCT01792518|709670|P1|Overall Study|Adverse Event|3
217755|NCT01791894|709693|P1|Overall Study|Adverse Event|1
217756|NCT01791803|709704|P4|Overall Study|Death|2
217757|NCT01791803|709705|P3|Overall Study|Death|2
217758|NCT01791803|709706|P2|Overall Study|Death|0
217759|NCT01791803|709707|P1|Overall Study|Death|0
217760|NCT01791803|709704|P4|Overall Study|Physician Decision|1
217761|NCT01791803|709705|P3|Overall Study|Physician Decision|0
217762|NCT01791803|709706|P2|Overall Study|Physician Decision|2
217763|NCT01791803|709707|P1|Overall Study|Physician Decision|0
217764|NCT01791803|709704|P4|Overall Study|Withdrawal by Subject|2
217765|NCT01791803|709705|P3|Overall Study|Withdrawal by Subject|0
217766|NCT01791803|709706|P2|Overall Study|Withdrawal by Subject|0
217767|NCT01791803|709707|P1|Overall Study|Withdrawal by Subject|0
217768|NCT01791725|709725|P3|Overall Study|Withdrawal by Subject|0
217769|NCT01791725|709726|P2|Overall Study|Withdrawal by Subject|1
217770|NCT01791725|709727|P1|Overall Study|Withdrawal by Subject|0
217771|NCT01791413|709773|P2|Overall Study|Lost to Follow-up|1
217772|NCT01791413|709774|P1|Overall Study|Lost to Follow-up|5
217773|NCT01791205|709783|P2|Phase II|Physician’s decision|0
217774|NCT01791205|709784|P1|Phase II|Physician’s decision|1
217775|NCT01791205|709783|P2|Phase II|Remission of disease|0
217776|NCT01791205|709784|P1|Phase II|Remission of disease|1
217777|NCT01791205|709783|P2|Phase II|Lost to Follow-up|0
217778|NCT01791205|709784|P1|Phase II|Lost to Follow-up|1
217779|NCT01791205|709783|P2|Phase II|Safety|0
217780|NCT01791205|709784|P1|Phase II|Safety|1
217781|NCT01791205|709783|P2|Phase II|Adverse Event|0
217782|NCT01791205|709784|P1|Phase II|Adverse Event|2
217783|NCT01791205|709783|P2|Phase II|Lack of Efficacy|0
217784|NCT01791205|709784|P1|Phase II|Lack of Efficacy|6
217785|NCT01791153|709868|P4|Overall Study|Withdrawal by Subject|1
217786|NCT01791153|709869|P3|Overall Study|Withdrawal by Subject|2
217787|NCT01791153|709870|P2|Overall Study|Withdrawal by Subject|2
217788|NCT01791153|709871|P1|Overall Study|Withdrawal by Subject|6
217789|NCT01791153|709868|P4|Overall Study|Protocol Violation|1
217790|NCT01791153|709869|P3|Overall Study|Protocol Violation|0
217791|NCT01791153|709870|P2|Overall Study|Protocol Violation|0
217792|NCT01791153|709871|P1|Overall Study|Protocol Violation|0
217793|NCT01791153|709868|P4|Overall Study|Physician Decision|1
217794|NCT01791153|709869|P3|Overall Study|Physician Decision|0
217795|NCT01791153|709870|P2|Overall Study|Physician Decision|0
217796|NCT01791153|709871|P1|Overall Study|Physician Decision|0
217797|NCT01791153|709868|P4|Overall Study|Non-Compliance|0
217798|NCT01791153|709869|P3|Overall Study|Non-Compliance|0
217799|NCT01791153|709870|P2|Overall Study|Non-Compliance|0
217800|NCT01791153|709871|P1|Overall Study|Non-Compliance|1
217801|NCT01791153|709868|P4|Overall Study|Lack of Efficacy|2
217802|NCT01791153|709869|P3|Overall Study|Lack of Efficacy|2
217803|NCT01791153|709870|P2|Overall Study|Lack of Efficacy|3
217804|NCT01791153|709871|P1|Overall Study|Lack of Efficacy|1
217805|NCT01791153|709868|P4|Overall Study|Adverse Event|0
217806|NCT01791153|709869|P3|Overall Study|Adverse Event|2
217807|NCT01791153|709870|P2|Overall Study|Adverse Event|3
217808|NCT01791153|709871|P1|Overall Study|Adverse Event|7
217809|NCT01790828|709933|P1|Overall Study|Not specified|34
217810|NCT01790633|709972|P2|Overall Study|RT failure and no follow-up ELISA|3
217811|NCT01790633|709973|P1|Overall Study|RT failure and no follow-up ELISA|0
217812|NCT01790633|709972|P2|Overall Study|Did not have serology performed|0
217813|NCT01790633|709973|P1|Overall Study|Did not have serology performed|47
217814|NCT01790633|709972|P2|Overall Study|Protocol Violation|2
217815|NCT01790633|709973|P1|Overall Study|Protocol Violation|1
217816|NCT01790516|709997|P2|Overall Study|Physician Decision|0
217817|NCT01790516|709998|P1|Overall Study|Physician Decision|1
217818|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
217819|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
217820|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
217821|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Not specified|3
217822|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
217823|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
217824|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
217825|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
217826|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
217827|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
217828|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
217829|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
217830|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
217831|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
217832|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
217833|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
217834|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
217835|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
217836|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
217837|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
217838|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
217839|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
217840|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
217841|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
217842|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
217843|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
217844|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
217845|NCT01789970|710039|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
217846|NCT01789970|710040|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
217847|NCT01789970|710041|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
217848|NCT01789970|710039|P3|Open-label Titration Period|Dropped out prior to dosing|0
217849|NCT01789970|710040|P2|Open-label Titration Period|Dropped out prior to dosing|0
217850|NCT01789970|710041|P1|Open-label Titration Period|Dropped out prior to dosing|2
217851|NCT01789970|710039|P3|Open-label Titration Period|Not specified|0
217852|NCT01789970|710040|P2|Open-label Titration Period|Not specified|0
217853|NCT01789970|710041|P1|Open-label Titration Period|Not specified|76
217854|NCT01789970|710039|P3|Open-label Titration Period|Pregnancy|0
217855|NCT01789970|710040|P2|Open-label Titration Period|Pregnancy|0
217856|NCT01789970|710041|P1|Open-label Titration Period|Pregnancy|2
217857|NCT01789970|710039|P3|Open-label Titration Period|Noncompliance with study procedures|0
217858|NCT01789970|710040|P2|Open-label Titration Period|Noncompliance with study procedures|0
217859|NCT01789970|710041|P1|Open-label Titration Period|Noncompliance with study procedures|8
217860|NCT01789970|710039|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
217861|NCT01789970|710040|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
217862|NCT01789970|710041|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
217863|NCT01789970|710039|P3|Open-label Titration Period|Noncompliance to study drug admin|0
217864|NCT01789970|710040|P2|Open-label Titration Period|Noncompliance to study drug admin|0
217865|NCT01789970|710041|P1|Open-label Titration Period|Noncompliance to study drug admin|11
217866|NCT01789970|710039|P3|Open-label Titration Period|Lost to Follow-up|0
217867|NCT01789970|710040|P2|Open-label Titration Period|Lost to Follow-up|0
217868|NCT01789970|710041|P1|Open-label Titration Period|Lost to Follow-up|5
217869|NCT01789970|710039|P3|Open-label Titration Period|Protocol Violation|0
217870|NCT01789970|710040|P2|Open-label Titration Period|Protocol Violation|0
217871|NCT01789970|710041|P1|Open-label Titration Period|Protocol Violation|18
217872|NCT01789970|710039|P3|Open-label Titration Period|Withdrawal by Subject|0
217873|NCT01789970|710040|P2|Open-label Titration Period|Withdrawal by Subject|0
217874|NCT01789970|710041|P1|Open-label Titration Period|Withdrawal by Subject|31
217875|NCT01789970|710039|P3|Open-label Titration Period|Lack of Efficacy|0
217876|NCT01789970|710040|P2|Open-label Titration Period|Lack of Efficacy|0
217877|NCT01789970|710041|P1|Open-label Titration Period|Lack of Efficacy|31
217878|NCT01789970|710039|P3|Open-label Titration Period|Adverse Event|0
217879|NCT01789970|710040|P2|Open-label Titration Period|Adverse Event|0
217880|NCT01789970|710041|P1|Open-label Titration Period|Adverse Event|68
217881|NCT01789476|710093|P2|Overall Study|Unable to get IV access|0
217882|NCT01789476|710094|P1|Overall Study|Unable to get IV access|1
217883|NCT01789476|710093|P2|Overall Study|Adverse Event|0
217884|NCT01789476|710094|P1|Overall Study|Adverse Event|1
217885|NCT01789476|710093|P2|Overall Study|Lack of Efficacy|2
217886|NCT01789476|710094|P1|Overall Study|Lack of Efficacy|6
217887|NCT01788566|710120|P1|Overall Study|Clinical Progressive Disease|3
217888|NCT01788566|710120|P1|Overall Study|Adverse Event|1
217889|NCT01788566|710120|P1|Overall Study|Death|4
217890|NCT01788358|710130|P1|Overall Study|Adverse Event|51
217891|NCT01788358|710130|P1|Overall Study|Lack of Efficacy|1
217892|NCT01788358|710130|P1|Overall Study|Withdrawal by Subject|26
217893|NCT01788358|710130|P1|Overall Study|Protocol Violation|3
217894|NCT01788358|710130|P1|Overall Study|Lost to Follow-up|5
217895|NCT01788358|710130|P1|Overall Study|Logistical difficulties|1
217896|NCT01788358|710130|P1|Overall Study|Unspecified|11
217897|NCT01788228|710144|P2|Overall Study|Migrated/moved from study area|0
217898|NCT01788228|710145|P1|Overall Study|Migrated/moved from study area|1
217899|NCT01788215|710164|P2|Overall Study|Lost to Follow-up|0
217900|NCT01788215|710165|P1|Overall Study|Lost to Follow-up|2
217901|NCT01788215|710164|P2|Overall Study|Withdrawal by Subject|1
217902|NCT01788215|710165|P1|Overall Study|Withdrawal by Subject|0
217903|NCT01788163|710194|P9|Overall Study|Withdrawal by Subject|1
217904|NCT01788163|710195|P8|Overall Study|Withdrawal by Subject|0
217905|NCT01788163|710196|P7|Overall Study|Withdrawal by Subject|0
217906|NCT01788163|710197|P6|Overall Study|Withdrawal by Subject|0
217907|NCT01788163|710198|P5|Overall Study|Withdrawal by Subject|0
217908|NCT01788163|710199|P4|Overall Study|Withdrawal by Subject|0
217909|NCT01788163|710200|P3|Overall Study|Withdrawal by Subject|0
217910|NCT01788163|710201|P2|Overall Study|Withdrawal by Subject|0
217911|NCT01788163|710202|P1|Overall Study|Withdrawal by Subject|2
217912|NCT01788163|710194|P9|Overall Study|Other|15
217913|NCT01788163|710195|P8|Overall Study|Other|48
217914|NCT01788163|710196|P7|Overall Study|Other|1
217915|NCT01788163|710197|P6|Overall Study|Other|7
217916|NCT01788163|710198|P5|Overall Study|Other|0
217917|NCT01788163|710199|P4|Overall Study|Other|0
217918|NCT01788163|710200|P3|Overall Study|Other|0
217919|NCT01788163|710201|P2|Overall Study|Other|0
217920|NCT01788163|710202|P1|Overall Study|Other|53
217921|NCT01788046|710365|P2|Overall Study|Protocol Specified Criteria|1
217922|NCT01788046|710366|P1|Overall Study|Protocol Specified Criteria|25
217923|NCT01788046|710365|P2|Overall Study|Death|5
217924|NCT01788046|710366|P1|Overall Study|Death|7
217925|NCT01788046|710365|P2|Overall Study|Lost to Follow-up|19
217926|NCT01788046|710366|P1|Overall Study|Lost to Follow-up|12
217927|NCT01788046|710365|P2|Overall Study|Withdrawal by Subject|12
217928|NCT01788046|710366|P1|Overall Study|Withdrawal by Subject|12
217929|NCT01787838|710382|P1|Overall Study|refused|1413
217930|NCT01787825|710386|P2|Overall Study|Data Not Analyzable|1
217931|NCT01787825|710387|P1|Overall Study|Data Not Analyzable|5
217932|NCT01787825|710386|P2|Overall Study|Subject Did Not Ingest Capsules|0
217933|NCT01787825|710387|P1|Overall Study|Subject Did Not Ingest Capsules|1
217934|NCT01787760|710405|P3|Overall Study|Near vision blur|0
217935|NCT01787760|710406|P2|Overall Study|Near vision blur|0
217936|NCT01787760|710407|P1|Overall Study|Near vision blur|1
217937|NCT01787760|710405|P3|Overall Study|Unsatisfactory visual response|0
217938|NCT01787760|710406|P2|Overall Study|Unsatisfactory visual response|1
217939|NCT01787760|710407|P1|Overall Study|Unsatisfactory visual response|1
217940|NCT01787760|710405|P3|Overall Study|Unsatisfactory physiological response|0
217941|NCT01787760|710406|P2|Overall Study|Unsatisfactory physiological response|4
217942|NCT01787760|710407|P1|Overall Study|Unsatisfactory physiological response|2
217943|NCT01787760|710405|P3|Overall Study|Unsatisfactory lens fitting performance|0
217944|NCT01787760|710406|P2|Overall Study|Unsatisfactory lens fitting performance|6
217945|NCT01787760|710407|P1|Overall Study|Unsatisfactory lens fitting performance|3
217946|NCT01787760|710405|P3|Overall Study|Stroke|0
217947|NCT01787760|710406|P2|Overall Study|Stroke|0
217948|NCT01787760|710407|P1|Overall Study|Stroke|1
217949|NCT01787760|710405|P3|Overall Study|Lost to Follow-up|1
217950|NCT01787760|710406|P2|Overall Study|Lost to Follow-up|0
217951|NCT01787760|710407|P1|Overall Study|Lost to Follow-up|1
217952|NCT01787760|710405|P3|Overall Study|Withdrawal by Subject|2
217953|NCT01787760|710406|P2|Overall Study|Withdrawal by Subject|1
217954|NCT01787760|710407|P1|Overall Study|Withdrawal by Subject|5
217955|NCT01787760|710405|P3|Overall Study|Protocol Violation|1
217956|NCT01787760|710406|P2|Overall Study|Protocol Violation|0
217957|NCT01787760|710407|P1|Overall Study|Protocol Violation|6
217958|NCT01787760|710405|P3|Overall Study|Lens handling difficulty|0
217959|NCT01787760|710406|P2|Overall Study|Lens handling difficulty|2
217960|NCT01787760|710407|P1|Overall Study|Lens handling difficulty|1
217961|NCT01787760|710405|P3|Overall Study|Lens discomfort|0
217962|NCT01787760|710406|P2|Overall Study|Lens discomfort|0
217963|NCT01787760|710407|P1|Overall Study|Lens discomfort|3
217964|NCT01787760|710405|P3|Overall Study|Relocation|0
217965|NCT01787760|710406|P2|Overall Study|Relocation|1
217966|NCT01787760|710407|P1|Overall Study|Relocation|1
217967|NCT01787760|710405|P3|Overall Study|Dryness|0
217968|NCT01787760|710406|P2|Overall Study|Dryness|1
217969|NCT01787760|710407|P1|Overall Study|Dryness|0
217970|NCT01787760|710405|P3|Overall Study|Decompensated on left exotropia|1
217971|NCT01787760|710406|P2|Overall Study|Decompensated on left exotropia|0
217972|NCT01787760|710407|P1|Overall Study|Decompensated on left exotropia|0
217973|NCT01787760|710405|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
217974|NCT01787760|710406|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
217975|NCT01787760|710407|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
217976|NCT01787591|710421|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
217977|NCT01787591|710422|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
217978|NCT01787591|710423|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
217979|NCT01787591|710424|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
217980|NCT01787461|710452|P2|Overall Study|Protocol Violation|0
217981|NCT01787461|710453|P1|Overall Study|Protocol Violation|3
217982|NCT01787461|710452|P2|Overall Study|Withdrawal by Subject|4
217983|NCT01787461|710453|P1|Overall Study|Withdrawal by Subject|3
217984|NCT01787461|710452|P2|Overall Study|No longer met eligibility criteria|0
217985|NCT01787461|710453|P1|Overall Study|No longer met eligibility criteria|1
217986|NCT01787461|710452|P2|Overall Study|Lost to Follow-up|2
217987|NCT01787461|710453|P1|Overall Study|Lost to Follow-up|3
217988|NCT01787461|710452|P2|Overall Study|Adverse Event|3
217989|NCT01787461|710453|P1|Overall Study|Adverse Event|4
217990|NCT01787279|710502|P1|Overall Study|Lack of Efficacy|1
217991|NCT01787279|710502|P1|Overall Study|Lost to Follow-up|2
217992|NCT01787188|710528|P3|Overall Study|Other, including patient moved|0
217993|NCT01787188|710529|P2|Overall Study|Other, including patient moved|3
217994|NCT01787188|710530|P1|Overall Study|Other, including patient moved|0
217995|NCT01787188|710528|P3|Overall Study|Lost to Follow-up|2
217996|NCT01787188|710529|P2|Overall Study|Lost to Follow-up|2
217997|NCT01787188|710530|P1|Overall Study|Lost to Follow-up|1
217998|NCT01787188|710528|P3|Overall Study|Protocol Violation|3
217999|NCT01787188|710529|P2|Overall Study|Protocol Violation|2
218000|NCT01787188|710530|P1|Overall Study|Protocol Violation|3
218001|NCT01787188|710528|P3|Overall Study|Withdrawal by Subject|2
218002|NCT01787188|710529|P2|Overall Study|Withdrawal by Subject|3
218003|NCT01787188|710530|P1|Overall Study|Withdrawal by Subject|4
218004|NCT01787188|710528|P3|Overall Study|Non-compliance with Study Drug|0
218005|NCT01787188|710529|P2|Overall Study|Non-compliance with Study Drug|1
218006|NCT01787188|710530|P1|Overall Study|Non-compliance with Study Drug|0
218007|NCT01787188|710528|P3|Overall Study|Lack of Efficacy|5
218008|NCT01787188|710529|P2|Overall Study|Lack of Efficacy|3
218009|NCT01787188|710530|P1|Overall Study|Lack of Efficacy|7
218010|NCT01787188|710528|P3|Overall Study|Adverse Event|6
218011|NCT01787188|710529|P2|Overall Study|Adverse Event|4
218012|NCT01787188|710530|P1|Overall Study|Adverse Event|2
218013|NCT01787032|710602|P6|Overall Study|Protocol Violation|1
218014|NCT01787032|710603|P5|Overall Study|Protocol Violation|1
218015|NCT01787032|710604|P4|Overall Study|Protocol Violation|0
218016|NCT01787032|710605|P3|Overall Study|Protocol Violation|0
218017|NCT01787032|710606|P2|Overall Study|Protocol Violation|0
218018|NCT01787032|710607|P1|Overall Study|Protocol Violation|0
218019|NCT01786993|710631|P2|Overall Study|Hospice Admission|0
218020|NCT01786993|710632|P1|Overall Study|Hospice Admission|1
218021|NCT01786993|710631|P2|Overall Study|System Explant|0
218022|NCT01786993|710632|P1|Overall Study|System Explant|1
218023|NCT01786993|710631|P2|Overall Study|Subject Non-Compliance|0
218024|NCT01786993|710632|P1|Overall Study|Subject Non-Compliance|1
218025|NCT01786993|710631|P2|Overall Study|Lost to Follow-up|1
218026|NCT01786993|710632|P1|Overall Study|Lost to Follow-up|0
218027|NCT01786993|710631|P2|Overall Study|Withdrawal by Subject|2
218028|NCT01786993|710632|P1|Overall Study|Withdrawal by Subject|3
218029|NCT01786993|710631|P2|Overall Study|Death|7
218030|NCT01786993|710632|P1|Overall Study|Death|6
218031|NCT01786707|710682|P2|Overall Study|Lost to Follow-up|1
218032|NCT01786707|710683|P1|Overall Study|Lost to Follow-up|1
218033|NCT01786668|710693|P4|Overall Study|Lost to Follow-up|0
218034|NCT01786668|710694|P3|Overall Study|Lost to Follow-up|1
218035|NCT01786668|710695|P2|Overall Study|Lost to Follow-up|0
218036|NCT01786668|710696|P1|Overall Study|Lost to Follow-up|1
218037|NCT01786668|710693|P4|Overall Study|Pregnancy|1
218038|NCT01786668|710694|P3|Overall Study|Pregnancy|0
218039|NCT01786668|710695|P2|Overall Study|Pregnancy|0
218040|NCT01786668|710696|P1|Overall Study|Pregnancy|0
218041|NCT01786668|710693|P4|Overall Study|Withdrawal by Subject|1
218042|NCT01786668|710694|P3|Overall Study|Withdrawal by Subject|3
218043|NCT01786668|710695|P2|Overall Study|Withdrawal by Subject|0
218044|NCT01786668|710696|P1|Overall Study|Withdrawal by Subject|0
218045|NCT01786668|710693|P4|Overall Study|Adverse Event|2
218046|NCT01786668|710694|P3|Overall Study|Adverse Event|1
218047|NCT01786668|710695|P2|Overall Study|Adverse Event|1
218048|NCT01786668|710696|P1|Overall Study|Adverse Event|0
218049|NCT01786629|710796|P2|Overall Study|Adverse Event|1
218050|NCT01786629|710797|P1|Overall Study|Adverse Event|0
218051|NCT01786629|710796|P2|Overall Study|Lack of Efficacy|4
218052|NCT01786629|710797|P1|Overall Study|Lack of Efficacy|0
218053|NCT01786551|710803|P1|Overall Study|Participant withdrew consent|2
218054|NCT01786330|710811|P2|Overall Study|Protocol Violation|0
218055|NCT01786330|710812|P1|Overall Study|Protocol Violation|1
218056|NCT01786330|710811|P2|Overall Study|Excluded intraoperatively|1
218057|NCT01786330|710812|P1|Overall Study|Excluded intraoperatively|0
218058|NCT01786330|710811|P2|Overall Study|Lost to Follow-up|1
218059|NCT01786330|710812|P1|Overall Study|Lost to Follow-up|0
218060|NCT01786330|710811|P2|Overall Study|Withdrawal by Subject|1
218061|NCT01786330|710812|P1|Overall Study|Withdrawal by Subject|0
218062|NCT01786174|710850|P2|Overall Study|Discontinued Study Drug|0
218063|NCT01786174|710851|P1|Overall Study|Discontinued Study Drug|2
218064|NCT01786109|710881|P3|Overall Study|adverse effects colon preparation|1
218065|NCT01786109|710882|P2|Overall Study|adverse effects colon preparation|0
218066|NCT01786109|710883|P1|Overall Study|adverse effects colon preparation|0
218067|NCT01786109|710881|P3|Overall Study|unrelated illness|1
218068|NCT01786109|710882|P2|Overall Study|unrelated illness|0
218069|NCT01786109|710883|P1|Overall Study|unrelated illness|0
218070|NCT01786109|710881|P3|Overall Study|fail manometry barostat tube placement|0
218071|NCT01786109|710882|P2|Overall Study|fail manometry barostat tube placement|0
218072|NCT01786109|710883|P1|Overall Study|fail manometry barostat tube placement|1
218073|NCT01785875|710912|P3|Overall Study|Missing|3
218074|NCT01785875|710913|P2|Overall Study|Missing|1
218075|NCT01785875|710914|P1|Overall Study|Missing|0
218076|NCT01785875|710912|P3|Overall Study|Protocol Specified Criteria|55
218077|NCT01785875|710913|P2|Overall Study|Protocol Specified Criteria|214
218078|NCT01785875|710914|P1|Overall Study|Protocol Specified Criteria|207
218079|NCT01785875|710912|P3|Overall Study|Sponsor Decision|0
218080|NCT01785875|710913|P2|Overall Study|Sponsor Decision|2
218081|NCT01785875|710914|P1|Overall Study|Sponsor Decision|0
218082|NCT01785875|710912|P3|Overall Study|Death|7
218083|NCT01785875|710913|P2|Overall Study|Death|16
218084|NCT01785875|710914|P1|Overall Study|Death|27
218085|NCT01785875|710912|P3|Overall Study|Lost to Follow-up|6
218086|NCT01785875|710913|P2|Overall Study|Lost to Follow-up|22
218087|NCT01785875|710914|P1|Overall Study|Lost to Follow-up|19
218088|NCT01785875|710912|P3|Overall Study|Withdrawal by Subject|36
218089|NCT01785875|710913|P2|Overall Study|Withdrawal by Subject|34
218090|NCT01785875|710914|P1|Overall Study|Withdrawal by Subject|41
218091|NCT01785849|710983|P2|Overall Study|Lost to Follow-up|11
218092|NCT01785849|710984|P1|Overall Study|Lost to Follow-up|10
218093|NCT01785849|710983|P2|Overall Study|Sponsor Decision|1
218094|NCT01785849|710984|P1|Overall Study|Sponsor Decision|0
218095|NCT01785849|710983|P2|Overall Study|Withdrawal by Subject|12
218096|NCT01785849|710984|P1|Overall Study|Withdrawal by Subject|15
218097|NCT01785849|710983|P2|Overall Study|Protocol Specified Criteria|1
218098|NCT01785849|710984|P1|Overall Study|Protocol Specified Criteria|29
218099|NCT01785849|710983|P2|Overall Study|Death|9
218100|NCT01785849|710984|P1|Overall Study|Death|7
218101|NCT01785628|711002|P2|Overall Study|Lost to Follow-up|3
218102|NCT01785628|711003|P1|Overall Study|Lost to Follow-up|2
218103|NCT01785615|711026|P4|Dietary Phase|Lost to Follow-up|24
218104|NCT01785615|711027|P3|Dietary Phase|Lost to Follow-up|0
218105|NCT01785615|711028|P2|Dietary Phase|Lost to Follow-up|0
218106|NCT01785615|711029|P1|Dietary Phase|Lost to Follow-up|0
218107|NCT01785602|711101|P2|Overall Study|Administrative problems|3
218108|NCT01785602|711102|P1|Overall Study|Administrative problems|7
218109|NCT01785602|711101|P2|Overall Study|Adverse Event|5
218110|NCT01785602|711102|P1|Overall Study|Adverse Event|3
218111|NCT01785602|711101|P2|Overall Study|Lost to Follow-up|1
218112|NCT01785602|711102|P1|Overall Study|Lost to Follow-up|1
218113|NCT01785602|711101|P2|Overall Study|Withdrawal by Subject|0
218114|NCT01785602|711102|P1|Overall Study|Withdrawal by Subject|2
218115|NCT01785524|711112|P2|Overall Study|Withdrawal by Subject|2
218116|NCT01785524|711113|P1|Overall Study|Withdrawal by Subject|2
218117|NCT01785472|711128|P3|Overall Study|Technical problems|1
218118|NCT01785472|711129|P2|Overall Study|Technical problems|0
218119|NCT01785472|711130|P1|Overall Study|Technical problems|0
218120|NCT01785472|711128|P3|Overall Study|Subject/guardian decision|11
218121|NCT01785472|711129|P2|Overall Study|Subject/guardian decision|10
218122|NCT01785472|711130|P1|Overall Study|Subject/guardian decision|15
218123|NCT01785472|711128|P3|Overall Study|Protocol deviation|2
218124|NCT01785472|711129|P2|Overall Study|Protocol deviation|2
218125|NCT01785472|711130|P1|Overall Study|Protocol deviation|0
218126|NCT01785472|711128|P3|Overall Study|Physician Decision|1
218127|NCT01785472|711129|P2|Overall Study|Physician Decision|1
218128|NCT01785472|711130|P1|Overall Study|Physician Decision|1
218129|NCT01785472|711128|P3|Overall Study|Lost to Follow-up|0
218130|NCT01785472|711129|P2|Overall Study|Lost to Follow-up|2
218131|NCT01785472|711130|P1|Overall Study|Lost to Follow-up|1
218132|NCT01785472|711128|P3|Overall Study|Lack of Efficacy|1
218133|NCT01785472|711129|P2|Overall Study|Lack of Efficacy|0
218134|NCT01785472|711130|P1|Overall Study|Lack of Efficacy|2
218135|NCT01785472|711128|P3|Overall Study|Adverse Event|6
218136|NCT01785472|711129|P2|Overall Study|Adverse Event|4
218137|NCT01785472|711130|P1|Overall Study|Adverse Event|5
218138|NCT01785160|711172|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
218139|NCT01785160|711172|P1|Treatment Period 1: Raltegravir|Not treated|1
218140|NCT01784965|711207|P2|Overall Study|Adverse Event|8
218141|NCT01784965|711208|P1|Overall Study|Adverse Event|0
218142|NCT01784965|711207|P2|Overall Study|Withdrawal by Subject|3
218143|NCT01784965|711208|P1|Overall Study|Withdrawal by Subject|6
218144|NCT01783938|711274|P2|Overall Study|Not Specified|0
218145|NCT01783938|711275|P1|Overall Study|Not Specified|1
218146|NCT01783938|711274|P2|Overall Study|Withdrew Consent|0
218147|NCT01783938|711275|P1|Overall Study|Withdrew Consent|3
218148|NCT01783938|711274|P2|Overall Study|Request to Discontinue Study Treatment|2
218149|NCT01783938|711275|P1|Overall Study|Request to Discontinue Study Treatment|1
218150|NCT01783938|711274|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
218151|NCT01783938|711275|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
218152|NCT01783938|711274|P2|Overall Study|Study Drug Toxicity|10
218153|NCT01783938|711275|P1|Overall Study|Study Drug Toxicity|22
218154|NCT01783938|711274|P2|Overall Study|Disease Progression|39
218155|NCT01783938|711275|P1|Overall Study|Disease Progression|18
218156|NCT01783886|711303|P3|Overall Study|Adverse Event|4
218157|NCT01783886|711304|P2|Overall Study|Adverse Event|5
218158|NCT01783886|711305|P1|Overall Study|Adverse Event|4
218159|NCT01783886|711303|P3|Overall Study|Withdrawal of consent by participant|4
218160|NCT01783886|711304|P2|Overall Study|Withdrawal of consent by participant|3
218161|NCT01783886|711305|P1|Overall Study|Withdrawal of consent by participant|1
218162|NCT01783886|711303|P3|Overall Study|Protocol deviation|2
218163|NCT01783886|711304|P2|Overall Study|Protocol deviation|0
218164|NCT01783886|711305|P1|Overall Study|Protocol deviation|0
218165|NCT01783886|711303|P3|Overall Study|Lost to Follow-up|0
218166|NCT01783886|711304|P2|Overall Study|Lost to Follow-up|3
218167|NCT01783886|711305|P1|Overall Study|Lost to Follow-up|0
218168|NCT01783821|711352|P2|Overall Study|Screen Failure|1
218169|NCT01783821|711353|P1|Overall Study|Screen Failure|1
218170|NCT01783730|711369|P1|Overall Study|Failed to meet inclusion criteria|6
218171|NCT01783678|711394|P6|Overall Study|Withdrew Consent|0
218172|NCT01783678|711395|P5|Overall Study|Withdrew Consent|0
218173|NCT01783678|711396|P4|Overall Study|Withdrew Consent|2
218174|NCT01783678|711397|P3|Overall Study|Withdrew Consent|0
218175|NCT01783678|711398|P2|Overall Study|Withdrew Consent|1
218176|NCT01783678|711399|P1|Overall Study|Withdrew Consent|1
218177|NCT01783678|711394|P6|Overall Study|Lost to Follow-up|0
218178|NCT01783678|711395|P5|Overall Study|Lost to Follow-up|1
218179|NCT01783678|711396|P4|Overall Study|Lost to Follow-up|2
218180|NCT01783678|711397|P3|Overall Study|Lost to Follow-up|0
218181|NCT01783678|711398|P2|Overall Study|Lost to Follow-up|4
218182|NCT01783678|711399|P1|Overall Study|Lost to Follow-up|0
218183|NCT01783678|711394|P6|Overall Study|Lack of Efficacy|5
218184|NCT01783678|711395|P5|Overall Study|Lack of Efficacy|6
218185|NCT01783678|711396|P4|Overall Study|Lack of Efficacy|3
218186|NCT01783678|711397|P3|Overall Study|Lack of Efficacy|1
218187|NCT01783678|711398|P2|Overall Study|Lack of Efficacy|13
218188|NCT01783678|711399|P1|Overall Study|Lack of Efficacy|1
218189|NCT01783678|711394|P6|Overall Study|Randomized but Not Treated|0
218190|NCT01783678|711395|P5|Overall Study|Randomized but Not Treated|0
218191|NCT01783678|711396|P4|Overall Study|Randomized but Not Treated|1
218192|NCT01783678|711397|P3|Overall Study|Randomized but Not Treated|0
218193|NCT01783678|711398|P2|Overall Study|Randomized but Not Treated|0
218194|NCT01783678|711399|P1|Overall Study|Randomized but Not Treated|0
218195|NCT01783639|711471|P1|Overall Study|Clinical indication for proximal EPD|1
218196|NCT01783639|711471|P1|Overall Study|Did not meet inclusion/exclusion|21
218197|NCT01783548|711477|P2|Overall Study|Lack of Efficacy|1
218198|NCT01783548|711478|P1|Overall Study|Lack of Efficacy|1
218199|NCT01783548|711477|P2|Overall Study|Lost to Follow-up|3
218200|NCT01783548|711478|P1|Overall Study|Lost to Follow-up|8
218201|NCT01783548|711477|P2|Overall Study|Protocol Violation|2
218202|NCT01783548|711478|P1|Overall Study|Protocol Violation|2
218203|NCT01783548|711477|P2|Overall Study|Non-compliance|0
218204|NCT01783548|711478|P1|Overall Study|Non-compliance|4
218205|NCT01783548|711477|P2|Overall Study|Withdrawal by Subject|8
218206|NCT01783548|711478|P1|Overall Study|Withdrawal by Subject|11
218207|NCT01783548|711477|P2|Overall Study|Adverse Event|4
218208|NCT01783548|711478|P1|Overall Study|Adverse Event|8
218209|NCT01783496|711496|P6|Overall Study|Withdrawal by Subject|0
218210|NCT01783496|711497|P5|Overall Study|Withdrawal by Subject|0
218211|NCT01783496|711498|P4|Overall Study|Withdrawal by Subject|0
218212|NCT01783496|711499|P3|Overall Study|Withdrawal by Subject|0
218213|NCT01783496|711500|P2|Overall Study|Withdrawal by Subject|0
218214|NCT01783496|711501|P1|Overall Study|Withdrawal by Subject|1
218215|NCT01783496|711496|P6|Overall Study|Lost to Follow-up|1
218216|NCT01783496|711497|P5|Overall Study|Lost to Follow-up|0
218217|NCT01783496|711498|P4|Overall Study|Lost to Follow-up|2
218218|NCT01783496|711499|P3|Overall Study|Lost to Follow-up|0
218219|NCT01783496|711500|P2|Overall Study|Lost to Follow-up|0
218220|NCT01783496|711501|P1|Overall Study|Lost to Follow-up|0
218221|NCT01783418|711537|P2|Overall Study|Withdrawal by Subject|0
218222|NCT01783418|711538|P1|Overall Study|Withdrawal by Subject|1
218223|NCT01783015|711584|P3|Open Label Treatment|Study Terminated by Sponsor|6
218224|NCT01783015|711585|P2|Open Label Treatment|Study Terminated by Sponsor|0
218225|NCT01783015|711586|P1|Open Label Treatment|Study Terminated by Sponsor|0
218226|NCT01783015|711584|P3|Blinded Treatment|Study Terminated by Sponsor|0
218227|NCT01783015|711585|P2|Blinded Treatment|Study Terminated by Sponsor|0
218228|NCT01783015|711586|P1|Blinded Treatment|Study Terminated by Sponsor|2
218229|NCT01783015|711584|P3|Blinded Treatment|Withdrawal by Subject|0
218230|NCT01783015|711585|P2|Blinded Treatment|Withdrawal by Subject|1
218231|NCT01783015|711586|P1|Blinded Treatment|Withdrawal by Subject|0
218232|NCT01783015|711584|P3|Blinded Treatment|Protocol Violation|0
218233|NCT01783015|711585|P2|Blinded Treatment|Protocol Violation|1
218234|NCT01783015|711586|P1|Blinded Treatment|Protocol Violation|0
218235|NCT01783015|711584|P3|Blinded Treatment|Adverse Event|0
218236|NCT01783015|711585|P2|Blinded Treatment|Adverse Event|1
218237|NCT01783015|711586|P1|Blinded Treatment|Adverse Event|0
218238|NCT01782885|711686|P2|Overall Study|Lost to Follow-up|6
218239|NCT01782885|711687|P1|Overall Study|Lost to Follow-up|4
218240|NCT01782872|711713|P4|Overall Study|Withdrawal by Subject|0
218241|NCT01782872|711714|P3|Overall Study|Withdrawal by Subject|0
218242|NCT01782872|711715|P2|Overall Study|Withdrawal by Subject|1
218243|NCT01782872|711716|P1|Overall Study|Withdrawal by Subject|0
218244|NCT01782872|711713|P4|Overall Study|Protocol Violation|1
218245|NCT01782872|711714|P3|Overall Study|Protocol Violation|0
218246|NCT01782872|711715|P2|Overall Study|Protocol Violation|0
218247|NCT01782872|711716|P1|Overall Study|Protocol Violation|0
218248|NCT01782859|711740|P2|Overall Study|Withdrawal by Subject|1
218249|NCT01782859|711741|P1|Overall Study|Withdrawal by Subject|0
218250|NCT01782859|711740|P2|Overall Study|Protocol Violation|6
218251|NCT01782859|711741|P1|Overall Study|Protocol Violation|6
218252|NCT01782742|711757|P2|Double-blind Treatment Phase|Adverse Event|0
218253|NCT01782742|711758|P1|Double-blind Treatment Phase|Adverse Event|1
218254|NCT01782482|711793|P2|Overall Study|Habitually wearing toric lens OS|1
218255|NCT01782482|711794|P1|Overall Study|Habitually wearing toric lens OS|0
218256|NCT01782482|711793|P2|Overall Study|Randomized in Error|2
218257|NCT01782482|711794|P1|Overall Study|Randomized in Error|2
218258|NCT01782482|711793|P2|Overall Study|Withdrawal by Subject|3
218259|NCT01782482|711794|P1|Overall Study|Withdrawal by Subject|2
218260|NCT01782482|711793|P2|Overall Study|Protocol Violation|0
218261|NCT01782482|711794|P1|Overall Study|Protocol Violation|1
218262|NCT01782482|711793|P2|Overall Study|Physician Decision|0
218263|NCT01782482|711794|P1|Overall Study|Physician Decision|1
218264|NCT01782482|711793|P2|Overall Study|Lost to Follow-up|3
218265|NCT01782482|711794|P1|Overall Study|Lost to Follow-up|2
218266|NCT01782482|711793|P2|Overall Study|Adverse Event|1
218267|NCT01782482|711794|P1|Overall Study|Adverse Event|2
218268|NCT01782469|711802|P1|Overall Study|Lost to Follow-up|1
218269|NCT01782326|711812|P2|Double-blind Treatment|Technical problems|5
218270|NCT01782326|711813|P1|Double-blind Treatment|Technical problems|0
218271|NCT01782326|711812|P2|Double-blind Treatment|Protocol deviation|7
218272|NCT01782326|711813|P1|Double-blind Treatment|Protocol deviation|8
218273|NCT01782326|711812|P2|Double-blind Treatment|Physician Decision|16
218274|NCT01782326|711813|P1|Double-blind Treatment|Physician Decision|13
218275|NCT01782326|711812|P2|Double-blind Treatment|Lack of Efficacy|22
218276|NCT01782326|711813|P1|Double-blind Treatment|Lack of Efficacy|17
218277|NCT01782326|711812|P2|Double-blind Treatment|Subject/guardian decision|125
218278|NCT01782326|711813|P1|Double-blind Treatment|Subject/guardian decision|111
218279|NCT01782326|711812|P2|Double-blind Treatment|Adverse Event|145
218280|NCT01782326|711813|P1|Double-blind Treatment|Adverse Event|129
218281|NCT01782326|711812|P2|Planned Treatment Epoch|Technical problems|4
218282|NCT01782326|711813|P1|Planned Treatment Epoch|Technical problems|0
218283|NCT01782326|711812|P2|Planned Treatment Epoch|Lost to Follow-up|4
218284|NCT01782326|711813|P1|Planned Treatment Epoch|Lost to Follow-up|4
218285|NCT01782326|711812|P2|Planned Treatment Epoch|Protocol deviation|3
218286|NCT01782326|711813|P1|Planned Treatment Epoch|Protocol deviation|2
218287|NCT01782326|711812|P2|Planned Treatment Epoch|Physician Decision|16
218288|NCT01782326|711813|P1|Planned Treatment Epoch|Physician Decision|18
218289|NCT01782326|711812|P2|Planned Treatment Epoch|Death|30
218290|NCT01782326|711813|P1|Planned Treatment Epoch|Death|29
218291|NCT01782326|711812|P2|Planned Treatment Epoch|Subject/guardian decision|151
218292|NCT01782326|711813|P1|Planned Treatment Epoch|Subject/guardian decision|149
218293|NCT01782222|711876|P3|Overall Study|Moved to other state|0
218294|NCT01782222|711877|P2|Overall Study|Moved to other state|1
218295|NCT01782222|711878|P1|Overall Study|Moved to other state|0
218296|NCT01782222|711876|P3|Overall Study|Withdrawal by Subject|1
218297|NCT01782222|711877|P2|Overall Study|Withdrawal by Subject|4
218298|NCT01782222|711878|P1|Overall Study|Withdrawal by Subject|1
218299|NCT01782222|711876|P3|Overall Study|Protocol Violation|0
218300|NCT01782222|711877|P2|Overall Study|Protocol Violation|0
218301|NCT01782222|711878|P1|Overall Study|Protocol Violation|1
218302|NCT01782222|711876|P3|Overall Study|Lack of Efficacy|0
218303|NCT01782222|711877|P2|Overall Study|Lack of Efficacy|1
218304|NCT01782222|711878|P1|Overall Study|Lack of Efficacy|2
218305|NCT01782222|711876|P3|Overall Study|Adverse Event|3
218306|NCT01782222|711877|P2|Overall Study|Adverse Event|5
218307|NCT01782222|711878|P1|Overall Study|Adverse Event|4
218308|NCT01781962|711910|P1|Overall Study|Other Miscellaneous Reasons|5
218309|NCT01781637|711918|P2|Overall Study|Withdrawal by Subject|0
218310|NCT01781637|711919|P1|Overall Study|Withdrawal by Subject|1
218311|NCT01781637|711918|P2|Overall Study|Lack of Efficacy|6
218312|NCT01781637|711919|P1|Overall Study|Lack of Efficacy|2
218313|NCT01781637|711918|P2|Overall Study|Adverse Event|0
218314|NCT01781637|711919|P1|Overall Study|Adverse Event|1
218315|NCT01781299|712006|P2|Overall Study|Withdrawal by Subject|1
218316|NCT01781299|712007|P1|Overall Study|Withdrawal by Subject|0
218317|NCT01781026|712043|P1|Overall Study|Lack of Efficacy|2
218318|NCT01780987|712049|P2|Overall Study|Not Receiving any Study Medication|1
218319|NCT01780987|712050|P1|Overall Study|Not Receiving any Study Medication|0
218320|NCT01780987|712049|P2|Overall Study|Changing Residence|0
218321|NCT01780987|712050|P1|Overall Study|Changing Residence|1
218322|NCT01780987|712049|P2|Overall Study|Request of Changing Hospital|1
218323|NCT01780987|712050|P1|Overall Study|Request of Changing Hospital|0
218324|NCT01780987|712049|P2|Overall Study|Withdrawal by Subject|0
218325|NCT01780987|712050|P1|Overall Study|Withdrawal by Subject|2
218326|NCT01780987|712049|P2|Overall Study|Adverse Event|4
218327|NCT01780987|712050|P1|Overall Study|Adverse Event|0
218328|NCT01780974|712068|P2|Overall Study|Adverse Event|3
218329|NCT01780974|712069|P1|Overall Study|Adverse Event|1
218330|NCT01780974|712068|P2|Overall Study|Death|0
218331|NCT01780974|712069|P1|Overall Study|Death|1
218332|NCT01780935|712079|P2|Overall Study|Patient withdrew consent|9
218333|NCT01780935|712080|P1|Overall Study|Patient withdrew consent|8
218334|NCT01780935|712079|P2|Overall Study|Protocol deviation|1
218335|NCT01780935|712080|P1|Overall Study|Protocol deviation|0
218336|NCT01780935|712079|P2|Overall Study|Physician Decision|1
218337|NCT01780935|712080|P1|Overall Study|Physician Decision|1
218338|NCT01780935|712079|P2|Overall Study|Lost to Follow-up|6
218339|NCT01780935|712080|P1|Overall Study|Lost to Follow-up|2
218340|NCT01780935|712079|P2|Overall Study|Death|6
218341|NCT01780935|712080|P1|Overall Study|Death|1
218342|NCT01780935|712079|P2|Overall Study|Adverse Event|4
218343|NCT01780935|712080|P1|Overall Study|Adverse Event|2
218344|NCT01780935|712079|P2|Overall Study|Admin problems due to early termination|309
218345|NCT01780935|712080|P1|Overall Study|Admin problems due to early termination|321
218346|NCT01780584|712171|P3|Overall Study|Protocol Violation|1
218347|NCT01780584|712172|P2|Overall Study|Protocol Violation|0
218348|NCT01780584|712173|P1|Overall Study|Protocol Violation|0
218349|NCT01780584|712171|P3|Overall Study|Adverse Event|0
218350|NCT01780584|712172|P2|Overall Study|Adverse Event|1
218351|NCT01780584|712173|P1|Overall Study|Adverse Event|0
218352|NCT01780584|712171|P3|Overall Study|Death|1
218353|NCT01780584|712172|P2|Overall Study|Death|0
218354|NCT01780584|712173|P1|Overall Study|Death|1
218355|NCT01780506|712195|P2|Overall Study|Still on Study|388
218356|NCT01780506|712196|P1|Overall Study|Still on Study|401
218357|NCT01780506|712195|P2|Overall Study|Lost to Follow-up|14
218358|NCT01780506|712196|P1|Overall Study|Lost to Follow-up|10
218359|NCT01780506|712195|P2|Overall Study|Withdrew Consent|15
218360|NCT01780506|712196|P1|Overall Study|Withdrew Consent|13
218361|NCT01780506|712195|P2|Overall Study|Protocol Violation|3
218362|NCT01780506|712196|P1|Overall Study|Protocol Violation|3
218363|NCT01780506|712195|P2|Overall Study|Non-Compliance with Study Drug|1
218364|NCT01780506|712196|P1|Overall Study|Non-Compliance with Study Drug|1
218365|NCT01780506|712195|P2|Overall Study|Investigator's Discretion|1
218366|NCT01780506|712196|P1|Overall Study|Investigator's Discretion|2
218367|NCT01780506|712195|P2|Overall Study|Lack of Efficacy|1
218368|NCT01780506|712196|P1|Overall Study|Lack of Efficacy|1
218369|NCT01780506|712195|P2|Overall Study|Pregnancy|0
218370|NCT01780506|712196|P1|Overall Study|Pregnancy|1
218371|NCT01780506|712195|P2|Overall Study|Death|1
218372|NCT01780506|712196|P1|Overall Study|Death|0
218373|NCT01780506|712195|P2|Overall Study|Adverse Event|8
218374|NCT01780506|712196|P1|Overall Study|Adverse Event|3
218375|NCT01780506|712195|P2|Overall Study|Randomized but not Treated|2
218376|NCT01780506|712196|P1|Overall Study|Randomized but not Treated|3
218377|NCT01780389|712234|P1|Overall Study|Adverse Event|1
218378|NCT01779648|712274|P2|Overall Study|Protocol Violation|0
218379|NCT01779648|712275|P1|Overall Study|Protocol Violation|1
218380|NCT01778985|712325|P2|Overall Study|Protocol Violation|1
218381|NCT01778985|712326|P1|Overall Study|Protocol Violation|4
218382|NCT01778985|712325|P2|Overall Study|Physician Decision|2
218383|NCT01778985|712326|P1|Overall Study|Physician Decision|2
218384|NCT01778985|712325|P2|Overall Study|Lost to Follow-up|0
218385|NCT01778985|712326|P1|Overall Study|Lost to Follow-up|1
218386|NCT01778855|712372|P2|Overall Study|Death|1
218387|NCT01778855|712373|P1|Overall Study|Death|0
218388|NCT01778751|712381|P2|Overall Study|Transfered care|0
218389|NCT01778751|712382|P1|Overall Study|Transfered care|1
218390|NCT01778751|712381|P2|Overall Study|Withdrawal by Subject|2
218391|NCT01778751|712382|P1|Overall Study|Withdrawal by Subject|0
218392|NCT01778751|712381|P2|Overall Study|Lost to Follow-up|0
218393|NCT01778751|712382|P1|Overall Study|Lost to Follow-up|1
218394|NCT01778530|712394|P1|Overall Study|Adverse event/side effect|1
218395|NCT01778530|712394|P1|Overall Study|Progression on study|1
218396|NCT01778127|712406|P3|Overall Study|Withdrawal by Subject|4
218397|NCT01778127|712407|P2|Overall Study|Withdrawal by Subject|1
218398|NCT01778127|712408|P1|Overall Study|Withdrawal by Subject|3
218399|NCT01778127|712406|P3|Overall Study|Lost to Follow-up|2
218400|NCT01778127|712407|P2|Overall Study|Lost to Follow-up|1
218401|NCT01778127|712408|P1|Overall Study|Lost to Follow-up|5
218402|NCT01778062|712451|P2|Overall Study|major protocol deviation|3
218403|NCT01778062|712452|P1|Overall Study|major protocol deviation|4
218404|NCT01778062|712451|P2|Overall Study|Consent Withdrawal|5
218405|NCT01778062|712452|P1|Overall Study|Consent Withdrawal|1
218406|NCT01778062|712451|P2|Overall Study|Adverse Event|3
218407|NCT01778062|712452|P1|Overall Study|Adverse Event|1
218408|NCT01778049|712466|P6|Double Blind Treatment Period|Other reason not defined above|1
218409|NCT01778049|712467|P5|Double Blind Treatment Period|Other reason not defined above|2
218410|NCT01778049|712468|P4|Double Blind Treatment Period|Other reason not defined above|2
218411|NCT01778049|712469|P3|Double Blind Treatment Period|Other reason not defined above|4
218412|NCT01778049|712470|P2|Double Blind Treatment Period|Other reason not defined above|0
218413|NCT01778049|712471|P1|Double Blind Treatment Period|Other reason not defined above|0
218414|NCT01778049|712466|P6|Double Blind Treatment Period|Not treated|0
218415|NCT01778049|712467|P5|Double Blind Treatment Period|Not treated|2
218416|NCT01778049|712468|P4|Double Blind Treatment Period|Not treated|2
218417|NCT01778049|712469|P3|Double Blind Treatment Period|Not treated|0
218418|NCT01778049|712470|P2|Double Blind Treatment Period|Not treated|0
218419|NCT01778049|712471|P1|Double Blind Treatment Period|Not treated|0
218420|NCT01778049|712466|P6|Double Blind Treatment Period|Withdrawal by Subject|1
218421|NCT01778049|712467|P5|Double Blind Treatment Period|Withdrawal by Subject|0
218422|NCT01778049|712468|P4|Double Blind Treatment Period|Withdrawal by Subject|2
218423|NCT01778049|712469|P3|Double Blind Treatment Period|Withdrawal by Subject|1
218424|NCT01778049|712470|P2|Double Blind Treatment Period|Withdrawal by Subject|0
218425|NCT01778049|712471|P1|Double Blind Treatment Period|Withdrawal by Subject|0
218426|NCT01778049|712466|P6|Double Blind Treatment Period|Lost to Follow-up|2
218427|NCT01778049|712467|P5|Double Blind Treatment Period|Lost to Follow-up|5
218428|NCT01778049|712468|P4|Double Blind Treatment Period|Lost to Follow-up|1
218429|NCT01778049|712469|P3|Double Blind Treatment Period|Lost to Follow-up|4
218430|NCT01778049|712470|P2|Double Blind Treatment Period|Lost to Follow-up|0
218431|NCT01778049|712471|P1|Double Blind Treatment Period|Lost to Follow-up|0
218432|NCT01778049|712466|P6|Double Blind Treatment Period|Protocol Violation|0
218433|NCT01778049|712467|P5|Double Blind Treatment Period|Protocol Violation|0
218434|NCT01778049|712468|P4|Double Blind Treatment Period|Protocol Violation|0
218435|NCT01778049|712469|P3|Double Blind Treatment Period|Protocol Violation|2
218436|NCT01778049|712470|P2|Double Blind Treatment Period|Protocol Violation|0
218437|NCT01778049|712471|P1|Double Blind Treatment Period|Protocol Violation|0
218438|NCT01778049|712466|P6|Double Blind Treatment Period|Lack of Efficacy|1
218439|NCT01778049|712467|P5|Double Blind Treatment Period|Lack of Efficacy|0
218440|NCT01778049|712468|P4|Double Blind Treatment Period|Lack of Efficacy|0
218441|NCT01778049|712469|P3|Double Blind Treatment Period|Lack of Efficacy|0
218442|NCT01778049|712470|P2|Double Blind Treatment Period|Lack of Efficacy|0
218443|NCT01778049|712471|P1|Double Blind Treatment Period|Lack of Efficacy|0
218444|NCT01778049|712466|P6|Double Blind Treatment Period|Adverse Event|2
218445|NCT01778049|712467|P5|Double Blind Treatment Period|Adverse Event|3
218446|NCT01778049|712468|P4|Double Blind Treatment Period|Adverse Event|5
218447|NCT01778049|712469|P3|Double Blind Treatment Period|Adverse Event|4
218448|NCT01778049|712470|P2|Double Blind Treatment Period|Adverse Event|0
218449|NCT01778049|712471|P1|Double Blind Treatment Period|Adverse Event|0
218450|NCT01778049|712466|P6|Open Label Treatment Period|Other reason not defined above|0
218451|NCT01778049|712467|P5|Open Label Treatment Period|Other reason not defined above|0
218452|NCT01778049|712468|P4|Open Label Treatment Period|Other reason not defined above|0
218453|NCT01778049|712469|P3|Open Label Treatment Period|Other reason not defined above|0
218454|NCT01778049|712470|P2|Open Label Treatment Period|Other reason not defined above|94
218455|NCT01778049|712471|P1|Open Label Treatment Period|Other reason not defined above|77
218456|NCT01778049|712466|P6|Open Label Treatment Period|Not treated|0
218457|NCT01778049|712467|P5|Open Label Treatment Period|Not treated|0
218458|NCT01778049|712468|P4|Open Label Treatment Period|Not treated|0
218459|NCT01778049|712469|P3|Open Label Treatment Period|Not treated|0
218460|NCT01778049|712470|P2|Open Label Treatment Period|Not treated|1
218461|NCT01778049|712471|P1|Open Label Treatment Period|Not treated|2
218462|NCT01778049|712466|P6|Open Label Treatment Period|Withdrawal by Subject|0
218463|NCT01778049|712467|P5|Open Label Treatment Period|Withdrawal by Subject|0
218464|NCT01778049|712468|P4|Open Label Treatment Period|Withdrawal by Subject|0
218465|NCT01778049|712469|P3|Open Label Treatment Period|Withdrawal by Subject|0
218466|NCT01778049|712470|P2|Open Label Treatment Period|Withdrawal by Subject|10
218467|NCT01778049|712471|P1|Open Label Treatment Period|Withdrawal by Subject|4
218468|NCT01778049|712466|P6|Open Label Treatment Period|Lost to Follow-up|0
218469|NCT01778049|712467|P5|Open Label Treatment Period|Lost to Follow-up|0
218470|NCT01778049|712468|P4|Open Label Treatment Period|Lost to Follow-up|0
218471|NCT01778049|712469|P3|Open Label Treatment Period|Lost to Follow-up|0
218472|NCT01778049|712470|P2|Open Label Treatment Period|Lost to Follow-up|3
218473|NCT01778049|712471|P1|Open Label Treatment Period|Lost to Follow-up|4
218474|NCT01778049|712466|P6|Open Label Treatment Period|Protocol Violation|0
218475|NCT01778049|712467|P5|Open Label Treatment Period|Protocol Violation|0
218476|NCT01778049|712468|P4|Open Label Treatment Period|Protocol Violation|0
218477|NCT01778049|712469|P3|Open Label Treatment Period|Protocol Violation|0
218478|NCT01778049|712470|P2|Open Label Treatment Period|Protocol Violation|5
218479|NCT01778049|712471|P1|Open Label Treatment Period|Protocol Violation|5
218480|NCT01778049|712466|P6|Open Label Treatment Period|Lack of Efficacy|0
218481|NCT01778049|712467|P5|Open Label Treatment Period|Lack of Efficacy|0
218482|NCT01778049|712468|P4|Open Label Treatment Period|Lack of Efficacy|0
218483|NCT01778049|712469|P3|Open Label Treatment Period|Lack of Efficacy|0
218484|NCT01778049|712470|P2|Open Label Treatment Period|Lack of Efficacy|1
218485|NCT01778049|712471|P1|Open Label Treatment Period|Lack of Efficacy|1
218486|NCT01778049|712466|P6|Open Label Treatment Period|Adverse Event|0
218487|NCT01778049|712467|P5|Open Label Treatment Period|Adverse Event|0
218488|NCT01778049|712468|P4|Open Label Treatment Period|Adverse Event|0
218489|NCT01778049|712469|P3|Open Label Treatment Period|Adverse Event|0
218490|NCT01778049|712470|P2|Open Label Treatment Period|Adverse Event|15
218491|NCT01778049|712471|P1|Open Label Treatment Period|Adverse Event|5
218492|NCT01778023|712489|P2|Overall Study|Withdrawal by Subject|3
218493|NCT01778023|712490|P1|Overall Study|Withdrawal by Subject|0
218494|NCT01777932|712517|P1|Overall Study|Patient refused further treatment|10
218495|NCT01777932|712517|P1|Overall Study|Reimbursement limit|9
218496|NCT01777932|712517|P1|Overall Study|Investigator decision|10
218497|NCT01777932|712517|P1|Overall Study|Lost to Follow-up|3
218498|NCT01777932|712517|P1|Overall Study|Adverse Event|34
218499|NCT01777932|712517|P1|Overall Study|Death|3
218500|NCT01777932|712517|P1|Overall Study|Disease progression|136
218501|NCT01777776|712535|P4|Overall Study|Withdrawal by Subject|1
218502|NCT01777776|712536|P3|Overall Study|Withdrawal by Subject|0
218503|NCT01777776|712537|P2|Overall Study|Withdrawal by Subject|0
218504|NCT01777776|712538|P1|Overall Study|Withdrawal by Subject|0
218505|NCT01777776|712535|P4|Overall Study|Disease Progression|3
218506|NCT01777776|712536|P3|Overall Study|Disease Progression|6
218507|NCT01777776|712537|P2|Overall Study|Disease Progression|8
218508|NCT01777776|712538|P1|Overall Study|Disease Progression|4
218509|NCT01777776|712535|P4|Overall Study|Adverse Event|0
218510|NCT01777776|712536|P3|Overall Study|Adverse Event|0
218511|NCT01777776|712537|P2|Overall Study|Adverse Event|4
218512|NCT01777776|712538|P1|Overall Study|Adverse Event|2
218513|NCT01777763|712597|P2|Overall Study|Treatment Failure|6
218514|NCT01777763|712598|P1|Overall Study|Treatment Failure|1
218515|NCT01777763|712597|P2|Overall Study|Withdrawal by Subject|2
218516|NCT01777763|712598|P1|Overall Study|Withdrawal by Subject|0
218517|NCT01777763|712597|P2|Overall Study|Protocol Violation|7
218518|NCT01777763|712598|P1|Overall Study|Protocol Violation|1
218519|NCT01777763|712597|P2|Overall Study|Adverse Event|32
218520|NCT01777763|712598|P1|Overall Study|Adverse Event|2
218521|NCT01777620|712622|P2|Overall Study|Subject Withdrawal|0
218522|NCT01777620|712623|P1|Overall Study|Subject Withdrawal|1
218523|NCT01777581|712649|P2|Overall Study|Lack of Efficacy|1
218524|NCT01777581|712650|P1|Overall Study|Lack of Efficacy|0
218525|NCT01777581|712649|P2|Overall Study|Adverse Event|0
218526|NCT01777581|712650|P1|Overall Study|Adverse Event|2
218527|NCT01777581|712649|P2|Overall Study|Lost to Follow-up|1
218528|NCT01777581|712650|P1|Overall Study|Lost to Follow-up|1
218529|NCT01777334|712697|P2|Overall Study|Withdrawal by Subject|11
218530|NCT01777334|712698|P1|Overall Study|Withdrawal by Subject|14
218531|NCT01777334|712697|P2|Overall Study|Lost to Follow-up|2
218532|NCT01777334|712698|P1|Overall Study|Lost to Follow-up|3
218533|NCT01777334|712697|P2|Overall Study|Protocol Violation|7
218534|NCT01777334|712698|P1|Overall Study|Protocol Violation|3
218535|NCT01777334|712697|P2|Overall Study|Lack of Efficacy|29
218536|NCT01777334|712698|P1|Overall Study|Lack of Efficacy|15
218537|NCT01777334|712697|P2|Overall Study|Adverse Event|14
218538|NCT01777334|712698|P1|Overall Study|Adverse Event|18
218539|NCT01777321|712708|P2|Overall Study|Withdrawal by Subject|1
218540|NCT01777321|712709|P1|Overall Study|Withdrawal by Subject|0
218541|NCT01777282|712750|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
218542|NCT01777282|712751|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
218543|NCT01777282|712752|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
218544|NCT01777282|712753|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
218545|NCT01777282|712754|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
218546|NCT01777282|712750|P5|Overall Study|Protocol Violation|2
218547|NCT01777282|712751|P4|Overall Study|Protocol Violation|0
218548|NCT01777282|712752|P3|Overall Study|Protocol Violation|1
218549|NCT01777282|712753|P2|Overall Study|Protocol Violation|0
218550|NCT01777282|712754|P1|Overall Study|Protocol Violation|2
218551|NCT01777282|712750|P5|Overall Study|Withdrawal by Subject|2
218552|NCT01777282|712751|P4|Overall Study|Withdrawal by Subject|1
218553|NCT01777282|712752|P3|Overall Study|Withdrawal by Subject|0
218554|NCT01777282|712753|P2|Overall Study|Withdrawal by Subject|0
218555|NCT01777282|712754|P1|Overall Study|Withdrawal by Subject|4
218556|NCT01777282|712750|P5|Overall Study|Adverse Event|3
218557|NCT01777282|712751|P4|Overall Study|Adverse Event|1
218558|NCT01777282|712752|P3|Overall Study|Adverse Event|2
218559|NCT01777282|712753|P2|Overall Study|Adverse Event|4
218560|NCT01777282|712754|P1|Overall Study|Adverse Event|4
218561|NCT01777282|712750|P5|Overall Study|New Antidiabetic Medication|0
218562|NCT01777282|712751|P4|Overall Study|New Antidiabetic Medication|0
218563|NCT01777282|712752|P3|Overall Study|New Antidiabetic Medication|1
218564|NCT01777282|712753|P2|Overall Study|New Antidiabetic Medication|0
218565|NCT01777282|712754|P1|Overall Study|New Antidiabetic Medication|0
218566|NCT01777282|712750|P5|Overall Study|Persistent Hyperglycemia|0
218567|NCT01777282|712751|P4|Overall Study|Persistent Hyperglycemia|0
218568|NCT01777282|712752|P3|Overall Study|Persistent Hyperglycemia|1
218569|NCT01777282|712753|P2|Overall Study|Persistent Hyperglycemia|0
218570|NCT01777282|712754|P1|Overall Study|Persistent Hyperglycemia|0
218571|NCT01777191|712807|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
218572|NCT01777191|712808|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
218573|NCT01777191|712807|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
218574|NCT01777191|712808|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
218575|NCT01777191|712807|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
218576|NCT01777191|712808|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
218577|NCT01777191|712807|P2|Safety Extension Per (Week 12-Week 48)|Death|1
218578|NCT01777191|712808|P1|Safety Extension Per (Week 12-Week 48)|Death|0
218579|NCT01777191|712807|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
218580|NCT01777191|712808|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
218581|NCT01777191|712807|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
218582|NCT01777191|712808|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
218583|NCT01777191|712807|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
218584|NCT01777191|712808|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
218585|NCT01777191|712807|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
218586|NCT01777191|712808|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
218587|NCT01777191|712807|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
218588|NCT01777191|712808|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
218589|NCT01777191|712807|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
218590|NCT01777191|712808|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
218591|NCT01777191|712807|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
218592|NCT01777191|712808|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
218593|NCT01776554|712871|P2|Overall Study|Unclassified|1
218594|NCT01776554|712872|P1|Overall Study|Unclassified|4
218595|NCT01776554|712871|P2|Overall Study|Protocol Violation|0
218596|NCT01776554|712872|P1|Overall Study|Protocol Violation|1
218597|NCT01776554|712871|P2|Overall Study|Administrative Reason|5
218598|NCT01776554|712872|P1|Overall Study|Administrative Reason|2
218599|NCT01776554|712871|P2|Overall Study|Lost to Follow-up|9
218600|NCT01776554|712872|P1|Overall Study|Lost to Follow-up|6
218601|NCT01776554|712871|P2|Overall Study|Withdrawal by Subject|8
218602|NCT01776554|712872|P1|Overall Study|Withdrawal by Subject|3
218603|NCT01776554|712871|P2|Overall Study|Adverse Event|0
218604|NCT01776554|712872|P1|Overall Study|Adverse Event|1
218605|NCT01776541|712915|P2|Overall Study|Withdrawal by Subject|20
218606|NCT01776541|712916|P1|Overall Study|Withdrawal by Subject|12
218607|NCT01776541|712915|P2|Overall Study|Protocol Violation|1
218608|NCT01776541|712916|P1|Overall Study|Protocol Violation|2
218609|NCT01776541|712915|P2|Overall Study|Unclassified|4
218610|NCT01776541|712916|P1|Overall Study|Unclassified|5
218611|NCT01776541|712915|P2|Overall Study|Lost to Follow-up|48
218612|NCT01776541|712916|P1|Overall Study|Lost to Follow-up|27
218613|NCT01776541|712915|P2|Overall Study|Death|0
218614|NCT01776541|712916|P1|Overall Study|Death|4
218615|NCT01776541|712915|P2|Overall Study|Administrative Reason|2
218616|NCT01776541|712916|P1|Overall Study|Administrative Reason|6
218617|NCT01775995|712937|P2|Overall Study|Lost to Follow-up|1
218618|NCT01775995|712938|P1|Overall Study|Lost to Follow-up|1
218619|NCT01775670|713015|P2|Overall Study|Lost to Follow-up|1
218620|NCT01775670|713016|P1|Overall Study|Lost to Follow-up|1
218621|NCT01775137|713042|P1|Overall Study|Withdrawal by participants|5
218622|NCT01775137|713042|P1|Overall Study|Adverse Event|1
218623|NCT01775137|713042|P1|Overall Study|Unsatisfactory therapeutic effect|2
218624|NCT01775137|713042|P1|Overall Study|Protocol deviation|2
218625|NCT01775137|713042|P1|Overall Study|Death|1
218626|NCT01774968|713069|P2|Overall Study|Withdrawal by Subject|11
218627|NCT01774968|713070|P1|Overall Study|Withdrawal by Subject|6
218628|NCT01774968|713069|P2|Overall Study|Sponsor Decision|2
218629|NCT01774968|713070|P1|Overall Study|Sponsor Decision|0
218630|NCT01774968|713069|P2|Overall Study|Protocol Violation|13
218631|NCT01774968|713070|P1|Overall Study|Protocol Violation|14
218632|NCT01774968|713069|P2|Overall Study|Physician Decision|1
218633|NCT01774968|713070|P1|Overall Study|Physician Decision|5
218634|NCT01774968|713069|P2|Overall Study|Lost to Follow-up|3
218635|NCT01774968|713070|P1|Overall Study|Lost to Follow-up|1
218636|NCT01774968|713069|P2|Overall Study|Death|1
218637|NCT01774968|713070|P1|Overall Study|Death|0
218638|NCT01774968|713069|P2|Overall Study|Adverse Event|4
218639|NCT01774968|713070|P1|Overall Study|Adverse Event|4
218640|NCT01774929|713104|P1|Overall Study|Adverse Event|3
218641|NCT01774903|713110|P1|Overall Study|Ineligible to continue the trial|1
218642|NCT01774903|713110|P1|Overall Study|Lack of Efficacy|1
218643|NCT01774903|713110|P1|Overall Study|Withdrawal by Subject|2
218644|NCT01774903|713110|P1|Overall Study|Adverse Event|7
218645|NCT01774344|713140|P2|Overall Study|Non-compliance with study drug|2
218646|NCT01774344|713141|P1|Overall Study|Non-compliance with study drug|0
218647|NCT01774344|713140|P2|Overall Study|Physician Decision|1
218648|NCT01774344|713141|P1|Overall Study|Physician Decision|0
218649|NCT01774344|713140|P2|Overall Study|Adverse event (AE)|1
218650|NCT01774344|713141|P1|Overall Study|Adverse event (AE)|0
218651|NCT01774344|713140|P2|Overall Study|AE not related to disease progression|47
218652|NCT01774344|713141|P1|Overall Study|AE not related to disease progression|12
218653|NCT01774344|713140|P2|Overall Study|Ongoing with treatment|65
218654|NCT01774344|713141|P1|Overall Study|Ongoing with treatment|10
218655|NCT01774344|713140|P2|Overall Study|Unspecified|0
218656|NCT01774344|713141|P1|Overall Study|Unspecified|1
218657|NCT01774344|713140|P2|Overall Study|Study drug never administered|5
218658|NCT01774344|713141|P1|Overall Study|Study drug never administered|1
218659|NCT01774344|713140|P2|Overall Study|Withdrawal by Subject|26
218660|NCT01774344|713141|P1|Overall Study|Withdrawal by Subject|5
218661|NCT01774344|713140|P2|Overall Study|Protocol Violation|1
218662|NCT01774344|713141|P1|Overall Study|Protocol Violation|3
218663|NCT01774305|713157|P2|Overall Study|Physician Decision|0
218664|NCT01774305|713158|P1|Overall Study|Physician Decision|1
218665|NCT01774253|713166|P1|Overall Study|Death|1
218666|NCT01774253|713166|P1|Overall Study|Withdrawal by Subject|2
218667|NCT01774253|713166|P1|Overall Study|Physician Decision|2
218668|NCT01774253|713166|P1|Overall Study|Lack of Efficacy|4
218669|NCT01774110|713185|P1|Overall Study|Lost to Follow-up|7
218670|NCT01774097|713193|P2|Overall Study|Adverse Event|1
218671|NCT01774097|713194|P1|Overall Study|Adverse Event|1
218672|NCT01774097|713193|P2|Overall Study|Withdrawal by Subject|1
218673|NCT01774097|713194|P1|Overall Study|Withdrawal by Subject|1
218674|NCT01774084|713224|P2|Overall Study|Personal reasons|0
218675|NCT01774084|713225|P1|Overall Study|Personal reasons|1
218676|NCT01773122|713254|P4|Overall Study|Due to amended age eligibility criteria|1
218677|NCT01773122|713255|P3|Overall Study|Due to amended age eligibility criteria|0
218678|NCT01773122|713256|P2|Overall Study|Due to amended age eligibility criteria|1
218679|NCT01773122|713257|P1|Overall Study|Due to amended age eligibility criteria|3
218680|NCT01773889|713271|P1|Overall Study|lack of funding|2
218681|NCT01773473|713277|P2|Overall Study|Lost to Follow-up|0
218682|NCT01773473|713278|P1|Overall Study|Lost to Follow-up|2
218683|NCT01773473|713277|P2|Overall Study|Withdrawal by Subject|3
218684|NCT01773473|713278|P1|Overall Study|Withdrawal by Subject|5
218685|NCT01773473|713277|P2|Overall Study|Non-Compliance with study drug|4
218686|NCT01773473|713278|P1|Overall Study|Non-Compliance with study drug|1
218687|NCT01773473|713277|P2|Overall Study|Lack of Efficacy|1
218688|NCT01773473|713278|P1|Overall Study|Lack of Efficacy|0
218689|NCT01773473|713277|P2|Overall Study|Sponsor Decision|0
218690|NCT01773473|713278|P1|Overall Study|Sponsor Decision|2
218691|NCT01773473|713277|P2|Overall Study|Physician Decision|5
218692|NCT01773473|713278|P1|Overall Study|Physician Decision|3
218693|NCT01773473|713277|P2|Overall Study|Protocol Violation|4
218694|NCT01773473|713278|P1|Overall Study|Protocol Violation|0
218695|NCT01773473|713277|P2|Overall Study|Adverse Event|2
218696|NCT01773473|713278|P1|Overall Study|Adverse Event|3
218697|NCT01773291|713299|P3|Overall Study|Withdrawal by Subject|1
218698|NCT01773291|713300|P2|Overall Study|Withdrawal by Subject|0
218699|NCT01773291|713301|P1|Overall Study|Withdrawal by Subject|0
218700|NCT01773291|713299|P3|Overall Study|Protocol Violation|0
218701|NCT01773291|713300|P2|Overall Study|Protocol Violation|0
218702|NCT01773291|713301|P1|Overall Study|Protocol Violation|1
218703|NCT01773226|713312|P1|Overall Study|Withdrawal by Subject|1
218704|NCT01772576|713336|P1|Overall Study|Withdrawal by Subject|6
218705|NCT01772576|713336|P1|Overall Study|Adverse Event|6
218706|NCT01772576|713336|P1|Overall Study|Study device not used|3
218707|NCT01772576|713336|P1|Overall Study|Lost to Follow-up|3
218708|NCT01772576|713336|P1|Overall Study|Protocol Violation|1
218709|NCT01772576|713336|P1|Overall Study|Death|15
218710|NCT01772550|713348|P3|Overall Study|Adverse Event|1
218711|NCT01772550|713349|P2|Overall Study|Adverse Event|0
218712|NCT01772550|713350|P1|Overall Study|Adverse Event|0
218713|NCT01772550|713348|P3|Overall Study|Unable to insert IV in antecubital vein|5
218714|NCT01772550|713349|P2|Overall Study|Unable to insert IV in antecubital vein|1
218715|NCT01772550|713350|P1|Overall Study|Unable to insert IV in antecubital vein|1
218716|NCT01772537|713391|P3|Overall Study|unsuccessful lumbar drain placement|0
218717|NCT01772537|713392|P2|Overall Study|unsuccessful lumbar drain placement|0
218718|NCT01772537|713393|P1|Overall Study|unsuccessful lumbar drain placement|1
218719|NCT01772368|713407|P1|Overall Study|Not specified|1
218720|NCT01772368|713407|P1|Overall Study|Protocol Violation|2
218721|NCT01772368|713407|P1|Overall Study|Withdrawal by Subject|3
218722|NCT01772368|713407|P1|Overall Study|Adverse Event|1
218723|NCT01772316|713453|P1|Overall Study|Withdrawn by sponsor decision|5
218724|NCT01772316|713453|P1|Overall Study|Inform consent withdrawn|1
218725|NCT01772316|713453|P1|Overall Study|Serious adverse event|1
218726|NCT01772147|713474|P3|Overall Study|Lack of Efficacy|6
218727|NCT01772147|713475|P2|Overall Study|Lack of Efficacy|6
218728|NCT01772147|713476|P1|Overall Study|Lack of Efficacy|8
218729|NCT01772147|713474|P3|Overall Study|Protocol Deviation|1
218730|NCT01772147|713475|P2|Overall Study|Protocol Deviation|1
218731|NCT01772147|713476|P1|Overall Study|Protocol Deviation|2
218732|NCT01772147|713474|P3|Overall Study|Lost to Follow-up|1
218733|NCT01772147|713475|P2|Overall Study|Lost to Follow-up|0
218734|NCT01772147|713476|P1|Overall Study|Lost to Follow-up|1
218735|NCT01772147|713474|P3|Overall Study|Withdrew Consent|4
218736|NCT01772147|713475|P2|Overall Study|Withdrew Consent|8
218737|NCT01772147|713476|P1|Overall Study|Withdrew Consent|7
218738|NCT01772147|713474|P3|Overall Study|Adverse Event|6
218739|NCT01772147|713475|P2|Overall Study|Adverse Event|10
218740|NCT01772147|713476|P1|Overall Study|Adverse Event|13
218741|NCT01772134|713496|P3|Overall Study|Randomized Study Medication Not Received|1
218742|NCT01772134|713497|P2|Overall Study|Randomized Study Medication Not Received|0
218743|NCT01772134|713498|P1|Overall Study|Randomized Study Medication Not Received|2
218744|NCT01772134|713496|P3|Overall Study|Protocol-defined Stopping Criteria|0
218745|NCT01772134|713497|P2|Overall Study|Protocol-defined Stopping Criteria|0
218746|NCT01772134|713498|P1|Overall Study|Protocol-defined Stopping Criteria|1
218747|NCT01772134|713496|P3|Overall Study|Lack of Efficacy|3
218748|NCT01772134|713497|P2|Overall Study|Lack of Efficacy|5
218749|NCT01772134|713498|P1|Overall Study|Lack of Efficacy|11
218750|NCT01772134|713496|P3|Overall Study|Protocol Deviation|3
218751|NCT01772134|713497|P2|Overall Study|Protocol Deviation|3
218752|NCT01772134|713498|P1|Overall Study|Protocol Deviation|4
218753|NCT01772134|713496|P3|Overall Study|Lost to Follow-up|0
218754|NCT01772134|713497|P2|Overall Study|Lost to Follow-up|0
218755|NCT01772134|713498|P1|Overall Study|Lost to Follow-up|2
218756|NCT01772134|713496|P3|Overall Study|Withdrew Consent|5
218757|NCT01772134|713497|P2|Overall Study|Withdrew Consent|1
218758|NCT01772134|713498|P1|Overall Study|Withdrew Consent|3
218759|NCT01772134|713496|P3|Overall Study|Adverse Event|10
218760|NCT01772134|713497|P2|Overall Study|Adverse Event|5
218761|NCT01772134|713498|P1|Overall Study|Adverse Event|6
218762|NCT01771913|713526|P2|Overall Study|Withdrawal by Subject|0
218763|NCT01771913|713527|P1|Overall Study|Withdrawal by Subject|1
218764|NCT01770860|713541|P1|Overall Study|Administrative decision made by the PI|1
218765|NCT01770860|713541|P1|Overall Study|Lost to Follow-up|1
218766|NCT01770860|713541|P1|Overall Study|Withdrawal by Subject|4
218767|NCT01770743|713589|P5|Overall Study|Moving Out of State|0
218768|NCT01770743|713590|P4|Overall Study|Moving Out of State|0
218769|NCT01770743|713591|P3|Overall Study|Moving Out of State|0
218770|NCT01770743|713592|P2|Overall Study|Moving Out of State|1
218771|NCT01770743|713593|P1|Overall Study|Moving Out of State|0
218772|NCT01770743|713589|P5|Overall Study|Sponsor Terminated Subject|0
218773|NCT01770743|713590|P4|Overall Study|Sponsor Terminated Subject|1
218774|NCT01770743|713591|P3|Overall Study|Sponsor Terminated Subject|0
218775|NCT01770743|713592|P2|Overall Study|Sponsor Terminated Subject|0
218776|NCT01770743|713593|P1|Overall Study|Sponsor Terminated Subject|1
218777|NCT01770743|713589|P5|Overall Study|Lost to Follow-up|1
218778|NCT01770743|713590|P4|Overall Study|Lost to Follow-up|0
218779|NCT01770743|713591|P3|Overall Study|Lost to Follow-up|0
218780|NCT01770743|713592|P2|Overall Study|Lost to Follow-up|2
218781|NCT01770743|713593|P1|Overall Study|Lost to Follow-up|0
218782|NCT01770743|713589|P5|Overall Study|Withdrawal by Subject|1
218783|NCT01770743|713590|P4|Overall Study|Withdrawal by Subject|1
218784|NCT01770743|713591|P3|Overall Study|Withdrawal by Subject|1
218785|NCT01770743|713592|P2|Overall Study|Withdrawal by Subject|0
218786|NCT01770743|713593|P1|Overall Study|Withdrawal by Subject|0
218787|NCT01770743|713589|P5|Overall Study|Adverse Event|0
218788|NCT01770743|713590|P4|Overall Study|Adverse Event|0
218789|NCT01770743|713591|P3|Overall Study|Adverse Event|0
218790|NCT01770743|713592|P2|Overall Study|Adverse Event|0
218791|NCT01770743|713593|P1|Overall Study|Adverse Event|1
218792|NCT01770509|713695|P2|Overall Study|Lost to Follow-up|2
218793|NCT01770509|713696|P1|Overall Study|Lost to Follow-up|1
218794|NCT01770509|713695|P2|Overall Study|Injury|1
218795|NCT01770509|713696|P1|Overall Study|Injury|0
218796|NCT01770392|713721|P1|Washout Period of at Least 14 Days|Adverse Event|1
218797|NCT01770379|713736|P3|Overall Study|Adverse Event|2
218798|NCT01770379|713737|P2|Overall Study|Adverse Event|3
218799|NCT01770379|713738|P1|Overall Study|Adverse Event|1
218800|NCT01770379|713736|P3|Overall Study|Lack of Efficacy|6
218801|NCT01770379|713737|P2|Overall Study|Lack of Efficacy|6
218802|NCT01770379|713738|P1|Overall Study|Lack of Efficacy|8
218803|NCT01770379|713736|P3|Overall Study|Lost to Follow-up|2
218804|NCT01770379|713737|P2|Overall Study|Lost to Follow-up|0
218805|NCT01770379|713738|P1|Overall Study|Lost to Follow-up|0
218806|NCT01770379|713736|P3|Overall Study|Physician Decision|2
218807|NCT01770379|713737|P2|Overall Study|Physician Decision|1
218808|NCT01770379|713738|P1|Overall Study|Physician Decision|0
218809|NCT01770379|713736|P3|Overall Study|Protocol Violation|1
218810|NCT01770379|713737|P2|Overall Study|Protocol Violation|1
218811|NCT01770379|713738|P1|Overall Study|Protocol Violation|0
218812|NCT01770379|713736|P3|Overall Study|study terminated by sponsor|22
218813|NCT01770379|713737|P2|Overall Study|study terminated by sponsor|23
218814|NCT01770379|713738|P1|Overall Study|study terminated by sponsor|22
218815|NCT01770379|713736|P3|Overall Study|Withdrawal by Subject|7
218816|NCT01770379|713737|P2|Overall Study|Withdrawal by Subject|10
218817|NCT01770379|713738|P1|Overall Study|Withdrawal by Subject|7
218818|NCT01770379|713736|P3|Overall Study|Technical issues|0
218819|NCT01770379|713737|P2|Overall Study|Technical issues|0
218820|NCT01770379|713738|P1|Overall Study|Technical issues|1
218821|NCT01770145|713775|P1|Treatment|Withdrawal by Subject|1
218822|NCT01770145|713775|P1|Treatment|Adverse Event|3
218823|NCT01770145|713775|P1|Baseline|Unable to define optimal dose|4
218824|NCT01770145|713775|P1|Baseline|Lost to Follow-up|1
218825|NCT01770145|713775|P1|Baseline|Withdrawal by Subject|1
218826|NCT01770145|713775|P1|Baseline|Adverse Event|20
218827|NCT01769508|713789|P1|Overall Study|Lost to Follow-up|1
218828|NCT01769508|713789|P1|Overall Study|Adverse Event|1
218829|NCT01769508|713789|P1|Overall Study|Withdrawal by Subject|1
218830|NCT01769508|713789|P1|Overall Study|Death|3
218831|NCT01769443|713800|P2|Overall Study|Study closure|0
218832|NCT01769443|713801|P1|Overall Study|Study closure|1
218833|NCT01769391|713845|P2|Overall Study|On Treatment at Study Conclusion|0
218834|NCT01769391|713846|P1|Overall Study|On Treatment at Study Conclusion|3
218835|NCT01769391|713845|P2|Overall Study|Investigator Decision|0
218836|NCT01769391|713846|P1|Overall Study|Investigator Decision|2
218837|NCT01769391|713845|P2|Overall Study|Withdrawal by Subject|3
218838|NCT01769391|713846|P1|Overall Study|Withdrawal by Subject|4
218839|NCT01769391|713845|P2|Overall Study|Progressive Disease|2
218840|NCT01769391|713846|P1|Overall Study|Progressive Disease|1
218841|NCT01769391|713845|P2|Overall Study|Adverse Event|3
218842|NCT01769391|713846|P1|Overall Study|Adverse Event|0
218843|NCT01769391|713845|P2|Overall Study|Death|1
218844|NCT01769391|713846|P1|Overall Study|Death|10
218845|NCT01769378|713865|P2|Overall Study|Lost to Follow-up|0
218846|NCT01769378|713866|P1|Overall Study|Lost to Follow-up|2
218847|NCT01769378|713865|P2|Overall Study|Sponsor Decision|0
218848|NCT01769378|713866|P1|Overall Study|Sponsor Decision|1
218849|NCT01769378|713865|P2|Overall Study|Withdrawal by Subject|3
218850|NCT01769378|713866|P1|Overall Study|Withdrawal by Subject|10
218851|NCT01769378|713865|P2|Overall Study|Protocol Violation|1
218852|NCT01769378|713866|P1|Overall Study|Protocol Violation|1
218853|NCT01769378|713865|P2|Overall Study|Entry criteria not met|0
218854|NCT01769378|713866|P1|Overall Study|Entry criteria not met|1
218855|NCT01769378|713865|P2|Overall Study|Adverse Event|0
218856|NCT01769378|713866|P1|Overall Study|Adverse Event|10
218857|NCT01769339|713914|P1|Overall Study|Adverse Event|1
218858|NCT01769339|713914|P1|Overall Study|Lost to Follow-up|42
218859|NCT01769326|713925|P4|Overall Study|Got sick and could not complete study|0
218860|NCT01769326|713926|P3|Overall Study|Got sick and could not complete study|1
218861|NCT01769326|713927|P2|Overall Study|Got sick and could not complete study|0
218862|NCT01769326|713928|P1|Overall Study|Got sick and could not complete study|0
218863|NCT01769326|713925|P4|Overall Study|got a job|0
218864|NCT01769326|713926|P3|Overall Study|got a job|0
218865|NCT01769326|713927|P2|Overall Study|got a job|1
218866|NCT01769326|713928|P1|Overall Study|got a job|0
218867|NCT01769326|713925|P4|Overall Study|unrelated injry|0
218868|NCT01769326|713926|P3|Overall Study|unrelated injry|0
218869|NCT01769326|713927|P2|Overall Study|unrelated injry|1
218870|NCT01769326|713928|P1|Overall Study|unrelated injry|1
218871|NCT01769326|713925|P4|Overall Study|Lost to Follow-up|0
218872|NCT01769326|713926|P3|Overall Study|Lost to Follow-up|0
218873|NCT01769326|713927|P2|Overall Study|Lost to Follow-up|2
218874|NCT01769326|713928|P1|Overall Study|Lost to Follow-up|1
218875|NCT01769196|713966|P2|Overall Study|Withdrew consent|40
218876|NCT01769196|713967|P1|Overall Study|Withdrew consent|36
218877|NCT01769196|713966|P2|Overall Study|Participant never dosed with study drug|0
218878|NCT01769196|713967|P1|Overall Study|Participant never dosed with study drug|1
218879|NCT01769196|713966|P2|Overall Study|Study terminated by sponsor|161
218880|NCT01769196|713967|P1|Overall Study|Study terminated by sponsor|160
218881|NCT01769196|713966|P2|Overall Study|Protocol Violation|3
218882|NCT01769196|713967|P1|Overall Study|Protocol Violation|0
218883|NCT01769196|713966|P2|Overall Study|Protocol defined criteria for withdrawal|11
218884|NCT01769196|713967|P1|Overall Study|Protocol defined criteria for withdrawal|9
218885|NCT01769196|713966|P2|Overall Study|Progressive disease|6
218886|NCT01769196|713967|P1|Overall Study|Progressive disease|11
218887|NCT01769196|713966|P2|Overall Study|Lack of Efficacy|2
218888|NCT01769196|713967|P1|Overall Study|Lack of Efficacy|3
218889|NCT01769196|713966|P2|Overall Study|Investigator Discretion|3
218890|NCT01769196|713967|P1|Overall Study|Investigator Discretion|7
218891|NCT01769196|713966|P2|Overall Study|Death|26
218892|NCT01769196|713967|P1|Overall Study|Death|21
218893|NCT01769196|713966|P2|Overall Study|Adverse Event|20
218894|NCT01769196|713967|P1|Overall Study|Adverse Event|24
218895|NCT01769105|713997|P2|Cross-over|Lost to Follow-up|0
218896|NCT01769105|713998|P1|Cross-over|Lost to Follow-up|5
218897|NCT01769105|713997|P2|First Intervention|Protocol Violation|2
218898|NCT01769105|713998|P1|First Intervention|Protocol Violation|2
218899|NCT01768676|714019|P2|Overall Study|Withdrawal by Subject|10
218900|NCT01768676|714020|P1|Overall Study|Withdrawal by Subject|3
218901|NCT01768676|714019|P2|Overall Study|Physician Decision|1
218902|NCT01768676|714020|P1|Overall Study|Physician Decision|4
218903|NCT01768676|714019|P2|Overall Study|Protocol Violation|1
218904|NCT01768676|714020|P1|Overall Study|Protocol Violation|1
218905|NCT01768676|714019|P2|Overall Study|Lost to Follow-up|16
218906|NCT01768676|714020|P1|Overall Study|Lost to Follow-up|13
218907|NCT01768676|714019|P2|Overall Study|Adverse Event|3
218908|NCT01768676|714020|P1|Overall Study|Adverse Event|3
218909|NCT01768559|714037|P3|Overall Study|Other than specified|5
218910|NCT01768559|714038|P2|Overall Study|Other than specified|8
218911|NCT01768559|714039|P1|Overall Study|Other than specified|9
218912|NCT01768559|714037|P3|Overall Study|Poor compliance to protocol|2
218913|NCT01768559|714038|P2|Overall Study|Poor compliance to protocol|3
218914|NCT01768559|714039|P1|Overall Study|Poor compliance to protocol|0
218915|NCT01768559|714037|P3|Overall Study|Lack of Efficacy|0
218916|NCT01768559|714038|P2|Overall Study|Lack of Efficacy|4
218917|NCT01768559|714039|P1|Overall Study|Lack of Efficacy|6
218918|NCT01768559|714037|P3|Overall Study|Adverse Event|5
218919|NCT01768559|714038|P2|Overall Study|Adverse Event|2
218920|NCT01768559|714039|P1|Overall Study|Adverse Event|15
218921|NCT01768559|714037|P3|Overall Study|Randomized but not treated|1
218922|NCT01768559|714038|P2|Overall Study|Randomized but not treated|0
218923|NCT01768559|714039|P1|Overall Study|Randomized but not treated|0
218924|NCT01768286|714104|P4|Overall Study|Withdrew Consent|0
218925|NCT01768286|714105|P3|Overall Study|Withdrew Consent|1
218926|NCT01768286|714106|P2|Overall Study|Withdrew Consent|0
218927|NCT01768286|714107|P1|Overall Study|Withdrew Consent|0
218928|NCT01768286|714104|P4|Overall Study|Lack of Efficacy|1
218929|NCT01768286|714105|P3|Overall Study|Lack of Efficacy|0
218930|NCT01768286|714106|P2|Overall Study|Lack of Efficacy|4
218931|NCT01768286|714107|P1|Overall Study|Lack of Efficacy|7
218932|NCT01768286|714104|P4|Overall Study|Randomized But Not Treated|0
218933|NCT01768286|714105|P3|Overall Study|Randomized But Not Treated|1
218934|NCT01768286|714106|P2|Overall Study|Randomized But Not Treated|0
218935|NCT01768286|714107|P1|Overall Study|Randomized But Not Treated|0
218936|NCT01768117|714169|P1|Overall Study|Protocol Violation|3
218937|NCT01768117|714169|P1|Overall Study|Withdrawal by Subject|2
218938|NCT01768117|714169|P1|Overall Study|Lost to Follow-up|1
218939|NCT01767987|714233|P2|Overall Study|Physician Decision|1
218940|NCT01767987|714234|P1|Overall Study|Physician Decision|4
218941|NCT01767597|714292|P2|Overall Study|Withdrawal by Subject|0
218942|NCT01767597|714293|P1|Overall Study|Withdrawal by Subject|1
218943|NCT01767597|714292|P2|Overall Study|Incomplete intervention|1
218944|NCT01767597|714293|P1|Overall Study|Incomplete intervention|3
218945|NCT01767519|714302|P3|Overall Study|Adverse Event|1
218946|NCT01767519|714303|P2|Overall Study|Adverse Event|5
218947|NCT01767519|714304|P1|Overall Study|Adverse Event|5
218948|NCT01767519|714302|P3|Overall Study|Lack of Efficacy|0
218949|NCT01767519|714303|P2|Overall Study|Lack of Efficacy|0
218950|NCT01767519|714304|P1|Overall Study|Lack of Efficacy|1
218951|NCT01767519|714302|P3|Overall Study|Lost to Follow-up|2
218952|NCT01767519|714303|P2|Overall Study|Lost to Follow-up|1
218953|NCT01767519|714304|P1|Overall Study|Lost to Follow-up|3
218954|NCT01767519|714302|P3|Overall Study|Personal Reasons|0
218955|NCT01767519|714303|P2|Overall Study|Personal Reasons|0
218956|NCT01767519|714304|P1|Overall Study|Personal Reasons|1
218957|NCT01767519|714302|P3|Overall Study|Protocol Violation|0
218958|NCT01767519|714303|P2|Overall Study|Protocol Violation|3
218959|NCT01767519|714304|P1|Overall Study|Protocol Violation|0
218960|NCT01767519|714302|P3|Overall Study|Other Reasons|2
218961|NCT01767519|714303|P2|Overall Study|Other Reasons|4
218962|NCT01767519|714304|P1|Overall Study|Other Reasons|4
218963|NCT01767467|714332|P2|Overall Study|Subject unavailable|1
218964|NCT01767467|714333|P1|Overall Study|Subject unavailable|0
218965|NCT01767467|714332|P2|Overall Study|Physician Decision|0
218966|NCT01767467|714333|P1|Overall Study|Physician Decision|1
218967|NCT01767467|714332|P2|Overall Study|Suspected Herpes Zoster episode|1
218968|NCT01767467|714333|P1|Overall Study|Suspected Herpes Zoster episode|0
218969|NCT01767467|714332|P2|Overall Study|Withdrawal by Subject|10
218970|NCT01767467|714333|P1|Overall Study|Withdrawal by Subject|7
218971|NCT01767467|714332|P2|Overall Study|Protocol Violation|0
218972|NCT01767467|714333|P1|Overall Study|Protocol Violation|1
218973|NCT01767467|714332|P2|Overall Study|Adverse Event|8
218974|NCT01767467|714333|P1|Overall Study|Adverse Event|8
218975|NCT01767116|714382|P2|Overall Study|Lost to Follow-up|2
218976|NCT01767116|714383|P1|Overall Study|Lost to Follow-up|2
218977|NCT01766921|714432|P2|Overall Study|Withdrawal by Subject|5
218978|NCT01766921|714433|P1|Overall Study|Withdrawal by Subject|14
218979|NCT01766921|714432|P2|Overall Study|Protocol Violation|1
218980|NCT01766921|714433|P1|Overall Study|Protocol Violation|1
218981|NCT01766921|714432|P2|Overall Study|Unclassified|2
218982|NCT01766921|714433|P1|Overall Study|Unclassified|2
218983|NCT01766921|714432|P2|Overall Study|Lost to Follow-up|3
218984|NCT01766921|714433|P1|Overall Study|Lost to Follow-up|1
218985|NCT01766921|714432|P2|Overall Study|Death|1
218986|NCT01766921|714433|P1|Overall Study|Death|1
218987|NCT01766921|714432|P2|Overall Study|Administrative Reason|5
218988|NCT01766921|714433|P1|Overall Study|Administrative Reason|5
218989|NCT01766778|714454|P2|Overall Study|Withdrawal by Subject|0
218990|NCT01766778|714455|P1|Overall Study|Withdrawal by Subject|1
218991|NCT01766778|714454|P2|Overall Study|Adverse Event|4
218992|NCT01766778|714455|P1|Overall Study|Adverse Event|4
218993|NCT01766336|714509|P2|Overall Study|Withdrawal by Subject|15
218994|NCT01766336|714510|P1|Overall Study|Withdrawal by Subject|18
218995|NCT01766336|714509|P2|Overall Study|Sponsor Decision|43
218996|NCT01766336|714510|P1|Overall Study|Sponsor Decision|52
218997|NCT01766336|714509|P2|Overall Study|Protocol Violation|1
218998|NCT01766336|714510|P1|Overall Study|Protocol Violation|0
218999|NCT01766336|714509|P2|Overall Study|Physician Decision|2
219000|NCT01766336|714510|P1|Overall Study|Physician Decision|4
219001|NCT01766336|714509|P2|Overall Study|Lost to Follow-up|3
219002|NCT01766336|714510|P1|Overall Study|Lost to Follow-up|1
219003|NCT01766336|714509|P2|Overall Study|Death|3
219004|NCT01766336|714510|P1|Overall Study|Death|4
219005|NCT01766336|714509|P2|Overall Study|Adverse Event|8
219006|NCT01766336|714510|P1|Overall Study|Adverse Event|11
219007|NCT01766310|714518|P2|Overall Study|Lost to Follow-up|3
219008|NCT01766310|714519|P1|Overall Study|Lost to Follow-up|1
219009|NCT01766050|714536|P1|Overall Study|Withdrawal by Subject|2
219010|NCT01766050|714536|P1|Overall Study|Lost to Follow-up|1
219011|NCT01766050|714536|P1|Overall Study|Adverse Event|1
219012|NCT01766037|714671|P2|Overall Study|nausea / discomfort|0
219013|NCT01766037|714672|P1|Overall Study|nausea / discomfort|3
219014|NCT01766037|714671|P2|Overall Study|medical - unrelated|2
219015|NCT01766037|714672|P1|Overall Study|medical - unrelated|1
219016|NCT01766037|714671|P2|Overall Study|Moved from area|0
219017|NCT01766037|714672|P1|Overall Study|Moved from area|5
219018|NCT01766037|714671|P2|Overall Study|Withdrawal by Subject|16
219019|NCT01766037|714672|P1|Overall Study|Withdrawal by Subject|18
219020|NCT01766037|714671|P2|Overall Study|Physician Decision|1
219021|NCT01766037|714672|P1|Overall Study|Physician Decision|0
219022|NCT01766037|714671|P2|Overall Study|Lost to Follow-up|10
219023|NCT01766037|714672|P1|Overall Study|Lost to Follow-up|0
219024|NCT01766037|714671|P2|Overall Study|Lack of Efficacy|0
219025|NCT01766037|714672|P1|Overall Study|Lack of Efficacy|1
219026|NCT01766037|714671|P2|Overall Study|Adverse Event|0
219027|NCT01766037|714672|P1|Overall Study|Adverse Event|1
219028|NCT01765764|714741|P3|Treatment Period|Other Miscellaneous Reasons|2
219029|NCT01765764|714742|P2|Treatment Period|Other Miscellaneous Reasons|2
219030|NCT01765764|714743|P1|Treatment Period|Other Miscellaneous Reasons|1
219031|NCT01765764|714741|P3|Treatment Period|Personal Reasons|1
219032|NCT01765764|714742|P2|Treatment Period|Personal Reasons|2
219033|NCT01765764|714743|P1|Treatment Period|Personal Reasons|1
219034|NCT01765764|714741|P3|Treatment Period|Lost to Follow-up|2
219035|NCT01765764|714742|P2|Treatment Period|Lost to Follow-up|3
219036|NCT01765764|714743|P1|Treatment Period|Lost to Follow-up|0
219037|NCT01765764|714741|P3|Treatment Period|Adverse Event|1
219038|NCT01765764|714742|P2|Treatment Period|Adverse Event|2
219039|NCT01765764|714743|P1|Treatment Period|Adverse Event|1
219040|NCT01765569|714760|P1|Period C|Death|1
219041|NCT01765569|714760|P1|Period B|Withdrawal by Subject|1
219042|NCT01765543|714781|P1|Overall Study|Withdrawal by Subject|2
219043|NCT01765543|714781|P1|Overall Study|Death|1
219044|NCT01765426|714833|P4|Overall Study|Lost to Follow-up|0
219045|NCT01765426|714834|P3|Overall Study|Lost to Follow-up|0
219046|NCT01765426|714835|P2|Overall Study|Lost to Follow-up|1
219047|NCT01765426|714836|P1|Overall Study|Lost to Follow-up|0
219048|NCT01765270|714892|P2|Overall Study|Withdrawal by Subject|1
219049|NCT01765270|714893|P1|Overall Study|Withdrawal by Subject|0
219050|NCT01765270|714892|P2|Overall Study|Physician Decision|0
219051|NCT01765270|714893|P1|Overall Study|Physician Decision|1
219052|NCT01765192|714915|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
219053|NCT01765192|714916|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
219054|NCT01765192|714915|P2|Treatment Period 2|Reason not specified|2
219055|NCT01765192|714916|P1|Treatment Period 2|Reason not specified|0
219056|NCT01765192|714915|P2|Washout Period|Reason not specified|0
219057|NCT01765192|714916|P1|Washout Period|Reason not specified|1
219058|NCT01765192|714915|P2|Washout Period|Voluntary Withdrawal|1
219059|NCT01765192|714916|P1|Washout Period|Voluntary Withdrawal|1
219060|NCT01765192|714915|P2|Treatment Period 1|Adverse Event|1
219061|NCT01765192|714916|P1|Treatment Period 1|Adverse Event|0
219062|NCT01765153|714936|P2|Rest Phase 2|Lost to Follow-up|1
219063|NCT01765153|714937|P1|Rest Phase 2|Lost to Follow-up|2
219064|NCT01765153|714936|P2|Training Phase 2|Withdrawal by Subject|1
219065|NCT01765153|714937|P1|Training Phase 2|Withdrawal by Subject|0
219066|NCT01765153|714936|P2|Rest Phase 1|Withdrawal by Subject|1
219067|NCT01765153|714937|P1|Rest Phase 1|Withdrawal by Subject|0
219068|NCT01765153|714936|P2|Training Phase 1|Poor participation in intervention|1
219069|NCT01765153|714937|P1|Training Phase 1|Poor participation in intervention|0
219070|NCT01765153|714936|P2|Training Phase 1|Format of intervention differed|0
219071|NCT01765153|714937|P1|Training Phase 1|Format of intervention differed|1
219072|NCT01764945|715047|P8|Overall Study|Adverse Event|0
219073|NCT01764945|715048|P7|Overall Study|Adverse Event|1
219074|NCT01764945|715049|P6|Overall Study|Adverse Event|0
219075|NCT01764945|715050|P5|Overall Study|Adverse Event|0
219076|NCT01764945|715051|P4|Overall Study|Adverse Event|0
219077|NCT01764945|715052|P3|Overall Study|Adverse Event|0
219078|NCT01764945|715053|P2|Overall Study|Adverse Event|1
219079|NCT01764945|715054|P1|Overall Study|Adverse Event|0
219080|NCT01764841|715100|P4|Overall Study|Lost to Follow-up|0
219081|NCT01764841|715101|P3|Overall Study|Lost to Follow-up|1
219082|NCT01764841|715102|P2|Overall Study|Lost to Follow-up|0
219083|NCT01764841|715103|P1|Overall Study|Lost to Follow-up|3
219084|NCT01764841|715100|P4|Overall Study|Withdrawal by Subject|15
219085|NCT01764841|715101|P3|Overall Study|Withdrawal by Subject|11
219086|NCT01764841|715102|P2|Overall Study|Withdrawal by Subject|24
219087|NCT01764841|715103|P1|Overall Study|Withdrawal by Subject|16
219088|NCT01764841|715100|P4|Overall Study|Protocol Violation|0
219089|NCT01764841|715101|P3|Overall Study|Protocol Violation|0
219090|NCT01764841|715102|P2|Overall Study|Protocol Violation|1
219091|NCT01764841|715103|P1|Overall Study|Protocol Violation|0
219092|NCT01764841|715100|P4|Overall Study|No Follow Up|0
219093|NCT01764841|715101|P3|Overall Study|No Follow Up|1
219094|NCT01764841|715102|P2|Overall Study|No Follow Up|0
219095|NCT01764841|715103|P1|Overall Study|No Follow Up|1
219096|NCT01764841|715100|P4|Overall Study|Death|4
219097|NCT01764841|715101|P3|Overall Study|Death|1
219098|NCT01764841|715102|P2|Overall Study|Death|0
219099|NCT01764841|715103|P1|Overall Study|Death|3
219100|NCT01764841|715100|P4|Overall Study|Logistical Difficulties|0
219101|NCT01764841|715101|P3|Overall Study|Logistical Difficulties|0
219102|NCT01764841|715102|P2|Overall Study|Logistical Difficulties|1
219103|NCT01764841|715103|P1|Overall Study|Logistical Difficulties|0
219104|NCT01764386|715151|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
219105|NCT01764386|715152|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
219106|NCT01764386|715151|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
219107|NCT01764386|715152|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
219108|NCT01764386|715151|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
219109|NCT01764386|715152|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
219110|NCT01764386|715151|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
219111|NCT01764386|715152|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
219112|NCT01764386|715151|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
219113|NCT01764386|715152|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
219114|NCT01764386|715151|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
219115|NCT01764386|715152|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
219116|NCT01764386|715151|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
219117|NCT01764386|715152|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
219118|NCT01764386|715151|P2|Controlled Treatment Period (CTP)|Adverse Event|0
219119|NCT01764386|715152|P1|Controlled Treatment Period (CTP)|Adverse Event|35
219120|NCT01764022|715195|P2|Overall Study|Protocol Violation|0
219121|NCT01764022|715196|P1|Overall Study|Protocol Violation|1
219122|NCT01764022|715195|P2|Overall Study|Physician Decision|2
219123|NCT01764022|715196|P1|Overall Study|Physician Decision|2
219124|NCT01764022|715195|P2|Overall Study|Lack of Efficacy|5
219125|NCT01764022|715196|P1|Overall Study|Lack of Efficacy|10
219126|NCT01764022|715195|P2|Overall Study|Withdrawal by Subject|4
219127|NCT01764022|715196|P1|Overall Study|Withdrawal by Subject|5
219128|NCT01764022|715195|P2|Overall Study|Death|1
219129|NCT01764022|715196|P1|Overall Study|Death|3
219130|NCT01763996|715224|P2|Treatment Period 2|Adverse Event|1
219131|NCT01763996|715225|P1|Treatment Period 2|Adverse Event|0
219132|NCT01763918|715255|P4|Overall Study|Sponsor Decision|0
219133|NCT01763918|715256|P3|Overall Study|Sponsor Decision|9
219134|NCT01763918|715257|P2|Overall Study|Sponsor Decision|0
219135|NCT01763918|715258|P1|Overall Study|Sponsor Decision|4
219136|NCT01763918|715255|P4|Overall Study|Withdrawal by Subject|2
219137|NCT01763918|715256|P3|Overall Study|Withdrawal by Subject|1
219138|NCT01763918|715257|P2|Overall Study|Withdrawal by Subject|1
219139|NCT01763918|715258|P1|Overall Study|Withdrawal by Subject|2
219140|NCT01763905|715356|P4|Overall Study|Lost to Follow-up|0
219141|NCT01763905|715357|P3|Overall Study|Lost to Follow-up|1
219142|NCT01763905|715358|P2|Overall Study|Lost to Follow-up|0
219143|NCT01763905|715359|P1|Overall Study|Lost to Follow-up|0
219144|NCT01763905|715356|P4|Overall Study|Decision by sponsor|0
219145|NCT01763905|715357|P3|Overall Study|Decision by sponsor|8
219146|NCT01763905|715358|P2|Overall Study|Decision by sponsor|0
219147|NCT01763905|715359|P1|Overall Study|Decision by sponsor|5
219148|NCT01763905|715356|P4|Overall Study|Withdrawal by Subject|1
219149|NCT01763905|715357|P3|Overall Study|Withdrawal by Subject|0
219150|NCT01763905|715358|P2|Overall Study|Withdrawal by Subject|1
219151|NCT01763905|715359|P1|Overall Study|Withdrawal by Subject|1
219152|NCT01763866|715477|P24|Overall Study|Death|0
219153|NCT01763866|715478|P23|Overall Study|Death|0
219154|NCT01763866|715479|P22|Overall Study|Death|0
219155|NCT01763866|715480|P21|Overall Study|Death|0
219156|NCT01763866|715481|P20|Overall Study|Death|0
219157|NCT01763866|715482|P19|Overall Study|Death|0
219158|NCT01763866|715483|P18|Overall Study|Death|0
219159|NCT01763866|715484|P17|Overall Study|Death|1
219160|NCT01763866|715485|P16|Overall Study|Death|0
219161|NCT01763866|715486|P15|Overall Study|Death|0
219162|NCT01763866|715487|P14|Overall Study|Death|0
219163|NCT01763866|715488|P13|Overall Study|Death|0
219164|NCT01763866|715489|P12|Overall Study|Death|0
219165|NCT01763866|715490|P11|Overall Study|Death|0
219166|NCT01763866|715491|P10|Overall Study|Death|0
219167|NCT01763866|715492|P9|Overall Study|Death|0
219168|NCT01763866|715493|P8|Overall Study|Death|0
219169|NCT01763866|715494|P7|Overall Study|Death|0
219170|NCT01763866|715495|P6|Overall Study|Death|0
219171|NCT01763866|715496|P5|Overall Study|Death|0
219172|NCT01763866|715497|P4|Overall Study|Death|0
219173|NCT01763866|715498|P3|Overall Study|Death|0
219174|NCT01763866|715499|P2|Overall Study|Death|0
219175|NCT01763866|715500|P1|Overall Study|Death|0
219176|NCT01763866|715477|P24|Overall Study|Lost to Follow-up|1
219177|NCT01763866|715478|P23|Overall Study|Lost to Follow-up|0
219178|NCT01763866|715479|P22|Overall Study|Lost to Follow-up|0
219179|NCT01763866|715480|P21|Overall Study|Lost to Follow-up|0
219180|NCT01763866|715481|P20|Overall Study|Lost to Follow-up|1
219181|NCT01763866|715482|P19|Overall Study|Lost to Follow-up|1
219182|NCT01763866|715483|P18|Overall Study|Lost to Follow-up|0
219183|NCT01763866|715484|P17|Overall Study|Lost to Follow-up|0
219184|NCT01763866|715485|P16|Overall Study|Lost to Follow-up|0
219185|NCT01763866|715486|P15|Overall Study|Lost to Follow-up|1
219186|NCT01763866|715487|P14|Overall Study|Lost to Follow-up|0
219187|NCT01763866|715488|P13|Overall Study|Lost to Follow-up|1
219188|NCT01763866|715489|P12|Overall Study|Lost to Follow-up|0
219189|NCT01763866|715490|P11|Overall Study|Lost to Follow-up|0
219190|NCT01763866|715491|P10|Overall Study|Lost to Follow-up|0
219191|NCT01763866|715492|P9|Overall Study|Lost to Follow-up|0
219192|NCT01763866|715493|P8|Overall Study|Lost to Follow-up|0
219193|NCT01763866|715494|P7|Overall Study|Lost to Follow-up|1
219194|NCT01763866|715495|P6|Overall Study|Lost to Follow-up|0
219195|NCT01763866|715496|P5|Overall Study|Lost to Follow-up|0
219196|NCT01763866|715497|P4|Overall Study|Lost to Follow-up|0
219197|NCT01763866|715498|P3|Overall Study|Lost to Follow-up|0
219198|NCT01763866|715499|P2|Overall Study|Lost to Follow-up|0
219199|NCT01763866|715500|P1|Overall Study|Lost to Follow-up|0
219200|NCT01763866|715477|P24|Overall Study|Decision by sponsor|0
219201|NCT01763866|715478|P23|Overall Study|Decision by sponsor|1
219202|NCT01763866|715479|P22|Overall Study|Decision by sponsor|0
219203|NCT01763866|715480|P21|Overall Study|Decision by sponsor|2
219204|NCT01763866|715481|P20|Overall Study|Decision by sponsor|0
219205|NCT01763866|715482|P19|Overall Study|Decision by sponsor|4
219206|NCT01763866|715483|P18|Overall Study|Decision by sponsor|0
219207|NCT01763866|715484|P17|Overall Study|Decision by sponsor|0
219208|NCT01763866|715485|P16|Overall Study|Decision by sponsor|0
219209|NCT01763866|715486|P15|Overall Study|Decision by sponsor|5
219210|NCT01763866|715487|P14|Overall Study|Decision by sponsor|0
219211|NCT01763866|715488|P13|Overall Study|Decision by sponsor|1
219212|NCT01763866|715489|P12|Overall Study|Decision by sponsor|0
219213|NCT01763866|715490|P11|Overall Study|Decision by sponsor|6
219214|NCT01763866|715491|P10|Overall Study|Decision by sponsor|0
219215|NCT01763866|715492|P9|Overall Study|Decision by sponsor|2
219216|NCT01763866|715493|P8|Overall Study|Decision by sponsor|0
219217|NCT01763866|715494|P7|Overall Study|Decision by sponsor|2
219218|NCT01763866|715495|P6|Overall Study|Decision by sponsor|0
219219|NCT01763866|715496|P5|Overall Study|Decision by sponsor|2
219220|NCT01763866|715497|P4|Overall Study|Decision by sponsor|0
219221|NCT01763866|715498|P3|Overall Study|Decision by sponsor|1
219222|NCT01763866|715499|P2|Overall Study|Decision by sponsor|0
219223|NCT01763866|715500|P1|Overall Study|Decision by sponsor|0
219224|NCT01763866|715477|P24|Overall Study|Withdrawal by Subject|1
219225|NCT01763866|715478|P23|Overall Study|Withdrawal by Subject|2
219226|NCT01763866|715479|P22|Overall Study|Withdrawal by Subject|1
219227|NCT01763866|715480|P21|Overall Study|Withdrawal by Subject|2
219228|NCT01763866|715481|P20|Overall Study|Withdrawal by Subject|1
219229|NCT01763866|715482|P19|Overall Study|Withdrawal by Subject|1
219230|NCT01763866|715483|P18|Overall Study|Withdrawal by Subject|1
219231|NCT01763866|715484|P17|Overall Study|Withdrawal by Subject|0
219232|NCT01763866|715485|P16|Overall Study|Withdrawal by Subject|3
219233|NCT01763866|715486|P15|Overall Study|Withdrawal by Subject|6
219234|NCT01763866|715487|P14|Overall Study|Withdrawal by Subject|0
219235|NCT01763866|715488|P13|Overall Study|Withdrawal by Subject|2
219236|NCT01763866|715489|P12|Overall Study|Withdrawal by Subject|2
219237|NCT01763866|715490|P11|Overall Study|Withdrawal by Subject|2
219238|NCT01763866|715491|P10|Overall Study|Withdrawal by Subject|1
219239|NCT01763866|715492|P9|Overall Study|Withdrawal by Subject|1
219240|NCT01763866|715493|P8|Overall Study|Withdrawal by Subject|0
219241|NCT01763866|715494|P7|Overall Study|Withdrawal by Subject|4
219242|NCT01763866|715495|P6|Overall Study|Withdrawal by Subject|3
219243|NCT01763866|715496|P5|Overall Study|Withdrawal by Subject|0
219244|NCT01763866|715497|P4|Overall Study|Withdrawal by Subject|0
219245|NCT01763866|715498|P3|Overall Study|Withdrawal by Subject|4
219246|NCT01763866|715499|P2|Overall Study|Withdrawal by Subject|1
219247|NCT01763866|715500|P1|Overall Study|Withdrawal by Subject|2
219248|NCT01763827|716060|P6|Overall Study|Lost to Follow-up|1
219249|NCT01763827|716061|P5|Overall Study|Lost to Follow-up|2
219250|NCT01763827|716062|P4|Overall Study|Lost to Follow-up|1
219251|NCT01763827|716063|P3|Overall Study|Lost to Follow-up|1
219252|NCT01763827|716064|P2|Overall Study|Lost to Follow-up|1
219253|NCT01763827|716065|P1|Overall Study|Lost to Follow-up|0
219254|NCT01763827|716060|P6|Overall Study|Decision by sponsor|1
219255|NCT01763827|716061|P5|Overall Study|Decision by sponsor|2
219256|NCT01763827|716062|P4|Overall Study|Decision by sponsor|0
219257|NCT01763827|716063|P3|Overall Study|Decision by sponsor|3
219258|NCT01763827|716064|P2|Overall Study|Decision by sponsor|0
219259|NCT01763827|716065|P1|Overall Study|Decision by sponsor|2
219260|NCT01763827|716060|P6|Overall Study|Withdrawal by Subject|0
219261|NCT01763827|716061|P5|Overall Study|Withdrawal by Subject|2
219262|NCT01763827|716062|P4|Overall Study|Withdrawal by Subject|0
219263|NCT01763827|716063|P3|Overall Study|Withdrawal by Subject|0
219264|NCT01763827|716064|P2|Overall Study|Withdrawal by Subject|0
219265|NCT01763827|716065|P1|Overall Study|Withdrawal by Subject|1
219266|NCT01763047|716236|P2|Period 2|Unsatisfactory lens Fitting|1
219267|NCT01763047|716237|P1|Period 2|Unsatisfactory lens Fitting|0
219268|NCT01763047|716236|P2|Period 2|Protocol Violation|2
219269|NCT01763047|716237|P1|Period 2|Protocol Violation|0
219270|NCT01763047|716236|P2|Period 2|Unsatisfactory Visual Response|1
219271|NCT01763047|716237|P1|Period 2|Unsatisfactory Visual Response|1
219272|NCT01763047|716236|P2|Period 2|Study Site office Closed|1
219273|NCT01763047|716237|P1|Period 2|Study Site office Closed|1
219274|NCT01763047|716236|P2|Period 2|No longer meets Eligibility Criteria|0
219275|NCT01763047|716237|P1|Period 2|No longer meets Eligibility Criteria|1
219276|NCT01763047|716236|P2|Period 2|Lens Discomfort|0
219277|NCT01763047|716237|P1|Period 2|Lens Discomfort|1
219278|NCT01763047|716236|P2|Period 1|Study Site office Closed|1
219279|NCT01763047|716237|P1|Period 1|Study Site office Closed|0
219280|NCT01763047|716236|P2|Period 1|Lens Power Not Available|1
219281|NCT01763047|716237|P1|Period 1|Lens Power Not Available|0
219282|NCT01763047|716236|P2|Period 1|Unsatisfactory Visual Response|3
219283|NCT01763047|716237|P1|Period 1|Unsatisfactory Visual Response|0
219284|NCT01763047|716236|P2|Period 1|Adverse Event|1
219285|NCT01763047|716237|P1|Period 1|Adverse Event|0
219286|NCT01763047|716236|P2|Period 1|No Longer Meets Eligibility criteria|0
219287|NCT01763047|716237|P1|Period 1|No Longer Meets Eligibility criteria|1
219288|NCT01763047|716236|P2|Period 1|Protocol Violation|4
219289|NCT01763047|716237|P1|Period 1|Protocol Violation|4
219290|NCT01763047|716236|P2|Period 1|Test Article Not Available|1
219291|NCT01763047|716237|P1|Period 1|Test Article Not Available|4
219292|NCT01762800|716283|P2|Overall Study|Withdrawal by Subject|4
219293|NCT01762800|716284|P1|Overall Study|Withdrawal by Subject|7
219294|NCT01762800|716283|P2|Overall Study|Physician Decision|1
219295|NCT01762800|716284|P1|Overall Study|Physician Decision|1
219296|NCT01762800|716283|P2|Overall Study|Study Closed/Terminated|1
219297|NCT01762800|716284|P1|Overall Study|Study Closed/Terminated|0
219298|NCT01762800|716283|P2|Overall Study|Lack of Efficacy|2
219299|NCT01762800|716284|P1|Overall Study|Lack of Efficacy|3
219300|NCT01762800|716283|P2|Overall Study|Adverse Event|13
219301|NCT01762800|716284|P1|Overall Study|Adverse Event|8
219310|NCT01762345|716437|P1|Overall Study|Protocol Violation|2
219311|NCT01762345|716437|P1|Overall Study|Adverse Event|5
219312|NCT01761565|716458|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
219313|NCT01761162|716480|P1|Overall Study|Withdrawal by Subject|3
219314|NCT01760876|716572|P1|Overall Study|Very poor baseline OCT quality|2
219315|NCT01760876|716572|P1|Overall Study|Major depression|1
219316|NCT01760876|716572|P1|Overall Study|Impaired renal function|1
219317|NCT01760876|716572|P1|Overall Study|Carcinoma of prostate|1
219318|NCT01760876|716572|P1|Overall Study|Non-cardiac death (head injury)|1
219319|NCT01759511|716606|P1|Overall Study|Withdrawal by Subject|3
219320|NCT01759511|716606|P1|Overall Study|Study Terminated by Sponsor|13
219321|NCT01759511|716606|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
219322|NCT01759511|716606|P1|Overall Study|Progressive Disease|5
219323|NCT01759511|716606|P1|Overall Study|Physician Decision|1
219324|NCT01759511|716606|P1|Overall Study|Lack of Efficacy|2
219325|NCT01759511|716606|P1|Overall Study|Death|2
219326|NCT01759511|716606|P1|Overall Study|Adverse Event|4
219327|NCT01759420|716614|P1|Overall Study|Inaccurate EKG machine readings|1
219328|NCT01759420|716614|P1|Overall Study|Screen failure|5
219329|NCT01759381|716621|P2|Overall Study|Death|0
219330|NCT01759381|716622|P1|Overall Study|Death|1
219331|NCT01759368|716630|P2|Overall Study|Lost to Follow-up|0
219332|NCT01759368|716631|P1|Overall Study|Lost to Follow-up|1
219333|NCT01759290|716649|P1|Overall Study|Unknown reason|4
219334|NCT01759290|716649|P1|Overall Study|Lost to Follow-up|53
219335|NCT01759290|716649|P1|Overall Study|Death|17
219336|NCT01759290|716649|P1|Overall Study|Physician Decision|2
219337|NCT01759290|716649|P1|Overall Study|Subjects withdrawn consent|5
219338|NCT01759264|716709|P1|Overall Study|Discontinued Humira Due to Business Trip|1
219339|NCT01759264|716709|P1|Overall Study|Withdrawal by Subject|3
219340|NCT01759264|716709|P1|Overall Study|Lost to Follow-up|2
219341|NCT01759264|716709|P1|Overall Study|Not Specified|2
219342|NCT01759264|716709|P1|Overall Study|Adverse Event|1
219343|NCT01759264|716709|P1|Overall Study|Serious Adverse Events (SAEs)|1
219344|NCT01758900|716737|P2|Overall Study|difficulty for further intubation|8
219345|NCT01758900|716738|P1|Overall Study|difficulty for further intubation|7
219346|NCT01758289|716756|P1|Overall Study|Adverse Event|9
219347|NCT01758289|716756|P1|Overall Study|Premature Study Termination|44
219348|NCT01757847|716782|P2|Overall Study|Withdrawal by Subject|4
219349|NCT01757847|716783|P1|Overall Study|Withdrawal by Subject|3
219350|NCT01757704|716793|P2|Overall Study|Protocol Violation|3
219351|NCT01757704|716794|P1|Overall Study|Protocol Violation|1
219352|NCT01757691|716812|P2|Overall Study|Administrative problems|0
219353|NCT01757691|716813|P1|Overall Study|Administrative problems|2
219354|NCT01757405|716849|P2|Overall Study|Withdrawal by Subject|1
219355|NCT01757405|716850|P1|Overall Study|Withdrawal by Subject|0
219356|NCT01757405|716849|P2|Overall Study|Lost to Follow-up|1
219357|NCT01757405|716850|P1|Overall Study|Lost to Follow-up|1
219358|NCT01757275|716868|P2|Overall Study|Not treated|4
219359|NCT01757275|716869|P1|Overall Study|Not treated|3
219360|NCT01757275|716868|P2|Overall Study|Withdrawal by Subject|4
219361|NCT01757275|716869|P1|Overall Study|Withdrawal by Subject|2
219362|NCT01757275|716868|P2|Overall Study|Adverse Event|3
219363|NCT01757275|716869|P1|Overall Study|Adverse Event|3
219364|NCT01757275|716868|P2|Overall Study|Lost to Follow-up|2
219365|NCT01757275|716869|P1|Overall Study|Lost to Follow-up|1
219366|NCT01757184|716893|P2|Double-Blind Period|Adverse Event|0
219367|NCT01757184|716894|P1|Double-Blind Period|Adverse Event|1
219368|NCT01756300|716929|P1|Overall Study|Withdrawal by Subject|1
219369|NCT01756300|716929|P1|Overall Study|Death|1
219370|NCT01756274|716951|P1|Overall Study|Laboratory error|1
219371|NCT01756274|716951|P1|Overall Study|Protocol Violation|2
219372|NCT01756235|716958|P1|Overall Study|Adalimumab Treatment was not Documented|2
219373|NCT01756157|716979|P2|First Intervention Period|Lost to Follow-up|2
219374|NCT01756157|716980|P1|First Intervention Period|Lost to Follow-up|0
219375|NCT01756157|716979|P2|First Intervention Period|Withdrawal by Subject|0
219376|NCT01756157|716980|P1|First Intervention Period|Withdrawal by Subject|1
219377|NCT01756079|716994|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
219378|NCT01756079|716994|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
219379|NCT01756079|716994|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
219380|NCT01756079|716994|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
219381|NCT01756079|716994|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
219382|NCT01756053|717000|P2|Period 2 (10 Days)|Protocol Violation|2
219383|NCT01756053|717001|P1|Period 2 (10 Days)|Protocol Violation|0
219384|NCT01756053|717000|P2|Period 1 (10 Days)|Protocol Violation|1
219385|NCT01756053|717001|P1|Period 1 (10 Days)|Protocol Violation|1
219386|NCT01755702|717021|P1|Washout Period II|Other Reason|5
219387|NCT01755702|717021|P1|Wash Out Period I|Other Reason|3
219388|NCT01755637|717063|P2|Period 1|Adverse Event|1
219389|NCT01755637|717064|P1|Period 1|Adverse Event|0
219390|NCT01755234|717097|P2|Overall Study|unblinded|0
219391|NCT01755234|717098|P1|Overall Study|unblinded|1
219392|NCT01755234|717097|P2|Overall Study|Withdrawal by Subject|1
219393|NCT01755234|717098|P1|Overall Study|Withdrawal by Subject|0
219394|NCT01755234|717097|P2|Overall Study|case cancelled|0
219395|NCT01755234|717098|P1|Overall Study|case cancelled|1
219396|NCT01755234|717097|P2|Overall Study|Change in surgical case|1
219397|NCT01755234|717098|P1|Overall Study|Change in surgical case|2
219398|NCT01755234|717097|P2|Overall Study|Lost to Follow-up|6
219399|NCT01755234|717098|P1|Overall Study|Lost to Follow-up|11
219400|NCT01755156|717129|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
219401|NCT01755156|717130|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
219402|NCT01755156|717129|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
219403|NCT01755156|717130|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
219404|NCT01755156|717129|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
219405|NCT01755156|717130|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
219406|NCT01755156|717129|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
219407|NCT01755156|717130|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
219408|NCT01755156|717129|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
219409|NCT01755156|717130|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
219410|NCT01755156|717129|P2|Phase A (Weeks 0-24)|Protocol Violation|1
219411|NCT01755156|717130|P1|Phase A (Weeks 0-24)|Protocol Violation|1
219412|NCT01755156|717129|P2|Phase A (Weeks 0-24)|Physician Decision|1
219413|NCT01755156|717130|P1|Phase A (Weeks 0-24)|Physician Decision|0
219414|NCT01755156|717129|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
219415|NCT01755156|717130|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
219416|NCT01755156|717129|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
219417|NCT01755156|717130|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
219418|NCT01755156|717129|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
219419|NCT01755156|717130|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
219420|NCT01755156|717129|P2|Phase A (Weeks 0-24)|Adverse Event|3
219421|NCT01755156|717130|P1|Phase A (Weeks 0-24)|Adverse Event|2
219422|NCT01755026|717193|P2|Overall Study|Withdrawal by Subject|1
219423|NCT01755026|717194|P1|Overall Study|Withdrawal by Subject|1
219424|NCT01755026|717193|P2|Overall Study|Adverse Event|0
219425|NCT01755026|717194|P1|Overall Study|Adverse Event|1
219426|NCT01754922|717202|P2|Overall Study|Adverse Event|1
219427|NCT01754922|717203|P1|Overall Study|Adverse Event|0
219428|NCT01754766|717216|P3|Overall Study|Personal reasons|0
219429|NCT01754766|717217|P2|Overall Study|Personal reasons|1
219430|NCT01754766|717218|P1|Overall Study|Personal reasons|1
219431|NCT01754727|717232|P1|Overall Study|Adalimumab Treatment was not Documented|2
219432|NCT01754493|717359|P1|Overall Study|Scheduling conflict|1
219433|NCT01754493|717359|P1|Overall Study|Moved out of town|1
219434|NCT01754493|717359|P1|Overall Study|Withdrawal by Subject|1
219435|NCT01754493|717359|P1|Overall Study|Lost to Follow-up|3
219436|NCT01754493|717359|P1|Overall Study|Adverse Event|1
219437|NCT01754467|717384|P1|Overall Study|Lost to Follow-up|1
219438|NCT01754402|717394|P3|Overall Study|Lack of Efficacy|1
219439|NCT01754402|717395|P2|Overall Study|Lack of Efficacy|0
219440|NCT01754402|717396|P1|Overall Study|Lack of Efficacy|0
219441|NCT01754402|717394|P3|Overall Study|Withdrawal by Subject|1
219442|NCT01754402|717395|P2|Overall Study|Withdrawal by Subject|0
219443|NCT01754402|717396|P1|Overall Study|Withdrawal by Subject|0
219444|NCT01754402|717394|P3|Overall Study|Adverse Event|1
219445|NCT01754402|717395|P2|Overall Study|Adverse Event|2
219446|NCT01754402|717396|P1|Overall Study|Adverse Event|2
219447|NCT01754402|717394|P3|Overall Study|Death|1
219448|NCT01754402|717395|P2|Overall Study|Death|0
219449|NCT01754402|717396|P1|Overall Study|Death|0
219450|NCT01754376|717403|P1|Overall Study|Lack of Efficacy|2
219451|NCT01754376|717403|P1|Overall Study|Adverse Event|1
219452|NCT01753856|717414|P2|Overall Study|Sponsor Decision|0
219453|NCT01753856|717415|P1|Overall Study|Sponsor Decision|2
219454|NCT01753856|717414|P2|Overall Study|Withdrawal by Subject|2
219455|NCT01753856|717415|P1|Overall Study|Withdrawal by Subject|0
219456|NCT01753856|717414|P2|Overall Study|Adverse Event|0
219457|NCT01753856|717415|P1|Overall Study|Adverse Event|1
219458|NCT01753518|717486|P2|Postpartum Follow-up|Lost to Follow-up|15
219459|NCT01753518|717487|P1|Postpartum Follow-up|Lost to Follow-up|22
219460|NCT01753518|717486|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
219461|NCT01753518|717487|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
219462|NCT01753518|717486|P2|Intention-to-Treat Analysis|Multifetal gestation|3
219463|NCT01753518|717487|P1|Intention-to-Treat Analysis|Multifetal gestation|2
219464|NCT01753518|717486|P2|Intention-to-Treat Analysis|Missing consent form|3
219465|NCT01753518|717487|P1|Intention-to-Treat Analysis|Missing consent form|5
219466|NCT01753336|717509|P1|Overall Study|Withdrawal by Subject|1
219467|NCT01753336|717509|P1|Overall Study|Sponsor's decision|2
219468|NCT01753336|717509|P1|Overall Study|Physician Decision|2
219469|NCT01753336|717509|P1|Overall Study|Lost to Follow-up|3
219470|NCT01753336|717509|P1|Overall Study|Patient decision|12
219471|NCT01753323|717521|P3|Overall Study|Adverse Event|1
219472|NCT01753323|717522|P2|Overall Study|Adverse Event|0
219473|NCT01753323|717523|P1|Overall Study|Adverse Event|0
219474|NCT01753323|717521|P3|Overall Study|Protocol deviation|0
219475|NCT01753323|717522|P2|Overall Study|Protocol deviation|0
219476|NCT01753323|717523|P1|Overall Study|Protocol deviation|1
219477|NCT01753323|717521|P3|Overall Study|Lack of Efficacy|8
219478|NCT01753323|717522|P2|Overall Study|Lack of Efficacy|0
219479|NCT01753323|717523|P1|Overall Study|Lack of Efficacy|0
219480|NCT01753310|717561|P2|Overall Study|Withdrawal by Subject|0
219481|NCT01753310|717562|P1|Overall Study|Withdrawal by Subject|1
219482|NCT01753310|717561|P2|Overall Study|Sponsor decision|0
219483|NCT01753310|717562|P1|Overall Study|Sponsor decision|1
219484|NCT01753310|717561|P2|Overall Study|Subject decision|2
219485|NCT01753310|717562|P1|Overall Study|Subject decision|2
219486|NCT01753310|717561|P2|Overall Study|Lost to Follow-up|0
219487|NCT01753310|717562|P1|Overall Study|Lost to Follow-up|2
219488|NCT01753310|717561|P2|Overall Study|Adverse Event|0
219489|NCT01753310|717562|P1|Overall Study|Adverse Event|1
219490|NCT01753310|717561|P2|Overall Study|Entered into open label extension study|22
219491|NCT01753310|717562|P1|Overall Study|Entered into open label extension study|25
219492|NCT01753115|717585|P3|Overall Study|Used excluded drug|0
219493|NCT01753115|717586|P2|Overall Study|Used excluded drug|1
219494|NCT01753115|717587|P1|Overall Study|Used excluded drug|0
219495|NCT01753115|717585|P3|Overall Study|Subject non-compliant|0
219496|NCT01753115|717586|P2|Overall Study|Subject non-compliant|3
219497|NCT01753115|717587|P1|Overall Study|Subject non-compliant|3
219498|NCT01753115|717585|P3|Overall Study|Withdrawal by Subject|6
219499|NCT01753115|717586|P2|Overall Study|Withdrawal by Subject|5
219500|NCT01753115|717587|P1|Overall Study|Withdrawal by Subject|6
219501|NCT01753115|717585|P3|Overall Study|Lost to Follow-up|8
219502|NCT01753115|717586|P2|Overall Study|Lost to Follow-up|6
219503|NCT01753115|717587|P1|Overall Study|Lost to Follow-up|3
219504|NCT01753076|717597|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
219505|NCT01753076|717598|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
219506|NCT01753076|717597|P2|Overall Study|Withdrawal by Subject|24
219507|NCT01753076|717598|P1|Overall Study|Withdrawal by Subject|14
219508|NCT01753076|717597|P2|Overall Study|Physician Decision|2
219509|NCT01753076|717598|P1|Overall Study|Physician Decision|4
219510|NCT01753076|717597|P2|Overall Study|Lost to Follow-up|1
219511|NCT01753076|717598|P1|Overall Study|Lost to Follow-up|2
219512|NCT01753076|717597|P2|Overall Study|Lack of Efficacy|1
219513|NCT01753076|717598|P1|Overall Study|Lack of Efficacy|3
219514|NCT01753076|717597|P2|Overall Study|Adverse Event|18
219515|NCT01753076|717598|P1|Overall Study|Adverse Event|17
219516|NCT01752907|717624|P2|Overall Study|Decision by Sponsor|9
219517|NCT01752907|717625|P1|Overall Study|Decision by Sponsor|6
219518|NCT01752907|717624|P2|Overall Study|Lost to Follow-up|1
219519|NCT01752907|717625|P1|Overall Study|Lost to Follow-up|2
219520|NCT01752907|717624|P2|Overall Study|Withdrawal by Subject|10
219521|NCT01752907|717625|P1|Overall Study|Withdrawal by Subject|4
219522|NCT01752855|717645|P2|Overall Study|Lack of Efficacy|2
219523|NCT01752855|717646|P1|Overall Study|Lack of Efficacy|0
219524|NCT01752855|717645|P2|Overall Study|Withdrew Consent|2
219525|NCT01752855|717646|P1|Overall Study|Withdrew Consent|0
219526|NCT01752855|717645|P2|Overall Study|Adverse Event|0
219527|NCT01752855|717646|P1|Overall Study|Adverse Event|1
219528|NCT01752023|717662|P2|Overall Study|Physician Decision|1
219529|NCT01752023|717663|P1|Overall Study|Physician Decision|2
219530|NCT01751867|717673|P2|Overall Study|Randomized but not treated.|1
219531|NCT01751867|717674|P1|Overall Study|Randomized but not treated.|2
219532|NCT01751867|717673|P2|Overall Study|Unspecified|37
219533|NCT01751867|717674|P1|Overall Study|Unspecified|11
219534|NCT01751867|717673|P2|Overall Study|Death|5
219535|NCT01751867|717674|P1|Overall Study|Death|0
219536|NCT01751867|717673|P2|Overall Study|Protocol Violation|2
219537|NCT01751867|717674|P1|Overall Study|Protocol Violation|0
219538|NCT01751867|717673|P2|Overall Study|Physician Decision|7
219539|NCT01751867|717674|P1|Overall Study|Physician Decision|4
219540|NCT01751867|717673|P2|Overall Study|Withdrawal by Subject|1
219541|NCT01751867|717674|P1|Overall Study|Withdrawal by Subject|3
219542|NCT01751867|717673|P2|Overall Study|Poor Compliance|5
219543|NCT01751867|717674|P1|Overall Study|Poor Compliance|0
219544|NCT01751867|717673|P2|Overall Study|Adverse Event|15
219545|NCT01751867|717674|P1|Overall Study|Adverse Event|8
219546|NCT01751867|717673|P2|Overall Study|Diease Progression|18
219547|NCT01751867|717674|P1|Overall Study|Diease Progression|4
219548|NCT01751867|717673|P2|Overall Study|Completed treatment,dropped in follow-up|8
219549|NCT01751867|717674|P1|Overall Study|Completed treatment,dropped in follow-up|4
219550|NCT01751802|717694|P2|Overall Study|Adverse Event|2
219551|NCT01751802|717695|P1|Overall Study|Adverse Event|4
219552|NCT01751178|717756|P3|Overall Study|Other Reason (unknown)|2
219553|NCT01751178|717757|P2|Overall Study|Other Reason (unknown)|0
219554|NCT01751178|717758|P1|Overall Study|Other Reason (unknown)|1
219555|NCT01751178|717756|P3|Overall Study|Adverse Event|0
219556|NCT01751178|717757|P2|Overall Study|Adverse Event|0
219557|NCT01751178|717758|P1|Overall Study|Adverse Event|2
219558|NCT01751165|717778|P3|Overall Study|Lost to Follow-up|1
219559|NCT01751165|717779|P2|Overall Study|Lost to Follow-up|1
219560|NCT01751165|717780|P1|Overall Study|Lost to Follow-up|1
219561|NCT01751165|717778|P3|Overall Study|Serious adverse event|0
219562|NCT01751165|717779|P2|Overall Study|Serious adverse event|2
219563|NCT01751165|717780|P1|Overall Study|Serious adverse event|0
219564|NCT01751165|717778|P3|Overall Study|Withdrawal by Subject|1
219565|NCT01751165|717779|P2|Overall Study|Withdrawal by Subject|0
219566|NCT01751165|717780|P1|Overall Study|Withdrawal by Subject|0
219567|NCT01751165|717778|P3|Overall Study|Adverse event, serious fatal|1
219568|NCT01751165|717779|P2|Overall Study|Adverse event, serious fatal|0
219569|NCT01751165|717780|P1|Overall Study|Adverse event, serious fatal|1
219570|NCT01751113|717820|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
219571|NCT01751113|717821|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
219572|NCT01751113|717822|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
219573|NCT01751113|717823|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
219574|NCT01751113|717824|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
219575|NCT01751113|717825|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
219576|NCT01751113|717820|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
219577|NCT01751113|717821|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
219578|NCT01751113|717822|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
219579|NCT01751113|717823|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
219580|NCT01751113|717824|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
219581|NCT01751113|717825|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
219582|NCT01751087|717866|P3|Overall Study|Physician Decision|1
219583|NCT01751087|717867|P2|Overall Study|Physician Decision|0
219584|NCT01751087|717868|P1|Overall Study|Physician Decision|0
219585|NCT01751087|717866|P3|Overall Study|Withdrawal by Subject|0
219586|NCT01751087|717867|P2|Overall Study|Withdrawal by Subject|0
219587|NCT01751087|717868|P1|Overall Study|Withdrawal by Subject|1
219588|NCT01750840|717937|P1|Overall Study|Lost to Follow-up|4
219589|NCT01750684|717944|P2|Overall Study|Protocol Violation|0
219590|NCT01750684|717945|P1|Overall Study|Protocol Violation|1
219591|NCT01750684|717944|P2|Overall Study|Withdrawn by Sponsor|1
219592|NCT01750684|717945|P1|Overall Study|Withdrawn by Sponsor|0
219593|NCT01750684|717944|P2|Overall Study|Non-compliance with Study Drug|1
219594|NCT01750684|717945|P1|Overall Study|Non-compliance with Study Drug|0
219595|NCT01750684|717944|P2|Overall Study|Death|0
219596|NCT01750684|717945|P1|Overall Study|Death|1
219597|NCT01750346|717980|P3|Overall Study|Adverse Event|0
219598|NCT01750346|717981|P2|Overall Study|Adverse Event|0
219599|NCT01750346|717982|P1|Overall Study|Adverse Event|1
219600|NCT01750294|718008|P1|Overall Study|Safety Endpoint|1
219601|NCT01750294|718008|P1|Overall Study|Withdrawal by Subject|1
219602|NCT01750242|718031|P1|Overall Study|Unreadable Images|3
219603|NCT01749982|718049|P4|Overall Study|Withdrawal by Subject|1
219604|NCT01749982|718050|P3|Overall Study|Withdrawal by Subject|0
219605|NCT01749982|718051|P2|Overall Study|Withdrawal by Subject|0
219606|NCT01749982|718052|P1|Overall Study|Withdrawal by Subject|0
219607|NCT01749982|718049|P4|Overall Study|Lost to Follow-up|1
219608|NCT01749982|718050|P3|Overall Study|Lost to Follow-up|0
219609|NCT01749982|718051|P2|Overall Study|Lost to Follow-up|0
219610|NCT01749982|718052|P1|Overall Study|Lost to Follow-up|0
219611|NCT01749982|718049|P4|Overall Study|Physician Decision|1
219612|NCT01749982|718050|P3|Overall Study|Physician Decision|0
219613|NCT01749982|718051|P2|Overall Study|Physician Decision|0
219614|NCT01749982|718052|P1|Overall Study|Physician Decision|0
219615|NCT01748760|718131|P2|Overall Study|Lost to Follow-up|1
219616|NCT01748760|718132|P1|Overall Study|Lost to Follow-up|5
219617|NCT01748760|718131|P2|Overall Study|Withdrawal by Subject|1
219618|NCT01748760|718132|P1|Overall Study|Withdrawal by Subject|1
219619|NCT01749800|718150|P3|Overall Study|Withdrawal by Subject|0
219620|NCT01749800|718151|P2|Overall Study|Withdrawal by Subject|1
219621|NCT01749800|718152|P1|Overall Study|Withdrawal by Subject|0
219622|NCT01749800|718150|P3|Overall Study|not meeting inclusion criteria|0
219623|NCT01749800|718151|P2|Overall Study|not meeting inclusion criteria|0
219624|NCT01749800|718152|P1|Overall Study|not meeting inclusion criteria|3
219625|NCT01749735|718162|P2|Overall Study|Withdrawal by Subject|0
219626|NCT01749735|718163|P1|Overall Study|Withdrawal by Subject|1
219627|NCT01748890|718229|P1|Overall Study|Insufficient recruitment for analysis|4
219628|NCT01748071|718244|P3|Overall Study|Adverse Event|0
219629|NCT01748071|718245|P2|Overall Study|Adverse Event|2
219630|NCT01748071|718246|P1|Overall Study|Adverse Event|2
219631|NCT01747811|718487|P2|Overall Study|Lack of Efficacy|4
219632|NCT01747811|718488|P1|Overall Study|Lack of Efficacy|2
219633|NCT01747772|718504|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
219634|NCT01747655|718512|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
219635|NCT01747655|718513|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
219636|NCT01747655|718512|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
219637|NCT01747655|718513|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
219638|NCT01747655|718512|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
219639|NCT01747655|718513|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
219640|NCT01747629|718543|P2|Overall Study|Not specified|1
219641|NCT01747629|718544|P1|Overall Study|Not specified|2
219642|NCT01747629|718543|P2|Overall Study|Not treated|0
219643|NCT01747629|718544|P1|Overall Study|Not treated|1
219644|NCT01747629|718543|P2|Overall Study|Inclusion criteria not met|0
219645|NCT01747629|718544|P1|Overall Study|Inclusion criteria not met|1
219646|NCT01747629|718543|P2|Overall Study|Noncompliance|1
219647|NCT01747629|718544|P1|Overall Study|Noncompliance|1
219648|NCT01747629|718543|P2|Overall Study|Withdrawal by Subject|2
219649|NCT01747629|718544|P1|Overall Study|Withdrawal by Subject|2
219650|NCT01747629|718543|P2|Overall Study|Adverse Event|2
219651|NCT01747629|718544|P1|Overall Study|Adverse Event|1
219652|NCT01746862|718611|P2|Overall Study|Entered puberty during the study|0
219653|NCT01746862|718612|P1|Overall Study|Entered puberty during the study|1
219654|NCT01746862|718611|P2|Overall Study|Consent withdrawal by parent’s guardian|2
219655|NCT01746862|718612|P1|Overall Study|Consent withdrawal by parent’s guardian|5
219656|NCT01746862|718611|P2|Overall Study|Protocol Violation|0
219657|NCT01746862|718612|P1|Overall Study|Protocol Violation|1
219658|NCT01746862|718611|P2|Overall Study|Withdrawal by Subject|1
219659|NCT01746862|718612|P1|Overall Study|Withdrawal by Subject|1
219660|NCT01746368|718682|P2|Overall Study|Withdrawal by Subject|1
219661|NCT01746368|718683|P1|Overall Study|Withdrawal by Subject|0
219662|NCT01746368|718682|P2|Overall Study|Lost to Follow-up|0
219663|NCT01746368|718683|P1|Overall Study|Lost to Follow-up|2
219664|NCT01746173|718710|P1|Overall Study|Disease Progression|2
219665|NCT01746108|718718|P3|Overall Study|Lost to Follow-up|0
219666|NCT01746108|718719|P2|Overall Study|Lost to Follow-up|1
219667|NCT01746108|718720|P1|Overall Study|Lost to Follow-up|0
219668|NCT01746108|718718|P3|Overall Study|Withdrawal by Subject|0
219669|NCT01746108|718719|P2|Overall Study|Withdrawal by Subject|1
219670|NCT01746108|718720|P1|Overall Study|Withdrawal by Subject|0
219671|NCT01746108|718718|P3|Overall Study|Adverse event, non-fatal|0
219672|NCT01746108|718719|P2|Overall Study|Adverse event, non-fatal|1
219673|NCT01746108|718720|P1|Overall Study|Adverse event, non-fatal|0
219674|NCT01746108|718718|P3|Overall Study|Migrated /moved from study area|0
219675|NCT01746108|718719|P2|Overall Study|Migrated /moved from study area|1
219676|NCT01746108|718720|P1|Overall Study|Migrated /moved from study area|0
219677|NCT01745380|718784|P2|Overall Study|Lack of Efficacy|1
219678|NCT01745380|718785|P1|Overall Study|Lack of Efficacy|0
219679|NCT01745380|718784|P2|Overall Study|Lost to Follow-up|0
219680|NCT01745380|718785|P1|Overall Study|Lost to Follow-up|1
219681|NCT01744977|718869|P2|Overall Study|No longer meets inclusion|0
219682|NCT01744977|718870|P1|Overall Study|No longer meets inclusion|6
219683|NCT01744977|718869|P2|Overall Study|Lost to Follow-up|0
219684|NCT01744977|718870|P1|Overall Study|Lost to Follow-up|2
219685|NCT01744977|718869|P2|Overall Study|Death|3
219686|NCT01744977|718870|P1|Overall Study|Death|2
219687|NCT01744977|718869|P2|Overall Study|Withdrawal by Subject|2
219688|NCT01744977|718870|P1|Overall Study|Withdrawal by Subject|1
219689|NCT01744691|718993|P1|Overall Study|Physician Decision|4
219690|NCT01744691|718993|P1|Overall Study|Withdrawal of consent for treatment|3
219691|NCT01744691|718993|P1|Overall Study|Unacceptable toxicity, AE or death|18
219692|NCT01744691|718993|P1|Overall Study|Progressive Disease|18
219693|NCT01744496|719000|P2|Maintenance Period|Subject left town|0
219694|NCT01744496|719001|P1|Maintenance Period|Subject left town|1
219695|NCT01744496|719000|P2|Maintenance Period|Withdrawal by Subject|1
219696|NCT01744496|719001|P1|Maintenance Period|Withdrawal by Subject|1
219697|NCT01744496|719000|P2|Maintenance Period|Protocol Violation|0
219698|NCT01744496|719001|P1|Maintenance Period|Protocol Violation|1
219699|NCT01744496|719000|P2|Maintenance Period|Adverse Event|3
219700|NCT01744496|719001|P1|Maintenance Period|Adverse Event|1
219701|NCT01744496|719000|P2|Titration Period|Personal reasons|1
219702|NCT01744496|719001|P1|Titration Period|Personal reasons|0
219703|NCT01744496|719000|P2|Titration Period|Adverse Event|1
219704|NCT01744496|719001|P1|Titration Period|Adverse Event|2
219705|NCT01744483|719022|P3|Overall Study|Routed to OSH|1
219706|NCT01744483|719023|P2|Overall Study|Routed to OSH|0
219707|NCT01744483|719024|P1|Overall Study|Routed to OSH|2
219708|NCT01744483|719022|P3|Overall Study|No ICU Admit|2
219709|NCT01744483|719023|P2|Overall Study|No ICU Admit|1
219710|NCT01744483|719024|P1|Overall Study|No ICU Admit|5
219711|NCT01744483|719022|P3|Overall Study|Withdrawal by Subject|2
219712|NCT01744483|719023|P2|Overall Study|Withdrawal by Subject|6
219713|NCT01744483|719024|P1|Overall Study|Withdrawal by Subject|4
219714|NCT01744483|719022|P3|Overall Study|Protocol Violation|1
219715|NCT01744483|719023|P2|Overall Study|Protocol Violation|2
219716|NCT01744483|719024|P1|Overall Study|Protocol Violation|1
219717|NCT01744483|719022|P3|Overall Study|Lost to Follow-up|11
219718|NCT01744483|719023|P2|Overall Study|Lost to Follow-up|9
219719|NCT01744483|719024|P1|Overall Study|Lost to Follow-up|8
219720|NCT01744483|719022|P3|Overall Study|Death|11
219721|NCT01744483|719023|P2|Overall Study|Death|4
219722|NCT01744483|719024|P1|Overall Study|Death|9
219723|NCT01744392|719032|P1|Overall Study|Physician Decision|1
219724|NCT01744197|719072|P2|Overall Study|No patch received|2
219725|NCT01744197|719073|P1|Overall Study|No patch received|2
219726|NCT01744197|719072|P2|Overall Study|Received 1 patch|1
219727|NCT01744197|719073|P1|Overall Study|Received 1 patch|2
219728|NCT01743092|719162|P2|Overall Study|Lost to Follow-up|15
219729|NCT01743092|719163|P1|Overall Study|Lost to Follow-up|14
219730|NCT01743027|719175|P4|Overall Study|Withdrawal by Subject|1
219731|NCT01743027|719176|P3|Overall Study|Withdrawal by Subject|3
219732|NCT01743027|719177|P2|Overall Study|Withdrawal by Subject|0
219733|NCT01743027|719178|P1|Overall Study|Withdrawal by Subject|1
219734|NCT01743027|719175|P4|Overall Study|Protocol Violation|0
219735|NCT01743027|719176|P3|Overall Study|Protocol Violation|1
219736|NCT01743027|719177|P2|Overall Study|Protocol Violation|1
219737|NCT01743027|719178|P1|Overall Study|Protocol Violation|1
219738|NCT01743027|719175|P4|Overall Study|Progressive Disease|0
219739|NCT01743027|719176|P3|Overall Study|Progressive Disease|3
219740|NCT01743027|719177|P2|Overall Study|Progressive Disease|4
219741|NCT01743027|719178|P1|Overall Study|Progressive Disease|1
219742|NCT01743027|719175|P4|Overall Study|Lost to Follow-up|0
219743|NCT01743027|719176|P3|Overall Study|Lost to Follow-up|2
219744|NCT01743027|719177|P2|Overall Study|Lost to Follow-up|0
219745|NCT01743027|719178|P1|Overall Study|Lost to Follow-up|0
219746|NCT01743027|719175|P4|Overall Study|Adverse Event|0
219747|NCT01743027|719176|P3|Overall Study|Adverse Event|0
219748|NCT01743027|719177|P2|Overall Study|Adverse Event|0
219749|NCT01743027|719178|P1|Overall Study|Adverse Event|2
219750|NCT01742897|719227|P1|Overall Study|Unspecified|1
219751|NCT01742897|719227|P1|Overall Study|Withdrawal by Subject|1
219752|NCT01742897|719227|P1|Overall Study|Adverse Event|3
219753|NCT01741792|719276|P3|Overall Study|Death|12
219754|NCT01741792|719277|P2|Overall Study|Death|1
219755|NCT01741792|719278|P1|Overall Study|Death|6
219756|NCT01741701|719345|P2|Overall Study|Withdrawal by Subject|1
219757|NCT01741701|719346|P1|Overall Study|Withdrawal by Subject|0
219758|NCT01741701|719345|P2|Overall Study|Adverse Event|1
219759|NCT01741701|719346|P1|Overall Study|Adverse Event|5
219760|NCT01741688|719362|P1|Overall Study|Withdrawal by Subject|1
219761|NCT01741688|719362|P1|Overall Study|Lack of insurance coverage|2
219762|NCT01740440|719582|P1|Overall Study|Lost to Follow-up|3
219763|NCT01740427|719590|P2|Overall Study|Study terminated by Sponsor|0
219764|NCT01740427|719591|P1|Overall Study|Study terminated by Sponsor|1
219765|NCT01740427|719590|P2|Overall Study|Lost to Follow-up|0
219766|NCT01740427|719591|P1|Overall Study|Lost to Follow-up|1
219767|NCT01740427|719590|P2|Overall Study|Protocol Violation|3
219768|NCT01740427|719591|P1|Overall Study|Protocol Violation|5
219769|NCT01740427|719590|P2|Overall Study|Death|2
219770|NCT01740427|719591|P1|Overall Study|Death|6
219771|NCT01740427|719590|P2|Overall Study|Unspecified reasons|4
219772|NCT01740427|719591|P1|Overall Study|Unspecified reasons|6
219773|NCT01740427|719590|P2|Overall Study|Subject refused continued treatment|9
219774|NCT01740427|719591|P1|Overall Study|Subject refused continued treatment|12
219775|NCT01740427|719590|P2|Overall Study|Global deterioration of health status|9
219776|NCT01740427|719591|P1|Overall Study|Global deterioration of health status|16
219777|NCT01740427|719590|P2|Overall Study|Adverse Event|9
219778|NCT01740427|719591|P1|Overall Study|Adverse Event|20
219779|NCT01740427|719590|P2|Overall Study|Objective progression or relapse|125
219780|NCT01740427|719591|P1|Overall Study|Objective progression or relapse|172
219781|NCT01740427|719590|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
219782|NCT01740427|719591|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
219783|NCT01740401|719618|P1|Overall Study|Did not reach primary endpoint|2
219784|NCT01740401|719618|P1|Overall Study|Adverse Event|2
219785|NCT01740401|719618|P1|Overall Study|Progression of disease|6
219786|NCT01740388|719627|P2|Overall Study|Subjects missing data, completed|36
219787|NCT01740388|719628|P1|Overall Study|Subjects missing data, completed|41
219788|NCT01740388|719627|P2|Overall Study|Physician Decision|6
219789|NCT01740388|719628|P1|Overall Study|Physician Decision|2
219790|NCT01740388|719627|P2|Overall Study|Lost to Follow-up|0
219791|NCT01740388|719628|P1|Overall Study|Lost to Follow-up|2
219792|NCT01740388|719627|P2|Overall Study|Withdrawal by Subject|2
219793|NCT01740388|719628|P1|Overall Study|Withdrawal by Subject|1
219794|NCT01740089|719680|P3|After 12 Weeks|Withdrawal by Subject|1
219795|NCT01740089|719681|P2|After 12 Weeks|Withdrawal by Subject|1
219796|NCT01740089|719682|P1|After 12 Weeks|Withdrawal by Subject|1
219797|NCT01740089|719680|P3|After 12 Weeks|Protocol Violation|1
219798|NCT01740089|719681|P2|After 12 Weeks|Protocol Violation|1
219799|NCT01740089|719682|P1|After 12 Weeks|Protocol Violation|1
219800|NCT01740089|719680|P3|After 12 Weeks|Adverse Event|5
219801|NCT01740089|719681|P2|After 12 Weeks|Adverse Event|0
219802|NCT01740089|719682|P1|After 12 Weeks|Adverse Event|2
219803|NCT01740089|719680|P3|After 12 Weeks|Lack of Efficacy|4
219804|NCT01740089|719681|P2|After 12 Weeks|Lack of Efficacy|1
219805|NCT01740089|719682|P1|After 12 Weeks|Lack of Efficacy|3
219894|NCT01736696|720220|P5|Overall Study|Withdrawal by Subject|0
219806|NCT01740089|719680|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
219807|NCT01740089|719681|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
219808|NCT01740089|719682|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
219809|NCT01740089|719680|P3|First 12 Weeks of Treatment|Adverse Event|2
219810|NCT01740089|719681|P2|First 12 Weeks of Treatment|Adverse Event|1
219811|NCT01740089|719682|P1|First 12 Weeks of Treatment|Adverse Event|0
219812|NCT01739803|719700|P2|Overall Study|Lost to Follow-up|6
219813|NCT01739803|719701|P1|Overall Study|Lost to Follow-up|9
219814|NCT01739595|719714|P3|Overall Study|Drug discrepancy|0
219815|NCT01739595|719715|P2|Overall Study|Drug discrepancy|0
219816|NCT01739595|719716|P1|Overall Study|Drug discrepancy|1
219817|NCT01739595|719714|P3|Overall Study|Lab assessment|0
219818|NCT01739595|719715|P2|Overall Study|Lab assessment|0
219819|NCT01739595|719716|P1|Overall Study|Lab assessment|1
219820|NCT01739595|719714|P3|Overall Study|Protocol Violation|0
219821|NCT01739595|719715|P2|Overall Study|Protocol Violation|0
219822|NCT01739595|719716|P1|Overall Study|Protocol Violation|1
219823|NCT01739595|719714|P3|Overall Study|Eligibility issue|0
219824|NCT01739595|719715|P2|Overall Study|Eligibility issue|0
219825|NCT01739595|719716|P1|Overall Study|Eligibility issue|3
219826|NCT01739595|719714|P3|Overall Study|Withdrawal by Subject|2
219827|NCT01739595|719715|P2|Overall Study|Withdrawal by Subject|1
219828|NCT01739595|719716|P1|Overall Study|Withdrawal by Subject|2
219829|NCT01739595|719714|P3|Overall Study|Lost to Follow-up|0
219830|NCT01739595|719715|P2|Overall Study|Lost to Follow-up|0
219831|NCT01739595|719716|P1|Overall Study|Lost to Follow-up|2
219832|NCT01739595|719714|P3|Overall Study|Adverse Event|0
219833|NCT01739595|719715|P2|Overall Study|Adverse Event|0
219834|NCT01739595|719716|P1|Overall Study|Adverse Event|3
219835|NCT01738984|719735|P2|Overall Study|Lost to Follow-up|39
219836|NCT01738984|719736|P1|Overall Study|Lost to Follow-up|59
219837|NCT01738984|719735|P2|Overall Study|Withdrawal by Subject|0
219838|NCT01738984|719736|P1|Overall Study|Withdrawal by Subject|1
219839|NCT01738984|719735|P2|Overall Study|Pregnancy|0
219840|NCT01738984|719736|P1|Overall Study|Pregnancy|4
219841|NCT01738971|719749|P3|Overall Study|Lost to Follow-up|17
219842|NCT01738971|719750|P2|Overall Study|Lost to Follow-up|30
219843|NCT01738971|719751|P1|Overall Study|Lost to Follow-up|19
219844|NCT01738919|719767|P2|Overall Study|Not treated in accordance to guidelines|1
219845|NCT01738919|719768|P1|Overall Study|Not treated in accordance to guidelines|0
219846|NCT01738919|719767|P2|Overall Study|Withdrawal by Subject|1
219847|NCT01738919|719768|P1|Overall Study|Withdrawal by Subject|0
219848|NCT01738919|719767|P2|Overall Study|Immigrated|1
219849|NCT01738919|719768|P1|Overall Study|Immigrated|0
219850|NCT01738919|719767|P2|Overall Study|Lost to Follow-up|0
219851|NCT01738919|719768|P1|Overall Study|Lost to Follow-up|1
219852|NCT01738646|719909|P1|Overall Study|Still Receiving Treatment|2
219853|NCT01738581|719919|P2|Overall Study|Lost to Follow-up|0
219854|NCT01738581|719920|P1|Overall Study|Lost to Follow-up|1
219855|NCT01738438|719938|P1|Overall Study|Adverse Event|3
219856|NCT01738438|719938|P1|Overall Study|Disease Progression|32
219857|NCT01737996|719956|P3|Overall Study|Withdrawal by Subject|1
219858|NCT01737996|719957|P2|Overall Study|Withdrawal by Subject|0
219859|NCT01737996|719958|P1|Overall Study|Withdrawal by Subject|0
219860|NCT01737996|719956|P3|Overall Study|Adverse Event|1
219861|NCT01737996|719957|P2|Overall Study|Adverse Event|1
219862|NCT01737996|719958|P1|Overall Study|Adverse Event|0
219863|NCT01737931|720020|P3|Overall Study|Physician Decision|0
219864|NCT01737931|720021|P2|Overall Study|Physician Decision|1
219865|NCT01737931|720022|P1|Overall Study|Physician Decision|0
219866|NCT01737931|720020|P3|Overall Study|Withdrawal by Subject|1
219867|NCT01737931|720021|P2|Overall Study|Withdrawal by Subject|1
219868|NCT01737931|720022|P1|Overall Study|Withdrawal by Subject|0
219869|NCT01737879|720037|P1|Overall Study|Sponsor decision|40
219870|NCT01737879|720037|P1|Overall Study|Death|1
219871|NCT01737840|720046|P2|Overall Study|Diagnosed with an other pathology|2
219872|NCT01737840|720047|P1|Overall Study|Diagnosed with an other pathology|2
219873|NCT01737710|720060|P5|Overall Study|Vaccinated in Error/Ineligible|0
219874|NCT01737710|720061|P4|Overall Study|Vaccinated in Error/Ineligible|0
219875|NCT01737710|720062|P3|Overall Study|Vaccinated in Error/Ineligible|0
219876|NCT01737710|720063|P2|Overall Study|Vaccinated in Error/Ineligible|1
219877|NCT01737710|720064|P1|Overall Study|Vaccinated in Error/Ineligible|1
219878|NCT01737710|720060|P5|Overall Study|Withdrawal by Subject|0
219879|NCT01737710|720061|P4|Overall Study|Withdrawal by Subject|0
219880|NCT01737710|720062|P3|Overall Study|Withdrawal by Subject|1
219881|NCT01737710|720063|P2|Overall Study|Withdrawal by Subject|1
219882|NCT01737710|720064|P1|Overall Study|Withdrawal by Subject|1
219883|NCT01737710|720060|P5|Overall Study|Lost to Follow-up|0
219884|NCT01737710|720061|P4|Overall Study|Lost to Follow-up|0
219885|NCT01737710|720062|P3|Overall Study|Lost to Follow-up|2
219886|NCT01737710|720063|P2|Overall Study|Lost to Follow-up|2
219887|NCT01737710|720064|P1|Overall Study|Lost to Follow-up|0
219888|NCT01737021|720157|P2|Overall Study|Lost to Follow-up|3
219889|NCT01737021|720158|P1|Overall Study|Lost to Follow-up|5
219890|NCT01736917|720204|P1|Overall Study|Protocol Violation|10
219891|NCT01736917|720204|P1|Overall Study|Adverse Event|1
219892|NCT01736696|720218|P7|Overall Study|Withdrawal by Subject|0
219893|NCT01736696|720219|P6|Overall Study|Withdrawal by Subject|0
219895|NCT01736696|720221|P4|Overall Study|Withdrawal by Subject|0
219896|NCT01736696|720222|P3|Overall Study|Withdrawal by Subject|1
219897|NCT01736696|720223|P2|Overall Study|Withdrawal by Subject|0
219898|NCT01736696|720224|P1|Overall Study|Withdrawal by Subject|0
219899|NCT01736657|720541|P1|Overall Study|insufficient vascular access|1
219900|NCT01736579|720550|P2|Overall Study|Termination of Study by Sponsor|2
219901|NCT01736579|720551|P1|Overall Study|Termination of Study by Sponsor|2
219902|NCT01736540|720585|P1|Overall Study|Unable to make MRI appointment|3
219903|NCT01736540|720585|P1|Overall Study|No show for MRI appointment|1
219904|NCT01736540|720585|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
219905|NCT01736540|720585|P1|Overall Study|Protocol Violation|1
219906|NCT01736540|720585|P1|Overall Study|Withdrawal by Subject|5
219907|NCT01736540|720585|P1|Overall Study|Abnormal test procedure|1
219908|NCT01736540|720585|P1|Overall Study|Death|1
219909|NCT01736540|720585|P1|Overall Study|Did not complete scan within 45 days|2
219910|NCT01736475|720651|P2|Overall Study|Other - Surgical procedure|0
219911|NCT01736475|720652|P1|Overall Study|Other - Surgical procedure|1
219912|NCT01736475|720651|P2|Overall Study|Other - Screen failure|0
219913|NCT01736475|720652|P1|Overall Study|Other - Screen failure|1
219914|NCT01736475|720651|P2|Overall Study|Protocol Violation|0
219915|NCT01736475|720652|P1|Overall Study|Protocol Violation|4
219916|NCT01736475|720651|P2|Overall Study|Withdrawal by Subject|0
219917|NCT01736475|720652|P1|Overall Study|Withdrawal by Subject|2
219918|NCT01736475|720651|P2|Overall Study|Adverse Event|0
219919|NCT01736475|720652|P1|Overall Study|Adverse Event|4
219920|NCT01736215|720705|P1|Overall Study|Insufficient data to perform analysis|8
219921|NCT01736215|720705|P1|Overall Study|Progressive disease stop chemotherapy|1
219922|NCT01736215|720705|P1|Overall Study|Adverse Event|4
219923|NCT01736215|720705|P1|Overall Study|Early termination of erythropoietin use|1
219924|NCT01736176|720717|P1|Overall Study|Unable to Complete PEG Placement|1
219925|NCT01736176|720717|P1|Overall Study|Lack of Efficacy|3
219926|NCT01736176|720717|P1|Overall Study|Withdrawal by Subject|4
219927|NCT01736176|720717|P1|Overall Study|Adverse Event|3
219928|NCT01735916|720764|P3|Overall Study|Withdrawal by Subject|0
219929|NCT01735916|720765|P2|Overall Study|Withdrawal by Subject|0
219930|NCT01735916|720766|P1|Overall Study|Withdrawal by Subject|3
219931|NCT01735916|720764|P3|Overall Study|Early termination of study by sponsor|7
219932|NCT01735916|720765|P2|Overall Study|Early termination of study by sponsor|19
219933|NCT01735916|720766|P1|Overall Study|Early termination of study by sponsor|4
219934|NCT01735916|720764|P3|Overall Study|Subject not eligible to be randomized|0
219935|NCT01735916|720765|P2|Overall Study|Subject not eligible to be randomized|0
219936|NCT01735916|720766|P1|Overall Study|Subject not eligible to be randomized|11
219937|NCT01735630|720804|P2|Overall Study|Withdrawal by Subject|9
219938|NCT01735630|720805|P1|Overall Study|Withdrawal by Subject|7
219939|NCT01735630|720804|P2|Overall Study|Sponsor Decision|1
219940|NCT01735630|720805|P1|Overall Study|Sponsor Decision|2
219941|NCT01735630|720804|P2|Overall Study|Physician Decision|1
219942|NCT01735630|720805|P1|Overall Study|Physician Decision|0
219943|NCT01735630|720804|P2|Overall Study|Lost to Follow-up|0
219944|NCT01735630|720805|P1|Overall Study|Lost to Follow-up|1
219945|NCT01735630|720804|P2|Overall Study|Adverse Event|7
219946|NCT01735630|720805|P1|Overall Study|Adverse Event|8
219947|NCT01735396|720832|P1|Overall Study|not evaluable|1
219948|NCT01735201|720861|P8|Overall Study|Other Miscellaneous Reasons|1
219949|NCT01735201|720862|P7|Overall Study|Other Miscellaneous Reasons|1
219950|NCT01735201|720863|P6|Overall Study|Other Miscellaneous Reasons|2
219951|NCT01735201|720864|P5|Overall Study|Other Miscellaneous Reasons|0
219952|NCT01735201|720865|P4|Overall Study|Other Miscellaneous Reasons|1
219953|NCT01735201|720866|P3|Overall Study|Other Miscellaneous Reasons|0
219954|NCT01735201|720867|P2|Overall Study|Other Miscellaneous Reasons|0
219955|NCT01735201|720868|P1|Overall Study|Other Miscellaneous Reasons|0
219956|NCT01735201|720861|P8|Overall Study|Protocol Violation|0
219957|NCT01735201|720862|P7|Overall Study|Protocol Violation|0
219958|NCT01735201|720863|P6|Overall Study|Protocol Violation|0
219959|NCT01735201|720864|P5|Overall Study|Protocol Violation|0
219960|NCT01735201|720865|P4|Overall Study|Protocol Violation|0
219961|NCT01735201|720866|P3|Overall Study|Protocol Violation|0
219962|NCT01735201|720867|P2|Overall Study|Protocol Violation|0
219963|NCT01735201|720868|P1|Overall Study|Protocol Violation|1
219964|NCT01735201|720861|P8|Overall Study|Personal Reasons|0
219965|NCT01735201|720862|P7|Overall Study|Personal Reasons|0
219966|NCT01735201|720863|P6|Overall Study|Personal Reasons|0
219967|NCT01735201|720864|P5|Overall Study|Personal Reasons|0
219968|NCT01735201|720865|P4|Overall Study|Personal Reasons|0
219969|NCT01735201|720866|P3|Overall Study|Personal Reasons|0
219970|NCT01735201|720867|P2|Overall Study|Personal Reasons|0
219971|NCT01735201|720868|P1|Overall Study|Personal Reasons|1
219972|NCT01735201|720861|P8|Overall Study|Adverse Event|1
219973|NCT01735201|720862|P7|Overall Study|Adverse Event|2
219974|NCT01735201|720863|P6|Overall Study|Adverse Event|3
219975|NCT01735201|720864|P5|Overall Study|Adverse Event|1
219976|NCT01735201|720865|P4|Overall Study|Adverse Event|1
219977|NCT01735201|720866|P3|Overall Study|Adverse Event|0
219978|NCT01735201|720867|P2|Overall Study|Adverse Event|1
219979|NCT01735201|720868|P1|Overall Study|Adverse Event|1
219980|NCT01735175|720904|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
219981|NCT01735175|720905|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
219982|NCT01735175|720904|P2|Overall Study|Death|2
219983|NCT01735175|720905|P1|Overall Study|Death|3
219984|NCT01735175|720904|P2|Overall Study|Lost to Follow-up|2
219985|NCT01735175|720905|P1|Overall Study|Lost to Follow-up|4
219986|NCT01735175|720904|P2|Overall Study|Withdrawal by Subject|2
219987|NCT01735175|720905|P1|Overall Study|Withdrawal by Subject|9
219988|NCT01734993|720925|P1|Overall Study|Lack of Efficacy|1
219989|NCT01734993|720925|P1|Overall Study|Adverse Event|1
219990|NCT01734785|720962|P4|Double−Blind Period|Not treated|0
219991|NCT01734785|720963|P3|Double−Blind Period|Not treated|0
219992|NCT01734785|720964|P2|Double−Blind Period|Not treated|0
219993|NCT01734785|720965|P1|Double−Blind Period|Not treated|1
219994|NCT01734785|720962|P4|Double−Blind Period|Withdrawal by Subject|0
219995|NCT01734785|720963|P3|Double−Blind Period|Withdrawal by Subject|0
219996|NCT01734785|720964|P2|Double−Blind Period|Withdrawal by Subject|0
219997|NCT01734785|720965|P1|Double−Blind Period|Withdrawal by Subject|2
219998|NCT01734785|720962|P4|Double−Blind Period|Lost to Follow-up|0
219999|NCT01734785|720963|P3|Double−Blind Period|Lost to Follow-up|2
220000|NCT01734785|720964|P2|Double−Blind Period|Lost to Follow-up|4
220001|NCT01734785|720965|P1|Double−Blind Period|Lost to Follow-up|2
220002|NCT01734785|720962|P4|Double−Blind Period|Protocol Violation|0
220003|NCT01734785|720963|P3|Double−Blind Period|Protocol Violation|1
220004|NCT01734785|720964|P2|Double−Blind Period|Protocol Violation|1
220005|NCT01734785|720965|P1|Double−Blind Period|Protocol Violation|0
220006|NCT01734785|720962|P4|Double−Blind Period|Lack of Efficacy|0
220007|NCT01734785|720963|P3|Double−Blind Period|Lack of Efficacy|0
220008|NCT01734785|720964|P2|Double−Blind Period|Lack of Efficacy|1
220009|NCT01734785|720965|P1|Double−Blind Period|Lack of Efficacy|0
220010|NCT01734785|720962|P4|Double−Blind Period|Adverse Event|0
220011|NCT01734785|720963|P3|Double−Blind Period|Adverse Event|2
220012|NCT01734785|720964|P2|Double−Blind Period|Adverse Event|3
220013|NCT01734785|720965|P1|Double−Blind Period|Adverse Event|0
220014|NCT01734785|720962|P4|Open−Label Period|Other Reasons|224
220015|NCT01734785|720963|P3|Open−Label Period|Other Reasons|0
220016|NCT01734785|720964|P2|Open−Label Period|Other Reasons|0
220017|NCT01734785|720965|P1|Open−Label Period|Other Reasons|0
220018|NCT01734785|720962|P4|Open−Label Period|Withdrawal by Subject|12
220019|NCT01734785|720963|P3|Open−Label Period|Withdrawal by Subject|0
220020|NCT01734785|720964|P2|Open−Label Period|Withdrawal by Subject|0
220021|NCT01734785|720965|P1|Open−Label Period|Withdrawal by Subject|0
220022|NCT01734785|720962|P4|Open−Label Period|Lost to Follow-up|14
220023|NCT01734785|720963|P3|Open−Label Period|Lost to Follow-up|0
220024|NCT01734785|720964|P2|Open−Label Period|Lost to Follow-up|0
220025|NCT01734785|720965|P1|Open−Label Period|Lost to Follow-up|0
220026|NCT01734785|720962|P4|Open−Label Period|Protocol Violation|13
220027|NCT01734785|720963|P3|Open−Label Period|Protocol Violation|0
220028|NCT01734785|720964|P2|Open−Label Period|Protocol Violation|0
220029|NCT01734785|720965|P1|Open−Label Period|Protocol Violation|0
220030|NCT01734785|720962|P4|Open−Label Period|Lack of Efficacy|1
220031|NCT01734785|720963|P3|Open−Label Period|Lack of Efficacy|0
220032|NCT01734785|720964|P2|Open−Label Period|Lack of Efficacy|0
220033|NCT01734785|720965|P1|Open−Label Period|Lack of Efficacy|0
220034|NCT01734785|720962|P4|Open−Label Period|Adverse Event|9
220035|NCT01734785|720963|P3|Open−Label Period|Adverse Event|0
220036|NCT01734785|720964|P2|Open−Label Period|Adverse Event|0
220037|NCT01734785|720965|P1|Open−Label Period|Adverse Event|0
220038|NCT01734772|720982|P2|Overall Study|Withdrawal by Subject|1
220039|NCT01734772|720983|P1|Overall Study|Withdrawal by Subject|0
220040|NCT01734772|720982|P2|Overall Study|Adverse Event|2
220041|NCT01734772|720983|P1|Overall Study|Adverse Event|1
220042|NCT01734395|721009|P1|Overall Study|Missing the reasons for not completed|3
220043|NCT01734395|721009|P1|Overall Study|Withdrawal by Subject|10
220044|NCT01734395|721009|P1|Overall Study|Adverse Event|40
220045|NCT01734395|721009|P1|Overall Study|Lack of Efficacy|5
220046|NCT01734395|721009|P1|Overall Study|Lost to Follow-up|287
220047|NCT01734395|721009|P1|Overall Study|Not specified|65
220048|NCT01733758|721067|P4|Overall Study|Inv Decision, HbA1c not controlled|1
220049|NCT01733758|721068|P3|Overall Study|Inv Decision, HbA1c not controlled|0
220050|NCT01733758|721069|P2|Overall Study|Inv Decision, HbA1c not controlled|1
220051|NCT01733758|721070|P1|Overall Study|Inv Decision, HbA1c not controlled|1
220052|NCT01733758|721067|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
220053|NCT01733758|721068|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
220054|NCT01733758|721069|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
220055|NCT01733758|721070|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
220056|NCT01733758|721067|P4|Overall Study|Non-compliance|0
220057|NCT01733758|721068|P3|Overall Study|Non-compliance|0
220058|NCT01733758|721069|P2|Overall Study|Non-compliance|0
220059|NCT01733758|721070|P1|Overall Study|Non-compliance|1
220060|NCT01733758|721067|P4|Overall Study|Protocol Violation|2
220061|NCT01733758|721068|P3|Overall Study|Protocol Violation|2
220062|NCT01733758|721069|P2|Overall Study|Protocol Violation|1
220063|NCT01733758|721070|P1|Overall Study|Protocol Violation|0
220064|NCT01733758|721067|P4|Overall Study|Persistent Hyperglycemia|0
220065|NCT01733758|721068|P3|Overall Study|Persistent Hyperglycemia|0
220066|NCT01733758|721069|P2|Overall Study|Persistent Hyperglycemia|2
220067|NCT01733758|721070|P1|Overall Study|Persistent Hyperglycemia|3
220068|NCT01733758|721067|P4|Overall Study|Withdrawal by Subject|3
220069|NCT01733758|721068|P3|Overall Study|Withdrawal by Subject|5
220070|NCT01733758|721069|P2|Overall Study|Withdrawal by Subject|1
220071|NCT01733758|721070|P1|Overall Study|Withdrawal by Subject|1
220072|NCT01733758|721067|P4|Overall Study|Adverse Event|1
220073|NCT01733758|721068|P3|Overall Study|Adverse Event|8
220074|NCT01733758|721069|P2|Overall Study|Adverse Event|7
220075|NCT01733758|721070|P1|Overall Study|Adverse Event|5
220076|NCT01733732|721136|P2|Overall Study|Did not attend all study visits|0
220077|NCT01733732|721137|P1|Overall Study|Did not attend all study visits|1
220078|NCT01733732|721136|P2|Overall Study|Adverse Event|0
220079|NCT01733732|721137|P1|Overall Study|Adverse Event|1
220080|NCT01733329|721173|P2|Overall Study|Uterine artery injury|0
220081|NCT01733329|721174|P1|Overall Study|Uterine artery injury|1
220082|NCT01733329|721173|P2|Overall Study|Protocol Violation|1
220083|NCT01733329|721174|P1|Overall Study|Protocol Violation|1
220084|NCT01733316|721186|P1|Overall Study|Withdrawal by Subject|1
220085|NCT01733316|721186|P1|Overall Study|Noncompliance|1
220086|NCT01732926|721251|P2|Overall Study|Blind Broken by Subject or Study Site|1
220087|NCT01732926|721252|P1|Overall Study|Blind Broken by Subject or Study Site|1
220088|NCT01732926|721251|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
220089|NCT01732926|721252|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
220090|NCT01732926|721251|P2|Overall Study|Other Reason|4
220091|NCT01732926|721252|P1|Overall Study|Other Reason|21
220092|NCT01732926|721251|P2|Overall Study|Physician Decision|11
220093|NCT01732926|721252|P1|Overall Study|Physician Decision|24
220094|NCT01732926|721251|P2|Overall Study|Withdrawal by Subject|8
220095|NCT01732926|721252|P1|Overall Study|Withdrawal by Subject|46
220096|NCT01732926|721251|P2|Overall Study|Study Terminated by Sponsor|80
220097|NCT01732926|721252|P1|Overall Study|Study Terminated by Sponsor|168
220098|NCT01732913|721268|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
220099|NCT01732913|721269|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
220100|NCT01732913|721268|P2|Overall Study|Other|1
220101|NCT01732913|721269|P1|Overall Study|Other|7
220102|NCT01732913|721268|P2|Overall Study|Physician Decision|7
220103|NCT01732913|721269|P1|Overall Study|Physician Decision|14
220104|NCT01732913|721268|P2|Overall Study|Withdrawal by Subject|4
220105|NCT01732913|721269|P1|Overall Study|Withdrawal by Subject|27
220106|NCT01732913|721268|P2|Overall Study|Study Terminated by Sponsor|55
220107|NCT01732913|721269|P1|Overall Study|Study Terminated by Sponsor|105
220108|NCT01732835|721283|P1|2-year Extended Follow-up|Death|1
220109|NCT01732835|721283|P1|2-year Extended Follow-up|Adverse Event|3
220110|NCT01732835|721283|P1|2-year Extended Follow-up|Withdrawal by Subject|1
220111|NCT01732835|721283|P1|6-month Primary Endpoint|Adverse Event|3
220112|NCT01732835|721283|P1|6-month Primary Endpoint|Withdrawal by Subject|2
220113|NCT01732835|721283|P1|6-month Primary Endpoint|Did not receive device|19
220114|NCT01732796|721317|P3|Overall Study|Other reason not defined above|2
220115|NCT01732796|721318|P2|Overall Study|Other reason not defined above|0
220116|NCT01732796|721319|P1|Overall Study|Other reason not defined above|1
220117|NCT01732796|721317|P3|Overall Study|Withdrawal by Subject|2
220118|NCT01732796|721318|P2|Overall Study|Withdrawal by Subject|8
220119|NCT01732796|721319|P1|Overall Study|Withdrawal by Subject|6
220120|NCT01732796|721317|P3|Overall Study|Lost to Follow-up|0
220121|NCT01732796|721318|P2|Overall Study|Lost to Follow-up|0
220122|NCT01732796|721319|P1|Overall Study|Lost to Follow-up|2
220123|NCT01732796|721317|P3|Overall Study|Lack of Efficacy|5
220124|NCT01732796|721318|P2|Overall Study|Lack of Efficacy|18
220125|NCT01732796|721319|P1|Overall Study|Lack of Efficacy|21
220126|NCT01732796|721317|P3|Overall Study|Adverse Event|4
220127|NCT01732796|721318|P2|Overall Study|Adverse Event|16
220128|NCT01732796|721319|P1|Overall Study|Adverse Event|16
220129|NCT01732770|721337|P2|Overall Study|Death|0
220130|NCT01732770|721338|P1|Overall Study|Death|1
220131|NCT01732770|721337|P2|Overall Study|Decision by Sponsor|2
220132|NCT01732770|721338|P1|Overall Study|Decision by Sponsor|2
220133|NCT01732770|721337|P2|Overall Study|Withdrawal by Subject|3
220134|NCT01732770|721338|P1|Overall Study|Withdrawal by Subject|5
220135|NCT01732770|721337|P2|Overall Study|Lost to Follow-up|3
220136|NCT01732770|721338|P1|Overall Study|Lost to Follow-up|2
220137|NCT01732757|721353|P3|Overall Study|Lost to Follow-up|0
220138|NCT01732757|721354|P2|Overall Study|Lost to Follow-up|0
220139|NCT01732757|721355|P1|Overall Study|Lost to Follow-up|1
220140|NCT01732692|721395|P2|Overall Study|Adverse Event|1
220141|NCT01732692|721396|P1|Overall Study|Adverse Event|0
220142|NCT01732588|721413|P3|First Intervention (7 Days)|Adverse Event|0
220143|NCT01732588|721414|P2|First Intervention (7 Days)|Adverse Event|1
220144|NCT01732588|721415|P1|First Intervention (7 Days)|Adverse Event|0
220145|NCT01732549|721431|P2|Overall Study|Not Specified|14
220146|NCT01732549|721432|P1|Overall Study|Not Specified|8
220147|NCT01732549|721431|P2|Overall Study|Disease progression|50
220148|NCT01732549|721432|P1|Overall Study|Disease progression|37
220149|NCT01732549|721431|P2|Overall Study|Consent withdrawn|6
220150|NCT01732549|721432|P1|Overall Study|Consent withdrawn|13
220151|NCT01732549|721431|P2|Overall Study|Adverse Event|3
220152|NCT01732549|721432|P1|Overall Study|Adverse Event|13
220153|NCT01732510|721459|P7|Overall Study|Study Terminated By Sponsor|6
220154|NCT01732510|721460|P6|Overall Study|Study Terminated By Sponsor|12
220155|NCT01732510|721461|P5|Overall Study|Study Terminated By Sponsor|0
220156|NCT01732510|721462|P4|Overall Study|Study Terminated By Sponsor|1
220157|NCT01732510|721463|P3|Overall Study|Study Terminated By Sponsor|0
220158|NCT01732510|721464|P2|Overall Study|Study Terminated By Sponsor|0
220159|NCT01732510|721465|P1|Overall Study|Study Terminated By Sponsor|0
220160|NCT01732510|721459|P7|Overall Study|Pregnancy|0
220161|NCT01732510|721460|P6|Overall Study|Pregnancy|0
220162|NCT01732510|721461|P5|Overall Study|Pregnancy|0
220163|NCT01732510|721462|P4|Overall Study|Pregnancy|1
220164|NCT01732510|721463|P3|Overall Study|Pregnancy|0
220165|NCT01732510|721464|P2|Overall Study|Pregnancy|0
220166|NCT01732510|721465|P1|Overall Study|Pregnancy|0
220167|NCT01732510|721459|P7|Overall Study|Physician Decision|0
220168|NCT01732510|721460|P6|Overall Study|Physician Decision|0
220169|NCT01732510|721461|P5|Overall Study|Physician Decision|0
220170|NCT01732510|721462|P4|Overall Study|Physician Decision|0
220171|NCT01732510|721463|P3|Overall Study|Physician Decision|0
220172|NCT01732510|721464|P2|Overall Study|Physician Decision|1
220173|NCT01732510|721465|P1|Overall Study|Physician Decision|0
220174|NCT01732510|721459|P7|Overall Study|Lost to Follow-up|0
220175|NCT01732510|721460|P6|Overall Study|Lost to Follow-up|1
220176|NCT01732510|721461|P5|Overall Study|Lost to Follow-up|0
220177|NCT01732510|721462|P4|Overall Study|Lost to Follow-up|1
220178|NCT01732510|721463|P3|Overall Study|Lost to Follow-up|1
220179|NCT01732510|721464|P2|Overall Study|Lost to Follow-up|0
220180|NCT01732510|721465|P1|Overall Study|Lost to Follow-up|0
220181|NCT01732510|721459|P7|Overall Study|Withdrawal by Subject|1
220182|NCT01732510|721460|P6|Overall Study|Withdrawal by Subject|0
220183|NCT01732510|721461|P5|Overall Study|Withdrawal by Subject|5
220184|NCT01732510|721462|P4|Overall Study|Withdrawal by Subject|1
220185|NCT01732510|721463|P3|Overall Study|Withdrawal by Subject|2
220186|NCT01732510|721464|P2|Overall Study|Withdrawal by Subject|3
220187|NCT01732510|721465|P1|Overall Study|Withdrawal by Subject|1
220188|NCT01732510|721459|P7|Overall Study|Protocol Violation|0
220189|NCT01732510|721460|P6|Overall Study|Protocol Violation|0
220190|NCT01732510|721461|P5|Overall Study|Protocol Violation|0
220191|NCT01732510|721462|P4|Overall Study|Protocol Violation|1
220192|NCT01732510|721463|P3|Overall Study|Protocol Violation|0
220193|NCT01732510|721464|P2|Overall Study|Protocol Violation|0
220194|NCT01732510|721465|P1|Overall Study|Protocol Violation|0
220195|NCT01732510|721459|P7|Overall Study|Adverse Event|1
220196|NCT01732510|721460|P6|Overall Study|Adverse Event|0
220197|NCT01732510|721461|P5|Overall Study|Adverse Event|0
220198|NCT01732510|721462|P4|Overall Study|Adverse Event|0
220199|NCT01732510|721463|P3|Overall Study|Adverse Event|1
220200|NCT01732510|721464|P2|Overall Study|Adverse Event|1
220201|NCT01732510|721465|P1|Overall Study|Adverse Event|0
220202|NCT01732484|721544|P1|Overall Study|chronical illness|5
220203|NCT01732484|721544|P1|Overall Study|Lost to Follow-up|14
220204|NCT01732484|721544|P1|Overall Study|Death|7
220205|NCT01732471|721552|P1|Overall Study|Withdrawal by Subject|1
220206|NCT01731938|721606|P2|Primary Part II|Missed Week 6 visit|3
220207|NCT01731938|721607|P1|Primary Part II|Missed Week 6 visit|2
220208|NCT01731938|721606|P2|Primary Part II|Death|1
220209|NCT01731938|721607|P1|Primary Part II|Death|2
220210|NCT01731938|721606|P2|Primary Part II|Lost to Follow-up|5
220211|NCT01731938|721607|P1|Primary Part II|Lost to Follow-up|4
220212|NCT01731938|721606|P2|Primary Part II|Withdrawal by Subject|4
220213|NCT01731938|721607|P1|Primary Part II|Withdrawal by Subject|5
220214|NCT01731938|721606|P2|Preliminary Part I|Missed Week 6 visit|3
220215|NCT01731938|721607|P1|Preliminary Part I|Missed Week 6 visit|0
220216|NCT01731938|721606|P2|Preliminary Part I|Lost to Follow-up|3
220217|NCT01731938|721607|P1|Preliminary Part I|Lost to Follow-up|0
220218|NCT01731938|721606|P2|Preliminary Part I|Physician Decision|0
220219|NCT01731938|721607|P1|Preliminary Part I|Physician Decision|1
220220|NCT01731938|721606|P2|Preliminary Part I|Withdrawal by Subject|2
220221|NCT01731938|721607|P1|Preliminary Part I|Withdrawal by Subject|2
220222|NCT01731470|721619|P1|Overall Study|Did not meet study criteria|1
220223|NCT01731470|721619|P1|Overall Study|Withdrawal by Subject|1
220224|NCT01730378|721645|P2|Overall Study|Lost to Follow-up|0
220225|NCT01730378|721646|P1|Overall Study|Lost to Follow-up|1
220226|NCT01730339|721677|P2|Overall Study|Un-specified|0
220227|NCT01730339|721678|P1|Overall Study|Un-specified|1
220228|NCT01730339|721677|P2|Overall Study|Lost to Follow-up|1
220229|NCT01730339|721678|P1|Overall Study|Lost to Follow-up|1
220230|NCT01730339|721677|P2|Overall Study|Withdrawal by Subject|2
220231|NCT01730339|721678|P1|Overall Study|Withdrawal by Subject|3
220232|NCT01730053|721718|P6|Overall Study|Other than specified|9
220233|NCT01730053|721719|P5|Overall Study|Other than specified|7
220234|NCT01730053|721720|P4|Overall Study|Other than specified|4
220235|NCT01730053|721721|P3|Overall Study|Other than specified|5
220236|NCT01730053|721722|P2|Overall Study|Other than specified|6
220237|NCT01730053|721723|P1|Overall Study|Other than specified|2
220238|NCT01730053|721718|P6|Overall Study|Poor compliance to protocol|2
220239|NCT01730053|721719|P5|Overall Study|Poor compliance to protocol|0
220240|NCT01730053|721720|P4|Overall Study|Poor compliance to protocol|0
220241|NCT01730053|721721|P3|Overall Study|Poor compliance to protocol|2
220242|NCT01730053|721722|P2|Overall Study|Poor compliance to protocol|2
220243|NCT01730053|721723|P1|Overall Study|Poor compliance to protocol|1
220244|NCT01730053|721718|P6|Overall Study|Adverse Event|2
220245|NCT01730053|721719|P5|Overall Study|Adverse Event|2
220246|NCT01730053|721720|P4|Overall Study|Adverse Event|3
220247|NCT01730053|721721|P3|Overall Study|Adverse Event|3
220248|NCT01730053|721722|P2|Overall Study|Adverse Event|6
220249|NCT01730053|721723|P1|Overall Study|Adverse Event|2
220250|NCT01730053|721718|P6|Overall Study|Physician Decision|0
220251|NCT01730053|721719|P5|Overall Study|Physician Decision|0
220252|NCT01730053|721720|P4|Overall Study|Physician Decision|1
220253|NCT01730053|721721|P3|Overall Study|Physician Decision|0
220254|NCT01730053|721722|P2|Overall Study|Physician Decision|0
220255|NCT01730053|721723|P1|Overall Study|Physician Decision|0
220256|NCT01730053|721718|P6|Overall Study|Participant moved|0
220257|NCT01730053|721719|P5|Overall Study|Participant moved|0
220258|NCT01730053|721720|P4|Overall Study|Participant moved|0
220259|NCT01730053|721721|P3|Overall Study|Participant moved|1
220260|NCT01730053|721722|P2|Overall Study|Participant moved|0
220261|NCT01730053|721723|P1|Overall Study|Participant moved|0
220262|NCT01730040|721882|P7|Overall Study|Poor compliance to protocol|1
220263|NCT01730040|721883|P6|Overall Study|Poor compliance to protocol|0
220264|NCT01730040|721884|P5|Overall Study|Poor compliance to protocol|0
220265|NCT01730040|721885|P4|Overall Study|Poor compliance to protocol|0
220266|NCT01730040|721886|P3|Overall Study|Poor compliance to protocol|0
220267|NCT01730040|721887|P2|Overall Study|Poor compliance to protocol|4
220268|NCT01730040|721888|P1|Overall Study|Poor compliance to protocol|2
220269|NCT01730040|721882|P7|Overall Study|Adverse Event|2
220270|NCT01730040|721883|P6|Overall Study|Adverse Event|1
220271|NCT01730040|721884|P5|Overall Study|Adverse Event|1
220272|NCT01730040|721885|P4|Overall Study|Adverse Event|3
220273|NCT01730040|721886|P3|Overall Study|Adverse Event|5
220274|NCT01730040|721887|P2|Overall Study|Adverse Event|3
220275|NCT01730040|721888|P1|Overall Study|Adverse Event|4
220276|NCT01730040|721882|P7|Overall Study|Other than specified|4
220277|NCT01730040|721883|P6|Overall Study|Other than specified|4
220278|NCT01730040|721884|P5|Overall Study|Other than specified|5
220279|NCT01730040|721885|P4|Overall Study|Other than specified|5
220280|NCT01730040|721886|P3|Overall Study|Other than specified|5
220281|NCT01730040|721887|P2|Overall Study|Other than specified|8
220282|NCT01730040|721888|P1|Overall Study|Other than specified|7
220283|NCT01730040|721882|P7|Overall Study|Physician Decision|1
220284|NCT01730040|721883|P6|Overall Study|Physician Decision|1
220285|NCT01730040|721884|P5|Overall Study|Physician Decision|0
220286|NCT01730040|721885|P4|Overall Study|Physician Decision|0
220287|NCT01730040|721886|P3|Overall Study|Physician Decision|0
220288|NCT01730040|721887|P2|Overall Study|Physician Decision|0
220289|NCT01730040|721888|P1|Overall Study|Physician Decision|0
220290|NCT01730040|721882|P7|Overall Study|Subject moved|1
220291|NCT01730040|721883|P6|Overall Study|Subject moved|0
220292|NCT01730040|721884|P5|Overall Study|Subject moved|0
220293|NCT01730040|721885|P4|Overall Study|Subject moved|0
220294|NCT01730040|721886|P3|Overall Study|Subject moved|1
220295|NCT01730040|721887|P2|Overall Study|Subject moved|0
220296|NCT01730040|721888|P1|Overall Study|Subject moved|0
220297|NCT01730040|721882|P7|Overall Study|Randomized but not treated|0
220298|NCT01730040|721883|P6|Overall Study|Randomized but not treated|1
220299|NCT01730040|721884|P5|Overall Study|Randomized but not treated|0
220300|NCT01730040|721885|P4|Overall Study|Randomized but not treated|0
220301|NCT01730040|721886|P3|Overall Study|Randomized but not treated|0
220302|NCT01730040|721887|P2|Overall Study|Randomized but not treated|0
220303|NCT01730040|721888|P1|Overall Study|Randomized but not treated|0
220304|NCT01729871|722067|P2|Overall Study|Unspecified|9
220305|NCT01729871|722068|P1|Overall Study|Unspecified|4
220306|NCT01729871|722067|P2|Overall Study|Withdrawal by Subject|3
220307|NCT01729871|722068|P1|Overall Study|Withdrawal by Subject|0
220308|NCT01729871|722067|P2|Overall Study|Protocol Violation|0
220309|NCT01729871|722068|P1|Overall Study|Protocol Violation|1
220310|NCT01729871|722067|P2|Overall Study|Physician Decision|2
220311|NCT01729871|722068|P1|Overall Study|Physician Decision|0
220312|NCT01729871|722067|P2|Overall Study|Lack of Efficacy|1
220313|NCT01729871|722068|P1|Overall Study|Lack of Efficacy|0
220314|NCT01729871|722067|P2|Overall Study|Death|1
220315|NCT01729871|722068|P1|Overall Study|Death|0
220316|NCT01729871|722067|P2|Overall Study|Adverse Event|7
220317|NCT01729871|722068|P1|Overall Study|Adverse Event|7
220318|NCT01729728|722087|P3|Overall Study|Protocol Violation|1
220319|NCT01729728|722088|P2|Overall Study|Protocol Violation|0
220320|NCT01729728|722089|P1|Overall Study|Protocol Violation|1
220321|NCT01729728|722087|P3|Overall Study|Adverse Event|0
220322|NCT01729728|722088|P2|Overall Study|Adverse Event|6
220323|NCT01729728|722089|P1|Overall Study|Adverse Event|0
220324|NCT01729559|722222|P2|Overall Study|Protocol Violation|28
220325|NCT01729559|722223|P1|Overall Study|Protocol Violation|31
220326|NCT01729026|722266|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
220327|NCT01729026|722267|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
220328|NCT01729026|722266|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
220329|NCT01729026|722267|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
220330|NCT01728792|722278|P5|Overall Study|Lost to Follow-up|0
220331|NCT01728792|722279|P4|Overall Study|Lost to Follow-up|2
220332|NCT01728792|722280|P3|Overall Study|Lost to Follow-up|4
220333|NCT01728792|722281|P2|Overall Study|Lost to Follow-up|1
220334|NCT01728792|722282|P1|Overall Study|Lost to Follow-up|2
220335|NCT01728792|722278|P5|Overall Study|Withdrawal of Consent|0
220336|NCT01728792|722279|P4|Overall Study|Withdrawal of Consent|1
220337|NCT01728792|722280|P3|Overall Study|Withdrawal of Consent|0
220338|NCT01728792|722281|P2|Overall Study|Withdrawal of Consent|1
220339|NCT01728792|722282|P1|Overall Study|Withdrawal of Consent|1
220340|NCT01728584|722333|P4|Overall Study|Other reason (not specified)|1
220341|NCT01728584|722334|P3|Overall Study|Other reason (not specified)|0
220342|NCT01728584|722335|P2|Overall Study|Other reason (not specified)|0
220343|NCT01728584|722336|P1|Overall Study|Other reason (not specified)|1
220344|NCT01728584|722333|P4|Overall Study|Screen failure|0
220345|NCT01728584|722334|P3|Overall Study|Screen failure|0
220346|NCT01728584|722335|P2|Overall Study|Screen failure|0
220347|NCT01728584|722336|P1|Overall Study|Screen failure|1
220348|NCT01728584|722333|P4|Overall Study|Withdrawal by Subject|0
220349|NCT01728584|722334|P3|Overall Study|Withdrawal by Subject|0
220350|NCT01728584|722335|P2|Overall Study|Withdrawal by Subject|0
220351|NCT01728584|722336|P1|Overall Study|Withdrawal by Subject|1
220352|NCT01728584|722333|P4|Overall Study|Physician Decision|0
220353|NCT01728584|722334|P3|Overall Study|Physician Decision|1
220354|NCT01728584|722335|P2|Overall Study|Physician Decision|0
220355|NCT01728584|722336|P1|Overall Study|Physician Decision|4
220356|NCT01728584|722333|P4|Overall Study|Adverse Event|0
220357|NCT01728584|722334|P3|Overall Study|Adverse Event|0
220358|NCT01728584|722335|P2|Overall Study|Adverse Event|0
220359|NCT01728584|722336|P1|Overall Study|Adverse Event|1
220360|NCT01728376|722394|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
220361|NCT01728376|722395|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
220362|NCT01728376|722396|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
220363|NCT01728376|722397|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
220364|NCT01728376|722398|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
220365|NCT01728376|722399|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
220366|NCT01728376|722394|P6|Overall Study|Did not receive treatment|0
220367|NCT01728376|722395|P5|Overall Study|Did not receive treatment|0
220368|NCT01728376|722396|P4|Overall Study|Did not receive treatment|0
220369|NCT01728376|722397|P3|Overall Study|Did not receive treatment|0
220370|NCT01728376|722398|P2|Overall Study|Did not receive treatment|1
220371|NCT01728376|722399|P1|Overall Study|Did not receive treatment|0
220372|NCT01728376|722394|P6|Overall Study|No relevant bacteria|1
220373|NCT01728376|722395|P5|Overall Study|No relevant bacteria|1
220374|NCT01728376|722396|P4|Overall Study|No relevant bacteria|0
220375|NCT01728376|722397|P3|Overall Study|No relevant bacteria|0
220376|NCT01728376|722398|P2|Overall Study|No relevant bacteria|0
220377|NCT01728376|722399|P1|Overall Study|No relevant bacteria|2
220378|NCT01728376|722394|P6|Overall Study|Persistent Positive Blood Cultures|0
220379|NCT01728376|722395|P5|Overall Study|Persistent Positive Blood Cultures|0
220380|NCT01728376|722396|P4|Overall Study|Persistent Positive Blood Cultures|0
220381|NCT01728376|722397|P3|Overall Study|Persistent Positive Blood Cultures|1
220382|NCT01728376|722398|P2|Overall Study|Persistent Positive Blood Cultures|0
220383|NCT01728376|722399|P1|Overall Study|Persistent Positive Blood Cultures|1
220384|NCT01728376|722394|P6|Overall Study|Adverse Event|0
220385|NCT01728376|722395|P5|Overall Study|Adverse Event|1
220386|NCT01728376|722396|P4|Overall Study|Adverse Event|1
220387|NCT01728376|722397|P3|Overall Study|Adverse Event|1
220388|NCT01728376|722398|P2|Overall Study|Adverse Event|1
220389|NCT01728376|722399|P1|Overall Study|Adverse Event|1
220390|NCT01728324|722472|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
220391|NCT01728324|722473|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
220392|NCT01728324|722474|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
220393|NCT01728324|722472|P3|Termination of RBV|Adverse Event (Placebo Period)|0
220394|NCT01728324|722473|P2|Termination of RBV|Adverse Event (Placebo Period)|1
220395|NCT01728324|722474|P1|Termination of RBV|Adverse Event (Placebo Period)|0
220396|NCT01728324|722472|P3|Termination of RBV|Other than stated|1
220397|NCT01728324|722473|P2|Termination of RBV|Other than stated|3
220398|NCT01728324|722474|P1|Termination of RBV|Other than stated|1
220399|NCT01728324|722472|P3|Termination of RBV|Withdrawal by Subject|2
220400|NCT01728324|722473|P2|Termination of RBV|Withdrawal by Subject|5
220401|NCT01728324|722474|P1|Termination of RBV|Withdrawal by Subject|9
220402|NCT01728324|722472|P3|Termination of RBV|Lack of Efficacy|7
220403|NCT01728324|722473|P2|Termination of RBV|Lack of Efficacy|11
220404|NCT01728324|722474|P1|Termination of RBV|Lack of Efficacy|14
220405|NCT01728324|722472|P3|Termination of RBV|Adverse Event|5
220406|NCT01728324|722473|P2|Termination of RBV|Adverse Event|16
220407|NCT01728324|722474|P1|Termination of RBV|Adverse Event|15
220408|NCT01728324|722472|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
220409|NCT01728324|722473|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
220410|NCT01728324|722474|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
220411|NCT01728324|722472|P3|Termination of FDV|Adverse Event (Placebo Period)|0
220412|NCT01728324|722473|P2|Termination of FDV|Adverse Event (Placebo Period)|1
220413|NCT01728324|722474|P1|Termination of FDV|Adverse Event (Placebo Period)|0
220414|NCT01728324|722472|P3|Termination of FDV|Other than stated|0
220415|NCT01728324|722473|P2|Termination of FDV|Other than stated|3
220416|NCT01728324|722474|P1|Termination of FDV|Other than stated|1
220417|NCT01728324|722472|P3|Termination of FDV|Withdrawal by Subject|2
220418|NCT01728324|722473|P2|Termination of FDV|Withdrawal by Subject|6
220419|NCT01728324|722474|P1|Termination of FDV|Withdrawal by Subject|9
220420|NCT01728324|722472|P3|Termination of FDV|Lack of Efficacy|8
220421|NCT01728324|722473|P2|Termination of FDV|Lack of Efficacy|12
220422|NCT01728324|722474|P1|Termination of FDV|Lack of Efficacy|14
220423|NCT01728324|722472|P3|Termination of FDV|Adverse Event|4
220424|NCT01728324|722473|P2|Termination of FDV|Adverse Event|13
220425|NCT01728324|722474|P1|Termination of FDV|Adverse Event|14
220426|NCT01728324|722472|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
220427|NCT01728324|722473|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
220428|NCT01728324|722474|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
220429|NCT01728324|722472|P3|Termination of DBV|Adverse Event (Placebo Period)|0
220430|NCT01728324|722473|P2|Termination of DBV|Adverse Event (Placebo Period)|1
220431|NCT01728324|722474|P1|Termination of DBV|Adverse Event (Placebo Period)|0
220432|NCT01728324|722472|P3|Termination of DBV|Other than stated|0
220433|NCT01728324|722473|P2|Termination of DBV|Other than stated|3
220434|NCT01728324|722474|P1|Termination of DBV|Other than stated|1
220435|NCT01728324|722472|P3|Termination of DBV|Withdrawal by Subject|2
220436|NCT01728324|722473|P2|Termination of DBV|Withdrawal by Subject|6
220437|NCT01728324|722474|P1|Termination of DBV|Withdrawal by Subject|9
220438|NCT01728324|722472|P3|Termination of DBV|Lack of Efficacy|8
220439|NCT01728324|722473|P2|Termination of DBV|Lack of Efficacy|12
220440|NCT01728324|722474|P1|Termination of DBV|Lack of Efficacy|14
220441|NCT01728324|722472|P3|Termination of DBV|Adverse Event|4
220442|NCT01728324|722473|P2|Termination of DBV|Adverse Event|13
220443|NCT01728324|722474|P1|Termination of DBV|Adverse Event|14
220444|NCT01728246|722495|P2|Overall Study|Adverse Event|5
220445|NCT01728246|722496|P1|Overall Study|Adverse Event|8
220446|NCT01728246|722495|P2|Overall Study|Lack of Efficacy|1
220447|NCT01728246|722496|P1|Overall Study|Lack of Efficacy|1
220448|NCT01728246|722495|P2|Overall Study|Lost to Follow-up|22
220449|NCT01728246|722496|P1|Overall Study|Lost to Follow-up|23
220450|NCT01728246|722495|P2|Overall Study|Withdrawal by Subject|3
220451|NCT01728246|722496|P1|Overall Study|Withdrawal by Subject|2
220452|NCT01728246|722495|P2|Overall Study|Protocol Violation|0
220453|NCT01728246|722496|P1|Overall Study|Protocol Violation|1
220454|NCT01728246|722495|P2|Overall Study|Participant needed rescue medication|5
220455|NCT01728246|722496|P1|Overall Study|Participant needed rescue medication|1
220456|NCT01728116|722514|P2|Overall Study|various not noted previously|0
220457|NCT01728116|722515|P1|Overall Study|various not noted previously|5
220458|NCT01728116|722514|P2|Overall Study|Incorrectly enrolled in Study|1
220459|NCT01728116|722515|P1|Overall Study|Incorrectly enrolled in Study|0
220460|NCT01728116|722514|P2|Overall Study|Inter-current finding at procedure|0
220461|NCT01728116|722515|P1|Overall Study|Inter-current finding at procedure|1
220462|NCT01728116|722514|P2|Overall Study|Subject Non-Compliance|0
220463|NCT01728116|722515|P1|Overall Study|Subject Non-Compliance|2
220464|NCT01728116|722514|P2|Overall Study|Physician Decision|0
220465|NCT01728116|722515|P1|Overall Study|Physician Decision|2
220466|NCT01728116|722514|P2|Overall Study|Lost to Follow-up|2
220467|NCT01728116|722515|P1|Overall Study|Lost to Follow-up|9
220468|NCT01728116|722514|P2|Overall Study|Procedure/device failure|0
220469|NCT01728116|722515|P1|Overall Study|Procedure/device failure|7
220470|NCT01728116|722514|P2|Overall Study|Adverse Event|0
220471|NCT01728116|722515|P1|Overall Study|Adverse Event|13
220472|NCT01728116|722514|P2|Overall Study|Withdrawal by Subject|9
220473|NCT01728116|722515|P1|Overall Study|Withdrawal by Subject|16
220474|NCT01728116|722514|P2|Overall Study|Sponsor Terminated Study|35
220475|NCT01728116|722515|P1|Overall Study|Sponsor Terminated Study|106
220476|NCT01727713|722577|P1|Overall Study|Protocol Deviation|2
220477|NCT01727713|722577|P1|Overall Study|Withdrawal by Subject|13
220478|NCT01727713|722577|P1|Overall Study|Participant Met Withdrawal Criteria|5
220479|NCT01727713|722577|P1|Overall Study|Adverse Event|10
220480|NCT01727713|722577|P1|Overall Study|Lost to Follow-up|5
220481|NCT01727700|722604|P3|Overall Study|Protocol Violation|0
220482|NCT01727700|722605|P2|Overall Study|Protocol Violation|0
220483|NCT01727700|722606|P1|Overall Study|Protocol Violation|2
220484|NCT01727700|722604|P3|Overall Study|Particpant withdrew consent|1
220485|NCT01727700|722605|P2|Overall Study|Particpant withdrew consent|3
220486|NCT01727700|722606|P1|Overall Study|Particpant withdrew consent|0
220487|NCT01727700|722604|P3|Overall Study|Adverse Event|1
220488|NCT01727700|722605|P2|Overall Study|Adverse Event|7
220489|NCT01727700|722606|P1|Overall Study|Adverse Event|0
220490|NCT01727505|722629|P2|Second 24 Hours|Missing data|1
220491|NCT01727505|722630|P1|Second 24 Hours|Missing data|0
220492|NCT01727505|722629|P2|First 24 Hours|Adverse Event|1
220493|NCT01727505|722630|P1|First 24 Hours|Adverse Event|0
220494|NCT01727258|722649|P3|Overall Study|Lost to Follow-up|0
220495|NCT01727258|722650|P2|Overall Study|Lost to Follow-up|0
220496|NCT01727258|722651|P1|Overall Study|Lost to Follow-up|1
220497|NCT01727258|722649|P3|Overall Study|Withdrawal by Subject|0
220498|NCT01727258|722650|P2|Overall Study|Withdrawal by Subject|1
220499|NCT01727258|722651|P1|Overall Study|Withdrawal by Subject|1
220500|NCT01727258|722649|P3|Overall Study|Noncompliance with Study Drug|1
220501|NCT01727258|722650|P2|Overall Study|Noncompliance with Study Drug|0
220502|NCT01727258|722651|P1|Overall Study|Noncompliance with Study Drug|0
220503|NCT01727258|722649|P3|Overall Study|Adverse Event|0
220504|NCT01727258|722650|P2|Overall Study|Adverse Event|2
220505|NCT01727258|722651|P1|Overall Study|Adverse Event|0
220506|NCT01727141|722693|P4|Overall Study|Withdrawal by Subject|11
220507|NCT01727141|722694|P3|Overall Study|Withdrawal by Subject|2
220508|NCT01727141|722695|P2|Overall Study|Withdrawal by Subject|4
220509|NCT01727141|722696|P1|Overall Study|Withdrawal by Subject|4
220510|NCT01727141|722693|P4|Overall Study|Protocol deviation|1
220511|NCT01727141|722694|P3|Overall Study|Protocol deviation|0
220512|NCT01727141|722695|P2|Overall Study|Protocol deviation|1
220513|NCT01727141|722696|P1|Overall Study|Protocol deviation|1
220514|NCT01727141|722693|P4|Overall Study|Death|1
220515|NCT01727141|722694|P3|Overall Study|Death|1
220516|NCT01727141|722695|P2|Overall Study|Death|1
220517|NCT01727141|722696|P1|Overall Study|Death|0
220518|NCT01727141|722693|P4|Overall Study|Lost to Follow-up|0
220519|NCT01727141|722694|P3|Overall Study|Lost to Follow-up|0
220520|NCT01727141|722695|P2|Overall Study|Lost to Follow-up|2
220521|NCT01727141|722696|P1|Overall Study|Lost to Follow-up|0
220522|NCT01727141|722693|P4|Overall Study|Physician Decision|2
220523|NCT01727141|722694|P3|Overall Study|Physician Decision|0
220524|NCT01727141|722695|P2|Overall Study|Physician Decision|1
220525|NCT01727141|722696|P1|Overall Study|Physician Decision|0
220526|NCT01727024|722746|P2|Period 1|Withdrawal by Subject|3
220527|NCT01727024|722747|P1|Period 1|Withdrawal by Subject|2
220528|NCT01727024|722746|P2|Period 1|Lost to Follow-up|1
220529|NCT01727024|722747|P1|Period 1|Lost to Follow-up|1
220530|NCT01726517|722769|P5|Overall Study|Withdrawal by Subject|0
220531|NCT01726517|722770|P4|Overall Study|Withdrawal by Subject|0
220532|NCT01726517|722771|P3|Overall Study|Withdrawal by Subject|1
220533|NCT01726517|722772|P2|Overall Study|Withdrawal by Subject|0
220534|NCT01726517|722773|P1|Overall Study|Withdrawal by Subject|0
220535|NCT01726335|722829|P1|Overall Study|Exacerbation of psychotic symptoms|1
220536|NCT01726335|722829|P1|Overall Study|Lost to Follow-up|2
220537|NCT01726335|722829|P1|Overall Study|Adverse Event|4
220538|NCT01726335|722829|P1|Overall Study|Withdrawal by Subject|15
220539|NCT01726335|722829|P1|Overall Study|Lost to Follow-up|2
220540|NCT01726049|722847|P2|Overall Study|refused second HC|2
220541|NCT01726049|722848|P1|Overall Study|refused second HC|0
220542|NCT01726049|722847|P2|Overall Study|Adverse Event|1
220543|NCT01726049|722848|P1|Overall Study|Adverse Event|4
220544|NCT01726049|722847|P2|Overall Study|Death|1
220545|NCT01726049|722848|P1|Overall Study|Death|1
220546|NCT01726023|722862|P2|Overall Study|Withdrawal by Subject|8
220547|NCT01726023|722863|P1|Overall Study|Withdrawal by Subject|16
220548|NCT01726023|722862|P2|Overall Study|Other Eligibility criteria|7
220549|NCT01726023|722863|P1|Overall Study|Other Eligibility criteria|7
220550|NCT01726023|722862|P2|Overall Study|Lost to Follow-up|10
220551|NCT01726023|722863|P1|Overall Study|Lost to Follow-up|5
220552|NCT01726023|722862|P2|Overall Study|Death|1
220553|NCT01726023|722863|P1|Overall Study|Death|1
220554|NCT01725529|722983|P3|Overall Study|Withdrawal by Subject|8
220555|NCT01725529|722984|P2|Overall Study|Withdrawal by Subject|14
220556|NCT01725529|722985|P1|Overall Study|Withdrawal by Subject|12
220557|NCT01725529|722983|P3|Overall Study|Protocol Violation|1
220558|NCT01725529|722984|P2|Overall Study|Protocol Violation|1
220559|NCT01725529|722985|P1|Overall Study|Protocol Violation|0
220560|NCT01725529|722983|P3|Overall Study|Lost to Follow-up|1
220561|NCT01725529|722984|P2|Overall Study|Lost to Follow-up|1
220562|NCT01725529|722985|P1|Overall Study|Lost to Follow-up|2
220563|NCT01725529|722983|P3|Overall Study|Adverse Event|0
220564|NCT01725529|722984|P2|Overall Study|Adverse Event|0
220565|NCT01725529|722985|P1|Overall Study|Adverse Event|1
220566|NCT01725451|723011|P4|Period 4|Adverse Event|0
220567|NCT01725451|723012|P3|Period 4|Adverse Event|1
220568|NCT01725451|723013|P2|Period 4|Adverse Event|0
220569|NCT01725451|723014|P1|Period 4|Adverse Event|0
220570|NCT01725451|723011|P4|Washout From Period 3|Adverse Event|0
220571|NCT01725451|723012|P3|Washout From Period 3|Adverse Event|0
220572|NCT01725451|723013|P2|Washout From Period 3|Adverse Event|1
220573|NCT01725451|723014|P1|Washout From Period 3|Adverse Event|0
220574|NCT01725451|723011|P4|Washout From Period 3|Protocol Violation|0
220575|NCT01725451|723012|P3|Washout From Period 3|Protocol Violation|1
220576|NCT01725451|723013|P2|Washout From Period 3|Protocol Violation|0
220577|NCT01725451|723014|P1|Washout From Period 3|Protocol Violation|0
220578|NCT01725451|723011|P4|Period 1|Withdrawal by Subject|0
220579|NCT01725451|723012|P3|Period 1|Withdrawal by Subject|0
220580|NCT01725451|723013|P2|Period 1|Withdrawal by Subject|0
220581|NCT01725451|723014|P1|Period 1|Withdrawal by Subject|1
220582|NCT01725386|723036|P2|Overall Study|Withdrawal by Subject|0
220583|NCT01725386|723037|P1|Overall Study|Withdrawal by Subject|10
220584|NCT01725386|723036|P2|Overall Study|Lost to Follow-up|6
220585|NCT01725386|723037|P1|Overall Study|Lost to Follow-up|81
220586|NCT01725386|723036|P2|Overall Study|Death|40
220587|NCT01725386|723037|P1|Overall Study|Death|84
220588|NCT01725308|723056|P3|Overall Study|Miscellaneous|3
220589|NCT01725308|723057|P2|Overall Study|Miscellaneous|0
220590|NCT01725308|723058|P1|Overall Study|Miscellaneous|2
220591|NCT01725308|723056|P3|Overall Study|Protocol Deviations|1
220592|NCT01725308|723057|P2|Overall Study|Protocol Deviations|1
220593|NCT01725308|723058|P1|Overall Study|Protocol Deviations|3
220594|NCT01725308|723056|P3|Overall Study|Lost to Follow-up|2
220595|NCT01725308|723057|P2|Overall Study|Lost to Follow-up|2
220596|NCT01725308|723058|P1|Overall Study|Lost to Follow-up|3
220597|NCT01725308|723056|P3|Overall Study|Subject Consent Withdrawal|5
220598|NCT01725308|723057|P2|Overall Study|Subject Consent Withdrawal|7
220599|NCT01725308|723058|P1|Overall Study|Subject Consent Withdrawal|12
220600|NCT01725308|723056|P3|Overall Study|Episode Change|2
220601|NCT01725308|723057|P2|Overall Study|Episode Change|0
220602|NCT01725308|723058|P1|Overall Study|Episode Change|3
220603|NCT01725308|723056|P3|Overall Study|Worsening of Underlying Disease|2
220604|NCT01725308|723057|P2|Overall Study|Worsening of Underlying Disease|0
220605|NCT01725308|723058|P1|Overall Study|Worsening of Underlying Disease|8
220606|NCT01725308|723056|P3|Overall Study|Lack of Efficacy|5
220607|NCT01725308|723057|P2|Overall Study|Lack of Efficacy|0
220608|NCT01725308|723058|P1|Overall Study|Lack of Efficacy|7
220609|NCT01725308|723056|P3|Overall Study|Adverse Event|21
220610|NCT01725308|723057|P2|Overall Study|Adverse Event|4
220611|NCT01725308|723058|P1|Overall Study|Adverse Event|5
220612|NCT01725308|723056|P3|Overall Study|Did Not Receive Drug|0
220613|NCT01725308|723057|P2|Overall Study|Did Not Receive Drug|0
220614|NCT01725308|723058|P1|Overall Study|Did Not Receive Drug|1
220615|NCT01725282|723112|P4|Overall Study|Lack of Efficacy|1
220616|NCT01725282|723113|P3|Overall Study|Lack of Efficacy|0
220617|NCT01725282|723114|P2|Overall Study|Lack of Efficacy|1
220618|NCT01725282|723115|P1|Overall Study|Lack of Efficacy|0
220619|NCT01725282|723112|P4|Overall Study|Withdrawal by Subject|1
220620|NCT01725282|723113|P3|Overall Study|Withdrawal by Subject|1
220621|NCT01725282|723114|P2|Overall Study|Withdrawal by Subject|0
220622|NCT01725282|723115|P1|Overall Study|Withdrawal by Subject|0
220623|NCT01725282|723112|P4|Overall Study|Study Site Withdrawal|0
220624|NCT01725282|723113|P3|Overall Study|Study Site Withdrawal|0
220625|NCT01725282|723114|P2|Overall Study|Study Site Withdrawal|1
220626|NCT01725282|723115|P1|Overall Study|Study Site Withdrawal|0
220627|NCT01725282|723112|P4|Overall Study|Met Exclusion Criteria|0
220628|NCT01725282|723113|P3|Overall Study|Met Exclusion Criteria|1
220629|NCT01725282|723114|P2|Overall Study|Met Exclusion Criteria|0
220630|NCT01725282|723115|P1|Overall Study|Met Exclusion Criteria|0
220631|NCT01725282|723112|P4|Overall Study|Exacerbation of Target Disease|1
220632|NCT01725282|723113|P3|Overall Study|Exacerbation of Target Disease|0
220633|NCT01725282|723114|P2|Overall Study|Exacerbation of Target Disease|0
220634|NCT01725282|723115|P1|Overall Study|Exacerbation of Target Disease|1
220635|NCT01725282|723112|P4|Overall Study|Adverse Event|4
220636|NCT01725282|723113|P3|Overall Study|Adverse Event|6
220637|NCT01725282|723114|P2|Overall Study|Adverse Event|3
220638|NCT01725282|723115|P1|Overall Study|Adverse Event|1
220639|NCT01725217|723148|P3|Overall Study|Withdrawal by Subject|0
220640|NCT01725217|723149|P2|Overall Study|Withdrawal by Subject|0
220641|NCT01725217|723150|P1|Overall Study|Withdrawal by Subject|1
220642|NCT01724528|723180|P2|Overall Study|Patient refused to attend last visit|0
220643|NCT01724528|723181|P1|Overall Study|Patient refused to attend last visit|1
220644|NCT01724528|723180|P2|Overall Study|Protocol Violation|1
220645|NCT01724528|723181|P1|Overall Study|Protocol Violation|0
220646|NCT01724528|723180|P2|Overall Study|Withdrawal by Subject|2
220647|NCT01724528|723181|P1|Overall Study|Withdrawal by Subject|0
220648|NCT01724528|723180|P2|Overall Study|Death|0
220649|NCT01724528|723181|P1|Overall Study|Death|3
220650|NCT01724359|723195|P1|Overall Study|Not specified|20
220651|NCT01724359|723195|P1|Overall Study|Death|1
220652|NCT01724359|723195|P1|Overall Study|Adverse Event|10
220653|NCT01724216|723208|P1|Overall Study|Scan was not completed|1
220654|NCT01724177|723212|P1|Overall Study|Unspecified|2
220655|NCT01724177|723212|P1|Overall Study|Progressive disease or Relapsed Disease|13
220656|NCT01724177|723212|P1|Overall Study|Adverse Event|6
220657|NCT01724021|723224|P2|Overall Study|Reason Not Specified|9
220658|NCT01724021|723225|P1|Overall Study|Reason Not Specified|6
220659|NCT01724021|723224|P2|Overall Study|Lack of Compliance|1
220660|NCT01724021|723225|P1|Overall Study|Lack of Compliance|0
220661|NCT01724021|723224|P2|Overall Study|Lost to Follow-up|7
220662|NCT01724021|723225|P1|Overall Study|Lost to Follow-up|0
220663|NCT01724021|723224|P2|Overall Study|Participant request/ Withdrew consent|10
220664|NCT01724021|723225|P1|Overall Study|Participant request/ Withdrew consent|13
220665|NCT01724021|723224|P2|Overall Study|Death|29
220666|NCT01724021|723225|P1|Overall Study|Death|24
220667|NCT01724021|723224|P2|Overall Study|Adverse Event|4
220668|NCT01724021|723225|P1|Overall Study|Adverse Event|5
220669|NCT01723904|723257|P1|Overall Study|Unable to follow protocol/ judged by inv|3
220670|NCT01723904|723257|P1|Overall Study|Adverse Event|5
220671|NCT01723904|723257|P1|Overall Study|Noncompliant|3
220672|NCT01723397|723278|P2|Study Period 2|Protocol Violation|1
220673|NCT01723397|723279|P1|Study Period 2|Protocol Violation|0
220674|NCT01723397|723278|P2|Study Period 1|Protocol Violation|1
220675|NCT01723397|723279|P1|Study Period 1|Protocol Violation|0
220676|NCT01723254|723293|P8|Overall Study|Withdrawal by Subject|2
220677|NCT01723254|723294|P7|Overall Study|Withdrawal by Subject|1
220678|NCT01723254|723295|P6|Overall Study|Withdrawal by Subject|1
220679|NCT01723254|723296|P5|Overall Study|Withdrawal by Subject|1
220680|NCT01723254|723297|P4|Overall Study|Withdrawal by Subject|0
220681|NCT01723254|723298|P3|Overall Study|Withdrawal by Subject|1
220682|NCT01723254|723299|P2|Overall Study|Withdrawal by Subject|2
220683|NCT01723254|723300|P1|Overall Study|Withdrawal by Subject|1
220684|NCT01723254|723293|P8|Overall Study|Protocol Violation|0
220685|NCT01723254|723294|P7|Overall Study|Protocol Violation|0
220686|NCT01723254|723295|P6|Overall Study|Protocol Violation|0
220687|NCT01723254|723296|P5|Overall Study|Protocol Violation|0
220688|NCT01723254|723297|P4|Overall Study|Protocol Violation|0
220689|NCT01723254|723298|P3|Overall Study|Protocol Violation|0
220690|NCT01723254|723299|P2|Overall Study|Protocol Violation|1
220691|NCT01723254|723300|P1|Overall Study|Protocol Violation|0
220692|NCT01723254|723293|P8|Overall Study|Move/Left to another country/city|0
220693|NCT01723254|723294|P7|Overall Study|Move/Left to another country/city|0
220694|NCT01723254|723295|P6|Overall Study|Move/Left to another country/city|0
220695|NCT01723254|723296|P5|Overall Study|Move/Left to another country/city|1
220696|NCT01723254|723297|P4|Overall Study|Move/Left to another country/city|1
220697|NCT01723254|723298|P3|Overall Study|Move/Left to another country/city|2
220698|NCT01723254|723299|P2|Overall Study|Move/Left to another country/city|0
220699|NCT01723254|723300|P1|Overall Study|Move/Left to another country/city|0
220700|NCT01723254|723293|P8|Overall Study|No longer have time to participate|0
220701|NCT01723254|723294|P7|Overall Study|No longer have time to participate|0
220702|NCT01723254|723295|P6|Overall Study|No longer have time to participate|0
220703|NCT01723254|723296|P5|Overall Study|No longer have time to participate|0
220704|NCT01723254|723297|P4|Overall Study|No longer have time to participate|1
220705|NCT01723254|723298|P3|Overall Study|No longer have time to participate|0
220706|NCT01723254|723299|P2|Overall Study|No longer have time to participate|0
220707|NCT01723254|723300|P1|Overall Study|No longer have time to participate|0
220708|NCT01723254|723293|P8|Overall Study|Personal issues|0
220709|NCT01723254|723294|P7|Overall Study|Personal issues|0
220710|NCT01723254|723295|P6|Overall Study|Personal issues|1
220711|NCT01723254|723296|P5|Overall Study|Personal issues|0
220712|NCT01723254|723297|P4|Overall Study|Personal issues|0
220713|NCT01723254|723298|P3|Overall Study|Personal issues|0
220714|NCT01723254|723299|P2|Overall Study|Personal issues|0
220715|NCT01723254|723300|P1|Overall Study|Personal issues|0
220716|NCT01723254|723293|P8|Overall Study|Conflict with work schedule|1
220717|NCT01723254|723294|P7|Overall Study|Conflict with work schedule|0
220718|NCT01723254|723295|P6|Overall Study|Conflict with work schedule|0
220719|NCT01723254|723296|P5|Overall Study|Conflict with work schedule|0
220720|NCT01723254|723297|P4|Overall Study|Conflict with work schedule|0
220721|NCT01723254|723298|P3|Overall Study|Conflict with work schedule|0
220722|NCT01723254|723299|P2|Overall Study|Conflict with work schedule|0
220723|NCT01723254|723300|P1|Overall Study|Conflict with work schedule|0
220724|NCT01723228|723352|P2|Overall Study|Not Specified|1
220725|NCT01723228|723353|P1|Overall Study|Not Specified|2
220726|NCT01723228|723352|P2|Overall Study|Lost to Follow-up|1
220727|NCT01723228|723353|P1|Overall Study|Lost to Follow-up|2
220728|NCT01723228|723352|P2|Overall Study|Protocol Violation|2
220729|NCT01723228|723353|P1|Overall Study|Protocol Violation|0
220730|NCT01723228|723352|P2|Overall Study|Withdrawal by Subject|1
220731|NCT01723228|723353|P1|Overall Study|Withdrawal by Subject|2
220732|NCT01723228|723352|P2|Overall Study|Adverse Event|6
220733|NCT01723228|723353|P1|Overall Study|Adverse Event|2
220734|NCT01722994|723371|P2|Overall Study|Missing data|17
220735|NCT01722994|723372|P1|Overall Study|Missing data|25
220736|NCT01722877|723386|P1|Overall Study|Lost to Follow-up|1
220737|NCT01722877|723386|P1|Overall Study|Death|1
220738|NCT01722266|723447|P4|Overall Study|Dropped out due to Nausea|0
220739|NCT01722266|723448|P3|Overall Study|Dropped out due to Nausea|2
220740|NCT01722266|723449|P2|Overall Study|Dropped out due to Nausea|0
220741|NCT01722266|723450|P1|Overall Study|Dropped out due to Nausea|0
220742|NCT01722266|723447|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
220743|NCT01722266|723448|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
220744|NCT01722266|723449|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
220745|NCT01722266|723450|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
220746|NCT01722266|723447|P4|Overall Study|Withdrawal by Subject|0
220747|NCT01722266|723448|P3|Overall Study|Withdrawal by Subject|0
220748|NCT01722266|723449|P2|Overall Study|Withdrawal by Subject|2
220749|NCT01722266|723450|P1|Overall Study|Withdrawal by Subject|1
220750|NCT01722162|723478|P2|Overall Study|Noncompliance|1
220751|NCT01722162|723479|P1|Overall Study|Noncompliance|0
220752|NCT01722162|723478|P2|Overall Study|Insurance denial post enrollment|1
220753|NCT01722162|723479|P1|Overall Study|Insurance denial post enrollment|0
220754|NCT01722162|723478|P2|Overall Study|Adverse Event|1
220755|NCT01722162|723479|P1|Overall Study|Adverse Event|1
220756|NCT01722162|723478|P2|Overall Study|Unrelated to study adverse event|2
220757|NCT01722162|723479|P1|Overall Study|Unrelated to study adverse event|2
220758|NCT01722162|723478|P2|Overall Study|Found ineligible|0
220759|NCT01722162|723479|P1|Overall Study|Found ineligible|1
220760|NCT01722162|723478|P2|Overall Study|Withdrawal by Subject|1
220761|NCT01722162|723479|P1|Overall Study|Withdrawal by Subject|1
220762|NCT01722097|723489|P2|Overall Study|Patient sheets not returned|5
220763|NCT01722097|723490|P1|Overall Study|Patient sheets not returned|6
220764|NCT01722071|723498|P2|Overall Study|Protocol Violation|0
220765|NCT01722071|723499|P1|Overall Study|Protocol Violation|1
220766|NCT01721772|723520|P2|Overall Study|Not specified|1
220767|NCT01721772|723521|P1|Overall Study|Not specified|0
220768|NCT01721772|723520|P2|Overall Study|Maximum clinical benefit|1
220769|NCT01721772|723521|P1|Overall Study|Maximum clinical benefit|1
220770|NCT01721772|723520|P2|Overall Study|Withdrawal by Subject|5
220771|NCT01721772|723521|P1|Overall Study|Withdrawal by Subject|7
220772|NCT01721772|723520|P2|Overall Study|Unrelated adverse event|3
220773|NCT01721772|723521|P1|Overall Study|Unrelated adverse event|2
220774|NCT01721772|723520|P2|Overall Study|Study drug toxicity|7
220775|NCT01721772|723521|P1|Overall Study|Study drug toxicity|5
220776|NCT01721772|723520|P2|Overall Study|Disease progression|175
220777|NCT01721772|723521|P1|Overall Study|Disease progression|96
220778|NCT01721759|723541|P1|Overall Study|Withdrawal by Subject|1
220779|NCT01721759|723541|P1|Overall Study|Adverse event unrelated to study drug|9
220780|NCT01721759|723541|P1|Overall Study|Study drug toxicity|14
220781|NCT01721759|723541|P1|Overall Study|Disease progression|78
220782|NCT01721746|723549|P3|Treatment Period|Unspecified|1
220783|NCT01721746|723550|P2|Treatment Period|Unspecified|1
220784|NCT01721746|723551|P1|Treatment Period|Unspecified|2
220785|NCT01721746|723549|P3|Treatment Period|Subject No Longer Met Study Criteria|0
220786|NCT01721746|723550|P2|Treatment Period|Subject No Longer Met Study Criteria|0
220787|NCT01721746|723551|P1|Treatment Period|Subject No Longer Met Study Criteria|4
220788|NCT01721746|723549|P3|Treatment Period|Poor/Non-compliance|0
220789|NCT01721746|723550|P2|Treatment Period|Poor/Non-compliance|0
220790|NCT01721746|723551|P1|Treatment Period|Poor/Non-compliance|1
220791|NCT01721746|723549|P3|Treatment Period|Maximum Clinical Benefit|3
220792|NCT01721746|723550|P2|Treatment Period|Maximum Clinical Benefit|0
220793|NCT01721746|723551|P1|Treatment Period|Maximum Clinical Benefit|1
220794|NCT01721746|723549|P3|Treatment Period|Subject Withdrew Consent|2
220795|NCT01721746|723550|P2|Treatment Period|Subject Withdrew Consent|0
220796|NCT01721746|723551|P1|Treatment Period|Subject Withdrew Consent|3
220797|NCT01721746|723549|P3|Treatment Period|Subject Request to Discontinue Treatment|6
220798|NCT01721746|723550|P2|Treatment Period|Subject Request to Discontinue Treatment|1
220799|NCT01721746|723551|P1|Treatment Period|Subject Request to Discontinue Treatment|19
220800|NCT01721746|723549|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
220801|NCT01721746|723550|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
220802|NCT01721746|723551|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
220803|NCT01721746|723549|P3|Treatment Period|Study Drug Toxicity|9
220804|NCT01721746|723550|P2|Treatment Period|Study Drug Toxicity|2
220805|NCT01721746|723551|P1|Treatment Period|Study Drug Toxicity|15
220806|NCT01721746|723549|P3|Treatment Period|Disease Progression|34
220807|NCT01721746|723550|P2|Treatment Period|Disease Progression|40
220808|NCT01721746|723551|P1|Treatment Period|Disease Progression|182
220809|NCT01721486|723574|P2|Overall Study|Physician Decision|1
220810|NCT01721486|723575|P1|Overall Study|Physician Decision|0
220811|NCT01721486|723574|P2|Overall Study|Protocol Violation|0
220812|NCT01721486|723575|P1|Overall Study|Protocol Violation|1
220813|NCT01721330|723589|P2|Overall Study|Withdrawal by Subject|1
220814|NCT01721330|723590|P1|Overall Study|Withdrawal by Subject|0
220815|NCT01721317|723598|P2|Overall Study|Withdrawal by Subject|1
220816|NCT01721317|723599|P1|Overall Study|Withdrawal by Subject|0
220817|NCT01721317|723598|P2|Overall Study|Physician Decision|1
220818|NCT01721317|723599|P1|Overall Study|Physician Decision|0
220819|NCT01721317|723598|P2|Overall Study|Study Closed / Terminated|2
220820|NCT01721317|723599|P1|Overall Study|Study Closed / Terminated|2
220821|NCT01721161|723678|P2|Overall Study|Not Specified|1
220822|NCT01721161|723679|P1|Overall Study|Not Specified|0
220823|NCT01721161|723678|P2|Overall Study|Withdrawal by Subject|1
220824|NCT01721161|723679|P1|Overall Study|Withdrawal by Subject|1
220825|NCT01721161|723678|P2|Overall Study|Lost to Follow-up|2
220826|NCT01721161|723679|P1|Overall Study|Lost to Follow-up|1
220827|NCT01721161|723678|P2|Overall Study|Adverse Event|3
220828|NCT01721161|723679|P1|Overall Study|Adverse Event|2
220829|NCT01721109|723702|P1|Extension Phase|Still on Study|35
220830|NCT01721109|723702|P1|Extension Phase|Non-Compliance with Study Drug|2
220831|NCT01721109|723702|P1|Main Phase|Non-Compliance with Study Drug|1
220832|NCT01721070|723808|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
220833|NCT01721057|723819|P7|Rescue Period|Lack of Efficacy|0
220834|NCT01721057|723820|P6|Rescue Period|Lack of Efficacy|0
220835|NCT01721057|723821|P5|Rescue Period|Lack of Efficacy|0
220836|NCT01721057|723822|P4|Rescue Period|Lack of Efficacy|2
220837|NCT01721057|723823|P3|Rescue Period|Lack of Efficacy|0
220838|NCT01721057|723824|P2|Rescue Period|Lack of Efficacy|0
220839|NCT01721057|723825|P1|Rescue Period|Lack of Efficacy|0
220840|NCT01721057|723819|P7|Rescue Period|Adverse Event|0
220841|NCT01721057|723820|P6|Rescue Period|Adverse Event|0
220842|NCT01721057|723821|P5|Rescue Period|Adverse Event|0
220843|NCT01721057|723822|P4|Rescue Period|Adverse Event|1
220844|NCT01721057|723823|P3|Rescue Period|Adverse Event|0
220845|NCT01721057|723824|P2|Rescue Period|Adverse Event|0
220846|NCT01721057|723825|P1|Rescue Period|Adverse Event|0
220847|NCT01721057|723819|P7|Treatment Period|Death|0
220848|NCT01721057|723820|P6|Treatment Period|Death|0
220849|NCT01721057|723821|P5|Treatment Period|Death|0
220850|NCT01721057|723822|P4|Treatment Period|Death|0
220851|NCT01721057|723823|P3|Treatment Period|Death|0
220852|NCT01721057|723824|P2|Treatment Period|Death|0
220853|NCT01721057|723825|P1|Treatment Period|Death|2
220854|NCT01721057|723819|P7|Treatment Period|Physician Decision|0
220855|NCT01721057|723820|P6|Treatment Period|Physician Decision|0
220856|NCT01721057|723821|P5|Treatment Period|Physician Decision|0
220857|NCT01721057|723822|P4|Treatment Period|Physician Decision|0
220858|NCT01721057|723823|P3|Treatment Period|Physician Decision|3
220859|NCT01721057|723824|P2|Treatment Period|Physician Decision|1
220860|NCT01721057|723825|P1|Treatment Period|Physician Decision|0
220861|NCT01721057|723819|P7|Treatment Period|Lost to Follow-up|0
220862|NCT01721057|723820|P6|Treatment Period|Lost to Follow-up|0
220863|NCT01721057|723821|P5|Treatment Period|Lost to Follow-up|0
220864|NCT01721057|723822|P4|Treatment Period|Lost to Follow-up|0
220865|NCT01721057|723823|P3|Treatment Period|Lost to Follow-up|0
220866|NCT01721057|723824|P2|Treatment Period|Lost to Follow-up|0
220867|NCT01721057|723825|P1|Treatment Period|Lost to Follow-up|1
220868|NCT01721057|723819|P7|Treatment Period|Lack of Efficacy|0
220869|NCT01721057|723820|P6|Treatment Period|Lack of Efficacy|0
220870|NCT01721057|723821|P5|Treatment Period|Lack of Efficacy|0
220871|NCT01721057|723822|P4|Treatment Period|Lack of Efficacy|0
220872|NCT01721057|723823|P3|Treatment Period|Lack of Efficacy|0
220873|NCT01721057|723824|P2|Treatment Period|Lack of Efficacy|3
220874|NCT01721057|723825|P1|Treatment Period|Lack of Efficacy|7
220875|NCT01721057|723819|P7|Treatment Period|Adverse Event|0
220876|NCT01721057|723820|P6|Treatment Period|Adverse Event|0
220877|NCT01721057|723821|P5|Treatment Period|Adverse Event|0
220878|NCT01721057|723822|P4|Treatment Period|Adverse Event|0
220879|NCT01721057|723823|P3|Treatment Period|Adverse Event|12
220880|NCT01721057|723824|P2|Treatment Period|Adverse Event|10
220881|NCT01721057|723825|P1|Treatment Period|Adverse Event|7
220882|NCT01721057|723819|P7|Treatment Period|Withdrawal by Subject|0
220883|NCT01721057|723820|P6|Treatment Period|Withdrawal by Subject|0
220884|NCT01721057|723821|P5|Treatment Period|Withdrawal by Subject|0
220885|NCT01721057|723822|P4|Treatment Period|Withdrawal by Subject|0
220886|NCT01721057|723823|P3|Treatment Period|Withdrawal by Subject|8
220887|NCT01721057|723824|P2|Treatment Period|Withdrawal by Subject|5
220888|NCT01721057|723825|P1|Treatment Period|Withdrawal by Subject|11
220889|NCT01720797|723897|P2|Overall Study|Withdrawal by Subject|0
220890|NCT01720797|723898|P1|Overall Study|Withdrawal by Subject|3
220891|NCT01720602|723904|P1|Overall Study|Progressive disease on therapy|2
220892|NCT01720602|723904|P1|Overall Study|Adverse Event|3
220893|NCT01719861|723972|P1|Cycle 2|Death|1
220894|NCT01719861|723972|P1|Cycle 1|Death|4
220895|NCT01719757|723980|P1|Overall Study|well controlled pain|27
220896|NCT01719757|723980|P1|Overall Study|Protocol Violation|1
220897|NCT01719757|723980|P1|Overall Study|Lost to Follow-up|20
220898|NCT01719757|723980|P1|Overall Study|Withdrawal by Subject|15
220899|NCT01719757|723980|P1|Overall Study|Adverse Event|38
220900|NCT01719172|724019|P1|Overall Study|Death|1
220901|NCT01719172|724019|P1|Overall Study|Lost to Follow-up|1
220902|NCT01719003|724033|P9|Overall Study|Lack of Efficacy|0
220903|NCT01719003|724034|P8|Overall Study|Lack of Efficacy|0
220904|NCT01719003|724035|P7|Overall Study|Lack of Efficacy|1
220905|NCT01719003|724036|P6|Overall Study|Lack of Efficacy|0
220906|NCT01719003|724037|P5|Overall Study|Lack of Efficacy|0
220907|NCT01719003|724038|P4|Overall Study|Lack of Efficacy|0
220908|NCT01719003|724039|P3|Overall Study|Lack of Efficacy|0
220909|NCT01719003|724040|P2|Overall Study|Lack of Efficacy|0
220910|NCT01719003|724041|P1|Overall Study|Lack of Efficacy|0
220911|NCT01719003|724033|P9|Overall Study|Reason other than those specified|1
220912|NCT01719003|724034|P8|Overall Study|Reason other than those specified|3
220913|NCT01719003|724035|P7|Overall Study|Reason other than those specified|0
220914|NCT01719003|724036|P6|Overall Study|Reason other than those specified|1
220915|NCT01719003|724037|P5|Overall Study|Reason other than those specified|4
220916|NCT01719003|724038|P4|Overall Study|Reason other than those specified|3
220917|NCT01719003|724039|P3|Overall Study|Reason other than those specified|2
220918|NCT01719003|724040|P2|Overall Study|Reason other than those specified|0
220919|NCT01719003|724041|P1|Overall Study|Reason other than those specified|0
220920|NCT01719003|724033|P9|Overall Study|Refusal to continue, not due to AE|1
220921|NCT01719003|724034|P8|Overall Study|Refusal to continue, not due to AE|7
220922|NCT01719003|724035|P7|Overall Study|Refusal to continue, not due to AE|8
220923|NCT01719003|724036|P6|Overall Study|Refusal to continue, not due to AE|3
220924|NCT01719003|724037|P5|Overall Study|Refusal to continue, not due to AE|4
220925|NCT01719003|724038|P4|Overall Study|Refusal to continue, not due to AE|4
220926|NCT01719003|724039|P3|Overall Study|Refusal to continue, not due to AE|4
220927|NCT01719003|724040|P2|Overall Study|Refusal to continue, not due to AE|5
220928|NCT01719003|724041|P1|Overall Study|Refusal to continue, not due to AE|2
220929|NCT01719003|724033|P9|Overall Study|Lost to Follow-up|2
220930|NCT01719003|724034|P8|Overall Study|Lost to Follow-up|2
220931|NCT01719003|724035|P7|Overall Study|Lost to Follow-up|3
220932|NCT01719003|724036|P6|Overall Study|Lost to Follow-up|4
220933|NCT01719003|724037|P5|Overall Study|Lost to Follow-up|3
220934|NCT01719003|724038|P4|Overall Study|Lost to Follow-up|2
220935|NCT01719003|724039|P3|Overall Study|Lost to Follow-up|7
220936|NCT01719003|724040|P2|Overall Study|Lost to Follow-up|6
220937|NCT01719003|724041|P1|Overall Study|Lost to Follow-up|0
220938|NCT01719003|724033|P9|Overall Study|Adverse Event|0
220939|NCT01719003|724034|P8|Overall Study|Adverse Event|5
220940|NCT01719003|724035|P7|Overall Study|Adverse Event|6
220941|NCT01719003|724036|P6|Overall Study|Adverse Event|3
220942|NCT01719003|724037|P5|Overall Study|Adverse Event|4
220943|NCT01719003|724038|P4|Overall Study|Adverse Event|3
220944|NCT01719003|724039|P3|Overall Study|Adverse Event|4
220945|NCT01719003|724040|P2|Overall Study|Adverse Event|5
220946|NCT01719003|724041|P1|Overall Study|Adverse Event|6
220947|NCT01719003|724033|P9|Overall Study|Non compliant with protocol|0
220948|NCT01719003|724034|P8|Overall Study|Non compliant with protocol|3
220949|NCT01719003|724035|P7|Overall Study|Non compliant with protocol|2
220950|NCT01719003|724036|P6|Overall Study|Non compliant with protocol|1
220951|NCT01719003|724037|P5|Overall Study|Non compliant with protocol|2
220952|NCT01719003|724038|P4|Overall Study|Non compliant with protocol|1
220953|NCT01719003|724039|P3|Overall Study|Non compliant with protocol|0
220954|NCT01719003|724040|P2|Overall Study|Non compliant with protocol|1
220955|NCT01719003|724041|P1|Overall Study|Non compliant with protocol|1
220956|NCT01718535|724122|P10|Overall Study|Bidirectional Sequencing not possible|0
220957|NCT01718535|724123|P9|Overall Study|Bidirectional Sequencing not possible|0
220958|NCT01718535|724124|P8|Overall Study|Bidirectional Sequencing not possible|0
220959|NCT01718535|724125|P7|Overall Study|Bidirectional Sequencing not possible|0
220960|NCT01718535|724126|P6|Overall Study|Bidirectional Sequencing not possible|0
220961|NCT01718535|724127|P5|Overall Study|Bidirectional Sequencing not possible|0
220962|NCT01718535|724128|P4|Overall Study|Bidirectional Sequencing not possible|1
220963|NCT01718535|724129|P3|Overall Study|Bidirectional Sequencing not possible|0
220964|NCT01718535|724130|P2|Overall Study|Bidirectional Sequencing not possible|0
220965|NCT01718535|724131|P1|Overall Study|Bidirectional Sequencing not possible|1
220966|NCT01718509|724155|P2|Overall Study|Lack of Efficacy|0
220967|NCT01718509|724156|P1|Overall Study|Lack of Efficacy|1
220968|NCT01718509|724155|P2|Overall Study|Protocol Violation|2
220969|NCT01718509|724156|P1|Overall Study|Protocol Violation|4
220970|NCT01718509|724155|P2|Overall Study|Not specified|11
220971|NCT01718509|724156|P1|Overall Study|Not specified|13
220972|NCT01718509|724155|P2|Overall Study|Adverse Event|7
220973|NCT01718509|724156|P1|Overall Study|Adverse Event|5
220974|NCT01718509|724155|P2|Overall Study|Withdrawal by Subject|13
220975|NCT01718509|724156|P1|Overall Study|Withdrawal by Subject|7
220976|NCT01718509|724155|P2|Overall Study|Lost to Follow-up|15
220977|NCT01718509|724156|P1|Overall Study|Lost to Follow-up|18
220978|NCT01718483|724202|P2|Overall Study|Lack of Efficacy|0
220979|NCT01718483|724203|P1|Overall Study|Lack of Efficacy|1
220980|NCT01718483|724202|P2|Overall Study|Pregnancy|1
220981|NCT01718483|724203|P1|Overall Study|Pregnancy|1
220982|NCT01718483|724202|P2|Overall Study|Not specified|4
220983|NCT01718483|724203|P1|Overall Study|Not specified|1
220984|NCT01718483|724202|P2|Overall Study|Protocol Violation|2
220985|NCT01718483|724203|P1|Overall Study|Protocol Violation|4
220986|NCT01718483|724202|P2|Overall Study|Lost to Follow-up|3
220987|NCT01718483|724203|P1|Overall Study|Lost to Follow-up|8
220988|NCT01718483|724202|P2|Overall Study|Adverse Event|12
220989|NCT01718483|724203|P1|Overall Study|Adverse Event|5
220990|NCT01718483|724202|P2|Overall Study|Withdrawal by Subject|12
220991|NCT01718483|724203|P1|Overall Study|Withdrawal by Subject|14
220992|NCT01717989|724262|P1|Overall Study|Other|40
220993|NCT01717989|724262|P1|Overall Study|Protocol-specified criteria|551
220994|NCT01717989|724262|P1|Overall Study|Death|439
220995|NCT01717989|724262|P1|Overall Study|Lost to Follow-up|11
220996|NCT01717989|724262|P1|Overall Study|Physician Decision|2
220997|NCT01717989|724262|P1|Overall Study|Withdrawal by Subject|11
220998|NCT01717989|724262|P1|Overall Study|Protocol deviation|6
220999|NCT01717989|724262|P1|Overall Study|Ineligibility determined|6
221000|NCT01717976|724330|P2|Overall Study|Protocol Violation|1
221001|NCT01717976|724331|P1|Overall Study|Protocol Violation|0
221002|NCT01717976|724330|P2|Overall Study|Death|1
221003|NCT01717976|724331|P1|Overall Study|Death|0
221004|NCT01717768|724368|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221005|NCT01717768|724369|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221006|NCT01717768|724370|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
221007|NCT01717768|724371|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221008|NCT01717768|724372|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221009|NCT01717768|724373|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221010|NCT01717768|724374|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221011|NCT01717768|724375|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221012|NCT01717768|724376|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221013|NCT01717768|724377|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221014|NCT01717768|724378|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221015|NCT01717768|724379|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
221016|NCT01717768|724368|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221017|NCT01717768|724369|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221018|NCT01717768|724370|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221019|NCT01717768|724371|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221020|NCT01717768|724372|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
221021|NCT01717768|724373|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221022|NCT01717768|724374|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221023|NCT01717768|724375|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221024|NCT01717768|724376|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221025|NCT01717768|724377|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221026|NCT01717768|724378|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221027|NCT01717768|724379|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
221028|NCT01717768|724368|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
221029|NCT01717768|724369|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221030|NCT01717768|724370|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221031|NCT01717768|724371|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221032|NCT01717768|724372|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221033|NCT01717768|724373|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221034|NCT01717768|724374|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221035|NCT01717768|724375|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221036|NCT01717768|724376|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221037|NCT01717768|724377|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221038|NCT01717768|724378|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221039|NCT01717768|724379|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
221040|NCT01717768|724368|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221041|NCT01717768|724369|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221042|NCT01717768|724370|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221043|NCT01717768|724371|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221044|NCT01717768|724372|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221045|NCT01717768|724373|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221046|NCT01717768|724374|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221047|NCT01717768|724375|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221048|NCT01717768|724376|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221049|NCT01717768|724377|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221050|NCT01717768|724378|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
221051|NCT01717768|724379|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
221052|NCT01717638|724430|P13|Overall Study|Withdrawal by Subject|18
221053|NCT01717638|724431|P12|Overall Study|Withdrawal by Subject|0
221054|NCT01717638|724432|P11|Overall Study|Withdrawal by Subject|0
221055|NCT01717638|724433|P10|Overall Study|Withdrawal by Subject|1
221056|NCT01717638|724434|P9|Overall Study|Withdrawal by Subject|2
221057|NCT01717638|724435|P8|Overall Study|Withdrawal by Subject|1
221058|NCT01717638|724436|P7|Overall Study|Withdrawal by Subject|2
221059|NCT01717638|724437|P6|Overall Study|Withdrawal by Subject|0
221060|NCT01717638|724438|P5|Overall Study|Withdrawal by Subject|1
221061|NCT01717638|724439|P4|Overall Study|Withdrawal by Subject|0
221062|NCT01717638|724440|P3|Overall Study|Withdrawal by Subject|1
221063|NCT01717638|724441|P2|Overall Study|Withdrawal by Subject|1
221064|NCT01717638|724442|P1|Overall Study|Withdrawal by Subject|0
221065|NCT01717638|724430|P13|Overall Study|Father in hospital|1
221066|NCT01717638|724431|P12|Overall Study|Father in hospital|0
221067|NCT01717638|724432|P11|Overall Study|Father in hospital|0
221068|NCT01717638|724433|P10|Overall Study|Father in hospital|0
221069|NCT01717638|724434|P9|Overall Study|Father in hospital|0
221070|NCT01717638|724435|P8|Overall Study|Father in hospital|0
221071|NCT01717638|724436|P7|Overall Study|Father in hospital|0
221072|NCT01717638|724437|P6|Overall Study|Father in hospital|0
221073|NCT01717638|724438|P5|Overall Study|Father in hospital|0
221074|NCT01717638|724439|P4|Overall Study|Father in hospital|0
221075|NCT01717638|724440|P3|Overall Study|Father in hospital|0
221076|NCT01717638|724441|P2|Overall Study|Father in hospital|0
221077|NCT01717638|724442|P1|Overall Study|Father in hospital|0
221078|NCT01717638|724430|P13|Overall Study|Lost to Follow-up|0
221079|NCT01717638|724431|P12|Overall Study|Lost to Follow-up|0
221080|NCT01717638|724432|P11|Overall Study|Lost to Follow-up|0
221081|NCT01717638|724433|P10|Overall Study|Lost to Follow-up|0
221082|NCT01717638|724434|P9|Overall Study|Lost to Follow-up|0
221083|NCT01717638|724435|P8|Overall Study|Lost to Follow-up|0
221084|NCT01717638|724436|P7|Overall Study|Lost to Follow-up|0
221085|NCT01717638|724437|P6|Overall Study|Lost to Follow-up|1
221086|NCT01717638|724438|P5|Overall Study|Lost to Follow-up|0
221087|NCT01717638|724439|P4|Overall Study|Lost to Follow-up|0
221088|NCT01717638|724440|P3|Overall Study|Lost to Follow-up|0
221089|NCT01717638|724441|P2|Overall Study|Lost to Follow-up|0
221090|NCT01717638|724442|P1|Overall Study|Lost to Follow-up|0
221091|NCT01717456|724586|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
221092|NCT01717456|724587|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
221093|NCT01717456|724586|P2|End of Treatment|Lost to Follow-up|1
221094|NCT01717456|724587|P1|End of Treatment|Lost to Follow-up|0
221095|NCT01717456|724586|P2|End of Treatment|Physician Decision|1
221096|NCT01717456|724587|P1|End of Treatment|Physician Decision|0
221097|NCT01717326|724675|P20|Overall Study|Withdrawal by Subject|3
221098|NCT01717326|724676|P19|Overall Study|Withdrawal by Subject|2
221099|NCT01717326|724677|P18|Overall Study|Withdrawal by Subject|0
221100|NCT01717326|724678|P17|Overall Study|Withdrawal by Subject|0
221101|NCT01717326|724679|P16|Overall Study|Withdrawal by Subject|1
221102|NCT01717326|724680|P15|Overall Study|Withdrawal by Subject|0
221103|NCT01717326|724681|P14|Overall Study|Withdrawal by Subject|0
221104|NCT01717326|724682|P13|Overall Study|Withdrawal by Subject|1
221105|NCT01717326|724683|P12|Overall Study|Withdrawal by Subject|0
221106|NCT01717326|724684|P11|Overall Study|Withdrawal by Subject|0
221107|NCT01717326|724685|P10|Overall Study|Withdrawal by Subject|1
221108|NCT01717326|724686|P9|Overall Study|Withdrawal by Subject|0
221109|NCT01717326|724687|P8|Overall Study|Withdrawal by Subject|0
221110|NCT01717326|724688|P7|Overall Study|Withdrawal by Subject|0
221111|NCT01717326|724689|P6|Overall Study|Withdrawal by Subject|0
221112|NCT01717326|724690|P5|Overall Study|Withdrawal by Subject|0
221113|NCT01717326|724691|P4|Overall Study|Withdrawal by Subject|0
221114|NCT01717326|724692|P3|Overall Study|Withdrawal by Subject|0
221115|NCT01717326|724693|P2|Overall Study|Withdrawal by Subject|1
221116|NCT01717326|724694|P1|Overall Study|Withdrawal by Subject|0
221117|NCT01717326|724675|P20|Overall Study|Protocol Violation|0
221118|NCT01717326|724676|P19|Overall Study|Protocol Violation|0
221119|NCT01717326|724677|P18|Overall Study|Protocol Violation|0
221120|NCT01717326|724678|P17|Overall Study|Protocol Violation|0
221121|NCT01717326|724679|P16|Overall Study|Protocol Violation|0
221122|NCT01717326|724680|P15|Overall Study|Protocol Violation|0
221123|NCT01717326|724681|P14|Overall Study|Protocol Violation|0
221124|NCT01717326|724682|P13|Overall Study|Protocol Violation|0
221125|NCT01717326|724683|P12|Overall Study|Protocol Violation|0
221126|NCT01717326|724684|P11|Overall Study|Protocol Violation|0
221127|NCT01717326|724685|P10|Overall Study|Protocol Violation|0
221128|NCT01717326|724686|P9|Overall Study|Protocol Violation|0
221129|NCT01717326|724687|P8|Overall Study|Protocol Violation|0
221130|NCT01717326|724688|P7|Overall Study|Protocol Violation|0
221131|NCT01717326|724689|P6|Overall Study|Protocol Violation|0
221132|NCT01717326|724690|P5|Overall Study|Protocol Violation|1
221133|NCT01717326|724691|P4|Overall Study|Protocol Violation|0
221134|NCT01717326|724692|P3|Overall Study|Protocol Violation|0
221135|NCT01717326|724693|P2|Overall Study|Protocol Violation|0
221136|NCT01717326|724694|P1|Overall Study|Protocol Violation|0
221137|NCT01717326|724675|P20|Overall Study|Physician Decision|0
221138|NCT01717326|724676|P19|Overall Study|Physician Decision|0
221139|NCT01717326|724677|P18|Overall Study|Physician Decision|0
221140|NCT01717326|724678|P17|Overall Study|Physician Decision|0
221141|NCT01717326|724679|P16|Overall Study|Physician Decision|0
221142|NCT01717326|724680|P15|Overall Study|Physician Decision|0
221143|NCT01717326|724681|P14|Overall Study|Physician Decision|0
221144|NCT01717326|724682|P13|Overall Study|Physician Decision|0
221145|NCT01717326|724683|P12|Overall Study|Physician Decision|0
221146|NCT01717326|724684|P11|Overall Study|Physician Decision|0
221147|NCT01717326|724685|P10|Overall Study|Physician Decision|1
221148|NCT01717326|724686|P9|Overall Study|Physician Decision|0
221149|NCT01717326|724687|P8|Overall Study|Physician Decision|0
221150|NCT01717326|724688|P7|Overall Study|Physician Decision|0
221151|NCT01717326|724689|P6|Overall Study|Physician Decision|0
221152|NCT01717326|724690|P5|Overall Study|Physician Decision|0
221153|NCT01717326|724691|P4|Overall Study|Physician Decision|0
221154|NCT01717326|724692|P3|Overall Study|Physician Decision|0
221155|NCT01717326|724693|P2|Overall Study|Physician Decision|0
221156|NCT01717326|724694|P1|Overall Study|Physician Decision|0
221157|NCT01717326|724675|P20|Overall Study|Lost to Follow-up|3
221158|NCT01717326|724676|P19|Overall Study|Lost to Follow-up|2
221159|NCT01717326|724677|P18|Overall Study|Lost to Follow-up|0
221160|NCT01717326|724678|P17|Overall Study|Lost to Follow-up|1
221161|NCT01717326|724679|P16|Overall Study|Lost to Follow-up|2
221162|NCT01717326|724680|P15|Overall Study|Lost to Follow-up|0
221163|NCT01717326|724681|P14|Overall Study|Lost to Follow-up|0
221164|NCT01717326|724682|P13|Overall Study|Lost to Follow-up|0
221165|NCT01717326|724683|P12|Overall Study|Lost to Follow-up|0
221166|NCT01717326|724684|P11|Overall Study|Lost to Follow-up|1
221167|NCT01717326|724685|P10|Overall Study|Lost to Follow-up|0
221168|NCT01717326|724686|P9|Overall Study|Lost to Follow-up|0
221169|NCT01717326|724687|P8|Overall Study|Lost to Follow-up|0
221170|NCT01717326|724688|P7|Overall Study|Lost to Follow-up|1
221171|NCT01717326|724689|P6|Overall Study|Lost to Follow-up|0
221172|NCT01717326|724690|P5|Overall Study|Lost to Follow-up|1
221173|NCT01717326|724691|P4|Overall Study|Lost to Follow-up|2
221174|NCT01717326|724692|P3|Overall Study|Lost to Follow-up|0
221175|NCT01717326|724693|P2|Overall Study|Lost to Follow-up|0
221176|NCT01717326|724694|P1|Overall Study|Lost to Follow-up|3
221177|NCT01717326|724675|P20|Overall Study|Death|0
221178|NCT01717326|724676|P19|Overall Study|Death|0
221179|NCT01717326|724677|P18|Overall Study|Death|0
221180|NCT01717326|724678|P17|Overall Study|Death|0
221181|NCT01717326|724679|P16|Overall Study|Death|0
221182|NCT01717326|724680|P15|Overall Study|Death|0
221183|NCT01717326|724681|P14|Overall Study|Death|0
221184|NCT01717326|724682|P13|Overall Study|Death|0
221185|NCT01717326|724683|P12|Overall Study|Death|0
221186|NCT01717326|724684|P11|Overall Study|Death|1
221187|NCT01717326|724685|P10|Overall Study|Death|0
221188|NCT01717326|724686|P9|Overall Study|Death|0
221189|NCT01717326|724687|P8|Overall Study|Death|0
221190|NCT01717326|724688|P7|Overall Study|Death|0
221191|NCT01717326|724689|P6|Overall Study|Death|0
221192|NCT01717326|724690|P5|Overall Study|Death|0
221193|NCT01717326|724691|P4|Overall Study|Death|0
221194|NCT01717326|724692|P3|Overall Study|Death|0
221195|NCT01717326|724693|P2|Overall Study|Death|0
221196|NCT01717326|724694|P1|Overall Study|Death|0
221197|NCT01717313|724958|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
221198|NCT01717313|724959|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
221199|NCT01717313|724958|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
221200|NCT01717313|724959|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
221201|NCT01717313|724958|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
221202|NCT01717313|724959|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
221203|NCT01717313|724958|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
221204|NCT01717313|724959|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
221205|NCT01717313|724958|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
221206|NCT01717313|724959|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
221207|NCT01717313|724958|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
221208|NCT01717313|724959|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
221209|NCT01717313|724958|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
221210|NCT01717313|724959|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
221211|NCT01717313|724958|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
221212|NCT01717313|724959|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
221213|NCT01717313|724958|P2|Phase A (Weeks 0 to 24)|Death|1
221214|NCT01717313|724959|P1|Phase A (Weeks 0 to 24)|Death|0
221215|NCT01717287|724997|P2|Overall Study|Protocol Violation|1
221216|NCT01717287|724998|P1|Overall Study|Protocol Violation|0
221217|NCT01717287|724997|P2|Overall Study|Lost to Follow-up|2
221218|NCT01717287|724998|P1|Overall Study|Lost to Follow-up|0
221219|NCT01717040|725022|P2|Overall Study|New Substance Use Disorder|0
221220|NCT01717040|725023|P1|Overall Study|New Substance Use Disorder|1
221221|NCT01717040|725022|P2|Overall Study|Required Medication Change|1
221222|NCT01717040|725023|P1|Overall Study|Required Medication Change|0
221223|NCT01717040|725022|P2|Overall Study|Adverse Event|0
221224|NCT01717040|725023|P1|Overall Study|Adverse Event|1
221225|NCT01717040|725022|P2|Overall Study|Lack of Efficacy|1
221226|NCT01717040|725023|P1|Overall Study|Lack of Efficacy|1
221227|NCT01717040|725022|P2|Overall Study|Lost to Follow-up|3
221228|NCT01717040|725023|P1|Overall Study|Lost to Follow-up|2
221229|NCT01716754|725041|P4|Overall Study|Withdrawal by Subject|3
221230|NCT01716754|725042|P3|Overall Study|Withdrawal by Subject|4
221231|NCT01716754|725043|P2|Overall Study|Withdrawal by Subject|0
221232|NCT01716754|725044|P1|Overall Study|Withdrawal by Subject|5
221233|NCT01716754|725041|P4|Overall Study|Adverse Event|1
221234|NCT01716754|725042|P3|Overall Study|Adverse Event|2
221235|NCT01716754|725043|P2|Overall Study|Adverse Event|2
221236|NCT01716754|725044|P1|Overall Study|Adverse Event|4
221237|NCT01716754|725041|P4|Overall Study|Lost to Follow-up|1
221238|NCT01716754|725042|P3|Overall Study|Lost to Follow-up|0
221239|NCT01716754|725043|P2|Overall Study|Lost to Follow-up|0
221240|NCT01716754|725044|P1|Overall Study|Lost to Follow-up|1
221241|NCT01716754|725041|P4|Overall Study|Physician Decision|0
221242|NCT01716754|725042|P3|Overall Study|Physician Decision|0
221243|NCT01716754|725043|P2|Overall Study|Physician Decision|0
221244|NCT01716754|725044|P1|Overall Study|Physician Decision|1
221245|NCT01716754|725041|P4|Overall Study|Non-compliance with study treatment|0
221246|NCT01716754|725042|P3|Overall Study|Non-compliance with study treatment|1
221247|NCT01716754|725043|P2|Overall Study|Non-compliance with study treatment|0
221248|NCT01716754|725044|P1|Overall Study|Non-compliance with study treatment|0
221249|NCT01716754|725041|P4|Overall Study|Protocol deviation|2
221250|NCT01716754|725042|P3|Overall Study|Protocol deviation|7
221251|NCT01716754|725043|P2|Overall Study|Protocol deviation|2
221252|NCT01716754|725044|P1|Overall Study|Protocol deviation|0
221253|NCT01716754|725041|P4|Overall Study|Death|1
221254|NCT01716754|725042|P3|Overall Study|Death|0
221255|NCT01716754|725043|P2|Overall Study|Death|0
221256|NCT01716754|725044|P1|Overall Study|Death|0
221257|NCT01716663|725065|P1|Overall Study|Treated with non-study catheter|2
221258|NCT01716663|725065|P1|Overall Study|Withdrawn prior to procedure|4
221259|NCT01716585|725075|P2|Open-label Treatment|Withdrawal by Subject|3
221260|NCT01716585|725076|P1|Open-label Treatment|Withdrawal by Subject|0
221261|NCT01716585|725075|P2|Open-label Treatment|Virologic Failure|2
221262|NCT01716585|725076|P1|Open-label Treatment|Virologic Failure|0
221263|NCT01716585|725075|P2|Open-label Treatment|Adverse Event|2
221264|NCT01716585|725076|P1|Open-label Treatment|Adverse Event|0
221265|NCT01716585|725075|P2|Double-blind Treatment|Not Specified|0
221266|NCT01716585|725076|P1|Double-blind Treatment|Not Specified|1
221267|NCT01716585|725075|P2|Double-blind Treatment|Subject Noncompliant|0
221268|NCT01716585|725076|P1|Double-blind Treatment|Subject Noncompliant|1
221269|NCT01716585|725075|P2|Double-blind Treatment|Lost to Follow-up|0
221270|NCT01716585|725076|P1|Double-blind Treatment|Lost to Follow-up|2
221271|NCT01716585|725075|P2|Double-blind Treatment|Withdrawal by Subject|0
221272|NCT01716585|725076|P1|Double-blind Treatment|Withdrawal by Subject|3
221273|NCT01716585|725075|P2|Double-blind Treatment|Adverse Event|1
221274|NCT01716585|725076|P1|Double-blind Treatment|Adverse Event|2
221275|NCT01716585|725075|P2|Double-blind Treatment|Did Not Receive Study Drug|1
221276|NCT01716585|725076|P1|Double-blind Treatment|Did Not Receive Study Drug|4
221277|NCT01716559|725088|P1|Overall Study|Other withdrawal reason|75
221278|NCT01716559|725088|P1|Overall Study|Withdrawal by Subject|4
221279|NCT01716559|725088|P1|Overall Study|Death|21
221280|NCT01716559|725088|P1|Overall Study|Adverse Event|11
221281|NCT01716520|725096|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
221282|NCT01716520|725097|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
221283|NCT01716520|725098|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
221284|NCT01716520|725099|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
221285|NCT01716520|725100|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
221286|NCT01716520|725101|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
221287|NCT01716520|725096|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
221288|NCT01716520|725097|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
221289|NCT01716520|725098|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
221290|NCT01716520|725099|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
221291|NCT01716520|725100|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
221292|NCT01716520|725101|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
221293|NCT01716520|725096|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
221294|NCT01716520|725097|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
221295|NCT01716520|725098|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
221296|NCT01716520|725099|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
221297|NCT01716520|725100|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
221298|NCT01716520|725101|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
221299|NCT01716520|725096|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
221300|NCT01716520|725097|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
221301|NCT01716520|725098|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
221302|NCT01716520|725099|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
221303|NCT01716520|725100|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
221304|NCT01716520|725101|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
221305|NCT01716520|725096|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
221306|NCT01716520|725097|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
221307|NCT01716520|725098|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
221308|NCT01716520|725099|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
221309|NCT01716520|725100|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
221310|NCT01716520|725101|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
221311|NCT01716520|725096|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
221312|NCT01716520|725097|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
221313|NCT01716520|725098|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
221314|NCT01716520|725099|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
221315|NCT01716520|725100|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
221316|NCT01716520|725101|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
221317|NCT01716520|725096|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
221318|NCT01716520|725097|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
221319|NCT01716520|725098|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
221320|NCT01716520|725099|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
221321|NCT01716520|725100|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
221322|NCT01716520|725101|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
221323|NCT01716520|725096|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
221324|NCT01716520|725097|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
221325|NCT01716520|725098|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
221326|NCT01716520|725099|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
221327|NCT01716520|725100|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
221328|NCT01716520|725101|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
221329|NCT01716520|725096|P6|Treatment Period 2 (14 Days)|Adverse Event|0
221330|NCT01716520|725097|P5|Treatment Period 2 (14 Days)|Adverse Event|1
221331|NCT01716520|725098|P4|Treatment Period 2 (14 Days)|Adverse Event|0
221332|NCT01716520|725099|P3|Treatment Period 2 (14 Days)|Adverse Event|0
221333|NCT01716520|725100|P2|Treatment Period 2 (14 Days)|Adverse Event|0
221334|NCT01716520|725101|P1|Treatment Period 2 (14 Days)|Adverse Event|0
221335|NCT01716520|725096|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
221336|NCT01716520|725097|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
221337|NCT01716520|725098|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
221338|NCT01716520|725099|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
221339|NCT01716520|725100|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
221340|NCT01716520|725101|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
221341|NCT01716520|725096|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
221342|NCT01716520|725097|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
221343|NCT01716520|725098|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
221344|NCT01716520|725099|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
221345|NCT01716520|725100|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
221346|NCT01716520|725101|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
221347|NCT01716520|725096|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
221348|NCT01716520|725097|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
221349|NCT01716520|725098|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
221350|NCT01716520|725099|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
221351|NCT01716520|725100|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
221352|NCT01716520|725101|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
221353|NCT01716520|725096|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
221354|NCT01716520|725097|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
221355|NCT01716520|725098|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
221356|NCT01716520|725099|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
221357|NCT01716520|725100|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
221358|NCT01716520|725101|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
221359|NCT01716520|725096|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
221360|NCT01716520|725097|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
221361|NCT01716520|725098|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
221362|NCT01716520|725099|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
221363|NCT01716520|725100|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
221364|NCT01716520|725101|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
221365|NCT01716520|725096|P6|Treatment Period 1 (14 Days)|Adverse Event|0
221366|NCT01716520|725097|P5|Treatment Period 1 (14 Days)|Adverse Event|0
221367|NCT01716520|725098|P4|Treatment Period 1 (14 Days)|Adverse Event|0
221368|NCT01716520|725099|P3|Treatment Period 1 (14 Days)|Adverse Event|0
221369|NCT01716520|725100|P2|Treatment Period 1 (14 Days)|Adverse Event|0
221370|NCT01716520|725101|P1|Treatment Period 1 (14 Days)|Adverse Event|1
221371|NCT01716234|725156|P7|Overall Study|Withdrawal by Subject|0
221372|NCT01716234|725157|P6|Overall Study|Withdrawal by Subject|3
221373|NCT01716234|725158|P5|Overall Study|Withdrawal by Subject|1
221374|NCT01716234|725159|P4|Overall Study|Withdrawal by Subject|2
221375|NCT01716234|725160|P3|Overall Study|Withdrawal by Subject|2
221376|NCT01716234|725161|P2|Overall Study|Withdrawal by Subject|0
221377|NCT01716234|725162|P1|Overall Study|Withdrawal by Subject|3
221378|NCT01716234|725156|P7|Overall Study|Adverse Event|0
221379|NCT01716234|725157|P6|Overall Study|Adverse Event|6
221380|NCT01716234|725158|P5|Overall Study|Adverse Event|3
221381|NCT01716234|725159|P4|Overall Study|Adverse Event|8
221382|NCT01716234|725160|P3|Overall Study|Adverse Event|2
221383|NCT01716234|725161|P2|Overall Study|Adverse Event|10
221384|NCT01716234|725162|P1|Overall Study|Adverse Event|7
221385|NCT01716234|725156|P7|Overall Study|Did not meet protocol eligibility|0
221386|NCT01716234|725157|P6|Overall Study|Did not meet protocol eligibility|4
221387|NCT01716234|725158|P5|Overall Study|Did not meet protocol eligibility|0
221388|NCT01716234|725159|P4|Overall Study|Did not meet protocol eligibility|0
221389|NCT01716234|725160|P3|Overall Study|Did not meet protocol eligibility|1
221390|NCT01716234|725161|P2|Overall Study|Did not meet protocol eligibility|0
221391|NCT01716234|725162|P1|Overall Study|Did not meet protocol eligibility|0
221392|NCT01716234|725156|P7|Overall Study|Lack of Efficacy|0
221393|NCT01716234|725157|P6|Overall Study|Lack of Efficacy|0
221394|NCT01716234|725158|P5|Overall Study|Lack of Efficacy|0
221395|NCT01716234|725159|P4|Overall Study|Lack of Efficacy|1
221396|NCT01716234|725160|P3|Overall Study|Lack of Efficacy|0
221397|NCT01716234|725161|P2|Overall Study|Lack of Efficacy|0
221398|NCT01716234|725162|P1|Overall Study|Lack of Efficacy|0
221399|NCT01716234|725156|P7|Overall Study|Protocol Violation|0
221400|NCT01716234|725157|P6|Overall Study|Protocol Violation|1
221401|NCT01716234|725158|P5|Overall Study|Protocol Violation|1
221402|NCT01716234|725159|P4|Overall Study|Protocol Violation|1
221403|NCT01716234|725160|P3|Overall Study|Protocol Violation|0
221404|NCT01716234|725161|P2|Overall Study|Protocol Violation|0
221405|NCT01716234|725162|P1|Overall Study|Protocol Violation|0
221406|NCT01716169|725225|P1|Overall Study|inconsistent dressing application|1
221407|NCT01716169|725225|P1|Overall Study|Withdrawal by Subject|1
221408|NCT01716169|725225|P1|Overall Study|Lost to Follow-up|1
221409|NCT01716169|725225|P1|Overall Study|Adverse Event|1
221410|NCT01716156|725234|P3|Overall Study|Lost to Follow-up|0
221411|NCT01716156|725235|P2|Overall Study|Lost to Follow-up|0
221412|NCT01716156|725236|P1|Overall Study|Lost to Follow-up|1
221413|NCT01716156|725234|P3|Overall Study|Withdrawal by Subject|2
221414|NCT01716156|725235|P2|Overall Study|Withdrawal by Subject|1
221415|NCT01716156|725236|P1|Overall Study|Withdrawal by Subject|0
221416|NCT01716156|725234|P3|Overall Study|Protocol Violation|0
221417|NCT01716156|725235|P2|Overall Study|Protocol Violation|0
221418|NCT01716156|725236|P1|Overall Study|Protocol Violation|1
221419|NCT01716052|725262|P2|Overall Study|Withdrawal of funding|1
221420|NCT01716052|725263|P1|Overall Study|Withdrawal of funding|1
221421|NCT01715896|725305|P2|Overall Study|Unspecified|5
221422|NCT01715896|725306|P1|Overall Study|Unspecified|2
221423|NCT01715896|725305|P2|Overall Study|Withdrawal by Subject|4
221424|NCT01715896|725306|P1|Overall Study|Withdrawal by Subject|1
221425|NCT01715896|725305|P2|Overall Study|Lost to Follow-up|2
221426|NCT01715896|725306|P1|Overall Study|Lost to Follow-up|0
221427|NCT01715857|725369|P1|Overall Study|Did Not Meet Eligibility Criteria|96
221428|NCT01715831|725379|P1|Overall Study|Adverse Event|1
221429|NCT01715415|725426|P2|Open-label Treatment|Subject Noncompliant|1
221430|NCT01715415|725427|P1|Open-label Treatment|Subject Noncompliant|0
221431|NCT01715415|725426|P2|Open-label Treatment|Adverse Event|1
221432|NCT01715415|725427|P1|Open-label Treatment|Adverse Event|0
221433|NCT01715415|725426|P2|Double-blind Treatment|Not Specified|0
221434|NCT01715415|725427|P1|Double-blind Treatment|Not Specified|1
221435|NCT01715415|725426|P2|Double-blind Treatment|Withdrawal by Subject|1
221436|NCT01715415|725427|P1|Double-blind Treatment|Withdrawal by Subject|1
221437|NCT01715415|725426|P2|Double-blind Treatment|Adverse Event|0
221438|NCT01715415|725427|P1|Double-blind Treatment|Adverse Event|3
221439|NCT01715415|725426|P2|Double-blind Treatment|Did Not Receive Study Drug|1
221440|NCT01715415|725427|P1|Double-blind Treatment|Did Not Receive Study Drug|0
221441|NCT01715298|725441|P2|Overall Study|Patient/guardian decision|9
221442|NCT01715298|725442|P1|Overall Study|Patient/guardian decision|7
221443|NCT01715298|725441|P2|Overall Study|Lost to Follow-up|2
221444|NCT01715298|725442|P1|Overall Study|Lost to Follow-up|0
221445|NCT01715129|725489|P1|Overall Study|Unspecified|1
221446|NCT01715129|725489|P1|Overall Study|Lost to Follow-up|1
221447|NCT01715129|725489|P1|Overall Study|Consent Withdrawn|2
221448|NCT01715129|725489|P1|Overall Study|Protocol Violation|1
221449|NCT01715129|725489|P1|Overall Study|Lack of Efficacy|3
221450|NCT01715129|725489|P1|Overall Study|Adverse Event, fatal|1
221451|NCT01714635|725518|P3|Overall Study|Missed 6-month exam|0
221452|NCT01714635|725519|P2|Overall Study|Missed 6-month exam|0
221453|NCT01714635|725520|P1|Overall Study|Missed 6-month exam|1
221454|NCT01714635|725518|P3|Overall Study|Discontinued|2
221455|NCT01714635|725519|P2|Overall Study|Discontinued|0
221456|NCT01714635|725520|P1|Overall Study|Discontinued|1
221457|NCT01714609|725536|P2|Overall Study|Protocol Violation|0
221458|NCT01714609|725537|P1|Overall Study|Protocol Violation|1
221459|NCT01714544|725543|P1|Overall Study|Withdrawal by Subject|1
221460|NCT01714544|725543|P1|Overall Study|Physician Decision|1
221461|NCT01714544|725543|P1|Overall Study|Lost to Follow-up|1
221462|NCT01713998|725570|P3|Overall Study|Withdrawal by Subject|0
221463|NCT01713998|725571|P2|Overall Study|Withdrawal by Subject|0
221464|NCT01713998|725572|P1|Overall Study|Withdrawal by Subject|1
221465|NCT01713998|725570|P3|Overall Study|Lost to Follow-up|2
221466|NCT01713998|725571|P2|Overall Study|Lost to Follow-up|0
221467|NCT01713998|725572|P1|Overall Study|Lost to Follow-up|2
221468|NCT01713933|725590|P1|Overall Study|Excluded from analysis as a BMI outlier|1
221469|NCT01713933|725590|P1|Overall Study|Withdrawal by Subject|3
221470|NCT01713933|725590|P1|Overall Study|Lost to Follow-up|2
221471|NCT01713686|725602|P1|Overall Study|Withdrawal by Subject|6
221472|NCT01713686|725602|P1|Overall Study|Lost to Follow-up|9
221473|NCT01713530|725653|P2|Overall Study|Unclassified|2
221474|NCT01713530|725654|P1|Overall Study|Unclassified|4
221475|NCT01713530|725653|P2|Overall Study|Withdrawal criteria|12
221476|NCT01713530|725654|P1|Overall Study|Withdrawal criteria|21
221477|NCT01713530|725653|P2|Overall Study|Adverse Event|5
221478|NCT01713530|725654|P1|Overall Study|Adverse Event|0
221479|NCT01713348|725685|P4|Overall Study|Lost to Follow-up|0
221480|NCT01713348|725686|P3|Overall Study|Lost to Follow-up|0
221481|NCT01713348|725687|P2|Overall Study|Lost to Follow-up|0
221482|NCT01713348|725688|P1|Overall Study|Lost to Follow-up|1
221483|NCT01713348|725685|P4|Overall Study|Withdrawal by Subject|0
221484|NCT01713348|725686|P3|Overall Study|Withdrawal by Subject|2
221485|NCT01713348|725687|P2|Overall Study|Withdrawal by Subject|2
221486|NCT01713348|725688|P1|Overall Study|Withdrawal by Subject|3
221487|NCT01713283|725718|P2|Overall Study|Lost to Follow-up|1
221488|NCT01713283|725719|P1|Overall Study|Lost to Follow-up|1
221489|NCT01713283|725718|P2|Overall Study|Lack of Efficacy|2
221490|NCT01713283|725719|P1|Overall Study|Lack of Efficacy|10
221491|NCT01713036|725741|P1|Overall Study|Death|1
221492|NCT01712984|725781|P3|Overall Study|Withdrawal by Subject|7
221493|NCT01712984|725782|P2|Overall Study|Withdrawal by Subject|6
221494|NCT01712984|725783|P1|Overall Study|Withdrawal by Subject|6
221495|NCT01712984|725781|P3|Overall Study|Lost to Follow-up|1
221496|NCT01712984|725782|P2|Overall Study|Lost to Follow-up|10
221497|NCT01712984|725783|P1|Overall Study|Lost to Follow-up|8
221498|NCT01712984|725781|P3|Overall Study|Protocol Violation|1
221499|NCT01712984|725782|P2|Overall Study|Protocol Violation|0
221500|NCT01712984|725783|P1|Overall Study|Protocol Violation|2
221501|NCT01712984|725781|P3|Overall Study|Adverse Event|1
221502|NCT01712984|725782|P2|Overall Study|Adverse Event|0
221503|NCT01712984|725783|P1|Overall Study|Adverse Event|0
221504|NCT01712854|725803|P1|Overall Study|Physician Decision|1
221505|NCT01712685|725826|P1|Overall Study|pt declined to participate before trmt|1
221506|NCT01712516|725842|P4|Overall Study|Withdrawal by Subject|9
221507|NCT01712516|725843|P3|Overall Study|Withdrawal by Subject|3
221508|NCT01712516|725844|P2|Overall Study|Withdrawal by Subject|9
221509|NCT01712516|725845|P1|Overall Study|Withdrawal by Subject|3
221510|NCT01712516|725842|P4|Overall Study|Physician Decision|1
221511|NCT01712516|725843|P3|Overall Study|Physician Decision|0
221512|NCT01712516|725844|P2|Overall Study|Physician Decision|0
221513|NCT01712516|725845|P1|Overall Study|Physician Decision|2
221514|NCT01712516|725842|P4|Overall Study|Protocol deviation|0
221515|NCT01712516|725843|P3|Overall Study|Protocol deviation|1
221516|NCT01712516|725844|P2|Overall Study|Protocol deviation|0
221517|NCT01712516|725845|P1|Overall Study|Protocol deviation|1
221518|NCT01712516|725842|P4|Overall Study|Death|0
221519|NCT01712516|725843|P3|Overall Study|Death|0
221520|NCT01712516|725844|P2|Overall Study|Death|1
221521|NCT01712516|725845|P1|Overall Study|Death|0
221522|NCT01712516|725842|P4|Overall Study|Lost to Follow-up|1
221523|NCT01712516|725843|P3|Overall Study|Lost to Follow-up|2
221524|NCT01712516|725844|P2|Overall Study|Lost to Follow-up|0
221525|NCT01712516|725845|P1|Overall Study|Lost to Follow-up|0
221526|NCT01712516|725842|P4|Overall Study|Technical problems|2
221527|NCT01712516|725843|P3|Overall Study|Technical problems|0
221528|NCT01712516|725844|P2|Overall Study|Technical problems|0
221529|NCT01712516|725845|P1|Overall Study|Technical problems|0
221530|NCT01712399|725895|P1|Overall Study|Study closure|345
221531|NCT01712399|725895|P1|Overall Study|Adverse Event|11
221532|NCT01712399|725895|P1|Overall Study|Death|1
221533|NCT01712399|725895|P1|Overall Study|Withdrawal by Subject|39
221534|NCT01712399|725895|P1|Overall Study|Lost to Follow-up|1
221535|NCT01712334|725941|P2|Treatment Period 1|Randomized in Error|2
221536|NCT01712334|725942|P1|Treatment Period 1|Randomized in Error|0
221537|NCT01712256|725950|P1|Overall Study|Lost to Follow-up|1
221538|NCT01712204|725961|P2|Overall Study|Protocol Violation|1
221539|NCT01712204|725962|P1|Overall Study|Protocol Violation|1
221540|NCT01712204|725961|P2|Overall Study|Lost to Follow-up|0
221541|NCT01712204|725962|P1|Overall Study|Lost to Follow-up|1
221542|NCT01712204|725961|P2|Overall Study|Withdrawal by Subject|3
221543|NCT01712204|725962|P1|Overall Study|Withdrawal by Subject|3
221544|NCT01712204|725961|P2|Overall Study|Adverse Event|1
221545|NCT01712204|725962|P1|Overall Study|Adverse Event|3
221546|NCT01712178|725970|P2|Overall Study|Lost to Follow-up|1
221547|NCT01712178|725971|P1|Overall Study|Lost to Follow-up|0
221548|NCT01712178|725970|P2|Overall Study|Serious adverse event/withdrew consent|1
221549|NCT01712178|725971|P1|Overall Study|Serious adverse event/withdrew consent|0
221550|NCT01712178|725970|P2|Overall Study|Withdrew consent due to an adverse event|1
221551|NCT01712178|725971|P1|Overall Study|Withdrew consent due to an adverse event|1
221552|NCT01712074|725996|P3|Double Blind Period|No longer met eligibility criteria|0
221553|NCT01712074|725997|P2|Double Blind Period|No longer met eligibility criteria|3
221554|NCT01712074|725998|P1|Double Blind Period|No longer met eligibility criteria|0
221555|NCT01712074|725996|P3|Double Blind Period|Protocol Violation|1
221556|NCT01712074|725997|P2|Double Blind Period|Protocol Violation|0
221557|NCT01712074|725998|P1|Double Blind Period|Protocol Violation|0
221558|NCT01712074|725996|P3|Double Blind Period|Unspecified|1
221559|NCT01712074|725997|P2|Double Blind Period|Unspecified|4
221560|NCT01712074|725998|P1|Double Blind Period|Unspecified|0
221561|NCT01712074|725996|P3|Double Blind Period|Lost to Follow-up|1
221562|NCT01712074|725997|P2|Double Blind Period|Lost to Follow-up|2
221563|NCT01712074|725998|P1|Double Blind Period|Lost to Follow-up|0
221564|NCT01712074|725996|P3|Double Blind Period|Death|0
221565|NCT01712074|725997|P2|Double Blind Period|Death|1
221566|NCT01712074|725998|P1|Double Blind Period|Death|0
221567|NCT01712074|725996|P3|Double Blind Period|No longer willing to participate|4
221568|NCT01712074|725997|P2|Double Blind Period|No longer willing to participate|2
221569|NCT01712074|725998|P1|Double Blind Period|No longer willing to participate|0
221570|NCT01712074|725996|P3|Double Blind Period|Adverse Event|1
221571|NCT01712074|725997|P2|Double Blind Period|Adverse Event|2
221572|NCT01712074|725998|P1|Double Blind Period|Adverse Event|0
221573|NCT01712074|725996|P3|Placebo Run-in Period|No longer willing to participate|0
221574|NCT01712074|725997|P2|Placebo Run-in Period|No longer willing to participate|0
221575|NCT01712074|725998|P1|Placebo Run-in Period|No longer willing to participate|1
221576|NCT01712074|725996|P3|Placebo Run-in Period|Unspecified|0
221577|NCT01712074|725997|P2|Placebo Run-in Period|Unspecified|0
221578|NCT01712074|725998|P1|Placebo Run-in Period|Unspecified|1
221579|NCT01712074|725996|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
221580|NCT01712074|725997|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
221581|NCT01712074|725998|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
221582|NCT01712074|725996|P3|Placebo Run-in Period|Lost to Follow-up|0
221583|NCT01712074|725997|P2|Placebo Run-in Period|Lost to Follow-up|0
221584|NCT01712074|725998|P1|Placebo Run-in Period|Lost to Follow-up|1
221585|NCT01712074|725996|P3|Placebo Run-in Period|Adverse Event|0
221586|NCT01712074|725997|P2|Placebo Run-in Period|Adverse Event|0
221587|NCT01712074|725998|P1|Placebo Run-in Period|Adverse Event|2
221588|NCT01712061|726054|P3|Overall Study|Unspecified|0
221589|NCT01712061|726055|P2|Overall Study|Unspecified|3
221590|NCT01712061|726056|P1|Overall Study|Unspecified|0
221591|NCT01712061|726054|P3|Overall Study|Withdrawal by Subject|1
221592|NCT01712061|726055|P2|Overall Study|Withdrawal by Subject|7
221593|NCT01712061|726056|P1|Overall Study|Withdrawal by Subject|1
221594|NCT01712061|726054|P3|Overall Study|Medication Error Without Associated AE|0
221595|NCT01712061|726055|P2|Overall Study|Medication Error Without Associated AE|1
221596|NCT01712061|726056|P1|Overall Study|Medication Error Without Associated AE|0
221597|NCT01712061|726054|P3|Overall Study|Did Not Meet Entrance Criteria|3
221598|NCT01712061|726055|P2|Overall Study|Did Not Meet Entrance Criteria|6
221599|NCT01712061|726056|P1|Overall Study|Did Not Meet Entrance Criteria|4
221600|NCT01712061|726054|P3|Overall Study|Lost to Follow-up|1
221601|NCT01712061|726055|P2|Overall Study|Lost to Follow-up|0
221602|NCT01712061|726056|P1|Overall Study|Lost to Follow-up|1
221603|NCT01712061|726054|P3|Overall Study|Death|1
221604|NCT01712061|726055|P2|Overall Study|Death|0
221605|NCT01712061|726056|P1|Overall Study|Death|0
221606|NCT01712061|726054|P3|Overall Study|Adverse Event|5
221607|NCT01712061|726055|P2|Overall Study|Adverse Event|9
221608|NCT01712061|726056|P1|Overall Study|Adverse Event|4
221609|NCT01712009|726096|P3|Overall Study|Decision by Sponsor|12
221610|NCT01712009|726097|P2|Overall Study|Decision by Sponsor|14
221611|NCT01712009|726098|P1|Overall Study|Decision by Sponsor|12
221612|NCT01712009|726096|P3|Overall Study|Lost to Follow-up|1
221613|NCT01712009|726097|P2|Overall Study|Lost to Follow-up|0
221614|NCT01712009|726098|P1|Overall Study|Lost to Follow-up|2
221615|NCT01712009|726096|P3|Overall Study|Withdrawal by Subject|8
221616|NCT01712009|726097|P2|Overall Study|Withdrawal by Subject|15
221617|NCT01712009|726098|P1|Overall Study|Withdrawal by Subject|24
221618|NCT01711866|726132|P1|Overall Study|Adverse Event|2
221619|NCT01711866|726132|P1|Overall Study|Withdrawal by Subject|3
221620|NCT01711866|726132|P1|Overall Study|Noncompliant|3
221621|NCT01711853|726137|P1|Overall Study|Not treated|3
221622|NCT01711736|726144|P2|Overall Study|Migrated/moved from study area|1
221623|NCT01711736|726145|P1|Overall Study|Migrated/moved from study area|2
221624|NCT01711736|726144|P2|Overall Study|Withdrawal by Subject|6
221625|NCT01711736|726145|P1|Overall Study|Withdrawal by Subject|6
221626|NCT01711736|726144|P2|Overall Study|Lost to Follow-up|1
221627|NCT01711736|726145|P1|Overall Study|Lost to Follow-up|4
221628|NCT01711645|726173|P1|Overall Study|Physician Decision|5
221629|NCT01711645|726173|P1|Overall Study|Lost to Follow-up|6
221630|NCT01711645|726173|P1|Overall Study|Withdrawal by Subject|8
221631|NCT01711216|726215|P1|Overall Study|no reason specified|22
221632|NCT01711216|726215|P1|Overall Study|variety of other minor reasons|83
221633|NCT01711216|726215|P1|Overall Study|Lost to Follow-up|46
221634|NCT01711216|726215|P1|Overall Study|Withdrawal by Subject|6
221635|NCT01711216|726215|P1|Overall Study|Pregnancy|56
221636|NCT01711216|726215|P1|Overall Study|Adverse Event|4
221637|NCT01710800|726268|P1|Overall Study|Protocol Violation|1
221638|NCT01710800|726268|P1|Overall Study|Withdrawal by Subject|21
221639|NCT01710657|726277|P3|Overall Study|Lack of Efficacy|1
221640|NCT01710657|726278|P2|Overall Study|Lack of Efficacy|1
221641|NCT01710657|726279|P1|Overall Study|Lack of Efficacy|0
221642|NCT01710657|726277|P3|Overall Study|Withdrawal by Subject|2
221643|NCT01710657|726278|P2|Overall Study|Withdrawal by Subject|1
221644|NCT01710657|726279|P1|Overall Study|Withdrawal by Subject|0
221645|NCT01710657|726277|P3|Overall Study|Adverse Event|28
221646|NCT01710657|726278|P2|Overall Study|Adverse Event|8
221647|NCT01710657|726279|P1|Overall Study|Adverse Event|14
221648|NCT01710657|726277|P3|Overall Study|Protocol Violation|0
221649|NCT01710657|726278|P2|Overall Study|Protocol Violation|2
221650|NCT01710657|726279|P1|Overall Study|Protocol Violation|2
221651|NCT01710657|726277|P3|Overall Study|Lost to Follow-up|1
221652|NCT01710657|726278|P2|Overall Study|Lost to Follow-up|0
221653|NCT01710657|726279|P1|Overall Study|Lost to Follow-up|2
221654|NCT01710527|726296|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
221655|NCT01710527|726297|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
221656|NCT01710514|726323|P2|Overall Study|Withdrawal by Subject|0
221657|NCT01710514|726324|P1|Overall Study|Withdrawal by Subject|1
221658|NCT01710514|726323|P2|Overall Study|Adverse Event|7
221659|NCT01710514|726324|P1|Overall Study|Adverse Event|6
221660|NCT01710501|726345|P3|Overall Study|Lost to Follow-up|0
221661|NCT01710501|726346|P2|Overall Study|Lost to Follow-up|0
221662|NCT01710501|726347|P1|Overall Study|Lost to Follow-up|2
221663|NCT01710345|726379|P3|Overall Study|Drug Dosing Error|0
221664|NCT01710345|726380|P2|Overall Study|Drug Dosing Error|0
221665|NCT01710345|726381|P1|Overall Study|Drug Dosing Error|1
221666|NCT01710345|726379|P3|Overall Study|Lack of Efficacy|1
221667|NCT01710345|726380|P2|Overall Study|Lack of Efficacy|3
221668|NCT01710345|726381|P1|Overall Study|Lack of Efficacy|2
221669|NCT01710345|726379|P3|Overall Study|Adverse Event|0
221670|NCT01710345|726380|P2|Overall Study|Adverse Event|2
221671|NCT01710345|726381|P1|Overall Study|Adverse Event|0
221672|NCT01710046|726402|P2|Overall Study|Lost to Follow-up|0
221673|NCT01710046|726403|P1|Overall Study|Lost to Follow-up|1
221674|NCT01710033|726443|P5|Stage 2|Adverse Event|1
221675|NCT01710033|726444|P4|Stage 2|Adverse Event|0
221676|NCT01710033|726445|P3|Stage 2|Adverse Event|0
221677|NCT01710033|726446|P2|Stage 2|Adverse Event|0
221678|NCT01710033|726447|P1|Stage 2|Adverse Event|0
221679|NCT01710020|726528|P1|Period 1|Protocol Violation|1
221680|NCT01709903|726547|P2|Overall Study|Adverse Event|18
221681|NCT01709903|726548|P1|Overall Study|Adverse Event|11
221682|NCT01709903|726547|P2|Overall Study|Withdrawal by Subject|6
221683|NCT01709903|726548|P1|Overall Study|Withdrawal by Subject|6
221684|NCT01709903|726547|P2|Overall Study|Lack of Efficacy|3
221685|NCT01709903|726548|P1|Overall Study|Lack of Efficacy|3
221686|NCT01709903|726547|P2|Overall Study|Protocol Violation|2
221687|NCT01709903|726548|P1|Overall Study|Protocol Violation|3
221688|NCT01709903|726547|P2|Overall Study|Death|0
221689|NCT01709903|726548|P1|Overall Study|Death|2
221690|NCT01709903|726547|P2|Overall Study|Lost to Follow-up|2
221691|NCT01709903|726548|P1|Overall Study|Lost to Follow-up|0
221692|NCT01709903|726547|P2|Overall Study|no longer needed study drug|1
221693|NCT01709903|726548|P1|Overall Study|no longer needed study drug|0
221694|NCT01709903|726547|P2|Overall Study|In ability to use device|1
221695|NCT01709903|726548|P1|Overall Study|In ability to use device|1
221696|NCT01709903|726547|P2|Overall Study|Abnormal test procedure results|0
221697|NCT01709903|726548|P1|Overall Study|Abnormal test procedure results|1
221698|NCT01709903|726547|P2|Overall Study|administrative problems|6
221699|NCT01709903|726548|P1|Overall Study|administrative problems|2
221700|NCT01709864|726572|P2|Overall Study|Death|1
221701|NCT01709864|726573|P1|Overall Study|Death|0
221702|NCT01709864|726572|P2|Overall Study|Adverse Event|2
221703|NCT01709864|726573|P1|Overall Study|Adverse Event|0
221704|NCT01709864|726572|P2|Overall Study|non-compliance with study treatment|1
221705|NCT01709864|726573|P1|Overall Study|non-compliance with study treatment|1
221706|NCT01709864|726572|P2|Overall Study|Lost to Follow-up|0
221707|NCT01709864|726573|P1|Overall Study|Lost to Follow-up|1
221708|NCT01709864|726572|P2|Overall Study|subject/guardian decision|6
221709|NCT01709864|726573|P1|Overall Study|subject/guardian decision|5
221710|NCT01709864|726572|P2|Overall Study|Physician Decision|1
221711|NCT01709864|726573|P1|Overall Study|Physician Decision|0
221712|NCT01709708|726644|P2|Overall Study|Protocol Violation|2
221713|NCT01709708|726645|P1|Overall Study|Protocol Violation|1
221714|NCT01709513|726654|P3|Overall Study|Unspecified|7
221715|NCT01709513|726655|P2|Overall Study|Unspecified|11
221716|NCT01709513|726656|P1|Overall Study|Unspecified|3
221717|NCT01709513|726654|P3|Overall Study|Poor compliance to protocol|0
221718|NCT01709513|726655|P2|Overall Study|Poor compliance to protocol|0
221719|NCT01709513|726656|P1|Overall Study|Poor compliance to protocol|2
221720|NCT01709513|726654|P3|Overall Study|Adverse Event|23
221721|NCT01709513|726655|P2|Overall Study|Adverse Event|31
221722|NCT01709513|726656|P1|Overall Study|Adverse Event|16
221723|NCT01709513|726654|P3|Overall Study|Randomized but not treated|0
221724|NCT01709513|726655|P2|Overall Study|Randomized but not treated|1
221725|NCT01709513|726656|P1|Overall Study|Randomized but not treated|0
221726|NCT01709500|726717|P2|Overall Study|Treatment ongoing|78
221727|NCT01709500|726718|P1|Overall Study|Treatment ongoing|156
221728|NCT01709500|726717|P2|Overall Study|Related to IMP administration|0
221729|NCT01709500|726718|P1|Overall Study|Related to IMP administration|1
221730|NCT01709500|726717|P2|Overall Study|Unspecified|1
221731|NCT01709500|726718|P1|Overall Study|Unspecified|3
221732|NCT01709500|726717|P2|Overall Study|Poor compliance to protocol|1
221733|NCT01709500|726718|P1|Overall Study|Poor compliance to protocol|2
221734|NCT01709500|726717|P2|Overall Study|Adverse Event|1
221735|NCT01709500|726718|P1|Overall Study|Adverse Event|5
221736|NCT01709500|726717|P2|Overall Study|Randomized but not treated|1
221737|NCT01709500|726718|P1|Overall Study|Randomized but not treated|0
221738|NCT01709331|726794|P1|Overall Study|Adverse Event|1
221739|NCT01709305|726800|P5|Phase 2|Withdrawal by Subject|12
221740|NCT01709305|726801|P4|Phase 2|Withdrawal by Subject|15
221741|NCT01709305|726802|P3|Phase 2|Withdrawal by Subject|6
221742|NCT01709305|726803|P2|Phase 2|Withdrawal by Subject|8
221743|NCT01709305|726804|P1|Phase 2|Withdrawal by Subject|0
221744|NCT01709305|726800|P5|Phase 2|Protocol Violation|9
221745|NCT01709305|726801|P4|Phase 2|Protocol Violation|13
221746|NCT01709305|726802|P3|Phase 2|Protocol Violation|19
221747|NCT01709305|726803|P2|Phase 2|Protocol Violation|19
221748|NCT01709305|726804|P1|Phase 2|Protocol Violation|0
221749|NCT01709305|726800|P5|Phase 2|Physician Decision|2
221750|NCT01709305|726801|P4|Phase 2|Physician Decision|1
221751|NCT01709305|726802|P3|Phase 2|Physician Decision|0
221752|NCT01709305|726803|P2|Phase 2|Physician Decision|2
221753|NCT01709305|726804|P1|Phase 2|Physician Decision|0
221754|NCT01709305|726800|P5|Phase 2|Travel, moving, etc.|5
221755|NCT01709305|726801|P4|Phase 2|Travel, moving, etc.|3
221756|NCT01709305|726802|P3|Phase 2|Travel, moving, etc.|3
221757|NCT01709305|726803|P2|Phase 2|Travel, moving, etc.|2
221758|NCT01709305|726804|P1|Phase 2|Travel, moving, etc.|0
221759|NCT01709305|726800|P5|Phase 2|Lost to Follow-up|5
221760|NCT01709305|726801|P4|Phase 2|Lost to Follow-up|9
221761|NCT01709305|726802|P3|Phase 2|Lost to Follow-up|6
221762|NCT01709305|726803|P2|Phase 2|Lost to Follow-up|10
221763|NCT01709305|726804|P1|Phase 2|Lost to Follow-up|0
221764|NCT01709305|726800|P5|Phase 2|Laboratory Adverse Event|1
221765|NCT01709305|726801|P4|Phase 2|Laboratory Adverse Event|1
221766|NCT01709305|726802|P3|Phase 2|Laboratory Adverse Event|0
221767|NCT01709305|726803|P2|Phase 2|Laboratory Adverse Event|1
221768|NCT01709305|726804|P1|Phase 2|Laboratory Adverse Event|0
221769|NCT01709305|726800|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
221770|NCT01709305|726801|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
221771|NCT01709305|726802|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
221772|NCT01709305|726803|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
221773|NCT01709305|726804|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
221774|NCT01709305|726800|P5|Phase 2|Death|0
221775|NCT01709305|726801|P4|Phase 2|Death|0
221776|NCT01709305|726802|P3|Phase 2|Death|1
221777|NCT01709305|726803|P2|Phase 2|Death|0
221778|NCT01709305|726804|P1|Phase 2|Death|0
221779|NCT01709305|726800|P5|Phase 2|Clinical Adverse Event|11
221780|NCT01709305|726801|P4|Phase 2|Clinical Adverse Event|6
221781|NCT01709305|726802|P3|Phase 2|Clinical Adverse Event|10
221782|NCT01709305|726803|P2|Phase 2|Clinical Adverse Event|10
221783|NCT01709305|726804|P1|Phase 2|Clinical Adverse Event|0
221784|NCT01709305|726800|P5|Phase 1|Withdrawal by Subject|0
221785|NCT01709305|726801|P4|Phase 1|Withdrawal by Subject|0
221786|NCT01709305|726802|P3|Phase 1|Withdrawal by Subject|0
221787|NCT01709305|726803|P2|Phase 1|Withdrawal by Subject|0
221788|NCT01709305|726804|P1|Phase 1|Withdrawal by Subject|218
221789|NCT01709305|726800|P5|Phase 1|Protocol Violation|0
221790|NCT01709305|726801|P4|Phase 1|Protocol Violation|0
221791|NCT01709305|726802|P3|Phase 1|Protocol Violation|0
221792|NCT01709305|726803|P2|Phase 1|Protocol Violation|0
221793|NCT01709305|726804|P1|Phase 1|Protocol Violation|118
221794|NCT01709305|726800|P5|Phase 1|Physician Decision|0
221795|NCT01709305|726801|P4|Phase 1|Physician Decision|0
221796|NCT01709305|726802|P3|Phase 1|Physician Decision|0
221797|NCT01709305|726803|P2|Phase 1|Physician Decision|0
221798|NCT01709305|726804|P1|Phase 1|Physician Decision|13
221799|NCT01709305|726800|P5|Phase 1|Travel, moving, etc.|0
221800|NCT01709305|726801|P4|Phase 1|Travel, moving, etc.|0
221801|NCT01709305|726802|P3|Phase 1|Travel, moving, etc.|0
221802|NCT01709305|726803|P2|Phase 1|Travel, moving, etc.|0
221803|NCT01709305|726804|P1|Phase 1|Travel, moving, etc.|30
221804|NCT01709305|726800|P5|Phase 1|Lost to Follow-up|0
221805|NCT01709305|726801|P4|Phase 1|Lost to Follow-up|0
221806|NCT01709305|726802|P3|Phase 1|Lost to Follow-up|0
221807|NCT01709305|726803|P2|Phase 1|Lost to Follow-up|0
221808|NCT01709305|726804|P1|Phase 1|Lost to Follow-up|147
221809|NCT01709305|726800|P5|Phase 1|Laboratory Adverse Event|0
221810|NCT01709305|726801|P4|Phase 1|Laboratory Adverse Event|0
221811|NCT01709305|726802|P3|Phase 1|Laboratory Adverse Event|0
221812|NCT01709305|726803|P2|Phase 1|Laboratory Adverse Event|0
221813|NCT01709305|726804|P1|Phase 1|Laboratory Adverse Event|16
221814|NCT01709305|726800|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
221815|NCT01709305|726801|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
221816|NCT01709305|726802|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
221817|NCT01709305|726803|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
221818|NCT01709305|726804|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
221819|NCT01709305|726800|P5|Phase 1|Death|0
221820|NCT01709305|726801|P4|Phase 1|Death|0
221821|NCT01709305|726802|P3|Phase 1|Death|0
221822|NCT01709305|726803|P2|Phase 1|Death|0
221823|NCT01709305|726804|P1|Phase 1|Death|2
221824|NCT01709305|726800|P5|Phase 1|Clinical Adverse Event|0
221825|NCT01709305|726801|P4|Phase 1|Clinical Adverse Event|0
221826|NCT01709305|726802|P3|Phase 1|Clinical Adverse Event|0
221827|NCT01709305|726803|P2|Phase 1|Clinical Adverse Event|0
221828|NCT01709305|726804|P1|Phase 1|Clinical Adverse Event|80
221829|NCT01709227|726841|P2|Overall Study|Pleural Peritoneal communication|9
221830|NCT01709227|726842|P1|Overall Study|Pleural Peritoneal communication|0
221831|NCT01709227|726841|P2|Overall Study|Physician Decision|0
221832|NCT01709227|726842|P1|Overall Study|Physician Decision|1
221833|NCT01709162|726868|P2|Overall Study|Withdrawal by Subject|1
221834|NCT01709162|726869|P1|Overall Study|Withdrawal by Subject|0
221835|NCT01709162|726868|P2|Overall Study|Not specified|0
221836|NCT01709162|726869|P1|Overall Study|Not specified|1
221837|NCT01709162|726868|P2|Overall Study|Administrative reason by sponsor|1
221838|NCT01709162|726869|P1|Overall Study|Administrative reason by sponsor|0
221839|NCT01709162|726868|P2|Overall Study|Study drug toxicity|0
221840|NCT01709162|726869|P1|Overall Study|Study drug toxicity|2
221841|NCT01709162|726868|P2|Overall Study|Disease progression|3
221842|NCT01709162|726869|P1|Overall Study|Disease progression|3
221843|NCT01709084|726890|P2|Overall Study|Not Treated|2
221844|NCT01709084|726891|P1|Overall Study|Not Treated|0
221845|NCT01709084|726890|P2|Overall Study|Participant Reached a Virologic Endpoint|1
221846|NCT01709084|726891|P1|Overall Study|Participant Reached a Virologic Endpoint|0
221847|NCT01709084|726890|P2|Overall Study|unspecified|3
221848|NCT01709084|726891|P1|Overall Study|unspecified|5
221849|NCT01709084|726890|P2|Overall Study|Adverse Event|0
221850|NCT01709084|726891|P1|Overall Study|Adverse Event|5
221851|NCT01709084|726890|P2|Overall Study|Withdrawal by Subject|2
221852|NCT01709084|726891|P1|Overall Study|Withdrawal by Subject|2
221853|NCT01709084|726890|P2|Overall Study|Lost to Follow-up|7
221854|NCT01709084|726891|P1|Overall Study|Lost to Follow-up|4
221855|NCT01708954|726919|P3|Step 2|Withdrawal by Subject|0
221856|NCT01708954|726920|P2|Step 2|Withdrawal by Subject|1
221857|NCT01708954|726921|P1|Step 2|Withdrawal by Subject|1
221858|NCT01708954|726919|P3|Step 2|Adverse Event|0
221859|NCT01708954|726920|P2|Step 2|Adverse Event|2
221860|NCT01708954|726921|P1|Step 2|Adverse Event|3
221861|NCT01708954|726919|P3|Step 2|Disease progression|0
221862|NCT01708954|726920|P2|Step 2|Disease progression|4
221863|NCT01708954|726921|P1|Step 2|Disease progression|9
221864|NCT01708954|726919|P3|Step 1|Ineligible or never received treatment|8
221865|NCT01708954|726920|P2|Step 1|Ineligible or never received treatment|2
221866|NCT01708954|726921|P1|Step 1|Ineligible or never received treatment|4
221867|NCT01708954|726919|P3|Step 1|Off-treatment reason not submitted|1
221868|NCT01708954|726920|P2|Step 1|Off-treatment reason not submitted|1
221869|NCT01708954|726921|P1|Step 1|Off-treatment reason not submitted|1
221870|NCT01708954|726919|P3|Step 1|Symptomatic deterioration|1
221871|NCT01708954|726920|P2|Step 1|Symptomatic deterioration|0
221872|NCT01708954|726921|P1|Step 1|Symptomatic deterioration|1
221873|NCT01708954|726919|P3|Step 1|Crossed over to Step 2|0
221874|NCT01708954|726920|P2|Step 1|Crossed over to Step 2|0
221875|NCT01708954|726921|P1|Step 1|Crossed over to Step 2|2
221876|NCT01708954|726919|P3|Step 1|Other complicating disease|0
221877|NCT01708954|726920|P2|Step 1|Other complicating disease|2
221878|NCT01708954|726921|P1|Step 1|Other complicating disease|0
221879|NCT01708954|726919|P3|Step 1|Withdrawal by Subject|3
221880|NCT01708954|726920|P2|Step 1|Withdrawal by Subject|5
221881|NCT01708954|726921|P1|Step 1|Withdrawal by Subject|2
221882|NCT01708954|726919|P3|Step 1|Death|3
221883|NCT01708954|726920|P2|Step 1|Death|2
221884|NCT01708954|726921|P1|Step 1|Death|3
221885|NCT01708954|726919|P3|Step 1|Adverse Event|13
221886|NCT01708954|726920|P2|Step 1|Adverse Event|11
221887|NCT01708954|726921|P1|Step 1|Adverse Event|3
221888|NCT01708954|726919|P3|Step 1|Disease progression|14
221889|NCT01708954|726920|P2|Step 1|Disease progression|17
221890|NCT01708954|726921|P1|Step 1|Disease progression|26
221891|NCT01708915|726946|P4|Overall Study|Other reasons than stated above|2
221892|NCT01708915|726947|P3|Overall Study|Other reasons than stated above|0
221893|NCT01708915|726948|P2|Overall Study|Other reasons than stated above|1
221894|NCT01708915|726949|P1|Overall Study|Other reasons than stated above|1
221895|NCT01708915|726946|P4|Overall Study|Withdrawal by Subject|2
221896|NCT01708915|726947|P3|Overall Study|Withdrawal by Subject|2
221897|NCT01708915|726948|P2|Overall Study|Withdrawal by Subject|1
221898|NCT01708915|726949|P1|Overall Study|Withdrawal by Subject|0
221899|NCT01708915|726946|P4|Overall Study|Protocol Violation|1
221900|NCT01708915|726947|P3|Overall Study|Protocol Violation|0
221901|NCT01708915|726948|P2|Overall Study|Protocol Violation|0
221902|NCT01708915|726949|P1|Overall Study|Protocol Violation|0
221903|NCT01708915|726946|P4|Overall Study|Lack of Efficacy|15
221904|NCT01708915|726947|P3|Overall Study|Lack of Efficacy|35
221905|NCT01708915|726948|P2|Overall Study|Lack of Efficacy|60
221906|NCT01708915|726949|P1|Overall Study|Lack of Efficacy|84
221907|NCT01708915|726946|P4|Overall Study|Adverse Event|13
221908|NCT01708915|726947|P3|Overall Study|Adverse Event|9
221909|NCT01708915|726948|P2|Overall Study|Adverse Event|0
221910|NCT01708915|726949|P1|Overall Study|Adverse Event|1
221911|NCT01708902|726978|P7|Overall Study|Other Reason|0
221912|NCT01708902|726979|P6|Overall Study|Other Reason|2
221913|NCT01708902|726980|P5|Overall Study|Other Reason|1
221914|NCT01708902|726981|P4|Overall Study|Other Reason|1
221915|NCT01708902|726982|P3|Overall Study|Other Reason|1
221916|NCT01708902|726983|P2|Overall Study|Other Reason|0
221917|NCT01708902|726984|P1|Overall Study|Other Reason|1
221918|NCT01708902|726978|P7|Overall Study|Refused to continue trial medication|1
221919|NCT01708902|726979|P6|Overall Study|Refused to continue trial medication|1
221920|NCT01708902|726980|P5|Overall Study|Refused to continue trial medication|8
221921|NCT01708902|726981|P4|Overall Study|Refused to continue trial medication|2
221922|NCT01708902|726982|P3|Overall Study|Refused to continue trial medication|4
221923|NCT01708902|726983|P2|Overall Study|Refused to continue trial medication|0
221924|NCT01708902|726984|P1|Overall Study|Refused to continue trial medication|8
221925|NCT01708902|726978|P7|Overall Study|Lost to Follow-up|1
221926|NCT01708902|726979|P6|Overall Study|Lost to Follow-up|0
221927|NCT01708902|726980|P5|Overall Study|Lost to Follow-up|0
221928|NCT01708902|726981|P4|Overall Study|Lost to Follow-up|2
221929|NCT01708902|726982|P3|Overall Study|Lost to Follow-up|2
221930|NCT01708902|726983|P2|Overall Study|Lost to Follow-up|1
221931|NCT01708902|726984|P1|Overall Study|Lost to Follow-up|2
221932|NCT01708902|726978|P7|Overall Study|Non compliance with protocol|0
221933|NCT01708902|726979|P6|Overall Study|Non compliance with protocol|0
221934|NCT01708902|726980|P5|Overall Study|Non compliance with protocol|0
221935|NCT01708902|726981|P4|Overall Study|Non compliance with protocol|3
221936|NCT01708902|726982|P3|Overall Study|Non compliance with protocol|1
221937|NCT01708902|726983|P2|Overall Study|Non compliance with protocol|2
221938|NCT01708902|726984|P1|Overall Study|Non compliance with protocol|0
221939|NCT01708902|726978|P7|Overall Study|Lack of Efficacy|0
221940|NCT01708902|726979|P6|Overall Study|Lack of Efficacy|1
221941|NCT01708902|726980|P5|Overall Study|Lack of Efficacy|0
221942|NCT01708902|726981|P4|Overall Study|Lack of Efficacy|0
221943|NCT01708902|726982|P3|Overall Study|Lack of Efficacy|0
221944|NCT01708902|726983|P2|Overall Study|Lack of Efficacy|1
221945|NCT01708902|726984|P1|Overall Study|Lack of Efficacy|3
221946|NCT01708902|726978|P7|Overall Study|Adverse Event|5
221947|NCT01708902|726979|P6|Overall Study|Adverse Event|3
221948|NCT01708902|726980|P5|Overall Study|Adverse Event|7
221949|NCT01708902|726981|P4|Overall Study|Adverse Event|2
221950|NCT01708902|726982|P3|Overall Study|Adverse Event|9
221951|NCT01708902|726983|P2|Overall Study|Adverse Event|4
221952|NCT01708902|726984|P1|Overall Study|Adverse Event|3
221953|NCT01708291|727057|P2|Overall Study|fighting|1
221954|NCT01708291|727058|P1|Overall Study|fighting|2
221955|NCT01708187|727097|P2|Overall Study|Lost to Follow-up|1
221956|NCT01708187|727098|P1|Overall Study|Lost to Follow-up|0
221957|NCT01708174|727107|P3|Treatment Period|Adverse Event|0
221958|NCT01708174|727108|P2|Treatment Period|Adverse Event|1
221959|NCT01708174|727109|P1|Treatment Period|Adverse Event|0
221960|NCT01708174|727107|P3|Treatment Period|Death|1
221961|NCT01708174|727108|P2|Treatment Period|Death|0
221962|NCT01708174|727109|P1|Treatment Period|Death|0
221963|NCT01708174|727107|P3|Treatment Period|Progressive disease|0
221964|NCT01708174|727108|P2|Treatment Period|Progressive disease|1
221965|NCT01708174|727109|P1|Treatment Period|Progressive disease|0
221966|NCT01708174|727107|P3|Treatment Period|Withdrawal by Subject|0
221967|NCT01708174|727108|P2|Treatment Period|Withdrawal by Subject|0
221968|NCT01708174|727109|P1|Treatment Period|Withdrawal by Subject|1
221969|NCT01708057|727146|P3|Overall Study|Withdrawal due to study termination.|1
221970|NCT01708057|727147|P2|Overall Study|Withdrawal due to study termination.|1
221971|NCT01708057|727148|P1|Overall Study|Withdrawal due to study termination.|1
221972|NCT01707667|727206|P2|Period 1|expulsion of colonic sensor catheter|0
221973|NCT01707667|727207|P1|Period 1|expulsion of colonic sensor catheter|1
221974|NCT01707290|727231|P2|Overall Study|Other unspecified|0
221975|NCT01707290|727232|P1|Overall Study|Other unspecified|17
221976|NCT01707290|727231|P2|Overall Study|Commercial drug available|1
221977|NCT01707290|727232|P1|Overall Study|Commercial drug available|60
221978|NCT01707290|727231|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
221979|NCT01707290|727232|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
221980|NCT01707290|727231|P2|Overall Study|Lost to Follow-up|0
221981|NCT01707290|727232|P1|Overall Study|Lost to Follow-up|3
221982|NCT01707290|727231|P2|Overall Study|Physician Decision|0
221983|NCT01707290|727232|P1|Overall Study|Physician Decision|1
221984|NCT01707290|727231|P2|Overall Study|Adverse event (AE)|0
221985|NCT01707290|727232|P1|Overall Study|Adverse event (AE)|1
221986|NCT01706926|727304|P4|Overall Study|Unspecified|3
221987|NCT01706926|727305|P3|Overall Study|Unspecified|4
221988|NCT01706926|727306|P2|Overall Study|Unspecified|4
221989|NCT01706926|727307|P1|Overall Study|Unspecified|4
221990|NCT01706926|727304|P4|Overall Study|Withdrawal by Subject|2
221991|NCT01706926|727305|P3|Overall Study|Withdrawal by Subject|1
221992|NCT01706926|727306|P2|Overall Study|Withdrawal by Subject|0
221993|NCT01706926|727307|P1|Overall Study|Withdrawal by Subject|2
221994|NCT01706926|727304|P4|Overall Study|Lost to Follow-up|0
221995|NCT01706926|727305|P3|Overall Study|Lost to Follow-up|1
221996|NCT01706926|727306|P2|Overall Study|Lost to Follow-up|0
221997|NCT01706926|727307|P1|Overall Study|Lost to Follow-up|0
221998|NCT01706770|727426|P2|Overall Study|Physician Decision|0
221999|NCT01706770|727427|P1|Overall Study|Physician Decision|1
222000|NCT01706770|727426|P2|Overall Study|Lost to Follow-up|0
222001|NCT01706770|727427|P1|Overall Study|Lost to Follow-up|1
222002|NCT01706575|727475|P1|Overall Study|Started but not Treated|6
222003|NCT01706575|727475|P1|Overall Study|Lost to Follow-up|2
222004|NCT01706575|727475|P1|Overall Study|Participant Withdrew Consent|4
222005|NCT01706328|727493|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
222006|NCT01706328|727494|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
222007|NCT01706328|727495|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
222008|NCT01706328|727493|P3|12-week Double-blind Treatment Period|Physician Decision|2
222009|NCT01706328|727494|P2|12-week Double-blind Treatment Period|Physician Decision|2
222010|NCT01706328|727495|P1|12-week Double-blind Treatment Period|Physician Decision|0
222011|NCT01706328|727493|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
222012|NCT01706328|727494|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
222013|NCT01706328|727495|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
222014|NCT01706328|727493|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
222015|NCT01706328|727494|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
222016|NCT01706328|727495|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
222017|NCT01706328|727493|P3|12-week Double-blind Treatment Period|Protocol Violation|2
222018|NCT01706328|727494|P2|12-week Double-blind Treatment Period|Protocol Violation|4
222019|NCT01706328|727495|P1|12-week Double-blind Treatment Period|Protocol Violation|0
222020|NCT01706328|727493|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
222021|NCT01706328|727494|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
222022|NCT01706328|727495|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
222023|NCT01706328|727493|P3|12-week Double-blind Treatment Period|Adverse Event|16
222024|NCT01706328|727494|P2|12-week Double-blind Treatment Period|Adverse Event|14
222025|NCT01706328|727495|P1|12-week Double-blind Treatment Period|Adverse Event|0
222026|NCT01706328|727493|P3|2-week Run-in Period|Lost to Follow-up|0
222027|NCT01706328|727494|P2|2-week Run-in Period|Lost to Follow-up|0
222028|NCT01706328|727495|P1|2-week Run-in Period|Lost to Follow-up|2
222029|NCT01706328|727493|P3|2-week Run-in Period|Adverse Event|0
222030|NCT01706328|727494|P2|2-week Run-in Period|Adverse Event|0
222031|NCT01706328|727495|P1|2-week Run-in Period|Adverse Event|4
222032|NCT01706328|727493|P3|2-week Run-in Period|Physician Decision|0
222033|NCT01706328|727494|P2|2-week Run-in Period|Physician Decision|0
222034|NCT01706328|727495|P1|2-week Run-in Period|Physician Decision|4
222035|NCT01706328|727493|P3|2-week Run-in Period|Withdrawal by Subject|0
222036|NCT01706328|727494|P2|2-week Run-in Period|Withdrawal by Subject|0
222037|NCT01706328|727495|P1|2-week Run-in Period|Withdrawal by Subject|15
222038|NCT01706328|727493|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
222039|NCT01706328|727494|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
222040|NCT01706328|727495|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
222041|NCT01706159|727507|P2|Overall Study|Unclassified|1
222042|NCT01706159|727508|P1|Overall Study|Unclassified|6
222043|NCT01706159|727507|P2|Overall Study|Withdrawal Criteria|1
222044|NCT01706159|727508|P1|Overall Study|Withdrawal Criteria|2
222209|NCT01703845|728105|P2|Overall Study|Protocol Violation|0
222045|NCT01706146|727522|P1|Overall Study|Developed AF and need for antiplatelets|2
222046|NCT01706146|727522|P1|Overall Study|Adverse Event|3
222047|NCT01706146|727522|P1|Overall Study|Withdrawal by Subject|1
222048|NCT01705717|727529|P2|Overall Study|Not Specified|2
222049|NCT01705717|727530|P1|Overall Study|Not Specified|0
222050|NCT01705717|727529|P2|Overall Study|Lack of Efficacy|1
222051|NCT01705717|727530|P1|Overall Study|Lack of Efficacy|0
222052|NCT01705717|727529|P2|Overall Study|Adverse Event|2
222053|NCT01705717|727530|P1|Overall Study|Adverse Event|2
222054|NCT01705652|727547|P2|Overall Study|non-compliance|1
222055|NCT01705652|727548|P1|Overall Study|non-compliance|1
222056|NCT01705652|727547|P2|Overall Study|Withdrawal by Subject|2
222057|NCT01705652|727548|P1|Overall Study|Withdrawal by Subject|1
222058|NCT01705652|727547|P2|Overall Study|Adverse Event|0
222059|NCT01705652|727548|P1|Overall Study|Adverse Event|1
222060|NCT01705574|727556|P2|Overall Study|Still on Study|125
222061|NCT01705574|727557|P1|Overall Study|Still on Study|135
222062|NCT01705574|727556|P2|Overall Study|Lost to Follow-up|15
222063|NCT01705574|727557|P1|Overall Study|Lost to Follow-up|11
222064|NCT01705574|727556|P2|Overall Study|Withdrew Consent|5
222065|NCT01705574|727557|P1|Overall Study|Withdrew Consent|8
222066|NCT01705574|727556|P2|Overall Study|Protocol Violation|0
222067|NCT01705574|727557|P1|Overall Study|Protocol Violation|1
222068|NCT01705574|727556|P2|Overall Study|Non-Compliance with Study Drug|4
222069|NCT01705574|727557|P1|Overall Study|Non-Compliance with Study Drug|4
222070|NCT01705574|727556|P2|Overall Study|Pregnancy|1
222071|NCT01705574|727557|P1|Overall Study|Pregnancy|1
222072|NCT01705574|727556|P2|Overall Study|Adverse Event|9
222073|NCT01705574|727557|P1|Overall Study|Adverse Event|3
222074|NCT01705574|727556|P2|Overall Study|Randomized but Not Treated|4
222075|NCT01705574|727557|P1|Overall Study|Randomized but Not Treated|4
222076|NCT01705145|727575|P1|Part B|Adverse Event|1
222077|NCT01704846|727622|P2|Treatment Period 2|Withdrawal by Subject|1
222078|NCT01704846|727623|P1|Treatment Period 2|Withdrawal by Subject|0
222079|NCT01704755|727678|P2|Overall Study|Withdrew consent and personal issues|0
222080|NCT01704755|727679|P1|Overall Study|Withdrew consent and personal issues|1
222081|NCT01704755|727678|P2|Overall Study|Other (not specified)|1
222082|NCT01704755|727679|P1|Overall Study|Other (not specified)|3
222083|NCT01704755|727678|P2|Overall Study|Withdrew consent|1
222084|NCT01704755|727679|P1|Overall Study|Withdrew consent|1
222085|NCT01704755|727678|P2|Overall Study|Lost to Follow-up|4
222086|NCT01704755|727679|P1|Overall Study|Lost to Follow-up|3
222087|NCT01704755|727678|P2|Overall Study|Adverse Event|1
222088|NCT01704755|727679|P1|Overall Study|Adverse Event|4
222089|NCT01704651|727693|P2|Overall Study|Post-op did not have laparotomy|1
222090|NCT01704651|727694|P1|Overall Study|Post-op did not have laparotomy|2
222091|NCT01704651|727693|P2|Overall Study|Nasogastric tube placement in surgery|1
222092|NCT01704651|727694|P1|Overall Study|Nasogastric tube placement in surgery|1
222093|NCT01704651|727693|P2|Overall Study|Pre-op change in treatment plan|4
222094|NCT01704651|727694|P1|Overall Study|Pre-op change in treatment plan|1
222095|NCT01704651|727693|P2|Overall Study|Pre-op withdrawal by subject|1
222096|NCT01704651|727694|P1|Overall Study|Pre-op withdrawal by subject|1
222097|NCT01704599|727702|P1|Overall Study|Adverse Event|1
222098|NCT01704495|727742|P4|Optional Safety Extension|Withdrawal by Subject|2
222099|NCT01704495|727743|P3|Optional Safety Extension|Withdrawal by Subject|1
222100|NCT01704495|727744|P2|Optional Safety Extension|Withdrawal by Subject|0
222101|NCT01704495|727745|P1|Optional Safety Extension|Withdrawal by Subject|2
222102|NCT01704495|727742|P4|Optional Safety Extension|Other reason|28
222103|NCT01704495|727743|P3|Optional Safety Extension|Other reason|30
222104|NCT01704495|727744|P2|Optional Safety Extension|Other reason|29
222105|NCT01704495|727745|P1|Optional Safety Extension|Other reason|27
222106|NCT01704495|727742|P4|Optional Safety Extension|Adverse Event|1
222107|NCT01704495|727743|P3|Optional Safety Extension|Adverse Event|0
222108|NCT01704495|727744|P2|Optional Safety Extension|Adverse Event|4
222109|NCT01704495|727745|P1|Optional Safety Extension|Adverse Event|0
222110|NCT01704495|727742|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
222111|NCT01704495|727743|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
222112|NCT01704495|727744|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
222113|NCT01704495|727745|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
222114|NCT01704495|727742|P4|Subjects Randomized|Protocol Violation|0
222115|NCT01704495|727743|P3|Subjects Randomized|Protocol Violation|2
222116|NCT01704495|727744|P2|Subjects Randomized|Protocol Violation|1
222117|NCT01704495|727745|P1|Subjects Randomized|Protocol Violation|1
222118|NCT01704495|727742|P4|Subjects Randomized|Withdrawal by Subject|5
222119|NCT01704495|727743|P3|Subjects Randomized|Withdrawal by Subject|5
222120|NCT01704495|727744|P2|Subjects Randomized|Withdrawal by Subject|5
222121|NCT01704495|727745|P1|Subjects Randomized|Withdrawal by Subject|5
222122|NCT01704495|727742|P4|Subjects Randomized|Adverse Event|7
222123|NCT01704495|727743|P3|Subjects Randomized|Adverse Event|0
222124|NCT01704495|727744|P2|Subjects Randomized|Adverse Event|2
222125|NCT01704495|727745|P1|Subjects Randomized|Adverse Event|8
222126|NCT01704495|727742|P4|Subjects Randomized|Discontinuation criteria met|0
222127|NCT01704495|727743|P3|Subjects Randomized|Discontinuation criteria met|2
222128|NCT01704495|727744|P2|Subjects Randomized|Discontinuation criteria met|2
222129|NCT01704495|727745|P1|Subjects Randomized|Discontinuation criteria met|4
222130|NCT01704495|727742|P4|Subjects Randomized|Other Reason|2
222131|NCT01704495|727743|P3|Subjects Randomized|Other Reason|3
222132|NCT01704495|727744|P2|Subjects Randomized|Other Reason|2
222133|NCT01704495|727745|P1|Subjects Randomized|Other Reason|3
222134|NCT01704287|727961|P5|Switch to Pembrolizumab Treatment Period|Ongoing in Study|16
222135|NCT01704287|727962|P4|Switch to Pembrolizumab Treatment Period|Ongoing in Study|21
222136|NCT01704287|727963|P3|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
222137|NCT01704287|727964|P2|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
222138|NCT01704287|727965|P1|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
222139|NCT01704287|727961|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
222140|NCT01704287|727962|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
222141|NCT01704287|727963|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
222142|NCT01704287|727964|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
222143|NCT01704287|727965|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
222144|NCT01704287|727961|P5|Switch to Pembrolizumab Treatment Period|Death|28
222145|NCT01704287|727962|P4|Switch to Pembrolizumab Treatment Period|Death|29
222146|NCT01704287|727963|P3|Switch to Pembrolizumab Treatment Period|Death|0
222147|NCT01704287|727964|P2|Switch to Pembrolizumab Treatment Period|Death|0
222148|NCT01704287|727965|P1|Switch to Pembrolizumab Treatment Period|Death|0
222149|NCT01704287|727961|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
222150|NCT01704287|727962|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
222151|NCT01704287|727963|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
222152|NCT01704287|727964|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
222153|NCT01704287|727965|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
222154|NCT01704287|727961|P5|Initial Treatment Period|Switched to Pembrolizumab|0
222155|NCT01704287|727962|P4|Initial Treatment Period|Switched to Pembrolizumab|0
222156|NCT01704287|727963|P3|Initial Treatment Period|Switched to Pembrolizumab|98
222157|NCT01704287|727964|P2|Initial Treatment Period|Switched to Pembrolizumab|0
222158|NCT01704287|727965|P1|Initial Treatment Period|Switched to Pembrolizumab|0
222159|NCT01704287|727961|P5|Initial Treatment Period|Lost to Follow-up|0
222160|NCT01704287|727962|P4|Initial Treatment Period|Lost to Follow-up|0
222161|NCT01704287|727963|P3|Initial Treatment Period|Lost to Follow-up|3
222162|NCT01704287|727964|P2|Initial Treatment Period|Lost to Follow-up|1
222163|NCT01704287|727965|P1|Initial Treatment Period|Lost to Follow-up|3
222164|NCT01704287|727961|P5|Initial Treatment Period|Ongoing in Study|0
222165|NCT01704287|727962|P4|Initial Treatment Period|Ongoing in Study|0
222166|NCT01704287|727963|P3|Initial Treatment Period|Ongoing in Study|44
222167|NCT01704287|727964|P2|Initial Treatment Period|Ongoing in Study|62
222168|NCT01704287|727965|P1|Initial Treatment Period|Ongoing in Study|52
222169|NCT01704287|727961|P5|Initial Treatment Period|Unspecified|0
222170|NCT01704287|727962|P4|Initial Treatment Period|Unspecified|0
222171|NCT01704287|727963|P3|Initial Treatment Period|Unspecified|0
222172|NCT01704287|727964|P2|Initial Treatment Period|Unspecified|0
222173|NCT01704287|727965|P1|Initial Treatment Period|Unspecified|1
222174|NCT01704287|727961|P5|Initial Treatment Period|Withdrawal by Subject|0
222175|NCT01704287|727962|P4|Initial Treatment Period|Withdrawal by Subject|0
222176|NCT01704287|727963|P3|Initial Treatment Period|Withdrawal by Subject|4
222177|NCT01704287|727964|P2|Initial Treatment Period|Withdrawal by Subject|1
222178|NCT01704287|727965|P1|Initial Treatment Period|Withdrawal by Subject|1
222179|NCT01704287|727961|P5|Initial Treatment Period|Death|0
222180|NCT01704287|727962|P4|Initial Treatment Period|Death|0
222181|NCT01704287|727963|P3|Initial Treatment Period|Death|30
222182|NCT01704287|727964|P2|Initial Treatment Period|Death|117
222183|NCT01704287|727965|P1|Initial Treatment Period|Death|123
222184|NCT01704261|728000|P2|Overall Study|Lost to Follow-up|0
222185|NCT01704261|728001|P1|Overall Study|Lost to Follow-up|1
222186|NCT01704261|728000|P2|Overall Study|Withdrawal by Subject|15
222187|NCT01704261|728001|P1|Overall Study|Withdrawal by Subject|12
222188|NCT01704079|728028|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
222189|NCT01704079|728029|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
222190|NCT01704079|728028|P2|Overall Study|Subject noncompliance|3
222191|NCT01704079|728029|P1|Overall Study|Subject noncompliance|2
222192|NCT01704079|728028|P2|Overall Study|Protocol Violation|0
222193|NCT01704079|728029|P1|Overall Study|Protocol Violation|1
222194|NCT01704079|728028|P2|Overall Study|Adverse Event|7
222195|NCT01704079|728029|P1|Overall Study|Adverse Event|4
222196|NCT01704079|728028|P2|Overall Study|Lost to Follow-up|5
222197|NCT01704079|728029|P1|Overall Study|Lost to Follow-up|2
222198|NCT01704079|728028|P2|Overall Study|Withdrawal by Subject|7
222199|NCT01704079|728029|P1|Overall Study|Withdrawal by Subject|5
222200|NCT01703988|728045|P4|Overall Study|Investigator Judgment|1
222201|NCT01703988|728046|P3|Overall Study|Investigator Judgment|0
222202|NCT01703988|728047|P2|Overall Study|Investigator Judgment|0
222203|NCT01703988|728048|P1|Overall Study|Investigator Judgment|0
222204|NCT01703858|728078|P3|Overall Study|Withdrawal by Subject|0
222205|NCT01703858|728079|P2|Overall Study|Withdrawal by Subject|1
222206|NCT01703858|728080|P1|Overall Study|Withdrawal by Subject|0
222207|NCT01703845|728105|P2|Overall Study|other than stated above|0
222208|NCT01703845|728106|P1|Overall Study|other than stated above|1
222210|NCT01703845|728106|P1|Overall Study|Protocol Violation|1
222211|NCT01703845|728105|P2|Overall Study|Adverse Event|0
222212|NCT01703845|728106|P1|Overall Study|Adverse Event|1
222213|NCT01703832|728143|P2|Overall Study|Withdrawal by Subject|0
222214|NCT01703832|728144|P1|Overall Study|Withdrawal by Subject|1
222215|NCT01703819|728176|P2|Overall Study|Withdrawal by Subject|1
222216|NCT01703819|728177|P1|Overall Study|Withdrawal by Subject|0
222217|NCT01703819|728176|P2|Overall Study|Adverse Event|1
222218|NCT01703819|728177|P1|Overall Study|Adverse Event|0
222219|NCT01703286|728234|P6|Period 2 Including Washout|Adverse Event|0
222220|NCT01703286|728235|P5|Period 2 Including Washout|Adverse Event|0
222221|NCT01703286|728236|P4|Period 2 Including Washout|Adverse Event|1
222222|NCT01703286|728237|P3|Period 2 Including Washout|Adverse Event|0
222223|NCT01703286|728238|P2|Period 2 Including Washout|Adverse Event|0
222224|NCT01703286|728239|P1|Period 2 Including Washout|Adverse Event|0
222225|NCT01703286|728234|P6|Period 1 Including Washout|Withdrawal by Subject|1
222226|NCT01703286|728235|P5|Period 1 Including Washout|Withdrawal by Subject|0
222227|NCT01703286|728236|P4|Period 1 Including Washout|Withdrawal by Subject|1
222228|NCT01703286|728237|P3|Period 1 Including Washout|Withdrawal by Subject|0
222229|NCT01703286|728238|P2|Period 1 Including Washout|Withdrawal by Subject|0
222230|NCT01703286|728239|P1|Period 1 Including Washout|Withdrawal by Subject|0
222231|NCT01703260|728262|P3|Overall Study|Study Termination|0
222232|NCT01703260|728263|P2|Overall Study|Study Termination|2
222233|NCT01703260|728264|P1|Overall Study|Study Termination|1
222234|NCT01703260|728262|P3|Overall Study|Withdrawal by Subject|1
222235|NCT01703260|728263|P2|Overall Study|Withdrawal by Subject|0
222236|NCT01703260|728264|P1|Overall Study|Withdrawal by Subject|0
222237|NCT01703260|728262|P3|Overall Study|Lost to Follow-up|0
222238|NCT01703260|728263|P2|Overall Study|Lost to Follow-up|0
222239|NCT01703260|728264|P1|Overall Study|Lost to Follow-up|1
222240|NCT01703260|728262|P3|Overall Study|Adverse Event|2
222241|NCT01703260|728263|P2|Overall Study|Adverse Event|2
222242|NCT01703260|728264|P1|Overall Study|Adverse Event|1
222243|NCT01703221|728290|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
222244|NCT01703221|728291|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
222245|NCT01703221|728292|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
222246|NCT01703221|728290|P3|Phase B - (Week 25 to 52)|Adverse Event|2
222247|NCT01703221|728291|P2|Phase B - (Week 25 to 52)|Adverse Event|3
222248|NCT01703221|728292|P1|Phase B - (Week 25 to 52)|Adverse Event|2
222249|NCT01703221|728290|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
222250|NCT01703221|728291|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
222251|NCT01703221|728292|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
222252|NCT01703221|728290|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
222253|NCT01703221|728291|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
222254|NCT01703221|728292|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
222255|NCT01703221|728290|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
222256|NCT01703221|728291|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
222257|NCT01703221|728292|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
222258|NCT01703221|728290|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
222259|NCT01703221|728291|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
222260|NCT01703221|728292|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
222261|NCT01703221|728290|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
222262|NCT01703221|728291|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
222263|NCT01703221|728292|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
222264|NCT01703221|728290|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
222265|NCT01703221|728291|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
222266|NCT01703221|728292|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
222267|NCT01703091|728323|P2|Overall Study|Sponsor Decision|0
222268|NCT01703091|728324|P1|Overall Study|Sponsor Decision|1
222269|NCT01703091|728323|P2|Overall Study|Withdrawal by Subject|0
222270|NCT01703091|728324|P1|Overall Study|Withdrawal by Subject|1
222271|NCT01703091|728323|P2|Overall Study|Physician Decision|1
222272|NCT01703091|728324|P1|Overall Study|Physician Decision|2
222273|NCT01703091|728323|P2|Overall Study|Adverse Event|3
222274|NCT01703091|728324|P1|Overall Study|Adverse Event|5
222275|NCT01703000|728340|P1|Overall Study|Death|1
222276|NCT01702987|728373|P2|Overall Study|Withdrawal by Subject|0
222277|NCT01702987|728374|P1|Overall Study|Withdrawal by Subject|1
222278|NCT01702961|728380|P1|Overall Study|Ongoing|11
222279|NCT01702961|728380|P1|Overall Study|Lost to Follow-up|2
222280|NCT01702961|728380|P1|Overall Study|Death|6
222281|NCT01702961|728380|P1|Overall Study|Relapse|20
222282|NCT01702961|728380|P1|Overall Study|Progressive disease|5
222283|NCT01702961|728380|P1|Overall Study|Additional treatment|3
222284|NCT01702532|728388|P2|Overall Study|Adverse Event|1
222285|NCT01702532|728389|P1|Overall Study|Adverse Event|0
222286|NCT01702519|728399|P2|Washout Period|Withdrawal by Subject|2
222287|NCT01702519|728400|P1|Washout Period|Withdrawal by Subject|0
222288|NCT01702519|728399|P2|Washout Period|Lost to Follow-up|0
222289|NCT01702519|728400|P1|Washout Period|Lost to Follow-up|1
222290|NCT01702454|728418|P2|Overall Study|Lost to Follow-up|6
222291|NCT01702454|728419|P1|Overall Study|Lost to Follow-up|3
222292|NCT01702454|728418|P2|Overall Study|Migrated/moved from study area|1
222293|NCT01702454|728419|P1|Overall Study|Migrated/moved from study area|0
222294|NCT01702454|728418|P2|Overall Study|Consent withdrawal|1
222295|NCT01702454|728419|P1|Overall Study|Consent withdrawal|0
222296|NCT01702363|728497|P1|Overall Study|Withdrawal by Subject|2
222297|NCT01702363|728497|P1|Overall Study|Lack of Efficacy|4
222298|NCT01702363|728497|P1|Overall Study|Adverse Event|14
222299|NCT01702311|728514|P2|Overall Study|Physician Decision|4
222300|NCT01702311|728515|P1|Overall Study|Physician Decision|3
222301|NCT01702311|728514|P2|Overall Study|Discharge less than 24 hours|7
222302|NCT01702311|728515|P1|Overall Study|Discharge less than 24 hours|10
222303|NCT01702311|728514|P2|Overall Study|Withdrawal by Subject|2
222304|NCT01702311|728515|P1|Overall Study|Withdrawal by Subject|3
222305|NCT01702298|728521|P1|Overall Study|Withdrawal by Subject|1
222306|NCT01702246|728549|P1|Overall Study|Physician Decision|1
222307|NCT01702246|728549|P1|Overall Study|Withdrawal by Subject|2
222308|NCT01702246|728549|P1|Overall Study|Lost to Follow-up|2
222309|NCT01702025|728603|P4|Overall Study|Adverse Event|0
222310|NCT01702025|728604|P3|Overall Study|Adverse Event|1
222311|NCT01702025|728605|P2|Overall Study|Adverse Event|1
222312|NCT01702025|728606|P1|Overall Study|Adverse Event|1
222313|NCT01702025|728603|P4|Overall Study|Equipment failure|0
222314|NCT01702025|728604|P3|Overall Study|Equipment failure|0
222315|NCT01702025|728605|P2|Overall Study|Equipment failure|0
222316|NCT01702025|728606|P1|Overall Study|Equipment failure|1
222317|NCT01701674|728635|P1|Overall Study|Unable to safely complete treatment|1
222318|NCT01701401|728658|P4|Overall Study|Protocol Violation|0
222319|NCT01701401|728659|P3|Overall Study|Protocol Violation|1
222320|NCT01701401|728660|P2|Overall Study|Protocol Violation|0
222321|NCT01701401|728661|P1|Overall Study|Protocol Violation|0
222322|NCT01701401|728658|P4|Overall Study|Adverse Event|0
222323|NCT01701401|728659|P3|Overall Study|Adverse Event|0
222324|NCT01701401|728660|P2|Overall Study|Adverse Event|0
222325|NCT01701401|728661|P1|Overall Study|Adverse Event|1
222326|NCT01701401|728658|P4|Overall Study|Lack of Efficacy|0
222327|NCT01701401|728659|P3|Overall Study|Lack of Efficacy|2
222328|NCT01701401|728660|P2|Overall Study|Lack of Efficacy|0
222329|NCT01701401|728661|P1|Overall Study|Lack of Efficacy|1
222330|NCT01701401|728658|P4|Overall Study|Withdrew Consent|2
222331|NCT01701401|728659|P3|Overall Study|Withdrew Consent|1
222332|NCT01701401|728660|P2|Overall Study|Withdrew Consent|3
222333|NCT01701401|728661|P1|Overall Study|Withdrew Consent|0
222334|NCT01701401|728658|P4|Overall Study|Lost to Follow-up|3
222335|NCT01701401|728659|P3|Overall Study|Lost to Follow-up|1
222336|NCT01701401|728660|P2|Overall Study|Lost to Follow-up|5
222337|NCT01701401|728661|P1|Overall Study|Lost to Follow-up|5
222338|NCT01701401|728658|P4|Overall Study|Randomized But Not Treated|1
222339|NCT01701401|728659|P3|Overall Study|Randomized But Not Treated|0
222340|NCT01701401|728660|P2|Overall Study|Randomized But Not Treated|1
222341|NCT01701401|728661|P1|Overall Study|Randomized But Not Treated|3
222342|NCT01701362|728713|P2|Overall Study|Reasons other than those mentioned above|5
222343|NCT01701362|728714|P1|Overall Study|Reasons other than those mentioned above|3
222344|NCT01701362|728713|P2|Overall Study|Randomized but not treated|2
222345|NCT01701362|728714|P1|Overall Study|Randomized but not treated|1
222346|NCT01701362|728713|P2|Overall Study|Death|1
222347|NCT01701362|728714|P1|Overall Study|Death|0
222348|NCT01701362|728713|P2|Overall Study|Insufficient clinical response|6
222349|NCT01701362|728714|P1|Overall Study|Insufficient clinical response|6
222350|NCT01701362|728713|P2|Overall Study|Lost to Follow-up|9
222351|NCT01701362|728714|P1|Overall Study|Lost to Follow-up|6
222352|NCT01701362|728713|P2|Overall Study|No longer willing to participate|14
222353|NCT01701362|728714|P1|Overall Study|No longer willing to participate|8
222354|NCT01701362|728713|P2|Overall Study|Protocol Violation|3
222355|NCT01701362|728714|P1|Overall Study|Protocol Violation|5
222356|NCT01701362|728713|P2|Overall Study|Adverse events related to study drug|10
222357|NCT01701362|728714|P1|Overall Study|Adverse events related to study drug|12
222358|NCT01701362|728713|P2|Overall Study|Adverse events not related to study drug|6
222359|NCT01701362|728714|P1|Overall Study|Adverse events not related to study drug|1
222360|NCT01701245|728750|P2|Overall Study|Did not complete the open label period|12
222361|NCT01701245|728751|P1|Overall Study|Did not complete the open label period|11
222362|NCT01701245|728750|P2|Overall Study|Protocol Violation|3
222363|NCT01701245|728751|P1|Overall Study|Protocol Violation|1
222364|NCT01701063|728783|P3|Overall Study|Unspecified|1
222365|NCT01701063|728784|P2|Overall Study|Unspecified|0
222366|NCT01701063|728785|P1|Overall Study|Unspecified|0
222367|NCT01701063|728783|P3|Overall Study|Withdrawal by Subject|1
222368|NCT01701063|728784|P2|Overall Study|Withdrawal by Subject|0
222369|NCT01701063|728785|P1|Overall Study|Withdrawal by Subject|0
222370|NCT01701063|728783|P3|Overall Study|Lost to Follow-up|0
222371|NCT01701063|728784|P2|Overall Study|Lost to Follow-up|1
222372|NCT01701063|728785|P1|Overall Study|Lost to Follow-up|0
222373|NCT01699685|728888|P2|Period 2|Lost to Follow-up|0
222374|NCT01699685|728889|P1|Period 2|Lost to Follow-up|1
222375|NCT01699685|728888|P2|Period 1|Patient request|1
222376|NCT01699685|728889|P1|Period 1|Patient request|0
222377|NCT01699685|728888|P2|Period 1|Other|1
222378|NCT01699685|728889|P1|Period 1|Other|0
222379|NCT01699685|728888|P2|Period 1|Medical or ethical, noncompliance|0
222380|NCT01699685|728889|P1|Period 1|Medical or ethical, noncompliance|2
222381|NCT01699685|728888|P2|Period 1|Adverse Event|1
222382|NCT01699685|728889|P1|Period 1|Adverse Event|1
222383|NCT01700530|728916|P3|Overall Study|Withdrawal by Subject|1
222384|NCT01700530|728917|P2|Overall Study|Withdrawal by Subject|3
222385|NCT01700530|728918|P1|Overall Study|Withdrawal by Subject|0
222386|NCT01700387|728944|P2|Overall Study|Lost to Follow-up|1
222387|NCT01700387|728945|P1|Overall Study|Lost to Follow-up|2
222388|NCT01700387|728944|P2|Overall Study|Adverse Event|1
222389|NCT01700387|728945|P1|Overall Study|Adverse Event|1
222390|NCT01700387|728944|P2|Overall Study|Withdrawal by Subject|2
222391|NCT01700387|728945|P1|Overall Study|Withdrawal by Subject|1
222392|NCT01700348|728955|P1|Overall Study|Lost to Follow-up|1
222393|NCT01700348|728955|P1|Overall Study|Withdrawal by Subject|22
222394|NCT01700192|728973|P2|Overall Study|Never received study drug|0
222395|NCT01700192|728974|P1|Overall Study|Never received study drug|1
222396|NCT01700192|728973|P2|Overall Study|Withdrawal by Subject|64
222397|NCT01700192|728974|P1|Overall Study|Withdrawal by Subject|56
222398|NCT01700192|728973|P2|Overall Study|Technical problems|1
222399|NCT01700192|728974|P1|Overall Study|Technical problems|0
222400|NCT01700192|728973|P2|Overall Study|Protocol Violation|4
222401|NCT01700192|728974|P1|Overall Study|Protocol Violation|3
222402|NCT01700192|728973|P2|Overall Study|Progressive disease|0
222403|NCT01700192|728974|P1|Overall Study|Progressive disease|1
222404|NCT01700192|728973|P2|Overall Study|Pregnancy|4
222405|NCT01700192|728974|P1|Overall Study|Pregnancy|1
222406|NCT01700192|728973|P2|Overall Study|Physician Decision|3
222407|NCT01700192|728974|P1|Overall Study|Physician Decision|2
222408|NCT01700192|728973|P2|Overall Study|Noncompliance with study drug|5
222409|NCT01700192|728974|P1|Overall Study|Noncompliance with study drug|0
222410|NCT01700192|728973|P2|Overall Study|Lost to Follow-up|29
222411|NCT01700192|728974|P1|Overall Study|Lost to Follow-up|42
222412|NCT01700192|728973|P2|Overall Study|Lack of Efficacy|0
222413|NCT01700192|728974|P1|Overall Study|Lack of Efficacy|1
222414|NCT01700192|728973|P2|Overall Study|Adverse Event|18
222415|NCT01700192|728974|P1|Overall Study|Adverse Event|73
222416|NCT01700179|728992|P1|Overall Study|Physician Decision|2
222417|NCT01700140|728999|P3|Overall Study|Inclusion/exclusion criteria deviation|0
222418|NCT01700140|729000|P2|Overall Study|Inclusion/exclusion criteria deviation|4
222419|NCT01700140|729001|P1|Overall Study|Inclusion/exclusion criteria deviation|1
222420|NCT01700140|728999|P3|Overall Study|Adverse Event|0
222421|NCT01700140|729000|P2|Overall Study|Adverse Event|1
222422|NCT01700140|729001|P1|Overall Study|Adverse Event|0
222423|NCT01700140|728999|P3|Overall Study|Aggravation of symptoms|0
222424|NCT01700140|729000|P2|Overall Study|Aggravation of symptoms|0
222425|NCT01700140|729001|P1|Overall Study|Aggravation of symptoms|1
222426|NCT01700140|728999|P3|Overall Study|Use of chemotherapy or surgical therapy|0
222427|NCT01700140|729000|P2|Overall Study|Use of chemotherapy or surgical therapy|1
222428|NCT01700140|729001|P1|Overall Study|Use of chemotherapy or surgical therapy|0
222429|NCT01700140|728999|P3|Overall Study|Discontinuation of radiotherapy|0
222430|NCT01700140|729000|P2|Overall Study|Discontinuation of radiotherapy|0
222431|NCT01700140|729001|P1|Overall Study|Discontinuation of radiotherapy|1
222432|NCT01700140|728999|P3|Overall Study|Use of rescue drugs|1
222433|NCT01700140|729000|P2|Overall Study|Use of rescue drugs|3
222434|NCT01700140|729001|P1|Overall Study|Use of rescue drugs|3
222435|NCT01699867|729033|P1|Overall Study|Screening Failure|3
222436|NCT01699815|729040|P2|Overall Study|Adverse Event|1
222437|NCT01699815|729041|P1|Overall Study|Adverse Event|0
222438|NCT01699815|729040|P2|Overall Study|record could not be located|0
222439|NCT01699815|729041|P1|Overall Study|record could not be located|1
222440|NCT01699815|729040|P2|Overall Study|Protocol Violation|7
222441|NCT01699815|729041|P1|Overall Study|Protocol Violation|4
222442|NCT01699789|729053|P2|Overall Study|Lost to Follow-up|101
222443|NCT01699789|729054|P1|Overall Study|Lost to Follow-up|83
222444|NCT01699789|729053|P2|Overall Study|Death|2
222445|NCT01699789|729054|P1|Overall Study|Death|1
222446|NCT01699789|729053|P2|Overall Study|Withdrawal by Subject|23
222447|NCT01699789|729054|P1|Overall Study|Withdrawal by Subject|18
222448|NCT01699750|729124|P2|Overall Study|Other|2
222449|NCT01699750|729125|P1|Overall Study|Other|0
222450|NCT01699750|729124|P2|Overall Study|Withdrew Consent|1
222451|NCT01699750|729125|P1|Overall Study|Withdrew Consent|0
222452|NCT01699087|729156|P1|Overall Study|Unable to make future visits|2
222453|NCT01699087|729156|P1|Overall Study|Screen failure (prior to treatment)|15
222454|NCT01699087|729156|P1|Overall Study|Lost to Follow-up|7
222455|NCT01699022|729170|P1|Overall Study|Early discontinuation from the study|3
222456|NCT01698814|729185|P2|Overall Study|Randomized in error|0
222457|NCT01698814|729186|P1|Overall Study|Randomized in error|1
222458|NCT01698814|729185|P2|Overall Study|Pregnancy|0
222459|NCT01698814|729186|P1|Overall Study|Pregnancy|1
222460|NCT01698814|729185|P2|Overall Study|Lost to Follow-up|1
222461|NCT01698814|729186|P1|Overall Study|Lost to Follow-up|0
222462|NCT01698814|729185|P2|Overall Study|Adverse Event|2
222463|NCT01698814|729186|P1|Overall Study|Adverse Event|0
222464|NCT01698801|729192|P1|Follow Up Phase|Death|4
222465|NCT01698801|729192|P1|Follow Up Phase|Withdrawal by Subject|1
222466|NCT01698801|729192|P1|Treatment Phase|Disease progression|1
222467|NCT01698801|729192|P1|Treatment Phase|Withdrawal by Subject|1
222468|NCT01698801|729192|P1|Treatment Phase|Not specified|4
222469|NCT01698801|729192|P1|Treatment Phase|Protocol Violation|1
222470|NCT01698801|729192|P1|Treatment Phase|Adverse Event|4
222471|NCT01698775|729203|P2|Phase B|Withdrawal by Subject|2
222472|NCT01698775|729204|P1|Phase B|Withdrawal by Subject|6
222473|NCT01698775|729203|P2|Phase B|Protocol Violation|1
222474|NCT01698775|729204|P1|Phase B|Protocol Violation|1
222475|NCT01698775|729203|P2|Phase B|Physician Decision|1
222476|NCT01698775|729204|P1|Phase B|Physician Decision|1
222477|NCT01698775|729203|P2|Phase B|Lost to Follow-up|1
222478|NCT01698775|729204|P1|Phase B|Lost to Follow-up|0
222479|NCT01698775|729203|P2|Phase B|Lack of Efficacy|1
222480|NCT01698775|729204|P1|Phase B|Lack of Efficacy|0
222481|NCT01698775|729203|P2|Phase B|Death|1
222482|NCT01698775|729204|P1|Phase B|Death|0
222483|NCT01698775|729203|P2|Phase B|Adverse Event|3
222484|NCT01698775|729204|P1|Phase B|Adverse Event|6
222485|NCT01698775|729203|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
222486|NCT01698775|729204|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
222487|NCT01698775|729203|P2|Phase A|Kidney [transplant]|1
222488|NCT01698775|729204|P1|Phase A|Kidney [transplant]|0
222489|NCT01698775|729203|P2|Phase A|Withdrawal by Subject|4
222490|NCT01698775|729204|P1|Phase A|Withdrawal by Subject|3
222491|NCT01698775|729203|P2|Phase A|Protocol Violation|0
222492|NCT01698775|729204|P1|Phase A|Protocol Violation|1
222493|NCT01698775|729203|P2|Phase A|Lost to Follow-up|2
222494|NCT01698775|729204|P1|Phase A|Lost to Follow-up|1
222495|NCT01698775|729203|P2|Phase A|Lack of Efficacy|0
222496|NCT01698775|729204|P1|Phase A|Lack of Efficacy|1
222497|NCT01698775|729203|P2|Phase A|Death|1
222498|NCT01698775|729204|P1|Phase A|Death|1
222499|NCT01698775|729203|P2|Phase A|Adverse Event|1
222500|NCT01698775|729204|P1|Phase A|Adverse Event|2
222501|NCT01698554|729247|P4|Overall Study|Other Miscellaneous Reasons|0
222502|NCT01698554|729248|P3|Overall Study|Other Miscellaneous Reasons|0
222503|NCT01698554|729249|P2|Overall Study|Other Miscellaneous Reasons|0
222504|NCT01698554|729250|P1|Overall Study|Other Miscellaneous Reasons|1
222505|NCT01698554|729247|P4|Overall Study|Protocol Violation|0
222506|NCT01698554|729248|P3|Overall Study|Protocol Violation|1
222507|NCT01698554|729249|P2|Overall Study|Protocol Violation|0
222508|NCT01698554|729250|P1|Overall Study|Protocol Violation|2
222509|NCT01698554|729247|P4|Overall Study|Personal Reasons|1
222510|NCT01698554|729248|P3|Overall Study|Personal Reasons|1
222511|NCT01698554|729249|P2|Overall Study|Personal Reasons|5
222512|NCT01698554|729250|P1|Overall Study|Personal Reasons|0
222513|NCT01698554|729247|P4|Overall Study|Lost to Follow-up|0
222514|NCT01698554|729248|P3|Overall Study|Lost to Follow-up|0
222515|NCT01698554|729249|P2|Overall Study|Lost to Follow-up|0
222516|NCT01698554|729250|P1|Overall Study|Lost to Follow-up|1
222517|NCT01698554|729247|P4|Overall Study|Adverse Event|1
222518|NCT01698554|729248|P3|Overall Study|Adverse Event|0
222519|NCT01698554|729249|P2|Overall Study|Adverse Event|5
222520|NCT01698554|729250|P1|Overall Study|Adverse Event|2
222521|NCT01698320|729289|P3|40-Week Open-Label Period|Lost to Follow-up|0
222522|NCT01698320|729290|P2|40-Week Open-Label Period|Lost to Follow-up|2
222523|NCT01698320|729291|P1|40-Week Open-Label Period|Lost to Follow-up|0
222524|NCT01698320|729289|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
222525|NCT01698320|729290|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
222526|NCT01698320|729291|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
222527|NCT01698320|729289|P3|40-Week Open-Label Period|Pregnancy|1
222528|NCT01698320|729290|P2|40-Week Open-Label Period|Pregnancy|2
222529|NCT01698320|729291|P1|40-Week Open-Label Period|Pregnancy|0
222530|NCT01698320|729289|P3|40-Week Open-Label Period|Withdrawal by Subject|7
222531|NCT01698320|729290|P2|40-Week Open-Label Period|Withdrawal by Subject|11
222532|NCT01698320|729291|P1|40-Week Open-Label Period|Withdrawal by Subject|0
222533|NCT01698320|729289|P3|40-Week Open-Label Period|Adverse Event|2
222534|NCT01698320|729290|P2|40-Week Open-Label Period|Adverse Event|3
222535|NCT01698320|729291|P1|40-Week Open-Label Period|Adverse Event|0
222536|NCT01698320|729289|P3|12-Week Double-Blind Period|Lost to Follow-up|4
222537|NCT01698320|729290|P2|12-Week Double-Blind Period|Lost to Follow-up|0
222538|NCT01698320|729291|P1|12-Week Double-Blind Period|Lost to Follow-up|0
222539|NCT01698320|729289|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
222540|NCT01698320|729290|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
222541|NCT01698320|729291|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
222542|NCT01698320|729289|P3|12-Week Double-Blind Period|Pregnancy|1
222543|NCT01698320|729290|P2|12-Week Double-Blind Period|Pregnancy|1
222544|NCT01698320|729291|P1|12-Week Double-Blind Period|Pregnancy|0
222545|NCT01698320|729289|P3|12-Week Double-Blind Period|Protocol Violation|2
222546|NCT01698320|729290|P2|12-Week Double-Blind Period|Protocol Violation|0
222547|NCT01698320|729291|P1|12-Week Double-Blind Period|Protocol Violation|0
222548|NCT01698320|729289|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
222549|NCT01698320|729290|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
222550|NCT01698320|729291|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
222551|NCT01698320|729289|P3|12-Week Double-Blind Period|Adverse Event|1
222552|NCT01698320|729290|P2|12-Week Double-Blind Period|Adverse Event|1
222553|NCT01698320|729291|P1|12-Week Double-Blind Period|Adverse Event|0
222554|NCT01698320|729289|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
222555|NCT01698320|729290|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
222556|NCT01698320|729291|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
222557|NCT01698320|729289|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
222558|NCT01698320|729290|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
222559|NCT01698320|729291|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
222560|NCT01698320|729289|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
222561|NCT01698320|729290|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
222562|NCT01698320|729291|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
222563|NCT01698320|729289|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
222564|NCT01698320|729290|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
222565|NCT01698320|729291|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
222566|NCT01697969|729309|P1|Overall Study|Did not meet inc/exc criteria|3
222567|NCT01697956|729316|P2|Overall Study|Protocol Violation|1
222568|NCT01697956|729317|P1|Overall Study|Protocol Violation|1
222569|NCT01697696|729347|P2|Overall Study|Subject/guardian decision|35
222570|NCT01697696|729348|P1|Overall Study|Subject/guardian decision|31
222571|NCT01697696|729347|P2|Overall Study|Lost to Follow-up|7
222572|NCT01697696|729348|P1|Overall Study|Lost to Follow-up|10
222573|NCT01697696|729347|P2|Overall Study|Death|2
222574|NCT01697696|729348|P1|Overall Study|Death|4
222575|NCT01697696|729347|P2|Overall Study|Physician Decision|0
222576|NCT01697696|729348|P1|Overall Study|Physician Decision|1
222577|NCT01697696|729347|P2|Overall Study|Protocol deviation|0
222578|NCT01697696|729348|P1|Overall Study|Protocol deviation|1
222579|NCT01697696|729347|P2|Overall Study|Study terminated by sponsor|3
222580|NCT01697696|729348|P1|Overall Study|Study terminated by sponsor|0
222581|NCT01697592|729380|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
222582|NCT01697592|729381|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
222583|NCT01697592|729382|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
222584|NCT01697592|729383|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
222585|NCT01697592|729384|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
222586|NCT01697592|729385|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
222587|NCT01697592|729386|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
222588|NCT01697592|729387|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
222589|NCT01697592|729388|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
222590|NCT01697592|729389|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
222591|NCT01697592|729380|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
222592|NCT01697592|729381|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
222593|NCT01697592|729382|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
222594|NCT01697592|729383|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
222595|NCT01697592|729384|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
222596|NCT01697592|729385|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
222597|NCT01697592|729386|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
222598|NCT01697592|729387|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
222599|NCT01697592|729388|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
222600|NCT01697592|729389|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
222601|NCT01697592|729380|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
222602|NCT01697592|729381|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
222603|NCT01697592|729382|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
222604|NCT01697592|729383|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
222605|NCT01697592|729384|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
222606|NCT01697592|729385|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
222607|NCT01697592|729386|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
222608|NCT01697592|729387|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
222609|NCT01697592|729388|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
222610|NCT01697592|729389|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
222611|NCT01697592|729380|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
222612|NCT01697592|729381|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
222613|NCT01697592|729382|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
222614|NCT01697592|729383|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
222615|NCT01697592|729384|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
222616|NCT01697592|729385|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
222617|NCT01697592|729386|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
222618|NCT01697592|729387|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
222619|NCT01697592|729388|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
222620|NCT01697592|729389|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
222621|NCT01697592|729380|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
222622|NCT01697592|729381|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
222623|NCT01697592|729382|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
222624|NCT01697592|729383|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
222625|NCT01697592|729384|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
222626|NCT01697592|729385|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
222627|NCT01697592|729386|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
222628|NCT01697592|729387|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
222629|NCT01697592|729388|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
222630|NCT01697592|729389|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
222631|NCT01697592|729380|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
222632|NCT01697592|729381|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
222633|NCT01697592|729382|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
222634|NCT01697592|729383|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
222635|NCT01697592|729384|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
222636|NCT01697592|729385|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
222637|NCT01697592|729386|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
222638|NCT01697592|729387|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
222639|NCT01697592|729388|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
222640|NCT01697592|729389|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
222641|NCT01697592|729380|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
222642|NCT01697592|729381|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
222643|NCT01697592|729382|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
222644|NCT01697592|729383|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
222645|NCT01697592|729384|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
222646|NCT01697592|729385|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
222647|NCT01697592|729386|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
222648|NCT01697592|729387|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
222649|NCT01697592|729388|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
222650|NCT01697592|729389|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
222651|NCT01697592|729380|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
222652|NCT01697592|729381|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
222653|NCT01697592|729382|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
222654|NCT01697592|729383|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
222655|NCT01697592|729384|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
222656|NCT01697592|729385|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
222657|NCT01697592|729386|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
222658|NCT01697592|729387|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
222659|NCT01697592|729388|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
222660|NCT01697592|729389|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
222661|NCT01697501|729453|P1|Overall Study|Protocol Violation|2
222662|NCT01697462|729496|P1|Overall Study|Missing|5
222663|NCT01697462|729496|P1|Overall Study|Unspecified|10
222664|NCT01697462|729496|P1|Overall Study|Death|1
222665|NCT01697462|729496|P1|Overall Study|Investigator Decision|21
222666|NCT01697462|729496|P1|Overall Study|Withdrawal by Subject|12
222667|NCT01697462|729496|P1|Overall Study|Lost to Follow-up|21
222668|NCT01697462|729496|P1|Overall Study|Adverse Event|6
222669|NCT01697462|729496|P1|Overall Study|Disease Progression|1
222670|NCT01697449|729503|P1|Overall Study|Missing|25
222671|NCT01697449|729503|P1|Overall Study|Unspecified|1
222672|NCT01697449|729503|P1|Overall Study|Death|2
222673|NCT01697449|729503|P1|Overall Study|Physician Decision|1
222674|NCT01697449|729503|P1|Overall Study|Withdrawal by Subject|2
222675|NCT01697449|729503|P1|Overall Study|Lost to Follow-up|5
222676|NCT01697449|729503|P1|Overall Study|Adverse Event|7
222677|NCT01697449|729503|P1|Overall Study|Disease progression|47
222678|NCT01697358|729514|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
222679|NCT01697358|729515|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
222680|NCT01697358|729514|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
222681|NCT01697358|729515|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
222682|NCT01697358|729514|P2|Period II: 6-24M Long-term Follow-up|Death|1
222683|NCT01697358|729515|P1|Period II: 6-24M Long-term Follow-up|Death|1
222684|NCT01697358|729514|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
222685|NCT01697358|729515|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
222686|NCT01697358|729514|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
222687|NCT01697358|729515|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
222688|NCT01697358|729514|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
222689|NCT01697358|729515|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
222690|NCT01697358|729514|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
222691|NCT01697358|729515|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
222692|NCT01697358|729514|P2|Period I: Randomization to 6 Months|Adverse Event|1
222693|NCT01697358|729515|P1|Period I: Randomization to 6 Months|Adverse Event|1
222694|NCT01697358|729514|P2|Period I: Randomization to 6 Months|Physician Decision|0
222695|NCT01697358|729515|P1|Period I: Randomization to 6 Months|Physician Decision|4
222696|NCT01697358|729514|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
222697|NCT01697358|729515|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
222698|NCT01697345|729531|P1|Overall Study|Withdrawal by Subject|1
222699|NCT01697319|729550|P1|Extension Phase|Terminated by Sponsor|15
222700|NCT01697319|729550|P1|Primary Phase|Withdrawal by Subject|1
222701|NCT01696994|729559|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
222702|NCT01696994|729560|P1|Overall Study|Refused Screen (Ovarian Screening)|0
222703|NCT01696994|729559|P2|Overall Study|Refused ASU (Control)|0
222704|NCT01696994|729560|P1|Overall Study|Refused ASU (Control)|311
222705|NCT01696994|729559|P2|Overall Study|No Ovaries at Baseline|4851
222706|NCT01696994|729560|P1|Overall Study|No Ovaries at Baseline|4807
222707|NCT01696994|729559|P2|Overall Study|Died Before ASU (Control)|0
222708|NCT01696994|729560|P1|Overall Study|Died Before ASU (Control)|73
222709|NCT01696994|729559|P2|Overall Study|Died Before Randomization|2
222710|NCT01696994|729560|P1|Overall Study|Died Before Randomization|1
222711|NCT01696994|729559|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
222885|NCT01692782|730205|P3|Overall Study|SAE not related to study drug|0
222712|NCT01696994|729560|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
222713|NCT01696981|729588|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
222714|NCT01696981|729589|P1|Overall Study|Refused Screen (Colorectal Screening)|0
222715|NCT01696981|729588|P2|Overall Study|Refused ASU (Control)|0
222716|NCT01696981|729589|P1|Overall Study|Refused ASU (Control)|920
222717|NCT01696981|729588|P2|Overall Study|Died Before ASU (Control)|0
222718|NCT01696981|729589|P1|Overall Study|Died Before ASU (Control)|278
222719|NCT01696981|729588|P2|Overall Study|Died Before Randomization|8
222720|NCT01696981|729589|P1|Overall Study|Died Before Randomization|3
222721|NCT01696981|729588|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
222722|NCT01696981|729589|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
222723|NCT01696968|729609|P2|Overall Study|Refused Screen (Lung Screening)|6796
222724|NCT01696968|729610|P1|Overall Study|Refused Screen (Lung Screening)|0
222725|NCT01696968|729609|P2|Overall Study|Refused ASU (Control)|0
222726|NCT01696968|729610|P1|Overall Study|Refused ASU (Control)|920
222727|NCT01696968|729609|P2|Overall Study|Died Before ASU (Control)|0
222728|NCT01696968|729610|P1|Overall Study|Died Before ASU (Control)|278
222729|NCT01696968|729609|P2|Overall Study|Died Before Randomization|8
222730|NCT01696968|729610|P1|Overall Study|Died Before Randomization|3
222731|NCT01696968|729609|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
222732|NCT01696968|729610|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
222733|NCT01696929|729630|P1|Overall Study|Physician Decision|1
222734|NCT01696773|729637|P2|Days 15-27, Washout|Adverse Event|0
222735|NCT01696773|729638|P1|Days 15-27, Washout|Adverse Event|1
222736|NCT01696695|729665|P1|Overall Study|Major Protocol Violation|192
222737|NCT01696695|729665|P1|Overall Study|Unspecified|74
222738|NCT01696695|729665|P1|Overall Study|Lost to Follow-up|48
222739|NCT01696695|729665|P1|Overall Study|Withdrawal by Subject|92
222740|NCT01696695|729665|P1|Overall Study|Adverse Event|74
222741|NCT01696695|729665|P1|Overall Study|Death|29
222742|NCT01696695|729665|P1|Overall Study|Disease progression|373
222743|NCT01696643|729677|P2|Overall Study|Participant Did Not Receive Study Drug|2
222744|NCT01696643|729678|P1|Overall Study|Participant Did Not Receive Study Drug|2
222745|NCT01696643|729677|P2|Overall Study|Medical Monitor Decision|2
222746|NCT01696643|729678|P1|Overall Study|Medical Monitor Decision|0
222747|NCT01696643|729677|P2|Overall Study|Participant Incarcerated|1
222748|NCT01696643|729678|P1|Overall Study|Participant Incarcerated|0
222749|NCT01696643|729677|P2|Overall Study|Site Error|1
222750|NCT01696643|729678|P1|Overall Study|Site Error|2
222751|NCT01696643|729677|P2|Overall Study|Participant on Restricted Bed Rest|0
222752|NCT01696643|729678|P1|Overall Study|Participant on Restricted Bed Rest|1
222753|NCT01696643|729677|P2|Overall Study|Withdrawal by Subject|149
222754|NCT01696643|729678|P1|Overall Study|Withdrawal by Subject|142
222755|NCT01696643|729677|P2|Overall Study|Study Terminated by Sponsor|294
222756|NCT01696643|729678|P1|Overall Study|Study Terminated by Sponsor|286
222757|NCT01696643|729677|P2|Overall Study|Protocol Violation|7
222758|NCT01696643|729678|P1|Overall Study|Protocol Violation|7
222759|NCT01696643|729677|P2|Overall Study|Pregnancy|1
222760|NCT01696643|729678|P1|Overall Study|Pregnancy|0
222761|NCT01696643|729677|P2|Overall Study|Physician Decision|2
222762|NCT01696643|729678|P1|Overall Study|Physician Decision|3
222763|NCT01696643|729677|P2|Overall Study|Lost to Follow-up|67
222764|NCT01696643|729678|P1|Overall Study|Lost to Follow-up|67
222765|NCT01696643|729677|P2|Overall Study|Lack of Efficacy|0
222766|NCT01696643|729678|P1|Overall Study|Lack of Efficacy|3
222767|NCT01696643|729677|P2|Overall Study|Death|2
222768|NCT01696643|729678|P1|Overall Study|Death|1
222769|NCT01696643|729677|P2|Overall Study|Adverse Event|7
222770|NCT01696643|729678|P1|Overall Study|Adverse Event|15
222771|NCT01696214|729706|P4|Overall Study|Lost to Follow-up|0
222772|NCT01696214|729707|P3|Overall Study|Lost to Follow-up|0
222773|NCT01696214|729708|P2|Overall Study|Lost to Follow-up|1
222774|NCT01696214|729709|P1|Overall Study|Lost to Follow-up|0
222775|NCT01696188|729721|P2|Overall Study|Protocol Violation|1
222776|NCT01696188|729722|P1|Overall Study|Protocol Violation|1
222777|NCT01696071|729734|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
222778|NCT01696071|729735|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
222779|NCT01696058|729763|P2|Overall Study|Other reason prematurely discontinued|3
222780|NCT01696058|729764|P1|Overall Study|Other reason prematurely discontinued|5
222781|NCT01696058|729763|P2|Overall Study|Withdrawal by Subject|6
222782|NCT01696058|729764|P1|Overall Study|Withdrawal by Subject|4
222783|NCT01696058|729763|P2|Overall Study|Lost to Follow-up|5
222784|NCT01696058|729764|P1|Overall Study|Lost to Follow-up|2
222785|NCT01696058|729763|P2|Overall Study|Protocol Violation|3
222786|NCT01696058|729764|P1|Overall Study|Protocol Violation|9
222787|NCT01696058|729763|P2|Overall Study|Lack of Efficacy|3
222788|NCT01696058|729764|P1|Overall Study|Lack of Efficacy|2
222789|NCT01696058|729763|P2|Overall Study|Adverse Event|11
222790|NCT01696058|729764|P1|Overall Study|Adverse Event|21
222791|NCT01695772|729790|P1|Overall Study|Unspecified Reason|1
222792|NCT01695772|729790|P1|Overall Study|Protocol Violation|2
222793|NCT01695772|729790|P1|Overall Study|Lost to Follow-up|4
222794|NCT01695772|729790|P1|Overall Study|Investigator Decision|5
222795|NCT01695772|729790|P1|Overall Study|Progressive Disease|8
222796|NCT01695772|729790|P1|Overall Study|Withdrawal by Subject|18
222797|NCT01695746|729802|P1|Overall Study|Participant not willing to participate|3
222798|NCT01695746|729802|P1|Overall Study|Protocol Violation|5
222799|NCT01695746|729802|P1|Overall Study|Non-compliance by the participant|3
222800|NCT01695746|729802|P1|Overall Study|Adverse Event|1
222801|NCT01695239|729851|P4|Overall Study|Protocol Violation|0
222802|NCT01695239|729852|P3|Overall Study|Protocol Violation|0
222803|NCT01695239|729853|P2|Overall Study|Protocol Violation|0
222804|NCT01695239|729854|P1|Overall Study|Protocol Violation|1
222805|NCT01695239|729851|P4|Overall Study|Lost to Follow-up|0
222806|NCT01695239|729852|P3|Overall Study|Lost to Follow-up|0
222807|NCT01695239|729853|P2|Overall Study|Lost to Follow-up|0
222808|NCT01695239|729854|P1|Overall Study|Lost to Follow-up|1
222809|NCT01695239|729851|P4|Overall Study|Sponsor Decision|0
222810|NCT01695239|729852|P3|Overall Study|Sponsor Decision|1
222811|NCT01695239|729853|P2|Overall Study|Sponsor Decision|0
222812|NCT01695239|729854|P1|Overall Study|Sponsor Decision|3
222813|NCT01695239|729851|P4|Overall Study|Withdrawal by Subject|0
222814|NCT01695239|729852|P3|Overall Study|Withdrawal by Subject|1
222815|NCT01695239|729853|P2|Overall Study|Withdrawal by Subject|1
222816|NCT01695239|729854|P1|Overall Study|Withdrawal by Subject|3
222817|NCT01695239|729851|P4|Overall Study|Lack of Efficacy|0
222818|NCT01695239|729852|P3|Overall Study|Lack of Efficacy|2
222819|NCT01695239|729853|P2|Overall Study|Lack of Efficacy|0
222820|NCT01695239|729854|P1|Overall Study|Lack of Efficacy|4
222821|NCT01695239|729851|P4|Overall Study|Adverse Event|3
222822|NCT01695239|729852|P3|Overall Study|Adverse Event|2
222823|NCT01695239|729853|P2|Overall Study|Adverse Event|2
222824|NCT01695239|729854|P1|Overall Study|Adverse Event|2
222825|NCT01695239|729851|P4|Overall Study|Entry Criteria Not Met|3
222826|NCT01695239|729852|P3|Overall Study|Entry Criteria Not Met|3
222827|NCT01695239|729853|P2|Overall Study|Entry Criteria Not Met|1
222828|NCT01695239|729854|P1|Overall Study|Entry Criteria Not Met|1
222829|NCT01695239|729851|P4|Overall Study|On Study Treatment|0
222830|NCT01695239|729852|P3|Overall Study|On Study Treatment|1
222831|NCT01695239|729853|P2|Overall Study|On Study Treatment|0
222832|NCT01695239|729854|P1|Overall Study|On Study Treatment|0
222833|NCT01694771|729957|P2|Overall Study|Other reasons|6
222834|NCT01694771|729958|P1|Overall Study|Other reasons|5
222835|NCT01694771|729957|P2|Overall Study|Consent withdrawn|9
222836|NCT01694771|729958|P1|Overall Study|Consent withdrawn|7
222837|NCT01694771|729957|P2|Overall Study|Lost to Follow-up|3
222838|NCT01694771|729958|P1|Overall Study|Lost to Follow-up|2
222839|NCT01694771|729957|P2|Overall Study|Non compliance protocol|6
222840|NCT01694771|729958|P1|Overall Study|Non compliance protocol|7
222841|NCT01694771|729957|P2|Overall Study|Lack of Efficacy|0
222842|NCT01694771|729958|P1|Overall Study|Lack of Efficacy|1
222843|NCT01694771|729957|P2|Overall Study|Adverse Event|16
222844|NCT01694771|729958|P1|Overall Study|Adverse Event|18
222845|NCT01694706|729982|P3|Overall Study|other reason not defined above|0
222846|NCT01694706|729983|P2|Overall Study|other reason not defined above|0
222847|NCT01694706|729984|P1|Overall Study|other reason not defined above|1
222848|NCT01694706|729982|P3|Overall Study|Adverse Event|0
222849|NCT01694706|729983|P2|Overall Study|Adverse Event|1
222850|NCT01694706|729984|P1|Overall Study|Adverse Event|0
222851|NCT01694420|730027|P1|Overall Study|Lost to Follow-up|3
222852|NCT01693367|730140|P2|Overall Study|Physician Decision|1
222853|NCT01693367|730141|P1|Overall Study|Physician Decision|0
222854|NCT01693367|730140|P2|Overall Study|Withdrawal by Subject|1
222855|NCT01693367|730141|P1|Overall Study|Withdrawal by Subject|1
222856|NCT01693185|730159|P2|Overall Study|diagnostic procedure after colonoscopy|6
222857|NCT01693185|730160|P1|Overall Study|diagnostic procedure after colonoscopy|0
222858|NCT01693029|730178|P2|Overall Study|Non-compliance|1
222859|NCT01693029|730179|P1|Overall Study|Non-compliance|2
222860|NCT01693029|730178|P2|Overall Study|Death|8
222861|NCT01693029|730179|P1|Overall Study|Death|5
222862|NCT01693029|730178|P2|Overall Study|Adverse Event|6
222863|NCT01693029|730179|P1|Overall Study|Adverse Event|1
222864|NCT01693029|730178|P2|Overall Study|Lost to Follow-up|1
222865|NCT01693029|730179|P1|Overall Study|Lost to Follow-up|0
222866|NCT01693029|730178|P2|Overall Study|Physician Decision|2
222867|NCT01693029|730179|P1|Overall Study|Physician Decision|0
222868|NCT01693029|730178|P2|Overall Study|Change in dialysis modality|1
222869|NCT01693029|730179|P1|Overall Study|Change in dialysis modality|2
222870|NCT01693029|730178|P2|Overall Study|Protocol Violation|7
222871|NCT01693029|730179|P1|Overall Study|Protocol Violation|6
222872|NCT01693029|730178|P2|Overall Study|Bindinging anti-EPO antibodies|2
222873|NCT01693029|730179|P1|Overall Study|Bindinging anti-EPO antibodies|6
222874|NCT01693029|730178|P2|Overall Study|Kidney transplantation|7
222875|NCT01693029|730179|P1|Overall Study|Kidney transplantation|7
222876|NCT01693029|730178|P2|Overall Study|Withdrawal by Subject|22
222877|NCT01693029|730179|P1|Overall Study|Withdrawal by Subject|15
222878|NCT01692938|730193|P2|Overall Study|Study completed prior to site completion|3
222879|NCT01692938|730194|P1|Overall Study|Study completed prior to site completion|3
222880|NCT01692938|730193|P2|Overall Study|Protocol Deviation|1
222881|NCT01692938|730194|P1|Overall Study|Protocol Deviation|1
222882|NCT01692782|730205|P3|Overall Study|Withdrawal by Subject|3
222883|NCT01692782|730206|P2|Overall Study|Withdrawal by Subject|10
222884|NCT01692782|730207|P1|Overall Study|Withdrawal by Subject|3
222886|NCT01692782|730206|P2|Overall Study|SAE not related to study drug|1
222887|NCT01692782|730207|P1|Overall Study|SAE not related to study drug|0
222888|NCT01692782|730205|P3|Overall Study|Non-compliant with study visits|1
222889|NCT01692782|730206|P2|Overall Study|Non-compliant with study visits|0
222890|NCT01692782|730207|P1|Overall Study|Non-compliant with study visits|0
222891|NCT01692782|730205|P3|Overall Study|Non-complance with study drug|1
222892|NCT01692782|730206|P2|Overall Study|Non-complance with study drug|4
222893|NCT01692782|730207|P1|Overall Study|Non-complance with study drug|0
222894|NCT01692782|730205|P3|Overall Study|Protocol Violation|2
222895|NCT01692782|730206|P2|Overall Study|Protocol Violation|0
222896|NCT01692782|730207|P1|Overall Study|Protocol Violation|1
222897|NCT01692782|730205|P3|Overall Study|Pregnancy|0
222898|NCT01692782|730206|P2|Overall Study|Pregnancy|0
222899|NCT01692782|730207|P1|Overall Study|Pregnancy|1
222900|NCT01692782|730205|P3|Overall Study|Lost to Follow-up|1
222901|NCT01692782|730206|P2|Overall Study|Lost to Follow-up|7
222902|NCT01692782|730207|P1|Overall Study|Lost to Follow-up|2
222903|NCT01692782|730205|P3|Overall Study|Lack of Efficacy|0
222904|NCT01692782|730206|P2|Overall Study|Lack of Efficacy|2
222905|NCT01692782|730207|P1|Overall Study|Lack of Efficacy|1
222906|NCT01692782|730205|P3|Overall Study|Adverse Event|2
222907|NCT01692782|730206|P2|Overall Study|Adverse Event|32
222908|NCT01692782|730207|P1|Overall Study|Adverse Event|12
222909|NCT01692626|730235|P2|Overall Study|Withdrawal by Subject|0
222910|NCT01692626|730236|P1|Overall Study|Withdrawal by Subject|1
222911|NCT01692626|730235|P2|Overall Study|Protocol Violation|2
222912|NCT01692626|730236|P1|Overall Study|Protocol Violation|1
222913|NCT01692626|730235|P2|Overall Study|Adverse Event|3
222914|NCT01692626|730236|P1|Overall Study|Adverse Event|2
222915|NCT01692626|730235|P2|Overall Study|Death|1
222916|NCT01692626|730236|P1|Overall Study|Death|0
222917|NCT01692301|730265|P2|Overall Study|Lost to Follow-up|1
222918|NCT01692301|730266|P1|Overall Study|Lost to Follow-up|1
222919|NCT01692301|730265|P2|Overall Study|Physician Decision|2
222920|NCT01692301|730266|P1|Overall Study|Physician Decision|2
222921|NCT01692301|730265|P2|Overall Study|Technical problems|1
222922|NCT01692301|730266|P1|Overall Study|Technical problems|0
222923|NCT01692301|730265|P2|Overall Study|Patient/guardian decision|15
222924|NCT01692301|730266|P1|Overall Study|Patient/guardian decision|16
222925|NCT01692301|730265|P2|Overall Study|Protocol deviation|2
222926|NCT01692301|730266|P1|Overall Study|Protocol deviation|9
222927|NCT01692301|730265|P2|Overall Study|Non-compliance with study treatment|2
222928|NCT01692301|730266|P1|Overall Study|Non-compliance with study treatment|1
222929|NCT01692301|730265|P2|Overall Study|Lack of Efficacy|5
222930|NCT01692301|730266|P1|Overall Study|Lack of Efficacy|0
222931|NCT01692301|730265|P2|Overall Study|Death|2
222932|NCT01692301|730266|P1|Overall Study|Death|1
222933|NCT01692301|730265|P2|Overall Study|Adverse Event|12
222934|NCT01692301|730266|P1|Overall Study|Adverse Event|15
222935|NCT01691885|730292|P2|Washout Period (7-9 Days)|Adverse Event|1
222936|NCT01691885|730293|P1|Washout Period (7-9 Days)|Adverse Event|0
222937|NCT01691885|730292|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
222938|NCT01691885|730293|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
222939|NCT01691794|730302|P3|Overall Study|Poor compliance/noncompliance|1
222940|NCT01691794|730303|P2|Overall Study|Poor compliance/noncompliance|0
222941|NCT01691794|730304|P1|Overall Study|Poor compliance/noncompliance|0
222942|NCT01691794|730302|P3|Overall Study|Lack of Efficacy|1
222943|NCT01691794|730303|P2|Overall Study|Lack of Efficacy|1
222944|NCT01691794|730304|P1|Overall Study|Lack of Efficacy|0
222945|NCT01691794|730302|P3|Overall Study|No longer meets study criteria|0
222946|NCT01691794|730303|P2|Overall Study|No longer meets study criteria|2
222947|NCT01691794|730304|P1|Overall Study|No longer meets study criteria|0
222948|NCT01691794|730302|P3|Overall Study|Adverse Event|1
222949|NCT01691794|730303|P2|Overall Study|Adverse Event|0
222950|NCT01691794|730304|P1|Overall Study|Adverse Event|0
222951|NCT01691521|730435|P3|Overall Study|Withdrawal by Subject|4
222952|NCT01691521|730436|P2|Overall Study|Withdrawal by Subject|9
222953|NCT01691521|730437|P1|Overall Study|Withdrawal by Subject|5
222954|NCT01691521|730435|P3|Overall Study|Physician Decision|0
222955|NCT01691521|730436|P2|Overall Study|Physician Decision|1
222956|NCT01691521|730437|P1|Overall Study|Physician Decision|2
222957|NCT01691521|730435|P3|Overall Study|Lost to Follow-up|2
222958|NCT01691521|730436|P2|Overall Study|Lost to Follow-up|2
222959|NCT01691521|730437|P1|Overall Study|Lost to Follow-up|0
222960|NCT01691521|730435|P3|Overall Study|Protocol Violation|0
222961|NCT01691521|730436|P2|Overall Study|Protocol Violation|3
222962|NCT01691521|730437|P1|Overall Study|Protocol Violation|0
222963|NCT01691521|730435|P3|Overall Study|Lack of Efficacy|2
222964|NCT01691521|730436|P2|Overall Study|Lack of Efficacy|1
222965|NCT01691521|730437|P1|Overall Study|Lack of Efficacy|1
222966|NCT01691521|730435|P3|Overall Study|Adverse Event|1
222967|NCT01691521|730436|P2|Overall Study|Adverse Event|0
222968|NCT01691521|730437|P1|Overall Study|Adverse Event|4
222969|NCT01691508|730459|P2|Overall Study|Withdrawal by Subject|0
222970|NCT01691508|730460|P1|Overall Study|Withdrawal by Subject|1
222971|NCT01691508|730459|P2|Overall Study|Adverse Event|3
222972|NCT01691508|730460|P1|Overall Study|Adverse Event|3
222973|NCT01691482|730474|P2|Treatment Period 2|Protocol Violation|1
222974|NCT01691482|730475|P1|Treatment Period 2|Protocol Violation|1
222975|NCT01691482|730474|P2|Treatment Period 2|Adverse Event|1
222976|NCT01691482|730475|P1|Treatment Period 2|Adverse Event|0
222977|NCT01691248|730564|P2|Overall Study|Not Treated|7
222978|NCT01691248|730565|P1|Overall Study|Not Treated|4
222979|NCT01691248|730564|P2|Overall Study|Reason not provided|4
222980|NCT01691248|730565|P1|Overall Study|Reason not provided|4
222981|NCT01691248|730564|P2|Overall Study|Lost to Follow-up|5
222982|NCT01691248|730565|P1|Overall Study|Lost to Follow-up|2
222983|NCT01691248|730564|P2|Overall Study|Confirmed CDAD|31
222984|NCT01691248|730565|P1|Overall Study|Confirmed CDAD|14
222985|NCT01691248|730564|P2|Overall Study|Withdrawal by Subject|18
222986|NCT01691248|730565|P1|Overall Study|Withdrawal by Subject|20
222987|NCT01691248|730564|P2|Overall Study|Adverse Event|22
222988|NCT01691248|730565|P1|Overall Study|Adverse Event|24
222989|NCT01691248|730564|P2|Overall Study|Protocol Violation|27
222990|NCT01691248|730565|P1|Overall Study|Protocol Violation|43
222991|NCT01691092|730575|P1|Overall Study|screen fail|19
222992|NCT01691092|730575|P1|Overall Study|used for different study|2
222993|NCT01691092|730575|P1|Overall Study|non-compliance|3
222994|NCT01691092|730575|P1|Overall Study|Withdrawal by Subject|3
222995|NCT01691092|730575|P1|Overall Study|Physician Decision|4
222996|NCT01691092|730575|P1|Overall Study|Lost to Follow-up|10
222997|NCT01691014|730583|P4|Overall Study|Lack of Efficacy|0
222998|NCT01691014|730584|P3|Overall Study|Lack of Efficacy|7
222999|NCT01691014|730585|P2|Overall Study|Lack of Efficacy|3
223000|NCT01691014|730586|P1|Overall Study|Lack of Efficacy|2
223001|NCT01691014|730583|P4|Overall Study|Adverse Event|1
223002|NCT01691014|730584|P3|Overall Study|Adverse Event|1
223003|NCT01691014|730585|P2|Overall Study|Adverse Event|5
223004|NCT01691014|730586|P1|Overall Study|Adverse Event|0
223005|NCT01691014|730583|P4|Overall Study|Withdrawal by Subject|1
223006|NCT01691014|730584|P3|Overall Study|Withdrawal by Subject|1
223007|NCT01691014|730585|P2|Overall Study|Withdrawal by Subject|1
223008|NCT01691014|730586|P1|Overall Study|Withdrawal by Subject|0
223009|NCT01691014|730583|P4|Overall Study|Unspecified|0
223010|NCT01691014|730584|P3|Overall Study|Unspecified|2
223011|NCT01691014|730585|P2|Overall Study|Unspecified|0
223012|NCT01691014|730586|P1|Overall Study|Unspecified|0
223013|NCT01691014|730583|P4|Overall Study|Premature Termination|3
223014|NCT01691014|730584|P3|Overall Study|Premature Termination|0
223015|NCT01691014|730585|P2|Overall Study|Premature Termination|6
223016|NCT01691014|730586|P1|Overall Study|Premature Termination|1
223017|NCT01690299|730671|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
223018|NCT01690299|730672|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
223019|NCT01690299|730673|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
223020|NCT01690299|730674|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
223021|NCT01690299|730675|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
223022|NCT01690299|730676|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
223023|NCT01690299|730671|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
223024|NCT01690299|730672|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
223025|NCT01690299|730673|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
223026|NCT01690299|730674|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
223027|NCT01690299|730675|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
223028|NCT01690299|730676|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
223029|NCT01690299|730671|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
223030|NCT01690299|730672|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
223031|NCT01690299|730673|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
223032|NCT01690299|730674|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
223033|NCT01690299|730675|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
223034|NCT01690299|730676|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
223035|NCT01690299|730671|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
223036|NCT01690299|730672|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
223037|NCT01690299|730673|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
223038|NCT01690299|730674|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
223039|NCT01690299|730675|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
223040|NCT01690299|730676|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
223041|NCT01690299|730671|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
223042|NCT01690299|730672|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
223043|NCT01690299|730673|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
223044|NCT01690299|730674|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
223045|NCT01690299|730675|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
223046|NCT01690299|730676|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
223047|NCT01690299|730671|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
223048|NCT01690299|730672|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
223049|NCT01690299|730673|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
223050|NCT01690299|730674|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
223051|NCT01690299|730675|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
223052|NCT01690299|730676|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
223053|NCT01690299|730671|P6|Placebo-controlled Phase (Weeks 0-16)|Unspecified|0
223054|NCT01690299|730672|P5|Placebo-controlled Phase (Weeks 0-16)|Unspecified|0
223055|NCT01690299|730673|P4|Placebo-controlled Phase (Weeks 0-16)|Unspecified|0
223056|NCT01690299|730674|P3|Placebo-controlled Phase (Weeks 0-16)|Unspecified|1
223057|NCT01690299|730675|P2|Placebo-controlled Phase (Weeks 0-16)|Unspecified|1
223058|NCT01690299|730676|P1|Placebo-controlled Phase (Weeks 0-16)|Unspecified|2
223059|NCT01690299|730671|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
223060|NCT01690299|730672|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
223061|NCT01690299|730673|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
223062|NCT01690299|730674|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
223063|NCT01690299|730675|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
223064|NCT01690299|730676|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
223065|NCT01690299|730671|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
223066|NCT01690299|730672|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
223067|NCT01690299|730673|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
223068|NCT01690299|730674|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
223069|NCT01690299|730675|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
223070|NCT01690299|730676|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
223071|NCT01690299|730671|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
223072|NCT01690299|730672|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
223073|NCT01690299|730673|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
223074|NCT01690299|730674|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
223075|NCT01690299|730675|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
223076|NCT01690299|730676|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
223077|NCT01690052|730812|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
223078|NCT01690052|730813|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
223079|NCT01689857|730830|P2|Overall Study|Lost to Follow-up|2
223080|NCT01689857|730831|P1|Overall Study|Lost to Follow-up|5
223081|NCT01689649|730837|P1|Overall Study|Lost to Follow-up|5
223082|NCT01689649|730837|P1|Overall Study|Protocol Violation|3
223083|NCT01689649|730837|P1|Overall Study|Non-compliance|11
223084|NCT01689649|730837|P1|Overall Study|Lack of Efficacy|3
223085|NCT01689532|730849|P2|Overall Study|Physician Decision|0
223086|NCT01689532|730850|P1|Overall Study|Physician Decision|2
223087|NCT01689532|730849|P2|Overall Study|Withdrawal by Subject|2
223088|NCT01689532|730850|P1|Overall Study|Withdrawal by Subject|1
223089|NCT01689532|730849|P2|Overall Study|Lack of Efficacy|2
223090|NCT01689532|730850|P1|Overall Study|Lack of Efficacy|2
223091|NCT01689532|730849|P2|Overall Study|Adverse Event|5
223092|NCT01689532|730850|P1|Overall Study|Adverse Event|9
223093|NCT01689519|730914|P2|Overall Study|Physician Decision|3
223094|NCT01689519|730915|P1|Overall Study|Physician Decision|0
223095|NCT01689519|730914|P2|Overall Study|Withdrawal by Subject|17
223096|NCT01689519|730915|P1|Overall Study|Withdrawal by Subject|17
223097|NCT01689519|730914|P2|Overall Study|Lost to Follow-up|2
223098|NCT01689519|730915|P1|Overall Study|Lost to Follow-up|6
223099|NCT01689519|730914|P2|Overall Study|Death|116
223100|NCT01689519|730915|P1|Overall Study|Death|143
223101|NCT01689363|730942|P8|Overall Study|Protocol Violation|0
223102|NCT01689363|730943|P7|Overall Study|Protocol Violation|0
223103|NCT01689363|730944|P6|Overall Study|Protocol Violation|0
223104|NCT01689363|730945|P5|Overall Study|Protocol Violation|0
223105|NCT01689363|730946|P4|Overall Study|Protocol Violation|0
223106|NCT01689363|730947|P3|Overall Study|Protocol Violation|0
223107|NCT01689363|730948|P2|Overall Study|Protocol Violation|1
223108|NCT01689363|730949|P1|Overall Study|Protocol Violation|0
223109|NCT01689337|731004|P1|Overall Study|Study Discontinuation|1
223110|NCT01689207|731043|P11|Overall Study|Adverse Event|0
223111|NCT01689207|731044|P10|Overall Study|Adverse Event|0
223112|NCT01689207|731045|P9|Overall Study|Adverse Event|1
223113|NCT01689207|731046|P8|Overall Study|Adverse Event|0
223114|NCT01689207|731047|P7|Overall Study|Adverse Event|0
223115|NCT01689207|731048|P6|Overall Study|Adverse Event|1
223116|NCT01689207|731049|P5|Overall Study|Adverse Event|2
223117|NCT01689207|731050|P4|Overall Study|Adverse Event|0
223118|NCT01689207|731051|P3|Overall Study|Adverse Event|0
223119|NCT01689207|731052|P2|Overall Study|Adverse Event|1
223120|NCT01689207|731053|P1|Overall Study|Adverse Event|0
223121|NCT01688921|731160|P2|Overall Study|informed consent|0
223122|NCT01688921|731161|P1|Overall Study|informed consent|3
223123|NCT01688921|731160|P2|Overall Study|Protocol Violation|1
223124|NCT01688921|731161|P1|Overall Study|Protocol Violation|0
223125|NCT01688921|731160|P2|Overall Study|Physician Decision|1
223126|NCT01688921|731161|P1|Overall Study|Physician Decision|6
223127|NCT01688921|731160|P2|Overall Study|Lost to Follow-up|13
223128|NCT01688921|731161|P1|Overall Study|Lost to Follow-up|7
223129|NCT01688882|731186|P2|Overall Study|Administrative problems|0
223130|NCT01688882|731187|P1|Overall Study|Administrative problems|1
223131|NCT01688882|731186|P2|Overall Study|Unsatisfactory therapeutic effect|1
223132|NCT01688882|731187|P1|Overall Study|Unsatisfactory therapeutic effect|1
223133|NCT01688882|731186|P2|Overall Study|Adverse Event|0
223134|NCT01688882|731187|P1|Overall Study|Adverse Event|1
223135|NCT01688830|731222|P21|Overall Study|Lost to Follow-up|0
223136|NCT01688830|731223|P20|Overall Study|Lost to Follow-up|0
223137|NCT01688830|731224|P19|Overall Study|Lost to Follow-up|0
223138|NCT01688830|731225|P18|Overall Study|Lost to Follow-up|0
223139|NCT01688830|731226|P17|Overall Study|Lost to Follow-up|0
223140|NCT01688830|731227|P16|Overall Study|Lost to Follow-up|0
223141|NCT01688830|731228|P15|Overall Study|Lost to Follow-up|0
223142|NCT01688830|731229|P14|Overall Study|Lost to Follow-up|0
223143|NCT01688830|731230|P13|Overall Study|Lost to Follow-up|0
223144|NCT01688830|731231|P12|Overall Study|Lost to Follow-up|0
223145|NCT01688830|731232|P11|Overall Study|Lost to Follow-up|1
223146|NCT01688830|731233|P10|Overall Study|Lost to Follow-up|0
223147|NCT01688830|731234|P9|Overall Study|Lost to Follow-up|0
223148|NCT01688830|731235|P8|Overall Study|Lost to Follow-up|0
223149|NCT01688830|731236|P7|Overall Study|Lost to Follow-up|0
223150|NCT01688830|731237|P6|Overall Study|Lost to Follow-up|0
223151|NCT01688830|731238|P5|Overall Study|Lost to Follow-up|0
223152|NCT01688830|731239|P4|Overall Study|Lost to Follow-up|0
223153|NCT01688830|731240|P3|Overall Study|Lost to Follow-up|0
223154|NCT01688830|731241|P2|Overall Study|Lost to Follow-up|0
223155|NCT01688830|731242|P1|Overall Study|Lost to Follow-up|0
223156|NCT01688726|731388|P2|Overall Study|Relocated abroad|1
223157|NCT01688726|731389|P1|Overall Study|Relocated abroad|0
223158|NCT01688726|731388|P2|Overall Study|Adverse Event|0
223159|NCT01688726|731389|P1|Overall Study|Adverse Event|1
223160|NCT01688635|731401|P2|Washout 3|Withdrawal by Subject|0
223161|NCT01688635|731402|P1|Washout 3|Withdrawal by Subject|1
223162|NCT01688635|731401|P2|Washout 2|Sponsor Decision|2
223163|NCT01688635|731402|P1|Washout 2|Sponsor Decision|1
223164|NCT01688635|731401|P2|Washout 2|Withdrawal by Subject|0
223165|NCT01688635|731402|P1|Washout 2|Withdrawal by Subject|1
223166|NCT01688635|731401|P2|Washout 2|Physician Decision|0
223167|NCT01688635|731402|P1|Washout 2|Physician Decision|1
223168|NCT01688635|731401|P2|Washout 1|Physician Decision|1
223169|NCT01688635|731402|P1|Washout 1|Physician Decision|0
223170|NCT01688635|731401|P2|Washout 1|Adverse Event|1
223171|NCT01688635|731402|P1|Washout 1|Adverse Event|0
223172|NCT01688635|731401|P2|Washout 1|Withdrawal by Subject|0
223173|NCT01688635|731402|P1|Washout 1|Withdrawal by Subject|1
223174|NCT01688050|731444|P1|Overall Study|Still be eligible for follow-up|37
223175|NCT01688050|731444|P1|Overall Study|Withdrawal by Subject|2
223176|NCT01688050|731444|P1|Overall Study|Lost to Follow-up|5
223177|NCT01688050|731444|P1|Overall Study|Conversion to open repair|1
223178|NCT01688050|731444|P1|Overall Study|Death|5
223179|NCT01687270|731455|P1|Overall Study|Lost to Follow-up|1
223180|NCT01687270|731455|P1|Overall Study|Lack of Efficacy|11
223181|NCT01687257|731466|P3|Overall Study|Investigator's Discretion|0
223182|NCT01687257|731467|P2|Overall Study|Investigator's Discretion|3
223183|NCT01687257|731468|P1|Overall Study|Investigator's Discretion|0
223184|NCT01687257|731466|P3|Overall Study|Adverse Event|0
223185|NCT01687257|731467|P2|Overall Study|Adverse Event|0
223186|NCT01687257|731468|P1|Overall Study|Adverse Event|1
223187|NCT01687257|731466|P3|Overall Study|Subject Withdrew Consent|1
223188|NCT01687257|731467|P2|Overall Study|Subject Withdrew Consent|1
223189|NCT01687257|731468|P1|Overall Study|Subject Withdrew Consent|1
223190|NCT01687257|731466|P3|Overall Study|Efficacy Failure|5
223191|NCT01687257|731467|P2|Overall Study|Efficacy Failure|0
223192|NCT01687257|731468|P1|Overall Study|Efficacy Failure|6
223193|NCT01687218|731533|P6|Overall Study|Relocated, no follow-up planned|0
223194|NCT01687218|731534|P5|Overall Study|Relocated, no follow-up planned|0
223195|NCT01687218|731535|P4|Overall Study|Relocated, no follow-up planned|1
223196|NCT01687218|731536|P3|Overall Study|Relocated, no follow-up planned|1
223197|NCT01687218|731537|P2|Overall Study|Relocated, no follow-up planned|0
223198|NCT01687218|731538|P1|Overall Study|Relocated, no follow-up planned|1
223199|NCT01687218|731533|P6|Overall Study|Withdrawal by Subject|0
223200|NCT01687218|731534|P5|Overall Study|Withdrawal by Subject|1
223201|NCT01687218|731535|P4|Overall Study|Withdrawal by Subject|1
223202|NCT01687218|731536|P3|Overall Study|Withdrawal by Subject|0
223203|NCT01687218|731537|P2|Overall Study|Withdrawal by Subject|3
223204|NCT01687218|731538|P1|Overall Study|Withdrawal by Subject|2
223205|NCT01687101|731562|P1|Overall Study|Lost to Follow-up|7
223206|NCT01686932|731589|P2|Period 1|Adverse Event|1
223207|NCT01686932|731590|P1|Period 1|Adverse Event|1
223208|NCT01686828|731620|P4|Overall Study|Weight Loss|0
223209|NCT01686828|731621|P3|Overall Study|Weight Loss|1
223210|NCT01686828|731622|P2|Overall Study|Weight Loss|0
223211|NCT01686828|731623|P1|Overall Study|Weight Loss|0
223212|NCT01686828|731620|P4|Overall Study|New Job|0
223213|NCT01686828|731621|P3|Overall Study|New Job|0
223214|NCT01686828|731622|P2|Overall Study|New Job|1
223215|NCT01686828|731623|P1|Overall Study|New Job|0
223216|NCT01686828|731620|P4|Overall Study|Physician Decision|0
223217|NCT01686828|731621|P3|Overall Study|Physician Decision|0
223218|NCT01686828|731622|P2|Overall Study|Physician Decision|0
223219|NCT01686828|731623|P1|Overall Study|Physician Decision|1
223220|NCT01686633|731697|P3|Overall Study|Lost to Follow-up|1
223221|NCT01686633|731698|P2|Overall Study|Lost to Follow-up|1
223222|NCT01686633|731699|P1|Overall Study|Lost to Follow-up|0
223223|NCT01686633|731697|P3|Overall Study|Protocol-defined Stopping Criteria|1
223224|NCT01686633|731698|P2|Overall Study|Protocol-defined Stopping Criteria|0
223225|NCT01686633|731699|P1|Overall Study|Protocol-defined Stopping Criteria|1
223226|NCT01686633|731697|P3|Overall Study|Protocol Violation|0
223227|NCT01686633|731698|P2|Overall Study|Protocol Violation|3
223228|NCT01686633|731699|P1|Overall Study|Protocol Violation|2
223229|NCT01686633|731697|P3|Overall Study|Adverse Event|3
223230|NCT01686633|731698|P2|Overall Study|Adverse Event|3
223231|NCT01686633|731699|P1|Overall Study|Adverse Event|4
223232|NCT01686633|731697|P3|Overall Study|Physician Decision|4
223233|NCT01686633|731698|P2|Overall Study|Physician Decision|4
223234|NCT01686633|731699|P1|Overall Study|Physician Decision|3
223235|NCT01686633|731697|P3|Overall Study|Withdrawal by Subject|5
223236|NCT01686633|731698|P2|Overall Study|Withdrawal by Subject|8
223237|NCT01686633|731699|P1|Overall Study|Withdrawal by Subject|8
223238|NCT01686633|731697|P3|Overall Study|Lack of Efficacy|11
223239|NCT01686633|731698|P2|Overall Study|Lack of Efficacy|13
223240|NCT01686633|731699|P1|Overall Study|Lack of Efficacy|33
223241|NCT01686568|731724|P2|Sub-Study|Not consented for sub-study|2
223242|NCT01686568|731725|P1|Sub-Study|Not consented for sub-study|2
223243|NCT01686568|731724|P2|Main Study|Liver enzymes above range of exclusion|0
223244|NCT01686568|731725|P1|Main Study|Liver enzymes above range of exclusion|1
223245|NCT01686568|731724|P2|Main Study|Noncompliance with protocol|1
223246|NCT01686568|731725|P1|Main Study|Noncompliance with protocol|0
223247|NCT01686568|731724|P2|Main Study|Withdrawal by Subject|3
223248|NCT01686568|731725|P1|Main Study|Withdrawal by Subject|1
223249|NCT01685983|731810|P1|Overall Study|Unspecified|7
223250|NCT01685983|731810|P1|Overall Study|Noncompliance with Study Drug|1
223251|NCT01685983|731810|P1|Overall Study|Physician Decision|13
223252|NCT01685983|731810|P1|Overall Study|Progressive Disease|32
223253|NCT01685983|731810|P1|Overall Study|Protocol Violation|2
223254|NCT01685983|731810|P1|Overall Study|Withdrawal by Subject|19
223255|NCT01685983|731810|P1|Overall Study|Death|1
223256|NCT01685983|731810|P1|Overall Study|Adverse Event|7
223257|NCT01685801|731824|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
223258|NCT01685801|731825|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
223259|NCT01685801|731826|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
223260|NCT01685801|731827|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
223261|NCT01685801|731824|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
223262|NCT01685801|731825|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
223263|NCT01685801|731826|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
223264|NCT01685801|731827|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
223265|NCT01685606|731875|P1|Overall Study|Withdrawal by Subject|1
223266|NCT01685437|731888|P1|Overall Study|Unable to make visits due to work|1
223267|NCT01685437|731888|P1|Overall Study|Protocol Violation|4
223268|NCT01685437|731888|P1|Overall Study|Adverse Event|1
223269|NCT01685437|731888|P1|Overall Study|Lost to Follow-up|3
223270|NCT01685437|731888|P1|Overall Study|Withdrawal by Subject|22
223271|NCT01685216|731911|P1|Overall Study|Did not receive study drug|1
223272|NCT01685203|731928|P7|Overall Study|Patient's decision|0
223273|NCT01685203|731929|P6|Overall Study|Patient's decision|1
223274|NCT01685203|731930|P5|Overall Study|Patient's decision|0
223275|NCT01685203|731931|P4|Overall Study|Patient's decision|0
223276|NCT01685203|731932|P3|Overall Study|Patient's decision|0
223277|NCT01685203|731933|P2|Overall Study|Patient's decision|0
223278|NCT01685203|731934|P1|Overall Study|Patient's decision|0
223279|NCT01685203|731928|P7|Overall Study|Adverse event and withdrew consent|0
223280|NCT01685203|731929|P6|Overall Study|Adverse event and withdrew consent|0
223281|NCT01685203|731930|P5|Overall Study|Adverse event and withdrew consent|0
223282|NCT01685203|731931|P4|Overall Study|Adverse event and withdrew consent|0
223283|NCT01685203|731932|P3|Overall Study|Adverse event and withdrew consent|0
223284|NCT01685203|731933|P2|Overall Study|Adverse event and withdrew consent|0
223285|NCT01685203|731934|P1|Overall Study|Adverse event and withdrew consent|1
223286|NCT01685203|731928|P7|Overall Study|Adverse Event|0
223287|NCT01685203|731929|P6|Overall Study|Adverse Event|2
223288|NCT01685203|731930|P5|Overall Study|Adverse Event|0
223289|NCT01685203|731931|P4|Overall Study|Adverse Event|0
223290|NCT01685203|731932|P3|Overall Study|Adverse Event|0
223291|NCT01685203|731933|P2|Overall Study|Adverse Event|0
223292|NCT01685203|731934|P1|Overall Study|Adverse Event|0
223293|NCT01685203|731928|P7|Overall Study|Lost to Follow-up|0
223294|NCT01685203|731929|P6|Overall Study|Lost to Follow-up|0
223295|NCT01685203|731930|P5|Overall Study|Lost to Follow-up|0
223296|NCT01685203|731931|P4|Overall Study|Lost to Follow-up|1
223297|NCT01685203|731932|P3|Overall Study|Lost to Follow-up|0
223298|NCT01685203|731933|P2|Overall Study|Lost to Follow-up|3
223299|NCT01685203|731934|P1|Overall Study|Lost to Follow-up|3
223300|NCT01685060|731978|P1|Overall Study|Death|8
223301|NCT01685060|731978|P1|Overall Study|Lost to Follow-up|1
223302|NCT01685060|731978|P1|Overall Study|Subject/guardian decision|20
223303|NCT01685060|731978|P1|Overall Study|Physician Decision|14
223304|NCT01685060|731978|P1|Overall Study|Progressive disease|69
223305|NCT01685060|731978|P1|Overall Study|Adverse Event|12
223306|NCT01685060|731978|P1|Overall Study|Rollover patients|16
223307|NCT01684930|731995|P2|Overall Study|Withdrawal by Subject|1
223308|NCT01684930|731996|P1|Overall Study|Withdrawal by Subject|3
223309|NCT01684878|732012|P4|Part 2: Randomized Phase|Participant noncompliance|1
223310|NCT01684878|732013|P3|Part 2: Randomized Phase|Participant noncompliance|0
223311|NCT01684878|732014|P2|Part 2: Randomized Phase|Participant noncompliance|0
223312|NCT01684878|732015|P1|Part 2: Randomized Phase|Participant noncompliance|0
223313|NCT01684878|732012|P4|Part 2: Randomized Phase|Alive at data-cut|7
223314|NCT01684878|732013|P3|Part 2: Randomized Phase|Alive at data-cut|13
223315|NCT01684878|732014|P2|Part 2: Randomized Phase|Alive at data-cut|0
223316|NCT01684878|732015|P1|Part 2: Randomized Phase|Alive at data-cut|0
223317|NCT01684878|732012|P4|Part 2: Randomized Phase|Death|68
223318|NCT01684878|732013|P3|Part 2: Randomized Phase|Death|62
223319|NCT01684878|732014|P2|Part 2: Randomized Phase|Death|0
223320|NCT01684878|732015|P1|Part 2: Randomized Phase|Death|0
223321|NCT01684878|732012|P4|Part 2: Randomized Phase|Lost to Follow-up|0
223322|NCT01684878|732013|P3|Part 2: Randomized Phase|Lost to Follow-up|2
223323|NCT01684878|732014|P2|Part 2: Randomized Phase|Lost to Follow-up|0
223324|NCT01684878|732015|P1|Part 2: Randomized Phase|Lost to Follow-up|0
223325|NCT01684878|732012|P4|Part 2: Randomized Phase|Participant withdrew consent|2
223326|NCT01684878|732013|P3|Part 2: Randomized Phase|Participant withdrew consent|1
223327|NCT01684878|732014|P2|Part 2: Randomized Phase|Participant withdrew consent|0
223328|NCT01684878|732015|P1|Part 2: Randomized Phase|Participant withdrew consent|0
223329|NCT01684878|732012|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
223330|NCT01684878|732013|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
223331|NCT01684878|732014|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
223332|NCT01684878|732015|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
223333|NCT01684878|732012|P4|Part 1: Safety Run in Phase|Death|0
223334|NCT01684878|732013|P3|Part 1: Safety Run in Phase|Death|0
223335|NCT01684878|732014|P2|Part 1: Safety Run in Phase|Death|20
223336|NCT01684878|732015|P1|Part 1: Safety Run in Phase|Death|15
223337|NCT01684878|732012|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
223338|NCT01684878|732013|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
223339|NCT01684878|732014|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
223340|NCT01684878|732015|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
223341|NCT01684215|732115|P4|Overall Study|Ongoing at date of cut-off|38
223342|NCT01684215|732116|P3|Overall Study|Ongoing at date of cut-off|4
223343|NCT01684215|732117|P2|Overall Study|Ongoing at date of cut-off|0
223344|NCT01684215|732118|P1|Overall Study|Ongoing at date of cut-off|0
223345|NCT01684215|732115|P4|Overall Study|Death|1
223346|NCT01684215|732116|P3|Overall Study|Death|0
223347|NCT01684215|732117|P2|Overall Study|Death|0
223348|NCT01684215|732118|P1|Overall Study|Death|0
223349|NCT01684215|732115|P4|Overall Study|Unspecified|0
223350|NCT01684215|732116|P3|Overall Study|Unspecified|1
223351|NCT01684215|732117|P2|Overall Study|Unspecified|0
223352|NCT01684215|732118|P1|Overall Study|Unspecified|0
223353|NCT01684215|732115|P4|Overall Study|Objective progression or relapse|0
223354|NCT01684215|732116|P3|Overall Study|Objective progression or relapse|0
223355|NCT01684215|732117|P2|Overall Study|Objective progression or relapse|6
223356|NCT01684215|732118|P1|Overall Study|Objective progression or relapse|5
223357|NCT01684215|732115|P4|Overall Study|Adverse Event|4
223358|NCT01684215|732116|P3|Overall Study|Adverse Event|1
223359|NCT01684215|732117|P2|Overall Study|Adverse Event|0
223360|NCT01684215|732118|P1|Overall Study|Adverse Event|1
223361|NCT01684046|732192|P2|Period 1, First 30 Days|Adverse Event|2
223362|NCT01684046|732193|P1|Period 1, First 30 Days|Adverse Event|0
223363|NCT01684033|732199|P2|Period 2, Second 30 Days|Adverse Event|0
223364|NCT01684033|732200|P1|Period 2, Second 30 Days|Adverse Event|1
223365|NCT01684033|732199|P2|Period 1, First 30 Days|Lost to Follow-up|0
223366|NCT01684033|732200|P1|Period 1, First 30 Days|Lost to Follow-up|1
223367|NCT01684033|732199|P2|Period 1, First 30 Days|Withdrawal by Subject|0
223368|NCT01684033|732200|P1|Period 1, First 30 Days|Withdrawal by Subject|1
223369|NCT01684033|732199|P2|Period 1, First 30 Days|Noncompliance|0
223370|NCT01684033|732200|P1|Period 1, First 30 Days|Noncompliance|1
223371|NCT01684033|732199|P2|Period 1, First 30 Days|Adverse Event|1
223372|NCT01684033|732200|P1|Period 1, First 30 Days|Adverse Event|1
223373|NCT01682876|732234|P4|Overall Study|Other|1
223374|NCT01682876|732235|P3|Overall Study|Other|1
223375|NCT01682876|732236|P2|Overall Study|Other|0
223376|NCT01682876|732237|P1|Overall Study|Other|1
223377|NCT01682876|732234|P4|Overall Study|Withdrawal by Subject|2
223378|NCT01682876|732235|P3|Overall Study|Withdrawal by Subject|0
223379|NCT01682876|732236|P2|Overall Study|Withdrawal by Subject|0
223380|NCT01682876|732237|P1|Overall Study|Withdrawal by Subject|4
223381|NCT01682876|732234|P4|Overall Study|Protocol Violation|1
223382|NCT01682876|732235|P3|Overall Study|Protocol Violation|1
223383|NCT01682876|732236|P2|Overall Study|Protocol Violation|1
223384|NCT01682876|732237|P1|Overall Study|Protocol Violation|1
223385|NCT01682876|732234|P4|Overall Study|Lost to Follow-up|11
223386|NCT01682876|732235|P3|Overall Study|Lost to Follow-up|9
223387|NCT01682876|732236|P2|Overall Study|Lost to Follow-up|15
223388|NCT01682876|732237|P1|Overall Study|Lost to Follow-up|11
223389|NCT01682876|732234|P4|Overall Study|Adverse Event|1
223390|NCT01682876|732235|P3|Overall Study|Adverse Event|0
223391|NCT01682876|732236|P2|Overall Study|Adverse Event|0
223392|NCT01682876|732237|P1|Overall Study|Adverse Event|0
223393|NCT01682876|732234|P4|Overall Study|Administrative reason|3
223394|NCT01682876|732235|P3|Overall Study|Administrative reason|0
223395|NCT01682876|732236|P2|Overall Study|Administrative reason|4
223396|NCT01682876|732237|P1|Overall Study|Administrative reason|4
223397|NCT01682863|732283|P3|Overall Study|Physician Decision|1
223398|NCT01682863|732284|P2|Overall Study|Physician Decision|0
223399|NCT01682863|732285|P1|Overall Study|Physician Decision|0
223400|NCT01682863|732283|P3|Overall Study|Adverse Event|2
223401|NCT01682863|732284|P2|Overall Study|Adverse Event|1
223402|NCT01682863|732285|P1|Overall Study|Adverse Event|0
223403|NCT01682863|732283|P3|Overall Study|Technical problems|0
223404|NCT01682863|732284|P2|Overall Study|Technical problems|0
223405|NCT01682863|732285|P1|Overall Study|Technical problems|1
223406|NCT01682863|732283|P3|Overall Study|Protocol deviation|1
223407|NCT01682863|732284|P2|Overall Study|Protocol deviation|0
223408|NCT01682863|732285|P1|Overall Study|Protocol deviation|1
223409|NCT01682863|732283|P3|Overall Study|Death|4
223410|NCT01682863|732284|P2|Overall Study|Death|3
223411|NCT01682863|732285|P1|Overall Study|Death|1
223412|NCT01682863|732283|P3|Overall Study|Lost to Follow-up|6
223413|NCT01682863|732284|P2|Overall Study|Lost to Follow-up|1
223414|NCT01682863|732285|P1|Overall Study|Lost to Follow-up|5
223415|NCT01682863|732283|P3|Overall Study|Subject/guardian decision|10
223416|NCT01682863|732284|P2|Overall Study|Subject/guardian decision|12
223417|NCT01682863|732285|P1|Overall Study|Subject/guardian decision|19
223418|NCT01682837|732314|P1|Baseline|Withdrawal by Subject|5
223419|NCT01682031|732358|P2|Overall Study|Patient stopped selenium on his own|1
223420|NCT01682031|732359|P1|Overall Study|Patient stopped selenium on his own|0
223421|NCT01682031|732358|P2|Overall Study|Patient could not swallow tablets|0
223422|NCT01682031|732359|P1|Overall Study|Patient could not swallow tablets|1
223423|NCT01682031|732358|P2|Overall Study|MRI results indicate increased nodul|1
223424|NCT01682031|732359|P1|Overall Study|MRI results indicate increased nodul|0
223425|NCT01682031|732358|P2|Overall Study|Adverse Event|2
223426|NCT01682031|732359|P1|Overall Study|Adverse Event|0
223427|NCT01682031|732358|P2|Overall Study|Withdrawal by Subject|1
223428|NCT01682031|732359|P1|Overall Study|Withdrawal by Subject|0
223429|NCT01683838|732381|P2|Overall Study|not specified|3
223430|NCT01683838|732382|P1|Overall Study|not specified|4
223431|NCT01683838|732381|P2|Overall Study|Lost to Follow-up|1
223432|NCT01683838|732382|P1|Overall Study|Lost to Follow-up|1
223433|NCT01683838|732381|P2|Overall Study|Withdrawal by Subject|5
223434|NCT01683838|732382|P1|Overall Study|Withdrawal by Subject|6
223435|NCT01683838|732381|P2|Overall Study|Protocol Violation|1
223436|NCT01683838|732382|P1|Overall Study|Protocol Violation|3
223437|NCT01683838|732381|P2|Overall Study|Adverse Event|2
223438|NCT01683838|732382|P1|Overall Study|Adverse Event|12
223439|NCT01683604|732422|P1|Overall Study|Unspecified|2
223440|NCT01683604|732422|P1|Overall Study|Lack of Efficacy|1
223441|NCT01683604|732422|P1|Overall Study|Adverse Event|2
223442|NCT01683383|732604|P2|Overall Study|Infant was not transported|0
223443|NCT01683383|732605|P1|Overall Study|Infant was not transported|1
223444|NCT01683266|732621|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
223445|NCT01683266|732622|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
223446|NCT01683266|732621|P2|Overall Study|Possibly Hypoglycemia|0
223447|NCT01683266|732622|P1|Overall Study|Possibly Hypoglycemia|1
223448|NCT01683266|732621|P2|Overall Study|Perceived Lack of Efficacy|1
223449|NCT01683266|732622|P1|Overall Study|Perceived Lack of Efficacy|1
223450|NCT01683266|732621|P2|Overall Study|Nonserious Hypoglycemia|3
223451|NCT01683266|732622|P1|Overall Study|Nonserious Hypoglycemia|0
223452|NCT01683266|732621|P2|Overall Study|Site Closure / Site Withdrawal|3
223453|NCT01683266|732622|P1|Overall Study|Site Closure / Site Withdrawal|1
223454|NCT01683266|732621|P2|Overall Study|Lost to Follow-up|0
223455|NCT01683266|732622|P1|Overall Study|Lost to Follow-up|5
223456|NCT01683266|732621|P2|Overall Study|Selection Criterion / Protocol Violation|5
223457|NCT01683266|732622|P1|Overall Study|Selection Criterion / Protocol Violation|7
223458|NCT01683266|732621|P2|Overall Study|Personal Reason|25
223459|NCT01683266|732622|P1|Overall Study|Personal Reason|17
223460|NCT01683266|732621|P2|Overall Study|Protocol Violation|6
223461|NCT01683266|732622|P1|Overall Study|Protocol Violation|13
223462|NCT01683266|732621|P2|Overall Study|Lack of Efficacy|2
223463|NCT01683266|732622|P1|Overall Study|Lack of Efficacy|5
223464|NCT01683266|732621|P2|Overall Study|Adverse Event|4
223465|NCT01683266|732622|P1|Overall Study|Adverse Event|5
223466|NCT01683058|732650|P1|Overall Study|Lack of Efficacy|2
223467|NCT01683058|732650|P1|Overall Study|Withdrawal by Subject|7
223468|NCT01683058|732650|P1|Overall Study|Subject Met Withdrawal Criteria|5
223469|NCT01683058|732650|P1|Overall Study|Adverse Event|6
223470|NCT01683058|732650|P1|Overall Study|Lost to Follow-up|9
223471|NCT01683019|732681|P3|Overall Study|Withdrawal by Subject|4
223472|NCT01683019|732682|P2|Overall Study|Withdrawal by Subject|1
223473|NCT01683019|732683|P1|Overall Study|Withdrawal by Subject|2
223474|NCT01682759|732693|P2|Overall Study|Withdrawal by Subject|55
223475|NCT01682759|732694|P1|Overall Study|Withdrawal by Subject|56
223476|NCT01682759|732693|P2|Overall Study|Physician Decision|1
223477|NCT01682759|732694|P1|Overall Study|Physician Decision|1
223478|NCT01682759|732693|P2|Overall Study|Lost to Follow-up|13
223479|NCT01682759|732694|P1|Overall Study|Lost to Follow-up|10
223480|NCT01682759|732693|P2|Overall Study|Death|1
223481|NCT01682759|732694|P1|Overall Study|Death|2
223482|NCT01682720|732718|P4|Overall Study|Adverse Event|1
223483|NCT01682720|732719|P3|Overall Study|Adverse Event|1
223484|NCT01682720|732720|P2|Overall Study|Adverse Event|0
223485|NCT01682720|732721|P1|Overall Study|Adverse Event|1
223486|NCT01682720|732718|P4|Overall Study|Subject Withdrew Consent|2
223487|NCT01682720|732719|P3|Overall Study|Subject Withdrew Consent|2
223488|NCT01682720|732720|P2|Overall Study|Subject Withdrew Consent|0
223489|NCT01682720|732721|P1|Overall Study|Subject Withdrew Consent|0
223490|NCT01682720|732718|P4|Overall Study|Lost to Follow-up|6
223491|NCT01682720|732719|P3|Overall Study|Lost to Follow-up|0
223492|NCT01682720|732720|P2|Overall Study|Lost to Follow-up|1
223493|NCT01682720|732721|P1|Overall Study|Lost to Follow-up|1
223494|NCT01682720|732718|P4|Overall Study|Efficacy Failure|30
223495|NCT01682720|732719|P3|Overall Study|Efficacy Failure|3
223496|NCT01682720|732720|P2|Overall Study|Efficacy Failure|3
223497|NCT01682720|732721|P1|Overall Study|Efficacy Failure|0
223498|NCT01682720|732718|P4|Overall Study|Terminated by Sponsor|0
223499|NCT01682720|732719|P3|Overall Study|Terminated by Sponsor|0
223500|NCT01682720|732720|P2|Overall Study|Terminated by Sponsor|0
223501|NCT01682720|732721|P1|Overall Study|Terminated by Sponsor|83
223502|NCT01682720|732718|P4|Overall Study|Randomized but Not Treated|0
223503|NCT01682720|732719|P3|Overall Study|Randomized but Not Treated|1
223504|NCT01682720|732720|P2|Overall Study|Randomized but Not Treated|1
223505|NCT01682720|732721|P1|Overall Study|Randomized but Not Treated|0
223506|NCT01682681|732738|P1|Overall Study|Low compliance|13
223507|NCT01682681|732738|P1|Overall Study|unspecified|21
223508|NCT01682681|732738|P1|Overall Study|tapering of topiramate|5
223509|NCT01682681|732738|P1|Overall Study|Adverse Event|46
223510|NCT01682681|732738|P1|Overall Study|Lost to Follow-up|174
223511|NCT01682681|732738|P1|Overall Study|Moved to other hospital|10
223512|NCT01682681|732738|P1|Overall Study|Withdrawal by Subject|1
223513|NCT01682681|732738|P1|Overall Study|Lack of Efficacy|62
223514|NCT01682603|732767|P1|Overall Study|Lost to Follow-up|3
223515|NCT01682460|732809|P1|Overall Study|Did not meet inclusion criteria|2
223516|NCT01682460|732809|P1|Overall Study|Withdrawal by Subject|2
223517|NCT01681628|732863|P2|19 Months Follow-up|Lost to Follow-up|43
223518|NCT01681628|732864|P1|19 Months Follow-up|Lost to Follow-up|61
223519|NCT01681628|732863|P2|19 Months Follow-up|Death|0
223520|NCT01681628|732864|P1|19 Months Follow-up|Death|1
223521|NCT01681628|732863|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
223522|NCT01681628|732864|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
223523|NCT01681628|732863|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
223524|NCT01681628|732864|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
223525|NCT01681576|732877|P2|Period 2|Non-compliance with study treatment|0
223526|NCT01681576|732878|P1|Period 2|Non-compliance with study treatment|1
223527|NCT01681576|732877|P2|Period 2|subject/guardian decision|1
223528|NCT01681576|732878|P1|Period 2|subject/guardian decision|3
223529|NCT01681576|732877|P2|Period 1|Protocol Deviation|0
223530|NCT01681576|732878|P1|Period 1|Protocol Deviation|1
223531|NCT01681576|732877|P2|Period 1|Adverse Event|0
223532|NCT01681576|732878|P1|Period 1|Adverse Event|1
223533|NCT01681511|732894|P2|Overall Study|No post-catheter sample collected|4
223534|NCT01681511|732895|P1|Overall Study|No post-catheter sample collected|11
223535|NCT01681511|732894|P2|Overall Study|No Daily Urine Sample Collected|1
223536|NCT01681511|732895|P1|Overall Study|No Daily Urine Sample Collected|0
223537|NCT01681511|732894|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
223538|NCT01681511|732895|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
223539|NCT01681511|732894|P2|Overall Study|Failed Inclusion/Exclusion|0
223540|NCT01681511|732895|P1|Overall Study|Failed Inclusion/Exclusion|3
223541|NCT01681511|732894|P2|Overall Study|No Treatment Received|3
223542|NCT01681511|732895|P1|Overall Study|No Treatment Received|1
223543|NCT01681472|732913|P4|Overall Study|Adverse Event|0
223544|NCT01681472|732914|P3|Overall Study|Adverse Event|0
223545|NCT01681472|732915|P2|Overall Study|Adverse Event|1
223546|NCT01681472|732916|P1|Overall Study|Adverse Event|0
223547|NCT01681368|732926|P1|Overall Study|Refused further follow up|1
223548|NCT01681368|732926|P1|Overall Study|Refused further treatment|1
223549|NCT01681277|732943|P5|Overall Study|Adverse Event|0
223550|NCT01681277|732944|P4|Overall Study|Adverse Event|0
223551|NCT01681277|732945|P3|Overall Study|Adverse Event|0
223552|NCT01681277|732946|P2|Overall Study|Adverse Event|0
223553|NCT01681277|732947|P1|Overall Study|Adverse Event|1
223554|NCT01681212|732988|P1|Overall Study|Administrative reason by sponsor|1
223555|NCT01681212|732988|P1|Overall Study|No longer met study criteria|5
223556|NCT01681069|733046|P2|Overall Study|Adverse Event|1
223557|NCT01681069|733047|P1|Overall Study|Adverse Event|0
223558|NCT01681069|733046|P2|Overall Study|Protocol Violation|1
223559|NCT01681069|733047|P1|Overall Study|Protocol Violation|1
223560|NCT01681069|733046|P2|Overall Study|Withdrawal by Subject|5
223561|NCT01681069|733047|P1|Overall Study|Withdrawal by Subject|4
223562|NCT01680991|733060|P3|Overall Study|PD confirmed in other hospital|0
223563|NCT01680991|733061|P2|Overall Study|PD confirmed in other hospital|0
223564|NCT01680991|733062|P1|Overall Study|PD confirmed in other hospital|1
223565|NCT01680991|733060|P3|Overall Study|Bad physical condition|1
223566|NCT01680991|733061|P2|Overall Study|Bad physical condition|0
223567|NCT01680991|733062|P1|Overall Study|Bad physical condition|0
223568|NCT01680991|733060|P3|Overall Study|Physician Decision|2
223569|NCT01680991|733061|P2|Overall Study|Physician Decision|7
223570|NCT01680991|733062|P1|Overall Study|Physician Decision|0
223571|NCT01680991|733060|P3|Overall Study|Progressive disease (PD)|0
223572|NCT01680991|733061|P2|Overall Study|Progressive disease (PD)|10
223573|NCT01680991|733062|P1|Overall Study|Progressive disease (PD)|0
223574|NCT01680991|733060|P3|Overall Study|Withdrawal by Subject|0
223575|NCT01680991|733061|P2|Overall Study|Withdrawal by Subject|1
223576|NCT01680991|733062|P1|Overall Study|Withdrawal by Subject|5
223577|NCT01680991|733060|P3|Overall Study|Protocol Violation|0
223578|NCT01680991|733061|P2|Overall Study|Protocol Violation|1
223579|NCT01680991|733062|P1|Overall Study|Protocol Violation|0
223580|NCT01680991|733060|P3|Overall Study|Death|1
223581|NCT01680991|733061|P2|Overall Study|Death|0
223582|NCT01680991|733062|P1|Overall Study|Death|1
223583|NCT01680991|733060|P3|Overall Study|Adverse Event|0
223584|NCT01680991|733061|P2|Overall Study|Adverse Event|0
223585|NCT01680991|733062|P1|Overall Study|Adverse Event|1
223586|NCT01680861|733142|P2|Early Post-transplant Period|Protocol Violation|1
223587|NCT01680861|733143|P1|Early Post-transplant Period|Protocol Violation|1
223588|NCT01680497|733189|P1|Overall Study|Lost to Follow-up|2
223589|NCT01680458|733199|P1|Overall Study|Protocol Violation|3
223590|NCT01680341|733210|P2|Overall Study|Unclassified|15
223591|NCT01680341|733211|P1|Overall Study|Unclassified|18
223592|NCT01680341|733210|P2|Overall Study|Adverse Event|2
223593|NCT01680341|733211|P1|Overall Study|Adverse Event|3
223594|NCT01680159|733282|P1|Increased Dose Period|Withdrawal by Subject|2
223595|NCT01680159|733282|P1|Increased Dose Period|Adverse Event|6
223596|NCT01680159|733282|P1|Screening Period|Not meet criteria for dose-up period|7
223597|NCT01680016|733309|P4|Overall Study|Withdrawal by Subject|1
223598|NCT01680016|733310|P3|Overall Study|Withdrawal by Subject|1
223599|NCT01680016|733311|P2|Overall Study|Withdrawal by Subject|7
223600|NCT01680016|733312|P1|Overall Study|Withdrawal by Subject|5
223601|NCT01680016|733309|P4|Overall Study|Protocol Violation|0
223602|NCT01680016|733310|P3|Overall Study|Protocol Violation|0
223603|NCT01680016|733311|P2|Overall Study|Protocol Violation|1
223604|NCT01680016|733312|P1|Overall Study|Protocol Violation|0
223605|NCT01680016|733309|P4|Overall Study|The Subject went out of The Trial|0
223606|NCT01680016|733310|P3|Overall Study|The Subject went out of The Trial|3
223607|NCT01680016|733311|P2|Overall Study|The Subject went out of The Trial|0
223608|NCT01680016|733312|P1|Overall Study|The Subject went out of The Trial|1
223609|NCT01680016|733309|P4|Overall Study|Adverse Event|4
223610|NCT01680016|733310|P3|Overall Study|Adverse Event|1
223611|NCT01680016|733311|P2|Overall Study|Adverse Event|0
223612|NCT01680016|733312|P1|Overall Study|Adverse Event|0
223613|NCT01679613|733374|P4|Overall Study|other than stated above|2
223614|NCT01679613|733375|P3|Overall Study|other than stated above|2
223615|NCT01679613|733376|P2|Overall Study|other than stated above|1
223616|NCT01679613|733377|P1|Overall Study|other than stated above|0
223617|NCT01679236|733420|P2|Overall Study|Lost to Follow-up|15
223618|NCT01679236|733421|P1|Overall Study|Lost to Follow-up|15
223619|NCT01679002|733468|P3|Overall Study|Adverse Event|0
223620|NCT01679002|733469|P2|Overall Study|Adverse Event|1
223621|NCT01679002|733470|P1|Overall Study|Adverse Event|1
223622|NCT01678911|733497|P2|Second Intervention|Lost to Follow-up|0
223623|NCT01678911|733498|P1|Second Intervention|Lost to Follow-up|2
223624|NCT01678820|733544|P3|Overall Study|Not treated with double-blind study drug|2
223625|NCT01678820|733545|P2|Overall Study|Not treated with double-blind study drug|2
223626|NCT01678820|733546|P1|Overall Study|Not treated with double-blind study drug|0
223627|NCT01678820|733544|P3|Overall Study|Protocol Violation|4
223628|NCT01678820|733545|P2|Overall Study|Protocol Violation|5
223629|NCT01678820|733546|P1|Overall Study|Protocol Violation|4
223630|NCT01678820|733544|P3|Overall Study|Physician Decision|1
223631|NCT01678820|733545|P2|Overall Study|Physician Decision|0
223632|NCT01678820|733546|P1|Overall Study|Physician Decision|0
223633|NCT01678820|733544|P3|Overall Study|Non-compliance with study drug|0
223634|NCT01678820|733545|P2|Overall Study|Non-compliance with study drug|1
223635|NCT01678820|733546|P1|Overall Study|Non-compliance with study drug|0
223636|NCT01678820|733544|P3|Overall Study|Lost to Follow-up|2
223637|NCT01678820|733545|P2|Overall Study|Lost to Follow-up|2
223638|NCT01678820|733546|P1|Overall Study|Lost to Follow-up|7
223639|NCT01678820|733544|P3|Overall Study|Adverse Event|2
223640|NCT01678820|733545|P2|Overall Study|Adverse Event|2
223641|NCT01678820|733546|P1|Overall Study|Adverse Event|2
223642|NCT01678820|733544|P3|Overall Study|Protocol Specified Criteria|1
223643|NCT01678820|733545|P2|Overall Study|Protocol Specified Criteria|3
223644|NCT01678820|733546|P1|Overall Study|Protocol Specified Criteria|2
223645|NCT01678820|733544|P3|Overall Study|Withdrawal by Subject|2
223646|NCT01678820|733545|P2|Overall Study|Withdrawal by Subject|5
223647|NCT01678820|733546|P1|Overall Study|Withdrawal by Subject|2
223648|NCT01678820|733544|P3|Overall Study|Study Terminated by Sponsor|43
223649|NCT01678820|733545|P2|Overall Study|Study Terminated by Sponsor|43
223650|NCT01678820|733546|P1|Overall Study|Study Terminated by Sponsor|45
223651|NCT01678807|733591|P3|Overall Study|Withdrawn by Parent/Guardian|0
223652|NCT01678807|733592|P2|Overall Study|Withdrawn by Parent/Guardian|1
223653|NCT01678807|733593|P1|Overall Study|Withdrawn by Parent/Guardian|0
223654|NCT01678807|733591|P3|Overall Study|Adverse Event|0
223655|NCT01678807|733592|P2|Overall Study|Adverse Event|4
223656|NCT01678807|733593|P1|Overall Study|Adverse Event|4
223657|NCT01678313|733606|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
223658|NCT01678313|733607|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
223659|NCT01678313|733606|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
223660|NCT01678313|733607|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
223661|NCT01678313|733606|P2|Completed the 3-month Therapy|Physician Decision|4
223662|NCT01678313|733607|P1|Completed the 3-month Therapy|Physician Decision|3
223663|NCT01678313|733606|P2|Completed the 3-month Therapy|Lost to Follow-up|8
223664|NCT01678313|733607|P1|Completed the 3-month Therapy|Lost to Follow-up|3
223665|NCT01678131|733641|P3|Overall Study|Withdrawal by Subject|2
223666|NCT01678131|733642|P2|Overall Study|Withdrawal by Subject|0
223667|NCT01678131|733643|P1|Overall Study|Withdrawal by Subject|0
223668|NCT01678131|733641|P3|Overall Study|Adverse Event|0
223669|NCT01678131|733642|P2|Overall Study|Adverse Event|1
223670|NCT01678131|733643|P1|Overall Study|Adverse Event|0
223671|NCT01677988|733651|P1|Overall Study|Lack of Efficacy|2
223672|NCT01677936|733664|P2|Overall Study|Protocol Violation|4
223673|NCT01677936|733665|P1|Overall Study|Protocol Violation|0
223674|NCT01677936|733664|P2|Overall Study|Lost to Follow-up|0
223675|NCT01677936|733665|P1|Overall Study|Lost to Follow-up|1
223676|NCT01677936|733664|P2|Overall Study|Adverse Event|0
223677|NCT01677936|733665|P1|Overall Study|Adverse Event|1
223678|NCT01677936|733664|P2|Overall Study|Protocol Violation|0
223679|NCT01677936|733665|P1|Overall Study|Protocol Violation|3
223680|NCT01677936|733664|P2|Overall Study|Lost to Follow-up|1
223681|NCT01677936|733665|P1|Overall Study|Lost to Follow-up|4
223682|NCT01677767|733673|P1|Overall Study|Non-compliance by the participants|3
223683|NCT01677767|733673|P1|Overall Study|Withdrawal by Subject|10
223684|NCT01677767|733673|P1|Overall Study|Protocol Violation|4
223685|NCT01677767|733673|P1|Overall Study|Death|4
223686|NCT01677767|733673|P1|Overall Study|Adverse Event|1
223687|NCT01677624|733687|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
223688|NCT01677299|733696|P4|Overall Study|Withdrawal by Subject|1
223689|NCT01677299|733697|P3|Overall Study|Withdrawal by Subject|0
223690|NCT01677299|733698|P2|Overall Study|Withdrawal by Subject|1
223691|NCT01677299|733699|P1|Overall Study|Withdrawal by Subject|0
223692|NCT01677299|733696|P4|Overall Study|Adverse Event|0
223693|NCT01677299|733697|P3|Overall Study|Adverse Event|1
223694|NCT01677299|733698|P2|Overall Study|Adverse Event|2
223695|NCT01677299|733699|P1|Overall Study|Adverse Event|0
223696|NCT01677195|733731|P3|Overall Study|Protocol Violation|4
223697|NCT01677195|733732|P2|Overall Study|Protocol Violation|3
223698|NCT01677195|733733|P1|Overall Study|Protocol Violation|7
223699|NCT01677195|733731|P3|Overall Study|Pregnancy|0
223700|NCT01677195|733732|P2|Overall Study|Pregnancy|1
223701|NCT01677195|733733|P1|Overall Study|Pregnancy|0
223702|NCT01677195|733731|P3|Overall Study|Physician Decision|2
223703|NCT01677195|733732|P2|Overall Study|Physician Decision|2
223704|NCT01677195|733733|P1|Overall Study|Physician Decision|1
223705|NCT01677195|733731|P3|Overall Study|Adverse Event|1
223706|NCT01677195|733732|P2|Overall Study|Adverse Event|4
223707|NCT01677195|733733|P1|Overall Study|Adverse Event|6
223708|NCT01677195|733731|P3|Overall Study|Withdrawal by Subject|1
223709|NCT01677195|733732|P2|Overall Study|Withdrawal by Subject|0
223710|NCT01677195|733733|P1|Overall Study|Withdrawal by Subject|1
223711|NCT01677195|733731|P3|Overall Study|Lost to Follow-up|22
223712|NCT01677195|733732|P2|Overall Study|Lost to Follow-up|22
223713|NCT01677195|733733|P1|Overall Study|Lost to Follow-up|14
223714|NCT01677182|733744|P3|Overall Study|Other reasons|2
223715|NCT01677182|733745|P2|Overall Study|Other reasons|5
223716|NCT01677182|733746|P1|Overall Study|Other reasons|1
223717|NCT01677182|733744|P3|Overall Study|Lack of Efficacy|1
223718|NCT01677182|733745|P2|Overall Study|Lack of Efficacy|0
223719|NCT01677182|733746|P1|Overall Study|Lack of Efficacy|3
223720|NCT01677182|733744|P3|Overall Study|Study termination|11
223721|NCT01677182|733745|P2|Overall Study|Study termination|9
223722|NCT01677182|733746|P1|Overall Study|Study termination|12
223723|NCT01677182|733744|P3|Overall Study|Withdrawal by Subject|10
223724|NCT01677182|733745|P2|Overall Study|Withdrawal by Subject|12
223725|NCT01677182|733746|P1|Overall Study|Withdrawal by Subject|7
223726|NCT01677182|733744|P3|Overall Study|Lost to Follow-up|3
223727|NCT01677182|733745|P2|Overall Study|Lost to Follow-up|0
223728|NCT01677182|733746|P1|Overall Study|Lost to Follow-up|4
223729|NCT01677182|733744|P3|Overall Study|Protocol Violation|4
223730|NCT01677182|733745|P2|Overall Study|Protocol Violation|1
223731|NCT01677182|733746|P1|Overall Study|Protocol Violation|5
223732|NCT01677182|733744|P3|Overall Study|Adverse Event|8
223733|NCT01677182|733745|P2|Overall Study|Adverse Event|1
223734|NCT01677182|733746|P1|Overall Study|Adverse Event|2
223735|NCT01676896|733781|P3|Overall Study|Withdrawal by Subject|19
223736|NCT01676896|733782|P2|Overall Study|Withdrawal by Subject|7
223737|NCT01676896|733783|P1|Overall Study|Withdrawal by Subject|12
223738|NCT01676220|733944|P2|Overall Study|No More Need of Insulin|0
223739|NCT01676220|733945|P1|Overall Study|No More Need of Insulin|1
223740|NCT01676220|733944|P2|Overall Study|Non Serious Hypoglycemia|0
223741|NCT01676220|733945|P1|Overall Study|Non Serious Hypoglycemia|2
223742|NCT01676220|733944|P2|Overall Study|Perceived Lack of Efficacy|1
223743|NCT01676220|733945|P1|Overall Study|Perceived Lack of Efficacy|3
223744|NCT01676220|733944|P2|Overall Study|Site Closure/Site Withdrawal|4
223745|NCT01676220|733945|P1|Overall Study|Site Closure/Site Withdrawal|1
223746|NCT01676220|733944|P2|Overall Study|Selection Criterion/Protocol Violation|9
223747|NCT01676220|733945|P1|Overall Study|Selection Criterion/Protocol Violation|9
223748|NCT01676220|733944|P2|Overall Study|Lost to Follow-up|18
223749|NCT01676220|733945|P1|Overall Study|Lost to Follow-up|11
223750|NCT01676220|733944|P2|Overall Study|Personal Reason|45
223751|NCT01676220|733945|P1|Overall Study|Personal Reason|34
223752|NCT01676220|733944|P2|Overall Study|Received Rescue Therapy|22
223753|NCT01676220|733945|P1|Overall Study|Received Rescue Therapy|14
223754|NCT01676220|733944|P2|Overall Study|Protocol Violation|12
223755|NCT01676220|733945|P1|Overall Study|Protocol Violation|11
223756|NCT01676220|733944|P2|Overall Study|Lack of Efficacy|5
223757|NCT01676220|733945|P1|Overall Study|Lack of Efficacy|2
223758|NCT01676220|733944|P2|Overall Study|Adverse Event|8
223759|NCT01676220|733945|P1|Overall Study|Adverse Event|10
223760|NCT01676220|733944|P2|Overall Study|Randomized But Not Treated|1
223761|NCT01676220|733945|P1|Overall Study|Randomized But Not Treated|4
223762|NCT01676012|733975|P1|Overall Study|incomplete set of videos|1
223763|NCT01676012|733975|P1|Overall Study|Adverse Event|2
223764|NCT01675661|733986|P2|Overall Study|Other reason|2
223765|NCT01675661|733987|P1|Overall Study|Other reason|1
223766|NCT01675661|733986|P2|Overall Study|Death|1
223767|NCT01675661|733987|P1|Overall Study|Death|0
223768|NCT01675661|733986|P2|Overall Study|Physician Decision|2
223769|NCT01675661|733987|P1|Overall Study|Physician Decision|0
223770|NCT01675661|733986|P2|Overall Study|Withdrawal by Subject|7
223771|NCT01675661|733987|P1|Overall Study|Withdrawal by Subject|3
223772|NCT01675661|733986|P2|Overall Study|Moved away|6
223773|NCT01675661|733987|P1|Overall Study|Moved away|5
223774|NCT01675661|733986|P2|Overall Study|Practical problems|5
223775|NCT01675661|733987|P1|Overall Study|Practical problems|9
223776|NCT01675661|733986|P2|Overall Study|Lost to Follow-up|23
223777|NCT01675661|733987|P1|Overall Study|Lost to Follow-up|22
223778|NCT01675544|733999|P1|Overall Study|Withdrawal by Subject|2
223779|NCT01675531|734004|P1|Overall Study|Protocol Violation|8
223780|NCT01675531|734004|P1|Overall Study|Lack of Efficacy|1
223781|NCT01675531|734004|P1|Overall Study|Withdrawal by Subject|7
223782|NCT01675531|734004|P1|Overall Study|Adverse Event|9
223783|NCT01675492|734011|P1|Overall Study|study completed early - product approval|42
223784|NCT01675427|734025|P1|Overall Study|Not Specified|2
223785|NCT01675427|734025|P1|Overall Study|Lost to Follow-up|5
223786|NCT01675427|734025|P1|Overall Study|Sample not Collected by Mistake|2
223787|NCT01675427|734025|P1|Overall Study|Participant Refused Sample Collection|18
223788|NCT01675427|734025|P1|Overall Study|Withdrawal by Subject|7
223789|NCT01675167|734312|P3|Double-blind Treatment Phase|Not specified|5
223790|NCT01675167|734313|P2|Double-blind Treatment Phase|Not specified|7
223791|NCT01675167|734314|P1|Double-blind Treatment Phase|Not specified|0
223792|NCT01675167|734312|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
223793|NCT01675167|734313|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
223794|NCT01675167|734314|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
223795|NCT01675167|734312|P3|Double-blind Treatment Phase|Lost to Follow-up|5
223796|NCT01675167|734313|P2|Double-blind Treatment Phase|Lost to Follow-up|1
223797|NCT01675167|734314|P1|Double-blind Treatment Phase|Lost to Follow-up|0
223798|NCT01675167|734312|P3|Double-blind Treatment Phase|Protocol Violation|11
223799|NCT01675167|734313|P2|Double-blind Treatment Phase|Protocol Violation|4
223800|NCT01675167|734314|P1|Double-blind Treatment Phase|Protocol Violation|0
223801|NCT01675167|734312|P3|Double-blind Treatment Phase|Adverse Event|13
223802|NCT01675167|734313|P2|Double-blind Treatment Phase|Adverse Event|5
223803|NCT01675167|734314|P1|Double-blind Treatment Phase|Adverse Event|0
223804|NCT01675167|734312|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
223805|NCT01675167|734313|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
223806|NCT01675167|734314|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
223807|NCT01675167|734312|P3|Double-blind Treatment Phase|Lack of Efficacy|61
223808|NCT01675167|734313|P2|Double-blind Treatment Phase|Lack of Efficacy|19
223809|NCT01675167|734314|P1|Double-blind Treatment Phase|Lack of Efficacy|0
223810|NCT01675167|734312|P3|Open-label Titration Phase|Not specified|0
223811|NCT01675167|734313|P2|Open-label Titration Phase|Not specified|0
223812|NCT01675167|734314|P1|Open-label Titration Phase|Not specified|55
223813|NCT01675167|734312|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
223814|NCT01675167|734313|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
223815|NCT01675167|734314|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
223816|NCT01675167|734312|P3|Open-label Titration Phase|Lost to Follow-up|0
223817|NCT01675167|734313|P2|Open-label Titration Phase|Lost to Follow-up|0
223818|NCT01675167|734314|P1|Open-label Titration Phase|Lost to Follow-up|15
223819|NCT01675167|734312|P3|Open-label Titration Phase|Protocol Violation|0
223820|NCT01675167|734313|P2|Open-label Titration Phase|Protocol Violation|0
223821|NCT01675167|734314|P1|Open-label Titration Phase|Protocol Violation|43
223822|NCT01675167|734312|P3|Open-label Titration Phase|Withdrawal by Subject|0
223823|NCT01675167|734313|P2|Open-label Titration Phase|Withdrawal by Subject|0
223824|NCT01675167|734314|P1|Open-label Titration Phase|Withdrawal by Subject|46
223825|NCT01675167|734312|P3|Open-label Titration Phase|Lack of Efficacy|0
223826|NCT01675167|734313|P2|Open-label Titration Phase|Lack of Efficacy|0
223827|NCT01675167|734314|P1|Open-label Titration Phase|Lack of Efficacy|63
223828|NCT01675167|734312|P3|Open-label Titration Phase|Adverse Event|0
223829|NCT01675167|734313|P2|Open-label Titration Phase|Adverse Event|0
223830|NCT01675167|734314|P1|Open-label Titration Phase|Adverse Event|81
223831|NCT01675141|734336|P1|Overall Study|No treatment, per protocol|1
223832|NCT01675141|734336|P1|Overall Study|Physician Decision|4
223833|NCT01675141|734336|P1|Overall Study|Withdrawal by Subject|3
223834|NCT01675141|734336|P1|Overall Study|Lenalidomide outside NIH|3
223835|NCT01675128|734349|P3|Overall Study|Pulmonary complication; off study|0
223836|NCT01675128|734350|P2|Overall Study|Pulmonary complication; off study|1
223837|NCT01675128|734351|P1|Overall Study|Pulmonary complication; off study|0
223838|NCT01675128|734349|P3|Overall Study|Refused further treatment|0
223839|NCT01675128|734350|P2|Overall Study|Refused further treatment|0
223840|NCT01675128|734351|P1|Overall Study|Refused further treatment|1
223841|NCT01675128|734349|P3|Overall Study|Disease progression on study|1
223842|NCT01675128|734350|P2|Overall Study|Disease progression on study|1
223843|NCT01675128|734351|P1|Overall Study|Disease progression on study|1
223844|NCT01675011|734379|P2|Overall Study|Trial terminated by Sponsor|1
223845|NCT01675011|734380|P1|Overall Study|Trial terminated by Sponsor|3
223846|NCT01674725|734388|P2|Overall Study|Lost to Follow-up|1
223847|NCT01674725|734389|P1|Overall Study|Lost to Follow-up|0
223848|NCT01674725|734388|P2|Overall Study|Withdrawal by Subject|0
223849|NCT01674725|734389|P1|Overall Study|Withdrawal by Subject|1
223850|NCT01674725|734388|P2|Overall Study|Did not receive study drug|0
223851|NCT01674725|734389|P1|Overall Study|Did not receive study drug|1
223852|NCT01674725|734388|P2|Overall Study|Adverse Event|0
223853|NCT01674725|734389|P1|Overall Study|Adverse Event|1
223854|NCT01674712|734408|P5|Overall Study|Lack of Efficacy|1
223855|NCT01674712|734409|P4|Overall Study|Lack of Efficacy|0
223856|NCT01674712|734410|P3|Overall Study|Lack of Efficacy|1
223857|NCT01674712|734411|P2|Overall Study|Lack of Efficacy|0
223858|NCT01674712|734412|P1|Overall Study|Lack of Efficacy|0
223859|NCT01674712|734408|P5|Overall Study|Administrative|1
223860|NCT01674712|734409|P4|Overall Study|Administrative|0
223861|NCT01674712|734410|P3|Overall Study|Administrative|0
223862|NCT01674712|734411|P2|Overall Study|Administrative|1
223863|NCT01674712|734412|P1|Overall Study|Administrative|0
223864|NCT01674712|734408|P5|Overall Study|Withdrawal by Subject|3
223865|NCT01674712|734409|P4|Overall Study|Withdrawal by Subject|4
223866|NCT01674712|734410|P3|Overall Study|Withdrawal by Subject|5
223867|NCT01674712|734411|P2|Overall Study|Withdrawal by Subject|2
223868|NCT01674712|734412|P1|Overall Study|Withdrawal by Subject|2
223869|NCT01674712|734408|P5|Overall Study|Protocol Violation|0
223870|NCT01674712|734409|P4|Overall Study|Protocol Violation|0
223871|NCT01674712|734410|P3|Overall Study|Protocol Violation|0
223872|NCT01674712|734411|P2|Overall Study|Protocol Violation|0
223873|NCT01674712|734412|P1|Overall Study|Protocol Violation|2
223874|NCT01674712|734408|P5|Overall Study|Lost to Follow-up|0
223875|NCT01674712|734409|P4|Overall Study|Lost to Follow-up|0
223876|NCT01674712|734410|P3|Overall Study|Lost to Follow-up|0
223877|NCT01674712|734411|P2|Overall Study|Lost to Follow-up|0
223878|NCT01674712|734412|P1|Overall Study|Lost to Follow-up|1
223879|NCT01674712|734408|P5|Overall Study|Adverse Event|6
223880|NCT01674712|734409|P4|Overall Study|Adverse Event|4
223881|NCT01674712|734410|P3|Overall Study|Adverse Event|3
223882|NCT01674712|734411|P2|Overall Study|Adverse Event|6
223883|NCT01674712|734412|P1|Overall Study|Adverse Event|5
223884|NCT01674647|734436|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
223885|NCT01674647|734437|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
223886|NCT01674647|734436|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
223887|NCT01674647|734437|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
223888|NCT01674647|734436|P2|30-day Safety Follow-up Period|Logistical difficulties|3
223889|NCT01674647|734437|P1|30-day Safety Follow-up Period|Logistical difficulties|1
223890|NCT01674647|734436|P2|30-day Safety Follow-up Period|Protocol Violation|22
223891|NCT01674647|734437|P1|30-day Safety Follow-up Period|Protocol Violation|39
223892|NCT01674647|734436|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
223893|NCT01674647|734437|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
223894|NCT01674647|734436|P2|30-day Safety Follow-up Period|Death|2
223895|NCT01674647|734437|P1|30-day Safety Follow-up Period|Death|3
223896|NCT01674647|734436|P2|Treatment Period|Protocol Violation|36
223897|NCT01674647|734437|P1|Treatment Period|Protocol Violation|56
223898|NCT01674647|734436|P2|Treatment Period|Treatment failure|14
223899|NCT01674647|734437|P1|Treatment Period|Treatment failure|0
223900|NCT01674647|734436|P2|Treatment Period|Logistical difficulties|8
223901|NCT01674647|734437|P1|Treatment Period|Logistical difficulties|5
223902|NCT01674647|734436|P2|Treatment Period|Switching to other therapy|2
223903|NCT01674647|734437|P1|Treatment Period|Switching to other therapy|5
223904|NCT01674647|734436|P2|Treatment Period|Withdrawal by Subject|16
223905|NCT01674647|734437|P1|Treatment Period|Withdrawal by Subject|19
223906|NCT01674647|734436|P2|Treatment Period|Lost to Follow-up|1
223907|NCT01674647|734437|P1|Treatment Period|Lost to Follow-up|1
223908|NCT01674647|734436|P2|Treatment Period|Non-compliance with study drug|0
223909|NCT01674647|734437|P1|Treatment Period|Non-compliance with study drug|3
223910|NCT01674647|734436|P2|Treatment Period|Adverse Event|22
223911|NCT01674647|734437|P1|Treatment Period|Adverse Event|60
223912|NCT01674647|734436|P2|Treatment Period|Physician Decision|1
223913|NCT01674647|734437|P1|Treatment Period|Physician Decision|3
223914|NCT01674647|734436|P2|Treatment Period|Efficacy outcome reached|1
223915|NCT01674647|734437|P1|Treatment Period|Efficacy outcome reached|0
223916|NCT01674647|734436|P2|Treatment Period|Death|1
223917|NCT01674647|734437|P1|Treatment Period|Death|4
223918|NCT01674634|734463|P1|Overall Study|Lost to Follow-up|3
223919|NCT01674634|734463|P1|Overall Study|Withdrawal by Subject|3
223920|NCT01674062|734511|P2|Overall Study|Programming Error|0
223921|NCT01674062|734512|P1|Overall Study|Programming Error|1
223922|NCT01674062|734511|P2|Overall Study|Death|1
223923|NCT01674062|734512|P1|Overall Study|Death|0
223924|NCT01674062|734511|P2|Overall Study|Adverse Event|1
223925|NCT01674062|734512|P1|Overall Study|Adverse Event|1
223926|NCT01674062|734511|P2|Overall Study|Not Specified|1
223927|NCT01674062|734512|P1|Overall Study|Not Specified|8
223928|NCT01674062|734511|P2|Overall Study|Insufficient Therapeutic Response|26
223929|NCT01674062|734512|P1|Overall Study|Insufficient Therapeutic Response|56
223930|NCT01674010|734527|P3|Randomization Phase 2|Withdrawal by Subject|7
223931|NCT01674010|734528|P2|Randomization Phase 2|Withdrawal by Subject|8
223932|NCT01674010|734529|P1|Randomization Phase 2|Withdrawal by Subject|0
223933|NCT01674010|734527|P3|Randomization Phase 2|Sponsor Decision|45
223934|NCT01674010|734528|P2|Randomization Phase 2|Sponsor Decision|42
223935|NCT01674010|734529|P1|Randomization Phase 2|Sponsor Decision|0
223936|NCT01674010|734527|P3|Randomization Phase 2|Protocol Violation|1
223937|NCT01674010|734528|P2|Randomization Phase 2|Protocol Violation|1
223938|NCT01674010|734529|P1|Randomization Phase 2|Protocol Violation|0
223939|NCT01674010|734527|P3|Randomization Phase 2|Pregnancy|1
223940|NCT01674010|734528|P2|Randomization Phase 2|Pregnancy|1
223941|NCT01674010|734529|P1|Randomization Phase 2|Pregnancy|0
223942|NCT01674010|734527|P3|Randomization Phase 2|Physician Decision|2
223943|NCT01674010|734528|P2|Randomization Phase 2|Physician Decision|0
223944|NCT01674010|734529|P1|Randomization Phase 2|Physician Decision|0
223945|NCT01674010|734527|P3|Randomization Phase 2|Mood episode recurrence|2
223946|NCT01674010|734528|P2|Randomization Phase 2|Mood episode recurrence|8
223947|NCT01674010|734529|P1|Randomization Phase 2|Mood episode recurrence|0
223948|NCT01674010|734527|P3|Randomization Phase 2|Lost to Follow-up|2
223949|NCT01674010|734528|P2|Randomization Phase 2|Lost to Follow-up|1
223950|NCT01674010|734529|P1|Randomization Phase 2|Lost to Follow-up|0
223951|NCT01674010|734527|P3|Randomization Phase 2|Adverse Event|1
223952|NCT01674010|734528|P2|Randomization Phase 2|Adverse Event|1
223953|NCT01674010|734529|P1|Randomization Phase 2|Adverse Event|0
223954|NCT01674010|734527|P3|Open Treatment Phase 1|Withdrawal by Subject|0
223955|NCT01674010|734528|P2|Open Treatment Phase 1|Withdrawal by Subject|0
223956|NCT01674010|734529|P1|Open Treatment Phase 1|Withdrawal by Subject|25
223957|NCT01674010|734527|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
223958|NCT01674010|734528|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
223959|NCT01674010|734529|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
223960|NCT01674010|734527|P3|Open Treatment Phase 1|Sponsor Decision|0
223961|NCT01674010|734528|P2|Open Treatment Phase 1|Sponsor Decision|0
223962|NCT01674010|734529|P1|Open Treatment Phase 1|Sponsor Decision|79
223963|NCT01674010|734527|P3|Open Treatment Phase 1|Protocol Violation|0
223964|NCT01674010|734528|P2|Open Treatment Phase 1|Protocol Violation|0
223965|NCT01674010|734529|P1|Open Treatment Phase 1|Protocol Violation|7
223966|NCT01674010|734527|P3|Open Treatment Phase 1|Physician Decision|0
223967|NCT01674010|734528|P2|Open Treatment Phase 1|Physician Decision|0
223968|NCT01674010|734529|P1|Open Treatment Phase 1|Physician Decision|9
223969|NCT01674010|734527|P3|Open Treatment Phase 1|Lost to Follow-up|0
223970|NCT01674010|734528|P2|Open Treatment Phase 1|Lost to Follow-up|0
223971|NCT01674010|734529|P1|Open Treatment Phase 1|Lost to Follow-up|19
223972|NCT01674010|734527|P3|Open Treatment Phase 1|Death|0
223973|NCT01674010|734528|P2|Open Treatment Phase 1|Death|0
223974|NCT01674010|734529|P1|Open Treatment Phase 1|Death|1
223975|NCT01674010|734527|P3|Open Treatment Phase 1|Adverse Event|0
223976|NCT01674010|734528|P2|Open Treatment Phase 1|Adverse Event|0
223977|NCT01674010|734529|P1|Open Treatment Phase 1|Adverse Event|10
223978|NCT01673984|734548|P2|Overall Study|Study termination|6
223979|NCT01673984|734549|P1|Overall Study|Study termination|9
223980|NCT01673984|734548|P2|Overall Study|Adverse Event|0
223981|NCT01673984|734549|P1|Overall Study|Adverse Event|1
223982|NCT01673867|734591|P2|Treatment|Physician Decision|1
223983|NCT01673867|734592|P1|Treatment|Physician Decision|0
223984|NCT01673867|734591|P2|Treatment|Symptomatic deterioration|1
223985|NCT01673867|734592|P1|Treatment|Symptomatic deterioration|0
223986|NCT01673867|734591|P2|Treatment|Required prolonged hospitalization|1
223987|NCT01673867|734592|P1|Treatment|Required prolonged hospitalization|0
223988|NCT01673867|734591|P2|Treatment|Health status not improved|0
223989|NCT01673867|734592|P1|Treatment|Health status not improved|1
223990|NCT01673867|734591|P2|Treatment|Required steroid therapy|0
223991|NCT01673867|734592|P1|Treatment|Required steroid therapy|1
223992|NCT01673867|734591|P2|Treatment|No longer meets criteria|0
223993|NCT01673867|734592|P1|Treatment|No longer meets criteria|2
223994|NCT01673867|734591|P2|Treatment|Maximum clinical benefit|10
223995|NCT01673867|734592|P1|Treatment|Maximum clinical benefit|0
223996|NCT01673867|734591|P2|Treatment|Withdrawal by Subject|6
223997|NCT01673867|734592|P1|Treatment|Withdrawal by Subject|4
223998|NCT01673867|734591|P2|Treatment|Requested treatment discontinuation|16
223999|NCT01673867|734592|P1|Treatment|Requested treatment discontinuation|5
224000|NCT01673867|734591|P2|Treatment|AE unrelated to study drug|11
224001|NCT01673867|734592|P1|Treatment|AE unrelated to study drug|19
224002|NCT01673867|734591|P2|Treatment|Death|1
224003|NCT01673867|734592|P1|Treatment|Death|1
224004|NCT01673867|734591|P2|Treatment|Study Drug Toxicity|42
224005|NCT01673867|734592|P1|Treatment|Study Drug Toxicity|17
224006|NCT01673867|734591|P2|Treatment|Disease Progression|179
224007|NCT01673867|734592|P1|Treatment|Disease Progression|194
224008|NCT01673867|734591|P2|Randomization|No longer meets criteria|5
224009|NCT01673867|734592|P1|Randomization|No longer meets criteria|4
224010|NCT01673867|734591|P2|Randomization|Lost to Follow-up|1
224011|NCT01673867|734592|P1|Randomization|Lost to Follow-up|0
224012|NCT01673867|734591|P2|Randomization|Withdrawal by Subject|12
224013|NCT01673867|734592|P1|Randomization|Withdrawal by Subject|0
224014|NCT01673867|734591|P2|Randomization|Requested treatment discontinuation|4
224015|NCT01673867|734592|P1|Randomization|Requested treatment discontinuation|0
224016|NCT01673867|734591|P2|Randomization|AE unrelated to study drug|0
224017|NCT01673867|734592|P1|Randomization|AE unrelated to study drug|1
224018|NCT01673854|734618|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
224019|NCT01673854|734618|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
224020|NCT01673854|734618|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
224021|NCT01673854|734618|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
224022|NCT01673854|734618|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
224023|NCT01673854|734618|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
224024|NCT01673854|734618|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
224025|NCT01673854|734618|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
224026|NCT01673854|734618|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
224027|NCT01673854|734618|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
224028|NCT01673854|734618|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
224029|NCT01673854|734618|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
224030|NCT01673698|734632|P2|Overall Study|Lost to Follow-up|13
224031|NCT01673698|734633|P1|Overall Study|Lost to Follow-up|51
224032|NCT01673620|734643|P2|Overall Study|Adverse Event|0
224033|NCT01673620|734644|P1|Overall Study|Adverse Event|1
224034|NCT01673594|734654|P2|Overall Study|Withdrawal by Subject|1
224035|NCT01673594|734655|P1|Overall Study|Withdrawal by Subject|0
224036|NCT01673594|734654|P2|Overall Study|Physician Decision|4
224037|NCT01673594|734655|P1|Overall Study|Physician Decision|2
224038|NCT01673594|734654|P2|Overall Study|Lost to Follow-up|0
224039|NCT01673594|734655|P1|Overall Study|Lost to Follow-up|1
224040|NCT01673594|734654|P2|Overall Study|Adverse Event|1
224041|NCT01673594|734655|P1|Overall Study|Adverse Event|3
224042|NCT01673490|734674|P1|Overall Study|Withdrawal by Subject|3
224043|NCT01673490|734674|P1|Overall Study|Adverse Event|3
224044|NCT01673490|734674|P1|Overall Study|Lost to Follow-up|1
224045|NCT01673347|734691|P1|Overall Study|failure of allograft|7
224046|NCT01673282|734700|P2|Overall Study|unspecified|6
224047|NCT01673282|734701|P1|Overall Study|unspecified|1
224048|NCT01673282|734700|P2|Overall Study|Withdrawal by Subject|3
224049|NCT01673282|734701|P1|Overall Study|Withdrawal by Subject|3
224050|NCT01673282|734700|P2|Overall Study|Lost to Follow-up|10
224051|NCT01673282|734701|P1|Overall Study|Lost to Follow-up|11
224052|NCT01673282|734700|P2|Overall Study|Lack of Efficacy|2
224053|NCT01673282|734701|P1|Overall Study|Lack of Efficacy|9
224054|NCT01673282|734700|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
224055|NCT01673282|734701|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
224056|NCT01673178|734737|P5|Overall Study|Unspecified|0
224057|NCT01673178|734738|P4|Overall Study|Unspecified|1
224058|NCT01673178|734739|P3|Overall Study|Unspecified|2
224059|NCT01673178|734740|P2|Overall Study|Unspecified|0
224060|NCT01673178|734741|P1|Overall Study|Unspecified|1
224061|NCT01673178|734737|P5|Overall Study|Adverse Event|0
224062|NCT01673178|734738|P4|Overall Study|Adverse Event|2
224063|NCT01673178|734739|P3|Overall Study|Adverse Event|0
224064|NCT01673178|734740|P2|Overall Study|Adverse Event|0
224065|NCT01673178|734741|P1|Overall Study|Adverse Event|1
224066|NCT01673178|734737|P5|Overall Study|Protocol Violation|0
224067|NCT01673178|734738|P4|Overall Study|Protocol Violation|1
224068|NCT01673178|734739|P3|Overall Study|Protocol Violation|0
224069|NCT01673178|734740|P2|Overall Study|Protocol Violation|1
224070|NCT01673178|734741|P1|Overall Study|Protocol Violation|1
224071|NCT01673178|734737|P5|Overall Study|Withdrawal by Subject|2
224072|NCT01673178|734738|P4|Overall Study|Withdrawal by Subject|4
224073|NCT01673178|734739|P3|Overall Study|Withdrawal by Subject|1
224074|NCT01673178|734740|P2|Overall Study|Withdrawal by Subject|0
224075|NCT01673178|734741|P1|Overall Study|Withdrawal by Subject|0
224076|NCT01673178|734737|P5|Overall Study|Lost to Follow-up|0
224077|NCT01673178|734738|P4|Overall Study|Lost to Follow-up|0
224078|NCT01673178|734739|P3|Overall Study|Lost to Follow-up|0
224079|NCT01673178|734740|P2|Overall Study|Lost to Follow-up|1
224080|NCT01673178|734741|P1|Overall Study|Lost to Follow-up|0
224081|NCT01673126|734980|P2|Overall Study|change of diagnosis|3
224082|NCT01673126|734981|P1|Overall Study|change of diagnosis|4
224083|NCT01673009|734997|P1|Overall Study|Withdrawal by Subject|8
224084|NCT01673009|734997|P1|Overall Study|Physician Decision|5
224085|NCT01672970|735082|P1|Overall Study|Enrolled but not treated|1
224086|NCT01672970|735082|P1|Overall Study|Unspecified|9
224087|NCT01672970|735082|P1|Overall Study|Lost to Follow-up|5
224088|NCT01672970|735082|P1|Overall Study|Withdrawal by Subject|2
224089|NCT01672970|735082|P1|Overall Study|Adverse Event|18
224090|NCT01672970|735082|P1|Overall Study|Lack of Efficacy|12
224091|NCT01672957|735118|P1|Overall Study|ICF Signed After Transplantation|5
224092|NCT01672957|735118|P1|Overall Study|Death|2
224093|NCT01672957|735118|P1|Overall Study|Protocol Violation|48
224094|NCT01672788|735137|P4|Washout Period 2 (7 Days)|Adverse Event|1
224095|NCT01672788|735138|P3|Washout Period 2 (7 Days)|Adverse Event|0
224096|NCT01672788|735139|P2|Washout Period 2 (7 Days)|Adverse Event|0
224097|NCT01672788|735140|P1|Washout Period 2 (7 Days)|Adverse Event|0
224098|NCT01672723|735170|P2|First Intervention|Adverse Event|0
224099|NCT01672723|735171|P1|First Intervention|Adverse Event|3
224100|NCT01672294|735208|P4|Overall Study|Lost to Follow-up|9
224101|NCT01672294|735209|P3|Overall Study|Lost to Follow-up|7
224102|NCT01672294|735210|P2|Overall Study|Lost to Follow-up|16
224103|NCT01672294|735211|P1|Overall Study|Lost to Follow-up|1
224104|NCT01672294|735208|P4|Overall Study|Excluded by study|0
224105|NCT01672294|735209|P3|Overall Study|Excluded by study|0
224106|NCT01672294|735210|P2|Overall Study|Excluded by study|1
224107|NCT01672294|735211|P1|Overall Study|Excluded by study|1
224108|NCT01672294|735208|P4|Overall Study|Withdrawal by Subject|4
224109|NCT01672294|735209|P3|Overall Study|Withdrawal by Subject|4
224110|NCT01672294|735210|P2|Overall Study|Withdrawal by Subject|4
224111|NCT01672294|735211|P1|Overall Study|Withdrawal by Subject|4
224112|NCT01671748|735244|P2|4 Week run-in Phase|Not eligible|0
224113|NCT01671748|735245|P1|4 Week run-in Phase|Not eligible|9
224114|NCT01671748|735244|P2|4 Week run-in Phase|Adverse Event|0
224115|NCT01671748|735245|P1|4 Week run-in Phase|Adverse Event|1
224116|NCT01671748|735244|P2|4 Week run-in Phase|Withdrawal by Subject|0
224117|NCT01671748|735245|P1|4 Week run-in Phase|Withdrawal by Subject|1
224118|NCT01671488|735272|P1|Overall Study|Withdrawal by Subject|1
224119|NCT01671280|735287|P1|Overall Study|Withdrawal by Subject|2
224120|NCT01671111|735293|P1|Overall Study|Unspecified|24
224121|NCT01671111|735293|P1|Overall Study|Physician Decision|1
224122|NCT01671111|735293|P1|Overall Study|Withdrawal by Subject|2
224123|NCT01671111|735293|P1|Overall Study|Lack of Efficacy|1
224124|NCT01671111|735293|P1|Overall Study|Adverse Event|2
224125|NCT01671059|735303|P1|Overall Study|Lack of Efficacy|1
224126|NCT01671059|735303|P1|Overall Study|Adverse Event|4
224127|NCT01670721|735395|P1|Overall Study|Other than specified above|38
224128|NCT01670721|735395|P1|Overall Study|Participant's decision|15
224129|NCT01670279|735414|P4|Overall Study|Participant met withdrawal criteria|1
224130|NCT01670279|735415|P3|Overall Study|Participant met withdrawal criteria|0
224131|NCT01670279|735416|P2|Overall Study|Participant met withdrawal criteria|0
224132|NCT01670279|735417|P1|Overall Study|Participant met withdrawal criteria|0
224133|NCT01670279|735414|P4|Overall Study|Physician Decision|0
224134|NCT01670279|735415|P3|Overall Study|Physician Decision|0
224135|NCT01670279|735416|P2|Overall Study|Physician Decision|1
224136|NCT01670279|735417|P1|Overall Study|Physician Decision|0
224137|NCT01670279|735414|P4|Overall Study|Adverse Event|0
224138|NCT01670279|735415|P3|Overall Study|Adverse Event|0
224139|NCT01670279|735416|P2|Overall Study|Adverse Event|1
224140|NCT01670279|735417|P1|Overall Study|Adverse Event|0
224141|NCT01670045|735457|P1|Overall Study|Lost to Follow-up|11
224142|NCT01670045|735457|P1|Overall Study|Death|1
224143|NCT01670045|735457|P1|Overall Study|Adverse Event|1
224144|NCT01670045|735457|P1|Overall Study|Withdrawal by Subject|3
224145|NCT01670019|735475|P2|Overall Study|Withdrawal by Subject|0
224146|NCT01670019|735476|P1|Overall Study|Withdrawal by Subject|6
224147|NCT01670019|735475|P2|Overall Study|Adverse Event|0
224148|NCT01670019|735476|P1|Overall Study|Adverse Event|3
224149|NCT01668797|735553|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
224150|NCT01668797|735554|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
224151|NCT01668797|735555|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
224152|NCT01668797|735556|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
224153|NCT01668797|735553|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
224154|NCT01668797|735554|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
224155|NCT01668797|735555|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
224156|NCT01668797|735556|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
224157|NCT01668797|735553|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
224158|NCT01668797|735554|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
224159|NCT01668797|735555|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
224160|NCT01668797|735556|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
224161|NCT01668797|735553|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
224162|NCT01668797|735554|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
224163|NCT01668797|735555|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
224164|NCT01668797|735556|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
224165|NCT01668797|735553|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
224166|NCT01668797|735554|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
224167|NCT01668797|735555|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
224168|NCT01668797|735556|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
224169|NCT01668797|735553|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
224170|NCT01668797|735554|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
224171|NCT01668797|735555|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
224172|NCT01668797|735556|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
224173|NCT01668797|735553|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
224174|NCT01668797|735554|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
224175|NCT01668797|735555|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
224176|NCT01668797|735556|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
224177|NCT01668797|735553|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
224178|NCT01668797|735554|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
224179|NCT01668797|735555|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
224180|NCT01668797|735556|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
224181|NCT01668797|735553|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
224182|NCT01668797|735554|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
224183|NCT01668797|735555|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
224184|NCT01668797|735556|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
224185|NCT01668797|735553|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
224186|NCT01668797|735554|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
224187|NCT01668797|735555|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
224188|NCT01668797|735556|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
224189|NCT01668797|735553|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
224190|NCT01668797|735554|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
224191|NCT01668797|735555|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
224192|NCT01668797|735556|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
224193|NCT01668797|735553|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
224194|NCT01668797|735554|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
224195|NCT01668797|735555|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
224196|NCT01668797|735556|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
224197|NCT01668797|735553|P4|Phase B (Stabilization Phase)|Protocol Violation|0
224198|NCT01668797|735554|P3|Phase B (Stabilization Phase)|Protocol Violation|0
224199|NCT01668797|735555|P2|Phase B (Stabilization Phase)|Protocol Violation|3
224200|NCT01668797|735556|P1|Phase B (Stabilization Phase)|Protocol Violation|0
224201|NCT01668797|735553|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
224202|NCT01668797|735554|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
224203|NCT01668797|735555|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
224204|NCT01668797|735556|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
224205|NCT01668797|735553|P4|Phase B (Stabilization Phase)|Physician Decision|0
224206|NCT01668797|735554|P3|Phase B (Stabilization Phase)|Physician Decision|0
224207|NCT01668797|735555|P2|Phase B (Stabilization Phase)|Physician Decision|11
224208|NCT01668797|735556|P1|Phase B (Stabilization Phase)|Physician Decision|0
224209|NCT01668797|735553|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
224210|NCT01668797|735554|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
224211|NCT01668797|735555|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
224212|NCT01668797|735556|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
224213|NCT01668797|735553|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
224214|NCT01668797|735554|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
224215|NCT01668797|735555|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
224216|NCT01668797|735556|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
224217|NCT01668797|735553|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
224218|NCT01668797|735554|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
224219|NCT01668797|735555|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
224220|NCT01668797|735556|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
224221|NCT01668797|735553|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
224222|NCT01668797|735554|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
224223|NCT01668797|735555|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
224224|NCT01668797|735556|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
224225|NCT01668797|735553|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
224226|NCT01668797|735554|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
224227|NCT01668797|735555|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
224228|NCT01668797|735556|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
224229|NCT01668797|735553|P4|Phase A (Conversion Phase)|Protocol Violation|0
224230|NCT01668797|735554|P3|Phase A (Conversion Phase)|Protocol Violation|0
224231|NCT01668797|735555|P2|Phase A (Conversion Phase)|Protocol Violation|0
224232|NCT01668797|735556|P1|Phase A (Conversion Phase)|Protocol Violation|2
224233|NCT01668797|735553|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
224234|NCT01668797|735554|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
224235|NCT01668797|735555|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
224236|NCT01668797|735556|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
224237|NCT01668797|735553|P4|Phase A (Conversion Phase)|Physician Decision|0
224238|NCT01668797|735554|P3|Phase A (Conversion Phase)|Physician Decision|0
224239|NCT01668797|735555|P2|Phase A (Conversion Phase)|Physician Decision|0
224240|NCT01668797|735556|P1|Phase A (Conversion Phase)|Physician Decision|2
224241|NCT01668797|735553|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
224242|NCT01668797|735554|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
224243|NCT01668797|735555|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
224244|NCT01668797|735556|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
224245|NCT01668797|735553|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
224246|NCT01668797|735554|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
224247|NCT01668797|735555|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
224248|NCT01668797|735556|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
224249|NCT01668784|735621|P2|Treated (Overall)|Not Specified|4
224250|NCT01668784|735622|P1|Treated (Overall)|Not Specified|0
224251|NCT01668784|735621|P2|Treated (Overall)|Maximal Clinical Benefit|3
224252|NCT01668784|735622|P1|Treated (Overall)|Maximal Clinical Benefit|2
224253|NCT01668784|735621|P2|Treated (Overall)|Withdrawal by Subject|3
224254|NCT01668784|735622|P1|Treated (Overall)|Withdrawal by Subject|2
224255|NCT01668784|735621|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
224256|NCT01668784|735622|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
224257|NCT01668784|735621|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
224258|NCT01668784|735622|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
224259|NCT01668784|735621|P2|Treated (Overall)|Death|1
224260|NCT01668784|735622|P1|Treated (Overall)|Death|1
224261|NCT01668784|735621|P2|Treated (Overall)|Study Drug Toxicity|53
224262|NCT01668784|735622|P1|Treated (Overall)|Study Drug Toxicity|35
224263|NCT01668784|735621|P2|Treated (Overall)|Disease Progression|273
224264|NCT01668784|735622|P1|Treated (Overall)|Disease Progression|285
224265|NCT01668784|735621|P2|Randomized (Pre-treatment)|Not Specified|1
224266|NCT01668784|735622|P1|Randomized (Pre-treatment)|Not Specified|0
224267|NCT01668784|735621|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
224268|NCT01668784|735622|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
224269|NCT01668784|735621|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
224270|NCT01668784|735622|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
224271|NCT01668784|735621|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
224272|NCT01668784|735622|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
224273|NCT01668784|735621|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
224274|NCT01668784|735622|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
224275|NCT01668784|735621|P2|Randomized (Pre-treatment)|Disease Progression|1
224276|NCT01668784|735622|P1|Randomized (Pre-treatment)|Disease Progression|0
224277|NCT01669902|735646|P1|Overall Study|Unspecified|8
224278|NCT01669902|735646|P1|Overall Study|Lack of Efficacy|10
224279|NCT01669902|735646|P1|Overall Study|Adverse Event|11
224280|NCT01669811|735681|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
224281|NCT01669811|735682|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
224282|NCT01669811|735681|P2|Overall Study|Adverse Event|6
224283|NCT01669811|735682|P1|Overall Study|Adverse Event|2
224284|NCT01669811|735681|P2|Overall Study|Withdrawal by Subject|2
224285|NCT01669811|735682|P1|Overall Study|Withdrawal by Subject|1
224286|NCT01669811|735681|P2|Overall Study|Investigator decision|1
224287|NCT01669811|735682|P1|Overall Study|Investigator decision|0
224288|NCT01669629|735749|P2|Period 1|protocol deviation|2
224289|NCT01669629|735750|P1|Period 1|protocol deviation|1
224290|NCT01669577|735773|P1|Overall Study|Physician Decision|34
224291|NCT01669577|735773|P1|Overall Study|Lost to Follow-up|78
224292|NCT01669577|735773|P1|Overall Study|Death|22
224293|NCT01669174|735779|P2|Overall Study|Administrative problems|2
224294|NCT01669174|735780|P1|Overall Study|Administrative problems|1
224295|NCT01669174|735779|P2|Overall Study|Adverse Event|2
224296|NCT01669174|735780|P1|Overall Study|Adverse Event|2
224297|NCT01669174|735779|P2|Overall Study|Lost to Follow-up|0
224298|NCT01669174|735780|P1|Overall Study|Lost to Follow-up|1
224299|NCT01669174|735779|P2|Overall Study|Subject withdrew consent|2
224300|NCT01669174|735780|P1|Overall Study|Subject withdrew consent|2
224301|NCT01669122|735796|P1|Washout Period II|Protocol Violation|2
224302|NCT01669122|735796|P1|Period I|Lost to Follow-up|1
224303|NCT01668667|735830|P4|Overall Study|Withdrawal by Subject|5
224304|NCT01668667|735831|P3|Overall Study|Withdrawal by Subject|5
224305|NCT01668667|735832|P2|Overall Study|Withdrawal by Subject|4
224306|NCT01668667|735833|P1|Overall Study|Withdrawal by Subject|7
224307|NCT01668667|735830|P4|Overall Study|Physician Decision|0
224308|NCT01668667|735831|P3|Overall Study|Physician Decision|1
224309|NCT01668667|735832|P2|Overall Study|Physician Decision|0
224310|NCT01668667|735833|P1|Overall Study|Physician Decision|3
224311|NCT01668667|735830|P4|Overall Study|Lost to Follow-up|6
224312|NCT01668667|735831|P3|Overall Study|Lost to Follow-up|7
224313|NCT01668667|735832|P2|Overall Study|Lost to Follow-up|4
224314|NCT01668667|735833|P1|Overall Study|Lost to Follow-up|9
224315|NCT01668667|735830|P4|Overall Study|Protocol Violation|5
224316|NCT01668667|735831|P3|Overall Study|Protocol Violation|12
224317|NCT01668667|735832|P2|Overall Study|Protocol Violation|10
224318|NCT01668667|735833|P1|Overall Study|Protocol Violation|6
224319|NCT01668667|735830|P4|Overall Study|Lack of Efficacy|3
224320|NCT01668667|735831|P3|Overall Study|Lack of Efficacy|2
224321|NCT01668667|735832|P2|Overall Study|Lack of Efficacy|2
224322|NCT01668667|735833|P1|Overall Study|Lack of Efficacy|3
224323|NCT01668667|735830|P4|Overall Study|Adverse Event|4
224324|NCT01668667|735831|P3|Overall Study|Adverse Event|4
224325|NCT01668667|735832|P2|Overall Study|Adverse Event|6
224326|NCT01668667|735833|P1|Overall Study|Adverse Event|3
224327|NCT01668654|735855|P1|Overall Study|Withdrawal by Subject|1
224328|NCT01668654|735855|P1|Overall Study|Study Closed/Terminated|3
224329|NCT01668589|735916|P4|Overall Study|Other|15
224330|NCT01668589|735917|P3|Overall Study|Other|7
224331|NCT01668589|735918|P2|Overall Study|Other|10
224332|NCT01668589|735919|P1|Overall Study|Other|44
224333|NCT01668589|735916|P4|Overall Study|Death|11
224334|NCT01668589|735917|P3|Overall Study|Death|2
224335|NCT01668589|735918|P2|Overall Study|Death|3
224336|NCT01668589|735919|P1|Overall Study|Death|12
224337|NCT01668589|735916|P4|Overall Study|Full Consent/Agreement Withdrawn|4
224338|NCT01668589|735917|P3|Overall Study|Full Consent/Agreement Withdrawn|11
224339|NCT01668589|735918|P2|Overall Study|Full Consent/Agreement Withdrawn|8
224340|NCT01668589|735919|P1|Overall Study|Full Consent/Agreement Withdrawn|54
224341|NCT01668589|735916|P4|Overall Study|Lost to Follow-up|5
224342|NCT01668589|735917|P3|Overall Study|Lost to Follow-up|15
224343|NCT01668589|735918|P2|Overall Study|Lost to Follow-up|37
224344|NCT01668589|735919|P1|Overall Study|Lost to Follow-up|29
224345|NCT01668173|735957|P1|Overall Study|Trial suspension|4
224346|NCT01668173|735957|P1|Overall Study|Adverse Event|3
224347|NCT01668004|736077|P1|Overall Study|Non-compliance with treatment|2
224348|NCT01668004|736077|P1|Overall Study|Lack of Efficacy|9
224349|NCT01668004|736077|P1|Overall Study|Lost to Follow-up|5
224350|NCT01668004|736077|P1|Overall Study|Withdrawal by Subject|2
224351|NCT01668004|736077|P1|Overall Study|Adverse Event|7
224352|NCT01667926|736099|P3|Overall Study|Side effects|0
224353|NCT01667926|736100|P2|Overall Study|Side effects|0
224354|NCT01667926|736101|P1|Overall Study|Side effects|3
224355|NCT01667926|736099|P3|Overall Study|Lost to Follow-up|1
224356|NCT01667926|736100|P2|Overall Study|Lost to Follow-up|2
224357|NCT01667926|736101|P1|Overall Study|Lost to Follow-up|1
224358|NCT01667926|736099|P3|Overall Study|Inclusion/Exclusion Criteria|5
224359|NCT01667926|736100|P2|Overall Study|Inclusion/Exclusion Criteria|0
224360|NCT01667926|736101|P1|Overall Study|Inclusion/Exclusion Criteria|0
224361|NCT01667926|736099|P3|Overall Study|Time committment|2
224362|NCT01667926|736100|P2|Overall Study|Time committment|0
224363|NCT01667926|736101|P1|Overall Study|Time committment|0
224364|NCT01667926|736099|P3|Overall Study|Physician Decision|1
224365|NCT01667926|736100|P2|Overall Study|Physician Decision|0
224366|NCT01667926|736101|P1|Overall Study|Physician Decision|0
224367|NCT01667926|736099|P3|Overall Study|Withdrawal by Subject|2
224368|NCT01667926|736100|P2|Overall Study|Withdrawal by Subject|2
224369|NCT01667926|736101|P1|Overall Study|Withdrawal by Subject|1
224370|NCT01667900|736114|P20|Part B|Death|0
224371|NCT01667900|736115|P19|Part B|Death|0
224372|NCT01667900|736116|P18|Part B|Death|0
224373|NCT01667900|736117|P17|Part B|Death|1
224374|NCT01667900|736118|P16|Part B|Death|0
224375|NCT01667900|736119|P15|Part B|Death|0
224376|NCT01667900|736120|P14|Part B|Death|0
224377|NCT01667900|736121|P13|Part B|Death|0
224378|NCT01667900|736122|P12|Part B|Death|0
224379|NCT01667900|736123|P11|Part B|Death|0
224380|NCT01667900|736124|P10|Part B|Death|0
224381|NCT01667900|736125|P9|Part B|Death|0
224382|NCT01667900|736126|P8|Part B|Death|0
224383|NCT01667900|736127|P7|Part B|Death|0
224384|NCT01667900|736128|P6|Part B|Death|0
224385|NCT01667900|736129|P5|Part B|Death|0
224386|NCT01667900|736130|P4|Part B|Death|0
224390|NCT01667731|736196|P5|Overall Study|Death|0
224391|NCT01667731|736197|P4|Overall Study|Death|0
224392|NCT01667731|736198|P3|Overall Study|Death|0
224393|NCT01667731|736199|P2|Overall Study|Death|1
224394|NCT01667731|736200|P1|Overall Study|Death|0
224395|NCT01667731|736196|P5|Overall Study|Subject Withdrew Consent|1
224396|NCT01667731|736197|P4|Overall Study|Subject Withdrew Consent|0
224397|NCT01667731|736198|P3|Overall Study|Subject Withdrew Consent|1
224398|NCT01667731|736199|P2|Overall Study|Subject Withdrew Consent|0
224399|NCT01667731|736200|P1|Overall Study|Subject Withdrew Consent|2
224400|NCT01667731|736196|P5|Overall Study|Lost to Follow-up|2
224401|NCT01667731|736197|P4|Overall Study|Lost to Follow-up|1
224402|NCT01667731|736198|P3|Overall Study|Lost to Follow-up|1
224403|NCT01667731|736199|P2|Overall Study|Lost to Follow-up|3
224404|NCT01667731|736200|P1|Overall Study|Lost to Follow-up|2
224405|NCT01667731|736196|P5|Overall Study|Efficacy Failure|24
224406|NCT01667731|736197|P4|Overall Study|Efficacy Failure|1
224407|NCT01667731|736198|P3|Overall Study|Efficacy Failure|0
224408|NCT01667731|736199|P2|Overall Study|Efficacy Failure|12
224409|NCT01667731|736200|P1|Overall Study|Efficacy Failure|1
224410|NCT01667731|736196|P5|Overall Study|Enrolled but not treated|1
224411|NCT01667731|736197|P4|Overall Study|Enrolled but not treated|0
224412|NCT01667731|736198|P3|Overall Study|Enrolled but not treated|0
224413|NCT01667731|736199|P2|Overall Study|Enrolled but not treated|0
224414|NCT01667731|736200|P1|Overall Study|Enrolled but not treated|0
224415|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
224416|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
224417|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
224418|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
224419|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
224420|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
224421|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
224422|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
224423|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
224424|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
224425|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
224426|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
224427|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
224428|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
224429|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
224430|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
224431|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
224432|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
224433|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
224434|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
224435|NCT01667679|736255|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
224436|NCT01667679|736256|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
224437|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
224438|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
224439|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
224440|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
224441|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
224442|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
224443|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
224444|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
224445|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
224446|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
224447|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
224448|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
224449|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
224450|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
224451|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
224452|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
224453|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
224454|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
224455|NCT01667679|736255|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
224456|NCT01667679|736256|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
224457|NCT01667432|736341|P1|Overall Study|Missing Information|4
224458|NCT01667432|736341|P1|Overall Study|Reason Not Specified|2
224459|NCT01667432|736341|P1|Overall Study|Principal Investigator Decision|1
224460|NCT01667432|736341|P1|Overall Study|Protocol Deviation|2
224461|NCT01667432|736341|P1|Overall Study|Adverse Event|1
224462|NCT01667432|736341|P1|Overall Study|Insufficient Therapeutic Response|4
224463|NCT01667432|736341|P1|Overall Study|Refused Treatment/Withdrew Consent|1
224464|NCT01667432|736341|P1|Overall Study|Lost to Follow-up|3
224465|NCT01667432|736341|P1|Overall Study|Moved to Another Center|3
224466|NCT01667432|736341|P1|Overall Study|Failure to Return|10
224467|NCT01667432|736341|P1|Overall Study|Premature Study Termination|26
224468|NCT01667224|736348|P2|Overall Study|Protocol Violation|1
224469|NCT01667224|736349|P1|Overall Study|Protocol Violation|1
224470|NCT01667224|736348|P2|Overall Study|Withdrawal by Subject|1
224471|NCT01667224|736349|P1|Overall Study|Withdrawal by Subject|3
224472|NCT01667107|736363|P2|Overall Study|Lack of Efficacy|1
224473|NCT01667107|736364|P1|Overall Study|Lack of Efficacy|0
224474|NCT01667107|736363|P2|Overall Study|Protocol Violation|1
224475|NCT01667107|736364|P1|Overall Study|Protocol Violation|0
224476|NCT01667107|736363|P2|Overall Study|Tolerability issues|2
224477|NCT01667107|736364|P1|Overall Study|Tolerability issues|0
224478|NCT01667107|736363|P2|Overall Study|Adverse Event|3
224479|NCT01667107|736364|P1|Overall Study|Adverse Event|4
224480|NCT01666951|736382|P2|Overall Study|Not dosed|1
224481|NCT01666951|736383|P1|Overall Study|Not dosed|1
224482|NCT01666782|736434|P2|Overall Study|Enrolled both years; year 1 data used|0
224483|NCT01666782|736435|P1|Overall Study|Enrolled both years; year 1 data used|4
224484|NCT01666782|736434|P2|Overall Study|Received 2 doses of vaccine|1
224485|NCT01666782|736435|P1|Overall Study|Received 2 doses of vaccine|0
224486|NCT01666119|736473|P1|Overall Study|Subject experiencing withdrawal symptoms|5
224664|NCT01662440|737413|P3|Overall Study|Lost to Follow-up|4
224487|NCT01666119|736473|P1|Overall Study|non compliance with study medication, pa|18
224488|NCT01666119|736473|P1|Overall Study|Lost to Follow-up|7
224489|NCT01666119|736473|P1|Overall Study|Withdrawal by Subject|16
224490|NCT01666119|736473|P1|Overall Study|Adverse Event|6
224491|NCT01666002|736480|P2|Overall Study|Lost to Follow-up|0
224492|NCT01666002|736481|P1|Overall Study|Lost to Follow-up|5
224493|NCT01665911|736502|P1|Overall Study|Adverse Event|1
224494|NCT01665911|736502|P1|Overall Study|Withdrawal by Subject|1
224495|NCT01665911|736502|P1|Overall Study|Protocol Violation|4
224496|NCT01665807|736511|P3|Overall Study|Withdrawal by Subject|1
224497|NCT01665807|736512|P2|Overall Study|Withdrawal by Subject|0
224498|NCT01665807|736513|P1|Overall Study|Withdrawal by Subject|2
224499|NCT01664949|736674|P2|Overall Study|Other Miscellaneous Reasons|1
224500|NCT01664949|736675|P1|Overall Study|Other Miscellaneous Reasons|3
224501|NCT01664949|736674|P2|Overall Study|Protocol Violation|5
224502|NCT01664949|736675|P1|Overall Study|Protocol Violation|5
224503|NCT01664949|736674|P2|Overall Study|Personal Reasons|4
224504|NCT01664949|736675|P1|Overall Study|Personal Reasons|3
224505|NCT01664949|736674|P2|Overall Study|Lost to Follow-up|2
224506|NCT01664949|736675|P1|Overall Study|Lost to Follow-up|1
224507|NCT01664949|736674|P2|Overall Study|Lack of Efficacy|1
224508|NCT01664949|736675|P1|Overall Study|Lack of Efficacy|1
224509|NCT01664949|736674|P2|Overall Study|Adverse Event|12
224510|NCT01664949|736675|P1|Overall Study|Adverse Event|11
224511|NCT01664923|736691|P2|Overall Study|Miscellaneous|1
224512|NCT01664923|736692|P1|Overall Study|Miscellaneous|5
224513|NCT01664923|736691|P2|Overall Study|Adverse Event|12
224514|NCT01664923|736692|P1|Overall Study|Adverse Event|16
224515|NCT01664923|736691|P2|Overall Study|Disease Progression|139
224516|NCT01664923|736692|P1|Overall Study|Disease Progression|58
224517|NCT01664923|736691|P2|Overall Study|Withdrawal by Subject|5
224518|NCT01664923|736692|P1|Overall Study|Withdrawal by Subject|11
224519|NCT01664923|736691|P2|Overall Study|Protocol Violation|0
224520|NCT01664923|736692|P1|Overall Study|Protocol Violation|2
224521|NCT01664923|736691|P2|Overall Study|Lost to Follow-up|1
224522|NCT01664923|736692|P1|Overall Study|Lost to Follow-up|0
224523|NCT01664923|736691|P2|Overall Study|Death|0
224524|NCT01664923|736692|P1|Overall Study|Death|1
224525|NCT01664624|736736|P4|Overall Study|Adverse Event|0
224526|NCT01664624|736737|P3|Overall Study|Adverse Event|0
224527|NCT01664624|736738|P2|Overall Study|Adverse Event|1
224528|NCT01664624|736739|P1|Overall Study|Adverse Event|0
224529|NCT01664533|736786|P1|Overall Study|Protocol Violation|3
224530|NCT01664533|736786|P1|Overall Study|Study termination|9
224531|NCT01664533|736786|P1|Overall Study|Lost to Follow-up|3
224532|NCT01664533|736786|P1|Overall Study|Death|42
224533|NCT01664494|736794|P1|Overall Study|Lost to Follow-up|99
224534|NCT01664494|736794|P1|Overall Study|Not specified|49
224535|NCT01664494|736794|P1|Overall Study|Death|18
224536|NCT01664494|736794|P1|Overall Study|Withdrawal by Subject|27
224537|NCT01664247|736801|P2|Overall Study|Unclassified|29
224538|NCT01664247|736802|P1|Overall Study|Unclassified|5
224539|NCT01664247|736801|P2|Overall Study|Withdrawal Criteria|4
224540|NCT01664247|736802|P1|Overall Study|Withdrawal Criteria|1
224541|NCT01664247|736801|P2|Overall Study|Protocol Violation|5
224542|NCT01664247|736802|P1|Overall Study|Protocol Violation|3
224543|NCT01664247|736801|P2|Overall Study|Adverse Event|3
224544|NCT01664247|736802|P1|Overall Study|Adverse Event|5
224545|NCT01664052|736881|P2|Phase 2|No device placement|4
224546|NCT01664052|736882|P1|Phase 2|No device placement|0
224547|NCT01664052|736881|P2|Phase 1|No HSG 1 hr post placement|0
224548|NCT01664052|736882|P1|Phase 1|No HSG 1 hr post placement|1
224549|NCT01664052|736881|P2|Phase 1|No device placement|0
224550|NCT01664052|736882|P1|Phase 1|No device placement|6
224551|NCT01664039|736900|P2|Overall Study|Noncompliance|1
224552|NCT01664039|736901|P1|Overall Study|Noncompliance|1
224553|NCT01664039|736900|P2|Overall Study|Withdrawal by Subject|3
224554|NCT01664039|736901|P1|Overall Study|Withdrawal by Subject|1
224555|NCT01664039|736900|P2|Overall Study|Lost to Follow-up|1
224556|NCT01664039|736901|P1|Overall Study|Lost to Follow-up|1
224557|NCT01664039|736900|P2|Overall Study|Adverse Event|4
224558|NCT01664039|736901|P1|Overall Study|Adverse Event|3
224559|NCT01663987|736923|P2|Overall Study|Other reason not defined above|0
224560|NCT01663987|736924|P1|Overall Study|Other reason not defined above|3
224561|NCT01663987|736923|P2|Overall Study|Withdrawal by Subject|3
224562|NCT01663987|736924|P1|Overall Study|Withdrawal by Subject|2
224563|NCT01663987|736923|P2|Overall Study|Lost to Follow-up|1
224564|NCT01663987|736924|P1|Overall Study|Lost to Follow-up|1
224565|NCT01663987|736923|P2|Overall Study|Adverse Event|2
224566|NCT01663987|736924|P1|Overall Study|Adverse Event|7
224567|NCT01663727|736967|P2|Overall Study|Lost to Follow-up|3
224568|NCT01663727|736968|P1|Overall Study|Lost to Follow-up|8
224569|NCT01663727|736967|P2|Overall Study|Alive in Follow-Up|132
224570|NCT01663727|736968|P1|Overall Study|Alive in Follow-Up|143
224571|NCT01663727|736967|P2|Overall Study|Alive on Treatment|39
224572|NCT01663727|736968|P1|Overall Study|Alive on Treatment|31
224573|NCT01663727|736967|P2|Overall Study|Death|65
224574|NCT01663727|736968|P1|Overall Study|Death|60
224575|NCT01663714|736996|P1|Long-Term Follow-Up|Non-compliance|1
224576|NCT01663714|736996|P1|Long-Term Follow-Up|Death|4
224577|NCT01663714|736996|P1|Long-Term Follow-Up|Lost to Follow-up|1
224578|NCT01663714|736996|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
224579|NCT01663714|736996|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
224580|NCT01663714|736996|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
224581|NCT01663532|737025|P2|Overall Study|Lack of Efficacy|60
224582|NCT01663532|737026|P1|Overall Study|Lack of Efficacy|15
224583|NCT01663532|737025|P2|Overall Study|Withdrawal by Subject|17
224584|NCT01663532|737026|P1|Overall Study|Withdrawal by Subject|35
224585|NCT01663532|737025|P2|Overall Study|Physician Decision|1
224586|NCT01663532|737026|P1|Overall Study|Physician Decision|1
224587|NCT01663532|737025|P2|Overall Study|Met Withdrawal Criteria|6
224588|NCT01663532|737026|P1|Overall Study|Met Withdrawal Criteria|7
224589|NCT01663532|737025|P2|Overall Study|Adverse Event|13
224590|NCT01663532|737026|P1|Overall Study|Adverse Event|7
224591|NCT01663532|737025|P2|Overall Study|Lost to Follow-up|10
224592|NCT01663532|737026|P1|Overall Study|Lost to Follow-up|9
224593|NCT01663506|737044|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
224594|NCT01663506|737044|P1|Overall Study|Adverse Event|1
224595|NCT01663506|737044|P1|Overall Study|Lost to Follow-up|1
224596|NCT01663506|737044|P1|Overall Study|Consent Withdrawal by Subject|1
224597|NCT01663506|737044|P1|Overall Study|Lack of Efficacy|3
224598|NCT01663233|737086|P2|Overall Study|Lost to Follow-up|1
224599|NCT01663233|737087|P1|Overall Study|Lost to Follow-up|0
224600|NCT01663233|737086|P2|Overall Study|Protocol Deviation|4
224601|NCT01663233|737087|P1|Overall Study|Protocol Deviation|1
224602|NCT01663233|737086|P2|Overall Study|Withdrawal by Subject|2
224603|NCT01663233|737087|P1|Overall Study|Withdrawal by Subject|3
224604|NCT01663103|737111|P2|Overall Study|dog bite|0
224605|NCT01663103|737112|P1|Overall Study|dog bite|1
224606|NCT01663103|737111|P2|Overall Study|Adverse Event|0
224607|NCT01663103|737112|P1|Overall Study|Adverse Event|1
224608|NCT01663103|737111|P2|Overall Study|Withdrawal by Subject|2
224609|NCT01663103|737112|P1|Overall Study|Withdrawal by Subject|1
224610|NCT01662999|737140|P6|Period 3|Withdrawal by Subject|0
224611|NCT01662999|737141|P5|Period 3|Withdrawal by Subject|0
224612|NCT01662999|737142|P4|Period 3|Withdrawal by Subject|0
224613|NCT01662999|737143|P3|Period 3|Withdrawal by Subject|0
224614|NCT01662999|737144|P2|Period 3|Withdrawal by Subject|1
224615|NCT01662999|737145|P1|Period 3|Withdrawal by Subject|0
224616|NCT01662986|737216|P2|Overall Study|Other than stated above|0
224617|NCT01662986|737217|P1|Overall Study|Other than stated above|3
224618|NCT01662986|737216|P2|Overall Study|Not Treated|0
224619|NCT01662986|737217|P1|Overall Study|Not Treated|1
224620|NCT01662986|737216|P2|Overall Study|Withdrawal by Subject|2
224621|NCT01662986|737217|P1|Overall Study|Withdrawal by Subject|2
224622|NCT01662986|737216|P2|Overall Study|Lost to Follow-up|4
224623|NCT01662986|737217|P1|Overall Study|Lost to Follow-up|5
224624|NCT01662986|737216|P2|Overall Study|Protocol Violation|3
224625|NCT01662986|737217|P1|Overall Study|Protocol Violation|2
224626|NCT01662986|737216|P2|Overall Study|Adverse Event|4
224627|NCT01662986|737217|P1|Overall Study|Adverse Event|5
224628|NCT01662648|737337|P2|Overall Study|LOE and Participant non-compliant|1
224629|NCT01662648|737338|P1|Overall Study|LOE and Participant non-compliant|0
224630|NCT01662648|737337|P2|Overall Study|LOE and other reason unspecified|0
224631|NCT01662648|737338|P1|Overall Study|LOE and other reason unspecified|1
224632|NCT01662648|737337|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
224633|NCT01662648|737338|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
224634|NCT01662648|737337|P2|Overall Study|Unspecified|11
224635|NCT01662648|737338|P1|Overall Study|Unspecified|8
224636|NCT01662648|737337|P2|Overall Study|Participant non-compliant|20
224637|NCT01662648|737338|P1|Overall Study|Participant non-compliant|16
224638|NCT01662648|737337|P2|Overall Study|Withdrawal by Subject|53
224639|NCT01662648|737338|P1|Overall Study|Withdrawal by Subject|36
224640|NCT01662648|737337|P2|Overall Study|Lost to Follow-up|36
224641|NCT01662648|737338|P1|Overall Study|Lost to Follow-up|24
224642|NCT01662648|737337|P2|Overall Study|Participant ineligible to continue trial|1
224643|NCT01662648|737338|P1|Overall Study|Participant ineligible to continue trial|1
224644|NCT01662648|737337|P2|Overall Study|Lack of Efficacy|16
224645|NCT01662648|737338|P1|Overall Study|Lack of Efficacy|17
224646|NCT01662648|737337|P2|Overall Study|Adverse Event|37
224647|NCT01662648|737338|P1|Overall Study|Adverse Event|40
224648|NCT01662648|737337|P2|Overall Study|Death|3
224649|NCT01662648|737338|P1|Overall Study|Death|1
224650|NCT01662635|737360|P1|Overall Study|scarce samples for evaluation|30
224651|NCT01662440|737412|P4|Overall Study|Withdrawal by Subject|2
224652|NCT01662440|737413|P3|Overall Study|Withdrawal by Subject|2
224653|NCT01662440|737414|P2|Overall Study|Withdrawal by Subject|2
224654|NCT01662440|737415|P1|Overall Study|Withdrawal by Subject|5
224655|NCT01662440|737412|P4|Overall Study|Protocol Violation|0
224656|NCT01662440|737413|P3|Overall Study|Protocol Violation|0
224657|NCT01662440|737414|P2|Overall Study|Protocol Violation|0
224658|NCT01662440|737415|P1|Overall Study|Protocol Violation|1
224659|NCT01662440|737412|P4|Overall Study|Subject moved to another country.|0
224660|NCT01662440|737413|P3|Overall Study|Subject moved to another country.|0
224661|NCT01662440|737414|P2|Overall Study|Subject moved to another country.|1
224662|NCT01662440|737415|P1|Overall Study|Subject moved to another country.|0
224663|NCT01662440|737412|P4|Overall Study|Lost to Follow-up|1
224665|NCT01662440|737414|P2|Overall Study|Lost to Follow-up|2
224666|NCT01662440|737415|P1|Overall Study|Lost to Follow-up|2
224667|NCT01662440|737412|P4|Overall Study|Death|0
224668|NCT01662440|737413|P3|Overall Study|Death|0
224669|NCT01662440|737414|P2|Overall Study|Death|1
224670|NCT01662440|737415|P1|Overall Study|Death|0
224671|NCT01662440|737412|P4|Overall Study|Adverse Event|1
224672|NCT01662440|737413|P3|Overall Study|Adverse Event|0
224673|NCT01662440|737414|P2|Overall Study|Adverse Event|0
224674|NCT01662440|737415|P1|Overall Study|Adverse Event|1
224675|NCT01662362|737463|P1|Overall Study|Lost to Follow-up|38
224676|NCT01662310|737468|P5|Open-Label Extension Phase|Withdrawal by Subject|7
224677|NCT01662310|737469|P4|Open-Label Extension Phase|Withdrawal by Subject|2
224678|NCT01662310|737470|P3|Open-Label Extension Phase|Withdrawal by Subject|0
224679|NCT01662310|737471|P2|Open-Label Extension Phase|Withdrawal by Subject|0
224680|NCT01662310|737472|P1|Open-Label Extension Phase|Withdrawal by Subject|0
224681|NCT01662310|737468|P5|Open-Label Extension Phase|Pregnancy|0
224682|NCT01662310|737469|P4|Open-Label Extension Phase|Pregnancy|1
224683|NCT01662310|737470|P3|Open-Label Extension Phase|Pregnancy|0
224684|NCT01662310|737471|P2|Open-Label Extension Phase|Pregnancy|0
224685|NCT01662310|737472|P1|Open-Label Extension Phase|Pregnancy|0
224686|NCT01662310|737468|P5|Open-Label Extension Phase|Lost to Follow-up|1
224687|NCT01662310|737469|P4|Open-Label Extension Phase|Lost to Follow-up|2
224688|NCT01662310|737470|P3|Open-Label Extension Phase|Lost to Follow-up|0
224689|NCT01662310|737471|P2|Open-Label Extension Phase|Lost to Follow-up|0
224690|NCT01662310|737472|P1|Open-Label Extension Phase|Lost to Follow-up|0
224691|NCT01662310|737468|P5|Open-Label Extension Phase|Lack of Efficacy|2
224692|NCT01662310|737469|P4|Open-Label Extension Phase|Lack of Efficacy|2
224693|NCT01662310|737470|P3|Open-Label Extension Phase|Lack of Efficacy|0
224694|NCT01662310|737471|P2|Open-Label Extension Phase|Lack of Efficacy|0
224695|NCT01662310|737472|P1|Open-Label Extension Phase|Lack of Efficacy|0
224696|NCT01662310|737468|P5|Open-Label Extension Phase|Death|0
224697|NCT01662310|737469|P4|Open-Label Extension Phase|Death|1
224698|NCT01662310|737470|P3|Open-Label Extension Phase|Death|0
224699|NCT01662310|737471|P2|Open-Label Extension Phase|Death|0
224700|NCT01662310|737472|P1|Open-Label Extension Phase|Death|0
224701|NCT01662310|737468|P5|Open-Label Extension Phase|Adverse Event|0
224702|NCT01662310|737469|P4|Open-Label Extension Phase|Adverse Event|3
224703|NCT01662310|737470|P3|Open-Label Extension Phase|Adverse Event|0
224704|NCT01662310|737471|P2|Open-Label Extension Phase|Adverse Event|0
224705|NCT01662310|737472|P1|Open-Label Extension Phase|Adverse Event|0
224706|NCT01662310|737468|P5|Double-Blind Phase|Randomized but not treated|0
224707|NCT01662310|737469|P4|Double-Blind Phase|Randomized but not treated|0
224708|NCT01662310|737470|P3|Double-Blind Phase|Randomized but not treated|0
224709|NCT01662310|737471|P2|Double-Blind Phase|Randomized but not treated|1
224710|NCT01662310|737472|P1|Double-Blind Phase|Randomized but not treated|0
224711|NCT01662310|737468|P5|Double-Blind Phase|unspecified|0
224712|NCT01662310|737469|P4|Double-Blind Phase|unspecified|0
224713|NCT01662310|737470|P3|Double-Blind Phase|unspecified|1
224714|NCT01662310|737471|P2|Double-Blind Phase|unspecified|0
224715|NCT01662310|737472|P1|Double-Blind Phase|unspecified|0
224716|NCT01662310|737468|P5|Double-Blind Phase|Withdrawal by Subject|0
224717|NCT01662310|737469|P4|Double-Blind Phase|Withdrawal by Subject|0
224718|NCT01662310|737470|P3|Double-Blind Phase|Withdrawal by Subject|3
224719|NCT01662310|737471|P2|Double-Blind Phase|Withdrawal by Subject|9
224720|NCT01662310|737472|P1|Double-Blind Phase|Withdrawal by Subject|0
224721|NCT01662310|737468|P5|Double-Blind Phase|Pregnancy|0
224722|NCT01662310|737469|P4|Double-Blind Phase|Pregnancy|0
224723|NCT01662310|737470|P3|Double-Blind Phase|Pregnancy|0
224724|NCT01662310|737471|P2|Double-Blind Phase|Pregnancy|2
224725|NCT01662310|737472|P1|Double-Blind Phase|Pregnancy|0
224726|NCT01662310|737468|P5|Double-Blind Phase|Lost to Follow-up|0
224727|NCT01662310|737469|P4|Double-Blind Phase|Lost to Follow-up|0
224728|NCT01662310|737470|P3|Double-Blind Phase|Lost to Follow-up|0
224729|NCT01662310|737471|P2|Double-Blind Phase|Lost to Follow-up|3
224730|NCT01662310|737472|P1|Double-Blind Phase|Lost to Follow-up|0
224731|NCT01662310|737468|P5|Double-Blind Phase|Adverse Event|0
224732|NCT01662310|737469|P4|Double-Blind Phase|Adverse Event|0
224733|NCT01662310|737470|P3|Double-Blind Phase|Adverse Event|1
224734|NCT01662310|737471|P2|Double-Blind Phase|Adverse Event|0
224735|NCT01662310|737472|P1|Double-Blind Phase|Adverse Event|0
224736|NCT01662310|737468|P5|Run-In or Stabilization Phase|unspecified|0
224737|NCT01662310|737469|P4|Run-In or Stabilization Phase|unspecified|0
224738|NCT01662310|737470|P3|Run-In or Stabilization Phase|unspecified|0
224739|NCT01662310|737471|P2|Run-In or Stabilization Phase|unspecified|0
224740|NCT01662310|737472|P1|Run-In or Stabilization Phase|unspecified|1
224741|NCT01662310|737468|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
224742|NCT01662310|737469|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
224743|NCT01662310|737470|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
224744|NCT01662310|737471|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
224745|NCT01662310|737472|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
224746|NCT01662310|737468|P5|Run-In or Stabilization Phase|Protocol Violation|0
224747|NCT01662310|737469|P4|Run-In or Stabilization Phase|Protocol Violation|0
224748|NCT01662310|737470|P3|Run-In or Stabilization Phase|Protocol Violation|0
224749|NCT01662310|737471|P2|Run-In or Stabilization Phase|Protocol Violation|0
224750|NCT01662310|737472|P1|Run-In or Stabilization Phase|Protocol Violation|15
224751|NCT01662310|737468|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
224752|NCT01662310|737469|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
224753|NCT01662310|737470|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
224754|NCT01662310|737471|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
224755|NCT01662310|737472|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
224756|NCT01662310|737468|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
224757|NCT01662310|737469|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
224758|NCT01662310|737470|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
224759|NCT01662310|737471|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
224760|NCT01662310|737472|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
224761|NCT01662310|737468|P5|Run-In or Stabilization Phase|Adverse Event|0
224762|NCT01662310|737469|P4|Run-In or Stabilization Phase|Adverse Event|0
224763|NCT01662310|737470|P3|Run-In or Stabilization Phase|Adverse Event|0
224764|NCT01662310|737471|P2|Run-In or Stabilization Phase|Adverse Event|0
224765|NCT01662310|737472|P1|Run-In or Stabilization Phase|Adverse Event|11
224766|NCT01662102|737506|P2|Overall Study|Sponsor's decision|0
224767|NCT01662102|737507|P1|Overall Study|Sponsor's decision|1
224768|NCT01662063|737515|P3|Overall Study|Not Specified|0
224769|NCT01662063|737516|P2|Overall Study|Not Specified|1
224770|NCT01662063|737517|P1|Overall Study|Not Specified|0
224771|NCT01662063|737515|P3|Overall Study|Physician Decision|0
224772|NCT01662063|737516|P2|Overall Study|Physician Decision|2
224773|NCT01662063|737517|P1|Overall Study|Physician Decision|0
224774|NCT01662063|737515|P3|Overall Study|Withdrawal by Subject|1
224775|NCT01662063|737516|P2|Overall Study|Withdrawal by Subject|4
224776|NCT01662063|737517|P1|Overall Study|Withdrawal by Subject|2
224777|NCT01662063|737515|P3|Overall Study|Protocol Violation|0
224778|NCT01662063|737516|P2|Overall Study|Protocol Violation|0
224779|NCT01662063|737517|P1|Overall Study|Protocol Violation|1
224780|NCT01662063|737515|P3|Overall Study|Lost to Follow-up|0
224781|NCT01662063|737516|P2|Overall Study|Lost to Follow-up|4
224782|NCT01662063|737517|P1|Overall Study|Lost to Follow-up|0
224783|NCT01662063|737515|P3|Overall Study|Lack of Efficacy|0
224784|NCT01662063|737516|P2|Overall Study|Lack of Efficacy|6
224785|NCT01662063|737517|P1|Overall Study|Lack of Efficacy|1
224786|NCT01662063|737515|P3|Overall Study|Adverse Event or Intercurrent Illness|0
224787|NCT01662063|737516|P2|Overall Study|Adverse Event or Intercurrent Illness|12
224788|NCT01662063|737517|P1|Overall Study|Adverse Event or Intercurrent Illness|1
224789|NCT01662024|737596|P1|Overall Study|Withdrawal by Subject|3
224790|NCT01662024|737596|P1|Overall Study|Pregnancy|2
224791|NCT01661933|737606|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
224792|NCT01661933|737606|P1|Low-dose Gluten Challenge|Physician Decision|2
224793|NCT01661790|737621|P2|Overall Study|Lost to Follow-up|2
224794|NCT01661790|737622|P1|Overall Study|Lost to Follow-up|0
224795|NCT01661205|737665|P1|Overall Study|Physician Decision|2
224796|NCT01661179|737676|P1|Overall Study|Other Eligibility criteria|4
224797|NCT01661179|737676|P1|Overall Study|Withdrawal by Subject|1
224798|NCT01661179|737676|P1|Overall Study|Death|1
224799|NCT01661140|737680|P3|Double-Blind Period|Administrative/Other|6
224800|NCT01661140|737681|P2|Double-Blind Period|Administrative/Other|7
224801|NCT01661140|737682|P1|Double-Blind Period|Administrative/Other|0
224802|NCT01661140|737680|P3|Double-Blind Period|Sponsor Termination|17
224803|NCT01661140|737681|P2|Double-Blind Period|Sponsor Termination|14
224804|NCT01661140|737682|P1|Double-Blind Period|Sponsor Termination|0
224805|NCT01661140|737680|P3|Double-Blind Period|Investigator's Decision|2
224806|NCT01661140|737681|P2|Double-Blind Period|Investigator's Decision|1
224807|NCT01661140|737682|P1|Double-Blind Period|Investigator's Decision|0
224808|NCT01661140|737680|P3|Double-Blind Period|Withdrawal by Subject|3
224809|NCT01661140|737681|P2|Double-Blind Period|Withdrawal by Subject|1
224810|NCT01661140|737682|P1|Double-Blind Period|Withdrawal by Subject|0
224811|NCT01661140|737680|P3|Double-Blind Period|Protocol Violation|3
224812|NCT01661140|737681|P2|Double-Blind Period|Protocol Violation|2
224813|NCT01661140|737682|P1|Double-Blind Period|Protocol Violation|0
224814|NCT01661140|737680|P3|Double-Blind Period|Adverse Event|18
224815|NCT01661140|737681|P2|Double-Blind Period|Adverse Event|16
224816|NCT01661140|737682|P1|Double-Blind Period|Adverse Event|0
224817|NCT01661140|737680|P3|Double-Blind Period|Refused Treatment|1
224818|NCT01661140|737681|P2|Double-Blind Period|Refused Treatment|0
224819|NCT01661140|737682|P1|Double-Blind Period|Refused Treatment|0
224820|NCT01661140|737680|P3|Open-Label Period|Lost to Follow-up|0
224821|NCT01661140|737681|P2|Open-Label Period|Lost to Follow-up|0
224822|NCT01661140|737682|P1|Open-Label Period|Lost to Follow-up|2
224823|NCT01661140|737680|P3|Open-Label Period|Did not meet EULAR criteria|0
224824|NCT01661140|737681|P2|Open-Label Period|Did not meet EULAR criteria|0
224825|NCT01661140|737682|P1|Open-Label Period|Did not meet EULAR criteria|1
224826|NCT01661140|737680|P3|Open-Label Period|Sponsor termination|0
224827|NCT01661140|737681|P2|Open-Label Period|Sponsor termination|0
224828|NCT01661140|737682|P1|Open-Label Period|Sponsor termination|16
224829|NCT01661140|737680|P3|Open-Label Period|Administrative/Other|0
224830|NCT01661140|737681|P2|Open-Label Period|Administrative/Other|0
224831|NCT01661140|737682|P1|Open-Label Period|Administrative/Other|1
224832|NCT01661140|737680|P3|Open-Label Period|Death|0
224833|NCT01661140|737681|P2|Open-Label Period|Death|0
224834|NCT01661140|737682|P1|Open-Label Period|Death|1
224835|NCT01661140|737680|P3|Open-Label Period|Investigator Decision|0
224836|NCT01661140|737681|P2|Open-Label Period|Investigator Decision|0
224837|NCT01661140|737682|P1|Open-Label Period|Investigator Decision|3
224838|NCT01661140|737680|P3|Open-Label Period|Withdrawal by Subject|0
224839|NCT01661140|737681|P2|Open-Label Period|Withdrawal by Subject|0
224840|NCT01661140|737682|P1|Open-Label Period|Withdrawal by Subject|5
224841|NCT01661140|737680|P3|Open-Label Period|Protocol Violation|0
224842|NCT01661140|737681|P2|Open-Label Period|Protocol Violation|0
224843|NCT01661140|737682|P1|Open-Label Period|Protocol Violation|3
224844|NCT01661140|737680|P3|Open-Label Period|Adverse Event|0
224845|NCT01661140|737681|P2|Open-Label Period|Adverse Event|0
224846|NCT01661140|737682|P1|Open-Label Period|Adverse Event|44
224847|NCT01661062|737728|P1|Overall Study|Withdrawal by Subject|2
224848|NCT01661062|737728|P1|Overall Study|Completed Treatment Off Study|3
224849|NCT01660906|737733|P1|Overall Study|Discontinued due to study drug toxicity|3
224850|NCT01660763|737764|P2|Overall Study|Patient ready for early discharge|4
224851|NCT01660763|737765|P1|Overall Study|Patient ready for early discharge|28
224852|NCT01660763|737764|P2|Overall Study|Withdrawal by Subject|0
224853|NCT01660763|737765|P1|Overall Study|Withdrawal by Subject|4
224854|NCT01660763|737764|P2|Overall Study|Protocol Violation|0
224855|NCT01660763|737765|P1|Overall Study|Protocol Violation|1
224856|NCT01660763|737764|P2|Overall Study|Adverse Event|7
224857|NCT01660763|737765|P1|Overall Study|Adverse Event|22
224858|NCT01660763|737764|P2|Overall Study|Lack of Efficacy|50
224859|NCT01660763|737765|P1|Overall Study|Lack of Efficacy|45
224860|NCT01660334|737795|P1|Overall Study|Lost to Follow-up|1
224861|NCT01660022|738038|P6|First Sequence (7 Days)|Protocol Violation|1
224862|NCT01660022|738039|P5|First Sequence (7 Days)|Protocol Violation|0
224863|NCT01660022|738040|P4|First Sequence (7 Days)|Protocol Violation|0
224864|NCT01660022|738041|P3|First Sequence (7 Days)|Protocol Violation|0
224865|NCT01660022|738042|P2|First Sequence (7 Days)|Protocol Violation|0
224866|NCT01660022|738043|P1|First Sequence (7 Days)|Protocol Violation|0
224867|NCT01660022|738038|P6|First Sequence (7 Days)|Adverse Event|3
224868|NCT01660022|738039|P5|First Sequence (7 Days)|Adverse Event|1
224869|NCT01660022|738040|P4|First Sequence (7 Days)|Adverse Event|0
224870|NCT01660022|738041|P3|First Sequence (7 Days)|Adverse Event|0
224871|NCT01660022|738042|P2|First Sequence (7 Days)|Adverse Event|0
224872|NCT01660022|738043|P1|First Sequence (7 Days)|Adverse Event|0
224873|NCT01660022|738038|P6|First Sequence (7 Days)|Withdrawal by Subject|0
224874|NCT01660022|738039|P5|First Sequence (7 Days)|Withdrawal by Subject|0
224875|NCT01660022|738040|P4|First Sequence (7 Days)|Withdrawal by Subject|1
224876|NCT01660022|738041|P3|First Sequence (7 Days)|Withdrawal by Subject|0
224877|NCT01660022|738042|P2|First Sequence (7 Days)|Withdrawal by Subject|1
224878|NCT01660022|738043|P1|First Sequence (7 Days)|Withdrawal by Subject|0
224879|NCT01659996|738102|P3|Overall Study|Withdrawal by Subject|5
224880|NCT01659996|738103|P2|Overall Study|Withdrawal by Subject|1
224881|NCT01659996|738104|P1|Overall Study|Withdrawal by Subject|4
224882|NCT01659996|738102|P3|Overall Study|Adverse Event|1
224883|NCT01659996|738103|P2|Overall Study|Adverse Event|0
224884|NCT01659996|738104|P1|Overall Study|Adverse Event|0
224885|NCT01659996|738102|P3|Overall Study|Lost to Follow-up|2
224886|NCT01659996|738103|P2|Overall Study|Lost to Follow-up|3
224887|NCT01659996|738104|P1|Overall Study|Lost to Follow-up|1
224888|NCT01659996|738102|P3|Overall Study|Protocol Violation|3
224889|NCT01659996|738103|P2|Overall Study|Protocol Violation|3
224890|NCT01659996|738104|P1|Overall Study|Protocol Violation|3
224891|NCT01659853|738136|P2|Washout , 3 to 7 Days|Protocol Violation|0
224892|NCT01659853|738137|P1|Washout , 3 to 7 Days|Protocol Violation|1
224893|NCT01659853|738136|P2|Washout , 3 to 7 Days|Adverse Event|0
224894|NCT01659853|738137|P1|Washout , 3 to 7 Days|Adverse Event|1
224895|NCT01659736|738147|P2|3-month Follow-up|Lost to Follow-up|1
224896|NCT01659736|738148|P1|3-month Follow-up|Lost to Follow-up|0
224897|NCT01659736|738147|P2|Treatment Period|Withdrawal by Subject|0
224898|NCT01659736|738148|P1|Treatment Period|Withdrawal by Subject|1
224899|NCT01659736|738147|P2|Treatment Period|Protocol Violation|1
224900|NCT01659736|738148|P1|Treatment Period|Protocol Violation|3
224901|NCT01659736|738147|P2|Treatment Period|Adverse Event|1
224902|NCT01659736|738148|P1|Treatment Period|Adverse Event|1
224903|NCT01659554|738162|P1|Overall Study|Study Termination|4
224904|NCT01659320|738169|P1|Overall Study|Physician Decision|1
224905|NCT01659320|738169|P1|Overall Study|Withdrawal by Subject|2
224906|NCT01659125|738188|P1|Overall Study|Failed to Start Treatment|2
224907|NCT01659125|738188|P1|Overall Study|Time Constraints|2
224908|NCT01659125|738188|P1|Overall Study|Technical Problem|1
224909|NCT01659125|738188|P1|Overall Study|Lost to Follow-up|7
224910|NCT01659125|738188|P1|Overall Study|Withdrawal by Subject|2
224911|NCT01659021|738195|P2|Overall Study|Still on Study|1
224912|NCT01659021|738196|P1|Overall Study|Still on Study|34
224913|NCT01659021|738195|P2|Overall Study|Withdrawal by Subject|16
224914|NCT01659021|738196|P1|Overall Study|Withdrawal by Subject|18
224915|NCT01659021|738195|P2|Overall Study|Physician Decision|16
224916|NCT01659021|738196|P1|Overall Study|Physician Decision|32
224917|NCT01659021|738195|P2|Overall Study|Other?|1
224918|NCT01659021|738196|P1|Overall Study|Other?|1
224919|NCT01659021|738195|P2|Overall Study|Lost to Follow-up|0
224920|NCT01659021|738196|P1|Overall Study|Lost to Follow-up|1
224921|NCT01659021|738195|P2|Overall Study|Adverse Event|3
224922|NCT01659021|738196|P1|Overall Study|Adverse Event|2
224923|NCT01658943|738214|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
224924|NCT01658943|738215|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
224925|NCT01658943|738214|P2|Overall Study|Not eligible|9
224926|NCT01658943|738215|P1|Overall Study|Not eligible|7
224927|NCT01658943|738214|P2|Overall Study|not protocol specified|1
224928|NCT01658943|738215|P1|Overall Study|not protocol specified|4
224929|NCT01658943|738214|P2|Overall Study|Death|2
224930|NCT01658943|738215|P1|Overall Study|Death|4
224931|NCT01658943|738214|P2|Overall Study|Progression/Relapse|40
224932|NCT01658943|738215|P1|Overall Study|Progression/Relapse|39
224933|NCT01658943|738214|P2|Overall Study|Withdrawal by Subject|2
224934|NCT01658943|738215|P1|Overall Study|Withdrawal by Subject|9
224935|NCT01658943|738214|P2|Overall Study|Adverse Event|13
224936|NCT01658943|738215|P1|Overall Study|Adverse Event|6
224937|NCT01658904|738230|P3|Overall Study|Principal Investigator discretion|0
224938|NCT01658904|738231|P2|Overall Study|Principal Investigator discretion|0
224939|NCT01658904|738232|P1|Overall Study|Principal Investigator discretion|2
224940|NCT01658813|738258|P1|Overall Study|Disease progression|3
224941|NCT01658735|738269|P3|Overall Study|Withdrawal by Subject|3
224942|NCT01658735|738270|P2|Overall Study|Withdrawal by Subject|5
224943|NCT01658735|738271|P1|Overall Study|Withdrawal by Subject|3
224944|NCT01658735|738269|P3|Overall Study|Protocol Violation|0
224945|NCT01658735|738270|P2|Overall Study|Protocol Violation|1
224946|NCT01658735|738271|P1|Overall Study|Protocol Violation|0
224947|NCT01658735|738269|P3|Overall Study|Lost to Follow-up|0
224948|NCT01658735|738270|P2|Overall Study|Lost to Follow-up|1
224949|NCT01658735|738271|P1|Overall Study|Lost to Follow-up|1
224950|NCT01658735|738269|P3|Overall Study|Lack of Efficacy|1
224951|NCT01658735|738270|P2|Overall Study|Lack of Efficacy|0
224952|NCT01658735|738271|P1|Overall Study|Lack of Efficacy|1
224953|NCT01658579|738313|P4|Treatment Period B|Unspecified|1
224954|NCT01658579|738314|P3|Treatment Period B|Unspecified|0
224955|NCT01658579|738315|P2|Treatment Period B|Unspecified|0
224956|NCT01658579|738316|P1|Treatment Period B|Unspecified|0
224957|NCT01658579|738313|P4|Treatment Period A|Adverse Event|0
224958|NCT01658579|738314|P3|Treatment Period A|Adverse Event|0
224959|NCT01658579|738315|P2|Treatment Period A|Adverse Event|0
224960|NCT01658579|738316|P1|Treatment Period A|Adverse Event|1
224961|NCT01658579|738313|P4|Treatment Period A|Unspecified|1
224962|NCT01658579|738314|P3|Treatment Period A|Unspecified|1
224963|NCT01658579|738315|P2|Treatment Period A|Unspecified|0
224964|NCT01658579|738316|P1|Treatment Period A|Unspecified|0
224965|NCT01658514|738344|P3|Overall Study|Protocol Violation|2
224966|NCT01658514|738345|P2|Overall Study|Protocol Violation|0
224967|NCT01658514|738346|P1|Overall Study|Protocol Violation|1
224968|NCT01658436|738357|P2|Overall Study|Death|0
224969|NCT01658436|738358|P1|Overall Study|Death|1
224970|NCT01658436|738357|P2|Overall Study|Subject/guardian decision|1
224971|NCT01658436|738358|P1|Overall Study|Subject/guardian decision|0
224972|NCT01658436|738357|P2|Overall Study|Study terminated by sponsor|1
224973|NCT01658436|738358|P1|Overall Study|Study terminated by sponsor|0
224974|NCT01658436|738357|P2|Overall Study|Progressive disease|4
224975|NCT01658436|738358|P1|Overall Study|Progressive disease|12
224976|NCT01658436|738357|P2|Overall Study|Physician Decision|0
224977|NCT01658436|738358|P1|Overall Study|Physician Decision|1
224978|NCT01658436|738357|P2|Overall Study|Adverse Event|5
224979|NCT01658436|738358|P1|Overall Study|Adverse Event|6
224980|NCT01658072|738367|P2|Overall Study|Protocol Violation|2
224981|NCT01658072|738368|P1|Overall Study|Protocol Violation|4
224982|NCT01658020|738376|P2|Overall Study|Protocol Violation|1
224983|NCT01658020|738377|P1|Overall Study|Protocol Violation|0
224984|NCT01658020|738376|P2|Overall Study|Withdrawal by Subject|5
224985|NCT01658020|738377|P1|Overall Study|Withdrawal by Subject|4
224986|NCT01658020|738376|P2|Overall Study|Lost to Follow-up|0
224987|NCT01658020|738377|P1|Overall Study|Lost to Follow-up|1
224988|NCT01658020|738376|P2|Overall Study|Adverse Event|3
224989|NCT01658020|738377|P1|Overall Study|Adverse Event|3
224990|NCT01657903|738393|P1|Overall Study|Withdrawal by Subject|1
224991|NCT01657903|738393|P1|Overall Study|Lost to Follow-up|1
224992|NCT01657877|738415|P1|Overall Study|Other Reason|2
224993|NCT01657877|738415|P1|Overall Study|Adverse Event|2
224994|NCT01657877|738415|P1|Overall Study|Protocol Violation|6
224995|NCT01657877|738415|P1|Overall Study|Withdrawal by Subject|4
224996|NCT01657461|738434|P2|Overall Study|Withdrawal by Subject|3
224997|NCT01657461|738435|P1|Overall Study|Withdrawal by Subject|1
224998|NCT01657461|738434|P2|Overall Study|Physician Decision|2
224999|NCT01657461|738435|P1|Overall Study|Physician Decision|0
225000|NCT01657461|738434|P2|Overall Study|Lost to Follow-up|3
225001|NCT01657461|738435|P1|Overall Study|Lost to Follow-up|0
225002|NCT01657461|738434|P2|Overall Study|Death|12
225003|NCT01657461|738435|P1|Overall Study|Death|9
225004|NCT01657370|738465|P6|Overall Study|Lost to Follow-up|1
225005|NCT01657370|738466|P5|Overall Study|Lost to Follow-up|0
225006|NCT01657370|738467|P4|Overall Study|Lost to Follow-up|0
225007|NCT01657370|738468|P3|Overall Study|Lost to Follow-up|1
225008|NCT01657370|738469|P2|Overall Study|Lost to Follow-up|0
225009|NCT01657370|738470|P1|Overall Study|Lost to Follow-up|2
225010|NCT01657370|738465|P6|Overall Study|Protocol Violation|0
225011|NCT01657370|738466|P5|Overall Study|Protocol Violation|0
225012|NCT01657370|738467|P4|Overall Study|Protocol Violation|1
225013|NCT01657370|738468|P3|Overall Study|Protocol Violation|1
225014|NCT01657370|738469|P2|Overall Study|Protocol Violation|1
225015|NCT01657370|738470|P1|Overall Study|Protocol Violation|1
225016|NCT01657370|738465|P6|Overall Study|Adverse Event|0
225017|NCT01657370|738466|P5|Overall Study|Adverse Event|1
225018|NCT01657370|738467|P4|Overall Study|Adverse Event|0
225019|NCT01657370|738468|P3|Overall Study|Adverse Event|0
225020|NCT01657370|738469|P2|Overall Study|Adverse Event|0
225021|NCT01657370|738470|P1|Overall Study|Adverse Event|0
225022|NCT01657370|738465|P6|Overall Study|Lack of Qualifying Event|2
225023|NCT01657370|738466|P5|Overall Study|Lack of Qualifying Event|1
225024|NCT01657370|738467|P4|Overall Study|Lack of Qualifying Event|2
225025|NCT01657370|738468|P3|Overall Study|Lack of Qualifying Event|3
225026|NCT01657370|738469|P2|Overall Study|Lack of Qualifying Event|0
225027|NCT01657370|738470|P1|Overall Study|Lack of Qualifying Event|1
225028|NCT01657370|738465|P6|Overall Study|Physician Decision|0
225029|NCT01657370|738466|P5|Overall Study|Physician Decision|5
225030|NCT01657370|738467|P4|Overall Study|Physician Decision|2
225031|NCT01657370|738468|P3|Overall Study|Physician Decision|1
225032|NCT01657370|738469|P2|Overall Study|Physician Decision|3
225033|NCT01657370|738470|P1|Overall Study|Physician Decision|2
225034|NCT01657370|738465|P6|Overall Study|Withdrawal by Subject|1
225035|NCT01657370|738466|P5|Overall Study|Withdrawal by Subject|0
225036|NCT01657370|738467|P4|Overall Study|Withdrawal by Subject|0
225037|NCT01657370|738468|P3|Overall Study|Withdrawal by Subject|1
225038|NCT01657370|738469|P2|Overall Study|Withdrawal by Subject|0
225039|NCT01657370|738470|P1|Overall Study|Withdrawal by Subject|0
225040|NCT01657292|738552|P1|Overall Study|Change of therapy|1
225041|NCT01657292|738552|P1|Overall Study|Violation of eligibility criteria|1
225042|NCT01657292|738552|P1|Overall Study|Withdrawal by Subject|2
225043|NCT01657292|738552|P1|Overall Study|Adverse Event|6
225044|NCT01657032|738561|P2|Overall Study|Lost to Follow-up|7
225045|NCT01657032|738562|P1|Overall Study|Lost to Follow-up|0
225046|NCT01657019|738588|P1|Overall Study|Not Specified|58
225047|NCT01657019|738588|P1|Overall Study|Lack of Efficacy|3
225048|NCT01657019|738588|P1|Overall Study|Protocol Violation|6
225049|NCT01657019|738588|P1|Overall Study|Lost to Follow-up|48
225050|NCT01657019|738588|P1|Overall Study|Adverse Event|55
225051|NCT01657019|738588|P1|Overall Study|Withdrawal by Subject|65
225052|NCT01656967|738602|P2|Overall Study|unsuccessful ETT insertion|2
225053|NCT01656967|738603|P1|Overall Study|unsuccessful ETT insertion|3
225054|NCT01656967|738602|P2|Overall Study|faulty monitor|0
225055|NCT01656967|738603|P1|Overall Study|faulty monitor|1
225056|NCT01656889|738625|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
225057|NCT01656889|738626|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
225058|NCT01656889|738625|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
225059|NCT01656889|738626|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
225060|NCT01656889|738625|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
225061|NCT01656889|738626|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
225062|NCT01656889|738625|P2|Post Treatment Follow-Up, 3 Months|Death|5
225063|NCT01656889|738626|P1|Post Treatment Follow-Up, 3 Months|Death|1
225064|NCT01656889|738625|P2|Treatment Period, 12 Weeks|Moved out of the area|2
225065|NCT01656889|738626|P1|Treatment Period, 12 Weeks|Moved out of the area|0
225066|NCT01656889|738625|P2|Treatment Period, 12 Weeks|Protocol Violation|1
225067|NCT01656889|738626|P1|Treatment Period, 12 Weeks|Protocol Violation|0
225068|NCT01656889|738625|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
225069|NCT01656889|738626|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
225070|NCT01656889|738625|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
225071|NCT01656889|738626|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
225072|NCT01656889|738625|P2|Treatment Period, 12 Weeks|Death|1
225073|NCT01656889|738626|P1|Treatment Period, 12 Weeks|Death|0
225074|NCT01656889|738625|P2|Treatment Period, 12 Weeks|Adverse Event|4
225075|NCT01656889|738626|P1|Treatment Period, 12 Weeks|Adverse Event|10
225076|NCT01656850|738646|P2|First Intervention (3 Months)|Withdrawal by Subject|4
225077|NCT01656850|738647|P1|First Intervention (3 Months)|Withdrawal by Subject|3
225078|NCT01656759|738738|P2|Overall Study|Protocol Violation|3
225079|NCT01656759|738739|P1|Overall Study|Protocol Violation|2
225080|NCT01656434|738770|P2|Overall Study|Withdrawal by Subject|7
225081|NCT01656434|738771|P1|Overall Study|Withdrawal by Subject|64
225082|NCT01656434|738770|P2|Overall Study|Participant withdrew consent|9
225083|NCT01656434|738771|P1|Overall Study|Participant withdrew consent|28
225084|NCT01656434|738770|P2|Overall Study|Participant moved|12
225085|NCT01656434|738771|P1|Overall Study|Participant moved|40
225086|NCT01656434|738770|P2|Overall Study|Non-compliance with protocol|15
225087|NCT01656434|738771|P1|Overall Study|Non-compliance with protocol|39
225088|NCT01656434|738770|P2|Overall Study|Part. discontinued; unrelated to drug|10
225089|NCT01656434|738771|P1|Overall Study|Part. discontinued; unrelated to drug|55
225090|NCT01656434|738770|P2|Overall Study|Participant discontinued; drug related|4
225091|NCT01656434|738771|P1|Overall Study|Participant discontinued; drug related|13
225092|NCT01656434|738770|P2|Overall Study|Study terminated by sponsor|348
225093|NCT01656434|738771|P1|Overall Study|Study terminated by sponsor|1501
225094|NCT01656434|738770|P2|Overall Study|Non-compliance with study drug|9
225095|NCT01656434|738771|P1|Overall Study|Non-compliance with study drug|48
225096|NCT01656434|738770|P2|Overall Study|Physician Decision|2
225097|NCT01656434|738771|P1|Overall Study|Physician Decision|7
225098|NCT01656434|738770|P2|Overall Study|Pregnancy|10
225099|NCT01656434|738771|P1|Overall Study|Pregnancy|45
225100|NCT01656434|738770|P2|Overall Study|Pregnancy wish|6
225101|NCT01656434|738771|P1|Overall Study|Pregnancy wish|18
225102|NCT01656434|738770|P2|Overall Study|Protocol Violation|0
225103|NCT01656434|738771|P1|Overall Study|Protocol Violation|7
225104|NCT01656434|738770|P2|Overall Study|Screen failure|0
225105|NCT01656434|738771|P1|Overall Study|Screen failure|2
225106|NCT01656434|738770|P2|Overall Study|Site discontinued study participation|9
225107|NCT01656434|738771|P1|Overall Study|Site discontinued study participation|24
225108|NCT01656434|738770|P2|Overall Study|Lost to Follow-up|76
225109|NCT01656434|738771|P1|Overall Study|Lost to Follow-up|309
225110|NCT01656434|738770|P2|Overall Study|Enrollment terminated at trial site|0
225111|NCT01656434|738771|P1|Overall Study|Enrollment terminated at trial site|2
225112|NCT01656434|738770|P2|Overall Study|Adverse Event|63
225113|NCT01656434|738771|P1|Overall Study|Adverse Event|199
225114|NCT01656408|738797|P10|Overall Study|Physician Decision|3
225115|NCT01656408|738798|P9|Overall Study|Physician Decision|1
225116|NCT01656408|738799|P8|Overall Study|Physician Decision|1
225117|NCT01656408|738800|P7|Overall Study|Physician Decision|0
225118|NCT01656408|738801|P6|Overall Study|Physician Decision|1
225119|NCT01656408|738802|P5|Overall Study|Physician Decision|1
225120|NCT01656408|738803|P4|Overall Study|Physician Decision|0
225121|NCT01656408|738804|P3|Overall Study|Physician Decision|1
225122|NCT01656408|738805|P2|Overall Study|Physician Decision|0
225123|NCT01656408|738806|P1|Overall Study|Physician Decision|1
225124|NCT01656408|738797|P10|Overall Study|Adverse Event|0
225125|NCT01656408|738798|P9|Overall Study|Adverse Event|1
225126|NCT01656408|738799|P8|Overall Study|Adverse Event|0
225127|NCT01656408|738800|P7|Overall Study|Adverse Event|1
225128|NCT01656408|738801|P6|Overall Study|Adverse Event|1
225129|NCT01656408|738802|P5|Overall Study|Adverse Event|0
225130|NCT01656408|738803|P4|Overall Study|Adverse Event|0
225131|NCT01656408|738804|P3|Overall Study|Adverse Event|1
225132|NCT01656408|738805|P2|Overall Study|Adverse Event|0
225133|NCT01656408|738806|P1|Overall Study|Adverse Event|0
225134|NCT01656304|738995|P1|Overall Study|Ineligible, uncontrolled hypertension|1
225135|NCT01656161|739001|P1|Overall Study|Withdrawal by Subject|1
225136|NCT01656161|739001|P1|Overall Study|Protocol Violation|1
225137|NCT01656161|739001|P1|Overall Study|Adverse Event|2
225138|NCT01656161|739001|P1|Overall Study|Death|3
225139|NCT01655498|739019|P1|Overall Study|Withdrawal by Subject|1
225140|NCT01655498|739019|P1|Overall Study|Protocol Violation|2
225141|NCT01655498|739019|P1|Overall Study|Unrelated health issue|2
225142|NCT01655381|739026|P1|Overall Study|Insufficient Treatment Response|1
225143|NCT01655381|739026|P1|Overall Study|Moved to Another City|1
225144|NCT01655381|739026|P1|Overall Study|Investigator Decision|1
225145|NCT01654666|739093|P3|Overall Study|Withdrawal by Subject|1
225146|NCT01654666|739094|P2|Overall Study|Withdrawal by Subject|4
225147|NCT01654666|739095|P1|Overall Study|Withdrawal by Subject|4
225148|NCT01654666|739093|P3|Overall Study|Lost to Follow-up|5
225149|NCT01654666|739094|P2|Overall Study|Lost to Follow-up|5
225150|NCT01654666|739095|P1|Overall Study|Lost to Follow-up|4
225151|NCT01654666|739093|P3|Overall Study|Protocol Violation|8
225152|NCT01654666|739094|P2|Overall Study|Protocol Violation|4
225153|NCT01654666|739095|P1|Overall Study|Protocol Violation|7
225154|NCT01654601|739120|P2|2nd Administration|Protocol Violation|1
225155|NCT01654601|739121|P1|2nd Administration|Protocol Violation|0
225156|NCT01654601|739120|P2|2nd Administration|Adverse Event|0
225157|NCT01654601|739121|P1|2nd Administration|Adverse Event|1
225158|NCT01654601|739120|P2|1st Administration|Protocol Violation|2
225159|NCT01654601|739121|P1|1st Administration|Protocol Violation|0
225160|NCT01654601|739120|P2|1st Administration|Withdrawal by Subject|0
225161|NCT01654601|739121|P1|1st Administration|Withdrawal by Subject|2
225162|NCT01654549|739135|P2|Overall Study|H.pylori eradication not successful|1
225163|NCT01654549|739136|P1|Overall Study|H.pylori eradication not successful|0
225164|NCT01654536|739148|P2|Overall Study|Withdrawal by Subject|25
225165|NCT01654536|739149|P1|Overall Study|Withdrawal by Subject|27
225166|NCT01654536|739148|P2|Overall Study|Physician Decision|8
225167|NCT01654536|739149|P1|Overall Study|Physician Decision|12
225168|NCT01654536|739148|P2|Overall Study|Lost to Follow-up|5
225169|NCT01654536|739149|P1|Overall Study|Lost to Follow-up|5
225170|NCT01654523|739185|P1|Overall Study|Withdrawal by Subject|1
225171|NCT01654302|739191|P2|Second Intervention (Day 7)|Lost to Follow-up|1
225172|NCT01654302|739192|P1|Second Intervention (Day 7)|Lost to Follow-up|1
225173|NCT01654276|739198|P1|Overall Study|Withdrawal by Subject|1
225174|NCT01654276|739198|P1|Overall Study|Lost to Follow-up|4
225175|NCT01654276|739198|P1|Overall Study|Lack of Efficacy|1
225176|NCT01654250|739252|P2|Overall Study|Lost to Follow-up|0
225177|NCT01654250|739253|P1|Overall Study|Lost to Follow-up|1
225178|NCT01654224|739270|P2|Overall Study|Insufficient blood sample|2
225179|NCT01654224|739271|P1|Overall Study|Insufficient blood sample|3
225180|NCT01654224|739270|P2|Overall Study|Did not receive allocation|8
225181|NCT01654224|739271|P1|Overall Study|Did not receive allocation|1
225182|NCT01654224|739270|P2|Overall Study|Lost to Follow-up|2
225183|NCT01654224|739271|P1|Overall Study|Lost to Follow-up|2
225184|NCT01653782|739293|P3|Overall Study|Lost to Follow-up|2
225185|NCT01653782|739294|P2|Overall Study|Lost to Follow-up|3
225186|NCT01653782|739295|P1|Overall Study|Lost to Follow-up|7
225187|NCT01653782|739293|P3|Overall Study|Withdrawal by Subject|4
225188|NCT01653782|739294|P2|Overall Study|Withdrawal by Subject|15
225189|NCT01653782|739295|P1|Overall Study|Withdrawal by Subject|9
225190|NCT01653743|739305|P2|Overall Study|Investigator discretion|0
225191|NCT01653743|739306|P1|Overall Study|Investigator discretion|3
225192|NCT01653743|739305|P2|Overall Study|Withdrawal by Subject|0
225193|NCT01653743|739306|P1|Overall Study|Withdrawal by Subject|1
225194|NCT01653262|739353|P1|Overall Study|AE, non-serious non-fatal|1
225195|NCT01653262|739353|P1|Overall Study|SAE, non-fatal|1
225196|NCT01653262|739353|P1|Overall Study|Lack of Efficacy|1
225197|NCT01653158|739366|P8|Overall Study|Withdrawal by Subject|0
225198|NCT01653158|739367|P7|Overall Study|Withdrawal by Subject|0
225199|NCT01653158|739368|P6|Overall Study|Withdrawal by Subject|0
225200|NCT01653158|739369|P5|Overall Study|Withdrawal by Subject|0
225201|NCT01653158|739370|P4|Overall Study|Withdrawal by Subject|0
225202|NCT01653158|739371|P3|Overall Study|Withdrawal by Subject|0
225203|NCT01653158|739372|P2|Overall Study|Withdrawal by Subject|0
225204|NCT01653158|739373|P1|Overall Study|Withdrawal by Subject|1
225205|NCT01653158|739366|P8|Overall Study|Progressive disease|9
225206|NCT01653158|739367|P7|Overall Study|Progressive disease|2
225207|NCT01653158|739368|P6|Overall Study|Progressive disease|1
225208|NCT01653158|739369|P5|Overall Study|Progressive disease|1
225209|NCT01653158|739370|P4|Overall Study|Progressive disease|0
225210|NCT01653158|739371|P3|Overall Study|Progressive disease|0
225211|NCT01653158|739372|P2|Overall Study|Progressive disease|0
225212|NCT01653158|739373|P1|Overall Study|Progressive disease|0
225213|NCT01653158|739366|P8|Overall Study|Unspecified|1
225214|NCT01653158|739367|P7|Overall Study|Unspecified|0
225215|NCT01653158|739368|P6|Overall Study|Unspecified|0
225216|NCT01653158|739369|P5|Overall Study|Unspecified|0
225217|NCT01653158|739370|P4|Overall Study|Unspecified|0
225218|NCT01653158|739371|P3|Overall Study|Unspecified|0
225219|NCT01653158|739372|P2|Overall Study|Unspecified|0
225220|NCT01653158|739373|P1|Overall Study|Unspecified|0
225221|NCT01653158|739366|P8|Overall Study|Adverse Event|3
225222|NCT01653158|739367|P7|Overall Study|Adverse Event|0
225223|NCT01653158|739368|P6|Overall Study|Adverse Event|0
225224|NCT01653158|739369|P5|Overall Study|Adverse Event|0
225225|NCT01653158|739370|P4|Overall Study|Adverse Event|1
225226|NCT01653158|739371|P3|Overall Study|Adverse Event|0
225227|NCT01653158|739372|P2|Overall Study|Adverse Event|0
225228|NCT01653158|739373|P1|Overall Study|Adverse Event|0
225229|NCT01653158|739366|P8|Overall Study|Death|2
225230|NCT01653158|739367|P7|Overall Study|Death|0
225231|NCT01653158|739368|P6|Overall Study|Death|0
225232|NCT01653158|739369|P5|Overall Study|Death|0
225233|NCT01653158|739370|P4|Overall Study|Death|1
225234|NCT01653158|739371|P3|Overall Study|Death|0
225235|NCT01653158|739372|P2|Overall Study|Death|0
225236|NCT01653158|739373|P1|Overall Study|Death|0
225237|NCT01653132|739645|P2|First Intervention|Protocol Violation|0
225238|NCT01653132|739646|P1|First Intervention|Protocol Violation|1
225239|NCT01652885|739696|P1|Overall Study|Adverse Event|1
225240|NCT01652729|739724|P3|Overall Study|Administrative|0
225241|NCT01652729|739725|P2|Overall Study|Administrative|0
225242|NCT01652729|739726|P1|Overall Study|Administrative|1
225243|NCT01652729|739724|P3|Overall Study|Lost to Follow-up|3
225244|NCT01652729|739725|P2|Overall Study|Lost to Follow-up|6
225245|NCT01652729|739726|P1|Overall Study|Lost to Follow-up|6
225246|NCT01652729|739724|P3|Overall Study|Protocol Violation|0
225247|NCT01652729|739725|P2|Overall Study|Protocol Violation|0
225248|NCT01652729|739726|P1|Overall Study|Protocol Violation|1
225249|NCT01652729|739724|P3|Overall Study|Physician Decision|1
225250|NCT01652729|739725|P2|Overall Study|Physician Decision|0
225251|NCT01652729|739726|P1|Overall Study|Physician Decision|1
225252|NCT01652729|739724|P3|Overall Study|Adverse Event|3
225253|NCT01652729|739725|P2|Overall Study|Adverse Event|0
225254|NCT01652729|739726|P1|Overall Study|Adverse Event|4
225255|NCT01652729|739724|P3|Overall Study|Withdrawal by Subject|7
225256|NCT01652729|739725|P2|Overall Study|Withdrawal by Subject|7
225257|NCT01652729|739726|P1|Overall Study|Withdrawal by Subject|14
225258|NCT01652716|739748|P2|Overall Study|Withdrawal by Subject|18
225259|NCT01652716|739749|P1|Overall Study|Withdrawal by Subject|33
225260|NCT01652716|739748|P2|Overall Study|Adverse Event|10
225261|NCT01652716|739749|P1|Overall Study|Adverse Event|7
225262|NCT01652716|739748|P2|Overall Study|Protocol Violation|1
225263|NCT01652716|739749|P1|Overall Study|Protocol Violation|2
225264|NCT01652716|739748|P2|Overall Study|Lost to Follow-up|11
225265|NCT01652716|739749|P1|Overall Study|Lost to Follow-up|12
225266|NCT01652716|739748|P2|Overall Study|Investigator decision|4
225267|NCT01652716|739749|P1|Overall Study|Investigator decision|1
225268|NCT01652716|739748|P2|Overall Study|Administrative|2
225269|NCT01652716|739749|P1|Overall Study|Administrative|0
225270|NCT01652716|739748|P2|Overall Study|Loss of glucose control|0
225271|NCT01652716|739749|P1|Overall Study|Loss of glucose control|1
225272|NCT01652703|739769|P6|Overall Study|Other|1
225273|NCT01652703|739770|P5|Overall Study|Other|1
225274|NCT01652703|739771|P4|Overall Study|Other|1
225275|NCT01652703|739772|P3|Overall Study|Other|0
225276|NCT01652703|739773|P2|Overall Study|Other|0
225277|NCT01652703|739774|P1|Overall Study|Other|0
225278|NCT01652703|739769|P6|Overall Study|Withdrawal by Subject|1
225279|NCT01652703|739770|P5|Overall Study|Withdrawal by Subject|0
225280|NCT01652703|739771|P4|Overall Study|Withdrawal by Subject|1
225281|NCT01652703|739772|P3|Overall Study|Withdrawal by Subject|3
225282|NCT01652703|739773|P2|Overall Study|Withdrawal by Subject|1
225283|NCT01652703|739774|P1|Overall Study|Withdrawal by Subject|0
225284|NCT01652690|739832|P2|Overall Study|Death|2
225285|NCT01652690|739833|P1|Overall Study|Death|5
225286|NCT01652690|739832|P2|Overall Study|Lost to Follow-up|6
225287|NCT01652690|739833|P1|Overall Study|Lost to Follow-up|6
225288|NCT01652690|739832|P2|Overall Study|Other|9
225289|NCT01652690|739833|P1|Overall Study|Other|8
225290|NCT01652690|739832|P2|Overall Study|Withdrawal by Subject|4
225291|NCT01652690|739833|P1|Overall Study|Withdrawal by Subject|16
225292|NCT01652664|739867|P2|Overall Study|Inadequate IOP control|0
225293|NCT01652664|739868|P1|Overall Study|Inadequate IOP control|1
225294|NCT01652664|739867|P2|Overall Study|Treatment Failure|1
225295|NCT01652664|739868|P1|Overall Study|Treatment Failure|5
225296|NCT01652573|739877|P2|Overall Study|Adverse Event|1
225297|NCT01652573|739878|P1|Overall Study|Adverse Event|0
225298|NCT01652287|739933|P2|Overall Study|Withdrawal by Subject|0
225299|NCT01652287|739934|P1|Overall Study|Withdrawal by Subject|2
225300|NCT01651949|739954|P3|Overall Study|Withdrawal by Subject|9
225301|NCT01651949|739955|P2|Overall Study|Withdrawal by Subject|18
225302|NCT01651949|739956|P1|Overall Study|Withdrawal by Subject|17
225303|NCT01651949|739954|P3|Overall Study|Screen failure|0
225304|NCT01651949|739955|P2|Overall Study|Screen failure|2
225305|NCT01651949|739956|P1|Overall Study|Screen failure|2
225306|NCT01651949|739954|P3|Overall Study|Adverse Event|1
225307|NCT01651949|739955|P2|Overall Study|Adverse Event|2
225308|NCT01651949|739956|P1|Overall Study|Adverse Event|0
225309|NCT01651949|739954|P3|Overall Study|Physician Decision|0
225310|NCT01651949|739955|P2|Overall Study|Physician Decision|2
225311|NCT01651949|739956|P1|Overall Study|Physician Decision|0
225312|NCT01651949|739954|P3|Overall Study|Protocol Violation|1
225313|NCT01651949|739955|P2|Overall Study|Protocol Violation|2
225314|NCT01651949|739956|P1|Overall Study|Protocol Violation|0
225315|NCT01651949|739954|P3|Overall Study|Lost to Follow-up|20
225316|NCT01651949|739955|P2|Overall Study|Lost to Follow-up|56
225317|NCT01651949|739956|P1|Overall Study|Lost to Follow-up|30
225318|NCT01651949|739954|P3|Overall Study|Unknown status|0
225319|NCT01651949|739955|P2|Overall Study|Unknown status|4
225320|NCT01651949|739956|P1|Overall Study|Unknown status|4
225321|NCT01651936|739976|P3|Extension Study|Study terminated by sponsor|13
225322|NCT01651936|739977|P2|Extension Study|Study terminated by sponsor|0
225323|NCT01651936|739978|P1|Extension Study|Study terminated by sponsor|0
225324|NCT01651936|739976|P3|Extension Study|Lack of Efficacy|1
225325|NCT01651936|739977|P2|Extension Study|Lack of Efficacy|0
225326|NCT01651936|739978|P1|Extension Study|Lack of Efficacy|0
225327|NCT01651936|739976|P3|Base Study|Study terminated by sponsor|0
225328|NCT01651936|739977|P2|Base Study|Study terminated by sponsor|16
225329|NCT01651936|739978|P1|Base Study|Study terminated by sponsor|21
225330|NCT01651936|739976|P3|Base Study|Early Escape|0
225331|NCT01651936|739977|P2|Base Study|Early Escape|8
225332|NCT01651936|739978|P1|Base Study|Early Escape|2
225333|NCT01651936|739976|P3|Base Study|Withdrawal by Subject|0
225334|NCT01651936|739977|P2|Base Study|Withdrawal by Subject|1
225335|NCT01651936|739978|P1|Base Study|Withdrawal by Subject|1
225336|NCT01651936|739976|P3|Base Study|Adverse Event|0
225337|NCT01651936|739977|P2|Base Study|Adverse Event|0
225338|NCT01651936|739978|P1|Base Study|Adverse Event|3
225339|NCT01651780|740001|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
225340|NCT01651780|740002|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
225341|NCT01651780|740001|P2|Overall Study|Lost to Follow-up|2
225342|NCT01651780|740002|P1|Overall Study|Lost to Follow-up|1
225343|NCT01651780|740001|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
225344|NCT01651780|740002|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
225345|NCT01651780|740001|P2|Overall Study|Withdrawal by Subject|0
225346|NCT01651780|740002|P1|Overall Study|Withdrawal by Subject|2
225347|NCT01651780|740001|P2|Overall Study|Reason Not Specified: No 30-day visit|2
225348|NCT01651780|740002|P1|Overall Study|Reason Not Specified: No 30-day visit|2
225349|NCT01651780|740001|P2|Overall Study|Physician decision: No 30-day visit|1
225350|NCT01651780|740002|P1|Overall Study|Physician decision: No 30-day visit|2
225351|NCT01651260|740052|P1|Overall Study|unable to apply product|3
225352|NCT01651208|740059|P2|Overall Study|Lost to Follow-up|16
225353|NCT01651208|740060|P1|Overall Study|Lost to Follow-up|14
225354|NCT01651000|740077|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
225355|NCT01651000|740078|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
225356|NCT01651000|740077|P2|Overall Study|Administrative reason|0
225357|NCT01651000|740078|P1|Overall Study|Administrative reason|1
225358|NCT01651000|740077|P2|Overall Study|Physician Decision|0
225359|NCT01651000|740078|P1|Overall Study|Physician Decision|1
225360|NCT01651000|740077|P2|Overall Study|Lack of Efficacy|1
225361|NCT01651000|740078|P1|Overall Study|Lack of Efficacy|1
225362|NCT01651000|740077|P2|Overall Study|Subject noncompliance|3
225363|NCT01651000|740078|P1|Overall Study|Subject noncompliance|0
225364|NCT01651000|740077|P2|Overall Study|Withdrawal by Subject|10
225365|NCT01651000|740078|P1|Overall Study|Withdrawal by Subject|2
225366|NCT01651000|740077|P2|Overall Study|Protocol Violation|3
225367|NCT01651000|740078|P1|Overall Study|Protocol Violation|0
225368|NCT01651000|740077|P2|Overall Study|Lost to Follow-up|2
225369|NCT01651000|740078|P1|Overall Study|Lost to Follow-up|3
225370|NCT01651000|740077|P2|Overall Study|Adverse Event|8
225371|NCT01651000|740078|P1|Overall Study|Adverse Event|2
225372|NCT01650831|740090|P1|Overall Study|Screen failure|1
225373|NCT01650805|740100|P2|Overall Study|Withdrawal by Subject|0
225374|NCT01650805|740101|P1|Overall Study|Withdrawal by Subject|1
225375|NCT01650779|740111|P1|Overall Study|Withdrawal by Subject|1
225376|NCT01650519|740120|P2|Overall Study|Withdrawal by Subject|0
225377|NCT01650519|740121|P1|Overall Study|Withdrawal by Subject|1
225378|NCT01650285|740181|P1|Overall Study|Adverse Event|1
225379|NCT01650246|740185|P1|Overall Study|Lack of Efficacy|30
225380|NCT01650246|740185|P1|Overall Study|Death|1
225381|NCT01650246|740185|P1|Overall Study|Withdrawal by Subject|26
225382|NCT01650246|740185|P1|Overall Study|Lost to Follow-up|5
225383|NCT01650246|740185|P1|Overall Study|Sponsor terminated study|53
225384|NCT01650246|740185|P1|Overall Study|Protocol Violation|5
225385|NCT01650246|740185|P1|Overall Study|Adverse Event|23
225386|NCT01649856|740192|P2|Overall Study|Ongoing in Follow-Up|152
225387|NCT01649856|740193|P1|Overall Study|Ongoing in Follow-Up|303
225388|NCT01649856|740192|P2|Overall Study|Not Specified|0
225389|NCT01649856|740193|P1|Overall Study|Not Specified|1
225390|NCT01649856|740192|P2|Overall Study|Lack of Compliance|1
225391|NCT01649856|740193|P1|Overall Study|Lack of Compliance|0
225392|NCT01649856|740192|P2|Overall Study|Lost to Follow-up|7
225393|NCT01649856|740193|P1|Overall Study|Lost to Follow-up|9
225394|NCT01649856|740192|P2|Overall Study|Stable or Progressed Disease|3
225395|NCT01649856|740193|P1|Overall Study|Stable or Progressed Disease|5
225396|NCT01649856|740192|P2|Overall Study|Death|26
225397|NCT01649856|740193|P1|Overall Study|Death|37
225398|NCT01649856|740192|P2|Overall Study|Treatment Failure|1
225399|NCT01649856|740193|P1|Overall Study|Treatment Failure|4
225400|NCT01649856|740192|P2|Overall Study|Protocol Violation|4
225401|NCT01649856|740193|P1|Overall Study|Protocol Violation|4
225402|NCT01649856|740192|P2|Overall Study|Withdrawal by Subject|9
225403|NCT01649856|740193|P1|Overall Study|Withdrawal by Subject|6
225404|NCT01649804|740225|P1|Overall Study|Administrative/Other|8
225405|NCT01649791|740237|P1|Overall Study|Adverse Event|1
225406|NCT01649791|740237|P1|Overall Study|Disease Progression|2
225407|NCT01649557|740247|P3|Overall Study|Lack of Efficacy|0
225408|NCT01649557|740248|P2|Overall Study|Lack of Efficacy|0
225409|NCT01649557|740249|P1|Overall Study|Lack of Efficacy|5
225410|NCT01649557|740247|P3|Overall Study|Protocol deviation|0
225411|NCT01649557|740248|P2|Overall Study|Protocol deviation|2
225412|NCT01649557|740249|P1|Overall Study|Protocol deviation|0
225413|NCT01649557|740247|P3|Overall Study|Withdrawal by Subject|4
225414|NCT01649557|740248|P2|Overall Study|Withdrawal by Subject|5
225415|NCT01649557|740249|P1|Overall Study|Withdrawal by Subject|15
225416|NCT01649557|740247|P3|Overall Study|Physician Decision|1
225417|NCT01649557|740248|P2|Overall Study|Physician Decision|2
225418|NCT01649557|740249|P1|Overall Study|Physician Decision|8
225419|NCT01649557|740247|P3|Overall Study|Met withdrawal criteria|0
225420|NCT01649557|740248|P2|Overall Study|Met withdrawal criteria|0
225421|NCT01649557|740249|P1|Overall Study|Met withdrawal criteria|4
225422|NCT01649557|740247|P3|Overall Study|Adverse Event|1
225423|NCT01649557|740248|P2|Overall Study|Adverse Event|5
225424|NCT01649557|740249|P1|Overall Study|Adverse Event|7
225425|NCT01649557|740247|P3|Overall Study|Lost to Follow-up|3
225426|NCT01649557|740248|P2|Overall Study|Lost to Follow-up|0
225427|NCT01649557|740249|P1|Overall Study|Lost to Follow-up|5
225428|NCT01649297|740311|P5|Overall Study|For other reason|0
225429|NCT01649297|740312|P4|Overall Study|For other reason|0
225430|NCT01649297|740313|P3|Overall Study|For other reason|2
225431|NCT01649297|740314|P2|Overall Study|For other reason|1
225432|NCT01649297|740315|P1|Overall Study|For other reason|4
225433|NCT01649297|740311|P5|Overall Study|Patient withdrawal (not due to AE)|1
225434|NCT01649297|740312|P4|Overall Study|Patient withdrawal (not due to AE)|1
225435|NCT01649297|740313|P3|Overall Study|Patient withdrawal (not due to AE)|4
225436|NCT01649297|740314|P2|Overall Study|Patient withdrawal (not due to AE)|6
225437|NCT01649297|740315|P1|Overall Study|Patient withdrawal (not due to AE)|3
225438|NCT01649297|740311|P5|Overall Study|Lost to Follow-up|0
225439|NCT01649297|740312|P4|Overall Study|Lost to Follow-up|3
225440|NCT01649297|740313|P3|Overall Study|Lost to Follow-up|4
225441|NCT01649297|740314|P2|Overall Study|Lost to Follow-up|1
225442|NCT01649297|740315|P1|Overall Study|Lost to Follow-up|1
225443|NCT01649297|740311|P5|Overall Study|Non compliant with Protocol|1
225444|NCT01649297|740312|P4|Overall Study|Non compliant with Protocol|2
225445|NCT01649297|740313|P3|Overall Study|Non compliant with Protocol|3
225446|NCT01649297|740314|P2|Overall Study|Non compliant with Protocol|0
225447|NCT01649297|740315|P1|Overall Study|Non compliant with Protocol|1
225448|NCT01649297|740311|P5|Overall Study|Lack of Efficacy|1
225449|NCT01649297|740312|P4|Overall Study|Lack of Efficacy|0
225450|NCT01649297|740313|P3|Overall Study|Lack of Efficacy|0
225451|NCT01649297|740314|P2|Overall Study|Lack of Efficacy|0
225452|NCT01649297|740315|P1|Overall Study|Lack of Efficacy|0
225453|NCT01649297|740311|P5|Overall Study|Adverse Event|1
225454|NCT01649297|740312|P4|Overall Study|Adverse Event|13
225455|NCT01649297|740313|P3|Overall Study|Adverse Event|4
225456|NCT01649297|740314|P2|Overall Study|Adverse Event|5
225457|NCT01649297|740315|P1|Overall Study|Adverse Event|5
225458|NCT01649232|740334|P2|Overall Study|Physician Decision|0
225459|NCT01649232|740335|P1|Overall Study|Physician Decision|2
225460|NCT01648790|740387|P5|Treatment 3|Withdrawal by Subject|0
225461|NCT01648790|740388|P4|Treatment 3|Withdrawal by Subject|1
225462|NCT01648790|740389|P3|Treatment 3|Withdrawal by Subject|0
225463|NCT01648790|740390|P2|Treatment 3|Withdrawal by Subject|0
225464|NCT01648790|740391|P1|Treatment 3|Withdrawal by Subject|0
225465|NCT01648699|740412|P1|Overall Study|Unspecified/unable to complete 4 visits|2
225466|NCT01648699|740412|P1|Overall Study|Lost to Follow-up|2
225467|NCT01648699|740412|P1|Overall Study|Death|1
225468|NCT01647542|740441|P3|Overall Study|Death|1
225469|NCT01647542|740442|P2|Overall Study|Death|0
225470|NCT01647542|740443|P1|Overall Study|Death|0
225471|NCT01647542|740441|P3|Overall Study|Lack of Efficacy|0
225472|NCT01647542|740442|P2|Overall Study|Lack of Efficacy|1
225473|NCT01647542|740443|P1|Overall Study|Lack of Efficacy|1
225474|NCT01647542|740441|P3|Overall Study|Study Termination|65
225475|NCT01647542|740442|P2|Overall Study|Study Termination|61
225476|NCT01647542|740443|P1|Overall Study|Study Termination|64
225477|NCT01647542|740441|P3|Overall Study|Withdrawal by Subject|0
225478|NCT01647542|740442|P2|Overall Study|Withdrawal by Subject|4
225479|NCT01647542|740443|P1|Overall Study|Withdrawal by Subject|6
225480|NCT01647542|740441|P3|Overall Study|Lost to Follow-up|2
225481|NCT01647542|740442|P2|Overall Study|Lost to Follow-up|2
225482|NCT01647542|740443|P1|Overall Study|Lost to Follow-up|0
225483|NCT01647542|740441|P3|Overall Study|Adverse Event|4
225484|NCT01647542|740442|P2|Overall Study|Adverse Event|5
225485|NCT01647542|740443|P1|Overall Study|Adverse Event|4
225486|NCT01647542|740441|P3|Overall Study|Major Protocol Deviation|0
225487|NCT01647542|740442|P2|Overall Study|Major Protocol Deviation|0
225488|NCT01647542|740443|P1|Overall Study|Major Protocol Deviation|1
225489|NCT01648582|740478|P3|Overall Study|Sponsor Decision|1
225490|NCT01648582|740479|P2|Overall Study|Sponsor Decision|1
225491|NCT01648582|740480|P1|Overall Study|Sponsor Decision|0
225492|NCT01648582|740478|P3|Overall Study|Physician Decision|3
225493|NCT01648582|740479|P2|Overall Study|Physician Decision|1
225494|NCT01648582|740480|P1|Overall Study|Physician Decision|0
225495|NCT01648582|740478|P3|Overall Study|Withdrawal by Subject|17
225496|NCT01648582|740479|P2|Overall Study|Withdrawal by Subject|17
225497|NCT01648582|740480|P1|Overall Study|Withdrawal by Subject|15
225498|NCT01648582|740478|P3|Overall Study|Protocol Violation|1
225499|NCT01648582|740479|P2|Overall Study|Protocol Violation|2
225500|NCT01648582|740480|P1|Overall Study|Protocol Violation|1
225501|NCT01648582|740478|P3|Overall Study|Lost to Follow-up|8
225502|NCT01648582|740479|P2|Overall Study|Lost to Follow-up|6
225503|NCT01648582|740480|P1|Overall Study|Lost to Follow-up|9
225504|NCT01648582|740478|P3|Overall Study|Death|0
225505|NCT01648582|740479|P2|Overall Study|Death|0
225506|NCT01648582|740480|P1|Overall Study|Death|1
225507|NCT01648582|740478|P3|Overall Study|Adverse Event|2
225508|NCT01648582|740479|P2|Overall Study|Adverse Event|11
225509|NCT01648582|740480|P1|Overall Study|Adverse Event|6
225510|NCT01648140|740584|P4|Overall Study|Lost to Follow-up|0
225511|NCT01648140|740585|P3|Overall Study|Lost to Follow-up|2
225512|NCT01648140|740586|P2|Overall Study|Lost to Follow-up|1
225513|NCT01648140|740587|P1|Overall Study|Lost to Follow-up|2
225514|NCT01648140|740584|P4|Overall Study|Withdrawal by Subject|2
225515|NCT01648140|740585|P3|Overall Study|Withdrawal by Subject|3
225516|NCT01648140|740586|P2|Overall Study|Withdrawal by Subject|3
225517|NCT01648140|740587|P1|Overall Study|Withdrawal by Subject|2
225518|NCT01648140|740584|P4|Overall Study|Adverse Event|0
225519|NCT01648140|740585|P3|Overall Study|Adverse Event|2
225520|NCT01648140|740586|P2|Overall Study|Adverse Event|1
225521|NCT01648140|740587|P1|Overall Study|Adverse Event|3
225522|NCT01648140|740584|P4|Overall Study|Lack of Efficacy|0
225523|NCT01648140|740585|P3|Overall Study|Lack of Efficacy|1
225524|NCT01648140|740586|P2|Overall Study|Lack of Efficacy|7
225525|NCT01648140|740587|P1|Overall Study|Lack of Efficacy|4
225526|NCT01648140|740584|P4|Overall Study|Physician Decision|0
225527|NCT01648140|740585|P3|Overall Study|Physician Decision|0
225528|NCT01648140|740586|P2|Overall Study|Physician Decision|0
225529|NCT01648140|740587|P1|Overall Study|Physician Decision|1
225530|NCT01648101|740752|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
225531|NCT01648101|740753|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
225532|NCT01648101|740754|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
225533|NCT01648101|740752|P3|Transition Phase (4 Weeks)|Study Terminated|0
225534|NCT01648101|740753|P2|Transition Phase (4 Weeks)|Study Terminated|0
225535|NCT01648101|740754|P1|Transition Phase (4 Weeks)|Study Terminated|1
225536|NCT01648101|740752|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
225537|NCT01648101|740753|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
225538|NCT01648101|740754|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
225539|NCT01648101|740752|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
225540|NCT01648101|740753|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
225541|NCT01648101|740754|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
225542|NCT01648101|740752|P3|Transition Phase (4 Weeks)|Adverse Event|2
225543|NCT01648101|740753|P2|Transition Phase (4 Weeks)|Adverse Event|3
225544|NCT01648101|740754|P1|Transition Phase (4 Weeks)|Adverse Event|4
225545|NCT01648101|740752|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
225546|NCT01648101|740753|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
225547|NCT01648101|740754|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
225548|NCT01648101|740752|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
225549|NCT01648101|740753|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
225550|NCT01648101|740754|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
225551|NCT01648101|740752|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
225552|NCT01648101|740753|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
225553|NCT01648101|740754|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
225554|NCT01648101|740752|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
225555|NCT01648101|740753|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
225556|NCT01648101|740754|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
225557|NCT01648101|740752|P3|Titration Phase (4 Weeks)|Adverse Event|3
225558|NCT01648101|740753|P2|Titration Phase (4 Weeks)|Adverse Event|2
225559|NCT01648101|740754|P1|Titration Phase (4 Weeks)|Adverse Event|0
225560|NCT01648101|740752|P3|Titration Phase (4 Weeks)|Protocol Violation|2
225561|NCT01648101|740753|P2|Titration Phase (4 Weeks)|Protocol Violation|1
225562|NCT01648101|740754|P1|Titration Phase (4 Weeks)|Protocol Violation|2
225563|NCT01647711|740841|P5|Overall Study|Other reason not defined|0
225564|NCT01647711|740842|P4|Overall Study|Other reason not defined|1
225565|NCT01647711|740843|P3|Overall Study|Other reason not defined|1
225566|NCT01647711|740844|P2|Overall Study|Other reason not defined|1
225567|NCT01647711|740845|P1|Overall Study|Other reason not defined|0
225568|NCT01647711|740841|P5|Overall Study|Refused to continue taking medication|1
225569|NCT01647711|740842|P4|Overall Study|Refused to continue taking medication|2
225570|NCT01647711|740843|P3|Overall Study|Refused to continue taking medication|0
225571|NCT01647711|740844|P2|Overall Study|Refused to continue taking medication|0
225572|NCT01647711|740845|P1|Overall Study|Refused to continue taking medication|0
225573|NCT01647711|740841|P5|Overall Study|Protocol Violation|1
225574|NCT01647711|740842|P4|Overall Study|Protocol Violation|0
225575|NCT01647711|740843|P3|Overall Study|Protocol Violation|0
225576|NCT01647711|740844|P2|Overall Study|Protocol Violation|0
225577|NCT01647711|740845|P1|Overall Study|Protocol Violation|0
225578|NCT01647711|740841|P5|Overall Study|Other adverse event|2
225579|NCT01647711|740842|P4|Overall Study|Other adverse event|0
225580|NCT01647711|740843|P3|Overall Study|Other adverse event|2
225581|NCT01647711|740844|P2|Overall Study|Other adverse event|0
225582|NCT01647711|740845|P1|Overall Study|Other adverse event|0
225583|NCT01647711|740841|P5|Overall Study|Progressive disease|2
225584|NCT01647711|740842|P4|Overall Study|Progressive disease|8
225585|NCT01647711|740843|P3|Overall Study|Progressive disease|6
225586|NCT01647711|740844|P2|Overall Study|Progressive disease|2
225587|NCT01647711|740845|P1|Overall Study|Progressive disease|6
225588|NCT01646827|740872|P2|Overall Study|Withdrawal by Subject|0
225589|NCT01646827|740873|P1|Overall Study|Withdrawal by Subject|1
225590|NCT01646827|740872|P2|Overall Study|Physician Decision|2
225591|NCT01646827|740873|P1|Overall Study|Physician Decision|1
225592|NCT01646827|740872|P2|Overall Study|Lost to Follow-up|3
225593|NCT01646827|740873|P1|Overall Study|Lost to Follow-up|0
225594|NCT01646398|740951|P2|Overall Study|Withdrawal by Subject|0
225595|NCT01646398|740952|P1|Overall Study|Withdrawal by Subject|1
225596|NCT01646385|740968|P2|Overall Study|Switched to alternate biologic|649
225597|NCT01646385|740969|P1|Overall Study|Switched to alternate biologic|636
225598|NCT01646385|740968|P2|Overall Study|Death|222
225599|NCT01646385|740969|P1|Overall Study|Death|202
225600|NCT01646320|741002|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
225601|NCT01646320|741003|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
225602|NCT01646320|741002|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
225603|NCT01646320|741003|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
225604|NCT01646320|741002|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
225605|NCT01646320|741003|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
225606|NCT01646320|741002|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
225607|NCT01646320|741003|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
225608|NCT01646320|741002|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
225609|NCT01646320|741003|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
225610|NCT01646320|741002|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
225611|NCT01646320|741003|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
225612|NCT01646320|741002|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
225613|NCT01646320|741003|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
225614|NCT01646320|741002|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
225615|NCT01646320|741003|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
225616|NCT01646320|741002|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
225617|NCT01646320|741003|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
225618|NCT01646320|741002|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
225619|NCT01646320|741003|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
225620|NCT01646320|741002|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
225621|NCT01646320|741003|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
225622|NCT01646268|741019|P2|Overall Study|Other|0
225623|NCT01646268|741020|P1|Overall Study|Other|2
225624|NCT01646268|741019|P2|Overall Study|Withdrawal by Subject|5
225625|NCT01646268|741020|P1|Overall Study|Withdrawal by Subject|2
225626|NCT01646268|741019|P2|Overall Study|Protocol Violation|1
225627|NCT01646268|741020|P1|Overall Study|Protocol Violation|0
225628|NCT01646268|741019|P2|Overall Study|Lack of Efficacy|3
225629|NCT01646268|741020|P1|Overall Study|Lack of Efficacy|1
225630|NCT01646268|741019|P2|Overall Study|Adverse Event|7
225631|NCT01646268|741020|P1|Overall Study|Adverse Event|6
225632|NCT01646255|741034|P2|Overall Study|Inclusion Criteria Deviation|0
225633|NCT01646255|741035|P1|Overall Study|Inclusion Criteria Deviation|1
225634|NCT01646255|741034|P2|Overall Study|Compliance is not well|0
225635|NCT01646255|741035|P1|Overall Study|Compliance is not well|1
225636|NCT01646255|741034|P2|Overall Study|Withdrawal by Subject|6
225637|NCT01646255|741035|P1|Overall Study|Withdrawal by Subject|10
225638|NCT01646255|741034|P2|Overall Study|Lack of Efficacy|0
225639|NCT01646255|741035|P1|Overall Study|Lack of Efficacy|2
225640|NCT01646255|741034|P2|Overall Study|Adverse Event|8
225641|NCT01646255|741035|P1|Overall Study|Adverse Event|7
225642|NCT01646177|741069|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
225643|NCT01646177|741070|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
225644|NCT01646177|741071|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
225645|NCT01646177|741072|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
225646|NCT01646177|741069|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
225647|NCT01646177|741070|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
225648|NCT01646177|741071|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
225649|NCT01646177|741072|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
225650|NCT01646177|741069|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
225651|NCT01646177|741070|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
225652|NCT01646177|741071|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
225653|NCT01646177|741072|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
225654|NCT01646177|741069|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
225655|NCT01646177|741070|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
225656|NCT01646177|741071|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
225657|NCT01646177|741072|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
225658|NCT01646177|741069|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
225659|NCT01646177|741070|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
225660|NCT01646177|741071|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
225661|NCT01646177|741072|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
225662|NCT01646177|741069|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
225663|NCT01646177|741070|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
225664|NCT01646177|741071|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
225665|NCT01646177|741072|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
225666|NCT01646138|741166|P5|Overall Study|Lost to Follow-up|2
225667|NCT01646138|741167|P4|Overall Study|Lost to Follow-up|0
225668|NCT01646138|741168|P3|Overall Study|Lost to Follow-up|0
225669|NCT01646138|741169|P2|Overall Study|Lost to Follow-up|0
225670|NCT01646138|741170|P1|Overall Study|Lost to Follow-up|0
225671|NCT01646125|741184|P2|Overall Study|Subject/Guardian decision|1
225672|NCT01646125|741185|P1|Overall Study|Subject/Guardian decision|1
225673|NCT01646125|741184|P2|Overall Study|Study terminated by sponsor|1
225674|NCT01646125|741185|P1|Overall Study|Study terminated by sponsor|2
225675|NCT01646125|741184|P2|Overall Study|Progressive disease|16
225676|NCT01646125|741185|P1|Overall Study|Progressive disease|22
225677|NCT01646125|741184|P2|Overall Study|Physician Decision|3
225678|NCT01646125|741185|P1|Overall Study|Physician Decision|1
225679|NCT01646125|741184|P2|Overall Study|Death|1
225680|NCT01646125|741185|P1|Overall Study|Death|1
225681|NCT01646125|741184|P2|Overall Study|Adverse Event|1
225682|NCT01646125|741185|P1|Overall Study|Adverse Event|2
225683|NCT01646125|741184|P2|Overall Study|Untreated|5
225684|NCT01646125|741185|P1|Overall Study|Untreated|2
225685|NCT01646073|741210|P2|Period B (12 Weeks)|Lost to Follow-up|1
225686|NCT01646073|741211|P1|Period B (12 Weeks)|Lost to Follow-up|0
225687|NCT01646073|741210|P2|Period B (12 Weeks)|Withdrawal by Subject|5
225688|NCT01646073|741211|P1|Period B (12 Weeks)|Withdrawal by Subject|1
225689|NCT01646073|741210|P2|Period B (12 Weeks)|Adverse Event|7
225690|NCT01646073|741211|P1|Period B (12 Weeks)|Adverse Event|0
225691|NCT01646073|741210|P2|Period A (12 Weeks)|Not Specified|1
225692|NCT01646073|741211|P1|Period A (12 Weeks)|Not Specified|0
225693|NCT01646073|741210|P2|Period A (12 Weeks)|Protocol Violation|1
225694|NCT01646073|741211|P1|Period A (12 Weeks)|Protocol Violation|0
225695|NCT01646073|741210|P2|Period A (12 Weeks)|Lack of Efficacy|0
225696|NCT01646073|741211|P1|Period A (12 Weeks)|Lack of Efficacy|1
225697|NCT01646073|741210|P2|Period A (12 Weeks)|Withdrawal by Subject|1
225698|NCT01646073|741211|P1|Period A (12 Weeks)|Withdrawal by Subject|1
225699|NCT01646073|741210|P2|Period A (12 Weeks)|Adverse Event|2
225700|NCT01646073|741211|P1|Period A (12 Weeks)|Adverse Event|0
225701|NCT01646021|741252|P2|Overall Study|Withdrawal by Subject|13
225702|NCT01646021|741253|P1|Overall Study|Withdrawal by Subject|6
225703|NCT01646021|741252|P2|Overall Study|Lost to Follow-up|2
225704|NCT01646021|741253|P1|Overall Study|Lost to Follow-up|1
225705|NCT01646021|741252|P2|Overall Study|Death|63
225706|NCT01646021|741253|P1|Overall Study|Death|59
225707|NCT01645735|741286|P2|Overall Study|Adverse Event|1
225708|NCT01645735|741287|P1|Overall Study|Adverse Event|0
225709|NCT01645735|741286|P2|Overall Study|Protocol Violation|0
225710|NCT01645735|741287|P1|Overall Study|Protocol Violation|1
225711|NCT01645735|741286|P2|Overall Study|Withdrawal by Subject|0
225712|NCT01645735|741287|P1|Overall Study|Withdrawal by Subject|1
225713|NCT01645735|741286|P2|Overall Study|Physician Decision|0
225714|NCT01645735|741287|P1|Overall Study|Physician Decision|2
225715|NCT01645280|741329|P5|Overall Study|Treatment not completed/Completed f/u|2
225716|NCT01645280|741330|P4|Overall Study|Treatment not completed/Completed f/u|0
225717|NCT01645280|741331|P3|Overall Study|Treatment not completed/Completed f/u|2
225718|NCT01645280|741332|P2|Overall Study|Treatment not completed/Completed f/u|1
225719|NCT01645280|741333|P1|Overall Study|Treatment not completed/Completed f/u|1
225720|NCT01645280|741329|P5|Overall Study|Unspecified|0
225721|NCT01645280|741330|P4|Overall Study|Unspecified|0
225722|NCT01645280|741331|P3|Overall Study|Unspecified|2
225723|NCT01645280|741332|P2|Overall Study|Unspecified|1
225724|NCT01645280|741333|P1|Overall Study|Unspecified|1
225725|NCT01645280|741329|P5|Overall Study|Lost to Follow-up|1
225726|NCT01645280|741330|P4|Overall Study|Lost to Follow-up|2
225727|NCT01645280|741331|P3|Overall Study|Lost to Follow-up|0
225728|NCT01645280|741332|P2|Overall Study|Lost to Follow-up|0
225729|NCT01645280|741333|P1|Overall Study|Lost to Follow-up|0
225730|NCT01645280|741329|P5|Overall Study|Withdrawal by Subject|5
225731|NCT01645280|741330|P4|Overall Study|Withdrawal by Subject|4
225732|NCT01645280|741331|P3|Overall Study|Withdrawal by Subject|2
225733|NCT01645280|741332|P2|Overall Study|Withdrawal by Subject|0
225734|NCT01645280|741333|P1|Overall Study|Withdrawal by Subject|4
225735|NCT01645280|741329|P5|Overall Study|Death|0
225736|NCT01645280|741330|P4|Overall Study|Death|0
225737|NCT01645280|741331|P3|Overall Study|Death|0
225738|NCT01645280|741332|P2|Overall Study|Death|1
225739|NCT01645280|741333|P1|Overall Study|Death|0
225740|NCT01645176|741361|P1|Overall Study|did not complete final MRI|1
225741|NCT01645176|741361|P1|Overall Study|Lack of Efficacy|4
225742|NCT01645111|741365|P1|Overall Study|Did not require Clevidipine|15
225743|NCT01644734|741404|P1|Overall Study|Missing documentation|238
225744|NCT01644734|741404|P1|Overall Study|Reasons other than stated above|7
225745|NCT01644734|741404|P1|Overall Study|Lost to Follow-up|17
225746|NCT01644734|741404|P1|Overall Study|Adverse Event|4
225747|NCT01644643|741418|P4|Overall Study|Other Eligibility criteria|2
225748|NCT01644643|741419|P3|Overall Study|Other Eligibility criteria|0
225749|NCT01644643|741420|P2|Overall Study|Other Eligibility criteria|0
225750|NCT01644643|741421|P1|Overall Study|Other Eligibility criteria|0
225751|NCT01644643|741418|P4|Overall Study|Withdrawal by Subject|1
225752|NCT01644643|741419|P3|Overall Study|Withdrawal by Subject|2
225753|NCT01644643|741420|P2|Overall Study|Withdrawal by Subject|0
225754|NCT01644643|741421|P1|Overall Study|Withdrawal by Subject|1
225755|NCT01644643|741418|P4|Overall Study|Lost to Follow-up|4
225756|NCT01644643|741419|P3|Overall Study|Lost to Follow-up|0
225757|NCT01644643|741420|P2|Overall Study|Lost to Follow-up|0
225758|NCT01644643|741421|P1|Overall Study|Lost to Follow-up|0
225759|NCT01644643|741418|P4|Overall Study|Death|3
225760|NCT01644643|741419|P3|Overall Study|Death|3
225761|NCT01644643|741420|P2|Overall Study|Death|0
225762|NCT01644643|741421|P1|Overall Study|Death|1
225763|NCT01644617|741586|P3|Overall Study|Adverse Event|6
225764|NCT01644617|741587|P2|Overall Study|Adverse Event|0
225765|NCT01644617|741588|P1|Overall Study|Adverse Event|3
225766|NCT01644617|741586|P3|Overall Study|Lost to Follow-up|0
225767|NCT01644617|741587|P2|Overall Study|Lost to Follow-up|1
225768|NCT01644617|741588|P1|Overall Study|Lost to Follow-up|0
225769|NCT01644617|741586|P3|Overall Study|Withdrawal by Subject|1
225770|NCT01644617|741587|P2|Overall Study|Withdrawal by Subject|4
225771|NCT01644617|741588|P1|Overall Study|Withdrawal by Subject|3
225772|NCT01644500|741645|P3|Overall Study|Lost to Follow-up|2
225773|NCT01644500|741646|P2|Overall Study|Lost to Follow-up|11
225774|NCT01644500|741647|P1|Overall Study|Lost to Follow-up|4
225775|NCT01644500|741645|P3|Overall Study|Sponsor Decision|1
225776|NCT01644500|741646|P2|Overall Study|Sponsor Decision|0
225777|NCT01644500|741647|P1|Overall Study|Sponsor Decision|0
225778|NCT01644500|741645|P3|Overall Study|Physician Decision|1
225779|NCT01644500|741646|P2|Overall Study|Physician Decision|1
225780|NCT01644500|741647|P1|Overall Study|Physician Decision|1
225781|NCT01644500|741645|P3|Overall Study|Withdrawal by Subject|12
225782|NCT01644500|741646|P2|Overall Study|Withdrawal by Subject|13
225783|NCT01644500|741647|P1|Overall Study|Withdrawal by Subject|11
225784|NCT01644500|741645|P3|Overall Study|Protocol Violation|0
225785|NCT01644500|741646|P2|Overall Study|Protocol Violation|1
225786|NCT01644500|741647|P1|Overall Study|Protocol Violation|1
225787|NCT01644500|741645|P3|Overall Study|Death|0
225788|NCT01644500|741646|P2|Overall Study|Death|1
225789|NCT01644500|741647|P1|Overall Study|Death|0
225790|NCT01644500|741645|P3|Overall Study|Adverse Event|2
225791|NCT01644500|741646|P2|Overall Study|Adverse Event|1
225792|NCT01644500|741647|P1|Overall Study|Adverse Event|7
225793|NCT01644474|741717|P2|Overall Study|Protocol Violation|0
225794|NCT01644474|741718|P1|Overall Study|Protocol Violation|1
225795|NCT01644474|741717|P2|Overall Study|Site scheduling error|1
225796|NCT01644474|741718|P1|Overall Study|Site scheduling error|1
225797|NCT01644474|741717|P2|Overall Study|Adverse Event|5
225798|NCT01644474|741718|P1|Overall Study|Adverse Event|4
225799|NCT01644474|741717|P2|Overall Study|Participant moved|1
225800|NCT01644474|741718|P1|Overall Study|Participant moved|0
225801|NCT01644474|741717|P2|Overall Study|Consent withdrawn by participant|1
225802|NCT01644474|741718|P1|Overall Study|Consent withdrawn by participant|0
225803|NCT01644474|741717|P2|Overall Study|Poor compliance to protocol|0
225804|NCT01644474|741718|P1|Overall Study|Poor compliance to protocol|1
225805|NCT01644188|741841|P2|Overall Study|Other than specified above|7
225806|NCT01644188|741842|P1|Overall Study|Other than specified above|6
225807|NCT01644188|741841|P2|Overall Study|Site closure|1
225808|NCT01644188|741842|P1|Overall Study|Site closure|1
225809|NCT01644188|741841|P2|Overall Study|Last visit outside protocol visit window|16
225810|NCT01644188|741842|P1|Overall Study|Last visit outside protocol visit window|14
225811|NCT01644188|741841|P2|Overall Study|Death|3
225812|NCT01644188|741842|P1|Overall Study|Death|4
225813|NCT01644188|741841|P2|Overall Study|Lost to Follow-up|0
225814|NCT01644188|741842|P1|Overall Study|Lost to Follow-up|1
225815|NCT01644188|741841|P2|Overall Study|Selection criteria finally not met|0
225816|NCT01644188|741842|P1|Overall Study|Selection criteria finally not met|2
225817|NCT01644188|741841|P2|Overall Study|Consent withdrawn by participant|7
225818|NCT01644188|741842|P1|Overall Study|Consent withdrawn by participant|14
225819|NCT01644188|741841|P2|Overall Study|Related to auto-injector administration|2
225820|NCT01644188|741842|P1|Overall Study|Related to auto-injector administration|2
225821|NCT01644188|741841|P2|Overall Study|Participant moved|2
225822|NCT01644188|741842|P1|Overall Study|Participant moved|7
225823|NCT01644188|741841|P2|Overall Study|Physician Decision|3
225824|NCT01644188|741842|P1|Overall Study|Physician Decision|1
225825|NCT01644188|741841|P2|Overall Study|Poor compliance to protocol|14
225826|NCT01644188|741842|P1|Overall Study|Poor compliance to protocol|26
225827|NCT01644188|741841|P2|Overall Study|Adverse Event|20
225828|NCT01644188|741842|P1|Overall Study|Adverse Event|44
225829|NCT01644175|741900|P2|Overall Study|Other than specified above|3
225830|NCT01644175|741901|P1|Overall Study|Other than specified above|0
225831|NCT01644175|741900|P2|Overall Study|Lost to Follow-up|0
225832|NCT01644175|741901|P1|Overall Study|Lost to Follow-up|1
225833|NCT01644175|741900|P2|Overall Study|Site closure|2
225834|NCT01644175|741901|P1|Overall Study|Site closure|2
225835|NCT01644175|741900|P2|Overall Study|Selection criteria finally not met|1
225836|NCT01644175|741901|P1|Overall Study|Selection criteria finally not met|0
225837|NCT01644175|741900|P2|Overall Study|Last visit outside protocol visit window|11
225838|NCT01644175|741901|P1|Overall Study|Last visit outside protocol visit window|4
225839|NCT01644175|741900|P2|Overall Study|Related to Autoinjector Administration|1
225840|NCT01644175|741901|P1|Overall Study|Related to Autoinjector Administration|2
225841|NCT01644175|741900|P2|Overall Study|Consent withdrawn by participant|4
225842|NCT01644175|741901|P1|Overall Study|Consent withdrawn by participant|3
225843|NCT01644175|741900|P2|Overall Study|Participant Moved|2
225844|NCT01644175|741901|P1|Overall Study|Participant Moved|1
225845|NCT01644175|741900|P2|Overall Study|Physician Decision|2
225846|NCT01644175|741901|P1|Overall Study|Physician Decision|1
225847|NCT01644175|741900|P2|Overall Study|Poor compliance to protocol|10
225848|NCT01644175|741901|P1|Overall Study|Poor compliance to protocol|9
225849|NCT01644175|741900|P2|Overall Study|Death|2
225850|NCT01644175|741901|P1|Overall Study|Death|1
225851|NCT01644175|741900|P2|Overall Study|Adverse Event|13
225852|NCT01644175|741901|P1|Overall Study|Adverse Event|8
225853|NCT01644175|741900|P2|Overall Study|Randomized But Not Treated|2
225854|NCT01644175|741901|P1|Overall Study|Randomized But Not Treated|0
225855|NCT01643928|741961|P5|Overall Study|Adverse Event|2
225856|NCT01643928|741962|P4|Overall Study|Adverse Event|1
225857|NCT01643928|741963|P3|Overall Study|Adverse Event|0
225858|NCT01643928|741964|P2|Overall Study|Adverse Event|1
225859|NCT01643928|741965|P1|Overall Study|Adverse Event|2
225860|NCT01643928|741961|P5|Overall Study|Unspecified|0
225861|NCT01643928|741962|P4|Overall Study|Unspecified|0
225862|NCT01643928|741963|P3|Overall Study|Unspecified|1
225863|NCT01643928|741964|P2|Overall Study|Unspecified|1
225864|NCT01643928|741965|P1|Overall Study|Unspecified|5
225865|NCT01643928|741961|P5|Overall Study|Pregnancy|0
225866|NCT01643928|741962|P4|Overall Study|Pregnancy|1
225867|NCT01643928|741963|P3|Overall Study|Pregnancy|0
225868|NCT01643928|741964|P2|Overall Study|Pregnancy|0
225869|NCT01643928|741965|P1|Overall Study|Pregnancy|0
225870|NCT01643928|741961|P5|Overall Study|Withdrawal by Subject|0
225871|NCT01643928|741962|P4|Overall Study|Withdrawal by Subject|1
225872|NCT01643928|741963|P3|Overall Study|Withdrawal by Subject|0
225873|NCT01643928|741964|P2|Overall Study|Withdrawal by Subject|0
225874|NCT01643928|741965|P1|Overall Study|Withdrawal by Subject|2
225875|NCT01643928|741961|P5|Overall Study|Lost to Follow-up|0
225876|NCT01643928|741962|P4|Overall Study|Lost to Follow-up|0
225877|NCT01643928|741963|P3|Overall Study|Lost to Follow-up|2
225878|NCT01643928|741964|P2|Overall Study|Lost to Follow-up|0
225879|NCT01643928|741965|P1|Overall Study|Lost to Follow-up|1
225880|NCT01643798|742260|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
225881|NCT01643798|742261|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
225882|NCT01643044|742296|P2|Overall Study|Delivered outside of hospital|2
225883|NCT01643044|742297|P1|Overall Study|Delivered outside of hospital|1
225884|NCT01643044|742296|P2|Overall Study|Miscarried baby|2
225885|NCT01643044|742297|P1|Overall Study|Miscarried baby|2
225886|NCT01643044|742296|P2|Overall Study|Lost to Follow-up|1
225887|NCT01643044|742297|P1|Overall Study|Lost to Follow-up|1
225888|NCT01642914|742306|P3|Overall Study|Other Reason|0
225889|NCT01642914|742307|P2|Overall Study|Other Reason|0
225890|NCT01642914|742308|P1|Overall Study|Other Reason|1
225891|NCT01642914|742306|P3|Overall Study|Lost to Follow-up|7
225892|NCT01642914|742307|P2|Overall Study|Lost to Follow-up|3
225893|NCT01642914|742308|P1|Overall Study|Lost to Follow-up|5
225894|NCT01642914|742306|P3|Overall Study|Withdrawal by Subject|10
225895|NCT01642914|742307|P2|Overall Study|Withdrawal by Subject|5
225896|NCT01642914|742308|P1|Overall Study|Withdrawal by Subject|5
225897|NCT01642914|742306|P3|Overall Study|Protocol Violation|6
225898|NCT01642914|742307|P2|Overall Study|Protocol Violation|13
225899|NCT01642914|742308|P1|Overall Study|Protocol Violation|15
225900|NCT01642914|742306|P3|Overall Study|Lack of Efficacy|2
225901|NCT01642914|742307|P2|Overall Study|Lack of Efficacy|4
225902|NCT01642914|742308|P1|Overall Study|Lack of Efficacy|9
225903|NCT01642914|742306|P3|Overall Study|Adverse Event|15
225904|NCT01642914|742307|P2|Overall Study|Adverse Event|7
225905|NCT01642914|742308|P1|Overall Study|Adverse Event|11
225906|NCT01642732|742383|P1|Overall Study|Withdrawal by Subject|1
225907|NCT01642615|742388|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
225908|NCT01642615|742389|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
225909|NCT01642615|742390|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
225910|NCT01642615|742388|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
225911|NCT01642615|742389|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
225912|NCT01642615|742390|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
225913|NCT01642615|742388|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
225914|NCT01642615|742389|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
225915|NCT01642615|742390|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
225916|NCT01642615|742388|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
225917|NCT01642615|742389|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
225918|NCT01642615|742390|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
225919|NCT01642615|742388|P3|Open Label Maintenance Phase|Did not receive treatment|0
225920|NCT01642615|742389|P2|Open Label Maintenance Phase|Did not receive treatment|0
225921|NCT01642615|742390|P1|Open Label Maintenance Phase|Did not receive treatment|1
225922|NCT01642615|742388|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
225923|NCT01642615|742389|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
225924|NCT01642615|742390|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
225925|NCT01642615|742388|P3|Open Label Maintenance Phase|Lost to Follow-up|0
225926|NCT01642615|742389|P2|Open Label Maintenance Phase|Lost to Follow-up|0
225927|NCT01642615|742390|P1|Open Label Maintenance Phase|Lost to Follow-up|1
225928|NCT01642615|742388|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
225929|NCT01642615|742389|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
225930|NCT01642615|742390|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
225931|NCT01642615|742388|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
225932|NCT01642615|742389|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
225933|NCT01642615|742390|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
225934|NCT01642602|742404|P1|Overall Study|Adverse Event|2
225935|NCT01642589|742411|P2|Overall Study|Withdrawal by Subject|1
225936|NCT01642589|742412|P1|Overall Study|Withdrawal by Subject|1
225937|NCT01642407|742451|P1|Overall Study|Insufficient clinical response|2
225938|NCT01642277|742495|P2|Overall Study|Withdrawal by Subject|0
225939|NCT01642277|742496|P1|Overall Study|Withdrawal by Subject|11
225940|NCT01642277|742495|P2|Overall Study|Protocol Violation|0
225941|NCT01642277|742496|P1|Overall Study|Protocol Violation|1
225942|NCT01642277|742495|P2|Overall Study|Physician Decision|0
225943|NCT01642277|742496|P1|Overall Study|Physician Decision|2
225944|NCT01642277|742495|P2|Overall Study|Adverse Event|0
225945|NCT01642277|742496|P1|Overall Study|Adverse Event|10
225946|NCT01642212|742528|P5|Open-label Extension|Not Specified|1
225947|NCT01642212|742529|P4|Open-label Extension|Not Specified|0
225948|NCT01642212|742530|P3|Open-label Extension|Not Specified|0
225949|NCT01642212|742531|P2|Open-label Extension|Not Specified|0
225950|NCT01642212|742532|P1|Open-label Extension|Not Specified|0
225951|NCT01642212|742528|P5|Open-label Extension|Lost to Follow-up|1
225952|NCT01642212|742529|P4|Open-label Extension|Lost to Follow-up|0
225953|NCT01642212|742530|P3|Open-label Extension|Lost to Follow-up|0
225954|NCT01642212|742531|P2|Open-label Extension|Lost to Follow-up|0
225955|NCT01642212|742532|P1|Open-label Extension|Lost to Follow-up|0
225956|NCT01642212|742528|P5|Open-label Extension|Consent Withdrawn|2
225957|NCT01642212|742529|P4|Open-label Extension|Consent Withdrawn|0
225958|NCT01642212|742530|P3|Open-label Extension|Consent Withdrawn|0
225959|NCT01642212|742531|P2|Open-label Extension|Consent Withdrawn|0
225960|NCT01642212|742532|P1|Open-label Extension|Consent Withdrawn|0
225961|NCT01642212|742528|P5|Open-label Extension|Sponsor Decision|4
225962|NCT01642212|742529|P4|Open-label Extension|Sponsor Decision|7
225963|NCT01642212|742530|P3|Open-label Extension|Sponsor Decision|0
225964|NCT01642212|742531|P2|Open-label Extension|Sponsor Decision|0
225965|NCT01642212|742532|P1|Open-label Extension|Sponsor Decision|0
225966|NCT01642212|742528|P5|Open-label Extension|Adverse Event|0
225967|NCT01642212|742529|P4|Open-label Extension|Adverse Event|3
225968|NCT01642212|742530|P3|Open-label Extension|Adverse Event|0
225969|NCT01642212|742531|P2|Open-label Extension|Adverse Event|0
225970|NCT01642212|742532|P1|Open-label Extension|Adverse Event|0
225971|NCT01642212|742528|P5|Double-blind Treatment|Adverse Event|0
225972|NCT01642212|742529|P4|Double-blind Treatment|Adverse Event|0
225973|NCT01642212|742530|P3|Double-blind Treatment|Adverse Event|1
225974|NCT01642212|742531|P2|Double-blind Treatment|Adverse Event|0
225975|NCT01642212|742532|P1|Double-blind Treatment|Adverse Event|0
225976|NCT01642212|742528|P5|Double-blind Treatment|Non-compliance|0
225977|NCT01642212|742529|P4|Double-blind Treatment|Non-compliance|0
225978|NCT01642212|742530|P3|Double-blind Treatment|Non-compliance|0
225979|NCT01642212|742531|P2|Double-blind Treatment|Non-compliance|1
225980|NCT01642212|742532|P1|Double-blind Treatment|Non-compliance|0
225981|NCT01642212|742528|P5|Double-blind Treatment|Not Specified|0
225982|NCT01642212|742529|P4|Double-blind Treatment|Not Specified|0
225983|NCT01642212|742530|P3|Double-blind Treatment|Not Specified|1
225984|NCT01642212|742531|P2|Double-blind Treatment|Not Specified|2
225985|NCT01642212|742532|P1|Double-blind Treatment|Not Specified|0
225986|NCT01642212|742528|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
225987|NCT01642212|742529|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
225988|NCT01642212|742530|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
225989|NCT01642212|742531|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
225990|NCT01642212|742532|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
225991|NCT01642004|742621|P2|Treatment|Missing from data|1
225992|NCT01642004|742622|P1|Treatment|Missing from data|0
225993|NCT01642004|742621|P2|Treatment|Unspecified|2
225994|NCT01642004|742622|P1|Treatment|Unspecified|1
225995|NCT01642004|742621|P2|Treatment|No longer meets study criteria|2
225996|NCT01642004|742622|P1|Treatment|No longer meets study criteria|1
225997|NCT01642004|742621|P2|Treatment|Poor/non-compliance|0
225998|NCT01642004|742622|P1|Treatment|Poor/non-compliance|1
225999|NCT01642004|742621|P2|Treatment|Maximum clinical benefit|7
226000|NCT01642004|742622|P1|Treatment|Maximum clinical benefit|2
226001|NCT01642004|742621|P2|Treatment|Withdrawal by Subject|9
226002|NCT01642004|742622|P1|Treatment|Withdrawal by Subject|5
226003|NCT01642004|742621|P2|Treatment|Adverse event unrelated to study drug|13
226004|NCT01642004|742622|P1|Treatment|Adverse event unrelated to study drug|6
226005|NCT01642004|742621|P2|Treatment|Death|0
226006|NCT01642004|742622|P1|Treatment|Death|1
226007|NCT01642004|742621|P2|Treatment|Study drug toxicity|13
226008|NCT01642004|742622|P1|Treatment|Study drug toxicity|5
226009|NCT01642004|742621|P2|Treatment|Disease progression|80
226010|NCT01642004|742622|P1|Treatment|Disease progression|88
226011|NCT01642004|742621|P2|Randomization|No longer meets study criteria|2
226012|NCT01642004|742622|P1|Randomization|No longer meets study criteria|2
226013|NCT01642004|742621|P2|Randomization|Withdrawal by Subject|6
226014|NCT01642004|742622|P1|Randomization|Withdrawal by Subject|1
226015|NCT01642004|742621|P2|Randomization|Adverse Event unrelated to study drug|0
226016|NCT01642004|742622|P1|Randomization|Adverse Event unrelated to study drug|1
226017|NCT01641991|742656|P4|Overall Study|no longer eligible|4
226018|NCT01641991|742657|P3|Overall Study|no longer eligible|0
226019|NCT01641991|742658|P2|Overall Study|no longer eligible|1
226020|NCT01641991|742659|P1|Overall Study|no longer eligible|2
226021|NCT01641991|742656|P4|Overall Study|Pregnancy|0
226022|NCT01641991|742657|P3|Overall Study|Pregnancy|1
226023|NCT01641991|742658|P2|Overall Study|Pregnancy|0
226024|NCT01641991|742659|P1|Overall Study|Pregnancy|0
226025|NCT01641991|742656|P4|Overall Study|Protocol Violation|0
226026|NCT01641991|742657|P3|Overall Study|Protocol Violation|3
226027|NCT01641991|742658|P2|Overall Study|Protocol Violation|1
226028|NCT01641991|742659|P1|Overall Study|Protocol Violation|1
226029|NCT01641991|742656|P4|Overall Study|Lost to Follow-up|1
226030|NCT01641991|742657|P3|Overall Study|Lost to Follow-up|3
226031|NCT01641991|742658|P2|Overall Study|Lost to Follow-up|2
226032|NCT01641991|742659|P1|Overall Study|Lost to Follow-up|0
226033|NCT01641991|742656|P4|Overall Study|Adverse Event|1
226034|NCT01641991|742657|P3|Overall Study|Adverse Event|2
226035|NCT01641991|742658|P2|Overall Study|Adverse Event|1
226036|NCT01641991|742659|P1|Overall Study|Adverse Event|2
226037|NCT01641991|742656|P4|Overall Study|Withdrawal by Subject|5
226038|NCT01641991|742657|P3|Overall Study|Withdrawal by Subject|1
226039|NCT01641991|742658|P2|Overall Study|Withdrawal by Subject|2
226040|NCT01641991|742659|P1|Overall Study|Withdrawal by Subject|4
226041|NCT01641991|742656|P4|Overall Study|Physician Decision|5
226042|NCT01641991|742657|P3|Overall Study|Physician Decision|7
226043|NCT01641991|742658|P2|Overall Study|Physician Decision|1
226044|NCT01641991|742659|P1|Overall Study|Physician Decision|0
226045|NCT01641952|742743|P1|Overall Study|Adverse Event|6
226046|NCT01641952|742743|P1|Overall Study|Lost to Follow-up|28
226047|NCT01641939|742759|P3|Overall Study|Study Terminated by Sponsor|3
226048|NCT01641939|742760|P2|Overall Study|Study Terminated by Sponsor|28
226049|NCT01641939|742761|P1|Overall Study|Study Terminated by Sponsor|10
226050|NCT01641939|742759|P3|Overall Study|Withdrawal by Subject|5
226051|NCT01641939|742760|P2|Overall Study|Withdrawal by Subject|11
226052|NCT01641939|742761|P1|Overall Study|Withdrawal by Subject|14
226053|NCT01641939|742759|P3|Overall Study|Lost to Follow-up|1
226054|NCT01641939|742760|P2|Overall Study|Lost to Follow-up|2
226055|NCT01641939|742761|P1|Overall Study|Lost to Follow-up|3
226056|NCT01641939|742759|P3|Overall Study|Death|61
226057|NCT01641939|742760|P2|Overall Study|Death|187
226058|NCT01641939|742761|P1|Overall Study|Death|90
226059|NCT01641926|742804|P4|Overall Study|Not Treated|0
226060|NCT01641926|742805|P3|Overall Study|Not Treated|1
226061|NCT01641926|742806|P2|Overall Study|Not Treated|1
226062|NCT01641926|742807|P1|Overall Study|Not Treated|1
226063|NCT01641926|742804|P4|Overall Study|Withdrawal by Subject|1
226064|NCT01641926|742805|P3|Overall Study|Withdrawal by Subject|6
226065|NCT01641926|742806|P2|Overall Study|Withdrawal by Subject|5
226066|NCT01641926|742807|P1|Overall Study|Withdrawal by Subject|13
226067|NCT01641926|742804|P4|Overall Study|Protocol Violation|1
226068|NCT01641926|742805|P3|Overall Study|Protocol Violation|0
226069|NCT01641926|742806|P2|Overall Study|Protocol Violation|0
226070|NCT01641926|742807|P1|Overall Study|Protocol Violation|1
226071|NCT01641926|742804|P4|Overall Study|Physician Decision|1
226072|NCT01641926|742805|P3|Overall Study|Physician Decision|0
226073|NCT01641926|742806|P2|Overall Study|Physician Decision|5
226074|NCT01641926|742807|P1|Overall Study|Physician Decision|6
226075|NCT01641926|742804|P4|Overall Study|Lost to Follow-up|0
226076|NCT01641926|742805|P3|Overall Study|Lost to Follow-up|1
226077|NCT01641926|742806|P2|Overall Study|Lost to Follow-up|2
226078|NCT01641926|742807|P1|Overall Study|Lost to Follow-up|2
226079|NCT01641926|742804|P4|Overall Study|Adverse Event|1
226080|NCT01641926|742805|P3|Overall Study|Adverse Event|3
226081|NCT01641926|742806|P2|Overall Study|Adverse Event|2
226082|NCT01641926|742807|P1|Overall Study|Adverse Event|5
226083|NCT01641900|742835|P2|Overall Study|Withdrawal by Subject|2
226084|NCT01641900|742836|P1|Overall Study|Withdrawal by Subject|2
226085|NCT01641861|742848|P2|Overall Study|Died due to drowning|1
226086|NCT01641861|742849|P1|Overall Study|Died due to drowning|0
226087|NCT01641861|742848|P2|Overall Study|Lost the tooth due to normal exfoliation|8
226088|NCT01641861|742849|P1|Overall Study|Lost the tooth due to normal exfoliation|14
226089|NCT01641861|742848|P2|Overall Study|Lost to Follow-up|16
226090|NCT01641861|742849|P1|Overall Study|Lost to Follow-up|21
226091|NCT01641822|742870|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
226092|NCT01641822|742871|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
226093|NCT01641822|742872|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
226094|NCT01641822|742870|P3|Comparative Phase|Withdrew consent|7
226095|NCT01641822|742871|P2|Comparative Phase|Withdrew consent|3
226096|NCT01641822|742872|P1|Comparative Phase|Withdrew consent|0
226097|NCT01641822|742870|P3|Comparative Phase|Adverse event, serious fatal|0
226098|NCT01641822|742871|P2|Comparative Phase|Adverse event, serious fatal|1
226099|NCT01641822|742872|P1|Comparative Phase|Adverse event, serious fatal|0
226100|NCT01641822|742870|P3|Comparative Phase|Pregnancy|1
226101|NCT01641822|742871|P2|Comparative Phase|Pregnancy|0
226102|NCT01641822|742872|P1|Comparative Phase|Pregnancy|0
226103|NCT01641822|742870|P3|Comparative Phase|Investigator's discretion|1
226104|NCT01641822|742871|P2|Comparative Phase|Investigator's discretion|0
226105|NCT01641822|742872|P1|Comparative Phase|Investigator's discretion|0
226106|NCT01641822|742870|P3|Comparative Phase|Noncompliance with study drug|0
226107|NCT01641822|742871|P2|Comparative Phase|Noncompliance with study drug|1
226108|NCT01641822|742872|P1|Comparative Phase|Noncompliance with study drug|0
226109|NCT01641822|742870|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
226110|NCT01641822|742871|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
226111|NCT01641822|742872|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
226112|NCT01641822|742870|P3|Run-in Phase|Withdrew consent|0
226113|NCT01641822|742871|P2|Run-in Phase|Withdrew consent|0
226114|NCT01641822|742872|P1|Run-in Phase|Withdrew consent|1
226115|NCT01641822|742870|P3|Run-in Phase|Adverse Event|0
226116|NCT01641822|742871|P2|Run-in Phase|Adverse Event|0
226117|NCT01641822|742872|P1|Run-in Phase|Adverse Event|3
226118|NCT01641822|742870|P3|Run-in Phase|Noncompliance with study drug|0
226119|NCT01641822|742871|P2|Run-in Phase|Noncompliance with study drug|0
226120|NCT01641822|742872|P1|Run-in Phase|Noncompliance with study drug|1
226121|NCT01641692|742889|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
226122|NCT01641692|742890|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
226123|NCT01641692|742891|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
226124|NCT01641692|742892|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
226125|NCT01641692|742893|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
226126|NCT01641692|742894|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
226127|NCT01641692|742895|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
226128|NCT01641692|742896|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
226129|NCT01641692|742889|P8|Washout Period 3 or Follow-up|Protocol Violation|0
226130|NCT01641692|742890|P7|Washout Period 3 or Follow-up|Protocol Violation|0
226131|NCT01641692|742891|P6|Washout Period 3 or Follow-up|Protocol Violation|1
226132|NCT01641692|742892|P5|Washout Period 3 or Follow-up|Protocol Violation|0
226133|NCT01641692|742893|P4|Washout Period 3 or Follow-up|Protocol Violation|0
226134|NCT01641692|742894|P3|Washout Period 3 or Follow-up|Protocol Violation|0
226135|NCT01641692|742895|P2|Washout Period 3 or Follow-up|Protocol Violation|0
226136|NCT01641692|742896|P1|Washout Period 3 or Follow-up|Protocol Violation|0
226137|NCT01641692|742889|P8|Treatment Period 3|Lost to Follow-up|0
226138|NCT01641692|742890|P7|Treatment Period 3|Lost to Follow-up|0
226139|NCT01641692|742891|P6|Treatment Period 3|Lost to Follow-up|0
226140|NCT01641692|742892|P5|Treatment Period 3|Lost to Follow-up|0
226141|NCT01641692|742893|P4|Treatment Period 3|Lost to Follow-up|0
226142|NCT01641692|742894|P3|Treatment Period 3|Lost to Follow-up|0
226143|NCT01641692|742895|P2|Treatment Period 3|Lost to Follow-up|1
226144|NCT01641692|742896|P1|Treatment Period 3|Lost to Follow-up|0
226145|NCT01641692|742889|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
226146|NCT01641692|742890|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
226147|NCT01641692|742891|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
226148|NCT01641692|742892|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
226149|NCT01641692|742893|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
226150|NCT01641692|742894|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
226151|NCT01641692|742895|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
226152|NCT01641692|742896|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
226153|NCT01641692|742889|P8|Treatment Period 3|Protocol Violation|0
226154|NCT01641692|742890|P7|Treatment Period 3|Protocol Violation|0
226155|NCT01641692|742891|P6|Treatment Period 3|Protocol Violation|0
226156|NCT01641692|742892|P5|Treatment Period 3|Protocol Violation|0
226157|NCT01641692|742893|P4|Treatment Period 3|Protocol Violation|0
226158|NCT01641692|742894|P3|Treatment Period 3|Protocol Violation|1
226159|NCT01641692|742895|P2|Treatment Period 3|Protocol Violation|0
226160|NCT01641692|742896|P1|Treatment Period 3|Protocol Violation|0
226161|NCT01641692|742889|P8|Treatment Period 3|Adverse Event|0
226162|NCT01641692|742890|P7|Treatment Period 3|Adverse Event|1
226163|NCT01641692|742891|P6|Treatment Period 3|Adverse Event|0
226164|NCT01641692|742892|P5|Treatment Period 3|Adverse Event|0
226165|NCT01641692|742893|P4|Treatment Period 3|Adverse Event|0
226166|NCT01641692|742894|P3|Treatment Period 3|Adverse Event|0
226167|NCT01641692|742895|P2|Treatment Period 3|Adverse Event|0
226168|NCT01641692|742896|P1|Treatment Period 3|Adverse Event|0
226169|NCT01641692|742889|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
226170|NCT01641692|742890|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
226171|NCT01641692|742891|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
226172|NCT01641692|742892|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
226173|NCT01641692|742893|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
226174|NCT01641692|742894|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
226175|NCT01641692|742895|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
226176|NCT01641692|742896|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
226177|NCT01641692|742889|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
226178|NCT01641692|742890|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
226179|NCT01641692|742891|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
226180|NCT01641692|742892|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
226181|NCT01641692|742893|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
226182|NCT01641692|742894|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
226183|NCT01641692|742895|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
226184|NCT01641692|742896|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
226185|NCT01641692|742889|P8|Treatment Period 2|Withdrawal by Subject|1
226186|NCT01641692|742890|P7|Treatment Period 2|Withdrawal by Subject|0
226187|NCT01641692|742891|P6|Treatment Period 2|Withdrawal by Subject|1
226188|NCT01641692|742892|P5|Treatment Period 2|Withdrawal by Subject|0
226189|NCT01641692|742893|P4|Treatment Period 2|Withdrawal by Subject|0
226190|NCT01641692|742894|P3|Treatment Period 2|Withdrawal by Subject|0
226191|NCT01641692|742895|P2|Treatment Period 2|Withdrawal by Subject|0
226192|NCT01641692|742896|P1|Treatment Period 2|Withdrawal by Subject|1
226193|NCT01641692|742889|P8|Treatment Period 2|Lost to Follow-up|0
226194|NCT01641692|742890|P7|Treatment Period 2|Lost to Follow-up|0
226195|NCT01641692|742891|P6|Treatment Period 2|Lost to Follow-up|1
226196|NCT01641692|742892|P5|Treatment Period 2|Lost to Follow-up|0
226197|NCT01641692|742893|P4|Treatment Period 2|Lost to Follow-up|0
226198|NCT01641692|742894|P3|Treatment Period 2|Lost to Follow-up|0
226199|NCT01641692|742895|P2|Treatment Period 2|Lost to Follow-up|0
226200|NCT01641692|742896|P1|Treatment Period 2|Lost to Follow-up|0
226201|NCT01641692|742889|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
226202|NCT01641692|742890|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
226203|NCT01641692|742891|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
226204|NCT01641692|742892|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
226205|NCT01641692|742893|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
226206|NCT01641692|742894|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
226207|NCT01641692|742895|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
226208|NCT01641692|742896|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
226209|NCT01641692|742889|P8|Treatment Period 2|Lack of Efficacy|0
226210|NCT01641692|742890|P7|Treatment Period 2|Lack of Efficacy|0
226211|NCT01641692|742891|P6|Treatment Period 2|Lack of Efficacy|0
226212|NCT01641692|742892|P5|Treatment Period 2|Lack of Efficacy|0
226213|NCT01641692|742893|P4|Treatment Period 2|Lack of Efficacy|0
226214|NCT01641692|742894|P3|Treatment Period 2|Lack of Efficacy|0
226215|NCT01641692|742895|P2|Treatment Period 2|Lack of Efficacy|0
226216|NCT01641692|742896|P1|Treatment Period 2|Lack of Efficacy|1
226217|NCT01641692|742889|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
226218|NCT01641692|742890|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
226219|NCT01641692|742891|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
226220|NCT01641692|742892|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
226221|NCT01641692|742893|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
226222|NCT01641692|742894|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
226223|NCT01641692|742895|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
226224|NCT01641692|742896|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
226225|NCT01641692|742889|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
226226|NCT01641692|742890|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
226227|NCT01641692|742891|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
226228|NCT01641692|742892|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
226229|NCT01641692|742893|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
226230|NCT01641692|742894|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
226231|NCT01641692|742895|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
226232|NCT01641692|742896|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
226233|NCT01641692|742889|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
226234|NCT01641692|742890|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
226235|NCT01641692|742891|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
226236|NCT01641692|742892|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
226237|NCT01641692|742893|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
226238|NCT01641692|742894|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
226239|NCT01641692|742895|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
226240|NCT01641692|742896|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
226241|NCT01641692|742889|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
226242|NCT01641692|742890|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
226243|NCT01641692|742891|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
226244|NCT01641692|742892|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
226245|NCT01641692|742893|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
226246|NCT01641692|742894|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
226247|NCT01641692|742895|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
226248|NCT01641692|742896|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
226249|NCT01641692|742889|P8|Treatment Period 1|Withdrawal by Subject|1
226250|NCT01641692|742890|P7|Treatment Period 1|Withdrawal by Subject|0
226251|NCT01641692|742891|P6|Treatment Period 1|Withdrawal by Subject|2
226252|NCT01641692|742892|P5|Treatment Period 1|Withdrawal by Subject|0
226253|NCT01641692|742893|P4|Treatment Period 1|Withdrawal by Subject|0
226254|NCT01641692|742894|P3|Treatment Period 1|Withdrawal by Subject|0
226255|NCT01641692|742895|P2|Treatment Period 1|Withdrawal by Subject|0
226256|NCT01641692|742896|P1|Treatment Period 1|Withdrawal by Subject|0
226257|NCT01641692|742889|P8|Treatment Period 1|Physician Decision|0
226258|NCT01641692|742890|P7|Treatment Period 1|Physician Decision|0
226259|NCT01641692|742891|P6|Treatment Period 1|Physician Decision|0
226260|NCT01641692|742892|P5|Treatment Period 1|Physician Decision|1
226261|NCT01641692|742893|P4|Treatment Period 1|Physician Decision|0
226262|NCT01641692|742894|P3|Treatment Period 1|Physician Decision|0
226263|NCT01641692|742895|P2|Treatment Period 1|Physician Decision|0
226264|NCT01641692|742896|P1|Treatment Period 1|Physician Decision|0
226265|NCT01641692|742889|P8|Treatment Period 1|Lost to Follow-up|0
226266|NCT01641692|742890|P7|Treatment Period 1|Lost to Follow-up|0
226267|NCT01641692|742891|P6|Treatment Period 1|Lost to Follow-up|0
226268|NCT01641692|742892|P5|Treatment Period 1|Lost to Follow-up|0
226269|NCT01641692|742893|P4|Treatment Period 1|Lost to Follow-up|0
226270|NCT01641692|742894|P3|Treatment Period 1|Lost to Follow-up|1
226271|NCT01641692|742895|P2|Treatment Period 1|Lost to Follow-up|0
226272|NCT01641692|742896|P1|Treatment Period 1|Lost to Follow-up|0
226273|NCT01641692|742889|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
226274|NCT01641692|742890|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
226275|NCT01641692|742891|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
226276|NCT01641692|742892|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
226277|NCT01641692|742893|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
226278|NCT01641692|742894|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
226279|NCT01641692|742895|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
226280|NCT01641692|742896|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
226281|NCT01641692|742889|P8|Treatment Period 1|Protocol Violation|0
226282|NCT01641692|742890|P7|Treatment Period 1|Protocol Violation|0
226283|NCT01641692|742891|P6|Treatment Period 1|Protocol Violation|0
226284|NCT01641692|742892|P5|Treatment Period 1|Protocol Violation|2
226285|NCT01641692|742893|P4|Treatment Period 1|Protocol Violation|0
226286|NCT01641692|742894|P3|Treatment Period 1|Protocol Violation|0
226287|NCT01641692|742895|P2|Treatment Period 1|Protocol Violation|0
226288|NCT01641692|742896|P1|Treatment Period 1|Protocol Violation|1
226289|NCT01641692|742889|P8|Treatment Period 1|Lack of Efficacy|1
226290|NCT01641692|742890|P7|Treatment Period 1|Lack of Efficacy|0
226291|NCT01641692|742891|P6|Treatment Period 1|Lack of Efficacy|0
226292|NCT01641692|742892|P5|Treatment Period 1|Lack of Efficacy|0
226293|NCT01641692|742893|P4|Treatment Period 1|Lack of Efficacy|0
226294|NCT01641692|742894|P3|Treatment Period 1|Lack of Efficacy|0
226295|NCT01641692|742895|P2|Treatment Period 1|Lack of Efficacy|0
226296|NCT01641692|742896|P1|Treatment Period 1|Lack of Efficacy|0
226297|NCT01641692|742889|P8|Treatment Period 1|Adverse Event|0
226298|NCT01641692|742890|P7|Treatment Period 1|Adverse Event|0
226299|NCT01641692|742891|P6|Treatment Period 1|Adverse Event|0
226300|NCT01641692|742892|P5|Treatment Period 1|Adverse Event|0
226301|NCT01641692|742893|P4|Treatment Period 1|Adverse Event|0
226302|NCT01641692|742894|P3|Treatment Period 1|Adverse Event|0
226303|NCT01641692|742895|P2|Treatment Period 1|Adverse Event|0
226304|NCT01641692|742896|P1|Treatment Period 1|Adverse Event|1
226305|NCT01641640|743096|P1|Overall Study|Adverse Event|1
226306|NCT01641640|743096|P1|Overall Study|Withdrawal by Subject|2
226307|NCT01641640|743096|P1|Overall Study|Lost to Follow-up|3
226308|NCT01641640|743096|P1|Overall Study|Efficacy failure|29
226309|NCT01641640|743096|P1|Overall Study|Enrolled but not treated|1
226310|NCT01641471|743107|P2|Overall Study|Protocol Violation|4
226311|NCT01641471|743108|P1|Overall Study|Protocol Violation|2
226312|NCT01641471|743107|P2|Overall Study|Lost to Follow-up|4
226313|NCT01641471|743108|P1|Overall Study|Lost to Follow-up|2
226314|NCT01641471|743107|P2|Overall Study|Withdrawal by Subject|19
226315|NCT01641471|743108|P1|Overall Study|Withdrawal by Subject|19
226316|NCT01641237|743114|P4|Period III|Lost to Follow-up|0
226317|NCT01641237|743115|P3|Period III|Lost to Follow-up|0
226318|NCT01641237|743116|P2|Period III|Lost to Follow-up|0
226319|NCT01641237|743117|P1|Period III|Lost to Follow-up|1
226320|NCT01641237|743114|P4|Period II|Withdrawal by Subject|0
226321|NCT01641237|743115|P3|Period II|Withdrawal by Subject|0
226322|NCT01641237|743116|P2|Period II|Withdrawal by Subject|0
226323|NCT01641237|743117|P1|Period II|Withdrawal by Subject|1
226324|NCT01641159|743141|P2|Overall Study|Withdrawal by Subject|1
226325|NCT01641159|743142|P1|Overall Study|Withdrawal by Subject|0
226326|NCT01641159|743141|P2|Overall Study|Lost to Follow-up|1
226327|NCT01641159|743142|P1|Overall Study|Lost to Follow-up|2
226328|NCT01641133|743153|P3|Overall Study|Lost to Follow-up|2
226329|NCT01641133|743154|P2|Overall Study|Lost to Follow-up|2
226330|NCT01641133|743155|P1|Overall Study|Lost to Follow-up|0
226331|NCT01641133|743153|P3|Overall Study|Withdrawal by Subject|3
226332|NCT01641133|743154|P2|Overall Study|Withdrawal by Subject|3
226333|NCT01641133|743155|P1|Overall Study|Withdrawal by Subject|5
226334|NCT01641133|743153|P3|Overall Study|Adverse Event|1
226335|NCT01641133|743154|P2|Overall Study|Adverse Event|0
226336|NCT01641133|743155|P1|Overall Study|Adverse Event|0
226337|NCT01641133|743153|P3|Overall Study|Migrated/moved from study area|1
226338|NCT01641133|743154|P2|Overall Study|Migrated/moved from study area|3
226339|NCT01641133|743155|P1|Overall Study|Migrated/moved from study area|5
226340|NCT01641133|743153|P3|Overall Study|Protocol Violation|1
226341|NCT01641133|743154|P2|Overall Study|Protocol Violation|1
226342|NCT01641133|743155|P1|Overall Study|Protocol Violation|0
226343|NCT01641081|743205|P10|Period 5|Adverse Event|0
226344|NCT01641081|743206|P9|Period 5|Adverse Event|0
226345|NCT01641081|743207|P8|Period 5|Adverse Event|0
226346|NCT01641081|743208|P7|Period 5|Adverse Event|0
226347|NCT01641081|743209|P6|Period 5|Adverse Event|0
226348|NCT01641081|743210|P5|Period 5|Adverse Event|0
226349|NCT01641081|743211|P4|Period 5|Adverse Event|0
226350|NCT01641081|743212|P3|Period 5|Adverse Event|2
226351|NCT01641081|743213|P2|Period 5|Adverse Event|0
226352|NCT01641081|743214|P1|Period 5|Adverse Event|0
226353|NCT01641081|743205|P10|Period 4|Adverse Event|0
226354|NCT01641081|743206|P9|Period 4|Adverse Event|0
226355|NCT01641081|743207|P8|Period 4|Adverse Event|0
226356|NCT01641081|743208|P7|Period 4|Adverse Event|0
226357|NCT01641081|743209|P6|Period 4|Adverse Event|0
226358|NCT01641081|743210|P5|Period 4|Adverse Event|0
226359|NCT01641081|743211|P4|Period 4|Adverse Event|1
226360|NCT01641081|743212|P3|Period 4|Adverse Event|0
226361|NCT01641081|743213|P2|Period 4|Adverse Event|1
226362|NCT01641081|743214|P1|Period 4|Adverse Event|0
226363|NCT01641081|743205|P10|Period 3|Withdrawal by Subject|0
226364|NCT01641081|743206|P9|Period 3|Withdrawal by Subject|1
226365|NCT01641081|743207|P8|Period 3|Withdrawal by Subject|0
226366|NCT01641081|743208|P7|Period 3|Withdrawal by Subject|0
226367|NCT01641081|743209|P6|Period 3|Withdrawal by Subject|0
226368|NCT01641081|743210|P5|Period 3|Withdrawal by Subject|0
226369|NCT01641081|743211|P4|Period 3|Withdrawal by Subject|0
226370|NCT01641081|743212|P3|Period 3|Withdrawal by Subject|0
226371|NCT01641081|743213|P2|Period 3|Withdrawal by Subject|0
226372|NCT01641081|743214|P1|Period 3|Withdrawal by Subject|0
226373|NCT01641081|743205|P10|Period 3|Adverse Event|0
226374|NCT01641081|743206|P9|Period 3|Adverse Event|0
226375|NCT01641081|743207|P8|Period 3|Adverse Event|0
226376|NCT01641081|743208|P7|Period 3|Adverse Event|0
226377|NCT01641081|743209|P6|Period 3|Adverse Event|0
226378|NCT01641081|743210|P5|Period 3|Adverse Event|0
226379|NCT01641081|743211|P4|Period 3|Adverse Event|0
226380|NCT01641081|743212|P3|Period 3|Adverse Event|1
226381|NCT01641081|743213|P2|Period 3|Adverse Event|0
226382|NCT01641081|743214|P1|Period 3|Adverse Event|0
226383|NCT01641081|743205|P10|Period 2|Protocol Violation|0
226384|NCT01641081|743206|P9|Period 2|Protocol Violation|0
226385|NCT01641081|743207|P8|Period 2|Protocol Violation|0
226386|NCT01641081|743208|P7|Period 2|Protocol Violation|0
226387|NCT01641081|743209|P6|Period 2|Protocol Violation|0
226388|NCT01641081|743210|P5|Period 2|Protocol Violation|0
226389|NCT01641081|743211|P4|Period 2|Protocol Violation|0
226390|NCT01641081|743212|P3|Period 2|Protocol Violation|0
226391|NCT01641081|743213|P2|Period 2|Protocol Violation|0
226392|NCT01641081|743214|P1|Period 2|Protocol Violation|1
226393|NCT01641081|743205|P10|Period 2|Withdrawal by Subject|0
226394|NCT01641081|743206|P9|Period 2|Withdrawal by Subject|0
226395|NCT01641081|743207|P8|Period 2|Withdrawal by Subject|0
226396|NCT01641081|743208|P7|Period 2|Withdrawal by Subject|2
226397|NCT01641081|743209|P6|Period 2|Withdrawal by Subject|0
226398|NCT01641081|743210|P5|Period 2|Withdrawal by Subject|0
226399|NCT01641081|743211|P4|Period 2|Withdrawal by Subject|1
226400|NCT01641081|743212|P3|Period 2|Withdrawal by Subject|0
226401|NCT01641081|743213|P2|Period 2|Withdrawal by Subject|0
226402|NCT01641081|743214|P1|Period 2|Withdrawal by Subject|0
226403|NCT01641081|743205|P10|Period 2|Adverse Event|0
226404|NCT01641081|743206|P9|Period 2|Adverse Event|0
226405|NCT01641081|743207|P8|Period 2|Adverse Event|0
226406|NCT01641081|743208|P7|Period 2|Adverse Event|0
226407|NCT01641081|743209|P6|Period 2|Adverse Event|1
226408|NCT01641081|743210|P5|Period 2|Adverse Event|0
226409|NCT01641081|743211|P4|Period 2|Adverse Event|0
226410|NCT01641081|743212|P3|Period 2|Adverse Event|0
226411|NCT01641081|743213|P2|Period 2|Adverse Event|0
226412|NCT01641081|743214|P1|Period 2|Adverse Event|0
226413|NCT01641081|743205|P10|Period 1|Adverse Event|0
226414|NCT01641081|743206|P9|Period 1|Adverse Event|0
226415|NCT01641081|743207|P8|Period 1|Adverse Event|2
226416|NCT01641081|743208|P7|Period 1|Adverse Event|0
226417|NCT01641081|743209|P6|Period 1|Adverse Event|0
226418|NCT01641081|743210|P5|Period 1|Adverse Event|0
226419|NCT01641081|743211|P4|Period 1|Adverse Event|0
226420|NCT01641081|743212|P3|Period 1|Adverse Event|0
226421|NCT01641081|743213|P2|Period 1|Adverse Event|0
226422|NCT01641081|743214|P1|Period 1|Adverse Event|1
226423|NCT01641081|743205|P10|Period 1|Protocol Violation|0
226424|NCT01641081|743206|P9|Period 1|Protocol Violation|0
226425|NCT01641081|743207|P8|Period 1|Protocol Violation|1
226426|NCT01641081|743208|P7|Period 1|Protocol Violation|0
226427|NCT01641081|743209|P6|Period 1|Protocol Violation|0
226428|NCT01641081|743210|P5|Period 1|Protocol Violation|1
226429|NCT01641081|743211|P4|Period 1|Protocol Violation|0
226430|NCT01641081|743212|P3|Period 1|Protocol Violation|0
226431|NCT01641081|743213|P2|Period 1|Protocol Violation|0
226432|NCT01641081|743214|P1|Period 1|Protocol Violation|0
226433|NCT01641081|743205|P10|Period 1|Sponsor request (potential unblinding)|0
226434|NCT01641081|743206|P9|Period 1|Sponsor request (potential unblinding)|0
226435|NCT01641081|743207|P8|Period 1|Sponsor request (potential unblinding)|0
226436|NCT01641081|743208|P7|Period 1|Sponsor request (potential unblinding)|1
226437|NCT01641081|743209|P6|Period 1|Sponsor request (potential unblinding)|0
226438|NCT01641081|743210|P5|Period 1|Sponsor request (potential unblinding)|0
226439|NCT01641081|743211|P4|Period 1|Sponsor request (potential unblinding)|0
226440|NCT01641081|743212|P3|Period 1|Sponsor request (potential unblinding)|0
226441|NCT01641081|743213|P2|Period 1|Sponsor request (potential unblinding)|0
226442|NCT01641081|743214|P1|Period 1|Sponsor request (potential unblinding)|0
226443|NCT01640964|743234|P3|Overall Study|Protocol Deviation|2
226444|NCT01640964|743235|P2|Overall Study|Protocol Deviation|1
226445|NCT01640964|743236|P1|Overall Study|Protocol Deviation|1
226446|NCT01640964|743234|P3|Overall Study|Lost to Follow-up|1
226447|NCT01640964|743235|P2|Overall Study|Lost to Follow-up|0
226448|NCT01640964|743236|P1|Overall Study|Lost to Follow-up|0
226449|NCT01640925|743253|P2|Overall Study|Previously enrolled in this trial|11
226450|NCT01640925|743254|P1|Overall Study|Previously enrolled in this trial|13
226451|NCT01640925|743253|P2|Overall Study|Withdrawal by Subject|0
226452|NCT01640925|743254|P1|Overall Study|Withdrawal by Subject|1
226453|NCT01639729|743260|P6|Overall Study|Withdrawal by Subject|0
226454|NCT01639729|743261|P5|Overall Study|Withdrawal by Subject|0
226455|NCT01639729|743262|P4|Overall Study|Withdrawal by Subject|1
226456|NCT01639729|743263|P3|Overall Study|Withdrawal by Subject|1
226457|NCT01639729|743264|P2|Overall Study|Withdrawal by Subject|0
226458|NCT01639729|743265|P1|Overall Study|Withdrawal by Subject|1
226459|NCT01640353|743301|P1|Overall Study|Physician Decision|1
226460|NCT01640353|743301|P1|Overall Study|Lost to Follow-up|12
226461|NCT01640353|743301|P1|Overall Study|Early site termination|3
226462|NCT01640353|743301|P1|Overall Study|Death|2
226463|NCT01640353|743301|P1|Overall Study|Withdrawal by Subject|5
226464|NCT01640353|743301|P1|Overall Study|Withdrawn from analysis at term site|12
226465|NCT01640353|743301|P1|Overall Study|Withdrew prior to treatment|10
226466|NCT01640314|743349|P2|Overall Study|Protocol Violation|1
226467|NCT01640314|743350|P1|Overall Study|Protocol Violation|0
226468|NCT01640184|743388|P3|Overall Study|Protocol Violation|1
226469|NCT01640184|743389|P2|Overall Study|Protocol Violation|0
226470|NCT01640184|743390|P1|Overall Study|Protocol Violation|0
226471|NCT01640184|743388|P3|Overall Study|Withdrawal by Subject|1
226472|NCT01640184|743389|P2|Overall Study|Withdrawal by Subject|1
226473|NCT01640184|743390|P1|Overall Study|Withdrawal by Subject|0
226474|NCT01640184|743388|P3|Overall Study|Physician Decision|0
226475|NCT01640184|743389|P2|Overall Study|Physician Decision|0
226476|NCT01640184|743390|P1|Overall Study|Physician Decision|3
226477|NCT01640184|743388|P3|Overall Study|Lost to Follow-up|0
226478|NCT01640184|743389|P2|Overall Study|Lost to Follow-up|1
226479|NCT01640184|743390|P1|Overall Study|Lost to Follow-up|4
226480|NCT01640184|743388|P3|Overall Study|Death|0
226481|NCT01640184|743389|P2|Overall Study|Death|0
226482|NCT01640184|743390|P1|Overall Study|Death|1
226483|NCT01640054|743419|P1|Overall Study|Adverse Event|2
226484|NCT01640054|743419|P1|Overall Study|Lack of Efficacy|3
226485|NCT01640054|743419|P1|Overall Study|Study-specific disc criteria|1
226486|NCT01639833|743429|P2|Overall Study|Withdrawal by Subject|2
226487|NCT01639833|743430|P1|Overall Study|Withdrawal by Subject|2
226488|NCT01639833|743429|P2|Overall Study|Death|2
226489|NCT01639833|743430|P1|Overall Study|Death|4
226490|NCT01639755|743438|P1|Overall Study|Patient had device explantation|4
226491|NCT01639755|743438|P1|Overall Study|Study Ongoing|15
226492|NCT01639742|743446|P1|Overall Study|Lost to Follow-up|1
226493|NCT01639742|743446|P1|Overall Study|Study Ongoing|17
226494|NCT01639560|743456|P2|Overall Study|Adverse Event|2
226495|NCT01639560|743457|P1|Overall Study|Adverse Event|0
226496|NCT01639560|743456|P2|Overall Study|Lost to Follow-up|11
226497|NCT01639560|743457|P1|Overall Study|Lost to Follow-up|9
226498|NCT01639560|743456|P2|Overall Study|Lack of Efficacy|2
226499|NCT01639560|743457|P1|Overall Study|Lack of Efficacy|1
226500|NCT01639560|743456|P2|Overall Study|Withdrawal by Subject|14
226501|NCT01639560|743457|P1|Overall Study|Withdrawal by Subject|9
226502|NCT01639144|743559|P2|Overall Study|Met postoperative exclusion criteria|3
226503|NCT01639144|743560|P1|Overall Study|Met postoperative exclusion criteria|4
226504|NCT01639144|743559|P2|Overall Study|Physician Decision|0
226505|NCT01639144|743560|P1|Overall Study|Physician Decision|2
226506|NCT01639144|743559|P2|Overall Study|Withdrawal by Subject|2
226507|NCT01639144|743560|P1|Overall Study|Withdrawal by Subject|4
226508|NCT01639001|743568|P2|Overall Study|Death|35
226509|NCT01639001|743569|P1|Overall Study|Death|35
226510|NCT01639001|743568|P2|Overall Study|Lost to Follow-up|0
226511|NCT01639001|743569|P1|Overall Study|Lost to Follow-up|1
226512|NCT01639001|743568|P2|Overall Study|Refused further follow-up|6
226513|NCT01639001|743569|P1|Overall Study|Refused further follow-up|3
226514|NCT01639001|743568|P2|Overall Study|Ongoing at date of cutoff|60
226515|NCT01639001|743569|P1|Overall Study|Ongoing at date of cutoff|65
226516|NCT01639001|743568|P2|Overall Study|Randomized but not treated|2
226517|NCT01639001|743569|P1|Overall Study|Randomized but not treated|0
226518|NCT01638000|743655|P2|Overall Study|Miscellaneous|2
226519|NCT01638000|743656|P1|Overall Study|Miscellaneous|2
226520|NCT01638000|743655|P2|Overall Study|Withdrawal by Subject|24
226521|NCT01638000|743656|P1|Overall Study|Withdrawal by Subject|21
226522|NCT01638000|743655|P2|Overall Study|Protocol Violation|13
226523|NCT01638000|743656|P1|Overall Study|Protocol Violation|11
226524|NCT01638000|743655|P2|Overall Study|Lack of Efficacy|6
226525|NCT01638000|743656|P1|Overall Study|Lack of Efficacy|5
226526|NCT01638000|743655|P2|Overall Study|Adverse Event|16
226527|NCT01638000|743656|P1|Overall Study|Adverse Event|14
226528|NCT01638000|743655|P2|Overall Study|Randomized but Never Received Drug|10
226529|NCT01638000|743656|P1|Overall Study|Randomized but Never Received Drug|7
226530|NCT01637961|743754|P1|Overall Study|Ineligible: inadequate pathology|1
226531|NCT01637961|743754|P1|Overall Study|Ineligible: wrong primary|1
226532|NCT01637922|743779|P2|Overall Study|Lost to Follow-up|0
226533|NCT01637922|743780|P1|Overall Study|Lost to Follow-up|2
226534|NCT01637922|743779|P2|Overall Study|Withdrawal by Subject|3
226535|NCT01637922|743780|P1|Overall Study|Withdrawal by Subject|0
226536|NCT01637922|743779|P2|Overall Study|Protocol Violation|1
226537|NCT01637922|743780|P1|Overall Study|Protocol Violation|0
226538|NCT01637922|743779|P2|Overall Study|Adverse Event|1
226539|NCT01637922|743780|P1|Overall Study|Adverse Event|0
226540|NCT01637584|743805|P2|Overall Study|Withdrawal by Subject|3
226541|NCT01637584|743806|P1|Overall Study|Withdrawal by Subject|1
226542|NCT01637272|743813|P1|Overall Study|Protocol Violation|2
226543|NCT01637272|743813|P1|Overall Study|Administrative problems|1
226544|NCT01637272|743813|P1|Overall Study|completed core, did not enter ext. phase|4
226545|NCT01637272|743813|P1|Overall Study|Lost to Follow-up|2
226546|NCT01637272|743813|P1|Overall Study|Withdrawal by Subject|3
226547|NCT01637272|743813|P1|Overall Study|Unsatisfactory therapeutic effect|2
226548|NCT01637272|743813|P1|Overall Study|Adverse Event|6
226549|NCT01636986|743893|P2|Overall Study|Corneal Staining|1
226550|NCT01636986|743894|P1|Overall Study|Corneal Staining|0
226551|NCT01636986|743893|P2|Overall Study|Withdrawal by Subject|1
226552|NCT01636986|743894|P1|Overall Study|Withdrawal by Subject|0
226553|NCT01636960|743900|P1|Maintenance Phase|Progressive disease|1
226554|NCT01636960|743900|P1|Maintenance Phase|Adverse Event|3
226555|NCT01636960|743900|P1|Maintenance Phase|Continued drug after regulatory approval|3
226556|NCT01636960|743900|P1|Induction Phase|Adverse Event|2
226557|NCT01636947|743908|P2|Overall Study|Did Not Meet Eligibility Criteria|4
226558|NCT01636947|743909|P1|Overall Study|Did Not Meet Eligibility Criteria|1
226559|NCT01636947|743908|P2|Overall Study|Adverse Event|1
226560|NCT01636947|743909|P1|Overall Study|Adverse Event|1
226561|NCT01636947|743908|P2|Overall Study|Withdrawal by Subject|3
226562|NCT01636947|743909|P1|Overall Study|Withdrawal by Subject|3
226563|NCT01636947|743908|P2|Overall Study|Protocol Violation|1
226564|NCT01636947|743909|P1|Overall Study|Protocol Violation|1
226565|NCT01636947|743908|P2|Overall Study|Lost to Follow-up|0
226566|NCT01636947|743909|P1|Overall Study|Lost to Follow-up|4
226567|NCT01636947|743908|P2|Overall Study|Not Treated|2
226568|NCT01636947|743909|P1|Overall Study|Not Treated|2
226569|NCT01636778|743929|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
226570|NCT01636778|743930|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
226571|NCT01636778|743931|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
226572|NCT01636778|743929|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
226573|NCT01636778|743930|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
226574|NCT01636778|743931|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
226575|NCT01636778|743929|P3|Follow-up Period After Part 2|Other|1
226576|NCT01636778|743930|P2|Follow-up Period After Part 2|Other|0
226577|NCT01636778|743931|P1|Follow-up Period After Part 2|Other|0
226578|NCT01636778|743929|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
226579|NCT01636778|743930|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
226580|NCT01636778|743931|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
226581|NCT01636778|743929|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
226582|NCT01636778|743930|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
226583|NCT01636778|743931|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
226584|NCT01636778|743929|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
226585|NCT01636778|743930|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
226586|NCT01636778|743931|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
226587|NCT01636778|743929|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
226588|NCT01636778|743930|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
226589|NCT01636778|743931|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
226590|NCT01636778|743929|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
226591|NCT01636778|743930|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
226592|NCT01636778|743931|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
226593|NCT01636713|744002|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
226594|NCT01636713|744003|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
226595|NCT01636713|744004|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
226596|NCT01636713|744002|P3|Overall Study|Withdrawal by Subject|8
226597|NCT01636713|744003|P2|Overall Study|Withdrawal by Subject|4
226598|NCT01636713|744004|P1|Overall Study|Withdrawal by Subject|5
226599|NCT01636713|744002|P3|Overall Study|Lost to Follow-up|1
226600|NCT01636713|744003|P2|Overall Study|Lost to Follow-up|0
226601|NCT01636713|744004|P1|Overall Study|Lost to Follow-up|0
226602|NCT01636713|744002|P3|Overall Study|Protocol Violation|1
226603|NCT01636713|744003|P2|Overall Study|Protocol Violation|0
226604|NCT01636713|744004|P1|Overall Study|Protocol Violation|3
226605|NCT01636713|744002|P3|Overall Study|Lack of Efficacy|2
226606|NCT01636713|744003|P2|Overall Study|Lack of Efficacy|6
226607|NCT01636713|744004|P1|Overall Study|Lack of Efficacy|6
226608|NCT01636713|744002|P3|Overall Study|Adverse Event|7
226609|NCT01636713|744003|P2|Overall Study|Adverse Event|16
226610|NCT01636713|744004|P1|Overall Study|Adverse Event|16
226611|NCT01636362|744054|P1|Overall Study|Withdrawal by Subject|1
226612|NCT01636362|744054|P1|Overall Study|Subject healed, not returning|1
226613|NCT01636362|744054|P1|Overall Study|Physician Decision|6
226614|NCT01636258|744062|P2|Overall Study|Lost to Follow-up|0
226615|NCT01636258|744063|P1|Overall Study|Lost to Follow-up|1
226616|NCT01636076|744103|P2|Overall Study|Withdrawal by Subject|10
226617|NCT01636076|744104|P1|Overall Study|Withdrawal by Subject|7
226618|NCT01636076|744103|P2|Overall Study|Adverse Event|11
226619|NCT01636076|744104|P1|Overall Study|Adverse Event|6
226620|NCT01636076|744103|P2|Overall Study|Non-compliance with study treatment|1
226621|NCT01636076|744104|P1|Overall Study|Non-compliance with study treatment|1
226622|NCT01636076|744103|P2|Overall Study|Physician Decision|1
226623|NCT01636076|744104|P1|Overall Study|Physician Decision|1
226624|NCT01636076|744103|P2|Overall Study|Lost to Follow-up|0
226625|NCT01636076|744104|P1|Overall Study|Lost to Follow-up|1
226626|NCT01636076|744103|P2|Overall Study|Lack of Efficacy|1
226627|NCT01636076|744104|P1|Overall Study|Lack of Efficacy|0
226628|NCT01636076|744103|P2|Overall Study|Terminated by sponsor|1
226629|NCT01636076|744104|P1|Overall Study|Terminated by sponsor|1
226630|NCT01635933|744175|P2|Overall Study|No longer had transportation|1
226631|NCT01635933|744176|P1|Overall Study|No longer had transportation|0
226632|NCT01635933|744175|P2|Overall Study|Noncompliance|1
226633|NCT01635933|744176|P1|Overall Study|Noncompliance|0
226634|NCT01635933|744175|P2|Overall Study|Subject decision|1
226635|NCT01635933|744176|P1|Overall Study|Subject decision|1
226636|NCT01635933|744175|P2|Overall Study|Lost to Follow-up|5
226637|NCT01635933|744176|P1|Overall Study|Lost to Follow-up|0
226638|NCT01635933|744175|P2|Overall Study|Adverse Event|0
226639|NCT01635933|744176|P1|Overall Study|Adverse Event|1
226640|NCT01635920|744188|P2|Overall Study|Subject decision|0
226641|NCT01635920|744189|P1|Overall Study|Subject decision|2
226642|NCT01635920|744188|P2|Overall Study|Lost to Follow-up|1
226643|NCT01635920|744189|P1|Overall Study|Lost to Follow-up|0
226644|NCT01635920|744188|P2|Overall Study|Adverse Event|0
226645|NCT01635920|744189|P1|Overall Study|Adverse Event|1
226646|NCT01635855|744202|P1|Overall Study|Withdrawal by Subject|4
226647|NCT01635218|744244|P3|Overall Study|Lost to Follow-up|6
226648|NCT01635218|744245|P2|Overall Study|Lost to Follow-up|7
226649|NCT01635218|744246|P1|Overall Study|Lost to Follow-up|3
226650|NCT01634659|744281|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
226651|NCT01634659|744282|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
226652|NCT01634659|744281|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
226653|NCT01634659|744282|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
226654|NCT01634555|744312|P1|Overall Study|Ongoing receiving treatment|13
226655|NCT01634555|744312|P1|Overall Study|Physician Decision|1
226656|NCT01634555|744312|P1|Overall Study|Adverse Event|3
226657|NCT01634360|744322|P2|Overall Study|Study termination by sponsor|44
226658|NCT01634360|744323|P1|Overall Study|Study termination by sponsor|18
226659|NCT01634360|744322|P2|Overall Study|Not specified|20
226660|NCT01634360|744323|P1|Overall Study|Not specified|3
226661|NCT01634360|744322|P2|Overall Study|Lack of Efficacy|14
226662|NCT01634360|744323|P1|Overall Study|Lack of Efficacy|4
226663|NCT01634360|744322|P2|Overall Study|Protocol Violation|1
226664|NCT01634360|744323|P1|Overall Study|Protocol Violation|1
226665|NCT01634360|744322|P2|Overall Study|subject withdrew consent|23
226666|NCT01634360|744323|P1|Overall Study|subject withdrew consent|13
226667|NCT01634360|744322|P2|Overall Study|Adverse Event|34
226668|NCT01634360|744323|P1|Overall Study|Adverse Event|10
226669|NCT01634243|744352|P2|Overall Study|Lack of Efficacy|0
226670|NCT01634243|744353|P1|Overall Study|Lack of Efficacy|1
226671|NCT01634243|744352|P2|Overall Study|Adverse Event|5
226672|NCT01634243|744353|P1|Overall Study|Adverse Event|5
226673|NCT01634165|744379|P4|Period 2|Adverse Event|0
226674|NCT01634165|744380|P3|Period 2|Adverse Event|0
226675|NCT01634165|744381|P2|Period 2|Adverse Event|1
226676|NCT01634165|744382|P1|Period 2|Adverse Event|0
226677|NCT01634152|744415|P3|Overall Study|Other reason not defined above|1
226678|NCT01634152|744416|P2|Overall Study|Other reason not defined above|0
226679|NCT01634152|744417|P1|Overall Study|Other reason not defined above|1
226680|NCT01634152|744415|P3|Overall Study|Not treated|0
226681|NCT01634152|744416|P2|Overall Study|Not treated|1
226682|NCT01634152|744417|P1|Overall Study|Not treated|0
226683|NCT01634152|744415|P3|Overall Study|Consent withdrawn not due to AE|1
226684|NCT01634152|744416|P2|Overall Study|Consent withdrawn not due to AE|0
226685|NCT01634152|744417|P1|Overall Study|Consent withdrawn not due to AE|1
226686|NCT01634152|744415|P3|Overall Study|Adverse Event|2
226687|NCT01634152|744416|P2|Overall Study|Adverse Event|0
226688|NCT01634152|744417|P1|Overall Study|Adverse Event|2
226689|NCT01634139|744500|P3|Overall Study|Not treated|0
226690|NCT01634139|744501|P2|Overall Study|Not treated|1
226691|NCT01634139|744502|P1|Overall Study|Not treated|1
226692|NCT01634139|744500|P3|Overall Study|Lost to Follow-up|0
226693|NCT01634139|744501|P2|Overall Study|Lost to Follow-up|2
226694|NCT01634139|744502|P1|Overall Study|Lost to Follow-up|0
226695|NCT01634139|744500|P3|Overall Study|Other|3
226696|NCT01634139|744501|P2|Overall Study|Other|0
226697|NCT01634139|744502|P1|Overall Study|Other|4
226698|NCT01634139|744500|P3|Overall Study|Consent withdrawn not due to AE|2
226699|NCT01634139|744501|P2|Overall Study|Consent withdrawn not due to AE|3
226700|NCT01634139|744502|P1|Overall Study|Consent withdrawn not due to AE|4
226701|NCT01634139|744500|P3|Overall Study|Non compliant with protocol|0
226702|NCT01634139|744501|P2|Overall Study|Non compliant with protocol|0
226703|NCT01634139|744502|P1|Overall Study|Non compliant with protocol|1
226704|NCT01634113|744603|P3|Overall Study|Not treated|1
226705|NCT01634113|744604|P2|Overall Study|Not treated|0
226706|NCT01634113|744605|P1|Overall Study|Not treated|0
226707|NCT01634100|744649|P6|Overall Study|Withdrawal by Subject|0
226708|NCT01634100|744650|P5|Overall Study|Withdrawal by Subject|0
226709|NCT01634100|744651|P4|Overall Study|Withdrawal by Subject|0
226710|NCT01634100|744652|P3|Overall Study|Withdrawal by Subject|1
226711|NCT01634100|744653|P2|Overall Study|Withdrawal by Subject|0
226712|NCT01634100|744654|P1|Overall Study|Withdrawal by Subject|1
226713|NCT01633944|744670|P3|Double-blind Treatment Phase|Not specified|0
226714|NCT01633944|744671|P2|Double-blind Treatment Phase|Not specified|7
226715|NCT01633944|744672|P1|Double-blind Treatment Phase|Not specified|0
226716|NCT01633944|744670|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
226717|NCT01633944|744671|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
226718|NCT01633944|744672|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
226719|NCT01633944|744670|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
226720|NCT01633944|744671|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
226721|NCT01633944|744672|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
226722|NCT01633944|744670|P3|Double-blind Treatment Phase|Lost to Follow-up|9
226723|NCT01633944|744671|P2|Double-blind Treatment Phase|Lost to Follow-up|4
226724|NCT01633944|744672|P1|Double-blind Treatment Phase|Lost to Follow-up|0
226725|NCT01633944|744670|P3|Double-blind Treatment Phase|Protocol Violation|10
226726|NCT01633944|744671|P2|Double-blind Treatment Phase|Protocol Violation|7
226727|NCT01633944|744672|P1|Double-blind Treatment Phase|Protocol Violation|0
226728|NCT01633944|744670|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
226729|NCT01633944|744671|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
226730|NCT01633944|744672|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
226731|NCT01633944|744670|P3|Double-blind Treatment Phase|Lack of Efficacy|23
226732|NCT01633944|744671|P2|Double-blind Treatment Phase|Lack of Efficacy|8
226733|NCT01633944|744672|P1|Double-blind Treatment Phase|Lack of Efficacy|0
226734|NCT01633944|744670|P3|Double-blind Treatment Phase|Adverse Event|7
226735|NCT01633944|744671|P2|Double-blind Treatment Phase|Adverse Event|13
226736|NCT01633944|744672|P1|Double-blind Treatment Phase|Adverse Event|0
226737|NCT01633944|744670|P3|Open-label Titration Phase|Not specified|0
226738|NCT01633944|744671|P2|Open-label Titration Phase|Not specified|0
226739|NCT01633944|744672|P1|Open-label Titration Phase|Not specified|68
226740|NCT01633944|744670|P3|Open-label Titration Phase|Lost to Follow-up|0
226741|NCT01633944|744671|P2|Open-label Titration Phase|Lost to Follow-up|0
226742|NCT01633944|744672|P1|Open-label Titration Phase|Lost to Follow-up|22
226743|NCT01633944|744670|P3|Open-label Titration Phase|Protocol Violation|0
226744|NCT01633944|744671|P2|Open-label Titration Phase|Protocol Violation|0
226745|NCT01633944|744672|P1|Open-label Titration Phase|Protocol Violation|24
226746|NCT01633944|744670|P3|Open-label Titration Phase|Withdrawal by Subject|0
226747|NCT01633944|744671|P2|Open-label Titration Phase|Withdrawal by Subject|0
226748|NCT01633944|744672|P1|Open-label Titration Phase|Withdrawal by Subject|34
226749|NCT01633944|744670|P3|Open-label Titration Phase|Lack of Efficacy|0
226750|NCT01633944|744671|P2|Open-label Titration Phase|Lack of Efficacy|0
226751|NCT01633944|744672|P1|Open-label Titration Phase|Lack of Efficacy|33
226752|NCT01633944|744670|P3|Open-label Titration Phase|Adverse Event|0
226753|NCT01633944|744671|P2|Open-label Titration Phase|Adverse Event|0
226754|NCT01633944|744672|P1|Open-label Titration Phase|Adverse Event|109
226755|NCT01632904|744749|P2|Overall Study|Reason for discontinuation not available|1
226756|NCT01632904|744750|P1|Overall Study|Reason for discontinuation not available|0
226757|NCT01632904|744749|P2|Overall Study|Disease Progression|1
226758|NCT01632904|744750|P1|Overall Study|Disease Progression|0
226759|NCT01632904|744749|P2|Overall Study|Subject decision|2
226760|NCT01632904|744750|P1|Overall Study|Subject decision|3
226761|NCT01632904|744749|P2|Overall Study|Physician Decision|1
226762|NCT01632904|744750|P1|Overall Study|Physician Decision|0
226763|NCT01632904|744749|P2|Overall Study|Adverse Event|1
226764|NCT01632904|744750|P1|Overall Study|Adverse Event|4
226765|NCT01632878|744760|P1|Treatment|no information on study completion|43
226766|NCT01632878|744760|P1|Treatment|missing information|4
226767|NCT01632878|744760|P1|Treatment|Physician Decision|34
226768|NCT01632878|744760|P1|Treatment|Withdrawal by Subject|36
226769|NCT01632878|744760|P1|Treatment|Lost to Follow-up|41
226770|NCT01632878|744760|P1|Screening|Physician Decision|268
226771|NCT01632800|744764|P1|Overall Study|Subject did not fit in apparatus|1
226772|NCT01632150|744844|P1|Overall Study|Moved to compassionate program|2
226773|NCT01632150|744844|P1|Overall Study|Patient underwent autologous transplant|1
226774|NCT01632150|744844|P1|Overall Study|Withdrawal by Subject|2
226775|NCT01632150|744844|P1|Overall Study|Unrelated adverse event|7
226776|NCT01632150|744844|P1|Overall Study|Study drug toxicity|1
226777|NCT01632150|744844|P1|Overall Study|Disease progression|27
226778|NCT01632020|744853|P2|Overall Study|Adverse Event|0
226779|NCT01632020|744854|P1|Overall Study|Adverse Event|1
226780|NCT01632020|744853|P2|Overall Study|Withdrawal by Subject|0
226781|NCT01632020|744854|P1|Overall Study|Withdrawal by Subject|1
226782|NCT01631864|744873|P2|Overall Study|Adverse Event|3
226783|NCT01631864|744874|P1|Overall Study|Adverse Event|2
226784|NCT01631864|744873|P2|Overall Study|Withdrawal by Subject|1
226785|NCT01631864|744874|P1|Overall Study|Withdrawal by Subject|0
226786|NCT01631825|744886|P1|Overall Study|Physician Decision|2
226787|NCT01631825|744886|P1|Overall Study|Discontinuation criteria|1
226788|NCT01631825|744886|P1|Overall Study|Protocol Violation|4
226789|NCT01631825|744886|P1|Overall Study|Withdrawal by Subject|9
226790|NCT01631825|744886|P1|Overall Study|Lack of Efficacy|7
226791|NCT01631825|744886|P1|Overall Study|Adverse Event|42
226792|NCT01631812|744906|P1|Overall Study|Physician Decision|3
226793|NCT01631812|744906|P1|Overall Study|Withdrawal by Subject|4
226794|NCT01631812|744906|P1|Overall Study|Lack of Efficacy|5
226795|NCT01631812|744906|P1|Overall Study|Adverse Event|25
226796|NCT01631435|745044|P1|Overall Study|incomplete study procedure|5
226797|NCT01631435|745044|P1|Overall Study|Withdrawal by Subject|2
226798|NCT01631435|745044|P1|Overall Study|Adverse Event|2
226799|NCT01631227|745051|P2|Overall Study|administrative|1
226800|NCT01631227|745052|P1|Overall Study|administrative|2
226801|NCT01631227|745051|P2|Overall Study|Adverse Event|0
226802|NCT01631227|745052|P1|Overall Study|Adverse Event|1
226803|NCT01631227|745051|P2|Overall Study|withdrawn consent|21
226804|NCT01631227|745052|P1|Overall Study|withdrawn consent|27
226805|NCT01630135|745118|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
226806|NCT01630135|745119|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
226807|NCT01629823|745183|P3|Washout Period|Protocol Violation|0
226808|NCT01629823|745184|P2|Washout Period|Protocol Violation|1
226809|NCT01629823|745185|P1|Washout Period|Protocol Violation|0
226810|NCT01629823|745183|P3|Washout Period|Pregnancy|0
226811|NCT01629823|745184|P2|Washout Period|Pregnancy|0
226812|NCT01629823|745185|P1|Washout Period|Pregnancy|1
226813|NCT01629823|745183|P3|Washout Period|Safety|0
226814|NCT01629823|745184|P2|Washout Period|Safety|5
226815|NCT01629823|745185|P1|Washout Period|Safety|2
226816|NCT01629823|745183|P3|Trial Period|Failed to hold medication|1
226817|NCT01629823|745184|P2|Trial Period|Failed to hold medication|0
226818|NCT01629823|745185|P1|Trial Period|Failed to hold medication|0
226819|NCT01629823|745183|P3|Trial Period|Out-of-window visit|0
226820|NCT01629823|745184|P2|Trial Period|Out-of-window visit|2
226821|NCT01629823|745185|P1|Trial Period|Out-of-window visit|0
226822|NCT01629823|745183|P3|Trial Period|Adverse Event|0
226823|NCT01629823|745184|P2|Trial Period|Adverse Event|1
226824|NCT01629823|745185|P1|Trial Period|Adverse Event|0
226825|NCT01629823|745183|P3|Trial Period|Pregnancy|0
226826|NCT01629823|745184|P2|Trial Period|Pregnancy|0
226827|NCT01629823|745185|P1|Trial Period|Pregnancy|1
226828|NCT01629823|745183|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
226829|NCT01629823|745184|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
226830|NCT01629823|745185|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
226831|NCT01629823|745183|P3|Trial Period|Missed visit|8
226832|NCT01629823|745184|P2|Trial Period|Missed visit|9
226833|NCT01629823|745185|P1|Trial Period|Missed visit|11
226834|NCT01629706|745220|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
226835|NCT01629706|745220|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
226836|NCT01629706|745220|P1|Phase 2 Habitual|Relocation prior to Dispense|1
226837|NCT01629706|745220|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
226838|NCT01629706|745220|P1|Phase 2 Habitual|Screen Failure|6
226839|NCT01629706|745220|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
226840|NCT01629706|745220|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
226841|NCT01629706|745220|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
226842|NCT01629706|745220|P1|Phase 1 PureVision|Screen Failure|4
226843|NCT01629693|745248|P2|Overall Study|Subject decision unrelated to AE|1
226844|NCT01629693|745249|P1|Overall Study|Subject decision unrelated to AE|0
226845|NCT01629693|745248|P2|Overall Study|Poor comfort of study lenses|2
226846|NCT01629693|745249|P1|Overall Study|Poor comfort of study lenses|0
226847|NCT01629693|745248|P2|Overall Study|Investigator decision|1
226848|NCT01629693|745249|P1|Overall Study|Investigator decision|0
226849|NCT01629693|745248|P2|Overall Study|Adverse Event|0
226850|NCT01629693|745249|P1|Overall Study|Adverse Event|1
226851|NCT01629693|745248|P2|Overall Study|Withdrawal by Subject|2
226852|NCT01629693|745249|P1|Overall Study|Withdrawal by Subject|2
226853|NCT01629693|745248|P2|Overall Study|Lost to Follow-up|4
226854|NCT01629693|745249|P1|Overall Study|Lost to Follow-up|2
226855|NCT01629667|745258|P3|Overall Study|Code break|0
226856|NCT01629667|745259|P2|Overall Study|Code break|0
226857|NCT01629667|745260|P1|Overall Study|Code break|1
226858|NCT01629667|745258|P3|Overall Study|Enrolled in another clinical study|0
226859|NCT01629667|745259|P2|Overall Study|Enrolled in another clinical study|1
226860|NCT01629667|745260|P1|Overall Study|Enrolled in another clinical study|0
226861|NCT01629667|745258|P3|Overall Study|Site error in safety follow-up|1
226862|NCT01629667|745259|P2|Overall Study|Site error in safety follow-up|0
226863|NCT01629667|745260|P1|Overall Study|Site error in safety follow-up|0
226864|NCT01629667|745258|P3|Overall Study|Started other medicine|1
226865|NCT01629667|745259|P2|Overall Study|Started other medicine|0
226866|NCT01629667|745260|P1|Overall Study|Started other medicine|1
226867|NCT01629667|745258|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
226868|NCT01629667|745259|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
226869|NCT01629667|745260|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
226870|NCT01629667|745258|P3|Overall Study|Requiring lung transplant|3
226871|NCT01629667|745259|P2|Overall Study|Requiring lung transplant|1
226872|NCT01629667|745260|P1|Overall Study|Requiring lung transplant|2
226873|NCT01629667|745258|P3|Overall Study|Ongoing AE worsening right heart failure|0
226874|NCT01629667|745259|P2|Overall Study|Ongoing AE worsening right heart failure|1
226875|NCT01629667|745260|P1|Overall Study|Ongoing AE worsening right heart failure|0
226876|NCT01629667|745258|P3|Overall Study|Randomized, not treated|0
226877|NCT01629667|745259|P2|Overall Study|Randomized, not treated|1
226878|NCT01629667|745260|P1|Overall Study|Randomized, not treated|2
226879|NCT01629667|745258|P3|Overall Study|Death|3
226880|NCT01629667|745259|P2|Overall Study|Death|5
226881|NCT01629667|745260|P1|Overall Study|Death|1
226882|NCT01629667|745258|P3|Overall Study|Withdrawal by Subject|28
226883|NCT01629667|745259|P2|Overall Study|Withdrawal by Subject|20
226884|NCT01629667|745260|P1|Overall Study|Withdrawal by Subject|31
226885|NCT01629667|745258|P3|Overall Study|Lost to Follow-up|1
226886|NCT01629667|745259|P2|Overall Study|Lost to Follow-up|1
226887|NCT01629667|745260|P1|Overall Study|Lost to Follow-up|0
226888|NCT01629589|745344|P2|Overall Study|Did not receive study vaccine|1
226889|NCT01629589|745345|P1|Overall Study|Did not receive study vaccine|0
226890|NCT01629589|745344|P2|Overall Study|Withdrawal by Subject|3
226891|NCT01629589|745345|P1|Overall Study|Withdrawal by Subject|2
226892|NCT01629589|745344|P2|Overall Study|Lost to Follow-up|1
226893|NCT01629589|745345|P1|Overall Study|Lost to Follow-up|2
226894|NCT01629589|745344|P2|Overall Study|Protocol Violation|2
226895|NCT01629589|745345|P1|Overall Study|Protocol Violation|4
226896|NCT01628965|745384|P1|Overall Study|Discontinuation criteria|8
226897|NCT01628965|745384|P1|Overall Study|Lost to Follow-up|1
226898|NCT01628965|745384|P1|Overall Study|Withdrawal by Subject|3
226899|NCT01628965|745384|P1|Overall Study|Lack of Efficacy|7
226900|NCT01628965|745384|P1|Overall Study|Adverse Event|30
226901|NCT01628926|745393|P3|Overall Study|Physician Decision|1
226902|NCT01628926|745394|P2|Overall Study|Physician Decision|2
226903|NCT01628926|745395|P1|Overall Study|Physician Decision|2
226904|NCT01628926|745393|P3|Overall Study|Discontinuation criteria|0
226905|NCT01628926|745394|P2|Overall Study|Discontinuation criteria|4
226906|NCT01628926|745395|P1|Overall Study|Discontinuation criteria|3
226907|NCT01628926|745393|P3|Overall Study|Protocol Violation|0
226908|NCT01628926|745394|P2|Overall Study|Protocol Violation|1
226909|NCT01628926|745395|P1|Overall Study|Protocol Violation|0
226910|NCT01628926|745393|P3|Overall Study|Withdrawal by Subject|2
226911|NCT01628926|745394|P2|Overall Study|Withdrawal by Subject|4
226912|NCT01628926|745395|P1|Overall Study|Withdrawal by Subject|6
226913|NCT01628926|745393|P3|Overall Study|Lack of Efficacy|5
226914|NCT01628926|745394|P2|Overall Study|Lack of Efficacy|1
226915|NCT01628926|745395|P1|Overall Study|Lack of Efficacy|2
226916|NCT01628926|745393|P3|Overall Study|Adverse Event|9
226917|NCT01628926|745394|P2|Overall Study|Adverse Event|11
226918|NCT01628926|745395|P1|Overall Study|Adverse Event|13
226919|NCT01628913|745444|P2|Overall Study|Physician Decision|3
226920|NCT01628913|745445|P1|Overall Study|Physician Decision|1
226921|NCT01628913|745444|P2|Overall Study|Withdrawal by Subject|0
226922|NCT01628913|745445|P1|Overall Study|Withdrawal by Subject|1
226923|NCT01628913|745444|P2|Overall Study|study terminated by Sponsor|9
226924|NCT01628913|745445|P1|Overall Study|study terminated by Sponsor|4
226925|NCT01628913|745444|P2|Overall Study|Death|0
226926|NCT01628913|745445|P1|Overall Study|Death|1
226927|NCT01628913|745444|P2|Overall Study|Protocol Violation|0
226928|NCT01628913|745445|P1|Overall Study|Protocol Violation|1
226929|NCT01628913|745444|P2|Overall Study|Disease Progression|14
226930|NCT01628913|745445|P1|Overall Study|Disease Progression|11
226931|NCT01628913|745444|P2|Overall Study|Adverse Event|5
226932|NCT01628913|745445|P1|Overall Study|Adverse Event|12
226933|NCT01628848|745459|P2|Overall Study|Physician Decision|1
226934|NCT01628848|745460|P1|Overall Study|Physician Decision|3
226935|NCT01628848|745459|P2|Overall Study|Withdrawal by Subject|2
226936|NCT01628848|745460|P1|Overall Study|Withdrawal by Subject|0
226937|NCT01628848|745459|P2|Overall Study|Lack of Efficacy|4
226938|NCT01628848|745460|P1|Overall Study|Lack of Efficacy|0
226939|NCT01628848|745459|P2|Overall Study|Adverse Event|7
226940|NCT01628848|745460|P1|Overall Study|Adverse Event|9
226941|NCT01628692|745494|P6|Overall Study|Completed 12 Week only|1
226942|NCT01628692|745495|P5|Overall Study|Completed 12 Week only|0
226943|NCT01628692|745496|P4|Overall Study|Completed 12 Week only|0
226944|NCT01628692|745497|P3|Overall Study|Completed 12 Week only|0
226945|NCT01628692|745498|P2|Overall Study|Completed 12 Week only|0
226946|NCT01628692|745499|P1|Overall Study|Completed 12 Week only|0
226947|NCT01628692|745494|P6|Overall Study|Administrative reason by sponsor|1
226948|NCT01628692|745495|P5|Overall Study|Administrative reason by sponsor|0
226949|NCT01628692|745496|P4|Overall Study|Administrative reason by sponsor|0
226950|NCT01628692|745497|P3|Overall Study|Administrative reason by sponsor|0
226951|NCT01628692|745498|P2|Overall Study|Administrative reason by sponsor|0
226952|NCT01628692|745499|P1|Overall Study|Administrative reason by sponsor|0
226953|NCT01628692|745494|P6|Overall Study|Poor compliance/noncompliance|0
226954|NCT01628692|745495|P5|Overall Study|Poor compliance/noncompliance|0
226955|NCT01628692|745496|P4|Overall Study|Poor compliance/noncompliance|0
226956|NCT01628692|745497|P3|Overall Study|Poor compliance/noncompliance|0
226957|NCT01628692|745498|P2|Overall Study|Poor compliance/noncompliance|0
226958|NCT01628692|745499|P1|Overall Study|Poor compliance/noncompliance|1
226959|NCT01628692|745494|P6|Overall Study|Death|0
226960|NCT01628692|745495|P5|Overall Study|Death|0
226961|NCT01628692|745496|P4|Overall Study|Death|0
226962|NCT01628692|745497|P3|Overall Study|Death|0
226963|NCT01628692|745498|P2|Overall Study|Death|1
226964|NCT01628692|745499|P1|Overall Study|Death|0
226965|NCT01628692|745494|P6|Overall Study|Withdrawal by Subject|0
226966|NCT01628692|745495|P5|Overall Study|Withdrawal by Subject|0
226967|NCT01628692|745496|P4|Overall Study|Withdrawal by Subject|0
226968|NCT01628692|745497|P3|Overall Study|Withdrawal by Subject|1
226969|NCT01628692|745498|P2|Overall Study|Withdrawal by Subject|1
226970|NCT01628692|745499|P1|Overall Study|Withdrawal by Subject|0
226971|NCT01628692|745494|P6|Overall Study|Adverse Event|0
226972|NCT01628692|745495|P5|Overall Study|Adverse Event|0
226973|NCT01628692|745496|P4|Overall Study|Adverse Event|0
226974|NCT01628692|745497|P3|Overall Study|Adverse Event|2
226975|NCT01628692|745498|P2|Overall Study|Adverse Event|0
226976|NCT01628692|745499|P1|Overall Study|Adverse Event|2
226977|NCT01628692|745494|P6|Overall Study|Lack of Efficacy|7
226978|NCT01628692|745495|P5|Overall Study|Lack of Efficacy|4
226979|NCT01628692|745496|P4|Overall Study|Lack of Efficacy|1
226980|NCT01628692|745497|P3|Overall Study|Lack of Efficacy|5
226981|NCT01628692|745498|P2|Overall Study|Lack of Efficacy|4
226982|NCT01628692|745499|P1|Overall Study|Lack of Efficacy|4
226983|NCT01628510|745567|P2|Overall Study|Death|1
226984|NCT01628510|745568|P1|Overall Study|Death|3
226985|NCT01628510|745567|P2|Overall Study|Withdrawal by Subject|4
226986|NCT01628510|745568|P1|Overall Study|Withdrawal by Subject|0
226987|NCT01628367|745576|P2|Overall Study|Adverse Event|0
226988|NCT01628367|745577|P1|Overall Study|Adverse Event|1
226989|NCT01627860|745623|P2|Overall Study|Protocol Violation|0
226990|NCT01627860|745624|P1|Overall Study|Protocol Violation|1
226991|NCT01627860|745623|P2|Overall Study|Seizure frequency doubled|1
226992|NCT01627860|745624|P1|Overall Study|Seizure frequency doubled|0
226993|NCT01627860|745623|P2|Overall Study|Withdrawal by Subject|1
226994|NCT01627860|745624|P1|Overall Study|Withdrawal by Subject|2
226995|NCT01627860|745623|P2|Overall Study|Adverse Event|4
226996|NCT01627860|745624|P1|Overall Study|Adverse Event|9
226997|NCT01627782|745638|P4|Overall Study|Randomized But Not Treated|0
226998|NCT01627782|745639|P3|Overall Study|Randomized But Not Treated|0
226999|NCT01627782|745640|P2|Overall Study|Randomized But Not Treated|0
227000|NCT01627782|745641|P1|Overall Study|Randomized But Not Treated|1
227001|NCT01627782|745638|P4|Overall Study|Unspecified|3
227002|NCT01627782|745639|P3|Overall Study|Unspecified|0
227003|NCT01627782|745640|P2|Overall Study|Unspecified|2
227004|NCT01627782|745641|P1|Overall Study|Unspecified|0
227005|NCT01627782|745638|P4|Overall Study|Withdrawal by Subject|0
227006|NCT01627782|745639|P3|Overall Study|Withdrawal by Subject|0
227007|NCT01627782|745640|P2|Overall Study|Withdrawal by Subject|1
227008|NCT01627782|745641|P1|Overall Study|Withdrawal by Subject|2
227009|NCT01627782|745638|P4|Overall Study|Protocol Violation|0
227010|NCT01627782|745639|P3|Overall Study|Protocol Violation|0
227011|NCT01627782|745640|P2|Overall Study|Protocol Violation|0
227012|NCT01627782|745641|P1|Overall Study|Protocol Violation|1
227013|NCT01627782|745638|P4|Overall Study|Lack of Efficacy|2
227014|NCT01627782|745639|P3|Overall Study|Lack of Efficacy|15
227015|NCT01627782|745640|P2|Overall Study|Lack of Efficacy|1
227016|NCT01627782|745641|P1|Overall Study|Lack of Efficacy|11
227017|NCT01627782|745638|P4|Overall Study|Adverse Event|1
227018|NCT01627782|745639|P3|Overall Study|Adverse Event|0
227019|NCT01627782|745640|P2|Overall Study|Adverse Event|2
227020|NCT01627782|745641|P1|Overall Study|Adverse Event|1
227021|NCT01627561|745699|P2|Overall Study|Withdrawal by Subject|2
227022|NCT01627561|745700|P1|Overall Study|Withdrawal by Subject|0
227023|NCT01627561|745699|P2|Overall Study|Migrated/moved from study area|1
227024|NCT01627561|745700|P1|Overall Study|Migrated/moved from study area|0
227025|NCT01627340|745748|P2|Overall Study|Withdrawal by Subject|0
227026|NCT01627340|745749|P1|Overall Study|Withdrawal by Subject|2
227027|NCT01627340|745748|P2|Overall Study|Pregnancy|0
227028|NCT01627340|745749|P1|Overall Study|Pregnancy|1
227029|NCT01627340|745748|P2|Overall Study|Lost to Follow-up|4
227030|NCT01627340|745749|P1|Overall Study|Lost to Follow-up|8
227031|NCT01627340|745748|P2|Overall Study|Adverse Event|0
227032|NCT01627340|745749|P1|Overall Study|Adverse Event|1
227033|NCT01627327|745767|P2|Overall Study|Withdrawal by Subject|3
227034|NCT01627327|745768|P1|Overall Study|Withdrawal by Subject|3
227035|NCT01627327|745767|P2|Overall Study|Physician Decision|0
227036|NCT01627327|745768|P1|Overall Study|Physician Decision|1
227037|NCT01627327|745767|P2|Overall Study|Lost to Follow-up|3
227038|NCT01627327|745768|P1|Overall Study|Lost to Follow-up|1
227039|NCT01627327|745767|P2|Overall Study|Protocol Violation|10
227040|NCT01627327|745768|P1|Overall Study|Protocol Violation|4
227041|NCT01627327|745767|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
227042|NCT01627327|745768|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
227043|NCT01627327|745767|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
227044|NCT01627327|745768|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
227045|NCT01627327|745767|P2|Overall Study|Adverse Event|12
227046|NCT01627327|745768|P1|Overall Study|Adverse Event|6
227047|NCT01627249|745781|P3|Overall Study|Missed Visit|0
227048|NCT01627249|745782|P2|Overall Study|Missed Visit|1
227049|NCT01627249|745783|P1|Overall Study|Missed Visit|1
227050|NCT01627249|745781|P3|Overall Study|Withdrawal by Subject|9
227051|NCT01627249|745782|P2|Overall Study|Withdrawal by Subject|6
227052|NCT01627249|745783|P1|Overall Study|Withdrawal by Subject|12
227053|NCT01627249|745781|P3|Overall Study|Death|3
227054|NCT01627249|745782|P2|Overall Study|Death|5
227055|NCT01627249|745783|P1|Overall Study|Death|3
227056|NCT01626690|745904|P2|Overall Study|Adverse Event|0
227057|NCT01626690|745905|P1|Overall Study|Adverse Event|1
227058|NCT01626690|745904|P2|Overall Study|Protocol Violation|0
227059|NCT01626690|745905|P1|Overall Study|Protocol Violation|1
227060|NCT01626456|745927|P2|Overall Study|Incarceration|2
227061|NCT01626456|745928|P1|Overall Study|Incarceration|0
227062|NCT01626456|745927|P2|Overall Study|Site Closure|3
227063|NCT01626456|745928|P1|Overall Study|Site Closure|2
227064|NCT01626456|745927|P2|Overall Study|Protocol Violation|1
227065|NCT01626456|745928|P1|Overall Study|Protocol Violation|1
227066|NCT01626456|745927|P2|Overall Study|Physician Decision|4
227067|NCT01626456|745928|P1|Overall Study|Physician Decision|1
227068|NCT01626456|745927|P2|Overall Study|Lack of Efficacy|7
227069|NCT01626456|745928|P1|Overall Study|Lack of Efficacy|6
227070|NCT01626456|745927|P2|Overall Study|Lost to Follow-up|27
227071|NCT01626456|745928|P1|Overall Study|Lost to Follow-up|2
227072|NCT01626456|745927|P2|Overall Study|Adverse Event|27
227073|NCT01626456|745928|P1|Overall Study|Adverse Event|2
227074|NCT01626456|745927|P2|Overall Study|Withdrawal by Subject|46
227075|NCT01626456|745928|P1|Overall Study|Withdrawal by Subject|21
227076|NCT01626391|745958|P2|Overall Study|Withdrawal by Subject|0
227077|NCT01626391|745959|P1|Overall Study|Withdrawal by Subject|1
227078|NCT01626391|745958|P2|Overall Study|Physician Decision|0
227079|NCT01626391|745959|P1|Overall Study|Physician Decision|1
227080|NCT01626118|745969|P4|Overall Study|Investigator Decision|0
227081|NCT01626118|745970|P3|Overall Study|Investigator Decision|0
227082|NCT01626118|745971|P2|Overall Study|Investigator Decision|1
227083|NCT01626118|745972|P1|Overall Study|Investigator Decision|0
227084|NCT01626118|745969|P4|Overall Study|Adverse Event|0
227085|NCT01626118|745970|P3|Overall Study|Adverse Event|1
227086|NCT01626118|745971|P2|Overall Study|Adverse Event|1
227087|NCT01626118|745972|P1|Overall Study|Adverse Event|0
227088|NCT01626118|745969|P4|Overall Study|Lost to Follow-up|0
227089|NCT01626118|745970|P3|Overall Study|Lost to Follow-up|0
227090|NCT01626118|745971|P2|Overall Study|Lost to Follow-up|0
227091|NCT01626118|745972|P1|Overall Study|Lost to Follow-up|1
227092|NCT01626118|745969|P4|Overall Study|Lack of Efficacy|3
227093|NCT01626118|745970|P3|Overall Study|Lack of Efficacy|1
227094|NCT01626118|745971|P2|Overall Study|Lack of Efficacy|0
227095|NCT01626118|745972|P1|Overall Study|Lack of Efficacy|1
227096|NCT01625910|746018|P2|Overall Study|Lost to Follow-up|4
227097|NCT01625910|746019|P1|Overall Study|Lost to Follow-up|3
227098|NCT01625845|746029|P2|Overall Study|Withdrawal by Subject|0
227099|NCT01625845|746030|P1|Overall Study|Withdrawal by Subject|2
227100|NCT01625845|746029|P2|Overall Study|Lost to Follow-up|1
227101|NCT01625845|746030|P1|Overall Study|Lost to Follow-up|2
227102|NCT01625845|746029|P2|Overall Study|Adverse Event|2
227103|NCT01625845|746030|P1|Overall Study|Adverse Event|1
227104|NCT01625689|746050|P2|Overall Study|Migration|1
227105|NCT01625689|746051|P1|Overall Study|Migration|2
227106|NCT01625377|746087|P2|Overall Study|Abnormal laboratory values|0
227107|NCT01625377|746088|P1|Overall Study|Abnormal laboratory values|1
227108|NCT01625377|746087|P2|Overall Study|Unsatisfactory therapeutic effect|1
227109|NCT01625377|746088|P1|Overall Study|Unsatisfactory therapeutic effect|0
227110|NCT01625377|746087|P2|Overall Study|Graft loss|0
227111|NCT01625377|746088|P1|Overall Study|Graft loss|1
227112|NCT01625377|746087|P2|Overall Study|Adverse Event|16
227113|NCT01625377|746088|P1|Overall Study|Adverse Event|3
227114|NCT01625377|746087|P2|Overall Study|Protocol Violation|3
227115|NCT01625377|746088|P1|Overall Study|Protocol Violation|0
227116|NCT01625377|746087|P2|Overall Study|Administrative Problem|1
227117|NCT01625377|746088|P1|Overall Study|Administrative Problem|1
227118|NCT01625377|746087|P2|Overall Study|Death|1
227119|NCT01625377|746088|P1|Overall Study|Death|1
227120|NCT01625338|746121|P3|Overall Study|Study Discontinued by Sponsor|1
227121|NCT01625338|746122|P2|Overall Study|Study Discontinued by Sponsor|0
227122|NCT01625338|746123|P1|Overall Study|Study Discontinued by Sponsor|0
227123|NCT01625338|746121|P3|Overall Study|Adverse Event|1
227124|NCT01625338|746122|P2|Overall Study|Adverse Event|0
227125|NCT01625338|746123|P1|Overall Study|Adverse Event|1
227126|NCT01625338|746121|P3|Overall Study|Subject Withdrew Consent|2
227127|NCT01625338|746122|P2|Overall Study|Subject Withdrew Consent|0
227128|NCT01625338|746123|P1|Overall Study|Subject Withdrew Consent|1
227129|NCT01625338|746121|P3|Overall Study|Investigator Decision|1
227130|NCT01625338|746122|P2|Overall Study|Investigator Decision|2
227131|NCT01625338|746123|P1|Overall Study|Investigator Decision|0
227132|NCT01625338|746121|P3|Overall Study|Lost to Follow-up|2
227133|NCT01625338|746122|P2|Overall Study|Lost to Follow-up|3
227134|NCT01625338|746123|P1|Overall Study|Lost to Follow-up|3
227135|NCT01625338|746121|P3|Overall Study|Efficacy Failure|31
227136|NCT01625338|746122|P2|Overall Study|Efficacy Failure|39
227137|NCT01625338|746123|P1|Overall Study|Efficacy Failure|27
227138|NCT01625338|746121|P3|Overall Study|Enrolled but not Treated|1
227139|NCT01625338|746122|P2|Overall Study|Enrolled but not Treated|0
227140|NCT01625338|746123|P1|Overall Study|Enrolled but not Treated|0
227141|NCT01624467|746189|P1|Overall Study|Subject Withdrew from Treatment|1
227142|NCT01624467|746189|P1|Overall Study|Per Sponsor Requirement|1
227143|NCT01624467|746189|P1|Overall Study|Progressive Disease|19
227144|NCT01624467|746189|P1|Overall Study|Adverse Event|7
227145|NCT01624467|746189|P1|Overall Study|Lost to Follow-up|1
227146|NCT01624467|746189|P1|Overall Study|Withdrawal by Subject|2
227147|NCT01624259|746228|P2|Overall Study|Abnormal laboratory measure|0
227148|NCT01624259|746229|P1|Overall Study|Abnormal laboratory measure|3
227149|NCT01624259|746228|P2|Overall Study|Lost to Follow-up|3
227150|NCT01624259|746229|P1|Overall Study|Lost to Follow-up|2
227151|NCT01624259|746228|P2|Overall Study|Physician Decision|1
227152|NCT01624259|746229|P1|Overall Study|Physician Decision|1
227153|NCT01624259|746228|P2|Overall Study|Withdrawal by Subject|7
227154|NCT01624259|746229|P1|Overall Study|Withdrawal by Subject|5
227155|NCT01624259|746228|P2|Overall Study|Protocol Violation|2
227156|NCT01624259|746229|P1|Overall Study|Protocol Violation|1
227157|NCT01624259|746228|P2|Overall Study|Adverse Event|18
227158|NCT01624259|746229|P1|Overall Study|Adverse Event|18
227159|NCT01624233|746278|P1|Period 3 - Maintenance|Withdrawal by Subject|2
227160|NCT01624233|746278|P1|Period 3 - Maintenance|Physician Decision|2
227161|NCT01624233|746278|P1|Period 3 - Maintenance|Lack of Efficacy|1
227162|NCT01624233|746278|P1|Period 3 - Maintenance|Adverse Event|2
227163|NCT01624233|746278|P1|Period 2 - Induction|Adverse Event|1
227164|NCT01623830|746331|P2|Overall Study|Exclusion from Study|2
227165|NCT01623830|746332|P1|Overall Study|Exclusion from Study|1
227166|NCT01623830|746331|P2|Overall Study|Withdrawal by Subject|7
227167|NCT01623830|746332|P1|Overall Study|Withdrawal by Subject|6
227168|NCT01623271|746356|P1|Overall Study|Withdrawal by Subject|2
227169|NCT01623154|746360|P1|Overall Study|Did not drink Pranactin Citric|4
227170|NCT01623115|746368|P2|Overall Study|Other than specified above|3
227171|NCT01623115|746369|P1|Overall Study|Other than specified above|0
227172|NCT01623115|746368|P2|Overall Study|Death|4
227173|NCT01623115|746369|P1|Overall Study|Death|0
227174|NCT01623115|746368|P2|Overall Study|Site closure|7
227175|NCT01623115|746369|P1|Overall Study|Site closure|1
227176|NCT01623115|746368|P2|Overall Study|Last visit outside protocol visit window|26
227177|NCT01623115|746369|P1|Overall Study|Last visit outside protocol visit window|14
227178|NCT01623115|746368|P2|Overall Study|Related to study drug administration|2
227179|NCT01623115|746369|P1|Overall Study|Related to study drug administration|0
227180|NCT01623115|746368|P2|Overall Study|Consent withdrawn by participant|6
227181|NCT01623115|746369|P1|Overall Study|Consent withdrawn by participant|2
227182|NCT01623115|746368|P2|Overall Study|Poor compliance to protocol|10
227183|NCT01623115|746369|P1|Overall Study|Poor compliance to protocol|4
227184|NCT01623115|746368|P2|Overall Study|Adverse Event|13
227185|NCT01623115|746369|P1|Overall Study|Adverse Event|10
227186|NCT01623115|746368|P2|Overall Study|Participants moved|5
227187|NCT01623115|746369|P1|Overall Study|Participants moved|1
227188|NCT01623115|746368|P2|Overall Study|Physician Decision|0
227189|NCT01623115|746369|P1|Overall Study|Physician Decision|1
227190|NCT01623115|746368|P2|Overall Study|Randomized but not treated|1
227191|NCT01623115|746369|P1|Overall Study|Randomized but not treated|0
227192|NCT01623050|746429|P1|Overall Study|Lost to Follow-up|9
227193|NCT01622673|746443|P6|Treatment Period 3|Protocol Violation|0
227194|NCT01622673|746444|P5|Treatment Period 3|Protocol Violation|0
227195|NCT01622673|746445|P4|Treatment Period 3|Protocol Violation|0
227196|NCT01622673|746446|P3|Treatment Period 3|Protocol Violation|0
227197|NCT01622673|746447|P2|Treatment Period 3|Protocol Violation|1
227198|NCT01622673|746448|P1|Treatment Period 3|Protocol Violation|0
227199|NCT01622673|746443|P6|Treatment Period 2|Withdrawal by Subject|0
227200|NCT01622673|746444|P5|Treatment Period 2|Withdrawal by Subject|0
227201|NCT01622673|746445|P4|Treatment Period 2|Withdrawal by Subject|1
227202|NCT01622673|746446|P3|Treatment Period 2|Withdrawal by Subject|0
227203|NCT01622673|746447|P2|Treatment Period 2|Withdrawal by Subject|0
227204|NCT01622673|746448|P1|Treatment Period 2|Withdrawal by Subject|0
227205|NCT01622673|746443|P6|Treatment Period 1|Protocol Violation|0
227206|NCT01622673|746444|P5|Treatment Period 1|Protocol Violation|0
227207|NCT01622673|746445|P4|Treatment Period 1|Protocol Violation|0
227208|NCT01622673|746446|P3|Treatment Period 1|Protocol Violation|0
227209|NCT01622673|746447|P2|Treatment Period 1|Protocol Violation|1
227210|NCT01622673|746448|P1|Treatment Period 1|Protocol Violation|0
227211|NCT01622673|746443|P6|Treatment Period 1|Withdrawal by Subject|0
227212|NCT01622673|746444|P5|Treatment Period 1|Withdrawal by Subject|0
227213|NCT01622673|746445|P4|Treatment Period 1|Withdrawal by Subject|1
227214|NCT01622673|746446|P3|Treatment Period 1|Withdrawal by Subject|0
227215|NCT01622673|746447|P2|Treatment Period 1|Withdrawal by Subject|0
227216|NCT01622673|746448|P1|Treatment Period 1|Withdrawal by Subject|0
227217|NCT01622231|746514|P1|Overall Study|Withdrawal by Subject|1
227218|NCT01622231|746514|P1|Overall Study|Physician Decision|1
227219|NCT01621191|746609|P1|Overall Study|Site Removed From Study|1
227220|NCT01621191|746609|P1|Overall Study|Lost to Follow-up|1
227221|NCT01621191|746609|P1|Overall Study|Lack of Efficacy|6
227222|NCT01621191|746609|P1|Overall Study|Withdrawal by Subject|8
227223|NCT01621191|746609|P1|Overall Study|Adverse Event|9
227224|NCT01621126|746620|P1|Overall Study|Physician Decision|6
227225|NCT01620489|746641|P2|Overall Study|Unclassified|2
227226|NCT01620489|746642|P1|Overall Study|Unclassified|1
227227|NCT01620489|746641|P2|Overall Study|Withdrawal Criteria|25
227228|NCT01620489|746642|P1|Overall Study|Withdrawal Criteria|17
227229|NCT01620489|746641|P2|Overall Study|Protocol Violation|3
227230|NCT01620489|746642|P1|Overall Study|Protocol Violation|0
227231|NCT01620489|746641|P2|Overall Study|Adverse Event|4
227232|NCT01620489|746642|P1|Overall Study|Adverse Event|17
227233|NCT01620255|746663|P5|Overall Study|Withdrawn at discretion of investigator|1
227234|NCT01620255|746664|P4|Overall Study|Withdrawn at discretion of investigator|0
227235|NCT01620255|746665|P3|Overall Study|Withdrawn at discretion of investigator|0
227236|NCT01620255|746666|P2|Overall Study|Withdrawn at discretion of investigator|0
227237|NCT01620255|746667|P1|Overall Study|Withdrawn at discretion of investigator|0
227238|NCT01620255|746663|P5|Overall Study|Adverse Event|1
227239|NCT01620255|746664|P4|Overall Study|Adverse Event|1
227240|NCT01620255|746665|P3|Overall Study|Adverse Event|0
227241|NCT01620255|746666|P2|Overall Study|Adverse Event|4
227242|NCT01620255|746667|P1|Overall Study|Adverse Event|0
227243|NCT01620255|746663|P5|Overall Study|Non-compliance|0
227244|NCT01620255|746664|P4|Overall Study|Non-compliance|0
227245|NCT01620255|746665|P3|Overall Study|Non-compliance|0
227246|NCT01620255|746666|P2|Overall Study|Non-compliance|1
227247|NCT01620255|746667|P1|Overall Study|Non-compliance|0
227248|NCT01620255|746663|P5|Overall Study|Participant underwent fecal transplant|0
227249|NCT01620255|746664|P4|Overall Study|Participant underwent fecal transplant|0
227250|NCT01620255|746665|P3|Overall Study|Participant underwent fecal transplant|1
227251|NCT01620255|746666|P2|Overall Study|Participant underwent fecal transplant|0
227252|NCT01620255|746667|P1|Overall Study|Participant underwent fecal transplant|0
227253|NCT01620255|746663|P5|Overall Study|Withdrawal by Subject|4
227254|NCT01620255|746664|P4|Overall Study|Withdrawal by Subject|2
227255|NCT01620255|746665|P3|Overall Study|Withdrawal by Subject|1
227256|NCT01620255|746666|P2|Overall Study|Withdrawal by Subject|1
227257|NCT01620255|746667|P1|Overall Study|Withdrawal by Subject|4
227258|NCT01620177|746744|P1|Overall Study|Randomized, Not Active due to Scheduling|1
227259|NCT01620177|746744|P1|Overall Study|Physician Decision|2
227260|NCT01620177|746744|P1|Overall Study|Lost to Follow-up|7
227261|NCT01620177|746744|P1|Overall Study|Withdrawal by Subject|26
227262|NCT01620177|746744|P1|Overall Study|Failure at Screening Visit|43
227263|NCT01620138|746769|P2|Overall Study|Adverse Event|0
227264|NCT01620138|746770|P1|Overall Study|Adverse Event|2
227265|NCT01620138|746769|P2|Overall Study|Lack of Efficacy|0
227266|NCT01620138|746770|P1|Overall Study|Lack of Efficacy|1
227267|NCT01620138|746769|P2|Overall Study|Withdrawal by Subject|0
227268|NCT01620138|746770|P1|Overall Study|Withdrawal by Subject|3
227269|NCT01620086|746778|P3|Overall Study|Physician Decision|0
227270|NCT01620086|746779|P2|Overall Study|Physician Decision|0
227271|NCT01620086|746780|P1|Overall Study|Physician Decision|1
227272|NCT01620086|746778|P3|Overall Study|failed study criteria|0
227273|NCT01620086|746779|P2|Overall Study|failed study criteria|4
227274|NCT01620086|746780|P1|Overall Study|failed study criteria|1
227275|NCT01620086|746778|P3|Overall Study|Withdrawal by Subject|0
227276|NCT01620086|746779|P2|Overall Study|Withdrawal by Subject|3
227277|NCT01620086|746780|P1|Overall Study|Withdrawal by Subject|3
227278|NCT01620060|746799|P1|Overall Study|Per Sponsor Decision|2
227279|NCT01620060|746799|P1|Overall Study|Family emergency|1
227280|NCT01620060|746799|P1|Overall Study|Did not comply with Study Produre|1
227281|NCT01620060|746799|P1|Overall Study|Withdrawal by Subject|1
227282|NCT01620060|746799|P1|Overall Study|Protocol Violation|1
227283|NCT01620060|746799|P1|Overall Study|Adverse Event|9
227284|NCT01619878|746818|P1|Follow-up at 12 Months of Age|Death|2
227285|NCT01619878|746818|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
227286|NCT01619878|746818|P1|6 Week Follow-up Phase|Adverse Event|1
227287|NCT01619800|746832|P2|Overall Study|study terminated|0
227288|NCT01619800|746833|P1|Overall Study|study terminated|2
227289|NCT01619787|746841|P1|Overall Study|Lost to Follow-up|5
227290|NCT01619579|746858|P2|Overall Study|Withdrawal by Subject|3
227291|NCT01619579|746859|P1|Overall Study|Withdrawal by Subject|0
227292|NCT01619059|746871|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
227293|NCT01619059|746872|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
227294|NCT01619059|746871|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
227295|NCT01619059|746872|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
227296|NCT01619059|746871|P2|Long-Term (LT) Treatment Period|Death|0
227297|NCT01619059|746872|P1|Long-Term (LT) Treatment Period|Death|1
227298|NCT01619059|746871|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
227299|NCT01619059|746872|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
227300|NCT01619059|746871|P2|Long-Term (LT) Treatment Period|Adverse Event|3
227301|NCT01619059|746872|P1|Long-Term (LT) Treatment Period|Adverse Event|2
227302|NCT01619059|746871|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
227303|NCT01619059|746872|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
227304|NCT01619059|746871|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
227305|NCT01619059|746872|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
227306|NCT01619059|746871|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
227307|NCT01619059|746872|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
227308|NCT01619059|746871|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
227309|NCT01619059|746872|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
227310|NCT01619059|746871|P2|Short-Term (ST) Treatment Period|Adverse Event|0
227311|NCT01619059|746872|P1|Short-Term (ST) Treatment Period|Adverse Event|1
227312|NCT01618968|746888|P4|Overall Study|Death|1
227313|NCT01618968|746889|P3|Overall Study|Death|0
227314|NCT01618968|746890|P2|Overall Study|Death|0
227315|NCT01618968|746891|P1|Overall Study|Death|0
227316|NCT01618968|746888|P4|Overall Study|Adverse Event|0
227317|NCT01618968|746889|P3|Overall Study|Adverse Event|0
227318|NCT01618968|746890|P2|Overall Study|Adverse Event|0
227319|NCT01618968|746891|P1|Overall Study|Adverse Event|1
227320|NCT01618864|746958|P1|Overall Study|Lost to Follow-up|2
227321|NCT01618864|746958|P1|Overall Study|Withdrawal by Subject|2
227322|NCT01618838|746967|P1|Overall Study|slow accrual, trial closed prematurely.|4
227323|NCT01618708|746973|P2|Overall Study|Randomized but not treated|2
227324|NCT01618708|746974|P1|Overall Study|Randomized but not treated|3
227325|NCT01618708|746973|P2|Overall Study|Other than specified above|1
227326|NCT01618708|746974|P1|Overall Study|Other than specified above|1
227327|NCT01618708|746973|P2|Overall Study|Technical problems|0
227328|NCT01618708|746974|P1|Overall Study|Technical problems|2
227329|NCT01618708|746973|P2|Overall Study|Lack of Efficacy|8
227330|NCT01618708|746974|P1|Overall Study|Lack of Efficacy|8
227331|NCT01618708|746973|P2|Overall Study|Withdrawal by Subject|22
227332|NCT01618708|746974|P1|Overall Study|Withdrawal by Subject|17
227333|NCT01618708|746973|P2|Overall Study|Lost to Follow-up|3
227334|NCT01618708|746974|P1|Overall Study|Lost to Follow-up|3
227335|NCT01618708|746973|P2|Overall Study|Adverse Event|10
227336|NCT01618708|746974|P1|Overall Study|Adverse Event|10
227337|NCT01618669|746988|P2|Overall Study|Miscellaneous Reason|1
227338|NCT01618669|746989|P1|Overall Study|Miscellaneous Reason|0
227339|NCT01618669|746988|P2|Overall Study|Withdrawal by Subject|9
227340|NCT01618669|746989|P1|Overall Study|Withdrawal by Subject|9
227341|NCT01618669|746988|P2|Overall Study|Protocol Violation|3
227342|NCT01618669|746989|P1|Overall Study|Protocol Violation|5
227343|NCT01618669|746988|P2|Overall Study|Adverse Event|7
227344|NCT01618669|746989|P1|Overall Study|Adverse Event|16
227345|NCT01618669|746988|P2|Overall Study|Randomized but Never Received Study Drug|2
227346|NCT01618669|746989|P1|Overall Study|Randomized but Never Received Study Drug|3
227347|NCT01618669|746988|P2|Overall Study|Lost to Follow-up|1
227348|NCT01618669|746989|P1|Overall Study|Lost to Follow-up|1
227349|NCT01618266|747042|P1|Overall Study|Protocol Violation|43
227350|NCT01618266|747042|P1|Overall Study|Lack of Efficacy|23
227351|NCT01618266|747042|P1|Overall Study|Other reasons|11
227352|NCT01618266|747042|P1|Overall Study|Treatment satisfaction|10
227353|NCT01618266|747042|P1|Overall Study|Lost to Follow-up|9
227354|NCT01618214|747079|P2|Overall Study|Unclassified|5
227355|NCT01618214|747080|P1|Overall Study|Unclassified|4
227356|NCT01618214|747079|P2|Overall Study|Withdrawal Criteria|2
227357|NCT01618214|747080|P1|Overall Study|Withdrawal Criteria|1
227358|NCT01618214|747079|P2|Overall Study|Protocol Violation|4
227359|NCT01618214|747080|P1|Overall Study|Protocol Violation|1
227360|NCT01618214|747079|P2|Overall Study|Lack of Efficacy|1
227361|NCT01618214|747080|P1|Overall Study|Lack of Efficacy|1
227362|NCT01618214|747079|P2|Overall Study|Adverse Event|1
227363|NCT01618214|747080|P1|Overall Study|Adverse Event|3
227364|NCT01618162|747096|P2|Overall Study|Unclassified|13
227365|NCT01618162|747097|P1|Overall Study|Unclassified|14
227366|NCT01618162|747096|P2|Overall Study|Withdrawal Criteria|10
227367|NCT01618162|747097|P1|Overall Study|Withdrawal Criteria|2
227368|NCT01618162|747096|P2|Overall Study|Adverse Event|2
227369|NCT01618162|747097|P1|Overall Study|Adverse Event|9
227370|NCT01618162|747096|P2|Overall Study|Protocol Violation|10
227371|NCT01618162|747097|P1|Overall Study|Protocol Violation|13
227372|NCT01618019|747117|P2|Overall Study|Withdrawal by Subject|14
227373|NCT01618019|747118|P1|Overall Study|Withdrawal by Subject|14
227374|NCT01617668|747140|P4|Overall Study|Subject/guardian decision|1
227375|NCT01617668|747141|P3|Overall Study|Subject/guardian decision|2
227376|NCT01617668|747142|P2|Overall Study|Subject/guardian decision|3
227377|NCT01617668|747143|P1|Overall Study|Subject/guardian decision|1
227378|NCT01617668|747140|P4|Overall Study|Progressive Disease|9
227379|NCT01617668|747141|P3|Overall Study|Progressive Disease|6
227380|NCT01617668|747142|P2|Overall Study|Progressive Disease|4
227381|NCT01617668|747143|P1|Overall Study|Progressive Disease|4
227382|NCT01617668|747140|P4|Overall Study|Physician Decision|0
227383|NCT01617668|747141|P3|Overall Study|Physician Decision|3
227384|NCT01617668|747142|P2|Overall Study|Physician Decision|2
227385|NCT01617668|747143|P1|Overall Study|Physician Decision|1
227386|NCT01617668|747140|P4|Overall Study|Adverse Event|5
227387|NCT01617668|747141|P3|Overall Study|Adverse Event|12
227388|NCT01617668|747142|P2|Overall Study|Adverse Event|0
227389|NCT01617668|747143|P1|Overall Study|Adverse Event|7
227390|NCT01617655|747184|P2|Overall Study|Other than specified above|2
227391|NCT01617655|747185|P1|Overall Study|Other than specified above|1
227392|NCT01617655|747184|P2|Overall Study|Site closure|5
227393|NCT01617655|747185|P1|Overall Study|Site closure|3
227394|NCT01617655|747184|P2|Overall Study|Last visit outside protocol visit window|10
227395|NCT01617655|747185|P1|Overall Study|Last visit outside protocol visit window|1
227396|NCT01617655|747184|P2|Overall Study|Consent withdrawn by participant|1
227397|NCT01617655|747185|P1|Overall Study|Consent withdrawn by participant|1
227398|NCT01617655|747184|P2|Overall Study|Participants moved|4
227399|NCT01617655|747185|P1|Overall Study|Participants moved|0
227400|NCT01617655|747184|P2|Overall Study|Poor compliance to protocol|4
227401|NCT01617655|747185|P1|Overall Study|Poor compliance to protocol|1
227402|NCT01617655|747184|P2|Overall Study|Adverse Event|3
227403|NCT01617655|747185|P1|Overall Study|Adverse Event|2
227404|NCT01617447|747270|P2|Overall Study|Physician Decision|2
227405|NCT01617447|747271|P1|Overall Study|Physician Decision|0
227406|NCT01617447|747270|P2|Overall Study|Adverse Event|1
227407|NCT01617447|747271|P1|Overall Study|Adverse Event|0
227408|NCT01617434|747279|P2|Overall Study|Unclassified|4
227409|NCT01617434|747280|P1|Overall Study|Unclassified|3
227410|NCT01617434|747279|P2|Overall Study|Withdrawal Criteria|37
227411|NCT01617434|747280|P1|Overall Study|Withdrawal Criteria|12
227412|NCT01617434|747279|P2|Overall Study|Protocol Violation|7
227413|NCT01617434|747280|P1|Overall Study|Protocol Violation|8
227414|NCT01617434|747279|P2|Overall Study|Adverse Event|3
227415|NCT01617434|747280|P1|Overall Study|Adverse Event|12
227416|NCT01617187|747312|P4|Treatment Through Study Completion|Protocol Violation|1
227417|NCT01617187|747313|P3|Treatment Through Study Completion|Protocol Violation|0
227418|NCT01617187|747314|P2|Treatment Through Study Completion|Protocol Violation|0
227419|NCT01617187|747315|P1|Treatment Through Study Completion|Protocol Violation|1
227420|NCT01617187|747312|P4|Treatment Through Study Completion|Withdrawal by Subject|6
227421|NCT01617187|747313|P3|Treatment Through Study Completion|Withdrawal by Subject|3
227422|NCT01617187|747314|P2|Treatment Through Study Completion|Withdrawal by Subject|8
227423|NCT01617187|747315|P1|Treatment Through Study Completion|Withdrawal by Subject|5
227424|NCT01617187|747312|P4|Treatment Through Study Completion|Lost to Follow-up|2
227425|NCT01617187|747313|P3|Treatment Through Study Completion|Lost to Follow-up|2
227426|NCT01617187|747314|P2|Treatment Through Study Completion|Lost to Follow-up|2
227427|NCT01617187|747315|P1|Treatment Through Study Completion|Lost to Follow-up|4
227428|NCT01617187|747312|P4|Treatment Through Study Completion|Adverse Event|1
227429|NCT01617187|747313|P3|Treatment Through Study Completion|Adverse Event|0
227430|NCT01617187|747314|P2|Treatment Through Study Completion|Adverse Event|1
227431|NCT01617187|747315|P1|Treatment Through Study Completion|Adverse Event|1
227432|NCT01617187|747312|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
227433|NCT01617187|747313|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
227434|NCT01617187|747314|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
227435|NCT01617187|747315|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
227436|NCT01617187|747312|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
227437|NCT01617187|747313|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
227438|NCT01617187|747314|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
227439|NCT01617187|747315|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
227440|NCT01617187|747312|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
227441|NCT01617187|747313|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
227442|NCT01617187|747314|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
227443|NCT01617187|747315|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
227444|NCT01617070|747385|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
227445|NCT01617005|747403|P1|Overall Study|Lack of motivation for treatment|1
227446|NCT01617005|747403|P1|Overall Study|Pregnancy|1
227447|NCT01616953|747412|P2|Overall Study|lack of bone and soft tissue|0
227448|NCT01616953|747413|P1|Overall Study|lack of bone and soft tissue|1
227449|NCT01616953|747412|P2|Overall Study|Lost to Follow-up|0
227450|NCT01616953|747413|P1|Overall Study|Lost to Follow-up|1
227451|NCT01616771|747421|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
227452|NCT01616459|747446|P4|Overall Study|Other reason|0
227453|NCT01616459|747447|P3|Overall Study|Other reason|1
227454|NCT01616459|747448|P2|Overall Study|Other reason|1
227455|NCT01616459|747449|P1|Overall Study|Other reason|0
227456|NCT01616459|747446|P4|Overall Study|Withdrawal by Subject|4
227457|NCT01616459|747447|P3|Overall Study|Withdrawal by Subject|4
227458|NCT01616459|747448|P2|Overall Study|Withdrawal by Subject|4
227459|NCT01616459|747449|P1|Overall Study|Withdrawal by Subject|2
227460|NCT01616459|747446|P4|Overall Study|Protocol Violation|2
227461|NCT01616459|747447|P3|Overall Study|Protocol Violation|0
227462|NCT01616459|747448|P2|Overall Study|Protocol Violation|0
227463|NCT01616459|747449|P1|Overall Study|Protocol Violation|0
227464|NCT01616459|747446|P4|Overall Study|Lost to Follow-up|2
227465|NCT01616459|747447|P3|Overall Study|Lost to Follow-up|3
227466|NCT01616459|747448|P2|Overall Study|Lost to Follow-up|11
227467|NCT01616459|747449|P1|Overall Study|Lost to Follow-up|1
227468|NCT01616459|747446|P4|Overall Study|Adverse Event|0
227469|NCT01616459|747447|P3|Overall Study|Adverse Event|2
227470|NCT01616459|747448|P2|Overall Study|Adverse Event|1
227471|NCT01616459|747449|P1|Overall Study|Adverse Event|1
227472|NCT01616173|747538|P3|Overall Study|Lost to Follow-up|0
227473|NCT01616173|747539|P2|Overall Study|Lost to Follow-up|2
227474|NCT01616173|747540|P1|Overall Study|Lost to Follow-up|0
227475|NCT01615939|747556|P2|Overall Study|Lost to Follow-up|0
227476|NCT01615939|747557|P1|Overall Study|Lost to Follow-up|5
227477|NCT01615822|747570|P3|Period 2|Lost to Follow-up|2
227478|NCT01615822|747571|P2|Period 2|Lost to Follow-up|1
227479|NCT01615822|747572|P1|Period 2|Lost to Follow-up|0
227480|NCT01615822|747570|P3|Period 1|Adverse Event|0
227481|NCT01615822|747571|P2|Period 1|Adverse Event|1
227482|NCT01615822|747572|P1|Period 1|Adverse Event|1
227483|NCT01615822|747570|P3|Period 1|Withdrawal by Subject|0
227484|NCT01615822|747571|P2|Period 1|Withdrawal by Subject|1
227485|NCT01615822|747572|P1|Period 1|Withdrawal by Subject|0
227486|NCT01615328|747618|P2|Overall Study|Lost to Follow-up|5
227487|NCT01615328|747619|P1|Overall Study|Lost to Follow-up|3
227488|NCT01615263|747631|P2|Overall Study|Post-randomization exclusion|2
227489|NCT01615263|747632|P1|Overall Study|Post-randomization exclusion|0
227490|NCT01615198|747646|P2|Overall Study|Adverse Event|5
227491|NCT01615198|747647|P1|Overall Study|Adverse Event|11
227492|NCT01615198|747646|P2|Overall Study|Lack of Efficacy|6
227493|NCT01615198|747647|P1|Overall Study|Lack of Efficacy|1
227494|NCT01615198|747646|P2|Overall Study|Lost to Follow-up|1
227495|NCT01615198|747647|P1|Overall Study|Lost to Follow-up|1
227496|NCT01615198|747646|P2|Overall Study|Physician Decision|1
227497|NCT01615198|747647|P1|Overall Study|Physician Decision|5
227498|NCT01615198|747646|P2|Overall Study|Protocol deviation|1
227499|NCT01615198|747647|P1|Overall Study|Protocol deviation|1
227500|NCT01615198|747646|P2|Overall Study|Withdrawal by Subject|5
227501|NCT01615198|747647|P1|Overall Study|Withdrawal by Subject|5
227502|NCT01615029|747680|P5|Overall Study|Ongoing|23
227503|NCT01615029|747681|P4|Overall Study|Ongoing|2
227504|NCT01615029|747682|P3|Overall Study|Ongoing|3
227505|NCT01615029|747683|P2|Overall Study|Ongoing|2
227506|NCT01615029|747684|P1|Overall Study|Ongoing|1
227507|NCT01615029|747680|P5|Overall Study|Physician Decision|1
227508|NCT01615029|747681|P4|Overall Study|Physician Decision|0
227509|NCT01615029|747682|P3|Overall Study|Physician Decision|0
227510|NCT01615029|747683|P2|Overall Study|Physician Decision|0
227511|NCT01615029|747684|P1|Overall Study|Physician Decision|0
227512|NCT01615029|747680|P5|Overall Study|Progressive disease|5
227513|NCT01615029|747681|P4|Overall Study|Progressive disease|1
227514|NCT01615029|747682|P3|Overall Study|Progressive disease|1
227515|NCT01615029|747683|P2|Overall Study|Progressive disease|1
227516|NCT01615029|747684|P1|Overall Study|Progressive disease|2
227517|NCT01615029|747680|P5|Overall Study|Lost to Follow-up|1
227518|NCT01615029|747681|P4|Overall Study|Lost to Follow-up|0
227519|NCT01615029|747682|P3|Overall Study|Lost to Follow-up|0
227520|NCT01615029|747683|P2|Overall Study|Lost to Follow-up|0
227521|NCT01615029|747684|P1|Overall Study|Lost to Follow-up|0
227522|NCT01615029|747680|P5|Overall Study|Death|1
227523|NCT01615029|747681|P4|Overall Study|Death|0
227524|NCT01615029|747682|P3|Overall Study|Death|0
227525|NCT01615029|747683|P2|Overall Study|Death|0
227526|NCT01615029|747684|P1|Overall Study|Death|0
227527|NCT01615029|747680|P5|Overall Study|Adverse Event|1
227528|NCT01615029|747681|P4|Overall Study|Adverse Event|0
227529|NCT01615029|747682|P3|Overall Study|Adverse Event|0
227530|NCT01615029|747683|P2|Overall Study|Adverse Event|0
227531|NCT01615029|747684|P1|Overall Study|Adverse Event|0
227532|NCT01614886|747707|P2|Overall Study|Protocol deviation|2
227533|NCT01614886|747708|P1|Overall Study|Protocol deviation|0
227534|NCT01614886|747707|P2|Overall Study|Death|0
227535|NCT01614886|747708|P1|Overall Study|Death|1
227536|NCT01614886|747707|P2|Overall Study|Withdrawal by Subject|4
227537|NCT01614886|747708|P1|Overall Study|Withdrawal by Subject|4
227538|NCT01614886|747707|P2|Overall Study|Adverse Event|20
227539|NCT01614886|747708|P1|Overall Study|Adverse Event|15
227540|NCT01614795|747726|P4|Overall Study|Ineligible|0
227541|NCT01614795|747727|P3|Overall Study|Ineligible|0
227542|NCT01614795|747728|P2|Overall Study|Ineligible|1
227543|NCT01614795|747729|P1|Overall Study|Ineligible|0
227544|NCT01614795|747726|P4|Overall Study|Withdrawal by Subject|2
227545|NCT01614795|747727|P3|Overall Study|Withdrawal by Subject|0
227546|NCT01614795|747728|P2|Overall Study|Withdrawal by Subject|1
227547|NCT01614795|747729|P1|Overall Study|Withdrawal by Subject|0
227548|NCT01614795|747726|P4|Overall Study|Physician Decision|1
227549|NCT01614795|747727|P3|Overall Study|Physician Decision|1
227550|NCT01614795|747728|P2|Overall Study|Physician Decision|0
227551|NCT01614795|747729|P1|Overall Study|Physician Decision|1
227552|NCT01614795|747726|P4|Overall Study|Lack of Efficacy|8
227553|NCT01614795|747727|P3|Overall Study|Lack of Efficacy|9
227554|NCT01614795|747728|P2|Overall Study|Lack of Efficacy|10
227555|NCT01614795|747729|P1|Overall Study|Lack of Efficacy|10
227556|NCT01614795|747726|P4|Overall Study|Adverse Event|1
227557|NCT01614795|747727|P3|Overall Study|Adverse Event|1
227558|NCT01614795|747728|P2|Overall Study|Adverse Event|0
227559|NCT01614795|747729|P1|Overall Study|Adverse Event|0
227560|NCT01614769|747739|P6|Period 3|Withdrawal by Subject|0
227561|NCT01614769|747740|P5|Period 3|Withdrawal by Subject|0
227562|NCT01614769|747741|P4|Period 3|Withdrawal by Subject|0
227563|NCT01614769|747742|P3|Period 3|Withdrawal by Subject|1
227564|NCT01614769|747743|P2|Period 3|Withdrawal by Subject|0
227565|NCT01614769|747744|P1|Period 3|Withdrawal by Subject|0
227566|NCT01614769|747739|P6|Period 1|Withdrawal by Subject|0
227567|NCT01614769|747740|P5|Period 1|Withdrawal by Subject|0
227568|NCT01614769|747741|P4|Period 1|Withdrawal by Subject|0
227569|NCT01614769|747742|P3|Period 1|Withdrawal by Subject|0
227570|NCT01614769|747743|P2|Period 1|Withdrawal by Subject|0
227571|NCT01614769|747744|P1|Period 1|Withdrawal by Subject|1
227572|NCT01614769|747739|P6|Period 1|Protocol Violation|0
227573|NCT01614769|747740|P5|Period 1|Protocol Violation|0
227574|NCT01614769|747741|P4|Period 1|Protocol Violation|1
227575|NCT01614769|747742|P3|Period 1|Protocol Violation|0
227576|NCT01614769|747743|P2|Period 1|Protocol Violation|0
227577|NCT01614769|747744|P1|Period 1|Protocol Violation|0
227578|NCT01614769|747739|P6|Period 1|Discontinued due to Hypoglycemia|1
227579|NCT01614769|747740|P5|Period 1|Discontinued due to Hypoglycemia|0
227580|NCT01614769|747741|P4|Period 1|Discontinued due to Hypoglycemia|1
227581|NCT01614769|747742|P3|Period 1|Discontinued due to Hypoglycemia|0
227582|NCT01614769|747743|P2|Period 1|Discontinued due to Hypoglycemia|0
227583|NCT01614769|747744|P1|Period 1|Discontinued due to Hypoglycemia|0
227584|NCT01614600|747766|P1|Overall Study|Protocol deviation|1
227585|NCT01614600|747766|P1|Overall Study|Unable to remove lens at the end of day|1
227586|NCT01614600|747766|P1|Overall Study|Discomfort|1
227587|NCT01614600|747766|P1|Overall Study|Unacceptable fit|1
227588|NCT01612702|747797|P2|Overall Study|Protocol Violation|11
227589|NCT01612702|747798|P1|Overall Study|Protocol Violation|11
227590|NCT01612676|747812|P4|Overall Study|Protocol Violation|0
227591|NCT01612676|747813|P3|Overall Study|Protocol Violation|0
227592|NCT01612676|747814|P2|Overall Study|Protocol Violation|1
227593|NCT01612676|747815|P1|Overall Study|Protocol Violation|0
227594|NCT01612676|747812|P4|Overall Study|Adverse Event|3
227595|NCT01612676|747813|P3|Overall Study|Adverse Event|1
227596|NCT01612676|747814|P2|Overall Study|Adverse Event|3
227597|NCT01612676|747815|P1|Overall Study|Adverse Event|2
227598|NCT01614470|747873|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
227599|NCT01614470|747874|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
227600|NCT01614470|747875|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
227601|NCT01614470|747873|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
227602|NCT01614470|747874|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
227603|NCT01614470|747875|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
227604|NCT01614457|747897|P2|Overall Study|Pregnancy (Self or Partner)|0
227605|NCT01614457|747898|P1|Overall Study|Pregnancy (Self or Partner)|1
227606|NCT01614457|747897|P2|Overall Study|Non-Compliance|0
227607|NCT01614457|747898|P1|Overall Study|Non-Compliance|1
227608|NCT01614249|747916|P2|Overall Study|Lost to Follow-up|23
227609|NCT01614249|747917|P1|Overall Study|Lost to Follow-up|11
227610|NCT01613599|747932|P1|Overall Study|Ongoing|81
227611|NCT01613599|747932|P1|Overall Study|Reason not specified|2
227612|NCT01613599|747932|P1|Overall Study|Withdrawal by Subject|6
227613|NCT01613599|747932|P1|Overall Study|Lost to Follow-up|2
227614|NCT01613599|747932|P1|Overall Study|Death|6
227615|NCT01613417|747947|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
227616|NCT01613417|747948|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
227617|NCT01613378|747985|P1|Overall Study|Other Reason|4
227618|NCT01613378|747985|P1|Overall Study|Lost to Follow-up|1
227619|NCT01613378|747985|P1|Overall Study|Death|2
227620|NCT01613378|747985|P1|Overall Study|Withdrawal by Subject|8
227621|NCT01613378|747985|P1|Overall Study|Adverse Event|11
227622|NCT01613378|747985|P1|Overall Study|Lack of Efficacy|13
227623|NCT01613326|748015|P2|Overall Study|Protocol Violation|1
227624|NCT01613326|748016|P1|Overall Study|Protocol Violation|0
227625|NCT01613326|748015|P2|Overall Study|Administrative|2
227626|NCT01613326|748016|P1|Overall Study|Administrative|0
227627|NCT01613326|748015|P2|Overall Study|Lost to Follow-up|1
227628|NCT01613326|748016|P1|Overall Study|Lost to Follow-up|0
227629|NCT01613326|748015|P2|Overall Study|Lack of Efficacy|1
227630|NCT01613326|748016|P1|Overall Study|Lack of Efficacy|0
227631|NCT01613326|748015|P2|Overall Study|inability to use device|0
227632|NCT01613326|748016|P1|Overall Study|inability to use device|1
227633|NCT01613326|748015|P2|Overall Study|Abnormal test procedure result(s)|0
227634|NCT01613326|748016|P1|Overall Study|Abnormal test procedure result(s)|2
227635|NCT01613326|748015|P2|Overall Study|Withdrawal by Subject|4
227636|NCT01613326|748016|P1|Overall Study|Withdrawal by Subject|3
227637|NCT01613326|748015|P2|Overall Study|Adverse Event|5
227638|NCT01613326|748016|P1|Overall Study|Adverse Event|7
227639|NCT01613248|748073|P6|Overall Study|Pregnancy|0
227640|NCT01613248|748074|P5|Overall Study|Pregnancy|0
227641|NCT01613248|748075|P4|Overall Study|Pregnancy|1
227642|NCT01613248|748076|P3|Overall Study|Pregnancy|0
227643|NCT01613248|748077|P2|Overall Study|Pregnancy|0
227644|NCT01613248|748078|P1|Overall Study|Pregnancy|0
227645|NCT01613248|748073|P6|Overall Study|Lack of Qualifying Event|18
227646|NCT01613248|748074|P5|Overall Study|Lack of Qualifying Event|15
227647|NCT01613248|748075|P4|Overall Study|Lack of Qualifying Event|11
227648|NCT01613248|748076|P3|Overall Study|Lack of Qualifying Event|10
227649|NCT01613248|748077|P2|Overall Study|Lack of Qualifying Event|11
227650|NCT01613248|748078|P1|Overall Study|Lack of Qualifying Event|9
227651|NCT01613248|748073|P6|Overall Study|Physician Decision|6
227652|NCT01613248|748074|P5|Overall Study|Physician Decision|7
227653|NCT01613248|748075|P4|Overall Study|Physician Decision|4
227654|NCT01613248|748076|P3|Overall Study|Physician Decision|9
227655|NCT01613248|748077|P2|Overall Study|Physician Decision|8
227656|NCT01613248|748078|P1|Overall Study|Physician Decision|8
227657|NCT01613248|748073|P6|Overall Study|Study Terminated by Sponsor|11
227658|NCT01613248|748074|P5|Overall Study|Study Terminated by Sponsor|9
227659|NCT01613248|748075|P4|Overall Study|Study Terminated by Sponsor|8
227660|NCT01613248|748076|P3|Overall Study|Study Terminated by Sponsor|8
227661|NCT01613248|748077|P2|Overall Study|Study Terminated by Sponsor|6
227662|NCT01613248|748078|P1|Overall Study|Study Terminated by Sponsor|4
227663|NCT01613248|748073|P6|Overall Study|Lost to Follow-up|2
227664|NCT01613248|748074|P5|Overall Study|Lost to Follow-up|4
227665|NCT01613248|748075|P4|Overall Study|Lost to Follow-up|8
227666|NCT01613248|748076|P3|Overall Study|Lost to Follow-up|4
227667|NCT01613248|748077|P2|Overall Study|Lost to Follow-up|7
227668|NCT01613248|748078|P1|Overall Study|Lost to Follow-up|5
227669|NCT01613248|748073|P6|Overall Study|Withdrawal by Subject|1
227670|NCT01613248|748074|P5|Overall Study|Withdrawal by Subject|0
227671|NCT01613248|748075|P4|Overall Study|Withdrawal by Subject|5
227672|NCT01613248|748076|P3|Overall Study|Withdrawal by Subject|2
227673|NCT01613248|748077|P2|Overall Study|Withdrawal by Subject|2
227674|NCT01613248|748078|P1|Overall Study|Withdrawal by Subject|3
227675|NCT01613248|748073|P6|Overall Study|Adverse Event|0
227676|NCT01613248|748074|P5|Overall Study|Adverse Event|0
227677|NCT01613248|748075|P4|Overall Study|Adverse Event|1
227678|NCT01613248|748076|P3|Overall Study|Adverse Event|0
227679|NCT01613248|748077|P2|Overall Study|Adverse Event|0
227680|NCT01613248|748078|P1|Overall Study|Adverse Event|0
227681|NCT01613131|748178|P2|Overall Study|Withdrawal by Subject|5
227682|NCT01613131|748179|P1|Overall Study|Withdrawal by Subject|3
227683|NCT01613027|748207|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
227684|NCT01613027|748207|P1|Overall Study|Lack of Efficacy|1
227685|NCT01613027|748207|P1|Overall Study|Switched Physician|1
227686|NCT01613027|748207|P1|Overall Study|Lost to Follow-up|5
227687|NCT01612858|748237|P2|Overall Study|Withdrawal by Subject|1
227688|NCT01612858|748238|P1|Overall Study|Withdrawal by Subject|5
227689|NCT01612156|748275|P2|Overall Study|Protocol Violation|0
227690|NCT01612156|748276|P1|Overall Study|Protocol Violation|2
227691|NCT01612000|748288|P4|Overall Study|Withdrawal by Subject|2
227692|NCT01612000|748289|P3|Overall Study|Withdrawal by Subject|2
227693|NCT01612000|748290|P2|Overall Study|Withdrawal by Subject|1
227694|NCT01612000|748291|P1|Overall Study|Withdrawal by Subject|3
227695|NCT01612000|748288|P4|Overall Study|Physician Decision|0
227696|NCT01612000|748289|P3|Overall Study|Physician Decision|1
227697|NCT01612000|748290|P2|Overall Study|Physician Decision|0
227698|NCT01612000|748291|P1|Overall Study|Physician Decision|0
227699|NCT01612000|748288|P4|Overall Study|Lost to Follow-up|8
227700|NCT01612000|748289|P3|Overall Study|Lost to Follow-up|4
227701|NCT01612000|748290|P2|Overall Study|Lost to Follow-up|4
227702|NCT01612000|748291|P1|Overall Study|Lost to Follow-up|6
227703|NCT01611974|748316|P3|Overall Study|Withdrawal by Subject|4
227704|NCT01611974|748317|P2|Overall Study|Withdrawal by Subject|1
227705|NCT01611974|748318|P1|Overall Study|Withdrawal by Subject|0
227706|NCT01611974|748316|P3|Overall Study|Physician Decision|2
227707|NCT01611974|748317|P2|Overall Study|Physician Decision|1
227708|NCT01611974|748318|P1|Overall Study|Physician Decision|5
227709|NCT01611974|748316|P3|Overall Study|Lost to Follow-up|0
227710|NCT01611974|748317|P2|Overall Study|Lost to Follow-up|1
227711|NCT01611974|748318|P1|Overall Study|Lost to Follow-up|0
227712|NCT01611974|748316|P3|Overall Study|Death|10
227713|NCT01611974|748317|P2|Overall Study|Death|12
227714|NCT01611974|748318|P1|Overall Study|Death|10
227715|NCT01611883|748364|P2|Overall Study|Adverse Event|1
227716|NCT01611883|748365|P1|Overall Study|Adverse Event|1
227717|NCT01611857|748391|P2|Overall Study|Withdrawal by Subject|2
227718|NCT01611857|748392|P1|Overall Study|Withdrawal by Subject|0
227719|NCT01611558|748440|P1|Maintenance Phase|Study drug toxicity|1
227720|NCT01611558|748440|P1|Maintenance Phase|Withdrawal by Subject|1
227721|NCT01611558|748440|P1|Induction Phase|Death|1
227722|NCT01611558|748440|P1|Induction Phase|Adverse event unrelated to study drug|1
227723|NCT01611558|748440|P1|Induction Phase|Not reported|5
227724|NCT01611558|748440|P1|Induction Phase|Disease progression|14
227725|NCT01611558|748440|P1|Induction Phase|Study drug toxicity|17
227726|NCT01610791|748446|P1|Overall Study|Not determined|5
227727|NCT01610791|748446|P1|Overall Study|Death|1
227728|NCT01610791|748446|P1|Overall Study|Adverse event and Investigator decision|1
227729|NCT01610791|748446|P1|Overall Study|Physician Decision|1
227730|NCT01610791|748446|P1|Overall Study|Adverse Event|6
227731|NCT01610791|748446|P1|Overall Study|Lost to Follow-up|7
227732|NCT01610713|748469|P2|Overall Study|Lost to Follow-up|1
227733|NCT01610713|748470|P1|Overall Study|Lost to Follow-up|0
227734|NCT01610713|748469|P2|Overall Study|adv. to use original dose/amitriptyline|0
227735|NCT01610713|748470|P1|Overall Study|adv. to use original dose/amitriptyline|1
227736|NCT01610713|748469|P2|Overall Study|low mood and poor motivation|0
227737|NCT01610713|748470|P1|Overall Study|low mood and poor motivation|1
227738|NCT01610713|748469|P2|Overall Study|Lack of Efficacy|0
227739|NCT01610713|748470|P1|Overall Study|Lack of Efficacy|1
227740|NCT01610713|748469|P2|Overall Study|Adverse Event|0
227741|NCT01610713|748470|P1|Overall Study|Adverse Event|3
227742|NCT01610700|748528|P2|Overall Study|subject took one dose of street cannabis|1
227743|NCT01610700|748529|P1|Overall Study|subject took one dose of street cannabis|0
227744|NCT01610700|748528|P2|Overall Study|Withdrawal by Subject|1
227745|NCT01610700|748529|P1|Overall Study|Withdrawal by Subject|0
227746|NCT01610700|748528|P2|Overall Study|Adverse Event|1
227747|NCT01610700|748529|P1|Overall Study|Adverse Event|3
227748|NCT01610687|748583|P1|Overall Study|Felt more alter without study medication|1
227749|NCT01610687|748583|P1|Overall Study|Cannabis affecting job|1
227750|NCT01610687|748583|P1|Overall Study|Death|1
227751|NCT01610687|748583|P1|Overall Study|Unable to make journey|1
227752|NCT01610687|748583|P1|Overall Study|Symptom control without study medication|2
227753|NCT01610687|748583|P1|Overall Study|Lost to Follow-up|4
227754|NCT01610687|748583|P1|Overall Study|Withdrawal by Subject|7
227755|NCT01610687|748583|P1|Overall Study|Moved out of area|6
227756|NCT01610687|748583|P1|Overall Study|Adverse Event|18
227757|NCT01610687|748583|P1|Overall Study|Lack of Efficacy|26
227758|NCT01610596|748596|P2|Overall Study|Lost to Follow-up|1
227759|NCT01610596|748597|P1|Overall Study|Lost to Follow-up|0
227760|NCT01610557|748634|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
227761|NCT01610557|748635|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
227762|NCT01610557|748636|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
227763|NCT01610557|748637|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
227764|NCT01610557|748638|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
227765|NCT01610557|748634|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
227766|NCT01610557|748635|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
227767|NCT01610557|748636|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
227768|NCT01610557|748637|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
227769|NCT01610557|748638|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
227770|NCT01610492|748651|P1|Overall Study|Physician Decision|1
227771|NCT01610492|748651|P1|Overall Study|Lack of Efficacy|2
227772|NCT01610297|748663|P1|Overall Study|Lost to Follow-up|1
227773|NCT01610167|748674|P3|Overall Study|Scheduling conflict.|2
227774|NCT01610167|748675|P2|Overall Study|Scheduling conflict.|0
227775|NCT01610167|748676|P1|Overall Study|Scheduling conflict.|0
227776|NCT01610076|748713|P2|Overall Study|Lost to Follow-up|4
227777|NCT01610076|748714|P1|Overall Study|Lost to Follow-up|3
227778|NCT01610076|748713|P2|Overall Study|Technical issue with video|1
227779|NCT01610076|748714|P1|Overall Study|Technical issue with video|0
227780|NCT01610063|748725|P2|Overall Study|Lost to Follow-up|20
227781|NCT01610063|748726|P1|Overall Study|Lost to Follow-up|42
227782|NCT01610037|748749|P3|Treatment and Follow up Period|Lost to Follow-up|4
227783|NCT01610037|748750|P2|Treatment and Follow up Period|Lost to Follow-up|6
227784|NCT01610037|748751|P1|Treatment and Follow up Period|Lost to Follow-up|1
227785|NCT01610037|748749|P3|Treatment and Follow up Period|Administrative problems|2
227786|NCT01610037|748750|P2|Treatment and Follow up Period|Administrative problems|3
227787|NCT01610037|748751|P1|Treatment and Follow up Period|Administrative problems|1
227788|NCT01610037|748749|P3|Treatment and Follow up Period|Death|4
227789|NCT01610037|748750|P2|Treatment and Follow up Period|Death|5
227790|NCT01610037|748751|P1|Treatment and Follow up Period|Death|10
227791|NCT01610037|748749|P3|Treatment and Follow up Period|Subject withdrew consent|16
227792|NCT01610037|748750|P2|Treatment and Follow up Period|Subject withdrew consent|14
227793|NCT01610037|748751|P1|Treatment and Follow up Period|Subject withdrew consent|13
227794|NCT01610037|748749|P3|All Patients|Abnormal test procedure result(s)|3
227795|NCT01610037|748750|P2|All Patients|Abnormal test procedure result(s)|1
227796|NCT01610037|748751|P1|All Patients|Abnormal test procedure result(s)|0
227797|NCT01610037|748749|P3|All Patients|Lost to Follow-up|0
227798|NCT01610037|748750|P2|All Patients|Lost to Follow-up|0
227799|NCT01610037|748751|P1|All Patients|Lost to Follow-up|1
227800|NCT01610037|748749|P3|All Patients|Administrative problems|4
227801|NCT01610037|748750|P2|All Patients|Administrative problems|4
227802|NCT01610037|748751|P1|All Patients|Administrative problems|1
227803|NCT01610037|748749|P3|All Patients|Abnormal laboratory value|0
227804|NCT01610037|748750|P2|All Patients|Abnormal laboratory value|1
227805|NCT01610037|748751|P1|All Patients|Abnormal laboratory value|1
227806|NCT01610037|748749|P3|All Patients|Protocol deviation|3
227807|NCT01610037|748750|P2|All Patients|Protocol deviation|3
227808|NCT01610037|748751|P1|All Patients|Protocol deviation|4
227809|NCT01610037|748749|P3|All Patients|Death|1
227810|NCT01610037|748750|P2|All Patients|Death|2
227811|NCT01610037|748751|P1|All Patients|Death|4
227812|NCT01610037|748749|P3|All Patients|Unsatisfactory therapeutic effect|27
227813|NCT01610037|748750|P2|All Patients|Unsatisfactory therapeutic effect|8
227814|NCT01610037|748751|P1|All Patients|Unsatisfactory therapeutic effect|9
227815|NCT01610037|748749|P3|All Patients|Withdrawal by Subject|20
227816|NCT01610037|748750|P2|All Patients|Withdrawal by Subject|10
227817|NCT01610037|748751|P1|All Patients|Withdrawal by Subject|12
227818|NCT01610037|748749|P3|All Patients|Adverse Event|26
227819|NCT01610037|748750|P2|All Patients|Adverse Event|22
227820|NCT01610037|748751|P1|All Patients|Adverse Event|27
227821|NCT01609790|748804|P3|Overall Study|Protocol Violation|8
227822|NCT01609790|748805|P2|Overall Study|Protocol Violation|7
227823|NCT01609790|748806|P1|Overall Study|Protocol Violation|1
227824|NCT01609582|748824|P2|Overall Study|Randomized, but not treated|3
227825|NCT01609582|748825|P1|Overall Study|Randomized, but not treated|0
227826|NCT01609582|748824|P2|Overall Study|Other|10
227827|NCT01609582|748825|P1|Overall Study|Other|9
227828|NCT01609582|748824|P2|Overall Study|Study Terminated by Sponsor|1548
227829|NCT01609582|748825|P1|Overall Study|Study Terminated by Sponsor|1543
227830|NCT01609582|748824|P2|Overall Study|Withdrawal by Subject|15
227831|NCT01609582|748825|P1|Overall Study|Withdrawal by Subject|21
227832|NCT01609582|748824|P2|Overall Study|Lost to Follow-up|10
227833|NCT01609582|748825|P1|Overall Study|Lost to Follow-up|10
227834|NCT01609582|748824|P2|Overall Study|Adverse Event|18
227835|NCT01609582|748825|P1|Overall Study|Adverse Event|20
227836|NCT01609543|748833|P1|Overall Study|Death|7
227837|NCT01609543|748833|P1|Overall Study|Protocol Violation|1
227838|NCT01609543|748833|P1|Overall Study|Withdrawal by Subject|1
227839|NCT01609543|748833|P1|Overall Study|Adverse Event|5
227840|NCT01609543|748833|P1|Overall Study|Disease Progression|28
227841|NCT01609478|748842|P3|Overall Study|Withdrawal by Subject|2
227842|NCT01609478|748843|P2|Overall Study|Withdrawal by Subject|0
227843|NCT01609478|748844|P1|Overall Study|Withdrawal by Subject|2
227844|NCT01609478|748842|P3|Overall Study|Physician Decision|1
227845|NCT01609478|748843|P2|Overall Study|Physician Decision|0
227846|NCT01609478|748844|P1|Overall Study|Physician Decision|1
227847|NCT01609478|748842|P3|Overall Study|Non-Compliance with study treatment|0
227848|NCT01609478|748843|P2|Overall Study|Non-Compliance with study treatment|0
227849|NCT01609478|748844|P1|Overall Study|Non-Compliance with study treatment|1
227850|NCT01609478|748842|P3|Overall Study|Protocol Deviation|1
227851|NCT01609478|748843|P2|Overall Study|Protocol Deviation|1
227852|NCT01609478|748844|P1|Overall Study|Protocol Deviation|0
227853|NCT01609478|748842|P3|Overall Study|Adverse Event|5
227854|NCT01609478|748843|P2|Overall Study|Adverse Event|1
227855|NCT01609478|748844|P1|Overall Study|Adverse Event|3
227856|NCT01609257|748910|P2|Overall Study|Non-compliance/Protocol deviation|6
227857|NCT01609257|748911|P1|Overall Study|Non-compliance/Protocol deviation|4
227858|NCT01609257|748910|P2|Overall Study|Voluntary Withdrawal by Subject|1
227859|NCT01609257|748911|P1|Overall Study|Voluntary Withdrawal by Subject|0
227860|NCT01609257|748910|P2|Overall Study|Lost to Follow-up|1
227861|NCT01609257|748911|P1|Overall Study|Lost to Follow-up|2
227862|NCT01609062|748983|P2|Extension Phase|Anticipated surgery & transition to EAP|1
227863|NCT01609062|748984|P1|Extension Phase|Anticipated surgery & transition to EAP|0
227864|NCT01609062|748983|P2|Extension Phase|Discontinued drug and then was pregnant|0
227865|NCT01609062|748984|P1|Extension Phase|Discontinued drug and then was pregnant|1
227866|NCT01609062|748983|P2|Extension Phase|Terminated by Sponsor|9
227867|NCT01609062|748984|P1|Extension Phase|Terminated by Sponsor|14
227868|NCT01609023|749027|P1|Overall Study|Personal reasons|1
227869|NCT01609023|749027|P1|Overall Study|Death|2
227870|NCT01609023|749027|P1|Overall Study|Physician Decision|2
227871|NCT01609023|749027|P1|Overall Study|Disease progression|10
227872|NCT01609023|749027|P1|Overall Study|Toxicity|3
227873|NCT01609023|749027|P1|Overall Study|Lost to Follow-up|8
227874|NCT01609023|749027|P1|Overall Study|Withdrawal by Subject|4
227875|NCT01609023|749027|P1|Overall Study|Lack of Efficacy|3
227876|NCT01609010|749039|P2|Overall Study|Lost to Follow-up|1
227877|NCT01609010|749040|P1|Overall Study|Lost to Follow-up|1
227878|NCT01609010|749039|P2|Overall Study|New cancer|0
227879|NCT01609010|749040|P1|Overall Study|New cancer|1
227880|NCT01609010|749039|P2|Overall Study|Protocol Violation|1
227881|NCT01609010|749040|P1|Overall Study|Protocol Violation|1
227882|NCT01609010|749039|P2|Overall Study|Pathology review|1
227883|NCT01609010|749040|P1|Overall Study|Pathology review|2
227884|NCT01609010|749039|P2|Overall Study|Other malignancy|0
227885|NCT01609010|749040|P1|Overall Study|Other malignancy|1
227886|NCT01609010|749039|P2|Overall Study|Not specified|0
227887|NCT01609010|749040|P1|Overall Study|Not specified|2
227888|NCT01609010|749039|P2|Overall Study|Withdrawal by Subject|2
227889|NCT01609010|749040|P1|Overall Study|Withdrawal by Subject|2
227890|NCT01609010|749039|P2|Overall Study|Adverse Event|6
227891|NCT01609010|749040|P1|Overall Study|Adverse Event|3
227892|NCT01609010|749039|P2|Overall Study|Progressive disease (PD)|10
227893|NCT01609010|749040|P1|Overall Study|Progressive disease (PD)|8
227894|NCT01609010|749039|P2|Overall Study|Stable disease (SD)|16
227895|NCT01609010|749040|P1|Overall Study|Stable disease (SD)|22
227896|NCT01608724|749101|P1|Overall Study|Safety reasons|1
227897|NCT01608724|749101|P1|Overall Study|bood sugar too high, etc.|3
227898|NCT01608724|749101|P1|Overall Study|Protocol Violation|6
227899|NCT01608724|749101|P1|Overall Study|Adverse Event|29
227900|NCT01608724|749101|P1|Overall Study|Study-specific discontinuation criteria|32
227901|NCT01608724|749101|P1|Overall Study|Lost to Follow-up|41
227902|NCT01608724|749101|P1|Overall Study|Withdrawal by Subject|131
227903|NCT01608321|749122|P2|Overall Study|Withdrawal by Subject|0
227904|NCT01608321|749123|P1|Overall Study|Withdrawal by Subject|1
227905|NCT01608308|749131|P2|Overall Study|pretreatment medical and billing reasons|2
227906|NCT01608308|749132|P1|Overall Study|pretreatment medical and billing reasons|0
227907|NCT01607593|749331|P1|Overall Study|Unspecified|4
227908|NCT01607593|749331|P1|Overall Study|Continuation|33
227909|NCT01607593|749331|P1|Overall Study|Lost to Follow-up|25
227910|NCT01607593|749331|P1|Overall Study|Lack of Efficacy|16
227911|NCT01607593|749331|P1|Overall Study|Adverse Event|15
227912|NCT01607476|749340|P3|Overall Study|Lost to Follow-up|2
227913|NCT01607476|749341|P2|Overall Study|Lost to Follow-up|0
227914|NCT01607476|749342|P1|Overall Study|Lost to Follow-up|0
227915|NCT01607476|749340|P3|Overall Study|Withdrawal by Subject|1
227916|NCT01607476|749341|P2|Overall Study|Withdrawal by Subject|0
227917|NCT01607476|749342|P1|Overall Study|Withdrawal by Subject|1
227918|NCT01607398|749436|P2|Overall Study|Severe COPD|0
227919|NCT01607398|749437|P1|Overall Study|Severe COPD|2
227920|NCT01607398|749436|P2|Overall Study|Adverse Event|2
227921|NCT01607398|749437|P1|Overall Study|Adverse Event|0
227922|NCT01606800|749538|P2|Overall Study|Missing completion status|0
227923|NCT01606800|749539|P1|Overall Study|Missing completion status|2
227924|NCT01606800|749538|P2|Overall Study|Participant withdrew consent|1
227925|NCT01606800|749539|P1|Overall Study|Participant withdrew consent|0
227926|NCT01606800|749538|P2|Overall Study|Adverse Event|1
227927|NCT01606800|749539|P1|Overall Study|Adverse Event|3
227928|NCT01606748|749547|P2|Overall Study|Withdrawal by Subject|0
227929|NCT01606748|749548|P1|Overall Study|Withdrawal by Subject|1
227930|NCT01606748|749547|P2|Overall Study|Progressive Disease|0
227931|NCT01606748|749548|P1|Overall Study|Progressive Disease|1
227932|NCT01606748|749547|P2|Overall Study|Adverse Event|0
227933|NCT01606748|749548|P1|Overall Study|Adverse Event|1
227934|NCT01606670|749589|P1|Overall Study|Other Reason|2
227935|NCT01606670|749589|P1|Overall Study|Withdrawal by Subject|3
227936|NCT01606670|749589|P1|Overall Study|Lost to Follow-up|3
227937|NCT01606670|749589|P1|Overall Study|Lack of Efficacy|2
227938|NCT01606670|749589|P1|Overall Study|Adverse Event|6
227939|NCT01606319|749599|P2|Overall Study|Adverse Event|4
227940|NCT01606319|749600|P1|Overall Study|Adverse Event|1
227941|NCT01606319|749599|P2|Overall Study|Lack of Efficacy|8
227942|NCT01606319|749600|P1|Overall Study|Lack of Efficacy|6
227943|NCT01606319|749599|P2|Overall Study|Physician Decision|2
227944|NCT01606319|749600|P1|Overall Study|Physician Decision|1
227945|NCT01606319|749599|P2|Overall Study|Withdrawal by Subject|12
227946|NCT01606319|749600|P1|Overall Study|Withdrawal by Subject|9
227947|NCT01606319|749599|P2|Overall Study|Lost to Follow-up|14
227948|NCT01606319|749600|P1|Overall Study|Lost to Follow-up|17
227949|NCT01606306|749618|P6|Overall Study|Physician Decision|0
227950|NCT01606306|749619|P5|Overall Study|Physician Decision|0
227951|NCT01606306|749620|P4|Overall Study|Physician Decision|0
227952|NCT01606306|749621|P3|Overall Study|Physician Decision|0
227953|NCT01606306|749622|P2|Overall Study|Physician Decision|2
227954|NCT01606306|749623|P1|Overall Study|Physician Decision|1
227955|NCT01606306|749618|P6|Overall Study|Withdrawal by Subject|4
227956|NCT01606306|749619|P5|Overall Study|Withdrawal by Subject|5
227957|NCT01606306|749620|P4|Overall Study|Withdrawal by Subject|4
227958|NCT01606306|749621|P3|Overall Study|Withdrawal by Subject|4
227959|NCT01606306|749622|P2|Overall Study|Withdrawal by Subject|3
227960|NCT01606306|749623|P1|Overall Study|Withdrawal by Subject|4
227961|NCT01606306|749618|P6|Overall Study|Lost to Follow-up|5
227962|NCT01606306|749619|P5|Overall Study|Lost to Follow-up|3
227963|NCT01606306|749620|P4|Overall Study|Lost to Follow-up|4
227964|NCT01606306|749621|P3|Overall Study|Lost to Follow-up|5
227965|NCT01606306|749622|P2|Overall Study|Lost to Follow-up|4
227966|NCT01606306|749623|P1|Overall Study|Lost to Follow-up|7
227967|NCT01606306|749618|P6|Overall Study|Adverse Event|0
227968|NCT01606306|749619|P5|Overall Study|Adverse Event|2
227969|NCT01606306|749620|P4|Overall Study|Adverse Event|1
227970|NCT01606306|749621|P3|Overall Study|Adverse Event|1
227971|NCT01606306|749622|P2|Overall Study|Adverse Event|0
227972|NCT01606306|749623|P1|Overall Study|Adverse Event|1
227973|NCT01606306|749618|P6|Overall Study|Lack of Efficacy|2
227974|NCT01606306|749619|P5|Overall Study|Lack of Efficacy|1
227975|NCT01606306|749620|P4|Overall Study|Lack of Efficacy|4
227976|NCT01606306|749621|P3|Overall Study|Lack of Efficacy|4
227977|NCT01606306|749622|P2|Overall Study|Lack of Efficacy|1
227978|NCT01606306|749623|P1|Overall Study|Lack of Efficacy|2
227979|NCT01606254|749633|P4|Overall Study|Adverse Event|1
227980|NCT01606254|749634|P3|Overall Study|Adverse Event|0
227981|NCT01606254|749635|P2|Overall Study|Adverse Event|1
227982|NCT01606254|749636|P1|Overall Study|Adverse Event|1
227983|NCT01606254|749633|P4|Overall Study|Withdrawal by Subject|2
227984|NCT01606254|749634|P3|Overall Study|Withdrawal by Subject|0
227985|NCT01606254|749635|P2|Overall Study|Withdrawal by Subject|3
227986|NCT01606254|749636|P1|Overall Study|Withdrawal by Subject|1
227987|NCT01606228|749718|P1|Overall Study|Adverse Event|1
227988|NCT01606228|749718|P1|Overall Study|Lack of Efficacy|2
227989|NCT01606228|749718|P1|Overall Study|Non-compliant|3
227990|NCT01606228|749718|P1|Overall Study|Withdrawal by Subject|3
227991|NCT01606228|749718|P1|Overall Study|Lost to Follow-up|20
227992|NCT01606202|749735|P2|Overall Study|Problems with administration|1
227993|NCT01606202|749736|P1|Overall Study|Problems with administration|0
227994|NCT01606202|749735|P2|Overall Study|Personal problems|1
227995|NCT01606202|749736|P1|Overall Study|Personal problems|0
227996|NCT01606202|749735|P2|Overall Study|Withdrawal by Subject|1
227997|NCT01606202|749736|P1|Overall Study|Withdrawal by Subject|2
227998|NCT01606202|749735|P2|Overall Study|Adverse Event|0
227999|NCT01606202|749736|P1|Overall Study|Adverse Event|5
228000|NCT01606189|749768|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
228001|NCT01606189|749769|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
228002|NCT01606189|749770|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
228003|NCT01606189|749771|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
228004|NCT01606189|749772|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
228005|NCT01606189|749773|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
228006|NCT01606189|749768|P6|Second Intenvention (14-20 Days)|Adverse Event|1
228007|NCT01606189|749769|P5|Second Intenvention (14-20 Days)|Adverse Event|0
228008|NCT01606189|749770|P4|Second Intenvention (14-20 Days)|Adverse Event|0
228096|NCT01604941|750190|P2|Overall Study|Early Study Termination|2
228009|NCT01606189|749771|P3|Second Intenvention (14-20 Days)|Adverse Event|0
228010|NCT01606189|749772|P2|Second Intenvention (14-20 Days)|Adverse Event|0
228011|NCT01606189|749773|P1|Second Intenvention (14-20 Days)|Adverse Event|0
228012|NCT01606176|749807|P2|Overall Study|Withdrawal by Subject|0
228013|NCT01606176|749808|P1|Overall Study|Withdrawal by Subject|1
228014|NCT01606176|749807|P2|Overall Study|Disease progression|0
228015|NCT01606176|749808|P1|Overall Study|Disease progression|1
228016|NCT01606176|749807|P2|Overall Study|Adverse Event|3
228017|NCT01606176|749808|P1|Overall Study|Adverse Event|2
228018|NCT01606137|749853|P1|Overall Study|Unable to collect consistent data|1
228019|NCT01606137|749853|P1|Overall Study|Patient moving|1
228020|NCT01606137|749853|P1|Overall Study|Unable to tolerate study med. taste|1
228021|NCT01606137|749853|P1|Overall Study|Personal reasons|1
228022|NCT01606137|749853|P1|Overall Study|Patient leaving country|1
228023|NCT01606137|749853|P1|Overall Study|Wanted to try another treatment|1
228024|NCT01606137|749853|P1|Overall Study|Not enough improvement|4
228025|NCT01606137|749853|P1|Overall Study|Spray causes nausea|1
228026|NCT01606137|749853|P1|Overall Study|Increased bilirubin|1
228027|NCT01606137|749853|P1|Overall Study|multiple sclerosis less stable|1
228028|NCT01606137|749853|P1|Overall Study|Issues with driving|4
228029|NCT01606137|749853|P1|Overall Study|Decreased/no pain|4
228030|NCT01606137|749853|P1|Overall Study|Death|1
228031|NCT01606137|749853|P1|Overall Study|Patient non-compliance|9
228032|NCT01606137|749853|P1|Overall Study|Protocol Violation|1
228033|NCT01606137|749853|P1|Overall Study|Lost to Follow-up|15
228034|NCT01606137|749853|P1|Overall Study|Lack of Efficacy|56
228035|NCT01606137|749853|P1|Overall Study|Withdrawal by Subject|74
228036|NCT01606137|749853|P1|Overall Study|Adverse Event|85
228037|NCT01606007|749876|P3|Overall Study|Poor/Non-compliance|0
228038|NCT01606007|749877|P2|Overall Study|Poor/Non-compliance|0
228039|NCT01606007|749878|P1|Overall Study|Poor/Non-compliance|1
228040|NCT01606007|749876|P3|Overall Study|Lost to Follow-up|5
228041|NCT01606007|749877|P2|Overall Study|Lost to Follow-up|8
228042|NCT01606007|749878|P1|Overall Study|Lost to Follow-up|6
228043|NCT01606007|749876|P3|Overall Study|discontinue study treatment|1
228044|NCT01606007|749877|P2|Overall Study|discontinue study treatment|2
228045|NCT01606007|749878|P1|Overall Study|discontinue study treatment|0
228046|NCT01606007|749876|P3|Overall Study|Adverse Event|1
228047|NCT01606007|749877|P2|Overall Study|Adverse Event|1
228048|NCT01606007|749878|P1|Overall Study|Adverse Event|0
228049|NCT01606007|749876|P3|Overall Study|Withdrawal by Subject|1
228050|NCT01606007|749877|P2|Overall Study|Withdrawal by Subject|6
228051|NCT01606007|749878|P1|Overall Study|Withdrawal by Subject|8
228052|NCT01606007|749876|P3|Overall Study|Pregnancy|1
228053|NCT01606007|749877|P2|Overall Study|Pregnancy|1
228054|NCT01606007|749878|P1|Overall Study|Pregnancy|0
228055|NCT01606007|749876|P3|Overall Study|Reason 'Other' in the protocol|1
228056|NCT01606007|749877|P2|Overall Study|Reason 'Other' in the protocol|1
228057|NCT01606007|749878|P1|Overall Study|Reason 'Other' in the protocol|0
228058|NCT01605916|749913|P5|Overall Study|Withdrawal by Subject|2
228059|NCT01605916|749914|P4|Overall Study|Withdrawal by Subject|0
228060|NCT01605916|749915|P3|Overall Study|Withdrawal by Subject|0
228061|NCT01605916|749916|P2|Overall Study|Withdrawal by Subject|1
228062|NCT01605916|749917|P1|Overall Study|Withdrawal by Subject|1
228063|NCT01605916|749913|P5|Overall Study|Lack of Efficacy|4
228064|NCT01605916|749914|P4|Overall Study|Lack of Efficacy|5
228065|NCT01605916|749915|P3|Overall Study|Lack of Efficacy|3
228066|NCT01605916|749916|P2|Overall Study|Lack of Efficacy|3
228067|NCT01605916|749917|P1|Overall Study|Lack of Efficacy|2
228068|NCT01605916|749913|P5|Overall Study|Adverse Event|0
228069|NCT01605916|749914|P4|Overall Study|Adverse Event|1
228070|NCT01605916|749915|P3|Overall Study|Adverse Event|0
228071|NCT01605916|749916|P2|Overall Study|Adverse Event|0
228072|NCT01605916|749917|P1|Overall Study|Adverse Event|1
228073|NCT01605877|749990|P1|Overall Study|Withdrawal by Subject|1
228074|NCT01605825|750054|P2|Overall Study|Non-Compliance with Protocol|0
228075|NCT01605825|750055|P1|Overall Study|Non-Compliance with Protocol|3
228076|NCT01605825|750054|P2|Overall Study|Non-Compliance -Investigational Drug|0
228077|NCT01605825|750055|P1|Overall Study|Non-Compliance -Investigational Drug|3
228078|NCT01605825|750054|P2|Overall Study|Withdrawal by Subject|1
228079|NCT01605825|750055|P1|Overall Study|Withdrawal by Subject|0
228080|NCT01605825|750054|P2|Overall Study|Adverse Event|2
228081|NCT01605825|750055|P1|Overall Study|Adverse Event|4
228082|NCT01605799|750063|P2|Overall Study|Withdrawal by Subject|1
228083|NCT01605799|750064|P1|Overall Study|Withdrawal by Subject|2
228084|NCT01605617|750079|P2|Washout Period of 4 Weeks|Study Terminated|1
228085|NCT01605617|750080|P1|Washout Period of 4 Weeks|Study Terminated|2
228086|NCT01605617|750079|P2|First Intervention|Adverse Event|1
228087|NCT01605617|750080|P1|First Intervention|Adverse Event|0
228088|NCT01605461|750139|P1|Overall Study|Withdrawal by Subject|1
228089|NCT01605461|750139|P1|Overall Study|Lost to Follow-up|3
228090|NCT01605370|750150|P2|Overall Study|Adverse Event|0
228091|NCT01605370|750151|P1|Overall Study|Adverse Event|1
228092|NCT01604941|750186|P6|Overall Study|Early Study Termination|0
228093|NCT01604941|750187|P5|Overall Study|Early Study Termination|0
228094|NCT01604941|750188|P4|Overall Study|Early Study Termination|3
228095|NCT01604941|750189|P3|Overall Study|Early Study Termination|3
228097|NCT01604941|750191|P1|Overall Study|Early Study Termination|9
228098|NCT01604941|750186|P6|Overall Study|Participant Decision|2
228099|NCT01604941|750187|P5|Overall Study|Participant Decision|0
228100|NCT01604941|750188|P4|Overall Study|Participant Decision|0
228101|NCT01604941|750189|P3|Overall Study|Participant Decision|0
228102|NCT01604941|750190|P2|Overall Study|Participant Decision|0
228103|NCT01604941|750191|P1|Overall Study|Participant Decision|0
228104|NCT01604941|750186|P6|Overall Study|Non-compliance|0
228105|NCT01604941|750187|P5|Overall Study|Non-compliance|0
228106|NCT01604941|750188|P4|Overall Study|Non-compliance|0
228107|NCT01604941|750189|P3|Overall Study|Non-compliance|0
228108|NCT01604941|750190|P2|Overall Study|Non-compliance|0
228109|NCT01604941|750191|P1|Overall Study|Non-compliance|1
228110|NCT01604941|750186|P6|Overall Study|Adverse Event|5
228111|NCT01604941|750187|P5|Overall Study|Adverse Event|1
228112|NCT01604941|750188|P4|Overall Study|Adverse Event|0
228113|NCT01604941|750189|P3|Overall Study|Adverse Event|0
228114|NCT01604941|750190|P2|Overall Study|Adverse Event|2
228115|NCT01604941|750191|P1|Overall Study|Adverse Event|1
228116|NCT01604850|750219|P2|Overall Study|Subject withdrew consent|0
228117|NCT01604850|750220|P1|Overall Study|Subject withdrew consent|1
228118|NCT01604850|750219|P2|Overall Study|Lost to Follow-up|0
228119|NCT01604850|750220|P1|Overall Study|Lost to Follow-up|1
228120|NCT01604850|750219|P2|Overall Study|Efficacy Failure|29
228121|NCT01604850|750220|P1|Overall Study|Efficacy Failure|50
228122|NCT01604850|750219|P2|Overall Study|Enrolled but never treated|1
228123|NCT01604850|750220|P1|Overall Study|Enrolled but never treated|0
228124|NCT01604278|750244|P2|Overall Study|Protocol Deviation|3
228125|NCT01604278|750245|P1|Overall Study|Protocol Deviation|5
228126|NCT01604278|750244|P2|Overall Study|Adverse Event|5
228127|NCT01604278|750245|P1|Overall Study|Adverse Event|3
228128|NCT01604278|750244|P2|Overall Study|Withdrawal by Subject|3
228129|NCT01604278|750245|P1|Overall Study|Withdrawal by Subject|3
228130|NCT01604278|750244|P2|Overall Study|Administrative problems|1
228131|NCT01604278|750245|P1|Overall Study|Administrative problems|2
228132|NCT01604278|750244|P2|Overall Study|Lost to Follow-up|0
228133|NCT01604278|750245|P1|Overall Study|Lost to Follow-up|1
228134|NCT01604278|750244|P2|Overall Study|Lack of Efficacy|1
228135|NCT01604278|750245|P1|Overall Study|Lack of Efficacy|0
228136|NCT01604265|750271|P2|Overall Study|Withdrawal by Subject|0
228137|NCT01604265|750272|P1|Overall Study|Withdrawal by Subject|1
228138|NCT01604265|750271|P2|Overall Study|Adverse Event|0
228139|NCT01604265|750272|P1|Overall Study|Adverse Event|1
228140|NCT01603875|750383|P3|Overall Study|Protocol Violation|0
228141|NCT01603875|750384|P2|Overall Study|Protocol Violation|1
228142|NCT01603875|750385|P1|Overall Study|Protocol Violation|0
228143|NCT01603875|750383|P3|Overall Study|Lost to Follow-up|6
228144|NCT01603875|750384|P2|Overall Study|Lost to Follow-up|3
228145|NCT01603875|750385|P1|Overall Study|Lost to Follow-up|4
228146|NCT01603875|750383|P3|Overall Study|Preexisting rabies antibody|3
228147|NCT01603875|750384|P2|Overall Study|Preexisting rabies antibody|4
228148|NCT01603875|750385|P1|Overall Study|Preexisting rabies antibody|3
228149|NCT01603459|750405|P1|Overall Study|Administrative reason|1
228150|NCT01603459|750405|P1|Overall Study|Non-compliance|1
228151|NCT01603459|750405|P1|Overall Study|Predefined discontinuation criteria|3
228152|NCT01603459|750405|P1|Overall Study|Lost to Follow-up|3
228153|NCT01603459|750405|P1|Overall Study|Withdrawal by Subject|5
228154|NCT01603459|750405|P1|Overall Study|Adverse Event|5
228155|NCT01603394|750556|P1|Overall Study|Adverse Event|1
228156|NCT01603277|750573|P2|Overall Study|Non-Compliance|1
228157|NCT01603277|750574|P1|Overall Study|Non-Compliance|2
228158|NCT01603277|750573|P2|Overall Study|Withdrawal by Subject|4
228159|NCT01603277|750574|P1|Overall Study|Withdrawal by Subject|5
228160|NCT01603277|750573|P2|Overall Study|Protocol Violation|10
228161|NCT01603277|750574|P1|Overall Study|Protocol Violation|6
228162|NCT01603277|750573|P2|Overall Study|Physician Decision|1
228163|NCT01603277|750574|P1|Overall Study|Physician Decision|0
228164|NCT01603277|750573|P2|Overall Study|Adverse Event|2
228165|NCT01603277|750574|P1|Overall Study|Adverse Event|1
228166|NCT01603121|750580|P2|Second Intervention, 10 Hours|Adverse Event|0
228167|NCT01603121|750581|P1|Second Intervention, 10 Hours|Adverse Event|1
228168|NCT01603082|750593|P2|Overall Study|Failed inclusion criterion after dosed|0
228169|NCT01603082|750594|P1|Overall Study|Failed inclusion criterion after dosed|1
228170|NCT01603082|750593|P2|Overall Study|Withdrawal by Subject|0
228171|NCT01603082|750594|P1|Overall Study|Withdrawal by Subject|1
228172|NCT01603082|750593|P2|Overall Study|Adverse Event|1
228173|NCT01603082|750594|P1|Overall Study|Adverse Event|0
228174|NCT01603043|750635|P2|Overall Study|Study Futility|3
228175|NCT01603043|750636|P1|Overall Study|Study Futility|7
228176|NCT01602744|750648|P2|Overall Study|Lost to Follow-up|8
228177|NCT01602744|750649|P1|Overall Study|Lost to Follow-up|13
228178|NCT01602744|750648|P2|Overall Study|Death|15
228179|NCT01602744|750649|P1|Overall Study|Death|17
228180|NCT01602562|750673|P2|Overall Study|Withdrawal by Subject|1
228181|NCT01602562|750674|P1|Overall Study|Withdrawal by Subject|1
228182|NCT01602562|750673|P2|Overall Study|Physician Decision|1
228183|NCT01602562|750674|P1|Overall Study|Physician Decision|1
228184|NCT01602562|750673|P2|Overall Study|Adverse Event|1
228185|NCT01602562|750674|P1|Overall Study|Adverse Event|3
228186|NCT01602549|750710|P2|Overall Study|Withdrawal by Subject|0
228187|NCT01602549|750711|P1|Overall Study|Withdrawal by Subject|1
228188|NCT01602549|750710|P2|Overall Study|Protocol Violation|1
228189|NCT01602549|750711|P1|Overall Study|Protocol Violation|0
228190|NCT01602510|750790|P3|Randomized Phase|Withdrawal by Subject|7
228191|NCT01602510|750791|P2|Randomized Phase|Withdrawal by Subject|6
228192|NCT01602510|750792|P1|Randomized Phase|Withdrawal by Subject|0
228193|NCT01602510|750790|P3|Randomized Phase|Physician Decision|2
228194|NCT01602510|750791|P2|Randomized Phase|Physician Decision|0
228195|NCT01602510|750792|P1|Randomized Phase|Physician Decision|0
228196|NCT01602510|750790|P3|Randomized Phase|Lost to Follow-up|3
228197|NCT01602510|750791|P2|Randomized Phase|Lost to Follow-up|1
228198|NCT01602510|750792|P1|Randomized Phase|Lost to Follow-up|0
228199|NCT01602510|750790|P3|Randomized Phase|Met protocol-defined stopping criteria|48
228200|NCT01602510|750791|P2|Randomized Phase|Met protocol-defined stopping criteria|58
228201|NCT01602510|750792|P1|Randomized Phase|Met protocol-defined stopping criteria|0
228202|NCT01602510|750790|P3|Randomized Phase|Protocol Violation|3
228203|NCT01602510|750791|P2|Randomized Phase|Protocol Violation|3
228204|NCT01602510|750792|P1|Randomized Phase|Protocol Violation|0
228205|NCT01602510|750790|P3|Randomized Phase|Lack of Efficacy|4
228206|NCT01602510|750791|P2|Randomized Phase|Lack of Efficacy|4
228207|NCT01602510|750792|P1|Randomized Phase|Lack of Efficacy|0
228208|NCT01602510|750790|P3|Randomized Phase|Adverse Event|6
228209|NCT01602510|750791|P2|Randomized Phase|Adverse Event|2
228210|NCT01602510|750792|P1|Randomized Phase|Adverse Event|0
228211|NCT01602510|750790|P3|Open Label Phase|Withdrawal by Subject|0
228212|NCT01602510|750791|P2|Open Label Phase|Withdrawal by Subject|0
228213|NCT01602510|750792|P1|Open Label Phase|Withdrawal by Subject|57
228214|NCT01602510|750790|P3|Open Label Phase|Physician Decision|0
228215|NCT01602510|750791|P2|Open Label Phase|Physician Decision|0
228216|NCT01602510|750792|P1|Open Label Phase|Physician Decision|19
228217|NCT01602510|750790|P3|Open Label Phase|Lost to Follow-up|0
228218|NCT01602510|750791|P2|Open Label Phase|Lost to Follow-up|0
228219|NCT01602510|750792|P1|Open Label Phase|Lost to Follow-up|22
228220|NCT01602510|750790|P3|Open Label Phase|Met protocol-defined stopping criteria|0
228221|NCT01602510|750791|P2|Open Label Phase|Met protocol-defined stopping criteria|0
228222|NCT01602510|750792|P1|Open Label Phase|Met protocol-defined stopping criteria|122
228223|NCT01602510|750790|P3|Open Label Phase|Protocol Violation|0
228224|NCT01602510|750791|P2|Open Label Phase|Protocol Violation|0
228225|NCT01602510|750792|P1|Open Label Phase|Protocol Violation|15
228226|NCT01602510|750790|P3|Open Label Phase|Lack of Efficacy|0
228227|NCT01602510|750791|P2|Open Label Phase|Lack of Efficacy|0
228228|NCT01602510|750792|P1|Open Label Phase|Lack of Efficacy|22
228229|NCT01602510|750790|P3|Open Label Phase|Adverse Event|0
228230|NCT01602510|750791|P2|Open Label Phase|Adverse Event|0
228231|NCT01602510|750792|P1|Open Label Phase|Adverse Event|46
228232|NCT01602484|750818|P2|Overall Study|Airway issues unrelated to study|1
228233|NCT01602484|750819|P1|Overall Study|Airway issues unrelated to study|0
228234|NCT01602380|750837|P2|Overall Study|Eligibility criteria not fulfilled|3
228235|NCT01602380|750838|P1|Overall Study|Eligibility criteria not fulfilled|2
228236|NCT01602380|750837|P2|Overall Study|Lost to Follow-up|1
228237|NCT01602380|750838|P1|Overall Study|Lost to Follow-up|6
228238|NCT01602380|750837|P2|Overall Study|Withdrawal by Subject|29
228239|NCT01602380|750838|P1|Overall Study|Withdrawal by Subject|22
228240|NCT01602380|750837|P2|Overall Study|Death|68
228241|NCT01602380|750838|P1|Overall Study|Death|63
228242|NCT01602341|750862|P2|Overall Study|Adverse Event|1
228243|NCT01602341|750863|P1|Overall Study|Adverse Event|0
228244|NCT01601821|750930|P2|Overall Study|Unspecified|1
228245|NCT01601821|750931|P1|Overall Study|Unspecified|5
228246|NCT01601821|750930|P2|Overall Study|Study Events|1
228247|NCT01601821|750931|P1|Overall Study|Study Events|7
228248|NCT01601821|750930|P2|Overall Study|Graft Loss|6
228249|NCT01601821|750931|P1|Overall Study|Graft Loss|6
228250|NCT01601821|750930|P2|Overall Study|Withdrawal by Subject|0
228251|NCT01601821|750931|P1|Overall Study|Withdrawal by Subject|1
228252|NCT01601821|750930|P2|Overall Study|Lost to Follow-up|14
228253|NCT01601821|750931|P1|Overall Study|Lost to Follow-up|6
228254|NCT01601821|750930|P2|Overall Study|Protocol Violation|2
228255|NCT01601821|750931|P1|Overall Study|Protocol Violation|2
228256|NCT01601821|750930|P2|Overall Study|Death|5
228257|NCT01601821|750931|P1|Overall Study|Death|2
228258|NCT01601704|750967|P2|Overall Study|Randomized but not dispensed study med|4
228259|NCT01601704|750968|P1|Overall Study|Randomized but not dispensed study med|1
228260|NCT01601470|750986|P1|Period 2 - LCZ696|Physician Decision|1
228261|NCT01601132|751001|P1|Overall Study|Protocol deviation|1
228262|NCT01601132|751001|P1|Overall Study|Patient withdrew consent|1
228263|NCT01600885|751035|P2|First Period|moved out of area|0
228264|NCT01600885|751036|P1|First Period|moved out of area|1
228265|NCT01600885|751035|P2|First Period|Adverse Event|1
228266|NCT01600885|751036|P1|First Period|Adverse Event|1
228267|NCT01600716|751053|P2|Overall Study|Adverse Event|1
228268|NCT01600716|751054|P1|Overall Study|Adverse Event|1
228269|NCT01600716|751053|P2|Overall Study|Lack of Efficacy|1
228270|NCT01600716|751054|P1|Overall Study|Lack of Efficacy|2
228271|NCT01600716|751053|P2|Overall Study|Pregnancy|0
228272|NCT01600716|751054|P1|Overall Study|Pregnancy|1
228273|NCT01600716|751053|P2|Overall Study|Lost to Follow-up|2
228274|NCT01600716|751054|P1|Overall Study|Lost to Follow-up|0
228275|NCT01600716|751053|P2|Overall Study|Personal Reasons|2
228276|NCT01600716|751054|P1|Overall Study|Personal Reasons|0
228277|NCT01600716|751053|P2|Overall Study|Other Reasons|1
228278|NCT01600716|751054|P1|Overall Study|Other Reasons|3
228279|NCT01600326|751109|P2|Overall Study|Lost to Follow-up|1
228280|NCT01600326|751110|P1|Overall Study|Lost to Follow-up|1
228281|NCT01600092|751186|P2|Overall Study|Randomized but not vaccinated|3
228282|NCT01600092|751187|P1|Overall Study|Randomized but not vaccinated|3
228283|NCT01600092|751186|P2|Overall Study|Physician Decision|1
228284|NCT01600092|751187|P1|Overall Study|Physician Decision|1
228285|NCT01600092|751186|P2|Overall Study|Withdrawal by parent/guardian|6
228286|NCT01600092|751187|P1|Overall Study|Withdrawal by parent/guardian|8
228287|NCT01600092|751186|P2|Overall Study|Lost to Follow-up|6
228288|NCT01600092|751187|P1|Overall Study|Lost to Follow-up|4
228289|NCT01600092|751186|P2|Overall Study|Adverse Event|0
228290|NCT01600092|751187|P1|Overall Study|Adverse Event|2
228291|NCT01600053|751201|P1|Overall Study|trial will not meet the interim endpoint|9
228292|NCT01600053|751201|P1|Overall Study|Adverse Event|2
228293|NCT01600014|751206|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
228294|NCT01600014|751207|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
228295|NCT01600014|751206|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
228296|NCT01600014|751207|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
228297|NCT01600014|751206|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
228298|NCT01600014|751207|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
228299|NCT01600014|751206|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
228300|NCT01600014|751207|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
228301|NCT01600014|751206|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
228302|NCT01600014|751207|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
228303|NCT01600014|751206|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
228304|NCT01600014|751207|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
228305|NCT01600014|751206|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
228306|NCT01600014|751207|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
228307|NCT01600014|751206|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
228308|NCT01600014|751207|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
228309|NCT01600014|751206|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
228310|NCT01600014|751207|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
228311|NCT01600014|751206|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
228312|NCT01600014|751207|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
228313|NCT01600014|751206|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
228314|NCT01600014|751207|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
228315|NCT01600014|751206|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
228316|NCT01600014|751207|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
228317|NCT01600014|751206|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
228318|NCT01600014|751207|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
228319|NCT01600014|751206|P2|1. Cycle & Observation Period D1 to W52|Other|0
228320|NCT01600014|751207|P1|1. Cycle & Observation Period D1 to W52|Other|27
228321|NCT01600014|751206|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
228322|NCT01600014|751207|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
228323|NCT01600014|751206|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
228324|NCT01600014|751207|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
228325|NCT01600014|751206|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
228326|NCT01600014|751207|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
228327|NCT01599806|751235|P2|Overall Study|Other Eligibility criteria|9
228328|NCT01599806|751236|P1|Overall Study|Other Eligibility criteria|11
228329|NCT01599806|751235|P2|Overall Study|Withdrawal by Subject|12
228330|NCT01599806|751236|P1|Overall Study|Withdrawal by Subject|12
228331|NCT01599806|751235|P2|Overall Study|Lost to Follow-up|20
228332|NCT01599806|751236|P1|Overall Study|Lost to Follow-up|20
228333|NCT01599650|751369|P3|Overall Study|Adverse Event|4
228334|NCT01599650|751370|P2|Overall Study|Adverse Event|8
228335|NCT01599650|751371|P1|Overall Study|Adverse Event|3
228336|NCT01599650|751369|P3|Overall Study|Withdrawal by Subject|10
228337|NCT01599650|751370|P2|Overall Study|Withdrawal by Subject|11
228338|NCT01599650|751371|P1|Overall Study|Withdrawal by Subject|11
228339|NCT01599650|751369|P3|Overall Study|Lost to Follow-up|3
228340|NCT01599650|751370|P2|Overall Study|Lost to Follow-up|3
228341|NCT01599650|751371|P1|Overall Study|Lost to Follow-up|3
228342|NCT01599650|751369|P3|Overall Study|Death|2
228343|NCT01599650|751370|P2|Overall Study|Death|1
228344|NCT01599650|751371|P1|Overall Study|Death|2
228345|NCT01599650|751369|P3|Overall Study|Protocol Violation|0
228346|NCT01599650|751370|P2|Overall Study|Protocol Violation|3
228347|NCT01599650|751371|P1|Overall Study|Protocol Violation|0
228348|NCT01599650|751369|P3|Overall Study|Physician Decision|7
228349|NCT01599650|751370|P2|Overall Study|Physician Decision|0
228350|NCT01599650|751371|P1|Overall Study|Physician Decision|2
228351|NCT01599650|751369|P3|Overall Study|Administrative issue|1
228352|NCT01599650|751370|P2|Overall Study|Administrative issue|0
228353|NCT01599650|751371|P1|Overall Study|Administrative issue|1
228354|NCT01599637|751410|P3|Overall Study|Adverse Event|0
228355|NCT01599637|751411|P2|Overall Study|Adverse Event|0
228356|NCT01599637|751412|P1|Overall Study|Adverse Event|1
228357|NCT01599637|751410|P3|Overall Study|administrative problems|0
228358|NCT01599637|751411|P2|Overall Study|administrative problems|2
228359|NCT01599637|751412|P1|Overall Study|administrative problems|0
228360|NCT01599585|751459|P2|Overall Study|randomized did not start treatment|3
228361|NCT01599585|751460|P1|Overall Study|randomized did not start treatment|3
228362|NCT01599585|751459|P2|Overall Study|Lost to Follow-up|5
228363|NCT01599585|751460|P1|Overall Study|Lost to Follow-up|3
228364|NCT01599585|751459|P2|Overall Study|Withdrawal by Subject|9
228365|NCT01599585|751460|P1|Overall Study|Withdrawal by Subject|16
228366|NCT01599325|751498|P1|Overall Study|Unspecified|2
228367|NCT01599325|751498|P1|Overall Study|Lack of Therapeutic Effect|9
228368|NCT01599325|751498|P1|Overall Study|Protocol Violation|1
228369|NCT01599325|751498|P1|Overall Study|Death|13
228370|NCT01599325|751498|P1|Overall Study|Withdrawal by Subject|20
228371|NCT01599325|751498|P1|Overall Study|Disease Progression|7
228372|NCT01599325|751498|P1|Overall Study|Adverse Event|5
228373|NCT01599234|751520|P2|Overall Study|Pregnancy|1
228374|NCT01599234|751521|P1|Overall Study|Pregnancy|0
228375|NCT01599234|751520|P2|Overall Study|Contra-indication discovered|1
228376|NCT01599234|751521|P1|Overall Study|Contra-indication discovered|0
228377|NCT01599234|751520|P2|Overall Study|Patient would not stop driving|0
228378|NCT01599234|751521|P1|Overall Study|Patient would not stop driving|1
228379|NCT01599234|751520|P2|Overall Study|Death|0
228380|NCT01599234|751521|P1|Overall Study|Death|1
228381|NCT01599234|751520|P2|Overall Study|Sponsor request as creatinine levels <50|1
228382|NCT01599234|751521|P1|Overall Study|Sponsor request as creatinine levels <50|0
228383|NCT01599234|751520|P2|Overall Study|Unable to operate spray|0
228384|NCT01599234|751521|P1|Overall Study|Unable to operate spray|1
228385|NCT01599234|751520|P2|Overall Study|Lack of Efficacy|4
228386|NCT01599234|751521|P1|Overall Study|Lack of Efficacy|2
228387|NCT01599234|751520|P2|Overall Study|Lost to Follow-up|2
228388|NCT01599234|751521|P1|Overall Study|Lost to Follow-up|1
228389|NCT01599234|751520|P2|Overall Study|Withdrawal by Subject|1
228390|NCT01599234|751521|P1|Overall Study|Withdrawal by Subject|2
228391|NCT01599234|751520|P2|Overall Study|Adverse Event|5
228392|NCT01599234|751521|P1|Overall Study|Adverse Event|9
228393|NCT01599104|751546|P3|Overall Study|Adverse Event|12
228394|NCT01599104|751547|P2|Overall Study|Adverse Event|6
228395|NCT01599104|751548|P1|Overall Study|Adverse Event|7
228396|NCT01599104|751546|P3|Overall Study|Lack of Efficacy|10
228397|NCT01599104|751547|P2|Overall Study|Lack of Efficacy|4
228398|NCT01599104|751548|P1|Overall Study|Lack of Efficacy|4
228399|NCT01599104|751546|P3|Overall Study|Non-compliance with study treatment|0
228400|NCT01599104|751547|P2|Overall Study|Non-compliance with study treatment|1
228401|NCT01599104|751548|P1|Overall Study|Non-compliance with study treatment|0
228402|NCT01599104|751546|P3|Overall Study|Physician Decision|2
228403|NCT01599104|751547|P2|Overall Study|Physician Decision|2
228404|NCT01599104|751548|P1|Overall Study|Physician Decision|3
228405|NCT01599104|751546|P3|Overall Study|Technical Problems|0
228406|NCT01599104|751547|P2|Overall Study|Technical Problems|0
228407|NCT01599104|751548|P1|Overall Study|Technical Problems|1
228408|NCT01599104|751546|P3|Overall Study|Withdrawal by Subject|2
228409|NCT01599104|751547|P2|Overall Study|Withdrawal by Subject|1
228410|NCT01599104|751548|P1|Overall Study|Withdrawal by Subject|1
228411|NCT01598987|751586|P1|Baseline to 24 Month|Lost to Follow-up|1
228412|NCT01598987|751586|P1|Baseline to 24 Month|Administrative problems|2
228413|NCT01598987|751586|P1|Baseline to 24 Month|Withdrawal by Subject|5
228414|NCT01598987|751586|P1|Baseline to Month 12|Withdrawal by Subject|4
228415|NCT01598987|751586|P1|Baseline to Month 12|Administrative problems|2
228416|NCT01598610|751635|P1|Overall Study|Adverse Event|1
228417|NCT01598532|751652|P1|Overall Study|Did not meet inclusion criteria|8
228418|NCT01598532|751652|P1|Overall Study|Lost to Follow-up|3
228419|NCT01598506|751661|P1|Overall Study|Withdrawal by Subject|2
228420|NCT01598129|751701|P1|Overall Study|Withdrawal by Subject|1
228421|NCT01598129|751701|P1|Overall Study|Deterioration of WHO status to WHO 4|2
228422|NCT01598129|751701|P1|Overall Study|Disease progression|6
228423|NCT01597908|751723|P2|Overall Study|Ongoing|202
228424|NCT01597908|751724|P1|Overall Study|Ongoing|236
228425|NCT01597908|751723|P2|Overall Study|Withdrawal by Subject|18
228426|NCT01597908|751724|P1|Overall Study|Withdrawal by Subject|10
228427|NCT01597908|751723|P2|Overall Study|Physician Decision|1
228428|NCT01597908|751724|P1|Overall Study|Physician Decision|2
228429|NCT01597908|751723|P2|Overall Study|Lost to Follow-up|9
228430|NCT01597908|751724|P1|Overall Study|Lost to Follow-up|4
228431|NCT01597908|751723|P2|Overall Study|Death|122
228432|NCT01597908|751724|P1|Overall Study|Death|100
228433|NCT01597596|751751|P2|Overall Study|Physician Decision|1
228434|NCT01597596|751752|P1|Overall Study|Physician Decision|0
228435|NCT01597596|751751|P2|Overall Study|Study terminated by sponsor|0
228436|NCT01597596|751752|P1|Overall Study|Study terminated by sponsor|1
228437|NCT01597492|751766|P2|Overall Study|Other Reason|0
228438|NCT01597492|751767|P1|Overall Study|Other Reason|2
228439|NCT01597492|751766|P2|Overall Study|Lost to Follow-up|2
228440|NCT01597492|751767|P1|Overall Study|Lost to Follow-up|0
228441|NCT01597492|751766|P2|Overall Study|Adverse Event|0
228442|NCT01597492|751767|P1|Overall Study|Adverse Event|3
228443|NCT01597492|751766|P2|Overall Study|Withdrawal by Subject|2
228444|NCT01597492|751767|P1|Overall Study|Withdrawal by Subject|1
228445|NCT01597479|751775|P2|Overall Study|Lost to Follow-up|0
228446|NCT01597479|751776|P1|Overall Study|Lost to Follow-up|1
228447|NCT01597479|751775|P2|Overall Study|Protocol Violation|0
228448|NCT01597479|751776|P1|Overall Study|Protocol Violation|1
228449|NCT01597245|751798|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228450|NCT01597245|751799|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228451|NCT01597245|751800|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
228452|NCT01597245|751801|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228453|NCT01597245|751802|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228454|NCT01597245|751803|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228455|NCT01597245|751804|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228456|NCT01597245|751805|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228457|NCT01597245|751806|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228458|NCT01597245|751807|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228459|NCT01597245|751808|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228460|NCT01597245|751809|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228461|NCT01597245|751810|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
228462|NCT01597245|751798|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
228463|NCT01597245|751799|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
228464|NCT01597245|751800|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
228465|NCT01597245|751801|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
228466|NCT01597245|751802|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
228467|NCT01597245|751803|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
228468|NCT01597245|751804|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
228469|NCT01597245|751805|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
228470|NCT01597245|751806|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
228471|NCT01597245|751807|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
228472|NCT01597245|751808|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
228473|NCT01597245|751809|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
228474|NCT01597245|751810|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
228475|NCT01597245|751798|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
228476|NCT01597245|751799|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
228477|NCT01597245|751800|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
228478|NCT01597245|751801|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
228479|NCT01597245|751802|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
228480|NCT01597245|751803|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
228481|NCT01597245|751804|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
228482|NCT01597245|751805|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
228483|NCT01597245|751806|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
228484|NCT01597245|751807|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
228485|NCT01597245|751808|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
228486|NCT01597245|751809|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
228487|NCT01597245|751810|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
228488|NCT01597245|751798|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
228489|NCT01597245|751799|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
228490|NCT01597245|751800|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
228491|NCT01597245|751801|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
228492|NCT01597245|751802|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
228493|NCT01597245|751803|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
228494|NCT01597245|751804|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
228495|NCT01597245|751805|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
228496|NCT01597245|751806|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
228497|NCT01597245|751807|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
228498|NCT01597245|751808|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
228499|NCT01597245|751809|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
228500|NCT01597245|751810|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
228501|NCT01597245|751798|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
228502|NCT01597245|751799|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
228503|NCT01597245|751800|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
228504|NCT01597245|751801|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
228505|NCT01597245|751802|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
228506|NCT01597245|751803|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
228507|NCT01597245|751804|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
228508|NCT01597245|751805|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
228509|NCT01597245|751806|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
228510|NCT01597245|751807|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
228511|NCT01597245|751808|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
228512|NCT01597245|751809|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
228513|NCT01597245|751810|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
228514|NCT01597245|751798|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
228515|NCT01597245|751799|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
228516|NCT01597245|751800|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
228517|NCT01597245|751801|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
228518|NCT01597245|751802|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
228519|NCT01597245|751803|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
228520|NCT01597245|751804|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
228521|NCT01597245|751805|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
228522|NCT01597245|751806|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
228523|NCT01597245|751807|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
228524|NCT01597245|751808|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
228525|NCT01597245|751809|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
228526|NCT01597245|751810|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
228527|NCT01597245|751798|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
228528|NCT01597245|751799|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
228529|NCT01597245|751800|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
228530|NCT01597245|751801|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
228531|NCT01597245|751802|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
228532|NCT01597245|751803|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
228533|NCT01597245|751804|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
228534|NCT01597245|751805|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
228535|NCT01597245|751806|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
228536|NCT01597245|751807|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
228537|NCT01597245|751808|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
228538|NCT01597245|751809|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
228539|NCT01597245|751810|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
228540|NCT01597245|751798|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
228541|NCT01597245|751799|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
228542|NCT01597245|751800|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
228543|NCT01597245|751801|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
228544|NCT01597245|751802|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
228545|NCT01597245|751803|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
228546|NCT01597245|751804|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
228547|NCT01597245|751805|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
228548|NCT01597245|751806|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
228549|NCT01597245|751807|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
228550|NCT01597245|751808|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
228551|NCT01597245|751809|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
228552|NCT01597245|751810|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
228553|NCT01597245|751798|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228554|NCT01597245|751799|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228555|NCT01597245|751800|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228556|NCT01597245|751801|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228557|NCT01597245|751802|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228558|NCT01597245|751803|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228559|NCT01597245|751804|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
228560|NCT01597245|751805|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
228561|NCT01597245|751806|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228562|NCT01597245|751807|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228563|NCT01597245|751808|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228564|NCT01597245|751809|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228565|NCT01597245|751810|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
228566|NCT01597245|751798|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228567|NCT01597245|751799|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228568|NCT01597245|751800|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228569|NCT01597245|751801|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228570|NCT01597245|751802|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228571|NCT01597245|751803|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228572|NCT01597245|751804|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228573|NCT01597245|751805|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228574|NCT01597245|751806|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228575|NCT01597245|751807|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
228576|NCT01597245|751808|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
228577|NCT01597245|751809|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
228578|NCT01597245|751810|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
228579|NCT01597245|751798|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
228580|NCT01597245|751799|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
228581|NCT01597245|751800|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
228582|NCT01597245|751801|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
228583|NCT01597245|751802|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
228584|NCT01597245|751803|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
228585|NCT01597245|751804|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
228586|NCT01597245|751805|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
228587|NCT01597245|751806|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
228588|NCT01597245|751807|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
228589|NCT01597245|751808|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
228590|NCT01597245|751809|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
228591|NCT01597245|751810|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
228592|NCT01597245|751798|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228593|NCT01597245|751799|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228594|NCT01597245|751800|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228595|NCT01597245|751801|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228596|NCT01597245|751802|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228597|NCT01597245|751803|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228598|NCT01597245|751804|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228599|NCT01597245|751805|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228600|NCT01597245|751806|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228601|NCT01597245|751807|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
228602|NCT01597245|751808|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
228603|NCT01597245|751809|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
228604|NCT01597245|751810|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
228605|NCT01597245|751798|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
228606|NCT01597245|751799|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
228607|NCT01597245|751800|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
228608|NCT01597245|751801|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
228609|NCT01597245|751802|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
228610|NCT01597245|751803|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
228611|NCT01597245|751804|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
228612|NCT01597245|751805|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
228613|NCT01597245|751806|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
228614|NCT01597245|751807|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
228615|NCT01597245|751808|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
228616|NCT01597245|751809|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
228617|NCT01597245|751810|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
228618|NCT01597245|751798|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
228619|NCT01597245|751799|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
228620|NCT01597245|751800|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
228621|NCT01597245|751801|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
228622|NCT01597245|751802|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
228623|NCT01597245|751803|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
228624|NCT01597245|751804|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
228625|NCT01597245|751805|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
228626|NCT01597245|751806|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
228627|NCT01597245|751807|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
228628|NCT01597245|751808|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
228629|NCT01597245|751809|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
228630|NCT01597245|751810|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
228631|NCT01597245|751798|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
228632|NCT01597245|751799|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
228633|NCT01597245|751800|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
228634|NCT01597245|751801|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
228635|NCT01597245|751802|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
228636|NCT01597245|751803|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
228637|NCT01597245|751804|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
228638|NCT01597245|751805|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
228639|NCT01597245|751806|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
228640|NCT01597245|751807|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
228641|NCT01597245|751808|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
228642|NCT01597245|751809|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
228643|NCT01597245|751810|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
228644|NCT01597050|751933|P2|Overall Study|Withdrawal by Subject|0
228645|NCT01597050|751934|P1|Overall Study|Withdrawal by Subject|1
228646|NCT01596972|751942|P2|Overall Study|Withdrawal by Subject|1
228647|NCT01596972|751943|P1|Overall Study|Withdrawal by Subject|0
228648|NCT01596972|751942|P2|Overall Study|Lost to Follow-up|4
228649|NCT01596972|751943|P1|Overall Study|Lost to Follow-up|0
228650|NCT01596972|751942|P2|Overall Study|Physician Decision|9
228651|NCT01596972|751943|P1|Overall Study|Physician Decision|1
228652|NCT01596582|751966|P2|Overall Study|Missing all outcome data|1
228653|NCT01596582|751967|P1|Overall Study|Missing all outcome data|1
228654|NCT01596582|751966|P2|Overall Study|Deemed ineligible after study visit|6
228655|NCT01596582|751967|P1|Overall Study|Deemed ineligible after study visit|3
228656|NCT01596504|751994|P3|Overall Study|Withdrawal by Subject|0
228657|NCT01596504|751995|P2|Overall Study|Withdrawal by Subject|0
228658|NCT01596504|751996|P1|Overall Study|Withdrawal by Subject|1
228659|NCT01596504|751994|P3|Overall Study|Adverse Event|1
228660|NCT01596504|751995|P2|Overall Study|Adverse Event|2
228661|NCT01596504|751996|P1|Overall Study|Adverse Event|1
228662|NCT01596504|751994|P3|Overall Study|Participant's Private Reason|0
228663|NCT01596504|751995|P2|Overall Study|Participant's Private Reason|1
228664|NCT01596504|751996|P1|Overall Study|Participant's Private Reason|0
228665|NCT01596062|752068|P3|Overall Study|Lack of Efficacy|1
228666|NCT01596062|752069|P2|Overall Study|Lack of Efficacy|0
228667|NCT01596062|752070|P1|Overall Study|Lack of Efficacy|0
228668|NCT01596062|752068|P3|Overall Study|Adverse Event|2
228669|NCT01596062|752069|P2|Overall Study|Adverse Event|0
228670|NCT01596062|752070|P1|Overall Study|Adverse Event|1
228671|NCT01595438|752133|P2|Overall Study|Other Eligibility criteria|9
228672|NCT01595438|752134|P1|Overall Study|Other Eligibility criteria|11
228673|NCT01595438|752133|P2|Overall Study|Withdrawal by Subject|12
228674|NCT01595438|752134|P1|Overall Study|Withdrawal by Subject|12
228675|NCT01595438|752133|P2|Overall Study|Lost to Follow-up|20
228676|NCT01595438|752134|P1|Overall Study|Lost to Follow-up|20
228677|NCT01594970|752303|P3|Overall Study|Lost to Follow-up|37
228678|NCT01594970|752304|P2|Overall Study|Lost to Follow-up|54
228679|NCT01594970|752305|P1|Overall Study|Lost to Follow-up|54
228680|NCT01594970|752303|P3|Overall Study|Adverse Event|23
228681|NCT01594970|752304|P2|Overall Study|Adverse Event|23
228682|NCT01594970|752305|P1|Overall Study|Adverse Event|17
228683|NCT01594970|752303|P3|Overall Study|Non-Adverse Event Related|6
228684|NCT01594970|752304|P2|Overall Study|Non-Adverse Event Related|5
228685|NCT01594970|752305|P1|Overall Study|Non-Adverse Event Related|4
228686|NCT01594762|752324|P2|Overall Study|Lost to Follow-up|10
228687|NCT01594762|752325|P1|Overall Study|Lost to Follow-up|10
228688|NCT01594762|752324|P2|Overall Study|Withdrawal by Subject|0
228689|NCT01594762|752325|P1|Overall Study|Withdrawal by Subject|1
228690|NCT01594749|752337|P2|Overall Study|Lost Source Documentation|0
228691|NCT01594749|752338|P1|Overall Study|Lost Source Documentation|1
228692|NCT01594749|752337|P2|Overall Study|Not Treated|10
228693|NCT01594749|752338|P1|Overall Study|Not Treated|4
228694|NCT01594749|752337|P2|Overall Study|Death|3
228695|NCT01594749|752338|P1|Overall Study|Death|9
228696|NCT01594749|752337|P2|Overall Study|Lost to Follow-up|0
228697|NCT01594749|752338|P1|Overall Study|Lost to Follow-up|1
228698|NCT01594749|752337|P2|Overall Study|Non-compliance with Protocol|1
228699|NCT01594749|752338|P1|Overall Study|Non-compliance with Protocol|0
228700|NCT01594749|752337|P2|Overall Study|Physician Decision|1
228701|NCT01594749|752338|P1|Overall Study|Physician Decision|1
228702|NCT01594749|752337|P2|Overall Study|Protocol Violation|0
228703|NCT01594749|752338|P1|Overall Study|Protocol Violation|2
228704|NCT01594749|752337|P2|Overall Study|Withdrawal by Subject|2
228705|NCT01594749|752338|P1|Overall Study|Withdrawal by Subject|2
228706|NCT01594749|752337|P2|Overall Study|Adverse Event|1
228707|NCT01594749|752338|P1|Overall Study|Adverse Event|2
228708|NCT01594411|752467|P1|Overall Study|Lost to Follow-up|2
228709|NCT01594125|752505|P5|Overall Study|Progressive Disease|7
228710|NCT01594125|752506|P4|Overall Study|Progressive Disease|3
228711|NCT01594125|752507|P3|Overall Study|Progressive Disease|3
228712|NCT01594125|752508|P2|Overall Study|Progressive Disease|12
228713|NCT01594125|752509|P1|Overall Study|Progressive Disease|3
228714|NCT01594125|752505|P5|Overall Study|Withdrawal by Subject|0
228715|NCT01594125|752506|P4|Overall Study|Withdrawal by Subject|1
228716|NCT01594125|752507|P3|Overall Study|Withdrawal by Subject|0
228717|NCT01594125|752508|P2|Overall Study|Withdrawal by Subject|0
228718|NCT01594125|752509|P1|Overall Study|Withdrawal by Subject|1
228719|NCT01593787|752569|P3|Overall Study|Adverse Event|0
228720|NCT01593787|752570|P2|Overall Study|Adverse Event|0
228721|NCT01593787|752571|P1|Overall Study|Adverse Event|1
228722|NCT01592864|752658|P2|Overall Study|Withdrawal by Subject|1
228723|NCT01592864|752659|P1|Overall Study|Withdrawal by Subject|0
228724|NCT01592786|752690|P1|Overall Study|Other|3
228725|NCT01592786|752690|P1|Overall Study|Lost to Follow-up|19
228726|NCT01592786|752690|P1|Overall Study|Withdrawal by Subject|23
228727|NCT01592786|752690|P1|Overall Study|Protocol Violation|14
228728|NCT01592786|752690|P1|Overall Study|Lack of Efficacy|19
228729|NCT01592786|752690|P1|Overall Study|Adverse Event|60
228730|NCT01592773|752694|P1|Overall Study|Other Reason|1
228731|NCT01592773|752694|P1|Overall Study|Inclusion/exclusion not meet|1
228732|NCT01592773|752694|P1|Overall Study|Protocol Violation|2
228733|NCT01592773|752694|P1|Overall Study|Lack of Efficacy|9
228734|NCT01592773|752694|P1|Overall Study|Adverse Event|17
228735|NCT01592773|752694|P1|Overall Study|Lost to Follow-up|19
228736|NCT01592773|752694|P1|Overall Study|Withdrawal by Subject|35
228737|NCT01592773|752694|P1|Overall Study|Study Terminated by Sponsor|582
228738|NCT01592760|752701|P3|24-hour Follow-Up|Lost to Follow-up|2
228739|NCT01592760|752702|P2|24-hour Follow-Up|Lost to Follow-up|3
228740|NCT01592760|752703|P1|24-hour Follow-Up|Lost to Follow-up|4
228741|NCT01592708|752746|P2|Overall Study|Protocol Violation|0
228742|NCT01592708|752747|P1|Overall Study|Protocol Violation|3
228743|NCT01592344|752787|P2|Overall Study|not available at primary outcome visit|4
228744|NCT01592344|752788|P1|Overall Study|not available at primary outcome visit|2
228745|NCT01592344|752787|P2|Overall Study|Lack of Efficacy|0
228746|NCT01592344|752788|P1|Overall Study|Lack of Efficacy|1
228747|NCT01592344|752787|P2|Overall Study|Adverse Event|1
228748|NCT01592344|752788|P1|Overall Study|Adverse Event|1
228749|NCT01592292|752802|P4|Overall Study|Not specified|1
228750|NCT01592292|752803|P3|Overall Study|Not specified|2
228751|NCT01592292|752804|P2|Overall Study|Not specified|1
228752|NCT01592292|752805|P1|Overall Study|Not specified|1
228753|NCT01592292|752802|P4|Overall Study|Withdrew consent|0
228754|NCT01592292|752803|P3|Overall Study|Withdrew consent|0
228755|NCT01592292|752804|P2|Overall Study|Withdrew consent|1
228756|NCT01592292|752805|P1|Overall Study|Withdrew consent|2
228757|NCT01592292|752802|P4|Overall Study|Follow-up loss|0
228758|NCT01592292|752803|P3|Overall Study|Follow-up loss|1
228759|NCT01592292|752804|P2|Overall Study|Follow-up loss|3
228760|NCT01592292|752805|P1|Overall Study|Follow-up loss|3
228761|NCT01592045|752850|P2|Overall Study|Moved out of country|0
228762|NCT01592045|752851|P1|Overall Study|Moved out of country|2
228763|NCT01592045|752850|P2|Overall Study|Withdrawal by Subject|0
228764|NCT01592045|752851|P1|Overall Study|Withdrawal by Subject|1
228765|NCT01592045|752850|P2|Overall Study|Adverse Event|1
228766|NCT01592045|752851|P1|Overall Study|Adverse Event|1
228767|NCT01592045|752850|P2|Overall Study|Disease Progression|1
228768|NCT01592045|752851|P1|Overall Study|Disease Progression|1
228769|NCT01591863|752869|P1|Overall Study|Lack of Efficacy|1
228770|NCT01591863|752869|P1|Overall Study|recurrence|9
228771|NCT01591863|752869|P1|Overall Study|Withdrawal by Subject|1
228772|NCT01591863|752869|P1|Overall Study|Adverse Event|3
228773|NCT01591681|752896|P1|Overall Study|Failed to use system during run-in|1
228774|NCT01591681|752896|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
228775|NCT01591616|752922|P1|Overall Study|Withdrawal by Subject|1
228776|NCT01591499|753063|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
228777|NCT01591499|753064|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
228778|NCT01591499|753065|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
228779|NCT01591499|753066|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
228780|NCT01591499|753063|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
228781|NCT01591499|753064|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
228782|NCT01591499|753065|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
228783|NCT01591499|753066|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
228784|NCT01591499|753063|P4|Baseline Visit|Withdrawal by Subject|2
228785|NCT01591499|753064|P3|Baseline Visit|Withdrawal by Subject|0
228786|NCT01591499|753065|P2|Baseline Visit|Withdrawal by Subject|2
228787|NCT01591499|753066|P1|Baseline Visit|Withdrawal by Subject|0
228788|NCT01591460|753132|P1|Overall Study|Protocol Violation|1
228789|NCT01591460|753132|P1|Overall Study|Withdrawal by Subject|1
228790|NCT01591460|753132|P1|Overall Study|Participant Refusal|3
228791|NCT01591460|753132|P1|Overall Study|Noncompliance|1
228792|NCT01591460|753132|P1|Overall Study|Lost to Follow-up|1
228793|NCT01591460|753132|P1|Overall Study|Treatment Discontinued by Error|1
228794|NCT01591460|753132|P1|Overall Study|Rebound or Breakthrough|3
228795|NCT01591460|753132|P1|Overall Study|Futility Rule (Week 24)|3
228796|NCT01591460|753132|P1|Overall Study|Futility Rule (Week 12)|7
228797|NCT01591460|753132|P1|Overall Study|Adverse Event or Intercurrent Illness|5
228798|NCT01591382|753223|P2|Overall Study|Participant Opted for Morphine PCA|1
228799|NCT01591382|753224|P1|Overall Study|Participant Opted for Morphine PCA|1
228800|NCT01591382|753223|P2|Overall Study|Discharged Prior to Study Completion|1
228801|NCT01591382|753224|P1|Overall Study|Discharged Prior to Study Completion|2
228802|NCT01590888|753348|P3|Overall Study|Lost to Follow-up|0
228803|NCT01590888|753349|P2|Overall Study|Lost to Follow-up|0
228804|NCT01590888|753350|P1|Overall Study|Lost to Follow-up|1
228805|NCT01590888|753348|P3|Overall Study|Adverse Event|1
228806|NCT01590888|753349|P2|Overall Study|Adverse Event|0
228807|NCT01590888|753350|P1|Overall Study|Adverse Event|3
228808|NCT01590810|753414|P5|Overall Study|Physician Decision|0
228809|NCT01590810|753415|P4|Overall Study|Physician Decision|0
228810|NCT01590810|753416|P3|Overall Study|Physician Decision|1
228811|NCT01590810|753417|P2|Overall Study|Physician Decision|1
228812|NCT01590810|753418|P1|Overall Study|Physician Decision|0
228813|NCT01590797|753563|P2|Overall Study|Other Protocol Specified Criteria|4
228814|NCT01590797|753564|P1|Overall Study|Other Protocol Specified Criteria|2
228815|NCT01590797|753563|P2|Overall Study|Withdrawal by Subject|5
228816|NCT01590797|753564|P1|Overall Study|Withdrawal by Subject|7
228817|NCT01590797|753563|P2|Overall Study|Protocol Violation|1
228818|NCT01590797|753564|P1|Overall Study|Protocol Violation|4
228819|NCT01590797|753563|P2|Overall Study|Lost to Follow-up|1
228820|NCT01590797|753564|P1|Overall Study|Lost to Follow-up|0
228821|NCT01590797|753563|P2|Overall Study|Lack of Efficacy|2
228822|NCT01590797|753564|P1|Overall Study|Lack of Efficacy|0
228823|NCT01590797|753563|P2|Overall Study|Adverse Event|3
228824|NCT01590797|753564|P1|Overall Study|Adverse Event|4
228825|NCT01590771|753580|P2|Overall Study|Adverse Event|7
228826|NCT01590771|753581|P1|Overall Study|Adverse Event|3
228827|NCT01590771|753580|P2|Overall Study|Lack of Efficacy|0
228828|NCT01590771|753581|P1|Overall Study|Lack of Efficacy|1
228829|NCT01590771|753580|P2|Overall Study|Lost to Follow-up|1
228830|NCT01590771|753581|P1|Overall Study|Lost to Follow-up|1
228831|NCT01590771|753580|P2|Overall Study|Protocol Violation|2
228832|NCT01590771|753581|P1|Overall Study|Protocol Violation|1
228833|NCT01590771|753580|P2|Overall Study|Withdrawal by Subject|15
228834|NCT01590771|753581|P1|Overall Study|Withdrawal by Subject|8
228835|NCT01590771|753580|P2|Overall Study|Other Protocol Specified Criteria|14
228836|NCT01590771|753581|P1|Overall Study|Other Protocol Specified Criteria|5
228837|NCT01590758|753609|P2|Overall Study|Lost to Follow-up|2
228838|NCT01590758|753610|P1|Overall Study|Lost to Follow-up|4
228839|NCT01590758|753609|P2|Overall Study|Physician Decision|2
228840|NCT01590758|753610|P1|Overall Study|Physician Decision|1
228841|NCT01590758|753609|P2|Overall Study|Withdrawal by Subject|3
228842|NCT01590758|753610|P1|Overall Study|Withdrawal by Subject|0
228843|NCT01590563|753620|P1|Overall Study|simple uterine hyperplasia - not related|1
228844|NCT01590212|753644|P3|Overall Study|Lost to Follow-up|3
228845|NCT01590212|753645|P2|Overall Study|Lost to Follow-up|2
228846|NCT01590212|753646|P1|Overall Study|Lost to Follow-up|1
228847|NCT01590212|753644|P3|Overall Study|Withdrawal by Subject|2
228848|NCT01590212|753645|P2|Overall Study|Withdrawal by Subject|2
228849|NCT01590212|753646|P1|Overall Study|Withdrawal by Subject|2
228850|NCT01589822|753690|P3|Overall Study|Missed 90 day visit|1
228851|NCT01589822|753691|P2|Overall Study|Missed 90 day visit|1
228852|NCT01589822|753692|P1|Overall Study|Missed 90 day visit|2
228853|NCT01589822|753690|P3|Overall Study|Death|0
228854|NCT01589822|753691|P2|Overall Study|Death|0
228855|NCT01589822|753692|P1|Overall Study|Death|1
228856|NCT01589822|753690|P3|Overall Study|Withdrawal by Subject|0
228857|NCT01589822|753691|P2|Overall Study|Withdrawal by Subject|2
228858|NCT01589822|753692|P1|Overall Study|Withdrawal by Subject|1
228859|NCT01589653|753711|P2|Overall Study|Unclassified|3
228860|NCT01589653|753712|P1|Overall Study|Unclassified|0
228861|NCT01589653|753711|P2|Overall Study|Withdrawal criteria|7
228862|NCT01589653|753712|P1|Overall Study|Withdrawal criteria|4
228863|NCT01589653|753711|P2|Overall Study|Protocol Violation|1
228864|NCT01589653|753712|P1|Overall Study|Protocol Violation|3
228865|NCT01589497|753741|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
228866|NCT01589497|753742|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
228867|NCT01589497|753743|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
228868|NCT01589497|753744|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
228869|NCT01589497|753741|P4|Overall Study|Death|0
228870|NCT01589497|753742|P3|Overall Study|Death|0
228871|NCT01589497|753743|P2|Overall Study|Death|0
228872|NCT01589497|753744|P1|Overall Study|Death|1
228873|NCT01589497|753741|P4|Overall Study|Withdrawal by Subject|1
228874|NCT01589497|753742|P3|Overall Study|Withdrawal by Subject|0
228875|NCT01589497|753743|P2|Overall Study|Withdrawal by Subject|1
228876|NCT01589497|753744|P1|Overall Study|Withdrawal by Subject|0
228877|NCT01589445|753782|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
228878|NCT01589445|753782|P1|002 (Metformin)-3 Months|Adverse Event|2
228879|NCT01589445|753782|P1|002 (Metformin)-3 Months|Protocol Violation|2
228880|NCT01589445|753782|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
228881|NCT01589445|753782|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
228882|NCT01589445|753782|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
228883|NCT01589445|753782|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
228884|NCT01589445|753782|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
228885|NCT01589445|753782|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
228886|NCT01589445|753782|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
228887|NCT01589237|753802|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
228888|NCT01589237|753803|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
228889|NCT01589237|753804|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
228890|NCT01589237|753805|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
228891|NCT01589237|753802|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
228892|NCT01589237|753803|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
228893|NCT01589237|753804|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
228894|NCT01589237|753805|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
228895|NCT01589237|753802|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
229156|NCT01582854|755189|P2|Overall Study|General Anaesthesia|1
228896|NCT01589237|753803|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
228897|NCT01589237|753804|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
228898|NCT01589237|753805|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
228899|NCT01589237|753802|P4|Part A (52 Weeks)|Subject/guardian decision|0
228900|NCT01589237|753803|P3|Part A (52 Weeks)|Subject/guardian decision|2
228901|NCT01589237|753804|P2|Part A (52 Weeks)|Subject/guardian decision|3
228902|NCT01589237|753805|P1|Part A (52 Weeks)|Subject/guardian decision|2
228903|NCT01588951|753854|P3|Overall Study|Ineligible in retrospect|1
228904|NCT01588951|753855|P2|Overall Study|Ineligible in retrospect|0
228905|NCT01588951|753856|P1|Overall Study|Ineligible in retrospect|0
228906|NCT01588548|753870|P6|Overall Study|Condition Under Investigation Worsened|3
228907|NCT01588548|753871|P5|Overall Study|Condition Under Investigation Worsened|3
228908|NCT01588548|753872|P4|Overall Study|Condition Under Investigation Worsened|4
228909|NCT01588548|753873|P3|Overall Study|Condition Under Investigation Worsened|4
228910|NCT01588548|753874|P2|Overall Study|Condition Under Investigation Worsened|6
228911|NCT01588548|753875|P1|Overall Study|Condition Under Investigation Worsened|3
228912|NCT01588548|753870|P6|Overall Study|Adverse Event|0
228913|NCT01588548|753871|P5|Overall Study|Adverse Event|1
228914|NCT01588548|753872|P4|Overall Study|Adverse Event|2
228915|NCT01588548|753873|P3|Overall Study|Adverse Event|1
228916|NCT01588548|753874|P2|Overall Study|Adverse Event|0
228917|NCT01588548|753875|P1|Overall Study|Adverse Event|0
228918|NCT01588548|753870|P6|Overall Study|Withdrawal by Subject|3
228919|NCT01588548|753871|P5|Overall Study|Withdrawal by Subject|2
228920|NCT01588548|753872|P4|Overall Study|Withdrawal by Subject|1
228921|NCT01588548|753873|P3|Overall Study|Withdrawal by Subject|1
228922|NCT01588548|753874|P2|Overall Study|Withdrawal by Subject|1
228923|NCT01588548|753875|P1|Overall Study|Withdrawal by Subject|0
228924|NCT01588496|753892|P3|Overall Study|Withdrawal by Subject|0
228925|NCT01588496|753893|P2|Overall Study|Withdrawal by Subject|1
228926|NCT01588496|753894|P1|Overall Study|Withdrawal by Subject|0
228927|NCT01588405|753933|P1|Overall Study|Clinical Worsening|1
228928|NCT01588405|753933|P1|Overall Study|Adverse Event|1
228929|NCT01588353|753960|P3|Step3|Adverse Event|2
228930|NCT01588353|753961|P2|Step3|Adverse Event|0
228931|NCT01588353|753962|P1|Step3|Adverse Event|0
228932|NCT01588353|753960|P3|Step2|Withdrawal by Subject|0
228933|NCT01588353|753961|P2|Step2|Withdrawal by Subject|1
228934|NCT01588353|753962|P1|Step2|Withdrawal by Subject|0
228935|NCT01588106|754005|P2|Overall Study|Withdrawal by Subject|4
228936|NCT01588106|754006|P1|Overall Study|Withdrawal by Subject|5
228937|NCT01587989|754014|P3|Randomized Study Treatment|Physician Decision|1
228938|NCT01587989|754015|P2|Randomized Study Treatment|Physician Decision|0
228939|NCT01587989|754016|P1|Randomized Study Treatment|Physician Decision|0
228940|NCT01587989|754014|P3|Randomized Study Treatment|Screening failure|0
228941|NCT01587989|754015|P2|Randomized Study Treatment|Screening failure|1
228942|NCT01587989|754016|P1|Randomized Study Treatment|Screening failure|0
228943|NCT01587989|754014|P3|Randomized Study Treatment|Withdrawal by Subject|0
228944|NCT01587989|754015|P2|Randomized Study Treatment|Withdrawal by Subject|1
228945|NCT01587989|754016|P1|Randomized Study Treatment|Withdrawal by Subject|0
228946|NCT01587989|754014|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
228947|NCT01587989|754015|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
228948|NCT01587989|754016|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
228949|NCT01587989|754014|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
228950|NCT01587989|754015|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
228951|NCT01587989|754016|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
228952|NCT01587989|754014|P3|12-Week Open-Label Run-In Period|Physician Decision|0
228953|NCT01587989|754015|P2|12-Week Open-Label Run-In Period|Physician Decision|0
228954|NCT01587989|754016|P1|12-Week Open-Label Run-In Period|Physician Decision|7
228955|NCT01587885|754077|P2|Treatment Period 1|Protocol Violation|2
228956|NCT01587885|754078|P1|Treatment Period 1|Protocol Violation|0
228957|NCT01587885|754077|P2|Treatment Period 1|Failure to Return|1
228958|NCT01587885|754078|P1|Treatment Period 1|Failure to Return|0
228959|NCT01587651|754094|P3|Overall Study|Withdrawal by Subject|0
228960|NCT01587651|754095|P2|Overall Study|Withdrawal by Subject|1
228961|NCT01587651|754096|P1|Overall Study|Withdrawal by Subject|0
228962|NCT01587651|754094|P3|Overall Study|Protocol Violation|1
228963|NCT01587651|754095|P2|Overall Study|Protocol Violation|1
228964|NCT01587651|754096|P1|Overall Study|Protocol Violation|0
228965|NCT01587651|754094|P3|Overall Study|Adverse Event|0
228966|NCT01587651|754095|P2|Overall Study|Adverse Event|1
228967|NCT01587651|754096|P1|Overall Study|Adverse Event|0
228968|NCT01587118|754123|P1|Overall Study|nonresponse|1
228969|NCT01587118|754123|P1|Overall Study|Relocation|1
228970|NCT01587118|754123|P1|Overall Study|Lost to Follow-up|2
228971|NCT01587118|754123|P1|Overall Study|Adverse Event|3
228972|NCT01587079|754147|P1|Overall Study|Adverse Event|14
228973|NCT01587079|754147|P1|Overall Study|Withdrawal by Subject|7
228974|NCT01587079|754147|P1|Overall Study|Physician Decision|2
228975|NCT01587079|754147|P1|Overall Study|Lost to Follow-up|2
228976|NCT01587079|754147|P1|Overall Study|Protocol Violation|5
228977|NCT01587079|754147|P1|Overall Study|Protocol-specified criteria|9
228978|NCT01587014|754278|P1|Overall Study|Death|2
228979|NCT01587001|754285|P2|Overall Study|Insufficient samples to complete testing|1
228980|NCT01587001|754286|P1|Overall Study|Insufficient samples to complete testing|4
228981|NCT01587001|754285|P2|Overall Study|Lost to Follow-up|0
228982|NCT01587001|754286|P1|Overall Study|Lost to Follow-up|2
228983|NCT01586806|754335|P3|Overall Study|Lost to Follow-up|2
228984|NCT01586806|754336|P2|Overall Study|Lost to Follow-up|3
228985|NCT01586806|754337|P1|Overall Study|Lost to Follow-up|2
228986|NCT01586806|754335|P3|Overall Study|Withdrawal by Subject|0
228987|NCT01586806|754336|P2|Overall Study|Withdrawal by Subject|0
228988|NCT01586806|754337|P1|Overall Study|Withdrawal by Subject|1
228989|NCT01586806|754335|P3|Overall Study|Protocol Violation|0
228990|NCT01586806|754336|P2|Overall Study|Protocol Violation|1
228991|NCT01586806|754337|P1|Overall Study|Protocol Violation|0
228992|NCT01586364|754357|P1|Overall Study|Other-Not specified|1
228993|NCT01586364|754357|P1|Overall Study|Other-PI discretion, site closing|2
228994|NCT01586364|754357|P1|Overall Study|Other-Site closure due to PI illness|1
228995|NCT01586364|754357|P1|Overall Study|Other-Subject wasn't getting much relief|1
228996|NCT01586364|754357|P1|Overall Study|Other-Did not feel better post-treatment|1
228997|NCT01586364|754357|P1|Overall Study|Lack of Efficacy|1
228998|NCT01586364|754357|P1|Overall Study|Protocol Violation|16
228999|NCT01586364|754357|P1|Overall Study|Lost to Follow-up|17
229000|NCT01586364|754357|P1|Overall Study|Adverse Event|37
229001|NCT01586364|754357|P1|Overall Study|Withdrawal by Subject|40
229002|NCT01586338|754410|P1|Overall Study|Unspecified|1
229003|NCT01586338|754410|P1|Overall Study|Withdrawal by participant|3
229004|NCT01586338|754410|P1|Overall Study|Lost to Follow-up|1
229005|NCT01586338|754410|P1|Overall Study|Adverse Event|3
229006|NCT01586195|754433|P1|Overall Study|Reason not specified|9
229007|NCT01586195|754433|P1|Overall Study|Started new anti-melanoma therapy|1
229008|NCT01586195|754433|P1|Overall Study|Withdrawal of Consent|5
229009|NCT01586195|754433|P1|Overall Study|Death|11
229010|NCT01585987|754456|P2|Treated|Poor/Non-Compliance|1
229011|NCT01585987|754457|P1|Treated|Poor/Non-Compliance|0
229012|NCT01585987|754456|P2|Treated|Subject Request|1
229013|NCT01585987|754457|P1|Treated|Subject Request|0
229014|NCT01585987|754456|P2|Treated|Non-Specified|2
229015|NCT01585987|754457|P1|Treated|Non-Specified|1
229016|NCT01585987|754456|P2|Treated|Maximum Clinical Benefit|1
229017|NCT01585987|754457|P1|Treated|Maximum Clinical Benefit|0
229018|NCT01585987|754456|P2|Treated|Lost to Follow-up|1
229019|NCT01585987|754457|P1|Treated|Lost to Follow-up|0
229020|NCT01585987|754456|P2|Treated|Death|0
229021|NCT01585987|754457|P1|Treated|Death|1
229022|NCT01585987|754456|P2|Treated|Withdrawal by Subject|2
229023|NCT01585987|754457|P1|Treated|Withdrawal by Subject|1
229024|NCT01585987|754456|P2|Treated|Adverse Event|0
229025|NCT01585987|754457|P1|Treated|Adverse Event|3
229026|NCT01585987|754456|P2|Treated|Study Drug Toxicity|5
229027|NCT01585987|754457|P1|Treated|Study Drug Toxicity|9
229028|NCT01585987|754456|P2|Treated|Disease Progression|36
229029|NCT01585987|754457|P1|Treated|Disease Progression|39
229030|NCT01585987|754456|P2|Randomized|No longer met criteria|2
229031|NCT01585987|754457|P1|Randomized|No longer met criteria|0
229032|NCT01585987|754456|P2|Randomized|Withdrawal by Subject|4
229033|NCT01585987|754457|P1|Randomized|Withdrawal by Subject|0
229034|NCT01585961|754472|P1|Overall Study|Ablation cancelled for slow-heal wound|1
229035|NCT01585961|754472|P1|Overall Study|Lost to Follow-up|23
229036|NCT01585961|754472|P1|Overall Study|Withdrawal by Subject|1
229037|NCT01585961|754472|P1|Overall Study|Decision to use non-study catheter|1
229038|NCT01585961|754472|P1|Overall Study|Physician Decision|1
229039|NCT01585961|754472|P1|Overall Study|Death|6
229040|NCT01585584|754549|P1|Overall Study|Physician Decision|2
229041|NCT01585584|754549|P1|Overall Study|Withdrawal by Subject|1
229042|NCT01585584|754549|P1|Overall Study|Lack of Efficacy|1
229043|NCT01585558|754556|P3|Overall Study|Lack of Efficacy|1
229044|NCT01585558|754557|P2|Overall Study|Lack of Efficacy|0
229045|NCT01585558|754558|P1|Overall Study|Lack of Efficacy|0
229046|NCT01585558|754556|P3|Overall Study|Protocol Violation|2
229047|NCT01585558|754557|P2|Overall Study|Protocol Violation|3
229048|NCT01585558|754558|P1|Overall Study|Protocol Violation|4
229049|NCT01585558|754556|P3|Overall Study|Adverse Event|1
229050|NCT01585558|754557|P2|Overall Study|Adverse Event|4
229051|NCT01585558|754558|P1|Overall Study|Adverse Event|3
229052|NCT01585558|754556|P3|Overall Study|Lost to Follow-up|3
229053|NCT01585558|754557|P2|Overall Study|Lost to Follow-up|0
229054|NCT01585558|754558|P1|Overall Study|Lost to Follow-up|2
229055|NCT01585558|754556|P3|Overall Study|Withdrawal by Subject|8
229056|NCT01585558|754557|P2|Overall Study|Withdrawal by Subject|5
229057|NCT01585558|754558|P1|Overall Study|Withdrawal by Subject|4
229058|NCT01585428|754792|P2|Overall Study|Death during treatment|0
229059|NCT01585428|754793|P1|Overall Study|Death during treatment|1
229060|NCT01585272|754817|P1|Overall Study|Withdrawal by Subject|10
229061|NCT01585272|754817|P1|Overall Study|Protocol Violation|7
229062|NCT01585272|754817|P1|Overall Study|Adverse Event|22
229063|NCT01585038|754827|P2|Overall Study|Adverse Event|2
229064|NCT01585038|754828|P1|Overall Study|Adverse Event|2
229065|NCT01584843|754844|P6|Second Treatment Period|Withdrawal by Subject|1
229066|NCT01584843|754845|P5|Second Treatment Period|Withdrawal by Subject|0
229067|NCT01584843|754846|P4|Second Treatment Period|Withdrawal by Subject|0
229068|NCT01584843|754847|P3|Second Treatment Period|Withdrawal by Subject|0
229069|NCT01584843|754848|P2|Second Treatment Period|Withdrawal by Subject|0
229070|NCT01584843|754849|P1|Second Treatment Period|Withdrawal by Subject|0
229071|NCT01584843|754844|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
229072|NCT01584843|754845|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
229073|NCT01584843|754846|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
229074|NCT01584843|754847|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
229075|NCT01584843|754848|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
229076|NCT01584843|754849|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
229077|NCT01584843|754844|P6|First Treatment Period|Protocol Violation|1
229078|NCT01584843|754845|P5|First Treatment Period|Protocol Violation|0
229079|NCT01584843|754846|P4|First Treatment Period|Protocol Violation|0
229080|NCT01584843|754847|P3|First Treatment Period|Protocol Violation|0
229081|NCT01584843|754848|P2|First Treatment Period|Protocol Violation|0
229082|NCT01584843|754849|P1|First Treatment Period|Protocol Violation|0
229083|NCT01584843|754844|P6|First Treatment Period|Adverse Event|0
229084|NCT01584843|754845|P5|First Treatment Period|Adverse Event|0
229085|NCT01584843|754846|P4|First Treatment Period|Adverse Event|0
229086|NCT01584843|754847|P3|First Treatment Period|Adverse Event|1
229087|NCT01584843|754848|P2|First Treatment Period|Adverse Event|0
229088|NCT01584843|754849|P1|First Treatment Period|Adverse Event|0
229089|NCT01584648|754960|P2|Overall Study|Ongoing|147
229090|NCT01584648|754961|P1|Overall Study|Ongoing|154
229091|NCT01584648|754960|P2|Overall Study|Death|55
229092|NCT01584648|754961|P1|Overall Study|Death|40
229093|NCT01584648|754960|P2|Overall Study|Withdrawal by Subject|5
229094|NCT01584648|754961|P1|Overall Study|Withdrawal by Subject|11
229095|NCT01584648|754960|P2|Overall Study|Physician Decision|2
229096|NCT01584648|754961|P1|Overall Study|Physician Decision|2
229097|NCT01584648|754960|P2|Overall Study|Lost to Follow-up|3
229098|NCT01584648|754961|P1|Overall Study|Lost to Follow-up|4
229099|NCT01584232|755048|P2|Overall Study|Lost to Follow-up|0
229100|NCT01584232|755049|P1|Overall Study|Lost to Follow-up|1
229101|NCT01584232|755048|P2|Overall Study|Physician Decision|1
229102|NCT01584232|755049|P1|Overall Study|Physician Decision|2
229103|NCT01584232|755048|P2|Overall Study|Withdrawal by Subject|1
229104|NCT01584232|755049|P1|Overall Study|Withdrawal by Subject|2
229105|NCT01584232|755048|P2|Overall Study|Adverse Event|1
229106|NCT01584232|755049|P1|Overall Study|Adverse Event|3
229107|NCT01583530|755095|P6|Overall Study|Lack of compliance|0
229108|NCT01583530|755096|P5|Overall Study|Lack of compliance|1
229109|NCT01583530|755097|P4|Overall Study|Lack of compliance|0
229110|NCT01583530|755098|P3|Overall Study|Lack of compliance|0
229111|NCT01583530|755099|P2|Overall Study|Lack of compliance|0
229112|NCT01583530|755100|P1|Overall Study|Lack of compliance|0
229113|NCT01583530|755095|P6|Overall Study|Lost to Follow-up|0
229114|NCT01583530|755096|P5|Overall Study|Lost to Follow-up|3
229115|NCT01583530|755097|P4|Overall Study|Lost to Follow-up|0
229116|NCT01583530|755098|P3|Overall Study|Lost to Follow-up|0
229117|NCT01583530|755099|P2|Overall Study|Lost to Follow-up|0
229118|NCT01583530|755100|P1|Overall Study|Lost to Follow-up|0
229119|NCT01583530|755095|P6|Overall Study|Withdrawal by Subject|2
229120|NCT01583530|755096|P5|Overall Study|Withdrawal by Subject|1
229121|NCT01583530|755097|P4|Overall Study|Withdrawal by Subject|1
229122|NCT01583530|755098|P3|Overall Study|Withdrawal by Subject|0
229123|NCT01583530|755099|P2|Overall Study|Withdrawal by Subject|3
229124|NCT01583530|755100|P1|Overall Study|Withdrawal by Subject|0
229125|NCT01583530|755095|P6|Overall Study|Adverse Event|1
229126|NCT01583530|755096|P5|Overall Study|Adverse Event|0
229127|NCT01583530|755097|P4|Overall Study|Adverse Event|0
229128|NCT01583530|755098|P3|Overall Study|Adverse Event|0
229129|NCT01583530|755099|P2|Overall Study|Adverse Event|0
229130|NCT01583530|755100|P1|Overall Study|Adverse Event|0
229131|NCT01583374|755162|P3|Overall Study|Unspecified|0
229132|NCT01583374|755163|P2|Overall Study|Unspecified|1
229133|NCT01583374|755164|P1|Overall Study|Unspecified|0
229134|NCT01583374|755162|P3|Overall Study|Protocol Violation|3
229135|NCT01583374|755163|P2|Overall Study|Protocol Violation|0
229136|NCT01583374|755164|P1|Overall Study|Protocol Violation|0
229137|NCT01583374|755162|P3|Overall Study|Lost to Follow-up|0
229138|NCT01583374|755163|P2|Overall Study|Lost to Follow-up|2
229139|NCT01583374|755164|P1|Overall Study|Lost to Follow-up|1
229140|NCT01583374|755162|P3|Overall Study|Withdrawal by Subject|5
229141|NCT01583374|755163|P2|Overall Study|Withdrawal by Subject|3
229142|NCT01583374|755164|P1|Overall Study|Withdrawal by Subject|8
229143|NCT01583374|755162|P3|Overall Study|Non-compliance with study drug|0
229144|NCT01583374|755163|P2|Overall Study|Non-compliance with study drug|1
229145|NCT01583374|755164|P1|Overall Study|Non-compliance with study drug|1
229146|NCT01583374|755162|P3|Overall Study|Lack of Efficacy|5
229147|NCT01583374|755163|P2|Overall Study|Lack of Efficacy|2
229148|NCT01583374|755164|P1|Overall Study|Lack of Efficacy|3
229149|NCT01583374|755162|P3|Overall Study|Adverse Event|12
229150|NCT01583374|755163|P2|Overall Study|Adverse Event|7
229151|NCT01583374|755164|P1|Overall Study|Adverse Event|6
229152|NCT01582945|755183|P1|Overall Study|Scheduling conflicts|1
229153|NCT01582945|755183|P1|Overall Study|Intolerable side-effects|1
229154|NCT01582854|755189|P2|Overall Study|Other Miscellaneous Reason|0
229155|NCT01582854|755190|P1|Overall Study|Other Miscellaneous Reason|1
229157|NCT01582854|755190|P1|Overall Study|General Anaesthesia|0
229158|NCT01582854|755189|P2|Overall Study|Carotid or Neurosurgery|1
229159|NCT01582854|755190|P1|Overall Study|Carotid or Neurosurgery|0
229160|NCT01582854|755189|P2|Overall Study|Disallowed Concomitant Medication|2
229161|NCT01582854|755190|P1|Overall Study|Disallowed Concomitant Medication|3
229162|NCT01582854|755189|P2|Overall Study|Recurrent Stroke|8
229163|NCT01582854|755190|P1|Overall Study|Recurrent Stroke|13
229164|NCT01582854|755189|P2|Overall Study|Physician Decision|1
229165|NCT01582854|755190|P1|Overall Study|Physician Decision|0
229166|NCT01582854|755189|P2|Overall Study|Lost to Follow-up|2
229167|NCT01582854|755190|P1|Overall Study|Lost to Follow-up|1
229168|NCT01582854|755189|P2|Overall Study|Withdrawal by Participant|11
229169|NCT01582854|755190|P1|Overall Study|Withdrawal by Participant|8
229170|NCT01582854|755189|P2|Overall Study|Adverse Event|3
229171|NCT01582854|755190|P1|Overall Study|Adverse Event|2
229172|NCT01582854|755189|P2|Overall Study|Death|5
229173|NCT01582854|755190|P1|Overall Study|Death|8
229174|NCT01582789|755218|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
229175|NCT01582789|755219|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
229176|NCT01582308|755277|P10|Period 4|Physician Decision|1
229177|NCT01582308|755278|P9|Period 4|Physician Decision|0
229178|NCT01582308|755279|P8|Period 4|Physician Decision|0
229179|NCT01582308|755280|P7|Period 4|Physician Decision|0
229180|NCT01582308|755281|P6|Period 4|Physician Decision|1
229181|NCT01582308|755282|P5|Period 4|Physician Decision|0
229182|NCT01582308|755283|P4|Period 4|Physician Decision|0
229183|NCT01582308|755284|P3|Period 4|Physician Decision|0
229184|NCT01582308|755285|P2|Period 4|Physician Decision|0
229185|NCT01582308|755286|P1|Period 4|Physician Decision|1
229186|NCT01582308|755277|P10|10-day Washout Following Period 1|Physician Decision|0
229187|NCT01582308|755278|P9|10-day Washout Following Period 1|Physician Decision|0
229188|NCT01582308|755279|P8|10-day Washout Following Period 1|Physician Decision|0
229189|NCT01582308|755280|P7|10-day Washout Following Period 1|Physician Decision|0
229190|NCT01582308|755281|P6|10-day Washout Following Period 1|Physician Decision|0
229191|NCT01582308|755282|P5|10-day Washout Following Period 1|Physician Decision|1
229192|NCT01582308|755283|P4|10-day Washout Following Period 1|Physician Decision|0
229193|NCT01582308|755284|P3|10-day Washout Following Period 1|Physician Decision|0
229194|NCT01582308|755285|P2|10-day Washout Following Period 1|Physician Decision|0
229195|NCT01582308|755286|P1|10-day Washout Following Period 1|Physician Decision|0
229196|NCT01582308|755277|P10|Period 1|Withdrawal by Subject|0
229197|NCT01582308|755278|P9|Period 1|Withdrawal by Subject|0
229198|NCT01582308|755279|P8|Period 1|Withdrawal by Subject|0
229199|NCT01582308|755280|P7|Period 1|Withdrawal by Subject|1
229200|NCT01582308|755281|P6|Period 1|Withdrawal by Subject|0
229201|NCT01582308|755282|P5|Period 1|Withdrawal by Subject|0
229202|NCT01582308|755283|P4|Period 1|Withdrawal by Subject|0
229203|NCT01582308|755284|P3|Period 1|Withdrawal by Subject|0
229204|NCT01582308|755285|P2|Period 1|Withdrawal by Subject|0
229205|NCT01582308|755286|P1|Period 1|Withdrawal by Subject|0
229206|NCT01582282|755314|P3|Overall Study|fasting blood glucose outside Protocol|0
229207|NCT01582282|755315|P2|Overall Study|fasting blood glucose outside Protocol|1
229208|NCT01582282|755316|P1|Overall Study|fasting blood glucose outside Protocol|0
229209|NCT01582282|755314|P3|Overall Study|Lost to Follow-up|0
229210|NCT01582282|755315|P2|Overall Study|Lost to Follow-up|0
229211|NCT01582282|755316|P1|Overall Study|Lost to Follow-up|1
229212|NCT01582282|755314|P3|Overall Study|Adverse Event|0
229213|NCT01582282|755315|P2|Overall Study|Adverse Event|1
229214|NCT01582282|755316|P1|Overall Study|Adverse Event|1
229215|NCT01582243|755339|P1|Overall Study|Lost to Follow-up|1
229216|NCT01582243|755339|P1|Overall Study|Adverse Event|1
229217|NCT01582243|755339|P1|Overall Study|Withdrawal by Subject|1
229218|NCT01582178|755350|P2|Overall Study|Physician Decision|5
229219|NCT01582178|755351|P1|Overall Study|Physician Decision|6
229220|NCT01582100|755372|P1|Overall Study|Withdrawal by Subject|1
229221|NCT01582100|755372|P1|Overall Study|Adverse Event|1
229222|NCT01582009|755376|P1|Overall Study|Physician Decision|1
229223|NCT01582009|755376|P1|Overall Study|Withdrawal by Subject|1
229224|NCT01581931|755384|P2|Washout|Adverse Event|1
229225|NCT01581931|755385|P1|Washout|Adverse Event|0
229226|NCT01581684|755409|P10|Overall Study|Other reason not defined|0
229227|NCT01581684|755410|P9|Overall Study|Other reason not defined|1
229228|NCT01581684|755411|P8|Overall Study|Other reason not defined|0
229229|NCT01581684|755412|P7|Overall Study|Other reason not defined|0
229230|NCT01581684|755413|P6|Overall Study|Other reason not defined|0
229231|NCT01581684|755414|P5|Overall Study|Other reason not defined|0
229232|NCT01581684|755415|P4|Overall Study|Other reason not defined|0
229233|NCT01581684|755416|P3|Overall Study|Other reason not defined|0
229234|NCT01581684|755417|P2|Overall Study|Other reason not defined|0
229235|NCT01581684|755418|P1|Overall Study|Other reason not defined|0
229236|NCT01581307|755525|P1|Overall Study|Withdrawal by Subject|1
229237|NCT01581021|755533|P2|Overall Study|Lack of Efficacy|1
229238|NCT01581021|755534|P1|Overall Study|Lack of Efficacy|0
229239|NCT01581021|755533|P2|Overall Study|Lenke 6 Classification|1
229240|NCT01581021|755534|P1|Overall Study|Lenke 6 Classification|0
229241|NCT01581021|755533|P2|Overall Study|Not Randomized|2
229242|NCT01581021|755534|P1|Overall Study|Not Randomized|1
229243|NCT01581021|755533|P2|Overall Study|Neuromuscular|1
229244|NCT01581021|755534|P1|Overall Study|Neuromuscular|2
229245|NCT01581021|755533|P2|Overall Study|More than 2 hooks in thoracic|0
229246|NCT01581021|755534|P1|Overall Study|More than 2 hooks in thoracic|3
229247|NCT01581021|755533|P2|Overall Study|Lost to Follow-up|6
229248|NCT01581021|755534|P1|Overall Study|Lost to Follow-up|4
229249|NCT01580995|755560|P2|Overall Study|Lost to Follow-up|2
229250|NCT01580995|755561|P1|Overall Study|Lost to Follow-up|2
229251|NCT01580488|755614|P1|Overall Study|Withdrawal by Subject|1
229252|NCT01580020|755755|P4|Overall Study|Lost to Follow-up|0
229253|NCT01580020|755756|P3|Overall Study|Lost to Follow-up|1
229254|NCT01580020|755757|P2|Overall Study|Lost to Follow-up|0
229255|NCT01580020|755758|P1|Overall Study|Lost to Follow-up|0
229256|NCT01580020|755755|P4|Overall Study|Administrative Problems|0
229257|NCT01580020|755756|P3|Overall Study|Administrative Problems|1
229258|NCT01580020|755757|P2|Overall Study|Administrative Problems|0
229259|NCT01580020|755758|P1|Overall Study|Administrative Problems|0
229260|NCT01580020|755755|P4|Overall Study|Adverse Event|1
229261|NCT01580020|755756|P3|Overall Study|Adverse Event|1
229262|NCT01580020|755757|P2|Overall Study|Adverse Event|1
229263|NCT01580020|755758|P1|Overall Study|Adverse Event|1
229264|NCT01580020|755755|P4|Overall Study|Withdrawal by Subject|0
229265|NCT01580020|755756|P3|Overall Study|Withdrawal by Subject|1
229266|NCT01580020|755757|P2|Overall Study|Withdrawal by Subject|1
229267|NCT01580020|755758|P1|Overall Study|Withdrawal by Subject|0
229268|NCT01580020|755755|P4|Overall Study|Lack of Efficacy|1
229269|NCT01580020|755756|P3|Overall Study|Lack of Efficacy|0
229270|NCT01580020|755757|P2|Overall Study|Lack of Efficacy|5
229271|NCT01580020|755758|P1|Overall Study|Lack of Efficacy|0
229272|NCT01579916|755802|P2|Overall Study|Death|0
229273|NCT01579916|755803|P1|Overall Study|Death|1
229274|NCT01579916|755802|P2|Overall Study|Withdrawal by Subject|1
229275|NCT01579916|755803|P1|Overall Study|Withdrawal by Subject|1
229276|NCT01579916|755802|P2|Overall Study|Lost to Follow-up|1
229277|NCT01579916|755803|P1|Overall Study|Lost to Follow-up|6
229278|NCT01579578|755855|P2|Overall Study|Ongoing|0
229279|NCT01579578|755856|P1|Overall Study|Ongoing|3
229280|NCT01579578|755855|P2|Overall Study|Eligibility criteria|9
229281|NCT01579578|755856|P1|Overall Study|Eligibility criteria|3
229282|NCT01579578|755855|P2|Overall Study|Withdrawal by Subject|1
229283|NCT01579578|755856|P1|Overall Study|Withdrawal by Subject|2
229284|NCT01579578|755855|P2|Overall Study|Lost to Follow-up|1
229285|NCT01579578|755856|P1|Overall Study|Lost to Follow-up|1
229286|NCT01579578|755855|P2|Overall Study|Death|1
229287|NCT01579578|755856|P1|Overall Study|Death|4
229288|NCT01579565|755868|P2|Treated|declined to return for final visit|1
229289|NCT01579565|755869|P1|Treated|declined to return for final visit|0
229290|NCT01579565|755868|P2|Treated|Lost to Follow-up|1
229291|NCT01579565|755869|P1|Treated|Lost to Follow-up|2
229292|NCT01579565|755868|P2|Treated|Physician Decision|1
229293|NCT01579565|755869|P1|Treated|Physician Decision|0
229294|NCT01579565|755868|P2|Randomized|prohibited preoperative medication|1
229295|NCT01579565|755869|P1|Randomized|prohibited preoperative medication|0
229296|NCT01579565|755868|P2|Randomized|prohibited preoperative eating|0
229297|NCT01579565|755869|P1|Randomized|prohibited preoperative eating|1
229298|NCT01579565|755868|P2|Randomized|inadequate preoperative pupil dilation|1
229299|NCT01579565|755869|P1|Randomized|inadequate preoperative pupil dilation|0
229300|NCT01579565|755868|P2|Randomized|Withdrawal by Subject|0
229301|NCT01579565|755869|P1|Randomized|Withdrawal by Subject|3
229302|NCT01579565|755868|P2|Randomized|Adverse Event|3
229303|NCT01579565|755869|P1|Randomized|Adverse Event|1
229304|NCT01579474|755903|P6|Overall Study|Withdrawal by Subject|0
229305|NCT01579474|755904|P5|Overall Study|Withdrawal by Subject|0
229306|NCT01579474|755905|P4|Overall Study|Withdrawal by Subject|0
229307|NCT01579474|755906|P3|Overall Study|Withdrawal by Subject|0
229308|NCT01579474|755907|P2|Overall Study|Withdrawal by Subject|0
229309|NCT01579474|755908|P1|Overall Study|Withdrawal by Subject|1
229310|NCT01579474|755903|P6|Overall Study|Lack of Efficacy|0
229311|NCT01579474|755904|P5|Overall Study|Lack of Efficacy|1
229312|NCT01579474|755905|P4|Overall Study|Lack of Efficacy|0
229313|NCT01579474|755906|P3|Overall Study|Lack of Efficacy|0
229314|NCT01579474|755907|P2|Overall Study|Lack of Efficacy|0
229315|NCT01579474|755908|P1|Overall Study|Lack of Efficacy|1
229316|NCT01579474|755903|P6|Overall Study|Adverse Event|1
229317|NCT01579474|755904|P5|Overall Study|Adverse Event|0
229318|NCT01579474|755905|P4|Overall Study|Adverse Event|0
229319|NCT01579474|755906|P3|Overall Study|Adverse Event|2
229320|NCT01579474|755907|P2|Overall Study|Adverse Event|13
229321|NCT01579474|755908|P1|Overall Study|Adverse Event|1
229322|NCT01579006|756055|P1|Overall Study|Scheduled surgery|1
229323|NCT01579006|756055|P1|Overall Study|Due to participant's health fund|1
229324|NCT01579006|756055|P1|Overall Study|Non-compliance|3
229325|NCT01579006|756055|P1|Overall Study|Withdrawal by Subject|5
229326|NCT01579006|756055|P1|Overall Study|Adverse Event|13
229327|NCT01579006|756055|P1|Overall Study|Lack of Efficacy|10
229328|NCT01578850|756105|P3|Period 2|Unspecified Reasons|0
229329|NCT01578850|756106|P2|Period 2|Unspecified Reasons|1
229330|NCT01578850|756107|P1|Period 2|Unspecified Reasons|0
229331|NCT01578850|756105|P3|Period 2|Study Terminated by Sponsor|4
229332|NCT01578850|756106|P2|Period 2|Study Terminated by Sponsor|5
229333|NCT01578850|756107|P1|Period 2|Study Terminated by Sponsor|0
229334|NCT01578850|756105|P3|Period 2|Withdrawal by Subject|2
229335|NCT01578850|756106|P2|Period 2|Withdrawal by Subject|2
229336|NCT01578850|756107|P1|Period 2|Withdrawal by Subject|0
229337|NCT01578850|756105|P3|Period 2|Lost to Follow-up|2
229338|NCT01578850|756106|P2|Period 2|Lost to Follow-up|1
229339|NCT01578850|756107|P1|Period 2|Lost to Follow-up|0
229340|NCT01578850|756105|P3|Period 2|Adverse Event|6
229341|NCT01578850|756106|P2|Period 2|Adverse Event|3
229342|NCT01578850|756107|P1|Period 2|Adverse Event|0
229343|NCT01578850|756105|P3|Period 2|Insufficient Clinical Response|0
229344|NCT01578850|756106|P2|Period 2|Insufficient Clinical Response|1
229345|NCT01578850|756107|P1|Period 2|Insufficient Clinical Response|0
229346|NCT01578850|756105|P3|Period 1|Study Terminated by Sponsor|0
229347|NCT01578850|756106|P2|Period 1|Study Terminated by Sponsor|0
229348|NCT01578850|756107|P1|Period 1|Study Terminated by Sponsor|3
229349|NCT01578850|756105|P3|Period 1|Withdrawal by Subject|0
229350|NCT01578850|756106|P2|Period 1|Withdrawal by Subject|0
229351|NCT01578850|756107|P1|Period 1|Withdrawal by Subject|9
229352|NCT01578850|756105|P3|Period 1|Does Not Meet Entrance Criteria|0
229353|NCT01578850|756106|P2|Period 1|Does Not Meet Entrance Criteria|0
229354|NCT01578850|756107|P1|Period 1|Does Not Meet Entrance Criteria|12
229355|NCT01578850|756105|P3|Period 1|Death|0
229356|NCT01578850|756106|P2|Period 1|Death|0
229357|NCT01578850|756107|P1|Period 1|Death|1
229358|NCT01578850|756105|P3|Period 1|Adverse Event|0
229359|NCT01578850|756106|P2|Period 1|Adverse Event|0
229360|NCT01578850|756107|P1|Period 1|Adverse Event|11
229361|NCT01578850|756105|P3|Period 1|Insufficient Clinical Response|0
229362|NCT01578850|756106|P2|Period 1|Insufficient Clinical Response|0
229363|NCT01578850|756107|P1|Period 1|Insufficient Clinical Response|1
229364|NCT01578785|756159|P2|Overall Study|Study terminated by sponsor|118
229365|NCT01578785|756160|P1|Overall Study|Study terminated by sponsor|59
229366|NCT01578785|756159|P2|Overall Study|Withdrawal by Subject|1
229367|NCT01578785|756160|P1|Overall Study|Withdrawal by Subject|0
229368|NCT01578330|756190|P1|Overall Study|Protocol Violation|5
229369|NCT01578330|756190|P1|Overall Study|Adverse Event|2
229370|NCT01578187|756197|P1|Usability Phase|Withdrawal by Subject|1
229371|NCT01577758|756231|P8|mCRC Expansion Phase|Progression Disease|19
229372|NCT01577758|756232|P7|mCRC Expansion Phase|Progression Disease|0
229373|NCT01577758|756233|P6|mCRC Expansion Phase|Progression Disease|0
229374|NCT01577758|756234|P5|mCRC Expansion Phase|Progression Disease|0
229375|NCT01577758|756235|P4|mCRC Expansion Phase|Progression Disease|0
229376|NCT01577758|756236|P3|mCRC Expansion Phase|Progression Disease|0
229377|NCT01577758|756237|P2|mCRC Expansion Phase|Progression Disease|0
229378|NCT01577758|756238|P1|mCRC Expansion Phase|Progression Disease|0
229379|NCT01577758|756231|P8|mCRC Expansion Phase|Withdrawal by Subject|2
229380|NCT01577758|756232|P7|mCRC Expansion Phase|Withdrawal by Subject|0
229381|NCT01577758|756233|P6|mCRC Expansion Phase|Withdrawal by Subject|0
229382|NCT01577758|756234|P5|mCRC Expansion Phase|Withdrawal by Subject|0
229383|NCT01577758|756235|P4|mCRC Expansion Phase|Withdrawal by Subject|0
229384|NCT01577758|756236|P3|mCRC Expansion Phase|Withdrawal by Subject|0
229385|NCT01577758|756237|P2|mCRC Expansion Phase|Withdrawal by Subject|0
229386|NCT01577758|756238|P1|mCRC Expansion Phase|Withdrawal by Subject|0
229387|NCT01577758|756231|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
229388|NCT01577758|756232|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
229389|NCT01577758|756233|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
229390|NCT01577758|756234|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
229391|NCT01577758|756235|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
229392|NCT01577758|756236|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
229393|NCT01577758|756237|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
229394|NCT01577758|756238|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
229395|NCT01577758|756231|P8|Dose Escalation Phase|Progression Disease|0
229396|NCT01577758|756232|P7|Dose Escalation Phase|Progression Disease|0
229397|NCT01577758|756233|P6|Dose Escalation Phase|Progression Disease|0
229398|NCT01577758|756234|P5|Dose Escalation Phase|Progression Disease|5
229399|NCT01577758|756235|P4|Dose Escalation Phase|Progression Disease|2
229400|NCT01577758|756236|P3|Dose Escalation Phase|Progression Disease|1
229401|NCT01577758|756237|P2|Dose Escalation Phase|Progression Disease|2
229402|NCT01577758|756238|P1|Dose Escalation Phase|Progression Disease|2
229403|NCT01577758|756231|P8|Dose Escalation Phase|Withdrawal by Subject|0
229404|NCT01577758|756232|P7|Dose Escalation Phase|Withdrawal by Subject|0
229405|NCT01577758|756233|P6|Dose Escalation Phase|Withdrawal by Subject|1
229406|NCT01577758|756234|P5|Dose Escalation Phase|Withdrawal by Subject|0
229407|NCT01577758|756235|P4|Dose Escalation Phase|Withdrawal by Subject|0
229408|NCT01577758|756236|P3|Dose Escalation Phase|Withdrawal by Subject|0
229409|NCT01577758|756237|P2|Dose Escalation Phase|Withdrawal by Subject|0
229410|NCT01577758|756238|P1|Dose Escalation Phase|Withdrawal by Subject|0
229411|NCT01577758|756231|P8|Dose Escalation Phase|Symptomatic Deterioration|0
229412|NCT01577758|756232|P7|Dose Escalation Phase|Symptomatic Deterioration|0
229413|NCT01577758|756233|P6|Dose Escalation Phase|Symptomatic Deterioration|1
229414|NCT01577758|756234|P5|Dose Escalation Phase|Symptomatic Deterioration|1
229415|NCT01577758|756235|P4|Dose Escalation Phase|Symptomatic Deterioration|0
229416|NCT01577758|756236|P3|Dose Escalation Phase|Symptomatic Deterioration|1
229417|NCT01577758|756237|P2|Dose Escalation Phase|Symptomatic Deterioration|0
229418|NCT01577758|756238|P1|Dose Escalation Phase|Symptomatic Deterioration|0
229419|NCT01577758|756231|P8|Dose Escalation Phase|Adverse Event|0
229420|NCT01577758|756232|P7|Dose Escalation Phase|Adverse Event|1
229421|NCT01577758|756233|P6|Dose Escalation Phase|Adverse Event|2
229422|NCT01577758|756234|P5|Dose Escalation Phase|Adverse Event|0
229423|NCT01577758|756235|P4|Dose Escalation Phase|Adverse Event|0
229424|NCT01577758|756236|P3|Dose Escalation Phase|Adverse Event|0
229425|NCT01577758|756237|P2|Dose Escalation Phase|Adverse Event|0
229426|NCT01577758|756238|P1|Dose Escalation Phase|Adverse Event|0
229427|NCT01577745|756277|P6|Overall Study|Alternative Therapy|0
229428|NCT01577745|756278|P5|Overall Study|Alternative Therapy|1
229429|NCT01577745|756279|P4|Overall Study|Alternative Therapy|1
229430|NCT01577745|756280|P3|Overall Study|Alternative Therapy|0
229431|NCT01577745|756281|P2|Overall Study|Alternative Therapy|0
229432|NCT01577745|756282|P1|Overall Study|Alternative Therapy|0
229433|NCT01577745|756277|P6|Overall Study|Lost to Follow-up|1
229434|NCT01577745|756278|P5|Overall Study|Lost to Follow-up|0
229435|NCT01577745|756279|P4|Overall Study|Lost to Follow-up|0
229436|NCT01577745|756280|P3|Overall Study|Lost to Follow-up|0
229437|NCT01577745|756281|P2|Overall Study|Lost to Follow-up|0
229438|NCT01577745|756282|P1|Overall Study|Lost to Follow-up|0
229439|NCT01577745|756277|P6|Overall Study|Physician Decision|0
229440|NCT01577745|756278|P5|Overall Study|Physician Decision|1
229441|NCT01577745|756279|P4|Overall Study|Physician Decision|1
229442|NCT01577745|756280|P3|Overall Study|Physician Decision|0
229443|NCT01577745|756281|P2|Overall Study|Physician Decision|0
229444|NCT01577745|756282|P1|Overall Study|Physician Decision|0
229445|NCT01577745|756277|P6|Overall Study|Death|3
229446|NCT01577745|756278|P5|Overall Study|Death|1
229447|NCT01577745|756279|P4|Overall Study|Death|1
229448|NCT01577745|756280|P3|Overall Study|Death|2
229449|NCT01577745|756281|P2|Overall Study|Death|2
229450|NCT01577745|756282|P1|Overall Study|Death|3
229451|NCT01577745|756277|P6|Overall Study|Withdrawal by Subject|0
229452|NCT01577745|756278|P5|Overall Study|Withdrawal by Subject|2
229453|NCT01577745|756279|P4|Overall Study|Withdrawal by Subject|3
229454|NCT01577745|756280|P3|Overall Study|Withdrawal by Subject|0
229455|NCT01577745|756281|P2|Overall Study|Withdrawal by Subject|1
229456|NCT01577745|756282|P1|Overall Study|Withdrawal by Subject|0
229457|NCT01577381|756466|P4|Overall Study|Ongoing at Date of Cut-Off|0
229458|NCT01577381|756467|P3|Overall Study|Ongoing at Date of Cut-Off|1
229459|NCT01577381|756468|P2|Overall Study|Ongoing at Date of Cut-Off|2
229460|NCT01577381|756469|P1|Overall Study|Ongoing at Date of Cut-Off|0
229461|NCT01577381|756466|P4|Overall Study|Discontinued|2
229462|NCT01577381|756467|P3|Overall Study|Discontinued|2
229463|NCT01577381|756468|P2|Overall Study|Discontinued|1
229464|NCT01577381|756469|P1|Overall Study|Discontinued|2
229465|NCT01577186|756598|P1|Overall Study|Unspecified|2
229466|NCT01577186|756598|P1|Overall Study|Non-Compliant|8
229467|NCT01577186|756598|P1|Overall Study|Ineligible to Continue|15
229468|NCT01577186|756598|P1|Overall Study|Insufficient Response|18
229469|NCT01577186|756598|P1|Overall Study|Withdrawal by Subject|35
229470|NCT01577186|756598|P1|Overall Study|Lost to Follow-up|28
229471|NCT01577186|756598|P1|Overall Study|Death|1
229472|NCT01577186|756598|P1|Overall Study|Adverse Event|23
229473|NCT01577160|756606|P1|Overall Study|Unspecified|9
229474|NCT01577160|756606|P1|Overall Study|Subject Uncooperative|7
229475|NCT01577160|756606|P1|Overall Study|Withdrawal by Subject|18
229476|NCT01577160|756606|P1|Overall Study|Lost to Follow-up|40
229477|NCT01577160|756606|P1|Overall Study|Lack of Efficacy|15
229478|NCT01577160|756606|P1|Overall Study|Adverse Event|9
229479|NCT01576718|756652|P7|Treatment Period|Noncompliance to study medication|1
229480|NCT01576718|756653|P6|Treatment Period|Noncompliance to study medication|1
229481|NCT01576718|756654|P5|Treatment Period|Noncompliance to study medication|0
229482|NCT01576718|756655|P4|Treatment Period|Noncompliance to study medication|0
229483|NCT01576718|756656|P3|Treatment Period|Noncompliance to study medication|0
229484|NCT01576718|756657|P2|Treatment Period|Noncompliance to study medication|0
229485|NCT01576718|756658|P1|Treatment Period|Noncompliance to study medication|0
229486|NCT01576718|756652|P7|Treatment Period|Lost to Follow-up|0
229487|NCT01576718|756653|P6|Treatment Period|Lost to Follow-up|0
229488|NCT01576718|756654|P5|Treatment Period|Lost to Follow-up|1
229489|NCT01576718|756655|P4|Treatment Period|Lost to Follow-up|0
229490|NCT01576718|756656|P3|Treatment Period|Lost to Follow-up|0
229491|NCT01576718|756657|P2|Treatment Period|Lost to Follow-up|0
229492|NCT01576718|756658|P1|Treatment Period|Lost to Follow-up|0
229493|NCT01576718|756652|P7|Treatment Period|Met stopping criteria|15
229494|NCT01576718|756653|P6|Treatment Period|Met stopping criteria|33
229495|NCT01576718|756654|P5|Treatment Period|Met stopping criteria|16
229496|NCT01576718|756655|P4|Treatment Period|Met stopping criteria|19
229497|NCT01576718|756656|P3|Treatment Period|Met stopping criteria|13
229498|NCT01576718|756657|P2|Treatment Period|Met stopping criteria|16
229499|NCT01576718|756658|P1|Treatment Period|Met stopping criteria|0
229500|NCT01576718|756652|P7|Treatment Period|Sponsor request|0
229501|NCT01576718|756653|P6|Treatment Period|Sponsor request|1
229502|NCT01576718|756654|P5|Treatment Period|Sponsor request|0
229503|NCT01576718|756655|P4|Treatment Period|Sponsor request|0
229504|NCT01576718|756656|P3|Treatment Period|Sponsor request|0
229505|NCT01576718|756657|P2|Treatment Period|Sponsor request|1
229506|NCT01576718|756658|P1|Treatment Period|Sponsor request|0
229507|NCT01576718|756652|P7|Treatment Period|Protocol Violation|12
229508|NCT01576718|756653|P6|Treatment Period|Protocol Violation|8
229509|NCT01576718|756654|P5|Treatment Period|Protocol Violation|6
229510|NCT01576718|756655|P4|Treatment Period|Protocol Violation|10
229511|NCT01576718|756656|P3|Treatment Period|Protocol Violation|4
229512|NCT01576718|756657|P2|Treatment Period|Protocol Violation|5
229513|NCT01576718|756658|P1|Treatment Period|Protocol Violation|0
229514|NCT01576718|756652|P7|Treatment Period|Physician Decision|0
229515|NCT01576718|756653|P6|Treatment Period|Physician Decision|0
229516|NCT01576718|756654|P5|Treatment Period|Physician Decision|1
229517|NCT01576718|756655|P4|Treatment Period|Physician Decision|1
229518|NCT01576718|756656|P3|Treatment Period|Physician Decision|1
229519|NCT01576718|756657|P2|Treatment Period|Physician Decision|1
229520|NCT01576718|756658|P1|Treatment Period|Physician Decision|0
229521|NCT01576718|756652|P7|Treatment Period|Withdrawal by Subject|2
229522|NCT01576718|756653|P6|Treatment Period|Withdrawal by Subject|4
229523|NCT01576718|756654|P5|Treatment Period|Withdrawal by Subject|2
229524|NCT01576718|756655|P4|Treatment Period|Withdrawal by Subject|0
229525|NCT01576718|756656|P3|Treatment Period|Withdrawal by Subject|1
229526|NCT01576718|756657|P2|Treatment Period|Withdrawal by Subject|1
229527|NCT01576718|756658|P1|Treatment Period|Withdrawal by Subject|0
229528|NCT01576718|756652|P7|Treatment Period|Adverse Event|0
229529|NCT01576718|756653|P6|Treatment Period|Adverse Event|1
229530|NCT01576718|756654|P5|Treatment Period|Adverse Event|1
229531|NCT01576718|756655|P4|Treatment Period|Adverse Event|1
229532|NCT01576718|756656|P3|Treatment Period|Adverse Event|1
229533|NCT01576718|756657|P2|Treatment Period|Adverse Event|1
229534|NCT01576718|756658|P1|Treatment Period|Adverse Event|0
229535|NCT01576718|756652|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
229536|NCT01576718|756653|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
229537|NCT01576718|756654|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
229538|NCT01576718|756655|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
229539|NCT01576718|756656|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
229540|NCT01576718|756657|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
229541|NCT01576718|756658|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
229542|NCT01576718|756652|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
229543|NCT01576718|756653|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
229544|NCT01576718|756654|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
229545|NCT01576718|756655|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
229546|NCT01576718|756656|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
229547|NCT01576718|756657|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
229548|NCT01576718|756658|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
229549|NCT01576718|756652|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
229550|NCT01576718|756653|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
229551|NCT01576718|756654|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
229552|NCT01576718|756655|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
229553|NCT01576718|756656|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
229554|NCT01576718|756657|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
229555|NCT01576718|756658|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
229556|NCT01576718|756652|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
229557|NCT01576718|756653|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
229558|NCT01576718|756654|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
229559|NCT01576718|756655|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
229560|NCT01576718|756656|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
229561|NCT01576718|756657|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
229562|NCT01576718|756658|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
229563|NCT01576718|756652|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
229564|NCT01576718|756653|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
229565|NCT01576718|756654|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
229566|NCT01576718|756655|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
229567|NCT01576718|756656|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
229568|NCT01576718|756657|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
229569|NCT01576718|756658|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
229570|NCT01576367|756750|P1|Overall Study|Moved to commercial use after 6 months|1
229571|NCT01576367|756750|P1|Overall Study|Unsatisfactory therapeutic effect|2
229572|NCT01576159|756762|P4|Overall Study|Protocol Violation|0
229573|NCT01576159|756763|P3|Overall Study|Protocol Violation|0
229574|NCT01576159|756764|P2|Overall Study|Protocol Violation|0
229575|NCT01576159|756765|P1|Overall Study|Protocol Violation|1
229576|NCT01576159|756762|P4|Overall Study|Lost to Follow-up|1
229577|NCT01576159|756763|P3|Overall Study|Lost to Follow-up|0
229578|NCT01576159|756764|P2|Overall Study|Lost to Follow-up|0
229579|NCT01576159|756765|P1|Overall Study|Lost to Follow-up|0
229580|NCT01576159|756762|P4|Overall Study|Physician Decision|0
229581|NCT01576159|756763|P3|Overall Study|Physician Decision|1
229582|NCT01576159|756764|P2|Overall Study|Physician Decision|0
229583|NCT01576159|756765|P1|Overall Study|Physician Decision|0
229584|NCT01576159|756762|P4|Overall Study|Withdrawal by Subject|0
229585|NCT01576159|756763|P3|Overall Study|Withdrawal by Subject|0
229586|NCT01576159|756764|P2|Overall Study|Withdrawal by Subject|1
229587|NCT01576159|756765|P1|Overall Study|Withdrawal by Subject|0
229588|NCT01576146|756783|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
229589|NCT01576146|756783|P1|Extension Period 2|Renal Transplant|1
229590|NCT01576146|756783|P1|Extension Period 2|Adverse Event|1
229591|NCT01576146|756783|P1|Extension Period 2|Death|1
229592|NCT01576146|756783|P1|Extension Period 2|Sponsor Decision|13
229593|NCT01576146|756783|P1|Extension Period 1|Renal Transplant|1
229594|NCT01576146|756783|P1|Extension Period 1|Parathyroidectomy|1
229595|NCT01576146|756783|P1|Extension Period 1|Lost to Follow-up|1
229596|NCT01576146|756783|P1|Extension Period 1|Withdrawal by Subject|1
229597|NCT01576146|756783|P1|Extension Period 1|Physician Decision|2
229598|NCT01576146|756783|P1|Extension Period 1|Death|2
229599|NCT01576146|756783|P1|Extension Period 1|Adverse Event|2
229600|NCT01576042|756816|P2|Overall Study|Physician Decision|0
229601|NCT01576042|756817|P1|Overall Study|Physician Decision|2
229602|NCT01575899|756853|P3|Overall Study|Protocol Violation|0
229603|NCT01575899|756854|P2|Overall Study|Protocol Violation|1
229604|NCT01575899|756855|P1|Overall Study|Protocol Violation|2
229605|NCT01575899|756853|P3|Overall Study|Lost to Follow-up|2
229606|NCT01575899|756854|P2|Overall Study|Lost to Follow-up|4
229607|NCT01575899|756855|P1|Overall Study|Lost to Follow-up|3
229608|NCT01575769|756865|P1|Overall Study|Study terminated by sponsor|40
229609|NCT01575769|756865|P1|Overall Study|Adverse Event|1
229610|NCT01575561|756908|P1|Overall Study|administration|1
229611|NCT01575561|756908|P1|Overall Study|Withdrawal by Subject|11
229612|NCT01575561|756908|P1|Overall Study|Protocol Violation|4
229613|NCT01575561|756908|P1|Overall Study|Lost to Follow-up|6
229614|NCT01575561|756908|P1|Overall Study|Lack of Efficacy|8
229615|NCT01575561|756908|P1|Overall Study|Adverse Event|9
229616|NCT01575197|756931|P3|Overall Study|Protocol Violation|1
229617|NCT01575197|756932|P2|Overall Study|Protocol Violation|1
229618|NCT01575197|756933|P1|Overall Study|Protocol Violation|2
229619|NCT01575197|756931|P3|Overall Study|Withdrawal by Subject|1
229620|NCT01575197|756932|P2|Overall Study|Withdrawal by Subject|1
229621|NCT01575197|756933|P1|Overall Study|Withdrawal by Subject|0
229622|NCT01575197|756931|P3|Overall Study|Lost to Follow-up|0
229623|NCT01575197|756932|P2|Overall Study|Lost to Follow-up|1
229624|NCT01575197|756933|P1|Overall Study|Lost to Follow-up|0
229625|NCT01575197|756931|P3|Overall Study|SAE|0
229626|NCT01575197|756932|P2|Overall Study|SAE|1
229627|NCT01575197|756933|P1|Overall Study|SAE|0
229628|NCT01575197|756931|P3|Overall Study|Migration out of study area|4
229629|NCT01575197|756932|P2|Overall Study|Migration out of study area|5
229630|NCT01575197|756933|P1|Overall Study|Migration out of study area|1
229631|NCT01575054|756955|P2|Overall Study|Adverse Event|8
229632|NCT01575054|756956|P1|Overall Study|Adverse Event|9
229633|NCT01575054|756955|P2|Overall Study|Lost to Follow-up|3
229634|NCT01575054|756956|P1|Overall Study|Lost to Follow-up|3
229635|NCT01575054|756955|P2|Overall Study|Personal Reasons|11
229636|NCT01575054|756956|P1|Overall Study|Personal Reasons|10
229637|NCT01575054|756955|P2|Overall Study|Protocol Violation|1
229638|NCT01575054|756956|P1|Overall Study|Protocol Violation|2
229639|NCT01575054|756955|P2|Overall Study|Other Reasons|3
229640|NCT01575054|756956|P1|Overall Study|Other Reasons|5
229641|NCT01575028|756972|P2|Overall Study|Physician Decision|1
229642|NCT01575028|756973|P1|Overall Study|Physician Decision|0
229643|NCT01574703|756983|P4|Overall Study|Death|0
229644|NCT01574703|756984|P3|Overall Study|Death|1
229645|NCT01574703|756985|P2|Overall Study|Death|1
229646|NCT01574703|756986|P1|Overall Study|Death|2
229647|NCT01574703|756983|P4|Overall Study|Lost to Follow-up|35
229648|NCT01574703|756984|P3|Overall Study|Lost to Follow-up|46
229649|NCT01574703|756985|P2|Overall Study|Lost to Follow-up|41
229650|NCT01574703|756986|P1|Overall Study|Lost to Follow-up|43
229651|NCT01574703|756983|P4|Overall Study|Met Withdrawal Criteria|0
229652|NCT01574703|756984|P3|Overall Study|Met Withdrawal Criteria|1
229653|NCT01574703|756985|P2|Overall Study|Met Withdrawal Criteria|1
229654|NCT01574703|756986|P1|Overall Study|Met Withdrawal Criteria|0
229655|NCT01574703|756983|P4|Overall Study|Withdrawal by Subject|61
229656|NCT01574703|756984|P3|Overall Study|Withdrawal by Subject|36
229657|NCT01574703|756985|P2|Overall Study|Withdrawal by Subject|52
229658|NCT01574703|756986|P1|Overall Study|Withdrawal by Subject|53
229659|NCT01574703|756983|P4|Overall Study|Unspecified Reason|16
229660|NCT01574703|756984|P3|Overall Study|Unspecified Reason|20
229661|NCT01574703|756985|P2|Overall Study|Unspecified Reason|15
229662|NCT01574703|756986|P1|Overall Study|Unspecified Reason|27
229663|NCT01574703|756983|P4|Overall Study|Protocol Violation|1
229664|NCT01574703|756984|P3|Overall Study|Protocol Violation|0
229665|NCT01574703|756985|P2|Overall Study|Protocol Violation|0
229666|NCT01574703|756986|P1|Overall Study|Protocol Violation|0
229667|NCT01574703|756983|P4|Overall Study|Adverse Event|1
229668|NCT01574703|756984|P3|Overall Study|Adverse Event|1
229669|NCT01574703|756985|P2|Overall Study|Adverse Event|2
229670|NCT01574703|756986|P1|Overall Study|Adverse Event|0
229671|NCT01574651|757030|P2|Overall Study|Withdrawal by Subject|10
229672|NCT01574651|757031|P1|Overall Study|Withdrawal by Subject|9
229673|NCT01574651|757030|P2|Overall Study|Protocol Violation|5
229674|NCT01574651|757031|P1|Overall Study|Protocol Violation|3
229675|NCT01574651|757030|P2|Overall Study|Unsatisfactory therapeutic effect|0
229676|NCT01574651|757031|P1|Overall Study|Unsatisfactory therapeutic effect|6
229677|NCT01574651|757030|P2|Overall Study|Abnormal test procedure result(s)|1
229678|NCT01574651|757031|P1|Overall Study|Abnormal test procedure result(s)|1
229679|NCT01574651|757030|P2|Overall Study|Abnormal laboratory value(s)|0
229680|NCT01574651|757031|P1|Overall Study|Abnormal laboratory value(s)|1
229681|NCT01574651|757030|P2|Overall Study|Adverse Event|27
229682|NCT01574651|757031|P1|Overall Study|Adverse Event|36
229683|NCT01574651|757030|P2|Overall Study|Patient's inability to use the device|1
229684|NCT01574651|757031|P1|Overall Study|Patient's inability to use the device|0
229685|NCT01574651|757030|P2|Overall Study|Death|3
229686|NCT01574651|757031|P1|Overall Study|Death|3
229687|NCT01574651|757030|P2|Overall Study|Administrative problems|1
229688|NCT01574651|757031|P1|Overall Study|Administrative problems|0
229689|NCT01574651|757030|P2|Overall Study|Lost to Follow-up|4
229690|NCT01574651|757031|P1|Overall Study|Lost to Follow-up|2
229691|NCT01574612|757053|P1|Overall Study|Lost to Follow-up|2
229692|NCT01574612|757053|P1|Overall Study|Withdrawal by Subject|1
229693|NCT01574612|757053|P1|Overall Study|non compliant with drug|2
229694|NCT01574612|757053|P1|Overall Study|Adverse Event|3
229695|NCT01574326|757059|P2|Overall Study|Other: Mainly kidney transplant|8
229696|NCT01574326|757060|P1|Overall Study|Other: Mainly kidney transplant|8
229697|NCT01574326|757059|P2|Overall Study|Adverse Event|3
229698|NCT01574326|757060|P1|Overall Study|Adverse Event|1
229699|NCT01574326|757059|P2|Overall Study|Physician Decision|3
229700|NCT01574326|757060|P1|Overall Study|Physician Decision|5
229701|NCT01574326|757059|P2|Overall Study|Withdrawal by Participant|4
229702|NCT01574326|757060|P1|Overall Study|Withdrawal by Participant|2
229703|NCT01574326|757059|P2|Overall Study|Randomized but not treated|1
229704|NCT01574326|757060|P1|Overall Study|Randomized but not treated|0
229705|NCT01574248|757073|P2|Overall Study|Missing primary endpoint data|0
229706|NCT01574248|757074|P1|Overall Study|Missing primary endpoint data|1
229707|NCT01574248|757073|P2|Overall Study|Withdrawal by Subject|0
229708|NCT01574248|757074|P1|Overall Study|Withdrawal by Subject|2
229709|NCT01574079|757118|P2|Overall Study|Lost to Follow-up|0
229710|NCT01574079|757119|P1|Overall Study|Lost to Follow-up|1
229711|NCT01574079|757118|P2|Overall Study|Physician Decision|2
229712|NCT01574079|757119|P1|Overall Study|Physician Decision|0
229713|NCT01573910|757131|P2|Overall Study|Patient decision unrelated to Advs Event|11
229714|NCT01573910|757132|P1|Overall Study|Patient decision unrelated to Advs Event|11
229715|NCT01573910|757131|P2|Overall Study|Protocol Violation|0
229716|NCT01573910|757132|P1|Overall Study|Protocol Violation|3
229717|NCT01573910|757131|P2|Overall Study|Withdrawal by Subject|1
229718|NCT01573910|757132|P1|Overall Study|Withdrawal by Subject|0
229719|NCT01573910|757131|P2|Overall Study|Lost to Follow-up|1
229720|NCT01573910|757132|P1|Overall Study|Lost to Follow-up|2
229721|NCT01573910|757131|P2|Overall Study|Adverse Event|4
229722|NCT01573910|757132|P1|Overall Study|Adverse Event|4
229723|NCT01573767|757144|P4|Overall Study|Withdrawal by Subject|0
229724|NCT01573767|757145|P3|Overall Study|Withdrawal by Subject|0
229725|NCT01573767|757146|P2|Overall Study|Withdrawal by Subject|1
229726|NCT01573767|757147|P1|Overall Study|Withdrawal by Subject|0
229727|NCT01573767|757144|P4|Overall Study|Physician Decision|2
229728|NCT01573767|757145|P3|Overall Study|Physician Decision|0
229729|NCT01573767|757146|P2|Overall Study|Physician Decision|2
229730|NCT01573767|757147|P1|Overall Study|Physician Decision|1
229731|NCT01573767|757144|P4|Overall Study|Lost to Follow-up|1
229732|NCT01573767|757145|P3|Overall Study|Lost to Follow-up|1
229733|NCT01573767|757146|P2|Overall Study|Lost to Follow-up|1
229734|NCT01573767|757147|P1|Overall Study|Lost to Follow-up|0
229735|NCT01573767|757144|P4|Overall Study|Protocol Violation|3
229736|NCT01573767|757145|P3|Overall Study|Protocol Violation|1
229737|NCT01573767|757146|P2|Overall Study|Protocol Violation|1
229738|NCT01573767|757147|P1|Overall Study|Protocol Violation|3
229739|NCT01573767|757144|P4|Overall Study|Lack of Efficacy|17
229740|NCT01573767|757145|P3|Overall Study|Lack of Efficacy|12
229741|NCT01573767|757146|P2|Overall Study|Lack of Efficacy|15
229742|NCT01573767|757147|P1|Overall Study|Lack of Efficacy|18
229743|NCT01573767|757144|P4|Overall Study|Adverse Event|1
229744|NCT01573767|757145|P3|Overall Study|Adverse Event|0
229745|NCT01573767|757146|P2|Overall Study|Adverse Event|1
229746|NCT01573767|757147|P1|Overall Study|Adverse Event|0
229747|NCT01573000|757223|P2|Long-Term Follow-Up|Lost to Follow-up|1
229748|NCT01573000|757224|P1|Long-Term Follow-Up|Lost to Follow-up|0
229749|NCT01573000|757223|P2|Long-Term Follow-Up|Death|0
229750|NCT01573000|757224|P1|Long-Term Follow-Up|Death|3
229751|NCT01573000|757223|P2|Crossover Phase|Death|3
229752|NCT01573000|757224|P1|Crossover Phase|Death|0
229753|NCT01573000|757223|P2|Crossover Phase|Lost to Follow-up|2
229754|NCT01573000|757224|P1|Crossover Phase|Lost to Follow-up|0
229755|NCT01573000|757223|P2|Crossover Phase|Lack of Efficacy|13
229756|NCT01573000|757224|P1|Crossover Phase|Lack of Efficacy|0
229757|NCT01573000|757223|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
229758|NCT01573000|757224|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
229759|NCT01573000|757223|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
229760|NCT01573000|757224|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
229761|NCT01573000|757223|P2|Dosimetric and Therapeutic Treatment|Death|1
229762|NCT01573000|757224|P1|Dosimetric and Therapeutic Treatment|Death|0
229763|NCT01573000|757223|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
229764|NCT01573000|757224|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
229765|NCT01573000|757223|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
229766|NCT01573000|757224|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
229767|NCT01572948|757320|P2|Overall Study|unable to contact|1
229768|NCT01572948|757321|P1|Overall Study|unable to contact|0
229769|NCT01572948|757320|P2|Overall Study|Lost to Follow-up|0
229770|NCT01572948|757321|P1|Overall Study|Lost to Follow-up|1
229771|NCT01572792|757342|P5|Extension Study|Site termination/COPD exacerbation/other|6
229772|NCT01572792|757343|P4|Extension Study|Site termination/COPD exacerbation/other|6
229773|NCT01572792|757344|P3|Extension Study|Site termination/COPD exacerbation/other|4
229774|NCT01572792|757345|P2|Extension Study|Site termination/COPD exacerbation/other|8
229775|NCT01572792|757346|P1|Extension Study|Site termination/COPD exacerbation/other|3
229776|NCT01572792|757342|P5|Extension Study|Adverse Event|4
229777|NCT01572792|757343|P4|Extension Study|Adverse Event|6
229778|NCT01572792|757344|P3|Extension Study|Adverse Event|5
229779|NCT01572792|757345|P2|Extension Study|Adverse Event|6
229780|NCT01572792|757346|P1|Extension Study|Adverse Event|7
229781|NCT01572792|757342|P5|Extension Study|Lack of Efficacy|2
229782|NCT01572792|757343|P4|Extension Study|Lack of Efficacy|2
229783|NCT01572792|757344|P3|Extension Study|Lack of Efficacy|3
229784|NCT01572792|757345|P2|Extension Study|Lack of Efficacy|3
229785|NCT01572792|757346|P1|Extension Study|Lack of Efficacy|2
229786|NCT01572792|757342|P5|Extension Study|Protocol Violation|3
229787|NCT01572792|757343|P4|Extension Study|Protocol Violation|4
229788|NCT01572792|757344|P3|Extension Study|Protocol Violation|3
229789|NCT01572792|757345|P2|Extension Study|Protocol Violation|4
229790|NCT01572792|757346|P1|Extension Study|Protocol Violation|0
229791|NCT01572792|757342|P5|Extension Study|Withdrawal by Subject|14
229792|NCT01572792|757343|P4|Extension Study|Withdrawal by Subject|8
229793|NCT01572792|757344|P3|Extension Study|Withdrawal by Subject|11
229794|NCT01572792|757345|P2|Extension Study|Withdrawal by Subject|6
229795|NCT01572792|757346|P1|Extension Study|Withdrawal by Subject|7
229796|NCT01572792|757342|P5|Extension Study|Lost to Follow-up|3
229797|NCT01572792|757343|P4|Extension Study|Lost to Follow-up|3
229798|NCT01572792|757344|P3|Extension Study|Lost to Follow-up|0
229799|NCT01572792|757345|P2|Extension Study|Lost to Follow-up|2
229800|NCT01572792|757346|P1|Extension Study|Lost to Follow-up|6
229801|NCT01572792|757342|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
229802|NCT01572792|757343|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
229803|NCT01572792|757344|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
229804|NCT01572792|757345|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
229805|NCT01572792|757346|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
229806|NCT01572792|757342|P5|Lead-in Study|Adverse Event|14
229807|NCT01572792|757343|P4|Lead-in Study|Adverse Event|16
229808|NCT01572792|757344|P3|Lead-in Study|Adverse Event|22
229809|NCT01572792|757345|P2|Lead-in Study|Adverse Event|21
229810|NCT01572792|757346|P1|Lead-in Study|Adverse Event|21
229811|NCT01572792|757342|P5|Lead-in Study|Lack of Efficacy|10
229812|NCT01572792|757343|P4|Lead-in Study|Lack of Efficacy|8
229813|NCT01572792|757344|P3|Lead-in Study|Lack of Efficacy|4
229814|NCT01572792|757345|P2|Lead-in Study|Lack of Efficacy|5
229815|NCT01572792|757346|P1|Lead-in Study|Lack of Efficacy|20
229816|NCT01572792|757342|P5|Lead-in Study|Protocol Violation|21
229817|NCT01572792|757343|P4|Lead-in Study|Protocol Violation|13
229818|NCT01572792|757344|P3|Lead-in Study|Protocol Violation|12
229819|NCT01572792|757345|P2|Lead-in Study|Protocol Violation|10
229820|NCT01572792|757346|P1|Lead-in Study|Protocol Violation|19
229821|NCT01572792|757342|P5|Lead-in Study|Withdrawal by Subject|11
229822|NCT01572792|757343|P4|Lead-in Study|Withdrawal by Subject|24
229823|NCT01572792|757344|P3|Lead-in Study|Withdrawal by Subject|12
229824|NCT01572792|757345|P2|Lead-in Study|Withdrawal by Subject|11
229825|NCT01572792|757346|P1|Lead-in Study|Withdrawal by Subject|22
229826|NCT01572792|757342|P5|Lead-in Study|Lost to Follow-up|4
229827|NCT01572792|757343|P4|Lead-in Study|Lost to Follow-up|2
229828|NCT01572792|757344|P3|Lead-in Study|Lost to Follow-up|4
229829|NCT01572792|757345|P2|Lead-in Study|Lost to Follow-up|9
229830|NCT01572792|757346|P1|Lead-in Study|Lost to Follow-up|5
229831|NCT01572740|757395|P2|Overall Study|unclassified|3
229832|NCT01572740|757396|P1|Overall Study|unclassified|4
229833|NCT01572740|757395|P2|Overall Study|Withdrawal by Subject|1
229834|NCT01572740|757396|P1|Overall Study|Withdrawal by Subject|1
229835|NCT01572740|757395|P2|Overall Study|Adverse Event|1
229836|NCT01572740|757396|P1|Overall Study|Adverse Event|1
229837|NCT01572727|757426|P2|Overall Study|Untreated|7
229838|NCT01572727|757427|P1|Overall Study|Untreated|4
229839|NCT01572727|757426|P2|Overall Study|Death|2
229840|NCT01572727|757427|P1|Overall Study|Death|2
229841|NCT01572727|757426|P2|Overall Study|Parent/guardian decision|9
229842|NCT01572727|757427|P1|Overall Study|Parent/guardian decision|14
229843|NCT01572727|757426|P2|Overall Study|Study terminated by sponsor|83
229844|NCT01572727|757427|P1|Overall Study|Study terminated by sponsor|61
229845|NCT01572727|757426|P2|Overall Study|Protocol Violation|1
229846|NCT01572727|757427|P1|Overall Study|Protocol Violation|0
229847|NCT01572727|757426|P2|Overall Study|Progressive disease|82
229848|NCT01572727|757427|P1|Overall Study|Progressive disease|59
229849|NCT01572727|757426|P2|Overall Study|Physician Decision|9
229850|NCT01572727|757427|P1|Overall Study|Physician Decision|23
229851|NCT01572727|757426|P2|Overall Study|Lost to Follow-up|1
229852|NCT01572727|757427|P1|Overall Study|Lost to Follow-up|1
229853|NCT01572727|757426|P2|Overall Study|Adverse Event|15
229854|NCT01572727|757427|P1|Overall Study|Adverse Event|43
229855|NCT01572675|757449|P2|Overall Study|Lost to Follow-up|27
229856|NCT01572675|757450|P1|Overall Study|Lost to Follow-up|22
229857|NCT01572675|757449|P2|Overall Study|Missing data|4
229858|NCT01572675|757450|P1|Overall Study|Missing data|1
229859|NCT01572675|757449|P2|Overall Study|Rheumatologist new evaluation|1
229860|NCT01572675|757450|P1|Overall Study|Rheumatologist new evaluation|0
229861|NCT01572675|757449|P2|Overall Study|Unknown reason|1
229862|NCT01572675|757450|P1|Overall Study|Unknown reason|1
229863|NCT01572675|757449|P2|Overall Study|Other disease detected|1
229864|NCT01572675|757450|P1|Overall Study|Other disease detected|1
229865|NCT01572675|757449|P2|Overall Study|Death unrelated to coxibs|1
229866|NCT01572675|757450|P1|Overall Study|Death unrelated to coxibs|1
229867|NCT01572675|757449|P2|Overall Study|Physician Decision|2
229868|NCT01572675|757450|P1|Overall Study|Physician Decision|2
229869|NCT01572675|757449|P2|Overall Study|Withdrawal by Subject|1
229870|NCT01572675|757450|P1|Overall Study|Withdrawal by Subject|5
229871|NCT01572675|757449|P2|Overall Study|Surgical intervention|6
229872|NCT01572675|757450|P1|Overall Study|Surgical intervention|3
229873|NCT01572675|757449|P2|Overall Study|Improved symptoms|2
229874|NCT01572675|757450|P1|Overall Study|Improved symptoms|8
229875|NCT01572675|757449|P2|Overall Study|Intolerance|5
229876|NCT01572675|757450|P1|Overall Study|Intolerance|6
229877|NCT01572675|757449|P2|Overall Study|Lack of Efficacy|31
229878|NCT01572675|757450|P1|Overall Study|Lack of Efficacy|31
229879|NCT01572675|757449|P2|Overall Study|Recovery|23
229880|NCT01572675|757450|P1|Overall Study|Recovery|16
229881|NCT01572675|757449|P2|Overall Study|End of prescribed treatment|118
229882|NCT01572675|757450|P1|Overall Study|End of prescribed treatment|140
229883|NCT01572480|757547|P1|Overall Study|Alt. therapy required|1
229884|NCT01571453|757587|P2|Overall Study|Administrative or other reason(s)|3
229885|NCT01571453|757588|P1|Overall Study|Administrative or other reason(s)|4
229886|NCT01571453|757587|P2|Overall Study|Lost to Follow-up|2
229887|NCT01571453|757588|P1|Overall Study|Lost to Follow-up|4
229888|NCT01571453|757587|P2|Overall Study|Withdrawal of consent|13
229889|NCT01571453|757588|P1|Overall Study|Withdrawal of consent|5
229890|NCT01571453|757587|P2|Overall Study|Protocol Violation|5
229891|NCT01571453|757588|P1|Overall Study|Protocol Violation|1
229892|NCT01571453|757587|P2|Overall Study|Non-compliance|4
229893|NCT01571453|757588|P1|Overall Study|Non-compliance|2
229894|NCT01571453|757587|P2|Overall Study|Lack of Efficacy|3
229895|NCT01571453|757588|P1|Overall Study|Lack of Efficacy|8
229896|NCT01571453|757587|P2|Overall Study|Adverse Event|32
229897|NCT01571453|757588|P1|Overall Study|Adverse Event|14
229898|NCT01571362|757604|P3|Double-Blind Treatment Period|Other - unspecified|1
229899|NCT01571362|757605|P2|Double-Blind Treatment Period|Other - unspecified|6
229900|NCT01571362|757606|P1|Double-Blind Treatment Period|Other - unspecified|0
229901|NCT01571362|757604|P3|Double-Blind Treatment Period|Insufficient clinical response|4
229902|NCT01571362|757605|P2|Double-Blind Treatment Period|Insufficient clinical response|16
229903|NCT01571362|757606|P1|Double-Blind Treatment Period|Insufficient clinical response|0
229904|NCT01571362|757604|P3|Double-Blind Treatment Period|Lost to Follow-up|6
229905|NCT01571362|757605|P2|Double-Blind Treatment Period|Lost to Follow-up|3
229906|NCT01571362|757606|P1|Double-Blind Treatment Period|Lost to Follow-up|0
229907|NCT01571362|757604|P3|Double-Blind Treatment Period|Adverse Event|14
229908|NCT01571362|757605|P2|Double-Blind Treatment Period|Adverse Event|9
229909|NCT01571362|757606|P1|Double-Blind Treatment Period|Adverse Event|0
229910|NCT01571362|757604|P3|Double-Blind Treatment Period|Protocol Violation|9
229911|NCT01571362|757605|P2|Double-Blind Treatment Period|Protocol Violation|8
229912|NCT01571362|757606|P1|Double-Blind Treatment Period|Protocol Violation|0
229913|NCT01571362|757604|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
229914|NCT01571362|757605|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
229915|NCT01571362|757606|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
229916|NCT01571362|757604|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
229917|NCT01571362|757605|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
229918|NCT01571362|757606|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
229919|NCT01571362|757604|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
229920|NCT01571362|757605|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
229921|NCT01571362|757606|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
229922|NCT01571362|757604|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
229923|NCT01571362|757605|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
230092|NCT01568112|758388|P2|Overall Study|Lost to Follow-up|0
229924|NCT01571362|757606|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
229925|NCT01571362|757604|P3|Open-Label Conversion + Titration Period|Adverse Event|0
229926|NCT01571362|757605|P2|Open-Label Conversion + Titration Period|Adverse Event|0
229927|NCT01571362|757606|P1|Open-Label Conversion + Titration Period|Adverse Event|57
229928|NCT01571362|757604|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
229929|NCT01571362|757605|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
229930|NCT01571362|757606|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
229931|NCT01571362|757604|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
229932|NCT01571362|757605|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
229933|NCT01571362|757606|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
229934|NCT01571232|757778|P2|Overall Study|Withdrawal by Subject|0
229935|NCT01571232|757779|P1|Overall Study|Withdrawal by Subject|1
229936|NCT01571232|757778|P2|Overall Study|Lost to Follow-up|1
229937|NCT01571232|757779|P1|Overall Study|Lost to Follow-up|0
229938|NCT01570751|757791|P2|Period B (16 Weeks)|Protocol Violation|1
229939|NCT01570751|757792|P1|Period B (16 Weeks)|Protocol Violation|0
229940|NCT01570751|757791|P2|Period B (16 Weeks)|Adverse Event|0
229941|NCT01570751|757792|P1|Period B (16 Weeks)|Adverse Event|1
229942|NCT01570751|757791|P2|Period A (16 Weeks)|Unclassified|3
229943|NCT01570751|757792|P1|Period A (16 Weeks)|Unclassified|2
229944|NCT01570751|757791|P2|Period A (16 Weeks)|Withdrawal criteria|1
229945|NCT01570751|757792|P1|Period A (16 Weeks)|Withdrawal criteria|0
229946|NCT01570751|757791|P2|Period A (16 Weeks)|Protocol Violation|1
229947|NCT01570751|757792|P1|Period A (16 Weeks)|Protocol Violation|1
229948|NCT01570686|757810|P2|Overall Study|Unsatisfactory therapeutic effect|1
229949|NCT01570686|757811|P1|Overall Study|Unsatisfactory therapeutic effect|2
229950|NCT01570686|757810|P2|Overall Study|Withdrawal by Subject|4
229951|NCT01570686|757811|P1|Overall Study|Withdrawal by Subject|4
229952|NCT01570686|757810|P2|Overall Study|Protocol Deviation|0
229953|NCT01570686|757811|P1|Overall Study|Protocol Deviation|3
229954|NCT01570686|757810|P2|Overall Study|Lost to Follow-up|3
229955|NCT01570686|757811|P1|Overall Study|Lost to Follow-up|4
229956|NCT01570686|757810|P2|Overall Study|Adverse Event|6
229957|NCT01570686|757811|P1|Overall Study|Adverse Event|8
229958|NCT01570686|757810|P2|Overall Study|Administrative problems|1
229959|NCT01570686|757811|P1|Overall Study|Administrative problems|0
229960|NCT01570686|757810|P2|Overall Study|Abnormal test procedure result(s)|1
229961|NCT01570686|757811|P1|Overall Study|Abnormal test procedure result(s)|1
229962|NCT01570309|757847|P2|Overall Study|Withdrawal by Subject|3
229963|NCT01570309|757848|P1|Overall Study|Withdrawal by Subject|3
229964|NCT01570244|757862|P1|Microgynon+Faldaprevir|Adverse Event|1
229965|NCT01570192|757884|P2|Overall Study|Physician Decision|1
229966|NCT01570192|757885|P1|Overall Study|Physician Decision|0
229967|NCT01570192|757884|P2|Overall Study|changed to palliative care|0
229968|NCT01570192|757885|P1|Overall Study|changed to palliative care|1
229969|NCT01570192|757884|P2|Overall Study|no qualifying organism|12
229970|NCT01570192|757885|P1|Overall Study|no qualifying organism|6
229971|NCT01569841|757891|P2|Period A (6 Weeks)|Withdrawal by Subject|1
229972|NCT01569841|757892|P1|Period A (6 Weeks)|Withdrawal by Subject|0
229973|NCT01569763|757981|P2|Overall Study|Adverse Event|0
229974|NCT01569763|757982|P1|Overall Study|Adverse Event|1
229975|NCT01569763|757981|P2|Overall Study|Lack of Efficacy|7
229976|NCT01569763|757982|P1|Overall Study|Lack of Efficacy|2
229977|NCT01569568|757994|P2|Overall Study|Physician Decision|2
229978|NCT01569568|757995|P1|Overall Study|Physician Decision|0
229979|NCT01569464|758018|P2|Overall Study|Other|1
229980|NCT01569464|758019|P1|Overall Study|Other|1
229981|NCT01569464|758018|P2|Overall Study|Withdrawal by Subject|1
229982|NCT01569464|758019|P1|Overall Study|Withdrawal by Subject|1
229983|NCT01569464|758018|P2|Overall Study|Lost to Follow-up|3
229984|NCT01569464|758019|P1|Overall Study|Lost to Follow-up|2
229985|NCT01569464|758018|P2|Overall Study|Protocol Violation|0
229986|NCT01569464|758019|P1|Overall Study|Protocol Violation|1
229987|NCT01569464|758018|P2|Overall Study|Lack of Efficacy|0
229988|NCT01569464|758019|P1|Overall Study|Lack of Efficacy|1
229989|NCT01569464|758018|P2|Overall Study|Adverse Event|0
229990|NCT01569464|758019|P1|Overall Study|Adverse Event|4
229991|NCT01569438|758057|P2|Overall Study|Protocol Violation|0
229992|NCT01569438|758058|P1|Overall Study|Protocol Violation|1
229993|NCT01569438|758057|P2|Overall Study|Withdrawal by Subject|1
229994|NCT01569438|758058|P1|Overall Study|Withdrawal by Subject|0
229995|NCT01569438|758057|P2|Overall Study|Lack of Efficacy|1
229996|NCT01569438|758058|P1|Overall Study|Lack of Efficacy|1
229997|NCT01569438|758057|P2|Overall Study|Adverse Event|7
229998|NCT01569438|758058|P1|Overall Study|Adverse Event|0
229999|NCT01569152|758072|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
230000|NCT01569152|758073|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
230001|NCT01569152|758074|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
230002|NCT01569152|758072|P3|Safety Extension, Period 3|Physician Decision|2
230003|NCT01569152|758073|P2|Safety Extension, Period 3|Physician Decision|0
230004|NCT01569152|758074|P1|Safety Extension, Period 3|Physician Decision|0
230005|NCT01569152|758072|P3|Safety Extension, Period 3|Withdrawal by Subject|2
230006|NCT01569152|758073|P2|Safety Extension, Period 3|Withdrawal by Subject|0
230007|NCT01569152|758074|P1|Safety Extension, Period 3|Withdrawal by Subject|0
230008|NCT01569152|758072|P3|Safety Extension, Period 3|Adverse Event|4
230009|NCT01569152|758073|P2|Safety Extension, Period 3|Adverse Event|0
230010|NCT01569152|758074|P1|Safety Extension, Period 3|Adverse Event|0
230011|NCT01569152|758072|P3|Phase IIa, Period 1|Withdrawal by Subject|0
230012|NCT01569152|758073|P2|Phase IIa, Period 1|Withdrawal by Subject|1
230013|NCT01569152|758074|P1|Phase IIa, Period 1|Withdrawal by Subject|2
230014|NCT01569152|758072|P3|Phase IIa, Period 1|Protocol Violation|0
230015|NCT01569152|758073|P2|Phase IIa, Period 1|Protocol Violation|1
230016|NCT01569152|758074|P1|Phase IIa, Period 1|Protocol Violation|0
230017|NCT01569152|758072|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
230018|NCT01569152|758073|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
230019|NCT01569152|758074|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
230020|NCT01569152|758072|P3|Phase IIa, Period 1|Lost to Follow-up|0
230021|NCT01569152|758073|P2|Phase IIa, Period 1|Lost to Follow-up|0
230022|NCT01569152|758074|P1|Phase IIa, Period 1|Lost to Follow-up|1
230023|NCT01569152|758072|P3|Phase IIa, Period 1|Adverse Event|0
230024|NCT01569152|758073|P2|Phase IIa, Period 1|Adverse Event|0
230025|NCT01569152|758074|P1|Phase IIa, Period 1|Adverse Event|4
230026|NCT01569152|758072|P3|Phase IIa, Period 1|Early Escape|0
230027|NCT01569152|758073|P2|Phase IIa, Period 1|Early Escape|22
230028|NCT01569152|758074|P1|Phase IIa, Period 1|Early Escape|5
230029|NCT01569074|758210|P5|Overall Study|Adverse Event|0
230030|NCT01569074|758211|P4|Overall Study|Adverse Event|0
230031|NCT01569074|758212|P3|Overall Study|Adverse Event|3
230032|NCT01569074|758213|P2|Overall Study|Adverse Event|0
230033|NCT01569074|758214|P1|Overall Study|Adverse Event|1
230034|NCT01569074|758210|P5|Overall Study|eg change in circumstances|1
230035|NCT01569074|758211|P4|Overall Study|eg change in circumstances|1
230036|NCT01569074|758212|P3|Overall Study|eg change in circumstances|0
230037|NCT01569074|758213|P2|Overall Study|eg change in circumstances|2
230038|NCT01569074|758214|P1|Overall Study|eg change in circumstances|0
230039|NCT01569074|758210|P5|Overall Study|Severe non-compliance to protocol|0
230040|NCT01569074|758211|P4|Overall Study|Severe non-compliance to protocol|0
230041|NCT01569074|758212|P3|Overall Study|Severe non-compliance to protocol|1
230042|NCT01569074|758213|P2|Overall Study|Severe non-compliance to protocol|0
230043|NCT01569074|758214|P1|Overall Study|Severe non-compliance to protocol|0
230044|NCT01569074|758210|P5|Overall Study|Study-specific discontinuation criteria|0
230045|NCT01569074|758211|P4|Overall Study|Study-specific discontinuation criteria|0
230046|NCT01569074|758212|P3|Overall Study|Study-specific discontinuation criteria|0
230047|NCT01569074|758213|P2|Overall Study|Study-specific discontinuation criteria|1
230048|NCT01569074|758214|P1|Overall Study|Study-specific discontinuation criteria|0
230049|NCT01569074|758210|P5|Overall Study|Study stopped|7
230050|NCT01569074|758211|P4|Overall Study|Study stopped|7
230051|NCT01569074|758212|P3|Overall Study|Study stopped|8
230052|NCT01569074|758213|P2|Overall Study|Study stopped|6
230053|NCT01569074|758214|P1|Overall Study|Study stopped|6
230054|NCT01568892|758294|P2|Open-label Phase|Ongoing|15
230055|NCT01568892|758295|P1|Open-label Phase|Ongoing|12
230056|NCT01568892|758294|P2|Open-label Phase|Lack of Efficacy|1
230057|NCT01568892|758295|P1|Open-label Phase|Lack of Efficacy|0
230058|NCT01568892|758294|P2|Open-label Phase|Adverse Event|0
230059|NCT01568892|758295|P1|Open-label Phase|Adverse Event|1
230060|NCT01568866|758333|P2|Overall Study|Randomized but Not Dosed|1
230061|NCT01568866|758334|P1|Overall Study|Randomized but Not Dosed|9
230062|NCT01568866|758333|P2|Overall Study|Lost to Follow-up|0
230063|NCT01568866|758334|P1|Overall Study|Lost to Follow-up|1
230064|NCT01568866|758333|P2|Overall Study|Protocol Non-compliance|4
230065|NCT01568866|758334|P1|Overall Study|Protocol Non-compliance|1
230066|NCT01568866|758333|P2|Overall Study|Death|13
230067|NCT01568866|758334|P1|Overall Study|Death|9
230068|NCT01568866|758333|P2|Overall Study|Withdrawal by Subject|6
230069|NCT01568866|758334|P1|Overall Study|Withdrawal by Subject|19
230070|NCT01568866|758333|P2|Overall Study|Physician Decision|18
230071|NCT01568866|758334|P1|Overall Study|Physician Decision|35
230072|NCT01568866|758333|P2|Overall Study|Patient Request|40
230073|NCT01568866|758334|P1|Overall Study|Patient Request|45
230074|NCT01568866|758333|P2|Overall Study|Adverse Event|65
230075|NCT01568866|758334|P1|Overall Study|Adverse Event|73
230076|NCT01568866|758333|P2|Overall Study|Disease Progression|117
230077|NCT01568866|758334|P1|Overall Study|Disease Progression|168
230078|NCT01568593|758365|P2|Overall Study|Adverse Event|2
230079|NCT01568593|758366|P1|Overall Study|Adverse Event|3
230080|NCT01568593|758365|P2|Overall Study|Lack of Efficacy|1
230081|NCT01568593|758366|P1|Overall Study|Lack of Efficacy|4
230082|NCT01568112|758386|P4|Overall Study|Withdrawal by Physician|1
230083|NCT01568112|758387|P3|Overall Study|Withdrawal by Physician|1
230084|NCT01568112|758388|P2|Overall Study|Withdrawal by Physician|0
230085|NCT01568112|758389|P1|Overall Study|Withdrawal by Physician|1
230086|NCT01568112|758386|P4|Overall Study|Withdrawal by Subject|7
230087|NCT01568112|758387|P3|Overall Study|Withdrawal by Subject|0
230088|NCT01568112|758388|P2|Overall Study|Withdrawal by Subject|3
230089|NCT01568112|758389|P1|Overall Study|Withdrawal by Subject|2
230090|NCT01568112|758386|P4|Overall Study|Lost to Follow-up|1
230091|NCT01568112|758387|P3|Overall Study|Lost to Follow-up|0
230093|NCT01568112|758389|P1|Overall Study|Lost to Follow-up|0
230094|NCT01568112|758386|P4|Overall Study|Withdrew due to Adverse Event|3
230095|NCT01568112|758387|P3|Overall Study|Withdrew due to Adverse Event|6
230096|NCT01568112|758388|P2|Overall Study|Withdrew due to Adverse Event|4
230097|NCT01568112|758389|P1|Overall Study|Withdrew due to Adverse Event|2
230098|NCT01568112|758386|P4|Overall Study|Randomized But Not Treated|0
230099|NCT01568112|758387|P3|Overall Study|Randomized But Not Treated|0
230100|NCT01568112|758388|P2|Overall Study|Randomized But Not Treated|1
230101|NCT01568112|758389|P1|Overall Study|Randomized But Not Treated|0
230102|NCT01568047|758547|P4|Overall Study|Adverse Event|1
230103|NCT01568047|758548|P3|Overall Study|Adverse Event|1
230104|NCT01568047|758549|P2|Overall Study|Adverse Event|0
230105|NCT01568047|758550|P1|Overall Study|Adverse Event|0
230106|NCT01568047|758547|P4|Overall Study|Withdrawal by Subject|0
230107|NCT01568047|758548|P3|Overall Study|Withdrawal by Subject|0
230108|NCT01568047|758549|P2|Overall Study|Withdrawal by Subject|1
230109|NCT01568047|758550|P1|Overall Study|Withdrawal by Subject|0
230110|NCT01568047|758547|P4|Overall Study|Ineligibility|0
230111|NCT01568047|758548|P3|Overall Study|Ineligibility|0
230112|NCT01568047|758549|P2|Overall Study|Ineligibility|0
230113|NCT01568047|758550|P1|Overall Study|Ineligibility|1
230114|NCT01568034|758568|P4|Overall Study|Withdrawal by Subject|0
230115|NCT01568034|758569|P3|Overall Study|Withdrawal by Subject|0
230116|NCT01568034|758570|P2|Overall Study|Withdrawal by Subject|0
230117|NCT01568034|758571|P1|Overall Study|Withdrawal by Subject|1
230118|NCT01567852|758618|P2|Overall Study|ECT discontinued|1
230119|NCT01567852|758619|P1|Overall Study|ECT discontinued|1
230120|NCT01567852|758618|P2|Overall Study|Withdrawal by Subject|6
230121|NCT01567852|758619|P1|Overall Study|Withdrawal by Subject|3
230122|NCT01567826|758637|P2|Overall Study|Lost to Follow-up|2
230123|NCT01567826|758638|P1|Overall Study|Lost to Follow-up|3
230124|NCT01567163|758667|P1|Overall Study|Lost to Follow-up|2
230125|NCT01567163|758667|P1|Overall Study|Progressive Disease|2
230126|NCT01566981|758707|P2|Overall Study|Lost to Follow-up|8
230127|NCT01566981|758708|P1|Overall Study|Lost to Follow-up|5
230128|NCT01566721|758739|P2|Overall Study|Withdrew Prior to Treatment|1
230129|NCT01566721|758740|P1|Overall Study|Withdrew Prior to Treatment|3
230130|NCT01566721|758739|P2|Overall Study|Not Specified|4
230131|NCT01566721|758740|P1|Overall Study|Not Specified|10
230132|NCT01566721|758739|P2|Overall Study|Death|3
230133|NCT01566721|758740|P1|Overall Study|Death|6
230134|NCT01566721|758739|P2|Overall Study|Lost to Follow-up|0
230135|NCT01566721|758740|P1|Overall Study|Lost to Follow-up|18
230136|NCT01566721|758739|P2|Overall Study|Disease Progression/Recurrence|28
230137|NCT01566721|758740|P1|Overall Study|Disease Progression/Recurrence|123
230138|NCT01566721|758739|P2|Overall Study|Withdrawal by Subject|15
230139|NCT01566721|758740|P1|Overall Study|Withdrawal by Subject|58
230140|NCT01566721|758739|P2|Overall Study|Ongoing Study|659
230141|NCT01566721|758740|P1|Overall Study|Ongoing Study|1649
230142|NCT01566604|758822|P2|Overall Study|Withdrawal by Subject|6
230143|NCT01566604|758823|P1|Overall Study|Withdrawal by Subject|9
230144|NCT01566604|758822|P2|Overall Study|Adverse Event|2
230145|NCT01566604|758823|P1|Overall Study|Adverse Event|4
230146|NCT01566604|758822|P2|Overall Study|Death|1
230147|NCT01566604|758823|P1|Overall Study|Death|4
230148|NCT01566604|758822|P2|Overall Study|Abnormal laboratory value|0
230149|NCT01566604|758823|P1|Overall Study|Abnormal laboratory value|2
230150|NCT01566604|758822|P2|Overall Study|Protocol deviation|0
230151|NCT01566604|758823|P1|Overall Study|Protocol deviation|2
230152|NCT01566604|758822|P2|Overall Study|Lack of Efficacy|2
230153|NCT01566604|758823|P1|Overall Study|Lack of Efficacy|1
230154|NCT01566604|758822|P2|Overall Study|Administrative problems|0
230155|NCT01566604|758823|P1|Overall Study|Administrative problems|1
230156|NCT01566604|758822|P2|Overall Study|Patient's inability to use the device|0
230157|NCT01566604|758823|P1|Overall Study|Patient's inability to use the device|1
230158|NCT01566435|758910|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
230159|NCT01566149|758983|P2|Overall Study|Withdrawal by Subject|0
230160|NCT01566149|758984|P1|Overall Study|Withdrawal by Subject|1
230161|NCT01566149|758983|P2|Overall Study|Protocol Violation|1
230162|NCT01566149|758984|P1|Overall Study|Protocol Violation|0
230163|NCT01566149|758983|P2|Overall Study|Non-compliance with study medication|0
230164|NCT01566149|758984|P1|Overall Study|Non-compliance with study medication|2
230165|NCT01566149|758983|P2|Overall Study|Adverse Event|1
230166|NCT01566149|758984|P1|Overall Study|Adverse Event|0
230167|NCT01565993|759017|P2|Overall Study|Physician Decision|3
230168|NCT01565993|759018|P1|Overall Study|Physician Decision|0
230169|NCT01565980|759026|P2|Overall Study|Withdrawal by Subject|3
230170|NCT01565980|759027|P1|Overall Study|Withdrawal by Subject|0
230171|NCT01565980|759026|P2|Overall Study|stopped medical treatment|0
230172|NCT01565980|759027|P1|Overall Study|stopped medical treatment|1
230173|NCT01565980|759026|P2|Overall Study|health complications|1
230174|NCT01565980|759027|P1|Overall Study|health complications|1
230175|NCT01565980|759026|P2|Overall Study|Lost to Follow-up|0
230176|NCT01565980|759027|P1|Overall Study|Lost to Follow-up|1
230177|NCT01565980|759026|P2|Overall Study|Death|0
230178|NCT01565980|759027|P1|Overall Study|Death|1
230179|NCT01565889|759086|P6|Part B|Lost to Follow-up|1
230180|NCT01565889|759087|P5|Part B|Lost to Follow-up|0
230181|NCT01565889|759088|P4|Part B|Lost to Follow-up|0
230182|NCT01565889|759089|P3|Part B|Lost to Follow-up|0
230183|NCT01565889|759090|P2|Part B|Lost to Follow-up|0
230184|NCT01565889|759091|P1|Part B|Lost to Follow-up|0
230185|NCT01565889|759086|P6|Part B|Lack of Efficacy|2
230186|NCT01565889|759087|P5|Part B|Lack of Efficacy|0
230187|NCT01565889|759088|P4|Part B|Lack of Efficacy|0
230188|NCT01565889|759089|P3|Part B|Lack of Efficacy|0
230189|NCT01565889|759090|P2|Part B|Lack of Efficacy|0
230190|NCT01565889|759091|P1|Part B|Lack of Efficacy|0
230191|NCT01565889|759086|P6|Part B|Withdrawal by Subject|1
230192|NCT01565889|759087|P5|Part B|Withdrawal by Subject|0
230193|NCT01565889|759088|P4|Part B|Withdrawal by Subject|0
230194|NCT01565889|759089|P3|Part B|Withdrawal by Subject|0
230195|NCT01565889|759090|P2|Part B|Withdrawal by Subject|0
230196|NCT01565889|759091|P1|Part B|Withdrawal by Subject|0
230197|NCT01565889|759086|P6|Part A|Withdrawal by Subject|0
230198|NCT01565889|759087|P5|Part A|Withdrawal by Subject|0
230199|NCT01565889|759088|P4|Part A|Withdrawal by Subject|0
230200|NCT01565889|759089|P3|Part A|Withdrawal by Subject|0
230201|NCT01565889|759090|P2|Part A|Withdrawal by Subject|0
230202|NCT01565889|759091|P1|Part A|Withdrawal by Subject|1
230203|NCT01565850|759122|P2|Overall Study|Withdrew Consent|2
230204|NCT01565850|759123|P1|Overall Study|Withdrew Consent|4
230205|NCT01565850|759122|P2|Overall Study|Participant noncompliance|0
230206|NCT01565850|759123|P1|Overall Study|Participant noncompliance|2
230207|NCT01565850|759122|P2|Overall Study|Investigator’s Discretion|1
230208|NCT01565850|759123|P1|Overall Study|Investigator’s Discretion|2
230209|NCT01565850|759122|P2|Overall Study|Lost to Follow-up|4
230210|NCT01565850|759123|P1|Overall Study|Lost to Follow-up|12
230211|NCT01565850|759122|P2|Overall Study|Adverse Event|1
230212|NCT01565850|759123|P1|Overall Study|Adverse Event|0
230213|NCT01565707|759143|P4|Overall Study|Miscellaneous|2
230214|NCT01565707|759144|P3|Overall Study|Miscellaneous|0
230215|NCT01565707|759145|P2|Overall Study|Miscellaneous|1
230216|NCT01565707|759146|P1|Overall Study|Miscellaneous|1
230217|NCT01565707|759143|P4|Overall Study|Randomized but not evaluable|0
230218|NCT01565707|759144|P3|Overall Study|Randomized but not evaluable|0
230219|NCT01565707|759145|P2|Overall Study|Randomized but not evaluable|0
230220|NCT01565707|759146|P1|Overall Study|Randomized but not evaluable|2
230221|NCT01565707|759143|P4|Overall Study|Withdrawal by Subject|1
230222|NCT01565707|759144|P3|Overall Study|Withdrawal by Subject|1
230223|NCT01565707|759145|P2|Overall Study|Withdrawal by Subject|1
230224|NCT01565707|759146|P1|Overall Study|Withdrawal by Subject|3
230225|NCT01565707|759143|P4|Overall Study|Protocol Violation|1
230226|NCT01565707|759144|P3|Overall Study|Protocol Violation|0
230227|NCT01565707|759145|P2|Overall Study|Protocol Violation|0
230228|NCT01565707|759146|P1|Overall Study|Protocol Violation|1
230229|NCT01565707|759143|P4|Overall Study|Lost to Follow-up|0
230230|NCT01565707|759144|P3|Overall Study|Lost to Follow-up|0
230231|NCT01565707|759145|P2|Overall Study|Lost to Follow-up|0
230232|NCT01565707|759146|P1|Overall Study|Lost to Follow-up|1
230233|NCT01565707|759143|P4|Overall Study|Adverse Event|1
230234|NCT01565707|759144|P3|Overall Study|Adverse Event|2
230235|NCT01565707|759145|P2|Overall Study|Adverse Event|6
230236|NCT01565707|759146|P1|Overall Study|Adverse Event|1
230237|NCT01565564|759239|P2|Overall Study|Lost to Follow-up|1
230238|NCT01565564|759240|P1|Overall Study|Lost to Follow-up|5
230239|NCT01565343|759290|P3|Overall Study|Administrative decision/technical issues|0
230240|NCT01565343|759291|P2|Overall Study|Administrative decision/technical issues|0
230241|NCT01565343|759292|P1|Overall Study|Administrative decision/technical issues|1
230242|NCT01565291|759322|P2|Overall Study|Withdrawal by Subject|0
230243|NCT01565291|759323|P1|Overall Study|Withdrawal by Subject|1
230244|NCT01565083|759333|P2|Overall Study|Unspecified|5
230245|NCT01565083|759334|P1|Overall Study|Unspecified|3
230246|NCT01565083|759333|P2|Overall Study|Death|23
230247|NCT01565083|759334|P1|Overall Study|Death|22
230248|NCT01565083|759333|P2|Overall Study|Lost to Follow-up|7
230249|NCT01565083|759334|P1|Overall Study|Lost to Follow-up|2
230250|NCT01565083|759333|P2|Overall Study|Withdrawal by Subject|4
230251|NCT01565083|759334|P1|Overall Study|Withdrawal by Subject|6
230252|NCT01564862|759371|P3|Overall Study|Other reason(s)|0
230253|NCT01564862|759372|P2|Overall Study|Other reason(s)|0
230254|NCT01564862|759373|P1|Overall Study|Other reason(s)|1
230255|NCT01564862|759371|P3|Overall Study|Lack of Efficacy|6
230256|NCT01564862|759372|P2|Overall Study|Lack of Efficacy|5
230257|NCT01564862|759373|P1|Overall Study|Lack of Efficacy|1
230258|NCT01564862|759371|P3|Overall Study|Voluntary Withdrawal|8
230259|NCT01564862|759372|P2|Overall Study|Voluntary Withdrawal|6
230260|NCT01564862|759373|P1|Overall Study|Voluntary Withdrawal|9
230261|NCT01564862|759371|P3|Overall Study|Lost to Follow-up|6
230262|NCT01564862|759372|P2|Overall Study|Lost to Follow-up|8
230263|NCT01564862|759373|P1|Overall Study|Lost to Follow-up|10
230264|NCT01564862|759371|P3|Overall Study|Major Protocol Deviation|4
230265|NCT01564862|759372|P2|Overall Study|Major Protocol Deviation|3
230266|NCT01564862|759373|P1|Overall Study|Major Protocol Deviation|3
230267|NCT01564862|759371|P3|Overall Study|Pretreatment Event or Adverse Event|6
230268|NCT01564862|759372|P2|Overall Study|Pretreatment Event or Adverse Event|12
230269|NCT01564862|759373|P1|Overall Study|Pretreatment Event or Adverse Event|6
230270|NCT01564758|759422|P1|Overall Study|Unspecified|3
230271|NCT01564758|759422|P1|Overall Study|Adverse Event|3
230272|NCT01564758|759422|P1|Overall Study|Death|8
230273|NCT01564732|759429|P2|Overall Study|Early termination by the study sponsor|5
230274|NCT01564732|759430|P1|Overall Study|Early termination by the study sponsor|6
230275|NCT01564537|759490|P2|Overall Study|Other Miscellaneous Reasons|2
230276|NCT01564537|759491|P1|Overall Study|Other Miscellaneous Reasons|1
230277|NCT01564537|759490|P2|Overall Study|Lost to Follow-up|0
230278|NCT01564537|759491|P1|Overall Study|Lost to Follow-up|1
230279|NCT01564537|759490|P2|Overall Study|Withdrawal by Participant|4
230280|NCT01564537|759491|P1|Overall Study|Withdrawal by Participant|4
230281|NCT01564459|759514|P3|Double-blind Treatment|Adverse Event|1
230282|NCT01564459|759515|P2|Double-blind Treatment|Adverse Event|0
230283|NCT01564459|759516|P1|Double-blind Treatment|Adverse Event|0
230284|NCT01564459|759514|P3|Run-In|Withdrawal by Subject|0
230285|NCT01564459|759515|P2|Run-In|Withdrawal by Subject|0
230286|NCT01564459|759516|P1|Run-In|Withdrawal by Subject|1
230287|NCT01564459|759514|P3|Run-In|Protocol Violation|0
230288|NCT01564459|759515|P2|Run-In|Protocol Violation|0
230289|NCT01564459|759516|P1|Run-In|Protocol Violation|1
230290|NCT01564459|759514|P3|Run-In|Non-compliance with study drug|0
230291|NCT01564459|759515|P2|Run-In|Non-compliance with study drug|0
230292|NCT01564459|759516|P1|Run-In|Non-compliance with study drug|2
230293|NCT01564459|759514|P3|Run-In|Lost to Follow-up|0
230294|NCT01564459|759515|P2|Run-In|Lost to Follow-up|0
230295|NCT01564459|759516|P1|Run-In|Lost to Follow-up|1
230296|NCT01564459|759514|P3|Run-In|Adverse Event|0
230297|NCT01564459|759515|P2|Run-In|Adverse Event|0
230298|NCT01564459|759516|P1|Run-In|Adverse Event|7
230299|NCT01564407|759540|P5|Overall Study|funding lost, study ended|0
230300|NCT01564407|759541|P4|Overall Study|funding lost, study ended|1
230301|NCT01564407|759542|P3|Overall Study|funding lost, study ended|0
230302|NCT01564407|759543|P2|Overall Study|funding lost, study ended|0
230303|NCT01564407|759544|P1|Overall Study|funding lost, study ended|0
230304|NCT01564407|759540|P5|Overall Study|Withdrawal by Subject|0
230305|NCT01564407|759541|P4|Overall Study|Withdrawal by Subject|0
230306|NCT01564407|759542|P3|Overall Study|Withdrawal by Subject|0
230307|NCT01564407|759543|P2|Overall Study|Withdrawal by Subject|1
230308|NCT01564407|759544|P1|Overall Study|Withdrawal by Subject|0
230309|NCT01564407|759540|P5|Overall Study|Lost to Follow-up|0
230310|NCT01564407|759541|P4|Overall Study|Lost to Follow-up|0
230311|NCT01564407|759542|P3|Overall Study|Lost to Follow-up|0
230312|NCT01564407|759543|P2|Overall Study|Lost to Follow-up|1
230313|NCT01564407|759544|P1|Overall Study|Lost to Follow-up|0
230314|NCT01564394|759585|P2|Overall Study|Withdrawal by Subject|10
230315|NCT01564394|759586|P1|Overall Study|Withdrawal by Subject|6
230316|NCT01563978|759600|P2|Overall Study|Adverse Event|2
230317|NCT01563978|759601|P1|Overall Study|Adverse Event|1
230318|NCT01563978|759600|P2|Overall Study|Dev. of study specific discont. criteria|0
230319|NCT01563978|759601|P1|Overall Study|Dev. of study specific discont. criteria|1
230320|NCT01563978|759600|P2|Overall Study|Lost to Follow-up|0
230321|NCT01563978|759601|P1|Overall Study|Lost to Follow-up|1
230322|NCT01563978|759600|P2|Overall Study|Physician Decision|0
230323|NCT01563978|759601|P1|Overall Study|Physician Decision|1
230324|NCT01563536|759627|P2|Overall Study|Lost to Follow-up|0
230325|NCT01563536|759628|P1|Overall Study|Lost to Follow-up|1
230326|NCT01563536|759627|P2|Overall Study|Withdrawal by Subject|2
230327|NCT01563536|759628|P1|Overall Study|Withdrawal by Subject|0
230328|NCT01563185|759662|P1|Overall Study|Non-Compliance with study drug|1
230329|NCT01563185|759662|P1|Overall Study|Withdrawal by Subject|1
230330|NCT01563029|759755|P5|Overall Study|Withdrawal by Subject|3
230331|NCT01563029|759756|P4|Overall Study|Withdrawal by Subject|4
230332|NCT01563029|759757|P3|Overall Study|Withdrawal by Subject|3
230333|NCT01563029|759758|P2|Overall Study|Withdrawal by Subject|1
230334|NCT01563029|759759|P1|Overall Study|Withdrawal by Subject|4
230335|NCT01563029|759755|P5|Overall Study|Physician Decision|2
230336|NCT01563029|759756|P4|Overall Study|Physician Decision|4
230337|NCT01563029|759757|P3|Overall Study|Physician Decision|2
230338|NCT01563029|759758|P2|Overall Study|Physician Decision|5
230339|NCT01563029|759759|P1|Overall Study|Physician Decision|3
230340|NCT01563029|759755|P5|Overall Study|Lost to Follow-up|1
230341|NCT01563029|759756|P4|Overall Study|Lost to Follow-up|1
230342|NCT01563029|759757|P3|Overall Study|Lost to Follow-up|1
230343|NCT01563029|759758|P2|Overall Study|Lost to Follow-up|0
230344|NCT01563029|759759|P1|Overall Study|Lost to Follow-up|1
230345|NCT01563029|759755|P5|Overall Study|Protocol defined stopping criteria|0
230346|NCT01563029|759756|P4|Overall Study|Protocol defined stopping criteria|0
230347|NCT01563029|759757|P3|Overall Study|Protocol defined stopping criteria|0
230348|NCT01563029|759758|P2|Overall Study|Protocol defined stopping criteria|0
230349|NCT01563029|759759|P1|Overall Study|Protocol defined stopping criteria|1
230350|NCT01563029|759755|P5|Overall Study|Protocol Violation|3
230351|NCT01563029|759756|P4|Overall Study|Protocol Violation|1
230352|NCT01563029|759757|P3|Overall Study|Protocol Violation|3
230353|NCT01563029|759758|P2|Overall Study|Protocol Violation|2
230354|NCT01563029|759759|P1|Overall Study|Protocol Violation|1
230355|NCT01563029|759755|P5|Overall Study|Lack of Efficacy|19
230356|NCT01563029|759756|P4|Overall Study|Lack of Efficacy|21
230357|NCT01563029|759757|P3|Overall Study|Lack of Efficacy|23
230358|NCT01563029|759758|P2|Overall Study|Lack of Efficacy|16
230359|NCT01563029|759759|P1|Overall Study|Lack of Efficacy|42
230360|NCT01563029|759755|P5|Overall Study|Adverse Event|1
230361|NCT01563029|759756|P4|Overall Study|Adverse Event|2
230362|NCT01563029|759757|P3|Overall Study|Adverse Event|1
230363|NCT01563029|759758|P2|Overall Study|Adverse Event|0
230364|NCT01563029|759759|P1|Overall Study|Adverse Event|1
230365|NCT01562873|759825|P2|Overall Study|Clinical PD and adverse event|0
230366|NCT01562873|759826|P1|Overall Study|Clinical PD and adverse event|1
230367|NCT01562873|759825|P2|Overall Study|Clinical Disease Progression|0
230368|NCT01562873|759826|P1|Overall Study|Clinical Disease Progression|9
230369|NCT01562873|759825|P2|Overall Study|Adverse Event|0
230370|NCT01562873|759826|P1|Overall Study|Adverse Event|1
230371|NCT01562873|759825|P2|Overall Study|Disease Progression per RECIST|0
230372|NCT01562873|759826|P1|Overall Study|Disease Progression per RECIST|10
230373|NCT01562743|759833|P1|Overall Study|Physician Decision|2
230374|NCT01562743|759833|P1|Overall Study|Lost to Follow-up|2
230375|NCT01562743|759833|P1|Overall Study|Discontinuation criteria|2
230376|NCT01562743|759833|P1|Overall Study|Protocol Violation|1
230377|NCT01562743|759833|P1|Overall Study|Withdrawal by Subject|13
230378|NCT01562743|759833|P1|Overall Study|Lack of Efficacy|3
230379|NCT01562743|759833|P1|Overall Study|Adverse Event|29
230380|NCT01562613|759852|P1|Overall Study|Withdrawal by Subject|2
230381|NCT01562613|759852|P1|Overall Study|Lost to Follow-up|2
230382|NCT01562548|759862|P4|Overall Study|Lost to Follow-up|0
230383|NCT01562548|759863|P3|Overall Study|Lost to Follow-up|1
230384|NCT01562548|759864|P2|Overall Study|Lost to Follow-up|0
230385|NCT01562548|759865|P1|Overall Study|Lost to Follow-up|0
230386|NCT01562327|759915|P1|Overall Study|Infusion not received at 6 month window|4
230387|NCT01562327|759915|P1|Overall Study|Participant drop-out|1
230388|NCT01562327|759915|P1|Overall Study|Lack of Efficacy|1
230389|NCT01562327|759915|P1|Overall Study|Adverse Event|2
230390|NCT01562314|759945|P2|Overall Study|Withdrawal by Subject|1
230391|NCT01562314|759946|P1|Overall Study|Withdrawal by Subject|0
230392|NCT01562314|759945|P2|Overall Study|Met Withdrawal Criteria|2
230393|NCT01562314|759946|P1|Overall Study|Met Withdrawal Criteria|3
230394|NCT01562314|759945|P2|Overall Study|Adverse Event|5
230395|NCT01562314|759946|P1|Overall Study|Adverse Event|10
230396|NCT01562275|760033|P13|Stage 2|Progression of Disease|4
230397|NCT01562275|760034|P12|Stage 2|Progression of Disease|12
230398|NCT01562275|760035|P11|Stage 2|Progression of Disease|0
230399|NCT01562275|760036|P10|Stage 2|Progression of Disease|0
230400|NCT01562275|760037|P9|Stage 2|Progression of Disease|0
230401|NCT01562275|760038|P8|Stage 2|Progression of Disease|0
230402|NCT01562275|760039|P7|Stage 2|Progression of Disease|0
230403|NCT01562275|760040|P6|Stage 2|Progression of Disease|0
230404|NCT01562275|760041|P5|Stage 2|Progression of Disease|0
230405|NCT01562275|760042|P4|Stage 2|Progression of Disease|0
230406|NCT01562275|760043|P3|Stage 2|Progression of Disease|0
230407|NCT01562275|760044|P2|Stage 2|Progression of Disease|0
230408|NCT01562275|760045|P1|Stage 2|Progression of Disease|0
230409|NCT01562275|760033|P13|Stage 2|Death|1
230410|NCT01562275|760034|P12|Stage 2|Death|2
230411|NCT01562275|760035|P11|Stage 2|Death|0
230412|NCT01562275|760036|P10|Stage 2|Death|0
230413|NCT01562275|760037|P9|Stage 2|Death|0
230414|NCT01562275|760038|P8|Stage 2|Death|0
230415|NCT01562275|760039|P7|Stage 2|Death|0
230416|NCT01562275|760040|P6|Stage 2|Death|0
230417|NCT01562275|760041|P5|Stage 2|Death|0
230418|NCT01562275|760042|P4|Stage 2|Death|0
230419|NCT01562275|760043|P3|Stage 2|Death|0
230420|NCT01562275|760044|P2|Stage 2|Death|0
230421|NCT01562275|760045|P1|Stage 2|Death|0
230422|NCT01562275|760033|P13|Stage 1|Withdrawal by Subject|0
230423|NCT01562275|760034|P12|Stage 1|Withdrawal by Subject|0
230424|NCT01562275|760035|P11|Stage 1|Withdrawal by Subject|0
230425|NCT01562275|760036|P10|Stage 1|Withdrawal by Subject|1
230426|NCT01562275|760037|P9|Stage 1|Withdrawal by Subject|0
230427|NCT01562275|760038|P8|Stage 1|Withdrawal by Subject|0
230428|NCT01562275|760039|P7|Stage 1|Withdrawal by Subject|1
230429|NCT01562275|760040|P6|Stage 1|Withdrawal by Subject|0
230430|NCT01562275|760041|P5|Stage 1|Withdrawal by Subject|0
230431|NCT01562275|760042|P4|Stage 1|Withdrawal by Subject|2
230432|NCT01562275|760043|P3|Stage 1|Withdrawal by Subject|0
230433|NCT01562275|760044|P2|Stage 1|Withdrawal by Subject|1
230434|NCT01562275|760045|P1|Stage 1|Withdrawal by Subject|0
230435|NCT01562275|760033|P13|Stage 1|Progression of Disease|0
230436|NCT01562275|760034|P12|Stage 1|Progression of Disease|0
230437|NCT01562275|760035|P11|Stage 1|Progression of Disease|3
230438|NCT01562275|760036|P10|Stage 1|Progression of Disease|5
230439|NCT01562275|760037|P9|Stage 1|Progression of Disease|2
230440|NCT01562275|760038|P8|Stage 1|Progression of Disease|7
230441|NCT01562275|760039|P7|Stage 1|Progression of Disease|1
230442|NCT01562275|760040|P6|Stage 1|Progression of Disease|4
230443|NCT01562275|760041|P5|Stage 1|Progression of Disease|2
230444|NCT01562275|760042|P4|Stage 1|Progression of Disease|1
230445|NCT01562275|760043|P3|Stage 1|Progression of Disease|2
230446|NCT01562275|760044|P2|Stage 1|Progression of Disease|6
230447|NCT01562275|760045|P1|Stage 1|Progression of Disease|2
230448|NCT01562275|760033|P13|Stage 1|Physician Decision|0
230449|NCT01562275|760034|P12|Stage 1|Physician Decision|0
230450|NCT01562275|760035|P11|Stage 1|Physician Decision|0
230451|NCT01562275|760036|P10|Stage 1|Physician Decision|0
230452|NCT01562275|760037|P9|Stage 1|Physician Decision|1
230453|NCT01562275|760038|P8|Stage 1|Physician Decision|0
230454|NCT01562275|760039|P7|Stage 1|Physician Decision|1
230455|NCT01562275|760040|P6|Stage 1|Physician Decision|0
230456|NCT01562275|760041|P5|Stage 1|Physician Decision|1
230457|NCT01562275|760042|P4|Stage 1|Physician Decision|0
230458|NCT01562275|760043|P3|Stage 1|Physician Decision|0
230459|NCT01562275|760044|P2|Stage 1|Physician Decision|0
230460|NCT01562275|760045|P1|Stage 1|Physician Decision|0
230461|NCT01562275|760033|P13|Stage 1|Non Compliance|0
230462|NCT01562275|760034|P12|Stage 1|Non Compliance|0
230463|NCT01562275|760035|P11|Stage 1|Non Compliance|0
230464|NCT01562275|760036|P10|Stage 1|Non Compliance|0
230465|NCT01562275|760037|P9|Stage 1|Non Compliance|0
230466|NCT01562275|760038|P8|Stage 1|Non Compliance|0
230467|NCT01562275|760039|P7|Stage 1|Non Compliance|0
230468|NCT01562275|760040|P6|Stage 1|Non Compliance|0
230469|NCT01562275|760041|P5|Stage 1|Non Compliance|0
230470|NCT01562275|760042|P4|Stage 1|Non Compliance|0
230471|NCT01562275|760043|P3|Stage 1|Non Compliance|1
230472|NCT01562275|760044|P2|Stage 1|Non Compliance|0
230473|NCT01562275|760045|P1|Stage 1|Non Compliance|0
230474|NCT01562275|760033|P13|Stage 1|Death|0
230475|NCT01562275|760034|P12|Stage 1|Death|0
230476|NCT01562275|760035|P11|Stage 1|Death|0
230477|NCT01562275|760036|P10|Stage 1|Death|0
230478|NCT01562275|760037|P9|Stage 1|Death|0
230479|NCT01562275|760038|P8|Stage 1|Death|0
230480|NCT01562275|760039|P7|Stage 1|Death|0
230481|NCT01562275|760040|P6|Stage 1|Death|0
230482|NCT01562275|760041|P5|Stage 1|Death|0
230483|NCT01562275|760042|P4|Stage 1|Death|0
230484|NCT01562275|760043|P3|Stage 1|Death|0
230485|NCT01562275|760044|P2|Stage 1|Death|0
230486|NCT01562275|760045|P1|Stage 1|Death|1
230487|NCT01562275|760033|P13|Stage 1|Adverse Event|0
230488|NCT01562275|760034|P12|Stage 1|Adverse Event|0
230489|NCT01562275|760035|P11|Stage 1|Adverse Event|0
230490|NCT01562275|760036|P10|Stage 1|Adverse Event|1
230491|NCT01562275|760037|P9|Stage 1|Adverse Event|0
230492|NCT01562275|760038|P8|Stage 1|Adverse Event|0
230493|NCT01562275|760039|P7|Stage 1|Adverse Event|0
230494|NCT01562275|760040|P6|Stage 1|Adverse Event|0
230495|NCT01562275|760041|P5|Stage 1|Adverse Event|1
230496|NCT01562275|760042|P4|Stage 1|Adverse Event|1
230497|NCT01562275|760043|P3|Stage 1|Adverse Event|0
230498|NCT01562275|760044|P2|Stage 1|Adverse Event|0
230499|NCT01562275|760045|P1|Stage 1|Adverse Event|0
230500|NCT01561898|760188|P4|Overall Study|Physician Decision|1
230501|NCT01561898|760189|P3|Overall Study|Physician Decision|7
230502|NCT01561898|760190|P2|Overall Study|Physician Decision|5
230503|NCT01561898|760191|P1|Overall Study|Physician Decision|1
230504|NCT01561898|760188|P4|Overall Study|Adverse Event|9
230505|NCT01561898|760189|P3|Overall Study|Adverse Event|14
230506|NCT01561898|760190|P2|Overall Study|Adverse Event|19
230507|NCT01561898|760191|P1|Overall Study|Adverse Event|1
230508|NCT01561898|760188|P4|Overall Study|Lost to Follow-up|0
230509|NCT01561898|760189|P3|Overall Study|Lost to Follow-up|1
230510|NCT01561898|760190|P2|Overall Study|Lost to Follow-up|0
230511|NCT01561898|760191|P1|Overall Study|Lost to Follow-up|0
230512|NCT01561898|760188|P4|Overall Study|Worsening of complications|0
230513|NCT01561898|760189|P3|Overall Study|Worsening of complications|0
230514|NCT01561898|760190|P2|Overall Study|Worsening of complications|1
230515|NCT01561898|760191|P1|Overall Study|Worsening of complications|0
230516|NCT01561898|760188|P4|Overall Study|Lack of Efficacy|5
230517|NCT01561898|760189|P3|Overall Study|Lack of Efficacy|10
230518|NCT01561898|760190|P2|Overall Study|Lack of Efficacy|8
230519|NCT01561898|760191|P1|Overall Study|Lack of Efficacy|0
230520|NCT01561898|760188|P4|Overall Study|Withdrawal by Subject|5
230521|NCT01561898|760189|P3|Overall Study|Withdrawal by Subject|12
230522|NCT01561898|760190|P2|Overall Study|Withdrawal by Subject|8
230523|NCT01561898|760191|P1|Overall Study|Withdrawal by Subject|0
230524|NCT01561560|760237|P2|Second Two Weeks of Wear|Adverse Event|1
230525|NCT01561560|760238|P1|Second Two Weeks of Wear|Adverse Event|0
230526|NCT01561560|760237|P2|First Two Weeks of Wear|Adverse Event|1
230527|NCT01561560|760238|P1|First Two Weeks of Wear|Adverse Event|0
230528|NCT01561560|760237|P2|First Two Weeks of Wear|Time/job conflict|1
230529|NCT01561560|760238|P1|First Two Weeks of Wear|Time/job conflict|0
230530|NCT01561313|760267|P2|Overall Study|Adverse event and withdrawal by subject|0
230531|NCT01561313|760268|P1|Overall Study|Adverse event and withdrawal by subject|1
230532|NCT01561313|760267|P2|Overall Study|Withdrawal by Subject|0
230533|NCT01561313|760268|P1|Overall Study|Withdrawal by Subject|1
230534|NCT01561300|760286|P2|Run in on Placebo|Adverse Event|0
230535|NCT01561300|760287|P1|Run in on Placebo|Adverse Event|1
230536|NCT01560819|760313|P2|Overall Study|Physician Decision|0
230537|NCT01560819|760314|P1|Overall Study|Physician Decision|1
230538|NCT01560507|760321|P3|Overall Study|Withdrawal by Subject|0
230539|NCT01560507|760322|P2|Overall Study|Withdrawal by Subject|1
230540|NCT01560507|760323|P1|Overall Study|Withdrawal by Subject|1
230541|NCT01560507|760321|P3|Overall Study|Lost to Follow-up|2
230542|NCT01560507|760322|P2|Overall Study|Lost to Follow-up|1
230543|NCT01560507|760323|P1|Overall Study|Lost to Follow-up|3
230544|NCT01560429|760336|P2|Overall Study|Protocol Violation|6
230545|NCT01560429|760337|P1|Overall Study|Protocol Violation|3
230546|NCT01560403|760347|P2|Overall Study|Lost to Follow-up|1
230547|NCT01560403|760348|P1|Overall Study|Lost to Follow-up|0
230548|NCT01560234|760366|P8|Overall Study|Lost to Follow-up|2
230549|NCT01560234|760367|P7|Overall Study|Lost to Follow-up|0
230550|NCT01560234|760368|P6|Overall Study|Lost to Follow-up|2
230551|NCT01560234|760369|P5|Overall Study|Lost to Follow-up|0
230552|NCT01560234|760370|P4|Overall Study|Lost to Follow-up|0
230553|NCT01560234|760371|P3|Overall Study|Lost to Follow-up|1
230554|NCT01560234|760372|P2|Overall Study|Lost to Follow-up|0
230555|NCT01560234|760373|P1|Overall Study|Lost to Follow-up|3
230556|NCT01559935|760451|P1|Maintenance Phase|Non-compliance|2
230557|NCT01559935|760451|P1|Maintenance Phase|Withdrawal by Subject|5
230558|NCT01559935|760451|P1|Maintenance Phase|Lack of Efficacy|18
230559|NCT01559935|760451|P1|Maintenance Phase|Toxicity|1
230560|NCT01559935|760451|P1|Maintenance Phase|Remains on study|28
230561|NCT01559935|760451|P1|BiRD Phase|Withdrawal by Subject|2
230562|NCT01559935|760451|P1|BiRD Phase|Lack of Efficacy|1
230563|NCT01559935|760451|P1|BiRD Phase|Toxicity|1
230564|NCT01559935|760451|P1|Car Phase|non-compliance|1
230565|NCT01559935|760451|P1|Car Phase|Insurance|1
230566|NCT01559935|760451|P1|Car Phase|Per protocol|1
230567|NCT01559935|760451|P1|Car Phase|Withdrawal by Subject|2
230568|NCT01559935|760451|P1|Car Phase|Physician Decision|1
230569|NCT01559935|760451|P1|Car Phase|Lost to Follow-up|1
230570|NCT01559935|760451|P1|Car Phase|Lack of Efficacy|2
230571|NCT01559935|760451|P1|Car Phase|Death|1
230572|NCT01559935|760451|P1|Car Phase|Toxicity|4
230573|NCT01559844|760487|P1|Overall Study|No Longer A Transplant Candidate|3
230574|NCT01559844|760487|P1|Overall Study|Efficacy Failure|10
230575|NCT01559844|760487|P1|Overall Study|Death|5
230576|NCT01559844|760487|P1|Overall Study|Consent Withdrawn|7
230577|NCT01559675|760500|P2|Overall Study|2nd operation on same patient excluded|12
230578|NCT01559675|760501|P1|Overall Study|2nd operation on same patient excluded|14
230579|NCT01559675|760500|P2|Overall Study|Protocol Violation|2
230580|NCT01559675|760501|P1|Overall Study|Protocol Violation|1
230581|NCT01559454|760532|P2|Overall Study|Lack of Efficacy|1
230582|NCT01559454|760533|P1|Overall Study|Lack of Efficacy|0
230583|NCT01559454|760532|P2|Overall Study|Protocol Violation|1
230584|NCT01559454|760533|P1|Overall Study|Protocol Violation|0
230585|NCT01559454|760532|P2|Overall Study|Physician Decision|1
230586|NCT01559454|760533|P1|Overall Study|Physician Decision|0
230587|NCT01559454|760532|P2|Overall Study|Withdrawal by Subject|1
230588|NCT01559454|760533|P1|Overall Study|Withdrawal by Subject|0
230589|NCT01559454|760532|P2|Overall Study|Lost to Follow-up|2
230590|NCT01559454|760533|P1|Overall Study|Lost to Follow-up|3
230591|NCT01559311|760552|P3|Overall Study|Adverse Event|1
230592|NCT01559311|760553|P2|Overall Study|Adverse Event|0
230593|NCT01559311|760554|P1|Overall Study|Adverse Event|0
230594|NCT01559311|760552|P3|Overall Study|Lost to Follow-up|2
230595|NCT01559311|760553|P2|Overall Study|Lost to Follow-up|3
230596|NCT01559311|760554|P1|Overall Study|Lost to Follow-up|0
230597|NCT01559311|760552|P3|Overall Study|Death|3
230598|NCT01559311|760553|P2|Overall Study|Death|2
230599|NCT01559311|760554|P1|Overall Study|Death|0
230600|NCT01559311|760552|P3|Overall Study|Withdrawal by Subject|0
230601|NCT01559311|760553|P2|Overall Study|Withdrawal by Subject|1
230602|NCT01559311|760554|P1|Overall Study|Withdrawal by Subject|2
230603|NCT01559311|760552|P3|Overall Study|Difficulty in cannulating the lateral ve|0
230604|NCT01559311|760553|P2|Overall Study|Difficulty in cannulating the lateral ve|0
230605|NCT01559311|760554|P1|Overall Study|Difficulty in cannulating the lateral ve|1
230606|NCT01559311|760552|P3|Overall Study|Protocol Violation|2
230607|NCT01559311|760553|P2|Overall Study|Protocol Violation|0
230608|NCT01559311|760554|P1|Overall Study|Protocol Violation|0
230609|NCT01559116|760565|P1|Overall Study|other than stated above|9
230610|NCT01559116|760565|P1|Overall Study|Withdrawal by Subject|4
230611|NCT01559116|760565|P1|Overall Study|Protocol Violation|1
230612|NCT01559116|760565|P1|Overall Study|Lost to Follow-up|1
230613|NCT01559116|760565|P1|Overall Study|Lack of Efficacy|1
230614|NCT01559116|760565|P1|Overall Study|Adverse Event|10
230615|NCT01559012|760648|P2|Overall Study|Withdrawal by Subject|1
230616|NCT01559012|760649|P1|Overall Study|Withdrawal by Subject|0
230617|NCT01558739|760685|P1|Overall Study|Protocol Violation|1
230618|NCT01558739|760685|P1|Overall Study|Disease Progression|4
230619|NCT01558739|760685|P1|Overall Study|Death|3
230620|NCT01558739|760685|P1|Overall Study|Withdrawal by Subject|2
230621|NCT01558739|760685|P1|Overall Study|Adverse Event|7
230622|NCT01558674|760710|P2|Part 1|Withdrawal by Subject|0
230623|NCT01558674|760711|P1|Part 1|Withdrawal by Subject|1
230624|NCT01558674|760710|P2|Part 1|Study Terminated by Sponsor|0
230625|NCT01558674|760711|P1|Part 1|Study Terminated by Sponsor|10
230626|NCT01558596|760757|P2|Overall Study|Protocol Violation|0
230627|NCT01558596|760758|P1|Overall Study|Protocol Violation|1
230628|NCT01558596|760757|P2|Overall Study|surgery elsewhere or cancelled|1
230629|NCT01558596|760758|P1|Overall Study|surgery elsewhere or cancelled|1
230630|NCT01558596|760757|P2|Overall Study|Withdrawal by Subject|0
230631|NCT01558596|760758|P1|Overall Study|Withdrawal by Subject|1
230632|NCT01558297|760773|P3|Overall Study|Withdrawal by Subject|1
230633|NCT01558297|760774|P2|Overall Study|Withdrawal by Subject|2
230634|NCT01558297|760775|P1|Overall Study|Withdrawal by Subject|2
230635|NCT01558271|760792|P3|Overall Study|Physician Decision|1
230636|NCT01558271|760793|P2|Overall Study|Physician Decision|2
230637|NCT01558271|760794|P1|Overall Study|Physician Decision|0
230638|NCT01558271|760792|P3|Overall Study|Withdrawal by Subject|12
230639|NCT01558271|760793|P2|Overall Study|Withdrawal by Subject|6
230640|NCT01558271|760794|P1|Overall Study|Withdrawal by Subject|10
230641|NCT01558271|760792|P3|Overall Study|Protocol Violation|0
230642|NCT01558271|760793|P2|Overall Study|Protocol Violation|0
230643|NCT01558271|760794|P1|Overall Study|Protocol Violation|1
230644|NCT01558271|760792|P3|Overall Study|Lost to Follow-up|0
230645|NCT01558271|760793|P2|Overall Study|Lost to Follow-up|0
230646|NCT01558271|760794|P1|Overall Study|Lost to Follow-up|1
230647|NCT01558271|760792|P3|Overall Study|Adverse Event|4
230648|NCT01558271|760793|P2|Overall Study|Adverse Event|3
230649|NCT01558271|760794|P1|Overall Study|Adverse Event|6
230650|NCT01558089|760860|P1|Overall Study|Withdrawal by Subject|6
230651|NCT01558089|760860|P1|Overall Study|Lost to Follow-up|5
230652|NCT01558089|760860|P1|Overall Study|Lack of Efficacy|1
230653|NCT01558089|760860|P1|Overall Study|Adverse Event|1
230654|NCT01557920|760875|P2|Overall Study|Lack of Efficacy|0
230655|NCT01557920|760876|P1|Overall Study|Lack of Efficacy|1
230656|NCT01557920|760875|P2|Overall Study|Withdrawal by Subject|3
230657|NCT01557920|760876|P1|Overall Study|Withdrawal by Subject|2
230658|NCT01557842|760939|P2|Overall Study|Not Ablated|0
230659|NCT01557842|760940|P1|Overall Study|Not Ablated|2
230660|NCT01557842|760939|P2|Overall Study|Study Terminated by Sponsor|4
230661|NCT01557842|760940|P1|Overall Study|Study Terminated by Sponsor|3
230662|NCT01557842|760939|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
230663|NCT01557842|760940|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
230664|NCT01557842|760939|P2|Overall Study|Lack of Efficacy|1
230665|NCT01557842|760940|P1|Overall Study|Lack of Efficacy|0
230666|NCT01557842|760939|P2|Overall Study|Death|0
230667|NCT01557842|760940|P1|Overall Study|Death|1
230668|NCT01557842|760939|P2|Overall Study|Lost to Follow-up|1
230669|NCT01557842|760940|P1|Overall Study|Lost to Follow-up|0
230670|NCT01557582|761010|P1|Overall Study|Operator error|2
230671|NCT01557582|761010|P1|Overall Study|Protocol Violation|4
230672|NCT01557569|761018|P2|Overall Study|noncompliance with rules of residential|1
230673|NCT01557569|761019|P1|Overall Study|noncompliance with rules of residential|0
230674|NCT01557569|761018|P2|Overall Study|Withdrawal by Subject|5
230675|NCT01557569|761019|P1|Overall Study|Withdrawal by Subject|3
230676|NCT01557569|761018|P2|Overall Study|high blood pressure|1
230677|NCT01557569|761019|P1|Overall Study|high blood pressure|0
230678|NCT01557569|761018|P2|Overall Study|Adverse Event|0
230679|NCT01557569|761019|P1|Overall Study|Adverse Event|2
230680|NCT01557504|761027|P2|Overall Study|Physician Decision|0
230681|NCT01557504|761028|P1|Overall Study|Physician Decision|1
230682|NCT01557348|761053|P2|Overall Study|Administrative|11
230683|NCT01557348|761054|P1|Overall Study|Administrative|18
230684|NCT01557348|761053|P2|Overall Study|Lost to Follow-up|22
230685|NCT01557348|761054|P1|Overall Study|Lost to Follow-up|26
230686|NCT01557348|761053|P2|Overall Study|Withdrawal by Subject|4
230687|NCT01557348|761054|P1|Overall Study|Withdrawal by Subject|5
230688|NCT01557348|761053|P2|Overall Study|Insufficient Therapeutic Response|28
230689|NCT01557348|761054|P1|Overall Study|Insufficient Therapeutic Response|13
230690|NCT01557348|761053|P2|Overall Study|Death|4
230691|NCT01557348|761054|P1|Overall Study|Death|7
230692|NCT01557348|761053|P2|Overall Study|Infusion reaction event|5
230693|NCT01557348|761054|P1|Overall Study|Infusion reaction event|5
230694|NCT01557348|761053|P2|Overall Study|Adverse Event|16
230695|NCT01557348|761054|P1|Overall Study|Adverse Event|6
230696|NCT01557283|761171|P1|Overall Study|Unspecified|6
230697|NCT01557283|761171|P1|Overall Study|Worsening of psoriasis|1
230698|NCT01557283|761171|P1|Overall Study|Participant’s weight too high for dose|1
230699|NCT01557283|761171|P1|Overall Study|Withdrawal by Subject|1
230700|NCT01557283|761171|P1|Overall Study|Non-compliance|1
230701|NCT01557283|761171|P1|Overall Study|Lack of Efficacy|1
230702|NCT01557283|761171|P1|Overall Study|Adverse Event|7
230703|NCT01557283|761171|P1|Overall Study|Non-responder|19
230704|NCT01557283|761171|P1|Overall Study|Lost to Follow-up|7
230705|NCT01557166|761183|P2|Overall Study|Unclassified|5
230706|NCT01557166|761184|P1|Overall Study|Unclassified|2
230707|NCT01557166|761183|P2|Overall Study|Psychiatric disorder|0
230708|NCT01557166|761184|P1|Overall Study|Psychiatric disorder|1
230709|NCT01557166|761183|P2|Overall Study|Target dose not tolerated|0
230710|NCT01557166|761184|P1|Overall Study|Target dose not tolerated|1
230711|NCT01557166|761183|P2|Overall Study|Withdrawn consent|20
230712|NCT01557166|761184|P1|Overall Study|Withdrawn consent|12
230713|NCT01557166|761183|P2|Overall Study|Protocol Violation|5
230714|NCT01557166|761184|P1|Overall Study|Protocol Violation|8
230715|NCT01557166|761183|P2|Overall Study|Lack of Efficacy|1
230716|NCT01557166|761184|P1|Overall Study|Lack of Efficacy|2
230717|NCT01557166|761183|P2|Overall Study|Adverse Event|6
230718|NCT01557166|761184|P1|Overall Study|Adverse Event|20
230719|NCT01556997|761199|P3|Overall Study|Not specified|7
230720|NCT01556997|761200|P2|Overall Study|Not specified|3
230721|NCT01556997|761201|P1|Overall Study|Not specified|2
230722|NCT01556997|761199|P3|Overall Study|Withdrawal by Subject|8
230723|NCT01556997|761200|P2|Overall Study|Withdrawal by Subject|6
230724|NCT01556997|761201|P1|Overall Study|Withdrawal by Subject|7
230725|NCT01556997|761199|P3|Overall Study|Physician Decision|1
230726|NCT01556997|761200|P2|Overall Study|Physician Decision|1
230727|NCT01556997|761201|P1|Overall Study|Physician Decision|1
230728|NCT01556997|761199|P3|Overall Study|Lost to Follow-up|4
230729|NCT01556997|761200|P2|Overall Study|Lost to Follow-up|6
230730|NCT01556997|761201|P1|Overall Study|Lost to Follow-up|6
230731|NCT01556997|761199|P3|Overall Study|Adverse Event|12
230732|NCT01556997|761200|P2|Overall Study|Adverse Event|12
230733|NCT01556997|761201|P1|Overall Study|Adverse Event|10
230734|NCT01556932|761212|P2|Time Point 60 Minutes|Withdrawal by Subject|1
230735|NCT01556932|761213|P1|Time Point 60 Minutes|Withdrawal by Subject|1
230736|NCT01556763|761239|P3|Overall Study|Withdrawal by Subject|0
230737|NCT01556763|761240|P2|Overall Study|Withdrawal by Subject|1
230738|NCT01556763|761241|P1|Overall Study|Withdrawal by Subject|0
230739|NCT01555463|761279|P2|Follow up|Other reason|3
230740|NCT01555463|761280|P1|Follow up|Other reason|3
230741|NCT01555463|761279|P2|Follow up|Protocol Violation|4
230742|NCT01555463|761280|P1|Follow up|Protocol Violation|2
230743|NCT01555463|761279|P2|Follow up|Lost to Follow-up|10
230744|NCT01555463|761280|P1|Follow up|Lost to Follow-up|9
230745|NCT01555463|761279|P2|Follow up|Withdrawal by Subject|22
230746|NCT01555463|761280|P1|Follow up|Withdrawal by Subject|22
230747|NCT01555463|761279|P2|Follow up|Death|1
230748|NCT01555463|761280|P1|Follow up|Death|0
230749|NCT01555463|761279|P2|Follow up|Adverse Event|5
230750|NCT01555463|761280|P1|Follow up|Adverse Event|2
230751|NCT01555463|761279|P2|Treatment|Other reason|3
230752|NCT01555463|761280|P1|Treatment|Other reason|2
230753|NCT01555463|761279|P2|Treatment|Protocol Violation|5
230754|NCT01555463|761280|P1|Treatment|Protocol Violation|4
230755|NCT01555463|761279|P2|Treatment|Lost to Follow-up|23
230756|NCT01555463|761280|P1|Treatment|Lost to Follow-up|28
230757|NCT01555463|761279|P2|Treatment|Withdrawal by Subject|36
230758|NCT01555463|761280|P1|Treatment|Withdrawal by Subject|24
230759|NCT01555463|761279|P2|Treatment|Adverse Event|12
230760|NCT01555463|761280|P1|Treatment|Adverse Event|6
230761|NCT01556165|761397|P2|Overall Study|Withdrawal of Consent|1
230762|NCT01556165|761398|P1|Overall Study|Withdrawal of Consent|7
230763|NCT01556165|761397|P2|Overall Study|Protocol Violation|3
230764|NCT01556165|761398|P1|Overall Study|Protocol Violation|0
230765|NCT01556165|761397|P2|Overall Study|Adverse Event|3
230766|NCT01556165|761398|P1|Overall Study|Adverse Event|5
230767|NCT01555983|761423|P6|Overall Study|Withdrawal by Subject|1
230768|NCT01555983|761424|P5|Overall Study|Withdrawal by Subject|1
230769|NCT01555983|761425|P4|Overall Study|Withdrawal by Subject|0
230770|NCT01555983|761426|P3|Overall Study|Withdrawal by Subject|0
230771|NCT01555983|761427|P2|Overall Study|Withdrawal by Subject|0
230772|NCT01555983|761428|P1|Overall Study|Withdrawal by Subject|1
230773|NCT01555931|761438|P2|Overall Study|Lost to Follow-up|5
230774|NCT01555931|761439|P1|Overall Study|Lost to Follow-up|2
230775|NCT01555164|761449|P2|Overall Study|Subject Withdrew Consent|11
230776|NCT01555164|761450|P1|Overall Study|Subject Withdrew Consent|6
230777|NCT01555164|761449|P2|Overall Study|Subject Non-compliance|6
230778|NCT01555164|761450|P1|Overall Study|Subject Non-compliance|14
230779|NCT01555164|761449|P2|Overall Study|Protocol Violation|5
230780|NCT01555164|761450|P1|Overall Study|Protocol Violation|9
230781|NCT01555164|761449|P2|Overall Study|Lost to Follow-up|3
230782|NCT01555164|761450|P1|Overall Study|Lost to Follow-up|4
230783|NCT01555164|761449|P2|Overall Study|Investigator's Discretion|2
230784|NCT01555164|761450|P1|Overall Study|Investigator's Discretion|2
230785|NCT01555164|761449|P2|Overall Study|Hyperglycemia|1
230786|NCT01555164|761450|P1|Overall Study|Hyperglycemia|0
230787|NCT01555164|761449|P2|Overall Study|Adverse Event|7
230788|NCT01555164|761450|P1|Overall Study|Adverse Event|5
230789|NCT01555151|761464|P4|Overall Study|Lost to Follow-up|1
230790|NCT01555151|761465|P3|Overall Study|Lost to Follow-up|0
230791|NCT01555151|761466|P2|Overall Study|Lost to Follow-up|0
230792|NCT01555151|761467|P1|Overall Study|Lost to Follow-up|0
230793|NCT01555151|761464|P4|Overall Study|Adverse Event|2
230794|NCT01555151|761465|P3|Overall Study|Adverse Event|1
230795|NCT01555151|761466|P2|Overall Study|Adverse Event|2
230796|NCT01555151|761467|P1|Overall Study|Adverse Event|1
230797|NCT01555151|761464|P4|Overall Study|Protocol Violation|5
230798|NCT01555151|761465|P3|Overall Study|Protocol Violation|3
230799|NCT01555151|761466|P2|Overall Study|Protocol Violation|3
230800|NCT01555151|761467|P1|Overall Study|Protocol Violation|3
230801|NCT01555151|761464|P4|Overall Study|Administrative|0
230802|NCT01555151|761465|P3|Overall Study|Administrative|2
230803|NCT01555151|761466|P2|Overall Study|Administrative|1
230804|NCT01555151|761467|P1|Overall Study|Administrative|3
230805|NCT01555151|761464|P4|Overall Study|Withdrawal by Subject|2
230806|NCT01555151|761465|P3|Overall Study|Withdrawal by Subject|0
230807|NCT01555151|761466|P2|Overall Study|Withdrawal by Subject|2
230808|NCT01555151|761467|P1|Overall Study|Withdrawal by Subject|6
230809|NCT01555138|761520|P2|Overall Study|Adverse Event|14
230810|NCT01555138|761521|P1|Overall Study|Adverse Event|14
230811|NCT01555138|761520|P2|Overall Study|Withdrawal by Subject|15
230812|NCT01555138|761521|P1|Overall Study|Withdrawal by Subject|16
230813|NCT01555138|761520|P2|Overall Study|Administrative problems|0
230814|NCT01555138|761521|P1|Overall Study|Administrative problems|8
230815|NCT01555138|761520|P2|Overall Study|Protocol Violation|3
230816|NCT01555138|761521|P1|Overall Study|Protocol Violation|5
230817|NCT01555138|761520|P2|Overall Study|Lack of Efficacy|2
230818|NCT01555138|761521|P1|Overall Study|Lack of Efficacy|2
230819|NCT01555138|761520|P2|Overall Study|Abnormal Lab reults|3
230820|NCT01555138|761521|P1|Overall Study|Abnormal Lab reults|1
230821|NCT01555138|761520|P2|Overall Study|Lost to Follow-up|0
230822|NCT01555138|761521|P1|Overall Study|Lost to Follow-up|1
230823|NCT01555138|761520|P2|Overall Study|Death|1
230824|NCT01555138|761521|P1|Overall Study|Death|0
230825|NCT01555073|761551|P4|Overall Study|Lost to Follow-up|5
230826|NCT01555073|761552|P3|Overall Study|Lost to Follow-up|0
230827|NCT01555073|761553|P2|Overall Study|Lost to Follow-up|2
230828|NCT01555073|761554|P1|Overall Study|Lost to Follow-up|1
230829|NCT01554904|761581|P1|Overall Study|Had sleep apnea on Home Study 1|1
230830|NCT01554904|761581|P1|Overall Study|Withdrawal by Subject|3
230831|NCT01554579|761601|P2|Overall Study|Withdrawal by Subject|1
230832|NCT01554579|761602|P1|Overall Study|Withdrawal by Subject|2
230833|NCT01554579|761601|P2|Overall Study|Lack of Efficacy|1
230834|NCT01554579|761602|P1|Overall Study|Lack of Efficacy|2
230835|NCT01554579|761601|P2|Overall Study|Adverse Event|25
230836|NCT01554579|761602|P1|Overall Study|Adverse Event|6
230837|NCT01554241|761616|P4|Overall Study|Withdrawal by Subject|0
230838|NCT01554241|761617|P3|Overall Study|Withdrawal by Subject|2
230839|NCT01554241|761618|P2|Overall Study|Withdrawal by Subject|0
230840|NCT01554241|761619|P1|Overall Study|Withdrawal by Subject|0
230841|NCT01554241|761616|P4|Overall Study|protocol specified change in eGFR|0
230842|NCT01554241|761617|P3|Overall Study|protocol specified change in eGFR|1
230843|NCT01554241|761618|P2|Overall Study|protocol specified change in eGFR|0
230844|NCT01554241|761619|P1|Overall Study|protocol specified change in eGFR|0
230845|NCT01554241|761616|P4|Overall Study|protocol specified renal stone|1
230846|NCT01554241|761617|P3|Overall Study|protocol specified renal stone|0
230847|NCT01554241|761618|P2|Overall Study|protocol specified renal stone|0
230848|NCT01554241|761619|P1|Overall Study|protocol specified renal stone|0
230849|NCT01554241|761616|P4|Overall Study|Death|0
230850|NCT01554241|761617|P3|Overall Study|Death|1
230851|NCT01554241|761618|P2|Overall Study|Death|1
230852|NCT01554241|761619|P1|Overall Study|Death|3
230853|NCT01554176|761635|P5|Run-out Phase|Protocol Violation|0
230854|NCT01554176|761636|P4|Run-out Phase|Protocol Violation|1
230855|NCT01554176|761637|P3|Run-out Phase|Protocol Violation|0
230856|NCT01554176|761638|P2|Run-out Phase|Protocol Violation|0
230857|NCT01554176|761639|P1|Run-out Phase|Protocol Violation|0
230858|NCT01554176|761635|P5|Treatment Phase|Lost to Follow-up|0
230859|NCT01554176|761636|P4|Treatment Phase|Lost to Follow-up|0
230860|NCT01554176|761637|P3|Treatment Phase|Lost to Follow-up|0
230861|NCT01554176|761638|P2|Treatment Phase|Lost to Follow-up|0
230862|NCT01554176|761639|P1|Treatment Phase|Lost to Follow-up|3
230863|NCT01554176|761635|P5|Treatment Phase|Withdrawal by Subject|0
230864|NCT01554176|761636|P4|Treatment Phase|Withdrawal by Subject|0
230865|NCT01554176|761637|P3|Treatment Phase|Withdrawal by Subject|0
230866|NCT01554176|761638|P2|Treatment Phase|Withdrawal by Subject|0
230867|NCT01554176|761639|P1|Treatment Phase|Withdrawal by Subject|1
230868|NCT01554176|761635|P5|Treatment Phase|Non-compliance with study drug|0
230869|NCT01554176|761636|P4|Treatment Phase|Non-compliance with study drug|0
230870|NCT01554176|761637|P3|Treatment Phase|Non-compliance with study drug|0
230871|NCT01554176|761638|P2|Treatment Phase|Non-compliance with study drug|0
230872|NCT01554176|761639|P1|Treatment Phase|Non-compliance with study drug|1
230873|NCT01554176|761635|P5|Treatment Phase|Adverse event, non-fatal|0
230874|NCT01554176|761636|P4|Treatment Phase|Adverse event, non-fatal|0
230875|NCT01554176|761637|P3|Treatment Phase|Adverse event, non-fatal|0
230876|NCT01554176|761638|P2|Treatment Phase|Adverse event, non-fatal|1
230877|NCT01554176|761639|P1|Treatment Phase|Adverse event, non-fatal|1
230878|NCT01554176|761635|P5|Treatment Phase|Lack of Efficacy|0
230879|NCT01554176|761636|P4|Treatment Phase|Lack of Efficacy|0
230880|NCT01554176|761637|P3|Treatment Phase|Lack of Efficacy|0
230881|NCT01554176|761638|P2|Treatment Phase|Lack of Efficacy|1
230882|NCT01554176|761639|P1|Treatment Phase|Lack of Efficacy|0
230883|NCT01554176|761635|P5|Treatment Phase|Physician Decision|0
230884|NCT01554176|761636|P4|Treatment Phase|Physician Decision|0
230885|NCT01554176|761637|P3|Treatment Phase|Physician Decision|0
230886|NCT01554176|761638|P2|Treatment Phase|Physician Decision|1
230887|NCT01554176|761639|P1|Treatment Phase|Physician Decision|1
230888|NCT01554176|761635|P5|Treatment Phase|Protocol Violation|0
230889|NCT01554176|761636|P4|Treatment Phase|Protocol Violation|0
230890|NCT01554176|761637|P3|Treatment Phase|Protocol Violation|0
230891|NCT01554176|761638|P2|Treatment Phase|Protocol Violation|2
230892|NCT01554176|761639|P1|Treatment Phase|Protocol Violation|1
230893|NCT01554163|761666|P2|Overall Study|Not Treated|0
230894|NCT01554163|761667|P1|Overall Study|Not Treated|1
230895|NCT01554163|761666|P2|Overall Study|Withdrawal by Subject|5
230896|NCT01554163|761667|P1|Overall Study|Withdrawal by Subject|1
230897|NCT01554163|761666|P2|Overall Study|Protocol Violation|4
230898|NCT01554163|761667|P1|Overall Study|Protocol Violation|0
230899|NCT01554163|761666|P2|Overall Study|Non-Compliance With Study Drug|1
230900|NCT01554163|761667|P1|Overall Study|Non-Compliance With Study Drug|1
230901|NCT01554163|761666|P2|Overall Study|Lost to Follow-up|0
230902|NCT01554163|761667|P1|Overall Study|Lost to Follow-up|1
230903|NCT01554163|761666|P2|Overall Study|Lack of Efficacy|0
230904|NCT01554163|761667|P1|Overall Study|Lack of Efficacy|1
230905|NCT01554163|761666|P2|Overall Study|Adverse Event|0
230906|NCT01554163|761667|P1|Overall Study|Adverse Event|3
230907|NCT01553851|761685|P1|Overall Study|constipation|1
230908|NCT01553851|761685|P1|Overall Study|Adverse Event|2
230909|NCT01553318|761713|P2|Overall Study|Protocol Violation|2
230910|NCT01553318|761714|P1|Overall Study|Protocol Violation|3
230911|NCT01552954|761749|P2|Overall Study|diagnosed DM|0
230912|NCT01552954|761750|P1|Overall Study|diagnosed DM|1
230913|NCT01552954|761749|P2|Overall Study|Protocol Violation|2
230914|NCT01552954|761750|P1|Overall Study|Protocol Violation|1
230915|NCT01552954|761749|P2|Overall Study|Withdrawal by Subject|1
230916|NCT01552954|761750|P1|Overall Study|Withdrawal by Subject|1
230917|NCT01552954|761749|P2|Overall Study|Lost to Follow-up|1
230918|NCT01552954|761750|P1|Overall Study|Lost to Follow-up|1
230919|NCT01552954|761749|P2|Overall Study|Adverse Event|2
230920|NCT01552954|761750|P1|Overall Study|Adverse Event|1
230921|NCT01552928|761766|P4|Period 3|Adverse Event|0
230922|NCT01552928|761767|P3|Period 3|Adverse Event|1
230923|NCT01552928|761768|P2|Period 3|Adverse Event|0
230924|NCT01552928|761769|P1|Period 3|Adverse Event|0
230925|NCT01552915|761816|P3|Overall Study|Not specified|6
230926|NCT01552915|761817|P2|Overall Study|Not specified|0
230927|NCT01552915|761818|P1|Overall Study|Not specified|2
230928|NCT01552915|761816|P3|Overall Study|Lack of Efficacy|4
230929|NCT01552915|761817|P2|Overall Study|Lack of Efficacy|1
230930|NCT01552915|761818|P1|Overall Study|Lack of Efficacy|8
230931|NCT01552915|761816|P3|Overall Study|Protocol Violation|4
230932|NCT01552915|761817|P2|Overall Study|Protocol Violation|4
230933|NCT01552915|761818|P1|Overall Study|Protocol Violation|0
230934|NCT01552915|761816|P3|Overall Study|Withdrawal by Subject|5
230935|NCT01552915|761817|P2|Overall Study|Withdrawal by Subject|4
230936|NCT01552915|761818|P1|Overall Study|Withdrawal by Subject|6
230937|NCT01552915|761816|P3|Overall Study|Lost to Follow-up|5
230938|NCT01552915|761817|P2|Overall Study|Lost to Follow-up|6
230939|NCT01552915|761818|P1|Overall Study|Lost to Follow-up|4
230940|NCT01552915|761816|P3|Overall Study|Adverse Event|3
230941|NCT01552915|761817|P2|Overall Study|Adverse Event|14
230942|NCT01552915|761818|P1|Overall Study|Adverse Event|3
230943|NCT01552902|761841|P3|Overall Study|Unspecified|3
230944|NCT01552902|761842|P2|Overall Study|Unspecified|4
230945|NCT01552902|761843|P1|Overall Study|Unspecified|3
230946|NCT01552902|761841|P3|Overall Study|Lost to Follow-up|6
230947|NCT01552902|761842|P2|Overall Study|Lost to Follow-up|3
230948|NCT01552902|761843|P1|Overall Study|Lost to Follow-up|1
230949|NCT01552902|761841|P3|Overall Study|Withdrawal by Subject|6
230950|NCT01552902|761842|P2|Overall Study|Withdrawal by Subject|9
230951|NCT01552902|761843|P1|Overall Study|Withdrawal by Subject|1
230952|NCT01552902|761841|P3|Overall Study|Lack of Efficacy|1
230953|NCT01552902|761842|P2|Overall Study|Lack of Efficacy|3
230954|NCT01552902|761843|P1|Overall Study|Lack of Efficacy|4
230955|NCT01552902|761841|P3|Overall Study|Protocol Violation|3
230956|NCT01552902|761842|P2|Overall Study|Protocol Violation|3
230957|NCT01552902|761843|P1|Overall Study|Protocol Violation|3
230958|NCT01552902|761841|P3|Overall Study|Adverse Event|14
230959|NCT01552902|761842|P2|Overall Study|Adverse Event|15
230960|NCT01552902|761843|P1|Overall Study|Adverse Event|1
230961|NCT01552772|761893|P1|Overall Study|Protocol Deviation|1
230962|NCT01552772|761893|P1|Overall Study|Adverse Event|1
230963|NCT01552772|761893|P1|Overall Study|Lost to Follow-up|2
230964|NCT01552694|761909|P2|Overall Study|Protocol Violation|1
230965|NCT01552694|761910|P1|Overall Study|Protocol Violation|0
230966|NCT01552694|761909|P2|Overall Study|Lost to Follow-up|1
230967|NCT01552694|761910|P1|Overall Study|Lost to Follow-up|0
230968|NCT01552681|761922|P2|Overall Study|Subject moved away|1
230969|NCT01552681|761923|P1|Overall Study|Subject moved away|0
230970|NCT01552681|761922|P2|Overall Study|Physician Decision|0
230971|NCT01552681|761923|P1|Overall Study|Physician Decision|1
230972|NCT01552681|761922|P2|Overall Study|Withdrawal by Subject|0
230973|NCT01552681|761923|P1|Overall Study|Withdrawal by Subject|4
230974|NCT01552603|761971|P1|Overall Study|Physician Decision|1
230975|NCT01552057|762001|P2|Overall Study|Physician Decision|0
230976|NCT01552057|762002|P1|Overall Study|Physician Decision|1
230977|NCT01552057|762001|P2|Overall Study|Entry Criteria Not Met|2
230978|NCT01552057|762002|P1|Overall Study|Entry Criteria Not Met|2
230979|NCT01552057|762001|P2|Overall Study|Withdrawal by Subject|8
230980|NCT01552057|762002|P1|Overall Study|Withdrawal by Subject|5
230981|NCT01552057|762001|P2|Overall Study|Lack of Efficacy|23
230982|NCT01552057|762002|P1|Overall Study|Lack of Efficacy|8
230983|NCT01552057|762001|P2|Overall Study|Adverse Event|15
230984|NCT01552057|762002|P1|Overall Study|Adverse Event|14
230985|NCT01551758|762068|P2|Overall Study|Withdrawal by Subject|17
230986|NCT01551758|762069|P1|Overall Study|Withdrawal by Subject|14
230987|NCT01551758|762068|P2|Overall Study|Physician Decision|3
230988|NCT01551758|762069|P1|Overall Study|Physician Decision|9
230989|NCT01551758|762068|P2|Overall Study|Lost to Follow-up|25
230990|NCT01551758|762069|P1|Overall Study|Lost to Follow-up|29
230991|NCT01551758|762068|P2|Overall Study|Met Protocol-defined stopping criteria|10
230992|NCT01551758|762069|P1|Overall Study|Met Protocol-defined stopping criteria|8
230993|NCT01551758|762068|P2|Overall Study|Protocol Violation|6
230994|NCT01551758|762069|P1|Overall Study|Protocol Violation|5
230995|NCT01551758|762068|P2|Overall Study|Lack of Efficacy|1
230996|NCT01551758|762069|P1|Overall Study|Lack of Efficacy|0
230997|NCT01551758|762068|P2|Overall Study|Adverse Event|43
230998|NCT01551758|762069|P1|Overall Study|Adverse Event|29
230999|NCT01551693|762109|P2|Overall Study|Withdrawal by Subject|1
231000|NCT01551693|762110|P1|Overall Study|Withdrawal by Subject|0
231001|NCT01551693|762109|P2|Overall Study|Adverse Event|1
231002|NCT01551693|762110|P1|Overall Study|Adverse Event|0
231003|NCT01551693|762109|P2|Overall Study|Disease Progression|0
231004|NCT01551693|762110|P1|Overall Study|Disease Progression|1
231005|NCT01551355|762126|P6|Overall Study|Lost to Follow-up|6
231006|NCT01551355|762127|P5|Overall Study|Lost to Follow-up|9
231007|NCT01551355|762128|P4|Overall Study|Lost to Follow-up|24
231008|NCT01551355|762129|P3|Overall Study|Lost to Follow-up|34
231009|NCT01551355|762130|P2|Overall Study|Lost to Follow-up|49
231010|NCT01551355|762131|P1|Overall Study|Lost to Follow-up|51
231011|NCT01551303|762145|P2|Overall Study|failed awareness check on vision test|7
231012|NCT01551303|762146|P1|Overall Study|failed awareness check on vision test|4
231013|NCT01551173|762160|P2|Overall Study|Not specified|3
231014|NCT01551173|762161|P1|Overall Study|Not specified|5
231015|NCT01551173|762160|P2|Overall Study|Lost to Follow-up|7
231016|NCT01551173|762161|P1|Overall Study|Lost to Follow-up|5
231017|NCT01551173|762160|P2|Overall Study|Adverse Event|6
231018|NCT01551173|762161|P1|Overall Study|Adverse Event|7
231019|NCT01551173|762160|P2|Overall Study|Withdrawal by Subject|16
231020|NCT01551173|762161|P1|Overall Study|Withdrawal by Subject|11
231021|NCT01550965|762181|P1|Overall Study|Not Specified|13
231022|NCT01550965|762181|P1|Overall Study|Lack of Efficacy|59
231023|NCT01550965|762181|P1|Overall Study|Lost to Follow-up|2
231024|NCT01550965|762181|P1|Overall Study|Withdrawal by Subject|10
231025|NCT01550965|762181|P1|Overall Study|Adverse Event|26
231026|NCT01550744|762221|P3|Double-Blind|unspecified|10
231027|NCT01550744|762222|P2|Double-Blind|unspecified|2
231028|NCT01550744|762223|P1|Double-Blind|unspecified|0
231029|NCT01550744|762221|P3|Double-Blind|Pregnancy|3
231030|NCT01550744|762222|P2|Double-Blind|Pregnancy|0
231031|NCT01550744|762223|P1|Double-Blind|Pregnancy|0
231032|NCT01550744|762221|P3|Double-Blind|Protocol Violation|4
231033|NCT01550744|762222|P2|Double-Blind|Protocol Violation|0
231034|NCT01550744|762223|P1|Double-Blind|Protocol Violation|0
231035|NCT01550744|762221|P3|Double-Blind|Lack of Efficacy|8
231036|NCT01550744|762222|P2|Double-Blind|Lack of Efficacy|2
231037|NCT01550744|762223|P1|Double-Blind|Lack of Efficacy|0
231038|NCT01550744|762221|P3|Double-Blind|Death|0
231039|NCT01550744|762222|P2|Double-Blind|Death|1
231040|NCT01550744|762223|P1|Double-Blind|Death|0
231041|NCT01550744|762221|P3|Double-Blind|Adverse Event|15
231042|NCT01550744|762222|P2|Double-Blind|Adverse Event|4
231043|NCT01550744|762223|P1|Double-Blind|Adverse Event|0
231044|NCT01550744|762221|P3|Double-Blind|Withdrawal by Subject|15
231045|NCT01550744|762222|P2|Double-Blind|Withdrawal by Subject|2
231046|NCT01550744|762223|P1|Double-Blind|Withdrawal by Subject|0
231047|NCT01550744|762221|P3|Double-Blind|Lost to Follow-up|12
231048|NCT01550744|762222|P2|Double-Blind|Lost to Follow-up|6
231049|NCT01550744|762223|P1|Double-Blind|Lost to Follow-up|0
231050|NCT01550744|762221|P3|Open-Label|unspecified|0
231051|NCT01550744|762222|P2|Open-Label|unspecified|0
231052|NCT01550744|762223|P1|Open-Label|unspecified|1
231053|NCT01550744|762221|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
231054|NCT01550744|762222|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
231055|NCT01550744|762223|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
231056|NCT01550744|762221|P3|Open-Label|Not all 3 study drug injections received|0
231057|NCT01550744|762222|P2|Open-Label|Not all 3 study drug injections received|0
231058|NCT01550744|762223|P1|Open-Label|Not all 3 study drug injections received|2
231059|NCT01550744|762221|P3|Open-Label|Protocol Violation|0
231060|NCT01550744|762222|P2|Open-Label|Protocol Violation|0
231061|NCT01550744|762223|P1|Open-Label|Protocol Violation|4
231062|NCT01550744|762221|P3|Open-Label|Lack of Efficacy|0
231063|NCT01550744|762222|P2|Open-Label|Lack of Efficacy|0
231064|NCT01550744|762223|P1|Open-Label|Lack of Efficacy|4
231065|NCT01550744|762221|P3|Open-Label|Adverse Event|0
231066|NCT01550744|762222|P2|Open-Label|Adverse Event|0
231067|NCT01550744|762223|P1|Open-Label|Adverse Event|11
231068|NCT01550744|762221|P3|Open-Label|Withdrawal by Subject|0
231069|NCT01550744|762222|P2|Open-Label|Withdrawal by Subject|0
231070|NCT01550744|762223|P1|Open-Label|Withdrawal by Subject|13
231071|NCT01550744|762221|P3|Open-Label|Lost to Follow-up|0
231072|NCT01550744|762222|P2|Open-Label|Lost to Follow-up|0
231073|NCT01550744|762223|P1|Open-Label|Lost to Follow-up|7
231074|NCT01550289|762264|P2|Overall Study|Withdrawal by Subject|3
231075|NCT01550289|762265|P1|Overall Study|Withdrawal by Subject|11
231076|NCT01550289|762264|P2|Overall Study|Lost to Follow-up|1
231077|NCT01550289|762265|P1|Overall Study|Lost to Follow-up|1
231078|NCT01550289|762264|P2|Overall Study|Protocol Violation|0
231079|NCT01550289|762265|P1|Overall Study|Protocol Violation|1
231080|NCT01549964|762316|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
231081|NCT01549964|762317|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
231082|NCT01549964|762318|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
231083|NCT01549964|762319|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
231084|NCT01549964|762316|P4|80-Week Extension Period|Lost to Follow-up|1
231085|NCT01549964|762317|P3|80-Week Extension Period|Lost to Follow-up|2
231086|NCT01549964|762318|P2|80-Week Extension Period|Lost to Follow-up|0
231087|NCT01549964|762319|P1|80-Week Extension Period|Lost to Follow-up|1
231088|NCT01549964|762316|P4|80-Week Extension Period|Voluntary Withdrawal|2
231089|NCT01549964|762317|P3|80-Week Extension Period|Voluntary Withdrawal|4
231090|NCT01549964|762318|P2|80-Week Extension Period|Voluntary Withdrawal|1
231091|NCT01549964|762319|P1|80-Week Extension Period|Voluntary Withdrawal|0
231092|NCT01549964|762316|P4|80-Week Extension Period|Study Terminated by Sponsor|132
231093|NCT01549964|762317|P3|80-Week Extension Period|Study Terminated by Sponsor|132
231094|NCT01549964|762318|P2|80-Week Extension Period|Study Terminated by Sponsor|137
231095|NCT01549964|762319|P1|80-Week Extension Period|Study Terminated by Sponsor|65
231096|NCT01549964|762316|P4|80-Week Extension Period|Pregnancy|0
231097|NCT01549964|762317|P3|80-Week Extension Period|Pregnancy|1
231098|NCT01549964|762318|P2|80-Week Extension Period|Pregnancy|0
231099|NCT01549964|762319|P1|80-Week Extension Period|Pregnancy|0
231100|NCT01549964|762316|P4|24-Week Treatment Period|Completion Status Unknown|0
231101|NCT01549964|762317|P3|24-Week Treatment Period|Completion Status Unknown|1
231102|NCT01549964|762318|P2|24-Week Treatment Period|Completion Status Unknown|0
231103|NCT01549964|762319|P1|24-Week Treatment Period|Completion Status Unknown|1
231104|NCT01549964|762316|P4|24-Week Treatment Period|Randomized but Not Treated|1
231105|NCT01549964|762317|P3|24-Week Treatment Period|Randomized but Not Treated|0
231106|NCT01549964|762318|P2|24-Week Treatment Period|Randomized but Not Treated|0
231107|NCT01549964|762319|P1|24-Week Treatment Period|Randomized but Not Treated|0
231108|NCT01549964|762316|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
231109|NCT01549964|762317|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
231110|NCT01549964|762318|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
231111|NCT01549964|762319|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
231112|NCT01549964|762316|P4|24-Week Treatment Period|Other|0
231113|NCT01549964|762317|P3|24-Week Treatment Period|Other|1
231114|NCT01549964|762318|P2|24-Week Treatment Period|Other|0
231115|NCT01549964|762319|P1|24-Week Treatment Period|Other|1
231116|NCT01549964|762316|P4|24-Week Treatment Period|Lack of Efficacy|1
231117|NCT01549964|762317|P3|24-Week Treatment Period|Lack of Efficacy|1
231118|NCT01549964|762318|P2|24-Week Treatment Period|Lack of Efficacy|0
231119|NCT01549964|762319|P1|24-Week Treatment Period|Lack of Efficacy|1
231120|NCT01549964|762316|P4|24-Week Treatment Period|Lost to Follow-up|2
231121|NCT01549964|762317|P3|24-Week Treatment Period|Lost to Follow-up|1
231122|NCT01549964|762318|P2|24-Week Treatment Period|Lost to Follow-up|0
231123|NCT01549964|762319|P1|24-Week Treatment Period|Lost to Follow-up|1
231124|NCT01549964|762316|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
231125|NCT01549964|762317|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
231126|NCT01549964|762318|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
231127|NCT01549964|762319|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
231128|NCT01549964|762316|P4|24-Week Treatment Period|Voluntary Withdrawal|8
231129|NCT01549964|762317|P3|24-Week Treatment Period|Voluntary Withdrawal|3
231130|NCT01549964|762318|P2|24-Week Treatment Period|Voluntary Withdrawal|3
231131|NCT01549964|762319|P1|24-Week Treatment Period|Voluntary Withdrawal|6
231132|NCT01549964|762316|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
231133|NCT01549964|762317|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
231134|NCT01549964|762318|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
231135|NCT01549964|762319|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
231136|NCT01549951|762337|P1|Overall Study|Other|2
231137|NCT01549951|762337|P1|Overall Study|Symptomatic deterioration|1
231138|NCT01549951|762337|P1|Overall Study|Progressive disease|29
231139|NCT01549951|762337|P1|Overall Study|Unsatisfactory therapeutic response|1
231140|NCT01549951|762337|P1|Overall Study|Withdrawal by Subject|2
231141|NCT01549951|762337|P1|Overall Study|Adverse Event|15
231142|NCT01549873|762364|P2|Overall Study|Physician Decision|1
231143|NCT01549873|762365|P1|Overall Study|Physician Decision|0
231144|NCT01549860|762377|P2|Overall Study|Physician Decision|1
231145|NCT01549860|762378|P1|Overall Study|Physician Decision|1
231146|NCT01549860|762377|P2|Overall Study|Withdrawal by Subject|0
231147|NCT01549860|762378|P1|Overall Study|Withdrawal by Subject|1
231148|NCT01549613|762390|P2|Overall Study|Lost to Follow-up|11
231149|NCT01549613|762391|P1|Overall Study|Lost to Follow-up|11
231150|NCT01549392|762410|P2|Overall Study|Withdrawal by Subject|0
231151|NCT01549392|762411|P1|Overall Study|Withdrawal by Subject|1
231152|NCT01549275|762430|P2|Overall Study|Lost to Follow-up|0
231153|NCT01549275|762431|P1|Overall Study|Lost to Follow-up|1
231154|NCT01549041|762443|P2|Overall Study|Adverse Event|4
231155|NCT01549041|762444|P1|Overall Study|Adverse Event|0
231156|NCT01549041|762443|P2|Overall Study|Lack of Efficacy|4
231157|NCT01549041|762444|P1|Overall Study|Lack of Efficacy|2
231158|NCT01548638|762491|P1|Overall Study|Withdrawal by Subject|1
231159|NCT01548638|762491|P1|Overall Study|Protocol Violation|3
231160|NCT01548573|762498|P1|Overall Study|Withdrawal by Subject|2
231161|NCT01548573|762498|P1|Overall Study|Death|3
231162|NCT01548417|762507|P2|Overall Study|Withdrawal by Subject|2
231163|NCT01548417|762508|P1|Overall Study|Withdrawal by Subject|0
231164|NCT01548287|762520|P5|Randomized Period|Adverse Event|0
231165|NCT01548287|762521|P4|Randomized Period|Adverse Event|0
231166|NCT01548287|762522|P3|Randomized Period|Adverse Event|5
231167|NCT01548287|762523|P2|Randomized Period|Adverse Event|2
231168|NCT01548287|762524|P1|Randomized Period|Adverse Event|0
231169|NCT01548287|762520|P5|Randomized Period|Did not meet inclusion criteria|0
231170|NCT01548287|762521|P4|Randomized Period|Did not meet inclusion criteria|0
231171|NCT01548287|762522|P3|Randomized Period|Did not meet inclusion criteria|2
231172|NCT01548287|762523|P2|Randomized Period|Did not meet inclusion criteria|0
231173|NCT01548287|762524|P1|Randomized Period|Did not meet inclusion criteria|0
231174|NCT01548287|762520|P5|Screening|Did not meet eligibility criteria|74
231175|NCT01548287|762521|P4|Screening|Did not meet eligibility criteria|0
231176|NCT01548287|762522|P3|Screening|Did not meet eligibility criteria|0
231177|NCT01548287|762523|P2|Screening|Did not meet eligibility criteria|0
231178|NCT01548287|762524|P1|Screening|Did not meet eligibility criteria|0
231179|NCT01548287|762520|P5|Screening|No reason provided|9
231180|NCT01548287|762521|P4|Screening|No reason provided|0
231181|NCT01548287|762522|P3|Screening|No reason provided|0
231182|NCT01548287|762523|P2|Screening|No reason provided|0
231183|NCT01548287|762524|P1|Screening|No reason provided|0
231184|NCT01547728|762554|P1|Overall Study|Screen failure|39
231185|NCT01547728|762554|P1|Overall Study|Drug not ready for subject|1
231186|NCT01547728|762554|P1|Overall Study|Change in procedure and equipment|1
231187|NCT01547598|762663|P2|Overall Study|Other Miscellaneous Reasons|1
231188|NCT01547598|762664|P1|Overall Study|Other Miscellaneous Reasons|2
231189|NCT01547598|762663|P2|Overall Study|Protocol Violation|1
231190|NCT01547598|762664|P1|Overall Study|Protocol Violation|1
231191|NCT01547598|762663|P2|Overall Study|Adverse Event|1
231192|NCT01547598|762664|P1|Overall Study|Adverse Event|1
231193|NCT01547598|762663|P2|Overall Study|Lost to Follow-up|1
231194|NCT01547598|762664|P1|Overall Study|Lost to Follow-up|1
231195|NCT01547598|762663|P2|Overall Study|Withdrew consent|1
231196|NCT01547598|762664|P1|Overall Study|Withdrew consent|1
231197|NCT01547286|762742|P1|Overall Study|Physician Decision|1
231198|NCT01547286|762742|P1|Overall Study|Did not meet all eligibility criteria|1
231199|NCT01547130|762760|P2|Overall Study|Lost to Follow-up|5
231200|NCT01547130|762761|P1|Overall Study|Lost to Follow-up|9
231201|NCT01546922|762775|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
231202|NCT01546922|762776|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
231203|NCT01546922|762775|P2|Second Period of 10 Weeks|Protocol Violation|1
231204|NCT01546922|762776|P1|Second Period of 10 Weeks|Protocol Violation|3
231205|NCT01546922|762775|P2|First Period of 10 Weeks|Investigator's judgment|0
231206|NCT01546922|762776|P1|First Period of 10 Weeks|Investigator's judgment|1
231207|NCT01546922|762775|P2|First Period of 10 Weeks|Withdrawal by Subject|1
231208|NCT01546922|762776|P1|First Period of 10 Weeks|Withdrawal by Subject|1
231209|NCT01546922|762775|P2|First Period of 10 Weeks|Protocol Violation|1
231210|NCT01546922|762776|P1|First Period of 10 Weeks|Protocol Violation|3
231211|NCT01546883|762782|P1|Overall Study|other unrelated illness|1
231212|NCT01546883|762782|P1|Overall Study|early closure of study|2
231213|NCT01546883|762782|P1|Overall Study|Lost to Follow-up|2
231214|NCT01546883|762782|P1|Overall Study|Adverse Event|4
231215|NCT01546883|762782|P1|Overall Study|Withdrawal by Subject|3
231216|NCT01546688|762788|P2|Overall Study|Lack of Efficacy|0
231217|NCT01546688|762789|P1|Overall Study|Lack of Efficacy|1
231218|NCT01546688|762788|P2|Overall Study|Withdrawal by Subject|1
231219|NCT01546688|762789|P1|Overall Study|Withdrawal by Subject|2
231220|NCT01546688|762788|P2|Overall Study|Adverse Event|4
231221|NCT01546688|762789|P1|Overall Study|Adverse Event|0
231222|NCT01546649|762821|P2|Overall Study|Withdrawal by Subject|2
231223|NCT01546649|762822|P1|Overall Study|Withdrawal by Subject|1
231224|NCT01546649|762821|P2|Overall Study|Discovery of secondary cancer|1
231225|NCT01546649|762822|P1|Overall Study|Discovery of secondary cancer|0
231226|NCT01546649|762821|P2|Overall Study|Recurrence|1
231227|NCT01546649|762822|P1|Overall Study|Recurrence|1
231228|NCT01546649|762821|P2|Overall Study|Lack of Efficacy|0
231229|NCT01546649|762822|P1|Overall Study|Lack of Efficacy|1
231230|NCT01546649|762821|P2|Overall Study|Protocol Violation|0
231231|NCT01546649|762822|P1|Overall Study|Protocol Violation|1
231232|NCT01546649|762821|P2|Overall Study|Adverse Event|5
231233|NCT01546649|762822|P1|Overall Study|Adverse Event|4
231234|NCT01546623|762857|P2|Overall Study|Did Not Receive Study Drug|1
231235|NCT01546623|762858|P1|Overall Study|Did Not Receive Study Drug|1
231236|NCT01546623|762857|P2|Overall Study|High Prostate specific antigen|1
231237|NCT01546623|762858|P1|Overall Study|High Prostate specific antigen|2
231238|NCT01546623|762857|P2|Overall Study|Major Protocol Deviation|1
231239|NCT01546623|762858|P1|Overall Study|Major Protocol Deviation|1
231240|NCT01546623|762857|P2|Overall Study|Adverse Event|3
231241|NCT01546623|762858|P1|Overall Study|Adverse Event|2
231242|NCT01546519|762888|P4|Overall Study|Withdrawal by Subject|0
231243|NCT01546519|762889|P3|Overall Study|Withdrawal by Subject|0
231244|NCT01546519|762890|P2|Overall Study|Withdrawal by Subject|0
231245|NCT01546519|762891|P1|Overall Study|Withdrawal by Subject|1
231246|NCT01546519|762888|P4|Overall Study|Physician Decision|3
231247|NCT01546519|762889|P3|Overall Study|Physician Decision|2
231248|NCT01546519|762890|P2|Overall Study|Physician Decision|5
231249|NCT01546519|762891|P1|Overall Study|Physician Decision|6
231250|NCT01546519|762888|P4|Overall Study|related to disease progression|1
231251|NCT01546519|762889|P3|Overall Study|related to disease progression|2
231252|NCT01546519|762890|P2|Overall Study|related to disease progression|2
231253|NCT01546519|762891|P1|Overall Study|related to disease progression|2
231254|NCT01546519|762888|P4|Overall Study|Death|1
231255|NCT01546519|762889|P3|Overall Study|Death|3
231256|NCT01546519|762890|P2|Overall Study|Death|1
231257|NCT01546519|762891|P1|Overall Study|Death|0
231258|NCT01546519|762888|P4|Overall Study|Adverse Event|1
231259|NCT01546519|762889|P3|Overall Study|Adverse Event|1
231260|NCT01546519|762890|P2|Overall Study|Adverse Event|0
231261|NCT01546519|762891|P1|Overall Study|Adverse Event|0
231262|NCT01546207|762956|P1|Overall Study|Death|1
231263|NCT01546155|762969|P1|Overall Study|could not tolerate long scan duration|3
231264|NCT01546142|762975|P2|Overall Study|Subject Randomized but Not Treated|0
231265|NCT01546142|762976|P1|Overall Study|Subject Randomized but Not Treated|1
231266|NCT01546142|762975|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
231267|NCT01546142|762976|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
231268|NCT01546142|762975|P2|Overall Study|Lost to Follow-up|15
231269|NCT01546142|762976|P1|Overall Study|Lost to Follow-up|20
231270|NCT01546142|762975|P2|Overall Study|Adverse Event|3
231271|NCT01546142|762976|P1|Overall Study|Adverse Event|6
231272|NCT01546142|762975|P2|Overall Study|Subject Noncompliance|1
231273|NCT01546142|762976|P1|Overall Study|Subject Noncompliance|1
231274|NCT01546142|762975|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
231275|NCT01546142|762976|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
231276|NCT01545388|763067|P3|Overall Study|Not specified|0
231277|NCT01545388|763068|P2|Overall Study|Not specified|1
231278|NCT01545388|763069|P1|Overall Study|Not specified|1
231279|NCT01545388|763067|P3|Overall Study|Withdrawal by Subject|2
231280|NCT01545388|763068|P2|Overall Study|Withdrawal by Subject|4
231281|NCT01545388|763069|P1|Overall Study|Withdrawal by Subject|1
231282|NCT01545388|763067|P3|Overall Study|Participant moved or relocated|0
231283|NCT01545388|763068|P2|Overall Study|Participant moved or relocated|0
231284|NCT01545388|763069|P1|Overall Study|Participant moved or relocated|1
231285|NCT01545388|763067|P3|Overall Study|Lack of Efficacy|5
231286|NCT01545388|763068|P2|Overall Study|Lack of Efficacy|2
231287|NCT01545388|763069|P1|Overall Study|Lack of Efficacy|3
231288|NCT01545388|763067|P3|Overall Study|Adverse Event|1
231289|NCT01545388|763068|P2|Overall Study|Adverse Event|4
231290|NCT01545388|763069|P1|Overall Study|Adverse Event|2
231291|NCT01544153|763149|P4|Overall Study|Non-smoker|0
231292|NCT01544153|763150|P3|Overall Study|Non-smoker|1
231293|NCT01544153|763151|P2|Overall Study|Non-smoker|0
231294|NCT01544153|763152|P1|Overall Study|Non-smoker|0
231295|NCT01544153|763149|P4|Overall Study|Under 18|0
231296|NCT01544153|763150|P3|Overall Study|Under 18|0
231297|NCT01544153|763151|P2|Overall Study|Under 18|1
231298|NCT01544153|763152|P1|Overall Study|Under 18|0
231299|NCT01544920|763233|P2|Overall Study|Withdrawal by Subject|4
231300|NCT01544920|763234|P1|Overall Study|Withdrawal by Subject|4
231301|NCT01544920|763233|P2|Overall Study|Physician Decision|1
231302|NCT01544920|763234|P1|Overall Study|Physician Decision|4
231303|NCT01544920|763233|P2|Overall Study|Protocol Violation|2
231304|NCT01544920|763234|P1|Overall Study|Protocol Violation|0
231305|NCT01544920|763233|P2|Overall Study|Lost to Follow-up|12
231306|NCT01544920|763234|P1|Overall Study|Lost to Follow-up|11
231307|NCT01544920|763233|P2|Overall Study|Death|1
231308|NCT01544920|763234|P1|Overall Study|Death|0
231309|NCT01544920|763233|P2|Overall Study|Adverse Event|3
231310|NCT01544920|763234|P1|Overall Study|Adverse Event|0
231311|NCT01544582|763245|P4|Analysis Population|Participant in Jail|0
231312|NCT01544582|763246|P3|Analysis Population|Participant in Jail|1
231313|NCT01544582|763247|P2|Analysis Population|Participant in Jail|0
231314|NCT01544582|763248|P1|Analysis Population|Participant in Jail|0
231315|NCT01544582|763245|P4|Analysis Population|Programmed Surgery|0
231316|NCT01544582|763246|P3|Analysis Population|Programmed Surgery|0
231317|NCT01544582|763247|P2|Analysis Population|Programmed Surgery|1
231318|NCT01544582|763248|P1|Analysis Population|Programmed Surgery|0
231319|NCT01544582|763245|P4|Analysis Population|Poor Participant Compliance|0
231320|NCT01544582|763246|P3|Analysis Population|Poor Participant Compliance|0
231321|NCT01544582|763247|P2|Analysis Population|Poor Participant Compliance|1
231322|NCT01544582|763248|P1|Analysis Population|Poor Participant Compliance|0
231323|NCT01544582|763245|P4|Analysis Population|Poor Adherence|0
231324|NCT01544582|763246|P3|Analysis Population|Poor Adherence|1
231325|NCT01544582|763247|P2|Analysis Population|Poor Adherence|0
231326|NCT01544582|763248|P1|Analysis Population|Poor Adherence|0
231327|NCT01544582|763245|P4|Analysis Population|No Social Insurance|0
231328|NCT01544582|763246|P3|Analysis Population|No Social Insurance|1
231329|NCT01544582|763247|P2|Analysis Population|No Social Insurance|0
231330|NCT01544582|763248|P1|Analysis Population|No Social Insurance|0
231331|NCT01544582|763245|P4|Analysis Population|Liver Transplantation|0
231332|NCT01544582|763246|P3|Analysis Population|Liver Transplantation|1
231333|NCT01544582|763247|P2|Analysis Population|Liver Transplantation|0
231334|NCT01544582|763248|P1|Analysis Population|Liver Transplantation|0
231335|NCT01544582|763245|P4|Analysis Population|Intolerance|0
231336|NCT01544582|763246|P3|Analysis Population|Intolerance|0
231337|NCT01544582|763247|P2|Analysis Population|Intolerance|1
231338|NCT01544582|763248|P1|Analysis Population|Intolerance|0
231339|NCT01544582|763245|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
231340|NCT01544582|763246|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
231341|NCT01544582|763247|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
231342|NCT01544582|763248|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
231343|NCT01544582|763245|P4|Analysis Population|Bad Tolerance to Treatment|0
231344|NCT01544582|763246|P3|Analysis Population|Bad Tolerance to Treatment|2
231345|NCT01544582|763247|P2|Analysis Population|Bad Tolerance to Treatment|0
231346|NCT01544582|763248|P1|Analysis Population|Bad Tolerance to Treatment|0
231347|NCT01544582|763245|P4|Analysis Population|Lost to Follow-up|5
231348|NCT01544582|763246|P3|Analysis Population|Lost to Follow-up|6
231349|NCT01544582|763247|P2|Analysis Population|Lost to Follow-up|6
231350|NCT01544582|763248|P1|Analysis Population|Lost to Follow-up|0
231351|NCT01544582|763245|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
231352|NCT01544582|763246|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
231353|NCT01544582|763247|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
231354|NCT01544582|763248|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
231355|NCT01544582|763245|P4|Analysis Population|Effectiveness Reason|12
231356|NCT01544582|763246|P3|Analysis Population|Effectiveness Reason|29
231357|NCT01544582|763247|P2|Analysis Population|Effectiveness Reason|48
231358|NCT01544582|763248|P1|Analysis Population|Effectiveness Reason|0
231359|NCT01544582|763245|P4|Analysis Population|Safety Reason|8
231360|NCT01544582|763246|P3|Analysis Population|Safety Reason|31
231361|NCT01544582|763247|P2|Analysis Population|Safety Reason|33
231362|NCT01544582|763248|P1|Analysis Population|Safety Reason|0
231363|NCT01544582|763245|P4|Analysis Population|Physician Decision|9
231364|NCT01544582|763246|P3|Analysis Population|Physician Decision|10
231365|NCT01544582|763247|P2|Analysis Population|Physician Decision|13
231366|NCT01544582|763248|P1|Analysis Population|Physician Decision|0
231367|NCT01544582|763245|P4|Analysis Population|Participant Refuses to Continue Study|4
231368|NCT01544582|763246|P3|Analysis Population|Participant Refuses to Continue Study|17
231369|NCT01544582|763247|P2|Analysis Population|Participant Refuses to Continue Study|15
231370|NCT01544582|763248|P1|Analysis Population|Participant Refuses to Continue Study|0
231371|NCT01544582|763245|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
231372|NCT01544582|763246|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
231373|NCT01544582|763247|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
231374|NCT01544582|763248|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
231375|NCT01544582|763245|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
231376|NCT01544582|763246|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
231377|NCT01544582|763247|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
231378|NCT01544582|763248|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
231379|NCT01544348|763345|P8|Overall Study|Physician Decision|0
231380|NCT01544348|763346|P7|Overall Study|Physician Decision|0
231381|NCT01544348|763347|P6|Overall Study|Physician Decision|1
231382|NCT01544348|763348|P5|Overall Study|Physician Decision|0
231383|NCT01544348|763349|P4|Overall Study|Physician Decision|0
231384|NCT01544348|763350|P3|Overall Study|Physician Decision|0
231385|NCT01544348|763351|P2|Overall Study|Physician Decision|0
231386|NCT01544348|763352|P1|Overall Study|Physician Decision|0
231387|NCT01544348|763345|P8|Overall Study|Withdrawal by Subject|0
231388|NCT01544348|763346|P7|Overall Study|Withdrawal by Subject|1
231389|NCT01544348|763347|P6|Overall Study|Withdrawal by Subject|2
231390|NCT01544348|763348|P5|Overall Study|Withdrawal by Subject|1
231391|NCT01544348|763349|P4|Overall Study|Withdrawal by Subject|0
231392|NCT01544348|763350|P3|Overall Study|Withdrawal by Subject|0
231393|NCT01544348|763351|P2|Overall Study|Withdrawal by Subject|0
231394|NCT01544348|763352|P1|Overall Study|Withdrawal by Subject|1
231395|NCT01544348|763345|P8|Overall Study|Lost to Follow-up|0
231396|NCT01544348|763346|P7|Overall Study|Lost to Follow-up|1
231397|NCT01544348|763347|P6|Overall Study|Lost to Follow-up|0
231398|NCT01544348|763348|P5|Overall Study|Lost to Follow-up|0
231399|NCT01544348|763349|P4|Overall Study|Lost to Follow-up|0
231400|NCT01544348|763350|P3|Overall Study|Lost to Follow-up|0
231401|NCT01544348|763351|P2|Overall Study|Lost to Follow-up|0
231402|NCT01544348|763352|P1|Overall Study|Lost to Follow-up|1
231403|NCT01544309|763394|P2|Overall Study|Administered prohibit prior medication|0
231404|NCT01544309|763395|P1|Overall Study|Administered prohibit prior medication|1
231405|NCT01544309|763394|P2|Overall Study|Not performed pre-dose examination|2
231406|NCT01544309|763395|P1|Overall Study|Not performed pre-dose examination|1
231407|NCT01544309|763394|P2|Overall Study|Physician Decision|1
231408|NCT01544309|763395|P1|Overall Study|Physician Decision|4
231409|NCT01544309|763394|P2|Overall Study|Protocol Violation|1
231410|NCT01544309|763395|P1|Overall Study|Protocol Violation|2
231411|NCT01544309|763394|P2|Overall Study|Withdrawal by Subject|7
231412|NCT01544309|763395|P1|Overall Study|Withdrawal by Subject|12
231413|NCT01544179|763433|P2|Overall Study|Eligibility criteria not fulfilled|0
231414|NCT01544179|763434|P1|Overall Study|Eligibility criteria not fulfilled|1
231415|NCT01544179|763433|P2|Overall Study|Withdrawal by Subject|7
231416|NCT01544179|763434|P1|Overall Study|Withdrawal by Subject|12
231417|NCT01544179|763433|P2|Overall Study|Adverse Event|1
231418|NCT01544179|763434|P1|Overall Study|Adverse Event|0
231419|NCT01544179|763433|P2|Overall Study|Lost to Follow-up|1
231420|NCT01544179|763434|P1|Overall Study|Lost to Follow-up|0
231421|NCT01544179|763433|P2|Overall Study|Death|37
231422|NCT01544179|763434|P1|Overall Study|Death|50
231423|NCT01543958|763523|P1|Overall Study|ART initiation|1
231424|NCT01543958|763523|P1|Overall Study|Loss to follow-up|3
231425|NCT01543828|763578|P2|Treatment 2|Lost to Follow-up|0
231426|NCT01543828|763579|P1|Treatment 2|Lost to Follow-up|1
231427|NCT01543685|763592|P5|Overall Study|Adverse Event|2
231428|NCT01543685|763593|P4|Overall Study|Adverse Event|0
231429|NCT01543685|763594|P3|Overall Study|Adverse Event|0
231430|NCT01543685|763595|P2|Overall Study|Adverse Event|1
231431|NCT01543685|763596|P1|Overall Study|Adverse Event|2
231432|NCT01543685|763592|P5|Overall Study|Lack of Efficacy|2
231433|NCT01543685|763593|P4|Overall Study|Lack of Efficacy|0
231434|NCT01543685|763594|P3|Overall Study|Lack of Efficacy|2
231435|NCT01543685|763595|P2|Overall Study|Lack of Efficacy|2
231436|NCT01543685|763596|P1|Overall Study|Lack of Efficacy|1
231437|NCT01543503|763668|P2|Overall Study|Screen failure|0
231438|NCT01543503|763669|P1|Overall Study|Screen failure|1
231439|NCT01543503|763668|P2|Overall Study|Participant went to United States|0
231440|NCT01543503|763669|P1|Overall Study|Participant went to United States|1
231441|NCT01543503|763668|P2|Overall Study|Participant consented to another study|2
231442|NCT01543503|763669|P1|Overall Study|Participant consented to another study|0
231443|NCT01543503|763668|P2|Overall Study|Moved to other rheumatologic site|1
231444|NCT01543503|763669|P1|Overall Study|Moved to other rheumatologic site|0
231445|NCT01543503|763668|P2|Overall Study|Participant did not attend a visit|0
231446|NCT01543503|763669|P1|Overall Study|Participant did not attend a visit|1
231447|NCT01543503|763668|P2|Overall Study|Site stopped participation|1
231448|NCT01543503|763669|P1|Overall Study|Site stopped participation|5
231449|NCT01543503|763668|P2|Overall Study|Participant recruited after closing date|1
231450|NCT01543503|763669|P1|Overall Study|Participant recruited after closing date|0
231451|NCT01543503|763668|P2|Overall Study|Investigator did not wish to participate|1
231452|NCT01543503|763669|P1|Overall Study|Investigator did not wish to participate|1
231453|NCT01543503|763668|P2|Overall Study|Participant decision to stop treatment|0
231454|NCT01543503|763669|P1|Overall Study|Participant decision to stop treatment|1
231455|NCT01543503|763668|P2|Overall Study|Participant moved to Scotland|0
231456|NCT01543503|763669|P1|Overall Study|Participant moved to Scotland|1
231457|NCT01543503|763668|P2|Overall Study|Participant transferred to another city|0
231458|NCT01543503|763669|P1|Overall Study|Participant transferred to another city|1
231459|NCT01543503|763668|P2|Overall Study|Participant will not return for visits|2
231460|NCT01543503|763669|P1|Overall Study|Participant will not return for visits|0
231461|NCT01543503|763668|P2|Overall Study|Participant moved to another city|0
231462|NCT01543503|763669|P1|Overall Study|Participant moved to another city|2
231463|NCT01543503|763668|P2|Overall Study|Incorrect medication received|0
231464|NCT01543503|763669|P1|Overall Study|Incorrect medication received|1
231465|NCT01543503|763668|P2|Overall Study|Refused to continue treatment|0
231466|NCT01543503|763669|P1|Overall Study|Refused to continue treatment|7
231467|NCT01543503|763668|P2|Overall Study|Participant did not complete last visit|2
231468|NCT01543503|763669|P1|Overall Study|Participant did not complete last visit|0
231469|NCT01543503|763668|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
231470|NCT01543503|763669|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
231471|NCT01543503|763668|P2|Overall Study|Intolerance to the biologic treatment|1
231472|NCT01543503|763669|P1|Overall Study|Intolerance to the biologic treatment|0
231473|NCT01543503|763668|P2|Overall Study|Change of jobs|1
231474|NCT01543503|763669|P1|Overall Study|Change of jobs|0
231475|NCT01543503|763668|P2|Overall Study|Participant withdrew informed consent|10
231476|NCT01543503|763669|P1|Overall Study|Participant withdrew informed consent|8
231477|NCT01543503|763668|P2|Overall Study|Lack of Efficacy|16
231478|NCT01543503|763669|P1|Overall Study|Lack of Efficacy|4
231479|NCT01543503|763668|P2|Overall Study|Adverse Event|13
231480|NCT01543503|763669|P1|Overall Study|Adverse Event|9
231481|NCT01543503|763668|P2|Overall Study|Lost to Follow-up|36
231482|NCT01543503|763669|P1|Overall Study|Lost to Follow-up|32
231483|NCT01543204|763713|P1|Overall Study|Lost to Follow-up|1
231484|NCT01543204|763713|P1|Overall Study|Requirement for Alternative Therapy|1
231485|NCT01543204|763713|P1|Overall Study|Withdrawal by Subject|4
231486|NCT01543204|763713|P1|Overall Study|Adverse Event|1
231487|NCT01543204|763713|P1|Overall Study|Non-compliance|1
231488|NCT01542788|763805|P2|Overall Study|Withdrawal by Subject|0
231489|NCT01542788|763806|P1|Overall Study|Withdrawal by Subject|1
231490|NCT01542788|763805|P2|Overall Study|Physician Decision|0
231491|NCT01542788|763806|P1|Overall Study|Physician Decision|1
231492|NCT01542788|763805|P2|Overall Study|Protocol Violation|0
231493|NCT01542788|763806|P1|Overall Study|Protocol Violation|2
231494|NCT01542788|763805|P2|Overall Study|Death|0
231495|NCT01542788|763806|P1|Overall Study|Death|3
231496|NCT01542788|763805|P2|Overall Study|Lost to Follow-up|0
231497|NCT01542788|763806|P1|Overall Study|Lost to Follow-up|5
231498|NCT01542788|763805|P2|Overall Study|Lack of Efficacy|71
231499|NCT01542788|763806|P1|Overall Study|Lack of Efficacy|41
231500|NCT01542788|763805|P2|Overall Study|Randomized but Not Treated|0
231501|NCT01542788|763806|P1|Overall Study|Randomized but Not Treated|2
231502|NCT01542632|763845|P6|Overall Study|Sponsor/Investigator Decision|0
231503|NCT01542632|763846|P5|Overall Study|Sponsor/Investigator Decision|1
231504|NCT01542632|763847|P4|Overall Study|Sponsor/Investigator Decision|0
231505|NCT01542632|763848|P3|Overall Study|Sponsor/Investigator Decision|0
231506|NCT01542632|763849|P2|Overall Study|Sponsor/Investigator Decision|0
231507|NCT01542632|763850|P1|Overall Study|Sponsor/Investigator Decision|0
231508|NCT01542632|763845|P6|Overall Study|Lost to Follow-up|0
231509|NCT01542632|763846|P5|Overall Study|Lost to Follow-up|0
231510|NCT01542632|763847|P4|Overall Study|Lost to Follow-up|0
231511|NCT01542632|763848|P3|Overall Study|Lost to Follow-up|0
231512|NCT01542632|763849|P2|Overall Study|Lost to Follow-up|1
231513|NCT01542632|763850|P1|Overall Study|Lost to Follow-up|0
231514|NCT01542632|763845|P6|Overall Study|Adverse Event|0
231515|NCT01542632|763846|P5|Overall Study|Adverse Event|0
231516|NCT01542632|763847|P4|Overall Study|Adverse Event|0
231517|NCT01542632|763848|P3|Overall Study|Adverse Event|1
231518|NCT01542632|763849|P2|Overall Study|Adverse Event|0
231519|NCT01542632|763850|P1|Overall Study|Adverse Event|0
231520|NCT01542632|763845|P6|Overall Study|Withdrawal of Consent|0
231521|NCT01542632|763846|P5|Overall Study|Withdrawal of Consent|3
231522|NCT01542632|763847|P4|Overall Study|Withdrawal of Consent|2
231523|NCT01542632|763848|P3|Overall Study|Withdrawal of Consent|0
231524|NCT01542632|763849|P2|Overall Study|Withdrawal of Consent|0
231525|NCT01542632|763850|P1|Overall Study|Withdrawal of Consent|0
231526|NCT01542034|763964|P2|Overall Study|Lost to Follow-up|6
231527|NCT01542034|763965|P1|Overall Study|Lost to Follow-up|7
231528|NCT01542034|763964|P2|Overall Study|Adverse Event|2
231529|NCT01542034|763965|P1|Overall Study|Adverse Event|2
231530|NCT01542034|763964|P2|Overall Study|Subject Noncompliance|0
231531|NCT01542034|763965|P1|Overall Study|Subject Noncompliance|1
231532|NCT01542034|763964|P2|Overall Study|Administrative decision|3
231533|NCT01542034|763965|P1|Overall Study|Administrative decision|0
231534|NCT01542034|763964|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
231535|NCT01542034|763965|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
231536|NCT01541969|763979|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
231537|NCT01541969|763980|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
231538|NCT01541969|763979|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
231539|NCT01541969|763980|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
231540|NCT01541969|763979|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
231541|NCT01541969|763980|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
231542|NCT01541969|763979|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
231543|NCT01541969|763980|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
231544|NCT01541969|763979|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
231545|NCT01541969|763980|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
231546|NCT01541969|763979|P2|Double-blind (0-12 Weeks)|Adverse Event|0
231547|NCT01541969|763980|P1|Double-blind (0-12 Weeks)|Adverse Event|2
231548|NCT01541969|763979|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
231549|NCT01541969|763980|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
231550|NCT01541969|763979|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
231551|NCT01541969|763980|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
231552|NCT01541969|763979|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
231553|NCT01541969|763980|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
231554|NCT01541969|763979|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
231555|NCT01541969|763980|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
231556|NCT01541930|763996|P1|Overall Study|Withdrawal by Subject|1
231557|NCT01541917|764018|P2|Overall Study|Withdrawal by Subject|7
231558|NCT01541917|764019|P1|Overall Study|Withdrawal by Subject|13
231559|NCT01541917|764018|P2|Overall Study|Lost to Follow-up|2
231560|NCT01541917|764019|P1|Overall Study|Lost to Follow-up|2
231561|NCT01541865|764035|P1|Overall Study|Protocol Violation|1
231562|NCT01541865|764035|P1|Overall Study|Adverse Event|1
231563|NCT01541865|764035|P1|Overall Study|Withdrawal by Subject|9
231564|NCT01541865|764035|P1|Overall Study|Lost to Follow-up|11
231565|NCT01541644|764065|P1|Overall Study|Withdrawal by Subject|3
231566|NCT01541397|764084|P2|Overall Study|Study ended prior to data collection|2
231567|NCT01541397|764085|P1|Overall Study|Study ended prior to data collection|4
231568|NCT01541371|764097|P1|Overall Study|Unspecified|6
231569|NCT01541371|764097|P1|Overall Study|Study medication non-compliance|3
231570|NCT01541371|764097|P1|Overall Study|Protocol Violation|6
231571|NCT01541371|764097|P1|Overall Study|Lack of Efficacy|12
231572|NCT01541371|764097|P1|Overall Study|Adverse Event|15
231573|NCT01541371|764097|P1|Overall Study|Lost to Follow-up|21
231574|NCT01541371|764097|P1|Overall Study|Withdrawal by Subject|14
231575|NCT01541254|764126|P1|Overall Study|alternate stent used|1
231576|NCT01541254|764126|P1|Overall Study|stent not required|1
231577|NCT01541254|764126|P1|Overall Study|GI bleed prior to procedure|1
231578|NCT01541254|764126|P1|Overall Study|enrolled after study closed|1
231579|NCT01541254|764126|P1|Overall Study|excluded - metal allergy|1
231580|NCT01541254|764126|P1|Overall Study|Withdrawal by Subject|1
231581|NCT01540981|764133|P2|Overall Study|Withdrawal by Subject|0
231582|NCT01540981|764134|P1|Overall Study|Withdrawal by Subject|1
231583|NCT01540851|764144|P2|Overall Study|Withdrawal by Subject|3
231584|NCT01540851|764145|P1|Overall Study|Withdrawal by Subject|7
231585|NCT01540851|764144|P2|Overall Study|Lost to Follow-up|15
231586|NCT01540851|764145|P1|Overall Study|Lost to Follow-up|14
231587|NCT01540487|764285|P2|Overall Study|Protocol Violation|0
231588|NCT01540487|764286|P1|Overall Study|Protocol Violation|1
231589|NCT01539759|764421|P2|Overall Study|Lost to Follow-up|8
231590|NCT01539759|764422|P1|Overall Study|Lost to Follow-up|6
231591|NCT01539642|764432|P2|Overall Study|Withdrawal by Subject|2
231592|NCT01539642|764433|P1|Overall Study|Withdrawal by Subject|2
231593|NCT01539642|764432|P2|Overall Study|Adverse Event|4
231594|NCT01539642|764433|P1|Overall Study|Adverse Event|6
231595|NCT01539642|764432|P2|Overall Study|Patient ready for early discharge|7
231596|NCT01539642|764433|P1|Overall Study|Patient ready for early discharge|8
231597|NCT01539642|764432|P2|Overall Study|Lack of Efficacy|18
231598|NCT01539642|764433|P1|Overall Study|Lack of Efficacy|20
231599|NCT01539538|764450|P2|Overall Study|PCA no longer required or PCA problem|7
231600|NCT01539538|764451|P1|Overall Study|PCA no longer required or PCA problem|3
231601|NCT01539538|764450|P2|Overall Study|Withdrawal by Subject|3
231602|NCT01539538|764451|P1|Overall Study|Withdrawal by Subject|2
231603|NCT01539538|764450|P2|Overall Study|Lack of Efficacy|16
231604|NCT01539538|764451|P1|Overall Study|Lack of Efficacy|13
231605|NCT01539538|764450|P2|Overall Study|Adverse Event|18
231606|NCT01539538|764451|P1|Overall Study|Adverse Event|13
231607|NCT01539525|764460|P3|Overall Study|Protocol Violation|4
231608|NCT01539525|764461|P2|Overall Study|Protocol Violation|1
231609|NCT01539525|764462|P1|Overall Study|Protocol Violation|1
231610|NCT01539525|764460|P3|Overall Study|Withdrawal by Subject|2
231611|NCT01539525|764461|P2|Overall Study|Withdrawal by Subject|3
231612|NCT01539525|764462|P1|Overall Study|Withdrawal by Subject|0
231613|NCT01539525|764460|P3|Overall Study|Lost to Follow-up|11
231614|NCT01539525|764461|P2|Overall Study|Lost to Follow-up|12
231615|NCT01539525|764462|P1|Overall Study|Lost to Follow-up|19
231616|NCT01539512|764481|P2|Overall Study|Richter's Transformation|0
231617|NCT01539512|764482|P1|Overall Study|Richter's Transformation|1
231618|NCT01539512|764481|P2|Overall Study|Withdrawal by Subject|5
231619|NCT01539512|764482|P1|Overall Study|Withdrawal by Subject|12
231620|NCT01539512|764481|P2|Overall Study|Physician Decision|1
231621|NCT01539512|764482|P1|Overall Study|Physician Decision|1
231622|NCT01539512|764481|P2|Overall Study|Adverse Event|7
231623|NCT01539512|764482|P1|Overall Study|Adverse Event|9
231624|NCT01539317|764498|P2|Overall Study|Screening Error. Deleted from analysis.|0
231625|NCT01539317|764499|P1|Overall Study|Screening Error. Deleted from analysis.|1
231626|NCT01539083|764529|P3|After Randomization (TP and VTP)|Progressive Disease|2
231627|NCT01539083|764530|P2|After Randomization (TP and VTP)|Progressive Disease|3
231628|NCT01539083|764531|P1|After Randomization (TP and VTP)|Progressive Disease|0
231629|NCT01539083|764529|P3|After Randomization (TP and VTP)|Death|6
231630|NCT01539083|764530|P2|After Randomization (TP and VTP)|Death|4
231631|NCT01539083|764531|P1|After Randomization (TP and VTP)|Death|0
231632|NCT01539083|764529|P3|After Randomization (TP and VTP)|Adverse Event|0
231633|NCT01539083|764530|P2|After Randomization (TP and VTP)|Adverse Event|1
231634|NCT01539083|764531|P1|After Randomization (TP and VTP)|Adverse Event|0
231635|NCT01539083|764529|P3|After Randomization (TP and VTP)|Withdrawal by Subject|1
231636|NCT01539083|764530|P2|After Randomization (TP and VTP)|Withdrawal by Subject|3
231637|NCT01539083|764531|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
231638|NCT01539083|764529|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
231639|NCT01539083|764530|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
231640|NCT01539083|764531|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
231641|NCT01539083|764529|P3|Before Randomization (VCD Induction)|Unspecified|0
231642|NCT01539083|764530|P2|Before Randomization (VCD Induction)|Unspecified|0
231643|NCT01539083|764531|P1|Before Randomization (VCD Induction)|Unspecified|5
231644|NCT01539083|764529|P3|Before Randomization (VCD Induction)|Progressive Disease|0
231645|NCT01539083|764530|P2|Before Randomization (VCD Induction)|Progressive Disease|0
231646|NCT01539083|764531|P1|Before Randomization (VCD Induction)|Progressive Disease|8
231647|NCT01539083|764529|P3|Before Randomization (VCD Induction)|Physician Decision|0
231648|NCT01539083|764530|P2|Before Randomization (VCD Induction)|Physician Decision|0
231649|NCT01539083|764531|P1|Before Randomization (VCD Induction)|Physician Decision|14
231650|NCT01539083|764529|P3|Before Randomization (VCD Induction)|Protocol Violation|0
231651|NCT01539083|764530|P2|Before Randomization (VCD Induction)|Protocol Violation|0
231652|NCT01539083|764531|P1|Before Randomization (VCD Induction)|Protocol Violation|2
231653|NCT01539083|764529|P3|Before Randomization (VCD Induction)|Death|0
231654|NCT01539083|764530|P2|Before Randomization (VCD Induction)|Death|0
231655|NCT01539083|764531|P1|Before Randomization (VCD Induction)|Death|6
231656|NCT01539083|764529|P3|Before Randomization (VCD Induction)|Adverse Event|0
231657|NCT01539083|764530|P2|Before Randomization (VCD Induction)|Adverse Event|0
231658|NCT01539083|764531|P1|Before Randomization (VCD Induction)|Adverse Event|14
231659|NCT01539083|764529|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
231660|NCT01539083|764530|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
231661|NCT01539083|764531|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
231662|NCT01538472|764573|P1|Overall Study|Death|1
231663|NCT01538472|764573|P1|Overall Study|Disease Progression|3
231664|NCT01537783|764607|P2|Overall Study|Lost to Follow-up|2
231665|NCT01537783|764608|P1|Overall Study|Lost to Follow-up|11
231666|NCT01537549|764659|P1|Overall Study|Withdrawal by Subject|2
231667|NCT01537549|764659|P1|Overall Study|Lost to Follow-up|1
231668|NCT01537432|764667|P2|Overall Study|Unsatisfactory therapeutic effect|0
231669|NCT01537432|764668|P1|Overall Study|Unsatisfactory therapeutic effect|1
231670|NCT01537432|764667|P2|Overall Study|Adverse Event|0
231671|NCT01537432|764668|P1|Overall Study|Adverse Event|1
231672|NCT01537432|764667|P2|Overall Study|Administrative problems|0
231673|NCT01537432|764668|P1|Overall Study|Administrative problems|1
231674|NCT01537432|764667|P2|Overall Study|Withdrawal by Subject|1
231675|NCT01537432|764668|P1|Overall Study|Withdrawal by Subject|0
231676|NCT01537432|764667|P2|Overall Study|Lost to Follow-up|1
231677|NCT01537432|764668|P1|Overall Study|Lost to Follow-up|3
231678|NCT01537302|764704|P1|Overall Study|Withdrawal by Subject|1
231679|NCT01537302|764704|P1|Overall Study|Lost to Follow-up|1
231680|NCT01537198|764711|P1|Overall Study|Not Specified|111
231681|NCT01537198|764711|P1|Overall Study|No Further Visits to the Clinic|37
231682|NCT01537198|764711|P1|Overall Study|Adverse Event|4
231683|NCT01537198|764711|P1|Overall Study|RSV infection|2
231684|NCT01537133|764740|P4|Overall Study|Lost to Follow-up|0
231685|NCT01537133|764741|P3|Overall Study|Lost to Follow-up|0
231686|NCT01537133|764742|P2|Overall Study|Lost to Follow-up|0
231687|NCT01537133|764743|P1|Overall Study|Lost to Follow-up|1
231688|NCT01537133|764740|P4|Overall Study|Withdrawal by Subject|0
231689|NCT01537133|764741|P3|Overall Study|Withdrawal by Subject|0
231690|NCT01537133|764742|P2|Overall Study|Withdrawal by Subject|0
231691|NCT01537133|764743|P1|Overall Study|Withdrawal by Subject|2
231692|NCT01537120|764759|P1|3 Weeks Placebo|Withdrawal by Subject|1
231693|NCT01537120|764759|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
231694|NCT01537081|764772|P3|Overall Study|Assigned but never dosed|0
231695|NCT01537081|764773|P2|Overall Study|Assigned but never dosed|0
231696|NCT01537081|764774|P1|Overall Study|Assigned but never dosed|1
231697|NCT01537081|764772|P3|Overall Study|Sponsor decision|0
231698|NCT01537081|764773|P2|Overall Study|Sponsor decision|1
231699|NCT01537081|764774|P1|Overall Study|Sponsor decision|0
231700|NCT01537081|764772|P3|Overall Study|Physician Decision|0
231701|NCT01537081|764773|P2|Overall Study|Physician Decision|6
231702|NCT01537081|764774|P1|Overall Study|Physician Decision|5
231703|NCT01537081|764772|P3|Overall Study|Withdrawal by Subject|3
231704|NCT01537081|764773|P2|Overall Study|Withdrawal by Subject|11
231705|NCT01537081|764774|P1|Overall Study|Withdrawal by Subject|6
231706|NCT01537081|764772|P3|Overall Study|Protocol Violation|2
231707|NCT01537081|764773|P2|Overall Study|Protocol Violation|2
231708|NCT01537081|764774|P1|Overall Study|Protocol Violation|3
231709|NCT01537081|764772|P3|Overall Study|Lost to Follow-up|9
231710|NCT01537081|764773|P2|Overall Study|Lost to Follow-up|15
231711|NCT01537081|764774|P1|Overall Study|Lost to Follow-up|17
231712|NCT01537081|764772|P3|Overall Study|Lack of Efficacy|0
231713|NCT01537081|764773|P2|Overall Study|Lack of Efficacy|1
231714|NCT01537081|764774|P1|Overall Study|Lack of Efficacy|2
231715|NCT01537081|764772|P3|Overall Study|Adverse Event|2
231716|NCT01537081|764773|P2|Overall Study|Adverse Event|2
231717|NCT01537081|764774|P1|Overall Study|Adverse Event|5
231718|NCT01537042|764787|P2|Overall Study|Other|1
231719|NCT01537042|764788|P1|Overall Study|Other|0
231720|NCT01537042|764787|P2|Overall Study|Protocol Violation|1
231721|NCT01537042|764788|P1|Overall Study|Protocol Violation|0
231722|NCT01537042|764787|P2|Overall Study|Lack of Efficacy|1
231723|NCT01537042|764788|P1|Overall Study|Lack of Efficacy|0
231724|NCT01537042|764787|P2|Overall Study|Adverse Event|2
231725|NCT01537042|764788|P1|Overall Study|Adverse Event|0
231726|NCT01536951|764826|P9|Second Intervention and Washout Period 2|Adverse Event|0
231727|NCT01536951|764827|P8|Second Intervention and Washout Period 2|Adverse Event|1
231728|NCT01536951|764828|P7|Second Intervention and Washout Period 2|Adverse Event|0
231729|NCT01536951|764829|P6|Second Intervention and Washout Period 2|Adverse Event|0
231730|NCT01536951|764830|P5|Second Intervention and Washout Period 2|Adverse Event|0
231731|NCT01536951|764831|P4|Second Intervention and Washout Period 2|Adverse Event|0
231732|NCT01536951|764832|P3|Second Intervention and Washout Period 2|Adverse Event|0
231733|NCT01536951|764833|P2|Second Intervention and Washout Period 2|Adverse Event|0
231734|NCT01536951|764834|P1|Second Intervention and Washout Period 2|Adverse Event|0
231735|NCT01536951|764826|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
231736|NCT01536951|764827|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
231737|NCT01536951|764828|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
231738|NCT01536951|764829|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
231739|NCT01536951|764830|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
231740|NCT01536951|764831|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
231741|NCT01536951|764832|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
231742|NCT01536951|764833|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
231743|NCT01536951|764834|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
231744|NCT01536860|764891|P3|Washout Period (3 Days)|Lost to Follow-up|0
231745|NCT01536860|764892|P2|Washout Period (3 Days)|Lost to Follow-up|0
231746|NCT01536860|764893|P1|Washout Period (3 Days)|Lost to Follow-up|1
231747|NCT01536704|764901|P4|Washout Period 3|Adverse Event|0
231748|NCT01536704|764902|P3|Washout Period 3|Adverse Event|1
231749|NCT01536704|764903|P2|Washout Period 3|Adverse Event|0
231750|NCT01536704|764904|P1|Washout Period 3|Adverse Event|0
231751|NCT01536704|764901|P4|Period 3|Adverse Event|1
231752|NCT01536704|764902|P3|Period 3|Adverse Event|0
231753|NCT01536704|764903|P2|Period 3|Adverse Event|0
231754|NCT01536704|764904|P1|Period 3|Adverse Event|0
231755|NCT01536704|764901|P4|Washout Period 2|Withdrawal by Subject|1
231756|NCT01536704|764902|P3|Washout Period 2|Withdrawal by Subject|0
231757|NCT01536704|764903|P2|Washout Period 2|Withdrawal by Subject|0
231758|NCT01536704|764904|P1|Washout Period 2|Withdrawal by Subject|0
231759|NCT01536704|764901|P4|Washout Period 2|Adverse Event|0
231760|NCT01536704|764902|P3|Washout Period 2|Adverse Event|0
231761|NCT01536704|764903|P2|Washout Period 2|Adverse Event|0
231762|NCT01536704|764904|P1|Washout Period 2|Adverse Event|1
231763|NCT01536704|764901|P4|Washout Period 1|Withdrawal by Subject|0
231764|NCT01536704|764902|P3|Washout Period 1|Withdrawal by Subject|0
231765|NCT01536704|764903|P2|Washout Period 1|Withdrawal by Subject|2
231766|NCT01536704|764904|P1|Washout Period 1|Withdrawal by Subject|1
231767|NCT01536587|764934|P1|Overall Study|Adverse Event|2
231768|NCT01536574|764973|P2|Overall Study|Lack of Efficacy|0
231769|NCT01536574|764974|P1|Overall Study|Lack of Efficacy|1
231770|NCT01536574|764973|P2|Overall Study|Withdrawal by Subject|2
231771|NCT01536574|764974|P1|Overall Study|Withdrawal by Subject|1
231772|NCT01536574|764973|P2|Overall Study|Adverse Event|5
231773|NCT01536574|764974|P1|Overall Study|Adverse Event|4
231774|NCT01536561|764992|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
231775|NCT01536561|764992|P1|Dosimetric and Therapeutic Treatment|Death|2
231776|NCT01536561|764992|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
231777|NCT01536561|764992|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
231778|NCT01536561|764992|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
231779|NCT01536561|764992|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
231780|NCT01536405|765069|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
231781|NCT01536405|765070|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
231782|NCT01536405|765069|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
231783|NCT01536405|765070|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
231784|NCT01536405|765069|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
231785|NCT01536405|765070|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
231786|NCT01536405|765069|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
231787|NCT01536405|765070|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
231788|NCT01536405|765069|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
231789|NCT01536405|765070|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
231790|NCT01536405|765069|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
231791|NCT01536405|765070|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
231792|NCT01536405|765069|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
231793|NCT01536405|765070|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
231794|NCT01536405|765069|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
231795|NCT01536405|765070|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
231796|NCT01536405|765069|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
231797|NCT01536405|765070|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
231798|NCT01536405|765069|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
231799|NCT01536405|765070|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
231800|NCT01536405|765069|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
231801|NCT01536405|765070|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
231802|NCT01536405|765069|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
231803|NCT01536405|765070|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
231804|NCT01536405|765069|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
231805|NCT01536405|765070|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
231806|NCT01536379|765108|P2|Overall Study|Withdrawal by Subject|1
231807|NCT01536379|765109|P1|Overall Study|Withdrawal by Subject|1
231808|NCT01536379|765108|P2|Overall Study|Adverse Event|2
231809|NCT01536379|765109|P1|Overall Study|Adverse Event|1
231810|NCT01536262|765201|P3|Overall Study|Other than stated above|0
231811|NCT01536262|765202|P2|Overall Study|Other than stated above|0
231812|NCT01536262|765203|P1|Overall Study|Other than stated above|1
231813|NCT01536262|765201|P3|Overall Study|Withdrawal by Subject|0
231814|NCT01536262|765202|P2|Overall Study|Withdrawal by Subject|1
231815|NCT01536262|765203|P1|Overall Study|Withdrawal by Subject|1
231816|NCT01536262|765201|P3|Overall Study|Adverse Event|2
231817|NCT01536262|765202|P2|Overall Study|Adverse Event|1
231818|NCT01536262|765203|P1|Overall Study|Adverse Event|6
231819|NCT01536171|765245|P1|Overall Study|Withdrawal by Subject|1
231820|NCT01536145|765250|P11|Overall Study|Adverse Event|3
231821|NCT01536145|765251|P10|Overall Study|Adverse Event|0
231822|NCT01536145|765252|P9|Overall Study|Adverse Event|0
231823|NCT01536145|765253|P8|Overall Study|Adverse Event|2
231824|NCT01536145|765254|P7|Overall Study|Adverse Event|0
231825|NCT01536145|765255|P6|Overall Study|Adverse Event|0
231826|NCT01536145|765256|P5|Overall Study|Adverse Event|0
231827|NCT01536145|765257|P4|Overall Study|Adverse Event|0
231828|NCT01536145|765258|P3|Overall Study|Adverse Event|0
231829|NCT01536145|765259|P2|Overall Study|Adverse Event|0
231830|NCT01536145|765260|P1|Overall Study|Adverse Event|0
231831|NCT01536145|765250|P11|Overall Study|Death|0
231832|NCT01536145|765251|P10|Overall Study|Death|0
231833|NCT01536145|765252|P9|Overall Study|Death|0
231834|NCT01536145|765253|P8|Overall Study|Death|0
231835|NCT01536145|765254|P7|Overall Study|Death|1
231836|NCT01536145|765255|P6|Overall Study|Death|0
231837|NCT01536145|765256|P5|Overall Study|Death|0
231838|NCT01536145|765257|P4|Overall Study|Death|0
231839|NCT01536145|765258|P3|Overall Study|Death|0
231840|NCT01536145|765259|P2|Overall Study|Death|0
231841|NCT01536145|765260|P1|Overall Study|Death|0
231842|NCT01536145|765250|P11|Overall Study|Unspecified|2
231843|NCT01536145|765251|P10|Overall Study|Unspecified|3
231844|NCT01536145|765252|P9|Overall Study|Unspecified|0
231845|NCT01536145|765253|P8|Overall Study|Unspecified|0
231846|NCT01536145|765254|P7|Overall Study|Unspecified|0
231847|NCT01536145|765255|P6|Overall Study|Unspecified|0
231848|NCT01536145|765256|P5|Overall Study|Unspecified|1
231849|NCT01536145|765257|P4|Overall Study|Unspecified|0
231850|NCT01536145|765258|P3|Overall Study|Unspecified|0
231851|NCT01536145|765259|P2|Overall Study|Unspecified|0
231852|NCT01536145|765260|P1|Overall Study|Unspecified|0
231853|NCT01536145|765250|P11|Overall Study|Withdrawal by Subject|2
231854|NCT01536145|765251|P10|Overall Study|Withdrawal by Subject|0
231855|NCT01536145|765252|P9|Overall Study|Withdrawal by Subject|2
231856|NCT01536145|765253|P8|Overall Study|Withdrawal by Subject|0
231857|NCT01536145|765254|P7|Overall Study|Withdrawal by Subject|0
231858|NCT01536145|765255|P6|Overall Study|Withdrawal by Subject|1
231859|NCT01536145|765256|P5|Overall Study|Withdrawal by Subject|0
231860|NCT01536145|765257|P4|Overall Study|Withdrawal by Subject|0
231861|NCT01536145|765258|P3|Overall Study|Withdrawal by Subject|1
231862|NCT01536145|765259|P2|Overall Study|Withdrawal by Subject|0
231863|NCT01536145|765260|P1|Overall Study|Withdrawal by Subject|0
231864|NCT01536145|765250|P11|Overall Study|Progressive disease|3
231865|NCT01536145|765251|P10|Overall Study|Progressive disease|3
231866|NCT01536145|765252|P9|Overall Study|Progressive disease|1
231867|NCT01536145|765253|P8|Overall Study|Progressive disease|2
231868|NCT01536145|765254|P7|Overall Study|Progressive disease|1
231869|NCT01536145|765255|P6|Overall Study|Progressive disease|2
231870|NCT01536145|765256|P5|Overall Study|Progressive disease|1
231871|NCT01536145|765257|P4|Overall Study|Progressive disease|2
231872|NCT01536145|765258|P3|Overall Study|Progressive disease|1
231873|NCT01536145|765259|P2|Overall Study|Progressive disease|4
231874|NCT01536145|765260|P1|Overall Study|Progressive disease|3
231875|NCT01536119|765367|P2|Overall Study|Lost to Follow-up|14
231876|NCT01536119|765368|P1|Overall Study|Lost to Follow-up|17
231877|NCT01536093|765394|P2|Overall Study|Withdrawal by Subject|1
231878|NCT01536093|765395|P1|Overall Study|Withdrawal by Subject|0
231879|NCT01536093|765394|P2|Overall Study|absence of maternal colostrum|0
231880|NCT01536093|765395|P1|Overall Study|absence of maternal colostrum|2
231881|NCT01536093|765394|P2|Overall Study|Death|2
231882|NCT01536093|765395|P1|Overall Study|Death|1
231883|NCT01536067|765411|P1|Overall Study|Disease Progression|1
231884|NCT01536015|765424|P2|Overall Study|Study closure|5
231885|NCT01536015|765425|P1|Overall Study|Study closure|5
231886|NCT01536015|765424|P2|Overall Study|Inclusion Criterion not met|0
231887|NCT01536015|765425|P1|Overall Study|Inclusion Criterion not met|2
231888|NCT01536015|765424|P2|Overall Study|Lost to Follow-up|1
231889|NCT01536015|765425|P1|Overall Study|Lost to Follow-up|0
231890|NCT01536015|765424|P2|Overall Study|Adverse Event|4
231891|NCT01536015|765425|P1|Overall Study|Adverse Event|1
231892|NCT01535807|765452|P2|Overall Study|Data collection error|1
231893|NCT01535807|765453|P1|Overall Study|Data collection error|1
231894|NCT01535807|765452|P2|Overall Study|Withdrawal by Subject|1
231895|NCT01535807|765453|P1|Overall Study|Withdrawal by Subject|1
231896|NCT01535729|765459|P1|Overall Study|No participant record available|5
231897|NCT01535729|765459|P1|Overall Study|Not treated|9
231898|NCT01535729|765459|P1|Overall Study|Screening failure|1
231899|NCT01535729|765459|P1|Overall Study|Protocol Violation|11
231900|NCT01535729|765459|P1|Overall Study|NSCLC grade IV histology not confirmed|20
231901|NCT01535729|765459|P1|Overall Study|No previous chemotherapy|33
231902|NCT01535729|765459|P1|Overall Study|Did not sign informed consent|1
231903|NCT01535729|765459|P1|Overall Study|Unspecified|19
231904|NCT01535729|765459|P1|Overall Study|Death|52
231905|NCT01535729|765459|P1|Overall Study|Lost to Follow-up|8
231906|NCT01535729|765459|P1|Overall Study|Discontinued treatment|25
231907|NCT01535729|765459|P1|Overall Study|Disease progression|230
231908|NCT01535729|765459|P1|Overall Study|Withdrawal by Subject|2
231909|NCT01535638|765500|P6|Treatment 3 (Single Dose)|Protocol Violation|0
231910|NCT01535638|765501|P5|Treatment 3 (Single Dose)|Protocol Violation|0
231911|NCT01535638|765502|P4|Treatment 3 (Single Dose)|Protocol Violation|1
231912|NCT01535638|765503|P3|Treatment 3 (Single Dose)|Protocol Violation|0
231913|NCT01535638|765504|P2|Treatment 3 (Single Dose)|Protocol Violation|0
231914|NCT01535638|765505|P1|Treatment 3 (Single Dose)|Protocol Violation|0
231915|NCT01535638|765500|P6|Treatment 1 (Single Dose)|Protocol Violation|1
231916|NCT01535638|765501|P5|Treatment 1 (Single Dose)|Protocol Violation|0
231917|NCT01535638|765502|P4|Treatment 1 (Single Dose)|Protocol Violation|0
231918|NCT01535638|765503|P3|Treatment 1 (Single Dose)|Protocol Violation|0
231919|NCT01535638|765504|P2|Treatment 1 (Single Dose)|Protocol Violation|0
231920|NCT01535638|765505|P1|Treatment 1 (Single Dose)|Protocol Violation|0
231921|NCT01535599|765519|P2|Overall Study|Noncompliance|1
231922|NCT01535599|765520|P1|Overall Study|Noncompliance|0
231923|NCT01535599|765519|P2|Overall Study|Stopped medication|1
231924|NCT01535599|765520|P1|Overall Study|Stopped medication|0
231925|NCT01535599|765519|P2|Overall Study|Unspecified|0
231926|NCT01535599|765520|P1|Overall Study|Unspecified|1
231927|NCT01535599|765519|P2|Overall Study|Did not use product|0
231928|NCT01535599|765520|P1|Overall Study|Did not use product|1
231929|NCT01535599|765519|P2|Overall Study|Randomized in Error|4
231930|NCT01535599|765520|P1|Overall Study|Randomized in Error|2
231931|NCT01535599|765519|P2|Overall Study|BL Culture + for Yeast//Fungi|1
231932|NCT01535599|765520|P1|Overall Study|BL Culture + for Yeast//Fungi|0
231933|NCT01535599|765519|P2|Overall Study|BL Culture + for Group A Strep|1
231934|NCT01535599|765520|P1|Overall Study|BL Culture + for Group A Strep|0
231935|NCT01535599|765519|P2|Overall Study|Treatment Failure|66
231936|NCT01535599|765520|P1|Overall Study|Treatment Failure|33
231937|NCT01535599|765519|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
231938|NCT01535599|765520|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
231939|NCT01535599|765519|P2|Overall Study|Lost to Follow-up|4
231940|NCT01535599|765520|P1|Overall Study|Lost to Follow-up|3
231941|NCT01535599|765519|P2|Overall Study|Adverse Event|15
231942|NCT01535599|765520|P1|Overall Study|Adverse Event|6
231943|NCT01535560|765532|P2|Overall Study|Randomized in Error|1
231944|NCT01535560|765533|P1|Overall Study|Randomized in Error|0
231945|NCT01535560|765532|P2|Overall Study|Other|1
231946|NCT01535560|765533|P1|Overall Study|Other|0
231947|NCT01535560|765532|P2|Overall Study|Treatment Failure|83
231948|NCT01535560|765533|P1|Overall Study|Treatment Failure|21
231949|NCT01535560|765532|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
231950|NCT01535560|765533|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
231951|NCT01535560|765532|P2|Overall Study|Lost to Follow-up|3
231952|NCT01535560|765533|P1|Overall Study|Lost to Follow-up|1
231953|NCT01535560|765532|P2|Overall Study|Adverse Event|7
231954|NCT01535560|765533|P1|Overall Study|Adverse Event|12
231955|NCT01535261|765576|P1|Overall Study|Adverse Event|12
231956|NCT01535261|765576|P1|Overall Study|Withdrawal by Subject|14
231957|NCT01535261|765576|P1|Overall Study|Lost to Follow-up|8
231958|NCT01535261|765576|P1|Overall Study|Death|5
231959|NCT01535261|765576|P1|Overall Study|Protocol Violation|3
231960|NCT01535261|765576|P1|Overall Study|Physician Decision|8
231961|NCT01535235|765589|P2|Overall Study|Adverse Event|0
231962|NCT01535235|765590|P1|Overall Study|Adverse Event|1
231963|NCT01535222|765604|P6|Overall Study|Inclusion/exclusion|0
231964|NCT01535222|765605|P5|Overall Study|Inclusion/exclusion|0
231965|NCT01535222|765606|P4|Overall Study|Inclusion/exclusion|0
231966|NCT01535222|765607|P3|Overall Study|Inclusion/exclusion|1
231967|NCT01535222|765608|P2|Overall Study|Inclusion/exclusion|0
231968|NCT01535222|765609|P1|Overall Study|Inclusion/exclusion|0
231969|NCT01535040|765640|P2|Overall Study|Multiple Reasons|1
231970|NCT01535040|765641|P1|Overall Study|Multiple Reasons|1
231971|NCT01535040|765640|P2|Overall Study|Toxicity|5
231972|NCT01535040|765641|P1|Overall Study|Toxicity|7
231973|NCT01535040|765640|P2|Overall Study|Never Started|4
231974|NCT01535040|765641|P1|Overall Study|Never Started|9
231975|NCT01535040|765640|P2|Overall Study|Withdrawal by Subject|10
231976|NCT01535040|765641|P1|Overall Study|Withdrawal by Subject|13
231977|NCT01535040|765640|P2|Overall Study|Physician Decision|1
231978|NCT01535040|765641|P1|Overall Study|Physician Decision|0
231979|NCT01534962|765682|P4|Overall Study|Discontinued at AF recurrence|31
231980|NCT01534962|765683|P3|Overall Study|Discontinued at AF recurrence|24
231981|NCT01534962|765684|P2|Overall Study|Discontinued at AF recurrence|26
231982|NCT01534962|765685|P1|Overall Study|Discontinued at AF recurrence|35
231983|NCT01534962|765682|P4|Overall Study|Randomized but did not start treatment|1
231984|NCT01534962|765683|P3|Overall Study|Randomized but did not start treatment|0
231985|NCT01534962|765684|P2|Overall Study|Randomized but did not start treatment|0
231986|NCT01534962|765685|P1|Overall Study|Randomized but did not start treatment|2
231987|NCT01534676|765742|P2|Overall Study|Study closed due to poor enrollment|1
231988|NCT01534676|765743|P1|Overall Study|Study closed due to poor enrollment|2
231989|NCT01534637|765749|P1|Overall Study|Liver Mets before treatment|1
231990|NCT01534637|765749|P1|Overall Study|Adverse Event|1
231991|NCT01534637|765749|P1|Overall Study|Withdrawal by Subject|1
231992|NCT01534637|765749|P1|Overall Study|Lack of Efficacy|3
231993|NCT01534637|765749|P1|Overall Study|Physician Decision|3
231994|NCT01534533|765759|P4|Overall Study|Withdrawal by Subject|1
231995|NCT01534533|765760|P3|Overall Study|Withdrawal by Subject|4
231996|NCT01534533|765761|P2|Overall Study|Withdrawal by Subject|3
231997|NCT01534533|765762|P1|Overall Study|Withdrawal by Subject|5
231998|NCT01534533|765759|P4|Overall Study|Lost to Follow-up|3
231999|NCT01534533|765760|P3|Overall Study|Lost to Follow-up|4
232000|NCT01534533|765761|P2|Overall Study|Lost to Follow-up|0
232001|NCT01534533|765762|P1|Overall Study|Lost to Follow-up|3
232002|NCT01534520|765790|P2|Overall Study|Adverse Event|1
232003|NCT01534520|765791|P1|Overall Study|Adverse Event|0
232004|NCT01534351|765806|P3|Overall Study|Study Terminated Early|0
232005|NCT01534351|765807|P2|Overall Study|Study Terminated Early|0
232006|NCT01534351|765808|P1|Overall Study|Study Terminated Early|1
232007|NCT01534208|765827|P2|Overall Study|Needed prohibited meds|0
232008|NCT01534208|765828|P1|Overall Study|Needed prohibited meds|1
232009|NCT01534208|765827|P2|Overall Study|PCP decision|0
232010|NCT01534208|765828|P1|Overall Study|PCP decision|1
232011|NCT01534208|765827|P2|Overall Study|Eligibility error|0
232012|NCT01534208|765828|P1|Overall Study|Eligibility error|3
232013|NCT01534208|765827|P2|Overall Study|Lab assessment|1
232014|NCT01534208|765828|P1|Overall Study|Lab assessment|2
232015|NCT01534208|765827|P2|Overall Study|Subject relocation|0
232016|NCT01534208|765828|P1|Overall Study|Subject relocation|2
232017|NCT01534208|765827|P2|Overall Study|Sponsor decision|1
232018|NCT01534208|765828|P1|Overall Study|Sponsor decision|4
232019|NCT01534208|765827|P2|Overall Study|Protocol Violation|2
232020|NCT01534208|765828|P1|Overall Study|Protocol Violation|2
232021|NCT01534208|765827|P2|Overall Study|Lack of Efficacy|3
232022|NCT01534208|765828|P1|Overall Study|Lack of Efficacy|0
232023|NCT01534208|765827|P2|Overall Study|Physician Decision|0
232024|NCT01534208|765828|P1|Overall Study|Physician Decision|2
232025|NCT01534208|765827|P2|Overall Study|Adverse Event|8
232026|NCT01534208|765828|P1|Overall Study|Adverse Event|15
232027|NCT01534208|765827|P2|Overall Study|Withdrawal by Subject|20
232028|NCT01534208|765828|P1|Overall Study|Withdrawal by Subject|6
232029|NCT01534208|765827|P2|Overall Study|Lost to Follow-up|14
232030|NCT01534208|765828|P1|Overall Study|Lost to Follow-up|19
232031|NCT01534182|765846|P2|Overall Study|Adverse Event|3
232032|NCT01534182|765847|P1|Overall Study|Adverse Event|7
232033|NCT01534182|765846|P2|Overall Study|Withdrawal by Subject|7
232034|NCT01534182|765847|P1|Overall Study|Withdrawal by Subject|4
232035|NCT01534182|765846|P2|Overall Study|Administrative problems|0
232036|NCT01534182|765847|P1|Overall Study|Administrative problems|1
232037|NCT01533935|765887|P5|Overall Study|Other reason not defined above|1
232038|NCT01533935|765888|P4|Overall Study|Other reason not defined above|0
232039|NCT01533935|765889|P3|Overall Study|Other reason not defined above|1
232040|NCT01533935|765890|P2|Overall Study|Other reason not defined above|0
232041|NCT01533935|765891|P1|Overall Study|Other reason not defined above|1
232042|NCT01533935|765887|P5|Overall Study|Withdrawal by Subject|4
232043|NCT01533935|765888|P4|Overall Study|Withdrawal by Subject|2
232044|NCT01533935|765889|P3|Overall Study|Withdrawal by Subject|5
232045|NCT01533935|765890|P2|Overall Study|Withdrawal by Subject|4
232046|NCT01533935|765891|P1|Overall Study|Withdrawal by Subject|0
232047|NCT01533935|765887|P5|Overall Study|Lost to Follow-up|0
232048|NCT01533935|765888|P4|Overall Study|Lost to Follow-up|0
232049|NCT01533935|765889|P3|Overall Study|Lost to Follow-up|1
232050|NCT01533935|765890|P2|Overall Study|Lost to Follow-up|0
232051|NCT01533935|765891|P1|Overall Study|Lost to Follow-up|0
232052|NCT01533935|765887|P5|Overall Study|Protocol Violation|0
232053|NCT01533935|765888|P4|Overall Study|Protocol Violation|0
232054|NCT01533935|765889|P3|Overall Study|Protocol Violation|0
232055|NCT01533935|765890|P2|Overall Study|Protocol Violation|2
232056|NCT01533935|765891|P1|Overall Study|Protocol Violation|0
232057|NCT01533935|765887|P5|Overall Study|Adverse Event|3
232058|NCT01533935|765888|P4|Overall Study|Adverse Event|5
232059|NCT01533935|765889|P3|Overall Study|Adverse Event|1
232060|NCT01533935|765890|P2|Overall Study|Adverse Event|7
232061|NCT01533935|765891|P1|Overall Study|Adverse Event|5
232062|NCT01533922|765918|P5|Overall Study|Other reason not defined above|0
232063|NCT01533922|765919|P4|Overall Study|Other reason not defined above|0
232064|NCT01533922|765920|P3|Overall Study|Other reason not defined above|1
232065|NCT01533922|765921|P2|Overall Study|Other reason not defined above|0
232066|NCT01533922|765922|P1|Overall Study|Other reason not defined above|2
232067|NCT01533922|765918|P5|Overall Study|Withdrawal by Subject|1
232068|NCT01533922|765919|P4|Overall Study|Withdrawal by Subject|2
232069|NCT01533922|765920|P3|Overall Study|Withdrawal by Subject|2
232070|NCT01533922|765921|P2|Overall Study|Withdrawal by Subject|1
232071|NCT01533922|765922|P1|Overall Study|Withdrawal by Subject|3
232072|NCT01533922|765918|P5|Overall Study|Protocol Violation|1
232073|NCT01533922|765919|P4|Overall Study|Protocol Violation|0
232074|NCT01533922|765920|P3|Overall Study|Protocol Violation|0
232075|NCT01533922|765921|P2|Overall Study|Protocol Violation|3
232076|NCT01533922|765922|P1|Overall Study|Protocol Violation|0
232077|NCT01533922|765918|P5|Overall Study|Lack of Efficacy|0
232078|NCT01533922|765919|P4|Overall Study|Lack of Efficacy|0
232079|NCT01533922|765920|P3|Overall Study|Lack of Efficacy|1
232080|NCT01533922|765921|P2|Overall Study|Lack of Efficacy|0
232081|NCT01533922|765922|P1|Overall Study|Lack of Efficacy|0
232082|NCT01533922|765918|P5|Overall Study|Adverse Event|4
232083|NCT01533922|765919|P4|Overall Study|Adverse Event|3
232084|NCT01533922|765920|P3|Overall Study|Adverse Event|6
232085|NCT01533922|765921|P2|Overall Study|Adverse Event|8
232086|NCT01533922|765922|P1|Overall Study|Adverse Event|5
232087|NCT01533493|765985|P2|Overall Study|Lost to Follow-up|0
232088|NCT01533493|765986|P1|Overall Study|Lost to Follow-up|2
232089|NCT01533493|765985|P2|Overall Study|Withdrawal by Subject|2
232090|NCT01533493|765986|P1|Overall Study|Withdrawal by Subject|1
232091|NCT01533493|765985|P2|Overall Study|Adverse Event|1
232092|NCT01533493|765986|P1|Overall Study|Adverse Event|2
232093|NCT01533428|765994|P2|Overall Study|Withdrawal by Subject|6
232094|NCT01533428|765995|P1|Overall Study|Withdrawal by Subject|7
232095|NCT01533428|765994|P2|Overall Study|Lost to Follow-up|1
232096|NCT01533428|765995|P1|Overall Study|Lost to Follow-up|2
232097|NCT01533428|765994|P2|Overall Study|Adverse Event|1
232098|NCT01533428|765995|P1|Overall Study|Adverse Event|0
232099|NCT01533246|766041|P1|Overall Study|Withdrawal by Subject|1
232100|NCT01533246|766041|P1|Overall Study|Adverse Event|1
232101|NCT01533181|766052|P2|Overall Study|Patient withdrawal pre-active treatment|0
232181|NCT01532414|766373|P3|Overall Study|No V6 semen sample|0
232102|NCT01533181|766053|P1|Overall Study|Patient withdrawal pre-active treatment|1
232103|NCT01533181|766052|P2|Overall Study|Disease progression pre-active treatment|1
232104|NCT01533181|766053|P1|Overall Study|Disease progression pre-active treatment|0
232105|NCT01532999|766170|P2|Overall Study|New job|2
232106|NCT01532999|766171|P1|Overall Study|New job|0
232107|NCT01532999|766170|P2|Overall Study|incarcerated|1
232108|NCT01532999|766171|P1|Overall Study|incarcerated|0
232109|NCT01532999|766170|P2|Overall Study|Adverse Event|1
232110|NCT01532999|766171|P1|Overall Study|Adverse Event|0
232111|NCT01532999|766170|P2|Overall Study|no show for week 9 assessments|4
232112|NCT01532999|766171|P1|Overall Study|no show for week 9 assessments|6
232113|NCT01532999|766170|P2|Overall Study|substantial noncompliance|0
232114|NCT01532999|766171|P1|Overall Study|substantial noncompliance|2
232115|NCT01532999|766170|P2|Overall Study|should not have been randomized|0
232116|NCT01532999|766171|P1|Overall Study|should not have been randomized|1
232117|NCT01532999|766170|P2|Overall Study|Relocated|0
232118|NCT01532999|766171|P1|Overall Study|Relocated|2
232119|NCT01532999|766170|P2|Overall Study|Withdrawal by Subject|0
232120|NCT01532999|766171|P1|Overall Study|Withdrawal by Subject|5
232121|NCT01532999|766170|P2|Overall Study|Physician Decision|2
232122|NCT01532999|766171|P1|Overall Study|Physician Decision|1
232123|NCT01532999|766170|P2|Overall Study|Lost to Follow-up|8
232124|NCT01532999|766171|P1|Overall Study|Lost to Follow-up|14
232125|NCT01532934|766253|P2|Overall Study|In controlled environment|2
232126|NCT01532934|766254|P1|Overall Study|In controlled environment|3
232127|NCT01532934|766253|P2|Overall Study|Lost to Follow-up|11
232128|NCT01532934|766254|P1|Overall Study|Lost to Follow-up|11
232129|NCT01532869|766266|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
232130|NCT01532869|766267|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
232131|NCT01532869|766266|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
232132|NCT01532869|766267|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
232133|NCT01532869|766266|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
232134|NCT01532869|766267|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
232135|NCT01532869|766266|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
232136|NCT01532869|766267|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
232137|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
232138|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
232139|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
232140|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
232141|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
232142|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
232143|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
232144|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
232145|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
232146|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
232147|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
232148|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
232149|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
232150|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
232151|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
232152|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
232153|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
232154|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
232155|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
232156|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
232157|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
232158|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
232159|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
232160|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
232161|NCT01532869|766266|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
232162|NCT01532869|766267|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
232163|NCT01531725|766304|P1|Overall Study|Protocol Violation|5
232164|NCT01532570|766325|P4|Overall Study|Withdrawal by Subject|0
232165|NCT01532570|766326|P3|Overall Study|Withdrawal by Subject|0
232166|NCT01532570|766327|P2|Overall Study|Withdrawal by Subject|1
232167|NCT01532570|766328|P1|Overall Study|Withdrawal by Subject|0
232168|NCT01532570|766325|P4|Overall Study|Lack of Efficacy|0
232169|NCT01532570|766326|P3|Overall Study|Lack of Efficacy|0
232170|NCT01532570|766327|P2|Overall Study|Lack of Efficacy|0
232171|NCT01532570|766328|P1|Overall Study|Lack of Efficacy|1
232172|NCT01532414|766373|P3|Overall Study|Withdrawn by sponsor|0
232173|NCT01532414|766374|P2|Overall Study|Withdrawn by sponsor|0
232174|NCT01532414|766375|P1|Overall Study|Withdrawn by sponsor|1
232175|NCT01532414|766373|P3|Overall Study|Unable to complete 24 hour PK|1
232176|NCT01532414|766374|P2|Overall Study|Unable to complete 24 hour PK|0
232177|NCT01532414|766375|P1|Overall Study|Unable to complete 24 hour PK|0
232178|NCT01532414|766373|P3|Overall Study|Adverse Event|1
232179|NCT01532414|766374|P2|Overall Study|Adverse Event|1
232180|NCT01532414|766375|P1|Overall Study|Adverse Event|0
232182|NCT01532414|766374|P2|Overall Study|No V6 semen sample|1
232183|NCT01532414|766375|P1|Overall Study|No V6 semen sample|0
232184|NCT01532414|766373|P3|Overall Study|Withdrawal by Subject|0
232185|NCT01532414|766374|P2|Overall Study|Withdrawal by Subject|0
232186|NCT01532414|766375|P1|Overall Study|Withdrawal by Subject|3
232187|NCT01532414|766373|P3|Overall Study|Lost to Follow-up|1
232188|NCT01532414|766374|P2|Overall Study|Lost to Follow-up|0
232189|NCT01532414|766375|P1|Overall Study|Lost to Follow-up|3
232190|NCT01531998|766441|P1|Overall Study|Withdrawal by Subject|3
232191|NCT01531387|766448|P2|Overall Study|Early termination of study|11
232192|NCT01531387|766449|P1|Overall Study|Early termination of study|11
232193|NCT01531205|766474|P1|Overall Study|Did not proceed to surgery|1
232194|NCT01530464|766496|P2|Washout (24h)|Withdrawal by Subject|1
232195|NCT01530464|766497|P1|Washout (24h)|Withdrawal by Subject|0
232196|NCT01530464|766496|P2|Washout (24h)|Withdrawal by Subject|0
232197|NCT01530464|766497|P1|Washout (24h)|Withdrawal by Subject|1
232198|NCT01530334|766549|P1|Overall Study|Progressive disease|47
232199|NCT01530334|766549|P1|Overall Study|unknown reason|1
232200|NCT01530334|766549|P1|Overall Study|Adverse Event|3
232201|NCT01530087|766583|P1|Overall Study|Physician Decision|2
232202|NCT01529645|766598|P10|Overall Study|Withdrawal by Subject|0
232203|NCT01529645|766599|P9|Overall Study|Withdrawal by Subject|0
232204|NCT01529645|766600|P8|Overall Study|Withdrawal by Subject|0
232205|NCT01529645|766601|P7|Overall Study|Withdrawal by Subject|0
232206|NCT01529645|766602|P6|Overall Study|Withdrawal by Subject|1
232207|NCT01529645|766603|P5|Overall Study|Withdrawal by Subject|1
232208|NCT01529645|766604|P4|Overall Study|Withdrawal by Subject|1
232209|NCT01529645|766605|P3|Overall Study|Withdrawal by Subject|0
232210|NCT01529645|766606|P2|Overall Study|Withdrawal by Subject|0
232211|NCT01529645|766607|P1|Overall Study|Withdrawal by Subject|2
232212|NCT01529645|766598|P10|Overall Study|SAE - Premature contractions|0
232213|NCT01529645|766599|P9|Overall Study|SAE - Premature contractions|0
232214|NCT01529645|766600|P8|Overall Study|SAE - Premature contractions|0
232215|NCT01529645|766601|P7|Overall Study|SAE - Premature contractions|0
232216|NCT01529645|766602|P6|Overall Study|SAE - Premature contractions|0
232217|NCT01529645|766603|P5|Overall Study|SAE - Premature contractions|0
232218|NCT01529645|766604|P4|Overall Study|SAE - Premature contractions|0
232219|NCT01529645|766605|P3|Overall Study|SAE - Premature contractions|1
232220|NCT01529645|766606|P2|Overall Study|SAE - Premature contractions|0
232221|NCT01529645|766607|P1|Overall Study|SAE - Premature contractions|0
232222|NCT01529645|766598|P10|Overall Study|Lost to Follow-up|0
232223|NCT01529645|766599|P9|Overall Study|Lost to Follow-up|1
232224|NCT01529645|766600|P8|Overall Study|Lost to Follow-up|0
232225|NCT01529645|766601|P7|Overall Study|Lost to Follow-up|2
232226|NCT01529645|766602|P6|Overall Study|Lost to Follow-up|0
232227|NCT01529645|766603|P5|Overall Study|Lost to Follow-up|1
232228|NCT01529645|766604|P4|Overall Study|Lost to Follow-up|1
232229|NCT01529645|766605|P3|Overall Study|Lost to Follow-up|1
232230|NCT01529645|766606|P2|Overall Study|Lost to Follow-up|1
232231|NCT01529645|766607|P1|Overall Study|Lost to Follow-up|0
232232|NCT01529632|766705|P2|Overall Study|Adverse Event|1
232233|NCT01529632|766706|P1|Overall Study|Adverse Event|1
232234|NCT01529632|766705|P2|Overall Study|Protocol Violation|1
232235|NCT01529632|766706|P1|Overall Study|Protocol Violation|0
232236|NCT01529632|766705|P2|Overall Study|Administrative problem|1
232237|NCT01529632|766706|P1|Overall Study|Administrative problem|2
232238|NCT01529515|766726|P4|DOUBLE BLIND PHASE|Unspecified|2
232239|NCT01529515|766727|P3|DOUBLE BLIND PHASE|Unspecified|9
232240|NCT01529515|766728|P2|DOUBLE BLIND PHASE|Unspecified|0
232241|NCT01529515|766729|P1|DOUBLE BLIND PHASE|Unspecified|0
232242|NCT01529515|766726|P4|DOUBLE BLIND PHASE|Protocol Violation|0
232243|NCT01529515|766727|P3|DOUBLE BLIND PHASE|Protocol Violation|1
232244|NCT01529515|766728|P2|DOUBLE BLIND PHASE|Protocol Violation|0
232245|NCT01529515|766729|P1|DOUBLE BLIND PHASE|Protocol Violation|0
232246|NCT01529515|766726|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
232247|NCT01529515|766727|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
232248|NCT01529515|766728|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
232249|NCT01529515|766729|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
232250|NCT01529515|766726|P4|DOUBLE BLIND PHASE|Pregnancy|0
232251|NCT01529515|766727|P3|DOUBLE BLIND PHASE|Pregnancy|1
232252|NCT01529515|766728|P2|DOUBLE BLIND PHASE|Pregnancy|0
232253|NCT01529515|766729|P1|DOUBLE BLIND PHASE|Pregnancy|0
232254|NCT01529515|766726|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
232255|NCT01529515|766727|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
232256|NCT01529515|766728|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
232257|NCT01529515|766729|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
232258|NCT01529515|766726|P4|DOUBLE BLIND PHASE|Adverse Event|0
232259|NCT01529515|766727|P3|DOUBLE BLIND PHASE|Adverse Event|1
232260|NCT01529515|766728|P2|DOUBLE BLIND PHASE|Adverse Event|0
232261|NCT01529515|766729|P1|DOUBLE BLIND PHASE|Adverse Event|0
232262|NCT01529515|766726|P4|MAINTENANCE PHASE|Unspecified|0
232263|NCT01529515|766727|P3|MAINTENANCE PHASE|Unspecified|0
232264|NCT01529515|766728|P2|MAINTENANCE PHASE|Unspecified|10
232265|NCT01529515|766729|P1|MAINTENANCE PHASE|Unspecified|0
232266|NCT01529515|766726|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
232267|NCT01529515|766727|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
232268|NCT01529515|766728|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
232269|NCT01529515|766729|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
232270|NCT01529515|766726|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
232271|NCT01529515|766727|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
232272|NCT01529515|766728|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
232273|NCT01529515|766729|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
232274|NCT01529515|766726|P4|MAINTENANCE PHASE|Protocol Violation|0
232275|NCT01529515|766727|P3|MAINTENANCE PHASE|Protocol Violation|0
232276|NCT01529515|766728|P2|MAINTENANCE PHASE|Protocol Violation|12
232277|NCT01529515|766729|P1|MAINTENANCE PHASE|Protocol Violation|0
232278|NCT01529515|766726|P4|MAINTENANCE PHASE|Lost to Follow-up|0
232279|NCT01529515|766727|P3|MAINTENANCE PHASE|Lost to Follow-up|0
232280|NCT01529515|766728|P2|MAINTENANCE PHASE|Lost to Follow-up|5
232281|NCT01529515|766729|P1|MAINTENANCE PHASE|Lost to Follow-up|0
232282|NCT01529515|766726|P4|MAINTENANCE PHASE|Lack of Efficacy|0
232283|NCT01529515|766727|P3|MAINTENANCE PHASE|Lack of Efficacy|0
232284|NCT01529515|766728|P2|MAINTENANCE PHASE|Lack of Efficacy|9
232285|NCT01529515|766729|P1|MAINTENANCE PHASE|Lack of Efficacy|0
232286|NCT01529515|766726|P4|MAINTENANCE PHASE|Adverse Event|0
232287|NCT01529515|766727|P3|MAINTENANCE PHASE|Adverse Event|0
232288|NCT01529515|766728|P2|MAINTENANCE PHASE|Adverse Event|10
232289|NCT01529515|766729|P1|MAINTENANCE PHASE|Adverse Event|0
232290|NCT01529515|766726|P4|TRANSITION PHASE|Unspecified|0
232291|NCT01529515|766727|P3|TRANSITION PHASE|Unspecified|0
232292|NCT01529515|766728|P2|TRANSITION PHASE|Unspecified|0
232293|NCT01529515|766729|P1|TRANSITION PHASE|Unspecified|9
232294|NCT01529515|766726|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
232295|NCT01529515|766727|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
232296|NCT01529515|766728|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
232297|NCT01529515|766729|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
232298|NCT01529515|766726|P4|TRANSITION PHASE|Withdrawal by Subject|0
232299|NCT01529515|766727|P3|TRANSITION PHASE|Withdrawal by Subject|0
232300|NCT01529515|766728|P2|TRANSITION PHASE|Withdrawal by Subject|0
232301|NCT01529515|766729|P1|TRANSITION PHASE|Withdrawal by Subject|51
232302|NCT01529515|766726|P4|TRANSITION PHASE|Protocol Violation|0
232303|NCT01529515|766727|P3|TRANSITION PHASE|Protocol Violation|0
232304|NCT01529515|766728|P2|TRANSITION PHASE|Protocol Violation|0
232305|NCT01529515|766729|P1|TRANSITION PHASE|Protocol Violation|4
232306|NCT01529515|766726|P4|TRANSITION PHASE|Lost to Follow-up|0
232307|NCT01529515|766727|P3|TRANSITION PHASE|Lost to Follow-up|0
232308|NCT01529515|766728|P2|TRANSITION PHASE|Lost to Follow-up|0
232309|NCT01529515|766729|P1|TRANSITION PHASE|Lost to Follow-up|19
232310|NCT01529515|766726|P4|TRANSITION PHASE|Lack of Efficacy|0
232311|NCT01529515|766727|P3|TRANSITION PHASE|Lack of Efficacy|0
232312|NCT01529515|766728|P2|TRANSITION PHASE|Lack of Efficacy|0
232313|NCT01529515|766729|P1|TRANSITION PHASE|Lack of Efficacy|19
232314|NCT01529515|766726|P4|TRANSITION PHASE|Death|0
232315|NCT01529515|766727|P3|TRANSITION PHASE|Death|0
232316|NCT01529515|766728|P2|TRANSITION PHASE|Death|0
232317|NCT01529515|766729|P1|TRANSITION PHASE|Death|1
232318|NCT01529515|766726|P4|TRANSITION PHASE|Adverse Event|0
232319|NCT01529515|766727|P3|TRANSITION PHASE|Adverse Event|0
232320|NCT01529515|766728|P2|TRANSITION PHASE|Adverse Event|0
232321|NCT01529515|766729|P1|TRANSITION PHASE|Adverse Event|16
232322|NCT01529385|766776|P2|Overall Study|Lost to Follow-up|1
232323|NCT01529385|766777|P1|Overall Study|Lost to Follow-up|2
232324|NCT01529112|766809|P2|Overall Study|Withdrawal by Subject|3
232325|NCT01529112|766810|P1|Overall Study|Withdrawal by Subject|7
232326|NCT01529112|766809|P2|Overall Study|Protocol Violation|0
232327|NCT01529112|766810|P1|Overall Study|Protocol Violation|1
232328|NCT01529112|766809|P2|Overall Study|Death|38
232329|NCT01529112|766810|P1|Overall Study|Death|59
232330|NCT01529112|766809|P2|Overall Study|Adverse Event|0
232331|NCT01529112|766810|P1|Overall Study|Adverse Event|2
232332|NCT01528969|766837|P2|Overall Study|absent from the school at baseline|0
232333|NCT01528969|766838|P1|Overall Study|absent from the school at baseline|2
232334|NCT01528735|766861|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
232335|NCT01528735|766862|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
232336|NCT01528735|766861|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
232337|NCT01528735|766862|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
232338|NCT01528696|766964|P2|Overall Study|See detailed description|19
232339|NCT01528696|766965|P1|Overall Study|See detailed description|18
232340|NCT01528605|766981|P6|Overall Study|Death|0
232341|NCT01528605|766982|P5|Overall Study|Death|0
232342|NCT01528605|766983|P4|Overall Study|Death|0
232343|NCT01528605|766984|P3|Overall Study|Death|0
232344|NCT01528605|766985|P2|Overall Study|Death|0
232345|NCT01528605|766986|P1|Overall Study|Death|1
232346|NCT01528605|766981|P6|Overall Study|Lost to Follow-up|0
232347|NCT01528605|766982|P5|Overall Study|Lost to Follow-up|0
232348|NCT01528605|766983|P4|Overall Study|Lost to Follow-up|1
232349|NCT01528605|766984|P3|Overall Study|Lost to Follow-up|1
232350|NCT01528605|766985|P2|Overall Study|Lost to Follow-up|0
232351|NCT01528605|766986|P1|Overall Study|Lost to Follow-up|1
232352|NCT01528345|767016|P2|Overall Study|Subject/Guardian Decision|0
232353|NCT01528345|767017|P1|Overall Study|Subject/Guardian Decision|5
232354|NCT01528345|767016|P2|Overall Study|Study Terminated by Sponsor|8
232355|NCT01528345|767017|P1|Overall Study|Study Terminated by Sponsor|4
232356|NCT01528345|767016|P2|Overall Study|Progressive Disease|40
232357|NCT01528345|767017|P1|Overall Study|Progressive Disease|26
232358|NCT01528345|767016|P2|Overall Study|Non-compliance with study treatment|0
232359|NCT01528345|767017|P1|Overall Study|Non-compliance with study treatment|1
232360|NCT01528345|767016|P2|Overall Study|Death|1
232361|NCT01528345|767017|P1|Overall Study|Death|1
232362|NCT01528345|767016|P2|Overall Study|Adverse Event|1
232363|NCT01528345|767017|P1|Overall Study|Adverse Event|10
232364|NCT01527487|767107|P2|Overall Study|Death|1
232365|NCT01527487|767108|P1|Overall Study|Death|0
232366|NCT01527487|767107|P2|Overall Study|Adverse Event|1
232367|NCT01527487|767108|P1|Overall Study|Adverse Event|1
232368|NCT01527487|767107|P2|Overall Study|Disease Progression|1
232369|NCT01527487|767108|P1|Overall Study|Disease Progression|4
232370|NCT01527487|767107|P2|Overall Study|MD Discretion/Lack of Efficacy|4
232371|NCT01527487|767108|P1|Overall Study|MD Discretion/Lack of Efficacy|3
232372|NCT01527370|767120|P1|Overall Study|Death|1
232373|NCT01527370|767120|P1|Overall Study|Physician Decision|1
232374|NCT01527370|767120|P1|Overall Study|Withdrawal by Subject|4
232375|NCT01527006|767139|P2|Extension Phase|Not Specified|3
232376|NCT01527006|767140|P1|Extension Phase|Not Specified|0
232377|NCT01527006|767139|P2|Extension Phase|Inadequate therapeutic effect|1
232378|NCT01527006|767140|P1|Extension Phase|Inadequate therapeutic effect|1
232379|NCT01527006|767139|P2|Extension Phase|Subject Choice|1
232380|NCT01527006|767140|P1|Extension Phase|Subject Choice|1
232381|NCT01527006|767139|P2|Extension Phase|Lost to Follow-up|1
232382|NCT01527006|767140|P1|Extension Phase|Lost to Follow-up|0
232383|NCT01527006|767139|P2|Extension Phase|Adverse Event|2
232384|NCT01527006|767140|P1|Extension Phase|Adverse Event|4
232385|NCT01527006|767139|P2|Core Study|Not Specified|2
232386|NCT01527006|767140|P1|Core Study|Not Specified|0
232387|NCT01527006|767139|P2|Core Study|Withdrawal by Subject|1
232388|NCT01527006|767140|P1|Core Study|Withdrawal by Subject|0
232389|NCT01527006|767139|P2|Core Study|Inadequate Therapeutic Effect|0
232390|NCT01527006|767140|P1|Core Study|Inadequate Therapeutic Effect|1
232391|NCT01527006|767139|P2|Core Study|Subject Choice|0
232392|NCT01527006|767140|P1|Core Study|Subject Choice|1
232393|NCT01527006|767139|P2|Core Study|Lost to Follow-up|1
232394|NCT01527006|767140|P1|Core Study|Lost to Follow-up|0
232395|NCT01527006|767139|P2|Core Study|Adverse Event|2
232396|NCT01527006|767140|P1|Core Study|Adverse Event|0
232397|NCT01526785|767207|P1|Overall Study|Withdrawal by Subject|2
232398|NCT01526785|767207|P1|Overall Study|Physician Decision|1
232399|NCT01526785|767207|P1|Overall Study|Death|2
232400|NCT01526785|767207|P1|Overall Study|Study Terminated by Sponsor|8
232401|NCT01526733|767217|P2|Phase 1|Withdrawal by Subject|1
232402|NCT01526733|767218|P1|Phase 1|Withdrawal by Subject|1
232403|NCT01526733|767217|P2|Phase 1|Protocol Violation|0
232404|NCT01526733|767218|P1|Phase 1|Protocol Violation|1
232405|NCT01526551|767236|P1|Overall Study|Lack of returned parental consent form|424
232406|NCT01526148|767278|P2|Overall Study|Incarcerated|2
232407|NCT01526148|767279|P1|Overall Study|Incarcerated|0
232408|NCT01526148|767278|P2|Overall Study|Moved out of state|0
232409|NCT01526148|767279|P1|Overall Study|Moved out of state|1
232410|NCT01526148|767278|P2|Overall Study|Unable to discontinue concomitant med|0
232411|NCT01526148|767279|P1|Overall Study|Unable to discontinue concomitant med|1
232412|NCT01526148|767278|P2|Overall Study|Unstable Medical Condition|0
232413|NCT01526148|767279|P1|Overall Study|Unstable Medical Condition|1
232414|NCT01526148|767278|P2|Overall Study|Withdrawal by Subject|0
232415|NCT01526148|767279|P1|Overall Study|Withdrawal by Subject|2
232416|NCT01526148|767278|P2|Overall Study|Lost to Follow-up|6
232417|NCT01526148|767279|P1|Overall Study|Lost to Follow-up|4
232418|NCT01526148|767278|P2|Overall Study|Adverse Event|5
232419|NCT01526148|767279|P1|Overall Study|Adverse Event|6
232420|NCT01525849|767296|P2|Overall Study|Anatomic exclusion criteria identified|3
232421|NCT01525849|767297|P1|Overall Study|Anatomic exclusion criteria identified|0
232422|NCT01525849|767296|P2|Overall Study|Unrelated medical issue (not treated)|2
232423|NCT01525849|767297|P1|Overall Study|Unrelated medical issue (not treated)|1
232424|NCT01525849|767296|P2|Overall Study|Withdrawal by Subject|9
232425|NCT01525849|767297|P1|Overall Study|Withdrawal by Subject|1
232426|NCT01525849|767296|P2|Overall Study|Lost to Follow-up|2
232427|NCT01525849|767297|P1|Overall Study|Lost to Follow-up|3
232428|NCT01525641|767353|P1|Overall Study|Other than stated above|7
232429|NCT01525641|767353|P1|Overall Study|Lost to follow-up (Changing hospital)|19
232430|NCT01525641|767353|P1|Overall Study|Lost to follow-up (Unknown reason)|10
232431|NCT01525641|767353|P1|Overall Study|Lost to follow-up (relocation)|1
232432|NCT01525641|767353|P1|Overall Study|Improvement|5
232433|NCT01525641|767353|P1|Overall Study|Lack of Efficacy|24
232434|NCT01525641|767353|P1|Overall Study|Adverse Event|73
232435|NCT01525641|767353|P1|Overall Study|No visit since the first visit|16
232436|NCT01525641|767353|P1|Overall Study|Case report form not collected|25
232437|NCT01525628|767367|P5|Overall Study|Other reason not defined above|0
232438|NCT01525628|767368|P4|Overall Study|Other reason not defined above|3
232439|NCT01525628|767369|P3|Overall Study|Other reason not defined above|0
232440|NCT01525628|767370|P2|Overall Study|Other reason not defined above|0
232441|NCT01525628|767371|P1|Overall Study|Other reason not defined above|0
232442|NCT01525628|767367|P5|Overall Study|Withdrawal by Subject|0
232443|NCT01525628|767368|P4|Overall Study|Withdrawal by Subject|0
232444|NCT01525628|767369|P3|Overall Study|Withdrawal by Subject|0
232445|NCT01525628|767370|P2|Overall Study|Withdrawal by Subject|1
232446|NCT01525628|767371|P1|Overall Study|Withdrawal by Subject|0
232447|NCT01525628|767367|P5|Overall Study|Lost to Follow-up|0
232448|NCT01525628|767368|P4|Overall Study|Lost to Follow-up|0
232449|NCT01525628|767369|P3|Overall Study|Lost to Follow-up|0
232450|NCT01525628|767370|P2|Overall Study|Lost to Follow-up|1
232451|NCT01525628|767371|P1|Overall Study|Lost to Follow-up|1
232452|NCT01525628|767367|P5|Overall Study|Protocol Violation|0
232453|NCT01525628|767368|P4|Overall Study|Protocol Violation|0
232454|NCT01525628|767369|P3|Overall Study|Protocol Violation|1
232455|NCT01525628|767370|P2|Overall Study|Protocol Violation|0
232456|NCT01525628|767371|P1|Overall Study|Protocol Violation|0
232457|NCT01525628|767367|P5|Overall Study|Lack of Efficacy|2
232458|NCT01525628|767368|P4|Overall Study|Lack of Efficacy|1
232459|NCT01525628|767369|P3|Overall Study|Lack of Efficacy|2
232460|NCT01525628|767370|P2|Overall Study|Lack of Efficacy|2
232461|NCT01525628|767371|P1|Overall Study|Lack of Efficacy|0
232462|NCT01525628|767367|P5|Overall Study|Adverse Event|1
232463|NCT01525628|767368|P4|Overall Study|Adverse Event|0
232464|NCT01525628|767369|P3|Overall Study|Adverse Event|2
232465|NCT01525628|767370|P2|Overall Study|Adverse Event|1
232466|NCT01525628|767371|P1|Overall Study|Adverse Event|1
232467|NCT01525615|767438|P3|Overall Study|Other reason not described above|1
232468|NCT01525615|767439|P2|Overall Study|Other reason not described above|0
232469|NCT01525615|767440|P1|Overall Study|Other reason not described above|1
232470|NCT01525615|767438|P3|Overall Study|Withdrawal by Subject|0
232471|NCT01525615|767439|P2|Overall Study|Withdrawal by Subject|0
232472|NCT01525615|767440|P1|Overall Study|Withdrawal by Subject|1
232473|NCT01525615|767438|P3|Overall Study|Lost to Follow-up|0
232474|NCT01525615|767439|P2|Overall Study|Lost to Follow-up|0
232475|NCT01525615|767440|P1|Overall Study|Lost to Follow-up|1
232476|NCT01525615|767438|P3|Overall Study|Adverse Event|5
232477|NCT01525615|767439|P2|Overall Study|Adverse Event|7
232478|NCT01525615|767440|P1|Overall Study|Adverse Event|11
232479|NCT01525550|767496|P2|Overall Study|Ongoing|23
232480|NCT01525550|767497|P1|Overall Study|Ongoing|45
232481|NCT01525550|767496|P2|Overall Study|Other Unspecified|2
232482|NCT01525550|767497|P1|Overall Study|Other Unspecified|0
232483|NCT01525550|767496|P2|Overall Study|Death|19
232484|NCT01525550|767497|P1|Overall Study|Death|10
232485|NCT01525550|767496|P2|Overall Study|Lost to Follow-up|1
232486|NCT01525550|767497|P1|Overall Study|Lost to Follow-up|4
232487|NCT01525550|767496|P2|Overall Study|Withdrawal by Subject|0
232488|NCT01525550|767497|P1|Overall Study|Withdrawal by Subject|2
232489|NCT01525238|767569|P3|Overall Study|Withdrawal by Subject|0
232490|NCT01525238|767570|P2|Overall Study|Withdrawal by Subject|0
232491|NCT01525238|767571|P1|Overall Study|Withdrawal by Subject|1
232492|NCT01525225|767636|P1|Enrollment|Not Specified|1
232493|NCT01525225|767636|P1|Enrollment|No longer met study criteria|1
232494|NCT01524913|767653|P3|Overall Study|Lost to Follow-up|0
232495|NCT01524913|767654|P2|Overall Study|Lost to Follow-up|0
232496|NCT01524913|767655|P1|Overall Study|Lost to Follow-up|4
232497|NCT01524900|767677|P5|Overall Study|No reason documented|0
232498|NCT01524900|767678|P4|Overall Study|No reason documented|1
232499|NCT01524900|767679|P3|Overall Study|No reason documented|0
232500|NCT01524900|767680|P2|Overall Study|No reason documented|1
232501|NCT01524900|767681|P1|Overall Study|No reason documented|2
232502|NCT01524900|767677|P5|Overall Study|Other reason than stated above|0
232503|NCT01524900|767678|P4|Overall Study|Other reason than stated above|0
232504|NCT01524900|767679|P3|Overall Study|Other reason than stated above|0
232505|NCT01524900|767680|P2|Overall Study|Other reason than stated above|1
232506|NCT01524900|767681|P1|Overall Study|Other reason than stated above|1
232507|NCT01524900|767677|P5|Overall Study|Lost to Follow-up|0
232508|NCT01524900|767678|P4|Overall Study|Lost to Follow-up|0
232509|NCT01524900|767679|P3|Overall Study|Lost to Follow-up|1
232510|NCT01524900|767680|P2|Overall Study|Lost to Follow-up|12
232511|NCT01524900|767681|P1|Overall Study|Lost to Follow-up|3
232512|NCT01524887|767726|P3|Overall Study|Use of prohibited medication|0
232513|NCT01524887|767727|P2|Overall Study|Use of prohibited medication|0
232514|NCT01524887|767728|P1|Overall Study|Use of prohibited medication|1
232515|NCT01524887|767726|P3|Overall Study|Withdrawal by Caregiver|2
232516|NCT01524887|767727|P2|Overall Study|Withdrawal by Caregiver|0
232517|NCT01524887|767728|P1|Overall Study|Withdrawal by Caregiver|0
232518|NCT01524887|767726|P3|Overall Study|Study termination|79
232519|NCT01524887|767727|P2|Overall Study|Study termination|87
232520|NCT01524887|767728|P1|Overall Study|Study termination|73
232521|NCT01524887|767726|P3|Overall Study|Protocol Violation|1
232522|NCT01524887|767727|P2|Overall Study|Protocol Violation|0
232523|NCT01524887|767728|P1|Overall Study|Protocol Violation|0
232524|NCT01524887|767726|P3|Overall Study|Adverse Event|1
232525|NCT01524887|767727|P2|Overall Study|Adverse Event|1
232526|NCT01524887|767728|P1|Overall Study|Adverse Event|5
232527|NCT01524887|767726|P3|Overall Study|Withdrawal by Subject|3
232528|NCT01524887|767727|P2|Overall Study|Withdrawal by Subject|2
232529|NCT01524887|767728|P1|Overall Study|Withdrawal by Subject|6
232530|NCT01524796|767772|P1|Overall Study|Adverse Event and Lack of Efficacy|1
232531|NCT01524796|767772|P1|Overall Study|Switch to carbamazapine|1
232532|NCT01524796|767772|P1|Overall Study|Nervous about confidentiality|1
232533|NCT01524796|767772|P1|Overall Study|Gall stone surgery|1
232534|NCT01524796|767772|P1|Overall Study|Deterioration of pains|1
232535|NCT01524796|767772|P1|Overall Study|Move|1
232536|NCT01524796|767772|P1|Overall Study|Withdrawal by Subject|4
232537|NCT01524796|767772|P1|Overall Study|The price|1
232538|NCT01524796|767772|P1|Overall Study|Lost to Follow-up|1
232539|NCT01524796|767772|P1|Overall Study|Lack of Efficacy|3
232540|NCT01524796|767772|P1|Overall Study|Adverse Event|13
232541|NCT01524783|767787|P2|Randomized and Treated|Death|1
232542|NCT01524783|767788|P1|Randomized and Treated|Death|4
232543|NCT01524783|767787|P2|Randomized and Treated|Protocol Violation|1
232544|NCT01524783|767788|P1|Randomized and Treated|Protocol Violation|1
232545|NCT01524783|767787|P2|Randomized and Treated|Withdrawal by Subject|5
232546|NCT01524783|767788|P1|Randomized and Treated|Withdrawal by Subject|15
232547|NCT01524783|767787|P2|Randomized and Treated|Disease Progression|70
232548|NCT01524783|767788|P1|Randomized and Treated|Disease Progression|76
232549|NCT01524783|767787|P2|Randomized and Treated|Adverse Event|7
232550|NCT01524783|767788|P1|Randomized and Treated|Adverse Event|59
232551|NCT01524783|767787|P2|Randomized But Not Treated|Randomized, did not receive drug|0
232552|NCT01524783|767788|P1|Randomized But Not Treated|Randomized, did not receive drug|2
232553|NCT01524770|767810|P2|First Intervention|Protocol Violation|0
232554|NCT01524770|767811|P1|First Intervention|Protocol Violation|1
232555|NCT01524770|767810|P2|First Intervention|Adverse Event|1
232556|NCT01524770|767811|P1|First Intervention|Adverse Event|1
232557|NCT01524770|767810|P2|First Intervention|Withdrawal by Subject|0
232558|NCT01524770|767811|P1|First Intervention|Withdrawal by Subject|1
232559|NCT01524198|767842|P2|Overall Study|Withdrawal by Subject|10
232560|NCT01524198|767843|P1|Overall Study|Withdrawal by Subject|15
232561|NCT01524198|767842|P2|Overall Study|Protocol Violation|6
232562|NCT01524198|767843|P1|Overall Study|Protocol Violation|8
232563|NCT01523886|767870|P2|Overall Study|surgery cancelled|1
232564|NCT01523886|767871|P1|Overall Study|surgery cancelled|0
232565|NCT01523873|767877|P1|Overall Study|Protocol Violation|422
232566|NCT01523756|767884|P2|Test Period 2|Withdrawal by Subject|1
232567|NCT01523756|767885|P1|Test Period 2|Withdrawal by Subject|0
232568|NCT01523756|767884|P2|Test Period 1|Adverse Event|0
232569|NCT01523756|767885|P1|Test Period 1|Adverse Event|1
232570|NCT01523756|767884|P2|Baseline Period|Adverse Event|1
232571|NCT01523756|767885|P1|Baseline Period|Adverse Event|0
232572|NCT01523743|767893|P2|Period 2|Adverse Event|0
232573|NCT01523743|767894|P1|Period 2|Adverse Event|1
232574|NCT01523743|767893|P2|Period 2|Withdrawal by Subject|2
232575|NCT01523743|767894|P1|Period 2|Withdrawal by Subject|0
232576|NCT01523743|767893|P2|Period 1|Felt unable to empty bladder|0
232577|NCT01523743|767894|P1|Period 1|Felt unable to empty bladder|1
232578|NCT01523743|767893|P2|Period 1|Lack of Efficacy|0
232579|NCT01523743|767894|P1|Period 1|Lack of Efficacy|1
232580|NCT01523743|767893|P2|Period 1|Lost to Follow-up|0
232581|NCT01523743|767894|P1|Period 1|Lost to Follow-up|1
232582|NCT01523743|767893|P2|Period 1|Withdrawal by Subject|2
232583|NCT01523743|767894|P1|Period 1|Withdrawal by Subject|6
232584|NCT01523743|767893|P2|Period 1|Adverse Event|0
232585|NCT01523743|767894|P1|Period 1|Adverse Event|1
232586|NCT01523587|767902|P2|Overall Study|Randomised but not treated|2
232587|NCT01523587|767903|P1|Overall Study|Randomised but not treated|6
232588|NCT01523587|767902|P2|Overall Study|no reason given|3
232589|NCT01523587|767903|P1|Overall Study|no reason given|2
232590|NCT01523587|767902|P2|Overall Study|Withdrawal by Subject|12
232591|NCT01523587|767903|P1|Overall Study|Withdrawal by Subject|23
232592|NCT01523587|767902|P2|Overall Study|Lost to Follow-up|2
232593|NCT01523587|767903|P1|Overall Study|Lost to Follow-up|2
232594|NCT01523587|767902|P2|Overall Study|Non Compliance with protocol|1
232595|NCT01523587|767903|P1|Overall Study|Non Compliance with protocol|2
232596|NCT01523587|767902|P2|Overall Study|Adverse Event|34
232597|NCT01523587|767903|P1|Overall Study|Adverse Event|52
232598|NCT01523392|767923|P2|Washout Period - 10 to 14 Days|Adverse Event|0
232599|NCT01523392|767924|P1|Washout Period - 10 to 14 Days|Adverse Event|1
232600|NCT01523392|767923|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
232601|NCT01523392|767924|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
232602|NCT01523392|767923|P2|Treatment Period 1|Withdrawal by Subject|0
232603|NCT01523392|767924|P1|Treatment Period 1|Withdrawal by Subject|2
232604|NCT01523366|767940|P2|Treatment Period 2|Not completed at least 7 days treatment|0
232605|NCT01523366|767941|P1|Treatment Period 2|Not completed at least 7 days treatment|1
232606|NCT01523366|767940|P2|Treatment Period 1|Withdrawal by Subject|0
232607|NCT01523366|767941|P1|Treatment Period 1|Withdrawal by Subject|1
232608|NCT01523301|767957|P2|Overall Study|Other Reason|2
232609|NCT01523301|767958|P1|Overall Study|Other Reason|0
232610|NCT01523301|767957|P2|Overall Study|Withdrawal by Subject|8
232611|NCT01523301|767958|P1|Overall Study|Withdrawal by Subject|6
232612|NCT01523301|767957|P2|Overall Study|Lost to Follow-up|0
232613|NCT01523301|767958|P1|Overall Study|Lost to Follow-up|1
232614|NCT01523301|767957|P2|Overall Study|Protocol Violation|4
232615|NCT01523301|767958|P1|Overall Study|Protocol Violation|3
232616|NCT01523301|767957|P2|Overall Study|Lack of Efficacy|2
232617|NCT01523301|767958|P1|Overall Study|Lack of Efficacy|0
232618|NCT01523301|767957|P2|Overall Study|Adverse Event|16
232619|NCT01523301|767958|P1|Overall Study|Adverse Event|25
232620|NCT01522976|767979|P3|Overall Study|Not protocol specified|27
232621|NCT01522976|767980|P2|Overall Study|Not protocol specified|27
232622|NCT01522976|767981|P1|Overall Study|Not protocol specified|22
232623|NCT01522976|767979|P3|Overall Study|Refusal unrelated to adverse event|14
232624|NCT01522976|767980|P2|Overall Study|Refusal unrelated to adverse event|13
232625|NCT01522976|767981|P1|Overall Study|Refusal unrelated to adverse event|10
232626|NCT01522976|767979|P3|Overall Study|Adverse Event|18
232627|NCT01522976|767980|P2|Overall Study|Adverse Event|7
232628|NCT01522976|767981|P1|Overall Study|Adverse Event|17
232629|NCT01522976|767979|P3|Overall Study|Disease progression|25
232630|NCT01522976|767980|P2|Overall Study|Disease progression|30
232631|NCT01522976|767981|P1|Overall Study|Disease progression|28
232632|NCT01522976|767979|P3|Overall Study|Still on treatment|6
232633|NCT01522976|767980|P2|Overall Study|Still on treatment|9
232634|NCT01522976|767981|P1|Overall Study|Still on treatment|9
232635|NCT01522976|767979|P3|Overall Study|Death|2
232636|NCT01522976|767980|P2|Overall Study|Death|6
232637|NCT01522976|767981|P1|Overall Study|Death|7
232638|NCT01522976|767979|P3|Overall Study|Ineligible|1
232639|NCT01522976|767980|P2|Overall Study|Ineligible|0
232640|NCT01522976|767981|P1|Overall Study|Ineligible|4
232641|NCT01522456|768039|P1|Overall Study|Tolerability Assessment|1
232642|NCT01522456|768039|P1|Overall Study|Pregnancy|1
232643|NCT01522456|768039|P1|Overall Study|Withdrawal by Subject|2
232644|NCT01522456|768039|P1|Overall Study|Lost to Follow-up|2
232645|NCT01522456|768039|P1|Overall Study|Adverse Event|2
232646|NCT01521923|768120|P4|Overall Study|AE, captured in Period 1|1
232647|NCT01521923|768121|P3|Overall Study|AE, captured in Period 1|0
232648|NCT01521923|768122|P2|Overall Study|AE, captured in Period 1|1
232649|NCT01521923|768123|P1|Overall Study|AE, captured in Period 1|0
232650|NCT01521923|768120|P4|Overall Study|Other|6
232651|NCT01521923|768121|P3|Overall Study|Other|3
232652|NCT01521923|768122|P2|Overall Study|Other|1
232653|NCT01521923|768123|P1|Overall Study|Other|2
232654|NCT01521923|768120|P4|Overall Study|Withdrawal by Subject|2
232655|NCT01521923|768121|P3|Overall Study|Withdrawal by Subject|1
232656|NCT01521923|768122|P2|Overall Study|Withdrawal by Subject|1
232657|NCT01521923|768123|P1|Overall Study|Withdrawal by Subject|1
232658|NCT01521923|768120|P4|Overall Study|Lost to Follow-up|1
232659|NCT01521923|768121|P3|Overall Study|Lost to Follow-up|2
232660|NCT01521923|768122|P2|Overall Study|Lost to Follow-up|0
232661|NCT01521923|768123|P1|Overall Study|Lost to Follow-up|1
232662|NCT01521923|768120|P4|Overall Study|Protocol Violation|0
232663|NCT01521923|768121|P3|Overall Study|Protocol Violation|1
232664|NCT01521923|768122|P2|Overall Study|Protocol Violation|0
232665|NCT01521923|768123|P1|Overall Study|Protocol Violation|0
232666|NCT01521923|768120|P4|Overall Study|Lack of Efficacy|0
232667|NCT01521923|768121|P3|Overall Study|Lack of Efficacy|0
232668|NCT01521923|768122|P2|Overall Study|Lack of Efficacy|1
232669|NCT01521923|768123|P1|Overall Study|Lack of Efficacy|1
232670|NCT01521923|768120|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
232671|NCT01521923|768121|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
232672|NCT01521923|768122|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
232673|NCT01521923|768123|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
232674|NCT01521923|768120|P4|Overall Study|AE, non-serious, non-fatal|2
232675|NCT01521923|768121|P3|Overall Study|AE, non-serious, non-fatal|6
232676|NCT01521923|768122|P2|Overall Study|AE, non-serious, non-fatal|3
232677|NCT01521923|768123|P1|Overall Study|AE, non-serious, non-fatal|1
232678|NCT01521923|768120|P4|Overall Study|SAE, non-fatal|0
232679|NCT01521923|768121|P3|Overall Study|SAE, non-fatal|2
232680|NCT01521923|768122|P2|Overall Study|SAE, non-fatal|2
232681|NCT01521923|768123|P1|Overall Study|SAE, non-fatal|0
232682|NCT01521923|768120|P4|Overall Study|AE, serious fatal|0
232683|NCT01521923|768121|P3|Overall Study|AE, serious fatal|0
232684|NCT01521923|768122|P2|Overall Study|AE, serious fatal|0
232685|NCT01521923|768123|P1|Overall Study|AE, serious fatal|1
232686|NCT01521897|768243|P1|Overall Study|Lost to Follow-up|5
232687|NCT01521897|768243|P1|Overall Study|Protocol Violation|18
232688|NCT01521884|768255|P1|Overall Study|Lost to Follow-up|4
232689|NCT01521884|768255|P1|Overall Study|Participant non-eligible|1
232690|NCT01521884|768255|P1|Overall Study|Protocol Violation|3
232691|NCT01521884|768255|P1|Overall Study|Physician Decision|2
232692|NCT01521884|768255|P1|Overall Study|Withdrawal by Subject|1
232693|NCT01521884|768255|P1|Overall Study|Pregnancy|1
232694|NCT01521884|768255|P1|Overall Study|Adverse Event|5
232695|NCT01521884|768255|P1|Overall Study|Non Responders|10
232696|NCT01521559|768352|P2|Overall Study|Other|2
232697|NCT01521559|768353|P1|Overall Study|Other|1
232698|NCT01521559|768352|P2|Overall Study|Protocol Violation|0
232699|NCT01521559|768353|P1|Overall Study|Protocol Violation|1
232700|NCT01521559|768352|P2|Overall Study|Lost to Follow-up|1
232701|NCT01521559|768353|P1|Overall Study|Lost to Follow-up|3
232702|NCT01521559|768352|P2|Overall Study|Withdrawal by Subject|11
232703|NCT01521559|768353|P1|Overall Study|Withdrawal by Subject|9
232704|NCT01521559|768352|P2|Overall Study|Death|0
232705|NCT01521559|768353|P1|Overall Study|Death|1
232706|NCT01521559|768352|P2|Overall Study|Adverse Event|4
232707|NCT01521559|768353|P1|Overall Study|Adverse Event|0
232708|NCT01521507|768376|P2|Stage 2: Observational Design|Physician Decision|0
232709|NCT01521507|768377|P1|Stage 2: Observational Design|Physician Decision|1
232710|NCT01521507|768376|P2|Stage 2: Observational Design|Withdrawal by Subject|1
232711|NCT01521507|768377|P1|Stage 2: Observational Design|Withdrawal by Subject|3
232712|NCT01521507|768376|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
232713|NCT01521507|768377|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
232714|NCT01521507|768376|P2|Stage 1: Randomized Design|Lost to Follow-up|2
232715|NCT01521507|768377|P1|Stage 1: Randomized Design|Lost to Follow-up|0
232716|NCT01521507|768376|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
232717|NCT01521507|768377|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
232718|NCT01521507|768376|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
232719|NCT01521507|768377|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
232720|NCT01521364|768394|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
232721|NCT01521364|768394|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
232722|NCT01520987|768470|P8|Overall Study|Withdrawal by Subject|0
232723|NCT01520987|768471|P7|Overall Study|Withdrawal by Subject|0
232724|NCT01520987|768472|P6|Overall Study|Withdrawal by Subject|1
232725|NCT01520987|768473|P5|Overall Study|Withdrawal by Subject|0
232726|NCT01520987|768474|P4|Overall Study|Withdrawal by Subject|0
232727|NCT01520987|768475|P3|Overall Study|Withdrawal by Subject|0
232728|NCT01520987|768476|P2|Overall Study|Withdrawal by Subject|0
232729|NCT01520987|768477|P1|Overall Study|Withdrawal by Subject|1
232730|NCT01520922|768537|P2|Survival Follow-up|Withdrawal by Subject|0
232731|NCT01520922|768538|P1|Survival Follow-up|Withdrawal by Subject|1
232732|NCT01520922|768537|P2|Follow up|Lost to Follow-up|1
232733|NCT01520922|768538|P1|Follow up|Lost to Follow-up|0
232734|NCT01520922|768537|P2|Treatment Phase|Adverse Event|5
232735|NCT01520922|768538|P1|Treatment Phase|Adverse Event|3
232736|NCT01520922|768537|P2|Treatment Phase|Progression|2
232737|NCT01520922|768538|P1|Treatment Phase|Progression|0
232738|NCT01520922|768537|P2|Treatment Phase|Physician Decision|1
232739|NCT01520922|768538|P1|Treatment Phase|Physician Decision|2
232740|NCT01520909|768600|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
232741|NCT01520909|768601|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
232742|NCT01520909|768602|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
232743|NCT01520909|768600|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
232744|NCT01520909|768601|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
232745|NCT01520909|768602|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
232746|NCT01520909|768600|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
232747|NCT01520909|768601|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
232748|NCT01520909|768602|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
232749|NCT01520909|768600|P3|Part 1 (Randomized Period)|Adverse Event|0
232750|NCT01520909|768601|P2|Part 1 (Randomized Period)|Adverse Event|2
232751|NCT01520909|768602|P1|Part 1 (Randomized Period)|Adverse Event|1
232752|NCT01520714|768719|P2|Overall Study|Lack of Efficacy|1
232753|NCT01520714|768720|P1|Overall Study|Lack of Efficacy|0
232754|NCT01520714|768719|P2|Overall Study|Adverse Event|2
232755|NCT01520714|768720|P1|Overall Study|Adverse Event|0
232756|NCT01520714|768719|P2|Overall Study|Protocol Violation|3
232757|NCT01520714|768720|P1|Overall Study|Protocol Violation|0
232758|NCT01520506|768732|P1|Overall Study|Withdrawal by Subject|1
232759|NCT01520506|768732|P1|Overall Study|Lost to Follow-up|1
232760|NCT01520506|768732|P1|Overall Study|Missed Visit|4
232761|NCT01520402|768783|P1|Overall Study|Physician Decision|3
232762|NCT01520402|768783|P1|Overall Study|Withdrawal by Subject|2
232763|NCT01519960|768797|P3|Overall Study|Lost to Follow-up|0
232764|NCT01519960|768798|P2|Overall Study|Lost to Follow-up|1
232765|NCT01519960|768799|P1|Overall Study|Lost to Follow-up|0
232766|NCT01519960|768797|P3|Overall Study|Withdrawal by Subject|0
232767|NCT01519960|768798|P2|Overall Study|Withdrawal by Subject|4
232768|NCT01519960|768799|P1|Overall Study|Withdrawal by Subject|0
232769|NCT01519960|768797|P3|Overall Study|Adverse Event|0
232770|NCT01519960|768798|P2|Overall Study|Adverse Event|1
232771|NCT01519960|768799|P1|Overall Study|Adverse Event|0
232772|NCT01519960|768797|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
232773|NCT01519960|768798|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
232774|NCT01519960|768799|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
232775|NCT01519960|768797|P3|Overall Study|Ongoing in Follow-Up|10
232776|NCT01519960|768798|P2|Overall Study|Ongoing in Follow-Up|11
232777|NCT01519960|768799|P1|Overall Study|Ongoing in Follow-Up|101
232778|NCT01519934|768905|P1|Overall Study|Lost to Follow-up|3
232779|NCT01519921|768914|P2|Overall Study|High alanine aminotransferase (ALT)|1
232780|NCT01519921|768915|P1|Overall Study|High alanine aminotransferase (ALT)|0
232781|NCT01519921|768914|P2|Overall Study|Treatment refusal|1
232782|NCT01519921|768915|P1|Overall Study|Treatment refusal|2
232783|NCT01519921|768914|P2|Overall Study|Lost to Follow-up|1
232784|NCT01519921|768915|P1|Overall Study|Lost to Follow-up|2
232785|NCT01519921|768914|P2|Overall Study|Withdrawal by Subject|0
232786|NCT01519921|768915|P1|Overall Study|Withdrawal by Subject|3
232787|NCT01519921|768914|P2|Overall Study|Lack of Efficacy|3
232788|NCT01519921|768915|P1|Overall Study|Lack of Efficacy|4
232789|NCT01519921|768914|P2|Overall Study|Adverse Event|9
232790|NCT01519921|768915|P1|Overall Study|Adverse Event|10
232791|NCT01519791|768966|P2|Overall Study|Lost to Follow-up|14
232792|NCT01519791|768967|P1|Overall Study|Lost to Follow-up|6
232793|NCT01519791|768966|P2|Overall Study|Withdrawal by Subject|37
232794|NCT01519791|768967|P1|Overall Study|Withdrawal by Subject|15
232795|NCT01519791|768966|P2|Overall Study|AE, non-serious non-fatal|31
232796|NCT01519791|768967|P1|Overall Study|AE, non-serious non-fatal|12
232797|NCT01519791|768966|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
232798|NCT01519791|768967|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
232799|NCT01519791|768966|P2|Overall Study|AE, serious fatal|1
232800|NCT01519791|768967|P1|Overall Study|AE, serious fatal|0
232801|NCT01519791|768966|P2|Overall Study|SAE, non-fatal|22
232802|NCT01519791|768967|P1|Overall Study|SAE, non-fatal|6
232803|NCT01519791|768966|P2|Overall Study|Lack of Efficacy|20
232804|NCT01519791|768967|P1|Overall Study|Lack of Efficacy|16
232805|NCT01519791|768966|P2|Overall Study|subjects randomized in error|0
232806|NCT01519791|768967|P1|Overall Study|subjects randomized in error|2
232807|NCT01519791|768966|P2|Overall Study|Other Reason|222
232808|NCT01519791|768967|P1|Overall Study|Other Reason|87
232809|NCT01519791|768966|P2|Overall Study|Protocol Violation|19
232810|NCT01519791|768967|P1|Overall Study|Protocol Violation|6
232811|NCT01519791|768966|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
232812|NCT01519791|768967|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
232813|NCT01519778|769031|P1|Overall Study|Physician Decision|1
232814|NCT01519778|769031|P1|Overall Study|Lost to Follow-up|10
232815|NCT01519778|769031|P1|Overall Study|Withdrawal by Subject|3
232816|NCT01519765|769037|P2|Overall Study|Withdrawal by Subject|1
232817|NCT01519765|769038|P1|Overall Study|Withdrawal by Subject|0
232818|NCT01519765|769037|P2|Overall Study|Protocol Violation|0
232819|NCT01519765|769038|P1|Overall Study|Protocol Violation|1
232820|NCT01519765|769037|P2|Overall Study|Lack of Efficacy|0
232821|NCT01519765|769038|P1|Overall Study|Lack of Efficacy|2
232822|NCT01519765|769037|P2|Overall Study|Adverse Event|1
232823|NCT01519765|769038|P1|Overall Study|Adverse Event|0
232824|NCT01519700|769116|P4|Overall Study|Other Reason|4
232825|NCT01519700|769117|P3|Overall Study|Other Reason|0
232826|NCT01519700|769118|P2|Overall Study|Other Reason|2
232827|NCT01519700|769119|P1|Overall Study|Other Reason|2
232828|NCT01519700|769116|P4|Overall Study|Withdrawal by Subject|2
232829|NCT01519700|769117|P3|Overall Study|Withdrawal by Subject|3
232830|NCT01519700|769118|P2|Overall Study|Withdrawal by Subject|3
232831|NCT01519700|769119|P1|Overall Study|Withdrawal by Subject|5
232832|NCT01519700|769116|P4|Overall Study|Physician Decision|0
232833|NCT01519700|769117|P3|Overall Study|Physician Decision|3
232834|NCT01519700|769118|P2|Overall Study|Physician Decision|1
232835|NCT01519700|769119|P1|Overall Study|Physician Decision|1
232836|NCT01519700|769116|P4|Overall Study|Lost to Follow-up|1
232837|NCT01519700|769117|P3|Overall Study|Lost to Follow-up|1
232838|NCT01519700|769118|P2|Overall Study|Lost to Follow-up|0
232839|NCT01519700|769119|P1|Overall Study|Lost to Follow-up|0
232840|NCT01519700|769116|P4|Overall Study|Death|0
232841|NCT01519700|769117|P3|Overall Study|Death|0
232842|NCT01519700|769118|P2|Overall Study|Death|0
232843|NCT01519700|769119|P1|Overall Study|Death|1
232844|NCT01519674|769154|P3|Overall Study|Unsclassified|3
232845|NCT01519674|769155|P2|Overall Study|Unsclassified|4
232846|NCT01519674|769156|P1|Overall Study|Unsclassified|10
232847|NCT01519674|769154|P3|Overall Study|Withdrawal Criteria|7
232848|NCT01519674|769155|P2|Overall Study|Withdrawal Criteria|2
232849|NCT01519674|769156|P1|Overall Study|Withdrawal Criteria|7
232850|NCT01519674|769154|P3|Overall Study|Protocol Violation|1
232851|NCT01519674|769155|P2|Overall Study|Protocol Violation|3
232852|NCT01519674|769156|P1|Overall Study|Protocol Violation|0
232853|NCT01519674|769154|P3|Overall Study|Lack of Efficacy|1
232854|NCT01519674|769155|P2|Overall Study|Lack of Efficacy|1
232855|NCT01519674|769156|P1|Overall Study|Lack of Efficacy|1
232856|NCT01519674|769154|P3|Overall Study|Adverse Event|0
232857|NCT01519674|769155|P2|Overall Study|Adverse Event|3
232858|NCT01519674|769156|P1|Overall Study|Adverse Event|3
232859|NCT01519661|769194|P1|Overall Study|Adverse Event|29
232860|NCT01519661|769194|P1|Overall Study|Lack of Efficacy|6
232861|NCT01519661|769194|P1|Overall Study|Withdrawal by Subject|17
232862|NCT01519661|769194|P1|Overall Study|Lost to Follow-up|3
232863|NCT01519661|769194|P1|Overall Study|Protocol deviation|6
232864|NCT01519518|769220|P2|Overall Study|Consent not available|10
232865|NCT01519518|769221|P1|Overall Study|Consent not available|7
232866|NCT01519427|769246|P1|Overall Study|disease progression|2
232867|NCT01519323|769253|P2|Overall Study|Study terminated by sponsor|1
232868|NCT01519323|769254|P1|Overall Study|Study terminated by sponsor|0
232869|NCT01519323|769253|P2|Overall Study|Death|2
232870|NCT01519323|769254|P1|Overall Study|Death|3
232871|NCT01519245|769314|P2|Overall Study|Met exclusion criteria, not analysed|2
232872|NCT01519245|769315|P1|Overall Study|Met exclusion criteria, not analysed|1
232873|NCT01519206|769327|P1|Overall Study|Missed Visit|2
232874|NCT01519206|769327|P1|Overall Study|Lost to Follow-up|3
232875|NCT01519167|769341|P2|Overall Study|Physician Decision|1
232876|NCT01519167|769342|P1|Overall Study|Physician Decision|0
232877|NCT01519167|769341|P2|Overall Study|Medical condition changes&deep sedation|2
232878|NCT01519167|769342|P1|Overall Study|Medical condition changes&deep sedation|0
232879|NCT01519167|769341|P2|Overall Study|Lack of Efficacy|1
232880|NCT01519167|769342|P1|Overall Study|Lack of Efficacy|0
232881|NCT01519167|769341|P2|Overall Study|Adverse Event|1
232882|NCT01519167|769342|P1|Overall Study|Adverse Event|0
232883|NCT01519167|769341|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
232884|NCT01519167|769342|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
232885|NCT01519089|769368|P2|Overall Study|Not received study drug|1
232886|NCT01519089|769369|P1|Overall Study|Not received study drug|0
232887|NCT01519089|769368|P2|Overall Study|Unspecified|6
232888|NCT01519089|769369|P1|Overall Study|Unspecified|2
232889|NCT01519089|769368|P2|Overall Study|Withdrawal by Subject|2
232890|NCT01519089|769369|P1|Overall Study|Withdrawal by Subject|0
232891|NCT01519089|769368|P2|Overall Study|Lost to Follow-up|0
232892|NCT01519089|769369|P1|Overall Study|Lost to Follow-up|1
232893|NCT01519089|769368|P2|Overall Study|Lack of Efficacy|2
232894|NCT01519089|769369|P1|Overall Study|Lack of Efficacy|0
232895|NCT01519089|769368|P2|Overall Study|Adverse Event|4
232896|NCT01519089|769369|P1|Overall Study|Adverse Event|4
232897|NCT01518946|769490|P3|Randomized Phase (First Intervention)|Not specified|0
232898|NCT01518946|769491|P2|Randomized Phase (First Intervention)|Not specified|1
232899|NCT01518946|769492|P1|Randomized Phase (First Intervention)|Not specified|0
232900|NCT01518946|769490|P3|Open-label Phase|Not specified|0
232901|NCT01518946|769491|P2|Open-label Phase|Not specified|0
232902|NCT01518946|769492|P1|Open-label Phase|Not specified|4
232903|NCT01518322|769503|P1|Overall Study|FeNO measurement was missing|13
232904|NCT01518257|769524|P2|Overall Study|Other Miscellaneous Reason|0
232905|NCT01518257|769525|P1|Overall Study|Other Miscellaneous Reason|1
232906|NCT01518257|769524|P2|Overall Study|Lost to Follow-up|0
232907|NCT01518257|769525|P1|Overall Study|Lost to Follow-up|1
232908|NCT01518244|769547|P1|Overall Study|Adverse Event|3
232909|NCT01518192|769555|P3|Overall Study|Lost to Follow-up|35
232910|NCT01518192|769556|P2|Overall Study|Lost to Follow-up|26
232911|NCT01518192|769557|P1|Overall Study|Lost to Follow-up|29
232912|NCT01518153|769578|P3|Donor Lymphocyte Infusion|Death|1
232913|NCT01518153|769579|P2|Donor Lymphocyte Infusion|Death|2
232914|NCT01518153|769580|P1|Donor Lymphocyte Infusion|Death|0
232915|NCT01518153|769578|P3|Stem Cell Transplant|Adverse Event|0
232916|NCT01518153|769579|P2|Stem Cell Transplant|Adverse Event|0
232917|NCT01518153|769580|P1|Stem Cell Transplant|Adverse Event|1
232918|NCT01518153|769578|P3|Stem Cell Transplant|Secondary graft failure|0
232919|NCT01518153|769579|P2|Stem Cell Transplant|Secondary graft failure|0
232920|NCT01518153|769580|P1|Stem Cell Transplant|Secondary graft failure|1
232921|NCT01518153|769578|P3|Stem Cell Transplant|Death|0
232922|NCT01518153|769579|P2|Stem Cell Transplant|Death|0
232923|NCT01518153|769580|P1|Stem Cell Transplant|Death|2
232924|NCT01518153|769578|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
232925|NCT01518153|769579|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
232926|NCT01518153|769580|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
232927|NCT01517984|769591|P4|Overall Study|Ineligible for randomization|0
232928|NCT01517984|769592|P3|Overall Study|Ineligible for randomization|0
232929|NCT01517984|769593|P2|Overall Study|Ineligible for randomization|14
232930|NCT01517984|769594|P1|Overall Study|Ineligible for randomization|0
232931|NCT01517984|769591|P4|Overall Study|Screen Failure|0
232932|NCT01517984|769592|P3|Overall Study|Screen Failure|0
232933|NCT01517984|769593|P2|Overall Study|Screen Failure|0
232934|NCT01517984|769594|P1|Overall Study|Screen Failure|4
232935|NCT01517984|769591|P4|Overall Study|Withdrawal by Subject|1
232936|NCT01517984|769592|P3|Overall Study|Withdrawal by Subject|4
232937|NCT01517984|769593|P2|Overall Study|Withdrawal by Subject|8
232938|NCT01517984|769594|P1|Overall Study|Withdrawal by Subject|1
232939|NCT01517984|769591|P4|Overall Study|Lost to Follow-up|0
232940|NCT01517984|769592|P3|Overall Study|Lost to Follow-up|0
232941|NCT01517984|769593|P2|Overall Study|Lost to Follow-up|1
232942|NCT01517984|769594|P1|Overall Study|Lost to Follow-up|0
232943|NCT01517750|769631|P4|Overall Study|Lost to Follow-up|1
232944|NCT01517750|769632|P3|Overall Study|Lost to Follow-up|4
232945|NCT01517750|769633|P2|Overall Study|Lost to Follow-up|2
232946|NCT01517750|769634|P1|Overall Study|Lost to Follow-up|1
232947|NCT01516437|769673|P4|Overall Study|Reason not specified|1
232948|NCT01516437|769674|P3|Overall Study|Reason not specified|1
232949|NCT01516437|769675|P2|Overall Study|Reason not specified|0
232950|NCT01516437|769676|P1|Overall Study|Reason not specified|0
232951|NCT01517412|769741|P2|Overall Study|Other than specified above|5
232952|NCT01517412|769742|P1|Overall Study|Other than specified above|8
232953|NCT01517412|769741|P2|Overall Study|Poor compliance to protocol|3
232954|NCT01517412|769742|P1|Overall Study|Poor compliance to protocol|8
232955|NCT01517412|769741|P2|Overall Study|Lack of Efficacy|5
232956|NCT01517412|769742|P1|Overall Study|Lack of Efficacy|10
232957|NCT01517412|769741|P2|Overall Study|Adverse Event|11
232958|NCT01517412|769742|P1|Overall Study|Adverse Event|10
232959|NCT01517373|769771|P6|Treatment Period|Medication error without AEs|2
232960|NCT01517373|769772|P5|Treatment Period|Medication error without AEs|0
232961|NCT01517373|769773|P4|Treatment Period|Medication error without AEs|1
232962|NCT01517373|769774|P3|Treatment Period|Medication error without AEs|2
232963|NCT01517373|769775|P2|Treatment Period|Medication error without AEs|0
232964|NCT01517373|769776|P1|Treatment Period|Medication error without AEs|0
232965|NCT01517373|769771|P6|Treatment Period|Lack of Efficacy|0
232966|NCT01517373|769772|P5|Treatment Period|Lack of Efficacy|2
232967|NCT01517373|769773|P4|Treatment Period|Lack of Efficacy|3
232968|NCT01517373|769774|P3|Treatment Period|Lack of Efficacy|1
232969|NCT01517373|769775|P2|Treatment Period|Lack of Efficacy|1
232970|NCT01517373|769776|P1|Treatment Period|Lack of Efficacy|0
232971|NCT01517373|769771|P6|Treatment Period|Protocol Violation|0
232972|NCT01517373|769772|P5|Treatment Period|Protocol Violation|1
232973|NCT01517373|769773|P4|Treatment Period|Protocol Violation|0
232974|NCT01517373|769774|P3|Treatment Period|Protocol Violation|0
232975|NCT01517373|769775|P2|Treatment Period|Protocol Violation|0
232976|NCT01517373|769776|P1|Treatment Period|Protocol Violation|0
232977|NCT01517373|769771|P6|Treatment Period|Unspecified|0
232978|NCT01517373|769772|P5|Treatment Period|Unspecified|1
232979|NCT01517373|769773|P4|Treatment Period|Unspecified|0
232980|NCT01517373|769774|P3|Treatment Period|Unspecified|0
232981|NCT01517373|769775|P2|Treatment Period|Unspecified|0
232982|NCT01517373|769776|P1|Treatment Period|Unspecified|0
232983|NCT01517373|769771|P6|Treatment Period|Withdrawal by Subject|3
232984|NCT01517373|769772|P5|Treatment Period|Withdrawal by Subject|2
232985|NCT01517373|769773|P4|Treatment Period|Withdrawal by Subject|2
232986|NCT01517373|769774|P3|Treatment Period|Withdrawal by Subject|2
232987|NCT01517373|769775|P2|Treatment Period|Withdrawal by Subject|3
232988|NCT01517373|769776|P1|Treatment Period|Withdrawal by Subject|0
232989|NCT01517373|769771|P6|Treatment Period|Lost to Follow-up|0
232990|NCT01517373|769772|P5|Treatment Period|Lost to Follow-up|0
232991|NCT01517373|769773|P4|Treatment Period|Lost to Follow-up|1
232992|NCT01517373|769774|P3|Treatment Period|Lost to Follow-up|1
232993|NCT01517373|769775|P2|Treatment Period|Lost to Follow-up|0
232994|NCT01517373|769776|P1|Treatment Period|Lost to Follow-up|0
232995|NCT01517373|769771|P6|Treatment Period|Adverse Event|2
232996|NCT01517373|769772|P5|Treatment Period|Adverse Event|0
232997|NCT01517373|769773|P4|Treatment Period|Adverse Event|0
232998|NCT01517373|769774|P3|Treatment Period|Adverse Event|0
232999|NCT01517373|769775|P2|Treatment Period|Adverse Event|0
233000|NCT01517373|769776|P1|Treatment Period|Adverse Event|0
233001|NCT01517373|769771|P6|Run-in Period|Unspecified|0
233002|NCT01517373|769772|P5|Run-in Period|Unspecified|0
233003|NCT01517373|769773|P4|Run-in Period|Unspecified|0
233004|NCT01517373|769774|P3|Run-in Period|Unspecified|0
233005|NCT01517373|769775|P2|Run-in Period|Unspecified|0
233006|NCT01517373|769776|P1|Run-in Period|Unspecified|1
233007|NCT01517373|769771|P6|Run-in Period|Sponsor Decision|0
233008|NCT01517373|769772|P5|Run-in Period|Sponsor Decision|0
233009|NCT01517373|769773|P4|Run-in Period|Sponsor Decision|0
233010|NCT01517373|769774|P3|Run-in Period|Sponsor Decision|0
233011|NCT01517373|769775|P2|Run-in Period|Sponsor Decision|0
233012|NCT01517373|769776|P1|Run-in Period|Sponsor Decision|3
233013|NCT01517373|769771|P6|Run-in Period|Withdrawal by Subject|0
233014|NCT01517373|769772|P5|Run-in Period|Withdrawal by Subject|0
233015|NCT01517373|769773|P4|Run-in Period|Withdrawal by Subject|0
233016|NCT01517373|769774|P3|Run-in Period|Withdrawal by Subject|0
233017|NCT01517373|769775|P2|Run-in Period|Withdrawal by Subject|0
233018|NCT01517373|769776|P1|Run-in Period|Withdrawal by Subject|12
233019|NCT01517373|769771|P6|Run-in Period|Lost to Follow-up|0
233020|NCT01517373|769772|P5|Run-in Period|Lost to Follow-up|0
233021|NCT01517373|769773|P4|Run-in Period|Lost to Follow-up|0
233022|NCT01517373|769774|P3|Run-in Period|Lost to Follow-up|0
233023|NCT01517373|769775|P2|Run-in Period|Lost to Follow-up|0
233024|NCT01517373|769776|P1|Run-in Period|Lost to Follow-up|1
233025|NCT01517373|769771|P6|Run-in Period|Did not meet eligibility criteria|0
233026|NCT01517373|769772|P5|Run-in Period|Did not meet eligibility criteria|0
233027|NCT01517373|769773|P4|Run-in Period|Did not meet eligibility criteria|0
233028|NCT01517373|769774|P3|Run-in Period|Did not meet eligibility criteria|0
233029|NCT01517373|769775|P2|Run-in Period|Did not meet eligibility criteria|0
233030|NCT01517373|769776|P1|Run-in Period|Did not meet eligibility criteria|34
233031|NCT01517373|769771|P6|Run-in Period|Adverse Event|0
233032|NCT01517373|769772|P5|Run-in Period|Adverse Event|0
233033|NCT01517373|769773|P4|Run-in Period|Adverse Event|0
233034|NCT01517373|769774|P3|Run-in Period|Adverse Event|0
233035|NCT01517373|769775|P2|Run-in Period|Adverse Event|0
233036|NCT01517373|769776|P1|Run-in Period|Adverse Event|5
233037|NCT01517373|769771|P6|Run-in Period|Death|0
233038|NCT01517373|769772|P5|Run-in Period|Death|0
233039|NCT01517373|769773|P4|Run-in Period|Death|0
233040|NCT01517373|769774|P3|Run-in Period|Death|0
233041|NCT01517373|769775|P2|Run-in Period|Death|0
233042|NCT01517373|769776|P1|Run-in Period|Death|1
233043|NCT01517295|769846|P2|Overall Study|Physician Decision|0
233044|NCT01517295|769847|P1|Overall Study|Physician Decision|1
233045|NCT01517282|769861|P4|Overall Study|Physician Decision|0
233046|NCT01517282|769862|P3|Overall Study|Physician Decision|0
233047|NCT01517282|769863|P2|Overall Study|Physician Decision|0
233048|NCT01517282|769864|P1|Overall Study|Physician Decision|1
233049|NCT01517282|769861|P4|Overall Study|Consent withdrawn|1
233050|NCT01517282|769862|P3|Overall Study|Consent withdrawn|1
233051|NCT01517282|769863|P2|Overall Study|Consent withdrawn|1
233052|NCT01517282|769864|P1|Overall Study|Consent withdrawn|0
233053|NCT01517178|769898|P2|Period 2|E.g. study termination|2
233054|NCT01517178|769899|P1|Period 2|E.g. study termination|2
233055|NCT01517178|769898|P2|Period 2|Withdrawal by Subject|0
233056|NCT01517178|769899|P1|Period 2|Withdrawal by Subject|3
233057|NCT01517178|769898|P2|Period 2|Adverse Event|0
233058|NCT01517178|769899|P1|Period 2|Adverse Event|1
233059|NCT01517178|769898|P2|Period 1|Withdrawal by Subject|1
233060|NCT01517178|769899|P1|Period 1|Withdrawal by Subject|0
233061|NCT01517178|769898|P2|Period 1|E.g. study termination|1
233062|NCT01517178|769899|P1|Period 1|E.g. study termination|3
233063|NCT01517178|769898|P2|Period 1|Lack of Efficacy|1
233064|NCT01517178|769899|P1|Period 1|Lack of Efficacy|0
233065|NCT01517178|769898|P2|Period 1|Adverse Event|2
233066|NCT01517178|769899|P1|Period 1|Adverse Event|1
233067|NCT01516970|769918|P2|Overall Study|Unspecified|7
233068|NCT01516970|769919|P1|Overall Study|Unspecified|9
233069|NCT01516970|769918|P2|Overall Study|Withdrawal by Subject|1
233070|NCT01516970|769919|P1|Overall Study|Withdrawal by Subject|1
233071|NCT01516970|769918|P2|Overall Study|Adverse Event|5
233072|NCT01516970|769919|P1|Overall Study|Adverse Event|1
233073|NCT01516970|769918|P2|Overall Study|Lost to Follow-up|8
233074|NCT01516970|769919|P1|Overall Study|Lost to Follow-up|7
233075|NCT01516892|769931|P1|Overall Study|Missing|1
233076|NCT01516892|769931|P1|Overall Study|Other Miscellaneous Reasons|43
233077|NCT01516892|769931|P1|Overall Study|Protocol Violation|60
233078|NCT01516892|769931|P1|Overall Study|Subject Withdrew Consent|92
233079|NCT01516892|769931|P1|Overall Study|Lost to Follow-up|82
233080|NCT01516892|769931|P1|Overall Study|Pregnancy|5
233081|NCT01516892|769931|P1|Overall Study|Lack of Efficacy|35
233082|NCT01516892|769931|P1|Overall Study|Adverse Event|25
233083|NCT01516879|769939|P2|Overall Study|Other|10
233084|NCT01516879|769940|P1|Overall Study|Other|5
233085|NCT01516879|769939|P2|Overall Study|Lost to Follow-up|11
233086|NCT01516879|769940|P1|Overall Study|Lost to Follow-up|2
233087|NCT01516879|769939|P2|Overall Study|Death|2
233088|NCT01516879|769940|P1|Overall Study|Death|0
233089|NCT01516879|769939|P2|Overall Study|Withdrawal by Subject|11
233090|NCT01516879|769940|P1|Overall Study|Withdrawal by Subject|9
233091|NCT01516749|769974|P1|Follow-up Off Therapy|Lost to Follow-up|1
233092|NCT01516749|769974|P1|Active Therapy|Lost to Follow-up|1
233093|NCT01516034|769994|P1|Overall Study|Lack of Efficacy|7
233094|NCT01516034|769994|P1|Overall Study|Physician Decision|1
233095|NCT01516008|770001|P3|Overall Study|Reason not specified|1
233096|NCT01516008|770002|P2|Overall Study|Reason not specified|0
233097|NCT01516008|770003|P1|Overall Study|Reason not specified|0
233098|NCT01516008|770001|P3|Overall Study|Protocol Violation|0
233099|NCT01516008|770002|P2|Overall Study|Protocol Violation|0
233100|NCT01516008|770003|P1|Overall Study|Protocol Violation|1
233101|NCT01516008|770001|P3|Overall Study|Lack of Efficacy|10
233102|NCT01516008|770002|P2|Overall Study|Lack of Efficacy|14
233103|NCT01516008|770003|P1|Overall Study|Lack of Efficacy|44
233104|NCT01516008|770001|P3|Overall Study|Adverse Event|7
233105|NCT01516008|770002|P2|Overall Study|Adverse Event|2
233106|NCT01516008|770003|P1|Overall Study|Adverse Event|0
233107|NCT01515865|770093|P3|Part B (Open-label)|Not Specified|0
233108|NCT01515865|770094|P2|Part B (Open-label)|Not Specified|0
233109|NCT01515865|770095|P1|Part B (Open-label)|Not Specified|1
233110|NCT01515865|770093|P3|Part B (Open-label)|Withdrawal by Subject|0
233111|NCT01515865|770094|P2|Part B (Open-label)|Withdrawal by Subject|0
233112|NCT01515865|770095|P1|Part B (Open-label)|Withdrawal by Subject|1
233113|NCT01515865|770093|P3|Part A (Open-label)|Not Specified|0
233114|NCT01515865|770094|P2|Part A (Open-label)|Not Specified|0
233115|NCT01515865|770095|P1|Part A (Open-label)|Not Specified|3
233116|NCT01515423|770163|P3|DOUBLE BLIND|Blind broken by investigator|0
233117|NCT01515423|770164|P2|DOUBLE BLIND|Blind broken by investigator|1
233118|NCT01515423|770165|P1|DOUBLE BLIND|Blind broken by investigator|0
233119|NCT01515423|770163|P3|DOUBLE BLIND|Unspecified|12
233120|NCT01515423|770164|P2|DOUBLE BLIND|Unspecified|6
233121|NCT01515423|770165|P1|DOUBLE BLIND|Unspecified|0
233122|NCT01515423|770163|P3|DOUBLE BLIND|Withdrawal by Subject|53
233123|NCT01515423|770164|P2|DOUBLE BLIND|Withdrawal by Subject|50
233124|NCT01515423|770165|P1|DOUBLE BLIND|Withdrawal by Subject|0
233125|NCT01515423|770163|P3|DOUBLE BLIND|Pregnancy|0
233126|NCT01515423|770164|P2|DOUBLE BLIND|Pregnancy|2
233127|NCT01515423|770165|P1|DOUBLE BLIND|Pregnancy|0
233128|NCT01515423|770163|P3|DOUBLE BLIND|Lost to Follow-up|12
233129|NCT01515423|770164|P2|DOUBLE BLIND|Lost to Follow-up|7
233130|NCT01515423|770165|P1|DOUBLE BLIND|Lost to Follow-up|0
233131|NCT01515423|770163|P3|DOUBLE BLIND|Death|2
233132|NCT01515423|770164|P2|DOUBLE BLIND|Death|1
233133|NCT01515423|770165|P1|DOUBLE BLIND|Death|0
233134|NCT01515423|770163|P3|DOUBLE BLIND|Adverse Event|13
233135|NCT01515423|770164|P2|DOUBLE BLIND|Adverse Event|15
233136|NCT01515423|770165|P1|DOUBLE BLIND|Adverse Event|0
233137|NCT01515423|770163|P3|Open Label Phase|Unspecified|0
233138|NCT01515423|770164|P2|Open Label Phase|Unspecified|0
233139|NCT01515423|770165|P1|Open Label Phase|Unspecified|28
233140|NCT01515423|770163|P3|Open Label Phase|excluded from DB Phase|0
233141|NCT01515423|770164|P2|Open Label Phase|excluded from DB Phase|0
233142|NCT01515423|770165|P1|Open Label Phase|excluded from DB Phase|70
233143|NCT01515423|770163|P3|Open Label Phase|Withdrawal by Subject|0
233144|NCT01515423|770164|P2|Open Label Phase|Withdrawal by Subject|0
233145|NCT01515423|770165|P1|Open Label Phase|Withdrawal by Subject|118
233146|NCT01515423|770163|P3|Open Label Phase|Lost to Follow-up|0
233147|NCT01515423|770164|P2|Open Label Phase|Lost to Follow-up|0
233148|NCT01515423|770165|P1|Open Label Phase|Lost to Follow-up|21
233149|NCT01515423|770163|P3|Open Label Phase|Lack of Efficacy|0
233150|NCT01515423|770164|P2|Open Label Phase|Lack of Efficacy|0
233151|NCT01515423|770165|P1|Open Label Phase|Lack of Efficacy|117
233152|NCT01515423|770163|P3|Open Label Phase|Death|0
233153|NCT01515423|770164|P2|Open Label Phase|Death|0
233154|NCT01515423|770165|P1|Open Label Phase|Death|2
233155|NCT01515423|770163|P3|Open Label Phase|Adverse Event|0
233156|NCT01515423|770164|P2|Open Label Phase|Adverse Event|0
233157|NCT01515423|770165|P1|Open Label Phase|Adverse Event|57
233158|NCT01515306|770206|P2|Overall Study|Ongoing receiving treatment|14
233159|NCT01515306|770207|P1|Overall Study|Ongoing receiving treatment|9
233160|NCT01515306|770206|P2|Overall Study|Progressive Disease|0
233161|NCT01515306|770207|P1|Overall Study|Progressive Disease|1
233162|NCT01515306|770206|P2|Overall Study|Adverse Event|0
233163|NCT01515306|770207|P1|Overall Study|Adverse Event|2
233164|NCT01515189|770220|P2|First Re-Induction Phase|Unspecified|0
233165|NCT01515189|770221|P1|First Re-Induction Phase|Unspecified|1
233166|NCT01515189|770220|P2|First Re-Induction Phase|No longer meets study criteria|0
233167|NCT01515189|770221|P1|First Re-Induction Phase|No longer meets study criteria|1
233168|NCT01515189|770220|P2|First Re-Induction Phase|Withdrawal by Subject|1
233169|NCT01515189|770221|P1|First Re-Induction Phase|Withdrawal by Subject|1
233170|NCT01515189|770220|P2|First Re-Induction Phase|Study drug toxicity|0
233171|NCT01515189|770221|P1|First Re-Induction Phase|Study drug toxicity|5
233172|NCT01515189|770220|P2|First Re-Induction Phase|Disease progression|14
233173|NCT01515189|770221|P1|First Re-Induction Phase|Disease progression|6
233174|NCT01515189|770220|P2|Induction|Unspecified|4
233175|NCT01515189|770221|P1|Induction|Unspecified|0
233176|NCT01515189|770220|P2|Induction|Lost to Follow-up|0
233177|NCT01515189|770221|P1|Induction|Lost to Follow-up|1
233178|NCT01515189|770220|P2|Induction|No longer meets study criteria|2
233179|NCT01515189|770221|P1|Induction|No longer meets study criteria|0
233180|NCT01515189|770220|P2|Induction|Withdrawal by Subject|9
233181|NCT01515189|770221|P1|Induction|Withdrawal by Subject|3
233182|NCT01515189|770220|P2|Induction|Adverse Event|9
233183|NCT01515189|770221|P1|Induction|Adverse Event|14
233184|NCT01515189|770220|P2|Induction|Death|17
233185|NCT01515189|770221|P1|Induction|Death|24
233186|NCT01515189|770220|P2|Induction|Study drug toxicity|36
233187|NCT01515189|770221|P1|Induction|Study drug toxicity|86
233188|NCT01515189|770220|P2|Induction|Disease Progression|155
233189|NCT01515189|770221|P1|Induction|Disease Progression|109
233190|NCT01514864|770251|P2|Overall Study|Study drug toxicity|0
233191|NCT01514864|770252|P1|Overall Study|Study drug toxicity|2
233192|NCT01514864|770251|P2|Overall Study|Disease progression|5
233193|NCT01514864|770252|P1|Overall Study|Disease progression|7
233194|NCT01514760|770268|P1|Overall Study|Lost to Follow-up|2
233195|NCT01514461|770297|P3|Overall Study|Death|0
233196|NCT01514461|770298|P2|Overall Study|Death|0
233197|NCT01514461|770299|P1|Overall Study|Death|1
233198|NCT01514461|770297|P3|Overall Study|Patient/guardian decision|1
233199|NCT01514461|770298|P2|Overall Study|Patient/guardian decision|1
233200|NCT01514461|770299|P1|Overall Study|Patient/guardian decision|1
233201|NCT01514461|770297|P3|Overall Study|Physician Decision|0
233202|NCT01514461|770298|P2|Overall Study|Physician Decision|1
233203|NCT01514461|770299|P1|Overall Study|Physician Decision|1
233204|NCT01514461|770297|P3|Overall Study|Adverse Event|3
233205|NCT01514461|770298|P2|Overall Study|Adverse Event|1
233206|NCT01514461|770299|P1|Overall Study|Adverse Event|2
233207|NCT01514422|770336|P1|Overall Study|Lost to Follow-up|1
233208|NCT01514240|770354|P2|Overall Study|Subject Decision|7
233209|NCT01514240|770355|P1|Overall Study|Subject Decision|2
233210|NCT01514240|770354|P2|Overall Study|Adverse Event|4
233211|NCT01514240|770355|P1|Overall Study|Adverse Event|4
233212|NCT01514136|770437|P8|Test Period 2; Test C*|Protocol Violation|0
233213|NCT01514136|770438|P7|Test Period 2; Test C*|Protocol Violation|1
233214|NCT01514136|770439|P6|Test Period 2; Test C*|Protocol Violation|0
233215|NCT01514136|770440|P5|Test Period 2; Test C*|Protocol Violation|0
233216|NCT01514136|770441|P4|Test Period 2; Test C*|Protocol Violation|0
233217|NCT01514136|770442|P3|Test Period 2; Test C*|Protocol Violation|0
233218|NCT01514136|770443|P2|Test Period 2; Test C*|Protocol Violation|0
233219|NCT01514136|770444|P1|Test Period 2; Test C*|Protocol Violation|0
233220|NCT01514136|770437|P8|Test Period 2; Test C*|holiday|0
233221|NCT01514136|770438|P7|Test Period 2; Test C*|holiday|1
233222|NCT01514136|770439|P6|Test Period 2; Test C*|holiday|0
233223|NCT01514136|770440|P5|Test Period 2; Test C*|holiday|0
233224|NCT01514136|770441|P4|Test Period 2; Test C*|holiday|0
233225|NCT01514136|770442|P3|Test Period 2; Test C*|holiday|0
233226|NCT01514136|770443|P2|Test Period 2; Test C*|holiday|0
233227|NCT01514136|770444|P1|Test Period 2; Test C*|holiday|0
233228|NCT01514136|770437|P8|Test Period 2; Test C*|Withdrawal by Subject|0
233229|NCT01514136|770438|P7|Test Period 2; Test C*|Withdrawal by Subject|1
233230|NCT01514136|770439|P6|Test Period 2; Test C*|Withdrawal by Subject|0
233231|NCT01514136|770440|P5|Test Period 2; Test C*|Withdrawal by Subject|0
233232|NCT01514136|770441|P4|Test Period 2; Test C*|Withdrawal by Subject|0
233233|NCT01514136|770442|P3|Test Period 2; Test C*|Withdrawal by Subject|0
233234|NCT01514136|770443|P2|Test Period 2; Test C*|Withdrawal by Subject|0
233235|NCT01514136|770444|P1|Test Period 2; Test C*|Withdrawal by Subject|0
233236|NCT01514136|770437|P8|Test Period 2; Test B*|Withdrawal by Subject|0
233237|NCT01514136|770438|P7|Test Period 2; Test B*|Withdrawal by Subject|0
233238|NCT01514136|770439|P6|Test Period 2; Test B*|Withdrawal by Subject|2
233239|NCT01514136|770440|P5|Test Period 2; Test B*|Withdrawal by Subject|0
233240|NCT01514136|770441|P4|Test Period 2; Test B*|Withdrawal by Subject|0
233241|NCT01514136|770442|P3|Test Period 2; Test B*|Withdrawal by Subject|0
233242|NCT01514136|770443|P2|Test Period 2; Test B*|Withdrawal by Subject|0
233243|NCT01514136|770444|P1|Test Period 2; Test B*|Withdrawal by Subject|0
233244|NCT01514136|770437|P8|Test Period 2; Test A*|Holiday|0
233245|NCT01514136|770438|P7|Test Period 2; Test A*|Holiday|0
233246|NCT01514136|770439|P6|Test Period 2; Test A*|Holiday|0
233247|NCT01514136|770440|P5|Test Period 2; Test A*|Holiday|1
233248|NCT01514136|770441|P4|Test Period 2; Test A*|Holiday|0
233249|NCT01514136|770442|P3|Test Period 2; Test A*|Holiday|0
233250|NCT01514136|770443|P2|Test Period 2; Test A*|Holiday|0
233251|NCT01514136|770444|P1|Test Period 2; Test A*|Holiday|0
233252|NCT01514136|770437|P8|Test Period 2; Test A*|Adverse Event|0
233253|NCT01514136|770438|P7|Test Period 2; Test A*|Adverse Event|0
233254|NCT01514136|770439|P6|Test Period 2; Test A*|Adverse Event|0
233255|NCT01514136|770440|P5|Test Period 2; Test A*|Adverse Event|1
233256|NCT01514136|770441|P4|Test Period 2; Test A*|Adverse Event|0
233257|NCT01514136|770442|P3|Test Period 2; Test A*|Adverse Event|0
233258|NCT01514136|770443|P2|Test Period 2; Test A*|Adverse Event|0
233259|NCT01514136|770444|P1|Test Period 2; Test A*|Adverse Event|0
233260|NCT01514136|770437|P8|Test Period 1; Test D|Subject took a break due to holiday|0
233261|NCT01514136|770438|P7|Test Period 1; Test D|Subject took a break due to holiday|0
233262|NCT01514136|770439|P6|Test Period 1; Test D|Subject took a break due to holiday|0
233263|NCT01514136|770440|P5|Test Period 1; Test D|Subject took a break due to holiday|0
233264|NCT01514136|770441|P4|Test Period 1; Test D|Subject took a break due to holiday|2
233265|NCT01514136|770442|P3|Test Period 1; Test D|Subject took a break due to holiday|0
233266|NCT01514136|770443|P2|Test Period 1; Test D|Subject took a break due to holiday|0
233267|NCT01514136|770444|P1|Test Period 1; Test D|Subject took a break due to holiday|0
233268|NCT01514136|770437|P8|Test Period 1; Test B|Withdrawal by Subject|0
233269|NCT01514136|770438|P7|Test Period 1; Test B|Withdrawal by Subject|0
233270|NCT01514136|770439|P6|Test Period 1; Test B|Withdrawal by Subject|0
233271|NCT01514136|770440|P5|Test Period 1; Test B|Withdrawal by Subject|0
233272|NCT01514136|770441|P4|Test Period 1; Test B|Withdrawal by Subject|0
233273|NCT01514136|770442|P3|Test Period 1; Test B|Withdrawal by Subject|0
233274|NCT01514136|770443|P2|Test Period 1; Test B|Withdrawal by Subject|1
233275|NCT01514136|770444|P1|Test Period 1; Test B|Withdrawal by Subject|0
233276|NCT01514136|770437|P8|Test Period 1; Test A|Break from study holiday|0
233277|NCT01514136|770438|P7|Test Period 1; Test A|Break from study holiday|0
233278|NCT01514136|770439|P6|Test Period 1; Test A|Break from study holiday|0
233279|NCT01514136|770440|P5|Test Period 1; Test A|Break from study holiday|0
233280|NCT01514136|770441|P4|Test Period 1; Test A|Break from study holiday|0
233281|NCT01514136|770442|P3|Test Period 1; Test A|Break from study holiday|0
233282|NCT01514136|770443|P2|Test Period 1; Test A|Break from study holiday|0
233283|NCT01514136|770444|P1|Test Period 1; Test A|Break from study holiday|2
233284|NCT01514136|770437|P8|Test Period 1; Test A|Protocol Violation|0
233285|NCT01514136|770438|P7|Test Period 1; Test A|Protocol Violation|0
233286|NCT01514136|770439|P6|Test Period 1; Test A|Protocol Violation|0
233287|NCT01514136|770440|P5|Test Period 1; Test A|Protocol Violation|0
233288|NCT01514136|770441|P4|Test Period 1; Test A|Protocol Violation|0
233289|NCT01514136|770442|P3|Test Period 1; Test A|Protocol Violation|0
233290|NCT01514136|770443|P2|Test Period 1; Test A|Protocol Violation|0
233291|NCT01514136|770444|P1|Test Period 1; Test A|Protocol Violation|1
233292|NCT01513590|770512|P2|Overall Study|Unclassified|10
233293|NCT01513590|770513|P1|Overall Study|Unclassified|5
233294|NCT01513590|770512|P2|Overall Study|Withdrawal Criteria|0
233295|NCT01513590|770513|P1|Overall Study|Withdrawal Criteria|3
233296|NCT01513590|770512|P2|Overall Study|Adverse Event|3
233297|NCT01513590|770513|P1|Overall Study|Adverse Event|2
233298|NCT01513473|770533|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
233299|NCT01513473|770534|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
233300|NCT01513473|770533|P2|Extension Trial (26 Weeks)|Adverse Event|1
233301|NCT01513473|770534|P1|Extension Trial (26 Weeks)|Adverse Event|0
233302|NCT01513473|770533|P2|Main Trial (26 Weeks)|Unclassified|2
233303|NCT01513473|770534|P1|Main Trial (26 Weeks)|Unclassified|0
233304|NCT01513473|770533|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
233305|NCT01513473|770534|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
233306|NCT01513473|770533|P2|Main Trial (26 Weeks)|Adverse Event|2
233307|NCT01513473|770534|P1|Main Trial (26 Weeks)|Adverse Event|0
233308|NCT01513460|770561|P3|Overall Study|Abnormal test procedure|0
233309|NCT01513460|770562|P2|Overall Study|Abnormal test procedure|0
233310|NCT01513460|770563|P1|Overall Study|Abnormal test procedure|1
233311|NCT01513460|770561|P3|Overall Study|Adverse Event|23
233312|NCT01513460|770562|P2|Overall Study|Adverse Event|18
233313|NCT01513460|770563|P1|Overall Study|Adverse Event|16
233314|NCT01513460|770561|P3|Overall Study|Withdrawal by Subject|21
233315|NCT01513460|770562|P2|Overall Study|Withdrawal by Subject|8
233316|NCT01513460|770563|P1|Overall Study|Withdrawal by Subject|7
233317|NCT01513460|770561|P3|Overall Study|Protocol deviations|3
233318|NCT01513460|770562|P2|Overall Study|Protocol deviations|4
233319|NCT01513460|770563|P1|Overall Study|Protocol deviations|3
233320|NCT01513460|770561|P3|Overall Study|Lack of Efficacy|5
233321|NCT01513460|770562|P2|Overall Study|Lack of Efficacy|2
233322|NCT01513460|770563|P1|Overall Study|Lack of Efficacy|1
233323|NCT01513460|770561|P3|Overall Study|Abnormal laboratory value|1
233324|NCT01513460|770562|P2|Overall Study|Abnormal laboratory value|0
233325|NCT01513460|770563|P1|Overall Study|Abnormal laboratory value|1
233326|NCT01513460|770561|P3|Overall Study|Lost to Follow-up|2
233327|NCT01513460|770562|P2|Overall Study|Lost to Follow-up|0
233328|NCT01513460|770563|P1|Overall Study|Lost to Follow-up|0
233329|NCT01513460|770561|P3|Overall Study|Death|1
233330|NCT01513460|770562|P2|Overall Study|Death|0
233331|NCT01513460|770563|P1|Overall Study|Death|0
233332|NCT01513330|770598|P2|Standard Care First,|not known|0
233333|NCT01513330|770599|P1|Standard Care First,|not known|1
233334|NCT01513330|770598|P2|Standard Care First,|Withdrawal by Subject|2
233335|NCT01513330|770599|P1|Standard Care First,|Withdrawal by Subject|1
233336|NCT01513330|770598|P2|Standard Care First,|Lack of Efficacy|2
233337|NCT01513330|770599|P1|Standard Care First,|Lack of Efficacy|2
233338|NCT01513330|770598|P2|SenSura Mio First,|not known|0
233339|NCT01513330|770599|P1|SenSura Mio First,|not known|1
233340|NCT01513330|770598|P2|SenSura Mio First,|Withdrawal by Subject|1
233341|NCT01513330|770599|P1|SenSura Mio First,|Withdrawal by Subject|1
233342|NCT01513330|770598|P2|SenSura Mio First,|Lack of Efficacy|1
233343|NCT01513330|770599|P1|SenSura Mio First,|Lack of Efficacy|0
233344|NCT01513330|770598|P2|SenSura Mio First,|Adverse Event|0
233345|NCT01513330|770599|P1|SenSura Mio First,|Adverse Event|2
233346|NCT01513317|770607|P2|Overall Study|Not specified|1
233347|NCT01513317|770608|P1|Overall Study|Not specified|0
233348|NCT01513317|770607|P2|Overall Study|Study terminated by sponsor|18
233349|NCT01513317|770608|P1|Overall Study|Study terminated by sponsor|18
233350|NCT01513317|770607|P2|Overall Study|Death|1
233351|NCT01513317|770608|P1|Overall Study|Death|1
233352|NCT01513317|770607|P2|Overall Study|Withdrawal by Subject|4
233353|NCT01513317|770608|P1|Overall Study|Withdrawal by Subject|15
233354|NCT01513291|770626|P5|Run-out Period|Withdrawal by Subject|0
233355|NCT01513291|770627|P4|Run-out Period|Withdrawal by Subject|1
233356|NCT01513291|770628|P3|Run-out Period|Withdrawal by Subject|0
233357|NCT01513291|770629|P2|Run-out Period|Withdrawal by Subject|0
233358|NCT01513291|770630|P1|Run-out Period|Withdrawal by Subject|0
233359|NCT01513291|770626|P5|Run-out Period|Lost to Follow-up|0
233360|NCT01513291|770627|P4|Run-out Period|Lost to Follow-up|1
233361|NCT01513291|770628|P3|Run-out Period|Lost to Follow-up|0
233362|NCT01513291|770629|P2|Run-out Period|Lost to Follow-up|0
233363|NCT01513291|770630|P1|Run-out Period|Lost to Follow-up|0
233364|NCT01513291|770626|P5|Treatment Period|Randomized not treated|0
233365|NCT01513291|770627|P4|Treatment Period|Randomized not treated|0
233366|NCT01513291|770628|P3|Treatment Period|Randomized not treated|0
233367|NCT01513291|770629|P2|Treatment Period|Randomized not treated|2
233368|NCT01513291|770630|P1|Treatment Period|Randomized not treated|0
233369|NCT01513291|770626|P5|Treatment Period|Withdrawal by Subject|0
233370|NCT01513291|770627|P4|Treatment Period|Withdrawal by Subject|0
233371|NCT01513291|770628|P3|Treatment Period|Withdrawal by Subject|0
233372|NCT01513291|770629|P2|Treatment Period|Withdrawal by Subject|5
233373|NCT01513291|770630|P1|Treatment Period|Withdrawal by Subject|8
233374|NCT01513291|770626|P5|Treatment Period|Protocol Violation|0
233375|NCT01513291|770627|P4|Treatment Period|Protocol Violation|0
233376|NCT01513291|770628|P3|Treatment Period|Protocol Violation|0
233377|NCT01513291|770629|P2|Treatment Period|Protocol Violation|2
233378|NCT01513291|770630|P1|Treatment Period|Protocol Violation|1
233379|NCT01513291|770626|P5|Treatment Period|Physician Decision|0
233380|NCT01513291|770627|P4|Treatment Period|Physician Decision|0
233381|NCT01513291|770628|P3|Treatment Period|Physician Decision|0
233382|NCT01513291|770629|P2|Treatment Period|Physician Decision|0
233383|NCT01513291|770630|P1|Treatment Period|Physician Decision|1
233384|NCT01513291|770626|P5|Treatment Period|Lost to Follow-up|0
233385|NCT01513291|770627|P4|Treatment Period|Lost to Follow-up|0
233386|NCT01513291|770628|P3|Treatment Period|Lost to Follow-up|0
233387|NCT01513291|770629|P2|Treatment Period|Lost to Follow-up|3
233388|NCT01513291|770630|P1|Treatment Period|Lost to Follow-up|2
233389|NCT01513291|770626|P5|Treatment Period|Lack of Efficacy|0
233390|NCT01513291|770627|P4|Treatment Period|Lack of Efficacy|0
233391|NCT01513291|770628|P3|Treatment Period|Lack of Efficacy|0
233392|NCT01513291|770629|P2|Treatment Period|Lack of Efficacy|0
233393|NCT01513291|770630|P1|Treatment Period|Lack of Efficacy|3
233394|NCT01513291|770626|P5|Treatment Period|Adverse Event|0
233395|NCT01513291|770627|P4|Treatment Period|Adverse Event|0
233396|NCT01513291|770628|P3|Treatment Period|Adverse Event|0
233397|NCT01513291|770629|P2|Treatment Period|Adverse Event|4
233398|NCT01513291|770630|P1|Treatment Period|Adverse Event|8
233399|NCT01513239|770658|P3|Overall Study|Withdrawal by Subject|42
233400|NCT01513239|770659|P2|Overall Study|Withdrawal by Subject|29
233401|NCT01513239|770660|P1|Overall Study|Withdrawal by Subject|27
233402|NCT01513239|770658|P3|Overall Study|Technical Problems|0
233403|NCT01513239|770659|P2|Overall Study|Technical Problems|2
233404|NCT01513239|770660|P1|Overall Study|Technical Problems|1
233405|NCT01513239|770658|P3|Overall Study|Protocol Violation|2
233406|NCT01513239|770659|P2|Overall Study|Protocol Violation|2
233407|NCT01513239|770660|P1|Overall Study|Protocol Violation|2
233408|NCT01513239|770658|P3|Overall Study|Physician Decision|4
233409|NCT01513239|770659|P2|Overall Study|Physician Decision|4
233410|NCT01513239|770660|P1|Overall Study|Physician Decision|4
233411|NCT01513239|770658|P3|Overall Study|Lost to Follow-up|6
233412|NCT01513239|770659|P2|Overall Study|Lost to Follow-up|10
233413|NCT01513239|770660|P1|Overall Study|Lost to Follow-up|11
233414|NCT01513239|770658|P3|Overall Study|Death|32
233415|NCT01513239|770659|P2|Overall Study|Death|22
233416|NCT01513239|770660|P1|Overall Study|Death|29
233417|NCT01513239|770658|P3|Overall Study|Adverse Event|2
233418|NCT01513239|770659|P2|Overall Study|Adverse Event|1
233419|NCT01513239|770660|P1|Overall Study|Adverse Event|1
233420|NCT01513148|770710|P2|Overall Study|Protocol Violation|2
233421|NCT01513148|770711|P1|Overall Study|Protocol Violation|2
233422|NCT01512979|770778|P2|Overall Study|Reason other than stated above|9
233423|NCT01512979|770779|P1|Overall Study|Reason other than stated above|13
233424|NCT01512979|770778|P2|Overall Study|Withdrawal by Subject|2
233425|NCT01512979|770779|P1|Overall Study|Withdrawal by Subject|1
233426|NCT01512979|770778|P2|Overall Study|Lost to Follow-up|5
233427|NCT01512979|770779|P1|Overall Study|Lost to Follow-up|2
233428|NCT01512979|770778|P2|Overall Study|Protocol Violation|4
233429|NCT01512979|770779|P1|Overall Study|Protocol Violation|1
233430|NCT01512979|770778|P2|Overall Study|Adverse Event|2
233431|NCT01512979|770779|P1|Overall Study|Adverse Event|2
233432|NCT01512745|770826|P2|Overall Study|Protocol Violation|0
233433|NCT01512745|770827|P1|Overall Study|Protocol Violation|1
233434|NCT01512745|770826|P2|Overall Study|Lack of Efficacy|2
233435|NCT01512745|770827|P1|Overall Study|Lack of Efficacy|2
233436|NCT01512745|770826|P2|Overall Study|Lost to Follow-up|0
233437|NCT01512745|770827|P1|Overall Study|Lost to Follow-up|4
233438|NCT01512745|770826|P2|Overall Study|Withdrawal by Subject|2
233439|NCT01512745|770827|P1|Overall Study|Withdrawal by Subject|2
233440|NCT01512745|770826|P2|Overall Study|Death|13
233441|NCT01512745|770827|P1|Overall Study|Death|9
233442|NCT01512745|770826|P2|Overall Study|Adverse Event|3
233443|NCT01512745|770827|P1|Overall Study|Adverse Event|22
233444|NCT01512368|770841|P1|Overall Study|Protocol Violation|3
233445|NCT01512160|770877|P4|Overall Study|Withdrawal by Subject|1
233446|NCT01512160|770878|P3|Overall Study|Withdrawal by Subject|0
233447|NCT01512160|770879|P2|Overall Study|Withdrawal by Subject|0
233448|NCT01512160|770880|P1|Overall Study|Withdrawal by Subject|1
233449|NCT01512160|770877|P4|Overall Study|Lost to Follow-up|0
233450|NCT01512160|770878|P3|Overall Study|Lost to Follow-up|0
233451|NCT01512160|770879|P2|Overall Study|Lost to Follow-up|0
233452|NCT01512160|770880|P1|Overall Study|Lost to Follow-up|1
233453|NCT01512108|770972|P2|Overall Study|Unclassified|3
233454|NCT01512108|770973|P1|Overall Study|Unclassified|11
233455|NCT01512108|770972|P2|Overall Study|Withdrawal Criteria|0
233456|NCT01512108|770973|P1|Overall Study|Withdrawal Criteria|1
233457|NCT01512108|770972|P2|Overall Study|Protocol Violation|2
233458|NCT01512108|770973|P1|Overall Study|Protocol Violation|1
233459|NCT01512108|770972|P2|Overall Study|Adverse Event|4
233460|NCT01512108|770973|P1|Overall Study|Adverse Event|9
233461|NCT01511939|770988|P3|Overall Study|Withdrawal by Subject|0
233462|NCT01511939|770989|P2|Overall Study|Withdrawal by Subject|1
233463|NCT01511939|770990|P1|Overall Study|Withdrawal by Subject|2
233464|NCT01511536|771019|P3|Phase 2|Unspecified|9
233465|NCT01511536|771020|P2|Phase 2|Unspecified|0
233466|NCT01511536|771021|P1|Phase 2|Unspecified|0
233467|NCT01511536|771019|P3|Phase 1|Unspecified|0
233468|NCT01511536|771020|P2|Phase 1|Unspecified|1
233469|NCT01511536|771021|P1|Phase 1|Unspecified|0
233470|NCT01511445|771043|P2|Overall Study|Protocol Violation|0
233471|NCT01511445|771044|P1|Overall Study|Protocol Violation|1
233472|NCT01511445|771043|P2|Overall Study|Protocol Violation|3
233473|NCT01511445|771044|P1|Overall Study|Protocol Violation|1
233474|NCT01511445|771043|P2|Overall Study|Lost to Follow-up|1
233475|NCT01511445|771044|P1|Overall Study|Lost to Follow-up|3
233476|NCT01511107|771064|P2|Overall Study|Withdrawal by Subject|20
233477|NCT01511107|771065|P1|Overall Study|Withdrawal by Subject|9
233478|NCT01511107|771064|P2|Overall Study|Lost to Follow-up|19
233479|NCT01511107|771065|P1|Overall Study|Lost to Follow-up|10
233480|NCT01511107|771064|P2|Overall Study|Ineligible|2
233481|NCT01511107|771065|P1|Overall Study|Ineligible|3
233482|NCT01510912|771132|P1|Overall Study|Other, including joint replacement|5
233483|NCT01510912|771132|P1|Overall Study|Lost to Follow-up|26
233484|NCT01510912|771132|P1|Overall Study|Protocol Violation|27
233485|NCT01510912|771132|P1|Overall Study|Physician Decision|1
233486|NCT01510912|771132|P1|Overall Study|Withdrawal by Subject|49
233487|NCT01510912|771132|P1|Overall Study|Non-compliance with trial drug|23
233488|NCT01510912|771132|P1|Overall Study|Lack of Efficacy|12
233489|NCT01510912|771132|P1|Overall Study|Adverse Event|99
233490|NCT01510769|771148|P3|Overall Study|Death|0
233491|NCT01510769|771149|P2|Overall Study|Death|1
233492|NCT01510769|771150|P1|Overall Study|Death|1
233493|NCT01510769|771148|P3|Overall Study|Withdrawal by Subject|3
233494|NCT01510769|771149|P2|Overall Study|Withdrawal by Subject|4
233495|NCT01510769|771150|P1|Overall Study|Withdrawal by Subject|3
233496|NCT01510769|771148|P3|Overall Study|Lost to Follow-up|5
233497|NCT01510769|771149|P2|Overall Study|Lost to Follow-up|1
233498|NCT01510769|771150|P1|Overall Study|Lost to Follow-up|5
233499|NCT01510769|771148|P3|Overall Study|Protocol Violation|9
233500|NCT01510769|771149|P2|Overall Study|Protocol Violation|10
233501|NCT01510769|771150|P1|Overall Study|Protocol Violation|11
233502|NCT01510769|771148|P3|Overall Study|Gout Flare|1
233503|NCT01510769|771149|P2|Overall Study|Gout Flare|3
233504|NCT01510769|771150|P1|Overall Study|Gout Flare|0
233505|NCT01510769|771148|P3|Overall Study|Adverse Event|4
233506|NCT01510769|771149|P2|Overall Study|Adverse Event|6
233507|NCT01510769|771150|P1|Overall Study|Adverse Event|7
233508|NCT01510756|771167|P1|Overall Study|Physician Decision|1
233509|NCT01510756|771167|P1|Overall Study|Lack of Efficacy|2
233510|NCT01510756|771167|P1|Overall Study|Death|1
233511|NCT01510717|771175|P2|Overall Study|Withdrawal by Subject|2
233512|NCT01510717|771176|P1|Overall Study|Withdrawal by Subject|0
233513|NCT01510717|771175|P2|Overall Study|Lost to Follow-up|1
233514|NCT01510717|771176|P1|Overall Study|Lost to Follow-up|0
233515|NCT01510717|771175|P2|Overall Study|Death|0
233516|NCT01510717|771176|P1|Overall Study|Death|1
233517|NCT01510717|771175|P2|Overall Study|Adverse Event|2
233518|NCT01510717|771176|P1|Overall Study|Adverse Event|1
233519|NCT01510158|771296|P3|Overall Study|Death|0
233520|NCT01510158|771297|P2|Overall Study|Death|0
233521|NCT01510158|771298|P1|Overall Study|Death|1
233522|NCT01510158|771296|P3|Overall Study|Withdrawal by Subject|10
233523|NCT01510158|771297|P2|Overall Study|Withdrawal by Subject|13
233524|NCT01510158|771298|P1|Overall Study|Withdrawal by Subject|10
233525|NCT01510158|771296|P3|Overall Study|Lost to Follow-up|9
233526|NCT01510158|771297|P2|Overall Study|Lost to Follow-up|16
233527|NCT01510158|771298|P1|Overall Study|Lost to Follow-up|13
233528|NCT01510158|771296|P3|Overall Study|Sponsor terminated study.|2
233529|NCT01510158|771297|P2|Overall Study|Sponsor terminated study.|0
233530|NCT01510158|771298|P1|Overall Study|Sponsor terminated study.|2
233531|NCT01510158|771296|P3|Overall Study|Protocol Violation|24
233532|NCT01510158|771297|P2|Overall Study|Protocol Violation|16
233533|NCT01510158|771298|P1|Overall Study|Protocol Violation|17
233534|NCT01510158|771296|P3|Overall Study|Gout flare|0
233535|NCT01510158|771297|P2|Overall Study|Gout flare|0
233536|NCT01510158|771298|P1|Overall Study|Gout flare|1
233537|NCT01510158|771296|P3|Overall Study|Adverse Event|5
233538|NCT01510158|771297|P2|Overall Study|Adverse Event|8
233539|NCT01510158|771298|P1|Overall Study|Adverse Event|7
233540|NCT01510145|771312|P1|Overall Study|Relative reported subject withdrew|1
233541|NCT01510145|771312|P1|Overall Study|Withdrawal by Subject|6
233542|NCT01510145|771312|P1|Overall Study|Lost to Follow-up|5
233543|NCT01510145|771312|P1|Overall Study|Adverse Event|6
233544|NCT01509664|771346|P2|Overall Study|Lost to Follow-up|21
233545|NCT01509664|771347|P1|Overall Study|Lost to Follow-up|15
233546|NCT01509079|771422|P2|Overall Study|started an excluded medication|1
233547|NCT01509079|771423|P1|Overall Study|started an excluded medication|0
233548|NCT01509079|771422|P2|Overall Study|Lack of Efficacy|2
233549|NCT01509079|771423|P1|Overall Study|Lack of Efficacy|0
233550|NCT01509053|771439|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
233551|NCT01509053|771439|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
233552|NCT01509053|771439|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
233553|NCT01509053|771439|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
233554|NCT01509053|771439|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
233555|NCT01509053|771439|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
233556|NCT01508936|771501|P2|Overall Study|Data from 2 sites deemed invalid|11
233557|NCT01508936|771502|P1|Overall Study|Data from 2 sites deemed invalid|4
233558|NCT01508936|771501|P2|Overall Study|Not specified|5
233559|NCT01508936|771502|P1|Overall Study|Not specified|0
233560|NCT01508936|771501|P2|Overall Study|Lost to Follow-up|9
233561|NCT01508936|771502|P1|Overall Study|Lost to Follow-up|2
233562|NCT01508936|771501|P2|Overall Study|Protocol Violation|3
233563|NCT01508936|771502|P1|Overall Study|Protocol Violation|2
233564|NCT01508936|771501|P2|Overall Study|Withdrawal by Subject|18
233565|NCT01508936|771502|P1|Overall Study|Withdrawal by Subject|4
233566|NCT01508936|771501|P2|Overall Study|Lack of Efficacy|1
233567|NCT01508936|771502|P1|Overall Study|Lack of Efficacy|0
233568|NCT01508936|771501|P2|Overall Study|Adverse Event|32
233569|NCT01508936|771502|P1|Overall Study|Adverse Event|11
233570|NCT01508910|771541|P4|Treatment|Sponsor Decision|1
233571|NCT01508910|771542|P3|Treatment|Sponsor Decision|0
233572|NCT01508910|771543|P2|Treatment|Sponsor Decision|0
233573|NCT01508910|771544|P1|Treatment|Sponsor Decision|0
233574|NCT01508910|771541|P4|Treatment|Withdrawal by Subject|1
233575|NCT01508910|771542|P3|Treatment|Withdrawal by Subject|6
233576|NCT01508910|771543|P2|Treatment|Withdrawal by Subject|1
233577|NCT01508910|771544|P1|Treatment|Withdrawal by Subject|0
233578|NCT01508910|771541|P4|Treatment|Lost to Follow-up|1
233579|NCT01508910|771542|P3|Treatment|Lost to Follow-up|2
233580|NCT01508910|771543|P2|Treatment|Lost to Follow-up|0
233581|NCT01508910|771544|P1|Treatment|Lost to Follow-up|0
233582|NCT01508910|771541|P4|Treatment|Death|0
233583|NCT01508910|771542|P3|Treatment|Death|2
233584|NCT01508910|771543|P2|Treatment|Death|3
233585|NCT01508910|771544|P1|Treatment|Death|2
233586|NCT01508702|771577|P2|Overall Study|Withdrawal by Subject|7
233587|NCT01508702|771578|P1|Overall Study|Withdrawal by Subject|11
233588|NCT01508702|771577|P2|Overall Study|Lost to Follow-up|2
233589|NCT01508702|771578|P1|Overall Study|Lost to Follow-up|1
233590|NCT01508702|771577|P2|Overall Study|Protocol Violation|1
233591|NCT01508702|771578|P1|Overall Study|Protocol Violation|2
233592|NCT01508702|771577|P2|Overall Study|Gout flare|0
233593|NCT01508702|771578|P1|Overall Study|Gout flare|2
233594|NCT01508702|771577|P2|Overall Study|Adverse Event|3
233595|NCT01508702|771578|P1|Overall Study|Adverse Event|7
233596|NCT01508676|771586|P2|Phase II (2 Weeks)|Medication Exclusion|0
233597|NCT01508676|771587|P1|Phase II (2 Weeks)|Medication Exclusion|1
233598|NCT01508676|771586|P2|Phase II (2 Weeks)|Skin Sensitivity|1
233599|NCT01508676|771587|P1|Phase II (2 Weeks)|Skin Sensitivity|0
233600|NCT01508676|771586|P2|Phase I (2 Weeks)|Positive Drug Screen|2
233601|NCT01508676|771587|P1|Phase I (2 Weeks)|Positive Drug Screen|0
233602|NCT01508676|771586|P2|Phase I (2 Weeks)|Wrong Pain Type|0
233603|NCT01508676|771587|P1|Phase I (2 Weeks)|Wrong Pain Type|1
233604|NCT01508676|771586|P2|Phase I (2 Weeks)|Medication Exclusion|1
233605|NCT01508676|771587|P1|Phase I (2 Weeks)|Medication Exclusion|1
233606|NCT01508325|771608|P2|Overall Study|Unspecified|2
233607|NCT01508325|771609|P1|Overall Study|Unspecified|2
233608|NCT01508325|771608|P2|Overall Study|Lost to Follow-up|6
233609|NCT01508325|771609|P1|Overall Study|Lost to Follow-up|5
233610|NCT01508325|771608|P2|Overall Study|Adverse Event|0
233611|NCT01508325|771609|P1|Overall Study|Adverse Event|1
233612|NCT01508325|771608|P2|Overall Study|Physician Decision|1
233613|NCT01508325|771609|P1|Overall Study|Physician Decision|2
233614|NCT01508325|771608|P2|Overall Study|Protocol Violation|3
233615|NCT01508325|771609|P1|Overall Study|Protocol Violation|0
233616|NCT01508325|771608|P2|Overall Study|Withdrawal by Subject|9
233617|NCT01508325|771609|P1|Overall Study|Withdrawal by Subject|8
233618|NCT01508169|771639|P2|Overall Study|Lost to Follow-up|2
233619|NCT01508169|771640|P1|Overall Study|Lost to Follow-up|1
233620|NCT01508169|771639|P2|Overall Study|Withdrawal by Subject|0
233621|NCT01508169|771640|P1|Overall Study|Withdrawal by Subject|1
233622|NCT01508169|771639|P2|Overall Study|Adverse Event|0
233623|NCT01508169|771640|P1|Overall Study|Adverse Event|1
233624|NCT01508130|771654|P2|Overall Study|Administrative|3
233625|NCT01508130|771655|P1|Overall Study|Administrative|14
233626|NCT01508130|771654|P2|Overall Study|Insufficient therapeutic response|23
233627|NCT01508130|771655|P1|Overall Study|Insufficient therapeutic response|74
233628|NCT01508130|771654|P2|Overall Study|Subject’s substantial non-compliance|9
233629|NCT01508130|771655|P1|Overall Study|Subject’s substantial non-compliance|25
233630|NCT01508130|771654|P2|Overall Study|Withdrawal by Subject|3
233631|NCT01508130|771655|P1|Overall Study|Withdrawal by Subject|3
233632|NCT01508130|771654|P2|Overall Study|Lost to Follow-up|2
233633|NCT01508130|771655|P1|Overall Study|Lost to Follow-up|25
233634|NCT01508130|771654|P2|Overall Study|Protocol Violation|0
233635|NCT01508130|771655|P1|Overall Study|Protocol Violation|2
233636|NCT01508130|771654|P2|Overall Study|Death|1
233637|NCT01508130|771655|P1|Overall Study|Death|3
233638|NCT01508130|771654|P2|Overall Study|Adverse Event|28
233639|NCT01508130|771655|P1|Overall Study|Adverse Event|81
233640|NCT01507896|771719|P1|Overall Study|The surgery was denied by the sponsor.|1
233641|NCT01507896|771719|P1|Overall Study|Withdrawal by Subject|1
233642|NCT01507831|771762|P2|Overall Study|Unspecified|6
233643|NCT01507831|771763|P1|Overall Study|Unspecified|3
233644|NCT01507831|771762|P2|Overall Study|Potential lost to follow-up|0
233645|NCT01507831|771763|P1|Overall Study|Potential lost to follow-up|3
233646|NCT01507831|771762|P2|Overall Study|Site closure|3
233647|NCT01507831|771763|P1|Overall Study|Site closure|0
233648|NCT01507831|771762|P2|Overall Study|Selection criteria finally not met|1
233649|NCT01507831|771763|P1|Overall Study|Selection criteria finally not met|0
233650|NCT01507831|771762|P2|Overall Study|Last visit outside protocol visit window|143
233651|NCT01507831|771763|P1|Overall Study|Last visit outside protocol visit window|51
233652|NCT01507831|771762|P2|Overall Study|Related to study drug administration|14
233653|NCT01507831|771763|P1|Overall Study|Related to study drug administration|5
233654|NCT01507831|771762|P2|Overall Study|Consent withdrawn by participant|72
233655|NCT01507831|771763|P1|Overall Study|Consent withdrawn by participant|34
233656|NCT01507831|771762|P2|Overall Study|Participant moved|19
233657|NCT01507831|771763|P1|Overall Study|Participant moved|5
233658|NCT01507831|771762|P2|Overall Study|Physician Decision|4
233659|NCT01507831|771763|P1|Overall Study|Physician Decision|0
233660|NCT01507831|771762|P2|Overall Study|Poor compliance to protocol|60
233661|NCT01507831|771763|P1|Overall Study|Poor compliance to protocol|38
233662|NCT01507831|771762|P2|Overall Study|Death|2
233663|NCT01507831|771763|P1|Overall Study|Death|6
233664|NCT01507831|771762|P2|Overall Study|Adverse Event|113
233665|NCT01507831|771763|P1|Overall Study|Adverse Event|48
233666|NCT01507831|771762|P2|Overall Study|Randomized but not treated|3
233667|NCT01507831|771763|P1|Overall Study|Randomized but not treated|0
233668|NCT01507662|771833|P2|Overall Study|Proxy interview done|3
233669|NCT01507662|771834|P1|Overall Study|Proxy interview done|2
233670|NCT01507662|771833|P2|Overall Study|Lost to Follow-up|523
233671|NCT01507662|771834|P1|Overall Study|Lost to Follow-up|498
233672|NCT01507662|771833|P2|Overall Study|Withdrawal by Subject|287
233673|NCT01507662|771834|P1|Overall Study|Withdrawal by Subject|290
233674|NCT01507662|771833|P2|Overall Study|Death|18
233675|NCT01507662|771834|P1|Overall Study|Death|26
233676|NCT01507246|771859|P2|Overall Study|Required different surgical procedures|1
233677|NCT01507246|771860|P1|Overall Study|Required different surgical procedures|2
233678|NCT01507090|771958|P1|Overall Study|incomplete dataset|18
233679|NCT01507051|771997|P4|Overall Study|Adverse Event|0
233680|NCT01507051|771998|P3|Overall Study|Adverse Event|0
233681|NCT01507051|771999|P2|Overall Study|Adverse Event|0
233682|NCT01507051|772000|P1|Overall Study|Adverse Event|1
233683|NCT01507051|771997|P4|Overall Study|Physician Decision|1
233684|NCT01507051|771998|P3|Overall Study|Physician Decision|0
233685|NCT01507051|771999|P2|Overall Study|Physician Decision|0
233686|NCT01507051|772000|P1|Overall Study|Physician Decision|0
233687|NCT01507051|771997|P4|Overall Study|Withdrawal by Subject|6
233688|NCT01507051|771998|P3|Overall Study|Withdrawal by Subject|1
233689|NCT01507051|771999|P2|Overall Study|Withdrawal by Subject|3
233690|NCT01507051|772000|P1|Overall Study|Withdrawal by Subject|1
233691|NCT01506960|772118|P1|Overall Study|Did not meet angiographic criteria|47
233692|NCT01506947|772124|P1|Overall Study|Did Not Meet Eligibility Criteria|3
233693|NCT01506947|772124|P1|Overall Study|Death|1
233694|NCT01506947|772124|P1|Overall Study|Adverse Event|5
233695|NCT01506947|772124|P1|Overall Study|Lost to Follow-up|7
233696|NCT01506908|772142|P2|Overall Study|Adverse Event|0
233697|NCT01506908|772143|P1|Overall Study|Adverse Event|1
233698|NCT01506882|772161|P2|Overall Study|Other Reason|0
233699|NCT01506882|772162|P1|Overall Study|Other Reason|2
233700|NCT01506882|772161|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
233701|NCT01506882|772162|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
233702|NCT01506882|772161|P2|Overall Study|AE, non-serious non-fatal|1
233703|NCT01506882|772162|P1|Overall Study|AE, non-serious non-fatal|3
233704|NCT01506882|772161|P2|Overall Study|SAE, non-fatal|0
233705|NCT01506882|772162|P1|Overall Study|SAE, non-fatal|2
233706|NCT01506882|772161|P2|Overall Study|Withdrawal by Subject|3
233707|NCT01506882|772162|P1|Overall Study|Withdrawal by Subject|9
233708|NCT01506882|772161|P2|Overall Study|Lost to Follow-up|0
233709|NCT01506882|772162|P1|Overall Study|Lost to Follow-up|1
233710|NCT01506882|772161|P2|Overall Study|Lack of Efficacy|3
233711|NCT01506882|772162|P1|Overall Study|Lack of Efficacy|4
233712|NCT01506726|772176|P2|Overall Study|Adverse Event|2
233713|NCT01506726|772177|P1|Overall Study|Adverse Event|1
233714|NCT01506596|772217|P1|Overall Study|ineligible pathology|1
233715|NCT01506323|772231|P2|Overall Study|Started another treatment|0
233716|NCT01506323|772232|P1|Overall Study|Started another treatment|1
233717|NCT01506323|772231|P2|Overall Study|Schedule or Transportation conflict|0
233718|NCT01506323|772232|P1|Overall Study|Schedule or Transportation conflict|8
233719|NCT01506323|772231|P2|Overall Study|Moved out of area|2
233720|NCT01506323|772232|P1|Overall Study|Moved out of area|5
233721|NCT01506323|772231|P2|Overall Study|Lack of Efficacy|3
233722|NCT01506323|772232|P1|Overall Study|Lack of Efficacy|1
233723|NCT01506323|772231|P2|Overall Study|Withdrawal by Subject|4
233724|NCT01506323|772232|P1|Overall Study|Withdrawal by Subject|4
233725|NCT01506323|772231|P2|Overall Study|Lost to Follow-up|4
233726|NCT01506323|772232|P1|Overall Study|Lost to Follow-up|5
233727|NCT01506193|772261|P3|Overall Study|Lost to Follow-up|3
233728|NCT01506193|772262|P2|Overall Study|Lost to Follow-up|3
233729|NCT01506193|772263|P1|Overall Study|Lost to Follow-up|8
233730|NCT01506193|772261|P3|Overall Study|Withdrawal by Subject|8
233731|NCT01506193|772262|P2|Overall Study|Withdrawal by Subject|1
233732|NCT01506193|772263|P1|Overall Study|Withdrawal by Subject|5
233733|NCT01506193|772261|P3|Overall Study|Adverse event, non-fatal|1
233734|NCT01506193|772262|P2|Overall Study|Adverse event, non-fatal|0
233735|NCT01506193|772263|P1|Overall Study|Adverse event, non-fatal|0
233736|NCT01506193|772261|P3|Overall Study|Migrated/moved from study area|1
233737|NCT01506193|772262|P2|Overall Study|Migrated/moved from study area|0
233738|NCT01506193|772263|P1|Overall Study|Migrated/moved from study area|0
233739|NCT01506193|772261|P3|Overall Study|Protocol Violation|1
233740|NCT01506193|772262|P2|Overall Study|Protocol Violation|0
233741|NCT01506193|772263|P1|Overall Study|Protocol Violation|1
233742|NCT01505881|772296|P2|Overall Study|Withdrawal by Subject|0
233743|NCT01505881|772297|P1|Overall Study|Withdrawal by Subject|2
233744|NCT01505881|772296|P2|Overall Study|Lost to Follow-up|0
233745|NCT01505881|772297|P1|Overall Study|Lost to Follow-up|2
233746|NCT01505881|772296|P2|Overall Study|Adverse Event|1
233747|NCT01505881|772297|P1|Overall Study|Adverse Event|0
233748|NCT01505647|772320|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
233749|NCT01505647|772321|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
233750|NCT01505647|772320|P2|Day 43 Through Day 182 Follow-up|Death|1
233751|NCT01505647|772321|P1|Day 43 Through Day 182 Follow-up|Death|0
233752|NCT01505647|772320|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
233753|NCT01505647|772321|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
233754|NCT01505647|772320|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
233755|NCT01505647|772321|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
233838|NCT01502371|772588|P5|Overall Study|Protocol Violation|10
233756|NCT01505647|772320|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
233757|NCT01505647|772321|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
233758|NCT01505608|772337|P2|Phase II|Protocol Violation|1
233759|NCT01505608|772338|P1|Phase II|Protocol Violation|0
233760|NCT01505608|772337|P2|Phase II|Lack of Efficacy|1
233761|NCT01505608|772338|P1|Phase II|Lack of Efficacy|2
233762|NCT01505608|772337|P2|Phase I|Withdrawal by Subject|1
233763|NCT01505608|772338|P1|Phase I|Withdrawal by Subject|0
233764|NCT01505608|772337|P2|Phase I|Adverse Event|1
233765|NCT01505608|772338|P1|Phase I|Adverse Event|0
233766|NCT01505608|772337|P2|Phase I|Lack of Efficacy|4
233767|NCT01505608|772338|P1|Phase I|Lack of Efficacy|0
233768|NCT01505387|772356|P2|Overall Study|Withdrawal by Subject|1
233769|NCT01505387|772357|P1|Overall Study|Withdrawal by Subject|1
233770|NCT01505387|772356|P2|Overall Study|Protocol Violation|0
233771|NCT01505387|772357|P1|Overall Study|Protocol Violation|1
233772|NCT01505374|772363|P2|Overall Study|Lost to Follow-up|0
233773|NCT01505374|772364|P1|Overall Study|Lost to Follow-up|1
233774|NCT01504971|772382|P1|Overall Study|Physician Decision|13
233775|NCT01504867|772411|P2|Overall Study|Consent revoked|1
233776|NCT01504867|772412|P1|Overall Study|Consent revoked|5
233777|NCT01504867|772411|P2|Overall Study|Inclusion criteria not met|2
233778|NCT01504867|772412|P1|Overall Study|Inclusion criteria not met|2
233779|NCT01503021|772465|P2|Overall Study|Moved, received transplant, etc.|7
233780|NCT01503021|772466|P1|Overall Study|Moved, received transplant, etc.|5
233781|NCT01503021|772465|P2|Overall Study|Withdrawal by Subject|8
233782|NCT01503021|772466|P1|Overall Study|Withdrawal by Subject|9
233783|NCT01503021|772465|P2|Overall Study|Protocol Violation|3
233784|NCT01503021|772466|P1|Overall Study|Protocol Violation|1
233785|NCT01503021|772465|P2|Overall Study|Physician Decision|0
233786|NCT01503021|772466|P1|Overall Study|Physician Decision|3
233787|NCT01503021|772465|P2|Overall Study|Lost to Follow-up|0
233788|NCT01503021|772466|P1|Overall Study|Lost to Follow-up|2
233789|NCT01503021|772465|P2|Overall Study|Death|2
233790|NCT01503021|772466|P1|Overall Study|Death|0
233791|NCT01503021|772465|P2|Overall Study|Adverse Event|6
233792|NCT01503021|772466|P1|Overall Study|Adverse Event|7
233793|NCT01502709|772522|P2|Overall Study|Lost to Follow-up|0
233794|NCT01502709|772523|P1|Overall Study|Lost to Follow-up|4
233795|NCT01502644|772536|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
233796|NCT01502644|772537|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
233797|NCT01502644|772538|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
233798|NCT01502644|772539|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
233799|NCT01502644|772536|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
233800|NCT01502644|772537|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
233801|NCT01502644|772538|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
233802|NCT01502644|772539|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
233803|NCT01502644|772536|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
233804|NCT01502644|772537|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
233805|NCT01502644|772538|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
233806|NCT01502644|772539|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
233807|NCT01502644|772536|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
233808|NCT01502644|772537|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
233809|NCT01502644|772538|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
233810|NCT01502644|772539|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
233811|NCT01502644|772536|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
233812|NCT01502644|772537|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
233813|NCT01502644|772538|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
233814|NCT01502644|772539|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
233815|NCT01502423|772549|P2|Overall Study|Withdrawal by Subject|1
233816|NCT01502423|772550|P1|Overall Study|Withdrawal by Subject|0
233817|NCT01502410|772572|P4|Overall Study|Withdrawal by Subject|0
233818|NCT01502410|772573|P3|Overall Study|Withdrawal by Subject|0
233819|NCT01502410|772574|P2|Overall Study|Withdrawal by Subject|0
233820|NCT01502410|772575|P1|Overall Study|Withdrawal by Subject|2
233821|NCT01502410|772572|P4|Overall Study|Physician Decision|0
233822|NCT01502410|772573|P3|Overall Study|Physician Decision|0
233823|NCT01502410|772574|P2|Overall Study|Physician Decision|1
233824|NCT01502410|772575|P1|Overall Study|Physician Decision|0
233825|NCT01502410|772572|P4|Overall Study|Lack of Efficacy|0
233826|NCT01502410|772573|P3|Overall Study|Lack of Efficacy|0
233827|NCT01502410|772574|P2|Overall Study|Lack of Efficacy|7
233828|NCT01502410|772575|P1|Overall Study|Lack of Efficacy|7
233829|NCT01502410|772572|P4|Overall Study|Adverse Event|0
233830|NCT01502410|772573|P3|Overall Study|Adverse Event|0
233831|NCT01502410|772574|P2|Overall Study|Adverse Event|2
233832|NCT01502410|772575|P1|Overall Study|Adverse Event|1
233833|NCT01502371|772588|P5|Overall Study|Excluded Medication|1
233834|NCT01502371|772589|P4|Overall Study|Excluded Medication|0
233835|NCT01502371|772590|P3|Overall Study|Excluded Medication|1
233836|NCT01502371|772591|P2|Overall Study|Excluded Medication|1
233837|NCT01502371|772592|P1|Overall Study|Excluded Medication|0
233839|NCT01502371|772589|P4|Overall Study|Protocol Violation|5
233840|NCT01502371|772590|P3|Overall Study|Protocol Violation|6
233841|NCT01502371|772591|P2|Overall Study|Protocol Violation|5
233842|NCT01502371|772592|P1|Overall Study|Protocol Violation|9
233843|NCT01502371|772588|P5|Overall Study|Technical Problems|1
233844|NCT01502371|772589|P4|Overall Study|Technical Problems|4
233845|NCT01502371|772590|P3|Overall Study|Technical Problems|2
233846|NCT01502371|772591|P2|Overall Study|Technical Problems|0
233847|NCT01502371|772592|P1|Overall Study|Technical Problems|1
233848|NCT01502371|772588|P5|Overall Study|Noncompliance with Study Drug|1
233849|NCT01502371|772589|P4|Overall Study|Noncompliance with Study Drug|2
233850|NCT01502371|772590|P3|Overall Study|Noncompliance with Study Drug|1
233851|NCT01502371|772591|P2|Overall Study|Noncompliance with Study Drug|0
233852|NCT01502371|772592|P1|Overall Study|Noncompliance with Study Drug|0
233853|NCT01502371|772588|P5|Overall Study|Physician Decision|1
233854|NCT01502371|772589|P4|Overall Study|Physician Decision|0
233855|NCT01502371|772590|P3|Overall Study|Physician Decision|0
233856|NCT01502371|772591|P2|Overall Study|Physician Decision|0
233857|NCT01502371|772592|P1|Overall Study|Physician Decision|3
233858|NCT01502371|772588|P5|Overall Study|Lack of Efficacy|4
233859|NCT01502371|772589|P4|Overall Study|Lack of Efficacy|2
233860|NCT01502371|772590|P3|Overall Study|Lack of Efficacy|2
233861|NCT01502371|772591|P2|Overall Study|Lack of Efficacy|3
233862|NCT01502371|772592|P1|Overall Study|Lack of Efficacy|3
233863|NCT01502371|772588|P5|Overall Study|Treatment Failure|30
233864|NCT01502371|772589|P4|Overall Study|Treatment Failure|19
233865|NCT01502371|772590|P3|Overall Study|Treatment Failure|12
233866|NCT01502371|772591|P2|Overall Study|Treatment Failure|20
233867|NCT01502371|772592|P1|Overall Study|Treatment Failure|22
233868|NCT01502371|772588|P5|Overall Study|Adverse Event|3
233869|NCT01502371|772589|P4|Overall Study|Adverse Event|4
233870|NCT01502371|772590|P3|Overall Study|Adverse Event|0
233871|NCT01502371|772591|P2|Overall Study|Adverse Event|1
233872|NCT01502371|772592|P1|Overall Study|Adverse Event|2
233873|NCT01502371|772588|P5|Overall Study|Withdrawal by Subject|1
233874|NCT01502371|772589|P4|Overall Study|Withdrawal by Subject|1
233875|NCT01502371|772590|P3|Overall Study|Withdrawal by Subject|1
233876|NCT01502371|772591|P2|Overall Study|Withdrawal by Subject|2
233877|NCT01502371|772592|P1|Overall Study|Withdrawal by Subject|1
233878|NCT01502228|772632|P1|Overall Study|Death|1
233879|NCT01502033|772637|P1|Overall Study|1 participant went back to school|1
233880|NCT01502033|772637|P1|Overall Study|1 participant had worsening depression|1
233881|NCT01502033|772637|P1|Overall Study|1 participant had scalp discomfort|1
233882|NCT01501110|772656|P2|Overall Study|Death|1
233883|NCT01501110|772657|P1|Overall Study|Death|0
233884|NCT01500720|772681|P2|Overall Study|Unspecified|8
233885|NCT01500720|772682|P1|Overall Study|Unspecified|4
233886|NCT01500720|772681|P2|Overall Study|Randomized But Not Treated|1
233887|NCT01500720|772682|P1|Overall Study|Randomized But Not Treated|1
233888|NCT01500694|772696|P2|Overall Study|Unspecified|3
233889|NCT01500694|772697|P1|Overall Study|Unspecified|9
233890|NCT01500694|772696|P2|Overall Study|Lack of Efficacy|5
233891|NCT01500694|772697|P1|Overall Study|Lack of Efficacy|14
233892|NCT01500694|772696|P2|Overall Study|Lost to Follow-up|3
233893|NCT01500694|772697|P1|Overall Study|Lost to Follow-up|2
233894|NCT01500694|772696|P2|Overall Study|Withdrawal by Subject|14
233895|NCT01500694|772697|P1|Overall Study|Withdrawal by Subject|23
233896|NCT01500694|772696|P2|Overall Study|Protocol Violation|1
233897|NCT01500694|772697|P1|Overall Study|Protocol Violation|0
233898|NCT01500694|772696|P2|Overall Study|Adverse Event|3
233899|NCT01500694|772697|P1|Overall Study|Adverse Event|4
233900|NCT01500629|772723|P2|Washout Period of 14 to 30 Days|Pregnancy|0
233901|NCT01500629|772724|P1|Washout Period of 14 to 30 Days|Pregnancy|1
233902|NCT01500434|772808|P1|Overall Study|Missed 12-month follow-up|5
233903|NCT01500434|772808|P1|Overall Study|Withdrawal by Subject|1
233904|NCT01500434|772808|P1|Overall Study|Death|1
233905|NCT01500382|772841|P4|Washout Period|Study site went out of business|0
233906|NCT01500382|772842|P3|Washout Period|Study site went out of business|1
233907|NCT01500382|772843|P2|Washout Period|Study site went out of business|0
233908|NCT01500382|772844|P1|Washout Period|Study site went out of business|0
233909|NCT01500317|772869|P3|Overall Study|Withdrawal by Subject|0
233910|NCT01500317|772870|P2|Overall Study|Withdrawal by Subject|2
233911|NCT01500317|772871|P1|Overall Study|Withdrawal by Subject|3
233912|NCT01500278|772893|P2|Week 13 - Week 104|Adverse Event|54
233913|NCT01500278|772894|P1|Week 13 - Week 104|Adverse Event|54
233914|NCT01500278|772893|P2|Week 13 - Week 104|Death|4
233915|NCT01500278|772894|P1|Week 13 - Week 104|Death|2
233916|NCT01500278|772893|P2|Week 13 - Week 104|Not completed|1
233917|NCT01500278|772894|P1|Week 13 - Week 104|Not completed|0
233918|NCT01500278|772893|P2|Week 13 - Week 104|Personal reason|1
233919|NCT01500278|772894|P1|Week 13 - Week 104|Personal reason|0
233920|NCT01500278|772893|P2|Week 13 - Week 104|Medical monitor decision|2
233921|NCT01500278|772894|P1|Week 13 - Week 104|Medical monitor decision|0
233922|NCT01500278|772893|P2|Week 13 - Week 104|Sponsor decision|2
233923|NCT01500278|772894|P1|Week 13 - Week 104|Sponsor decision|0
233924|NCT01500278|772893|P2|Week 13 - Week 104|Relocation|1
233925|NCT01500278|772894|P1|Week 13 - Week 104|Relocation|0
233926|NCT01500278|772893|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
233927|NCT01500278|772894|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
233928|NCT01500278|772893|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
233929|NCT01500278|772894|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
233930|NCT01500278|772893|P2|Week 13 - Week 104|Principal investigator retiring|0
233931|NCT01500278|772894|P1|Week 13 - Week 104|Principal investigator retiring|1
233932|NCT01500278|772893|P2|Week 13 - Week 104|Protocol deviation|0
233933|NCT01500278|772894|P1|Week 13 - Week 104|Protocol deviation|1
233934|NCT01500278|772893|P2|Week 13 - Week 104|Exclusion criteria not met|0
233935|NCT01500278|772894|P1|Week 13 - Week 104|Exclusion criteria not met|1
233936|NCT01500278|772893|P2|Week 13 - Week 104|Withdrawn in error|0
233937|NCT01500278|772894|P1|Week 13 - Week 104|Withdrawn in error|1
233938|NCT01500278|772893|P2|Week 13 - Week 104|Sponsor request|0
233939|NCT01500278|772894|P1|Week 13 - Week 104|Sponsor request|4
233940|NCT01500278|772893|P2|Week 13 - Week 104|False positive test|2
233941|NCT01500278|772894|P1|Week 13 - Week 104|False positive test|1
233942|NCT01500278|772893|P2|Week 13 - Week 104|Recurrent infections|0
233943|NCT01500278|772894|P1|Week 13 - Week 104|Recurrent infections|1
233944|NCT01500278|772893|P2|Week 13 - Week 104|Non/bad compliance|5
233945|NCT01500278|772894|P1|Week 13 - Week 104|Non/bad compliance|7
233946|NCT01500278|772893|P2|Week 13 - Week 104|Week 24 Non-Responder|16
233947|NCT01500278|772894|P1|Week 13 - Week 104|Week 24 Non-Responder|20
233948|NCT01500278|772893|P2|Week 13 - Week 104|Withdrawal by Subject|13
233949|NCT01500278|772894|P1|Week 13 - Week 104|Withdrawal by Subject|22
233950|NCT01500278|772893|P2|Week 13 - Week 104|Lost to Follow-up|5
233951|NCT01500278|772894|P1|Week 13 - Week 104|Lost to Follow-up|6
233952|NCT01500278|772893|P2|Week 13 - Week 104|Protocol Violation|6
233953|NCT01500278|772894|P1|Week 13 - Week 104|Protocol Violation|6
233954|NCT01500278|772893|P2|Week 13 - Week 104|Lack of Efficacy|12
233955|NCT01500278|772894|P1|Week 13 - Week 104|Lack of Efficacy|11
233956|NCT01500278|772893|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
233957|NCT01500278|772894|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
233958|NCT01500278|772893|P2|Week 0 - Week 12|Other serious disease|1
233959|NCT01500278|772894|P1|Week 0 - Week 12|Other serious disease|0
233960|NCT01500278|772893|P2|Week 0 - Week 12|Personal reason|1
233961|NCT01500278|772894|P1|Week 0 - Week 12|Personal reason|0
233962|NCT01500278|772893|P2|Week 0 - Week 12|Sponsor decision|0
233963|NCT01500278|772894|P1|Week 0 - Week 12|Sponsor decision|1
233964|NCT01500278|772893|P2|Week 0 - Week 12|Prior history of serious disease|0
233965|NCT01500278|772894|P1|Week 0 - Week 12|Prior history of serious disease|1
233966|NCT01500278|772893|P2|Week 0 - Week 12|Investigator decision|0
233967|NCT01500278|772894|P1|Week 0 - Week 12|Investigator decision|1
233968|NCT01500278|772893|P2|Week 0 - Week 12|Exclusion criteria not met|0
233969|NCT01500278|772894|P1|Week 0 - Week 12|Exclusion criteria not met|1
233970|NCT01500278|772893|P2|Week 0 - Week 12|Patient decision|0
233971|NCT01500278|772894|P1|Week 0 - Week 12|Patient decision|1
233972|NCT01500278|772893|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
233973|NCT01500278|772894|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
233974|NCT01500278|772893|P2|Week 0 - Week 12|Withdrawal by Subject|2
233975|NCT01500278|772894|P1|Week 0 - Week 12|Withdrawal by Subject|7
233976|NCT01500278|772893|P2|Week 0 - Week 12|Lost to Follow-up|1
233977|NCT01500278|772894|P1|Week 0 - Week 12|Lost to Follow-up|1
233978|NCT01500278|772893|P2|Week 0 - Week 12|Protocol Violation|16
233979|NCT01500278|772894|P1|Week 0 - Week 12|Protocol Violation|10
233980|NCT01500278|772893|P2|Week 0 - Week 12|Lack of Efficacy|1
233981|NCT01500278|772894|P1|Week 0 - Week 12|Lack of Efficacy|0
233982|NCT01500252|772918|P2|Overall Study|Lost to Follow-up|4
233983|NCT01500252|772919|P1|Overall Study|Lost to Follow-up|5
233984|NCT01500252|772918|P2|Overall Study|Death|2
233985|NCT01500252|772919|P1|Overall Study|Death|4
233986|NCT01500226|772945|P2|Overall Study|Other Reasons|16
233987|NCT01500226|772946|P1|Overall Study|Other Reasons|19
233988|NCT01500226|772945|P2|Overall Study|Lost to Follow-up|5
233989|NCT01500226|772946|P1|Overall Study|Lost to Follow-up|9
233990|NCT01500226|772945|P2|Overall Study|Lack of Efficacy|30
233991|NCT01500226|772946|P1|Overall Study|Lack of Efficacy|14
233992|NCT01500226|772945|P2|Overall Study|Physician Decision|15
233993|NCT01500226|772946|P1|Overall Study|Physician Decision|17
233994|NCT01500226|772945|P2|Overall Study|Protocol Violation|39
233995|NCT01500226|772946|P1|Overall Study|Protocol Violation|53
233996|NCT01500226|772945|P2|Overall Study|Disease Progression|14
233997|NCT01500226|772946|P1|Overall Study|Disease Progression|16
233998|NCT01500226|772945|P2|Overall Study|Death|4
233999|NCT01500226|772946|P1|Overall Study|Death|12
234000|NCT01500226|772945|P2|Overall Study|Withdrawal by Subject|96
234001|NCT01500226|772946|P1|Overall Study|Withdrawal by Subject|93
234002|NCT01500226|772945|P2|Overall Study|Chemo Completed or Change in Therapy|237
234003|NCT01500226|772946|P1|Overall Study|Chemo Completed or Change in Therapy|235
234004|NCT01500226|772945|P2|Overall Study|Adverse Event|38
234005|NCT01500226|772946|P1|Overall Study|Adverse Event|31
234006|NCT01500213|772958|P2|Overall Study|Other Reasons|5
234007|NCT01500213|772959|P1|Overall Study|Other Reasons|7
234008|NCT01500213|772958|P2|Overall Study|Lost to Follow-up|6
234009|NCT01500213|772959|P1|Overall Study|Lost to Follow-up|3
234010|NCT01500213|772958|P2|Overall Study|Lack of Efficacy|7
234011|NCT01500213|772959|P1|Overall Study|Lack of Efficacy|9
234012|NCT01500213|772958|P2|Overall Study|Physician Decision|10
234013|NCT01500213|772959|P1|Overall Study|Physician Decision|12
234014|NCT01500213|772958|P2|Overall Study|Protocol Violation|19
234015|NCT01500213|772959|P1|Overall Study|Protocol Violation|19
234016|NCT01500213|772958|P2|Overall Study|Disease Progression|21
234017|NCT01500213|772959|P1|Overall Study|Disease Progression|13
234018|NCT01500213|772958|P2|Overall Study|Death|3
234019|NCT01500213|772959|P1|Overall Study|Death|7
234020|NCT01500213|772958|P2|Overall Study|Withdrawal by Subject|37
234021|NCT01500213|772959|P1|Overall Study|Withdrawal by Subject|28
234022|NCT01500213|772958|P2|Overall Study|Chemo Completed or Change in Therapy|81
234023|NCT01500213|772959|P1|Overall Study|Chemo Completed or Change in Therapy|84
234024|NCT01500213|772958|P2|Overall Study|Adverse Event|35
234025|NCT01500213|772959|P1|Overall Study|Adverse Event|35
234026|NCT01500135|772971|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
234027|NCT01500135|772972|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
234028|NCT01500135|772971|P2|Overall Study|Participant was a Safety Concern|0
234029|NCT01500135|772972|P1|Overall Study|Participant was a Safety Concern|1
234030|NCT01500135|772971|P2|Overall Study|Patient Missed Scheduled Appointments|1
234031|NCT01500135|772972|P1|Overall Study|Patient Missed Scheduled Appointments|0
234032|NCT01500135|772971|P2|Overall Study|Principal Investigator (PI) Discretion|0
234033|NCT01500135|772972|P1|Overall Study|Principal Investigator (PI) Discretion|1
234034|NCT01500135|772971|P2|Overall Study|Fatal Adverse Event (AE)|5
234035|NCT01500135|772972|P1|Overall Study|Fatal Adverse Event (AE)|5
234036|NCT01500135|772971|P2|Overall Study|Lost to Follow-up|4
234037|NCT01500135|772972|P1|Overall Study|Lost to Follow-up|6
234038|NCT01500135|772971|P2|Overall Study|Withdrawal of Consent|0
234039|NCT01500135|772972|P1|Overall Study|Withdrawal of Consent|4
234040|NCT01500083|772997|P2|Overall Study|Other Reasons|5
234041|NCT01500083|772998|P1|Overall Study|Other Reasons|2
234042|NCT01500083|772997|P2|Overall Study|Investigator Discretion|8
234043|NCT01500083|772998|P1|Overall Study|Investigator Discretion|3
234044|NCT01500083|772997|P2|Overall Study|Disease Progression|10
234045|NCT01500083|772998|P1|Overall Study|Disease Progression|2
234046|NCT01500083|772997|P2|Overall Study|Withdrawal of Consent|1
234047|NCT01500083|772998|P1|Overall Study|Withdrawal of Consent|0
234048|NCT01500083|772997|P2|Overall Study|Lost to Follow-up|0
234049|NCT01500083|772998|P1|Overall Study|Lost to Follow-up|1
234050|NCT01500083|772997|P2|Overall Study|Death|2
234051|NCT01500083|772998|P1|Overall Study|Death|0
234052|NCT01500083|772997|P2|Overall Study|Adverse Event|17
234053|NCT01500083|772998|P1|Overall Study|Adverse Event|4
234054|NCT01500031|773004|P1|Overall Study|Withdrawal by Subject|4
234055|NCT01500031|773004|P1|Overall Study|Death|1
234056|NCT01499849|773039|P2|Overall Study|Other Reasons|30
234057|NCT01499849|773040|P1|Overall Study|Other Reasons|27
234058|NCT01499849|773039|P2|Overall Study|Lost to Follow-up|3
234059|NCT01499849|773040|P1|Overall Study|Lost to Follow-up|6
234060|NCT01499849|773039|P2|Overall Study|Lack of Efficacy|4
234061|NCT01499849|773040|P1|Overall Study|Lack of Efficacy|3
234062|NCT01499849|773039|P2|Overall Study|Physician Decision|19
234063|NCT01499849|773040|P1|Overall Study|Physician Decision|20
234064|NCT01499849|773039|P2|Overall Study|Protocol Violation|11
234065|NCT01499849|773040|P1|Overall Study|Protocol Violation|11
234066|NCT01499849|773039|P2|Overall Study|Disease Progression|10
234067|NCT01499849|773040|P1|Overall Study|Disease Progression|11
234068|NCT01499849|773039|P2|Overall Study|Death|7
234069|NCT01499849|773040|P1|Overall Study|Death|5
234070|NCT01499849|773039|P2|Overall Study|Withdrawal by Subject|43
234071|NCT01499849|773040|P1|Overall Study|Withdrawal by Subject|43
234072|NCT01499849|773039|P2|Overall Study|Chemo completed or Change in Therapy|67
234073|NCT01499849|773040|P1|Overall Study|Chemo completed or Change in Therapy|70
234074|NCT01499849|773039|P2|Overall Study|Adverse Event|32
234075|NCT01499849|773040|P1|Overall Study|Adverse Event|28
234076|NCT01499810|773050|P1|Overall Study|Withdrawal by Subject|1
234077|NCT01499810|773050|P1|Overall Study|Protocol Violation|1
234078|NCT01499810|773050|P1|Overall Study|Lost to Follow-up|10
234079|NCT01499667|773100|P3|Overall Study|Lack of Efficacy|0
234080|NCT01499667|773101|P2|Overall Study|Lack of Efficacy|0
234081|NCT01499667|773102|P1|Overall Study|Lack of Efficacy|2
234082|NCT01499667|773100|P3|Overall Study|Withdrawal by Subject|1
234083|NCT01499667|773101|P2|Overall Study|Withdrawal by Subject|1
234084|NCT01499667|773102|P1|Overall Study|Withdrawal by Subject|2
234085|NCT01499667|773100|P3|Overall Study|Adverse Event|2
234086|NCT01499667|773101|P2|Overall Study|Adverse Event|2
234087|NCT01499667|773102|P1|Overall Study|Adverse Event|0
234088|NCT01499667|773100|P3|Overall Study|Protocol Violation|2
234089|NCT01499667|773101|P2|Overall Study|Protocol Violation|3
234090|NCT01499667|773102|P1|Overall Study|Protocol Violation|1
234091|NCT01499667|773100|P3|Overall Study|administrative problems|5
234092|NCT01499667|773101|P2|Overall Study|administrative problems|5
234093|NCT01499667|773102|P1|Overall Study|administrative problems|4
234094|NCT01499576|773150|P1|Overall Study|Withdrawal by Subject|9
234095|NCT01499576|773150|P1|Overall Study|Physician Decision|12
234096|NCT01499355|773164|P4|Double-Blind Period|Lost to Follow-up|0
234097|NCT01499355|773165|P3|Double-Blind Period|Lost to Follow-up|0
234098|NCT01499355|773166|P2|Double-Blind Period|Lost to Follow-up|1
234099|NCT01499355|773167|P1|Double-Blind Period|Lost to Follow-up|0
234100|NCT01499355|773164|P4|Double-Blind Period|Consent Withdrawn|2
234101|NCT01499355|773165|P3|Double-Blind Period|Consent Withdrawn|1
234102|NCT01499355|773166|P2|Double-Blind Period|Consent Withdrawn|0
234103|NCT01499355|773167|P1|Double-Blind Period|Consent Withdrawn|0
234104|NCT01499355|773164|P4|Double-Blind Period|Investigator Decision|3
234105|NCT01499355|773165|P3|Double-Blind Period|Investigator Decision|3
234106|NCT01499355|773166|P2|Double-Blind Period|Investigator Decision|0
234107|NCT01499355|773167|P1|Double-Blind Period|Investigator Decision|0
234108|NCT01499355|773164|P4|Double-Blind Period|Death|0
234109|NCT01499355|773165|P3|Double-Blind Period|Death|0
234110|NCT01499355|773166|P2|Double-Blind Period|Death|1
234111|NCT01499355|773167|P1|Double-Blind Period|Death|0
234112|NCT01499355|773164|P4|Double-Blind Period|Not Specified|2
234113|NCT01499355|773165|P3|Double-Blind Period|Not Specified|2
234114|NCT01499355|773166|P2|Double-Blind Period|Not Specified|1
234115|NCT01499355|773167|P1|Double-Blind Period|Not Specified|0
234116|NCT01499355|773164|P4|Double-Blind Period|Study Termination|14
234117|NCT01499355|773165|P3|Double-Blind Period|Study Termination|16
234118|NCT01499355|773166|P2|Double-Blind Period|Study Termination|18
234119|NCT01499355|773167|P1|Double-Blind Period|Study Termination|0
234120|NCT01499355|773164|P4|Double-Blind Period|Adverse Event|2
234121|NCT01499355|773165|P3|Double-Blind Period|Adverse Event|3
234122|NCT01499355|773166|P2|Double-Blind Period|Adverse Event|2
234123|NCT01499355|773167|P1|Double-Blind Period|Adverse Event|0
234124|NCT01499355|773164|P4|Run-In Period|Adverse Event|0
234125|NCT01499355|773165|P3|Run-In Period|Adverse Event|0
234126|NCT01499355|773166|P2|Run-In Period|Adverse Event|0
234127|NCT01499355|773167|P1|Run-In Period|Adverse Event|8
234128|NCT01499355|773164|P4|Run-In Period|Consent Withdrawn|0
234129|NCT01499355|773165|P3|Run-In Period|Consent Withdrawn|0
234130|NCT01499355|773166|P2|Run-In Period|Consent Withdrawn|0
234131|NCT01499355|773167|P1|Run-In Period|Consent Withdrawn|1
234132|NCT01499355|773164|P4|Run-In Period|Investigator Decision|0
234133|NCT01499355|773165|P3|Run-In Period|Investigator Decision|0
234134|NCT01499355|773166|P2|Run-In Period|Investigator Decision|0
234135|NCT01499355|773167|P1|Run-In Period|Investigator Decision|2
234136|NCT01499355|773164|P4|Run-In Period|Death|0
234137|NCT01499355|773165|P3|Run-In Period|Death|0
234138|NCT01499355|773166|P2|Run-In Period|Death|0
234139|NCT01499355|773167|P1|Run-In Period|Death|2
234140|NCT01499355|773164|P4|Run-In Period|Not Specified|0
234141|NCT01499355|773165|P3|Run-In Period|Not Specified|0
234142|NCT01499355|773166|P2|Run-In Period|Not Specified|0
234143|NCT01499355|773167|P1|Run-In Period|Not Specified|3
234144|NCT01499355|773164|P4|Run-In Period|Study Termination|0
234145|NCT01499355|773165|P3|Run-In Period|Study Termination|0
234146|NCT01499355|773166|P2|Run-In Period|Study Termination|0
234147|NCT01499355|773167|P1|Run-In Period|Study Termination|15
234148|NCT01499303|773200|P2|Overall Study|Other|1
234149|NCT01499303|773201|P1|Overall Study|Other|0
234150|NCT01499303|773200|P2|Overall Study|Adverse Event|4
234151|NCT01499303|773201|P1|Overall Study|Adverse Event|1
234152|NCT01499303|773200|P2|Overall Study|Withdrawal by Subject|1
234153|NCT01499303|773201|P1|Overall Study|Withdrawal by Subject|0
234154|NCT01499303|773200|P2|Overall Study|Ongoing|1
234155|NCT01499303|773201|P1|Overall Study|Ongoing|2
234156|NCT01499290|773209|P2|Overall Study|Adverse Event|7
234157|NCT01499290|773210|P1|Overall Study|Adverse Event|14
234158|NCT01499290|773209|P2|Overall Study|Lack of Efficacy|8
234159|NCT01499290|773210|P1|Overall Study|Lack of Efficacy|7
234160|NCT01499290|773209|P2|Overall Study|Condition improved/subject recovered|0
234161|NCT01499290|773210|P1|Overall Study|Condition improved/subject recovered|1
234162|NCT01499290|773209|P2|Overall Study|Not specified in study report|5
234163|NCT01499290|773210|P1|Overall Study|Not specified in study report|11
234164|NCT01499290|773209|P2|Overall Study|Withdrawal by Subject|15
234165|NCT01499290|773210|P1|Overall Study|Withdrawal by Subject|22
234166|NCT01499277|773260|P2|Overall Study|Lack of therapeutic response and other|7
234167|NCT01499277|773261|P1|Overall Study|Lack of therapeutic response and other|8
234168|NCT01499277|773260|P2|Overall Study|Withdrawal by Subject|6
234169|NCT01499277|773261|P1|Overall Study|Withdrawal by Subject|16
234170|NCT01499277|773260|P2|Overall Study|Protocol Violation|3
234171|NCT01499277|773261|P1|Overall Study|Protocol Violation|2
234172|NCT01499277|773260|P2|Overall Study|Lost to Follow-up|8
234173|NCT01499277|773261|P1|Overall Study|Lost to Follow-up|15
234174|NCT01499277|773260|P2|Overall Study|Death|2
234175|NCT01499277|773261|P1|Overall Study|Death|3
234176|NCT01499277|773260|P2|Overall Study|Adverse Event|6
234177|NCT01499277|773261|P1|Overall Study|Adverse Event|3
234178|NCT01499199|773283|P1|Overall Study|Lack of Efficacy|1
234179|NCT01499199|773283|P1|Overall Study|Adverse Event|1
234180|NCT01499134|773320|P2|Overall Study|Withdrawal by Subject|1
234181|NCT01499134|773321|P1|Overall Study|Withdrawal by Subject|0
234182|NCT01499095|773343|P2|Overall Study|Perceived Lack of Efficacy|1
234183|NCT01499095|773344|P1|Overall Study|Perceived Lack of Efficacy|1
234184|NCT01499095|773343|P2|Overall Study|Change in Injection Schedule|0
234185|NCT01499095|773344|P1|Overall Study|Change in Injection Schedule|2
234186|NCT01499095|773343|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
234187|NCT01499095|773344|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
234188|NCT01499095|773343|P2|Overall Study|Hypoglycemia|1
234189|NCT01499095|773344|P1|Overall Study|Hypoglycemia|3
234190|NCT01499095|773343|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
234191|NCT01499095|773344|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
234192|NCT01499095|773343|P2|Overall Study|Lost to Follow-up|4
234193|NCT01499095|773344|P1|Overall Study|Lost to Follow-up|6
234194|NCT01499095|773343|P2|Overall Study|Diverse Reasons|25
234195|NCT01499095|773344|P1|Overall Study|Diverse Reasons|22
234196|NCT01499095|773343|P2|Overall Study|Received Rescue Therapy|40
234197|NCT01499095|773344|P1|Overall Study|Received Rescue Therapy|32
234198|NCT01499095|773343|P2|Overall Study|Protocol Violation|7
234199|NCT01499095|773344|P1|Overall Study|Protocol Violation|6
234200|NCT01499095|773343|P2|Overall Study|Lack of Efficacy|1
234201|NCT01499095|773344|P1|Overall Study|Lack of Efficacy|2
234202|NCT01499095|773343|P2|Overall Study|Adverse Event|7
234203|NCT01499095|773344|P1|Overall Study|Adverse Event|12
234204|NCT01499095|773343|P2|Overall Study|Randomized But Not Treated|1
234205|NCT01499095|773344|P1|Overall Study|Randomized But Not Treated|1
234206|NCT01499082|773374|P2|Overall Study|Lost to Follow-up|3
234207|NCT01499082|773375|P1|Overall Study|Lost to Follow-up|1
234208|NCT01499082|773374|P2|Overall Study|Hypoglycemia|3
234209|NCT01499082|773375|P1|Overall Study|Hypoglycemia|2
234210|NCT01499082|773374|P2|Overall Study|Site Closure for Noncompliance|2
234211|NCT01499082|773375|P1|Overall Study|Site Closure for Noncompliance|5
234212|NCT01499082|773374|P2|Overall Study|Diverse Reasons|14
234213|NCT01499082|773375|P1|Overall Study|Diverse Reasons|18
234214|NCT01499082|773374|P2|Overall Study|Protocol Violation|8
234215|NCT01499082|773375|P1|Overall Study|Protocol Violation|6
234216|NCT01499082|773374|P2|Overall Study|Lack of Efficacy|1
234217|NCT01499082|773375|P1|Overall Study|Lack of Efficacy|1
234218|NCT01499082|773374|P2|Overall Study|Adverse Event|16
234219|NCT01499082|773375|P1|Overall Study|Adverse Event|12
234220|NCT01499082|773374|P2|Overall Study|Randomized but not Treated|1
234221|NCT01499082|773375|P1|Overall Study|Randomized but not Treated|0
234222|NCT01498822|773405|P2|Overall Study|Lost to Follow-up|3
234223|NCT01498822|773406|P1|Overall Study|Lost to Follow-up|8
234224|NCT01498822|773405|P2|Overall Study|Withdrawal by Subject|25
234225|NCT01498822|773406|P1|Overall Study|Withdrawal by Subject|15
234226|NCT01498822|773405|P2|Overall Study|Adverse Event, serious fatal|1
234227|NCT01498822|773406|P1|Overall Study|Adverse Event, serious fatal|1
234228|NCT01498822|773405|P2|Overall Study|SAE, non-fatal|2
234229|NCT01498822|773406|P1|Overall Study|SAE, non-fatal|2
234230|NCT01498822|773405|P2|Overall Study|AE, non-serious non-fatal|17
234231|NCT01498822|773406|P1|Overall Study|AE, non-serious non-fatal|8
234232|NCT01498822|773405|P2|Overall Study|Lack of Efficacy|2
234233|NCT01498822|773406|P1|Overall Study|Lack of Efficacy|7
234234|NCT01498822|773405|P2|Overall Study|Other Reason|2
234235|NCT01498822|773406|P1|Overall Study|Other Reason|5
234236|NCT01498822|773405|P2|Overall Study|Protocol Violation|4
234237|NCT01498822|773406|P1|Overall Study|Protocol Violation|8
234238|NCT01498692|773433|P1|Overall Study|Missed 12-month visit|3
234239|NCT01498692|773433|P1|Overall Study|Withdrawal by Subject|1
234240|NCT01498692|773433|P1|Overall Study|Death|4
234241|NCT01498679|773464|P2|Overall Study|Withdrawal by Subject|4
234242|NCT01498679|773465|P1|Overall Study|Withdrawal by Subject|12
234243|NCT01498679|773464|P2|Overall Study|Physician Decision|2
234244|NCT01498679|773465|P1|Overall Study|Physician Decision|0
234245|NCT01498679|773464|P2|Overall Study|Protocol Violation|0
234246|NCT01498679|773465|P1|Overall Study|Protocol Violation|4
234247|NCT01498679|773464|P2|Overall Study|Lack of Efficacy|12
234248|NCT01498679|773465|P1|Overall Study|Lack of Efficacy|72
234249|NCT01498679|773464|P2|Overall Study|Adverse Event|4
234250|NCT01498679|773465|P1|Overall Study|Adverse Event|1
234251|NCT01498653|773481|P2|Overall Study|Withdrawal by Subject|3
234252|NCT01498653|773482|P1|Overall Study|Withdrawal by Subject|2
234253|NCT01498653|773481|P2|Overall Study|Physician Decision|0
234254|NCT01498653|773482|P1|Overall Study|Physician Decision|2
234255|NCT01498653|773481|P2|Overall Study|Lost to Follow-up|0
234256|NCT01498653|773482|P1|Overall Study|Lost to Follow-up|1
234257|NCT01498653|773481|P2|Overall Study|Protocol Violation|4
234258|NCT01498653|773482|P1|Overall Study|Protocol Violation|0
234259|NCT01498653|773481|P2|Overall Study|Lack of Efficacy|26
234260|NCT01498653|773482|P1|Overall Study|Lack of Efficacy|12
234261|NCT01498653|773481|P2|Overall Study|Adverse Event|2
234262|NCT01498653|773482|P1|Overall Study|Adverse Event|2
234263|NCT01498640|773496|P1|Overall Study|not specified|3
234264|NCT01498640|773496|P1|Overall Study|Death|1
234265|NCT01498640|773496|P1|Overall Study|Lost to Follow-up|1
234266|NCT01498575|773526|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
234267|NCT01498575|773527|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
234268|NCT01498575|773526|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
234269|NCT01498575|773527|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
234270|NCT01498575|773526|P2|Overall Sample|Withdrawal by Subject|14
234271|NCT01498575|773527|P1|Overall Sample|Withdrawal by Subject|60
234272|NCT01498458|773544|P1|Overall Study|Physician Decision|3
234273|NCT01498458|773544|P1|Overall Study|Adverse Event|4
234274|NCT01498185|773599|P5|Overall Study|No longer met criteria, etc|2
234275|NCT01498185|773600|P4|Overall Study|No longer met criteria, etc|0
234276|NCT01498185|773601|P3|Overall Study|No longer met criteria, etc|0
234277|NCT01498185|773602|P2|Overall Study|No longer met criteria, etc|0
234278|NCT01498185|773603|P1|Overall Study|No longer met criteria, etc|0
234279|NCT01498185|773599|P5|Overall Study|Withdrawal by Subject|1
234280|NCT01498185|773600|P4|Overall Study|Withdrawal by Subject|2
234281|NCT01498185|773601|P3|Overall Study|Withdrawal by Subject|0
234282|NCT01498185|773602|P2|Overall Study|Withdrawal by Subject|1
234283|NCT01498185|773603|P1|Overall Study|Withdrawal by Subject|1
234284|NCT01498185|773599|P5|Overall Study|Adverse Event|0
234285|NCT01498185|773600|P4|Overall Study|Adverse Event|1
234286|NCT01498185|773601|P3|Overall Study|Adverse Event|0
234287|NCT01498185|773602|P2|Overall Study|Adverse Event|0
234288|NCT01498185|773603|P1|Overall Study|Adverse Event|0
234289|NCT01498120|773643|P1|Overall Study|Unspecified|4
234290|NCT01498120|773643|P1|Overall Study|AE, non-serious non-fatal|3
234291|NCT01498120|773643|P1|Overall Study|Withdrawal by Subject|5
234292|NCT01498120|773643|P1|Overall Study|Lost to Follow-up|1
234293|NCT01498068|773650|P2|Overall Study|Withdrawal by Subject|1
234294|NCT01498068|773651|P1|Overall Study|Withdrawal by Subject|1
234295|NCT01497938|773669|P2|Overall Study|Device Violation|0
234296|NCT01497938|773670|P1|Overall Study|Device Violation|1
234297|NCT01497938|773669|P2|Overall Study|Withdrawal by Subject|0
234298|NCT01497938|773670|P1|Overall Study|Withdrawal by Subject|4
234299|NCT01497938|773669|P2|Overall Study|Physician Decision|1
234300|NCT01497938|773670|P1|Overall Study|Physician Decision|0
234301|NCT01497938|773669|P2|Overall Study|Adverse Event|1
234302|NCT01497938|773670|P1|Overall Study|Adverse Event|0
234303|NCT01497899|773682|P4|Open-Label Extension Phase|Still in the Open-Label Extension Phase|38
234304|NCT01497899|773683|P3|Open-Label Extension Phase|Still in the Open-Label Extension Phase|69
234305|NCT01497899|773684|P2|Open-Label Extension Phase|Still in the Open-Label Extension Phase|53
234306|NCT01497899|773685|P1|Open-Label Extension Phase|Still in the Open-Label Extension Phase|104
234307|NCT01497899|773682|P4|Open-Label Extension Phase|Lost to Follow-up|0
234308|NCT01497899|773683|P3|Open-Label Extension Phase|Lost to Follow-up|1
234309|NCT01497899|773684|P2|Open-Label Extension Phase|Lost to Follow-up|0
234310|NCT01497899|773685|P1|Open-Label Extension Phase|Lost to Follow-up|1
234311|NCT01497899|773682|P4|Double-Blind Phase|Subject Non-Compliance|0
234312|NCT01497899|773683|P3|Double-Blind Phase|Subject Non-Compliance|0
234313|NCT01497899|773684|P2|Double-Blind Phase|Subject Non-Compliance|1
234314|NCT01497899|773685|P1|Double-Blind Phase|Subject Non-Compliance|0
234315|NCT01497899|773682|P4|Double-Blind Phase|Lost to Follow-up|0
234316|NCT01497899|773683|P3|Double-Blind Phase|Lost to Follow-up|0
234317|NCT01497899|773684|P2|Double-Blind Phase|Lost to Follow-up|2
234318|NCT01497899|773685|P1|Double-Blind Phase|Lost to Follow-up|3
234319|NCT01497899|773682|P4|Double-Blind Phase|Withdrew Consent|0
234320|NCT01497899|773683|P3|Double-Blind Phase|Withdrew Consent|0
234321|NCT01497899|773684|P2|Double-Blind Phase|Withdrew Consent|1
234322|NCT01497899|773685|P1|Double-Blind Phase|Withdrew Consent|0
234323|NCT01497899|773682|P4|Double-Blind Phase|Investigator's Discretion|0
234324|NCT01497899|773683|P3|Double-Blind Phase|Investigator's Discretion|0
234325|NCT01497899|773684|P2|Double-Blind Phase|Investigator's Discretion|0
234326|NCT01497899|773685|P1|Double-Blind Phase|Investigator's Discretion|1
234327|NCT01497899|773682|P4|Double-Blind Phase|Lack of Efficacy|0
234328|NCT01497899|773683|P3|Double-Blind Phase|Lack of Efficacy|0
234329|NCT01497899|773684|P2|Double-Blind Phase|Lack of Efficacy|1
234330|NCT01497899|773685|P1|Double-Blind Phase|Lack of Efficacy|0
234331|NCT01497899|773682|P4|Double-Blind Phase|Adverse Event|0
234332|NCT01497899|773683|P3|Double-Blind Phase|Adverse Event|0
234333|NCT01497899|773684|P2|Double-Blind Phase|Adverse Event|0
234334|NCT01497899|773685|P1|Double-Blind Phase|Adverse Event|1
234335|NCT01497899|773682|P4|Double-Blind Phase|Randomized but not Treated|0
234336|NCT01497899|773683|P3|Double-Blind Phase|Randomized but not Treated|0
234337|NCT01497899|773684|P2|Double-Blind Phase|Randomized but not Treated|0
234338|NCT01497899|773685|P1|Double-Blind Phase|Randomized but not Treated|1
234339|NCT01497366|773713|P2|Overall Study|Randomized but not treated|21
234340|NCT01497366|773714|P1|Overall Study|Randomized but not treated|7
234341|NCT01497366|773713|P2|Overall Study|Death|1
234342|NCT01497366|773714|P1|Overall Study|Death|1
234343|NCT01497366|773713|P2|Overall Study|Other|0
234344|NCT01497366|773714|P1|Overall Study|Other|5
234345|NCT01497366|773713|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
234346|NCT01497366|773714|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
234347|NCT01497366|773713|P2|Overall Study|Withdrawal by Subject|6
234348|NCT01497366|773714|P1|Overall Study|Withdrawal by Subject|6
234349|NCT01497366|773713|P2|Overall Study|Lost to Follow-up|10
234350|NCT01497366|773714|P1|Overall Study|Lost to Follow-up|11
234351|NCT01497366|773713|P2|Overall Study|Virologic failure|50
234352|NCT01497366|773714|P1|Overall Study|Virologic failure|2
234353|NCT01497275|773732|P1|Overall Study|Adverse Event|1
234354|NCT01497275|773732|P1|Overall Study|Death|1
234355|NCT01497262|773739|P1|Overall Study|Protocol Violation|1
234356|NCT01497262|773739|P1|Overall Study|Adverse Event|2
234357|NCT01497262|773739|P1|Overall Study|Withdrawal by Subject|2
234358|NCT01497262|773739|P1|Overall Study|Physician Decision|1
234359|NCT01497262|773739|P1|Overall Study|Abnormal Test Procedure Result|1
234360|NCT01497262|773739|P1|Overall Study|Abnormal Lab Values|4
234361|NCT01497197|773746|P2|Overall Study|Unspecified|1
234362|NCT01497197|773747|P1|Overall Study|Unspecified|3
234363|NCT01497197|773746|P2|Overall Study|All embryos discarded|3
234364|NCT01497197|773747|P1|Overall Study|All embryos discarded|0
234365|NCT01497197|773746|P2|Overall Study|Intention to freeze all embryos|1
234366|NCT01497197|773747|P1|Overall Study|Intention to freeze all embryos|0
234367|NCT01497197|773746|P2|Overall Study|No fertilisation|5
234368|NCT01497197|773747|P1|Overall Study|No fertilisation|6
234369|NCT01497197|773746|P2|Overall Study|No oocytes retrieved|2
234370|NCT01497197|773747|P1|Overall Study|No oocytes retrieved|3
234371|NCT01497197|773746|P2|Overall Study|Risk of OHSS|0
234372|NCT01497197|773747|P1|Overall Study|Risk of OHSS|1
234373|NCT01497197|773746|P2|Overall Study|Excessive/lack of response to treatment|0
234374|NCT01497197|773747|P1|Overall Study|Excessive/lack of response to treatment|1
234375|NCT01497197|773746|P2|Overall Study|Withdrawal by Subject|1
234376|NCT01497197|773747|P1|Overall Study|Withdrawal by Subject|2
234377|NCT01497197|773746|P2|Overall Study|Protocol Violation|2
234378|NCT01497197|773747|P1|Overall Study|Protocol Violation|0
234379|NCT01497197|773746|P2|Overall Study|Lost to Follow-up|0
234380|NCT01497197|773747|P1|Overall Study|Lost to Follow-up|1
234381|NCT01496807|773782|P1|Overall Study|Change in diagnosis|1
234382|NCT01496807|773782|P1|Overall Study|Participant preference/toxicity|8
234383|NCT01496807|773782|P1|Overall Study|Progressive Disease|21
234384|NCT01496469|773794|P2|Overall Study|Other|1
234385|NCT01496469|773795|P1|Overall Study|Other|1
234386|NCT01496469|773794|P2|Overall Study|BP exceeds protocol limits|2
234387|NCT01496469|773795|P1|Overall Study|BP exceeds protocol limits|1
234388|NCT01496469|773794|P2|Overall Study|Withdrawal by Subject|4
234389|NCT01496469|773795|P1|Overall Study|Withdrawal by Subject|4
234390|NCT01496469|773794|P2|Overall Study|Lost to Follow-up|1
234391|NCT01496469|773795|P1|Overall Study|Lost to Follow-up|1
234392|NCT01496469|773794|P2|Overall Study|Protocol Violation|0
234393|NCT01496469|773795|P1|Overall Study|Protocol Violation|2
234394|NCT01496469|773794|P2|Overall Study|Adverse Event|0
234395|NCT01496469|773795|P1|Overall Study|Adverse Event|1
234396|NCT01496456|773805|P1|Overall Study|Lost to Follow-up|7
234397|NCT01496456|773805|P1|Overall Study|Protocol Violation|1
234398|NCT01496430|773818|P3|Overall Study|Other|0
234399|NCT01496430|773819|P2|Overall Study|Other|0
234400|NCT01496430|773820|P1|Overall Study|Other|2
234401|NCT01496430|773818|P3|Overall Study|Principal Investigator Discretion|1
234402|NCT01496430|773819|P2|Overall Study|Principal Investigator Discretion|1
234403|NCT01496430|773820|P1|Overall Study|Principal Investigator Discretion|0
234404|NCT01496430|773818|P3|Overall Study|Voluntary Withdrawal|6
234405|NCT01496430|773819|P2|Overall Study|Voluntary Withdrawal|1
234406|NCT01496430|773820|P1|Overall Study|Voluntary Withdrawal|2
234407|NCT01496430|773818|P3|Overall Study|Lost to Follow-up|1
234408|NCT01496430|773819|P2|Overall Study|Lost to Follow-up|3
234409|NCT01496430|773820|P1|Overall Study|Lost to Follow-up|2
234410|NCT01496430|773818|P3|Overall Study|Major Protocol Deviation|1
234411|NCT01496430|773819|P2|Overall Study|Major Protocol Deviation|0
234412|NCT01496430|773820|P1|Overall Study|Major Protocol Deviation|0
234413|NCT01496430|773818|P3|Overall Study|Adverse Event|1
234414|NCT01496430|773819|P2|Overall Study|Adverse Event|0
234415|NCT01496430|773820|P1|Overall Study|Adverse Event|0
234416|NCT01496287|773932|P1|Overall Study|Incomplete anesthesia|5
234417|NCT01496287|773932|P1|Overall Study|Lost to Follow-up|1
234418|NCT01496274|773942|P2|Overall Study|Lost to Follow-up|3
234419|NCT01496274|773943|P1|Overall Study|Lost to Follow-up|0
234420|NCT01496274|773942|P2|Overall Study|Withdrawal by Subject|0
234421|NCT01496274|773943|P1|Overall Study|Withdrawal by Subject|2
234422|NCT01496274|773942|P2|Overall Study|Adverse Event|1
234423|NCT01496274|773943|P1|Overall Study|Adverse Event|1
234424|NCT01496274|773942|P2|Overall Study|Protocol Violation|1
234425|NCT01496274|773943|P1|Overall Study|Protocol Violation|0
234426|NCT01496183|773988|P2|Overall Study|Withdrawal by Subject|1
234427|NCT01496183|773989|P1|Overall Study|Withdrawal by Subject|0
234428|NCT01496183|773988|P2|Overall Study|Physician Decision|1
234429|NCT01496183|773989|P1|Overall Study|Physician Decision|3
234430|NCT01495975|773997|P2|Overall Study|Lost to Follow-up|0
234431|NCT01495975|773998|P1|Overall Study|Lost to Follow-up|1
234432|NCT01495793|774122|P1|Overall Study|Violation of inclusion criteria|1
234433|NCT01495793|774122|P1|Overall Study|Lost to Follow-up|1
234434|NCT01495702|774135|P2|Randomized Phase|Protocol Violation|1
234435|NCT01495702|774136|P1|Randomized Phase|Protocol Violation|3
234436|NCT01495702|774135|P2|Randomized Phase|Participant Noncompliance|0
234437|NCT01495702|774136|P1|Randomized Phase|Participant Noncompliance|1
234438|NCT01495702|774135|P2|Randomized Phase|Lost to Follow-up|3
234439|NCT01495702|774136|P1|Randomized Phase|Lost to Follow-up|4
234440|NCT01495702|774135|P2|Randomized Phase|Withdrew Consent|18
234441|NCT01495702|774136|P1|Randomized Phase|Withdrew Consent|10
234442|NCT01495702|774135|P2|Randomized Phase|Investigators Discretion|0
234443|NCT01495702|774136|P1|Randomized Phase|Investigators Discretion|2
234444|NCT01495702|774135|P2|Randomized Phase|Lack of Efficacy|0
234445|NCT01495702|774136|P1|Randomized Phase|Lack of Efficacy|2
234446|NCT01495702|774135|P2|Randomized Phase|Death|0
234447|NCT01495702|774136|P1|Randomized Phase|Death|1
234448|NCT01495702|774135|P2|Randomized Phase|Adverse Event|2
234449|NCT01495702|774136|P1|Randomized Phase|Adverse Event|2
234450|NCT01495702|774135|P2|Randomized Phase|Randomized But Not Treated|4
234451|NCT01495702|774136|P1|Randomized Phase|Randomized But Not Treated|1
234452|NCT01495000|774207|P2|Overall Study|Withdrawal by Subject|10
234453|NCT01495000|774208|P1|Overall Study|Withdrawal by Subject|10
234454|NCT01495000|774207|P2|Overall Study|Protocol Violation|0
234455|NCT01495000|774208|P1|Overall Study|Protocol Violation|1
234456|NCT01495000|774207|P2|Overall Study|Lost to Follow-up|2
234457|NCT01495000|774208|P1|Overall Study|Lost to Follow-up|2
234458|NCT01494987|774250|P2|Overall Study|Subject Withdrew Consent|3
234459|NCT01494987|774251|P1|Overall Study|Subject Withdrew Consent|2
234460|NCT01494987|774250|P2|Overall Study|Subject Non-Compliance|10
234461|NCT01494987|774251|P1|Overall Study|Subject Non-Compliance|9
234462|NCT01494987|774250|P2|Overall Study|Protocol Violation|3
234463|NCT01494987|774251|P1|Overall Study|Protocol Violation|3
234464|NCT01494987|774250|P2|Overall Study|Lost to Follow-up|1
234465|NCT01494987|774251|P1|Overall Study|Lost to Follow-up|1
234466|NCT01494987|774250|P2|Overall Study|Investigator's Discretion|2
234467|NCT01494987|774251|P1|Overall Study|Investigator's Discretion|1
234468|NCT01494987|774250|P2|Overall Study|Hyperglycemia|4
234469|NCT01494987|774251|P1|Overall Study|Hyperglycemia|6
234470|NCT01494987|774250|P2|Overall Study|Adverse Event|5
234471|NCT01494987|774251|P1|Overall Study|Adverse Event|6
234472|NCT01494818|774265|P2|Overall Study|Lost to Follow-up|0
234473|NCT01494818|774266|P1|Overall Study|Lost to Follow-up|1
234474|NCT01494818|774265|P2|Overall Study|Relocation|2
234475|NCT01494818|774266|P1|Overall Study|Relocation|1
234476|NCT01494649|774297|P2|Overall Study|Lost to Follow-up|1
234477|NCT01494649|774298|P1|Overall Study|Lost to Follow-up|0
234478|NCT01494610|774314|P2|Period 4|Protocol Violation|0
234479|NCT01494610|774315|P1|Period 4|Protocol Violation|1
234480|NCT01494610|774314|P2|Period 3|Withdrawal by Subject|0
234481|NCT01494610|774315|P1|Period 3|Withdrawal by Subject|1
234482|NCT01494610|774314|P2|Period 3|Adverse Event|0
234483|NCT01494610|774315|P1|Period 3|Adverse Event|1
234484|NCT01494610|774314|P2|Period 1|Withdrawal by Subject|1
234485|NCT01494610|774315|P1|Period 1|Withdrawal by Subject|1
234486|NCT01494584|774383|P1|Overall Study|Study Closed/Terminated|1
234487|NCT01494532|774515|P6|Overall Study|Withdrawal by Subject|0
234488|NCT01494532|774516|P5|Overall Study|Withdrawal by Subject|2
234489|NCT01494532|774517|P4|Overall Study|Withdrawal by Subject|3
234490|NCT01494532|774518|P3|Overall Study|Withdrawal by Subject|4
234491|NCT01494532|774519|P2|Overall Study|Withdrawal by Subject|1
234492|NCT01494532|774520|P1|Overall Study|Withdrawal by Subject|3
234493|NCT01494532|774515|P6|Overall Study|Physician Decision|0
234494|NCT01494532|774516|P5|Overall Study|Physician Decision|0
234495|NCT01494532|774517|P4|Overall Study|Physician Decision|2
234496|NCT01494532|774518|P3|Overall Study|Physician Decision|1
234497|NCT01494532|774519|P2|Overall Study|Physician Decision|1
234498|NCT01494532|774520|P1|Overall Study|Physician Decision|0
234499|NCT01494532|774515|P6|Overall Study|Lost to Follow-up|0
234500|NCT01494532|774516|P5|Overall Study|Lost to Follow-up|0
234501|NCT01494532|774517|P4|Overall Study|Lost to Follow-up|2
234502|NCT01494532|774518|P3|Overall Study|Lost to Follow-up|0
234503|NCT01494532|774519|P2|Overall Study|Lost to Follow-up|0
234504|NCT01494532|774520|P1|Overall Study|Lost to Follow-up|1
234505|NCT01494532|774515|P6|Overall Study|Protocol-defined stopping criteria|0
234506|NCT01494532|774516|P5|Overall Study|Protocol-defined stopping criteria|0
234507|NCT01494532|774517|P4|Overall Study|Protocol-defined stopping criteria|0
234508|NCT01494532|774518|P3|Overall Study|Protocol-defined stopping criteria|1
234509|NCT01494532|774519|P2|Overall Study|Protocol-defined stopping criteria|0
234510|NCT01494532|774520|P1|Overall Study|Protocol-defined stopping criteria|0
234511|NCT01494532|774515|P6|Overall Study|Protocol deviation|0
234512|NCT01494532|774516|P5|Overall Study|Protocol deviation|3
234513|NCT01494532|774517|P4|Overall Study|Protocol deviation|2
234514|NCT01494532|774518|P3|Overall Study|Protocol deviation|3
234515|NCT01494532|774519|P2|Overall Study|Protocol deviation|1
234516|NCT01494532|774520|P1|Overall Study|Protocol deviation|2
234517|NCT01494532|774515|P6|Overall Study|Lack of Efficacy|0
234518|NCT01494532|774516|P5|Overall Study|Lack of Efficacy|2
234519|NCT01494532|774517|P4|Overall Study|Lack of Efficacy|0
234520|NCT01494532|774518|P3|Overall Study|Lack of Efficacy|0
234521|NCT01494532|774519|P2|Overall Study|Lack of Efficacy|0
234522|NCT01494532|774520|P1|Overall Study|Lack of Efficacy|0
234523|NCT01494532|774515|P6|Overall Study|Adverse Event|0
234524|NCT01494532|774516|P5|Overall Study|Adverse Event|5
234525|NCT01494532|774517|P4|Overall Study|Adverse Event|6
234526|NCT01494532|774518|P3|Overall Study|Adverse Event|8
234527|NCT01494532|774519|P2|Overall Study|Adverse Event|1
234528|NCT01494532|774520|P1|Overall Study|Adverse Event|4
234529|NCT01494506|774675|P3|Overall Study|Other|1
234530|NCT01494506|774676|P2|Overall Study|Other|3
234531|NCT01494506|774677|P1|Overall Study|Other|0
234532|NCT01494506|774675|P3|Overall Study|Sponsor Decision|1
234533|NCT01494506|774676|P2|Overall Study|Sponsor Decision|0
234534|NCT01494506|774677|P1|Overall Study|Sponsor Decision|0
234535|NCT01494506|774675|P3|Overall Study|Clinical Deterioration|13
234536|NCT01494506|774676|P2|Overall Study|Clinical Deterioration|17
234537|NCT01494506|774677|P1|Overall Study|Clinical Deterioration|21
234538|NCT01494506|774675|P3|Overall Study|Withdrawal by Subject|14
234539|NCT01494506|774676|P2|Overall Study|Withdrawal by Subject|20
234540|NCT01494506|774677|P1|Overall Study|Withdrawal by Subject|17
234541|NCT01494506|774675|P3|Overall Study|Physician Decision|4
234542|NCT01494506|774676|P2|Overall Study|Physician Decision|5
234543|NCT01494506|774677|P1|Overall Study|Physician Decision|7
234544|NCT01494506|774675|P3|Overall Study|Death|2
234545|NCT01494506|774676|P2|Overall Study|Death|5
234546|NCT01494506|774677|P1|Overall Study|Death|9
234547|NCT01494506|774675|P3|Overall Study|Adverse Event|11
234548|NCT01494506|774676|P2|Overall Study|Adverse Event|10
234549|NCT01494506|774677|P1|Overall Study|Adverse Event|17
234550|NCT01494506|774675|P3|Overall Study|Lack of Efficacy|57
234551|NCT01494506|774676|P2|Overall Study|Lack of Efficacy|83
234552|NCT01494506|774677|P1|Overall Study|Lack of Efficacy|77
234553|NCT01494467|774714|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
234554|NCT01494467|774715|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
234555|NCT01494467|774714|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
234556|NCT01494467|774715|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
234557|NCT01494467|774714|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
234558|NCT01494467|774715|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
234559|NCT01494467|774714|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
234560|NCT01494467|774715|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
234561|NCT01494467|774714|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
234562|NCT01494467|774715|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
234563|NCT01494467|774714|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
234564|NCT01494467|774715|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
234565|NCT01494467|774714|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
234566|NCT01494467|774715|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
234567|NCT01494467|774714|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
234568|NCT01494467|774715|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
234569|NCT01494467|774714|P2|Part A Vehicle Control (12 Weeks)|Other|1
234570|NCT01494467|774715|P1|Part A Vehicle Control (12 Weeks)|Other|1
234571|NCT01494467|774714|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
234572|NCT01494467|774715|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
234573|NCT01494467|774714|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
234574|NCT01494467|774715|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
234575|NCT01494467|774714|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
234576|NCT01494467|774715|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
234577|NCT01494467|774714|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
234578|NCT01494467|774715|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
234579|NCT01494467|774714|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
234580|NCT01494467|774715|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
234581|NCT01494350|774731|P1|Overall Study|Worsening of lesion|1
234582|NCT01494298|774741|P2|Overall Study|Protocol Violation|8
234583|NCT01494298|774742|P1|Overall Study|Protocol Violation|2
234584|NCT01493687|774767|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
234585|NCT01493687|774768|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
234586|NCT01493687|774767|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
234587|NCT01493687|774768|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
234588|NCT01493687|774767|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
234589|NCT01493687|774768|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
234590|NCT01493687|774767|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
234591|NCT01493687|774768|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
234592|NCT01493687|774767|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
234593|NCT01493687|774768|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
234594|NCT01493687|774767|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
234595|NCT01493687|774768|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
234596|NCT01493687|774767|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
234597|NCT01493687|774768|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
234598|NCT01493687|774767|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
234599|NCT01493687|774768|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
234600|NCT01493687|774767|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
234601|NCT01493687|774768|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
234602|NCT01493687|774767|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
234603|NCT01493687|774768|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
234604|NCT01493687|774767|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
234605|NCT01493687|774768|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
234606|NCT01493687|774767|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
234607|NCT01493687|774768|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
234608|NCT01493687|774767|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
234609|NCT01493687|774768|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
234610|NCT01493687|774767|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
234611|NCT01493687|774768|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
234612|NCT01493687|774767|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
234613|NCT01493687|774768|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
234614|NCT01493557|774787|P3|Adding the Second Strategy|Withdrawal by Subject|0
234615|NCT01493557|774788|P2|Adding the Second Strategy|Withdrawal by Subject|1
234616|NCT01493557|774789|P1|Adding the Second Strategy|Withdrawal by Subject|0
234617|NCT01493557|774787|P3|Adding the Second Strategy|Other adverse event|0
234618|NCT01493557|774788|P2|Adding the Second Strategy|Other adverse event|2
234619|NCT01493557|774789|P1|Adding the Second Strategy|Other adverse event|1
234620|NCT01493557|774787|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
234621|NCT01493557|774788|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
234622|NCT01493557|774789|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
234623|NCT01493557|774787|P3|Randomized to Management Strategies|Other than stated above|0
234624|NCT01493557|774788|P2|Randomized to Management Strategies|Other than stated above|3
234625|NCT01493557|774789|P1|Randomized to Management Strategies|Other than stated above|1
234626|NCT01493557|774787|P3|Randomized to Management Strategies|Withdrawal by Subject|0
234627|NCT01493557|774788|P2|Randomized to Management Strategies|Withdrawal by Subject|1
234628|NCT01493557|774789|P1|Randomized to Management Strategies|Withdrawal by Subject|0
234629|NCT01493557|774787|P3|Randomized to Management Strategies|Protocol Violation|0
234630|NCT01493557|774788|P2|Randomized to Management Strategies|Protocol Violation|0
234631|NCT01493557|774789|P1|Randomized to Management Strategies|Protocol Violation|3
234632|NCT01493557|774787|P3|Randomized to Management Strategies|Other adverse event|0
234633|NCT01493557|774788|P2|Randomized to Management Strategies|Other adverse event|5
234634|NCT01493557|774789|P1|Randomized to Management Strategies|Other adverse event|8
234635|NCT01493557|774787|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
234636|NCT01493557|774788|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
234637|NCT01493557|774789|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
234638|NCT01493557|774787|P3|Not Randomized to Management Strategies|Other than stated above|21
234639|NCT01493557|774788|P2|Not Randomized to Management Strategies|Other than stated above|0
234640|NCT01493557|774789|P1|Not Randomized to Management Strategies|Other than stated above|0
234641|NCT01493557|774787|P3|Not Randomized to Management Strategies|Early termination|34
234642|NCT01493557|774788|P2|Not Randomized to Management Strategies|Early termination|0
234643|NCT01493557|774789|P1|Not Randomized to Management Strategies|Early termination|0
234644|NCT01493557|774787|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
234645|NCT01493557|774788|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
234646|NCT01493557|774789|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
234647|NCT01493557|774787|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
234648|NCT01493557|774788|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
234649|NCT01493557|774789|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
234650|NCT01493557|774787|P3|Not Randomized to Management Strategies|Protocol Violation|1
234651|NCT01493557|774788|P2|Not Randomized to Management Strategies|Protocol Violation|0
234652|NCT01493557|774789|P1|Not Randomized to Management Strategies|Protocol Violation|0
234653|NCT01493557|774787|P3|Not Randomized to Management Strategies|Other adverse event|54
234654|NCT01493557|774788|P2|Not Randomized to Management Strategies|Other adverse event|0
234655|NCT01493557|774789|P1|Not Randomized to Management Strategies|Other adverse event|0
234656|NCT01493557|774787|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
234657|NCT01493557|774788|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
234658|NCT01493557|774789|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
234659|NCT01493557|774787|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
234660|NCT01493557|774788|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
234661|NCT01493557|774789|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
234662|NCT01493531|774817|P3|Overall Study|Death|0
234663|NCT01493531|774818|P2|Overall Study|Death|1
234664|NCT01493531|774819|P1|Overall Study|Death|0
234665|NCT01493531|774817|P3|Overall Study|Withdrawal by Subject|11
234666|NCT01493531|774818|P2|Overall Study|Withdrawal by Subject|13
234667|NCT01493531|774819|P1|Overall Study|Withdrawal by Subject|16
234668|NCT01493531|774817|P3|Overall Study|Lost to Follow-up|11
234669|NCT01493531|774818|P2|Overall Study|Lost to Follow-up|7
234670|NCT01493531|774819|P1|Overall Study|Lost to Follow-up|5
234671|NCT01493531|774817|P3|Overall Study|Sponsor terminated study|3
234672|NCT01493531|774818|P2|Overall Study|Sponsor terminated study|2
234673|NCT01493531|774819|P1|Overall Study|Sponsor terminated study|5
234674|NCT01493531|774817|P3|Overall Study|Protocol Violation|12
234675|NCT01493531|774818|P2|Overall Study|Protocol Violation|15
234676|NCT01493531|774819|P1|Overall Study|Protocol Violation|8
234677|NCT01493531|774817|P3|Overall Study|Gout flare|2
234678|NCT01493531|774818|P2|Overall Study|Gout flare|0
234679|NCT01493531|774819|P1|Overall Study|Gout flare|3
234680|NCT01493531|774817|P3|Overall Study|Adverse Event|9
234681|NCT01493531|774818|P2|Overall Study|Adverse Event|12
234682|NCT01493531|774819|P1|Overall Study|Adverse Event|4
234683|NCT01493427|774833|P1|Overall Study|Other|2
234684|NCT01493427|774833|P1|Overall Study|Inability to Follow Instructions|2
234685|NCT01493427|774833|P1|Overall Study|Lost to Follow-up|2
234686|NCT01493427|774833|P1|Overall Study|Personal Reasons|4
234687|NCT01493427|774833|P1|Overall Study|Adverse Event|10
234688|NCT01493089|774853|P2|Overall Study|Physician Decision|1
234689|NCT01493089|774854|P1|Overall Study|Physician Decision|0
234690|NCT01493089|774853|P2|Overall Study|Withdrawal by Subject|0
234691|NCT01493089|774854|P1|Overall Study|Withdrawal by Subject|1
234692|NCT01493089|774853|P2|Overall Study|Protocol Violation|2
234693|NCT01493089|774854|P1|Overall Study|Protocol Violation|2
234694|NCT01492439|774872|P2|Overall Study|Withdrew from RTE|9
234695|NCT01492439|774873|P1|Overall Study|Withdrew from RTE|4
234696|NCT01492426|774921|P2|Follow-Up|Lost to Follow-up|6
234697|NCT01492426|774922|P1|Follow-Up|Lost to Follow-up|12
234698|NCT01492426|774921|P2|Follow-Up|Participant Withdrew Consent|1
234699|NCT01492426|774922|P1|Follow-Up|Participant Withdrew Consent|6
234700|NCT01492426|774921|P2|Follow-Up|Unspecified|2
234701|NCT01492426|774922|P1|Follow-Up|Unspecified|4
234702|NCT01492426|774921|P2|Follow-Up|Death|0
234703|NCT01492426|774922|P1|Follow-Up|Death|1
234704|NCT01492426|774921|P2|Follow-Up|Protocol Requires no Follow-Up|1
234705|NCT01492426|774922|P1|Follow-Up|Protocol Requires no Follow-Up|2
234706|NCT01492426|774921|P2|Treatment|Participant does not meet study criteria|0
234707|NCT01492426|774922|P1|Treatment|Participant does not meet study criteria|1
234708|NCT01492426|774921|P2|Treatment|Lost to Follow-up|4
234709|NCT01492426|774922|P1|Treatment|Lost to Follow-up|9
234710|NCT01492426|774921|P2|Treatment|Subject requested discontinue study drug|3
234711|NCT01492426|774922|P1|Treatment|Subject requested discontinue study drug|7
234712|NCT01492426|774921|P2|Treatment|Poor compliance/noncompliance|0
234713|NCT01492426|774922|P1|Treatment|Poor compliance/noncompliance|1
234714|NCT01492426|774921|P2|Treatment|Participant withdrew consent|2
234715|NCT01492426|774922|P1|Treatment|Participant withdrew consent|1
234716|NCT01492426|774921|P2|Treatment|Lack of Efficacy|5
234717|NCT01492426|774922|P1|Treatment|Lack of Efficacy|38
234718|NCT01492426|774921|P2|Treatment|Adverse Event|25
234719|NCT01492426|774922|P1|Treatment|Adverse Event|25
234720|NCT01492426|774921|P2|Treatment|Unspecified|0
234721|NCT01492426|774922|P1|Treatment|Unspecified|1
234722|NCT01492426|774921|P2|Treatment|Death|1
234723|NCT01492426|774922|P1|Treatment|Death|0
234724|NCT01492400|774940|P2|Overall Study|Adverse Event|5
234725|NCT01492400|774941|P1|Overall Study|Adverse Event|10
234726|NCT01492400|774940|P2|Overall Study|Lack of Efficacy|1
234727|NCT01492400|774941|P1|Overall Study|Lack of Efficacy|1
234728|NCT01492400|774940|P2|Overall Study|Pregnancy|1
234729|NCT01492400|774941|P1|Overall Study|Pregnancy|0
234730|NCT01492400|774940|P2|Overall Study|Lost to Follow-up|1
234731|NCT01492400|774941|P1|Overall Study|Lost to Follow-up|3
234732|NCT01492400|774940|P2|Overall Study|Personal Reasons|5
234733|NCT01492400|774941|P1|Overall Study|Personal Reasons|0
234734|NCT01492400|774940|P2|Overall Study|Miscellaneous Reasons|3
234735|NCT01492400|774941|P1|Overall Study|Miscellaneous Reasons|2
234736|NCT01492088|774954|P3|Overall Study|Reason Not Specified|12
234737|NCT01492088|774955|P2|Overall Study|Reason Not Specified|6
234738|NCT01492088|774956|P1|Overall Study|Reason Not Specified|2
234739|NCT01492088|774954|P3|Overall Study|Death|1
234740|NCT01492088|774955|P2|Overall Study|Death|6
234741|NCT01492088|774956|P1|Overall Study|Death|1
234742|NCT01492088|774954|P3|Overall Study|Withdrawal by Patient|0
234743|NCT01492088|774955|P2|Overall Study|Withdrawal by Patient|2
234744|NCT01492088|774956|P1|Overall Study|Withdrawal by Patient|0
234745|NCT01491919|775026|P3|Overall Study|Insufficient PK sampling|1
234746|NCT01491919|775027|P2|Overall Study|Insufficient PK sampling|2
234747|NCT01491919|775028|P1|Overall Study|Insufficient PK sampling|1
234748|NCT01491737|775076|P2|Overall Study|Reason not specified|3
234749|NCT01491737|775077|P1|Overall Study|Reason not specified|2
234750|NCT01491737|775076|P2|Overall Study|Death|28
234751|NCT01491737|775077|P1|Overall Study|Death|33
234752|NCT01491737|775076|P2|Overall Study|Lost to Follow-up|6
234753|NCT01491737|775077|P1|Overall Study|Lost to Follow-up|1
234754|NCT01491737|775076|P2|Overall Study|Withdrawal of consent|13
234755|NCT01491737|775077|P1|Overall Study|Withdrawal of consent|13
234756|NCT01491672|775100|P3|Overall Study|Death|0
234757|NCT01491672|775101|P2|Overall Study|Death|4
234758|NCT01491672|775102|P1|Overall Study|Death|0
234759|NCT01491672|775100|P3|Overall Study|Protocol deviation|0
234760|NCT01491672|775101|P2|Overall Study|Protocol deviation|1
234761|NCT01491672|775102|P1|Overall Study|Protocol deviation|0
234762|NCT01491672|775100|P3|Overall Study|Disease progression|6
234763|NCT01491672|775101|P2|Overall Study|Disease progression|34
234764|NCT01491672|775102|P1|Overall Study|Disease progression|42
234765|NCT01491672|775100|P3|Overall Study|Adverse Event|4
234766|NCT01491672|775101|P2|Overall Study|Adverse Event|10
234767|NCT01491672|775102|P1|Overall Study|Adverse Event|8
234768|NCT01491672|775100|P3|Overall Study|Withdrawal by Subject|0
234769|NCT01491672|775101|P2|Overall Study|Withdrawal by Subject|7
234770|NCT01491672|775102|P1|Overall Study|Withdrawal by Subject|6
234771|NCT01491672|775100|P3|Overall Study|Lost to Follow-up|1
234772|NCT01491672|775101|P2|Overall Study|Lost to Follow-up|4
234773|NCT01491672|775102|P1|Overall Study|Lost to Follow-up|0
234774|NCT01491607|775139|P1|Overall Study|Withdrawal by Subject|3
234775|NCT01491607|775139|P1|Overall Study|Lost to Follow-up|7
234776|NCT01491035|775348|P8|Overall Study|Lost to Follow-up|0
234777|NCT01491035|775349|P7|Overall Study|Lost to Follow-up|0
234778|NCT01491035|775350|P6|Overall Study|Lost to Follow-up|0
234779|NCT01491035|775351|P5|Overall Study|Lost to Follow-up|1
234780|NCT01491035|775352|P4|Overall Study|Lost to Follow-up|0
234781|NCT01491035|775353|P3|Overall Study|Lost to Follow-up|0
234782|NCT01491035|775354|P2|Overall Study|Lost to Follow-up|0
234783|NCT01491035|775355|P1|Overall Study|Lost to Follow-up|0
234784|NCT01489956|775442|P3|Overall Study|Withdrawal by Subject|1
234785|NCT01489956|775443|P2|Overall Study|Withdrawal by Subject|0
234786|NCT01489956|775444|P1|Overall Study|Withdrawal by Subject|0
234787|NCT01489956|775442|P3|Overall Study|Lost to Follow-up|0
234788|NCT01489956|775443|P2|Overall Study|Lost to Follow-up|0
234789|NCT01489956|775444|P1|Overall Study|Lost to Follow-up|1
234790|NCT01489891|775481|P2|Overall Study|Endoscopy failure|0
234791|NCT01489891|775482|P1|Overall Study|Endoscopy failure|1
234792|NCT01490866|775624|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
234793|NCT01490866|775624|P1|Axitinib Maintenance Therapy|Protocol Violation|2
234794|NCT01490866|775624|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
234795|NCT01490866|775624|P1|Axitinib Maintenance Therapy|Adverse Event|12
234796|NCT01490866|775624|P1|Axitinib Maintenance Therapy|Disease Progression|30
234797|NCT01490866|775624|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
234798|NCT01490866|775624|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
234799|NCT01490866|775624|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
234800|NCT01490866|775624|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
234801|NCT01490866|775624|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
234802|NCT01490866|775624|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
234803|NCT01490840|775635|P2|Phase 2|Adverse Event|1
234804|NCT01490840|775636|P1|Phase 2|Adverse Event|1
234805|NCT01490840|775635|P2|Phase 2|Lost to Follow-up|1
234806|NCT01490840|775636|P1|Phase 2|Lost to Follow-up|1
234807|NCT01490840|775635|P2|Phase 2|Permanent interruption of fingolimod|1
234808|NCT01490840|775636|P1|Phase 2|Permanent interruption of fingolimod|0
234809|NCT01490840|775635|P2|Phase 2|Withdrawal by Subject|3
234810|NCT01490840|775636|P1|Phase 2|Withdrawal by Subject|4
234811|NCT01490840|775635|P2|Phase 1|Visit 6a omitted|0
234812|NCT01490840|775636|P1|Phase 1|Visit 6a omitted|1
234813|NCT01490840|775635|P2|Phase 1|Withdrawal by Subject|5
234814|NCT01490840|775636|P1|Phase 1|Withdrawal by Subject|6
234815|NCT01490840|775635|P2|Phase 1|Adverse Event|1
234816|NCT01490840|775636|P1|Phase 1|Adverse Event|2
234817|NCT01490840|775635|P2|Phase 1|Lost to Follow-up|0
234818|NCT01490840|775636|P1|Phase 1|Lost to Follow-up|1
234819|NCT01490294|775662|P4|Overall Study|Adverse Event|0
234820|NCT01490294|775663|P3|Overall Study|Adverse Event|0
234821|NCT01490294|775664|P2|Overall Study|Adverse Event|0
234822|NCT01490294|775665|P1|Overall Study|Adverse Event|1
234823|NCT01490294|775662|P4|Overall Study|Prematurely discontinuation|1
234824|NCT01490294|775663|P3|Overall Study|Prematurely discontinuation|1
234825|NCT01490294|775664|P2|Overall Study|Prematurely discontinuation|0
234826|NCT01490294|775665|P1|Overall Study|Prematurely discontinuation|4
234827|NCT01490190|775899|P1|Overall Study|Ring expulsion|2
234828|NCT01490190|775899|P1|Overall Study|Inconvenience|1
234829|NCT01490190|775899|P1|Overall Study|Relocation|1
234830|NCT01490190|775899|P1|Overall Study|Lost to Follow-up|13
234831|NCT01490190|775899|P1|Overall Study|Protocol Violation|5
234832|NCT01490190|775899|P1|Overall Study|Adverse Event|17
234833|NCT01490190|775899|P1|Overall Study|Withdrawal by Subject|9
234834|NCT01490125|775920|P6|Period III|Lack of Efficacy|0
234835|NCT01490125|775921|P5|Period III|Lack of Efficacy|1
234836|NCT01490125|775922|P4|Period III|Lack of Efficacy|0
234837|NCT01490125|775923|P3|Period III|Lack of Efficacy|0
234838|NCT01490125|775924|P2|Period III|Lack of Efficacy|0
234839|NCT01490125|775925|P1|Period III|Lack of Efficacy|0
234840|NCT01490125|775920|P6|Period III|Death|0
234841|NCT01490125|775921|P5|Period III|Death|0
234842|NCT01490125|775922|P4|Period III|Death|1
234843|NCT01490125|775923|P3|Period III|Death|0
234844|NCT01490125|775924|P2|Period III|Death|0
234845|NCT01490125|775925|P1|Period III|Death|0
234846|NCT01490125|775920|P6|Period III|Adverse Event|0
234847|NCT01490125|775921|P5|Period III|Adverse Event|0
234848|NCT01490125|775922|P4|Period III|Adverse Event|1
234849|NCT01490125|775923|P3|Period III|Adverse Event|0
234850|NCT01490125|775924|P2|Period III|Adverse Event|1
234851|NCT01490125|775925|P1|Period III|Adverse Event|3
234852|NCT01490125|775920|P6|Period II|Withdrawal by Subject|0
234853|NCT01490125|775921|P5|Period II|Withdrawal by Subject|0
234854|NCT01490125|775922|P4|Period II|Withdrawal by Subject|0
234855|NCT01490125|775923|P3|Period II|Withdrawal by Subject|0
234856|NCT01490125|775924|P2|Period II|Withdrawal by Subject|0
234857|NCT01490125|775925|P1|Period II|Withdrawal by Subject|1
234858|NCT01490125|775920|P6|Period II|Lost to Follow-up|0
234859|NCT01490125|775921|P5|Period II|Lost to Follow-up|0
234860|NCT01490125|775922|P4|Period II|Lost to Follow-up|0
234861|NCT01490125|775923|P3|Period II|Lost to Follow-up|0
234862|NCT01490125|775924|P2|Period II|Lost to Follow-up|1
234863|NCT01490125|775925|P1|Period II|Lost to Follow-up|0
234864|NCT01490125|775920|P6|Period II|Protocol Violation|0
234865|NCT01490125|775921|P5|Period II|Protocol Violation|0
234866|NCT01490125|775922|P4|Period II|Protocol Violation|1
234867|NCT01490125|775923|P3|Period II|Protocol Violation|1
234868|NCT01490125|775924|P2|Period II|Protocol Violation|0
234869|NCT01490125|775925|P1|Period II|Protocol Violation|0
234870|NCT01490125|775920|P6|Period II|Adverse Event|2
234871|NCT01490125|775921|P5|Period II|Adverse Event|4
234872|NCT01490125|775922|P4|Period II|Adverse Event|2
234873|NCT01490125|775923|P3|Period II|Adverse Event|2
234874|NCT01490125|775924|P2|Period II|Adverse Event|3
234875|NCT01490125|775925|P1|Period II|Adverse Event|2
234876|NCT01490125|775920|P6|Period I|Withdrawal by Subject|1
234877|NCT01490125|775921|P5|Period I|Withdrawal by Subject|2
234878|NCT01490125|775922|P4|Period I|Withdrawal by Subject|1
234879|NCT01490125|775923|P3|Period I|Withdrawal by Subject|2
234880|NCT01490125|775924|P2|Period I|Withdrawal by Subject|3
234881|NCT01490125|775925|P1|Period I|Withdrawal by Subject|1
234882|NCT01490125|775920|P6|Period I|Protocol Violation|0
234883|NCT01490125|775921|P5|Period I|Protocol Violation|0
234884|NCT01490125|775922|P4|Period I|Protocol Violation|1
234885|NCT01490125|775923|P3|Period I|Protocol Violation|1
234886|NCT01490125|775924|P2|Period I|Protocol Violation|1
234887|NCT01490125|775925|P1|Period I|Protocol Violation|1
234888|NCT01490125|775920|P6|Period I|Adverse Event|4
234889|NCT01490125|775921|P5|Period I|Adverse Event|2
234890|NCT01490125|775922|P4|Period I|Adverse Event|3
234891|NCT01490125|775923|P3|Period I|Adverse Event|1
234892|NCT01490125|775924|P2|Period I|Adverse Event|1
234893|NCT01490125|775925|P1|Period I|Adverse Event|4
234894|NCT01490086|775953|P5|Overall Study|Subject left hospital|0
234895|NCT01490086|775954|P4|Overall Study|Subject left hospital|1
234896|NCT01490086|775955|P3|Overall Study|Subject left hospital|0
234897|NCT01490086|775956|P2|Overall Study|Subject left hospital|1
234898|NCT01490086|775957|P1|Overall Study|Subject left hospital|0
234899|NCT01490086|775953|P5|Overall Study|Subject uncontrollable and abusive|0
234900|NCT01490086|775954|P4|Overall Study|Subject uncontrollable and abusive|0
234901|NCT01490086|775955|P3|Overall Study|Subject uncontrollable and abusive|0
234902|NCT01490086|775956|P2|Overall Study|Subject uncontrollable and abusive|1
234903|NCT01490086|775957|P1|Overall Study|Subject uncontrollable and abusive|0
234904|NCT01490086|775953|P5|Overall Study|Worsening of symptoms|0
234905|NCT01490086|775954|P4|Overall Study|Worsening of symptoms|1
234906|NCT01490086|775955|P3|Overall Study|Worsening of symptoms|0
234907|NCT01490086|775956|P2|Overall Study|Worsening of symptoms|1
234908|NCT01490086|775957|P1|Overall Study|Worsening of symptoms|0
234909|NCT01490086|775953|P5|Overall Study|Lack of Efficacy|8
234910|NCT01490086|775954|P4|Overall Study|Lack of Efficacy|0
234911|NCT01490086|775955|P3|Overall Study|Lack of Efficacy|1
234912|NCT01490086|775956|P2|Overall Study|Lack of Efficacy|3
234913|NCT01490086|775957|P1|Overall Study|Lack of Efficacy|0
234914|NCT01490086|775953|P5|Overall Study|Adverse Event|0
234915|NCT01490086|775954|P4|Overall Study|Adverse Event|2
234916|NCT01490086|775955|P3|Overall Study|Adverse Event|1
234917|NCT01490086|775956|P2|Overall Study|Adverse Event|0
234918|NCT01490086|775957|P1|Overall Study|Adverse Event|0
234919|NCT01490086|775953|P5|Overall Study|Physician Decision|1
234920|NCT01490086|775954|P4|Overall Study|Physician Decision|3
234921|NCT01490086|775955|P3|Overall Study|Physician Decision|2
234922|NCT01490086|775956|P2|Overall Study|Physician Decision|4
234923|NCT01490086|775957|P1|Overall Study|Physician Decision|3
234924|NCT01490086|775953|P5|Overall Study|Lost to Follow-up|1
234925|NCT01490086|775954|P4|Overall Study|Lost to Follow-up|0
234926|NCT01490086|775955|P3|Overall Study|Lost to Follow-up|0
234927|NCT01490086|775956|P2|Overall Study|Lost to Follow-up|0
234928|NCT01490086|775957|P1|Overall Study|Lost to Follow-up|0
234929|NCT01490086|775953|P5|Overall Study|Abnormal laboratory findings|0
234930|NCT01490086|775954|P4|Overall Study|Abnormal laboratory findings|0
234931|NCT01490086|775955|P3|Overall Study|Abnormal laboratory findings|0
234932|NCT01490086|775956|P2|Overall Study|Abnormal laboratory findings|0
234933|NCT01490086|775957|P1|Overall Study|Abnormal laboratory findings|1
234934|NCT01490086|775953|P5|Overall Study|Non-compliance|0
234935|NCT01490086|775954|P4|Overall Study|Non-compliance|0
234936|NCT01490086|775955|P3|Overall Study|Non-compliance|0
234937|NCT01490086|775956|P2|Overall Study|Non-compliance|1
234938|NCT01490086|775957|P1|Overall Study|Non-compliance|0
234939|NCT01490086|775953|P5|Overall Study|Consent withdrawn|1
234940|NCT01490086|775954|P4|Overall Study|Consent withdrawn|0
234941|NCT01490086|775955|P3|Overall Study|Consent withdrawn|3
234942|NCT01490086|775956|P2|Overall Study|Consent withdrawn|4
234943|NCT01490086|775957|P1|Overall Study|Consent withdrawn|4
234944|NCT01490060|775991|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
234945|NCT01490060|775992|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
234946|NCT01490060|775993|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
234947|NCT01490060|775994|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
234948|NCT01490060|775991|P4|Cycle 2|Non-Compliance|0
234949|NCT01490060|775992|P3|Cycle 2|Non-Compliance|1
234950|NCT01490060|775993|P2|Cycle 2|Non-Compliance|0
234951|NCT01490060|775994|P1|Cycle 2|Non-Compliance|0
234952|NCT01490060|775991|P4|Cycle 2|Change of Treatment|0
234953|NCT01490060|775992|P3|Cycle 2|Change of Treatment|0
234954|NCT01490060|775993|P2|Cycle 2|Change of Treatment|1
234955|NCT01490060|775994|P1|Cycle 2|Change of Treatment|1
234956|NCT01490060|775991|P4|Cycle 1|Treatment at Another Facility|1
234957|NCT01490060|775992|P3|Cycle 1|Treatment at Another Facility|0
234958|NCT01490060|775993|P2|Cycle 1|Treatment at Another Facility|0
234959|NCT01490060|775994|P1|Cycle 1|Treatment at Another Facility|0
234960|NCT01490060|775991|P4|Cycle 1|Withdrawal by Subject|1
234961|NCT01490060|775992|P3|Cycle 1|Withdrawal by Subject|0
234962|NCT01490060|775993|P2|Cycle 1|Withdrawal by Subject|0
234963|NCT01490060|775994|P1|Cycle 1|Withdrawal by Subject|0
234964|NCT01490060|775991|P4|Cycle 1|Insurance Denied|0
234965|NCT01490060|775992|P3|Cycle 1|Insurance Denied|2
234966|NCT01490060|775993|P2|Cycle 1|Insurance Denied|0
234967|NCT01490060|775994|P1|Cycle 1|Insurance Denied|0
234968|NCT01490060|775991|P4|Cycle 1|Change of Treatment|1
234969|NCT01490060|775992|P3|Cycle 1|Change of Treatment|1
234970|NCT01490060|775993|P2|Cycle 1|Change of Treatment|1
234971|NCT01490060|775994|P1|Cycle 1|Change of Treatment|0
234972|NCT01489527|776014|P2|Overall Study|Not compliant|0
234973|NCT01489527|776015|P1|Overall Study|Not compliant|1
234974|NCT01489527|776014|P2|Overall Study|Procedures|0
234975|NCT01489527|776015|P1|Overall Study|Procedures|1
234976|NCT01489527|776014|P2|Overall Study|Lost to Follow-up|1
234977|NCT01489527|776015|P1|Overall Study|Lost to Follow-up|5
234978|NCT01489527|776014|P2|Overall Study|Withdrawal by Subject|4
234979|NCT01489527|776015|P1|Overall Study|Withdrawal by Subject|0
234980|NCT01489527|776014|P2|Overall Study|Participant moved|7
234981|NCT01489527|776015|P1|Overall Study|Participant moved|6
234982|NCT01489527|776014|P2|Overall Study|Pregnancy|14
234983|NCT01489527|776015|P1|Overall Study|Pregnancy|9
234984|NCT01489358|776032|P3|Overall Study|Lost to Follow-up|2
234985|NCT01489358|776033|P2|Overall Study|Lost to Follow-up|0
234986|NCT01489358|776034|P1|Overall Study|Lost to Follow-up|0
234987|NCT01489254|776084|P4|Open-label Extension Part|Other reasons for not completing study|5
234988|NCT01489254|776085|P3|Open-label Extension Part|Other reasons for not completing study|0
234989|NCT01489254|776086|P2|Open-label Extension Part|Other reasons for not completing study|0
234990|NCT01489254|776087|P1|Open-label Extension Part|Other reasons for not completing study|0
234991|NCT01489254|776084|P4|Open-label Extension Part|Lost to Follow-up|9
234992|NCT01489254|776085|P3|Open-label Extension Part|Lost to Follow-up|0
234993|NCT01489254|776086|P2|Open-label Extension Part|Lost to Follow-up|0
234994|NCT01489254|776087|P1|Open-label Extension Part|Lost to Follow-up|0
234995|NCT01489254|776084|P4|Open-label Extension Part|Protocol Violation|1
234996|NCT01489254|776085|P3|Open-label Extension Part|Protocol Violation|0
234997|NCT01489254|776086|P2|Open-label Extension Part|Protocol Violation|0
234998|NCT01489254|776087|P1|Open-label Extension Part|Protocol Violation|0
234999|NCT01489254|776084|P4|Open-label Extension Part|Withdrawal by Subject|30
235000|NCT01489254|776085|P3|Open-label Extension Part|Withdrawal by Subject|0
235001|NCT01489254|776086|P2|Open-label Extension Part|Withdrawal by Subject|0
235002|NCT01489254|776087|P1|Open-label Extension Part|Withdrawal by Subject|0
235003|NCT01489254|776084|P4|Open-label Extension Part|Pregnancy|3
235004|NCT01489254|776085|P3|Open-label Extension Part|Pregnancy|0
235005|NCT01489254|776086|P2|Open-label Extension Part|Pregnancy|0
235006|NCT01489254|776087|P1|Open-label Extension Part|Pregnancy|0
235007|NCT01489254|776084|P4|Open-label Extension Part|Adverse Event|10
235008|NCT01489254|776085|P3|Open-label Extension Part|Adverse Event|0
235009|NCT01489254|776086|P2|Open-label Extension Part|Adverse Event|0
235010|NCT01489254|776087|P1|Open-label Extension Part|Adverse Event|0
235011|NCT01489254|776084|P4|Double-blind Part|Other reasons for not completing study|0
235012|NCT01489254|776085|P3|Double-blind Part|Other reasons for not completing study|0
235013|NCT01489254|776086|P2|Double-blind Part|Other reasons for not completing study|6
235014|NCT01489254|776087|P1|Double-blind Part|Other reasons for not completing study|4
235015|NCT01489254|776084|P4|Double-blind Part|Lost to Follow-up|0
235016|NCT01489254|776085|P3|Double-blind Part|Lost to Follow-up|0
235017|NCT01489254|776086|P2|Double-blind Part|Lost to Follow-up|2
235018|NCT01489254|776087|P1|Double-blind Part|Lost to Follow-up|1
235019|NCT01489254|776084|P4|Double-blind Part|Withdrawal by Subject|0
235020|NCT01489254|776085|P3|Double-blind Part|Withdrawal by Subject|1
235021|NCT01489254|776086|P2|Double-blind Part|Withdrawal by Subject|20
235022|NCT01489254|776087|P1|Double-blind Part|Withdrawal by Subject|12
235023|NCT01489254|776084|P4|Double-blind Part|Pregnancy|0
235024|NCT01489254|776085|P3|Double-blind Part|Pregnancy|0
235025|NCT01489254|776086|P2|Double-blind Part|Pregnancy|3
235026|NCT01489254|776087|P1|Double-blind Part|Pregnancy|1
235027|NCT01489254|776084|P4|Double-blind Part|Adverse Event|0
235028|NCT01489254|776085|P3|Double-blind Part|Adverse Event|2
235029|NCT01489254|776086|P2|Double-blind Part|Adverse Event|2
235030|NCT01489254|776087|P1|Double-blind Part|Adverse Event|7
235031|NCT01489189|776098|P2|Overall Study|Missed Visit|4
235032|NCT01489189|776099|P1|Overall Study|Missed Visit|1
235033|NCT01489189|776098|P2|Overall Study|Death|8
235034|NCT01489189|776099|P1|Overall Study|Death|10
235035|NCT01489189|776098|P2|Overall Study|Withdrawal by Subject|23
235036|NCT01489189|776099|P1|Overall Study|Withdrawal by Subject|20
235037|NCT01488994|776126|P2|Overall Study|Withdrawal by Subject|1
235038|NCT01488994|776127|P1|Overall Study|Withdrawal by Subject|0
235039|NCT01488578|776231|P1|Overall Study|Protocol Violation|1836
235040|NCT01488487|776265|P1|Overall Study|Withdrawal by Subject|2
235041|NCT01488487|776265|P1|Overall Study|Death|1
235042|NCT01488487|776265|P1|Overall Study|Adverse Event|6
235043|NCT01488448|776274|P2|Overall Study|Protocol Violation|3
235044|NCT01488448|776275|P1|Overall Study|Protocol Violation|4
235045|NCT01488448|776274|P2|Overall Study|Physician Decision|9
235046|NCT01488448|776275|P1|Overall Study|Physician Decision|4
235047|NCT01488448|776274|P2|Overall Study|Adverse Event|4
235048|NCT01488448|776275|P1|Overall Study|Adverse Event|9
235049|NCT01488448|776274|P2|Overall Study|Withdrawal by Subject|1
235050|NCT01488448|776275|P1|Overall Study|Withdrawal by Subject|3
235051|NCT01488370|776317|P3|Overall Study|Protocol Violation|1
235052|NCT01488370|776318|P2|Overall Study|Protocol Violation|1
235053|NCT01488370|776319|P1|Overall Study|Protocol Violation|0
235054|NCT01488071|776366|P2|Overall Study|Administrative or Other Reason(s)|4
235055|NCT01488071|776367|P1|Overall Study|Administrative or Other Reason(s)|5
235056|NCT01488071|776366|P2|Overall Study|Lost to Follow-up|0
235057|NCT01488071|776367|P1|Overall Study|Lost to Follow-up|1
235058|NCT01488071|776366|P2|Overall Study|Withdrawal of Consent|12
235059|NCT01488071|776367|P1|Overall Study|Withdrawal of Consent|14
235060|NCT01488071|776366|P2|Overall Study|Protocol Violation|7
235061|NCT01488071|776367|P1|Overall Study|Protocol Violation|5
235062|NCT01488071|776366|P2|Overall Study|Non-compliance with study drug|0
235063|NCT01488071|776367|P1|Overall Study|Non-compliance with study drug|2
235064|NCT01488071|776366|P2|Overall Study|Lack of Efficacy|17
235065|NCT01488071|776367|P1|Overall Study|Lack of Efficacy|11
235066|NCT01488071|776366|P2|Overall Study|Adverse Event|23
235067|NCT01488071|776367|P1|Overall Study|Adverse Event|15
235068|NCT01487863|776447|P2|Overall Study|Death|19
235069|NCT01487863|776448|P1|Overall Study|Death|19
235070|NCT01487577|776465|P1|Overall Study|Became ineligible after signing consent|1
235071|NCT01487525|776479|P2|Overall Study|Withdrawal by Subject|1
235072|NCT01487525|776480|P1|Overall Study|Withdrawal by Subject|0
235073|NCT01486966|776498|P2|Overall Study|Withdrawal by Subject|1
235074|NCT01486966|776499|P1|Overall Study|Withdrawal by Subject|0
235075|NCT01486966|776498|P2|Overall Study|Adverse Event|1
235076|NCT01486966|776499|P1|Overall Study|Adverse Event|0
235077|NCT01486927|776523|P1|Overall Study|Subject did not reach 6 mo of treatment|1
235078|NCT01486927|776523|P1|Overall Study|Withdrawal by Subject|8
235079|NCT01486927|776523|P1|Overall Study|50 Exposure days not reached|2
235080|NCT01486927|776523|P1|Overall Study|Physician Decision|1
235081|NCT01486927|776523|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
235082|NCT01486758|776556|P2|Overall Study|Lost to Follow-up|1
235083|NCT01486758|776557|P1|Overall Study|Lost to Follow-up|0
235084|NCT01486446|776624|P2|Overall Study|Adverse Event|0
235085|NCT01486446|776625|P1|Overall Study|Adverse Event|1
235086|NCT01486238|776647|P2|Overall Study|Lost to Follow-up|3
235087|NCT01486238|776648|P1|Overall Study|Lost to Follow-up|0
235088|NCT01486238|776647|P2|Overall Study|Withdrawal by Subject|1
235089|NCT01486238|776648|P1|Overall Study|Withdrawal by Subject|2
235090|NCT01486238|776647|P2|Overall Study|Death|2
235091|NCT01486238|776648|P1|Overall Study|Death|0
235092|NCT01485991|776662|P2|Overall Study|randomized but not treated|2
235093|NCT01485991|776663|P1|Overall Study|randomized but not treated|6
235094|NCT01485991|776662|P2|Overall Study|Withdrawal by Subject|20
235095|NCT01485991|776663|P1|Overall Study|Withdrawal by Subject|13
235096|NCT01485991|776662|P2|Overall Study|Lost to Follow-up|10
235097|NCT01485991|776663|P1|Overall Study|Lost to Follow-up|13
235098|NCT01485991|776662|P2|Overall Study|Adverse Event|4
235099|NCT01485991|776663|P1|Overall Study|Adverse Event|0
235100|NCT01485887|776673|P1|Overall Study|Primary disease markedly improved|1
235101|NCT01485887|776673|P1|Overall Study|Deterioration of primary disease|1
235102|NCT01485887|776673|P1|Overall Study|Adverse Event|8
235103|NCT01485887|776673|P1|Overall Study|Withdrawal by Subject|2
235104|NCT01485796|776685|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
235105|NCT01485796|776685|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
235106|NCT01485796|776685|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
235107|NCT01485796|776685|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
235108|NCT01485796|776685|P1|Period 2: Epoch 2|Switch to safety follow-up|26
235109|NCT01485796|776685|P1|Period 2: Epoch 2|Adverse Event|3
235110|NCT01485796|776685|P1|Period 2: Epoch 2|Withdrawal by Subject|6
235111|NCT01485796|776685|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
235112|NCT01485640|776707|P1|Overall Study|Terminated by Sponsor|95
235113|NCT01485640|776707|P1|Overall Study|Withdrawal by Subject|14
235114|NCT01485640|776707|P1|Overall Study|Protocol Violation|1
235115|NCT01485640|776707|P1|Overall Study|Lack of Efficacy|2
235116|NCT01485640|776707|P1|Overall Study|Adverse Event|10
235117|NCT01485536|776712|P1|Overall Study|Adverse Event|1
235118|NCT01485536|776712|P1|Overall Study|Withdrawal by Subject|3
235119|NCT01485172|776727|P6|Overall Study|Withdrawal by Subject|1
235120|NCT01485172|776728|P5|Overall Study|Withdrawal by Subject|1
235121|NCT01485172|776729|P4|Overall Study|Withdrawal by Subject|1
235122|NCT01485172|776730|P3|Overall Study|Withdrawal by Subject|0
235123|NCT01485172|776731|P2|Overall Study|Withdrawal by Subject|0
235124|NCT01485172|776732|P1|Overall Study|Withdrawal by Subject|2
235125|NCT01485172|776727|P6|Overall Study|Physician Decision|0
235126|NCT01485172|776728|P5|Overall Study|Physician Decision|1
235127|NCT01485172|776729|P4|Overall Study|Physician Decision|0
235128|NCT01485172|776730|P3|Overall Study|Physician Decision|0
235129|NCT01485172|776731|P2|Overall Study|Physician Decision|0
235130|NCT01485172|776732|P1|Overall Study|Physician Decision|0
235131|NCT01485172|776727|P6|Overall Study|Lost to Follow-up|1
235132|NCT01485172|776728|P5|Overall Study|Lost to Follow-up|0
235133|NCT01485172|776729|P4|Overall Study|Lost to Follow-up|0
235134|NCT01485172|776730|P3|Overall Study|Lost to Follow-up|1
235135|NCT01485172|776731|P2|Overall Study|Lost to Follow-up|0
235136|NCT01485172|776732|P1|Overall Study|Lost to Follow-up|0
235137|NCT01485172|776727|P6|Overall Study|Protocol defined stopping criteria|0
235138|NCT01485172|776728|P5|Overall Study|Protocol defined stopping criteria|1
235139|NCT01485172|776729|P4|Overall Study|Protocol defined stopping criteria|0
235140|NCT01485172|776730|P3|Overall Study|Protocol defined stopping criteria|0
235141|NCT01485172|776731|P2|Overall Study|Protocol defined stopping criteria|0
235142|NCT01485172|776732|P1|Overall Study|Protocol defined stopping criteria|1
235143|NCT01485172|776727|P6|Overall Study|Protocol Violation|0
235144|NCT01485172|776728|P5|Overall Study|Protocol Violation|1
235145|NCT01485172|776729|P4|Overall Study|Protocol Violation|5
235146|NCT01485172|776730|P3|Overall Study|Protocol Violation|4
235147|NCT01485172|776731|P2|Overall Study|Protocol Violation|0
235148|NCT01485172|776732|P1|Overall Study|Protocol Violation|0
235149|NCT01485172|776727|P6|Overall Study|Lack of Efficacy|0
235150|NCT01485172|776728|P5|Overall Study|Lack of Efficacy|0
235151|NCT01485172|776729|P4|Overall Study|Lack of Efficacy|0
235152|NCT01485172|776730|P3|Overall Study|Lack of Efficacy|0
235153|NCT01485172|776731|P2|Overall Study|Lack of Efficacy|0
235154|NCT01485172|776732|P1|Overall Study|Lack of Efficacy|2
235155|NCT01485172|776727|P6|Overall Study|Adverse Event|2
235156|NCT01485172|776728|P5|Overall Study|Adverse Event|1
235157|NCT01485172|776729|P4|Overall Study|Adverse Event|2
235158|NCT01485172|776730|P3|Overall Study|Adverse Event|2
235159|NCT01485172|776731|P2|Overall Study|Adverse Event|1
235160|NCT01485172|776732|P1|Overall Study|Adverse Event|2
235161|NCT01485094|776809|P3|Overall Study|Withdrawal by Subject|0
235162|NCT01485094|776810|P2|Overall Study|Withdrawal by Subject|1
235163|NCT01485094|776811|P1|Overall Study|Withdrawal by Subject|1
235164|NCT01485094|776809|P3|Overall Study|Lost to Follow-up|0
235165|NCT01485094|776810|P2|Overall Study|Lost to Follow-up|0
235166|NCT01485094|776811|P1|Overall Study|Lost to Follow-up|1
235167|NCT01485094|776809|P3|Overall Study|Adverse Event|1
235168|NCT01485094|776810|P2|Overall Study|Adverse Event|1
235169|NCT01485094|776811|P1|Overall Study|Adverse Event|1
235170|NCT01484977|776852|P1|Overall Study|Lack of Compliance|1
235171|NCT01484977|776852|P1|Overall Study|Low White Blood Cell Count|1
235172|NCT01484977|776852|P1|Overall Study|Moving Overseas|1
235173|NCT01484977|776852|P1|Overall Study|Subject Protocol Non-compliant|1
235174|NCT01484977|776852|P1|Overall Study|Withdrawal by Subject|4
235175|NCT01484977|776852|P1|Overall Study|Lost to Follow-up|1
235176|NCT01484977|776852|P1|Overall Study|Protocol Violation|6
235177|NCT01484977|776852|P1|Overall Study|Lack of Efficacy|4
235178|NCT01484977|776852|P1|Overall Study|Adverse Event|8
235179|NCT01484951|776856|P1|Overall Study|Non-Compliance|1
235180|NCT01484951|776856|P1|Overall Study|Personal Reasons|1
235181|NCT01484951|776856|P1|Overall Study|Adverse Event|3
235182|NCT01484938|776861|P1|Overall Study|Noncompliance|1
235183|NCT01484938|776861|P1|Overall Study|Lost to Follow-up|1
235184|NCT01484938|776861|P1|Overall Study|Adverse Event|2
235185|NCT01484912|776868|P2|Overall Study|Physician Decision|1
235186|NCT01484912|776869|P1|Overall Study|Physician Decision|0
235187|NCT01484912|776868|P2|Overall Study|Withdrawal by Subject|0
235188|NCT01484912|776869|P1|Overall Study|Withdrawal by Subject|1
235189|NCT01484873|776879|P1|Overall Study|Withdrawal by Subject|2
235190|NCT01484561|776898|P2|Overall Study|Adverse Event|4
235191|NCT01484561|776899|P1|Overall Study|Adverse Event|1
235192|NCT01484561|776898|P2|Overall Study|Not specified|1
235193|NCT01484561|776899|P1|Overall Study|Not specified|1
235194|NCT01484561|776898|P2|Overall Study|Withdrawal by Subject|0
235195|NCT01484561|776899|P1|Overall Study|Withdrawal by Subject|3
235196|NCT01484561|776898|P2|Overall Study|Lost to Follow-up|0
235197|NCT01484561|776899|P1|Overall Study|Lost to Follow-up|1
235198|NCT01484561|776898|P2|Overall Study|Lack of Efficacy|1
235199|NCT01484561|776899|P1|Overall Study|Lack of Efficacy|3
235200|NCT01484197|776993|P4|Treatment Period 2|Subject withdrew consent|1
235201|NCT01484197|776994|P3|Treatment Period 2|Subject withdrew consent|0
235202|NCT01484197|776995|P2|Treatment Period 2|Subject withdrew consent|0
235203|NCT01484197|776996|P1|Treatment Period 2|Subject withdrew consent|0
235204|NCT01484197|776993|P4|Treatment Period 1|Adverse Event|0
235205|NCT01484197|776994|P3|Treatment Period 1|Adverse Event|0
235206|NCT01484197|776995|P2|Treatment Period 1|Adverse Event|0
235207|NCT01484197|776996|P1|Treatment Period 1|Adverse Event|1
235208|NCT01484132|777079|P1|Overall Study|No post-treatment urine sample collected|10
235209|NCT01484132|777079|P1|Overall Study|No pre-treatment urine sample collected|1
235210|NCT01484132|777079|P1|Overall Study|Ineligible|1
235211|NCT01484132|777079|P1|Overall Study|Difficulty with time commitment|2
235212|NCT01484132|777079|P1|Overall Study|Lost to Follow-up|8
235213|NCT01484054|777087|P2|Period 1|Withdrawal by Subject|1
235214|NCT01484054|777088|P1|Period 1|Withdrawal by Subject|0
235215|NCT01484028|777106|P4|Period 1|Lens Discomfort|0
235216|NCT01484028|777107|P3|Period 1|Lens Discomfort|0
235217|NCT01484028|777108|P2|Period 1|Lens Discomfort|1
235218|NCT01484028|777109|P1|Period 1|Lens Discomfort|0
235219|NCT01484028|777106|P4|Period 1|Non-Compliance to Protocol|1
235220|NCT01484028|777107|P3|Period 1|Non-Compliance to Protocol|0
235221|NCT01484028|777108|P2|Period 1|Non-Compliance to Protocol|1
235222|NCT01484028|777109|P1|Period 1|Non-Compliance to Protocol|0
235223|NCT01484028|777106|P4|Period 1|Lost to Follow-up|0
235224|NCT01484028|777107|P3|Period 1|Lost to Follow-up|0
235225|NCT01484028|777108|P2|Period 1|Lost to Follow-up|1
235226|NCT01484028|777109|P1|Period 1|Lost to Follow-up|0
235227|NCT01483937|777202|P2|Overall Study|Withdrawal by Subject|3
235228|NCT01483937|777203|P1|Overall Study|Withdrawal by Subject|4
235229|NCT01483924|777230|P5|Overall Study|Sponsor concern over ECG result|0
235230|NCT01483924|777231|P4|Overall Study|Sponsor concern over ECG result|1
235231|NCT01483924|777232|P3|Overall Study|Sponsor concern over ECG result|0
235232|NCT01483924|777233|P2|Overall Study|Sponsor concern over ECG result|0
235233|NCT01483924|777234|P1|Overall Study|Sponsor concern over ECG result|0
235234|NCT01483924|777230|P5|Overall Study|Non-compliance|1
235235|NCT01483924|777231|P4|Overall Study|Non-compliance|1
235236|NCT01483924|777232|P3|Overall Study|Non-compliance|0
235237|NCT01483924|777233|P2|Overall Study|Non-compliance|0
235238|NCT01483924|777234|P1|Overall Study|Non-compliance|0
235239|NCT01483924|777230|P5|Overall Study|Adverse Event|0
235240|NCT01483924|777231|P4|Overall Study|Adverse Event|1
235241|NCT01483924|777232|P3|Overall Study|Adverse Event|1
235242|NCT01483924|777233|P2|Overall Study|Adverse Event|0
235243|NCT01483924|777234|P1|Overall Study|Adverse Event|0
235244|NCT01483924|777230|P5|Overall Study|Withdrawal by Subject|1
235245|NCT01483924|777231|P4|Overall Study|Withdrawal by Subject|1
235246|NCT01483924|777232|P3|Overall Study|Withdrawal by Subject|0
235247|NCT01483924|777233|P2|Overall Study|Withdrawal by Subject|0
235248|NCT01483924|777234|P1|Overall Study|Withdrawal by Subject|2
235249|NCT01483820|777282|P1|Overall Study|Death|1
235250|NCT01483820|777282|P1|Overall Study|Adverse Event|1
235251|NCT01483820|777282|P1|Overall Study|Lack of Efficacy|6
235252|NCT01483651|777291|P6|Overall Study|Withdrawal by Subject|1
235253|NCT01483651|777292|P5|Overall Study|Withdrawal by Subject|0
235254|NCT01483651|777293|P4|Overall Study|Withdrawal by Subject|0
235255|NCT01483651|777294|P3|Overall Study|Withdrawal by Subject|1
235256|NCT01483651|777295|P2|Overall Study|Withdrawal by Subject|1
235257|NCT01483651|777296|P1|Overall Study|Withdrawal by Subject|0
235258|NCT01483625|777306|P2|Overall Study|Due to other reason|0
235259|NCT01483625|777307|P1|Overall Study|Due to other reason|1
235260|NCT01483625|777306|P2|Overall Study|Refused to continue medication|1
235261|NCT01483625|777307|P1|Overall Study|Refused to continue medication|2
235262|NCT01483625|777306|P2|Overall Study|Adverse Event|1
235263|NCT01483625|777307|P1|Overall Study|Adverse Event|1
235264|NCT01483183|777364|P10|Overall Study|Withdrawal by Subject|1
235265|NCT01483183|777365|P9|Overall Study|Withdrawal by Subject|0
235266|NCT01483183|777366|P8|Overall Study|Withdrawal by Subject|0
235267|NCT01483183|777367|P7|Overall Study|Withdrawal by Subject|0
235268|NCT01483183|777368|P6|Overall Study|Withdrawal by Subject|0
235269|NCT01483183|777369|P5|Overall Study|Withdrawal by Subject|0
235270|NCT01483183|777370|P4|Overall Study|Withdrawal by Subject|0
235271|NCT01483183|777371|P3|Overall Study|Withdrawal by Subject|0
235272|NCT01483183|777372|P2|Overall Study|Withdrawal by Subject|0
235273|NCT01483183|777373|P1|Overall Study|Withdrawal by Subject|0
235274|NCT01483183|777364|P10|Overall Study|Physician Decision|0
235275|NCT01483183|777365|P9|Overall Study|Physician Decision|0
235276|NCT01483183|777366|P8|Overall Study|Physician Decision|0
235277|NCT01483183|777367|P7|Overall Study|Physician Decision|2
235278|NCT01483183|777368|P6|Overall Study|Physician Decision|0
235279|NCT01483183|777369|P5|Overall Study|Physician Decision|0
235280|NCT01483183|777370|P4|Overall Study|Physician Decision|0
235281|NCT01483183|777371|P3|Overall Study|Physician Decision|0
235282|NCT01483183|777372|P2|Overall Study|Physician Decision|0
235283|NCT01483183|777373|P1|Overall Study|Physician Decision|0
235284|NCT01482910|777443|P2|Overall Study|Death|0
235285|NCT01482910|777444|P1|Overall Study|Death|1
235286|NCT01482910|777443|P2|Overall Study|Withdrawal by Subject|2
235287|NCT01482910|777444|P1|Overall Study|Withdrawal by Subject|7
235288|NCT01482910|777443|P2|Overall Study|Protocol Violation|1
235289|NCT01482910|777444|P1|Overall Study|Protocol Violation|1
235290|NCT01482910|777443|P2|Overall Study|Lost to Follow-up|1
235291|NCT01482910|777444|P1|Overall Study|Lost to Follow-up|0
235292|NCT01482910|777443|P2|Overall Study|Adverse Event|5
235293|NCT01482910|777444|P1|Overall Study|Adverse Event|6
235294|NCT01482884|777456|P2|Overall Study|Withdrawal by Subject|13
235295|NCT01482884|777457|P1|Overall Study|Withdrawal by Subject|8
235296|NCT01482884|777456|P2|Overall Study|Adverse Event|1
235297|NCT01482884|777457|P1|Overall Study|Adverse Event|2
235298|NCT01482884|777456|P2|Overall Study|Lack of Efficacy|1
235299|NCT01482884|777457|P1|Overall Study|Lack of Efficacy|0
235300|NCT01482884|777456|P2|Overall Study|Lost to Follow-up|2
235301|NCT01482884|777457|P1|Overall Study|Lost to Follow-up|2
235302|NCT01482884|777456|P2|Overall Study|Protocol Violation|0
235303|NCT01482884|777457|P1|Overall Study|Protocol Violation|1
235304|NCT01482884|777456|P2|Overall Study|Medical decision due to lack of efficacy|1
235305|NCT01482884|777457|P1|Overall Study|Medical decision due to lack of efficacy|0
235306|NCT01482819|777483|P1|Overall Study|Lost to Follow-up|2
235307|NCT01482767|777503|P2|Overall Study|Nurse error|0
235308|NCT01482767|777504|P1|Overall Study|Nurse error|1
235309|NCT01482767|777503|P2|Overall Study|Ineligible|5
235310|NCT01482767|777504|P1|Overall Study|Ineligible|0
235311|NCT01482767|777503|P2|Overall Study|Alternate HCV treatment|8
235312|NCT01482767|777504|P1|Overall Study|Alternate HCV treatment|7
235313|NCT01482767|777503|P2|Overall Study|Non-adherence to study requirements|7
235314|NCT01482767|777504|P1|Overall Study|Non-adherence to study requirements|4
235315|NCT01482767|777503|P2|Overall Study|Site closure|14
235316|NCT01482767|777504|P1|Overall Study|Site closure|22
235317|NCT01482767|777503|P2|Overall Study|Adverse Event|3
235318|NCT01482767|777504|P1|Overall Study|Adverse Event|0
235319|NCT01482767|777503|P2|Overall Study|Lost to Follow-up|6
235320|NCT01482767|777504|P1|Overall Study|Lost to Follow-up|12
235321|NCT01482767|777503|P2|Overall Study|Withdrawal by Subject|5
235322|NCT01482767|777504|P1|Overall Study|Withdrawal by Subject|7
235323|NCT01482767|777503|P2|Overall Study|Death|1
235324|NCT01482767|777504|P1|Overall Study|Death|1
235325|NCT01482429|777526|P2|Protocol|Protocol Violation|0
235326|NCT01482429|777527|P1|Protocol|Protocol Violation|275
235327|NCT01482429|777526|P2|Care Usual|Lost to Follow-up|1
235328|NCT01482429|777527|P1|Care Usual|Lost to Follow-up|0
235329|NCT01482429|777526|P2|Care Usual|Protocol Violation|172
235330|NCT01482429|777527|P1|Care Usual|Protocol Violation|0
235331|NCT01482312|777539|P3|Period 2, 90 Minutes of Wear|Unspecified|0
235332|NCT01482312|777540|P2|Period 2, 90 Minutes of Wear|Unspecified|0
235333|NCT01482312|777541|P1|Period 2, 90 Minutes of Wear|Unspecified|1
235334|NCT01482312|777539|P3|Period 1, 90 Minutes of Wear|Unspecified|0
235335|NCT01482312|777540|P2|Period 1, 90 Minutes of Wear|Unspecified|0
235336|NCT01482312|777541|P1|Period 1, 90 Minutes of Wear|Unspecified|1
235337|NCT01482221|777555|P3|Overall Study|Physician Decision|0
235338|NCT01482221|777556|P2|Overall Study|Physician Decision|1
235339|NCT01482221|777557|P1|Overall Study|Physician Decision|0
235340|NCT01482221|777555|P3|Overall Study|Incorrect randomization|0
235341|NCT01482221|777556|P2|Overall Study|Incorrect randomization|1
235342|NCT01482221|777557|P1|Overall Study|Incorrect randomization|0
235343|NCT01482221|777555|P3|Overall Study|Withdrawal by Subject|12
235344|NCT01482221|777556|P2|Overall Study|Withdrawal by Subject|7
235345|NCT01482221|777557|P1|Overall Study|Withdrawal by Subject|10
235346|NCT01482221|777555|P3|Overall Study|Adverse Event|3
235347|NCT01482221|777556|P2|Overall Study|Adverse Event|7
235348|NCT01482221|777557|P1|Overall Study|Adverse Event|1
235349|NCT01482221|777555|P3|Overall Study|Severe Non-Compliance to Protocol|1
235350|NCT01482221|777556|P2|Overall Study|Severe Non-Compliance to Protocol|0
235351|NCT01482221|777557|P1|Overall Study|Severe Non-Compliance to Protocol|1
235352|NCT01482221|777555|P3|Overall Study|Condition under Investigation Worsened|4
235353|NCT01482221|777556|P2|Overall Study|Condition under Investigation Worsened|2
235354|NCT01482221|777557|P1|Overall Study|Condition under Investigation Worsened|3
235355|NCT01482221|777555|P3|Overall Study|Study-Specific Withdrawal Criteria|1
235356|NCT01482221|777556|P2|Overall Study|Study-Specific Withdrawal Criteria|0
235357|NCT01482221|777557|P1|Overall Study|Study-Specific Withdrawal Criteria|2
235358|NCT01482221|777555|P3|Overall Study|Lost to Follow-up|1
235359|NCT01482221|777556|P2|Overall Study|Lost to Follow-up|2
235360|NCT01482221|777557|P1|Overall Study|Lost to Follow-up|3
235361|NCT01482221|777555|P3|Overall Study|Lack of Efficacy|1
235362|NCT01482221|777556|P2|Overall Study|Lack of Efficacy|0
235363|NCT01482221|777557|P1|Overall Study|Lack of Efficacy|1
235364|NCT01482065|777633|P2|Overall Study|Withdrawal by Subject|1
235365|NCT01482065|777634|P1|Overall Study|Withdrawal by Subject|0
235366|NCT01481896|777655|P1|Overall Study|Lost to Follow-up|12
235367|NCT01481324|777708|P3|Overall Study|Missing Data|2
235368|NCT01481324|777709|P2|Overall Study|Missing Data|2
235369|NCT01481324|777710|P1|Overall Study|Missing Data|0
235370|NCT01481116|777729|P3|Overall Study|Hypoglycemic Event|0
235371|NCT01481116|777730|P2|Overall Study|Hypoglycemic Event|0
235372|NCT01481116|777731|P1|Overall Study|Hypoglycemic Event|4
235373|NCT01481116|777729|P3|Overall Study|Death|0
235374|NCT01481116|777730|P2|Overall Study|Death|1
235375|NCT01481116|777731|P1|Overall Study|Death|2
235376|NCT01481116|777729|P3|Overall Study|Investigator's Discretion|0
235377|NCT01481116|777730|P2|Overall Study|Investigator's Discretion|0
235378|NCT01481116|777731|P1|Overall Study|Investigator's Discretion|2
235379|NCT01481116|777729|P3|Overall Study|Non-Compliant With Study Drug|1
235380|NCT01481116|777730|P2|Overall Study|Non-Compliant With Study Drug|1
235381|NCT01481116|777731|P1|Overall Study|Non-Compliant With Study Drug|0
235382|NCT01481116|777729|P3|Overall Study|Sponsor Decision|3
235383|NCT01481116|777730|P2|Overall Study|Sponsor Decision|1
235384|NCT01481116|777731|P1|Overall Study|Sponsor Decision|0
235385|NCT01481116|777729|P3|Overall Study|Investigator Decision|1
235386|NCT01481116|777730|P2|Overall Study|Investigator Decision|2
235387|NCT01481116|777731|P1|Overall Study|Investigator Decision|3
235388|NCT01481116|777729|P3|Overall Study|Participant Moved Out of Country|1
235389|NCT01481116|777730|P2|Overall Study|Participant Moved Out of Country|0
235390|NCT01481116|777731|P1|Overall Study|Participant Moved Out of Country|1
235391|NCT01481116|777729|P3|Overall Study|Participant Moved Out of Area|1
235392|NCT01481116|777730|P2|Overall Study|Participant Moved Out of Area|0
235393|NCT01481116|777731|P1|Overall Study|Participant Moved Out of Area|2
235394|NCT01481116|777729|P3|Overall Study|Participant Started Taking Glipizide|0
235395|NCT01481116|777730|P2|Overall Study|Participant Started Taking Glipizide|0
235396|NCT01481116|777731|P1|Overall Study|Participant Started Taking Glipizide|1
235397|NCT01481116|777729|P3|Overall Study|Unspecified|0
235398|NCT01481116|777730|P2|Overall Study|Unspecified|1
235399|NCT01481116|777731|P1|Overall Study|Unspecified|1
235400|NCT01481116|777729|P3|Overall Study|Contraindications|0
235401|NCT01481116|777730|P2|Overall Study|Contraindications|1
235402|NCT01481116|777731|P1|Overall Study|Contraindications|1
235403|NCT01481116|777729|P3|Overall Study|Lack of Efficacy|1
235404|NCT01481116|777730|P2|Overall Study|Lack of Efficacy|3
235405|NCT01481116|777731|P1|Overall Study|Lack of Efficacy|3
235406|NCT01481116|777729|P3|Overall Study|Pregnancy|1
235407|NCT01481116|777730|P2|Overall Study|Pregnancy|0
235408|NCT01481116|777731|P1|Overall Study|Pregnancy|0
235409|NCT01481116|777729|P3|Overall Study|Study Termination|713
235410|NCT01481116|777730|P2|Overall Study|Study Termination|729
235411|NCT01481116|777731|P1|Overall Study|Study Termination|730
235412|NCT01481116|777729|P3|Overall Study|Withdrawal by Subject|37
235413|NCT01481116|777730|P2|Overall Study|Withdrawal by Subject|33
235414|NCT01481116|777731|P1|Overall Study|Withdrawal by Subject|37
235415|NCT01481116|777729|P3|Overall Study|Lost to Follow-up|11
235416|NCT01481116|777730|P2|Overall Study|Lost to Follow-up|12
235417|NCT01481116|777731|P1|Overall Study|Lost to Follow-up|8
235418|NCT01481116|777729|P3|Overall Study|Major Protocol Deviation|1
235419|NCT01481116|777730|P2|Overall Study|Major Protocol Deviation|7
235420|NCT01481116|777731|P1|Overall Study|Major Protocol Deviation|3
235421|NCT01481116|777729|P3|Overall Study|Adverse Event|42
235422|NCT01481116|777730|P2|Overall Study|Adverse Event|26
235423|NCT01481116|777731|P1|Overall Study|Adverse Event|26
235424|NCT01480674|777757|P1|Overall Study|visit not done|10
235425|NCT01480674|777757|P1|Overall Study|Lost to Follow-up|2
235426|NCT01480674|777757|P1|Overall Study|Death|23
235427|NCT01480596|777771|P2|Overall Study|MG exacerbation or change in medication|2
235428|NCT01480596|777772|P1|Overall Study|MG exacerbation or change in medication|2
235429|NCT01480596|777771|P2|Overall Study|Adverse Event|0
235430|NCT01480596|777772|P1|Overall Study|Adverse Event|3
235431|NCT01480284|777820|P2|Overall Study|Physician Decision|0
235432|NCT01480284|777821|P1|Overall Study|Physician Decision|1
235433|NCT01480284|777820|P2|Overall Study|Lost to Follow-up|0
235434|NCT01480284|777821|P1|Overall Study|Lost to Follow-up|1
235435|NCT01480284|777820|P2|Overall Study|Study closed/terminated|0
235436|NCT01480284|777821|P1|Overall Study|Study closed/terminated|3
235437|NCT01480284|777820|P2|Overall Study|Adverse Event|0
235438|NCT01480284|777821|P1|Overall Study|Adverse Event|1
235439|NCT01480284|777820|P2|Overall Study|Withdrawal by Subject|0
235440|NCT01480284|777821|P1|Overall Study|Withdrawal by Subject|2
235441|NCT01480076|777904|P1|Overall Study|Not Specified|52
235442|NCT01480076|777904|P1|Overall Study|Investigator Decision|13
235443|NCT01480076|777904|P1|Overall Study|Lost to Follow-up|7
235444|NCT01480076|777904|P1|Overall Study|Withdrawal by Subject|105
235445|NCT01480076|777904|P1|Overall Study|Non-compliance With Study Protocol|15
235446|NCT01480076|777904|P1|Overall Study|Disease Progression|5
235447|NCT01480076|777904|P1|Overall Study|Death|2
235448|NCT01480076|777904|P1|Overall Study|Adverse Event|39
235449|NCT01480076|777904|P1|Overall Study|Run-in Failure|52
235450|NCT01479868|778023|P1|Overall Study|Initiation of new HCV Therapy|1
235451|NCT01479868|778023|P1|Overall Study|Sponsor's Decision|1
235452|NCT01479868|778023|P1|Overall Study|Withdrawal by Subject|1
235453|NCT01479868|778023|P1|Overall Study|Protocol Violation|1
235454|NCT01479868|778023|P1|Overall Study|Lost to Follow-up|4
235455|NCT01479868|778023|P1|Overall Study|Adverse Event|1
235456|NCT01479777|778038|P1|Overall Study|Physician Decision|2
235457|NCT01479764|778050|P2|Treated|Lost to Follow-up|2
235458|NCT01479764|778051|P1|Treated|Lost to Follow-up|0
235459|NCT01479764|778050|P2|Randomized|Withdrawal by Subject|0
235460|NCT01479764|778051|P1|Randomized|Withdrawal by Subject|1
235461|NCT01479764|778050|P2|Randomized|Adverse Event|1
235462|NCT01479764|778051|P1|Randomized|Adverse Event|1
235463|NCT01479621|778074|P7|Treatment Period|Met stopping criteria|6
235464|NCT01479621|778075|P6|Treatment Period|Met stopping criteria|20
235465|NCT01479621|778076|P5|Treatment Period|Met stopping criteria|9
235466|NCT01479621|778077|P4|Treatment Period|Met stopping criteria|4
235467|NCT01479621|778078|P3|Treatment Period|Met stopping criteria|7
235468|NCT01479621|778079|P2|Treatment Period|Met stopping criteria|8
235469|NCT01479621|778080|P1|Treatment Period|Met stopping criteria|0
235470|NCT01479621|778074|P7|Treatment Period|Lost to Follow-up|1
235471|NCT01479621|778075|P6|Treatment Period|Lost to Follow-up|2
235472|NCT01479621|778076|P5|Treatment Period|Lost to Follow-up|2
235473|NCT01479621|778077|P4|Treatment Period|Lost to Follow-up|0
235474|NCT01479621|778078|P3|Treatment Period|Lost to Follow-up|1
235475|NCT01479621|778079|P2|Treatment Period|Lost to Follow-up|0
235476|NCT01479621|778080|P1|Treatment Period|Lost to Follow-up|0
235477|NCT01479621|778074|P7|Treatment Period|Sponsor request subject to be withdrawn|3
235478|NCT01479621|778075|P6|Treatment Period|Sponsor request subject to be withdrawn|1
235479|NCT01479621|778076|P5|Treatment Period|Sponsor request subject to be withdrawn|1
235480|NCT01479621|778077|P4|Treatment Period|Sponsor request subject to be withdrawn|1
235481|NCT01479621|778078|P3|Treatment Period|Sponsor request subject to be withdrawn|3
235482|NCT01479621|778079|P2|Treatment Period|Sponsor request subject to be withdrawn|2
235483|NCT01479621|778080|P1|Treatment Period|Sponsor request subject to be withdrawn|0
235484|NCT01479621|778074|P7|Treatment Period|Pregnancy|0
235485|NCT01479621|778075|P6|Treatment Period|Pregnancy|0
235486|NCT01479621|778076|P5|Treatment Period|Pregnancy|0
235487|NCT01479621|778077|P4|Treatment Period|Pregnancy|0
235488|NCT01479621|778078|P3|Treatment Period|Pregnancy|2
235489|NCT01479621|778079|P2|Treatment Period|Pregnancy|0
235490|NCT01479621|778080|P1|Treatment Period|Pregnancy|0
235491|NCT01479621|778074|P7|Treatment Period|Protocol Violation|6
235492|NCT01479621|778075|P6|Treatment Period|Protocol Violation|10
235493|NCT01479621|778076|P5|Treatment Period|Protocol Violation|2
235494|NCT01479621|778077|P4|Treatment Period|Protocol Violation|5
235495|NCT01479621|778078|P3|Treatment Period|Protocol Violation|6
235496|NCT01479621|778079|P2|Treatment Period|Protocol Violation|9
235497|NCT01479621|778080|P1|Treatment Period|Protocol Violation|0
235498|NCT01479621|778074|P7|Treatment Period|Non-compliance to study drug|1
235499|NCT01479621|778075|P6|Treatment Period|Non-compliance to study drug|0
235500|NCT01479621|778076|P5|Treatment Period|Non-compliance to study drug|0
235501|NCT01479621|778077|P4|Treatment Period|Non-compliance to study drug|0
235502|NCT01479621|778078|P3|Treatment Period|Non-compliance to study drug|0
235503|NCT01479621|778079|P2|Treatment Period|Non-compliance to study drug|1
235504|NCT01479621|778080|P1|Treatment Period|Non-compliance to study drug|0
235505|NCT01479621|778074|P7|Treatment Period|Physician Decision|0
235506|NCT01479621|778075|P6|Treatment Period|Physician Decision|1
235507|NCT01479621|778076|P5|Treatment Period|Physician Decision|1
235508|NCT01479621|778077|P4|Treatment Period|Physician Decision|0
235509|NCT01479621|778078|P3|Treatment Period|Physician Decision|0
235510|NCT01479621|778079|P2|Treatment Period|Physician Decision|0
235511|NCT01479621|778080|P1|Treatment Period|Physician Decision|0
235512|NCT01479621|778074|P7|Treatment Period|Withdrawal by Subject|1
235513|NCT01479621|778075|P6|Treatment Period|Withdrawal by Subject|5
235514|NCT01479621|778076|P5|Treatment Period|Withdrawal by Subject|5
235515|NCT01479621|778077|P4|Treatment Period|Withdrawal by Subject|2
235516|NCT01479621|778078|P3|Treatment Period|Withdrawal by Subject|2
235517|NCT01479621|778079|P2|Treatment Period|Withdrawal by Subject|4
235518|NCT01479621|778080|P1|Treatment Period|Withdrawal by Subject|0
235519|NCT01479621|778074|P7|Treatment Period|Adverse Event|2
235520|NCT01479621|778075|P6|Treatment Period|Adverse Event|2
235521|NCT01479621|778076|P5|Treatment Period|Adverse Event|1
235522|NCT01479621|778077|P4|Treatment Period|Adverse Event|0
235523|NCT01479621|778078|P3|Treatment Period|Adverse Event|0
235524|NCT01479621|778079|P2|Treatment Period|Adverse Event|0
235525|NCT01479621|778080|P1|Treatment Period|Adverse Event|0
235526|NCT01479621|778074|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
235527|NCT01479621|778075|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
235528|NCT01479621|778076|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
235529|NCT01479621|778077|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
235530|NCT01479621|778078|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
235531|NCT01479621|778079|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
235532|NCT01479621|778080|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
235533|NCT01479621|778074|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
235534|NCT01479621|778075|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
235535|NCT01479621|778076|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
235536|NCT01479621|778077|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
235537|NCT01479621|778078|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
235538|NCT01479621|778079|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
235539|NCT01479621|778080|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
235540|NCT01479621|778074|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
235541|NCT01479621|778075|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
235542|NCT01479621|778076|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
235543|NCT01479621|778077|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
235544|NCT01479621|778078|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
235628|NCT01478360|778443|P2|Overall Study|Lost to Follow-up|0
235545|NCT01479621|778079|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
235546|NCT01479621|778080|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
235547|NCT01479621|778074|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
235548|NCT01479621|778075|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
235549|NCT01479621|778076|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
235550|NCT01479621|778077|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
235551|NCT01479621|778078|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
235552|NCT01479621|778079|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
235553|NCT01479621|778080|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
235554|NCT01479621|778074|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
235555|NCT01479621|778075|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
235556|NCT01479621|778076|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
235557|NCT01479621|778077|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
235558|NCT01479621|778078|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
235559|NCT01479621|778079|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
235560|NCT01479621|778080|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
235561|NCT01479595|778168|P2|Overall Study|Adverse Event|1
235562|NCT01479595|778169|P1|Overall Study|Adverse Event|2
235563|NCT01479595|778168|P2|Overall Study|Protocol deviation|1
235564|NCT01479595|778169|P1|Overall Study|Protocol deviation|0
235565|NCT01479530|778214|P2|Overall Study|Withdrawal of Consent|2
235566|NCT01479530|778215|P1|Overall Study|Withdrawal of Consent|3
235567|NCT01479530|778214|P2|Overall Study|Protocol Violation|3
235568|NCT01479530|778215|P1|Overall Study|Protocol Violation|2
235569|NCT01479530|778214|P2|Overall Study|Lack of Efficacy|1
235570|NCT01479530|778215|P1|Overall Study|Lack of Efficacy|0
235571|NCT01479530|778214|P2|Overall Study|Adverse Event|6
235572|NCT01479530|778215|P1|Overall Study|Adverse Event|5
235573|NCT01479374|778252|P3|Overall Study|Other|5
235574|NCT01479374|778253|P2|Overall Study|Other|4
235575|NCT01479374|778254|P1|Overall Study|Other|0
235576|NCT01479374|778252|P3|Overall Study|Decision Unrelated to Adverse Event|0
235577|NCT01479374|778253|P2|Overall Study|Decision Unrelated to Adverse Event|1
235578|NCT01479374|778254|P1|Overall Study|Decision Unrelated to Adverse Event|0
235579|NCT01479374|778252|P3|Overall Study|Lost to Follow-up|0
235580|NCT01479374|778253|P2|Overall Study|Lost to Follow-up|2
235581|NCT01479374|778254|P1|Overall Study|Lost to Follow-up|1
235582|NCT01479374|778252|P3|Overall Study|Adverse Event|0
235583|NCT01479374|778253|P2|Overall Study|Adverse Event|1
235584|NCT01479374|778254|P1|Overall Study|Adverse Event|2
235585|NCT01478971|778319|P1|Peginesatide Treatment Period|Other|4
235586|NCT01478971|778319|P1|Peginesatide Treatment Period|Lost to Follow-up|4
235587|NCT01478971|778319|P1|Peginesatide Treatment Period|Death|4
235588|NCT01478971|778319|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
235589|NCT01478971|778319|P1|Peginesatide Treatment Period|Adverse Event|1
235590|NCT01478971|778319|P1|Standard of Care Period|Other|4
235591|NCT01478971|778319|P1|Standard of Care Period|Lost to Follow-up|9
235592|NCT01478971|778319|P1|Standard of Care Period|Death|8
235593|NCT01478971|778319|P1|Standard of Care Period|Withdrawal by Subject|3
235594|NCT01478971|778319|P1|Standard of Care Period|Adverse Event|1
235595|NCT01478958|778336|P3|Overall Study|Unable to comply|2
235596|NCT01478958|778337|P2|Overall Study|Unable to comply|0
235597|NCT01478958|778338|P1|Overall Study|Unable to comply|0
235598|NCT01478958|778336|P3|Overall Study|Re-located|0
235599|NCT01478958|778337|P2|Overall Study|Re-located|1
235600|NCT01478958|778338|P1|Overall Study|Re-located|0
235601|NCT01478958|778336|P3|Overall Study|Weight loss|0
235602|NCT01478958|778337|P2|Overall Study|Weight loss|0
235603|NCT01478958|778338|P1|Overall Study|Weight loss|1
235604|NCT01478958|778336|P3|Overall Study|Withdrawal by Subject|1
235605|NCT01478958|778337|P2|Overall Study|Withdrawal by Subject|1
235606|NCT01478958|778338|P1|Overall Study|Withdrawal by Subject|1
235607|NCT01478828|778346|P1|Overall Study|Adverse Event|1
235608|NCT01478620|778351|P1|Overall Study|Lost to Follow-up|6
235609|NCT01478594|778357|P2|Overall Study|Study Closed by Sponsor|5
235610|NCT01478594|778358|P1|Overall Study|Study Closed by Sponsor|8
235611|NCT01478594|778357|P2|Overall Study|Withdrawal by Subject|3
235612|NCT01478594|778358|P1|Overall Study|Withdrawal by Subject|9
235613|NCT01478594|778357|P2|Overall Study|Lost to Follow-up|1
235614|NCT01478594|778358|P1|Overall Study|Lost to Follow-up|3
235615|NCT01478594|778357|P2|Overall Study|Death|18
235616|NCT01478594|778358|P1|Overall Study|Death|45
235617|NCT01478594|778357|P2|Overall Study|Randomized but Never Received Study Drug|1
235618|NCT01478594|778358|P1|Overall Study|Randomized but Never Received Study Drug|0
235619|NCT01478373|778430|P1|Survival Phase|Progressive Disease|27
235620|NCT01478373|778430|P1|Survival Phase|crossover to another study|2
235621|NCT01478373|778430|P1|Survival Phase|Protocol Violation|1
235622|NCT01478373|778430|P1|Survival Phase|Adverse Event|8
235623|NCT01478373|778430|P1|Treatment Phase|Protocol Violation|1
235624|NCT01478360|778443|P2|Overall Study|Administrative problems|2
235625|NCT01478360|778444|P1|Overall Study|Administrative problems|1
235626|NCT01478360|778443|P2|Overall Study|Adverse Event|1
235627|NCT01478360|778444|P1|Overall Study|Adverse Event|0
235629|NCT01478360|778444|P1|Overall Study|Lost to Follow-up|1
235630|NCT01478347|778450|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
235631|NCT01478347|778450|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
235632|NCT01478347|778450|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
235633|NCT01478113|778468|P2|Overall Study|Physician Decision|0
235634|NCT01478113|778469|P1|Overall Study|Physician Decision|1
235635|NCT01478113|778468|P2|Overall Study|Withdrawal by Subject|1
235636|NCT01478113|778469|P1|Overall Study|Withdrawal by Subject|0
235637|NCT01478087|778487|P1|Overall Study|due to sponsor closing study|1
235638|NCT01478048|778494|P2|Overall Study|Physician Decision|0
235639|NCT01478048|778495|P1|Overall Study|Physician Decision|1
235640|NCT01478048|778494|P2|Overall Study|Not reported|0
235641|NCT01478048|778495|P1|Overall Study|Not reported|1
235642|NCT01478048|778494|P2|Overall Study|no longer meets study criteria|0
235643|NCT01478048|778495|P1|Overall Study|no longer meets study criteria|1
235644|NCT01478048|778494|P2|Overall Study|poor/non-compliance|1
235645|NCT01478048|778495|P1|Overall Study|poor/non-compliance|1
235646|NCT01478048|778494|P2|Overall Study|non-specified|3
235647|NCT01478048|778495|P1|Overall Study|non-specified|1
235648|NCT01478048|778494|P2|Overall Study|Withdrawal by Subject|5
235649|NCT01478048|778495|P1|Overall Study|Withdrawal by Subject|2
235650|NCT01478048|778494|P2|Overall Study|subject request to discontinue treatment|5
235651|NCT01478048|778495|P1|Overall Study|subject request to discontinue treatment|1
235652|NCT01478048|778494|P2|Overall Study|Adverse Event|9
235653|NCT01478048|778495|P1|Overall Study|Adverse Event|1
235654|NCT01478048|778494|P2|Overall Study|study drug toxicity|13
235655|NCT01478048|778495|P1|Overall Study|study drug toxicity|8
235656|NCT01478048|778494|P2|Overall Study|Disease Progression|32
235657|NCT01478048|778495|P1|Overall Study|Disease Progression|46
235658|NCT01477892|778524|P2|Overall Study|Withdrawal by Subject|2
235659|NCT01477892|778525|P1|Overall Study|Withdrawal by Subject|0
235660|NCT01477853|778536|P3|Phase B|Study terminated by sponsor|11
235661|NCT01477853|778537|P2|Phase B|Study terminated by sponsor|10
235662|NCT01477853|778538|P1|Phase B|Study terminated by sponsor|12
235663|NCT01477853|778536|P3|Phase B|Lost to Follow-up|0
235664|NCT01477853|778537|P2|Phase B|Lost to Follow-up|1
235665|NCT01477853|778538|P1|Phase B|Lost to Follow-up|0
235666|NCT01477853|778536|P3|Phase A|Study terminated by sponsor|39
235667|NCT01477853|778537|P2|Phase A|Study terminated by sponsor|40
235668|NCT01477853|778538|P1|Phase A|Study terminated by sponsor|37
235669|NCT01477853|778536|P3|Phase A|Physician Decision|1
235670|NCT01477853|778537|P2|Phase A|Physician Decision|0
235671|NCT01477853|778538|P1|Phase A|Physician Decision|1
235672|NCT01477853|778536|P3|Phase A|Lost to Follow-up|2
235673|NCT01477853|778537|P2|Phase A|Lost to Follow-up|3
235674|NCT01477853|778538|P1|Phase A|Lost to Follow-up|4
235675|NCT01477853|778536|P3|Phase A|Adverse Event|2
235676|NCT01477853|778537|P2|Phase A|Adverse Event|2
235677|NCT01477853|778538|P1|Phase A|Adverse Event|1
235678|NCT01477749|778605|P1|Overall Study|Physician Decision|4
235679|NCT01477333|778713|P1|Overall Study|Clinical Deterioration|1
235680|NCT01477333|778713|P1|Overall Study|Withdrawal by Subject|1
235681|NCT01477333|778713|P1|Overall Study|Adverse Event|1
235682|NCT01475734|778731|P2|Overall Study|Physician Decision|1
235683|NCT01475734|778732|P1|Overall Study|Physician Decision|0
235684|NCT01475734|778731|P2|Overall Study|Protocol Violation|0
235685|NCT01475734|778732|P1|Overall Study|Protocol Violation|1
235686|NCT01475734|778731|P2|Overall Study|Withdrawal by Subject|0
235687|NCT01475734|778732|P1|Overall Study|Withdrawal by Subject|1
235688|NCT01475721|778760|P2|Overall Study|Withdrawal by Subject|8
235689|NCT01475721|778761|P1|Overall Study|Withdrawal by Subject|8
235690|NCT01475721|778760|P2|Overall Study|Death|6
235691|NCT01475721|778761|P1|Overall Study|Death|3
235692|NCT01476722|778791|P1|Overall Study|Adverse Event|1
235693|NCT01476696|778798|P3|Overall Study|Withdrawal by Subject|0
235694|NCT01476696|778799|P2|Overall Study|Withdrawal by Subject|0
235695|NCT01476696|778800|P1|Overall Study|Withdrawal by Subject|1
235696|NCT01476696|778798|P3|Overall Study|Sponsor decision|0
235697|NCT01476696|778799|P2|Overall Study|Sponsor decision|1
235698|NCT01476696|778800|P1|Overall Study|Sponsor decision|2
235699|NCT01476475|778816|P2|Overall Study|Other reasons|2
235700|NCT01476475|778817|P1|Overall Study|Other reasons|4
235701|NCT01476475|778816|P2|Overall Study|Poor compliance to protocol|1
235702|NCT01476475|778817|P1|Overall Study|Poor compliance to protocol|1
235703|NCT01476475|778816|P2|Overall Study|Adverse Event|0
235704|NCT01476475|778817|P1|Overall Study|Adverse Event|6
235705|NCT01475851|779246|P2|Overall Study|Protocol defined stopping criteria|0
235706|NCT01475851|779247|P1|Overall Study|Protocol defined stopping criteria|1
235707|NCT01475838|779275|P2|Extension Phase|Participant Noncompliance|0
235708|NCT01475838|779276|P1|Extension Phase|Participant Noncompliance|1
235709|NCT01475838|779275|P2|Randomized Phase|Protocol Violation|4
235710|NCT01475838|779276|P1|Randomized Phase|Protocol Violation|9
235711|NCT01475838|779275|P2|Randomized Phase|Participant Noncompliance|5
235712|NCT01475838|779276|P1|Randomized Phase|Participant Noncompliance|1
235713|NCT01475838|779275|P2|Randomized Phase|Lost to Follow-up|4
235714|NCT01475838|779276|P1|Randomized Phase|Lost to Follow-up|3
235715|NCT01475838|779275|P2|Randomized Phase|Withdrew Consent|14
235716|NCT01475838|779276|P1|Randomized Phase|Withdrew Consent|10
235717|NCT01475838|779275|P2|Randomized Phase|Investigators Discretion|2
235718|NCT01475838|779276|P1|Randomized Phase|Investigators Discretion|1
235719|NCT01475838|779275|P2|Randomized Phase|Pregnancy|1
235720|NCT01475838|779276|P1|Randomized Phase|Pregnancy|0
235721|NCT01475838|779275|P2|Randomized Phase|Adverse Event|1
235722|NCT01475838|779276|P1|Randomized Phase|Adverse Event|6
235723|NCT01475838|779275|P2|Randomized Phase|Randomized but Not Treated|5
235724|NCT01475838|779276|P1|Randomized Phase|Randomized but Not Treated|0
235725|NCT01475487|779291|P2|Overall Study|had to leave early for personal reasons|1
235726|NCT01475487|779292|P1|Overall Study|had to leave early for personal reasons|2
235727|NCT01475474|779304|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
235728|NCT01475474|779304|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
235729|NCT01475461|779315|P7|Treatment Period|Adverse Event|0
235730|NCT01475461|779316|P6|Treatment Period|Adverse Event|0
235731|NCT01475461|779317|P5|Treatment Period|Adverse Event|0
235732|NCT01475461|779318|P4|Treatment Period|Adverse Event|1
235733|NCT01475461|779319|P3|Treatment Period|Adverse Event|0
235734|NCT01475461|779320|P2|Treatment Period|Adverse Event|0
235735|NCT01475461|779321|P1|Treatment Period|Adverse Event|0
235736|NCT01475461|779315|P7|Treatment Period|Medication Error|0
235737|NCT01475461|779316|P6|Treatment Period|Medication Error|0
235738|NCT01475461|779317|P5|Treatment Period|Medication Error|0
235739|NCT01475461|779318|P4|Treatment Period|Medication Error|1
235740|NCT01475461|779319|P3|Treatment Period|Medication Error|0
235741|NCT01475461|779320|P2|Treatment Period|Medication Error|0
235742|NCT01475461|779321|P1|Treatment Period|Medication Error|0
235743|NCT01475461|779315|P7|Treatment Period|Lack of Efficacy|0
235744|NCT01475461|779316|P6|Treatment Period|Lack of Efficacy|1
235745|NCT01475461|779317|P5|Treatment Period|Lack of Efficacy|1
235746|NCT01475461|779318|P4|Treatment Period|Lack of Efficacy|2
235747|NCT01475461|779319|P3|Treatment Period|Lack of Efficacy|0
235748|NCT01475461|779320|P2|Treatment Period|Lack of Efficacy|2
235749|NCT01475461|779321|P1|Treatment Period|Lack of Efficacy|0
235750|NCT01475461|779315|P7|Treatment Period|Protocol Violation|1
235751|NCT01475461|779316|P6|Treatment Period|Protocol Violation|0
235752|NCT01475461|779317|P5|Treatment Period|Protocol Violation|0
235753|NCT01475461|779318|P4|Treatment Period|Protocol Violation|0
235754|NCT01475461|779319|P3|Treatment Period|Protocol Violation|0
235755|NCT01475461|779320|P2|Treatment Period|Protocol Violation|1
235756|NCT01475461|779321|P1|Treatment Period|Protocol Violation|0
235757|NCT01475461|779315|P7|Treatment Period|Unspecified|0
235758|NCT01475461|779316|P6|Treatment Period|Unspecified|0
235759|NCT01475461|779317|P5|Treatment Period|Unspecified|0
235760|NCT01475461|779318|P4|Treatment Period|Unspecified|0
235761|NCT01475461|779319|P3|Treatment Period|Unspecified|0
235762|NCT01475461|779320|P2|Treatment Period|Unspecified|1
235763|NCT01475461|779321|P1|Treatment Period|Unspecified|0
235764|NCT01475461|779315|P7|Treatment Period|Withdrawal by Subject|0
235765|NCT01475461|779316|P6|Treatment Period|Withdrawal by Subject|2
235766|NCT01475461|779317|P5|Treatment Period|Withdrawal by Subject|2
235767|NCT01475461|779318|P4|Treatment Period|Withdrawal by Subject|0
235768|NCT01475461|779319|P3|Treatment Period|Withdrawal by Subject|2
235769|NCT01475461|779320|P2|Treatment Period|Withdrawal by Subject|2
235770|NCT01475461|779321|P1|Treatment Period|Withdrawal by Subject|0
235771|NCT01475461|779315|P7|Treatment Period|Lost to Follow-up|1
235772|NCT01475461|779316|P6|Treatment Period|Lost to Follow-up|2
235773|NCT01475461|779317|P5|Treatment Period|Lost to Follow-up|1
235774|NCT01475461|779318|P4|Treatment Period|Lost to Follow-up|3
235775|NCT01475461|779319|P3|Treatment Period|Lost to Follow-up|2
235776|NCT01475461|779320|P2|Treatment Period|Lost to Follow-up|3
235777|NCT01475461|779321|P1|Treatment Period|Lost to Follow-up|0
235778|NCT01475461|779315|P7|Treatment Period|Death|0
235779|NCT01475461|779316|P6|Treatment Period|Death|0
235780|NCT01475461|779317|P5|Treatment Period|Death|0
235781|NCT01475461|779318|P4|Treatment Period|Death|1
235782|NCT01475461|779319|P3|Treatment Period|Death|0
235783|NCT01475461|779320|P2|Treatment Period|Death|0
235784|NCT01475461|779321|P1|Treatment Period|Death|0
235785|NCT01475461|779315|P7|Run-in Period|Protocol Violation|0
235786|NCT01475461|779316|P6|Run-in Period|Protocol Violation|0
235787|NCT01475461|779317|P5|Run-in Period|Protocol Violation|0
235788|NCT01475461|779318|P4|Run-in Period|Protocol Violation|0
235789|NCT01475461|779319|P3|Run-in Period|Protocol Violation|0
235790|NCT01475461|779320|P2|Run-in Period|Protocol Violation|0
235791|NCT01475461|779321|P1|Run-in Period|Protocol Violation|4
235792|NCT01475461|779315|P7|Run-in Period|Unspecified|0
235793|NCT01475461|779316|P6|Run-in Period|Unspecified|0
235794|NCT01475461|779317|P5|Run-in Period|Unspecified|0
235795|NCT01475461|779318|P4|Run-in Period|Unspecified|0
235796|NCT01475461|779319|P3|Run-in Period|Unspecified|0
235797|NCT01475461|779320|P2|Run-in Period|Unspecified|0
235798|NCT01475461|779321|P1|Run-in Period|Unspecified|3
235799|NCT01475461|779315|P7|Run-in Period|Withdrawal by Subject|0
235800|NCT01475461|779316|P6|Run-in Period|Withdrawal by Subject|0
235801|NCT01475461|779317|P5|Run-in Period|Withdrawal by Subject|0
235802|NCT01475461|779318|P4|Run-in Period|Withdrawal by Subject|0
235803|NCT01475461|779319|P3|Run-in Period|Withdrawal by Subject|0
235804|NCT01475461|779320|P2|Run-in Period|Withdrawal by Subject|0
235805|NCT01475461|779321|P1|Run-in Period|Withdrawal by Subject|11
235806|NCT01475461|779315|P7|Run-in Period|Lost to Follow-up|0
235807|NCT01475461|779316|P6|Run-in Period|Lost to Follow-up|0
235808|NCT01475461|779317|P5|Run-in Period|Lost to Follow-up|0
235809|NCT01475461|779318|P4|Run-in Period|Lost to Follow-up|0
235810|NCT01475461|779319|P3|Run-in Period|Lost to Follow-up|0
235811|NCT01475461|779320|P2|Run-in Period|Lost to Follow-up|0
235812|NCT01475461|779321|P1|Run-in Period|Lost to Follow-up|7
235813|NCT01475461|779315|P7|Run-in Period|Not meet eligibility criteria|0
235814|NCT01475461|779316|P6|Run-in Period|Not meet eligibility criteria|0
235815|NCT01475461|779317|P5|Run-in Period|Not meet eligibility criteria|0
235816|NCT01475461|779318|P4|Run-in Period|Not meet eligibility criteria|0
235817|NCT01475461|779319|P3|Run-in Period|Not meet eligibility criteria|0
235818|NCT01475461|779320|P2|Run-in Period|Not meet eligibility criteria|0
235819|NCT01475461|779321|P1|Run-in Period|Not meet eligibility criteria|16
235820|NCT01475253|779402|P4|Randomized, Blinded Study|Lost to Follow-up|0
235821|NCT01475253|779403|P3|Randomized, Blinded Study|Lost to Follow-up|0
235822|NCT01475253|779404|P2|Randomized, Blinded Study|Lost to Follow-up|0
235823|NCT01475253|779405|P1|Randomized, Blinded Study|Lost to Follow-up|1
235824|NCT01475253|779402|P4|Randomized, Blinded Study|Withdrawal by Subject|0
235825|NCT01475253|779403|P3|Randomized, Blinded Study|Withdrawal by Subject|0
235826|NCT01475253|779404|P2|Randomized, Blinded Study|Withdrawal by Subject|1
235827|NCT01475253|779405|P1|Randomized, Blinded Study|Withdrawal by Subject|1
235828|NCT01475214|779434|P3|Overall Study|Withdrawal by Subject|1
235829|NCT01475214|779435|P2|Overall Study|Withdrawal by Subject|4
235830|NCT01475214|779436|P1|Overall Study|Withdrawal by Subject|2
235831|NCT01475214|779434|P3|Overall Study|Physician Decision|0
235832|NCT01475214|779435|P2|Overall Study|Physician Decision|0
235833|NCT01475214|779436|P1|Overall Study|Physician Decision|2
235834|NCT01475214|779434|P3|Overall Study|Lost to Follow-up|1
235835|NCT01475214|779435|P2|Overall Study|Lost to Follow-up|0
235836|NCT01475214|779436|P1|Overall Study|Lost to Follow-up|1
235837|NCT01475097|779461|P2|Overall Study|Protocol Violation|1
235838|NCT01475097|779462|P1|Overall Study|Protocol Violation|1
235839|NCT01475071|779470|P1|Overall Study|Lost to Follow-up|1
235840|NCT01475071|779470|P1|Overall Study|Withdrawal by Subject|6
235841|NCT01475071|779470|P1|Overall Study|Physician Decision|1
235842|NCT01474993|779480|P2|Overall Study|Adverse Event|1
235843|NCT01474993|779481|P1|Overall Study|Adverse Event|0
235844|NCT01474993|779480|P2|Overall Study|Lost to Follow-up|2
235845|NCT01474993|779481|P1|Overall Study|Lost to Follow-up|1
235846|NCT01474876|779519|P3|Overall Study|Investigator's decision and pt request|0
235847|NCT01474876|779520|P2|Overall Study|Investigator's decision and pt request|0
235848|NCT01474876|779521|P1|Overall Study|Investigator's decision and pt request|1
235849|NCT01474876|779519|P3|Overall Study|Patient's request|0
235850|NCT01474876|779520|P2|Overall Study|Patient's request|5
235851|NCT01474876|779521|P1|Overall Study|Patient's request|19
235852|NCT01474876|779519|P3|Overall Study|Investigator's decision|0
235853|NCT01474876|779520|P2|Overall Study|Investigator's decision|6
235854|NCT01474876|779521|P1|Overall Study|Investigator's decision|28
235855|NCT01474876|779519|P3|Overall Study|Lost to Follow-up|0
235856|NCT01474876|779520|P2|Overall Study|Lost to Follow-up|4
235857|NCT01474876|779521|P1|Overall Study|Lost to Follow-up|5
235858|NCT01474876|779519|P3|Overall Study|Serious Adverse Event|0
235859|NCT01474876|779520|P2|Overall Study|Serious Adverse Event|3
235860|NCT01474876|779521|P1|Overall Study|Serious Adverse Event|2
235861|NCT01474876|779519|P3|Overall Study|Adverse Event|0
235862|NCT01474876|779520|P2|Overall Study|Adverse Event|5
235863|NCT01474876|779521|P1|Overall Study|Adverse Event|11
235864|NCT01474772|779567|P2|Follow-up|AE not Related to Study Drug|1
235865|NCT01474772|779568|P1|Follow-up|AE not Related to Study Drug|0
235866|NCT01474772|779567|P2|Period 2|Reason not Specified|2
235867|NCT01474772|779568|P1|Period 2|Reason not Specified|0
235868|NCT01474772|779567|P2|Period 2|Lost to Follow-up|1
235869|NCT01474772|779568|P1|Period 2|Lost to Follow-up|1
235870|NCT01474772|779567|P2|Period 2|Withdrawal by Subject|4
235871|NCT01474772|779568|P1|Period 2|Withdrawal by Subject|3
235872|NCT01474772|779567|P2|Period 2|Lack of Efficacy|0
235873|NCT01474772|779568|P1|Period 2|Lack of Efficacy|1
235874|NCT01474772|779567|P2|Period 2|AE not Related to Study Drug|1
235875|NCT01474772|779568|P1|Period 2|AE not Related to Study Drug|4
235876|NCT01474772|779567|P2|Period 2|AE Related to Study Drug|1
235877|NCT01474772|779568|P1|Period 2|AE Related to Study Drug|0
235878|NCT01474772|779567|P2|Period 2|Death|1
235879|NCT01474772|779568|P1|Period 2|Death|0
235880|NCT01474772|779567|P2|Washout|Reason not Specified|1
235881|NCT01474772|779568|P1|Washout|Reason not Specified|0
235882|NCT01474772|779567|P2|Washout|Lost to Follow-up|1
235883|NCT01474772|779568|P1|Washout|Lost to Follow-up|0
235884|NCT01474772|779567|P2|Washout|Withdrawal by Subject|0
235885|NCT01474772|779568|P1|Washout|Withdrawal by Subject|1
235886|NCT01474772|779567|P2|Washout|AE not Related to Study Drug|0
235887|NCT01474772|779568|P1|Washout|AE not Related to Study Drug|2
235888|NCT01474772|779567|P2|Period 1|Reason not Specified|1
235889|NCT01474772|779568|P1|Period 1|Reason not Specified|1
235890|NCT01474772|779567|P2|Period 1|Lost to Follow-up|0
235891|NCT01474772|779568|P1|Period 1|Lost to Follow-up|1
235892|NCT01474772|779567|P2|Period 1|Withdrawal by Subject|1
235893|NCT01474772|779568|P1|Period 1|Withdrawal by Subject|3
235894|NCT01474772|779567|P2|Period 1|AE not Related to Study Drug|0
235895|NCT01474772|779568|P1|Period 1|AE not Related to Study Drug|1
235896|NCT01474772|779567|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
235897|NCT01474772|779568|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
235898|NCT01474681|779618|P4|Overall Study|Death|6
235899|NCT01474681|779619|P3|Overall Study|Death|2
235900|NCT01474681|779620|P2|Overall Study|Death|3
235901|NCT01474681|779621|P1|Overall Study|Death|0
235902|NCT01474551|779663|P1|Overall Study|Death|1
235903|NCT01474538|779669|P2|Treatment Period 2|Protocol Violation|0
235904|NCT01474538|779670|P1|Treatment Period 2|Protocol Violation|1
235905|NCT01474538|779669|P2|Treatment Period 2|Physician Decision|1
235906|NCT01474538|779670|P1|Treatment Period 2|Physician Decision|0
235907|NCT01474538|779669|P2|Treatment Period 2|Sponsor decision|0
235908|NCT01474538|779670|P1|Treatment Period 2|Sponsor decision|1
235909|NCT01474538|779669|P2|Treatment Period 2|Withdrawal by Subject|0
235910|NCT01474538|779670|P1|Treatment Period 2|Withdrawal by Subject|2
235911|NCT01474538|779669|P2|Treatment Period 2|Adverse Event|1
235912|NCT01474538|779670|P1|Treatment Period 2|Adverse Event|1
235913|NCT01474538|779669|P2|Treatment Period 2|Death|0
235914|NCT01474538|779670|P1|Treatment Period 2|Death|1
235915|NCT01474538|779669|P2|Treatment Period 1|Protocol Violation|1
235916|NCT01474538|779670|P1|Treatment Period 1|Protocol Violation|0
235917|NCT01474538|779669|P2|Treatment Period 1|Withdrawal by Subject|3
235918|NCT01474538|779670|P1|Treatment Period 1|Withdrawal by Subject|1
235919|NCT01474538|779669|P2|Treatment Period 1|Physician Decision|0
235920|NCT01474538|779670|P1|Treatment Period 1|Physician Decision|1
235921|NCT01474538|779669|P2|Treatment Period 1|Death|0
235922|NCT01474538|779670|P1|Treatment Period 1|Death|1
235923|NCT01474512|779687|P10|Maintenance Period|Treated but Discontinued in Induction|0
235924|NCT01474512|779688|P9|Maintenance Period|Treated but Discontinued in Induction|0
235925|NCT01474512|779689|P8|Maintenance Period|Treated but Discontinued in Induction|0
235926|NCT01474512|779690|P7|Maintenance Period|Treated but Discontinued in Induction|0
235927|NCT01474512|779691|P6|Maintenance Period|Treated but Discontinued in Induction|0
235928|NCT01474512|779692|P5|Maintenance Period|Treated but Discontinued in Induction|1
235929|NCT01474512|779693|P4|Maintenance Period|Treated but Discontinued in Induction|0
235930|NCT01474512|779694|P3|Maintenance Period|Treated but Discontinued in Induction|0
235931|NCT01474512|779695|P2|Maintenance Period|Treated but Discontinued in Induction|0
235932|NCT01474512|779696|P1|Maintenance Period|Treated but Discontinued in Induction|0
235933|NCT01474512|779687|P10|Maintenance Period|Protocol Violation|1
235934|NCT01474512|779688|P9|Maintenance Period|Protocol Violation|0
235935|NCT01474512|779689|P8|Maintenance Period|Protocol Violation|1
235936|NCT01474512|779690|P7|Maintenance Period|Protocol Violation|0
235937|NCT01474512|779691|P6|Maintenance Period|Protocol Violation|0
235938|NCT01474512|779692|P5|Maintenance Period|Protocol Violation|0
235939|NCT01474512|779693|P4|Maintenance Period|Protocol Violation|1
235940|NCT01474512|779694|P3|Maintenance Period|Protocol Violation|0
235941|NCT01474512|779695|P2|Maintenance Period|Protocol Violation|0
235942|NCT01474512|779696|P1|Maintenance Period|Protocol Violation|0
235943|NCT01474512|779687|P10|Maintenance Period|Lack of Efficacy|12
235944|NCT01474512|779688|P9|Maintenance Period|Lack of Efficacy|11
235945|NCT01474512|779689|P8|Maintenance Period|Lack of Efficacy|11
235946|NCT01474512|779690|P7|Maintenance Period|Lack of Efficacy|0
235947|NCT01474512|779691|P6|Maintenance Period|Lack of Efficacy|0
235948|NCT01474512|779692|P5|Maintenance Period|Lack of Efficacy|0
235949|NCT01474512|779693|P4|Maintenance Period|Lack of Efficacy|1
235950|NCT01474512|779694|P3|Maintenance Period|Lack of Efficacy|0
235951|NCT01474512|779695|P2|Maintenance Period|Lack of Efficacy|0
235952|NCT01474512|779696|P1|Maintenance Period|Lack of Efficacy|0
235953|NCT01474512|779687|P10|Maintenance Period|Clinical Relapse|0
235954|NCT01474512|779688|P9|Maintenance Period|Clinical Relapse|0
235955|NCT01474512|779689|P8|Maintenance Period|Clinical Relapse|0
235956|NCT01474512|779690|P7|Maintenance Period|Clinical Relapse|0
235957|NCT01474512|779691|P6|Maintenance Period|Clinical Relapse|0
235958|NCT01474512|779692|P5|Maintenance Period|Clinical Relapse|0
235959|NCT01474512|779693|P4|Maintenance Period|Clinical Relapse|1
235960|NCT01474512|779694|P3|Maintenance Period|Clinical Relapse|0
235961|NCT01474512|779695|P2|Maintenance Period|Clinical Relapse|0
235962|NCT01474512|779696|P1|Maintenance Period|Clinical Relapse|0
235963|NCT01474512|779687|P10|Maintenance Period|Investigator Decision|0
235964|NCT01474512|779688|P9|Maintenance Period|Investigator Decision|0
235965|NCT01474512|779689|P8|Maintenance Period|Investigator Decision|2
235966|NCT01474512|779690|P7|Maintenance Period|Investigator Decision|0
235967|NCT01474512|779691|P6|Maintenance Period|Investigator Decision|1
235968|NCT01474512|779692|P5|Maintenance Period|Investigator Decision|0
235969|NCT01474512|779693|P4|Maintenance Period|Investigator Decision|0
235970|NCT01474512|779694|P3|Maintenance Period|Investigator Decision|0
235971|NCT01474512|779695|P2|Maintenance Period|Investigator Decision|0
235972|NCT01474512|779696|P1|Maintenance Period|Investigator Decision|0
235973|NCT01474512|779687|P10|Maintenance Period|Death|0
235974|NCT01474512|779688|P9|Maintenance Period|Death|0
235975|NCT01474512|779689|P8|Maintenance Period|Death|0
235976|NCT01474512|779690|P7|Maintenance Period|Death|0
235977|NCT01474512|779691|P6|Maintenance Period|Death|2
235978|NCT01474512|779692|P5|Maintenance Period|Death|0
235979|NCT01474512|779693|P4|Maintenance Period|Death|0
235980|NCT01474512|779694|P3|Maintenance Period|Death|0
235981|NCT01474512|779695|P2|Maintenance Period|Death|0
235982|NCT01474512|779696|P1|Maintenance Period|Death|0
235983|NCT01474512|779687|P10|Maintenance Period|Lost to Follow-up|1
235984|NCT01474512|779688|P9|Maintenance Period|Lost to Follow-up|1
235985|NCT01474512|779689|P8|Maintenance Period|Lost to Follow-up|2
235986|NCT01474512|779690|P7|Maintenance Period|Lost to Follow-up|0
235987|NCT01474512|779691|P6|Maintenance Period|Lost to Follow-up|0
235988|NCT01474512|779692|P5|Maintenance Period|Lost to Follow-up|3
235989|NCT01474512|779693|P4|Maintenance Period|Lost to Follow-up|3
235990|NCT01474512|779694|P3|Maintenance Period|Lost to Follow-up|0
235991|NCT01474512|779695|P2|Maintenance Period|Lost to Follow-up|0
235992|NCT01474512|779696|P1|Maintenance Period|Lost to Follow-up|0
235993|NCT01474512|779687|P10|Maintenance Period|Withdrawal by Subject|1
235994|NCT01474512|779688|P9|Maintenance Period|Withdrawal by Subject|3
235995|NCT01474512|779689|P8|Maintenance Period|Withdrawal by Subject|6
235996|NCT01474512|779690|P7|Maintenance Period|Withdrawal by Subject|1
235997|NCT01474512|779691|P6|Maintenance Period|Withdrawal by Subject|3
235998|NCT01474512|779692|P5|Maintenance Period|Withdrawal by Subject|2
235999|NCT01474512|779693|P4|Maintenance Period|Withdrawal by Subject|6
236000|NCT01474512|779694|P3|Maintenance Period|Withdrawal by Subject|0
236001|NCT01474512|779695|P2|Maintenance Period|Withdrawal by Subject|0
236002|NCT01474512|779696|P1|Maintenance Period|Withdrawal by Subject|0
236003|NCT01474512|779687|P10|Maintenance Period|Adverse Event|3
236004|NCT01474512|779688|P9|Maintenance Period|Adverse Event|1
236005|NCT01474512|779689|P8|Maintenance Period|Adverse Event|19
236006|NCT01474512|779690|P7|Maintenance Period|Adverse Event|0
236007|NCT01474512|779691|P6|Maintenance Period|Adverse Event|7
236008|NCT01474512|779692|P5|Maintenance Period|Adverse Event|2
236009|NCT01474512|779693|P4|Maintenance Period|Adverse Event|4
236010|NCT01474512|779694|P3|Maintenance Period|Adverse Event|0
236011|NCT01474512|779695|P2|Maintenance Period|Adverse Event|0
236012|NCT01474512|779696|P1|Maintenance Period|Adverse Event|0
236013|NCT01474512|779687|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
236014|NCT01474512|779688|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
236015|NCT01474512|779689|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
236016|NCT01474512|779690|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
236017|NCT01474512|779691|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
236018|NCT01474512|779692|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
236019|NCT01474512|779693|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
236020|NCT01474512|779694|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
236021|NCT01474512|779695|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
236022|NCT01474512|779696|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
236023|NCT01474512|779687|P10|Induction Period|Lost to Follow-up|0
236024|NCT01474512|779688|P9|Induction Period|Lost to Follow-up|0
236025|NCT01474512|779689|P8|Induction Period|Lost to Follow-up|0
236026|NCT01474512|779690|P7|Induction Period|Lost to Follow-up|0
236027|NCT01474512|779691|P6|Induction Period|Lost to Follow-up|0
236028|NCT01474512|779692|P5|Induction Period|Lost to Follow-up|0
236029|NCT01474512|779693|P4|Induction Period|Lost to Follow-up|0
236030|NCT01474512|779694|P3|Induction Period|Lost to Follow-up|2
236031|NCT01474512|779695|P2|Induction Period|Lost to Follow-up|0
236032|NCT01474512|779696|P1|Induction Period|Lost to Follow-up|1
236033|NCT01474512|779687|P10|Induction Period|Sponsor Decision|0
236034|NCT01474512|779688|P9|Induction Period|Sponsor Decision|0
236035|NCT01474512|779689|P8|Induction Period|Sponsor Decision|0
236036|NCT01474512|779690|P7|Induction Period|Sponsor Decision|0
236037|NCT01474512|779691|P6|Induction Period|Sponsor Decision|0
236038|NCT01474512|779692|P5|Induction Period|Sponsor Decision|0
236039|NCT01474512|779693|P4|Induction Period|Sponsor Decision|0
236040|NCT01474512|779694|P3|Induction Period|Sponsor Decision|1
236041|NCT01474512|779695|P2|Induction Period|Sponsor Decision|1
236042|NCT01474512|779696|P1|Induction Period|Sponsor Decision|1
236043|NCT01474512|779687|P10|Induction Period|Protocol Violation|0
236044|NCT01474512|779688|P9|Induction Period|Protocol Violation|0
236045|NCT01474512|779689|P8|Induction Period|Protocol Violation|0
236046|NCT01474512|779690|P7|Induction Period|Protocol Violation|0
236047|NCT01474512|779691|P6|Induction Period|Protocol Violation|0
236048|NCT01474512|779692|P5|Induction Period|Protocol Violation|0
236049|NCT01474512|779693|P4|Induction Period|Protocol Violation|0
236050|NCT01474512|779694|P3|Induction Period|Protocol Violation|0
236051|NCT01474512|779695|P2|Induction Period|Protocol Violation|6
236052|NCT01474512|779696|P1|Induction Period|Protocol Violation|3
236053|NCT01474512|779687|P10|Induction Period|Withdrawal by Subject|0
236054|NCT01474512|779688|P9|Induction Period|Withdrawal by Subject|0
236055|NCT01474512|779689|P8|Induction Period|Withdrawal by Subject|0
236056|NCT01474512|779690|P7|Induction Period|Withdrawal by Subject|0
236057|NCT01474512|779691|P6|Induction Period|Withdrawal by Subject|0
236058|NCT01474512|779692|P5|Induction Period|Withdrawal by Subject|0
236059|NCT01474512|779693|P4|Induction Period|Withdrawal by Subject|0
236060|NCT01474512|779694|P3|Induction Period|Withdrawal by Subject|5
236061|NCT01474512|779695|P2|Induction Period|Withdrawal by Subject|6
236062|NCT01474512|779696|P1|Induction Period|Withdrawal by Subject|6
236063|NCT01474512|779687|P10|Induction Period|Lack of Efficacy|0
236064|NCT01474512|779688|P9|Induction Period|Lack of Efficacy|0
236065|NCT01474512|779689|P8|Induction Period|Lack of Efficacy|0
236066|NCT01474512|779690|P7|Induction Period|Lack of Efficacy|0
236067|NCT01474512|779691|P6|Induction Period|Lack of Efficacy|0
236068|NCT01474512|779692|P5|Induction Period|Lack of Efficacy|0
236069|NCT01474512|779693|P4|Induction Period|Lack of Efficacy|0
236070|NCT01474512|779694|P3|Induction Period|Lack of Efficacy|0
236071|NCT01474512|779695|P2|Induction Period|Lack of Efficacy|1
236072|NCT01474512|779696|P1|Induction Period|Lack of Efficacy|7
236073|NCT01474512|779687|P10|Induction Period|Adverse Event|0
236074|NCT01474512|779688|P9|Induction Period|Adverse Event|0
236075|NCT01474512|779689|P8|Induction Period|Adverse Event|0
236076|NCT01474512|779690|P7|Induction Period|Adverse Event|0
236077|NCT01474512|779691|P6|Induction Period|Adverse Event|0
236078|NCT01474512|779692|P5|Induction Period|Adverse Event|0
236079|NCT01474512|779693|P4|Induction Period|Adverse Event|0
236080|NCT01474512|779694|P3|Induction Period|Adverse Event|10
236081|NCT01474512|779695|P2|Induction Period|Adverse Event|10
236082|NCT01474512|779696|P1|Induction Period|Adverse Event|6
236083|NCT01474434|779765|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
236084|NCT01474434|779766|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
236085|NCT01474434|779767|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
236086|NCT01474434|779768|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
236087|NCT01474434|779765|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
236088|NCT01474434|779766|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
236089|NCT01474434|779767|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
236090|NCT01474434|779768|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
236091|NCT01474434|779765|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
236092|NCT01474434|779766|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
236093|NCT01474434|779767|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
236094|NCT01474434|779768|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
236095|NCT01474317|779810|P1|Overall Study|Subject ineligible for study|1
236096|NCT01474317|779810|P1|Overall Study|Adverse Event|1
236097|NCT01474291|779819|P1|Overall Study|Death|2
236098|NCT01474291|779819|P1|Overall Study|No Reason Reported|10
236099|NCT01474291|779819|P1|Overall Study|Patient No Longer Wanted to Participate|12
236100|NCT01474291|779819|P1|Overall Study|Lost to Follow-up|29
236101|NCT01474291|779819|P1|Overall Study|Adverse Event|53
236102|NCT01474291|779819|P1|Overall Study|Lack of Treatment Efficacy|88
236103|NCT01474291|779819|P1|Overall Study|Not Evaluable for Efficacy|26
236104|NCT01474239|779863|P2|Overall Study|Withdrawal for Economic Reason|0
236105|NCT01474239|779864|P1|Overall Study|Withdrawal for Economic Reason|1
236106|NCT01474239|779863|P2|Overall Study|Clinical Disease Progression|1
236107|NCT01474239|779864|P1|Overall Study|Clinical Disease Progression|7
236108|NCT01474239|779863|P2|Overall Study|Death|1
236109|NCT01474239|779864|P1|Overall Study|Death|1
236110|NCT01474239|779863|P2|Overall Study|Withdrawal by Subject|2
236111|NCT01474239|779864|P1|Overall Study|Withdrawal by Subject|1
236112|NCT01474239|779863|P2|Overall Study|Adverse Event|3
236113|NCT01474239|779864|P1|Overall Study|Adverse Event|12
236114|NCT01474239|779863|P2|Overall Study|Disease Progression|25
236115|NCT01474239|779864|P1|Overall Study|Disease Progression|37
236116|NCT01473953|780058|P5|Overall Study|Unspecified|0
236117|NCT01473953|780059|P4|Overall Study|Unspecified|0
236118|NCT01473953|780060|P3|Overall Study|Unspecified|0
236119|NCT01473953|780061|P2|Overall Study|Unspecified|0
236120|NCT01473953|780062|P1|Overall Study|Unspecified|1
236121|NCT01473836|780104|P1|Overall Study|Does not meet entrance criteria|1
236122|NCT01473836|780104|P1|Overall Study|Lack of Efficacy|1
236123|NCT01473836|780104|P1|Overall Study|Adverse Event|4
236124|NCT01473758|780115|P4|Cycle 2|Adverse Event|0
236125|NCT01473758|780116|P3|Cycle 2|Adverse Event|5
236126|NCT01473758|780117|P2|Cycle 2|Adverse Event|0
236127|NCT01473758|780118|P1|Cycle 2|Adverse Event|0
236128|NCT01473758|780115|P4|Cycle 1|Withdrawal by Subject|0
236129|NCT01473758|780116|P3|Cycle 1|Withdrawal by Subject|0
236130|NCT01473758|780117|P2|Cycle 1|Withdrawal by Subject|1
236131|NCT01473758|780118|P1|Cycle 1|Withdrawal by Subject|1
236132|NCT01473758|780115|P4|Cycle 1|Adverse Event|0
236133|NCT01473758|780116|P3|Cycle 1|Adverse Event|0
236134|NCT01473758|780117|P2|Cycle 1|Adverse Event|2
236135|NCT01473758|780118|P1|Cycle 1|Adverse Event|10
236136|NCT01473602|780255|P2|Overall Study|Physician Decision|0
236137|NCT01473602|780256|P1|Overall Study|Physician Decision|1
236138|NCT01473602|780255|P2|Overall Study|Withdrawal by Subject|4
236139|NCT01473602|780256|P1|Overall Study|Withdrawal by Subject|5
236140|NCT01473602|780255|P2|Overall Study|Lost to Follow-up|1
236141|NCT01473602|780256|P1|Overall Study|Lost to Follow-up|1
236142|NCT01473602|780255|P2|Overall Study|Death|1
236143|NCT01473602|780256|P1|Overall Study|Death|0
236144|NCT01473602|780255|P2|Overall Study|Adverse Event|2
236145|NCT01473602|780256|P1|Overall Study|Adverse Event|1
236146|NCT01473589|780292|P2|Overall Study|Entry criteria not met|1
236147|NCT01473589|780293|P1|Overall Study|Entry criteria not met|0
236148|NCT01473589|780292|P2|Overall Study|Physician Decision|1
236149|NCT01473589|780293|P1|Overall Study|Physician Decision|0
236150|NCT01473589|780292|P2|Overall Study|Withdrawal by Subject|11
236151|NCT01473589|780293|P1|Overall Study|Withdrawal by Subject|5
236152|NCT01473589|780292|P2|Overall Study|Protocol Violation|0
236153|NCT01473589|780293|P1|Overall Study|Protocol Violation|1
236154|NCT01473589|780292|P2|Overall Study|Lost to Follow-up|2
236155|NCT01473589|780293|P1|Overall Study|Lost to Follow-up|2
236156|NCT01473589|780292|P2|Overall Study|Death|0
236157|NCT01473589|780293|P1|Overall Study|Death|2
236158|NCT01473589|780292|P2|Overall Study|Adverse Event|1
236159|NCT01473589|780293|P1|Overall Study|Adverse Event|1
236160|NCT01473563|780327|P1|Overall Study|Lost to FU post tx discontinuation|1
236161|NCT01473524|780349|P3|Overall Study|Withdrawal by Subject|1
236162|NCT01473524|780350|P2|Overall Study|Withdrawal by Subject|1
236163|NCT01473524|780351|P1|Overall Study|Withdrawal by Subject|2
236164|NCT01473524|780349|P3|Overall Study|Death|0
236165|NCT01473524|780350|P2|Overall Study|Death|0
236166|NCT01473524|780351|P1|Overall Study|Death|1
236167|NCT01473524|780349|P3|Overall Study|Adverse Event|2
236168|NCT01473524|780350|P2|Overall Study|Adverse Event|8
236169|NCT01473524|780351|P1|Overall Study|Adverse Event|4
236170|NCT01473394|780384|P2|Overall Study|Lost to Follow-up|11
236171|NCT01473394|780385|P1|Overall Study|Lost to Follow-up|9
236172|NCT01473394|780384|P2|Overall Study|Withdrew Consent|10
236173|NCT01473394|780385|P1|Overall Study|Withdrew Consent|12
236174|NCT01473394|780384|P2|Overall Study|Protocol Violation|5
236175|NCT01473394|780385|P1|Overall Study|Protocol Violation|7
236176|NCT01473394|780384|P2|Overall Study|Insufficient Therapeutic Response|1
236177|NCT01473394|780385|P1|Overall Study|Insufficient Therapeutic Response|4
236178|NCT01473394|780384|P2|Overall Study|Adverse Event|16
236179|NCT01473394|780385|P1|Overall Study|Adverse Event|13
236180|NCT01473381|780399|P4|Overall Study|Other Reasons|3
236181|NCT01473381|780400|P3|Overall Study|Other Reasons|1
236182|NCT01473381|780401|P2|Overall Study|Other Reasons|0
236183|NCT01473381|780402|P1|Overall Study|Other Reasons|0
236184|NCT01473381|780399|P4|Overall Study|Lost to Follow-up|23
236185|NCT01473381|780400|P3|Overall Study|Lost to Follow-up|35
236186|NCT01473381|780401|P2|Overall Study|Lost to Follow-up|28
236187|NCT01473381|780402|P1|Overall Study|Lost to Follow-up|25
236188|NCT01473381|780399|P4|Overall Study|Withdrawal of Consent|26
236189|NCT01473381|780400|P3|Overall Study|Withdrawal of Consent|20
236190|NCT01473381|780401|P2|Overall Study|Withdrawal of Consent|21
236191|NCT01473381|780402|P1|Overall Study|Withdrawal of Consent|20
236192|NCT01473381|780399|P4|Overall Study|Protocol Violation|17
236193|NCT01473381|780400|P3|Overall Study|Protocol Violation|19
236194|NCT01473381|780401|P2|Overall Study|Protocol Violation|23
236195|NCT01473381|780402|P1|Overall Study|Protocol Violation|17
236196|NCT01473381|780399|P4|Overall Study|Insufficient Therapeutic Response|3
236197|NCT01473381|780400|P3|Overall Study|Insufficient Therapeutic Response|2
236198|NCT01473381|780401|P2|Overall Study|Insufficient Therapeutic Response|1
236199|NCT01473381|780402|P1|Overall Study|Insufficient Therapeutic Response|10
236200|NCT01473381|780399|P4|Overall Study|Adverse Event|17
236201|NCT01473381|780400|P3|Overall Study|Adverse Event|25
236202|NCT01473381|780401|P2|Overall Study|Adverse Event|20
236203|NCT01473381|780402|P1|Overall Study|Adverse Event|8
236204|NCT01472939|780486|P4|Overall Study|Withdrawal by Subject|4
236205|NCT01472939|780487|P3|Overall Study|Withdrawal by Subject|1
236206|NCT01472939|780488|P2|Overall Study|Withdrawal by Subject|3
236207|NCT01472939|780489|P1|Overall Study|Withdrawal by Subject|9
236208|NCT01472939|780486|P4|Overall Study|Protocol Violation|1
236209|NCT01472939|780487|P3|Overall Study|Protocol Violation|0
236210|NCT01472939|780488|P2|Overall Study|Protocol Violation|3
236211|NCT01472939|780489|P1|Overall Study|Protocol Violation|3
236212|NCT01472939|780486|P4|Overall Study|Withdrawal By PI|0
236213|NCT01472939|780487|P3|Overall Study|Withdrawal By PI|0
236214|NCT01472939|780488|P2|Overall Study|Withdrawal By PI|0
236215|NCT01472939|780489|P1|Overall Study|Withdrawal By PI|1
236216|NCT01472939|780486|P4|Overall Study|Prohibited Medication|0
236217|NCT01472939|780487|P3|Overall Study|Prohibited Medication|0
236218|NCT01472939|780488|P2|Overall Study|Prohibited Medication|1
236219|NCT01472939|780489|P1|Overall Study|Prohibited Medication|0
236220|NCT01472939|780486|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
236221|NCT01472939|780487|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
236222|NCT01472939|780488|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
236223|NCT01472939|780489|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
236224|NCT01472939|780486|P4|Overall Study|Lost to Follow-up|0
236225|NCT01472939|780487|P3|Overall Study|Lost to Follow-up|2
236226|NCT01472939|780488|P2|Overall Study|Lost to Follow-up|0
236227|NCT01472939|780489|P1|Overall Study|Lost to Follow-up|3
236228|NCT01472939|780486|P4|Overall Study|Lack of Efficacy|1
236229|NCT01472939|780487|P3|Overall Study|Lack of Efficacy|0
236230|NCT01472939|780488|P2|Overall Study|Lack of Efficacy|0
236231|NCT01472939|780489|P1|Overall Study|Lack of Efficacy|1
236232|NCT01472939|780486|P4|Overall Study|Adverse Event|14
236233|NCT01472939|780487|P3|Overall Study|Adverse Event|7
236234|NCT01472939|780488|P2|Overall Study|Adverse Event|7
236235|NCT01472939|780489|P1|Overall Study|Adverse Event|3
236236|NCT01472835|780533|P2|Overall Study|Lost to Follow-up|0
236237|NCT01472835|780534|P1|Overall Study|Lost to Follow-up|2
236238|NCT01472380|780589|P1|1 Day Period Between Dosing|Protocol Violation|1
236239|NCT01472380|780589|P1|Efavirenz Alone|Withdrawal by Subject|1
236240|NCT01472341|780600|P1|Overall Study|Death|9
236241|NCT01472341|780600|P1|Overall Study|Laboratory parameters unavailable|25
236242|NCT01472341|780600|P1|Overall Study|Lost to Follow-up|52
236243|NCT01472341|780600|P1|Overall Study|Withdrawal by Subject|39
236244|NCT01472341|780600|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
236245|NCT01472341|780600|P1|Overall Study|Started insulin therapy|55
236246|NCT01472289|780606|P1|Overall Study|Death|2
236247|NCT01472185|780618|P2|Overall Study|Subject Withdrew Consent|3
236248|NCT01472185|780619|P1|Overall Study|Subject Withdrew Consent|6
236249|NCT01472185|780618|P2|Overall Study|Subject Noncompliance|15
236250|NCT01472185|780619|P1|Overall Study|Subject Noncompliance|8
236251|NCT01472185|780618|P2|Overall Study|Protocol Violation|1
236252|NCT01472185|780619|P1|Overall Study|Protocol Violation|5
236253|NCT01472185|780618|P2|Overall Study|Lost to Follow-up|1
236254|NCT01472185|780619|P1|Overall Study|Lost to Follow-up|4
236255|NCT01472185|780618|P2|Overall Study|Investigator’s Discretion|1
236256|NCT01472185|780619|P1|Overall Study|Investigator’s Discretion|3
236257|NCT01472185|780618|P2|Overall Study|Hyperglycemia|2
236258|NCT01472185|780619|P1|Overall Study|Hyperglycemia|5
236259|NCT01472185|780618|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
236260|NCT01472185|780619|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
236261|NCT01472185|780618|P2|Overall Study|Randomized but Not Treated|1
236262|NCT01472185|780619|P1|Overall Study|Randomized but Not Treated|0
236263|NCT01471782|780639|P6|Overall Study|Death|1
236264|NCT01471782|780640|P5|Overall Study|Death|0
236265|NCT01471782|780641|P4|Overall Study|Death|0
236266|NCT01471782|780642|P3|Overall Study|Death|0
236267|NCT01471782|780643|P2|Overall Study|Death|0
236268|NCT01471782|780644|P1|Overall Study|Death|0
236269|NCT01471782|780639|P6|Overall Study|Withdrawal by Parent/Guardian|0
236270|NCT01471782|780640|P5|Overall Study|Withdrawal by Parent/Guardian|1
236271|NCT01471782|780641|P4|Overall Study|Withdrawal by Parent/Guardian|0
236272|NCT01471782|780642|P3|Overall Study|Withdrawal by Parent/Guardian|0
236273|NCT01471782|780643|P2|Overall Study|Withdrawal by Parent/Guardian|0
236274|NCT01471782|780644|P1|Overall Study|Withdrawal by Parent/Guardian|0
236275|NCT01471782|780639|P6|Overall Study|Physician Decision|8
236276|NCT01471782|780640|P5|Overall Study|Physician Decision|3
236277|NCT01471782|780641|P4|Overall Study|Physician Decision|0
236278|NCT01471782|780642|P3|Overall Study|Physician Decision|0
236279|NCT01471782|780643|P2|Overall Study|Physician Decision|0
236280|NCT01471782|780644|P1|Overall Study|Physician Decision|0
236281|NCT01471782|780639|P6|Overall Study|Disease Relapse|1
236282|NCT01471782|780640|P5|Overall Study|Disease Relapse|2
236283|NCT01471782|780641|P4|Overall Study|Disease Relapse|1
236284|NCT01471782|780642|P3|Overall Study|Disease Relapse|0
236285|NCT01471782|780643|P2|Overall Study|Disease Relapse|0
236286|NCT01471782|780644|P1|Overall Study|Disease Relapse|0
236287|NCT01471782|780639|P6|Overall Study|Change of Chemotherapy|4
236288|NCT01471782|780640|P5|Overall Study|Change of Chemotherapy|1
236289|NCT01471782|780641|P4|Overall Study|Change of Chemotherapy|0
236290|NCT01471782|780642|P3|Overall Study|Change of Chemotherapy|0
236291|NCT01471782|780643|P2|Overall Study|Change of Chemotherapy|1
236292|NCT01471782|780644|P1|Overall Study|Change of Chemotherapy|1
236293|NCT01471782|780639|P6|Overall Study|Other|5
236294|NCT01471782|780640|P5|Overall Study|Other|6
236295|NCT01471782|780641|P4|Overall Study|Other|1
236296|NCT01471782|780642|P3|Overall Study|Other|1
236297|NCT01471782|780643|P2|Overall Study|Other|0
236298|NCT01471782|780644|P1|Overall Study|Other|0
236299|NCT01471782|780639|P6|Overall Study|Adverse Event|1
236300|NCT01471782|780640|P5|Overall Study|Adverse Event|3
236301|NCT01471782|780641|P4|Overall Study|Adverse Event|2
236302|NCT01471782|780642|P3|Overall Study|Adverse Event|2
236303|NCT01471782|780643|P2|Overall Study|Adverse Event|1
236304|NCT01471782|780644|P1|Overall Study|Adverse Event|1
236305|NCT01471782|780639|P6|Overall Study|Lack of Efficacy|18
236306|NCT01471782|780640|P5|Overall Study|Lack of Efficacy|5
236307|NCT01471782|780641|P4|Overall Study|Lack of Efficacy|1
236308|NCT01471782|780642|P3|Overall Study|Lack of Efficacy|1
236309|NCT01471782|780643|P2|Overall Study|Lack of Efficacy|2
236310|NCT01471782|780644|P1|Overall Study|Lack of Efficacy|1
236311|NCT01471782|780639|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
236312|NCT01471782|780640|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
236313|NCT01471782|780641|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
236314|NCT01471782|780642|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
236315|NCT01471782|780643|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
236316|NCT01471782|780644|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
236317|NCT01471691|780698|P2|Overall Study|Lack of Efficacy|1
236318|NCT01471691|780699|P1|Overall Study|Lack of Efficacy|0
236319|NCT01471574|780713|P4|Follow-up Period|Follow-up no longer required|0
236320|NCT01471574|780714|P3|Follow-up Period|Follow-up no longer required|0
236321|NCT01471574|780715|P2|Follow-up Period|Follow-up no longer required|1
236322|NCT01471574|780716|P1|Follow-up Period|Follow-up no longer required|0
236323|NCT01471574|780713|P4|Follow-up Period|Death|0
236324|NCT01471574|780714|P3|Follow-up Period|Death|1
236325|NCT01471574|780715|P2|Follow-up Period|Death|0
236326|NCT01471574|780716|P1|Follow-up Period|Death|0
236327|NCT01471574|780713|P4|Follow-up Period|Lost to Follow-up|2
236328|NCT01471574|780714|P3|Follow-up Period|Lost to Follow-up|3
236329|NCT01471574|780715|P2|Follow-up Period|Lost to Follow-up|1
236330|NCT01471574|780716|P1|Follow-up Period|Lost to Follow-up|4
236331|NCT01471574|780713|P4|Follow-up Period|Withdrawal by Subject|1
236332|NCT01471574|780714|P3|Follow-up Period|Withdrawal by Subject|3
236333|NCT01471574|780715|P2|Follow-up Period|Withdrawal by Subject|0
236334|NCT01471574|780716|P1|Follow-up Period|Withdrawal by Subject|3
236335|NCT01471574|780713|P4|Treatment Period|Not specified|0
236336|NCT01471574|780714|P3|Treatment Period|Not specified|0
236337|NCT01471574|780715|P2|Treatment Period|Not specified|0
236338|NCT01471574|780716|P1|Treatment Period|Not specified|1
236339|NCT01471574|780713|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
236340|NCT01471574|780714|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
236341|NCT01471574|780715|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
236342|NCT01471574|780716|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
236343|NCT01471574|780713|P4|Treatment Period|Lost to Follow-up|0
236344|NCT01471574|780714|P3|Treatment Period|Lost to Follow-up|2
236345|NCT01471574|780715|P2|Treatment Period|Lost to Follow-up|2
236346|NCT01471574|780716|P1|Treatment Period|Lost to Follow-up|1
236347|NCT01471574|780713|P4|Treatment Period|Patient Requested Discontinue Study drug|1
236348|NCT01471574|780714|P3|Treatment Period|Patient Requested Discontinue Study drug|1
236349|NCT01471574|780715|P2|Treatment Period|Patient Requested Discontinue Study drug|0
236350|NCT01471574|780716|P1|Treatment Period|Patient Requested Discontinue Study drug|4
236351|NCT01471574|780713|P4|Treatment Period|Withdrawal by Subject|0
236352|NCT01471574|780714|P3|Treatment Period|Withdrawal by Subject|1
236353|NCT01471574|780715|P2|Treatment Period|Withdrawal by Subject|1
236354|NCT01471574|780716|P1|Treatment Period|Withdrawal by Subject|5
236355|NCT01471574|780713|P4|Treatment Period|Adverse Event|1
236356|NCT01471574|780714|P3|Treatment Period|Adverse Event|6
236357|NCT01471574|780715|P2|Treatment Period|Adverse Event|3
236358|NCT01471574|780716|P1|Treatment Period|Adverse Event|7
236359|NCT01471574|780713|P4|Treatment Period|Lack of Efficacy|1
236360|NCT01471574|780714|P3|Treatment Period|Lack of Efficacy|14
236361|NCT01471574|780715|P2|Treatment Period|Lack of Efficacy|4
236362|NCT01471574|780716|P1|Treatment Period|Lack of Efficacy|12
236363|NCT01471379|780748|P3|Overall Study|Study terminated|0
236364|NCT01471379|780749|P2|Overall Study|Study terminated|1
236365|NCT01471379|780750|P1|Overall Study|Study terminated|0
236366|NCT01471379|780748|P3|Overall Study|Adverse Event|0
236367|NCT01471379|780749|P2|Overall Study|Adverse Event|0
236368|NCT01471379|780750|P1|Overall Study|Adverse Event|1
236369|NCT01471353|780770|P1|Overall Study|remain on study|3
236370|NCT01471197|780778|P2|Overall Study|Study Drug Toxicity|0
236371|NCT01471197|780779|P1|Overall Study|Study Drug Toxicity|1
236372|NCT01471197|780778|P2|Overall Study|Death|0
236373|NCT01471197|780779|P1|Overall Study|Death|1
236374|NCT01471197|780778|P2|Overall Study|Disease Progression|2
236375|NCT01471197|780779|P1|Overall Study|Disease Progression|4
236376|NCT01471171|780789|P2|Treatment Period 2|Adverse Event|0
236377|NCT01471171|780790|P1|Treatment Period 2|Adverse Event|1
236378|NCT01471171|780789|P2|Treatment Period 1|Adverse Event|1
236379|NCT01471171|780790|P1|Treatment Period 1|Adverse Event|4
236380|NCT01471015|780808|P3|Overall Study|Death|1
236381|NCT01471015|780809|P2|Overall Study|Death|1
236382|NCT01471015|780810|P1|Overall Study|Death|0
236383|NCT01470469|780852|P2|Overall Study|Not specified|1
236384|NCT01470469|780853|P1|Overall Study|Not specified|2
236385|NCT01470469|780852|P2|Overall Study|Protocol Violation|1
236386|NCT01470469|780853|P1|Overall Study|Protocol Violation|1
236387|NCT01470469|780852|P2|Overall Study|Lost to Follow-up|2
236388|NCT01470469|780853|P1|Overall Study|Lost to Follow-up|2
236389|NCT01470469|780852|P2|Overall Study|Adverse Event|7
236390|NCT01470469|780853|P1|Overall Study|Adverse Event|0
236391|NCT01470469|780852|P2|Overall Study|Lack of Efficacy|7
236392|NCT01470469|780853|P1|Overall Study|Lack of Efficacy|1
236393|NCT01470469|780852|P2|Overall Study|Withdrawal by Subject|6
236394|NCT01470469|780853|P1|Overall Study|Withdrawal by Subject|4
236395|NCT01470417|780873|P2|Overall Study|Disease progression|2
236396|NCT01470417|780874|P1|Overall Study|Disease progression|0
236397|NCT01470248|780886|P1|Overall Study|Withdrawal by Subject|1
236398|NCT01470144|780942|P1|Overall Study|Patient’s and investigator’s decision|1
236399|NCT01470144|780942|P1|Overall Study|Lung transplant|6
236400|NCT01470144|780942|P1|Overall Study|Death|1
236401|NCT01470144|780942|P1|Overall Study|Adverse Event|2
236402|NCT01469819|780981|P1|Overall Study|Technical malfunction of SmartPill data|3
236403|NCT01469819|780981|P1|Overall Study|Could not swallow SmartPill|2
236404|NCT01469819|780981|P1|Overall Study|Did not meet inclusionary criteria|2
236405|NCT01469819|780981|P1|Overall Study|Withdrawal by Subject|1
236406|NCT01469637|781005|P2|Second Intervention|Incarcerated|0
236407|NCT01469637|781006|P1|Second Intervention|Incarcerated|1
236408|NCT01469637|781005|P2|First Intervention|Unacceptable behavior|1
236409|NCT01469637|781006|P1|First Intervention|Unacceptable behavior|0
236410|NCT01469546|781014|P1|Received 5 mg Dose|Physician Decision|3
236411|NCT01469546|781014|P1|Received 5 mg Dose|Progressive Disease|3
236412|NCT01469546|781014|P1|Received 5 mg Dose|Protocol Violation|2
236413|NCT01469546|781014|P1|Received 5 mg Dose|Death|2
236414|NCT01469546|781014|P1|Received 5 mg Dose|Adverse Event|13
236415|NCT01469364|781021|P1|Overall Study|Withdrawal by Subject|1
236416|NCT01469364|781021|P1|Overall Study|Adverse Event|1
236417|NCT01469182|781072|P2|Overall Study|Did not meet Protocol Eligibility|0
236418|NCT01469182|781073|P1|Overall Study|Did not meet Protocol Eligibility|3
236419|NCT01469182|781072|P2|Overall Study|Protocol Violation|2
236420|NCT01469182|781073|P1|Overall Study|Protocol Violation|4
236421|NCT01469182|781072|P2|Overall Study|Withdrawal by Subject|1
236422|NCT01469182|781073|P1|Overall Study|Withdrawal by Subject|4
236423|NCT01469182|781072|P2|Overall Study|Lost to Follow-up|0
236424|NCT01469182|781073|P1|Overall Study|Lost to Follow-up|3
236425|NCT01469182|781072|P2|Overall Study|Adverse Event|3
236426|NCT01469182|781073|P1|Overall Study|Adverse Event|21
236427|NCT01469065|781100|P5|Overall Study|Not specified|0
236428|NCT01469065|781101|P4|Overall Study|Not specified|0
236429|NCT01469065|781102|P3|Overall Study|Not specified|0
236430|NCT01469065|781103|P2|Overall Study|Not specified|1
236431|NCT01469065|781104|P1|Overall Study|Not specified|0
236432|NCT01469065|781100|P5|Overall Study|Lack of Efficacy|1
236433|NCT01469065|781101|P4|Overall Study|Lack of Efficacy|0
236434|NCT01469065|781102|P3|Overall Study|Lack of Efficacy|0
236435|NCT01469065|781103|P2|Overall Study|Lack of Efficacy|0
236436|NCT01469065|781104|P1|Overall Study|Lack of Efficacy|0
236437|NCT01469052|781200|P6|Overall Study|Unspecified|0
236438|NCT01469052|781201|P5|Overall Study|Unspecified|1
236439|NCT01469052|781202|P4|Overall Study|Unspecified|0
236440|NCT01469052|781203|P3|Overall Study|Unspecified|0
236441|NCT01469052|781204|P2|Overall Study|Unspecified|1
236442|NCT01469052|781205|P1|Overall Study|Unspecified|0
236443|NCT01469052|781200|P6|Overall Study|Moved to rollover protocol|1
236444|NCT01469052|781201|P5|Overall Study|Moved to rollover protocol|0
236445|NCT01469052|781202|P4|Overall Study|Moved to rollover protocol|0
236446|NCT01469052|781203|P3|Overall Study|Moved to rollover protocol|1
236447|NCT01469052|781204|P2|Overall Study|Moved to rollover protocol|0
236448|NCT01469052|781205|P1|Overall Study|Moved to rollover protocol|1
236449|NCT01469052|781200|P6|Overall Study|Lack of Efficacy|2
236450|NCT01469052|781201|P5|Overall Study|Lack of Efficacy|0
236451|NCT01469052|781202|P4|Overall Study|Lack of Efficacy|0
236452|NCT01469052|781203|P3|Overall Study|Lack of Efficacy|0
236453|NCT01469052|781204|P2|Overall Study|Lack of Efficacy|0
236454|NCT01469052|781205|P1|Overall Study|Lack of Efficacy|0
236455|NCT01469052|781200|P6|Overall Study|Progressive disease|2
236456|NCT01469052|781201|P5|Overall Study|Progressive disease|7
236457|NCT01469052|781202|P4|Overall Study|Progressive disease|3
236458|NCT01469052|781203|P3|Overall Study|Progressive disease|5
236459|NCT01469052|781204|P2|Overall Study|Progressive disease|0
236460|NCT01469052|781205|P1|Overall Study|Progressive disease|3
236461|NCT01469052|781200|P6|Overall Study|Adverse Event|1
236462|NCT01469052|781201|P5|Overall Study|Adverse Event|0
236463|NCT01469052|781202|P4|Overall Study|Adverse Event|2
236464|NCT01469052|781203|P3|Overall Study|Adverse Event|0
236465|NCT01469052|781204|P2|Overall Study|Adverse Event|3
236466|NCT01469052|781205|P1|Overall Study|Adverse Event|2
236467|NCT01469000|781267|P2|Overall Study|On treatment, not yet died or PD|7
236468|NCT01469000|781268|P1|Overall Study|On treatment, not yet died or PD|23
236469|NCT01469000|781267|P2|Overall Study|Entry Criteria Not Met|0
236470|NCT01469000|781268|P1|Overall Study|Entry Criteria Not Met|1
236471|NCT01469000|781267|P2|Overall Study|Physician Decision|1
236472|NCT01469000|781268|P1|Overall Study|Physician Decision|0
236473|NCT01469000|781267|P2|Overall Study|Withdrawal by Subject|1
236474|NCT01469000|781268|P1|Overall Study|Withdrawal by Subject|9
236475|NCT01468818|781282|P1|Overall Study|Death during treatment|2
236476|NCT01468311|781340|P1|Overall Study|Withdrawal by Subject|1
236477|NCT01468311|781340|P1|Overall Study|mobilization failure|1
236478|NCT01468233|781352|P6|Treatment Period 2|Not specified|0
236479|NCT01468233|781353|P5|Treatment Period 2|Not specified|1
236480|NCT01468233|781354|P4|Treatment Period 2|Not specified|0
236481|NCT01468233|781355|P3|Treatment Period 2|Not specified|3
236482|NCT01468233|781356|P2|Treatment Period 2|Not specified|0
236483|NCT01468233|781357|P1|Treatment Period 2|Not specified|0
236484|NCT01468233|781352|P6|Treatment Period 2|Lost to Follow-up|0
236485|NCT01468233|781353|P5|Treatment Period 2|Lost to Follow-up|2
236486|NCT01468233|781354|P4|Treatment Period 2|Lost to Follow-up|0
236487|NCT01468233|781355|P3|Treatment Period 2|Lost to Follow-up|3
236488|NCT01468233|781356|P2|Treatment Period 2|Lost to Follow-up|0
236489|NCT01468233|781357|P1|Treatment Period 2|Lost to Follow-up|0
236490|NCT01468233|781352|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
236491|NCT01468233|781353|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
236492|NCT01468233|781354|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
236493|NCT01468233|781355|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
236494|NCT01468233|781356|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
236495|NCT01468233|781357|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
236496|NCT01468233|781352|P6|Treatment Period 2|Withdrawal by Subject|1
236497|NCT01468233|781353|P5|Treatment Period 2|Withdrawal by Subject|1
236498|NCT01468233|781354|P4|Treatment Period 2|Withdrawal by Subject|1
236499|NCT01468233|781355|P3|Treatment Period 2|Withdrawal by Subject|9
236500|NCT01468233|781356|P2|Treatment Period 2|Withdrawal by Subject|0
236501|NCT01468233|781357|P1|Treatment Period 2|Withdrawal by Subject|0
236502|NCT01468233|781352|P6|Treatment Period 2|Lack of Efficacy|1
236503|NCT01468233|781353|P5|Treatment Period 2|Lack of Efficacy|0
236504|NCT01468233|781354|P4|Treatment Period 2|Lack of Efficacy|2
236505|NCT01468233|781355|P3|Treatment Period 2|Lack of Efficacy|9
236506|NCT01468233|781356|P2|Treatment Period 2|Lack of Efficacy|0
236507|NCT01468233|781357|P1|Treatment Period 2|Lack of Efficacy|0
236508|NCT01468233|781352|P6|Treatment Period 2|Adverse Event|1
236509|NCT01468233|781353|P5|Treatment Period 2|Adverse Event|2
236510|NCT01468233|781354|P4|Treatment Period 2|Adverse Event|0
236511|NCT01468233|781355|P3|Treatment Period 2|Adverse Event|3
236512|NCT01468233|781356|P2|Treatment Period 2|Adverse Event|0
236513|NCT01468233|781357|P1|Treatment Period 2|Adverse Event|0
236514|NCT01468233|781352|P6|Treatment Period 1|Not specified|0
236515|NCT01468233|781353|P5|Treatment Period 1|Not specified|0
236516|NCT01468233|781354|P4|Treatment Period 1|Not specified|0
236517|NCT01468233|781355|P3|Treatment Period 1|Not specified|0
236518|NCT01468233|781356|P2|Treatment Period 1|Not specified|1
236519|NCT01468233|781357|P1|Treatment Period 1|Not specified|1
236520|NCT01468233|781352|P6|Treatment Period 1|Lost to Follow-up|0
236521|NCT01468233|781353|P5|Treatment Period 1|Lost to Follow-up|0
236522|NCT01468233|781354|P4|Treatment Period 1|Lost to Follow-up|0
236523|NCT01468233|781355|P3|Treatment Period 1|Lost to Follow-up|0
236524|NCT01468233|781356|P2|Treatment Period 1|Lost to Follow-up|0
236525|NCT01468233|781357|P1|Treatment Period 1|Lost to Follow-up|3
236526|NCT01468233|781352|P6|Treatment Period 1|Withdrawal by Subject|0
236527|NCT01468233|781353|P5|Treatment Period 1|Withdrawal by Subject|0
236528|NCT01468233|781354|P4|Treatment Period 1|Withdrawal by Subject|0
236529|NCT01468233|781355|P3|Treatment Period 1|Withdrawal by Subject|0
236530|NCT01468233|781356|P2|Treatment Period 1|Withdrawal by Subject|4
236531|NCT01468233|781357|P1|Treatment Period 1|Withdrawal by Subject|3
236532|NCT01468233|781352|P6|Treatment Period 1|Adverse Event|0
236533|NCT01468233|781353|P5|Treatment Period 1|Adverse Event|0
236534|NCT01468233|781354|P4|Treatment Period 1|Adverse Event|0
236535|NCT01468233|781355|P3|Treatment Period 1|Adverse Event|0
236536|NCT01468233|781356|P2|Treatment Period 1|Adverse Event|3
236537|NCT01468233|781357|P1|Treatment Period 1|Adverse Event|5
236538|NCT01468207|781379|P6|Treatment Period 2|Not specified|2
236539|NCT01468207|781380|P5|Treatment Period 2|Not specified|1
236540|NCT01468207|781381|P4|Treatment Period 2|Not specified|1
236541|NCT01468207|781382|P3|Treatment Period 2|Not specified|5
236542|NCT01468207|781383|P2|Treatment Period 2|Not specified|0
236543|NCT01468207|781384|P1|Treatment Period 2|Not specified|0
236544|NCT01468207|781379|P6|Treatment Period 2|Lost to Follow-up|0
236545|NCT01468207|781380|P5|Treatment Period 2|Lost to Follow-up|0
236546|NCT01468207|781381|P4|Treatment Period 2|Lost to Follow-up|1
236547|NCT01468207|781382|P3|Treatment Period 2|Lost to Follow-up|5
236548|NCT01468207|781383|P2|Treatment Period 2|Lost to Follow-up|0
236549|NCT01468207|781384|P1|Treatment Period 2|Lost to Follow-up|0
236550|NCT01468207|781379|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
236551|NCT01468207|781380|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
236552|NCT01468207|781381|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
236553|NCT01468207|781382|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
236554|NCT01468207|781383|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
236555|NCT01468207|781384|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
236556|NCT01468207|781379|P6|Treatment Period 2|Withdrawal by Subject|2
236557|NCT01468207|781380|P5|Treatment Period 2|Withdrawal by Subject|0
236558|NCT01468207|781381|P4|Treatment Period 2|Withdrawal by Subject|0
236559|NCT01468207|781382|P3|Treatment Period 2|Withdrawal by Subject|5
236560|NCT01468207|781383|P2|Treatment Period 2|Withdrawal by Subject|0
236561|NCT01468207|781384|P1|Treatment Period 2|Withdrawal by Subject|0
236562|NCT01468207|781379|P6|Treatment Period 2|Lack of Efficacy|2
236563|NCT01468207|781380|P5|Treatment Period 2|Lack of Efficacy|0
236564|NCT01468207|781381|P4|Treatment Period 2|Lack of Efficacy|1
236565|NCT01468207|781382|P3|Treatment Period 2|Lack of Efficacy|1
236566|NCT01468207|781383|P2|Treatment Period 2|Lack of Efficacy|0
236567|NCT01468207|781384|P1|Treatment Period 2|Lack of Efficacy|0
236568|NCT01468207|781379|P6|Treatment Period 2|Adverse Event|1
236569|NCT01468207|781380|P5|Treatment Period 2|Adverse Event|2
236570|NCT01468207|781381|P4|Treatment Period 2|Adverse Event|1
236571|NCT01468207|781382|P3|Treatment Period 2|Adverse Event|6
236572|NCT01468207|781383|P2|Treatment Period 2|Adverse Event|0
236573|NCT01468207|781384|P1|Treatment Period 2|Adverse Event|0
236574|NCT01468207|781379|P6|Treatment Period 1|Not specified|0
236575|NCT01468207|781380|P5|Treatment Period 1|Not specified|0
236576|NCT01468207|781381|P4|Treatment Period 1|Not specified|0
236577|NCT01468207|781382|P3|Treatment Period 1|Not specified|0
236578|NCT01468207|781383|P2|Treatment Period 1|Not specified|2
236579|NCT01468207|781384|P1|Treatment Period 1|Not specified|0
236580|NCT01468207|781379|P6|Treatment Period 1|Lost to Follow-up|0
236581|NCT01468207|781380|P5|Treatment Period 1|Lost to Follow-up|0
236582|NCT01468207|781381|P4|Treatment Period 1|Lost to Follow-up|0
236583|NCT01468207|781382|P3|Treatment Period 1|Lost to Follow-up|0
236584|NCT01468207|781383|P2|Treatment Period 1|Lost to Follow-up|1
236585|NCT01468207|781384|P1|Treatment Period 1|Lost to Follow-up|2
236586|NCT01468207|781379|P6|Treatment Period 1|Withdrawal by Subject|0
236587|NCT01468207|781380|P5|Treatment Period 1|Withdrawal by Subject|0
236588|NCT01468207|781381|P4|Treatment Period 1|Withdrawal by Subject|0
236589|NCT01468207|781382|P3|Treatment Period 1|Withdrawal by Subject|0
236590|NCT01468207|781383|P2|Treatment Period 1|Withdrawal by Subject|4
236591|NCT01468207|781384|P1|Treatment Period 1|Withdrawal by Subject|5
236592|NCT01468207|781379|P6|Treatment Period 1|Protocol Violation|0
236593|NCT01468207|781380|P5|Treatment Period 1|Protocol Violation|0
236594|NCT01468207|781381|P4|Treatment Period 1|Protocol Violation|0
236595|NCT01468207|781382|P3|Treatment Period 1|Protocol Violation|0
236596|NCT01468207|781383|P2|Treatment Period 1|Protocol Violation|1
236597|NCT01468207|781384|P1|Treatment Period 1|Protocol Violation|1
236598|NCT01468207|781379|P6|Treatment Period 1|Adverse Event|0
236599|NCT01468207|781380|P5|Treatment Period 1|Adverse Event|0
236600|NCT01468207|781381|P4|Treatment Period 1|Adverse Event|0
236601|NCT01468207|781382|P3|Treatment Period 1|Adverse Event|0
236602|NCT01468207|781383|P2|Treatment Period 1|Adverse Event|0
236603|NCT01468207|781384|P1|Treatment Period 1|Adverse Event|1
236604|NCT01468181|781409|P5|Overall Study|Withdrawal by Subject|0
236605|NCT01468181|781410|P4|Overall Study|Withdrawal by Subject|0
236606|NCT01468181|781411|P3|Overall Study|Withdrawal by Subject|0
236607|NCT01468181|781412|P2|Overall Study|Withdrawal by Subject|1
236608|NCT01468181|781413|P1|Overall Study|Withdrawal by Subject|0
236609|NCT01468181|781409|P5|Overall Study|Lost to Follow-up|1
236610|NCT01468181|781410|P4|Overall Study|Lost to Follow-up|0
236611|NCT01468181|781411|P3|Overall Study|Lost to Follow-up|1
236612|NCT01468181|781412|P2|Overall Study|Lost to Follow-up|0
236613|NCT01468181|781413|P1|Overall Study|Lost to Follow-up|0
236614|NCT01468181|781409|P5|Overall Study|Physician Decision|1
236615|NCT01468181|781410|P4|Overall Study|Physician Decision|1
236616|NCT01468181|781411|P3|Overall Study|Physician Decision|0
236617|NCT01468181|781412|P2|Overall Study|Physician Decision|0
236618|NCT01468181|781413|P1|Overall Study|Physician Decision|0
236619|NCT01468181|781409|P5|Overall Study|Protocol Violation|1
236620|NCT01468181|781410|P4|Overall Study|Protocol Violation|0
236621|NCT01468181|781411|P3|Overall Study|Protocol Violation|1
236622|NCT01468181|781412|P2|Overall Study|Protocol Violation|0
236623|NCT01468181|781413|P1|Overall Study|Protocol Violation|2
236624|NCT01468181|781409|P5|Overall Study|Adverse Event|2
236625|NCT01468181|781410|P4|Overall Study|Adverse Event|2
236626|NCT01468181|781411|P3|Overall Study|Adverse Event|6
236627|NCT01468181|781412|P2|Overall Study|Adverse Event|1
236628|NCT01468181|781413|P1|Overall Study|Adverse Event|8
236629|NCT01468077|781462|P2|Overall Study|Physician Decision|0
236630|NCT01468077|781463|P1|Overall Study|Physician Decision|1
236631|NCT01468077|781462|P2|Overall Study|Lack of Efficacy|1
236632|NCT01468077|781463|P1|Overall Study|Lack of Efficacy|1
236633|NCT01468077|781462|P2|Overall Study|Adverse Event|2
236634|NCT01468077|781463|P1|Overall Study|Adverse Event|2
236635|NCT01467960|781516|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
236636|NCT01467960|781517|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
236637|NCT01467960|781518|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
236638|NCT01467960|781519|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
236639|NCT01467960|781520|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
236640|NCT01467960|781521|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
236641|NCT01467713|781580|P4|Overall Study|Reason not Specified|7
236642|NCT01467713|781581|P3|Overall Study|Reason not Specified|8
236643|NCT01467713|781582|P2|Overall Study|Reason not Specified|11
236644|NCT01467713|781583|P1|Overall Study|Reason not Specified|6
236645|NCT01467713|781580|P4|Overall Study|Relapse|35
236646|NCT01467713|781581|P3|Overall Study|Relapse|28
236647|NCT01467713|781582|P2|Overall Study|Relapse|25
236648|NCT01467713|781583|P1|Overall Study|Relapse|35
236649|NCT01467713|781580|P4|Overall Study|Pregnancy|3
236650|NCT01467713|781581|P3|Overall Study|Pregnancy|1
236651|NCT01467713|781582|P2|Overall Study|Pregnancy|1
236652|NCT01467713|781583|P1|Overall Study|Pregnancy|0
236653|NCT01467713|781580|P4|Overall Study|Study Termination|29
236654|NCT01467713|781581|P3|Overall Study|Study Termination|28
236655|NCT01467713|781582|P2|Overall Study|Study Termination|33
236656|NCT01467713|781583|P1|Overall Study|Study Termination|23
236657|NCT01467713|781580|P4|Overall Study|Voluntary Withdrawal|20
236658|NCT01467713|781581|P3|Overall Study|Voluntary Withdrawal|21
236659|NCT01467713|781582|P2|Overall Study|Voluntary Withdrawal|14
236660|NCT01467713|781583|P1|Overall Study|Voluntary Withdrawal|18
236661|NCT01467713|781580|P4|Overall Study|Lost to Follow-up|9
236662|NCT01467713|781581|P3|Overall Study|Lost to Follow-up|6
236663|NCT01467713|781582|P2|Overall Study|Lost to Follow-up|12
236664|NCT01467713|781583|P1|Overall Study|Lost to Follow-up|9
236665|NCT01467713|781580|P4|Overall Study|Major Protocol Deviation|1
236666|NCT01467713|781581|P3|Overall Study|Major Protocol Deviation|4
236667|NCT01467713|781582|P2|Overall Study|Major Protocol Deviation|4
236668|NCT01467713|781583|P1|Overall Study|Major Protocol Deviation|2
236669|NCT01467713|781580|P4|Overall Study|Pretreatment Event or Adverse Event|5
236670|NCT01467713|781581|P3|Overall Study|Pretreatment Event or Adverse Event|6
236671|NCT01467713|781582|P2|Overall Study|Pretreatment Event or Adverse Event|4
236672|NCT01467713|781583|P1|Overall Study|Pretreatment Event or Adverse Event|9
236673|NCT01467700|781637|P4|Overall Study|Reason not Specified|8
236674|NCT01467700|781638|P3|Overall Study|Reason not Specified|2
236675|NCT01467700|781639|P2|Overall Study|Reason not Specified|3
236676|NCT01467700|781640|P1|Overall Study|Reason not Specified|1
236677|NCT01467700|781637|P4|Overall Study|Lack of Efficacy|1
236678|NCT01467700|781638|P3|Overall Study|Lack of Efficacy|2
236679|NCT01467700|781639|P2|Overall Study|Lack of Efficacy|0
236680|NCT01467700|781640|P1|Overall Study|Lack of Efficacy|2
236681|NCT01467700|781637|P4|Overall Study|Pregnancy|0
236682|NCT01467700|781638|P3|Overall Study|Pregnancy|1
236683|NCT01467700|781639|P2|Overall Study|Pregnancy|1
236684|NCT01467700|781640|P1|Overall Study|Pregnancy|0
236685|NCT01467700|781637|P4|Overall Study|Study Termination|7
236686|NCT01467700|781638|P3|Overall Study|Study Termination|10
236687|NCT01467700|781639|P2|Overall Study|Study Termination|5
236688|NCT01467700|781640|P1|Overall Study|Study Termination|6
236689|NCT01467700|781637|P4|Overall Study|Voluntary Withdrawal|2
236690|NCT01467700|781638|P3|Overall Study|Voluntary Withdrawal|6
236691|NCT01467700|781639|P2|Overall Study|Voluntary Withdrawal|7
236692|NCT01467700|781640|P1|Overall Study|Voluntary Withdrawal|5
236693|NCT01467700|781637|P4|Overall Study|Lost to Follow-up|3
236694|NCT01467700|781638|P3|Overall Study|Lost to Follow-up|2
236695|NCT01467700|781639|P2|Overall Study|Lost to Follow-up|5
236696|NCT01467700|781640|P1|Overall Study|Lost to Follow-up|6
236697|NCT01467700|781637|P4|Overall Study|Major Protocol Deviation|3
236698|NCT01467700|781638|P3|Overall Study|Major Protocol Deviation|2
236699|NCT01467700|781639|P2|Overall Study|Major Protocol Deviation|3
236700|NCT01467700|781640|P1|Overall Study|Major Protocol Deviation|3
236701|NCT01467700|781637|P4|Overall Study|Pretreatment Event or Adverse Event|3
236702|NCT01467700|781638|P3|Overall Study|Pretreatment Event or Adverse Event|2
236703|NCT01467700|781639|P2|Overall Study|Pretreatment Event or Adverse Event|4
236704|NCT01467700|781640|P1|Overall Study|Pretreatment Event or Adverse Event|6
236705|NCT01467661|781682|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
236706|NCT01467661|781682|P1|Overall Study|Lack of Efficacy|3
236707|NCT01467661|781682|P1|Overall Study|Withdrawal by Subject|1
236708|NCT01467661|781682|P1|Overall Study|Adverse Event|16
236709|NCT01467583|781702|P3|Overall Study|Protocol Violation|2
236710|NCT01467583|781703|P2|Overall Study|Protocol Violation|0
236711|NCT01467583|781704|P1|Overall Study|Protocol Violation|0
236712|NCT01467583|781702|P3|Overall Study|Withdrawal by Subject|0
236713|NCT01467583|781703|P2|Overall Study|Withdrawal by Subject|0
236714|NCT01467583|781704|P1|Overall Study|Withdrawal by Subject|1
236715|NCT01467583|781702|P3|Overall Study|Death|0
236716|NCT01467583|781703|P2|Overall Study|Death|1
236717|NCT01467583|781704|P1|Overall Study|Death|1
236718|NCT01467570|781717|P2|Overall Study|Lost to Follow-up|9
236719|NCT01467570|781718|P1|Overall Study|Lost to Follow-up|8
236720|NCT01467505|781755|P2|Overall Study|Study Terminated by Sponsor|3
236721|NCT01467505|781756|P1|Overall Study|Study Terminated by Sponsor|28
236722|NCT01467505|781755|P2|Overall Study|Withdrawal by Subject|0
236723|NCT01467505|781756|P1|Overall Study|Withdrawal by Subject|4
236724|NCT01467505|781755|P2|Overall Study|Adverse Event|0
236725|NCT01467505|781756|P1|Overall Study|Adverse Event|1
236726|NCT01467492|781788|P2|Overall Study|Enrolled But Not Treated|0
236727|NCT01467492|781789|P1|Overall Study|Enrolled But Not Treated|1
236728|NCT01467492|781788|P2|Overall Study|Undefined|0
236729|NCT01467492|781789|P1|Overall Study|Undefined|2
236730|NCT01467492|781788|P2|Overall Study|Lost to Follow-up|2
236731|NCT01467492|781789|P1|Overall Study|Lost to Follow-up|3
236732|NCT01467492|781788|P2|Overall Study|Adverse Event|3
236733|NCT01467492|781789|P1|Overall Study|Adverse Event|4
236734|NCT01467492|781788|P2|Overall Study|Study Terminated by Sponsor|4
236735|NCT01467492|781789|P1|Overall Study|Study Terminated by Sponsor|6
236736|NCT01467492|781788|P2|Overall Study|Withdrawal by Subject|4
236737|NCT01467492|781789|P1|Overall Study|Withdrawal by Subject|6
236738|NCT01467479|781813|P3|Overall Study|Unspecified|0
236739|NCT01467479|781814|P2|Overall Study|Unspecified|0
236740|NCT01467479|781815|P1|Overall Study|Unspecified|1
236741|NCT01467479|781813|P3|Overall Study|Study Terminated by Sponsor|3
236742|NCT01467479|781814|P2|Overall Study|Study Terminated by Sponsor|3
236743|NCT01467479|781815|P1|Overall Study|Study Terminated by Sponsor|1
236744|NCT01467479|781813|P3|Overall Study|Withdrawal of Consent|7
236745|NCT01467479|781814|P2|Overall Study|Withdrawal of Consent|7
236746|NCT01467479|781815|P1|Overall Study|Withdrawal of Consent|3
236747|NCT01467479|781813|P3|Overall Study|Lost to Follow-up|3
236748|NCT01467479|781814|P2|Overall Study|Lost to Follow-up|5
236749|NCT01467479|781815|P1|Overall Study|Lost to Follow-up|2
236750|NCT01467479|781813|P3|Overall Study|Death|1
236751|NCT01467479|781814|P2|Overall Study|Death|0
236752|NCT01467479|781815|P1|Overall Study|Death|0
236753|NCT01467479|781813|P3|Overall Study|Adverse Event|0
236754|NCT01467479|781814|P2|Overall Study|Adverse Event|2
236755|NCT01467479|781815|P1|Overall Study|Adverse Event|1
236756|NCT01467479|781813|P3|Overall Study|No Study Medication|2
236757|NCT01467479|781814|P2|Overall Study|No Study Medication|0
236758|NCT01467479|781815|P1|Overall Study|No Study Medication|1
236759|NCT01467076|781845|P3|Overall Study|Lost to Follow-up|0
236760|NCT01467076|781846|P2|Overall Study|Lost to Follow-up|0
236761|NCT01467076|781847|P1|Overall Study|Lost to Follow-up|1
236762|NCT01466881|781864|P1|Overall Study|Other reason not protocol specified|5
236763|NCT01466881|781864|P1|Overall Study|Death|4
236764|NCT01466881|781864|P1|Overall Study|Progression/relapse|20
236765|NCT01466881|781864|P1|Overall Study|Adverse Event|6
236766|NCT01466881|781864|P1|Overall Study|Ineligible|5
236767|NCT01466790|781881|P8|Overall Study|Withdrawal by Subject|1
236768|NCT01466790|781882|P7|Overall Study|Withdrawal by Subject|1
236769|NCT01466790|781883|P6|Overall Study|Withdrawal by Subject|0
236770|NCT01466790|781884|P5|Overall Study|Withdrawal by Subject|1
236771|NCT01466790|781885|P4|Overall Study|Withdrawal by Subject|0
236772|NCT01466790|781886|P3|Overall Study|Withdrawal by Subject|0
236773|NCT01466790|781887|P2|Overall Study|Withdrawal by Subject|1
236774|NCT01466790|781888|P1|Overall Study|Withdrawal by Subject|1
236775|NCT01466790|781881|P8|Overall Study|Lost to Follow-up|0
236776|NCT01466790|781882|P7|Overall Study|Lost to Follow-up|0
236777|NCT01466790|781883|P6|Overall Study|Lost to Follow-up|0
236778|NCT01466790|781884|P5|Overall Study|Lost to Follow-up|0
236779|NCT01466790|781885|P4|Overall Study|Lost to Follow-up|0
236780|NCT01466790|781886|P3|Overall Study|Lost to Follow-up|0
236781|NCT01466790|781887|P2|Overall Study|Lost to Follow-up|0
236782|NCT01466790|781888|P1|Overall Study|Lost to Follow-up|2
236783|NCT01466790|781881|P8|Overall Study|Adverse Event|0
236784|NCT01466790|781882|P7|Overall Study|Adverse Event|0
236785|NCT01466790|781883|P6|Overall Study|Adverse Event|0
236786|NCT01466790|781884|P5|Overall Study|Adverse Event|2
236787|NCT01466790|781885|P4|Overall Study|Adverse Event|0
236788|NCT01466790|781886|P3|Overall Study|Adverse Event|0
236789|NCT01466790|781887|P2|Overall Study|Adverse Event|0
236790|NCT01466790|781888|P1|Overall Study|Adverse Event|1
236791|NCT01466673|781952|P2|Overall Study|Adverse Event|1
236792|NCT01466673|781953|P1|Overall Study|Adverse Event|2
236793|NCT01466673|781952|P2|Overall Study|Lost to Follow-up|5
236794|NCT01466673|781953|P1|Overall Study|Lost to Follow-up|3
236795|NCT01466673|781952|P2|Overall Study|Non-compliance with study treatment|0
236796|NCT01466673|781953|P1|Overall Study|Non-compliance with study treatment|2
236797|NCT01466595|781979|P2|Overall Study|Withdrawal by Subject|1
236798|NCT01466595|781980|P1|Overall Study|Withdrawal by Subject|0
236799|NCT01466387|782076|P6|Overall Study|Protocol Violation|0
236800|NCT01466387|782077|P5|Overall Study|Protocol Violation|0
236801|NCT01466387|782078|P4|Overall Study|Protocol Violation|1
236802|NCT01466387|782079|P3|Overall Study|Protocol Violation|0
236803|NCT01466387|782080|P2|Overall Study|Protocol Violation|0
236804|NCT01466387|782081|P1|Overall Study|Protocol Violation|1
236805|NCT01466387|782076|P6|Overall Study|Lost to Follow-up|1
236806|NCT01466387|782077|P5|Overall Study|Lost to Follow-up|0
236807|NCT01466387|782078|P4|Overall Study|Lost to Follow-up|0
236808|NCT01466387|782079|P3|Overall Study|Lost to Follow-up|0
236809|NCT01466387|782080|P2|Overall Study|Lost to Follow-up|0
236810|NCT01466387|782081|P1|Overall Study|Lost to Follow-up|0
236811|NCT01466387|782076|P6|Overall Study|Adverse Event|0
236812|NCT01466387|782077|P5|Overall Study|Adverse Event|0
236813|NCT01466387|782078|P4|Overall Study|Adverse Event|1
236814|NCT01466387|782079|P3|Overall Study|Adverse Event|1
236815|NCT01466387|782080|P2|Overall Study|Adverse Event|0
236816|NCT01466387|782081|P1|Overall Study|Adverse Event|0
236817|NCT01466348|782142|P2|Period I - First Intervention|Withdrawal by Subject|1
236818|NCT01466348|782143|P1|Period I - First Intervention|Withdrawal by Subject|0
236819|NCT01466270|782171|P2|Overall Study|Multiple|1
236820|NCT01466270|782172|P1|Overall Study|Multiple|1
236821|NCT01466270|782171|P2|Overall Study|Toxicity|1
236822|NCT01466270|782172|P1|Overall Study|Toxicity|4
236823|NCT01466270|782171|P2|Overall Study|Progression|0
236824|NCT01466270|782172|P1|Overall Study|Progression|1
236825|NCT01466270|782171|P2|Overall Study|Lost to Follow-up|3
236826|NCT01466270|782172|P1|Overall Study|Lost to Follow-up|1
236827|NCT01466270|782171|P2|Overall Study|Physician Decision|0
236828|NCT01466270|782172|P1|Overall Study|Physician Decision|1
236829|NCT01466270|782171|P2|Overall Study|Withdrawal by Subject|1
236830|NCT01466270|782172|P1|Overall Study|Withdrawal by Subject|4
236831|NCT01466192|782184|P1|Overall Study|Withdrawal by Subject|3
236832|NCT01466192|782184|P1|Overall Study|Physician Decision|1
236833|NCT01466179|782188|P1|Overall Study|Other|3
236834|NCT01466179|782188|P1|Overall Study|Protocol Violation|2
236835|NCT01466179|782188|P1|Overall Study|Withdrawal by Subject|7
236836|NCT01466179|782188|P1|Overall Study|Death|7
236837|NCT01466179|782188|P1|Overall Study|Lack of Efficacy|14
236838|NCT01466179|782188|P1|Overall Study|Disease relapse|23
236839|NCT01466179|782188|P1|Overall Study|Adverse Event|32
236840|NCT01466179|782188|P1|Overall Study|Progressive disease|43
236841|NCT01466179|782188|P1|Overall Study|Physician Decision|46
236842|NCT01466179|782188|P1|Overall Study|Ongoing in core study|2
236843|NCT01466153|782211|P3|Overall Study|Other-Unspecified|2
236844|NCT01466153|782212|P2|Overall Study|Other-Unspecified|4
236845|NCT01466153|782213|P1|Overall Study|Other-Unspecified|6
236846|NCT01466153|782211|P3|Overall Study|Randomized-Not Treated|4
236847|NCT01466153|782212|P2|Overall Study|Randomized-Not Treated|3
236848|NCT01466153|782213|P1|Overall Study|Randomized-Not Treated|2
236849|NCT01466153|782211|P3|Overall Study|Investigator Discretion|2
236850|NCT01466153|782212|P2|Overall Study|Investigator Discretion|2
236851|NCT01466153|782213|P1|Overall Study|Investigator Discretion|3
236852|NCT01466153|782211|P3|Overall Study|Withdrawal of Consent|0
236853|NCT01466153|782212|P2|Overall Study|Withdrawal of Consent|0
236854|NCT01466153|782213|P1|Overall Study|Withdrawal of Consent|2
236855|NCT01466153|782211|P3|Overall Study|Adverse Event|17
236856|NCT01466153|782212|P2|Overall Study|Adverse Event|13
236857|NCT01466153|782213|P1|Overall Study|Adverse Event|14
236858|NCT01466153|782211|P3|Overall Study|Disease Progression|0
236859|NCT01466153|782212|P2|Overall Study|Disease Progression|2
236860|NCT01466153|782213|P1|Overall Study|Disease Progression|2
236861|NCT01466062|782268|P1|Overall Study|Withdrawal by Subject|1
236862|NCT01466062|782268|P1|Overall Study|Adverse Event|1
236863|NCT01465958|782289|P2|Subcutaneous (SC) Phase|Adverse Event|1
236864|NCT01465958|782290|P1|Subcutaneous (SC) Phase|Adverse Event|0
236865|NCT01465958|782289|P2|Run-in Phase|Protocol Violation|0
236866|NCT01465958|782290|P1|Run-in Phase|Protocol Violation|1
236867|NCT01465802|782303|P5|Overall Study|Death|2
236868|NCT01465802|782304|P4|Overall Study|Death|10
236869|NCT01465802|782305|P3|Overall Study|Death|0
236870|NCT01465802|782306|P2|Overall Study|Death|12
236871|NCT01465802|782307|P1|Overall Study|Death|15
236872|NCT01465802|782303|P5|Overall Study|Reason not specified|2
236873|NCT01465802|782304|P4|Overall Study|Reason not specified|10
236874|NCT01465802|782305|P3|Overall Study|Reason not specified|0
236875|NCT01465802|782306|P2|Overall Study|Reason not specified|4
236876|NCT01465802|782307|P1|Overall Study|Reason not specified|9
236877|NCT01465802|782303|P5|Overall Study|Lost to Follow-up|0
236878|NCT01465802|782304|P4|Overall Study|Lost to Follow-up|0
236879|NCT01465802|782305|P3|Overall Study|Lost to Follow-up|0
236880|NCT01465802|782306|P2|Overall Study|Lost to Follow-up|1
236881|NCT01465802|782307|P1|Overall Study|Lost to Follow-up|1
236882|NCT01465802|782303|P5|Overall Study|Withdrawal by Subject|1
236883|NCT01465802|782304|P4|Overall Study|Withdrawal by Subject|8
236884|NCT01465802|782305|P3|Overall Study|Withdrawal by Subject|0
236885|NCT01465802|782306|P2|Overall Study|Withdrawal by Subject|7
236886|NCT01465802|782307|P1|Overall Study|Withdrawal by Subject|7
236887|NCT01465802|782303|P5|Overall Study|Study terminated by sponsor|7
236888|NCT01465802|782304|P4|Overall Study|Study terminated by sponsor|1
236889|NCT01465802|782305|P3|Overall Study|Study terminated by sponsor|0
236890|NCT01465802|782306|P2|Overall Study|Study terminated by sponsor|0
236891|NCT01465802|782307|P1|Overall Study|Study terminated by sponsor|1
236892|NCT01465763|782359|P3|Overall Study|Death|0
236893|NCT01465763|782360|P2|Overall Study|Death|0
236894|NCT01465763|782361|P1|Overall Study|Death|1
236895|NCT01465763|782359|P3|Overall Study|Protocol Violation|1
236896|NCT01465763|782360|P2|Overall Study|Protocol Violation|1
236897|NCT01465763|782361|P1|Overall Study|Protocol Violation|4
236898|NCT01465763|782359|P3|Overall Study|Unspecified|0
236899|NCT01465763|782360|P2|Overall Study|Unspecified|0
236900|NCT01465763|782361|P1|Overall Study|Unspecified|2
236901|NCT01465763|782359|P3|Overall Study|Adverse Event|1
236902|NCT01465763|782360|P2|Overall Study|Adverse Event|0
236903|NCT01465763|782361|P1|Overall Study|Adverse Event|9
236904|NCT01465763|782359|P3|Overall Study|Insufficient Clinical Response|1
236905|NCT01465763|782360|P2|Overall Study|Insufficient Clinical Response|0
236906|NCT01465763|782361|P1|Overall Study|Insufficient Clinical Response|11
236907|NCT01465763|782359|P3|Overall Study|Withdrawal by Subject|1
236908|NCT01465763|782360|P2|Overall Study|Withdrawal by Subject|0
236909|NCT01465763|782361|P1|Overall Study|Withdrawal by Subject|4
236910|NCT01465386|782431|P1|Overall Study|Adverse Event|1
236911|NCT01465386|782431|P1|Overall Study|Lack of Efficacy|3
236912|NCT01465230|782435|P1|Overall Study|Withdrawal by Subject|2
236913|NCT01465178|782441|P2|Overall Study|Withdrawal by Subject|0
236914|NCT01465178|782442|P1|Overall Study|Withdrawal by Subject|1
236915|NCT01465022|782466|P3|Overall Study|Not Randomized|70
236916|NCT01465022|782467|P2|Overall Study|Not Randomized|0
236917|NCT01465022|782468|P1|Overall Study|Not Randomized|0
236918|NCT01465022|782466|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
236919|NCT01465022|782467|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
236920|NCT01465022|782468|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
236921|NCT01465022|782466|P3|Overall Study|Lost to Follow-up|0
236922|NCT01465022|782467|P2|Overall Study|Lost to Follow-up|14
236923|NCT01465022|782468|P1|Overall Study|Lost to Follow-up|15
236924|NCT01464931|782502|P2|Overall Study|Withdrawal by Subject|0
236925|NCT01464931|782503|P1|Overall Study|Withdrawal by Subject|1
236926|NCT01464827|782567|P14|Overall Study|Not Treated|2
236927|NCT01464827|782568|P13|Overall Study|Not Treated|0
236928|NCT01464827|782569|P12|Overall Study|Not Treated|1
236929|NCT01464827|782570|P11|Overall Study|Not Treated|0
236930|NCT01464827|782571|P10|Overall Study|Not Treated|2
236931|NCT01464827|782572|P9|Overall Study|Not Treated|0
236932|NCT01464827|782573|P8|Overall Study|Not Treated|0
236933|NCT01464827|782574|P7|Overall Study|Not Treated|1
236934|NCT01464827|782575|P6|Overall Study|Not Treated|0
236935|NCT01464827|782576|P5|Overall Study|Not Treated|1
236936|NCT01464827|782577|P4|Overall Study|Not Treated|0
236937|NCT01464827|782578|P3|Overall Study|Not Treated|0
236938|NCT01464827|782579|P2|Overall Study|Not Treated|2
236939|NCT01464827|782580|P1|Overall Study|Not Treated|0
236940|NCT01464827|782567|P14|Overall Study|Other|0
236941|NCT01464827|782568|P13|Overall Study|Other|1
236942|NCT01464827|782569|P12|Overall Study|Other|0
236943|NCT01464827|782570|P11|Overall Study|Other|2
236944|NCT01464827|782571|P10|Overall Study|Other|1
236945|NCT01464827|782572|P9|Overall Study|Other|3
236946|NCT01464827|782573|P8|Overall Study|Other|0
236947|NCT01464827|782574|P7|Overall Study|Other|1
236948|NCT01464827|782575|P6|Overall Study|Other|0
236949|NCT01464827|782576|P5|Overall Study|Other|3
236950|NCT01464827|782577|P4|Overall Study|Other|2
236951|NCT01464827|782578|P3|Overall Study|Other|0
236952|NCT01464827|782579|P2|Overall Study|Other|3
236953|NCT01464827|782580|P1|Overall Study|Other|2
236954|NCT01464827|782567|P14|Overall Study|Lost to Follow-up|1
236955|NCT01464827|782568|P13|Overall Study|Lost to Follow-up|0
236956|NCT01464827|782569|P12|Overall Study|Lost to Follow-up|1
236957|NCT01464827|782570|P11|Overall Study|Lost to Follow-up|0
236958|NCT01464827|782571|P10|Overall Study|Lost to Follow-up|0
236959|NCT01464827|782572|P9|Overall Study|Lost to Follow-up|0
236960|NCT01464827|782573|P8|Overall Study|Lost to Follow-up|2
236961|NCT01464827|782574|P7|Overall Study|Lost to Follow-up|2
236962|NCT01464827|782575|P6|Overall Study|Lost to Follow-up|1
236963|NCT01464827|782576|P5|Overall Study|Lost to Follow-up|3
236964|NCT01464827|782577|P4|Overall Study|Lost to Follow-up|2
236965|NCT01464827|782578|P3|Overall Study|Lost to Follow-up|0
236966|NCT01464827|782579|P2|Overall Study|Lost to Follow-up|2
236967|NCT01464827|782580|P1|Overall Study|Lost to Follow-up|0
236968|NCT01464827|782567|P14|Overall Study|Withdrawal by Subject|0
236969|NCT01464827|782568|P13|Overall Study|Withdrawal by Subject|0
236970|NCT01464827|782569|P12|Overall Study|Withdrawal by Subject|0
236971|NCT01464827|782570|P11|Overall Study|Withdrawal by Subject|0
236972|NCT01464827|782571|P10|Overall Study|Withdrawal by Subject|0
236973|NCT01464827|782572|P9|Overall Study|Withdrawal by Subject|0
236974|NCT01464827|782573|P8|Overall Study|Withdrawal by Subject|1
236975|NCT01464827|782574|P7|Overall Study|Withdrawal by Subject|0
236976|NCT01464827|782575|P6|Overall Study|Withdrawal by Subject|0
236977|NCT01464827|782576|P5|Overall Study|Withdrawal by Subject|1
236978|NCT01464827|782577|P4|Overall Study|Withdrawal by Subject|0
236979|NCT01464827|782578|P3|Overall Study|Withdrawal by Subject|0
236980|NCT01464827|782579|P2|Overall Study|Withdrawal by Subject|0
236981|NCT01464827|782580|P1|Overall Study|Withdrawal by Subject|1
236982|NCT01464827|782567|P14|Overall Study|Adverse Event|0
236983|NCT01464827|782568|P13|Overall Study|Adverse Event|1
236984|NCT01464827|782569|P12|Overall Study|Adverse Event|0
236985|NCT01464827|782570|P11|Overall Study|Adverse Event|0
236986|NCT01464827|782571|P10|Overall Study|Adverse Event|0
236987|NCT01464827|782572|P9|Overall Study|Adverse Event|0
236988|NCT01464827|782573|P8|Overall Study|Adverse Event|0
236989|NCT01464827|782574|P7|Overall Study|Adverse Event|0
236990|NCT01464827|782575|P6|Overall Study|Adverse Event|0
236991|NCT01464827|782576|P5|Overall Study|Adverse Event|0
236992|NCT01464827|782577|P4|Overall Study|Adverse Event|0
236993|NCT01464827|782578|P3|Overall Study|Adverse Event|0
236994|NCT01464827|782579|P2|Overall Study|Adverse Event|0
236995|NCT01464827|782580|P1|Overall Study|Adverse Event|0
236996|NCT01464788|782627|P3|Overall Study|Patient had hemorrhage after tPA started|0
236997|NCT01464788|782628|P2|Overall Study|Patient had hemorrhage after tPA started|1
236998|NCT01464788|782629|P1|Overall Study|Patient had hemorrhage after tPA started|0
236999|NCT01464788|782627|P3|Overall Study|Lost to Follow-up|0
237000|NCT01464788|782628|P2|Overall Study|Lost to Follow-up|1
237001|NCT01464788|782629|P1|Overall Study|Lost to Follow-up|0
237002|NCT01464619|782642|P2|Overall Study|Lost to Follow-up|4
237003|NCT01464619|782643|P1|Overall Study|Lost to Follow-up|3
237004|NCT01464424|782663|P2|Period 1, First 6 Weeks|Adverse Event|1
237005|NCT01464424|782664|P1|Period 1, First 6 Weeks|Adverse Event|0
237006|NCT01464307|782686|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
237007|NCT01464307|782687|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
237008|NCT01464307|782686|P2|Open-Label Extension Period|Non-compliance|0
237009|NCT01464307|782687|P1|Open-Label Extension Period|Non-compliance|9
237010|NCT01464307|782686|P2|Open-Label Extension Period|Lost to Follow-up|0
237011|NCT01464307|782687|P1|Open-Label Extension Period|Lost to Follow-up|1
237012|NCT01464307|782686|P2|Open-Label Extension Period|Death|0
237013|NCT01464307|782687|P1|Open-Label Extension Period|Death|1
237014|NCT01464307|782686|P2|Open-Label Extension Period|Lack of Efficacy|0
237015|NCT01464307|782687|P1|Open-Label Extension Period|Lack of Efficacy|5
237016|NCT01464307|782686|P2|Open-Label Extension Period|Withdrawal by Subject|0
237017|NCT01464307|782687|P1|Open-Label Extension Period|Withdrawal by Subject|14
237018|NCT01464307|782686|P2|Open-Label Extension Period|Adverse Event|0
237019|NCT01464307|782687|P1|Open-Label Extension Period|Adverse Event|15
237020|NCT01464307|782686|P2|Main Period|Predefined discontinuation criteria|1
237021|NCT01464307|782687|P1|Main Period|Predefined discontinuation criteria|2
237022|NCT01464307|782686|P2|Main Period|Withdrawal by Subject|2
237023|NCT01464307|782687|P1|Main Period|Withdrawal by Subject|5
237024|NCT01464307|782686|P2|Main Period|Lack of Efficacy|0
237025|NCT01464307|782687|P1|Main Period|Lack of Efficacy|2
237026|NCT01464307|782686|P2|Main Period|Adverse Event|1
237027|NCT01464307|782687|P1|Main Period|Adverse Event|6
237028|NCT01464307|782686|P2|Main Period|Death|1
237029|NCT01464307|782687|P1|Main Period|Death|0
237030|NCT01464255|782702|P2|Overall Study|unresolve corneal staining|1
237031|NCT01464255|782703|P1|Overall Study|unresolve corneal staining|0
237032|NCT01464021|782748|P1|Overall Study|various|11
237033|NCT01464021|782748|P1|Overall Study|Lack of Efficacy|1
237034|NCT01464021|782748|P1|Overall Study|Lost to Follow-up|1
237035|NCT01464021|782748|P1|Overall Study|Withdrawal by Subject|13
237036|NCT01463982|782764|P4|Overall Study|Treatment delay over 5 week|0
237037|NCT01463982|782765|P3|Overall Study|Treatment delay over 5 week|1
237038|NCT01463982|782766|P2|Overall Study|Treatment delay over 5 week|0
237039|NCT01463982|782767|P1|Overall Study|Treatment delay over 5 week|0
237040|NCT01463982|782764|P4|Overall Study|Withdrawal by Subject|0
237041|NCT01463982|782765|P3|Overall Study|Withdrawal by Subject|1
237042|NCT01463982|782766|P2|Overall Study|Withdrawal by Subject|1
237043|NCT01463982|782767|P1|Overall Study|Withdrawal by Subject|0
237044|NCT01463878|782783|P2|Overall Study|no longer met criteria for tube feed|2
237045|NCT01463878|782784|P1|Overall Study|no longer met criteria for tube feed|2
237046|NCT01463696|782798|P8|Overall Study|Not Treated|0
237047|NCT01463696|782799|P7|Overall Study|Not Treated|1
237048|NCT01463696|782800|P6|Overall Study|Not Treated|0
237049|NCT01463696|782801|P5|Overall Study|Not Treated|0
237050|NCT01463696|782802|P4|Overall Study|Not Treated|0
237051|NCT01463696|782803|P3|Overall Study|Not Treated|0
237052|NCT01463696|782804|P2|Overall Study|Not Treated|0
237053|NCT01463696|782805|P1|Overall Study|Not Treated|0
237054|NCT01463696|782798|P8|Overall Study|Withdrawal by Subject|0
237055|NCT01463696|782799|P7|Overall Study|Withdrawal by Subject|2
237056|NCT01463696|782800|P6|Overall Study|Withdrawal by Subject|1
237057|NCT01463696|782801|P5|Overall Study|Withdrawal by Subject|1
237058|NCT01463696|782802|P4|Overall Study|Withdrawal by Subject|1
237059|NCT01463696|782803|P3|Overall Study|Withdrawal by Subject|0
237060|NCT01463696|782804|P2|Overall Study|Withdrawal by Subject|0
237061|NCT01463696|782805|P1|Overall Study|Withdrawal by Subject|0
237062|NCT01463696|782798|P8|Overall Study|Progressive Disease|2
237063|NCT01463696|782799|P7|Overall Study|Progressive Disease|4
237064|NCT01463696|782800|P6|Overall Study|Progressive Disease|1
237065|NCT01463696|782801|P5|Overall Study|Progressive Disease|0
237066|NCT01463696|782802|P4|Overall Study|Progressive Disease|1
237067|NCT01463696|782803|P3|Overall Study|Progressive Disease|0
237068|NCT01463696|782804|P2|Overall Study|Progressive Disease|1
237069|NCT01463696|782805|P1|Overall Study|Progressive Disease|0
237070|NCT01463696|782798|P8|Overall Study|Lost to Follow-up|0
237071|NCT01463696|782799|P7|Overall Study|Lost to Follow-up|0
237072|NCT01463696|782800|P6|Overall Study|Lost to Follow-up|0
237073|NCT01463696|782801|P5|Overall Study|Lost to Follow-up|0
237074|NCT01463696|782802|P4|Overall Study|Lost to Follow-up|0
237075|NCT01463696|782803|P3|Overall Study|Lost to Follow-up|1
237076|NCT01463696|782804|P2|Overall Study|Lost to Follow-up|0
237077|NCT01463696|782805|P1|Overall Study|Lost to Follow-up|0
237078|NCT01463696|782798|P8|Overall Study|Adverse Event|2
237079|NCT01463696|782799|P7|Overall Study|Adverse Event|3
237080|NCT01463696|782800|P6|Overall Study|Adverse Event|1
237081|NCT01463696|782801|P5|Overall Study|Adverse Event|0
237082|NCT01463696|782802|P4|Overall Study|Adverse Event|2
237083|NCT01463696|782803|P3|Overall Study|Adverse Event|0
237084|NCT01463696|782804|P2|Overall Study|Adverse Event|1
237085|NCT01463696|782805|P1|Overall Study|Adverse Event|0
237086|NCT01463683|782858|P3|Overall Study|Withdrawal by Subject|2
237087|NCT01463683|782859|P2|Overall Study|Withdrawal by Subject|17
237088|NCT01463683|782860|P1|Overall Study|Withdrawal by Subject|5
237089|NCT01463683|782858|P3|Overall Study|Pregnancy|1
237090|NCT01463683|782859|P2|Overall Study|Pregnancy|2
237091|NCT01463683|782860|P1|Overall Study|Pregnancy|2
237092|NCT01463683|782858|P3|Overall Study|Physician Decision|1
237093|NCT01463683|782859|P2|Overall Study|Physician Decision|3
237094|NCT01463683|782860|P1|Overall Study|Physician Decision|0
237095|NCT01463683|782858|P3|Overall Study|Lost to Follow-up|7
237096|NCT01463683|782859|P2|Overall Study|Lost to Follow-up|9
237097|NCT01463683|782860|P1|Overall Study|Lost to Follow-up|10
237098|NCT01463683|782858|P3|Overall Study|Adverse Event|0
237099|NCT01463683|782859|P2|Overall Study|Adverse Event|0
237100|NCT01463683|782860|P1|Overall Study|Adverse Event|2
237101|NCT01463527|782875|P2|Overall Study|Crying >20% of sedation|6
237102|NCT01463527|782876|P1|Overall Study|Crying >20% of sedation|5
237103|NCT01463527|782875|P2|Overall Study|Protocol Violation|1
237104|NCT01463527|782876|P1|Overall Study|Protocol Violation|1
237105|NCT01463293|782897|P3|Overall Study|Other|2
237106|NCT01463293|782898|P2|Overall Study|Other|0
237107|NCT01463293|782899|P1|Overall Study|Other|0
237108|NCT01463293|782897|P3|Overall Study|Withdrawal by Subject|5
237109|NCT01463293|782898|P2|Overall Study|Withdrawal by Subject|10
237110|NCT01463293|782899|P1|Overall Study|Withdrawal by Subject|4
237111|NCT01463293|782897|P3|Overall Study|Adverse Event|0
237112|NCT01463293|782898|P2|Overall Study|Adverse Event|2
237113|NCT01463293|782899|P1|Overall Study|Adverse Event|1
237114|NCT01463293|782897|P3|Overall Study|Lost to Follow-up|5
237115|NCT01463293|782898|P2|Overall Study|Lost to Follow-up|4
237116|NCT01463293|782899|P1|Overall Study|Lost to Follow-up|1
237117|NCT01463111|782907|P1|Overall Study|Physician Decision|2
237118|NCT01463111|782907|P1|Overall Study|Lost to Follow-up|5
237119|NCT01463111|782907|P1|Overall Study|Withdrawal by Subject|2
237120|NCT01463033|782917|P2|Overall Study|Death|2
237121|NCT01463033|782918|P1|Overall Study|Death|3
237122|NCT01463033|782917|P2|Overall Study|Lost to Follow-up|4
237123|NCT01463033|782918|P1|Overall Study|Lost to Follow-up|4
237124|NCT01463007|782925|P1|Overall Study|Physician Decision|1
237125|NCT01462942|782936|P5|Overall Study|Protocol Violation|6
237126|NCT01462942|782937|P4|Overall Study|Protocol Violation|9
237127|NCT01462942|782938|P3|Overall Study|Protocol Violation|9
237128|NCT01462942|782939|P2|Overall Study|Protocol Violation|6
237129|NCT01462942|782940|P1|Overall Study|Protocol Violation|4
237130|NCT01462942|782936|P5|Overall Study|Lost to Follow-up|1
237131|NCT01462942|782937|P4|Overall Study|Lost to Follow-up|1
237132|NCT01462942|782938|P3|Overall Study|Lost to Follow-up|1
237133|NCT01462942|782939|P2|Overall Study|Lost to Follow-up|1
237134|NCT01462942|782940|P1|Overall Study|Lost to Follow-up|0
237135|NCT01462942|782936|P5|Overall Study|Lack of Efficacy|3
237136|NCT01462942|782937|P4|Overall Study|Lack of Efficacy|5
237137|NCT01462942|782938|P3|Overall Study|Lack of Efficacy|4
237138|NCT01462942|782939|P2|Overall Study|Lack of Efficacy|0
237139|NCT01462942|782940|P1|Overall Study|Lack of Efficacy|6
237140|NCT01462942|782936|P5|Overall Study|Withdrawal by Subject|19
237141|NCT01462942|782937|P4|Overall Study|Withdrawal by Subject|16
237142|NCT01462942|782938|P3|Overall Study|Withdrawal by Subject|14
237143|NCT01462942|782939|P2|Overall Study|Withdrawal by Subject|10
237144|NCT01462942|782940|P1|Overall Study|Withdrawal by Subject|14
237145|NCT01462942|782936|P5|Overall Study|Other, including COPD exacerbation|5
237146|NCT01462942|782937|P4|Overall Study|Other, including COPD exacerbation|8
237147|NCT01462942|782938|P3|Overall Study|Other, including COPD exacerbation|2
237148|NCT01462942|782939|P2|Overall Study|Other, including COPD exacerbation|5
237149|NCT01462942|782940|P1|Overall Study|Other, including COPD exacerbation|3
237150|NCT01462942|782936|P5|Overall Study|Adverse Event|11
237151|NCT01462942|782937|P4|Overall Study|Adverse Event|11
237152|NCT01462942|782938|P3|Overall Study|Adverse Event|10
237153|NCT01462942|782939|P2|Overall Study|Adverse Event|12
237154|NCT01462942|782940|P1|Overall Study|Adverse Event|7
237155|NCT01462929|782970|P3|Overall Study|Lack of Efficacy|1
237156|NCT01462929|782971|P2|Overall Study|Lack of Efficacy|0
237157|NCT01462929|782972|P1|Overall Study|Lack of Efficacy|0
237158|NCT01462929|782970|P3|Overall Study|Withdrawal by Subject|0
237159|NCT01462929|782971|P2|Overall Study|Withdrawal by Subject|1
237160|NCT01462929|782972|P1|Overall Study|Withdrawal by Subject|2
237161|NCT01462929|782970|P3|Overall Study|Adverse Event|4
237162|NCT01462929|782971|P2|Overall Study|Adverse Event|3
237163|NCT01462929|782972|P1|Overall Study|Adverse Event|3
237164|NCT01462695|783013|P2|Overall Study|Inevaluable (did not receive study drug)|0
237165|NCT01462695|783014|P1|Overall Study|Inevaluable (did not receive study drug)|1
237166|NCT01462695|783013|P2|Overall Study|Withdrawal by Subject|0
237167|NCT01462695|783014|P1|Overall Study|Withdrawal by Subject|2
237168|NCT01462695|783013|P2|Overall Study|Physician Decision|0
237169|NCT01462695|783014|P1|Overall Study|Physician Decision|5
237170|NCT01462695|783013|P2|Overall Study|Lack of Efficacy|12
237171|NCT01462695|783014|P1|Overall Study|Lack of Efficacy|6
237172|NCT01462695|783013|P2|Overall Study|Death|0
237173|NCT01462695|783014|P1|Overall Study|Death|2
237174|NCT01462695|783013|P2|Overall Study|Adverse Event|1
237175|NCT01462695|783014|P1|Overall Study|Adverse Event|1
237176|NCT01462435|783024|P4|Overall Study|Lost to Follow-up|1
237177|NCT01462435|783025|P3|Overall Study|Lost to Follow-up|0
237178|NCT01462435|783026|P2|Overall Study|Lost to Follow-up|0
237179|NCT01462435|783027|P1|Overall Study|Lost to Follow-up|0
237180|NCT01462435|783024|P4|Overall Study|Withdrawal by Subject|1
237181|NCT01462435|783025|P3|Overall Study|Withdrawal by Subject|0
237182|NCT01462435|783026|P2|Overall Study|Withdrawal by Subject|0
237183|NCT01462435|783027|P1|Overall Study|Withdrawal by Subject|0
237184|NCT01462435|783024|P4|Overall Study|Physician Decision|0
237185|NCT01462435|783025|P3|Overall Study|Physician Decision|1
237186|NCT01462435|783026|P2|Overall Study|Physician Decision|0
237187|NCT01462435|783027|P1|Overall Study|Physician Decision|0
237188|NCT01462435|783024|P4|Overall Study|Lack of Efficacy|3
237189|NCT01462435|783025|P3|Overall Study|Lack of Efficacy|0
237190|NCT01462435|783026|P2|Overall Study|Lack of Efficacy|0
237191|NCT01462435|783027|P1|Overall Study|Lack of Efficacy|1
237192|NCT01462370|783065|P2|Overall Study|Withdrawal by Subject|3
237193|NCT01462370|783066|P1|Overall Study|Withdrawal by Subject|0
237194|NCT01462370|783065|P2|Overall Study|Physician Decision|1
237195|NCT01462370|783066|P1|Overall Study|Physician Decision|0
237196|NCT01462370|783065|P2|Overall Study|Lack of Qualifying Event|1
237197|NCT01462370|783066|P1|Overall Study|Lack of Qualifying Event|1
237198|NCT01462357|783101|P3|Month 24|Migrated/moved from study area|0
237199|NCT01462357|783102|P2|Month 24|Migrated/moved from study area|2
237200|NCT01462357|783103|P1|Month 24|Migrated/moved from study area|0
237201|NCT01462357|783101|P3|Month 24|Lost to Follow-up|6
237202|NCT01462357|783102|P2|Month 24|Lost to Follow-up|4
237203|NCT01462357|783103|P1|Month 24|Lost to Follow-up|2
237204|NCT01462357|783101|P3|Month 24|Withdrawal by Subject|3
237205|NCT01462357|783102|P2|Month 24|Withdrawal by Subject|8
237206|NCT01462357|783103|P1|Month 24|Withdrawal by Subject|2
237207|NCT01462357|783101|P3|Month 18|Unspecified|1
237208|NCT01462357|783102|P2|Month 18|Unspecified|1
237209|NCT01462357|783103|P1|Month 18|Unspecified|0
237210|NCT01462357|783101|P3|Month 18|Lost to Follow-up|5
237211|NCT01462357|783102|P2|Month 18|Lost to Follow-up|4
237212|NCT01462357|783103|P1|Month 18|Lost to Follow-up|1
237213|NCT01462357|783101|P3|Month 18|Withdrawal by Subject|3
237214|NCT01462357|783102|P2|Month 18|Withdrawal by Subject|6
237215|NCT01462357|783103|P1|Month 18|Withdrawal by Subject|2
237216|NCT01462357|783101|P3|Month 12|Lost to Follow-up|5
237217|NCT01462357|783102|P2|Month 12|Lost to Follow-up|4
237218|NCT01462357|783103|P1|Month 12|Lost to Follow-up|1
237219|NCT01462357|783101|P3|Month 12|Withdrawal by Subject|3
237220|NCT01462357|783102|P2|Month 12|Withdrawal by Subject|6
237221|NCT01462357|783103|P1|Month 12|Withdrawal by Subject|2
237222|NCT01462357|783101|P3|Month 7|Withdrawal by Subject|6
237223|NCT01462357|783102|P2|Month 7|Withdrawal by Subject|5
237224|NCT01462357|783103|P1|Month 7|Withdrawal by Subject|1
237225|NCT01462344|783176|P2|Overall Study|Lost to Follow-up|7
237226|NCT01462344|783177|P1|Overall Study|Lost to Follow-up|7
237227|NCT01462344|783176|P2|Overall Study|Protocol Violation|53
237228|NCT01462344|783177|P1|Overall Study|Protocol Violation|68
237229|NCT01462344|783176|P2|Overall Study|Lack of Efficacy|6
237230|NCT01462344|783177|P1|Overall Study|Lack of Efficacy|5
237231|NCT01462344|783176|P2|Overall Study|Asthma Exacerbation|35
237232|NCT01462344|783177|P1|Overall Study|Asthma Exacerbation|34
237233|NCT01462344|783176|P2|Overall Study|Adverse Event|23
237234|NCT01462344|783177|P1|Overall Study|Adverse Event|24
237235|NCT01462344|783176|P2|Overall Study|Withdrawal by Subject|226
237236|NCT01462344|783177|P1|Overall Study|Withdrawal by Subject|245
237237|NCT01462318|783199|P3|Extension Phase|Adverse Event|22
237238|NCT01462318|783200|P2|Extension Phase|Adverse Event|0
237239|NCT01462318|783201|P1|Extension Phase|Adverse Event|0
237240|NCT01462318|783199|P3|Extension Phase|Investigator Decision|5
237241|NCT01462318|783200|P2|Extension Phase|Investigator Decision|0
237242|NCT01462318|783201|P1|Extension Phase|Investigator Decision|0
237243|NCT01462318|783199|P3|Extension Phase|Withdrawal by Subject|15
237244|NCT01462318|783200|P2|Extension Phase|Withdrawal by Subject|0
237245|NCT01462318|783201|P1|Extension Phase|Withdrawal by Subject|0
237246|NCT01462318|783199|P3|Extension Phase|Disease Progression|1
237247|NCT01462318|783200|P2|Extension Phase|Disease Progression|0
237248|NCT01462318|783201|P1|Extension Phase|Disease Progression|0
237249|NCT01462318|783199|P3|Extension Phase|Not Specified|1
237250|NCT01462318|783200|P2|Extension Phase|Not Specified|0
237251|NCT01462318|783201|P1|Extension Phase|Not Specified|0
237252|NCT01462318|783199|P3|Extension Phase|Lost to Follow-up|1
237253|NCT01462318|783200|P2|Extension Phase|Lost to Follow-up|0
237254|NCT01462318|783201|P1|Extension Phase|Lost to Follow-up|0
237255|NCT01462318|783199|P3|Main Study / TP-DI Study|Adverse Event|0
237256|NCT01462318|783200|P2|Main Study / TP-DI Study|Adverse Event|0
237257|NCT01462318|783201|P1|Main Study / TP-DI Study|Adverse Event|4
237258|NCT01462318|783199|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
237259|NCT01462318|783200|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
237260|NCT01462318|783201|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
237261|NCT01462318|783199|P3|Main Study / TP-DI Study|Not Specified|0
237262|NCT01462318|783200|P2|Main Study / TP-DI Study|Not Specified|0
237263|NCT01462318|783201|P1|Main Study / TP-DI Study|Not Specified|2
237264|NCT01462266|783224|P2|Overall Study|Screen failure|1
237265|NCT01462266|783225|P1|Overall Study|Screen failure|1
237266|NCT01462266|783224|P2|Overall Study|Withdrawal by Subject|2
237267|NCT01462266|783225|P1|Overall Study|Withdrawal by Subject|7
237268|NCT01462266|783224|P2|Overall Study|Protocol Violation|3
237269|NCT01462266|783225|P1|Overall Study|Protocol Violation|1
237270|NCT01462266|783224|P2|Overall Study|Physician Decision|5
237271|NCT01462266|783225|P1|Overall Study|Physician Decision|2
237272|NCT01462266|783224|P2|Overall Study|Creatinine and eGFR, excluded medication|4
237273|NCT01462266|783225|P1|Overall Study|Creatinine and eGFR, excluded medication|8
237274|NCT01462266|783224|P2|Overall Study|Non-compliance with study drug|0
237275|NCT01462266|783225|P1|Overall Study|Non-compliance with study drug|3
237276|NCT01462266|783224|P2|Overall Study|Lost to Follow-up|3
237277|NCT01462266|783225|P1|Overall Study|Lost to Follow-up|4
237278|NCT01462266|783224|P2|Overall Study|Lack of Efficacy|2
237279|NCT01462266|783225|P1|Overall Study|Lack of Efficacy|0
237280|NCT01462266|783224|P2|Overall Study|Death|1
237281|NCT01462266|783225|P1|Overall Study|Death|2
237282|NCT01462266|783224|P2|Overall Study|Adverse Event|6
237283|NCT01462266|783225|P1|Overall Study|Adverse Event|7
237284|NCT01462227|783241|P4|Second Assignment|Protocol Violation|0
237285|NCT01462227|783242|P3|Second Assignment|Protocol Violation|1
237286|NCT01462227|783243|P2|Second Assignment|Protocol Violation|1
237287|NCT01462227|783244|P1|Second Assignment|Protocol Violation|0
237288|NCT01462227|783241|P4|Second Assignment|Lost to Follow-up|0
237289|NCT01462227|783242|P3|Second Assignment|Lost to Follow-up|0
237290|NCT01462227|783243|P2|Second Assignment|Lost to Follow-up|0
237291|NCT01462227|783244|P1|Second Assignment|Lost to Follow-up|1
237292|NCT01462162|783262|P1|Overall Study|Unspecified|2
237293|NCT01462162|783262|P1|Overall Study|Abnormal laboratory parameters|1
237294|NCT01462162|783262|P1|Overall Study|Lack of Efficacy|4
237295|NCT01462162|783262|P1|Overall Study|Adverse Event|5
237296|NCT01462084|783287|P2|Overall Study|Protocol Violation|1
237297|NCT01462084|783288|P1|Overall Study|Protocol Violation|1
237298|NCT01462084|783287|P2|Overall Study|Withdrawal by Subject|0
237299|NCT01462084|783288|P1|Overall Study|Withdrawal by Subject|1
237300|NCT01462045|783299|P3|Overall Study|Family matter|0
237301|NCT01462045|783300|P2|Overall Study|Family matter|1
237302|NCT01462045|783301|P1|Overall Study|Family matter|0
237303|NCT01461993|783315|P3|Overall Study|Unspecified|6
237304|NCT01461993|783316|P2|Overall Study|Unspecified|15
237305|NCT01461993|783317|P1|Overall Study|Unspecified|13
237306|NCT01461993|783315|P3|Overall Study|Did not meet entrance criteria|0
237307|NCT01461993|783316|P2|Overall Study|Did not meet entrance criteria|3
237308|NCT01461993|783317|P1|Overall Study|Did not meet entrance criteria|2
237309|NCT01461993|783315|P3|Overall Study|No longer met eligibility criteria|10
237310|NCT01461993|783316|P2|Overall Study|No longer met eligibility criteria|18
237311|NCT01461993|783317|P1|Overall Study|No longer met eligibility criteria|13
237312|NCT01461993|783315|P3|Overall Study|Adverse Event|3
237313|NCT01461993|783316|P2|Overall Study|Adverse Event|11
237314|NCT01461993|783317|P1|Overall Study|Adverse Event|9
237315|NCT01461993|783315|P3|Overall Study|Protocol Violation|7
237316|NCT01461993|783316|P2|Overall Study|Protocol Violation|9
237317|NCT01461993|783317|P1|Overall Study|Protocol Violation|10
237318|NCT01461993|783315|P3|Overall Study|Lost to Follow-up|22
237319|NCT01461993|783316|P2|Overall Study|Lost to Follow-up|48
237320|NCT01461993|783317|P1|Overall Study|Lost to Follow-up|44
237321|NCT01461993|783315|P3|Overall Study|Withdrawal by Subject|16
237322|NCT01461993|783316|P2|Overall Study|Withdrawal by Subject|53
237323|NCT01461993|783317|P1|Overall Study|Withdrawal by Subject|60
237324|NCT01461980|783342|P3|Overall Study|Randomized but not vaccinated|7
237325|NCT01461980|783343|P2|Overall Study|Randomized but not vaccinated|8
237326|NCT01461980|783344|P1|Overall Study|Randomized but not vaccinated|4
237327|NCT01461980|783342|P3|Overall Study|No longer willing to participate|54
237328|NCT01461980|783343|P2|Overall Study|No longer willing to participate|38
237329|NCT01461980|783344|P1|Overall Study|No longer willing to participate|52
237330|NCT01461980|783342|P3|Overall Study|Lost to Follow-up|51
237331|NCT01461980|783343|P2|Overall Study|Lost to Follow-up|53
237332|NCT01461980|783344|P1|Overall Study|Lost to Follow-up|52
237333|NCT01461980|783342|P3|Overall Study|No longer meets eligibility criteria|19
237334|NCT01461980|783343|P2|Overall Study|No longer meets eligibility criteria|9
237335|NCT01461980|783344|P1|Overall Study|No longer meets eligibility criteria|18
237336|NCT01461980|783342|P3|Overall Study|Protocol Violation|16
237337|NCT01461980|783343|P2|Overall Study|Protocol Violation|19
237338|NCT01461980|783344|P1|Overall Study|Protocol Violation|12
237339|NCT01461980|783342|P3|Overall Study|Adverse Event|6
237340|NCT01461980|783343|P2|Overall Study|Adverse Event|5
237341|NCT01461980|783344|P1|Overall Study|Adverse Event|12
237342|NCT01461980|783342|P3|Overall Study|Medication error|6
237343|NCT01461980|783343|P2|Overall Study|Medication error|5
237344|NCT01461980|783344|P1|Overall Study|Medication error|7
237345|NCT01461980|783342|P3|Overall Study|Unspecified|6
237346|NCT01461980|783343|P2|Overall Study|Unspecified|8
237347|NCT01461980|783344|P1|Overall Study|Unspecified|9
237348|NCT01461811|783376|P2|Overall Study|Noncompliance|1
237349|NCT01461811|783377|P1|Overall Study|Noncompliance|1
237350|NCT01461811|783376|P2|Overall Study|Subject decision unrelated to an AE|1
237351|NCT01461811|783377|P1|Overall Study|Subject decision unrelated to an AE|1
237352|NCT01461811|783376|P2|Overall Study|Adverse Event|1
237353|NCT01461811|783377|P1|Overall Study|Adverse Event|2
237354|NCT01461707|783416|P2|Overall Study|Withdrawal by Subject|0
237355|NCT01461707|783417|P1|Overall Study|Withdrawal by Subject|1
237356|NCT01461551|783445|P3|Overall Study|Physician Decision|2
237357|NCT01461551|783446|P2|Overall Study|Physician Decision|1
237358|NCT01461551|783447|P1|Overall Study|Physician Decision|2
237359|NCT01461538|783458|P3|Overall Study|Withdrawal by Subject|0
237360|NCT01461538|783459|P2|Overall Study|Withdrawal by Subject|1
237361|NCT01461538|783460|P1|Overall Study|Withdrawal by Subject|1
237362|NCT01461538|783458|P3|Overall Study|Study Stopped by Sponsor|0
237363|NCT01461538|783459|P2|Overall Study|Study Stopped by Sponsor|1
237364|NCT01461538|783460|P1|Overall Study|Study Stopped by Sponsor|2
237365|NCT01461538|783458|P3|Overall Study|Death|2
237366|NCT01461538|783459|P2|Overall Study|Death|6
237367|NCT01461538|783460|P1|Overall Study|Death|15
237368|NCT01461369|783518|P3|Overall Study|Withdrawal by Subject|2
237369|NCT01461369|783519|P2|Overall Study|Withdrawal by Subject|3
237370|NCT01461369|783520|P1|Overall Study|Withdrawal by Subject|1
237371|NCT01461369|783518|P3|Overall Study|Protocol Violation|2
237372|NCT01461369|783519|P2|Overall Study|Protocol Violation|2
237373|NCT01461369|783520|P1|Overall Study|Protocol Violation|1
237374|NCT01461369|783518|P3|Overall Study|Adverse Event|4
237375|NCT01461369|783519|P2|Overall Study|Adverse Event|12
237376|NCT01461369|783520|P1|Overall Study|Adverse Event|9
237377|NCT01461369|783518|P3|Overall Study|Lost to Follow-up|3
237378|NCT01461369|783519|P2|Overall Study|Lost to Follow-up|0
237379|NCT01461369|783520|P1|Overall Study|Lost to Follow-up|0
237380|NCT01461369|783518|P3|Overall Study|Lack of Efficacy|6
237381|NCT01461369|783519|P2|Overall Study|Lack of Efficacy|0
237382|NCT01461369|783520|P1|Overall Study|Lack of Efficacy|2
237383|NCT01461096|783545|P2|Overall Study|Lost to Follow-up|4
237384|NCT01461096|783546|P1|Overall Study|Lost to Follow-up|8
237385|NCT01461096|783545|P2|Overall Study|Subj not willing to adhere to reqs|4
237386|NCT01461096|783546|P1|Overall Study|Subj not willing to adhere to reqs|3
237387|NCT01461096|783545|P2|Overall Study|Withdrawal by Subject|3
237388|NCT01461096|783546|P1|Overall Study|Withdrawal by Subject|5
237389|NCT01461096|783545|P2|Overall Study|Site is closing|30
237390|NCT01461096|783546|P1|Overall Study|Site is closing|27
237391|NCT01461096|783545|P2|Overall Study|Subj not able to get to clinic|13
237392|NCT01461096|783546|P1|Overall Study|Subj not able to get to clinic|15
237393|NCT01461096|783545|P2|Overall Study|Severe debilitation, unable to continue|1
237394|NCT01461096|783546|P1|Overall Study|Severe debilitation, unable to continue|1
237395|NCT01461096|783545|P2|Overall Study|Death|6
237396|NCT01461096|783546|P1|Overall Study|Death|3
237397|NCT01461057|783562|P2|Overall Study|Physician Decision|1
237398|NCT01461057|783563|P1|Overall Study|Physician Decision|0
237399|NCT01461057|783562|P2|Overall Study|Withdrawal by Subject|3
237400|NCT01461057|783563|P1|Overall Study|Withdrawal by Subject|2
237401|NCT01461057|783562|P2|Overall Study|Death|8
237402|NCT01461057|783563|P1|Overall Study|Death|7
237403|NCT01461057|783562|P2|Overall Study|Currently in safety follow up|3
237404|NCT01461057|783563|P1|Overall Study|Currently in safety follow up|4
237405|NCT01461057|783562|P2|Overall Study|Currently in treatment|0
237406|NCT01461057|783563|P1|Overall Study|Currently in treatment|2
237407|NCT01461044|783573|P2|Overall Study|Lost to Follow-up|5
237408|NCT01461044|783574|P1|Overall Study|Lost to Follow-up|12
237409|NCT01461044|783573|P2|Overall Study|Death|35
237410|NCT01461044|783574|P1|Overall Study|Death|58
237411|NCT01460628|783674|P1|Overall Study|Withdrawal by Subject|2
237412|NCT01460628|783674|P1|Overall Study|Adverse Event|3
237413|NCT01460446|783686|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
237414|NCT01460446|783687|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
237415|NCT01460446|783686|P2|Overall Study|Pregnancy|0
237416|NCT01460446|783687|P1|Overall Study|Pregnancy|1
237417|NCT01460446|783686|P2|Overall Study|Surgery/Illness|1
237418|NCT01460446|783687|P1|Overall Study|Surgery/Illness|1
237419|NCT01460446|783686|P2|Overall Study|Non-compliance & Consent Withdrawn|3
237420|NCT01460446|783687|P1|Overall Study|Non-compliance & Consent Withdrawn|1
237421|NCT01460446|783686|P2|Overall Study|Consent Withdrawn|4
237422|NCT01460446|783687|P1|Overall Study|Consent Withdrawn|0
237423|NCT01460446|783686|P2|Overall Study|Non-compliance|9
237424|NCT01460446|783687|P1|Overall Study|Non-compliance|2
237425|NCT01460342|783716|P2|Overall Study|Lack of Efficacy|0
237426|NCT01460342|783717|P1|Overall Study|Lack of Efficacy|1
237427|NCT01460342|783716|P2|Overall Study|Physician Decision|3
237428|NCT01460342|783717|P1|Overall Study|Physician Decision|1
237429|NCT01460342|783716|P2|Overall Study|Withdrawal by Subject|4
237430|NCT01460342|783717|P1|Overall Study|Withdrawal by Subject|3
237431|NCT01460342|783716|P2|Overall Study|Protocol Violation|1
237432|NCT01460342|783717|P1|Overall Study|Protocol Violation|0
237433|NCT01460342|783716|P2|Overall Study|Lost to Follow-up|2
237434|NCT01460342|783717|P1|Overall Study|Lost to Follow-up|1
237435|NCT01460342|783716|P2|Overall Study|Adverse Event|4
237436|NCT01460342|783717|P1|Overall Study|Adverse Event|5
237437|NCT01460290|783737|P1|Overall Study|Elevated liver function|1
237438|NCT01460290|783737|P1|Overall Study|Adverse Event|3
237439|NCT01459913|783761|P4|Overall Study|Did Not Meet Inclusion Criteria|1
237440|NCT01459913|783762|P3|Overall Study|Did Not Meet Inclusion Criteria|0
237441|NCT01459913|783763|P2|Overall Study|Did Not Meet Inclusion Criteria|0
237442|NCT01459913|783764|P1|Overall Study|Did Not Meet Inclusion Criteria|0
237443|NCT01459913|783761|P4|Overall Study|Unspecified|1
237444|NCT01459913|783762|P3|Overall Study|Unspecified|3
237445|NCT01459913|783763|P2|Overall Study|Unspecified|0
237446|NCT01459913|783764|P1|Overall Study|Unspecified|0
237447|NCT01459913|783761|P4|Overall Study|Study Terminated by Sponsor|11
237448|NCT01459913|783762|P3|Overall Study|Study Terminated by Sponsor|9
237449|NCT01459913|783763|P2|Overall Study|Study Terminated by Sponsor|15
237450|NCT01459913|783764|P1|Overall Study|Study Terminated by Sponsor|30
237451|NCT01459913|783761|P4|Overall Study|Physician Decision|0
237452|NCT01459913|783762|P3|Overall Study|Physician Decision|0
237453|NCT01459913|783763|P2|Overall Study|Physician Decision|1
237454|NCT01459913|783764|P1|Overall Study|Physician Decision|0
237455|NCT01459913|783761|P4|Overall Study|Non- Compliance|3
237456|NCT01459913|783762|P3|Overall Study|Non- Compliance|0
237457|NCT01459913|783763|P2|Overall Study|Non- Compliance|0
237458|NCT01459913|783764|P1|Overall Study|Non- Compliance|0
237459|NCT01459913|783761|P4|Overall Study|Death|1
237460|NCT01459913|783762|P3|Overall Study|Death|0
237461|NCT01459913|783763|P2|Overall Study|Death|0
237462|NCT01459913|783764|P1|Overall Study|Death|0
237463|NCT01459913|783761|P4|Overall Study|Lost to Follow-up|8
237464|NCT01459913|783762|P3|Overall Study|Lost to Follow-up|1
237465|NCT01459913|783763|P2|Overall Study|Lost to Follow-up|4
237466|NCT01459913|783764|P1|Overall Study|Lost to Follow-up|7
237467|NCT01459913|783761|P4|Overall Study|Withdrawal by Subject|5
237468|NCT01459913|783762|P3|Overall Study|Withdrawal by Subject|0
237469|NCT01459913|783763|P2|Overall Study|Withdrawal by Subject|0
237470|NCT01459913|783764|P1|Overall Study|Withdrawal by Subject|4
237471|NCT01459913|783761|P4|Overall Study|Adverse Event|3
237472|NCT01459913|783762|P3|Overall Study|Adverse Event|0
237473|NCT01459913|783763|P2|Overall Study|Adverse Event|0
237474|NCT01459913|783764|P1|Overall Study|Adverse Event|0
237475|NCT01459783|783795|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
237476|NCT01459783|783796|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
237477|NCT01459783|783795|P2|6 Months to 12 Months|Lost to Follow-up|7
237478|NCT01459783|783796|P1|6 Months to 12 Months|Lost to Follow-up|2
237479|NCT01459783|783795|P2|6 Months to 12 Months|Withdrawal by Subject|5
237480|NCT01459783|783796|P1|6 Months to 12 Months|Withdrawal by Subject|6
237481|NCT01459783|783795|P2|6 Months to 12 Months|Death|1
237482|NCT01459783|783796|P1|6 Months to 12 Months|Death|0
237483|NCT01459783|783795|P2|Baseline to 6 Months|Lost to Follow-up|14
237484|NCT01459783|783796|P1|Baseline to 6 Months|Lost to Follow-up|19
237485|NCT01459783|783795|P2|Baseline to 6 Months|Withdrawal by Subject|6
237486|NCT01459783|783796|P1|Baseline to 6 Months|Withdrawal by Subject|12
237487|NCT01459783|783795|P2|Baseline to 6 Months|Death|0
237488|NCT01459783|783796|P1|Baseline to 6 Months|Death|1
237489|NCT01459068|784008|P2|Overall Study|Death|1
237490|NCT01459068|784009|P1|Overall Study|Death|0
237491|NCT01459068|784008|P2|Overall Study|Lost to Follow-up|15
237492|NCT01459068|784009|P1|Overall Study|Lost to Follow-up|31
237493|NCT01459068|784008|P2|Overall Study|Withdrawal by Subject|18
237494|NCT01459068|784009|P1|Overall Study|Withdrawal by Subject|8
237495|NCT01459016|784025|P1|Overall Study|Amendment Discontinuation Criteria|4
237496|NCT01459016|784025|P1|Overall Study|Withdrawal by Subject|11
237497|NCT01458951|784042|P3|Overall Study|Insufficient Clinical Response|11
237498|NCT01458951|784043|P2|Overall Study|Insufficient Clinical Response|0
237499|NCT01458951|784044|P1|Overall Study|Insufficient Clinical Response|17
237500|NCT01458951|784042|P3|Overall Study|Adverse Event|2
237501|NCT01458951|784043|P2|Overall Study|Adverse Event|0
237502|NCT01458951|784044|P1|Overall Study|Adverse Event|7
237503|NCT01458951|784042|P3|Overall Study|Withdrawal by Subject|2
237504|NCT01458951|784043|P2|Overall Study|Withdrawal by Subject|0
237505|NCT01458951|784044|P1|Overall Study|Withdrawal by Subject|2
237506|NCT01458951|784042|P3|Overall Study|Protocol Violation|0
237507|NCT01458951|784043|P2|Overall Study|Protocol Violation|1
237508|NCT01458951|784044|P1|Overall Study|Protocol Violation|5
237509|NCT01458951|784042|P3|Overall Study|Unspecified|0
237510|NCT01458951|784043|P2|Overall Study|Unspecified|0
237511|NCT01458951|784044|P1|Overall Study|Unspecified|1
237512|NCT01458639|784069|P1|Overall Study|Inability to obtain subject blood sample|1
237513|NCT01458639|784069|P1|Overall Study|Equipment issue|1
237514|NCT01458639|784069|P1|Overall Study|Physician Decision|4
237515|NCT01458587|784081|P2|Overall Study|Withdrawal by Subject|0
237516|NCT01458587|784082|P1|Overall Study|Withdrawal by Subject|1
237517|NCT01458574|784245|P3|Overall Study|Randomized but not treated|0
237518|NCT01458574|784246|P2|Overall Study|Randomized but not treated|1
237519|NCT01458574|784247|P1|Overall Study|Randomized but not treated|0
237520|NCT01458574|784245|P3|Overall Study|Unspecified|0
237521|NCT01458574|784246|P2|Overall Study|Unspecified|1
237522|NCT01458574|784247|P1|Overall Study|Unspecified|2
237523|NCT01458574|784245|P3|Overall Study|Withdrawal by Subject|5
237524|NCT01458574|784246|P2|Overall Study|Withdrawal by Subject|3
237525|NCT01458574|784247|P1|Overall Study|Withdrawal by Subject|6
237526|NCT01458574|784245|P3|Overall Study|Protocol Violation|0
237527|NCT01458574|784246|P2|Overall Study|Protocol Violation|1
237528|NCT01458574|784247|P1|Overall Study|Protocol Violation|0
237529|NCT01458574|784245|P3|Overall Study|Pregnancy|0
237530|NCT01458574|784246|P2|Overall Study|Pregnancy|1
237531|NCT01458574|784247|P1|Overall Study|Pregnancy|1
237532|NCT01458574|784245|P3|Overall Study|Lost to Follow-up|1
237533|NCT01458574|784246|P2|Overall Study|Lost to Follow-up|2
237534|NCT01458574|784247|P1|Overall Study|Lost to Follow-up|3
237535|NCT01458574|784245|P3|Overall Study|Lack of Efficacy|132
237536|NCT01458574|784246|P2|Overall Study|Lack of Efficacy|53
237537|NCT01458574|784247|P1|Overall Study|Lack of Efficacy|70
237538|NCT01458574|784245|P3|Overall Study|Adverse Event|7
237539|NCT01458574|784246|P2|Overall Study|Adverse Event|9
237540|NCT01458574|784247|P1|Overall Study|Adverse Event|5
237541|NCT01458535|784377|P6|Overall Study|Adverse Event|0
237542|NCT01458535|784378|P5|Overall Study|Adverse Event|0
237543|NCT01458535|784379|P4|Overall Study|Adverse Event|1
237544|NCT01458535|784380|P3|Overall Study|Adverse Event|0
237545|NCT01458535|784381|P2|Overall Study|Adverse Event|0
237546|NCT01458535|784382|P1|Overall Study|Adverse Event|0
237547|NCT01458535|784377|P6|Overall Study|Lost to Follow-up|2
237548|NCT01458535|784378|P5|Overall Study|Lost to Follow-up|2
237549|NCT01458535|784379|P4|Overall Study|Lost to Follow-up|3
237550|NCT01458535|784380|P3|Overall Study|Lost to Follow-up|0
237551|NCT01458535|784381|P2|Overall Study|Lost to Follow-up|2
237552|NCT01458535|784382|P1|Overall Study|Lost to Follow-up|0
237553|NCT01458535|784377|P6|Overall Study|Withdrawal by Subject|1
237554|NCT01458535|784378|P5|Overall Study|Withdrawal by Subject|1
237555|NCT01458535|784379|P4|Overall Study|Withdrawal by Subject|0
237556|NCT01458535|784380|P3|Overall Study|Withdrawal by Subject|2
237557|NCT01458535|784381|P2|Overall Study|Withdrawal by Subject|0
237558|NCT01458535|784382|P1|Overall Study|Withdrawal by Subject|0
237559|NCT01458535|784377|P6|Overall Study|Other|1
237560|NCT01458535|784378|P5|Overall Study|Other|1
237561|NCT01458535|784379|P4|Overall Study|Other|0
237562|NCT01458535|784380|P3|Overall Study|Other|0
237563|NCT01458535|784381|P2|Overall Study|Other|0
237564|NCT01458535|784382|P1|Overall Study|Other|0
237565|NCT01458275|784440|P3|Overall Study|Withdrawal by Subject|1
237566|NCT01458275|784441|P2|Overall Study|Withdrawal by Subject|2
237567|NCT01458275|784442|P1|Overall Study|Withdrawal by Subject|3
237568|NCT01458275|784440|P3|Overall Study|Protocol Violation|2
237569|NCT01458275|784441|P2|Overall Study|Protocol Violation|5
237570|NCT01458275|784442|P1|Overall Study|Protocol Violation|5
237571|NCT01458275|784440|P3|Overall Study|Lost to Follow-up|5
237572|NCT01458275|784441|P2|Overall Study|Lost to Follow-up|2
237573|NCT01458275|784442|P1|Overall Study|Lost to Follow-up|3
237574|NCT01458275|784440|P3|Overall Study|Adverse Event|1
237575|NCT01458275|784441|P2|Overall Study|Adverse Event|4
237576|NCT01458275|784442|P1|Overall Study|Adverse Event|3
237577|NCT01458249|784484|P1|Overall Study|Ongoing|1
237578|NCT01458249|784484|P1|Overall Study|Not specified|2
237579|NCT01458249|784484|P1|Overall Study|Adverse Event|4
237580|NCT01458249|784484|P1|Overall Study|Not treated|1
237581|NCT01458210|784503|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
237582|NCT01458210|784503|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
237583|NCT01458210|784503|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
237584|NCT01458210|784503|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
237585|NCT01458171|784520|P1|Overall Study|Adverse Event|1
237586|NCT01458106|784543|P2|Overall Study|Withdrawn Per Protocol|1
237587|NCT01458106|784544|P1|Overall Study|Withdrawn Per Protocol|0
237588|NCT01458106|784543|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
237589|NCT01458106|784544|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
237590|NCT01458106|784543|P2|Overall Study|Withdrawal by Subject|0
237591|NCT01458106|784544|P1|Overall Study|Withdrawal by Subject|2
237592|NCT01457950|784621|P4|Open-Label Phase|Withdrawal by Subject|0
237593|NCT01457950|784622|P3|Open-Label Phase|Withdrawal by Subject|2
237594|NCT01457950|784623|P2|Open-Label Phase|Withdrawal by Subject|0
237595|NCT01457950|784624|P1|Open-Label Phase|Withdrawal by Subject|0
237596|NCT01457950|784621|P4|Open-Label Phase|Protocol Violation|1
237597|NCT01457950|784622|P3|Open-Label Phase|Protocol Violation|0
237598|NCT01457950|784623|P2|Open-Label Phase|Protocol Violation|0
237599|NCT01457950|784624|P1|Open-Label Phase|Protocol Violation|0
237600|NCT01457950|784621|P4|Open-Label Phase|Adverse Event|1
237601|NCT01457950|784622|P3|Open-Label Phase|Adverse Event|0
237602|NCT01457950|784623|P2|Open-Label Phase|Adverse Event|0
237603|NCT01457950|784624|P1|Open-Label Phase|Adverse Event|0
237604|NCT01457950|784621|P4|Double-Blind Phase|Withdrawal by Subject|0
237605|NCT01457950|784622|P3|Double-Blind Phase|Withdrawal by Subject|0
237606|NCT01457950|784623|P2|Double-Blind Phase|Withdrawal by Subject|2
237607|NCT01457950|784624|P1|Double-Blind Phase|Withdrawal by Subject|6
237608|NCT01457950|784621|P4|Double-Blind Phase|Protocol Violation|0
237609|NCT01457950|784622|P3|Double-Blind Phase|Protocol Violation|0
237610|NCT01457950|784623|P2|Double-Blind Phase|Protocol Violation|1
237611|NCT01457950|784624|P1|Double-Blind Phase|Protocol Violation|2
237612|NCT01457950|784621|P4|Double-Blind Phase|Continuation Criteria Not Met|0
237613|NCT01457950|784622|P3|Double-Blind Phase|Continuation Criteria Not Met|0
237614|NCT01457950|784623|P2|Double-Blind Phase|Continuation Criteria Not Met|0
237615|NCT01457950|784624|P1|Double-Blind Phase|Continuation Criteria Not Met|1
237616|NCT01457846|784706|P2|Overall Study|Lost to Follow-up|0
237617|NCT01457846|784707|P1|Overall Study|Lost to Follow-up|1
237618|NCT01457846|784706|P2|Overall Study|Withdrawal by Subject|1
237619|NCT01457846|784707|P1|Overall Study|Withdrawal by Subject|1
237620|NCT01457846|784706|P2|Overall Study|Unclassified reason for not completed|10
237621|NCT01457846|784707|P1|Overall Study|Unclassified reason for not completed|11
237622|NCT01457846|784706|P2|Overall Study|Death|16
237623|NCT01457846|784707|P1|Overall Study|Death|27
237624|NCT01457846|784706|P2|Overall Study|Did not receive treatment|1
237625|NCT01457846|784707|P1|Overall Study|Did not receive treatment|0
237626|NCT01457846|784706|P2|Overall Study|Death before treatment|2
237627|NCT01457846|784707|P1|Overall Study|Death before treatment|1
237628|NCT01457703|784723|P2|Overall Study|Withdrawal by Subject|4
237629|NCT01457703|784724|P1|Overall Study|Withdrawal by Subject|1
237630|NCT01457703|784723|P2|Overall Study|Screen Failure|7
237631|NCT01457703|784724|P1|Overall Study|Screen Failure|5
237632|NCT01457339|784821|P2|Period 6 (250 mg)|Personal appointment|1
237633|NCT01457339|784822|P1|Period 6 (250 mg)|Personal appointment|0
237634|NCT01457339|784821|P2|Period 6 (250 mg)|Family Emergency|0
237635|NCT01457339|784822|P1|Period 6 (250 mg)|Family Emergency|1
237636|NCT01457339|784821|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
237637|NCT01457339|784822|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
237638|NCT01457339|784821|P2|Period 3 (100 mg)|Adverse Event|1
237639|NCT01457339|784822|P1|Period 3 (100 mg)|Adverse Event|0
237640|NCT01457053|784988|P2|Overall Study|Unable to undergo selected treatment|1
237641|NCT01457053|784989|P1|Overall Study|Unable to undergo selected treatment|1
237642|NCT01457014|784995|P4|First Night|Withdrawal by Subject|0
237643|NCT01457014|784996|P3|First Night|Withdrawal by Subject|0
237644|NCT01457014|784997|P2|First Night|Withdrawal by Subject|0
237645|NCT01457014|784998|P1|First Night|Withdrawal by Subject|3
237646|NCT01457014|784995|P4|First Night|Didn't meet inclusion/exclusion criteria|0
237647|NCT01457014|784996|P3|First Night|Didn't meet inclusion/exclusion criteria|0
237648|NCT01457014|784997|P2|First Night|Didn't meet inclusion/exclusion criteria|0
237649|NCT01457014|784998|P1|First Night|Didn't meet inclusion/exclusion criteria|37
237650|NCT01456962|785015|P2|Overall Study|Lost to Follow-up|1
237651|NCT01456962|785016|P1|Overall Study|Lost to Follow-up|2
237652|NCT01456936|785026|P4|Overall Study|Randomized but not treated|21
237653|NCT01456936|785027|P3|Overall Study|Randomized but not treated|16
237654|NCT01456936|785028|P2|Overall Study|Randomized but not treated|28
237655|NCT01456936|785029|P1|Overall Study|Randomized but not treated|21
237656|NCT01456936|785026|P4|Overall Study|Death|3
237657|NCT01456936|785027|P3|Overall Study|Death|1
237658|NCT01456936|785028|P2|Overall Study|Death|3
237659|NCT01456936|785029|P1|Overall Study|Death|0
237660|NCT01456936|785026|P4|Overall Study|Adverse event (study drug unrelated)|9
237661|NCT01456936|785027|P3|Overall Study|Adverse event (study drug unrelated)|9
237662|NCT01456936|785028|P2|Overall Study|Adverse event (study drug unrelated)|7
237663|NCT01456936|785029|P1|Overall Study|Adverse event (study drug unrelated)|9
237664|NCT01456936|785026|P4|Overall Study|Adverse event (study drug)|17
237665|NCT01456936|785027|P3|Overall Study|Adverse event (study drug)|26
237666|NCT01456936|785028|P2|Overall Study|Adverse event (study drug)|21
237667|NCT01456936|785029|P1|Overall Study|Adverse event (study drug)|25
237668|NCT01456936|785026|P4|Overall Study|Medication error|1
237669|NCT01456936|785027|P3|Overall Study|Medication error|0
237670|NCT01456936|785028|P2|Overall Study|Medication error|1
237671|NCT01456936|785029|P1|Overall Study|Medication error|0
237672|NCT01456936|785026|P4|Overall Study|Lost to Follow-up|127
237673|NCT01456936|785027|P3|Overall Study|Lost to Follow-up|144
237674|NCT01456936|785028|P2|Overall Study|Lost to Follow-up|126
237675|NCT01456936|785029|P1|Overall Study|Lost to Follow-up|135
237676|NCT01456936|785026|P4|Overall Study|No longer willing to participate|248
237677|NCT01456936|785027|P3|Overall Study|No longer willing to participate|224
237678|NCT01456936|785028|P2|Overall Study|No longer willing to participate|218
237679|NCT01456936|785029|P1|Overall Study|No longer willing to participate|195
237680|NCT01456936|785026|P4|Overall Study|Insufficient clinical response|13
237681|NCT01456936|785027|P3|Overall Study|Insufficient clinical response|14
237682|NCT01456936|785028|P2|Overall Study|Insufficient clinical response|4
237683|NCT01456936|785029|P1|Overall Study|Insufficient clinical response|4
237684|NCT01456936|785026|P4|Overall Study|Pregnancy|1
237685|NCT01456936|785027|P3|Overall Study|Pregnancy|0
237686|NCT01456936|785028|P2|Overall Study|Pregnancy|0
237687|NCT01456936|785029|P1|Overall Study|Pregnancy|1
237688|NCT01456936|785026|P4|Overall Study|Protocol Violation|5
237689|NCT01456936|785027|P3|Overall Study|Protocol Violation|5
237690|NCT01456936|785028|P2|Overall Study|Protocol Violation|2
237691|NCT01456936|785029|P1|Overall Study|Protocol Violation|4
237692|NCT01456936|785026|P4|Overall Study|No longer meets eligibility criteria|5
237693|NCT01456936|785027|P3|Overall Study|No longer meets eligibility criteria|6
237694|NCT01456936|785028|P2|Overall Study|No longer meets eligibility criteria|8
237695|NCT01456936|785029|P1|Overall Study|No longer meets eligibility criteria|4
237696|NCT01456936|785026|P4|Overall Study|Other reason|33
237697|NCT01456936|785027|P3|Overall Study|Other reason|36
237698|NCT01456936|785028|P2|Overall Study|Other reason|30
237699|NCT01456936|785029|P1|Overall Study|Other reason|41
237700|NCT01456195|785151|P3|Overall Study|Other Reasons|3
237701|NCT01456195|785152|P2|Overall Study|Other Reasons|1
237702|NCT01456195|785153|P1|Overall Study|Other Reasons|2
237703|NCT01456195|785151|P3|Overall Study|Lack of Efficacy|0
237704|NCT01456195|785152|P2|Overall Study|Lack of Efficacy|1
237705|NCT01456195|785153|P1|Overall Study|Lack of Efficacy|0
237706|NCT01456195|785151|P3|Overall Study|Voluntary Withdrawal|7
237707|NCT01456195|785152|P2|Overall Study|Voluntary Withdrawal|3
237708|NCT01456195|785153|P1|Overall Study|Voluntary Withdrawal|5
237709|NCT01456195|785151|P3|Overall Study|Lost to Follow-up|3
237710|NCT01456195|785152|P2|Overall Study|Lost to Follow-up|1
237711|NCT01456195|785153|P1|Overall Study|Lost to Follow-up|3
237712|NCT01456195|785151|P3|Overall Study|Pretreatment Event/Adverse Event|1
237713|NCT01456195|785152|P2|Overall Study|Pretreatment Event/Adverse Event|4
237714|NCT01456195|785153|P1|Overall Study|Pretreatment Event/Adverse Event|1
237715|NCT01456169|785173|P3|Overall Study|Other|0
237716|NCT01456169|785174|P2|Overall Study|Other|1
237717|NCT01456169|785175|P1|Overall Study|Other|1
237718|NCT01456169|785173|P3|Overall Study|Lack of Efficacy|0
237719|NCT01456169|785174|P2|Overall Study|Lack of Efficacy|0
237720|NCT01456169|785175|P1|Overall Study|Lack of Efficacy|2
237721|NCT01456169|785173|P3|Overall Study|Voluntary Withdrawal|2
237722|NCT01456169|785174|P2|Overall Study|Voluntary Withdrawal|0
237723|NCT01456169|785175|P1|Overall Study|Voluntary Withdrawal|3
237724|NCT01456169|785173|P3|Overall Study|Major Protocol Deviation|3
237725|NCT01456169|785174|P2|Overall Study|Major Protocol Deviation|2
237726|NCT01456169|785175|P1|Overall Study|Major Protocol Deviation|3
237727|NCT01456169|785173|P3|Overall Study|Adverse Event|7
237728|NCT01456169|785174|P2|Overall Study|Adverse Event|2
237729|NCT01456169|785175|P1|Overall Study|Adverse Event|1
237730|NCT01456130|785235|P1|Overall Study|Other|1
237731|NCT01456130|785235|P1|Overall Study|Lack of Efficacy|4
237732|NCT01456130|785235|P1|Overall Study|Voluntary Withdrawal|1
237733|NCT01456130|785235|P1|Overall Study|Adverse Event|4
237734|NCT01456052|785245|P3|Overall Study|Treatment Failure|1
237735|NCT01456052|785246|P2|Overall Study|Treatment Failure|1
237736|NCT01456052|785247|P1|Overall Study|Treatment Failure|0
237737|NCT01456052|785245|P3|Overall Study|Physician Decision|1
237738|NCT01456052|785246|P2|Overall Study|Physician Decision|0
237739|NCT01456052|785247|P1|Overall Study|Physician Decision|1
237740|NCT01456052|785245|P3|Overall Study|Protocol Violation|0
237741|NCT01456052|785246|P2|Overall Study|Protocol Violation|1
237742|NCT01456052|785247|P1|Overall Study|Protocol Violation|0
237743|NCT01456052|785245|P3|Overall Study|Consent withdrawn|1
237744|NCT01456052|785246|P2|Overall Study|Consent withdrawn|2
237745|NCT01456052|785247|P1|Overall Study|Consent withdrawn|0
237746|NCT01456052|785245|P3|Overall Study|Adverse Event|2
237747|NCT01456052|785246|P2|Overall Study|Adverse Event|1
237748|NCT01456052|785247|P1|Overall Study|Adverse Event|1
237749|NCT01456039|785267|P3|Phase 2 (Second Step)|Unspecified|1
237750|NCT01456039|785268|P2|Phase 2 (Second Step)|Unspecified|0
237751|NCT01456039|785269|P1|Phase 2 (Second Step)|Unspecified|0
237752|NCT01456039|785267|P3|Phase 2 (Second Step)|Protocol Violation|1
237753|NCT01456039|785268|P2|Phase 2 (Second Step)|Protocol Violation|0
237754|NCT01456039|785269|P1|Phase 2 (Second Step)|Protocol Violation|0
237755|NCT01456039|785267|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
237756|NCT01456039|785268|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
237757|NCT01456039|785269|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
237758|NCT01456039|785267|P3|Phase 2 (Second Step)|Adverse Event|10
237759|NCT01456039|785268|P2|Phase 2 (Second Step)|Adverse Event|0
237760|NCT01456039|785269|P1|Phase 2 (Second Step)|Adverse Event|0
237761|NCT01456039|785267|P3|Phase 2 (Second Step)|Disease Progression|17
237762|NCT01456039|785268|P2|Phase 2 (Second Step)|Disease Progression|0
237763|NCT01456039|785269|P1|Phase 2 (Second Step)|Disease Progression|0
237764|NCT01456039|785267|P3|Phase 1 (First Step)|Not specified|0
237765|NCT01456039|785268|P2|Phase 1 (First Step)|Not specified|1
237766|NCT01456039|785269|P1|Phase 1 (First Step)|Not specified|0
237767|NCT01456039|785267|P3|Phase 1 (First Step)|Adverse Event|0
237768|NCT01456039|785268|P2|Phase 1 (First Step)|Adverse Event|3
237769|NCT01456039|785269|P1|Phase 1 (First Step)|Adverse Event|0
237770|NCT01456039|785267|P3|Phase 1 (First Step)|Withdrawal by Subject|0
237771|NCT01456039|785268|P2|Phase 1 (First Step)|Withdrawal by Subject|2
237772|NCT01456039|785269|P1|Phase 1 (First Step)|Withdrawal by Subject|1
237773|NCT01456039|785267|P3|Phase 1 (First Step)|Disease Progression|0
237774|NCT01456039|785268|P2|Phase 1 (First Step)|Disease Progression|1
237775|NCT01456039|785269|P1|Phase 1 (First Step)|Disease Progression|1
237776|NCT01455428|785412|P2|Overall Study|Unspecified|4
237777|NCT01455428|785413|P1|Overall Study|Unspecified|2
237778|NCT01455428|785412|P2|Overall Study|Did not receive treatment|1
237779|NCT01455428|785413|P1|Overall Study|Did not receive treatment|1
237780|NCT01455428|785412|P2|Overall Study|Insufficient clinical response|2
237781|NCT01455428|785413|P1|Overall Study|Insufficient clinical response|0
237782|NCT01455428|785412|P2|Overall Study|Did not meet entrance criteria|2
237783|NCT01455428|785413|P1|Overall Study|Did not meet entrance criteria|0
237784|NCT01455428|785412|P2|Overall Study|Withdrawal by Subject|5
237785|NCT01455428|785413|P1|Overall Study|Withdrawal by Subject|2
237786|NCT01455428|785412|P2|Overall Study|Lost to Follow-up|1
237787|NCT01455428|785413|P1|Overall Study|Lost to Follow-up|1
237788|NCT01455428|785412|P2|Overall Study|Adverse Event|2
237789|NCT01455428|785413|P1|Overall Study|Adverse Event|6
237790|NCT01455428|785412|P2|Overall Study|Protocol Violation|1
237791|NCT01455428|785413|P1|Overall Study|Protocol Violation|2
237792|NCT01455415|785469|P2|Follow-up|Unspecified Reason|0
237793|NCT01455415|785470|P1|Follow-up|Unspecified Reason|1
237794|NCT01455415|785469|P2|Follow-up|Withdrawal by Subject|0
237795|NCT01455415|785470|P1|Follow-up|Withdrawal by Subject|2
237796|NCT01455415|785469|P2|Follow-up|Lack of Efficacy|1
237797|NCT01455415|785470|P1|Follow-up|Lack of Efficacy|0
237798|NCT01455415|785469|P2|Follow-up|AE Related to Study Drug|1
237799|NCT01455415|785470|P1|Follow-up|AE Related to Study Drug|0
237800|NCT01455415|785469|P2|Period 2|Protocol Violation|0
237801|NCT01455415|785470|P1|Period 2|Protocol Violation|2
237802|NCT01455415|785469|P2|Period 2|Unspecified Reason|3
237803|NCT01455415|785470|P1|Period 2|Unspecified Reason|2
237804|NCT01455415|785469|P2|Period 2|Withdrawal by Subject|3
237805|NCT01455415|785470|P1|Period 2|Withdrawal by Subject|2
237806|NCT01455415|785469|P2|Period 2|Lack of Efficacy|0
237807|NCT01455415|785470|P1|Period 2|Lack of Efficacy|2
237808|NCT01455415|785469|P2|Period 2|AE Not Related to Study Drug|1
237809|NCT01455415|785470|P1|Period 2|AE Not Related to Study Drug|2
237810|NCT01455415|785469|P2|Period 2|Lost to Follow-up|1
237811|NCT01455415|785470|P1|Period 2|Lost to Follow-up|2
237812|NCT01455415|785469|P2|Period 2|AE Related to Study Drug|2
237813|NCT01455415|785470|P1|Period 2|AE Related to Study Drug|1
237814|NCT01455415|785469|P2|Washout|Protocol Violation|1
237815|NCT01455415|785470|P1|Washout|Protocol Violation|0
237816|NCT01455415|785469|P2|Washout|Unspecified Reason|2
237817|NCT01455415|785470|P1|Washout|Unspecified Reason|1
237818|NCT01455415|785469|P2|Washout|AE Not Related to Study Drug|3
237819|NCT01455415|785470|P1|Washout|AE Not Related to Study Drug|2
237820|NCT01455415|785469|P2|Washout|Drug Error not Associated to AE|1
237821|NCT01455415|785470|P1|Washout|Drug Error not Associated to AE|2
237822|NCT01455415|785469|P2|Washout|Lost to Follow-up|0
237823|NCT01455415|785470|P1|Washout|Lost to Follow-up|1
237824|NCT01455415|785469|P2|Washout|AE Related to Study Drug|0
237825|NCT01455415|785470|P1|Washout|AE Related to Study Drug|2
237826|NCT01455415|785469|P2|Period 1|Protocol Violation|2
237827|NCT01455415|785470|P1|Period 1|Protocol Violation|0
237828|NCT01455415|785469|P2|Period 1|Unspecified Reason|1
237829|NCT01455415|785470|P1|Period 1|Unspecified Reason|1
237830|NCT01455415|785469|P2|Period 1|Withdrawal by Subject|5
237831|NCT01455415|785470|P1|Period 1|Withdrawal by Subject|4
237832|NCT01455415|785469|P2|Period 1|AE Not Related to Study Drug|6
237833|NCT01455415|785470|P1|Period 1|AE Not Related to Study Drug|2
237834|NCT01455415|785469|P2|Period 1|Drug Error not Associated to AE|1
237835|NCT01455415|785470|P1|Period 1|Drug Error not Associated to AE|0
237836|NCT01455415|785469|P2|Period 1|Lost To Follow-up Related to Study Drug|3
237837|NCT01455415|785470|P1|Period 1|Lost To Follow-up Related to Study Drug|3
237838|NCT01455415|785469|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
237839|NCT01455415|785470|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
237840|NCT01455220|785520|P1|Overall Study|screen fail|30
237841|NCT01455194|785530|P4|Overall Study|Miscellaneous|4
237842|NCT01455194|785531|P3|Overall Study|Miscellaneous|1
237843|NCT01455194|785532|P2|Overall Study|Miscellaneous|5
237844|NCT01455194|785533|P1|Overall Study|Miscellaneous|4
237845|NCT01455194|785530|P4|Overall Study|Discontinuation criterion fulfilled|2
237846|NCT01455194|785531|P3|Overall Study|Discontinuation criterion fulfilled|0
237847|NCT01455194|785532|P2|Overall Study|Discontinuation criterion fulfilled|2
237848|NCT01455194|785533|P1|Overall Study|Discontinuation criterion fulfilled|3
237849|NCT01455194|785530|P4|Overall Study|Pregnancy|0
237850|NCT01455194|785531|P3|Overall Study|Pregnancy|1
237851|NCT01455194|785532|P2|Overall Study|Pregnancy|1
237852|NCT01455194|785533|P1|Overall Study|Pregnancy|0
237853|NCT01455194|785530|P4|Overall Study|Lost to Follow-up|1
237854|NCT01455194|785531|P3|Overall Study|Lost to Follow-up|1
237855|NCT01455194|785532|P2|Overall Study|Lost to Follow-up|0
237856|NCT01455194|785533|P1|Overall Study|Lost to Follow-up|2
237857|NCT01455194|785530|P4|Overall Study|Withdrawal by Subject|9
237858|NCT01455194|785531|P3|Overall Study|Withdrawal by Subject|12
237859|NCT01455194|785532|P2|Overall Study|Withdrawal by Subject|16
237860|NCT01455194|785533|P1|Overall Study|Withdrawal by Subject|21
237861|NCT01455194|785530|P4|Overall Study|Adverse Event|3
237862|NCT01455194|785531|P3|Overall Study|Adverse Event|1
237863|NCT01455194|785532|P2|Overall Study|Adverse Event|1
237864|NCT01455194|785533|P1|Overall Study|Adverse Event|1
237865|NCT01455194|785530|P4|Overall Study|Deterioration in asthma|9
237866|NCT01455194|785531|P3|Overall Study|Deterioration in asthma|14
237867|NCT01455194|785532|P2|Overall Study|Deterioration in asthma|6
237868|NCT01455194|785533|P1|Overall Study|Deterioration in asthma|12
237869|NCT01455194|785530|P4|Overall Study|Randomisation Failure|0
237870|NCT01455194|785531|P3|Overall Study|Randomisation Failure|0
237871|NCT01455194|785532|P2|Overall Study|Randomisation Failure|0
237872|NCT01455194|785533|P1|Overall Study|Randomisation Failure|90
237873|NCT01455194|785530|P4|Overall Study|Screen Failure|0
237874|NCT01455194|785531|P3|Overall Study|Screen Failure|0
237875|NCT01455194|785532|P2|Overall Study|Screen Failure|0
237876|NCT01455194|785533|P1|Overall Study|Screen Failure|20
237877|NCT01455012|785596|P2|Overall Study|Unknown reason|0
237878|NCT01455012|785597|P1|Overall Study|Unknown reason|2
237879|NCT01455012|785596|P2|Overall Study|Withdrawal by Subject|1
237880|NCT01455012|785597|P1|Overall Study|Withdrawal by Subject|3
237881|NCT01455012|785596|P2|Overall Study|Lack of Efficacy|1
237882|NCT01455012|785597|P1|Overall Study|Lack of Efficacy|6
237883|NCT01455012|785596|P2|Overall Study|Adverse Event|2
237884|NCT01455012|785597|P1|Overall Study|Adverse Event|0
237885|NCT01454934|785631|P2|Overall Study|Ongoing, survival follow-up|2
237886|NCT01454934|785632|P1|Overall Study|Ongoing, survival follow-up|1
237887|NCT01454934|785631|P2|Overall Study|Not treated|2
237888|NCT01454934|785632|P1|Overall Study|Not treated|1
237889|NCT01454934|785631|P2|Overall Study|Not specified|16
237890|NCT01454934|785632|P1|Overall Study|Not specified|5
237891|NCT01454934|785631|P2|Overall Study|Clinical progression|25
237892|NCT01454934|785632|P1|Overall Study|Clinical progression|28
237893|NCT01454934|785631|P2|Overall Study|Withdrawn consent|5
237894|NCT01454934|785632|P1|Overall Study|Withdrawn consent|2
237895|NCT01454934|785631|P2|Overall Study|Lost to Follow-up|1
237896|NCT01454934|785632|P1|Overall Study|Lost to Follow-up|0
237897|NCT01454934|785631|P2|Overall Study|Withdrawal by Subject|15
237898|NCT01454934|785632|P1|Overall Study|Withdrawal by Subject|11
237899|NCT01454934|785631|P2|Overall Study|Adverse Event|24
237900|NCT01454934|785632|P1|Overall Study|Adverse Event|28
237901|NCT01454934|785631|P2|Overall Study|Disease progression|180
237902|NCT01454934|785632|P1|Overall Study|Disease progression|194
237903|NCT01454830|785644|P2|Overall Study|Withdrawal - no polysomnography|2
237904|NCT01454830|785645|P1|Overall Study|Withdrawal - no polysomnography|3
237905|NCT01454830|785644|P2|Overall Study|Post-allocation Exclude-other treatment|7
237906|NCT01454830|785645|P1|Overall Study|Post-allocation Exclude-other treatment|6
237907|NCT01454830|785644|P2|Overall Study|Post-allocation Exclude-refused PAP|2
237908|NCT01454830|785645|P1|Overall Study|Post-allocation Exclude-refused PAP|0
237909|NCT01454830|785644|P2|Overall Study|Post-allocation Exclude- AHI<10|12
237910|NCT01454830|785645|P1|Overall Study|Post-allocation Exclude- AHI<10|18
237911|NCT01454830|785644|P2|Overall Study|Withdrawal by Subject|4
237912|NCT01454830|785645|P1|Overall Study|Withdrawal by Subject|4
237913|NCT01454778|785676|P1|Overall Study|Death|1
237914|NCT01454778|785676|P1|Overall Study|Lost to Follow-up|2
237915|NCT01454726|785687|P2|Overall Study|Withdrawal by Subject|1
237916|NCT01454726|785688|P1|Overall Study|Withdrawal by Subject|0
237917|NCT01454583|785697|P3|3rd Year|Lost to Follow-up|297
237918|NCT01454583|785698|P2|3rd Year|Lost to Follow-up|512
237919|NCT01454583|785699|P1|3rd Year|Lost to Follow-up|1959
237920|NCT01454583|785697|P3|2nd Year|Lost to Follow-up|737
237921|NCT01454583|785698|P2|2nd Year|Lost to Follow-up|1049
237922|NCT01454583|785699|P1|2nd Year|Lost to Follow-up|3965
237923|NCT01454583|785697|P3|1st Year|Lost to Follow-up|180
237924|NCT01454583|785698|P2|1st Year|Lost to Follow-up|318
237925|NCT01454583|785699|P1|1st Year|Lost to Follow-up|1057
237926|NCT01454531|785767|P1|Overall Study|Other|1
237927|NCT01454531|785767|P1|Overall Study|Delay in IMP administration|1
237928|NCT01454531|785767|P1|Overall Study|Physician Decision|1
237929|NCT01454531|785767|P1|Overall Study|Lost to Follow-up|1
237930|NCT01454531|785767|P1|Overall Study|Withdrawal by Subject|5
237931|NCT01454531|785767|P1|Overall Study|Adverse Event|14
237932|NCT01454401|785803|P1|Overall Study|non-adherence|1
237933|NCT01454401|785803|P1|Overall Study|osteomyelitis|2
237934|NCT01454401|785803|P1|Overall Study|hospitalised|1
237935|NCT01454401|785803|P1|Overall Study|Death|1
237936|NCT01454063|785816|P2|Randomized|Protocol Violation|1
237937|NCT01454063|785817|P1|Randomized|Protocol Violation|0
237938|NCT01454063|785816|P2|Randomized|Adverse Event|1
237939|NCT01454063|785817|P1|Randomized|Adverse Event|1
237940|NCT01453998|785838|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
237941|NCT01453998|785839|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
237942|NCT01453998|785840|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
237943|NCT01453946|785905|P1|Overall Study|Adverse Event|3
237944|NCT01453946|785905|P1|Overall Study|Lack of Efficacy|3
237945|NCT01453946|785905|P1|Overall Study|Protocol Violation|2
237946|NCT01453946|785905|P1|Overall Study|Did not receive drug for the taper phase|1
237947|NCT01453855|785922|P2|Overall Study|Other|1
237948|NCT01453855|785923|P1|Overall Study|Other|0
237949|NCT01453855|785922|P2|Overall Study|Inadequate Control of IOP|5
237950|NCT01453855|785923|P1|Overall Study|Inadequate Control of IOP|1
237951|NCT01453855|785922|P2|Overall Study|Noncompliance|0
237952|NCT01453855|785923|P1|Overall Study|Noncompliance|1
237953|NCT01453855|785922|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
237954|NCT01453855|785923|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
237955|NCT01453855|785922|P2|Overall Study|Lost to Follow-up|1
237956|NCT01453855|785923|P1|Overall Study|Lost to Follow-up|2
237957|NCT01453855|785922|P2|Overall Study|Adverse Event|4
237958|NCT01453855|785923|P1|Overall Study|Adverse Event|3
237959|NCT01453725|785931|P2|Overall Study|Physician Decision|1
237960|NCT01453725|785932|P1|Overall Study|Physician Decision|1
237961|NCT01453725|785931|P2|Overall Study|Pregnancy|0
237962|NCT01453725|785932|P1|Overall Study|Pregnancy|1
237963|NCT01453725|785931|P2|Overall Study|Pregnancy Wish|2
237964|NCT01453725|785932|P1|Overall Study|Pregnancy Wish|0
237965|NCT01453725|785931|P2|Overall Study|Withdrawal by Subject|3
237966|NCT01453725|785932|P1|Overall Study|Withdrawal by Subject|2
237967|NCT01453725|785931|P2|Overall Study|Protocol Violation|0
237968|NCT01453725|785932|P1|Overall Study|Protocol Violation|1
237969|NCT01453725|785931|P2|Overall Study|Non-compliance With Protocol|2
237970|NCT01453725|785932|P1|Overall Study|Non-compliance With Protocol|1
237971|NCT01453725|785931|P2|Overall Study|Lost to Follow-up|0
237972|NCT01453725|785932|P1|Overall Study|Lost to Follow-up|4
237973|NCT01453725|785931|P2|Overall Study|Adverse Event|3
237974|NCT01453725|785932|P1|Overall Study|Adverse Event|3
237975|NCT01452529|785954|P3|Double-blind (DB) Period|Administrative|7
237976|NCT01452529|785955|P2|Double-blind (DB) Period|Administrative|11
237977|NCT01452529|785956|P1|Double-blind (DB) Period|Administrative|0
237978|NCT01452529|785954|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
237979|NCT01452529|785955|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
237980|NCT01452529|785956|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
237981|NCT01452529|785954|P3|Double-blind (DB) Period|Lack of Efficacy|44
237982|NCT01452529|785955|P2|Double-blind (DB) Period|Lack of Efficacy|16
237983|NCT01452529|785956|P1|Double-blind (DB) Period|Lack of Efficacy|0
237984|NCT01452529|785954|P3|Double-blind (DB) Period|Lost to Follow-up|3
237985|NCT01452529|785955|P2|Double-blind (DB) Period|Lost to Follow-up|5
237986|NCT01452529|785956|P1|Double-blind (DB) Period|Lost to Follow-up|0
237987|NCT01452529|785954|P3|Double-blind (DB) Period|Withdrawal by Subject|14
237988|NCT01452529|785955|P2|Double-blind (DB) Period|Withdrawal by Subject|15
237989|NCT01452529|785956|P1|Double-blind (DB) Period|Withdrawal by Subject|0
237990|NCT01452529|785954|P3|Double-blind (DB) Period|Adverse Event|11
237991|NCT01452529|785955|P2|Double-blind (DB) Period|Adverse Event|18
237992|NCT01452529|785956|P1|Double-blind (DB) Period|Adverse Event|0
238079|NCT01451814|786484|P2|Overall Study|Lost to Follow-up|4
237993|NCT01452529|785954|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
237994|NCT01452529|785955|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
237995|NCT01452529|785956|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
237996|NCT01452529|785954|P3|Run-in Period|Administrative|0
237997|NCT01452529|785955|P2|Run-in Period|Administrative|0
237998|NCT01452529|785956|P1|Run-in Period|Administrative|21
237999|NCT01452529|785954|P3|Run-in Period|Confirmed or suspected diversion|0
238000|NCT01452529|785955|P2|Run-in Period|Confirmed or suspected diversion|0
238001|NCT01452529|785956|P1|Run-in Period|Confirmed or suspected diversion|23
238002|NCT01452529|785954|P3|Run-in Period|Lack of Efficacy|0
238003|NCT01452529|785955|P2|Run-in Period|Lack of Efficacy|0
238004|NCT01452529|785956|P1|Run-in Period|Lack of Efficacy|46
238005|NCT01452529|785954|P3|Run-in Period|Lost to Follow-up|0
238006|NCT01452529|785955|P2|Run-in Period|Lost to Follow-up|0
238007|NCT01452529|785956|P1|Run-in Period|Lost to Follow-up|19
238008|NCT01452529|785954|P3|Run-in Period|Withdrawal by Subject|0
238009|NCT01452529|785955|P2|Run-in Period|Withdrawal by Subject|0
238010|NCT01452529|785956|P1|Run-in Period|Withdrawal by Subject|49
238011|NCT01452529|785954|P3|Run-in Period|Adverse Event|0
238012|NCT01452529|785955|P2|Run-in Period|Adverse Event|0
238013|NCT01452529|785956|P1|Run-in Period|Adverse Event|96
238014|NCT01453595|785966|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
238015|NCT01453595|785967|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
238016|NCT01453595|785968|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
238017|NCT01453374|786087|P1|Overall Study|Incarcerated|2
238018|NCT01453374|786087|P1|Overall Study|Withdrawal by Subject|5
238019|NCT01453374|786087|P1|Overall Study|Lost to Follow-up|3
238020|NCT01453374|786087|P1|Overall Study|Lack of Efficacy|1
238021|NCT01453374|786087|P1|Overall Study|Adverse Event|7
238022|NCT01453348|786106|P3|Overall Study|Protocol Violation|0
238023|NCT01453348|786107|P2|Overall Study|Protocol Violation|0
238024|NCT01453348|786108|P1|Overall Study|Protocol Violation|1
238025|NCT01453348|786106|P3|Overall Study|Withdrawal by Subject|0
238026|NCT01453348|786107|P2|Overall Study|Withdrawal by Subject|1
238027|NCT01453348|786108|P1|Overall Study|Withdrawal by Subject|0
238028|NCT01453348|786106|P3|Overall Study|Death|1
238029|NCT01453348|786107|P2|Overall Study|Death|0
238030|NCT01453348|786108|P1|Overall Study|Death|0
238031|NCT01453296|786124|P2|Treatment Period 2|Withdrawal by Subject|0
238032|NCT01453296|786125|P1|Treatment Period 2|Withdrawal by Subject|1
238033|NCT01453296|786124|P2|Treatment Period 2|Adverse Event|0
238034|NCT01453296|786125|P1|Treatment Period 2|Adverse Event|1
238035|NCT01453296|786124|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
238036|NCT01453296|786125|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
238037|NCT01453296|786124|P2|Treatment Period 1|Adverse Event|1
238038|NCT01453296|786125|P1|Treatment Period 1|Adverse Event|0
238039|NCT01453049|786225|P2|Overall Study|Randomized in Error|0
238040|NCT01453049|786226|P1|Overall Study|Randomized in Error|1
238041|NCT01453049|786225|P2|Overall Study|Withdrawal by Subject|0
238042|NCT01453049|786226|P1|Overall Study|Withdrawal by Subject|1
238043|NCT01453049|786225|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
238044|NCT01453049|786226|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
238045|NCT01453049|786225|P2|Overall Study|Lost to Follow-up|1
238046|NCT01453049|786226|P1|Overall Study|Lost to Follow-up|2
238047|NCT01453049|786225|P2|Overall Study|Protocol Violation|5
238048|NCT01453049|786226|P1|Overall Study|Protocol Violation|2
238049|NCT01453036|786299|P3|Overall Study|Lost to Follow-up|31
238050|NCT01453036|786300|P2|Overall Study|Lost to Follow-up|115
238051|NCT01453036|786301|P1|Overall Study|Lost to Follow-up|26
238052|NCT01453023|786309|P2|Treatment Period 2|Protocol Violation|1
238053|NCT01453023|786310|P1|Treatment Period 2|Protocol Violation|0
238054|NCT01453023|786309|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
238055|NCT01453023|786310|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
238056|NCT01453023|786309|P2|Treatment Period (TP) 1|Protocol Violation|0
238057|NCT01453023|786310|P1|Treatment Period (TP) 1|Protocol Violation|1
238058|NCT01452347|786389|P2|Overall Study|Other reason not defined above|0
238059|NCT01452347|786390|P1|Overall Study|Other reason not defined above|2
238060|NCT01452347|786389|P2|Overall Study|Not treated|3
238061|NCT01452347|786390|P1|Overall Study|Not treated|6
238062|NCT01452347|786389|P2|Overall Study|Withdrawal by Subject|3
238063|NCT01452347|786390|P1|Overall Study|Withdrawal by Subject|3
238064|NCT01452347|786389|P2|Overall Study|Lost to Follow-up|0
238065|NCT01452347|786390|P1|Overall Study|Lost to Follow-up|2
238066|NCT01452347|786389|P2|Overall Study|Non compliance protocol|0
238067|NCT01452347|786390|P1|Overall Study|Non compliance protocol|2
238068|NCT01452347|786389|P2|Overall Study|Adverse Event|1
238069|NCT01452347|786390|P1|Overall Study|Adverse Event|2
238070|NCT01452152|786422|P3|Overall Study|Study termination by sponsor|4
238071|NCT01452152|786423|P2|Overall Study|Study termination by sponsor|0
238072|NCT01452152|786424|P1|Overall Study|Study termination by sponsor|5
238073|NCT01451931|786460|P3|Overall Study|Withdrawal by Subject|22
238074|NCT01451931|786461|P2|Overall Study|Withdrawal by Subject|22
238075|NCT01451931|786462|P1|Overall Study|Withdrawal by Subject|16
238076|NCT01451931|786460|P3|Overall Study|Lost to Follow-up|21
238077|NCT01451931|786461|P2|Overall Study|Lost to Follow-up|36
238078|NCT01451931|786462|P1|Overall Study|Lost to Follow-up|17
238080|NCT01451814|786485|P1|Overall Study|Lost to Follow-up|5
238081|NCT01451814|786484|P2|Overall Study|Withdrawal by Subject|1
238082|NCT01451814|786485|P1|Overall Study|Withdrawal by Subject|1
238083|NCT01451762|786517|P3|Overall Study|Lost to Follow-up|6
238084|NCT01451762|786518|P2|Overall Study|Lost to Follow-up|6
238085|NCT01451762|786519|P1|Overall Study|Lost to Follow-up|3
238086|NCT01451749|786529|P2|Overall Study|Withdrawal by Subject|1
238087|NCT01451749|786530|P1|Overall Study|Withdrawal by Subject|0
238088|NCT01451749|786529|P2|Overall Study|Adverse Event|0
238089|NCT01451749|786530|P1|Overall Study|Adverse Event|2
238090|NCT01451749|786529|P2|Overall Study|Meet the exclusion criteria,and|1
238091|NCT01451749|786530|P1|Overall Study|Meet the exclusion criteria,and|1
238092|NCT01451749|786529|P2|Overall Study|Lost to Follow-up|5
238093|NCT01451749|786530|P1|Overall Study|Lost to Follow-up|15
238094|NCT01451749|786529|P2|Overall Study|Protocol Violation|7
238095|NCT01451749|786530|P1|Overall Study|Protocol Violation|14
238096|NCT01451723|786542|P2|Overall Study|study halted|5
238097|NCT01451723|786543|P1|Overall Study|study halted|6
238098|NCT01451645|786553|P2|Overall Study|Lost to Follow-up|3
238099|NCT01451645|786554|P1|Overall Study|Lost to Follow-up|4
238100|NCT01451645|786553|P2|Overall Study|Withdrawal by Subject|2
238101|NCT01451645|786554|P1|Overall Study|Withdrawal by Subject|4
238102|NCT01451645|786553|P2|Overall Study|Adverse Event|3
238103|NCT01451645|786554|P1|Overall Study|Adverse Event|0
238104|NCT01451645|786553|P2|Overall Study|Protocol Violation|0
238105|NCT01451645|786554|P1|Overall Study|Protocol Violation|1
238106|NCT01451554|786625|P2|Overall Study|Withdrawal by Subject|9
238107|NCT01451554|786626|P1|Overall Study|Withdrawal by Subject|14
238108|NCT01451541|786637|P3|Overall Study|randomization error, noncompliance|8
238109|NCT01451541|786638|P2|Overall Study|randomization error, noncompliance|10
238110|NCT01451541|786639|P1|Overall Study|randomization error, noncompliance|11
238111|NCT01451541|786637|P3|Overall Study|Withdrawal by Subject|6
238112|NCT01451541|786638|P2|Overall Study|Withdrawal by Subject|8
238113|NCT01451541|786639|P1|Overall Study|Withdrawal by Subject|15
238114|NCT01451541|786637|P3|Overall Study|Lost to Follow-up|7
238115|NCT01451541|786638|P2|Overall Study|Lost to Follow-up|4
238116|NCT01451541|786639|P1|Overall Study|Lost to Follow-up|4
238117|NCT01451541|786637|P3|Overall Study|Lack of Efficacy|0
238118|NCT01451541|786638|P2|Overall Study|Lack of Efficacy|0
238119|NCT01451541|786639|P1|Overall Study|Lack of Efficacy|2
238120|NCT01451541|786637|P3|Overall Study|Adverse Event|6
238121|NCT01451541|786638|P2|Overall Study|Adverse Event|3
238122|NCT01451541|786639|P1|Overall Study|Adverse Event|4
238123|NCT01451437|786688|P9|Overall Study|Withdrawal by Subject|0
238124|NCT01451437|786689|P8|Overall Study|Withdrawal by Subject|0
238125|NCT01451437|786690|P7|Overall Study|Withdrawal by Subject|1
238126|NCT01451437|786691|P6|Overall Study|Withdrawal by Subject|0
238127|NCT01451437|786692|P5|Overall Study|Withdrawal by Subject|1
238128|NCT01451437|786693|P4|Overall Study|Withdrawal by Subject|0
238129|NCT01451437|786694|P3|Overall Study|Withdrawal by Subject|0
238130|NCT01451437|786695|P2|Overall Study|Withdrawal by Subject|0
238131|NCT01451437|786696|P1|Overall Study|Withdrawal by Subject|0
238132|NCT01451437|786688|P9|Overall Study|Protocol Violation|0
238133|NCT01451437|786689|P8|Overall Study|Protocol Violation|0
238134|NCT01451437|786690|P7|Overall Study|Protocol Violation|1
238135|NCT01451437|786691|P6|Overall Study|Protocol Violation|0
238136|NCT01451437|786692|P5|Overall Study|Protocol Violation|0
238137|NCT01451437|786693|P4|Overall Study|Protocol Violation|0
238138|NCT01451437|786694|P3|Overall Study|Protocol Violation|0
238139|NCT01451437|786695|P2|Overall Study|Protocol Violation|0
238140|NCT01451437|786696|P1|Overall Study|Protocol Violation|0
238141|NCT01451437|786688|P9|Overall Study|Disease Progression|3
238142|NCT01451437|786689|P8|Overall Study|Disease Progression|1
238143|NCT01451437|786690|P7|Overall Study|Disease Progression|3
238144|NCT01451437|786691|P6|Overall Study|Disease Progression|2
238145|NCT01451437|786692|P5|Overall Study|Disease Progression|3
238146|NCT01451437|786693|P4|Overall Study|Disease Progression|1
238147|NCT01451437|786694|P3|Overall Study|Disease Progression|1
238148|NCT01451437|786695|P2|Overall Study|Disease Progression|0
238149|NCT01451437|786696|P1|Overall Study|Disease Progression|0
238150|NCT01451437|786688|P9|Overall Study|Physician Decision|0
238151|NCT01451437|786689|P8|Overall Study|Physician Decision|0
238152|NCT01451437|786690|P7|Overall Study|Physician Decision|0
238153|NCT01451437|786691|P6|Overall Study|Physician Decision|0
238154|NCT01451437|786692|P5|Overall Study|Physician Decision|0
238155|NCT01451437|786693|P4|Overall Study|Physician Decision|0
238156|NCT01451437|786694|P3|Overall Study|Physician Decision|2
238157|NCT01451437|786695|P2|Overall Study|Physician Decision|1
238158|NCT01451437|786696|P1|Overall Study|Physician Decision|1
238159|NCT01451437|786688|P9|Overall Study|Adverse Event|1
238160|NCT01451437|786689|P8|Overall Study|Adverse Event|2
238161|NCT01451437|786690|P7|Overall Study|Adverse Event|1
238162|NCT01451437|786691|P6|Overall Study|Adverse Event|1
238163|NCT01451437|786692|P5|Overall Study|Adverse Event|0
238164|NCT01451437|786693|P4|Overall Study|Adverse Event|0
238165|NCT01451437|786694|P3|Overall Study|Adverse Event|0
238166|NCT01451437|786695|P2|Overall Study|Adverse Event|0
238167|NCT01451437|786696|P1|Overall Study|Adverse Event|0
238168|NCT01451424|786828|P4|Overall Study|Adverse Event|1
238169|NCT01451424|786829|P3|Overall Study|Adverse Event|0
238170|NCT01451424|786830|P2|Overall Study|Adverse Event|0
238171|NCT01451424|786831|P1|Overall Study|Adverse Event|0
238172|NCT01451424|786828|P4|Overall Study|Physician Decision|1
238173|NCT01451424|786829|P3|Overall Study|Physician Decision|1
238174|NCT01451424|786830|P2|Overall Study|Physician Decision|0
238175|NCT01451424|786831|P1|Overall Study|Physician Decision|0
238176|NCT01451424|786828|P4|Overall Study|Lost to Follow-up|1
238177|NCT01451424|786829|P3|Overall Study|Lost to Follow-up|0
238178|NCT01451424|786830|P2|Overall Study|Lost to Follow-up|1
238179|NCT01451424|786831|P1|Overall Study|Lost to Follow-up|0
238180|NCT01451424|786828|P4|Overall Study|Withdrawal by Subject|2
238181|NCT01451424|786829|P3|Overall Study|Withdrawal by Subject|0
238182|NCT01451424|786830|P2|Overall Study|Withdrawal by Subject|1
238183|NCT01451424|786831|P1|Overall Study|Withdrawal by Subject|1
238184|NCT01451398|786889|P2|Overall Study|Lack of Efficacy|1
238185|NCT01451398|786890|P1|Overall Study|Lack of Efficacy|0
238186|NCT01451398|786889|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
238187|NCT01451398|786890|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
238188|NCT01451398|786889|P2|Overall Study|Moved out of country|1
238189|NCT01451398|786890|P1|Overall Study|Moved out of country|0
238190|NCT01451398|786889|P2|Overall Study|Non-compliance with protocol|1
238191|NCT01451398|786890|P1|Overall Study|Non-compliance with protocol|1
238192|NCT01451398|786889|P2|Overall Study|Non-compliance with study drug|3
238193|NCT01451398|786890|P1|Overall Study|Non-compliance with study drug|1
238194|NCT01451398|786889|P2|Overall Study|Lost to Follow-up|4
238195|NCT01451398|786890|P1|Overall Study|Lost to Follow-up|6
238196|NCT01451398|786889|P2|Overall Study|Withdrawal by Subject|14
238197|NCT01451398|786890|P1|Overall Study|Withdrawal by Subject|10
238198|NCT01451398|786889|P2|Overall Study|Physician Decision|1
238199|NCT01451398|786890|P1|Overall Study|Physician Decision|1
238200|NCT01451398|786889|P2|Overall Study|Protocol Violation|2
238201|NCT01451398|786890|P1|Overall Study|Protocol Violation|1
238202|NCT01451398|786889|P2|Overall Study|Adverse Event|9
238203|NCT01451398|786890|P1|Overall Study|Adverse Event|7
238204|NCT01451203|786924|P2|Post-treatment Period|Investigator decision|1
238205|NCT01451203|786925|P1|Post-treatment Period|Investigator decision|0
238206|NCT01451203|786924|P2|Post-treatment Period|Adverse Event|1
238207|NCT01451203|786925|P1|Post-treatment Period|Adverse Event|0
238208|NCT01451203|786924|P2|Post-treatment Period|Lack of Efficacy|28
238209|NCT01451203|786925|P1|Post-treatment Period|Lack of Efficacy|12
238210|NCT01451203|786924|P2|Post-treatment Period|Consent withdrawn|4
238211|NCT01451203|786925|P1|Post-treatment Period|Consent withdrawn|2
238212|NCT01451203|786924|P2|Double-blind Treatment Period|Investigator decision|0
238213|NCT01451203|786925|P1|Double-blind Treatment Period|Investigator decision|2
238214|NCT01451203|786924|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
238215|NCT01451203|786925|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
238216|NCT01451203|786924|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
238217|NCT01451203|786925|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
238218|NCT01451203|786924|P2|Double-blind Treatment Period|Adverse Event|9
238219|NCT01451203|786925|P1|Double-blind Treatment Period|Adverse Event|6
238220|NCT01451203|786924|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
238221|NCT01451203|786925|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
238222|NCT01451203|786924|P2|Double-blind Treatment Period|Lack of Efficacy|36
238223|NCT01451203|786925|P1|Double-blind Treatment Period|Lack of Efficacy|71
238224|NCT01451203|786924|P2|Double-blind Treatment Period|Consent Withdrawn|2
238225|NCT01451203|786925|P1|Double-blind Treatment Period|Consent Withdrawn|3
238226|NCT01451203|786924|P2|Double-blind Treatment Period|Did not receive treatment|2
238227|NCT01451203|786925|P1|Double-blind Treatment Period|Did not receive treatment|1
238228|NCT01450813|786943|P4|Overall Study|Physician Decision|3
238229|NCT01450813|786944|P3|Overall Study|Physician Decision|0
238230|NCT01450813|786945|P2|Overall Study|Physician Decision|1
238231|NCT01450813|786946|P1|Overall Study|Physician Decision|1
238232|NCT01450800|786960|P2|Overall Study|Protocol Violation|3
238233|NCT01450800|786961|P1|Overall Study|Protocol Violation|1
238234|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
238235|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
238236|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Not reported|1
238237|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Not reported|0
238238|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
238239|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
238240|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
238241|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
238242|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
238243|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
238244|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
238245|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
238246|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Death|6
238247|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Death|5
238248|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
238249|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|11
238250|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
238251|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|14
238252|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
238253|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|25
238254|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
238255|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Study drug toxicity|85
238256|NCT01450761|786996|P2|Treatment With Blinded Study Therapy|Disease progression|409
238257|NCT01450761|786997|P1|Treatment With Blinded Study Therapy|Disease progression|314
238258|NCT01450761|786996|P2|Lead-in Chemotherapy|Lost to Follow-up|0
238259|NCT01450761|786997|P1|Lead-in Chemotherapy|Lost to Follow-up|2
238260|NCT01450761|786996|P2|Lead-in Chemotherapy|Unspecified|2
238261|NCT01450761|786997|P1|Lead-in Chemotherapy|Unspecified|2
238262|NCT01450761|786996|P2|Lead-in Chemotherapy|Death|3
238263|NCT01450761|786997|P1|Lead-in Chemotherapy|Death|3
238264|NCT01450761|786996|P2|Lead-in Chemotherapy|No longer meets study criteria|7
238265|NCT01450761|786997|P1|Lead-in Chemotherapy|No longer meets study criteria|3
238266|NCT01450761|786996|P2|Lead-in Chemotherapy|Study drug toxicity|10
238267|NCT01450761|786997|P1|Lead-in Chemotherapy|Study drug toxicity|6
238268|NCT01450761|786996|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
238269|NCT01450761|786997|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
238270|NCT01450761|786996|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
238271|NCT01450761|786997|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
238272|NCT01450761|786996|P2|Lead-in Chemotherapy|Disease progression|32
238273|NCT01450761|786997|P1|Lead-in Chemotherapy|Disease progression|33
238274|NCT01450761|786996|P2|Randomization|Unspecified|1
238275|NCT01450761|786997|P1|Randomization|Unspecified|0
238276|NCT01450761|786996|P2|Randomization|Adverse Event unrelated to study drug|0
238277|NCT01450761|786997|P1|Randomization|Adverse Event unrelated to study drug|1
238278|NCT01450761|786996|P2|Randomization|Disease progression|2
238279|NCT01450761|786997|P1|Randomization|Disease progression|0
238280|NCT01450761|786996|P2|Randomization|Withdrawal by Subject|0
238281|NCT01450761|786997|P1|Randomization|Withdrawal by Subject|2
238282|NCT01450761|786996|P2|Randomization|Subject no longer meets study criteria|2
238283|NCT01450761|786997|P1|Randomization|Subject no longer meets study criteria|1
238284|NCT01450696|787009|P2|Overall Study|Study Terminated by Sponsor|58
238285|NCT01450696|787010|P1|Overall Study|Study Terminated by Sponsor|53
238286|NCT01450696|787009|P2|Overall Study|Withdrawal by Subject|2
238287|NCT01450696|787010|P1|Overall Study|Withdrawal by Subject|13
238288|NCT01450696|787009|P2|Overall Study|Non-Compliance|0
238289|NCT01450696|787010|P1|Overall Study|Non-Compliance|1
238290|NCT01450696|787009|P2|Overall Study|Lost to Follow-up|3
238291|NCT01450696|787010|P1|Overall Study|Lost to Follow-up|3
238292|NCT01450696|787009|P2|Overall Study|Death|84
238293|NCT01450696|787010|P1|Overall Study|Death|77
238294|NCT01450696|787009|P2|Overall Study|Never Treated|1
238295|NCT01450696|787010|P1|Overall Study|Never Treated|1
238296|NCT01450683|787032|P1|Overall Study|Adverse Event|2
238297|NCT01450631|787038|P2|Overall Study|Withdrawal by Subject|0
238298|NCT01450631|787039|P1|Overall Study|Withdrawal by Subject|1
238299|NCT01450631|787038|P2|Overall Study|Lost to Follow-up|4
238300|NCT01450631|787039|P1|Overall Study|Lost to Follow-up|2
238301|NCT01450007|787170|P3|Overall Study|Adverse Event|0
238302|NCT01450007|787171|P2|Overall Study|Adverse Event|1
238303|NCT01450007|787172|P1|Overall Study|Adverse Event|0
238304|NCT01450007|787170|P3|Overall Study|Protocol Violation|1
238305|NCT01450007|787171|P2|Overall Study|Protocol Violation|1
238306|NCT01450007|787172|P1|Overall Study|Protocol Violation|0
238307|NCT01450007|787170|P3|Overall Study|Late exclusion before treatment|2
238308|NCT01450007|787171|P2|Overall Study|Late exclusion before treatment|3
238309|NCT01450007|787172|P1|Overall Study|Late exclusion before treatment|2
238310|NCT01449955|787191|P2|Overall Study|Withdrawal by Subject|2
238311|NCT01449955|787192|P1|Overall Study|Withdrawal by Subject|1
238312|NCT01449929|787200|P2|Overall Study|Ongoing|213
238313|NCT01449929|787201|P1|Overall Study|Ongoing|224
238314|NCT01449929|787200|P2|Overall Study|Physician Decision|3
238315|NCT01449929|787201|P1|Overall Study|Physician Decision|2
238316|NCT01449929|787200|P2|Overall Study|Withdrawal by Subject|1
238317|NCT01449929|787201|P1|Overall Study|Withdrawal by Subject|1
238318|NCT01449929|787200|P2|Overall Study|Lost to Follow-up|10
238319|NCT01449929|787201|P1|Overall Study|Lost to Follow-up|6
238320|NCT01449929|787200|P2|Overall Study|Protocol-defined Stopping Criteria|1
238321|NCT01449929|787201|P1|Overall Study|Protocol-defined Stopping Criteria|1
238322|NCT01449929|787200|P2|Overall Study|Protocol Violation|3
238323|NCT01449929|787201|P1|Overall Study|Protocol Violation|3
238324|NCT01449929|787200|P2|Overall Study|Lack of Efficacy|2
238325|NCT01449929|787201|P1|Overall Study|Lack of Efficacy|2
238326|NCT01449929|787200|P2|Overall Study|Adverse Event|9
238327|NCT01449929|787201|P1|Overall Study|Adverse Event|3
238328|NCT01449812|787240|P3|Overall Study|Lost to Follow-up|0
238329|NCT01449812|787241|P2|Overall Study|Lost to Follow-up|0
238330|NCT01449812|787242|P1|Overall Study|Lost to Follow-up|1
238331|NCT01449812|787240|P3|Overall Study|Withdrawal by Subject|1
238332|NCT01449812|787241|P2|Overall Study|Withdrawal by Subject|0
238333|NCT01449812|787242|P1|Overall Study|Withdrawal by Subject|0
238334|NCT01449812|787240|P3|Overall Study|Migrated/moved from study area|0
238335|NCT01449812|787241|P2|Overall Study|Migrated/moved from study area|0
238336|NCT01449812|787242|P1|Overall Study|Migrated/moved from study area|1
238337|NCT01449708|787357|P2|Overall Study|respiratory failure|0
238338|NCT01449708|787358|P1|Overall Study|respiratory failure|1
238339|NCT01449708|787357|P2|Overall Study|surgical complication|2
238340|NCT01449708|787358|P1|Overall Study|surgical complication|1
238341|NCT01449708|787357|P2|Overall Study|Protocol Violation|1
238342|NCT01449708|787358|P1|Overall Study|Protocol Violation|0
238343|NCT01449682|787369|P2|Overall Study|Adverse Event|0
238344|NCT01449682|787370|P1|Overall Study|Adverse Event|1
238345|NCT01449682|787369|P2|Overall Study|Death|1
238346|NCT01449682|787370|P1|Overall Study|Death|0
238347|NCT01449539|787382|P1|Overall Study|Toxicity not study related|1
238348|NCT01449539|787382|P1|Overall Study|Withdrawal by Subject|3
238349|NCT01449526|787388|P2|Overall Study|Cannot maintain visits|1
238350|NCT01449526|787389|P1|Overall Study|Cannot maintain visits|0
238351|NCT01449526|787388|P2|Overall Study|Lack of Motivation|1
238352|NCT01449526|787389|P1|Overall Study|Lack of Motivation|0
238353|NCT01449526|787388|P2|Overall Study|Symptoms/complaints|1
238354|NCT01449526|787389|P1|Overall Study|Symptoms/complaints|0
238355|NCT01449526|787388|P2|Overall Study|Withdrawal by Subject|1
238356|NCT01449526|787389|P1|Overall Study|Withdrawal by Subject|1
238357|NCT01449526|787388|P2|Overall Study|Lost to Follow-up|2
238358|NCT01449526|787389|P1|Overall Study|Lost to Follow-up|1
238359|NCT01449370|787477|P25|Overall Study|Death|1
238360|NCT01449370|787478|P24|Overall Study|Death|0
238361|NCT01449370|787479|P23|Overall Study|Death|0
238362|NCT01449370|787480|P22|Overall Study|Death|0
238363|NCT01449370|787481|P21|Overall Study|Death|0
238364|NCT01449370|787482|P20|Overall Study|Death|0
238365|NCT01449370|787483|P19|Overall Study|Death|0
238366|NCT01449370|787484|P18|Overall Study|Death|0
238367|NCT01449370|787485|P17|Overall Study|Death|0
238368|NCT01449370|787486|P16|Overall Study|Death|0
238369|NCT01449370|787487|P15|Overall Study|Death|0
238370|NCT01449370|787488|P14|Overall Study|Death|0
238371|NCT01449370|787489|P13|Overall Study|Death|0
238372|NCT01449370|787490|P12|Overall Study|Death|0
238373|NCT01449370|787491|P11|Overall Study|Death|0
238374|NCT01449370|787492|P10|Overall Study|Death|0
238375|NCT01449370|787493|P9|Overall Study|Death|0
238376|NCT01449370|787494|P8|Overall Study|Death|0
238377|NCT01449370|787495|P7|Overall Study|Death|0
238378|NCT01449370|787496|P6|Overall Study|Death|0
238379|NCT01449370|787497|P5|Overall Study|Death|0
238380|NCT01449370|787498|P4|Overall Study|Death|0
238381|NCT01449370|787499|P3|Overall Study|Death|0
238382|NCT01449370|787500|P2|Overall Study|Death|0
238383|NCT01449370|787501|P1|Overall Study|Death|0
238384|NCT01449370|787477|P25|Overall Study|Medication Prohibited by Protocol|0
238385|NCT01449370|787478|P24|Overall Study|Medication Prohibited by Protocol|1
238386|NCT01449370|787479|P23|Overall Study|Medication Prohibited by Protocol|0
238387|NCT01449370|787480|P22|Overall Study|Medication Prohibited by Protocol|0
238388|NCT01449370|787481|P21|Overall Study|Medication Prohibited by Protocol|0
238389|NCT01449370|787482|P20|Overall Study|Medication Prohibited by Protocol|0
238390|NCT01449370|787483|P19|Overall Study|Medication Prohibited by Protocol|0
238391|NCT01449370|787484|P18|Overall Study|Medication Prohibited by Protocol|0
238392|NCT01449370|787485|P17|Overall Study|Medication Prohibited by Protocol|0
238393|NCT01449370|787486|P16|Overall Study|Medication Prohibited by Protocol|0
238394|NCT01449370|787487|P15|Overall Study|Medication Prohibited by Protocol|0
238395|NCT01449370|787488|P14|Overall Study|Medication Prohibited by Protocol|0
238396|NCT01449370|787489|P13|Overall Study|Medication Prohibited by Protocol|0
238397|NCT01449370|787490|P12|Overall Study|Medication Prohibited by Protocol|0
238398|NCT01449370|787491|P11|Overall Study|Medication Prohibited by Protocol|0
238399|NCT01449370|787492|P10|Overall Study|Medication Prohibited by Protocol|0
238400|NCT01449370|787493|P9|Overall Study|Medication Prohibited by Protocol|0
238401|NCT01449370|787494|P8|Overall Study|Medication Prohibited by Protocol|0
238402|NCT01449370|787495|P7|Overall Study|Medication Prohibited by Protocol|0
238403|NCT01449370|787496|P6|Overall Study|Medication Prohibited by Protocol|0
238404|NCT01449370|787497|P5|Overall Study|Medication Prohibited by Protocol|0
238405|NCT01449370|787498|P4|Overall Study|Medication Prohibited by Protocol|0
238406|NCT01449370|787499|P3|Overall Study|Medication Prohibited by Protocol|0
238407|NCT01449370|787500|P2|Overall Study|Medication Prohibited by Protocol|0
238408|NCT01449370|787501|P1|Overall Study|Medication Prohibited by Protocol|0
238409|NCT01449370|787477|P25|Overall Study|Other|0
238410|NCT01449370|787478|P24|Overall Study|Other|1
238411|NCT01449370|787479|P23|Overall Study|Other|1
238412|NCT01449370|787480|P22|Overall Study|Other|0
238413|NCT01449370|787481|P21|Overall Study|Other|0
238414|NCT01449370|787482|P20|Overall Study|Other|0
238415|NCT01449370|787483|P19|Overall Study|Other|0
238416|NCT01449370|787484|P18|Overall Study|Other|0
238417|NCT01449370|787485|P17|Overall Study|Other|0
238418|NCT01449370|787486|P16|Overall Study|Other|0
238419|NCT01449370|787487|P15|Overall Study|Other|0
238420|NCT01449370|787488|P14|Overall Study|Other|0
238421|NCT01449370|787489|P13|Overall Study|Other|0
238422|NCT01449370|787490|P12|Overall Study|Other|0
238423|NCT01449370|787491|P11|Overall Study|Other|0
238424|NCT01449370|787492|P10|Overall Study|Other|1
238425|NCT01449370|787493|P9|Overall Study|Other|1
238426|NCT01449370|787494|P8|Overall Study|Other|0
238427|NCT01449370|787495|P7|Overall Study|Other|0
238428|NCT01449370|787496|P6|Overall Study|Other|0
238429|NCT01449370|787497|P5|Overall Study|Other|0
238430|NCT01449370|787498|P4|Overall Study|Other|0
238431|NCT01449370|787499|P3|Overall Study|Other|0
238432|NCT01449370|787500|P2|Overall Study|Other|0
238433|NCT01449370|787501|P1|Overall Study|Other|0
238434|NCT01449370|787477|P25|Overall Study|Lost to Follow-up|0
238435|NCT01449370|787478|P24|Overall Study|Lost to Follow-up|0
238436|NCT01449370|787479|P23|Overall Study|Lost to Follow-up|0
238437|NCT01449370|787480|P22|Overall Study|Lost to Follow-up|0
238438|NCT01449370|787481|P21|Overall Study|Lost to Follow-up|1
238439|NCT01449370|787482|P20|Overall Study|Lost to Follow-up|0
238440|NCT01449370|787483|P19|Overall Study|Lost to Follow-up|0
238441|NCT01449370|787484|P18|Overall Study|Lost to Follow-up|0
238442|NCT01449370|787485|P17|Overall Study|Lost to Follow-up|0
238443|NCT01449370|787486|P16|Overall Study|Lost to Follow-up|0
238444|NCT01449370|787487|P15|Overall Study|Lost to Follow-up|0
238445|NCT01449370|787488|P14|Overall Study|Lost to Follow-up|0
238446|NCT01449370|787489|P13|Overall Study|Lost to Follow-up|0
238447|NCT01449370|787490|P12|Overall Study|Lost to Follow-up|0
238448|NCT01449370|787491|P11|Overall Study|Lost to Follow-up|0
238449|NCT01449370|787492|P10|Overall Study|Lost to Follow-up|0
238450|NCT01449370|787493|P9|Overall Study|Lost to Follow-up|0
238451|NCT01449370|787494|P8|Overall Study|Lost to Follow-up|0
238452|NCT01449370|787495|P7|Overall Study|Lost to Follow-up|0
238453|NCT01449370|787496|P6|Overall Study|Lost to Follow-up|0
238454|NCT01449370|787497|P5|Overall Study|Lost to Follow-up|0
238455|NCT01449370|787498|P4|Overall Study|Lost to Follow-up|0
238456|NCT01449370|787499|P3|Overall Study|Lost to Follow-up|0
238457|NCT01449370|787500|P2|Overall Study|Lost to Follow-up|0
238458|NCT01449370|787501|P1|Overall Study|Lost to Follow-up|0
238459|NCT01449370|787477|P25|Overall Study|Participant Decision|1
238460|NCT01449370|787478|P24|Overall Study|Participant Decision|0
238461|NCT01449370|787479|P23|Overall Study|Participant Decision|0
238462|NCT01449370|787480|P22|Overall Study|Participant Decision|1
238463|NCT01449370|787481|P21|Overall Study|Participant Decision|0
238464|NCT01449370|787482|P20|Overall Study|Participant Decision|0
238465|NCT01449370|787483|P19|Overall Study|Participant Decision|1
238466|NCT01449370|787484|P18|Overall Study|Participant Decision|0
238467|NCT01449370|787485|P17|Overall Study|Participant Decision|3
238468|NCT01449370|787486|P16|Overall Study|Participant Decision|1
238469|NCT01449370|787487|P15|Overall Study|Participant Decision|0
238470|NCT01449370|787488|P14|Overall Study|Participant Decision|1
238471|NCT01449370|787489|P13|Overall Study|Participant Decision|1
238472|NCT01449370|787490|P12|Overall Study|Participant Decision|0
238473|NCT01449370|787491|P11|Overall Study|Participant Decision|0
238474|NCT01449370|787492|P10|Overall Study|Participant Decision|0
238475|NCT01449370|787493|P9|Overall Study|Participant Decision|1
238476|NCT01449370|787494|P8|Overall Study|Participant Decision|1
238477|NCT01449370|787495|P7|Overall Study|Participant Decision|0
238478|NCT01449370|787496|P6|Overall Study|Participant Decision|0
238479|NCT01449370|787497|P5|Overall Study|Participant Decision|0
238480|NCT01449370|787498|P4|Overall Study|Participant Decision|0
238481|NCT01449370|787499|P3|Overall Study|Participant Decision|0
238482|NCT01449370|787500|P2|Overall Study|Participant Decision|0
238483|NCT01449370|787501|P1|Overall Study|Participant Decision|0
238484|NCT01449370|787477|P25|Overall Study|Adverse Event|3
238485|NCT01449370|787478|P24|Overall Study|Adverse Event|1
238486|NCT01449370|787479|P23|Overall Study|Adverse Event|0
238487|NCT01449370|787480|P22|Overall Study|Adverse Event|1
238488|NCT01449370|787481|P21|Overall Study|Adverse Event|0
238489|NCT01449370|787482|P20|Overall Study|Adverse Event|1
238490|NCT01449370|787483|P19|Overall Study|Adverse Event|1
238491|NCT01449370|787484|P18|Overall Study|Adverse Event|0
238492|NCT01449370|787485|P17|Overall Study|Adverse Event|0
238493|NCT01449370|787486|P16|Overall Study|Adverse Event|1
238494|NCT01449370|787487|P15|Overall Study|Adverse Event|0
238495|NCT01449370|787488|P14|Overall Study|Adverse Event|2
238496|NCT01449370|787489|P13|Overall Study|Adverse Event|0
238497|NCT01449370|787490|P12|Overall Study|Adverse Event|0
238498|NCT01449370|787491|P11|Overall Study|Adverse Event|0
238499|NCT01449370|787492|P10|Overall Study|Adverse Event|1
238500|NCT01449370|787493|P9|Overall Study|Adverse Event|1
238501|NCT01449370|787494|P8|Overall Study|Adverse Event|0
238502|NCT01449370|787495|P7|Overall Study|Adverse Event|0
238503|NCT01449370|787496|P6|Overall Study|Adverse Event|0
238504|NCT01449370|787497|P5|Overall Study|Adverse Event|0
238505|NCT01449370|787498|P4|Overall Study|Adverse Event|1
238506|NCT01449370|787499|P3|Overall Study|Adverse Event|0
238507|NCT01449370|787500|P2|Overall Study|Adverse Event|2
238508|NCT01449370|787501|P1|Overall Study|Adverse Event|1
238509|NCT01449370|787477|P25|Overall Study|Disease Progression|3
238510|NCT01449370|787478|P24|Overall Study|Disease Progression|7
238511|NCT01449370|787479|P23|Overall Study|Disease Progression|3
238512|NCT01449370|787480|P22|Overall Study|Disease Progression|2
238513|NCT01449370|787481|P21|Overall Study|Disease Progression|5
238514|NCT01449370|787482|P20|Overall Study|Disease Progression|2
238515|NCT01449370|787483|P19|Overall Study|Disease Progression|1
238516|NCT01449370|787484|P18|Overall Study|Disease Progression|3
238517|NCT01449370|787485|P17|Overall Study|Disease Progression|4
238518|NCT01449370|787486|P16|Overall Study|Disease Progression|1
238519|NCT01449370|787487|P15|Overall Study|Disease Progression|3
238520|NCT01449370|787488|P14|Overall Study|Disease Progression|8
238521|NCT01449370|787489|P13|Overall Study|Disease Progression|2
238522|NCT01449370|787490|P12|Overall Study|Disease Progression|3
238523|NCT01449370|787491|P11|Overall Study|Disease Progression|3
238524|NCT01449370|787492|P10|Overall Study|Disease Progression|1
238525|NCT01449370|787493|P9|Overall Study|Disease Progression|9
238526|NCT01449370|787494|P8|Overall Study|Disease Progression|2
238527|NCT01449370|787495|P7|Overall Study|Disease Progression|3
238528|NCT01449370|787496|P6|Overall Study|Disease Progression|3
238529|NCT01449370|787497|P5|Overall Study|Disease Progression|3
238530|NCT01449370|787498|P4|Overall Study|Disease Progression|3
238531|NCT01449370|787499|P3|Overall Study|Disease Progression|8
238532|NCT01449370|787500|P2|Overall Study|Disease Progression|4
238533|NCT01449370|787501|P1|Overall Study|Disease Progression|5
238534|NCT01449279|787879|P1|Overall Study|Toxicity|2
238535|NCT01449279|787879|P1|Overall Study|Lack of Efficacy|5
238536|NCT01449006|787904|P2|Overall Study|Protocol Violation|0
238537|NCT01449006|787905|P1|Overall Study|Protocol Violation|1
238538|NCT01449006|787904|P2|Overall Study|Withdrawal by Subject|0
238539|NCT01449006|787905|P1|Overall Study|Withdrawal by Subject|1
238540|NCT01449006|787904|P2|Overall Study|Lost to Follow-up|0
238541|NCT01449006|787905|P1|Overall Study|Lost to Follow-up|1
238542|NCT01448850|787919|P2|Overall Study|Unspecified|12
238543|NCT01448850|787920|P1|Overall Study|Unspecified|15
238544|NCT01448850|787919|P2|Overall Study|Lost to Follow-up|1
238545|NCT01448850|787920|P1|Overall Study|Lost to Follow-up|3
238546|NCT01448850|787919|P2|Overall Study|Withdrawal by Subject|21
238547|NCT01448850|787920|P1|Overall Study|Withdrawal by Subject|13
238548|NCT01448850|787919|P2|Overall Study|Death|6
238549|NCT01448850|787920|P1|Overall Study|Death|3
238550|NCT01448707|787945|P2|Overall Study|Unspecified|4
238551|NCT01448707|787946|P1|Overall Study|Unspecified|7
238552|NCT01448707|787945|P2|Overall Study|Withdrawal by Subject|7
238553|NCT01448707|787946|P1|Overall Study|Withdrawal by Subject|6
238554|NCT01448707|787945|P2|Overall Study|Lost to Follow-up|6
238555|NCT01448707|787946|P1|Overall Study|Lost to Follow-up|2
238556|NCT01448707|787945|P2|Overall Study|Adverse Event|1
238557|NCT01448707|787946|P1|Overall Study|Adverse Event|3
238558|NCT01448616|787967|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
238559|NCT01448616|787968|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
238560|NCT01448616|787969|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
238561|NCT01448616|787970|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
238562|NCT01448616|787967|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
238563|NCT01448616|787968|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
238564|NCT01448616|787969|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
238565|NCT01448616|787970|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
238566|NCT01448616|787967|P4|Study Drug (Treatment Phase)|Adverse Event|0
238567|NCT01448616|787968|P3|Study Drug (Treatment Phase)|Adverse Event|1
238568|NCT01448616|787969|P2|Study Drug (Treatment Phase)|Adverse Event|1
238569|NCT01448616|787970|P1|Study Drug (Treatment Phase)|Adverse Event|0
238570|NCT01448616|787967|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
238571|NCT01448616|787968|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
238572|NCT01448616|787969|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
238573|NCT01448616|787970|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
238574|NCT01448616|787967|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
238575|NCT01448616|787968|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
238576|NCT01448616|787969|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
238577|NCT01448616|787970|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
238578|NCT01448213|788017|P2|Overall Study|Protocol Violation|2
238579|NCT01448213|788018|P1|Overall Study|Protocol Violation|1
238580|NCT01448213|788017|P2|Overall Study|Adverse Event|10
238581|NCT01448213|788018|P1|Overall Study|Adverse Event|4
238582|NCT01448213|788017|P2|Overall Study|Lost to Follow-up|10
238583|NCT01448213|788018|P1|Overall Study|Lost to Follow-up|12
238584|NCT01448057|788028|P2|Overall Study|Withdrawal by Subject|0
238585|NCT01448057|788029|P1|Overall Study|Withdrawal by Subject|2
238586|NCT01448057|788028|P2|Overall Study|Adverse Event|2
238587|NCT01448057|788029|P1|Overall Study|Adverse Event|0
238588|NCT01448057|788028|P2|Overall Study|Lost to Follow-up|0
238589|NCT01448057|788029|P1|Overall Study|Lost to Follow-up|3
238590|NCT01448057|788028|P2|Overall Study|Protocol Violation|2
238591|NCT01448057|788029|P1|Overall Study|Protocol Violation|3
238592|NCT01448044|788039|P2|Follow Up Period|not specified|11
238593|NCT01448044|788040|P1|Follow Up Period|not specified|5
238594|NCT01448044|788039|P2|Follow Up Period|Lost to Follow-up|2
238595|NCT01448044|788040|P1|Follow Up Period|Lost to Follow-up|6
238596|NCT01448044|788039|P2|Follow Up Period|Withdrawal by Subject|1
238597|NCT01448044|788040|P1|Follow Up Period|Withdrawal by Subject|1
238598|NCT01448044|788039|P2|Treatment Period|Other reason|0
238599|NCT01448044|788040|P1|Treatment Period|Other reason|2
238600|NCT01448044|788039|P2|Treatment Period|Lost to Follow-up|1
238601|NCT01448044|788040|P1|Treatment Period|Lost to Follow-up|2
238602|NCT01448044|788039|P2|Treatment Period|Participant does not meet study criteria|0
238603|NCT01448044|788040|P1|Treatment Period|Participant does not meet study criteria|1
238604|NCT01448044|788039|P2|Treatment Period|Completed 24 weeks treatment period only|0
238605|NCT01448044|788040|P1|Treatment Period|Completed 24 weeks treatment period only|8
238606|NCT01448044|788039|P2|Treatment Period|Subject requested discontinue study drug|0
238607|NCT01448044|788040|P1|Treatment Period|Subject requested discontinue study drug|1
238608|NCT01448044|788039|P2|Treatment Period|Lack of Efficacy|12
238609|NCT01448044|788040|P1|Treatment Period|Lack of Efficacy|5
238610|NCT01448044|788039|P2|Treatment Period|Adverse Event|3
238611|NCT01448044|788040|P1|Treatment Period|Adverse Event|4
238612|NCT01447927|788056|P2|Overall Study|Withdrawal by Subject|0
238613|NCT01447927|788057|P1|Overall Study|Withdrawal by Subject|1
238614|NCT01447927|788056|P2|Overall Study|Adverse Event|3
238615|NCT01447927|788057|P1|Overall Study|Adverse Event|4
238616|NCT01447719|788087|P1|Overall Study|Family withdrew autopsy consent|7
238617|NCT01447719|788087|P1|Overall Study|Withdrawal by Subject|2
238618|NCT01447719|788087|P1|Overall Study|Subject still living at end of study|79
238619|NCT01447719|788087|P1|Overall Study|Invalid image or not imaged|3
238620|NCT01447719|788087|P1|Overall Study|Image acquisition failure|2
238621|NCT01447576|788113|P1|Overall Study|Physician Decision|6
238622|NCT01447576|788113|P1|Overall Study|Lack of Efficacy|68
238623|NCT01447576|788113|P1|Overall Study|Protocol deviation|83
238624|NCT01447576|788113|P1|Overall Study|Withdrawal by Subject|100
238625|NCT01447576|788113|P1|Overall Study|Participant met withdrawal criteria|40
238626|NCT01447576|788113|P1|Overall Study|Adverse Event|127
238627|NCT01447576|788113|P1|Overall Study|Lost to Follow-up|52
238628|NCT01447446|788146|P6|Overall Study|Reason not Specified|0
238629|NCT01447446|788147|P5|Overall Study|Reason not Specified|1
238630|NCT01447446|788148|P4|Overall Study|Reason not Specified|1
238631|NCT01447446|788149|P3|Overall Study|Reason not Specified|1
238632|NCT01447446|788150|P2|Overall Study|Reason not Specified|1
238633|NCT01447446|788151|P1|Overall Study|Reason not Specified|1
238634|NCT01447446|788146|P6|Overall Study|New Treatment Started|0
238635|NCT01447446|788147|P5|Overall Study|New Treatment Started|2
238636|NCT01447446|788148|P4|Overall Study|New Treatment Started|0
238637|NCT01447446|788149|P3|Overall Study|New Treatment Started|1
238638|NCT01447446|788150|P2|Overall Study|New Treatment Started|2
238639|NCT01447446|788151|P1|Overall Study|New Treatment Started|8
238640|NCT01447446|788146|P6|Overall Study|SVR12 Assessment|5
238641|NCT01447446|788147|P5|Overall Study|SVR12 Assessment|5
238642|NCT01447446|788148|P4|Overall Study|SVR12 Assessment|1
238643|NCT01447446|788149|P3|Overall Study|SVR12 Assessment|2
238644|NCT01447446|788150|P2|Overall Study|SVR12 Assessment|1
238645|NCT01447446|788151|P1|Overall Study|SVR12 Assessment|13
238646|NCT01447446|788146|P6|Overall Study|Administrative/Other|4
238647|NCT01447446|788147|P5|Overall Study|Administrative/Other|33
238648|NCT01447446|788148|P4|Overall Study|Administrative/Other|2
238649|NCT01447446|788149|P3|Overall Study|Administrative/Other|10
238650|NCT01447446|788150|P2|Overall Study|Administrative/Other|9
238651|NCT01447446|788151|P1|Overall Study|Administrative/Other|34
238652|NCT01447446|788146|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
238653|NCT01447446|788147|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
238654|NCT01447446|788148|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
238655|NCT01447446|788149|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
238656|NCT01447446|788150|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
238657|NCT01447446|788151|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
238658|NCT01447446|788146|P6|Overall Study|Failure to Return/Consent Withdrawn|9
238659|NCT01447446|788147|P5|Overall Study|Failure to Return/Consent Withdrawn|69
238660|NCT01447446|788148|P4|Overall Study|Failure to Return/Consent Withdrawn|7
238661|NCT01447446|788149|P3|Overall Study|Failure to Return/Consent Withdrawn|31
238662|NCT01447446|788150|P2|Overall Study|Failure to Return/Consent Withdrawn|78
238663|NCT01447446|788151|P1|Overall Study|Failure to Return/Consent Withdrawn|357
238664|NCT01447446|788146|P6|Overall Study|Adverse Event|0
238665|NCT01447446|788147|P5|Overall Study|Adverse Event|2
238666|NCT01447446|788148|P4|Overall Study|Adverse Event|0
238667|NCT01447446|788149|P3|Overall Study|Adverse Event|1
238668|NCT01447446|788150|P2|Overall Study|Adverse Event|0
238669|NCT01447446|788151|P1|Overall Study|Adverse Event|3
238670|NCT01447446|788146|P6|Overall Study|Death|0
238671|NCT01447446|788147|P5|Overall Study|Death|7
238672|NCT01447446|788148|P4|Overall Study|Death|1
238673|NCT01447446|788149|P3|Overall Study|Death|2
238674|NCT01447446|788150|P2|Overall Study|Death|3
238675|NCT01447446|788151|P1|Overall Study|Death|6
238676|NCT01447433|788241|P2|Overall Study|Protocol Violation|1
238677|NCT01447433|788242|P1|Overall Study|Protocol Violation|1
238678|NCT01447433|788241|P2|Overall Study|Withdrawal by Subject|3
238679|NCT01447433|788242|P1|Overall Study|Withdrawal by Subject|3
238680|NCT01447433|788241|P2|Overall Study|Lost to Follow-up|2
238681|NCT01447433|788242|P1|Overall Study|Lost to Follow-up|0
238682|NCT01447420|788269|P3|Overall Study|Lack of Efficacy|8
238683|NCT01447420|788270|P2|Overall Study|Lack of Efficacy|19
238684|NCT01447420|788271|P1|Overall Study|Lack of Efficacy|1
238685|NCT01447420|788269|P3|Overall Study|Withdrawal by Subject|0
238686|NCT01447420|788270|P2|Overall Study|Withdrawal by Subject|1
238687|NCT01447420|788271|P1|Overall Study|Withdrawal by Subject|4
238688|NCT01447420|788269|P3|Overall Study|Protocol Violation|0
238689|NCT01447420|788270|P2|Overall Study|Protocol Violation|3
238690|NCT01447420|788271|P1|Overall Study|Protocol Violation|3
238691|NCT01447420|788269|P3|Overall Study|Adverse Event|2
238692|NCT01447420|788270|P2|Overall Study|Adverse Event|4
238693|NCT01447420|788271|P1|Overall Study|Adverse Event|2
238694|NCT01446796|788384|P2|Overall Study|Withdrawal by Subject|0
238695|NCT01446796|788385|P1|Overall Study|Withdrawal by Subject|1
238696|NCT01446419|788410|P2|Overall Study|Terminated per protocol|0
238697|NCT01446419|788411|P1|Overall Study|Terminated per protocol|3
238698|NCT01446419|788410|P2|Overall Study|Withdrawal by Subject|1
238699|NCT01446419|788411|P1|Overall Study|Withdrawal by Subject|1
238700|NCT01446419|788410|P2|Overall Study|Death|0
238701|NCT01446419|788411|P1|Overall Study|Death|1
238702|NCT01446289|788425|P4|Overall Study|Withdrawal by Subject|0
238703|NCT01446289|788426|P3|Overall Study|Withdrawal by Subject|1
238704|NCT01446289|788427|P2|Overall Study|Withdrawal by Subject|0
238705|NCT01446289|788428|P1|Overall Study|Withdrawal by Subject|1
238706|NCT01446237|788471|P1|Overall Study|Withdrawal by Subject|7
238707|NCT01446237|788471|P1|Overall Study|Lost to Follow-up|2
238708|NCT01446237|788471|P1|Overall Study|Adverse Event|1
238709|NCT01446003|788479|P2|Period 2|Adverse Event|0
238710|NCT01446003|788480|P1|Period 2|Adverse Event|1
238711|NCT01446003|788479|P2|Period 1|Protocol Violation|0
238712|NCT01446003|788480|P1|Period 1|Protocol Violation|2
238713|NCT01445951|788501|P3|Overall Study|Cough|0
238714|NCT01445951|788502|P2|Overall Study|Cough|1
238715|NCT01445951|788503|P1|Overall Study|Cough|0
238716|NCT01445951|788501|P3|Overall Study|Sponsor decision - subject travel|0
238717|NCT01445951|788502|P2|Overall Study|Sponsor decision - subject travel|1
238718|NCT01445951|788503|P1|Overall Study|Sponsor decision - subject travel|0
238719|NCT01445951|788501|P3|Overall Study|Non-compliance with protocol|0
238720|NCT01445951|788502|P2|Overall Study|Non-compliance with protocol|1
238721|NCT01445951|788503|P1|Overall Study|Non-compliance with protocol|0
238722|NCT01445951|788501|P3|Overall Study|Non-compliance with study drug|0
238723|NCT01445951|788502|P2|Overall Study|Non-compliance with study drug|2
238724|NCT01445951|788503|P1|Overall Study|Non-compliance with study drug|1
238725|NCT01445951|788501|P3|Overall Study|Death|1
238726|NCT01445951|788502|P2|Overall Study|Death|0
238727|NCT01445951|788503|P1|Overall Study|Death|0
238728|NCT01445951|788501|P3|Overall Study|Pregnancy|4
238729|NCT01445951|788502|P2|Overall Study|Pregnancy|1
238730|NCT01445951|788503|P1|Overall Study|Pregnancy|0
238731|NCT01445951|788501|P3|Overall Study|Lost to Follow-up|4
238732|NCT01445951|788502|P2|Overall Study|Lost to Follow-up|2
238733|NCT01445951|788503|P1|Overall Study|Lost to Follow-up|1
238734|NCT01445951|788501|P3|Overall Study|Physician Decision|0
238735|NCT01445951|788502|P2|Overall Study|Physician Decision|1
238736|NCT01445951|788503|P1|Overall Study|Physician Decision|3
238737|NCT01445951|788501|P3|Overall Study|Withdrawal by Subject|8
238738|NCT01445951|788502|P2|Overall Study|Withdrawal by Subject|16
238739|NCT01445951|788503|P1|Overall Study|Withdrawal by Subject|21
238740|NCT01445951|788501|P3|Overall Study|Protocol Violation|2
238741|NCT01445951|788502|P2|Overall Study|Protocol Violation|2
238742|NCT01445951|788503|P1|Overall Study|Protocol Violation|2
238743|NCT01445951|788501|P3|Overall Study|Adverse Event|0
238744|NCT01445951|788502|P2|Overall Study|Adverse Event|9
238745|NCT01445951|788503|P1|Overall Study|Adverse Event|16
238746|NCT01445847|788571|P2|Overall Study|Missed Data|0
238747|NCT01445847|788572|P1|Overall Study|Missed Data|1
238748|NCT01445847|788571|P2|Overall Study|Protocol Violation|14
238749|NCT01445847|788572|P1|Overall Study|Protocol Violation|13
238750|NCT01445769|788578|P1|Overall Study|Lost to Follow-up|5
238751|NCT01445769|788578|P1|Overall Study|Disease Progression|1
238752|NCT01445769|788578|P1|Overall Study|Consent Withdrawn|2
238753|NCT01445678|788598|P2|Overall Study|Withdrawal by Subject|5
238754|NCT01445678|788599|P1|Overall Study|Withdrawal by Subject|9
238755|NCT01445678|788598|P2|Overall Study|Protocol Violation|1
238756|NCT01445678|788599|P1|Overall Study|Protocol Violation|1
238757|NCT01445678|788598|P2|Overall Study|Lost to Follow-up|5
238758|NCT01445678|788599|P1|Overall Study|Lost to Follow-up|8
238759|NCT01445678|788598|P2|Overall Study|Lack of Efficacy|2
238760|NCT01445678|788599|P1|Overall Study|Lack of Efficacy|0
238761|NCT01445678|788598|P2|Overall Study|Adverse Event|8
238762|NCT01445678|788599|P1|Overall Study|Adverse Event|12
238763|NCT01445652|788617|P2|Overall Study|Adverse Event|0
238764|NCT01445652|788618|P1|Overall Study|Adverse Event|1
238765|NCT01445652|788617|P2|Overall Study|Failed teach session|0
238766|NCT01445652|788618|P1|Overall Study|Failed teach session|2
238767|NCT01445652|788617|P2|Overall Study|Failed to attend scheduled visit|3
238768|NCT01445652|788618|P1|Overall Study|Failed to attend scheduled visit|2
238769|NCT01445652|788617|P2|Overall Study|Not comfortable in lenses|0
238770|NCT01445652|788618|P1|Overall Study|Not comfortable in lenses|5
238771|NCT01445613|788636|P1|1-year Follow-up|Received a non-study stent|2
238772|NCT01445613|788636|P1|1-year Follow-up|Physician Decision|2
238773|NCT01445613|788636|P1|1-year Follow-up|Death|30
238774|NCT01445613|788636|P1|1-year Follow-up|Lost to Follow-up|2
238775|NCT01445613|788636|P1|1-year Follow-up|Missed visit|29
238776|NCT01445613|788636|P1|1-year Follow-up|Withdrawal by Subject|12
238777|NCT01445613|788636|P1|30-day Follow-up|Death|3
238778|NCT01445613|788636|P1|30-day Follow-up|Missed visit|23
238779|NCT01445613|788636|P1|30-day Follow-up|Physician Decision|3
238780|NCT01445613|788636|P1|30-day Follow-up|Withdrawal by Subject|6
238781|NCT01445548|788654|P1|Overall Study|Adverse Event|1
238782|NCT01444898|788693|P1|Overall Study|Withdrawal by Subject|1
238783|NCT01444781|788708|P3|Overall Study|Withdrawal by Subject|2
238784|NCT01444781|788709|P2|Overall Study|Withdrawal by Subject|1
238785|NCT01444781|788710|P1|Overall Study|Withdrawal by Subject|3
238786|NCT01444781|788708|P3|Overall Study|Lost to Follow-up|1
238787|NCT01444781|788709|P2|Overall Study|Lost to Follow-up|3
238788|NCT01444781|788710|P1|Overall Study|Lost to Follow-up|0
238789|NCT01444651|788750|P2|Overall Study|Missing data|1
238790|NCT01444651|788751|P1|Overall Study|Missing data|1
238791|NCT01444651|788750|P2|Overall Study|Non-fasting|1
238792|NCT01444651|788751|P1|Overall Study|Non-fasting|2
238793|NCT01444651|788750|P2|Overall Study|Lost to Follow-up|5
238794|NCT01444651|788751|P1|Overall Study|Lost to Follow-up|5
238795|NCT01444651|788750|P2|Overall Study|Adverse Event|2
238796|NCT01444651|788751|P1|Overall Study|Adverse Event|3
238797|NCT01444456|788767|P1|Overall Study|Not treated|104
238798|NCT01444456|788767|P1|Overall Study|Other|18
238799|NCT01444456|788767|P1|Overall Study|Ineligibility determined|23
238800|NCT01444456|788767|P1|Overall Study|Death|73
238801|NCT01444456|788767|P1|Overall Study|Lost to Follow-up|37
238802|NCT01444456|788767|P1|Overall Study|Physician Decision|9
238803|NCT01444456|788767|P1|Overall Study|Withdrawal by Subject|21
238804|NCT01444430|788778|P2|Overall Study|CRF termination module not completed.|1
238805|NCT01444430|788779|P1|Overall Study|CRF termination module not completed.|0
238806|NCT01444430|788778|P2|Overall Study|Lost to Follow-up|0
238807|NCT01444430|788779|P1|Overall Study|Lost to Follow-up|2
238808|NCT01444430|788778|P2|Overall Study|Death|8
238809|NCT01444430|788779|P1|Overall Study|Death|6
238810|NCT01444430|788778|P2|Overall Study|Withdrawal by Subject|72
238811|NCT01444430|788779|P1|Overall Study|Withdrawal by Subject|53
238812|NCT01444417|788801|P2|Overall Study|Withdrawal by Subject|0
238813|NCT01444417|788802|P1|Overall Study|Withdrawal by Subject|2
238814|NCT01444417|788801|P2|Overall Study|Ineligibility Determined|1
238815|NCT01444417|788802|P1|Overall Study|Ineligibility Determined|0
238816|NCT01444391|788818|P1|Overall Study|Death|1
238817|NCT01444378|788826|P1|Overall Study|Missed Visits|10
238818|NCT01444378|788826|P1|Overall Study|Administrative Closure Of The Study|2
238819|NCT01444378|788826|P1|Overall Study|Death|3
238820|NCT01444378|788826|P1|Overall Study|Withdrawal by Subject|1
238821|NCT01444378|788826|P1|Overall Study|Lost to Follow-up|1
238822|NCT01444300|788938|P2|Overall Study|Adverse Event|0
238823|NCT01444300|788939|P1|Overall Study|Adverse Event|4
238824|NCT01444092|788971|P1|Overall Study|Other Eligibility criteria|7
238825|NCT01444092|788971|P1|Overall Study|Withdrawal by Subject|1
238826|NCT01444092|788971|P1|Overall Study|Protocol Violation|1
238827|NCT01444092|788971|P1|Overall Study|Adverse Event|8
238828|NCT01443923|788979|P2|Overall Study|Adverse Event|0
238829|NCT01443923|788980|P1|Overall Study|Adverse Event|1
238830|NCT01443858|788997|P3|Overall Study|Lost to Follow-up|2
238831|NCT01443858|788998|P2|Overall Study|Lost to Follow-up|5
238832|NCT01443858|788999|P1|Overall Study|Lost to Follow-up|5
238833|NCT01443858|788997|P3|Overall Study|Lack of Efficacy|0
238834|NCT01443858|788998|P2|Overall Study|Lack of Efficacy|0
238835|NCT01443858|788999|P1|Overall Study|Lack of Efficacy|1
238836|NCT01443858|788997|P3|Overall Study|Withdrawal by Subject|5
238837|NCT01443858|788998|P2|Overall Study|Withdrawal by Subject|8
238838|NCT01443858|788999|P1|Overall Study|Withdrawal by Subject|9
238839|NCT01443845|789021|P2|Overall Study|Lost to Follow-up|13
238840|NCT01443845|789022|P1|Overall Study|Lost to Follow-up|9
238841|NCT01443845|789021|P2|Overall Study|Military Conflict - Site Terminated|21
238842|NCT01443845|789022|P1|Overall Study|Military Conflict - Site Terminated|20
238843|NCT01443845|789021|P2|Overall Study|Withdrawal by Subject|67
238844|NCT01443845|789022|P1|Overall Study|Withdrawal by Subject|63
238845|NCT01443845|789021|P2|Overall Study|Adverse Event|138
238846|NCT01443845|789022|P1|Overall Study|Adverse Event|64
238847|NCT01443845|789021|P2|Overall Study|Lack of Efficacy|5
238848|NCT01443845|789022|P1|Overall Study|Lack of Efficacy|10
238849|NCT01443845|789021|P2|Overall Study|Deterioration in pulmonary function|4
238850|NCT01443845|789022|P1|Overall Study|Deterioration in pulmonary function|1
238851|NCT01443845|789021|P2|Overall Study|Other reasons, such as COPD exacerbation|44
238852|NCT01443845|789022|P1|Overall Study|Other reasons, such as COPD exacerbation|44
238853|NCT01443845|789021|P2|Overall Study|Protocol Violation|45
238854|NCT01443845|789022|P1|Overall Study|Protocol Violation|43
238855|NCT01443403|789043|P4|Overall Study|Other - Miscellaneous|1
238856|NCT01443403|789044|P3|Overall Study|Other - Miscellaneous|0
238857|NCT01443403|789045|P2|Overall Study|Other - Miscellaneous|0
238858|NCT01443403|789046|P1|Overall Study|Other - Miscellaneous|1
238859|NCT01443403|789043|P4|Overall Study|Use of Prohibited Treatment|0
238860|NCT01443403|789044|P3|Overall Study|Use of Prohibited Treatment|0
238861|NCT01443403|789045|P2|Overall Study|Use of Prohibited Treatment|3
238862|NCT01443403|789046|P1|Overall Study|Use of Prohibited Treatment|2
238863|NCT01443403|789043|P4|Overall Study|Protocol Violation|1
238864|NCT01443403|789044|P3|Overall Study|Protocol Violation|1
238865|NCT01443403|789045|P2|Overall Study|Protocol Violation|1
238866|NCT01443403|789046|P1|Overall Study|Protocol Violation|2
238867|NCT01443403|789043|P4|Overall Study|Lost to Follow-up|1
238868|NCT01443403|789044|P3|Overall Study|Lost to Follow-up|0
238869|NCT01443403|789045|P2|Overall Study|Lost to Follow-up|0
238870|NCT01443403|789046|P1|Overall Study|Lost to Follow-up|0
238871|NCT01443403|789043|P4|Overall Study|Withdrawal by Subject|1
238872|NCT01443403|789044|P3|Overall Study|Withdrawal by Subject|2
238873|NCT01443403|789045|P2|Overall Study|Withdrawal by Subject|1
238874|NCT01443403|789046|P1|Overall Study|Withdrawal by Subject|0
238875|NCT01443403|789043|P4|Overall Study|Adverse Event|5
238876|NCT01443403|789044|P3|Overall Study|Adverse Event|4
238877|NCT01443403|789045|P2|Overall Study|Adverse Event|1
238878|NCT01443403|789046|P1|Overall Study|Adverse Event|1
238879|NCT01443364|789193|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
238880|NCT01443364|789193|P1|Overall Study|AE, non-serious non-fatal|8
238881|NCT01443364|789193|P1|Overall Study|SAE, non-fatal|6
238882|NCT01443364|789193|P1|Overall Study|Other Reason|4
238883|NCT01443364|789193|P1|Overall Study|Withdrawal by Subject|5
238884|NCT01443364|789193|P1|Overall Study|Lost to Follow-up|3
238885|NCT01443364|789193|P1|Overall Study|Lack of Efficacy|14
238886|NCT01443130|789322|P6|Overall Study|Death of Subject's Infant|0
238887|NCT01443130|789323|P5|Overall Study|Death of Subject's Infant|0
238888|NCT01443130|789324|P4|Overall Study|Death of Subject's Infant|0
238889|NCT01443130|789325|P3|Overall Study|Death of Subject's Infant|11
238890|NCT01443130|789326|P2|Overall Study|Death of Subject's Infant|10
238891|NCT01443130|789327|P1|Overall Study|Death of Subject's Infant|5
238892|NCT01443130|789322|P6|Overall Study|Withdrawal by Subject|2
238893|NCT01443130|789323|P5|Overall Study|Withdrawal by Subject|7
238894|NCT01443130|789324|P4|Overall Study|Withdrawal by Subject|7
238895|NCT01443130|789325|P3|Overall Study|Withdrawal by Subject|12
238896|NCT01443130|789326|P2|Overall Study|Withdrawal by Subject|14
238897|NCT01443130|789327|P1|Overall Study|Withdrawal by Subject|15
238898|NCT01443130|789322|P6|Overall Study|Protocol Violation|3
238899|NCT01443130|789323|P5|Overall Study|Protocol Violation|2
238900|NCT01443130|789324|P4|Overall Study|Protocol Violation|2
238901|NCT01443130|789325|P3|Overall Study|Protocol Violation|3
238902|NCT01443130|789326|P2|Overall Study|Protocol Violation|1
238903|NCT01443130|789327|P1|Overall Study|Protocol Violation|2
238904|NCT01443130|789322|P6|Overall Study|Adverse Event|0
238905|NCT01443130|789323|P5|Overall Study|Adverse Event|0
238906|NCT01443130|789324|P4|Overall Study|Adverse Event|0
238907|NCT01443130|789325|P3|Overall Study|Adverse Event|1
238908|NCT01443130|789326|P2|Overall Study|Adverse Event|1
238909|NCT01443130|789327|P1|Overall Study|Adverse Event|2
238910|NCT01443130|789322|P6|Overall Study|Death|8
238911|NCT01443130|789323|P5|Overall Study|Death|10
238912|NCT01443130|789324|P4|Overall Study|Death|7
238913|NCT01443130|789325|P3|Overall Study|Death|0
238914|NCT01443130|789326|P2|Overall Study|Death|1
238915|NCT01443130|789327|P1|Overall Study|Death|0
238916|NCT01443130|789322|P6|Overall Study|Lost to Follow-up|21
238917|NCT01443130|789323|P5|Overall Study|Lost to Follow-up|25
238918|NCT01443130|789324|P4|Overall Study|Lost to Follow-up|23
238919|NCT01443130|789325|P3|Overall Study|Lost to Follow-up|50
238920|NCT01443130|789326|P2|Overall Study|Lost to Follow-up|42
238921|NCT01443130|789327|P1|Overall Study|Lost to Follow-up|44
238922|NCT01443078|789377|P1|Overall Study|Patient had brain mets|1
238923|NCT01443078|789377|P1|Overall Study|Withdrawal by Subject|1
238924|NCT01443078|789377|P1|Overall Study|Responded to neoadjuvant platinum txt|27
238925|NCT01443026|789383|P2|Overall Study|Lost to Follow-up|1
238926|NCT01443026|789384|P1|Overall Study|Lost to Follow-up|2
238927|NCT01443026|789383|P2|Overall Study|Withdrawal by Subject|3
238928|NCT01443026|789384|P1|Overall Study|Withdrawal by Subject|0
238929|NCT01443026|789383|P2|Overall Study|Death|1
238930|NCT01443026|789384|P1|Overall Study|Death|0
238931|NCT01443026|789383|P2|Overall Study|Physician Decision|0
238932|NCT01443026|789384|P1|Overall Study|Physician Decision|1
238933|NCT01442779|789399|P1|Overall Study|Non-compliance|1
238934|NCT01442779|789399|P1|Overall Study|Death|3
238935|NCT01442779|789399|P1|Overall Study|Withdrawal by Subject|3
238936|NCT01442688|789407|P2|Second Intervention|Adverse Event|0
238937|NCT01442688|789408|P1|Second Intervention|Adverse Event|1
238938|NCT01442688|789407|P2|First Intervention|subject incarcerated|0
238939|NCT01442688|789408|P1|First Intervention|subject incarcerated|1
238940|NCT01442688|789407|P2|First Intervention|Withdrawal by Subject|0
238941|NCT01442688|789408|P1|First Intervention|Withdrawal by Subject|1
238942|NCT01442675|789416|P1|Overall Study|Withdrawal by Subject|4
238943|NCT01442675|789416|P1|Overall Study|Lost to Follow-up|2
238944|NCT01442675|789416|P1|Overall Study|Protocol Violation|6
238945|NCT01442376|789429|P3|Overall Study|Not eligible for subsequent cycles|0
238946|NCT01442376|789430|P2|Overall Study|Not eligible for subsequent cycles|2
238947|NCT01442376|789431|P1|Overall Study|Not eligible for subsequent cycles|1
238948|NCT01442376|789429|P3|Overall Study|Patients not treated|1
238949|NCT01442376|789430|P2|Overall Study|Patients not treated|3
238950|NCT01442376|789431|P1|Overall Study|Patients not treated|2
238951|NCT01442376|789429|P3|Overall Study|Withdrawal of consent|1
238952|NCT01442376|789430|P2|Overall Study|Withdrawal of consent|0
238953|NCT01442376|789431|P1|Overall Study|Withdrawal of consent|0
238954|NCT01442376|789429|P3|Overall Study|Death|1
238955|NCT01442376|789430|P2|Overall Study|Death|1
238956|NCT01442376|789431|P1|Overall Study|Death|0
238957|NCT01442376|789429|P3|Overall Study|Adverse Event|2
238958|NCT01442376|789430|P2|Overall Study|Adverse Event|3
238959|NCT01442376|789431|P1|Overall Study|Adverse Event|0
238960|NCT01442181|789444|P2|Overall Study|atrial fibrillation not noted|1
238961|NCT01442181|789445|P1|Overall Study|atrial fibrillation not noted|0
238962|NCT01442181|789444|P2|Overall Study|patient in an additional study|0
238963|NCT01442181|789445|P1|Overall Study|patient in an additional study|1
238964|NCT01442181|789444|P2|Overall Study|Lost to Follow-up|1
238965|NCT01442181|789445|P1|Overall Study|Lost to Follow-up|1
238966|NCT01442181|789444|P2|Overall Study|low ejection factor|1
238967|NCT01442181|789445|P1|Overall Study|low ejection factor|0
238968|NCT01442181|789444|P2|Overall Study|no insurance for surgery|0
238969|NCT01442181|789445|P1|Overall Study|no insurance for surgery|1
238970|NCT01442181|789444|P2|Overall Study|patient refused surgery|0
238971|NCT01442181|789445|P1|Overall Study|patient refused surgery|1
238972|NCT01442155|789469|P1|Overall Study|Lost to Follow-up|2
238973|NCT01442155|789469|P1|Overall Study|Adverse Event|2
238974|NCT01442155|789469|P1|Overall Study|Recurrence|26
238975|NCT01442155|789469|P1|Overall Study|Complete remission|35
238976|NCT01442103|789485|P1|Overall Study|Lost to Follow-up|2
238977|NCT01442064|789495|P6|Overall Study|Condition mandated other intervention|2
238978|NCT01442064|789496|P5|Overall Study|Condition mandated other intervention|0
238979|NCT01442064|789497|P4|Overall Study|Condition mandated other intervention|0
238980|NCT01442064|789498|P3|Overall Study|Condition mandated other intervention|2
238981|NCT01442064|789499|P2|Overall Study|Condition mandated other intervention|1
238982|NCT01442064|789500|P1|Overall Study|Condition mandated other intervention|1
238983|NCT01442064|789495|P6|Overall Study|Subject non-compliance|2
238984|NCT01442064|789496|P5|Overall Study|Subject non-compliance|0
238985|NCT01442064|789497|P4|Overall Study|Subject non-compliance|0
238986|NCT01442064|789498|P3|Overall Study|Subject non-compliance|0
238987|NCT01442064|789499|P2|Overall Study|Subject non-compliance|0
238988|NCT01442064|789500|P1|Overall Study|Subject non-compliance|0
238989|NCT01442064|789495|P6|Overall Study|Sponsor decision|87
238990|NCT01442064|789496|P5|Overall Study|Sponsor decision|95
238991|NCT01442064|789497|P4|Overall Study|Sponsor decision|88
238992|NCT01442064|789498|P3|Overall Study|Sponsor decision|92
238993|NCT01442064|789499|P2|Overall Study|Sponsor decision|88
238994|NCT01442064|789500|P1|Overall Study|Sponsor decision|82
238995|NCT01442064|789495|P6|Overall Study|Withdrawal by Subject|1
238996|NCT01442064|789496|P5|Overall Study|Withdrawal by Subject|2
238997|NCT01442064|789497|P4|Overall Study|Withdrawal by Subject|2
238998|NCT01442064|789498|P3|Overall Study|Withdrawal by Subject|2
238999|NCT01442064|789499|P2|Overall Study|Withdrawal by Subject|3
239000|NCT01442064|789500|P1|Overall Study|Withdrawal by Subject|6
239001|NCT01442064|789495|P6|Overall Study|Physician Decision|1
239002|NCT01442064|789496|P5|Overall Study|Physician Decision|3
239003|NCT01442064|789497|P4|Overall Study|Physician Decision|3
239004|NCT01442064|789498|P3|Overall Study|Physician Decision|2
239005|NCT01442064|789499|P2|Overall Study|Physician Decision|1
239006|NCT01442064|789500|P1|Overall Study|Physician Decision|1
239007|NCT01442064|789495|P6|Overall Study|Lost to Follow-up|3
239008|NCT01442064|789496|P5|Overall Study|Lost to Follow-up|3
239009|NCT01442064|789497|P4|Overall Study|Lost to Follow-up|1
239010|NCT01442064|789498|P3|Overall Study|Lost to Follow-up|1
239011|NCT01442064|789499|P2|Overall Study|Lost to Follow-up|5
239012|NCT01442064|789500|P1|Overall Study|Lost to Follow-up|5
239013|NCT01442064|789495|P6|Overall Study|Death|3
239014|NCT01442064|789496|P5|Overall Study|Death|1
239015|NCT01442064|789497|P4|Overall Study|Death|3
239016|NCT01442064|789498|P3|Overall Study|Death|3
239017|NCT01442064|789499|P2|Overall Study|Death|1
239018|NCT01442064|789500|P1|Overall Study|Death|0
239019|NCT01442064|789495|P6|Overall Study|Adverse Event|0
239020|NCT01442064|789496|P5|Overall Study|Adverse Event|2
239021|NCT01442064|789497|P4|Overall Study|Adverse Event|1
239022|NCT01442064|789498|P3|Overall Study|Adverse Event|2
239023|NCT01442064|789499|P2|Overall Study|Adverse Event|2
239024|NCT01442064|789500|P1|Overall Study|Adverse Event|2
239025|NCT01442038|789537|P2|Overall Study|Study Terminated By Sponsor|3
239026|NCT01442038|789538|P1|Overall Study|Study Terminated By Sponsor|2
239027|NCT01442038|789537|P2|Overall Study|Investigator's Discretion|16
239028|NCT01442038|789538|P1|Overall Study|Investigator's Discretion|13
239029|NCT01442038|789537|P2|Overall Study|Protocol Deviation|20
239030|NCT01442038|789538|P1|Overall Study|Protocol Deviation|9
239031|NCT01442038|789537|P2|Overall Study|Adverse Event|15
239032|NCT01442038|789538|P1|Overall Study|Adverse Event|26
239033|NCT01442038|789537|P2|Overall Study|Lost to Follow-up|51
239034|NCT01442038|789538|P1|Overall Study|Lost to Follow-up|37
239035|NCT01442038|789537|P2|Overall Study|Participant Withdrew Consent|102
239036|NCT01442038|789538|P1|Overall Study|Participant Withdrew Consent|137
239037|NCT01442038|789537|P2|Overall Study|Investigator-Initiated Early Closure|43
239038|NCT01442038|789538|P1|Overall Study|Investigator-Initiated Early Closure|44
239039|NCT01442038|789537|P2|Overall Study|Death|29
239040|NCT01442038|789538|P1|Overall Study|Death|35
239041|NCT01441973|789552|P2|Overall Study|Nonrelated cardiac amyloidosis|1
239042|NCT01441973|789553|P1|Overall Study|Nonrelated cardiac amyloidosis|0
239043|NCT01441973|789552|P2|Overall Study|Poor compliance/noncompliance|1
239044|NCT01441973|789553|P1|Overall Study|Poor compliance/noncompliance|0
239045|NCT01441973|789552|P2|Overall Study|Patient request to discontinue treatment|1
239046|NCT01441973|789553|P1|Overall Study|Patient request to discontinue treatment|1
239047|NCT01441973|789552|P2|Overall Study|Adverse event unrelated to study drug|0
239048|NCT01441973|789553|P1|Overall Study|Adverse event unrelated to study drug|3
239049|NCT01441973|789552|P2|Overall Study|Disease progression|2
239050|NCT01441973|789553|P1|Overall Study|Disease progression|4
239051|NCT01441960|789567|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
239052|NCT01441960|789568|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
239053|NCT01441960|789567|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
239054|NCT01441960|789568|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
239055|NCT01441960|789567|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
239056|NCT01441960|789568|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
239057|NCT01441765|789589|P2|Overall Study|Death|0
239058|NCT01441765|789590|P1|Overall Study|Death|1
239059|NCT01441596|789607|P3|Overall Study|Not treated|1
239060|NCT01441596|789608|P2|Overall Study|Not treated|1
239061|NCT01441596|789609|P1|Overall Study|Not treated|0
239062|NCT01441596|789607|P3|Overall Study|Withdrawal by Subject|2
239063|NCT01441596|789608|P2|Overall Study|Withdrawal by Subject|0
239064|NCT01441596|789609|P1|Overall Study|Withdrawal by Subject|4
239065|NCT01441596|789607|P3|Overall Study|Other reason not defined below|1
239066|NCT01441596|789608|P2|Overall Study|Other reason not defined below|2
239067|NCT01441596|789609|P1|Overall Study|Other reason not defined below|0
239068|NCT01441440|789656|P3|Overall Study|Difficllty in keeping the schedule|0
239069|NCT01441440|789657|P2|Overall Study|Difficllty in keeping the schedule|1
239070|NCT01441440|789658|P1|Overall Study|Difficllty in keeping the schedule|1
239071|NCT01441440|789656|P3|Overall Study|Work-related matter|0
239072|NCT01441440|789657|P2|Overall Study|Work-related matter|1
239073|NCT01441440|789658|P1|Overall Study|Work-related matter|0
239074|NCT01441440|789656|P3|Overall Study|Moving|1
239075|NCT01441440|789657|P2|Overall Study|Moving|1
239076|NCT01441440|789658|P1|Overall Study|Moving|0
239077|NCT01441440|789656|P3|Overall Study|Lack of Efficacy|1
239078|NCT01441440|789657|P2|Overall Study|Lack of Efficacy|0
239079|NCT01441440|789658|P1|Overall Study|Lack of Efficacy|1
239080|NCT01441440|789656|P3|Overall Study|Pregnancy|0
239081|NCT01441440|789657|P2|Overall Study|Pregnancy|0
239082|NCT01441440|789658|P1|Overall Study|Pregnancy|1
239083|NCT01441440|789656|P3|Overall Study|Withdrawal by Subject|9
239084|NCT01441440|789657|P2|Overall Study|Withdrawal by Subject|9
239085|NCT01441440|789658|P1|Overall Study|Withdrawal by Subject|11
239086|NCT01441440|789656|P3|Overall Study|Lost to Follow-up|1
239087|NCT01441440|789657|P2|Overall Study|Lost to Follow-up|2
239088|NCT01441440|789658|P1|Overall Study|Lost to Follow-up|0
239089|NCT01441440|789656|P3|Overall Study|Adverse Event|9
239090|NCT01441440|789657|P2|Overall Study|Adverse Event|9
239091|NCT01441440|789658|P1|Overall Study|Adverse Event|2
239092|NCT01441440|789656|P3|Overall Study|Death|1
239093|NCT01441440|789657|P2|Overall Study|Death|0
239094|NCT01441440|789658|P1|Overall Study|Death|1
239095|NCT01441414|789681|P1|Overall Study|Subject refused further follow-up|1
239096|NCT01441414|789681|P1|Overall Study|Study terminated by sponsor|2
239097|NCT01441414|789681|P1|Overall Study|Other reasons|3
239098|NCT01441414|789681|P1|Overall Study|Participant died|9
239099|NCT01441180|789760|P3|Overall Study|Discontinued|2
239100|NCT01441180|789761|P2|Overall Study|Discontinued|0
239101|NCT01441180|789762|P1|Overall Study|Discontinued|0
239102|NCT01441180|789760|P3|Overall Study|Lost to Follow-up|1
239103|NCT01441180|789761|P2|Overall Study|Lost to Follow-up|1
239104|NCT01441180|789762|P1|Overall Study|Lost to Follow-up|1
239105|NCT01441102|789773|P1|Overall Study|Withdrawal by Subject|2
239106|NCT01441102|789773|P1|Overall Study|Adverse Event|1
239107|NCT01440972|789813|P2|Overall Study|Withdrawal by Subject|2
239108|NCT01440972|789814|P1|Overall Study|Withdrawal by Subject|3
239109|NCT01440946|789838|P2|Overall Study|Physician Decision|0
239110|NCT01440946|789839|P1|Overall Study|Physician Decision|1
239111|NCT01440946|789838|P2|Overall Study|Lost to Follow-up|1
239112|NCT01440946|789839|P1|Overall Study|Lost to Follow-up|1
239113|NCT01440881|789878|P2|Overall Study|Death|1
239114|NCT01440881|789879|P1|Overall Study|Death|0
239115|NCT01440647|789920|P2|Overall Study|Death|3
239116|NCT01440647|789921|P1|Overall Study|Death|2
239117|NCT01440595|789940|P3|Overall Study|Study terminated by sponsor.|1
239118|NCT01440595|789941|P2|Overall Study|Study terminated by sponsor.|2
239119|NCT01440595|789942|P1|Overall Study|Study terminated by sponsor.|1
239120|NCT01440595|789940|P3|Overall Study|Lost to Follow-up|0
239121|NCT01440595|789941|P2|Overall Study|Lost to Follow-up|1
239122|NCT01440595|789942|P1|Overall Study|Lost to Follow-up|0
239123|NCT01440569|789962|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
239124|NCT01440569|789963|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
239125|NCT01440569|789962|P2|Open-Label Rollover Phase|Lost to Follow-up|3
239126|NCT01440569|789963|P1|Open-Label Rollover Phase|Lost to Follow-up|26
239127|NCT01440569|789962|P2|Open-Label Rollover Phase|Withdrew Consent|1
239128|NCT01440569|789963|P1|Open-Label Rollover Phase|Withdrew Consent|11
239213|NCT01440283|790090|P1|Overall Study|Withdrawal by Subject|4
239129|NCT01440569|789962|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
239130|NCT01440569|789963|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
239131|NCT01440569|789962|P2|Open-Label Rollover Phase|Lack of Efficacy|0
239132|NCT01440569|789963|P1|Open-Label Rollover Phase|Lack of Efficacy|2
239133|NCT01440569|789962|P2|Open-Label Rollover Phase|Pregnancy|0
239134|NCT01440569|789963|P1|Open-Label Rollover Phase|Pregnancy|1
239135|NCT01440569|789962|P2|Open-Label Rollover Phase|Adverse Event|0
239136|NCT01440569|789963|P1|Open-Label Rollover Phase|Adverse Event|3
239137|NCT01440569|789962|P2|Main Study|Protocol Violation|0
239138|NCT01440569|789963|P1|Main Study|Protocol Violation|1
239139|NCT01440569|789962|P2|Main Study|Subject Non-Compliance|0
239140|NCT01440569|789963|P1|Main Study|Subject Non-Compliance|3
239141|NCT01440569|789962|P2|Main Study|Lost to Follow-up|2
239142|NCT01440569|789963|P1|Main Study|Lost to Follow-up|13
239143|NCT01440569|789962|P2|Main Study|Withdrew Consent|1
239144|NCT01440569|789963|P1|Main Study|Withdrew Consent|7
239145|NCT01440569|789962|P2|Main Study|Investigator's Discretion|1
239146|NCT01440569|789963|P1|Main Study|Investigator's Discretion|1
239147|NCT01440569|789962|P2|Main Study|Pregnancy|0
239148|NCT01440569|789963|P1|Main Study|Pregnancy|1
239149|NCT01440569|789962|P2|Main Study|Adverse Event|0
239150|NCT01440569|789963|P1|Main Study|Adverse Event|9
239151|NCT01440569|789962|P2|Main Study|Enrolled but not treated|0
239152|NCT01440569|789963|P1|Main Study|Enrolled but not treated|1
239153|NCT01440517|789998|P1|Overall Study|Subject withdrawn prior to dosing|1
239154|NCT01440374|790029|P4|Part 3: Extension|Physician Decision|14
239155|NCT01440374|790030|P3|Part 3: Extension|Physician Decision|0
239156|NCT01440374|790031|P2|Part 3: Extension|Physician Decision|0
239157|NCT01440374|790032|P1|Part 3: Extension|Physician Decision|0
239158|NCT01440374|790029|P4|Part 3: Extension|Adverse Event|13
239159|NCT01440374|790030|P3|Part 3: Extension|Adverse Event|0
239160|NCT01440374|790031|P2|Part 3: Extension|Adverse Event|0
239161|NCT01440374|790032|P1|Part 3: Extension|Adverse Event|0
239162|NCT01440374|790029|P4|Part 3: Extension|Withdrawal by Subject|5
239163|NCT01440374|790030|P3|Part 3: Extension|Withdrawal by Subject|0
239164|NCT01440374|790031|P2|Part 3: Extension|Withdrawal by Subject|0
239165|NCT01440374|790032|P1|Part 3: Extension|Withdrawal by Subject|0
239166|NCT01440374|790029|P4|Part 2; Double-blind Phase|Not treated|0
239167|NCT01440374|790030|P3|Part 2; Double-blind Phase|Not treated|1
239168|NCT01440374|790031|P2|Part 2; Double-blind Phase|Not treated|0
239169|NCT01440374|790032|P1|Part 2; Double-blind Phase|Not treated|0
239170|NCT01440374|790029|P4|Part 2; Double-blind Phase|Adverse Event|0
239171|NCT01440374|790030|P3|Part 2; Double-blind Phase|Adverse Event|31
239172|NCT01440374|790031|P2|Part 2; Double-blind Phase|Adverse Event|7
239173|NCT01440374|790032|P1|Part 2; Double-blind Phase|Adverse Event|0
239174|NCT01440374|790029|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
239175|NCT01440374|790030|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
239176|NCT01440374|790031|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
239177|NCT01440374|790032|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
239178|NCT01440374|790029|P4|Part 2; Double-blind Phase|Protocol Violation|0
239179|NCT01440374|790030|P3|Part 2; Double-blind Phase|Protocol Violation|1
239180|NCT01440374|790031|P2|Part 2; Double-blind Phase|Protocol Violation|0
239181|NCT01440374|790032|P1|Part 2; Double-blind Phase|Protocol Violation|0
239182|NCT01440374|790029|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
239183|NCT01440374|790030|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
239184|NCT01440374|790031|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
239185|NCT01440374|790032|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
239186|NCT01440374|790029|P4|Part 2; Double-blind Phase|Physician Decision|0
239187|NCT01440374|790030|P3|Part 2; Double-blind Phase|Physician Decision|17
239188|NCT01440374|790031|P2|Part 2; Double-blind Phase|Physician Decision|8
239189|NCT01440374|790032|P1|Part 2; Double-blind Phase|Physician Decision|0
239190|NCT01440374|790029|P4|Part 1: Open-label Phase|Physician Decision|0
239191|NCT01440374|790030|P3|Part 1: Open-label Phase|Physician Decision|0
239192|NCT01440374|790031|P2|Part 1: Open-label Phase|Physician Decision|0
239193|NCT01440374|790032|P1|Part 1: Open-label Phase|Physician Decision|1
239194|NCT01440374|790029|P4|Part 1: Open-label Phase|Adverse Event|0
239195|NCT01440374|790030|P3|Part 1: Open-label Phase|Adverse Event|0
239196|NCT01440374|790031|P2|Part 1: Open-label Phase|Adverse Event|0
239197|NCT01440374|790032|P1|Part 1: Open-label Phase|Adverse Event|5
239198|NCT01440322|790067|P2|Overall Study|Other Non-Product Related|0
239199|NCT01440322|790068|P1|Overall Study|Other Non-Product Related|1
239200|NCT01440322|790067|P2|Overall Study|Unrelated Medical Problem|1
239201|NCT01440322|790068|P1|Overall Study|Unrelated Medical Problem|0
239202|NCT01440322|790067|P2|Overall Study|Other Product Related|0
239203|NCT01440322|790068|P1|Overall Study|Other Product Related|1
239204|NCT01440322|790067|P2|Overall Study|Unacceptable Subjective Vision|0
239205|NCT01440322|790068|P1|Overall Study|Unacceptable Subjective Vision|1
239206|NCT01440322|790067|P2|Overall Study|Symptoms and Problems|0
239207|NCT01440322|790068|P1|Overall Study|Symptoms and Problems|1
239208|NCT01440322|790067|P2|Overall Study|Biomicroscopy|0
239209|NCT01440322|790068|P1|Overall Study|Biomicroscopy|1
239210|NCT01440322|790067|P2|Overall Study|Discomfort|0
239211|NCT01440322|790068|P1|Overall Study|Discomfort|2
239212|NCT01440283|790090|P1|Overall Study|Physician Decision|3
239214|NCT01440283|790090|P1|Overall Study|Death|3
239215|NCT01440101|790105|P3|Overall Study|Not Specified|0
239216|NCT01440101|790106|P2|Overall Study|Not Specified|1
239217|NCT01440101|790107|P1|Overall Study|Not Specified|0
239218|NCT01440101|790105|P3|Overall Study|Withdrawal by Subject|1
239219|NCT01440101|790106|P2|Overall Study|Withdrawal by Subject|3
239220|NCT01440101|790107|P1|Overall Study|Withdrawal by Subject|0
239221|NCT01440101|790105|P3|Overall Study|Adverse Event|0
239222|NCT01440101|790106|P2|Overall Study|Adverse Event|0
239223|NCT01440101|790107|P1|Overall Study|Adverse Event|2
239224|NCT01440049|790140|P1|Overall Study|Adverse Event|5
239225|NCT01439971|790172|P5|Overall Study|Required number in cohort dosed|1
239226|NCT01439971|790173|P4|Overall Study|Required number in cohort dosed|0
239227|NCT01439971|790174|P3|Overall Study|Required number in cohort dosed|2
239228|NCT01439971|790175|P2|Overall Study|Required number in cohort dosed|1
239229|NCT01439971|790176|P1|Overall Study|Required number in cohort dosed|0
239230|NCT01439945|790356|P4|Double-Blind Treatment Phase|Ineligible|1
239231|NCT01439945|790357|P3|Double-Blind Treatment Phase|Ineligible|0
239232|NCT01439945|790358|P2|Double-Blind Treatment Phase|Ineligible|2
239233|NCT01439945|790359|P1|Double-Blind Treatment Phase|Ineligible|1
239234|NCT01439945|790356|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
239235|NCT01439945|790357|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
239236|NCT01439945|790358|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
239237|NCT01439945|790359|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
239238|NCT01439724|790384|P2|Overall Study|missing consultation|8
239239|NCT01439724|790385|P1|Overall Study|missing consultation|9
239240|NCT01439360|790397|P2|Overall Study|Withdrawal by Subject|129
239241|NCT01439360|790398|P1|Overall Study|Withdrawal by Subject|140
239242|NCT01439360|790397|P2|Overall Study|Protocol Violation|0
239243|NCT01439360|790398|P1|Overall Study|Protocol Violation|1
239244|NCT01439360|790397|P2|Overall Study|Others|5
239245|NCT01439360|790398|P1|Overall Study|Others|10
239246|NCT01439360|790397|P2|Overall Study|Lost to Follow-up|58
239247|NCT01439360|790398|P1|Overall Study|Lost to Follow-up|43
239248|NCT01439360|790397|P2|Overall Study|Adverse Event|16
239249|NCT01439360|790398|P1|Overall Study|Adverse Event|4
239250|NCT01439282|790448|P2|Overall Study|Not specified|1
239251|NCT01439282|790449|P1|Overall Study|Not specified|1
239252|NCT01439282|790448|P2|Overall Study|Withdrawal by Subject|0
239253|NCT01439282|790449|P1|Overall Study|Withdrawal by Subject|2
239254|NCT01439282|790448|P2|Overall Study|Adverse Event|0
239255|NCT01439282|790449|P1|Overall Study|Adverse Event|5
239256|NCT01439204|790459|P2|Overall Study|poor/non-compliance|0
239257|NCT01439204|790460|P1|Overall Study|poor/non-compliance|3
239258|NCT01439204|790459|P2|Overall Study|No longer meets study criteria|0
239259|NCT01439204|790460|P1|Overall Study|No longer meets study criteria|1
239260|NCT01439204|790459|P2|Overall Study|Lost to Follow-up|2
239261|NCT01439204|790460|P1|Overall Study|Lost to Follow-up|0
239262|NCT01439204|790459|P2|Overall Study|Withdrawal by Subject|1
239263|NCT01439204|790460|P1|Overall Study|Withdrawal by Subject|0
239264|NCT01439126|790494|P2|Overall Study|Other-Miscellaneous|12
239265|NCT01439126|790495|P1|Overall Study|Other-Miscellaneous|12
239266|NCT01439126|790494|P2|Overall Study|Other-Use of prohibited treatment|2
239267|NCT01439126|790495|P1|Overall Study|Other-Use of prohibited treatment|0
239268|NCT01439126|790494|P2|Overall Study|Lost to Follow-up|3
239269|NCT01439126|790495|P1|Overall Study|Lost to Follow-up|6
239270|NCT01439126|790494|P2|Overall Study|Protocol Violation|4
239271|NCT01439126|790495|P1|Overall Study|Protocol Violation|6
239272|NCT01439126|790494|P2|Overall Study|Withdrawal by Subject|21
239273|NCT01439126|790495|P1|Overall Study|Withdrawal by Subject|5
239274|NCT01439126|790494|P2|Overall Study|Adverse Event|0
239275|NCT01439126|790495|P1|Overall Study|Adverse Event|2
239276|NCT01438996|790533|P3|Overall Study|Not meeting Inclusion Criteria|0
239277|NCT01438996|790534|P2|Overall Study|Not meeting Inclusion Criteria|1
239278|NCT01438996|790535|P1|Overall Study|Not meeting Inclusion Criteria|4
239279|NCT01438814|790569|P2|Overall Study|Not specified|4
239280|NCT01438814|790570|P1|Overall Study|Not specified|2
239281|NCT01438814|790569|P2|Overall Study|Withdrawal by Subject|2
239282|NCT01438814|790570|P1|Overall Study|Withdrawal by Subject|4
239283|NCT01438814|790569|P2|Overall Study|Lost to Follow-up|3
239284|NCT01438814|790570|P1|Overall Study|Lost to Follow-up|4
239285|NCT01438814|790569|P2|Overall Study|Protocol Violation|2
239286|NCT01438814|790570|P1|Overall Study|Protocol Violation|1
239287|NCT01438814|790569|P2|Overall Study|Adverse Event|3
239288|NCT01438814|790570|P1|Overall Study|Adverse Event|3
239289|NCT01438541|790606|P1|Overall Study|discharge from the hospital|5
239290|NCT01438541|790606|P1|Overall Study|Withdrawal by Subject|1
239291|NCT01438541|790606|P1|Overall Study|Physician Decision|1
239292|NCT01438489|790615|P3|Overall Study|Inadequate venous access|0
239293|NCT01438489|790616|P2|Overall Study|Inadequate venous access|2
239294|NCT01438489|790617|P1|Overall Study|Inadequate venous access|0
239295|NCT01438489|790615|P3|Overall Study|Did not complete all 3 follow-up visits|2
239296|NCT01438489|790616|P2|Overall Study|Did not complete all 3 follow-up visits|5
239297|NCT01438489|790617|P1|Overall Study|Did not complete all 3 follow-up visits|2
239298|NCT01438489|790615|P3|Overall Study|Received prohibited medication|0
239299|NCT01438489|790616|P2|Overall Study|Received prohibited medication|0
239300|NCT01438489|790617|P1|Overall Study|Received prohibited medication|1
239301|NCT01438489|790615|P3|Overall Study|AE/SAEs|1
239302|NCT01438489|790616|P2|Overall Study|AE/SAEs|1
239303|NCT01438489|790617|P1|Overall Study|AE/SAEs|2
239304|NCT01438489|790615|P3|Overall Study|Investigator decision|0
239305|NCT01438489|790616|P2|Overall Study|Investigator decision|1
239306|NCT01438489|790617|P1|Overall Study|Investigator decision|0
239307|NCT01438489|790615|P3|Overall Study|Subject choice/Subject moved|1
239308|NCT01438489|790616|P2|Overall Study|Subject choice/Subject moved|1
239309|NCT01438489|790617|P1|Overall Study|Subject choice/Subject moved|2
239310|NCT01438489|790615|P3|Overall Study|Sponsor decision|4
239311|NCT01438489|790616|P2|Overall Study|Sponsor decision|1
239312|NCT01438489|790617|P1|Overall Study|Sponsor decision|4
239313|NCT01438489|790615|P3|Overall Study|Death|1
239314|NCT01438489|790616|P2|Overall Study|Death|0
239315|NCT01438489|790617|P1|Overall Study|Death|0
239316|NCT01438489|790615|P3|Overall Study|Withdrawal by Subject|8
239317|NCT01438489|790616|P2|Overall Study|Withdrawal by Subject|3
239318|NCT01438489|790617|P1|Overall Study|Withdrawal by Subject|11
239319|NCT01438489|790615|P3|Overall Study|Lost to Follow-up|2
239320|NCT01438489|790616|P2|Overall Study|Lost to Follow-up|2
239321|NCT01438489|790617|P1|Overall Study|Lost to Follow-up|4
239322|NCT01438424|790660|P1|Overall Study|Participant noncompliance|20
239323|NCT01438424|790660|P1|Overall Study|No longer met inclusion criteria|1
239324|NCT01438424|790660|P1|Overall Study|Pregnancy|7
239325|NCT01438424|790660|P1|Overall Study|Need for drug prohibited by protocol|14
239326|NCT01438424|790660|P1|Overall Study|Abnormal laboratory test result|14
239327|NCT01438424|790660|P1|Overall Study|Lost to Follow-up|17
239328|NCT01438424|790660|P1|Overall Study|Adverse Event|17
239329|NCT01438424|790660|P1|Overall Study|Death|22
239330|NCT01438424|790660|P1|Overall Study|Progression of chronic hepatitis B|22
239331|NCT01438424|790660|P1|Overall Study|Withdrawal by Subject|104
239332|NCT01438424|790660|P1|Overall Study|Not identified|55
239333|NCT01438424|790660|P1|Overall Study|Minimal virologic response|95
239334|NCT01438424|790660|P1|Overall Study|Continuing treatment|29
239335|NCT01438307|790698|P2|Overall Study|Death|1
239336|NCT01438307|790699|P1|Overall Study|Death|1
239337|NCT01438294|790713|P2|Overall Study|Lost to Follow-up|7
239338|NCT01438294|790714|P1|Overall Study|Lost to Follow-up|3
239339|NCT01438177|790757|P1|Overall Study|Initiation of new therapy|1
239340|NCT01438177|790757|P1|Overall Study|Withdrawal by Subject|1
239341|NCT01438151|790763|P1|Overall Study|study terminated|8
239342|NCT01438060|790769|P2|On Study Beyond Week 140|Other Reason|3
239343|NCT01438060|790770|P1|On Study Beyond Week 140|Other Reason|0
239344|NCT01438060|790769|P2|On Study Beyond Week 140|Death|1
239345|NCT01438060|790770|P1|On Study Beyond Week 140|Death|0
239346|NCT01438060|790769|P2|On Study Beyond Week 140|Withdrawal by Subject|1
239347|NCT01438060|790770|P1|On Study Beyond Week 140|Withdrawal by Subject|0
239348|NCT01438060|790769|P2|On Study Beyond Week 140|Lack of Efficacy|1
239349|NCT01438060|790770|P1|On Study Beyond Week 140|Lack of Efficacy|0
239350|NCT01438060|790769|P2|On Study Beyond Week 140|Adverse Event|2
239351|NCT01438060|790770|P1|On Study Beyond Week 140|Adverse Event|0
239352|NCT01438060|790769|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
239353|NCT01438060|790770|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
239354|NCT01438060|790769|P2|Extension Phase: Week 10 to Week 130|Death|12
239355|NCT01438060|790770|P1|Extension Phase: Week 10 to Week 130|Death|22
239356|NCT01438060|790769|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
239357|NCT01438060|790770|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
239358|NCT01438060|790769|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
239359|NCT01438060|790770|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
239360|NCT01438060|790769|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
239361|NCT01438060|790770|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
239362|NCT01438060|790769|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
239363|NCT01438060|790770|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
239364|NCT01438060|790769|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
239365|NCT01438060|790770|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
239366|NCT01438060|790769|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
239367|NCT01438060|790770|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
239368|NCT01438060|790769|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
239369|NCT01438060|790770|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
239370|NCT01438060|790769|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
239371|NCT01438060|790770|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
239372|NCT01438060|790769|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
239373|NCT01438060|790770|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
239374|NCT01438060|790769|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
239375|NCT01438060|790770|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
239376|NCT01438060|790769|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
239377|NCT01438060|790770|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
239378|NCT01437995|790851|P3|Overall Study|Lost to Follow-up|20
239379|NCT01437995|790852|P2|Overall Study|Lost to Follow-up|18
239380|NCT01437995|790853|P1|Overall Study|Lost to Follow-up|11
239381|NCT01437943|790875|P2|Overall Study|Adverse Event|0
239382|NCT01437943|790876|P1|Overall Study|Adverse Event|2
239383|NCT01437943|790875|P2|Overall Study|Subject expressed pregnancy plans|0
239384|NCT01437943|790876|P1|Overall Study|Subject expressed pregnancy plans|1
239385|NCT01437943|790875|P2|Overall Study|Aliskiren trials terminated by Novartis|2
239386|NCT01437943|790876|P1|Overall Study|Aliskiren trials terminated by Novartis|4
239387|NCT01437878|790884|P2|Overall Study|Withdrawal by Subject|0
239388|NCT01437878|790885|P1|Overall Study|Withdrawal by Subject|1
239389|NCT01437540|790927|P2|Overall Study|Withdrawal by Subject|15
239390|NCT01437540|790928|P1|Overall Study|Withdrawal by Subject|31
239391|NCT01437540|790927|P2|Overall Study|Adverse Event|13
239392|NCT01437540|790928|P1|Overall Study|Adverse Event|26
239393|NCT01437540|790927|P2|Overall Study|Protocol Violation|12
239394|NCT01437540|790928|P1|Overall Study|Protocol Violation|24
239395|NCT01437540|790927|P2|Overall Study|Lack of Efficacy|11
239396|NCT01437540|790928|P1|Overall Study|Lack of Efficacy|23
239397|NCT01437540|790927|P2|Overall Study|Lost to Follow-up|5
239398|NCT01437540|790928|P1|Overall Study|Lost to Follow-up|3
239399|NCT01437540|790927|P2|Overall Study|COPD exacerbation|3
239400|NCT01437540|790928|P1|Overall Study|COPD exacerbation|13
239401|NCT01437540|790927|P2|Overall Study|Not listed below|6
239402|NCT01437540|790928|P1|Overall Study|Not listed below|7
239403|NCT01437423|790949|P1|Overall Study|Off label usage|3
239404|NCT01437423|790949|P1|Overall Study|Lost to Follow-up|12
239405|NCT01437397|790961|P5|Overall Study|Site termination/COPD exacerbation/other|14
239406|NCT01437397|790962|P4|Overall Study|Site termination/COPD exacerbation/other|9
239407|NCT01437397|790963|P3|Overall Study|Site termination/COPD exacerbation/other|9
239408|NCT01437397|790964|P2|Overall Study|Site termination/COPD exacerbation/other|8
239409|NCT01437397|790965|P1|Overall Study|Site termination/COPD exacerbation/other|10
239410|NCT01437397|790961|P5|Overall Study|Adverse Event|21
239411|NCT01437397|790962|P4|Overall Study|Adverse Event|14
239412|NCT01437397|790963|P3|Overall Study|Adverse Event|16
239413|NCT01437397|790964|P2|Overall Study|Adverse Event|22
239414|NCT01437397|790965|P1|Overall Study|Adverse Event|21
239415|NCT01437397|790961|P5|Overall Study|Lack of Efficacy|20
239416|NCT01437397|790962|P4|Overall Study|Lack of Efficacy|10
239417|NCT01437397|790963|P3|Overall Study|Lack of Efficacy|8
239418|NCT01437397|790964|P2|Overall Study|Lack of Efficacy|4
239419|NCT01437397|790965|P1|Overall Study|Lack of Efficacy|5
239420|NCT01437397|790961|P5|Overall Study|Protocol Violation|19
239421|NCT01437397|790962|P4|Overall Study|Protocol Violation|21
239422|NCT01437397|790963|P3|Overall Study|Protocol Violation|13
239423|NCT01437397|790964|P2|Overall Study|Protocol Violation|12
239424|NCT01437397|790965|P1|Overall Study|Protocol Violation|10
239425|NCT01437397|790961|P5|Overall Study|Withdrawal by Subject|22
239426|NCT01437397|790962|P4|Overall Study|Withdrawal by Subject|11
239427|NCT01437397|790963|P3|Overall Study|Withdrawal by Subject|24
239428|NCT01437397|790964|P2|Overall Study|Withdrawal by Subject|12
239429|NCT01437397|790965|P1|Overall Study|Withdrawal by Subject|11
239430|NCT01437397|790961|P5|Overall Study|Lost to Follow-up|5
239431|NCT01437397|790962|P4|Overall Study|Lost to Follow-up|4
239432|NCT01437397|790963|P3|Overall Study|Lost to Follow-up|2
239433|NCT01437397|790964|P2|Overall Study|Lost to Follow-up|4
239434|NCT01437397|790965|P1|Overall Study|Lost to Follow-up|9
239435|NCT01437319|790992|P3|Phase II|Protocol Violation|0
239436|NCT01437319|790993|P2|Phase II|Protocol Violation|1
239437|NCT01437319|790994|P1|Phase II|Protocol Violation|0
239438|NCT01437319|790992|P3|Phase II|Study related symptoms/complaints|19
239439|NCT01437319|790993|P2|Phase II|Study related symptoms/complaints|28
239440|NCT01437319|790994|P1|Phase II|Study related symptoms/complaints|0
239441|NCT01437319|790992|P3|Phase II|Lost to Follow-up|2
239442|NCT01437319|790993|P2|Phase II|Lost to Follow-up|7
239443|NCT01437319|790994|P1|Phase II|Lost to Follow-up|0
239444|NCT01437319|790992|P3|Phase II|Withdrawal by Subject|16
239445|NCT01437319|790993|P2|Phase II|Withdrawal by Subject|8
239446|NCT01437319|790994|P1|Phase II|Withdrawal by Subject|0
239447|NCT01437319|790992|P3|Phase I|Withdrawal by Subject|0
239448|NCT01437319|790993|P2|Phase I|Withdrawal by Subject|0
239449|NCT01437319|790994|P1|Phase I|Withdrawal by Subject|25
239450|NCT01437319|790992|P3|Phase I|Study related symptoms/complaints|0
239451|NCT01437319|790993|P2|Phase I|Study related symptoms/complaints|0
239452|NCT01437319|790994|P1|Phase I|Study related symptoms/complaints|27
239453|NCT01437319|790992|P3|Phase I|Protocol Violation|0
239454|NCT01437319|790993|P2|Phase I|Protocol Violation|0
239455|NCT01437319|790994|P1|Phase I|Protocol Violation|1
239456|NCT01437319|790992|P3|Phase I|Lost to Follow-up|0
239457|NCT01437319|790993|P2|Phase I|Lost to Follow-up|0
239458|NCT01437319|790994|P1|Phase I|Lost to Follow-up|2
239459|NCT01437267|791009|P6|Overall Study|Protocol Violation|0
239460|NCT01437267|791010|P5|Overall Study|Protocol Violation|0
239461|NCT01437267|791011|P4|Overall Study|Protocol Violation|0
239462|NCT01437267|791012|P3|Overall Study|Protocol Violation|0
239463|NCT01437267|791013|P2|Overall Study|Protocol Violation|1
239464|NCT01437267|791014|P1|Overall Study|Protocol Violation|0
239465|NCT01437267|791009|P6|Overall Study|Withdrawal by Subject|0
239466|NCT01437267|791010|P5|Overall Study|Withdrawal by Subject|0
239467|NCT01437267|791011|P4|Overall Study|Withdrawal by Subject|1
239468|NCT01437267|791012|P3|Overall Study|Withdrawal by Subject|0
239469|NCT01437267|791013|P2|Overall Study|Withdrawal by Subject|0
239470|NCT01437267|791014|P1|Overall Study|Withdrawal by Subject|0
239471|NCT01437111|791057|P1|Overall Study|Protocol Violation|1
239472|NCT01437111|791057|P1|Overall Study|Lost to Follow-up|5
239473|NCT01437111|791057|P1|Overall Study|Physician Decision|1
239474|NCT01437111|791057|P1|Overall Study|Not reported|5
239475|NCT01437111|791057|P1|Overall Study|Withdrawal by Subject|4
239476|NCT01437111|791057|P1|Overall Study|Adverse Event|2
239477|NCT01436643|791135|P4|Core Phase (16 Weeks)|Protocol Violation|0
239478|NCT01436643|791136|P3|Core Phase (16 Weeks)|Protocol Violation|1
239479|NCT01436643|791137|P2|Core Phase (16 Weeks)|Protocol Violation|1
239480|NCT01436643|791138|P1|Core Phase (16 Weeks)|Protocol Violation|1
239481|NCT01436643|791135|P4|Core Phase (16 Weeks)|Abnormal Test result|0
239482|NCT01436643|791136|P3|Core Phase (16 Weeks)|Abnormal Test result|1
239483|NCT01436643|791137|P2|Core Phase (16 Weeks)|Abnormal Test result|0
239484|NCT01436643|791138|P1|Core Phase (16 Weeks)|Abnormal Test result|0
239485|NCT01436643|791135|P4|Core Phase (16 Weeks)|Adverse Event|0
239486|NCT01436643|791136|P3|Core Phase (16 Weeks)|Adverse Event|1
239487|NCT01436643|791137|P2|Core Phase (16 Weeks)|Adverse Event|3
239488|NCT01436643|791138|P1|Core Phase (16 Weeks)|Adverse Event|0
239489|NCT01436643|791135|P4|2-week Pre-treatment|Protocol Violation|4
239490|NCT01436643|791136|P3|2-week Pre-treatment|Protocol Violation|0
239491|NCT01436643|791137|P2|2-week Pre-treatment|Protocol Violation|0
239492|NCT01436643|791138|P1|2-week Pre-treatment|Protocol Violation|0
239493|NCT01436643|791135|P4|2-week Pre-treatment|Adverse Event|5
239494|NCT01436643|791136|P3|2-week Pre-treatment|Adverse Event|0
239495|NCT01436643|791137|P2|2-week Pre-treatment|Adverse Event|0
239496|NCT01436643|791138|P1|2-week Pre-treatment|Adverse Event|0
239497|NCT01436643|791135|P4|2-week Pre-treatment|Abnormal test result|1
239498|NCT01436643|791136|P3|2-week Pre-treatment|Abnormal test result|0
239499|NCT01436643|791137|P2|2-week Pre-treatment|Abnormal test result|0
239500|NCT01436643|791138|P1|2-week Pre-treatment|Abnormal test result|0
239501|NCT01436500|791173|P5|Overall Study|not specified|0
239502|NCT01436500|791174|P4|Overall Study|not specified|1
239503|NCT01436500|791175|P3|Overall Study|not specified|0
239504|NCT01436500|791176|P2|Overall Study|not specified|1
239505|NCT01436500|791177|P1|Overall Study|not specified|0
239506|NCT01436500|791173|P5|Overall Study|discontinued study drug|0
239507|NCT01436500|791174|P4|Overall Study|discontinued study drug|0
239508|NCT01436500|791175|P3|Overall Study|discontinued study drug|0
239509|NCT01436500|791176|P2|Overall Study|discontinued study drug|0
239510|NCT01436500|791177|P1|Overall Study|discontinued study drug|1
239511|NCT01436500|791173|P5|Overall Study|initiation of dialysis|1
239512|NCT01436500|791174|P4|Overall Study|initiation of dialysis|0
239513|NCT01436500|791175|P3|Overall Study|initiation of dialysis|0
239514|NCT01436500|791176|P2|Overall Study|initiation of dialysis|0
239515|NCT01436500|791177|P1|Overall Study|initiation of dialysis|0
239516|NCT01436500|791173|P5|Overall Study|liver transplant|0
239517|NCT01436500|791174|P4|Overall Study|liver transplant|0
239518|NCT01436500|791175|P3|Overall Study|liver transplant|0
239519|NCT01436500|791176|P2|Overall Study|liver transplant|0
239520|NCT01436500|791177|P1|Overall Study|liver transplant|1
239521|NCT01436500|791173|P5|Overall Study|Physician Decision|0
239522|NCT01436500|791174|P4|Overall Study|Physician Decision|0
239523|NCT01436500|791175|P3|Overall Study|Physician Decision|1
239524|NCT01436500|791176|P2|Overall Study|Physician Decision|0
239525|NCT01436500|791177|P1|Overall Study|Physician Decision|0
239526|NCT01436500|791173|P5|Overall Study|Withdrawal by Subject|2
239527|NCT01436500|791174|P4|Overall Study|Withdrawal by Subject|0
239528|NCT01436500|791175|P3|Overall Study|Withdrawal by Subject|2
239529|NCT01436500|791176|P2|Overall Study|Withdrawal by Subject|0
239530|NCT01436500|791177|P1|Overall Study|Withdrawal by Subject|0
239531|NCT01436500|791173|P5|Overall Study|Adverse Event|1
239532|NCT01436500|791174|P4|Overall Study|Adverse Event|0
239533|NCT01436500|791175|P3|Overall Study|Adverse Event|2
239534|NCT01436500|791176|P2|Overall Study|Adverse Event|2
239535|NCT01436500|791177|P1|Overall Study|Adverse Event|0
239536|NCT01436500|791173|P5|Overall Study|Death|0
239537|NCT01436500|791174|P4|Overall Study|Death|0
239538|NCT01436500|791175|P3|Overall Study|Death|0
239539|NCT01436500|791176|P2|Overall Study|Death|0
239540|NCT01436500|791177|P1|Overall Study|Death|1
239541|NCT01436370|791227|P8|Overall Study|Lost to Follow-up|0
239542|NCT01436370|791228|P7|Overall Study|Lost to Follow-up|0
239543|NCT01436370|791229|P6|Overall Study|Lost to Follow-up|0
239544|NCT01436370|791230|P5|Overall Study|Lost to Follow-up|1
239545|NCT01436370|791231|P4|Overall Study|Lost to Follow-up|0
239546|NCT01436370|791232|P3|Overall Study|Lost to Follow-up|0
239547|NCT01436370|791233|P2|Overall Study|Lost to Follow-up|0
239548|NCT01436370|791234|P1|Overall Study|Lost to Follow-up|0
239549|NCT01436253|791344|P1|Overall Study|Not meeting all eligibility criteria|117
239550|NCT01436253|791344|P1|Overall Study|Lost to Follow-up|182
239551|NCT01436201|791349|P1|Overall Study|Protocol Violation|1
239552|NCT01436201|791349|P1|Overall Study|Withdrawal by Subject|1
239553|NCT01436201|791349|P1|Overall Study|Adverse Event|2
239554|NCT01436175|791359|P1|Overall Study|Unspecified|826
239555|NCT01436175|791359|P1|Overall Study|Met blood pressure or pulse withdrawal|63
239556|NCT01436175|791359|P1|Overall Study|Lack of Efficacy|24
239557|NCT01436175|791359|P1|Overall Study|Lost to Follow-up|89
239558|NCT01436175|791359|P1|Overall Study|Withdrawal by Subject|108
239559|NCT01436175|791359|P1|Overall Study|Protocol Violation|49
239560|NCT01436175|791359|P1|Overall Study|Adverse Event|111
239561|NCT01436162|791386|P3|Randomized Phase|Not Specified|4
239562|NCT01436162|791387|P2|Randomized Phase|Not Specified|5
239563|NCT01436162|791388|P1|Randomized Phase|Not Specified|2
239564|NCT01436162|791386|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
239565|NCT01436162|791387|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
239566|NCT01436162|791388|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
239567|NCT01436162|791386|P3|Randomized Phase|Lack of Efficacy|1
239568|NCT01436162|791387|P2|Randomized Phase|Lack of Efficacy|1
239569|NCT01436162|791388|P1|Randomized Phase|Lack of Efficacy|0
239570|NCT01436162|791386|P3|Randomized Phase|Lost to Follow-up|4
239571|NCT01436162|791387|P2|Randomized Phase|Lost to Follow-up|5
239572|NCT01436162|791388|P1|Randomized Phase|Lost to Follow-up|17
239573|NCT01436162|791386|P3|Randomized Phase|Withdrawal by Subject|8
239574|NCT01436162|791387|P2|Randomized Phase|Withdrawal by Subject|9
239575|NCT01436162|791388|P1|Randomized Phase|Withdrawal by Subject|16
239576|NCT01436162|791386|P3|Randomized Phase|Protocol Violation|2
239577|NCT01436162|791387|P2|Randomized Phase|Protocol Violation|4
239578|NCT01436162|791388|P1|Randomized Phase|Protocol Violation|4
239579|NCT01436162|791386|P3|Randomized Phase|Adverse Event|6
239580|NCT01436162|791387|P2|Randomized Phase|Adverse Event|5
239581|NCT01436162|791388|P1|Randomized Phase|Adverse Event|1
239582|NCT01436162|791386|P3|Single-blind Lead-in Phase|Not Specified|0
239583|NCT01436162|791387|P2|Single-blind Lead-in Phase|Not Specified|0
239584|NCT01436162|791388|P1|Single-blind Lead-in Phase|Not Specified|107
239585|NCT01436162|791386|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
239586|NCT01436162|791387|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
239587|NCT01436162|791388|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
239588|NCT01436162|791386|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
239589|NCT01436162|791387|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
239590|NCT01436162|791388|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
239591|NCT01436162|791386|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
239592|NCT01436162|791387|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
239593|NCT01436162|791388|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
239594|NCT01436162|791386|P3|Single-blind Lead-in Phase|Protocol Violation|0
239595|NCT01436162|791387|P2|Single-blind Lead-in Phase|Protocol Violation|0
239596|NCT01436162|791388|P1|Single-blind Lead-in Phase|Protocol Violation|24
239597|NCT01436162|791386|P3|Single-blind Lead-in Phase|Adverse Event|0
239598|NCT01436162|791387|P2|Single-blind Lead-in Phase|Adverse Event|0
239599|NCT01436162|791388|P1|Single-blind Lead-in Phase|Adverse Event|26
239600|NCT01436149|791422|P3|Randomized Phase|Not Specified|11
239601|NCT01436149|791423|P2|Randomized Phase|Not Specified|5
239602|NCT01436149|791424|P1|Randomized Phase|Not Specified|12
239603|NCT01436149|791422|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
239604|NCT01436149|791423|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
239605|NCT01436149|791424|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
239606|NCT01436149|791422|P3|Randomized Phase|Lack of Efficacy|1
239607|NCT01436149|791423|P2|Randomized Phase|Lack of Efficacy|0
239608|NCT01436149|791424|P1|Randomized Phase|Lack of Efficacy|0
239609|NCT01436149|791422|P3|Randomized Phase|Lost to Follow-up|6
239610|NCT01436149|791423|P2|Randomized Phase|Lost to Follow-up|5
239611|NCT01436149|791424|P1|Randomized Phase|Lost to Follow-up|34
239612|NCT01436149|791422|P3|Randomized Phase|Withdrawal by Subject|10
239613|NCT01436149|791423|P2|Randomized Phase|Withdrawal by Subject|10
239614|NCT01436149|791424|P1|Randomized Phase|Withdrawal by Subject|16
239615|NCT01436149|791422|P3|Randomized Phase|Protocol Violation|0
239616|NCT01436149|791423|P2|Randomized Phase|Protocol Violation|5
239617|NCT01436149|791424|P1|Randomized Phase|Protocol Violation|4
239618|NCT01436149|791422|P3|Randomized Phase|Adverse Event|11
239619|NCT01436149|791423|P2|Randomized Phase|Adverse Event|10
239620|NCT01436149|791424|P1|Randomized Phase|Adverse Event|9
239621|NCT01436149|791422|P3|Antidepressant Lead-in Phase|Not Specified|0
239622|NCT01436149|791423|P2|Antidepressant Lead-in Phase|Not Specified|0
239623|NCT01436149|791424|P1|Antidepressant Lead-in Phase|Not Specified|119
239624|NCT01436149|791422|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
239625|NCT01436149|791423|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
239626|NCT01436149|791424|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
239627|NCT01436149|791422|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
239628|NCT01436149|791423|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
239629|NCT01436149|791424|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
239630|NCT01436149|791422|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
239631|NCT01436149|791423|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
239632|NCT01436149|791424|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
239633|NCT01436149|791422|P3|Antidepressant Lead-in Phase|Protocol Violation|0
239634|NCT01436149|791423|P2|Antidepressant Lead-in Phase|Protocol Violation|0
239635|NCT01436149|791424|P1|Antidepressant Lead-in Phase|Protocol Violation|29
239636|NCT01436149|791422|P3|Antidepressant Lead-in Phase|Adverse Event|0
239637|NCT01436149|791423|P2|Antidepressant Lead-in Phase|Adverse Event|0
239638|NCT01436149|791424|P1|Antidepressant Lead-in Phase|Adverse Event|39
239639|NCT01436110|791455|P3|Overall Study|Did Not Receive Trial Medication|3
239640|NCT01436110|791456|P2|Overall Study|Did Not Receive Trial Medication|0
239641|NCT01436110|791457|P1|Overall Study|Did Not Receive Trial Medication|1
239642|NCT01436110|791455|P3|Overall Study|Protocol Violation|1
239643|NCT01436110|791456|P2|Overall Study|Protocol Violation|1
239644|NCT01436110|791457|P1|Overall Study|Protocol Violation|3
239645|NCT01436110|791455|P3|Overall Study|Lost to Follow-up|3
239646|NCT01436110|791456|P2|Overall Study|Lost to Follow-up|1
239647|NCT01436110|791457|P1|Overall Study|Lost to Follow-up|1
239648|NCT01436110|791455|P3|Overall Study|Physician Decision|1
239649|NCT01436110|791456|P2|Overall Study|Physician Decision|1
239650|NCT01436110|791457|P1|Overall Study|Physician Decision|3
239651|NCT01436110|791455|P3|Overall Study|Adverse Event|2
239652|NCT01436110|791456|P2|Overall Study|Adverse Event|1
239653|NCT01436110|791457|P1|Overall Study|Adverse Event|2
239654|NCT01436110|791455|P3|Overall Study|Withdrawal by Subject|4
239655|NCT01436110|791456|P2|Overall Study|Withdrawal by Subject|8
239656|NCT01436110|791457|P1|Overall Study|Withdrawal by Subject|6
239657|NCT01436110|791455|P3|Overall Study|Lack of Efficacy|9
239658|NCT01436110|791456|P2|Overall Study|Lack of Efficacy|14
239659|NCT01436110|791457|P1|Overall Study|Lack of Efficacy|23
239660|NCT01436084|791480|P1|Overall Study|Early Closure of Study|1
239661|NCT01436084|791480|P1|Overall Study|Withdrawal by Subject|1
239662|NCT01436084|791480|P1|Overall Study|Disease Progression|2
239663|NCT01436071|791486|P2|Overall Study|Did Not Receive Trial Medication|3
239664|NCT01436071|791487|P1|Overall Study|Did Not Receive Trial Medication|3
239665|NCT01436071|791486|P2|Overall Study|Withdrawal by Subject|2
239666|NCT01436071|791487|P1|Overall Study|Withdrawal by Subject|2
239667|NCT01436071|791486|P2|Overall Study|Physician Decision|0
239668|NCT01436071|791487|P1|Overall Study|Physician Decision|1
239669|NCT01436071|791486|P2|Overall Study|Lost to Follow-up|1
239670|NCT01436071|791487|P1|Overall Study|Lost to Follow-up|3
239671|NCT01436071|791486|P2|Overall Study|Protocol Violation|1
239672|NCT01436071|791487|P1|Overall Study|Protocol Violation|0
239673|NCT01436071|791486|P2|Overall Study|Lack of Efficacy|7
239674|NCT01436071|791487|P1|Overall Study|Lack of Efficacy|16
239675|NCT01436071|791486|P2|Overall Study|Adverse Event|0
239676|NCT01436071|791487|P1|Overall Study|Adverse Event|1
239677|NCT01435928|791529|P3|Double Blind Phase - 28 Weeks|Administrative|2
239678|NCT01435928|791530|P2|Double Blind Phase - 28 Weeks|Administrative|5
239679|NCT01435928|791531|P1|Double Blind Phase - 28 Weeks|Administrative|0
239680|NCT01435928|791529|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
239681|NCT01435928|791530|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
239682|NCT01435928|791531|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
239683|NCT01435928|791529|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
239684|NCT01435928|791530|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
239685|NCT01435928|791531|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
239686|NCT01435928|791529|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
239687|NCT01435928|791530|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
239688|NCT01435928|791531|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
239689|NCT01435928|791529|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
239690|NCT01435928|791530|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
239691|NCT01435928|791531|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
239692|NCT01435928|791529|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
239693|NCT01435928|791530|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
239694|NCT01435928|791531|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
239695|NCT01435928|791529|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
239696|NCT01435928|791530|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
239697|NCT01435928|791531|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
239698|NCT01435928|791529|P3|Open Label Phase - up to 24 Weeks|Administrative|0
239699|NCT01435928|791530|P2|Open Label Phase - up to 24 Weeks|Administrative|0
239700|NCT01435928|791531|P1|Open Label Phase - up to 24 Weeks|Administrative|14
239701|NCT01435928|791529|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
239702|NCT01435928|791530|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
239703|NCT01435928|791531|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
239704|NCT01435928|791529|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
239705|NCT01435928|791530|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
239706|NCT01435928|791531|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
239707|NCT01435928|791529|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
239708|NCT01435928|791530|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
239709|NCT01435928|791531|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
239710|NCT01435928|791529|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
239711|NCT01435928|791530|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
239712|NCT01435928|791531|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
239713|NCT01435928|791529|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
239714|NCT01435928|791530|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
239715|NCT01435928|791531|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
239716|NCT01435928|791529|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
239717|NCT01435928|791530|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
239718|NCT01435928|791531|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
239719|NCT01435928|791529|P3|Open Label Phase - up to 24 Weeks|Death|0
239720|NCT01435928|791530|P2|Open Label Phase - up to 24 Weeks|Death|0
239721|NCT01435928|791531|P1|Open Label Phase - up to 24 Weeks|Death|1
239722|NCT01435928|791529|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
239723|NCT01435928|791530|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
239724|NCT01435928|791531|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
239725|NCT01435798|791558|P1|Overall Study|Withdrawal by Subject|1
239726|NCT01435759|791577|P6|Double-blind Phase|Not Specified|0
239727|NCT01435759|791578|P5|Double-blind Phase|Not Specified|0
239728|NCT01435759|791579|P4|Double-blind Phase|Not Specified|2
239729|NCT01435759|791580|P3|Double-blind Phase|Not Specified|0
239730|NCT01435759|791581|P2|Double-blind Phase|Not Specified|2
239731|NCT01435759|791582|P1|Double-blind Phase|Not Specified|8
239732|NCT01435759|791577|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
239733|NCT01435759|791578|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
239734|NCT01435759|791579|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
239735|NCT01435759|791580|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
239736|NCT01435759|791581|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
239737|NCT01435759|791582|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
239738|NCT01435759|791577|P6|Double-blind Phase|Lost to Follow-up|3
239739|NCT01435759|791578|P5|Double-blind Phase|Lost to Follow-up|3
239740|NCT01435759|791579|P4|Double-blind Phase|Lost to Follow-up|0
239741|NCT01435759|791580|P3|Double-blind Phase|Lost to Follow-up|2
239742|NCT01435759|791581|P2|Double-blind Phase|Lost to Follow-up|1
239743|NCT01435759|791582|P1|Double-blind Phase|Lost to Follow-up|31
239744|NCT01435759|791577|P6|Double-blind Phase|Withdrawal by Subject|2
239745|NCT01435759|791578|P5|Double-blind Phase|Withdrawal by Subject|2
239746|NCT01435759|791579|P4|Double-blind Phase|Withdrawal by Subject|4
239747|NCT01435759|791580|P3|Double-blind Phase|Withdrawal by Subject|3
239748|NCT01435759|791581|P2|Double-blind Phase|Withdrawal by Subject|4
239749|NCT01435759|791582|P1|Double-blind Phase|Withdrawal by Subject|17
239750|NCT01435759|791577|P6|Double-blind Phase|Protocol Violation|1
239751|NCT01435759|791578|P5|Double-blind Phase|Protocol Violation|0
239752|NCT01435759|791579|P4|Double-blind Phase|Protocol Violation|2
239753|NCT01435759|791580|P3|Double-blind Phase|Protocol Violation|1
239754|NCT01435759|791581|P2|Double-blind Phase|Protocol Violation|0
239755|NCT01435759|791582|P1|Double-blind Phase|Protocol Violation|2
239756|NCT01435759|791577|P6|Double-blind Phase|Adverse Event|3
239757|NCT01435759|791578|P5|Double-blind Phase|Adverse Event|1
239758|NCT01435759|791579|P4|Double-blind Phase|Adverse Event|1
239759|NCT01435759|791580|P3|Double-blind Phase|Adverse Event|1
239760|NCT01435759|791581|P2|Double-blind Phase|Adverse Event|0
239761|NCT01435759|791582|P1|Double-blind Phase|Adverse Event|7
239762|NCT01435759|791577|P6|Antidepressant Lead-in Phase|Not Specified|0
239763|NCT01435759|791578|P5|Antidepressant Lead-in Phase|Not Specified|0
239764|NCT01435759|791579|P4|Antidepressant Lead-in Phase|Not Specified|0
239765|NCT01435759|791580|P3|Antidepressant Lead-in Phase|Not Specified|0
239766|NCT01435759|791581|P2|Antidepressant Lead-in Phase|Not Specified|0
239767|NCT01435759|791582|P1|Antidepressant Lead-in Phase|Not Specified|119
239768|NCT01435759|791577|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
239769|NCT01435759|791578|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
239770|NCT01435759|791579|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
239771|NCT01435759|791580|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
239772|NCT01435759|791581|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
239773|NCT01435759|791582|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
239774|NCT01435759|791577|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
239775|NCT01435759|791578|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
239776|NCT01435759|791579|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
239777|NCT01435759|791580|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
239778|NCT01435759|791581|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
239779|NCT01435759|791582|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
239780|NCT01435759|791577|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
239781|NCT01435759|791578|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
239782|NCT01435759|791579|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
239783|NCT01435759|791580|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
239784|NCT01435759|791581|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
239785|NCT01435759|791582|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
239786|NCT01435759|791577|P6|Antidepressant Lead-in Phase|Protocol Violation|0
239787|NCT01435759|791578|P5|Antidepressant Lead-in Phase|Protocol Violation|0
239788|NCT01435759|791579|P4|Antidepressant Lead-in Phase|Protocol Violation|0
239789|NCT01435759|791580|P3|Antidepressant Lead-in Phase|Protocol Violation|0
239790|NCT01435759|791581|P2|Antidepressant Lead-in Phase|Protocol Violation|0
239791|NCT01435759|791582|P1|Antidepressant Lead-in Phase|Protocol Violation|16
239792|NCT01435759|791577|P6|Antidepressant Lead-in Phase|Adverse Event|0
239793|NCT01435759|791578|P5|Antidepressant Lead-in Phase|Adverse Event|0
239794|NCT01435759|791579|P4|Antidepressant Lead-in Phase|Adverse Event|0
239795|NCT01435759|791580|P3|Antidepressant Lead-in Phase|Adverse Event|0
239796|NCT01435759|791581|P2|Antidepressant Lead-in Phase|Adverse Event|0
239797|NCT01435759|791582|P1|Antidepressant Lead-in Phase|Adverse Event|40
239798|NCT01435655|791609|P1|Overall Study|Unspecified|1
239799|NCT01435655|791609|P1|Overall Study|Death|2
239800|NCT01435577|791623|P2|Overall Study|Alternative treatment started|1
239801|NCT01435577|791624|P1|Overall Study|Alternative treatment started|0
239802|NCT01435577|791623|P2|Overall Study|Lack of Efficacy|51
239803|NCT01435577|791624|P1|Overall Study|Lack of Efficacy|7
239804|NCT01435577|791623|P2|Overall Study|Adverse Event|0
239805|NCT01435577|791624|P1|Overall Study|Adverse Event|10
239806|NCT01435460|791674|P2|Overall Study|Did not meet eligibility criteria|0
239807|NCT01435460|791675|P1|Overall Study|Did not meet eligibility criteria|2
239808|NCT01435460|791674|P2|Overall Study|Protocol Violation|1
239809|NCT01435460|791675|P1|Overall Study|Protocol Violation|0
239810|NCT01435460|791674|P2|Overall Study|Withdrawal by Subject|3
239811|NCT01435460|791675|P1|Overall Study|Withdrawal by Subject|1
239812|NCT01435460|791674|P2|Overall Study|Lost to Follow-up|1
239813|NCT01435460|791675|P1|Overall Study|Lost to Follow-up|6
239814|NCT01435460|791674|P2|Overall Study|Adverse Event|1
239815|NCT01435460|791675|P1|Overall Study|Adverse Event|2
239816|NCT01435265|791689|P2|Overall Study|Lost to Follow-up|1
239817|NCT01435265|791690|P1|Overall Study|Lost to Follow-up|0
239818|NCT01435122|791704|P1|Overall Study|Early withdrawal due to toxicity|8
239819|NCT01435031|791713|P1|ITT at 1 Year|Lost to Follow-up|5
239820|NCT01435031|791713|P1|ITT at 1 Year|Withdrawal by Subject|2
239821|NCT01435031|791713|P1|ITT at 1 Year|Death|1
239822|NCT01435031|791713|P1|ITT at 6 Months|Lost to Follow-up|3
239823|NCT01435031|791713|P1|ITT at 6 Months|Death|2
239824|NCT01435031|791713|P1|ITT at 1 Month|Lost to Follow-up|4
239825|NCT01435031|791713|P1|ITT at 1 Month|Death|1
239826|NCT01435031|791713|P1|ITT at 1 Month|Withdrawal by Subject|1
239827|NCT01434823|791793|P2|Overall Study|Incomplete data in medical record|7
239828|NCT01434823|791794|P1|Overall Study|Incomplete data in medical record|4
239829|NCT01434693|791812|P4|Overall Study|Lost to Follow-up|0
239830|NCT01434693|791813|P3|Overall Study|Lost to Follow-up|0
239831|NCT01434693|791814|P2|Overall Study|Lost to Follow-up|0
239832|NCT01434693|791815|P1|Overall Study|Lost to Follow-up|1
239833|NCT01434693|791812|P4|Overall Study|Withdrawal by Subject|1
239834|NCT01434693|791813|P3|Overall Study|Withdrawal by Subject|1
239835|NCT01434693|791814|P2|Overall Study|Withdrawal by Subject|0
239836|NCT01434693|791815|P1|Overall Study|Withdrawal by Subject|1
239837|NCT01434693|791812|P4|Overall Study|Adverse Event|0
239838|NCT01434693|791813|P3|Overall Study|Adverse Event|0
239839|NCT01434693|791814|P2|Overall Study|Adverse Event|0
239840|NCT01434693|791815|P1|Overall Study|Adverse Event|1
239841|NCT01434680|791829|P4|Overall Study|Protocol Violation|0
239842|NCT01434680|791830|P3|Overall Study|Protocol Violation|0
239843|NCT01434680|791831|P2|Overall Study|Protocol Violation|1
239844|NCT01434680|791832|P1|Overall Study|Protocol Violation|1
239845|NCT01434680|791829|P4|Overall Study|Lost to Follow-up|0
239846|NCT01434680|791830|P3|Overall Study|Lost to Follow-up|0
239847|NCT01434680|791831|P2|Overall Study|Lost to Follow-up|1
239848|NCT01434680|791832|P1|Overall Study|Lost to Follow-up|1
239849|NCT01434680|791829|P4|Overall Study|Withdrawal by Subject|0
239850|NCT01434680|791830|P3|Overall Study|Withdrawal by Subject|2
239851|NCT01434680|791831|P2|Overall Study|Withdrawal by Subject|0
239852|NCT01434680|791832|P1|Overall Study|Withdrawal by Subject|1
239853|NCT01434654|791849|P2|Overall Study|Lost to Follow-up|0
239854|NCT01434654|791850|P1|Overall Study|Lost to Follow-up|1
239855|NCT01434654|791849|P2|Overall Study|Withdrawal by Subject|0
239856|NCT01434654|791850|P1|Overall Study|Withdrawal by Subject|1
239857|NCT01433549|791946|P2|Phase 2: Second Study Product|Adverse Event|1
239858|NCT01433549|791947|P1|Phase 2: Second Study Product|Adverse Event|0
239859|NCT01433471|791957|P2|Overall Study|Withdrawal by Subject|1
239860|NCT01433471|791958|P1|Overall Study|Withdrawal by Subject|0
239861|NCT01433354|791974|P1|Overall Study|Subject Withdrew Consent|3
239862|NCT01433354|791974|P1|Overall Study|Lack of Efficacy|17
239863|NCT01433354|791974|P1|Overall Study|Protocol Violation|2
239864|NCT01433354|791974|P1|Overall Study|Administrative problems|90
239865|NCT01433354|791974|P1|Overall Study|Lost to Follow-up|1
239866|NCT01433354|791974|P1|Overall Study|Adverse Event|6
239867|NCT01433263|791990|P2|Overall Study|Withdrawal by Subject|7
239868|NCT01433263|791991|P1|Overall Study|Withdrawal by Subject|10
239869|NCT01433263|791990|P2|Overall Study|Protocol Deviation|0
239870|NCT01433263|791991|P1|Overall Study|Protocol Deviation|1
239871|NCT01433263|791990|P2|Overall Study|Lost to Follow-up|1
239872|NCT01433263|791991|P1|Overall Study|Lost to Follow-up|0
239873|NCT01433263|791990|P2|Overall Study|Death|3
239874|NCT01433263|791991|P1|Overall Study|Death|5
239875|NCT01433263|791990|P2|Overall Study|Adverse Event|1
239876|NCT01433263|791991|P1|Overall Study|Adverse Event|3
239877|NCT01433250|792020|P2|Overall Study|Withdrawal by Subject|2
239878|NCT01433250|792021|P1|Overall Study|Withdrawal by Subject|3
239879|NCT01433250|792020|P2|Overall Study|Protocol Violation|1
239880|NCT01433250|792021|P1|Overall Study|Protocol Violation|0
239881|NCT01433172|792040|P3|Overall Study|Death|0
239882|NCT01433172|792041|P2|Overall Study|Death|2
239883|NCT01433172|792042|P1|Overall Study|Death|0
239884|NCT01433172|792040|P3|Overall Study|Disease Progression|1
239885|NCT01433172|792041|P2|Overall Study|Disease Progression|0
239886|NCT01433172|792042|P1|Overall Study|Disease Progression|0
239887|NCT01433172|792040|P3|Overall Study|Withdrawal by Subject|0
239888|NCT01433172|792041|P2|Overall Study|Withdrawal by Subject|1
239889|NCT01433172|792042|P1|Overall Study|Withdrawal by Subject|0
239890|NCT01433159|792054|P2|Overall Study|Protocol Violation|1
239891|NCT01433159|792055|P1|Overall Study|Protocol Violation|0
239892|NCT01433159|792054|P2|Overall Study|Physician Decision|0
239893|NCT01433159|792055|P1|Overall Study|Physician Decision|1
239894|NCT01433159|792054|P2|Overall Study|Adverse Event|0
239895|NCT01433159|792055|P1|Overall Study|Adverse Event|1
239896|NCT01433055|792087|P2|Overall Study|Severely elevated triglycerides at entry|0
239897|NCT01433055|792088|P1|Overall Study|Severely elevated triglycerides at entry|1
239898|NCT01433055|792087|P2|Overall Study|Diagnosed with cancer unrelated to study|0
239899|NCT01433055|792088|P1|Overall Study|Diagnosed with cancer unrelated to study|1
239900|NCT01432938|792110|P2|Second Intervention|Adverse Event|0
239901|NCT01432938|792111|P1|Second Intervention|Adverse Event|1
239902|NCT01432938|792110|P2|First Intervention|Physician Decision|0
239903|NCT01432938|792111|P1|First Intervention|Physician Decision|1
239904|NCT01432938|792110|P2|First Intervention|Protocol Violation|0
239905|NCT01432938|792111|P1|First Intervention|Protocol Violation|1
239906|NCT01432756|792141|P4|Overall Study|Lost to Follow-up|1
239907|NCT01432756|792142|P3|Overall Study|Lost to Follow-up|2
239908|NCT01432756|792143|P2|Overall Study|Lost to Follow-up|0
239909|NCT01432756|792144|P1|Overall Study|Lost to Follow-up|1
239910|NCT01432626|792152|P1|Overall Study|Imaging agent not available|1
239911|NCT01432626|792152|P1|Overall Study|Only 1 image competed|2
239912|NCT01432626|792152|P1|Overall Study|Withdrawal by Subject|2
239913|NCT01432626|792152|P1|Overall Study|LV function recovered|2
239914|NCT01432600|792159|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
239915|NCT01432600|792160|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
239916|NCT01432600|792161|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
239917|NCT01432574|792177|P1|Overall Study|Not interested|1
239918|NCT01432574|792177|P1|Overall Study|Moved|2
239919|NCT01432457|792223|P3|Overall Study|Did not take study drug|3
239920|NCT01432457|792224|P2|Overall Study|Did not take study drug|6
239921|NCT01432457|792225|P1|Overall Study|Did not take study drug|6
239922|NCT01432457|792223|P3|Overall Study|Reasons not defined|4
239923|NCT01432457|792224|P2|Overall Study|Reasons not defined|3
239924|NCT01432457|792225|P1|Overall Study|Reasons not defined|2
239925|NCT01432457|792223|P3|Overall Study|Withdrawal by Subject|9
239926|NCT01432457|792224|P2|Overall Study|Withdrawal by Subject|11
239927|NCT01432457|792225|P1|Overall Study|Withdrawal by Subject|6
239928|NCT01432457|792223|P3|Overall Study|Protocol Violation|6
239929|NCT01432457|792224|P2|Overall Study|Protocol Violation|2
239930|NCT01432457|792225|P1|Overall Study|Protocol Violation|3
239931|NCT01432457|792223|P3|Overall Study|Lost to Follow-up|20
239932|NCT01432457|792224|P2|Overall Study|Lost to Follow-up|15
239933|NCT01432457|792225|P1|Overall Study|Lost to Follow-up|11
239934|NCT01432457|792223|P3|Overall Study|Lack of Efficacy|1
239935|NCT01432457|792224|P2|Overall Study|Lack of Efficacy|1
239936|NCT01432457|792225|P1|Overall Study|Lack of Efficacy|2
239937|NCT01432457|792223|P3|Overall Study|Adverse Event|16
239938|NCT01432457|792224|P2|Overall Study|Adverse Event|10
239939|NCT01432457|792225|P1|Overall Study|Adverse Event|7
239940|NCT01432444|792254|P3|Extension Phase|Withdrawal by Subject|13
239941|NCT01432444|792255|P2|Extension Phase|Withdrawal by Subject|0
239942|NCT01432444|792256|P1|Extension Phase|Withdrawal by Subject|0
239943|NCT01432444|792254|P3|Extension Phase|Physician Decision|1
239944|NCT01432444|792255|P2|Extension Phase|Physician Decision|0
239945|NCT01432444|792256|P1|Extension Phase|Physician Decision|0
239946|NCT01432444|792254|P3|Extension Phase|Met Withdrawal Criteria|144
239947|NCT01432444|792255|P2|Extension Phase|Met Withdrawal Criteria|0
239948|NCT01432444|792256|P1|Extension Phase|Met Withdrawal Criteria|0
239949|NCT01432444|792254|P3|Extension Phase|Sponsor Discontinued Trial|7
239950|NCT01432444|792255|P2|Extension Phase|Sponsor Discontinued Trial|0
239951|NCT01432444|792256|P1|Extension Phase|Sponsor Discontinued Trial|0
239952|NCT01432444|792254|P3|Extension Phase|Adverse Event|10
239953|NCT01432444|792255|P2|Extension Phase|Adverse Event|0
239954|NCT01432444|792256|P1|Extension Phase|Adverse Event|0
239955|NCT01432444|792254|P3|Extension Phase|Lost to Follow-up|17
239956|NCT01432444|792255|P2|Extension Phase|Lost to Follow-up|0
239957|NCT01432444|792256|P1|Extension Phase|Lost to Follow-up|0
239958|NCT01432444|792254|P3|Treatment Phase|Lack of Efficacy|0
239959|NCT01432444|792255|P2|Treatment Phase|Lack of Efficacy|10
239960|NCT01432444|792256|P1|Treatment Phase|Lack of Efficacy|0
239961|NCT01432444|792254|P3|Treatment Phase|Protocol Deviation|0
239962|NCT01432444|792255|P2|Treatment Phase|Protocol Deviation|3
239963|NCT01432444|792256|P1|Treatment Phase|Protocol Deviation|0
239964|NCT01432444|792254|P3|Treatment Phase|Withdrawal by Subject|0
239965|NCT01432444|792255|P2|Treatment Phase|Withdrawal by Subject|41
239966|NCT01432444|792256|P1|Treatment Phase|Withdrawal by Subject|0
239967|NCT01432444|792254|P3|Treatment Phase|Physician Decision|0
239968|NCT01432444|792255|P2|Treatment Phase|Physician Decision|5
239969|NCT01432444|792256|P1|Treatment Phase|Physician Decision|0
239970|NCT01432444|792254|P3|Treatment Phase|Met Withdrawal Criteria|0
239971|NCT01432444|792255|P2|Treatment Phase|Met Withdrawal Criteria|11
239972|NCT01432444|792256|P1|Treatment Phase|Met Withdrawal Criteria|0
239973|NCT01432444|792254|P3|Treatment Phase|Adverse Event|0
239974|NCT01432444|792255|P2|Treatment Phase|Adverse Event|37
239975|NCT01432444|792256|P1|Treatment Phase|Adverse Event|0
239976|NCT01432444|792254|P3|Treatment Phase|Lost to Follow-up|0
239977|NCT01432444|792255|P2|Treatment Phase|Lost to Follow-up|33
239978|NCT01432444|792256|P1|Treatment Phase|Lost to Follow-up|0
239979|NCT01432444|792254|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
239980|NCT01432444|792255|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
239981|NCT01432444|792256|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
239982|NCT01432444|792254|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
239983|NCT01432444|792255|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
239984|NCT01432444|792256|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
239985|NCT01432444|792254|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
239986|NCT01432444|792255|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
239987|NCT01432444|792256|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
239988|NCT01432444|792254|P3|Tolerability/Cross-titration Phase|Physician Decision|0
239989|NCT01432444|792255|P2|Tolerability/Cross-titration Phase|Physician Decision|0
239990|NCT01432444|792256|P1|Tolerability/Cross-titration Phase|Physician Decision|8
239991|NCT01432444|792254|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
239992|NCT01432444|792255|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
239993|NCT01432444|792256|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
239994|NCT01432444|792254|P3|Tolerability/Cross-titration Phase|Adverse Event|0
239995|NCT01432444|792255|P2|Tolerability/Cross-titration Phase|Adverse Event|0
239996|NCT01432444|792256|P1|Tolerability/Cross-titration Phase|Adverse Event|16
239997|NCT01432444|792254|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
239998|NCT01432444|792255|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
239999|NCT01432444|792256|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
240000|NCT01432366|792282|P1|Overall Study|Unspecified|14
240001|NCT01432366|792282|P1|Overall Study|Investigator Forget to Complete Visits|1
240002|NCT01432366|792282|P1|Overall Study|Site Closed|20
240003|NCT01432366|792282|P1|Overall Study|Lack of Efficacy|1
240004|NCT01432366|792282|P1|Overall Study|Lost to Follow-up|13
240005|NCT01432366|792282|P1|Overall Study|Pregnancy|1
240006|NCT01432366|792282|P1|Overall Study|Withdrawal Due to Non-Compliance|3
240007|NCT01432366|792282|P1|Overall Study|Adverse Event|8
240008|NCT01432366|792282|P1|Overall Study|Non-Responder|7
240009|NCT01432327|792304|P4|Posttest 1 Year|Allergic reaction|1
240010|NCT01432327|792305|P3|Posttest 1 Year|Allergic reaction|1
240011|NCT01432327|792306|P2|Posttest 1 Year|Allergic reaction|0
240012|NCT01432327|792307|P1|Posttest 1 Year|Allergic reaction|0
240013|NCT01432327|792304|P4|Posttest 1 Year|Lost to Follow-up|2
240014|NCT01432327|792305|P3|Posttest 1 Year|Lost to Follow-up|4
240015|NCT01432327|792306|P2|Posttest 1 Year|Lost to Follow-up|0
240016|NCT01432327|792307|P1|Posttest 1 Year|Lost to Follow-up|0
240017|NCT01432327|792304|P4|Posttest 1 Year|Measurement have to take place in future|20
240018|NCT01432327|792305|P3|Posttest 1 Year|Measurement have to take place in future|15
240019|NCT01432327|792306|P2|Posttest 1 Year|Measurement have to take place in future|28
240020|NCT01432327|792307|P1|Posttest 1 Year|Measurement have to take place in future|24
240021|NCT01432327|792304|P4|Posttest 6 Months|Withdrawal by Subject|0
240022|NCT01432327|792305|P3|Posttest 6 Months|Withdrawal by Subject|1
240023|NCT01432327|792306|P2|Posttest 6 Months|Withdrawal by Subject|0
240024|NCT01432327|792307|P1|Posttest 6 Months|Withdrawal by Subject|0
240025|NCT01432327|792304|P4|Posttest 6 Months|Allergic reaction|0
240026|NCT01432327|792305|P3|Posttest 6 Months|Allergic reaction|1
240027|NCT01432327|792306|P2|Posttest 6 Months|Allergic reaction|0
240028|NCT01432327|792307|P1|Posttest 6 Months|Allergic reaction|0
240029|NCT01432327|792304|P4|Posttest 6 Months|Lost to Follow-up|2
240030|NCT01432327|792305|P3|Posttest 6 Months|Lost to Follow-up|3
240031|NCT01432327|792306|P2|Posttest 6 Months|Lost to Follow-up|0
240032|NCT01432327|792307|P1|Posttest 6 Months|Lost to Follow-up|0
240033|NCT01432327|792304|P4|Posttest 3 Months|Allergic reaction|0
240034|NCT01432327|792305|P3|Posttest 3 Months|Allergic reaction|0
240035|NCT01432327|792306|P2|Posttest 3 Months|Allergic reaction|2
240036|NCT01432327|792307|P1|Posttest 3 Months|Allergic reaction|0
240037|NCT01432327|792304|P4|Posttest 3 Months|Lost to Follow-up|1
240038|NCT01432327|792305|P3|Posttest 3 Months|Lost to Follow-up|2
240039|NCT01432327|792306|P2|Posttest 3 Months|Lost to Follow-up|0
240040|NCT01432327|792307|P1|Posttest 3 Months|Lost to Follow-up|1
240041|NCT01432327|792304|P4|Posttest 3 Months|depression|0
240042|NCT01432327|792305|P3|Posttest 3 Months|depression|0
240043|NCT01432327|792306|P2|Posttest 3 Months|depression|0
240044|NCT01432327|792307|P1|Posttest 3 Months|depression|3
240045|NCT01432262|792319|P2|Overall Study|Withdrawal by Subject|1
240046|NCT01432262|792320|P1|Overall Study|Withdrawal by Subject|2
240047|NCT01431976|792414|P1|Overall Study|Withdrawal by Subject|1
240048|NCT01431976|792414|P1|Overall Study|Physician Decision|1
240049|NCT01431976|792414|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
240050|NCT01431976|792414|P1|Overall Study|Lack of Efficacy|2
240051|NCT01431976|792414|P1|Overall Study|Adverse Event|6
240052|NCT01431963|792425|P1|Overall Study|Withdrawal by Subject|3
240053|NCT01431963|792425|P1|Overall Study|Physician Decision|4
240054|NCT01431963|792425|P1|Overall Study|Protocol-defined Stopping Criteria|2
240055|NCT01431963|792425|P1|Overall Study|Protocol Violation|1
240056|NCT01431963|792425|P1|Overall Study|Lack of Efficacy|7
240057|NCT01431963|792425|P1|Overall Study|Adverse Event|18
240058|NCT01431950|792433|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
240059|NCT01431950|792434|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
240060|NCT01431950|792433|P2|Overall Study|Lost to Follow-up|1
240061|NCT01431950|792434|P1|Overall Study|Lost to Follow-up|0
240062|NCT01431950|792433|P2|Overall Study|Lack of Efficacy|1
240063|NCT01431950|792434|P1|Overall Study|Lack of Efficacy|2
240064|NCT01431950|792433|P2|Overall Study|Physician Decision|1
240065|NCT01431950|792434|P1|Overall Study|Physician Decision|2
240066|NCT01431950|792433|P2|Overall Study|Adverse Event|2
240067|NCT01431950|792434|P1|Overall Study|Adverse Event|2
240068|NCT01431950|792433|P2|Overall Study|Protocol Violation|3
240069|NCT01431950|792434|P1|Overall Study|Protocol Violation|2
240070|NCT01431950|792433|P2|Overall Study|Withdrawal by Subject|3
240071|NCT01431950|792434|P1|Overall Study|Withdrawal by Subject|4
240072|NCT01431950|792433|P2|Overall Study|Study Site Closed/Terminated|3
240073|NCT01431950|792434|P1|Overall Study|Study Site Closed/Terminated|7
240074|NCT01431716|792472|P1|Overall Study|Withdrawal of consent|1
240075|NCT01431521|792497|P4|Overall Study|Withdrawal by Subject|0
240076|NCT01431521|792498|P3|Overall Study|Withdrawal by Subject|1
240077|NCT01431521|792499|P2|Overall Study|Withdrawal by Subject|0
240078|NCT01431521|792500|P1|Overall Study|Withdrawal by Subject|0
240079|NCT01431508|792521|P1|Overall Study|Unable to Follow Protocol Procedures|1
240080|NCT01431508|792521|P1|Overall Study|Lack of Efficacy|1
240081|NCT01431287|792572|P5|Overall Study|not stated above|1
240082|NCT01431287|792573|P4|Overall Study|not stated above|2
240083|NCT01431287|792574|P3|Overall Study|not stated above|2
240084|NCT01431287|792575|P2|Overall Study|not stated above|2
240085|NCT01431287|792576|P1|Overall Study|not stated above|4
240086|NCT01431287|792572|P5|Overall Study|Consent withdrawn not due to AE|29
240087|NCT01431287|792573|P4|Overall Study|Consent withdrawn not due to AE|19
240088|NCT01431287|792574|P3|Overall Study|Consent withdrawn not due to AE|34
240089|NCT01431287|792575|P2|Overall Study|Consent withdrawn not due to AE|30
240090|NCT01431287|792576|P1|Overall Study|Consent withdrawn not due to AE|29
240091|NCT01431287|792572|P5|Overall Study|Lost to Follow-up|1
240092|NCT01431287|792573|P4|Overall Study|Lost to Follow-up|3
240093|NCT01431287|792574|P3|Overall Study|Lost to Follow-up|2
240094|NCT01431287|792575|P2|Overall Study|Lost to Follow-up|3
240095|NCT01431287|792576|P1|Overall Study|Lost to Follow-up|0
240096|NCT01431287|792572|P5|Overall Study|Non compliant with protocol|5
240097|NCT01431287|792573|P4|Overall Study|Non compliant with protocol|6
240098|NCT01431287|792574|P3|Overall Study|Non compliant with protocol|5
240099|NCT01431287|792575|P2|Overall Study|Non compliant with protocol|6
240100|NCT01431287|792576|P1|Overall Study|Non compliant with protocol|6
240101|NCT01431287|792572|P5|Overall Study|Adverse Event|41
240102|NCT01431287|792573|P4|Overall Study|Adverse Event|33
240103|NCT01431287|792574|P3|Overall Study|Adverse Event|53
240104|NCT01431287|792575|P2|Overall Study|Adverse Event|57
240105|NCT01431287|792576|P1|Overall Study|Adverse Event|59
240106|NCT01431287|792572|P5|Overall Study|not treated|0
240107|NCT01431287|792573|P4|Overall Study|not treated|0
240108|NCT01431287|792574|P3|Overall Study|not treated|1
240109|NCT01431287|792575|P2|Overall Study|not treated|0
240110|NCT01431287|792576|P1|Overall Study|not treated|0
240111|NCT01431274|792738|P5|Overall Study|Other reason not stated above|4
240112|NCT01431274|792739|P4|Overall Study|Other reason not stated above|2
240113|NCT01431274|792740|P3|Overall Study|Other reason not stated above|7
240114|NCT01431274|792741|P2|Overall Study|Other reason not stated above|5
240115|NCT01431274|792742|P1|Overall Study|Other reason not stated above|6
240116|NCT01431274|792738|P5|Overall Study|Lost to Follow-up|0
240117|NCT01431274|792739|P4|Overall Study|Lost to Follow-up|4
240118|NCT01431274|792740|P3|Overall Study|Lost to Follow-up|1
240119|NCT01431274|792741|P2|Overall Study|Lost to Follow-up|7
240120|NCT01431274|792742|P1|Overall Study|Lost to Follow-up|6
240121|NCT01431274|792738|P5|Overall Study|Non compliant with protocol|4
240122|NCT01431274|792739|P4|Overall Study|Non compliant with protocol|4
240123|NCT01431274|792740|P3|Overall Study|Non compliant with protocol|4
240124|NCT01431274|792741|P2|Overall Study|Non compliant with protocol|8
240125|NCT01431274|792742|P1|Overall Study|Non compliant with protocol|5
240126|NCT01431274|792738|P5|Overall Study|Consent withdrawn not due to AE|11
240127|NCT01431274|792739|P4|Overall Study|Consent withdrawn not due to AE|20
240128|NCT01431274|792740|P3|Overall Study|Consent withdrawn not due to AE|17
240129|NCT01431274|792741|P2|Overall Study|Consent withdrawn not due to AE|20
240130|NCT01431274|792742|P1|Overall Study|Consent withdrawn not due to AE|29
240131|NCT01431274|792738|P5|Overall Study|Adverse Event|37
240132|NCT01431274|792739|P4|Overall Study|Adverse Event|30
240133|NCT01431274|792740|P3|Overall Study|Adverse Event|43
240134|NCT01431274|792741|P2|Overall Study|Adverse Event|37
240135|NCT01431274|792742|P1|Overall Study|Adverse Event|51
240136|NCT01431144|792920|P2|Overall Study|Implant mobility and removal|0
240137|NCT01431144|792921|P1|Overall Study|Implant mobility and removal|2
240138|NCT01431079|792940|P2|Overall Study|Lost to Follow-up|39
240139|NCT01431079|792941|P1|Overall Study|Lost to Follow-up|35
240140|NCT01430754|793020|P2|Run-In Phase|Lost to Follow-up|0
240141|NCT01430754|793021|P1|Run-In Phase|Lost to Follow-up|1
240142|NCT01430754|793020|P2|Run-In Phase|Withdrawal by Subject|0
240143|NCT01430754|793021|P1|Run-In Phase|Withdrawal by Subject|2
240144|NCT01430754|793020|P2|Run-In Phase|Other|0
240145|NCT01430754|793021|P1|Run-In Phase|Other|2
240146|NCT01430754|793020|P2|Run-In Phase|Adverse Event|0
240147|NCT01430754|793021|P1|Run-In Phase|Adverse Event|2
240148|NCT01430754|793020|P2|Run-In Phase|Protocol Violation|0
240149|NCT01430754|793021|P1|Run-In Phase|Protocol Violation|6
240150|NCT01430754|793020|P2|Run-In Phase|Circadian Period Ineligible|0
240151|NCT01430754|793021|P1|Run-In Phase|Circadian Period Ineligible|24
240152|NCT01430624|793079|P3|Overall Study|technical or eligibility|2
240153|NCT01430624|793080|P2|Overall Study|technical or eligibility|5
240154|NCT01430624|793081|P1|Overall Study|technical or eligibility|5
240155|NCT01430624|793079|P3|Overall Study|Lost to Follow-up|27
240156|NCT01430624|793080|P2|Overall Study|Lost to Follow-up|29
240157|NCT01430624|793081|P1|Overall Study|Lost to Follow-up|23
240158|NCT01430611|793112|P2|Overall Study|Withdrawal by Subject|14
240159|NCT01430611|793113|P1|Overall Study|Withdrawal by Subject|15
240160|NCT01430611|793112|P2|Overall Study|Lost to Follow-up|0
240161|NCT01430611|793113|P1|Overall Study|Lost to Follow-up|1
240162|NCT01430611|793112|P2|Overall Study|Protocol Violation|0
240163|NCT01430611|793113|P1|Overall Study|Protocol Violation|1
240164|NCT01430611|793112|P2|Overall Study|Adverse Event|1
240165|NCT01430611|793113|P1|Overall Study|Adverse Event|0
240166|NCT01430585|793131|P1|Overall Study|Unspecified|7
240167|NCT01430585|793131|P1|Overall Study|Study Terminated by Sponsor|3
240168|NCT01430585|793131|P1|Overall Study|Objective Progression or Relapse|3
240169|NCT01430585|793131|P1|Overall Study|Death|1
240170|NCT01430468|793166|P2|Overall Study|Withdrawal by Subject|1
240171|NCT01430468|793167|P1|Overall Study|Withdrawal by Subject|1
240172|NCT01430468|793166|P2|Overall Study|Physician Decision|1
240173|NCT01430468|793167|P1|Overall Study|Physician Decision|2
240174|NCT01430403|793176|P3|Overall Study|Withdrawal by Subject|3
240175|NCT01430403|793177|P2|Overall Study|Withdrawal by Subject|1
240176|NCT01430403|793178|P1|Overall Study|Withdrawal by Subject|9
240177|NCT01430403|793176|P3|Overall Study|Protocol Violation|2
240178|NCT01430403|793177|P2|Overall Study|Protocol Violation|3
240179|NCT01430403|793178|P1|Overall Study|Protocol Violation|2
240180|NCT01430403|793176|P3|Overall Study|Physician Decision|0
240181|NCT01430403|793177|P2|Overall Study|Physician Decision|0
240182|NCT01430403|793178|P1|Overall Study|Physician Decision|1
240183|NCT01430403|793176|P3|Overall Study|Lost to Follow-up|3
240184|NCT01430403|793177|P2|Overall Study|Lost to Follow-up|5
240185|NCT01430403|793178|P1|Overall Study|Lost to Follow-up|5
240186|NCT01430130|793276|P1|Overall Study|Infection on Control Side of Incision|1
240187|NCT01430130|793276|P1|Overall Study|Lost to Follow-up|1
240188|NCT01430104|793282|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
240189|NCT01429623|793318|P2|Overall Study|No post baseline data|4
240190|NCT01429623|793319|P1|Overall Study|No post baseline data|4
240191|NCT01429623|793318|P2|Overall Study|Conversion to Alzheimer's disease|21
240192|NCT01429623|793319|P1|Overall Study|Conversion to Alzheimer's disease|14
240193|NCT01429623|793318|P2|Overall Study|Assorted|2
240194|NCT01429623|793319|P1|Overall Study|Assorted|1
240195|NCT01429623|793318|P2|Overall Study|Protocol Violation|2
240196|NCT01429623|793319|P1|Overall Study|Protocol Violation|3
240197|NCT01429623|793318|P2|Overall Study|Physician Decision|3
240198|NCT01429623|793319|P1|Overall Study|Physician Decision|2
240199|NCT01429623|793318|P2|Overall Study|Withdrawal by Subject|13
240200|NCT01429623|793319|P1|Overall Study|Withdrawal by Subject|19
240201|NCT01429623|793318|P2|Overall Study|Adverse Event|14
240202|NCT01429623|793319|P1|Overall Study|Adverse Event|7
240203|NCT01429623|793318|P2|Overall Study|Death|0
240204|NCT01429623|793319|P1|Overall Study|Death|1
240205|NCT01429584|793333|P2|Overall Study|Protocol Violation|1
240206|NCT01429584|793334|P1|Overall Study|Protocol Violation|0
240207|NCT01429584|793333|P2|Overall Study|Withdrawal by Subject|0
240208|NCT01429584|793334|P1|Overall Study|Withdrawal by Subject|1
240209|NCT01429441|793365|P2|Overall Study|Withdrawal by Subject|18
240210|NCT01429441|793366|P1|Overall Study|Withdrawal by Subject|27
240211|NCT01429441|793365|P2|Overall Study|Physician Decision|0
240212|NCT01429441|793366|P1|Overall Study|Physician Decision|1
240213|NCT01429441|793365|P2|Overall Study|Lost to Follow-up|2
240214|NCT01429441|793366|P1|Overall Study|Lost to Follow-up|5
240215|NCT01429441|793365|P2|Overall Study|Death|2
240216|NCT01429441|793366|P1|Overall Study|Death|0
240217|NCT01429441|793365|P2|Overall Study|Adverse Event|1
240218|NCT01429441|793366|P1|Overall Study|Adverse Event|5
240219|NCT01429077|793381|P2|Overall Study|Lost to Follow-up|3
240220|NCT01429077|793382|P1|Overall Study|Lost to Follow-up|0
240221|NCT01429051|793405|P1|Tolerability Phase|Other|2
240222|NCT01429051|793405|P1|Tolerability Phase|Physician Decision|1
240223|NCT01429051|793405|P1|Tolerability Phase|Withdrawal by Subject|5
240224|NCT01429051|793405|P1|Tolerability Phase|Adverse Event|2
240225|NCT01429051|793405|P1|Tolerability Phase|Death|5
240226|NCT01429051|793405|P1|Efficacy Phase|Death|1
240227|NCT01429051|793405|P1|Efficacy Phase|Adverse Event|1
240228|NCT01429051|793405|P1|Titration Phase|Less than 3 BTP episodes per week|2
240229|NCT01429051|793405|P1|Titration Phase|Unsuccessful titration at any dose|1
240230|NCT01429051|793405|P1|Titration Phase|Physician Decision|1
240231|NCT01429051|793405|P1|Titration Phase|Withdrawal by Subject|7
240232|NCT01429051|793405|P1|Titration Phase|Death|1
240233|NCT01428882|793428|P2|Overall Study|Protocol Violation|3
240234|NCT01428882|793429|P1|Overall Study|Protocol Violation|4
240235|NCT01428882|793428|P2|Overall Study|Lack of Efficacy|7
240236|NCT01428882|793429|P1|Overall Study|Lack of Efficacy|2
240237|NCT01428713|793452|P2|Overall Study|Adverse Event|2
240238|NCT01428713|793453|P1|Overall Study|Adverse Event|0
240239|NCT01428713|793452|P2|Overall Study|Withdrawal by Subject|1
240240|NCT01428713|793453|P1|Overall Study|Withdrawal by Subject|1
240241|NCT01428713|793452|P2|Overall Study|Non-compliance|2
240242|NCT01428713|793453|P1|Overall Study|Non-compliance|2
240243|NCT01428661|793462|P3|Open Label Extension|**Various|185
240244|NCT01428661|793463|P2|Open Label Extension|**Various|0
240245|NCT01428661|793464|P1|Open Label Extension|**Various|0
240246|NCT01428661|793462|P3|Open Label Extension|Lack of Efficacy|24
240247|NCT01428661|793463|P2|Open Label Extension|Lack of Efficacy|0
240248|NCT01428661|793464|P1|Open Label Extension|Lack of Efficacy|0
240249|NCT01428661|793462|P3|Open Label Extension|Withdrawal by Subject|49
240250|NCT01428661|793463|P2|Open Label Extension|Withdrawal by Subject|0
240251|NCT01428661|793464|P1|Open Label Extension|Withdrawal by Subject|0
240252|NCT01428661|793462|P3|Open Label Extension|Lost to Follow-up|38
240253|NCT01428661|793463|P2|Open Label Extension|Lost to Follow-up|0
240254|NCT01428661|793464|P1|Open Label Extension|Lost to Follow-up|0
240255|NCT01428661|793462|P3|Open Label Extension|Adverse Event|15
240256|NCT01428661|793463|P2|Open Label Extension|Adverse Event|0
240257|NCT01428661|793464|P1|Open Label Extension|Adverse Event|0
240258|NCT01428661|793462|P3|Open Label Extension|Protocol Violation|9
240259|NCT01428661|793463|P2|Open Label Extension|Protocol Violation|0
240260|NCT01428661|793464|P1|Open Label Extension|Protocol Violation|0
240261|NCT01428661|793462|P3|Double-Masked Phase|*Various|0
240262|NCT01428661|793463|P2|Double-Masked Phase|*Various|6
240263|NCT01428661|793464|P1|Double-Masked Phase|*Various|1
240264|NCT01428661|793462|P3|Double-Masked Phase|Lack of Efficacy|0
240265|NCT01428661|793463|P2|Double-Masked Phase|Lack of Efficacy|1
240266|NCT01428661|793464|P1|Double-Masked Phase|Lack of Efficacy|2
240267|NCT01428661|793462|P3|Double-Masked Phase|Withdrawal by Subject|0
240268|NCT01428661|793463|P2|Double-Masked Phase|Withdrawal by Subject|20
240269|NCT01428661|793464|P1|Double-Masked Phase|Withdrawal by Subject|18
240270|NCT01428661|793462|P3|Double-Masked Phase|Lost to Follow-up|0
240271|NCT01428661|793463|P2|Double-Masked Phase|Lost to Follow-up|14
240272|NCT01428661|793464|P1|Double-Masked Phase|Lost to Follow-up|14
240273|NCT01428661|793462|P3|Double-Masked Phase|Adverse Event|0
240274|NCT01428661|793463|P2|Double-Masked Phase|Adverse Event|4
240275|NCT01428661|793464|P1|Double-Masked Phase|Adverse Event|13
240276|NCT01428661|793462|P3|Double-Masked Phase|Protocol Violation|0
240277|NCT01428661|793463|P2|Double-Masked Phase|Protocol Violation|4
240278|NCT01428661|793464|P1|Double-Masked Phase|Protocol Violation|9
240279|NCT01428583|793472|P1|Overall Study|Unspecified|6
240280|NCT01428583|793472|P1|Overall Study|Sponsor’s request|3
240281|NCT01428583|793472|P1|Overall Study|Confirmed positive urine drug test|8
240282|NCT01428583|793472|P1|Overall Study|Non-compliant|25
240283|NCT01428583|793472|P1|Overall Study|Physician Decision|12
240284|NCT01428583|793472|P1|Overall Study|Protocol Violation|1
240285|NCT01428583|793472|P1|Overall Study|Pregnancy|1
240286|NCT01428583|793472|P1|Overall Study|Death|1
240287|NCT01428583|793472|P1|Overall Study|Lost to Follow-up|17
240288|NCT01428583|793472|P1|Overall Study|Lack of Efficacy|37
240289|NCT01428583|793472|P1|Overall Study|Withdrawal by Subject|51
240290|NCT01428583|793472|P1|Overall Study|Adverse Event|75
240291|NCT01428258|793496|P2|Intervention 1|Withdrawal by Subject|0
240292|NCT01428258|793497|P1|Intervention 1|Withdrawal by Subject|2
240293|NCT01428128|793519|P1|Overall Study|Adverse Event|1
240294|NCT01428128|793519|P1|Overall Study|Received Neulasta in one cycle|2
240295|NCT01428128|793519|P1|Overall Study|Screen failure by p53|10
240296|NCT01428128|793519|P1|Overall Study|Withdrawal by Subject|4
240297|NCT01428115|793523|P1|Overall Study|Withdrawal by Subject|4
240298|NCT01428115|793523|P1|Overall Study|Protocol Violation|3
240299|NCT01428115|793523|P1|Overall Study|Pregnancy|1
240300|NCT01428115|793523|P1|Overall Study|Lost to Follow-up|10
240301|NCT01428115|793523|P1|Overall Study|Lack of Efficacy|3
240302|NCT01428076|793538|P2|Overall Study|Adverse Event|1
240303|NCT01428076|793539|P1|Overall Study|Adverse Event|0
240304|NCT01428063|793550|P3|Overall Study|No longer meets study criteria|0
240305|NCT01428063|793551|P2|Overall Study|No longer meets study criteria|1
240306|NCT01428063|793552|P1|Overall Study|No longer meets study criteria|0
240307|NCT01428063|793550|P3|Overall Study|Lost to Follow-up|0
240308|NCT01428063|793551|P2|Overall Study|Lost to Follow-up|2
240309|NCT01428063|793552|P1|Overall Study|Lost to Follow-up|0
240310|NCT01428063|793550|P3|Overall Study|Adverse Event|0
240311|NCT01428063|793551|P2|Overall Study|Adverse Event|3
240312|NCT01428063|793552|P1|Overall Study|Adverse Event|2
240313|NCT01428063|793550|P3|Overall Study|Lack of Efficacy|1
240314|NCT01428063|793551|P2|Overall Study|Lack of Efficacy|4
240315|NCT01428063|793552|P1|Overall Study|Lack of Efficacy|8
240316|NCT01427933|793623|P2|Overall Study|Investigator's Decision|0
240317|NCT01427933|793624|P1|Overall Study|Investigator's Decision|1
240318|NCT01427933|793623|P2|Overall Study|Not Specified|0
240319|NCT01427933|793624|P1|Overall Study|Not Specified|1
240320|NCT01427933|793623|P2|Overall Study|Lost to Follow-up|5
240321|NCT01427933|793624|P1|Overall Study|Lost to Follow-up|1
240322|NCT01427933|793623|P2|Overall Study|Withdrawal by Subject|8
240323|NCT01427933|793624|P1|Overall Study|Withdrawal by Subject|5
240324|NCT01427920|793644|P2|Overall Study|Unclassified|8
240325|NCT01427920|793645|P1|Overall Study|Unclassified|2
240326|NCT01427920|793644|P2|Overall Study|Withdrawal Criteria|4
240327|NCT01427920|793645|P1|Overall Study|Withdrawal Criteria|4
240328|NCT01427920|793644|P2|Overall Study|Protocol Violation|3
240329|NCT01427920|793645|P1|Overall Study|Protocol Violation|1
240330|NCT01427920|793644|P2|Overall Study|Lack of Efficacy|0
240331|NCT01427920|793645|P1|Overall Study|Lack of Efficacy|1
240332|NCT01427920|793644|P2|Overall Study|Adverse Event|2
240333|NCT01427920|793645|P1|Overall Study|Adverse Event|1
240334|NCT01427907|793665|P2|Overall Study|Withdrawal by Subject|4
240335|NCT01427907|793666|P1|Overall Study|Withdrawal by Subject|3
240336|NCT01427803|793687|P2|Overall Study|did not take product|0
240337|NCT01427803|793688|P1|Overall Study|did not take product|1
240338|NCT01427803|793687|P2|Overall Study|Physician Decision|0
240339|NCT01427803|793688|P1|Overall Study|Physician Decision|3
240340|NCT01427803|793687|P2|Overall Study|Protocol Violation|0
240341|NCT01427803|793688|P1|Overall Study|Protocol Violation|1
240342|NCT01427803|793687|P2|Overall Study|Unable to complete full treatment period|0
240343|NCT01427803|793688|P1|Overall Study|Unable to complete full treatment period|6
240344|NCT01427803|793687|P2|Overall Study|Withdrawal by Subject|0
240345|NCT01427803|793688|P1|Overall Study|Withdrawal by Subject|20
240346|NCT01427803|793687|P2|Overall Study|Lost to Follow-up|26
240347|NCT01427803|793688|P1|Overall Study|Lost to Follow-up|32
240348|NCT01427751|793702|P2|Overall Study|Other miscellaneous reasons|4
240349|NCT01427751|793703|P1|Overall Study|Other miscellaneous reasons|6
240350|NCT01427751|793702|P2|Overall Study|Death|0
240351|NCT01427751|793703|P1|Overall Study|Death|2
240352|NCT01427751|793702|P2|Overall Study|Protocol Violation|4
240353|NCT01427751|793703|P1|Overall Study|Protocol Violation|6
240354|NCT01427751|793702|P2|Overall Study|Withdrawal of consent|2
240355|NCT01427751|793703|P1|Overall Study|Withdrawal of consent|2
240356|NCT01427751|793702|P2|Overall Study|Lost to Follow-up|1
240357|NCT01427751|793703|P1|Overall Study|Lost to Follow-up|3
240358|NCT01427751|793702|P2|Overall Study|No further treatment benefit expected|1
240359|NCT01427751|793703|P1|Overall Study|No further treatment benefit expected|5
240360|NCT01427751|793702|P2|Overall Study|Adverse Event|2
240361|NCT01427751|793703|P1|Overall Study|Adverse Event|18
240362|NCT01427738|793723|P2|Overall Study|Lost to Follow-up|5
240363|NCT01427738|793724|P1|Overall Study|Lost to Follow-up|1
240364|NCT01427738|793723|P2|Overall Study|Subject not willing to adhere to reqs|2
240365|NCT01427738|793724|P1|Overall Study|Subject not willing to adhere to reqs|1
240366|NCT01427738|793723|P2|Overall Study|Withdrawal by Subject|2
240367|NCT01427738|793724|P1|Overall Study|Withdrawal by Subject|0
240368|NCT01427738|793723|P2|Overall Study|Subject unable to get to clinic|2
240369|NCT01427738|793724|P1|Overall Study|Subject unable to get to clinic|5
240370|NCT01427738|793723|P2|Overall Study|Severe debilitation, unable to continue|1
240371|NCT01427738|793724|P1|Overall Study|Severe debilitation, unable to continue|0
240372|NCT01427738|793723|P2|Overall Study|Death|9
240373|NCT01427738|793724|P1|Overall Study|Death|12
240374|NCT01427309|793787|P4|Overall Study|Withdrawal by Subject|55
240375|NCT01427309|793788|P3|Overall Study|Withdrawal by Subject|61
240376|NCT01427309|793789|P2|Overall Study|Withdrawal by Subject|148
240377|NCT01427309|793790|P1|Overall Study|Withdrawal by Subject|148
240378|NCT01427309|793787|P4|Overall Study|Serious adverse event|61
240379|NCT01427309|793788|P3|Overall Study|Serious adverse event|50
240380|NCT01427309|793789|P2|Overall Study|Serious adverse event|45
240381|NCT01427309|793790|P1|Overall Study|Serious adverse event|52
240382|NCT01427309|793787|P4|Overall Study|Adverse Event|1
240383|NCT01427309|793788|P3|Overall Study|Adverse Event|3
240384|NCT01427309|793789|P2|Overall Study|Adverse Event|0
240385|NCT01427309|793790|P1|Overall Study|Adverse Event|0
240386|NCT01427309|793787|P4|Overall Study|Protocol Violation|124
240387|NCT01427309|793788|P3|Overall Study|Protocol Violation|125
240388|NCT01427309|793789|P2|Overall Study|Protocol Violation|69
240389|NCT01427309|793790|P1|Overall Study|Protocol Violation|42
240390|NCT01427309|793787|P4|Overall Study|Lost to Follow-up|135
240391|NCT01427309|793788|P3|Overall Study|Lost to Follow-up|122
240392|NCT01427309|793789|P2|Overall Study|Lost to Follow-up|145
240393|NCT01427309|793790|P1|Overall Study|Lost to Follow-up|130
240394|NCT01426958|793828|P1|Overall Study|Adverse Event|2
240395|NCT01426854|793857|P2|Overall Study|Other|2
240396|NCT01426854|793858|P1|Overall Study|Other|3
240397|NCT01426854|793857|P2|Overall Study|Protocol Deviation|1
240398|NCT01426854|793858|P1|Overall Study|Protocol Deviation|0
240399|NCT01426854|793857|P2|Overall Study|Treatment Failure|16
240400|NCT01426854|793858|P1|Overall Study|Treatment Failure|0
240401|NCT01426854|793857|P2|Overall Study|Noncompliance|1
240402|NCT01426854|793858|P1|Overall Study|Noncompliance|0
240403|NCT01426854|793857|P2|Overall Study|Lost to Follow-up|0
240404|NCT01426854|793858|P1|Overall Study|Lost to Follow-up|3
240405|NCT01426854|793857|P2|Overall Study|Subject Decision Unrelated to AE|6
240406|NCT01426854|793858|P1|Overall Study|Subject Decision Unrelated to AE|5
240407|NCT01426854|793857|P2|Overall Study|Adverse Event|5
240408|NCT01426854|793858|P1|Overall Study|Adverse Event|1
240409|NCT01426789|793868|P6|Part 2|Adverse Event|0
240410|NCT01426789|793869|P5|Part 2|Adverse Event|1
240411|NCT01426789|793870|P4|Part 2|Adverse Event|0
240412|NCT01426789|793871|P3|Part 2|Adverse Event|2
240413|NCT01426789|793872|P2|Part 2|Adverse Event|0
240414|NCT01426789|793873|P1|Part 2|Adverse Event|0
240415|NCT01426789|793868|P6|Part 2|Lack of Efficacy|0
240416|NCT01426789|793869|P5|Part 2|Lack of Efficacy|2
240417|NCT01426789|793870|P4|Part 2|Lack of Efficacy|0
240418|NCT01426789|793871|P3|Part 2|Lack of Efficacy|5
240419|NCT01426789|793872|P2|Part 2|Lack of Efficacy|0
240420|NCT01426789|793873|P1|Part 2|Lack of Efficacy|0
240421|NCT01426789|793868|P6|Part 2|Withdrawal by Subject|0
240422|NCT01426789|793869|P5|Part 2|Withdrawal by Subject|2
240423|NCT01426789|793870|P4|Part 2|Withdrawal by Subject|1
240424|NCT01426789|793871|P3|Part 2|Withdrawal by Subject|0
240425|NCT01426789|793872|P2|Part 2|Withdrawal by Subject|0
240426|NCT01426789|793873|P1|Part 2|Withdrawal by Subject|0
240427|NCT01426789|793868|P6|Part 2|Lost to Follow-up|0
240428|NCT01426789|793869|P5|Part 2|Lost to Follow-up|1
240429|NCT01426789|793870|P4|Part 2|Lost to Follow-up|0
240430|NCT01426789|793871|P3|Part 2|Lost to Follow-up|4
240431|NCT01426789|793872|P2|Part 2|Lost to Follow-up|0
240432|NCT01426789|793873|P1|Part 2|Lost to Follow-up|0
240433|NCT01426789|793868|P6|Part 2|Administrative problems|0
240434|NCT01426789|793869|P5|Part 2|Administrative problems|1
240435|NCT01426789|793870|P4|Part 2|Administrative problems|0
240436|NCT01426789|793871|P3|Part 2|Administrative problems|2
240437|NCT01426789|793872|P2|Part 2|Administrative problems|0
240438|NCT01426789|793873|P1|Part 2|Administrative problems|0
240439|NCT01426789|793868|P6|Part 2|Death|0
240440|NCT01426789|793869|P5|Part 2|Death|1
240441|NCT01426789|793870|P4|Part 2|Death|0
240442|NCT01426789|793871|P3|Part 2|Death|1
240443|NCT01426789|793872|P2|Part 2|Death|0
240444|NCT01426789|793873|P1|Part 2|Death|0
240445|NCT01426789|793868|P6|Part 2|Protocol deviation|0
240446|NCT01426789|793869|P5|Part 2|Protocol deviation|0
240447|NCT01426789|793870|P4|Part 2|Protocol deviation|0
240448|NCT01426789|793871|P3|Part 2|Protocol deviation|1
240449|NCT01426789|793872|P2|Part 2|Protocol deviation|0
240450|NCT01426789|793873|P1|Part 2|Protocol deviation|0
240451|NCT01426789|793868|P6|Part 1|Adverse Event|0
240452|NCT01426789|793869|P5|Part 1|Adverse Event|0
240453|NCT01426789|793870|P4|Part 1|Adverse Event|0
240454|NCT01426789|793871|P3|Part 1|Adverse Event|0
240455|NCT01426789|793872|P2|Part 1|Adverse Event|0
240456|NCT01426789|793873|P1|Part 1|Adverse Event|3
240457|NCT01426789|793868|P6|Part 1|Lack of Efficacy|0
240458|NCT01426789|793869|P5|Part 1|Lack of Efficacy|0
240459|NCT01426789|793870|P4|Part 1|Lack of Efficacy|0
240460|NCT01426789|793871|P3|Part 1|Lack of Efficacy|0
240461|NCT01426789|793872|P2|Part 1|Lack of Efficacy|1
240462|NCT01426789|793873|P1|Part 1|Lack of Efficacy|2
240463|NCT01426789|793868|P6|Part 1|Lost to Follow-up|0
240464|NCT01426789|793869|P5|Part 1|Lost to Follow-up|0
240465|NCT01426789|793870|P4|Part 1|Lost to Follow-up|0
240466|NCT01426789|793871|P3|Part 1|Lost to Follow-up|0
240467|NCT01426789|793872|P2|Part 1|Lost to Follow-up|2
240468|NCT01426789|793873|P1|Part 1|Lost to Follow-up|1
240469|NCT01426789|793868|P6|Part 1|Protocol deviation|0
240470|NCT01426789|793869|P5|Part 1|Protocol deviation|0
240471|NCT01426789|793870|P4|Part 1|Protocol deviation|0
240472|NCT01426789|793871|P3|Part 1|Protocol deviation|0
240473|NCT01426789|793872|P2|Part 1|Protocol deviation|1
240474|NCT01426789|793873|P1|Part 1|Protocol deviation|0
240475|NCT01426438|793918|P2|Overall Study|Missed Scan|2
240476|NCT01426438|793919|P1|Overall Study|Missed Scan|2
240477|NCT01426438|793918|P2|Overall Study|Poor scan quality|2
240478|NCT01426438|793919|P1|Overall Study|Poor scan quality|3
240479|NCT01426438|793918|P2|Overall Study|Off study Treatment|3
240480|NCT01426438|793919|P1|Overall Study|Off study Treatment|9
240481|NCT01426438|793918|P2|Overall Study|Lost to Follow-up|3
240482|NCT01426438|793919|P1|Overall Study|Lost to Follow-up|1
240483|NCT01426425|793951|P1|Overall Study|Met inclusion/exclusion, not treated|2
240484|NCT01426425|793951|P1|Overall Study|Inclusion/exclusion criteria not met|151
240485|NCT01426425|793951|P1|Overall Study|Exited prior to EP study|22
240486|NCT01426373|793957|P1|Overall Study|Miscellaneous Reasons|4
240487|NCT01426373|793957|P1|Overall Study|Participant Convenience|10
240488|NCT01426373|793957|P1|Overall Study|Lost to Follow-up|14
240489|NCT01426373|793957|P1|Overall Study|Adverse Event|6
240490|NCT01426347|793990|P2|Overall Study|Withdrawal by Subject|0
240491|NCT01426347|793991|P1|Overall Study|Withdrawal by Subject|5
240492|NCT01426347|793990|P2|Overall Study|Protocol Violation|0
240493|NCT01426347|793991|P1|Overall Study|Protocol Violation|2
240494|NCT01426347|793990|P2|Overall Study|Lost to Follow-up|3
240495|NCT01426347|793991|P1|Overall Study|Lost to Follow-up|0
240496|NCT01426269|793999|P3|Period 2: 40 Weeks|Relapsed|18
240497|NCT01426269|794000|P2|Period 2: 40 Weeks|Relapsed|9
240498|NCT01426269|794001|P1|Period 2: 40 Weeks|Relapsed|0
240499|NCT01426269|793999|P3|Period 2: 40 Weeks|Site closed|5
240500|NCT01426269|794000|P2|Period 2: 40 Weeks|Site closed|6
240501|NCT01426269|794001|P1|Period 2: 40 Weeks|Site closed|0
240502|NCT01426269|793999|P3|Period 2: 40 Weeks|Lost to Follow-up|6
240503|NCT01426269|794000|P2|Period 2: 40 Weeks|Lost to Follow-up|8
240504|NCT01426269|794001|P1|Period 2: 40 Weeks|Lost to Follow-up|0
240505|NCT01426269|793999|P3|Period 2: 40 Weeks|Protocol Violation|5
240506|NCT01426269|794000|P2|Period 2: 40 Weeks|Protocol Violation|5
240507|NCT01426269|794001|P1|Period 2: 40 Weeks|Protocol Violation|0
240508|NCT01426269|793999|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
240509|NCT01426269|794000|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
240510|NCT01426269|794001|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
240511|NCT01426269|793999|P3|Period 2: 40 Weeks|Adverse Event|2
240512|NCT01426269|794000|P2|Period 2: 40 Weeks|Adverse Event|1
240513|NCT01426269|794001|P1|Period 2: 40 Weeks|Adverse Event|0
240514|NCT01426269|793999|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
240515|NCT01426269|794000|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
240602|NCT01425359|794240|P1|Overall Study|Subject Withdrew Consent|1
240516|NCT01426269|794001|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
240517|NCT01426269|793999|P3|Eligibility for Period 2, Randomization|Did not qualify|0
240518|NCT01426269|794000|P2|Eligibility for Period 2, Randomization|Did not qualify|0
240519|NCT01426269|794001|P1|Eligibility for Period 2, Randomization|Did not qualify|42
240520|NCT01426269|793999|P3|Period 1: 12 Weeks|Pregnancy|0
240521|NCT01426269|794000|P2|Period 1: 12 Weeks|Pregnancy|0
240522|NCT01426269|794001|P1|Period 1: 12 Weeks|Pregnancy|1
240523|NCT01426269|793999|P3|Period 1: 12 Weeks|Lost to Follow-up|0
240524|NCT01426269|794000|P2|Period 1: 12 Weeks|Lost to Follow-up|0
240525|NCT01426269|794001|P1|Period 1: 12 Weeks|Lost to Follow-up|22
240526|NCT01426269|793999|P3|Period 1: 12 Weeks|Protocol Violation|0
240527|NCT01426269|794000|P2|Period 1: 12 Weeks|Protocol Violation|0
240528|NCT01426269|794001|P1|Period 1: 12 Weeks|Protocol Violation|5
240529|NCT01426269|793999|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
240530|NCT01426269|794000|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
240531|NCT01426269|794001|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
240532|NCT01426269|793999|P3|Period 1: 12 Weeks|Adverse Event|0
240533|NCT01426269|794000|P2|Period 1: 12 Weeks|Adverse Event|0
240534|NCT01426269|794001|P1|Period 1: 12 Weeks|Adverse Event|5
240535|NCT01426113|794036|P2|Overall Study|Adverse Event|1
240536|NCT01426113|794037|P1|Overall Study|Adverse Event|0
240537|NCT01426113|794036|P2|Overall Study|Study Discontinued|1
240538|NCT01426113|794037|P1|Overall Study|Study Discontinued|1
240539|NCT01425814|794083|P6|Period 5|Stability criteria not fulfilled|1
240540|NCT01425814|794084|P5|Period 5|Stability criteria not fulfilled|0
240541|NCT01425814|794085|P4|Period 5|Stability criteria not fulfilled|0
240542|NCT01425814|794086|P3|Period 5|Stability criteria not fulfilled|1
240543|NCT01425814|794087|P2|Period 5|Stability criteria not fulfilled|0
240544|NCT01425814|794088|P1|Period 5|Stability criteria not fulfilled|0
240545|NCT01425814|794083|P6|Period 4|Adverse Event|0
240546|NCT01425814|794084|P5|Period 4|Adverse Event|0
240547|NCT01425814|794085|P4|Period 4|Adverse Event|0
240548|NCT01425814|794086|P3|Period 4|Adverse Event|1
240549|NCT01425814|794087|P2|Period 4|Adverse Event|0
240550|NCT01425814|794088|P1|Period 4|Adverse Event|1
240551|NCT01425814|794083|P6|Period 3|Adverse Event|1
240552|NCT01425814|794084|P5|Period 3|Adverse Event|0
240553|NCT01425814|794085|P4|Period 3|Adverse Event|0
240554|NCT01425814|794086|P3|Period 3|Adverse Event|0
240555|NCT01425814|794087|P2|Period 3|Adverse Event|0
240556|NCT01425814|794088|P1|Period 3|Adverse Event|0
240557|NCT01425814|794083|P6|Period 2|Stability criteria not fulfilled|0
240558|NCT01425814|794084|P5|Period 2|Stability criteria not fulfilled|0
240559|NCT01425814|794085|P4|Period 2|Stability criteria not fulfilled|0
240560|NCT01425814|794086|P3|Period 2|Stability criteria not fulfilled|0
240561|NCT01425814|794087|P2|Period 2|Stability criteria not fulfilled|1
240562|NCT01425814|794088|P1|Period 2|Stability criteria not fulfilled|0
240563|NCT01425814|794083|P6|Period 1|Stability criteria not fulfilled|0
240564|NCT01425814|794084|P5|Period 1|Stability criteria not fulfilled|0
240565|NCT01425814|794085|P4|Period 1|Stability criteria not fulfilled|0
240566|NCT01425814|794086|P3|Period 1|Stability criteria not fulfilled|0
240567|NCT01425814|794087|P2|Period 1|Stability criteria not fulfilled|1
240568|NCT01425814|794088|P1|Period 1|Stability criteria not fulfilled|0
240569|NCT01425749|794182|P2|Overall Study|progression of melanoma|1
240570|NCT01425749|794183|P1|Overall Study|progression of melanoma|0
240571|NCT01425632|794201|P3|Overall Study|Withdrawal by Subject|1
240572|NCT01425632|794202|P2|Overall Study|Withdrawal by Subject|0
240573|NCT01425632|794203|P1|Overall Study|Withdrawal by Subject|0
240574|NCT01425632|794201|P3|Overall Study|Protocol Violation|2
240575|NCT01425632|794202|P2|Overall Study|Protocol Violation|0
240576|NCT01425632|794203|P1|Overall Study|Protocol Violation|0
240577|NCT01425632|794201|P3|Overall Study|Physician Decision|0
240578|NCT01425632|794202|P2|Overall Study|Physician Decision|0
240579|NCT01425632|794203|P1|Overall Study|Physician Decision|1
240580|NCT01425632|794201|P3|Overall Study|Adverse Event|1
240581|NCT01425632|794202|P2|Overall Study|Adverse Event|1
240582|NCT01425632|794203|P1|Overall Study|Adverse Event|0
240583|NCT01425528|794213|P2|Overall Study|Withdrawal by Subject|1
240584|NCT01425528|794214|P1|Overall Study|Withdrawal by Subject|1
240585|NCT01425463|794222|P2|Overall Study|Unknown Reason|7
240586|NCT01425463|794223|P1|Overall Study|Unknown Reason|4
240587|NCT01425463|794222|P2|Overall Study|Withdrawal by Subject|5
240588|NCT01425463|794223|P1|Overall Study|Withdrawal by Subject|7
240589|NCT01425463|794222|P2|Overall Study|Lost to Follow-up|2
240590|NCT01425463|794223|P1|Overall Study|Lost to Follow-up|5
240591|NCT01425463|794222|P2|Overall Study|Protocol Violation|2
240592|NCT01425463|794223|P1|Overall Study|Protocol Violation|2
240593|NCT01425463|794222|P2|Overall Study|Lack of Efficacy|1
240594|NCT01425463|794223|P1|Overall Study|Lack of Efficacy|1
240595|NCT01425463|794222|P2|Overall Study|Adverse Event|7
240596|NCT01425463|794223|P1|Overall Study|Adverse Event|5
240597|NCT01425359|794239|P2|Overall Study|Did Not Meet Qualifying Criteria|5
240598|NCT01425359|794240|P1|Overall Study|Did Not Meet Qualifying Criteria|3
240599|NCT01425359|794239|P2|Overall Study|Investigator’s Discretion|0
240600|NCT01425359|794240|P1|Overall Study|Investigator’s Discretion|2
240601|NCT01425359|794239|P2|Overall Study|Subject Withdrew Consent|2
240603|NCT01425359|794239|P2|Overall Study|Protocol Violation|2
240604|NCT01425359|794240|P1|Overall Study|Protocol Violation|1
240605|NCT01425359|794239|P2|Overall Study|Unsatisfactory Response|0
240606|NCT01425359|794240|P1|Overall Study|Unsatisfactory Response|1
240607|NCT01425359|794239|P2|Overall Study|Death|1
240608|NCT01425359|794240|P1|Overall Study|Death|0
240609|NCT01425359|794239|P2|Overall Study|Revascularization|1
240610|NCT01425359|794240|P1|Overall Study|Revascularization|0
240611|NCT01425359|794239|P2|Overall Study|Adverse Event|8
240612|NCT01425359|794240|P1|Overall Study|Adverse Event|9
240613|NCT01425359|794239|P2|Overall Study|Randomized but Not Treated|3
240614|NCT01425359|794240|P1|Overall Study|Randomized but Not Treated|2
240615|NCT01425203|794282|P3|Crossover Phase|Other virologic failure criteria|3
240616|NCT01425203|794283|P2|Crossover Phase|Other virologic failure criteria|0
240617|NCT01425203|794284|P1|Crossover Phase|Other virologic failure criteria|0
240618|NCT01425203|794282|P3|Crossover Phase|Failure at futility timepoint|3
240619|NCT01425203|794283|P2|Crossover Phase|Failure at futility timepoint|0
240620|NCT01425203|794284|P1|Crossover Phase|Failure at futility timepoint|0
240621|NCT01425203|794282|P3|Treatment Phase|Did not receive treatment|0
240622|NCT01425203|794283|P2|Treatment Phase|Did not receive treatment|1
240623|NCT01425203|794284|P1|Treatment Phase|Did not receive treatment|0
240624|NCT01425203|794282|P3|Treatment Phase|Unidentified reasons|0
240625|NCT01425203|794283|P2|Treatment Phase|Unidentified reasons|5
240626|NCT01425203|794284|P1|Treatment Phase|Unidentified reasons|11
240627|NCT01425203|794282|P3|Treatment Phase|Other virologic failure criteria|0
240628|NCT01425203|794283|P2|Treatment Phase|Other virologic failure criteria|3
240629|NCT01425203|794284|P1|Treatment Phase|Other virologic failure criteria|5
240630|NCT01425203|794282|P3|Treatment Phase|Failure at futility timepoint|0
240631|NCT01425203|794283|P2|Treatment Phase|Failure at futility timepoint|27
240632|NCT01425203|794284|P1|Treatment Phase|Failure at futility timepoint|8
240633|NCT01425203|794282|P3|Treatment Phase|DC during PR Lead-in Phase|0
240634|NCT01425203|794283|P2|Treatment Phase|DC during PR Lead-in Phase|1
240635|NCT01425203|794284|P1|Treatment Phase|DC during PR Lead-in Phase|3
240636|NCT01425190|794301|P3|Overall Study|Full dose not consumed.|0
240637|NCT01425190|794302|P2|Overall Study|Full dose not consumed.|0
240638|NCT01425190|794303|P1|Overall Study|Full dose not consumed.|1
240639|NCT01424930|794339|P2|Overall Study|Reason not specified|6
240640|NCT01424930|794340|P1|Overall Study|Reason not specified|0
240641|NCT01424930|794339|P2|Overall Study|Screen Failure|1
240642|NCT01424930|794340|P1|Overall Study|Screen Failure|0
240643|NCT01424930|794339|P2|Overall Study|Progressive Disease|6
240644|NCT01424930|794340|P1|Overall Study|Progressive Disease|3
240645|NCT01424930|794339|P2|Overall Study|Death|0
240646|NCT01424930|794340|P1|Overall Study|Death|1
240647|NCT01424930|794339|P2|Overall Study|Adverse Event|1
240648|NCT01424930|794340|P1|Overall Study|Adverse Event|0
240649|NCT01424813|794354|P2|Overall Study|not specified|2
240650|NCT01424813|794355|P1|Overall Study|not specified|1
240651|NCT01424813|794354|P2|Overall Study|Protocol Violation|0
240652|NCT01424813|794355|P1|Overall Study|Protocol Violation|1
240653|NCT01424813|794354|P2|Overall Study|Withdrawal by Subject|0
240654|NCT01424813|794355|P1|Overall Study|Withdrawal by Subject|3
240655|NCT01424644|794375|P2|Overall Study|Unable to Classify|0
240656|NCT01424644|794376|P1|Overall Study|Unable to Classify|1
240657|NCT01424644|794375|P2|Overall Study|Administrative Reason|0
240658|NCT01424644|794376|P1|Overall Study|Administrative Reason|1
240659|NCT01424644|794375|P2|Overall Study|Protocol Violation|3
240660|NCT01424644|794376|P1|Overall Study|Protocol Violation|4
240661|NCT01424644|794375|P2|Overall Study|Lost to Follow-up|12
240662|NCT01424644|794376|P1|Overall Study|Lost to Follow-up|16
240663|NCT01424644|794375|P2|Overall Study|Withdrawal by Subject|12
240664|NCT01424644|794376|P1|Overall Study|Withdrawal by Subject|9
240665|NCT01424644|794375|P2|Overall Study|Adverse Event|0
240666|NCT01424644|794376|P1|Overall Study|Adverse Event|2
240667|NCT01424501|794396|P6|Overall Study|Lost to Follow-up|0
240668|NCT01424501|794397|P5|Overall Study|Lost to Follow-up|0
240669|NCT01424501|794398|P4|Overall Study|Lost to Follow-up|0
240670|NCT01424501|794399|P3|Overall Study|Lost to Follow-up|1
240671|NCT01424501|794400|P2|Overall Study|Lost to Follow-up|0
240672|NCT01424501|794401|P1|Overall Study|Lost to Follow-up|0
240673|NCT01424501|794396|P6|Overall Study|Withdrawal by Subject|0
240674|NCT01424501|794397|P5|Overall Study|Withdrawal by Subject|0
240675|NCT01424501|794398|P4|Overall Study|Withdrawal by Subject|0
240676|NCT01424501|794399|P3|Overall Study|Withdrawal by Subject|1
240677|NCT01424501|794400|P2|Overall Study|Withdrawal by Subject|1
240678|NCT01424501|794401|P1|Overall Study|Withdrawal by Subject|1
240679|NCT01424228|794567|P2|Overall Study|Unplanned journey|1
240680|NCT01424228|794568|P1|Overall Study|Unplanned journey|0
240681|NCT01424228|794567|P2|Overall Study|Worsening of symptoms|0
240682|NCT01424228|794568|P1|Overall Study|Worsening of symptoms|1
240683|NCT01424228|794567|P2|Overall Study|Non-compliance|0
240684|NCT01424228|794568|P1|Overall Study|Non-compliance|2
240685|NCT01424228|794567|P2|Overall Study|inclusion/exclusion criteria not met|2
240686|NCT01424228|794568|P1|Overall Study|inclusion/exclusion criteria not met|2
240687|NCT01424228|794567|P2|Overall Study|Lack of Efficacy|7
240688|NCT01424228|794568|P1|Overall Study|Lack of Efficacy|5
240689|NCT01424228|794567|P2|Overall Study|Sponsor's decision|12
240690|NCT01424228|794568|P1|Overall Study|Sponsor's decision|9
240691|NCT01424228|794567|P2|Overall Study|Adverse Event|14
240692|NCT01424228|794568|P1|Overall Study|Adverse Event|10
240693|NCT01424228|794567|P2|Overall Study|Withdrawal by Subject|11
240694|NCT01424228|794568|P1|Overall Study|Withdrawal by Subject|27
240695|NCT01424189|794608|P2|Overall Study|Death|1
240696|NCT01424189|794609|P1|Overall Study|Death|3
240697|NCT01424189|794608|P2|Overall Study|Subject moved|0
240698|NCT01424189|794609|P1|Overall Study|Subject moved|1
240699|NCT01424189|794608|P2|Overall Study|Withdrawal by Subject|4
240700|NCT01424189|794609|P1|Overall Study|Withdrawal by Subject|4
240701|NCT01424189|794608|P2|Overall Study|Lost to Follow-up|1
240702|NCT01424189|794609|P1|Overall Study|Lost to Follow-up|4
240703|NCT01424189|794608|P2|Overall Study|Adverse Event|0
240704|NCT01424189|794609|P1|Overall Study|Adverse Event|1
240705|NCT01423916|794650|P3|Overall Study|Protocol Deviation|0
240706|NCT01423916|794651|P2|Overall Study|Protocol Deviation|0
240707|NCT01423916|794652|P1|Overall Study|Protocol Deviation|1
240708|NCT01423916|794650|P3|Overall Study|Withdrawal by Subject|3
240709|NCT01423916|794651|P2|Overall Study|Withdrawal by Subject|10
240710|NCT01423916|794652|P1|Overall Study|Withdrawal by Subject|3
240711|NCT01423916|794650|P3|Overall Study|Physician Decision|1
240712|NCT01423916|794651|P2|Overall Study|Physician Decision|0
240713|NCT01423916|794652|P1|Overall Study|Physician Decision|1
240714|NCT01423916|794650|P3|Overall Study|Met Withdrawal Criteria|1
240715|NCT01423916|794651|P2|Overall Study|Met Withdrawal Criteria|1
240716|NCT01423916|794652|P1|Overall Study|Met Withdrawal Criteria|1
240717|NCT01423916|794650|P3|Overall Study|Adverse Event|2
240718|NCT01423916|794651|P2|Overall Study|Adverse Event|9
240719|NCT01423916|794652|P1|Overall Study|Adverse Event|5
240720|NCT01423617|794726|P2|Overall Study|Lost to Follow-up|1
240721|NCT01423617|794727|P1|Overall Study|Lost to Follow-up|0
240722|NCT01423604|794744|P2|Randomized|Patient decision|9
240723|NCT01423604|794745|P1|Randomized|Patient decision|5
240724|NCT01423604|794744|P2|Randomized|Other - unspecified|31
240725|NCT01423604|794745|P1|Randomized|Other - unspecified|37
240726|NCT01423604|794744|P2|Randomized|Physician Decision|13
240727|NCT01423604|794745|P1|Randomized|Physician Decision|16
240728|NCT01423604|794744|P2|Randomized|Death|0
240729|NCT01423604|794745|P1|Randomized|Death|1
240730|NCT01423604|794744|P2|Randomized|Adverse Event|10
240731|NCT01423604|794745|P1|Randomized|Adverse Event|4
240732|NCT01423604|794744|P2|Safety Run-In|Patient decision|0
240733|NCT01423604|794745|P1|Safety Run-In|Patient decision|1
240734|NCT01423604|794744|P2|Safety Run-In|Disease progression|0
240735|NCT01423604|794745|P1|Safety Run-In|Disease progression|3
240736|NCT01423604|794744|P2|Safety Run-In|Physician Decision|0
240737|NCT01423604|794745|P1|Safety Run-In|Physician Decision|1
240738|NCT01423604|794744|P2|Safety Run-In|Death|0
240739|NCT01423604|794745|P1|Safety Run-In|Death|1
240740|NCT01423604|794744|P2|Safety Run-In|Adverse Event|0
240741|NCT01423604|794745|P1|Safety Run-In|Adverse Event|3
240742|NCT01423253|794760|P1|Overall Study|Withdrawal by Subject|2
240743|NCT01423253|794760|P1|Overall Study|Protocol Violation|2
240744|NCT01423253|794760|P1|Overall Study|Lost to Follow-up|1
240745|NCT01423253|794760|P1|Overall Study|Lack of Efficacy|2
240746|NCT01423253|794760|P1|Overall Study|Adverse Event|2
240747|NCT01423084|794782|P2|Overall Study|Withdrawal by Subject|3
240748|NCT01423084|794783|P1|Overall Study|Withdrawal by Subject|2
240749|NCT01423084|794782|P2|Overall Study|Adverse Event|1
240750|NCT01423084|794783|P1|Overall Study|Adverse Event|0
240751|NCT01422915|794813|P1|Overall Study|Adverse Event|1
240752|NCT01422889|794818|P1|Overall Study|No Data Entered for Study Stent|9
240753|NCT01422876|794833|P10|Week 52|Death|0
240754|NCT01422876|794834|P9|Week 52|Death|1
240755|NCT01422876|794835|P8|Week 52|Death|3
240756|NCT01422876|794836|P7|Week 52|Death|1
240757|NCT01422876|794837|P6|Week 52|Death|0
240758|NCT01422876|794838|P5|Week 52|Death|0
240759|NCT01422876|794839|P4|Week 52|Death|1
240760|NCT01422876|794840|P3|Week 52|Death|0
240761|NCT01422876|794841|P2|Week 52|Death|1
240762|NCT01422876|794842|P1|Week 52|Death|0
240763|NCT01422876|794833|P10|Week 52|Consent withdrawn|9
240764|NCT01422876|794834|P9|Week 52|Consent withdrawn|13
240765|NCT01422876|794835|P8|Week 52|Consent withdrawn|12
240766|NCT01422876|794836|P7|Week 52|Consent withdrawn|10
240767|NCT01422876|794837|P6|Week 52|Consent withdrawn|12
240768|NCT01422876|794838|P5|Week 52|Consent withdrawn|7
240769|NCT01422876|794839|P4|Week 52|Consent withdrawn|12
240770|NCT01422876|794840|P3|Week 52|Consent withdrawn|6
240771|NCT01422876|794841|P2|Week 52|Consent withdrawn|4
240772|NCT01422876|794842|P1|Week 52|Consent withdrawn|9
240773|NCT01422876|794833|P10|Week 52|Lost to Follow-up|8
240774|NCT01422876|794834|P9|Week 52|Lost to Follow-up|7
240775|NCT01422876|794835|P8|Week 52|Lost to Follow-up|8
240776|NCT01422876|794836|P7|Week 52|Lost to Follow-up|5
240777|NCT01422876|794837|P6|Week 52|Lost to Follow-up|5
240778|NCT01422876|794838|P5|Week 52|Lost to Follow-up|8
240779|NCT01422876|794839|P4|Week 52|Lost to Follow-up|5
240780|NCT01422876|794840|P3|Week 52|Lost to Follow-up|7
240781|NCT01422876|794841|P2|Week 52|Lost to Follow-up|5
240782|NCT01422876|794842|P1|Week 52|Lost to Follow-up|3
240783|NCT01422876|794833|P10|Week 24|Death|0
240784|NCT01422876|794834|P9|Week 24|Death|0
240785|NCT01422876|794835|P8|Week 24|Death|0
240786|NCT01422876|794836|P7|Week 24|Death|0
240787|NCT01422876|794837|P6|Week 24|Death|0
240788|NCT01422876|794838|P5|Week 24|Death|0
240789|NCT01422876|794839|P4|Week 24|Death|0
240790|NCT01422876|794840|P3|Week 24|Death|0
240791|NCT01422876|794841|P2|Week 24|Death|1
240792|NCT01422876|794842|P1|Week 24|Death|0
240793|NCT01422876|794833|P10|Week 24|Consent withdrawn|6
240794|NCT01422876|794834|P9|Week 24|Consent withdrawn|3
240795|NCT01422876|794835|P8|Week 24|Consent withdrawn|4
240796|NCT01422876|794836|P7|Week 24|Consent withdrawn|5
240797|NCT01422876|794837|P6|Week 24|Consent withdrawn|6
240798|NCT01422876|794838|P5|Week 24|Consent withdrawn|5
240799|NCT01422876|794839|P4|Week 24|Consent withdrawn|4
240800|NCT01422876|794840|P3|Week 24|Consent withdrawn|3
240801|NCT01422876|794841|P2|Week 24|Consent withdrawn|1
240802|NCT01422876|794842|P1|Week 24|Consent withdrawn|5
240803|NCT01422876|794833|P10|Week 24|Lost to Follow-up|4
240804|NCT01422876|794834|P9|Week 24|Lost to Follow-up|3
240805|NCT01422876|794835|P8|Week 24|Lost to Follow-up|3
240806|NCT01422876|794836|P7|Week 24|Lost to Follow-up|1
240807|NCT01422876|794837|P6|Week 24|Lost to Follow-up|0
240808|NCT01422876|794838|P5|Week 24|Lost to Follow-up|2
240809|NCT01422876|794839|P4|Week 24|Lost to Follow-up|4
240810|NCT01422876|794840|P3|Week 24|Lost to Follow-up|2
240811|NCT01422876|794841|P2|Week 24|Lost to Follow-up|1
240812|NCT01422876|794842|P1|Week 24|Lost to Follow-up|1
240813|NCT01422850|794889|P1|Overall Study|Physician Decision|3
240814|NCT01422824|794895|P1|Overall Study|Lost to Follow-up|37
240815|NCT01422824|794895|P1|Overall Study|Case record form not evaluated|1
240816|NCT01422720|794900|P1|Overall Study|Ineligibility|1
240817|NCT01422720|794900|P1|Overall Study|Withdrawal by Subject|4
240818|NCT01422720|794900|P1|Overall Study|Lack of Efficacy|1
240819|NCT01422720|794900|P1|Overall Study|Adverse Event|16
240820|NCT01422538|794911|P3|Overall Study|Missed visit|1
240821|NCT01422538|794912|P2|Overall Study|Missed visit|1
240822|NCT01422538|794913|P1|Overall Study|Missed visit|0
240823|NCT01422538|794911|P3|Overall Study|Lost to Follow-up|1
240824|NCT01422538|794912|P2|Overall Study|Lost to Follow-up|1
240825|NCT01422538|794913|P1|Overall Study|Lost to Follow-up|0
240826|NCT01422382|794957|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
240827|NCT01422304|794973|P2|Overall Study|Not Treated|11
240828|NCT01422304|794974|P1|Overall Study|Not Treated|3
240829|NCT01422304|794973|P2|Overall Study|Did Not Meet Protocol Eligibility|2
240830|NCT01422304|794974|P1|Overall Study|Did Not Meet Protocol Eligibility|0
240831|NCT01422304|794973|P2|Overall Study|Withdrawal by Subject|2
240832|NCT01422304|794974|P1|Overall Study|Withdrawal by Subject|4
240833|NCT01422304|794973|P2|Overall Study|Protocol Violation|0
240834|NCT01422304|794974|P1|Overall Study|Protocol Violation|1
240835|NCT01422304|794973|P2|Overall Study|Never Entered Follow-up|1
240836|NCT01422304|794974|P1|Overall Study|Never Entered Follow-up|2
240837|NCT01422304|794973|P2|Overall Study|Lost to Follow-up|20
240838|NCT01422304|794974|P1|Overall Study|Lost to Follow-up|14
240839|NCT01422304|794973|P2|Overall Study|Adverse Event|1
240840|NCT01422304|794974|P1|Overall Study|Adverse Event|0
240841|NCT01422239|795006|P2|Overall Study|Lost to Follow-up|3
240842|NCT01422239|795007|P1|Overall Study|Lost to Follow-up|4
240843|NCT01422213|795029|P3|Overall Study|Administrative or Other Reason(s)|2
240844|NCT01422213|795030|P2|Overall Study|Administrative or Other Reason(s)|4
240845|NCT01422213|795031|P1|Overall Study|Administrative or Other Reason(s)|5
240846|NCT01422213|795029|P3|Overall Study|Lost to Follow-up|5
240847|NCT01422213|795030|P2|Overall Study|Lost to Follow-up|3
240848|NCT01422213|795031|P1|Overall Study|Lost to Follow-up|3
240849|NCT01422213|795029|P3|Overall Study|Withdrawal of Consent|5
240850|NCT01422213|795030|P2|Overall Study|Withdrawal of Consent|3
240851|NCT01422213|795031|P1|Overall Study|Withdrawal of Consent|7
240852|NCT01422213|795029|P3|Overall Study|Protocol Violation|4
240853|NCT01422213|795030|P2|Overall Study|Protocol Violation|2
240854|NCT01422213|795031|P1|Overall Study|Protocol Violation|0
240855|NCT01422213|795029|P3|Overall Study|Non-compliance with study drug|0
240856|NCT01422213|795030|P2|Overall Study|Non-compliance with study drug|1
240857|NCT01422213|795031|P1|Overall Study|Non-compliance with study drug|0
240858|NCT01422213|795029|P3|Overall Study|Lack of Efficacy|2
240859|NCT01422213|795030|P2|Overall Study|Lack of Efficacy|2
240860|NCT01422213|795031|P1|Overall Study|Lack of Efficacy|10
240861|NCT01422213|795029|P3|Overall Study|Adverse Event|11
240862|NCT01422213|795030|P2|Overall Study|Adverse Event|7
240863|NCT01422213|795031|P1|Overall Study|Adverse Event|8
240864|NCT01422187|795092|P3|Overall Study|Lost to Follow-up|0
240865|NCT01422187|795093|P2|Overall Study|Lost to Follow-up|1
240866|NCT01422187|795094|P1|Overall Study|Lost to Follow-up|0
240867|NCT01422187|795092|P3|Overall Study|Personal reason|0
240868|NCT01422187|795093|P2|Overall Study|Personal reason|0
240869|NCT01422187|795094|P1|Overall Study|Personal reason|1
240870|NCT01421719|795125|P1|Overall Study|Withdrawal by Subject|4
240871|NCT01421667|795134|P4|Overall Study|Lost to Follow-up|0
240872|NCT01421667|795135|P3|Overall Study|Lost to Follow-up|0
240873|NCT01421667|795136|P2|Overall Study|Lost to Follow-up|1
240874|NCT01421667|795137|P1|Overall Study|Lost to Follow-up|0
240875|NCT01421667|795134|P4|Overall Study|Withdrawal by Subject|1
240876|NCT01421667|795135|P3|Overall Study|Withdrawal by Subject|2
240877|NCT01421667|795136|P2|Overall Study|Withdrawal by Subject|1
240878|NCT01421667|795137|P1|Overall Study|Withdrawal by Subject|0
240879|NCT01421641|795198|P2|Overall Study|Protocol Violation|2
240880|NCT01421641|795199|P1|Overall Study|Protocol Violation|2
240881|NCT01421511|795221|P2|Overall Study|Death|1
240882|NCT01421511|795222|P1|Overall Study|Death|1
240883|NCT01421511|795221|P2|Overall Study|Withdrawal by Subject|5
240884|NCT01421511|795222|P1|Overall Study|Withdrawal by Subject|6
240885|NCT01421511|795221|P2|Overall Study|Physician Decision|1
240886|NCT01421511|795222|P1|Overall Study|Physician Decision|0
240887|NCT01421511|795221|P2|Overall Study|Randomized but didn't receive study drug|7
240888|NCT01421511|795222|P1|Overall Study|Randomized but didn't receive study drug|1
240889|NCT01421511|795221|P2|Overall Study|Lost to Follow-up|14
240890|NCT01421511|795222|P1|Overall Study|Lost to Follow-up|11
240891|NCT01421459|795272|P2|Overall Study|Withdrawal by Subject|16
240892|NCT01421459|795273|P1|Overall Study|Withdrawal by Subject|12
240893|NCT01421459|795272|P2|Overall Study|Protocol Violation|5
240894|NCT01421459|795273|P1|Overall Study|Protocol Violation|8
240895|NCT01421459|795272|P2|Overall Study|Physician Decision|9
240896|NCT01421459|795273|P1|Overall Study|Physician Decision|9
240897|NCT01421459|795272|P2|Overall Study|Lost to Follow-up|9
240898|NCT01421459|795273|P1|Overall Study|Lost to Follow-up|8
240899|NCT01421459|795272|P2|Overall Study|Lack of Efficacy|2
240900|NCT01421459|795273|P1|Overall Study|Lack of Efficacy|1
240901|NCT01421459|795272|P2|Overall Study|Death|1
240902|NCT01421459|795273|P1|Overall Study|Death|1
240903|NCT01421459|795272|P2|Overall Study|Adverse Event|10
240904|NCT01421459|795273|P1|Overall Study|Adverse Event|6
240905|NCT01421303|795311|P1|Overall Study|Withdrawal by Subject|1
240906|NCT01421303|795311|P1|Overall Study|Unspecified|7
240907|NCT01421303|795311|P1|Overall Study|Non compliance with study procedure|1
240908|NCT01421303|795311|P1|Overall Study|Lost to Follow-up|13
240909|NCT01421277|795338|P2|Overall Study|Incomplete baseline data|31
240910|NCT01421277|795339|P1|Overall Study|Incomplete baseline data|0
240911|NCT01421277|795338|P2|Overall Study|Lack of qualifying event|61
240912|NCT01421277|795339|P1|Overall Study|Lack of qualifying event|0
240913|NCT01421147|795351|P2|Extension Period|Withdrawal by Subject|3
240914|NCT01421147|795352|P1|Extension Period|Withdrawal by Subject|5
240915|NCT01421147|795351|P2|Extension Period|Physician Decision|0
240916|NCT01421147|795352|P1|Extension Period|Physician Decision|1
240917|NCT01421147|795351|P2|Extension Period|Lost to Follow-up|5
240918|NCT01421147|795352|P1|Extension Period|Lost to Follow-up|2
240919|NCT01421147|795351|P2|Extension Period|Death|1
240920|NCT01421147|795352|P1|Extension Period|Death|0
240921|NCT01421147|795351|P2|Extension Period|Adverse Event|2
240922|NCT01421147|795352|P1|Extension Period|Adverse Event|0
240923|NCT01421147|795351|P2|Treatment Period|Withdrawal by Subject|5
240924|NCT01421147|795352|P1|Treatment Period|Withdrawal by Subject|10
240925|NCT01421147|795351|P2|Treatment Period|Physician Decision|2
240926|NCT01421147|795352|P1|Treatment Period|Physician Decision|2
240927|NCT01421147|795351|P2|Treatment Period|Lost to Follow-up|1
240928|NCT01421147|795352|P1|Treatment Period|Lost to Follow-up|2
240929|NCT01421147|795351|P2|Treatment Period|Adverse Event|3
240930|NCT01421147|795352|P1|Treatment Period|Adverse Event|2
240931|NCT01421134|795384|P2|Overall Study|Lost to Follow-up|1
240932|NCT01421134|795385|P1|Overall Study|Lost to Follow-up|1
240933|NCT01421134|795384|P2|Overall Study|Administrative|1
240934|NCT01421134|795385|P1|Overall Study|Administrative|0
240935|NCT01421134|795384|P2|Overall Study|Withdrawal by Subject|1
240936|NCT01421134|795385|P1|Overall Study|Withdrawal by Subject|1
240937|NCT01421134|795384|P2|Overall Study|Protocol Violation|3
240938|NCT01421134|795385|P1|Overall Study|Protocol Violation|0
240939|NCT01421134|795384|P2|Overall Study|Lack of Efficacy|4
240940|NCT01421134|795385|P1|Overall Study|Lack of Efficacy|2
240941|NCT01421134|795384|P2|Overall Study|Adverse Event|5
240942|NCT01421134|795385|P1|Overall Study|Adverse Event|3
240943|NCT01420926|795405|P2|Overall Study|Continues on active treatment|3
240944|NCT01420926|795406|P1|Overall Study|Continues on active treatment|1
240945|NCT01420926|795405|P2|Overall Study|Physician Decision|5
240946|NCT01420926|795406|P1|Overall Study|Physician Decision|7
240947|NCT01420926|795405|P2|Overall Study|Non-protocol treatment|20
240948|NCT01420926|795406|P1|Overall Study|Non-protocol treatment|17
240949|NCT01420926|795405|P2|Overall Study|Withdrawal by Subject|16
240950|NCT01420926|795406|P1|Overall Study|Withdrawal by Subject|11
240951|NCT01420926|795405|P2|Overall Study|Death|17
240952|NCT01420926|795406|P1|Overall Study|Death|18
240953|NCT01420926|795405|P2|Overall Study|Adverse Event|4
240954|NCT01420926|795406|P1|Overall Study|Adverse Event|6
240955|NCT01420081|795464|P9|Overall Study|Ongoing at data cut off|0
240956|NCT01420081|795465|P8|Overall Study|Ongoing at data cut off|0
240957|NCT01420081|795466|P7|Overall Study|Ongoing at data cut off|0
240958|NCT01420081|795467|P6|Overall Study|Ongoing at data cut off|1
240959|NCT01420081|795468|P5|Overall Study|Ongoing at data cut off|2
240960|NCT01420081|795469|P4|Overall Study|Ongoing at data cut off|0
240961|NCT01420081|795470|P3|Overall Study|Ongoing at data cut off|0
240962|NCT01420081|795471|P2|Overall Study|Ongoing at data cut off|0
240963|NCT01420081|795472|P1|Overall Study|Ongoing at data cut off|0
240964|NCT01420081|795464|P9|Overall Study|Other Reasons|0
240965|NCT01420081|795465|P8|Overall Study|Other Reasons|0
240966|NCT01420081|795466|P7|Overall Study|Other Reasons|0
240967|NCT01420081|795467|P6|Overall Study|Other Reasons|0
240968|NCT01420081|795468|P5|Overall Study|Other Reasons|0
240969|NCT01420081|795469|P4|Overall Study|Other Reasons|0
240970|NCT01420081|795470|P3|Overall Study|Other Reasons|1
240971|NCT01420081|795471|P2|Overall Study|Other Reasons|0
240972|NCT01420081|795472|P1|Overall Study|Other Reasons|0
240973|NCT01420081|795464|P9|Overall Study|Subject Refused Futher Follow-up|0
240974|NCT01420081|795465|P8|Overall Study|Subject Refused Futher Follow-up|0
240975|NCT01420081|795466|P7|Overall Study|Subject Refused Futher Follow-up|0
240976|NCT01420081|795467|P6|Overall Study|Subject Refused Futher Follow-up|0
240977|NCT01420081|795468|P5|Overall Study|Subject Refused Futher Follow-up|1
240978|NCT01420081|795469|P4|Overall Study|Subject Refused Futher Follow-up|0
240979|NCT01420081|795470|P3|Overall Study|Subject Refused Futher Follow-up|1
240980|NCT01420081|795471|P2|Overall Study|Subject Refused Futher Follow-up|0
240981|NCT01420081|795472|P1|Overall Study|Subject Refused Futher Follow-up|0
240982|NCT01420081|795464|P9|Overall Study|Study Terminated by Sponsor|2
240983|NCT01420081|795465|P8|Overall Study|Study Terminated by Sponsor|2
240984|NCT01420081|795466|P7|Overall Study|Study Terminated by Sponsor|3
240985|NCT01420081|795467|P6|Overall Study|Study Terminated by Sponsor|6
240986|NCT01420081|795468|P5|Overall Study|Study Terminated by Sponsor|9
240987|NCT01420081|795469|P4|Overall Study|Study Terminated by Sponsor|3
240988|NCT01420081|795470|P3|Overall Study|Study Terminated by Sponsor|1
240989|NCT01420081|795471|P2|Overall Study|Study Terminated by Sponsor|1
240990|NCT01420081|795472|P1|Overall Study|Study Terminated by Sponsor|2
240991|NCT01420081|795464|P9|Overall Study|Lost to Follow-up|0
240992|NCT01420081|795465|P8|Overall Study|Lost to Follow-up|0
240993|NCT01420081|795466|P7|Overall Study|Lost to Follow-up|0
240994|NCT01420081|795467|P6|Overall Study|Lost to Follow-up|1
240995|NCT01420081|795468|P5|Overall Study|Lost to Follow-up|1
240996|NCT01420081|795469|P4|Overall Study|Lost to Follow-up|0
240997|NCT01420081|795470|P3|Overall Study|Lost to Follow-up|0
240998|NCT01420081|795471|P2|Overall Study|Lost to Follow-up|0
240999|NCT01420081|795472|P1|Overall Study|Lost to Follow-up|0
241000|NCT01420081|795464|P9|Overall Study|Death|1
241001|NCT01420081|795465|P8|Overall Study|Death|1
241002|NCT01420081|795466|P7|Overall Study|Death|0
241003|NCT01420081|795467|P6|Overall Study|Death|12
241004|NCT01420081|795468|P5|Overall Study|Death|7
241005|NCT01420081|795469|P4|Overall Study|Death|0
241006|NCT01420081|795470|P3|Overall Study|Death|8
241007|NCT01420081|795471|P2|Overall Study|Death|0
241008|NCT01420081|795472|P1|Overall Study|Death|1
241009|NCT01419769|795544|P1|Overall Study|Not evaluable due to pigtail stents|1
241010|NCT01419769|795544|P1|Overall Study|Did not receive the AXIOS stent|3
241011|NCT01419314|795565|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
241012|NCT01419314|795566|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
241013|NCT01419314|795565|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
241014|NCT01419314|795566|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
241015|NCT01419314|795565|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
241016|NCT01419314|795566|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
241017|NCT01419236|795603|P2|Overall Study|Entry Criteria Not Met|0
241018|NCT01419236|795604|P1|Overall Study|Entry Criteria Not Met|1
241019|NCT01419236|795603|P2|Overall Study|Withdrawal by Subject|4
241020|NCT01419236|795604|P1|Overall Study|Withdrawal by Subject|1
241021|NCT01419236|795603|P2|Overall Study|Physician Decision|0
241022|NCT01419236|795604|P1|Overall Study|Physician Decision|1
241023|NCT01419236|795603|P2|Overall Study|Lost to Follow-up|0
241024|NCT01419236|795604|P1|Overall Study|Lost to Follow-up|1
241025|NCT01419236|795603|P2|Overall Study|Lack of Efficacy|1
241026|NCT01419236|795604|P1|Overall Study|Lack of Efficacy|0
241027|NCT01419236|795603|P2|Overall Study|Adverse Event|0
241028|NCT01419236|795604|P1|Overall Study|Adverse Event|1
241029|NCT01419197|795628|P2|Overall Study|Lost to Follow-up|4
241030|NCT01419197|795629|P1|Overall Study|Lost to Follow-up|14
241031|NCT01419197|795628|P2|Overall Study|Reason Not Specified|1
241032|NCT01419197|795629|P1|Overall Study|Reason Not Specified|0
241033|NCT01419197|795628|P2|Overall Study|Study Completed by Sponsor|34
241034|NCT01419197|795629|P1|Overall Study|Study Completed by Sponsor|103
241035|NCT01419197|795628|P2|Overall Study|Withdrawal by Subject|32
241036|NCT01419197|795629|P1|Overall Study|Withdrawal by Subject|33
241037|NCT01419197|795628|P2|Overall Study|Non-compliance|1
241038|NCT01419197|795629|P1|Overall Study|Non-compliance|3
241039|NCT01419197|795628|P2|Overall Study|Physician Decision|4
241040|NCT01419197|795629|P1|Overall Study|Physician Decision|4
241041|NCT01419197|795628|P2|Overall Study|Death|122
241042|NCT01419197|795629|P1|Overall Study|Death|247
241043|NCT01419184|795654|P2|Overall Study|Participant randomized, not treated|0
241044|NCT01419184|795655|P1|Overall Study|Participant randomized, not treated|1
241045|NCT01419184|795654|P2|Overall Study|No IRLOS-No adverse event treatment date|1
241046|NCT01419184|795655|P1|Overall Study|No IRLOS-No adverse event treatment date|0
241047|NCT01419184|795654|P2|Overall Study|No IRLOS-non trial antibiotic used|2
241048|NCT01419184|795655|P1|Overall Study|No IRLOS-non trial antibiotic used|1
241049|NCT01419184|795654|P2|Overall Study|No IRLOS-randomized, not treated|4
241050|NCT01419184|795655|P1|Overall Study|No IRLOS-randomized, not treated|2
241051|NCT01419184|795654|P2|Overall Study|No IRLOS-No in-patient end date reported|6
241052|NCT01419184|795655|P1|Overall Study|No IRLOS-No in-patient end date reported|3
241053|NCT01419184|795654|P2|Overall Study|Site data not available|2
241054|NCT01419184|795655|P1|Overall Study|Site data not available|3
241055|NCT01418937|795693|P1|Overall Study|Withdrawal by Subject|1
241056|NCT01418937|795693|P1|Overall Study|Pregnancy|1
241057|NCT01418937|795693|P1|Overall Study|Protocol Violation|1
241058|NCT01418937|795693|P1|Overall Study|Lost to Follow-up|5
241059|NCT01418365|795724|P2|Second Intervention|Withdrawal by Subject|1
241060|NCT01418365|795725|P1|Second Intervention|Withdrawal by Subject|0
241061|NCT01418365|795724|P2|First Intervention|Non-compliance|0
241062|NCT01418365|795725|P1|First Intervention|Non-compliance|1
241063|NCT01418365|795724|P2|First Intervention|Withdrawal by Subject|1
241064|NCT01418365|795725|P1|First Intervention|Withdrawal by Subject|0
241065|NCT01418209|795736|P3|Overall Study|Did not provide hot flash diary data|3
241066|NCT01418209|795737|P2|Overall Study|Did not provide hot flash diary data|3
241067|NCT01418209|795738|P1|Overall Study|Did not provide hot flash diary data|1
241068|NCT01418209|795736|P3|Overall Study|Withdrawal by Subject|1
241069|NCT01418209|795737|P2|Overall Study|Withdrawal by Subject|0
241070|NCT01418209|795738|P1|Overall Study|Withdrawal by Subject|1
241071|NCT01417481|795792|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
241072|NCT01417481|795793|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
241073|NCT01417377|795858|P1|Overall Study|Enrolled, but not treated|1
241074|NCT01417377|795858|P1|Overall Study|Lost to Follow-up|12
241075|NCT01417195|795867|P2|Overall Study|No transfer due to elevated progesterone|0
241076|NCT01417195|795868|P1|Overall Study|No transfer due to elevated progesterone|1
241077|NCT01417195|795867|P2|Overall Study|No transfer due to risk of OHSS|0
241078|NCT01417195|795868|P1|Overall Study|No transfer due to risk of OHSS|1
241079|NCT01417195|795867|P2|Overall Study|No embryos for transfer|1
241080|NCT01417195|795868|P1|Overall Study|No embryos for transfer|0
241081|NCT01417195|795867|P2|Overall Study|Stimulation failure|0
241082|NCT01417195|795868|P1|Overall Study|Stimulation failure|1
241083|NCT01417156|795884|P1|Overall Study|Protocol Violation|2
241084|NCT01417156|795884|P1|Overall Study|Adverse Event|12
241085|NCT01417104|795894|P2|Overall Study|Adverse Event|0
241086|NCT01417104|795895|P1|Overall Study|Adverse Event|1
241087|NCT01417104|795894|P2|Overall Study|Failure to make contact|1
241088|NCT01417104|795895|P1|Overall Study|Failure to make contact|0
241089|NCT01417104|795894|P2|Overall Study|Withdrawal by Subject|1
241090|NCT01417104|795895|P1|Overall Study|Withdrawal by Subject|5
241091|NCT01417078|795905|P1|Overall Study|Withdrawal by Subject|1
241092|NCT01416610|795928|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
241093|NCT01416610|795928|P1|Overall Study|Lost to Follow-up|7
241094|NCT01416610|795928|P1|Overall Study|Withdrawal by Subject|13
241095|NCT01416610|795928|P1|Overall Study|No reason given|5
241096|NCT01416610|795928|P1|Overall Study|Lack of Efficacy|4
241097|NCT01416610|795928|P1|Overall Study|Adverse Event -Patient decision|3
241098|NCT01416610|795928|P1|Overall Study|Adverse Event|4
241099|NCT01416571|795942|P1|Overall Study|Lost to Follow-up|2
241100|NCT01416272|795969|P1|Overall Study|Study related complaints|1
241101|NCT01416272|795969|P1|Overall Study|Lost to Follow-up|1
241102|NCT01416272|795969|P1|Overall Study|Unacceptable distance visual acuity|2
241103|NCT01416155|795975|P1|Overall Study|Not specified|7
241104|NCT01416155|795975|P1|Overall Study|Investigator decision|8
241105|NCT01416155|795975|P1|Overall Study|Withdrawal by Subject|33
241106|NCT01416155|795975|P1|Overall Study|Positive for anti-BG00002 antibodies|2
241107|NCT01416155|795975|P1|Overall Study|Adverse Event|8
241108|NCT01416142|795982|P3|PureVision2 HD|Inability to maintain lens wear|1
241109|NCT01416142|795983|P2|PureVision2 HD|Inability to maintain lens wear|0
241110|NCT01416142|795984|P1|PureVision2 HD|Inability to maintain lens wear|0
241111|NCT01415986|796011|P1|Overall Study|Lost to Follow-up|1
241112|NCT01415921|796028|P2|Overall Study|Other|0
241113|NCT01415921|796029|P1|Overall Study|Other|2
241114|NCT01415921|796028|P2|Overall Study|Withdrawal by Subject|1
241115|NCT01415921|796029|P1|Overall Study|Withdrawal by Subject|0
241116|NCT01415921|796028|P2|Overall Study|Physician Decision|1
241117|NCT01415921|796029|P1|Overall Study|Physician Decision|1
241118|NCT01415921|796028|P2|Overall Study|Adverse Event|1
241119|NCT01415921|796029|P1|Overall Study|Adverse Event|0
241120|NCT01415908|796039|P2|Overall Study|Withdrawal by Subject|0
241121|NCT01415908|796040|P1|Overall Study|Withdrawal by Subject|1
241122|NCT01415531|796068|P2|Overall Study|Other Reasons|2
241123|NCT01415531|796069|P1|Overall Study|Other Reasons|3
241124|NCT01415531|796068|P2|Overall Study|Lack of Compliance|4
241125|NCT01415531|796069|P1|Overall Study|Lack of Compliance|1
241126|NCT01415531|796068|P2|Overall Study|Lost to Follow-up|14
241127|NCT01415531|796069|P1|Overall Study|Lost to Follow-up|6
241128|NCT01415531|796068|P2|Overall Study|Withdrawal by Subject|4
241129|NCT01415531|796069|P1|Overall Study|Withdrawal by Subject|5
241130|NCT01415531|796068|P2|Overall Study|Protocol Violation|1
241131|NCT01415531|796069|P1|Overall Study|Protocol Violation|0
241132|NCT01415531|796068|P2|Overall Study|Lack of Efficacy|2
241133|NCT01415531|796069|P1|Overall Study|Lack of Efficacy|3
241134|NCT01415531|796068|P2|Overall Study|Adverse Event|10
241135|NCT01415531|796069|P1|Overall Study|Adverse Event|7
241136|NCT01415518|796079|P2|Overall Study|Condition under Investigation Worsened|1
241137|NCT01415518|796080|P1|Overall Study|Condition under Investigation Worsened|1
241138|NCT01415518|796079|P2|Overall Study|Death|1
241139|NCT01415518|796080|P1|Overall Study|Death|1
241140|NCT01415518|796079|P2|Overall Study|Adverse Event|4
241141|NCT01415518|796080|P1|Overall Study|Adverse Event|3
241142|NCT01415518|796079|P2|Overall Study|Lost to Follow-up|5
241143|NCT01415518|796080|P1|Overall Study|Lost to Follow-up|3
241144|NCT01415518|796079|P2|Overall Study|Protocol Violation|8
241145|NCT01415518|796080|P1|Overall Study|Protocol Violation|6
241146|NCT01415518|796079|P2|Overall Study|Withdrawal by Subject|12
241147|NCT01415518|796080|P1|Overall Study|Withdrawal by Subject|2
241148|NCT01415401|796180|P1|Overall Study|Terminated by Sponsor|1
241149|NCT01415401|796180|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
241150|NCT01415401|796180|P1|Overall Study|Adverse Event|5
241151|NCT01415349|796185|P2|Treatment Period 1|Withdrawal by Subject|1
241152|NCT01415349|796186|P1|Treatment Period 1|Withdrawal by Subject|0
241153|NCT01415349|796185|P2|Treatment Period 1|Adverse Event|1
241154|NCT01415349|796186|P1|Treatment Period 1|Adverse Event|0
241155|NCT01414855|796198|P1|Overall Study|Withdrawal by Subject|1
241156|NCT01414855|796198|P1|Overall Study|Physician Decision|1
241157|NCT01414855|796198|P1|Overall Study|Other Reasons- Unspecified|1
241158|NCT01414855|796198|P1|Overall Study|Disease progression,|2
241159|NCT01414855|796198|P1|Overall Study|Adverse Event|8
241160|NCT01414205|796249|P2|Overall Study|Randomized but not Treated|1
241161|NCT01414205|796250|P1|Overall Study|Randomized but not Treated|1
241162|NCT01414205|796249|P2|Overall Study|Physician Decision|1
241163|NCT01414205|796250|P1|Overall Study|Physician Decision|0
241164|NCT01414205|796249|P2|Overall Study|Lost to Follow-up|4
241165|NCT01414205|796250|P1|Overall Study|Lost to Follow-up|1
241166|NCT01414205|796249|P2|Overall Study|Death|1
241167|NCT01414205|796250|P1|Overall Study|Death|5
241168|NCT01414166|796319|P2|Overall Study|Withdrawal by Subject|5
241169|NCT01414166|796320|P1|Overall Study|Withdrawal by Subject|3
241170|NCT01414166|796319|P2|Overall Study|Study terminated by Sponsor|75
241171|NCT01414166|796320|P1|Overall Study|Study terminated by Sponsor|68
241172|NCT01414166|796319|P2|Overall Study|Protocol Violation|0
241173|NCT01414166|796320|P1|Overall Study|Protocol Violation|2
241174|NCT01414166|796319|P2|Overall Study|Physician Decision|0
241175|NCT01414166|796320|P1|Overall Study|Physician Decision|2
241176|NCT01414166|796319|P2|Overall Study|Non-compliance with study drug|0
241177|NCT01414166|796320|P1|Overall Study|Non-compliance with study drug|2
241178|NCT01414166|796319|P2|Overall Study|Lost to Follow-up|1
241179|NCT01414166|796320|P1|Overall Study|Lost to Follow-up|4
241180|NCT01414166|796319|P2|Overall Study|Adverse Event|2
241181|NCT01414166|796320|P1|Overall Study|Adverse Event|10
241182|NCT01414114|796383|P1|Overall Study|Other|2
241183|NCT01414114|796383|P1|Overall Study|Withdrawal by Subject|1
241184|NCT01414114|796383|P1|Overall Study|Adverse Event|2
241185|NCT01413958|796416|P2|Overall Study|Lost to Follow-up|1
241186|NCT01413958|796417|P1|Overall Study|Lost to Follow-up|0
241187|NCT01413542|796468|P4|Overall Study|Adverse Event|1
241188|NCT01413542|796469|P3|Overall Study|Adverse Event|0
241189|NCT01413542|796470|P2|Overall Study|Adverse Event|0
241190|NCT01413542|796471|P1|Overall Study|Adverse Event|0
241191|NCT01413542|796468|P4|Overall Study|Physician Decision|0
241192|NCT01413542|796469|P3|Overall Study|Physician Decision|3
241193|NCT01413542|796470|P2|Overall Study|Physician Decision|0
241194|NCT01413542|796471|P1|Overall Study|Physician Decision|1
241195|NCT01413360|796493|P1|Overall Study|Adverse Event|1
241196|NCT01413360|796493|P1|Overall Study|Lost to Follow-up|2
241197|NCT01413204|796501|P3|Overall Study|Fasting plasma glucose level increased|10
241198|NCT01413204|796502|P2|Overall Study|Fasting plasma glucose level increased|0
241199|NCT01413204|796503|P1|Overall Study|Fasting plasma glucose level increased|1
241200|NCT01413204|796501|P3|Overall Study|Clearly not eligible for the study|1
241201|NCT01413204|796502|P2|Overall Study|Clearly not eligible for the study|0
241202|NCT01413204|796503|P1|Overall Study|Clearly not eligible for the study|0
241203|NCT01413204|796501|P3|Overall Study|Withdrawal by Subject|4
241204|NCT01413204|796502|P2|Overall Study|Withdrawal by Subject|4
241205|NCT01413204|796503|P1|Overall Study|Withdrawal by Subject|1
241206|NCT01413204|796501|P3|Overall Study|Physician Decision|2
241207|NCT01413204|796502|P2|Overall Study|Physician Decision|0
241208|NCT01413204|796503|P1|Overall Study|Physician Decision|3
241209|NCT01413204|796501|P3|Overall Study|Adverse Event|2
241210|NCT01413204|796502|P2|Overall Study|Adverse Event|2
241211|NCT01413204|796503|P1|Overall Study|Adverse Event|1
241212|NCT01413191|796511|P1|Overall Study|Death|1
241213|NCT01413191|796511|P1|Overall Study|Disease Progression|5
241214|NCT01413191|796511|P1|Overall Study|Lost to Follow-up|5
241215|NCT01412983|796515|P2|1st Period|Inability to maintain wear|1
241216|NCT01412983|796516|P1|1st Period|Inability to maintain wear|0
241217|NCT01412983|796515|P2|1st Period|Unacceptable lens movement|1
241218|NCT01412983|796516|P1|1st Period|Unacceptable lens movement|0
241219|NCT01412983|796515|P2|1st Period|Positive slit lamp finding|1
241220|NCT01412983|796516|P1|1st Period|Positive slit lamp finding|0
241221|NCT01412983|796515|P2|1st Period|Ineligible|1
241222|NCT01412983|796516|P1|1st Period|Ineligible|0
241223|NCT01412957|796526|P2|Overall Study|Death|133
241224|NCT01412957|796527|P1|Overall Study|Death|136
241225|NCT01412957|796526|P2|Overall Study|Lost to Follow-up|2
241226|NCT01412957|796527|P1|Overall Study|Lost to Follow-up|7
241227|NCT01412957|796526|P2|Overall Study|Withdrawal by Subject|22
241228|NCT01412957|796527|P1|Overall Study|Withdrawal by Subject|6
241229|NCT01412944|796549|P6|Entire: IV + Maintenance|Adverse Event|0
241230|NCT01412944|796550|P5|Entire: IV + Maintenance|Adverse Event|0
241231|NCT01412944|796551|P4|Entire: IV + Maintenance|Adverse Event|0
241232|NCT01412944|796552|P3|Entire: IV + Maintenance|Adverse Event|0
241233|NCT01412944|796553|P2|Entire: IV + Maintenance|Adverse Event|1
241234|NCT01412944|796554|P1|Entire: IV + Maintenance|Adverse Event|0
241235|NCT01412944|796549|P6|Entire: IV + Maintenance|Lack of Efficacy|0
241236|NCT01412944|796550|P5|Entire: IV + Maintenance|Lack of Efficacy|0
241237|NCT01412944|796551|P4|Entire: IV + Maintenance|Lack of Efficacy|0
241238|NCT01412944|796552|P3|Entire: IV + Maintenance|Lack of Efficacy|0
241239|NCT01412944|796553|P2|Entire: IV + Maintenance|Lack of Efficacy|1
241240|NCT01412944|796554|P1|Entire: IV + Maintenance|Lack of Efficacy|0
241241|NCT01412944|796549|P6|Entire: IV + Maintenance|Lost to Follow-up|0
241242|NCT01412944|796550|P5|Entire: IV + Maintenance|Lost to Follow-up|0
241243|NCT01412944|796551|P4|Entire: IV + Maintenance|Lost to Follow-up|0
241244|NCT01412944|796552|P3|Entire: IV + Maintenance|Lost to Follow-up|0
241245|NCT01412944|796553|P2|Entire: IV + Maintenance|Lost to Follow-up|1
241246|NCT01412944|796554|P1|Entire: IV + Maintenance|Lost to Follow-up|0
241247|NCT01412944|796549|P6|Entire: IV + Maintenance|Protocol deviation|0
241248|NCT01412944|796550|P5|Entire: IV + Maintenance|Protocol deviation|0
241249|NCT01412944|796551|P4|Entire: IV + Maintenance|Protocol deviation|0
241250|NCT01412944|796552|P3|Entire: IV + Maintenance|Protocol deviation|0
241251|NCT01412944|796553|P2|Entire: IV + Maintenance|Protocol deviation|1
241252|NCT01412944|796554|P1|Entire: IV + Maintenance|Protocol deviation|0
241253|NCT01412944|796549|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
241254|NCT01412944|796550|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
241255|NCT01412944|796551|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
241256|NCT01412944|796552|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
241257|NCT01412944|796553|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
241258|NCT01412944|796554|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
241259|NCT01412944|796549|P6|Entire: IV + Maintenance|Lack of Efficacy|0
241260|NCT01412944|796550|P5|Entire: IV + Maintenance|Lack of Efficacy|1
241261|NCT01412944|796551|P4|Entire: IV + Maintenance|Lack of Efficacy|0
241262|NCT01412944|796552|P3|Entire: IV + Maintenance|Lack of Efficacy|0
241263|NCT01412944|796553|P2|Entire: IV + Maintenance|Lack of Efficacy|0
241264|NCT01412944|796554|P1|Entire: IV + Maintenance|Lack of Efficacy|0
241265|NCT01412944|796549|P6|Entire: IV + Maintenance|Lost to Follow-up|1
241266|NCT01412944|796550|P5|Entire: IV + Maintenance|Lost to Follow-up|0
241267|NCT01412944|796551|P4|Entire: IV + Maintenance|Lost to Follow-up|0
241268|NCT01412944|796552|P3|Entire: IV + Maintenance|Lost to Follow-up|0
241269|NCT01412944|796553|P2|Entire: IV + Maintenance|Lost to Follow-up|0
241270|NCT01412944|796554|P1|Entire: IV + Maintenance|Lost to Follow-up|0
241271|NCT01412944|796549|P6|Entire: IV + Maintenance|Protocol deviation|1
241272|NCT01412944|796550|P5|Entire: IV + Maintenance|Protocol deviation|0
241273|NCT01412944|796551|P4|Entire: IV + Maintenance|Protocol deviation|0
241274|NCT01412944|796552|P3|Entire: IV + Maintenance|Protocol deviation|0
241275|NCT01412944|796553|P2|Entire: IV + Maintenance|Protocol deviation|0
241276|NCT01412944|796554|P1|Entire: IV + Maintenance|Protocol deviation|0
241277|NCT01412944|796549|P6|Entire: IV + Maintenance|Adverse Event|0
241278|NCT01412944|796550|P5|Entire: IV + Maintenance|Adverse Event|1
241279|NCT01412944|796551|P4|Entire: IV + Maintenance|Adverse Event|0
241280|NCT01412944|796552|P3|Entire: IV + Maintenance|Adverse Event|0
241281|NCT01412944|796553|P2|Entire: IV + Maintenance|Adverse Event|0
241282|NCT01412944|796554|P1|Entire: IV + Maintenance|Adverse Event|0
241283|NCT01412944|796549|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
241284|NCT01412944|796550|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
241285|NCT01412944|796551|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
241286|NCT01412944|796552|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
241287|NCT01412944|796553|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
241288|NCT01412944|796554|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
241289|NCT01412944|796549|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
241290|NCT01412944|796550|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
241291|NCT01412944|796551|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
241292|NCT01412944|796552|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
241293|NCT01412944|796553|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
241294|NCT01412944|796554|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
241295|NCT01412944|796549|P6|IV: Per CAIN457A2307|Protocol deviation|0
241296|NCT01412944|796550|P5|IV: Per CAIN457A2307|Protocol deviation|0
241297|NCT01412944|796551|P4|IV: Per CAIN457A2307|Protocol deviation|0
241298|NCT01412944|796552|P3|IV: Per CAIN457A2307|Protocol deviation|0
241299|NCT01412944|796553|P2|IV: Per CAIN457A2307|Protocol deviation|1
241300|NCT01412944|796554|P1|IV: Per CAIN457A2307|Protocol deviation|0
241301|NCT01412944|796549|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
241302|NCT01412944|796550|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
241303|NCT01412944|796551|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
241304|NCT01412944|796552|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
241305|NCT01412944|796553|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
241306|NCT01412944|796554|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
241307|NCT01412944|796549|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
241308|NCT01412944|796550|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
241309|NCT01412944|796551|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
241310|NCT01412944|796552|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
241311|NCT01412944|796553|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
241312|NCT01412944|796554|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
241313|NCT01412944|796549|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
241314|NCT01412944|796550|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
241315|NCT01412944|796551|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
241316|NCT01412944|796552|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
241317|NCT01412944|796553|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
241318|NCT01412944|796554|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
241319|NCT01412944|796549|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
241320|NCT01412944|796550|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
241321|NCT01412944|796551|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
241322|NCT01412944|796552|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
241323|NCT01412944|796553|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
241324|NCT01412944|796554|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
241325|NCT01412879|796600|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
241326|NCT01412879|796601|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
241327|NCT01412879|796602|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
241328|NCT01412879|796600|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
241329|NCT01412879|796601|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
241330|NCT01412879|796602|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
241331|NCT01412879|796600|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
241332|NCT01412879|796601|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
241333|NCT01412879|796602|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
241334|NCT01412879|796600|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
241335|NCT01412879|796601|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
241336|NCT01412879|796602|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
241337|NCT01412879|796600|P3|Initial Registration (Induction Therapy)|Adverse Event|0
241338|NCT01412879|796601|P2|Initial Registration (Induction Therapy)|Adverse Event|3
241339|NCT01412879|796602|P1|Initial Registration (Induction Therapy)|Adverse Event|5
241340|NCT01412801|796622|P6|Overall Study|Relocated to another area|0
241341|NCT01412801|796623|P5|Overall Study|Relocated to another area|0
241342|NCT01412801|796624|P4|Overall Study|Relocated to another area|0
241343|NCT01412801|796625|P3|Overall Study|Relocated to another area|2
241344|NCT01412801|796626|P2|Overall Study|Relocated to another area|0
241345|NCT01412801|796627|P1|Overall Study|Relocated to another area|0
241346|NCT01412801|796622|P6|Overall Study|Withdrawal by Subject|0
241347|NCT01412801|796623|P5|Overall Study|Withdrawal by Subject|0
241348|NCT01412801|796624|P4|Overall Study|Withdrawal by Subject|0
241349|NCT01412801|796625|P3|Overall Study|Withdrawal by Subject|1
241350|NCT01412801|796626|P2|Overall Study|Withdrawal by Subject|2
241351|NCT01412801|796627|P1|Overall Study|Withdrawal by Subject|3
241352|NCT01412801|796622|P6|Overall Study|Lost to Follow-up|1
241353|NCT01412801|796623|P5|Overall Study|Lost to Follow-up|1
241354|NCT01412801|796624|P4|Overall Study|Lost to Follow-up|0
241355|NCT01412801|796625|P3|Overall Study|Lost to Follow-up|4
241356|NCT01412801|796626|P2|Overall Study|Lost to Follow-up|2
241357|NCT01412801|796627|P1|Overall Study|Lost to Follow-up|1
241358|NCT01412801|796622|P6|Overall Study|Death|2
241359|NCT01412801|796623|P5|Overall Study|Death|2
241360|NCT01412801|796624|P4|Overall Study|Death|4
241361|NCT01412801|796625|P3|Overall Study|Death|0
241362|NCT01412801|796626|P2|Overall Study|Death|1
241363|NCT01412801|796627|P1|Overall Study|Death|0
241364|NCT01412424|796775|P1|Extension Treatment Period|Patient Request|2
241365|NCT01412424|796775|P1|Extension Treatment Period|Treatment Failure|2
241366|NCT01412424|796775|P1|Extension Treatment Period|Adverse Event|2
241367|NCT01412424|796775|P1|Core Treatment Period|Sponsor Request|1
241368|NCT01412424|796775|P1|Core Treatment Period|Lost to Follow-up|2
241369|NCT01412424|796775|P1|Core Treatment Period|Patient Request|5
241370|NCT01412424|796775|P1|Core Treatment Period|Adverse Event|21
241371|NCT01412424|796775|P1|Core Treatment Period|Treatment Failure|24
241372|NCT01412151|796824|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
241373|NCT01412151|796824|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
241374|NCT01412151|796824|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
241375|NCT01412151|796824|P1|Week 0 - 306 - Treatment Period|Death|1
241376|NCT01411891|796835|P2|Overall Study|Catheter dislodgement or loss to follow-|2
241377|NCT01411891|796836|P1|Overall Study|Catheter dislodgement or loss to follow-|3
241378|NCT01411852|796844|P2|Hospital Intervention Phase|Vascular access failed|0
241379|NCT01411852|796845|P1|Hospital Intervention Phase|Vascular access failed|1
241380|NCT01411852|796844|P2|Hospital Intervention Phase|Withdrawal by Subject|0
241381|NCT01411852|796845|P1|Hospital Intervention Phase|Withdrawal by Subject|1
241382|NCT01411852|796844|P2|Hospital Intervention Phase|Spinal cord injury|0
241383|NCT01411852|796845|P1|Hospital Intervention Phase|Spinal cord injury|2
241384|NCT01411852|796844|P2|Hospital Intervention Phase|Other ineligible|2
241385|NCT01411852|796845|P1|Hospital Intervention Phase|Other ineligible|2
241386|NCT01411852|796844|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
241387|NCT01411852|796845|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
241388|NCT01411852|796844|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
241389|NCT01411852|796845|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
241390|NCT01411852|796844|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
241391|NCT01411852|796845|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
241392|NCT01411852|796844|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
241393|NCT01411852|796845|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
241394|NCT01411852|796844|P2|Hospital Intervention Phase|CPR administered|1
241395|NCT01411852|796845|P1|Hospital Intervention Phase|CPR administered|3
241396|NCT01411852|796844|P2|Hospital Intervention Phase|Miscommunication error|2
241397|NCT01411852|796845|P1|Hospital Intervention Phase|Miscommunication error|1
241398|NCT01411852|796844|P2|Hospital Intervention Phase|No qualifying SBP|1
241399|NCT01411852|796845|P1|Hospital Intervention Phase|No qualifying SBP|5
241400|NCT01411852|796844|P2|Hospital Intervention Phase|Severe head injury|4
241401|NCT01411852|796845|P1|Hospital Intervention Phase|Severe head injury|5
241402|NCT01411852|796844|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
241403|NCT01411852|796845|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
241404|NCT01411852|796844|P2|Prehospital Intervention Phase|Found to be under age|1
241405|NCT01411852|796845|P1|Prehospital Intervention Phase|Found to be under age|0
241406|NCT01411852|796844|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
241407|NCT01411852|796845|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
241408|NCT01411852|796844|P2|Prehospital Intervention Phase|No qualifying SBP|4
241409|NCT01411852|796845|P1|Prehospital Intervention Phase|No qualifying SBP|5
241410|NCT01411228|796946|P3|Overall Study|Withdrawal by Subject|0
241411|NCT01411228|796947|P2|Overall Study|Withdrawal by Subject|0
241412|NCT01411228|796948|P1|Overall Study|Withdrawal by Subject|1
241413|NCT01411228|796946|P3|Overall Study|Lost to Follow-up|1
241414|NCT01411228|796947|P2|Overall Study|Lost to Follow-up|0
241415|NCT01411228|796948|P1|Overall Study|Lost to Follow-up|0
241416|NCT01411215|796970|P2|Overall Study|Screen failure|1
241417|NCT01411215|796971|P1|Overall Study|Screen failure|0
241418|NCT01411215|796970|P2|Overall Study|Unspecified|17
241419|NCT01411215|796971|P1|Overall Study|Unspecified|12
241420|NCT01411215|796970|P2|Overall Study|Withdrawal by Subject|21
241421|NCT01411215|796971|P1|Overall Study|Withdrawal by Subject|34
241422|NCT01411215|796970|P2|Overall Study|Protocol Violation|5
241423|NCT01411215|796971|P1|Overall Study|Protocol Violation|3
241424|NCT01411215|796970|P2|Overall Study|Study terminated by sponsor|15
241425|NCT01411215|796971|P1|Overall Study|Study terminated by sponsor|2
241426|NCT01411215|796970|P2|Overall Study|Did not meet entrance criteria|1
241427|NCT01411215|796971|P1|Overall Study|Did not meet entrance criteria|0
241428|NCT01411215|796970|P2|Overall Study|Lost to Follow-up|18
241429|NCT01411215|796971|P1|Overall Study|Lost to Follow-up|12
241430|NCT01411215|796970|P2|Overall Study|Lack of Efficacy|4
241431|NCT01411215|796971|P1|Overall Study|Lack of Efficacy|2
241432|NCT01411215|796970|P2|Overall Study|Adverse Event|2
241433|NCT01411215|796971|P1|Overall Study|Adverse Event|1
241434|NCT01410604|797030|P2|Overall Study|Physician Decision|1
241435|NCT01410604|797031|P1|Overall Study|Physician Decision|0
241436|NCT01410604|797030|P2|Overall Study|Lost to Follow-up|0
241437|NCT01410604|797031|P1|Overall Study|Lost to Follow-up|1
241438|NCT01410604|797030|P2|Overall Study|Adverse Event|1
241439|NCT01410604|797031|P1|Overall Study|Adverse Event|2
241440|NCT01410474|797067|P2|Overall Study|Withdrawal by Subject|1
241441|NCT01410474|797068|P1|Overall Study|Withdrawal by Subject|0
241442|NCT01410448|797091|P2|Overall Study|Death|3
241443|NCT01410448|797092|P1|Overall Study|Death|2
241444|NCT01410448|797091|P2|Overall Study|Protocol Violation|4
241445|NCT01410448|797092|P1|Overall Study|Protocol Violation|0
241446|NCT01410448|797091|P2|Overall Study|Withdrawal by Subject|2
241447|NCT01410448|797092|P1|Overall Study|Withdrawal by Subject|3
241448|NCT01410448|797091|P2|Overall Study|Lost to Follow-up|0
241449|NCT01410448|797092|P1|Overall Study|Lost to Follow-up|1
241450|NCT01410448|797091|P2|Overall Study|Administrative issues|1
241451|NCT01410448|797092|P1|Overall Study|Administrative issues|2
241452|NCT01410448|797091|P2|Overall Study|Graft loss|1
241453|NCT01410448|797092|P1|Overall Study|Graft loss|4
241454|NCT01410448|797091|P2|Overall Study|No conversion to everolimus|24
241455|NCT01410448|797092|P1|Overall Study|No conversion to everolimus|0
241456|NCT01410240|797158|P3|Overall Study|Missed week 6 assessments|1
241457|NCT01410240|797159|P2|Overall Study|Missed week 6 assessments|1
241458|NCT01410240|797160|P1|Overall Study|Missed week 6 assessments|1
241459|NCT01410240|797158|P3|Overall Study|Physician Decision|1
241460|NCT01410240|797159|P2|Overall Study|Physician Decision|0
241461|NCT01410240|797160|P1|Overall Study|Physician Decision|0
241462|NCT01410227|797231|P4|Overall Study|Met Excl. Criteria After Starting Study|0
241463|NCT01410227|797232|P3|Overall Study|Met Excl. Criteria After Starting Study|1
241464|NCT01410227|797233|P2|Overall Study|Met Excl. Criteria After Starting Study|0
241465|NCT01410227|797234|P1|Overall Study|Met Excl. Criteria After Starting Study|0
241466|NCT01410227|797231|P4|Overall Study|Pregnancy|1
241467|NCT01410227|797232|P3|Overall Study|Pregnancy|0
241468|NCT01410227|797233|P2|Overall Study|Pregnancy|0
241469|NCT01410227|797234|P1|Overall Study|Pregnancy|0
241470|NCT01410227|797231|P4|Overall Study|Withdrawal by Subject|0
241471|NCT01410227|797232|P3|Overall Study|Withdrawal by Subject|1
241472|NCT01410227|797233|P2|Overall Study|Withdrawal by Subject|0
241473|NCT01410227|797234|P1|Overall Study|Withdrawal by Subject|3
241474|NCT01410227|797231|P4|Overall Study|Adverse Event|0
241475|NCT01410227|797232|P3|Overall Study|Adverse Event|0
241476|NCT01410227|797233|P2|Overall Study|Adverse Event|0
241477|NCT01410227|797234|P1|Overall Study|Adverse Event|1
241478|NCT01410110|797306|P2|Overall Study|Withdrawal by Subject|2
241479|NCT01410110|797307|P1|Overall Study|Withdrawal by Subject|4
241480|NCT01409993|797331|P4|Overall Study|Lost to Follow-up|0
241481|NCT01409993|797332|P3|Overall Study|Lost to Follow-up|0
241482|NCT01409993|797333|P2|Overall Study|Lost to Follow-up|1
241483|NCT01409993|797334|P1|Overall Study|Lost to Follow-up|0
241484|NCT01409993|797331|P4|Overall Study|Withdrawal by Subject|4
241485|NCT01409993|797332|P3|Overall Study|Withdrawal by Subject|0
241486|NCT01409993|797333|P2|Overall Study|Withdrawal by Subject|0
241487|NCT01409993|797334|P1|Overall Study|Withdrawal by Subject|0
241488|NCT01409993|797331|P4|Overall Study|Adverse Event|1
241489|NCT01409993|797332|P3|Overall Study|Adverse Event|3
241490|NCT01409993|797333|P2|Overall Study|Adverse Event|4
241491|NCT01409993|797334|P1|Overall Study|Adverse Event|4
241492|NCT01409837|797354|P2|Overall Study|Physician Decision|1
241493|NCT01409837|797355|P1|Overall Study|Physician Decision|0
241494|NCT01409837|797354|P2|Overall Study|Lost to Follow-up|0
241495|NCT01409837|797355|P1|Overall Study|Lost to Follow-up|1
241496|NCT01409837|797354|P2|Overall Study|Withdrawal by Subject|1
241497|NCT01409837|797355|P1|Overall Study|Withdrawal by Subject|2
241498|NCT01409707|797380|P3|Overall Study|Withdrawal by Subject|16
241499|NCT01409707|797381|P2|Overall Study|Withdrawal by Subject|17
241500|NCT01409707|797382|P1|Overall Study|Withdrawal by Subject|5
241501|NCT01409564|797394|P2|Overall Study|brain abnormalities found in T1 MR|2
241502|NCT01409564|797395|P1|Overall Study|brain abnormalities found in T1 MR|1
241503|NCT01409564|797394|P2|Overall Study|low medication compliance|3
241504|NCT01409564|797395|P1|Overall Study|low medication compliance|4
241505|NCT01409434|797413|P1|Overall Study|Protocol Violation|4
241506|NCT01409382|797423|P2|Overall Study|Had a 2nd trimester loss after accident|0
241507|NCT01409382|797424|P1|Overall Study|Had a 2nd trimester loss after accident|1
241508|NCT01409382|797423|P2|Overall Study|Did not manage to get pregnant|70
241509|NCT01409382|797424|P1|Overall Study|Did not manage to get pregnant|64
241510|NCT01409382|797423|P2|Overall Study|Still pregnant when study ended|2
241511|NCT01409382|797424|P1|Overall Study|Still pregnant when study ended|13
241512|NCT01409382|797423|P2|Overall Study|Multiple pregnancy|4
241513|NCT01409382|797424|P1|Overall Study|Multiple pregnancy|2
241514|NCT01409382|797423|P2|Overall Study|Protocol Violation|3
241515|NCT01409382|797424|P1|Overall Study|Protocol Violation|0
241516|NCT01409382|797423|P2|Overall Study|Lost to Follow-up|1
241517|NCT01409382|797424|P1|Overall Study|Lost to Follow-up|1
241518|NCT01408888|797488|P2|Second Intervention|Adverse Event|0
241519|NCT01408888|797489|P1|Second Intervention|Adverse Event|1
241520|NCT01408888|797488|P2|Second Intervention|Withdrawal by Subject|0
241521|NCT01408888|797489|P1|Second Intervention|Withdrawal by Subject|1
241522|NCT01408888|797488|P2|First Intervention|Withdrawal by Subject|2
241523|NCT01408888|797489|P1|First Intervention|Withdrawal by Subject|0
241524|NCT01408888|797488|P2|First Intervention|Adverse Event|1
241525|NCT01408888|797489|P1|First Intervention|Adverse Event|0
241526|NCT01408628|797566|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
241527|NCT01408628|797566|P1|Completed 6 Month Follow-Up|Protocol Violation|6
241528|NCT01408628|797566|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
241529|NCT01408628|797566|P1|Consented|Withdrawal by Subject|12
241530|NCT01408537|797572|P1|Overall Study|Lost to Follow-up|3
241531|NCT01408537|797572|P1|Overall Study|Protocol Violation|3
241532|NCT01408537|797572|P1|Overall Study|Withdrawal by Subject|2
241533|NCT01408485|797588|P1|Overall Study|Withdrawal by Subject|21
241534|NCT01408303|797606|P3|Overall Study|Noncompliance|1
241535|NCT01408303|797607|P2|Overall Study|Noncompliance|0
241536|NCT01408303|797608|P1|Overall Study|Noncompliance|1
241537|NCT01408303|797606|P3|Overall Study|Protocol Violation|0
241538|NCT01408303|797607|P2|Overall Study|Protocol Violation|1
241539|NCT01408303|797608|P1|Overall Study|Protocol Violation|0
241540|NCT01408303|797606|P3|Overall Study|Withdrawal by Subject|1
241541|NCT01408303|797607|P2|Overall Study|Withdrawal by Subject|3
241542|NCT01408303|797608|P1|Overall Study|Withdrawal by Subject|2
241543|NCT01408303|797606|P3|Overall Study|Lost to Follow-up|2
241544|NCT01408303|797607|P2|Overall Study|Lost to Follow-up|1
241545|NCT01408303|797608|P1|Overall Study|Lost to Follow-up|0
241546|NCT01408303|797606|P3|Overall Study|Adverse Event|2
241547|NCT01408303|797607|P2|Overall Study|Adverse Event|7
241548|NCT01408303|797608|P1|Overall Study|Adverse Event|3
241549|NCT01408277|797618|P2|Overall Study|Protocol Violation|0
241550|NCT01408277|797619|P1|Overall Study|Protocol Violation|2
241551|NCT01408277|797618|P2|Overall Study|Withdrawal by Subject|0
241552|NCT01408277|797619|P1|Overall Study|Withdrawal by Subject|2
241553|NCT01408277|797618|P2|Overall Study|Lost to Follow-up|0
241554|NCT01408277|797619|P1|Overall Study|Lost to Follow-up|1
241555|NCT01408277|797618|P2|Overall Study|Adverse Event|4
241556|NCT01408277|797619|P1|Overall Study|Adverse Event|3
241557|NCT01407354|797625|P2|First Intervention|Physician Decision|0
241558|NCT01407354|797626|P1|First Intervention|Physician Decision|1
241559|NCT01407354|797625|P2|First Intervention|Adverse Event|0
241560|NCT01407354|797626|P1|First Intervention|Adverse Event|1
241561|NCT01407354|797625|P2|First Intervention|Withdrawal by Subject|2
241562|NCT01407354|797626|P1|First Intervention|Withdrawal by Subject|0
241563|NCT01407276|797642|P8|Overall Study|Withdrawal by Subject|1
241564|NCT01407276|797643|P7|Overall Study|Withdrawal by Subject|0
241565|NCT01407276|797644|P6|Overall Study|Withdrawal by Subject|0
241566|NCT01407276|797645|P5|Overall Study|Withdrawal by Subject|0
241567|NCT01407276|797646|P4|Overall Study|Withdrawal by Subject|0
241568|NCT01407276|797647|P3|Overall Study|Withdrawal by Subject|0
241569|NCT01407276|797648|P2|Overall Study|Withdrawal by Subject|0
241570|NCT01407276|797649|P1|Overall Study|Withdrawal by Subject|0
241571|NCT01406938|797819|P6|Follow up|Lost to Follow-up|1
241572|NCT01406938|797820|P5|Follow up|Lost to Follow-up|2
241573|NCT01406938|797821|P4|Follow up|Lost to Follow-up|1
241574|NCT01406938|797822|P3|Follow up|Lost to Follow-up|0
241575|NCT01406938|797823|P2|Follow up|Lost to Follow-up|1
241576|NCT01406938|797824|P1|Follow up|Lost to Follow-up|1
241577|NCT01406938|797819|P6|Follow up|Physician Decision|1
241578|NCT01406938|797820|P5|Follow up|Physician Decision|3
241579|NCT01406938|797821|P4|Follow up|Physician Decision|0
241580|NCT01406938|797822|P3|Follow up|Physician Decision|2
241581|NCT01406938|797823|P2|Follow up|Physician Decision|0
241582|NCT01406938|797824|P1|Follow up|Physician Decision|0
241583|NCT01406938|797819|P6|Follow up|Protocol Violation|0
241584|NCT01406938|797820|P5|Follow up|Protocol Violation|0
241585|NCT01406938|797821|P4|Follow up|Protocol Violation|0
241586|NCT01406938|797822|P3|Follow up|Protocol Violation|1
241587|NCT01406938|797823|P2|Follow up|Protocol Violation|0
241588|NCT01406938|797824|P1|Follow up|Protocol Violation|0
241589|NCT01406938|797819|P6|Follow up|Patient/guardian decision|1
241590|NCT01406938|797820|P5|Follow up|Patient/guardian decision|4
241591|NCT01406938|797821|P4|Follow up|Patient/guardian decision|2
241592|NCT01406938|797822|P3|Follow up|Patient/guardian decision|4
241593|NCT01406938|797823|P2|Follow up|Patient/guardian decision|2
241594|NCT01406938|797824|P1|Follow up|Patient/guardian decision|4
241595|NCT01406938|797819|P6|Follow up|Lack of Efficacy|0
241596|NCT01406938|797820|P5|Follow up|Lack of Efficacy|0
241597|NCT01406938|797821|P4|Follow up|Lack of Efficacy|0
241598|NCT01406938|797822|P3|Follow up|Lack of Efficacy|1
241599|NCT01406938|797823|P2|Follow up|Lack of Efficacy|2
241600|NCT01406938|797824|P1|Follow up|Lack of Efficacy|3
241601|NCT01406938|797819|P6|Maintenance Period|Lack of Efficacy|5
241602|NCT01406938|797820|P5|Maintenance Period|Lack of Efficacy|3
241603|NCT01406938|797821|P4|Maintenance Period|Lack of Efficacy|1
241604|NCT01406938|797822|P3|Maintenance Period|Lack of Efficacy|2
241605|NCT01406938|797823|P2|Maintenance Period|Lack of Efficacy|0
241606|NCT01406938|797824|P1|Maintenance Period|Lack of Efficacy|0
241607|NCT01406938|797819|P6|Maintenance Period|Lost to Follow-up|0
241608|NCT01406938|797820|P5|Maintenance Period|Lost to Follow-up|4
241609|NCT01406938|797821|P4|Maintenance Period|Lost to Follow-up|0
241610|NCT01406938|797822|P3|Maintenance Period|Lost to Follow-up|0
241611|NCT01406938|797823|P2|Maintenance Period|Lost to Follow-up|0
241612|NCT01406938|797824|P1|Maintenance Period|Lost to Follow-up|0
241613|NCT01406938|797819|P6|Maintenance Period|Pregnancy|0
241614|NCT01406938|797820|P5|Maintenance Period|Pregnancy|1
241615|NCT01406938|797821|P4|Maintenance Period|Pregnancy|0
241616|NCT01406938|797822|P3|Maintenance Period|Pregnancy|0
241617|NCT01406938|797823|P2|Maintenance Period|Pregnancy|0
241618|NCT01406938|797824|P1|Maintenance Period|Pregnancy|0
241619|NCT01406938|797819|P6|Maintenance Period|Protocol Violation|2
241620|NCT01406938|797820|P5|Maintenance Period|Protocol Violation|2
241621|NCT01406938|797821|P4|Maintenance Period|Protocol Violation|2
241622|NCT01406938|797822|P3|Maintenance Period|Protocol Violation|2
241623|NCT01406938|797823|P2|Maintenance Period|Protocol Violation|0
241624|NCT01406938|797824|P1|Maintenance Period|Protocol Violation|0
241625|NCT01406938|797819|P6|Maintenance Period|Subject/guardian decision|7
241626|NCT01406938|797820|P5|Maintenance Period|Subject/guardian decision|10
241627|NCT01406938|797821|P4|Maintenance Period|Subject/guardian decision|7
241628|NCT01406938|797822|P3|Maintenance Period|Subject/guardian decision|11
241629|NCT01406938|797823|P2|Maintenance Period|Subject/guardian decision|0
241630|NCT01406938|797824|P1|Maintenance Period|Subject/guardian decision|0
241631|NCT01406938|797819|P6|Maintenance Period|Death|0
241632|NCT01406938|797820|P5|Maintenance Period|Death|1
241633|NCT01406938|797821|P4|Maintenance Period|Death|0
241634|NCT01406938|797822|P3|Maintenance Period|Death|0
241635|NCT01406938|797823|P2|Maintenance Period|Death|0
241636|NCT01406938|797824|P1|Maintenance Period|Death|0
241637|NCT01406938|797819|P6|Maintenance Period|Adverse Event|2
241638|NCT01406938|797820|P5|Maintenance Period|Adverse Event|4
241639|NCT01406938|797821|P4|Maintenance Period|Adverse Event|8
241640|NCT01406938|797822|P3|Maintenance Period|Adverse Event|2
241641|NCT01406938|797823|P2|Maintenance Period|Adverse Event|0
241642|NCT01406938|797824|P1|Maintenance Period|Adverse Event|0
241643|NCT01406938|797819|P6|Induction Period|Lost to Follow-up|0
241644|NCT01406938|797820|P5|Induction Period|Lost to Follow-up|0
241645|NCT01406938|797821|P4|Induction Period|Lost to Follow-up|0
241646|NCT01406938|797822|P3|Induction Period|Lost to Follow-up|0
241647|NCT01406938|797823|P2|Induction Period|Lost to Follow-up|3
241648|NCT01406938|797824|P1|Induction Period|Lost to Follow-up|2
241649|NCT01406938|797819|P6|Induction Period|Lack of Efficacy|0
241650|NCT01406938|797820|P5|Induction Period|Lack of Efficacy|0
241651|NCT01406938|797821|P4|Induction Period|Lack of Efficacy|0
241652|NCT01406938|797822|P3|Induction Period|Lack of Efficacy|0
241653|NCT01406938|797823|P2|Induction Period|Lack of Efficacy|0
241654|NCT01406938|797824|P1|Induction Period|Lack of Efficacy|1
241655|NCT01406938|797819|P6|Induction Period|Adverse Event|0
241656|NCT01406938|797820|P5|Induction Period|Adverse Event|0
241657|NCT01406938|797821|P4|Induction Period|Adverse Event|0
241658|NCT01406938|797822|P3|Induction Period|Adverse Event|0
241659|NCT01406938|797823|P2|Induction Period|Adverse Event|9
241660|NCT01406938|797824|P1|Induction Period|Adverse Event|8
241661|NCT01406938|797819|P6|Induction Period|Protocol deviation|0
241662|NCT01406938|797820|P5|Induction Period|Protocol deviation|0
241663|NCT01406938|797821|P4|Induction Period|Protocol deviation|0
241664|NCT01406938|797822|P3|Induction Period|Protocol deviation|0
241665|NCT01406938|797823|P2|Induction Period|Protocol deviation|0
241666|NCT01406938|797824|P1|Induction Period|Protocol deviation|1
241667|NCT01406938|797819|P6|Induction Period|Subject/guardian decision|0
241668|NCT01406938|797820|P5|Induction Period|Subject/guardian decision|0
241669|NCT01406938|797821|P4|Induction Period|Subject/guardian decision|0
241670|NCT01406938|797822|P3|Induction Period|Subject/guardian decision|0
241671|NCT01406938|797823|P2|Induction Period|Subject/guardian decision|8
241672|NCT01406938|797824|P1|Induction Period|Subject/guardian decision|6
241673|NCT01406795|797940|P1|Overall Study|Withdrawal by Subject|1
241674|NCT01406574|797954|P4|Overall Study|Definite progression of primary disease|0
241675|NCT01406574|797955|P3|Overall Study|Definite progression of primary disease|0
241676|NCT01406574|797956|P2|Overall Study|Definite progression of primary disease|0
241677|NCT01406574|797957|P1|Overall Study|Definite progression of primary disease|1
241678|NCT01406574|797954|P4|Overall Study|Withdrawal by Subject|0
241679|NCT01406574|797955|P3|Overall Study|Withdrawal by Subject|0
241680|NCT01406574|797956|P2|Overall Study|Withdrawal by Subject|1
241681|NCT01406574|797957|P1|Overall Study|Withdrawal by Subject|0
241682|NCT01406574|797954|P4|Overall Study|Physician Decision|1
241683|NCT01406574|797955|P3|Overall Study|Physician Decision|0
241684|NCT01406574|797956|P2|Overall Study|Physician Decision|0
241685|NCT01406574|797957|P1|Overall Study|Physician Decision|0
241686|NCT01406574|797954|P4|Overall Study|Adverse Event|3
241687|NCT01406574|797955|P3|Overall Study|Adverse Event|1
241688|NCT01406574|797956|P2|Overall Study|Adverse Event|0
241689|NCT01406574|797957|P1|Overall Study|Adverse Event|0
241690|NCT01406015|797971|P2|Overall Study|Withdrawal by Subject|3
241691|NCT01406015|797972|P1|Overall Study|Withdrawal by Subject|3
241692|NCT01405950|797988|P4|Overall Study|Withdrawal by Subject|0
241693|NCT01405950|797989|P3|Overall Study|Withdrawal by Subject|0
241694|NCT01405950|797990|P2|Overall Study|Withdrawal by Subject|0
241695|NCT01405950|797991|P1|Overall Study|Withdrawal by Subject|1
241696|NCT01405924|798026|P1|Overall Study|Missing/Incomplete Data|2
241697|NCT01405924|798026|P1|Overall Study|Protocol Violation|8
241698|NCT01405898|798038|P2|Overall Study|Withdrawal by Subject|2
241699|NCT01405898|798039|P1|Overall Study|Withdrawal by Subject|2
241700|NCT01405820|798063|P6|Open-Label Treatment Period|Adverse Event|0
241701|NCT01405820|798064|P5|Open-Label Treatment Period|Adverse Event|0
241702|NCT01405820|798065|P4|Open-Label Treatment Period|Adverse Event|1
241703|NCT01405820|798066|P3|Open-Label Treatment Period|Adverse Event|0
241704|NCT01405820|798067|P2|Open-Label Treatment Period|Adverse Event|0
241705|NCT01405820|798068|P1|Open-Label Treatment Period|Adverse Event|0
241706|NCT01405820|798063|P6|Open-Label Treatment Period|Physician Decision|0
241707|NCT01405820|798064|P5|Open-Label Treatment Period|Physician Decision|1
241708|NCT01405820|798065|P4|Open-Label Treatment Period|Physician Decision|2
241709|NCT01405820|798066|P3|Open-Label Treatment Period|Physician Decision|1
241710|NCT01405820|798067|P2|Open-Label Treatment Period|Physician Decision|0
241711|NCT01405820|798068|P1|Open-Label Treatment Period|Physician Decision|0
241712|NCT01405820|798063|P6|Open-Label Treatment Period|Not Specified|1
241713|NCT01405820|798064|P5|Open-Label Treatment Period|Not Specified|1
241714|NCT01405820|798065|P4|Open-Label Treatment Period|Not Specified|1
241715|NCT01405820|798066|P3|Open-Label Treatment Period|Not Specified|1
241716|NCT01405820|798067|P2|Open-Label Treatment Period|Not Specified|1
241717|NCT01405820|798068|P1|Open-Label Treatment Period|Not Specified|1
241718|NCT01405820|798063|P6|Open-Label Treatment Period|Withdrawal by Subject|1
241719|NCT01405820|798064|P5|Open-Label Treatment Period|Withdrawal by Subject|0
241720|NCT01405820|798065|P4|Open-Label Treatment Period|Withdrawal by Subject|1
241721|NCT01405820|798066|P3|Open-Label Treatment Period|Withdrawal by Subject|1
241722|NCT01405820|798067|P2|Open-Label Treatment Period|Withdrawal by Subject|1
241723|NCT01405820|798068|P1|Open-Label Treatment Period|Withdrawal by Subject|3
241724|NCT01405820|798063|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
241725|NCT01405820|798064|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
241726|NCT01405820|798065|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
241727|NCT01405820|798066|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
241728|NCT01405820|798067|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
241729|NCT01405820|798068|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
241730|NCT01405820|798063|P6|Randomized Treatment Period|Death|0
241731|NCT01405820|798064|P5|Randomized Treatment Period|Death|0
241732|NCT01405820|798065|P4|Randomized Treatment Period|Death|1
241733|NCT01405820|798066|P3|Randomized Treatment Period|Death|0
241734|NCT01405820|798067|P2|Randomized Treatment Period|Death|0
241735|NCT01405820|798068|P1|Randomized Treatment Period|Death|0
241736|NCT01405820|798063|P6|Randomized Treatment Period|Treatment Arm Closed|28
241737|NCT01405820|798064|P5|Randomized Treatment Period|Treatment Arm Closed|33
241738|NCT01405820|798065|P4|Randomized Treatment Period|Treatment Arm Closed|36
241739|NCT01405820|798066|P3|Randomized Treatment Period|Treatment Arm Closed|20
241740|NCT01405820|798067|P2|Randomized Treatment Period|Treatment Arm Closed|0
241741|NCT01405820|798068|P1|Randomized Treatment Period|Treatment Arm Closed|0
241742|NCT01405820|798063|P6|Randomized Treatment Period|Incorrect Study Treatment|0
241743|NCT01405820|798064|P5|Randomized Treatment Period|Incorrect Study Treatment|2
241744|NCT01405820|798065|P4|Randomized Treatment Period|Incorrect Study Treatment|0
241745|NCT01405820|798066|P3|Randomized Treatment Period|Incorrect Study Treatment|3
241746|NCT01405820|798067|P2|Randomized Treatment Period|Incorrect Study Treatment|0
241747|NCT01405820|798068|P1|Randomized Treatment Period|Incorrect Study Treatment|0
241748|NCT01405820|798063|P6|Randomized Treatment Period|Rescue|8
241749|NCT01405820|798064|P5|Randomized Treatment Period|Rescue|8
241750|NCT01405820|798065|P4|Randomized Treatment Period|Rescue|10
241751|NCT01405820|798066|P3|Randomized Treatment Period|Rescue|13
241752|NCT01405820|798067|P2|Randomized Treatment Period|Rescue|1
241753|NCT01405820|798068|P1|Randomized Treatment Period|Rescue|0
241754|NCT01405820|798063|P6|Randomized Treatment Period|Physician Decision|0
241755|NCT01405820|798064|P5|Randomized Treatment Period|Physician Decision|0
241756|NCT01405820|798065|P4|Randomized Treatment Period|Physician Decision|0
241757|NCT01405820|798066|P3|Randomized Treatment Period|Physician Decision|1
241758|NCT01405820|798067|P2|Randomized Treatment Period|Physician Decision|2
241759|NCT01405820|798068|P1|Randomized Treatment Period|Physician Decision|0
241760|NCT01405820|798063|P6|Randomized Treatment Period|Not Specified|0
241761|NCT01405820|798064|P5|Randomized Treatment Period|Not Specified|0
241762|NCT01405820|798065|P4|Randomized Treatment Period|Not Specified|1
241763|NCT01405820|798066|P3|Randomized Treatment Period|Not Specified|1
241764|NCT01405820|798067|P2|Randomized Treatment Period|Not Specified|2
241765|NCT01405820|798068|P1|Randomized Treatment Period|Not Specified|2
241766|NCT01405820|798063|P6|Randomized Treatment Period|Withdrawal by Subject|0
241767|NCT01405820|798064|P5|Randomized Treatment Period|Withdrawal by Subject|0
241768|NCT01405820|798065|P4|Randomized Treatment Period|Withdrawal by Subject|2
241769|NCT01405820|798066|P3|Randomized Treatment Period|Withdrawal by Subject|2
241770|NCT01405820|798067|P2|Randomized Treatment Period|Withdrawal by Subject|2
241771|NCT01405820|798068|P1|Randomized Treatment Period|Withdrawal by Subject|6
241772|NCT01405820|798063|P6|Randomized Treatment Period|Adverse Event|1
241773|NCT01405820|798064|P5|Randomized Treatment Period|Adverse Event|2
241774|NCT01405820|798065|P4|Randomized Treatment Period|Adverse Event|0
241775|NCT01405820|798066|P3|Randomized Treatment Period|Adverse Event|3
241776|NCT01405820|798067|P2|Randomized Treatment Period|Adverse Event|3
241777|NCT01405820|798068|P1|Randomized Treatment Period|Adverse Event|3
241778|NCT01405768|798164|P2|Overall Study|Didn't complete questionnaire correctly|0
241779|NCT01405768|798165|P1|Overall Study|Didn't complete questionnaire correctly|4
241780|NCT01405742|798177|P2|Overall Study|Lost to Follow-up|0
241781|NCT01405742|798178|P1|Overall Study|Lost to Follow-up|1
241782|NCT01405560|798188|P1|Overall Study|Physician Decision|1
241783|NCT01405508|798203|P4|Overall Study|AE, non-serious non-fatal|0
241784|NCT01405508|798204|P3|Overall Study|AE, non-serious non-fatal|0
241785|NCT01405508|798205|P2|Overall Study|AE, non-serious non-fatal|1
241786|NCT01405508|798206|P1|Overall Study|AE, non-serious non-fatal|1
241787|NCT01405027|798246|P2|Overall Study|Other or Unknown|25
241788|NCT01405027|798247|P1|Overall Study|Other or Unknown|12
241789|NCT01405027|798246|P2|Overall Study|Death|0
241790|NCT01405027|798247|P1|Overall Study|Death|1
241791|NCT01405027|798246|P2|Overall Study|Investigator judgement|2
241792|NCT01405027|798247|P1|Overall Study|Investigator judgement|0
241793|NCT01405027|798246|P2|Overall Study|Lost to Follow-up|24
241794|NCT01405027|798247|P1|Overall Study|Lost to Follow-up|16
241795|NCT01405027|798246|P2|Overall Study|Withdrawn consent|0
241796|NCT01405027|798247|P1|Overall Study|Withdrawn consent|3
241797|NCT01404988|798264|P3|Overall Study|Lost to Follow-up|1
241798|NCT01404988|798265|P2|Overall Study|Lost to Follow-up|2
241799|NCT01404988|798266|P1|Overall Study|Lost to Follow-up|1
241800|NCT01404988|798264|P3|Overall Study|Withdrawal by Subject|0
241801|NCT01404988|798265|P2|Overall Study|Withdrawal by Subject|2
241802|NCT01404988|798266|P1|Overall Study|Withdrawal by Subject|2
241803|NCT01404988|798264|P3|Overall Study|Adverse Event|0
241804|NCT01404988|798265|P2|Overall Study|Adverse Event|0
241805|NCT01404988|798266|P1|Overall Study|Adverse Event|1
241806|NCT01404988|798264|P3|Overall Study|Death|2
241807|NCT01404988|798265|P2|Overall Study|Death|0
241808|NCT01404988|798266|P1|Overall Study|Death|2
241809|NCT01404234|798394|P1|Overall Study|Withdrawal by Subject|2
241810|NCT01404208|798410|P2|Overall Study|Discontinued|0
241811|NCT01404208|798411|P1|Overall Study|Discontinued|3
241812|NCT01403987|798476|P3|Overall Study|Residents forgot their secret PIN|18
241813|NCT01403987|798477|P2|Overall Study|Residents forgot their secret PIN|17
241814|NCT01403987|798478|P1|Overall Study|Residents forgot their secret PIN|18
241815|NCT01403805|798494|P2|Overall Study|Death|1
241816|NCT01403805|798495|P1|Overall Study|Death|0
241817|NCT01403805|798494|P2|Overall Study|Lost to Follow-up|2
241818|NCT01403805|798495|P1|Overall Study|Lost to Follow-up|0
241819|NCT01403805|798494|P2|Overall Study|Withdrawal by Subject|4
241820|NCT01403805|798495|P1|Overall Study|Withdrawal by Subject|0
241821|NCT01403194|798532|P1|Overall Study|Lost to Follow-up|8
241822|NCT01403194|798532|P1|Overall Study|Screen Failure|2
241823|NCT01403051|798544|P2|Overall Study|Lost to Follow-up|5
241824|NCT01403051|798545|P1|Overall Study|Lost to Follow-up|5
241825|NCT01403051|798544|P2|Overall Study|Withdrawal by Subject|1
241826|NCT01403051|798545|P1|Overall Study|Withdrawal by Subject|2
241827|NCT01403051|798544|P2|Overall Study|Death|0
241828|NCT01403051|798545|P1|Overall Study|Death|1
241829|NCT01403051|798544|P2|Overall Study|Protocol Violation|0
241830|NCT01403051|798545|P1|Overall Study|Protocol Violation|2
241831|NCT01402986|798581|P4|Overall Study|Unspecified|6
241832|NCT01402986|798582|P3|Overall Study|Unspecified|1
241833|NCT01402986|798583|P2|Overall Study|Unspecified|5
241834|NCT01402986|798584|P1|Overall Study|Unspecified|2
241835|NCT01402986|798581|P4|Overall Study|Lost to Follow-up|1
241836|NCT01402986|798582|P3|Overall Study|Lost to Follow-up|0
241837|NCT01402986|798583|P2|Overall Study|Lost to Follow-up|0
241838|NCT01402986|798584|P1|Overall Study|Lost to Follow-up|0
241839|NCT01402986|798581|P4|Overall Study|Death|2
241840|NCT01402986|798582|P3|Overall Study|Death|0
241841|NCT01402986|798583|P2|Overall Study|Death|0
241842|NCT01402986|798584|P1|Overall Study|Death|0
241843|NCT01402986|798581|P4|Overall Study|Withdrawal by Subject|13
241844|NCT01402986|798582|P3|Overall Study|Withdrawal by Subject|7
241845|NCT01402986|798583|P2|Overall Study|Withdrawal by Subject|10
241846|NCT01402986|798584|P1|Overall Study|Withdrawal by Subject|7
241847|NCT01402947|798719|P2|First Intervention|Adverse Event|1
241848|NCT01402947|798720|P1|First Intervention|Adverse Event|0
241849|NCT01402869|798731|P3|Overall Study|Required Tooth Extraction|1
241850|NCT01402869|798732|P2|Overall Study|Required Tooth Extraction|0
241851|NCT01402869|798733|P1|Overall Study|Required Tooth Extraction|0
241852|NCT01402817|798747|P1|Overall Study|Study Suspended by FDA|8
241853|NCT01402817|798747|P1|Overall Study|Withdrawal by Subject|3
241854|NCT01402700|798752|P1|Overall Study|Missed Visit|1
241855|NCT01402700|798752|P1|Overall Study|Withdrawal by Subject|3
241856|NCT01402700|798752|P1|Overall Study|Death|3
241857|NCT01402570|798756|P1|Overall Study|Adverse Event|1
241858|NCT01402284|798784|P1|Overall Study|Non compliance|2
241859|NCT01402284|798784|P1|Overall Study|Disease progression on study|9
241860|NCT01402284|798784|P1|Overall Study|Physician Decision|1
241861|NCT01402284|798784|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
241862|NCT01402284|798784|P1|Overall Study|Withdrawal consent|1
241863|NCT01402102|798866|P2|Overall Study|Withdrawal by Subject|2
241864|NCT01402102|798867|P1|Overall Study|Withdrawal by Subject|0
241865|NCT01402102|798866|P2|Overall Study|Insufficiency of compliance|1
241866|NCT01402102|798867|P1|Overall Study|Insufficiency of compliance|1
241867|NCT01402102|798866|P2|Overall Study|Protocol Violation|0
241868|NCT01402102|798867|P1|Overall Study|Protocol Violation|1
241869|NCT01402063|798887|P2|Overall Study|Withdrawal by Subject|3
241870|NCT01402063|798888|P1|Overall Study|Withdrawal by Subject|3
241871|NCT01401842|798896|P2|Overall Study|other/unknown|17
241872|NCT01401842|798897|P1|Overall Study|other/unknown|28
241873|NCT01401842|798896|P2|Overall Study|on profile|5
241874|NCT01401842|798897|P1|Overall Study|on profile|9
241875|NCT01401842|798896|P2|Overall Study|invalid follow-up strength data|4
241876|NCT01401842|798897|P1|Overall Study|invalid follow-up strength data|1
241877|NCT01401842|798896|P2|Overall Study|discharged from US Army|4
241878|NCT01401842|798897|P1|Overall Study|discharged from US Army|3
241879|NCT01401842|798896|P2|Overall Study|changed companies|34
241880|NCT01401842|798897|P1|Overall Study|changed companies|20
241881|NCT01401842|798896|P2|Overall Study|academic reason|1
241882|NCT01401842|798897|P1|Overall Study|academic reason|4
241883|NCT01401842|798896|P2|Overall Study|Withdrawal by Subject|2
241884|NCT01401842|798897|P1|Overall Study|Withdrawal by Subject|3
241885|NCT01401647|798910|P3|Overall Study|Lost to Follow-up|1
241886|NCT01401647|798911|P2|Overall Study|Lost to Follow-up|3
241887|NCT01401647|798912|P1|Overall Study|Lost to Follow-up|3
241888|NCT01401647|798910|P3|Overall Study|Withdrawal by Subject|2
241889|NCT01401647|798911|P2|Overall Study|Withdrawal by Subject|5
241890|NCT01401647|798912|P1|Overall Study|Withdrawal by Subject|1
241891|NCT01401478|798967|P1|Overall Study|Serious adverse event|1
241892|NCT01401478|798967|P1|Overall Study|Low intact parathyroid hormone|1
241893|NCT01401478|798967|P1|Overall Study|Hyperphosphatemia and adverse event|1
241894|NCT01401478|798967|P1|Overall Study|Blood samples not available|1
241895|NCT01401478|798967|P1|Overall Study|Withdrawal by Subject|3
241896|NCT01401478|798967|P1|Overall Study|Kidney transplantation|3
241897|NCT01401478|798967|P1|Overall Study|Lost to Follow-up|5
241898|NCT01401478|798967|P1|Overall Study|Hyperphosphatemia|5
241899|NCT01401478|798967|P1|Overall Study|Adverse Event|5
241900|NCT01401478|798967|P1|Overall Study|Study drug not available|6
241901|NCT01401465|798980|P2|Treatment Period 2|Withdrawal by Subject|1
241902|NCT01401465|798981|P1|Treatment Period 2|Withdrawal by Subject|0
241903|NCT01401465|798980|P2|Treatment Period 2|Lost to Follow-up|1
241904|NCT01401465|798981|P1|Treatment Period 2|Lost to Follow-up|0
241905|NCT01401465|798980|P2|Treatment Period 1|Scheduling Difficulties|1
241906|NCT01401465|798981|P1|Treatment Period 1|Scheduling Difficulties|1
241907|NCT01401465|798980|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
241908|NCT01401465|798981|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
241909|NCT01401465|798980|P2|Treatment Period 1|Non-Compliance to Study Drug|0
241910|NCT01401465|798981|P1|Treatment Period 1|Non-Compliance to Study Drug|1
241911|NCT01401465|798980|P2|Treatment Period 1|Withdrawal by Subject|4
241912|NCT01401465|798981|P1|Treatment Period 1|Withdrawal by Subject|1
241913|NCT01401465|798980|P2|Treatment Period 1|Protocol Violation|0
241914|NCT01401465|798981|P1|Treatment Period 1|Protocol Violation|5
241915|NCT01401465|798980|P2|Treatment Period 1|Pregnancy|1
241916|NCT01401465|798981|P1|Treatment Period 1|Pregnancy|0
241917|NCT01401465|798980|P2|Treatment Period 1|Adverse Event|1
241918|NCT01401465|798981|P1|Treatment Period 1|Adverse Event|4
241919|NCT01401361|799044|P1|Overall Study|Subject/family decision post procedure|2
241920|NCT01401361|799044|P1|Overall Study|Lost to Follow-up|3
241921|NCT01401361|799044|P1|Overall Study|Physician Decision|1
241922|NCT01401361|799044|P1|Overall Study|Lack of Efficacy|6
241923|NCT01401361|799044|P1|Overall Study|Withdrawal by Subject|16
241924|NCT01401322|799050|P1|Overall Study|Physician Decision|1
241925|NCT01401322|799050|P1|Overall Study|Withdrawal by Subject|1
241926|NCT01401283|799056|P2|Overall Study|suspicion of malignant hyperthermia|1
241927|NCT01401283|799057|P1|Overall Study|suspicion of malignant hyperthermia|0
241928|NCT01401283|799056|P2|Overall Study|no central venous access|1
241929|NCT01401283|799057|P1|Overall Study|no central venous access|0
241930|NCT01401283|799056|P2|Overall Study|preoperative arrhythmia|0
241931|NCT01401283|799057|P1|Overall Study|preoperative arrhythmia|5
241932|NCT01401283|799056|P2|Overall Study|surgery cancelled|8
241933|NCT01401283|799057|P1|Overall Study|surgery cancelled|5
241934|NCT01401153|799123|P2|Second Test Day|illness|5
241935|NCT01401153|799124|P1|Second Test Day|illness|0
241936|NCT01401153|799123|P2|First Test Day|Learning disabilities; illness|10
241937|NCT01401153|799124|P1|First Test Day|Learning disabilities; illness|1
241938|NCT01401062|799171|P2|Overall Study|Withdrawal by Subject|1
241939|NCT01401062|799172|P1|Overall Study|Withdrawal by Subject|1
241940|NCT01401062|799171|P2|Overall Study|Physician Decision|0
241941|NCT01401062|799172|P1|Overall Study|Physician Decision|1
241942|NCT01401062|799171|P2|Overall Study|Death|7
241943|NCT01401062|799172|P1|Overall Study|Death|9
241944|NCT01401010|799195|P2|Overall Study|Could not interpret assay results|0
241945|NCT01401010|799196|P1|Overall Study|Could not interpret assay results|1
241946|NCT01400958|799221|P2|Overall Study|Adverse Event|0
241947|NCT01400958|799222|P1|Overall Study|Adverse Event|1
241948|NCT01400958|799221|P2|Overall Study|Withdrawal by Subject|1
241949|NCT01400958|799222|P1|Overall Study|Withdrawal by Subject|0
241950|NCT01400958|799221|P2|Overall Study|Physician Decision|1
241951|NCT01400958|799222|P1|Overall Study|Physician Decision|0
241952|NCT01400932|799232|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
241953|NCT01400932|799233|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
241954|NCT01400932|799232|P2|Overall Study|Protocol Deviation|1
241955|NCT01400932|799233|P1|Overall Study|Protocol Deviation|0
241956|NCT01400932|799232|P2|Overall Study|Lost to Follow-up|0
241957|NCT01400932|799233|P1|Overall Study|Lost to Follow-up|1
241958|NCT01400932|799232|P2|Overall Study|Withdrawal by Subject|6
241959|NCT01400932|799233|P1|Overall Study|Withdrawal by Subject|2
241960|NCT01400932|799232|P2|Overall Study|Lack of Efficacy|3
241961|NCT01400932|799233|P1|Overall Study|Lack of Efficacy|0
241962|NCT01400932|799232|P2|Overall Study|Adverse Event|5
241963|NCT01400932|799233|P1|Overall Study|Adverse Event|10
241964|NCT01400919|799255|P1|Overall Study|Missed visit|2
241965|NCT01400919|799255|P1|Overall Study|Lost to Follow-up|2
241966|NCT01400919|799255|P1|Overall Study|Withdrawal by Subject|4
241967|NCT01400841|799300|P1|Extended Study Phase (2 Years)|Adverse Event|2
241968|NCT01400841|799300|P1|Initial Study Phase (6 Months)|Death|1
241969|NCT01400698|799338|P6|Overall Study|Unspecified|0
241970|NCT01400698|799339|P5|Overall Study|Unspecified|1
241971|NCT01400698|799340|P4|Overall Study|Unspecified|2
241972|NCT01400698|799341|P3|Overall Study|Unspecified|0
241973|NCT01400698|799342|P2|Overall Study|Unspecified|2
241974|NCT01400698|799343|P1|Overall Study|Unspecified|4
241975|NCT01400698|799338|P6|Overall Study|Adverse Event|0
241976|NCT01400698|799339|P5|Overall Study|Adverse Event|0
241977|NCT01400698|799340|P4|Overall Study|Adverse Event|0
241978|NCT01400698|799341|P3|Overall Study|Adverse Event|0
241979|NCT01400698|799342|P2|Overall Study|Adverse Event|0
241980|NCT01400698|799343|P1|Overall Study|Adverse Event|1
241981|NCT01400698|799338|P6|Overall Study|Non-compliance|0
241982|NCT01400698|799339|P5|Overall Study|Non-compliance|0
241983|NCT01400698|799340|P4|Overall Study|Non-compliance|1
241984|NCT01400698|799341|P3|Overall Study|Non-compliance|0
241985|NCT01400698|799342|P2|Overall Study|Non-compliance|1
241986|NCT01400698|799343|P1|Overall Study|Non-compliance|0
241987|NCT01400698|799338|P6|Overall Study|Protocol Violation|0
241988|NCT01400698|799339|P5|Overall Study|Protocol Violation|1
241989|NCT01400698|799340|P4|Overall Study|Protocol Violation|0
241990|NCT01400698|799341|P3|Overall Study|Protocol Violation|0
241991|NCT01400698|799342|P2|Overall Study|Protocol Violation|1
241992|NCT01400698|799343|P1|Overall Study|Protocol Violation|0
241993|NCT01400698|799338|P6|Overall Study|Withdrawal by Subject|3
241994|NCT01400698|799339|P5|Overall Study|Withdrawal by Subject|1
241995|NCT01400698|799340|P4|Overall Study|Withdrawal by Subject|4
241996|NCT01400698|799341|P3|Overall Study|Withdrawal by Subject|0
241997|NCT01400698|799342|P2|Overall Study|Withdrawal by Subject|2
241998|NCT01400698|799343|P1|Overall Study|Withdrawal by Subject|8
241999|NCT01400698|799338|P6|Overall Study|Lost to Follow-up|3
242000|NCT01400698|799339|P5|Overall Study|Lost to Follow-up|4
242001|NCT01400698|799340|P4|Overall Study|Lost to Follow-up|1
242002|NCT01400698|799341|P3|Overall Study|Lost to Follow-up|2
242003|NCT01400698|799342|P2|Overall Study|Lost to Follow-up|5
242004|NCT01400698|799343|P1|Overall Study|Lost to Follow-up|2
242005|NCT01400516|799367|P2|Primary Trial|Withdrawal by Subject|2
242006|NCT01400516|799368|P1|Primary Trial|Withdrawal by Subject|0
242007|NCT01400451|799381|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
242008|NCT01400451|799382|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
242009|NCT01400451|799383|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
242010|NCT01400451|799381|P3|Combination Treatment (or Intended)|Disease Progression|1
242011|NCT01400451|799382|P2|Combination Treatment (or Intended)|Disease Progression|1
242012|NCT01400451|799383|P1|Combination Treatment (or Intended)|Disease Progression|3
242013|NCT01400451|799381|P3|Combination Treatment (or Intended)|Adverse Event|0
242014|NCT01400451|799382|P2|Combination Treatment (or Intended)|Adverse Event|0
242015|NCT01400451|799383|P1|Combination Treatment (or Intended)|Adverse Event|1
242016|NCT01400451|799381|P3|Combination Treatment (or Intended)|Drug Toxicity|0
242017|NCT01400451|799382|P2|Combination Treatment (or Intended)|Drug Toxicity|1
242018|NCT01400451|799383|P1|Combination Treatment (or Intended)|Drug Toxicity|0
242019|NCT01400451|799381|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
242020|NCT01400451|799382|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
242021|NCT01400451|799383|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
242022|NCT01400425|799397|P1|Overall Study|Withdrawal by Subject|10
242023|NCT01400412|799410|P2|Overall Study|Never started study treatment|3
242024|NCT01400412|799411|P1|Overall Study|Never started study treatment|0
242025|NCT01400412|799410|P2|Overall Study|Unable to complete|3
242026|NCT01400412|799411|P1|Overall Study|Unable to complete|3
242027|NCT01400412|799410|P2|Overall Study|Withdrawal by Subject|4
242028|NCT01400412|799411|P1|Overall Study|Withdrawal by Subject|3
242029|NCT01400412|799410|P2|Overall Study|Lost to Follow-up|7
242030|NCT01400412|799411|P1|Overall Study|Lost to Follow-up|4
242031|NCT01400243|799457|P2|Overall Study|Protocol Violation|11
242032|NCT01400243|799458|P1|Overall Study|Protocol Violation|8
242033|NCT01400139|799480|P1|HYD Extension Period|Administrative|10
242034|NCT01400139|799480|P1|HYD Extension Period|Withdrawal by Subject|5
242035|NCT01400139|799480|P1|HYD Extension Period|Adverse Event|8
242036|NCT01400139|799480|P1|HYD Core Study|Did not qualify for Maintenance Period|14
242037|NCT01400139|799480|P1|HYD Core Study|Administrative|56
242038|NCT01400139|799480|P1|HYD Core Study|Confirmed or suspected diversion|20
242039|NCT01400139|799480|P1|HYD Core Study|Lost to Follow-up|39
242040|NCT01400139|799480|P1|HYD Core Study|Withdrawal by Subject|114
242041|NCT01400139|799480|P1|HYD Core Study|Lack of Efficacy|59
242042|NCT01400139|799480|P1|HYD Core Study|Adverse Event|210
242043|NCT01400113|799490|P2|Overall Study|Withdrawal by Subject|1
242044|NCT01400113|799491|P1|Overall Study|Withdrawal by Subject|1
242045|NCT01399788|799506|P2|First Intervention Period|Adverse Event|0
242046|NCT01399788|799507|P1|First Intervention Period|Adverse Event|1
242047|NCT01399723|799529|P2|Overall Study|Lost to Follow-up|1
242048|NCT01399723|799530|P1|Overall Study|Lost to Follow-up|0
242049|NCT01399697|799543|P3|Overall Study|Sponsor Decision|0
242050|NCT01399697|799544|P2|Overall Study|Sponsor Decision|0
242051|NCT01399697|799545|P1|Overall Study|Sponsor Decision|1
242052|NCT01399697|799543|P3|Overall Study|Clinical RA remission|0
242053|NCT01399697|799544|P2|Overall Study|Clinical RA remission|0
242054|NCT01399697|799545|P1|Overall Study|Clinical RA remission|1
242055|NCT01399697|799543|P3|Overall Study|Positive result for hepatitis B|0
242056|NCT01399697|799544|P2|Overall Study|Positive result for hepatitis B|0
242057|NCT01399697|799545|P1|Overall Study|Positive result for hepatitis B|1
242058|NCT01399697|799543|P3|Overall Study|Inclusion Error|0
242059|NCT01399697|799544|P2|Overall Study|Inclusion Error|0
242060|NCT01399697|799545|P1|Overall Study|Inclusion Error|2
242061|NCT01399697|799543|P3|Overall Study|Non-Compliant|0
242062|NCT01399697|799544|P2|Overall Study|Non-Compliant|0
242063|NCT01399697|799545|P1|Overall Study|Non-Compliant|1
242064|NCT01399697|799543|P3|Overall Study|Protocol Violation|0
242065|NCT01399697|799544|P2|Overall Study|Protocol Violation|0
242066|NCT01399697|799545|P1|Overall Study|Protocol Violation|2
242067|NCT01399697|799543|P3|Overall Study|Lack of Efficacy|1
242068|NCT01399697|799544|P2|Overall Study|Lack of Efficacy|0
242069|NCT01399697|799545|P1|Overall Study|Lack of Efficacy|9
242070|NCT01399697|799543|P3|Overall Study|Investigator Decisión|2
242071|NCT01399697|799544|P2|Overall Study|Investigator Decisión|0
242072|NCT01399697|799545|P1|Overall Study|Investigator Decisión|1
242073|NCT01399697|799543|P3|Overall Study|Withdrawal by Subject|0
242074|NCT01399697|799544|P2|Overall Study|Withdrawal by Subject|0
242075|NCT01399697|799545|P1|Overall Study|Withdrawal by Subject|8
242076|NCT01399697|799543|P3|Overall Study|Lost to Follow-up|0
242077|NCT01399697|799544|P2|Overall Study|Lost to Follow-up|0
242078|NCT01399697|799545|P1|Overall Study|Lost to Follow-up|2
242079|NCT01399697|799543|P3|Overall Study|Adverse Event|1
242080|NCT01399697|799544|P2|Overall Study|Adverse Event|3
242081|NCT01399697|799545|P1|Overall Study|Adverse Event|13
242082|NCT01399619|799572|P4|Overall Study|Not treated|2
242083|NCT01399619|799573|P3|Overall Study|Not treated|0
242084|NCT01399619|799574|P2|Overall Study|Not treated|0
242085|NCT01399619|799575|P1|Overall Study|Not treated|0
242086|NCT01399619|799572|P4|Overall Study|Protocol Violation|1
242087|NCT01399619|799573|P3|Overall Study|Protocol Violation|0
242088|NCT01399619|799574|P2|Overall Study|Protocol Violation|0
242089|NCT01399619|799575|P1|Overall Study|Protocol Violation|0
242090|NCT01399619|799572|P4|Overall Study|Withdrawal by Subject|4
242091|NCT01399619|799573|P3|Overall Study|Withdrawal by Subject|3
242092|NCT01399619|799574|P2|Overall Study|Withdrawal by Subject|0
242093|NCT01399619|799575|P1|Overall Study|Withdrawal by Subject|6
242094|NCT01399619|799572|P4|Overall Study|Lack of Efficacy|0
242095|NCT01399619|799573|P3|Overall Study|Lack of Efficacy|5
242096|NCT01399619|799574|P2|Overall Study|Lack of Efficacy|0
242097|NCT01399619|799575|P1|Overall Study|Lack of Efficacy|9
242098|NCT01399619|799572|P4|Overall Study|Adverse Event|10
242099|NCT01399619|799573|P3|Overall Study|Adverse Event|4
242100|NCT01399619|799574|P2|Overall Study|Adverse Event|0
242101|NCT01399619|799575|P1|Overall Study|Adverse Event|10
242102|NCT01399593|799638|P2|Overall Study|Transplantectomy|1
242103|NCT01399593|799639|P1|Overall Study|Transplantectomy|0
242104|NCT01399593|799638|P2|Overall Study|Death|1
242105|NCT01399593|799639|P1|Overall Study|Death|1
242106|NCT01399593|799638|P2|Overall Study|Adverse Event|0
242107|NCT01399593|799639|P1|Overall Study|Adverse Event|1
242108|NCT01399593|799638|P2|Overall Study|Physician Decision|0
242109|NCT01399593|799639|P1|Overall Study|Physician Decision|1
242110|NCT01399190|799651|P1|Overall Study|Physician Decision|2
242111|NCT01399190|799651|P1|Overall Study|Participant's Request|5
242112|NCT01399190|799651|P1|Overall Study|Adverse Event|8
242113|NCT01399190|799651|P1|Overall Study|Not Eligible for Final Analysis|5
242114|NCT01399125|799659|P2|Overall Study|Protocol Deviation|2
242115|NCT01399125|799660|P1|Overall Study|Protocol Deviation|5
242116|NCT01399125|799659|P2|Overall Study|Death|1
242117|NCT01399125|799660|P1|Overall Study|Death|0
242118|NCT01399125|799659|P2|Overall Study|Administrative Problems|11
242119|NCT01399125|799660|P1|Overall Study|Administrative Problems|7
242120|NCT01399125|799659|P2|Overall Study|Lost to Follow-up|3
242121|NCT01399125|799660|P1|Overall Study|Lost to Follow-up|2
242122|NCT01399125|799659|P2|Overall Study|Withdrawal by Subject|8
242123|NCT01399125|799660|P1|Overall Study|Withdrawal by Subject|5
242124|NCT01399125|799659|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
242125|NCT01399125|799660|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
242126|NCT01399125|799659|P2|Overall Study|Abnormal Lab values|1
242127|NCT01399125|799660|P1|Overall Study|Abnormal Lab values|0
242128|NCT01399125|799659|P2|Overall Study|Adverse Event|30
242129|NCT01399125|799660|P1|Overall Study|Adverse Event|32
242130|NCT01399099|799674|P1|Overall Study|Miscellaneous|4
242131|NCT01399099|799674|P1|Overall Study|Infection|1
242132|NCT01399099|799674|P1|Overall Study|Skin Irritation|13
242133|NCT01399099|799674|P1|Overall Study|Protocol Violation|1
242134|NCT01399099|799674|P1|Overall Study|Physician Decision|1
242135|NCT01399099|799674|P1|Overall Study|Lost to Follow-up|11
242136|NCT01399047|799681|P2|Overall Study|Withdrawal by Subject|1
242137|NCT01399047|799682|P1|Overall Study|Withdrawal by Subject|0
242138|NCT01398956|799710|P1|Overall Study|Subject moved a long distance|1
242139|NCT01398956|799710|P1|Overall Study|Withdrawal Criteria No.3|1
242140|NCT01398956|799710|P1|Overall Study|AE, non-serious non-fatal|4
242141|NCT01398956|799710|P1|Overall Study|Withdrawal by Subject|4
242142|NCT01398787|799729|P1|Overall Study|Adverse Event|1
242143|NCT01398514|799747|P2|Overall Study|Failure to show a conditioned response|3
242144|NCT01398514|799748|P1|Overall Study|Failure to show a conditioned response|4
242145|NCT01398514|799747|P2|Overall Study|Physiologic non-responsiveness|3
242146|NCT01398514|799748|P1|Overall Study|Physiologic non-responsiveness|1
242147|NCT01398514|799747|P2|Overall Study|Non-compliance with study procedures|0
242148|NCT01398514|799748|P1|Overall Study|Non-compliance with study procedures|2
242149|NCT01398514|799747|P2|Overall Study|Adverse Event|0
242150|NCT01398514|799748|P1|Overall Study|Adverse Event|1
242151|NCT01398410|799783|P2|Overall Study|Not Specified|29
242152|NCT01398410|799784|P1|Overall Study|Not Specified|36
242153|NCT01398410|799783|P2|Overall Study|Inadequate Therapeutic Effect|0
242154|NCT01398410|799784|P1|Overall Study|Inadequate Therapeutic Effect|2
242155|NCT01398410|799783|P2|Overall Study|Participants Choice|11
242156|NCT01398410|799784|P1|Overall Study|Participants Choice|8
242157|NCT01398410|799783|P2|Overall Study|Adverse Event|16
242158|NCT01398410|799784|P1|Overall Study|Adverse Event|12
242159|NCT01398176|799794|P2|Overall Study|Physician Decision|3
242160|NCT01398176|799795|P1|Overall Study|Physician Decision|2
242161|NCT01398176|799794|P2|Overall Study|Lost to Follow-up|3
242162|NCT01398176|799795|P1|Overall Study|Lost to Follow-up|1
242163|NCT01397890|799803|P2|Overall Study|Others|1
242164|NCT01397890|799804|P1|Overall Study|Others|2
242165|NCT01397890|799803|P2|Overall Study|Severe Non-Compliance to Protocol|1
242166|NCT01397890|799804|P1|Overall Study|Severe Non-Compliance to Protocol|2
242167|NCT01397890|799803|P2|Overall Study|Adverse Event|2
242168|NCT01397890|799804|P1|Overall Study|Adverse Event|1
242169|NCT01397890|799803|P2|Overall Study|Condition under Investigation Worsened|3
242170|NCT01397890|799804|P1|Overall Study|Condition under Investigation Worsened|1
242171|NCT01397890|799803|P2|Overall Study|Lost to Follow-up|4
242172|NCT01397890|799804|P1|Overall Study|Lost to Follow-up|1
242173|NCT01397890|799803|P2|Overall Study|Death|3
242174|NCT01397890|799804|P1|Overall Study|Death|2
242175|NCT01397890|799803|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
242176|NCT01397890|799804|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
242177|NCT01397890|799803|P2|Overall Study|Withdrawal by Subject|11
242178|NCT01397890|799804|P1|Overall Study|Withdrawal by Subject|7
242179|NCT01397786|799874|P3|Phase B|Lack of Efficacy|14
242180|NCT01397786|799875|P2|Phase B|Lack of Efficacy|7
242181|NCT01397786|799876|P1|Phase B|Lack of Efficacy|22
242182|NCT01397786|799874|P3|Phase B|Protocol Deviation|4
242183|NCT01397786|799875|P2|Phase B|Protocol Deviation|2
242184|NCT01397786|799876|P1|Phase B|Protocol Deviation|1
242185|NCT01397786|799874|P3|Phase B|Withdrawal by Subject|30
242186|NCT01397786|799875|P2|Phase B|Withdrawal by Subject|45
242187|NCT01397786|799876|P1|Phase B|Withdrawal by Subject|102
242188|NCT01397786|799874|P3|Phase B|Physician Decision|3
242189|NCT01397786|799875|P2|Phase B|Physician Decision|1
242190|NCT01397786|799876|P1|Phase B|Physician Decision|9
242191|NCT01397786|799874|P3|Phase B|Subject Met Withdrawal Criteria|38
242192|NCT01397786|799875|P2|Phase B|Subject Met Withdrawal Criteria|5
242193|NCT01397786|799876|P1|Phase B|Subject Met Withdrawal Criteria|38
242194|NCT01397786|799874|P3|Phase B|Adverse Event|27
242195|NCT01397786|799875|P2|Phase B|Adverse Event|23
242196|NCT01397786|799876|P1|Phase B|Adverse Event|109
242197|NCT01397786|799874|P3|Phase B|Lost to Follow-up|22
242198|NCT01397786|799875|P2|Phase B|Lost to Follow-up|12
242199|NCT01397786|799876|P1|Phase B|Lost to Follow-up|22
242200|NCT01397786|799874|P3|Phase A|Lack of Efficacy|1
242201|NCT01397786|799875|P2|Phase A|Lack of Efficacy|0
242202|NCT01397786|799876|P1|Phase A|Lack of Efficacy|0
242203|NCT01397786|799874|P3|Phase A|Withdrawal by Subject|5
242204|NCT01397786|799875|P2|Phase A|Withdrawal by Subject|0
242205|NCT01397786|799876|P1|Phase A|Withdrawal by Subject|0
242206|NCT01397786|799874|P3|Phase A|Physician Decision|1
242207|NCT01397786|799875|P2|Phase A|Physician Decision|0
242208|NCT01397786|799876|P1|Phase A|Physician Decision|0
242209|NCT01397786|799874|P3|Phase A|Subject Met Withdrawal Criteria|7
242210|NCT01397786|799875|P2|Phase A|Subject Met Withdrawal Criteria|0
242211|NCT01397786|799876|P1|Phase A|Subject Met Withdrawal Criteria|0
242212|NCT01397786|799874|P3|Phase A|Adverse Event|8
242213|NCT01397786|799875|P2|Phase A|Adverse Event|0
242214|NCT01397786|799876|P1|Phase A|Adverse Event|0
242215|NCT01397786|799874|P3|Phase A|Lost to Follow-up|6
242216|NCT01397786|799875|P2|Phase A|Lost to Follow-up|0
242217|NCT01397786|799876|P1|Phase A|Lost to Follow-up|0
242218|NCT01397747|799942|P1|Overall Study|FIT excluded|34
242219|NCT01397747|799942|P1|Overall Study|Colonoscopy excluded|304
242220|NCT01397747|799942|P1|Overall Study|Multitarget DNA test excluded|689
242221|NCT01397461|799974|P3|Overall Study|Not treated|1
242222|NCT01397461|799975|P2|Overall Study|Not treated|0
242223|NCT01397461|799976|P1|Overall Study|Not treated|0
242224|NCT01397461|799974|P3|Overall Study|Lack of Efficacy|0
242225|NCT01397461|799975|P2|Overall Study|Lack of Efficacy|3
242226|NCT01397461|799976|P1|Overall Study|Lack of Efficacy|0
242227|NCT01397461|799974|P3|Overall Study|Lost to Follow-up|1
242228|NCT01397461|799975|P2|Overall Study|Lost to Follow-up|2
242229|NCT01397461|799976|P1|Overall Study|Lost to Follow-up|0
242230|NCT01397461|799974|P3|Overall Study|Withdrawal by Subject|0
242231|NCT01397461|799975|P2|Overall Study|Withdrawal by Subject|1
242232|NCT01397461|799976|P1|Overall Study|Withdrawal by Subject|2
242233|NCT01397448|799987|P3|Overall Study|Not specified|4
242234|NCT01397448|799988|P2|Overall Study|Not specified|7
242235|NCT01397448|799989|P1|Overall Study|Not specified|8
242236|NCT01397448|799987|P3|Overall Study|Lack of Efficacy|5
242237|NCT01397448|799988|P2|Overall Study|Lack of Efficacy|0
242238|NCT01397448|799989|P1|Overall Study|Lack of Efficacy|2
242239|NCT01397448|799987|P3|Overall Study|Withdrawal by Subject|3
242240|NCT01397448|799988|P2|Overall Study|Withdrawal by Subject|4
242241|NCT01397448|799989|P1|Overall Study|Withdrawal by Subject|4
242242|NCT01397448|799987|P3|Overall Study|Adverse Event|6
242243|NCT01397448|799988|P2|Overall Study|Adverse Event|4
242244|NCT01397448|799989|P1|Overall Study|Adverse Event|4
242245|NCT01397409|800010|P10|Stage 3|Other Miscellaneous Reasons|0
242246|NCT01397409|800011|P9|Stage 3|Other Miscellaneous Reasons|0
242247|NCT01397409|800012|P8|Stage 3|Other Miscellaneous Reasons|1
242248|NCT01397409|800013|P7|Stage 3|Other Miscellaneous Reasons|0
242249|NCT01397409|800014|P6|Stage 3|Other Miscellaneous Reasons|0
242250|NCT01397409|800015|P5|Stage 3|Other Miscellaneous Reasons|0
242251|NCT01397409|800016|P4|Stage 3|Other Miscellaneous Reasons|0
242252|NCT01397409|800017|P3|Stage 3|Other Miscellaneous Reasons|0
242253|NCT01397409|800018|P2|Stage 3|Other Miscellaneous Reasons|0
242254|NCT01397409|800019|P1|Stage 3|Other Miscellaneous Reasons|0
242255|NCT01397409|800010|P10|Stage 3|Adverse Event|0
242256|NCT01397409|800011|P9|Stage 3|Adverse Event|0
242257|NCT01397409|800012|P8|Stage 3|Adverse Event|1
242258|NCT01397409|800013|P7|Stage 3|Adverse Event|0
242259|NCT01397409|800014|P6|Stage 3|Adverse Event|0
242260|NCT01397409|800015|P5|Stage 3|Adverse Event|0
242261|NCT01397409|800016|P4|Stage 3|Adverse Event|0
242262|NCT01397409|800017|P3|Stage 3|Adverse Event|0
242263|NCT01397409|800018|P2|Stage 3|Adverse Event|0
242264|NCT01397409|800019|P1|Stage 3|Adverse Event|0
242265|NCT01397409|800010|P10|Stage 2|Other Miscellaneous Reasons|0
242266|NCT01397409|800011|P9|Stage 2|Other Miscellaneous Reasons|0
242267|NCT01397409|800012|P8|Stage 2|Other Miscellaneous Reasons|0
242268|NCT01397409|800013|P7|Stage 2|Other Miscellaneous Reasons|0
242269|NCT01397409|800014|P6|Stage 2|Other Miscellaneous Reasons|1
242270|NCT01397409|800015|P5|Stage 2|Other Miscellaneous Reasons|1
242271|NCT01397409|800016|P4|Stage 2|Other Miscellaneous Reasons|0
242272|NCT01397409|800017|P3|Stage 2|Other Miscellaneous Reasons|0
242273|NCT01397409|800018|P2|Stage 2|Other Miscellaneous Reasons|0
242274|NCT01397409|800019|P1|Stage 2|Other Miscellaneous Reasons|0
242275|NCT01397409|800010|P10|Stage 2|Personal Reasons|0
242276|NCT01397409|800011|P9|Stage 2|Personal Reasons|0
242277|NCT01397409|800012|P8|Stage 2|Personal Reasons|0
242278|NCT01397409|800013|P7|Stage 2|Personal Reasons|0
242279|NCT01397409|800014|P6|Stage 2|Personal Reasons|0
242280|NCT01397409|800015|P5|Stage 2|Personal Reasons|1
242281|NCT01397409|800016|P4|Stage 2|Personal Reasons|0
242282|NCT01397409|800017|P3|Stage 2|Personal Reasons|0
242283|NCT01397409|800018|P2|Stage 2|Personal Reasons|0
242284|NCT01397409|800019|P1|Stage 2|Personal Reasons|0
242285|NCT01397409|800010|P10|Stage 2|Adverse Event|0
242286|NCT01397409|800011|P9|Stage 2|Adverse Event|0
242287|NCT01397409|800012|P8|Stage 2|Adverse Event|0
242288|NCT01397409|800013|P7|Stage 2|Adverse Event|0
242289|NCT01397409|800014|P6|Stage 2|Adverse Event|3
242290|NCT01397409|800015|P5|Stage 2|Adverse Event|6
242291|NCT01397409|800016|P4|Stage 2|Adverse Event|0
242292|NCT01397409|800017|P3|Stage 2|Adverse Event|0
242293|NCT01397409|800018|P2|Stage 2|Adverse Event|0
242294|NCT01397409|800019|P1|Stage 2|Adverse Event|0
242295|NCT01397253|800059|P2|Overall Study|Reviewed by only 1 pharmacist|149
242296|NCT01397253|800060|P1|Overall Study|Reviewed by only 1 pharmacist|126
242297|NCT01397084|800066|P1|Overall Study|Used other proton pump inhibitor|1
242298|NCT01397084|800066|P1|Overall Study|Lost to Follow-up|1
242299|NCT01397084|800066|P1|Overall Study|Withdrawal by Subject|1
242300|NCT01397084|800066|P1|Overall Study|Adverse Event|2
242301|NCT01397084|800066|P1|Overall Study|Protocol Violation|2
242302|NCT01397084|800066|P1|Overall Study|Severe Non-Compliance to Protocol|1
242303|NCT01396525|800073|P1|Overall Study|Lost to Follow-up|4
242304|NCT01396525|800073|P1|Overall Study|Death|14
242305|NCT01396525|800073|P1|Overall Study|Withdrawal by Subject|8
242306|NCT01396512|800173|P2|Overall Study|Withdrawal by Subject|1
242307|NCT01396512|800174|P1|Overall Study|Withdrawal by Subject|0
242308|NCT01396434|800189|P3|Overall Study|Unspecified|0
242309|NCT01396434|800190|P2|Overall Study|Unspecified|0
242310|NCT01396434|800191|P1|Overall Study|Unspecified|10
242311|NCT01396434|800189|P3|Overall Study|Lost to Follow-up|0
242312|NCT01396434|800190|P2|Overall Study|Lost to Follow-up|0
242313|NCT01396434|800191|P1|Overall Study|Lost to Follow-up|1
242314|NCT01396421|800203|P4|Overall Study|Lack of Efficacy|18
242315|NCT01396421|800204|P3|Overall Study|Lack of Efficacy|7
242316|NCT01396421|800205|P2|Overall Study|Lack of Efficacy|17
242317|NCT01396421|800206|P1|Overall Study|Lack of Efficacy|7
242318|NCT01396421|800203|P4|Overall Study|Protocol Deviation|0
242319|NCT01396421|800204|P3|Overall Study|Protocol Deviation|1
242320|NCT01396421|800205|P2|Overall Study|Protocol Deviation|1
242321|NCT01396421|800206|P1|Overall Study|Protocol Deviation|2
242322|NCT01396421|800203|P4|Overall Study|Withdrawal by Subject|21
242323|NCT01396421|800204|P3|Overall Study|Withdrawal by Subject|13
242324|NCT01396421|800205|P2|Overall Study|Withdrawal by Subject|24
242325|NCT01396421|800206|P1|Overall Study|Withdrawal by Subject|31
242326|NCT01396421|800203|P4|Overall Study|Physician Decision|3
242327|NCT01396421|800204|P3|Overall Study|Physician Decision|0
242328|NCT01396421|800205|P2|Overall Study|Physician Decision|1
242329|NCT01396421|800206|P1|Overall Study|Physician Decision|1
242330|NCT01396421|800203|P4|Overall Study|Participant Met Withdrawal Criteria|0
242331|NCT01396421|800204|P3|Overall Study|Participant Met Withdrawal Criteria|1
242332|NCT01396421|800205|P2|Overall Study|Participant Met Withdrawal Criteria|0
242333|NCT01396421|800206|P1|Overall Study|Participant Met Withdrawal Criteria|1
242334|NCT01396421|800203|P4|Overall Study|Adverse Event|32
242335|NCT01396421|800204|P3|Overall Study|Adverse Event|12
242336|NCT01396421|800205|P2|Overall Study|Adverse Event|15
242337|NCT01396421|800206|P1|Overall Study|Adverse Event|17
242338|NCT01396421|800203|P4|Overall Study|Lost to Follow-up|1
242339|NCT01396421|800204|P3|Overall Study|Lost to Follow-up|0
242340|NCT01396421|800205|P2|Overall Study|Lost to Follow-up|0
242341|NCT01396421|800206|P1|Overall Study|Lost to Follow-up|0
242342|NCT01396395|800278|P2|Overall Study|Unspecified|1
242343|NCT01396395|800279|P1|Overall Study|Unspecified|0
242344|NCT01396395|800278|P2|Overall Study|Lost to Follow-up|11
242345|NCT01396395|800279|P1|Overall Study|Lost to Follow-up|17
242346|NCT01396395|800278|P2|Overall Study|Adverse Event|2
242347|NCT01396395|800279|P1|Overall Study|Adverse Event|10
242348|NCT01396395|800278|P2|Overall Study|Protocol Violation|1
242349|NCT01396395|800279|P1|Overall Study|Protocol Violation|3
242350|NCT01396395|800278|P2|Overall Study|Withdrawal by Subject|12
242351|NCT01396395|800279|P1|Overall Study|Withdrawal by Subject|10
242352|NCT01396265|800319|P1|Rifa+Afatinib|Withdrawal by Subject|1
242353|NCT01396187|800408|P5|Overall Study|Unspecified|1
242354|NCT01396187|800409|P4|Overall Study|Unspecified|0
242355|NCT01396187|800410|P3|Overall Study|Unspecified|0
242356|NCT01396187|800411|P2|Overall Study|Unspecified|1
242357|NCT01396187|800412|P1|Overall Study|Unspecified|1
242358|NCT01396187|800408|P5|Overall Study|Withdrawal by Subject|0
242359|NCT01396187|800409|P4|Overall Study|Withdrawal by Subject|0
242360|NCT01396187|800410|P3|Overall Study|Withdrawal by Subject|1
242361|NCT01396187|800411|P2|Overall Study|Withdrawal by Subject|1
242362|NCT01396187|800412|P1|Overall Study|Withdrawal by Subject|0
242363|NCT01396187|800408|P5|Overall Study|Adverse Event|0
242364|NCT01396187|800409|P4|Overall Study|Adverse Event|0
242365|NCT01396187|800410|P3|Overall Study|Adverse Event|0
242366|NCT01396187|800411|P2|Overall Study|Adverse Event|1
242367|NCT01396187|800412|P1|Overall Study|Adverse Event|0
242368|NCT01396161|800512|P7|Overall Study|unspecified|1
242369|NCT01396161|800513|P6|Overall Study|unspecified|0
242370|NCT01396161|800514|P5|Overall Study|unspecified|0
242371|NCT01396161|800515|P4|Overall Study|unspecified|0
242372|NCT01396161|800516|P3|Overall Study|unspecified|0
242373|NCT01396161|800517|P2|Overall Study|unspecified|0
242374|NCT01396161|800518|P1|Overall Study|unspecified|0
242375|NCT01396161|800512|P7|Overall Study|Withdrawal by Subject|0
242376|NCT01396161|800513|P6|Overall Study|Withdrawal by Subject|0
242377|NCT01396161|800514|P5|Overall Study|Withdrawal by Subject|1
242378|NCT01396161|800515|P4|Overall Study|Withdrawal by Subject|0
242379|NCT01396161|800516|P3|Overall Study|Withdrawal by Subject|0
242380|NCT01396161|800517|P2|Overall Study|Withdrawal by Subject|0
242381|NCT01396161|800518|P1|Overall Study|Withdrawal by Subject|0
242382|NCT01396083|800573|P2|Overall Study|Lost to Follow-up|0
242383|NCT01396083|800574|P1|Overall Study|Lost to Follow-up|1
242384|NCT01396083|800573|P2|Overall Study|Administrative problems|0
242385|NCT01396083|800574|P1|Overall Study|Administrative problems|1
242386|NCT01396083|800573|P2|Overall Study|Abnormal laboratory value(s)|0
242387|NCT01396083|800574|P1|Overall Study|Abnormal laboratory value(s)|1
242388|NCT01396083|800573|P2|Overall Study|Protocol deviation(s)|1
242389|NCT01396083|800574|P1|Overall Study|Protocol deviation(s)|0
242390|NCT01396083|800573|P2|Overall Study|Consent withdrawn|5
242391|NCT01396083|800574|P1|Overall Study|Consent withdrawn|4
242392|NCT01396083|800573|P2|Overall Study|Unsatisfactory therapeutic effect|13
242393|NCT01396083|800574|P1|Overall Study|Unsatisfactory therapeutic effect|2
242394|NCT01396083|800573|P2|Overall Study|Adverse Event|28
242395|NCT01396083|800574|P1|Overall Study|Adverse Event|2
242396|NCT01396070|800598|P1|Overall Study|Lack of Efficacy|4
242397|NCT01396070|800598|P1|Overall Study|Physician Decision|3
242398|NCT01396070|800598|P1|Overall Study|Adverse Event|8
242399|NCT01396070|800598|P1|Overall Study|Death|2
242400|NCT01396070|800598|P1|Overall Study|Withdrawal by Subject|2
242401|NCT01396057|800607|P2|Overall Study|Consent withdrawn|2
242402|NCT01396057|800608|P1|Overall Study|Consent withdrawn|3
242403|NCT01396057|800607|P2|Overall Study|Protocol deviation|4
242404|NCT01396057|800608|P1|Overall Study|Protocol deviation|4
242405|NCT01396057|800607|P2|Overall Study|Unsatisfactory therapeutic effect|6
242406|NCT01396057|800608|P1|Overall Study|Unsatisfactory therapeutic effect|2
242407|NCT01396057|800607|P2|Overall Study|Adverse Event|6
242408|NCT01396057|800608|P1|Overall Study|Adverse Event|2
242409|NCT01396005|800657|P2|Overall Study|Non-compliance with protocol|1
242410|NCT01396005|800658|P1|Overall Study|Non-compliance with protocol|0
242411|NCT01396005|800657|P2|Overall Study|Withdrawal by Subject|1
242412|NCT01396005|800658|P1|Overall Study|Withdrawal by Subject|0
242413|NCT01395901|800689|P2|Overall Study|Withdrawal of consent|0
242414|NCT01395901|800690|P1|Overall Study|Withdrawal of consent|1
242415|NCT01395901|800689|P2|Overall Study|Adverse Event|1
242416|NCT01395901|800690|P1|Overall Study|Adverse Event|0
242417|NCT01395901|800689|P2|Overall Study|Randomized but not received study drug|4
242418|NCT01395901|800690|P1|Overall Study|Randomized but not received study drug|5
242419|NCT01395901|800689|P2|Overall Study|Lost to Follow-up|0
242420|NCT01395901|800690|P1|Overall Study|Lost to Follow-up|4
242421|NCT01395888|800706|P3|Treatment Period (TP)|Withdrawal by Subject|3
242422|NCT01395888|800707|P2|Treatment Period (TP)|Withdrawal by Subject|2
242423|NCT01395888|800708|P1|Treatment Period (TP)|Withdrawal by Subject|0
242424|NCT01395888|800706|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
242425|NCT01395888|800707|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
242426|NCT01395888|800708|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
242427|NCT01395888|800706|P3|Treatment Period (TP)|Protocol Violation|5
242428|NCT01395888|800707|P2|Treatment Period (TP)|Protocol Violation|1
242429|NCT01395888|800708|P1|Treatment Period (TP)|Protocol Violation|0
242430|NCT01395888|800706|P3|Treatment Period (TP)|Lack of Efficacy|3
242431|NCT01395888|800707|P2|Treatment Period (TP)|Lack of Efficacy|4
242432|NCT01395888|800708|P1|Treatment Period (TP)|Lack of Efficacy|0
242433|NCT01395888|800706|P3|Treatment Period (TP)|Adverse Event|6
242434|NCT01395888|800707|P2|Treatment Period (TP)|Adverse Event|7
242435|NCT01395888|800708|P1|Treatment Period (TP)|Adverse Event|0
242436|NCT01395888|800706|P3|2-week Run-in Period|Withdrawal by Subject|0
242437|NCT01395888|800707|P2|2-week Run-in Period|Withdrawal by Subject|0
242438|NCT01395888|800708|P1|2-week Run-in Period|Withdrawal by Subject|4
242439|NCT01395888|800706|P3|2-week Run-in Period|Protocol Violation|0
242440|NCT01395888|800707|P2|2-week Run-in Period|Protocol Violation|0
242441|NCT01395888|800708|P1|2-week Run-in Period|Protocol Violation|2
242442|NCT01395888|800706|P3|2-week Run-in Period|Lost to Follow-up|0
242443|NCT01395888|800707|P2|2-week Run-in Period|Lost to Follow-up|0
242444|NCT01395888|800708|P1|2-week Run-in Period|Lost to Follow-up|1
242445|NCT01395888|800706|P3|2-week Run-in Period|Continuation Criteria Not Met|0
242446|NCT01395888|800707|P2|2-week Run-in Period|Continuation Criteria Not Met|0
242447|NCT01395888|800708|P1|2-week Run-in Period|Continuation Criteria Not Met|13
242448|NCT01395888|800706|P3|2-week Run-in Period|Adverse Event|0
242449|NCT01395888|800707|P2|2-week Run-in Period|Adverse Event|0
242450|NCT01395888|800708|P1|2-week Run-in Period|Adverse Event|2
242451|NCT01395823|800716|P2|Overall Study|Withdrawal by Subject|4
242452|NCT01395823|800717|P1|Overall Study|Withdrawal by Subject|5
242453|NCT01395823|800716|P2|Overall Study|GI symptoms|0
242454|NCT01395823|800717|P1|Overall Study|GI symptoms|1
242455|NCT01395823|800716|P2|Overall Study|Transplant|0
242456|NCT01395823|800717|P1|Overall Study|Transplant|1
242457|NCT01395823|800716|P2|Overall Study|Lost to Follow-up|0
242458|NCT01395823|800717|P1|Overall Study|Lost to Follow-up|1
242459|NCT01395823|800716|P2|Overall Study|Physician Decision|1
242460|NCT01395823|800717|P1|Overall Study|Physician Decision|3
242461|NCT01395823|800716|P2|Overall Study|Death|4
242462|NCT01395823|800717|P1|Overall Study|Death|4
242463|NCT01395784|800723|P1|Overall Study|Physician Decision|5
242464|NCT01395784|800723|P1|Overall Study|Withdrawal by Subject|3
242465|NCT01395784|800723|P1|Overall Study|Lost to Follow-up|7
242466|NCT01395524|800737|P3|Overall Study|Subject had spinal surgery|1
242467|NCT01395524|800738|P2|Overall Study|Subject had spinal surgery|0
242468|NCT01395524|800739|P1|Overall Study|Subject had spinal surgery|0
242469|NCT01395524|800737|P3|Overall Study|Did not receive treatment|3
242470|NCT01395524|800738|P2|Overall Study|Did not receive treatment|1
242471|NCT01395524|800739|P1|Overall Study|Did not receive treatment|1
242472|NCT01395524|800737|P3|Overall Study|Withdrawal by Subject|8
242473|NCT01395524|800738|P2|Overall Study|Withdrawal by Subject|8
242474|NCT01395524|800739|P1|Overall Study|Withdrawal by Subject|4
242475|NCT01395524|800737|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
242476|NCT01395524|800738|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
242477|NCT01395524|800739|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
242478|NCT01395524|800737|P3|Overall Study|Death|0
242479|NCT01395524|800738|P2|Overall Study|Death|0
242480|NCT01395524|800739|P1|Overall Study|Death|1
242481|NCT01395524|800737|P3|Overall Study|Adverse Event|3
242482|NCT01395524|800738|P2|Overall Study|Adverse Event|4
242483|NCT01395524|800739|P1|Overall Study|Adverse Event|4
242484|NCT01395524|800737|P3|Overall Study|Severe noncompliance with protocol|0
242485|NCT01395524|800738|P2|Overall Study|Severe noncompliance with protocol|0
242486|NCT01395524|800739|P1|Overall Study|Severe noncompliance with protocol|1
242487|NCT01395524|800737|P3|Overall Study|Study-Specific Withdrawal Criteria|0
242488|NCT01395524|800738|P2|Overall Study|Study-Specific Withdrawal Criteria|2
242489|NCT01395524|800739|P1|Overall Study|Study-Specific Withdrawal Criteria|1
242490|NCT01395524|800737|P3|Overall Study|Lost to Follow-up|1
242491|NCT01395524|800738|P2|Overall Study|Lost to Follow-up|1
242492|NCT01395524|800739|P1|Overall Study|Lost to Follow-up|3
242493|NCT01395524|800737|P3|Overall Study|Non-compliance with study schedule|1
242494|NCT01395524|800738|P2|Overall Study|Non-compliance with study schedule|0
242495|NCT01395524|800739|P1|Overall Study|Non-compliance with study schedule|1
242496|NCT01395394|800762|P3|Baseline Study Visit|Protocol Violation|0
242497|NCT01395394|800763|P2|Baseline Study Visit|Protocol Violation|0
242498|NCT01395394|800764|P1|Baseline Study Visit|Protocol Violation|1
242499|NCT01395368|800775|P1|Overall Study|Withdrawal by Subject|2
242500|NCT01395368|800775|P1|Overall Study|Physician Decision|14
242501|NCT01395017|800797|P2|Overall Study|Sponsor discontinued study|4
242502|NCT01395017|800798|P1|Overall Study|Sponsor discontinued study|1
242503|NCT01395017|800797|P2|Overall Study|Disease progression|58
242504|NCT01395017|800798|P1|Overall Study|Disease progression|42
242505|NCT01395017|800797|P2|Overall Study|Death|3
242506|NCT01395017|800798|P1|Overall Study|Death|4
242507|NCT01395017|800797|P2|Overall Study|Protocol deviation|2
242508|NCT01395017|800798|P1|Overall Study|Protocol deviation|1
242509|NCT01395017|800797|P2|Overall Study|Withdrawal by Subject|8
242510|NCT01395017|800798|P1|Overall Study|Withdrawal by Subject|14
242511|NCT01395017|800797|P2|Overall Study|Physician Decision|15
242512|NCT01395017|800798|P1|Overall Study|Physician Decision|11
242513|NCT01395017|800797|P2|Overall Study|Adverse Event|12
242514|NCT01395017|800798|P1|Overall Study|Adverse Event|26
242515|NCT01395017|800797|P2|Overall Study|Lost to Follow-up|0
242516|NCT01395017|800798|P1|Overall Study|Lost to Follow-up|1
242517|NCT01394991|800808|P2|Overall Study|Prematurely Termination of Trial|10
242518|NCT01394991|800809|P1|Overall Study|Prematurely Termination of Trial|9
242519|NCT01394991|800808|P2|Overall Study|Disease Progression|7
242520|NCT01394991|800809|P1|Overall Study|Disease Progression|7
242521|NCT01394991|800808|P2|Overall Study|Chemotherapy Termination|15
242522|NCT01394991|800809|P1|Overall Study|Chemotherapy Termination|10
242523|NCT01394991|800808|P2|Overall Study|Withdrawal by Subject|17
242524|NCT01394991|800809|P1|Overall Study|Withdrawal by Subject|20
242525|NCT01394991|800808|P2|Overall Study|Protocol Violation|1
242526|NCT01394991|800809|P1|Overall Study|Protocol Violation|1
242527|NCT01394991|800808|P2|Overall Study|Physician Decision|3
242528|NCT01394991|800809|P1|Overall Study|Physician Decision|1
242529|NCT01394991|800808|P2|Overall Study|Lost to Follow-up|8
242530|NCT01394991|800809|P1|Overall Study|Lost to Follow-up|6
242531|NCT01394991|800808|P2|Overall Study|Lack of Efficacy|7
242532|NCT01394991|800809|P1|Overall Study|Lack of Efficacy|5
242533|NCT01394991|800808|P2|Overall Study|Adverse Event|4
242534|NCT01394991|800809|P1|Overall Study|Adverse Event|0
242535|NCT01394718|800840|P2|Overall Study|Met protocol-specific stopping criteria|1
242536|NCT01394718|800841|P1|Overall Study|Met protocol-specific stopping criteria|2
242537|NCT01394276|800871|P1|Overall Study|Symptoms of concurrent diseases|1
242538|NCT01394276|800871|P1|Overall Study|unavailability of drug at the Hospital|2
242539|NCT01394276|800871|P1|Overall Study|Pregnancy|1
242540|NCT01394276|800871|P1|Overall Study|Participant moved to another site|1
242541|NCT01394276|800871|P1|Overall Study|Lost to Follow-up|5
242542|NCT01394276|800871|P1|Overall Study|Insufficient compliance|9
242543|NCT01394276|800871|P1|Overall Study|Insufficient therapeutic effect|17
242544|NCT01394276|800871|P1|Overall Study|Remission of disease|2
242545|NCT01394276|800871|P1|Overall Study|Not related AEs|9
242546|NCT01394276|800871|P1|Overall Study|Related Adverse event (AEs)|15
242547|NCT01394250|800895|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
242548|NCT01394250|800896|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
242549|NCT01394250|800895|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
242550|NCT01394250|800896|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
242551|NCT01393964|800920|P3|Overall Study|non-specified|1
242552|NCT01393964|800921|P2|Overall Study|non-specified|0
242553|NCT01393964|800922|P1|Overall Study|non-specified|2
242554|NCT01393964|800920|P3|Overall Study|study drug toxicity|0
242555|NCT01393964|800921|P2|Overall Study|study drug toxicity|0
242556|NCT01393964|800922|P1|Overall Study|study drug toxicity|1
242557|NCT01393964|800920|P3|Overall Study|Disease Progression|3
242558|NCT01393964|800921|P2|Overall Study|Disease Progression|3
242559|NCT01393964|800922|P1|Overall Study|Disease Progression|3
242560|NCT01393964|800920|P3|Overall Study|Withdrawal by Subject|1
242561|NCT01393964|800921|P2|Overall Study|Withdrawal by Subject|0
242562|NCT01393964|800922|P1|Overall Study|Withdrawal by Subject|0
242563|NCT01393964|800920|P3|Overall Study|Adverse Event|0
242564|NCT01393964|800921|P2|Overall Study|Adverse Event|1
242565|NCT01393964|800922|P1|Overall Study|Adverse Event|0
242566|NCT01393899|800963|P3|Overall Study|Adverse Event|3
242567|NCT01393899|800964|P2|Overall Study|Adverse Event|5
242568|NCT01393899|800965|P1|Overall Study|Adverse Event|1
242569|NCT01393899|800963|P3|Overall Study|Lack of Efficacy|16
242570|NCT01393899|800964|P2|Overall Study|Lack of Efficacy|21
242571|NCT01393899|800965|P1|Overall Study|Lack of Efficacy|26
242572|NCT01393899|800963|P3|Overall Study|Does not meet entrance criteria|1
242573|NCT01393899|800964|P2|Overall Study|Does not meet entrance criteria|0
242574|NCT01393899|800965|P1|Overall Study|Does not meet entrance criteria|1
242575|NCT01393899|800963|P3|Overall Study|Lost to Follow-up|1
242576|NCT01393899|800964|P2|Overall Study|Lost to Follow-up|0
242577|NCT01393899|800965|P1|Overall Study|Lost to Follow-up|0
242578|NCT01393899|800963|P3|Overall Study|Withdrawal by Subject|1
242579|NCT01393899|800964|P2|Overall Study|Withdrawal by Subject|2
242580|NCT01393899|800965|P1|Overall Study|Withdrawal by Subject|2
242581|NCT01393899|800963|P3|Overall Study|Unspecified|0
242582|NCT01393899|800964|P2|Overall Study|Unspecified|0
242583|NCT01393899|800965|P1|Overall Study|Unspecified|1
242584|NCT01393899|800963|P3|Overall Study|Study terminated by sponsor|1
242585|NCT01393899|800964|P2|Overall Study|Study terminated by sponsor|0
242586|NCT01393899|800965|P1|Overall Study|Study terminated by sponsor|1
242587|NCT01393743|801019|P2|Overall Study|Inadequate therapeutic effect|0
242588|NCT01393743|801020|P1|Overall Study|Inadequate therapeutic effect|2
242589|NCT01393743|801019|P2|Overall Study|Participant's Choice|3
242590|NCT01393743|801020|P1|Overall Study|Participant's Choice|2
242591|NCT01393743|801019|P2|Overall Study|Lost to Follow-up|1
242592|NCT01393743|801020|P1|Overall Study|Lost to Follow-up|1
242593|NCT01393743|801019|P2|Overall Study|Adverse Event|9
242594|NCT01393743|801020|P1|Overall Study|Adverse Event|5
242595|NCT01393730|801038|P1|Overall Study|Adverse Event|1
242596|NCT01393730|801038|P1|Overall Study|Other|2
242597|NCT01393730|801038|P1|Overall Study|Withdrawal by Subject|3
242598|NCT01393626|801071|P4|Overall Study|Protocol Violation|0
242599|NCT01393626|801072|P3|Overall Study|Protocol Violation|2
242600|NCT01393626|801073|P2|Overall Study|Protocol Violation|0
242601|NCT01393626|801074|P1|Overall Study|Protocol Violation|1
242602|NCT01393626|801071|P4|Overall Study|Unspecified|0
242603|NCT01393626|801072|P3|Overall Study|Unspecified|0
242604|NCT01393626|801073|P2|Overall Study|Unspecified|0
242605|NCT01393626|801074|P1|Overall Study|Unspecified|1
242606|NCT01393626|801071|P4|Overall Study|Withdrawal by Subject|0
242607|NCT01393626|801072|P3|Overall Study|Withdrawal by Subject|0
242608|NCT01393626|801073|P2|Overall Study|Withdrawal by Subject|4
242609|NCT01393626|801074|P1|Overall Study|Withdrawal by Subject|6
242610|NCT01393626|801071|P4|Overall Study|Lost to Follow-up|0
242611|NCT01393626|801072|P3|Overall Study|Lost to Follow-up|1
242612|NCT01393626|801073|P2|Overall Study|Lost to Follow-up|1
242613|NCT01393626|801074|P1|Overall Study|Lost to Follow-up|1
242614|NCT01393626|801071|P4|Overall Study|Lack of Efficacy|1
242615|NCT01393626|801072|P3|Overall Study|Lack of Efficacy|4
242616|NCT01393626|801073|P2|Overall Study|Lack of Efficacy|6
242617|NCT01393626|801074|P1|Overall Study|Lack of Efficacy|6
242618|NCT01393626|801071|P4|Overall Study|Did not meet entrance criteria|0
242619|NCT01393626|801072|P3|Overall Study|Did not meet entrance criteria|0
242620|NCT01393626|801073|P2|Overall Study|Did not meet entrance criteria|0
242621|NCT01393626|801074|P1|Overall Study|Did not meet entrance criteria|1
242622|NCT01393626|801071|P4|Overall Study|Adverse Event|0
242623|NCT01393626|801072|P3|Overall Study|Adverse Event|5
242624|NCT01393626|801073|P2|Overall Study|Adverse Event|1
242625|NCT01393626|801074|P1|Overall Study|Adverse Event|2
242626|NCT01393613|801154|P4|Overall Study|Lack of Efficacy|21
242627|NCT01393613|801155|P3|Overall Study|Lack of Efficacy|16
242628|NCT01393613|801156|P2|Overall Study|Lack of Efficacy|20
242629|NCT01393613|801157|P1|Overall Study|Lack of Efficacy|9
242630|NCT01393613|801154|P4|Overall Study|Protocol Deviation|0
242631|NCT01393613|801155|P3|Overall Study|Protocol Deviation|0
242632|NCT01393613|801156|P2|Overall Study|Protocol Deviation|1
242633|NCT01393613|801157|P1|Overall Study|Protocol Deviation|2
242634|NCT01393613|801154|P4|Overall Study|Withdrawal by Subject|21
242635|NCT01393613|801155|P3|Overall Study|Withdrawal by Subject|23
242636|NCT01393613|801156|P2|Overall Study|Withdrawal by Subject|25
242637|NCT01393613|801157|P1|Overall Study|Withdrawal by Subject|15
242638|NCT01393613|801154|P4|Overall Study|Physician Decision|1
242639|NCT01393613|801155|P3|Overall Study|Physician Decision|0
242640|NCT01393613|801156|P2|Overall Study|Physician Decision|0
242641|NCT01393613|801157|P1|Overall Study|Physician Decision|2
242642|NCT01393613|801154|P4|Overall Study|Participant Met Withdrawal Criteria|1
242643|NCT01393613|801155|P3|Overall Study|Participant Met Withdrawal Criteria|2
242644|NCT01393613|801156|P2|Overall Study|Participant Met Withdrawal Criteria|0
242645|NCT01393613|801157|P1|Overall Study|Participant Met Withdrawal Criteria|0
242646|NCT01393613|801154|P4|Overall Study|Adverse Event|22
242647|NCT01393613|801155|P3|Overall Study|Adverse Event|13
242648|NCT01393613|801156|P2|Overall Study|Adverse Event|11
242649|NCT01393613|801157|P1|Overall Study|Adverse Event|11
242650|NCT01393444|801219|P1|Overall Study|Determined ineligible during screening.|2
242651|NCT01393444|801219|P1|Overall Study|Withdrawal by Subject|1
242652|NCT01393106|801239|P1|Overall Study|Lack of Efficacy|1
242653|NCT01393106|801239|P1|Overall Study|Withdrawal by Subject|1
242654|NCT01393106|801239|P1|Overall Study|Adverse Event|3
242655|NCT01392742|801256|P1|Overall Study|Missing information|13
242656|NCT01392742|801256|P1|Overall Study|Unspecified|3
242657|NCT01392742|801256|P1|Overall Study|Protocol Violation|14
242658|NCT01392742|801256|P1|Overall Study|Adverse event/intercurrent illness|17
242659|NCT01392742|801256|P1|Overall Study|ITR and Protocol deviation|1
242660|NCT01392742|801256|P1|Overall Study|Insufficient therapeutic response (ITR)|30
242661|NCT01392742|801256|P1|Overall Study|Lost to Follow-up|34
242662|NCT01392742|801256|P1|Overall Study|No treatment/no cooperation/withdrew|12
242663|NCT01392742|801256|P1|Overall Study|Failure to return|35
242664|NCT01392742|801256|P1|Overall Study|Premature study termination|42
242665|NCT01392677|801302|P2|Overall Study|Other reason|2
242666|NCT01392677|801303|P1|Overall Study|Other reason|3
242667|NCT01392677|801302|P2|Overall Study|Incorrect enrollment|3
242668|NCT01392677|801303|P1|Overall Study|Incorrect enrollment|2
242669|NCT01392677|801302|P2|Overall Study|Withdrawal by Subject|2
242670|NCT01392677|801303|P1|Overall Study|Withdrawal by Subject|0
242671|NCT01392677|801302|P2|Overall Study|Adverse Event|1
242672|NCT01392677|801303|P1|Overall Study|Adverse Event|3
242673|NCT01392573|801319|P2|Overall Study|Unclassified|6
242674|NCT01392573|801320|P1|Overall Study|Unclassified|9
242675|NCT01392573|801319|P2|Overall Study|Site closure|7
242676|NCT01392573|801320|P1|Overall Study|Site closure|8
242677|NCT01392573|801319|P2|Overall Study|Withdrawal Criteria|15
242678|NCT01392573|801320|P1|Overall Study|Withdrawal Criteria|13
242679|NCT01392573|801319|P2|Overall Study|Protocol Violation|2
242680|NCT01392573|801320|P1|Overall Study|Protocol Violation|0
242681|NCT01392573|801319|P2|Overall Study|Lack of Efficacy|2
242682|NCT01392573|801320|P1|Overall Study|Lack of Efficacy|1
242683|NCT01392573|801319|P2|Overall Study|Adverse Event|3
242684|NCT01392573|801320|P1|Overall Study|Adverse Event|1
242685|NCT01392560|801328|P1|Overall Study|discontinued during placebo run-in|2
242686|NCT01392560|801328|P1|Overall Study|not entered|8
242687|NCT01392560|801328|P1|Overall Study|Adverse Event|2
242688|NCT01392547|801334|P1|Overall Study|Unclassified|1
242689|NCT01392547|801334|P1|Overall Study|Withdrawal criteria|3
242690|NCT01392547|801334|P1|Overall Study|Non-compliance|2
242691|NCT01392547|801334|P1|Overall Study|Adverse Event|2
242692|NCT01392495|801348|P1|Overall Study|Adverse Event|3
242693|NCT01392495|801348|P1|Overall Study|Withdrawal by Subject|2
242694|NCT01392495|801348|P1|Overall Study|Administrative problems|8
242695|NCT01392495|801348|P1|Overall Study|Death|3
242696|NCT01392378|801365|P5|Toddler Dose|Withdrawal by Parent|1
242697|NCT01392378|801366|P4|Toddler Dose|Withdrawal by Parent|1
242698|NCT01392378|801367|P3|Toddler Dose|Withdrawal by Parent|0
242699|NCT01392378|801368|P2|Toddler Dose|Withdrawal by Parent|1
242700|NCT01392378|801369|P1|Toddler Dose|Withdrawal by Parent|0
242701|NCT01392378|801365|P5|Toddler Dose|Lost to Follow-up|0
242702|NCT01392378|801366|P4|Toddler Dose|Lost to Follow-up|1
242703|NCT01392378|801367|P3|Toddler Dose|Lost to Follow-up|0
242704|NCT01392378|801368|P2|Toddler Dose|Lost to Follow-up|0
242705|NCT01392378|801369|P1|Toddler Dose|Lost to Follow-up|0
242706|NCT01392378|801365|P5|After Infant Series|Withdrawal by Parent|1
242707|NCT01392378|801366|P4|After Infant Series|Withdrawal by Parent|0
242708|NCT01392378|801367|P3|After Infant Series|Withdrawal by Parent|1
242709|NCT01392378|801368|P2|After Infant Series|Withdrawal by Parent|1
242710|NCT01392378|801369|P1|After Infant Series|Withdrawal by Parent|0
242711|NCT01392378|801365|P5|After Infant Series|Lost to Follow-up|0
242712|NCT01392378|801366|P4|After Infant Series|Lost to Follow-up|0
242713|NCT01392378|801367|P3|After Infant Series|Lost to Follow-up|1
242714|NCT01392378|801368|P2|After Infant Series|Lost to Follow-up|0
242715|NCT01392378|801369|P1|After Infant Series|Lost to Follow-up|0
242716|NCT01392378|801365|P5|Infant Series|Withdrawal by Parent|0
242717|NCT01392378|801366|P4|Infant Series|Withdrawal by Parent|0
242718|NCT01392378|801367|P3|Infant Series|Withdrawal by Parent|0
242719|NCT01392378|801368|P2|Infant Series|Withdrawal by Parent|1
242720|NCT01392378|801369|P1|Infant Series|Withdrawal by Parent|4
242721|NCT01392378|801365|P5|Infant Series|Protocol Violation|0
242722|NCT01392378|801366|P4|Infant Series|Protocol Violation|0
242723|NCT01392378|801367|P3|Infant Series|Protocol Violation|0
242724|NCT01392378|801368|P2|Infant Series|Protocol Violation|1
242725|NCT01392378|801369|P1|Infant Series|Protocol Violation|0
242726|NCT01392378|801365|P5|Infant Series|Lost to Follow-up|0
242727|NCT01392378|801366|P4|Infant Series|Lost to Follow-up|1
242728|NCT01392378|801367|P3|Infant Series|Lost to Follow-up|0
242729|NCT01392378|801368|P2|Infant Series|Lost to Follow-up|0
242730|NCT01392378|801369|P1|Infant Series|Lost to Follow-up|0
242731|NCT01392378|801365|P5|Infant Series|Adverse Event|0
242732|NCT01392378|801366|P4|Infant Series|Adverse Event|1
242733|NCT01392378|801367|P3|Infant Series|Adverse Event|0
242734|NCT01392378|801368|P2|Infant Series|Adverse Event|0
242735|NCT01392378|801369|P1|Infant Series|Adverse Event|0
242736|NCT01392326|801509|P3|Overall Study|Adverse Event|11
242737|NCT01392326|801510|P2|Overall Study|Adverse Event|6
242738|NCT01392326|801511|P1|Overall Study|Adverse Event|9
242739|NCT01392326|801509|P3|Overall Study|Lack of Efficacy|15
242740|NCT01392326|801510|P2|Overall Study|Lack of Efficacy|10
242741|NCT01392326|801511|P1|Overall Study|Lack of Efficacy|14
242742|NCT01392326|801509|P3|Overall Study|Lost to Follow-up|4
242743|NCT01392326|801510|P2|Overall Study|Lost to Follow-up|3
242744|NCT01392326|801511|P1|Overall Study|Lost to Follow-up|1
242745|NCT01392326|801509|P3|Overall Study|Physician Decision|2
242746|NCT01392326|801510|P2|Overall Study|Physician Decision|5
242747|NCT01392326|801511|P1|Overall Study|Physician Decision|7
242748|NCT01392326|801509|P3|Overall Study|Pregnancy|1
242749|NCT01392326|801510|P2|Overall Study|Pregnancy|0
242750|NCT01392326|801511|P1|Overall Study|Pregnancy|0
242751|NCT01392326|801509|P3|Overall Study|Protocol Violation|0
242752|NCT01392326|801510|P2|Overall Study|Protocol Violation|0
242753|NCT01392326|801511|P1|Overall Study|Protocol Violation|2
242754|NCT01392326|801509|P3|Overall Study|Withdrawal by Subject|15
242755|NCT01392326|801510|P2|Overall Study|Withdrawal by Subject|11
242756|NCT01392326|801511|P1|Overall Study|Withdrawal by Subject|12
242757|NCT01392326|801509|P3|Overall Study|Death|0
242758|NCT01392326|801510|P2|Overall Study|Death|0
242759|NCT01392326|801511|P1|Overall Study|Death|2
242760|NCT01392300|801548|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
242761|NCT01392300|801549|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
242762|NCT01392300|801550|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
242763|NCT01392300|801548|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
242764|NCT01392300|801549|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
242765|NCT01392300|801550|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
242766|NCT01392300|801548|P3|Open Label Extension (OLEX) Period|Adverse Event|7
242767|NCT01392300|801549|P2|Open Label Extension (OLEX) Period|Adverse Event|0
242768|NCT01392300|801550|P1|Open Label Extension (OLEX) Period|Adverse Event|0
242769|NCT01392300|801548|P3|Open Label Extension (OLEX) Period|Death|4
242770|NCT01392300|801549|P2|Open Label Extension (OLEX) Period|Death|0
242771|NCT01392300|801550|P1|Open Label Extension (OLEX) Period|Death|0
242772|NCT01392300|801548|P3|Open Label Extension (OLEX) Period|Non-compliance|1
242773|NCT01392300|801549|P2|Open Label Extension (OLEX) Period|Non-compliance|0
242774|NCT01392300|801550|P1|Open Label Extension (OLEX) Period|Non-compliance|0
242775|NCT01392300|801548|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
242776|NCT01392300|801549|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
242777|NCT01392300|801550|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
242778|NCT01392300|801548|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
242779|NCT01392300|801549|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
242780|NCT01392300|801550|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
242781|NCT01392300|801548|P3|Main Period (MP)|Non-compliance|0
242782|NCT01392300|801549|P2|Main Period (MP)|Non-compliance|0
242783|NCT01392300|801550|P1|Main Period (MP)|Non-compliance|1
242784|NCT01392300|801548|P3|Main Period (MP)|Lost to Follow-up|0
242785|NCT01392300|801549|P2|Main Period (MP)|Lost to Follow-up|3
242786|NCT01392300|801550|P1|Main Period (MP)|Lost to Follow-up|3
242787|NCT01392300|801548|P3|Main Period (MP)|Withdrawal by Subject|0
242788|NCT01392300|801549|P2|Main Period (MP)|Withdrawal by Subject|1
242789|NCT01392300|801550|P1|Main Period (MP)|Withdrawal by Subject|5
242790|NCT01392300|801548|P3|Main Period (MP)|Predefined discontinuation criteria|0
242791|NCT01392300|801549|P2|Main Period (MP)|Predefined discontinuation criteria|3
242792|NCT01392300|801550|P1|Main Period (MP)|Predefined discontinuation criteria|2
242793|NCT01392170|801678|P1|Overall Study|Ineligible|1
242794|NCT01392170|801678|P1|Overall Study|Withdrawal by Subject|1
242795|NCT01391819|801726|P1|Overall Study|Unspecified|9
242796|NCT01391819|801726|P1|Overall Study|Death|3
242797|NCT01391819|801726|P1|Overall Study|Lost to Follow-up|252
242798|NCT01391819|801726|P1|Overall Study|Migrated/moved from study area|82
242799|NCT01391819|801726|P1|Overall Study|Withdrawal by Subject|56
242800|NCT01391663|801757|P4|Overall Study|Withdrawal by Subject|0
242801|NCT01391663|801758|P3|Overall Study|Withdrawal by Subject|1
242802|NCT01391663|801759|P2|Overall Study|Withdrawal by Subject|0
242803|NCT01391663|801760|P1|Overall Study|Withdrawal by Subject|0
242804|NCT01391507|801806|P4|Overall Study|Protocol Violation|2
242805|NCT01391507|801807|P3|Overall Study|Protocol Violation|1
242806|NCT01391507|801808|P2|Overall Study|Protocol Violation|1
242807|NCT01391507|801809|P1|Overall Study|Protocol Violation|2
242808|NCT01391507|801806|P4|Overall Study|Lack of Efficacy|1
242809|NCT01391507|801807|P3|Overall Study|Lack of Efficacy|0
242810|NCT01391507|801808|P2|Overall Study|Lack of Efficacy|0
242811|NCT01391507|801809|P1|Overall Study|Lack of Efficacy|0
242812|NCT01391507|801806|P4|Overall Study|Withdrawal by Subject|1
242813|NCT01391507|801807|P3|Overall Study|Withdrawal by Subject|1
242814|NCT01391507|801808|P2|Overall Study|Withdrawal by Subject|2
242815|NCT01391507|801809|P1|Overall Study|Withdrawal by Subject|1
242816|NCT01391507|801806|P4|Overall Study|Adverse Event|2
242817|NCT01391507|801807|P3|Overall Study|Adverse Event|2
242818|NCT01391507|801808|P2|Overall Study|Adverse Event|1
242819|NCT01391507|801809|P1|Overall Study|Adverse Event|1
242820|NCT01391507|801806|P4|Overall Study|Death|1
242821|NCT01391507|801807|P3|Overall Study|Death|0
242822|NCT01391507|801808|P2|Overall Study|Death|0
242823|NCT01391507|801809|P1|Overall Study|Death|0
242824|NCT01390181|801870|P1|Overall Study|Study Terminated due to Low Accrual|3
242825|NCT01390181|801870|P1|Overall Study|Lost to Follow-up|1
242826|NCT01390857|802023|P1|Overall Study|No Visit after the First Visit|7
242827|NCT01390857|802023|P1|Overall Study|Lost to Follow-up|1
242828|NCT01390857|802023|P1|Overall Study|Protocol Violation|2
242829|NCT01390844|802034|P4|Follow-Up Phase|Non-Medical Reasons|0
242830|NCT01390844|802035|P3|Follow-Up Phase|Non-Medical Reasons|1
242831|NCT01390844|802036|P2|Follow-Up Phase|Non-Medical Reasons|1
242832|NCT01390844|802037|P1|Follow-Up Phase|Non-Medical Reasons|1
242833|NCT01390844|802034|P4|Treatment Phase|Non-GCP Compliant|3
242834|NCT01390844|802035|P3|Treatment Phase|Non-GCP Compliant|10
242835|NCT01390844|802036|P2|Treatment Phase|Non-GCP Compliant|0
242836|NCT01390844|802037|P1|Treatment Phase|Non-GCP Compliant|0
242837|NCT01390844|802034|P4|Treatment Phase|Non-Medical Reasons|1
242838|NCT01390844|802035|P3|Treatment Phase|Non-Medical Reasons|8
242839|NCT01390844|802036|P2|Treatment Phase|Non-Medical Reasons|1
242840|NCT01390844|802037|P1|Treatment Phase|Non-Medical Reasons|5
242841|NCT01390844|802034|P4|Treatment Phase|Treatment Failure|13
242842|NCT01390844|802035|P3|Treatment Phase|Treatment Failure|10
242843|NCT01390844|802036|P2|Treatment Phase|Treatment Failure|25
242844|NCT01390844|802037|P1|Treatment Phase|Treatment Failure|23
242845|NCT01390844|802034|P4|Treatment Phase|Adverse Event|2
242846|NCT01390844|802035|P3|Treatment Phase|Adverse Event|3
242847|NCT01390844|802036|P2|Treatment Phase|Adverse Event|2
242848|NCT01390844|802037|P1|Treatment Phase|Adverse Event|12
242849|NCT01390779|802364|P1|Overall Study|Physician Decision|1
242850|NCT01390649|802369|P1|Overall Study|Physician Decision|1
242851|NCT01390441|802379|P5|Extension Period|Protocol Violation|0
242852|NCT01390441|802380|P4|Extension Period|Protocol Violation|1
242853|NCT01390441|802381|P3|Extension Period|Protocol Violation|0
242854|NCT01390441|802382|P2|Extension Period|Protocol Violation|1
242855|NCT01390441|802383|P1|Extension Period|Protocol Violation|3
242856|NCT01390441|802379|P5|Treatment Period|Lost to Follow-up|0
242857|NCT01390441|802380|P4|Treatment Period|Lost to Follow-up|0
242858|NCT01390441|802381|P3|Treatment Period|Lost to Follow-up|0
242859|NCT01390441|802382|P2|Treatment Period|Lost to Follow-up|0
242860|NCT01390441|802383|P1|Treatment Period|Lost to Follow-up|1
242861|NCT01390441|802379|P5|Treatment Period|Withdrawal by Subject|1
242862|NCT01390441|802380|P4|Treatment Period|Withdrawal by Subject|0
242863|NCT01390441|802381|P3|Treatment Period|Withdrawal by Subject|1
242864|NCT01390441|802382|P2|Treatment Period|Withdrawal by Subject|0
242865|NCT01390441|802383|P1|Treatment Period|Withdrawal by Subject|0
242866|NCT01390441|802379|P5|Treatment Period|Adverse Event|2
242867|NCT01390441|802380|P4|Treatment Period|Adverse Event|1
242868|NCT01390441|802381|P3|Treatment Period|Adverse Event|1
242869|NCT01390441|802382|P2|Treatment Period|Adverse Event|0
242870|NCT01390441|802383|P1|Treatment Period|Adverse Event|0
242871|NCT01390441|802379|P5|Treatment Period|Unknown due to early stopping of study|7
242872|NCT01390441|802380|P4|Treatment Period|Unknown due to early stopping of study|11
242873|NCT01390441|802381|P3|Treatment Period|Unknown due to early stopping of study|8
242874|NCT01390441|802382|P2|Treatment Period|Unknown due to early stopping of study|0
242875|NCT01390441|802383|P1|Treatment Period|Unknown due to early stopping of study|0
242876|NCT01390441|802379|P5|Treatment Period|Lack of Efficacy|1
242877|NCT01390441|802380|P4|Treatment Period|Lack of Efficacy|0
242878|NCT01390441|802381|P3|Treatment Period|Lack of Efficacy|0
242879|NCT01390441|802382|P2|Treatment Period|Lack of Efficacy|0
242880|NCT01390441|802383|P1|Treatment Period|Lack of Efficacy|0
242881|NCT01390441|802379|P5|Treatment Period|Physician Decision|0
242882|NCT01390441|802380|P4|Treatment Period|Physician Decision|1
242883|NCT01390441|802381|P3|Treatment Period|Physician Decision|0
242884|NCT01390441|802382|P2|Treatment Period|Physician Decision|0
242885|NCT01390441|802383|P1|Treatment Period|Physician Decision|0
242886|NCT01390441|802379|P5|Treatment Period|Protocol Violation|0
242887|NCT01390441|802380|P4|Treatment Period|Protocol Violation|0
242888|NCT01390441|802381|P3|Treatment Period|Protocol Violation|0
242889|NCT01390441|802382|P2|Treatment Period|Protocol Violation|1
242890|NCT01390441|802383|P1|Treatment Period|Protocol Violation|0
242891|NCT01390428|802448|P6|Overall Study|Withdrawal by Subject|0
242892|NCT01390428|802449|P5|Overall Study|Withdrawal by Subject|0
242893|NCT01390428|802450|P4|Overall Study|Withdrawal by Subject|0
242894|NCT01390428|802451|P3|Overall Study|Withdrawal by Subject|1
242895|NCT01390428|802452|P2|Overall Study|Withdrawal by Subject|0
242896|NCT01390428|802453|P1|Overall Study|Withdrawal by Subject|0
242897|NCT01390428|802448|P6|Overall Study|Elective Surgery|0
242898|NCT01390428|802449|P5|Overall Study|Elective Surgery|1
242899|NCT01390428|802450|P4|Overall Study|Elective Surgery|0
242900|NCT01390428|802451|P3|Overall Study|Elective Surgery|0
242901|NCT01390428|802452|P2|Overall Study|Elective Surgery|0
242902|NCT01390428|802453|P1|Overall Study|Elective Surgery|0
242903|NCT01390402|802516|P1|Overall Study|Disease Progression|4
242904|NCT01390402|802516|P1|Overall Study|Death|1
242905|NCT01390389|802522|P2|Overall Study|Screen Fail|1
242906|NCT01390389|802523|P1|Overall Study|Screen Fail|2
242907|NCT01390389|802522|P2|Overall Study|Withdrawal by Subject|0
242908|NCT01390389|802523|P1|Overall Study|Withdrawal by Subject|2
242909|NCT01390038|802529|P1|Overall Study|Simpliciti System Removal|2
242910|NCT01390038|802529|P1|Overall Study|Withdrawal by Subject|4
242911|NCT01390038|802529|P1|Overall Study|Lost to Follow-up|1
242912|NCT01390038|802529|P1|Overall Study|Death|1
242913|NCT01389973|802539|P1|Overall Study|Unspecified|10
242914|NCT01389973|802539|P1|Overall Study|Trial Stopped by Sponsor|9
242915|NCT01389973|802539|P1|Overall Study|Lost to Follow-up|1
242916|NCT01389882|802549|P2|Overall Study|Withdrawal by Subject|1
242917|NCT01389882|802550|P1|Overall Study|Withdrawal by Subject|0
242918|NCT01389882|802549|P2|Overall Study|Respiratory rate > 80/min during study|3
242919|NCT01389882|802550|P1|Overall Study|Respiratory rate > 80/min during study|1
242920|NCT01389817|802638|P2|Overall Study|Withdrawal by Subject|0
242921|NCT01389817|802639|P1|Overall Study|Withdrawal by Subject|2
242922|NCT01389817|802638|P2|Overall Study|Lost to Follow-up|0
242923|NCT01389817|802639|P1|Overall Study|Lost to Follow-up|1
242924|NCT01389817|802638|P2|Overall Study|Physician Decision|0
242925|NCT01389817|802639|P1|Overall Study|Physician Decision|1
242926|NCT01389596|802648|P3|Overall Study|Other Unspecified|0
242927|NCT01389596|802649|P2|Overall Study|Other Unspecified|1
242928|NCT01389596|802650|P1|Overall Study|Other Unspecified|2
242929|NCT01389596|802648|P3|Overall Study|Death|0
242930|NCT01389596|802649|P2|Overall Study|Death|1
242931|NCT01389596|802650|P1|Overall Study|Death|0
242932|NCT01389596|802648|P3|Overall Study|Adverse Event|0
242933|NCT01389596|802649|P2|Overall Study|Adverse Event|4
242934|NCT01389596|802650|P1|Overall Study|Adverse Event|1
242935|NCT01389596|802648|P3|Overall Study|Insufficient Clinical Response|5
242936|NCT01389596|802649|P2|Overall Study|Insufficient Clinical Response|4
242937|NCT01389596|802650|P1|Overall Study|Insufficient Clinical Response|3
242938|NCT01389596|802648|P3|Overall Study|Withdrawal by Subject|2
242939|NCT01389596|802649|P2|Overall Study|Withdrawal by Subject|2
242940|NCT01389596|802650|P1|Overall Study|Withdrawal by Subject|1
242941|NCT01389596|802648|P3|Overall Study|Protocol Violation|3
242942|NCT01389596|802649|P2|Overall Study|Protocol Violation|4
242943|NCT01389596|802650|P1|Overall Study|Protocol Violation|3
242944|NCT01389323|802709|P1|Follow-up Period (up to 48 Weeks)|Unspecified|3
242945|NCT01389323|802709|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
242946|NCT01389323|802709|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
242947|NCT01389323|802709|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
242948|NCT01389323|802709|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
242949|NCT01389323|802709|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
242950|NCT01389323|802709|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
242951|NCT01389323|802709|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
242952|NCT01389323|802709|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
242953|NCT01389323|802709|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
242954|NCT01389323|802709|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
242955|NCT01389102|802772|P6|Overall Study|Investigator Judgement|0
242956|NCT01389102|802773|P5|Overall Study|Investigator Judgement|0
242957|NCT01389102|802774|P4|Overall Study|Investigator Judgement|0
242958|NCT01389102|802775|P3|Overall Study|Investigator Judgement|0
242959|NCT01389102|802776|P2|Overall Study|Investigator Judgement|1
242960|NCT01389102|802777|P1|Overall Study|Investigator Judgement|0
242961|NCT01389102|802772|P6|Overall Study|Unavailable due to husband's illness|0
242962|NCT01389102|802773|P5|Overall Study|Unavailable due to husband's illness|0
242963|NCT01389102|802774|P4|Overall Study|Unavailable due to husband's illness|0
242964|NCT01389102|802775|P3|Overall Study|Unavailable due to husband's illness|0
242965|NCT01389102|802776|P2|Overall Study|Unavailable due to husband's illness|1
242966|NCT01389102|802777|P1|Overall Study|Unavailable due to husband's illness|0
242967|NCT01389102|802772|P6|Overall Study|Subject Moved|0
242968|NCT01389102|802773|P5|Overall Study|Subject Moved|0
242969|NCT01389102|802774|P4|Overall Study|Subject Moved|0
242970|NCT01389102|802775|P3|Overall Study|Subject Moved|1
242971|NCT01389102|802776|P2|Overall Study|Subject Moved|0
242972|NCT01389102|802777|P1|Overall Study|Subject Moved|2
242973|NCT01389102|802772|P6|Overall Study|Subject Traveling Out of Country|0
242974|NCT01389102|802773|P5|Overall Study|Subject Traveling Out of Country|0
242975|NCT01389102|802774|P4|Overall Study|Subject Traveling Out of Country|1
242976|NCT01389102|802775|P3|Overall Study|Subject Traveling Out of Country|0
242977|NCT01389102|802776|P2|Overall Study|Subject Traveling Out of Country|0
242978|NCT01389102|802777|P1|Overall Study|Subject Traveling Out of Country|0
242979|NCT01389102|802772|P6|Overall Study|Withdrawal by Subject|3
242980|NCT01389102|802773|P5|Overall Study|Withdrawal by Subject|3
242981|NCT01389102|802774|P4|Overall Study|Withdrawal by Subject|2
242982|NCT01389102|802775|P3|Overall Study|Withdrawal by Subject|9
242983|NCT01389102|802776|P2|Overall Study|Withdrawal by Subject|4
242984|NCT01389102|802777|P1|Overall Study|Withdrawal by Subject|7
242985|NCT01389102|802772|P6|Overall Study|Protocol Violation|1
242986|NCT01389102|802773|P5|Overall Study|Protocol Violation|1
242987|NCT01389102|802774|P4|Overall Study|Protocol Violation|0
242988|NCT01389102|802775|P3|Overall Study|Protocol Violation|3
242989|NCT01389102|802776|P2|Overall Study|Protocol Violation|0
242990|NCT01389102|802777|P1|Overall Study|Protocol Violation|0
242991|NCT01389102|802772|P6|Overall Study|Lost to Follow-up|1
242992|NCT01389102|802773|P5|Overall Study|Lost to Follow-up|4
242993|NCT01389102|802774|P4|Overall Study|Lost to Follow-up|2
242994|NCT01389102|802775|P3|Overall Study|Lost to Follow-up|1
242995|NCT01389102|802776|P2|Overall Study|Lost to Follow-up|1
242996|NCT01389102|802777|P1|Overall Study|Lost to Follow-up|4
242997|NCT01389102|802772|P6|Overall Study|Hurricane Katrina|1
242998|NCT01389102|802773|P5|Overall Study|Hurricane Katrina|3
242999|NCT01389102|802774|P4|Overall Study|Hurricane Katrina|0
243000|NCT01389102|802775|P3|Overall Study|Hurricane Katrina|3
243001|NCT01389102|802776|P2|Overall Study|Hurricane Katrina|2
243002|NCT01389102|802777|P1|Overall Study|Hurricane Katrina|4
243003|NCT01389102|802772|P6|Overall Study|Adverse Event|2
243004|NCT01389102|802773|P5|Overall Study|Adverse Event|2
243005|NCT01389102|802774|P4|Overall Study|Adverse Event|2
243006|NCT01389102|802775|P3|Overall Study|Adverse Event|2
243007|NCT01389102|802776|P2|Overall Study|Adverse Event|3
243008|NCT01389102|802777|P1|Overall Study|Adverse Event|1
243009|NCT01388907|802855|P2|Overall Study|Adverse Event|0
243010|NCT01388907|802856|P1|Overall Study|Adverse Event|2
243011|NCT01388816|802872|P4|Overall Study|Protocol Violation|0
243012|NCT01388816|802873|P3|Overall Study|Protocol Violation|2
243013|NCT01388816|802874|P2|Overall Study|Protocol Violation|0
243014|NCT01388816|802875|P1|Overall Study|Protocol Violation|0
243015|NCT01388816|802872|P4|Overall Study|Withdrawal by Subject|0
243016|NCT01388816|802873|P3|Overall Study|Withdrawal by Subject|1
243017|NCT01388816|802874|P2|Overall Study|Withdrawal by Subject|1
243018|NCT01388816|802875|P1|Overall Study|Withdrawal by Subject|2
243019|NCT01388816|802872|P4|Overall Study|Lost to Follow-up|0
243020|NCT01388816|802873|P3|Overall Study|Lost to Follow-up|0
243021|NCT01388816|802874|P2|Overall Study|Lost to Follow-up|1
243022|NCT01388816|802875|P1|Overall Study|Lost to Follow-up|0
243023|NCT01388816|802872|P4|Overall Study|Adverse Event|0
243024|NCT01388816|802873|P3|Overall Study|Adverse Event|0
243025|NCT01388816|802874|P2|Overall Study|Adverse Event|2
243026|NCT01388816|802875|P1|Overall Study|Adverse Event|0
243027|NCT01388790|802904|P1|Overall Study|Ongoing at data cut−off date|8
243028|NCT01388647|802911|P2|Overall Study|Adverse Event|2
243029|NCT01388647|802912|P1|Overall Study|Adverse Event|1
243030|NCT01388530|802923|P1|Overall Study|Lost to Follow-up|5
243031|NCT01388491|802932|P2|Overall Study|Pregnancy|0
243032|NCT01388491|802933|P1|Overall Study|Pregnancy|1
243033|NCT01388491|802932|P2|Overall Study|Noncompliance|0
243034|NCT01388491|802933|P1|Overall Study|Noncompliance|2
243035|NCT01388491|802932|P2|Overall Study|Protocol Violation|0
243036|NCT01388491|802933|P1|Overall Study|Protocol Violation|2
243037|NCT01388491|802932|P2|Overall Study|Lost to Follow-up|3
243038|NCT01388491|802933|P1|Overall Study|Lost to Follow-up|4
243039|NCT01388491|802932|P2|Overall Study|Withdrawal by Subject|10
243040|NCT01388491|802933|P1|Overall Study|Withdrawal by Subject|6
243041|NCT01388491|802932|P2|Overall Study|Sponsor Request|7
243042|NCT01388491|802933|P1|Overall Study|Sponsor Request|9
243043|NCT01388491|802932|P2|Overall Study|Adverse Event|9
243044|NCT01388491|802933|P1|Overall Study|Adverse Event|10
243045|NCT01388361|802968|P3|Overall Study|Unclassified|1
243046|NCT01388361|802969|P2|Overall Study|Unclassified|0
243047|NCT01388361|802970|P1|Overall Study|Unclassified|0
243048|NCT01388361|802968|P3|Overall Study|Withdrawal criteria|10
243049|NCT01388361|802969|P2|Overall Study|Withdrawal criteria|7
243050|NCT01388361|802970|P1|Overall Study|Withdrawal criteria|12
243051|NCT01388361|802968|P3|Overall Study|Protocol Violation|2
243052|NCT01388361|802969|P2|Overall Study|Protocol Violation|0
243053|NCT01388361|802970|P1|Overall Study|Protocol Violation|0
243054|NCT01388361|802968|P3|Overall Study|Adverse Event|1
243055|NCT01388361|802969|P2|Overall Study|Adverse Event|5
243056|NCT01388361|802970|P1|Overall Study|Adverse Event|0
243057|NCT01388166|802987|P1|Overall Study|Others than specified above|13
243058|NCT01388166|802987|P1|Overall Study|Lost to Follow-up|30
243059|NCT01388166|802987|P1|Overall Study|Adverse Event|16
243060|NCT01387789|802993|P1|Overall Study|Lost to Follow-up|1
243061|NCT01387789|802993|P1|Overall Study|Lack of Efficacy|2
243062|NCT01387789|802993|P1|Overall Study|Adverse Event|5
243063|NCT01387737|803007|P2|Overall Study|Clearly not eligible for the study|3
243064|NCT01387737|803008|P1|Overall Study|Clearly not eligible for the study|1
243065|NCT01387737|803007|P2|Overall Study|Withdrawal by Subject|31
243066|NCT01387737|803008|P1|Overall Study|Withdrawal by Subject|27
243067|NCT01387737|803007|P2|Overall Study|Physician Decision|10
243068|NCT01387737|803008|P1|Overall Study|Physician Decision|3
243069|NCT01387737|803007|P2|Overall Study|Lack of Efficacy|0
243070|NCT01387737|803008|P1|Overall Study|Lack of Efficacy|1
243071|NCT01387737|803007|P2|Overall Study|Adverse Event|30
243072|NCT01387737|803008|P1|Overall Study|Adverse Event|20
243073|NCT01387594|803042|P2|Overall Study|Lost to Follow-up|1
243074|NCT01387594|803043|P1|Overall Study|Lost to Follow-up|0
243075|NCT01387594|803042|P2|Overall Study|Withdrawal by Subject|2
243076|NCT01387594|803043|P1|Overall Study|Withdrawal by Subject|0
243077|NCT01387542|803071|P1|Overall Study|Lost to Follow-up|1
243078|NCT01387542|803071|P1|Overall Study|Non-compliant|1
243079|NCT01387542|803071|P1|Overall Study|Insufficient response|1
243080|NCT01387542|803071|P1|Overall Study|Changed diagnosis|1
243081|NCT01387542|803071|P1|Overall Study|Withdrawal by Subject|1
243082|NCT01387542|803071|P1|Overall Study|Adverse Event|3
243083|NCT01387347|803089|P2|Overall Study|Lost to Follow-up|1
243084|NCT01387347|803090|P1|Overall Study|Lost to Follow-up|2
243085|NCT01387230|803103|P3|Overall Study|Withdrawal by Subject|0
243086|NCT01387230|803104|P2|Overall Study|Withdrawal by Subject|1
243087|NCT01387230|803105|P1|Overall Study|Withdrawal by Subject|4
243088|NCT01387230|803103|P3|Overall Study|Lost to Follow-up|1
243089|NCT01387230|803104|P2|Overall Study|Lost to Follow-up|0
243090|NCT01387230|803105|P1|Overall Study|Lost to Follow-up|0
243091|NCT01387230|803103|P3|Overall Study|Protocol-defined Stopping Criteria|5
243092|NCT01387230|803104|P2|Overall Study|Protocol-defined Stopping Criteria|0
243093|NCT01387230|803105|P1|Overall Study|Protocol-defined Stopping Criteria|6
243094|NCT01387230|803103|P3|Overall Study|Lack of Efficacy|4
243095|NCT01387230|803104|P2|Overall Study|Lack of Efficacy|5
243096|NCT01387230|803105|P1|Overall Study|Lack of Efficacy|8
243097|NCT01387230|803103|P3|Overall Study|Adverse Event|3
243098|NCT01387230|803104|P2|Overall Study|Adverse Event|1
243099|NCT01387230|803105|P1|Overall Study|Adverse Event|0
243100|NCT01387074|803151|P1|Overall Study|Lack of Efficacy|1
243101|NCT01387074|803151|P1|Overall Study|Lost to Follow-up|7
243102|NCT01387022|803164|P2|Overall Study|Lost to Follow-up|3
243103|NCT01387022|803165|P1|Overall Study|Lost to Follow-up|0
243104|NCT01387022|803164|P2|Overall Study|Death|1
243105|NCT01387022|803165|P1|Overall Study|Death|1
243106|NCT01386944|803192|P1|Overall Study|Unspecified reason|8
243107|NCT01386944|803192|P1|Overall Study|Lost to Follow-up|8
243108|NCT01386944|803192|P1|Overall Study|Lack of Efficacy|14
243109|NCT01386944|803192|P1|Overall Study|Adverse Event|26
243110|NCT01386788|803202|P1|Overall Study|Lost to Follow-up|2
243111|NCT01386606|803222|P4|Overall Study|T levels too high|0
243112|NCT01386606|803223|P3|Overall Study|T levels too high|1
243113|NCT01386606|803224|P2|Overall Study|T levels too high|1
243114|NCT01386606|803225|P1|Overall Study|T levels too high|0
243115|NCT01386606|803222|P4|Overall Study|Unable to draw PK|0
243116|NCT01386606|803223|P3|Overall Study|Unable to draw PK|0
243117|NCT01386606|803224|P2|Overall Study|Unable to draw PK|0
243118|NCT01386606|803225|P1|Overall Study|Unable to draw PK|1
243119|NCT01386606|803222|P4|Overall Study|Subject incarcerated|0
243120|NCT01386606|803223|P3|Overall Study|Subject incarcerated|0
243121|NCT01386606|803224|P2|Overall Study|Subject incarcerated|1
243122|NCT01386606|803225|P1|Overall Study|Subject incarcerated|0
243123|NCT01386606|803222|P4|Overall Study|Lost to Follow-up|0
243124|NCT01386606|803223|P3|Overall Study|Lost to Follow-up|0
243125|NCT01386606|803224|P2|Overall Study|Lost to Follow-up|0
243126|NCT01386606|803225|P1|Overall Study|Lost to Follow-up|2
243127|NCT01386606|803222|P4|Overall Study|Protocol Violation|1
243128|NCT01386606|803223|P3|Overall Study|Protocol Violation|1
243129|NCT01386606|803224|P2|Overall Study|Protocol Violation|0
243130|NCT01386606|803225|P1|Overall Study|Protocol Violation|1
243131|NCT01386606|803222|P4|Overall Study|Withdrawal by Subject|0
243132|NCT01386606|803223|P3|Overall Study|Withdrawal by Subject|1
243133|NCT01386606|803224|P2|Overall Study|Withdrawal by Subject|1
243134|NCT01386606|803225|P1|Overall Study|Withdrawal by Subject|0
243135|NCT01386606|803222|P4|Overall Study|Adverse Event|0
243136|NCT01386606|803223|P3|Overall Study|Adverse Event|0
243137|NCT01386606|803224|P2|Overall Study|Adverse Event|1
243138|NCT01386606|803225|P1|Overall Study|Adverse Event|0
243139|NCT01386125|803255|P2|Overall Study|Participant Leaving Country|0
243140|NCT01386125|803256|P1|Overall Study|Participant Leaving Country|1
243141|NCT01386125|803255|P2|Overall Study|Lack of Efficacy|1
243142|NCT01386125|803256|P1|Overall Study|Lack of Efficacy|0
243143|NCT01386125|803255|P2|Overall Study|Adverse Event|5
243144|NCT01386125|803256|P1|Overall Study|Adverse Event|2
243145|NCT01386125|803255|P2|Overall Study|Withdrawal by Subject|12
243146|NCT01386125|803256|P1|Overall Study|Withdrawal by Subject|13
243147|NCT01386125|803255|P2|Overall Study|Disease Progress|2
243148|NCT01386125|803256|P1|Overall Study|Disease Progress|1
243149|NCT01386125|803255|P2|Overall Study|Protocol Violation|7
243150|NCT01386125|803256|P1|Overall Study|Protocol Violation|5
243151|NCT01386125|803255|P2|Overall Study|Physician Decision|1
243152|NCT01386125|803256|P1|Overall Study|Physician Decision|0
243153|NCT01386125|803255|P2|Overall Study|Lost to Follow-up|9
243154|NCT01386125|803256|P1|Overall Study|Lost to Follow-up|3
243155|NCT01386008|803264|P1|Overall Study|Adverse Event|3
243156|NCT01386008|803264|P1|Overall Study|exited w/o incident /study discontinued|17
243157|NCT01385995|803273|P2|Period 1, 2 Months|Physician Decision|0
243158|NCT01385995|803274|P1|Period 1, 2 Months|Physician Decision|1
243159|NCT01385566|803328|P6|Overall Study|Withdrawal by Subject|0
243160|NCT01385566|803329|P5|Overall Study|Withdrawal by Subject|0
243161|NCT01385566|803330|P4|Overall Study|Withdrawal by Subject|1
243162|NCT01385566|803331|P3|Overall Study|Withdrawal by Subject|0
243163|NCT01385566|803332|P2|Overall Study|Withdrawal by Subject|0
243164|NCT01385566|803333|P1|Overall Study|Withdrawal by Subject|0
243165|NCT01385566|803328|P6|Overall Study|Lost to Follow-up|0
243166|NCT01385566|803329|P5|Overall Study|Lost to Follow-up|0
243167|NCT01385566|803330|P4|Overall Study|Lost to Follow-up|0
243168|NCT01385566|803331|P3|Overall Study|Lost to Follow-up|0
243169|NCT01385566|803332|P2|Overall Study|Lost to Follow-up|0
243170|NCT01385566|803333|P1|Overall Study|Lost to Follow-up|1
243171|NCT01385371|803387|P2|Overall Study|Administrative|2
243172|NCT01385371|803388|P1|Overall Study|Administrative|2
243173|NCT01385371|803387|P2|Overall Study|Protocol Violation|21
243174|NCT01385371|803388|P1|Overall Study|Protocol Violation|25
243175|NCT01385371|803387|P2|Overall Study|Withdrawal by Subject|39
243176|NCT01385371|803388|P1|Overall Study|Withdrawal by Subject|52
243177|NCT01385371|803387|P2|Overall Study|Lost to Follow-up|16
243178|NCT01385371|803388|P1|Overall Study|Lost to Follow-up|16
243179|NCT01385371|803387|P2|Overall Study|Adverse Event|19
243180|NCT01385371|803388|P1|Overall Study|Adverse Event|54
243181|NCT01385202|803418|P1|Overall Study|Withdrawn|1
243182|NCT01385202|803418|P1|Overall Study|Not Eligible|11
243183|NCT01385202|803418|P1|Overall Study|Lost to Follow-up|6
243184|NCT01384760|803486|P2|Overall Study|Protocol Violation|0
243185|NCT01384760|803487|P1|Overall Study|Protocol Violation|16
243186|NCT01384760|803486|P2|Overall Study|Lost to Follow-up|6
243187|NCT01384760|803487|P1|Overall Study|Lost to Follow-up|0
243188|NCT01384292|803498|P3|Part B|Severe non-compliance to protocol|0
243189|NCT01384292|803499|P2|Part B|Severe non-compliance to protocol|0
243190|NCT01384292|803500|P1|Part B|Severe non-compliance to protocol|1
243191|NCT01384019|803512|P2|Overall Study|MRI refusal|6
243192|NCT01384019|803513|P1|Overall Study|MRI refusal|6
243193|NCT01384019|803512|P2|Overall Study|Death|0
243194|NCT01384019|803513|P1|Overall Study|Death|1
243195|NCT01384019|803512|P2|Overall Study|Withdrawal by Subject|0
243196|NCT01384019|803513|P1|Overall Study|Withdrawal by Subject|3
243197|NCT01383993|803522|P3|Overall Study|Marketed voriconazole in post-therapy|0
243198|NCT01383993|803523|P2|Overall Study|Marketed voriconazole in post-therapy|0
243199|NCT01383993|803524|P1|Overall Study|Marketed voriconazole in post-therapy|2
243200|NCT01383993|803522|P3|Overall Study|Withdrawal by Subject|1
243201|NCT01383993|803523|P2|Overall Study|Withdrawal by Subject|0
243202|NCT01383993|803524|P1|Overall Study|Withdrawal by Subject|0
243203|NCT01383993|803522|P3|Overall Study|Adverse Event|0
243204|NCT01383993|803523|P2|Overall Study|Adverse Event|1
243205|NCT01383993|803524|P1|Overall Study|Adverse Event|1
243206|NCT01383928|803574|P3|Phase 2|Unsatisfactory therapeutic response|1
243207|NCT01383928|803575|P2|Phase 2|Unsatisfactory therapeutic response|0
243208|NCT01383928|803576|P1|Phase 2|Unsatisfactory therapeutic response|0
243209|NCT01383928|803574|P3|Phase 2|Withdrawal by Subject|4
243210|NCT01383928|803575|P2|Phase 2|Withdrawal by Subject|0
243211|NCT01383928|803576|P1|Phase 2|Withdrawal by Subject|0
243212|NCT01383928|803574|P3|Phase 2|Progressive Disease|5
243213|NCT01383928|803575|P2|Phase 2|Progressive Disease|0
243214|NCT01383928|803576|P1|Phase 2|Progressive Disease|0
243215|NCT01383928|803574|P3|Phase 2|Other|4
243216|NCT01383928|803575|P2|Phase 2|Other|0
243217|NCT01383928|803576|P1|Phase 2|Other|0
243218|NCT01383928|803574|P3|Phase 2|Adverse Event|8
243219|NCT01383928|803575|P2|Phase 2|Adverse Event|0
243220|NCT01383928|803576|P1|Phase 2|Adverse Event|0
243221|NCT01383928|803574|P3|Phase 2|Autologous Stem Cell Transplantation|18
243222|NCT01383928|803575|P2|Phase 2|Autologous Stem Cell Transplantation|0
243223|NCT01383928|803576|P1|Phase 2|Autologous Stem Cell Transplantation|0
243224|NCT01383928|803574|P3|Phase 1|Progressive Disease|0
243225|NCT01383928|803575|P2|Phase 1|Progressive Disease|1
243226|NCT01383928|803576|P1|Phase 1|Progressive Disease|1
243227|NCT01383928|803574|P3|Phase 1|Other|0
243228|NCT01383928|803575|P2|Phase 1|Other|3
243229|NCT01383928|803576|P1|Phase 1|Other|1
243230|NCT01383928|803574|P3|Phase 1|Adverse Event|0
243231|NCT01383928|803575|P2|Phase 1|Adverse Event|2
243232|NCT01383928|803576|P1|Phase 1|Adverse Event|1
243233|NCT01383928|803574|P3|Phase 1|Autologous Stem Cell Transplantation|0
243234|NCT01383928|803575|P2|Phase 1|Autologous Stem Cell Transplantation|1
243235|NCT01383928|803576|P1|Phase 1|Autologous Stem Cell Transplantation|2
243236|NCT01383707|803640|P1|Overall Study|Progressive disease|23
243237|NCT01383707|803640|P1|Overall Study|Adverse Event|14
243238|NCT01383707|803640|P1|Overall Study|Sponsor's decision|2
243239|NCT01383707|803640|P1|Overall Study|Not specified|8
243240|NCT01383707|803640|P1|Overall Study|Death|19
243241|NCT01383707|803640|P1|Overall Study|Consent withdrawal|6
243242|NCT01383499|803654|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
243243|NCT01383499|803655|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
243244|NCT01383499|803656|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
243245|NCT01383499|803657|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
243246|NCT01383486|803707|P1|Overall Study|Did not take any product|6
243247|NCT01383486|803707|P1|Overall Study|Incomplete information for analysis|2
243248|NCT01383486|803707|P1|Overall Study|Lost to Follow-up|10
243249|NCT01383356|803713|P2|Period 1|Personal|2
243250|NCT01383356|803714|P1|Period 1|Personal|0
243251|NCT01383356|803713|P2|Period 1|Out of Range Mid-study-Test|1
243252|NCT01383356|803714|P1|Period 1|Out of Range Mid-study-Test|0
243253|NCT01383356|803713|P2|Period 1|Non-compliance|0
243254|NCT01383356|803714|P1|Period 1|Non-compliance|3
243255|NCT01383356|803713|P2|Period 1|Adverse Event|3
243256|NCT01383356|803714|P1|Period 1|Adverse Event|5
243257|NCT01383174|803744|P2|6 Month Assessment|Refused to complete|0
243258|NCT01383174|803745|P1|6 Month Assessment|Refused to complete|4
243259|NCT01383174|803744|P2|6 Month Assessment|Lost to Follow-up|1
243260|NCT01383174|803745|P1|6 Month Assessment|Lost to Follow-up|1
243261|NCT01383174|803744|P2|3 Month Assessment|Refused to complete|0
243262|NCT01383174|803745|P1|3 Month Assessment|Refused to complete|4
243263|NCT01383174|803744|P2|3 Month Assessment|Lost to Follow-up|0
243264|NCT01383174|803745|P1|3 Month Assessment|Lost to Follow-up|2
243265|NCT01383174|803744|P2|3 Month Assessment|Death|1
243266|NCT01383174|803745|P1|3 Month Assessment|Death|0
243267|NCT01383096|803772|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
243268|NCT01383096|803773|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
243269|NCT01383096|803774|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
243270|NCT01383096|803772|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
243271|NCT01383096|803773|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
243272|NCT01383096|803774|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
243273|NCT01383096|803772|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
243274|NCT01383096|803773|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
243275|NCT01383096|803774|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
243276|NCT01383096|803772|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
243277|NCT01383096|803773|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
243278|NCT01383096|803774|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
243279|NCT01383096|803772|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
243280|NCT01383096|803773|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
243281|NCT01383096|803774|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
243282|NCT01383096|803772|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
243283|NCT01383096|803773|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
243284|NCT01383096|803774|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
243285|NCT01383096|803772|P3|Third Intervention (8 Days)|Adverse Event|0
243286|NCT01383096|803773|P2|Third Intervention (8 Days)|Adverse Event|0
243287|NCT01383096|803774|P1|Third Intervention (8 Days)|Adverse Event|1
243288|NCT01383096|803772|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
243289|NCT01383096|803773|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
243290|NCT01383096|803774|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
243291|NCT01383096|803772|P3|Third Intervention (8 Days)|Elevated AST|0
243292|NCT01383096|803773|P2|Third Intervention (8 Days)|Elevated AST|1
243293|NCT01383096|803774|P1|Third Intervention (8 Days)|Elevated AST|0
243294|NCT01383096|803772|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
243295|NCT01383096|803773|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
243296|NCT01383096|803774|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
243297|NCT01383096|803772|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
243298|NCT01383096|803773|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
243299|NCT01383096|803774|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
243300|NCT01382940|803842|P1|Overall Study|Protocol Violation|20
243301|NCT01382940|803842|P1|Overall Study|Withdrawal by Subject|23
243302|NCT01382940|803842|P1|Overall Study|Physician Decision|7
243303|NCT01382940|803842|P1|Overall Study|Lost to Follow-up|4
243304|NCT01382940|803842|P1|Overall Study|Adverse Event|19
243305|NCT01382446|803904|P2|Overall Study|Removal from Mechanical Ventilation|3
243306|NCT01382446|803905|P1|Overall Study|Removal from Mechanical Ventilation|3
243307|NCT01382446|803904|P2|Overall Study|Withdrawal by Subject|1
243308|NCT01382446|803905|P1|Overall Study|Withdrawal by Subject|0
243309|NCT01382251|803932|P2|Overall Study|Contacted after study closed|1
243310|NCT01382251|803933|P1|Overall Study|Contacted after study closed|1
243311|NCT01382251|803932|P2|Overall Study|Lost to Follow-up|4
243312|NCT01382251|803933|P1|Overall Study|Lost to Follow-up|4
243313|NCT01382251|803932|P2|Overall Study|Surgeries cancelled or delayed|16
243314|NCT01382251|803933|P1|Overall Study|Surgeries cancelled or delayed|16
243315|NCT01382225|803946|P2|Overall Study|Other|2
243316|NCT01382225|803947|P1|Overall Study|Other|4
243317|NCT01382225|803946|P2|Overall Study|Subject Withdrew Consent|2
243318|NCT01382225|803947|P1|Overall Study|Subject Withdrew Consent|5
243319|NCT01382225|803946|P2|Overall Study|Protocol Violation|1
243320|NCT01382225|803947|P1|Overall Study|Protocol Violation|2
243321|NCT01382225|803946|P2|Overall Study|Adverse Event|2
243322|NCT01382225|803947|P1|Overall Study|Adverse Event|3
243323|NCT01382212|803969|P1|Overall Study|Withdrew consent|1
243324|NCT01382212|803969|P1|Overall Study|Kidney transplant|1
243325|NCT01381926|804032|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
243326|NCT01381926|804033|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
243327|NCT01381926|804032|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
243328|NCT01381926|804033|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
243329|NCT01381900|804046|P3|Overall Study|Early withdraw|1
243330|NCT01381900|804047|P2|Overall Study|Early withdraw|1
243331|NCT01381900|804048|P1|Overall Study|Early withdraw|3
243332|NCT01381900|804046|P3|Overall Study|Withdrawal by Subject|1
243333|NCT01381900|804047|P2|Overall Study|Withdrawal by Subject|0
243334|NCT01381900|804048|P1|Overall Study|Withdrawal by Subject|0
243335|NCT01381900|804046|P3|Overall Study|Protocol Violation|1
243336|NCT01381900|804047|P2|Overall Study|Protocol Violation|1
243337|NCT01381900|804048|P1|Overall Study|Protocol Violation|0
243338|NCT01381900|804046|P3|Overall Study|Physician Decision|1
243339|NCT01381900|804047|P2|Overall Study|Physician Decision|1
243340|NCT01381900|804048|P1|Overall Study|Physician Decision|0
243341|NCT01381900|804046|P3|Overall Study|Noncompliance with study drug|1
243342|NCT01381900|804047|P2|Overall Study|Noncompliance with study drug|0
243343|NCT01381900|804048|P1|Overall Study|Noncompliance with study drug|0
243344|NCT01381900|804046|P3|Overall Study|Adverse Event|7
243345|NCT01381900|804047|P2|Overall Study|Adverse Event|6
243346|NCT01381900|804048|P1|Overall Study|Adverse Event|4
243347|NCT01381900|804046|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
243348|NCT01381900|804047|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
243349|NCT01381900|804048|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
243350|NCT01381679|804068|P1|Overall Study|Lost to Follow-up|885
243351|NCT01381679|804068|P1|Overall Study|Adverse Event|3
243352|NCT01381575|804083|P3|Overall Study|Withdrawal by Subject|4
243353|NCT01381575|804084|P2|Overall Study|Withdrawal by Subject|0
243354|NCT01381575|804085|P1|Overall Study|Withdrawal by Subject|0
243355|NCT01381575|804083|P3|Overall Study|Protocol Violation|1
243356|NCT01381575|804084|P2|Overall Study|Protocol Violation|0
243357|NCT01381575|804085|P1|Overall Study|Protocol Violation|0
243358|NCT01381575|804083|P3|Overall Study|Lost to Follow-up|1
243359|NCT01381575|804084|P2|Overall Study|Lost to Follow-up|0
243360|NCT01381575|804085|P1|Overall Study|Lost to Follow-up|0
243361|NCT01381575|804083|P3|Overall Study|Adverse Event|1
243362|NCT01381575|804084|P2|Overall Study|Adverse Event|0
243363|NCT01381575|804085|P1|Overall Study|Adverse Event|0
243364|NCT01381575|804083|P3|Overall Study|Unspecified|0
243365|NCT01381575|804084|P2|Overall Study|Unspecified|10
243366|NCT01381575|804085|P1|Overall Study|Unspecified|2
243367|NCT01381016|804170|P2|Overall Study|Physician Decision|2
243368|NCT01381016|804171|P1|Overall Study|Physician Decision|0
243369|NCT01381016|804170|P2|Overall Study|Withdrawal by Subject|1
243370|NCT01381016|804171|P1|Overall Study|Withdrawal by Subject|0
243371|NCT01381016|804170|P2|Overall Study|Screen Failure|2
243372|NCT01381016|804171|P1|Overall Study|Screen Failure|2
243373|NCT01381016|804170|P2|Overall Study|Lost to Follow-up|1
243374|NCT01381016|804171|P1|Overall Study|Lost to Follow-up|1
243375|NCT01380834|804181|P2|Overall Study|Physician Decision|0
243376|NCT01380834|804182|P1|Overall Study|Physician Decision|1
243377|NCT01380782|804194|P4|Overall Study|Withdrawal by Subject|1
243378|NCT01380782|804195|P3|Overall Study|Withdrawal by Subject|1
243379|NCT01380782|804196|P2|Overall Study|Withdrawal by Subject|0
243380|NCT01380782|804197|P1|Overall Study|Withdrawal by Subject|0
243381|NCT01380782|804194|P4|Overall Study|Physician Decision|0
243382|NCT01380782|804195|P3|Overall Study|Physician Decision|0
243383|NCT01380782|804196|P2|Overall Study|Physician Decision|0
243384|NCT01380782|804197|P1|Overall Study|Physician Decision|1
243385|NCT01380782|804194|P4|Overall Study|Lack of Efficacy|3
243386|NCT01380782|804195|P3|Overall Study|Lack of Efficacy|10
243387|NCT01380782|804196|P2|Overall Study|Lack of Efficacy|9
243388|NCT01380782|804197|P1|Overall Study|Lack of Efficacy|10
243389|NCT01380782|804194|P4|Overall Study|Death|0
243390|NCT01380782|804195|P3|Overall Study|Death|0
243391|NCT01380782|804196|P2|Overall Study|Death|0
243392|NCT01380782|804197|P1|Overall Study|Death|1
243393|NCT01380782|804194|P4|Overall Study|Adverse Event|0
243394|NCT01380782|804195|P3|Overall Study|Adverse Event|0
243395|NCT01380782|804196|P2|Overall Study|Adverse Event|1
243396|NCT01380782|804197|P1|Overall Study|Adverse Event|0
243397|NCT01380769|804220|P2|Overall Study|Protocol Violation|1
243398|NCT01380769|804221|P1|Overall Study|Protocol Violation|0
243399|NCT01380769|804220|P2|Overall Study|Adverse Event|1
243400|NCT01380769|804221|P1|Overall Study|Adverse Event|1
243401|NCT01380769|804220|P2|Overall Study|Physician Decision|1
243402|NCT01380769|804221|P1|Overall Study|Physician Decision|1
243403|NCT01380769|804220|P2|Overall Study|Withdrawal by Subject|11
243404|NCT01380769|804221|P1|Overall Study|Withdrawal by Subject|7
243405|NCT01380730|804237|P8|Overall Study|Death|0
243406|NCT01380730|804238|P7|Overall Study|Death|0
243407|NCT01380730|804239|P6|Overall Study|Death|0
243408|NCT01380730|804240|P5|Overall Study|Death|1
243409|NCT01380730|804241|P4|Overall Study|Death|0
243410|NCT01380730|804242|P3|Overall Study|Death|0
243411|NCT01380730|804243|P2|Overall Study|Death|0
243412|NCT01380730|804244|P1|Overall Study|Death|0
243413|NCT01380379|804311|P1|Overall Study|Pregnancy|1
243414|NCT01380327|804324|P3|Overall Study|Questionable onset of epilepsy|1
243415|NCT01380327|804325|P2|Overall Study|Questionable onset of epilepsy|0
243416|NCT01380327|804326|P1|Overall Study|Questionable onset of epilepsy|0
243417|NCT01380327|804324|P3|Overall Study|Housing situation precluded ability to k|1
243418|NCT01380327|804325|P2|Overall Study|Housing situation precluded ability to k|0
243419|NCT01380327|804326|P1|Overall Study|Housing situation precluded ability to k|0
243420|NCT01380327|804324|P3|Overall Study|Withdrawal by Subject|1
243421|NCT01380327|804325|P2|Overall Study|Withdrawal by Subject|0
243422|NCT01380327|804326|P1|Overall Study|Withdrawal by Subject|0
243423|NCT01380327|804324|P3|Overall Study|Protocol Violation|3
243424|NCT01380327|804325|P2|Overall Study|Protocol Violation|2
243425|NCT01380327|804326|P1|Overall Study|Protocol Violation|3
243426|NCT01380327|804324|P3|Overall Study|Lost to Follow-up|1
243427|NCT01380327|804325|P2|Overall Study|Lost to Follow-up|1
243428|NCT01380327|804326|P1|Overall Study|Lost to Follow-up|0
243429|NCT01380145|804357|P1|Overall Study|Progressive disease|4
243430|NCT01380093|804365|P9|Treatment Phase: Third Intervention|Unspecified|1
243431|NCT01380093|804366|P8|Treatment Phase: Third Intervention|Unspecified|0
243432|NCT01380093|804367|P7|Treatment Phase: Third Intervention|Unspecified|0
243433|NCT01380093|804368|P6|Treatment Phase: Third Intervention|Unspecified|0
243434|NCT01380093|804369|P5|Treatment Phase: Third Intervention|Unspecified|0
243435|NCT01380093|804370|P4|Treatment Phase: Third Intervention|Unspecified|0
243436|NCT01380093|804371|P3|Treatment Phase: Third Intervention|Unspecified|0
243437|NCT01380093|804372|P2|Treatment Phase: Third Intervention|Unspecified|0
243438|NCT01380093|804373|P1|Treatment Phase: Third Intervention|Unspecified|0
243439|NCT01380093|804365|P9|Treatment Phase: Third Intervention|Non-compliance|1
243440|NCT01380093|804366|P8|Treatment Phase: Third Intervention|Non-compliance|0
243441|NCT01380093|804367|P7|Treatment Phase: Third Intervention|Non-compliance|0
243442|NCT01380093|804368|P6|Treatment Phase: Third Intervention|Non-compliance|0
243443|NCT01380093|804369|P5|Treatment Phase: Third Intervention|Non-compliance|0
243444|NCT01380093|804370|P4|Treatment Phase: Third Intervention|Non-compliance|0
243445|NCT01380093|804371|P3|Treatment Phase: Third Intervention|Non-compliance|0
243446|NCT01380093|804372|P2|Treatment Phase: Third Intervention|Non-compliance|0
243447|NCT01380093|804373|P1|Treatment Phase: Third Intervention|Non-compliance|0
243448|NCT01380093|804365|P9|Treatment Phase: Second Intervention|Unspecified|0
243449|NCT01380093|804366|P8|Treatment Phase: Second Intervention|Unspecified|0
243450|NCT01380093|804367|P7|Treatment Phase: Second Intervention|Unspecified|0
243451|NCT01380093|804368|P6|Treatment Phase: Second Intervention|Unspecified|0
243452|NCT01380093|804369|P5|Treatment Phase: Second Intervention|Unspecified|0
243453|NCT01380093|804370|P4|Treatment Phase: Second Intervention|Unspecified|1
243454|NCT01380093|804371|P3|Treatment Phase: Second Intervention|Unspecified|0
243455|NCT01380093|804372|P2|Treatment Phase: Second Intervention|Unspecified|0
243456|NCT01380093|804373|P1|Treatment Phase: Second Intervention|Unspecified|0
243457|NCT01380093|804365|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
243458|NCT01380093|804366|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
243459|NCT01380093|804367|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
243460|NCT01380093|804368|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
243461|NCT01380093|804369|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
243462|NCT01380093|804370|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
243463|NCT01380093|804371|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
243464|NCT01380093|804372|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
243465|NCT01380093|804373|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
243466|NCT01380093|804365|P9|Drug Discrimination Phase: Day 2|Backup participant|0
243467|NCT01380093|804366|P8|Drug Discrimination Phase: Day 2|Backup participant|0
243468|NCT01380093|804367|P7|Drug Discrimination Phase: Day 2|Backup participant|0
243469|NCT01380093|804368|P6|Drug Discrimination Phase: Day 2|Backup participant|0
243470|NCT01380093|804369|P5|Drug Discrimination Phase: Day 2|Backup participant|0
243471|NCT01380093|804370|P4|Drug Discrimination Phase: Day 2|Backup participant|0
243472|NCT01380093|804371|P3|Drug Discrimination Phase: Day 2|Backup participant|1
243473|NCT01380093|804372|P2|Drug Discrimination Phase: Day 2|Backup participant|0
243474|NCT01380093|804373|P1|Drug Discrimination Phase: Day 2|Backup participant|0
243475|NCT01380093|804365|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
243476|NCT01380093|804366|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
243477|NCT01380093|804367|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
243478|NCT01380093|804368|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
243479|NCT01380093|804369|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
243480|NCT01380093|804370|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
243481|NCT01380093|804371|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
243482|NCT01380093|804372|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
243483|NCT01380093|804373|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
243484|NCT01380093|804365|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
243485|NCT01380093|804366|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
243486|NCT01380093|804367|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
243487|NCT01380093|804368|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
243488|NCT01380093|804369|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
243489|NCT01380093|804370|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
243490|NCT01380093|804371|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
243491|NCT01380093|804372|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
243492|NCT01380093|804373|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
243493|NCT01380093|804365|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
243494|NCT01380093|804366|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
243495|NCT01380093|804367|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
243496|NCT01380093|804368|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
243497|NCT01380093|804369|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
243498|NCT01380093|804370|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
243499|NCT01380093|804371|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
243500|NCT01380093|804372|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
243501|NCT01380093|804373|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
243502|NCT01380093|804365|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
243503|NCT01380093|804366|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
243504|NCT01380093|804367|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
243505|NCT01380093|804368|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
243506|NCT01380093|804369|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
243507|NCT01380093|804370|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
243508|NCT01380093|804371|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
243509|NCT01380093|804372|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
243510|NCT01380093|804373|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
243511|NCT01380093|804365|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
243512|NCT01380093|804366|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
243513|NCT01380093|804367|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
243514|NCT01380093|804368|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
243515|NCT01380093|804369|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
243516|NCT01380093|804370|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
243517|NCT01380093|804371|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
243518|NCT01380093|804372|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
243519|NCT01380093|804373|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
243520|NCT01380093|804365|P9|Naloxone Challenge Phase|Screen failures|0
243521|NCT01380093|804366|P8|Naloxone Challenge Phase|Screen failures|0
243522|NCT01380093|804367|P7|Naloxone Challenge Phase|Screen failures|0
243523|NCT01380093|804368|P6|Naloxone Challenge Phase|Screen failures|0
243524|NCT01380093|804369|P5|Naloxone Challenge Phase|Screen failures|0
243525|NCT01380093|804370|P4|Naloxone Challenge Phase|Screen failures|0
243526|NCT01380093|804371|P3|Naloxone Challenge Phase|Screen failures|0
243527|NCT01380093|804372|P2|Naloxone Challenge Phase|Screen failures|0
243528|NCT01380093|804373|P1|Naloxone Challenge Phase|Screen failures|21
243529|NCT01380080|804665|P2|Overall Study|Lost to Follow-up|0
243530|NCT01380080|804666|P1|Overall Study|Lost to Follow-up|2
243531|NCT01380080|804665|P2|Overall Study|Not willing to adhere to requirements|1
243695|NCT01377480|805225|P3|Overall Study|Protocol Violation|0
243532|NCT01380080|804666|P1|Overall Study|Not willing to adhere to requirements|3
243533|NCT01380080|804665|P2|Overall Study|Not able to get to clinic|0
243534|NCT01380080|804666|P1|Overall Study|Not able to get to clinic|4
243535|NCT01380080|804665|P2|Overall Study|Withdrawal by Subject|0
243536|NCT01380080|804666|P1|Overall Study|Withdrawal by Subject|4
243537|NCT01380080|804665|P2|Overall Study|Death|22
243538|NCT01380080|804666|P1|Overall Study|Death|20
243539|NCT01379937|804691|P4|Overall Study|Lost to Follow-up|0
243540|NCT01379937|804692|P3|Overall Study|Lost to Follow-up|2
243541|NCT01379937|804693|P2|Overall Study|Lost to Follow-up|2
243542|NCT01379937|804694|P1|Overall Study|Lost to Follow-up|1
243543|NCT01379937|804691|P4|Overall Study|Consent withdrawal|0
243544|NCT01379937|804692|P3|Overall Study|Consent withdrawal|0
243545|NCT01379937|804693|P2|Overall Study|Consent withdrawal|1
243546|NCT01379937|804694|P1|Overall Study|Consent withdrawal|0
243547|NCT01379937|804691|P4|Overall Study|Protocol Violation|1
243548|NCT01379937|804692|P3|Overall Study|Protocol Violation|0
243549|NCT01379937|804693|P2|Overall Study|Protocol Violation|0
243550|NCT01379937|804694|P1|Overall Study|Protocol Violation|0
243551|NCT01379781|804776|P2|Overall Study|Lost to Follow-up|8
243552|NCT01379781|804777|P1|Overall Study|Lost to Follow-up|11
243553|NCT01379768|804786|P3|Overall Study|Lost to Follow-up|0
243554|NCT01379768|804787|P2|Overall Study|Lost to Follow-up|0
243555|NCT01379768|804788|P1|Overall Study|Lost to Follow-up|2
243556|NCT01379768|804786|P3|Overall Study|Adverse Event|0
243557|NCT01379768|804787|P2|Overall Study|Adverse Event|1
243558|NCT01379768|804788|P1|Overall Study|Adverse Event|1
243559|NCT01379703|804811|P3|9 Months Through 18 Months|Reason Unknown|0
243560|NCT01379703|804812|P2|9 Months Through 18 Months|Reason Unknown|23
243561|NCT01379703|804813|P1|9 Months Through 18 Months|Reason Unknown|0
243562|NCT01379703|804811|P3|9 Months Through 18 Months|Fatigue|0
243563|NCT01379703|804812|P2|9 Months Through 18 Months|Fatigue|1
243564|NCT01379703|804813|P1|9 Months Through 18 Months|Fatigue|0
243565|NCT01379703|804811|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
243566|NCT01379703|804812|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
243567|NCT01379703|804813|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
243568|NCT01379703|804811|P3|9 Months Through 18 Months|Patient Noncompliance|0
243569|NCT01379703|804812|P2|9 Months Through 18 Months|Patient Noncompliance|4
243570|NCT01379703|804813|P1|9 Months Through 18 Months|Patient Noncompliance|0
243571|NCT01379703|804811|P3|9 Months Through 18 Months|Treatment failure|0
243572|NCT01379703|804812|P2|9 Months Through 18 Months|Treatment failure|5
243573|NCT01379703|804813|P1|9 Months Through 18 Months|Treatment failure|0
243574|NCT01379703|804811|P3|9 Months Through 18 Months|Adverse Event|0
243575|NCT01379703|804812|P2|9 Months Through 18 Months|Adverse Event|6
243576|NCT01379703|804813|P1|9 Months Through 18 Months|Adverse Event|0
243577|NCT01379703|804811|P3|9 Months Through 18 Months|Withdrawal by Subject|0
243578|NCT01379703|804812|P2|9 Months Through 18 Months|Withdrawal by Subject|11
243579|NCT01379703|804813|P1|9 Months Through 18 Months|Withdrawal by Subject|0
243580|NCT01379703|804811|P3|9 Months Through 18 Months|Lost to Follow-up|0
243581|NCT01379703|804812|P2|9 Months Through 18 Months|Lost to Follow-up|178
243582|NCT01379703|804813|P1|9 Months Through 18 Months|Lost to Follow-up|0
243583|NCT01379703|804811|P3|Study Start Through 9 Months|Reason unknown|24
243584|NCT01379703|804812|P2|Study Start Through 9 Months|Reason unknown|31
243585|NCT01379703|804813|P1|Study Start Through 9 Months|Reason unknown|2
243586|NCT01379703|804811|P3|Study Start Through 9 Months|Increased triglycerides|0
243587|NCT01379703|804812|P2|Study Start Through 9 Months|Increased triglycerides|1
243588|NCT01379703|804813|P1|Study Start Through 9 Months|Increased triglycerides|0
243589|NCT01379703|804811|P3|Study Start Through 9 Months|Poor general condition|0
243590|NCT01379703|804812|P2|Study Start Through 9 Months|Poor general condition|1
243591|NCT01379703|804813|P1|Study Start Through 9 Months|Poor general condition|0
243592|NCT01379703|804811|P3|Study Start Through 9 Months|Medication not available|1
243593|NCT01379703|804812|P2|Study Start Through 9 Months|Medication not available|2
243594|NCT01379703|804813|P1|Study Start Through 9 Months|Medication not available|0
243595|NCT01379703|804811|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
243596|NCT01379703|804812|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
243597|NCT01379703|804813|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
243598|NCT01379703|804811|P3|Study Start Through 9 Months|Patient Noncompliance|1
243599|NCT01379703|804812|P2|Study Start Through 9 Months|Patient Noncompliance|0
243600|NCT01379703|804813|P1|Study Start Through 9 Months|Patient Noncompliance|0
243601|NCT01379703|804811|P3|Study Start Through 9 Months|Treatment Failure|2
243602|NCT01379703|804812|P2|Study Start Through 9 Months|Treatment Failure|2
243603|NCT01379703|804813|P1|Study Start Through 9 Months|Treatment Failure|0
243604|NCT01379703|804811|P3|Study Start Through 9 Months|Withdrawal by Subject|1
243605|NCT01379703|804812|P2|Study Start Through 9 Months|Withdrawal by Subject|6
243606|NCT01379703|804813|P1|Study Start Through 9 Months|Withdrawal by Subject|0
243607|NCT01379703|804811|P3|Study Start Through 9 Months|Adverse Event|10
243608|NCT01379703|804812|P2|Study Start Through 9 Months|Adverse Event|14
243609|NCT01379703|804813|P1|Study Start Through 9 Months|Adverse Event|0
243610|NCT01379703|804811|P3|Study Start Through 9 Months|Lost to Follow-up|104
243611|NCT01379703|804812|P2|Study Start Through 9 Months|Lost to Follow-up|61
243612|NCT01379703|804813|P1|Study Start Through 9 Months|Lost to Follow-up|2
243613|NCT01379534|804913|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
243614|NCT01379534|804914|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
243615|NCT01379534|804913|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
243616|NCT01379534|804914|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
243617|NCT01379534|804913|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
243618|NCT01379534|804914|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
243619|NCT01379534|804913|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
243620|NCT01379534|804914|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
243621|NCT01379534|804913|P2|Treatment Phase|Adverse Event|7
243622|NCT01379534|804914|P1|Treatment Phase|Adverse Event|7
243623|NCT01379534|804913|P2|Treatment Phase|Progressive disease|22
243624|NCT01379534|804914|P1|Treatment Phase|Progressive disease|13
243625|NCT01379534|804913|P2|Treatment Phase|Withdrawal by Subject|2
243626|NCT01379534|804914|P1|Treatment Phase|Withdrawal by Subject|2
243627|NCT01379521|804934|P2|Post-Treatment Evaluations|Death|0
243628|NCT01379521|804935|P1|Post-Treatment Evaluations|Death|1
243629|NCT01379521|804934|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
243630|NCT01379521|804935|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
243631|NCT01379521|804934|P2|Post-Treatment Evaluations|Disease Progression|20
243632|NCT01379521|804935|P1|Post-Treatment Evaluations|Disease Progression|22
243633|NCT01379521|804934|P2|Overall Study -Treatment Period|Death|1
243634|NCT01379521|804935|P1|Overall Study -Treatment Period|Death|2
243635|NCT01379521|804934|P2|Overall Study -Treatment Period|Administrative Problems|0
243636|NCT01379521|804935|P1|Overall Study -Treatment Period|Administrative Problems|1
243637|NCT01379521|804934|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
243638|NCT01379521|804935|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
243639|NCT01379521|804934|P2|Overall Study -Treatment Period|Protocol Deviation|2
243640|NCT01379521|804935|P1|Overall Study -Treatment Period|Protocol Deviation|0
243641|NCT01379521|804934|P2|Overall Study -Treatment Period|New Cancer Therapy|0
243642|NCT01379521|804935|P1|Overall Study -Treatment Period|New Cancer Therapy|1
243643|NCT01379521|804934|P2|Overall Study -Treatment Period|Disease Progression|22
243644|NCT01379521|804935|P1|Overall Study -Treatment Period|Disease Progression|23
243645|NCT01379521|804934|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
243646|NCT01379521|804935|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
243647|NCT01379521|804934|P2|Overall Study -Treatment Period|Adverse Event|0
243648|NCT01379521|804935|P1|Overall Study -Treatment Period|Adverse Event|3
243649|NCT01378975|805005|P2|Overall Study|Withdrew Consent|3
243650|NCT01378975|805006|P1|Overall Study|Withdrew Consent|4
243651|NCT01378975|805005|P2|Overall Study|Lost to Follow-up|1
243652|NCT01378975|805006|P1|Overall Study|Lost to Follow-up|4
243653|NCT01378975|805005|P2|Overall Study|Investigator Request|0
243654|NCT01378975|805006|P1|Overall Study|Investigator Request|1
243655|NCT01378975|805005|P2|Overall Study|Death|46
243656|NCT01378975|805006|P1|Overall Study|Death|77
243657|NCT01378962|805032|P1|Overall Study|Unspecified|2
243658|NCT01378962|805032|P1|Overall Study|Lost to Follow-up|1
243659|NCT01378962|805032|P1|Overall Study|Death|14
243660|NCT01378429|805058|P2|Overall Study|Noncompliance with study drug|0
243661|NCT01378429|805059|P1|Overall Study|Noncompliance with study drug|1
243662|NCT01378325|805101|P2|Overall Study|Protocol Violation|1
243663|NCT01378325|805102|P1|Overall Study|Protocol Violation|0
243664|NCT01378195|805119|P2|Overall Study|Lost to Follow-up|18
243665|NCT01378195|805120|P1|Overall Study|Lost to Follow-up|29
243666|NCT01378117|805133|P3|Overall Study|discharged before med given|1
243667|NCT01378117|805134|P2|Overall Study|discharged before med given|0
243668|NCT01378117|805135|P1|Overall Study|discharged before med given|2
243669|NCT01378117|805133|P3|Overall Study|withdrawal|2
243670|NCT01378117|805134|P2|Overall Study|withdrawal|1
243671|NCT01378117|805135|P1|Overall Study|withdrawal|2
243672|NCT01378104|805145|P2|Overall Study|Withdrawal by Subject|13
243673|NCT01378104|805146|P1|Overall Study|Withdrawal by Subject|12
243674|NCT01378104|805145|P2|Overall Study|Lack of Efficacy|5
243675|NCT01378104|805146|P1|Overall Study|Lack of Efficacy|7
243676|NCT01378104|805145|P2|Overall Study|Adverse Event|8
243677|NCT01378104|805146|P1|Overall Study|Adverse Event|8
243678|NCT01377480|805224|P4|Overall Study|Not specified|6
243679|NCT01377480|805225|P3|Overall Study|Not specified|7
243680|NCT01377480|805226|P2|Overall Study|Not specified|0
243681|NCT01377480|805227|P1|Overall Study|Not specified|0
243682|NCT01377480|805224|P4|Overall Study|Serious adverse event|1
243683|NCT01377480|805225|P3|Overall Study|Serious adverse event|1
243684|NCT01377480|805226|P2|Overall Study|Serious adverse event|0
243685|NCT01377480|805227|P1|Overall Study|Serious adverse event|0
243686|NCT01377480|805224|P4|Overall Study|Withdrawal by Subject|0
243687|NCT01377480|805225|P3|Overall Study|Withdrawal by Subject|1
243688|NCT01377480|805226|P2|Overall Study|Withdrawal by Subject|0
243689|NCT01377480|805227|P1|Overall Study|Withdrawal by Subject|0
243690|NCT01377480|805224|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
243691|NCT01377480|805225|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
243692|NCT01377480|805226|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
243693|NCT01377480|805227|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
243694|NCT01377480|805224|P4|Overall Study|Protocol Violation|4
243696|NCT01377480|805226|P2|Overall Study|Protocol Violation|0
243697|NCT01377480|805227|P1|Overall Study|Protocol Violation|0
243698|NCT01377233|805306|P5|Double-blind|Administrative or other|1
243699|NCT01377233|805307|P4|Double-blind|Administrative or other|1
243700|NCT01377233|805308|P3|Double-blind|Administrative or other|0
243701|NCT01377233|805309|P2|Double-blind|Administrative or other|0
243702|NCT01377233|805310|P1|Double-blind|Administrative or other|0
243703|NCT01377233|805306|P5|Double-blind|Withdrawal by Subject|0
243704|NCT01377233|805307|P4|Double-blind|Withdrawal by Subject|1
243705|NCT01377233|805308|P3|Double-blind|Withdrawal by Subject|0
243706|NCT01377233|805309|P2|Double-blind|Withdrawal by Subject|0
243707|NCT01377233|805310|P1|Double-blind|Withdrawal by Subject|0
243708|NCT01377233|805306|P5|Double-blind|Protocol Violation|1
243709|NCT01377233|805307|P4|Double-blind|Protocol Violation|0
243710|NCT01377233|805308|P3|Double-blind|Protocol Violation|0
243711|NCT01377233|805309|P2|Double-blind|Protocol Violation|0
243712|NCT01377233|805310|P1|Double-blind|Protocol Violation|0
243713|NCT01377233|805306|P5|Double-blind|Adverse Event|0
243714|NCT01377233|805307|P4|Double-blind|Adverse Event|2
243715|NCT01377233|805308|P3|Double-blind|Adverse Event|2
243716|NCT01377233|805309|P2|Double-blind|Adverse Event|1
243717|NCT01377233|805310|P1|Double-blind|Adverse Event|0
243718|NCT01377233|805306|P5|Open-label|Withdrawal by Subject|0
243719|NCT01377233|805307|P4|Open-label|Withdrawal by Subject|0
243720|NCT01377233|805308|P3|Open-label|Withdrawal by Subject|0
243721|NCT01377233|805309|P2|Open-label|Withdrawal by Subject|0
243722|NCT01377233|805310|P1|Open-label|Withdrawal by Subject|3
243723|NCT01377233|805306|P5|Open-label|Adverse Event|0
243724|NCT01377233|805307|P4|Open-label|Adverse Event|0
243725|NCT01377233|805308|P3|Open-label|Adverse Event|0
243726|NCT01377233|805309|P2|Open-label|Adverse Event|0
243727|NCT01377233|805310|P1|Open-label|Adverse Event|1
243728|NCT01377194|805337|P3|Overall Study|Lost to Follow-up|11
243729|NCT01377194|805338|P2|Overall Study|Lost to Follow-up|8
243730|NCT01377194|805339|P1|Overall Study|Lost to Follow-up|14
243731|NCT01377194|805337|P3|Overall Study|Withdrawal by Subject|7
243732|NCT01377194|805338|P2|Overall Study|Withdrawal by Subject|10
243733|NCT01377194|805339|P1|Overall Study|Withdrawal by Subject|8
243734|NCT01377194|805337|P3|Overall Study|Protocol Violation|6
243735|NCT01377194|805338|P2|Overall Study|Protocol Violation|10
243736|NCT01377194|805339|P1|Overall Study|Protocol Violation|4
243737|NCT01377194|805337|P3|Overall Study|Lack of Efficacy|3
243738|NCT01377194|805338|P2|Overall Study|Lack of Efficacy|3
243739|NCT01377194|805339|P1|Overall Study|Lack of Efficacy|3
243740|NCT01377194|805337|P3|Overall Study|Adverse Event|19
243741|NCT01377194|805338|P2|Overall Study|Adverse Event|12
243742|NCT01377194|805339|P1|Overall Study|Adverse Event|3
243743|NCT01377012|805353|P3|Extension Study, Weeks 104-260|Adverse Event|1
243744|NCT01377012|805354|P2|Extension Study, Weeks 104-260|Adverse Event|2
243745|NCT01377012|805355|P1|Extension Study, Weeks 104-260|Adverse Event|0
243746|NCT01377012|805353|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
243747|NCT01377012|805354|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
243748|NCT01377012|805355|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
243749|NCT01377012|805353|P3|Extension Study, Weeks 104-260|Physician Decision|0
243750|NCT01377012|805354|P2|Extension Study, Weeks 104-260|Physician Decision|0
243751|NCT01377012|805355|P1|Extension Study, Weeks 104-260|Physician Decision|1
243752|NCT01377012|805353|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
243753|NCT01377012|805354|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
243754|NCT01377012|805355|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
243755|NCT01377012|805353|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
243756|NCT01377012|805354|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
243757|NCT01377012|805355|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
243758|NCT01377012|805353|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
243759|NCT01377012|805354|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
243760|NCT01377012|805355|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
243761|NCT01377012|805353|P3|Core Study|Adverse Event|13
243762|NCT01377012|805354|P2|Core Study|Adverse Event|14
243763|NCT01377012|805355|P1|Core Study|Adverse Event|10
243764|NCT01377012|805353|P3|Core Study|Death|1
243765|NCT01377012|805354|P2|Core Study|Death|1
243766|NCT01377012|805355|P1|Core Study|Death|1
243767|NCT01377012|805353|P3|Core Study|Lack of Efficacy|37
243768|NCT01377012|805354|P2|Core Study|Lack of Efficacy|28
243769|NCT01377012|805355|P1|Core Study|Lack of Efficacy|41
243770|NCT01377012|805353|P3|Core Study|Lost to Follow-up|4
243771|NCT01377012|805354|P2|Core Study|Lost to Follow-up|5
243772|NCT01377012|805355|P1|Core Study|Lost to Follow-up|7
243773|NCT01377012|805353|P3|Core Study|No Longer require treatment|1
243774|NCT01377012|805354|P2|Core Study|No Longer require treatment|0
243775|NCT01377012|805355|P1|Core Study|No Longer require treatment|0
243776|NCT01377012|805353|P3|Core Study|Non-Compliant with study treatment|1
243777|NCT01377012|805354|P2|Core Study|Non-Compliant with study treatment|0
243778|NCT01377012|805355|P1|Core Study|Non-Compliant with study treatment|0
243779|NCT01377012|805353|P3|Core Study|Physician Decision|10
243780|NCT01377012|805354|P2|Core Study|Physician Decision|4
243781|NCT01377012|805355|P1|Core Study|Physician Decision|5
243782|NCT01377012|805353|P3|Core Study|Pregnancy|1
243783|NCT01377012|805354|P2|Core Study|Pregnancy|0
243784|NCT01377012|805355|P1|Core Study|Pregnancy|0
243785|NCT01377012|805353|P3|Core Study|Protocol Violation|2
243786|NCT01377012|805354|P2|Core Study|Protocol Violation|3
243787|NCT01377012|805355|P1|Core Study|Protocol Violation|7
243788|NCT01377012|805353|P3|Core Study|Withdrawal by Subject|18
243789|NCT01377012|805354|P2|Core Study|Withdrawal by Subject|23
243790|NCT01377012|805355|P1|Core Study|Withdrawal by Subject|15
243791|NCT01377012|805353|P3|Core Study|Technical problems|0
243792|NCT01377012|805354|P2|Core Study|Technical problems|0
243793|NCT01377012|805355|P1|Core Study|Technical problems|1
243794|NCT01377012|805353|P3|Core Study|Study terminated by Sponsor|46
243795|NCT01377012|805354|P2|Core Study|Study terminated by Sponsor|54
243796|NCT01377012|805355|P1|Core Study|Study terminated by Sponsor|47
243797|NCT01376908|805392|P2|Overall Study|Withdrawal by Subject|2
243798|NCT01376908|805393|P1|Overall Study|Withdrawal by Subject|1
243799|NCT01376908|805392|P2|Overall Study|Protocol Violation|1
243800|NCT01376908|805393|P1|Overall Study|Protocol Violation|1
243801|NCT01376804|805426|P1|Treatment Period|Patient did not receive study drug|1
243802|NCT01376804|805426|P1|Treatment Period|Adverse Event|6
243803|NCT01376804|805426|P1|Treatment Period|Withdrawal by Subject|1
243804|NCT01376700|805437|P1|Overall Study|Low or high titer inhibitor|8
243805|NCT01376700|805437|P1|Overall Study|Sponsor terminated study early|8
243806|NCT01376388|805499|P1|Overall Study|Withdrawal by Subject|3
243807|NCT01376388|805499|P1|Overall Study|Lack of Efficacy|2
243808|NCT01376388|805499|P1|Overall Study|Adverse Event|13
243809|NCT01376245|805547|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
243810|NCT01376245|805548|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
243811|NCT01376245|805549|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
243812|NCT01376245|805550|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
243813|NCT01376245|805551|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
243814|NCT01376245|805547|P5|24-week, Double-blind Treatment Period|Physician Decision|0
243815|NCT01376245|805548|P4|24-week, Double-blind Treatment Period|Physician Decision|1
243816|NCT01376245|805549|P3|24-week, Double-blind Treatment Period|Physician Decision|1
243817|NCT01376245|805550|P2|24-week, Double-blind Treatment Period|Physician Decision|0
243818|NCT01376245|805551|P1|24-week, Double-blind Treatment Period|Physician Decision|0
243819|NCT01376245|805547|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
243820|NCT01376245|805548|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
243821|NCT01376245|805549|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
243822|NCT01376245|805550|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
243823|NCT01376245|805551|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
243824|NCT01376245|805547|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
243825|NCT01376245|805548|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
243826|NCT01376245|805549|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
243827|NCT01376245|805550|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
243828|NCT01376245|805551|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
243829|NCT01376245|805547|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
243830|NCT01376245|805548|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
243831|NCT01376245|805549|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
243832|NCT01376245|805550|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
243833|NCT01376245|805551|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
243834|NCT01376245|805547|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
243835|NCT01376245|805548|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
243836|NCT01376245|805549|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
243837|NCT01376245|805550|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
243838|NCT01376245|805551|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
243839|NCT01376245|805547|P5|24-week, Double-blind Treatment Period|Adverse Event|18
243840|NCT01376245|805548|P4|24-week, Double-blind Treatment Period|Adverse Event|8
243841|NCT01376245|805549|P3|24-week, Double-blind Treatment Period|Adverse Event|7
243842|NCT01376245|805550|P2|24-week, Double-blind Treatment Period|Adverse Event|16
243843|NCT01376245|805551|P1|24-week, Double-blind Treatment Period|Adverse Event|0
243844|NCT01376245|805547|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
243845|NCT01376245|805548|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
243846|NCT01376245|805549|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
243847|NCT01376245|805550|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
243848|NCT01376245|805551|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
243849|NCT01376245|805547|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
243850|NCT01376245|805548|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
243851|NCT01376245|805549|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
243852|NCT01376245|805550|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
243853|NCT01376245|805551|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
243854|NCT01376245|805547|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
243855|NCT01376245|805548|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
243856|NCT01376245|805549|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
243857|NCT01376245|805550|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
243858|NCT01376245|805551|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
243859|NCT01376245|805547|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
243860|NCT01376245|805548|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
243861|NCT01376245|805549|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
243862|NCT01376245|805550|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
243863|NCT01376245|805551|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
243864|NCT01376245|805547|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
243865|NCT01376245|805548|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
243866|NCT01376245|805549|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
243867|NCT01376245|805550|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
243868|NCT01376245|805551|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
243869|NCT01376089|805567|P2|Overall Study|Patient received no contrast media|4
243870|NCT01376089|805568|P1|Overall Study|Patient received no contrast media|3
243871|NCT01376037|805591|P2|Overall Study|Lost to Follow-up|2
243872|NCT01376037|805592|P1|Overall Study|Lost to Follow-up|0
243873|NCT01375777|805607|P9|Overall Study|Other|1
243874|NCT01375777|805608|P8|Overall Study|Other|0
243875|NCT01375777|805609|P7|Overall Study|Other|0
243876|NCT01375777|805610|P6|Overall Study|Other|0
243877|NCT01375777|805611|P5|Overall Study|Other|0
243878|NCT01375777|805612|P4|Overall Study|Other|0
243879|NCT01375777|805613|P3|Overall Study|Other|0
243880|NCT01375777|805614|P2|Overall Study|Other|1
243881|NCT01375777|805615|P1|Overall Study|Other|1
243882|NCT01375777|805607|P9|Overall Study|Lost to Follow-up|0
243883|NCT01375777|805608|P8|Overall Study|Lost to Follow-up|0
243884|NCT01375777|805609|P7|Overall Study|Lost to Follow-up|1
243885|NCT01375777|805610|P6|Overall Study|Lost to Follow-up|0
243886|NCT01375777|805611|P5|Overall Study|Lost to Follow-up|0
243887|NCT01375777|805612|P4|Overall Study|Lost to Follow-up|0
243888|NCT01375777|805613|P3|Overall Study|Lost to Follow-up|0
243889|NCT01375777|805614|P2|Overall Study|Lost to Follow-up|0
243890|NCT01375777|805615|P1|Overall Study|Lost to Follow-up|1
243891|NCT01375777|805607|P9|Overall Study|Withdrawal by Subject|1
243892|NCT01375777|805608|P8|Overall Study|Withdrawal by Subject|2
243893|NCT01375777|805609|P7|Overall Study|Withdrawal by Subject|1
243894|NCT01375777|805610|P6|Overall Study|Withdrawal by Subject|1
243895|NCT01375777|805611|P5|Overall Study|Withdrawal by Subject|1
243896|NCT01375777|805612|P4|Overall Study|Withdrawal by Subject|0
243897|NCT01375777|805613|P3|Overall Study|Withdrawal by Subject|1
243898|NCT01375777|805614|P2|Overall Study|Withdrawal by Subject|2
243899|NCT01375777|805615|P1|Overall Study|Withdrawal by Subject|0
243900|NCT01375764|805685|P5|Overall Study|Other|0
243901|NCT01375764|805686|P4|Overall Study|Other|1
243902|NCT01375764|805687|P3|Overall Study|Other|0
243903|NCT01375764|805688|P2|Overall Study|Other|0
243904|NCT01375764|805689|P1|Overall Study|Other|0
243905|NCT01375764|805685|P5|Overall Study|Withdrawal by Subject|1
243906|NCT01375764|805686|P4|Overall Study|Withdrawal by Subject|0
243907|NCT01375764|805687|P3|Overall Study|Withdrawal by Subject|0
243908|NCT01375764|805688|P2|Overall Study|Withdrawal by Subject|0
243909|NCT01375764|805689|P1|Overall Study|Withdrawal by Subject|2
243910|NCT01375764|805685|P5|Overall Study|Lost to Follow-up|0
243911|NCT01375764|805686|P4|Overall Study|Lost to Follow-up|0
243912|NCT01375764|805687|P3|Overall Study|Lost to Follow-up|0
243913|NCT01375764|805688|P2|Overall Study|Lost to Follow-up|1
243914|NCT01375764|805689|P1|Overall Study|Lost to Follow-up|0
243915|NCT01375751|805735|P3|Overall Study|Other|0
243916|NCT01375751|805736|P2|Overall Study|Other|1
243917|NCT01375751|805737|P1|Overall Study|Other|0
243918|NCT01375608|805781|P1|Overall Study|Withdrawal by Subject|2
243919|NCT01375374|805790|P1|Overall Study|Adverse Event|1
243920|NCT01375049|805840|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
243921|NCT01375049|805840|P1|Overall Study|Withdrawal by Subject|2
243922|NCT01375049|805840|P1|Overall Study|Lost to Follow-up|1
243923|NCT01375049|805840|P1|Overall Study|Adverse Event|2
243924|NCT01374971|805855|P1|Overall Study|Withdrawal by Subject|1
243925|NCT01374919|805860|P1|Overall Study|Withdrawal by Subject|2
243926|NCT01374568|805879|P2|Overall Study|Lab unable to analyze BTM|2
243927|NCT01374568|805880|P1|Overall Study|Lab unable to analyze BTM|0
243928|NCT01374451|805890|P2|Overall Study|Administrative problems|0
243929|NCT01374451|805891|P1|Overall Study|Administrative problems|1
243930|NCT01374425|805937|P2|Overall Study|Not Specified|43
243931|NCT01374425|805938|P1|Overall Study|Not Specified|41
243932|NCT01374425|805937|P2|Overall Study|Lost to Follow-up|1
243933|NCT01374425|805938|P1|Overall Study|Lost to Follow-up|2
243934|NCT01374425|805937|P2|Overall Study|Sponsor Decision|1
243935|NCT01374425|805938|P1|Overall Study|Sponsor Decision|0
243936|NCT01374425|805937|P2|Overall Study|Protocol Violation|3
243937|NCT01374425|805938|P1|Overall Study|Protocol Violation|2
243938|NCT01374425|805937|P2|Overall Study|Refused Treatment|24
243939|NCT01374425|805938|P1|Overall Study|Refused Treatment|10
243940|NCT01374425|805937|P2|Overall Study|Withdrawal by Subject|7
243941|NCT01374425|805938|P1|Overall Study|Withdrawal by Subject|6
243942|NCT01374425|805937|P2|Overall Study|Death (Adverse Event)|4
243943|NCT01374425|805938|P1|Overall Study|Death (Adverse Event)|2
243944|NCT01374425|805937|P2|Overall Study|Death (Progression of Disease)|0
243945|NCT01374425|805938|P1|Overall Study|Death (Progression of Disease)|1
243946|NCT01374425|805937|P2|Overall Study|Adverse Event|18
243947|NCT01374425|805938|P1|Overall Study|Adverse Event|29
243948|NCT01374425|805937|P2|Overall Study|Clinical Disease Progression|6
243949|NCT01374425|805938|P1|Overall Study|Clinical Disease Progression|9
243950|NCT01374425|805937|P2|Overall Study|Radiographic Disease Progression|81
243951|NCT01374425|805938|P1|Overall Study|Radiographic Disease Progression|86
243952|NCT01374269|806023|P2|Overall Study|closed research|2
243953|NCT01374269|806024|P1|Overall Study|closed research|1
243954|NCT01374269|806023|P2|Overall Study|Lost to Follow-up|3
243955|NCT01374269|806024|P1|Overall Study|Lost to Follow-up|1
243956|NCT01374269|806023|P2|Overall Study|Withdrawal by Subject|0
243957|NCT01374269|806024|P1|Overall Study|Withdrawal by Subject|4
243958|NCT01374178|806152|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
243959|NCT01374178|806153|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
243960|NCT01374178|806152|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
243961|NCT01374178|806153|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
243962|NCT01374087|806171|P2|Overall Study|Not provided|13
243963|NCT01374087|806172|P1|Overall Study|Not provided|13
243964|NCT01374087|806171|P2|Overall Study|Disease progression|2
243965|NCT01374087|806172|P1|Overall Study|Disease progression|2
243966|NCT01374087|806171|P2|Overall Study|Adverse Event|1
243967|NCT01374087|806172|P1|Overall Study|Adverse Event|0
243968|NCT01373918|806182|P2|Overall Study|Physician Decision|1
243969|NCT01373918|806183|P1|Overall Study|Physician Decision|0
243970|NCT01373346|806222|P1|Overall Study|Death|1
243971|NCT01373294|806245|P2|Overall Study|Adverse Event|0
243972|NCT01373294|806246|P1|Overall Study|Adverse Event|1
243973|NCT01373281|806255|P2|Overall Study|Serious adverse event|5
243974|NCT01373281|806256|P1|Overall Study|Serious adverse event|6
243975|NCT01373281|806255|P2|Overall Study|Adverse Event|4
243976|NCT01373281|806256|P1|Overall Study|Adverse Event|4
243977|NCT01373281|806255|P2|Overall Study|Lost to Follow-up|1
243978|NCT01373281|806256|P1|Overall Study|Lost to Follow-up|4
243979|NCT01373281|806255|P2|Overall Study|Protocol Violation|4
243980|NCT01373281|806256|P1|Overall Study|Protocol Violation|13
243981|NCT01373281|806255|P2|Overall Study|Withdrawal by Subject|31
243982|NCT01373281|806256|P1|Overall Study|Withdrawal by Subject|52
243983|NCT01372995|806275|P3|Overall Study|Physician Decision|1
243984|NCT01372995|806276|P2|Overall Study|Physician Decision|0
243985|NCT01372995|806277|P1|Overall Study|Physician Decision|0
243986|NCT01372995|806275|P3|Overall Study|Spouse withdrew participant from study|0
243987|NCT01372995|806276|P2|Overall Study|Spouse withdrew participant from study|1
243988|NCT01372995|806277|P1|Overall Study|Spouse withdrew participant from study|0
243989|NCT01372878|806324|P1|Overall Study|incomplete study procedure|104
243990|NCT01372878|806324|P1|Overall Study|Protocol Violation|17
243991|NCT01372878|806324|P1|Overall Study|Withdrawal by Subject|63
243992|NCT01372748|806344|P2|Overall Study|Withdrawal by Subject|5
243993|NCT01372748|806345|P1|Overall Study|Withdrawal by Subject|7
243994|NCT01372748|806344|P2|Overall Study|Lost to Follow-up|34
243995|NCT01372748|806345|P1|Overall Study|Lost to Follow-up|16
243996|NCT01372605|806355|P2|Overall Study|Changed medical home|0
243997|NCT01372605|806356|P1|Overall Study|Changed medical home|2
243998|NCT01372605|806355|P2|Overall Study|Moved|0
243999|NCT01372605|806356|P1|Overall Study|Moved|3
244000|NCT01372605|806355|P2|Overall Study|Withdrawal by Subject|7
244001|NCT01372605|806356|P1|Overall Study|Withdrawal by Subject|4
244002|NCT01372605|806355|P2|Overall Study|Lost to Follow-up|1
244003|NCT01372605|806356|P1|Overall Study|Lost to Follow-up|2
244004|NCT01372605|806355|P2|Overall Study|Death|2
244005|NCT01372605|806356|P1|Overall Study|Death|1
244006|NCT01372501|806382|P1|Overall Study|Device migration|1
244007|NCT01372501|806382|P1|Overall Study|Adverse Event|4
244008|NCT01372410|806405|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
244009|NCT01372410|806406|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
244010|NCT01372410|806407|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
244011|NCT01372410|806408|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
244012|NCT01372410|806409|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
244013|NCT01372410|806410|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
244014|NCT01372410|806411|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
244015|NCT01372410|806412|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
244016|NCT01372410|806405|P8|Treatment Period 3 (7 Days)|Adverse Event|0
244017|NCT01372410|806406|P7|Treatment Period 3 (7 Days)|Adverse Event|0
244018|NCT01372410|806407|P6|Treatment Period 3 (7 Days)|Adverse Event|0
244019|NCT01372410|806408|P5|Treatment Period 3 (7 Days)|Adverse Event|0
244020|NCT01372410|806409|P4|Treatment Period 3 (7 Days)|Adverse Event|0
244021|NCT01372410|806410|P3|Treatment Period 3 (7 Days)|Adverse Event|1
244022|NCT01372410|806411|P2|Treatment Period 3 (7 Days)|Adverse Event|0
244023|NCT01372410|806412|P1|Treatment Period 3 (7 Days)|Adverse Event|0
244024|NCT01372410|806405|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
244025|NCT01372410|806406|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
244026|NCT01372410|806407|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
244027|NCT01372410|806408|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
244028|NCT01372410|806409|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
244029|NCT01372410|806410|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
244030|NCT01372410|806411|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
244031|NCT01372410|806412|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
244032|NCT01372410|806405|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
244033|NCT01372410|806406|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
244034|NCT01372410|806407|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
244035|NCT01372410|806408|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
244036|NCT01372410|806409|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
244037|NCT01372410|806410|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
244038|NCT01372410|806411|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
244039|NCT01372410|806412|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
244040|NCT01372410|806405|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
244041|NCT01372410|806406|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
244042|NCT01372410|806407|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
244043|NCT01372410|806408|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
244044|NCT01372410|806409|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
244045|NCT01372410|806410|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
244046|NCT01372410|806411|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
244047|NCT01372410|806412|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
244048|NCT01372410|806405|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
244049|NCT01372410|806406|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
244050|NCT01372410|806407|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
244051|NCT01372410|806408|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
244052|NCT01372410|806409|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
244053|NCT01372410|806410|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
244054|NCT01372410|806411|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
244055|NCT01372410|806412|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
244056|NCT01372410|806405|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
244057|NCT01372410|806406|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
244058|NCT01372410|806407|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
244059|NCT01372410|806408|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
244060|NCT01372410|806409|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
244061|NCT01372410|806410|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
244062|NCT01372410|806411|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
244063|NCT01372410|806412|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
244064|NCT01372410|806405|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
244065|NCT01372410|806406|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
244066|NCT01372410|806407|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
244067|NCT01372410|806408|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
244068|NCT01372410|806409|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
244069|NCT01372410|806410|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
244070|NCT01372410|806411|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
244071|NCT01372410|806412|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
244072|NCT01372410|806405|P8|Treatment Period 1 (7 Days)|Adverse Event|0
244073|NCT01372410|806406|P7|Treatment Period 1 (7 Days)|Adverse Event|1
244074|NCT01372410|806407|P6|Treatment Period 1 (7 Days)|Adverse Event|0
244075|NCT01372410|806408|P5|Treatment Period 1 (7 Days)|Adverse Event|0
244076|NCT01372410|806409|P4|Treatment Period 1 (7 Days)|Adverse Event|0
244077|NCT01372410|806410|P3|Treatment Period 1 (7 Days)|Adverse Event|0
244078|NCT01372410|806411|P2|Treatment Period 1 (7 Days)|Adverse Event|1
244079|NCT01372410|806412|P1|Treatment Period 1 (7 Days)|Adverse Event|0
244080|NCT01372410|806405|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
244081|NCT01372410|806406|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
244082|NCT01372410|806407|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
244083|NCT01372410|806408|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
244084|NCT01372410|806409|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
244085|NCT01372410|806410|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
244086|NCT01372410|806411|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
244087|NCT01372410|806412|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
244088|NCT01372384|806449|P1|Overall Study|Progression of disease|3
244089|NCT01372150|806459|P3|Overall Study|Randomized but not treated|0
244090|NCT01372150|806460|P2|Overall Study|Randomized but not treated|1
244091|NCT01372150|806461|P1|Overall Study|Randomized but not treated|0
244092|NCT01372150|806459|P3|Overall Study|Adverse Event|2
244093|NCT01372150|806460|P2|Overall Study|Adverse Event|1
244094|NCT01372150|806461|P1|Overall Study|Adverse Event|2
244095|NCT01372150|806459|P3|Overall Study|Other|2
244096|NCT01372150|806460|P2|Overall Study|Other|0
244097|NCT01372150|806461|P1|Overall Study|Other|1
244098|NCT01372150|806459|P3|Overall Study|Withdrawal by Subject|2
244099|NCT01372150|806460|P2|Overall Study|Withdrawal by Subject|7
244100|NCT01372150|806461|P1|Overall Study|Withdrawal by Subject|2
244101|NCT01372150|806459|P3|Overall Study|Protocol Violation|3
244102|NCT01372150|806460|P2|Overall Study|Protocol Violation|0
244103|NCT01372150|806461|P1|Overall Study|Protocol Violation|1
244104|NCT01372150|806459|P3|Overall Study|Lost to Follow-up|6
244105|NCT01372150|806460|P2|Overall Study|Lost to Follow-up|5
244106|NCT01372150|806461|P1|Overall Study|Lost to Follow-up|4
244107|NCT01372150|806459|P3|Overall Study|Lack of Efficacy|1
244108|NCT01372150|806460|P2|Overall Study|Lack of Efficacy|0
244109|NCT01372150|806461|P1|Overall Study|Lack of Efficacy|3
244110|NCT01371994|806480|P2|Overall Study|Miscellaneous Reasons|4
244111|NCT01371994|806481|P1|Overall Study|Miscellaneous Reasons|6
244112|NCT01371994|806480|P2|Overall Study|Physician Decision|1
244113|NCT01371994|806481|P1|Overall Study|Physician Decision|1
244114|NCT01371994|806480|P2|Overall Study|Randomized but Never Received Study Drug|6
244115|NCT01371994|806481|P1|Overall Study|Randomized but Never Received Study Drug|6
244116|NCT01371994|806480|P2|Overall Study|Protocol Violation|17
244117|NCT01371994|806481|P1|Overall Study|Protocol Violation|24
244118|NCT01371994|806480|P2|Overall Study|Lost to Follow-up|1
244119|NCT01371994|806481|P1|Overall Study|Lost to Follow-up|1
244120|NCT01371994|806480|P2|Overall Study|Withdrawal by Subject|7
244121|NCT01371994|806481|P1|Overall Study|Withdrawal by Subject|13
244122|NCT01371994|806480|P2|Overall Study|Lack of Efficacy|0
244123|NCT01371994|806481|P1|Overall Study|Lack of Efficacy|3
244124|NCT01371994|806480|P2|Overall Study|Adverse Event|6
244125|NCT01371994|806481|P1|Overall Study|Adverse Event|3
244126|NCT01371877|806525|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
244127|NCT01371877|806526|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
244128|NCT01371851|806538|P2|Overall Study|Blood Pressure outside study parameters|0
244129|NCT01371851|806539|P1|Overall Study|Blood Pressure outside study parameters|2
244130|NCT01371851|806538|P2|Overall Study|non study related adverse event|0
244131|NCT01371851|806539|P1|Overall Study|non study related adverse event|1
244132|NCT01371851|806538|P2|Overall Study|was arrested and put in jail|1
244133|NCT01371851|806539|P1|Overall Study|was arrested and put in jail|0
244134|NCT01371851|806538|P2|Overall Study|Lost to Follow-up|8
244135|NCT01371851|806539|P1|Overall Study|Lost to Follow-up|5
244136|NCT01371838|806547|P2|Overall Study|Surgery|0
244137|NCT01371838|806548|P1|Overall Study|Surgery|1
244138|NCT01371838|806547|P2|Overall Study|Lack of therapeutic response|1
244139|NCT01371838|806548|P1|Overall Study|Lack of therapeutic response|0
244140|NCT01371838|806547|P2|Overall Study|Last follow-up visit not conducted|0
244141|NCT01371838|806548|P1|Overall Study|Last follow-up visit not conducted|2
244142|NCT01371838|806547|P2|Overall Study|Investigator Decision|8
244143|NCT01371838|806548|P1|Overall Study|Investigator Decision|3
244144|NCT01371838|806547|P2|Overall Study|Protocol Violation|0
244145|NCT01371838|806548|P1|Overall Study|Protocol Violation|3
244146|NCT01371838|806547|P2|Overall Study|Death|4
244147|NCT01371838|806548|P1|Overall Study|Death|3
244148|NCT01371838|806547|P2|Overall Study|Lost to Follow-up|20
244149|NCT01371838|806548|P1|Overall Study|Lost to Follow-up|10
244150|NCT01371838|806547|P2|Overall Study|Withdrawal by Subject|33
244151|NCT01371838|806548|P1|Overall Study|Withdrawal by Subject|27
244152|NCT01371825|806584|P1|Primary Efficacy Analysis Period|Death|3
244153|NCT01371747|806619|P6|Overall Study|Other Reasons|1
244154|NCT01371747|806620|P5|Overall Study|Other Reasons|0
244155|NCT01371747|806621|P4|Overall Study|Other Reasons|0
244156|NCT01371747|806622|P3|Overall Study|Other Reasons|2
244157|NCT01371747|806623|P2|Overall Study|Other Reasons|1
244158|NCT01371747|806624|P1|Overall Study|Other Reasons|2
244159|NCT01371747|806619|P6|Overall Study|Withdrawal by Subject|4
244160|NCT01371747|806620|P5|Overall Study|Withdrawal by Subject|2
244161|NCT01371747|806621|P4|Overall Study|Withdrawal by Subject|2
244162|NCT01371747|806622|P3|Overall Study|Withdrawal by Subject|5
244163|NCT01371747|806623|P2|Overall Study|Withdrawal by Subject|12
244164|NCT01371747|806624|P1|Overall Study|Withdrawal by Subject|6
244165|NCT01371747|806619|P6|Overall Study|Physician Decision|0
244166|NCT01371747|806620|P5|Overall Study|Physician Decision|1
244167|NCT01371747|806621|P4|Overall Study|Physician Decision|0
244168|NCT01371747|806622|P3|Overall Study|Physician Decision|0
244169|NCT01371747|806623|P2|Overall Study|Physician Decision|0
244170|NCT01371747|806624|P1|Overall Study|Physician Decision|0
244171|NCT01371747|806619|P6|Overall Study|Non-Compliance|1
244172|NCT01371747|806620|P5|Overall Study|Non-Compliance|0
244173|NCT01371747|806621|P4|Overall Study|Non-Compliance|0
244174|NCT01371747|806622|P3|Overall Study|Non-Compliance|3
244175|NCT01371747|806623|P2|Overall Study|Non-Compliance|4
244176|NCT01371747|806624|P1|Overall Study|Non-Compliance|3
244177|NCT01371747|806619|P6|Overall Study|Protocol Violation|0
244178|NCT01371747|806620|P5|Overall Study|Protocol Violation|0
244179|NCT01371747|806621|P4|Overall Study|Protocol Violation|0
244180|NCT01371747|806622|P3|Overall Study|Protocol Violation|1
244181|NCT01371747|806623|P2|Overall Study|Protocol Violation|0
244182|NCT01371747|806624|P1|Overall Study|Protocol Violation|0
244183|NCT01371747|806619|P6|Overall Study|Low Serum Potassium Results|3
244184|NCT01371747|806620|P5|Overall Study|Low Serum Potassium Results|0
244185|NCT01371747|806621|P4|Overall Study|Low Serum Potassium Results|1
244186|NCT01371747|806622|P3|Overall Study|Low Serum Potassium Results|1
244187|NCT01371747|806623|P2|Overall Study|Low Serum Potassium Results|1
244188|NCT01371747|806624|P1|Overall Study|Low Serum Potassium Results|1
244189|NCT01371747|806619|P6|Overall Study|High Serum Potassium Results|2
244190|NCT01371747|806620|P5|Overall Study|High Serum Potassium Results|0
244191|NCT01371747|806621|P4|Overall Study|High Serum Potassium Results|2
244192|NCT01371747|806622|P3|Overall Study|High Serum Potassium Results|1
244193|NCT01371747|806623|P2|Overall Study|High Serum Potassium Results|1
244194|NCT01371747|806624|P1|Overall Study|High Serum Potassium Results|1
244195|NCT01371747|806619|P6|Overall Study|Abnormal Renal Function|1
244196|NCT01371747|806620|P5|Overall Study|Abnormal Renal Function|0
244197|NCT01371747|806621|P4|Overall Study|Abnormal Renal Function|1
244198|NCT01371747|806622|P3|Overall Study|Abnormal Renal Function|0
244199|NCT01371747|806623|P2|Overall Study|Abnormal Renal Function|2
244200|NCT01371747|806624|P1|Overall Study|Abnormal Renal Function|0
244201|NCT01371747|806619|P6|Overall Study|Death|0
244202|NCT01371747|806620|P5|Overall Study|Death|2
244203|NCT01371747|806621|P4|Overall Study|Death|1
244204|NCT01371747|806622|P3|Overall Study|Death|4
244205|NCT01371747|806623|P2|Overall Study|Death|0
244206|NCT01371747|806624|P1|Overall Study|Death|1
244207|NCT01371747|806619|P6|Overall Study|Adverse Event|2
244208|NCT01371747|806620|P5|Overall Study|Adverse Event|2
244209|NCT01371747|806621|P4|Overall Study|Adverse Event|2
244210|NCT01371747|806622|P3|Overall Study|Adverse Event|7
244211|NCT01371747|806623|P2|Overall Study|Adverse Event|2
244212|NCT01371747|806624|P1|Overall Study|Adverse Event|4
244213|NCT01371734|806689|P3|Overall Study|Lack of Efficacy|0
244214|NCT01371734|806690|P2|Overall Study|Lack of Efficacy|2
244215|NCT01371734|806691|P1|Overall Study|Lack of Efficacy|2
244216|NCT01371734|806689|P3|Overall Study|Adverse Event|3
244217|NCT01371734|806690|P2|Overall Study|Adverse Event|8
244218|NCT01371734|806691|P1|Overall Study|Adverse Event|8
244219|NCT01371734|806689|P3|Overall Study|Protocol Violation|2
244220|NCT01371734|806690|P2|Overall Study|Protocol Violation|1
244221|NCT01371734|806691|P1|Overall Study|Protocol Violation|3
244222|NCT01371734|806689|P3|Overall Study|Lost to Follow-up|1
244223|NCT01371734|806690|P2|Overall Study|Lost to Follow-up|3
244224|NCT01371734|806691|P1|Overall Study|Lost to Follow-up|5
244225|NCT01371734|806689|P3|Overall Study|Withdrawal by Subject|9
244226|NCT01371734|806690|P2|Overall Study|Withdrawal by Subject|4
244227|NCT01371734|806691|P1|Overall Study|Withdrawal by Subject|3
244228|NCT01371734|806689|P3|Overall Study|Not specified|2
244229|NCT01371734|806690|P2|Overall Study|Not specified|1
244230|NCT01371734|806691|P1|Overall Study|Not specified|2
244231|NCT01371721|806711|P3|Overall Study|Randomized but not treated|0
244232|NCT01371721|806712|P2|Overall Study|Randomized but not treated|0
244233|NCT01371721|806713|P1|Overall Study|Randomized but not treated|1
244234|NCT01371721|806711|P3|Overall Study|Lack of Efficacy|3
244235|NCT01371721|806712|P2|Overall Study|Lack of Efficacy|4
244236|NCT01371721|806713|P1|Overall Study|Lack of Efficacy|2
244237|NCT01371721|806711|P3|Overall Study|Not specified|0
244238|NCT01371721|806712|P2|Overall Study|Not specified|3
244239|NCT01371721|806713|P1|Overall Study|Not specified|2
244240|NCT01371721|806711|P3|Overall Study|Withdrawal by Subject|11
244241|NCT01371721|806712|P2|Overall Study|Withdrawal by Subject|7
244242|NCT01371721|806713|P1|Overall Study|Withdrawal by Subject|5
244243|NCT01371721|806711|P3|Overall Study|Lost to Follow-up|6
244244|NCT01371721|806712|P2|Overall Study|Lost to Follow-up|2
244245|NCT01371721|806713|P1|Overall Study|Lost to Follow-up|8
244246|NCT01371721|806711|P3|Overall Study|Protocol Violation|5
244247|NCT01371721|806712|P2|Overall Study|Protocol Violation|4
244248|NCT01371721|806713|P1|Overall Study|Protocol Violation|6
244249|NCT01371721|806711|P3|Overall Study|Adverse Event|5
244250|NCT01371721|806712|P2|Overall Study|Adverse Event|4
244251|NCT01371721|806713|P1|Overall Study|Adverse Event|5
244252|NCT01371708|806746|P3|Overall Study|Started but did not receive treatment|1
244253|NCT01371708|806747|P2|Overall Study|Started but did not receive treatment|0
244254|NCT01371708|806748|P1|Overall Study|Started but did not receive treatment|1
244255|NCT01371708|806746|P3|Overall Study|Adverse Event|12
244256|NCT01371708|806747|P2|Overall Study|Adverse Event|8
244257|NCT01371708|806748|P1|Overall Study|Adverse Event|5
244258|NCT01371708|806746|P3|Overall Study|Not specified|4
244259|NCT01371708|806747|P2|Overall Study|Not specified|2
244260|NCT01371708|806748|P1|Overall Study|Not specified|3
244261|NCT01371708|806746|P3|Overall Study|Medication error/not related to AE|0
244262|NCT01371708|806747|P2|Overall Study|Medication error/not related to AE|1
244263|NCT01371708|806748|P1|Overall Study|Medication error/not related to AE|0
244264|NCT01371708|806746|P3|Overall Study|No longer willing to participate|13
244265|NCT01371708|806747|P2|Overall Study|No longer willing to participate|7
244266|NCT01371708|806748|P1|Overall Study|No longer willing to participate|7
244267|NCT01371708|806746|P3|Overall Study|Protocol Violation|2
244268|NCT01371708|806747|P2|Overall Study|Protocol Violation|1
244269|NCT01371708|806748|P1|Overall Study|Protocol Violation|2
244270|NCT01371708|806746|P3|Overall Study|Lost to Follow-up|7
244271|NCT01371708|806747|P2|Overall Study|Lost to Follow-up|9
244272|NCT01371708|806748|P1|Overall Study|Lost to Follow-up|5
244273|NCT01371708|806746|P3|Overall Study|Insufficient clinical response|0
244274|NCT01371708|806747|P2|Overall Study|Insufficient clinical response|2
244275|NCT01371708|806748|P1|Overall Study|Insufficient clinical response|3
244276|NCT01371643|806780|P2|Overall Study|Withdrawal by Subject|0
244277|NCT01371643|806781|P1|Overall Study|Withdrawal by Subject|3
244278|NCT01371565|806791|P1|Overall Study|Resection of neuroendocrine tumor|1
244279|NCT01371565|806791|P1|Overall Study|Death|1
244280|NCT01371565|806791|P1|Overall Study|Withdrawal by Subject|1
244281|NCT01371552|806795|P6|Part 1, First 3 Days|Inconvenience|0
244282|NCT01371552|806796|P5|Part 1, First 3 Days|Inconvenience|0
244283|NCT01371552|806797|P4|Part 1, First 3 Days|Inconvenience|0
244284|NCT01371552|806798|P3|Part 1, First 3 Days|Inconvenience|1
244285|NCT01371552|806799|P2|Part 1, First 3 Days|Inconvenience|0
244286|NCT01371552|806800|P1|Part 1, First 3 Days|Inconvenience|0
244287|NCT01371539|806827|P2|Period Two: One Week|Time/job conflict|1
244288|NCT01371539|806828|P1|Period Two: One Week|Time/job conflict|0
244289|NCT01371539|806827|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
244290|NCT01371539|806828|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
244291|NCT01371539|806827|P2|Period Two: One Week|Lost to Follow-up|1
244292|NCT01371539|806828|P1|Period Two: One Week|Lost to Follow-up|0
244293|NCT01371539|806827|P2|Period One: One Week|Lost to Follow-up|1
244294|NCT01371539|806828|P1|Period One: One Week|Lost to Follow-up|0
244295|NCT01371006|806838|P2|Overall Study|Adverse Event|0
244296|NCT01371006|806839|P1|Overall Study|Adverse Event|1
244297|NCT01370863|806880|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
244298|NCT01370863|806881|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
244299|NCT01370863|806880|P2|Overall Study|Did not want second pH/MII monitoring|1
244300|NCT01370863|806881|P1|Overall Study|Did not want second pH/MII monitoring|1
244301|NCT01370863|806880|P2|Overall Study|Adverse Event|1
244302|NCT01370863|806881|P1|Overall Study|Adverse Event|1
244303|NCT01370733|806906|P2|Overall Study|Protocol Violation|3
244304|NCT01370733|806907|P1|Overall Study|Protocol Violation|1
244305|NCT01370733|806906|P2|Overall Study|Physician Decision|2
244306|NCT01370733|806907|P1|Overall Study|Physician Decision|0
244307|NCT01370733|806906|P2|Overall Study|Lack of Efficacy|5
244308|NCT01370733|806907|P1|Overall Study|Lack of Efficacy|3
244309|NCT01370733|806906|P2|Overall Study|Adverse Event|4
244310|NCT01370733|806907|P1|Overall Study|Adverse Event|2
244311|NCT01370733|806906|P2|Overall Study|Lost to Follow-up|0
244312|NCT01370733|806907|P1|Overall Study|Lost to Follow-up|3
244313|NCT01370733|806906|P2|Overall Study|Withdrawal by Subject|8
244314|NCT01370733|806907|P1|Overall Study|Withdrawal by Subject|8
244315|NCT01370694|806929|P1|Overall Study|Progressive disease|2
244316|NCT01370694|806929|P1|Overall Study|Switched to rituximab|4
244317|NCT01370655|806951|P12|Period 2|Withdrawal by Subject|0
244318|NCT01370655|806952|P11|Period 2|Withdrawal by Subject|0
244319|NCT01370655|806953|P10|Period 2|Withdrawal by Subject|0
244320|NCT01370655|806954|P9|Period 2|Withdrawal by Subject|1
244321|NCT01370655|806955|P8|Period 2|Withdrawal by Subject|0
244322|NCT01370655|806956|P7|Period 2|Withdrawal by Subject|0
244323|NCT01370655|806957|P6|Period 2|Withdrawal by Subject|0
244324|NCT01370655|806958|P5|Period 2|Withdrawal by Subject|0
244325|NCT01370655|806959|P4|Period 2|Withdrawal by Subject|0
244326|NCT01370655|806960|P3|Period 2|Withdrawal by Subject|0
244327|NCT01370655|806961|P2|Period 2|Withdrawal by Subject|0
244328|NCT01370655|806962|P1|Period 2|Withdrawal by Subject|0
244329|NCT01370655|806951|P12|Period 2|met protocol specified stopping criteria|0
244330|NCT01370655|806952|P11|Period 2|met protocol specified stopping criteria|1
244331|NCT01370655|806953|P10|Period 2|met protocol specified stopping criteria|0
244332|NCT01370655|806954|P9|Period 2|met protocol specified stopping criteria|1
244333|NCT01370655|806955|P8|Period 2|met protocol specified stopping criteria|0
244334|NCT01370655|806956|P7|Period 2|met protocol specified stopping criteria|1
244335|NCT01370655|806957|P6|Period 2|met protocol specified stopping criteria|0
244336|NCT01370655|806958|P5|Period 2|met protocol specified stopping criteria|0
244337|NCT01370655|806959|P4|Period 2|met protocol specified stopping criteria|0
244338|NCT01370655|806960|P3|Period 2|met protocol specified stopping criteria|1
244339|NCT01370655|806961|P2|Period 2|met protocol specified stopping criteria|0
244340|NCT01370655|806962|P1|Period 2|met protocol specified stopping criteria|0
244341|NCT01370655|806951|P12|Period 2|Adverse Event|0
244342|NCT01370655|806952|P11|Period 2|Adverse Event|0
244343|NCT01370655|806953|P10|Period 2|Adverse Event|0
244344|NCT01370655|806954|P9|Period 2|Adverse Event|0
244345|NCT01370655|806955|P8|Period 2|Adverse Event|1
244346|NCT01370655|806956|P7|Period 2|Adverse Event|0
244347|NCT01370655|806957|P6|Period 2|Adverse Event|0
244348|NCT01370655|806958|P5|Period 2|Adverse Event|1
244349|NCT01370655|806959|P4|Period 2|Adverse Event|0
244350|NCT01370655|806960|P3|Period 2|Adverse Event|1
244351|NCT01370655|806961|P2|Period 2|Adverse Event|0
244352|NCT01370655|806962|P1|Period 2|Adverse Event|0
244353|NCT01370655|806951|P12|Period 1|Adverse Event|0
244354|NCT01370655|806952|P11|Period 1|Adverse Event|0
244355|NCT01370655|806953|P10|Period 1|Adverse Event|0
244356|NCT01370655|806954|P9|Period 1|Adverse Event|0
244357|NCT01370655|806955|P8|Period 1|Adverse Event|0
244358|NCT01370655|806956|P7|Period 1|Adverse Event|1
244359|NCT01370655|806957|P6|Period 1|Adverse Event|0
244360|NCT01370655|806958|P5|Period 1|Adverse Event|0
244361|NCT01370655|806959|P4|Period 1|Adverse Event|0
244362|NCT01370655|806960|P3|Period 1|Adverse Event|0
244363|NCT01370655|806961|P2|Period 1|Adverse Event|0
244364|NCT01370655|806962|P1|Period 1|Adverse Event|2
244365|NCT01370642|806999|P3|Overall Study|Withdrawal by Subject|3
244366|NCT01370642|807000|P2|Overall Study|Withdrawal by Subject|4
244367|NCT01370642|807001|P1|Overall Study|Withdrawal by Subject|2
244368|NCT01370642|806999|P3|Overall Study|Physician Decision|2
244369|NCT01370642|807000|P2|Overall Study|Physician Decision|1
244370|NCT01370642|807001|P1|Overall Study|Physician Decision|4
244371|NCT01370642|806999|P3|Overall Study|Lost to Follow-up|1
244372|NCT01370642|807000|P2|Overall Study|Lost to Follow-up|0
244373|NCT01370642|807001|P1|Overall Study|Lost to Follow-up|0
244374|NCT01370642|806999|P3|Overall Study|Detectable HCV RNA|22
244375|NCT01370642|807000|P2|Overall Study|Detectable HCV RNA|0
244376|NCT01370642|807001|P1|Overall Study|Detectable HCV RNA|0
244377|NCT01370642|806999|P3|Overall Study|Adverse Event|1
244378|NCT01370642|807000|P2|Overall Study|Adverse Event|1
244379|NCT01370642|807001|P1|Overall Study|Adverse Event|2
244380|NCT01370616|807032|P2|Overall Study|Withdrawal by Subject|34
244381|NCT01370616|807033|P1|Overall Study|Withdrawal by Subject|34
244382|NCT01370616|807032|P2|Overall Study|Technical Problems|5
244383|NCT01370616|807033|P1|Overall Study|Technical Problems|3
244384|NCT01370616|807032|P2|Overall Study|Recovery|0
244385|NCT01370616|807033|P1|Overall Study|Recovery|1
244386|NCT01370616|807032|P2|Overall Study|Progressive Disease|1
244387|NCT01370616|807033|P1|Overall Study|Progressive Disease|0
244388|NCT01370616|807032|P2|Overall Study|Physician Decision|6
244389|NCT01370616|807033|P1|Overall Study|Physician Decision|6
244390|NCT01370616|807032|P2|Overall Study|Lost to Follow-up|3
244391|NCT01370616|807033|P1|Overall Study|Lost to Follow-up|0
244392|NCT01370616|807032|P2|Overall Study|Lack of Efficacy|2
244393|NCT01370616|807033|P1|Overall Study|Lack of Efficacy|6
244394|NCT01370616|807032|P2|Overall Study|Death|0
244395|NCT01370616|807033|P1|Overall Study|Death|1
244396|NCT01370616|807032|P2|Overall Study|Adverse Event|16
244397|NCT01370616|807033|P1|Overall Study|Adverse Event|11
244398|NCT01370603|807057|P2|Period 2|Withdrawal by Subject|0
244399|NCT01370603|807058|P1|Period 2|Withdrawal by Subject|1
244400|NCT01370603|807057|P2|Period 2|Lost to Follow-up|0
244401|NCT01370603|807058|P1|Period 2|Lost to Follow-up|1
244402|NCT01370603|807057|P2|Period 2|Adverse Event|4
244403|NCT01370603|807058|P1|Period 2|Adverse Event|1
244404|NCT01370603|807057|P2|Crossover Washout|Non-compliance with Study Drug|2
244405|NCT01370603|807058|P1|Crossover Washout|Non-compliance with Study Drug|0
244406|NCT01370603|807057|P2|Crossover Washout|Withdrawal by Subject|1
244407|NCT01370603|807058|P1|Crossover Washout|Withdrawal by Subject|4
244408|NCT01370603|807057|P2|Crossover Washout|Protocol Violation|0
244409|NCT01370603|807058|P1|Crossover Washout|Protocol Violation|1
244410|NCT01370603|807057|P2|Crossover Washout|Lost to Follow-up|0
244411|NCT01370603|807058|P1|Crossover Washout|Lost to Follow-up|2
244412|NCT01370603|807057|P2|Crossover Washout|Adverse Event|1
244413|NCT01370603|807058|P1|Crossover Washout|Adverse Event|2
244414|NCT01370603|807057|P2|Period 1|Withdrawal by Subject|5
244415|NCT01370603|807058|P1|Period 1|Withdrawal by Subject|5
244416|NCT01370603|807057|P2|Period 1|Protocol Violation|2
244417|NCT01370603|807058|P1|Period 1|Protocol Violation|2
244418|NCT01370603|807057|P2|Period 1|Lost to Follow-up|0
244419|NCT01370603|807058|P1|Period 1|Lost to Follow-up|2
244420|NCT01370603|807057|P2|Period 1|Adverse Event|3
244421|NCT01370603|807058|P1|Period 1|Adverse Event|5
244422|NCT01370590|807076|P2|Period 2|Withdrawal by Subject|1
244423|NCT01370590|807077|P1|Period 2|Withdrawal by Subject|1
244424|NCT01370590|807076|P2|Period 2|Adverse Event|1
244425|NCT01370590|807077|P1|Period 2|Adverse Event|0
244426|NCT01370590|807076|P2|Crossover Washout Period|Withdrawal by Subject|2
244427|NCT01370590|807077|P1|Crossover Washout Period|Withdrawal by Subject|2
244428|NCT01370590|807076|P2|Crossover Washout Period|Non-compliance with Study Drug|0
244429|NCT01370590|807077|P1|Crossover Washout Period|Non-compliance with Study Drug|1
244430|NCT01370590|807076|P2|Crossover Washout Period|Lost to Follow-up|0
244431|NCT01370590|807077|P1|Crossover Washout Period|Lost to Follow-up|2
244432|NCT01370590|807076|P2|Crossover Washout Period|Adverse Event|4
244433|NCT01370590|807077|P1|Crossover Washout Period|Adverse Event|1
244434|NCT01370590|807076|P2|Period 1|Could not access randomization system|1
244435|NCT01370590|807077|P1|Period 1|Could not access randomization system|0
244436|NCT01370590|807076|P2|Period 1|Withdrawal by Subject|2
244437|NCT01370590|807077|P1|Period 1|Withdrawal by Subject|4
244438|NCT01370590|807076|P2|Period 1|Protocol Violation|2
244439|NCT01370590|807077|P1|Period 1|Protocol Violation|2
244440|NCT01370590|807076|P2|Period 1|Lost to Follow-up|2
244441|NCT01370590|807077|P1|Period 1|Lost to Follow-up|2
244442|NCT01370590|807076|P2|Period 1|Adverse Event|4
244443|NCT01370590|807077|P1|Period 1|Adverse Event|8
244444|NCT01370538|807095|P2|Overall Study|Lost to follow up|10
244445|NCT01370538|807096|P1|Overall Study|Lost to follow up|6
244446|NCT01370538|807095|P2|Overall Study|Development of study specific withdrawal|1
244447|NCT01370538|807096|P1|Overall Study|Development of study specific withdrawal|1
244448|NCT01370538|807095|P2|Overall Study|Protocol Violation|5
244449|NCT01370538|807096|P1|Overall Study|Protocol Violation|8
244450|NCT01370538|807095|P2|Overall Study|Adverse Event|0
244451|NCT01370538|807096|P1|Overall Study|Adverse Event|1
244452|NCT01370538|807095|P2|Overall Study|Eligibility criteria not fulfilled|1
244453|NCT01370538|807096|P1|Overall Study|Eligibility criteria not fulfilled|0
244454|NCT01370538|807095|P2|Overall Study|Voluntary Discontinuation by Subject|2
244455|NCT01370538|807096|P1|Overall Study|Voluntary Discontinuation by Subject|3
244456|NCT01370525|807112|P2|Overall Study|Lost to follow up|6
244457|NCT01370525|807113|P1|Overall Study|Lost to follow up|2
244458|NCT01370525|807112|P2|Overall Study|Protocol Violation|1
244459|NCT01370525|807113|P1|Overall Study|Protocol Violation|2
244460|NCT01370525|807112|P2|Overall Study|Adverse Event|1
244461|NCT01370525|807113|P1|Overall Study|Adverse Event|0
244462|NCT01370525|807112|P2|Overall Study|Eligibility criteria not fulfilled|0
244463|NCT01370525|807113|P1|Overall Study|Eligibility criteria not fulfilled|2
244464|NCT01370525|807112|P2|Overall Study|Voluntary Discontinuation by Subject|3
244465|NCT01370525|807113|P1|Overall Study|Voluntary Discontinuation by Subject|2
244466|NCT01370408|807137|P1|Overall Study|treatment failure|9
244467|NCT01370356|807150|P2|Overall Study|AE Not Related to Study Drug|4
244468|NCT01370356|807151|P1|Overall Study|AE Not Related to Study Drug|1
244469|NCT01370356|807150|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
244470|NCT01370356|807151|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
244471|NCT01370356|807150|P2|Overall Study|Protocol Violation|3
244472|NCT01370356|807151|P1|Overall Study|Protocol Violation|3
244473|NCT01370356|807150|P2|Overall Study|Reason not specified|43
244474|NCT01370356|807151|P1|Overall Study|Reason not specified|39
244475|NCT01370356|807150|P2|Overall Study|Withdrawal by Subject|59
244476|NCT01370356|807151|P1|Overall Study|Withdrawal by Subject|54
244477|NCT01370356|807150|P2|Overall Study|Lost to Follow-up|81
244478|NCT01370356|807151|P1|Overall Study|Lost to Follow-up|76
244479|NCT01370356|807150|P2|Overall Study|Lack of Efficacy|28
244480|NCT01370356|807151|P1|Overall Study|Lack of Efficacy|6
244481|NCT01370356|807150|P2|Overall Study|Death|0
244482|NCT01370356|807151|P1|Overall Study|Death|1
244483|NCT01370265|807165|P2|First Intervention|Adverse Event|1
244484|NCT01370265|807166|P1|First Intervention|Adverse Event|1
244485|NCT01370083|807185|P2|Overall Study|Adverse Event|1
244486|NCT01370083|807186|P1|Overall Study|Adverse Event|0
244487|NCT01370083|807185|P2|Overall Study|Lost to Follow-up|0
244488|NCT01370083|807186|P1|Overall Study|Lost to Follow-up|2
244489|NCT01370005|807199|P3|Overall Study|Other reason not defined above|2
244490|NCT01370005|807200|P2|Overall Study|Other reason not defined above|0
244491|NCT01370005|807201|P1|Overall Study|Other reason not defined above|3
244492|NCT01370005|807199|P3|Overall Study|Patient refusal to continue,not due toAE|0
244493|NCT01370005|807200|P2|Overall Study|Patient refusal to continue,not due toAE|4
244494|NCT01370005|807201|P1|Overall Study|Patient refusal to continue,not due toAE|5
244495|NCT01370005|807199|P3|Overall Study|Lost to Follow-up|1
244496|NCT01370005|807200|P2|Overall Study|Lost to Follow-up|1
244497|NCT01370005|807201|P1|Overall Study|Lost to Follow-up|1
244498|NCT01370005|807199|P3|Overall Study|Non compliant with protocol|2
244499|NCT01370005|807200|P2|Overall Study|Non compliant with protocol|1
244500|NCT01370005|807201|P1|Overall Study|Non compliant with protocol|0
244501|NCT01370005|807199|P3|Overall Study|Lack of Efficacy|0
244502|NCT01370005|807200|P2|Overall Study|Lack of Efficacy|0
244503|NCT01370005|807201|P1|Overall Study|Lack of Efficacy|1
244504|NCT01370005|807199|P3|Overall Study|Adverse Event|6
244505|NCT01370005|807200|P2|Overall Study|Adverse Event|5
244506|NCT01370005|807201|P1|Overall Study|Adverse Event|5
244507|NCT01370005|807199|P3|Overall Study|Not treated|0
244508|NCT01370005|807200|P2|Overall Study|Not treated|0
244509|NCT01370005|807201|P1|Overall Study|Not treated|1
244510|NCT01369849|807283|P3|Overall Study|Ineligible prior to treatment|1
244511|NCT01369849|807284|P2|Overall Study|Ineligible prior to treatment|0
244512|NCT01369849|807285|P1|Overall Study|Ineligible prior to treatment|0
244513|NCT01369784|807294|P1|Overall Study|Protocol Violation|12
244514|NCT01369680|807377|P4|Overall Study|Lost to Follow-up|2
244515|NCT01369680|807378|P3|Overall Study|Lost to Follow-up|1
244516|NCT01369680|807379|P2|Overall Study|Lost to Follow-up|0
244517|NCT01369680|807380|P1|Overall Study|Lost to Follow-up|0
244518|NCT01369641|807401|P1|Overall Study|Withdrawal by Subject|1
244519|NCT01369615|807407|P2|Overall Study|Lost to Follow-up|1
244520|NCT01369615|807408|P1|Overall Study|Lost to Follow-up|0
244521|NCT01369615|807407|P2|Overall Study|Withdrawal by Subject|1
244522|NCT01369615|807408|P1|Overall Study|Withdrawal by Subject|0
244523|NCT01369485|807416|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
244524|NCT01369485|807417|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
244525|NCT01369485|807416|P2|Open Label Phase (Week 12 to Month 12)|Death|1
244526|NCT01369485|807417|P1|Open Label Phase (Week 12 to Month 12)|Death|0
244527|NCT01369485|807416|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
244528|NCT01369485|807417|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
244529|NCT01369485|807416|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
244530|NCT01369485|807417|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
244531|NCT01369485|807416|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
244532|NCT01369485|807417|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
244533|NCT01369485|807416|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
244534|NCT01369485|807417|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
244535|NCT01369485|807416|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
244536|NCT01369485|807417|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
244537|NCT01369485|807416|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
244538|NCT01369485|807417|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
244539|NCT01369485|807416|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
244540|NCT01369485|807417|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
244541|NCT01369485|807416|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
244542|NCT01369485|807417|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
244543|NCT01369355|807463|P6|Overall Study|Not Treated|0
244544|NCT01369355|807464|P5|Overall Study|Not Treated|0
244545|NCT01369355|807465|P4|Overall Study|Not Treated|0
244546|NCT01369355|807466|P3|Overall Study|Not Treated|1
244547|NCT01369355|807467|P2|Overall Study|Not Treated|0
244548|NCT01369355|807468|P1|Overall Study|Not Treated|0
244549|NCT01369355|807463|P6|Overall Study|unspecified|0
244550|NCT01369355|807464|P5|Overall Study|unspecified|1
244551|NCT01369355|807465|P4|Overall Study|unspecified|0
244552|NCT01369355|807466|P3|Overall Study|unspecified|0
244553|NCT01369355|807467|P2|Overall Study|unspecified|0
244554|NCT01369355|807468|P1|Overall Study|unspecified|0
244555|NCT01369355|807463|P6|Overall Study|Withdrawal by Subject|22
244556|NCT01369355|807464|P5|Overall Study|Withdrawal by Subject|8
244557|NCT01369355|807465|P4|Overall Study|Withdrawal by Subject|6
244558|NCT01369355|807466|P3|Overall Study|Withdrawal by Subject|7
244559|NCT01369355|807467|P2|Overall Study|Withdrawal by Subject|2
244560|NCT01369355|807468|P1|Overall Study|Withdrawal by Subject|6
244561|NCT01369355|807463|P6|Overall Study|Lost to Follow-up|6
244562|NCT01369355|807464|P5|Overall Study|Lost to Follow-up|5
244563|NCT01369355|807465|P4|Overall Study|Lost to Follow-up|2
244564|NCT01369355|807466|P3|Overall Study|Lost to Follow-up|1
244565|NCT01369355|807467|P2|Overall Study|Lost to Follow-up|0
244566|NCT01369355|807468|P1|Overall Study|Lost to Follow-up|1
244567|NCT01369355|807463|P6|Overall Study|Protocol Violation|2
244568|NCT01369355|807464|P5|Overall Study|Protocol Violation|0
244569|NCT01369355|807465|P4|Overall Study|Protocol Violation|0
244570|NCT01369355|807466|P3|Overall Study|Protocol Violation|1
244571|NCT01369355|807467|P2|Overall Study|Protocol Violation|1
244572|NCT01369355|807468|P1|Overall Study|Protocol Violation|0
244573|NCT01369355|807463|P6|Overall Study|Lack of Efficacy|217
244574|NCT01369355|807464|P5|Overall Study|Lack of Efficacy|126
244575|NCT01369355|807465|P4|Overall Study|Lack of Efficacy|15
244576|NCT01369355|807466|P3|Overall Study|Lack of Efficacy|15
244577|NCT01369355|807467|P2|Overall Study|Lack of Efficacy|14
244578|NCT01369355|807468|P1|Overall Study|Lack of Efficacy|15
244579|NCT01369355|807463|P6|Overall Study|Adverse Event|25
244580|NCT01369355|807464|P5|Overall Study|Adverse Event|14
244581|NCT01369355|807465|P4|Overall Study|Adverse Event|7
244582|NCT01369355|807466|P3|Overall Study|Adverse Event|6
244583|NCT01369355|807467|P2|Overall Study|Adverse Event|12
244584|NCT01369355|807468|P1|Overall Study|Adverse Event|9
244585|NCT01369342|807497|P3|Overall Study|Not Treated|0
244586|NCT01369342|807498|P2|Overall Study|Not Treated|0
244587|NCT01369342|807499|P1|Overall Study|Not Treated|1
244588|NCT01369342|807497|P3|Overall Study|Lost to Follow-up|1
244589|NCT01369342|807498|P2|Overall Study|Lost to Follow-up|2
244590|NCT01369342|807499|P1|Overall Study|Lost to Follow-up|5
244591|NCT01369342|807497|P3|Overall Study|Withdrawal by Subject|2
244592|NCT01369342|807498|P2|Overall Study|Withdrawal by Subject|7
244593|NCT01369342|807499|P1|Overall Study|Withdrawal by Subject|7
244594|NCT01369329|807522|P3|Overall Study|Unspecified|2
244595|NCT01369329|807523|P2|Overall Study|Unspecified|3
244596|NCT01369329|807524|P1|Overall Study|Unspecified|2
244597|NCT01369329|807522|P3|Overall Study|Lost to Follow-up|2
244598|NCT01369329|807523|P2|Overall Study|Lost to Follow-up|2
244599|NCT01369329|807524|P1|Overall Study|Lost to Follow-up|2
244600|NCT01369329|807522|P3|Overall Study|Withdrawal by Subject|10
244601|NCT01369329|807523|P2|Overall Study|Withdrawal by Subject|6
244602|NCT01369329|807524|P1|Overall Study|Withdrawal by Subject|8
244603|NCT01369225|807550|P6|Overall Study|Adverse Event|0
244604|NCT01369225|807551|P5|Overall Study|Adverse Event|1
244605|NCT01369225|807552|P4|Overall Study|Adverse Event|1
244606|NCT01369225|807553|P3|Overall Study|Adverse Event|0
244607|NCT01369225|807554|P2|Overall Study|Adverse Event|0
244608|NCT01369225|807555|P1|Overall Study|Adverse Event|0
244609|NCT01369225|807550|P6|Overall Study|Unspecified|0
244610|NCT01369225|807551|P5|Overall Study|Unspecified|1
244611|NCT01369225|807552|P4|Overall Study|Unspecified|0
244612|NCT01369225|807553|P3|Overall Study|Unspecified|0
244613|NCT01369225|807554|P2|Overall Study|Unspecified|0
244614|NCT01369225|807555|P1|Overall Study|Unspecified|1
244615|NCT01369225|807550|P6|Overall Study|Does Not Meet Entrance Criteria|0
244616|NCT01369225|807551|P5|Overall Study|Does Not Meet Entrance Criteria|0
244617|NCT01369225|807552|P4|Overall Study|Does Not Meet Entrance Criteria|0
244618|NCT01369225|807553|P3|Overall Study|Does Not Meet Entrance Criteria|1
244619|NCT01369225|807554|P2|Overall Study|Does Not Meet Entrance Criteria|0
244620|NCT01369225|807555|P1|Overall Study|Does Not Meet Entrance Criteria|0
244621|NCT01369225|807550|P6|Overall Study|Withdrawal by Subject|0
244622|NCT01369225|807551|P5|Overall Study|Withdrawal by Subject|0
244623|NCT01369225|807552|P4|Overall Study|Withdrawal by Subject|1
244624|NCT01369225|807553|P3|Overall Study|Withdrawal by Subject|2
244625|NCT01369225|807554|P2|Overall Study|Withdrawal by Subject|0
244626|NCT01369225|807555|P1|Overall Study|Withdrawal by Subject|1
244627|NCT01368965|807653|P1|Overall Study|Lost to Follow-up|12
244628|NCT01368900|807662|P1|Overall Study|Lost to Follow-up|7
244629|NCT01368835|807737|P1|Overall Study|Lost to Follow-up|11
244630|NCT01368835|807737|P1|Overall Study|Inclusion criteria/photography quality|22
244631|NCT01368536|807779|P3|Overall Study|Protocol deviation|1
244632|NCT01368536|807780|P2|Overall Study|Protocol deviation|3
244633|NCT01368536|807781|P1|Overall Study|Protocol deviation|0
244634|NCT01368536|807779|P3|Overall Study|Administrative problems|35
244635|NCT01368536|807780|P2|Overall Study|Administrative problems|39
244636|NCT01368536|807781|P1|Overall Study|Administrative problems|34
244637|NCT01368536|807779|P3|Overall Study|Lost to Follow-up|5
244638|NCT01368536|807780|P2|Overall Study|Lost to Follow-up|3
244639|NCT01368536|807781|P1|Overall Study|Lost to Follow-up|3
244640|NCT01368536|807779|P3|Overall Study|Withdrawal by Subject|4
244641|NCT01368536|807780|P2|Overall Study|Withdrawal by Subject|5
244642|NCT01368536|807781|P1|Overall Study|Withdrawal by Subject|2
244643|NCT01368536|807779|P3|Overall Study|No longer required study medication|1
244644|NCT01368536|807780|P2|Overall Study|No longer required study medication|0
244645|NCT01368536|807781|P1|Overall Study|No longer required study medication|0
244646|NCT01368536|807779|P3|Overall Study|Unsatisfactory therapeutic effect|2
244647|NCT01368536|807780|P2|Overall Study|Unsatisfactory therapeutic effect|2
244648|NCT01368536|807781|P1|Overall Study|Unsatisfactory therapeutic effect|7
244649|NCT01368536|807779|P3|Overall Study|Abnormal test procedure result(s)|1
244650|NCT01368536|807780|P2|Overall Study|Abnormal test procedure result(s)|0
244651|NCT01368536|807781|P1|Overall Study|Abnormal test procedure result(s)|0
244652|NCT01368536|807779|P3|Overall Study|Abnormal laboratory value(s)|2
244653|NCT01368536|807780|P2|Overall Study|Abnormal laboratory value(s)|1
244654|NCT01368536|807781|P1|Overall Study|Abnormal laboratory value(s)|0
244655|NCT01368536|807779|P3|Overall Study|Adverse Event|8
244656|NCT01368536|807780|P2|Overall Study|Adverse Event|6
244657|NCT01368536|807781|P1|Overall Study|Adverse Event|5
244658|NCT01368432|807804|P2|Overall Study|Lost to Follow-up|1
244659|NCT01368432|807805|P1|Overall Study|Lost to Follow-up|0
244660|NCT01368406|807839|P2|Overall Study|started working|3
244661|NCT01368406|807840|P1|Overall Study|started working|2
244662|NCT01368406|807839|P2|Overall Study|relapse of the disease|2
244663|NCT01368406|807840|P1|Overall Study|relapse of the disease|3
244664|NCT01368406|807839|P2|Overall Study|Withdrawal by Subject|4
244665|NCT01368406|807840|P1|Overall Study|Withdrawal by Subject|8
244666|NCT01368406|807839|P2|Overall Study|Lost to Follow-up|4
244667|NCT01368406|807840|P1|Overall Study|Lost to Follow-up|8
244668|NCT01368276|807848|P2|Overall Study|Death|10
244669|NCT01368276|807849|P1|Overall Study|Death|1
244670|NCT01368211|807886|P2|Second Platelets Transfusion|No need for additional transfusion|2
244671|NCT01368211|807887|P1|Second Platelets Transfusion|No need for additional transfusion|1
244672|NCT01368081|807915|P13|Overall Study|Other reason not defined above|3
244673|NCT01368081|807916|P12|Overall Study|Other reason not defined above|0
244674|NCT01368081|807917|P11|Overall Study|Other reason not defined above|0
244675|NCT01368081|807918|P10|Overall Study|Other reason not defined above|1
244676|NCT01368081|807919|P9|Overall Study|Other reason not defined above|0
244677|NCT01368081|807920|P8|Overall Study|Other reason not defined above|0
244678|NCT01368081|807921|P7|Overall Study|Other reason not defined above|2
244679|NCT01368081|807922|P6|Overall Study|Other reason not defined above|1
244680|NCT01368081|807923|P5|Overall Study|Other reason not defined above|0
244681|NCT01368081|807924|P4|Overall Study|Other reason not defined above|1
244682|NCT01368081|807925|P3|Overall Study|Other reason not defined above|0
244683|NCT01368081|807926|P2|Overall Study|Other reason not defined above|0
244684|NCT01368081|807927|P1|Overall Study|Other reason not defined above|2
244685|NCT01368081|807915|P13|Overall Study|Withdrawal by Subject|0
244686|NCT01368081|807916|P12|Overall Study|Withdrawal by Subject|2
244687|NCT01368081|807917|P11|Overall Study|Withdrawal by Subject|3
244688|NCT01368081|807918|P10|Overall Study|Withdrawal by Subject|4
244689|NCT01368081|807919|P9|Overall Study|Withdrawal by Subject|5
244690|NCT01368081|807920|P8|Overall Study|Withdrawal by Subject|2
244691|NCT01368081|807921|P7|Overall Study|Withdrawal by Subject|4
244692|NCT01368081|807922|P6|Overall Study|Withdrawal by Subject|3
244693|NCT01368081|807923|P5|Overall Study|Withdrawal by Subject|0
244694|NCT01368081|807924|P4|Overall Study|Withdrawal by Subject|1
244695|NCT01368081|807925|P3|Overall Study|Withdrawal by Subject|1
244696|NCT01368081|807926|P2|Overall Study|Withdrawal by Subject|4
244697|NCT01368081|807927|P1|Overall Study|Withdrawal by Subject|4
244698|NCT01368081|807915|P13|Overall Study|Lost to Follow-up|1
244699|NCT01368081|807916|P12|Overall Study|Lost to Follow-up|0
244700|NCT01368081|807917|P11|Overall Study|Lost to Follow-up|0
244701|NCT01368081|807918|P10|Overall Study|Lost to Follow-up|0
244702|NCT01368081|807919|P9|Overall Study|Lost to Follow-up|0
244703|NCT01368081|807920|P8|Overall Study|Lost to Follow-up|0
244704|NCT01368081|807921|P7|Overall Study|Lost to Follow-up|0
244705|NCT01368081|807922|P6|Overall Study|Lost to Follow-up|0
244706|NCT01368081|807923|P5|Overall Study|Lost to Follow-up|0
244707|NCT01368081|807924|P4|Overall Study|Lost to Follow-up|0
244708|NCT01368081|807925|P3|Overall Study|Lost to Follow-up|0
244709|NCT01368081|807926|P2|Overall Study|Lost to Follow-up|0
244710|NCT01368081|807927|P1|Overall Study|Lost to Follow-up|0
244711|NCT01368081|807915|P13|Overall Study|Protocol Violation|0
244712|NCT01368081|807916|P12|Overall Study|Protocol Violation|0
244713|NCT01368081|807917|P11|Overall Study|Protocol Violation|0
244714|NCT01368081|807918|P10|Overall Study|Protocol Violation|0
244715|NCT01368081|807919|P9|Overall Study|Protocol Violation|0
244716|NCT01368081|807920|P8|Overall Study|Protocol Violation|1
244717|NCT01368081|807921|P7|Overall Study|Protocol Violation|0
244718|NCT01368081|807922|P6|Overall Study|Protocol Violation|1
244719|NCT01368081|807923|P5|Overall Study|Protocol Violation|0
244720|NCT01368081|807924|P4|Overall Study|Protocol Violation|0
244721|NCT01368081|807925|P3|Overall Study|Protocol Violation|0
244722|NCT01368081|807926|P2|Overall Study|Protocol Violation|0
244723|NCT01368081|807927|P1|Overall Study|Protocol Violation|0
244724|NCT01368081|807915|P13|Overall Study|Lack of Efficacy|0
244725|NCT01368081|807916|P12|Overall Study|Lack of Efficacy|0
244726|NCT01368081|807917|P11|Overall Study|Lack of Efficacy|0
244727|NCT01368081|807918|P10|Overall Study|Lack of Efficacy|0
244728|NCT01368081|807919|P9|Overall Study|Lack of Efficacy|0
244729|NCT01368081|807920|P8|Overall Study|Lack of Efficacy|2
244730|NCT01368081|807921|P7|Overall Study|Lack of Efficacy|0
244731|NCT01368081|807922|P6|Overall Study|Lack of Efficacy|0
244732|NCT01368081|807923|P5|Overall Study|Lack of Efficacy|0
244733|NCT01368081|807924|P4|Overall Study|Lack of Efficacy|1
244734|NCT01368081|807925|P3|Overall Study|Lack of Efficacy|0
244735|NCT01368081|807926|P2|Overall Study|Lack of Efficacy|1
244736|NCT01368081|807927|P1|Overall Study|Lack of Efficacy|0
244737|NCT01368081|807915|P13|Overall Study|Adverse Event|3
244738|NCT01368081|807916|P12|Overall Study|Adverse Event|1
244739|NCT01368081|807917|P11|Overall Study|Adverse Event|6
244740|NCT01368081|807918|P10|Overall Study|Adverse Event|5
244741|NCT01368081|807919|P9|Overall Study|Adverse Event|3
244742|NCT01368081|807920|P8|Overall Study|Adverse Event|2
244743|NCT01368081|807921|P7|Overall Study|Adverse Event|6
244744|NCT01368081|807922|P6|Overall Study|Adverse Event|5
244745|NCT01368081|807923|P5|Overall Study|Adverse Event|2
244746|NCT01368081|807924|P4|Overall Study|Adverse Event|2
244747|NCT01368081|807925|P3|Overall Study|Adverse Event|3
244748|NCT01368081|807926|P2|Overall Study|Adverse Event|4
244749|NCT01368081|807927|P1|Overall Study|Adverse Event|4
244750|NCT01368042|807981|P1|Overall Study|Transplanted|1
244751|NCT01368042|807981|P1|Overall Study|Lost to Follow-up|4
244752|NCT01368042|807981|P1|Overall Study|Protocol Violation|11
244753|NCT01368042|807981|P1|Overall Study|Death|14
244754|NCT01367886|808001|P1|Overall Study|Death|1
244755|NCT01367886|808001|P1|Overall Study|Lack of Efficacy|2
244756|NCT01367886|808001|P1|Overall Study|Lost to Follow-up|4
244757|NCT01367834|808051|P2|Overall Study|Study was ended.|1
244758|NCT01367834|808052|P1|Overall Study|Study was ended.|0
244759|NCT01367834|808051|P2|Overall Study|Withdrawal by Subject|2
244760|NCT01367834|808052|P1|Overall Study|Withdrawal by Subject|2
244761|NCT01367704|808076|P2|Overall Study|Lost to Follow-up|161
244762|NCT01367704|808077|P1|Overall Study|Lost to Follow-up|47
244763|NCT01367665|808089|P2|Overall Study|Other|0
244764|NCT01367665|808090|P1|Overall Study|Other|8
244765|NCT01367665|808089|P2|Overall Study|Suitable for surgery|0
244766|NCT01367665|808090|P1|Overall Study|Suitable for surgery|2
244767|NCT01367665|808089|P2|Overall Study|Lack of Efficacy|0
244768|NCT01367665|808090|P1|Overall Study|Lack of Efficacy|2
244769|NCT01367665|808089|P2|Overall Study|Non-compliance|0
244770|NCT01367665|808090|P1|Overall Study|Non-compliance|4
244771|NCT01367665|808089|P2|Overall Study|Protocol Violation|0
244772|NCT01367665|808090|P1|Overall Study|Protocol Violation|4
244773|NCT01367665|808089|P2|Overall Study|Not treated|0
244774|NCT01367665|808090|P1|Overall Study|Not treated|1
244775|NCT01367665|808089|P2|Overall Study|Progression of Disease|15
244776|NCT01367665|808090|P1|Overall Study|Progression of Disease|55
244777|NCT01367665|808089|P2|Overall Study|Withdrawal by Subject|2
244778|NCT01367665|808090|P1|Overall Study|Withdrawal by Subject|60
244779|NCT01367665|808089|P2|Overall Study|Complete Response|0
244780|NCT01367665|808090|P1|Overall Study|Complete Response|42
244781|NCT01367665|808089|P2|Overall Study|Lost to Follow-up|0
244782|NCT01367665|808090|P1|Overall Study|Lost to Follow-up|4
244783|NCT01367665|808089|P2|Overall Study|Investigator Request|1
244784|NCT01367665|808090|P1|Overall Study|Investigator Request|13
244785|NCT01367665|808089|P2|Overall Study|Death|1
244786|NCT01367665|808090|P1|Overall Study|Death|9
244787|NCT01367665|808089|P2|Overall Study|Adverse Event|5
244788|NCT01367665|808090|P1|Overall Study|Adverse Event|173
244789|NCT01367457|808099|P3|Overall Study|Suspected DP/suspected active infection|0
244790|NCT01367457|808100|P2|Overall Study|Suspected DP/suspected active infection|0
244791|NCT01367457|808101|P1|Overall Study|Suspected DP/suspected active infection|1
244792|NCT01367457|808099|P3|Overall Study|Palliative. Overall decline|0
244793|NCT01367457|808100|P2|Overall Study|Palliative. Overall decline|0
244794|NCT01367457|808101|P1|Overall Study|Palliative. Overall decline|1
244795|NCT01367457|808099|P3|Overall Study|Patient's Wish|0
244796|NCT01367457|808100|P2|Overall Study|Patient's Wish|0
244797|NCT01367457|808101|P1|Overall Study|Patient's Wish|1
244798|NCT01367457|808099|P3|Overall Study|CD, Suspected disease progression (DP)|0
244799|NCT01367457|808100|P2|Overall Study|CD, Suspected disease progression (DP)|0
244800|NCT01367457|808101|P1|Overall Study|CD, Suspected disease progression (DP)|1
244801|NCT01367457|808099|P3|Overall Study|Death from septic shock|0
244802|NCT01367457|808100|P2|Overall Study|Death from septic shock|0
244803|NCT01367457|808101|P1|Overall Study|Death from septic shock|1
244804|NCT01367457|808099|P3|Overall Study|Lost to Follow-up|0
244805|NCT01367457|808100|P2|Overall Study|Lost to Follow-up|0
244806|NCT01367457|808101|P1|Overall Study|Lost to Follow-up|1
244807|NCT01367457|808099|P3|Overall Study|Rejection of treatment|0
244808|NCT01367457|808100|P2|Overall Study|Rejection of treatment|0
244809|NCT01367457|808101|P1|Overall Study|Rejection of treatment|1
244810|NCT01367457|808099|P3|Overall Study|Overall decline|0
244811|NCT01367457|808100|P2|Overall Study|Overall decline|0
244812|NCT01367457|808101|P1|Overall Study|Overall decline|1
244813|NCT01367457|808099|P3|Overall Study|Intestinal obstruction with necrosis|0
244814|NCT01367457|808100|P2|Overall Study|Intestinal obstruction with necrosis|0
244815|NCT01367457|808101|P1|Overall Study|Intestinal obstruction with necrosis|1
244816|NCT01367457|808099|P3|Overall Study|No clinical benefit|0
244817|NCT01367457|808100|P2|Overall Study|No clinical benefit|0
244818|NCT01367457|808101|P1|Overall Study|No clinical benefit|1
244819|NCT01367457|808099|P3|Overall Study|Stabilisation + frequent infections|0
244820|NCT01367457|808100|P2|Overall Study|Stabilisation + frequent infections|0
244821|NCT01367457|808101|P1|Overall Study|Stabilisation + frequent infections|1
244822|NCT01367457|808099|P3|Overall Study|Overall status worsens to grade 4|0
244823|NCT01367457|808100|P2|Overall Study|Overall status worsens to grade 4|0
244824|NCT01367457|808101|P1|Overall Study|Overall status worsens to grade 4|1
244825|NCT01367457|808099|P3|Overall Study|Uncontrolled pain|0
244826|NCT01367457|808100|P2|Overall Study|Uncontrolled pain|0
244827|NCT01367457|808101|P1|Overall Study|Uncontrolled pain|1
244828|NCT01367457|808099|P3|Overall Study|CD, associated leukaemia|0
244829|NCT01367457|808100|P2|Overall Study|CD, associated leukaemia|0
244830|NCT01367457|808101|P1|Overall Study|CD, associated leukaemia|1
244831|NCT01367457|808099|P3|Overall Study|Withdrawal by Subject|0
244832|NCT01367457|808100|P2|Overall Study|Withdrawal by Subject|0
244833|NCT01367457|808101|P1|Overall Study|Withdrawal by Subject|1
244834|NCT01367457|808099|P3|Overall Study|Choledocolithiasis and pancreatitis|0
244835|NCT01367457|808100|P2|Overall Study|Choledocolithiasis and pancreatitis|0
244836|NCT01367457|808101|P1|Overall Study|Choledocolithiasis and pancreatitis|1
244837|NCT01367457|808099|P3|Overall Study|low grade toxicities + stable disease|0
244838|NCT01367457|808100|P2|Overall Study|low grade toxicities + stable disease|0
244839|NCT01367457|808101|P1|Overall Study|low grade toxicities + stable disease|1
244840|NCT01367457|808099|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
244841|NCT01367457|808100|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
244842|NCT01367457|808101|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
244843|NCT01367457|808099|P3|Overall Study|Bleeding from cavernous haemangioma|0
244844|NCT01367457|808100|P2|Overall Study|Bleeding from cavernous haemangioma|0
244845|NCT01367457|808101|P1|Overall Study|Bleeding from cavernous haemangioma|1
244846|NCT01367457|808099|P3|Overall Study|Investigator's opinion, stable disease|0
244847|NCT01367457|808100|P2|Overall Study|Investigator's opinion, stable disease|0
244848|NCT01367457|808101|P1|Overall Study|Investigator's opinion, stable disease|1
244849|NCT01367457|808099|P3|Overall Study|Patient asks for rest + slow progression|0
244850|NCT01367457|808100|P2|Overall Study|Patient asks for rest + slow progression|0
244851|NCT01367457|808101|P1|Overall Study|Patient asks for rest + slow progression|1
244852|NCT01367457|808099|P3|Overall Study|Progression|0
244853|NCT01367457|808100|P2|Overall Study|Progression|0
244854|NCT01367457|808101|P1|Overall Study|Progression|137
244855|NCT01367457|808099|P3|Overall Study|Toxicity|0
244856|NCT01367457|808100|P2|Overall Study|Toxicity|0
244857|NCT01367457|808101|P1|Overall Study|Toxicity|16
244858|NCT01367457|808099|P3|Overall Study|Progression and death|0
244859|NCT01367457|808100|P2|Overall Study|Progression and death|0
244860|NCT01367457|808101|P1|Overall Study|Progression and death|8
244861|NCT01367457|808099|P3|Overall Study|Clinical decline (CD)|0
244862|NCT01367457|808100|P2|Overall Study|Clinical decline (CD)|0
244863|NCT01367457|808101|P1|Overall Study|Clinical decline (CD)|2
244864|NCT01367457|808099|P3|Overall Study|Investigator's decision|0
244865|NCT01367457|808100|P2|Overall Study|Investigator's decision|0
244866|NCT01367457|808101|P1|Overall Study|Investigator's decision|2
244867|NCT01367457|808099|P3|Overall Study|Death|0
244868|NCT01367457|808100|P2|Overall Study|Death|0
244869|NCT01367457|808101|P1|Overall Study|Death|2
244870|NCT01367249|808123|P2|Overall Study|Not Specified|10
244871|NCT01367249|808124|P1|Overall Study|Not Specified|3
244872|NCT01367249|808123|P2|Overall Study|Withdrawal by Subject|6
244873|NCT01367249|808124|P1|Overall Study|Withdrawal by Subject|6
244874|NCT01367158|808143|P11|Overall Study|Protocol Violation|0
244875|NCT01367158|808144|P10|Overall Study|Protocol Violation|0
244876|NCT01367158|808145|P9|Overall Study|Protocol Violation|0
244877|NCT01367158|808146|P8|Overall Study|Protocol Violation|0
244878|NCT01367158|808147|P7|Overall Study|Protocol Violation|0
244879|NCT01367158|808148|P6|Overall Study|Protocol Violation|0
244880|NCT01367158|808149|P5|Overall Study|Protocol Violation|0
244881|NCT01367158|808150|P4|Overall Study|Protocol Violation|0
244882|NCT01367158|808151|P3|Overall Study|Protocol Violation|0
244883|NCT01367158|808152|P2|Overall Study|Protocol Violation|1
244884|NCT01367158|808153|P1|Overall Study|Protocol Violation|0
244885|NCT01367158|808143|P11|Overall Study|Lost to Follow-up|1
244886|NCT01367158|808144|P10|Overall Study|Lost to Follow-up|0
244887|NCT01367158|808145|P9|Overall Study|Lost to Follow-up|0
244888|NCT01367158|808146|P8|Overall Study|Lost to Follow-up|1
244889|NCT01367158|808147|P7|Overall Study|Lost to Follow-up|0
244890|NCT01367158|808148|P6|Overall Study|Lost to Follow-up|2
244891|NCT01367158|808149|P5|Overall Study|Lost to Follow-up|0
244892|NCT01367158|808150|P4|Overall Study|Lost to Follow-up|1
244893|NCT01367158|808151|P3|Overall Study|Lost to Follow-up|0
244894|NCT01367158|808152|P2|Overall Study|Lost to Follow-up|0
244895|NCT01367158|808153|P1|Overall Study|Lost to Follow-up|0
244896|NCT01367158|808143|P11|Overall Study|Withdrew consent|0
244897|NCT01367158|808144|P10|Overall Study|Withdrew consent|0
244898|NCT01367158|808145|P9|Overall Study|Withdrew consent|0
244899|NCT01367158|808146|P8|Overall Study|Withdrew consent|1
244900|NCT01367158|808147|P7|Overall Study|Withdrew consent|0
244901|NCT01367158|808148|P6|Overall Study|Withdrew consent|0
244902|NCT01367158|808149|P5|Overall Study|Withdrew consent|2
244903|NCT01367158|808150|P4|Overall Study|Withdrew consent|0
244904|NCT01367158|808151|P3|Overall Study|Withdrew consent|1
244905|NCT01367158|808152|P2|Overall Study|Withdrew consent|2
244906|NCT01367158|808153|P1|Overall Study|Withdrew consent|0
244907|NCT01367119|808297|P2|Overall Study|Withdrawal by Subject|1
244908|NCT01367119|808298|P1|Overall Study|Withdrawal by Subject|1
244909|NCT01367119|808297|P2|Overall Study|Adverse Event|0
244910|NCT01367119|808298|P1|Overall Study|Adverse Event|1
244911|NCT01366846|808353|P4|Overall Study|Scheduling Conflicts|0
244912|NCT01366846|808354|P3|Overall Study|Scheduling Conflicts|1
244913|NCT01366846|808355|P2|Overall Study|Scheduling Conflicts|0
244914|NCT01366846|808356|P1|Overall Study|Scheduling Conflicts|0
244915|NCT01366846|808353|P4|Overall Study|Communication Difficulties|1
244916|NCT01366846|808354|P3|Overall Study|Communication Difficulties|0
244917|NCT01366846|808355|P2|Overall Study|Communication Difficulties|4
244918|NCT01366846|808356|P1|Overall Study|Communication Difficulties|1
244919|NCT01366846|808353|P4|Overall Study|Withdrawal by Subject|0
244920|NCT01366846|808354|P3|Overall Study|Withdrawal by Subject|0
244921|NCT01366846|808355|P2|Overall Study|Withdrawal by Subject|0
244922|NCT01366846|808356|P1|Overall Study|Withdrawal by Subject|2
244923|NCT01366638|808379|P3|Overall Study|Not specified|0
244924|NCT01366638|808380|P2|Overall Study|Not specified|0
244925|NCT01366638|808381|P1|Overall Study|Not specified|1
244926|NCT01366638|808379|P3|Overall Study|Withdrawal by Subject|6
244927|NCT01366638|808380|P2|Overall Study|Withdrawal by Subject|0
244928|NCT01366638|808381|P1|Overall Study|Withdrawal by Subject|0
244929|NCT01366534|808418|P3|Overall Study|Declined challenged|0
244930|NCT01366534|808419|P2|Overall Study|Declined challenged|1
244931|NCT01366534|808420|P1|Overall Study|Declined challenged|0
244932|NCT01366534|808418|P3|Overall Study|Migrated|0
244933|NCT01366534|808419|P2|Overall Study|Migrated|1
244934|NCT01366534|808420|P1|Overall Study|Migrated|1
244935|NCT01366534|808418|P3|Overall Study|Lost to Follow-up|0
244936|NCT01366534|808419|P2|Overall Study|Lost to Follow-up|0
244937|NCT01366534|808420|P1|Overall Study|Lost to Follow-up|1
244938|NCT01366521|808470|P4|Overall Study|Withdrawal by Subject|0
244939|NCT01366521|808471|P3|Overall Study|Withdrawal by Subject|0
244940|NCT01366521|808472|P2|Overall Study|Withdrawal by Subject|1
244941|NCT01366521|808473|P1|Overall Study|Withdrawal by Subject|0
244942|NCT01366521|808470|P4|Overall Study|Physician Decision|0
244943|NCT01366521|808471|P3|Overall Study|Physician Decision|1
244944|NCT01366521|808472|P2|Overall Study|Physician Decision|0
244945|NCT01366521|808473|P1|Overall Study|Physician Decision|0
244946|NCT01366521|808470|P4|Overall Study|Protocol Violation|0
244947|NCT01366521|808471|P3|Overall Study|Protocol Violation|1
244948|NCT01366521|808472|P2|Overall Study|Protocol Violation|0
244949|NCT01366521|808473|P1|Overall Study|Protocol Violation|0
244950|NCT01366521|808470|P4|Overall Study|Adverse Event|0
244951|NCT01366521|808471|P3|Overall Study|Adverse Event|0
244952|NCT01366521|808472|P2|Overall Study|Adverse Event|0
244953|NCT01366521|808473|P1|Overall Study|Adverse Event|1
244954|NCT01366443|808548|P1|Overall Study|Under 18 yo|1
244955|NCT01366443|808548|P1|Overall Study|Lost to Follow-up|2
244956|NCT01366209|808562|P2|Overall Study|Withdrew consent|3
244957|NCT01366209|808563|P1|Overall Study|Withdrew consent|4
244958|NCT01366209|808562|P2|Overall Study|Sponsors decision|1
244959|NCT01366209|808563|P1|Overall Study|Sponsors decision|0
244960|NCT01366209|808562|P2|Overall Study|Physician Decision|0
244961|NCT01366209|808563|P1|Overall Study|Physician Decision|1
244962|NCT01366209|808562|P2|Overall Study|Lost to Follow-up|1
244963|NCT01366209|808563|P1|Overall Study|Lost to Follow-up|2
244964|NCT01366209|808562|P2|Overall Study|Lung transplantation|1
244965|NCT01366209|808563|P1|Overall Study|Lung transplantation|6
244966|NCT01366209|808562|P2|Overall Study|Death|19
244967|NCT01366209|808563|P1|Overall Study|Death|12
244968|NCT01366209|808562|P2|Overall Study|Withdrawal by Subject|4
244969|NCT01366209|808563|P1|Overall Study|Withdrawal by Subject|4
244970|NCT01366209|808562|P2|Overall Study|Adverse Event|7
244971|NCT01366209|808563|P1|Overall Study|Adverse Event|6
244972|NCT01366092|808569|P1|Overall Study|Withdrawal by Subject|1
244973|NCT01366092|808569|P1|Overall Study|Physician Decision|1
244974|NCT01366092|808569|P1|Overall Study|Progressive cGVHD|2
244975|NCT01365910|808578|P1|Overall Study|pt did not get tx, nausea/vomiting|1
244976|NCT01365910|808578|P1|Overall Study|other complicating disease|1
244977|NCT01365910|808578|P1|Overall Study|Adverse Event|3
244978|NCT01365910|808578|P1|Overall Study|disease progression|18
244979|NCT01365910|808578|P1|Overall Study|Withdrawal by Subject|7
244980|NCT01365546|808673|P1|Overall Study|Study termination|1
244981|NCT01365546|808673|P1|Overall Study|Screen failure|9
244982|NCT01365546|808673|P1|Overall Study|Withdrawal by Subject|1
244983|NCT01365507|808683|P2|Overall Study|Unclassified|4
244984|NCT01365507|808684|P1|Overall Study|Unclassified|1
244985|NCT01365507|808683|P2|Overall Study|Withdrawal Criteria|5
244986|NCT01365507|808684|P1|Overall Study|Withdrawal Criteria|8
244987|NCT01365494|808700|P2|Overall Study|Lost to Follow-up|2
244988|NCT01365494|808701|P1|Overall Study|Lost to Follow-up|1
244989|NCT01365494|808700|P2|Overall Study|Withdrawal by Subject|1
244990|NCT01365494|808701|P1|Overall Study|Withdrawal by Subject|0
244991|NCT01365494|808700|P2|Overall Study|Adverse Event|0
244992|NCT01365494|808701|P1|Overall Study|Adverse Event|1
244993|NCT01365481|808717|P4|Overall Study|Unsatisfactory therapeutic effect|0
244994|NCT01365481|808718|P3|Overall Study|Unsatisfactory therapeutic effect|1
244995|NCT01365481|808719|P2|Overall Study|Unsatisfactory therapeutic effect|0
244996|NCT01365481|808720|P1|Overall Study|Unsatisfactory therapeutic effect|0
244997|NCT01365481|808717|P4|Overall Study|Protocol deviation|1
244998|NCT01365481|808718|P3|Overall Study|Protocol deviation|0
244999|NCT01365481|808719|P2|Overall Study|Protocol deviation|1
245000|NCT01365481|808720|P1|Overall Study|Protocol deviation|0
245001|NCT01365481|808717|P4|Overall Study|Administrative problems|0
245002|NCT01365481|808718|P3|Overall Study|Administrative problems|0
245003|NCT01365481|808719|P2|Overall Study|Administrative problems|1
245004|NCT01365481|808720|P1|Overall Study|Administrative problems|0
245005|NCT01365481|808717|P4|Overall Study|Abnormal laboratory value(s)|0
245006|NCT01365481|808718|P3|Overall Study|Abnormal laboratory value(s)|0
245007|NCT01365481|808719|P2|Overall Study|Abnormal laboratory value(s)|1
245008|NCT01365481|808720|P1|Overall Study|Abnormal laboratory value(s)|0
245009|NCT01365481|808717|P4|Overall Study|Lost to Follow-up|3
245010|NCT01365481|808718|P3|Overall Study|Lost to Follow-up|2
245011|NCT01365481|808719|P2|Overall Study|Lost to Follow-up|1
245012|NCT01365481|808720|P1|Overall Study|Lost to Follow-up|1
245013|NCT01365481|808717|P4|Overall Study|Withdrawal by Subject|1
245014|NCT01365481|808718|P3|Overall Study|Withdrawal by Subject|1
245015|NCT01365481|808719|P2|Overall Study|Withdrawal by Subject|2
245016|NCT01365481|808720|P1|Overall Study|Withdrawal by Subject|0
245017|NCT01365481|808717|P4|Overall Study|Adverse Event|2
245018|NCT01365481|808718|P3|Overall Study|Adverse Event|0
245019|NCT01365481|808719|P2|Overall Study|Adverse Event|9
245020|NCT01365481|808720|P1|Overall Study|Adverse Event|6
245021|NCT01365468|808740|P2|Overall Study|Lost to Follow-up|0
245022|NCT01365468|808741|P1|Overall Study|Lost to Follow-up|2
245023|NCT01365468|808740|P2|Overall Study|Disease progression|0
245024|NCT01365468|808741|P1|Overall Study|Disease progression|1
245025|NCT01365468|808740|P2|Overall Study|Physician Decision|0
245026|NCT01365468|808741|P1|Overall Study|Physician Decision|1
245027|NCT01365455|808756|P5|Maintenance Period|Subject/guardian decision|1
245028|NCT01365455|808757|P4|Maintenance Period|Subject/guardian decision|4
245029|NCT01365455|808758|P3|Maintenance Period|Subject/guardian decision|2
245030|NCT01365455|808759|P2|Maintenance Period|Subject/guardian decision|6
245031|NCT01365455|808760|P1|Maintenance Period|Subject/guardian decision|4
245032|NCT01365455|808756|P5|Maintenance Period|Protocol deviation|0
245033|NCT01365455|808757|P4|Maintenance Period|Protocol deviation|0
245034|NCT01365455|808758|P3|Maintenance Period|Protocol deviation|0
245035|NCT01365455|808759|P2|Maintenance Period|Protocol deviation|1
245036|NCT01365455|808760|P1|Maintenance Period|Protocol deviation|1
245037|NCT01365455|808756|P5|Maintenance Period|Pregnancy|2
245038|NCT01365455|808757|P4|Maintenance Period|Pregnancy|0
245039|NCT01365455|808758|P3|Maintenance Period|Pregnancy|0
245040|NCT01365455|808759|P2|Maintenance Period|Pregnancy|4
245041|NCT01365455|808760|P1|Maintenance Period|Pregnancy|0
245042|NCT01365455|808756|P5|Maintenance Period|Physician Decision|1
245043|NCT01365455|808757|P4|Maintenance Period|Physician Decision|0
245044|NCT01365455|808758|P3|Maintenance Period|Physician Decision|0
245045|NCT01365455|808759|P2|Maintenance Period|Physician Decision|1
245046|NCT01365455|808760|P1|Maintenance Period|Physician Decision|0
245047|NCT01365455|808756|P5|Maintenance Period|Non-compliance with study treatment|0
245048|NCT01365455|808757|P4|Maintenance Period|Non-compliance with study treatment|1
245049|NCT01365455|808758|P3|Maintenance Period|Non-compliance with study treatment|0
245050|NCT01365455|808759|P2|Maintenance Period|Non-compliance with study treatment|0
245051|NCT01365455|808760|P1|Maintenance Period|Non-compliance with study treatment|0
245052|NCT01365455|808756|P5|Maintenance Period|Lost to Follow-up|3
245053|NCT01365455|808757|P4|Maintenance Period|Lost to Follow-up|0
245054|NCT01365455|808758|P3|Maintenance Period|Lost to Follow-up|0
245055|NCT01365455|808759|P2|Maintenance Period|Lost to Follow-up|4
245056|NCT01365455|808760|P1|Maintenance Period|Lost to Follow-up|2
245057|NCT01365455|808756|P5|Maintenance Period|Lack of Efficacy|2
245058|NCT01365455|808757|P4|Maintenance Period|Lack of Efficacy|2
245059|NCT01365455|808758|P3|Maintenance Period|Lack of Efficacy|0
245060|NCT01365455|808759|P2|Maintenance Period|Lack of Efficacy|2
245061|NCT01365455|808760|P1|Maintenance Period|Lack of Efficacy|10
245062|NCT01365455|808756|P5|Maintenance Period|Adverse Event|4
245063|NCT01365455|808757|P4|Maintenance Period|Adverse Event|2
245064|NCT01365455|808758|P3|Maintenance Period|Adverse Event|1
245065|NCT01365455|808759|P2|Maintenance Period|Adverse Event|5
245066|NCT01365455|808760|P1|Maintenance Period|Adverse Event|12
245067|NCT01365455|808756|P5|Induction Period|Lost to Follow-up|0
245068|NCT01365455|808757|P4|Induction Period|Lost to Follow-up|0
245069|NCT01365455|808758|P3|Induction Period|Lost to Follow-up|3
245070|NCT01365455|808759|P2|Induction Period|Lost to Follow-up|0
245071|NCT01365455|808760|P1|Induction Period|Lost to Follow-up|0
245072|NCT01365455|808756|P5|Induction Period|Subject/guardian decision|0
245073|NCT01365455|808757|P4|Induction Period|Subject/guardian decision|0
245074|NCT01365455|808758|P3|Induction Period|Subject/guardian decision|8
245075|NCT01365455|808759|P2|Induction Period|Subject/guardian decision|1
245076|NCT01365455|808760|P1|Induction Period|Subject/guardian decision|9
245077|NCT01365455|808756|P5|Induction Period|Protocol deviation|0
245078|NCT01365455|808757|P4|Induction Period|Protocol deviation|0
245079|NCT01365455|808758|P3|Induction Period|Protocol deviation|1
245080|NCT01365455|808759|P2|Induction Period|Protocol deviation|1
245081|NCT01365455|808760|P1|Induction Period|Protocol deviation|0
245082|NCT01365455|808756|P5|Induction Period|Pregnancy|0
245083|NCT01365455|808757|P4|Induction Period|Pregnancy|0
245084|NCT01365455|808758|P3|Induction Period|Pregnancy|0
245085|NCT01365455|808759|P2|Induction Period|Pregnancy|1
245086|NCT01365455|808760|P1|Induction Period|Pregnancy|0
245087|NCT01365455|808756|P5|Induction Period|Lack of Efficacy|0
245088|NCT01365455|808757|P4|Induction Period|Lack of Efficacy|0
245089|NCT01365455|808758|P3|Induction Period|Lack of Efficacy|0
245090|NCT01365455|808759|P2|Induction Period|Lack of Efficacy|1
245091|NCT01365455|808760|P1|Induction Period|Lack of Efficacy|1
245092|NCT01365455|808756|P5|Induction Period|Adverse Event|0
245093|NCT01365455|808757|P4|Induction Period|Adverse Event|0
245094|NCT01365455|808758|P3|Induction Period|Adverse Event|4
245095|NCT01365455|808759|P2|Induction Period|Adverse Event|3
245096|NCT01365455|808760|P1|Induction Period|Adverse Event|5
245097|NCT01365273|808850|P2|Overall Study|Physician Decision|0
245098|NCT01365273|808851|P1|Overall Study|Physician Decision|1
245099|NCT01365273|808850|P2|Overall Study|Protocol Violation|1
245100|NCT01365273|808851|P1|Overall Study|Protocol Violation|0
245101|NCT01365273|808850|P2|Overall Study|Lost to Follow-up|0
245102|NCT01365273|808851|P1|Overall Study|Lost to Follow-up|1
245103|NCT01365130|808861|P1|Overall Study|Progression/worsening of Dx prior to txt|2
245104|NCT01365091|808869|P4|Period 2|Adverse Event|0
245105|NCT01365091|808870|P3|Period 2|Adverse Event|1
245106|NCT01365091|808871|P2|Period 2|Adverse Event|0
245107|NCT01365091|808872|P1|Period 2|Adverse Event|0
245108|NCT01365091|808869|P4|Period 2|Withdrawal by Subject|0
245109|NCT01365091|808870|P3|Period 2|Withdrawal by Subject|0
245110|NCT01365091|808871|P2|Period 2|Withdrawal by Subject|0
245111|NCT01365091|808872|P1|Period 2|Withdrawal by Subject|1
245112|NCT01365091|808869|P4|Period 1|Personal reasons|0
245113|NCT01365091|808870|P3|Period 1|Personal reasons|1
245114|NCT01365091|808871|P2|Period 1|Personal reasons|0
245115|NCT01365091|808872|P1|Period 1|Personal reasons|0
245116|NCT01365091|808869|P4|Period 1|Withdrawal by Subject|0
245117|NCT01365091|808870|P3|Period 1|Withdrawal by Subject|0
245118|NCT01365091|808871|P2|Period 1|Withdrawal by Subject|1
245119|NCT01365091|808872|P1|Period 1|Withdrawal by Subject|0
245120|NCT01365091|808869|P4|Period 1|No longer met study criteria|0
245121|NCT01365091|808870|P3|Period 1|No longer met study criteria|0
245122|NCT01365091|808871|P2|Period 1|No longer met study criteria|1
245123|NCT01365091|808872|P1|Period 1|No longer met study criteria|0
245124|NCT01365091|808869|P4|Period 1|Positive test result for drugs of abuse|0
245125|NCT01365091|808870|P3|Period 1|Positive test result for drugs of abuse|0
245126|NCT01365091|808871|P2|Period 1|Positive test result for drugs of abuse|0
245127|NCT01365091|808872|P1|Period 1|Positive test result for drugs of abuse|1
245128|NCT01365091|808869|P4|Period 1|Adverse Event|3
245129|NCT01365091|808870|P3|Period 1|Adverse Event|2
245130|NCT01365091|808871|P2|Period 1|Adverse Event|0
245131|NCT01365091|808872|P1|Period 1|Adverse Event|1
245132|NCT01365052|808900|P2|Overall Study|Adverse Event|4
245133|NCT01365052|808901|P1|Overall Study|Adverse Event|4
245134|NCT01365039|808917|P2|Overall Study|Study related symptoms and complaints|0
245135|NCT01365039|808918|P1|Overall Study|Study related symptoms and complaints|1
245136|NCT01364922|808929|P3|Double-Blind (DB) Period|Other, Unspecified|0
245137|NCT01364922|808930|P2|Double-Blind (DB) Period|Other, Unspecified|1
245138|NCT01364922|808931|P1|Double-Blind (DB) Period|Other, Unspecified|0
245139|NCT01364922|808929|P3|Double-Blind (DB) Period|Adverse Event|1
245140|NCT01364922|808930|P2|Double-Blind (DB) Period|Adverse Event|0
245141|NCT01364922|808931|P1|Double-Blind (DB) Period|Adverse Event|0
245142|NCT01364922|808929|P3|Double-Blind (DB) Period|Subject Noncompliant|0
245143|NCT01364922|808930|P2|Double-Blind (DB) Period|Subject Noncompliant|1
245144|NCT01364922|808931|P1|Double-Blind (DB) Period|Subject Noncompliant|0
245145|NCT01364922|808929|P3|Double-Blind (DB) Period|Lack of Efficacy|4
245146|NCT01364922|808930|P2|Double-Blind (DB) Period|Lack of Efficacy|3
245147|NCT01364922|808931|P1|Double-Blind (DB) Period|Lack of Efficacy|0
245148|NCT01364922|808929|P3|Open-label (OL) Period|Other, Unspecified|0
245149|NCT01364922|808930|P2|Open-label (OL) Period|Other, Unspecified|0
245150|NCT01364922|808931|P1|Open-label (OL) Period|Other, Unspecified|1
245151|NCT01364922|808929|P3|Open-label (OL) Period|Lost to Follow-up|0
245152|NCT01364922|808930|P2|Open-label (OL) Period|Lost to Follow-up|0
245153|NCT01364922|808931|P1|Open-label (OL) Period|Lost to Follow-up|1
245154|NCT01364922|808929|P3|Open-label (OL) Period|Lack of Efficacy|0
245155|NCT01364922|808930|P2|Open-label (OL) Period|Lack of Efficacy|0
245156|NCT01364922|808931|P1|Open-label (OL) Period|Lack of Efficacy|3
245157|NCT01364922|808929|P3|Open-label (OL) Period|Withdrawal by Subject|0
245158|NCT01364922|808930|P2|Open-label (OL) Period|Withdrawal by Subject|0
245159|NCT01364922|808931|P1|Open-label (OL) Period|Withdrawal by Subject|4
245160|NCT01364922|808929|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
245161|NCT01364922|808930|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
245162|NCT01364922|808931|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
245163|NCT01364922|808929|P3|Open-label (OL) Period|Adverse Event|0
245164|NCT01364922|808930|P2|Open-label (OL) Period|Adverse Event|0
245165|NCT01364922|808931|P1|Open-label (OL) Period|Adverse Event|7
245166|NCT01364727|808958|P1|Overall Study|Not Eligible|2
245167|NCT01364649|808966|P2|Overall Study|Other|1
245168|NCT01364649|808967|P1|Overall Study|Other|4
245169|NCT01364649|808966|P2|Overall Study|Lost to Follow-up|13
245170|NCT01364649|808967|P1|Overall Study|Lost to Follow-up|12
245171|NCT01364649|808966|P2|Overall Study|Withdrawal of Consent|7
245172|NCT01364649|808967|P1|Overall Study|Withdrawal of Consent|9
245173|NCT01364649|808966|P2|Overall Study|Protocol Deviations|8
245174|NCT01364649|808967|P1|Overall Study|Protocol Deviations|4
245175|NCT01364649|808966|P2|Overall Study|Non-compliance with Investigational Drug|0
245176|NCT01364649|808967|P1|Overall Study|Non-compliance with Investigational Drug|1
245177|NCT01364649|808966|P2|Overall Study|Lack of Efficacy|0
245178|NCT01364649|808967|P1|Overall Study|Lack of Efficacy|6
245179|NCT01364649|808966|P2|Overall Study|Pretreatment Event or Adverse Event|14
245180|NCT01364649|808967|P1|Overall Study|Pretreatment Event or Adverse Event|20
245181|NCT01364428|808989|P2|Overall Study|Other|3
245182|NCT01364428|808990|P1|Overall Study|Other|3
245183|NCT01364428|808989|P2|Overall Study|Withdrawal Criteria|10
245184|NCT01364428|808990|P1|Overall Study|Withdrawal Criteria|14
245185|NCT01364428|808989|P2|Overall Study|Protocol Violation|0
245186|NCT01364428|808990|P1|Overall Study|Protocol Violation|2
245187|NCT01364428|808989|P2|Overall Study|Adverse Event|2
245188|NCT01364428|808990|P1|Overall Study|Adverse Event|1
245189|NCT01364389|809007|P3|Overall Study|Adverse Event|0
245190|NCT01364389|809008|P2|Overall Study|Adverse Event|0
245191|NCT01364389|809009|P1|Overall Study|Adverse Event|1
245192|NCT01364389|809007|P3|Overall Study|Administrative problems|0
245193|NCT01364389|809008|P2|Overall Study|Administrative problems|0
245194|NCT01364389|809009|P1|Overall Study|Administrative problems|1
245195|NCT01364389|809007|P3|Overall Study|Protocol deviation|1
245196|NCT01364389|809008|P2|Overall Study|Protocol deviation|0
245197|NCT01364389|809009|P1|Overall Study|Protocol deviation|0
245198|NCT01364389|809007|P3|Overall Study|Withdrawal by Subject|0
245199|NCT01364389|809008|P2|Overall Study|Withdrawal by Subject|1
245200|NCT01364389|809009|P1|Overall Study|Withdrawal by Subject|0
245201|NCT01364298|809028|P2|Overall Study|Unspecified|3
245202|NCT01364298|809029|P1|Overall Study|Unspecified|1
245203|NCT01364298|809028|P2|Overall Study|Withdrawal by Subject|3
245204|NCT01364298|809029|P1|Overall Study|Withdrawal by Subject|3
245205|NCT01364298|809028|P2|Overall Study|Lost to Follow-up|10
245206|NCT01364298|809029|P1|Overall Study|Lost to Follow-up|5
245207|NCT01364298|809028|P2|Overall Study|Lack of Efficacy|0
245208|NCT01364298|809029|P1|Overall Study|Lack of Efficacy|1
245209|NCT01364298|809028|P2|Overall Study|Lack of adherence to treatment|3
245210|NCT01364298|809029|P1|Overall Study|Lack of adherence to treatment|1
245211|NCT01364298|809028|P2|Overall Study|Adverse Event|4
245212|NCT01364298|809029|P1|Overall Study|Adverse Event|3
245213|NCT01363986|809071|P1|Overall Study|Disease progression|1
245214|NCT01363908|809081|P2|Chronic Dosing (CD) Phase|Early study termination|3
245215|NCT01363908|809082|P1|Chronic Dosing (CD) Phase|Early study termination|9
245216|NCT01363908|809081|P2|Chronic Dosing (CD) Phase|Physician Decision|1
245217|NCT01363908|809082|P1|Chronic Dosing (CD) Phase|Physician Decision|0
245218|NCT01363908|809081|P2|Chronic Dosing (CD) Phase|Patient decision|1
245219|NCT01363908|809082|P1|Chronic Dosing (CD) Phase|Patient decision|0
245220|NCT01363908|809081|P2|Chronic Dosing (CD) Phase|Adverse Event|1
245221|NCT01363908|809082|P1|Chronic Dosing (CD) Phase|Adverse Event|1
245222|NCT01363765|809118|P2|Overall Study|smear during intervention|0
245223|NCT01363765|809119|P1|Overall Study|smear during intervention|2170
245224|NCT01363765|809118|P2|Overall Study|age not recorded (used for cross-linkage|354
245225|NCT01363765|809119|P1|Overall Study|age not recorded (used for cross-linkage|117
245226|NCT01363765|809118|P2|Overall Study|non-resident|76
245227|NCT01363765|809119|P1|Overall Study|non-resident|156
245228|NCT01363765|809118|P2|Overall Study|duplicate records|3177
245229|NCT01363765|809119|P1|Overall Study|duplicate records|736
245230|NCT01363765|809118|P2|Overall Study|non-diagnostic|1124
245231|NCT01363765|809119|P1|Overall Study|non-diagnostic|2621
245232|NCT01363713|809131|P1|Overall Study|Withdrawal by Subject|2
245233|NCT01363713|809131|P1|Overall Study|Protocol Violation|3
245234|NCT01363713|809131|P1|Overall Study|Adverse Event|1
245235|NCT01363700|809140|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
245236|NCT01363700|809141|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
245237|NCT01363700|809142|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
245238|NCT01363700|809143|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
245239|NCT01363700|809144|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
245240|NCT01363661|809163|P2|Overall Study|Lost to Follow-up|1
245241|NCT01363661|809164|P1|Overall Study|Lost to Follow-up|3
245242|NCT01363661|809163|P2|Overall Study|Protocol Violation|0
245243|NCT01363661|809164|P1|Overall Study|Protocol Violation|1
245244|NCT01363661|809163|P2|Overall Study|Withdrawal by Subject|1
245245|NCT01363661|809164|P1|Overall Study|Withdrawal by Subject|1
245246|NCT01363661|809163|P2|Overall Study|Adverse Event|2
245247|NCT01363661|809164|P1|Overall Study|Adverse Event|9
245248|NCT01363440|809205|P3|Overall Study|Other|2
245249|NCT01363440|809206|P2|Overall Study|Other|5
245250|NCT01363440|809207|P1|Overall Study|Other|4
245251|NCT01363440|809205|P3|Overall Study|Lost to Follow-up|5
245252|NCT01363440|809206|P2|Overall Study|Lost to Follow-up|4
245253|NCT01363440|809207|P1|Overall Study|Lost to Follow-up|2
245254|NCT01363440|809205|P3|Overall Study|Withdrawal by Subject|11
245255|NCT01363440|809206|P2|Overall Study|Withdrawal by Subject|11
245256|NCT01363440|809207|P1|Overall Study|Withdrawal by Subject|9
245257|NCT01363440|809205|P3|Overall Study|Death|5
245258|NCT01363440|809206|P2|Overall Study|Death|7
245259|NCT01363440|809207|P1|Overall Study|Death|3
245260|NCT01363440|809205|P3|Overall Study|Adverse Event|4
245261|NCT01363440|809206|P2|Overall Study|Adverse Event|4
245262|NCT01363440|809207|P1|Overall Study|Adverse Event|5
245263|NCT01363349|809253|P2|Overall Study|missing|2
245264|NCT01363349|809254|P1|Overall Study|missing|1
245265|NCT01363349|809253|P2|Overall Study|Not reported|37
245266|NCT01363349|809254|P1|Overall Study|Not reported|36
245267|NCT01363349|809253|P2|Overall Study|Lost to Follow-up|6
245268|NCT01363349|809254|P1|Overall Study|Lost to Follow-up|5
245269|NCT01363349|809253|P2|Overall Study|Withdrawal by Subject|6
245270|NCT01363349|809254|P1|Overall Study|Withdrawal by Subject|14
245271|NCT01363349|809253|P2|Overall Study|Non compliance/Protocol deviations|2
245272|NCT01363349|809254|P1|Overall Study|Non compliance/Protocol deviations|2
245273|NCT01363349|809253|P2|Overall Study|Lack of Efficacy|10
245274|NCT01363349|809254|P1|Overall Study|Lack of Efficacy|3
245275|NCT01363349|809253|P2|Overall Study|Adverse Event|7
245276|NCT01363349|809254|P1|Overall Study|Adverse Event|6
245277|NCT01363297|809265|P5|Overall Study|Death|30
245278|NCT01363297|809266|P4|Overall Study|Death|10
245279|NCT01363297|809267|P3|Overall Study|Death|6
245280|NCT01363297|809268|P2|Overall Study|Death|6
245281|NCT01363297|809269|P1|Overall Study|Death|3
245282|NCT01363297|809265|P5|Overall Study|Not specified|1
245283|NCT01363297|809266|P4|Overall Study|Not specified|0
245284|NCT01363297|809267|P3|Overall Study|Not specified|0
245285|NCT01363297|809268|P2|Overall Study|Not specified|0
245286|NCT01363297|809269|P1|Overall Study|Not specified|0
245287|NCT01363076|809361|P2|Overall Study|Withdrawal by Subject|1
245288|NCT01363076|809362|P1|Overall Study|Withdrawal by Subject|0
245289|NCT01363011|809394|P2|Extension Phase|Rolled Over to Another Gilead Study|1
245290|NCT01363011|809395|P1|Extension Phase|Rolled Over to Another Gilead Study|2
245291|NCT01363011|809394|P2|Extension Phase|Lost to Follow-up|2
245292|NCT01363011|809395|P1|Extension Phase|Lost to Follow-up|0
245293|NCT01363011|809394|P2|Extension Phase|Withdrew Consent|1
245294|NCT01363011|809395|P1|Extension Phase|Withdrew Consent|0
245295|NCT01363011|809394|P2|Extension Phase|Investigator's Discretion|2
245296|NCT01363011|809395|P1|Extension Phase|Investigator's Discretion|2
245297|NCT01363011|809394|P2|Extension Phase|Lack of Efficacy|1
245298|NCT01363011|809395|P1|Extension Phase|Lack of Efficacy|0
245299|NCT01363011|809394|P2|Extension Phase|Adverse Event|1
245300|NCT01363011|809395|P1|Extension Phase|Adverse Event|1
245301|NCT01363011|809394|P2|Main Study|Protocol Violation|1
245302|NCT01363011|809395|P1|Main Study|Protocol Violation|0
245303|NCT01363011|809394|P2|Main Study|Withdrew Consent|4
245304|NCT01363011|809395|P1|Main Study|Withdrew Consent|1
245305|NCT01363011|809394|P2|Main Study|Investigator's Discretion|1
245306|NCT01363011|809395|P1|Main Study|Investigator's Discretion|1
245307|NCT01363011|809394|P2|Main Study|Adverse Event|3
245308|NCT01363011|809395|P1|Main Study|Adverse Event|2
245309|NCT01362608|809520|P2|Overall Study|Adverse Event|2
245310|NCT01362608|809521|P1|Overall Study|Adverse Event|0
245311|NCT01362608|809520|P2|Overall Study|Lack of Efficacy|2
245312|NCT01362608|809521|P1|Overall Study|Lack of Efficacy|0
245313|NCT01362608|809520|P2|Overall Study|Withdrawal by Subject|2
245314|NCT01362608|809521|P1|Overall Study|Withdrawal by Subject|1
245315|NCT01362608|809520|P2|Overall Study|Lost to Follow-up|1
245316|NCT01362608|809521|P1|Overall Study|Lost to Follow-up|3
245317|NCT01362608|809520|P2|Overall Study|Protocol Violation|1
245318|NCT01362608|809521|P1|Overall Study|Protocol Violation|0
245319|NCT01362530|809559|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
245320|NCT01362530|809560|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
245321|NCT01362530|809559|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
245322|NCT01362530|809560|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
245323|NCT01362530|809559|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
245324|NCT01362530|809560|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
245325|NCT01362530|809559|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
245326|NCT01362530|809560|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
245327|NCT01362530|809559|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
245328|NCT01362530|809560|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
245329|NCT01362530|809559|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
245330|NCT01362530|809560|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
245331|NCT01362530|809559|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
245332|NCT01362530|809560|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
245333|NCT01362530|809559|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
245334|NCT01362530|809560|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
245335|NCT01362530|809559|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
245336|NCT01362530|809560|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
245337|NCT01362530|809559|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
245338|NCT01362530|809560|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
245339|NCT01362530|809559|P2|Base Study (Cycle 1)|Protocol Violation|0
245340|NCT01362530|809560|P1|Base Study (Cycle 1)|Protocol Violation|2
245341|NCT01362530|809559|P2|Base Study (Cycle 1)|Physician Decision|1
245342|NCT01362530|809560|P1|Base Study (Cycle 1)|Physician Decision|0
245343|NCT01362530|809559|P2|Base Study (Cycle 1)|Adverse Event|0
245344|NCT01362530|809560|P1|Base Study (Cycle 1)|Adverse Event|2
245345|NCT01362517|809573|P1|Overall Study|Lost to Follow-up|1
245346|NCT01362517|809573|P1|Overall Study|Protocol Violation|1
245347|NCT01362491|809584|P3|Overall Study|Ineligible|0
245348|NCT01362491|809585|P2|Overall Study|Ineligible|0
245349|NCT01362491|809586|P1|Overall Study|Ineligible|1
245350|NCT01362439|809634|P1|Overall Study|Participant who withdrew consent|8
245351|NCT01362439|809634|P1|Overall Study|Study medication non-compliant|1
245352|NCT01362439|809634|P1|Overall Study|Lost to Follow-up|2
245353|NCT01362439|809634|P1|Overall Study|Lack of Efficacy|3
245354|NCT01362439|809634|P1|Overall Study|Adverse Event|1
245355|NCT01362296|809651|P4|Crossover Phase|Study Closed/Terminated|0
245356|NCT01362296|809652|P3|Crossover Phase|Study Closed/Terminated|1
245357|NCT01362296|809653|P2|Crossover Phase|Study Closed/Terminated|0
245358|NCT01362296|809654|P1|Crossover Phase|Study Closed/Terminated|0
245359|NCT01362296|809651|P4|Crossover Phase|Adverse Event|0
245360|NCT01362296|809652|P3|Crossover Phase|Adverse Event|4
245361|NCT01362296|809653|P2|Crossover Phase|Adverse Event|0
245362|NCT01362296|809654|P1|Crossover Phase|Adverse Event|0
245363|NCT01362296|809651|P4|Crossover Phase|Withdrawal by Subject|1
245364|NCT01362296|809652|P3|Crossover Phase|Withdrawal by Subject|2
245365|NCT01362296|809653|P2|Crossover Phase|Withdrawal by Subject|0
245366|NCT01362296|809654|P1|Crossover Phase|Withdrawal by Subject|0
245367|NCT01362296|809651|P4|Crossover Phase|PD including Death due to PD|1
245368|NCT01362296|809652|P3|Crossover Phase|PD including Death due to PD|16
245369|NCT01362296|809653|P2|Crossover Phase|PD including Death due to PD|0
245370|NCT01362296|809654|P1|Crossover Phase|PD including Death due to PD|0
245371|NCT01362296|809651|P4|Randomized Phase (RP)|Study Closed/Terminated|0
245372|NCT01362296|809652|P3|Randomized Phase (RP)|Study Closed/Terminated|0
245373|NCT01362296|809653|P2|Randomized Phase (RP)|Study Closed/Terminated|1
245374|NCT01362296|809654|P1|Randomized Phase (RP)|Study Closed/Terminated|8
245375|NCT01362296|809651|P4|Randomized Phase (RP)|Adverse Event|0
245376|NCT01362296|809652|P3|Randomized Phase (RP)|Adverse Event|0
245377|NCT01362296|809653|P2|Randomized Phase (RP)|Adverse Event|4
245378|NCT01362296|809654|P1|Randomized Phase (RP)|Adverse Event|20
245379|NCT01362296|809651|P4|Randomized Phase (RP)|Withdrawal by Subject|0
245380|NCT01362296|809652|P3|Randomized Phase (RP)|Withdrawal by Subject|0
245381|NCT01362296|809653|P2|Randomized Phase (RP)|Withdrawal by Subject|1
245382|NCT01362296|809654|P1|Randomized Phase (RP)|Withdrawal by Subject|2
245383|NCT01362296|809651|P4|Randomized Phase (RP)|Physician Decision|0
245384|NCT01362296|809652|P3|Randomized Phase (RP)|Physician Decision|0
245385|NCT01362296|809653|P2|Randomized Phase (RP)|Physician Decision|9
245386|NCT01362296|809654|P1|Randomized Phase (RP)|Physician Decision|1
245387|NCT01362296|809651|P4|Randomized Phase (RP)|PD including Death due to PD|0
245388|NCT01362296|809652|P3|Randomized Phase (RP)|PD including Death due to PD|0
245389|NCT01362296|809653|P2|Randomized Phase (RP)|PD including Death due to PD|28
245390|NCT01362296|809654|P1|Randomized Phase (RP)|PD including Death due to PD|56
245391|NCT01362244|809702|P2|Overall Study|Protocol Defined Stopping Criteria|1
245392|NCT01362244|809703|P1|Overall Study|Protocol Defined Stopping Criteria|0
245393|NCT01362244|809702|P2|Overall Study|Did not Meet Continuation Criteria|11
245394|NCT01362244|809703|P1|Overall Study|Did not Meet Continuation Criteria|17
245395|NCT01362244|809702|P2|Overall Study|Withdrawal by Subject|1
245396|NCT01362244|809703|P1|Overall Study|Withdrawal by Subject|2
245397|NCT01362244|809702|P2|Overall Study|Protocol Violation|1
245398|NCT01362244|809703|P1|Overall Study|Protocol Violation|5
245399|NCT01362244|809702|P2|Overall Study|Lost to Follow-up|2
245400|NCT01362244|809703|P1|Overall Study|Lost to Follow-up|0
245401|NCT01362244|809702|P2|Overall Study|Lack of Efficacy|11
245402|NCT01362244|809703|P1|Overall Study|Lack of Efficacy|5
245403|NCT01362244|809702|P2|Overall Study|Adverse Event|5
245404|NCT01362244|809703|P1|Overall Study|Adverse Event|3
245405|NCT01362140|809786|P2|Overall Study|Discontinued Without Receiving Treatment|1
245406|NCT01362140|809787|P1|Overall Study|Discontinued Without Receiving Treatment|0
245407|NCT01362140|809786|P2|Overall Study|Protocol-specified Criteria|2
245408|NCT01362140|809787|P1|Overall Study|Protocol-specified Criteria|1
245409|NCT01362140|809786|P2|Overall Study|Other|1
245410|NCT01362140|809787|P1|Overall Study|Other|1
245411|NCT01362140|809786|P2|Overall Study|Death|1
245412|NCT01362140|809787|P1|Overall Study|Death|2
245413|NCT01362140|809786|P2|Overall Study|Administrative Decision|1
245414|NCT01362140|809787|P1|Overall Study|Administrative Decision|0
245415|NCT01362140|809786|P2|Overall Study|Withdrawal by Subject|3
245416|NCT01362140|809787|P1|Overall Study|Withdrawal by Subject|3
245417|NCT01362140|809786|P2|Overall Study|Adverse Event|2
245418|NCT01362140|809787|P1|Overall Study|Adverse Event|2
245419|NCT01362140|809786|P2|Overall Study|Noncompliance|0
245420|NCT01362140|809787|P1|Overall Study|Noncompliance|1
245421|NCT01362062|809811|P2|Overall Study|Had significant improvement|0
245422|NCT01362062|809812|P1|Overall Study|Had significant improvement|9
245423|NCT01362062|809811|P2|Overall Study|Detected with Spondylo-arthritis|0
245424|NCT01362062|809812|P1|Overall Study|Detected with Spondylo-arthritis|1
245425|NCT01362062|809811|P2|Overall Study|Non-compliant participant|0
245426|NCT01362062|809812|P1|Overall Study|Non-compliant participant|2
245427|NCT01362062|809811|P2|Overall Study|Withdrawal by Subject|0
245428|NCT01362062|809812|P1|Overall Study|Withdrawal by Subject|2
245429|NCT01362062|809811|P2|Overall Study|Lost to Follow-up|0
245430|NCT01362062|809812|P1|Overall Study|Lost to Follow-up|11
245431|NCT01362062|809811|P2|Overall Study|Adverse Event|0
245432|NCT01362062|809812|P1|Overall Study|Adverse Event|1
245433|NCT01362049|809833|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
245434|NCT01362049|809834|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
245435|NCT01362049|809835|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
245436|NCT01362049|809836|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
245437|NCT01362049|809833|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
245438|NCT01362049|809834|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
245439|NCT01362049|809835|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
245440|NCT01362049|809836|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
245441|NCT01360645|809888|P4|Phase A+|Protocol Deviation|4
245442|NCT01360645|809889|P3|Phase A+|Protocol Deviation|0
245443|NCT01360645|809890|P2|Phase A+|Protocol Deviation|0
245444|NCT01360645|809891|P1|Phase A+|Protocol Deviation|0
245445|NCT01360645|809888|P4|Phase A+|Withdrawal by Subject|5
245446|NCT01360645|809889|P3|Phase A+|Withdrawal by Subject|0
245447|NCT01360645|809890|P2|Phase A+|Withdrawal by Subject|0
245448|NCT01360645|809891|P1|Phase A+|Withdrawal by Subject|0
245449|NCT01360645|809888|P4|Phase A+|Physician Decision|2
245450|NCT01360645|809889|P3|Phase A+|Physician Decision|0
245451|NCT01360645|809890|P2|Phase A+|Physician Decision|0
245452|NCT01360645|809891|P1|Phase A+|Physician Decision|0
245453|NCT01360645|809888|P4|Phase A+|Met Withdrawal Criteria|4
245454|NCT01360645|809889|P3|Phase A+|Met Withdrawal Criteria|0
245455|NCT01360645|809890|P2|Phase A+|Met Withdrawal Criteria|0
245456|NCT01360645|809891|P1|Phase A+|Met Withdrawal Criteria|0
245457|NCT01360645|809888|P4|Phase A+|Adverse Event|2
245458|NCT01360645|809889|P3|Phase A+|Adverse Event|0
245459|NCT01360645|809890|P2|Phase A+|Adverse Event|0
245460|NCT01360645|809891|P1|Phase A+|Adverse Event|0
245461|NCT01360645|809888|P4|Phase A+|Lost to Follow-up|7
245462|NCT01360645|809889|P3|Phase A+|Lost to Follow-up|0
245463|NCT01360645|809890|P2|Phase A+|Lost to Follow-up|0
245464|NCT01360645|809891|P1|Phase A+|Lost to Follow-up|0
245465|NCT01360645|809888|P4|Phase B (6 Weeks)|Protocol Deviation|0
245466|NCT01360645|809889|P3|Phase B (6 Weeks)|Protocol Deviation|3
245467|NCT01360645|809890|P2|Phase B (6 Weeks)|Protocol Deviation|1
245468|NCT01360645|809891|P1|Phase B (6 Weeks)|Protocol Deviation|0
245469|NCT01360645|809888|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
245470|NCT01360645|809889|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
245471|NCT01360645|809890|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
245472|NCT01360645|809891|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
245473|NCT01360645|809888|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
245474|NCT01360645|809889|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
245475|NCT01360645|809890|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
245476|NCT01360645|809891|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
245477|NCT01360645|809888|P4|Phase B (6 Weeks)|Adverse Event|0
245478|NCT01360645|809889|P3|Phase B (6 Weeks)|Adverse Event|0
245479|NCT01360645|809890|P2|Phase B (6 Weeks)|Adverse Event|6
245480|NCT01360645|809891|P1|Phase B (6 Weeks)|Adverse Event|0
245481|NCT01360645|809888|P4|Phase B (6 Weeks)|Lost to Follow-up|0
245482|NCT01360645|809889|P3|Phase B (6 Weeks)|Lost to Follow-up|0
245483|NCT01360645|809890|P2|Phase B (6 Weeks)|Lost to Follow-up|1
245484|NCT01360645|809891|P1|Phase B (6 Weeks)|Lost to Follow-up|0
245485|NCT01360645|809888|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
245486|NCT01360645|809889|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
245487|NCT01360645|809890|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
245488|NCT01360645|809891|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
245489|NCT01360645|809888|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
245490|NCT01360645|809889|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
245491|NCT01360645|809890|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
245492|NCT01360645|809891|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
245493|NCT01360645|809888|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
245494|NCT01360645|809889|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
245495|NCT01360645|809890|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
245496|NCT01360645|809891|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
245497|NCT01360645|809888|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
245498|NCT01360645|809889|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
245499|NCT01360645|809890|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
245500|NCT01360645|809891|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
245501|NCT01360645|809888|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
245502|NCT01360645|809889|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
245503|NCT01360645|809890|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
245504|NCT01360645|809891|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
245505|NCT01360645|809888|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
245506|NCT01360645|809889|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
245507|NCT01360645|809890|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
245508|NCT01360645|809891|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
245509|NCT01360632|809946|P5|Phase A+|Protocol Deviation|3
245510|NCT01360632|809947|P4|Phase A+|Protocol Deviation|0
245511|NCT01360632|809948|P3|Phase A+|Protocol Deviation|0
245512|NCT01360632|809949|P2|Phase A+|Protocol Deviation|0
245513|NCT01360632|809950|P1|Phase A+|Protocol Deviation|0
245514|NCT01360632|809946|P5|Phase A+|Withdrawal by Subject|8
245515|NCT01360632|809947|P4|Phase A+|Withdrawal by Subject|0
245516|NCT01360632|809948|P3|Phase A+|Withdrawal by Subject|0
245517|NCT01360632|809949|P2|Phase A+|Withdrawal by Subject|0
245518|NCT01360632|809950|P1|Phase A+|Withdrawal by Subject|0
245519|NCT01360632|809946|P5|Phase A+|Physician Decision|3
245520|NCT01360632|809947|P4|Phase A+|Physician Decision|0
245521|NCT01360632|809948|P3|Phase A+|Physician Decision|0
245522|NCT01360632|809949|P2|Phase A+|Physician Decision|0
245523|NCT01360632|809950|P1|Phase A+|Physician Decision|0
245524|NCT01360632|809946|P5|Phase A+|Met Withdrawal Criteria|7
245525|NCT01360632|809947|P4|Phase A+|Met Withdrawal Criteria|0
245526|NCT01360632|809948|P3|Phase A+|Met Withdrawal Criteria|0
245527|NCT01360632|809949|P2|Phase A+|Met Withdrawal Criteria|0
245528|NCT01360632|809950|P1|Phase A+|Met Withdrawal Criteria|0
245529|NCT01360632|809946|P5|Phase A+|Adverse Event|2
245530|NCT01360632|809947|P4|Phase A+|Adverse Event|0
245531|NCT01360632|809948|P3|Phase A+|Adverse Event|0
245532|NCT01360632|809949|P2|Phase A+|Adverse Event|0
245533|NCT01360632|809950|P1|Phase A+|Adverse Event|0
245534|NCT01360632|809946|P5|Phase A+|Lost to Follow-up|2
245535|NCT01360632|809947|P4|Phase A+|Lost to Follow-up|0
245536|NCT01360632|809948|P3|Phase A+|Lost to Follow-up|0
245537|NCT01360632|809949|P2|Phase A+|Lost to Follow-up|0
245538|NCT01360632|809950|P1|Phase A+|Lost to Follow-up|0
245539|NCT01360632|809946|P5|Phase B (6 Weeks)|Lack of Efficacy|0
245540|NCT01360632|809947|P4|Phase B (6 Weeks)|Lack of Efficacy|0
245541|NCT01360632|809948|P3|Phase B (6 Weeks)|Lack of Efficacy|0
245542|NCT01360632|809949|P2|Phase B (6 Weeks)|Lack of Efficacy|1
245543|NCT01360632|809950|P1|Phase B (6 Weeks)|Lack of Efficacy|0
245544|NCT01360632|809946|P5|Phase B (6 Weeks)|Protocol Deviation|0
245545|NCT01360632|809947|P4|Phase B (6 Weeks)|Protocol Deviation|1
245546|NCT01360632|809948|P3|Phase B (6 Weeks)|Protocol Deviation|4
245547|NCT01360632|809949|P2|Phase B (6 Weeks)|Protocol Deviation|1
245548|NCT01360632|809950|P1|Phase B (6 Weeks)|Protocol Deviation|0
245549|NCT01360632|809946|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
245550|NCT01360632|809947|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
245551|NCT01360632|809948|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
245552|NCT01360632|809949|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
245553|NCT01360632|809950|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
245554|NCT01360632|809946|P5|Phase B (6 Weeks)|Physician Decision|0
245555|NCT01360632|809947|P4|Phase B (6 Weeks)|Physician Decision|1
245556|NCT01360632|809948|P3|Phase B (6 Weeks)|Physician Decision|0
245557|NCT01360632|809949|P2|Phase B (6 Weeks)|Physician Decision|0
245558|NCT01360632|809950|P1|Phase B (6 Weeks)|Physician Decision|0
245559|NCT01360632|809946|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
245560|NCT01360632|809947|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
245561|NCT01360632|809948|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
245562|NCT01360632|809949|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
245563|NCT01360632|809950|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
245564|NCT01360632|809946|P5|Phase B (6 Weeks)|Adverse Event|0
245565|NCT01360632|809947|P4|Phase B (6 Weeks)|Adverse Event|3
245566|NCT01360632|809948|P3|Phase B (6 Weeks)|Adverse Event|9
245567|NCT01360632|809949|P2|Phase B (6 Weeks)|Adverse Event|3
245568|NCT01360632|809950|P1|Phase B (6 Weeks)|Adverse Event|0
245569|NCT01360632|809946|P5|Phase B (6 Weeks)|Lost to Follow-up|0
245570|NCT01360632|809947|P4|Phase B (6 Weeks)|Lost to Follow-up|0
245571|NCT01360632|809948|P3|Phase B (6 Weeks)|Lost to Follow-up|1
245572|NCT01360632|809949|P2|Phase B (6 Weeks)|Lost to Follow-up|1
245573|NCT01360632|809950|P1|Phase B (6 Weeks)|Lost to Follow-up|0
245574|NCT01360632|809946|P5|Phase A (8 Weeks)|Protocol Deviation|0
245575|NCT01360632|809947|P4|Phase A (8 Weeks)|Protocol Deviation|0
245576|NCT01360632|809948|P3|Phase A (8 Weeks)|Protocol Deviation|0
245577|NCT01360632|809949|P2|Phase A (8 Weeks)|Protocol Deviation|0
245578|NCT01360632|809950|P1|Phase A (8 Weeks)|Protocol Deviation|39
245579|NCT01360632|809946|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
245580|NCT01360632|809947|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
245581|NCT01360632|809948|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
245582|NCT01360632|809949|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
245583|NCT01360632|809950|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
245584|NCT01360632|809946|P5|Phase A (8 Weeks)|Physician Decision|0
245585|NCT01360632|809947|P4|Phase A (8 Weeks)|Physician Decision|0
245586|NCT01360632|809948|P3|Phase A (8 Weeks)|Physician Decision|0
245587|NCT01360632|809949|P2|Phase A (8 Weeks)|Physician Decision|0
245588|NCT01360632|809950|P1|Phase A (8 Weeks)|Physician Decision|10
245589|NCT01360632|809946|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
245590|NCT01360632|809947|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
245591|NCT01360632|809948|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
245592|NCT01360632|809949|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
245593|NCT01360632|809950|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
245594|NCT01360632|809946|P5|Phase A (8 Weeks)|Adverse Event|0
245595|NCT01360632|809947|P4|Phase A (8 Weeks)|Adverse Event|0
245596|NCT01360632|809948|P3|Phase A (8 Weeks)|Adverse Event|0
245597|NCT01360632|809949|P2|Phase A (8 Weeks)|Adverse Event|0
245598|NCT01360632|809950|P1|Phase A (8 Weeks)|Adverse Event|60
245599|NCT01360632|809946|P5|Phase A (8 Weeks)|Lost to Follow-up|0
245600|NCT01360632|809947|P4|Phase A (8 Weeks)|Lost to Follow-up|0
245601|NCT01360632|809948|P3|Phase A (8 Weeks)|Lost to Follow-up|0
245602|NCT01360632|809949|P2|Phase A (8 Weeks)|Lost to Follow-up|0
245603|NCT01360632|809950|P1|Phase A (8 Weeks)|Lost to Follow-up|27
245604|NCT01361594|810042|P2|Overall Study|Withdrawal by Subject|2
245605|NCT01361594|810043|P1|Overall Study|Withdrawal by Subject|1
245606|NCT01361568|810057|P6|Overall Study|Withdrawal by Subject|1
245607|NCT01361568|810058|P5|Overall Study|Withdrawal by Subject|0
245608|NCT01361568|810059|P4|Overall Study|Withdrawal by Subject|0
245609|NCT01361568|810060|P3|Overall Study|Withdrawal by Subject|0
245610|NCT01361568|810061|P2|Overall Study|Withdrawal by Subject|1
245611|NCT01361568|810062|P1|Overall Study|Withdrawal by Subject|2
245612|NCT01361568|810057|P6|Overall Study|Physician Decision|1
245613|NCT01361568|810058|P5|Overall Study|Physician Decision|0
245614|NCT01361568|810059|P4|Overall Study|Physician Decision|0
245615|NCT01361568|810060|P3|Overall Study|Physician Decision|0
245616|NCT01361568|810061|P2|Overall Study|Physician Decision|0
245617|NCT01361568|810062|P1|Overall Study|Physician Decision|0
245618|NCT01361568|810057|P6|Overall Study|Adverse Event|0
245619|NCT01361568|810058|P5|Overall Study|Adverse Event|1
245620|NCT01361568|810059|P4|Overall Study|Adverse Event|0
245621|NCT01361568|810060|P3|Overall Study|Adverse Event|0
245622|NCT01361568|810061|P2|Overall Study|Adverse Event|0
245623|NCT01361568|810062|P1|Overall Study|Adverse Event|0
245624|NCT01361464|810092|P1|Overall Study|Withdrawal by Subject|2
245625|NCT01361464|810092|P1|Overall Study|Death|1
245626|NCT01361308|810101|P2|Overall Study|Not Specified|1
245627|NCT01361308|810102|P1|Overall Study|Not Specified|0
245628|NCT01361308|810101|P2|Overall Study|Failed C-SSRS|2
245629|NCT01361308|810102|P1|Overall Study|Failed C-SSRS|5
245630|NCT01361308|810101|P2|Overall Study|Eligibility Criteria Not Met|3
245631|NCT01361308|810102|P1|Overall Study|Eligibility Criteria Not Met|2
245632|NCT01361308|810101|P2|Overall Study|Adverse Event|4
245633|NCT01361308|810102|P1|Overall Study|Adverse Event|8
245634|NCT01361308|810101|P2|Overall Study|Lost to Follow-up|4
245635|NCT01361308|810102|P1|Overall Study|Lost to Follow-up|5
245636|NCT01361308|810101|P2|Overall Study|Protocol Violation|0
245637|NCT01361308|810102|P1|Overall Study|Protocol Violation|1
245638|NCT01361308|810101|P2|Overall Study|Lack of Efficacy|0
245639|NCT01361308|810102|P1|Overall Study|Lack of Efficacy|2
245640|NCT01361308|810101|P2|Overall Study|Physician Decision|3
245641|NCT01361308|810102|P1|Overall Study|Physician Decision|3
245642|NCT01361308|810101|P2|Overall Study|Withdrawal by Subject|13
245643|NCT01361308|810102|P1|Overall Study|Withdrawal by Subject|9
245644|NCT01361178|810144|P2|Overall Study|Death|0
245645|NCT01361178|810145|P1|Overall Study|Death|13
245646|NCT01361126|810153|P2|Overall Study|Sponsor decision|2
245647|NCT01361126|810154|P1|Overall Study|Sponsor decision|0
245648|NCT01361009|810187|P1|Overall Study|Protocol Violation|116
245649|NCT01360996|810197|P3|Overall Study|Noncompliant|0
245650|NCT01360996|810198|P2|Overall Study|Noncompliant|0
245651|NCT01360996|810199|P1|Overall Study|Noncompliant|2
245652|NCT01360996|810197|P3|Overall Study|Withdrawal by Subject|2
245653|NCT01360996|810198|P2|Overall Study|Withdrawal by Subject|3
245654|NCT01360996|810199|P1|Overall Study|Withdrawal by Subject|4
245655|NCT01360840|810221|P3|Overall Study|Ongoing at data cut-off|9
245656|NCT01360840|810222|P2|Overall Study|Ongoing at data cut-off|10
245657|NCT01360840|810223|P1|Overall Study|Ongoing at data cut-off|10
245658|NCT01360554|810275|P2|Overall Study|Randomized but not treated.|3
245659|NCT01360554|810276|P1|Overall Study|Randomized but not treated.|3
245660|NCT01360554|810275|P2|Overall Study|Other, not specified|0
245661|NCT01360554|810276|P1|Overall Study|Other, not specified|1
245662|NCT01360554|810275|P2|Overall Study|Study terminated by sponsor|37
245663|NCT01360554|810276|P1|Overall Study|Study terminated by sponsor|49
245664|NCT01360554|810275|P2|Overall Study|Withdrawal by Subject|24
245665|NCT01360554|810276|P1|Overall Study|Withdrawal by Subject|23
245666|NCT01360554|810275|P2|Overall Study|Lost to Follow-up|4
245667|NCT01360554|810276|P1|Overall Study|Lost to Follow-up|4
245668|NCT01360554|810275|P2|Overall Study|Death|371
245669|NCT01360554|810276|P1|Overall Study|Death|359
245670|NCT01360021|810315|P3|Overall Study|Adverse Event|3
245671|NCT01360021|810316|P2|Overall Study|Adverse Event|3
245672|NCT01360021|810317|P1|Overall Study|Adverse Event|2
245673|NCT01360021|810315|P3|Overall Study|Withdrawal by Subject|2
245674|NCT01360021|810316|P2|Overall Study|Withdrawal by Subject|0
245675|NCT01360021|810317|P1|Overall Study|Withdrawal by Subject|4
245676|NCT01360021|810315|P3|Overall Study|Protocol Violation|1
245677|NCT01360021|810316|P2|Overall Study|Protocol Violation|0
245678|NCT01360021|810317|P1|Overall Study|Protocol Violation|0
245679|NCT01360021|810315|P3|Overall Study|Eligibility criteria + other|1
245680|NCT01360021|810316|P2|Overall Study|Eligibility criteria + other|1
245681|NCT01360021|810317|P1|Overall Study|Eligibility criteria + other|2
245682|NCT01359943|810343|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
245683|NCT01359943|810344|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
245684|NCT01359943|810345|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
245685|NCT01359943|810343|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
245686|NCT01359943|810344|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
245687|NCT01359943|810345|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
245688|NCT01359943|810343|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
245689|NCT01359943|810344|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
245690|NCT01359943|810345|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
245691|NCT01359943|810343|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
245692|NCT01359943|810344|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
245693|NCT01359943|810345|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
245694|NCT01359943|810343|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
245695|NCT01359943|810344|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
245696|NCT01359943|810345|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
245697|NCT01359943|810343|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
245698|NCT01359943|810344|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
245699|NCT01359943|810345|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
245700|NCT01359943|810343|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
245701|NCT01359943|810344|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
245702|NCT01359943|810345|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
245703|NCT01359943|810343|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
245704|NCT01359943|810344|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
245705|NCT01359943|810345|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
245706|NCT01359943|810343|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
245707|NCT01359943|810344|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
245708|NCT01359943|810345|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
245709|NCT01359943|810343|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
245710|NCT01359943|810344|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
245711|NCT01359943|810345|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
245712|NCT01359943|810343|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
245713|NCT01359943|810344|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
245714|NCT01359943|810345|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
245715|NCT01359943|810343|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
245716|NCT01359943|810344|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
245717|NCT01359943|810345|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
245718|NCT01359943|810343|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
245719|NCT01359943|810344|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
245720|NCT01359943|810345|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
245721|NCT01359943|810343|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
245722|NCT01359943|810344|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
245723|NCT01359943|810345|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
245724|NCT01359943|810343|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
245725|NCT01359943|810344|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
245726|NCT01359943|810345|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
245727|NCT01359904|810393|P2|Overall Study|Withdrawal by Subject|0
245728|NCT01359904|810394|P1|Overall Study|Withdrawal by Subject|1
245729|NCT01359644|810431|P10|Follow-up Period|Lost to Follow-up|0
245730|NCT01359644|810432|P9|Follow-up Period|Lost to Follow-up|0
245731|NCT01359644|810433|P8|Follow-up Period|Lost to Follow-up|2
245732|NCT01359644|810434|P7|Follow-up Period|Lost to Follow-up|1
245733|NCT01359644|810435|P6|Follow-up Period|Lost to Follow-up|0
245734|NCT01359644|810436|P5|Follow-up Period|Lost to Follow-up|0
245735|NCT01359644|810437|P4|Follow-up Period|Lost to Follow-up|0
245736|NCT01359644|810438|P3|Follow-up Period|Lost to Follow-up|0
245737|NCT01359644|810439|P2|Follow-up Period|Lost to Follow-up|0
245738|NCT01359644|810440|P1|Follow-up Period|Lost to Follow-up|0
245739|NCT01359644|810431|P10|Follow-up Period|Withdrawal by Subject|0
245740|NCT01359644|810432|P9|Follow-up Period|Withdrawal by Subject|0
245741|NCT01359644|810433|P8|Follow-up Period|Withdrawal by Subject|0
245742|NCT01359644|810434|P7|Follow-up Period|Withdrawal by Subject|0
245743|NCT01359644|810435|P6|Follow-up Period|Withdrawal by Subject|1
245744|NCT01359644|810436|P5|Follow-up Period|Withdrawal by Subject|0
245745|NCT01359644|810437|P4|Follow-up Period|Withdrawal by Subject|0
245746|NCT01359644|810438|P3|Follow-up Period|Withdrawal by Subject|0
245747|NCT01359644|810439|P2|Follow-up Period|Withdrawal by Subject|0
245748|NCT01359644|810440|P1|Follow-up Period|Withdrawal by Subject|0
245749|NCT01359644|810431|P10|Treatment Period|Lost to Follow-up|0
245750|NCT01359644|810432|P9|Treatment Period|Lost to Follow-up|0
245751|NCT01359644|810433|P8|Treatment Period|Lost to Follow-up|0
245752|NCT01359644|810434|P7|Treatment Period|Lost to Follow-up|0
245753|NCT01359644|810435|P6|Treatment Period|Lost to Follow-up|1
245754|NCT01359644|810436|P5|Treatment Period|Lost to Follow-up|0
245755|NCT01359644|810437|P4|Treatment Period|Lost to Follow-up|0
245756|NCT01359644|810438|P3|Treatment Period|Lost to Follow-up|0
245757|NCT01359644|810439|P2|Treatment Period|Lost to Follow-up|0
245758|NCT01359644|810440|P1|Treatment Period|Lost to Follow-up|0
245759|NCT01359644|810431|P10|Treatment Period|Adverse Event|0
245760|NCT01359644|810432|P9|Treatment Period|Adverse Event|0
245761|NCT01359644|810433|P8|Treatment Period|Adverse Event|0
245762|NCT01359644|810434|P7|Treatment Period|Adverse Event|0
245763|NCT01359644|810435|P6|Treatment Period|Adverse Event|1
245764|NCT01359644|810436|P5|Treatment Period|Adverse Event|0
245765|NCT01359644|810437|P4|Treatment Period|Adverse Event|0
245766|NCT01359644|810438|P3|Treatment Period|Adverse Event|1
245767|NCT01359644|810439|P2|Treatment Period|Adverse Event|0
245768|NCT01359644|810440|P1|Treatment Period|Adverse Event|0
245769|NCT01359644|810431|P10|Treatment Period|Lack of Efficacy|0
245770|NCT01359644|810432|P9|Treatment Period|Lack of Efficacy|0
245771|NCT01359644|810433|P8|Treatment Period|Lack of Efficacy|0
245772|NCT01359644|810434|P7|Treatment Period|Lack of Efficacy|0
245773|NCT01359644|810435|P6|Treatment Period|Lack of Efficacy|0
245774|NCT01359644|810436|P5|Treatment Period|Lack of Efficacy|0
245775|NCT01359644|810437|P4|Treatment Period|Lack of Efficacy|0
245776|NCT01359644|810438|P3|Treatment Period|Lack of Efficacy|0
245777|NCT01359644|810439|P2|Treatment Period|Lack of Efficacy|1
245778|NCT01359644|810440|P1|Treatment Period|Lack of Efficacy|0
245779|NCT01359449|810484|P2|Overall Study|Withdrawal by Subject|2
245780|NCT01359449|810485|P1|Overall Study|Withdrawal by Subject|3
245781|NCT01359449|810484|P2|Overall Study|Protocol Violation|2
245782|NCT01359449|810485|P1|Overall Study|Protocol Violation|0
245783|NCT01359449|810484|P2|Overall Study|Lost to Follow-up|0
245784|NCT01359449|810485|P1|Overall Study|Lost to Follow-up|1
245785|NCT01359254|810531|P2|Overall Study|Death|0
245786|NCT01359254|810532|P1|Overall Study|Death|1
245787|NCT01359150|810542|P2|Overall Study|Unspecified|0
245788|NCT01359150|810543|P1|Overall Study|Unspecified|1
245789|NCT01359150|810542|P2|Overall Study|Adverse Event|3
245790|NCT01359150|810543|P1|Overall Study|Adverse Event|4
245791|NCT01359150|810542|P2|Overall Study|Withdrawal by Subject|1
245792|NCT01359150|810543|P1|Overall Study|Withdrawal by Subject|1
245793|NCT01359150|810542|P2|Overall Study|Lack of Efficacy|1
245794|NCT01359150|810543|P1|Overall Study|Lack of Efficacy|1
245795|NCT01358864|810580|P8|Overall Study|Not treated|0
245796|NCT01358864|810581|P7|Overall Study|Not treated|1
245797|NCT01358864|810582|P6|Overall Study|Not treated|0
245798|NCT01358864|810583|P5|Overall Study|Not treated|0
245799|NCT01358864|810584|P4|Overall Study|Not treated|0
245800|NCT01358864|810585|P3|Overall Study|Not treated|0
245801|NCT01358864|810586|P2|Overall Study|Not treated|0
245802|NCT01358864|810587|P1|Overall Study|Not treated|0
245803|NCT01358864|810580|P8|Overall Study|Other reason not defined above|0
245804|NCT01358864|810581|P7|Overall Study|Other reason not defined above|2
245805|NCT01358864|810582|P6|Overall Study|Other reason not defined above|0
245806|NCT01358864|810583|P5|Overall Study|Other reason not defined above|0
245807|NCT01358864|810584|P4|Overall Study|Other reason not defined above|0
245808|NCT01358864|810585|P3|Overall Study|Other reason not defined above|0
245809|NCT01358864|810586|P2|Overall Study|Other reason not defined above|0
245810|NCT01358864|810587|P1|Overall Study|Other reason not defined above|2
245811|NCT01358864|810580|P8|Overall Study|Withdrawal by Subject|3
245812|NCT01358864|810581|P7|Overall Study|Withdrawal by Subject|1
245813|NCT01358864|810582|P6|Overall Study|Withdrawal by Subject|1
245814|NCT01358864|810583|P5|Overall Study|Withdrawal by Subject|0
245815|NCT01358864|810584|P4|Overall Study|Withdrawal by Subject|0
245816|NCT01358864|810585|P3|Overall Study|Withdrawal by Subject|2
245817|NCT01358864|810586|P2|Overall Study|Withdrawal by Subject|4
245818|NCT01358864|810587|P1|Overall Study|Withdrawal by Subject|3
245819|NCT01358864|810580|P8|Overall Study|Lost to Follow-up|1
245820|NCT01358864|810581|P7|Overall Study|Lost to Follow-up|0
245821|NCT01358864|810582|P6|Overall Study|Lost to Follow-up|0
245822|NCT01358864|810583|P5|Overall Study|Lost to Follow-up|0
245823|NCT01358864|810584|P4|Overall Study|Lost to Follow-up|0
245824|NCT01358864|810585|P3|Overall Study|Lost to Follow-up|1
245825|NCT01358864|810586|P2|Overall Study|Lost to Follow-up|0
245826|NCT01358864|810587|P1|Overall Study|Lost to Follow-up|0
245827|NCT01358864|810580|P8|Overall Study|Lack of Efficacy|44
245828|NCT01358864|810581|P7|Overall Study|Lack of Efficacy|49
245829|NCT01358864|810582|P6|Overall Study|Lack of Efficacy|4
245830|NCT01358864|810583|P5|Overall Study|Lack of Efficacy|7
245831|NCT01358864|810584|P4|Overall Study|Lack of Efficacy|19
245832|NCT01358864|810585|P3|Overall Study|Lack of Efficacy|4
245833|NCT01358864|810586|P2|Overall Study|Lack of Efficacy|3
245834|NCT01358864|810587|P1|Overall Study|Lack of Efficacy|26
245835|NCT01358864|810580|P8|Overall Study|Adverse Event|7
245836|NCT01358864|810581|P7|Overall Study|Adverse Event|12
245837|NCT01358864|810582|P6|Overall Study|Adverse Event|8
245838|NCT01358864|810583|P5|Overall Study|Adverse Event|4
245839|NCT01358864|810584|P4|Overall Study|Adverse Event|0
245840|NCT01358864|810585|P3|Overall Study|Adverse Event|9
245841|NCT01358864|810586|P2|Overall Study|Adverse Event|6
245842|NCT01358864|810587|P1|Overall Study|Adverse Event|0
245843|NCT01358825|810678|P2|Overall Study|Blood sample not drawn|1
245844|NCT01358825|810679|P1|Overall Study|Blood sample not drawn|0
245845|NCT01358760|810703|P3|Overall Study|Entry criteria not met/Non-compliance|16
245846|NCT01358760|810704|P2|Overall Study|Entry criteria not met/Non-compliance|12
245847|NCT01358760|810705|P1|Overall Study|Entry criteria not met/Non-compliance|12
245848|NCT01358760|810703|P3|Overall Study|Physician Decision|1
245849|NCT01358760|810704|P2|Overall Study|Physician Decision|0
245850|NCT01358760|810705|P1|Overall Study|Physician Decision|1
245851|NCT01358760|810703|P3|Overall Study|Withdrawal by Subject|2
245852|NCT01358760|810704|P2|Overall Study|Withdrawal by Subject|3
245853|NCT01358760|810705|P1|Overall Study|Withdrawal by Subject|5
245854|NCT01358760|810703|P3|Overall Study|Lost to Follow-up|3
245855|NCT01358760|810704|P2|Overall Study|Lost to Follow-up|1
245856|NCT01358760|810705|P1|Overall Study|Lost to Follow-up|1
245857|NCT01358760|810703|P3|Overall Study|Adverse Event|3
245858|NCT01358760|810704|P2|Overall Study|Adverse Event|4
245859|NCT01358760|810705|P1|Overall Study|Adverse Event|3
245860|NCT01358734|810740|P3|Overall Study|Not Specified|4
245861|NCT01358734|810741|P2|Overall Study|Not Specified|5
245862|NCT01358734|810742|P1|Overall Study|Not Specified|2
245863|NCT01358734|810740|P3|Overall Study|Non-compliance with study drug|1
245864|NCT01358734|810741|P2|Overall Study|Non-compliance with study drug|0
245865|NCT01358734|810742|P1|Overall Study|Non-compliance with study drug|0
245866|NCT01358734|810740|P3|Overall Study|Progressive Disease|13
245867|NCT01358734|810741|P2|Overall Study|Progressive Disease|11
245868|NCT01358734|810742|P1|Overall Study|Progressive Disease|5
245869|NCT01358734|810740|P3|Overall Study|Death|2
245870|NCT01358734|810741|P2|Overall Study|Death|7
245871|NCT01358734|810742|P1|Overall Study|Death|3
245872|NCT01358734|810740|P3|Overall Study|Withdrawal by Subject|3
245873|NCT01358734|810741|P2|Overall Study|Withdrawal by Subject|6
245874|NCT01358734|810742|P1|Overall Study|Withdrawal by Subject|1
245875|NCT01358734|810740|P3|Overall Study|Lack of Efficacy|3
245876|NCT01358734|810741|P2|Overall Study|Lack of Efficacy|1
245877|NCT01358734|810742|P1|Overall Study|Lack of Efficacy|0
245878|NCT01358734|810740|P3|Overall Study|Adverse Event|3
245879|NCT01358734|810741|P2|Overall Study|Adverse Event|7
245880|NCT01358734|810742|P1|Overall Study|Adverse Event|4
245881|NCT01358708|810761|P2|Double-Blind Treatment Phase|Protocol Violation|0
245882|NCT01358708|810762|P1|Double-Blind Treatment Phase|Protocol Violation|1
245883|NCT01358708|810761|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
245884|NCT01358708|810762|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
245885|NCT01358578|810785|P6|Follow-up Period|Physician Decision|0
245886|NCT01358578|810786|P5|Follow-up Period|Physician Decision|0
245887|NCT01358578|810787|P4|Follow-up Period|Physician Decision|2
245888|NCT01358578|810788|P3|Follow-up Period|Physician Decision|0
245889|NCT01358578|810789|P2|Follow-up Period|Physician Decision|1
245890|NCT01358578|810790|P1|Follow-up Period|Physician Decision|1
245891|NCT01358578|810785|P6|Follow-up Period|Withdrawal by Subject|0
245892|NCT01358578|810786|P5|Follow-up Period|Withdrawal by Subject|0
245893|NCT01358578|810787|P4|Follow-up Period|Withdrawal by Subject|12
245894|NCT01358578|810788|P3|Follow-up Period|Withdrawal by Subject|1
245895|NCT01358578|810789|P2|Follow-up Period|Withdrawal by Subject|3
245896|NCT01358578|810790|P1|Follow-up Period|Withdrawal by Subject|3
245897|NCT01358578|810785|P6|Follow-up Period|Pregnancy|0
245898|NCT01358578|810786|P5|Follow-up Period|Pregnancy|0
245899|NCT01358578|810787|P4|Follow-up Period|Pregnancy|0
245900|NCT01358578|810788|P3|Follow-up Period|Pregnancy|0
245901|NCT01358578|810789|P2|Follow-up Period|Pregnancy|0
245902|NCT01358578|810790|P1|Follow-up Period|Pregnancy|1
245903|NCT01358578|810785|P6|Follow-up Period|non- compliance with study treatment|0
245904|NCT01358578|810786|P5|Follow-up Period|non- compliance with study treatment|0
245905|NCT01358578|810787|P4|Follow-up Period|non- compliance with study treatment|0
245906|NCT01358578|810788|P3|Follow-up Period|non- compliance with study treatment|0
245907|NCT01358578|810789|P2|Follow-up Period|non- compliance with study treatment|0
245908|NCT01358578|810790|P1|Follow-up Period|non- compliance with study treatment|1
245909|NCT01358578|810785|P6|Follow-up Period|Lost to Follow-up|0
245910|NCT01358578|810786|P5|Follow-up Period|Lost to Follow-up|0
245911|NCT01358578|810787|P4|Follow-up Period|Lost to Follow-up|4
245912|NCT01358578|810788|P3|Follow-up Period|Lost to Follow-up|0
245913|NCT01358578|810789|P2|Follow-up Period|Lost to Follow-up|1
245914|NCT01358578|810790|P1|Follow-up Period|Lost to Follow-up|0
245915|NCT01358578|810785|P6|Follow-up Period|Lack of Efficacy|0
245916|NCT01358578|810786|P5|Follow-up Period|Lack of Efficacy|0
245917|NCT01358578|810787|P4|Follow-up Period|Lack of Efficacy|1
245918|NCT01358578|810788|P3|Follow-up Period|Lack of Efficacy|4
245919|NCT01358578|810789|P2|Follow-up Period|Lack of Efficacy|0
245920|NCT01358578|810790|P1|Follow-up Period|Lack of Efficacy|3
245921|NCT01358578|810785|P6|Follow-up Period|Adverse Event|0
245922|NCT01358578|810786|P5|Follow-up Period|Adverse Event|0
245923|NCT01358578|810787|P4|Follow-up Period|Adverse Event|0
245924|NCT01358578|810788|P3|Follow-up Period|Adverse Event|0
245925|NCT01358578|810789|P2|Follow-up Period|Adverse Event|1
245926|NCT01358578|810790|P1|Follow-up Period|Adverse Event|1
245927|NCT01358578|810785|P6|Maintenance Period|Withdrawal by Subject|3
245928|NCT01358578|810786|P5|Maintenance Period|Withdrawal by Subject|6
245929|NCT01358578|810787|P4|Maintenance Period|Withdrawal by Subject|15
245930|NCT01358578|810788|P3|Maintenance Period|Withdrawal by Subject|2
245931|NCT01358578|810789|P2|Maintenance Period|Withdrawal by Subject|7
245932|NCT01358578|810790|P1|Maintenance Period|Withdrawal by Subject|12
245933|NCT01358578|810785|P6|Maintenance Period|Protocol deviation|2
245934|NCT01358578|810786|P5|Maintenance Period|Protocol deviation|2
245935|NCT01358578|810787|P4|Maintenance Period|Protocol deviation|2
245936|NCT01358578|810788|P3|Maintenance Period|Protocol deviation|0
245937|NCT01358578|810789|P2|Maintenance Period|Protocol deviation|4
245938|NCT01358578|810790|P1|Maintenance Period|Protocol deviation|7
245939|NCT01358578|810785|P6|Maintenance Period|Pregnancy|0
245940|NCT01358578|810786|P5|Maintenance Period|Pregnancy|0
245941|NCT01358578|810787|P4|Maintenance Period|Pregnancy|0
245942|NCT01358578|810788|P3|Maintenance Period|Pregnancy|0
245943|NCT01358578|810789|P2|Maintenance Period|Pregnancy|0
245944|NCT01358578|810790|P1|Maintenance Period|Pregnancy|1
245945|NCT01358578|810785|P6|Maintenance Period|Physician Decision|0
245946|NCT01358578|810786|P5|Maintenance Period|Physician Decision|0
245947|NCT01358578|810787|P4|Maintenance Period|Physician Decision|1
245948|NCT01358578|810788|P3|Maintenance Period|Physician Decision|0
245949|NCT01358578|810789|P2|Maintenance Period|Physician Decision|1
245950|NCT01358578|810790|P1|Maintenance Period|Physician Decision|0
245951|NCT01358578|810785|P6|Maintenance Period|Non-compliance with study treatment|2
245952|NCT01358578|810786|P5|Maintenance Period|Non-compliance with study treatment|1
245953|NCT01358578|810787|P4|Maintenance Period|Non-compliance with study treatment|2
245954|NCT01358578|810788|P3|Maintenance Period|Non-compliance with study treatment|0
245955|NCT01358578|810789|P2|Maintenance Period|Non-compliance with study treatment|1
245956|NCT01358578|810790|P1|Maintenance Period|Non-compliance with study treatment|3
245957|NCT01358578|810785|P6|Maintenance Period|Lost to Follow-up|1
245958|NCT01358578|810786|P5|Maintenance Period|Lost to Follow-up|1
245959|NCT01358578|810787|P4|Maintenance Period|Lost to Follow-up|5
245960|NCT01358578|810788|P3|Maintenance Period|Lost to Follow-up|0
245961|NCT01358578|810789|P2|Maintenance Period|Lost to Follow-up|0
245962|NCT01358578|810790|P1|Maintenance Period|Lost to Follow-up|4
245963|NCT01358578|810785|P6|Maintenance Period|Lack of Efficacy|0
245964|NCT01358578|810786|P5|Maintenance Period|Lack of Efficacy|3
245965|NCT01358578|810787|P4|Maintenance Period|Lack of Efficacy|11
245966|NCT01358578|810788|P3|Maintenance Period|Lack of Efficacy|0
245967|NCT01358578|810789|P2|Maintenance Period|Lack of Efficacy|2
245968|NCT01358578|810790|P1|Maintenance Period|Lack of Efficacy|10
245969|NCT01358578|810785|P6|Maintenance Period|Adverse Event|3
245970|NCT01358578|810786|P5|Maintenance Period|Adverse Event|4
245971|NCT01358578|810787|P4|Maintenance Period|Adverse Event|6
245972|NCT01358578|810788|P3|Maintenance Period|Adverse Event|0
245973|NCT01358578|810789|P2|Maintenance Period|Adverse Event|7
245974|NCT01358578|810790|P1|Maintenance Period|Adverse Event|2
245975|NCT01358578|810785|P6|Induction Period|Withdrawal by Subject|0
245976|NCT01358578|810786|P5|Induction Period|Withdrawal by Subject|0
245977|NCT01358578|810787|P4|Induction Period|Withdrawal by Subject|6
245978|NCT01358578|810788|P3|Induction Period|Withdrawal by Subject|10
245979|NCT01358578|810789|P2|Induction Period|Withdrawal by Subject|5
245980|NCT01358578|810790|P1|Induction Period|Withdrawal by Subject|5
245981|NCT01358578|810785|P6|Induction Period|technical problems|0
245982|NCT01358578|810786|P5|Induction Period|technical problems|0
245983|NCT01358578|810787|P4|Induction Period|technical problems|1
245984|NCT01358578|810788|P3|Induction Period|technical problems|1
245985|NCT01358578|810789|P2|Induction Period|technical problems|0
245986|NCT01358578|810790|P1|Induction Period|technical problems|0
245987|NCT01358578|810785|P6|Induction Period|Protocol Deviation|0
245988|NCT01358578|810786|P5|Induction Period|Protocol Deviation|0
245989|NCT01358578|810787|P4|Induction Period|Protocol Deviation|3
245990|NCT01358578|810788|P3|Induction Period|Protocol Deviation|0
245991|NCT01358578|810789|P2|Induction Period|Protocol Deviation|5
245992|NCT01358578|810790|P1|Induction Period|Protocol Deviation|3
245993|NCT01358578|810785|P6|Induction Period|Physician Decision|0
245994|NCT01358578|810786|P5|Induction Period|Physician Decision|0
245995|NCT01358578|810787|P4|Induction Period|Physician Decision|0
245996|NCT01358578|810788|P3|Induction Period|Physician Decision|2
245997|NCT01358578|810789|P2|Induction Period|Physician Decision|1
245998|NCT01358578|810790|P1|Induction Period|Physician Decision|2
245999|NCT01358578|810785|P6|Induction Period|Lost to Follow-up|0
246000|NCT01358578|810786|P5|Induction Period|Lost to Follow-up|0
246001|NCT01358578|810787|P4|Induction Period|Lost to Follow-up|4
246002|NCT01358578|810788|P3|Induction Period|Lost to Follow-up|1
246003|NCT01358578|810789|P2|Induction Period|Lost to Follow-up|0
246004|NCT01358578|810790|P1|Induction Period|Lost to Follow-up|0
246005|NCT01358578|810785|P6|Induction Period|Lack of Efficacy|0
246006|NCT01358578|810786|P5|Induction Period|Lack of Efficacy|0
246007|NCT01358578|810787|P4|Induction Period|Lack of Efficacy|1
246008|NCT01358578|810788|P3|Induction Period|Lack of Efficacy|9
246009|NCT01358578|810789|P2|Induction Period|Lack of Efficacy|0
246010|NCT01358578|810790|P1|Induction Period|Lack of Efficacy|0
246011|NCT01358578|810785|P6|Induction Period|Adverse Event|0
246012|NCT01358578|810786|P5|Induction Period|Adverse Event|0
246013|NCT01358578|810787|P4|Induction Period|Adverse Event|6
246014|NCT01358578|810788|P3|Induction Period|Adverse Event|2
246015|NCT01358578|810789|P2|Induction Period|Adverse Event|4
246016|NCT01358578|810790|P1|Induction Period|Adverse Event|2
246017|NCT01358526|810842|P3|Double-blind Phase|Administrative|10
246018|NCT01358526|810843|P2|Double-blind Phase|Administrative|6
246019|NCT01358526|810844|P1|Double-blind Phase|Administrative|0
246020|NCT01358526|810842|P3|Double-blind Phase|Confirmed or suspected diversion|6
246021|NCT01358526|810843|P2|Double-blind Phase|Confirmed or suspected diversion|5
246022|NCT01358526|810844|P1|Double-blind Phase|Confirmed or suspected diversion|0
246023|NCT01358526|810842|P3|Double-blind Phase|Lack of Efficacy|73
246024|NCT01358526|810843|P2|Double-blind Phase|Lack of Efficacy|31
246025|NCT01358526|810844|P1|Double-blind Phase|Lack of Efficacy|0
246026|NCT01358526|810842|P3|Double-blind Phase|Lost to Follow-up|1
246027|NCT01358526|810843|P2|Double-blind Phase|Lost to Follow-up|4
246028|NCT01358526|810844|P1|Double-blind Phase|Lost to Follow-up|0
246029|NCT01358526|810842|P3|Double-blind Phase|Withdrawal by Subject|8
246030|NCT01358526|810843|P2|Double-blind Phase|Withdrawal by Subject|10
246031|NCT01358526|810844|P1|Double-blind Phase|Withdrawal by Subject|0
246032|NCT01358526|810842|P3|Double-blind Phase|Adverse Event|23
246033|NCT01358526|810843|P2|Double-blind Phase|Adverse Event|24
246034|NCT01358526|810844|P1|Double-blind Phase|Adverse Event|0
246035|NCT01358526|810842|P3|Open-label Titration Period|Did not qualify|0
246036|NCT01358526|810843|P2|Open-label Titration Period|Did not qualify|0
246037|NCT01358526|810844|P1|Open-label Titration Period|Did not qualify|178
246038|NCT01358526|810842|P3|Open-label Titration Period|Administrative|0
246039|NCT01358526|810843|P2|Open-label Titration Period|Administrative|0
246040|NCT01358526|810844|P1|Open-label Titration Period|Administrative|8
246041|NCT01358526|810842|P3|Open-label Titration Period|Confirmed or suspected diversion|0
246042|NCT01358526|810843|P2|Open-label Titration Period|Confirmed or suspected diversion|0
246043|NCT01358526|810844|P1|Open-label Titration Period|Confirmed or suspected diversion|16
246044|NCT01358526|810842|P3|Open-label Titration Period|Lack of Efficacy|0
246045|NCT01358526|810843|P2|Open-label Titration Period|Lack of Efficacy|0
246046|NCT01358526|810844|P1|Open-label Titration Period|Lack of Efficacy|107
246047|NCT01358526|810842|P3|Open-label Titration Period|Lost to Follow-up|0
246048|NCT01358526|810843|P2|Open-label Titration Period|Lost to Follow-up|0
246049|NCT01358526|810844|P1|Open-label Titration Period|Lost to Follow-up|25
246050|NCT01358526|810842|P3|Open-label Titration Period|Withdrawal by Subject|0
246051|NCT01358526|810843|P2|Open-label Titration Period|Withdrawal by Subject|0
246052|NCT01358526|810844|P1|Open-label Titration Period|Withdrawal by Subject|65
246053|NCT01358526|810842|P3|Open-label Titration Period|Adverse Event|0
246054|NCT01358526|810843|P2|Open-label Titration Period|Adverse Event|0
246055|NCT01358526|810844|P1|Open-label Titration Period|Adverse Event|95
246056|NCT01358357|810861|P3|Double-Blind Phase|Administrative|0
246057|NCT01358357|810862|P2|Double-Blind Phase|Administrative|1
246058|NCT01358357|810863|P1|Double-Blind Phase|Administrative|0
246059|NCT01358357|810861|P3|Double-Blind Phase|Recurrence of mood event|0
246060|NCT01358357|810862|P2|Double-Blind Phase|Recurrence of mood event|64
246061|NCT01358357|810863|P1|Double-Blind Phase|Recurrence of mood event|48
246062|NCT01358357|810861|P3|Double-Blind Phase|Terminated at study completion|0
246063|NCT01358357|810862|P2|Double-Blind Phase|Terminated at study completion|0
246064|NCT01358357|810863|P1|Double-Blind Phase|Terminated at study completion|2
246065|NCT01358357|810861|P3|Double-Blind Phase|Protocol Violation|0
246066|NCT01358357|810862|P2|Double-Blind Phase|Protocol Violation|12
246067|NCT01358357|810863|P1|Double-Blind Phase|Protocol Violation|16
246068|NCT01358357|810861|P3|Double-Blind Phase|Protocol Violation|0
246069|NCT01358357|810862|P2|Double-Blind Phase|Protocol Violation|11
246070|NCT01358357|810863|P1|Double-Blind Phase|Protocol Violation|1
246071|NCT01358357|810861|P3|Double-Blind Phase|Lost to Follow-up|0
246072|NCT01358357|810862|P2|Double-Blind Phase|Lost to Follow-up|7
246073|NCT01358357|810863|P1|Double-Blind Phase|Lost to Follow-up|5
246074|NCT01358357|810861|P3|Double-Blind Phase|Adverse Event|0
246075|NCT01358357|810862|P2|Double-Blind Phase|Adverse Event|5
246076|NCT01358357|810863|P1|Double-Blind Phase|Adverse Event|8
246077|NCT01358357|810861|P3|Open Label Phase|Mood episode|42
246078|NCT01358357|810862|P2|Open Label Phase|Mood episode|0
246079|NCT01358357|810863|P1|Open Label Phase|Mood episode|0
246080|NCT01358357|810861|P3|Open Label Phase|Terminated at study completion|5
246081|NCT01358357|810862|P2|Open Label Phase|Terminated at study completion|0
246082|NCT01358357|810863|P1|Open Label Phase|Terminated at study completion|0
246083|NCT01358357|810861|P3|Open Label Phase|Did not meet criteria for DB phase|16
246165|NCT01357850|811033|P1|Overall Study|Lost to Follow-up|1
246084|NCT01358357|810862|P2|Open Label Phase|Did not meet criteria for DB phase|0
246085|NCT01358357|810863|P1|Open Label Phase|Did not meet criteria for DB phase|0
246086|NCT01358357|810861|P3|Open Label Phase|Withdrawal by Subject|112
246087|NCT01358357|810862|P2|Open Label Phase|Withdrawal by Subject|0
246088|NCT01358357|810863|P1|Open Label Phase|Withdrawal by Subject|0
246089|NCT01358357|810861|P3|Open Label Phase|Protocol Violation|45
246090|NCT01358357|810862|P2|Open Label Phase|Protocol Violation|0
246091|NCT01358357|810863|P1|Open Label Phase|Protocol Violation|0
246092|NCT01358357|810861|P3|Open Label Phase|Lost to Follow-up|76
246093|NCT01358357|810862|P2|Open Label Phase|Lost to Follow-up|0
246094|NCT01358357|810863|P1|Open Label Phase|Lost to Follow-up|0
246095|NCT01358357|810861|P3|Open Label Phase|Lack of Efficacy|107
246096|NCT01358357|810862|P2|Open Label Phase|Lack of Efficacy|0
246097|NCT01358357|810863|P1|Open Label Phase|Lack of Efficacy|0
246098|NCT01358357|810861|P3|Open Label Phase|Adverse Event|59
246099|NCT01358357|810862|P2|Open Label Phase|Adverse Event|0
246100|NCT01358357|810863|P1|Open Label Phase|Adverse Event|0
246101|NCT01358175|810899|P3|Overall Study|Adverse Event|11
246102|NCT01358175|810900|P2|Overall Study|Adverse Event|11
246103|NCT01358175|810901|P1|Overall Study|Adverse Event|6
246104|NCT01358175|810899|P3|Overall Study|Lack of Efficacy|6
246105|NCT01358175|810900|P2|Overall Study|Lack of Efficacy|8
246106|NCT01358175|810901|P1|Overall Study|Lack of Efficacy|3
246107|NCT01358175|810899|P3|Overall Study|Lost to Follow-up|3
246108|NCT01358175|810900|P2|Overall Study|Lost to Follow-up|1
246109|NCT01358175|810901|P1|Overall Study|Lost to Follow-up|1
246110|NCT01358175|810899|P3|Overall Study|Non Compliance with Study Treatment|1
246111|NCT01358175|810900|P2|Overall Study|Non Compliance with Study Treatment|1
246112|NCT01358175|810901|P1|Overall Study|Non Compliance with Study Treatment|0
246113|NCT01358175|810899|P3|Overall Study|Physician Decision|0
246114|NCT01358175|810900|P2|Overall Study|Physician Decision|0
246115|NCT01358175|810901|P1|Overall Study|Physician Decision|1
246116|NCT01358175|810899|P3|Overall Study|Pregnancy|0
246117|NCT01358175|810900|P2|Overall Study|Pregnancy|1
246118|NCT01358175|810901|P1|Overall Study|Pregnancy|0
246119|NCT01358175|810899|P3|Overall Study|Technical issues|0
246120|NCT01358175|810900|P2|Overall Study|Technical issues|1
246121|NCT01358175|810901|P1|Overall Study|Technical issues|0
246122|NCT01358175|810899|P3|Overall Study|Withdrawal by Subject|10
246123|NCT01358175|810900|P2|Overall Study|Withdrawal by Subject|5
246124|NCT01358175|810901|P1|Overall Study|Withdrawal by Subject|9
246125|NCT01358175|810899|P3|Overall Study|Death|1
246126|NCT01358175|810900|P2|Overall Study|Death|0
246127|NCT01358175|810901|P1|Overall Study|Death|1
246128|NCT01357980|810938|P4|Overall Study|Consent withdrawn|0
246129|NCT01357980|810939|P3|Overall Study|Consent withdrawn|1
246130|NCT01357980|810940|P2|Overall Study|Consent withdrawn|0
246131|NCT01357980|810941|P1|Overall Study|Consent withdrawn|0
246132|NCT01357980|810938|P4|Overall Study|Lack of Efficacy|0
246133|NCT01357980|810939|P3|Overall Study|Lack of Efficacy|0
246134|NCT01357980|810940|P2|Overall Study|Lack of Efficacy|1
246135|NCT01357980|810941|P1|Overall Study|Lack of Efficacy|0
246136|NCT01357889|810985|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
246137|NCT01357889|810986|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
246138|NCT01357889|810985|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
246139|NCT01357889|810986|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
246140|NCT01357889|810985|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
246141|NCT01357889|810986|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
246142|NCT01357889|810985|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
246143|NCT01357889|810986|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
246144|NCT01357889|810985|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
246145|NCT01357889|810986|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
246146|NCT01357889|810985|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
246147|NCT01357889|810986|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
246148|NCT01357889|810985|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
246149|NCT01357889|810986|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
246150|NCT01357889|810985|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
246233|NCT01356602|811304|P1|Overall Study|Lack of Efficacy|0
246151|NCT01357889|810986|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
246152|NCT01357889|810985|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
246153|NCT01357889|810986|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
246154|NCT01357889|810985|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
246155|NCT01357889|810986|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
246156|NCT01357889|810985|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
246157|NCT01357889|810986|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
246158|NCT01357889|810985|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
246159|NCT01357889|810986|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
246160|NCT01357889|810985|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
246161|NCT01357889|810986|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
246162|NCT01357850|811030|P4|Overall Study|Lost to Follow-up|0
246163|NCT01357850|811031|P3|Overall Study|Lost to Follow-up|0
246164|NCT01357850|811032|P2|Overall Study|Lost to Follow-up|0
246166|NCT01357655|811124|P2|Overall Study|Subject Withdrew Consent|0
246167|NCT01357655|811125|P1|Overall Study|Subject Withdrew Consent|1
246168|NCT01357655|811124|P2|Overall Study|Study Drug Toxicity|0
246169|NCT01357655|811125|P1|Overall Study|Study Drug Toxicity|11
246170|NCT01357655|811124|P2|Overall Study|Reason Unspecified|0
246171|NCT01357655|811125|P1|Overall Study|Reason Unspecified|1
246172|NCT01357655|811124|P2|Overall Study|Maximum Clinical Benefit|0
246173|NCT01357655|811125|P1|Overall Study|Maximum Clinical Benefit|2
246174|NCT01357655|811124|P2|Overall Study|Lost to Follow-up|0
246175|NCT01357655|811125|P1|Overall Study|Lost to Follow-up|2
246176|NCT01357655|811124|P2|Overall Study|Disease Progression|0
246177|NCT01357655|811125|P1|Overall Study|Disease Progression|1
246178|NCT01357655|811124|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
246179|NCT01357655|811125|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
246180|NCT01357655|811124|P2|Overall Study|Administrative Reason by Sponsor|0
246181|NCT01357655|811125|P1|Overall Study|Administrative Reason by Sponsor|45
246182|NCT01357616|811142|P2|Overall Study|Withdrawal by Subject|0
246183|NCT01357616|811143|P1|Overall Study|Withdrawal by Subject|1
246184|NCT01357616|811142|P2|Overall Study|Decision Unrelated to Adverse Event|1
246185|NCT01357616|811143|P1|Overall Study|Decision Unrelated to Adverse Event|3
246186|NCT01357616|811142|P2|Overall Study|Inadequate Control of IOP|2
246187|NCT01357616|811143|P1|Overall Study|Inadequate Control of IOP|1
246188|NCT01357616|811142|P2|Overall Study|Protocol Violation|2
246189|NCT01357616|811143|P1|Overall Study|Protocol Violation|0
246190|NCT01357616|811142|P2|Overall Study|Lost to Follow-up|3
246191|NCT01357616|811143|P1|Overall Study|Lost to Follow-up|4
246192|NCT01357616|811142|P2|Overall Study|Adverse Event|1
246193|NCT01357616|811143|P1|Overall Study|Adverse Event|1
246194|NCT01357551|811157|P2|Overall Study|Lost to Follow-up|6
246195|NCT01357551|811158|P1|Overall Study|Lost to Follow-up|16
246196|NCT01357551|811157|P2|Overall Study|Death|1
246197|NCT01357551|811158|P1|Overall Study|Death|0
246198|NCT01357551|811157|P2|Overall Study|Withdrawal by Subject|4
246199|NCT01357551|811158|P1|Overall Study|Withdrawal by Subject|6
246200|NCT01357239|811185|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
246201|NCT01357239|811186|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
246202|NCT01357239|811187|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
246203|NCT01357239|811188|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
246204|NCT01357239|811185|P4|Stratum II: Partially-Methylated|Adverse Event|1
246205|NCT01357239|811186|P3|Stratum II: Partially-Methylated|Adverse Event|0
246206|NCT01357239|811187|P2|Stratum II: Partially-Methylated|Adverse Event|0
246207|NCT01357239|811188|P1|Stratum II: Partially-Methylated|Adverse Event|0
246208|NCT01357239|811185|P4|Stratum I: Fully-Methylated|Adverse Event|0
246209|NCT01357239|811186|P3|Stratum I: Fully-Methylated|Adverse Event|1
246210|NCT01357239|811187|P2|Stratum I: Fully-Methylated|Adverse Event|0
246211|NCT01357239|811188|P1|Stratum I: Fully-Methylated|Adverse Event|0
246212|NCT01357239|811185|P4|Stratum: All Patients|Subject withdrew consent|1
246213|NCT01357239|811186|P3|Stratum: All Patients|Subject withdrew consent|1
246214|NCT01357239|811187|P2|Stratum: All Patients|Subject withdrew consent|0
246215|NCT01357239|811188|P1|Stratum: All Patients|Subject withdrew consent|0
246216|NCT01357239|811185|P4|Stratum: All Patients|Adverse Event|1
246217|NCT01357239|811186|P3|Stratum: All Patients|Adverse Event|1
246218|NCT01357239|811187|P2|Stratum: All Patients|Adverse Event|0
246219|NCT01357239|811188|P1|Stratum: All Patients|Adverse Event|0
246220|NCT01356966|811266|P2|Overall Study|Physician Decision|0
246221|NCT01356966|811267|P1|Overall Study|Physician Decision|1
246222|NCT01356966|811266|P2|Overall Study|Withdrawal by Subject|2
246223|NCT01356966|811267|P1|Overall Study|Withdrawal by Subject|1
246224|NCT01356940|811279|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
246225|NCT01356940|811280|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
246226|NCT01356940|811279|P2|First Intervention (28 Days)|Adverse Event|0
246227|NCT01356940|811280|P1|First Intervention (28 Days)|Adverse Event|1
246228|NCT01356602|811302|P3|Overall Study|Adverse Event|1
246229|NCT01356602|811303|P2|Overall Study|Adverse Event|1
246230|NCT01356602|811304|P1|Overall Study|Adverse Event|0
246231|NCT01356602|811302|P3|Overall Study|Lack of Efficacy|4
246232|NCT01356602|811303|P2|Overall Study|Lack of Efficacy|1
246234|NCT01356602|811302|P3|Overall Study|Withdrawal by Subject|7
246235|NCT01356602|811303|P2|Overall Study|Withdrawal by Subject|3
246236|NCT01356602|811304|P1|Overall Study|Withdrawal by Subject|4
246237|NCT01356602|811302|P3|Overall Study|Lost to Follow-up|6
246238|NCT01356602|811303|P2|Overall Study|Lost to Follow-up|5
246239|NCT01356602|811304|P1|Overall Study|Lost to Follow-up|4
246240|NCT01356602|811302|P3|Overall Study|Administrative Problems|5
246241|NCT01356602|811303|P2|Overall Study|Administrative Problems|4
246242|NCT01356602|811304|P1|Overall Study|Administrative Problems|1
246243|NCT01356602|811302|P3|Overall Study|Protocol Deviation|1
246244|NCT01356602|811303|P2|Overall Study|Protocol Deviation|1
246245|NCT01356602|811304|P1|Overall Study|Protocol Deviation|0
246246|NCT01356589|811363|P1|Overall Study|Dose data not recorded|2
246247|NCT01356589|811363|P1|Overall Study|Enrolled, but not treated|3
246248|NCT01356407|811420|P2|Overall Study|Not complete Endoscopy|2
246249|NCT01356407|811421|P1|Overall Study|Not complete Endoscopy|2
246250|NCT01356407|811420|P2|Overall Study|Could not afford IMP administration|1
246251|NCT01356407|811421|P1|Overall Study|Could not afford IMP administration|0
246252|NCT01356407|811420|P2|Overall Study|Patient Withdrew Consent|1
246253|NCT01356407|811421|P1|Overall Study|Patient Withdrew Consent|2
246254|NCT01356407|811420|P2|Overall Study|Lost to Follow-up|0
246255|NCT01356407|811421|P1|Overall Study|Lost to Follow-up|2
246256|NCT01355679|811459|P1|Overall Study|benign tumor types found at biopsy|2
246257|NCT01355627|811468|P2|Overall Study|Other|1
246258|NCT01355627|811469|P1|Overall Study|Other|1
246259|NCT01355627|811468|P2|Overall Study|Fatal Adverse Event|23
246260|NCT01355627|811469|P1|Overall Study|Fatal Adverse Event|19
246261|NCT01355627|811468|P2|Overall Study|Lost to Follow-up|7
246262|NCT01355627|811469|P1|Overall Study|Lost to Follow-up|8
246263|NCT01355627|811468|P2|Overall Study|Request By the Patient to Discontinue|7
246264|NCT01355627|811469|P1|Overall Study|Request By the Patient to Discontinue|5
246265|NCT01355523|811508|P2|Overall Study|Adverse Event|2
246266|NCT01355523|811509|P1|Overall Study|Adverse Event|0
246267|NCT01355523|811508|P2|Overall Study|Protocol Violation|2
246268|NCT01355523|811509|P1|Overall Study|Protocol Violation|0
246269|NCT01355523|811508|P2|Overall Study|Lost to Follow-up|2
246270|NCT01355523|811509|P1|Overall Study|Lost to Follow-up|0
246271|NCT01355523|811508|P2|Overall Study|Withdrawal by Subject|4
246272|NCT01355523|811509|P1|Overall Study|Withdrawal by Subject|1
246273|NCT01355302|811585|P3|Phase 1b|Study terminated by sponsor|0
246274|NCT01355302|811586|P2|Phase 1b|Study terminated by sponsor|0
246275|NCT01355302|811587|P1|Phase 1b|Study terminated by sponsor|2
246276|NCT01355302|811585|P3|Phase 1b|Death|0
246277|NCT01355302|811586|P2|Phase 1b|Death|0
246278|NCT01355302|811587|P1|Phase 1b|Death|4
246279|NCT01355081|811628|P3|Overall Study|Non Compliance with Study Medication|0
246280|NCT01355081|811629|P2|Overall Study|Non Compliance with Study Medication|1
246281|NCT01355081|811630|P1|Overall Study|Non Compliance with Study Medication|0
246282|NCT01355081|811628|P3|Overall Study|Lack of Efficacy|1
246283|NCT01355081|811629|P2|Overall Study|Lack of Efficacy|1
246284|NCT01355081|811630|P1|Overall Study|Lack of Efficacy|2
246285|NCT01355081|811628|P3|Overall Study|Withdrawal of Consent|3
246286|NCT01355081|811629|P2|Overall Study|Withdrawal of Consent|3
246287|NCT01355081|811630|P1|Overall Study|Withdrawal of Consent|2
246288|NCT01355081|811628|P3|Overall Study|Lost to Follow-up|1
246289|NCT01355081|811629|P2|Overall Study|Lost to Follow-up|0
246290|NCT01355081|811630|P1|Overall Study|Lost to Follow-up|0
246291|NCT01355081|811628|P3|Overall Study|Major Protocol Deviation|0
246292|NCT01355081|811629|P2|Overall Study|Major Protocol Deviation|1
246293|NCT01355081|811630|P1|Overall Study|Major Protocol Deviation|0
246294|NCT01355081|811628|P3|Overall Study|Pretreatment Event or Adverse Event|6
246295|NCT01355081|811629|P2|Overall Study|Pretreatment Event or Adverse Event|4
246296|NCT01355081|811630|P1|Overall Study|Pretreatment Event or Adverse Event|3
246297|NCT01355068|811653|P2|First Intervention Period|Withdrawal by Subject|1
246298|NCT01355068|811654|P1|First Intervention Period|Withdrawal by Subject|0
246299|NCT01355068|811653|P2|First Intervention Period|Adverse Event|1
246300|NCT01355068|811654|P1|First Intervention Period|Adverse Event|0
246301|NCT01354938|811677|P1|Overall Study|Lost to Follow-up|1
246302|NCT01354899|811683|P1|Overall Study|Protocol Violation|1
246303|NCT01354899|811683|P1|Overall Study|discharge from the hospital|2
246304|NCT01354431|811704|P3|Participants Treated|Withdrawal by Subject|1
246305|NCT01354431|811705|P2|Participants Treated|Withdrawal by Subject|2
246306|NCT01354431|811706|P1|Participants Treated|Withdrawal by Subject|1
246307|NCT01354431|811704|P3|Participants Treated|Adverse Event|4
246308|NCT01354431|811705|P2|Participants Treated|Adverse Event|2
246309|NCT01354431|811706|P1|Participants Treated|Adverse Event|1
246310|NCT01354431|811704|P3|Participants Treated|Death|0
246311|NCT01354431|811705|P2|Participants Treated|Death|1
246312|NCT01354431|811706|P1|Participants Treated|Death|0
246313|NCT01354431|811704|P3|Participants Treated|Study Drug Toxicity|4
246314|NCT01354431|811705|P2|Participants Treated|Study Drug Toxicity|7
246315|NCT01354431|811706|P1|Participants Treated|Study Drug Toxicity|2
246316|NCT01354431|811704|P3|Participants Treated|Disease Progression|41
246317|NCT01354431|811705|P2|Participants Treated|Disease Progression|40
246318|NCT01354431|811706|P1|Participants Treated|Disease Progression|49
246319|NCT01354431|811704|P3|Participants Treated|Continuing Treatment|4
246320|NCT01354431|811705|P2|Participants Treated|Continuing Treatment|2
246321|NCT01354431|811706|P1|Participants Treated|Continuing Treatment|6
246322|NCT01354431|811704|P3|Randomized to Enter Treatment Period|No longer met criteria|0
246323|NCT01354431|811705|P2|Randomized to Enter Treatment Period|No longer met criteria|0
246324|NCT01354431|811706|P1|Randomized to Enter Treatment Period|No longer met criteria|1
246325|NCT01354314|811730|P4|Overall Study|Less than 90% Adherence|4
246326|NCT01354314|811731|P3|Overall Study|Less than 90% Adherence|6
246327|NCT01354314|811732|P2|Overall Study|Less than 90% Adherence|2
246328|NCT01354314|811733|P1|Overall Study|Less than 90% Adherence|4
246329|NCT01354314|811730|P4|Overall Study|Protocol Violation|0
246330|NCT01354314|811731|P3|Overall Study|Protocol Violation|0
246331|NCT01354314|811732|P2|Overall Study|Protocol Violation|1
246332|NCT01354314|811733|P1|Overall Study|Protocol Violation|1
246333|NCT01354314|811730|P4|Overall Study|Adverse Event|1
246334|NCT01354314|811731|P3|Overall Study|Adverse Event|0
246335|NCT01354314|811732|P2|Overall Study|Adverse Event|0
246336|NCT01354314|811733|P1|Overall Study|Adverse Event|0
246337|NCT01354314|811730|P4|Overall Study|Withdrawal by Subject|0
246338|NCT01354314|811731|P3|Overall Study|Withdrawal by Subject|1
246339|NCT01354314|811732|P2|Overall Study|Withdrawal by Subject|0
246340|NCT01354314|811733|P1|Overall Study|Withdrawal by Subject|0
246341|NCT01354314|811730|P4|Overall Study|Lost to Follow-up|1
246342|NCT01354314|811731|P3|Overall Study|Lost to Follow-up|1
246343|NCT01354314|811732|P2|Overall Study|Lost to Follow-up|0
246344|NCT01354314|811733|P1|Overall Study|Lost to Follow-up|1
246345|NCT01354223|811869|P2|Overall Study|Withdrawal by Subject|1
246346|NCT01354223|811870|P1|Overall Study|Withdrawal by Subject|3
246347|NCT01354132|811929|P2|1 Month Post Study Medication|Withdrawal by Subject|3
246348|NCT01354132|811930|P1|1 Month Post Study Medication|Withdrawal by Subject|1
246349|NCT01354132|811929|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
246350|NCT01354132|811930|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
246351|NCT01354132|811929|P2|Double Blind (Visits 1-7)|Adverse Event|0
246352|NCT01354132|811930|P1|Double Blind (Visits 1-7)|Adverse Event|1
246353|NCT01354132|811929|P2|Randomization|Withdrawal by Subject|1
246354|NCT01354132|811930|P1|Randomization|Withdrawal by Subject|0
246355|NCT01354132|811929|P2|Randomization|Physician Decision|0
246356|NCT01354132|811930|P1|Randomization|Physician Decision|1
246357|NCT01354106|811968|P1|Overall Study|Withdrawal by Subject|2
246358|NCT01354028|811974|P2|Overall Study|No quiet alert state|1
246359|NCT01354028|811975|P1|Overall Study|No quiet alert state|0
246360|NCT01354028|811974|P2|Overall Study|Discharged before study start|2
246361|NCT01354028|811975|P1|Overall Study|Discharged before study start|2
246362|NCT01354028|811974|P2|Overall Study|Physician Decision|2
246363|NCT01354028|811975|P1|Overall Study|Physician Decision|0
246364|NCT01353963|812011|P1|Overall Study|Adverse Event|2
246365|NCT01353911|812029|P8|Overall Study|Status Not Recorded|0
246366|NCT01353911|812030|P7|Overall Study|Status Not Recorded|0
246367|NCT01353911|812031|P6|Overall Study|Status Not Recorded|0
246368|NCT01353911|812032|P5|Overall Study|Status Not Recorded|0
246369|NCT01353911|812033|P4|Overall Study|Status Not Recorded|0
246370|NCT01353911|812034|P3|Overall Study|Status Not Recorded|1
246371|NCT01353911|812035|P2|Overall Study|Status Not Recorded|0
246372|NCT01353911|812036|P1|Overall Study|Status Not Recorded|4
246373|NCT01353911|812029|P8|Overall Study|Withdrawal by Subject|9
246374|NCT01353911|812030|P7|Overall Study|Withdrawal by Subject|3
246375|NCT01353911|812031|P6|Overall Study|Withdrawal by Subject|3
246376|NCT01353911|812032|P5|Overall Study|Withdrawal by Subject|2
246377|NCT01353911|812033|P4|Overall Study|Withdrawal by Subject|2
246378|NCT01353911|812034|P3|Overall Study|Withdrawal by Subject|4
246379|NCT01353911|812035|P2|Overall Study|Withdrawal by Subject|3
246380|NCT01353911|812036|P1|Overall Study|Withdrawal by Subject|2
246381|NCT01353911|812029|P8|Overall Study|Lost to Follow-up|6
246382|NCT01353911|812030|P7|Overall Study|Lost to Follow-up|3
246383|NCT01353911|812031|P6|Overall Study|Lost to Follow-up|4
246384|NCT01353911|812032|P5|Overall Study|Lost to Follow-up|4
246385|NCT01353911|812033|P4|Overall Study|Lost to Follow-up|0
246386|NCT01353911|812034|P3|Overall Study|Lost to Follow-up|4
246387|NCT01353911|812035|P2|Overall Study|Lost to Follow-up|6
246388|NCT01353911|812036|P1|Overall Study|Lost to Follow-up|2
246389|NCT01353898|812116|P6|Overall Study|Study site terminated|1
246390|NCT01353898|812117|P5|Overall Study|Study site terminated|0
246391|NCT01353898|812118|P4|Overall Study|Study site terminated|0
246392|NCT01353898|812119|P3|Overall Study|Study site terminated|0
246393|NCT01353898|812120|P2|Overall Study|Study site terminated|0
246394|NCT01353898|812121|P1|Overall Study|Study site terminated|0
246395|NCT01353859|812147|P1|Overall Study|Lack of Efficacy|1
246396|NCT01353859|812147|P1|Overall Study|Adverse Event|3
246397|NCT01353664|812160|P1|Overall Study|Disease Progression|16
246398|NCT01353664|812160|P1|Overall Study|Unspecified|3
246399|NCT01353586|812166|P2|Overall Study|Neurological exam not done|1
246400|NCT01353586|812167|P1|Overall Study|Neurological exam not done|0
246401|NCT01353586|812166|P2|Overall Study|Never had insertion of study catheter|1
246402|NCT01353586|812167|P1|Overall Study|Never had insertion of study catheter|4
246403|NCT01353586|812166|P2|Overall Study|Procedure terminated prior to ablation|0
246404|NCT01353586|812167|P1|Overall Study|Procedure terminated prior to ablation|3
246405|NCT01353508|812185|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
246406|NCT01353508|812186|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
246407|NCT01353508|812187|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
246408|NCT01353508|812188|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
246409|NCT01353508|812185|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
246410|NCT01353508|812186|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
246411|NCT01353508|812187|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
246412|NCT01353508|812188|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
246413|NCT01353274|812266|P1|Overall Study|No case report form (CRF) collected|28
246414|NCT01353222|812276|P2|Overall Study|Site closed research department|0
246415|NCT01353222|812277|P1|Overall Study|Site closed research department|1
246416|NCT01353222|812276|P2|Overall Study|Study Terminated|37
246417|NCT01353222|812277|P1|Overall Study|Study Terminated|31
246418|NCT01353222|812276|P2|Overall Study|Withdrawal by Subject|5
246419|NCT01353222|812277|P1|Overall Study|Withdrawal by Subject|8
246420|NCT01353222|812276|P2|Overall Study|Death|30
246421|NCT01353222|812277|P1|Overall Study|Death|30
246422|NCT01352845|812311|P2|Overall Study|Death|0
246423|NCT01352845|812312|P1|Overall Study|Death|3
246424|NCT01352845|812311|P2|Overall Study|Protocol Violation|6
246425|NCT01352845|812312|P1|Overall Study|Protocol Violation|12
246426|NCT01352845|812311|P2|Overall Study|Unspecified|7
246427|NCT01352845|812312|P1|Overall Study|Unspecified|17
246428|NCT01352845|812311|P2|Overall Study|Adverse Event|6
246429|NCT01352845|812312|P1|Overall Study|Adverse Event|22
246430|NCT01352845|812311|P2|Overall Study|Pregnancy|7
246431|NCT01352845|812312|P1|Overall Study|Pregnancy|27
246432|NCT01352845|812311|P2|Overall Study|No Longer Meets Eligibility Criteria|11
246433|NCT01352845|812312|P1|Overall Study|No Longer Meets Eligibility Criteria|24
246434|NCT01352845|812311|P2|Overall Study|Withdrawal by Subject|16
246435|NCT01352845|812312|P1|Overall Study|Withdrawal by Subject|48
246436|NCT01352845|812311|P2|Overall Study|No Longer Willing to Participate|58
246437|NCT01352845|812312|P1|Overall Study|No Longer Willing to Participate|205
246438|NCT01352845|812311|P2|Overall Study|Lost to Follow-up|92
246439|NCT01352845|812312|P1|Overall Study|Lost to Follow-up|313
246440|NCT01352793|812401|P2|Overall Study|No longer meets eligibility criteria|15
246441|NCT01352793|812402|P1|Overall Study|No longer meets eligibility criteria|25
246442|NCT01352793|812401|P2|Overall Study|Randomized but not vaccinated|0
246443|NCT01352793|812402|P1|Overall Study|Randomized but not vaccinated|8
246444|NCT01352793|812401|P2|Overall Study|Death|0
246445|NCT01352793|812402|P1|Overall Study|Death|1
246446|NCT01352793|812401|P2|Overall Study|Medication error|2
246447|NCT01352793|812402|P1|Overall Study|Medication error|2
246448|NCT01352793|812401|P2|Overall Study|Unspecified|7
246449|NCT01352793|812402|P1|Overall Study|Unspecified|25
246450|NCT01352793|812401|P2|Overall Study|Pregnancy|8
246451|NCT01352793|812402|P1|Overall Study|Pregnancy|26
246452|NCT01352793|812401|P2|Overall Study|Physician Decision|0
246453|NCT01352793|812402|P1|Overall Study|Physician Decision|1
246454|NCT01352793|812401|P2|Overall Study|Adverse Event|10
246455|NCT01352793|812402|P1|Overall Study|Adverse Event|44
246456|NCT01352793|812401|P2|Overall Study|Protocol Violation|23
246457|NCT01352793|812402|P1|Overall Study|Protocol Violation|44
246458|NCT01352793|812401|P2|Overall Study|Withdrawal by Subject|55
246459|NCT01352793|812402|P1|Overall Study|Withdrawal by Subject|120
246460|NCT01352793|812401|P2|Overall Study|Lost to Follow-up|125
246461|NCT01352793|812402|P1|Overall Study|Lost to Follow-up|289
246462|NCT01352741|812426|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
246463|NCT01352741|812427|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
246464|NCT01352741|812426|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
246465|NCT01352741|812427|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
246466|NCT01352741|812426|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
246467|NCT01352741|812427|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
246468|NCT01352741|812426|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
246469|NCT01352741|812427|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
246470|NCT01352741|812426|P2|Double-blind Comparative Period|Not Specified|2
246471|NCT01352741|812427|P1|Double-blind Comparative Period|Not Specified|1
246472|NCT01352741|812426|P2|Double-blind Comparative Period|Withdrawal of consent|3
246473|NCT01352741|812427|P1|Double-blind Comparative Period|Withdrawal of consent|8
246474|NCT01352741|812426|P2|Double-blind Comparative Period|Death|1
246475|NCT01352741|812427|P1|Double-blind Comparative Period|Death|0
246476|NCT01352741|812426|P2|Double-blind Comparative Period|Lost to Follow-up|0
246477|NCT01352741|812427|P1|Double-blind Comparative Period|Lost to Follow-up|1
246478|NCT01352741|812426|P2|Double-blind Comparative Period|Adverse Event|17
246479|NCT01352741|812427|P1|Double-blind Comparative Period|Adverse Event|16
246480|NCT01352741|812426|P2|Double-blind Comparative Period|Lack of Efficacy|3
246481|NCT01352741|812427|P1|Double-blind Comparative Period|Lack of Efficacy|0
246482|NCT01352741|812426|P2|Double-blind Comparative Period|Protocol Violation|0
246483|NCT01352741|812427|P1|Double-blind Comparative Period|Protocol Violation|2
246484|NCT01352741|812426|P2|Open-label Tapentadol Titration Period|Not Specified|0
246485|NCT01352741|812427|P1|Open-label Tapentadol Titration Period|Not Specified|4
246571|NCT01350934|812794|P1|Base Study|Non-Compliance With Study Drug|2
246486|NCT01352741|812426|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
246487|NCT01352741|812427|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
246488|NCT01352741|812426|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
246489|NCT01352741|812427|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
246490|NCT01352741|812426|P2|Open-label Tapentadol Titration Period|Adverse Event|0
246491|NCT01352741|812427|P1|Open-label Tapentadol Titration Period|Adverse Event|34
246492|NCT01352741|812426|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
246493|NCT01352741|812427|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
246494|NCT01352741|812426|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
246495|NCT01352741|812427|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
246496|NCT01352715|812521|P2|Overall Study|major ineligibility|1
246497|NCT01352715|812522|P1|Overall Study|major ineligibility|2
246498|NCT01352715|812521|P2|Overall Study|no final visit in closeout period|12
246499|NCT01352715|812522|P1|Overall Study|no final visit in closeout period|15
246500|NCT01352715|812521|P2|Overall Study|site closure|15
246501|NCT01352715|812522|P1|Overall Study|site closure|16
246502|NCT01352715|812521|P2|Overall Study|Withdrawal by Subject|8
246503|NCT01352715|812522|P1|Overall Study|Withdrawal by Subject|4
246504|NCT01352715|812521|P2|Overall Study|Lost to Follow-up|7
246505|NCT01352715|812522|P1|Overall Study|Lost to Follow-up|5
246506|NCT01352715|812521|P2|Overall Study|Death|3
246507|NCT01352715|812522|P1|Overall Study|Death|3
246508|NCT01352585|812544|P1|Overall Study|Not specified|7
246509|NCT01352585|812544|P1|Overall Study|Lost to Follow-up|1
246510|NCT01352585|812544|P1|Overall Study|Adverse Event|3
246511|NCT01352507|812557|P2|Treatment Period 2|Lack of Efficacy|0
246512|NCT01352507|812558|P1|Treatment Period 2|Lack of Efficacy|1
246513|NCT01352507|812557|P2|Treatment Period 2|Withdrawal by Subject|3
246514|NCT01352507|812558|P1|Treatment Period 2|Withdrawal by Subject|4
246515|NCT01352507|812557|P2|Treatment Period 2|Entry Criteria Not Met|0
246516|NCT01352507|812558|P1|Treatment Period 2|Entry Criteria Not Met|1
246517|NCT01352507|812557|P2|Washout Period|Withdrawal by Subject|1
246518|NCT01352507|812558|P1|Washout Period|Withdrawal by Subject|0
246519|NCT01352507|812557|P2|Treatment Period 1|Physician Decision|0
246520|NCT01352507|812558|P1|Treatment Period 1|Physician Decision|1
246521|NCT01352507|812557|P2|Treatment Period 1|Withdrawal by Subject|5
246522|NCT01352507|812558|P1|Treatment Period 1|Withdrawal by Subject|7
246523|NCT01352507|812557|P2|Treatment Period 1|Lost to Follow-up|4
246524|NCT01352507|812558|P1|Treatment Period 1|Lost to Follow-up|3
246525|NCT01352507|812557|P2|Treatment Period 1|Adverse Event|0
246526|NCT01352507|812558|P1|Treatment Period 1|Adverse Event|3
246527|NCT01352416|812598|P4|Overall Study|Physician Decision|1
246528|NCT01352416|812599|P3|Overall Study|Physician Decision|2
246529|NCT01352416|812600|P2|Overall Study|Physician Decision|2
246530|NCT01352416|812601|P1|Overall Study|Physician Decision|1
246531|NCT01351623|812611|P1|Overall Study|Death|2
246532|NCT01351623|812611|P1|Overall Study|Withdrawal by Subject|1
246533|NCT01351623|812611|P1|Overall Study|Adverse Event|4
246534|NCT01351623|812611|P1|Overall Study|Protocol Violation|2
246535|NCT01351025|812676|P2|Week 24 - 44|unable to get to clinic|1
246536|NCT01351025|812677|P1|Week 24 - 44|unable to get to clinic|1
246537|NCT01351025|812676|P2|Week 24 - 44|Site closed|1
246538|NCT01351025|812677|P1|Week 24 - 44|Site closed|0
246539|NCT01351025|812676|P2|Week 24 - 44|Lost to Follow-up|2
246540|NCT01351025|812677|P1|Week 24 - 44|Lost to Follow-up|0
246541|NCT01351025|812676|P2|Week 0 - 20|Withdrawal by Subject|0
246542|NCT01351025|812677|P1|Week 0 - 20|Withdrawal by Subject|1
246543|NCT01351025|812676|P2|Week 0 - 20|Lost to Follow-up|1
246544|NCT01351025|812677|P1|Week 0 - 20|Lost to Follow-up|2
246545|NCT01350999|812710|P3|Overall Study|Difficulty Making it to Study Visit|5
246546|NCT01350999|812711|P2|Overall Study|Difficulty Making it to Study Visit|1
246547|NCT01350999|812712|P1|Overall Study|Difficulty Making it to Study Visit|1
246548|NCT01350999|812710|P3|Overall Study|Voluntary withdrawal|6
246549|NCT01350999|812711|P2|Overall Study|Voluntary withdrawal|4
246550|NCT01350999|812712|P1|Overall Study|Voluntary withdrawal|3
246551|NCT01350999|812710|P3|Overall Study|Adverse Event|10
246552|NCT01350999|812711|P2|Overall Study|Adverse Event|9
246553|NCT01350999|812712|P1|Overall Study|Adverse Event|4
246554|NCT01350973|812750|P3|Overall Study|Voluntary Withdrawal|1
246555|NCT01350973|812751|P2|Overall Study|Voluntary Withdrawal|1
246556|NCT01350973|812752|P1|Overall Study|Voluntary Withdrawal|2
246557|NCT01350973|812750|P3|Overall Study|Adverse Event|7
246558|NCT01350973|812751|P2|Overall Study|Adverse Event|7
246559|NCT01350973|812752|P1|Overall Study|Adverse Event|4
246560|NCT01350934|812793|P2|Extension Study|Withdrawal by Subject|1
246561|NCT01350934|812794|P1|Extension Study|Withdrawal by Subject|0
246562|NCT01350934|812793|P2|Extension Study|Lack of Efficacy|1
246563|NCT01350934|812794|P1|Extension Study|Lack of Efficacy|0
246564|NCT01350934|812793|P2|Extension Study|Protocol Violation|1
246565|NCT01350934|812794|P1|Extension Study|Protocol Violation|1
246566|NCT01350934|812793|P2|Extension Study|Lost to Follow-up|0
246567|NCT01350934|812794|P1|Extension Study|Lost to Follow-up|2
246568|NCT01350934|812793|P2|Extension Study|Adverse Event|1
246569|NCT01350934|812794|P1|Extension Study|Adverse Event|2
246570|NCT01350934|812793|P2|Base Study|Non-Compliance With Study Drug|0
246572|NCT01350934|812793|P2|Base Study|Withdrawal by Subject|2
246573|NCT01350934|812794|P1|Base Study|Withdrawal by Subject|1
246574|NCT01350934|812793|P2|Base Study|Protocol Violation|1
246575|NCT01350934|812794|P1|Base Study|Protocol Violation|1
246576|NCT01350934|812793|P2|Base Study|Lost to Follow-up|0
246577|NCT01350934|812794|P1|Base Study|Lost to Follow-up|1
246578|NCT01350934|812793|P2|Base Study|Adverse Event|0
246579|NCT01350934|812794|P1|Base Study|Adverse Event|6
246580|NCT01350804|812816|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
246581|NCT01350804|812817|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
246582|NCT01350804|812818|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
246583|NCT01350804|812819|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
246584|NCT01350804|812816|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
246585|NCT01350804|812817|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
246586|NCT01350804|812818|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
246587|NCT01350804|812819|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
246588|NCT01350804|812816|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
246589|NCT01350804|812817|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
246590|NCT01350804|812818|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
246591|NCT01350804|812819|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
246592|NCT01350804|812816|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
246593|NCT01350804|812817|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
246594|NCT01350804|812818|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
246595|NCT01350804|812819|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
246596|NCT01350804|812816|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
246597|NCT01350804|812817|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
246598|NCT01350804|812818|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
246599|NCT01350804|812819|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
246600|NCT01350804|812816|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
246601|NCT01350804|812817|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
246602|NCT01350804|812818|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
246603|NCT01350804|812819|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
246604|NCT01350804|812816|P4|Core Study|Adverse Event|8
246605|NCT01350804|812817|P3|Core Study|Adverse Event|8
246606|NCT01350804|812818|P2|Core Study|Adverse Event|10
246607|NCT01350804|812819|P1|Core Study|Adverse Event|8
246608|NCT01350804|812816|P4|Core Study|Death|0
246609|NCT01350804|812817|P3|Core Study|Death|1
246610|NCT01350804|812818|P2|Core Study|Death|1
246611|NCT01350804|812819|P1|Core Study|Death|1
246612|NCT01350804|812816|P4|Core Study|Lack of Efficacy|5
246613|NCT01350804|812817|P3|Core Study|Lack of Efficacy|18
246614|NCT01350804|812818|P2|Core Study|Lack of Efficacy|19
246615|NCT01350804|812819|P1|Core Study|Lack of Efficacy|16
246616|NCT01350804|812816|P4|Core Study|Lost to Follow-up|1
246617|NCT01350804|812817|P3|Core Study|Lost to Follow-up|2
246618|NCT01350804|812818|P2|Core Study|Lost to Follow-up|0
246619|NCT01350804|812819|P1|Core Study|Lost to Follow-up|3
246620|NCT01350804|812816|P4|Core Study|Physician Decision|3
246621|NCT01350804|812817|P3|Core Study|Physician Decision|1
246622|NCT01350804|812818|P2|Core Study|Physician Decision|0
246623|NCT01350804|812819|P1|Core Study|Physician Decision|1
246624|NCT01350804|812816|P4|Core Study|Protocol deviation|0
246625|NCT01350804|812817|P3|Core Study|Protocol deviation|1
246626|NCT01350804|812818|P2|Core Study|Protocol deviation|0
246627|NCT01350804|812819|P1|Core Study|Protocol deviation|1
246628|NCT01350804|812816|P4|Core Study|Study terminated by Sponsor|2
246629|NCT01350804|812817|P3|Core Study|Study terminated by Sponsor|0
246630|NCT01350804|812818|P2|Core Study|Study terminated by Sponsor|0
246631|NCT01350804|812819|P1|Core Study|Study terminated by Sponsor|0
246632|NCT01350804|812816|P4|Core Study|Withdrawal by Subject|7
246633|NCT01350804|812817|P3|Core Study|Withdrawal by Subject|16
246634|NCT01350804|812818|P2|Core Study|Withdrawal by Subject|17
246635|NCT01350804|812819|P1|Core Study|Withdrawal by Subject|11
246636|NCT01350544|812916|P2|Overall Study|Lost to Follow-up|15
246637|NCT01350544|812917|P1|Overall Study|Lost to Follow-up|18
246638|NCT01350544|812916|P2|Overall Study|Incarceration|0
246639|NCT01350544|812917|P1|Overall Study|Incarceration|1
246640|NCT01350544|812916|P2|Overall Study|Withdrawal by Subject|1
246641|NCT01350544|812917|P1|Overall Study|Withdrawal by Subject|0
246642|NCT01350544|812916|P2|Overall Study|Medical Issues|1
246643|NCT01350544|812917|P1|Overall Study|Medical Issues|1
246644|NCT01350544|812916|P2|Overall Study|Moved out of LA County|2
246645|NCT01350544|812917|P1|Overall Study|Moved out of LA County|2
246646|NCT01350544|812916|P2|Overall Study|Death|2
246647|NCT01350544|812917|P1|Overall Study|Death|1
246648|NCT01350544|812916|P2|Overall Study|Administrative Withdrawal|1
246649|NCT01350544|812917|P1|Overall Study|Administrative Withdrawal|0
246650|NCT01350414|812932|P1|Overall Study|Physician Decision|2
246651|NCT01350414|812932|P1|Overall Study|Withdrawal by Subject|4
246652|NCT01350414|812932|P1|Overall Study|Lost to Follow-up|13
246653|NCT01350271|812971|P3|Overall Study|Lost to Follow-up|26
246654|NCT01350271|812972|P2|Overall Study|Lost to Follow-up|17
246655|NCT01350271|812973|P1|Overall Study|Lost to Follow-up|21
246656|NCT01350128|813012|P1|Overall Study|Lost to Follow-up|2
246657|NCT01350128|813012|P1|Overall Study|Physician Decision|1
246658|NCT01350128|813012|P1|Overall Study|Protocol discontinuation criteria|8
246659|NCT01350128|813012|P1|Overall Study|Withdrawal by Subject|3
246660|NCT01350115|813076|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
246661|NCT01350115|813077|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
246662|NCT01350115|813076|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
246663|NCT01350115|813077|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
246664|NCT01350115|813076|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
246665|NCT01350115|813077|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
246666|NCT01349959|813108|P1|Overall Study|Patients are followed for survival|7
246667|NCT01349907|813139|P2|Overall Study|Administrative|1
246668|NCT01349907|813140|P1|Overall Study|Administrative|1
246669|NCT01349907|813139|P2|Overall Study|Protocol Violation|13
246670|NCT01349907|813140|P1|Overall Study|Protocol Violation|33
246671|NCT01349907|813139|P2|Overall Study|Withdrawal by Subject|8
246672|NCT01349907|813140|P1|Overall Study|Withdrawal by Subject|30
246673|NCT01349907|813139|P2|Overall Study|Lost to Follow-up|6
246674|NCT01349907|813140|P1|Overall Study|Lost to Follow-up|25
246675|NCT01349907|813139|P2|Overall Study|Treatment failure|4
246676|NCT01349907|813140|P1|Overall Study|Treatment failure|13
246677|NCT01349907|813139|P2|Overall Study|Adverse Event|11
246678|NCT01349907|813140|P1|Overall Study|Adverse Event|37
246679|NCT01349829|813178|P2|Overall Study|Migrated/moved|7
246680|NCT01349829|813179|P1|Overall Study|Migrated/moved|2
246681|NCT01349829|813178|P2|Overall Study|Consent withdrawal|8
246682|NCT01349829|813179|P1|Overall Study|Consent withdrawal|3
246683|NCT01349829|813178|P2|Overall Study|Lost to Follow-up|8
246684|NCT01349829|813179|P1|Overall Study|Lost to Follow-up|4
246685|NCT01349816|813197|P1|Overall Study|Protocol-specified criteria|8
246686|NCT01349816|813197|P1|Overall Study|Protocol Violation|1
246687|NCT01349816|813197|P1|Overall Study|Lost to Follow-up|2
246688|NCT01349816|813197|P1|Overall Study|Adverse Event|14
246689|NCT01349816|813197|P1|Overall Study|Physician Decision|1
246690|NCT01349816|813197|P1|Overall Study|Withdrawal by Subject|4
246691|NCT01349803|813263|P4|Overall Study|Protocol-specified criteria|0
246692|NCT01349803|813264|P3|Overall Study|Protocol-specified criteria|3
246693|NCT01349803|813265|P2|Overall Study|Protocol-specified criteria|1
246694|NCT01349803|813266|P1|Overall Study|Protocol-specified criteria|0
246695|NCT01349803|813263|P4|Overall Study|Withdrawal by Subject|0
246696|NCT01349803|813264|P3|Overall Study|Withdrawal by Subject|0
246697|NCT01349803|813265|P2|Overall Study|Withdrawal by Subject|0
246698|NCT01349803|813266|P1|Overall Study|Withdrawal by Subject|1
246699|NCT01349803|813263|P4|Overall Study|Adverse Event|2
246700|NCT01349803|813264|P3|Overall Study|Adverse Event|0
246701|NCT01349803|813265|P2|Overall Study|Adverse Event|0
246702|NCT01349803|813266|P1|Overall Study|Adverse Event|0
246703|NCT01349790|813336|P1|Overall Study|Lost to Follow-up|1
246704|NCT01349790|813336|P1|Overall Study|Adverse Event|1
246705|NCT01349790|813336|P1|Overall Study|Withdrawal by Patient|2
246706|NCT01349790|813336|P1|Overall Study|Death|2
246707|NCT01349790|813336|P1|Overall Study|Investigator Judgement|3
246708|NCT01349595|813357|P2|Overall Study|Lack of funding|2
246709|NCT01349595|813358|P1|Overall Study|Lack of funding|2
246710|NCT01349465|813375|P2|Overall Study|Subject Ineligible To Continue The Trial|19
246711|NCT01349465|813376|P1|Overall Study|Subject Ineligible To Continue The Trial|0
246712|NCT01349465|813375|P2|Overall Study|Withdrawal by Subject|2
246713|NCT01349465|813376|P1|Overall Study|Withdrawal by Subject|4
246714|NCT01349465|813375|P2|Overall Study|Lost to Follow-up|1
246715|NCT01349465|813376|P1|Overall Study|Lost to Follow-up|10
246716|NCT01349465|813375|P2|Overall Study|Death|0
246717|NCT01349465|813376|P1|Overall Study|Death|3
246718|NCT01349465|813375|P2|Overall Study|Adverse Event|0
246719|NCT01349465|813376|P1|Overall Study|Adverse Event|1
246720|NCT01349192|813397|P2|Overall Study|Failure to adhere to Protocol|0
246721|NCT01349192|813398|P1|Overall Study|Failure to adhere to Protocol|2
246722|NCT01349192|813397|P2|Overall Study|Lost to Follow-up|3
246723|NCT01349192|813398|P1|Overall Study|Lost to Follow-up|1
246724|NCT01349192|813397|P2|Overall Study|Withdrawal by Subject|2
246725|NCT01349192|813398|P1|Overall Study|Withdrawal by Subject|0
246726|NCT01349192|813397|P2|Overall Study|Protocol Violation|1
246727|NCT01349192|813398|P1|Overall Study|Protocol Violation|0
246728|NCT01348854|813423|P2|Overall Study|Withdrawal by Subject|0
246729|NCT01348854|813424|P1|Overall Study|Withdrawal by Subject|1
246730|NCT01348854|813423|P2|Overall Study|Lost to Follow-up|1
246731|NCT01348854|813424|P1|Overall Study|Lost to Follow-up|2
246732|NCT01348789|813432|P1|Overall Study|Withdrawal by Subject|2
246733|NCT01348789|813432|P1|Overall Study|Protocol Violation|2
246734|NCT01348776|813443|P1|Overall Study|Lost to Follow-up|3
246735|NCT01348425|813474|P2|Overall Study|Imaging was not taken.|1
246736|NCT01348425|813475|P1|Overall Study|Imaging was not taken.|1
246737|NCT01348165|813487|P7|Overall Study|Adverse Event|1
246738|NCT01348165|813488|P6|Overall Study|Adverse Event|0
246739|NCT01348165|813489|P5|Overall Study|Adverse Event|0
246740|NCT01348165|813490|P4|Overall Study|Adverse Event|0
246741|NCT01348165|813491|P3|Overall Study|Adverse Event|0
246742|NCT01348165|813492|P2|Overall Study|Adverse Event|0
246743|NCT01348165|813493|P1|Overall Study|Adverse Event|0
246744|NCT01348139|813622|P6|Period 1|Adverse Event|0
246745|NCT01348139|813623|P5|Period 1|Adverse Event|0
246746|NCT01348139|813624|P4|Period 1|Adverse Event|0
246747|NCT01348139|813625|P3|Period 1|Adverse Event|0
246748|NCT01348139|813626|P2|Period 1|Adverse Event|0
246749|NCT01348139|813627|P1|Period 1|Adverse Event|1
246750|NCT01348100|813708|P7|Overall Study|Administrative Problems|1
246751|NCT01348100|813709|P6|Overall Study|Administrative Problems|1
246752|NCT01348100|813710|P5|Overall Study|Administrative Problems|0
246753|NCT01348100|813711|P4|Overall Study|Administrative Problems|0
246754|NCT01348100|813712|P3|Overall Study|Administrative Problems|0
246755|NCT01348100|813713|P2|Overall Study|Administrative Problems|0
246756|NCT01348100|813714|P1|Overall Study|Administrative Problems|0
246757|NCT01348100|813708|P7|Overall Study|Lost to Follow-up|1
246758|NCT01348100|813709|P6|Overall Study|Lost to Follow-up|0
246759|NCT01348100|813710|P5|Overall Study|Lost to Follow-up|0
246760|NCT01348100|813711|P4|Overall Study|Lost to Follow-up|0
246761|NCT01348100|813712|P3|Overall Study|Lost to Follow-up|0
246762|NCT01348100|813713|P2|Overall Study|Lost to Follow-up|0
246763|NCT01348100|813714|P1|Overall Study|Lost to Follow-up|0
246764|NCT01348100|813708|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
246765|NCT01348100|813709|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
246766|NCT01348100|813710|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
246767|NCT01348100|813711|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
246768|NCT01348100|813712|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
246769|NCT01348100|813713|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
246770|NCT01348100|813714|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
246771|NCT01348100|813708|P7|Overall Study|Protocol Deviation|0
246772|NCT01348100|813709|P6|Overall Study|Protocol Deviation|0
246773|NCT01348100|813710|P5|Overall Study|Protocol Deviation|0
246774|NCT01348100|813711|P4|Overall Study|Protocol Deviation|1
246775|NCT01348100|813712|P3|Overall Study|Protocol Deviation|0
246776|NCT01348100|813713|P2|Overall Study|Protocol Deviation|0
246777|NCT01348100|813714|P1|Overall Study|Protocol Deviation|0
246778|NCT01348100|813708|P7|Overall Study|Subject Withdrew Consent|1
246779|NCT01348100|813709|P6|Overall Study|Subject Withdrew Consent|0
246780|NCT01348100|813710|P5|Overall Study|Subject Withdrew Consent|1
246781|NCT01348100|813711|P4|Overall Study|Subject Withdrew Consent|0
246782|NCT01348100|813712|P3|Overall Study|Subject Withdrew Consent|2
246783|NCT01348100|813713|P2|Overall Study|Subject Withdrew Consent|0
246784|NCT01348100|813714|P1|Overall Study|Subject Withdrew Consent|0
246785|NCT01348087|813759|P1|Overall Study|Adverse Event|25
246786|NCT01348087|813759|P1|Overall Study|Subject withdrew consent|7
246787|NCT01348087|813759|P1|Overall Study|Lost to Follow-up|1
246788|NCT01348087|813759|P1|Overall Study|protocol deviation|1
246789|NCT01348087|813759|P1|Overall Study|Administrative problems|79
246790|NCT01348087|813759|P1|Overall Study|Unsatisfactory therapeutic effect|35
246791|NCT01347931|813773|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
246792|NCT01347879|813785|P2|Overall Study|Not known|3
246793|NCT01347879|813786|P1|Overall Study|Not known|2
246794|NCT01347879|813785|P2|Overall Study|Withdrawal by Subject|2
246795|NCT01347879|813786|P1|Overall Study|Withdrawal by Subject|3
246796|NCT01347879|813785|P2|Overall Study|Lost to Follow-up|0
246797|NCT01347879|813786|P1|Overall Study|Lost to Follow-up|2
246798|NCT01347879|813785|P2|Overall Study|Adverse Event|12
246799|NCT01347879|813786|P1|Overall Study|Adverse Event|0
246800|NCT01347840|813818|P1|Overall Study|Withdrawal by Subject|1
246801|NCT01347710|813841|P1|Overall Study|Other|3
246802|NCT01347710|813841|P1|Overall Study|Physician Decision|2
246803|NCT01347710|813841|P1|Overall Study|Lost to Follow-up|1
246804|NCT01347710|813841|P1|Overall Study|issue with vitals prior to dosing|1
246805|NCT01347710|813841|P1|Overall Study|Angio or SPECT not completed|18
246806|NCT01347710|813841|P1|Overall Study|Adverse Event|4
246807|NCT01347710|813841|P1|Overall Study|Withdrawal by Subject|2
246808|NCT01347580|813862|P2|Overall Study|Had other reason|6
246809|NCT01347580|813863|P1|Overall Study|Had other reason|9
246810|NCT01347580|813862|P2|Overall Study|Lost to Follow-up|1
246811|NCT01347580|813863|P1|Overall Study|Lost to Follow-up|3
246812|NCT01347580|813862|P2|Overall Study|Protocol Violation|7
246813|NCT01347580|813863|P1|Overall Study|Protocol Violation|10
246814|NCT01347580|813862|P2|Overall Study|Death|19
246815|NCT01347580|813863|P1|Overall Study|Death|30
246816|NCT01347580|813862|P2|Overall Study|Withdrawal by Subject|23
246817|NCT01347580|813863|P1|Overall Study|Withdrawal by Subject|13
246818|NCT01347554|813893|P2|Overall Study|Lack of Efficacy|11
246819|NCT01347554|813894|P1|Overall Study|Lack of Efficacy|7
246820|NCT01347112|813931|P2|Overall Study|Lost to Follow-up|5
246821|NCT01347112|813932|P1|Overall Study|Lost to Follow-up|3
246822|NCT01347112|813931|P2|Overall Study|Withdrawal by Subject|7
246823|NCT01347112|813932|P1|Overall Study|Withdrawal by Subject|1
246824|NCT01347086|813952|P10|Overall Study|failed screening visit|1
246825|NCT01347086|813953|P9|Overall Study|failed screening visit|0
246826|NCT01347086|813954|P8|Overall Study|failed screening visit|1
246827|NCT01347086|813955|P7|Overall Study|failed screening visit|1
246828|NCT01347086|813956|P6|Overall Study|failed screening visit|0
246829|NCT01347086|813957|P5|Overall Study|failed screening visit|0
246830|NCT01347086|813958|P4|Overall Study|failed screening visit|0
246831|NCT01347086|813959|P3|Overall Study|failed screening visit|1
246832|NCT01347086|813960|P2|Overall Study|failed screening visit|0
246833|NCT01347086|813961|P1|Overall Study|failed screening visit|0
246834|NCT01347073|814060|P1|Overall Study|Liver Transplant|1
246835|NCT01347073|814060|P1|Overall Study|Adverse Event|1
246836|NCT01346774|814139|P2|Overall Study|Adverse Event|2
246837|NCT01346774|814140|P1|Overall Study|Adverse Event|1
246838|NCT01346774|814139|P2|Overall Study|Protocol Violation|3
246839|NCT01346774|814140|P1|Overall Study|Protocol Violation|2
246840|NCT01346774|814139|P2|Overall Study|Withdrawal by Subject|4
246841|NCT01346774|814140|P1|Overall Study|Withdrawal by Subject|1
246842|NCT01346774|814139|P2|Overall Study|Lost to Follow-up|4
246843|NCT01346774|814140|P1|Overall Study|Lost to Follow-up|3
246844|NCT01346774|814139|P2|Overall Study|Did not take a single dose|4
246845|NCT01346774|814140|P1|Overall Study|Did not take a single dose|6
246846|NCT01346592|814149|P3|Overall Study|Unable to Classify|6
246847|NCT01346592|814150|P2|Overall Study|Unable to Classify|3
246848|NCT01346592|814151|P1|Overall Study|Unable to Classify|7
246849|NCT01346592|814149|P3|Overall Study|Administrative reason|0
246850|NCT01346592|814150|P2|Overall Study|Administrative reason|0
246851|NCT01346592|814151|P1|Overall Study|Administrative reason|1
246852|NCT01346592|814149|P3|Overall Study|Inappropriate enrollment|1
246853|NCT01346592|814150|P2|Overall Study|Inappropriate enrollment|1
246854|NCT01346592|814151|P1|Overall Study|Inappropriate enrollment|3
246855|NCT01346592|814149|P3|Overall Study|Withdrawal by Subject|38
246856|NCT01346592|814150|P2|Overall Study|Withdrawal by Subject|51
246857|NCT01346592|814151|P1|Overall Study|Withdrawal by Subject|77
246858|NCT01346592|814149|P3|Overall Study|Adverse Event|0
246859|NCT01346592|814150|P2|Overall Study|Adverse Event|1
246860|NCT01346592|814151|P1|Overall Study|Adverse Event|0
246861|NCT01346592|814149|P3|Overall Study|Death|4
246862|NCT01346592|814150|P2|Overall Study|Death|3
246863|NCT01346592|814151|P1|Overall Study|Death|1
246864|NCT01346592|814149|P3|Overall Study|Protocol Violation|0
246865|NCT01346592|814150|P2|Overall Study|Protocol Violation|1
246866|NCT01346592|814151|P1|Overall Study|Protocol Violation|2
246867|NCT01346592|814149|P3|Overall Study|Lost to Follow-up|29
246868|NCT01346592|814150|P2|Overall Study|Lost to Follow-up|29
246869|NCT01346592|814151|P1|Overall Study|Lost to Follow-up|62
246870|NCT01346514|814243|P2|Overall Study|Death|4
246871|NCT01346514|814244|P1|Overall Study|Death|3
246872|NCT01346514|814243|P2|Overall Study|Withdrawal by Subject|3
246873|NCT01346514|814244|P1|Overall Study|Withdrawal by Subject|7
246874|NCT01346514|814243|P2|Overall Study|Lost to Follow-up|30
246875|NCT01346514|814244|P1|Overall Study|Lost to Follow-up|19
246876|NCT01346501|814264|P2|Overall Study|Not Specified|12
246877|NCT01346501|814265|P1|Overall Study|Not Specified|8
246878|NCT01346501|814264|P2|Overall Study|Initiated Other Biological Agents|1
246879|NCT01346501|814265|P1|Overall Study|Initiated Other Biological Agents|3
246880|NCT01346475|814298|P2|First Intervention|Lost to Follow-up|3
246881|NCT01346475|814299|P1|First Intervention|Lost to Follow-up|4
246882|NCT01346293|814324|P2|Overall Study|Other|0
246883|NCT01346293|814325|P1|Overall Study|Other|1
246884|NCT01346293|814324|P2|Overall Study|Withdrawal by Subject|4
246885|NCT01346293|814325|P1|Overall Study|Withdrawal by Subject|15
246886|NCT01346293|814324|P2|Overall Study|Lost to Follow-up|8
246887|NCT01346293|814325|P1|Overall Study|Lost to Follow-up|21
246888|NCT01346293|814324|P2|Overall Study|Protocol Violation|9
246889|NCT01346293|814325|P1|Overall Study|Protocol Violation|30
246890|NCT01346176|814354|P3|Completed Satisfaction Survey|Lost to Follow-up|4
246891|NCT01346176|814355|P2|Completed Satisfaction Survey|Lost to Follow-up|4
246892|NCT01346176|814356|P1|Completed Satisfaction Survey|Lost to Follow-up|3
246893|NCT01346176|814354|P3|Completed Satisfaction Survey|Death|2
246894|NCT01346176|814355|P2|Completed Satisfaction Survey|Death|0
246895|NCT01346176|814356|P1|Completed Satisfaction Survey|Death|3
246896|NCT01346176|814354|P3|Completed Advance Directive|Other reason did not complete AD|7
246897|NCT01346176|814355|P2|Completed Advance Directive|Other reason did not complete AD|12
246898|NCT01346176|814356|P1|Completed Advance Directive|Other reason did not complete AD|7
246899|NCT01346176|814354|P3|Completed Advance Directive|Became Ineligible|1
246900|NCT01346176|814355|P2|Completed Advance Directive|Became Ineligible|0
246901|NCT01346176|814356|P1|Completed Advance Directive|Became Ineligible|3
246902|NCT01346176|814354|P3|Completed Advance Directive|Death|2
246903|NCT01346176|814355|P2|Completed Advance Directive|Death|2
246904|NCT01346176|814356|P1|Completed Advance Directive|Death|3
246905|NCT01346176|814354|P3|Recruited|Protocol Violation|0
246906|NCT01346176|814355|P2|Recruited|Protocol Violation|0
246907|NCT01346176|814356|P1|Recruited|Protocol Violation|1
246908|NCT01346059|814385|P2|Overall Study|Withdrawal by Subject|0
246909|NCT01346059|814386|P1|Overall Study|Withdrawal by Subject|1
246910|NCT01345929|814398|P2|Overall Study|Patient withdrawal|1
246911|NCT01345929|814399|P1|Overall Study|Patient withdrawal|0
246912|NCT01345929|814398|P2|Overall Study|40,000 CFU/ML|0
246913|NCT01345929|814399|P1|Overall Study|40,000 CFU/ML|1
246914|NCT01345929|814398|P2|Overall Study|Didn't meet eligibility criteria|0
246915|NCT01345929|814399|P1|Overall Study|Didn't meet eligibility criteria|2
246916|NCT01345929|814398|P2|Overall Study|Adverse Event|1
246917|NCT01345929|814399|P1|Overall Study|Adverse Event|0
246918|NCT01345929|814398|P2|Overall Study|Lost to Follow-up|9
246919|NCT01345929|814399|P1|Overall Study|Lost to Follow-up|9
246920|NCT01345929|814398|P2|Overall Study|Withdrawal by Subject|8
246921|NCT01345929|814399|P1|Overall Study|Withdrawal by Subject|9
246922|NCT01345786|814411|P4|Overall Study|Lost to Follow-up|2
246923|NCT01345786|814412|P3|Overall Study|Lost to Follow-up|0
246924|NCT01345786|814413|P2|Overall Study|Lost to Follow-up|0
246925|NCT01345786|814414|P1|Overall Study|Lost to Follow-up|0
246926|NCT01345786|814411|P4|Overall Study|Administrative|0
246927|NCT01345786|814412|P3|Overall Study|Administrative|0
246928|NCT01345786|814413|P2|Overall Study|Administrative|5
246929|NCT01345786|814414|P1|Overall Study|Administrative|3
246930|NCT01345786|814411|P4|Overall Study|Noncompliance with protocol|0
246931|NCT01345786|814412|P3|Overall Study|Noncompliance with protocol|1
246932|NCT01345786|814413|P2|Overall Study|Noncompliance with protocol|0
246933|NCT01345786|814414|P1|Overall Study|Noncompliance with protocol|1
246934|NCT01345786|814411|P4|Overall Study|Subject withdrew consent|0
246935|NCT01345786|814412|P3|Overall Study|Subject withdrew consent|1
246936|NCT01345786|814413|P2|Overall Study|Subject withdrew consent|2
246937|NCT01345786|814414|P1|Overall Study|Subject withdrew consent|2
246938|NCT01345786|814411|P4|Overall Study|Adverse Event|1
246939|NCT01345786|814412|P3|Overall Study|Adverse Event|3
246940|NCT01345786|814413|P2|Overall Study|Adverse Event|1
246941|NCT01345786|814414|P1|Overall Study|Adverse Event|0
246942|NCT01345682|814494|P2|Overall Study|Reason other than those specified above|2
246943|NCT01345682|814495|P1|Overall Study|Reason other than those specified above|3
246944|NCT01345682|814494|P2|Overall Study|Not treated|1
246945|NCT01345682|814495|P1|Overall Study|Not treated|2
246946|NCT01345682|814494|P2|Overall Study|Refused to continue trial medication|9
246947|NCT01345682|814495|P1|Overall Study|Refused to continue trial medication|16
246948|NCT01345682|814494|P2|Overall Study|Lost to Follow-up|1
246949|NCT01345682|814495|P1|Overall Study|Lost to Follow-up|0
246950|NCT01345682|814494|P2|Overall Study|Non-compliance with protocol|1
246951|NCT01345682|814495|P1|Overall Study|Non-compliance with protocol|0
246952|NCT01345682|814494|P2|Overall Study|Adverse Event|41
246953|NCT01345682|814495|P1|Overall Study|Adverse Event|49
246954|NCT01345682|814494|P2|Overall Study|Worsening of underlying cancer disease|13
246955|NCT01345682|814495|P1|Overall Study|Worsening of underlying cancer disease|21
246956|NCT01345682|814494|P2|Overall Study|Progressive disease per RECIST|89
246957|NCT01345682|814495|P1|Overall Study|Progressive disease per RECIST|215
246958|NCT01345630|814529|P2|Overall Study|Insufficient clinical response|11
246959|NCT01345630|814530|P1|Overall Study|Insufficient clinical response|48
246960|NCT01345630|814529|P2|Overall Study|No longer willing to participate|12
246961|NCT01345630|814530|P1|Overall Study|No longer willing to participate|9
246962|NCT01345630|814529|P2|Overall Study|Withdrawn due to pregnancy|2
246963|NCT01345630|814530|P1|Overall Study|Withdrawn due to pregnancy|1
246964|NCT01345630|814529|P2|Overall Study|Other reasons|8
246965|NCT01345630|814530|P1|Overall Study|Other reasons|6
246966|NCT01345630|814529|P2|Overall Study|Study terminated by sponsor|285
246967|NCT01345630|814530|P1|Overall Study|Study terminated by sponsor|254
246968|NCT01345630|814529|P2|Overall Study|Medication error without associated AE|1
246969|NCT01345630|814530|P1|Overall Study|Medication error without associated AE|0
246970|NCT01345630|814529|P2|Overall Study|Protocol Violation|1
246971|NCT01345630|814530|P1|Overall Study|Protocol Violation|4
246972|NCT01345630|814529|P2|Overall Study|Lost to Follow-up|16
246973|NCT01345630|814530|P1|Overall Study|Lost to Follow-up|17
246974|NCT01345630|814529|P2|Overall Study|Adverse Event|23
246975|NCT01345630|814530|P1|Overall Study|Adverse Event|22
246976|NCT01345591|814586|P1|Overall Study|Lost to Follow-up|1
246977|NCT01345318|814595|P1|Overall Study|Unspecified|3
246978|NCT01345318|814595|P1|Overall Study|Withdrawal by Subject|41
246979|NCT01345318|814595|P1|Overall Study|Protocol Violation|1
246980|NCT01345318|814595|P1|Overall Study|Lost to Follow-up|2
246981|NCT01345318|814595|P1|Overall Study|Lack of Efficacy|17
246982|NCT01345318|814595|P1|Overall Study|Adverse Event|16
246983|NCT01345292|814603|P3|Overall Study|Withdrawal by Subject|1
246984|NCT01345292|814604|P2|Overall Study|Withdrawal by Subject|0
246985|NCT01345292|814605|P1|Overall Study|Withdrawal by Subject|2
246986|NCT01345253|814636|P2|Overall Study|Withdrawal by Subject|19
246987|NCT01345253|814637|P1|Overall Study|Withdrawal by Subject|9
246988|NCT01345253|814636|P2|Overall Study|Physician Decision|12
246989|NCT01345253|814637|P1|Overall Study|Physician Decision|4
246990|NCT01345253|814636|P2|Overall Study|Lost to Follow-up|8
246991|NCT01345253|814637|P1|Overall Study|Lost to Follow-up|3
246992|NCT01345253|814636|P2|Overall Study|Met Protocol Defined Stopping Criteria|1
246993|NCT01345253|814637|P1|Overall Study|Met Protocol Defined Stopping Criteria|6
246994|NCT01345253|814636|P2|Overall Study|Protocol Violation|5
246995|NCT01345253|814637|P1|Overall Study|Protocol Violation|1
246996|NCT01345253|814636|P2|Overall Study|Lack of Efficacy|7
246997|NCT01345253|814637|P1|Overall Study|Lack of Efficacy|11
246998|NCT01345253|814636|P2|Overall Study|Adverse Event|27
246999|NCT01345253|814637|P1|Overall Study|Adverse Event|22
247000|NCT01345240|814656|P5|Overall Study|Serious Adverse Event|1
247001|NCT01345240|814657|P4|Overall Study|Serious Adverse Event|2
247002|NCT01345240|814658|P3|Overall Study|Serious Adverse Event|2
247003|NCT01345240|814659|P2|Overall Study|Serious Adverse Event|2
247004|NCT01345240|814660|P1|Overall Study|Serious Adverse Event|1
247005|NCT01345240|814656|P5|Overall Study|Lost to Follow-up|6
247006|NCT01345240|814657|P4|Overall Study|Lost to Follow-up|8
247007|NCT01345240|814658|P3|Overall Study|Lost to Follow-up|8
247008|NCT01345240|814659|P2|Overall Study|Lost to Follow-up|12
247009|NCT01345240|814660|P1|Overall Study|Lost to Follow-up|1
247010|NCT01345162|814755|P2|Overall Study|Protocol Violation|4
247011|NCT01345162|814756|P1|Overall Study|Protocol Violation|2
247012|NCT01345123|814765|P3|Overall Study|participants no longer with health plan|88
247013|NCT01345123|814766|P2|Overall Study|participants no longer with health plan|85
247014|NCT01345123|814767|P1|Overall Study|participants no longer with health plan|79
247015|NCT01345058|814789|P2|Overall Study|Participant No-Show at Multiple Visits|0
247016|NCT01345058|814790|P1|Overall Study|Participant No-Show at Multiple Visits|1
247017|NCT01345058|814789|P2|Overall Study|Participant Stopped Taking Study Drug|0
247018|NCT01345058|814790|P1|Overall Study|Participant Stopped Taking Study Drug|1
247019|NCT01345058|814789|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
247020|NCT01345058|814790|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
247021|NCT01345058|814789|P2|Overall Study|Participant Reported Increase in Events|0
247022|NCT01345058|814790|P1|Overall Study|Participant Reported Increase in Events|1
247023|NCT01345058|814789|P2|Overall Study|Withdrawal by Subject|0
247024|NCT01345058|814790|P1|Overall Study|Withdrawal by Subject|1
247025|NCT01344876|814804|P5|Overall Study|Definite progression of primary disease|0
247026|NCT01344876|814805|P4|Overall Study|Definite progression of primary disease|3
247027|NCT01344876|814806|P3|Overall Study|Definite progression of primary disease|0
247028|NCT01344876|814807|P2|Overall Study|Definite progression of primary disease|0
247029|NCT01344876|814808|P1|Overall Study|Definite progression of primary disease|1
247030|NCT01344876|814804|P5|Overall Study|Withdrawal by Subject|0
247031|NCT01344876|814805|P4|Overall Study|Withdrawal by Subject|0
247032|NCT01344876|814806|P3|Overall Study|Withdrawal by Subject|1
247033|NCT01344876|814807|P2|Overall Study|Withdrawal by Subject|0
247034|NCT01344876|814808|P1|Overall Study|Withdrawal by Subject|0
247035|NCT01344876|814804|P5|Overall Study|Adverse Event|1
247036|NCT01344876|814805|P4|Overall Study|Adverse Event|0
247037|NCT01344876|814806|P3|Overall Study|Adverse Event|0
247038|NCT01344876|814807|P2|Overall Study|Adverse Event|0
247039|NCT01344876|814808|P1|Overall Study|Adverse Event|0
247040|NCT01344759|814824|P2|Overall Study|Patients failed to reach sedation level|2
247041|NCT01344759|814825|P1|Overall Study|Patients failed to reach sedation level|0
247042|NCT01344629|814857|P2|Crossover Period 2|Withdrawal by Subject|1
247043|NCT01344629|814858|P1|Crossover Period 2|Withdrawal by Subject|0
247044|NCT01344538|814887|P2|Overall Study|Lost to Follow-up|0
247045|NCT01344538|814888|P1|Overall Study|Lost to Follow-up|1
247046|NCT01344538|814887|P2|Overall Study|Adverse Event|1
247047|NCT01344538|814888|P1|Overall Study|Adverse Event|1
247048|NCT01344460|814894|P1|Overall Study|Lost to Follow-up|2
247049|NCT01344460|814894|P1|Overall Study|Withdrawal by Subject|1
247050|NCT01344447|814939|P1|Overall Study|Error of power injector|1
247051|NCT01344447|814939|P1|Overall Study|Bolus tracking failed|1
247052|NCT01344447|814939|P1|Overall Study|MRA unsuccessful|1
247053|NCT01344447|814939|P1|Overall Study|Physician Decision|1
247054|NCT01344447|814939|P1|Overall Study|The contrast was not seen|1
247055|NCT01344447|814939|P1|Overall Study|Withdrawal by Subject|1
247056|NCT01344447|814939|P1|Overall Study|Protocol Violation|1
247057|NCT01344447|814939|P1|Overall Study|Adverse Event|1
247058|NCT01344369|814983|P2|Second Intervention|Emesis within 2 x Tmax|1
247059|NCT01344369|814984|P1|Second Intervention|Emesis within 2 x Tmax|0
247060|NCT01344369|814983|P2|Washout of 28 Days|Physician Decision|1
247061|NCT01344369|814984|P1|Washout of 28 Days|Physician Decision|0
247062|NCT01344369|814983|P2|Washout of 28 Days|Withdrawal by Subject|0
247063|NCT01344369|814984|P1|Washout of 28 Days|Withdrawal by Subject|1
247064|NCT01344161|815002|P2|Overall Study|Protocol Violation|1
247065|NCT01344161|815003|P1|Overall Study|Protocol Violation|1
247066|NCT01344161|815002|P2|Overall Study|Pregnancy|1
247067|NCT01344161|815003|P1|Overall Study|Pregnancy|0
247068|NCT01344161|815002|P2|Overall Study|Lost to Follow-up|1
247069|NCT01344161|815003|P1|Overall Study|Lost to Follow-up|4
247070|NCT01344057|815015|P1|Overall Study|Premature Withdrawal|1
247071|NCT01343901|815022|P1|Overall Study|Participant decision|1
247072|NCT01343901|815022|P1|Overall Study|Management by another medical team|11
247073|NCT01343901|815022|P1|Overall Study|Lost to Follow-up|12
247074|NCT01343901|815022|P1|Overall Study|Physician Decision|4
247075|NCT01343901|815022|P1|Overall Study|Death|85
247076|NCT01343888|815046|P3|Overall Study|other than stated above|1
247077|NCT01343888|815047|P2|Overall Study|other than stated above|0
247078|NCT01343888|815048|P1|Overall Study|other than stated above|0
247079|NCT01343888|815046|P3|Overall Study|Withdrawal by Subject|2
247080|NCT01343888|815047|P2|Overall Study|Withdrawal by Subject|4
247081|NCT01343888|815048|P1|Overall Study|Withdrawal by Subject|4
247082|NCT01343888|815046|P3|Overall Study|Protocol Violation|0
247083|NCT01343888|815047|P2|Overall Study|Protocol Violation|2
247084|NCT01343888|815048|P1|Overall Study|Protocol Violation|0
247085|NCT01343888|815046|P3|Overall Study|Lost to Follow-up|1
247086|NCT01343888|815047|P2|Overall Study|Lost to Follow-up|2
247087|NCT01343888|815048|P1|Overall Study|Lost to Follow-up|0
247088|NCT01343888|815046|P3|Overall Study|Lack of Efficacy|13
247089|NCT01343888|815047|P2|Overall Study|Lack of Efficacy|9
247090|NCT01343888|815048|P1|Overall Study|Lack of Efficacy|9
247091|NCT01343888|815046|P3|Overall Study|Adverse Event|5
247092|NCT01343888|815047|P2|Overall Study|Adverse Event|22
247093|NCT01343888|815048|P1|Overall Study|Adverse Event|12
247094|NCT01343823|815108|P4|Overall Study|Withdrawal by Subject|0
247095|NCT01343823|815109|P3|Overall Study|Withdrawal by Subject|0
247096|NCT01343823|815110|P2|Overall Study|Withdrawal by Subject|0
247097|NCT01343823|815111|P1|Overall Study|Withdrawal by Subject|1
247098|NCT01343823|815108|P4|Overall Study|Study Terminated|1
247099|NCT01343823|815109|P3|Overall Study|Study Terminated|0
247100|NCT01343823|815110|P2|Overall Study|Study Terminated|0
247101|NCT01343823|815111|P1|Overall Study|Study Terminated|1
247102|NCT01343277|815145|P2|Overall Study|Subsequent anticancer therapy|0
247103|NCT01343277|815146|P1|Overall Study|Subsequent anticancer therapy|1
247104|NCT01343277|815145|P2|Overall Study|Treatment ongoing|2
247105|NCT01343277|815146|P1|Overall Study|Treatment ongoing|8
247106|NCT01343277|815145|P2|Overall Study|Randomized not treated|21
247107|NCT01343277|815146|P1|Overall Study|Randomized not treated|6
247108|NCT01343277|815145|P2|Overall Study|Disease progression|138
247109|NCT01343277|815146|P1|Overall Study|Disease progression|270
247110|NCT01343277|815145|P2|Overall Study|Adverse Event|13
247111|NCT01343277|815146|P1|Overall Study|Adverse Event|67
247112|NCT01343277|815145|P2|Overall Study|Death|1
247113|NCT01343277|815146|P1|Overall Study|Death|10
247114|NCT01343277|815145|P2|Overall Study|Physician Decision|2
247115|NCT01343277|815146|P1|Overall Study|Physician Decision|1
247116|NCT01343277|815145|P2|Overall Study|Withdrawal by Subject|13
247117|NCT01343277|815146|P1|Overall Study|Withdrawal by Subject|18
247118|NCT01343277|815145|P2|Overall Study|Unspecified|3
247119|NCT01343277|815146|P1|Overall Study|Unspecified|3
247120|NCT01343082|815179|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
247121|NCT01343082|815180|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
247122|NCT01343082|815181|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
247123|NCT01343082|815179|P3|Treatment Period , Switched to DE-111|Physician Decision|2
247124|NCT01343082|815180|P2|Treatment Period , Switched to DE-111|Physician Decision|2
247125|NCT01343082|815181|P1|Treatment Period , Switched to DE-111|Physician Decision|0
247126|NCT01343082|815179|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
247127|NCT01343082|815180|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
247128|NCT01343082|815181|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
247129|NCT01343082|815179|P3|Treatment Period , Switched to DE-111|Adverse Event|3
247130|NCT01343082|815180|P2|Treatment Period , Switched to DE-111|Adverse Event|4
247131|NCT01343082|815181|P1|Treatment Period , Switched to DE-111|Adverse Event|1
247132|NCT01343082|815179|P3|The run-in Period|Not meeting criteria|5
247133|NCT01343082|815180|P2|The run-in Period|Not meeting criteria|4
247134|NCT01343082|815181|P1|The run-in Period|Not meeting criteria|3
247135|NCT01343056|815189|P4|Overall Study|Lost to Follow-up|9
247136|NCT01343056|815190|P3|Overall Study|Lost to Follow-up|3
247137|NCT01343056|815191|P2|Overall Study|Lost to Follow-up|5
247138|NCT01343056|815192|P1|Overall Study|Lost to Follow-up|7
247139|NCT01342965|815260|P2|Overall Study|Withdrawal by Subject|9
247140|NCT01342965|815261|P1|Overall Study|Withdrawal by Subject|2
247141|NCT01342965|815260|P2|Overall Study|Other Reasons- Unspecified|38
247142|NCT01342965|815261|P1|Overall Study|Other Reasons- Unspecified|44
247143|NCT01342965|815260|P2|Overall Study|Lost to Follow-up|3
247144|NCT01342965|815261|P1|Overall Study|Lost to Follow-up|5
247145|NCT01342965|815260|P2|Overall Study|Death|57
247146|NCT01342965|815261|P1|Overall Study|Death|58
247147|NCT01342926|815279|P4|Overall Study|Withdrawal by Subject|5
247148|NCT01342926|815280|P3|Overall Study|Withdrawal by Subject|3
247149|NCT01342926|815281|P2|Overall Study|Withdrawal by Subject|4
247150|NCT01342926|815282|P1|Overall Study|Withdrawal by Subject|2
247151|NCT01342926|815279|P4|Overall Study|Investigator Discretion|0
247152|NCT01342926|815280|P3|Overall Study|Investigator Discretion|0
247153|NCT01342926|815281|P2|Overall Study|Investigator Discretion|2
247154|NCT01342926|815282|P1|Overall Study|Investigator Discretion|2
247155|NCT01342926|815279|P4|Overall Study|Lost to Follow-up|0
247156|NCT01342926|815280|P3|Overall Study|Lost to Follow-up|1
247157|NCT01342926|815281|P2|Overall Study|Lost to Follow-up|1
247158|NCT01342926|815282|P1|Overall Study|Lost to Follow-up|0
247159|NCT01342926|815279|P4|Overall Study|Adverse Event|7
247160|NCT01342926|815280|P3|Overall Study|Adverse Event|10
247161|NCT01342926|815281|P2|Overall Study|Adverse Event|8
247162|NCT01342926|815282|P1|Overall Study|Adverse Event|5
247163|NCT01342913|815362|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
247164|NCT01342913|815363|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
247165|NCT01342913|815364|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
247166|NCT01342913|815362|P3|Double-Blind Treatment Period|Physician Decision|0
247167|NCT01342913|815363|P2|Double-Blind Treatment Period|Physician Decision|2
247168|NCT01342913|815364|P1|Double-Blind Treatment Period|Physician Decision|0
247169|NCT01342913|815362|P3|Double-Blind Treatment Period|Lost to Follow-up|3
247170|NCT01342913|815363|P2|Double-Blind Treatment Period|Lost to Follow-up|1
247171|NCT01342913|815364|P1|Double-Blind Treatment Period|Lost to Follow-up|0
247172|NCT01342913|815362|P3|Double-Blind Treatment Period|Protocol Violation|9
247173|NCT01342913|815363|P2|Double-Blind Treatment Period|Protocol Violation|6
247174|NCT01342913|815364|P1|Double-Blind Treatment Period|Protocol Violation|0
247175|NCT01342913|815362|P3|Double-Blind Treatment Period|Lack of Efficacy|3
247176|NCT01342913|815363|P2|Double-Blind Treatment Period|Lack of Efficacy|2
247177|NCT01342913|815364|P1|Double-Blind Treatment Period|Lack of Efficacy|0
247178|NCT01342913|815362|P3|Double-Blind Treatment Period|Adverse Event|6
247179|NCT01342913|815363|P2|Double-Blind Treatment Period|Adverse Event|3
247180|NCT01342913|815364|P1|Double-Blind Treatment Period|Adverse Event|0
247181|NCT01342913|815362|P3|2-week Run-in Period|Continuation Criteria Not Met|0
247182|NCT01342913|815363|P2|2-week Run-in Period|Continuation Criteria Not Met|0
247183|NCT01342913|815364|P1|2-week Run-in Period|Continuation Criteria Not Met|88
247184|NCT01342913|815362|P3|2-week Run-in Period|Protocol Violation|0
247185|NCT01342913|815363|P2|2-week Run-in Period|Protocol Violation|0
247186|NCT01342913|815364|P1|2-week Run-in Period|Protocol Violation|5
247187|NCT01342913|815362|P3|2-week Run-in Period|Adverse Event|0
247188|NCT01342913|815363|P2|2-week Run-in Period|Adverse Event|0
247189|NCT01342913|815364|P1|2-week Run-in Period|Adverse Event|2
247190|NCT01342913|815362|P3|2-week Run-in Period|Withdrawal by Subject|0
247191|NCT01342913|815363|P2|2-week Run-in Period|Withdrawal by Subject|0
247192|NCT01342913|815364|P1|2-week Run-in Period|Withdrawal by Subject|7
247193|NCT01342913|815362|P3|2-week Run-in Period|Physician Decision|0
247194|NCT01342913|815363|P2|2-week Run-in Period|Physician Decision|0
247195|NCT01342913|815364|P1|2-week Run-in Period|Physician Decision|6
247196|NCT01342913|815362|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
247197|NCT01342913|815363|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
247198|NCT01342913|815364|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
247199|NCT01342640|815383|P1|Overall Study|Unspecified|1
247200|NCT01342640|815383|P1|Overall Study|Lost to Follow-up|21
247201|NCT01342640|815383|P1|Overall Study|Protocol Violation|16
247202|NCT01342640|815383|P1|Overall Study|Adverse Event|3
247203|NCT01342510|815478|P4|Overall Study|Protocol Violation|11
247204|NCT01342510|815479|P3|Overall Study|Protocol Violation|13
247205|NCT01342510|815480|P2|Overall Study|Protocol Violation|6
247206|NCT01342510|815481|P1|Overall Study|Protocol Violation|12
247207|NCT01342484|815494|P3|Overall Study|Withdrawal by Subject|0
247208|NCT01342484|815495|P2|Overall Study|Withdrawal by Subject|0
247209|NCT01342484|815496|P1|Overall Study|Withdrawal by Subject|1
247210|NCT01342484|815494|P3|Overall Study|Protocol Violation|1
247211|NCT01342484|815495|P2|Overall Study|Protocol Violation|0
247212|NCT01342484|815496|P1|Overall Study|Protocol Violation|0
247213|NCT01342484|815494|P3|Overall Study|Other Reasons|0
247214|NCT01342484|815495|P2|Overall Study|Other Reasons|0
247215|NCT01342484|815496|P1|Overall Study|Other Reasons|1
247216|NCT01342445|815552|P2|Overall Study|Experienced side effects|2
247217|NCT01342445|815553|P1|Overall Study|Experienced side effects|0
247218|NCT01342341|815569|P2|Overall Study|Lost to Follow-up|4
247219|NCT01342341|815570|P1|Overall Study|Lost to Follow-up|4
247220|NCT01342094|815591|P2|Overall Study|Withdrawal by Subject|2
247221|NCT01342094|815592|P1|Overall Study|Withdrawal by Subject|0
247222|NCT01342094|815591|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
247223|NCT01342094|815592|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
247224|NCT01342094|815591|P2|Overall Study|Adverse Event|0
247225|NCT01342094|815592|P1|Overall Study|Adverse Event|5
247226|NCT01342081|815601|P3|Overall Study|Withdrawal by Subject|0
247227|NCT01342081|815602|P2|Overall Study|Withdrawal by Subject|1
247228|NCT01342081|815603|P1|Overall Study|Withdrawal by Subject|1
247229|NCT01342081|815601|P3|Overall Study|Physician Decision|0
247230|NCT01342081|815602|P2|Overall Study|Physician Decision|1
247231|NCT01342081|815603|P1|Overall Study|Physician Decision|0
247232|NCT01342081|815601|P3|Overall Study|Adverse Event|0
247233|NCT01342081|815602|P2|Overall Study|Adverse Event|0
247234|NCT01342081|815603|P1|Overall Study|Adverse Event|1
247235|NCT01342081|815601|P3|Overall Study|Did not receive allocated intervention|1
247236|NCT01342081|815602|P2|Overall Study|Did not receive allocated intervention|0
247237|NCT01342081|815603|P1|Overall Study|Did not receive allocated intervention|0
247238|NCT01341990|815613|P2|Overall Study|Withdrawal by Subject|0
247239|NCT01341990|815614|P1|Overall Study|Withdrawal by Subject|2
247240|NCT01341990|815613|P2|Overall Study|Torn Study Lens|0
247241|NCT01341990|815614|P1|Overall Study|Torn Study Lens|1
247242|NCT01341990|815613|P2|Overall Study|Adverse Event|1
247243|NCT01341990|815614|P1|Overall Study|Adverse Event|0
247244|NCT01341782|815638|P2|Overall Study|Other|0
247245|NCT01341782|815639|P1|Overall Study|Other|5
247246|NCT01341782|815638|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
247247|NCT01341782|815639|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
247248|NCT01341782|815638|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
247249|NCT01341782|815639|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
247250|NCT01341782|815638|P2|Overall Study|Missed 3 consecutive doses|4
247251|NCT01341782|815639|P1|Overall Study|Missed 3 consecutive doses|0
247252|NCT01341782|815638|P2|Overall Study|Withdrawal by Subject|5
247253|NCT01341782|815639|P1|Overall Study|Withdrawal by Subject|6
247254|NCT01341782|815638|P2|Overall Study|Adverse Event|1
247255|NCT01341782|815639|P1|Overall Study|Adverse Event|1
247256|NCT01340937|815666|P4|Period 3: Toddler Vaccinations|Technical problem|0
247257|NCT01340937|815667|P3|Period 3: Toddler Vaccinations|Technical problem|1
247258|NCT01340937|815668|P2|Period 3: Toddler Vaccinations|Technical problem|1
247259|NCT01340937|815669|P1|Period 3: Toddler Vaccinations|Technical problem|1
247260|NCT01340937|815666|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
247261|NCT01340937|815667|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
247262|NCT01340937|815668|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
247263|NCT01340937|815669|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
247264|NCT01340937|815666|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
247265|NCT01340937|815667|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
247266|NCT01340937|815668|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
247267|NCT01340937|815669|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
247268|NCT01340937|815666|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
247269|NCT01340937|815667|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
247270|NCT01340937|815668|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
247271|NCT01340937|815669|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
247272|NCT01340937|815666|P4|Period 2: Interim Period|Technical problems|3
247273|NCT01340937|815667|P3|Period 2: Interim Period|Technical problems|6
247274|NCT01340937|815668|P2|Period 2: Interim Period|Technical problems|4
247275|NCT01340937|815669|P1|Period 2: Interim Period|Technical problems|4
247276|NCT01340937|815666|P4|Period 2: Interim Period|Protocol Violation|3
247277|NCT01340937|815667|P3|Period 2: Interim Period|Protocol Violation|6
247278|NCT01340937|815668|P2|Period 2: Interim Period|Protocol Violation|3
247279|NCT01340937|815669|P1|Period 2: Interim Period|Protocol Violation|5
247280|NCT01340937|815666|P4|Period 2: Interim Period|Physician Decision|0
247281|NCT01340937|815667|P3|Period 2: Interim Period|Physician Decision|1
247282|NCT01340937|815668|P2|Period 2: Interim Period|Physician Decision|1
247283|NCT01340937|815669|P1|Period 2: Interim Period|Physician Decision|0
247284|NCT01340937|815666|P4|Period 2: Interim Period|Lost to Follow-up|23
247285|NCT01340937|815667|P3|Period 2: Interim Period|Lost to Follow-up|53
247286|NCT01340937|815668|P2|Period 2: Interim Period|Lost to Follow-up|48
247287|NCT01340937|815669|P1|Period 2: Interim Period|Lost to Follow-up|29
247288|NCT01340937|815666|P4|Period 2: Interim Period|Adverse Event|0
247289|NCT01340937|815667|P3|Period 2: Interim Period|Adverse Event|1
247290|NCT01340937|815668|P2|Period 2: Interim Period|Adverse Event|0
247291|NCT01340937|815669|P1|Period 2: Interim Period|Adverse Event|1
247292|NCT01340937|815666|P4|Period 2: Interim Period|Withdrawal by Subject|12
247293|NCT01340937|815667|P3|Period 2: Interim Period|Withdrawal by Subject|17
247294|NCT01340937|815668|P2|Period 2: Interim Period|Withdrawal by Subject|23
247295|NCT01340937|815669|P1|Period 2: Interim Period|Withdrawal by Subject|28
247296|NCT01340937|815666|P4|Period 1: Infant Series|Randomized but not vaccinated|1
247297|NCT01340937|815667|P3|Period 1: Infant Series|Randomized but not vaccinated|2
247298|NCT01340937|815668|P2|Period 1: Infant Series|Randomized but not vaccinated|5
247299|NCT01340937|815669|P1|Period 1: Infant Series|Randomized but not vaccinated|0
247300|NCT01340937|815666|P4|Period 1: Infant Series|Withdrawal by Subject|15
247301|NCT01340937|815667|P3|Period 1: Infant Series|Withdrawal by Subject|30
247302|NCT01340937|815668|P2|Period 1: Infant Series|Withdrawal by Subject|32
247303|NCT01340937|815669|P1|Period 1: Infant Series|Withdrawal by Subject|33
247304|NCT01340937|815666|P4|Period 1: Infant Series|Protocol Violation|3
247305|NCT01340937|815667|P3|Period 1: Infant Series|Protocol Violation|4
247306|NCT01340937|815668|P2|Period 1: Infant Series|Protocol Violation|4
247307|NCT01340937|815669|P1|Period 1: Infant Series|Protocol Violation|1
247308|NCT01340937|815666|P4|Period 1: Infant Series|Physician Decision|0
247309|NCT01340937|815667|P3|Period 1: Infant Series|Physician Decision|1
247310|NCT01340937|815668|P2|Period 1: Infant Series|Physician Decision|3
247311|NCT01340937|815669|P1|Period 1: Infant Series|Physician Decision|2
247312|NCT01340937|815666|P4|Period 1: Infant Series|Lost to Follow-up|13
247313|NCT01340937|815667|P3|Period 1: Infant Series|Lost to Follow-up|12
247314|NCT01340937|815668|P2|Period 1: Infant Series|Lost to Follow-up|14
247315|NCT01340937|815669|P1|Period 1: Infant Series|Lost to Follow-up|20
247316|NCT01340937|815666|P4|Period 1: Infant Series|Death|0
247317|NCT01340937|815667|P3|Period 1: Infant Series|Death|2
247318|NCT01340937|815668|P2|Period 1: Infant Series|Death|0
247319|NCT01340937|815669|P1|Period 1: Infant Series|Death|2
247320|NCT01340937|815666|P4|Period 1: Infant Series|Adverse Event|0
247321|NCT01340937|815667|P3|Period 1: Infant Series|Adverse Event|4
247322|NCT01340937|815668|P2|Period 1: Infant Series|Adverse Event|1
247323|NCT01340937|815669|P1|Period 1: Infant Series|Adverse Event|0
247324|NCT01340937|815666|P4|Period 1: Infant Series|Other protocol criterion not met|0
247325|NCT01340937|815667|P3|Period 1: Infant Series|Other protocol criterion not met|1
247326|NCT01340937|815668|P2|Period 1: Infant Series|Other protocol criterion not met|1
247327|NCT01340937|815669|P1|Period 1: Infant Series|Other protocol criterion not met|0
247328|NCT01340794|815828|P2|Overall Study|Withdrawal by Subject|1
247329|NCT01340794|815829|P1|Overall Study|Withdrawal by Subject|0
247330|NCT01340768|815845|P2|Overall Study|Other|0
247331|NCT01340768|815846|P1|Overall Study|Other|2
247332|NCT01340768|815845|P2|Overall Study|Withdrawal by Subject|1
247333|NCT01340768|815846|P1|Overall Study|Withdrawal by Subject|5
247334|NCT01340768|815845|P2|Overall Study|Lost to Follow-up|4
247335|NCT01340768|815846|P1|Overall Study|Lost to Follow-up|10
247336|NCT01340664|815857|P3|Overall Study|Not specified|2
247337|NCT01340664|815858|P2|Overall Study|Not specified|2
247338|NCT01340664|815859|P1|Overall Study|Not specified|1
247339|NCT01340664|815857|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
247340|NCT01340664|815858|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
247341|NCT01340664|815859|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
247342|NCT01340664|815857|P3|Overall Study|Glycemic withdrawal criteria|0
247343|NCT01340664|815858|P2|Overall Study|Glycemic withdrawal criteria|0
247344|NCT01340664|815859|P1|Overall Study|Glycemic withdrawal criteria|2
247345|NCT01340664|815857|P3|Overall Study|Withdrawal by Subject|0
247346|NCT01340664|815858|P2|Overall Study|Withdrawal by Subject|4
247347|NCT01340664|815859|P1|Overall Study|Withdrawal by Subject|2
247348|NCT01340664|815857|P3|Overall Study|Lost to Follow-up|2
247349|NCT01340664|815858|P2|Overall Study|Lost to Follow-up|0
247350|NCT01340664|815859|P1|Overall Study|Lost to Follow-up|2
247351|NCT01340664|815857|P3|Overall Study|Adverse Event|7
247352|NCT01340664|815858|P2|Overall Study|Adverse Event|1
247353|NCT01340664|815859|P1|Overall Study|Adverse Event|0
247354|NCT01340651|815876|P1|Overall Study|Commercial Supply per Sponsor|12
247355|NCT01340651|815876|P1|Overall Study|Consent Withdrawn|2
247356|NCT01340651|815876|P1|Overall Study|Adverse Event|3
247357|NCT01340625|815892|P2|Washout Period of 28 Days|Withdrawal by Subject|0
247358|NCT01340625|815893|P1|Washout Period of 28 Days|Withdrawal by Subject|1
247359|NCT01340625|815892|P2|First Intervention|Adverse Event|0
247360|NCT01340625|815893|P1|First Intervention|Adverse Event|1
247361|NCT01340209|816001|P3|Overall Study|Other reason not defined above|4
247362|NCT01340209|816002|P2|Overall Study|Other reason not defined above|5
247363|NCT01340209|816003|P1|Overall Study|Other reason not defined above|3
247364|NCT01340209|816001|P3|Overall Study|Withdrawal by Subject|1
247365|NCT01340209|816002|P2|Overall Study|Withdrawal by Subject|0
247366|NCT01340209|816003|P1|Overall Study|Withdrawal by Subject|0
247367|NCT01340209|816001|P3|Overall Study|Protocol Violation|1
247368|NCT01340209|816002|P2|Overall Study|Protocol Violation|2
247369|NCT01340209|816003|P1|Overall Study|Protocol Violation|1
247370|NCT01340209|816001|P3|Overall Study|Adverse Event|2
247371|NCT01340209|816002|P2|Overall Study|Adverse Event|1
247372|NCT01340209|816003|P1|Overall Study|Adverse Event|1
247373|NCT01340196|816038|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
247374|NCT01340066|816078|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
247375|NCT01340066|816079|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
247376|NCT01340066|816080|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
247377|NCT01340066|816078|P3|5 Week Double Blind Randomization Period|Physician Decision|0
247378|NCT01340066|816079|P2|5 Week Double Blind Randomization Period|Physician Decision|1
247379|NCT01340066|816080|P1|5 Week Double Blind Randomization Period|Physician Decision|0
247380|NCT01340066|816078|P3|5 Week Double Blind Randomization Period|Adverse Event|2
247381|NCT01340066|816079|P2|5 Week Double Blind Randomization Period|Adverse Event|2
247382|NCT01340066|816080|P1|5 Week Double Blind Randomization Period|Adverse Event|0
247383|NCT01340066|816078|P3|Placebo Run in Period|Screen Failures|0
247384|NCT01340066|816079|P2|Placebo Run in Period|Screen Failures|0
247385|NCT01340066|816080|P1|Placebo Run in Period|Screen Failures|27
247386|NCT01340027|816099|P12|Overall Study|Miscellaneous|0
247387|NCT01340027|816100|P11|Overall Study|Miscellaneous|1
247388|NCT01340027|816101|P10|Overall Study|Miscellaneous|0
247389|NCT01340027|816102|P9|Overall Study|Miscellaneous|0
247390|NCT01340027|816103|P8|Overall Study|Miscellaneous|0
247391|NCT01340027|816104|P7|Overall Study|Miscellaneous|0
247392|NCT01340027|816105|P6|Overall Study|Miscellaneous|0
247393|NCT01340027|816106|P5|Overall Study|Miscellaneous|0
247394|NCT01340027|816107|P4|Overall Study|Miscellaneous|1
247395|NCT01340027|816108|P3|Overall Study|Miscellaneous|0
247396|NCT01340027|816109|P2|Overall Study|Miscellaneous|0
247397|NCT01340027|816110|P1|Overall Study|Miscellaneous|0
247398|NCT01340027|816099|P12|Overall Study|Withdrawal by Subject|1
247399|NCT01340027|816100|P11|Overall Study|Withdrawal by Subject|0
247400|NCT01340027|816101|P10|Overall Study|Withdrawal by Subject|2
247401|NCT01340027|816102|P9|Overall Study|Withdrawal by Subject|1
247402|NCT01340027|816103|P8|Overall Study|Withdrawal by Subject|4
247403|NCT01340027|816104|P7|Overall Study|Withdrawal by Subject|3
247404|NCT01340027|816105|P6|Overall Study|Withdrawal by Subject|2
247405|NCT01340027|816106|P5|Overall Study|Withdrawal by Subject|3
247406|NCT01340027|816107|P4|Overall Study|Withdrawal by Subject|3
247407|NCT01340027|816108|P3|Overall Study|Withdrawal by Subject|1
247408|NCT01340027|816109|P2|Overall Study|Withdrawal by Subject|3
247409|NCT01340027|816110|P1|Overall Study|Withdrawal by Subject|4
247410|NCT01340027|816099|P12|Overall Study|Protocol Violation|0
247411|NCT01340027|816100|P11|Overall Study|Protocol Violation|0
247412|NCT01340027|816101|P10|Overall Study|Protocol Violation|2
247413|NCT01340027|816102|P9|Overall Study|Protocol Violation|2
247414|NCT01340027|816103|P8|Overall Study|Protocol Violation|1
247415|NCT01340027|816104|P7|Overall Study|Protocol Violation|0
247416|NCT01340027|816105|P6|Overall Study|Protocol Violation|0
247417|NCT01340027|816106|P5|Overall Study|Protocol Violation|6
247418|NCT01340027|816107|P4|Overall Study|Protocol Violation|0
247419|NCT01340027|816108|P3|Overall Study|Protocol Violation|0
247420|NCT01340027|816109|P2|Overall Study|Protocol Violation|2
247421|NCT01340027|816110|P1|Overall Study|Protocol Violation|1
247422|NCT01340027|816099|P12|Overall Study|Lost to Follow-up|0
247423|NCT01340027|816100|P11|Overall Study|Lost to Follow-up|0
247424|NCT01340027|816101|P10|Overall Study|Lost to Follow-up|1
247425|NCT01340027|816102|P9|Overall Study|Lost to Follow-up|0
247426|NCT01340027|816103|P8|Overall Study|Lost to Follow-up|0
247427|NCT01340027|816104|P7|Overall Study|Lost to Follow-up|1
247428|NCT01340027|816105|P6|Overall Study|Lost to Follow-up|0
247429|NCT01340027|816106|P5|Overall Study|Lost to Follow-up|0
247430|NCT01340027|816107|P4|Overall Study|Lost to Follow-up|0
247431|NCT01340027|816108|P3|Overall Study|Lost to Follow-up|0
247432|NCT01340027|816109|P2|Overall Study|Lost to Follow-up|1
247433|NCT01340027|816110|P1|Overall Study|Lost to Follow-up|0
247434|NCT01340027|816099|P12|Overall Study|Lack of Efficacy|0
247435|NCT01340027|816100|P11|Overall Study|Lack of Efficacy|0
247436|NCT01340027|816101|P10|Overall Study|Lack of Efficacy|0
247437|NCT01340027|816102|P9|Overall Study|Lack of Efficacy|1
247438|NCT01340027|816103|P8|Overall Study|Lack of Efficacy|1
247439|NCT01340027|816104|P7|Overall Study|Lack of Efficacy|1
247440|NCT01340027|816105|P6|Overall Study|Lack of Efficacy|0
247441|NCT01340027|816106|P5|Overall Study|Lack of Efficacy|0
247442|NCT01340027|816107|P4|Overall Study|Lack of Efficacy|0
247443|NCT01340027|816108|P3|Overall Study|Lack of Efficacy|0
247444|NCT01340027|816109|P2|Overall Study|Lack of Efficacy|0
247445|NCT01340027|816110|P1|Overall Study|Lack of Efficacy|0
247446|NCT01340027|816099|P12|Overall Study|Adverse Event|3
247447|NCT01340027|816100|P11|Overall Study|Adverse Event|1
247448|NCT01340027|816101|P10|Overall Study|Adverse Event|1
247449|NCT01340027|816102|P9|Overall Study|Adverse Event|4
247450|NCT01340027|816103|P8|Overall Study|Adverse Event|1
247451|NCT01340027|816104|P7|Overall Study|Adverse Event|2
247452|NCT01340027|816105|P6|Overall Study|Adverse Event|2
247453|NCT01340027|816106|P5|Overall Study|Adverse Event|1
247454|NCT01340027|816107|P4|Overall Study|Adverse Event|0
247455|NCT01340027|816108|P3|Overall Study|Adverse Event|2
247456|NCT01340027|816109|P2|Overall Study|Adverse Event|1
247457|NCT01340027|816110|P1|Overall Study|Adverse Event|0
247458|NCT01340027|816099|P12|Overall Study|Randomized but Never Received Study Drug|0
247459|NCT01340027|816100|P11|Overall Study|Randomized but Never Received Study Drug|0
247460|NCT01340027|816101|P10|Overall Study|Randomized but Never Received Study Drug|0
247461|NCT01340027|816102|P9|Overall Study|Randomized but Never Received Study Drug|0
247462|NCT01340027|816103|P8|Overall Study|Randomized but Never Received Study Drug|0
247463|NCT01340027|816104|P7|Overall Study|Randomized but Never Received Study Drug|0
247464|NCT01340027|816105|P6|Overall Study|Randomized but Never Received Study Drug|0
247465|NCT01340027|816106|P5|Overall Study|Randomized but Never Received Study Drug|0
247466|NCT01340027|816107|P4|Overall Study|Randomized but Never Received Study Drug|0
247467|NCT01340027|816108|P3|Overall Study|Randomized but Never Received Study Drug|1
247468|NCT01340027|816109|P2|Overall Study|Randomized but Never Received Study Drug|0
247469|NCT01340027|816110|P1|Overall Study|Randomized but Never Received Study Drug|0
247470|NCT01340014|816486|P2|Period 2, Second 7 Days|Adverse Event|1
247471|NCT01340014|816487|P1|Period 2, Second 7 Days|Adverse Event|0
247472|NCT01340014|816486|P2|Period 1, First 7 Days|Personal Reasons|0
247473|NCT01340014|816487|P1|Period 1, First 7 Days|Personal Reasons|1
247474|NCT01340014|816486|P2|Period 1, First 7 Days|Adverse Event|0
247475|NCT01340014|816487|P1|Period 1, First 7 Days|Adverse Event|1
247476|NCT01339923|816508|P7|Overall Study|Withdrawal by Subject|2
247477|NCT01339923|816509|P6|Overall Study|Withdrawal by Subject|3
247478|NCT01339923|816510|P5|Overall Study|Withdrawal by Subject|4
247479|NCT01339923|816511|P4|Overall Study|Withdrawal by Subject|1
247480|NCT01339923|816512|P3|Overall Study|Withdrawal by Subject|6
247481|NCT01339923|816513|P2|Overall Study|Withdrawal by Subject|11
247482|NCT01339923|816514|P1|Overall Study|Withdrawal by Subject|7
247483|NCT01339923|816508|P7|Overall Study|Unable to Classify|5
247484|NCT01339923|816509|P6|Overall Study|Unable to Classify|1
247485|NCT01339923|816510|P5|Overall Study|Unable to Classify|0
247486|NCT01339923|816511|P4|Overall Study|Unable to Classify|0
247487|NCT01339923|816512|P3|Overall Study|Unable to Classify|1
247488|NCT01339923|816513|P2|Overall Study|Unable to Classify|0
247489|NCT01339923|816514|P1|Overall Study|Unable to Classify|1
247490|NCT01339923|816508|P7|Overall Study|Protocol Violation|1
247491|NCT01339923|816509|P6|Overall Study|Protocol Violation|3
247492|NCT01339923|816510|P5|Overall Study|Protocol Violation|0
247493|NCT01339923|816511|P4|Overall Study|Protocol Violation|0
247494|NCT01339923|816512|P3|Overall Study|Protocol Violation|0
247495|NCT01339923|816513|P2|Overall Study|Protocol Violation|0
247496|NCT01339923|816514|P1|Overall Study|Protocol Violation|0
247497|NCT01339923|816508|P7|Overall Study|Lost to Follow-up|5
247498|NCT01339923|816509|P6|Overall Study|Lost to Follow-up|1
247499|NCT01339923|816510|P5|Overall Study|Lost to Follow-up|1
247500|NCT01339923|816511|P4|Overall Study|Lost to Follow-up|3
247501|NCT01339923|816512|P3|Overall Study|Lost to Follow-up|0
247502|NCT01339923|816513|P2|Overall Study|Lost to Follow-up|4
247503|NCT01339923|816514|P1|Overall Study|Lost to Follow-up|4
247504|NCT01339923|816508|P7|Overall Study|Inappropriate Enrollment|0
247505|NCT01339923|816509|P6|Overall Study|Inappropriate Enrollment|1
247506|NCT01339923|816510|P5|Overall Study|Inappropriate Enrollment|0
247507|NCT01339923|816511|P4|Overall Study|Inappropriate Enrollment|0
247508|NCT01339923|816512|P3|Overall Study|Inappropriate Enrollment|0
247509|NCT01339923|816513|P2|Overall Study|Inappropriate Enrollment|0
247510|NCT01339923|816514|P1|Overall Study|Inappropriate Enrollment|1
247511|NCT01339923|816508|P7|Overall Study|Adverse Event|1
247512|NCT01339923|816509|P6|Overall Study|Adverse Event|0
247513|NCT01339923|816510|P5|Overall Study|Adverse Event|0
247514|NCT01339923|816511|P4|Overall Study|Adverse Event|0
247515|NCT01339923|816512|P3|Overall Study|Adverse Event|1
247516|NCT01339923|816513|P2|Overall Study|Adverse Event|1
247517|NCT01339923|816514|P1|Overall Study|Adverse Event|1
247518|NCT01339897|816587|P4|Overall Study|Adverse Event|1
247519|NCT01339897|816588|P3|Overall Study|Adverse Event|0
247520|NCT01339897|816589|P2|Overall Study|Adverse Event|0
247521|NCT01339897|816590|P1|Overall Study|Adverse Event|1
247522|NCT01339832|816616|P1|Overall Study|Death|11
247523|NCT01339832|816616|P1|Overall Study|Lost to Follow-up|3
247524|NCT01339429|816627|P1|Overall Study|Physician Decision|3
247525|NCT01339429|816627|P1|Overall Study|Withdrawal by Subject|1
247526|NCT01339390|816667|P2|Overall Study|Lost to Follow-up|127
247527|NCT01339390|816668|P1|Overall Study|Lost to Follow-up|125
247528|NCT01339390|816667|P2|Overall Study|Death|29
247529|NCT01339390|816668|P1|Overall Study|Death|32
247530|NCT01339052|816726|P2|Overall Study|Physician Decision|0
247531|NCT01339052|816727|P1|Overall Study|Physician Decision|1
247532|NCT01339052|816726|P2|Overall Study|Withdrawal by Subject|3
247533|NCT01339052|816727|P1|Overall Study|Withdrawal by Subject|0
247534|NCT01339052|816726|P2|Overall Study|Adverse Event|1
247535|NCT01339052|816727|P1|Overall Study|Adverse Event|1
247536|NCT01339052|816726|P2|Overall Study|Disease progression|46
247537|NCT01339052|816727|P1|Overall Study|Disease progression|13
247538|NCT01339000|816749|P2|Overall Study|study closed due to lack of drug supply|0
247539|NCT01339000|816750|P1|Overall Study|study closed due to lack of drug supply|1
247540|NCT01338870|816770|P6|Overall Study|Adverse Event|1
247541|NCT01338870|816771|P5|Overall Study|Adverse Event|4
247542|NCT01338870|816772|P4|Overall Study|Adverse Event|5
247543|NCT01338870|816773|P3|Overall Study|Adverse Event|1
247544|NCT01338870|816774|P2|Overall Study|Adverse Event|4
247545|NCT01338870|816775|P1|Overall Study|Adverse Event|4
247546|NCT01338870|816770|P6|Overall Study|Protocol Violation|1
247547|NCT01338870|816771|P5|Overall Study|Protocol Violation|1
247548|NCT01338870|816772|P4|Overall Study|Protocol Violation|2
247549|NCT01338870|816773|P3|Overall Study|Protocol Violation|2
247550|NCT01338870|816774|P2|Overall Study|Protocol Violation|2
247551|NCT01338870|816775|P1|Overall Study|Protocol Violation|0
247552|NCT01338870|816770|P6|Overall Study|Unspecified|2
247553|NCT01338870|816771|P5|Overall Study|Unspecified|0
247554|NCT01338870|816772|P4|Overall Study|Unspecified|2
247555|NCT01338870|816773|P3|Overall Study|Unspecified|3
247556|NCT01338870|816774|P2|Overall Study|Unspecified|3
247557|NCT01338870|816775|P1|Overall Study|Unspecified|3
247558|NCT01338870|816770|P6|Overall Study|Withdrawal by Subject|2
247559|NCT01338870|816771|P5|Overall Study|Withdrawal by Subject|0
247560|NCT01338870|816772|P4|Overall Study|Withdrawal by Subject|0
247561|NCT01338870|816773|P3|Overall Study|Withdrawal by Subject|4
247562|NCT01338870|816774|P2|Overall Study|Withdrawal by Subject|3
247563|NCT01338870|816775|P1|Overall Study|Withdrawal by Subject|2
247564|NCT01338870|816770|P6|Overall Study|Lost to Follow-up|0
247565|NCT01338870|816771|P5|Overall Study|Lost to Follow-up|1
247566|NCT01338870|816772|P4|Overall Study|Lost to Follow-up|0
247567|NCT01338870|816773|P3|Overall Study|Lost to Follow-up|1
247568|NCT01338870|816774|P2|Overall Study|Lost to Follow-up|0
247569|NCT01338870|816775|P1|Overall Study|Lost to Follow-up|0
247570|NCT01338818|816830|P1|Overall Study|Protocol Deviation|4
247571|NCT01338818|816830|P1|Overall Study|Administrative problems|3
247572|NCT01338818|816830|P1|Overall Study|Lost to Follow-up|4
247573|NCT01338818|816830|P1|Overall Study|Withdrawal by Subject|11
247574|NCT01338818|816830|P1|Overall Study|no longer require study drug|1
247575|NCT01338818|816830|P1|Overall Study|Lack of Efficacy|5
247576|NCT01338818|816830|P1|Overall Study|Adverse Event|8
247577|NCT01338792|816836|P1|Overall Study|Withdrawal by Subject|1
247578|NCT01338792|816836|P1|Overall Study|Death|1
247579|NCT01338792|816836|P1|Overall Study|Adverse Event|2
247580|NCT01338636|816851|P1|Overall Study|Withdrawn due to lack of improvement|8
247581|NCT01338610|816865|P3|Overall Study|Adverse Event|0
247582|NCT01338610|816866|P2|Overall Study|Adverse Event|0
247583|NCT01338610|816867|P1|Overall Study|Adverse Event|3
247584|NCT01338610|816865|P3|Overall Study|Protocol Violation|1
247585|NCT01338610|816866|P2|Overall Study|Protocol Violation|0
247586|NCT01338610|816867|P1|Overall Study|Protocol Violation|1
247587|NCT01338610|816865|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
247588|NCT01338610|816866|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
247589|NCT01338610|816867|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
247590|NCT01338493|816874|P1|12 Months Follow up|Lost to Follow-up|9
247591|NCT01338493|816874|P1|6 Months Follow up|Missed visit|8
247592|NCT01338493|816874|P1|6 Months Follow up|Lost to Follow-up|11
247593|NCT01338493|816874|P1|Discharge|Missed visit|1
247594|NCT01338493|816874|P1|Discharge|Death|1
247595|NCT01338493|816874|P1|Enrolled|Patient not implanted|4
247596|NCT01338493|816874|P1|Enrolled|Withdrawal by Subject|1
247597|NCT01338025|816881|P2|Overall Study|Found ineligible after starting|0
247598|NCT01338025|816882|P1|Overall Study|Found ineligible after starting|1
247599|NCT01338025|816881|P2|Overall Study|Withdrawal by Subject|2
247600|NCT01338025|816882|P1|Overall Study|Withdrawal by Subject|0
247601|NCT01338025|816881|P2|Overall Study|Unexpected closure of study|9
247602|NCT01338025|816882|P1|Overall Study|Unexpected closure of study|10
247603|NCT01338012|816894|P1|Overall Study|Study terminated|4
247604|NCT01338012|816894|P1|Overall Study|Death|4
247605|NCT01337960|816901|P3|Overall Study|Withdrawal by Subject|0
247606|NCT01337960|816902|P2|Overall Study|Withdrawal by Subject|0
247607|NCT01337960|816903|P1|Overall Study|Withdrawal by Subject|1
247608|NCT01337960|816901|P3|Overall Study|Lost to Follow-up|0
247609|NCT01337960|816902|P2|Overall Study|Lost to Follow-up|0
247610|NCT01337960|816903|P1|Overall Study|Lost to Follow-up|1
247611|NCT01337674|816936|P4|Treatment Period 2|Withdrawal by Subject|0
247612|NCT01337674|816937|P3|Treatment Period 2|Withdrawal by Subject|1
247613|NCT01337674|816938|P2|Treatment Period 2|Withdrawal by Subject|0
247614|NCT01337674|816939|P1|Treatment Period 2|Withdrawal by Subject|0
247615|NCT01337674|816936|P4|Treatment Period 1|Discontinued due to blood draws|1
247616|NCT01337674|816937|P3|Treatment Period 1|Discontinued due to blood draws|0
247617|NCT01337674|816938|P2|Treatment Period 1|Discontinued due to blood draws|0
247618|NCT01337674|816939|P1|Treatment Period 1|Discontinued due to blood draws|0
247619|NCT01337674|816936|P4|Treatment Period 1|Adverse Event|0
247620|NCT01337674|816937|P3|Treatment Period 1|Adverse Event|0
247621|NCT01337674|816938|P2|Treatment Period 1|Adverse Event|1
247622|NCT01337674|816939|P1|Treatment Period 1|Adverse Event|0
247623|NCT01337635|816957|P2|Overall Study|Lost to Follow-up|1
247624|NCT01337635|816958|P1|Overall Study|Lost to Follow-up|0
247625|NCT01337297|817006|P2|Overall Study|Lost to Follow-up|3
247626|NCT01337297|817007|P1|Overall Study|Lost to Follow-up|1
247627|NCT01337297|817006|P2|Overall Study|They entered to single anodal tDCS|3
247628|NCT01337297|817007|P1|Overall Study|They entered to single anodal tDCS|4
247629|NCT01337167|817015|P2|Toddler Vaccinations|Withdrawal by Subject|0
247630|NCT01337167|817016|P1|Toddler Vaccinations|Withdrawal by Subject|3
247631|NCT01337167|817015|P2|Toddler Vaccinations|Protocol Violation|1
247632|NCT01337167|817016|P1|Toddler Vaccinations|Protocol Violation|0
247633|NCT01337167|817015|P2|Toddler Vaccinations|Lost to Follow-up|12
247634|NCT01337167|817016|P1|Toddler Vaccinations|Lost to Follow-up|11
247635|NCT01337167|817015|P2|Interim Period|Other protocol criterion not met|1
247636|NCT01337167|817016|P1|Interim Period|Other protocol criterion not met|0
247637|NCT01337167|817015|P2|Interim Period|Withdrawal by Subject|10
247638|NCT01337167|817016|P1|Interim Period|Withdrawal by Subject|18
247639|NCT01337167|817015|P2|Interim Period|Protocol Violation|3
247640|NCT01337167|817016|P1|Interim Period|Protocol Violation|5
247641|NCT01337167|817015|P2|Interim Period|Physician Decision|3
247642|NCT01337167|817016|P1|Interim Period|Physician Decision|6
247643|NCT01337167|817015|P2|Interim Period|Non-compliance with study drug|0
247644|NCT01337167|817016|P1|Interim Period|Non-compliance with study drug|1
247645|NCT01337167|817015|P2|Interim Period|Lost to Follow-up|23
247646|NCT01337167|817016|P1|Interim Period|Lost to Follow-up|51
247647|NCT01337167|817015|P2|Infant Series|Randomized but not vaccinated|3
247648|NCT01337167|817016|P1|Infant Series|Randomized but not vaccinated|5
247649|NCT01337167|817015|P2|Infant Series|Withdrawal by Subject|4
247650|NCT01337167|817016|P1|Infant Series|Withdrawal by Subject|15
247651|NCT01337167|817015|P2|Infant Series|Protocol Violation|9
247652|NCT01337167|817016|P1|Infant Series|Protocol Violation|22
247653|NCT01337167|817015|P2|Infant Series|Physician Decision|1
247654|NCT01337167|817016|P1|Infant Series|Physician Decision|3
247655|NCT01337167|817015|P2|Infant Series|Non-compliance with study drug|1
247656|NCT01337167|817016|P1|Infant Series|Non-compliance with study drug|2
247657|NCT01337167|817015|P2|Infant Series|Lost to Follow-up|7
247658|NCT01337167|817016|P1|Infant Series|Lost to Follow-up|13
247659|NCT01337167|817015|P2|Infant Series|Death|1
247660|NCT01337167|817016|P1|Infant Series|Death|1
247661|NCT01337167|817015|P2|Infant Series|Adverse Event|1
247662|NCT01337167|817016|P1|Infant Series|Adverse Event|1
247663|NCT01337115|817084|P2|Overall Study|Protocol Violation|0
247664|NCT01337115|817085|P1|Overall Study|Protocol Violation|2
247665|NCT01337050|817104|P3|Overall Study|Participants refused further follow-up|7
247666|NCT01337050|817105|P2|Overall Study|Participants refused further follow-up|7
247667|NCT01337050|817106|P1|Overall Study|Participants refused further follow-up|0
247668|NCT01337050|817104|P3|Overall Study|Unspecified|8
247669|NCT01337050|817105|P2|Overall Study|Unspecified|6
247670|NCT01337050|817106|P1|Overall Study|Unspecified|4
247671|NCT01337050|817104|P3|Overall Study|Death|4
247672|NCT01337050|817105|P2|Overall Study|Death|0
247673|NCT01337050|817106|P1|Overall Study|Death|0
247674|NCT01336894|817166|P2|Follow-up|Study terminated prematurely|7
247675|NCT01336894|817167|P1|Follow-up|Study terminated prematurely|2
247676|NCT01336764|817187|P2|Overall Study|Withdrawal by Subject|5
247677|NCT01336764|817188|P1|Overall Study|Withdrawal by Subject|5
247678|NCT01336738|817199|P5|Overall Study|Unspecified|4
247679|NCT01336738|817200|P4|Overall Study|Unspecified|3
247680|NCT01336738|817201|P3|Overall Study|Unspecified|2
247681|NCT01336738|817202|P2|Overall Study|Unspecified|3
247682|NCT01336738|817203|P1|Overall Study|Unspecified|3
247683|NCT01336738|817199|P5|Overall Study|Withdrawal by Subject|1
247684|NCT01336738|817200|P4|Overall Study|Withdrawal by Subject|1
247685|NCT01336738|817201|P3|Overall Study|Withdrawal by Subject|2
247686|NCT01336738|817202|P2|Overall Study|Withdrawal by Subject|0
247687|NCT01336738|817203|P1|Overall Study|Withdrawal by Subject|2
247688|NCT01336738|817199|P5|Overall Study|Protocol Violation|0
247689|NCT01336738|817200|P4|Overall Study|Protocol Violation|0
247690|NCT01336738|817201|P3|Overall Study|Protocol Violation|0
247691|NCT01336738|817202|P2|Overall Study|Protocol Violation|1
247692|NCT01336738|817203|P1|Overall Study|Protocol Violation|0
247693|NCT01336738|817199|P5|Overall Study|Did not meet entrance criteria|0
247694|NCT01336738|817200|P4|Overall Study|Did not meet entrance criteria|0
247695|NCT01336738|817201|P3|Overall Study|Did not meet entrance criteria|0
247696|NCT01336738|817202|P2|Overall Study|Did not meet entrance criteria|1
247697|NCT01336738|817203|P1|Overall Study|Did not meet entrance criteria|0
247698|NCT01336738|817199|P5|Overall Study|Lost to Follow-up|2
247699|NCT01336738|817200|P4|Overall Study|Lost to Follow-up|2
247700|NCT01336738|817201|P3|Overall Study|Lost to Follow-up|2
247701|NCT01336738|817202|P2|Overall Study|Lost to Follow-up|1
247702|NCT01336738|817203|P1|Overall Study|Lost to Follow-up|2
247703|NCT01336738|817199|P5|Overall Study|Adverse Event|3
247704|NCT01336738|817200|P4|Overall Study|Adverse Event|1
247705|NCT01336738|817201|P3|Overall Study|Adverse Event|2
247706|NCT01336738|817202|P2|Overall Study|Adverse Event|3
247707|NCT01336738|817203|P1|Overall Study|Adverse Event|0
247708|NCT01336712|817245|P1|Overall Study|Lack of Efficacy|1
247709|NCT01336712|817245|P1|Overall Study|Death|2
247710|NCT01336647|817258|P3|Overall Study|Lost to Follow-up|3
247711|NCT01336647|817259|P2|Overall Study|Lost to Follow-up|1
247712|NCT01336647|817260|P1|Overall Study|Lost to Follow-up|4
247713|NCT01336608|817274|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
247714|NCT01336608|817275|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
247715|NCT01336608|817276|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
247716|NCT01336608|817277|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
247717|NCT01336608|817274|P4|24-week, Double-blind Treatment Period|Physician Decision|1
247718|NCT01336608|817275|P3|24-week, Double-blind Treatment Period|Physician Decision|1
247719|NCT01336608|817276|P2|24-week, Double-blind Treatment Period|Physician Decision|3
247720|NCT01336608|817277|P1|24-week, Double-blind Treatment Period|Physician Decision|0
247721|NCT01336608|817274|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
247722|NCT01336608|817275|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
247723|NCT01336608|817276|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
247724|NCT01336608|817277|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
247725|NCT01336608|817274|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
247726|NCT01336608|817275|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
247727|NCT01336608|817276|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
247728|NCT01336608|817277|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
247729|NCT01336608|817274|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
247730|NCT01336608|817275|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
247731|NCT01336608|817276|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
247732|NCT01336608|817277|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
247733|NCT01336608|817274|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
247734|NCT01336608|817275|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
247735|NCT01336608|817276|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
247736|NCT01336608|817277|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
247737|NCT01336608|817274|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
247738|NCT01336608|817275|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
247739|NCT01336608|817276|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
247740|NCT01336608|817277|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
247741|NCT01336608|817274|P4|24-week, Double-blind Treatment Period|Adverse Event|7
247742|NCT01336608|817275|P3|24-week, Double-blind Treatment Period|Adverse Event|6
247743|NCT01336608|817276|P2|24-week, Double-blind Treatment Period|Adverse Event|8
247744|NCT01336608|817277|P1|24-week, Double-blind Treatment Period|Adverse Event|0
247745|NCT01336608|817274|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
247746|NCT01336608|817275|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
247747|NCT01336608|817276|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
247748|NCT01336608|817277|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
247749|NCT01336608|817274|P4|2-week, Single-blind Run-In Period|Physician Decision|0
247750|NCT01336608|817275|P3|2-week, Single-blind Run-In Period|Physician Decision|0
247751|NCT01336608|817276|P2|2-week, Single-blind Run-In Period|Physician Decision|0
247752|NCT01336608|817277|P1|2-week, Single-blind Run-In Period|Physician Decision|1
247753|NCT01336608|817274|P4|2-week, Single-blind Run-In Period|Adverse Event|0
247754|NCT01336608|817275|P3|2-week, Single-blind Run-In Period|Adverse Event|0
247755|NCT01336608|817276|P2|2-week, Single-blind Run-In Period|Adverse Event|0
247756|NCT01336608|817277|P1|2-week, Single-blind Run-In Period|Adverse Event|1
247757|NCT01336608|817274|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
247758|NCT01336608|817275|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
247759|NCT01336608|817276|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
247760|NCT01336608|817277|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
247761|NCT01336608|817274|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
247762|NCT01336608|817275|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
247763|NCT01336608|817276|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
247764|NCT01336608|817277|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
247765|NCT01336569|817291|P1|Overall Study|Lost to Follow-up|4
247766|NCT01336205|817314|P2|Overall Study|Did not receive treatment|0
247767|NCT01336205|817315|P1|Overall Study|Did not receive treatment|4
247768|NCT01336205|817314|P2|Overall Study|Withdrawal by Subject|38
247769|NCT01336205|817315|P1|Overall Study|Withdrawal by Subject|72
247770|NCT01336205|817314|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
247771|NCT01336205|817315|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
247772|NCT01336205|817314|P2|Overall Study|Death|1
247773|NCT01336205|817315|P1|Overall Study|Death|1
247774|NCT01336205|817314|P2|Overall Study|Adverse Event|6
247775|NCT01336205|817315|P1|Overall Study|Adverse Event|56
247776|NCT01336205|817314|P2|Overall Study|Severe noncompliance with protocol|2
247777|NCT01336205|817315|P1|Overall Study|Severe noncompliance with protocol|9
247778|NCT01336205|817314|P2|Overall Study|Lack of Efficacy|0
247779|NCT01336205|817315|P1|Overall Study|Lack of Efficacy|4
247780|NCT01336205|817314|P2|Overall Study|Study-Specific Withdrawal Criteria|7
247781|NCT01336205|817315|P1|Overall Study|Study-Specific Withdrawal Criteria|16
247782|NCT01336205|817314|P2|Overall Study|Lost to Follow-up|20
247783|NCT01336205|817315|P1|Overall Study|Lost to Follow-up|40
247784|NCT01336205|817314|P2|Overall Study|Other|9
247785|NCT01336205|817315|P1|Overall Study|Other|22
247786|NCT01336023|817343|P3|Week 27 to 52|Unclassified|9
247787|NCT01336023|817344|P2|Week 27 to 52|Unclassified|18
247788|NCT01336023|817345|P1|Week 27 to 52|Unclassified|13
247789|NCT01336023|817343|P3|Week 27 to 52|Withdrawal Criteria|16
247790|NCT01336023|817344|P2|Week 27 to 52|Withdrawal Criteria|19
247791|NCT01336023|817345|P1|Week 27 to 52|Withdrawal Criteria|14
247792|NCT01336023|817343|P3|Week 27 to 52|Protocol Violation|1
247793|NCT01336023|817344|P2|Week 27 to 52|Protocol Violation|2
247794|NCT01336023|817345|P1|Week 27 to 52|Protocol Violation|0
247795|NCT01336023|817343|P3|Week 27 to 52|Adverse Event|2
247796|NCT01336023|817344|P2|Week 27 to 52|Adverse Event|5
247797|NCT01336023|817345|P1|Week 27 to 52|Adverse Event|1
247798|NCT01336023|817343|P3|Week 0 to Week 26|Unclassified|9
247799|NCT01336023|817344|P2|Week 0 to Week 26|Unclassified|16
247800|NCT01336023|817345|P1|Week 0 to Week 26|Unclassified|5
247801|NCT01336023|817343|P3|Week 0 to Week 26|Withdrawal Criteria|40
247802|NCT01336023|817344|P2|Week 0 to Week 26|Withdrawal Criteria|69
247803|NCT01336023|817345|P1|Week 0 to Week 26|Withdrawal Criteria|34
247804|NCT01336023|817343|P3|Week 0 to Week 26|Protocol Violation|0
247805|NCT01336023|817344|P2|Week 0 to Week 26|Protocol Violation|2
247806|NCT01336023|817345|P1|Week 0 to Week 26|Protocol Violation|1
247807|NCT01336023|817343|P3|Week 0 to Week 26|Lack of Efficacy|0
247808|NCT01336023|817344|P2|Week 0 to Week 26|Lack of Efficacy|1
247809|NCT01336023|817345|P1|Week 0 to Week 26|Lack of Efficacy|0
247810|NCT01336023|817343|P3|Week 0 to Week 26|Adverse Event|24
247811|NCT01336023|817344|P2|Week 0 to Week 26|Adverse Event|10
247812|NCT01336023|817345|P1|Week 0 to Week 26|Adverse Event|8
247813|NCT01335997|817366|P2|Period III|Lost to Follow-up|0
247814|NCT01335997|817367|P1|Period III|Lost to Follow-up|1
247815|NCT01335997|817366|P2|Period III|Protocol Violation|1
247816|NCT01335997|817367|P1|Period III|Protocol Violation|0
247817|NCT01335997|817366|P2|Period III|Study Terminated by Sponsor|76
247818|NCT01335997|817367|P1|Period III|Study Terminated by Sponsor|77
247819|NCT01335997|817366|P2|Period III|Adverse Event|2
247820|NCT01335997|817367|P1|Period III|Adverse Event|0
247821|NCT01335997|817366|P2|Period I and II|Physician Decision|1
247822|NCT01335997|817367|P1|Period I and II|Physician Decision|2
247823|NCT01335997|817366|P2|Period I and II|Protocol Violation|10
247824|NCT01335997|817367|P1|Period I and II|Protocol Violation|9
247825|NCT01335997|817366|P2|Period I and II|Study Terminated by Sponsor|415
247826|NCT01335997|817367|P1|Period I and II|Study Terminated by Sponsor|406
247827|NCT01335997|817366|P2|Period I and II|Withdrawal by Subject|4
247828|NCT01335997|817367|P1|Period I and II|Withdrawal by Subject|9
247829|NCT01335997|817366|P2|Period I and II|Lost to Follow-up|5
247830|NCT01335997|817367|P1|Period I and II|Lost to Follow-up|3
247831|NCT01335997|817366|P2|Period I and II|Noncompliance with Study Drug|1
247832|NCT01335997|817367|P1|Period I and II|Noncompliance with Study Drug|1
247833|NCT01335997|817366|P2|Period I and II|Adverse Event|43
247834|NCT01335997|817367|P1|Period I and II|Adverse Event|63
247835|NCT01335971|817380|P3|Overall Study|Did not complete bronchoscopy|1
247836|NCT01335971|817381|P2|Overall Study|Did not complete bronchoscopy|1
247837|NCT01335971|817382|P1|Overall Study|Did not complete bronchoscopy|1
247838|NCT01335971|817380|P3|Overall Study|Withdrawal by Subject|0
247839|NCT01335971|817381|P2|Overall Study|Withdrawal by Subject|0
247840|NCT01335971|817382|P1|Overall Study|Withdrawal by Subject|1
247841|NCT01335698|817478|P5|Treatment Stage 2|Continuing treatment|6
247842|NCT01335698|817479|P4|Treatment Stage 2|Continuing treatment|19
247843|NCT01335698|817480|P3|Treatment Stage 2|Continuing treatment|13
247844|NCT01335698|817481|P2|Treatment Stage 2|Continuing treatment|3
247845|NCT01335698|817482|P1|Treatment Stage 2|Continuing treatment|11
247846|NCT01335698|817478|P5|Treatment Stage 2|Poor compliance/noncompliance|0
247847|NCT01335698|817479|P4|Treatment Stage 2|Poor compliance/noncompliance|3
247848|NCT01335698|817480|P3|Treatment Stage 2|Poor compliance/noncompliance|0
247849|NCT01335698|817481|P2|Treatment Stage 2|Poor compliance/noncompliance|0
247850|NCT01335698|817482|P1|Treatment Stage 2|Poor compliance/noncompliance|1
247851|NCT01335698|817478|P5|Treatment Stage 2|Withdrawal by Subject|0
247852|NCT01335698|817479|P4|Treatment Stage 2|Withdrawal by Subject|0
247853|NCT01335698|817480|P3|Treatment Stage 2|Withdrawal by Subject|0
247854|NCT01335698|817481|P2|Treatment Stage 2|Withdrawal by Subject|0
247855|NCT01335698|817482|P1|Treatment Stage 2|Withdrawal by Subject|1
247856|NCT01335698|817478|P5|Treatment Stage 2|Adverse Event|0
247857|NCT01335698|817479|P4|Treatment Stage 2|Adverse Event|1
247858|NCT01335698|817480|P3|Treatment Stage 2|Adverse Event|0
247859|NCT01335698|817481|P2|Treatment Stage 2|Adverse Event|0
247860|NCT01335698|817482|P1|Treatment Stage 2|Adverse Event|0
247861|NCT01335698|817478|P5|Treatment Stage 2|Lack of Efficacy|0
247862|NCT01335698|817479|P4|Treatment Stage 2|Lack of Efficacy|1
247863|NCT01335698|817480|P3|Treatment Stage 2|Lack of Efficacy|3
247864|NCT01335698|817481|P2|Treatment Stage 2|Lack of Efficacy|1
247865|NCT01335698|817482|P1|Treatment Stage 2|Lack of Efficacy|2
247866|NCT01335698|817478|P5|Treatment Stage 1|Not specified|0
247867|NCT01335698|817479|P4|Treatment Stage 1|Not specified|1
247868|NCT01335698|817480|P3|Treatment Stage 1|Not specified|0
247869|NCT01335698|817481|P2|Treatment Stage 1|Not specified|0
247870|NCT01335698|817482|P1|Treatment Stage 1|Not specified|1
247871|NCT01335698|817478|P5|Treatment Stage 1|No longer meets study criteria|0
247872|NCT01335698|817479|P4|Treatment Stage 1|No longer meets study criteria|1
247873|NCT01335698|817480|P3|Treatment Stage 1|No longer meets study criteria|0
247874|NCT01335698|817481|P2|Treatment Stage 1|No longer meets study criteria|1
247875|NCT01335698|817482|P1|Treatment Stage 1|No longer meets study criteria|1
247876|NCT01335698|817478|P5|Treatment Stage 1|Poor compliance/noncompliance|0
247877|NCT01335698|817479|P4|Treatment Stage 1|Poor compliance/noncompliance|2
247878|NCT01335698|817480|P3|Treatment Stage 1|Poor compliance/noncompliance|0
247879|NCT01335698|817481|P2|Treatment Stage 1|Poor compliance/noncompliance|1
247880|NCT01335698|817482|P1|Treatment Stage 1|Poor compliance/noncompliance|0
247881|NCT01335698|817478|P5|Treatment Stage 1|Lost to Follow-up|0
247882|NCT01335698|817479|P4|Treatment Stage 1|Lost to Follow-up|0
247883|NCT01335698|817480|P3|Treatment Stage 1|Lost to Follow-up|0
247884|NCT01335698|817481|P2|Treatment Stage 1|Lost to Follow-up|1
247885|NCT01335698|817482|P1|Treatment Stage 1|Lost to Follow-up|1
247886|NCT01335698|817478|P5|Treatment Stage 1|Withdrawal by Subject|0
247887|NCT01335698|817479|P4|Treatment Stage 1|Withdrawal by Subject|1
247888|NCT01335698|817480|P3|Treatment Stage 1|Withdrawal by Subject|0
247889|NCT01335698|817481|P2|Treatment Stage 1|Withdrawal by Subject|2
247890|NCT01335698|817482|P1|Treatment Stage 1|Withdrawal by Subject|1
247891|NCT01335698|817478|P5|Treatment Stage 1|Adverse Event|1
247892|NCT01335698|817479|P4|Treatment Stage 1|Adverse Event|1
247893|NCT01335698|817480|P3|Treatment Stage 1|Adverse Event|2
247894|NCT01335698|817481|P2|Treatment Stage 1|Adverse Event|2
247895|NCT01335698|817482|P1|Treatment Stage 1|Adverse Event|1
247896|NCT01335698|817478|P5|Treatment Stage 1|Lack of Efficacy|1
247897|NCT01335698|817479|P4|Treatment Stage 1|Lack of Efficacy|3
247898|NCT01335698|817480|P3|Treatment Stage 1|Lack of Efficacy|3
247899|NCT01335698|817481|P2|Treatment Stage 1|Lack of Efficacy|1
247900|NCT01335698|817482|P1|Treatment Stage 1|Lack of Efficacy|3
247901|NCT01335477|817540|P2|Overall Study|Reason other than those stated above|2
247902|NCT01335477|817541|P1|Overall Study|Reason other than those stated above|2
247903|NCT01335477|817540|P2|Overall Study|Not treated|2
247904|NCT01335477|817541|P1|Overall Study|Not treated|1
247905|NCT01335477|817540|P2|Overall Study|Consent withdrawn, not due to AE|9
247906|NCT01335477|817541|P1|Overall Study|Consent withdrawn, not due to AE|7
247907|NCT01335477|817540|P2|Overall Study|Lost to Follow-up|2
247908|NCT01335477|817541|P1|Overall Study|Lost to Follow-up|1
247909|NCT01335477|817540|P2|Overall Study|Non compliant with protocol|2
247910|NCT01335477|817541|P1|Overall Study|Non compliant with protocol|0
247911|NCT01335477|817540|P2|Overall Study|Adverse Event|42
247912|NCT01335477|817541|P1|Overall Study|Adverse Event|30
247913|NCT01335464|817605|P2|Overall Study|Reason other than those stated above|1
247914|NCT01335464|817606|P1|Overall Study|Reason other than those stated above|1
247915|NCT01335464|817605|P2|Overall Study|Not treated|0
247916|NCT01335464|817606|P1|Overall Study|Not treated|2
247917|NCT01335464|817605|P2|Overall Study|Consent withdrawn, not due to AE|23
247918|NCT01335464|817606|P1|Overall Study|Consent withdrawn, not due to AE|12
247919|NCT01335464|817605|P2|Overall Study|Non compliant with protocol|0
247920|NCT01335464|817606|P1|Overall Study|Non compliant with protocol|2
247921|NCT01335464|817605|P2|Overall Study|Adverse Event|25
247922|NCT01335464|817606|P1|Overall Study|Adverse Event|15
247923|NCT01334918|817744|P2|Overall Study|Withdrawal by Subject|1
247924|NCT01334918|817745|P1|Overall Study|Withdrawal by Subject|0
247925|NCT01334918|817744|P2|Overall Study|Adverse Event|0
247926|NCT01334918|817745|P1|Overall Study|Adverse Event|2
247927|NCT01334918|817744|P2|Overall Study|Did not receive study drug|0
247928|NCT01334918|817745|P1|Overall Study|Did not receive study drug|6
247929|NCT01334866|817771|P1|Overall Study|medically necessary post-procedure|1
247930|NCT01334866|817771|P1|Overall Study|medically necessary prior to procedure|2
247931|NCT01334866|817771|P1|Overall Study|Physician Decision|3
247932|NCT01334866|817771|P1|Overall Study|Lost to Follow-up|3
247933|NCT01334866|817771|P1|Overall Study|Withdrawal by Subject|10
247934|NCT01334710|817808|P1|Overall Study|Trial was terminated|3
247935|NCT01334606|817812|P1|Overall Study|Study Terminated due to slow enrolment|18
247936|NCT01334554|817820|P2|Overall Study|Adverse Event|2
247937|NCT01334554|817821|P1|Overall Study|Adverse Event|4
247938|NCT01334515|817831|P2|Overall Study|Withdrawal by Subject|1
247939|NCT01334515|817832|P1|Overall Study|Withdrawal by Subject|1
247940|NCT01334515|817831|P2|Overall Study|Physician Decision|1
247941|NCT01334515|817832|P1|Overall Study|Physician Decision|1
247942|NCT01334515|817831|P2|Overall Study|Lack of Efficacy|21
247943|NCT01334515|817832|P1|Overall Study|Lack of Efficacy|8
247944|NCT01334515|817831|P2|Overall Study|Death|0
247945|NCT01334515|817832|P1|Overall Study|Death|1
247946|NCT01334515|817831|P2|Overall Study|Adverse Event|6
247947|NCT01334515|817832|P1|Overall Study|Adverse Event|1
247948|NCT01334125|817870|P2|Overall Study|Lost to Follow-up|3
247949|NCT01334125|817871|P1|Overall Study|Lost to Follow-up|3
247950|NCT01333956|817887|P4|Overall Study|Withdrawal by Subject|0
247951|NCT01333956|817888|P3|Overall Study|Withdrawal by Subject|1
247952|NCT01333956|817889|P2|Overall Study|Withdrawal by Subject|2
247953|NCT01333956|817890|P1|Overall Study|Withdrawal by Subject|0
247954|NCT01333956|817887|P4|Overall Study|Unable to complete study procedure|1
247955|NCT01333956|817888|P3|Overall Study|Unable to complete study procedure|0
247956|NCT01333956|817889|P2|Overall Study|Unable to complete study procedure|0
247957|NCT01333956|817890|P1|Overall Study|Unable to complete study procedure|1
247958|NCT01333956|817887|P4|Overall Study|Lost to Follow-up|1
247959|NCT01333956|817888|P3|Overall Study|Lost to Follow-up|0
247960|NCT01333956|817889|P2|Overall Study|Lost to Follow-up|2
247961|NCT01333956|817890|P1|Overall Study|Lost to Follow-up|1
247962|NCT01333865|817924|P1|Overall Study|Adverse Event|2
247963|NCT01333722|817944|P2|Overall Study|Withdrawal by Subject|1
247964|NCT01333722|817945|P1|Overall Study|Withdrawal by Subject|0
247965|NCT01333722|817944|P2|Overall Study|Lack of Efficacy|2
247966|NCT01333722|817945|P1|Overall Study|Lack of Efficacy|0
247967|NCT01333501|817970|P2|Overall Study|Withdrawn consent|12
247968|NCT01333501|817971|P1|Overall Study|Withdrawn consent|3
247969|NCT01333501|817970|P2|Overall Study|Unsatisfactory therapeutic effect|7
247970|NCT01333501|817971|P1|Overall Study|Unsatisfactory therapeutic effect|1
247971|NCT01333501|817970|P2|Overall Study|Abnormal laboratory value|1
247972|NCT01333501|817971|P1|Overall Study|Abnormal laboratory value|2
247973|NCT01333501|817970|P2|Overall Study|Adverse Event|1
247974|NCT01333501|817971|P1|Overall Study|Adverse Event|3
247975|NCT01333475|818038|P2|Overall Study|Toxicity|3
247976|NCT01333475|818039|P1|Overall Study|Toxicity|1
247977|NCT01333475|818038|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
247978|NCT01333475|818039|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
247979|NCT01333397|818065|P5|Overall Study|Lost to Follow-up|0
247980|NCT01333397|818066|P4|Overall Study|Lost to Follow-up|1
247981|NCT01333397|818067|P3|Overall Study|Lost to Follow-up|0
247982|NCT01333397|818068|P2|Overall Study|Lost to Follow-up|0
247983|NCT01333397|818069|P1|Overall Study|Lost to Follow-up|1
247984|NCT01333189|818143|P2|Overall Study|Moved from region|1
247985|NCT01333189|818144|P1|Overall Study|Moved from region|0
247986|NCT01333189|818143|P2|Overall Study|Transportation difficulties|1
247987|NCT01333189|818144|P1|Overall Study|Transportation difficulties|0
247988|NCT01333189|818143|P2|Overall Study|Adverse Event|0
247989|NCT01333189|818144|P1|Overall Study|Adverse Event|1
247990|NCT01333189|818143|P2|Overall Study|Time constraints|0
247991|NCT01333189|818144|P1|Overall Study|Time constraints|1
247992|NCT01332994|818172|P1|Overall Study|Not Specified|8
247993|NCT01332994|818172|P1|Overall Study|Administrative Problem|2
247994|NCT01332994|818172|P1|Overall Study|Withdrawal by Subject|15
247995|NCT01332994|818172|P1|Overall Study|Protocol Violation|6
247996|NCT01332994|818172|P1|Overall Study|Lost to Follow-up|4
247997|NCT01332994|818172|P1|Overall Study|Lack of Efficacy|1
247998|NCT01332994|818172|P1|Overall Study|Death|1
247999|NCT01332994|818172|P1|Overall Study|Adverse Event|34
248000|NCT01332968|818241|P8|Follow-Up Period|Lost to Follow-up|2
248001|NCT01332968|818242|P7|Follow-Up Period|Lost to Follow-up|1
248002|NCT01332968|818243|P6|Follow-Up Period|Lost to Follow-up|0
248003|NCT01332968|818244|P5|Follow-Up Period|Lost to Follow-up|0
248004|NCT01332968|818245|P4|Follow-Up Period|Lost to Follow-up|0
248005|NCT01332968|818246|P3|Follow-Up Period|Lost to Follow-up|0
248006|NCT01332968|818247|P2|Follow-Up Period|Lost to Follow-up|0
248007|NCT01332968|818248|P1|Follow-Up Period|Lost to Follow-up|0
248008|NCT01332968|818241|P8|Follow-Up Period|Withdrawal by Subject|2
248009|NCT01332968|818242|P7|Follow-Up Period|Withdrawal by Subject|1
248010|NCT01332968|818243|P6|Follow-Up Period|Withdrawal by Subject|0
248011|NCT01332968|818244|P5|Follow-Up Period|Withdrawal by Subject|0
248012|NCT01332968|818245|P4|Follow-Up Period|Withdrawal by Subject|0
248013|NCT01332968|818246|P3|Follow-Up Period|Withdrawal by Subject|0
248014|NCT01332968|818247|P2|Follow-Up Period|Withdrawal by Subject|0
248015|NCT01332968|818248|P1|Follow-Up Period|Withdrawal by Subject|0
248016|NCT01332968|818241|P8|Follow-Up Period|Follow-up ongoing|505
248017|NCT01332968|818242|P7|Follow-Up Period|Follow-up ongoing|502
248018|NCT01332968|818243|P6|Follow-Up Period|Follow-up ongoing|0
248019|NCT01332968|818244|P5|Follow-Up Period|Follow-up ongoing|0
248020|NCT01332968|818245|P4|Follow-Up Period|Follow-up ongoing|0
248021|NCT01332968|818246|P3|Follow-Up Period|Follow-up ongoing|0
248022|NCT01332968|818247|P2|Follow-Up Period|Follow-up ongoing|0
248023|NCT01332968|818248|P1|Follow-Up Period|Follow-up ongoing|0
248024|NCT01332968|818241|P8|Follow-Up Period|Death|22
248025|NCT01332968|818242|P7|Follow-Up Period|Death|38
248026|NCT01332968|818243|P6|Follow-Up Period|Death|0
248027|NCT01332968|818244|P5|Follow-Up Period|Death|0
248028|NCT01332968|818245|P4|Follow-Up Period|Death|0
248029|NCT01332968|818246|P3|Follow-Up Period|Death|0
248030|NCT01332968|818247|P2|Follow-Up Period|Death|0
248031|NCT01332968|818248|P1|Follow-Up Period|Death|0
248032|NCT01332968|818241|P8|Maintenance/Observation Period|Treatment ongoing|0
248033|NCT01332968|818242|P7|Maintenance/Observation Period|Treatment ongoing|0
248034|NCT01332968|818243|P6|Maintenance/Observation Period|Treatment ongoing|8
248035|NCT01332968|818244|P5|Maintenance/Observation Period|Treatment ongoing|10
248036|NCT01332968|818245|P4|Maintenance/Observation Period|Treatment ongoing|62
248037|NCT01332968|818246|P3|Maintenance/Observation Period|Treatment ongoing|54
248038|NCT01332968|818247|P2|Maintenance/Observation Period|Treatment ongoing|0
248039|NCT01332968|818248|P1|Maintenance/Observation Period|Treatment ongoing|0
248040|NCT01332968|818241|P8|Maintenance/Observation Period|Adverse Event|0
248041|NCT01332968|818242|P7|Maintenance/Observation Period|Adverse Event|0
248042|NCT01332968|818243|P6|Maintenance/Observation Period|Adverse Event|0
248043|NCT01332968|818244|P5|Maintenance/Observation Period|Adverse Event|0
248044|NCT01332968|818245|P4|Maintenance/Observation Period|Adverse Event|65
248045|NCT01332968|818246|P3|Maintenance/Observation Period|Adverse Event|50
248046|NCT01332968|818247|P2|Maintenance/Observation Period|Adverse Event|0
248047|NCT01332968|818248|P1|Maintenance/Observation Period|Adverse Event|0
248048|NCT01332968|818241|P8|Maintenance/Observation Period|Death|0
248049|NCT01332968|818242|P7|Maintenance/Observation Period|Death|0
248050|NCT01332968|818243|P6|Maintenance/Observation Period|Death|0
248051|NCT01332968|818244|P5|Maintenance/Observation Period|Death|0
248052|NCT01332968|818245|P4|Maintenance/Observation Period|Death|6
248053|NCT01332968|818246|P3|Maintenance/Observation Period|Death|5
248054|NCT01332968|818247|P2|Maintenance/Observation Period|Death|0
248055|NCT01332968|818248|P1|Maintenance/Observation Period|Death|0
248056|NCT01332968|818241|P8|Maintenance/Observation Period|Lost to Follow-up|0
248057|NCT01332968|818242|P7|Maintenance/Observation Period|Lost to Follow-up|0
248058|NCT01332968|818243|P6|Maintenance/Observation Period|Lost to Follow-up|0
248059|NCT01332968|818244|P5|Maintenance/Observation Period|Lost to Follow-up|0
248060|NCT01332968|818245|P4|Maintenance/Observation Period|Lost to Follow-up|2
248061|NCT01332968|818246|P3|Maintenance/Observation Period|Lost to Follow-up|1
248062|NCT01332968|818247|P2|Maintenance/Observation Period|Lost to Follow-up|0
248063|NCT01332968|818248|P1|Maintenance/Observation Period|Lost to Follow-up|0
248064|NCT01332968|818241|P8|Maintenance/Observation Period|Non-compliance|0
248065|NCT01332968|818242|P7|Maintenance/Observation Period|Non-compliance|0
248066|NCT01332968|818243|P6|Maintenance/Observation Period|Non-compliance|1
248067|NCT01332968|818244|P5|Maintenance/Observation Period|Non-compliance|0
248068|NCT01332968|818245|P4|Maintenance/Observation Period|Non-compliance|3
248069|NCT01332968|818246|P3|Maintenance/Observation Period|Non-compliance|2
248070|NCT01332968|818247|P2|Maintenance/Observation Period|Non-compliance|0
248071|NCT01332968|818248|P1|Maintenance/Observation Period|Non-compliance|0
248072|NCT01332968|818241|P8|Maintenance/Observation Period|Other|0
248073|NCT01332968|818242|P7|Maintenance/Observation Period|Other|0
248074|NCT01332968|818243|P6|Maintenance/Observation Period|Other|0
248075|NCT01332968|818244|P5|Maintenance/Observation Period|Other|0
248076|NCT01332968|818245|P4|Maintenance/Observation Period|Other|5
248077|NCT01332968|818246|P3|Maintenance/Observation Period|Other|4
248078|NCT01332968|818247|P2|Maintenance/Observation Period|Other|0
248079|NCT01332968|818248|P1|Maintenance/Observation Period|Other|0
248080|NCT01332968|818241|P8|Maintenance/Observation Period|Physician Decision|0
248081|NCT01332968|818242|P7|Maintenance/Observation Period|Physician Decision|0
248082|NCT01332968|818243|P6|Maintenance/Observation Period|Physician Decision|0
248083|NCT01332968|818244|P5|Maintenance/Observation Period|Physician Decision|0
248084|NCT01332968|818245|P4|Maintenance/Observation Period|Physician Decision|19
248085|NCT01332968|818246|P3|Maintenance/Observation Period|Physician Decision|14
248086|NCT01332968|818247|P2|Maintenance/Observation Period|Physician Decision|0
248087|NCT01332968|818248|P1|Maintenance/Observation Period|Physician Decision|0
248088|NCT01332968|818241|P8|Maintenance/Observation Period|Progressive disease|0
248089|NCT01332968|818242|P7|Maintenance/Observation Period|Progressive disease|0
248090|NCT01332968|818243|P6|Maintenance/Observation Period|Progressive disease|0
248091|NCT01332968|818244|P5|Maintenance/Observation Period|Progressive disease|0
248092|NCT01332968|818245|P4|Maintenance/Observation Period|Progressive disease|39
248093|NCT01332968|818246|P3|Maintenance/Observation Period|Progressive disease|72
248094|NCT01332968|818247|P2|Maintenance/Observation Period|Progressive disease|0
248095|NCT01332968|818248|P1|Maintenance/Observation Period|Progressive disease|0
248096|NCT01332968|818241|P8|Maintenance/Observation Period|Protocol Violation|0
248097|NCT01332968|818242|P7|Maintenance/Observation Period|Protocol Violation|0
248098|NCT01332968|818243|P6|Maintenance/Observation Period|Protocol Violation|0
248099|NCT01332968|818244|P5|Maintenance/Observation Period|Protocol Violation|0
248100|NCT01332968|818245|P4|Maintenance/Observation Period|Protocol Violation|1
248101|NCT01332968|818246|P3|Maintenance/Observation Period|Protocol Violation|1
248102|NCT01332968|818247|P2|Maintenance/Observation Period|Protocol Violation|0
248103|NCT01332968|818248|P1|Maintenance/Observation Period|Protocol Violation|0
248104|NCT01332968|818241|P8|Maintenance/Observation Period|Withdrawal by Subject|0
248105|NCT01332968|818242|P7|Maintenance/Observation Period|Withdrawal by Subject|0
248106|NCT01332968|818243|P6|Maintenance/Observation Period|Withdrawal by Subject|0
248107|NCT01332968|818244|P5|Maintenance/Observation Period|Withdrawal by Subject|0
248108|NCT01332968|818245|P4|Maintenance/Observation Period|Withdrawal by Subject|5
248109|NCT01332968|818246|P3|Maintenance/Observation Period|Withdrawal by Subject|10
248110|NCT01332968|818247|P2|Maintenance/Observation Period|Withdrawal by Subject|0
248111|NCT01332968|818248|P1|Maintenance/Observation Period|Withdrawal by Subject|0
248112|NCT01332968|818241|P8|Induction Period|Randomized, but not treated|0
248113|NCT01332968|818242|P7|Induction Period|Randomized, but not treated|0
248114|NCT01332968|818243|P6|Induction Period|Randomized, but not treated|0
248115|NCT01332968|818244|P5|Induction Period|Randomized, but not treated|0
248116|NCT01332968|818245|P4|Induction Period|Randomized, but not treated|0
248117|NCT01332968|818246|P3|Induction Period|Randomized, but not treated|0
248118|NCT01332968|818247|P2|Induction Period|Randomized, but not treated|7
248119|NCT01332968|818248|P1|Induction Period|Randomized, but not treated|4
248120|NCT01332968|818241|P8|Induction Period|Adverse Event|0
248121|NCT01332968|818242|P7|Induction Period|Adverse Event|0
248122|NCT01332968|818243|P6|Induction Period|Adverse Event|0
248123|NCT01332968|818244|P5|Induction Period|Adverse Event|0
248124|NCT01332968|818245|P4|Induction Period|Adverse Event|0
248125|NCT01332968|818246|P3|Induction Period|Adverse Event|0
248126|NCT01332968|818247|P2|Induction Period|Adverse Event|26
248127|NCT01332968|818248|P1|Induction Period|Adverse Event|23
248128|NCT01332968|818241|P8|Induction Period|Death|0
248129|NCT01332968|818242|P7|Induction Period|Death|0
248130|NCT01332968|818243|P6|Induction Period|Death|0
248131|NCT01332968|818244|P5|Induction Period|Death|0
248132|NCT01332968|818245|P4|Induction Period|Death|0
248133|NCT01332968|818246|P3|Induction Period|Death|0
248134|NCT01332968|818247|P2|Induction Period|Death|4
248135|NCT01332968|818248|P1|Induction Period|Death|1
248136|NCT01332968|818241|P8|Induction Period|Non-compliance|0
248137|NCT01332968|818242|P7|Induction Period|Non-compliance|0
248138|NCT01332968|818243|P6|Induction Period|Non-compliance|0
248139|NCT01332968|818244|P5|Induction Period|Non-compliance|0
248140|NCT01332968|818245|P4|Induction Period|Non-compliance|0
248141|NCT01332968|818246|P3|Induction Period|Non-compliance|0
248142|NCT01332968|818247|P2|Induction Period|Non-compliance|0
248143|NCT01332968|818248|P1|Induction Period|Non-compliance|1
248144|NCT01332968|818241|P8|Induction Period|Other|0
248145|NCT01332968|818242|P7|Induction Period|Other|0
248146|NCT01332968|818243|P6|Induction Period|Other|0
248147|NCT01332968|818244|P5|Induction Period|Other|0
248148|NCT01332968|818245|P4|Induction Period|Other|0
248149|NCT01332968|818246|P3|Induction Period|Other|0
248150|NCT01332968|818247|P2|Induction Period|Other|2
248151|NCT01332968|818248|P1|Induction Period|Other|2
248152|NCT01332968|818241|P8|Induction Period|Physician Decision|0
248153|NCT01332968|818242|P7|Induction Period|Physician Decision|0
248154|NCT01332968|818243|P6|Induction Period|Physician Decision|0
248155|NCT01332968|818244|P5|Induction Period|Physician Decision|0
248156|NCT01332968|818245|P4|Induction Period|Physician Decision|0
248157|NCT01332968|818246|P3|Induction Period|Physician Decision|0
248158|NCT01332968|818247|P2|Induction Period|Physician Decision|1
248159|NCT01332968|818248|P1|Induction Period|Physician Decision|6
248160|NCT01332968|818241|P8|Induction Period|Progressive disease|0
248161|NCT01332968|818242|P7|Induction Period|Progressive disease|0
248162|NCT01332968|818243|P6|Induction Period|Progressive disease|0
248163|NCT01332968|818244|P5|Induction Period|Progressive disease|0
248164|NCT01332968|818245|P4|Induction Period|Progressive disease|0
248165|NCT01332968|818246|P3|Induction Period|Progressive disease|0
248166|NCT01332968|818247|P2|Induction Period|Progressive disease|7
248167|NCT01332968|818248|P1|Induction Period|Progressive disease|15
248168|NCT01332968|818241|P8|Induction Period|Protocol Violation|0
248169|NCT01332968|818242|P7|Induction Period|Protocol Violation|0
248170|NCT01332968|818243|P6|Induction Period|Protocol Violation|0
248171|NCT01332968|818244|P5|Induction Period|Protocol Violation|0
248172|NCT01332968|818245|P4|Induction Period|Protocol Violation|0
248173|NCT01332968|818246|P3|Induction Period|Protocol Violation|0
248174|NCT01332968|818247|P2|Induction Period|Protocol Violation|4
248175|NCT01332968|818248|P1|Induction Period|Protocol Violation|3
248176|NCT01332968|818241|P8|Induction Period|Withdrawal by Subject|0
248177|NCT01332968|818242|P7|Induction Period|Withdrawal by Subject|0
248178|NCT01332968|818243|P6|Induction Period|Withdrawal by Subject|0
248179|NCT01332968|818244|P5|Induction Period|Withdrawal by Subject|0
248180|NCT01332968|818245|P4|Induction Period|Withdrawal by Subject|0
248181|NCT01332968|818246|P3|Induction Period|Withdrawal by Subject|0
248182|NCT01332968|818247|P2|Induction Period|Withdrawal by Subject|5
248183|NCT01332968|818248|P1|Induction Period|Withdrawal by Subject|3
248184|NCT01332318|818432|P4|Overall Study|Protocol Violation|1
248185|NCT01332318|818433|P3|Overall Study|Protocol Violation|1
248186|NCT01332318|818434|P2|Overall Study|Protocol Violation|0
248187|NCT01332318|818435|P1|Overall Study|Protocol Violation|1
248188|NCT01332318|818432|P4|Overall Study|Withdrawal by Subject|1
248189|NCT01332318|818433|P3|Overall Study|Withdrawal by Subject|0
248190|NCT01332318|818434|P2|Overall Study|Withdrawal by Subject|1
248191|NCT01332318|818435|P1|Overall Study|Withdrawal by Subject|1
248192|NCT01332318|818432|P4|Overall Study|Adverse Event|0
248193|NCT01332318|818433|P3|Overall Study|Adverse Event|0
248194|NCT01332318|818434|P2|Overall Study|Adverse Event|3
248195|NCT01332318|818435|P1|Overall Study|Adverse Event|0
248196|NCT01332305|818546|P5|Overall Study|Physician Decision|0
248197|NCT01332305|818547|P4|Overall Study|Physician Decision|1
248198|NCT01332305|818548|P3|Overall Study|Physician Decision|0
248199|NCT01332305|818549|P2|Overall Study|Physician Decision|0
248200|NCT01332305|818550|P1|Overall Study|Physician Decision|0
248201|NCT01332305|818546|P5|Overall Study|Treatment Failure|0
248202|NCT01332305|818547|P4|Overall Study|Treatment Failure|0
248203|NCT01332305|818548|P3|Overall Study|Treatment Failure|0
248204|NCT01332305|818549|P2|Overall Study|Treatment Failure|1
248205|NCT01332305|818550|P1|Overall Study|Treatment Failure|1
248206|NCT01332305|818546|P5|Overall Study|Withdrawal by Sponsor|1
248207|NCT01332305|818547|P4|Overall Study|Withdrawal by Sponsor|1
248208|NCT01332305|818548|P3|Overall Study|Withdrawal by Sponsor|0
248209|NCT01332305|818549|P2|Overall Study|Withdrawal by Sponsor|0
248210|NCT01332305|818550|P1|Overall Study|Withdrawal by Sponsor|1
248211|NCT01332305|818546|P5|Overall Study|Protocol Violation|3
248212|NCT01332305|818547|P4|Overall Study|Protocol Violation|0
248213|NCT01332305|818548|P3|Overall Study|Protocol Violation|1
248214|NCT01332305|818549|P2|Overall Study|Protocol Violation|2
248215|NCT01332305|818550|P1|Overall Study|Protocol Violation|1
248216|NCT01332305|818546|P5|Overall Study|Lost to Follow-up|3
248217|NCT01332305|818547|P4|Overall Study|Lost to Follow-up|2
248218|NCT01332305|818548|P3|Overall Study|Lost to Follow-up|3
248219|NCT01332305|818549|P2|Overall Study|Lost to Follow-up|2
248220|NCT01332305|818550|P1|Overall Study|Lost to Follow-up|0
248221|NCT01332305|818546|P5|Overall Study|Withdrawal by Subject|0
248222|NCT01332305|818547|P4|Overall Study|Withdrawal by Subject|1
248223|NCT01332305|818548|P3|Overall Study|Withdrawal by Subject|4
248224|NCT01332305|818549|P2|Overall Study|Withdrawal by Subject|5
248225|NCT01332305|818550|P1|Overall Study|Withdrawal by Subject|6
248226|NCT01332305|818546|P5|Overall Study|Adverse Event|5
248227|NCT01332305|818547|P4|Overall Study|Adverse Event|3
248228|NCT01332305|818548|P3|Overall Study|Adverse Event|6
248229|NCT01332305|818549|P2|Overall Study|Adverse Event|4
248230|NCT01332305|818550|P1|Overall Study|Adverse Event|1
248231|NCT01332292|818572|P2|Treatment Period 2 (14 Days)|Physician Decision|1
248232|NCT01332292|818573|P1|Treatment Period 2 (14 Days)|Physician Decision|1
248233|NCT01332292|818572|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
248234|NCT01332292|818573|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
248235|NCT01332292|818572|P2|Treatment Period 1 (14 Days)|Adverse Event|0
248236|NCT01332292|818573|P1|Treatment Period 1 (14 Days)|Adverse Event|1
248237|NCT01332227|818664|P2|Overall Study|Patient began prohibited medication|1
248238|NCT01332227|818665|P1|Overall Study|Patient began prohibited medication|0
248239|NCT01332227|818664|P2|Overall Study|Patient moved from area|0
248240|NCT01332227|818665|P1|Overall Study|Patient moved from area|1
248241|NCT01332227|818664|P2|Overall Study|Poor compliance/noncompliance|1
248242|NCT01332227|818665|P1|Overall Study|Poor compliance/noncompliance|1
248243|NCT01332227|818664|P2|Overall Study|Lack of Efficacy|1
248244|NCT01332227|818665|P1|Overall Study|Lack of Efficacy|3
248245|NCT01332227|818664|P2|Overall Study|Lost to Follow-up|0
248246|NCT01332227|818665|P1|Overall Study|Lost to Follow-up|2
248247|NCT01332227|818664|P2|Overall Study|Withdrawal by Subject|1
248248|NCT01332227|818665|P1|Overall Study|Withdrawal by Subject|5
248249|NCT01332227|818664|P2|Overall Study|Adverse Event|1
248250|NCT01332227|818665|P1|Overall Study|Adverse Event|4
248251|NCT01332149|818685|P2|Overall Study|Randomized but not treated|2
248252|NCT01332149|818686|P1|Overall Study|Randomized but not treated|1
248253|NCT01332149|818685|P2|Overall Study|Did not meet entrance criteria|4
248254|NCT01332149|818686|P1|Overall Study|Did not meet entrance criteria|3
248255|NCT01332149|818685|P2|Overall Study|Insufficient clinical response|7
248256|NCT01332149|818686|P1|Overall Study|Insufficient clinical response|4
248257|NCT01332149|818685|P2|Overall Study|Lost to Follow-up|1
248258|NCT01332149|818686|P1|Overall Study|Lost to Follow-up|1
248259|NCT01332149|818685|P2|Overall Study|Withdrawal by Subject|5
248260|NCT01332149|818686|P1|Overall Study|Withdrawal by Subject|4
248261|NCT01332149|818685|P2|Overall Study|Protocol Violation|3
248262|NCT01332149|818686|P1|Overall Study|Protocol Violation|1
248263|NCT01332149|818685|P2|Overall Study|Other unspecified|7
248264|NCT01332149|818686|P1|Overall Study|Other unspecified|5
248265|NCT01332149|818685|P2|Overall Study|Adverse Event|9
248266|NCT01332149|818686|P1|Overall Study|Adverse Event|11
248267|NCT01332019|818764|P2|Overall Study|Adverse Event|22
248268|NCT01332019|818765|P1|Overall Study|Adverse Event|13
248269|NCT01332019|818764|P2|Overall Study|Lost to Follow-up|7
248270|NCT01332019|818765|P1|Overall Study|Lost to Follow-up|4
248271|NCT01332019|818764|P2|Overall Study|Withdrawal by Subject|71
248272|NCT01332019|818765|P1|Overall Study|Withdrawal by Subject|73
248273|NCT01332019|818764|P2|Overall Study|Physician Decision|3
248274|NCT01332019|818765|P1|Overall Study|Physician Decision|4
248275|NCT01332019|818764|P2|Overall Study|Death|1
248276|NCT01332019|818765|P1|Overall Study|Death|2
248277|NCT01332019|818764|P2|Overall Study|Not Specified|18
248278|NCT01332019|818765|P1|Overall Study|Not Specified|16
248279|NCT01332019|818764|P2|Overall Study|Was Not Dosed|0
248280|NCT01332019|818765|P1|Overall Study|Was Not Dosed|1
248281|NCT01331824|818847|P1|Overall Study|Withdrawal by Subject|1
248282|NCT01331824|818847|P1|Overall Study|Disease Progression|9
248283|NCT01331824|818847|P1|Overall Study|Death|1
248284|NCT01331824|818847|P1|Overall Study|Adverse Event|2
248285|NCT01331681|818881|P3|Overall Study|Not Received Study Treatment|2
248286|NCT01331681|818882|P2|Overall Study|Not Received Study Treatment|0
248287|NCT01331681|818883|P1|Overall Study|Not Received Study Treatment|0
248288|NCT01331681|818881|P3|Overall Study|Switching to other therapy|1
248289|NCT01331681|818882|P2|Overall Study|Switching to other therapy|0
248290|NCT01331681|818883|P1|Overall Study|Switching to other therapy|0
248291|NCT01331681|818881|P3|Overall Study|Sponsor decision|0
248292|NCT01331681|818882|P2|Overall Study|Sponsor decision|1
248293|NCT01331681|818883|P1|Overall Study|Sponsor decision|1
248294|NCT01331681|818881|P3|Overall Study|Therapeutic procedure required|0
248295|NCT01331681|818882|P2|Overall Study|Therapeutic procedure required|0
248296|NCT01331681|818883|P1|Overall Study|Therapeutic procedure required|1
248297|NCT01331681|818881|P3|Overall Study|Physician Decision|4
248298|NCT01331681|818882|P2|Overall Study|Physician Decision|0
248299|NCT01331681|818883|P1|Overall Study|Physician Decision|2
248300|NCT01331681|818881|P3|Overall Study|Lost to Follow-up|1
248301|NCT01331681|818882|P2|Overall Study|Lost to Follow-up|4
248302|NCT01331681|818883|P1|Overall Study|Lost to Follow-up|2
248303|NCT01331681|818881|P3|Overall Study|Protocol Violation|0
248304|NCT01331681|818882|P2|Overall Study|Protocol Violation|1
248305|NCT01331681|818883|P1|Overall Study|Protocol Violation|1
248306|NCT01331681|818881|P3|Overall Study|Withdrawal by Subject|15
248307|NCT01331681|818882|P2|Overall Study|Withdrawal by Subject|8
248308|NCT01331681|818883|P1|Overall Study|Withdrawal by Subject|12
248309|NCT01331681|818881|P3|Overall Study|Lack of Efficacy|0
248310|NCT01331681|818882|P2|Overall Study|Lack of Efficacy|1
248311|NCT01331681|818883|P1|Overall Study|Lack of Efficacy|0
248312|NCT01331681|818881|P3|Overall Study|Death|2
248313|NCT01331681|818882|P2|Overall Study|Death|6
248314|NCT01331681|818883|P1|Overall Study|Death|6
248315|NCT01331681|818881|P3|Overall Study|Adverse Event|10
248316|NCT01331681|818882|P2|Overall Study|Adverse Event|13
248317|NCT01331681|818883|P1|Overall Study|Adverse Event|10
248318|NCT01331291|818922|P2|Overall Study|Death|1
248319|NCT01331291|818923|P1|Overall Study|Death|0
248320|NCT01331291|818922|P2|Overall Study|Lack of Efficacy|8
248321|NCT01331291|818923|P1|Overall Study|Lack of Efficacy|2
248322|NCT01331161|818957|P2|Overall Study|Pregnancy|1
248323|NCT01331161|818958|P1|Overall Study|Pregnancy|0
248324|NCT01331161|818957|P2|Overall Study|Lost to Follow-up|1
248325|NCT01331161|818958|P1|Overall Study|Lost to Follow-up|0
248326|NCT01331161|818957|P2|Overall Study|Physician Decision|0
248327|NCT01331161|818958|P1|Overall Study|Physician Decision|1
248328|NCT01331109|818966|P1|Overall Study|Study Terminated by Sponsor|38
248329|NCT01331109|818966|P1|Overall Study|Lost to Follow-up|1
248330|NCT01331109|818966|P1|Overall Study|Withdrawal by Subject|7
248331|NCT01331109|818966|P1|Overall Study|Protocol Violation|3
248332|NCT01331109|818966|P1|Overall Study|Lack of Efficacy|2
248333|NCT01331109|818966|P1|Overall Study|Adverse Event|6
248334|NCT01331005|818978|P2|Overall Study|Withdrawal by Subject|3
248335|NCT01331005|818979|P1|Overall Study|Withdrawal by Subject|2
248336|NCT01331005|818978|P2|Overall Study|Lost to Follow-up|1
248337|NCT01331005|818979|P1|Overall Study|Lost to Follow-up|2
248338|NCT01330914|818985|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
248339|NCT01330914|818985|P1|Overall Study|Withdrawal by Subject|4
248340|NCT01330628|818991|P2|Overall Study|Didn't receive study treatment|0
248341|NCT01330628|818992|P1|Overall Study|Didn't receive study treatment|1
248342|NCT01330628|818991|P2|Overall Study|Withdrawn|6
248343|NCT01330628|818992|P1|Overall Study|Withdrawn|18
248344|NCT01330628|818991|P2|Overall Study|Adverse Event|25
248345|NCT01330628|818992|P1|Overall Study|Adverse Event|44
248346|NCT01330628|818991|P2|Overall Study|Lost to Follow-up|6
248347|NCT01330628|818992|P1|Overall Study|Lost to Follow-up|5
248348|NCT01330628|818991|P2|Overall Study|Death|3
248349|NCT01330628|818992|P1|Overall Study|Death|2
248350|NCT01330433|819002|P2|Overall Study|Lost to Follow-up|0
248351|NCT01330433|819003|P1|Overall Study|Lost to Follow-up|1
248352|NCT01330433|819002|P2|Overall Study|Death|3
248353|NCT01330433|819003|P1|Overall Study|Death|1
248354|NCT01330381|819042|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
248355|NCT01330381|819043|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
248356|NCT01330381|819044|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
248357|NCT01330381|819042|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
248358|NCT01330381|819043|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
248359|NCT01330381|819044|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
248360|NCT01330381|819042|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
248361|NCT01330381|819043|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
248362|NCT01330381|819044|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
248363|NCT01330381|819042|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
248364|NCT01330381|819043|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
248365|NCT01330381|819044|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
248366|NCT01330381|819042|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
248367|NCT01330381|819043|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
248368|NCT01330381|819044|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
248369|NCT01330381|819042|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
248370|NCT01330381|819043|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
248371|NCT01330381|819044|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
248372|NCT01330381|819042|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
248373|NCT01330381|819043|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
248374|NCT01330381|819044|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
248375|NCT01330381|819042|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
248376|NCT01330381|819043|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
248377|NCT01330381|819044|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
248378|NCT01330381|819042|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
248379|NCT01330381|819043|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
248380|NCT01330381|819044|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
248381|NCT01330381|819042|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
248382|NCT01330381|819043|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
248383|NCT01330381|819044|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
248384|NCT01330316|819105|P2|Overall Study|other than above|1
248385|NCT01330316|819106|P1|Overall Study|other than above|0
248386|NCT01330316|819105|P2|Overall Study|Withdrawal by Subject|1
248387|NCT01330316|819106|P1|Overall Study|Withdrawal by Subject|0
248388|NCT01330316|819105|P2|Overall Study|Lost to Follow-up|1
248389|NCT01330316|819106|P1|Overall Study|Lost to Follow-up|0
248390|NCT01330316|819105|P2|Overall Study|Lack of Efficacy|10
248391|NCT01330316|819106|P1|Overall Study|Lack of Efficacy|0
248392|NCT01330316|819105|P2|Overall Study|Adverse Event|2
248393|NCT01330316|819106|P1|Overall Study|Adverse Event|2
248394|NCT01330303|819142|P2|Period 1|Withdrawal by Subject|1
248395|NCT01330303|819143|P1|Period 1|Withdrawal by Subject|0
248396|NCT01330303|819142|P2|Period 1|Protocol Violation|1
248397|NCT01330303|819143|P1|Period 1|Protocol Violation|0
248398|NCT01330303|819142|P2|Period 1|Adverse Event|0
248399|NCT01330303|819143|P1|Period 1|Adverse Event|1
248400|NCT01330108|819177|P1|Overall Study|Withdrawal by Subject|4
248401|NCT01330030|819184|P2|Overall Study|Lost to Follow-up|17
248402|NCT01330030|819185|P1|Overall Study|Lost to Follow-up|16
248403|NCT01330017|819196|P5|Overall Study|Unknown Reason|2
248404|NCT01330017|819197|P4|Overall Study|Unknown Reason|7
248405|NCT01330017|819198|P3|Overall Study|Unknown Reason|5
248406|NCT01330017|819199|P2|Overall Study|Unknown Reason|3
248407|NCT01330017|819200|P1|Overall Study|Unknown Reason|5
248408|NCT01330017|819196|P5|Overall Study|Protocol Violation|0
248409|NCT01330017|819197|P4|Overall Study|Protocol Violation|1
248410|NCT01330017|819198|P3|Overall Study|Protocol Violation|0
248411|NCT01330017|819199|P2|Overall Study|Protocol Violation|0
248412|NCT01330017|819200|P1|Overall Study|Protocol Violation|0
248413|NCT01330017|819196|P5|Overall Study|Lost to Follow-up|0
248414|NCT01330017|819197|P4|Overall Study|Lost to Follow-up|0
248415|NCT01330017|819198|P3|Overall Study|Lost to Follow-up|1
248416|NCT01330017|819199|P2|Overall Study|Lost to Follow-up|0
248417|NCT01330017|819200|P1|Overall Study|Lost to Follow-up|0
248418|NCT01330017|819196|P5|Overall Study|Withdrawal by Subject|1
248419|NCT01330017|819197|P4|Overall Study|Withdrawal by Subject|0
248420|NCT01330017|819198|P3|Overall Study|Withdrawal by Subject|1
248421|NCT01330017|819199|P2|Overall Study|Withdrawal by Subject|0
248422|NCT01330017|819200|P1|Overall Study|Withdrawal by Subject|0
248423|NCT01330017|819196|P5|Overall Study|Adverse Event|0
248424|NCT01330017|819197|P4|Overall Study|Adverse Event|4
248425|NCT01330017|819198|P3|Overall Study|Adverse Event|1
248426|NCT01330017|819199|P2|Overall Study|Adverse Event|1
248427|NCT01330017|819200|P1|Overall Study|Adverse Event|0
248428|NCT01329978|819249|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
248429|NCT01329978|819250|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
248430|NCT01329978|819251|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
248431|NCT01329978|819252|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
248432|NCT01329978|819253|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
248433|NCT01329978|819249|P5|Rerandomization Treatment Period|Lost to Follow-up|3
248434|NCT01329978|819250|P4|Rerandomization Treatment Period|Lost to Follow-up|5
248435|NCT01329978|819251|P3|Rerandomization Treatment Period|Lost to Follow-up|0
248436|NCT01329978|819252|P2|Rerandomization Treatment Period|Lost to Follow-up|0
248437|NCT01329978|819253|P1|Rerandomization Treatment Period|Lost to Follow-up|0
248438|NCT01329978|819249|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
248439|NCT01329978|819250|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
248440|NCT01329978|819251|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
248441|NCT01329978|819252|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
248442|NCT01329978|819253|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
248443|NCT01329978|819249|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
248444|NCT01329978|819250|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
248445|NCT01329978|819251|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
248446|NCT01329978|819252|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
248447|NCT01329978|819253|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
248448|NCT01329978|819249|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
248449|NCT01329978|819250|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
248450|NCT01329978|819251|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
248451|NCT01329978|819252|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
248452|NCT01329978|819253|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
248453|NCT01329978|819249|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
248454|NCT01329978|819250|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
248455|NCT01329978|819251|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
248456|NCT01329978|819252|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
248457|NCT01329978|819253|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
248458|NCT01329978|819249|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
248459|NCT01329978|819250|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
248460|NCT01329978|819251|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
248461|NCT01329978|819252|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
248462|NCT01329978|819253|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
248463|NCT01329939|819327|P4|Overall Study|Adverse Event|3
248464|NCT01329939|819328|P3|Overall Study|Adverse Event|0
248465|NCT01329939|819329|P2|Overall Study|Adverse Event|0
248466|NCT01329939|819330|P1|Overall Study|Adverse Event|0
248467|NCT01329939|819327|P4|Overall Study|Withdrawal by Subject|0
248468|NCT01329939|819328|P3|Overall Study|Withdrawal by Subject|0
248469|NCT01329939|819329|P2|Overall Study|Withdrawal by Subject|1
248470|NCT01329939|819330|P1|Overall Study|Withdrawal by Subject|0
248471|NCT01329939|819327|P4|Overall Study|Lost to Follow-up|2
248472|NCT01329939|819328|P3|Overall Study|Lost to Follow-up|1
248473|NCT01329939|819329|P2|Overall Study|Lost to Follow-up|0
248474|NCT01329939|819330|P1|Overall Study|Lost to Follow-up|3
248475|NCT01329562|819394|P2|Overall Study|Physician Decision|1
248476|NCT01329562|819395|P1|Overall Study|Physician Decision|0
248477|NCT01329562|819394|P2|Overall Study|Subject withdrew due to personal issues.|2
248478|NCT01329562|819395|P1|Overall Study|Subject withdrew due to personal issues.|3
248479|NCT01329562|819394|P2|Overall Study|Lost to Follow-up|1
248480|NCT01329562|819395|P1|Overall Study|Lost to Follow-up|1
248481|NCT01329562|819394|P2|Overall Study|Protocol Violation|3
248482|NCT01329562|819395|P1|Overall Study|Protocol Violation|5
248483|NCT01329549|819444|P1|Overall Study|Adverse Event|1
248484|NCT01329549|819444|P1|Overall Study|Withdrawal by Subject|1
248485|NCT01329419|819455|P1|Overall Study|Protocol Violation|235
248486|NCT01329263|819463|P2|Overall Study|Withdrawal by Subject|2
248487|NCT01329263|819464|P1|Overall Study|Withdrawal by Subject|1
248488|NCT01329263|819463|P2|Overall Study|Lost to Follow-up|21
248489|NCT01329263|819464|P1|Overall Study|Lost to Follow-up|4
248490|NCT01329029|819501|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
248491|NCT01329029|819502|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
248492|NCT01329029|819501|P2|Overall Study|Lost to Follow-up|5
248493|NCT01329029|819502|P1|Overall Study|Lost to Follow-up|8
248494|NCT01329029|819501|P2|Overall Study|Physician Decision|13
248495|NCT01329029|819502|P1|Overall Study|Physician Decision|16
248496|NCT01329029|819501|P2|Overall Study|COPD Exacerbation|18
248497|NCT01329029|819502|P1|Overall Study|COPD Exacerbation|11
248498|NCT01329029|819501|P2|Overall Study|Other|20
248499|NCT01329029|819502|P1|Overall Study|Other|14
248500|NCT01329029|819501|P2|Overall Study|Death|19
248501|NCT01329029|819502|P1|Overall Study|Death|16
248502|NCT01329029|819501|P2|Overall Study|Adverse Event|29
248503|NCT01329029|819502|P1|Overall Study|Adverse Event|82
248504|NCT01329029|819501|P2|Overall Study|Withdrawal by Subject|87
248505|NCT01329029|819502|P1|Overall Study|Withdrawal by Subject|117
248506|NCT01328951|819592|P2|Overall Study|Not Specified|6
248507|NCT01328951|819593|P1|Overall Study|Not Specified|11
248508|NCT01328951|819592|P2|Overall Study|Study Closed by the Sponsor|31
248509|NCT01328951|819593|P1|Overall Study|Study Closed by the Sponsor|36
248510|NCT01328951|819592|P2|Overall Study|Withdrawal by Subject|6
248511|NCT01328951|819593|P1|Overall Study|Withdrawal by Subject|6
248512|NCT01328951|819592|P2|Overall Study|Lost to Follow-up|7
248513|NCT01328951|819593|P1|Overall Study|Lost to Follow-up|6
248514|NCT01328951|819592|P2|Overall Study|Death|258
248515|NCT01328951|819593|P1|Overall Study|Death|243
248516|NCT01328951|819592|P2|Overall Study|Adverse Event|0
248517|NCT01328951|819593|P1|Overall Study|Adverse Event|2
248518|NCT01328951|819592|P2|Overall Study|Disease Progression|14
248519|NCT01328951|819593|P1|Overall Study|Disease Progression|17
248520|NCT01328756|819662|P1|Overall Study|Unspecified|29
248521|NCT01328756|819662|P1|Overall Study|Lost to Follow-up|5
248522|NCT01328756|819662|P1|Overall Study|Withdrawal by Subject|41
248523|NCT01328756|819662|P1|Overall Study|Lack of Efficacy|5
248524|NCT01328756|819662|P1|Overall Study|Adverse Event|39
248525|NCT01328756|819662|P1|Overall Study|Protocol Violation|4
248526|NCT01328717|819679|P1|Overall Study|Adverse Event|1
248527|NCT01328574|819684|P1|Overall Study|Refused further treatment|1
248528|NCT01328548|819698|P2|Overall Study|Protocol Violation|0
248529|NCT01328548|819699|P1|Overall Study|Protocol Violation|1
248530|NCT01328548|819698|P2|Overall Study|Death|0
248531|NCT01328548|819699|P1|Overall Study|Death|3
248532|NCT01328496|819719|P2|Overall Study|Significant Change in Health Status|0
248533|NCT01328496|819720|P1|Overall Study|Significant Change in Health Status|1
248534|NCT01328444|819738|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
248535|NCT01328444|819739|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
248536|NCT01328444|819740|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
248537|NCT01328444|819741|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
248538|NCT01328444|819742|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
248539|NCT01328444|819743|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
248540|NCT01328444|819738|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
248541|NCT01328444|819739|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
248542|NCT01328444|819740|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
248543|NCT01328444|819741|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
248544|NCT01328444|819742|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
248545|NCT01328444|819743|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
248546|NCT01328444|819738|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
248547|NCT01328444|819739|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
248548|NCT01328444|819740|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
248549|NCT01328444|819741|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
248550|NCT01328444|819742|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
248551|NCT01328444|819743|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
248552|NCT01328444|819738|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
248553|NCT01328444|819739|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
248554|NCT01328444|819740|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
248555|NCT01328444|819741|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
248556|NCT01328444|819742|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
248557|NCT01328444|819743|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
248558|NCT01328444|819738|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
248559|NCT01328444|819739|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
248560|NCT01328444|819740|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
248561|NCT01328444|819741|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
248562|NCT01328444|819742|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
248563|NCT01328444|819743|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
248564|NCT01328444|819738|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
248565|NCT01328444|819739|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
248566|NCT01328444|819740|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
248567|NCT01328444|819741|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
248568|NCT01328444|819742|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
248569|NCT01328444|819743|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
248570|NCT01328444|819738|P6|Washout Period (14 Days)|Withdrawal by Subject|1
248571|NCT01328444|819739|P5|Washout Period (14 Days)|Withdrawal by Subject|0
248572|NCT01328444|819740|P4|Washout Period (14 Days)|Withdrawal by Subject|0
248573|NCT01328444|819741|P3|Washout Period (14 Days)|Withdrawal by Subject|0
248574|NCT01328444|819742|P2|Washout Period (14 Days)|Withdrawal by Subject|0
248575|NCT01328444|819743|P1|Washout Period (14 Days)|Withdrawal by Subject|0
248576|NCT01328444|819738|P6|Washout Period (14 Days)|Lack of Efficacy|1
248577|NCT01328444|819739|P5|Washout Period (14 Days)|Lack of Efficacy|0
248578|NCT01328444|819740|P4|Washout Period (14 Days)|Lack of Efficacy|0
248579|NCT01328444|819741|P3|Washout Period (14 Days)|Lack of Efficacy|0
248580|NCT01328444|819742|P2|Washout Period (14 Days)|Lack of Efficacy|0
248581|NCT01328444|819743|P1|Washout Period (14 Days)|Lack of Efficacy|0
248582|NCT01328444|819738|P6|Washout Period (14 Days)|Adverse Event|2
248583|NCT01328444|819739|P5|Washout Period (14 Days)|Adverse Event|1
248584|NCT01328444|819740|P4|Washout Period (14 Days)|Adverse Event|1
248585|NCT01328444|819741|P3|Washout Period (14 Days)|Adverse Event|0
248586|NCT01328444|819742|P2|Washout Period (14 Days)|Adverse Event|1
248587|NCT01328444|819743|P1|Washout Period (14 Days)|Adverse Event|1
248588|NCT01328444|819738|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
248589|NCT01328444|819739|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
248590|NCT01328444|819740|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
248591|NCT01328444|819741|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
248592|NCT01328444|819742|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
248593|NCT01328444|819743|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
248594|NCT01328444|819738|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
248595|NCT01328444|819739|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
248596|NCT01328444|819740|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
248597|NCT01328444|819741|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
248598|NCT01328444|819742|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
248761|NCT01326845|820495|P2|Overall Study|Misisng|3
248599|NCT01328444|819743|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
248600|NCT01328444|819738|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
248601|NCT01328444|819739|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
248602|NCT01328444|819740|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
248603|NCT01328444|819741|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
248604|NCT01328444|819742|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
248605|NCT01328444|819743|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
248606|NCT01328444|819738|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
248607|NCT01328444|819739|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
248608|NCT01328444|819740|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
248609|NCT01328444|819741|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
248777|NCT01326026|820531|P2|Overall Study|Adverse Event|3
248610|NCT01328444|819742|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
248611|NCT01328444|819743|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
248612|NCT01328444|819738|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
248613|NCT01328444|819739|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
248614|NCT01328444|819740|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
248615|NCT01328444|819741|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
248616|NCT01328444|819742|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
248617|NCT01328444|819743|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
248618|NCT01328444|819738|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
248619|NCT01328444|819739|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
248620|NCT01328444|819740|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
248621|NCT01328444|819741|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
248622|NCT01328444|819742|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
248623|NCT01328444|819743|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
248624|NCT01328431|819789|P2|12 Month (12M)|Lost to Follow-up|91
248625|NCT01328431|819790|P1|12 Month (12M)|Lost to Follow-up|82
248626|NCT01328431|819789|P2|12 Month (12M)|Death|6
248627|NCT01328431|819790|P1|12 Month (12M)|Death|2
248628|NCT01328431|819789|P2|3 Month (3M)|Lost to Follow-up|70
248629|NCT01328431|819790|P1|3 Month (3M)|Lost to Follow-up|75
248630|NCT01328431|819789|P2|3 Month (3M)|Death|2
248631|NCT01328431|819790|P1|3 Month (3M)|Death|2
248632|NCT01328431|819789|P2|1 Month (1M)|Lost to Follow-up|58
248633|NCT01328431|819790|P1|1 Month (1M)|Lost to Follow-up|55
248634|NCT01328431|819789|P2|Baseline|Protocol Violation|2
248635|NCT01328431|819790|P1|Baseline|Protocol Violation|0
248636|NCT01328366|819846|P1|Overall Study|Lost to Follow-up|7
248637|NCT01328366|819846|P1|Overall Study|Withdrawal by Subject|2
248638|NCT01328366|819846|P1|Overall Study|Death|1
248639|NCT01328080|819942|P1|Overall Study|Lost to Follow-up|5
248640|NCT01328054|819946|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
248641|NCT01328054|819947|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
248642|NCT01328054|819946|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
248643|NCT01328054|819947|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
248644|NCT01328054|819946|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
248645|NCT01328054|819947|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
248646|NCT01328041|819972|P1|Overall Study|Withdrawal by Subject|7
248647|NCT01328041|819972|P1|Overall Study|Physician Decision|2
248648|NCT01328041|819972|P1|Overall Study|Lost to Follow-up|7
248649|NCT01328041|819972|P1|Overall Study|Protocol Violation|7
248650|NCT01328041|819972|P1|Overall Study|Lack of Efficacy|27
248651|NCT01328041|819972|P1|Overall Study|Adverse Event|7
248652|NCT01327885|820021|P2|Overall Study|Ongoing|1
248653|NCT01327885|820022|P1|Overall Study|Ongoing|1
248654|NCT01327885|820021|P2|Overall Study|Not treated|1
248655|NCT01327885|820022|P1|Overall Study|Not treated|1
248656|NCT01327885|820021|P2|Overall Study|Withdrawal of consent from study|4
248657|NCT01327885|820022|P1|Overall Study|Withdrawal of consent from study|2
248658|NCT01327885|820021|P2|Overall Study|Not specified|6
248659|NCT01327885|820022|P1|Overall Study|Not specified|8
248660|NCT01327885|820021|P2|Overall Study|Subject choice|10
248661|NCT01327885|820022|P1|Overall Study|Subject choice|5
248662|NCT01327885|820021|P2|Overall Study|Adverse Event|10
248663|NCT01327885|820022|P1|Overall Study|Adverse Event|14
248664|NCT01327885|820021|P2|Overall Study|Clinical progression|27
248665|NCT01327885|820022|P1|Overall Study|Clinical progression|24
248666|NCT01327885|820021|P2|Overall Study|Disease progression-according to RECIST|165
248667|NCT01327885|820022|P1|Overall Study|Disease progression-according to RECIST|173
248668|NCT01327703|820034|P2|Second Treatment Period|Protocol Violation|1
248669|NCT01327703|820035|P1|Second Treatment Period|Protocol Violation|0
248670|NCT01327703|820034|P2|Second Treatment Period|Adverse Event|1
248671|NCT01327703|820035|P1|Second Treatment Period|Adverse Event|1
248672|NCT01327651|820091|P9|Post Study Follow-up|Lost to Follow-up|2
248673|NCT01327651|820092|P8|Post Study Follow-up|Lost to Follow-up|1
248674|NCT01327651|820093|P7|Post Study Follow-up|Lost to Follow-up|4
248675|NCT01327651|820094|P6|Post Study Follow-up|Lost to Follow-up|0
248676|NCT01327651|820095|P5|Post Study Follow-up|Lost to Follow-up|0
248677|NCT01327651|820096|P4|Post Study Follow-up|Lost to Follow-up|0
248678|NCT01327651|820097|P3|Post Study Follow-up|Lost to Follow-up|1
248679|NCT01327651|820098|P2|Post Study Follow-up|Lost to Follow-up|1
248680|NCT01327651|820099|P1|Post Study Follow-up|Lost to Follow-up|0
248681|NCT01327651|820091|P9|Self-administered Dosing Period|Withdrawal by Subject|1
248682|NCT01327651|820092|P8|Self-administered Dosing Period|Withdrawal by Subject|1
248683|NCT01327651|820093|P7|Self-administered Dosing Period|Withdrawal by Subject|2
248684|NCT01327651|820094|P6|Self-administered Dosing Period|Withdrawal by Subject|0
248685|NCT01327651|820095|P5|Self-administered Dosing Period|Withdrawal by Subject|0
248686|NCT01327651|820096|P4|Self-administered Dosing Period|Withdrawal by Subject|1
248687|NCT01327651|820097|P3|Self-administered Dosing Period|Withdrawal by Subject|0
248688|NCT01327651|820098|P2|Self-administered Dosing Period|Withdrawal by Subject|1
248689|NCT01327651|820099|P1|Self-administered Dosing Period|Withdrawal by Subject|0
248690|NCT01327651|820091|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
248691|NCT01327651|820092|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
248692|NCT01327651|820093|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
248693|NCT01327651|820094|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
248694|NCT01327651|820095|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
248695|NCT01327651|820096|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
248696|NCT01327651|820097|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
248697|NCT01327651|820098|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
248698|NCT01327651|820099|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
248699|NCT01327651|820091|P9|Self-administered Dosing Period|Lost to Follow-up|10
248700|NCT01327651|820092|P8|Self-administered Dosing Period|Lost to Follow-up|9
248701|NCT01327651|820093|P7|Self-administered Dosing Period|Lost to Follow-up|8
248702|NCT01327651|820094|P6|Self-administered Dosing Period|Lost to Follow-up|0
248703|NCT01327651|820095|P5|Self-administered Dosing Period|Lost to Follow-up|3
248704|NCT01327651|820096|P4|Self-administered Dosing Period|Lost to Follow-up|2
248705|NCT01327651|820097|P3|Self-administered Dosing Period|Lost to Follow-up|4
248706|NCT01327651|820098|P2|Self-administered Dosing Period|Lost to Follow-up|2
248707|NCT01327651|820099|P1|Self-administered Dosing Period|Lost to Follow-up|3
248708|NCT01327599|820218|P1|Overall Study|Withdrawal of Consent|1
248709|NCT01327599|820218|P1|Overall Study|Could Not Attend Visit|1
248710|NCT01327599|820218|P1|Overall Study|Adverse Event|1
248711|NCT01327547|820228|P2|Overall Study|Continuing in the study|56
248712|NCT01327547|820229|P1|Overall Study|Continuing in the study|56
248713|NCT01327547|820228|P2|Overall Study|Non-compliance with study procedures|0
248714|NCT01327547|820229|P1|Overall Study|Non-compliance with study procedures|1
248715|NCT01327547|820228|P2|Overall Study|Requirement for prohibited medication|0
248716|NCT01327547|820229|P1|Overall Study|Requirement for prohibited medication|2
248717|NCT01327547|820228|P2|Overall Study|Non-compliance - alcohol consumption|1
248718|NCT01327547|820229|P1|Overall Study|Non-compliance - alcohol consumption|0
248719|NCT01327547|820228|P2|Overall Study|Does Not Meet Entrance Criteria|2
248720|NCT01327547|820229|P1|Overall Study|Does Not Meet Entrance Criteria|2
248721|NCT01327547|820228|P2|Overall Study|Withdrawal by Subject|4
248722|NCT01327547|820229|P1|Overall Study|Withdrawal by Subject|2
248723|NCT01327547|820228|P2|Overall Study|Non-Compliance With Study Treatment|1
248724|NCT01327547|820229|P1|Overall Study|Non-Compliance With Study Treatment|0
248725|NCT01327547|820228|P2|Overall Study|Lost to Follow-up|1
248726|NCT01327547|820229|P1|Overall Study|Lost to Follow-up|3
248727|NCT01327547|820228|P2|Overall Study|Death|1
248728|NCT01327547|820229|P1|Overall Study|Death|0
248729|NCT01327547|820228|P2|Overall Study|Adverse Event|1
248730|NCT01327547|820229|P1|Overall Study|Adverse Event|4
248731|NCT01327482|820274|P1|Overall Study|Adverse Event|1
248732|NCT01327339|820279|P1|Overall Study|Protocol Violation|8
248733|NCT01327300|820414|P2|Washout (3 Weeks)|Withdrawal by Subject|0
248734|NCT01327300|820415|P1|Washout (3 Weeks)|Withdrawal by Subject|1
248735|NCT01327053|820433|P2|Overall Study|Untreated|1
248736|NCT01327053|820434|P1|Overall Study|Untreated|0
248737|NCT01327053|820433|P2|Overall Study|Withdrawal by Subject|28
248738|NCT01327053|820434|P1|Overall Study|Withdrawal by Subject|5
248739|NCT01327053|820433|P2|Overall Study|Protocol Violation|1
248740|NCT01327053|820434|P1|Overall Study|Protocol Violation|0
248741|NCT01327053|820433|P2|Overall Study|Progressive Disease|6
248742|NCT01327053|820434|P1|Overall Study|Progressive Disease|15
248743|NCT01327053|820433|P2|Overall Study|Physician Decision|10
248744|NCT01327053|820434|P1|Overall Study|Physician Decision|3
248745|NCT01327053|820433|P2|Overall Study|Non-compliance with study treatment|3
248746|NCT01327053|820434|P1|Overall Study|Non-compliance with study treatment|0
248747|NCT01327053|820433|P2|Overall Study|Lost to Follow-up|4
248748|NCT01327053|820434|P1|Overall Study|Lost to Follow-up|1
248749|NCT01327053|820433|P2|Overall Study|Death|4
248750|NCT01327053|820434|P1|Overall Study|Death|0
248751|NCT01327053|820433|P2|Overall Study|Adverse Event|48
248752|NCT01327053|820434|P1|Overall Study|Adverse Event|16
248753|NCT01326962|820462|P1|Overall Study|Not Specified|2
248754|NCT01326962|820462|P1|Overall Study|Lost to Follow-up|3
248755|NCT01326962|820462|P1|Overall Study|Withdrawal by Subject|1
248756|NCT01326962|820462|P1|Overall Study|Adverse Event|1
248757|NCT01326910|820480|P2|Overall Study|Protocol Violation|1
248758|NCT01326910|820481|P1|Overall Study|Protocol Violation|1
248759|NCT01326910|820480|P2|Overall Study|Withdrawal by Subject|2
248760|NCT01326910|820481|P1|Overall Study|Withdrawal by Subject|3
248762|NCT01326845|820496|P1|Overall Study|Misisng|1
248763|NCT01326845|820495|P2|Overall Study|Adverse Event|0
248764|NCT01326845|820496|P1|Overall Study|Adverse Event|1
248765|NCT01326845|820495|P2|Overall Study|Administrative Problems|2
248766|NCT01326845|820496|P1|Overall Study|Administrative Problems|5
248767|NCT01326533|820520|P2|Overall Study|Adverse Event|0
248768|NCT01326533|820521|P1|Overall Study|Adverse Event|1
248769|NCT01326533|820520|P2|Overall Study|Withdrawal by Subject|0
248770|NCT01326533|820521|P1|Overall Study|Withdrawal by Subject|1
248771|NCT01326533|820520|P2|Overall Study|Lost to Follow-up|0
248772|NCT01326533|820521|P1|Overall Study|Lost to Follow-up|2
248773|NCT01326026|820531|P2|Overall Study|Other|3
248774|NCT01326026|820532|P1|Overall Study|Other|3
248775|NCT01326026|820531|P2|Overall Study|Withdrawal Criteria|7
248776|NCT01326026|820532|P1|Overall Study|Withdrawal Criteria|5
248778|NCT01326026|820532|P1|Overall Study|Adverse Event|4
248779|NCT01325701|820597|P2|Overall Study|Rollerover Extension Study|0
248780|NCT01325701|820598|P1|Overall Study|Rollerover Extension Study|4
248781|NCT01325701|820597|P2|Overall Study|Withdrawal by Subject|1
248782|NCT01325701|820598|P1|Overall Study|Withdrawal by Subject|2
248783|NCT01325701|820597|P2|Overall Study|Physician Decision|2
248784|NCT01325701|820598|P1|Overall Study|Physician Decision|2
248785|NCT01325701|820597|P2|Overall Study|Protocol Violation|0
248786|NCT01325701|820598|P1|Overall Study|Protocol Violation|1
248787|NCT01325701|820597|P2|Overall Study|Adverse Event|0
248788|NCT01325701|820598|P1|Overall Study|Adverse Event|12
248789|NCT01325623|820608|P1|Overall Study|Withdrawal by Subject|3
248790|NCT01325532|820652|P2|Overall Study|Withdrawal by Subject|0
248791|NCT01325532|820653|P1|Overall Study|Withdrawal by Subject|2
248792|NCT01325493|820665|P2|Overall Study|Allergy|0
248793|NCT01325493|820666|P1|Overall Study|Allergy|1
248794|NCT01325493|820665|P2|Overall Study|loss of neuromonitoring signals|2
248795|NCT01325493|820666|P1|Overall Study|loss of neuromonitoring signals|0
248796|NCT01325493|820665|P2|Overall Study|Protocol Violation|1
248797|NCT01325493|820666|P1|Overall Study|Protocol Violation|0
248798|NCT01325428|820678|P1|Part B|Other reason not defined above|1
248799|NCT01325428|820678|P1|Part B|Refused continue taking trial medication|2
248800|NCT01325428|820678|P1|Part A|Other reason not defined above|2
248801|NCT01325428|820678|P1|Part A|Refused continue taking trial medication|2
248802|NCT01325428|820678|P1|Part A|Other adverse event|1
248803|NCT01325428|820678|P1|Part A|Clinical signs, symptoms of progression|2
248804|NCT01325428|820678|P1|Part A|Progressive disease according to RECIST|9
248805|NCT01325350|820698|P5|Overall Study|Did Not Receive Treatment|1
248806|NCT01325350|820699|P4|Overall Study|Did Not Receive Treatment|0
248807|NCT01325350|820700|P3|Overall Study|Did Not Receive Treatment|1
248808|NCT01325350|820701|P2|Overall Study|Did Not Receive Treatment|1
248809|NCT01325350|820702|P1|Overall Study|Did Not Receive Treatment|0
248810|NCT01325350|820698|P5|Overall Study|Withdrawal by Subject|0
248811|NCT01325350|820699|P4|Overall Study|Withdrawal by Subject|1
248812|NCT01325350|820700|P3|Overall Study|Withdrawal by Subject|1
248813|NCT01325350|820701|P2|Overall Study|Withdrawal by Subject|0
248814|NCT01325350|820702|P1|Overall Study|Withdrawal by Subject|0
248815|NCT01325350|820698|P5|Overall Study|Protocol Violation|0
248816|NCT01325350|820699|P4|Overall Study|Protocol Violation|1
248817|NCT01325350|820700|P3|Overall Study|Protocol Violation|0
248818|NCT01325350|820701|P2|Overall Study|Protocol Violation|0
248819|NCT01325350|820702|P1|Overall Study|Protocol Violation|0
248820|NCT01325350|820698|P5|Overall Study|Personal Reasons|3
248821|NCT01325350|820699|P4|Overall Study|Personal Reasons|5
248822|NCT01325350|820700|P3|Overall Study|Personal Reasons|6
248823|NCT01325350|820701|P2|Overall Study|Personal Reasons|1
248824|NCT01325350|820702|P1|Overall Study|Personal Reasons|2
248825|NCT01325350|820698|P5|Overall Study|Lost to Follow-up|5
248826|NCT01325350|820699|P4|Overall Study|Lost to Follow-up|1
248827|NCT01325350|820700|P3|Overall Study|Lost to Follow-up|5
248828|NCT01325350|820701|P2|Overall Study|Lost to Follow-up|0
248829|NCT01325350|820702|P1|Overall Study|Lost to Follow-up|1
248830|NCT01325350|820698|P5|Overall Study|Pregnancy|1
248831|NCT01325350|820699|P4|Overall Study|Pregnancy|0
248832|NCT01325350|820700|P3|Overall Study|Pregnancy|1
248833|NCT01325350|820701|P2|Overall Study|Pregnancy|0
248834|NCT01325350|820702|P1|Overall Study|Pregnancy|0
248835|NCT01325350|820698|P5|Overall Study|Adverse Event|2
248836|NCT01325350|820699|P4|Overall Study|Adverse Event|1
248837|NCT01325350|820700|P3|Overall Study|Adverse Event|3
248838|NCT01325350|820701|P2|Overall Study|Adverse Event|3
248839|NCT01325350|820702|P1|Overall Study|Adverse Event|3
248840|NCT01325337|820744|P5|Overall Study|Withdrawal by Subject|1
248841|NCT01325337|820745|P4|Overall Study|Withdrawal by Subject|0
248842|NCT01325337|820746|P3|Overall Study|Withdrawal by Subject|1
248843|NCT01325337|820747|P2|Overall Study|Withdrawal by Subject|0
248844|NCT01325337|820748|P1|Overall Study|Withdrawal by Subject|1
248845|NCT01325337|820744|P5|Overall Study|Personal Reasons|3
248846|NCT01325337|820745|P4|Overall Study|Personal Reasons|8
248847|NCT01325337|820746|P3|Overall Study|Personal Reasons|4
248848|NCT01325337|820747|P2|Overall Study|Personal Reasons|5
248849|NCT01325337|820748|P1|Overall Study|Personal Reasons|2
248850|NCT01325337|820744|P5|Overall Study|Lost to Follow-up|2
248851|NCT01325337|820745|P4|Overall Study|Lost to Follow-up|1
248852|NCT01325337|820746|P3|Overall Study|Lost to Follow-up|2
248853|NCT01325337|820747|P2|Overall Study|Lost to Follow-up|2
248854|NCT01325337|820748|P1|Overall Study|Lost to Follow-up|2
248855|NCT01325337|820744|P5|Overall Study|Adverse Event|2
248856|NCT01325337|820745|P4|Overall Study|Adverse Event|1
248857|NCT01325337|820746|P3|Overall Study|Adverse Event|2
248858|NCT01325337|820747|P2|Overall Study|Adverse Event|2
248859|NCT01325337|820748|P1|Overall Study|Adverse Event|0
248860|NCT01324310|820822|P1|Overall Study|Disease Progression|1
248861|NCT01324310|820822|P1|Overall Study|Adverse Event|1
248862|NCT01324271|820842|P2|Overall Study|Physician Decision|0
248863|NCT01324271|820843|P1|Overall Study|Physician Decision|1
248864|NCT01324271|820842|P2|Overall Study|Lost to Follow-up|0
248865|NCT01324271|820843|P1|Overall Study|Lost to Follow-up|3
248866|NCT01324947|820858|P1|Overall Study|1 discontinued before starting drug|1
248867|NCT01324947|820858|P1|Overall Study|Withdrawal by Subject|3
248868|NCT01324947|820858|P1|Overall Study|Progressive Disease|50
248869|NCT01324947|820858|P1|Overall Study|Unspecified|3
248870|NCT01324947|820858|P1|Overall Study|Death|10
248871|NCT01324947|820858|P1|Overall Study|Adverse Event|7
248872|NCT01324622|820891|P2|Overall Study|Lack of Efficacy|0
248873|NCT01324622|820892|P1|Overall Study|Lack of Efficacy|1
248874|NCT01324622|820891|P2|Overall Study|Death|0
248875|NCT01324622|820892|P1|Overall Study|Death|1
248876|NCT01324622|820891|P2|Overall Study|Lost to Follow-up|7
248877|NCT01324622|820892|P1|Overall Study|Lost to Follow-up|7
248878|NCT01324440|820922|P2|Overall Study|Subject moved|1
248879|NCT01324440|820923|P1|Overall Study|Subject moved|0
248880|NCT01324401|820937|P2|Overall Study|Physician Decision|3
248881|NCT01324401|820938|P1|Overall Study|Physician Decision|1
248882|NCT01324388|820949|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
248883|NCT01324388|820950|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
248884|NCT01324388|820951|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
248885|NCT01324388|820952|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
248886|NCT01324388|820949|P4|Part 2 of Study: First Intervention|Protocol Violation|1
248887|NCT01324388|820950|P3|Part 2 of Study: First Intervention|Protocol Violation|0
248888|NCT01324388|820951|P2|Part 2 of Study: First Intervention|Protocol Violation|0
248889|NCT01324388|820952|P1|Part 2 of Study: First Intervention|Protocol Violation|0
248890|NCT01324388|820949|P4|Part 1 of Study|Physician Decision|0
248891|NCT01324388|820950|P3|Part 1 of Study|Physician Decision|0
248892|NCT01324388|820951|P2|Part 1 of Study|Physician Decision|0
248893|NCT01324388|820952|P1|Part 1 of Study|Physician Decision|1
248894|NCT01324388|820949|P4|Part 1 of Study|Protocol Violation|0
248895|NCT01324388|820950|P3|Part 1 of Study|Protocol Violation|0
248896|NCT01324388|820951|P2|Part 1 of Study|Protocol Violation|2
248897|NCT01324388|820952|P1|Part 1 of Study|Protocol Violation|1
248898|NCT01324388|820949|P4|Part 1 of Study|Adverse Event|0
248899|NCT01324388|820950|P3|Part 1 of Study|Adverse Event|0
248900|NCT01324388|820951|P2|Part 1 of Study|Adverse Event|0
248901|NCT01324388|820952|P1|Part 1 of Study|Adverse Event|2
248902|NCT01324349|820973|P2|Overall Study|Withdrawal by Subject|1
248903|NCT01324349|820974|P1|Overall Study|Withdrawal by Subject|0
248904|NCT01324349|820973|P2|Overall Study|Death|1
248905|NCT01324349|820974|P1|Overall Study|Death|1
248906|NCT01324323|820984|P1|Overall Study|Withdrawal by Subject|1
248907|NCT01324102|821021|P2|Overall Study|illness|6
248908|NCT01324102|821022|P1|Overall Study|illness|1
248909|NCT01323920|821050|P1|Overall Study|Withdrawal by Subject|1
248910|NCT01323920|821050|P1|Overall Study|Death|5
248911|NCT01323790|821091|P3|Overall Study|Severe non-compliance with protocol|2
248912|NCT01323790|821092|P2|Overall Study|Severe non-compliance with protocol|2
248913|NCT01323790|821093|P1|Overall Study|Severe non-compliance with protocol|2
248914|NCT01323790|821091|P3|Overall Study|Did Not Receive Treatment|1
248915|NCT01323790|821092|P2|Overall Study|Did Not Receive Treatment|0
248916|NCT01323790|821093|P1|Overall Study|Did Not Receive Treatment|2
248917|NCT01323790|821091|P3|Overall Study|Withdrawal by Subject|13
248918|NCT01323790|821092|P2|Overall Study|Withdrawal by Subject|20
248919|NCT01323790|821093|P1|Overall Study|Withdrawal by Subject|23
248920|NCT01323790|821091|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
248921|NCT01323790|821092|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
248922|NCT01323790|821093|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
248923|NCT01323790|821091|P3|Overall Study|Adverse Event|12
248924|NCT01323790|821092|P2|Overall Study|Adverse Event|24
248925|NCT01323790|821093|P1|Overall Study|Adverse Event|11
248926|NCT01323790|821091|P3|Overall Study|Lack of Efficacy|3
248927|NCT01323790|821092|P2|Overall Study|Lack of Efficacy|0
248928|NCT01323790|821093|P1|Overall Study|Lack of Efficacy|3
248929|NCT01323790|821091|P3|Overall Study|Study-Specific Withdrawal Criteria|3
248930|NCT01323790|821092|P2|Overall Study|Study-Specific Withdrawal Criteria|3
248931|NCT01323790|821093|P1|Overall Study|Study-Specific Withdrawal Criteria|0
248932|NCT01323790|821091|P3|Overall Study|Lost to Follow-up|9
248933|NCT01323790|821092|P2|Overall Study|Lost to Follow-up|9
248934|NCT01323790|821093|P1|Overall Study|Lost to Follow-up|11
248935|NCT01323790|821091|P3|Overall Study|Other|1
248936|NCT01323790|821092|P2|Overall Study|Other|2
248937|NCT01323790|821093|P1|Overall Study|Other|3
248938|NCT01323673|821144|P2|Overall Study|Withdrawal by Subject|3
248939|NCT01323673|821145|P1|Overall Study|Withdrawal by Subject|2
248940|NCT01323673|821144|P2|Overall Study|Protocol Violation|0
248941|NCT01323673|821145|P1|Overall Study|Protocol Violation|1
248942|NCT01323673|821144|P2|Overall Study|Lost to Follow-up|1
248943|NCT01323673|821145|P1|Overall Study|Lost to Follow-up|0
248944|NCT01323673|821144|P2|Overall Study|Adverse Event|1
248945|NCT01323673|821145|P1|Overall Study|Adverse Event|0
248946|NCT01323660|821165|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
248947|NCT01323660|821166|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
248948|NCT01323660|821167|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
248949|NCT01323660|821168|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
248950|NCT01323660|821169|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
248951|NCT01323660|821170|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
248952|NCT01323660|821165|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
248953|NCT01323660|821166|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
248954|NCT01323660|821167|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
248955|NCT01323660|821168|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
248956|NCT01323660|821169|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
248957|NCT01323660|821170|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
248958|NCT01323660|821165|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
248959|NCT01323660|821166|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
248960|NCT01323660|821167|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
248961|NCT01323660|821168|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
248962|NCT01323660|821169|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
248963|NCT01323660|821170|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
248964|NCT01323660|821165|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
248965|NCT01323660|821166|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
248966|NCT01323660|821167|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
248967|NCT01323660|821168|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
248968|NCT01323660|821169|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
248969|NCT01323660|821170|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
248970|NCT01323660|821165|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
248971|NCT01323660|821166|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
248972|NCT01323660|821167|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
248973|NCT01323660|821168|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
248974|NCT01323660|821169|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
248975|NCT01323660|821170|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
248976|NCT01323660|821165|P6|Washout Period (14 Days)|Lack of Efficacy|2
248977|NCT01323660|821166|P5|Washout Period (14 Days)|Lack of Efficacy|2
248978|NCT01323660|821167|P4|Washout Period (14 Days)|Lack of Efficacy|3
248979|NCT01323660|821168|P3|Washout Period (14 Days)|Lack of Efficacy|1
248980|NCT01323660|821169|P2|Washout Period (14 Days)|Lack of Efficacy|0
248981|NCT01323660|821170|P1|Washout Period (14 Days)|Lack of Efficacy|0
248982|NCT01323660|821165|P6|Washout Period (14 Days)|Adverse Event|0
248983|NCT01323660|821166|P5|Washout Period (14 Days)|Adverse Event|1
248984|NCT01323660|821167|P4|Washout Period (14 Days)|Adverse Event|0
248985|NCT01323660|821168|P3|Washout Period (14 Days)|Adverse Event|0
248986|NCT01323660|821169|P2|Washout Period (14 Days)|Adverse Event|0
248987|NCT01323660|821170|P1|Washout Period (14 Days)|Adverse Event|0
248988|NCT01323660|821165|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
248989|NCT01323660|821166|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
248990|NCT01323660|821167|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
248991|NCT01323660|821168|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
248992|NCT01323660|821169|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
248993|NCT01323660|821170|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
248994|NCT01323660|821165|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
248995|NCT01323660|821166|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
248996|NCT01323660|821167|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
248997|NCT01323660|821168|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
248998|NCT01323660|821169|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
248999|NCT01323660|821170|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
249000|NCT01323660|821165|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
249001|NCT01323660|821166|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
249002|NCT01323660|821167|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
249003|NCT01323660|821168|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
249004|NCT01323660|821169|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
249005|NCT01323660|821170|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
249006|NCT01323660|821165|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
249007|NCT01323660|821166|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
249008|NCT01323660|821167|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
249009|NCT01323660|821168|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
249010|NCT01323660|821169|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
249011|NCT01323660|821170|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
249012|NCT01323660|821165|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
249013|NCT01323660|821166|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
249170|NCT01322347|821590|P1|Overall Study|Protocol Violation|5
249014|NCT01323660|821167|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
249015|NCT01323660|821168|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
249016|NCT01323660|821169|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
249017|NCT01323660|821170|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
249018|NCT01323660|821165|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
249019|NCT01323660|821166|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
249020|NCT01323660|821167|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
249021|NCT01323660|821168|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
249022|NCT01323660|821169|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
249023|NCT01323660|821170|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
249024|NCT01323647|821216|P2|Overall Study|Lost to Follow-up|0
249025|NCT01323647|821217|P1|Overall Study|Lost to Follow-up|2
249026|NCT01323647|821216|P2|Overall Study|Withdrawal by Subject|0
249027|NCT01323647|821217|P1|Overall Study|Withdrawal by Subject|5
249028|NCT01323647|821216|P2|Overall Study|Migrated/moved from study area|0
249029|NCT01323647|821217|P1|Overall Study|Migrated/moved from study area|2
249030|NCT01323634|821234|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
249031|NCT01323634|821235|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
249032|NCT01323634|821236|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
249033|NCT01323634|821234|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
249034|NCT01323634|821235|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
249035|NCT01323634|821236|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
249036|NCT01323634|821234|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
249037|NCT01323634|821235|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
249038|NCT01323634|821236|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
249039|NCT01323634|821234|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
249040|NCT01323634|821235|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
249041|NCT01323634|821236|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
249042|NCT01323634|821234|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
249043|NCT01323634|821235|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
249044|NCT01323634|821236|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
249045|NCT01323634|821234|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
249046|NCT01323634|821235|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
249047|NCT01323634|821236|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
249048|NCT01323634|821234|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
249049|NCT01323634|821235|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
249050|NCT01323634|821236|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
249051|NCT01323634|821234|P3|2-week Run-in Period|Adverse Event|0
249052|NCT01323634|821235|P2|2-week Run-in Period|Adverse Event|0
249053|NCT01323634|821236|P1|2-week Run-in Period|Adverse Event|1
249054|NCT01323634|821234|P3|2-week Run-in Period|Protocol Violation|0
249055|NCT01323634|821235|P2|2-week Run-in Period|Protocol Violation|0
249056|NCT01323634|821236|P1|2-week Run-in Period|Protocol Violation|1
249057|NCT01323634|821234|P3|2-week Run-in Period|Physician Decision|0
249058|NCT01323634|821235|P2|2-week Run-in Period|Physician Decision|0
249059|NCT01323634|821236|P1|2-week Run-in Period|Physician Decision|5
249060|NCT01323634|821234|P3|2-week Run-in Period|Withdrawal by Subject|0
249061|NCT01323634|821235|P2|2-week Run-in Period|Withdrawal by Subject|0
249062|NCT01323634|821236|P1|2-week Run-in Period|Withdrawal by Subject|7
249063|NCT01323634|821234|P3|2-week Run-in Period|Continuation Criteria not Met|0
249064|NCT01323634|821235|P2|2-week Run-in Period|Continuation Criteria not Met|0
249065|NCT01323634|821236|P1|2-week Run-in Period|Continuation Criteria not Met|73
249066|NCT01323634|821234|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
249067|NCT01323634|821235|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
249068|NCT01323634|821236|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
249069|NCT01323621|821246|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
249070|NCT01323621|821247|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
249071|NCT01323621|821248|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
249072|NCT01323621|821246|P3|12-week, Double-blind Treatment Period|Physician Decision|1
249073|NCT01323621|821247|P2|12-week, Double-blind Treatment Period|Physician Decision|2
249074|NCT01323621|821248|P1|12-week, Double-blind Treatment Period|Physician Decision|0
249075|NCT01323621|821246|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
249076|NCT01323621|821247|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
249077|NCT01323621|821248|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
249078|NCT01323621|821246|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
249079|NCT01323621|821247|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
249080|NCT01323621|821248|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
249081|NCT01323621|821246|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
249082|NCT01323621|821247|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
249083|NCT01323621|821248|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
249084|NCT01323621|821246|P3|12-week, Double-blind Treatment Period|Adverse Event|5
249085|NCT01323621|821247|P2|12-week, Double-blind Treatment Period|Adverse Event|1
249086|NCT01323621|821248|P1|12-week, Double-blind Treatment Period|Adverse Event|0
249087|NCT01323621|821246|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
249171|NCT01322347|821589|P2|Overall Study|Physician Decision|1
249088|NCT01323621|821247|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
249089|NCT01323621|821248|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
249090|NCT01323621|821246|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
249091|NCT01323621|821247|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
249092|NCT01323621|821248|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
249093|NCT01323621|821246|P3|2-week, Single-blind Run In Period|Protocol Violation|0
249094|NCT01323621|821247|P2|2-week, Single-blind Run In Period|Protocol Violation|0
249095|NCT01323621|821248|P1|2-week, Single-blind Run In Period|Protocol Violation|1
249096|NCT01323621|821246|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
249097|NCT01323621|821247|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
249098|NCT01323621|821248|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
249099|NCT01323621|821246|P3|2-week, Single-blind Run In Period|Physician Decision|0
249100|NCT01323621|821247|P2|2-week, Single-blind Run In Period|Physician Decision|0
249101|NCT01323621|821248|P1|2-week, Single-blind Run In Period|Physician Decision|7
249102|NCT01323621|821246|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
249103|NCT01323621|821247|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
249104|NCT01323621|821248|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
249105|NCT01323582|821267|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
249106|NCT01323582|821268|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
249107|NCT01323582|821267|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
249108|NCT01323582|821268|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
249109|NCT01323582|821267|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
249110|NCT01323582|821268|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
249111|NCT01323478|821284|P1|Overall Study|Administrative or Other Reasons|8
249112|NCT01323478|821284|P1|Overall Study|Withdrawal of Consent|1
249113|NCT01323478|821284|P1|Overall Study|Protocol Violation|1
249114|NCT01323478|821284|P1|Overall Study|Non-compliance With Study Product|3
249115|NCT01323478|821284|P1|Overall Study|Lack of Efficacy|4
249116|NCT01323478|821284|P1|Overall Study|Adverse Event|7
249117|NCT01323387|821297|P1|Overall Study|radiographic data unavailable|1
249118|NCT01323387|821297|P1|Overall Study|Withdrawal by Subject|41
249119|NCT01323387|821297|P1|Overall Study|Revision|14
249120|NCT01323387|821297|P1|Overall Study|Withdrawal by Subject|1
249121|NCT01323387|821297|P1|Overall Study|Protocol Violation|11
249122|NCT01323387|821297|P1|Overall Study|Randomized but never treated|16
249123|NCT01323270|821310|P2|Overall Study|Randomized, but not vaccinated|0
249124|NCT01323270|821311|P1|Overall Study|Randomized, but not vaccinated|1
249125|NCT01323270|821310|P2|Overall Study|Death|0
249126|NCT01323270|821311|P1|Overall Study|Death|1
249127|NCT01323270|821310|P2|Overall Study|Not eligible|1
249128|NCT01323270|821311|P1|Overall Study|Not eligible|1
249129|NCT01323270|821310|P2|Overall Study|Physician Decision|2
249130|NCT01323270|821311|P1|Overall Study|Physician Decision|0
249131|NCT01323270|821310|P2|Overall Study|Unspecified|3
249132|NCT01323270|821311|P1|Overall Study|Unspecified|0
249133|NCT01323270|821310|P2|Overall Study|Adverse Event|0
249134|NCT01323270|821311|P1|Overall Study|Adverse Event|8
249135|NCT01323270|821310|P2|Overall Study|Lost to Follow-up|6
249136|NCT01323270|821311|P1|Overall Study|Lost to Follow-up|4
249137|NCT01323270|821310|P2|Overall Study|Protocol Violation|7
249138|NCT01323270|821311|P1|Overall Study|Protocol Violation|9
249139|NCT01323270|821310|P2|Overall Study|Withdrawal by Subject|10
249140|NCT01323270|821311|P1|Overall Study|Withdrawal by Subject|19
249141|NCT01323192|821333|P2|Overall Study|Nonmedical reasons|1
249142|NCT01323192|821334|P1|Overall Study|Nonmedical reasons|0
249143|NCT01323192|821333|P2|Overall Study|Noncompliance with study medication|3
249144|NCT01323192|821334|P1|Overall Study|Noncompliance with study medication|0
249145|NCT01323192|821333|P2|Overall Study|Withdrawal by Subject|1
249146|NCT01323192|821334|P1|Overall Study|Withdrawal by Subject|3
249147|NCT01323192|821333|P2|Overall Study|Adverse Event|1
249148|NCT01323192|821334|P1|Overall Study|Adverse Event|6
249149|NCT01322386|821573|P2|Overall Study|Physician Decision|1
249150|NCT01322386|821574|P1|Overall Study|Physician Decision|0
249151|NCT01322386|821573|P2|Overall Study|Protocol Violation|1
249152|NCT01322386|821574|P1|Overall Study|Protocol Violation|0
249153|NCT01322347|821589|P2|Overall Study|moved/changed dialysis|4
249154|NCT01322347|821590|P1|Overall Study|moved/changed dialysis|2
249155|NCT01322347|821589|P2|Overall Study|study drug withheld > 12 wks|1
249156|NCT01322347|821590|P1|Overall Study|study drug withheld > 12 wks|0
249157|NCT01322347|821589|P2|Overall Study|kidney transplant|1
249158|NCT01322347|821590|P1|Overall Study|kidney transplant|3
249159|NCT01322347|821589|P2|Overall Study|ineligible|3
249160|NCT01322347|821590|P1|Overall Study|ineligible|6
249161|NCT01322347|821589|P2|Overall Study|sponsor decision|3
249162|NCT01322347|821590|P1|Overall Study|sponsor decision|1
249163|NCT01322347|821589|P2|Overall Study|blood transfusion|5
249164|NCT01322347|821590|P1|Overall Study|blood transfusion|5
249165|NCT01322347|821589|P2|Overall Study|non-protocol change to ESA or IV iron|6
249166|NCT01322347|821590|P1|Overall Study|non-protocol change to ESA or IV iron|14
249167|NCT01322347|821589|P2|Overall Study|Withdrawal by Subject|4
249168|NCT01322347|821590|P1|Overall Study|Withdrawal by Subject|1
249169|NCT01322347|821589|P2|Overall Study|Protocol Violation|2
249172|NCT01322347|821590|P1|Overall Study|Physician Decision|2
249173|NCT01322347|821589|P2|Overall Study|Death|3
249174|NCT01322347|821590|P1|Overall Study|Death|5
249175|NCT01322347|821589|P2|Overall Study|Adverse Event|2
249176|NCT01322347|821590|P1|Overall Study|Adverse Event|7
249177|NCT01322009|821651|P2|Overall Study|ng tube discontinued|1
249178|NCT01322009|821652|P1|Overall Study|ng tube discontinued|0
249179|NCT01322009|821651|P2|Overall Study|Adverse Event|1
249180|NCT01322009|821652|P1|Overall Study|Adverse Event|0
249181|NCT01322009|821651|P2|Overall Study|Death|1
249182|NCT01322009|821652|P1|Overall Study|Death|0
249183|NCT01321749|821662|P2|Overall Study|Withdrawal by Subject|4
249184|NCT01321749|821663|P1|Overall Study|Withdrawal by Subject|5
249185|NCT01321749|821662|P2|Overall Study|Protocol Violation|7
249186|NCT01321749|821663|P1|Overall Study|Protocol Violation|4
249187|NCT01321749|821662|P2|Overall Study|Lost to Follow-up|11
249188|NCT01321749|821663|P1|Overall Study|Lost to Follow-up|4
249189|NCT01321723|821672|P3|Overall Study|Withdrawal by Subject|2
249190|NCT01321723|821673|P2|Overall Study|Withdrawal by Subject|0
249191|NCT01321723|821674|P1|Overall Study|Withdrawal by Subject|2
249192|NCT01321723|821672|P3|Overall Study|Adverse Event|2
249193|NCT01321723|821673|P2|Overall Study|Adverse Event|5
249194|NCT01321723|821674|P1|Overall Study|Adverse Event|3
249195|NCT01321710|821696|P3|Overall Study|Lost to Follow-up|0
249196|NCT01321710|821697|P2|Overall Study|Lost to Follow-up|5
249197|NCT01321710|821698|P1|Overall Study|Lost to Follow-up|4
249198|NCT01321697|821713|P1|Overall Study|Study Terminated|7
249199|NCT01321554|821719|P4|OOL Lenvatinib Treatment Period|Death|1
249200|NCT01321554|821720|P3|OOL Lenvatinib Treatment Period|Death|1
249201|NCT01321554|821721|P2|OOL Lenvatinib Treatment Period|Death|0
249202|NCT01321554|821722|P1|OOL Lenvatinib Treatment Period|Death|0
249203|NCT01321554|821719|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
249204|NCT01321554|821720|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
249205|NCT01321554|821721|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
249206|NCT01321554|821722|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
249207|NCT01321554|821719|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
249208|NCT01321554|821720|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
249209|NCT01321554|821721|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
249210|NCT01321554|821722|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
249211|NCT01321554|821719|P4|OOL Lenvatinib Treatment Period|Not specified|0
249212|NCT01321554|821720|P3|OOL Lenvatinib Treatment Period|Not specified|5
249213|NCT01321554|821721|P2|OOL Lenvatinib Treatment Period|Not specified|0
249214|NCT01321554|821722|P1|OOL Lenvatinib Treatment Period|Not specified|0
249215|NCT01321554|821719|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
249216|NCT01321554|821720|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
249217|NCT01321554|821721|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
249218|NCT01321554|821722|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
249219|NCT01321554|821719|P4|OOL Lenvatinib Treatment Period|Participant choice|0
249220|NCT01321554|821720|P3|OOL Lenvatinib Treatment Period|Participant choice|3
249221|NCT01321554|821721|P2|OOL Lenvatinib Treatment Period|Participant choice|0
249222|NCT01321554|821722|P1|OOL Lenvatinib Treatment Period|Participant choice|0
249223|NCT01321554|821719|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
249224|NCT01321554|821720|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
249225|NCT01321554|821721|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
249226|NCT01321554|821722|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
249227|NCT01321554|821719|P4|Randomization Phase|Death|0
249228|NCT01321554|821720|P3|Randomization Phase|Death|0
249229|NCT01321554|821721|P2|Randomization Phase|Death|1
249230|NCT01321554|821722|P1|Randomization Phase|Death|0
249231|NCT01321554|821719|P4|Randomization Phase|Withdrawal by Subject|0
249232|NCT01321554|821720|P3|Randomization Phase|Withdrawal by Subject|0
249233|NCT01321554|821721|P2|Randomization Phase|Withdrawal by Subject|0
249234|NCT01321554|821722|P1|Randomization Phase|Withdrawal by Subject|4
249235|NCT01321554|821719|P4|Randomization Phase|Participant choice|0
249236|NCT01321554|821720|P3|Randomization Phase|Participant choice|0
249237|NCT01321554|821721|P2|Randomization Phase|Participant choice|0
249238|NCT01321554|821722|P1|Randomization Phase|Participant choice|4
249239|NCT01321554|821719|P4|Randomization Phase|Adverse Event|0
249240|NCT01321554|821720|P3|Randomization Phase|Adverse Event|0
249241|NCT01321554|821721|P2|Randomization Phase|Adverse Event|3
249242|NCT01321554|821722|P1|Randomization Phase|Adverse Event|37
249243|NCT01321008|821735|P1|Overall Study|Early Study Termination|1
249244|NCT01320735|821754|P1|Overall Study|Investigator Unable to be Contacted|17
249245|NCT01320735|821754|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
249246|NCT01320735|821754|P1|Overall Study|Not Specified|1
249247|NCT01320735|821754|P1|Overall Study|Protocol Violation|1
249248|NCT01320735|821754|P1|Overall Study|Progression/Hormone-Refractory Pca|55
249249|NCT01320735|821754|P1|Overall Study|Administrative Reason|6
249250|NCT01320735|821754|P1|Overall Study|Lost to Follow-up|13
249251|NCT01320735|821754|P1|Overall Study|Withdrawal by Subject|3
249252|NCT01320735|821754|P1|Overall Study|Adverse Event|3
249253|NCT01320683|821771|P1|Overall Study|Positive antibody response|1
249254|NCT01320293|821797|P1|Overall Study|Adverse Event|1
249255|NCT01320293|821797|P1|Overall Study|Lack of Efficacy|1
249256|NCT01320202|821805|P2|Overall Study|regained renal function|0
249257|NCT01320202|821806|P1|Overall Study|regained renal function|1
249258|NCT01320202|821805|P2|Overall Study|ineligible|0
249259|NCT01320202|821806|P1|Overall Study|ineligible|3
249260|NCT01320202|821805|P2|Overall Study|sponsor request|0
249261|NCT01320202|821806|P1|Overall Study|sponsor request|2
249262|NCT01320202|821805|P2|Overall Study|moved/changed dialysis|2
249263|NCT01320202|821806|P1|Overall Study|moved/changed dialysis|5
249264|NCT01320202|821805|P2|Overall Study|blood transfusion|7
249265|NCT01320202|821806|P1|Overall Study|blood transfusion|1
249266|NCT01320202|821805|P2|Overall Study|kidney transplant|2
249267|NCT01320202|821806|P1|Overall Study|kidney transplant|1
249268|NCT01320202|821805|P2|Overall Study|non-protocol change to ESA or IV iron|20
249427|NCT01318083|822560|P2|Overall Study|Adverse Event|1
249269|NCT01320202|821806|P1|Overall Study|non-protocol change to ESA or IV iron|17
249270|NCT01320202|821805|P2|Overall Study|Withdrawal by Subject|3
249271|NCT01320202|821806|P1|Overall Study|Withdrawal by Subject|10
249272|NCT01320202|821805|P2|Overall Study|Protocol Violation|1
249273|NCT01320202|821806|P1|Overall Study|Protocol Violation|2
249274|NCT01320202|821805|P2|Overall Study|Physician Decision|1
249275|NCT01320202|821806|P1|Overall Study|Physician Decision|3
249276|NCT01320202|821805|P2|Overall Study|Lost to Follow-up|0
249277|NCT01320202|821806|P1|Overall Study|Lost to Follow-up|1
249278|NCT01320202|821805|P2|Overall Study|Death|3
249279|NCT01320202|821806|P1|Overall Study|Death|5
249280|NCT01320202|821805|P2|Overall Study|Adverse Event|5
249281|NCT01320202|821806|P1|Overall Study|Adverse Event|5
249282|NCT01319877|821870|P2|Overall Study|Reason Not Specified|5
249283|NCT01319877|821871|P1|Overall Study|Reason Not Specified|4
249284|NCT01319877|821870|P2|Overall Study|Withdrawal by Subject|1
249285|NCT01319877|821871|P1|Overall Study|Withdrawal by Subject|0
249286|NCT01319877|821870|P2|Overall Study|Disease Progression|2
249287|NCT01319877|821871|P1|Overall Study|Disease Progression|2
249288|NCT01319877|821870|P2|Overall Study|Physician Decision|0
249289|NCT01319877|821871|P1|Overall Study|Physician Decision|2
249290|NCT01319877|821870|P2|Overall Study|Lost to Follow-up|37
249291|NCT01319877|821871|P1|Overall Study|Lost to Follow-up|100
249292|NCT01319721|822021|P2|Overall Study|Lost to Follow-up|6
249293|NCT01319721|822022|P1|Overall Study|Lost to Follow-up|1
249294|NCT01319422|822067|P2|Overall Study|Withdrawal by Subject|0
249295|NCT01319422|822068|P1|Overall Study|Withdrawal by Subject|1
249296|NCT01318876|822111|P1|Day 29 Survey|survey not completed-don't know why|1825
249297|NCT01318876|822111|P1|Day 8 Survey|survey not completed-don't know why|1724
249298|NCT01318876|822111|P1|Day 8 Survey|email address invalid|96
249299|NCT01318512|822209|P1|Maintenance Period (6 Months)|Protocol Violation|9
249300|NCT01318512|822209|P1|Maintenance Period (6 Months)|Death|2
249301|NCT01318499|822228|P3|Overall Study|Not Specified|22
249302|NCT01318499|822229|P2|Overall Study|Not Specified|10
249303|NCT01318499|822230|P1|Overall Study|Not Specified|7
249304|NCT01318499|822228|P3|Overall Study|Patient Did Not Use Study Medication|14
249305|NCT01318499|822229|P2|Overall Study|Patient Did Not Use Study Medication|28
249306|NCT01318499|822230|P1|Overall Study|Patient Did Not Use Study Medication|18
249307|NCT01318499|822228|P3|Overall Study|Protocol Violation|2
249308|NCT01318499|822229|P2|Overall Study|Protocol Violation|4
249309|NCT01318499|822230|P1|Overall Study|Protocol Violation|2
249310|NCT01318499|822228|P3|Overall Study|Treatment Failure|101
249311|NCT01318499|822229|P2|Overall Study|Treatment Failure|19
249312|NCT01318499|822230|P1|Overall Study|Treatment Failure|19
249313|NCT01318499|822228|P3|Overall Study|Noncompliance|0
249314|NCT01318499|822229|P2|Overall Study|Noncompliance|3
249315|NCT01318499|822230|P1|Overall Study|Noncompliance|2
249316|NCT01318499|822228|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
249317|NCT01318499|822229|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
249318|NCT01318499|822230|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
249319|NCT01318499|822228|P3|Overall Study|Adverse Event|6
249320|NCT01318499|822229|P2|Overall Study|Adverse Event|11
249321|NCT01318499|822230|P1|Overall Study|Adverse Event|16
249322|NCT01318382|822253|P1|Overall Study|Protocol Violation|1
249323|NCT01318382|822253|P1|Overall Study|Device Malfunction|10
249324|NCT01318382|822253|P1|Overall Study|Physician Decision|2
249325|NCT01318135|822311|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
249326|NCT01318135|822312|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
249327|NCT01318135|822313|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
249328|NCT01318135|822314|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
249329|NCT01318135|822315|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
249330|NCT01318135|822316|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
249331|NCT01318135|822317|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
249332|NCT01318135|822318|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
249333|NCT01318135|822311|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
249334|NCT01318135|822312|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
249335|NCT01318135|822313|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
249336|NCT01318135|822314|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
249337|NCT01318135|822315|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
249338|NCT01318135|822316|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
249339|NCT01318135|822317|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
249340|NCT01318135|822318|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
249341|NCT01318135|822311|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
249342|NCT01318135|822312|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
249343|NCT01318135|822313|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
249344|NCT01318135|822314|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
249345|NCT01318135|822315|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
249346|NCT01318135|822316|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
249347|NCT01318135|822317|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
249348|NCT01318135|822318|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
249349|NCT01318135|822311|P8|Entered - Long-Term Extension Study|Protocol Violation|0
249350|NCT01318135|822312|P7|Entered - Long-Term Extension Study|Protocol Violation|0
249351|NCT01318135|822313|P6|Entered - Long-Term Extension Study|Protocol Violation|0
249352|NCT01318135|822314|P5|Entered - Long-Term Extension Study|Protocol Violation|1
249353|NCT01318135|822315|P4|Entered - Long-Term Extension Study|Protocol Violation|0
249354|NCT01318135|822316|P3|Entered - Long-Term Extension Study|Protocol Violation|0
249355|NCT01318135|822317|P2|Entered - Long-Term Extension Study|Protocol Violation|1
249356|NCT01318135|822318|P1|Entered - Long-Term Extension Study|Protocol Violation|1
249357|NCT01318135|822311|P8|Entered - Long-Term Extension Study|Adverse Event|0
249358|NCT01318135|822312|P7|Entered - Long-Term Extension Study|Adverse Event|0
249359|NCT01318135|822313|P6|Entered - Long-Term Extension Study|Adverse Event|2
249360|NCT01318135|822314|P5|Entered - Long-Term Extension Study|Adverse Event|4
249361|NCT01318135|822315|P4|Entered - Long-Term Extension Study|Adverse Event|3
249362|NCT01318135|822316|P3|Entered - Long-Term Extension Study|Adverse Event|4
249363|NCT01318135|822317|P2|Entered - Long-Term Extension Study|Adverse Event|3
249364|NCT01318135|822318|P1|Entered - Long-Term Extension Study|Adverse Event|9
249365|NCT01318135|822311|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
249366|NCT01318135|822312|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
249367|NCT01318135|822313|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
249368|NCT01318135|822314|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
249369|NCT01318135|822315|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
249370|NCT01318135|822316|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
249371|NCT01318135|822317|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
249372|NCT01318135|822318|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
249373|NCT01318135|822311|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
249374|NCT01318135|822312|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
249375|NCT01318135|822313|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
249376|NCT01318135|822314|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
249377|NCT01318135|822315|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
249378|NCT01318135|822316|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
249379|NCT01318135|822317|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
249380|NCT01318135|822318|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
249381|NCT01318122|822450|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
249382|NCT01318122|822451|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
249383|NCT01318122|822452|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
249384|NCT01318122|822453|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
249385|NCT01318122|822450|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
249386|NCT01318122|822451|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
249387|NCT01318122|822452|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
249388|NCT01318122|822453|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
249389|NCT01318122|822450|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
249390|NCT01318122|822451|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
249391|NCT01318122|822452|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
249392|NCT01318122|822453|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
249393|NCT01318122|822450|P4|Entered - Long-Term Extension Study|Adverse Event|4
249394|NCT01318122|822451|P3|Entered - Long-Term Extension Study|Adverse Event|2
249395|NCT01318122|822452|P2|Entered - Long-Term Extension Study|Adverse Event|6
249396|NCT01318122|822453|P1|Entered - Long-Term Extension Study|Adverse Event|6
249397|NCT01318122|822450|P4|Enrolled - Long-Term Extension Study|Other|0
249398|NCT01318122|822451|P3|Enrolled - Long-Term Extension Study|Other|0
249399|NCT01318122|822452|P2|Enrolled - Long-Term Extension Study|Other|0
249400|NCT01318122|822453|P1|Enrolled - Long-Term Extension Study|Other|1
249401|NCT01318122|822450|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
249402|NCT01318122|822451|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
249403|NCT01318122|822452|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
249404|NCT01318122|822453|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
249405|NCT01318109|822522|P3|Overall Study|Schedule Conflict|0
249406|NCT01318109|822523|P2|Overall Study|Schedule Conflict|1
249407|NCT01318109|822524|P1|Overall Study|Schedule Conflict|0
249408|NCT01318109|822522|P3|Overall Study|Withdrawal by Subject|0
249409|NCT01318109|822523|P2|Overall Study|Withdrawal by Subject|0
249410|NCT01318109|822524|P1|Overall Study|Withdrawal by Subject|1
249411|NCT01318109|822522|P3|Overall Study|Adverse Event|0
249412|NCT01318109|822523|P2|Overall Study|Adverse Event|2
249413|NCT01318109|822524|P1|Overall Study|Adverse Event|0
249414|NCT01318083|822559|P3|Overall Study|Lack of Study Medication Compliance|0
249415|NCT01318083|822560|P2|Overall Study|Lack of Study Medication Compliance|1
249416|NCT01318083|822561|P1|Overall Study|Lack of Study Medication Compliance|0
249417|NCT01318083|822559|P3|Overall Study|Treatment Complications|0
249418|NCT01318083|822560|P2|Overall Study|Treatment Complications|0
249419|NCT01318083|822561|P1|Overall Study|Treatment Complications|1
249420|NCT01318083|822559|P3|Overall Study|Lack of Efficacy|1
249421|NCT01318083|822560|P2|Overall Study|Lack of Efficacy|0
249422|NCT01318083|822561|P1|Overall Study|Lack of Efficacy|0
249423|NCT01318083|822559|P3|Overall Study|Withdrawal by Subject|2
249424|NCT01318083|822560|P2|Overall Study|Withdrawal by Subject|0
249425|NCT01318083|822561|P1|Overall Study|Withdrawal by Subject|1
249426|NCT01318083|822559|P3|Overall Study|Adverse Event|2
249428|NCT01318083|822561|P1|Overall Study|Adverse Event|4
249429|NCT01318070|822596|P3|Overall Study|Principal Investigator Discretion|0
249430|NCT01318070|822597|P2|Overall Study|Principal Investigator Discretion|0
249431|NCT01318070|822598|P1|Overall Study|Principal Investigator Discretion|1
249432|NCT01318070|822596|P3|Overall Study|Lack of Efficacy|1
249433|NCT01318070|822597|P2|Overall Study|Lack of Efficacy|0
249434|NCT01318070|822598|P1|Overall Study|Lack of Efficacy|0
249435|NCT01318070|822596|P3|Overall Study|Withdrawal by Subject|1
249436|NCT01318070|822597|P2|Overall Study|Withdrawal by Subject|1
249437|NCT01318070|822598|P1|Overall Study|Withdrawal by Subject|0
249438|NCT01318070|822596|P3|Overall Study|Adverse Event|5
249439|NCT01318070|822597|P2|Overall Study|Adverse Event|1
249440|NCT01318070|822598|P1|Overall Study|Adverse Event|1
249441|NCT01317797|822642|P3|Overall Study|Withdrawal of Patient|1
249442|NCT01317797|822643|P2|Overall Study|Withdrawal of Patient|0
249443|NCT01317797|822644|P1|Overall Study|Withdrawal of Patient|0
249444|NCT01317797|822642|P3|Overall Study|Other|0
249445|NCT01317797|822643|P2|Overall Study|Other|1
249446|NCT01317797|822644|P1|Overall Study|Other|0
249447|NCT01317641|822721|P9|Overall Study|Withdrawal by Subject|0
249448|NCT01317641|822722|P8|Overall Study|Withdrawal by Subject|0
249449|NCT01317641|822723|P7|Overall Study|Withdrawal by Subject|1
249450|NCT01317641|822724|P6|Overall Study|Withdrawal by Subject|0
249451|NCT01317641|822725|P5|Overall Study|Withdrawal by Subject|0
249452|NCT01317641|822726|P4|Overall Study|Withdrawal by Subject|0
249453|NCT01317641|822727|P3|Overall Study|Withdrawal by Subject|0
249454|NCT01317641|822728|P2|Overall Study|Withdrawal by Subject|0
249455|NCT01317641|822729|P1|Overall Study|Withdrawal by Subject|0
249456|NCT01317641|822721|P9|Overall Study|Disease progression|4
249457|NCT01317641|822722|P8|Overall Study|Disease progression|3
249458|NCT01317641|822723|P7|Overall Study|Disease progression|0
249459|NCT01317641|822724|P6|Overall Study|Disease progression|0
249460|NCT01317641|822725|P5|Overall Study|Disease progression|0
249461|NCT01317641|822726|P4|Overall Study|Disease progression|0
249462|NCT01317641|822727|P3|Overall Study|Disease progression|0
249463|NCT01317641|822728|P2|Overall Study|Disease progression|0
249464|NCT01317641|822729|P1|Overall Study|Disease progression|0
249465|NCT01317641|822721|P9|Overall Study|Protocol Violation|0
249466|NCT01317641|822722|P8|Overall Study|Protocol Violation|0
249467|NCT01317641|822723|P7|Overall Study|Protocol Violation|0
249468|NCT01317641|822724|P6|Overall Study|Protocol Violation|0
249469|NCT01317641|822725|P5|Overall Study|Protocol Violation|0
249470|NCT01317641|822726|P4|Overall Study|Protocol Violation|0
249471|NCT01317641|822727|P3|Overall Study|Protocol Violation|0
249472|NCT01317641|822728|P2|Overall Study|Protocol Violation|0
249473|NCT01317641|822729|P1|Overall Study|Protocol Violation|1
249474|NCT01317641|822721|P9|Overall Study|Adverse Event|0
249475|NCT01317641|822722|P8|Overall Study|Adverse Event|1
249476|NCT01317641|822723|P7|Overall Study|Adverse Event|2
249477|NCT01317641|822724|P6|Overall Study|Adverse Event|0
249478|NCT01317641|822725|P5|Overall Study|Adverse Event|0
249479|NCT01317641|822726|P4|Overall Study|Adverse Event|1
249480|NCT01317641|822727|P3|Overall Study|Adverse Event|0
249481|NCT01317641|822728|P2|Overall Study|Adverse Event|1
249482|NCT01317641|822729|P1|Overall Study|Adverse Event|0
249483|NCT01317641|822721|P9|Overall Study|Not treated|1
249484|NCT01317641|822722|P8|Overall Study|Not treated|1
249485|NCT01317641|822723|P7|Overall Study|Not treated|0
249486|NCT01317641|822724|P6|Overall Study|Not treated|0
249487|NCT01317641|822725|P5|Overall Study|Not treated|0
249488|NCT01317641|822726|P4|Overall Study|Not treated|0
249489|NCT01317641|822727|P3|Overall Study|Not treated|0
249490|NCT01317641|822728|P2|Overall Study|Not treated|0
249491|NCT01317641|822729|P1|Overall Study|Not treated|0
249492|NCT01317615|822831|P1|Overall Study|Adverse Event|7
249493|NCT01317615|822831|P1|Overall Study|Abnormal laboratory value(s)|1
249494|NCT01317615|822831|P1|Overall Study|Withdrawal by Subject|5
249495|NCT01317615|822831|P1|Overall Study|Death|6
249496|NCT01317615|822831|P1|Overall Study|New cancer therapy|5
249497|NCT01317615|822831|P1|Overall Study|Disease progression|25
249498|NCT01317160|822842|P2|Overall Study|Withdrawal by Subject|2
249499|NCT01317160|822843|P1|Overall Study|Withdrawal by Subject|0
249500|NCT01317160|822842|P2|Overall Study|Lost to Follow-up|3
249501|NCT01317160|822843|P1|Overall Study|Lost to Follow-up|3
249502|NCT01317160|822842|P2|Overall Study|Incorrect inclusion|1
249503|NCT01317160|822843|P1|Overall Study|Incorrect inclusion|1
249504|NCT01317004|822853|P2|Overall Study|Adverse Event|3
249505|NCT01317004|822854|P1|Overall Study|Adverse Event|3
249506|NCT01317004|822853|P2|Overall Study|Protocol Violation|2
249507|NCT01317004|822854|P1|Overall Study|Protocol Violation|0
249508|NCT01317004|822853|P2|Overall Study|Withdrawal by Subject|4
249509|NCT01317004|822854|P1|Overall Study|Withdrawal by Subject|1
249510|NCT01316913|822887|P4|Overall Study|Withdrawal by Subject|6
249511|NCT01316913|822888|P3|Overall Study|Withdrawal by Subject|10
249512|NCT01316913|822889|P2|Overall Study|Withdrawal by Subject|9
249513|NCT01316913|822890|P1|Overall Study|Withdrawal by Subject|10
249514|NCT01316913|822887|P4|Overall Study|Lost to Follow-up|2
249515|NCT01316913|822888|P3|Overall Study|Lost to Follow-up|0
249516|NCT01316913|822889|P2|Overall Study|Lost to Follow-up|1
249517|NCT01316913|822890|P1|Overall Study|Lost to Follow-up|0
249518|NCT01316913|822887|P4|Overall Study|Protocol-defined Stopping Criteria|6
249519|NCT01316913|822888|P3|Overall Study|Protocol-defined Stopping Criteria|11
249520|NCT01316913|822889|P2|Overall Study|Protocol-defined Stopping Criteria|8
249521|NCT01316913|822890|P1|Overall Study|Protocol-defined Stopping Criteria|7
249522|NCT01316913|822887|P4|Overall Study|Protocol Violation|1
249523|NCT01316913|822888|P3|Overall Study|Protocol Violation|4
249524|NCT01316913|822889|P2|Overall Study|Protocol Violation|4
249525|NCT01316913|822890|P1|Overall Study|Protocol Violation|1
249526|NCT01316913|822887|P4|Overall Study|Lack of Efficacy|13
249527|NCT01316913|822888|P3|Overall Study|Lack of Efficacy|9
249528|NCT01316913|822889|P2|Overall Study|Lack of Efficacy|12
249529|NCT01316913|822890|P1|Overall Study|Lack of Efficacy|22
249530|NCT01316913|822887|P4|Overall Study|Adverse Event|11
249531|NCT01316913|822888|P3|Overall Study|Adverse Event|15
249532|NCT01316913|822889|P2|Overall Study|Adverse Event|20
249533|NCT01316913|822890|P1|Overall Study|Adverse Event|17
249534|NCT01316900|822912|P4|Overall Study|Withdrawal by Subject|9
249535|NCT01316900|822913|P3|Overall Study|Withdrawal by Subject|6
249536|NCT01316900|822914|P2|Overall Study|Withdrawal by Subject|8
249537|NCT01316900|822915|P1|Overall Study|Withdrawal by Subject|7
249538|NCT01316900|822912|P4|Overall Study|Lost to Follow-up|1
249539|NCT01316900|822913|P3|Overall Study|Lost to Follow-up|1
249540|NCT01316900|822914|P2|Overall Study|Lost to Follow-up|0
249541|NCT01316900|822915|P1|Overall Study|Lost to Follow-up|1
249542|NCT01316900|822912|P4|Overall Study|Protocol-defined Stopping Criteria|5
249543|NCT01316900|822913|P3|Overall Study|Protocol-defined Stopping Criteria|10
249544|NCT01316900|822914|P2|Overall Study|Protocol-defined Stopping Criteria|3
249545|NCT01316900|822915|P1|Overall Study|Protocol-defined Stopping Criteria|2
249546|NCT01316900|822912|P4|Overall Study|Protocol Violation|0
249547|NCT01316900|822913|P3|Overall Study|Protocol Violation|4
249548|NCT01316900|822914|P2|Overall Study|Protocol Violation|1
249549|NCT01316900|822915|P1|Overall Study|Protocol Violation|7
249550|NCT01316900|822912|P4|Overall Study|Lack of Efficacy|7
249551|NCT01316900|822913|P3|Overall Study|Lack of Efficacy|5
249552|NCT01316900|822914|P2|Overall Study|Lack of Efficacy|9
249553|NCT01316900|822915|P1|Overall Study|Lack of Efficacy|17
249554|NCT01316900|822912|P4|Overall Study|Adverse Event|9
249555|NCT01316900|822913|P3|Overall Study|Adverse Event|15
249556|NCT01316900|822914|P2|Overall Study|Adverse Event|10
249557|NCT01316900|822915|P1|Overall Study|Adverse Event|10
249558|NCT01316887|822936|P3|Overall Study|Withdrawal by Subject|15
249559|NCT01316887|822937|P2|Overall Study|Withdrawal by Subject|16
249560|NCT01316887|822938|P1|Overall Study|Withdrawal by Subject|8
249561|NCT01316887|822936|P3|Overall Study|Lost to Follow-up|5
249562|NCT01316887|822937|P2|Overall Study|Lost to Follow-up|7
249563|NCT01316887|822938|P1|Overall Study|Lost to Follow-up|1
249564|NCT01316887|822936|P3|Overall Study|Study Closed/Terminated|3
249565|NCT01316887|822937|P2|Overall Study|Study Closed/Terminated|4
249566|NCT01316887|822938|P1|Overall Study|Study Closed/Terminated|2
249567|NCT01316887|822936|P3|Overall Study|Protocol-defined Stopping Criteria|36
249568|NCT01316887|822937|P2|Overall Study|Protocol-defined Stopping Criteria|37
249569|NCT01316887|822938|P1|Overall Study|Protocol-defined Stopping Criteria|8
249570|NCT01316887|822936|P3|Overall Study|Protocol Violation|6
249571|NCT01316887|822937|P2|Overall Study|Protocol Violation|6
249572|NCT01316887|822938|P1|Overall Study|Protocol Violation|2
249573|NCT01316887|822936|P3|Overall Study|Lack of Efficacy|1
249574|NCT01316887|822937|P2|Overall Study|Lack of Efficacy|3
249575|NCT01316887|822938|P1|Overall Study|Lack of Efficacy|9
249576|NCT01316887|822936|P3|Overall Study|Adverse Event|17
249577|NCT01316887|822937|P2|Overall Study|Adverse Event|21
249578|NCT01316887|822938|P1|Overall Study|Adverse Event|13
249579|NCT01316692|823000|P1|Overall Study|Disease Progression|7
249580|NCT01316692|823000|P1|Overall Study|Adverse Event|5
249581|NCT01316614|823009|P1|Overall Study|Medically unstable|1
249582|NCT01316614|823009|P1|Overall Study|Inadequate number of passes|2
249583|NCT01316614|823009|P1|Overall Study|Cystic lesion|5
249584|NCT01316614|823009|P1|Overall Study|Cytology slides not available for review|4
249585|NCT01316614|823009|P1|Overall Study|No solid lesion and FNA not indicated|25
249586|NCT01316575|823026|P2|Overall Study|Required alternate treatment|1
249587|NCT01316575|823027|P1|Overall Study|Required alternate treatment|0
249588|NCT01316575|823026|P2|Overall Study|Withdrawal by Subject|0
249589|NCT01316575|823027|P1|Overall Study|Withdrawal by Subject|2
249590|NCT01316419|823039|P1|Overall Study|Lost to Follow-up|19
249681|NCT01314872|823424|P7|Period 2|Adverse event, non-fatal|0
249591|NCT01316419|823039|P1|Overall Study|Violated inclusion/exclusion criterion|143
249592|NCT01316419|823039|P1|Overall Study|Not treated|103
249593|NCT01316380|823065|P3|Overall Study|Not treated|0
249594|NCT01316380|823066|P2|Overall Study|Not treated|0
249595|NCT01316380|823067|P1|Overall Study|Not treated|1
249596|NCT01316380|823065|P3|Overall Study|Other|1
249597|NCT01316380|823066|P2|Overall Study|Other|1
249598|NCT01316380|823067|P1|Overall Study|Other|0
249599|NCT01316380|823065|P3|Overall Study|Withdrawal by Subject|0
249600|NCT01316380|823066|P2|Overall Study|Withdrawal by Subject|2
249601|NCT01316380|823067|P1|Overall Study|Withdrawal by Subject|1
249602|NCT01316380|823065|P3|Overall Study|Protocol Violation|1
249603|NCT01316380|823066|P2|Overall Study|Protocol Violation|0
249604|NCT01316380|823067|P1|Overall Study|Protocol Violation|0
249605|NCT01316380|823065|P3|Overall Study|Adverse Event|1
249606|NCT01316380|823066|P2|Overall Study|Adverse Event|2
249607|NCT01316380|823067|P1|Overall Study|Adverse Event|0
249608|NCT01316224|823233|P1|Overall Study|Not Specified|1
249609|NCT01316224|823233|P1|Overall Study|Adverse Event With Treatment Failure|1
249610|NCT01316224|823233|P1|Overall Study|Withdrawal by Subject|1
249611|NCT01316224|823233|P1|Overall Study|Lack of Efficacy|1
249612|NCT01316224|823233|P1|Overall Study|Adverse Event|3
249613|NCT01316224|823233|P1|Overall Study|Protocol Violation|3
249614|NCT01316055|823250|P3|Overall Study|Lost to Follow-up|0
249615|NCT01316055|823251|P2|Overall Study|Lost to Follow-up|0
249616|NCT01316055|823252|P1|Overall Study|Lost to Follow-up|1
249617|NCT01315847|823277|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
249618|NCT01315847|823278|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
249619|NCT01315847|823277|P2|Part I, Period 1|Reached maximum number of arterial lines|0
249620|NCT01315847|823278|P1|Part I, Period 1|Reached maximum number of arterial lines|3
249621|NCT01315249|823322|P2|Overall Study|Death|1
249622|NCT01315249|823323|P1|Overall Study|Death|0
249623|NCT01315249|823322|P2|Overall Study|Lost to Follow-up|2
249624|NCT01315249|823323|P1|Overall Study|Lost to Follow-up|0
249625|NCT01315249|823322|P2|Overall Study|Lack of Efficacy|1
249626|NCT01315249|823323|P1|Overall Study|Lack of Efficacy|0
249627|NCT01315249|823322|P2|Overall Study|inability to use device|0
249628|NCT01315249|823323|P1|Overall Study|inability to use device|1
249629|NCT01315249|823322|P2|Overall Study|Administrative problems|0
249630|NCT01315249|823323|P1|Overall Study|Administrative problems|1
249631|NCT01315249|823322|P2|Overall Study|Abnormal test results|2
249632|NCT01315249|823323|P1|Overall Study|Abnormal test results|1
249633|NCT01315249|823322|P2|Overall Study|Protocol Violation|5
249634|NCT01315249|823323|P1|Overall Study|Protocol Violation|8
249635|NCT01315249|823322|P2|Overall Study|Withdrawal by Subject|10
249636|NCT01315249|823323|P1|Overall Study|Withdrawal by Subject|11
249637|NCT01315249|823322|P2|Overall Study|Adverse Event|26
249638|NCT01315249|823323|P1|Overall Study|Adverse Event|22
249639|NCT01315028|823385|P2|Overall Study|Death|1
249640|NCT01315028|823386|P1|Overall Study|Death|0
249641|NCT01315028|823385|P2|Overall Study|Lost to Follow-up|0
249642|NCT01315028|823386|P1|Overall Study|Lost to Follow-up|1
249643|NCT01314872|823416|P15|Period 2|Lost to Follow-up|6
249644|NCT01314872|823417|P14|Period 2|Lost to Follow-up|2
249645|NCT01314872|823418|P13|Period 2|Lost to Follow-up|7
249646|NCT01314872|823419|P12|Period 2|Lost to Follow-up|6
249647|NCT01314872|823420|P11|Period 2|Lost to Follow-up|0
249648|NCT01314872|823421|P10|Period 2|Lost to Follow-up|0
249649|NCT01314872|823422|P9|Period 2|Lost to Follow-up|0
249650|NCT01314872|823423|P8|Period 2|Lost to Follow-up|0
249651|NCT01314872|823424|P7|Period 2|Lost to Follow-up|0
249652|NCT01314872|823425|P6|Period 2|Lost to Follow-up|0
249653|NCT01314872|823426|P5|Period 2|Lost to Follow-up|0
249654|NCT01314872|823427|P4|Period 2|Lost to Follow-up|0
249655|NCT01314872|823428|P3|Period 2|Lost to Follow-up|0
249656|NCT01314872|823429|P2|Period 2|Lost to Follow-up|0
249657|NCT01314872|823430|P1|Period 2|Lost to Follow-up|0
249658|NCT01314872|823416|P15|Period 2|Withdrawal by Subject|4
249659|NCT01314872|823417|P14|Period 2|Withdrawal by Subject|12
249660|NCT01314872|823418|P13|Period 2|Withdrawal by Subject|17
249661|NCT01314872|823419|P12|Period 2|Withdrawal by Subject|14
249662|NCT01314872|823420|P11|Period 2|Withdrawal by Subject|0
249663|NCT01314872|823421|P10|Period 2|Withdrawal by Subject|0
249664|NCT01314872|823422|P9|Period 2|Withdrawal by Subject|0
249665|NCT01314872|823423|P8|Period 2|Withdrawal by Subject|0
249666|NCT01314872|823424|P7|Period 2|Withdrawal by Subject|0
249667|NCT01314872|823425|P6|Period 2|Withdrawal by Subject|0
249668|NCT01314872|823426|P5|Period 2|Withdrawal by Subject|0
249669|NCT01314872|823427|P4|Period 2|Withdrawal by Subject|0
249670|NCT01314872|823428|P3|Period 2|Withdrawal by Subject|0
249671|NCT01314872|823429|P2|Period 2|Withdrawal by Subject|0
249672|NCT01314872|823430|P1|Period 2|Withdrawal by Subject|0
249673|NCT01314872|823416|P15|Period 2|Adverse event, non-fatal|9
249674|NCT01314872|823417|P14|Period 2|Adverse event, non-fatal|24
249675|NCT01314872|823418|P13|Period 2|Adverse event, non-fatal|16
249676|NCT01314872|823419|P12|Period 2|Adverse event, non-fatal|13
249677|NCT01314872|823420|P11|Period 2|Adverse event, non-fatal|0
249678|NCT01314872|823421|P10|Period 2|Adverse event, non-fatal|0
249679|NCT01314872|823422|P9|Period 2|Adverse event, non-fatal|0
249680|NCT01314872|823423|P8|Period 2|Adverse event, non-fatal|0
249682|NCT01314872|823425|P6|Period 2|Adverse event, non-fatal|0
249683|NCT01314872|823426|P5|Period 2|Adverse event, non-fatal|0
249684|NCT01314872|823427|P4|Period 2|Adverse event, non-fatal|0
249685|NCT01314872|823428|P3|Period 2|Adverse event, non-fatal|0
249686|NCT01314872|823429|P2|Period 2|Adverse event, non-fatal|0
249687|NCT01314872|823430|P1|Period 2|Adverse event, non-fatal|0
249688|NCT01314872|823416|P15|Period 2|Study terminated by Sponsor|0
249689|NCT01314872|823417|P14|Period 2|Study terminated by Sponsor|3
249690|NCT01314872|823418|P13|Period 2|Study terminated by Sponsor|2
249691|NCT01314872|823419|P12|Period 2|Study terminated by Sponsor|2
249692|NCT01314872|823420|P11|Period 2|Study terminated by Sponsor|0
249693|NCT01314872|823421|P10|Period 2|Study terminated by Sponsor|0
249694|NCT01314872|823422|P9|Period 2|Study terminated by Sponsor|0
249695|NCT01314872|823423|P8|Period 2|Study terminated by Sponsor|0
249696|NCT01314872|823424|P7|Period 2|Study terminated by Sponsor|0
249697|NCT01314872|823425|P6|Period 2|Study terminated by Sponsor|0
249698|NCT01314872|823426|P5|Period 2|Study terminated by Sponsor|0
249699|NCT01314872|823427|P4|Period 2|Study terminated by Sponsor|0
249700|NCT01314872|823428|P3|Period 2|Study terminated by Sponsor|0
249701|NCT01314872|823429|P2|Period 2|Study terminated by Sponsor|0
249702|NCT01314872|823430|P1|Period 2|Study terminated by Sponsor|0
249703|NCT01314872|823416|P15|Period 2|Pregnancy|1
249704|NCT01314872|823417|P14|Period 2|Pregnancy|0
249705|NCT01314872|823418|P13|Period 2|Pregnancy|0
249706|NCT01314872|823419|P12|Period 2|Pregnancy|0
249707|NCT01314872|823420|P11|Period 2|Pregnancy|0
249708|NCT01314872|823421|P10|Period 2|Pregnancy|0
249709|NCT01314872|823422|P9|Period 2|Pregnancy|0
249710|NCT01314872|823423|P8|Period 2|Pregnancy|0
249711|NCT01314872|823424|P7|Period 2|Pregnancy|0
249712|NCT01314872|823425|P6|Period 2|Pregnancy|0
249713|NCT01314872|823426|P5|Period 2|Pregnancy|0
249714|NCT01314872|823427|P4|Period 2|Pregnancy|0
249715|NCT01314872|823428|P3|Period 2|Pregnancy|0
249716|NCT01314872|823429|P2|Period 2|Pregnancy|0
249717|NCT01314872|823430|P1|Period 2|Pregnancy|0
249718|NCT01314872|823416|P15|Period 2|Lack of Efficacy|2
249719|NCT01314872|823417|P14|Period 2|Lack of Efficacy|9
249720|NCT01314872|823418|P13|Period 2|Lack of Efficacy|12
249721|NCT01314872|823419|P12|Period 2|Lack of Efficacy|7
249722|NCT01314872|823420|P11|Period 2|Lack of Efficacy|0
249723|NCT01314872|823421|P10|Period 2|Lack of Efficacy|0
249724|NCT01314872|823422|P9|Period 2|Lack of Efficacy|0
249725|NCT01314872|823423|P8|Period 2|Lack of Efficacy|0
249726|NCT01314872|823424|P7|Period 2|Lack of Efficacy|0
249727|NCT01314872|823425|P6|Period 2|Lack of Efficacy|0
249728|NCT01314872|823426|P5|Period 2|Lack of Efficacy|0
249729|NCT01314872|823427|P4|Period 2|Lack of Efficacy|0
249730|NCT01314872|823428|P3|Period 2|Lack of Efficacy|0
249731|NCT01314872|823429|P2|Period 2|Lack of Efficacy|0
249732|NCT01314872|823430|P1|Period 2|Lack of Efficacy|0
249733|NCT01314872|823416|P15|Period 2|Non-compliance with study drug|2
249734|NCT01314872|823417|P14|Period 2|Non-compliance with study drug|1
249735|NCT01314872|823418|P13|Period 2|Non-compliance with study drug|3
249736|NCT01314872|823419|P12|Period 2|Non-compliance with study drug|3
249737|NCT01314872|823420|P11|Period 2|Non-compliance with study drug|0
249738|NCT01314872|823421|P10|Period 2|Non-compliance with study drug|0
249739|NCT01314872|823422|P9|Period 2|Non-compliance with study drug|0
249740|NCT01314872|823423|P8|Period 2|Non-compliance with study drug|0
249741|NCT01314872|823424|P7|Period 2|Non-compliance with study drug|0
249742|NCT01314872|823425|P6|Period 2|Non-compliance with study drug|0
249743|NCT01314872|823426|P5|Period 2|Non-compliance with study drug|0
249744|NCT01314872|823427|P4|Period 2|Non-compliance with study drug|0
249745|NCT01314872|823428|P3|Period 2|Non-compliance with study drug|0
249746|NCT01314872|823429|P2|Period 2|Non-compliance with study drug|0
249747|NCT01314872|823430|P1|Period 2|Non-compliance with study drug|0
249748|NCT01314872|823416|P15|Period 2|Protocol Violation|0
249749|NCT01314872|823417|P14|Period 2|Protocol Violation|2
249750|NCT01314872|823418|P13|Period 2|Protocol Violation|3
249751|NCT01314872|823419|P12|Period 2|Protocol Violation|3
249752|NCT01314872|823420|P11|Period 2|Protocol Violation|0
249753|NCT01314872|823421|P10|Period 2|Protocol Violation|0
249754|NCT01314872|823422|P9|Period 2|Protocol Violation|0
249755|NCT01314872|823423|P8|Period 2|Protocol Violation|0
249756|NCT01314872|823424|P7|Period 2|Protocol Violation|0
249757|NCT01314872|823425|P6|Period 2|Protocol Violation|0
249758|NCT01314872|823426|P5|Period 2|Protocol Violation|0
249759|NCT01314872|823427|P4|Period 2|Protocol Violation|0
249760|NCT01314872|823428|P3|Period 2|Protocol Violation|0
249761|NCT01314872|823429|P2|Period 2|Protocol Violation|0
249762|NCT01314872|823430|P1|Period 2|Protocol Violation|0
249763|NCT01314872|823416|P15|Treatment Period 1|Lost to Follow-up|0
249764|NCT01314872|823417|P14|Treatment Period 1|Lost to Follow-up|0
249765|NCT01314872|823418|P13|Treatment Period 1|Lost to Follow-up|0
249766|NCT01314872|823419|P12|Treatment Period 1|Lost to Follow-up|0
249767|NCT01314872|823420|P11|Treatment Period 1|Lost to Follow-up|0
249768|NCT01314872|823421|P10|Treatment Period 1|Lost to Follow-up|0
249769|NCT01314872|823422|P9|Treatment Period 1|Lost to Follow-up|1
249770|NCT01314872|823423|P8|Treatment Period 1|Lost to Follow-up|1
249771|NCT01314872|823424|P7|Treatment Period 1|Lost to Follow-up|1
249772|NCT01314872|823425|P6|Treatment Period 1|Lost to Follow-up|1
249773|NCT01314872|823426|P5|Treatment Period 1|Lost to Follow-up|1
249774|NCT01314872|823427|P4|Treatment Period 1|Lost to Follow-up|2
249775|NCT01314872|823428|P3|Treatment Period 1|Lost to Follow-up|2
249776|NCT01314872|823429|P2|Treatment Period 1|Lost to Follow-up|1
249777|NCT01314872|823430|P1|Treatment Period 1|Lost to Follow-up|0
249778|NCT01314872|823416|P15|Treatment Period 1|Withdrawal by Subject|0
249779|NCT01314872|823417|P14|Treatment Period 1|Withdrawal by Subject|0
249780|NCT01314872|823418|P13|Treatment Period 1|Withdrawal by Subject|0
249781|NCT01314872|823419|P12|Treatment Period 1|Withdrawal by Subject|0
249782|NCT01314872|823420|P11|Treatment Period 1|Withdrawal by Subject|1
249783|NCT01314872|823421|P10|Treatment Period 1|Withdrawal by Subject|2
249784|NCT01314872|823422|P9|Treatment Period 1|Withdrawal by Subject|2
249785|NCT01314872|823423|P8|Treatment Period 1|Withdrawal by Subject|2
249786|NCT01314872|823424|P7|Treatment Period 1|Withdrawal by Subject|3
249787|NCT01314872|823425|P6|Treatment Period 1|Withdrawal by Subject|1
249788|NCT01314872|823426|P5|Treatment Period 1|Withdrawal by Subject|3
249789|NCT01314872|823427|P4|Treatment Period 1|Withdrawal by Subject|2
249790|NCT01314872|823428|P3|Treatment Period 1|Withdrawal by Subject|0
249791|NCT01314872|823429|P2|Treatment Period 1|Withdrawal by Subject|1
249792|NCT01314872|823430|P1|Treatment Period 1|Withdrawal by Subject|3
249793|NCT01314872|823416|P15|Treatment Period 1|Adverse event, non-fatal|0
249794|NCT01314872|823417|P14|Treatment Period 1|Adverse event, non-fatal|0
249795|NCT01314872|823418|P13|Treatment Period 1|Adverse event, non-fatal|0
249796|NCT01314872|823419|P12|Treatment Period 1|Adverse event, non-fatal|0
249797|NCT01314872|823420|P11|Treatment Period 1|Adverse event, non-fatal|1
249798|NCT01314872|823421|P10|Treatment Period 1|Adverse event, non-fatal|0
249799|NCT01314872|823422|P9|Treatment Period 1|Adverse event, non-fatal|3
249800|NCT01314872|823423|P8|Treatment Period 1|Adverse event, non-fatal|2
249801|NCT01314872|823424|P7|Treatment Period 1|Adverse event, non-fatal|4
249802|NCT01314872|823425|P6|Treatment Period 1|Adverse event, non-fatal|4
249803|NCT01314872|823426|P5|Treatment Period 1|Adverse event, non-fatal|2
249804|NCT01314872|823427|P4|Treatment Period 1|Adverse event, non-fatal|2
249805|NCT01314872|823428|P3|Treatment Period 1|Adverse event, non-fatal|3
249806|NCT01314872|823429|P2|Treatment Period 1|Adverse event, non-fatal|2
249807|NCT01314872|823430|P1|Treatment Period 1|Adverse event, non-fatal|4
249808|NCT01314872|823416|P15|Treatment Period 1|Lack of Efficacy|0
249809|NCT01314872|823417|P14|Treatment Period 1|Lack of Efficacy|0
249810|NCT01314872|823418|P13|Treatment Period 1|Lack of Efficacy|0
249811|NCT01314872|823419|P12|Treatment Period 1|Lack of Efficacy|0
249812|NCT01314872|823420|P11|Treatment Period 1|Lack of Efficacy|0
249813|NCT01314872|823421|P10|Treatment Period 1|Lack of Efficacy|0
249814|NCT01314872|823422|P9|Treatment Period 1|Lack of Efficacy|0
249815|NCT01314872|823423|P8|Treatment Period 1|Lack of Efficacy|2
249816|NCT01314872|823424|P7|Treatment Period 1|Lack of Efficacy|0
249817|NCT01314872|823425|P6|Treatment Period 1|Lack of Efficacy|1
249818|NCT01314872|823426|P5|Treatment Period 1|Lack of Efficacy|0
249819|NCT01314872|823427|P4|Treatment Period 1|Lack of Efficacy|0
249820|NCT01314872|823428|P3|Treatment Period 1|Lack of Efficacy|0
249821|NCT01314872|823429|P2|Treatment Period 1|Lack of Efficacy|0
249822|NCT01314872|823430|P1|Treatment Period 1|Lack of Efficacy|1
249823|NCT01314872|823416|P15|Treatment Period 1|Physician Decision|0
249824|NCT01314872|823417|P14|Treatment Period 1|Physician Decision|0
249825|NCT01314872|823418|P13|Treatment Period 1|Physician Decision|0
249826|NCT01314872|823419|P12|Treatment Period 1|Physician Decision|0
249827|NCT01314872|823420|P11|Treatment Period 1|Physician Decision|0
249828|NCT01314872|823421|P10|Treatment Period 1|Physician Decision|1
249829|NCT01314872|823422|P9|Treatment Period 1|Physician Decision|0
249830|NCT01314872|823423|P8|Treatment Period 1|Physician Decision|0
249831|NCT01314872|823424|P7|Treatment Period 1|Physician Decision|0
249832|NCT01314872|823425|P6|Treatment Period 1|Physician Decision|0
249833|NCT01314872|823426|P5|Treatment Period 1|Physician Decision|0
249834|NCT01314872|823427|P4|Treatment Period 1|Physician Decision|1
249835|NCT01314872|823428|P3|Treatment Period 1|Physician Decision|0
249836|NCT01314872|823429|P2|Treatment Period 1|Physician Decision|1
249837|NCT01314872|823430|P1|Treatment Period 1|Physician Decision|0
249838|NCT01314872|823416|P15|Treatment Period 1|Protocol Violation|0
249839|NCT01314872|823417|P14|Treatment Period 1|Protocol Violation|0
249840|NCT01314872|823418|P13|Treatment Period 1|Protocol Violation|0
249841|NCT01314872|823419|P12|Treatment Period 1|Protocol Violation|0
249842|NCT01314872|823420|P11|Treatment Period 1|Protocol Violation|1
249843|NCT01314872|823421|P10|Treatment Period 1|Protocol Violation|1
249844|NCT01314872|823422|P9|Treatment Period 1|Protocol Violation|0
249845|NCT01314872|823423|P8|Treatment Period 1|Protocol Violation|0
249846|NCT01314872|823424|P7|Treatment Period 1|Protocol Violation|0
249847|NCT01314872|823425|P6|Treatment Period 1|Protocol Violation|0
249848|NCT01314872|823426|P5|Treatment Period 1|Protocol Violation|1
249849|NCT01314872|823427|P4|Treatment Period 1|Protocol Violation|0
249850|NCT01314872|823428|P3|Treatment Period 1|Protocol Violation|1
249851|NCT01314872|823429|P2|Treatment Period 1|Protocol Violation|1
249852|NCT01314872|823430|P1|Treatment Period 1|Protocol Violation|2
249853|NCT01314716|823534|P2|Open-Label Phase|Physician Decision|4
249854|NCT01314716|823535|P1|Open-Label Phase|Physician Decision|5
249855|NCT01314716|823534|P2|Open-Label Phase|Withdrawal by Subject|2
249856|NCT01314716|823535|P1|Open-Label Phase|Withdrawal by Subject|1
249857|NCT01314716|823534|P2|Open-Label Phase|Adverse Event|6
249858|NCT01314716|823535|P1|Open-Label Phase|Adverse Event|4
249859|NCT01314716|823534|P2|Double-Blind Phase|Physician Decision|1
249860|NCT01314716|823535|P1|Double-Blind Phase|Physician Decision|0
249861|NCT01314716|823534|P2|Double-Blind Phase|Sponsor request|2
249862|NCT01314716|823535|P1|Double-Blind Phase|Sponsor request|1
249863|NCT01314716|823534|P2|Double-Blind Phase|Lost to Follow-up|1
249864|NCT01314716|823535|P1|Double-Blind Phase|Lost to Follow-up|0
249865|NCT01314716|823534|P2|Double-Blind Phase|Withdrawal by Subject|6
249866|NCT01314716|823535|P1|Double-Blind Phase|Withdrawal by Subject|5
249867|NCT01314716|823534|P2|Double-Blind Phase|Adverse Event|4
249868|NCT01314716|823535|P1|Double-Blind Phase|Adverse Event|10
249869|NCT01314716|823534|P2|Double-Blind Phase|Randomized but not treated|1
249870|NCT01314716|823535|P1|Double-Blind Phase|Randomized but not treated|1
249871|NCT01314703|823547|P1|Overall Study|screen failure and closed enrollment|8
249872|NCT01314443|823556|P4|Overall Study|Protocol Violation|1
249873|NCT01314443|823557|P3|Overall Study|Protocol Violation|1
249874|NCT01314443|823558|P2|Overall Study|Protocol Violation|2
249875|NCT01314443|823559|P1|Overall Study|Protocol Violation|2
249876|NCT01314443|823556|P4|Overall Study|Withdrawal by Subject|1
249877|NCT01314443|823557|P3|Overall Study|Withdrawal by Subject|1
249878|NCT01314443|823558|P2|Overall Study|Withdrawal by Subject|1
249879|NCT01314443|823559|P1|Overall Study|Withdrawal by Subject|2
249880|NCT01314261|823608|P4|Overall Study|Virologic Failure|1
249881|NCT01314261|823609|P3|Overall Study|Virologic Failure|0
249882|NCT01314261|823610|P2|Overall Study|Virologic Failure|1
249883|NCT01314261|823611|P1|Overall Study|Virologic Failure|0
249884|NCT01314261|823608|P4|Overall Study|Lost to Follow-up|2
249885|NCT01314261|823609|P3|Overall Study|Lost to Follow-up|2
249886|NCT01314261|823610|P2|Overall Study|Lost to Follow-up|0
249887|NCT01314261|823611|P1|Overall Study|Lost to Follow-up|1
249888|NCT01314261|823608|P4|Overall Study|Withdrawal by Subject|0
249889|NCT01314261|823609|P3|Overall Study|Withdrawal by Subject|1
249890|NCT01314261|823610|P2|Overall Study|Withdrawal by Subject|3
249891|NCT01314261|823611|P1|Overall Study|Withdrawal by Subject|0
249892|NCT01314261|823608|P4|Overall Study|Adverse Event|0
249893|NCT01314261|823609|P3|Overall Study|Adverse Event|0
249894|NCT01314261|823610|P2|Overall Study|Adverse Event|0
249895|NCT01314261|823611|P1|Overall Study|Adverse Event|1
249896|NCT01314118|823662|P1|Overall Study|Ongoing|62
249897|NCT01314118|823662|P1|Overall Study|Unspecified|2
249898|NCT01314118|823662|P1|Overall Study|Withdrawal by Subject|11
249899|NCT01314118|823662|P1|Overall Study|Protocol Violation|5
249900|NCT01314118|823662|P1|Overall Study|Death|4
249901|NCT01314118|823662|P1|Overall Study|Physician Decision|11
249902|NCT01314118|823662|P1|Overall Study|Progressive disease|27
249903|NCT01314118|823662|P1|Overall Study|Adverse Event|9
249904|NCT01314105|823671|P2|Overall Study|Progressive Disease|4
249905|NCT01314105|823672|P1|Overall Study|Progressive Disease|6
249906|NCT01313923|823765|P1|Overall Study|Physician Decision|3
249907|NCT01313884|823781|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
249908|NCT01313858|823788|P3|Overall Study|Lost to Follow-up|47
249909|NCT01313858|823789|P2|Overall Study|Lost to Follow-up|51
249910|NCT01313858|823790|P1|Overall Study|Lost to Follow-up|35
249911|NCT01313858|823788|P3|Overall Study|Premature Treatment Termination|191
249912|NCT01313858|823789|P2|Overall Study|Premature Treatment Termination|219
249913|NCT01313858|823790|P1|Overall Study|Premature Treatment Termination|251
249914|NCT01313780|823813|P2|Overall Study|missing data|3
249915|NCT01313780|823814|P1|Overall Study|missing data|3
249916|NCT01313780|823813|P2|Overall Study|Protocol Violation|4
249917|NCT01313780|823814|P1|Overall Study|Protocol Violation|10
249918|NCT01313780|823813|P2|Overall Study|Withdrawal by Subject|8
249919|NCT01313780|823814|P1|Overall Study|Withdrawal by Subject|2
249920|NCT01313780|823813|P2|Overall Study|Adverse Event|11
249921|NCT01313780|823814|P1|Overall Study|Adverse Event|6
249922|NCT01313780|823813|P2|Overall Study|Lack of Efficacy|2
249923|NCT01313780|823814|P1|Overall Study|Lack of Efficacy|4
249924|NCT01313728|823822|P1|Informed Consent to Baseline|Withdrawal by Subject|1
249925|NCT01313689|823839|P4|24-Week Randomization 2|Withdrawal by Subject|1
249926|NCT01313689|823840|P3|24-Week Randomization 2|Withdrawal by Subject|1
249927|NCT01313689|823841|P2|24-Week Randomization 2|Withdrawal by Subject|0
249928|NCT01313689|823842|P1|24-Week Randomization 2|Withdrawal by Subject|0
249929|NCT01313689|823839|P4|24-Week Randomization 2|Adverse Event|0
249930|NCT01313689|823840|P3|24-Week Randomization 2|Adverse Event|2
249931|NCT01313689|823841|P2|24-Week Randomization 2|Adverse Event|0
249932|NCT01313689|823842|P1|24-Week Randomization 2|Adverse Event|0
249933|NCT01313689|823839|P4|24-Week Randomization 1|Withdrawal by Subject|0
249934|NCT01313689|823840|P3|24-Week Randomization 1|Withdrawal by Subject|0
249935|NCT01313689|823841|P2|24-Week Randomization 1|Withdrawal by Subject|0
249936|NCT01313689|823842|P1|24-Week Randomization 1|Withdrawal by Subject|5
249937|NCT01313689|823839|P4|24-Week Randomization 1|Physician Decision|0
249938|NCT01313689|823840|P3|24-Week Randomization 1|Physician Decision|0
249939|NCT01313689|823841|P2|24-Week Randomization 1|Physician Decision|5
249940|NCT01313689|823842|P1|24-Week Randomization 1|Physician Decision|4
249941|NCT01313689|823839|P4|24-Week Randomization 1|Adverse Event|0
249942|NCT01313689|823840|P3|24-Week Randomization 1|Adverse Event|0
249943|NCT01313689|823841|P2|24-Week Randomization 1|Adverse Event|5
249944|NCT01313689|823842|P1|24-Week Randomization 1|Adverse Event|10
249945|NCT01313676|823909|P4|Overall Study|Missing|0
249946|NCT01313676|823910|P3|Overall Study|Missing|1
249947|NCT01313676|823911|P2|Overall Study|Missing|1
249948|NCT01313676|823912|P1|Overall Study|Missing|1
249949|NCT01313676|823909|P4|Overall Study|Investigator Site Closed|10
249950|NCT01313676|823910|P3|Overall Study|Investigator Site Closed|15
249951|NCT01313676|823911|P2|Overall Study|Investigator Site Closed|11
249952|NCT01313676|823912|P1|Overall Study|Investigator Site Closed|12
249953|NCT01313676|823909|P4|Overall Study|Sponsor Terminated Study Treatment|1
249954|NCT01313676|823910|P3|Overall Study|Sponsor Terminated Study Treatment|0
249955|NCT01313676|823911|P2|Overall Study|Sponsor Terminated Study Treatment|1
249956|NCT01313676|823912|P1|Overall Study|Sponsor Terminated Study Treatment|1
249957|NCT01313676|823909|P4|Overall Study|Decision by Participant or Proxy|492
249958|NCT01313676|823910|P3|Overall Study|Decision by Participant or Proxy|515
249959|NCT01313676|823911|P2|Overall Study|Decision by Participant or Proxy|527
249960|NCT01313676|823912|P1|Overall Study|Decision by Participant or Proxy|643
249961|NCT01313676|823909|P4|Overall Study|Physician Decision|48
249962|NCT01313676|823910|P3|Overall Study|Physician Decision|62
249963|NCT01313676|823911|P2|Overall Study|Physician Decision|64
249964|NCT01313676|823912|P1|Overall Study|Physician Decision|53
249965|NCT01313676|823909|P4|Overall Study|Lost to Follow-up|0
249966|NCT01313676|823910|P3|Overall Study|Lost to Follow-up|1
249967|NCT01313676|823911|P2|Overall Study|Lost to Follow-up|0
249968|NCT01313676|823912|P1|Overall Study|Lost to Follow-up|0
249969|NCT01313676|823909|P4|Overall Study|Study Closed/terminated|9
249970|NCT01313676|823910|P3|Overall Study|Study Closed/terminated|9
249971|NCT01313676|823911|P2|Overall Study|Study Closed/terminated|6
249972|NCT01313676|823912|P1|Overall Study|Study Closed/terminated|7
249973|NCT01313676|823909|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
249974|NCT01313676|823910|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
249975|NCT01313676|823911|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
249976|NCT01313676|823912|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
249977|NCT01313676|823909|P4|Overall Study|Protocol Violation|44
249978|NCT01313676|823910|P3|Overall Study|Protocol Violation|46
249979|NCT01313676|823911|P2|Overall Study|Protocol Violation|44
249980|NCT01313676|823912|P1|Overall Study|Protocol Violation|37
249981|NCT01313676|823909|P4|Overall Study|Lack of Efficacy|46
249982|NCT01313676|823910|P3|Overall Study|Lack of Efficacy|65
249983|NCT01313676|823911|P2|Overall Study|Lack of Efficacy|90
249984|NCT01313676|823912|P1|Overall Study|Lack of Efficacy|98
249985|NCT01313676|823909|P4|Overall Study|Adverse Event|333
249986|NCT01313676|823910|P3|Overall Study|Adverse Event|372
249987|NCT01313676|823911|P2|Overall Study|Adverse Event|365
249988|NCT01313676|823912|P1|Overall Study|Adverse Event|395
249989|NCT01313663|823932|P2|Overall Study|Withdrawal by Subject|1
249990|NCT01313663|823933|P1|Overall Study|Withdrawal by Subject|2
249991|NCT01313663|823932|P2|Overall Study|Physician Decision|2
249992|NCT01313663|823933|P1|Overall Study|Physician Decision|0
249993|NCT01313663|823932|P2|Overall Study|Lost to Follow-up|1
249994|NCT01313663|823933|P1|Overall Study|Lost to Follow-up|0
249995|NCT01313663|823932|P2|Overall Study|Study Closed/Terminated|4
249996|NCT01313663|823933|P1|Overall Study|Study Closed/Terminated|2
249997|NCT01313650|823971|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
249998|NCT01313650|823972|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
249999|NCT01313650|823973|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
250000|NCT01313650|823974|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
250001|NCT01313650|823971|P4|Overall Study|Protocol Violation|6
250002|NCT01313650|823972|P3|Overall Study|Protocol Violation|5
250003|NCT01313650|823973|P2|Overall Study|Protocol Violation|7
250004|NCT01313650|823974|P1|Overall Study|Protocol Violation|4
250005|NCT01313650|823971|P4|Overall Study|Withdrawal by Subject|15
250006|NCT01313650|823972|P3|Overall Study|Withdrawal by Subject|15
250007|NCT01313650|823973|P2|Overall Study|Withdrawal by Subject|20
250008|NCT01313650|823974|P1|Overall Study|Withdrawal by Subject|16
250009|NCT01313650|823971|P4|Overall Study|Lost to Follow-up|2
250010|NCT01313650|823972|P3|Overall Study|Lost to Follow-up|3
250011|NCT01313650|823973|P2|Overall Study|Lost to Follow-up|0
250012|NCT01313650|823974|P1|Overall Study|Lost to Follow-up|1
250013|NCT01313650|823971|P4|Overall Study|Lack of Efficacy|20
250014|NCT01313650|823972|P3|Overall Study|Lack of Efficacy|32
250015|NCT01313650|823973|P2|Overall Study|Lack of Efficacy|20
250016|NCT01313650|823974|P1|Overall Study|Lack of Efficacy|37
250017|NCT01313650|823971|P4|Overall Study|Adverse Event|23
250018|NCT01313650|823972|P3|Overall Study|Adverse Event|24
250019|NCT01313650|823973|P2|Overall Study|Adverse Event|34
250020|NCT01313650|823974|P1|Overall Study|Adverse Event|9
250021|NCT01313637|824000|P4|Overall Study|Withdrawal by Subject|15
250022|NCT01313637|824001|P3|Overall Study|Withdrawal by Subject|18
250023|NCT01313637|824002|P2|Overall Study|Withdrawal by Subject|13
250024|NCT01313637|824003|P1|Overall Study|Withdrawal by Subject|11
250025|NCT01313637|824000|P4|Overall Study|Lost to Follow-up|3
250026|NCT01313637|824001|P3|Overall Study|Lost to Follow-up|1
250027|NCT01313637|824002|P2|Overall Study|Lost to Follow-up|2
250028|NCT01313637|824003|P1|Overall Study|Lost to Follow-up|0
250029|NCT01313637|824000|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
250030|NCT01313637|824001|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
250031|NCT01313637|824002|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
250032|NCT01313637|824003|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
250033|NCT01313637|824000|P4|Overall Study|Protocol Violation|5
250034|NCT01313637|824001|P3|Overall Study|Protocol Violation|11
250035|NCT01313637|824002|P2|Overall Study|Protocol Violation|3
250036|NCT01313637|824003|P1|Overall Study|Protocol Violation|4
250037|NCT01313637|824000|P4|Overall Study|Lack of Efficacy|24
250038|NCT01313637|824001|P3|Overall Study|Lack of Efficacy|37
250039|NCT01313637|824002|P2|Overall Study|Lack of Efficacy|38
250040|NCT01313637|824003|P1|Overall Study|Lack of Efficacy|44
250041|NCT01313637|824000|P4|Overall Study|Adverse Event|18
250042|NCT01313637|824001|P3|Overall Study|Adverse Event|25
250043|NCT01313637|824002|P2|Overall Study|Adverse Event|24
250044|NCT01313637|824003|P1|Overall Study|Adverse Event|17
250045|NCT01313624|824027|P2|Open-Label Phase|Lost to Follow-up|1
250046|NCT01313624|824028|P1|Open-Label Phase|Lost to Follow-up|1
250047|NCT01313624|824027|P2|Open-Label Phase|Withdrawal by Subject|2
250048|NCT01313624|824028|P1|Open-Label Phase|Withdrawal by Subject|2
250049|NCT01313624|824027|P2|Open-Label Phase|Adverse Event|10
250050|NCT01313624|824028|P1|Open-Label Phase|Adverse Event|1
250051|NCT01313624|824027|P2|Double-Blind Phase|Lack of Efficacy|0
250052|NCT01313624|824028|P1|Double-Blind Phase|Lack of Efficacy|1
250053|NCT01313624|824027|P2|Double-Blind Phase|Physician Decision|0
250054|NCT01313624|824028|P1|Double-Blind Phase|Physician Decision|1
250055|NCT01313624|824027|P2|Double-Blind Phase|Lost to Follow-up|2
250056|NCT01313624|824028|P1|Double-Blind Phase|Lost to Follow-up|0
250057|NCT01313624|824027|P2|Double-Blind Phase|Withdrawal by Subject|4
250058|NCT01313624|824028|P1|Double-Blind Phase|Withdrawal by Subject|9
250059|NCT01313624|824027|P2|Double-Blind Phase|Adverse Event|4
250060|NCT01313624|824028|P1|Double-Blind Phase|Adverse Event|27
250061|NCT01313312|824124|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
250062|NCT01313312|824124|P1|Overall Study|Subject Withdrawn Early in Error|4
250063|NCT01313312|824124|P1|Overall Study|Observational Phase|1
250064|NCT01313312|824124|P1|Overall Study|Investigator Decision|1
250065|NCT01313312|824124|P1|Overall Study|Lack of Efficacy|3
250066|NCT01313312|824124|P1|Overall Study|Withdrawal by Subject|18
250067|NCT01313312|824124|P1|Overall Study|Adverse Event|5
250068|NCT01313299|824171|P3|Overall Study|Lack of subject compliance|1
250069|NCT01313299|824172|P2|Overall Study|Lack of subject compliance|0
250070|NCT01313299|824173|P1|Overall Study|Lack of subject compliance|0
250071|NCT01313299|824171|P3|Overall Study|Family reason and moved out of state|0
250072|NCT01313299|824172|P2|Overall Study|Family reason and moved out of state|2
250073|NCT01313299|824173|P1|Overall Study|Family reason and moved out of state|0
250074|NCT01313299|824171|P3|Overall Study|Withdrawal by Subject|2
250075|NCT01313299|824172|P2|Overall Study|Withdrawal by Subject|0
250076|NCT01313299|824173|P1|Overall Study|Withdrawal by Subject|1
250077|NCT01313299|824171|P3|Overall Study|Protocol Violation|0
250078|NCT01313299|824172|P2|Overall Study|Protocol Violation|0
250079|NCT01313299|824173|P1|Overall Study|Protocol Violation|2
250080|NCT01313299|824171|P3|Overall Study|Lost to Follow-up|0
250081|NCT01313299|824172|P2|Overall Study|Lost to Follow-up|0
250082|NCT01313299|824173|P1|Overall Study|Lost to Follow-up|1
250083|NCT01313299|824171|P3|Overall Study|Adverse Event|1
250084|NCT01313299|824172|P2|Overall Study|Adverse Event|1
250085|NCT01313299|824173|P1|Overall Study|Adverse Event|3
250086|NCT01313273|824189|P2|Overall Study|Screening Chromogranin A-in normal range|1
250087|NCT01313273|824190|P1|Overall Study|Screening Chromogranin A-in normal range|0
250088|NCT01313273|824189|P2|Overall Study|Withdrawal by Subject|0
250089|NCT01313273|824190|P1|Overall Study|Withdrawal by Subject|1
250090|NCT01313273|824189|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
250091|NCT01313273|824190|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
250092|NCT01313221|824205|P3|Overall Study|Pregnancy|2
250093|NCT01313221|824206|P2|Overall Study|Pregnancy|0
250094|NCT01313221|824207|P1|Overall Study|Pregnancy|0
250095|NCT01313221|824205|P3|Overall Study|Physician Decision|2
250096|NCT01313221|824206|P2|Overall Study|Physician Decision|0
250097|NCT01313221|824207|P1|Overall Study|Physician Decision|0
250098|NCT01313221|824205|P3|Overall Study|Disease progression|2
250099|NCT01313221|824206|P2|Overall Study|Disease progression|0
250100|NCT01313221|824207|P1|Overall Study|Disease progression|0
250101|NCT01313221|824205|P3|Overall Study|Adverse Event|7
250102|NCT01313221|824206|P2|Overall Study|Adverse Event|0
250103|NCT01313221|824207|P1|Overall Study|Adverse Event|0
250104|NCT01313221|824205|P3|Overall Study|Other|0
250105|NCT01313221|824206|P2|Overall Study|Other|0
250106|NCT01313221|824207|P1|Overall Study|Other|1
250107|NCT01313221|824205|P3|Overall Study|Lost to Follow-up|1
250108|NCT01313221|824206|P2|Overall Study|Lost to Follow-up|3
250109|NCT01313221|824207|P1|Overall Study|Lost to Follow-up|6
250110|NCT01313221|824205|P3|Overall Study|Requirement for alternative therapy|1
250111|NCT01313221|824206|P2|Overall Study|Requirement for alternative therapy|1
250112|NCT01313221|824207|P1|Overall Study|Requirement for alternative therapy|0
250113|NCT01313221|824205|P3|Overall Study|Withdrawal by Subject|5
250114|NCT01313221|824206|P2|Overall Study|Withdrawal by Subject|3
250115|NCT01313221|824207|P1|Overall Study|Withdrawal by Subject|2
250116|NCT01313221|824205|P3|Overall Study|Non-compliance|2
250117|NCT01313221|824206|P2|Overall Study|Non-compliance|0
250118|NCT01313221|824207|P1|Overall Study|Non-compliance|3
250119|NCT01313221|824205|P3|Overall Study|Protocol Violation|1
250120|NCT01313221|824206|P2|Overall Study|Protocol Violation|1
250121|NCT01313221|824207|P1|Overall Study|Protocol Violation|0
250122|NCT01313208|824259|P2|Open-label Phase (Weeks 13 - 24)|Other|0
250123|NCT01313208|824260|P1|Open-label Phase (Weeks 13 - 24)|Other|2
250124|NCT01313208|824259|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
250125|NCT01313208|824260|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
250126|NCT01313208|824259|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
250127|NCT01313208|824260|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
250128|NCT01313208|824259|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
250129|NCT01313208|824260|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
250130|NCT01313208|824259|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
250131|NCT01313208|824260|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
250132|NCT01313208|824259|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
250133|NCT01313208|824260|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
250134|NCT01313208|824259|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
250135|NCT01313208|824260|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
250136|NCT01313208|824259|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
250137|NCT01313208|824260|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
250138|NCT01313208|824259|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
250139|NCT01313208|824260|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
250140|NCT01313182|824350|P2|Overall Study|Protocol Violation|92
250141|NCT01313182|824351|P1|Overall Study|Protocol Violation|66
250142|NCT01313117|824357|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
250143|NCT01313117|824357|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
250144|NCT01313078|824364|P1|Overall Study|Withdrawal by Subject|1
250145|NCT01313078|824364|P1|Overall Study|Discontinued study drug|1
250146|NCT01313078|824364|P1|Overall Study|Death|1
250147|NCT01313039|824369|P1|Overall Study|Adverse Event|1
250148|NCT01313039|824369|P1|Overall Study|Physician Decision|1
250149|NCT01312961|824375|P2|Overall Study|Other than specified above|3
250150|NCT01312961|824376|P1|Overall Study|Other than specified above|2
250151|NCT01312961|824375|P2|Overall Study|Poor compliance to protocol|0
250152|NCT01312961|824376|P1|Overall Study|Poor compliance to protocol|1
250153|NCT01312961|824375|P2|Overall Study|Lack of Efficacy|1
250154|NCT01312961|824376|P1|Overall Study|Lack of Efficacy|11
250155|NCT01312961|824375|P2|Overall Study|Adverse Event|3
250156|NCT01312961|824376|P1|Overall Study|Adverse Event|3
250157|NCT01312467|824493|P1|Overall Study|Ineligible|4
250158|NCT01312467|824493|P1|Overall Study|Another medical condition|1
250159|NCT01312467|824493|P1|Overall Study|Deported to country of origin|1
250160|NCT01312467|824493|P1|Overall Study|Withdrawal by Subject|2
250161|NCT01312467|824493|P1|Overall Study|Lost to Follow-up|1
250162|NCT01312467|824493|P1|Overall Study|Adverse Event|4
250163|NCT01312428|824499|P2|Overall Study|Study Termination|4
250164|NCT01312428|824500|P1|Overall Study|Study Termination|3
250165|NCT01312129|824527|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
250166|NCT01312129|824528|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
250167|NCT01311687|824554|P2|PFS Follow-up Phase|On PFS follow-up at data cut-off|1
250168|NCT01311687|824555|P1|PFS Follow-up Phase|On PFS follow-up at data cut-off|3
250169|NCT01311687|824554|P2|Treatment Phase|On treatment at data cut-off|11
250170|NCT01311687|824555|P1|Treatment Phase|On treatment at data cut-off|60
250171|NCT01311661|824605|P1|Overall Study|Withdrawal by Subject|2
250172|NCT01311661|824605|P1|Overall Study|Protocol Violation|3
250173|NCT01311661|824605|P1|Overall Study|Adverse Event|2
250174|NCT01311557|824749|P2|Overall Study|Withdrawal by Subject|2
250175|NCT01311557|824750|P1|Overall Study|Withdrawal by Subject|1
250176|NCT01311557|824749|P2|Overall Study|Lost to Follow-up|1
250177|NCT01311557|824750|P1|Overall Study|Lost to Follow-up|0
250178|NCT01311557|824749|P2|Overall Study|Protocol Violation|2
250179|NCT01311557|824750|P1|Overall Study|Protocol Violation|4
250180|NCT01311557|824749|P2|Overall Study|Serious adverse event|1
250181|NCT01311557|824750|P1|Overall Study|Serious adverse event|0
250182|NCT01311505|824766|P2|First Intervention Period|Protocol Violation|1
250183|NCT01311505|824767|P1|First Intervention Period|Protocol Violation|0
250184|NCT01311024|824823|P2|Overall Study|Protocol Violation|22
250185|NCT01311024|824824|P1|Overall Study|Protocol Violation|35
250186|NCT01310803|824832|P2|Overall Study|Subject terminated by Sponsor|0
250187|NCT01310803|824833|P1|Overall Study|Subject terminated by Sponsor|1
250188|NCT01310777|824844|P3|Overall Study|Other|2
250189|NCT01310777|824845|P2|Overall Study|Other|1
250190|NCT01310777|824846|P1|Overall Study|Other|4
250191|NCT01310777|824844|P3|Overall Study|Inadequate Control of IOP|10
250192|NCT01310777|824845|P2|Overall Study|Inadequate Control of IOP|7
250193|NCT01310777|824846|P1|Overall Study|Inadequate Control of IOP|5
250194|NCT01310777|824844|P3|Overall Study|Patient's Decision Unrelated to AE|2
250195|NCT01310777|824845|P2|Overall Study|Patient's Decision Unrelated to AE|1
250196|NCT01310777|824846|P1|Overall Study|Patient's Decision Unrelated to AE|1
250197|NCT01310777|824844|P3|Overall Study|Lost to Follow-up|1
250198|NCT01310777|824845|P2|Overall Study|Lost to Follow-up|4
250199|NCT01310777|824846|P1|Overall Study|Lost to Follow-up|0
250200|NCT01310777|824844|P3|Overall Study|Adverse Event|15
250201|NCT01310777|824845|P2|Overall Study|Adverse Event|1
250202|NCT01310777|824846|P1|Overall Study|Adverse Event|23
250203|NCT01310699|824856|P2|Overall Study|Patients did not complete tandem.|6
250204|NCT01310699|824857|P1|Overall Study|Patients did not complete tandem.|4
250205|NCT01310413|824880|P7|From Day U0 to Day U385|Lost to Follow-up|2
250206|NCT01310413|824881|P6|From Day U0 to Day U385|Lost to Follow-up|0
250207|NCT01310413|824882|P5|From Day U0 to Day U385|Lost to Follow-up|0
250208|NCT01310413|824883|P4|From Day U0 to Day U385|Lost to Follow-up|0
250209|NCT01310413|824884|P3|From Day U0 to Day U385|Lost to Follow-up|0
250210|NCT01310413|824885|P2|From Day U0 to Day U385|Lost to Follow-up|0
250211|NCT01310413|824886|P1|From Day U0 to Day U385|Lost to Follow-up|0
250212|NCT01310413|824880|P7|From Day U0 to Day U385|Withdrawal by Subject|1
250213|NCT01310413|824881|P6|From Day U0 to Day U385|Withdrawal by Subject|0
250214|NCT01310413|824882|P5|From Day U0 to Day U385|Withdrawal by Subject|0
250215|NCT01310413|824883|P4|From Day U0 to Day U385|Withdrawal by Subject|0
250216|NCT01310413|824884|P3|From Day U0 to Day U385|Withdrawal by Subject|0
250217|NCT01310413|824885|P2|From Day U0 to Day U385|Withdrawal by Subject|0
250218|NCT01310413|824886|P1|From Day U0 to Day U385|Withdrawal by Subject|0
250219|NCT01310413|824880|P7|Day 0 to Day 385|Unspecified|0
250220|NCT01310413|824881|P6|Day 0 to Day 385|Unspecified|0
250221|NCT01310413|824882|P5|Day 0 to Day 385|Unspecified|0
250222|NCT01310413|824883|P4|Day 0 to Day 385|Unspecified|0
250223|NCT01310413|824884|P3|Day 0 to Day 385|Unspecified|3
250224|NCT01310413|824885|P2|Day 0 to Day 385|Unspecified|0
250225|NCT01310413|824886|P1|Day 0 to Day 385|Unspecified|1
250226|NCT01310413|824880|P7|Day 0 to Day 385|Migrated/moved from study area|0
250227|NCT01310413|824881|P6|Day 0 to Day 385|Migrated/moved from study area|0
250228|NCT01310413|824882|P5|Day 0 to Day 385|Migrated/moved from study area|1
250229|NCT01310413|824883|P4|Day 0 to Day 385|Migrated/moved from study area|1
250230|NCT01310413|824884|P3|Day 0 to Day 385|Migrated/moved from study area|1
250231|NCT01310413|824885|P2|Day 0 to Day 385|Migrated/moved from study area|3
250232|NCT01310413|824886|P1|Day 0 to Day 385|Migrated/moved from study area|3
250233|NCT01310413|824880|P7|Day 0 to Day 385|Lost to Follow-up|0
250234|NCT01310413|824881|P6|Day 0 to Day 385|Lost to Follow-up|2
250235|NCT01310413|824882|P5|Day 0 to Day 385|Lost to Follow-up|1
250236|NCT01310413|824883|P4|Day 0 to Day 385|Lost to Follow-up|5
250237|NCT01310413|824884|P3|Day 0 to Day 385|Lost to Follow-up|3
250238|NCT01310413|824885|P2|Day 0 to Day 385|Lost to Follow-up|3
250239|NCT01310413|824886|P1|Day 0 to Day 385|Lost to Follow-up|18
250240|NCT01310413|824880|P7|Day 0 to Day 385|Withdrawal by Subject|0
250241|NCT01310413|824881|P6|Day 0 to Day 385|Withdrawal by Subject|1
250242|NCT01310413|824882|P5|Day 0 to Day 385|Withdrawal by Subject|1
250243|NCT01310413|824883|P4|Day 0 to Day 385|Withdrawal by Subject|2
250244|NCT01310413|824884|P3|Day 0 to Day 385|Withdrawal by Subject|0
250245|NCT01310413|824885|P2|Day 0 to Day 385|Withdrawal by Subject|2
250246|NCT01310413|824886|P1|Day 0 to Day 385|Withdrawal by Subject|5
250247|NCT01310127|825068|P2|Overall Study|advanced psc cataract outlier|0
250248|NCT01310127|825069|P1|Overall Study|advanced psc cataract outlier|1
250249|NCT01310127|825068|P2|Overall Study|Protocol Violation|1
250250|NCT01310127|825069|P1|Overall Study|Protocol Violation|1
250251|NCT01309997|825083|P2|Overall Study|Withdrawal by Subject|1
250252|NCT01309997|825084|P1|Overall Study|Withdrawal by Subject|1
250253|NCT01309997|825083|P2|Overall Study|Lack of Efficacy|2
250254|NCT01309997|825084|P1|Overall Study|Lack of Efficacy|2
250255|NCT01309997|825083|P2|Overall Study|Death|3
250256|NCT01309997|825084|P1|Overall Study|Death|1
250257|NCT01309997|825083|P2|Overall Study|Adverse Event|0
250258|NCT01309997|825084|P1|Overall Study|Adverse Event|1
250259|NCT01309919|825108|P2|Overall Study|Did not receive a postpartum IUD|48
250260|NCT01309919|825109|P1|Overall Study|Did not receive a postpartum IUD|17
250261|NCT01309893|825121|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
250262|NCT01309893|825122|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
250263|NCT01309893|825121|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
250264|NCT01309893|825122|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
250265|NCT01308788|825145|P2|2-year Treatment|medication change by treating physician|11
250266|NCT01308788|825146|P1|2-year Treatment|medication change by treating physician|4
250267|NCT01308762|825181|P3|Overall Study|Protocol Violation|0
250268|NCT01308762|825182|P2|Overall Study|Protocol Violation|1
250269|NCT01308762|825183|P1|Overall Study|Protocol Violation|0
250270|NCT01308736|825196|P2|Overall Study|Did not attend a single session|5
250271|NCT01308736|825197|P1|Overall Study|Did not attend a single session|6
250272|NCT01309841|825206|P3|Overall Study|Severe non-compliance with protocol|2
250273|NCT01309841|825207|P2|Overall Study|Severe non-compliance with protocol|5
250274|NCT01309841|825208|P1|Overall Study|Severe non-compliance with protocol|0
250275|NCT01309841|825206|P3|Overall Study|Did Not Receive Treatment|1
250276|NCT01309841|825207|P2|Overall Study|Did Not Receive Treatment|0
250277|NCT01309841|825208|P1|Overall Study|Did Not Receive Treatment|2
250278|NCT01309841|825206|P3|Overall Study|Withdrawal by Subject|13
250279|NCT01309841|825207|P2|Overall Study|Withdrawal by Subject|6
250280|NCT01309841|825208|P1|Overall Study|Withdrawal by Subject|17
250281|NCT01309841|825206|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
250282|NCT01309841|825207|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
250283|NCT01309841|825208|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
250284|NCT01309841|825206|P3|Overall Study|Death|0
250285|NCT01309841|825207|P2|Overall Study|Death|0
250286|NCT01309841|825208|P1|Overall Study|Death|1
250287|NCT01309841|825206|P3|Overall Study|Adverse Event|11
250288|NCT01309841|825207|P2|Overall Study|Adverse Event|22
250289|NCT01309841|825208|P1|Overall Study|Adverse Event|9
250290|NCT01309841|825206|P3|Overall Study|Lack of Efficacy|2
250291|NCT01309841|825207|P2|Overall Study|Lack of Efficacy|0
250292|NCT01309841|825208|P1|Overall Study|Lack of Efficacy|0
250293|NCT01309841|825206|P3|Overall Study|Study-Specific Withdrawal Criteria|2
250294|NCT01309841|825207|P2|Overall Study|Study-Specific Withdrawal Criteria|1
250295|NCT01309841|825208|P1|Overall Study|Study-Specific Withdrawal Criteria|3
250296|NCT01309841|825206|P3|Overall Study|Lost to Follow-up|4
250297|NCT01309841|825207|P2|Overall Study|Lost to Follow-up|6
250298|NCT01309841|825208|P1|Overall Study|Lost to Follow-up|7
250299|NCT01309841|825206|P3|Overall Study|Other|1
250300|NCT01309841|825207|P2|Overall Study|Other|1
250301|NCT01309841|825208|P1|Overall Study|Other|0
250302|NCT01309828|825248|P2|Overall Study|Other|0
250303|NCT01309828|825249|P1|Overall Study|Other|1
250304|NCT01309828|825248|P2|Overall Study|Major Protocol Deviation|1
250305|NCT01309828|825249|P1|Overall Study|Major Protocol Deviation|0
250306|NCT01309828|825248|P2|Overall Study|Voluntary Withdrawal|4
250307|NCT01309828|825249|P1|Overall Study|Voluntary Withdrawal|5
250308|NCT01309828|825248|P2|Overall Study|Adverse Event|11
250309|NCT01309828|825249|P1|Overall Study|Adverse Event|10
250310|NCT01309737|825283|P5|Week 16 to 52|Unspecified|0
250311|NCT01309737|825284|P4|Week 16 to 52|Unspecified|2
250312|NCT01309737|825285|P3|Week 16 to 52|Unspecified|0
250313|NCT01309737|825286|P2|Week 16 to 52|Unspecified|12
250314|NCT01309737|825287|P1|Week 16 to 52|Unspecified|10
250315|NCT01309737|825283|P5|Week 16 to 52|Withdrawal by Subject|2
250316|NCT01309737|825284|P4|Week 16 to 52|Withdrawal by Subject|0
250317|NCT01309737|825285|P3|Week 16 to 52|Withdrawal by Subject|0
250318|NCT01309737|825286|P2|Week 16 to 52|Withdrawal by Subject|6
250319|NCT01309737|825287|P1|Week 16 to 52|Withdrawal by Subject|5
250320|NCT01309737|825283|P5|Week 16 to 52|Lost to Follow-up|4
250321|NCT01309737|825284|P4|Week 16 to 52|Lost to Follow-up|1
250322|NCT01309737|825285|P3|Week 16 to 52|Lost to Follow-up|0
250323|NCT01309737|825286|P2|Week 16 to 52|Lost to Follow-up|2
250324|NCT01309737|825287|P1|Week 16 to 52|Lost to Follow-up|4
250325|NCT01309737|825283|P5|Week 16 to 52|Lack of Efficacy|21
250326|NCT01309737|825284|P4|Week 16 to 52|Lack of Efficacy|25
250327|NCT01309737|825285|P3|Week 16 to 52|Lack of Efficacy|0
250328|NCT01309737|825286|P2|Week 16 to 52|Lack of Efficacy|76
250329|NCT01309737|825287|P1|Week 16 to 52|Lack of Efficacy|107
250330|NCT01309737|825283|P5|Week 16 to 52|Adverse Event|5
250331|NCT01309737|825284|P4|Week 16 to 52|Adverse Event|6
250332|NCT01309737|825285|P3|Week 16 to 52|Adverse Event|0
250333|NCT01309737|825286|P2|Week 16 to 52|Adverse Event|7
250334|NCT01309737|825287|P1|Week 16 to 52|Adverse Event|7
250335|NCT01309737|825283|P5|Week 16 to 52|Death|1
250336|NCT01309737|825284|P4|Week 16 to 52|Death|0
250337|NCT01309737|825285|P3|Week 16 to 52|Death|0
250338|NCT01309737|825286|P2|Week 16 to 52|Death|0
250339|NCT01309737|825287|P1|Week 16 to 52|Death|0
250340|NCT01309737|825283|P5|Week 0 to 16|Randomized, but not treated|0
250341|NCT01309737|825284|P4|Week 0 to 16|Randomized, but not treated|0
250342|NCT01309737|825285|P3|Week 0 to 16|Randomized, but not treated|0
250343|NCT01309737|825286|P2|Week 0 to 16|Randomized, but not treated|0
250344|NCT01309737|825287|P1|Week 0 to 16|Randomized, but not treated|1
250345|NCT01309737|825283|P5|Week 0 to 16|Unspecified|0
250346|NCT01309737|825284|P4|Week 0 to 16|Unspecified|0
250347|NCT01309737|825285|P3|Week 0 to 16|Unspecified|4
250348|NCT01309737|825286|P2|Week 0 to 16|Unspecified|14
250349|NCT01309737|825287|P1|Week 0 to 16|Unspecified|10
250350|NCT01309737|825283|P5|Week 0 to 16|Withdrawal by Subject|0
250351|NCT01309737|825284|P4|Week 0 to 16|Withdrawal by Subject|0
250352|NCT01309737|825285|P3|Week 0 to 16|Withdrawal by Subject|7
250353|NCT01309737|825286|P2|Week 0 to 16|Withdrawal by Subject|6
250354|NCT01309737|825287|P1|Week 0 to 16|Withdrawal by Subject|7
250355|NCT01309737|825283|P5|Week 0 to 16|Lost to Follow-up|0
250356|NCT01309737|825284|P4|Week 0 to 16|Lost to Follow-up|0
250357|NCT01309737|825285|P3|Week 0 to 16|Lost to Follow-up|3
250358|NCT01309737|825286|P2|Week 0 to 16|Lost to Follow-up|8
250359|NCT01309737|825287|P1|Week 0 to 16|Lost to Follow-up|7
250360|NCT01309737|825283|P5|Week 0 to 16|Lack of Efficacy|0
250361|NCT01309737|825284|P4|Week 0 to 16|Lack of Efficacy|0
250362|NCT01309737|825285|P3|Week 0 to 16|Lack of Efficacy|24
250363|NCT01309737|825286|P2|Week 0 to 16|Lack of Efficacy|2
250364|NCT01309737|825287|P1|Week 0 to 16|Lack of Efficacy|15
250365|NCT01309737|825283|P5|Week 0 to 16|Adverse Event|0
250366|NCT01309737|825284|P4|Week 0 to 16|Adverse Event|0
250367|NCT01309737|825285|P3|Week 0 to 16|Adverse Event|5
250368|NCT01309737|825286|P2|Week 0 to 16|Adverse Event|10
250369|NCT01309737|825287|P1|Week 0 to 16|Adverse Event|11
250370|NCT01309737|825283|P5|Week 0 to 16|Death|0
250371|NCT01309737|825284|P4|Week 0 to 16|Death|0
250372|NCT01309737|825285|P3|Week 0 to 16|Death|1
250373|NCT01309737|825286|P2|Week 0 to 16|Death|0
250374|NCT01309737|825287|P1|Week 0 to 16|Death|1
250375|NCT01309672|825482|P1|Overall Study|Withdrawal by Subject|3
250376|NCT01309672|825482|P1|Overall Study|Adverse Event|5
250377|NCT01309672|825482|P1|Overall Study|Unspecified|9
250378|NCT01309672|825482|P1|Overall Study|Lack of Efficacy|20
250379|NCT01309659|825492|P2|Overall Study|Protocol Violation|1
250380|NCT01309659|825493|P1|Overall Study|Protocol Violation|0
250381|NCT01309386|825598|P2|Overall Study|Adverse Event|8
250382|NCT01309386|825599|P1|Overall Study|Adverse Event|5
250383|NCT01309386|825598|P2|Overall Study|Lack of Efficacy|1
250384|NCT01309386|825599|P1|Overall Study|Lack of Efficacy|3
250385|NCT01309386|825598|P2|Overall Study|Physician Decision|1
250386|NCT01309386|825599|P1|Overall Study|Physician Decision|1
250387|NCT01309386|825598|P2|Overall Study|Progressive disease|11
250388|NCT01309386|825599|P1|Overall Study|Progressive disease|9
250389|NCT01309386|825598|P2|Overall Study|Withdrawal by Subject|0
250390|NCT01309386|825599|P1|Overall Study|Withdrawal by Subject|2
250391|NCT01309386|825598|P2|Overall Study|Unspecified|0
250392|NCT01309386|825599|P1|Overall Study|Unspecified|2
250393|NCT01309308|825647|P2|Overall Study|Lost to Follow-up|4
250394|NCT01309308|825648|P1|Overall Study|Lost to Follow-up|6
250395|NCT01309282|825656|P1|Overall Study|Lost to Follow-up|1
250396|NCT01309269|825673|P1|Overall Study|Enrolled but not Treated|107
250397|NCT01309269|825673|P1|Overall Study|Study Completion Data Not Recorded|95
250398|NCT01309269|825673|P1|Overall Study|Other|1
250399|NCT01309269|825673|P1|Overall Study|Unspecified|256
250400|NCT01309269|825673|P1|Overall Study|Administrative Problems|141
250401|NCT01309269|825673|P1|Overall Study|Kidney Transplant|25
250402|NCT01309269|825673|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
250403|NCT01309269|825673|P1|Overall Study|Lack of Acceptance|15
250404|NCT01309269|825673|P1|Overall Study|Withdrawal by Subject|25
250405|NCT01309269|825673|P1|Overall Study|Adverse Event|56
250406|NCT01309243|825681|P2|Extension Phase|Lost to Follow-up|0
250407|NCT01309243|825682|P1|Extension Phase|Lost to Follow-up|6
250408|NCT01309243|825681|P2|Randomized Phase Through Week 96|Protocol Violation|1
250409|NCT01309243|825682|P1|Randomized Phase Through Week 96|Protocol Violation|1
250410|NCT01309243|825681|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
250411|NCT01309243|825682|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
250412|NCT01309243|825681|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
250413|NCT01309243|825682|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
250414|NCT01309243|825681|P2|Randomized Phase Through Week 96|Withdrew Consent|18
250415|NCT01309243|825682|P1|Randomized Phase Through Week 96|Withdrew Consent|12
250416|NCT01309243|825681|P2|Randomized Phase Through Week 96|Investigators Discretion|6
250417|NCT01309243|825682|P1|Randomized Phase Through Week 96|Investigators Discretion|3
250418|NCT01309243|825681|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
250419|NCT01309243|825682|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
250420|NCT01309243|825681|P2|Randomized Phase Through Week 96|Pregnancy|0
250421|NCT01309243|825682|P1|Randomized Phase Through Week 96|Pregnancy|2
250422|NCT01309243|825681|P2|Randomized Phase Through Week 96|Death|1
250423|NCT01309243|825682|P1|Randomized Phase Through Week 96|Death|0
250424|NCT01309243|825681|P2|Randomized Phase Through Week 96|Adverse Event|43
250425|NCT01309243|825682|P1|Randomized Phase Through Week 96|Adverse Event|12
250426|NCT01309243|825681|P2|Randomized Phase Through Week 96|Randomized but not treated|7
250427|NCT01309243|825682|P1|Randomized Phase Through Week 96|Randomized but not treated|6
250428|NCT01309204|825708|P2|Overall Study|Other|1
250429|NCT01309204|825709|P1|Overall Study|Other|4
250430|NCT01309204|825708|P2|Overall Study|Inadequate control of IOP|4
250431|NCT01309204|825709|P1|Overall Study|Inadequate control of IOP|4
250432|NCT01309204|825708|P2|Overall Study|Subject's decision unrelated to an AE|10
250433|NCT01309204|825709|P1|Overall Study|Subject's decision unrelated to an AE|9
250434|NCT01309204|825708|P2|Overall Study|Lost to Follow-up|2
250435|NCT01309204|825709|P1|Overall Study|Lost to Follow-up|2
250436|NCT01309204|825708|P2|Overall Study|Adverse Event|58
250437|NCT01309204|825709|P1|Overall Study|Adverse Event|48
250438|NCT01309100|825715|P1|Overall Study|Positive Slit lamp finding|1
250439|NCT01309100|825715|P1|Overall Study|Protocol Violation|1
250440|NCT01308580|825757|P2|Overall Study|Lost to Follow-up|7
250441|NCT01308580|825758|P1|Overall Study|Lost to Follow-up|12
250442|NCT01308567|825801|P3|Overall Study|Lost to Follow-up|4
250443|NCT01308567|825802|P2|Overall Study|Lost to Follow-up|4
250444|NCT01308567|825803|P1|Overall Study|Lost to Follow-up|2
250445|NCT01308476|825843|P2|Overall Study|Other|0
250446|NCT01308476|825844|P1|Overall Study|Other|1
250447|NCT01308476|825843|P2|Overall Study|Lost to Follow-up|2
250448|NCT01308476|825844|P1|Overall Study|Lost to Follow-up|2
250449|NCT01308463|825864|P1|Overall Study|Revision|2
250450|NCT01308463|825864|P1|Overall Study|Death|4
250451|NCT01308463|825864|P1|Overall Study|Study Discontinued|23
250452|NCT01308424|825877|P3|Randomization|Physician Decision|1
250453|NCT01308424|825878|P2|Randomization|Physician Decision|1
250454|NCT01308424|825879|P1|Randomization|Physician Decision|0
250455|NCT01308424|825877|P3|Randomization|Lost to Follow-up|0
250456|NCT01308424|825878|P2|Randomization|Lost to Follow-up|1
250457|NCT01308424|825879|P1|Randomization|Lost to Follow-up|0
250458|NCT01308424|825877|P3|Randomization|Adverse Event|1
250459|NCT01308424|825878|P2|Randomization|Adverse Event|1
250460|NCT01308424|825879|P1|Randomization|Adverse Event|0
250461|NCT01308424|825877|P3|Baseline Eligibility|Screen Failures|0
250462|NCT01308424|825878|P2|Baseline Eligibility|Screen Failures|0
250463|NCT01308424|825879|P1|Baseline Eligibility|Screen Failures|71
250464|NCT01307787|825888|P2|Overall Study|Withdrawal by Subject|0
250465|NCT01307787|825889|P1|Overall Study|Withdrawal by Subject|2
250466|NCT01307423|825931|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
250467|NCT01307423|825932|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
250468|NCT01307423|825933|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
250469|NCT01307423|825934|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
250470|NCT01307423|825935|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
250471|NCT01307423|825936|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
250472|NCT01307423|825937|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
250473|NCT01307423|825931|P7|Active Treatment Phase (Week 25-52)|Unspecified|0
250474|NCT01307423|825932|P6|Active Treatment Phase (Week 25-52)|Unspecified|0
250475|NCT01307423|825933|P5|Active Treatment Phase (Week 25-52)|Unspecified|0
250476|NCT01307423|825934|P4|Active Treatment Phase (Week 25-52)|Unspecified|1
250477|NCT01307423|825935|P3|Active Treatment Phase (Week 25-52)|Unspecified|0
250478|NCT01307423|825936|P2|Active Treatment Phase (Week 25-52)|Unspecified|0
250479|NCT01307423|825937|P1|Active Treatment Phase (Week 25-52)|Unspecified|0
250480|NCT01307423|825931|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
250481|NCT01307423|825932|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
250482|NCT01307423|825933|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
250483|NCT01307423|825934|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
250484|NCT01307423|825935|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
250485|NCT01307423|825936|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
250486|NCT01307423|825937|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
250487|NCT01307423|825931|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
250488|NCT01307423|825932|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
250489|NCT01307423|825933|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
250490|NCT01307423|825934|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
250491|NCT01307423|825935|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
250492|NCT01307423|825936|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
250493|NCT01307423|825937|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
250494|NCT01307423|825931|P7|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
250495|NCT01307423|825932|P6|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|1
250496|NCT01307423|825933|P5|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
250497|NCT01307423|825934|P4|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
250498|NCT01307423|825935|P3|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
250499|NCT01307423|825936|P2|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
250500|NCT01307423|825937|P1|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
250501|NCT01307423|825931|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
250502|NCT01307423|825932|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
250503|NCT01307423|825933|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
250504|NCT01307423|825934|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
250505|NCT01307423|825935|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
250506|NCT01307423|825936|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
250507|NCT01307423|825937|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
250508|NCT01307423|825931|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
250509|NCT01307423|825932|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
250510|NCT01307423|825933|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
250511|NCT01307423|825934|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
250512|NCT01307423|825935|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
250513|NCT01307423|825936|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
250514|NCT01307423|825937|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
250515|NCT01307423|825931|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
250516|NCT01307423|825932|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
250517|NCT01307423|825933|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
250518|NCT01307423|825934|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
250519|NCT01307423|825935|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
250520|NCT01307423|825936|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
250521|NCT01307423|825937|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
250522|NCT01307423|825931|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
250523|NCT01307423|825932|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
250524|NCT01307423|825933|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
250525|NCT01307423|825934|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
250526|NCT01307423|825935|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
250527|NCT01307423|825936|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
250528|NCT01307423|825937|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
250529|NCT01307423|825931|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
250530|NCT01307423|825932|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
250531|NCT01307423|825933|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
250532|NCT01307423|825934|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
250533|NCT01307423|825935|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
250534|NCT01307423|825936|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
250535|NCT01307423|825937|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
250536|NCT01307423|825931|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
250537|NCT01307423|825932|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
250695|NCT01306617|826229|P1|Overall Study|Non-compliance|0
250538|NCT01307423|825933|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
250539|NCT01307423|825934|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
250540|NCT01307423|825935|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
250541|NCT01307423|825936|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
250542|NCT01307423|825937|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
250543|NCT01307423|825931|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
250544|NCT01307423|825932|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
250545|NCT01307423|825933|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
250546|NCT01307423|825934|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
250547|NCT01307423|825935|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
250548|NCT01307423|825936|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
250549|NCT01307423|825937|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
250550|NCT01307423|825931|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
250551|NCT01307423|825932|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
250552|NCT01307423|825933|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
250553|NCT01307423|825934|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
250554|NCT01307423|825935|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
250555|NCT01307423|825936|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
250556|NCT01307423|825937|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
250557|NCT01307423|825931|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
250558|NCT01307423|825932|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
250559|NCT01307423|825933|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
250560|NCT01307423|825934|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
250561|NCT01307423|825935|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
250562|NCT01307423|825936|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
250563|NCT01307423|825937|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
250564|NCT01307423|825931|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
250565|NCT01307423|825932|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
250566|NCT01307423|825933|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
250567|NCT01307423|825934|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
250568|NCT01307423|825935|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
250569|NCT01307423|825936|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
250570|NCT01307423|825937|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
250571|NCT01307319|826049|P3|Overall Study|Not specified|3
250572|NCT01307319|826050|P2|Overall Study|Not specified|4
250573|NCT01307319|826051|P1|Overall Study|Not specified|0
250574|NCT01307319|826049|P3|Overall Study|Withdrawal by Subject|2
250575|NCT01307319|826050|P2|Overall Study|Withdrawal by Subject|1
250576|NCT01307319|826051|P1|Overall Study|Withdrawal by Subject|0
250577|NCT01307319|826049|P3|Overall Study|Protocol Violation|0
250578|NCT01307319|826050|P2|Overall Study|Protocol Violation|1
250579|NCT01307319|826051|P1|Overall Study|Protocol Violation|1
250580|NCT01307319|826049|P3|Overall Study|Lost to Follow-up|1
250581|NCT01307319|826050|P2|Overall Study|Lost to Follow-up|0
250582|NCT01307319|826051|P1|Overall Study|Lost to Follow-up|1
250583|NCT01307319|826049|P3|Overall Study|Adverse Event|1
250584|NCT01307319|826050|P2|Overall Study|Adverse Event|2
250585|NCT01307319|826051|P1|Overall Study|Adverse Event|2
250586|NCT01307111|826065|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
250587|NCT01307111|826066|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
250588|NCT01307111|826065|P2|IUD Insertion|Lost to Follow-up|0
250589|NCT01307111|826066|P1|IUD Insertion|Lost to Follow-up|2
250590|NCT01307046|826076|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
250591|NCT01307046|826077|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
250592|NCT01307046|826076|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
250593|NCT01307046|826077|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
250594|NCT01307046|826076|P2|Overall Study|Withdrawal by Subject|1
250595|NCT01307046|826077|P1|Overall Study|Withdrawal by Subject|1
250596|NCT01307046|826076|P2|Overall Study|Physician Decision|0
250597|NCT01307046|826077|P1|Overall Study|Physician Decision|2
250598|NCT01307046|826076|P2|Overall Study|Lack of Efficacy|2
250599|NCT01307046|826077|P1|Overall Study|Lack of Efficacy|0
250600|NCT01307046|826076|P2|Overall Study|Adverse Event|3
250601|NCT01307046|826077|P1|Overall Study|Adverse Event|3
250602|NCT01307033|826089|P4|44-week Open-label Extension|Death|1
250603|NCT01307033|826090|P3|44-week Open-label Extension|Death|0
250604|NCT01307033|826091|P2|44-week Open-label Extension|Death|0
250605|NCT01307033|826092|P1|44-week Open-label Extension|Death|0
250606|NCT01307033|826089|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
250607|NCT01307033|826090|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
250608|NCT01307033|826091|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
250609|NCT01307033|826092|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
250610|NCT01307033|826089|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
250611|NCT01307033|826090|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
250612|NCT01307033|826091|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
250613|NCT01307033|826092|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
250614|NCT01307033|826089|P4|44-week Open-label Extension|Physician Decision|0
250615|NCT01307033|826090|P3|44-week Open-label Extension|Physician Decision|1
250616|NCT01307033|826091|P2|44-week Open-label Extension|Physician Decision|0
250617|NCT01307033|826092|P1|44-week Open-label Extension|Physician Decision|0
250618|NCT01307033|826089|P4|44-week Open-label Extension|Withdrawal by Subject|1
250619|NCT01307033|826090|P3|44-week Open-label Extension|Withdrawal by Subject|2
250620|NCT01307033|826091|P2|44-week Open-label Extension|Withdrawal by Subject|0
250621|NCT01307033|826092|P1|44-week Open-label Extension|Withdrawal by Subject|0
250622|NCT01307033|826089|P4|44-week Open-label Extension|Adverse Event|1
250623|NCT01307033|826090|P3|44-week Open-label Extension|Adverse Event|2
250624|NCT01307033|826091|P2|44-week Open-label Extension|Adverse Event|0
250625|NCT01307033|826092|P1|44-week Open-label Extension|Adverse Event|0
250626|NCT01307033|826089|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
250627|NCT01307033|826090|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
250628|NCT01307033|826091|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
250629|NCT01307033|826092|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
250630|NCT01307033|826089|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
250631|NCT01307033|826090|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
250632|NCT01307033|826091|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
250633|NCT01307033|826092|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
250634|NCT01307033|826089|P4|8-week Double-blind Period|Lack of Efficacy|0
250635|NCT01307033|826090|P3|8-week Double-blind Period|Lack of Efficacy|0
250636|NCT01307033|826091|P2|8-week Double-blind Period|Lack of Efficacy|0
250637|NCT01307033|826092|P1|8-week Double-blind Period|Lack of Efficacy|1
250638|NCT01307033|826089|P4|8-week Double-blind Period|Withdrawal by Subject|0
250639|NCT01307033|826090|P3|8-week Double-blind Period|Withdrawal by Subject|0
250640|NCT01307033|826091|P2|8-week Double-blind Period|Withdrawal by Subject|1
250641|NCT01307033|826092|P1|8-week Double-blind Period|Withdrawal by Subject|4
250642|NCT01307033|826089|P4|8-week Double-blind Period|Adverse Event|0
250643|NCT01307033|826090|P3|8-week Double-blind Period|Adverse Event|0
250644|NCT01307033|826091|P2|8-week Double-blind Period|Adverse Event|0
250645|NCT01307033|826092|P1|8-week Double-blind Period|Adverse Event|2
250646|NCT01307020|826114|P10|Overall Study|Electronic data capture failure|0
250647|NCT01307020|826115|P9|Overall Study|Electronic data capture failure|0
250648|NCT01307020|826116|P8|Overall Study|Electronic data capture failure|0
250649|NCT01307020|826117|P7|Overall Study|Electronic data capture failure|0
250650|NCT01307020|826118|P6|Overall Study|Electronic data capture failure|0
250651|NCT01307020|826119|P5|Overall Study|Electronic data capture failure|0
250652|NCT01307020|826120|P4|Overall Study|Electronic data capture failure|0
250653|NCT01307020|826121|P3|Overall Study|Electronic data capture failure|0
250654|NCT01307020|826122|P2|Overall Study|Electronic data capture failure|1
250655|NCT01307020|826123|P1|Overall Study|Electronic data capture failure|0
250656|NCT01307020|826114|P10|Overall Study|Lost to Follow-up|0
250657|NCT01307020|826115|P9|Overall Study|Lost to Follow-up|0
250658|NCT01307020|826116|P8|Overall Study|Lost to Follow-up|0
250659|NCT01307020|826117|P7|Overall Study|Lost to Follow-up|1
250660|NCT01307020|826118|P6|Overall Study|Lost to Follow-up|0
250661|NCT01307020|826119|P5|Overall Study|Lost to Follow-up|0
250662|NCT01307020|826120|P4|Overall Study|Lost to Follow-up|1
250663|NCT01307020|826121|P3|Overall Study|Lost to Follow-up|1
250664|NCT01307020|826122|P2|Overall Study|Lost to Follow-up|0
250665|NCT01307020|826123|P1|Overall Study|Lost to Follow-up|0
250666|NCT01306968|826169|P4|Overall Study|Withdrew over privacy concerns|1
250667|NCT01306968|826170|P3|Overall Study|Withdrew over privacy concerns|0
250668|NCT01306968|826171|P2|Overall Study|Withdrew over privacy concerns|0
250669|NCT01306968|826172|P1|Overall Study|Withdrew over privacy concerns|0
250670|NCT01306968|826169|P4|Overall Study|Withdrew - time commitment|2
250671|NCT01306968|826170|P3|Overall Study|Withdrew - time commitment|0
250672|NCT01306968|826171|P2|Overall Study|Withdrew - time commitment|0
250673|NCT01306968|826172|P1|Overall Study|Withdrew - time commitment|0
250674|NCT01306968|826169|P4|Overall Study|Relocated and left active duty|1
250675|NCT01306968|826170|P3|Overall Study|Relocated and left active duty|1
250676|NCT01306968|826171|P2|Overall Study|Relocated and left active duty|1
250677|NCT01306968|826172|P1|Overall Study|Relocated and left active duty|0
250678|NCT01306968|826169|P4|Overall Study|Physician Decision|0
250679|NCT01306968|826170|P3|Overall Study|Physician Decision|0
250680|NCT01306968|826171|P2|Overall Study|Physician Decision|1
250681|NCT01306968|826172|P1|Overall Study|Physician Decision|0
250682|NCT01306968|826169|P4|Overall Study|Lost to Follow-up|0
250683|NCT01306968|826170|P3|Overall Study|Lost to Follow-up|0
250684|NCT01306968|826171|P2|Overall Study|Lost to Follow-up|1
250685|NCT01306968|826172|P1|Overall Study|Lost to Follow-up|1
250686|NCT01306877|826196|P2|Overall Study|Physician Decision|1
250687|NCT01306877|826197|P1|Overall Study|Physician Decision|0
250688|NCT01306877|826196|P2|Overall Study|Lost to Follow-up|3
250689|NCT01306877|826197|P1|Overall Study|Lost to Follow-up|3
250690|NCT01306643|826215|P1|Overall Study|Other: Change in Eligibility Status|1
250691|NCT01306643|826215|P1|Overall Study|Disease Progression|7
250692|NCT01306643|826215|P1|Overall Study|Adverse Event|5
250693|NCT01306617|826227|P3|Overall Study|Non-compliance|0
250694|NCT01306617|826228|P2|Overall Study|Non-compliance|1
250696|NCT01306617|826227|P3|Overall Study|Virologic Failure|5
250697|NCT01306617|826228|P2|Overall Study|Virologic Failure|0
250698|NCT01306617|826229|P1|Overall Study|Virologic Failure|0
250699|NCT01306617|826227|P3|Overall Study|Adverse Event|0
250700|NCT01306617|826228|P2|Overall Study|Adverse Event|0
250701|NCT01306617|826229|P1|Overall Study|Adverse Event|1
250702|NCT01306305|826272|P2|Overall Study|Withdrew consent|0
250703|NCT01306305|826273|P1|Overall Study|Withdrew consent|1
250704|NCT01306305|826272|P2|Overall Study|Lost to Follow-up|0
250705|NCT01306305|826273|P1|Overall Study|Lost to Follow-up|1
250706|NCT01306253|826310|P2|Overall Study|Lost to Follow-up|1
250707|NCT01306253|826311|P1|Overall Study|Lost to Follow-up|1
250708|NCT01306214|826328|P3|Overall Study|Not treated|1
250709|NCT01306214|826329|P2|Overall Study|Not treated|1
250710|NCT01306214|826330|P1|Overall Study|Not treated|1
250711|NCT01306214|826328|P3|Overall Study|Withdrawal by Subject|16
250712|NCT01306214|826329|P2|Overall Study|Withdrawal by Subject|22
250713|NCT01306214|826330|P1|Overall Study|Withdrawal by Subject|24
250714|NCT01306214|826328|P3|Overall Study|Lost to Follow-up|4
250715|NCT01306214|826329|P2|Overall Study|Lost to Follow-up|5
250716|NCT01306214|826330|P1|Overall Study|Lost to Follow-up|3
250717|NCT01306214|826328|P3|Overall Study|Death|1
250718|NCT01306214|826329|P2|Overall Study|Death|0
250719|NCT01306214|826330|P1|Overall Study|Death|0
250720|NCT01306201|826347|P1|Overall Study|Files unreadable|3
250721|NCT01306201|826347|P1|Overall Study|Files could not be processed|3
250722|NCT01306201|826347|P1|Overall Study|Arrhythmia|4
250723|NCT01306162|826369|P4|Washout 1|Non-compliance to protocol|0
250724|NCT01306162|826370|P3|Washout 1|Non-compliance to protocol|0
250725|NCT01306162|826371|P2|Washout 1|Non-compliance to protocol|1
250726|NCT01306162|826372|P1|Washout 1|Non-compliance to protocol|0
250727|NCT01306162|826369|P4|Period 1|Adverse Event|1
250728|NCT01306162|826370|P3|Period 1|Adverse Event|0
250729|NCT01306162|826371|P2|Period 1|Adverse Event|0
250730|NCT01306162|826372|P1|Period 1|Adverse Event|0
250731|NCT01306032|826406|P6|Disease Progression/Crossover|other/symptomatic progression|0
250732|NCT01306032|826407|P5|Disease Progression/Crossover|other/symptomatic progression|0
250733|NCT01306032|826408|P4|Disease Progression/Crossover|other/symptomatic progression|2
250734|NCT01306032|826409|P3|Disease Progression/Crossover|other/symptomatic progression|0
250735|NCT01306032|826410|P2|Disease Progression/Crossover|other/symptomatic progression|2
250736|NCT01306032|826411|P1|Disease Progression/Crossover|other/symptomatic progression|0
250737|NCT01306032|826406|P6|Disease Progression/Crossover|Withdrawal by Subject|0
250738|NCT01306032|826407|P5|Disease Progression/Crossover|Withdrawal by Subject|0
250739|NCT01306032|826408|P4|Disease Progression/Crossover|Withdrawal by Subject|1
250740|NCT01306032|826409|P3|Disease Progression/Crossover|Withdrawal by Subject|0
250741|NCT01306032|826410|P2|Disease Progression/Crossover|Withdrawal by Subject|0
250742|NCT01306032|826411|P1|Disease Progression/Crossover|Withdrawal by Subject|0
250743|NCT01306032|826406|P6|First Intervention|Progressive disease|0
250744|NCT01306032|826407|P5|First Intervention|Progressive disease|2
250745|NCT01306032|826408|P4|First Intervention|Progressive disease|0
250746|NCT01306032|826409|P3|First Intervention|Progressive disease|0
250747|NCT01306032|826410|P2|First Intervention|Progressive disease|0
250748|NCT01306032|826411|P1|First Intervention|Progressive disease|0
250749|NCT01306032|826406|P6|First Intervention|Ineligible|1
250750|NCT01306032|826407|P5|First Intervention|Ineligible|0
250751|NCT01306032|826408|P4|First Intervention|Ineligible|0
250752|NCT01306032|826409|P3|First Intervention|Ineligible|0
250753|NCT01306032|826410|P2|First Intervention|Ineligible|0
250754|NCT01306032|826411|P1|First Intervention|Ineligible|0
250755|NCT01306032|826406|P6|First Intervention|Death|0
250756|NCT01306032|826407|P5|First Intervention|Death|0
250757|NCT01306032|826408|P4|First Intervention|Death|0
250758|NCT01306032|826409|P3|First Intervention|Death|1
250759|NCT01306032|826410|P2|First Intervention|Death|0
250760|NCT01306032|826411|P1|First Intervention|Death|0
250761|NCT01306032|826406|P6|First Intervention|Withdrawal by Subject|0
250762|NCT01306032|826407|P5|First Intervention|Withdrawal by Subject|0
250763|NCT01306032|826408|P4|First Intervention|Withdrawal by Subject|1
250764|NCT01306032|826409|P3|First Intervention|Withdrawal by Subject|0
250765|NCT01306032|826410|P2|First Intervention|Withdrawal by Subject|2
250766|NCT01306032|826411|P1|First Intervention|Withdrawal by Subject|0
250767|NCT01306032|826406|P6|First Intervention|Adverse Event|1
250768|NCT01306032|826407|P5|First Intervention|Adverse Event|0
250769|NCT01306032|826408|P4|First Intervention|Adverse Event|0
250770|NCT01306032|826409|P3|First Intervention|Adverse Event|1
250771|NCT01306032|826410|P2|First Intervention|Adverse Event|0
250772|NCT01306032|826411|P1|First Intervention|Adverse Event|1
250773|NCT01305577|826491|P3|Overall Study|Protocol Deviation|1
250774|NCT01305577|826492|P2|Overall Study|Protocol Deviation|1
250775|NCT01305577|826493|P1|Overall Study|Protocol Deviation|0
250776|NCT01305577|826491|P3|Overall Study|Lost to Follow-up|2
250777|NCT01305577|826492|P2|Overall Study|Lost to Follow-up|3
250778|NCT01305577|826493|P1|Overall Study|Lost to Follow-up|4
250779|NCT01305577|826491|P3|Overall Study|Withdrawal by Subject|6
250780|NCT01305577|826492|P2|Overall Study|Withdrawal by Subject|5
250781|NCT01305577|826493|P1|Overall Study|Withdrawal by Subject|7
250782|NCT01305577|826491|P3|Overall Study|Adverse Event|1
250783|NCT01305577|826492|P2|Overall Study|Adverse Event|2
250784|NCT01305577|826493|P1|Overall Study|Adverse Event|2
250785|NCT01305564|826522|P1|Overall Study|Physician Decision|3
250786|NCT01305564|826522|P1|Overall Study|Withdrawal by Subject|1
250787|NCT01305564|826522|P1|Overall Study|Lost to Follow-up|12
250788|NCT01305564|826522|P1|Overall Study|Death|21
250789|NCT01305408|826549|P2|Overall Study|Not specified|0
250790|NCT01305408|826550|P1|Overall Study|Not specified|1
250791|NCT01305408|826549|P2|Overall Study|Noncompliance with study procedures|1
250792|NCT01305408|826550|P1|Overall Study|Noncompliance with study procedures|0
250793|NCT01305408|826549|P2|Overall Study|Noncompliance with study medication|1
250794|NCT01305408|826550|P1|Overall Study|Noncompliance with study medication|0
250795|NCT01305408|826549|P2|Overall Study|Lost to Follow-up|3
250796|NCT01305408|826550|P1|Overall Study|Lost to Follow-up|5
250797|NCT01305408|826549|P2|Overall Study|Protocol Violation|6
250798|NCT01305408|826550|P1|Overall Study|Protocol Violation|4
250799|NCT01305408|826549|P2|Overall Study|Withdrawal by Subject|9
250800|NCT01305408|826550|P1|Overall Study|Withdrawal by Subject|9
250801|NCT01305408|826549|P2|Overall Study|Lack of Efficacy|4
250802|NCT01305408|826550|P1|Overall Study|Lack of Efficacy|3
250803|NCT01305408|826549|P2|Overall Study|Adverse Event|7
250804|NCT01305408|826550|P1|Overall Study|Adverse Event|10
250805|NCT01305239|826626|P1|Overall Study|Exemestane taken prior to inclusion only|1
250806|NCT01305239|826626|P1|Overall Study|Adverse Event|22
250807|NCT01305200|826637|P3|Overall Study|Death|0
250808|NCT01305200|826638|P2|Overall Study|Death|2
250809|NCT01305200|826639|P1|Overall Study|Death|0
250810|NCT01305200|826637|P3|Overall Study|Ineligible|1
250811|NCT01305200|826638|P2|Overall Study|Ineligible|2
250812|NCT01305200|826639|P1|Overall Study|Ineligible|1
250813|NCT01305200|826637|P3|Overall Study|Withdrawal by Subject|1
250814|NCT01305200|826638|P2|Overall Study|Withdrawal by Subject|21
250815|NCT01305200|826639|P1|Overall Study|Withdrawal by Subject|24
250816|NCT01305200|826637|P3|Overall Study|Physician Decision|1
250817|NCT01305200|826638|P2|Overall Study|Physician Decision|6
250818|NCT01305200|826639|P1|Overall Study|Physician Decision|4
250819|NCT01305044|826669|P2|Overall Study|Withdrawal by Subject|6
250820|NCT01305044|826670|P1|Overall Study|Withdrawal by Subject|3
250821|NCT01304706|826700|P1|Overall Study|Discontinued due to failed drug admin.|1
250822|NCT01304706|826700|P1|Overall Study|Lost to Follow-up|7
250823|NCT01304706|826700|P1|Overall Study|Withdrawal by Subject|3
250824|NCT01304706|826700|P1|Overall Study|Death|3
250825|NCT01304706|826700|P1|Overall Study|Lack of Efficacy|1
250826|NCT01304706|826700|P1|Overall Study|Adverse Event|2
250827|NCT01304693|826709|P5|Overall Study|Decision Unrelated to an Adverse Event|0
250828|NCT01304693|826710|P4|Overall Study|Decision Unrelated to an Adverse Event|1
250829|NCT01304693|826711|P3|Overall Study|Decision Unrelated to an Adverse Event|1
250830|NCT01304693|826712|P2|Overall Study|Decision Unrelated to an Adverse Event|0
250831|NCT01304693|826713|P1|Overall Study|Decision Unrelated to an Adverse Event|0
250832|NCT01304693|826709|P5|Overall Study|Adverse Event|1
250833|NCT01304693|826710|P4|Overall Study|Adverse Event|0
250834|NCT01304693|826711|P3|Overall Study|Adverse Event|0
250835|NCT01304693|826712|P2|Overall Study|Adverse Event|0
250836|NCT01304693|826713|P1|Overall Study|Adverse Event|0
250837|NCT01304329|826758|P6|Third Intervention (3 Days)|Adverse Event|0
250838|NCT01304329|826759|P5|Third Intervention (3 Days)|Adverse Event|0
250839|NCT01304329|826760|P4|Third Intervention (3 Days)|Adverse Event|0
250840|NCT01304329|826761|P3|Third Intervention (3 Days)|Adverse Event|0
250841|NCT01304329|826762|P2|Third Intervention (3 Days)|Adverse Event|1
250842|NCT01304329|826763|P1|Third Intervention (3 Days)|Adverse Event|0
250843|NCT01304147|826883|P2|Second Intervention (7days)|Withdrawal by Subject|1
250844|NCT01304147|826884|P1|Second Intervention (7days)|Withdrawal by Subject|1
250845|NCT01303861|826918|P4|Overall Study|Pregnancy|0
250846|NCT01303861|826919|P3|Overall Study|Pregnancy|0
250847|NCT01303861|826920|P2|Overall Study|Pregnancy|0
250848|NCT01303861|826921|P1|Overall Study|Pregnancy|1
250849|NCT01303861|826918|P4|Overall Study|Adverse Event|5
250850|NCT01303861|826919|P3|Overall Study|Adverse Event|0
250851|NCT01303861|826920|P2|Overall Study|Adverse Event|1
250852|NCT01303861|826921|P1|Overall Study|Adverse Event|4
250853|NCT01303861|826918|P4|Overall Study|Withdrawal by Subject|23
250854|NCT01303861|826919|P3|Overall Study|Withdrawal by Subject|8
250855|NCT01303861|826920|P2|Overall Study|Withdrawal by Subject|8
250856|NCT01303861|826921|P1|Overall Study|Withdrawal by Subject|16
250857|NCT01303861|826918|P4|Overall Study|Lack of Efficacy|0
250858|NCT01303861|826919|P3|Overall Study|Lack of Efficacy|1
250859|NCT01303861|826920|P2|Overall Study|Lack of Efficacy|2
250860|NCT01303861|826921|P1|Overall Study|Lack of Efficacy|3
250861|NCT01303861|826918|P4|Overall Study|Lost to Follow-up|31
250862|NCT01303861|826919|P3|Overall Study|Lost to Follow-up|27
250863|NCT01303861|826920|P2|Overall Study|Lost to Follow-up|14
250864|NCT01303861|826921|P1|Overall Study|Lost to Follow-up|34
250865|NCT01303627|826980|P2|Overall Study|the failure while performing URS|1
250866|NCT01303627|826981|P1|Overall Study|the failure while performing URS|0
250867|NCT01303510|826989|P2|Overall Study|Lost to Follow-up|0
250868|NCT01303510|826990|P1|Overall Study|Lost to Follow-up|1
250869|NCT01303445|827004|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
250870|NCT01303445|827005|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
250871|NCT01303445|827004|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
250872|NCT01303445|827005|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
250873|NCT01303445|827004|P2|Washout (14 Days)|Lost to Follow-up|2
250874|NCT01303445|827005|P1|Washout (14 Days)|Lost to Follow-up|0
250875|NCT01303445|827004|P2|Washout (14 Days)|Protocol Violation|0
250876|NCT01303445|827005|P1|Washout (14 Days)|Protocol Violation|1
250877|NCT01303445|827004|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
250878|NCT01303445|827005|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
250879|NCT01303445|827004|P2|Second Intervention (7 Days)|Adverse Event|2
250880|NCT01303445|827005|P1|Second Intervention (7 Days)|Adverse Event|0
250881|NCT01303445|827004|P2|First Intervention (7 Days)|Withdrawal by Subject|0
250882|NCT01303445|827005|P1|First Intervention (7 Days)|Withdrawal by Subject|1
250883|NCT01303380|827046|P1|Overall Study|Lack of compliance to study procedures|1
250884|NCT01303159|827105|P1|Overall Study|Study Termination|7
250885|NCT01303159|827105|P1|Overall Study|Death|16
250886|NCT01302938|827112|P2|Overall Study|Adverse Event|0
250887|NCT01302938|827113|P1|Overall Study|Adverse Event|1
250888|NCT01302938|827112|P2|Overall Study|Withdrawal by Subject|0
250889|NCT01302938|827113|P1|Overall Study|Withdrawal by Subject|1
250890|NCT01302899|827158|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
250891|NCT01302899|827159|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
250892|NCT01302899|827158|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
250893|NCT01302899|827159|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
250894|NCT01302691|827239|P2|Overall Study|Protocol Violation|0
250895|NCT01302691|827240|P1|Overall Study|Protocol Violation|1
250896|NCT01302691|827239|P2|Overall Study|Physician Decision|1
250897|NCT01302691|827240|P1|Overall Study|Physician Decision|0
250898|NCT01302691|827239|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
250899|NCT01302691|827240|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
250900|NCT01302691|827239|P2|Overall Study|Lost to Follow-up|0
250901|NCT01302691|827240|P1|Overall Study|Lost to Follow-up|1
250902|NCT01302691|827239|P2|Overall Study|Death|1
250903|NCT01302691|827240|P1|Overall Study|Death|0
250904|NCT01302691|827239|P2|Overall Study|Adverse Event|0
250905|NCT01302691|827240|P1|Overall Study|Adverse Event|2
250906|NCT01302548|827260|P2|Overall Study|Lost to Follow-up|1
250907|NCT01302548|827261|P1|Overall Study|Lost to Follow-up|2
250908|NCT01302418|827311|P1|Overall Study|Non-evaluable|9
250909|NCT01302418|827311|P1|Overall Study|Protocol Violation|9
250910|NCT01302392|827317|P2|Overall Study|Withdrawal by Subject|1
250911|NCT01302392|827318|P1|Overall Study|Withdrawal by Subject|6
250912|NCT01302392|827317|P2|Overall Study|Lost to Follow-up|0
250913|NCT01302392|827318|P1|Overall Study|Lost to Follow-up|1
250914|NCT01302366|827338|P1|Overall Study|patient choice or noncompliance|5
250915|NCT01302119|827346|P2|Overall Study|Non-specific|1
250916|NCT01302119|827347|P1|Overall Study|Non-specific|4
250917|NCT01302119|827346|P2|Overall Study|Non-compliance|2
250918|NCT01302119|827347|P1|Overall Study|Non-compliance|4
250919|NCT01302119|827346|P2|Overall Study|Adverse Event|1
250920|NCT01302119|827347|P1|Overall Study|Adverse Event|2
250921|NCT01302119|827346|P2|Overall Study|Lost to Follow-up|4
250922|NCT01302119|827347|P1|Overall Study|Lost to Follow-up|10
250923|NCT01302119|827346|P2|Overall Study|Withdrawal by Subject|20
250924|NCT01302119|827347|P1|Overall Study|Withdrawal by Subject|30
250925|NCT01302067|827362|P3|Overall Study|Adverse Event|45
250926|NCT01302067|827363|P2|Overall Study|Adverse Event|14
250927|NCT01302067|827364|P1|Overall Study|Adverse Event|27
250928|NCT01302067|827362|P3|Overall Study|Protocol Violation|8
250929|NCT01302067|827363|P2|Overall Study|Protocol Violation|0
250930|NCT01302067|827364|P1|Overall Study|Protocol Violation|11
250931|NCT01302067|827362|P3|Overall Study|Not specified|3
250932|NCT01302067|827363|P2|Overall Study|Not specified|1
250933|NCT01302067|827364|P1|Overall Study|Not specified|1
250934|NCT01302067|827362|P3|Overall Study|Withdrawal by Subject|10
250935|NCT01302067|827363|P2|Overall Study|Withdrawal by Subject|6
250936|NCT01302067|827364|P1|Overall Study|Withdrawal by Subject|13
250937|NCT01302067|827362|P3|Overall Study|Lost to Follow-up|15
250938|NCT01302067|827363|P2|Overall Study|Lost to Follow-up|4
250939|NCT01302067|827364|P1|Overall Study|Lost to Follow-up|9
250940|NCT01302067|827362|P3|Overall Study|Lack of Efficacy|2
250941|NCT01302067|827363|P2|Overall Study|Lack of Efficacy|4
250942|NCT01302067|827364|P1|Overall Study|Lack of Efficacy|8
250943|NCT01302067|827362|P3|Overall Study|Physician Decision|14
250944|NCT01302067|827363|P2|Overall Study|Physician Decision|5
250945|NCT01302067|827364|P1|Overall Study|Physician Decision|9
250946|NCT01302067|827362|P3|Overall Study|Death|1
250947|NCT01302067|827363|P2|Overall Study|Death|0
250948|NCT01302067|827364|P1|Overall Study|Death|0
250949|NCT01302054|827435|P3|Double-Blind Treatment Phase|Unspecified|9
250950|NCT01302054|827436|P2|Double-Blind Treatment Phase|Unspecified|4
250951|NCT01302054|827437|P1|Double-Blind Treatment Phase|Unspecified|0
250952|NCT01302054|827435|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
250953|NCT01302054|827436|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
250954|NCT01302054|827437|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
250955|NCT01302054|827435|P3|Double-Blind Treatment Phase|Adverse Event|10
250956|NCT01302054|827436|P2|Double-Blind Treatment Phase|Adverse Event|10
250957|NCT01302054|827437|P1|Double-Blind Treatment Phase|Adverse Event|0
250958|NCT01302054|827435|P3|Double-Blind Treatment Phase|Protocol Violation|6
250959|NCT01302054|827436|P2|Double-Blind Treatment Phase|Protocol Violation|3
250960|NCT01302054|827437|P1|Double-Blind Treatment Phase|Protocol Violation|0
250961|NCT01302054|827435|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
250962|NCT01302054|827436|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
250963|NCT01302054|827437|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
250964|NCT01302054|827435|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
250965|NCT01302054|827436|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
250966|NCT01302054|827437|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
250967|NCT01302054|827435|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
250968|NCT01302054|827436|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
250969|NCT01302054|827437|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
250970|NCT01302054|827435|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
250971|NCT01302054|827436|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
250972|NCT01302054|827437|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
250973|NCT01302054|827435|P3|Tolterodine Open-Label Run-In Phase|Unspecified|0
250974|NCT01302054|827436|P2|Tolterodine Open-Label Run-In Phase|Unspecified|0
250975|NCT01302054|827437|P1|Tolterodine Open-Label Run-In Phase|Unspecified|7
250976|NCT01302054|827435|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
250977|NCT01302054|827436|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
250978|NCT01302054|827437|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
250979|NCT01302054|827435|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
250980|NCT01302054|827436|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
250981|NCT01302054|827437|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
250982|NCT01302054|827435|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
250983|NCT01302054|827436|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
250984|NCT01302054|827437|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
250985|NCT01302054|827435|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
250986|NCT01302054|827436|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
250987|NCT01302054|827437|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
250988|NCT01302054|827435|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
250989|NCT01302054|827436|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
250990|NCT01302054|827437|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
250991|NCT01302054|827435|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
250992|NCT01302054|827436|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
250993|NCT01302054|827437|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
250994|NCT01302041|827464|P1|Overall Study|Other - Miscellaneous Reason|1
250995|NCT01302041|827464|P1|Overall Study|Withdrawal by Subject|1
250996|NCT01302041|827464|P1|Overall Study|Death|3
250997|NCT01302041|827464|P1|Overall Study|Continuing on Study|45
250998|NCT01301950|827506|P2|Overall Study|Surgery was cancelled by patient|1
250999|NCT01301950|827507|P1|Overall Study|Surgery was cancelled by patient|0
251000|NCT01301833|827525|P4|Overall Study|Personal matter|0
251001|NCT01301833|827526|P3|Overall Study|Personal matter|0
251002|NCT01301833|827527|P2|Overall Study|Personal matter|0
251003|NCT01301833|827528|P1|Overall Study|Personal matter|1
251004|NCT01301833|827525|P4|Overall Study|Withdrawal by Subject|2
251005|NCT01301833|827526|P3|Overall Study|Withdrawal by Subject|1
251006|NCT01301833|827527|P2|Overall Study|Withdrawal by Subject|1
251007|NCT01301833|827528|P1|Overall Study|Withdrawal by Subject|3
251008|NCT01301833|827525|P4|Overall Study|Physician Decision|0
251009|NCT01301833|827526|P3|Overall Study|Physician Decision|1
251010|NCT01301833|827527|P2|Overall Study|Physician Decision|1
251011|NCT01301833|827528|P1|Overall Study|Physician Decision|3
251012|NCT01301833|827525|P4|Overall Study|Lack of Efficacy|0
251013|NCT01301833|827526|P3|Overall Study|Lack of Efficacy|0
251014|NCT01301833|827527|P2|Overall Study|Lack of Efficacy|1
251015|NCT01301833|827528|P1|Overall Study|Lack of Efficacy|1
251016|NCT01301833|827525|P4|Overall Study|Adverse Event|5
251017|NCT01301833|827526|P3|Overall Study|Adverse Event|5
251018|NCT01301833|827527|P2|Overall Study|Adverse Event|5
251019|NCT01301833|827528|P1|Overall Study|Adverse Event|7
251020|NCT01301729|827566|P1|Overall Study|Violated Selection Criteria|1
251021|NCT01301729|827566|P1|Overall Study|Participant did not Return for Treatment|1
251022|NCT01301729|827566|P1|Overall Study|Withdrawal by Subject|2
251023|NCT01301508|827579|P2|Overall Study|Lost to Follow-up|1
251024|NCT01301508|827580|P1|Overall Study|Lost to Follow-up|0
251025|NCT01301508|827579|P2|Overall Study|Withdrawal by Subject|2
251026|NCT01301508|827580|P1|Overall Study|Withdrawal by Subject|1
251027|NCT01301274|827600|P2|Overall Study|Physician Decision|1
251028|NCT01301274|827601|P1|Overall Study|Physician Decision|2
251029|NCT01301092|827616|P3|Overall Study|Lost to Follow-up|1
251030|NCT01301092|827617|P2|Overall Study|Lost to Follow-up|0
251031|NCT01301092|827618|P1|Overall Study|Lost to Follow-up|0
251032|NCT01301079|827635|P2|Overall Study|Lost to Follow-up|2
251033|NCT01301079|827636|P1|Overall Study|Lost to Follow-up|2
251034|NCT01301066|827714|P2|Overall Study|Other|0
251035|NCT01301066|827715|P1|Overall Study|Other|2
251036|NCT01301066|827714|P2|Overall Study|Physician Decision|1
251037|NCT01301066|827715|P1|Overall Study|Physician Decision|0
251038|NCT01301066|827714|P2|Overall Study|Sponsor Decision|1
251039|NCT01301066|827715|P1|Overall Study|Sponsor Decision|2
251040|NCT01301066|827714|P2|Overall Study|Adverse Event|6
251041|NCT01301066|827715|P1|Overall Study|Adverse Event|6
251042|NCT01301066|827714|P2|Overall Study|Withdrawal by Subject|9
251043|NCT01301066|827715|P1|Overall Study|Withdrawal by Subject|4
251044|NCT01301066|827714|P2|Overall Study|Protocol Violation|7
251045|NCT01301066|827715|P1|Overall Study|Protocol Violation|8
251046|NCT01301066|827714|P2|Overall Study|Lost to Follow-up|11
251047|NCT01301066|827715|P1|Overall Study|Lost to Follow-up|5
251048|NCT01301027|827723|P2|Overall Study|Volume Overload|0
251049|NCT01301027|827724|P1|Overall Study|Volume Overload|3
251050|NCT01301027|827723|P2|Overall Study|Transplant|2
251051|NCT01301027|827724|P1|Overall Study|Transplant|0
251052|NCT01301027|827723|P2|Overall Study|Fracture|3
251053|NCT01301027|827724|P1|Overall Study|Fracture|1
251054|NCT01301027|827723|P2|Overall Study|Adverse Event|2
251055|NCT01301027|827724|P1|Overall Study|Adverse Event|0
251056|NCT01301027|827723|P2|Overall Study|Withdrawal by Subject|3
251057|NCT01301027|827724|P1|Overall Study|Withdrawal by Subject|2
251058|NCT01301027|827723|P2|Overall Study|Physician Decision|0
251059|NCT01301027|827724|P1|Overall Study|Physician Decision|2
251060|NCT01300923|827736|P2|Overall Study|Physician Decision|2
251061|NCT01300923|827737|P1|Overall Study|Physician Decision|0
251062|NCT01300819|827750|P2|Overall Study|Follow up call was not done|0
251063|NCT01300819|827751|P1|Overall Study|Follow up call was not done|1
251064|NCT01300819|827750|P2|Overall Study|Safety follow up not done by mistake|1
251065|NCT01300819|827751|P1|Overall Study|Safety follow up not done by mistake|0
251066|NCT01300819|827750|P2|Overall Study|Administrative reason|1
251067|NCT01300819|827751|P1|Overall Study|Administrative reason|0
251068|NCT01300819|827750|P2|Overall Study|Refusal to down titrate study drug|1
251069|NCT01300819|827751|P1|Overall Study|Refusal to down titrate study drug|0
251070|NCT01300819|827750|P2|Overall Study|Patient was 1 month late for Visit 10|1
251071|NCT01300819|827751|P1|Overall Study|Patient was 1 month late for Visit 10|0
251072|NCT01300819|827750|P2|Overall Study|Withdrawal by Subject|12
251073|NCT01300819|827751|P1|Overall Study|Withdrawal by Subject|10
251074|NCT01300819|827750|P2|Overall Study|Lack of Efficacy|1
251075|NCT01300819|827751|P1|Overall Study|Lack of Efficacy|2
251076|NCT01300819|827750|P2|Overall Study|Adverse Event|27
251077|NCT01300819|827751|P1|Overall Study|Adverse Event|9
251078|NCT01300767|827779|P1|Overall Study|Unacceptable fit|1
251079|NCT01300767|827779|P1|Overall Study|Biomicroscopy|1
251080|NCT01300767|827779|P1|Overall Study|Discomfort|2
251081|NCT01300741|827807|P1|Overall Study|Discomfort|1
251082|NCT01300741|827807|P1|Overall Study|Lost to Follow-up|1
251083|NCT01300741|827807|P1|Overall Study|Lens deposits|1
251084|NCT01300728|827837|P2|Overall Study|Physician Decision|0
251085|NCT01300728|827838|P1|Overall Study|Physician Decision|1
251086|NCT01300728|827837|P2|Overall Study|Withdrawal by Subject|1
251087|NCT01300728|827838|P1|Overall Study|Withdrawal by Subject|1
251088|NCT01300650|827852|P1|Overall Study|Adverse Event|1
251089|NCT01300546|827879|P2|Overall Study|Adverse Event|1
251090|NCT01300546|827880|P1|Overall Study|Adverse Event|0
251091|NCT01300546|827879|P2|Overall Study|Lack of Efficacy|3
251092|NCT01300546|827880|P1|Overall Study|Lack of Efficacy|0
251093|NCT01300546|827879|P2|Overall Study|Lost to Follow-up|2
251094|NCT01300546|827880|P1|Overall Study|Lost to Follow-up|0
251095|NCT01300546|827879|P2|Overall Study|Withdrawal by Subject|0
251096|NCT01300546|827880|P1|Overall Study|Withdrawal by Subject|1
251097|NCT01300455|827910|P2|Washout|Withdrawal by Subject|0
251098|NCT01300455|827911|P1|Washout|Withdrawal by Subject|1
251099|NCT01300351|827931|P2|Overall Study|Withdrawal by Subject|10
251100|NCT01300351|827932|P1|Overall Study|Withdrawal by Subject|7
251101|NCT01300351|827931|P2|Overall Study|Adverse Event|4
251102|NCT01300351|827932|P1|Overall Study|Adverse Event|0
251103|NCT01300351|827931|P2|Overall Study|Lost to Follow-up|1
251104|NCT01300351|827932|P1|Overall Study|Lost to Follow-up|0
251105|NCT01300351|827931|P2|Overall Study|Ongoing treatment at data cut-off|23
251106|NCT01300351|827932|P1|Overall Study|Ongoing treatment at data cut-off|27
251107|NCT01300351|827931|P2|Overall Study|Did not receive treatment|0
251108|NCT01300351|827932|P1|Overall Study|Did not receive treatment|2
251109|NCT01300338|827948|P2|Overall Study|Lost to Follow-up|0
251110|NCT01300338|827949|P1|Overall Study|Lost to Follow-up|5
251111|NCT01300286|827957|P1|Overall Study|did not get dosed|1
251112|NCT01300260|827967|P2|Period 2 of Study: Second Intervention|Adverse Event|1
251113|NCT01300260|827968|P1|Period 2 of Study: Second Intervention|Adverse Event|0
251114|NCT01300260|827967|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
251115|NCT01300260|827968|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
251116|NCT01300260|827967|P2|Period 1 of Study: First Intervention|Adverse Event|1
251117|NCT01300260|827968|P1|Period 1 of Study: First Intervention|Adverse Event|0
251118|NCT01300247|828000|P2|Overall Study|Non-Compliance|1
251119|NCT01300247|828001|P1|Overall Study|Non-Compliance|0
251120|NCT01300247|828000|P2|Overall Study|Withdrawal by Subject|0
251121|NCT01300247|828001|P1|Overall Study|Withdrawal by Subject|1
251122|NCT01300247|828000|P2|Overall Study|Lost to Follow-up|0
251123|NCT01300247|828001|P1|Overall Study|Lost to Follow-up|2
251124|NCT01300247|828000|P2|Overall Study|Death|1
251125|NCT01300247|828001|P1|Overall Study|Death|1
251126|NCT01300234|828033|P2|Overall Study|Lost to Follow-up|2
251127|NCT01300234|828034|P1|Overall Study|Lost to Follow-up|0
251128|NCT01300234|828033|P2|Overall Study|Withdrawal by Subject|5
251129|NCT01300234|828034|P1|Overall Study|Withdrawal by Subject|1
251130|NCT01300234|828033|P2|Overall Study|Protocol Violation|3
251131|NCT01300234|828034|P1|Overall Study|Protocol Violation|2
251132|NCT01300234|828033|P2|Overall Study|Adverse Event|0
251133|NCT01300234|828034|P1|Overall Study|Adverse Event|1
251134|NCT01300052|828066|P2|Overall Study|Protocol Violation|1
251135|NCT01300052|828067|P1|Overall Study|Protocol Violation|1
251136|NCT01300052|828066|P2|Overall Study|Withdrawal by Subject|2
251137|NCT01300052|828067|P1|Overall Study|Withdrawal by Subject|2
251138|NCT01300052|828066|P2|Overall Study|Adverse Event|0
251139|NCT01300052|828067|P1|Overall Study|Adverse Event|3
251140|NCT01299961|828085|P1|Overall Study|Lost to Follow-up|1
251141|NCT01299961|828085|P1|Overall Study|Lack of Efficacy|2
251142|NCT01299961|828085|P1|Overall Study|Adverse Event|3
251143|NCT01299909|828094|P3|Overall Study|Lost to Follow-up|17
251144|NCT01299909|828095|P2|Overall Study|Lost to Follow-up|18
251145|NCT01299909|828096|P1|Overall Study|Lost to Follow-up|22
251146|NCT01299896|828105|P2|Overall Study|Lost to Follow-up|11
251147|NCT01299896|828106|P1|Overall Study|Lost to Follow-up|0
251148|NCT01299896|828105|P2|Overall Study|Withdrawal by Subject|7
251149|NCT01299896|828106|P1|Overall Study|Withdrawal by Subject|1
251150|NCT01299805|828114|P2|Overall Study|Adverse Event|0
251151|NCT01299805|828115|P1|Overall Study|Adverse Event|2
251152|NCT01299584|828143|P1|Overall Study|Protocol Violation|9
251153|NCT01299571|828150|P1|Overall Study|Protocol Violation|107
251154|NCT01299480|828161|P5|Overall Study|Started, but not vaccinated|0
251155|NCT01299480|828162|P4|Overall Study|Started, but not vaccinated|1
251156|NCT01299480|828163|P3|Overall Study|Started, but not vaccinated|1
251157|NCT01299480|828164|P2|Overall Study|Started, but not vaccinated|0
251158|NCT01299480|828165|P1|Overall Study|Started, but not vaccinated|0
251159|NCT01299480|828161|P5|Overall Study|Unspecified|3
251160|NCT01299480|828162|P4|Overall Study|Unspecified|0
251161|NCT01299480|828163|P3|Overall Study|Unspecified|3
251162|NCT01299480|828164|P2|Overall Study|Unspecified|2
251163|NCT01299480|828165|P1|Overall Study|Unspecified|3
251164|NCT01299480|828161|P5|Overall Study|Lost to Follow-up|2
251165|NCT01299480|828162|P4|Overall Study|Lost to Follow-up|1
251166|NCT01299480|828163|P3|Overall Study|Lost to Follow-up|2
251167|NCT01299480|828164|P2|Overall Study|Lost to Follow-up|1
251168|NCT01299480|828165|P1|Overall Study|Lost to Follow-up|3
251169|NCT01299480|828161|P5|Overall Study|Physician Decision|0
251170|NCT01299480|828162|P4|Overall Study|Physician Decision|2
251171|NCT01299480|828163|P3|Overall Study|Physician Decision|0
251172|NCT01299480|828164|P2|Overall Study|Physician Decision|1
251173|NCT01299480|828165|P1|Overall Study|Physician Decision|1
251174|NCT01299480|828161|P5|Overall Study|Withdrawal due to pregnancy|0
251175|NCT01299480|828162|P4|Overall Study|Withdrawal due to pregnancy|0
251176|NCT01299480|828163|P3|Overall Study|Withdrawal due to pregnancy|1
251177|NCT01299480|828164|P2|Overall Study|Withdrawal due to pregnancy|1
251178|NCT01299480|828165|P1|Overall Study|Withdrawal due to pregnancy|0
251179|NCT01299480|828161|P5|Overall Study|Adverse Event|0
251180|NCT01299480|828162|P4|Overall Study|Adverse Event|4
251181|NCT01299480|828163|P3|Overall Study|Adverse Event|5
251182|NCT01299480|828164|P2|Overall Study|Adverse Event|4
251183|NCT01299480|828165|P1|Overall Study|Adverse Event|6
251184|NCT01299480|828161|P5|Overall Study|Withdrawal by Subject|4
251185|NCT01299480|828162|P4|Overall Study|Withdrawal by Subject|3
251186|NCT01299480|828163|P3|Overall Study|Withdrawal by Subject|7
251187|NCT01299480|828164|P2|Overall Study|Withdrawal by Subject|4
251188|NCT01299480|828165|P1|Overall Study|Withdrawal by Subject|3
251189|NCT01299480|828161|P5|Overall Study|Protocol Violation|1
251190|NCT01299480|828162|P4|Overall Study|Protocol Violation|1
251191|NCT01299480|828163|P3|Overall Study|Protocol Violation|8
251192|NCT01299480|828164|P2|Overall Study|Protocol Violation|5
251193|NCT01299480|828165|P1|Overall Study|Protocol Violation|7
251194|NCT01299480|828161|P5|Overall Study|No longer willing to participate|10
251195|NCT01299480|828162|P4|Overall Study|No longer willing to participate|13
251196|NCT01299480|828163|P3|Overall Study|No longer willing to participate|14
251197|NCT01299480|828164|P2|Overall Study|No longer willing to participate|17
251198|NCT01299480|828165|P1|Overall Study|No longer willing to participate|19
251199|NCT01299389|828367|P4|Post-observational|unspecified|6
251200|NCT01299389|828368|P3|Post-observational|unspecified|12
251201|NCT01299389|828369|P2|Post-observational|unspecified|0
251202|NCT01299389|828370|P1|Post-observational|unspecified|0
251203|NCT01299389|828367|P4|Double-blind|fail to meet “study population” criteria|0
251204|NCT01299389|828368|P3|Double-blind|fail to meet “study population” criteria|0
251205|NCT01299389|828369|P2|Double-blind|fail to meet “study population” criteria|1
251206|NCT01299389|828370|P1|Double-blind|fail to meet “study population” criteria|0
251207|NCT01299389|828367|P4|Double-blind|unspecified|0
251208|NCT01299389|828368|P3|Double-blind|unspecified|0
251209|NCT01299389|828369|P2|Double-blind|unspecified|1
251210|NCT01299389|828370|P1|Double-blind|unspecified|1
251211|NCT01299389|828367|P4|Double-blind|Withdrawal by Subject|0
251212|NCT01299389|828368|P3|Double-blind|Withdrawal by Subject|0
251213|NCT01299389|828369|P2|Double-blind|Withdrawal by Subject|13
251214|NCT01299389|828370|P1|Double-blind|Withdrawal by Subject|16
251215|NCT01299389|828367|P4|Double-blind|Lost to Follow-up|0
251216|NCT01299389|828368|P3|Double-blind|Lost to Follow-up|0
251217|NCT01299389|828369|P2|Double-blind|Lost to Follow-up|1
251218|NCT01299389|828370|P1|Double-blind|Lost to Follow-up|2
251219|NCT01299389|828367|P4|Double-blind|Lack of Efficacy|0
251220|NCT01299389|828368|P3|Double-blind|Lack of Efficacy|0
251221|NCT01299389|828369|P2|Double-blind|Lack of Efficacy|21
251222|NCT01299389|828370|P1|Double-blind|Lack of Efficacy|45
251223|NCT01299389|828367|P4|Double-blind|Adverse Event|0
251224|NCT01299389|828368|P3|Double-blind|Adverse Event|0
251225|NCT01299389|828369|P2|Double-blind|Adverse Event|27
251226|NCT01299389|828370|P1|Double-blind|Adverse Event|45
251227|NCT01299376|828392|P2|Extension (Weeks 9 to 52)|Physician Decision|0
251228|NCT01299376|828393|P1|Extension (Weeks 9 to 52)|Physician Decision|1
251229|NCT01299376|828392|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
251230|NCT01299376|828393|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
251231|NCT01299376|828392|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
251232|NCT01299376|828393|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
251233|NCT01299376|828392|P2|Extension (Weeks 9 to 52)|Adverse Event|3
251234|NCT01299376|828393|P1|Extension (Weeks 9 to 52)|Adverse Event|2
251235|NCT01299376|828392|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
251236|NCT01299376|828393|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
251237|NCT01299376|828392|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
251238|NCT01299376|828393|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
251239|NCT01299376|828392|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
251240|NCT01299376|828393|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
251241|NCT01299376|828392|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
251242|NCT01299376|828393|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
251243|NCT01299376|828392|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
251244|NCT01299376|828393|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
251245|NCT01299376|828392|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
251246|NCT01299376|828393|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
251247|NCT01299376|828392|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
251248|NCT01299376|828393|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
251249|NCT01299025|828467|P2|Overall Study|Lost to Follow-up|0
251250|NCT01299025|828468|P1|Overall Study|Lost to Follow-up|1
251251|NCT01299025|828467|P2|Overall Study|Withdrawal by Subject|1
251252|NCT01299025|828468|P1|Overall Study|Withdrawal by Subject|2
251253|NCT01298778|828482|P2|Overall Study|not meet inclusion/exclusion criteria|1
251254|NCT01298778|828483|P1|Overall Study|not meet inclusion/exclusion criteria|0
251255|NCT01298778|828482|P2|Overall Study|Protocol Violation|1
251256|NCT01298778|828483|P1|Overall Study|Protocol Violation|0
251257|NCT01298778|828482|P2|Overall Study|Withdrawal by Subject|1
251258|NCT01298778|828483|P1|Overall Study|Withdrawal by Subject|0
251259|NCT01298778|828482|P2|Overall Study|Incorrect use of VAS|0
251260|NCT01298778|828483|P1|Overall Study|Incorrect use of VAS|1
251261|NCT01298778|828482|P2|Overall Study|Lost to Follow-up|3
251262|NCT01298778|828483|P1|Overall Study|Lost to Follow-up|2
251263|NCT01298661|828506|P3|Overall Study|Withdrawal by Subject|2
251264|NCT01298661|828507|P2|Overall Study|Withdrawal by Subject|0
251265|NCT01298661|828508|P1|Overall Study|Withdrawal by Subject|2
251266|NCT01298648|828586|P1|Overall Study|Lost to Follow-up|21
251267|NCT01298648|828586|P1|Overall Study|Withdrawal by Subject|2
251268|NCT01298531|828606|P2|Overall Study|Not specified|1
251269|NCT01298531|828607|P1|Overall Study|Not specified|2
251270|NCT01298531|828606|P2|Overall Study|Does not meet entrance criteria|1
251271|NCT01298531|828607|P1|Overall Study|Does not meet entrance criteria|0
251272|NCT01298531|828606|P2|Overall Study|Adverse Event|3
251273|NCT01298531|828607|P1|Overall Study|Adverse Event|4
251274|NCT01298531|828606|P2|Overall Study|Protocol Violation|1
251275|NCT01298531|828607|P1|Overall Study|Protocol Violation|1
251276|NCT01298531|828606|P2|Overall Study|Lost to Follow-up|0
251277|NCT01298531|828607|P1|Overall Study|Lost to Follow-up|2
251278|NCT01298531|828606|P2|Overall Study|Lack of Efficacy|1
251279|NCT01298531|828607|P1|Overall Study|Lack of Efficacy|0
251280|NCT01298518|828736|P3|Overall Study|Withdrawal by Subject|1
251281|NCT01298518|828737|P2|Overall Study|Withdrawal by Subject|0
251282|NCT01298518|828738|P1|Overall Study|Withdrawal by Subject|0
251283|NCT01298362|828792|P2|Overall Study|Did not provide 12month BMD measurements|43
251284|NCT01298362|828793|P1|Overall Study|Did not provide 12month BMD measurements|38
251285|NCT01298323|828813|P2|Overall Study|Eligibility criteria not fulfilled|1
251286|NCT01298323|828814|P1|Overall Study|Eligibility criteria not fulfilled|0
251287|NCT01298323|828813|P2|Overall Study|Ongoing|55
251288|NCT01298323|828814|P1|Overall Study|Ongoing|55
251289|NCT01298323|828813|P2|Overall Study|Other|9
251290|NCT01298323|828814|P1|Overall Study|Other|10
251291|NCT01298323|828813|P2|Overall Study|Protocol Violation|0
251292|NCT01298323|828814|P1|Overall Study|Protocol Violation|1
251293|NCT01298323|828813|P2|Overall Study|Withdrawal by Subject|3
251294|NCT01298323|828814|P1|Overall Study|Withdrawal by Subject|6
251295|NCT01298323|828813|P2|Overall Study|Lost to Follow-up|0
251296|NCT01298323|828814|P1|Overall Study|Lost to Follow-up|1
251297|NCT01298323|828813|P2|Overall Study|Death|16
251298|NCT01298323|828814|P1|Overall Study|Death|11
251299|NCT01298323|828813|P2|Overall Study|Adverse Event|4
251300|NCT01298323|828814|P1|Overall Study|Adverse Event|2
251301|NCT01297920|828877|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
251302|NCT01297920|828878|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
251303|NCT01297920|828879|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
251304|NCT01297920|828877|P3|Overall Study|Inadequate Control of IOP|17
251305|NCT01297920|828878|P2|Overall Study|Inadequate Control of IOP|9
251306|NCT01297920|828879|P1|Overall Study|Inadequate Control of IOP|7
251307|NCT01297920|828877|P3|Overall Study|Protocol Violation|0
251308|NCT01297920|828878|P2|Overall Study|Protocol Violation|3
251309|NCT01297920|828879|P1|Overall Study|Protocol Violation|1
251310|NCT01297920|828877|P3|Overall Study|Noncompliance|0
251311|NCT01297920|828878|P2|Overall Study|Noncompliance|0
251312|NCT01297920|828879|P1|Overall Study|Noncompliance|1
251313|NCT01297920|828877|P3|Overall Study|Patient Decision Unrelated to AE|2
251314|NCT01297920|828878|P2|Overall Study|Patient Decision Unrelated to AE|5
251315|NCT01297920|828879|P1|Overall Study|Patient Decision Unrelated to AE|6
251316|NCT01297920|828877|P3|Overall Study|Adverse Event|38
251317|NCT01297920|828878|P2|Overall Study|Adverse Event|10
251318|NCT01297920|828879|P1|Overall Study|Adverse Event|42
251319|NCT01297517|828923|P3|Overall Study|Inadequate Control of IOP|2
251320|NCT01297517|828924|P2|Overall Study|Inadequate Control of IOP|1
251321|NCT01297517|828925|P1|Overall Study|Inadequate Control of IOP|1
251322|NCT01297517|828923|P3|Overall Study|Protocol Violation|1
251323|NCT01297517|828924|P2|Overall Study|Protocol Violation|1
251324|NCT01297517|828925|P1|Overall Study|Protocol Violation|1
251325|NCT01297517|828923|P3|Overall Study|Noncompliance|0
251326|NCT01297517|828924|P2|Overall Study|Noncompliance|0
251327|NCT01297517|828925|P1|Overall Study|Noncompliance|1
251328|NCT01297517|828923|P3|Overall Study|Patient Decision Unrelated to AE|7
251329|NCT01297517|828924|P2|Overall Study|Patient Decision Unrelated to AE|3
251330|NCT01297517|828925|P1|Overall Study|Patient Decision Unrelated to AE|2
251331|NCT01297517|828923|P3|Overall Study|Lost to Follow-up|1
251332|NCT01297517|828924|P2|Overall Study|Lost to Follow-up|0
251333|NCT01297517|828925|P1|Overall Study|Lost to Follow-up|1
251334|NCT01297517|828923|P3|Overall Study|Adverse Event|16
251335|NCT01297517|828924|P2|Overall Study|Adverse Event|7
251336|NCT01297517|828925|P1|Overall Study|Adverse Event|21
251337|NCT01297504|828933|P1|Overall Study|Protocol Violation|3
251338|NCT01297504|828933|P1|Overall Study|Site Closure|3
251339|NCT01297504|828933|P1|Overall Study|Withdrawal by Subject|9
251340|NCT01297504|828933|P1|Overall Study|Lost to Follow-up|43
251341|NCT01297504|828933|P1|Overall Study|Death|3
251342|NCT01297504|828933|P1|Overall Study|No Study Visits|4
251343|NCT01297504|828933|P1|Overall Study|Received Palivizumab in Previous Season|1
251344|NCT01297504|828933|P1|Overall Study|Invalid Consent|1
251345|NCT01297491|828947|P2|Overall Study|Death|1
251346|NCT01297491|828948|P1|Overall Study|Death|2
251347|NCT01297491|828947|P2|Overall Study|Patient/Guardian decision|4
251348|NCT01297491|828948|P1|Overall Study|Patient/Guardian decision|3
251349|NCT01297491|828947|P2|Overall Study|Progressive disease|20
251350|NCT01297491|828948|P1|Overall Study|Progressive disease|11
251351|NCT01297491|828947|P2|Overall Study|Physician Decision|2
251352|NCT01297491|828948|P1|Overall Study|Physician Decision|3
251353|NCT01297491|828947|P2|Overall Study|Adverse Event|6
251354|NCT01297491|828948|P1|Overall Study|Adverse Event|11
251355|NCT01297465|828966|P2|Overall Study|Intention to Freeze all Embryos|1
251356|NCT01297465|828967|P1|Overall Study|Intention to Freeze all Embryos|0
251357|NCT01297465|828966|P2|Overall Study|All Embryos Discarded|1
251358|NCT01297465|828967|P1|Overall Study|All Embryos Discarded|0
251359|NCT01297465|828966|P2|Overall Study|No Fertilization|4
251360|NCT01297465|828967|P1|Overall Study|No Fertilization|6
251361|NCT01297465|828966|P2|Overall Study|Poor oocyte quality|1
251362|NCT01297465|828967|P1|Overall Study|Poor oocyte quality|0
251363|NCT01297465|828966|P2|Overall Study|No Oocytes Retrieved|1
251364|NCT01297465|828967|P1|Overall Study|No Oocytes Retrieved|1
251365|NCT01297465|828966|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
251366|NCT01297465|828967|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
251367|NCT01297465|828966|P2|Overall Study|Lack of Ovarian Response|1
251368|NCT01297465|828967|P1|Overall Study|Lack of Ovarian Response|1
251369|NCT01297322|829020|P2|Overall Study|Withdrawal by Subject|1
251370|NCT01297322|829021|P1|Overall Study|Withdrawal by Subject|0
251371|NCT01297322|829020|P2|Overall Study|Lost to Follow-up|0
251372|NCT01297322|829021|P1|Overall Study|Lost to Follow-up|1
251373|NCT01297270|829049|P3|Overall Study|Not treated|0
251374|NCT01297270|829050|P2|Overall Study|Not treated|1
251375|NCT01297270|829051|P1|Overall Study|Not treated|0
251376|NCT01297270|829049|P3|Overall Study|Other reason not defined above|1
251377|NCT01297270|829050|P2|Overall Study|Other reason not defined above|3
251378|NCT01297270|829051|P1|Overall Study|Other reason not defined above|3
251379|NCT01297270|829049|P3|Overall Study|Withdrawal by Subject|7
251380|NCT01297270|829050|P2|Overall Study|Withdrawal by Subject|15
251381|NCT01297270|829051|P1|Overall Study|Withdrawal by Subject|7
251382|NCT01297270|829049|P3|Overall Study|Protocol Violation|0
251383|NCT01297270|829050|P2|Overall Study|Protocol Violation|2
251384|NCT01297270|829051|P1|Overall Study|Protocol Violation|0
251385|NCT01297270|829049|P3|Overall Study|Lost to Follow-up|1
251386|NCT01297270|829050|P2|Overall Study|Lost to Follow-up|2
251387|NCT01297270|829051|P1|Overall Study|Lost to Follow-up|1
251388|NCT01297270|829049|P3|Overall Study|Lack of Efficacy|15
251389|NCT01297270|829050|P2|Overall Study|Lack of Efficacy|17
251390|NCT01297270|829051|P1|Overall Study|Lack of Efficacy|15
251391|NCT01297270|829049|P3|Overall Study|Adverse Event|5
251392|NCT01297270|829050|P2|Overall Study|Adverse Event|32
251393|NCT01297270|829051|P1|Overall Study|Adverse Event|19
251394|NCT01297062|829100|P7|Overall Study|Subject Decision|2
251395|NCT01297062|829101|P6|Overall Study|Subject Decision|1
251396|NCT01297062|829102|P5|Overall Study|Subject Decision|1
251397|NCT01297062|829103|P4|Overall Study|Subject Decision|1
251398|NCT01297062|829104|P3|Overall Study|Subject Decision|0
251399|NCT01297062|829105|P2|Overall Study|Subject Decision|1
251400|NCT01297062|829106|P1|Overall Study|Subject Decision|1
251401|NCT01297062|829100|P7|Overall Study|Protocol Violation|0
251402|NCT01297062|829101|P6|Overall Study|Protocol Violation|0
251403|NCT01297062|829102|P5|Overall Study|Protocol Violation|1
251404|NCT01297062|829103|P4|Overall Study|Protocol Violation|0
251405|NCT01297062|829104|P3|Overall Study|Protocol Violation|0
251406|NCT01297062|829105|P2|Overall Study|Protocol Violation|0
251407|NCT01297062|829106|P1|Overall Study|Protocol Violation|0
251408|NCT01297062|829100|P7|Overall Study|Physician Decision|6
251409|NCT01297062|829101|P6|Overall Study|Physician Decision|0
251410|NCT01297062|829102|P5|Overall Study|Physician Decision|0
251411|NCT01297062|829103|P4|Overall Study|Physician Decision|0
251412|NCT01297062|829104|P3|Overall Study|Physician Decision|1
251413|NCT01297062|829105|P2|Overall Study|Physician Decision|0
251414|NCT01297062|829106|P1|Overall Study|Physician Decision|1
251415|NCT01297062|829100|P7|Overall Study|Adverse Event|0
251416|NCT01297062|829101|P6|Overall Study|Adverse Event|0
251417|NCT01297062|829102|P5|Overall Study|Adverse Event|0
251418|NCT01297062|829103|P4|Overall Study|Adverse Event|0
251419|NCT01297062|829104|P3|Overall Study|Adverse Event|1
251420|NCT01297062|829105|P2|Overall Study|Adverse Event|0
251421|NCT01297062|829106|P1|Overall Study|Adverse Event|2
251422|NCT01296698|829168|P2|Overall Study|Study Terminated by Sponsor|12
251423|NCT01296698|829169|P1|Overall Study|Study Terminated by Sponsor|209
251424|NCT01296698|829168|P2|Overall Study|Difficulty Contacting Subject|0
251425|NCT01296698|829169|P1|Overall Study|Difficulty Contacting Subject|2
251426|NCT01296698|829168|P2|Overall Study|Withdrawal by Subject|0
251427|NCT01296698|829169|P1|Overall Study|Withdrawal by Subject|12
251428|NCT01296698|829168|P2|Overall Study|Lost to Follow-up|1
251429|NCT01296698|829169|P1|Overall Study|Lost to Follow-up|19
251430|NCT01296698|829168|P2|Overall Study|Death|0
251431|NCT01296698|829169|P1|Overall Study|Death|1
251432|NCT01296698|829168|P2|Overall Study|Adverse Event|0
251433|NCT01296698|829169|P1|Overall Study|Adverse Event|1
251434|NCT01296412|829234|P2|Overall Study|Withdrawal by Subject|13
251435|NCT01296412|829235|P1|Overall Study|Withdrawal by Subject|10
251436|NCT01296412|829234|P2|Overall Study|Pregnancy|1
251437|NCT01296412|829235|P1|Overall Study|Pregnancy|0
251438|NCT01296412|829234|P2|Overall Study|Physician Decision|3
251439|NCT01296412|829235|P1|Overall Study|Physician Decision|1
251440|NCT01296412|829234|P2|Overall Study|Other reason not specified|15
251441|NCT01296412|829235|P1|Overall Study|Other reason not specified|20
251442|NCT01296412|829234|P2|Overall Study|Non-compliance with study drug|2
251443|NCT01296412|829235|P1|Overall Study|Non-compliance with study drug|1
251444|NCT01296412|829234|P2|Overall Study|Lost to Follow-up|7
251445|NCT01296412|829235|P1|Overall Study|Lost to Follow-up|10
251446|NCT01296412|829234|P2|Overall Study|Lack of Efficacy|0
251447|NCT01296412|829235|P1|Overall Study|Lack of Efficacy|1
251448|NCT01296412|829234|P2|Overall Study|Adverse Event|29
251449|NCT01296412|829235|P1|Overall Study|Adverse Event|8
251450|NCT01296152|829265|P1|Overall Study|Unwilling to adhere to study requirement|1
251451|NCT01296035|829292|P1|Overall Study|Withdrawal by Subject|1
251452|NCT01295905|829299|P2|Overall Study|Met exclusion criteria|0
251453|NCT01295905|829300|P1|Overall Study|Met exclusion criteria|1
251454|NCT01295905|829299|P2|Overall Study|Did not meet inclusion criteria|0
251455|NCT01295905|829300|P1|Overall Study|Did not meet inclusion criteria|1
251456|NCT01295814|829334|P2|Overall Study|Withdrawal by Subject|0
251457|NCT01295814|829335|P1|Overall Study|Withdrawal by Subject|2
251458|NCT01295814|829334|P2|Overall Study|Lack of Efficacy|2
251459|NCT01295814|829335|P1|Overall Study|Lack of Efficacy|0
251460|NCT01295281|829351|P2|First Intervention (7 Days)|Death|1
251461|NCT01295281|829352|P1|First Intervention (7 Days)|Death|0
251462|NCT01295034|829379|P2|Overall Study|Lost to Follow-up|5
251463|NCT01295034|829380|P1|Overall Study|Lost to Follow-up|5
251464|NCT01294917|829388|P1|Overall Study|Inconvenience|1
251465|NCT01294917|829388|P1|Overall Study|Relocation|5
251466|NCT01294800|829398|P4|Overall Study|Did Not Meet Protocol Eligibility|0
251467|NCT01294800|829399|P3|Overall Study|Did Not Meet Protocol Eligibility|1
251468|NCT01294800|829400|P2|Overall Study|Did Not Meet Protocol Eligibility|1
251469|NCT01294800|829401|P1|Overall Study|Did Not Meet Protocol Eligibility|2
251470|NCT01294800|829398|P4|Overall Study|Non-compliance With Protocol|0
251471|NCT01294800|829399|P3|Overall Study|Non-compliance With Protocol|1
251472|NCT01294800|829400|P2|Overall Study|Non-compliance With Protocol|1
251473|NCT01294800|829401|P1|Overall Study|Non-compliance With Protocol|0
251474|NCT01294800|829398|P4|Overall Study|Lost to Follow-up|0
251475|NCT01294800|829399|P3|Overall Study|Lost to Follow-up|1
251476|NCT01294800|829400|P2|Overall Study|Lost to Follow-up|0
251477|NCT01294800|829401|P1|Overall Study|Lost to Follow-up|0
251478|NCT01294800|829398|P4|Overall Study|Subject Withdrew Consent|11
251479|NCT01294800|829399|P3|Overall Study|Subject Withdrew Consent|2
251480|NCT01294800|829400|P2|Overall Study|Subject Withdrew Consent|2
251481|NCT01294800|829401|P1|Overall Study|Subject Withdrew Consent|2
251482|NCT01294800|829398|P4|Overall Study|Adverse Event|5
251483|NCT01294800|829399|P3|Overall Study|Adverse Event|12
251484|NCT01294800|829400|P2|Overall Study|Adverse Event|6
251485|NCT01294800|829401|P1|Overall Study|Adverse Event|7
251486|NCT01294787|829427|P6|Period 3|Adverse Event|0
251487|NCT01294787|829428|P5|Period 3|Adverse Event|1
251488|NCT01294787|829429|P4|Period 3|Adverse Event|0
251489|NCT01294787|829430|P3|Period 3|Adverse Event|0
251490|NCT01294787|829431|P2|Period 3|Adverse Event|0
251491|NCT01294787|829432|P1|Period 3|Adverse Event|0
251492|NCT01294787|829427|P6|Period 2|No longer needs study drug|0
251493|NCT01294787|829428|P5|Period 2|No longer needs study drug|0
251494|NCT01294787|829429|P4|Period 2|No longer needs study drug|1
251495|NCT01294787|829430|P3|Period 2|No longer needs study drug|0
251496|NCT01294787|829431|P2|Period 2|No longer needs study drug|0
251497|NCT01294787|829432|P1|Period 2|No longer needs study drug|0
251498|NCT01294787|829427|P6|Period 2|Adverse Event|0
251499|NCT01294787|829428|P5|Period 2|Adverse Event|0
251500|NCT01294787|829429|P4|Period 2|Adverse Event|1
251501|NCT01294787|829430|P3|Period 2|Adverse Event|0
251502|NCT01294787|829431|P2|Period 2|Adverse Event|3
251503|NCT01294787|829432|P1|Period 2|Adverse Event|0
251504|NCT01294787|829427|P6|Period 1|Administrative problem|1
251505|NCT01294787|829428|P5|Period 1|Administrative problem|0
251506|NCT01294787|829429|P4|Period 1|Administrative problem|0
251507|NCT01294787|829430|P3|Period 1|Administrative problem|1
251508|NCT01294787|829431|P2|Period 1|Administrative problem|0
251509|NCT01294787|829432|P1|Period 1|Administrative problem|0
251510|NCT01294787|829427|P6|Period 1|Withdrawal by Subject|1
251511|NCT01294787|829428|P5|Period 1|Withdrawal by Subject|1
251512|NCT01294787|829429|P4|Period 1|Withdrawal by Subject|1
251513|NCT01294787|829430|P3|Period 1|Withdrawal by Subject|0
251514|NCT01294787|829431|P2|Period 1|Withdrawal by Subject|0
251515|NCT01294787|829432|P1|Period 1|Withdrawal by Subject|0
251516|NCT01294787|829427|P6|Period 1|Adverse Event|0
251517|NCT01294787|829428|P5|Period 1|Adverse Event|1
251518|NCT01294787|829429|P4|Period 1|Adverse Event|0
251519|NCT01294787|829430|P3|Period 1|Adverse Event|0
251520|NCT01294787|829431|P2|Period 1|Adverse Event|0
251521|NCT01294787|829432|P1|Period 1|Adverse Event|0
251522|NCT01294696|829523|P1|Overall Study|Site closure|52
251523|NCT01294696|829523|P1|Overall Study|Missing BPI Response|7
251524|NCT01294696|829523|P1|Overall Study|Protocol Violation|8
251525|NCT01294696|829523|P1|Overall Study|Screening failures|7
251526|NCT01294683|829537|P2|Post Crossover (Period III)|Withdrawal by Subject|2
251527|NCT01294683|829538|P1|Post Crossover (Period III)|Withdrawal by Subject|3
251528|NCT01294683|829537|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
251529|NCT01294683|829538|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
251530|NCT01294683|829537|P2|Post Crossover (Period III)|Lost to Follow-up|3
251531|NCT01294683|829538|P1|Post Crossover (Period III)|Lost to Follow-up|1
251532|NCT01294683|829537|P2|Post Crossover (Period III)|Adverse Event|6
251533|NCT01294683|829538|P1|Post Crossover (Period III)|Adverse Event|6
251534|NCT01294683|829537|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
251535|NCT01294683|829538|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
251536|NCT01294683|829537|P2|Precrossover (Periods I/II)|Technical Problems|1
251537|NCT01294683|829538|P1|Precrossover (Periods I/II)|Technical Problems|0
251538|NCT01294683|829537|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
251539|NCT01294683|829538|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
251540|NCT01294683|829537|P2|Precrossover (Periods I/II)|Protocol Violation|5
251541|NCT01294683|829538|P1|Precrossover (Periods I/II)|Protocol Violation|5
251542|NCT01294683|829537|P2|Precrossover (Periods I/II)|Physician Decision|0
251543|NCT01294683|829538|P1|Precrossover (Periods I/II)|Physician Decision|1
251544|NCT01294683|829537|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
251545|NCT01294683|829538|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
251546|NCT01294683|829537|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
251547|NCT01294683|829538|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
251548|NCT01294683|829537|P2|Precrossover (Periods I/II)|Adverse Event|52
251549|NCT01294683|829538|P1|Precrossover (Periods I/II)|Adverse Event|49
251550|NCT01294644|829591|P3|Overall Study|Miscellaneous Reason|4
251551|NCT01294644|829592|P2|Overall Study|Miscellaneous Reason|1
251552|NCT01294644|829593|P1|Overall Study|Miscellaneous Reason|2
251553|NCT01294644|829591|P3|Overall Study|Lost to Follow-up|5
251554|NCT01294644|829592|P2|Overall Study|Lost to Follow-up|2
251555|NCT01294644|829593|P1|Overall Study|Lost to Follow-up|3
251556|NCT01294644|829591|P3|Overall Study|Withdrawal by Subject|4
251557|NCT01294644|829592|P2|Overall Study|Withdrawal by Subject|7
251558|NCT01294644|829593|P1|Overall Study|Withdrawal by Subject|3
251559|NCT01294644|829591|P3|Overall Study|Adverse Event|1
251560|NCT01294644|829592|P2|Overall Study|Adverse Event|0
251561|NCT01294644|829593|P1|Overall Study|Adverse Event|2
251562|NCT01294592|829624|P2|Overall Study|Withdrawal by Subject|28
251563|NCT01294592|829625|P1|Overall Study|Withdrawal by Subject|28
251564|NCT01294592|829624|P2|Overall Study|Physician Decision|11
251565|NCT01294592|829625|P1|Overall Study|Physician Decision|6
251566|NCT01294592|829624|P2|Overall Study|Lost to Follow-up|9
251567|NCT01294592|829625|P1|Overall Study|Lost to Follow-up|7
251568|NCT01294592|829624|P2|Overall Study|Protocol Violation|7
251569|NCT01294592|829625|P1|Overall Study|Protocol Violation|1
251570|NCT01294592|829624|P2|Overall Study|Lack of Efficacy|5
251571|NCT01294592|829625|P1|Overall Study|Lack of Efficacy|7
251572|NCT01294592|829624|P2|Overall Study|Adverse Event|13
251573|NCT01294592|829625|P1|Overall Study|Adverse Event|28
251574|NCT01294553|829653|P1|Overall Study|Protocol Violation|268
251575|NCT01294553|829653|P1|Overall Study|Duplicated Participants|1
251576|NCT01294514|829659|P1|Overall Study|Excluded due to Arrhythmia|1
251577|NCT01294462|829669|P2|Overall Study|Withdrawal by Subject|63
251578|NCT01294462|829670|P1|Overall Study|Withdrawal by Subject|65
251579|NCT01294462|829669|P2|Overall Study|Lost to Follow-up|0
251580|NCT01294462|829670|P1|Overall Study|Lost to Follow-up|1
251581|NCT01294449|829684|P2|Overall Study|Withdrawal by Subject|3
251582|NCT01294449|829685|P1|Overall Study|Withdrawal by Subject|1
251583|NCT01294449|829684|P2|Overall Study|Death|12
251584|NCT01294449|829685|P1|Overall Study|Death|11
251585|NCT01294436|829693|P2|Overall Study|poor/non-compliance|5
251586|NCT01294436|829694|P1|Overall Study|poor/non-compliance|2
251587|NCT01294436|829693|P2|Overall Study|subject no longer meets study criteria|20
251588|NCT01294436|829694|P1|Overall Study|subject no longer meets study criteria|5
251589|NCT01294436|829693|P2|Overall Study|Withdrawal by Subject|28
251590|NCT01294436|829694|P1|Overall Study|Withdrawal by Subject|11
251591|NCT01294436|829693|P2|Overall Study|Adverse Event|17
251592|NCT01294436|829694|P1|Overall Study|Adverse Event|10
251593|NCT01294423|829729|P3|Overall Study|poor/non-compliance|1
251594|NCT01294423|829730|P2|Overall Study|poor/non-compliance|0
251595|NCT01294423|829731|P1|Overall Study|poor/non-compliance|1
251596|NCT01294423|829729|P3|Overall Study|subject no longer meets study criteria|2
251597|NCT01294423|829730|P2|Overall Study|subject no longer meets study criteria|5
251598|NCT01294423|829731|P1|Overall Study|subject no longer meets study criteria|2
251599|NCT01294423|829729|P3|Overall Study|Withdrawal by Subject|2
251600|NCT01294423|829730|P2|Overall Study|Withdrawal by Subject|2
251601|NCT01294423|829731|P1|Overall Study|Withdrawal by Subject|1
251602|NCT01294423|829729|P3|Overall Study|Adverse Event|3
251603|NCT01294423|829730|P2|Overall Study|Adverse Event|2
251604|NCT01294423|829731|P1|Overall Study|Adverse Event|1
251605|NCT01294371|829779|P1|Overall Study|Other|14
251606|NCT01294371|829779|P1|Overall Study|Administrative Reason|1
251607|NCT01294371|829779|P1|Overall Study|Lost to Follow-up|6
251608|NCT01294371|829779|P1|Overall Study|Withdrawal by Subject|12
251609|NCT01294371|829779|P1|Overall Study|Adverse Event|1
251610|NCT01294150|829824|P2|Overall Study|Physician Decision|2
251611|NCT01294150|829825|P1|Overall Study|Physician Decision|2
251612|NCT01294046|829834|P1|Overall Study|Stimulation response inadqequate|1
251613|NCT01294046|829834|P1|Overall Study|Eligibility criteria expanded|1
251614|NCT01294046|829834|P1|Overall Study|Infection and surgical explant|1
251615|NCT01293968|829849|P2|Overall Study|non-cooperation|3
251616|NCT01293968|829850|P1|Overall Study|non-cooperation|3
251617|NCT01293695|829870|P2|Overall Study|Lost to Follow-up|6
251618|NCT01293695|829871|P1|Overall Study|Lost to Follow-up|8
251619|NCT01293695|829870|P2|Overall Study|Withdrawal by Subject|1
251620|NCT01293695|829871|P1|Overall Study|Withdrawal by Subject|7
251621|NCT01293240|829885|P1|Overall Study|Noncompliance|2
251622|NCT01293084|829900|P1|Overall Study|Withdrawal by Subject|2
251623|NCT01293084|829900|P1|Overall Study|Physician Decision|3
251624|NCT01293032|829912|P4|Treatment|Disease Progression, relapse|0
251625|NCT01293032|829913|P3|Treatment|Disease Progression, relapse|0
251626|NCT01293032|829914|P2|Treatment|Disease Progression, relapse|1
251627|NCT01293032|829915|P1|Treatment|Disease Progression, relapse|0
251628|NCT01293032|829912|P4|Treatment|Withdrawal by Subject|0
251629|NCT01293032|829913|P3|Treatment|Withdrawal by Subject|0
251630|NCT01293032|829914|P2|Treatment|Withdrawal by Subject|4
251631|NCT01293032|829915|P1|Treatment|Withdrawal by Subject|2
251632|NCT01293032|829912|P4|Treatment|Adverse Event|1
251633|NCT01293032|829913|P3|Treatment|Adverse Event|1
251634|NCT01293032|829914|P2|Treatment|Adverse Event|0
251635|NCT01293032|829915|P1|Treatment|Adverse Event|0
251636|NCT01293032|829912|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
251637|NCT01293032|829913|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
251638|NCT01293032|829914|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
251639|NCT01293032|829915|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
251640|NCT01293006|829926|P4|Period 2|Lost to Follow-up|0
251641|NCT01293006|829927|P3|Period 2|Lost to Follow-up|0
251642|NCT01293006|829928|P2|Period 2|Lost to Follow-up|0
251643|NCT01293006|829929|P1|Period 2|Lost to Follow-up|1
251644|NCT01292928|829950|P1|Overall Study|Physician Decision|2
251645|NCT01292928|829950|P1|Overall Study|Lost to Follow-up|6
251646|NCT01292928|829950|P1|Overall Study|Withdrawal by Subject|8
251647|NCT01292928|829950|P1|Overall Study|Death|8
251648|NCT01292837|829967|P1|Overall Study|Further treatment determined|1
251649|NCT01292837|829967|P1|Overall Study|Adverse Event|1
251650|NCT01292603|830004|P6|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
251651|NCT01292603|830005|P5|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
251652|NCT01292603|830006|P4|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
251653|NCT01292603|830007|P3|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
251654|NCT01292603|830008|P2|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
251655|NCT01292603|830009|P1|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
251656|NCT01292603|830004|P6|Part 2: Survival Follow-UP|Death|3
251657|NCT01292603|830005|P5|Part 2: Survival Follow-UP|Death|1
251658|NCT01292603|830006|P4|Part 2: Survival Follow-UP|Death|0
251659|NCT01292603|830007|P3|Part 2: Survival Follow-UP|Death|0
251660|NCT01292603|830008|P2|Part 2: Survival Follow-UP|Death|0
251661|NCT01292603|830009|P1|Part 2: Survival Follow-UP|Death|0
251662|NCT01292603|830004|P6|Part 2: Regular Follow-Up|Noncompliance|0
251663|NCT01292603|830005|P5|Part 2: Regular Follow-Up|Noncompliance|1
251664|NCT01292603|830006|P4|Part 2: Regular Follow-Up|Noncompliance|0
251665|NCT01292603|830007|P3|Part 2: Regular Follow-Up|Noncompliance|0
251666|NCT01292603|830008|P2|Part 2: Regular Follow-Up|Noncompliance|0
251667|NCT01292603|830009|P1|Part 2: Regular Follow-Up|Noncompliance|0
251668|NCT01292603|830004|P6|Part 2: Regular Follow-Up|Disease Progression|4
251669|NCT01292603|830005|P5|Part 2: Regular Follow-Up|Disease Progression|2
251670|NCT01292603|830006|P4|Part 2: Regular Follow-Up|Disease Progression|0
251671|NCT01292603|830007|P3|Part 2: Regular Follow-Up|Disease Progression|0
251672|NCT01292603|830008|P2|Part 2: Regular Follow-Up|Disease Progression|0
251673|NCT01292603|830009|P1|Part 2: Regular Follow-Up|Disease Progression|0
251674|NCT01292603|830004|P6|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|72
251675|NCT01292603|830005|P5|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|73
251676|NCT01292603|830006|P4|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
251677|NCT01292603|830007|P3|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
251678|NCT01292603|830008|P2|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
251679|NCT01292603|830009|P1|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
251680|NCT01292603|830004|P6|Part 2: Regular Follow-Up|Death|2
251681|NCT01292603|830005|P5|Part 2: Regular Follow-Up|Death|2
251682|NCT01292603|830006|P4|Part 2: Regular Follow-Up|Death|0
251683|NCT01292603|830007|P3|Part 2: Regular Follow-Up|Death|0
251684|NCT01292603|830008|P2|Part 2: Regular Follow-Up|Death|0
251685|NCT01292603|830009|P1|Part 2: Regular Follow-Up|Death|0
251686|NCT01292603|830004|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
251687|NCT01292603|830005|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
251688|NCT01292603|830006|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
251689|NCT01292603|830007|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
251690|NCT01292603|830008|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
251691|NCT01292603|830009|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
251692|NCT01292603|830004|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
251693|NCT01292603|830005|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
251694|NCT01292603|830006|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
251695|NCT01292603|830007|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
251696|NCT01292603|830008|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
251697|NCT01292603|830009|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
251698|NCT01292603|830004|P6|Part 2: Dose Confirmation Period|Adverse Event|9
251699|NCT01292603|830005|P5|Part 2: Dose Confirmation Period|Adverse Event|7
251700|NCT01292603|830006|P4|Part 2: Dose Confirmation Period|Adverse Event|0
251701|NCT01292603|830007|P3|Part 2: Dose Confirmation Period|Adverse Event|0
251702|NCT01292603|830008|P2|Part 2: Dose Confirmation Period|Adverse Event|0
251703|NCT01292603|830009|P1|Part 2: Dose Confirmation Period|Adverse Event|0
251704|NCT01292603|830004|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
251705|NCT01292603|830005|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
251706|NCT01292603|830006|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
251707|NCT01292603|830007|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
251708|NCT01292603|830008|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
251709|NCT01292603|830009|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
251710|NCT01292603|830004|P6|Part 2: Dose Confirmation Period|Physician Decision|0
251711|NCT01292603|830005|P5|Part 2: Dose Confirmation Period|Physician Decision|2
251712|NCT01292603|830006|P4|Part 2: Dose Confirmation Period|Physician Decision|0
251713|NCT01292603|830007|P3|Part 2: Dose Confirmation Period|Physician Decision|0
251714|NCT01292603|830008|P2|Part 2: Dose Confirmation Period|Physician Decision|0
251715|NCT01292603|830009|P1|Part 2: Dose Confirmation Period|Physician Decision|0
251716|NCT01292603|830004|P6|Part 2: Dose Confirmation Period|Death|0
251717|NCT01292603|830005|P5|Part 2: Dose Confirmation Period|Death|1
251718|NCT01292603|830006|P4|Part 2: Dose Confirmation Period|Death|0
251719|NCT01292603|830007|P3|Part 2: Dose Confirmation Period|Death|0
251720|NCT01292603|830008|P2|Part 2: Dose Confirmation Period|Death|0
251721|NCT01292603|830009|P1|Part 2: Dose Confirmation Period|Death|0
251722|NCT01292603|830004|P6|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
251723|NCT01292603|830005|P5|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
251724|NCT01292603|830006|P4|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
251725|NCT01292603|830007|P3|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|1
251726|NCT01292603|830008|P2|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|2
251727|NCT01292603|830009|P1|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|3
251728|NCT01292603|830004|P6|Part 1: Survival Follow-Up|Death|0
251729|NCT01292603|830005|P5|Part 1: Survival Follow-Up|Death|0
251730|NCT01292603|830006|P4|Part 1: Survival Follow-Up|Death|0
251731|NCT01292603|830007|P3|Part 1: Survival Follow-Up|Death|1
251732|NCT01292603|830008|P2|Part 1: Survival Follow-Up|Death|0
251733|NCT01292603|830009|P1|Part 1: Survival Follow-Up|Death|1
251734|NCT01292603|830004|P6|Part 1: Regular Follow-Up Period|Adverse Event|0
251735|NCT01292603|830005|P5|Part 1: Regular Follow-Up Period|Adverse Event|0
251736|NCT01292603|830006|P4|Part 1: Regular Follow-Up Period|Adverse Event|0
251737|NCT01292603|830007|P3|Part 1: Regular Follow-Up Period|Adverse Event|0
251738|NCT01292603|830008|P2|Part 1: Regular Follow-Up Period|Adverse Event|0
251739|NCT01292603|830009|P1|Part 1: Regular Follow-Up Period|Adverse Event|1
251740|NCT01292603|830004|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
251741|NCT01292603|830005|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
251742|NCT01292603|830006|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
251743|NCT01292603|830007|P3|Part 1: Regular Follow-Up Period|Disease Progression|2
251744|NCT01292603|830008|P2|Part 1: Regular Follow-Up Period|Disease Progression|2
251745|NCT01292603|830009|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
251746|NCT01292603|830004|P6|Part 1: Regular Follow-Up Period|Death|0
251747|NCT01292603|830005|P5|Part 1: Regular Follow-Up Period|Death|0
251748|NCT01292603|830006|P4|Part 1: Regular Follow-Up Period|Death|0
251749|NCT01292603|830007|P3|Part 1: Regular Follow-Up Period|Death|2
251750|NCT01292603|830008|P2|Part 1: Regular Follow-Up Period|Death|0
251751|NCT01292603|830009|P1|Part 1: Regular Follow-Up Period|Death|1
251752|NCT01292603|830004|P6|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
251753|NCT01292603|830005|P5|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
251754|NCT01292603|830006|P4|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
251755|NCT01292603|830007|P3|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|19
251756|NCT01292603|830008|P2|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|15
251757|NCT01292603|830009|P1|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|11
251758|NCT01292603|830004|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
251759|NCT01292603|830005|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
251760|NCT01292603|830006|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
251761|NCT01292603|830007|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
251762|NCT01292603|830008|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
251763|NCT01292603|830009|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
251764|NCT01292603|830004|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
251765|NCT01292603|830005|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
251766|NCT01292603|830006|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
251767|NCT01292603|830007|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
251768|NCT01292603|830008|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
251769|NCT01292603|830009|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
251770|NCT01292603|830004|P6|Part 1: Pilot Dose Selection Period|Death|0
251771|NCT01292603|830005|P5|Part 1: Pilot Dose Selection Period|Death|0
251772|NCT01292603|830006|P4|Part 1: Pilot Dose Selection Period|Death|1
251773|NCT01292603|830007|P3|Part 1: Pilot Dose Selection Period|Death|0
251774|NCT01292603|830008|P2|Part 1: Pilot Dose Selection Period|Death|0
251775|NCT01292603|830009|P1|Part 1: Pilot Dose Selection Period|Death|0
251776|NCT01292603|830004|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
251777|NCT01292603|830005|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
251778|NCT01292603|830006|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
251779|NCT01292603|830007|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
251780|NCT01292603|830008|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
251781|NCT01292603|830009|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
251782|NCT01292486|830062|P1|Overall Study|Physician Decision|1
251783|NCT01292486|830062|P1|Overall Study|Adverse Event|1
251784|NCT01292486|830062|P1|Overall Study|Did not meet screening criteria|2
251785|NCT01292486|830062|P1|Overall Study|Protocol Violation|2
251786|NCT01292473|830076|P4|Overall Study|Disease Progression|6
251787|NCT01292473|830077|P3|Overall Study|Disease Progression|3
251788|NCT01292473|830078|P2|Overall Study|Disease Progression|1
251789|NCT01292473|830079|P1|Overall Study|Disease Progression|0
251790|NCT01292473|830076|P4|Overall Study|Physician Decision|0
251791|NCT01292473|830077|P3|Overall Study|Physician Decision|0
251792|NCT01292473|830078|P2|Overall Study|Physician Decision|1
251793|NCT01292473|830079|P1|Overall Study|Physician Decision|0
251794|NCT01292473|830076|P4|Overall Study|Withdrawal by Subject|3
251795|NCT01292473|830077|P3|Overall Study|Withdrawal by Subject|3
251796|NCT01292473|830078|P2|Overall Study|Withdrawal by Subject|4
251797|NCT01292473|830079|P1|Overall Study|Withdrawal by Subject|3
251798|NCT01292473|830076|P4|Overall Study|Lost to Follow-up|2
251799|NCT01292473|830077|P3|Overall Study|Lost to Follow-up|2
251800|NCT01292473|830078|P2|Overall Study|Lost to Follow-up|1
251801|NCT01292473|830079|P1|Overall Study|Lost to Follow-up|1
251802|NCT01292473|830076|P4|Overall Study|Adverse Event|1
251803|NCT01292473|830077|P3|Overall Study|Adverse Event|1
251804|NCT01292473|830078|P2|Overall Study|Adverse Event|0
251805|NCT01292473|830079|P1|Overall Study|Adverse Event|1
251806|NCT01292239|830138|P2|Overall Study|Withdrawal by Subject|6
251807|NCT01292239|830139|P1|Overall Study|Withdrawal by Subject|3
251808|NCT01292239|830138|P2|Overall Study|Not specified|1
251809|NCT01292239|830139|P1|Overall Study|Not specified|1
251810|NCT01292226|830160|P1|Overall Study|Not specified|2
251811|NCT01292226|830160|P1|Overall Study|Withdrawal by Subject|1
251812|NCT01292226|830160|P1|Overall Study|Protocol Violation|3
251813|NCT01292226|830160|P1|Overall Study|Graft loss|1
251814|NCT01292226|830160|P1|Overall Study|Death|1
251815|NCT01292226|830160|P1|Overall Study|Adverse Event|5
251816|NCT01292187|830193|P2|Overall Study|All other reasons|3
251817|NCT01292187|830194|P1|Overall Study|All other reasons|1
251818|NCT01292187|830193|P2|Overall Study|Withdrawal by Subject|5
251819|NCT01292187|830194|P1|Overall Study|Withdrawal by Subject|6
251820|NCT01292187|830193|P2|Overall Study|Adverse Event|5
251821|NCT01292187|830194|P1|Overall Study|Adverse Event|10
251822|NCT01291277|830284|P2|Overall Study|Lost to Follow-up|1
251823|NCT01291277|830285|P1|Overall Study|Lost to Follow-up|3
251824|NCT01291277|830284|P2|Overall Study|Death|2
251825|NCT01291277|830285|P1|Overall Study|Death|2
251826|NCT01291225|830297|P2|Overall Study|Lost to Follow-up|39
251827|NCT01291225|830298|P1|Overall Study|Lost to Follow-up|85
251828|NCT01291173|830312|P4|Overall Study|Excluded therapy|0
251829|NCT01291173|830313|P3|Overall Study|Excluded therapy|1
251830|NCT01291173|830314|P2|Overall Study|Excluded therapy|0
251831|NCT01291173|830315|P1|Overall Study|Excluded therapy|0
251832|NCT01291173|830312|P4|Overall Study|Subject was unblinded|0
251833|NCT01291173|830313|P3|Overall Study|Subject was unblinded|1
251834|NCT01291173|830314|P2|Overall Study|Subject was unblinded|0
251835|NCT01291173|830315|P1|Overall Study|Subject was unblinded|0
251836|NCT01291173|830312|P4|Overall Study|Lack of compliance|1
251837|NCT01291173|830313|P3|Overall Study|Lack of compliance|0
251838|NCT01291173|830314|P2|Overall Study|Lack of compliance|0
251839|NCT01291173|830315|P1|Overall Study|Lack of compliance|0
251840|NCT01291173|830312|P4|Overall Study|Unable to meet visit schedule|0
251841|NCT01291173|830313|P3|Overall Study|Unable to meet visit schedule|1
251842|NCT01291173|830314|P2|Overall Study|Unable to meet visit schedule|0
251843|NCT01291173|830315|P1|Overall Study|Unable to meet visit schedule|0
251844|NCT01291173|830312|P4|Overall Study|Lost to Follow-up|2
251845|NCT01291173|830313|P3|Overall Study|Lost to Follow-up|3
251846|NCT01291173|830314|P2|Overall Study|Lost to Follow-up|6
251847|NCT01291173|830315|P1|Overall Study|Lost to Follow-up|4
251848|NCT01291173|830312|P4|Overall Study|Withdrawal by Subject|2
251849|NCT01291173|830313|P3|Overall Study|Withdrawal by Subject|4
251850|NCT01291173|830314|P2|Overall Study|Withdrawal by Subject|4
251851|NCT01291173|830315|P1|Overall Study|Withdrawal by Subject|6
251852|NCT01291173|830312|P4|Overall Study|Protocol Violation|5
251853|NCT01291173|830313|P3|Overall Study|Protocol Violation|2
251854|NCT01291173|830314|P2|Overall Study|Protocol Violation|2
251855|NCT01291173|830315|P1|Overall Study|Protocol Violation|7
251856|NCT01291173|830312|P4|Overall Study|Adverse Event|3
251857|NCT01291173|830313|P3|Overall Study|Adverse Event|1
251858|NCT01291173|830314|P2|Overall Study|Adverse Event|3
251859|NCT01291173|830315|P1|Overall Study|Adverse Event|0
251860|NCT01291017|830424|P1|Overall Study|Withdrawal by Subject|3
251861|NCT01291017|830424|P1|Overall Study|Lost to Follow-up|2
251862|NCT01290887|830457|P2|Overall Study|Not specified|6
251863|NCT01290887|830458|P1|Overall Study|Not specified|3
251864|NCT01290887|830457|P2|Overall Study|Sponsor closure of study|476
251865|NCT01290887|830458|P1|Overall Study|Sponsor closure of study|420
251866|NCT01290887|830457|P2|Overall Study|Non-compliance to study medications|0
251867|NCT01290887|830458|P1|Overall Study|Non-compliance to study medications|1
251868|NCT01290887|830457|P2|Overall Study|Non-compliance to study procedures|1
251869|NCT01290887|830458|P1|Overall Study|Non-compliance to study procedures|0
251870|NCT01290887|830457|P2|Overall Study|Lost to Follow-up|4
251871|NCT01290887|830458|P1|Overall Study|Lost to Follow-up|4
251872|NCT01290887|830457|P2|Overall Study|Protocol Violation|1
251873|NCT01290887|830458|P1|Overall Study|Protocol Violation|2
251874|NCT01290887|830457|P2|Overall Study|Withdrawal by Subject|32
251875|NCT01290887|830458|P1|Overall Study|Withdrawal by Subject|26
251876|NCT01290887|830457|P2|Overall Study|Lack of Efficacy|5
251877|NCT01290887|830458|P1|Overall Study|Lack of Efficacy|4
251878|NCT01290887|830457|P2|Overall Study|Adverse Event|11
251879|NCT01290887|830458|P1|Overall Study|Adverse Event|6
251880|NCT01290822|830496|P1|Overall Study|Physician Decision|10
251881|NCT01290822|830496|P1|Overall Study|Withdrawal by Subject|1
251882|NCT01290796|830505|P1|Overall Study|Withdrawal by Sponsor|1
251883|NCT01290796|830505|P1|Overall Study|Secondary Surgical Intervention|2
251884|NCT01290796|830505|P1|Overall Study|Physician Decision|2
251885|NCT01290796|830505|P1|Overall Study|Withdrawal by Subject|4
251886|NCT01290796|830505|P1|Overall Study|Lost to Follow-up|21
251887|NCT01290757|830521|P2|Overall Study|Other|1
251888|NCT01290757|830522|P1|Overall Study|Other|0
251889|NCT01290757|830521|P2|Overall Study|Protocol Violation|1
251890|NCT01290757|830522|P1|Overall Study|Protocol Violation|1
251891|NCT01290757|830521|P2|Overall Study|Adverse Event|0
251892|NCT01290757|830522|P1|Overall Study|Adverse Event|1
251893|NCT01290731|830538|P1|Overall Study|Withdrawal by Subject|1
251894|NCT01290718|830550|P1|Overall Study|Early termination of the study|4
251895|NCT01290679|830559|P2|Overall Study|Subject Entered Another Trial|5
251896|NCT01290679|830560|P1|Overall Study|Subject Entered Another Trial|0
251897|NCT01290679|830559|P2|Overall Study|Withdrawal by Subject|5
251898|NCT01290679|830560|P1|Overall Study|Withdrawal by Subject|6
251899|NCT01290679|830559|P2|Overall Study|Protocol Violation|1
251900|NCT01290679|830560|P1|Overall Study|Protocol Violation|0
251901|NCT01290679|830559|P2|Overall Study|Lost to Follow-up|10
251902|NCT01290679|830560|P1|Overall Study|Lost to Follow-up|8
251903|NCT01290679|830559|P2|Overall Study|Adverse Event|0
251904|NCT01290679|830560|P1|Overall Study|Adverse Event|2
251905|NCT01290666|830629|P1|Overall Study|Early Termination of Study|4
251906|NCT01290666|830629|P1|Overall Study|Withdrawal by Subject|23
251907|NCT01290666|830629|P1|Overall Study|Lost to Follow-up|11
251908|NCT01290341|830698|P2|Overall Study|Negative baseline culture and others|11
251909|NCT01290341|830699|P1|Overall Study|Negative baseline culture and others|44
251910|NCT01290341|830698|P2|Overall Study|Withdrawal by Subject|5
251911|NCT01290341|830699|P1|Overall Study|Withdrawal by Subject|19
251912|NCT01290341|830698|P2|Overall Study|Lost to Follow-up|10
251913|NCT01290341|830699|P1|Overall Study|Lost to Follow-up|21
251914|NCT01290341|830698|P2|Overall Study|Adverse Event|0
251915|NCT01290341|830699|P1|Overall Study|Adverse Event|1
251916|NCT01290341|830698|P2|Overall Study|Protocol Violation|3
251917|NCT01290341|830699|P1|Overall Study|Protocol Violation|7
251918|NCT01290263|830709|P5|Overall Study|Participant Non-Compliance|1
251919|NCT01290263|830710|P4|Overall Study|Participant Non-Compliance|1
251920|NCT01290263|830711|P3|Overall Study|Participant Non-Compliance|0
251921|NCT01290263|830712|P2|Overall Study|Participant Non-Compliance|0
251922|NCT01290263|830713|P1|Overall Study|Participant Non-Compliance|0
251923|NCT01290263|830709|P5|Overall Study|Withdrawal by Subject|2
251924|NCT01290263|830710|P4|Overall Study|Withdrawal by Subject|1
251925|NCT01290263|830711|P3|Overall Study|Withdrawal by Subject|0
251926|NCT01290263|830712|P2|Overall Study|Withdrawal by Subject|1
251927|NCT01290263|830713|P1|Overall Study|Withdrawal by Subject|3
251928|NCT01290263|830709|P5|Overall Study|Lack of Efficacy|33
251929|NCT01290263|830710|P4|Overall Study|Lack of Efficacy|24
251930|NCT01290263|830711|P3|Overall Study|Lack of Efficacy|7
251931|NCT01290263|830712|P2|Overall Study|Lack of Efficacy|2
251932|NCT01290263|830713|P1|Overall Study|Lack of Efficacy|8
251933|NCT01290263|830709|P5|Overall Study|Adverse Event|1
251934|NCT01290263|830710|P4|Overall Study|Adverse Event|1
251935|NCT01290263|830711|P3|Overall Study|Adverse Event|0
251936|NCT01290263|830712|P2|Overall Study|Adverse Event|0
251937|NCT01290263|830713|P1|Overall Study|Adverse Event|0
251938|NCT01290224|830729|P1|Overall Study|Refused Further Treatment|4
251939|NCT01290224|830729|P1|Overall Study|Adverse Event|1
251940|NCT01290094|830740|P1|Overall Study|Lost to Follow-up|5
251941|NCT01290094|830740|P1|Overall Study|Withdrawal by Subject|1
251942|NCT01290068|830753|P2|Overall Study|Other|1
251943|NCT01290068|830754|P1|Overall Study|Other|3
251944|NCT01290068|830753|P2|Overall Study|Withdrawal by subject prior to implant|2
251945|NCT01290068|830754|P1|Overall Study|Withdrawal by subject prior to implant|0
251946|NCT01290068|830753|P2|Overall Study|Lost to Follow-up|0
251947|NCT01290068|830754|P1|Overall Study|Lost to Follow-up|3
251948|NCT01290068|830753|P2|Overall Study|Adverse Event|3
251949|NCT01290068|830754|P1|Overall Study|Adverse Event|1
251950|NCT01290029|830766|P1|Overall Study|Other|2
251951|NCT01289990|830792|P13|Overall Study|Not treated|0
251952|NCT01289990|830793|P12|Overall Study|Not treated|2
251953|NCT01289990|830794|P11|Overall Study|Not treated|1
251954|NCT01289990|830795|P10|Overall Study|Not treated|0
251955|NCT01289990|830796|P9|Overall Study|Not treated|1
251956|NCT01289990|830797|P8|Overall Study|Not treated|0
251957|NCT01289990|830798|P7|Overall Study|Not treated|1
251958|NCT01289990|830799|P6|Overall Study|Not treated|0
251959|NCT01289990|830800|P5|Overall Study|Not treated|0
251960|NCT01289990|830801|P4|Overall Study|Not treated|0
251961|NCT01289990|830802|P3|Overall Study|Not treated|0
251962|NCT01289990|830803|P2|Overall Study|Not treated|0
251963|NCT01289990|830804|P1|Overall Study|Not treated|0
251964|NCT01289990|830792|P13|Overall Study|did not continue in extension|56
251965|NCT01289990|830793|P12|Overall Study|did not continue in extension|34
251966|NCT01289990|830794|P11|Overall Study|did not continue in extension|45
251967|NCT01289990|830795|P10|Overall Study|did not continue in extension|48
251968|NCT01289990|830796|P9|Overall Study|did not continue in extension|44
251969|NCT01289990|830797|P8|Overall Study|did not continue in extension|36
251970|NCT01289990|830798|P7|Overall Study|did not continue in extension|54
251971|NCT01289990|830799|P6|Overall Study|did not continue in extension|50
251972|NCT01289990|830800|P5|Overall Study|did not continue in extension|48
251973|NCT01289990|830801|P4|Overall Study|did not continue in extension|51
251974|NCT01289990|830802|P3|Overall Study|did not continue in extension|51
251975|NCT01289990|830803|P2|Overall Study|did not continue in extension|45
251976|NCT01289990|830804|P1|Overall Study|did not continue in extension|41
251977|NCT01289990|830792|P13|Overall Study|discontinued in preceding trial|24
251978|NCT01289990|830793|P12|Overall Study|discontinued in preceding trial|17
251979|NCT01289990|830794|P11|Overall Study|discontinued in preceding trial|17
251980|NCT01289990|830795|P10|Overall Study|discontinued in preceding trial|21
251981|NCT01289990|830796|P9|Overall Study|discontinued in preceding trial|17
251982|NCT01289990|830797|P8|Overall Study|discontinued in preceding trial|8
251983|NCT01289990|830798|P7|Overall Study|discontinued in preceding trial|18
251984|NCT01289990|830799|P6|Overall Study|discontinued in preceding trial|12
251985|NCT01289990|830800|P5|Overall Study|discontinued in preceding trial|11
251986|NCT01289990|830801|P4|Overall Study|discontinued in preceding trial|17
251987|NCT01289990|830802|P3|Overall Study|discontinued in preceding trial|41
251988|NCT01289990|830803|P2|Overall Study|discontinued in preceding trial|20
251989|NCT01289990|830804|P1|Overall Study|discontinued in preceding trial|18
251990|NCT01289990|830792|P13|Overall Study|Withdrawal by Subject|16
251991|NCT01289990|830793|P12|Overall Study|Withdrawal by Subject|13
251992|NCT01289990|830794|P11|Overall Study|Withdrawal by Subject|11
251993|NCT01289990|830795|P10|Overall Study|Withdrawal by Subject|13
251994|NCT01289990|830796|P9|Overall Study|Withdrawal by Subject|12
251995|NCT01289990|830797|P8|Overall Study|Withdrawal by Subject|9
251996|NCT01289990|830798|P7|Overall Study|Withdrawal by Subject|13
251997|NCT01289990|830799|P6|Overall Study|Withdrawal by Subject|7
251998|NCT01289990|830800|P5|Overall Study|Withdrawal by Subject|8
251999|NCT01289990|830801|P4|Overall Study|Withdrawal by Subject|13
252000|NCT01289990|830802|P3|Overall Study|Withdrawal by Subject|12
252001|NCT01289990|830803|P2|Overall Study|Withdrawal by Subject|14
252002|NCT01289990|830804|P1|Overall Study|Withdrawal by Subject|15
252003|NCT01289990|830792|P13|Overall Study|Lost to Follow-up|2
252004|NCT01289990|830793|P12|Overall Study|Lost to Follow-up|1
252005|NCT01289990|830794|P11|Overall Study|Lost to Follow-up|2
252006|NCT01289990|830795|P10|Overall Study|Lost to Follow-up|4
252007|NCT01289990|830796|P9|Overall Study|Lost to Follow-up|1
252008|NCT01289990|830797|P8|Overall Study|Lost to Follow-up|2
252009|NCT01289990|830798|P7|Overall Study|Lost to Follow-up|2
252010|NCT01289990|830799|P6|Overall Study|Lost to Follow-up|4
252011|NCT01289990|830800|P5|Overall Study|Lost to Follow-up|3
252012|NCT01289990|830801|P4|Overall Study|Lost to Follow-up|5
252013|NCT01289990|830802|P3|Overall Study|Lost to Follow-up|5
252014|NCT01289990|830803|P2|Overall Study|Lost to Follow-up|2
252015|NCT01289990|830804|P1|Overall Study|Lost to Follow-up|3
252016|NCT01289990|830792|P13|Overall Study|Death|0
252017|NCT01289990|830793|P12|Overall Study|Death|1
252018|NCT01289990|830794|P11|Overall Study|Death|0
252019|NCT01289990|830795|P10|Overall Study|Death|0
252020|NCT01289990|830796|P9|Overall Study|Death|0
252021|NCT01289990|830797|P8|Overall Study|Death|0
252022|NCT01289990|830798|P7|Overall Study|Death|0
252023|NCT01289990|830799|P6|Overall Study|Death|1
252024|NCT01289990|830800|P5|Overall Study|Death|2
252025|NCT01289990|830801|P4|Overall Study|Death|1
252026|NCT01289990|830802|P3|Overall Study|Death|0
252027|NCT01289990|830803|P2|Overall Study|Death|0
252028|NCT01289990|830804|P1|Overall Study|Death|0
252029|NCT01289847|830988|P1|Overall Study|Patient could not comply with visits|1
252030|NCT01289821|830997|P1|Survival Follow-up Period|Clinical endpoint reached|16
252031|NCT01289821|830997|P1|Survival Follow-up Period|Lost to Follow-up|1
252032|NCT01289821|830997|P1|Survival Follow-up Period|Protocol Violation|1
252033|NCT01289821|830997|P1|Safety Follow-up Period|Unspecified reason|1
252034|NCT01289821|830997|P1|Safety Follow-up Period|Protocol Violation|3
252035|NCT01289821|830997|P1|Safety Follow-up Period|Withdrawal by Subject|1
252036|NCT01289821|830997|P1|Treatment Period|Therapeutic procedure required|1
252037|NCT01289821|830997|P1|Treatment Period|Clinical Progression|2
252038|NCT01289821|830997|P1|Treatment Period|Radiological Progression|43
252039|NCT01289821|830997|P1|Treatment Period|Adverse Event|4
252040|NCT01289821|830997|P1|Treatment Period|Physician Decision|3
252041|NCT01289821|830997|P1|Treatment Period|Withdrawal by Subject|1
252042|NCT01289782|831008|P2|Overall Study|Reason not specified|2
252043|NCT01289782|831009|P1|Overall Study|Reason not specified|1
252044|NCT01289782|831008|P2|Overall Study|Sponsor's Decision|0
252045|NCT01289782|831009|P1|Overall Study|Sponsor's Decision|1
252046|NCT01289782|831008|P2|Overall Study|Withdrawal by Subject|2
252047|NCT01289782|831009|P1|Overall Study|Withdrawal by Subject|8
252048|NCT01289782|831008|P2|Overall Study|Protocol Violation|1
252049|NCT01289782|831009|P1|Overall Study|Protocol Violation|1
252050|NCT01289782|831008|P2|Overall Study|Lost to Follow-up|7
252051|NCT01289782|831009|P1|Overall Study|Lost to Follow-up|14
252052|NCT01289639|831081|P3|Overall Study|Lost to Follow-up|0
252053|NCT01289639|831082|P2|Overall Study|Lost to Follow-up|0
252054|NCT01289639|831083|P1|Overall Study|Lost to Follow-up|1
252055|NCT01289574|831109|P3|Overall Study|Subject wanted alternate treatment|0
252056|NCT01289574|831110|P2|Overall Study|Subject wanted alternate treatment|1
252057|NCT01289574|831111|P1|Overall Study|Subject wanted alternate treatment|0
252058|NCT01289574|831109|P3|Overall Study|Adverse Event|0
252059|NCT01289574|831110|P2|Overall Study|Adverse Event|1
252060|NCT01289574|831111|P1|Overall Study|Adverse Event|0
252061|NCT01289574|831109|P3|Overall Study|Withdrawal by Subject|1
252062|NCT01289574|831110|P2|Overall Study|Withdrawal by Subject|1
252063|NCT01289574|831111|P1|Overall Study|Withdrawal by Subject|1
252064|NCT01289574|831109|P3|Overall Study|Lost to Follow-up|1
252065|NCT01289574|831110|P2|Overall Study|Lost to Follow-up|0
252066|NCT01289574|831111|P1|Overall Study|Lost to Follow-up|2
252067|NCT01289574|831109|P3|Overall Study|Lack of Efficacy|1
252068|NCT01289574|831110|P2|Overall Study|Lack of Efficacy|0
252069|NCT01289574|831111|P1|Overall Study|Lack of Efficacy|4
252070|NCT01289418|831183|P1|Day 29 Survey|participants did not complete the survey|2185
252071|NCT01289418|831183|P1|Day 29 Survey|email address invalid|283
252072|NCT01289418|831183|P1|Day 8 Survey|participants did not complete the survey|1935
252073|NCT01289418|831183|P1|Day 8 Survey|email address invalid|283
252074|NCT01289210|831202|P1|Overall Study|Adverse Event|1
252075|NCT01289119|831212|P6|Overall Study|Other|0
252076|NCT01289119|831213|P5|Overall Study|Other|0
252077|NCT01289119|831214|P4|Overall Study|Other|0
252078|NCT01289119|831215|P3|Overall Study|Other|1
252079|NCT01289119|831216|P2|Overall Study|Other|0
252080|NCT01289119|831217|P1|Overall Study|Other|1
252081|NCT01289119|831212|P6|Overall Study|Lack of Efficacy|1
252082|NCT01289119|831213|P5|Overall Study|Lack of Efficacy|1
252083|NCT01289119|831214|P4|Overall Study|Lack of Efficacy|1
252084|NCT01289119|831215|P3|Overall Study|Lack of Efficacy|1
252085|NCT01289119|831216|P2|Overall Study|Lack of Efficacy|1
252086|NCT01289119|831217|P1|Overall Study|Lack of Efficacy|0
252087|NCT01289119|831212|P6|Overall Study|Pregnancy|0
252088|NCT01289119|831213|P5|Overall Study|Pregnancy|0
252089|NCT01289119|831214|P4|Overall Study|Pregnancy|0
252090|NCT01289119|831215|P3|Overall Study|Pregnancy|0
252091|NCT01289119|831216|P2|Overall Study|Pregnancy|1
252092|NCT01289119|831217|P1|Overall Study|Pregnancy|0
252093|NCT01289119|831212|P6|Overall Study|Withdrawal by Subject|1
252094|NCT01289119|831213|P5|Overall Study|Withdrawal by Subject|1
252095|NCT01289119|831214|P4|Overall Study|Withdrawal by Subject|3
252096|NCT01289119|831215|P3|Overall Study|Withdrawal by Subject|4
252097|NCT01289119|831216|P2|Overall Study|Withdrawal by Subject|2
252098|NCT01289119|831217|P1|Overall Study|Withdrawal by Subject|4
252099|NCT01289119|831212|P6|Overall Study|Lost to Follow-up|1
252100|NCT01289119|831213|P5|Overall Study|Lost to Follow-up|0
252101|NCT01289119|831214|P4|Overall Study|Lost to Follow-up|0
252102|NCT01289119|831215|P3|Overall Study|Lost to Follow-up|0
252103|NCT01289119|831216|P2|Overall Study|Lost to Follow-up|3
252104|NCT01289119|831217|P1|Overall Study|Lost to Follow-up|0
252105|NCT01289119|831212|P6|Overall Study|Major Protocol Deviation|1
252106|NCT01289119|831213|P5|Overall Study|Major Protocol Deviation|2
252107|NCT01289119|831214|P4|Overall Study|Major Protocol Deviation|0
252108|NCT01289119|831215|P3|Overall Study|Major Protocol Deviation|3
252109|NCT01289119|831216|P2|Overall Study|Major Protocol Deviation|1
252110|NCT01289119|831217|P1|Overall Study|Major Protocol Deviation|2
252111|NCT01289119|831212|P6|Overall Study|Adverse Event|0
252112|NCT01289119|831213|P5|Overall Study|Adverse Event|1
252113|NCT01289119|831214|P4|Overall Study|Adverse Event|2
252114|NCT01289119|831215|P3|Overall Study|Adverse Event|0
252115|NCT01289119|831216|P2|Overall Study|Adverse Event|1
252116|NCT01289119|831217|P1|Overall Study|Adverse Event|2
252117|NCT01289041|831331|P1|Overall Study|Death|1
252118|NCT01289041|831331|P1|Overall Study|Withdrawal by Subject|3
252119|NCT01289041|831331|P1|Overall Study|Progressive Disease|41
252120|NCT01289041|831331|P1|Overall Study|Physician Decision|1
252121|NCT01289041|831331|P1|Overall Study|Adverse Event|24
252122|NCT01289028|831343|P1|Overall Study|Missing reason for discon|1
252123|NCT01289028|831343|P1|Overall Study|Abnormal Lab Value|1
252124|NCT01289028|831343|P1|Overall Study|New Cancer Therapy|2
252125|NCT01289028|831343|P1|Overall Study|Lost to Follow-up|2
252126|NCT01289028|831343|P1|Overall Study|No longer required|2
252127|NCT01289028|831343|P1|Overall Study|Lack of Efficacy|2
252128|NCT01289028|831343|P1|Overall Study|Death|4
252129|NCT01289028|831343|P1|Overall Study|Withdrawal by Subject|6
252130|NCT01289028|831343|P1|Overall Study|Adverse Event|14
252131|NCT01289028|831343|P1|Overall Study|Progressive Disease|49
252132|NCT01289015|831357|P2|Overall Study|Negative baseline culture and others|20
252133|NCT01289015|831358|P1|Overall Study|Negative baseline culture and others|33
252134|NCT01289015|831357|P2|Overall Study|Disease progression|0
252135|NCT01289015|831358|P1|Overall Study|Disease progression|1
252136|NCT01289015|831357|P2|Overall Study|Withdrawal by Subject|8
252137|NCT01289015|831358|P1|Overall Study|Withdrawal by Subject|17
252138|NCT01289015|831357|P2|Overall Study|Lost to Follow-up|17
252139|NCT01289015|831358|P1|Overall Study|Lost to Follow-up|33
252140|NCT01289015|831357|P2|Overall Study|Adverse Event|0
252141|NCT01289015|831358|P1|Overall Study|Adverse Event|3
252142|NCT01289015|831357|P2|Overall Study|Protocol Violation|9
252143|NCT01289015|831358|P1|Overall Study|Protocol Violation|12
252144|NCT01288911|831368|P2|Overall Study|Randomized but never received study drug|2
252145|NCT01288911|831369|P1|Overall Study|Randomized but never received study drug|1
252146|NCT01288911|831368|P2|Overall Study|Miscellaneous Reason|39
252147|NCT01288911|831369|P1|Overall Study|Miscellaneous Reason|23
252148|NCT01288911|831368|P2|Overall Study|Withdrawal by Subject|21
252149|NCT01288911|831369|P1|Overall Study|Withdrawal by Subject|21
252150|NCT01288911|831368|P2|Overall Study|Protocol Violation|0
252151|NCT01288911|831369|P1|Overall Study|Protocol Violation|1
252152|NCT01288911|831368|P2|Overall Study|Progressive Disease|99
252153|NCT01288911|831369|P1|Overall Study|Progressive Disease|69
252154|NCT01288911|831368|P2|Overall Study|Lost to Follow-up|2
252155|NCT01288911|831369|P1|Overall Study|Lost to Follow-up|0
252156|NCT01288911|831368|P2|Overall Study|Death|7
252157|NCT01288911|831369|P1|Overall Study|Death|10
252158|NCT01288729|831451|P2|Overall Study|Withdrawal by Subject|0
252159|NCT01288729|831452|P1|Overall Study|Withdrawal by Subject|1
252160|NCT01288612|831461|P3|Overall Study|Unable to intubate|0
252161|NCT01288612|831462|P2|Overall Study|Unable to intubate|3
252162|NCT01288612|831463|P1|Overall Study|Unable to intubate|0
252163|NCT01288612|831461|P3|Overall Study|Declined|62
252164|NCT01288612|831462|P2|Overall Study|Declined|63
252165|NCT01288612|831463|P1|Overall Study|Declined|78
252166|NCT01288612|831461|P3|Overall Study|Unable to contact|20
252167|NCT01288612|831462|P2|Overall Study|Unable to contact|16
252168|NCT01288612|831463|P1|Overall Study|Unable to contact|11
252169|NCT01288469|831499|P3|Overall Study|Exclusion criteria finally met|0
252170|NCT01288469|831500|P2|Overall Study|Exclusion criteria finally met|0
252171|NCT01288469|831501|P1|Overall Study|Exclusion criteria finally met|1
252172|NCT01288469|831499|P3|Overall Study|Consent withdrawn by subject|1
252173|NCT01288469|831500|P2|Overall Study|Consent withdrawn by subject|1
252174|NCT01288469|831501|P1|Overall Study|Consent withdrawn by subject|1
252175|NCT01288469|831499|P3|Overall Study|Participant Moved|0
252176|NCT01288469|831500|P2|Overall Study|Participant Moved|0
252177|NCT01288469|831501|P1|Overall Study|Participant Moved|1
252178|NCT01288469|831499|P3|Overall Study|Poor compliance to protocol|0
252179|NCT01288469|831500|P2|Overall Study|Poor compliance to protocol|1
252180|NCT01288469|831501|P1|Overall Study|Poor compliance to protocol|0
252181|NCT01288469|831499|P3|Overall Study|Adverse Event|1
252182|NCT01288469|831500|P2|Overall Study|Adverse Event|1
252183|NCT01288469|831501|P1|Overall Study|Adverse Event|4
252184|NCT01288443|831533|P6|Overall Study|Other than above|0
252185|NCT01288443|831534|P5|Overall Study|Other than above|1
252186|NCT01288443|831535|P4|Overall Study|Other than above|2
252187|NCT01288443|831536|P3|Overall Study|Other than above|0
252188|NCT01288443|831537|P2|Overall Study|Other than above|0
252189|NCT01288443|831538|P1|Overall Study|Other than above|0
252190|NCT01288443|831533|P6|Overall Study|Study drug auto-injector administration|1
252191|NCT01288443|831534|P5|Overall Study|Study drug auto-injector administration|1
252192|NCT01288443|831535|P4|Overall Study|Study drug auto-injector administration|0
252193|NCT01288443|831536|P3|Overall Study|Study drug auto-injector administration|0
252194|NCT01288443|831537|P2|Overall Study|Study drug auto-injector administration|0
252195|NCT01288443|831538|P1|Overall Study|Study drug auto-injector administration|0
252196|NCT01288443|831533|P6|Overall Study|Lost to Follow-up|0
252197|NCT01288443|831534|P5|Overall Study|Lost to Follow-up|0
252198|NCT01288443|831535|P4|Overall Study|Lost to Follow-up|0
252199|NCT01288443|831536|P3|Overall Study|Lost to Follow-up|0
252200|NCT01288443|831537|P2|Overall Study|Lost to Follow-up|1
252201|NCT01288443|831538|P1|Overall Study|Lost to Follow-up|0
252202|NCT01288443|831533|P6|Overall Study|Consent withdrawn by Participant|1
252203|NCT01288443|831534|P5|Overall Study|Consent withdrawn by Participant|0
252204|NCT01288443|831535|P4|Overall Study|Consent withdrawn by Participant|0
252205|NCT01288443|831536|P3|Overall Study|Consent withdrawn by Participant|0
252206|NCT01288443|831537|P2|Overall Study|Consent withdrawn by Participant|0
252207|NCT01288443|831538|P1|Overall Study|Consent withdrawn by Participant|0
252208|NCT01288443|831533|P6|Overall Study|Participant Moved|1
252209|NCT01288443|831534|P5|Overall Study|Participant Moved|2
252210|NCT01288443|831535|P4|Overall Study|Participant Moved|1
252211|NCT01288443|831536|P3|Overall Study|Participant Moved|0
252212|NCT01288443|831537|P2|Overall Study|Participant Moved|0
252213|NCT01288443|831538|P1|Overall Study|Participant Moved|0
252214|NCT01288443|831533|P6|Overall Study|Poor compliance to protocol|1
252215|NCT01288443|831534|P5|Overall Study|Poor compliance to protocol|0
252216|NCT01288443|831535|P4|Overall Study|Poor compliance to protocol|0
252217|NCT01288443|831536|P3|Overall Study|Poor compliance to protocol|0
252218|NCT01288443|831537|P2|Overall Study|Poor compliance to protocol|0
252219|NCT01288443|831538|P1|Overall Study|Poor compliance to protocol|0
252220|NCT01288443|831533|P6|Overall Study|Adverse Event|1
252221|NCT01288443|831534|P5|Overall Study|Adverse Event|3
252222|NCT01288443|831535|P4|Overall Study|Adverse Event|1
252223|NCT01288443|831536|P3|Overall Study|Adverse Event|1
252224|NCT01288443|831537|P2|Overall Study|Adverse Event|0
252225|NCT01288443|831538|P1|Overall Study|Adverse Event|0
252226|NCT01288287|831588|P1|Overall Study|Unknown Status|7
252227|NCT01288287|831588|P1|Overall Study|Unknown Reason|1
252228|NCT01288287|831588|P1|Overall Study|Other Reason|13
252229|NCT01288287|831588|P1|Overall Study|Lack of Efficacy|13
252230|NCT01288287|831588|P1|Overall Study|Withdrawal by Subject|4
252231|NCT01288287|831588|P1|Overall Study|Lost to Follow-up|8
252232|NCT01288209|831603|P2|Overall Study|Not specified|0
252233|NCT01288209|831604|P1|Overall Study|Not specified|1
252234|NCT01288209|831603|P2|Overall Study|Withdrawal by Subject|3
252235|NCT01288209|831604|P1|Overall Study|Withdrawal by Subject|1
252236|NCT01288079|831634|P4|Overall Study|Other or Study Termination|8
252237|NCT01288079|831635|P3|Overall Study|Other or Study Termination|14
252238|NCT01288079|831636|P2|Overall Study|Other or Study Termination|15
252239|NCT01288079|831637|P1|Overall Study|Other or Study Termination|11
252240|NCT01288079|831634|P4|Overall Study|Lost to Follow-up|0
252241|NCT01288079|831635|P3|Overall Study|Lost to Follow-up|1
252242|NCT01288079|831636|P2|Overall Study|Lost to Follow-up|1
252243|NCT01288079|831637|P1|Overall Study|Lost to Follow-up|1
252244|NCT01288079|831634|P4|Overall Study|Study-Specific Withdrawal Criteria|0
252245|NCT01288079|831635|P3|Overall Study|Study-Specific Withdrawal Criteria|0
252246|NCT01288079|831636|P2|Overall Study|Study-Specific Withdrawal Criteria|1
252247|NCT01288079|831637|P1|Overall Study|Study-Specific Withdrawal Criteria|1
252248|NCT01288079|831634|P4|Overall Study|Lack of Efficacy|2
252249|NCT01288079|831635|P3|Overall Study|Lack of Efficacy|0
252250|NCT01288079|831636|P2|Overall Study|Lack of Efficacy|2
252251|NCT01288079|831637|P1|Overall Study|Lack of Efficacy|2
252252|NCT01288079|831634|P4|Overall Study|Condition under Investigation Worsened|1
252253|NCT01288079|831635|P3|Overall Study|Condition under Investigation Worsened|0
252254|NCT01288079|831636|P2|Overall Study|Condition under Investigation Worsened|0
252255|NCT01288079|831637|P1|Overall Study|Condition under Investigation Worsened|0
252256|NCT01288079|831634|P4|Overall Study|Severe Non-Compliance to Protocol|3
252257|NCT01288079|831635|P3|Overall Study|Severe Non-Compliance to Protocol|1
252258|NCT01288079|831636|P2|Overall Study|Severe Non-Compliance to Protocol|3
252259|NCT01288079|831637|P1|Overall Study|Severe Non-Compliance to Protocol|1
252260|NCT01288079|831634|P4|Overall Study|Adverse Event|3
252261|NCT01288079|831635|P3|Overall Study|Adverse Event|2
252262|NCT01288079|831636|P2|Overall Study|Adverse Event|1
252263|NCT01288079|831637|P1|Overall Study|Adverse Event|2
252264|NCT01288079|831634|P4|Overall Study|Withdrawal by Subject|0
252265|NCT01288079|831635|P3|Overall Study|Withdrawal by Subject|1
252266|NCT01288079|831636|P2|Overall Study|Withdrawal by Subject|4
252267|NCT01288079|831637|P1|Overall Study|Withdrawal by Subject|2
252268|NCT01287897|831661|P4|Overall Study|Unspecified|0
252269|NCT01287897|831662|P3|Overall Study|Unspecified|1
252270|NCT01287897|831663|P2|Overall Study|Unspecified|0
252271|NCT01287897|831664|P1|Overall Study|Unspecified|1
252272|NCT01287897|831661|P4|Overall Study|Not meeting entrance criteria|0
252273|NCT01287897|831662|P3|Overall Study|Not meeting entrance criteria|0
252274|NCT01287897|831663|P2|Overall Study|Not meeting entrance criteria|1
252275|NCT01287897|831664|P1|Overall Study|Not meeting entrance criteria|1
252276|NCT01287897|831661|P4|Overall Study|Not consented properly|0
252277|NCT01287897|831662|P3|Overall Study|Not consented properly|0
252278|NCT01287897|831663|P2|Overall Study|Not consented properly|1
252279|NCT01287897|831664|P1|Overall Study|Not consented properly|0
252280|NCT01287897|831661|P4|Overall Study|Withdrawal by Subject|2
252281|NCT01287897|831662|P3|Overall Study|Withdrawal by Subject|3
252282|NCT01287897|831663|P2|Overall Study|Withdrawal by Subject|5
252283|NCT01287897|831664|P1|Overall Study|Withdrawal by Subject|1
252284|NCT01287897|831661|P4|Overall Study|Lost to Follow-up|0
252285|NCT01287897|831662|P3|Overall Study|Lost to Follow-up|2
252286|NCT01287897|831663|P2|Overall Study|Lost to Follow-up|0
252287|NCT01287897|831664|P1|Overall Study|Lost to Follow-up|0
252288|NCT01287897|831661|P4|Overall Study|Protocol Violation|1
252289|NCT01287897|831662|P3|Overall Study|Protocol Violation|0
252290|NCT01287897|831663|P2|Overall Study|Protocol Violation|1
252291|NCT01287897|831664|P1|Overall Study|Protocol Violation|1
252292|NCT01287897|831661|P4|Overall Study|Lack of Efficacy|0
252293|NCT01287897|831662|P3|Overall Study|Lack of Efficacy|0
252294|NCT01287897|831663|P2|Overall Study|Lack of Efficacy|0
252295|NCT01287897|831664|P1|Overall Study|Lack of Efficacy|2
252296|NCT01287897|831661|P4|Overall Study|Adverse Event|4
252297|NCT01287897|831662|P3|Overall Study|Adverse Event|6
252298|NCT01287897|831663|P2|Overall Study|Adverse Event|3
252299|NCT01287897|831664|P1|Overall Study|Adverse Event|5
252300|NCT01287832|831715|P2|Overall Study|Death|1
252301|NCT01287832|831716|P1|Overall Study|Death|0
252302|NCT01287832|831715|P2|Overall Study|Adverse Event|0
252303|NCT01287832|831716|P1|Overall Study|Adverse Event|1
252304|NCT01287754|831724|P2|Overall Study|Protocol Violation|3
252305|NCT01287754|831725|P1|Overall Study|Protocol Violation|0
252306|NCT01287754|831724|P2|Overall Study|Lost to Follow-up|6
252307|NCT01287754|831725|P1|Overall Study|Lost to Follow-up|1
252308|NCT01287754|831724|P2|Overall Study|Death|12
252309|NCT01287754|831725|P1|Overall Study|Death|2
252310|NCT01287611|831737|P2|Overall Study|Exclusion due to expanded Kerr incision|3
252311|NCT01287611|831738|P1|Overall Study|Exclusion due to expanded Kerr incision|4
252312|NCT01287611|831737|P2|Overall Study|Lost to Follow-up|16
252313|NCT01287611|831738|P1|Overall Study|Lost to Follow-up|29
252314|NCT01287416|831748|P2|6 Month Follow-up|Lost to Follow-up|2
252315|NCT01287416|831749|P1|6 Month Follow-up|Lost to Follow-up|3
252316|NCT01287416|831748|P2|Pre-post Training|Lost to Follow-up|1
252317|NCT01287416|831749|P1|Pre-post Training|Lost to Follow-up|5
252318|NCT01287416|831748|P2|Pre-post Training|Withdrawal by Subject|24
252319|NCT01287416|831749|P1|Pre-post Training|Withdrawal by Subject|17
252320|NCT01287403|831785|P1|1st Intervention (1 Day)|Adverse Event|1
252321|NCT01287364|831801|P2|Overall Study|Other Reason|2
252322|NCT01287364|831802|P1|Overall Study|Other Reason|4
252323|NCT01287364|831801|P2|Overall Study|Protocol Violation|5
252324|NCT01287364|831802|P1|Overall Study|Protocol Violation|5
252325|NCT01287364|831801|P2|Overall Study|Adverse Event|3
252326|NCT01287364|831802|P1|Overall Study|Adverse Event|0
252327|NCT01287221|831824|P2|Overall Study|Withdrawal by Subject|1
252328|NCT01287221|831825|P1|Overall Study|Withdrawal by Subject|0
252329|NCT01287221|831824|P2|Overall Study|Adverse Event|3
252330|NCT01287221|831825|P1|Overall Study|Adverse Event|3
252331|NCT01287221|831824|P2|Overall Study|Lack of Perceived Benefit|1
252332|NCT01287221|831825|P1|Overall Study|Lack of Perceived Benefit|1
252333|NCT01287195|831852|P1|Overall Study|Withdrawal by Subject|2
252334|NCT01287117|831867|P4|Overall Study|Disease Progression|5
252335|NCT01287117|831868|P3|Overall Study|Disease Progression|6
252336|NCT01287117|831869|P2|Overall Study|Disease Progression|5
252337|NCT01287117|831870|P1|Overall Study|Disease Progression|10
252338|NCT01287117|831867|P4|Overall Study|Patient/Legal Guardian's Decision|5
252339|NCT01287117|831868|P3|Overall Study|Patient/Legal Guardian's Decision|8
252340|NCT01287117|831869|P2|Overall Study|Patient/Legal Guardian's Decision|6
252341|NCT01287117|831870|P1|Overall Study|Patient/Legal Guardian's Decision|2
252342|NCT01287117|831867|P4|Overall Study|Physician Decision|1
252343|NCT01287117|831868|P3|Overall Study|Physician Decision|1
252344|NCT01287117|831869|P2|Overall Study|Physician Decision|1
252345|NCT01287117|831870|P1|Overall Study|Physician Decision|0
252346|NCT01287117|831867|P4|Overall Study|Lost to Follow-up|0
252347|NCT01287117|831868|P3|Overall Study|Lost to Follow-up|0
252348|NCT01287117|831869|P2|Overall Study|Lost to Follow-up|1
252349|NCT01287117|831870|P1|Overall Study|Lost to Follow-up|1
252350|NCT01287117|831867|P4|Overall Study|Adverse Event|1
252351|NCT01287117|831868|P3|Overall Study|Adverse Event|1
252352|NCT01287117|831869|P2|Overall Study|Adverse Event|1
252353|NCT01287117|831870|P1|Overall Study|Adverse Event|2
252354|NCT01287065|831916|P6|Treatment Period 1|Withdrawal by Subject|1
252355|NCT01287065|831917|P5|Treatment Period 1|Withdrawal by Subject|0
252356|NCT01287065|831918|P4|Treatment Period 1|Withdrawal by Subject|0
252357|NCT01287065|831919|P3|Treatment Period 1|Withdrawal by Subject|0
252358|NCT01287065|831920|P2|Treatment Period 1|Withdrawal by Subject|0
252359|NCT01287065|831921|P1|Treatment Period 1|Withdrawal by Subject|0
252360|NCT01287065|831916|P6|Treatment Period 1|Adverse Event|0
252361|NCT01287065|831917|P5|Treatment Period 1|Adverse Event|1
252362|NCT01287065|831918|P4|Treatment Period 1|Adverse Event|0
252363|NCT01287065|831919|P3|Treatment Period 1|Adverse Event|0
252364|NCT01287065|831920|P2|Treatment Period 1|Adverse Event|0
252365|NCT01287065|831921|P1|Treatment Period 1|Adverse Event|0
252366|NCT01287039|831940|P2|Overall Study|Lost to Follow-up|2
252367|NCT01287039|831941|P1|Overall Study|Lost to Follow-up|3
252368|NCT01287039|831940|P2|Overall Study|Withdrawal by Subject|11
252369|NCT01287039|831941|P1|Overall Study|Withdrawal by Subject|14
252370|NCT01287039|831940|P2|Overall Study|Adverse Event|4
252371|NCT01287039|831941|P1|Overall Study|Adverse Event|7
252372|NCT01287039|831940|P2|Overall Study|Change of residence|0
252373|NCT01287039|831941|P1|Overall Study|Change of residence|1
252374|NCT01287039|831940|P2|Overall Study|Death|0
252375|NCT01287039|831941|P1|Overall Study|Death|1
252376|NCT01287039|831940|P2|Overall Study|Problem with travel|1
252377|NCT01287039|831941|P1|Overall Study|Problem with travel|0
252378|NCT01287039|831940|P2|Overall Study|Noncompliance with study medication|1
252379|NCT01287039|831941|P1|Overall Study|Noncompliance with study medication|0
252380|NCT01287039|831940|P2|Overall Study|Excluded medication taken|0
252381|NCT01287039|831941|P1|Overall Study|Excluded medication taken|1
252382|NCT01287039|831940|P2|Overall Study|Protocol Violation|3
252383|NCT01287039|831941|P1|Overall Study|Protocol Violation|2
252384|NCT01287039|831940|P2|Overall Study|Elective surgery|1
252385|NCT01287039|831941|P1|Overall Study|Elective surgery|0
252386|NCT01287039|831940|P2|Overall Study|Change of location/residence|3
252387|NCT01287039|831941|P1|Overall Study|Change of location/residence|0
252388|NCT01287039|831940|P2|Overall Study|Noncompliance with study procedures|1
252389|NCT01287039|831941|P1|Overall Study|Noncompliance with study procedures|0
252390|NCT01286753|832008|P2|Overall Study|Participant to Receive Radiotherapy|0
252391|NCT01286753|832009|P1|Overall Study|Participant to Receive Radiotherapy|1
252392|NCT01286753|832008|P2|Overall Study|Discontinued to Join Extension Study|4
252393|NCT01286753|832009|P1|Overall Study|Discontinued to Join Extension Study|6
252394|NCT01286753|832008|P2|Overall Study|Withdrawal of Consent|2
252395|NCT01286753|832009|P1|Overall Study|Withdrawal of Consent|0
252396|NCT01286753|832008|P2|Overall Study|Refused Treatment|0
252397|NCT01286753|832009|P1|Overall Study|Refused Treatment|1
252398|NCT01286753|832008|P2|Overall Study|Progression|13
252399|NCT01286753|832009|P1|Overall Study|Progression|11
252400|NCT01286753|832008|P2|Overall Study|Adverse Event|6
252401|NCT01286753|832009|P1|Overall Study|Adverse Event|7
252402|NCT01286740|832027|P1|Overall Study|Protocol Violation|1
252403|NCT01286740|832027|P1|Overall Study|Enrolled but not treated|1
252404|NCT01286558|832045|P2|Overall Study|Withdrawal by Subject|1
252405|NCT01286558|832046|P1|Overall Study|Withdrawal by Subject|0
252406|NCT01286558|832045|P2|Overall Study|Adverse Event|1
252407|NCT01286558|832046|P1|Overall Study|Adverse Event|1
252408|NCT01286311|832148|P2|Overall Study|Physician did not want outreach sent|0
252409|NCT01286311|832149|P1|Overall Study|Physician did not want outreach sent|14
252410|NCT01286207|832166|P3|Overall Study|Unspecified|13
252411|NCT01286207|832167|P2|Overall Study|Unspecified|47
252412|NCT01286207|832168|P1|Overall Study|Unspecified|37
252413|NCT01286207|832166|P3|Overall Study|Lack of Response|8
252414|NCT01286207|832167|P2|Overall Study|Lack of Response|38
252415|NCT01286207|832168|P1|Overall Study|Lack of Response|92
252416|NCT01286207|832166|P3|Overall Study|Withdrawal by Subject|41
252417|NCT01286207|832167|P2|Overall Study|Withdrawal by Subject|79
252418|NCT01286207|832168|P1|Overall Study|Withdrawal by Subject|93
252419|NCT01286207|832166|P3|Overall Study|Lost to Follow-up|20
252420|NCT01286207|832167|P2|Overall Study|Lost to Follow-up|43
252421|NCT01286207|832168|P1|Overall Study|Lost to Follow-up|49
252422|NCT01286207|832166|P3|Overall Study|Adverse Event|8
252423|NCT01286207|832167|P2|Overall Study|Adverse Event|41
252424|NCT01286207|832168|P1|Overall Study|Adverse Event|27
252425|NCT01286168|832188|P1|Overall Study|Surgical Drains Fell Out at Home|2
252426|NCT01286168|832188|P1|Overall Study|Withdrawal by Subject|1
252427|NCT01286129|832202|P2|Overall Study|Could not comply with study requirements|4
252428|NCT01286129|832203|P1|Overall Study|Could not comply with study requirements|4
252429|NCT01286129|832202|P2|Overall Study|Withdrawal by Subject|1
252430|NCT01286129|832203|P1|Overall Study|Withdrawal by Subject|4
252431|NCT01286077|832213|P2|Overall Study|refill medication not received in time|0
252432|NCT01286077|832214|P1|Overall Study|refill medication not received in time|1
252433|NCT01286077|832213|P2|Overall Study|Progression of disease|1
252434|NCT01286077|832214|P1|Overall Study|Progression of disease|0
252435|NCT01286077|832213|P2|Overall Study|Patient's decision to stop treatment|0
252436|NCT01286077|832214|P1|Overall Study|Patient's decision to stop treatment|3
252437|NCT01286077|832213|P2|Overall Study|The subject starts with alternative MMY|3
252438|NCT01286077|832214|P1|Overall Study|The subject starts with alternative MMY|0
252439|NCT01286077|832213|P2|Overall Study|Non-compliance|0
252440|NCT01286077|832214|P1|Overall Study|Non-compliance|1
252441|NCT01286077|832213|P2|Overall Study|Intercurrent illness|0
252442|NCT01286077|832214|P1|Overall Study|Intercurrent illness|1
252443|NCT01286077|832213|P2|Overall Study|Withdrawal by Subject|2
252444|NCT01286077|832214|P1|Overall Study|Withdrawal by Subject|0
252445|NCT01286077|832213|P2|Overall Study|Protocol Violation|1
252446|NCT01286077|832214|P1|Overall Study|Protocol Violation|1
252447|NCT01286077|832213|P2|Overall Study|Death|0
252448|NCT01286077|832214|P1|Overall Study|Death|1
252449|NCT01286077|832213|P2|Overall Study|Adverse Event|0
252450|NCT01286077|832214|P1|Overall Study|Adverse Event|2
252451|NCT01286012|832250|P2|Overall Study|peritoneal dialysis, randomized in error|3
252452|NCT01286012|832251|P1|Overall Study|peritoneal dialysis, randomized in error|1
252453|NCT01286012|832250|P2|Overall Study|Physician Decision|0
252454|NCT01286012|832251|P1|Overall Study|Physician Decision|2
252455|NCT01286012|832250|P2|Overall Study|Withdrawal by Subject|4
252456|NCT01286012|832251|P1|Overall Study|Withdrawal by Subject|4
252457|NCT01286012|832250|P2|Overall Study|Protocol Violation|1
252458|NCT01286012|832251|P1|Overall Study|Protocol Violation|1
252459|NCT01286012|832250|P2|Overall Study|Death|3
252460|NCT01286012|832251|P1|Overall Study|Death|2
252461|NCT01286012|832250|P2|Overall Study|Adverse Event|3
252462|NCT01286012|832251|P1|Overall Study|Adverse Event|3
252463|NCT01285908|832268|P3|Baseline Measurement|unable to tolerate procedure|0
252464|NCT01285908|832269|P2|Baseline Measurement|unable to tolerate procedure|0
252465|NCT01285908|832270|P1|Baseline Measurement|unable to tolerate procedure|1
252466|NCT01285908|832268|P3|Baseline Measurement|History of stroke, exclusion criteria|0
252467|NCT01285908|832269|P2|Baseline Measurement|History of stroke, exclusion criteria|0
252468|NCT01285908|832270|P1|Baseline Measurement|History of stroke, exclusion criteria|1
252469|NCT01285908|832268|P3|Baseline Measurement|unable to insert catheter|0
252470|NCT01285908|832269|P2|Baseline Measurement|unable to insert catheter|0
252471|NCT01285908|832270|P1|Baseline Measurement|unable to insert catheter|1
252472|NCT01285609|832364|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
252473|NCT01285609|832365|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
252474|NCT01285609|832364|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
252475|NCT01285609|832365|P1|Treated With Blinded Therapy|Poor/Non-Compliance|0
252476|NCT01285609|832364|P2|Treated With Blinded Therapy|Not Reported|4
252477|NCT01285609|832365|P1|Treated With Blinded Therapy|Not Reported|4
252478|NCT01285609|832364|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
252479|NCT01285609|832365|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
252480|NCT01285609|832364|P2|Treated With Blinded Therapy|Death|3
252481|NCT01285609|832365|P1|Treated With Blinded Therapy|Death|11
252482|NCT01285609|832364|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
252483|NCT01285609|832365|P1|Treated With Blinded Therapy|Withdrawal by Subject|18
252484|NCT01285609|832364|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
252485|NCT01285609|832365|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
252486|NCT01285609|832364|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
252487|NCT01285609|832365|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
252488|NCT01285609|832364|P2|Treated With Blinded Therapy|Progressive Disease|305
252489|NCT01285609|832365|P1|Treated With Blinded Therapy|Progressive Disease|220
252490|NCT01285609|832364|P2|Randomized|Randomized but not Treated|4
252491|NCT01285609|832365|P1|Randomized|Randomized but not Treated|4
252492|NCT01285609|832364|P2|Randomized|Undisclosed Reasons|0
252493|NCT01285609|832365|P1|Randomized|Undisclosed Reasons|1
252494|NCT01285609|832364|P2|Randomized|Subject No Longer Met Study Criteria|1
252495|NCT01285609|832365|P1|Randomized|Subject No Longer Met Study Criteria|1
252496|NCT01285609|832364|P2|Randomized|Withdrawal by Subject|11
252497|NCT01285609|832365|P1|Randomized|Withdrawal by Subject|8
252498|NCT01285609|832364|P2|Randomized|Death|7
252499|NCT01285609|832365|P1|Randomized|Death|5
252500|NCT01285609|832364|P2|Randomized|Study Drug Toxicity|14
252501|NCT01285609|832365|P1|Randomized|Study Drug Toxicity|13
252502|NCT01285609|832364|P2|Randomized|Adverse Event Unrelated to Study Drug|18
252503|NCT01285609|832365|P1|Randomized|Adverse Event Unrelated to Study Drug|18
252504|NCT01285609|832364|P2|Randomized|Progressive Disease|61
252505|NCT01285609|832365|P1|Randomized|Progressive Disease|41
252506|NCT01285518|832383|P8|Overall Study|Lost to Follow-up|0
252507|NCT01285518|832384|P7|Overall Study|Lost to Follow-up|0
252508|NCT01285518|832385|P6|Overall Study|Lost to Follow-up|1
252509|NCT01285518|832386|P5|Overall Study|Lost to Follow-up|0
252510|NCT01285518|832387|P4|Overall Study|Lost to Follow-up|0
252511|NCT01285518|832388|P3|Overall Study|Lost to Follow-up|0
252512|NCT01285518|832389|P2|Overall Study|Lost to Follow-up|0
252513|NCT01285518|832390|P1|Overall Study|Lost to Follow-up|0
252514|NCT01285492|832650|P2|Overall Study|Death|0
252515|NCT01285492|832651|P1|Overall Study|Death|1
252516|NCT01285492|832650|P2|Overall Study|Withdrawal by Subject|1
252517|NCT01285492|832651|P1|Overall Study|Withdrawal by Subject|2
252518|NCT01285492|832650|P2|Overall Study|Protocol Violation|0
252519|NCT01285492|832651|P1|Overall Study|Protocol Violation|3
252520|NCT01285492|832650|P2|Overall Study|Adverse Event|0
252521|NCT01285492|832651|P1|Overall Study|Adverse Event|11
252522|NCT01285401|832683|P2|Overall Study|Prematurely withdrawn from the study|29
252523|NCT01285401|832684|P1|Overall Study|Prematurely withdrawn from the study|17
252524|NCT01285323|832724|P2|Overall Study|Not specified|3
252525|NCT01285323|832725|P1|Overall Study|Not specified|1
252526|NCT01285323|832724|P2|Overall Study|Lost to Follow-up|1
252527|NCT01285323|832725|P1|Overall Study|Lost to Follow-up|1
252528|NCT01285323|832724|P2|Overall Study|Non-compliance with study procedures|3
252529|NCT01285323|832725|P1|Overall Study|Non-compliance with study procedures|2
252530|NCT01285323|832724|P2|Overall Study|Protocol Violation|2
252531|NCT01285323|832725|P1|Overall Study|Protocol Violation|1
252532|NCT01285323|832724|P2|Overall Study|Withdrawal by Subject|11
252533|NCT01285323|832725|P1|Overall Study|Withdrawal by Subject|15
252534|NCT01285323|832724|P2|Overall Study|Lack of Efficacy|2
252535|NCT01285323|832725|P1|Overall Study|Lack of Efficacy|4
252536|NCT01285323|832724|P2|Overall Study|Adverse Event|8
252537|NCT01285323|832725|P1|Overall Study|Adverse Event|9
252538|NCT01285310|832760|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
252539|NCT01285310|832761|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
252540|NCT01285310|832762|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
252541|NCT01285310|832763|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
252542|NCT01285310|832764|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
252543|NCT01285310|832760|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
252544|NCT01285310|832761|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
252545|NCT01285310|832762|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
252546|NCT01285310|832763|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
252547|NCT01285310|832764|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
252548|NCT01285310|832760|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
252549|NCT01285310|832761|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
252550|NCT01285310|832762|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
252551|NCT01285310|832763|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
252552|NCT01285310|832764|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
252553|NCT01285310|832760|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
252554|NCT01285310|832761|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
252555|NCT01285310|832762|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
252556|NCT01285310|832763|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
252557|NCT01285310|832764|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
252558|NCT01285310|832760|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
252559|NCT01285310|832761|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
252560|NCT01285310|832762|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
252561|NCT01285310|832763|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
252562|NCT01285310|832764|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
252563|NCT01285310|832760|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
252564|NCT01285310|832761|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
252565|NCT01285310|832762|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
252566|NCT01285310|832763|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
252567|NCT01285310|832764|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
252568|NCT01285310|832760|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
252569|NCT01285310|832761|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
252570|NCT01285310|832762|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
252571|NCT01285310|832763|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
252572|NCT01285310|832764|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
252573|NCT01285310|832760|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
252574|NCT01285310|832761|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
252575|NCT01285310|832762|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
252576|NCT01285310|832763|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
252577|NCT01285310|832764|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
252578|NCT01285310|832760|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
252579|NCT01285310|832761|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
252580|NCT01285310|832762|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
252581|NCT01285310|832763|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
252582|NCT01285310|832764|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
252583|NCT01285310|832760|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
252584|NCT01285310|832761|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
252585|NCT01285310|832762|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
252586|NCT01285310|832763|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
252587|NCT01285310|832764|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
252588|NCT01285310|832760|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
252589|NCT01285310|832761|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
252590|NCT01285310|832762|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
252591|NCT01285310|832763|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
252592|NCT01285310|832764|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
252593|NCT01285310|832760|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
252594|NCT01285310|832761|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
252595|NCT01285310|832762|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
252596|NCT01285310|832763|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
252597|NCT01285310|832764|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
252598|NCT01284959|833029|P3|Overall Study|Adverse Event|1
252599|NCT01284959|833030|P2|Overall Study|Adverse Event|0
252600|NCT01284959|833031|P1|Overall Study|Adverse Event|0
252601|NCT01284959|833029|P3|Overall Study|Withdrawal by Subject|0
252602|NCT01284959|833030|P2|Overall Study|Withdrawal by Subject|0
252603|NCT01284959|833031|P1|Overall Study|Withdrawal by Subject|1
252604|NCT01284634|833061|P4|Overall Study|Adverse Event|1
252605|NCT01284634|833062|P3|Overall Study|Adverse Event|2
252606|NCT01284634|833063|P2|Overall Study|Adverse Event|0
252607|NCT01284634|833064|P1|Overall Study|Adverse Event|1
252608|NCT01284621|833206|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
252609|NCT01284621|833207|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
252610|NCT01284621|833208|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
252611|NCT01284621|833209|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
252612|NCT01284621|833210|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
252613|NCT01284621|833211|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
252614|NCT01284504|833268|P2|Overall Study|Withdrawal by Subject|0
252615|NCT01284504|833269|P1|Overall Study|Withdrawal by Subject|1
252616|NCT01284491|833275|P1|Overall Study|Study termination|13
252617|NCT01284361|833285|P1|Overall Study|Lost to Follow-up|2
252618|NCT01284361|833285|P1|Overall Study|Adverse Event|1
252619|NCT01284361|833285|P1|Overall Study|Protocol Violation|5
252620|NCT01284361|833285|P1|Overall Study|Withdrawal by Subject|1
252621|NCT01284114|833306|P1|Overall Study|dizziness|1
252622|NCT01284114|833306|P1|Overall Study|Symptomatic hypotension|1
252623|NCT01284114|833306|P1|Overall Study|From the results of ALLTITUDE study|1
252624|NCT01284114|833306|P1|Overall Study|viral infection|1
252625|NCT01284062|833318|P4|Overall Study|Site Closed|0
252626|NCT01284062|833319|P3|Overall Study|Site Closed|1
252627|NCT01284062|833320|P2|Overall Study|Site Closed|0
252628|NCT01284062|833321|P1|Overall Study|Site Closed|0
252629|NCT01284062|833318|P4|Overall Study|Unspecified|1
252630|NCT01284062|833319|P3|Overall Study|Unspecified|0
252631|NCT01284062|833320|P2|Overall Study|Unspecified|0
252632|NCT01284062|833321|P1|Overall Study|Unspecified|0
252633|NCT01284062|833318|P4|Overall Study|Withdrawal by Subject|5
252634|NCT01284062|833319|P3|Overall Study|Withdrawal by Subject|2
252635|NCT01284062|833320|P2|Overall Study|Withdrawal by Subject|1
252636|NCT01284062|833321|P1|Overall Study|Withdrawal by Subject|3
252637|NCT01284062|833318|P4|Overall Study|Protocol Violation|2
252638|NCT01284062|833319|P3|Overall Study|Protocol Violation|0
252639|NCT01284062|833320|P2|Overall Study|Protocol Violation|0
252640|NCT01284062|833321|P1|Overall Study|Protocol Violation|1
252641|NCT01284062|833318|P4|Overall Study|Medication error without adverse event|0
252642|NCT01284062|833319|P3|Overall Study|Medication error without adverse event|1
252643|NCT01284062|833320|P2|Overall Study|Medication error without adverse event|0
252644|NCT01284062|833321|P1|Overall Study|Medication error without adverse event|0
252645|NCT01284062|833318|P4|Overall Study|Lack of Efficacy|1
252646|NCT01284062|833319|P3|Overall Study|Lack of Efficacy|2
252647|NCT01284062|833320|P2|Overall Study|Lack of Efficacy|2
252648|NCT01284062|833321|P1|Overall Study|Lack of Efficacy|3
252649|NCT01284062|833318|P4|Overall Study|Adverse Event|5
252650|NCT01284062|833319|P3|Overall Study|Adverse Event|0
252651|NCT01284062|833320|P2|Overall Study|Adverse Event|5
252652|NCT01284062|833321|P1|Overall Study|Adverse Event|4
252653|NCT01283971|833395|P2|Overall Study|Administrative reasons|1
252654|NCT01283971|833396|P1|Overall Study|Administrative reasons|1
252655|NCT01283971|833395|P2|Overall Study|Failure to return|1
252656|NCT01283971|833396|P1|Overall Study|Failure to return|0
252657|NCT01283971|833395|P2|Overall Study|Refused treatment|1
252658|NCT01283971|833396|P1|Overall Study|Refused treatment|3
252659|NCT01283971|833395|P2|Overall Study|Protocol Violation|1
252660|NCT01283971|833396|P1|Overall Study|Protocol Violation|5
252661|NCT01283971|833395|P2|Overall Study|Insufficient therapeutic responses|3
252662|NCT01283971|833396|P1|Overall Study|Insufficient therapeutic responses|3
252663|NCT01283971|833395|P2|Overall Study|Adverse Event|5
252664|NCT01283971|833396|P1|Overall Study|Adverse Event|3
252665|NCT01282866|833440|P1|Overall Study|Adverse Event|1
252666|NCT01283581|833449|P3|Overall Study|"Early termination"|1
252667|NCT01283581|833450|P2|Overall Study|"Early termination"|0
252668|NCT01283581|833451|P1|Overall Study|"Early termination"|0
252669|NCT01283581|833449|P3|Overall Study|Investigator unblinded|1
252670|NCT01283581|833450|P2|Overall Study|Investigator unblinded|0
252671|NCT01283581|833451|P1|Overall Study|Investigator unblinded|0
252672|NCT01283581|833449|P3|Overall Study|Noncompliance|0
252673|NCT01283581|833450|P2|Overall Study|Noncompliance|0
252674|NCT01283581|833451|P1|Overall Study|Noncompliance|1
252675|NCT01283581|833449|P3|Overall Study|Protocol Violation|2
252676|NCT01283581|833450|P2|Overall Study|Protocol Violation|1
252677|NCT01283581|833451|P1|Overall Study|Protocol Violation|0
252678|NCT01283581|833449|P3|Overall Study|Physician Decision|2
252679|NCT01283581|833450|P2|Overall Study|Physician Decision|1
252680|NCT01283581|833451|P1|Overall Study|Physician Decision|0
252681|NCT01283581|833449|P3|Overall Study|Adverse Event|4
252682|NCT01283581|833450|P2|Overall Study|Adverse Event|1
252683|NCT01283581|833451|P1|Overall Study|Adverse Event|1
252684|NCT01283581|833449|P3|Overall Study|Withdrawal by Subject|2
252685|NCT01283581|833450|P2|Overall Study|Withdrawal by Subject|5
252686|NCT01283581|833451|P1|Overall Study|Withdrawal by Subject|2
252687|NCT01283581|833449|P3|Overall Study|Lost to Follow-up|8
252688|NCT01283581|833450|P2|Overall Study|Lost to Follow-up|6
252689|NCT01283581|833451|P1|Overall Study|Lost to Follow-up|8
252690|NCT01283516|833515|P9|Overall Study|Withdrawal by Subject|11
252691|NCT01283516|833516|P8|Overall Study|Withdrawal by Subject|0
252692|NCT01283516|833517|P7|Overall Study|Withdrawal by Subject|0
252693|NCT01283516|833518|P6|Overall Study|Withdrawal by Subject|0
252694|NCT01283516|833519|P5|Overall Study|Withdrawal by Subject|1
252695|NCT01283516|833520|P4|Overall Study|Withdrawal by Subject|0
252696|NCT01283516|833521|P3|Overall Study|Withdrawal by Subject|0
252697|NCT01283516|833522|P2|Overall Study|Withdrawal by Subject|0
252698|NCT01283516|833523|P1|Overall Study|Withdrawal by Subject|0
252699|NCT01283516|833515|P9|Overall Study|Disease Progression|81
252700|NCT01283516|833516|P8|Overall Study|Disease Progression|2
252701|NCT01283516|833517|P7|Overall Study|Disease Progression|6
252702|NCT01283516|833518|P6|Overall Study|Disease Progression|7
252703|NCT01283516|833519|P5|Overall Study|Disease Progression|12
252704|NCT01283516|833520|P4|Overall Study|Disease Progression|3
252705|NCT01283516|833521|P3|Overall Study|Disease Progression|2
252706|NCT01283516|833522|P2|Overall Study|Disease Progression|2
252707|NCT01283516|833523|P1|Overall Study|Disease Progression|2
252708|NCT01283516|833515|P9|Overall Study|Death|6
252709|NCT01283516|833516|P8|Overall Study|Death|1
252710|NCT01283516|833517|P7|Overall Study|Death|0
252711|NCT01283516|833518|P6|Overall Study|Death|1
252712|NCT01283516|833519|P5|Overall Study|Death|0
252713|NCT01283516|833520|P4|Overall Study|Death|0
252714|NCT01283516|833521|P3|Overall Study|Death|0
252715|NCT01283516|833522|P2|Overall Study|Death|0
252716|NCT01283516|833523|P1|Overall Study|Death|0
252717|NCT01283516|833515|P9|Overall Study|Adverse Event|24
252718|NCT01283516|833516|P8|Overall Study|Adverse Event|0
252719|NCT01283516|833517|P7|Overall Study|Adverse Event|2
252720|NCT01283516|833518|P6|Overall Study|Adverse Event|0
252721|NCT01283516|833519|P5|Overall Study|Adverse Event|0
252722|NCT01283516|833520|P4|Overall Study|Adverse Event|0
252723|NCT01283516|833521|P3|Overall Study|Adverse Event|0
252724|NCT01283516|833522|P2|Overall Study|Adverse Event|0
252725|NCT01283516|833523|P1|Overall Study|Adverse Event|0
252726|NCT01283464|833547|P2|Overall Study|Physician Decision|0
252727|NCT01283464|833548|P1|Overall Study|Physician Decision|1
252728|NCT01283464|833547|P2|Overall Study|Withdrawal by Subject|0
252729|NCT01283464|833548|P1|Overall Study|Withdrawal by Subject|1
252730|NCT01283464|833547|P2|Overall Study|Lost to Follow-up|1
252731|NCT01283464|833548|P1|Overall Study|Lost to Follow-up|0
252732|NCT01283334|833554|P1|Overall Study|Physician Decision|1
252733|NCT01283334|833554|P1|Overall Study|Adverse Event|4
252734|NCT01283334|833554|P1|Overall Study|Inability to Swallow Everolimus Pills|1
252735|NCT01283334|833554|P1|Overall Study|Withdrawal by Subject|1
252736|NCT01283282|833569|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
252737|NCT01283282|833570|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
252738|NCT01283282|833569|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
252739|NCT01283282|833570|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
252740|NCT01283282|833569|P2|First Intervention (6 Weeks)|Physician Decision|1
252741|NCT01283282|833570|P1|First Intervention (6 Weeks)|Physician Decision|0
252742|NCT01283152|833590|P2|Overall Study|Refused HESA|0
252743|NCT01283152|833591|P1|Overall Study|Refused HESA|1
252744|NCT01283152|833590|P2|Overall Study|Discharged prior to 24 hr assessment|0
252745|NCT01283152|833591|P1|Overall Study|Discharged prior to 24 hr assessment|1
252746|NCT01283139|833605|P4|Overall Study|Participant randomized in error|0
252747|NCT01283139|833606|P3|Overall Study|Participant randomized in error|1
252748|NCT01283139|833607|P2|Overall Study|Participant randomized in error|0
252749|NCT01283139|833608|P1|Overall Study|Participant randomized in error|0
252750|NCT01283139|833605|P4|Overall Study|Missed follow-up visit|2
252751|NCT01283139|833606|P3|Overall Study|Missed follow-up visit|2
252752|NCT01283139|833607|P2|Overall Study|Missed follow-up visit|1
252753|NCT01283139|833608|P1|Overall Study|Missed follow-up visit|0
252754|NCT01283139|833605|P4|Overall Study|Pregnancy|0
252755|NCT01283139|833606|P3|Overall Study|Pregnancy|1
252756|NCT01283139|833607|P2|Overall Study|Pregnancy|1
252757|NCT01283139|833608|P1|Overall Study|Pregnancy|0
252758|NCT01283139|833605|P4|Overall Study|Participant's refusal to continue|1
252759|NCT01283139|833606|P3|Overall Study|Participant's refusal to continue|1
252760|NCT01283139|833607|P2|Overall Study|Participant's refusal to continue|3
252761|NCT01283139|833608|P1|Overall Study|Participant's refusal to continue|0
252762|NCT01283139|833605|P4|Overall Study|Early termination due to AE/SAE|0
252763|NCT01283139|833606|P3|Overall Study|Early termination due to AE/SAE|0
252764|NCT01283139|833607|P2|Overall Study|Early termination due to AE/SAE|1
252765|NCT01283139|833608|P1|Overall Study|Early termination due to AE/SAE|1
252766|NCT01283139|833605|P4|Overall Study|Lack of Efficacy|1
252767|NCT01283139|833606|P3|Overall Study|Lack of Efficacy|2
252768|NCT01283139|833607|P2|Overall Study|Lack of Efficacy|2
252769|NCT01283139|833608|P1|Overall Study|Lack of Efficacy|1
252770|NCT01283139|833605|P4|Overall Study|Death|2
252771|NCT01283139|833606|P3|Overall Study|Death|2
252772|NCT01283139|833607|P2|Overall Study|Death|0
252773|NCT01283139|833608|P1|Overall Study|Death|2
252774|NCT01283139|833605|P4|Overall Study|Withdrawal by Subject|8
252775|NCT01283139|833606|P3|Overall Study|Withdrawal by Subject|6
252776|NCT01283139|833607|P2|Overall Study|Withdrawal by Subject|8
252777|NCT01283139|833608|P1|Overall Study|Withdrawal by Subject|8
252778|NCT01283139|833605|P4|Overall Study|Lost to Follow-up|1
252779|NCT01283139|833606|P3|Overall Study|Lost to Follow-up|3
252780|NCT01283139|833607|P2|Overall Study|Lost to Follow-up|2
252781|NCT01283139|833608|P1|Overall Study|Lost to Follow-up|5
252782|NCT01283035|833650|P1|Overall Study|Subject later found ineligible|1
252783|NCT01282814|833667|P2|Washout of 7 Days|Withdrawal by Subject|0
252784|NCT01282814|833668|P1|Washout of 7 Days|Withdrawal by Subject|2
252785|NCT01282814|833667|P2|First Intervention|Emesis During Dosing Interval|3
252786|NCT01282814|833668|P1|First Intervention|Emesis During Dosing Interval|0
252787|NCT01282801|833680|P2|Second Intervention|Emesis During Critical Breakfast|1
252788|NCT01282801|833681|P1|Second Intervention|Emesis During Critical Breakfast|0
252789|NCT01282476|833705|P1|Overall Study|Death|11
252790|NCT01282424|833711|P1|Overall Study|Investigator Request|7
252791|NCT01282424|833711|P1|Overall Study|Withdrew Consent|4
252792|NCT01282424|833711|P1|Overall Study|Adverse Event|25
252793|NCT01282424|833711|P1|Overall Study|Treatment Ongoing|40
252794|NCT01282372|833728|P1|Overall Study|Adverse Event|12
252795|NCT01282372|833728|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
252796|NCT01282372|833728|P1|Overall Study|Presence of AE, Regression of Symptoms|1
252797|NCT01282372|833728|P1|Overall Study|Presence of AE, Lack of Efficacy|1
252798|NCT01282372|833728|P1|Overall Study|Death|1
252799|NCT01282372|833728|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
252800|NCT01282372|833728|P1|Overall Study|Withdrawal by Subject|11
252801|NCT01282372|833728|P1|Overall Study|Lost to Follow-up|23
252802|NCT01282372|833728|P1|Overall Study|Lack of Efficacy / Exacerbation|25
252803|NCT01282294|833756|P1|Overall Study|Physician Decision|1
252804|NCT01282294|833756|P1|Overall Study|Patient non-compliance|2
252805|NCT01282294|833756|P1|Overall Study|Adverse Event|1
252806|NCT01282294|833756|P1|Overall Study|Screening failure|1
252807|NCT01282294|833756|P1|Overall Study|Lost to Follow-up|14
252808|NCT01282229|833785|P1|Overall Study|Protocol Violation|2
252809|NCT01282203|833815|P1|Overall Study|Adverse Event|1
252810|NCT01282164|833837|P2|Overall Study|Lack of hypoglycemia during ITT|0
252811|NCT01282164|833838|P1|Overall Study|Lack of hypoglycemia during ITT|1
252812|NCT01281865|833891|P2|Overall Study|Lack of Efficacy|0
252813|NCT01281865|833892|P1|Overall Study|Lack of Efficacy|1
252814|NCT01281865|833891|P2|Overall Study|Withdrawal by Subject|0
252815|NCT01281865|833892|P1|Overall Study|Withdrawal by Subject|1
252816|NCT01281865|833891|P2|Overall Study|Adverse Event|1
252817|NCT01281865|833892|P1|Overall Study|Adverse Event|1
252818|NCT01281839|833900|P2|Overall Study|Reason not specified|1
252819|NCT01281839|833901|P1|Overall Study|Reason not specified|0
252820|NCT01281839|833900|P2|Overall Study|Withdrawal by Subject|10
252821|NCT01281839|833901|P1|Overall Study|Withdrawal by Subject|4
252822|NCT01281839|833900|P2|Overall Study|Lost to Follow-up|3
252823|NCT01281839|833901|P1|Overall Study|Lost to Follow-up|6
252824|NCT01281644|833962|P1|Overall Study|Withdrawal by Subject|2
252825|NCT01281644|833962|P1|Overall Study|Lost to Follow-up|3
252826|NCT01281306|834003|P7|Overall Study|Randomized in error|0
252827|NCT01281306|834004|P6|Overall Study|Randomized in error|0
252828|NCT01281306|834005|P5|Overall Study|Randomized in error|0
252829|NCT01281306|834006|P4|Overall Study|Randomized in error|1
252830|NCT01281306|834007|P3|Overall Study|Randomized in error|0
252831|NCT01281306|834008|P2|Overall Study|Randomized in error|0
252832|NCT01281306|834009|P1|Overall Study|Randomized in error|1
252833|NCT01281306|834003|P7|Overall Study|Adverse Event|3
252834|NCT01281306|834004|P6|Overall Study|Adverse Event|3
252835|NCT01281306|834005|P5|Overall Study|Adverse Event|5
252836|NCT01281306|834006|P4|Overall Study|Adverse Event|3
252837|NCT01281306|834007|P3|Overall Study|Adverse Event|2
252838|NCT01281306|834008|P2|Overall Study|Adverse Event|2
252839|NCT01281306|834009|P1|Overall Study|Adverse Event|3
252840|NCT01281306|834003|P7|Overall Study|Death|0
252841|NCT01281306|834004|P6|Overall Study|Death|0
252842|NCT01281306|834005|P5|Overall Study|Death|0
252843|NCT01281306|834006|P4|Overall Study|Death|0
252844|NCT01281306|834007|P3|Overall Study|Death|0
252845|NCT01281306|834008|P2|Overall Study|Death|0
252846|NCT01281306|834009|P1|Overall Study|Death|1
252847|NCT01281306|834003|P7|Overall Study|Lost to Follow-up|1
252848|NCT01281306|834004|P6|Overall Study|Lost to Follow-up|0
252849|NCT01281306|834005|P5|Overall Study|Lost to Follow-up|0
252850|NCT01281306|834006|P4|Overall Study|Lost to Follow-up|2
252851|NCT01281306|834007|P3|Overall Study|Lost to Follow-up|0
252852|NCT01281306|834008|P2|Overall Study|Lost to Follow-up|0
252853|NCT01281306|834009|P1|Overall Study|Lost to Follow-up|1
252854|NCT01281306|834003|P7|Overall Study|Condition no longer requires study drug|1
252855|NCT01281306|834004|P6|Overall Study|Condition no longer requires study drug|1
252856|NCT01281306|834005|P5|Overall Study|Condition no longer requires study drug|0
252857|NCT01281306|834006|P4|Overall Study|Condition no longer requires study drug|0
252858|NCT01281306|834007|P3|Overall Study|Condition no longer requires study drug|0
252859|NCT01281306|834008|P2|Overall Study|Condition no longer requires study drug|0
252860|NCT01281306|834009|P1|Overall Study|Condition no longer requires study drug|1
252861|NCT01281306|834003|P7|Overall Study|Protocol deviation|0
252862|NCT01281306|834004|P6|Overall Study|Protocol deviation|0
252863|NCT01281306|834005|P5|Overall Study|Protocol deviation|1
252864|NCT01281306|834006|P4|Overall Study|Protocol deviation|1
252865|NCT01281306|834007|P3|Overall Study|Protocol deviation|1
252866|NCT01281306|834008|P2|Overall Study|Protocol deviation|1
252867|NCT01281306|834009|P1|Overall Study|Protocol deviation|0
252868|NCT01281306|834003|P7|Overall Study|Withdrawal by Subject|1
252869|NCT01281306|834004|P6|Overall Study|Withdrawal by Subject|3
252870|NCT01281306|834005|P5|Overall Study|Withdrawal by Subject|1
252871|NCT01281306|834006|P4|Overall Study|Withdrawal by Subject|4
252872|NCT01281306|834007|P3|Overall Study|Withdrawal by Subject|2
252873|NCT01281306|834008|P2|Overall Study|Withdrawal by Subject|0
252874|NCT01281306|834009|P1|Overall Study|Withdrawal by Subject|1
252875|NCT01281306|834003|P7|Overall Study|Lack of Efficacy|1
252876|NCT01281306|834004|P6|Overall Study|Lack of Efficacy|0
252877|NCT01281306|834005|P5|Overall Study|Lack of Efficacy|2
252878|NCT01281306|834006|P4|Overall Study|Lack of Efficacy|0
252879|NCT01281306|834007|P3|Overall Study|Lack of Efficacy|3
252880|NCT01281306|834008|P2|Overall Study|Lack of Efficacy|1
252881|NCT01281306|834009|P1|Overall Study|Lack of Efficacy|0
252882|NCT01281202|834125|P2|Overall Study|Incarceration|3
252883|NCT01281202|834126|P1|Overall Study|Incarceration|0
252884|NCT01281202|834125|P2|Overall Study|Lost to Follow-up|13
252885|NCT01281202|834126|P1|Overall Study|Lost to Follow-up|11
252886|NCT01281202|834125|P2|Overall Study|Administrative|8
252887|NCT01281202|834126|P1|Overall Study|Administrative|2
252888|NCT01281202|834125|P2|Overall Study|Protocol Violation|10
252889|NCT01281202|834126|P1|Overall Study|Protocol Violation|11
252890|NCT01281202|834125|P2|Overall Study|Withdrawal by Subject|2
252891|NCT01281202|834126|P1|Overall Study|Withdrawal by Subject|2
252892|NCT01281202|834125|P2|Overall Study|Adverse Event|0
252893|NCT01281202|834126|P1|Overall Study|Adverse Event|2
252894|NCT01281124|834134|P1|Overall Study|Death|1
252895|NCT01280981|834149|P1|Overall Study|Study site closure|1
252896|NCT01280981|834149|P1|Overall Study|Elective surgery|2
252897|NCT01280981|834149|P1|Overall Study|Withdrawal of consent|3
252898|NCT01280981|834149|P1|Overall Study|Non-compliance with protocol|3
252899|NCT01280981|834149|P1|Overall Study|Failed to return|45
252900|NCT01280981|834149|P1|Overall Study|Irregular or discontinued menses|3
252901|NCT01280981|834149|P1|Overall Study|Adverse Event|6
252902|NCT01280981|834149|P1|Overall Study|Lost to Follow-up|3
252903|NCT01280981|834149|P1|Overall Study|Lack of Efficacy|13
252904|NCT01280981|834149|P1|Overall Study|Protocol Violation|2
252905|NCT01280981|834149|P1|Overall Study|Withdrawal by Subject|11
252906|NCT01280968|834160|P2|Overall Study|Unable to Smoke in Supine Position|0
252907|NCT01280968|834161|P1|Overall Study|Unable to Smoke in Supine Position|1
252908|NCT01280968|834160|P2|Overall Study|Pre-existing Neurological Condition|0
252909|NCT01280968|834161|P1|Overall Study|Pre-existing Neurological Condition|1
252910|NCT01280968|834160|P2|Overall Study|Scheduling Conflicts|1
252911|NCT01280968|834161|P1|Overall Study|Scheduling Conflicts|1
252912|NCT01280968|834160|P2|Overall Study|Adverse Event|0
252913|NCT01280968|834161|P1|Overall Study|Adverse Event|1
252914|NCT01280968|834160|P2|Overall Study|Anxiety|0
252915|NCT01280968|834161|P1|Overall Study|Anxiety|2
252916|NCT01280968|834160|P2|Overall Study|Commuting Problems|0
252917|NCT01280968|834161|P1|Overall Study|Commuting Problems|2
252918|NCT01280968|834160|P2|Overall Study|Unable to Follow Experimental Protocol|0
252919|NCT01280968|834161|P1|Overall Study|Unable to Follow Experimental Protocol|2
252920|NCT01280968|834160|P2|Overall Study|Lost to Follow-up|2
252921|NCT01280968|834161|P1|Overall Study|Lost to Follow-up|8
252922|NCT01280955|834177|P1|Overall Study|Withdrawal by Subject|1
252923|NCT01280955|834177|P1|Overall Study|Death|2
252924|NCT01280656|834257|P3|Overall Study|Other|7
252925|NCT01280656|834258|P2|Overall Study|Other|7
252926|NCT01280656|834259|P1|Overall Study|Other|1
252927|NCT01280656|834257|P3|Overall Study|Treatment shortening (RGT)|5
252928|NCT01280656|834258|P2|Overall Study|Treatment shortening (RGT)|4
252929|NCT01280656|834259|P1|Overall Study|Treatment shortening (RGT)|0
252930|NCT01280656|834257|P3|Overall Study|Lack of Efficacy|38
252931|NCT01280656|834258|P2|Overall Study|Lack of Efficacy|22
252932|NCT01280656|834259|P1|Overall Study|Lack of Efficacy|1
252933|NCT01280656|834257|P3|Overall Study|Adverse Event|13
252934|NCT01280656|834258|P2|Overall Study|Adverse Event|14
252935|NCT01280656|834259|P1|Overall Study|Adverse Event|1
252936|NCT01280591|834326|P4|Overall Study|Does not meet exclusion #27 criteria|1
252937|NCT01280591|834327|P3|Overall Study|Does not meet exclusion #27 criteria|0
252938|NCT01280591|834328|P2|Overall Study|Does not meet exclusion #27 criteria|0
252939|NCT01280591|834329|P1|Overall Study|Does not meet exclusion #27 criteria|0
252940|NCT01280591|834326|P4|Overall Study|Withdrawal by Subject|2
252941|NCT01280591|834327|P3|Overall Study|Withdrawal by Subject|0
252942|NCT01280591|834328|P2|Overall Study|Withdrawal by Subject|0
252943|NCT01280591|834329|P1|Overall Study|Withdrawal by Subject|0
252944|NCT01280357|834434|P1|Overall Study|IInsufficient data/No data supplied|12
252945|NCT01280357|834434|P1|Overall Study|Excluded no internal monitoring|14
252946|NCT01280266|834443|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
252947|NCT01280266|834444|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
252948|NCT01280266|834443|P2|First Intervention (Week 1-4)|Adverse Event|0
252949|NCT01280266|834444|P1|First Intervention (Week 1-4)|Adverse Event|1
252950|NCT01279447|834516|P2|Overall Study|Lost to Follow-up|1
252951|NCT01279447|834517|P1|Overall Study|Lost to Follow-up|3
252952|NCT01279200|834544|P2|Overall Study|Adverse Event|0
252953|NCT01279200|834545|P1|Overall Study|Adverse Event|1
252954|NCT01279200|834544|P2|Overall Study|Lost to Follow-up|1
252955|NCT01279200|834545|P1|Overall Study|Lost to Follow-up|0
252956|NCT01279200|834544|P2|Overall Study|ultrasound screening failure|1
252957|NCT01279200|834545|P1|Overall Study|ultrasound screening failure|0
252958|NCT01279200|834544|P2|Overall Study|Inconvenience of ultrasound visit|1
252959|NCT01279200|834545|P1|Overall Study|Inconvenience of ultrasound visit|0
252960|NCT01279200|834544|P2|Overall Study|Patient withdrawal due to high cost|1
252961|NCT01279200|834545|P1|Overall Study|Patient withdrawal due to high cost|0
252962|NCT01279200|834544|P2|Overall Study|Withdrawal by Subject|3
252963|NCT01279200|834545|P1|Overall Study|Withdrawal by Subject|1
252964|NCT01279070|834566|P2|Overall Study|Acute exacerbation|1
252965|NCT01279070|834567|P1|Overall Study|Acute exacerbation|3
252966|NCT01279070|834566|P2|Overall Study|Withdrawal by Subject|3
252967|NCT01279070|834567|P1|Overall Study|Withdrawal by Subject|2
252968|NCT01279044|834586|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
252969|NCT01279044|834587|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
252970|NCT01279044|834588|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
252971|NCT01279044|834586|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
252972|NCT01279044|834587|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
252973|NCT01279044|834588|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
252974|NCT01279044|834586|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
252975|NCT01279044|834587|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
252976|NCT01279044|834588|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
252977|NCT01278797|834662|P2|Period 1|Protocol Violation|0
252978|NCT01278797|834663|P1|Period 1|Protocol Violation|1
252979|NCT01278797|834662|P2|Period 1|Adverse Event|1
252980|NCT01278797|834663|P1|Period 1|Adverse Event|0
252981|NCT01278745|834675|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
252982|NCT01278745|834676|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
252983|NCT01278745|834677|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
252984|NCT01278745|834678|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
252985|NCT01278745|834675|P4|Overall Study|Ineligible|61
252986|NCT01278745|834676|P3|Overall Study|Ineligible|42
252987|NCT01278745|834677|P2|Overall Study|Ineligible|0
252988|NCT01278745|834678|P1|Overall Study|Ineligible|0
252989|NCT01278745|834675|P4|Overall Study|Sponsor Decision|6
252990|NCT01278745|834676|P3|Overall Study|Sponsor Decision|62
252991|NCT01278745|834677|P2|Overall Study|Sponsor Decision|0
252992|NCT01278745|834678|P1|Overall Study|Sponsor Decision|1
252993|NCT01278745|834675|P4|Overall Study|Withdrawal by Subject|1
252994|NCT01278745|834676|P3|Overall Study|Withdrawal by Subject|5
252995|NCT01278745|834677|P2|Overall Study|Withdrawal by Subject|1
252996|NCT01278745|834678|P1|Overall Study|Withdrawal by Subject|1
252997|NCT01278745|834675|P4|Overall Study|Physician Decision|9
252998|NCT01278745|834676|P3|Overall Study|Physician Decision|0
252999|NCT01278745|834677|P2|Overall Study|Physician Decision|0
253000|NCT01278745|834678|P1|Overall Study|Physician Decision|1
253001|NCT01278745|834675|P4|Overall Study|Death|0
253002|NCT01278745|834676|P3|Overall Study|Death|7
253003|NCT01278745|834677|P2|Overall Study|Death|5
253004|NCT01278745|834678|P1|Overall Study|Death|2
253005|NCT01278615|834710|P1|Overall Study|Withdrawal by Subject|2
253006|NCT01278407|834736|P5|Extension Phase|Not Specified|3
253007|NCT01278407|834737|P4|Extension Phase|Not Specified|1
253008|NCT01278407|834738|P3|Extension Phase|Not Specified|0
253009|NCT01278407|834739|P2|Extension Phase|Not Specified|0
253010|NCT01278407|834740|P1|Extension Phase|Not Specified|0
253011|NCT01278407|834736|P5|Extension Phase|Participant's Choice|11
253012|NCT01278407|834737|P4|Extension Phase|Participant's Choice|4
253013|NCT01278407|834738|P3|Extension Phase|Participant's Choice|0
253014|NCT01278407|834739|P2|Extension Phase|Participant's Choice|0
253015|NCT01278407|834740|P1|Extension Phase|Participant's Choice|0
253016|NCT01278407|834736|P5|Extension Phase|Adverse Event|16
253017|NCT01278407|834737|P4|Extension Phase|Adverse Event|7
253018|NCT01278407|834738|P3|Extension Phase|Adverse Event|0
253019|NCT01278407|834739|P2|Extension Phase|Adverse Event|0
253020|NCT01278407|834740|P1|Extension Phase|Adverse Event|0
253021|NCT01278407|834736|P5|Confirmatory Phase|Not Specified|0
253022|NCT01278407|834737|P4|Confirmatory Phase|Not Specified|0
253023|NCT01278407|834738|P3|Confirmatory Phase|Not Specified|2
253024|NCT01278407|834739|P2|Confirmatory Phase|Not Specified|1
253025|NCT01278407|834740|P1|Confirmatory Phase|Not Specified|1
253026|NCT01278407|834736|P5|Confirmatory Phase|Participant's Choice|0
253027|NCT01278407|834737|P4|Confirmatory Phase|Participant's Choice|0
253028|NCT01278407|834738|P3|Confirmatory Phase|Participant's Choice|3
253029|NCT01278407|834739|P2|Confirmatory Phase|Participant's Choice|5
253030|NCT01278407|834740|P1|Confirmatory Phase|Participant's Choice|3
253031|NCT01278407|834736|P5|Confirmatory Phase|Adverse Event|0
253032|NCT01278407|834737|P4|Confirmatory Phase|Adverse Event|0
253033|NCT01278407|834738|P3|Confirmatory Phase|Adverse Event|1
253034|NCT01278407|834739|P2|Confirmatory Phase|Adverse Event|10
253035|NCT01278407|834740|P1|Confirmatory Phase|Adverse Event|5
253036|NCT01278394|834753|P1|Overall Study|Lost to Follow-up|1
253037|NCT01278342|834766|P3|Overall Study|Other|0
253038|NCT01278342|834767|P2|Overall Study|Other|0
253039|NCT01278342|834768|P1|Overall Study|Other|1
253040|NCT01278342|834766|P3|Overall Study|Administrative problems|0
253041|NCT01278342|834767|P2|Overall Study|Administrative problems|0
253042|NCT01278342|834768|P1|Overall Study|Administrative problems|2
253043|NCT01278342|834766|P3|Overall Study|Lost to Follow-up|0
253044|NCT01278342|834767|P2|Overall Study|Lost to Follow-up|0
253045|NCT01278342|834768|P1|Overall Study|Lost to Follow-up|1
253046|NCT01278342|834766|P3|Overall Study|Physician Decision|0
253047|NCT01278342|834767|P2|Overall Study|Physician Decision|1
253048|NCT01278342|834768|P1|Overall Study|Physician Decision|0
253049|NCT01277211|834790|P2|Overall Study|Discontinued prior to treatment|13
253050|NCT01277211|834791|P1|Overall Study|Discontinued prior to treatment|24
253051|NCT01277211|834790|P2|Overall Study|Pregnancy wish|2
253052|NCT01277211|834791|P1|Overall Study|Pregnancy wish|0
253053|NCT01277211|834790|P2|Overall Study|Administrative|0
253054|NCT01277211|834791|P1|Overall Study|Administrative|3
253055|NCT01277211|834790|P2|Overall Study|Did not meet protocol eligibility|0
253056|NCT01277211|834791|P1|Overall Study|Did not meet protocol eligibility|1
253057|NCT01277211|834790|P2|Overall Study|Non-compliance with protocol|4
253058|NCT01277211|834791|P1|Overall Study|Non-compliance with protocol|13
253059|NCT01277211|834790|P2|Overall Study|Withdrew Consent|9
253060|NCT01277211|834791|P1|Overall Study|Withdrew Consent|9
253061|NCT01277211|834790|P2|Overall Study|Did not wish to continue|0
253062|NCT01277211|834791|P1|Overall Study|Did not wish to continue|17
253063|NCT01277211|834790|P2|Overall Study|Lost to Follow-up|9
253064|NCT01277211|834791|P1|Overall Study|Lost to Follow-up|14
253065|NCT01277211|834790|P2|Overall Study|Pregnancy|4
253066|NCT01277211|834791|P1|Overall Study|Pregnancy|9
253067|NCT01277211|834790|P2|Overall Study|Adverse Event|22
253068|NCT01277211|834791|P1|Overall Study|Adverse Event|60
253069|NCT01277042|834822|P2|Overall Study|Withdrawal by Subject|0
253070|NCT01277042|834823|P1|Overall Study|Withdrawal by Subject|2
253071|NCT01277042|834822|P2|Overall Study|Lost to Follow-up|2
253072|NCT01277042|834823|P1|Overall Study|Lost to Follow-up|2
253073|NCT01277042|834822|P2|Overall Study|Adverse Event|3
253074|NCT01277042|834823|P1|Overall Study|Adverse Event|4
253075|NCT01278173|834845|P1|Overall Study|Withdrawal by Subject|1
253076|NCT01278173|834845|P1|Overall Study|Protocol Violation|1
253077|NCT01278173|834845|P1|Overall Study|Administrative or other reason|4
253078|NCT01278173|834845|P1|Overall Study|Adverse Event|8
253079|NCT01278173|834845|P1|Overall Study|Lack of Efficacy|13
253080|NCT01278160|834852|P2|Overall Study|Unclassified|2
253081|NCT01278160|834853|P1|Overall Study|Unclassified|1
253082|NCT01278160|834852|P2|Overall Study|Withdrawal by Subject|2
253083|NCT01278160|834853|P1|Overall Study|Withdrawal by Subject|3
253084|NCT01278160|834852|P2|Overall Study|Lost to Follow-up|1
253085|NCT01278160|834853|P1|Overall Study|Lost to Follow-up|0
253086|NCT01278160|834852|P2|Overall Study|Adverse Event|1
253087|NCT01278160|834853|P1|Overall Study|Adverse Event|1
253088|NCT01278030|834869|P2|Overall Study|Withdrawal by Subject|4
253089|NCT01278030|834870|P1|Overall Study|Withdrawal by Subject|8
253090|NCT01277861|834878|P2|Overall Study|Physician Decision|2
253091|NCT01277861|834879|P1|Overall Study|Physician Decision|2
253092|NCT01277822|834891|P2|Overall Study|Participant moved|0
253093|NCT01277822|834892|P1|Overall Study|Participant moved|1
253094|NCT01277822|834891|P2|Overall Study|Contraindicated medication used|1
253095|NCT01277822|834892|P1|Overall Study|Contraindicated medication used|2
253096|NCT01277822|834891|P2|Overall Study|Lost to Follow-up|1
253097|NCT01277822|834892|P1|Overall Study|Lost to Follow-up|2
253098|NCT01277822|834891|P2|Overall Study|Protocol Violation|0
253099|NCT01277822|834892|P1|Overall Study|Protocol Violation|1
253100|NCT01277822|834891|P2|Overall Study|Physician Decision|1
253101|NCT01277822|834892|P1|Overall Study|Physician Decision|1
253102|NCT01277822|834891|P2|Overall Study|Withdrawal by Subject|7
253103|NCT01277822|834892|P1|Overall Study|Withdrawal by Subject|6
253104|NCT01277822|834891|P2|Overall Study|Adverse Event|1
253105|NCT01277822|834892|P1|Overall Study|Adverse Event|2
253106|NCT01277757|834912|P1|Overall Study|Withdrawal by Subject|1
253107|NCT01277757|834912|P1|Overall Study|Disease Progression|1
253108|NCT01277718|834919|P2|Period 2 - Second Intervention|Physician Decision|2
253109|NCT01277718|834920|P1|Period 2 - Second Intervention|Physician Decision|0
253110|NCT01277718|834919|P2|Period 2 - Second Intervention|Protocol Violation|1
253111|NCT01277718|834920|P1|Period 2 - Second Intervention|Protocol Violation|0
253112|NCT01277601|834935|P4|Overall Study|Subject Terminated from Study by Sponsor|2
253113|NCT01277601|834936|P3|Overall Study|Subject Terminated from Study by Sponsor|0
253114|NCT01277601|834937|P2|Overall Study|Subject Terminated from Study by Sponsor|1
253115|NCT01277601|834938|P1|Overall Study|Subject Terminated from Study by Sponsor|0
253116|NCT01277601|834935|P4|Overall Study|Protocol Violation|0
253117|NCT01277601|834936|P3|Overall Study|Protocol Violation|5
253118|NCT01277601|834937|P2|Overall Study|Protocol Violation|2
253119|NCT01277601|834938|P1|Overall Study|Protocol Violation|0
253120|NCT01277601|834935|P4|Overall Study|Subject Never Dosed with Study Drug|1
253121|NCT01277601|834936|P3|Overall Study|Subject Never Dosed with Study Drug|3
253122|NCT01277601|834937|P2|Overall Study|Subject Never Dosed with Study Drug|2
253123|NCT01277601|834938|P1|Overall Study|Subject Never Dosed with Study Drug|1
253124|NCT01277601|834935|P4|Overall Study|Noncompliance with Study Drug|0
253125|NCT01277601|834936|P3|Overall Study|Noncompliance with Study Drug|2
253126|NCT01277601|834937|P2|Overall Study|Noncompliance with Study Drug|3
253127|NCT01277601|834938|P1|Overall Study|Noncompliance with Study Drug|1
253128|NCT01277601|834935|P4|Overall Study|Pregnancy|1
253129|NCT01277601|834936|P3|Overall Study|Pregnancy|4
253130|NCT01277601|834937|P2|Overall Study|Pregnancy|2
253131|NCT01277601|834938|P1|Overall Study|Pregnancy|2
253132|NCT01277601|834935|P4|Overall Study|Physician Decision|6
253133|NCT01277601|834936|P3|Overall Study|Physician Decision|1
253134|NCT01277601|834937|P2|Overall Study|Physician Decision|5
253135|NCT01277601|834938|P1|Overall Study|Physician Decision|3
253136|NCT01277601|834935|P4|Overall Study|Lost to Follow-up|2
253137|NCT01277601|834936|P3|Overall Study|Lost to Follow-up|4
253138|NCT01277601|834937|P2|Overall Study|Lost to Follow-up|9
253139|NCT01277601|834938|P1|Overall Study|Lost to Follow-up|7
253140|NCT01277601|834935|P4|Overall Study|Withdrawal by Subject|17
253141|NCT01277601|834936|P3|Overall Study|Withdrawal by Subject|8
253142|NCT01277601|834937|P2|Overall Study|Withdrawal by Subject|21
253143|NCT01277601|834938|P1|Overall Study|Withdrawal by Subject|18
253144|NCT01277601|834935|P4|Overall Study|Adverse Event|7
253145|NCT01277601|834936|P3|Overall Study|Adverse Event|0
253146|NCT01277601|834937|P2|Overall Study|Adverse Event|3
253147|NCT01277601|834938|P1|Overall Study|Adverse Event|5
253148|NCT01277549|835029|P2|Overall Study|Physician Decision|1
253149|NCT01277549|835030|P1|Overall Study|Physician Decision|2
253150|NCT01277549|835029|P2|Overall Study|Protocol Violation|1
253151|NCT01277549|835030|P1|Overall Study|Protocol Violation|10
253152|NCT01277549|835029|P2|Overall Study|Withdrawal by Subject|3
253153|NCT01277549|835030|P1|Overall Study|Withdrawal by Subject|1
253154|NCT01277549|835029|P2|Overall Study|Failed to meet eligibility criteria|9
253155|NCT01277549|835030|P1|Overall Study|Failed to meet eligibility criteria|13
253156|NCT01277523|835047|P3|Overall Study|Other Reason not Defined|0
253157|NCT01277523|835048|P2|Overall Study|Other Reason not Defined|1
253158|NCT01277523|835049|P1|Overall Study|Other Reason not Defined|0
253159|NCT01277523|835047|P3|Overall Study|Protocol Violation|0
253160|NCT01277523|835048|P2|Overall Study|Protocol Violation|0
253161|NCT01277523|835049|P1|Overall Study|Protocol Violation|2
253162|NCT01277523|835047|P3|Overall Study|Adverse Event|0
253163|NCT01277523|835048|P2|Overall Study|Adverse Event|0
253164|NCT01277523|835049|P1|Overall Study|Adverse Event|1
253165|NCT01277510|835101|P2|Open-label Phase|Never received investigational product|0
253166|NCT01277510|835102|P1|Open-label Phase|Never received investigational product|2
253167|NCT01277510|835101|P2|Open-label Phase|Protocol-specified criteria|0
253168|NCT01277510|835102|P1|Open-label Phase|Protocol-specified criteria|1
253169|NCT01277510|835101|P2|Open-label Phase|Administrative decision|3
253170|NCT01277510|835102|P1|Open-label Phase|Administrative decision|4
253171|NCT01277510|835101|P2|Double-blind Phase|Other|1
253172|NCT01277510|835102|P1|Double-blind Phase|Other|1
253173|NCT01277510|835101|P2|Double-blind Phase|Protocol-specified criteria|6
253174|NCT01277510|835102|P1|Double-blind Phase|Protocol-specified criteria|2
253175|NCT01277510|835101|P2|Double-blind Phase|Death|1
253176|NCT01277510|835102|P1|Double-blind Phase|Death|0
253177|NCT01277510|835101|P2|Double-blind Phase|Administrative decision|9
253178|NCT01277510|835102|P1|Double-blind Phase|Administrative decision|7
253179|NCT01277510|835101|P2|Double-blind Phase|Withdrawal by Subject|0
253180|NCT01277510|835102|P1|Double-blind Phase|Withdrawal by Subject|2
253181|NCT01277510|835101|P2|Double-blind Phase|Adverse Event|0
253182|NCT01277510|835102|P1|Double-blind Phase|Adverse Event|1
253183|NCT01277510|835101|P2|Double-blind Phase|Non-compliance|1
253184|NCT01277510|835102|P1|Double-blind Phase|Non-compliance|0
253185|NCT01277302|835136|P3|8-Month Alternate Dose Regimen Period|Relocation|1
253186|NCT01277302|835137|P2|8-Month Alternate Dose Regimen Period|Relocation|0
253187|NCT01277302|835138|P1|8-Month Alternate Dose Regimen Period|Relocation|1
253188|NCT01277302|835136|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
253189|NCT01277302|835137|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
253190|NCT01277302|835138|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
253191|NCT01277302|835136|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
253192|NCT01277302|835137|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
253193|NCT01277302|835138|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
253194|NCT01277302|835136|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
253195|NCT01277302|835137|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
253196|NCT01277302|835138|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
253197|NCT01277302|835136|P3|8-Month Alternate Dose Regimen Period|Death|0
253198|NCT01277302|835137|P2|8-Month Alternate Dose Regimen Period|Death|1
253199|NCT01277302|835138|P1|8-Month Alternate Dose Regimen Period|Death|0
253200|NCT01277302|835136|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
253201|NCT01277302|835137|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
253202|NCT01277302|835138|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
253203|NCT01277302|835136|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
253204|NCT01277302|835137|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
253205|NCT01277302|835138|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
253206|NCT01277302|835136|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
253207|NCT01277302|835137|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
253208|NCT01277302|835138|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
253209|NCT01277302|835136|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
253210|NCT01277302|835137|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
253211|NCT01277302|835138|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
253212|NCT01276847|835171|P3|Overall Study|Withdrawal by Subject|0
253213|NCT01276847|835172|P2|Overall Study|Withdrawal by Subject|0
253214|NCT01276847|835173|P1|Overall Study|Withdrawal by Subject|1
253215|NCT01276821|835183|P2|Overall Study|Protocol Violation|1
253216|NCT01276821|835184|P1|Overall Study|Protocol Violation|0
253217|NCT01276756|835204|P2|Overall Study|Adverse Event|2
253218|NCT01276756|835205|P1|Overall Study|Adverse Event|3
253219|NCT01276756|835204|P2|Overall Study|Lost to Follow-up|0
253220|NCT01276756|835205|P1|Overall Study|Lost to Follow-up|2
253221|NCT01276639|835222|P5|Week 16 to 52|Unspecified|3
253222|NCT01276639|835223|P4|Week 16 to 52|Unspecified|1
253223|NCT01276639|835224|P3|Week 16 to 52|Unspecified|0
253224|NCT01276639|835225|P2|Week 16 to 52|Unspecified|12
253225|NCT01276639|835226|P1|Week 16 to 52|Unspecified|10
253226|NCT01276639|835222|P5|Week 16 to 52|Withdrawal by Subject|1
253227|NCT01276639|835223|P4|Week 16 to 52|Withdrawal by Subject|0
253228|NCT01276639|835224|P3|Week 16 to 52|Withdrawal by Subject|0
253229|NCT01276639|835225|P2|Week 16 to 52|Withdrawal by Subject|4
253230|NCT01276639|835226|P1|Week 16 to 52|Withdrawal by Subject|4
253231|NCT01276639|835222|P5|Week 16 to 52|Lost to Follow-up|1
253232|NCT01276639|835223|P4|Week 16 to 52|Lost to Follow-up|0
253233|NCT01276639|835224|P3|Week 16 to 52|Lost to Follow-up|0
253234|NCT01276639|835225|P2|Week 16 to 52|Lost to Follow-up|1
253235|NCT01276639|835226|P1|Week 16 to 52|Lost to Follow-up|3
253236|NCT01276639|835222|P5|Week 16 to 52|Lack of Efficacy|13
253237|NCT01276639|835223|P4|Week 16 to 52|Lack of Efficacy|14
253238|NCT01276639|835224|P3|Week 16 to 52|Lack of Efficacy|0
253239|NCT01276639|835225|P2|Week 16 to 52|Lack of Efficacy|71
253240|NCT01276639|835226|P1|Week 16 to 52|Lack of Efficacy|99
253241|NCT01276639|835222|P5|Week 16 to 52|Adverse Event|3
253242|NCT01276639|835223|P4|Week 16 to 52|Adverse Event|1
253243|NCT01276639|835224|P3|Week 16 to 52|Adverse Event|0
253244|NCT01276639|835225|P2|Week 16 to 52|Adverse Event|13
253245|NCT01276639|835226|P1|Week 16 to 52|Adverse Event|10
253246|NCT01276639|835222|P5|Week 16 to 52|Death|0
253247|NCT01276639|835223|P4|Week 16 to 52|Death|0
253248|NCT01276639|835224|P3|Week 16 to 52|Death|0
253249|NCT01276639|835225|P2|Week 16 to 52|Death|0
253250|NCT01276639|835226|P1|Week 16 to 52|Death|1
253251|NCT01276639|835222|P5|Week 0 to 16|Randomized, But Not Treated|0
253252|NCT01276639|835223|P4|Week 0 to 16|Randomized, But Not Treated|0
253253|NCT01276639|835224|P3|Week 0 to 16|Randomized, But Not Treated|0
253254|NCT01276639|835225|P2|Week 0 to 16|Randomized, But Not Treated|1
253255|NCT01276639|835226|P1|Week 0 to 16|Randomized, But Not Treated|0
253256|NCT01276639|835222|P5|Week 0 to 16|Unspecified|0
253257|NCT01276639|835223|P4|Week 0 to 16|Unspecified|0
253258|NCT01276639|835224|P3|Week 0 to 16|Unspecified|2
253259|NCT01276639|835225|P2|Week 0 to 16|Unspecified|7
253260|NCT01276639|835226|P1|Week 0 to 16|Unspecified|7
253261|NCT01276639|835222|P5|Week 0 to 16|Withdrawal by Subject|0
253262|NCT01276639|835223|P4|Week 0 to 16|Withdrawal by Subject|0
253263|NCT01276639|835224|P3|Week 0 to 16|Withdrawal by Subject|4
253264|NCT01276639|835225|P2|Week 0 to 16|Withdrawal by Subject|5
253265|NCT01276639|835226|P1|Week 0 to 16|Withdrawal by Subject|8
253266|NCT01276639|835222|P5|Week 0 to 16|Lost to Follow-up|0
253267|NCT01276639|835223|P4|Week 0 to 16|Lost to Follow-up|0
253268|NCT01276639|835224|P3|Week 0 to 16|Lost to Follow-up|3
253269|NCT01276639|835225|P2|Week 0 to 16|Lost to Follow-up|5
253270|NCT01276639|835226|P1|Week 0 to 16|Lost to Follow-up|3
253271|NCT01276639|835222|P5|Week 0 to 16|Lack of Efficacy|0
253272|NCT01276639|835223|P4|Week 0 to 16|Lack of Efficacy|0
253273|NCT01276639|835224|P3|Week 0 to 16|Lack of Efficacy|25
253274|NCT01276639|835225|P2|Week 0 to 16|Lack of Efficacy|15
253275|NCT01276639|835226|P1|Week 0 to 16|Lack of Efficacy|20
253276|NCT01276639|835222|P5|Week 0 to 16|Adverse Event|0
253277|NCT01276639|835223|P4|Week 0 to 16|Adverse Event|0
253278|NCT01276639|835224|P3|Week 0 to 16|Adverse Event|11
253279|NCT01276639|835225|P2|Week 0 to 16|Adverse Event|8
253280|NCT01276639|835226|P1|Week 0 to 16|Adverse Event|11
253281|NCT01276639|835222|P5|Week 0 to 16|Death|0
253282|NCT01276639|835223|P4|Week 0 to 16|Death|0
253283|NCT01276639|835224|P3|Week 0 to 16|Death|0
253284|NCT01276639|835225|P2|Week 0 to 16|Death|0
253285|NCT01276639|835226|P1|Week 0 to 16|Death|1
253286|NCT01276509|835431|P4|Overall Study|Unspecified|0
253287|NCT01276509|835432|P3|Overall Study|Unspecified|0
253288|NCT01276509|835433|P2|Overall Study|Unspecified|1
253289|NCT01276509|835434|P1|Overall Study|Unspecified|0
253290|NCT01276509|835431|P4|Overall Study|Withdrawal by Subject|0
253291|NCT01276509|835432|P3|Overall Study|Withdrawal by Subject|0
253292|NCT01276509|835433|P2|Overall Study|Withdrawal by Subject|2
253293|NCT01276509|835434|P1|Overall Study|Withdrawal by Subject|1
253294|NCT01276509|835431|P4|Overall Study|Pregnancy|0
253295|NCT01276509|835432|P3|Overall Study|Pregnancy|0
253296|NCT01276509|835433|P2|Overall Study|Pregnancy|0
253297|NCT01276509|835434|P1|Overall Study|Pregnancy|1
253298|NCT01276509|835431|P4|Overall Study|Lack of Efficacy|2
253299|NCT01276509|835432|P3|Overall Study|Lack of Efficacy|1
253300|NCT01276509|835433|P2|Overall Study|Lack of Efficacy|1
253301|NCT01276509|835434|P1|Overall Study|Lack of Efficacy|2
253302|NCT01276509|835431|P4|Overall Study|Adverse Event|3
253303|NCT01276509|835432|P3|Overall Study|Adverse Event|4
253304|NCT01276509|835433|P2|Overall Study|Adverse Event|8
253305|NCT01276509|835434|P1|Overall Study|Adverse Event|9
253306|NCT01276457|835487|P2|Extension Study|Lack of Efficacy|1
253307|NCT01276457|835488|P1|Extension Study|Lack of Efficacy|3
253308|NCT01276457|835487|P2|Extension Study|Death|1
253309|NCT01276457|835488|P1|Extension Study|Death|0
253310|NCT01276457|835487|P2|Extension Study|Lost to Follow-up|0
253311|NCT01276457|835488|P1|Extension Study|Lost to Follow-up|3
253312|NCT01276457|835487|P2|Core Study|Lack of Efficacy|12
253313|NCT01276457|835488|P1|Core Study|Lack of Efficacy|3
253314|NCT01276457|835487|P2|Core Study|Death|2
253315|NCT01276457|835488|P1|Core Study|Death|2
253316|NCT01276457|835487|P2|Core Study|Administrative problems|1
253317|NCT01276457|835488|P1|Core Study|Administrative problems|1
253318|NCT01276457|835487|P2|Core Study|Lost to Follow-up|2
253319|NCT01276457|835488|P1|Core Study|Lost to Follow-up|1
253320|NCT01276457|835487|P2|Core Study|Adverse Event|3
253321|NCT01276457|835488|P1|Core Study|Adverse Event|6
253322|NCT01276353|835502|P2|Extension|Prohibited concomitant medications|1
253323|NCT01276353|835503|P1|Extension|Prohibited concomitant medications|0
253324|NCT01276353|835502|P2|Extension|Physician Decision|0
253325|NCT01276353|835503|P1|Extension|Physician Decision|1
253326|NCT01276353|835502|P2|Extension|Withdrawal of study drug 4 days in a row|1
253327|NCT01276353|835503|P1|Extension|Withdrawal of study drug 4 days in a row|3
253328|NCT01276353|835502|P2|Extension|Withdrawal by Subject|2
253329|NCT01276353|835503|P1|Extension|Withdrawal by Subject|1
253330|NCT01276353|835502|P2|Extension|Adverse Event|5
253331|NCT01276353|835503|P1|Extension|Adverse Event|2
253332|NCT01276353|835502|P2|Double-blind|Withdrawal by Subject|0
253333|NCT01276353|835503|P1|Double-blind|Withdrawal by Subject|1
253334|NCT01276353|835502|P2|Double-blind|Adverse Event|0
253335|NCT01276353|835503|P1|Double-blind|Adverse Event|2
253336|NCT01276327|835515|P2|Overall Study|Withdrawal by Subject|0
253337|NCT01276327|835516|P1|Overall Study|Withdrawal by Subject|1
253338|NCT01276327|835515|P2|Overall Study|Adverse Event|3
253339|NCT01276327|835516|P1|Overall Study|Adverse Event|1
253340|NCT01276288|835566|P4|Overall Study|not treated|0
253341|NCT01276288|835567|P3|Overall Study|not treated|0
253342|NCT01276288|835568|P2|Overall Study|not treated|0
253343|NCT01276288|835569|P1|Overall Study|not treated|1
253344|NCT01276288|835566|P4|Overall Study|Adverse Event|0
253345|NCT01276288|835567|P3|Overall Study|Adverse Event|0
253346|NCT01276288|835568|P2|Overall Study|Adverse Event|1
253347|NCT01276288|835569|P1|Overall Study|Adverse Event|1
253348|NCT01276223|835696|P3|Overall Study|Protocol Violation|0
253349|NCT01276223|835697|P2|Overall Study|Protocol Violation|0
253350|NCT01276223|835698|P1|Overall Study|Protocol Violation|1
253351|NCT01276223|835696|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
253352|NCT01276223|835697|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
253353|NCT01276223|835698|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
253354|NCT01276223|835696|P3|Overall Study|Not specified|1
253355|NCT01276223|835697|P2|Overall Study|Not specified|0
253356|NCT01276223|835698|P1|Overall Study|Not specified|0
253357|NCT01276223|835696|P3|Overall Study|Lost to Follow-up|1
253358|NCT01276223|835697|P2|Overall Study|Lost to Follow-up|0
253359|NCT01276223|835698|P1|Overall Study|Lost to Follow-up|0
253360|NCT01276223|835696|P3|Overall Study|Adverse Event|1
253361|NCT01276223|835697|P2|Overall Study|Adverse Event|4
253362|NCT01276223|835698|P1|Overall Study|Adverse Event|7
253363|NCT01276106|835720|P4|Overall Study|Insufficient therapeutic effects|0
253364|NCT01276106|835721|P3|Overall Study|Insufficient therapeutic effects|2
253365|NCT01276106|835722|P2|Overall Study|Insufficient therapeutic effects|0
253366|NCT01276106|835723|P1|Overall Study|Insufficient therapeutic effects|0
253367|NCT01276106|835720|P4|Overall Study|Protocol Violation|2
253368|NCT01276106|835721|P3|Overall Study|Protocol Violation|0
253369|NCT01276106|835722|P2|Overall Study|Protocol Violation|1
253370|NCT01276106|835723|P1|Overall Study|Protocol Violation|1
253371|NCT01276106|835720|P4|Overall Study|Physician Decision|1
253372|NCT01276106|835721|P3|Overall Study|Physician Decision|1
253373|NCT01276106|835722|P2|Overall Study|Physician Decision|0
253374|NCT01276106|835723|P1|Overall Study|Physician Decision|0
253375|NCT01276106|835720|P4|Overall Study|Lost to Follow-up|0
253376|NCT01276106|835721|P3|Overall Study|Lost to Follow-up|1
253377|NCT01276106|835722|P2|Overall Study|Lost to Follow-up|1
253378|NCT01276106|835723|P1|Overall Study|Lost to Follow-up|2
253379|NCT01276106|835720|P4|Overall Study|Lack of Efficacy|1
253380|NCT01276106|835721|P3|Overall Study|Lack of Efficacy|0
253381|NCT01276106|835722|P2|Overall Study|Lack of Efficacy|1
253382|NCT01276106|835723|P1|Overall Study|Lack of Efficacy|0
253383|NCT01276106|835720|P4|Overall Study|Withdrawal by Subject|6
253384|NCT01276106|835721|P3|Overall Study|Withdrawal by Subject|1
253385|NCT01276106|835722|P2|Overall Study|Withdrawal by Subject|3
253386|NCT01276106|835723|P1|Overall Study|Withdrawal by Subject|6
253387|NCT01276106|835720|P4|Overall Study|Adverse Event|3
253388|NCT01276106|835721|P3|Overall Study|Adverse Event|11
253389|NCT01276106|835722|P2|Overall Study|Adverse Event|3
253390|NCT01276106|835723|P1|Overall Study|Adverse Event|3
253391|NCT01276054|835735|P2|Overall Study|No one to oversee trial after P.I. left|2
253392|NCT01276054|835736|P1|Overall Study|No one to oversee trial after P.I. left|2
253393|NCT01275755|835744|P2|Run-out Placebo Period|Lost to Follow-up|0
253394|NCT01275755|835745|P1|Run-out Placebo Period|Lost to Follow-up|1
253395|NCT01275755|835744|P2|Double-blind Treatment Period|Withdrawal by Subject|0
253396|NCT01275755|835745|P1|Double-blind Treatment Period|Withdrawal by Subject|1
253397|NCT01275755|835744|P2|Double-blind Treatment Period|Lost to Follow-up|1
253398|NCT01275755|835745|P1|Double-blind Treatment Period|Lost to Follow-up|1
253399|NCT01275755|835744|P2|Double-blind Treatment Period|Adverse Event|2
253400|NCT01275755|835745|P1|Double-blind Treatment Period|Adverse Event|0
253401|NCT01275625|835751|P1|Overall Study|Not specified|1
253402|NCT01275625|835751|P1|Overall Study|Adverse Event|4
253403|NCT01275625|835751|P1|Overall Study|Protocol Violation|1
253404|NCT01275625|835751|P1|Overall Study|Withdrawal by Subject|3
253405|NCT01275625|835751|P1|Overall Study|Lost to Follow-up|1
253406|NCT01275625|835751|P1|Overall Study|Lack of Efficacy|2
253407|NCT01275625|835751|P1|Overall Study|Death|1
253408|NCT01275430|835769|P1|Overall Study|Inability to achieve maximum p-wave|1
253409|NCT01275430|835769|P1|Overall Study|Device Malfunction|1
253410|NCT01275430|835769|P1|Overall Study|No Contrast Injection|6
253411|NCT01275430|835769|P1|Overall Study|Adverse Event|1
253412|NCT01275196|835788|P2|Overall Study|Suboptimal response/treatment failure|6
253413|NCT01275196|835789|P1|Overall Study|Suboptimal response/treatment failure|5
253414|NCT01275196|835788|P2|Overall Study|Protocol Violation|0
253415|NCT01275196|835789|P1|Overall Study|Protocol Violation|1
253416|NCT01275196|835788|P2|Overall Study|Disease Progression|5
253417|NCT01275196|835789|P1|Overall Study|Disease Progression|6
253418|NCT01275196|835788|P2|Overall Study|Lost to Follow-up|0
253419|NCT01275196|835789|P1|Overall Study|Lost to Follow-up|1
253420|NCT01275196|835788|P2|Overall Study|Withdrawal by Subject|5
253421|NCT01275196|835789|P1|Overall Study|Withdrawal by Subject|4
253422|NCT01275196|835788|P2|Overall Study|Adverse Event|5
253423|NCT01275196|835789|P1|Overall Study|Adverse Event|3
253424|NCT01275131|835832|P4|Period 2 (Crossover)|Withdrawal by Subject|2
253425|NCT01275131|835833|P3|Period 2 (Crossover)|Withdrawal by Subject|1
253426|NCT01275131|835834|P2|Period 2 (Crossover)|Withdrawal by Subject|0
253427|NCT01275131|835835|P1|Period 2 (Crossover)|Withdrawal by Subject|1
253428|NCT01275131|835832|P4|Period 2 (Crossover)|Adverse Event|0
253429|NCT01275131|835833|P3|Period 2 (Crossover)|Adverse Event|0
253430|NCT01275131|835834|P2|Period 2 (Crossover)|Adverse Event|1
253431|NCT01275131|835835|P1|Period 2 (Crossover)|Adverse Event|0
253432|NCT01275131|835832|P4|Period 1|Physician Decision|0
253433|NCT01275131|835833|P3|Period 1|Physician Decision|0
253434|NCT01275131|835834|P2|Period 1|Physician Decision|0
253435|NCT01275131|835835|P1|Period 1|Physician Decision|1
253436|NCT01275131|835832|P4|Period 1|Withdrawal by Subject|2
253437|NCT01275131|835833|P3|Period 1|Withdrawal by Subject|3
253438|NCT01275131|835834|P2|Period 1|Withdrawal by Subject|0
253439|NCT01275131|835835|P1|Period 1|Withdrawal by Subject|1
253440|NCT01275066|835878|P3|Overall Study|Not Diagnosed w/ Disease|0
253441|NCT01275066|835879|P2|Overall Study|Not Diagnosed w/ Disease|0
253442|NCT01275066|835880|P1|Overall Study|Not Diagnosed w/ Disease|1
253443|NCT01275066|835878|P3|Overall Study|Withdrawal by Subject|1
253444|NCT01275066|835879|P2|Overall Study|Withdrawal by Subject|0
253445|NCT01275066|835880|P1|Overall Study|Withdrawal by Subject|0
253446|NCT01274715|835909|P1|Overall Study|After consent, met exclusion criteria.|1
253447|NCT01274715|835909|P1|Overall Study|After consent, met exclusion criteria.|1
253448|NCT01274715|835909|P1|Overall Study|After consent, met exclusion criteria.|1
253449|NCT01274715|835909|P1|Overall Study|Lost to Follow-up|1
253450|NCT01274559|835933|P2|Overall Study|Withdrawal by Subject|13
253451|NCT01274559|835934|P1|Overall Study|Withdrawal by Subject|25
253452|NCT01274559|835933|P2|Overall Study|Study Terminated by Sponsor|87
253453|NCT01274559|835934|P1|Overall Study|Study Terminated by Sponsor|79
253454|NCT01274559|835933|P2|Overall Study|Protocol Violation|23
253455|NCT01274559|835934|P1|Overall Study|Protocol Violation|28
253456|NCT01274559|835933|P2|Overall Study|Physician Decision|1
253457|NCT01274559|835934|P1|Overall Study|Physician Decision|2
253458|NCT01274559|835933|P2|Overall Study|Non-compliance with Study Drug|4
253459|NCT01274559|835934|P1|Overall Study|Non-compliance with Study Drug|2
253460|NCT01274559|835933|P2|Overall Study|Lost to Follow-up|3
253461|NCT01274559|835934|P1|Overall Study|Lost to Follow-up|3
253462|NCT01274559|835933|P2|Overall Study|Death|1
253463|NCT01274559|835934|P1|Overall Study|Death|1
253464|NCT01274559|835933|P2|Overall Study|Adverse Event|13
253465|NCT01274559|835934|P1|Overall Study|Adverse Event|57
253466|NCT01274533|835984|P1|Overall Study|Disease progression|2
253467|NCT01274533|835984|P1|Overall Study|Non-compliance|1
253468|NCT01274533|835984|P1|Overall Study|Withdrawal by Subject|1
253469|NCT01274429|835989|P1|Overall Study|Study closed do to lack of funding|5
253470|NCT01273883|835998|P2|Second Intervention|Lack of Efficacy|0
253471|NCT01273883|835999|P1|Second Intervention|Lack of Efficacy|1
253472|NCT01273883|835998|P2|Second Intervention|Lost to Follow-up|1
253473|NCT01273883|835999|P1|Second Intervention|Lost to Follow-up|1
253474|NCT01273883|835998|P2|First Intervention|Adverse Event|1
253475|NCT01273883|835999|P1|First Intervention|Adverse Event|2
253476|NCT01273818|836025|P3|Overall Study|Physician Decision|9
253477|NCT01273818|836026|P2|Overall Study|Physician Decision|2
253478|NCT01273818|836027|P1|Overall Study|Physician Decision|13
253479|NCT01273805|836037|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
253480|NCT01273805|836038|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
253481|NCT01273623|836065|P1|Overall Study|did not meet IVUS criteria|29
253482|NCT01273597|836072|P1|Overall Study|Reason Not Reported|1
253483|NCT01273597|836072|P1|Overall Study|Underwent Kidney Transplantation|2
253484|NCT01273597|836072|P1|Overall Study|Adverse Event|5
253485|NCT01273519|836087|P3|Overall Study|Not Specified|1
253486|NCT01273519|836088|P2|Overall Study|Not Specified|1
253487|NCT01273519|836089|P1|Overall Study|Not Specified|6
253488|NCT01273519|836087|P3|Overall Study|Lack of Efficacy|4
253489|NCT01273519|836088|P2|Overall Study|Lack of Efficacy|3
253490|NCT01273519|836089|P1|Overall Study|Lack of Efficacy|8
253491|NCT01273519|836087|P3|Overall Study|Lost to Follow-up|3
253492|NCT01273519|836088|P2|Overall Study|Lost to Follow-up|1
253493|NCT01273519|836089|P1|Overall Study|Lost to Follow-up|2
253494|NCT01273519|836087|P3|Overall Study|Adverse Event|0
253495|NCT01273519|836088|P2|Overall Study|Adverse Event|0
253496|NCT01273519|836089|P1|Overall Study|Adverse Event|3
253497|NCT01273181|836126|P4|Phase 2, Dose 2|Death during treatment|1
253498|NCT01273181|836127|P3|Phase 2, Dose 2|Death during treatment|0
253499|NCT01273181|836128|P2|Phase 2, Dose 2|Death during treatment|0
253500|NCT01273181|836129|P1|Phase 2, Dose 2|Death during treatment|0
253501|NCT01273181|836126|P4|Phase 2, Dose 1|Study termination|0
253502|NCT01273181|836127|P3|Phase 2, Dose 1|Study termination|1
253503|NCT01273181|836128|P2|Phase 2, Dose 1|Study termination|0
253504|NCT01273181|836129|P1|Phase 2, Dose 1|Study termination|0
253505|NCT01273181|836126|P4|Phase I, Dose 2|Death during treatment|0
253506|NCT01273181|836127|P3|Phase I, Dose 2|Death during treatment|0
253507|NCT01273181|836128|P2|Phase I, Dose 2|Death during treatment|1
253508|NCT01273181|836129|P1|Phase I, Dose 2|Death during treatment|0
253509|NCT01273181|836126|P4|Phase I, Dose 1|Study termination|0
253510|NCT01273181|836127|P3|Phase I, Dose 1|Study termination|0
253511|NCT01273181|836128|P2|Phase I, Dose 1|Study termination|0
253512|NCT01273181|836129|P1|Phase I, Dose 1|Study termination|1
253513|NCT01273064|836148|P5|Overall Study|Physician Decision|1
253514|NCT01273064|836149|P4|Overall Study|Physician Decision|0
253515|NCT01273064|836150|P3|Overall Study|Physician Decision|0
253516|NCT01273064|836151|P2|Overall Study|Physician Decision|0
253517|NCT01273064|836152|P1|Overall Study|Physician Decision|0
253518|NCT01273064|836148|P5|Overall Study|Lost to Follow-up|0
253519|NCT01273064|836149|P4|Overall Study|Lost to Follow-up|0
253520|NCT01273064|836150|P3|Overall Study|Lost to Follow-up|0
253521|NCT01273064|836151|P2|Overall Study|Lost to Follow-up|0
253522|NCT01273064|836152|P1|Overall Study|Lost to Follow-up|1
253523|NCT01273064|836148|P5|Overall Study|Study Termination|8
253524|NCT01273064|836149|P4|Overall Study|Study Termination|16
253525|NCT01273064|836150|P3|Overall Study|Study Termination|26
253526|NCT01273064|836151|P2|Overall Study|Study Termination|27
253527|NCT01273064|836152|P1|Overall Study|Study Termination|13
253528|NCT01273064|836148|P5|Overall Study|Withdrawal by Subject|0
253529|NCT01273064|836149|P4|Overall Study|Withdrawal by Subject|2
253530|NCT01273064|836150|P3|Overall Study|Withdrawal by Subject|2
253531|NCT01273064|836151|P2|Overall Study|Withdrawal by Subject|2
253532|NCT01273064|836152|P1|Overall Study|Withdrawal by Subject|4
253533|NCT01273064|836148|P5|Overall Study|Adverse Event|1
253534|NCT01273064|836149|P4|Overall Study|Adverse Event|2
253535|NCT01273064|836150|P3|Overall Study|Adverse Event|3
253536|NCT01273064|836151|P2|Overall Study|Adverse Event|1
253537|NCT01273064|836152|P1|Overall Study|Adverse Event|5
253538|NCT01273038|836171|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
253539|NCT01273038|836172|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
253540|NCT01273038|836171|P2|Second Intervention (14 Days)|Adverse Event|1
253541|NCT01273038|836172|P1|Second Intervention (14 Days)|Adverse Event|0
253542|NCT01272947|836180|P2|Overall Study|Abnormal Laboratory Value|2
253543|NCT01272947|836181|P1|Overall Study|Abnormal Laboratory Value|2
253544|NCT01272934|836191|P2|Overall Study|Abnormal Laboratory Value|1
253545|NCT01272934|836192|P1|Overall Study|Abnormal Laboratory Value|0
253546|NCT01272934|836191|P2|Overall Study|Adverse Event|1
253547|NCT01272934|836192|P1|Overall Study|Adverse Event|0
253548|NCT01272921|836202|P2|Overall Study|Protocol Violation|1
253549|NCT01272921|836203|P1|Overall Study|Protocol Violation|2
253550|NCT01272908|836211|P1|Re-Treatment Period|Withdrawal by Subject|1
253551|NCT01272908|836211|P1|Re-Treatment Period|Lack of Efficacy|3
253552|NCT01272908|836211|P1|Re-Treatment Period|Adverse Event|2
253553|NCT01272908|836211|P1|Initial Treatment Period|Withdrawal by Subject|1
253554|NCT01272908|836211|P1|Initial Treatment Period|Protocol Violation|1
253555|NCT01272908|836211|P1|Initial Treatment Period|Lack of Efficacy|5
253556|NCT01272908|836211|P1|Initial Treatment Period|Adverse Event|1
253557|NCT01272869|836251|P2|Period 2 (14 Days)|Adverse Event|0
253558|NCT01272869|836252|P1|Period 2 (14 Days)|Adverse Event|1
253559|NCT01272804|836264|P6|Overall Study|Adverse Event|1
253560|NCT01272804|836265|P5|Overall Study|Adverse Event|2
253561|NCT01272804|836266|P4|Overall Study|Adverse Event|0
253562|NCT01272804|836267|P3|Overall Study|Adverse Event|0
253563|NCT01272804|836268|P2|Overall Study|Adverse Event|0
253564|NCT01272804|836269|P1|Overall Study|Adverse Event|1
253565|NCT01272661|836427|P3|Overall Study|lost to followup/case closed/ no birth|72
253566|NCT01272661|836428|P2|Overall Study|lost to followup/case closed/ no birth|209
253567|NCT01272661|836429|P1|Overall Study|lost to followup/case closed/ no birth|126
253568|NCT01272635|836454|P4|Overall Study|Lost to Follow-up|23
253569|NCT01272635|836455|P3|Overall Study|Lost to Follow-up|31
253570|NCT01272635|836456|P2|Overall Study|Lost to Follow-up|20
253571|NCT01272635|836457|P1|Overall Study|Lost to Follow-up|31
253572|NCT01272232|836522|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
253573|NCT01272232|836523|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
253574|NCT01272232|836524|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
253575|NCT01272232|836522|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
253576|NCT01272232|836523|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
253577|NCT01272232|836524|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
253578|NCT01272232|836522|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
253579|NCT01272232|836523|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
253580|NCT01272232|836524|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
253581|NCT01272232|836522|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
253582|NCT01272232|836523|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
253583|NCT01272232|836524|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
253584|NCT01272232|836522|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
253585|NCT01272232|836523|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
253586|NCT01272232|836524|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
253587|NCT01272232|836522|P3|Weeks 0-56|Unclassified|12
253588|NCT01272232|836523|P2|Weeks 0-56|Unclassified|7
253589|NCT01272232|836524|P1|Weeks 0-56|Unclassified|16
253590|NCT01272232|836522|P3|Weeks 0-56|Withdrawal criteria|37
253591|NCT01272232|836523|P2|Weeks 0-56|Withdrawal criteria|14
253592|NCT01272232|836524|P1|Weeks 0-56|Withdrawal criteria|32
253593|NCT01272232|836522|P3|Weeks 0-56|Protocol Violation|13
253594|NCT01272232|836523|P2|Weeks 0-56|Protocol Violation|8
253595|NCT01272232|836524|P1|Weeks 0-56|Protocol Violation|12
253596|NCT01272232|836522|P3|Weeks 0-56|Lack of Efficacy|3
253597|NCT01272232|836523|P2|Weeks 0-56|Lack of Efficacy|0
253598|NCT01272232|836524|P1|Weeks 0-56|Lack of Efficacy|0
253599|NCT01272232|836522|P3|Weeks 0-56|Adverse Event|7
253600|NCT01272232|836523|P2|Weeks 0-56|Adverse Event|18
253601|NCT01272232|836524|P1|Weeks 0-56|Adverse Event|39
253602|NCT01272219|836569|P6|Main + Extension Period: Week 0-172|Unclassified|51
253603|NCT01272219|836570|P5|Main + Extension Period: Week 0-172|Unclassified|61
253604|NCT01272219|836571|P4|Main + Extension Period: Week 0-172|Unclassified|0
253605|NCT01272219|836572|P3|Main + Extension Period: Week 0-172|Unclassified|0
253606|NCT01272219|836573|P2|Main + Extension Period: Week 0-172|Unclassified|0
253607|NCT01272219|836574|P1|Main + Extension Period: Week 0-172|Unclassified|0
253608|NCT01272219|836569|P6|Main + Extension Period: Week 0-172|Missing reason|0
253609|NCT01272219|836570|P5|Main + Extension Period: Week 0-172|Missing reason|1
253610|NCT01272219|836571|P4|Main + Extension Period: Week 0-172|Missing reason|0
253611|NCT01272219|836572|P3|Main + Extension Period: Week 0-172|Missing reason|0
253612|NCT01272219|836573|P2|Main + Extension Period: Week 0-172|Missing reason|0
253613|NCT01272219|836574|P1|Main + Extension Period: Week 0-172|Missing reason|0
253614|NCT01272219|836569|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
253615|NCT01272219|836570|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
253616|NCT01272219|836571|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
253617|NCT01272219|836572|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
253618|NCT01272219|836573|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
253619|NCT01272219|836574|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
253620|NCT01272219|836569|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
253621|NCT01272219|836570|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
253622|NCT01272219|836571|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
253623|NCT01272219|836572|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
253624|NCT01272219|836573|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
253625|NCT01272219|836574|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
253626|NCT01272219|836569|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
253627|NCT01272219|836570|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
253628|NCT01272219|836571|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
253629|NCT01272219|836572|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
253630|NCT01272219|836573|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
253631|NCT01272219|836574|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
253632|NCT01272219|836569|P6|Main + Extension Period: Week 0-172|Adverse Event|43
253633|NCT01272219|836570|P5|Main + Extension Period: Week 0-172|Adverse Event|191
253634|NCT01272219|836571|P4|Main + Extension Period: Week 0-172|Adverse Event|0
253635|NCT01272219|836572|P3|Main + Extension Period: Week 0-172|Adverse Event|0
253636|NCT01272219|836573|P2|Main + Extension Period: Week 0-172|Adverse Event|0
253637|NCT01272219|836574|P1|Main + Extension Period: Week 0-172|Adverse Event|0
253638|NCT01272219|836569|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
253639|NCT01272219|836570|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
253640|NCT01272219|836571|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
253641|NCT01272219|836572|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
253642|NCT01272219|836573|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
253643|NCT01272219|836574|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
253644|NCT01272219|836569|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
253645|NCT01272219|836570|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
253646|NCT01272219|836571|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
253647|NCT01272219|836572|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
253648|NCT01272219|836573|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
253649|NCT01272219|836574|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
253650|NCT01272219|836569|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
253651|NCT01272219|836570|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
253652|NCT01272219|836571|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
253653|NCT01272219|836572|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
253654|NCT01272219|836573|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
253655|NCT01272219|836574|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
253656|NCT01272219|836569|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
253657|NCT01272219|836570|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
253658|NCT01272219|836571|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
253659|NCT01272219|836572|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
253660|NCT01272219|836573|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
253661|NCT01272219|836574|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
253662|NCT01272219|836569|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
253663|NCT01272219|836570|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
253664|NCT01272219|836571|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
253665|NCT01272219|836572|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
253666|NCT01272219|836573|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
253667|NCT01272219|836574|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
253668|NCT01272219|836569|P6|Main Period: Week 0 to Week 56|Unclassified|34
253669|NCT01272219|836570|P5|Main Period: Week 0 to Week 56|Unclassified|42
253670|NCT01272219|836571|P4|Main Period: Week 0 to Week 56|Unclassified|29
253671|NCT01272219|836572|P3|Main Period: Week 0 to Week 56|Unclassified|0
253672|NCT01272219|836573|P2|Main Period: Week 0 to Week 56|Unclassified|0
253673|NCT01272219|836574|P1|Main Period: Week 0 to Week 56|Unclassified|36
253674|NCT01272219|836569|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
253675|NCT01272219|836570|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
253676|NCT01272219|836571|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
253677|NCT01272219|836572|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
253678|NCT01272219|836573|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
253679|NCT01272219|836574|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
253680|NCT01272219|836569|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
253681|NCT01272219|836570|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
253682|NCT01272219|836571|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
253683|NCT01272219|836572|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
253684|NCT01272219|836573|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
253775|NCT01271803|836757|P2|Stage 2|Withdrawal by Subject|0
253685|NCT01272219|836574|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
253686|NCT01272219|836569|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
253687|NCT01272219|836570|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
253688|NCT01272219|836571|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
253689|NCT01272219|836572|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
253690|NCT01272219|836573|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
253691|NCT01272219|836574|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
253692|NCT01272219|836569|P6|Main Period: Week 0 to Week 56|Adverse Event|29
253693|NCT01272219|836570|P5|Main Period: Week 0 to Week 56|Adverse Event|152
253694|NCT01272219|836571|P4|Main Period: Week 0 to Week 56|Adverse Event|16
253695|NCT01272219|836572|P3|Main Period: Week 0 to Week 56|Adverse Event|0
253696|NCT01272219|836573|P2|Main Period: Week 0 to Week 56|Adverse Event|0
253697|NCT01272219|836574|P1|Main Period: Week 0 to Week 56|Adverse Event|86
253698|NCT01272193|836608|P2|Overall Study|Unclassified|7
253699|NCT01272193|836609|P1|Overall Study|Unclassified|8
253700|NCT01272193|836608|P2|Overall Study|Withdrawal Criteria|1
253701|NCT01272193|836609|P1|Overall Study|Withdrawal Criteria|1
253702|NCT01272193|836608|P2|Overall Study|Lack of Efficacy|3
253703|NCT01272193|836609|P1|Overall Study|Lack of Efficacy|0
253704|NCT01272193|836608|P2|Overall Study|Adverse Event|1
253705|NCT01272193|836609|P1|Overall Study|Adverse Event|1
253706|NCT01272180|836629|P4|Overall Study|Protocol Violation|1
253707|NCT01272180|836630|P3|Overall Study|Protocol Violation|0
253708|NCT01272180|836631|P2|Overall Study|Protocol Violation|1
253709|NCT01272180|836632|P1|Overall Study|Protocol Violation|0
253710|NCT01272180|836629|P4|Overall Study|Inappropriate enrollment|1
253711|NCT01272180|836630|P3|Overall Study|Inappropriate enrollment|1
253712|NCT01272180|836631|P2|Overall Study|Inappropriate enrollment|0
253713|NCT01272180|836632|P1|Overall Study|Inappropriate enrollment|0
253714|NCT01272180|836629|P4|Overall Study|Lost to Follow-up|10
253715|NCT01272180|836630|P3|Overall Study|Lost to Follow-up|8
253716|NCT01272180|836631|P2|Overall Study|Lost to Follow-up|14
253717|NCT01272180|836632|P1|Overall Study|Lost to Follow-up|15
253718|NCT01272180|836629|P4|Overall Study|Withdrawal by Subject|2
253719|NCT01272180|836630|P3|Overall Study|Withdrawal by Subject|3
253720|NCT01272180|836631|P2|Overall Study|Withdrawal by Subject|6
253721|NCT01272180|836632|P1|Overall Study|Withdrawal by Subject|2
253722|NCT01272180|836629|P4|Overall Study|Adverse Event|0
253723|NCT01272180|836630|P3|Overall Study|Adverse Event|1
253724|NCT01272180|836631|P2|Overall Study|Adverse Event|0
253725|NCT01272180|836632|P1|Overall Study|Adverse Event|0
253726|NCT01272011|836681|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
253727|NCT01272011|836682|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
253728|NCT01272011|836683|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
253729|NCT01271803|836747|P12|Stage 2|Ongoing in the Study|14
253730|NCT01271803|836748|P11|Stage 2|Ongoing in the Study|6
253731|NCT01271803|836749|P10|Stage 2|Ongoing in the Study|0
253732|NCT01271803|836750|P9|Stage 2|Ongoing in the Study|0
253733|NCT01271803|836751|P8|Stage 2|Ongoing in the Study|0
253734|NCT01271803|836752|P7|Stage 2|Ongoing in the Study|0
253735|NCT01271803|836753|P6|Stage 2|Ongoing in the Study|0
253736|NCT01271803|836754|P5|Stage 2|Ongoing in the Study|0
253737|NCT01271803|836755|P4|Stage 2|Ongoing in the Study|0
253738|NCT01271803|836756|P3|Stage 2|Ongoing in the Study|0
253739|NCT01271803|836757|P2|Stage 2|Ongoing in the Study|0
253740|NCT01271803|836758|P1|Stage 2|Ongoing in the Study|0
253741|NCT01271803|836747|P12|Stage 2|Unspecified|0
253742|NCT01271803|836748|P11|Stage 2|Unspecified|1
253743|NCT01271803|836749|P10|Stage 2|Unspecified|0
253744|NCT01271803|836750|P9|Stage 2|Unspecified|0
253745|NCT01271803|836751|P8|Stage 2|Unspecified|0
253746|NCT01271803|836752|P7|Stage 2|Unspecified|0
253747|NCT01271803|836753|P6|Stage 2|Unspecified|0
253748|NCT01271803|836754|P5|Stage 2|Unspecified|0
253749|NCT01271803|836755|P4|Stage 2|Unspecified|0
253750|NCT01271803|836756|P3|Stage 2|Unspecified|0
253751|NCT01271803|836757|P2|Stage 2|Unspecified|0
253752|NCT01271803|836758|P1|Stage 2|Unspecified|0
253753|NCT01271803|836747|P12|Stage 2|Physician Decision|1
253754|NCT01271803|836748|P11|Stage 2|Physician Decision|0
253755|NCT01271803|836749|P10|Stage 2|Physician Decision|0
253756|NCT01271803|836750|P9|Stage 2|Physician Decision|0
253757|NCT01271803|836751|P8|Stage 2|Physician Decision|0
253758|NCT01271803|836752|P7|Stage 2|Physician Decision|0
253759|NCT01271803|836753|P6|Stage 2|Physician Decision|0
253760|NCT01271803|836754|P5|Stage 2|Physician Decision|0
253761|NCT01271803|836755|P4|Stage 2|Physician Decision|0
253762|NCT01271803|836756|P3|Stage 2|Physician Decision|0
253763|NCT01271803|836757|P2|Stage 2|Physician Decision|0
253764|NCT01271803|836758|P1|Stage 2|Physician Decision|0
253765|NCT01271803|836747|P12|Stage 2|Withdrawal by Subject|2
253766|NCT01271803|836748|P11|Stage 2|Withdrawal by Subject|0
253767|NCT01271803|836749|P10|Stage 2|Withdrawal by Subject|0
253768|NCT01271803|836750|P9|Stage 2|Withdrawal by Subject|0
253769|NCT01271803|836751|P8|Stage 2|Withdrawal by Subject|0
253770|NCT01271803|836752|P7|Stage 2|Withdrawal by Subject|0
253771|NCT01271803|836753|P6|Stage 2|Withdrawal by Subject|0
253772|NCT01271803|836754|P5|Stage 2|Withdrawal by Subject|0
253773|NCT01271803|836755|P4|Stage 2|Withdrawal by Subject|0
253774|NCT01271803|836756|P3|Stage 2|Withdrawal by Subject|0
253776|NCT01271803|836758|P1|Stage 2|Withdrawal by Subject|0
253777|NCT01271803|836747|P12|Stage 2|Death|2
253778|NCT01271803|836748|P11|Stage 2|Death|2
253779|NCT01271803|836749|P10|Stage 2|Death|0
253780|NCT01271803|836750|P9|Stage 2|Death|0
253781|NCT01271803|836751|P8|Stage 2|Death|0
253782|NCT01271803|836752|P7|Stage 2|Death|0
253783|NCT01271803|836753|P6|Stage 2|Death|0
253784|NCT01271803|836754|P5|Stage 2|Death|0
253785|NCT01271803|836755|P4|Stage 2|Death|0
253786|NCT01271803|836756|P3|Stage 2|Death|0
253787|NCT01271803|836757|P2|Stage 2|Death|0
253788|NCT01271803|836758|P1|Stage 2|Death|0
253789|NCT01271803|836747|P12|Stage 2|Adverse Event|3
253790|NCT01271803|836748|P11|Stage 2|Adverse Event|1
253791|NCT01271803|836749|P10|Stage 2|Adverse Event|0
253792|NCT01271803|836750|P9|Stage 2|Adverse Event|0
253793|NCT01271803|836751|P8|Stage 2|Adverse Event|0
253794|NCT01271803|836752|P7|Stage 2|Adverse Event|0
253795|NCT01271803|836753|P6|Stage 2|Adverse Event|0
253796|NCT01271803|836754|P5|Stage 2|Adverse Event|0
253797|NCT01271803|836755|P4|Stage 2|Adverse Event|0
253798|NCT01271803|836756|P3|Stage 2|Adverse Event|0
253799|NCT01271803|836757|P2|Stage 2|Adverse Event|0
253800|NCT01271803|836758|P1|Stage 2|Adverse Event|0
253801|NCT01271803|836747|P12|Stage 2|Progressive disease|17
253802|NCT01271803|836748|P11|Stage 2|Progressive disease|17
253803|NCT01271803|836749|P10|Stage 2|Progressive disease|0
253804|NCT01271803|836750|P9|Stage 2|Progressive disease|0
253805|NCT01271803|836751|P8|Stage 2|Progressive disease|0
253806|NCT01271803|836752|P7|Stage 2|Progressive disease|0
253807|NCT01271803|836753|P6|Stage 2|Progressive disease|0
253808|NCT01271803|836754|P5|Stage 2|Progressive disease|0
253809|NCT01271803|836755|P4|Stage 2|Progressive disease|0
253810|NCT01271803|836756|P3|Stage 2|Progressive disease|0
253811|NCT01271803|836757|P2|Stage 2|Progressive disease|0
253812|NCT01271803|836758|P1|Stage 2|Progressive disease|0
253813|NCT01271803|836747|P12|Stage 1|Ongoing in the Study|0
253814|NCT01271803|836748|P11|Stage 1|Ongoing in the Study|0
253815|NCT01271803|836749|P10|Stage 1|Ongoing in the Study|0
253816|NCT01271803|836750|P9|Stage 1|Ongoing in the Study|1
253817|NCT01271803|836751|P8|Stage 1|Ongoing in the Study|1
253818|NCT01271803|836752|P7|Stage 1|Ongoing in the Study|1
253819|NCT01271803|836753|P6|Stage 1|Ongoing in the Study|0
253820|NCT01271803|836754|P5|Stage 1|Ongoing in the Study|3
253821|NCT01271803|836755|P4|Stage 1|Ongoing in the Study|1
253822|NCT01271803|836756|P3|Stage 1|Ongoing in the Study|11
253823|NCT01271803|836757|P2|Stage 1|Ongoing in the Study|1
253824|NCT01271803|836758|P1|Stage 1|Ongoing in the Study|0
253825|NCT01271803|836747|P12|Stage 1|Unspecified|0
253826|NCT01271803|836748|P11|Stage 1|Unspecified|0
253827|NCT01271803|836749|P10|Stage 1|Unspecified|0
253828|NCT01271803|836750|P9|Stage 1|Unspecified|0
253829|NCT01271803|836751|P8|Stage 1|Unspecified|0
253830|NCT01271803|836752|P7|Stage 1|Unspecified|0
253831|NCT01271803|836753|P6|Stage 1|Unspecified|0
253832|NCT01271803|836754|P5|Stage 1|Unspecified|0
253833|NCT01271803|836755|P4|Stage 1|Unspecified|0
253834|NCT01271803|836756|P3|Stage 1|Unspecified|2
253835|NCT01271803|836757|P2|Stage 1|Unspecified|0
253836|NCT01271803|836758|P1|Stage 1|Unspecified|0
253837|NCT01271803|836747|P12|Stage 1|Withdrawal by Subject|0
253838|NCT01271803|836748|P11|Stage 1|Withdrawal by Subject|0
253839|NCT01271803|836749|P10|Stage 1|Withdrawal by Subject|0
253840|NCT01271803|836750|P9|Stage 1|Withdrawal by Subject|0
253841|NCT01271803|836751|P8|Stage 1|Withdrawal by Subject|0
253842|NCT01271803|836752|P7|Stage 1|Withdrawal by Subject|0
253843|NCT01271803|836753|P6|Stage 1|Withdrawal by Subject|0
253844|NCT01271803|836754|P5|Stage 1|Withdrawal by Subject|0
253845|NCT01271803|836755|P4|Stage 1|Withdrawal by Subject|0
253846|NCT01271803|836756|P3|Stage 1|Withdrawal by Subject|1
253847|NCT01271803|836757|P2|Stage 1|Withdrawal by Subject|0
253848|NCT01271803|836758|P1|Stage 1|Withdrawal by Subject|0
253849|NCT01271803|836747|P12|Stage 1|Physician Decision|0
253850|NCT01271803|836748|P11|Stage 1|Physician Decision|0
253851|NCT01271803|836749|P10|Stage 1|Physician Decision|0
253852|NCT01271803|836750|P9|Stage 1|Physician Decision|0
253853|NCT01271803|836751|P8|Stage 1|Physician Decision|0
253854|NCT01271803|836752|P7|Stage 1|Physician Decision|1
253855|NCT01271803|836753|P6|Stage 1|Physician Decision|0
253856|NCT01271803|836754|P5|Stage 1|Physician Decision|0
253857|NCT01271803|836755|P4|Stage 1|Physician Decision|0
253858|NCT01271803|836756|P3|Stage 1|Physician Decision|0
253859|NCT01271803|836757|P2|Stage 1|Physician Decision|0
253860|NCT01271803|836758|P1|Stage 1|Physician Decision|1
253861|NCT01271803|836747|P12|Stage 1|Death|0
253862|NCT01271803|836748|P11|Stage 1|Death|0
253863|NCT01271803|836749|P10|Stage 1|Death|0
253864|NCT01271803|836750|P9|Stage 1|Death|0
253865|NCT01271803|836751|P8|Stage 1|Death|0
253866|NCT01271803|836752|P7|Stage 1|Death|0
253867|NCT01271803|836753|P6|Stage 1|Death|1
253868|NCT01271803|836754|P5|Stage 1|Death|0
253869|NCT01271803|836755|P4|Stage 1|Death|0
253870|NCT01271803|836756|P3|Stage 1|Death|0
253871|NCT01271803|836757|P2|Stage 1|Death|0
253872|NCT01271803|836758|P1|Stage 1|Death|1
253873|NCT01271803|836747|P12|Stage 1|Adverse Event|0
253874|NCT01271803|836748|P11|Stage 1|Adverse Event|0
253875|NCT01271803|836749|P10|Stage 1|Adverse Event|0
253876|NCT01271803|836750|P9|Stage 1|Adverse Event|0
253877|NCT01271803|836751|P8|Stage 1|Adverse Event|0
253878|NCT01271803|836752|P7|Stage 1|Adverse Event|0
253879|NCT01271803|836753|P6|Stage 1|Adverse Event|0
253880|NCT01271803|836754|P5|Stage 1|Adverse Event|0
253881|NCT01271803|836755|P4|Stage 1|Adverse Event|0
253882|NCT01271803|836756|P3|Stage 1|Adverse Event|1
253883|NCT01271803|836757|P2|Stage 1|Adverse Event|0
253884|NCT01271803|836758|P1|Stage 1|Adverse Event|0
253885|NCT01271803|836747|P12|Stage 1|Progressive disease|0
253886|NCT01271803|836748|P11|Stage 1|Progressive disease|0
253887|NCT01271803|836749|P10|Stage 1|Progressive disease|2
253888|NCT01271803|836750|P9|Stage 1|Progressive disease|4
253889|NCT01271803|836751|P8|Stage 1|Progressive disease|2
253890|NCT01271803|836752|P7|Stage 1|Progressive disease|2
253891|NCT01271803|836753|P6|Stage 1|Progressive disease|3
253892|NCT01271803|836754|P5|Stage 1|Progressive disease|1
253893|NCT01271803|836755|P4|Stage 1|Progressive disease|2
253894|NCT01271803|836756|P3|Stage 1|Progressive disease|12
253895|NCT01271803|836757|P2|Stage 1|Progressive disease|7
253896|NCT01271803|836758|P1|Stage 1|Progressive disease|3
253897|NCT01271712|836931|P2|Survival Follow-up|Ongoing with open-label treatment|1
253898|NCT01271712|836932|P1|Survival Follow-up|Ongoing with open-label treatment|14
253899|NCT01271712|836931|P2|Survival Follow-up|Death|3
253900|NCT01271712|836932|P1|Survival Follow-up|Death|13
253901|NCT01271712|836931|P2|Safety Follow-up|Ongoing with open-label treatment|0
253902|NCT01271712|836932|P1|Safety Follow-up|Ongoing with open-label treatment|3
253903|NCT01271712|836931|P2|Safety Follow-up|Protocol Violation|0
253904|NCT01271712|836932|P1|Safety Follow-up|Protocol Violation|1
253905|NCT01271712|836931|P2|Safety Follow-up|Withdrawal by Subject|1
253906|NCT01271712|836932|P1|Safety Follow-up|Withdrawal by Subject|1
253907|NCT01271712|836931|P2|Safety Follow-up|Death|2
253908|NCT01271712|836932|P1|Safety Follow-up|Death|4
253909|NCT01271712|836931|P2|Open Label Treatment|Ongoing with open-label treatment|33
253910|NCT01271712|836932|P1|Open Label Treatment|Ongoing with open-label treatment|24
253911|NCT01271712|836931|P2|Open Label Treatment|Progressive disease|13
253912|NCT01271712|836932|P1|Open Label Treatment|Progressive disease|12
253913|NCT01271712|836931|P2|Open Label Treatment|Adverse Event|4
253914|NCT01271712|836932|P1|Open Label Treatment|Adverse Event|2
253915|NCT01271712|836931|P2|Open Label Treatment|Physician Decision|0
253916|NCT01271712|836932|P1|Open Label Treatment|Physician Decision|2
253917|NCT01271712|836931|P2|Open Label Treatment|Withdrawal by Subject|5
253918|NCT01271712|836932|P1|Open Label Treatment|Withdrawal by Subject|0
253919|NCT01271712|836931|P2|Open Label Treatment|Death|1
253920|NCT01271712|836932|P1|Open Label Treatment|Death|1
253921|NCT01271712|836931|P2|Double Blind Treatment|receive no study drug|0
253922|NCT01271712|836932|P1|Double Blind Treatment|receive no study drug|1
253923|NCT01271712|836931|P2|Double Blind Treatment|Ongoing in double-blind treatment|3
253924|NCT01271712|836932|P1|Double Blind Treatment|Ongoing in double-blind treatment|53
253925|NCT01271712|836931|P2|Double Blind Treatment|Non compliance with study drug|0
253926|NCT01271712|836932|P1|Double Blind Treatment|Non compliance with study drug|2
253927|NCT01271712|836931|P2|Double Blind Treatment|Withdrawal by Subject|0
253928|NCT01271712|836932|P1|Double Blind Treatment|Withdrawal by Subject|4
253929|NCT01271712|836931|P2|Double Blind Treatment|Progressive disease|3
253930|NCT01271712|836932|P1|Double Blind Treatment|Progressive disease|21
253931|NCT01271712|836931|P2|Double Blind Treatment|Adverse Event|4
253932|NCT01271712|836932|P1|Double Blind Treatment|Adverse Event|8
253933|NCT01271712|836931|P2|Double Blind Treatment|Lack of Efficacy|0
253934|NCT01271712|836932|P1|Double Blind Treatment|Lack of Efficacy|1
253935|NCT01271712|836931|P2|Double Blind Treatment|Death|0
253936|NCT01271712|836932|P1|Double Blind Treatment|Death|2
253937|NCT01270971|837027|P2|Overall Study|Non-specific|3
253938|NCT01270971|837028|P1|Overall Study|Non-specific|7
253939|NCT01270971|837027|P2|Overall Study|Non compliance|2
253940|NCT01270971|837028|P1|Overall Study|Non compliance|2
253941|NCT01270971|837027|P2|Overall Study|Adverse Event|2
253942|NCT01270971|837028|P1|Overall Study|Adverse Event|1
253943|NCT01270971|837027|P2|Overall Study|Lost to Follow-up|5
253944|NCT01270971|837028|P1|Overall Study|Lost to Follow-up|18
253945|NCT01270971|837027|P2|Overall Study|Withdrawal by Subject|11
253946|NCT01270971|837028|P1|Overall Study|Withdrawal by Subject|24
253947|NCT01270958|837040|P1|Overall Study|Did not meet inclusion criteria for age|2
253948|NCT01270958|837040|P1|Overall Study|Lost to Follow-up|2
253949|NCT01270880|837069|P1|Overall Study|Never rec'd treatment, but registered.|1
253950|NCT01270841|837094|P4|Overall Study|Enrolled in error|0
253951|NCT01270841|837095|P3|Overall Study|Enrolled in error|0
253952|NCT01270841|837096|P2|Overall Study|Enrolled in error|1
253953|NCT01270841|837097|P1|Overall Study|Enrolled in error|0
253954|NCT01270841|837094|P4|Overall Study|Protocol Violation|0
253955|NCT01270841|837095|P3|Overall Study|Protocol Violation|0
253956|NCT01270841|837096|P2|Overall Study|Protocol Violation|5
253957|NCT01270841|837097|P1|Overall Study|Protocol Violation|1
253958|NCT01270841|837094|P4|Overall Study|Did not qualify|5
253959|NCT01270841|837095|P3|Overall Study|Did not qualify|4
253960|NCT01270841|837096|P2|Overall Study|Did not qualify|3
253961|NCT01270841|837097|P1|Overall Study|Did not qualify|6
253962|NCT01270841|837094|P4|Overall Study|Physician Decision|0
253963|NCT01270841|837095|P3|Overall Study|Physician Decision|0
253964|NCT01270841|837096|P2|Overall Study|Physician Decision|1
253965|NCT01270841|837097|P1|Overall Study|Physician Decision|0
253966|NCT01270841|837094|P4|Overall Study|Lost to Follow-up|2
253967|NCT01270841|837095|P3|Overall Study|Lost to Follow-up|4
253968|NCT01270841|837096|P2|Overall Study|Lost to Follow-up|1
253969|NCT01270841|837097|P1|Overall Study|Lost to Follow-up|3
253970|NCT01270841|837094|P4|Overall Study|Withdrawal by Subject|3
253971|NCT01270841|837095|P3|Overall Study|Withdrawal by Subject|3
253972|NCT01270841|837096|P2|Overall Study|Withdrawal by Subject|2
253973|NCT01270841|837097|P1|Overall Study|Withdrawal by Subject|3
253974|NCT01270841|837094|P4|Overall Study|Adverse Event|3
253975|NCT01270841|837095|P3|Overall Study|Adverse Event|0
253976|NCT01270841|837096|P2|Overall Study|Adverse Event|1
253977|NCT01270841|837097|P1|Overall Study|Adverse Event|0
253978|NCT01270828|837121|P3|Double Blind Phase|Adverse event related to study drug|0
253979|NCT01270828|837122|P2|Double Blind Phase|Adverse event related to study drug|7
253980|NCT01270828|837123|P1|Double Blind Phase|Adverse event related to study drug|5
253981|NCT01270828|837121|P3|Double Blind Phase|Adverse event not related to study drug|0
253982|NCT01270828|837122|P2|Double Blind Phase|Adverse event not related to study drug|1
253983|NCT01270828|837123|P1|Double Blind Phase|Adverse event not related to study drug|1
253984|NCT01270828|837121|P3|Double Blind Phase|Lack of Efficacy|0
253985|NCT01270828|837122|P2|Double Blind Phase|Lack of Efficacy|11
253986|NCT01270828|837123|P1|Double Blind Phase|Lack of Efficacy|2
253987|NCT01270828|837121|P3|Double Blind Phase|Lost to Follow-up|0
253988|NCT01270828|837122|P2|Double Blind Phase|Lost to Follow-up|2
253989|NCT01270828|837123|P1|Double Blind Phase|Lost to Follow-up|1
253990|NCT01270828|837121|P3|Double Blind Phase|Withdrawal by Subject|0
253991|NCT01270828|837122|P2|Double Blind Phase|Withdrawal by Subject|15
253992|NCT01270828|837123|P1|Double Blind Phase|Withdrawal by Subject|6
253993|NCT01270828|837121|P3|Double Blind Phase|Reason Unspecified|0
253994|NCT01270828|837122|P2|Double Blind Phase|Reason Unspecified|4
253995|NCT01270828|837123|P1|Double Blind Phase|Reason Unspecified|7
253996|NCT01270828|837121|P3|Double Blind Phase|Protocol and GCP non-compliance|0
253997|NCT01270828|837122|P2|Double Blind Phase|Protocol and GCP non-compliance|3
253998|NCT01270828|837123|P1|Double Blind Phase|Protocol and GCP non-compliance|4
253999|NCT01270828|837121|P3|Double Blind Phase|Protocol Violation|0
254000|NCT01270828|837122|P2|Double Blind Phase|Protocol Violation|1
254001|NCT01270828|837123|P1|Double Blind Phase|Protocol Violation|0
254002|NCT01270828|837121|P3|Double Blind Phase|Death|0
254003|NCT01270828|837122|P2|Double Blind Phase|Death|1
254004|NCT01270828|837123|P1|Double Blind Phase|Death|0
254005|NCT01270828|837121|P3|Pregabalin CR SB|Protocol Violation|8
254006|NCT01270828|837122|P2|Pregabalin CR SB|Protocol Violation|0
254007|NCT01270828|837123|P1|Pregabalin CR SB|Protocol Violation|0
254008|NCT01270828|837121|P3|Pregabalin CR SB|Unrelated AE|8
254009|NCT01270828|837122|P2|Pregabalin CR SB|Unrelated AE|0
254010|NCT01270828|837123|P1|Pregabalin CR SB|Unrelated AE|0
254011|NCT01270828|837121|P3|Pregabalin CR SB|Lost to Follow-up|10
254012|NCT01270828|837122|P2|Pregabalin CR SB|Lost to Follow-up|0
254013|NCT01270828|837123|P1|Pregabalin CR SB|Lost to Follow-up|0
254014|NCT01270828|837121|P3|Pregabalin CR SB|Withdrawal by Subject|29
254015|NCT01270828|837122|P2|Pregabalin CR SB|Withdrawal by Subject|0
254016|NCT01270828|837123|P1|Pregabalin CR SB|Withdrawal by Subject|0
254017|NCT01270828|837121|P3|Pregabalin CR SB|Lack of Efficacy|32
254018|NCT01270828|837122|P2|Pregabalin CR SB|Lack of Efficacy|0
254019|NCT01270828|837123|P1|Pregabalin CR SB|Lack of Efficacy|0
254020|NCT01270828|837121|P3|Pregabalin CR SB|Related adverse event|46
254021|NCT01270828|837122|P2|Pregabalin CR SB|Related adverse event|0
254022|NCT01270828|837123|P1|Pregabalin CR SB|Related adverse event|0
254023|NCT01270828|837121|P3|Pregabalin CR SB|Enrolled but not treated|5
254024|NCT01270828|837122|P2|Pregabalin CR SB|Enrolled but not treated|0
254025|NCT01270828|837123|P1|Pregabalin CR SB|Enrolled but not treated|0
254026|NCT01270828|837121|P3|Pregabalin CR SB|Reason Unspecified|8
254027|NCT01270828|837122|P2|Pregabalin CR SB|Reason Unspecified|0
254028|NCT01270828|837123|P1|Pregabalin CR SB|Reason Unspecified|0
254029|NCT01270802|837165|P2|Overall Study|Lost to Follow-up|1
254030|NCT01270802|837166|P1|Overall Study|Lost to Follow-up|0
254031|NCT01270802|837165|P2|Overall Study|Adverse Event|0
254032|NCT01270802|837166|P1|Overall Study|Adverse Event|1
254033|NCT01270802|837165|P2|Overall Study|Withdrawal by Subject|0
254034|NCT01270802|837166|P1|Overall Study|Withdrawal by Subject|1
254035|NCT01270620|837288|P2|Overall Study|Withdrawal by Subject|3
254036|NCT01270620|837289|P1|Overall Study|Withdrawal by Subject|1
254037|NCT01270503|837371|P1|Overall Study|Lost to Follow-up|1
254038|NCT01270464|837379|P3|Overall Study|Not Specified|3
254039|NCT01270464|837380|P2|Overall Study|Not Specified|1
254040|NCT01270464|837381|P1|Overall Study|Not Specified|1
254041|NCT01270464|837379|P3|Overall Study|Lost to Follow-up|1
254042|NCT01270464|837380|P2|Overall Study|Lost to Follow-up|3
254043|NCT01270464|837381|P1|Overall Study|Lost to Follow-up|2
254044|NCT01270464|837379|P3|Overall Study|Withdrawal by Subject|4
254045|NCT01270464|837380|P2|Overall Study|Withdrawal by Subject|1
254046|NCT01270464|837381|P1|Overall Study|Withdrawal by Subject|2
254047|NCT01270464|837379|P3|Overall Study|Adverse Event|7
254048|NCT01270464|837380|P2|Overall Study|Adverse Event|1
254049|NCT01270464|837381|P1|Overall Study|Adverse Event|9
254050|NCT01270464|837379|P3|Overall Study|Lack of Efficacy|1
254051|NCT01270464|837380|P2|Overall Study|Lack of Efficacy|3
254052|NCT01270464|837381|P1|Overall Study|Lack of Efficacy|2
254053|NCT01270464|837379|P3|Overall Study|Protocol Violation|2
254054|NCT01270464|837380|P2|Overall Study|Protocol Violation|3
254055|NCT01270464|837381|P1|Overall Study|Protocol Violation|4
254056|NCT01270256|837430|P2|Overall Study|Withdrawal by Subject|0
254057|NCT01270256|837431|P1|Overall Study|Withdrawal by Subject|1
254058|NCT01270139|837440|P3|Overall Study|Lost to Follow-up|2
254059|NCT01270139|837441|P2|Overall Study|Lost to Follow-up|9
254060|NCT01270139|837442|P1|Overall Study|Lost to Follow-up|10
254061|NCT01270139|837440|P3|Overall Study|Adverse Event|18
254062|NCT01270139|837441|P2|Overall Study|Adverse Event|17
254063|NCT01270139|837442|P1|Overall Study|Adverse Event|8
254064|NCT01269918|837494|P2|Overall Study|Did not receive study drug|3
254065|NCT01269918|837495|P1|Overall Study|Did not receive study drug|0
254066|NCT01269346|837544|P1|Extension Phase|Started a prohibited con med|1
254067|NCT01269346|837544|P1|Extension Phase|Clinical progression|1
254068|NCT01269346|837544|P1|Extension Phase|Physician decision or participant choice|9
254069|NCT01269346|837544|P1|Extension Phase|Disease progression|22
254070|NCT01269346|837544|P1|Extension Phase|Withdrawal by Subject|4
254071|NCT01269346|837544|P1|Extension Phase|Adverse Event|6
254072|NCT01269346|837544|P1|Treatment Phase|Not specified|2
254073|NCT01269346|837544|P1|Treatment Phase|Withdrawal by Subject|1
254074|NCT01269346|837544|P1|Treatment Phase|Adverse Event|3
254075|NCT01269346|837544|P1|Treatment Phase|Disease progression|3
254076|NCT01269125|837555|P3|Overall Study|Lost to Follow-up|0
254077|NCT01269125|837556|P2|Overall Study|Lost to Follow-up|0
254078|NCT01269125|837557|P1|Overall Study|Lost to Follow-up|4
254079|NCT01269125|837555|P3|Overall Study|Adverse Event|0
254080|NCT01269125|837556|P2|Overall Study|Adverse Event|5
254081|NCT01269125|837557|P1|Overall Study|Adverse Event|3
254082|NCT01268891|837596|P2|Overall Study|Administrative or other reason(s)|0
254083|NCT01268891|837597|P1|Overall Study|Administrative or other reason(s)|1
254084|NCT01268891|837596|P2|Overall Study|Withdrawal of Consent|1
254085|NCT01268891|837597|P1|Overall Study|Withdrawal of Consent|3
254086|NCT01268891|837596|P2|Overall Study|Lack of Efficacy|0
254087|NCT01268891|837597|P1|Overall Study|Lack of Efficacy|1
254088|NCT01268891|837596|P2|Overall Study|Adverse Event|7
254089|NCT01268891|837597|P1|Overall Study|Adverse Event|3
254090|NCT01268566|837616|P1|Overall Study|Death|30
254091|NCT01268566|837616|P1|Overall Study|Withdrawal by Subject|12
254092|NCT01268566|837616|P1|Overall Study|Lost to Follow-up|1
254093|NCT01268501|837634|P1|Overall Study|Handling Difficulties|2
254094|NCT01268501|837634|P1|Overall Study|Unacceptable Subjective Vision|3
254095|NCT01268501|837634|P1|Overall Study|Withdrawal by Subject|3
254096|NCT01268501|837634|P1|Overall Study|Lost to Follow-up|1
254097|NCT01268488|837638|P1|Overall Study|Physician Decision|2
254098|NCT01268488|837638|P1|Overall Study|Adverse Event|3
254099|NCT01268306|837645|P1|Overall Study|Lost to Follow-up|1
254100|NCT01268293|837649|P1|Overall Study|Subject choice|1
254101|NCT01268293|837649|P1|Overall Study|Adverse Event|1
254102|NCT01268293|837649|P1|Overall Study|Disease progression|7
254103|NCT01268267|837654|P1|Overall Study|Protocol Violation|1
254104|NCT01268150|837675|P1|Extension Phase|Not specified|6
254105|NCT01268150|837675|P1|Extension Phase|Disease progression|18
254106|NCT01268150|837675|P1|Extension Phase|Adverse Event|3
254107|NCT01268150|837675|P1|Treatment Phase|Not specified|4
254108|NCT01268150|837675|P1|Treatment Phase|Withdrawal by Subject|3
254109|NCT01268150|837675|P1|Treatment Phase|Adverse Event|3
254110|NCT01268150|837675|P1|Treatment Phase|Progression of disease|18
254111|NCT01268098|837694|P2|Overall Study|Adverse Event|0
254112|NCT01268098|837695|P1|Overall Study|Adverse Event|1
254113|NCT01267994|837703|P1|Overall Study|Adverse Event|2
254114|NCT01267266|837772|P2|Lead-in Phase|Withdrawal by Subject|0
254115|NCT01267266|837773|P1|Lead-in Phase|Withdrawal by Subject|1
254116|NCT01267266|837772|P2|Lead-in Phase|Adverse Event|0
254117|NCT01267266|837773|P1|Lead-in Phase|Adverse Event|2
254118|NCT01267266|837772|P2|Lead-in Phase|Lack of Efficacy|0
254119|NCT01267266|837773|P1|Lead-in Phase|Lack of Efficacy|20
254120|NCT01267266|837772|P2|Enrollment Phase|Withdrawal by Subject|0
254121|NCT01267266|837773|P1|Enrollment Phase|Withdrawal by Subject|2
254122|NCT01267253|837786|P1|Overall Study|Inevaluable-never received study treatme|2
254123|NCT01267253|837786|P1|Overall Study|Ineligible - required test not done|1
254124|NCT01267201|837821|P6|Second Intervention Period|Withdrawal by Subject|0
254125|NCT01267201|837822|P5|Second Intervention Period|Withdrawal by Subject|0
254126|NCT01267201|837823|P4|Second Intervention Period|Withdrawal by Subject|0
254127|NCT01267201|837824|P3|Second Intervention Period|Withdrawal by Subject|0
254128|NCT01267201|837825|P2|Second Intervention Period|Withdrawal by Subject|1
254129|NCT01267201|837826|P1|Second Intervention Period|Withdrawal by Subject|0
254130|NCT01267201|837821|P6|First Intervention Period|Withdrawal by Subject|0
254131|NCT01267201|837822|P5|First Intervention Period|Withdrawal by Subject|0
254132|NCT01267201|837823|P4|First Intervention Period|Withdrawal by Subject|0
254133|NCT01267201|837824|P3|First Intervention Period|Withdrawal by Subject|0
254134|NCT01267201|837825|P2|First Intervention Period|Withdrawal by Subject|0
254135|NCT01267201|837826|P1|First Intervention Period|Withdrawal by Subject|1
254136|NCT01267175|837843|P1|Overall Study|Lost to Follow-up|1
254137|NCT01267175|837843|P1|Overall Study|Withdrawal by Subject|1
254138|NCT01266967|837915|P2|Overall Study|Withdrawal by Subject|3
254139|NCT01266967|837916|P1|Overall Study|Withdrawal by Subject|3
254140|NCT01266967|837915|P2|Overall Study|Physician Decision|1
254141|NCT01266967|837916|P1|Overall Study|Physician Decision|0
254142|NCT01266967|837915|P2|Overall Study|Lost to Follow-up|1
254143|NCT01266967|837916|P1|Overall Study|Lost to Follow-up|2
254144|NCT01266967|837915|P2|Overall Study|Study Closed/Terminated|17
254145|NCT01266967|837916|P1|Overall Study|Study Closed/Terminated|15
254146|NCT01266967|837915|P2|Overall Study|Death|61
254147|NCT01266967|837916|P1|Overall Study|Death|69
254148|NCT01266876|837968|P5|Overall Study|Adverse Event|0
254149|NCT01266876|837969|P4|Overall Study|Adverse Event|1
254150|NCT01266876|837970|P3|Overall Study|Adverse Event|0
254151|NCT01266876|837971|P2|Overall Study|Adverse Event|0
254152|NCT01266876|837972|P1|Overall Study|Adverse Event|0
254153|NCT01266850|838079|P5|Overall Study|Site Closure|0
254154|NCT01266850|838080|P4|Overall Study|Site Closure|1
254155|NCT01266850|838081|P3|Overall Study|Site Closure|1
254156|NCT01266850|838082|P2|Overall Study|Site Closure|1
254157|NCT01266850|838083|P1|Overall Study|Site Closure|0
254158|NCT01266850|838079|P5|Overall Study|Adverse Event|1
254159|NCT01266850|838080|P4|Overall Study|Adverse Event|0
254160|NCT01266850|838081|P3|Overall Study|Adverse Event|0
254161|NCT01266850|838082|P2|Overall Study|Adverse Event|0
254162|NCT01266850|838083|P1|Overall Study|Adverse Event|0
254163|NCT01266850|838079|P5|Overall Study|Protocol Violation|2
254164|NCT01266850|838080|P4|Overall Study|Protocol Violation|1
254165|NCT01266850|838081|P3|Overall Study|Protocol Violation|0
254166|NCT01266850|838082|P2|Overall Study|Protocol Violation|1
254167|NCT01266850|838083|P1|Overall Study|Protocol Violation|0
254168|NCT01266850|838079|P5|Overall Study|Physician Decision|3
254169|NCT01266850|838080|P4|Overall Study|Physician Decision|4
254170|NCT01266850|838081|P3|Overall Study|Physician Decision|4
254171|NCT01266850|838082|P2|Overall Study|Physician Decision|6
254172|NCT01266850|838083|P1|Overall Study|Physician Decision|3
254173|NCT01266850|838079|P5|Overall Study|Withdrawal by Subject|12
254174|NCT01266850|838080|P4|Overall Study|Withdrawal by Subject|9
254175|NCT01266850|838081|P3|Overall Study|Withdrawal by Subject|6
254176|NCT01266850|838082|P2|Overall Study|Withdrawal by Subject|9
254177|NCT01266850|838083|P1|Overall Study|Withdrawal by Subject|8
254178|NCT01266850|838079|P5|Overall Study|Lost to Follow-up|12
254179|NCT01266850|838080|P4|Overall Study|Lost to Follow-up|13
254180|NCT01266850|838081|P3|Overall Study|Lost to Follow-up|13
254181|NCT01266850|838082|P2|Overall Study|Lost to Follow-up|19
254182|NCT01266850|838083|P1|Overall Study|Lost to Follow-up|19
254183|NCT01266824|838137|P2|Overall Study|Study terminated prior to completion|3
254184|NCT01266824|838138|P1|Overall Study|Study terminated prior to completion|2
254185|NCT01266265|838161|P2|Overall Study|Clinical worsening|1
254186|NCT01266265|838162|P1|Overall Study|Clinical worsening|1
254187|NCT01266265|838161|P2|Overall Study|Site closed early|3
254188|NCT01266265|838162|P1|Overall Study|Site closed early|4
254189|NCT01266265|838161|P2|Overall Study|Lung transplant|5
254190|NCT01266265|838162|P1|Overall Study|Lung transplant|6
254191|NCT01266265|838161|P2|Overall Study|Non-compliance|5
254192|NCT01266265|838162|P1|Overall Study|Non-compliance|8
254193|NCT01266265|838161|P2|Overall Study|Enrolled in another clinical study|26
254194|NCT01266265|838162|P1|Overall Study|Enrolled in another clinical study|15
254195|NCT01266265|838161|P2|Overall Study|Stopped/changed PAH medication(s)|9
254196|NCT01266265|838162|P1|Overall Study|Stopped/changed PAH medication(s)|16
254197|NCT01266265|838161|P2|Overall Study|Transferred care to another provider|28
254198|NCT01266265|838162|P1|Overall Study|Transferred care to another provider|22
254199|NCT01266265|838161|P2|Overall Study|Respiratory-related adverse event|1
254200|NCT01266265|838162|P1|Overall Study|Respiratory-related adverse event|2
254201|NCT01266265|838161|P2|Overall Study|Withdrawal by Subject|11
254202|NCT01266265|838162|P1|Overall Study|Withdrawal by Subject|13
254203|NCT01266265|838161|P2|Overall Study|Lost to Follow-up|28
254204|NCT01266265|838162|P1|Overall Study|Lost to Follow-up|23
254205|NCT01266265|838161|P2|Overall Study|Death|73
254206|NCT01266265|838162|P1|Overall Study|Death|95
254207|NCT01266148|838170|P2|Overall Study|missing mGFR value + AE|0
254208|NCT01266148|838171|P1|Overall Study|missing mGFR value + AE|1
254209|NCT01266148|838170|P2|Overall Study|Death|3
254210|NCT01266148|838171|P1|Overall Study|Death|2
254211|NCT01266148|838170|P2|Overall Study|2 2R rejections|0
254212|NCT01266148|838171|P1|Overall Study|2 2R rejections|1
254213|NCT01266148|838170|P2|Overall Study|Ongoing rejection|0
254214|NCT01266148|838171|P1|Overall Study|Ongoing rejection|1
254215|NCT01266148|838170|P2|Overall Study|Adverse Event|0
254216|NCT01266148|838171|P1|Overall Study|Adverse Event|2
254217|NCT01266122|838199|P2|Overall Study|Lost to Follow-up|6
254218|NCT01266122|838200|P1|Overall Study|Lost to Follow-up|6
254219|NCT01266070|838208|P1|Overall Study|Protocol Violation|1
254220|NCT01266070|838208|P1|Overall Study|Adverse Event|3
254221|NCT01266031|838216|P3|Overall Study|Adverse Event|3
254222|NCT01266031|838217|P2|Overall Study|Adverse Event|0
254223|NCT01266031|838218|P1|Overall Study|Adverse Event|0
254224|NCT01266031|838216|P3|Overall Study|Not treated|0
254225|NCT01266031|838217|P2|Overall Study|Not treated|3
254226|NCT01266031|838218|P1|Overall Study|Not treated|0
254227|NCT01266018|838226|P2|Overall Study|Progressive disease|1
254228|NCT01266018|838227|P1|Overall Study|Progressive disease|0
254229|NCT01266018|838226|P2|Overall Study|Physician Decision|0
254230|NCT01266018|838227|P1|Overall Study|Physician Decision|1
254231|NCT01265992|838238|P1|Overall Study|Did not receive treatment|1
254232|NCT01265992|838238|P1|Overall Study|Stopped treatment|3
254233|NCT01265992|838238|P1|Overall Study|Administrative reasons|2
254234|NCT01265992|838238|P1|Overall Study|Adverse Event|1
254235|NCT01265992|838238|P1|Overall Study|Withdrawal by Subject|1
254236|NCT01265992|838238|P1|Overall Study|Lost to Follow-up|1
254237|NCT01265875|838264|P1|Overall Study|Uncooperative/unreliable|1
254238|NCT01265823|838272|P1|Overall Study|Participant Request|1
254239|NCT01265823|838272|P1|Overall Study|Protocol Violation|1
254240|NCT01265823|838272|P1|Overall Study|Failure to Return|4
254241|NCT01265823|838272|P1|Overall Study|Unsatisfactory Response Efficacy|1
254242|NCT01265797|838301|P2|Open Label Month|Lost to Follow-up|1
254243|NCT01265797|838302|P1|Open Label Month|Lost to Follow-up|0
254244|NCT01265797|838301|P2|Blinded Month|Diary data incomplete|1
254245|NCT01265797|838302|P1|Blinded Month|Diary data incomplete|0
254246|NCT01265797|838301|P2|Blinded Month|Adverse Event|0
254247|NCT01265797|838302|P1|Blinded Month|Adverse Event|2
254248|NCT01265797|838301|P2|Blinded Month|Protocol Violation|1
254249|NCT01265797|838302|P1|Blinded Month|Protocol Violation|2
254250|NCT01265797|838301|P2|Blinded Month|Lost to Follow-up|0
254251|NCT01265797|838302|P1|Blinded Month|Lost to Follow-up|1
254252|NCT01265797|838301|P2|Blinded Month|Lack of Efficacy|0
254253|NCT01265797|838302|P1|Blinded Month|Lack of Efficacy|5
254254|NCT01265797|838301|P2|Run-in Month|1st seizure during run-in month|1
254255|NCT01265797|838302|P1|Run-in Month|1st seizure during run-in month|0
254256|NCT01265797|838301|P2|Run-in Month|Withdrawal by Subject|4
254257|NCT01265797|838302|P1|Run-in Month|Withdrawal by Subject|0
254258|NCT01265784|838333|P3|Overall Study|Incorrectly Randomized|1
254259|NCT01265784|838334|P2|Overall Study|Incorrectly Randomized|0
254260|NCT01265784|838335|P1|Overall Study|Incorrectly Randomized|0
254261|NCT01265784|838333|P3|Overall Study|Protocol Violation|0
254262|NCT01265784|838334|P2|Overall Study|Protocol Violation|0
254263|NCT01265784|838335|P1|Overall Study|Protocol Violation|2
254264|NCT01265784|838333|P3|Overall Study|Death|0
254265|NCT01265784|838334|P2|Overall Study|Death|0
254266|NCT01265784|838335|P1|Overall Study|Death|3
254267|NCT01265784|838333|P3|Overall Study|Adverse Event|0
254268|NCT01265784|838334|P2|Overall Study|Adverse Event|0
254269|NCT01265784|838335|P1|Overall Study|Adverse Event|1
254270|NCT01265784|838333|P3|Overall Study|Physician Decision|1
254271|NCT01265784|838334|P2|Overall Study|Physician Decision|0
254272|NCT01265784|838335|P1|Overall Study|Physician Decision|1
254273|NCT01265784|838333|P3|Overall Study|Withdrawal by Subject|0
254274|NCT01265784|838334|P2|Overall Study|Withdrawal by Subject|5
254275|NCT01265784|838335|P1|Overall Study|Withdrawal by Subject|0
254276|NCT01265784|838333|P3|Overall Study|Lost to Follow-up|2
254277|NCT01265784|838334|P2|Overall Study|Lost to Follow-up|3
254278|NCT01265784|838335|P1|Overall Study|Lost to Follow-up|5
254279|NCT01265615|838405|P4|Overall Study|Protocol Violation|3
254280|NCT01265615|838406|P3|Overall Study|Protocol Violation|4
254281|NCT01265615|838407|P2|Overall Study|Protocol Violation|2
254282|NCT01265615|838408|P1|Overall Study|Protocol Violation|2
254283|NCT01265563|838459|P5|Overall Study|Withdrawal by Subject|2
254284|NCT01265563|838460|P4|Overall Study|Withdrawal by Subject|0
254285|NCT01265563|838461|P3|Overall Study|Withdrawal by Subject|1
254286|NCT01265563|838462|P2|Overall Study|Withdrawal by Subject|1
254287|NCT01265563|838463|P1|Overall Study|Withdrawal by Subject|0
254288|NCT01265498|838503|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
254289|NCT01265498|838504|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
254290|NCT01265420|838640|P1|Overall Study|Lost to Follow-up|1
254291|NCT01265394|838644|P1|Overall Study|Subjects withdrawn|37
254292|NCT01265056|838651|P2|Overall Study|Withdrawal by Subject|1
254293|NCT01265056|838652|P1|Overall Study|Withdrawal by Subject|1
254294|NCT01265056|838651|P2|Overall Study|Withdrawal by Subject|1
254295|NCT01265056|838652|P1|Overall Study|Withdrawal by Subject|1
254296|NCT01264939|838679|P2|Overall Study|Disease Progression|11
254297|NCT01264939|838680|P1|Overall Study|Disease Progression|8
254298|NCT01264939|838679|P2|Overall Study|Patient/Guardian Decision|10
254299|NCT01264939|838680|P1|Overall Study|Patient/Guardian Decision|8
254300|NCT01264939|838679|P2|Overall Study|Physician Decision|1
254301|NCT01264939|838680|P1|Overall Study|Physician Decision|1
254302|NCT01264939|838679|P2|Overall Study|Lost to Follow-up|3
254303|NCT01264939|838680|P1|Overall Study|Lost to Follow-up|0
254304|NCT01264939|838679|P2|Overall Study|Adverse Event|3
254305|NCT01264939|838680|P1|Overall Study|Adverse Event|1
254306|NCT01264887|838706|P1|Overall Study|Not Specified|2
254307|NCT01264887|838706|P1|Overall Study|Sponsor Decision Administrative Reasons|2
254308|NCT01264887|838706|P1|Overall Study|Withdrawal by Subject|6
254309|NCT01264887|838706|P1|Overall Study|Physician Decision|4
254310|NCT01264887|838706|P1|Overall Study|Lack of Efficacy|5
254311|NCT01264887|838706|P1|Overall Study|Death|7
254312|NCT01264887|838706|P1|Overall Study|Adverse Event|5
254313|NCT01264835|838717|P1|Overall Study|Lost to Follow-up|1
254314|NCT01264770|838727|P6|Overall Study|Adverse Event|1
254315|NCT01264770|838728|P5|Overall Study|Adverse Event|2
254316|NCT01264770|838729|P4|Overall Study|Adverse Event|0
254317|NCT01264770|838730|P3|Overall Study|Adverse Event|8
254318|NCT01264770|838731|P2|Overall Study|Adverse Event|7
254319|NCT01264770|838732|P1|Overall Study|Adverse Event|7
254320|NCT01264770|838727|P6|Overall Study|Lost to Follow-up|0
254321|NCT01264770|838728|P5|Overall Study|Lost to Follow-up|0
254322|NCT01264770|838729|P4|Overall Study|Lost to Follow-up|1
254323|NCT01264770|838730|P3|Overall Study|Lost to Follow-up|1
254324|NCT01264770|838731|P2|Overall Study|Lost to Follow-up|0
254325|NCT01264770|838732|P1|Overall Study|Lost to Follow-up|0
254326|NCT01264770|838727|P6|Overall Study|Dev. of study specific discont. criteria|1
254327|NCT01264770|838728|P5|Overall Study|Dev. of study specific discont. criteria|1
254328|NCT01264770|838729|P4|Overall Study|Dev. of study specific discont. criteria|0
254329|NCT01264770|838730|P3|Overall Study|Dev. of study specific discont. criteria|0
254330|NCT01264770|838731|P2|Overall Study|Dev. of study specific discont. criteria|0
254331|NCT01264770|838732|P1|Overall Study|Dev. of study specific discont. criteria|2
254332|NCT01264770|838727|P6|Overall Study|Lack of therapeutic response|0
254333|NCT01264770|838728|P5|Overall Study|Lack of therapeutic response|1
254334|NCT01264770|838729|P4|Overall Study|Lack of therapeutic response|1
254335|NCT01264770|838730|P3|Overall Study|Lack of therapeutic response|2
254336|NCT01264770|838731|P2|Overall Study|Lack of therapeutic response|0
254337|NCT01264770|838732|P1|Overall Study|Lack of therapeutic response|1
254338|NCT01264770|838727|P6|Overall Study|Severe non-compliance to protocol|0
254339|NCT01264770|838728|P5|Overall Study|Severe non-compliance to protocol|0
254340|NCT01264770|838729|P4|Overall Study|Severe non-compliance to protocol|1
254341|NCT01264770|838730|P3|Overall Study|Severe non-compliance to protocol|1
254342|NCT01264770|838731|P2|Overall Study|Severe non-compliance to protocol|0
254343|NCT01264770|838732|P1|Overall Study|Severe non-compliance to protocol|0
254344|NCT01264770|838727|P6|Overall Study|e.g., change in circumstances|4
254345|NCT01264770|838728|P5|Overall Study|e.g., change in circumstances|4
254346|NCT01264770|838729|P4|Overall Study|e.g., change in circumstances|3
254347|NCT01264770|838730|P3|Overall Study|e.g., change in circumstances|3
254348|NCT01264770|838731|P2|Overall Study|e.g., change in circumstances|3
254349|NCT01264770|838732|P1|Overall Study|e.g., change in circumstances|8
254350|NCT01264770|838727|P6|Overall Study|Not reported|0
254351|NCT01264770|838728|P5|Overall Study|Not reported|0
254352|NCT01264770|838729|P4|Overall Study|Not reported|0
254353|NCT01264770|838730|P3|Overall Study|Not reported|1
254354|NCT01264770|838731|P2|Overall Study|Not reported|0
254355|NCT01264770|838732|P1|Overall Study|Not reported|0
254356|NCT01264380|838833|P3|Period C|Adverse Event|1
254357|NCT01264380|838834|P2|Period C|Adverse Event|0
254358|NCT01264380|838835|P1|Period C|Adverse Event|0
254359|NCT01264380|838833|P3|Period C|Withdrawal by Subject|1
254360|NCT01264380|838834|P2|Period C|Withdrawal by Subject|0
254361|NCT01264380|838835|P1|Period C|Withdrawal by Subject|0
254362|NCT01264380|838833|P3|Period C|Follow-up for survival status|6
254363|NCT01264380|838834|P2|Period C|Follow-up for survival status|0
254364|NCT01264380|838835|P1|Period C|Follow-up for survival status|0
254365|NCT01264380|838833|P3|Period C|Death|2
254366|NCT01264380|838834|P2|Period C|Death|0
254367|NCT01264380|838835|P1|Period C|Death|0
254368|NCT01264380|838833|P3|Period C|Disease Progression|4
254369|NCT01264380|838834|P2|Period C|Disease Progression|0
254370|NCT01264380|838835|P1|Period C|Disease Progression|0
254371|NCT01264081|838856|P1|Started Treatment|Not complete cycle 1 due to death|1
254372|NCT01264081|838856|P1|Started Treatment|Withdrawal by Subject|1
254373|NCT01264081|838856|P1|Participants Screened|Screening failures|30
254374|NCT01264016|838861|P1|Overall Study|Felt faint at sight of blood|1
254375|NCT01264016|838861|P1|Overall Study|Withdrawal by Subject|1
254376|NCT01263925|838869|P2|Overall Study|Withdrawal/ Not specified|1
254377|NCT01263925|838870|P1|Overall Study|Withdrawal/ Not specified|0
254378|NCT01263925|838869|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
254379|NCT01263925|838870|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
254380|NCT01263925|838869|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
254381|NCT01263925|838870|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
254382|NCT01263925|838869|P2|Overall Study|AE/ Withdrawal|4
254383|NCT01263925|838870|P1|Overall Study|AE/ Withdrawal|1
254384|NCT01263925|838869|P2|Overall Study|AE/ Unsatisfactory Compliance|2
254385|NCT01263925|838870|P1|Overall Study|AE/ Unsatisfactory Compliance|2
254386|NCT01263925|838869|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
254387|NCT01263925|838870|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
254388|NCT01263925|838869|P2|Overall Study|Lost to Follow-up|1
254389|NCT01263925|838870|P1|Overall Study|Lost to Follow-up|3
254390|NCT01263925|838869|P2|Overall Study|Not specified|4
254391|NCT01263925|838870|P1|Overall Study|Not specified|4
254392|NCT01263925|838869|P2|Overall Study|Withdrawal by Subject|8
254393|NCT01263925|838870|P1|Overall Study|Withdrawal by Subject|6
254394|NCT01263925|838869|P2|Overall Study|Unsatisfactory Compliance of Subject|5
254395|NCT01263925|838870|P1|Overall Study|Unsatisfactory Compliance of Subject|8
254396|NCT01263925|838869|P2|Overall Study|Adverse Event|22
254397|NCT01263925|838870|P1|Overall Study|Adverse Event|23
254398|NCT01263925|838869|P2|Overall Study|Lack of Efficacy|1
254399|NCT01263925|838870|P1|Overall Study|Lack of Efficacy|0
254400|NCT01263925|838869|P2|Overall Study|Protocol Violation|0
254401|NCT01263925|838870|P1|Overall Study|Protocol Violation|1
254402|NCT01263873|838904|P2|Overall Study|One provider unable to complete numbers|1
254403|NCT01263873|838905|P1|Overall Study|One provider unable to complete numbers|1
254404|NCT01263691|838950|P6|Overall Study|Adverse Event|0
254405|NCT01263691|838951|P5|Overall Study|Adverse Event|0
254406|NCT01263691|838952|P4|Overall Study|Adverse Event|0
254407|NCT01263691|838953|P3|Overall Study|Adverse Event|0
254408|NCT01263691|838954|P2|Overall Study|Adverse Event|0
254409|NCT01263691|838955|P1|Overall Study|Adverse Event|1
254410|NCT01263691|838950|P6|Overall Study|Withdrawal by Subject|0
254411|NCT01263691|838951|P5|Overall Study|Withdrawal by Subject|0
254412|NCT01263691|838952|P4|Overall Study|Withdrawal by Subject|0
254413|NCT01263691|838953|P3|Overall Study|Withdrawal by Subject|0
254414|NCT01263691|838954|P2|Overall Study|Withdrawal by Subject|0
254415|NCT01263691|838955|P1|Overall Study|Withdrawal by Subject|1
254416|NCT01263691|838950|P6|Overall Study|Lost to Follow-up|0
254417|NCT01263691|838951|P5|Overall Study|Lost to Follow-up|0
254418|NCT01263691|838952|P4|Overall Study|Lost to Follow-up|1
254419|NCT01263691|838953|P3|Overall Study|Lost to Follow-up|1
254420|NCT01263691|838954|P2|Overall Study|Lost to Follow-up|0
254421|NCT01263691|838955|P1|Overall Study|Lost to Follow-up|1
254422|NCT01263665|839065|P1|Overall Study|Surgical Bypass|2
254423|NCT01263665|839065|P1|Overall Study|Amputation above the ankle|1
254424|NCT01263665|839065|P1|Overall Study|Death|2
254425|NCT01263665|839065|P1|Overall Study|Lost to Follow-up|3
254426|NCT01263665|839065|P1|Overall Study|Withdrew Consent|1
254427|NCT01263639|839072|P2|Overall Study|Exclusion =Admission greater than 7 days|9
254428|NCT01263639|839073|P1|Overall Study|Exclusion =Admission greater than 7 days|7
254429|NCT01263639|839072|P2|Overall Study|Lost to Follow-up|70
254430|NCT01263639|839073|P1|Overall Study|Lost to Follow-up|66
254431|NCT01263561|839081|P2|Overall Study|Death|2
254432|NCT01263561|839082|P1|Overall Study|Death|1
254433|NCT01263509|839094|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
254434|NCT01263509|839095|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
254435|NCT01263509|839096|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
254436|NCT01263509|839097|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
254437|NCT01263509|839094|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
254438|NCT01263509|839095|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
254439|NCT01263509|839096|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
254440|NCT01263509|839097|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
254441|NCT01263509|839094|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
254442|NCT01263509|839095|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
254443|NCT01263509|839096|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
254444|NCT01263509|839097|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
254445|NCT01263509|839094|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
254446|NCT01263509|839095|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
254447|NCT01263509|839096|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
254448|NCT01263509|839097|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
254449|NCT01263509|839094|P4|Entered - Long-Term Extension Study|Adverse Event|1
254450|NCT01263509|839095|P3|Entered - Long-Term Extension Study|Adverse Event|4
254451|NCT01263509|839096|P2|Entered - Long-Term Extension Study|Adverse Event|5
254452|NCT01263509|839097|P1|Entered - Long-Term Extension Study|Adverse Event|5
254453|NCT01263496|839226|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
254454|NCT01263496|839227|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
254455|NCT01263496|839228|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
254456|NCT01263496|839229|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
254457|NCT01263496|839230|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
254458|NCT01263496|839231|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
254459|NCT01263496|839232|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
254535|NCT01263470|839597|P2|Overall Study|Study Drug Non-compliance|0
254460|NCT01263496|839233|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
254461|NCT01263496|839234|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
254462|NCT01263496|839226|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
254463|NCT01263496|839227|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
254464|NCT01263496|839228|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
254465|NCT01263496|839229|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
254466|NCT01263496|839230|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
254467|NCT01263496|839231|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
254468|NCT01263496|839232|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
254469|NCT01263496|839233|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
254470|NCT01263496|839234|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
254471|NCT01263496|839226|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
254472|NCT01263496|839227|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
254473|NCT01263496|839228|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
254474|NCT01263496|839229|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
254475|NCT01263496|839230|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
254476|NCT01263496|839231|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
254477|NCT01263496|839232|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
254478|NCT01263496|839233|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
254479|NCT01263496|839234|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
254480|NCT01263496|839226|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
254481|NCT01263496|839227|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
254482|NCT01263496|839228|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
254483|NCT01263496|839229|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
254484|NCT01263496|839230|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
254485|NCT01263496|839231|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
254486|NCT01263496|839232|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
254487|NCT01263496|839233|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
254488|NCT01263496|839234|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
254489|NCT01263496|839226|P9|Entered - Long-Term Extension Study|Adverse Event|1
254490|NCT01263496|839227|P8|Entered - Long-Term Extension Study|Adverse Event|0
254491|NCT01263496|839228|P7|Entered - Long-Term Extension Study|Adverse Event|0
254492|NCT01263496|839229|P6|Entered - Long-Term Extension Study|Adverse Event|0
254493|NCT01263496|839230|P5|Entered - Long-Term Extension Study|Adverse Event|1
254494|NCT01263496|839231|P4|Entered - Long-Term Extension Study|Adverse Event|3
254495|NCT01263496|839232|P3|Entered - Long-Term Extension Study|Adverse Event|6
254496|NCT01263496|839233|P2|Entered - Long-Term Extension Study|Adverse Event|5
254497|NCT01263496|839234|P1|Entered - Long-Term Extension Study|Adverse Event|0
254498|NCT01263496|839226|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
254499|NCT01263496|839227|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
254500|NCT01263496|839228|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
254501|NCT01263496|839229|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
254502|NCT01263496|839230|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
254503|NCT01263496|839231|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
254504|NCT01263496|839232|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
254505|NCT01263496|839233|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
254506|NCT01263496|839234|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
254507|NCT01263496|839226|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
254508|NCT01263496|839227|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
254509|NCT01263496|839228|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
254510|NCT01263496|839229|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
254511|NCT01263496|839230|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
254512|NCT01263496|839231|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
254513|NCT01263496|839232|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
254514|NCT01263496|839233|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
254515|NCT01263496|839234|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
254516|NCT01263483|839529|P3|Overall Study|Participant Unavailability|1
254517|NCT01263483|839530|P2|Overall Study|Participant Unavailability|1
254518|NCT01263483|839531|P1|Overall Study|Participant Unavailability|0
254519|NCT01263483|839529|P3|Overall Study|Protocol Violation|1
254520|NCT01263483|839530|P2|Overall Study|Protocol Violation|1
254521|NCT01263483|839531|P1|Overall Study|Protocol Violation|0
254522|NCT01263483|839529|P3|Overall Study|Lack of Efficacy|0
254523|NCT01263483|839530|P2|Overall Study|Lack of Efficacy|0
254524|NCT01263483|839531|P1|Overall Study|Lack of Efficacy|2
254525|NCT01263483|839529|P3|Overall Study|Withdrawal by Subject|0
254526|NCT01263483|839530|P2|Overall Study|Withdrawal by Subject|0
254527|NCT01263483|839531|P1|Overall Study|Withdrawal by Subject|1
254528|NCT01263483|839529|P3|Overall Study|Adverse Event|3
254529|NCT01263483|839530|P2|Overall Study|Adverse Event|0
254530|NCT01263483|839531|P1|Overall Study|Adverse Event|4
254531|NCT01263470|839593|P6|Overall Study|Study Drug Non-compliance|0
254532|NCT01263470|839594|P5|Overall Study|Study Drug Non-compliance|1
254533|NCT01263470|839595|P4|Overall Study|Study Drug Non-compliance|0
254534|NCT01263470|839596|P3|Overall Study|Study Drug Non-compliance|0
254536|NCT01263470|839598|P1|Overall Study|Study Drug Non-compliance|0
254537|NCT01263470|839593|P6|Overall Study|Participant Unavailability|0
254538|NCT01263470|839594|P5|Overall Study|Participant Unavailability|0
254539|NCT01263470|839595|P4|Overall Study|Participant Unavailability|0
254540|NCT01263470|839596|P3|Overall Study|Participant Unavailability|0
254541|NCT01263470|839597|P2|Overall Study|Participant Unavailability|1
254542|NCT01263470|839598|P1|Overall Study|Participant Unavailability|0
254543|NCT01263470|839593|P6|Overall Study|Lack of Efficacy|0
254544|NCT01263470|839594|P5|Overall Study|Lack of Efficacy|0
254545|NCT01263470|839595|P4|Overall Study|Lack of Efficacy|0
254546|NCT01263470|839596|P3|Overall Study|Lack of Efficacy|2
254547|NCT01263470|839597|P2|Overall Study|Lack of Efficacy|0
254548|NCT01263470|839598|P1|Overall Study|Lack of Efficacy|0
254549|NCT01263470|839593|P6|Overall Study|Withdrawal by Subject|2
254550|NCT01263470|839594|P5|Overall Study|Withdrawal by Subject|0
254551|NCT01263470|839595|P4|Overall Study|Withdrawal by Subject|2
254552|NCT01263470|839596|P3|Overall Study|Withdrawal by Subject|1
254553|NCT01263470|839597|P2|Overall Study|Withdrawal by Subject|1
254554|NCT01263470|839598|P1|Overall Study|Withdrawal by Subject|0
254555|NCT01263470|839593|P6|Overall Study|Protocol Violation|1
254556|NCT01263470|839594|P5|Overall Study|Protocol Violation|0
254557|NCT01263470|839595|P4|Overall Study|Protocol Violation|0
254558|NCT01263470|839596|P3|Overall Study|Protocol Violation|0
254559|NCT01263470|839597|P2|Overall Study|Protocol Violation|1
254560|NCT01263470|839598|P1|Overall Study|Protocol Violation|0
254561|NCT01263470|839593|P6|Overall Study|Adverse Event|2
254562|NCT01263470|839594|P5|Overall Study|Adverse Event|2
254563|NCT01263470|839595|P4|Overall Study|Adverse Event|1
254564|NCT01263470|839596|P3|Overall Study|Adverse Event|1
254565|NCT01263470|839597|P2|Overall Study|Adverse Event|2
254566|NCT01263470|839598|P1|Overall Study|Adverse Event|2
254567|NCT01263444|839708|P1|Overall Study|Protocol Violation|1
254568|NCT01263444|839708|P1|Overall Study|Withdrawal by Subject|1
254569|NCT01263444|839708|P1|Overall Study|Adverse Event|8
254570|NCT01263054|839749|P2|Overall Study|Other|1
254571|NCT01263054|839750|P1|Overall Study|Other|0
254572|NCT01263054|839749|P2|Overall Study|Qualification Violation|0
254573|NCT01263054|839750|P1|Overall Study|Qualification Violation|1
254574|NCT01263054|839749|P2|Overall Study|Withdrawal by Subject|3
254575|NCT01263054|839750|P1|Overall Study|Withdrawal by Subject|1
254576|NCT01263054|839749|P2|Overall Study|Lost to Follow-up|2
254577|NCT01263054|839750|P1|Overall Study|Lost to Follow-up|2
254578|NCT01263054|839749|P2|Overall Study|Death|0
254579|NCT01263054|839750|P1|Overall Study|Death|1
254580|NCT01263028|839768|P1|Overall Study|Study terminated due to low enrollment.|4
254581|NCT01263028|839768|P1|Overall Study|Adverse Event|1
254582|NCT01263028|839768|P1|Overall Study|Withdrawal by Subject|1
254583|NCT01263015|839778|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
254584|NCT01263015|839779|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
254585|NCT01263015|839778|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
254586|NCT01263015|839779|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
254587|NCT01263015|839778|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
254588|NCT01263015|839779|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
254589|NCT01263015|839778|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
254590|NCT01263015|839779|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
254591|NCT01263015|839778|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
254592|NCT01263015|839779|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
254593|NCT01263015|839778|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
254594|NCT01263015|839779|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
254595|NCT01263015|839778|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
254596|NCT01263015|839779|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
254597|NCT01263015|839778|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
254598|NCT01263015|839779|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
254599|NCT01263015|839778|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
254600|NCT01263015|839779|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
254601|NCT01263015|839778|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
254602|NCT01263015|839779|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
254603|NCT01263015|839778|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
254604|NCT01263015|839779|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
254605|NCT01263015|839778|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
254606|NCT01263015|839779|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
254607|NCT01262989|839805|P2|Period 2|Intercurrent disease|1
254608|NCT01262989|839806|P1|Period 2|Intercurrent disease|0
254609|NCT01262989|839805|P2|Period 1|Positive answer for exclusion criteria|1
254610|NCT01262989|839806|P1|Period 1|Positive answer for exclusion criteria|0
254611|NCT01262989|839805|P2|Period 1|Intercurrent disease|1
254612|NCT01262989|839806|P1|Period 1|Intercurrent disease|0
254613|NCT01262989|839805|P2|Period 1|Lost to Follow-up|1
254614|NCT01262989|839806|P1|Period 1|Lost to Follow-up|1
254615|NCT01262872|839824|P8|Step 2|Migrated/moved from study area|3
254616|NCT01262872|839825|P7|Step 2|Migrated/moved from study area|2
254617|NCT01262872|839826|P6|Step 2|Migrated/moved from study area|6
254618|NCT01262872|839827|P5|Step 2|Migrated/moved from study area|2
254619|NCT01262872|839828|P4|Step 2|Migrated/moved from study area|3
254620|NCT01262872|839829|P3|Step 2|Migrated/moved from study area|4
254621|NCT01262872|839830|P2|Step 2|Migrated/moved from study area|0
254622|NCT01262872|839831|P1|Step 2|Migrated/moved from study area|0
254623|NCT01262872|839824|P8|Step 2|Withdrawal by Subject|1
254624|NCT01262872|839825|P7|Step 2|Withdrawal by Subject|2
254625|NCT01262872|839826|P6|Step 2|Withdrawal by Subject|1
254626|NCT01262872|839827|P5|Step 2|Withdrawal by Subject|3
254627|NCT01262872|839828|P4|Step 2|Withdrawal by Subject|6
254628|NCT01262872|839829|P3|Step 2|Withdrawal by Subject|4
254629|NCT01262872|839830|P2|Step 2|Withdrawal by Subject|0
254630|NCT01262872|839831|P1|Step 2|Withdrawal by Subject|0
254631|NCT01262872|839824|P8|Step 2|Protocol Violation|1
254632|NCT01262872|839825|P7|Step 2|Protocol Violation|3
254633|NCT01262872|839826|P6|Step 2|Protocol Violation|0
254634|NCT01262872|839827|P5|Step 2|Protocol Violation|0
254635|NCT01262872|839828|P4|Step 2|Protocol Violation|0
254636|NCT01262872|839829|P3|Step 2|Protocol Violation|1
254637|NCT01262872|839830|P2|Step 2|Protocol Violation|0
254638|NCT01262872|839831|P1|Step 2|Protocol Violation|0
254639|NCT01262872|839824|P8|Step 2|Death|1
254640|NCT01262872|839825|P7|Step 2|Death|2
254641|NCT01262872|839826|P6|Step 2|Death|2
254642|NCT01262872|839827|P5|Step 2|Death|0
254643|NCT01262872|839828|P4|Step 2|Death|1
254644|NCT01262872|839829|P3|Step 2|Death|0
254645|NCT01262872|839830|P2|Step 2|Death|0
254646|NCT01262872|839831|P1|Step 2|Death|0
254647|NCT01262820|840093|P1|Overall Study|Drug held for 21+ days|1
254648|NCT01262820|840093|P1|Overall Study|Lack of Efficacy|9
254649|NCT01262820|840093|P1|Overall Study|Adverse Event|5
254650|NCT01262573|840115|P2|Overall Study|Withdrawal by Subject|1
254651|NCT01262573|840116|P1|Overall Study|Withdrawal by Subject|0
254652|NCT01262456|840138|P3|1-Month Open-Label Extension Period|Other Reason|0
254653|NCT01262456|840139|P2|1-Month Open-Label Extension Period|Other Reason|1
254654|NCT01262456|840140|P1|1-Month Open-Label Extension Period|Other Reason|0
254655|NCT01262456|840138|P3|1-Month Open-Label Extension Period|Protocol Violation|2
254656|NCT01262456|840139|P2|1-Month Open-Label Extension Period|Protocol Violation|0
254657|NCT01262456|840140|P1|1-Month Open-Label Extension Period|Protocol Violation|1
254658|NCT01262456|840138|P3|1-Month Open-Label Extension Period|Adverse Event|2
254659|NCT01262456|840139|P2|1-Month Open-Label Extension Period|Adverse Event|0
254660|NCT01262456|840140|P1|1-Month Open-Label Extension Period|Adverse Event|2
254661|NCT01262456|840138|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
254662|NCT01262456|840139|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
254663|NCT01262456|840140|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
254664|NCT01262456|840138|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
254665|NCT01262456|840139|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
254666|NCT01262456|840140|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
254667|NCT01262456|840138|P3|3-Month Double-Blind Period|Protocol Violation|6
254668|NCT01262456|840139|P2|3-Month Double-Blind Period|Protocol Violation|6
254669|NCT01262456|840140|P1|3-Month Double-Blind Period|Protocol Violation|3
254670|NCT01262456|840138|P3|3-Month Double-Blind Period|Adverse Event|8
254671|NCT01262456|840139|P2|3-Month Double-Blind Period|Adverse Event|4
254672|NCT01262456|840140|P1|3-Month Double-Blind Period|Adverse Event|6
254673|NCT01262456|840138|P3|3-Month Double-Blind Period|Lost to Follow-up|3
254674|NCT01262456|840139|P2|3-Month Double-Blind Period|Lost to Follow-up|5
254675|NCT01262456|840140|P1|3-Month Double-Blind Period|Lost to Follow-up|4
254676|NCT01262456|840138|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
254677|NCT01262456|840139|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
254678|NCT01262456|840140|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
254679|NCT01262352|840183|P2|Washout|Extended Washout|1
254680|NCT01262352|840184|P1|Washout|Extended Washout|0
254681|NCT01262352|840183|P2|Washout|Adverse Event|1
254682|NCT01262352|840184|P1|Washout|Adverse Event|1
254683|NCT01262352|840183|P2|Period 1|Illness after randomization|0
254684|NCT01262352|840184|P1|Period 1|Illness after randomization|1
254685|NCT01262287|840202|P2|Overall Study|Lost to Follow-up|1
254686|NCT01262287|840203|P1|Overall Study|Lost to Follow-up|2
254687|NCT01262092|840264|P2|Gabapentin Taper|noncompliance - missed medications|0
254688|NCT01262092|840265|P1|Gabapentin Taper|noncompliance - missed medications|1
254689|NCT01262092|840264|P2|Buprenorphine Taper|noncompliance - missed medication|1
254690|NCT01262092|840265|P1|Buprenorphine Taper|noncompliance - missed medication|1
254691|NCT01262092|840264|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
254692|NCT01262092|840265|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
254693|NCT01262092|840264|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
254694|NCT01262092|840265|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
254695|NCT01262027|840271|P1|Overall Study|Protocol Violation|1
254696|NCT01262027|840271|P1|Overall Study|Withdrawal by Subject|3
254697|NCT01262027|840271|P1|Overall Study|Adverse Event|1
254698|NCT01261975|840276|P1|Overall Study|Surgical complication|1
254699|NCT01261624|840297|P2|Week 13 to Week 24|Insufficient Response|1
254700|NCT01261624|840298|P1|Week 13 to Week 24|Insufficient Response|0
254701|NCT01261624|840297|P2|Week 0 to Week 12|Insufficient Response|2
254702|NCT01261624|840298|P1|Week 0 to Week 12|Insufficient Response|0
254703|NCT01261624|840297|P2|Week 0 to Week 12|Disease Progression|1
254704|NCT01261624|840298|P1|Week 0 to Week 12|Disease Progression|1
254705|NCT01261390|840339|P4|Overall Study|Lost to Follow-up|6
254706|NCT01261390|840340|P3|Overall Study|Lost to Follow-up|5
254707|NCT01261390|840341|P2|Overall Study|Lost to Follow-up|6
254708|NCT01261390|840342|P1|Overall Study|Lost to Follow-up|1
254709|NCT01261390|840339|P4|Overall Study|Loss of Interest in the Study|0
254710|NCT01261390|840340|P3|Overall Study|Loss of Interest in the Study|0
254711|NCT01261390|840341|P2|Overall Study|Loss of Interest in the Study|1
254712|NCT01261390|840342|P1|Overall Study|Loss of Interest in the Study|3
254713|NCT01261390|840339|P4|Overall Study|Relocation|0
254714|NCT01261390|840340|P3|Overall Study|Relocation|0
254715|NCT01261390|840341|P2|Overall Study|Relocation|1
254716|NCT01261390|840342|P1|Overall Study|Relocation|0
254717|NCT01261390|840339|P4|Overall Study|Dissatisfaction with Treatment|2
254718|NCT01261390|840340|P3|Overall Study|Dissatisfaction with Treatment|1
254719|NCT01261390|840341|P2|Overall Study|Dissatisfaction with Treatment|1
254720|NCT01261390|840342|P1|Overall Study|Dissatisfaction with Treatment|2
254721|NCT01261390|840339|P4|Overall Study|Significant Concurrent Illness|0
254722|NCT01261390|840340|P3|Overall Study|Significant Concurrent Illness|1
254723|NCT01261390|840341|P2|Overall Study|Significant Concurrent Illness|0
254724|NCT01261390|840342|P1|Overall Study|Significant Concurrent Illness|1
254764|NCT01260948|840549|P2|Second Intervention|Emesis|1
254765|NCT01260948|840550|P1|Second Intervention|Emesis|0
254766|NCT01260948|840549|P2|Washout of 28 Days|Withdrawal by Subject|3
254767|NCT01260948|840550|P1|Washout of 28 Days|Withdrawal by Subject|1
254768|NCT01260922|840560|P2|Second Intervention|Emesis|2
254769|NCT01260922|840561|P1|Second Intervention|Emesis|0
254770|NCT01260922|840560|P2|Washout of 28 Days|Withdrawal by Subject|2
254771|NCT01260922|840561|P1|Washout of 28 Days|Withdrawal by Subject|4
254772|NCT01260922|840560|P2|First Intervention|Withdrawal by Subject|1
254773|NCT01260922|840561|P1|First Intervention|Withdrawal by Subject|0
254774|NCT01260896|840571|P2|First Intervention|Withdrawn Due to Emesis|0
254775|NCT01260896|840572|P1|First Intervention|Withdrawn Due to Emesis|2
254776|NCT01260701|840630|P1|Overall Study|Did not begin protocol therapy|1
254777|NCT01260701|840630|P1|Overall Study|Ineligible|4
254778|NCT01260701|840630|P1|Overall Study|Under review|1
254779|NCT01260701|840630|P1|Overall Study|Not protocol specified|3
254780|NCT01260701|840630|P1|Overall Study|Death|2
254781|NCT01260701|840630|P1|Overall Study|Progression|53
254782|NCT01260701|840630|P1|Overall Study|Withdrawal by Subject|2
254783|NCT01260701|840630|P1|Overall Study|Adverse Event|9
254784|NCT01260584|840683|P4|Period 2|Withdrawal by Subject|0
254785|NCT01260584|840684|P3|Period 2|Withdrawal by Subject|0
254786|NCT01260584|840685|P2|Period 2|Withdrawal by Subject|1
254787|NCT01260584|840686|P1|Period 2|Withdrawal by Subject|0
254788|NCT01260584|840683|P4|Period 2|Adverse Event|0
254789|NCT01260584|840684|P3|Period 2|Adverse Event|2
254790|NCT01260584|840685|P2|Period 2|Adverse Event|0
254791|NCT01260584|840686|P1|Period 2|Adverse Event|1
254792|NCT01260584|840683|P4|Period 2|Protocol Violation|1
254793|NCT01260584|840684|P3|Period 2|Protocol Violation|3
254794|NCT01260584|840685|P2|Period 2|Protocol Violation|2
254795|NCT01260584|840686|P1|Period 2|Protocol Violation|0
254796|NCT01260584|840683|P4|Period 1|Adverse Event|0
254797|NCT01260584|840684|P3|Period 1|Adverse Event|1
254798|NCT01260584|840685|P2|Period 1|Adverse Event|0
254799|NCT01260584|840686|P1|Period 1|Adverse Event|0
254800|NCT01260584|840683|P4|Period 1|Protocol Violation|1
254801|NCT01260584|840684|P3|Period 1|Protocol Violation|1
254802|NCT01260584|840685|P2|Period 1|Protocol Violation|0
254803|NCT01260584|840686|P1|Period 1|Protocol Violation|0
254804|NCT01260467|840729|P1|Overall Study|Withdrawal by Subject|2
254805|NCT01260350|840761|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
254806|NCT01260350|840762|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
254807|NCT01260350|840763|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
254808|NCT01260350|840764|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
254809|NCT01260350|840765|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
254810|NCT01260350|840766|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
254811|NCT01260350|840767|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
254812|NCT01260350|840768|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
254813|NCT01260350|840769|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
254814|NCT01260350|840770|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
254815|NCT01260350|840771|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
254816|NCT01260350|840772|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
254817|NCT01260350|840773|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
254818|NCT01260350|840774|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
254819|NCT01260350|840775|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
254820|NCT01260350|840776|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
254821|NCT01260350|840777|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
254822|NCT01260350|840778|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
254823|NCT01260350|840779|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
254824|NCT01260350|840780|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
254825|NCT01260350|840781|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
254826|NCT01260350|840782|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
254827|NCT01260350|840761|P22|Overall Study|Lack of Efficacy|0
254828|NCT01260350|840762|P21|Overall Study|Lack of Efficacy|3
254829|NCT01260350|840763|P20|Overall Study|Lack of Efficacy|0
254830|NCT01260350|840764|P19|Overall Study|Lack of Efficacy|0
254831|NCT01260350|840765|P18|Overall Study|Lack of Efficacy|1
254832|NCT01260350|840766|P17|Overall Study|Lack of Efficacy|0
254833|NCT01260350|840767|P16|Overall Study|Lack of Efficacy|0
254834|NCT01260350|840768|P15|Overall Study|Lack of Efficacy|0
254835|NCT01260350|840769|P14|Overall Study|Lack of Efficacy|0
254836|NCT01260350|840770|P13|Overall Study|Lack of Efficacy|0
254837|NCT01260350|840771|P12|Overall Study|Lack of Efficacy|0
254838|NCT01260350|840772|P11|Overall Study|Lack of Efficacy|0
254839|NCT01260350|840773|P10|Overall Study|Lack of Efficacy|0
254840|NCT01260350|840774|P9|Overall Study|Lack of Efficacy|0
254841|NCT01260350|840775|P8|Overall Study|Lack of Efficacy|0
254842|NCT01260350|840776|P7|Overall Study|Lack of Efficacy|0
254843|NCT01260350|840777|P6|Overall Study|Lack of Efficacy|0
254844|NCT01260350|840778|P5|Overall Study|Lack of Efficacy|0
254845|NCT01260350|840779|P4|Overall Study|Lack of Efficacy|0
254846|NCT01260350|840780|P3|Overall Study|Lack of Efficacy|0
254847|NCT01260350|840781|P2|Overall Study|Lack of Efficacy|0
254848|NCT01260350|840782|P1|Overall Study|Lack of Efficacy|0
254849|NCT01260311|840989|P1|Overall Study|Fesoterodine Started Before Enrollment|1
254850|NCT01260311|840989|P1|Overall Study|Medication Stopped|1
254851|NCT01260311|840989|P1|Overall Study|Gone to Province|2
254852|NCT01260311|840989|P1|Overall Study|Financial Constraints|77
254853|NCT01260311|840989|P1|Overall Study|Withdrawal by Subject|6
254854|NCT01260311|840989|P1|Overall Study|Lost to Follow-up|25
254855|NCT01260311|840989|P1|Overall Study|Lack of Efficacy|4
254856|NCT01260311|840989|P1|Overall Study|Adverse Event|11
254857|NCT01260194|841020|P1|Overall Study|Withdrawal of Consent|1
254858|NCT01260142|841038|P6|Treatment Period 1|Withdrawal by Subject|1
254859|NCT01260142|841039|P5|Treatment Period 1|Withdrawal by Subject|0
254860|NCT01260142|841040|P4|Treatment Period 1|Withdrawal by Subject|0
254861|NCT01260142|841041|P3|Treatment Period 1|Withdrawal by Subject|0
254862|NCT01260142|841042|P2|Treatment Period 1|Withdrawal by Subject|0
254863|NCT01260142|841043|P1|Treatment Period 1|Withdrawal by Subject|0
254864|NCT01260142|841038|P6|Treatment Period 1|Unexplained elevated sys. BP|0
254865|NCT01260142|841039|P5|Treatment Period 1|Unexplained elevated sys. BP|1
254866|NCT01260142|841040|P4|Treatment Period 1|Unexplained elevated sys. BP|0
254867|NCT01260142|841041|P3|Treatment Period 1|Unexplained elevated sys. BP|0
254868|NCT01260142|841042|P2|Treatment Period 1|Unexplained elevated sys. BP|0
254869|NCT01260142|841043|P1|Treatment Period 1|Unexplained elevated sys. BP|0
254870|NCT01260142|841038|P6|Treatment Period 1|Study on hold|2
254871|NCT01260142|841039|P5|Treatment Period 1|Study on hold|1
254872|NCT01260142|841040|P4|Treatment Period 1|Study on hold|0
254873|NCT01260142|841041|P3|Treatment Period 1|Study on hold|0
254874|NCT01260142|841042|P2|Treatment Period 1|Study on hold|1
254875|NCT01260142|841043|P1|Treatment Period 1|Study on hold|1
254876|NCT01259726|841097|P4|Overall Study|Lost to Follow-up|3
254877|NCT01259726|841098|P3|Overall Study|Lost to Follow-up|1
254878|NCT01259726|841099|P2|Overall Study|Lost to Follow-up|1
254879|NCT01259726|841100|P1|Overall Study|Lost to Follow-up|1
254880|NCT01259726|841097|P4|Overall Study|Withdrawal by Subject|1
254881|NCT01259726|841098|P3|Overall Study|Withdrawal by Subject|2
254882|NCT01259726|841099|P2|Overall Study|Withdrawal by Subject|3
254883|NCT01259726|841100|P1|Overall Study|Withdrawal by Subject|1
254884|NCT01259726|841097|P4|Overall Study|Physician Decision|1
254885|NCT01259726|841098|P3|Overall Study|Physician Decision|1
254886|NCT01259726|841099|P2|Overall Study|Physician Decision|0
254887|NCT01259726|841100|P1|Overall Study|Physician Decision|2
254888|NCT01259726|841097|P4|Overall Study|Death|0
254889|NCT01259726|841098|P3|Overall Study|Death|0
254890|NCT01259726|841099|P2|Overall Study|Death|0
254891|NCT01259726|841100|P1|Overall Study|Death|1
254892|NCT01259713|841132|P2|Overall Study|Subject Withdrew Consent|7
254893|NCT01259713|841133|P1|Overall Study|Subject Withdrew Consent|12
254894|NCT01259713|841132|P2|Overall Study|Protocol Violation|4
254895|NCT01259713|841133|P1|Overall Study|Protocol Violation|5
254896|NCT01259713|841132|P2|Overall Study|Lack of Efficacy|0
254897|NCT01259713|841133|P1|Overall Study|Lack of Efficacy|2
254898|NCT01259713|841132|P2|Overall Study|Investigators Discretion|6
254899|NCT01259713|841133|P1|Overall Study|Investigators Discretion|14
254900|NCT01259713|841132|P2|Overall Study|Death Not Related to IFI|1
254901|NCT01259713|841133|P1|Overall Study|Death Not Related to IFI|8
254902|NCT01259713|841132|P2|Overall Study|Adverse Event|23
254903|NCT01259713|841133|P1|Overall Study|Adverse Event|54
254904|NCT01259492|841159|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
254905|NCT01259492|841160|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
254906|NCT01259492|841161|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
254907|NCT01259492|841162|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
254908|NCT01259492|841159|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
254909|NCT01259492|841160|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
254910|NCT01259492|841161|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
254911|NCT01259492|841162|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
254912|NCT01259492|841159|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
254913|NCT01259492|841160|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
254914|NCT01259492|841161|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
254915|NCT01259492|841162|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
254916|NCT01259492|841159|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
254917|NCT01259492|841160|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
254918|NCT01259492|841161|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
254919|NCT01259492|841162|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
254920|NCT01259492|841159|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
254921|NCT01259492|841160|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
254922|NCT01259492|841161|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
254923|NCT01259492|841162|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
254924|NCT01259492|841159|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
254925|NCT01259492|841160|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
254926|NCT01259492|841161|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
254927|NCT01259492|841162|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
254928|NCT01259492|841159|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
254929|NCT01259492|841160|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
254930|NCT01259492|841161|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
254931|NCT01259492|841162|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
254932|NCT01259492|841159|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
254933|NCT01259492|841160|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
254934|NCT01259492|841161|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
254935|NCT01259492|841162|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
254936|NCT01259492|841159|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
254937|NCT01259492|841160|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
254938|NCT01259492|841161|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
254939|NCT01259492|841162|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
254940|NCT01259492|841159|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
254941|NCT01259492|841160|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
254942|NCT01259492|841161|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
254943|NCT01259492|841162|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
254944|NCT01259492|841159|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
254945|NCT01259492|841160|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
254946|NCT01259492|841161|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
254947|NCT01259492|841162|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
254948|NCT01259492|841159|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
255032|NCT01259102|841441|P3|Overall Study|Other|1
254949|NCT01259492|841160|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
254950|NCT01259492|841161|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
254951|NCT01259492|841162|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
254952|NCT01259492|841159|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
254953|NCT01259492|841160|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
254954|NCT01259492|841161|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
254955|NCT01259492|841162|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
254956|NCT01259492|841159|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
254957|NCT01259492|841160|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
254958|NCT01259492|841161|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
254959|NCT01259492|841162|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
254960|NCT01259492|841159|P4|Period 1 (9 Weeks)|Protocol Violation|1
254961|NCT01259492|841160|P3|Period 1 (9 Weeks)|Protocol Violation|3
254962|NCT01259492|841161|P2|Period 1 (9 Weeks)|Protocol Violation|6
254963|NCT01259492|841162|P1|Period 1 (9 Weeks)|Protocol Violation|5
254964|NCT01259492|841159|P4|Period 1 (9 Weeks)|Administrative Problems|2
254965|NCT01259492|841160|P3|Period 1 (9 Weeks)|Administrative Problems|1
254966|NCT01259492|841161|P2|Period 1 (9 Weeks)|Administrative Problems|1
254967|NCT01259492|841162|P1|Period 1 (9 Weeks)|Administrative Problems|0
254968|NCT01259492|841159|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
254969|NCT01259492|841160|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
254970|NCT01259492|841161|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
254971|NCT01259492|841162|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
254972|NCT01259492|841159|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
254973|NCT01259492|841160|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
254974|NCT01259492|841161|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
254975|NCT01259492|841162|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
254976|NCT01259492|841159|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
254977|NCT01259492|841160|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
254978|NCT01259492|841161|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
254979|NCT01259492|841162|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
254980|NCT01259492|841159|P4|Period 1 (9 Weeks)|Adverse Event|3
254981|NCT01259492|841160|P3|Period 1 (9 Weeks)|Adverse Event|26
254982|NCT01259492|841161|P2|Period 1 (9 Weeks)|Adverse Event|18
254983|NCT01259492|841162|P1|Period 1 (9 Weeks)|Adverse Event|13
254984|NCT01259466|841211|P2|Overall Study|Withdrawal by Subject|9
254985|NCT01259466|841212|P1|Overall Study|Withdrawal by Subject|1
254986|NCT01259401|841250|P2|4-month Follow-up|Lost to Follow-up|1
254987|NCT01259401|841251|P1|4-month Follow-up|Lost to Follow-up|0
254988|NCT01259401|841250|P2|4-month Follow-up|Death|1
254989|NCT01259401|841251|P1|4-month Follow-up|Death|0
254990|NCT01259375|841259|P1|Overall Study|Adverse Event|1
254991|NCT01259297|841276|P8|Double Blind Randomized Period|Other reasons|1
254992|NCT01259297|841277|P7|Double Blind Randomized Period|Other reasons|3
254993|NCT01259297|841278|P6|Double Blind Randomized Period|Other reasons|2
254994|NCT01259297|841279|P5|Double Blind Randomized Period|Other reasons|1
254995|NCT01259297|841280|P4|Double Blind Randomized Period|Other reasons|0
254996|NCT01259297|841281|P3|Double Blind Randomized Period|Other reasons|0
254997|NCT01259297|841282|P2|Double Blind Randomized Period|Other reasons|1
254998|NCT01259297|841283|P1|Double Blind Randomized Period|Other reasons|0
254999|NCT01259297|841276|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
255000|NCT01259297|841277|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
255001|NCT01259297|841278|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
255002|NCT01259297|841279|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
255003|NCT01259297|841280|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
255004|NCT01259297|841281|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
255005|NCT01259297|841282|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
255006|NCT01259297|841283|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
255007|NCT01259297|841276|P8|Double Blind Randomized Period|Death|1
255008|NCT01259297|841277|P7|Double Blind Randomized Period|Death|2
255009|NCT01259297|841278|P6|Double Blind Randomized Period|Death|5
255010|NCT01259297|841279|P5|Double Blind Randomized Period|Death|1
255011|NCT01259297|841280|P4|Double Blind Randomized Period|Death|2
255012|NCT01259297|841281|P3|Double Blind Randomized Period|Death|1
255013|NCT01259297|841282|P2|Double Blind Randomized Period|Death|1
255014|NCT01259297|841283|P1|Double Blind Randomized Period|Death|1
255015|NCT01259284|841314|P3|Overall Study|Study Termination|0
255016|NCT01259284|841315|P2|Overall Study|Study Termination|0
255017|NCT01259284|841316|P1|Overall Study|Study Termination|2
255018|NCT01259245|841326|P2|Overall Study|Death|2
255019|NCT01259245|841327|P1|Overall Study|Death|1
255020|NCT01259245|841326|P2|Overall Study|Withdrawal by Subject|24
255021|NCT01259245|841327|P1|Overall Study|Withdrawal by Subject|27
255022|NCT01259115|841402|P2|Period 2|Adverse Event|0
255023|NCT01259115|841403|P1|Period 2|Adverse Event|1
255024|NCT01259115|841402|P2|Period 1|Lost to Follow-up|1
255025|NCT01259115|841403|P1|Period 1|Lost to Follow-up|0
255026|NCT01259115|841402|P2|Period 1|Protocol Violation|0
255027|NCT01259115|841403|P1|Period 1|Protocol Violation|2
255028|NCT01259115|841402|P2|Period 1|Adverse Event|0
255029|NCT01259115|841403|P1|Period 1|Adverse Event|1
255030|NCT01259102|841439|P5|Overall Study|Other|1
255031|NCT01259102|841440|P4|Overall Study|Other|1
255033|NCT01259102|841442|P2|Overall Study|Other|0
255034|NCT01259102|841443|P1|Overall Study|Other|0
255035|NCT01259102|841439|P5|Overall Study|Adverse Event|0
255036|NCT01259102|841440|P4|Overall Study|Adverse Event|1
255037|NCT01259102|841441|P3|Overall Study|Adverse Event|1
255038|NCT01259102|841442|P2|Overall Study|Adverse Event|0
255039|NCT01259102|841443|P1|Overall Study|Adverse Event|1
255040|NCT01258998|841500|P1|Overall Study|Ineligible|1
255041|NCT01258803|841533|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
255042|NCT01258803|841534|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
255043|NCT01258803|841535|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
255044|NCT01258803|841536|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
255045|NCT01258803|841537|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
255046|NCT01258803|841538|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
255047|NCT01258803|841533|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
255048|NCT01258803|841534|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
255049|NCT01258803|841535|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
255050|NCT01258803|841536|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
255051|NCT01258803|841537|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
255052|NCT01258803|841538|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
255053|NCT01258803|841533|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
255054|NCT01258803|841534|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
255055|NCT01258803|841535|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
255056|NCT01258803|841536|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
255057|NCT01258803|841537|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
255058|NCT01258803|841538|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
255059|NCT01258738|841575|P2|Open-label Period|Withdrawn due to pregnancy|1
255060|NCT01258738|841576|P1|Open-label Period|Withdrawn due to pregnancy|1
255061|NCT01258738|841575|P2|Open-label Period|Other Reasons|1
255062|NCT01258738|841576|P1|Open-label Period|Other Reasons|0
255063|NCT01258738|841575|P2|Open-label Period|Adverse Event|5
255064|NCT01258738|841576|P1|Open-label Period|Adverse Event|4
255065|NCT01258738|841575|P2|Open-label Period|Protocol Violation|2
255066|NCT01258738|841576|P1|Open-label Period|Protocol Violation|2
255067|NCT01258738|841575|P2|Open-label Period|Withdrawal by Subject|6
255068|NCT01258738|841576|P1|Open-label Period|Withdrawal by Subject|5
255069|NCT01258738|841575|P2|Open-label Period|Lost to Follow-up|2
255070|NCT01258738|841576|P1|Open-label Period|Lost to Follow-up|0
255071|NCT01258738|841575|P2|Open-label Period|Insufficient clinical response|3
255072|NCT01258738|841576|P1|Open-label Period|Insufficient clinical response|5
255073|NCT01258738|841575|P2|Open-label Period|Did not meet inclusion criteria|1
255074|NCT01258738|841576|P1|Open-label Period|Did not meet inclusion criteria|0
255075|NCT01258738|841575|P2|Double-blind Period|Adverse Event|1
255076|NCT01258738|841576|P1|Double-blind Period|Adverse Event|3
255077|NCT01258738|841575|P2|Double-blind Period|Protocol Violation|1
255078|NCT01258738|841576|P1|Double-blind Period|Protocol Violation|1
255079|NCT01258738|841575|P2|Double-blind Period|Withdrawal by Subject|2
255080|NCT01258738|841576|P1|Double-blind Period|Withdrawal by Subject|2
255081|NCT01258738|841575|P2|Double-blind Period|Did not meet inclusion criteria|3
255082|NCT01258738|841576|P1|Double-blind Period|Did not meet inclusion criteria|3
255083|NCT01258660|841714|P2|Overall Study|Invalid for primary analysis data set|6
255084|NCT01258660|841715|P1|Overall Study|Invalid for primary analysis data set|4
255085|NCT01258660|841714|P2|Overall Study|Protocol Violation|1
255086|NCT01258660|841715|P1|Overall Study|Protocol Violation|0
255087|NCT01258660|841714|P2|Overall Study|due to relocation|0
255088|NCT01258660|841715|P1|Overall Study|due to relocation|2
255089|NCT01258660|841714|P2|Overall Study|Withdrawal by Subject|0
255090|NCT01258660|841715|P1|Overall Study|Withdrawal by Subject|3
255091|NCT01258660|841714|P2|Overall Study|Adverse Event|4
255092|NCT01258660|841715|P1|Overall Study|Adverse Event|2
255093|NCT01258595|841734|P2|Overall Study|Withdrawal by Subject|1
255094|NCT01258595|841735|P1|Overall Study|Withdrawal by Subject|0
255095|NCT01258595|841734|P2|Overall Study|Lost to Follow-up|0
255096|NCT01258595|841735|P1|Overall Study|Lost to Follow-up|1
255097|NCT01256684|841772|P3|Overall Study|Entry criteria not met/non-compliance|6
255098|NCT01256684|841773|P2|Overall Study|Entry criteria not met/non-compliance|7
255099|NCT01256684|841774|P1|Overall Study|Entry criteria not met/non-compliance|4
255100|NCT01256684|841772|P3|Overall Study|Lack of Efficacy|1
255101|NCT01256684|841773|P2|Overall Study|Lack of Efficacy|1
255102|NCT01256684|841774|P1|Overall Study|Lack of Efficacy|0
255103|NCT01256684|841772|P3|Overall Study|Physician Decision|0
255104|NCT01256684|841773|P2|Overall Study|Physician Decision|1
255105|NCT01256684|841774|P1|Overall Study|Physician Decision|0
255106|NCT01256684|841772|P3|Overall Study|Withdrawal by Subject|2
255107|NCT01256684|841773|P2|Overall Study|Withdrawal by Subject|0
255108|NCT01256684|841774|P1|Overall Study|Withdrawal by Subject|4
255109|NCT01256684|841772|P3|Overall Study|Adverse Event|2
255110|NCT01256684|841773|P2|Overall Study|Adverse Event|4
255111|NCT01256684|841774|P1|Overall Study|Adverse Event|1
255112|NCT01256658|841808|P2|Period 1|Death|44
255113|NCT01256658|841809|P1|Period 1|Death|48
255114|NCT01256658|841808|P2|Period 1|Withdrawal by Subject|43
255115|NCT01256658|841809|P1|Period 1|Withdrawal by Subject|35
255116|NCT01256658|841808|P2|Period 1|Lost to Follow-up|661
255117|NCT01256658|841809|P1|Period 1|Lost to Follow-up|837
255118|NCT01256567|841859|P1|Overall Study|Withdrawal by Subject|1
255119|NCT01256502|841869|P1|Overall Study|Protocol deviation|1
255120|NCT01256502|841869|P1|Overall Study|Personal reasons|5
255121|NCT01256502|841869|P1|Overall Study|Had scaffold removed|4
255122|NCT01256476|841881|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
255123|NCT01256476|841882|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
255124|NCT01256476|841881|P2|Overall Study|Subject non-compliance|1
255125|NCT01256476|841882|P1|Overall Study|Subject non-compliance|0
255126|NCT01256476|841881|P2|Overall Study|Physician Decision|1
255127|NCT01256476|841882|P1|Overall Study|Physician Decision|0
255128|NCT01256476|841881|P2|Overall Study|Persistent ALT or AST elevation|0
255129|NCT01256476|841882|P1|Overall Study|Persistent ALT or AST elevation|1
255130|NCT01256476|841881|P2|Overall Study|Lost to Follow-up|2
255131|NCT01256476|841882|P1|Overall Study|Lost to Follow-up|1
255132|NCT01256476|841881|P2|Overall Study|Withdrawal by Subject|1
255133|NCT01256476|841882|P1|Overall Study|Withdrawal by Subject|2
255134|NCT01256476|841881|P2|Overall Study|Adverse Event|1
255135|NCT01256476|841882|P1|Overall Study|Adverse Event|2
255136|NCT01258101|841976|P4|Overall Study|Other reason|8
255137|NCT01258101|841977|P3|Overall Study|Other reason|1
255138|NCT01258101|841978|P2|Overall Study|Other reason|8
255139|NCT01258101|841979|P1|Overall Study|Other reason|7
255140|NCT01258101|841976|P4|Overall Study|PCR positive at week 24|1
255141|NCT01258101|841977|P3|Overall Study|PCR positive at week 24|0
255142|NCT01258101|841978|P2|Overall Study|PCR positive at week 24|0
255143|NCT01258101|841979|P1|Overall Study|PCR positive at week 24|0
255144|NCT01258101|841976|P4|Overall Study|Lost to Follow-up|6
255145|NCT01258101|841977|P3|Overall Study|Lost to Follow-up|0
255146|NCT01258101|841978|P2|Overall Study|Lost to Follow-up|5
255147|NCT01258101|841979|P1|Overall Study|Lost to Follow-up|5
255148|NCT01258101|841976|P4|Overall Study|Patient´s compliance|2
255149|NCT01258101|841977|P3|Overall Study|Patient´s compliance|1
255150|NCT01258101|841978|P2|Overall Study|Patient´s compliance|3
255151|NCT01258101|841979|P1|Overall Study|Patient´s compliance|4
255152|NCT01258101|841976|P4|Overall Study|Patient is not able to attend visits|6
255153|NCT01258101|841977|P3|Overall Study|Patient is not able to attend visits|7
255154|NCT01258101|841978|P2|Overall Study|Patient is not able to attend visits|9
255155|NCT01258101|841979|P1|Overall Study|Patient is not able to attend visits|8
255156|NCT01258101|841976|P4|Overall Study|Informed consent has been withdrawn|1
255157|NCT01258101|841977|P3|Overall Study|Informed consent has been withdrawn|1
255158|NCT01258101|841978|P2|Overall Study|Informed consent has been withdrawn|2
255159|NCT01258101|841979|P1|Overall Study|Informed consent has been withdrawn|2
255160|NCT01258101|841976|P4|Overall Study|Extra exclusion criterion amended|1
255161|NCT01258101|841977|P3|Overall Study|Extra exclusion criterion amended|1
255162|NCT01258101|841978|P2|Overall Study|Extra exclusion criterion amended|1
255163|NCT01258101|841979|P1|Overall Study|Extra exclusion criterion amended|2
255164|NCT01258101|841976|P4|Overall Study|Adverse Event|0
255165|NCT01258101|841977|P3|Overall Study|Adverse Event|0
255166|NCT01258101|841978|P2|Overall Study|Adverse Event|6
255167|NCT01258101|841979|P1|Overall Study|Adverse Event|5
255168|NCT01257581|842087|P3|Overall Study|Death|4
255169|NCT01257581|842088|P2|Overall Study|Death|2
255170|NCT01257581|842089|P1|Overall Study|Death|2
255171|NCT01257581|842087|P3|Overall Study|Early Termination|2
255172|NCT01257581|842088|P2|Overall Study|Early Termination|1
255173|NCT01257581|842089|P1|Overall Study|Early Termination|3
255174|NCT01257542|842129|P2|Overall Study|Withdrawal by Subject|2
255175|NCT01257542|842130|P1|Overall Study|Withdrawal by Subject|0
255176|NCT01257542|842129|P2|Overall Study|Protocol Violation|5
255177|NCT01257542|842130|P1|Overall Study|Protocol Violation|3
255178|NCT01257503|842150|P2|Overall Study|strep culture positive at enrollment|0
255179|NCT01257503|842151|P1|Overall Study|strep culture positive at enrollment|1
255180|NCT01257503|842150|P2|Overall Study|Over 5 years old at enrollment|1
255181|NCT01257503|842151|P1|Overall Study|Over 5 years old at enrollment|0
255182|NCT01257503|842150|P2|Overall Study|Lost to Follow-up|10
255183|NCT01257503|842151|P1|Overall Study|Lost to Follow-up|7
255184|NCT01257425|842180|P2|Overall Study|Death|0
255185|NCT01257425|842181|P1|Overall Study|Death|1
255186|NCT01257425|842180|P2|Overall Study|Withdrawal by Subject|1
255187|NCT01257425|842181|P1|Overall Study|Withdrawal by Subject|0
255188|NCT01257425|842180|P2|Overall Study|Protocol Violation|1
255189|NCT01257425|842181|P1|Overall Study|Protocol Violation|1
255190|NCT01257425|842180|P2|Overall Study|Adverse Event|1
255191|NCT01257425|842181|P1|Overall Study|Adverse Event|1
255192|NCT01257425|842180|P2|Overall Study|Lack of Efficacy|3
255193|NCT01257425|842181|P1|Overall Study|Lack of Efficacy|3
255194|NCT01257230|842223|P3|Overall Study|Other reason not defined above|3
255195|NCT01257230|842224|P2|Overall Study|Other reason not defined above|5
255196|NCT01257230|842225|P1|Overall Study|Other reason not defined above|1
255197|NCT01257230|842223|P3|Overall Study|Withdrawal by Subject|1
255198|NCT01257230|842224|P2|Overall Study|Withdrawal by Subject|4
255199|NCT01257230|842225|P1|Overall Study|Withdrawal by Subject|0
255200|NCT01257230|842223|P3|Overall Study|Protocol Violation|1
255201|NCT01257230|842224|P2|Overall Study|Protocol Violation|0
255202|NCT01257230|842225|P1|Overall Study|Protocol Violation|3
255203|NCT01257230|842223|P3|Overall Study|Lack of Efficacy|0
255204|NCT01257230|842224|P2|Overall Study|Lack of Efficacy|1
255205|NCT01257230|842225|P1|Overall Study|Lack of Efficacy|0
255206|NCT01257230|842223|P3|Overall Study|Adverse Event|0
255207|NCT01257230|842224|P2|Overall Study|Adverse Event|0
255208|NCT01257230|842225|P1|Overall Study|Adverse Event|2
255209|NCT01257230|842223|P3|Overall Study|Not Treated|1
255210|NCT01257230|842224|P2|Overall Study|Not Treated|0
255211|NCT01257230|842225|P1|Overall Study|Not Treated|0
255212|NCT01257204|842302|P3|Follow-up Period (up to Week 48)|Unspecified|5
255213|NCT01257204|842303|P2|Follow-up Period (up to Week 48)|Unspecified|0
255214|NCT01257204|842304|P1|Follow-up Period (up to Week 48)|Unspecified|0
255215|NCT01257204|842302|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
255216|NCT01257204|842303|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
255217|NCT01257204|842304|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
255218|NCT01257204|842302|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
255219|NCT01257204|842303|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
255220|NCT01257204|842304|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
255221|NCT01257204|842302|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
255222|NCT01257204|842303|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
255223|NCT01257204|842304|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
255224|NCT01257204|842302|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
255225|NCT01257204|842303|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
255226|NCT01257204|842304|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
255227|NCT01257204|842302|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
255228|NCT01257204|842303|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
255229|NCT01257204|842304|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
255230|NCT01257204|842302|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
255231|NCT01257204|842303|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
255232|NCT01257204|842304|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
255233|NCT01257204|842302|P3|Treatment Period (up to Week 24)|Adverse Event|2
255234|NCT01257204|842303|P2|Treatment Period (up to Week 24)|Adverse Event|1
255235|NCT01257204|842304|P1|Treatment Period (up to Week 24)|Adverse Event|3
255236|NCT01257204|842302|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
255237|NCT01257204|842303|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
255238|NCT01257204|842304|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
255239|NCT01256450|842350|P3|Double-blind Treatment|Not specified|12
255240|NCT01256450|842351|P2|Double-blind Treatment|Not specified|9
255241|NCT01256450|842352|P1|Double-blind Treatment|Not specified|0
255242|NCT01256450|842350|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
255243|NCT01256450|842351|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
255244|NCT01256450|842352|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
255245|NCT01256450|842350|P3|Double-blind Treatment|Non-compliance|4
255246|NCT01256450|842351|P2|Double-blind Treatment|Non-compliance|5
255247|NCT01256450|842352|P1|Double-blind Treatment|Non-compliance|0
255248|NCT01256450|842350|P3|Double-blind Treatment|Lack of analgesic effect|6
255249|NCT01256450|842351|P2|Double-blind Treatment|Lack of analgesic effect|5
255250|NCT01256450|842352|P1|Double-blind Treatment|Lack of analgesic effect|0
255251|NCT01256450|842350|P3|Double-blind Treatment|Withdrawal by Subject|1
255252|NCT01256450|842351|P2|Double-blind Treatment|Withdrawal by Subject|0
255253|NCT01256450|842352|P1|Double-blind Treatment|Withdrawal by Subject|0
255254|NCT01256450|842350|P3|Double-blind Treatment|Lost to Follow-up|7
255255|NCT01256450|842351|P2|Double-blind Treatment|Lost to Follow-up|1
255256|NCT01256450|842352|P1|Double-blind Treatment|Lost to Follow-up|0
255257|NCT01256450|842350|P3|Double-blind Treatment|Adverse Event|6
255258|NCT01256450|842351|P2|Double-blind Treatment|Adverse Event|8
255259|NCT01256450|842352|P1|Double-blind Treatment|Adverse Event|0
255260|NCT01256450|842350|P3|Open-label Titration|Not specified|0
255261|NCT01256450|842351|P2|Open-label Titration|Not specified|0
255262|NCT01256450|842352|P1|Open-label Titration|Not specified|13
255263|NCT01256450|842350|P3|Open-label Titration|Screen failure|0
255264|NCT01256450|842351|P2|Open-label Titration|Screen failure|0
255265|NCT01256450|842352|P1|Open-label Titration|Screen failure|1
255266|NCT01256450|842350|P3|Open-label Titration|Non-compliance|0
255267|NCT01256450|842351|P2|Open-label Titration|Non-compliance|0
255268|NCT01256450|842352|P1|Open-label Titration|Non-compliance|9
255269|NCT01256450|842350|P3|Open-label Titration|Lack of analgesic effect|0
255270|NCT01256450|842351|P2|Open-label Titration|Lack of analgesic effect|0
255271|NCT01256450|842352|P1|Open-label Titration|Lack of analgesic effect|30
255272|NCT01256450|842350|P3|Open-label Titration|Lost to Follow-up|0
255273|NCT01256450|842351|P2|Open-label Titration|Lost to Follow-up|0
255274|NCT01256450|842352|P1|Open-label Titration|Lost to Follow-up|7
255275|NCT01256450|842350|P3|Open-label Titration|Adverse Event|0
255276|NCT01256450|842351|P2|Open-label Titration|Adverse Event|0
255277|NCT01256450|842352|P1|Open-label Titration|Adverse Event|39
255278|NCT01256411|842410|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
255279|NCT01256411|842411|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
255280|NCT01256411|842412|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
255281|NCT01256411|842413|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
255282|NCT01256411|842414|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
255283|NCT01256411|842415|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
255284|NCT01256411|842410|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
255285|NCT01256411|842411|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
255286|NCT01256411|842412|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
255287|NCT01256411|842413|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
255288|NCT01256411|842414|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
255289|NCT01256411|842415|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
255290|NCT01256411|842410|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
255291|NCT01256411|842411|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
255292|NCT01256411|842412|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
255293|NCT01256411|842413|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
255294|NCT01256411|842414|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
255295|NCT01256411|842415|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
255296|NCT01256411|842410|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
255297|NCT01256411|842411|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
255298|NCT01256411|842412|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
255299|NCT01256411|842413|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
255300|NCT01256411|842414|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
255301|NCT01256411|842415|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
255302|NCT01256411|842410|P6|Extension by Mono or Combination Therapy|Adverse Event|1
255303|NCT01256411|842411|P5|Extension by Mono or Combination Therapy|Adverse Event|6
255304|NCT01256411|842412|P4|Extension by Mono or Combination Therapy|Adverse Event|0
255305|NCT01256411|842413|P3|Extension by Mono or Combination Therapy|Adverse Event|0
255306|NCT01256411|842414|P2|Extension by Mono or Combination Therapy|Adverse Event|0
255307|NCT01256411|842415|P1|Extension by Mono or Combination Therapy|Adverse Event|0
255308|NCT01256411|842410|P6|Extension by Maximum Treatment|Adverse Event|0
255309|NCT01256411|842411|P5|Extension by Maximum Treatment|Adverse Event|0
255310|NCT01256411|842412|P4|Extension by Maximum Treatment|Adverse Event|0
255311|NCT01256411|842413|P3|Extension by Maximum Treatment|Adverse Event|1
255312|NCT01256411|842414|P2|Extension by Maximum Treatment|Adverse Event|2
255313|NCT01256411|842415|P1|Extension by Maximum Treatment|Adverse Event|4
255314|NCT01256411|842410|P6|Extension by Maximum Treatment|Lack of Efficacy|0
255315|NCT01256411|842411|P5|Extension by Maximum Treatment|Lack of Efficacy|0
255316|NCT01256411|842412|P4|Extension by Maximum Treatment|Lack of Efficacy|0
255317|NCT01256411|842413|P3|Extension by Maximum Treatment|Lack of Efficacy|1
255318|NCT01256411|842414|P2|Extension by Maximum Treatment|Lack of Efficacy|0
255319|NCT01256411|842415|P1|Extension by Maximum Treatment|Lack of Efficacy|1
255320|NCT01256411|842410|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
255321|NCT01256411|842411|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
255322|NCT01256411|842412|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
255323|NCT01256411|842413|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
255324|NCT01256411|842414|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
255325|NCT01256411|842415|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
255326|NCT01256411|842410|P6|Extension by Maximum Treatment|Lost to Follow-up|0
255327|NCT01256411|842411|P5|Extension by Maximum Treatment|Lost to Follow-up|0
255328|NCT01256411|842412|P4|Extension by Maximum Treatment|Lost to Follow-up|0
255329|NCT01256411|842413|P3|Extension by Maximum Treatment|Lost to Follow-up|0
255330|NCT01256411|842414|P2|Extension by Maximum Treatment|Lost to Follow-up|2
255331|NCT01256411|842415|P1|Extension by Maximum Treatment|Lost to Follow-up|1
255332|NCT01256411|842410|P6|Extension by Maximum Treatment|Protocol deviation|0
255333|NCT01256411|842411|P5|Extension by Maximum Treatment|Protocol deviation|0
255334|NCT01256411|842412|P4|Extension by Maximum Treatment|Protocol deviation|0
255335|NCT01256411|842413|P3|Extension by Maximum Treatment|Protocol deviation|1
255336|NCT01256411|842414|P2|Extension by Maximum Treatment|Protocol deviation|0
255337|NCT01256411|842415|P1|Extension by Maximum Treatment|Protocol deviation|0
255338|NCT01256385|842441|P2|Overall Study|Withdrawal by Subject|2
255339|NCT01256385|842442|P1|Overall Study|Withdrawal by Subject|2
255340|NCT01256385|842441|P2|Overall Study|Physician Decision|1
255341|NCT01256385|842442|P1|Overall Study|Physician Decision|1
255342|NCT01256294|842462|P2|Overall Study|Protocol deviation|1
255343|NCT01256294|842463|P1|Overall Study|Protocol deviation|2
255344|NCT01256294|842462|P2|Overall Study|Withdrawal by Subject|1
255345|NCT01256294|842463|P1|Overall Study|Withdrawal by Subject|1
255346|NCT01256294|842462|P2|Overall Study|Adverse Event|0
255347|NCT01256294|842463|P1|Overall Study|Adverse Event|1
255348|NCT01256190|842485|P2|Overall Study|Lost to Follow-up|0
255349|NCT01256190|842486|P1|Overall Study|Lost to Follow-up|2
255350|NCT01256177|842502|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
255351|NCT01256177|842503|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
255352|NCT01256177|842502|P2|Overall Study|Lack of Efficacy|2
255353|NCT01256177|842503|P1|Overall Study|Lack of Efficacy|11
255354|NCT01256177|842502|P2|Overall Study|Condition under Investigation Worsened|0
255355|NCT01256177|842503|P1|Overall Study|Condition under Investigation Worsened|1
255356|NCT01256177|842502|P2|Overall Study|Severe Non-Compliance to Protocol|2
255444|NCT01254890|842893|P1|Overall Study|Disease Progression|0
255357|NCT01256177|842503|P1|Overall Study|Severe Non-Compliance to Protocol|4
255358|NCT01256177|842502|P2|Overall Study|Adverse Event|9
255359|NCT01256177|842503|P1|Overall Study|Adverse Event|8
255360|NCT01256177|842502|P2|Overall Study|Lost to Follow-up|2
255361|NCT01256177|842503|P1|Overall Study|Lost to Follow-up|2
255362|NCT01256177|842502|P2|Overall Study|Withdrawal by Subject|22
255363|NCT01256177|842503|P1|Overall Study|Withdrawal by Subject|23
255364|NCT01256060|842559|P4|Overall Study|Lost to Follow-up|0
255365|NCT01256060|842560|P3|Overall Study|Lost to Follow-up|0
255366|NCT01256060|842561|P2|Overall Study|Lost to Follow-up|1
255367|NCT01256060|842562|P1|Overall Study|Lost to Follow-up|0
255368|NCT01256008|842581|P3|Overall Study|Withdrawal by Subject|10
255369|NCT01256008|842582|P2|Overall Study|Withdrawal by Subject|3
255370|NCT01256008|842583|P1|Overall Study|Withdrawal by Subject|2
255371|NCT01256008|842581|P3|Overall Study|Lost to Follow-up|11
255372|NCT01256008|842582|P2|Overall Study|Lost to Follow-up|4
255373|NCT01256008|842583|P1|Overall Study|Lost to Follow-up|6
255374|NCT01255904|842605|P2|Overall Study|Physician Decision|4
255375|NCT01255904|842606|P1|Overall Study|Physician Decision|1
255376|NCT01255787|842616|P4|Overall Study|Noncompliance with Study Drug|0
255377|NCT01255787|842617|P3|Overall Study|Noncompliance with Study Drug|0
255378|NCT01255787|842618|P2|Overall Study|Noncompliance with Study Drug|1
255379|NCT01255787|842619|P1|Overall Study|Noncompliance with Study Drug|3
255380|NCT01255787|842616|P4|Overall Study|Lack of Efficacy|2
255381|NCT01255787|842617|P3|Overall Study|Lack of Efficacy|2
255382|NCT01255787|842618|P2|Overall Study|Lack of Efficacy|2
255383|NCT01255787|842619|P1|Overall Study|Lack of Efficacy|2
255384|NCT01255787|842616|P4|Overall Study|Pregnancy|1
255385|NCT01255787|842617|P3|Overall Study|Pregnancy|0
255386|NCT01255787|842618|P2|Overall Study|Pregnancy|0
255387|NCT01255787|842619|P1|Overall Study|Pregnancy|0
255388|NCT01255787|842616|P4|Overall Study|Withdrawal of Consent|4
255389|NCT01255787|842617|P3|Overall Study|Withdrawal of Consent|3
255390|NCT01255787|842618|P2|Overall Study|Withdrawal of Consent|9
255391|NCT01255787|842619|P1|Overall Study|Withdrawal of Consent|3
255392|NCT01255787|842616|P4|Overall Study|Lost to Follow-up|2
255393|NCT01255787|842617|P3|Overall Study|Lost to Follow-up|4
255394|NCT01255787|842618|P2|Overall Study|Lost to Follow-up|2
255395|NCT01255787|842619|P1|Overall Study|Lost to Follow-up|1
255396|NCT01255787|842616|P4|Overall Study|Major Protocol Deviation|4
255397|NCT01255787|842617|P3|Overall Study|Major Protocol Deviation|0
255398|NCT01255787|842618|P2|Overall Study|Major Protocol Deviation|1
255399|NCT01255787|842619|P1|Overall Study|Major Protocol Deviation|1
255400|NCT01255787|842616|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
255401|NCT01255787|842617|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
255402|NCT01255787|842618|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
255403|NCT01255787|842619|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
255404|NCT01255761|842647|P2|Overall Study|Other Reasons|18
255405|NCT01255761|842648|P1|Overall Study|Other Reasons|37
255406|NCT01255761|842647|P2|Overall Study|Withdrawal by Subject|27
255407|NCT01255761|842648|P1|Overall Study|Withdrawal by Subject|11
255408|NCT01255761|842647|P2|Overall Study|Lost to Follow-up|8
255409|NCT01255761|842648|P1|Overall Study|Lost to Follow-up|10
255410|NCT01255761|842647|P2|Overall Study|Protocol Violation|5
255411|NCT01255761|842648|P1|Overall Study|Protocol Violation|9
255412|NCT01255761|842647|P2|Overall Study|Lack of Efficacy|74
255413|NCT01255761|842648|P1|Overall Study|Lack of Efficacy|86
255414|NCT01255761|842647|P2|Overall Study|Adverse Event|43
255415|NCT01255761|842648|P1|Overall Study|Adverse Event|29
255416|NCT01255722|842733|P3|Overall Study|beta-blocker contraindicated|0
255417|NCT01255722|842734|P2|Overall Study|beta-blocker contraindicated|0
255418|NCT01255722|842735|P1|Overall Study|beta-blocker contraindicated|2
255419|NCT01255722|842733|P3|Overall Study|asymptomatic patient|0
255420|NCT01255722|842734|P2|Overall Study|asymptomatic patient|0
255421|NCT01255722|842735|P1|Overall Study|asymptomatic patient|1
255422|NCT01255722|842733|P3|Overall Study|Adverse Event|1
255423|NCT01255722|842734|P2|Overall Study|Adverse Event|1
255424|NCT01255722|842735|P1|Overall Study|Adverse Event|0
255425|NCT01255631|842760|P2|Overall Study|poor enrollment, no data analyzed|6
255426|NCT01255631|842761|P1|Overall Study|poor enrollment, no data analyzed|9
255427|NCT01255592|842779|P2|Overall Study|Other|1
255428|NCT01255592|842780|P1|Overall Study|Other|0
255429|NCT01255592|842779|P2|Overall Study|Withdrawal by Subject|0
255430|NCT01255592|842780|P1|Overall Study|Withdrawal by Subject|1
255431|NCT01255592|842779|P2|Overall Study|Adverse Event|0
255432|NCT01255592|842780|P1|Overall Study|Adverse Event|5
255433|NCT01255436|842843|P2|Overall Study|Death, stroke, or MI|3
255434|NCT01255436|842844|P1|Overall Study|Death, stroke, or MI|4
255435|NCT01255436|842843|P2|Overall Study|Lost to Follow-up|191
255436|NCT01255436|842844|P1|Overall Study|Lost to Follow-up|178
255437|NCT01255423|842858|P2|Overall Study|Use of prohibited medications|1
255438|NCT01255423|842859|P1|Overall Study|Use of prohibited medications|0
255439|NCT01255423|842858|P2|Overall Study|Abnormal Laboratory value|2
255440|NCT01255423|842859|P1|Overall Study|Abnormal Laboratory value|3
255441|NCT01255306|842875|P2|Overall Study|Physician Decision|1
255442|NCT01255306|842876|P1|Overall Study|Physician Decision|1
255443|NCT01254890|842892|P2|Overall Study|Disease Progression|5
255445|NCT01254890|842892|P2|Overall Study|Withdrawal by Subject|2
255446|NCT01254890|842893|P1|Overall Study|Withdrawal by Subject|1
255447|NCT01254890|842892|P2|Overall Study|Ineligible|3
255448|NCT01254890|842893|P1|Overall Study|Ineligible|0
255449|NCT01254747|842927|P4|Overall Study|Discomfort|0
255450|NCT01254747|842928|P3|Overall Study|Discomfort|0
255451|NCT01254747|842929|P2|Overall Study|Discomfort|4
255452|NCT01254747|842930|P1|Overall Study|Discomfort|0
255453|NCT01254747|842927|P4|Overall Study|Biomicroscopy|0
255454|NCT01254747|842928|P3|Overall Study|Biomicroscopy|1
255455|NCT01254747|842929|P2|Overall Study|Biomicroscopy|0
255456|NCT01254747|842930|P1|Overall Study|Biomicroscopy|0
255457|NCT01254747|842927|P4|Overall Study|Lost to Follow-up|0
255458|NCT01254747|842928|P3|Overall Study|Lost to Follow-up|1
255459|NCT01254747|842929|P2|Overall Study|Lost to Follow-up|0
255460|NCT01254747|842930|P1|Overall Study|Lost to Follow-up|0
255461|NCT01254747|842927|P4|Overall Study|Symptoms and problems|0
255462|NCT01254747|842928|P3|Overall Study|Symptoms and problems|1
255463|NCT01254747|842929|P2|Overall Study|Symptoms and problems|2
255464|NCT01254747|842930|P1|Overall Study|Symptoms and problems|0
255465|NCT01254747|842927|P4|Overall Study|Difficult removal handling|0
255466|NCT01254747|842928|P3|Overall Study|Difficult removal handling|1
255467|NCT01254747|842929|P2|Overall Study|Difficult removal handling|0
255468|NCT01254747|842930|P1|Overall Study|Difficult removal handling|0
255469|NCT01254747|842927|P4|Overall Study|Unacceptable subjective vision|2
255470|NCT01254747|842928|P3|Overall Study|Unacceptable subjective vision|0
255471|NCT01254747|842929|P2|Overall Study|Unacceptable subjective vision|0
255472|NCT01254747|842930|P1|Overall Study|Unacceptable subjective vision|0
255473|NCT01254721|842970|P2|Overall Study|Wrongly randomization|1
255474|NCT01254721|842971|P1|Overall Study|Wrongly randomization|0
255475|NCT01254721|842970|P2|Overall Study|Withdrawal by Subject|11
255476|NCT01254721|842971|P1|Overall Study|Withdrawal by Subject|8
255477|NCT01254721|842970|P2|Overall Study|Adverse Event|3
255478|NCT01254721|842971|P1|Overall Study|Adverse Event|2
255479|NCT01254721|842970|P2|Overall Study|technical problum|0
255480|NCT01254721|842971|P1|Overall Study|technical problum|1
255481|NCT01254721|842970|P2|Overall Study|Death|1
255482|NCT01254721|842971|P1|Overall Study|Death|0
255483|NCT01254721|842970|P2|Overall Study|Lack of Efficacy|2
255484|NCT01254721|842971|P1|Overall Study|Lack of Efficacy|4
255485|NCT01254721|842970|P2|Overall Study|Lost to Follow-up|4
255486|NCT01254721|842971|P1|Overall Study|Lost to Follow-up|0
255487|NCT01254669|842981|P2|Overall Study|called to clinic during intervention|1
255488|NCT01254669|842982|P1|Overall Study|called to clinic during intervention|1
255489|NCT01254669|842981|P2|Overall Study|time constraint|2
255490|NCT01254669|842982|P1|Overall Study|time constraint|2
255491|NCT01254669|842981|P2|Overall Study|Withdrawal by Subject|1
255492|NCT01254669|842982|P1|Overall Study|Withdrawal by Subject|0
255493|NCT01254656|842993|P3|Overall Study|Death|0
255494|NCT01254656|842994|P2|Overall Study|Death|1
255495|NCT01254656|842995|P1|Overall Study|Death|0
255496|NCT01254656|842993|P3|Overall Study|Adverse Event|0
255497|NCT01254656|842994|P2|Overall Study|Adverse Event|1
255498|NCT01254656|842995|P1|Overall Study|Adverse Event|1
255499|NCT01254656|842993|P3|Overall Study|Pregnancy|2
255500|NCT01254656|842994|P2|Overall Study|Pregnancy|0
255501|NCT01254656|842995|P1|Overall Study|Pregnancy|0
255502|NCT01254656|842993|P3|Overall Study|Withdrawal by Subject|1
255503|NCT01254656|842994|P2|Overall Study|Withdrawal by Subject|2
255504|NCT01254656|842995|P1|Overall Study|Withdrawal by Subject|2
255505|NCT01254656|842993|P3|Overall Study|Lost to Follow-up|2
255506|NCT01254656|842994|P2|Overall Study|Lost to Follow-up|0
255507|NCT01254656|842995|P1|Overall Study|Lost to Follow-up|1
255508|NCT01254656|842993|P3|Overall Study|Lack of Efficacy|0
255509|NCT01254656|842994|P2|Overall Study|Lack of Efficacy|0
255510|NCT01254656|842995|P1|Overall Study|Lack of Efficacy|3
255511|NCT01254656|842993|P3|Overall Study|Discontinued due to termination of study|13
255512|NCT01254656|842994|P2|Overall Study|Discontinued due to termination of study|39
255513|NCT01254656|842995|P1|Overall Study|Discontinued due to termination of study|40
255514|NCT01254643|843021|P1|Overall Study|Withdrawal by Subject|1
255515|NCT01254604|843031|P2|Overall Study|Adverse Event|2
255516|NCT01254604|843032|P1|Overall Study|Adverse Event|3
255517|NCT01254604|843031|P2|Overall Study|Withdrawal by Subject|4
255518|NCT01254604|843032|P1|Overall Study|Withdrawal by Subject|2
255519|NCT01254604|843031|P2|Overall Study|Protocol Violation|2
255520|NCT01254604|843032|P1|Overall Study|Protocol Violation|2
255521|NCT01254604|843031|P2|Overall Study|Lost to Follow-up|1
255522|NCT01254604|843032|P1|Overall Study|Lost to Follow-up|1
255523|NCT01254565|843050|P6|Overall Study|Other|0
255524|NCT01254565|843051|P5|Overall Study|Other|0
255525|NCT01254565|843052|P4|Overall Study|Other|1
255526|NCT01254565|843053|P3|Overall Study|Other|0
255527|NCT01254565|843054|P2|Overall Study|Other|0
255528|NCT01254565|843055|P1|Overall Study|Other|0
255529|NCT01254565|843050|P6|Overall Study|Did not Receive Treatment|4
255530|NCT01254565|843051|P5|Overall Study|Did not Receive Treatment|3
255531|NCT01254565|843052|P4|Overall Study|Did not Receive Treatment|0
255532|NCT01254565|843053|P3|Overall Study|Did not Receive Treatment|0
255533|NCT01254565|843054|P2|Overall Study|Did not Receive Treatment|1
255534|NCT01254565|843055|P1|Overall Study|Did not Receive Treatment|1
255535|NCT01254565|843050|P6|Overall Study|Non-compliance to Study Procedures|0
255536|NCT01254565|843051|P5|Overall Study|Non-compliance to Study Procedures|1
255537|NCT01254565|843052|P4|Overall Study|Non-compliance to Study Procedures|0
255538|NCT01254565|843053|P3|Overall Study|Non-compliance to Study Procedures|0
255539|NCT01254565|843054|P2|Overall Study|Non-compliance to Study Procedures|0
255540|NCT01254565|843055|P1|Overall Study|Non-compliance to Study Procedures|0
255541|NCT01254409|843109|P4|Overall Study|Adverse Event|0
255542|NCT01254409|843110|P3|Overall Study|Adverse Event|0
255543|NCT01254409|843111|P2|Overall Study|Adverse Event|1
255544|NCT01254409|843112|P1|Overall Study|Adverse Event|0
255545|NCT01254344|843181|P2|Overall Study|Withdrawal by Subject|6
255546|NCT01254344|843182|P1|Overall Study|Withdrawal by Subject|3
255547|NCT01254344|843181|P2|Overall Study|Protocol Violation|4
255548|NCT01254344|843182|P1|Overall Study|Protocol Violation|1
255549|NCT01254344|843181|P2|Overall Study|Physician Decision|4
255550|NCT01254344|843182|P1|Overall Study|Physician Decision|7
255551|NCT01254344|843181|P2|Overall Study|Adverse Event|5
255552|NCT01254344|843182|P1|Overall Study|Adverse Event|2
255553|NCT01254331|843190|P1|Extension Phase|Lost to Follow-up|3
255554|NCT01254331|843190|P1|Extension Phase|Lack of Efficacy|1
255555|NCT01254331|843190|P1|Initial Phase|Pregnancy|1
255556|NCT01254331|843190|P1|Initial Phase|Withdrawal by Subject|1
255557|NCT01254331|843190|P1|Initial Phase|Adverse Event|3
255558|NCT01254318|843208|P1|Overall Study|Death|47
255559|NCT01254318|843208|P1|Overall Study|Lost to Follow-up|5
255560|NCT01254305|843217|P3|Overall Study|Other Reasons|2
255561|NCT01254305|843218|P2|Overall Study|Other Reasons|0
255562|NCT01254305|843219|P1|Overall Study|Other Reasons|0
255563|NCT01254305|843217|P3|Overall Study|Lost to Follow-up|5
255564|NCT01254305|843218|P2|Overall Study|Lost to Follow-up|6
255565|NCT01254305|843219|P1|Overall Study|Lost to Follow-up|10
255566|NCT01254305|843217|P3|Overall Study|Withdrawal by Subject|4
255567|NCT01254305|843218|P2|Overall Study|Withdrawal by Subject|2
255568|NCT01254305|843219|P1|Overall Study|Withdrawal by Subject|4
255569|NCT01254305|843217|P3|Overall Study|Protocol Violation|3
255570|NCT01254305|843218|P2|Overall Study|Protocol Violation|7
255571|NCT01254305|843219|P1|Overall Study|Protocol Violation|1
255572|NCT01254305|843217|P3|Overall Study|Lack of Efficacy|1
255573|NCT01254305|843218|P2|Overall Study|Lack of Efficacy|0
255574|NCT01254305|843219|P1|Overall Study|Lack of Efficacy|1
255575|NCT01254305|843217|P3|Overall Study|Adverse Event|2
255576|NCT01254305|843218|P2|Overall Study|Adverse Event|3
255577|NCT01254305|843219|P1|Overall Study|Adverse Event|6
255578|NCT01254292|843235|P2|LCS12 Extension Phase|Lost to Follow-up|0
255579|NCT01254292|843236|P1|LCS12 Extension Phase|Lost to Follow-up|1
255580|NCT01254292|843235|P2|LCS12 Extension Phase|Pregnancy|0
255581|NCT01254292|843236|P1|LCS12 Extension Phase|Pregnancy|2
255582|NCT01254292|843235|P2|LCS12 Extension Phase|Other unknown|0
255583|NCT01254292|843236|P1|LCS12 Extension Phase|Other unknown|4
255584|NCT01254292|843235|P2|LCS12 Extension Phase|Withdrawal by Subject|0
255585|NCT01254292|843236|P1|LCS12 Extension Phase|Withdrawal by Subject|7
255586|NCT01254292|843235|P2|LCS12 Extension Phase|Adverse Event|0
255587|NCT01254292|843236|P1|LCS12 Extension Phase|Adverse Event|9
255588|NCT01254292|843235|P2|LCS12 Extension Phase|Wish for pregnancy|0
255589|NCT01254292|843236|P1|LCS12 Extension Phase|Wish for pregnancy|14
255590|NCT01254292|843235|P2|Comparative Phase|Wish for pregnancy|6
255591|NCT01254292|843236|P1|Comparative Phase|Wish for pregnancy|4
255592|NCT01254292|843235|P2|Comparative Phase|Protocol Violation|2
255593|NCT01254292|843236|P1|Comparative Phase|Protocol Violation|1
255594|NCT01254292|843235|P2|Comparative Phase|Withdrawal by Subject|21
255595|NCT01254292|843236|P1|Comparative Phase|Withdrawal by Subject|20
255596|NCT01254292|843235|P2|Comparative Phase|Pregnancy|6
255597|NCT01254292|843236|P1|Comparative Phase|Pregnancy|2
255598|NCT01254292|843235|P2|Comparative Phase|Lost to Follow-up|21
255599|NCT01254292|843236|P1|Comparative Phase|Lost to Follow-up|3
255600|NCT01254292|843235|P2|Comparative Phase|Adverse Event|25
255601|NCT01254292|843236|P1|Comparative Phase|Adverse Event|25
255602|NCT01254188|843309|P1|Overall Study|per investigator discretion|20
255603|NCT01254188|843309|P1|Overall Study|Adverse Event|43
255604|NCT01254188|843309|P1|Overall Study|Withdrawal by Subject|7
255605|NCT01254188|843309|P1|Overall Study|Lost to Follow-up|5
255606|NCT01254188|843309|P1|Overall Study|Death|4
255607|NCT01254188|843309|P1|Overall Study|Pregnancy|2
255608|NCT01254188|843309|P1|Overall Study|Protocol Violation|6
255609|NCT01254188|843309|P1|Overall Study|Disease Progression|6
255610|NCT01254045|843320|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
255611|NCT01254045|843321|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
255612|NCT01254045|843322|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
255613|NCT01254045|843323|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
255614|NCT01254045|843324|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
255615|NCT01254045|843325|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
255616|NCT01253811|843379|P1|Overall Study|Withdrawal criteria|1
255617|NCT01253577|843398|P1|Overall Study|Lost to Follow-up|3
255618|NCT01253564|843406|P1|Overall Study|Serious Adverse Event|1
255619|NCT01253564|843406|P1|Overall Study|Withdrawal by Subject|1
255620|NCT01253564|843406|P1|Overall Study|Disease Progression|22
255621|NCT01253447|843450|P1|Overall Study|Adverse Event|2
255622|NCT01253408|843457|P3|Overall Study|Adverse Event|0
255623|NCT01253408|843458|P2|Overall Study|Adverse Event|1
255624|NCT01253408|843459|P1|Overall Study|Adverse Event|0
255625|NCT01253369|843482|P1|Overall Study|Not Evaluable|3
255626|NCT01253369|843482|P1|Overall Study|Progressive disease|23
255627|NCT01253369|843482|P1|Overall Study|Death|1
255628|NCT01253369|843482|P1|Overall Study|Withdrawal by Subject|2
255629|NCT01253369|843482|P1|Overall Study|Adverse Event|4
255630|NCT01253304|843516|P4|Overall Study|Adverse Event|1
255631|NCT01253304|843517|P3|Overall Study|Adverse Event|0
255632|NCT01253304|843518|P2|Overall Study|Adverse Event|0
255633|NCT01253304|843519|P1|Overall Study|Adverse Event|0
255634|NCT01253265|843558|P5|Overall Study|Withdrawal by Subject|1
255635|NCT01253265|843559|P4|Overall Study|Withdrawal by Subject|0
255636|NCT01253265|843560|P3|Overall Study|Withdrawal by Subject|0
255637|NCT01253265|843561|P2|Overall Study|Withdrawal by Subject|0
255638|NCT01253265|843562|P1|Overall Study|Withdrawal by Subject|0
255639|NCT01253265|843558|P5|Overall Study|Met Predefined Discontinuation Criteria|0
255640|NCT01253265|843559|P4|Overall Study|Met Predefined Discontinuation Criteria|0
255641|NCT01253265|843560|P3|Overall Study|Met Predefined Discontinuation Criteria|0
255642|NCT01253265|843561|P2|Overall Study|Met Predefined Discontinuation Criteria|0
255643|NCT01253265|843562|P1|Overall Study|Met Predefined Discontinuation Criteria|1
255644|NCT01253187|843606|P6|Period 3|non-compliance|0
255645|NCT01253187|843607|P5|Period 3|non-compliance|1
255646|NCT01253187|843608|P4|Period 3|non-compliance|0
255647|NCT01253187|843609|P3|Period 3|non-compliance|0
255648|NCT01253187|843610|P2|Period 3|non-compliance|0
255649|NCT01253187|843611|P1|Period 3|non-compliance|0
255650|NCT01253187|843606|P6|Period 3|difficulty with blood sampling|0
255651|NCT01253187|843607|P5|Period 3|difficulty with blood sampling|0
255652|NCT01253187|843608|P4|Period 3|difficulty with blood sampling|0
255653|NCT01253187|843609|P3|Period 3|difficulty with blood sampling|0
255654|NCT01253187|843610|P2|Period 3|difficulty with blood sampling|1
255655|NCT01253187|843611|P1|Period 3|difficulty with blood sampling|0
255656|NCT01253187|843606|P6|Period 3|Pregnancy|0
255657|NCT01253187|843607|P5|Period 3|Pregnancy|0
255658|NCT01253187|843608|P4|Period 3|Pregnancy|0
255659|NCT01253187|843609|P3|Period 3|Pregnancy|0
255660|NCT01253187|843610|P2|Period 3|Pregnancy|0
255661|NCT01253187|843611|P1|Period 3|Pregnancy|1
255662|NCT01253187|843606|P6|Period 2|Withdrawal by Subject|0
255663|NCT01253187|843607|P5|Period 2|Withdrawal by Subject|1
255664|NCT01253187|843608|P4|Period 2|Withdrawal by Subject|0
255665|NCT01253187|843609|P3|Period 2|Withdrawal by Subject|0
255666|NCT01253187|843610|P2|Period 2|Withdrawal by Subject|0
255667|NCT01253187|843611|P1|Period 2|Withdrawal by Subject|0
255668|NCT01253174|843640|P6|Period 3|Pregnancy|0
255669|NCT01253174|843641|P5|Period 3|Pregnancy|0
255670|NCT01253174|843642|P4|Period 3|Pregnancy|0
255671|NCT01253174|843643|P3|Period 3|Pregnancy|1
255672|NCT01253174|843644|P2|Period 3|Pregnancy|0
255673|NCT01253174|843645|P1|Period 3|Pregnancy|0
255674|NCT01253174|843640|P6|Period 3|Withdrawal by Subject|0
255675|NCT01253174|843641|P5|Period 3|Withdrawal by Subject|1
255676|NCT01253174|843642|P4|Period 3|Withdrawal by Subject|0
255677|NCT01253174|843643|P3|Period 3|Withdrawal by Subject|0
255678|NCT01253174|843644|P2|Period 3|Withdrawal by Subject|1
255679|NCT01253174|843645|P1|Period 3|Withdrawal by Subject|0
255680|NCT01253174|843640|P6|Period 2|Adverse Event|0
255681|NCT01253174|843641|P5|Period 2|Adverse Event|0
255682|NCT01253174|843642|P4|Period 2|Adverse Event|0
255683|NCT01253174|843643|P3|Period 2|Adverse Event|1
255684|NCT01253174|843644|P2|Period 2|Adverse Event|0
255685|NCT01253174|843645|P1|Period 2|Adverse Event|0
255686|NCT01253174|843640|P6|Period 1|Randomized but not treated|0
255687|NCT01253174|843641|P5|Period 1|Randomized but not treated|1
255688|NCT01253174|843642|P4|Period 1|Randomized but not treated|0
255689|NCT01253174|843643|P3|Period 1|Randomized but not treated|1
255690|NCT01253174|843644|P2|Period 1|Randomized but not treated|1
255691|NCT01253174|843645|P1|Period 1|Randomized but not treated|0
255692|NCT01253135|843680|P1|Amended Protocol|Non-compliance|1
255693|NCT01253135|843680|P1|Original Protocol|Protocol Amendment|15
255694|NCT01253044|843699|P2|Overall Study|Lost to Follow-up|29
255695|NCT01253044|843700|P1|Overall Study|Lost to Follow-up|38
255696|NCT01253018|843710|P2|Overall Study|Withdrawal by Subject|1
255697|NCT01253018|843711|P1|Overall Study|Withdrawal by Subject|1
255698|NCT01253018|843710|P2|Overall Study|Robot Repair Issues|0
255699|NCT01253018|843711|P1|Overall Study|Robot Repair Issues|2
255700|NCT01253018|843710|P2|Overall Study|Lost to Follow-up|1
255701|NCT01253018|843711|P1|Overall Study|Lost to Follow-up|1
255702|NCT01252966|843725|P2|Overall Study|Withdrawal by Subject|3
255703|NCT01252966|843726|P1|Overall Study|Withdrawal by Subject|7
255704|NCT01252966|843725|P2|Overall Study|Lost to Follow-up|10
255705|NCT01252966|843726|P1|Overall Study|Lost to Follow-up|16
255706|NCT01252940|843742|P2|Extension Phase|Withdrawal by Subject|1
255707|NCT01252940|843743|P1|Extension Phase|Withdrawal by Subject|1
255708|NCT01252940|843742|P2|Extension Phase|Subject Non-compliance|0
255709|NCT01252940|843743|P1|Extension Phase|Subject Non-compliance|1
255710|NCT01252940|843742|P2|Extension Phase|Physician Decision|1
255711|NCT01252940|843743|P1|Extension Phase|Physician Decision|0
255712|NCT01252940|843742|P2|Extension Phase|Lost to Follow-up|0
255713|NCT01252940|843743|P1|Extension Phase|Lost to Follow-up|5
255714|NCT01252940|843742|P2|Extension Phase|Lack of Efficacy|0
255715|NCT01252940|843743|P1|Extension Phase|Lack of Efficacy|1
255716|NCT01252940|843742|P2|Extension Phase|Adverse Event|1
255717|NCT01252940|843743|P1|Extension Phase|Adverse Event|2
255718|NCT01252940|843742|P2|Main Study Phase|Subject Non-compliance|1
255719|NCT01252940|843743|P1|Main Study Phase|Subject Non-compliance|1
255720|NCT01252940|843742|P2|Main Study Phase|Withdrawal by Subject|5
255721|NCT01252940|843743|P1|Main Study Phase|Withdrawal by Subject|6
255722|NCT01252940|843742|P2|Main Study Phase|Protocol Violation|2
255723|NCT01252940|843743|P1|Main Study Phase|Protocol Violation|4
255724|NCT01252940|843742|P2|Main Study Phase|Physician Decision|0
255725|NCT01252940|843743|P1|Main Study Phase|Physician Decision|1
255726|NCT01252940|843742|P2|Main Study Phase|Lost to Follow-up|1
255727|NCT01252940|843743|P1|Main Study Phase|Lost to Follow-up|6
255728|NCT01252940|843742|P2|Main Study Phase|Lack of Efficacy|0
255729|NCT01252940|843743|P1|Main Study Phase|Lack of Efficacy|1
255730|NCT01252940|843742|P2|Main Study Phase|Adverse Event|1
255731|NCT01252940|843743|P1|Main Study Phase|Adverse Event|3
255732|NCT01252940|843742|P2|Main Study Phase|Randomized but not treated|2
255733|NCT01252940|843743|P1|Main Study Phase|Randomized but not treated|4
255734|NCT01252810|843774|P2|Overall Study|Various reasons|0
255735|NCT01252810|843775|P1|Overall Study|Various reasons|8
255736|NCT01252810|843774|P2|Overall Study|Physician Decision|1
255737|NCT01252810|843775|P1|Overall Study|Physician Decision|2
255738|NCT01252810|843774|P2|Overall Study|Lost to Follow-up|1
255739|NCT01252810|843775|P1|Overall Study|Lost to Follow-up|0
255740|NCT01252810|843774|P2|Overall Study|Withdrawal by Subject|1
255741|NCT01252810|843775|P1|Overall Study|Withdrawal by Subject|4
255742|NCT01252355|843788|P3|Overall Study|Other Than Above|7
255743|NCT01252355|843789|P2|Overall Study|Other Than Above|7
255744|NCT01252355|843790|P1|Overall Study|Other Than Above|8
255745|NCT01252355|843788|P3|Overall Study|Randomized but not Treated|0
255746|NCT01252355|843789|P2|Overall Study|Randomized but not Treated|0
255747|NCT01252355|843790|P1|Overall Study|Randomized but not Treated|2
255748|NCT01252355|843788|P3|Overall Study|Sponsor Early Termination of Study|146
255749|NCT01252355|843789|P2|Overall Study|Sponsor Early Termination of Study|149
255750|NCT01252355|843790|P1|Overall Study|Sponsor Early Termination of Study|149
255751|NCT01252355|843788|P3|Overall Study|Progressive Disease|0
255752|NCT01252355|843789|P2|Overall Study|Progressive Disease|0
255753|NCT01252355|843790|P1|Overall Study|Progressive Disease|2
255754|NCT01252355|843788|P3|Overall Study|Poor Compliance to Protocol|1
255755|NCT01252355|843789|P2|Overall Study|Poor Compliance to Protocol|1
255756|NCT01252355|843790|P1|Overall Study|Poor Compliance to Protocol|1
255757|NCT01252355|843788|P3|Overall Study|Lost to Follow-up|1
255758|NCT01252355|843789|P2|Overall Study|Lost to Follow-up|0
255759|NCT01252355|843790|P1|Overall Study|Lost to Follow-up|0
255760|NCT01252355|843788|P3|Overall Study|Lack of Efficacy|2
255761|NCT01252355|843789|P2|Overall Study|Lack of Efficacy|4
255762|NCT01252355|843790|P1|Overall Study|Lack of Efficacy|6
255763|NCT01252355|843788|P3|Overall Study|Adverse Event|22
255764|NCT01252355|843789|P2|Overall Study|Adverse Event|17
255765|NCT01252355|843790|P1|Overall Study|Adverse Event|9
255766|NCT01252290|843828|P1|Overall Study|Withdrawal by Subject|1
255767|NCT01252238|843847|P3|Overall Study|Sponsor terminated study|4
255768|NCT01252238|843848|P2|Overall Study|Sponsor terminated study|4
255769|NCT01252238|843849|P1|Overall Study|Sponsor terminated study|4
255770|NCT01252186|843860|P3|Overall Study|Other - Miscellaneous Reasons|7
255771|NCT01252186|843861|P2|Overall Study|Other - Miscellaneous Reasons|5
255772|NCT01252186|843862|P1|Overall Study|Other - Miscellaneous Reasons|5
255773|NCT01252186|843860|P3|Overall Study|Lost to Follow-up|11
255774|NCT01252186|843861|P2|Overall Study|Lost to Follow-up|10
255775|NCT01252186|843862|P1|Overall Study|Lost to Follow-up|10
255776|NCT01252186|843860|P3|Overall Study|Sponsor Request|0
255777|NCT01252186|843861|P2|Overall Study|Sponsor Request|1
255778|NCT01252186|843862|P1|Overall Study|Sponsor Request|2
255779|NCT01252186|843860|P3|Overall Study|Pregnancy|0
255780|NCT01252186|843861|P2|Overall Study|Pregnancy|2
255781|NCT01252186|843862|P1|Overall Study|Pregnancy|2
255782|NCT01252186|843860|P3|Overall Study|Protocol Violation|1
255783|NCT01252186|843861|P2|Overall Study|Protocol Violation|0
255784|NCT01252186|843862|P1|Overall Study|Protocol Violation|0
255785|NCT01252186|843860|P3|Overall Study|Non-compliance|4
255786|NCT01252186|843861|P2|Overall Study|Non-compliance|3
255787|NCT01252186|843862|P1|Overall Study|Non-compliance|0
255788|NCT01252186|843860|P3|Overall Study|Physician Decision|1
255789|NCT01252186|843861|P2|Overall Study|Physician Decision|0
255790|NCT01252186|843862|P1|Overall Study|Physician Decision|0
255791|NCT01252186|843860|P3|Overall Study|Withdrawal by Subject|2
255792|NCT01252186|843861|P2|Overall Study|Withdrawal by Subject|5
255793|NCT01252186|843862|P1|Overall Study|Withdrawal by Subject|2
255794|NCT01252186|843860|P3|Overall Study|Adverse Event|8
255795|NCT01252186|843861|P2|Overall Study|Adverse Event|6
255796|NCT01252186|843862|P1|Overall Study|Adverse Event|9
255797|NCT01252134|843935|P6|Period 1, 8 Hours|Personal Reasons|0
255798|NCT01252134|843936|P5|Period 1, 8 Hours|Personal Reasons|0
255799|NCT01252134|843937|P4|Period 1, 8 Hours|Personal Reasons|0
255800|NCT01252134|843938|P3|Period 1, 8 Hours|Personal Reasons|1
255801|NCT01252134|843939|P2|Period 1, 8 Hours|Personal Reasons|1
255802|NCT01252134|843940|P1|Period 1, 8 Hours|Personal Reasons|0
255803|NCT01252095|843959|P2|Overall Study|Disease progression|0
255804|NCT01252095|843960|P1|Overall Study|Disease progression|1
255805|NCT01251952|843978|P1|Overall Study|Adverse Event|1
255806|NCT01251770|843984|P2|Overall Study|Protocol Violation|7
255807|NCT01251770|843985|P1|Overall Study|Protocol Violation|13
255808|NCT01251653|844036|P9|Overall Study|Other reason not mentioned above|0
255809|NCT01251653|844037|P8|Overall Study|Other reason not mentioned above|2
255810|NCT01251653|844038|P7|Overall Study|Other reason not mentioned above|0
255811|NCT01251653|844039|P6|Overall Study|Other reason not mentioned above|0
255812|NCT01251653|844040|P5|Overall Study|Other reason not mentioned above|0
255813|NCT01251653|844041|P4|Overall Study|Other reason not mentioned above|0
255814|NCT01251653|844042|P3|Overall Study|Other reason not mentioned above|0
255815|NCT01251653|844043|P2|Overall Study|Other reason not mentioned above|0
255816|NCT01251653|844044|P1|Overall Study|Other reason not mentioned above|0
255817|NCT01251653|844036|P9|Overall Study|Withdrawal by Subject|0
255818|NCT01251653|844037|P8|Overall Study|Withdrawal by Subject|1
255819|NCT01251653|844038|P7|Overall Study|Withdrawal by Subject|0
255820|NCT01251653|844039|P6|Overall Study|Withdrawal by Subject|1
255821|NCT01251653|844040|P5|Overall Study|Withdrawal by Subject|1
255822|NCT01251653|844041|P4|Overall Study|Withdrawal by Subject|0
255823|NCT01251653|844042|P3|Overall Study|Withdrawal by Subject|1
255824|NCT01251653|844043|P2|Overall Study|Withdrawal by Subject|0
255825|NCT01251653|844044|P1|Overall Study|Withdrawal by Subject|1
255826|NCT01251653|844036|P9|Overall Study|Adverse Event|1
255827|NCT01251653|844037|P8|Overall Study|Adverse Event|2
255828|NCT01251653|844038|P7|Overall Study|Adverse Event|2
255829|NCT01251653|844039|P6|Overall Study|Adverse Event|0
255830|NCT01251653|844040|P5|Overall Study|Adverse Event|1
255831|NCT01251653|844041|P4|Overall Study|Adverse Event|1
255832|NCT01251653|844042|P3|Overall Study|Adverse Event|2
255833|NCT01251653|844043|P2|Overall Study|Adverse Event|0
255834|NCT01251653|844044|P1|Overall Study|Adverse Event|1
255835|NCT01251653|844036|P9|Overall Study|Dose-limiting toxicity|0
255836|NCT01251653|844037|P8|Overall Study|Dose-limiting toxicity|0
255837|NCT01251653|844038|P7|Overall Study|Dose-limiting toxicity|2
255838|NCT01251653|844039|P6|Overall Study|Dose-limiting toxicity|0
255839|NCT01251653|844040|P5|Overall Study|Dose-limiting toxicity|0
255840|NCT01251653|844041|P4|Overall Study|Dose-limiting toxicity|1
255841|NCT01251653|844042|P3|Overall Study|Dose-limiting toxicity|1
255842|NCT01251653|844043|P2|Overall Study|Dose-limiting toxicity|1
255843|NCT01251653|844044|P1|Overall Study|Dose-limiting toxicity|0
255844|NCT01251653|844036|P9|Overall Study|Progressive Disease|5
255845|NCT01251653|844037|P8|Overall Study|Progressive Disease|7
255846|NCT01251653|844038|P7|Overall Study|Progressive Disease|14
255847|NCT01251653|844039|P6|Overall Study|Progressive Disease|17
255848|NCT01251653|844040|P5|Overall Study|Progressive Disease|0
255849|NCT01251653|844041|P4|Overall Study|Progressive Disease|4
255850|NCT01251653|844042|P3|Overall Study|Progressive Disease|16
255851|NCT01251653|844043|P2|Overall Study|Progressive Disease|7
255852|NCT01251653|844044|P1|Overall Study|Progressive Disease|1
255853|NCT01251614|844172|P3|Overall Study|Lost to Follow-up|0
255854|NCT01251614|844173|P2|Overall Study|Lost to Follow-up|1
255855|NCT01251614|844174|P1|Overall Study|Lost to Follow-up|0
255856|NCT01251614|844172|P3|Overall Study|Withdrawal by Subject|1
255857|NCT01251614|844173|P2|Overall Study|Withdrawal by Subject|2
255858|NCT01251614|844174|P1|Overall Study|Withdrawal by Subject|0
255859|NCT01251614|844172|P3|Overall Study|Loss of Disease Control|0
255860|NCT01251614|844173|P2|Overall Study|Loss of Disease Control|1
255861|NCT01251614|844174|P1|Overall Study|Loss of Disease Control|0
255862|NCT01251614|844172|P3|Overall Study|Pregnancy|2
255863|NCT01251614|844173|P2|Overall Study|Pregnancy|0
255864|NCT01251614|844174|P1|Overall Study|Pregnancy|0
255865|NCT01251614|844172|P3|Overall Study|Clearing of Psoriatic Lesions|0
255866|NCT01251614|844173|P2|Overall Study|Clearing of Psoriatic Lesions|0
255867|NCT01251614|844174|P1|Overall Study|Clearing of Psoriatic Lesions|1
255868|NCT01251614|844172|P3|Overall Study|Lack of Efficacy|4
255869|NCT01251614|844173|P2|Overall Study|Lack of Efficacy|9
255870|NCT01251614|844174|P1|Overall Study|Lack of Efficacy|1
255871|NCT01251614|844172|P3|Overall Study|Adverse Event|1
255872|NCT01251614|844173|P2|Overall Study|Adverse Event|0
255873|NCT01251614|844174|P1|Overall Study|Adverse Event|1
255874|NCT01251380|844281|P1|Overall Study|Lost to Follow-up|2
255875|NCT01251380|844281|P1|Overall Study|Adverse Event|1
255876|NCT01251380|844281|P1|Overall Study|Lack of Efficacy|1
255877|NCT01251380|844281|P1|Overall Study|Withdrawal by Subject|6
255878|NCT01251380|844281|P1|Overall Study|Other (Not otherwise specified)|12
255879|NCT01251354|844305|P1|Overall Study|Disease Progression|4
255880|NCT01251354|844305|P1|Overall Study|Investigator's Decision|1
255881|NCT01251354|844305|P1|Overall Study|Adverse Event|1
255882|NCT01251146|844348|P2|Overall Study|Lost to Follow-up|10
255883|NCT01251146|844349|P1|Overall Study|Lost to Follow-up|3
255884|NCT01251120|844371|P2|Overall Study|Lack of Efficacy|1
255885|NCT01251120|844372|P1|Overall Study|Lack of Efficacy|0
255886|NCT01250925|844437|P3|Overall Study|Adverse Event|1
255887|NCT01250925|844438|P2|Overall Study|Adverse Event|0
255888|NCT01250925|844439|P1|Overall Study|Adverse Event|0
255889|NCT01250925|844437|P3|Overall Study|Physician Decision|1
255890|NCT01250925|844438|P2|Overall Study|Physician Decision|2
255891|NCT01250925|844439|P1|Overall Study|Physician Decision|0
255892|NCT01250925|844437|P3|Overall Study|Protocol Violation|0
255893|NCT01250925|844438|P2|Overall Study|Protocol Violation|0
255894|NCT01250925|844439|P1|Overall Study|Protocol Violation|2
255895|NCT01250925|844437|P3|Overall Study|Withdrawal by Subject|0
255896|NCT01250925|844438|P2|Overall Study|Withdrawal by Subject|0
255897|NCT01250925|844439|P1|Overall Study|Withdrawal by Subject|2
255898|NCT01250925|844437|P3|Overall Study|Lost to Follow-up|0
255899|NCT01250925|844438|P2|Overall Study|Lost to Follow-up|1
255900|NCT01250925|844439|P1|Overall Study|Lost to Follow-up|1
255901|NCT01250769|844505|P4|Overall Study|Adverse Event|0
255902|NCT01250769|844506|P3|Overall Study|Adverse Event|1
255903|NCT01250769|844507|P2|Overall Study|Adverse Event|0
255904|NCT01250769|844508|P1|Overall Study|Adverse Event|0
255905|NCT01250769|844505|P4|Overall Study|Withdrawal by Subject|0
255906|NCT01250769|844506|P3|Overall Study|Withdrawal by Subject|1
255907|NCT01250769|844507|P2|Overall Study|Withdrawal by Subject|1
255908|NCT01250769|844508|P1|Overall Study|Withdrawal by Subject|0
255909|NCT01250756|844540|P2|After Toddler Dose|Adverse Event|1
255910|NCT01250756|844541|P1|After Toddler Dose|Adverse Event|0
255911|NCT01250756|844540|P2|Toddler Dose|Adverse Event|1
255912|NCT01250756|844541|P1|Toddler Dose|Adverse Event|0
255913|NCT01250756|844540|P2|After Infant Series|Unspecified|1
255914|NCT01250756|844541|P1|After Infant Series|Unspecified|2
255915|NCT01250756|844540|P2|After Infant Series|Withdrawal by Subject|1
255916|NCT01250756|844541|P1|After Infant Series|Withdrawal by Subject|4
255917|NCT01250756|844540|P2|After Infant Series|Adverse Event|2
255918|NCT01250756|844541|P1|After Infant Series|Adverse Event|5
255919|NCT01250756|844540|P2|Infant Series|Unspecified|0
255920|NCT01250756|844541|P1|Infant Series|Unspecified|22
255921|NCT01250756|844540|P2|Infant Series|Randomized, Not Vaccinated|2
255922|NCT01250756|844541|P1|Infant Series|Randomized, Not Vaccinated|2
255923|NCT01250756|844540|P2|Infant Series|Withdrawal by Subject|5
255924|NCT01250756|844541|P1|Infant Series|Withdrawal by Subject|4
255925|NCT01250509|844658|P2|Overall Study|Lost to Follow-up|2
255926|NCT01250509|844659|P1|Overall Study|Lost to Follow-up|5
255927|NCT01250418|844673|P2|Overall Study|monitor data failure|1
255928|NCT01250418|844674|P1|Overall Study|monitor data failure|1
255929|NCT01250379|844682|P2|Overall Study|Participant noncompliance|0
255930|NCT01250379|844683|P1|Overall Study|Participant noncompliance|2
255931|NCT01250379|844682|P2|Overall Study|Not specified|4
255932|NCT01250379|844683|P1|Overall Study|Not specified|0
255933|NCT01250379|844682|P2|Overall Study|Adverse Event|4
255934|NCT01250379|844683|P1|Overall Study|Adverse Event|5
255935|NCT01250379|844682|P2|Overall Study|Lost to Follow-up|6
255936|NCT01250379|844683|P1|Overall Study|Lost to Follow-up|9
255937|NCT01250379|844682|P2|Overall Study|Protocol Violation|8
255938|NCT01250379|844683|P1|Overall Study|Protocol Violation|2
255939|NCT01250379|844682|P2|Overall Study|Physician Decision|3
255940|NCT01250379|844683|P1|Overall Study|Physician Decision|11
255941|NCT01250379|844682|P2|Overall Study|Withdrawal by Subject|20
255942|NCT01250379|844683|P1|Overall Study|Withdrawal by Subject|32
255943|NCT01250379|844682|P2|Overall Study|Death|148
255944|NCT01250379|844683|P1|Overall Study|Death|141
255945|NCT01250171|844772|P3|Overall Study|Administrative reasons|0
255946|NCT01250171|844773|P2|Overall Study|Administrative reasons|0
255947|NCT01250171|844774|P1|Overall Study|Administrative reasons|1
255948|NCT01250145|844805|P2|Overall Study|Withdrawal by Subject|4
255949|NCT01250145|844806|P1|Overall Study|Withdrawal by Subject|0
255950|NCT01250145|844805|P2|Overall Study|Adverse Event|1
255951|NCT01250145|844806|P1|Overall Study|Adverse Event|2
255952|NCT01250119|844826|P2|Treatment Phase|Unknown reason|4
255953|NCT01250119|844827|P1|Treatment Phase|Unknown reason|0
255954|NCT01250119|844826|P2|Treatment Phase|Adverse Event|2
255955|NCT01250119|844827|P1|Treatment Phase|Adverse Event|0
255956|NCT01250119|844826|P2|Treatment Phase|Withdrawal by Subject|1
255957|NCT01250119|844827|P1|Treatment Phase|Withdrawal by Subject|0
255958|NCT01250119|844826|P2|Treatment Phase|Death|2
255959|NCT01250119|844827|P1|Treatment Phase|Death|0
255960|NCT01250119|844826|P2|Treatment Phase|Progressive Disease|32
255961|NCT01250119|844827|P1|Treatment Phase|Progressive Disease|0
255962|NCT01250119|844826|P2|Diagnostic Phase|Participants Not Tested|0
255963|NCT01250119|844827|P1|Diagnostic Phase|Participants Not Tested|44
255964|NCT01250119|844826|P2|Diagnostic Phase|Failed to Produce a Test Results|0
255965|NCT01250119|844827|P1|Diagnostic Phase|Failed to Produce a Test Results|69
255966|NCT01250054|844842|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
255967|NCT01250054|844843|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
255968|NCT01250002|844851|P2|Overall Study|Change to open surgical procedure|3
255969|NCT01250002|844852|P1|Overall Study|Change to open surgical procedure|4
255970|NCT01249833|844917|P2|Overall Study|Lost to Follow-up|1
255971|NCT01249833|844918|P1|Overall Study|Lost to Follow-up|0
255972|NCT01249664|844932|P2|Overall Study|Adverse Event|0
255973|NCT01249664|844933|P1|Overall Study|Adverse Event|1
255974|NCT01249664|844932|P2|Overall Study|Withdrawal by Subject|0
255975|NCT01249664|844933|P1|Overall Study|Withdrawal by Subject|5
255976|NCT01249651|844983|P1|Overall Study|Sponsor Decision|1
255977|NCT01249651|844983|P1|Overall Study|Protocol Violation|1
255978|NCT01249651|844983|P1|Overall Study|Adverse Event|1
255979|NCT01249651|844983|P1|Overall Study|Withdrawal by Subject|4
255980|NCT01249417|844993|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
255981|NCT01249417|844994|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
255982|NCT01249417|844995|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
255983|NCT01249417|844993|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
255984|NCT01249417|844994|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
255985|NCT01249417|844995|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
255986|NCT01249417|844993|P3|Treatment Phase - ITT Population|Adverse Event|1
255987|NCT01249417|844994|P2|Treatment Phase - ITT Population|Adverse Event|0
255988|NCT01249417|844995|P1|Treatment Phase - ITT Population|Adverse Event|0
255989|NCT01249417|844993|P3|Treatment Phase - ITT Population|Not specified|1
255990|NCT01249417|844994|P2|Treatment Phase - ITT Population|Not specified|0
255991|NCT01249417|844995|P1|Treatment Phase - ITT Population|Not specified|0
255992|NCT01249417|844993|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
255993|NCT01249417|844994|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
255994|NCT01249417|844995|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
255995|NCT01249417|844993|P3|Randomised Population|Study treatment not received|2
255996|NCT01249417|844994|P2|Randomised Population|Study treatment not received|0
255997|NCT01249417|844995|P1|Randomised Population|Study treatment not received|0
255998|NCT01249274|845011|P2|Overall Study|Received inpatient substance treatment|2
255999|NCT01249274|845012|P1|Overall Study|Received inpatient substance treatment|1
256000|NCT01249274|845011|P2|Overall Study|Lost to Follow-up|4
256001|NCT01249274|845012|P1|Overall Study|Lost to Follow-up|3
256002|NCT01249261|845038|P2|Overall Study|Withdrawal by Subject|0
256003|NCT01249261|845039|P1|Overall Study|Withdrawal by Subject|1
256004|NCT01249157|845067|P1|Overall Study|Withdrawal by Subject|1
256005|NCT01249131|845071|P6|Washout Period of 10 Days|Adverse Event|0
256006|NCT01249131|845072|P5|Washout Period of 10 Days|Adverse Event|1
256007|NCT01249131|845073|P4|Washout Period of 10 Days|Adverse Event|0
256008|NCT01249131|845074|P3|Washout Period of 10 Days|Adverse Event|0
256009|NCT01249131|845075|P2|Washout Period of 10 Days|Adverse Event|0
256010|NCT01249131|845076|P1|Washout Period of 10 Days|Adverse Event|0
256011|NCT01249118|845096|P3|First Washout Period|Physician Decision|0
256012|NCT01249118|845097|P2|First Washout Period|Physician Decision|1
256013|NCT01249118|845098|P1|First Washout Period|Physician Decision|0
256014|NCT01249092|845132|P1|Overall Study|Unable to tolerate expected SE -nausea|1
256015|NCT01249092|845132|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
256016|NCT01248949|845143|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
256017|NCT01248949|845144|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
256018|NCT01248949|845145|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
256019|NCT01248949|845146|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
256020|NCT01248949|845147|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
256021|NCT01248949|845143|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
256022|NCT01248949|845144|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
256023|NCT01248949|845145|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
256024|NCT01248949|845146|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
256025|NCT01248949|845147|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
256026|NCT01248949|845143|P5|Overall Study|Pi Decision Due To Declining Status|0
256027|NCT01248949|845144|P4|Overall Study|Pi Decision Due To Declining Status|0
256028|NCT01248949|845145|P3|Overall Study|Pi Decision Due To Declining Status|1
256029|NCT01248949|845146|P2|Overall Study|Pi Decision Due To Declining Status|0
256030|NCT01248949|845147|P1|Overall Study|Pi Decision Due To Declining Status|0
256031|NCT01248949|845143|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
256032|NCT01248949|845144|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
256033|NCT01248949|845145|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
256034|NCT01248949|845146|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
256035|NCT01248949|845147|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
256036|NCT01248949|845143|P5|Overall Study|Participant Went To Hospice|0
256037|NCT01248949|845144|P4|Overall Study|Participant Went To Hospice|0
256038|NCT01248949|845145|P3|Overall Study|Participant Went To Hospice|1
256039|NCT01248949|845146|P2|Overall Study|Participant Went To Hospice|0
256040|NCT01248949|845147|P1|Overall Study|Participant Went To Hospice|0
256041|NCT01248949|845143|P5|Overall Study|Entered Hospice And Refused Follow Up|1
256042|NCT01248949|845144|P4|Overall Study|Entered Hospice And Refused Follow Up|0
256043|NCT01248949|845145|P3|Overall Study|Entered Hospice And Refused Follow Up|0
256044|NCT01248949|845146|P2|Overall Study|Entered Hospice And Refused Follow Up|0
256045|NCT01248949|845147|P1|Overall Study|Entered Hospice And Refused Follow Up|0
256046|NCT01248949|845143|P5|Overall Study|Palliative Radiation To Brain Metastases|0
256047|NCT01248949|845144|P4|Overall Study|Palliative Radiation To Brain Metastases|0
256048|NCT01248949|845145|P3|Overall Study|Palliative Radiation To Brain Metastases|0
256049|NCT01248949|845146|P2|Overall Study|Palliative Radiation To Brain Metastases|0
256050|NCT01248949|845147|P1|Overall Study|Palliative Radiation To Brain Metastases|1
256051|NCT01248949|845143|P5|Overall Study|Alternative Therapy.|0
256052|NCT01248949|845144|P4|Overall Study|Alternative Therapy.|0
256053|NCT01248949|845145|P3|Overall Study|Alternative Therapy.|0
256054|NCT01248949|845146|P2|Overall Study|Alternative Therapy.|0
256055|NCT01248949|845147|P1|Overall Study|Alternative Therapy.|1
256056|NCT01248949|845143|P5|Overall Study|Alternative Therapy|0
256057|NCT01248949|845144|P4|Overall Study|Alternative Therapy|0
256058|NCT01248949|845145|P3|Overall Study|Alternative Therapy|0
256059|NCT01248949|845146|P2|Overall Study|Alternative Therapy|0
256060|NCT01248949|845147|P1|Overall Study|Alternative Therapy|1
256061|NCT01248949|845143|P5|Overall Study|Death|2
256062|NCT01248949|845144|P4|Overall Study|Death|6
256063|NCT01248949|845145|P3|Overall Study|Death|21
256064|NCT01248949|845146|P2|Overall Study|Death|7
256065|NCT01248949|845147|P1|Overall Study|Death|22
256066|NCT01248949|845143|P5|Overall Study|Withdrawal by Subject|1
256067|NCT01248949|845144|P4|Overall Study|Withdrawal by Subject|3
256068|NCT01248949|845145|P3|Overall Study|Withdrawal by Subject|11
256069|NCT01248949|845146|P2|Overall Study|Withdrawal by Subject|3
256070|NCT01248949|845147|P1|Overall Study|Withdrawal by Subject|5
256071|NCT01248949|845143|P5|Overall Study|Lost to Follow-up|0
256072|NCT01248949|845144|P4|Overall Study|Lost to Follow-up|1
256073|NCT01248949|845145|P3|Overall Study|Lost to Follow-up|2
256074|NCT01248949|845146|P2|Overall Study|Lost to Follow-up|2
256075|NCT01248949|845147|P1|Overall Study|Lost to Follow-up|2
256076|NCT01248936|845259|P1|Overall Study|Other reason|3
256077|NCT01248936|845259|P1|Overall Study|Refused Treatment|1
256078|NCT01248936|845259|P1|Overall Study|Lost to Follow-up|7
256079|NCT01248936|845259|P1|Overall Study|Adverse Event|8
256080|NCT01248936|845259|P1|Overall Study|Withdrawal of Consent|20
256081|NCT01248936|845259|P1|Overall Study|Death|26
256082|NCT01248936|845259|P1|Overall Study|Progression of Disease|50
256083|NCT01248936|845259|P1|Overall Study|Sponsor Decision|259
256084|NCT01248884|845272|P3|Overall Study|Adverse Event|0
256085|NCT01248884|845273|P2|Overall Study|Adverse Event|0
256086|NCT01248884|845274|P1|Overall Study|Adverse Event|1
256087|NCT01248884|845272|P3|Overall Study|Withdrawal by Subject|1
256088|NCT01248884|845273|P2|Overall Study|Withdrawal by Subject|3
256089|NCT01248884|845274|P1|Overall Study|Withdrawal by Subject|1
256090|NCT01248793|845326|P2|Overall Study|Withdrawal by Subject|3
256091|NCT01248793|845327|P1|Overall Study|Withdrawal by Subject|3
256092|NCT01248793|845326|P2|Overall Study|Protocol Violation|1
256093|NCT01248793|845327|P1|Overall Study|Protocol Violation|0
256094|NCT01248793|845326|P2|Overall Study|Adverse Event|1
256095|NCT01248793|845327|P1|Overall Study|Adverse Event|1
256096|NCT01248793|845326|P2|Overall Study|Lost to Follow-up|1
256097|NCT01248793|845327|P1|Overall Study|Lost to Follow-up|0
256098|NCT01248780|845341|P2|Overall Study|Not treated|1
256099|NCT01248780|845342|P1|Overall Study|Not treated|0
256100|NCT01248780|845341|P2|Overall Study|Withdrawal by Subject|4
256101|NCT01248780|845342|P1|Overall Study|Withdrawal by Subject|4
256102|NCT01248780|845341|P2|Overall Study|Protocol Violation|1
256103|NCT01248780|845342|P1|Overall Study|Protocol Violation|1
256104|NCT01248780|845341|P2|Overall Study|Adverse Event|7
256105|NCT01248780|845342|P1|Overall Study|Adverse Event|2
256106|NCT01248780|845341|P2|Overall Study|Death|1
256107|NCT01248780|845342|P1|Overall Study|Death|0
256108|NCT01248780|845341|P2|Overall Study|Lost to Follow-up|1
256109|NCT01248780|845342|P1|Overall Study|Lost to Follow-up|0
256110|NCT01248780|845341|P2|Overall Study|Lack of Efficacy|0
256111|NCT01248780|845342|P1|Overall Study|Lack of Efficacy|2
256112|NCT01248728|845356|P2|Overall Study|Lack of Efficacy|0
256113|NCT01248728|845357|P1|Overall Study|Lack of Efficacy|1
256114|NCT01248728|845356|P2|Overall Study|Withdrawal by Subject|1
256115|NCT01248728|845357|P1|Overall Study|Withdrawal by Subject|2
256116|NCT01248728|845356|P2|Overall Study|Adverse Event|1
256117|NCT01248728|845357|P1|Overall Study|Adverse Event|1
256118|NCT01248468|845374|P3|Overall Study|Withdrawal by Subject|0
256119|NCT01248468|845375|P2|Overall Study|Withdrawal by Subject|2
256120|NCT01248468|845376|P1|Overall Study|Withdrawal by Subject|4
256121|NCT01248468|845374|P3|Overall Study|Pregnancy|0
256122|NCT01248468|845375|P2|Overall Study|Pregnancy|0
256123|NCT01248468|845376|P1|Overall Study|Pregnancy|1
256124|NCT01248468|845374|P3|Overall Study|Lost to Follow-up|4
256125|NCT01248468|845375|P2|Overall Study|Lost to Follow-up|12
256126|NCT01248468|845376|P1|Overall Study|Lost to Follow-up|9
256127|NCT01248468|845374|P3|Overall Study|Administrative problem|0
256128|NCT01248468|845375|P2|Overall Study|Administrative problem|0
256129|NCT01248468|845376|P1|Overall Study|Administrative problem|1
256130|NCT01248455|845393|P1|Overall Study|switched to alternate treatment|1
256131|NCT01248364|845402|P4|Overall Study|Adverse Event|0
256132|NCT01248364|845403|P3|Overall Study|Adverse Event|0
256133|NCT01248364|845404|P2|Overall Study|Adverse Event|1
256134|NCT01248364|845405|P1|Overall Study|Adverse Event|0
256135|NCT01248130|845468|P2|Overall Study|Ineligible|0
256136|NCT01248130|845469|P1|Overall Study|Ineligible|1
256137|NCT01248130|845468|P2|Overall Study|Protocol Violation|0
256138|NCT01248130|845469|P1|Overall Study|Protocol Violation|1
256139|NCT01248065|845477|P2|Overall Study|Other|5
256140|NCT01248065|845478|P1|Overall Study|Other|3
256141|NCT01248065|845477|P2|Overall Study|Third treatment failure event|1
256142|NCT01248065|845478|P1|Overall Study|Third treatment failure event|3
256143|NCT01248065|845477|P2|Overall Study|Adverse Event|0
256144|NCT01248065|845478|P1|Overall Study|Adverse Event|3
256145|NCT01248065|845477|P2|Overall Study|Withdrawal by Subject|11
256146|NCT01248065|845478|P1|Overall Study|Withdrawal by Subject|14
256147|NCT01248065|845477|P2|Overall Study|Lost to Follow-up|5
256148|NCT01248065|845478|P1|Overall Study|Lost to Follow-up|3
256149|NCT01248013|845488|P1|Overall Study|Withdrawal by Subject|14
256150|NCT01247922|845503|P1|Overall Study|Disease progression|4
256151|NCT01247090|845613|P3|Overall Study|Withdrawal by Subject|0
256152|NCT01247090|845614|P2|Overall Study|Withdrawal by Subject|1
256153|NCT01247090|845615|P1|Overall Study|Withdrawal by Subject|0
256154|NCT01247090|845613|P3|Overall Study|Physician Decision|0
256155|NCT01247090|845614|P2|Overall Study|Physician Decision|0
256156|NCT01247090|845615|P1|Overall Study|Physician Decision|1
256157|NCT01246999|845644|P4|Overall Study|Withdrawal by Subject|2
256158|NCT01246999|845645|P3|Overall Study|Withdrawal by Subject|0
256159|NCT01246999|845646|P2|Overall Study|Withdrawal by Subject|0
256160|NCT01246999|845647|P1|Overall Study|Withdrawal by Subject|0
256161|NCT01246999|845644|P4|Overall Study|Lost to Follow-up|0
256162|NCT01246999|845645|P3|Overall Study|Lost to Follow-up|0
256163|NCT01246999|845646|P2|Overall Study|Lost to Follow-up|1
256164|NCT01246999|845647|P1|Overall Study|Lost to Follow-up|0
256165|NCT01246973|845682|P2|Overall Study|Withdrawal by Subject|13
256166|NCT01246973|845683|P1|Overall Study|Withdrawal by Subject|7
256167|NCT01246973|845682|P2|Overall Study|Adverse Event|9
256168|NCT01246973|845683|P1|Overall Study|Adverse Event|16
256169|NCT01246973|845682|P2|Overall Study|unspecified|25
256170|NCT01246973|845683|P1|Overall Study|unspecified|38
256171|NCT01246960|845693|P2|Overall Study|Withdrawal (by participant or physician)|3
256172|NCT01246960|845694|P1|Overall Study|Withdrawal (by participant or physician)|3
256173|NCT01246960|845693|P2|Overall Study|Lost to Follow-up|1
256174|NCT01246960|845694|P1|Overall Study|Lost to Follow-up|3
256175|NCT01246206|845758|P1|Overall Study|Patient did not receive study regiments.|1
256176|NCT01246011|845781|P3|Overall Study|Withdrawal by Subject|1
256177|NCT01246011|845782|P2|Overall Study|Withdrawal by Subject|0
256178|NCT01246011|845783|P1|Overall Study|Withdrawal by Subject|0
256179|NCT01246011|845781|P3|Overall Study|If needed warfarin clinically, withdrawn|3
256180|NCT01246011|845782|P2|Overall Study|If needed warfarin clinically, withdrawn|0
256181|NCT01246011|845783|P1|Overall Study|If needed warfarin clinically, withdrawn|0
256182|NCT01245764|845795|P4|Study Phase A|Lost to Follow-up|0
256183|NCT01245764|845796|P3|Study Phase A|Lost to Follow-up|5
256184|NCT01245764|845797|P2|Study Phase A|Lost to Follow-up|0
256185|NCT01245764|845798|P1|Study Phase A|Lost to Follow-up|0
256186|NCT01245764|845795|P4|Study Phase A|Protocol Violation|2
256187|NCT01245764|845796|P3|Study Phase A|Protocol Violation|2
256188|NCT01245764|845797|P2|Study Phase A|Protocol Violation|3
256189|NCT01245764|845798|P1|Study Phase A|Protocol Violation|6
256190|NCT01245764|845795|P4|Study Phase A|Other|1
256191|NCT01245764|845796|P3|Study Phase A|Other|3
256192|NCT01245764|845797|P2|Study Phase A|Other|2
256193|NCT01245764|845798|P1|Study Phase A|Other|3
256194|NCT01245751|845836|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
256195|NCT01245751|845837|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
256196|NCT01245751|845838|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
256197|NCT01245751|845839|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
256198|NCT01245751|845836|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
256199|NCT01245751|845837|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
256200|NCT01245751|845838|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
256201|NCT01245751|845839|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
256202|NCT01245751|845836|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
256203|NCT01245751|845837|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
256204|NCT01245751|845838|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
256205|NCT01245751|845839|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
256206|NCT01245387|845933|P1|Overall Study|Missing discontinuation status|369
256207|NCT01245387|845933|P1|Overall Study|Unspecified|131
256208|NCT01245387|845933|P1|Overall Study|Death|3
256209|NCT01245387|845933|P1|Overall Study|Adverse Event|9
256210|NCT01245387|845933|P1|Overall Study|Lack of Efficacy|195
256211|NCT01245387|845933|P1|Overall Study|Lost to Follow-up|106
256212|NCT01245374|845982|P1|Overall Study|Withdrawal by Subject|3
256213|NCT01245374|845982|P1|Overall Study|Protocol Violation|1
256214|NCT01245283|846005|P3|Overall Study|Lost to Follow-up|11
256215|NCT01245283|846006|P2|Overall Study|Lost to Follow-up|11
256216|NCT01245283|846007|P1|Overall Study|Lost to Follow-up|14
256217|NCT01245140|846052|P2|Overall Study|Refused Treatment/Did Not Coopera|1
256218|NCT01245140|846053|P1|Overall Study|Refused Treatment/Did Not Coopera|0
256219|NCT01245140|846052|P2|Overall Study|Withdrawal by Subject|1
256220|NCT01245140|846053|P1|Overall Study|Withdrawal by Subject|0
256221|NCT01245140|846052|P2|Overall Study|Protocol Violation|1
256222|NCT01245140|846053|P1|Overall Study|Protocol Violation|0
256223|NCT01245140|846052|P2|Overall Study|Lack of Efficacy|4
256224|NCT01245140|846053|P1|Overall Study|Lack of Efficacy|2
256225|NCT01245140|846052|P2|Overall Study|Adverse Event|3
256226|NCT01245140|846053|P1|Overall Study|Adverse Event|1
256227|NCT01245101|846109|P2|Period 3 (Treatment)|Withdrawal by Subject|0
256228|NCT01245101|846110|P1|Period 3 (Treatment)|Withdrawal by Subject|1
256229|NCT01245101|846109|P2|Period 2 (Washout)|Withdrawal by Subject|0
256230|NCT01245101|846110|P1|Period 2 (Washout)|Withdrawal by Subject|1
256231|NCT01245101|846109|P2|Period 1 (Treatment)|Withdrawal by Subject|0
256232|NCT01245101|846110|P1|Period 1 (Treatment)|Withdrawal by Subject|2
256233|NCT01245062|846120|P3|Cross-over Phase|Ongoing|34
256234|NCT01245062|846121|P2|Cross-over Phase|Ongoing|0
256235|NCT01245062|846122|P1|Cross-over Phase|Ongoing|0
256236|NCT01245062|846120|P3|Cross-over Phase|Withdrew Consent|3
256237|NCT01245062|846121|P2|Cross-over Phase|Withdrew Consent|0
256238|NCT01245062|846122|P1|Cross-over Phase|Withdrew Consent|0
256239|NCT01245062|846120|P3|Cross-over Phase|Death|14
256240|NCT01245062|846121|P2|Cross-over Phase|Death|0
256241|NCT01245062|846122|P1|Cross-over Phase|Death|0
256242|NCT01245062|846120|P3|Randomization Phase|Ongoing|0
256243|NCT01245062|846121|P2|Randomization Phase|Ongoing|65
256244|NCT01245062|846122|P1|Randomization Phase|Ongoing|169
256245|NCT01245062|846120|P3|Randomization Phase|Withdrew Consent|0
256246|NCT01245062|846121|P2|Randomization Phase|Withdrew Consent|10
256247|NCT01245062|846122|P1|Randomization Phase|Withdrew Consent|6
256248|NCT01245062|846120|P3|Randomization Phase|Physician Decision|0
256249|NCT01245062|846121|P2|Randomization Phase|Physician Decision|3
256250|NCT01245062|846122|P1|Randomization Phase|Physician Decision|2
256251|NCT01245062|846120|P3|Randomization Phase|Lost to Follow-up|0
256252|NCT01245062|846121|P2|Randomization Phase|Lost to Follow-up|1
256253|NCT01245062|846122|P1|Randomization Phase|Lost to Follow-up|2
256254|NCT01245062|846120|P3|Randomization Phase|Death|0
256255|NCT01245062|846121|P2|Randomization Phase|Death|29
256256|NCT01245062|846122|P1|Randomization Phase|Death|35
256257|NCT01244984|846157|P3|Overall Study|Withdrawal by Subject|2
256258|NCT01244984|846158|P2|Overall Study|Withdrawal by Subject|2
256259|NCT01244984|846159|P1|Overall Study|Withdrawal by Subject|1
256260|NCT01244984|846157|P3|Overall Study|Protocol Defined Stopping Criteria|0
256261|NCT01244984|846158|P2|Overall Study|Protocol Defined Stopping Criteria|1
256262|NCT01244984|846159|P1|Overall Study|Protocol Defined Stopping Criteria|1
256263|NCT01244984|846157|P3|Overall Study|Protocol Violation|0
256264|NCT01244984|846158|P2|Overall Study|Protocol Violation|0
256265|NCT01244984|846159|P1|Overall Study|Protocol Violation|1
256266|NCT01244984|846157|P3|Overall Study|Adverse Event|2
256267|NCT01244984|846158|P2|Overall Study|Adverse Event|11
256268|NCT01244984|846159|P1|Overall Study|Adverse Event|2
256269|NCT01244906|846233|P1|Overall Study|Progression of disease post treatment|6
256270|NCT01244906|846233|P1|Overall Study|Death|2
256271|NCT01244893|846242|P2|1-Week Follow Up|Lost to Follow-up|0
256272|NCT01244893|846243|P1|1-Week Follow Up|Lost to Follow-up|1
256273|NCT01244893|846242|P2|Baseline|Protocol Violation|1
256274|NCT01244893|846243|P1|Baseline|Protocol Violation|0
256275|NCT01244828|846255|P1|Overall Study|Other reason (not specified)|1
256276|NCT01244828|846255|P1|Overall Study|Lost to Follow-up|2
256277|NCT01244828|846255|P1|Overall Study|Lack of Efficacy|7
256278|NCT01244828|846255|P1|Overall Study|Withdrawal by Subject|31
256279|NCT01244828|846255|P1|Overall Study|Adverse Event|37
256280|NCT01244815|846271|P4|Overall Study|Did Not Meet Protocol Eligibility|0
256281|NCT01244815|846272|P3|Overall Study|Did Not Meet Protocol Eligibility|0
256282|NCT01244815|846273|P2|Overall Study|Did Not Meet Protocol Eligibility|1
256283|NCT01244815|846274|P1|Overall Study|Did Not Meet Protocol Eligibility|0
256284|NCT01244815|846271|P4|Overall Study|Protocol Violation|1
256285|NCT01244815|846272|P3|Overall Study|Protocol Violation|3
256286|NCT01244815|846273|P2|Overall Study|Protocol Violation|4
256287|NCT01244815|846274|P1|Overall Study|Protocol Violation|7
256288|NCT01244815|846271|P4|Overall Study|Withdrawal by Subject|3
256289|NCT01244815|846272|P3|Overall Study|Withdrawal by Subject|0
256290|NCT01244815|846273|P2|Overall Study|Withdrawal by Subject|2
256291|NCT01244815|846274|P1|Overall Study|Withdrawal by Subject|0
256292|NCT01244815|846271|P4|Overall Study|Lost to Follow-up|2
256293|NCT01244815|846272|P3|Overall Study|Lost to Follow-up|3
256294|NCT01244815|846273|P2|Overall Study|Lost to Follow-up|2
256295|NCT01244815|846274|P1|Overall Study|Lost to Follow-up|3
256296|NCT01244815|846271|P4|Overall Study|Treatment Failure|1
256297|NCT01244815|846272|P3|Overall Study|Treatment Failure|0
256298|NCT01244815|846273|P2|Overall Study|Treatment Failure|0
256299|NCT01244815|846274|P1|Overall Study|Treatment Failure|0
256300|NCT01244815|846271|P4|Overall Study|Adverse Event|5
256301|NCT01244815|846272|P3|Overall Study|Adverse Event|5
256302|NCT01244815|846273|P2|Overall Study|Adverse Event|7
256303|NCT01244815|846274|P1|Overall Study|Adverse Event|4
256304|NCT01244815|846271|P4|Overall Study|Not Treated|0
256305|NCT01244815|846272|P3|Overall Study|Not Treated|0
256306|NCT01244815|846273|P2|Overall Study|Not Treated|1
256307|NCT01244815|846274|P1|Overall Study|Not Treated|0
256308|NCT01244620|846360|P4|Overall Study|Study terminated|4
256309|NCT01244620|846361|P3|Overall Study|Study terminated|4
256310|NCT01244620|846362|P2|Overall Study|Study terminated|4
256311|NCT01244620|846363|P1|Overall Study|Study terminated|4
256312|NCT01244516|846422|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
256313|NCT01244516|846423|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
256314|NCT01244516|846424|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
256315|NCT01244516|846422|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
256316|NCT01244516|846423|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
256404|NCT01243177|846791|P1|Overall Study|Other Reason|11
256317|NCT01244516|846424|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
256318|NCT01244516|846422|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
256319|NCT01244516|846423|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
256320|NCT01244516|846424|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
256321|NCT01244516|846422|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
256322|NCT01244516|846423|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
256323|NCT01244516|846424|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
256324|NCT01244516|846422|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
256325|NCT01244516|846423|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
256326|NCT01244516|846424|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
256327|NCT01244516|846422|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
256328|NCT01244516|846423|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
256329|NCT01244516|846424|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
256330|NCT01244516|846422|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
256331|NCT01244516|846423|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
256332|NCT01244516|846424|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
256333|NCT01244490|846445|P3|Overall Study|Not specified|1
256334|NCT01244490|846446|P2|Overall Study|Not specified|0
256335|NCT01244490|846447|P1|Overall Study|Not specified|0
256336|NCT01244490|846445|P3|Overall Study|Lost to Follow-up|3
256337|NCT01244490|846446|P2|Overall Study|Lost to Follow-up|6
256338|NCT01244490|846447|P1|Overall Study|Lost to Follow-up|0
256339|NCT01244490|846445|P3|Overall Study|Adverse Event|5
256340|NCT01244490|846446|P2|Overall Study|Adverse Event|9
256341|NCT01244490|846447|P1|Overall Study|Adverse Event|1
256342|NCT01244490|846445|P3|Overall Study|Withdrawal by Subject|9
256343|NCT01244490|846446|P2|Overall Study|Withdrawal by Subject|4
256344|NCT01244490|846447|P1|Overall Study|Withdrawal by Subject|4
256345|NCT01244490|846445|P3|Overall Study|Lack of Efficacy|5
256346|NCT01244490|846446|P2|Overall Study|Lack of Efficacy|5
256347|NCT01244490|846447|P1|Overall Study|Lack of Efficacy|14
256348|NCT01244425|846515|P2|Overall Study|Adverse Event|1
256349|NCT01244425|846516|P1|Overall Study|Adverse Event|1
256350|NCT01244425|846515|P2|Overall Study|Withdrawal by Subject|2
256351|NCT01244425|846516|P1|Overall Study|Withdrawal by Subject|2
256352|NCT01244126|846548|P3|Overall Study|Protocol Violation|9
256353|NCT01244126|846549|P2|Overall Study|Protocol Violation|3
256354|NCT01244126|846550|P1|Overall Study|Protocol Violation|3
256355|NCT01244061|846563|P2|Overall Study|Randomized but not treated|2
256356|NCT01244061|846564|P1|Overall Study|Randomized but not treated|2
256357|NCT01244061|846563|P2|Overall Study|Adverse Event|2
256358|NCT01244061|846564|P1|Overall Study|Adverse Event|5
256359|NCT01244061|846563|P2|Overall Study|Protocol Violation|1
256360|NCT01244061|846564|P1|Overall Study|Protocol Violation|1
256361|NCT01244061|846563|P2|Overall Study|Not specified|19
256362|NCT01244061|846564|P1|Overall Study|Not specified|8
256363|NCT01244061|846563|P2|Overall Study|Withdrawal by Subject|46
256364|NCT01244061|846564|P1|Overall Study|Withdrawal by Subject|29
256365|NCT01244061|846563|P2|Overall Study|Lost to Follow-up|30
256366|NCT01244061|846564|P1|Overall Study|Lost to Follow-up|34
256367|NCT01244061|846563|P2|Overall Study|Lack of Efficacy|3
256368|NCT01244061|846564|P1|Overall Study|Lack of Efficacy|1
256369|NCT01244061|846563|P2|Overall Study|Did not meet entrance criteria|0
256370|NCT01244061|846564|P1|Overall Study|Did not meet entrance criteria|1
256371|NCT01244061|846563|P2|Overall Study|Death|0
256372|NCT01244061|846564|P1|Overall Study|Death|1
256373|NCT01243944|846578|P2|Overall Study|Physician Decision|2
256374|NCT01243944|846579|P1|Overall Study|Physician Decision|2
256375|NCT01243944|846578|P2|Overall Study|Patient decision|5
256376|NCT01243944|846579|P1|Overall Study|Patient decision|6
256377|NCT01243944|846578|P2|Overall Study|Disease progression|1
256378|NCT01243944|846579|P1|Overall Study|Disease progression|5
256379|NCT01243944|846578|P2|Overall Study|Lack of Efficacy|98
256380|NCT01243944|846579|P1|Overall Study|Lack of Efficacy|0
256381|NCT01243944|846578|P2|Overall Study|Adverse Event|2
256382|NCT01243944|846579|P1|Overall Study|Adverse Event|4
256383|NCT01243892|846603|P2|Overall Study|Did not meet eligibility criteria|0
256384|NCT01243892|846604|P1|Overall Study|Did not meet eligibility criteria|2
256385|NCT01243775|846614|P1|Overall Study|Withdrawal by Subject|2
256386|NCT01243671|846621|P1|Overall Study|Not Specified|1
256387|NCT01243671|846621|P1|Overall Study|Anti-adalimumab antibody positive|1
256388|NCT01243671|846621|P1|Overall Study|Adverse Event|3
256389|NCT01243411|846668|P1|Overall Study|Other|8
256390|NCT01243411|846668|P1|Overall Study|Adverse Event|5
256391|NCT01243411|846668|P1|Overall Study|Lost to Follow-up|10
256392|NCT01243411|846668|P1|Overall Study|Withdrawal by Subject|18
256393|NCT01243242|846775|P2|Overall Study|non compliance|0
256394|NCT01243242|846776|P1|Overall Study|non compliance|1
256395|NCT01243242|846775|P2|Overall Study|sponsor decision|1
256396|NCT01243242|846776|P1|Overall Study|sponsor decision|0
256397|NCT01243242|846775|P2|Overall Study|Physician Decision|1
256398|NCT01243242|846776|P1|Overall Study|Physician Decision|0
256399|NCT01243242|846775|P2|Overall Study|Withdrawal by Subject|1
256400|NCT01243242|846776|P1|Overall Study|Withdrawal by Subject|1
256401|NCT01243242|846775|P2|Overall Study|Adverse Event|1
256402|NCT01243242|846776|P1|Overall Study|Adverse Event|1
256403|NCT01243177|846790|P2|Overall Study|Other Reason|12
256405|NCT01243177|846790|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
256406|NCT01243177|846791|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
256407|NCT01243177|846790|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
256408|NCT01243177|846791|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
256409|NCT01243177|846790|P2|Overall Study|AE, non-serious non-fatal|58
256410|NCT01243177|846791|P1|Overall Study|AE, non-serious non-fatal|40
256411|NCT01243177|846790|P2|Overall Study|SAE, non-fatal|9
256412|NCT01243177|846791|P1|Overall Study|SAE, non-fatal|7
256413|NCT01243177|846790|P2|Overall Study|AE, serious fatal|1
256414|NCT01243177|846791|P1|Overall Study|AE, serious fatal|0
256415|NCT01243177|846790|P2|Overall Study|Withdrawal by Subject|38
256416|NCT01243177|846791|P1|Overall Study|Withdrawal by Subject|46
256417|NCT01243177|846790|P2|Overall Study|Lost to Follow-up|18
256418|NCT01243177|846791|P1|Overall Study|Lost to Follow-up|15
256419|NCT01243177|846790|P2|Overall Study|Protocol Violation|10
256420|NCT01243177|846791|P1|Overall Study|Protocol Violation|11
256421|NCT01243177|846790|P2|Overall Study|Lack of Efficacy|31
256422|NCT01243177|846791|P1|Overall Study|Lack of Efficacy|47
256423|NCT01242813|846812|P1|Overall Study|Lost to Follow-up|2
256424|NCT01242748|846834|P2|Overall Study|Miscellaneous reasons|3
256425|NCT01242748|846835|P1|Overall Study|Miscellaneous reasons|8
256426|NCT01242748|846834|P2|Overall Study|Withdrawal by Subject|2
256427|NCT01242748|846835|P1|Overall Study|Withdrawal by Subject|10
256428|NCT01242748|846834|P2|Overall Study|Protocol Violation|0
256429|NCT01242748|846835|P1|Overall Study|Protocol Violation|1
256430|NCT01242748|846834|P2|Overall Study|Physician Decision|2
256431|NCT01242748|846835|P1|Overall Study|Physician Decision|3
256432|NCT01242748|846834|P2|Overall Study|Lost to Follow-up|2
256433|NCT01242748|846835|P1|Overall Study|Lost to Follow-up|6
256434|NCT01242748|846834|P2|Overall Study|Adverse Event|5
256435|NCT01242748|846835|P1|Overall Study|Adverse Event|10
256436|NCT01242514|846875|P3|Overall Study|Adverse Event|19
256437|NCT01242514|846876|P2|Overall Study|Adverse Event|18
256438|NCT01242514|846877|P1|Overall Study|Adverse Event|129
256439|NCT01242514|846875|P3|Overall Study|Lost to Follow-up|4
256440|NCT01242514|846876|P2|Overall Study|Lost to Follow-up|5
256441|NCT01242514|846877|P1|Overall Study|Lost to Follow-up|14
256442|NCT01242514|846875|P3|Overall Study|Dev. of study specific discont. criteria|5
256443|NCT01242514|846876|P2|Overall Study|Dev. of study specific discont. criteria|3
256444|NCT01242514|846877|P1|Overall Study|Dev. of study specific discont. criteria|21
256445|NCT01242514|846875|P3|Overall Study|Lack of therapeutic response|10
256446|NCT01242514|846876|P2|Overall Study|Lack of therapeutic response|16
256447|NCT01242514|846877|P1|Overall Study|Lack of therapeutic response|99
256448|NCT01242514|846875|P3|Overall Study|Severe non-compliance to protocol|1
256449|NCT01242514|846876|P2|Overall Study|Severe non-compliance to protocol|2
256450|NCT01242514|846877|P1|Overall Study|Severe non-compliance to protocol|5
256451|NCT01242514|846875|P3|Overall Study|Subject decision|2
256452|NCT01242514|846876|P2|Overall Study|Subject decision|8
256453|NCT01242514|846877|P1|Overall Study|Subject decision|33
256454|NCT01242514|846875|P3|Overall Study|e.g., project closure|171
256455|NCT01242514|846876|P2|Overall Study|e.g., project closure|305
256456|NCT01242514|846877|P1|Overall Study|e.g., project closure|1042
256457|NCT01242371|846896|P2|Overall Study|Protocol Violation|3
256458|NCT01242371|846897|P1|Overall Study|Protocol Violation|0
256459|NCT01242371|846896|P2|Overall Study|Withdrawal by Subject|2
256460|NCT01242371|846897|P1|Overall Study|Withdrawal by Subject|2
256461|NCT01242176|846903|P2|Washout Period of 7 Days|Non-compliant with protocol|0
256462|NCT01242176|846904|P1|Washout Period of 7 Days|Non-compliant with protocol|1
256463|NCT01242176|846903|P2|Washout Period of 7 Days|Adverse Event|2
256464|NCT01242176|846904|P1|Washout Period of 7 Days|Adverse Event|0
256465|NCT01242111|846914|P1|Overall Study|Did not consent to MOR-100 follow-up|1
256466|NCT01242111|846914|P1|Overall Study|Withdrawal by Subject|1
256467|NCT01242111|846914|P1|Overall Study|Adverse Event|1
256468|NCT01242085|846926|P3|Overall Study|medically unable to have surgery|0
256469|NCT01242085|846927|P2|Overall Study|medically unable to have surgery|5
256470|NCT01242085|846928|P1|Overall Study|medically unable to have surgery|4
256471|NCT01242085|846926|P3|Overall Study|Withdrawal by Subject|0
256472|NCT01242085|846927|P2|Overall Study|Withdrawal by Subject|2
256473|NCT01242085|846928|P1|Overall Study|Withdrawal by Subject|4
256474|NCT01241760|846958|P2|Overall Study|Not specified|1
256475|NCT01241760|846959|P1|Overall Study|Not specified|1
256476|NCT01241760|846958|P2|Overall Study|Switch To Commercially Available Medicat|4
256477|NCT01241760|846959|P1|Overall Study|Switch To Commercially Available Medicat|1
256478|NCT01241760|846958|P2|Overall Study|Withdrawal by Subject|13
256479|NCT01241760|846959|P1|Overall Study|Withdrawal by Subject|13
256480|NCT01241760|846958|P2|Overall Study|Lost to Follow-up|22
256481|NCT01241760|846959|P1|Overall Study|Lost to Follow-up|18
256482|NCT01241760|846958|P2|Overall Study|Adverse Event|0
256483|NCT01241760|846959|P1|Overall Study|Adverse Event|1
256484|NCT01241591|846982|P4|Overall Study|Adverse Event|4
256485|NCT01241591|846983|P3|Overall Study|Adverse Event|12
256486|NCT01241591|846984|P2|Overall Study|Adverse Event|11
256487|NCT01241591|846985|P1|Overall Study|Adverse Event|3
256488|NCT01241591|846982|P4|Overall Study|Not specified|1
256489|NCT01241591|846983|P3|Overall Study|Not specified|0
256490|NCT01241591|846984|P2|Overall Study|Not specified|1
256491|NCT01241591|846985|P1|Overall Study|Not specified|0
256492|NCT01241591|846982|P4|Overall Study|Withdrawal by Subject|2
256493|NCT01241591|846983|P3|Overall Study|Withdrawal by Subject|2
256494|NCT01241591|846984|P2|Overall Study|Withdrawal by Subject|4
256495|NCT01241591|846985|P1|Overall Study|Withdrawal by Subject|6
256496|NCT01241591|846982|P4|Overall Study|Screen Failure|0
256497|NCT01241591|846983|P3|Overall Study|Screen Failure|1
256498|NCT01241591|846984|P2|Overall Study|Screen Failure|2
256499|NCT01241591|846985|P1|Overall Study|Screen Failure|3
256500|NCT01241591|846982|P4|Overall Study|Lost to Follow-up|2
256501|NCT01241591|846983|P3|Overall Study|Lost to Follow-up|2
256502|NCT01241591|846984|P2|Overall Study|Lost to Follow-up|2
256503|NCT01241591|846985|P1|Overall Study|Lost to Follow-up|1
256504|NCT01241591|846982|P4|Overall Study|Protocol Violation|0
256505|NCT01241591|846983|P3|Overall Study|Protocol Violation|3
256506|NCT01241591|846984|P2|Overall Study|Protocol Violation|2
256507|NCT01241591|846985|P1|Overall Study|Protocol Violation|5
256508|NCT01241591|846982|P4|Overall Study|Lack of Efficacy|3
256509|NCT01241591|846983|P3|Overall Study|Lack of Efficacy|2
256510|NCT01241591|846984|P2|Overall Study|Lack of Efficacy|2
256511|NCT01241591|846985|P1|Overall Study|Lack of Efficacy|5
256512|NCT01241552|847188|P4|Overall Study|Lost to Follow-up|16
256513|NCT01241552|847189|P3|Overall Study|Lost to Follow-up|15
256514|NCT01241552|847190|P2|Overall Study|Lost to Follow-up|11
256515|NCT01241552|847191|P1|Overall Study|Lost to Follow-up|2
256516|NCT01241552|847188|P4|Overall Study|Physician Decision|3
256517|NCT01241552|847189|P3|Overall Study|Physician Decision|2
256518|NCT01241552|847190|P2|Overall Study|Physician Decision|4
256519|NCT01241552|847191|P1|Overall Study|Physician Decision|2
256520|NCT01241552|847188|P4|Overall Study|Withdrawal by Subject|15
256521|NCT01241552|847189|P3|Overall Study|Withdrawal by Subject|14
256522|NCT01241552|847190|P2|Overall Study|Withdrawal by Subject|15
256523|NCT01241552|847191|P1|Overall Study|Withdrawal by Subject|7
256524|NCT01241552|847188|P4|Overall Study|Protocol Violation|1
256525|NCT01241552|847189|P3|Overall Study|Protocol Violation|6
256526|NCT01241552|847190|P2|Overall Study|Protocol Violation|2
256527|NCT01241552|847191|P1|Overall Study|Protocol Violation|0
256528|NCT01241552|847188|P4|Overall Study|Progressive Disease|2
256529|NCT01241552|847189|P3|Overall Study|Progressive Disease|1
256530|NCT01241552|847190|P2|Overall Study|Progressive Disease|0
256531|NCT01241552|847191|P1|Overall Study|Progressive Disease|0
256532|NCT01241552|847188|P4|Overall Study|Technical Problems|2
256533|NCT01241552|847189|P3|Overall Study|Technical Problems|2
256534|NCT01241552|847190|P2|Overall Study|Technical Problems|0
256535|NCT01241552|847191|P1|Overall Study|Technical Problems|2
256536|NCT01241552|847188|P4|Overall Study|Adverse Event|0
256537|NCT01241552|847189|P3|Overall Study|Adverse Event|0
256538|NCT01241552|847190|P2|Overall Study|Adverse Event|1
256539|NCT01241552|847191|P1|Overall Study|Adverse Event|1
256540|NCT01241552|847188|P4|Overall Study|Death|25
256541|NCT01241552|847189|P3|Overall Study|Death|20
256542|NCT01241552|847190|P2|Overall Study|Death|30
256543|NCT01241552|847191|P1|Overall Study|Death|26
256544|NCT01241552|847188|P4|Overall Study|Lack of Efficacy|0
256545|NCT01241552|847189|P3|Overall Study|Lack of Efficacy|0
256546|NCT01241552|847190|P2|Overall Study|Lack of Efficacy|0
256547|NCT01241552|847191|P1|Overall Study|Lack of Efficacy|1
256548|NCT01241292|847286|P2|Overall Study|Withdrawal by Subject|2
256549|NCT01241292|847287|P1|Overall Study|Withdrawal by Subject|0
256550|NCT01241292|847286|P2|Overall Study|Disease Progression|0
256551|NCT01241292|847287|P1|Overall Study|Disease Progression|1
256552|NCT01241279|847311|P2|Overall Study|Lost to Follow-up|1
256553|NCT01241279|847312|P1|Overall Study|Lost to Follow-up|0
256554|NCT01241240|847322|P2|Overall Study|Personal Reasons|1
256555|NCT01241240|847323|P1|Overall Study|Personal Reasons|1
256556|NCT01241240|847322|P2|Overall Study|Lost to Follow-up|4
256557|NCT01241240|847323|P1|Overall Study|Lost to Follow-up|2
256558|NCT01241240|847322|P2|Overall Study|Adverse Event|4
256559|NCT01241240|847323|P1|Overall Study|Adverse Event|5
256560|NCT01240915|847341|P9|Overall Study|Insufficient Clinical Response|3
256561|NCT01240915|847342|P8|Overall Study|Insufficient Clinical Response|0
256562|NCT01240915|847343|P7|Overall Study|Insufficient Clinical Response|6
256563|NCT01240915|847344|P6|Overall Study|Insufficient Clinical Response|3
256564|NCT01240915|847345|P5|Overall Study|Insufficient Clinical Response|1
256565|NCT01240915|847346|P4|Overall Study|Insufficient Clinical Response|0
256566|NCT01240915|847347|P3|Overall Study|Insufficient Clinical Response|0
256567|NCT01240915|847348|P2|Overall Study|Insufficient Clinical Response|0
256568|NCT01240915|847349|P1|Overall Study|Insufficient Clinical Response|0
256569|NCT01240915|847341|P9|Overall Study|Unspecified|0
256570|NCT01240915|847342|P8|Overall Study|Unspecified|0
256571|NCT01240915|847343|P7|Overall Study|Unspecified|0
256572|NCT01240915|847344|P6|Overall Study|Unspecified|0
256573|NCT01240915|847345|P5|Overall Study|Unspecified|2
256574|NCT01240915|847346|P4|Overall Study|Unspecified|0
256575|NCT01240915|847347|P3|Overall Study|Unspecified|0
256576|NCT01240915|847348|P2|Overall Study|Unspecified|0
256577|NCT01240915|847349|P1|Overall Study|Unspecified|0
256578|NCT01240915|847341|P9|Overall Study|Withdrawal by Subject|3
256579|NCT01240915|847342|P8|Overall Study|Withdrawal by Subject|3
256580|NCT01240915|847343|P7|Overall Study|Withdrawal by Subject|2
256581|NCT01240915|847344|P6|Overall Study|Withdrawal by Subject|4
256582|NCT01240915|847345|P5|Overall Study|Withdrawal by Subject|0
256583|NCT01240915|847346|P4|Overall Study|Withdrawal by Subject|2
256584|NCT01240915|847347|P3|Overall Study|Withdrawal by Subject|0
256585|NCT01240915|847348|P2|Overall Study|Withdrawal by Subject|1
256586|NCT01240915|847349|P1|Overall Study|Withdrawal by Subject|2
256587|NCT01240915|847341|P9|Overall Study|Lost to Follow-up|1
256588|NCT01240915|847342|P8|Overall Study|Lost to Follow-up|1
256589|NCT01240915|847343|P7|Overall Study|Lost to Follow-up|0
256590|NCT01240915|847344|P6|Overall Study|Lost to Follow-up|1
256591|NCT01240915|847345|P5|Overall Study|Lost to Follow-up|1
256592|NCT01240915|847346|P4|Overall Study|Lost to Follow-up|0
256593|NCT01240915|847347|P3|Overall Study|Lost to Follow-up|0
256594|NCT01240915|847348|P2|Overall Study|Lost to Follow-up|0
256595|NCT01240915|847349|P1|Overall Study|Lost to Follow-up|0
256596|NCT01240915|847341|P9|Overall Study|Adverse Event|1
256597|NCT01240915|847342|P8|Overall Study|Adverse Event|0
256598|NCT01240915|847343|P7|Overall Study|Adverse Event|0
256599|NCT01240915|847344|P6|Overall Study|Adverse Event|2
256600|NCT01240915|847345|P5|Overall Study|Adverse Event|0
256601|NCT01240915|847346|P4|Overall Study|Adverse Event|1
256602|NCT01240915|847347|P3|Overall Study|Adverse Event|0
256603|NCT01240915|847348|P2|Overall Study|Adverse Event|0
256604|NCT01240915|847349|P1|Overall Study|Adverse Event|0
256605|NCT01240863|847623|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
256606|NCT01240863|847624|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
256607|NCT01240863|847625|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
256608|NCT01240863|847623|P3|Double-blind Treatment Period (12 Weeks)|Not specified|5
256609|NCT01240863|847624|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
256610|NCT01240863|847625|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
256611|NCT01240863|847623|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
256612|NCT01240863|847624|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
256613|NCT01240863|847625|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
256614|NCT01240863|847623|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
256615|NCT01240863|847624|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
256616|NCT01240863|847625|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
256617|NCT01240863|847623|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
256618|NCT01240863|847624|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
256619|NCT01240863|847625|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
256620|NCT01240863|847623|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
256621|NCT01240863|847624|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
256622|NCT01240863|847625|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
256623|NCT01240863|847623|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
256624|NCT01240863|847624|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
256625|NCT01240863|847625|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
256626|NCT01240863|847623|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
256627|NCT01240863|847624|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
256628|NCT01240863|847625|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
256629|NCT01240863|847623|P3|Open-label Titration Period|Not specified|0
256630|NCT01240863|847624|P2|Open-label Titration Period|Not specified|0
256631|NCT01240863|847625|P1|Open-label Titration Period|Not specified|7
256632|NCT01240863|847623|P3|Open-label Titration Period|Dropped out prior to dosing|0
256633|NCT01240863|847624|P2|Open-label Titration Period|Dropped out prior to dosing|0
256634|NCT01240863|847625|P1|Open-label Titration Period|Dropped out prior to dosing|2
256635|NCT01240863|847623|P3|Open-label Titration Period|Noncompliance to study procedures|0
256636|NCT01240863|847624|P2|Open-label Titration Period|Noncompliance to study procedures|0
256637|NCT01240863|847625|P1|Open-label Titration Period|Noncompliance to study procedures|3
256638|NCT01240863|847623|P3|Open-label Titration Period|Noncompliance to study drug admin|0
256639|NCT01240863|847624|P2|Open-label Titration Period|Noncompliance to study drug admin|0
256640|NCT01240863|847625|P1|Open-label Titration Period|Noncompliance to study drug admin|3
256641|NCT01240863|847623|P3|Open-label Titration Period|Protocol Violation|0
256642|NCT01240863|847624|P2|Open-label Titration Period|Protocol Violation|0
256643|NCT01240863|847625|P1|Open-label Titration Period|Protocol Violation|7
256644|NCT01240863|847623|P3|Open-label Titration Period|Withdrawal by Subject|0
256645|NCT01240863|847624|P2|Open-label Titration Period|Withdrawal by Subject|0
256646|NCT01240863|847625|P1|Open-label Titration Period|Withdrawal by Subject|9
256647|NCT01240863|847623|P3|Open-label Titration Period|Lack of Efficacy|0
256648|NCT01240863|847624|P2|Open-label Titration Period|Lack of Efficacy|0
256649|NCT01240863|847625|P1|Open-label Titration Period|Lack of Efficacy|19
256650|NCT01240863|847623|P3|Open-label Titration Period|Adverse Event|0
256651|NCT01240863|847624|P2|Open-label Titration Period|Adverse Event|0
256652|NCT01240863|847625|P1|Open-label Titration Period|Adverse Event|47
256653|NCT01240811|847687|P3|Overall Study|Withdrawal by Subject|1
256654|NCT01240811|847688|P2|Overall Study|Withdrawal by Subject|0
256655|NCT01240811|847689|P1|Overall Study|Withdrawal by Subject|0
256656|NCT01240811|847687|P3|Overall Study|Physician Decision|0
256657|NCT01240811|847688|P2|Overall Study|Physician Decision|1
256658|NCT01240811|847689|P1|Overall Study|Physician Decision|0
256659|NCT01240785|847699|P2|Overall Study|Protocol Violation|3
256660|NCT01240785|847700|P1|Overall Study|Protocol Violation|0
256661|NCT01240785|847699|P2|Overall Study|Lost to Follow-up|0
256662|NCT01240785|847700|P1|Overall Study|Lost to Follow-up|1
256663|NCT01240746|847731|P3|Overall Study|Withdrawal by Subject|59
256664|NCT01240746|847732|P2|Overall Study|Withdrawal by Subject|13
256665|NCT01240746|847733|P1|Overall Study|Withdrawal by Subject|10
256666|NCT01240746|847731|P3|Overall Study|Protocol Violation|72
256667|NCT01240746|847732|P2|Overall Study|Protocol Violation|15
256668|NCT01240746|847733|P1|Overall Study|Protocol Violation|24
256669|NCT01240746|847731|P3|Overall Study|Lost to Follow-up|102
256670|NCT01240746|847732|P2|Overall Study|Lost to Follow-up|20
256671|NCT01240746|847733|P1|Overall Study|Lost to Follow-up|23
256672|NCT01240746|847731|P3|Overall Study|Adverse Event|10
256673|NCT01240746|847732|P2|Overall Study|Adverse Event|0
256674|NCT01240746|847733|P1|Overall Study|Adverse Event|2
256675|NCT01240590|847788|P5|Phase II|Refused further treatment|1
256676|NCT01240590|847789|P4|Phase II|Refused further treatment|2
256677|NCT01240590|847790|P3|Phase II|Refused further treatment|0
256678|NCT01240590|847791|P2|Phase II|Refused further treatment|0
256679|NCT01240590|847792|P1|Phase II|Refused further treatment|0
256680|NCT01240590|847788|P5|Phase I|Refused further treatment|0
256681|NCT01240590|847789|P4|Phase I|Refused further treatment|0
256682|NCT01240590|847790|P3|Phase I|Refused further treatment|3
256683|NCT01240590|847791|P2|Phase I|Refused further treatment|0
256684|NCT01240590|847792|P1|Phase I|Refused further treatment|0
256685|NCT01240551|847820|P2|Overall Study|Lost to Follow-up|1
256686|NCT01240551|847821|P1|Overall Study|Lost to Follow-up|1
256687|NCT01240551|847820|P2|Overall Study|Refused further treatment|2
256688|NCT01240551|847821|P1|Overall Study|Refused further treatment|3
256689|NCT01240382|847831|P2|Overall Study|Fear of adverse events|1
256690|NCT01240382|847832|P1|Overall Study|Fear of adverse events|0
256691|NCT01240382|847831|P2|Overall Study|Lack of Efficacy|2
256692|NCT01240382|847832|P1|Overall Study|Lack of Efficacy|0
256693|NCT01240382|847831|P2|Overall Study|Adverse Event|1
256694|NCT01240382|847832|P1|Overall Study|Adverse Event|2
256695|NCT01240356|847842|P2|Overall Study|MRI contraindication|0
256696|NCT01240356|847843|P1|Overall Study|MRI contraindication|1
256697|NCT01240356|847842|P2|Overall Study|Withdrawal by Subject|0
256698|NCT01240356|847843|P1|Overall Study|Withdrawal by Subject|2
256699|NCT01240200|847862|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
256700|NCT01240200|847863|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
256701|NCT01240135|847871|P2|Period Two, 14 Days of Wear|Adverse Event|1
256702|NCT01240135|847872|P1|Period Two, 14 Days of Wear|Adverse Event|0
256703|NCT01240135|847871|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
256704|NCT01240135|847872|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
256705|NCT01239992|847887|P1|Overall Study|Withdrawal by Subject|2
256706|NCT01239797|847896|P2|Treated Participants|Poor/Non-compliance|1
256707|NCT01239797|847897|P1|Treated Participants|Poor/Non-compliance|0
256708|NCT01239797|847896|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
256709|NCT01239797|847897|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
256710|NCT01239797|847896|P2|Treated Participants|Death|1
256711|NCT01239797|847897|P1|Treated Participants|Death|1
256712|NCT01239797|847896|P2|Treated Participants|Non-specified|11
256713|NCT01239797|847897|P1|Treated Participants|Non-specified|1
256714|NCT01239797|847896|P2|Treated Participants|Withdrawal by Subject|23
256715|NCT01239797|847897|P1|Treated Participants|Withdrawal by Subject|27
256716|NCT01239797|847896|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
256717|NCT01239797|847897|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
256718|NCT01239797|847896|P2|Treated Participants|Study Drug Toxicity|44
256719|NCT01239797|847897|P1|Treated Participants|Study Drug Toxicity|30
256720|NCT01239797|847896|P2|Treated Participants|Disease Progression|161
256721|NCT01239797|847897|P1|Treated Participants|Disease Progression|153
256722|NCT01239745|847905|P1|Overall Study|Adverse Event|1
256723|NCT01239745|847905|P1|Overall Study|Study terminated by sponsor|45
256724|NCT01239732|847916|P1|Overall Study|Unspecified|19
256725|NCT01239732|847916|P1|Overall Study|Treatment failure|2
256726|NCT01239732|847916|P1|Overall Study|Investigator's decision|4
256727|NCT01239732|847916|P1|Overall Study|Study termination by sponsor|2
256728|NCT01239732|847916|P1|Overall Study|Participant non compliance|5
256729|NCT01239732|847916|P1|Overall Study|Protocol Violation|3
256730|NCT01239732|847916|P1|Overall Study|Adverse Event|6
256731|NCT01239732|847916|P1|Overall Study|Withdrawal by Subject|87
256732|NCT01239732|847916|P1|Overall Study|Death|226
256733|NCT01239732|847916|P1|Overall Study|Termination of study per protocol|667
256734|NCT01239680|847929|P2|Overall Study|Withdrawal by Subject|0
256735|NCT01239680|847930|P1|Overall Study|Withdrawal by Subject|2
256736|NCT01239394|847953|P1|Overall Study|Adverse Event|1
256737|NCT01239342|847968|P2|Overall Study|Reason Unknown|1
256738|NCT01239342|847969|P1|Overall Study|Reason Unknown|1
256739|NCT01239342|847968|P2|Overall Study|Withdrawal by Subject|5
256740|NCT01239342|847969|P1|Overall Study|Withdrawal by Subject|1
256741|NCT01239342|847968|P2|Overall Study|Adverse Event|0
256742|NCT01239342|847969|P1|Overall Study|Adverse Event|1
256743|NCT01239316|847985|P1|Overall Study|Adverse Event|1
256744|NCT01239316|847985|P1|Overall Study|Progression/Relapse|11
256745|NCT01239121|848000|P3|Overall Study|Withdrawal by Subject|0
256746|NCT01239121|848001|P2|Overall Study|Withdrawal by Subject|4
256747|NCT01239121|848002|P1|Overall Study|Withdrawal by Subject|2
256748|NCT01239043|848024|P2|Overall Study|Protocol Violation|1
256749|NCT01239043|848025|P1|Overall Study|Protocol Violation|2
256750|NCT01238991|848053|P10|Overall Study|Admission to a nursing home|0
256751|NCT01238991|848054|P9|Overall Study|Admission to a nursing home|0
256752|NCT01238991|848055|P8|Overall Study|Admission to a nursing home|0
256753|NCT01238991|848056|P7|Overall Study|Admission to a nursing home|0
256754|NCT01238991|848057|P6|Overall Study|Admission to a nursing home|0
256755|NCT01238991|848058|P5|Overall Study|Admission to a nursing home|0
256756|NCT01238991|848059|P4|Overall Study|Admission to a nursing home|0
256757|NCT01238991|848060|P3|Overall Study|Admission to a nursing home|1
256758|NCT01238991|848061|P2|Overall Study|Admission to a nursing home|0
256759|NCT01238991|848062|P1|Overall Study|Admission to a nursing home|1
256760|NCT01238991|848053|P10|Overall Study|Caregiver's request|0
256761|NCT01238991|848054|P9|Overall Study|Caregiver's request|1
256762|NCT01238991|848055|P8|Overall Study|Caregiver's request|0
256763|NCT01238991|848056|P7|Overall Study|Caregiver's request|0
256764|NCT01238991|848057|P6|Overall Study|Caregiver's request|0
256765|NCT01238991|848058|P5|Overall Study|Caregiver's request|0
256766|NCT01238991|848059|P4|Overall Study|Caregiver's request|0
256767|NCT01238991|848060|P3|Overall Study|Caregiver's request|0
256768|NCT01238991|848061|P2|Overall Study|Caregiver's request|0
256769|NCT01238991|848062|P1|Overall Study|Caregiver's request|0
256770|NCT01238991|848053|P10|Overall Study|Study Terminated by Sponsor|2
256771|NCT01238991|848054|P9|Overall Study|Study Terminated by Sponsor|2
256772|NCT01238991|848055|P8|Overall Study|Study Terminated by Sponsor|4
256773|NCT01238991|848056|P7|Overall Study|Study Terminated by Sponsor|7
256774|NCT01238991|848057|P6|Overall Study|Study Terminated by Sponsor|0
256775|NCT01238991|848058|P5|Overall Study|Study Terminated by Sponsor|1
256776|NCT01238991|848059|P4|Overall Study|Study Terminated by Sponsor|0
256777|NCT01238991|848060|P3|Overall Study|Study Terminated by Sponsor|0
256778|NCT01238991|848061|P2|Overall Study|Study Terminated by Sponsor|0
256779|NCT01238991|848062|P1|Overall Study|Study Terminated by Sponsor|0
256780|NCT01238991|848053|P10|Overall Study|Withdrawal by Subject|0
256781|NCT01238991|848054|P9|Overall Study|Withdrawal by Subject|0
256782|NCT01238991|848055|P8|Overall Study|Withdrawal by Subject|0
256783|NCT01238991|848056|P7|Overall Study|Withdrawal by Subject|0
256784|NCT01238991|848057|P6|Overall Study|Withdrawal by Subject|0
256785|NCT01238991|848058|P5|Overall Study|Withdrawal by Subject|0
256786|NCT01238991|848059|P4|Overall Study|Withdrawal by Subject|0
256787|NCT01238991|848060|P3|Overall Study|Withdrawal by Subject|1
256788|NCT01238991|848061|P2|Overall Study|Withdrawal by Subject|0
256789|NCT01238991|848062|P1|Overall Study|Withdrawal by Subject|0
256790|NCT01238991|848053|P10|Overall Study|Lack of Efficacy|0
256791|NCT01238991|848054|P9|Overall Study|Lack of Efficacy|1
256792|NCT01238991|848055|P8|Overall Study|Lack of Efficacy|0
256793|NCT01238991|848056|P7|Overall Study|Lack of Efficacy|0
256794|NCT01238991|848057|P6|Overall Study|Lack of Efficacy|0
256795|NCT01238991|848058|P5|Overall Study|Lack of Efficacy|0
256796|NCT01238991|848059|P4|Overall Study|Lack of Efficacy|0
256797|NCT01238991|848060|P3|Overall Study|Lack of Efficacy|1
256798|NCT01238991|848061|P2|Overall Study|Lack of Efficacy|0
256799|NCT01238991|848062|P1|Overall Study|Lack of Efficacy|0
256800|NCT01238991|848053|P10|Overall Study|Death|0
256801|NCT01238991|848054|P9|Overall Study|Death|0
256802|NCT01238991|848055|P8|Overall Study|Death|0
256803|NCT01238991|848056|P7|Overall Study|Death|0
256804|NCT01238991|848057|P6|Overall Study|Death|0
256805|NCT01238991|848058|P5|Overall Study|Death|0
256806|NCT01238991|848059|P4|Overall Study|Death|1
256807|NCT01238991|848060|P3|Overall Study|Death|0
256808|NCT01238991|848061|P2|Overall Study|Death|0
256809|NCT01238991|848062|P1|Overall Study|Death|0
256810|NCT01238991|848053|P10|Overall Study|Adverse Event|0
256811|NCT01238991|848054|P9|Overall Study|Adverse Event|0
256812|NCT01238991|848055|P8|Overall Study|Adverse Event|1
256813|NCT01238991|848056|P7|Overall Study|Adverse Event|1
256814|NCT01238991|848057|P6|Overall Study|Adverse Event|0
256815|NCT01238991|848058|P5|Overall Study|Adverse Event|1
256816|NCT01238991|848059|P4|Overall Study|Adverse Event|1
256817|NCT01238991|848060|P3|Overall Study|Adverse Event|3
256818|NCT01238991|848061|P2|Overall Study|Adverse Event|0
256819|NCT01238991|848062|P1|Overall Study|Adverse Event|1
256820|NCT01238900|848149|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
256821|NCT01238900|848149|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
256822|NCT01238861|848163|P6|Overall Study|Withdrawal by Subject|9
256823|NCT01238861|848164|P5|Overall Study|Withdrawal by Subject|10
256824|NCT01238861|848165|P4|Overall Study|Withdrawal by Subject|8
256825|NCT01238861|848166|P3|Overall Study|Withdrawal by Subject|4
256826|NCT01238861|848167|P2|Overall Study|Withdrawal by Subject|5
256827|NCT01238861|848168|P1|Overall Study|Withdrawal by Subject|6
256828|NCT01238861|848163|P6|Overall Study|Adverse Event|0
256829|NCT01238861|848164|P5|Overall Study|Adverse Event|0
256830|NCT01238861|848165|P4|Overall Study|Adverse Event|0
256831|NCT01238861|848166|P3|Overall Study|Adverse Event|0
256832|NCT01238861|848167|P2|Overall Study|Adverse Event|1
256833|NCT01238861|848168|P1|Overall Study|Adverse Event|0
256834|NCT01238861|848163|P6|Overall Study|Lack of compliance|1
256835|NCT01238861|848164|P5|Overall Study|Lack of compliance|0
256836|NCT01238861|848165|P4|Overall Study|Lack of compliance|0
256837|NCT01238861|848166|P3|Overall Study|Lack of compliance|0
256838|NCT01238861|848167|P2|Overall Study|Lack of compliance|0
256839|NCT01238861|848168|P1|Overall Study|Lack of compliance|0
256840|NCT01238861|848163|P6|Overall Study|Serious adverse event|1
256841|NCT01238861|848164|P5|Overall Study|Serious adverse event|0
256842|NCT01238861|848165|P4|Overall Study|Serious adverse event|0
256843|NCT01238861|848166|P3|Overall Study|Serious adverse event|0
256844|NCT01238861|848167|P2|Overall Study|Serious adverse event|0
256845|NCT01238861|848168|P1|Overall Study|Serious adverse event|0
256846|NCT01238861|848163|P6|Overall Study|Unable to continue visits|1
256847|NCT01238861|848164|P5|Overall Study|Unable to continue visits|0
256848|NCT01238861|848165|P4|Overall Study|Unable to continue visits|1
256849|NCT01238861|848166|P3|Overall Study|Unable to continue visits|0
256850|NCT01238861|848167|P2|Overall Study|Unable to continue visits|0
256851|NCT01238861|848168|P1|Overall Study|Unable to continue visits|0
256852|NCT01238861|848163|P6|Overall Study|Personal problems|0
256853|NCT01238861|848164|P5|Overall Study|Personal problems|0
256854|NCT01238861|848165|P4|Overall Study|Personal problems|1
256855|NCT01238861|848166|P3|Overall Study|Personal problems|0
256856|NCT01238861|848167|P2|Overall Study|Personal problems|0
256857|NCT01238861|848168|P1|Overall Study|Personal problems|0
256858|NCT01238861|848163|P6|Overall Study|Strongyloides stercoralis antibodies +|0
256859|NCT01238861|848164|P5|Overall Study|Strongyloides stercoralis antibodies +|0
256860|NCT01238861|848165|P4|Overall Study|Strongyloides stercoralis antibodies +|1
256861|NCT01238861|848166|P3|Overall Study|Strongyloides stercoralis antibodies +|0
256862|NCT01238861|848167|P2|Overall Study|Strongyloides stercoralis antibodies +|0
256863|NCT01238861|848168|P1|Overall Study|Strongyloides stercoralis antibodies +|0
256864|NCT01238861|848163|P6|Overall Study|Subject moved out of state/area|0
256865|NCT01238861|848164|P5|Overall Study|Subject moved out of state/area|0
256866|NCT01238861|848165|P4|Overall Study|Subject moved out of state/area|1
256867|NCT01238861|848166|P3|Overall Study|Subject moved out of state/area|1
256868|NCT01238861|848167|P2|Overall Study|Subject moved out of state/area|0
256869|NCT01238861|848168|P1|Overall Study|Subject moved out of state/area|0
256870|NCT01238861|848163|P6|Overall Study|Subject traveled to Argentina by 1 year|0
256871|NCT01238861|848164|P5|Overall Study|Subject traveled to Argentina by 1 year|0
256872|NCT01238861|848165|P4|Overall Study|Subject traveled to Argentina by 1 year|0
256873|NCT01238861|848166|P3|Overall Study|Subject traveled to Argentina by 1 year|1
256874|NCT01238861|848167|P2|Overall Study|Subject traveled to Argentina by 1 year|0
256875|NCT01238861|848168|P1|Overall Study|Subject traveled to Argentina by 1 year|0
256876|NCT01238861|848163|P6|Overall Study|Incorrect enrollment/randomization|0
256877|NCT01238861|848164|P5|Overall Study|Incorrect enrollment/randomization|1
256878|NCT01238861|848165|P4|Overall Study|Incorrect enrollment/randomization|0
256879|NCT01238861|848166|P3|Overall Study|Incorrect enrollment/randomization|1
256880|NCT01238861|848167|P2|Overall Study|Incorrect enrollment/randomization|0
256881|NCT01238861|848168|P1|Overall Study|Incorrect enrollment/randomization|0
256882|NCT01238861|848163|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
256883|NCT01238861|848164|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
256884|NCT01238861|848165|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
256885|NCT01238861|848166|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
256886|NCT01238861|848167|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
256887|NCT01238861|848168|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
256888|NCT01238861|848163|P6|Overall Study|Unplanned surgery|0
256889|NCT01238861|848164|P5|Overall Study|Unplanned surgery|0
256890|NCT01238861|848165|P4|Overall Study|Unplanned surgery|0
256891|NCT01238861|848166|P3|Overall Study|Unplanned surgery|0
256892|NCT01238861|848167|P2|Overall Study|Unplanned surgery|0
256893|NCT01238861|848168|P1|Overall Study|Unplanned surgery|1
256894|NCT01238861|848163|P6|Overall Study|Lost to Follow-up|2
256895|NCT01238861|848164|P5|Overall Study|Lost to Follow-up|1
256896|NCT01238861|848165|P4|Overall Study|Lost to Follow-up|1
256897|NCT01238861|848166|P3|Overall Study|Lost to Follow-up|3
256898|NCT01238861|848167|P2|Overall Study|Lost to Follow-up|2
256899|NCT01238861|848168|P1|Overall Study|Lost to Follow-up|4
256900|NCT01238848|848248|P2|Overall Study|Physician Decision|5
256901|NCT01238848|848249|P1|Overall Study|Physician Decision|13
256902|NCT01238822|848257|P1|Overall Study|COULD NOT SWALLOW PILLS|3
256903|NCT01238575|848286|P2|Overall Study|Adverse Event|0
256904|NCT01238575|848287|P1|Overall Study|Adverse Event|2
256905|NCT01238575|848286|P2|Overall Study|Lack of Efficacy|4
256906|NCT01238575|848287|P1|Overall Study|Lack of Efficacy|2
256907|NCT01238211|848339|P1|Overall Study|Investigator/Patient Decision|3
256908|NCT01238211|848339|P1|Overall Study|Non-protocol treatment|4
256909|NCT01238211|848339|P1|Overall Study|Withdrawal by Subject|7
256910|NCT01238211|848339|P1|Overall Study|Relapse/Progression|2
256911|NCT01238211|848339|P1|Overall Study|Death|4
256912|NCT01238211|848339|P1|Overall Study|Adverse Event|7
256913|NCT01238211|848339|P1|Overall Study|Continues active treatment|31
256914|NCT01237340|848372|P1|Overall Study|Early termination of the trial|36
256915|NCT01237340|848372|P1|Overall Study|Withdrawal by Subject|1
256916|NCT01237340|848372|P1|Overall Study|Adverse Event|3
256917|NCT01237327|848386|P2|Overall Study|Lost to Follow-up|0
256918|NCT01237327|848387|P1|Overall Study|Lost to Follow-up|3
256919|NCT01237327|848386|P2|Overall Study|Withdrawal by Subject|3
256920|NCT01237327|848387|P1|Overall Study|Withdrawal by Subject|1
256921|NCT01237327|848386|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
256922|NCT01237327|848387|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
256923|NCT01237327|848386|P2|Overall Study|Progression of Disease: Extension Study|13
256924|NCT01237327|848387|P1|Overall Study|Progression of Disease: Extension Study|15
256925|NCT01237327|848386|P2|Overall Study|Progression of Disease: Core Study|22
256926|NCT01237327|848387|P1|Overall Study|Progression of Disease: Core Study|18
256927|NCT01237327|848386|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
256928|NCT01237327|848387|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
256929|NCT01237327|848386|P2|Overall Study|Protocol Violation: Core Study|0
256930|NCT01237327|848387|P1|Overall Study|Protocol Violation: Core Study|1
256931|NCT01237223|848416|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
256932|NCT01237223|848417|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
256933|NCT01237223|848418|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
256934|NCT01237223|848419|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
256935|NCT01237223|848420|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
256936|NCT01237223|848421|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
256937|NCT01237223|848416|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
256938|NCT01237223|848417|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
256939|NCT01237223|848418|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
256940|NCT01237223|848419|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
256941|NCT01237223|848420|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
256942|NCT01237223|848421|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
256943|NCT01237223|848416|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
256944|NCT01237223|848417|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
256945|NCT01237223|848418|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
256946|NCT01237223|848419|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
256947|NCT01237223|848420|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
256948|NCT01237223|848421|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
256949|NCT01237223|848416|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
256950|NCT01237223|848417|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
256951|NCT01237223|848418|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
256952|NCT01237223|848419|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
256953|NCT01237223|848420|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
256954|NCT01237223|848421|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
256955|NCT01237223|848416|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
256956|NCT01237223|848417|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
256957|NCT01237223|848418|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
256958|NCT01237223|848419|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
256959|NCT01237223|848420|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
256960|NCT01237223|848421|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
256961|NCT01237223|848416|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
256962|NCT01237223|848417|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
256963|NCT01237223|848418|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
256964|NCT01237223|848419|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
256965|NCT01237223|848420|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
256966|NCT01237223|848421|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
256967|NCT01237223|848416|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
256968|NCT01237223|848417|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
256969|NCT01237223|848418|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
256970|NCT01237223|848419|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
256971|NCT01237223|848420|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
256972|NCT01237223|848421|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
256973|NCT01237223|848416|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
256974|NCT01237223|848417|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
256975|NCT01237223|848418|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
256976|NCT01237223|848419|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
256977|NCT01237223|848420|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
256978|NCT01237223|848421|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
256979|NCT01237223|848416|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
256980|NCT01237223|848417|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
256981|NCT01237223|848418|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
256982|NCT01237223|848419|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
256983|NCT01237223|848420|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
256984|NCT01237223|848421|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
256985|NCT01237223|848416|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
256986|NCT01237223|848417|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
256987|NCT01237223|848418|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
256988|NCT01237223|848419|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
256989|NCT01237223|848420|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
256990|NCT01237223|848421|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
256991|NCT01237054|848480|P1|Overall Study|imaging 10C0096|1
256992|NCT01236573|848500|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
256993|NCT01236573|848501|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
256994|NCT01236573|848502|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
256995|NCT01236573|848503|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
256996|NCT01236573|848504|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
256997|NCT01236573|848505|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
256998|NCT01236573|848506|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
256999|NCT01236573|848507|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
257000|NCT01236573|848508|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
257001|NCT01236573|848509|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
257002|NCT01236573|848510|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
257003|NCT01236573|848500|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257004|NCT01236573|848501|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257005|NCT01236573|848502|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
257006|NCT01236573|848503|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257007|NCT01236573|848504|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257008|NCT01236573|848505|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257009|NCT01236573|848506|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257010|NCT01236573|848507|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257011|NCT01236573|848508|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257012|NCT01236573|848509|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257013|NCT01236573|848510|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
257014|NCT01236573|848500|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
257015|NCT01236573|848501|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
257016|NCT01236573|848502|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
257017|NCT01236573|848503|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
257018|NCT01236573|848504|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
257019|NCT01236573|848505|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
257020|NCT01236573|848506|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
257021|NCT01236573|848507|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
257022|NCT01236573|848508|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
257023|NCT01236573|848509|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
257024|NCT01236573|848510|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
257025|NCT01236534|848548|P2|Overall Study|Adverse Event|0
257026|NCT01236534|848549|P1|Overall Study|Adverse Event|3
257027|NCT01236365|848579|P2|Overall Study|Dropped at Randomization due to high LFT|0
257028|NCT01236365|848580|P1|Overall Study|Dropped at Randomization due to high LFT|1
257029|NCT01236365|848579|P2|Overall Study|Moved Out of State|0
257030|NCT01236365|848580|P1|Overall Study|Moved Out of State|1
257031|NCT01236365|848579|P2|Overall Study|Lost to Follow-up|2
257032|NCT01236365|848580|P1|Overall Study|Lost to Follow-up|0
257033|NCT01236339|848594|P2|Overall Study|Termination of study by sponsor|13
257034|NCT01236339|848595|P1|Overall Study|Termination of study by sponsor|11
257035|NCT01236118|848663|P3|Overall Study|Withdrawal by Subject|1
257036|NCT01236118|848664|P2|Overall Study|Withdrawal by Subject|0
257037|NCT01236118|848665|P1|Overall Study|Withdrawal by Subject|0
257038|NCT01236118|848663|P3|Overall Study|Physician Decision|0
257039|NCT01236118|848664|P2|Overall Study|Physician Decision|1
257040|NCT01236118|848665|P1|Overall Study|Physician Decision|0
257041|NCT01236118|848663|P3|Overall Study|Adverse Event|2
257042|NCT01236118|848664|P2|Overall Study|Adverse Event|0
257043|NCT01236118|848665|P1|Overall Study|Adverse Event|2
257044|NCT01236001|848866|P2|Overall Study|Planned Visit After End of Study|1
257045|NCT01236001|848867|P1|Overall Study|Planned Visit After End of Study|0
257046|NCT01236001|848866|P2|Overall Study|Incompliance|0
257047|NCT01236001|848867|P1|Overall Study|Incompliance|1
257048|NCT01236001|848866|P2|Overall Study|Lost to Follow-up|1
257049|NCT01236001|848867|P1|Overall Study|Lost to Follow-up|6
257050|NCT01236001|848866|P2|Overall Study|Lack of Efficacy|6
257051|NCT01236001|848867|P1|Overall Study|Lack of Efficacy|6
257052|NCT01236001|848866|P2|Overall Study|Adverse Event|14
257053|NCT01236001|848867|P1|Overall Study|Adverse Event|5
257054|NCT01235975|848899|P2|Overall Study|Lost to Follow-up|3
257055|NCT01235975|848900|P1|Overall Study|Lost to Follow-up|7
257056|NCT01235975|848899|P2|Overall Study|Migrated/moved from study area|1
257057|NCT01235975|848900|P1|Overall Study|Migrated/moved from study area|2
257058|NCT01235975|848899|P2|Overall Study|Withdrawal by Subject|2
257059|NCT01235975|848900|P1|Overall Study|Withdrawal by Subject|8
257060|NCT01235975|848899|P2|Overall Study|Serious Adverse Event|1
257061|NCT01235975|848900|P1|Overall Study|Serious Adverse Event|0
257062|NCT01235741|848955|P3|Follow-Up Post Treatment up to Month 6|not specified|0
257063|NCT01235741|848956|P2|Follow-Up Post Treatment up to Month 6|not specified|1
257064|NCT01235741|848957|P1|Follow-Up Post Treatment up to Month 6|not specified|0
257065|NCT01235741|848955|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
257066|NCT01235741|848956|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
257067|NCT01235741|848957|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
257068|NCT01235741|848955|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
257069|NCT01235741|848956|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
257070|NCT01235741|848957|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
257071|NCT01235741|848955|P3|Randomized to Treatment|Sponsor terminated study|34
257072|NCT01235741|848956|P2|Randomized to Treatment|Sponsor terminated study|35
257073|NCT01235741|848957|P1|Randomized to Treatment|Sponsor terminated study|0
257074|NCT01235741|848955|P3|Randomized to Treatment|Adverse Event|1
257075|NCT01235741|848956|P2|Randomized to Treatment|Adverse Event|1
257076|NCT01235741|848957|P1|Randomized to Treatment|Adverse Event|0
257077|NCT01235741|848955|P3|Randomized to Treatment|Withdrawal by Subject|1
257078|NCT01235741|848956|P2|Randomized to Treatment|Withdrawal by Subject|0
257079|NCT01235741|848957|P1|Randomized to Treatment|Withdrawal by Subject|0
257080|NCT01235741|848955|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
257081|NCT01235741|848956|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
257082|NCT01235741|848957|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
257083|NCT01235741|848955|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
257084|NCT01235741|848956|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
257085|NCT01235741|848957|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
257086|NCT01235741|848955|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
257087|NCT01235741|848956|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
257088|NCT01235741|848957|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
257089|NCT01235741|848955|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
257090|NCT01235741|848956|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
257091|NCT01235741|848957|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
257092|NCT01235741|848955|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
257093|NCT01235741|848956|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
257094|NCT01235741|848957|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
257095|NCT01235741|848955|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
257096|NCT01235741|848956|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
257097|NCT01235741|848957|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
257098|NCT01235728|848984|P8|Overall Study|Protocol Violation|0
257099|NCT01235728|848985|P7|Overall Study|Protocol Violation|0
257100|NCT01235728|848986|P6|Overall Study|Protocol Violation|0
257101|NCT01235728|848987|P5|Overall Study|Protocol Violation|0
257102|NCT01235728|848988|P4|Overall Study|Protocol Violation|1
257103|NCT01235728|848989|P3|Overall Study|Protocol Violation|0
257104|NCT01235728|848990|P2|Overall Study|Protocol Violation|0
257105|NCT01235728|848991|P1|Overall Study|Protocol Violation|0
257106|NCT01235715|849001|P2|Overall Study|Physician Decision|2
257107|NCT01235715|849002|P1|Overall Study|Physician Decision|0
257108|NCT01235598|849042|P2|Overall Study|Withdrawal by Subject|0
257109|NCT01235598|849043|P1|Overall Study|Withdrawal by Subject|1
257110|NCT01235598|849042|P2|Overall Study|Lack of Efficacy|1
257111|NCT01235598|849043|P1|Overall Study|Lack of Efficacy|0
257112|NCT01235598|849042|P2|Overall Study|Adverse Event|3
257113|NCT01235598|849043|P1|Overall Study|Adverse Event|0
257114|NCT01235507|849086|P1|Overall Study|Withdrawal by Subject|1
257115|NCT01235507|849086|P1|Overall Study|Adverse Event|1
257116|NCT01235442|849100|P2|Overall Study|Other unspecified|2
257117|NCT01235442|849101|P1|Overall Study|Other unspecified|1
257118|NCT01235442|849100|P2|Overall Study|Administrative decision|2
257119|NCT01235442|849101|P1|Overall Study|Administrative decision|1
257120|NCT01235442|849100|P2|Overall Study|Noncompliance|2
257121|NCT01235442|849101|P1|Overall Study|Noncompliance|1
257122|NCT01235442|849100|P2|Overall Study|Lack of Efficacy|3
257123|NCT01235442|849101|P1|Overall Study|Lack of Efficacy|1
257124|NCT01235442|849100|P2|Overall Study|Withdrawal by Subject|9
257125|NCT01235442|849101|P1|Overall Study|Withdrawal by Subject|15
257126|NCT01235442|849100|P2|Overall Study|Adverse Event|6
257127|NCT01235442|849101|P1|Overall Study|Adverse Event|4
257128|NCT01235442|849100|P2|Overall Study|Protocol Violation|3
257129|NCT01235442|849101|P1|Overall Study|Protocol Violation|3
257130|NCT01235442|849100|P2|Overall Study|Ineligibility determined|4
257131|NCT01235442|849101|P1|Overall Study|Ineligibility determined|5
257132|NCT01235442|849100|P2|Overall Study|Pregnancy|1
257133|NCT01235442|849101|P1|Overall Study|Pregnancy|1
257134|NCT01235442|849100|P2|Overall Study|Death|2
257135|NCT01235442|849101|P1|Overall Study|Death|0
257136|NCT01235442|849100|P2|Overall Study|Lost to Follow-up|10
257137|NCT01235442|849101|P1|Overall Study|Lost to Follow-up|12
257138|NCT01235403|849119|P1|Overall Study|Other reasons for premature termination|4
257139|NCT01235403|849119|P1|Overall Study|Lack of Efficacy|2
257140|NCT01235403|849119|P1|Overall Study|Withdrawal by Subject|4
257141|NCT01235403|849119|P1|Overall Study|Lost to Follow-up|2
257142|NCT01235403|849119|P1|Overall Study|Adverse Event|14
257143|NCT01235338|849136|P2|Overall Study|Prohibited meds|0
257144|NCT01235338|849137|P1|Overall Study|Prohibited meds|1
257145|NCT01235338|849136|P2|Overall Study|Positive drug screen|1
257146|NCT01235338|849137|P1|Overall Study|Positive drug screen|0
257147|NCT01235338|849136|P2|Overall Study|Exclusion criteria violations|1
257148|NCT01235338|849137|P1|Overall Study|Exclusion criteria violations|1
257149|NCT01235338|849136|P2|Overall Study|Withdrawal by Subject|0
257150|NCT01235338|849137|P1|Overall Study|Withdrawal by Subject|5
257151|NCT01235338|849136|P2|Overall Study|Protocol Violation|1
257152|NCT01235338|849137|P1|Overall Study|Protocol Violation|1
257153|NCT01235338|849136|P2|Overall Study|Adverse Event|2
257154|NCT01235338|849137|P1|Overall Study|Adverse Event|3
257155|NCT01235234|849182|P3|Overall Study|Adverse Event|1
257156|NCT01235234|849183|P2|Overall Study|Adverse Event|2
257157|NCT01235234|849184|P1|Overall Study|Adverse Event|2
257158|NCT01234883|849228|P2|Overall Study|Inclusion/exclusion failure|0
257159|NCT01234883|849229|P1|Overall Study|Inclusion/exclusion failure|1
257160|NCT01234883|849228|P2|Overall Study|Technical difficulties with IV infusion|1
257161|NCT01234883|849229|P1|Overall Study|Technical difficulties with IV infusion|0
257162|NCT01234883|849228|P2|Overall Study|Parent/guardian withdrew consent|2
257163|NCT01234883|849229|P1|Overall Study|Parent/guardian withdrew consent|1
257164|NCT01234883|849228|P2|Overall Study|Early treatment release|10
257165|NCT01234883|849229|P1|Overall Study|Early treatment release|8
257166|NCT01234675|849271|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
257167|NCT01234675|849272|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
257168|NCT01234675|849271|P2|First Intervention (6 Weeks)|Adverse Event|1
257169|NCT01234675|849272|P1|First Intervention (6 Weeks)|Adverse Event|0
257170|NCT01234467|849286|P1|Overall Study|Other complicating disease (stroke)|1
257171|NCT01234467|849286|P1|Overall Study|Physician Decision|1
257172|NCT01234467|849286|P1|Overall Study|Clinical deterioration|1
257173|NCT01234467|849286|P1|Overall Study|Disease Progression|2
257174|NCT01234467|849286|P1|Overall Study|Withdrawal by Subject|2
257175|NCT01234467|849286|P1|Overall Study|Death|2
257176|NCT01234467|849286|P1|Overall Study|Adverse Event|3
257177|NCT01234337|849297|P2|Overall Study|Withdrawal by Subject|7
257178|NCT01234337|849298|P1|Overall Study|Withdrawal by Subject|11
257179|NCT01234337|849297|P2|Overall Study|Protocol Violation|3
257180|NCT01234337|849298|P1|Overall Study|Protocol Violation|2
257181|NCT01234337|849297|P2|Overall Study|Lost to Follow-up|1
257182|NCT01234337|849298|P1|Overall Study|Lost to Follow-up|0
257183|NCT01234337|849297|P2|Overall Study|Randomized but not Treated|4
257184|NCT01234337|849298|P1|Overall Study|Randomized but not Treated|6
257185|NCT01234337|849297|P2|Overall Study|Non-compliant with study medication|2
257186|NCT01234337|849298|P1|Overall Study|Non-compliant with study medication|3
257187|NCT01234337|849297|P2|Overall Study|InvestigatorDecision notProtocolDriven|3
257188|NCT01234337|849298|P1|Overall Study|InvestigatorDecision notProtocolDriven|4
257189|NCT01234337|849297|P2|Overall Study|Ongoing|24
257190|NCT01234337|849298|P1|Overall Study|Ongoing|16
257191|NCT01234337|849297|P2|Overall Study|Adverse Event|20
257192|NCT01234337|849298|P1|Overall Study|Adverse Event|55
257193|NCT01233999|849347|P1|Overall Study|Lost to Follow-up|1
257194|NCT01233999|849347|P1|Overall Study|Withdrawal by Subject|1
257195|NCT01233869|849366|P4|Extended Treatment Period (46 Months)|Adverse Event|1
257196|NCT01233869|849367|P3|Extended Treatment Period (46 Months)|Adverse Event|0
257197|NCT01233869|849368|P2|Extended Treatment Period (46 Months)|Adverse Event|0
257198|NCT01233869|849369|P1|Extended Treatment Period (46 Months)|Adverse Event|1
257199|NCT01233869|849366|P4|Extended Treatment Period (46 Months)|Unspecified|3
257200|NCT01233869|849367|P3|Extended Treatment Period (46 Months)|Unspecified|0
257201|NCT01233869|849368|P2|Extended Treatment Period (46 Months)|Unspecified|0
257202|NCT01233869|849369|P1|Extended Treatment Period (46 Months)|Unspecified|3
257203|NCT01233869|849366|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
257204|NCT01233869|849367|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
257205|NCT01233869|849368|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
257206|NCT01233869|849369|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
257207|NCT01233869|849366|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
257208|NCT01233869|849367|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
257209|NCT01233869|849368|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
257210|NCT01233869|849369|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
257211|NCT01233869|849366|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
257212|NCT01233869|849367|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
257213|NCT01233869|849368|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
257214|NCT01233869|849369|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
257215|NCT01233869|849366|P4|Initial Treatment Period (24 Months)|Adverse Event|3
257216|NCT01233869|849367|P3|Initial Treatment Period (24 Months)|Adverse Event|0
257217|NCT01233869|849368|P2|Initial Treatment Period (24 Months)|Adverse Event|17
257218|NCT01233869|849369|P1|Initial Treatment Period (24 Months)|Adverse Event|9
257219|NCT01233869|849366|P4|Initial Treatment Period (24 Months)|Death|0
257220|NCT01233869|849367|P3|Initial Treatment Period (24 Months)|Death|0
257221|NCT01233869|849368|P2|Initial Treatment Period (24 Months)|Death|0
257222|NCT01233869|849369|P1|Initial Treatment Period (24 Months)|Death|1
257223|NCT01233817|849455|P1|Overall Study|Withdrawal by Subject|2
257224|NCT01233817|849455|P1|Overall Study|Lost to Follow-up|1
257228|NCT01232894|849527|P2|Overall Study|Physician Decision|1
257229|NCT01232894|849528|P1|Overall Study|Physician Decision|2
257230|NCT01232894|849527|P2|Overall Study|Withdrawal by Subject|5
257231|NCT01232894|849528|P1|Overall Study|Withdrawal by Subject|8
257232|NCT01232894|849527|P2|Overall Study|Protocol Violation|1
257233|NCT01232894|849528|P1|Overall Study|Protocol Violation|1
257234|NCT01232894|849527|P2|Overall Study|Death|0
257235|NCT01232894|849528|P1|Overall Study|Death|1
257236|NCT01232894|849527|P2|Overall Study|Lost to Follow-up|1
257237|NCT01232894|849528|P1|Overall Study|Lost to Follow-up|0
257238|NCT01232868|849536|P2|Overall Study|Lost to Follow-up|4
257239|NCT01232868|849537|P1|Overall Study|Lost to Follow-up|2
257240|NCT01232790|849551|P2|Second Crossover|Withdrawal by Subject|2
257241|NCT01232790|849552|P1|Second Crossover|Withdrawal by Subject|1
257242|NCT01232790|849551|P2|First Crossover|Withdrawal by Subject|0
257243|NCT01232790|849552|P1|First Crossover|Withdrawal by Subject|1
257244|NCT01232790|849551|P2|Initial Assessment|Withdrawal by Subject|1
257245|NCT01232790|849552|P1|Initial Assessment|Withdrawal by Subject|0
257246|NCT01232790|849551|P2|Randomization|Physician Decision|1
257247|NCT01232790|849552|P1|Randomization|Physician Decision|0
257248|NCT01232790|849551|P2|Randomization|Protocol Violation|1
257249|NCT01232790|849552|P1|Randomization|Protocol Violation|0
257250|NCT01232790|849551|P2|Randomization|Withdrawal by Subject|0
257251|NCT01232790|849552|P1|Randomization|Withdrawal by Subject|2
257252|NCT01233284|849606|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
257253|NCT01233284|849607|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
257254|NCT01233284|849608|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
257255|NCT01233284|849609|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
257256|NCT01233284|849610|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
257257|NCT01233284|849606|P5|Period 4 (4 Weeks)|Adverse Event|0
257258|NCT01233284|849607|P4|Period 4 (4 Weeks)|Adverse Event|0
257259|NCT01233284|849608|P3|Period 4 (4 Weeks)|Adverse Event|0
257260|NCT01233284|849609|P2|Period 4 (4 Weeks)|Adverse Event|1
257261|NCT01233284|849610|P1|Period 4 (4 Weeks)|Adverse Event|0
257262|NCT01233284|849606|P5|Period 3 (4 Weeks)|Other|0
257263|NCT01233284|849607|P4|Period 3 (4 Weeks)|Other|1
257264|NCT01233284|849608|P3|Period 3 (4 Weeks)|Other|0
257265|NCT01233284|849609|P2|Period 3 (4 Weeks)|Other|0
257266|NCT01233284|849610|P1|Period 3 (4 Weeks)|Other|0
257267|NCT01233284|849606|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
257268|NCT01233284|849607|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
257269|NCT01233284|849608|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
257270|NCT01233284|849609|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
257271|NCT01233284|849610|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
257272|NCT01233284|849606|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
257273|NCT01233284|849607|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
257274|NCT01233284|849608|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
257275|NCT01233284|849609|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
257276|NCT01233284|849610|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
257277|NCT01233284|849606|P5|Period 1 (4 Weeks)|Other|0
257278|NCT01233284|849607|P4|Period 1 (4 Weeks)|Other|0
257279|NCT01233284|849608|P3|Period 1 (4 Weeks)|Other|1
257280|NCT01233284|849609|P2|Period 1 (4 Weeks)|Other|0
257281|NCT01233284|849610|P1|Period 1 (4 Weeks)|Other|0
257282|NCT01233284|849606|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
257283|NCT01233284|849607|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
257284|NCT01233284|849608|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
257285|NCT01233284|849609|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
257286|NCT01233284|849610|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
257287|NCT01233284|849606|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
257288|NCT01233284|849607|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
257289|NCT01233284|849608|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
257290|NCT01233284|849609|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
257291|NCT01233284|849610|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
257292|NCT01233258|849691|P6|First Intervention (6 Months)|Non-compliance with study medication|0
257293|NCT01233258|849692|P5|First Intervention (6 Months)|Non-compliance with study medication|0
257294|NCT01233258|849693|P4|First Intervention (6 Months)|Non-compliance with study medication|0
257295|NCT01233258|849694|P3|First Intervention (6 Months)|Non-compliance with study medication|0
257296|NCT01233258|849695|P2|First Intervention (6 Months)|Non-compliance with study medication|0
257297|NCT01233258|849696|P1|First Intervention (6 Months)|Non-compliance with study medication|1
257298|NCT01233258|849691|P6|First Intervention (6 Months)|Protocol Violation|0
257299|NCT01233258|849692|P5|First Intervention (6 Months)|Protocol Violation|0
257300|NCT01233258|849693|P4|First Intervention (6 Months)|Protocol Violation|0
257301|NCT01233258|849694|P3|First Intervention (6 Months)|Protocol Violation|1
257302|NCT01233258|849695|P2|First Intervention (6 Months)|Protocol Violation|0
257303|NCT01233258|849696|P1|First Intervention (6 Months)|Protocol Violation|0
257304|NCT01233258|849691|P6|First Intervention (6 Months)|Withdrawal by Subject|1
257305|NCT01233258|849692|P5|First Intervention (6 Months)|Withdrawal by Subject|0
257306|NCT01233258|849693|P4|First Intervention (6 Months)|Withdrawal by Subject|1
257307|NCT01233258|849694|P3|First Intervention (6 Months)|Withdrawal by Subject|0
257308|NCT01233258|849695|P2|First Intervention (6 Months)|Withdrawal by Subject|0
257309|NCT01233258|849696|P1|First Intervention (6 Months)|Withdrawal by Subject|0
257310|NCT01233232|849716|P3|Overall Study|Voluntary Discontinuation by Subject|0
257311|NCT01233232|849717|P2|Overall Study|Voluntary Discontinuation by Subject|0
257312|NCT01233232|849718|P1|Overall Study|Voluntary Discontinuation by Subject|1
257313|NCT01233076|849771|P2|Period 2, One Week|Lost to Follow-up|0
257314|NCT01233076|849772|P1|Period 2, One Week|Lost to Follow-up|1
257315|NCT01232569|849780|P4|Double-blind Treatment Period|Death|0
257316|NCT01232569|849781|P3|Double-blind Treatment Period|Death|0
257317|NCT01232569|849782|P2|Double-blind Treatment Period|Death|0
257318|NCT01232569|849783|P1|Double-blind Treatment Period|Death|2
257319|NCT01232569|849780|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
257320|NCT01232569|849781|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
257321|NCT01232569|849782|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
257322|NCT01232569|849783|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
257323|NCT01232569|849780|P4|Double-blind Treatment Period|Physician Decision|0
257324|NCT01232569|849781|P3|Double-blind Treatment Period|Physician Decision|0
257325|NCT01232569|849782|P2|Double-blind Treatment Period|Physician Decision|0
257326|NCT01232569|849783|P1|Double-blind Treatment Period|Physician Decision|1
257327|NCT01232569|849780|P4|Double-blind Treatment Period|Lack of Efficacy|0
257328|NCT01232569|849781|P3|Double-blind Treatment Period|Lack of Efficacy|0
257329|NCT01232569|849782|P2|Double-blind Treatment Period|Lack of Efficacy|2
257330|NCT01232569|849783|P1|Double-blind Treatment Period|Lack of Efficacy|1
257331|NCT01232569|849780|P4|Double-blind Treatment Period|Lost to Follow-up|0
257332|NCT01232569|849781|P3|Double-blind Treatment Period|Lost to Follow-up|0
257333|NCT01232569|849782|P2|Double-blind Treatment Period|Lost to Follow-up|0
257334|NCT01232569|849783|P1|Double-blind Treatment Period|Lost to Follow-up|4
257335|NCT01232569|849780|P4|Double-blind Treatment Period|Escape|0
257336|NCT01232569|849781|P3|Double-blind Treatment Period|Escape|0
257337|NCT01232569|849782|P2|Double-blind Treatment Period|Escape|2
257338|NCT01232569|849783|P1|Double-blind Treatment Period|Escape|2
257339|NCT01232569|849780|P4|Double-blind Treatment Period|Withdrawal by Subject|0
257340|NCT01232569|849781|P3|Double-blind Treatment Period|Withdrawal by Subject|0
257341|NCT01232569|849782|P2|Double-blind Treatment Period|Withdrawal by Subject|2
257342|NCT01232569|849783|P1|Double-blind Treatment Period|Withdrawal by Subject|9
257343|NCT01232491|849863|P2|Overall Study|Other|18
257344|NCT01232491|849864|P1|Overall Study|Other|21
257345|NCT01232491|849863|P2|Overall Study|Withdrawal Criteria|21
257346|NCT01232491|849864|P1|Overall Study|Withdrawal Criteria|12
257347|NCT01232491|849863|P2|Overall Study|Protocol Violation|11
257348|NCT01232491|849864|P1|Overall Study|Protocol Violation|13
257349|NCT01232491|849863|P2|Overall Study|Lack of Efficacy|5
257350|NCT01232491|849864|P1|Overall Study|Lack of Efficacy|1
257351|NCT01232491|849863|P2|Overall Study|Adverse Event|8
257352|NCT01232491|849864|P1|Overall Study|Adverse Event|13
257353|NCT01232296|849893|P2|Overall Study|Death|6
257354|NCT01232296|849894|P1|Overall Study|Death|1
257355|NCT01232296|849893|P2|Overall Study|Subject/guardian decision|2
257356|NCT01232296|849894|P1|Overall Study|Subject/guardian decision|10
257357|NCT01232296|849893|P2|Overall Study|Technical problems|0
257358|NCT01232296|849894|P1|Overall Study|Technical problems|3
257359|NCT01232296|849893|P2|Overall Study|Study terminated by sponsor|1
257360|NCT01232296|849894|P1|Overall Study|Study terminated by sponsor|0
257361|NCT01232296|849893|P2|Overall Study|Progressive disease|61
257362|NCT01232296|849894|P1|Overall Study|Progressive disease|43
257363|NCT01232296|849893|P2|Overall Study|Physician Decision|1
257364|NCT01232296|849894|P1|Overall Study|Physician Decision|1
257365|NCT01232296|849893|P2|Overall Study|Adverse Event|12
257366|NCT01232296|849894|P1|Overall Study|Adverse Event|24
257367|NCT01232283|849911|P8|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
257368|NCT01232283|849912|P7|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
257369|NCT01232283|849913|P6|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|1
257370|NCT01232283|849914|P5|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
257371|NCT01232283|849915|P4|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
257372|NCT01232283|849916|P3|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
257373|NCT01232283|849917|P2|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
257374|NCT01232283|849918|P1|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
257375|NCT01232283|849911|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
257376|NCT01232283|849912|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
257377|NCT01232283|849913|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
257378|NCT01232283|849914|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
257379|NCT01232283|849915|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
257380|NCT01232283|849916|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
257381|NCT01232283|849917|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
257382|NCT01232283|849918|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
257383|NCT01232283|849911|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
257384|NCT01232283|849912|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
257385|NCT01232283|849913|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
257386|NCT01232283|849914|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
257387|NCT01232283|849915|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
257388|NCT01232283|849916|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
257389|NCT01232283|849917|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
257390|NCT01232283|849918|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
257391|NCT01232283|849911|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
257392|NCT01232283|849912|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
257393|NCT01232283|849913|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
257394|NCT01232283|849914|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
257395|NCT01232283|849915|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
257396|NCT01232283|849916|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
257397|NCT01232283|849917|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
257398|NCT01232283|849918|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
257399|NCT01232283|849911|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
257400|NCT01232283|849912|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
257401|NCT01232283|849913|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
257402|NCT01232283|849914|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
257403|NCT01232283|849915|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
257404|NCT01232283|849916|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
257405|NCT01232283|849917|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
257406|NCT01232283|849918|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
257407|NCT01232283|849911|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
257408|NCT01232283|849912|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
257409|NCT01232283|849913|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
257410|NCT01232283|849914|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
257411|NCT01232283|849915|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
257412|NCT01232283|849916|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
257413|NCT01232283|849917|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
257414|NCT01232283|849918|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
257415|NCT01232283|849911|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
257416|NCT01232283|849912|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
257417|NCT01232283|849913|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
257418|NCT01232283|849914|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
257419|NCT01232283|849915|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
257420|NCT01232283|849916|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
257421|NCT01232283|849917|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
257422|NCT01232283|849918|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
257423|NCT01232283|849911|P8|Maintenance Phase (Weeks16-32)|Unspecified|0
257424|NCT01232283|849912|P7|Maintenance Phase (Weeks16-32)|Unspecified|0
257425|NCT01232283|849913|P6|Maintenance Phase (Weeks16-32)|Unspecified|0
257426|NCT01232283|849914|P5|Maintenance Phase (Weeks16-32)|Unspecified|0
257427|NCT01232283|849915|P4|Maintenance Phase (Weeks16-32)|Unspecified|0
257428|NCT01232283|849916|P3|Maintenance Phase (Weeks16-32)|Unspecified|2
257429|NCT01232283|849917|P2|Maintenance Phase (Weeks16-32)|Unspecified|0
257430|NCT01232283|849918|P1|Maintenance Phase (Weeks16-32)|Unspecified|0
257431|NCT01232283|849911|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
257432|NCT01232283|849912|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
257433|NCT01232283|849913|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
257434|NCT01232283|849914|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
257435|NCT01232283|849915|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
257436|NCT01232283|849916|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
257437|NCT01232283|849917|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
257438|NCT01232283|849918|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
257439|NCT01232283|849911|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
257440|NCT01232283|849912|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
257441|NCT01232283|849913|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
257442|NCT01232283|849914|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
257443|NCT01232283|849915|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
257444|NCT01232283|849916|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
257445|NCT01232283|849917|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
257446|NCT01232283|849918|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
257447|NCT01232283|849911|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
257448|NCT01232283|849912|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
257449|NCT01232283|849913|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
257450|NCT01232283|849914|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
257451|NCT01232283|849915|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
257452|NCT01232283|849916|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
257453|NCT01232283|849917|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
257454|NCT01232283|849918|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
257455|NCT01232283|849911|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
257456|NCT01232283|849912|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
257457|NCT01232283|849913|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
257458|NCT01232283|849914|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
257459|NCT01232283|849915|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
257460|NCT01232283|849916|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
257461|NCT01232283|849917|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
257462|NCT01232283|849918|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
257463|NCT01232283|849911|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
257464|NCT01232283|849912|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
257465|NCT01232283|849913|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
257466|NCT01232283|849914|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
257467|NCT01232283|849915|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
257468|NCT01232283|849916|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
257469|NCT01232283|849917|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
257470|NCT01232283|849918|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
257471|NCT01232283|849911|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
257472|NCT01232283|849912|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
257473|NCT01232283|849913|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
257474|NCT01232283|849914|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
257475|NCT01232283|849915|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
257476|NCT01232283|849916|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
257477|NCT01232283|849917|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
257478|NCT01232283|849918|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
257479|NCT01232283|849911|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
257480|NCT01232283|849912|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
257481|NCT01232283|849913|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
257482|NCT01232283|849914|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
257483|NCT01232283|849915|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
257484|NCT01232283|849916|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
257485|NCT01232283|849917|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
257486|NCT01232283|849918|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
257487|NCT01232283|849911|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
257488|NCT01232283|849912|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
257489|NCT01232283|849913|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
257490|NCT01232283|849914|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
257491|NCT01232283|849915|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
257492|NCT01232283|849916|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
257493|NCT01232283|849917|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
257494|NCT01232283|849918|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
257495|NCT01232283|849911|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
257496|NCT01232283|849912|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
257497|NCT01232283|849913|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
257498|NCT01232283|849914|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
257499|NCT01232283|849915|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
257500|NCT01232283|849916|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
257501|NCT01232283|849917|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
257502|NCT01232283|849918|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
257503|NCT01232283|849911|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
257504|NCT01232283|849912|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
257505|NCT01232283|849913|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
257506|NCT01232283|849914|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
257507|NCT01232283|849915|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
257508|NCT01232283|849916|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
257509|NCT01232283|849917|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
257510|NCT01232283|849918|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
257511|NCT01232283|849911|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
257512|NCT01232283|849912|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
257513|NCT01232283|849913|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
257514|NCT01232283|849914|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
257515|NCT01232283|849915|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
257516|NCT01232283|849916|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
257517|NCT01232283|849917|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
257518|NCT01232283|849918|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
257519|NCT01232283|849911|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
257520|NCT01232283|849912|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
257521|NCT01232283|849913|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
257522|NCT01232283|849914|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
257523|NCT01232283|849915|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
257524|NCT01232283|849916|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
257525|NCT01232283|849917|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
257526|NCT01232283|849918|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
257527|NCT01232127|849957|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
257528|NCT01232127|849958|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
257529|NCT01232127|849959|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
257530|NCT01231984|849983|P4|Study Period 2|Did not continue to meet I/E Criteria|1
257531|NCT01231984|849984|P3|Study Period 2|Did not continue to meet I/E Criteria|0
257532|NCT01231984|849985|P2|Study Period 2|Did not continue to meet I/E Criteria|1
257533|NCT01231984|849986|P1|Study Period 2|Did not continue to meet I/E Criteria|1
257534|NCT01231984|849983|P4|Study Period 2|Lost to Follow-up|3
257535|NCT01231984|849984|P3|Study Period 2|Lost to Follow-up|0
257536|NCT01231984|849985|P2|Study Period 2|Lost to Follow-up|0
257537|NCT01231984|849986|P1|Study Period 2|Lost to Follow-up|1
257538|NCT01231984|849983|P4|Study Period 2|Withdrawal by Subject|0
257539|NCT01231984|849984|P3|Study Period 2|Withdrawal by Subject|0
257540|NCT01231984|849985|P2|Study Period 2|Withdrawal by Subject|1
257541|NCT01231984|849986|P1|Study Period 2|Withdrawal by Subject|1
257542|NCT01231984|849983|P4|Study Period 1|Not Specified|1
257543|NCT01231984|849984|P3|Study Period 1|Not Specified|0
257544|NCT01231984|849985|P2|Study Period 1|Not Specified|0
257545|NCT01231984|849986|P1|Study Period 1|Not Specified|0
257546|NCT01231984|849983|P4|Study Period 1|Adverse Event|0
257547|NCT01231984|849984|P3|Study Period 1|Adverse Event|0
257548|NCT01231984|849985|P2|Study Period 1|Adverse Event|0
257549|NCT01231984|849986|P1|Study Period 1|Adverse Event|1
257550|NCT01231984|849983|P4|Study Period 1|Protocol Violation|3
257551|NCT01231984|849984|P3|Study Period 1|Protocol Violation|2
257552|NCT01231984|849985|P2|Study Period 1|Protocol Violation|4
257553|NCT01231984|849986|P1|Study Period 1|Protocol Violation|3
257554|NCT01231984|849983|P4|Study Period 1|Non-compliance with study requirements|1
257555|NCT01231984|849984|P3|Study Period 1|Non-compliance with study requirements|2
257556|NCT01231984|849985|P2|Study Period 1|Non-compliance with study requirements|0
257557|NCT01231984|849986|P1|Study Period 1|Non-compliance with study requirements|5
257558|NCT01231984|849983|P4|Study Period 1|Screen Failure|1
257559|NCT01231984|849984|P3|Study Period 1|Screen Failure|0
257560|NCT01231984|849985|P2|Study Period 1|Screen Failure|0
257561|NCT01231984|849986|P1|Study Period 1|Screen Failure|0
257562|NCT01231984|849983|P4|Study Period 1|Did not continue to meet I/E Criteria|2
257563|NCT01231984|849984|P3|Study Period 1|Did not continue to meet I/E Criteria|2
257564|NCT01231984|849985|P2|Study Period 1|Did not continue to meet I/E Criteria|2
257565|NCT01231984|849986|P1|Study Period 1|Did not continue to meet I/E Criteria|2
257566|NCT01231984|849983|P4|Study Period 1|Lost to Follow-up|0
257567|NCT01231984|849984|P3|Study Period 1|Lost to Follow-up|1
257568|NCT01231984|849985|P2|Study Period 1|Lost to Follow-up|1
257569|NCT01231984|849986|P1|Study Period 1|Lost to Follow-up|1
257570|NCT01231984|849983|P4|Study Period 1|Withdrawal by Subject|1
257571|NCT01231984|849984|P3|Study Period 1|Withdrawal by Subject|0
257572|NCT01231984|849985|P2|Study Period 1|Withdrawal by Subject|0
257573|NCT01231984|849986|P1|Study Period 1|Withdrawal by Subject|0
257574|NCT01231607|850044|P5|Overall Study|Withdrawal by Subject|9
257575|NCT01231607|850045|P4|Overall Study|Withdrawal by Subject|17
257576|NCT01231607|850046|P3|Overall Study|Withdrawal by Subject|14
257577|NCT01231607|850047|P2|Overall Study|Withdrawal by Subject|9
257578|NCT01231607|850048|P1|Overall Study|Withdrawal by Subject|9
257579|NCT01231607|850044|P5|Overall Study|Protocol Violation|2
257580|NCT01231607|850045|P4|Overall Study|Protocol Violation|2
257581|NCT01231607|850046|P3|Overall Study|Protocol Violation|0
257582|NCT01231607|850047|P2|Overall Study|Protocol Violation|2
257583|NCT01231607|850048|P1|Overall Study|Protocol Violation|3
257584|NCT01231607|850044|P5|Overall Study|Physician Decision|4
257585|NCT01231607|850045|P4|Overall Study|Physician Decision|5
257586|NCT01231607|850046|P3|Overall Study|Physician Decision|3
257587|NCT01231607|850047|P2|Overall Study|Physician Decision|4
257588|NCT01231607|850048|P1|Overall Study|Physician Decision|4
257589|NCT01231607|850044|P5|Overall Study|Lost to Follow-up|4
257590|NCT01231607|850045|P4|Overall Study|Lost to Follow-up|10
257591|NCT01231607|850046|P3|Overall Study|Lost to Follow-up|10
257592|NCT01231607|850047|P2|Overall Study|Lost to Follow-up|11
257593|NCT01231607|850048|P1|Overall Study|Lost to Follow-up|13
257594|NCT01231607|850044|P5|Overall Study|Adverse Event|5
257595|NCT01231607|850045|P4|Overall Study|Adverse Event|4
257596|NCT01231607|850046|P3|Overall Study|Adverse Event|4
257597|NCT01231607|850047|P2|Overall Study|Adverse Event|8
257598|NCT01231607|850048|P1|Overall Study|Adverse Event|0
257599|NCT01231581|850140|P2|Overall Study|Ongoing|0
257600|NCT01231581|850141|P1|Overall Study|Ongoing|1
257601|NCT01231581|850140|P2|Overall Study|Death|64
257602|NCT01231581|850141|P1|Overall Study|Death|65
257603|NCT01231581|850140|P2|Overall Study|Study Closed/Terminated|5
257604|NCT01231581|850141|P1|Overall Study|Study Closed/Terminated|6
257605|NCT01231581|850140|P2|Overall Study|Withdrawal by Subject|9
257606|NCT01231581|850141|P1|Overall Study|Withdrawal by Subject|6
257607|NCT01231581|850140|P2|Overall Study|Lost to Follow-up|2
257608|NCT01231581|850141|P1|Overall Study|Lost to Follow-up|2
257609|NCT01231516|850161|P2|Open-label Phase|Ongoing at the time of analysis|23
257610|NCT01231516|850162|P1|Open-label Phase|Ongoing at the time of analysis|282
257611|NCT01231516|850161|P2|Open-label Phase|Withdrawal by Subject|0
257612|NCT01231516|850162|P1|Open-label Phase|Withdrawal by Subject|1
257613|NCT01231516|850161|P2|Open-label Phase|Lost to Follow-up|0
257614|NCT01231516|850162|P1|Open-label Phase|Lost to Follow-up|3
257615|NCT01231516|850161|P2|Open-label Phase|Protocol Violation|0
257616|NCT01231516|850162|P1|Open-label Phase|Protocol Violation|2
257617|NCT01231516|850161|P2|Open-label Phase|Lack of Efficacy|3
257618|NCT01231516|850162|P1|Open-label Phase|Lack of Efficacy|7
257619|NCT01231516|850161|P2|48 Week Double-blind Phase|Site Closed|1
257620|NCT01231516|850162|P1|48 Week Double-blind Phase|Site Closed|3
257621|NCT01231516|850161|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
257622|NCT01231516|850162|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
257623|NCT01231516|850161|P2|48 Week Double-blind Phase|Physician Decision|1
257624|NCT01231516|850162|P1|48 Week Double-blind Phase|Physician Decision|1
257625|NCT01231516|850161|P2|48 Week Double-blind Phase|Lost to Follow-up|10
257626|NCT01231516|850162|P1|48 Week Double-blind Phase|Lost to Follow-up|5
257627|NCT01231516|850161|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
257628|NCT01231516|850162|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
257629|NCT01231516|850161|P2|48 Week Double-blind Phase|Protocol Violation|6
257630|NCT01231516|850162|P1|48 Week Double-blind Phase|Protocol Violation|9
257631|NCT01231516|850161|P2|48 Week Double-blind Phase|Lack of Efficacy|42
257632|NCT01231516|850162|P1|48 Week Double-blind Phase|Lack of Efficacy|20
257633|NCT01231516|850161|P2|48 Week Double-blind Phase|Adverse Event|11
257634|NCT01231516|850162|P1|48 Week Double-blind Phase|Adverse Event|4
257635|NCT01231503|850192|P8|Overall Study|Protocol Violation|0
257636|NCT01231503|850193|P7|Overall Study|Protocol Violation|0
257637|NCT01231503|850194|P6|Overall Study|Protocol Violation|0
257638|NCT01231503|850195|P5|Overall Study|Protocol Violation|0
257639|NCT01231503|850196|P4|Overall Study|Protocol Violation|1
257640|NCT01231503|850197|P3|Overall Study|Protocol Violation|0
257641|NCT01231503|850198|P2|Overall Study|Protocol Violation|0
257642|NCT01231503|850199|P1|Overall Study|Protocol Violation|0
257643|NCT01231503|850192|P8|Overall Study|Lost to Follow-up|6
257644|NCT01231503|850193|P7|Overall Study|Lost to Follow-up|6
257645|NCT01231503|850194|P6|Overall Study|Lost to Follow-up|9
257646|NCT01231503|850195|P5|Overall Study|Lost to Follow-up|7
257647|NCT01231503|850196|P4|Overall Study|Lost to Follow-up|5
257648|NCT01231503|850197|P3|Overall Study|Lost to Follow-up|8
257649|NCT01231503|850198|P2|Overall Study|Lost to Follow-up|10
257650|NCT01231503|850199|P1|Overall Study|Lost to Follow-up|8
257651|NCT01231503|850192|P8|Overall Study|Withdrawal by Subject|2
257652|NCT01231503|850193|P7|Overall Study|Withdrawal by Subject|1
257653|NCT01231503|850194|P6|Overall Study|Withdrawal by Subject|5
257654|NCT01231503|850195|P5|Overall Study|Withdrawal by Subject|3
257655|NCT01231503|850196|P4|Overall Study|Withdrawal by Subject|1
257656|NCT01231503|850197|P3|Overall Study|Withdrawal by Subject|3
257657|NCT01231503|850198|P2|Overall Study|Withdrawal by Subject|3
257658|NCT01231503|850199|P1|Overall Study|Withdrawal by Subject|6
257659|NCT01231503|850192|P8|Overall Study|Adverse event, serious fatal|0
257660|NCT01231503|850193|P7|Overall Study|Adverse event, serious fatal|0
257661|NCT01231503|850194|P6|Overall Study|Adverse event, serious fatal|1
257662|NCT01231503|850195|P5|Overall Study|Adverse event, serious fatal|0
257663|NCT01231503|850196|P4|Overall Study|Adverse event, serious fatal|1
257664|NCT01231503|850197|P3|Overall Study|Adverse event, serious fatal|1
257665|NCT01231503|850198|P2|Overall Study|Adverse event, serious fatal|0
257666|NCT01231503|850199|P1|Overall Study|Adverse event, serious fatal|0
257667|NCT01231503|850192|P8|Overall Study|Adverse Event|0
257668|NCT01231503|850193|P7|Overall Study|Adverse Event|0
257669|NCT01231503|850194|P6|Overall Study|Adverse Event|1
257670|NCT01231503|850195|P5|Overall Study|Adverse Event|0
257671|NCT01231503|850196|P4|Overall Study|Adverse Event|0
257672|NCT01231503|850197|P3|Overall Study|Adverse Event|0
257673|NCT01231503|850198|P2|Overall Study|Adverse Event|0
257674|NCT01231503|850199|P1|Overall Study|Adverse Event|0
257675|NCT01231464|850415|P2|Overall Study|Withdrawal by Subject|2
257676|NCT01231464|850416|P1|Overall Study|Withdrawal by Subject|3
257677|NCT01231464|850415|P2|Overall Study|Lost to Follow-up|2
257678|NCT01231464|850416|P1|Overall Study|Lost to Follow-up|1
257679|NCT01231464|850415|P2|Overall Study|Protocol Violation|2
257680|NCT01231464|850416|P1|Overall Study|Protocol Violation|1
257681|NCT01231464|850415|P2|Overall Study|Adverse Event|1
257682|NCT01231464|850416|P1|Overall Study|Adverse Event|0
257683|NCT01231373|850437|P4|Overall Study|Withdrew Consent|0
257684|NCT01231373|850438|P3|Overall Study|Withdrew Consent|0
257685|NCT01231373|850439|P2|Overall Study|Withdrew Consent|0
257686|NCT01231373|850440|P1|Overall Study|Withdrew Consent|1
257687|NCT01231373|850437|P4|Overall Study|Lost to Follow-up|1
257688|NCT01231373|850438|P3|Overall Study|Lost to Follow-up|0
257689|NCT01231373|850439|P2|Overall Study|Lost to Follow-up|0
257690|NCT01231373|850440|P1|Overall Study|Lost to Follow-up|0
257691|NCT01231373|850437|P4|Overall Study|Withdrew consent prior to randomization|0
257692|NCT01231373|850438|P3|Overall Study|Withdrew consent prior to randomization|0
257693|NCT01231373|850439|P2|Overall Study|Withdrew consent prior to randomization|1
257694|NCT01231373|850440|P1|Overall Study|Withdrew consent prior to randomization|2
257695|NCT01231321|850479|P1|Overall Study|Lack of Efficacy|2
257696|NCT01231321|850479|P1|Overall Study|Adverse Event|3
257697|NCT01230892|850502|P2|Overall Study|Lost to Follow-up|0
257698|NCT01230892|850503|P1|Overall Study|Lost to Follow-up|2
257699|NCT01230892|850502|P2|Overall Study|Withdrawal by Subject|1
257700|NCT01230892|850503|P1|Overall Study|Withdrawal by Subject|1
257701|NCT01230827|850513|P4|Overall Study|Study terminated by Sponsor|63
257702|NCT01230827|850514|P3|Overall Study|Study terminated by Sponsor|56
257703|NCT01230827|850515|P2|Overall Study|Study terminated by Sponsor|2
257704|NCT01230827|850516|P1|Overall Study|Study terminated by Sponsor|0
257705|NCT01230827|850513|P4|Overall Study|Recovery|0
257706|NCT01230827|850514|P3|Overall Study|Recovery|0
257707|NCT01230827|850515|P2|Overall Study|Recovery|6
257708|NCT01230827|850516|P1|Overall Study|Recovery|0
257709|NCT01230827|850513|P4|Overall Study|Adverse Event|7
257710|NCT01230827|850514|P3|Overall Study|Adverse Event|3
257711|NCT01230827|850515|P2|Overall Study|Adverse Event|2
257712|NCT01230827|850516|P1|Overall Study|Adverse Event|4
257713|NCT01230827|850513|P4|Overall Study|Lack of Efficacy|3
257714|NCT01230827|850514|P3|Overall Study|Lack of Efficacy|2
257715|NCT01230827|850515|P2|Overall Study|Lack of Efficacy|1
257716|NCT01230827|850516|P1|Overall Study|Lack of Efficacy|14
257717|NCT01230827|850513|P4|Overall Study|Withdrawal by Subject|2
257718|NCT01230827|850514|P3|Overall Study|Withdrawal by Subject|3
257719|NCT01230827|850515|P2|Overall Study|Withdrawal by Subject|0
257720|NCT01230827|850516|P1|Overall Study|Withdrawal by Subject|1
257721|NCT01230827|850513|P4|Overall Study|Lost to Follow-up|3
257722|NCT01230827|850514|P3|Overall Study|Lost to Follow-up|1
257723|NCT01230827|850515|P2|Overall Study|Lost to Follow-up|0
257724|NCT01230827|850516|P1|Overall Study|Lost to Follow-up|0
257725|NCT01230814|850532|P2|Overall Study|Discontinued (not due to adverse event)|1
257726|NCT01230814|850533|P1|Overall Study|Discontinued (not due to adverse event)|2
257727|NCT01230814|850532|P2|Overall Study|Lost to Follow-up|3
257728|NCT01230814|850533|P1|Overall Study|Lost to Follow-up|11
257729|NCT01230788|850545|P1|Overall Study|Prescribed exclusion drug|1
257730|NCT01230749|850557|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
257731|NCT01230749|850558|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
257732|NCT01230749|850559|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
257733|NCT01230749|850560|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
257734|NCT01230749|850557|P4|Overall Study|Withdrawal by Subject|0
257735|NCT01230749|850558|P3|Overall Study|Withdrawal by Subject|0
257736|NCT01230749|850559|P2|Overall Study|Withdrawal by Subject|1
257737|NCT01230749|850560|P1|Overall Study|Withdrawal by Subject|0
257738|NCT01230749|850557|P4|Overall Study|Physician Decision|0
257739|NCT01230749|850558|P3|Overall Study|Physician Decision|1
257740|NCT01230749|850559|P2|Overall Study|Physician Decision|0
257741|NCT01230749|850560|P1|Overall Study|Physician Decision|0
257742|NCT01230749|850557|P4|Overall Study|Adverse Event|1
257743|NCT01230749|850558|P3|Overall Study|Adverse Event|0
257744|NCT01230749|850559|P2|Overall Study|Adverse Event|0
257745|NCT01230749|850560|P1|Overall Study|Adverse Event|0
257746|NCT01230710|850595|P1|Overall Study|Withdrawal of Consent|1
257747|NCT01230710|850595|P1|Overall Study|Death|4
257748|NCT01230710|850595|P1|Overall Study|Lost to Follow-up|3
257749|NCT01230710|850595|P1|Overall Study|Disease Progression|41
257750|NCT01230307|850621|P2|Overall Study|LVAD Placement|2
257751|NCT01230307|850622|P1|Overall Study|LVAD Placement|0
257752|NCT01230060|850642|P1|Overall Study|Withdrawal by Subject|1
257753|NCT01229735|850715|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
257754|NCT01229735|850716|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
257755|NCT01229735|850715|P2|Overall Study|AE, non-serious non-fatal|17
257756|NCT01229735|850716|P1|Overall Study|AE, non-serious non-fatal|13
257757|NCT01229735|850715|P2|Overall Study|SAE, non-fatal|4
257758|NCT01229735|850716|P1|Overall Study|SAE, non-fatal|0
257759|NCT01229735|850715|P2|Overall Study|Other Reason|10
257760|NCT01229735|850716|P1|Overall Study|Other Reason|13
257761|NCT01229735|850715|P2|Overall Study|Withdrawal by Subject|17
257762|NCT01229735|850716|P1|Overall Study|Withdrawal by Subject|18
257763|NCT01229735|850715|P2|Overall Study|Lost to Follow-up|2
257764|NCT01229735|850716|P1|Overall Study|Lost to Follow-up|0
257765|NCT01229735|850715|P2|Overall Study|Protocol Violation|8
257766|NCT01229735|850716|P1|Overall Study|Protocol Violation|13
257767|NCT01229735|850715|P2|Overall Study|Lack of Efficacy|8
257768|NCT01229735|850716|P1|Overall Study|Lack of Efficacy|8
257769|NCT01229436|850764|P1|Overall Study|Lost to Follow-up|3
257770|NCT01229436|850764|P1|Overall Study|Withdrawal by Subject|2
257771|NCT01229397|850826|P2|Overall Study|Migrated/moved from study area|0
257772|NCT01229397|850827|P1|Overall Study|Migrated/moved from study area|1
257773|NCT01229397|850826|P2|Overall Study|Lost to Follow-up|6
257774|NCT01229397|850827|P1|Overall Study|Lost to Follow-up|7
257775|NCT01229397|850826|P2|Overall Study|Withdrawal by Subject|3
257776|NCT01229397|850827|P1|Overall Study|Withdrawal by Subject|3
257777|NCT01229371|850845|P4|Overall Study|Withdrawal by Subject|0
257778|NCT01229371|850846|P3|Overall Study|Withdrawal by Subject|0
257779|NCT01229371|850847|P2|Overall Study|Withdrawal by Subject|1
257780|NCT01229371|850848|P1|Overall Study|Withdrawal by Subject|0
257781|NCT01229176|850899|P8|Overall Study|Lost to Follow-up|2
257782|NCT01229176|850900|P7|Overall Study|Lost to Follow-up|0
257783|NCT01229176|850901|P6|Overall Study|Lost to Follow-up|1
257784|NCT01229176|850902|P5|Overall Study|Lost to Follow-up|1
257785|NCT01229176|850903|P4|Overall Study|Lost to Follow-up|0
257786|NCT01229176|850904|P3|Overall Study|Lost to Follow-up|0
257787|NCT01229176|850905|P2|Overall Study|Lost to Follow-up|3
257788|NCT01229176|850906|P1|Overall Study|Lost to Follow-up|0
257789|NCT01229176|850899|P8|Overall Study|Withdrawal by Subject|1
257790|NCT01229176|850900|P7|Overall Study|Withdrawal by Subject|0
257791|NCT01229176|850901|P6|Overall Study|Withdrawal by Subject|1
257792|NCT01229176|850902|P5|Overall Study|Withdrawal by Subject|1
257793|NCT01229176|850903|P4|Overall Study|Withdrawal by Subject|1
257794|NCT01229176|850904|P3|Overall Study|Withdrawal by Subject|0
257795|NCT01229176|850905|P2|Overall Study|Withdrawal by Subject|0
257796|NCT01229176|850906|P1|Overall Study|Withdrawal by Subject|0
257797|NCT01229150|850960|P4|Overall Study|Toxicity|0
257798|NCT01229150|850961|P3|Overall Study|Toxicity|0
257799|NCT01229150|850962|P2|Overall Study|Toxicity|2
257800|NCT01229150|850963|P1|Overall Study|Toxicity|2
257801|NCT01229111|851020|P1|Overall Study|Death|1
257802|NCT01228747|851069|P2|Overall Study|Other Reason|5
257803|NCT01228747|851070|P1|Overall Study|Other Reason|2
257804|NCT01228747|851069|P2|Overall Study|Withdrawal by Subject|1
257805|NCT01228747|851070|P1|Overall Study|Withdrawal by Subject|5
257806|NCT01228747|851069|P2|Overall Study|Lost to Follow-up|3
257807|NCT01228747|851070|P1|Overall Study|Lost to Follow-up|4
257808|NCT01228747|851069|P2|Overall Study|Protocol Violation|5
257809|NCT01228747|851070|P1|Overall Study|Protocol Violation|6
257810|NCT01228747|851069|P2|Overall Study|Lack of Efficacy|27
257811|NCT01228747|851070|P1|Overall Study|Lack of Efficacy|40
257812|NCT01228747|851069|P2|Overall Study|Adverse Event|4
257813|NCT01228747|851070|P1|Overall Study|Adverse Event|8
257814|NCT01228734|851086|P2|Overall Study|Randomized, but not treated|4
257815|NCT01228734|851087|P1|Overall Study|Randomized, but not treated|0
257816|NCT01228734|851086|P2|Overall Study|Ongoing at clinical cut-off date|4
257817|NCT01228734|851087|P1|Overall Study|Ongoing at clinical cut-off date|16
257818|NCT01228591|851101|P2|Baseline|Lack of Efficacy|2
257819|NCT01228591|851102|P1|Baseline|Lack of Efficacy|1
257820|NCT01228175|851129|P2|Overall Study|Physician Decision|1
257821|NCT01228175|851130|P1|Overall Study|Physician Decision|1
257822|NCT01228175|851129|P2|Overall Study|Withdrawal by Subject|2
257823|NCT01228175|851130|P1|Overall Study|Withdrawal by Subject|1
257824|NCT01228175|851129|P2|Overall Study|Lost to Follow-up|50
257825|NCT01228175|851130|P1|Overall Study|Lost to Follow-up|61
257826|NCT01228071|851156|P1|Overall Study|Withdrawal by Subject|1
257827|NCT01228071|851156|P1|Overall Study|Protocol Violation|1
257828|NCT01228019|851162|P1|Overall Study|Violation of Entry Criterion|9
257829|NCT01228019|851162|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
257830|NCT01228019|851162|P1|Overall Study|Missing pre-treatment data|72
257831|NCT01228019|851162|P1|Overall Study|Duplicate enrollment|1
257832|NCT01228019|851162|P1|Overall Study|Dose Violation|70
257833|NCT01227928|851228|P2|Overall Study|Death|12
257834|NCT01227928|851229|P1|Overall Study|Death|14
257835|NCT01227928|851228|P2|Overall Study|Withdrawal by Subject|3
257836|NCT01227928|851229|P1|Overall Study|Withdrawal by Subject|4
257837|NCT01227928|851228|P2|Overall Study|Lost to Follow-up|2
257838|NCT01227928|851229|P1|Overall Study|Lost to Follow-up|4
257839|NCT01227902|851267|P4|Overall Study|Withdrawal by Subject|3
257840|NCT01227902|851268|P3|Overall Study|Withdrawal by Subject|4
257841|NCT01227902|851269|P2|Overall Study|Withdrawal by Subject|2
257842|NCT01227902|851270|P1|Overall Study|Withdrawal by Subject|4
257843|NCT01227902|851267|P4|Overall Study|Physician Decision|0
257844|NCT01227902|851268|P3|Overall Study|Physician Decision|1
257845|NCT01227902|851269|P2|Overall Study|Physician Decision|1
257846|NCT01227902|851270|P1|Overall Study|Physician Decision|0
257847|NCT01227902|851267|P4|Overall Study|Lost to Follow-up|2
257848|NCT01227902|851268|P3|Overall Study|Lost to Follow-up|1
257849|NCT01227902|851269|P2|Overall Study|Lost to Follow-up|0
257850|NCT01227902|851270|P1|Overall Study|Lost to Follow-up|0
257851|NCT01227902|851267|P4|Overall Study|Protocol Violation|0
257852|NCT01227902|851268|P3|Overall Study|Protocol Violation|0
257853|NCT01227902|851269|P2|Overall Study|Protocol Violation|0
257854|NCT01227902|851270|P1|Overall Study|Protocol Violation|1
257855|NCT01227902|851267|P4|Overall Study|Lack of Efficacy|1
257856|NCT01227902|851268|P3|Overall Study|Lack of Efficacy|2
257857|NCT01227902|851269|P2|Overall Study|Lack of Efficacy|2
257858|NCT01227902|851270|P1|Overall Study|Lack of Efficacy|1
257859|NCT01227902|851267|P4|Overall Study|Adverse Event|4
257860|NCT01227902|851268|P3|Overall Study|Adverse Event|11
257861|NCT01227902|851269|P2|Overall Study|Adverse Event|8
257862|NCT01227902|851270|P1|Overall Study|Adverse Event|12
257863|NCT01227889|851363|P2|Crossover Phase|In Follow-up|11
257864|NCT01227889|851364|P1|Crossover Phase|In Follow-up|0
257865|NCT01227889|851363|P2|Crossover Phase|Ongoing|4
257866|NCT01227889|851364|P1|Crossover Phase|Ongoing|0
257867|NCT01227889|851363|P2|Crossover Phase|Death|20
257868|NCT01227889|851364|P1|Crossover Phase|Death|0
257869|NCT01227889|851363|P2|Crossover Phase|Withdrawal by Subject|1
257870|NCT01227889|851364|P1|Crossover Phase|Withdrawal by Subject|0
257871|NCT01227889|851363|P2|Randomized Phase (RP)|In Follow-up|10
257872|NCT01227889|851364|P1|Randomized Phase (RP)|In Follow-up|49
257873|NCT01227889|851363|P2|Randomized Phase (RP)|Ongoing|2
257874|NCT01227889|851364|P1|Randomized Phase (RP)|Ongoing|53
257875|NCT01227889|851363|P2|Randomized Phase (RP)|Crossed Over|36
257876|NCT01227889|851364|P1|Randomized Phase (RP)|Crossed Over|0
257877|NCT01227889|851363|P2|Randomized Phase (RP)|Death|8
257878|NCT01227889|851364|P1|Randomized Phase (RP)|Death|78
257879|NCT01227889|851363|P2|Randomized Phase (RP)|Withdrawal by Subject|5
257880|NCT01227889|851364|P1|Randomized Phase (RP)|Withdrawal by Subject|2
257881|NCT01227889|851363|P2|Randomized Phase (RP)|Physician Decision|1
257882|NCT01227889|851364|P1|Randomized Phase (RP)|Physician Decision|2
257883|NCT01227889|851363|P2|Randomized Phase (RP)|Lost to Follow-up|1
257884|NCT01227889|851364|P1|Randomized Phase (RP)|Lost to Follow-up|3
257885|NCT01227824|851392|P2|Open-label Phase|Ongoing|0
257886|NCT01227824|851393|P1|Open-label Phase|Ongoing|337
257887|NCT01227824|851392|P2|Open-label Phase|Protocol Violation|0
257888|NCT01227824|851393|P1|Open-label Phase|Protocol Violation|1
257889|NCT01227824|851392|P2|Double-blind Phase|Withdrawal by Subject|14
257890|NCT01227824|851393|P1|Double-blind Phase|Withdrawal by Subject|10
257891|NCT01227824|851392|P2|Double-blind Phase|Lost to Follow-up|10
257892|NCT01227824|851393|P1|Double-blind Phase|Lost to Follow-up|6
257893|NCT01227824|851392|P2|Double-blind Phase|Study Closed/Terminated|4
257894|NCT01227824|851393|P1|Double-blind Phase|Study Closed/Terminated|6
257895|NCT01227824|851392|P2|Double-blind Phase|Met Protocol-defined Stopping Criteria|3
257896|NCT01227824|851393|P1|Double-blind Phase|Met Protocol-defined Stopping Criteria|2
257897|NCT01227824|851392|P2|Double-blind Phase|Protocol Violation|16
257898|NCT01227824|851393|P1|Double-blind Phase|Protocol Violation|13
257899|NCT01227824|851392|P2|Double-blind Phase|Lack of Efficacy|25
257900|NCT01227824|851393|P1|Double-blind Phase|Lack of Efficacy|17
257901|NCT01227824|851392|P2|Double-blind Phase|Adverse Event|7
257902|NCT01227824|851393|P1|Double-blind Phase|Adverse Event|8
257903|NCT01227707|851487|P1|Overall Study|Death|1
257904|NCT01227707|851487|P1|Overall Study|Medical decision|6
257905|NCT01227707|851487|P1|Overall Study|Patient non-compliance|3
257906|NCT01227707|851487|P1|Overall Study|Withdrawal by Subject|1
257907|NCT01227707|851487|P1|Overall Study|Progression of disease|3
257908|NCT01227707|851487|P1|Overall Study|Adverse Event|10
257909|NCT01227668|851514|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
257910|NCT01227668|851515|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
257911|NCT01227668|851514|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
257912|NCT01227668|851515|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
257913|NCT01227668|851514|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
257914|NCT01227668|851515|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
257915|NCT01227668|851514|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
257916|NCT01227668|851515|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
257917|NCT01227668|851514|P2|Phase 2 (Randomization Phase)|Adverse Event|1
257918|NCT01227668|851515|P1|Phase 2 (Randomization Phase)|Adverse Event|0
257919|NCT01227668|851514|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
257920|NCT01227668|851515|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
257921|NCT01227668|851514|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
257922|NCT01227668|851515|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
257923|NCT01227668|851514|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
257924|NCT01227668|851515|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
257925|NCT01227668|851514|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
257926|NCT01227668|851515|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
257927|NCT01227668|851514|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
257928|NCT01227668|851515|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
257929|NCT01227668|851514|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
257930|NCT01227668|851515|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
257931|NCT01227668|851514|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
257932|NCT01227668|851515|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
257933|NCT01227629|851561|P10|Overall Study|Not Specified|1
257934|NCT01227629|851562|P9|Overall Study|Not Specified|2
257935|NCT01227629|851563|P8|Overall Study|Not Specified|0
257936|NCT01227629|851564|P7|Overall Study|Not Specified|0
257937|NCT01227629|851565|P6|Overall Study|Not Specified|0
257938|NCT01227629|851566|P5|Overall Study|Not Specified|0
257939|NCT01227629|851567|P4|Overall Study|Not Specified|1
257940|NCT01227629|851568|P3|Overall Study|Not Specified|0
257941|NCT01227629|851569|P2|Overall Study|Not Specified|0
257942|NCT01227629|851570|P1|Overall Study|Not Specified|0
257943|NCT01227629|851561|P10|Overall Study|Withdrawal by Subject|1
257944|NCT01227629|851562|P9|Overall Study|Withdrawal by Subject|0
257945|NCT01227629|851563|P8|Overall Study|Withdrawal by Subject|0
257946|NCT01227629|851564|P7|Overall Study|Withdrawal by Subject|2
257947|NCT01227629|851565|P6|Overall Study|Withdrawal by Subject|0
257948|NCT01227629|851566|P5|Overall Study|Withdrawal by Subject|0
257949|NCT01227629|851567|P4|Overall Study|Withdrawal by Subject|0
257950|NCT01227629|851568|P3|Overall Study|Withdrawal by Subject|0
257951|NCT01227629|851569|P2|Overall Study|Withdrawal by Subject|0
257952|NCT01227629|851570|P1|Overall Study|Withdrawal by Subject|0
257953|NCT01227629|851561|P10|Overall Study|Lost to Follow-up|0
257954|NCT01227629|851562|P9|Overall Study|Lost to Follow-up|0
257955|NCT01227629|851563|P8|Overall Study|Lost to Follow-up|0
257956|NCT01227629|851564|P7|Overall Study|Lost to Follow-up|0
257957|NCT01227629|851565|P6|Overall Study|Lost to Follow-up|0
257958|NCT01227629|851566|P5|Overall Study|Lost to Follow-up|1
257959|NCT01227629|851567|P4|Overall Study|Lost to Follow-up|0
257960|NCT01227629|851568|P3|Overall Study|Lost to Follow-up|0
257961|NCT01227629|851569|P2|Overall Study|Lost to Follow-up|0
257962|NCT01227629|851570|P1|Overall Study|Lost to Follow-up|0
257963|NCT01227629|851561|P10|Overall Study|Protocol Violation|0
257964|NCT01227629|851562|P9|Overall Study|Protocol Violation|0
257965|NCT01227629|851563|P8|Overall Study|Protocol Violation|0
257966|NCT01227629|851564|P7|Overall Study|Protocol Violation|0
257967|NCT01227629|851565|P6|Overall Study|Protocol Violation|0
257968|NCT01227629|851566|P5|Overall Study|Protocol Violation|0
257969|NCT01227629|851567|P4|Overall Study|Protocol Violation|1
257970|NCT01227629|851568|P3|Overall Study|Protocol Violation|0
257971|NCT01227629|851569|P2|Overall Study|Protocol Violation|0
257972|NCT01227629|851570|P1|Overall Study|Protocol Violation|0
257973|NCT01227629|851561|P10|Overall Study|Adverse Event|0
257974|NCT01227629|851562|P9|Overall Study|Adverse Event|4
257975|NCT01227629|851563|P8|Overall Study|Adverse Event|6
257976|NCT01227629|851564|P7|Overall Study|Adverse Event|6
257977|NCT01227629|851565|P6|Overall Study|Adverse Event|1
257978|NCT01227629|851566|P5|Overall Study|Adverse Event|1
257979|NCT01227629|851567|P4|Overall Study|Adverse Event|6
257980|NCT01227629|851568|P3|Overall Study|Adverse Event|1
257981|NCT01227629|851569|P2|Overall Study|Adverse Event|2
257982|NCT01227629|851570|P1|Overall Study|Adverse Event|2
257983|NCT01227577|851806|P1|Overall Study|Adverse Event|17
257984|NCT01227577|851806|P1|Overall Study|Lack of Efficacy|5
257985|NCT01227577|851806|P1|Overall Study|Withdrawal by Subject|4
257986|NCT01227577|851806|P1|Overall Study|Lost to Follow-up|1
257987|NCT01227577|851806|P1|Overall Study|Administrative problems|2
257988|NCT01227577|851806|P1|Overall Study|Death|3
257989|NCT01227577|851806|P1|Overall Study|Protocol deviation|3
257990|NCT01227564|851821|P3|Overall Study|Participant moved to another town|1
257991|NCT01227564|851822|P2|Overall Study|Participant moved to another town|0
257992|NCT01227564|851823|P1|Overall Study|Participant moved to another town|0
257993|NCT01227564|851821|P3|Overall Study|No Longer Willing to Participate|5
257994|NCT01227564|851822|P2|Overall Study|No Longer Willing to Participate|2
257995|NCT01227564|851823|P1|Overall Study|No Longer Willing to Participate|4
257996|NCT01227512|851961|P2|Overall Study|Participant met withdrawal criteria|1
257997|NCT01227512|851962|P1|Overall Study|Participant met withdrawal criteria|0
257998|NCT01227512|851961|P2|Overall Study|Withdrawal by Subject|0
257999|NCT01227512|851962|P1|Overall Study|Withdrawal by Subject|3
258000|NCT01227512|851961|P2|Overall Study|Adverse Event|3
258001|NCT01227512|851962|P1|Overall Study|Adverse Event|4
258002|NCT01227512|851961|P2|Overall Study|Physician Decision|6
258003|NCT01227512|851962|P1|Overall Study|Physician Decision|6
258004|NCT01227421|851996|P3|Overall Study|Randomized in error|0
258005|NCT01227421|851997|P2|Overall Study|Randomized in error|1
258006|NCT01227421|851998|P1|Overall Study|Randomized in error|1
258007|NCT01227421|851996|P3|Overall Study|Protocol Violation|2
258008|NCT01227421|851997|P2|Overall Study|Protocol Violation|1
258009|NCT01227421|851998|P1|Overall Study|Protocol Violation|1
258010|NCT01227421|851996|P3|Overall Study|Withdrawal by Subject|1
258011|NCT01227421|851997|P2|Overall Study|Withdrawal by Subject|2
258012|NCT01227421|851998|P1|Overall Study|Withdrawal by Subject|1
258013|NCT01227421|851996|P3|Overall Study|Adverse Event|2
258014|NCT01227421|851997|P2|Overall Study|Adverse Event|7
258015|NCT01227421|851998|P1|Overall Study|Adverse Event|2
258016|NCT01227421|851996|P3|Overall Study|Lost to Follow-up|5
258017|NCT01227421|851997|P2|Overall Study|Lost to Follow-up|7
258018|NCT01227421|851998|P1|Overall Study|Lost to Follow-up|6
258019|NCT01227395|852050|P2|Overall Study|Protocol Violation|1
258020|NCT01227395|852051|P1|Overall Study|Protocol Violation|0
258021|NCT01227278|852091|P2|Overall Study|Unspecified|2
258022|NCT01227278|852092|P1|Overall Study|Unspecified|1
258023|NCT01227278|852091|P2|Overall Study|Death|2
258024|NCT01227278|852092|P1|Overall Study|Death|0
258025|NCT01227278|852091|P2|Overall Study|Withdrawal by Subject|4
258026|NCT01227278|852092|P1|Overall Study|Withdrawal by Subject|4
258027|NCT01227265|852119|P3|Overall Study|Adverse Event|5
258028|NCT01227265|852120|P2|Overall Study|Adverse Event|10
258029|NCT01227265|852121|P1|Overall Study|Adverse Event|6
258030|NCT01227265|852119|P3|Overall Study|Lost to Follow-up|3
258031|NCT01227265|852120|P2|Overall Study|Lost to Follow-up|0
258032|NCT01227265|852121|P1|Overall Study|Lost to Follow-up|2
258033|NCT01227265|852119|P3|Overall Study|Withdrawal by Subject|3
258034|NCT01227265|852120|P2|Overall Study|Withdrawal by Subject|7
258035|NCT01227265|852121|P1|Overall Study|Withdrawal by Subject|7
258036|NCT01227265|852119|P3|Overall Study|Protocol Violation|0
258037|NCT01227265|852120|P2|Overall Study|Protocol Violation|1
258038|NCT01227265|852121|P1|Overall Study|Protocol Violation|2
258039|NCT01227265|852119|P3|Overall Study|Did Not Meet Protocol Eligibility|1
258040|NCT01227265|852120|P2|Overall Study|Did Not Meet Protocol Eligibility|0
258041|NCT01227265|852121|P1|Overall Study|Did Not Meet Protocol Eligibility|0
258042|NCT01227265|852119|P3|Overall Study|Administrative|2
258043|NCT01227265|852120|P2|Overall Study|Administrative|0
258044|NCT01227265|852121|P1|Overall Study|Administrative|1
258045|NCT01227265|852119|P3|Overall Study|Did Not Receive Treatment|0
258046|NCT01227265|852120|P2|Overall Study|Did Not Receive Treatment|2
258047|NCT01227265|852121|P1|Overall Study|Did Not Receive Treatment|1
258048|NCT01227018|852158|P1|Overall Study|Withdrew after beginning treatment|4
258049|NCT01227018|852158|P1|Overall Study|Toxicity|2
258050|NCT01227018|852158|P1|Overall Study|Disease progression|9
258051|NCT01226745|852185|P6|Overall Study|Unspecified|1
258052|NCT01226745|852186|P5|Overall Study|Unspecified|3
258053|NCT01226745|852187|P4|Overall Study|Unspecified|4
258054|NCT01226745|852188|P3|Overall Study|Unspecified|8
258055|NCT01226745|852189|P2|Overall Study|Unspecified|7
258056|NCT01226745|852190|P1|Overall Study|Unspecified|6
258057|NCT01226745|852185|P6|Overall Study|Death|1
258058|NCT01226745|852186|P5|Overall Study|Death|0
258059|NCT01226745|852187|P4|Overall Study|Death|0
258060|NCT01226745|852188|P3|Overall Study|Death|0
258061|NCT01226745|852189|P2|Overall Study|Death|0
258062|NCT01226745|852190|P1|Overall Study|Death|1
258063|NCT01226745|852185|P6|Overall Study|Lost to Follow-up|2
258064|NCT01226745|852186|P5|Overall Study|Lost to Follow-up|1
258065|NCT01226745|852187|P4|Overall Study|Lost to Follow-up|1
258066|NCT01226745|852188|P3|Overall Study|Lost to Follow-up|6
258067|NCT01226745|852189|P2|Overall Study|Lost to Follow-up|6
258068|NCT01226745|852190|P1|Overall Study|Lost to Follow-up|2
258069|NCT01226745|852185|P6|Overall Study|Did not complete schedule of assessments|1
258070|NCT01226745|852186|P5|Overall Study|Did not complete schedule of assessments|0
258071|NCT01226745|852187|P4|Overall Study|Did not complete schedule of assessments|0
258072|NCT01226745|852188|P3|Overall Study|Did not complete schedule of assessments|6
258073|NCT01226745|852189|P2|Overall Study|Did not complete schedule of assessments|3
258074|NCT01226745|852190|P1|Overall Study|Did not complete schedule of assessments|8
258075|NCT01226511|852301|P2|Taper Period|Parent/Caregiver Decision|1
258076|NCT01226511|852302|P1|Taper Period|Parent/Caregiver Decision|1
258077|NCT01226511|852301|P2|Taper Period|Protocol Violation|0
258078|NCT01226511|852302|P1|Taper Period|Protocol Violation|1
258079|NCT01226511|852301|P2|Taper Period|Lost to Follow-up|2
258080|NCT01226511|852302|P1|Taper Period|Lost to Follow-up|2
258081|NCT01226511|852301|P2|Taper Period|Adverse Event|0
258082|NCT01226511|852302|P1|Taper Period|Adverse Event|1
258083|NCT01226511|852301|P2|Extension Treatment Period|Sponsor Decision|1
258084|NCT01226511|852302|P1|Extension Treatment Period|Sponsor Decision|1
258085|NCT01226511|852301|P2|Extension Treatment Period|Parent/Caregiver Decision|8
258086|NCT01226511|852302|P1|Extension Treatment Period|Parent/Caregiver Decision|8
258087|NCT01226511|852301|P2|Extension Treatment Period|Withdrawal by Subject|3
258088|NCT01226511|852302|P1|Extension Treatment Period|Withdrawal by Subject|1
258089|NCT01226511|852301|P2|Extension Treatment Period|Protocol Violation|2
258090|NCT01226511|852302|P1|Extension Treatment Period|Protocol Violation|2
258091|NCT01226511|852301|P2|Extension Treatment Period|Lost to Follow-up|3
258092|NCT01226511|852302|P1|Extension Treatment Period|Lost to Follow-up|4
258093|NCT01226511|852301|P2|Extension Treatment Period|Lack of Efficacy|2
258094|NCT01226511|852302|P1|Extension Treatment Period|Lack of Efficacy|3
258095|NCT01226511|852301|P2|Extension Treatment Period|Adverse Event|8
258096|NCT01226511|852302|P1|Extension Treatment Period|Adverse Event|8
258097|NCT01226511|852301|P2|Acute Treatment Period|Withdrawal by Subject|6
258098|NCT01226511|852302|P1|Acute Treatment Period|Withdrawal by Subject|10
258099|NCT01226511|852301|P2|Acute Treatment Period|Protocol Violation|5
258100|NCT01226511|852302|P1|Acute Treatment Period|Protocol Violation|5
258101|NCT01226511|852301|P2|Acute Treatment Period|Parent/caregiver decision|7
258102|NCT01226511|852302|P1|Acute Treatment Period|Parent/caregiver decision|5
258103|NCT01226511|852301|P2|Acute Treatment Period|Lost to Follow-up|6
258104|NCT01226511|852302|P1|Acute Treatment Period|Lost to Follow-up|3
258105|NCT01226511|852301|P2|Acute Treatment Period|Lack of Efficacy|1
258106|NCT01226511|852302|P1|Acute Treatment Period|Lack of Efficacy|2
258107|NCT01226511|852301|P2|Acute Treatment Period|Adverse Event|6
258108|NCT01226511|852302|P1|Acute Treatment Period|Adverse Event|7
258109|NCT01226459|852340|P2|Overall Study|Pregnancy|0
258110|NCT01226459|852341|P1|Overall Study|Pregnancy|1
258111|NCT01226459|852340|P2|Overall Study|Lost to Follow-up|8
258112|NCT01226459|852341|P1|Overall Study|Lost to Follow-up|4
258113|NCT01226459|852340|P2|Overall Study|Withdrawal by Subject|13
258114|NCT01226459|852341|P1|Overall Study|Withdrawal by Subject|10
258115|NCT01226459|852340|P2|Overall Study|Protocol Violation|3
258116|NCT01226459|852341|P1|Overall Study|Protocol Violation|4
258117|NCT01226459|852340|P2|Overall Study|Adverse Event|8
258118|NCT01226459|852341|P1|Overall Study|Adverse Event|2
258119|NCT01226121|852359|P3|Overall Study|Lost to Follow-up|1
258120|NCT01226121|852360|P2|Overall Study|Lost to Follow-up|0
258121|NCT01226121|852361|P1|Overall Study|Lost to Follow-up|2
258122|NCT01226095|852372|P1|Overall Study|Poor compliance|1
258123|NCT01226043|852397|P4|30-week Observational Phase|Physician Decision|2
258124|NCT01226043|852398|P3|30-week Observational Phase|Physician Decision|2
258125|NCT01226043|852399|P2|30-week Observational Phase|Physician Decision|0
258126|NCT01226043|852400|P1|30-week Observational Phase|Physician Decision|0
258127|NCT01226043|852397|P4|30-week Observational Phase|Withdrawal by Subject|7
258128|NCT01226043|852398|P3|30-week Observational Phase|Withdrawal by Subject|1
258129|NCT01226043|852399|P2|30-week Observational Phase|Withdrawal by Subject|0
258130|NCT01226043|852400|P1|30-week Observational Phase|Withdrawal by Subject|0
258131|NCT01226043|852397|P4|30-week Observational Phase|Lost to Follow-up|2
258132|NCT01226043|852398|P3|30-week Observational Phase|Lost to Follow-up|2
258133|NCT01226043|852399|P2|30-week Observational Phase|Lost to Follow-up|0
258134|NCT01226043|852400|P1|30-week Observational Phase|Lost to Follow-up|0
258135|NCT01226043|852397|P4|30-week Observational Phase|Protocol Violation|1
258136|NCT01226043|852398|P3|30-week Observational Phase|Protocol Violation|0
258137|NCT01226043|852399|P2|30-week Observational Phase|Protocol Violation|0
258138|NCT01226043|852400|P1|30-week Observational Phase|Protocol Violation|0
258139|NCT01226043|852397|P4|30-week Observational Phase|Adverse Event|1
258140|NCT01226043|852398|P3|30-week Observational Phase|Adverse Event|1
258141|NCT01226043|852399|P2|30-week Observational Phase|Adverse Event|0
258142|NCT01226043|852400|P1|30-week Observational Phase|Adverse Event|0
258143|NCT01226043|852397|P4|6-week Re-randomization Phase|completed in error|1
258144|NCT01226043|852398|P3|6-week Re-randomization Phase|completed in error|0
258145|NCT01226043|852399|P2|6-week Re-randomization Phase|completed in error|0
258146|NCT01226043|852400|P1|6-week Re-randomization Phase|completed in error|0
258147|NCT01226043|852397|P4|6-week Re-randomization Phase|Physician Decision|2
258148|NCT01226043|852398|P3|6-week Re-randomization Phase|Physician Decision|3
258149|NCT01226043|852399|P2|6-week Re-randomization Phase|Physician Decision|0
258150|NCT01226043|852400|P1|6-week Re-randomization Phase|Physician Decision|0
258151|NCT01226043|852397|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
258152|NCT01226043|852398|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
258153|NCT01226043|852399|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
258154|NCT01226043|852400|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
258155|NCT01226043|852397|P4|6-week Re-randomization Phase|Lost to Follow-up|3
258156|NCT01226043|852398|P3|6-week Re-randomization Phase|Lost to Follow-up|1
258157|NCT01226043|852399|P2|6-week Re-randomization Phase|Lost to Follow-up|0
258158|NCT01226043|852400|P1|6-week Re-randomization Phase|Lost to Follow-up|0
258159|NCT01226043|852397|P4|6-week Re-randomization Phase|Protocol Violation|1
258160|NCT01226043|852398|P3|6-week Re-randomization Phase|Protocol Violation|1
258161|NCT01226043|852399|P2|6-week Re-randomization Phase|Protocol Violation|0
258162|NCT01226043|852400|P1|6-week Re-randomization Phase|Protocol Violation|0
258163|NCT01226043|852397|P4|6-week Re-randomization Phase|Adverse Event|1
258164|NCT01226043|852398|P3|6-week Re-randomization Phase|Adverse Event|1
258165|NCT01226043|852399|P2|6-week Re-randomization Phase|Adverse Event|0
258166|NCT01226043|852400|P1|6-week Re-randomization Phase|Adverse Event|0
258167|NCT01226043|852397|P4|4-week Crossover Phase - Period 2|Physician Decision|0
258168|NCT01226043|852398|P3|4-week Crossover Phase - Period 2|Physician Decision|0
258169|NCT01226043|852399|P2|4-week Crossover Phase - Period 2|Physician Decision|5
258170|NCT01226043|852400|P1|4-week Crossover Phase - Period 2|Physician Decision|4
258171|NCT01226043|852397|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
258172|NCT01226043|852398|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
258173|NCT01226043|852399|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
258174|NCT01226043|852400|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
258175|NCT01226043|852397|P4|4-week Crossover Phase - Period 1|Physician Decision|0
258176|NCT01226043|852398|P3|4-week Crossover Phase - Period 1|Physician Decision|0
258177|NCT01226043|852399|P2|4-week Crossover Phase - Period 1|Physician Decision|6
258178|NCT01226043|852400|P1|4-week Crossover Phase - Period 1|Physician Decision|0
258179|NCT01226043|852397|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
258180|NCT01226043|852398|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
258181|NCT01226043|852399|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
258182|NCT01226043|852400|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
258183|NCT01226043|852397|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
258184|NCT01226043|852398|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
258185|NCT01226043|852399|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
258186|NCT01226043|852400|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
258187|NCT01226043|852397|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
258188|NCT01226043|852398|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
258189|NCT01226043|852399|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
258190|NCT01226043|852400|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
258191|NCT01225991|852438|P1|Overall Study|Withdrawal by Subject|6
258192|NCT01225952|852445|P3|Overall Study|Surgical complications|0
258193|NCT01225952|852446|P2|Overall Study|Surgical complications|0
258194|NCT01225952|852447|P1|Overall Study|Surgical complications|1
258195|NCT01225952|852445|P3|Overall Study|Withdrawal by Subject|5
258196|NCT01225952|852446|P2|Overall Study|Withdrawal by Subject|4
258197|NCT01225952|852447|P1|Overall Study|Withdrawal by Subject|4
258198|NCT01225952|852445|P3|Overall Study|Study Eye Explanted|1
258199|NCT01225952|852446|P2|Overall Study|Study Eye Explanted|0
258200|NCT01225952|852447|P1|Overall Study|Study Eye Explanted|0
258201|NCT01225952|852445|P3|Overall Study|Lost to Follow-up|0
258202|NCT01225952|852446|P2|Overall Study|Lost to Follow-up|0
258203|NCT01225952|852447|P1|Overall Study|Lost to Follow-up|1
258204|NCT01225835|852541|P2|Overall Study|not specified|1
258205|NCT01225835|852542|P1|Overall Study|not specified|1
258206|NCT01225835|852541|P2|Overall Study|Adverse Event|1
258207|NCT01225835|852542|P1|Overall Study|Adverse Event|2
258208|NCT01225835|852541|P2|Overall Study|Did not meet hCG criterion|0
258209|NCT01225835|852542|P1|Overall Study|Did not meet hCG criterion|2
258210|NCT01225835|852541|P2|Overall Study|Completed protocol|1
258211|NCT01225835|852542|P1|Overall Study|Completed protocol|2
258212|NCT01225822|852590|P5|Overall Study|Not Specified|7
258213|NCT01225822|852591|P4|Overall Study|Not Specified|10
258214|NCT01225822|852592|P3|Overall Study|Not Specified|7
258215|NCT01225822|852593|P2|Overall Study|Not Specified|10
258216|NCT01225822|852594|P1|Overall Study|Not Specified|13
258217|NCT01225822|852590|P5|Overall Study|Withdrawal by Subject|6
258218|NCT01225822|852591|P4|Overall Study|Withdrawal by Subject|11
258219|NCT01225822|852592|P3|Overall Study|Withdrawal by Subject|7
258220|NCT01225822|852593|P2|Overall Study|Withdrawal by Subject|7
258221|NCT01225822|852594|P1|Overall Study|Withdrawal by Subject|6
258222|NCT01225822|852590|P5|Overall Study|Lost to Follow-up|0
258223|NCT01225822|852591|P4|Overall Study|Lost to Follow-up|1
258224|NCT01225822|852592|P3|Overall Study|Lost to Follow-up|0
258225|NCT01225822|852593|P2|Overall Study|Lost to Follow-up|0
258226|NCT01225822|852594|P1|Overall Study|Lost to Follow-up|0
258227|NCT01225822|852590|P5|Overall Study|Protocol Violation|4
258228|NCT01225822|852591|P4|Overall Study|Protocol Violation|7
258229|NCT01225822|852592|P3|Overall Study|Protocol Violation|6
258230|NCT01225822|852593|P2|Overall Study|Protocol Violation|8
258231|NCT01225822|852594|P1|Overall Study|Protocol Violation|6
258232|NCT01225822|852590|P5|Overall Study|Adverse Event|14
258233|NCT01225822|852591|P4|Overall Study|Adverse Event|23
258234|NCT01225822|852592|P3|Overall Study|Adverse Event|18
258235|NCT01225822|852593|P2|Overall Study|Adverse Event|31
258236|NCT01225822|852594|P1|Overall Study|Adverse Event|13
258237|NCT01225731|852661|P13|Part 3|Withdrawal by Subject|4
258238|NCT01225731|852662|P12|Part 3|Withdrawal by Subject|6
258239|NCT01225731|852663|P11|Part 3|Withdrawal by Subject|4
258240|NCT01225731|852664|P10|Part 3|Withdrawal by Subject|0
258241|NCT01225731|852665|P9|Part 3|Withdrawal by Subject|0
258242|NCT01225731|852666|P8|Part 3|Withdrawal by Subject|0
258243|NCT01225731|852667|P7|Part 3|Withdrawal by Subject|0
258244|NCT01225731|852668|P6|Part 3|Withdrawal by Subject|0
258245|NCT01225731|852669|P5|Part 3|Withdrawal by Subject|0
258246|NCT01225731|852670|P4|Part 3|Withdrawal by Subject|0
258247|NCT01225731|852671|P3|Part 3|Withdrawal by Subject|0
258248|NCT01225731|852672|P2|Part 3|Withdrawal by Subject|0
258249|NCT01225731|852673|P1|Part 3|Withdrawal by Subject|0
258250|NCT01225731|852661|P13|Part 3|Physician Decision|2
258251|NCT01225731|852662|P12|Part 3|Physician Decision|1
258252|NCT01225731|852663|P11|Part 3|Physician Decision|0
258253|NCT01225731|852664|P10|Part 3|Physician Decision|0
258254|NCT01225731|852665|P9|Part 3|Physician Decision|0
258255|NCT01225731|852666|P8|Part 3|Physician Decision|0
258256|NCT01225731|852667|P7|Part 3|Physician Decision|0
258257|NCT01225731|852668|P6|Part 3|Physician Decision|0
258258|NCT01225731|852669|P5|Part 3|Physician Decision|0
258259|NCT01225731|852670|P4|Part 3|Physician Decision|0
258260|NCT01225731|852671|P3|Part 3|Physician Decision|0
258261|NCT01225731|852672|P2|Part 3|Physician Decision|0
258262|NCT01225731|852673|P1|Part 3|Physician Decision|0
258263|NCT01225731|852661|P13|Part 3|Lost to Follow-up|1
258264|NCT01225731|852662|P12|Part 3|Lost to Follow-up|2
258265|NCT01225731|852663|P11|Part 3|Lost to Follow-up|1
258266|NCT01225731|852664|P10|Part 3|Lost to Follow-up|0
258267|NCT01225731|852665|P9|Part 3|Lost to Follow-up|0
258268|NCT01225731|852666|P8|Part 3|Lost to Follow-up|0
258269|NCT01225731|852667|P7|Part 3|Lost to Follow-up|0
258270|NCT01225731|852668|P6|Part 3|Lost to Follow-up|0
258271|NCT01225731|852669|P5|Part 3|Lost to Follow-up|0
258272|NCT01225731|852670|P4|Part 3|Lost to Follow-up|0
258273|NCT01225731|852671|P3|Part 3|Lost to Follow-up|0
258274|NCT01225731|852672|P2|Part 3|Lost to Follow-up|0
258275|NCT01225731|852673|P1|Part 3|Lost to Follow-up|0
258276|NCT01225731|852661|P13|Part 3|Adverse Event|0
258277|NCT01225731|852662|P12|Part 3|Adverse Event|1
258278|NCT01225731|852663|P11|Part 3|Adverse Event|1
258279|NCT01225731|852664|P10|Part 3|Adverse Event|0
258280|NCT01225731|852665|P9|Part 3|Adverse Event|0
258281|NCT01225731|852666|P8|Part 3|Adverse Event|0
258282|NCT01225731|852667|P7|Part 3|Adverse Event|0
258283|NCT01225731|852668|P6|Part 3|Adverse Event|0
258284|NCT01225731|852669|P5|Part 3|Adverse Event|0
258285|NCT01225731|852670|P4|Part 3|Adverse Event|0
258286|NCT01225731|852671|P3|Part 3|Adverse Event|0
258287|NCT01225731|852672|P2|Part 3|Adverse Event|0
258288|NCT01225731|852673|P1|Part 3|Adverse Event|0
258289|NCT01225731|852661|P13|Part 2|Withdrawal by Subject|0
258290|NCT01225731|852662|P12|Part 2|Withdrawal by Subject|0
258291|NCT01225731|852663|P11|Part 2|Withdrawal by Subject|0
258292|NCT01225731|852664|P10|Part 2|Withdrawal by Subject|0
258293|NCT01225731|852665|P9|Part 2|Withdrawal by Subject|1
258294|NCT01225731|852666|P8|Part 2|Withdrawal by Subject|4
258295|NCT01225731|852667|P7|Part 2|Withdrawal by Subject|3
258296|NCT01225731|852668|P6|Part 2|Withdrawal by Subject|1
258297|NCT01225731|852669|P5|Part 2|Withdrawal by Subject|0
258298|NCT01225731|852670|P4|Part 2|Withdrawal by Subject|0
258299|NCT01225731|852671|P3|Part 2|Withdrawal by Subject|0
258300|NCT01225731|852672|P2|Part 2|Withdrawal by Subject|0
258301|NCT01225731|852673|P1|Part 2|Withdrawal by Subject|0
258302|NCT01225731|852661|P13|Part 2|Physician Decision|0
258303|NCT01225731|852662|P12|Part 2|Physician Decision|0
258304|NCT01225731|852663|P11|Part 2|Physician Decision|0
258305|NCT01225731|852664|P10|Part 2|Physician Decision|0
258306|NCT01225731|852665|P9|Part 2|Physician Decision|2
258307|NCT01225731|852666|P8|Part 2|Physician Decision|2
258308|NCT01225731|852667|P7|Part 2|Physician Decision|0
258309|NCT01225731|852668|P6|Part 2|Physician Decision|0
258310|NCT01225731|852669|P5|Part 2|Physician Decision|0
258311|NCT01225731|852670|P4|Part 2|Physician Decision|0
258312|NCT01225731|852671|P3|Part 2|Physician Decision|0
258313|NCT01225731|852672|P2|Part 2|Physician Decision|0
258314|NCT01225731|852673|P1|Part 2|Physician Decision|0
258315|NCT01225731|852661|P13|Part 2|Lost to Follow-up|0
258316|NCT01225731|852662|P12|Part 2|Lost to Follow-up|0
258317|NCT01225731|852663|P11|Part 2|Lost to Follow-up|0
258318|NCT01225731|852664|P10|Part 2|Lost to Follow-up|0
258319|NCT01225731|852665|P9|Part 2|Lost to Follow-up|1
258320|NCT01225731|852666|P8|Part 2|Lost to Follow-up|3
258321|NCT01225731|852667|P7|Part 2|Lost to Follow-up|0
258322|NCT01225731|852668|P6|Part 2|Lost to Follow-up|0
258323|NCT01225731|852669|P5|Part 2|Lost to Follow-up|0
258324|NCT01225731|852670|P4|Part 2|Lost to Follow-up|0
258325|NCT01225731|852671|P3|Part 2|Lost to Follow-up|0
258326|NCT01225731|852672|P2|Part 2|Lost to Follow-up|0
258327|NCT01225731|852673|P1|Part 2|Lost to Follow-up|0
258328|NCT01225731|852661|P13|Part 2|Pregnancy|0
258329|NCT01225731|852662|P12|Part 2|Pregnancy|0
258330|NCT01225731|852663|P11|Part 2|Pregnancy|0
258331|NCT01225731|852664|P10|Part 2|Pregnancy|0
258332|NCT01225731|852665|P9|Part 2|Pregnancy|1
258333|NCT01225731|852666|P8|Part 2|Pregnancy|0
258334|NCT01225731|852667|P7|Part 2|Pregnancy|1
258335|NCT01225731|852668|P6|Part 2|Pregnancy|0
258336|NCT01225731|852669|P5|Part 2|Pregnancy|0
258337|NCT01225731|852670|P4|Part 2|Pregnancy|0
258338|NCT01225731|852671|P3|Part 2|Pregnancy|0
258339|NCT01225731|852672|P2|Part 2|Pregnancy|0
258340|NCT01225731|852673|P1|Part 2|Pregnancy|0
258341|NCT01225731|852661|P13|Part 2|Lack of Efficacy|0
258342|NCT01225731|852662|P12|Part 2|Lack of Efficacy|0
258343|NCT01225731|852663|P11|Part 2|Lack of Efficacy|0
258344|NCT01225731|852664|P10|Part 2|Lack of Efficacy|0
258345|NCT01225731|852665|P9|Part 2|Lack of Efficacy|3
258346|NCT01225731|852666|P8|Part 2|Lack of Efficacy|12
258347|NCT01225731|852667|P7|Part 2|Lack of Efficacy|0
258348|NCT01225731|852668|P6|Part 2|Lack of Efficacy|1
258349|NCT01225731|852669|P5|Part 2|Lack of Efficacy|0
258350|NCT01225731|852670|P4|Part 2|Lack of Efficacy|0
258351|NCT01225731|852671|P3|Part 2|Lack of Efficacy|0
258352|NCT01225731|852672|P2|Part 2|Lack of Efficacy|0
258353|NCT01225731|852673|P1|Part 2|Lack of Efficacy|0
258354|NCT01225731|852661|P13|Part 2|Adverse Event|0
258355|NCT01225731|852662|P12|Part 2|Adverse Event|0
258356|NCT01225731|852663|P11|Part 2|Adverse Event|0
258357|NCT01225731|852664|P10|Part 2|Adverse Event|0
258358|NCT01225731|852665|P9|Part 2|Adverse Event|2
258359|NCT01225731|852666|P8|Part 2|Adverse Event|4
258360|NCT01225731|852667|P7|Part 2|Adverse Event|4
258361|NCT01225731|852668|P6|Part 2|Adverse Event|0
258362|NCT01225731|852669|P5|Part 2|Adverse Event|0
258363|NCT01225731|852670|P4|Part 2|Adverse Event|0
258364|NCT01225731|852671|P3|Part 2|Adverse Event|0
258365|NCT01225731|852672|P2|Part 2|Adverse Event|0
258366|NCT01225731|852673|P1|Part 2|Adverse Event|0
258367|NCT01225731|852661|P13|Part 2|Protocol Violation|0
258368|NCT01225731|852662|P12|Part 2|Protocol Violation|0
258369|NCT01225731|852663|P11|Part 2|Protocol Violation|0
258370|NCT01225731|852664|P10|Part 2|Protocol Violation|0
258371|NCT01225731|852665|P9|Part 2|Protocol Violation|1
258372|NCT01225731|852666|P8|Part 2|Protocol Violation|0
258373|NCT01225731|852667|P7|Part 2|Protocol Violation|0
258374|NCT01225731|852668|P6|Part 2|Protocol Violation|1
258375|NCT01225731|852669|P5|Part 2|Protocol Violation|0
258376|NCT01225731|852670|P4|Part 2|Protocol Violation|0
258377|NCT01225731|852671|P3|Part 2|Protocol Violation|0
258378|NCT01225731|852672|P2|Part 2|Protocol Violation|0
258379|NCT01225731|852673|P1|Part 2|Protocol Violation|0
258380|NCT01225731|852661|P13|Part 1|Protocol Violation|0
258381|NCT01225731|852662|P12|Part 1|Protocol Violation|0
258382|NCT01225731|852663|P11|Part 1|Protocol Violation|0
258383|NCT01225731|852664|P10|Part 1|Protocol Violation|0
258384|NCT01225731|852665|P9|Part 1|Protocol Violation|0
258385|NCT01225731|852666|P8|Part 1|Protocol Violation|0
258386|NCT01225731|852667|P7|Part 1|Protocol Violation|0
258387|NCT01225731|852668|P6|Part 1|Protocol Violation|0
258388|NCT01225731|852669|P5|Part 1|Protocol Violation|0
258389|NCT01225731|852670|P4|Part 1|Protocol Violation|1
258390|NCT01225731|852671|P3|Part 1|Protocol Violation|0
258391|NCT01225731|852672|P2|Part 1|Protocol Violation|0
258392|NCT01225731|852673|P1|Part 1|Protocol Violation|0
258393|NCT01225731|852661|P13|Part 1|Withdrawal by Subject|0
258394|NCT01225731|852662|P12|Part 1|Withdrawal by Subject|0
258395|NCT01225731|852663|P11|Part 1|Withdrawal by Subject|0
258396|NCT01225731|852664|P10|Part 1|Withdrawal by Subject|0
258397|NCT01225731|852665|P9|Part 1|Withdrawal by Subject|0
258398|NCT01225731|852666|P8|Part 1|Withdrawal by Subject|0
258399|NCT01225731|852667|P7|Part 1|Withdrawal by Subject|0
258400|NCT01225731|852668|P6|Part 1|Withdrawal by Subject|0
258401|NCT01225731|852669|P5|Part 1|Withdrawal by Subject|4
258402|NCT01225731|852670|P4|Part 1|Withdrawal by Subject|0
258403|NCT01225731|852671|P3|Part 1|Withdrawal by Subject|0
258404|NCT01225731|852672|P2|Part 1|Withdrawal by Subject|3
258405|NCT01225731|852673|P1|Part 1|Withdrawal by Subject|0
258406|NCT01225731|852661|P13|Part 1|Adverse Event|0
258407|NCT01225731|852662|P12|Part 1|Adverse Event|0
258408|NCT01225731|852663|P11|Part 1|Adverse Event|0
258409|NCT01225731|852664|P10|Part 1|Adverse Event|0
258410|NCT01225731|852665|P9|Part 1|Adverse Event|0
258411|NCT01225731|852666|P8|Part 1|Adverse Event|0
258412|NCT01225731|852667|P7|Part 1|Adverse Event|0
258413|NCT01225731|852668|P6|Part 1|Adverse Event|0
258414|NCT01225731|852669|P5|Part 1|Adverse Event|1
258415|NCT01225731|852670|P4|Part 1|Adverse Event|1
258416|NCT01225731|852671|P3|Part 1|Adverse Event|1
258417|NCT01225731|852672|P2|Part 1|Adverse Event|2
258418|NCT01225731|852673|P1|Part 1|Adverse Event|1
258419|NCT01225731|852661|P13|Part 1|Did not meet eligibility criteria|0
258420|NCT01225731|852662|P12|Part 1|Did not meet eligibility criteria|0
258421|NCT01225731|852663|P11|Part 1|Did not meet eligibility criteria|0
258422|NCT01225731|852664|P10|Part 1|Did not meet eligibility criteria|0
258423|NCT01225731|852665|P9|Part 1|Did not meet eligibility criteria|0
258424|NCT01225731|852666|P8|Part 1|Did not meet eligibility criteria|0
258425|NCT01225731|852667|P7|Part 1|Did not meet eligibility criteria|0
258426|NCT01225731|852668|P6|Part 1|Did not meet eligibility criteria|0
258427|NCT01225731|852669|P5|Part 1|Did not meet eligibility criteria|1
258428|NCT01225731|852670|P4|Part 1|Did not meet eligibility criteria|0
258429|NCT01225731|852671|P3|Part 1|Did not meet eligibility criteria|0
258430|NCT01225731|852672|P2|Part 1|Did not meet eligibility criteria|0
258431|NCT01225731|852673|P1|Part 1|Did not meet eligibility criteria|1
258432|NCT01225562|852768|P3|Overall Study|Lost to Follow-up|1
258433|NCT01225562|852769|P2|Overall Study|Lost to Follow-up|6
258434|NCT01225562|852770|P1|Overall Study|Lost to Follow-up|3
258435|NCT01225562|852768|P3|Overall Study|Withdrawal by Subject|52
258436|NCT01225562|852769|P2|Overall Study|Withdrawal by Subject|50
258437|NCT01225562|852770|P1|Overall Study|Withdrawal by Subject|52
258438|NCT01225549|852787|P10|Period 6 - Washout|Disallowed medication|0
258439|NCT01225549|852788|P9|Period 6 - Washout|Disallowed medication|0
258440|NCT01225549|852789|P8|Period 6 - Washout|Disallowed medication|0
258441|NCT01225549|852790|P7|Period 6 - Washout|Disallowed medication|0
258442|NCT01225549|852791|P6|Period 6 - Washout|Disallowed medication|0
258443|NCT01225549|852792|P5|Period 6 - Washout|Disallowed medication|0
258444|NCT01225549|852793|P4|Period 6 - Washout|Disallowed medication|1
258445|NCT01225549|852794|P3|Period 6 - Washout|Disallowed medication|0
258446|NCT01225549|852795|P2|Period 6 - Washout|Disallowed medication|0
258447|NCT01225549|852796|P1|Period 6 - Washout|Disallowed medication|0
258448|NCT01225549|852787|P10|Period 4 - Washout|Disallowed medication|0
258449|NCT01225549|852788|P9|Period 4 - Washout|Disallowed medication|0
258450|NCT01225549|852789|P8|Period 4 - Washout|Disallowed medication|0
258451|NCT01225549|852790|P7|Period 4 - Washout|Disallowed medication|0
258452|NCT01225549|852791|P6|Period 4 - Washout|Disallowed medication|0
258453|NCT01225549|852792|P5|Period 4 - Washout|Disallowed medication|0
258454|NCT01225549|852793|P4|Period 4 - Washout|Disallowed medication|0
258455|NCT01225549|852794|P3|Period 4 - Washout|Disallowed medication|0
258456|NCT01225549|852795|P2|Period 4 - Washout|Disallowed medication|1
258457|NCT01225549|852796|P1|Period 4 - Washout|Disallowed medication|0
258458|NCT01225211|852879|P10|Overall Study|Unspecified|1
258459|NCT01225211|852880|P9|Overall Study|Unspecified|0
258460|NCT01225211|852881|P8|Overall Study|Unspecified|0
258461|NCT01225211|852882|P7|Overall Study|Unspecified|0
258462|NCT01225211|852883|P6|Overall Study|Unspecified|0
258463|NCT01225211|852884|P5|Overall Study|Unspecified|0
258464|NCT01225211|852885|P4|Overall Study|Unspecified|0
258465|NCT01225211|852886|P3|Overall Study|Unspecified|0
258466|NCT01225211|852887|P2|Overall Study|Unspecified|0
258467|NCT01225211|852888|P1|Overall Study|Unspecified|0
258468|NCT01225211|852879|P10|Overall Study|Withdrawal by Subject|3
258469|NCT01225211|852880|P9|Overall Study|Withdrawal by Subject|1
258470|NCT01225211|852881|P8|Overall Study|Withdrawal by Subject|0
258471|NCT01225211|852882|P7|Overall Study|Withdrawal by Subject|1
258472|NCT01225211|852883|P6|Overall Study|Withdrawal by Subject|0
258473|NCT01225211|852884|P5|Overall Study|Withdrawal by Subject|0
258474|NCT01225211|852885|P4|Overall Study|Withdrawal by Subject|0
258475|NCT01225211|852886|P3|Overall Study|Withdrawal by Subject|0
258476|NCT01225211|852887|P2|Overall Study|Withdrawal by Subject|0
258477|NCT01225211|852888|P1|Overall Study|Withdrawal by Subject|0
258478|NCT01225211|852879|P10|Overall Study|Adverse Event|1
258479|NCT01225211|852880|P9|Overall Study|Adverse Event|0
258480|NCT01225211|852881|P8|Overall Study|Adverse Event|0
258481|NCT01225211|852882|P7|Overall Study|Adverse Event|0
258482|NCT01225211|852883|P6|Overall Study|Adverse Event|0
258483|NCT01225211|852884|P5|Overall Study|Adverse Event|0
258484|NCT01225211|852885|P4|Overall Study|Adverse Event|0
258485|NCT01225211|852886|P3|Overall Study|Adverse Event|1
258486|NCT01225211|852887|P2|Overall Study|Adverse Event|0
258487|NCT01225211|852888|P1|Overall Study|Adverse Event|0
258488|NCT01225159|852991|P2|Overall Study|Change operation|0
258489|NCT01225159|852992|P1|Overall Study|Change operation|1
258490|NCT01224821|853022|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
258491|NCT01224821|853022|P1|Long-Term Follow-Up|Death|2
258492|NCT01224821|853022|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
258493|NCT01224821|853022|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
258494|NCT01224821|853022|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
258495|NCT01224821|853022|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
258496|NCT01224821|853022|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
258497|NCT01224821|853022|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
258498|NCT01224782|853041|P1|Overall Study|Transplantation|1
258499|NCT01224782|853041|P1|Overall Study|Deterioration|1
258500|NCT01224782|853041|P1|Overall Study|Financial Reasons|1
258501|NCT01224782|853041|P1|Overall Study|Change of Treatment|1
258502|NCT01224782|853041|P1|Overall Study|Start of Dialysis|3
258503|NCT01224782|853041|P1|Overall Study|Not Specified|4
258504|NCT01224782|853041|P1|Overall Study|Noncompliance|10
258505|NCT01224782|853041|P1|Overall Study|Adverse Reaction|11
258506|NCT01224782|853041|P1|Overall Study|Adverse Event|12
258507|NCT01224782|853041|P1|Overall Study|Improvement|13
258508|NCT01224782|853041|P1|Overall Study|Death|14
258509|NCT01224782|853041|P1|Overall Study|Withdrawal by Subject|16
258510|NCT01224782|853041|P1|Overall Study|Lost to Follow-up|177
258511|NCT01224639|853058|P8|Overall Study|Adverse Event|1
258512|NCT01224639|853059|P7|Overall Study|Adverse Event|0
258513|NCT01224639|853060|P6|Overall Study|Adverse Event|0
258514|NCT01224639|853061|P5|Overall Study|Adverse Event|0
258515|NCT01224639|853062|P4|Overall Study|Adverse Event|0
258516|NCT01224639|853063|P3|Overall Study|Adverse Event|0
258517|NCT01224639|853064|P2|Overall Study|Adverse Event|0
258518|NCT01224639|853065|P1|Overall Study|Adverse Event|0
258519|NCT01224639|853058|P8|Overall Study|Withdrawal by Subject|1
258520|NCT01224639|853059|P7|Overall Study|Withdrawal by Subject|1
258521|NCT01224639|853060|P6|Overall Study|Withdrawal by Subject|0
258522|NCT01224639|853061|P5|Overall Study|Withdrawal by Subject|2
258523|NCT01224639|853062|P4|Overall Study|Withdrawal by Subject|0
258524|NCT01224639|853063|P3|Overall Study|Withdrawal by Subject|0
258525|NCT01224639|853064|P2|Overall Study|Withdrawal by Subject|0
258526|NCT01224639|853065|P1|Overall Study|Withdrawal by Subject|0
258527|NCT01224431|853183|P2|Overall Study|no video record|1
258528|NCT01224431|853184|P1|Overall Study|no video record|0
258529|NCT01224431|853183|P2|Overall Study|not randomized|4
258530|NCT01224431|853184|P1|Overall Study|not randomized|0
258531|NCT01224171|853203|P2|Overall Study|Lost to Follow-up|3
258532|NCT01224171|853204|P1|Overall Study|Lost to Follow-up|0
258533|NCT01224171|853203|P2|Overall Study|Withdrawal of Consent|4
258534|NCT01224171|853204|P1|Overall Study|Withdrawal of Consent|2
258535|NCT01224171|853203|P2|Overall Study|Lack of Efficacy|1
258536|NCT01224171|853204|P1|Overall Study|Lack of Efficacy|5
258537|NCT01224171|853203|P2|Overall Study|Protocol Violation|1
258538|NCT01224171|853204|P1|Overall Study|Protocol Violation|0
258539|NCT01224171|853203|P2|Overall Study|Adverse Event|4
258540|NCT01224171|853204|P1|Overall Study|Adverse Event|8
258541|NCT01223937|853239|P2|Overall Study|Not specified|1
258542|NCT01223937|853240|P1|Overall Study|Not specified|4
258543|NCT01223937|853239|P2|Overall Study|Protocol Violation|7
258544|NCT01223937|853240|P1|Overall Study|Protocol Violation|8
258545|NCT01223937|853239|P2|Overall Study|Adverse Event|4
258546|NCT01223937|853240|P1|Overall Study|Adverse Event|1
258547|NCT01223937|853239|P2|Overall Study|Lost to Follow-up|4
258548|NCT01223937|853240|P1|Overall Study|Lost to Follow-up|1
258549|NCT01223937|853239|P2|Overall Study|Withdrawal by Subject|2
258550|NCT01223937|853240|P1|Overall Study|Withdrawal by Subject|3
258551|NCT01223365|853286|P1|Open-label Treatment Period|Physician Decision|2
258552|NCT01223365|853286|P1|Open-label Treatment Period|Starting physical therapy|1
258553|NCT01223365|853286|P1|Open-label Treatment Period|"Out of window"|1
258554|NCT01223365|853286|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
258555|NCT01223365|853286|P1|Open-label Treatment Period|Moved out of area|2
258556|NCT01223365|853286|P1|Open-label Treatment Period|Noncompliance with study procedures|6
258557|NCT01223365|853286|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
258558|NCT01223365|853286|P1|Open-label Treatment Period|Lost to Follow-up|7
258559|NCT01223365|853286|P1|Open-label Treatment Period|Protocol Violation|15
258560|NCT01223365|853286|P1|Open-label Treatment Period|Withdrawal by Subject|19
258561|NCT01223365|853286|P1|Open-label Treatment Period|Lack of Efficacy|2
258562|NCT01223365|853286|P1|Open-label Treatment Period|Adverse Event|39
258563|NCT01223365|853286|P1|Open-label Titration Period|Starting physical therapy|1
258564|NCT01223365|853286|P1|Open-label Titration Period|Noncompliance with study procedures|2
258565|NCT01223365|853286|P1|Open-label Titration Period|Noncompliance with study drug admin|1
258566|NCT01223365|853286|P1|Open-label Titration Period|Lost to Follow-up|2
258567|NCT01223365|853286|P1|Open-label Titration Period|Protocol Violation|1
258568|NCT01223365|853286|P1|Open-label Titration Period|Withdrawal by Subject|5
258569|NCT01223365|853286|P1|Open-label Titration Period|Lack of Efficacy|3
258570|NCT01223365|853286|P1|Open-label Titration Period|Adverse Event|23
258571|NCT01223365|853286|P1|Open-label Titration Period|Enrolled but not treated|1
258572|NCT01223196|853329|P2|Overall Study|Withdrawal by Subject|0
258573|NCT01223196|853330|P1|Overall Study|Withdrawal by Subject|1
258574|NCT01223196|853329|P2|Overall Study|Physician Decision|0
258575|NCT01223196|853330|P1|Overall Study|Physician Decision|1
258576|NCT01223196|853329|P2|Overall Study|Lost to Follow-up|0
258577|NCT01223196|853330|P1|Overall Study|Lost to Follow-up|2
258578|NCT01223027|853342|P2|Overall Study|Study terminated by sponsor|8
258579|NCT01223027|853343|P1|Overall Study|Study terminated by sponsor|2
258580|NCT01223027|853342|P2|Overall Study|New therapy for study indication|8
258581|NCT01223027|853343|P1|Overall Study|New therapy for study indication|17
258582|NCT01223027|853342|P2|Overall Study|Subject/guardian decicion|16
258583|NCT01223027|853343|P1|Overall Study|Subject/guardian decicion|18
258584|NCT01223027|853342|P2|Overall Study|Protocol Violation|1
258585|NCT01223027|853343|P1|Overall Study|Protocol Violation|2
258586|NCT01223027|853342|P2|Overall Study|Progressive Disease|183
258587|NCT01223027|853343|P1|Overall Study|Progressive Disease|167
258588|NCT01223027|853342|P2|Overall Study|Physician Decision|8
258589|NCT01223027|853343|P1|Overall Study|Physician Decision|4
258590|NCT01223027|853342|P2|Overall Study|Lost to Follow-up|1
258591|NCT01223027|853343|P1|Overall Study|Lost to Follow-up|2
258592|NCT01223027|853342|P2|Overall Study|Death|42
258593|NCT01223027|853343|P1|Overall Study|Death|42
258594|NCT01223027|853342|P2|Overall Study|Adverse Event|10
258595|NCT01223027|853343|P1|Overall Study|Adverse Event|20
258596|NCT01222715|853395|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
258597|NCT01222715|853396|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
258598|NCT01222715|853395|P2|Overall Study|Ineligible|1
258599|NCT01222715|853396|P1|Overall Study|Ineligible|0
258600|NCT01222715|853395|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
258601|NCT01222715|853396|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
258602|NCT01222715|853395|P2|Overall Study|Refusal of further protocol therapy|4
258603|NCT01222715|853396|P1|Overall Study|Refusal of further protocol therapy|0
258604|NCT01222715|853395|P2|Overall Study|Physician Decision|2
258605|NCT01222715|853396|P1|Overall Study|Physician Decision|12
258606|NCT01222715|853395|P2|Overall Study|Lack of Efficacy|14
258607|NCT01222715|853396|P1|Overall Study|Lack of Efficacy|22
258608|NCT01222715|853395|P2|Overall Study|Death|1
258609|NCT01222715|853396|P1|Overall Study|Death|0
258610|NCT01222715|853395|P2|Overall Study|Adverse Event|4
258611|NCT01222715|853396|P1|Overall Study|Adverse Event|0
258612|NCT01222533|853435|P1|Overall Study|Other|4
258613|NCT01222533|853435|P1|Overall Study|Withdrawal by Subject|5
258614|NCT01222533|853435|P1|Overall Study|Adverse Event|5
258615|NCT01222520|853574|P2|Double-blind Period|Study medication stolen|0
258616|NCT01222520|853575|P1|Double-blind Period|Study medication stolen|1
258617|NCT01222520|853574|P2|Double-blind Period|Lack of Efficacy|1
258618|NCT01222520|853575|P1|Double-blind Period|Lack of Efficacy|0
258619|NCT01222520|853574|P2|Double-blind Period|Adverse Event|1
258620|NCT01222520|853575|P1|Double-blind Period|Adverse Event|0
258621|NCT01222520|853574|P2|Open-label run-in Period|Number of patients fulfilled|3
258622|NCT01222520|853575|P1|Open-label run-in Period|Number of patients fulfilled|0
258623|NCT01222520|853574|P2|Open-label run-in Period|Blood pressure criteria not met|18
258624|NCT01222520|853575|P1|Open-label run-in Period|Blood pressure criteria not met|0
258625|NCT01222520|853574|P2|Open-label run-in Period|Withdrawal by Subject|2
258626|NCT01222520|853575|P1|Open-label run-in Period|Withdrawal by Subject|0
258627|NCT01222507|853593|P1|Overall Study|Withdrawal by Subject|1
258628|NCT01222507|853593|P1|Overall Study|Physician Decision|1
258629|NCT01222403|853599|P2|Overall Study|Inappropriate enrollment|2
258630|NCT01222403|853600|P1|Overall Study|Inappropriate enrollment|0
258631|NCT01222104|853703|P1|Overall Study|Death|10
258632|NCT01222104|853703|P1|Overall Study|Lost to Follow-up|37
258633|NCT01222078|853717|P1|Overall Study|Early termination of the study|1
258634|NCT01221948|853751|P1|Overall Study|Protocol Violation|4
258635|NCT01221948|853751|P1|Overall Study|Death|1
258636|NCT01221948|853751|P1|Overall Study|not disclosed|2
258637|NCT01221948|853751|P1|Overall Study|Withdrawal by Subject|2
258638|NCT01221948|853751|P1|Overall Study|Physician Decision|5
258639|NCT01221753|853762|P1|Overall Study|Adverse Event|1
258640|NCT01221727|853769|P2|Overall Study|Withdrawal by Subject|1
258641|NCT01221727|853770|P1|Overall Study|Withdrawal by Subject|1
258642|NCT01221727|853769|P2|Overall Study|Physician Decision|0
258643|NCT01221727|853770|P1|Overall Study|Physician Decision|2
258644|NCT01221623|853791|P2|Overall Study|Other|2
258645|NCT01221623|853792|P1|Overall Study|Other|5
258646|NCT01221623|853791|P2|Overall Study|Death|0
258647|NCT01221623|853792|P1|Overall Study|Death|1
258648|NCT01221623|853791|P2|Overall Study|Adverse Event|3
258649|NCT01221623|853792|P1|Overall Study|Adverse Event|6
258650|NCT01221623|853791|P2|Overall Study|Lost to Follow-up|1
258651|NCT01221623|853792|P1|Overall Study|Lost to Follow-up|7
258652|NCT01221623|853791|P2|Overall Study|Withdrawal by Subject|8
258653|NCT01221623|853792|P1|Overall Study|Withdrawal by Subject|19
258654|NCT01221597|853816|P2|Overall Study|Death|0
258655|NCT01221597|853817|P1|Overall Study|Death|2
258656|NCT01221597|853816|P2|Overall Study|Other|4
258657|NCT01221597|853817|P1|Overall Study|Other|3
258658|NCT01221597|853816|P2|Overall Study|Protocol Violation|0
258659|NCT01221597|853817|P1|Overall Study|Protocol Violation|1
258660|NCT01221597|853816|P2|Overall Study|Lost to Follow-up|5
258661|NCT01221597|853817|P1|Overall Study|Lost to Follow-up|6
258662|NCT01221597|853816|P2|Overall Study|Withdrawal by Subject|6
258663|NCT01221597|853817|P1|Overall Study|Withdrawal by Subject|20
258664|NCT01221597|853816|P2|Overall Study|Adverse Event|1
258665|NCT01221597|853817|P1|Overall Study|Adverse Event|4
258666|NCT01221363|853874|P2|Overall Study|Withdrawal by Subject|5
258667|NCT01221363|853875|P1|Overall Study|Withdrawal by Subject|11
258668|NCT01221363|853874|P2|Overall Study|Pregnancy|0
258669|NCT01221363|853875|P1|Overall Study|Pregnancy|1
258670|NCT01221350|853885|P2|Overall Study|Withdrawal by Subject|2
258671|NCT01221350|853886|P1|Overall Study|Withdrawal by Subject|4
258672|NCT01221350|853885|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
258673|NCT01221350|853886|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
258674|NCT01221350|853885|P2|Overall Study|Discontinued intervention (GERD)|0
258675|NCT01221350|853886|P1|Overall Study|Discontinued intervention (GERD)|1
258676|NCT01221285|853945|P1|Overall Study|Withdrawal by Subject|1
258677|NCT01221272|853954|P2|Period 2|Adverse Event|2
258678|NCT01221272|853955|P1|Period 2|Adverse Event|0
258679|NCT01221272|853954|P2|Period 1|Significant Dosing Noncompliance|1
258680|NCT01221272|853955|P1|Period 1|Significant Dosing Noncompliance|0
258681|NCT01221272|853954|P2|Period 1|Consent Withdrawal|1
258682|NCT01221272|853955|P1|Period 1|Consent Withdrawal|0
258683|NCT01221272|853954|P2|Period 1|Adverse Event|0
258684|NCT01221272|853955|P1|Period 1|Adverse Event|2
258685|NCT01221090|853974|P4|Overall Study|Withdrawal by Subject|2
258686|NCT01221090|853975|P3|Overall Study|Withdrawal by Subject|27
258687|NCT01221090|853976|P2|Overall Study|Withdrawal by Subject|22
258688|NCT01221090|853977|P1|Overall Study|Withdrawal by Subject|0
258689|NCT01221090|853974|P4|Overall Study|Non-Compliant or Unable to Contact|20
258690|NCT01221090|853975|P3|Overall Study|Non-Compliant or Unable to Contact|15
258691|NCT01221090|853976|P2|Overall Study|Non-Compliant or Unable to Contact|12
258692|NCT01221090|853977|P1|Overall Study|Non-Compliant or Unable to Contact|15
258693|NCT01220609|854022|P1|Overall Study|Ineligible-Never treated|1
258694|NCT01220609|854022|P1|Overall Study|Ineligible- Wrong cell type|1
258695|NCT01220609|854022|P1|Overall Study|Ineligible-Wrong primary cancer site|1
258696|NCT01220557|854030|P2|Overall Study|attended less than 6 lessons|2
258697|NCT01220557|854031|P1|Overall Study|attended less than 6 lessons|1
258698|NCT01220557|854030|P2|Overall Study|Lost to Follow-up|3
258699|NCT01220557|854031|P1|Overall Study|Lost to Follow-up|5
258700|NCT01220401|854062|P1|Overall Study|Protocol Violation|1
258701|NCT01220401|854062|P1|Overall Study|Withdrawal by Subject|2
258702|NCT01220297|854071|P1|Overall Study|Lost to Follow-up|1
258703|NCT01220297|854071|P1|Overall Study|Death|2
258704|NCT01220180|854088|P1|Overall Study|Randomized but not treated|1
258705|NCT01220180|854088|P1|Overall Study|Death|1
258706|NCT01220180|854088|P1|Overall Study|Lack of Efficacy|22
258707|NCT01220180|854088|P1|Overall Study|Adverse Event|35
258708|NCT01220180|854088|P1|Overall Study|Unspecified|72
258709|NCT01220180|854088|P1|Overall Study|Lost to Follow-up|76
258710|NCT01220128|854118|P7|Overall Study|Consent withdrawn by subject|0
258711|NCT01220128|854119|P6|Overall Study|Consent withdrawn by subject|0
258712|NCT01220128|854120|P5|Overall Study|Consent withdrawn by subject|0
258713|NCT01220128|854121|P4|Overall Study|Consent withdrawn by subject|0
258714|NCT01220128|854122|P3|Overall Study|Consent withdrawn by subject|0
258715|NCT01220128|854123|P2|Overall Study|Consent withdrawn by subject|0
258716|NCT01220128|854124|P1|Overall Study|Consent withdrawn by subject|1
258717|NCT01220128|854118|P7|Overall Study|Unspecified|0
258718|NCT01220128|854119|P6|Overall Study|Unspecified|0
258719|NCT01220128|854120|P5|Overall Study|Unspecified|0
258720|NCT01220128|854121|P4|Overall Study|Unspecified|0
258721|NCT01220128|854122|P3|Overall Study|Unspecified|1
258722|NCT01220128|854123|P2|Overall Study|Unspecified|0
258723|NCT01220128|854124|P1|Overall Study|Unspecified|0
258724|NCT01220128|854118|P7|Overall Study|Adverse event, non-fatal|3
258725|NCT01220128|854119|P6|Overall Study|Adverse event, non-fatal|0
258726|NCT01220128|854120|P5|Overall Study|Adverse event, non-fatal|0
258727|NCT01220128|854121|P4|Overall Study|Adverse event, non-fatal|0
258728|NCT01220128|854122|P3|Overall Study|Adverse event, non-fatal|0
258729|NCT01220128|854123|P2|Overall Study|Adverse event, non-fatal|0
258730|NCT01220128|854124|P1|Overall Study|Adverse event, non-fatal|1
258731|NCT01220128|854118|P7|Overall Study|Adverse event, serious fatal|1
258732|NCT01220128|854119|P6|Overall Study|Adverse event, serious fatal|0
258733|NCT01220128|854120|P5|Overall Study|Adverse event, serious fatal|0
258734|NCT01220128|854121|P4|Overall Study|Adverse event, serious fatal|0
258735|NCT01220128|854122|P3|Overall Study|Adverse event, serious fatal|0
258736|NCT01220128|854123|P2|Overall Study|Adverse event, serious fatal|0
258737|NCT01220128|854124|P1|Overall Study|Adverse event, serious fatal|2
258738|NCT01220128|854118|P7|Overall Study|Sponsor study termination|1
258739|NCT01220128|854119|P6|Overall Study|Sponsor study termination|0
258740|NCT01220128|854120|P5|Overall Study|Sponsor study termination|0
258741|NCT01220128|854121|P4|Overall Study|Sponsor study termination|0
258742|NCT01220128|854122|P3|Overall Study|Sponsor study termination|0
258743|NCT01220128|854123|P2|Overall Study|Sponsor study termination|1
258744|NCT01220128|854124|P1|Overall Study|Sponsor study termination|0
258745|NCT01220128|854118|P7|Overall Study|Progressive disease|0
258746|NCT01220128|854119|P6|Overall Study|Progressive disease|0
258747|NCT01220128|854120|P5|Overall Study|Progressive disease|0
258748|NCT01220128|854121|P4|Overall Study|Progressive disease|0
258749|NCT01220128|854122|P3|Overall Study|Progressive disease|2
258750|NCT01220128|854123|P2|Overall Study|Progressive disease|0
258751|NCT01220128|854124|P1|Overall Study|Progressive disease|0
258752|NCT01219985|854329|P1|Overall Study|Physician Decision|20
258753|NCT01219933|854335|P1|Overall Study|Lack of Efficacy|1
258754|NCT01219933|854335|P1|Overall Study|Protocol Violation|8
258755|NCT01219933|854335|P1|Overall Study|Withdrawal by Subject|5
258756|NCT01219933|854335|P1|Overall Study|GC free|1
258757|NCT01219933|854335|P1|Overall Study|Lost to Follow-up|3
258758|NCT01219933|854335|P1|Overall Study|No LDA maintained|7
258759|NCT01219933|854335|P1|Overall Study|No LDA reached|5
258760|NCT01219933|854335|P1|Overall Study|Adverse Event|8
258761|NCT01218867|854545|P11|Overall Study|Death during treatment|0
258762|NCT01218867|854546|P10|Overall Study|Death during treatment|0
258763|NCT01218867|854547|P9|Overall Study|Death during treatment|0
258764|NCT01218867|854548|P8|Overall Study|Death during treatment|0
258765|NCT01218867|854549|P7|Overall Study|Death during treatment|1
258766|NCT01218867|854550|P6|Overall Study|Death during treatment|0
258767|NCT01218867|854551|P5|Overall Study|Death during treatment|0
258768|NCT01218867|854552|P4|Overall Study|Death during treatment|0
258769|NCT01218867|854553|P3|Overall Study|Death during treatment|0
258770|NCT01218867|854554|P2|Overall Study|Death during treatment|0
258771|NCT01218867|854555|P1|Overall Study|Death during treatment|0
258772|NCT01218802|854603|P2|Overall Study|Incarcerated|0
258773|NCT01218802|854604|P1|Overall Study|Incarcerated|2
258774|NCT01218802|854603|P2|Overall Study|Adverse Event|2
258775|NCT01218802|854604|P1|Overall Study|Adverse Event|0
258776|NCT01218802|854603|P2|Overall Study|Withdrawal by Subject|10
258777|NCT01218802|854604|P1|Overall Study|Withdrawal by Subject|3
258778|NCT01218802|854603|P2|Overall Study|Lost to Follow-up|6
258779|NCT01218802|854604|P1|Overall Study|Lost to Follow-up|5
258780|NCT01218646|854616|P4|Overall Study|Protocol Violation|1
258781|NCT01218646|854617|P3|Overall Study|Protocol Violation|1
258782|NCT01218646|854618|P2|Overall Study|Protocol Violation|0
258783|NCT01218646|854619|P1|Overall Study|Protocol Violation|0
258784|NCT01218646|854616|P4|Overall Study|Lost to Follow-up|0
258785|NCT01218646|854617|P3|Overall Study|Lost to Follow-up|0
258786|NCT01218646|854618|P2|Overall Study|Lost to Follow-up|0
258787|NCT01218646|854619|P1|Overall Study|Lost to Follow-up|1
258788|NCT01218646|854616|P4|Overall Study|Adverse Event|0
258789|NCT01218646|854617|P3|Overall Study|Adverse Event|1
258790|NCT01218646|854618|P2|Overall Study|Adverse Event|0
258791|NCT01218646|854619|P1|Overall Study|Adverse Event|0
258792|NCT01218594|854657|P1|Overall Study|Physician Decision|6
258793|NCT01218594|854657|P1|Overall Study|Adverse Event|2
258794|NCT01218594|854657|P1|Overall Study|Withdrawal by Subject|3
258795|NCT01218594|854657|P1|Overall Study|Death|1
258796|NCT01218477|854665|P4|Overall Study|Maximum clinical benefit|0
258797|NCT01218477|854666|P3|Overall Study|Maximum clinical benefit|0
258798|NCT01218477|854667|P2|Overall Study|Maximum clinical benefit|2
258799|NCT01218477|854668|P1|Overall Study|Maximum clinical benefit|0
258800|NCT01218477|854665|P4|Overall Study|Administrative reason by sponsor|0
258801|NCT01218477|854666|P3|Overall Study|Administrative reason by sponsor|1
258802|NCT01218477|854667|P2|Overall Study|Administrative reason by sponsor|0
258803|NCT01218477|854668|P1|Overall Study|Administrative reason by sponsor|0
258804|NCT01218477|854665|P4|Overall Study|Prepared for cell transplantation|0
258805|NCT01218477|854666|P3|Overall Study|Prepared for cell transplantation|1
258806|NCT01218477|854667|P2|Overall Study|Prepared for cell transplantation|1
258807|NCT01218477|854668|P1|Overall Study|Prepared for cell transplantation|0
258808|NCT01218477|854665|P4|Overall Study|Withdrawal by Subject|0
258809|NCT01218477|854666|P3|Overall Study|Withdrawal by Subject|1
258810|NCT01218477|854667|P2|Overall Study|Withdrawal by Subject|0
258811|NCT01218477|854668|P1|Overall Study|Withdrawal by Subject|0
258812|NCT01218477|854665|P4|Overall Study|No longer meets study criteria|0
258813|NCT01218477|854666|P3|Overall Study|No longer meets study criteria|0
258814|NCT01218477|854667|P2|Overall Study|No longer meets study criteria|0
258815|NCT01218477|854668|P1|Overall Study|No longer meets study criteria|1
258816|NCT01218477|854665|P4|Overall Study|Study drug toxicity|0
258817|NCT01218477|854666|P3|Overall Study|Study drug toxicity|5
258818|NCT01218477|854667|P2|Overall Study|Study drug toxicity|2
258819|NCT01218477|854668|P1|Overall Study|Study drug toxicity|0
258820|NCT01218477|854665|P4|Overall Study|Disease progression|2
258821|NCT01218477|854666|P3|Overall Study|Disease progression|6
258822|NCT01218477|854667|P2|Overall Study|Disease progression|3
258823|NCT01218477|854668|P1|Overall Study|Disease progression|2
258824|NCT01218438|854685|P1|Epoch 4|Withdrawal by Subject|2
258825|NCT01218438|854685|P1|Epoch 4|Physician Decision|1
258826|NCT01218438|854685|P1|Epoch 3|Adverse Event|1
258827|NCT01218438|854685|P1|Epoch 3|Withdrawal by Subject|3
258828|NCT01218438|854685|P1|Epoch 1|Adverse Event|1
258829|NCT01218438|854685|P1|Epoch 1|Physician Decision|2
258830|NCT01218308|854840|P2|Overall Study|Unspecified|21
258831|NCT01218308|854841|P1|Overall Study|Unspecified|14
258832|NCT01218308|854840|P2|Overall Study|Lost to Follow-up|31
258833|NCT01218308|854841|P1|Overall Study|Lost to Follow-up|27
258834|NCT01218308|854840|P2|Overall Study|Withdrawal by Subject|64
258835|NCT01218308|854841|P1|Overall Study|Withdrawal by Subject|61
258836|NCT01218308|854840|P2|Overall Study|Protocol Violation|2
258837|NCT01218308|854841|P1|Overall Study|Protocol Violation|0
258838|NCT01218308|854840|P2|Overall Study|Adverse Event|2
258839|NCT01218308|854841|P1|Overall Study|Adverse Event|1
258840|NCT01218243|854885|P2|Overall Study|Protocol Violation|10
258841|NCT01218243|854886|P1|Overall Study|Protocol Violation|5
258842|NCT01218243|854885|P2|Overall Study|Lost to Follow-up|3
258843|NCT01218243|854886|P1|Overall Study|Lost to Follow-up|3
258844|NCT01218243|854885|P2|Overall Study|Lack of Efficacy|1
258845|NCT01218243|854886|P1|Overall Study|Lack of Efficacy|1
258846|NCT01218100|854904|P4|Overall Study|Other Reason|4
258847|NCT01218100|854905|P3|Overall Study|Other Reason|6
258848|NCT01218100|854906|P2|Overall Study|Other Reason|2
258849|NCT01218100|854907|P1|Overall Study|Other Reason|2
258850|NCT01218100|854904|P4|Overall Study|Lost to Follow-up|1
258851|NCT01218100|854905|P3|Overall Study|Lost to Follow-up|2
258852|NCT01218100|854906|P2|Overall Study|Lost to Follow-up|8
258853|NCT01218100|854907|P1|Overall Study|Lost to Follow-up|3
258854|NCT01218100|854904|P4|Overall Study|Withdrawal by Subject|7
258855|NCT01218100|854905|P3|Overall Study|Withdrawal by Subject|6
258856|NCT01218100|854906|P2|Overall Study|Withdrawal by Subject|2
258857|NCT01218100|854907|P1|Overall Study|Withdrawal by Subject|5
258858|NCT01218100|854904|P4|Overall Study|Protocol Violation|1
258859|NCT01218100|854905|P3|Overall Study|Protocol Violation|1
258860|NCT01218100|854906|P2|Overall Study|Protocol Violation|0
258861|NCT01218100|854907|P1|Overall Study|Protocol Violation|0
258862|NCT01218100|854904|P4|Overall Study|Lack of Efficacy|12
258863|NCT01218100|854905|P3|Overall Study|Lack of Efficacy|5
258864|NCT01218100|854906|P2|Overall Study|Lack of Efficacy|6
258865|NCT01218100|854907|P1|Overall Study|Lack of Efficacy|9
258866|NCT01218100|854904|P4|Overall Study|Adverse Event|7
258867|NCT01218100|854905|P3|Overall Study|Adverse Event|6
258868|NCT01218100|854906|P2|Overall Study|Adverse Event|6
258869|NCT01218100|854907|P1|Overall Study|Adverse Event|4
258870|NCT01218100|854904|P4|Overall Study|Did not meet InclusionExclusion criteria|2
258871|NCT01218100|854905|P3|Overall Study|Did not meet InclusionExclusion criteria|1
258872|NCT01218100|854906|P2|Overall Study|Did not meet InclusionExclusion criteria|1
258873|NCT01218100|854907|P1|Overall Study|Did not meet InclusionExclusion criteria|1
258874|NCT01218087|854923|P2|Overall Study|Transferred|5
258875|NCT01218087|854924|P1|Overall Study|Transferred|8
258876|NCT01218087|854923|P2|Overall Study|Withdrawal by Subject|0
258877|NCT01218087|854924|P1|Overall Study|Withdrawal by Subject|5
258878|NCT01218087|854923|P2|Overall Study|Death|1
258879|NCT01218087|854924|P1|Overall Study|Death|2
258880|NCT01218009|854934|P2|Overall Study|Sponsor terminated study|163
258881|NCT01218009|854935|P1|Overall Study|Sponsor terminated study|161
258882|NCT01218009|854934|P2|Overall Study|Withdrawal by Subject|1
258883|NCT01218009|854935|P1|Overall Study|Withdrawal by Subject|3
258884|NCT01218009|854934|P2|Overall Study|Protocol Violation|1
258885|NCT01218009|854935|P1|Overall Study|Protocol Violation|2
258886|NCT01217957|854958|P5|Phase 2|Withdrawal by Patient|1
258887|NCT01217957|854959|P4|Phase 2|Withdrawal by Patient|0
258888|NCT01217957|854960|P3|Phase 2|Withdrawal by Patient|0
258889|NCT01217957|854961|P2|Phase 2|Withdrawal by Patient|0
258890|NCT01217957|854962|P1|Phase 2|Withdrawal by Patient|0
258891|NCT01217957|854958|P5|Phase 1|Withdrawal by Patient|0
258892|NCT01217957|854959|P4|Phase 1|Withdrawal by Patient|1
258893|NCT01217957|854960|P3|Phase 1|Withdrawal by Patient|1
258894|NCT01217957|854961|P2|Phase 1|Withdrawal by Patient|0
258895|NCT01217957|854962|P1|Phase 1|Withdrawal by Patient|1
258896|NCT01217944|855021|P3|Overall Study|Lack of Efficacy|0
258897|NCT01217944|855022|P2|Overall Study|Lack of Efficacy|0
258898|NCT01217944|855023|P1|Overall Study|Lack of Efficacy|1
258899|NCT01217944|855021|P3|Overall Study|Withdrawal by Subject|0
258900|NCT01217944|855022|P2|Overall Study|Withdrawal by Subject|2
258901|NCT01217944|855023|P1|Overall Study|Withdrawal by Subject|1
258902|NCT01217944|855021|P3|Overall Study|Lost to Follow-up|0
258903|NCT01217944|855022|P2|Overall Study|Lost to Follow-up|1
258904|NCT01217944|855023|P1|Overall Study|Lost to Follow-up|3
258905|NCT01217944|855021|P3|Overall Study|Protocol Violation|0
258906|NCT01217944|855022|P2|Overall Study|Protocol Violation|1
258907|NCT01217944|855023|P1|Overall Study|Protocol Violation|1
258908|NCT01217892|855066|P4|Overall Study|Poor/Non-Compliance|0
258909|NCT01217892|855067|P3|Overall Study|Poor/Non-Compliance|1
258910|NCT01217892|855068|P2|Overall Study|Poor/Non-Compliance|0
258911|NCT01217892|855069|P1|Overall Study|Poor/Non-Compliance|0
258912|NCT01217892|855066|P4|Overall Study|Incorrect enrollment|0
258913|NCT01217892|855067|P3|Overall Study|Incorrect enrollment|1
258914|NCT01217892|855068|P2|Overall Study|Incorrect enrollment|1
258915|NCT01217892|855069|P1|Overall Study|Incorrect enrollment|0
258916|NCT01217892|855066|P4|Overall Study|Subject no longer meets study criteria|8
258917|NCT01217892|855067|P3|Overall Study|Subject no longer meets study criteria|4
258918|NCT01217892|855068|P2|Overall Study|Subject no longer meets study criteria|2
258919|NCT01217892|855069|P1|Overall Study|Subject no longer meets study criteria|5
258920|NCT01217892|855066|P4|Overall Study|Lab value|0
258921|NCT01217892|855067|P3|Overall Study|Lab value|1
258922|NCT01217892|855068|P2|Overall Study|Lab value|0
258923|NCT01217892|855069|P1|Overall Study|Lab value|1
258924|NCT01217892|855066|P4|Overall Study|Withdrawal by Subject|0
258925|NCT01217892|855067|P3|Overall Study|Withdrawal by Subject|1
258926|NCT01217892|855068|P2|Overall Study|Withdrawal by Subject|2
258927|NCT01217892|855069|P1|Overall Study|Withdrawal by Subject|0
258928|NCT01217892|855066|P4|Overall Study|Adverse Event|0
258929|NCT01217892|855067|P3|Overall Study|Adverse Event|1
258930|NCT01217892|855068|P2|Overall Study|Adverse Event|1
258931|NCT01217892|855069|P1|Overall Study|Adverse Event|1
258932|NCT01217801|855115|P2|Period 1|Withdrawal by Subject|1
258933|NCT01217801|855116|P1|Period 1|Withdrawal by Subject|0
258934|NCT01217801|855115|P2|Period 1|Protocol Violation|1
258935|NCT01217801|855116|P1|Period 1|Protocol Violation|1
258936|NCT01217606|855145|P2|9-Month Masked Extension|Lack of Efficacy|0
258937|NCT01217606|855146|P1|9-Month Masked Extension|Lack of Efficacy|2
258938|NCT01217606|855145|P2|9-Month Masked Extension|Pregnancy|0
258939|NCT01217606|855146|P1|9-Month Masked Extension|Pregnancy|1
258940|NCT01217606|855145|P2|9-Month Masked Extension|Lost to Follow-up|0
258941|NCT01217606|855146|P1|9-Month Masked Extension|Lost to Follow-up|1
258942|NCT01217606|855145|P2|9-Month Masked Extension|Personal Reasons|1
258943|NCT01217606|855146|P1|9-Month Masked Extension|Personal Reasons|2
258944|NCT01217606|855145|P2|9-Month Masked Extension|Other Reasons|4
258945|NCT01217606|855146|P1|9-Month Masked Extension|Other Reasons|4
258946|NCT01217606|855145|P2|9-Month Masked Extension|Adverse Event|6
258947|NCT01217606|855146|P1|9-Month Masked Extension|Adverse Event|3
258948|NCT01217606|855145|P2|Initial Treatment Phase|Adverse Event|6
258949|NCT01217606|855146|P1|Initial Treatment Phase|Adverse Event|10
258950|NCT01217606|855145|P2|Initial Treatment Phase|Lack of Efficacy|0
258951|NCT01217606|855146|P1|Initial Treatment Phase|Lack of Efficacy|1
258952|NCT01217606|855145|P2|Initial Treatment Phase|Personal Reasons|2
258953|NCT01217606|855146|P1|Initial Treatment Phase|Personal Reasons|0
258954|NCT01217606|855145|P2|Initial Treatment Phase|Protocol Violation|2
258955|NCT01217606|855146|P1|Initial Treatment Phase|Protocol Violation|3
258956|NCT01217606|855145|P2|Initial Treatment Phase|Other Reasons|2
258957|NCT01217606|855146|P1|Initial Treatment Phase|Other Reasons|0
258958|NCT01217476|855177|P2|Overall Study|Other|0
258959|NCT01217476|855178|P1|Overall Study|Other|2
258960|NCT01217476|855177|P2|Overall Study|Protocol Deviation|0
258961|NCT01217476|855178|P1|Overall Study|Protocol Deviation|1
258962|NCT01217476|855177|P2|Overall Study|Surgery on the Target Limb|2
258963|NCT01217476|855178|P1|Overall Study|Surgery on the Target Limb|0
258964|NCT01217476|855177|P2|Overall Study|Withdrawal by Subject|3
258965|NCT01217476|855178|P1|Overall Study|Withdrawal by Subject|3
258966|NCT01217476|855177|P2|Overall Study|Physician Decision|1
258967|NCT01217476|855178|P1|Overall Study|Physician Decision|0
258968|NCT01217476|855177|P2|Overall Study|Adverse Event|1
258969|NCT01217476|855178|P1|Overall Study|Adverse Event|6
258970|NCT01217463|855188|P2|Overall Study|Other|1
258971|NCT01217463|855189|P1|Overall Study|Other|1
258972|NCT01217463|855188|P2|Overall Study|Patient Non-compliant|0
258973|NCT01217463|855189|P1|Overall Study|Patient Non-compliant|1
258974|NCT01217463|855188|P2|Overall Study|Surgery on the Target Limb|1
258975|NCT01217463|855189|P1|Overall Study|Surgery on the Target Limb|0
258976|NCT01217463|855188|P2|Overall Study|Withdrawal by Subject|0
258977|NCT01217463|855189|P1|Overall Study|Withdrawal by Subject|3
258978|NCT01217463|855188|P2|Overall Study|Physician Decision|1
258979|NCT01217463|855189|P1|Overall Study|Physician Decision|0
258980|NCT01217463|855188|P2|Overall Study|Adverse Event|5
258981|NCT01217463|855189|P1|Overall Study|Adverse Event|8
258982|NCT01217112|855216|P5|Overall Study|Physician Decision|1
258983|NCT01217112|855217|P4|Overall Study|Physician Decision|0
258984|NCT01217112|855218|P3|Overall Study|Physician Decision|0
258985|NCT01217112|855219|P2|Overall Study|Physician Decision|0
258986|NCT01217112|855220|P1|Overall Study|Physician Decision|0
258987|NCT01217112|855216|P5|Overall Study|Withdrawal by Subject|0
258988|NCT01217112|855217|P4|Overall Study|Withdrawal by Subject|0
258989|NCT01217112|855218|P3|Overall Study|Withdrawal by Subject|1
258990|NCT01217112|855219|P2|Overall Study|Withdrawal by Subject|0
258991|NCT01217112|855220|P1|Overall Study|Withdrawal by Subject|0
258992|NCT01217112|855216|P5|Overall Study|Adverse Event|0
258993|NCT01217112|855217|P4|Overall Study|Adverse Event|2
258994|NCT01217112|855218|P3|Overall Study|Adverse Event|0
258995|NCT01217112|855219|P2|Overall Study|Adverse Event|2
258996|NCT01217112|855220|P1|Overall Study|Adverse Event|0
258997|NCT01217073|855453|P8|Extension Period|Withdrawal by Subject|8
258998|NCT01217073|855454|P7|Extension Period|Withdrawal by Subject|30
258999|NCT01217073|855455|P6|Extension Period|Withdrawal by Subject|0
259000|NCT01217073|855456|P5|Extension Period|Withdrawal by Subject|0
259001|NCT01217073|855457|P4|Extension Period|Withdrawal by Subject|0
259002|NCT01217073|855458|P3|Extension Period|Withdrawal by Subject|0
259003|NCT01217073|855459|P2|Extension Period|Withdrawal by Subject|0
259004|NCT01217073|855460|P1|Extension Period|Withdrawal by Subject|0
259005|NCT01217073|855453|P8|Extension Period|Site discontinued study participation|2
259006|NCT01217073|855454|P7|Extension Period|Site discontinued study participation|7
259007|NCT01217073|855455|P6|Extension Period|Site discontinued study participation|0
259008|NCT01217073|855456|P5|Extension Period|Site discontinued study participation|0
259009|NCT01217073|855457|P4|Extension Period|Site discontinued study participation|0
259010|NCT01217073|855458|P3|Extension Period|Site discontinued study participation|0
259011|NCT01217073|855459|P2|Extension Period|Site discontinued study participation|0
259012|NCT01217073|855460|P1|Extension Period|Site discontinued study participation|0
259013|NCT01217073|855453|P8|Extension Period|Protocol Violation|1
259014|NCT01217073|855454|P7|Extension Period|Protocol Violation|2
259015|NCT01217073|855455|P6|Extension Period|Protocol Violation|0
259016|NCT01217073|855456|P5|Extension Period|Protocol Violation|0
259017|NCT01217073|855457|P4|Extension Period|Protocol Violation|0
259018|NCT01217073|855458|P3|Extension Period|Protocol Violation|0
259019|NCT01217073|855459|P2|Extension Period|Protocol Violation|0
259020|NCT01217073|855460|P1|Extension Period|Protocol Violation|0
259021|NCT01217073|855453|P8|Extension Period|Physician Decision|1
259022|NCT01217073|855454|P7|Extension Period|Physician Decision|4
259023|NCT01217073|855455|P6|Extension Period|Physician Decision|0
259024|NCT01217073|855456|P5|Extension Period|Physician Decision|0
259025|NCT01217073|855457|P4|Extension Period|Physician Decision|0
259026|NCT01217073|855458|P3|Extension Period|Physician Decision|0
259027|NCT01217073|855459|P2|Extension Period|Physician Decision|0
259028|NCT01217073|855460|P1|Extension Period|Physician Decision|0
259029|NCT01217073|855453|P8|Extension Period|Non-compliance with study drug|1
259030|NCT01217073|855454|P7|Extension Period|Non-compliance with study drug|0
259031|NCT01217073|855455|P6|Extension Period|Non-compliance with study drug|0
259032|NCT01217073|855456|P5|Extension Period|Non-compliance with study drug|0
259033|NCT01217073|855457|P4|Extension Period|Non-compliance with study drug|0
259034|NCT01217073|855458|P3|Extension Period|Non-compliance with study drug|0
259035|NCT01217073|855459|P2|Extension Period|Non-compliance with study drug|0
259036|NCT01217073|855460|P1|Extension Period|Non-compliance with study drug|0
259037|NCT01217073|855453|P8|Extension Period|Lost to Follow-up|1
259038|NCT01217073|855454|P7|Extension Period|Lost to Follow-up|9
259039|NCT01217073|855455|P6|Extension Period|Lost to Follow-up|0
259040|NCT01217073|855456|P5|Extension Period|Lost to Follow-up|0
259041|NCT01217073|855457|P4|Extension Period|Lost to Follow-up|0
259042|NCT01217073|855458|P3|Extension Period|Lost to Follow-up|0
259043|NCT01217073|855459|P2|Extension Period|Lost to Follow-up|0
259044|NCT01217073|855460|P1|Extension Period|Lost to Follow-up|0
259045|NCT01217073|855453|P8|Extension Period|Lack of Efficacy|0
259046|NCT01217073|855454|P7|Extension Period|Lack of Efficacy|3
259047|NCT01217073|855455|P6|Extension Period|Lack of Efficacy|0
259048|NCT01217073|855456|P5|Extension Period|Lack of Efficacy|0
259049|NCT01217073|855457|P4|Extension Period|Lack of Efficacy|0
259050|NCT01217073|855458|P3|Extension Period|Lack of Efficacy|0
259051|NCT01217073|855459|P2|Extension Period|Lack of Efficacy|0
259052|NCT01217073|855460|P1|Extension Period|Lack of Efficacy|0
259053|NCT01217073|855453|P8|Extension Period|Excluded medication|0
259054|NCT01217073|855454|P7|Extension Period|Excluded medication|2
259055|NCT01217073|855455|P6|Extension Period|Excluded medication|0
259056|NCT01217073|855456|P5|Extension Period|Excluded medication|0
259057|NCT01217073|855457|P4|Extension Period|Excluded medication|0
259058|NCT01217073|855458|P3|Extension Period|Excluded medication|0
259059|NCT01217073|855459|P2|Extension Period|Excluded medication|0
259060|NCT01217073|855460|P1|Extension Period|Excluded medication|0
259061|NCT01217073|855453|P8|Extension Period|Death|0
259062|NCT01217073|855454|P7|Extension Period|Death|1
259063|NCT01217073|855455|P6|Extension Period|Death|0
259064|NCT01217073|855456|P5|Extension Period|Death|0
259065|NCT01217073|855457|P4|Extension Period|Death|0
259066|NCT01217073|855458|P3|Extension Period|Death|0
259067|NCT01217073|855459|P2|Extension Period|Death|0
259068|NCT01217073|855460|P1|Extension Period|Death|0
259069|NCT01217073|855453|P8|Extension Period|Creatinine/eGFR|1
259070|NCT01217073|855454|P7|Extension Period|Creatinine/eGFR|11
259071|NCT01217073|855455|P6|Extension Period|Creatinine/eGFR|0
259072|NCT01217073|855456|P5|Extension Period|Creatinine/eGFR|0
259073|NCT01217073|855457|P4|Extension Period|Creatinine/eGFR|0
259074|NCT01217073|855458|P3|Extension Period|Creatinine/eGFR|0
259075|NCT01217073|855459|P2|Extension Period|Creatinine/eGFR|0
259076|NCT01217073|855460|P1|Extension Period|Creatinine/eGFR|0
259077|NCT01217073|855453|P8|Extension Period|Contraindication to study medication|0
259078|NCT01217073|855454|P7|Extension Period|Contraindication to study medication|1
259079|NCT01217073|855455|P6|Extension Period|Contraindication to study medication|0
259080|NCT01217073|855456|P5|Extension Period|Contraindication to study medication|0
259081|NCT01217073|855457|P4|Extension Period|Contraindication to study medication|0
259082|NCT01217073|855458|P3|Extension Period|Contraindication to study medication|0
259083|NCT01217073|855459|P2|Extension Period|Contraindication to study medication|0
259084|NCT01217073|855460|P1|Extension Period|Contraindication to study medication|0
259085|NCT01217073|855453|P8|Extension Period|ALT/AST|0
259086|NCT01217073|855454|P7|Extension Period|ALT/AST|2
259087|NCT01217073|855455|P6|Extension Period|ALT/AST|0
259088|NCT01217073|855456|P5|Extension Period|ALT/AST|0
259089|NCT01217073|855457|P4|Extension Period|ALT/AST|0
259090|NCT01217073|855458|P3|Extension Period|ALT/AST|0
259091|NCT01217073|855459|P2|Extension Period|ALT/AST|0
259092|NCT01217073|855460|P1|Extension Period|ALT/AST|0
259093|NCT01217073|855453|P8|Extension Period|Adverse Event|5
259094|NCT01217073|855454|P7|Extension Period|Adverse Event|19
259095|NCT01217073|855455|P6|Extension Period|Adverse Event|0
259096|NCT01217073|855456|P5|Extension Period|Adverse Event|0
259097|NCT01217073|855457|P4|Extension Period|Adverse Event|0
259098|NCT01217073|855458|P3|Extension Period|Adverse Event|0
259099|NCT01217073|855459|P2|Extension Period|Adverse Event|0
259100|NCT01217073|855460|P1|Extension Period|Adverse Event|0
259101|NCT01217073|855453|P8|Base Period|Withdrawal by Subject|0
259102|NCT01217073|855454|P7|Base Period|Withdrawal by Subject|0
259103|NCT01217073|855455|P6|Base Period|Withdrawal by Subject|5
259104|NCT01217073|855456|P5|Base Period|Withdrawal by Subject|5
259105|NCT01217073|855457|P4|Base Period|Withdrawal by Subject|1
259106|NCT01217073|855458|P3|Base Period|Withdrawal by Subject|5
259107|NCT01217073|855459|P2|Base Period|Withdrawal by Subject|5
259108|NCT01217073|855460|P1|Base Period|Withdrawal by Subject|4
259109|NCT01217073|855453|P8|Base Period|Protocol Violation|0
259110|NCT01217073|855454|P7|Base Period|Protocol Violation|0
259111|NCT01217073|855455|P6|Base Period|Protocol Violation|2
259112|NCT01217073|855456|P5|Base Period|Protocol Violation|1
259113|NCT01217073|855457|P4|Base Period|Protocol Violation|0
259114|NCT01217073|855458|P3|Base Period|Protocol Violation|0
259115|NCT01217073|855459|P2|Base Period|Protocol Violation|0
259116|NCT01217073|855460|P1|Base Period|Protocol Violation|1
259117|NCT01217073|855453|P8|Base Period|Physician Decision|0
259118|NCT01217073|855454|P7|Base Period|Physician Decision|0
259119|NCT01217073|855455|P6|Base Period|Physician Decision|0
259120|NCT01217073|855456|P5|Base Period|Physician Decision|1
259121|NCT01217073|855457|P4|Base Period|Physician Decision|0
259122|NCT01217073|855458|P3|Base Period|Physician Decision|0
259123|NCT01217073|855459|P2|Base Period|Physician Decision|0
259124|NCT01217073|855460|P1|Base Period|Physician Decision|0
259125|NCT01217073|855453|P8|Base Period|Lost to Follow-up|0
259126|NCT01217073|855454|P7|Base Period|Lost to Follow-up|0
259127|NCT01217073|855455|P6|Base Period|Lost to Follow-up|0
259128|NCT01217073|855456|P5|Base Period|Lost to Follow-up|3
259129|NCT01217073|855457|P4|Base Period|Lost to Follow-up|1
259130|NCT01217073|855458|P3|Base Period|Lost to Follow-up|1
259131|NCT01217073|855459|P2|Base Period|Lost to Follow-up|0
259132|NCT01217073|855460|P1|Base Period|Lost to Follow-up|0
259133|NCT01217073|855453|P8|Base Period|Lack of Efficacy|0
259134|NCT01217073|855454|P7|Base Period|Lack of Efficacy|0
259135|NCT01217073|855455|P6|Base Period|Lack of Efficacy|1
259136|NCT01217073|855456|P5|Base Period|Lack of Efficacy|0
259137|NCT01217073|855457|P4|Base Period|Lack of Efficacy|0
259138|NCT01217073|855458|P3|Base Period|Lack of Efficacy|0
259139|NCT01217073|855459|P2|Base Period|Lack of Efficacy|0
259140|NCT01217073|855460|P1|Base Period|Lack of Efficacy|0
259141|NCT01217073|855453|P8|Base Period|Excluded medication|0
259142|NCT01217073|855454|P7|Base Period|Excluded medication|0
259143|NCT01217073|855455|P6|Base Period|Excluded medication|0
259144|NCT01217073|855456|P5|Base Period|Excluded medication|1
259145|NCT01217073|855457|P4|Base Period|Excluded medication|0
259146|NCT01217073|855458|P3|Base Period|Excluded medication|0
259147|NCT01217073|855459|P2|Base Period|Excluded medication|0
259148|NCT01217073|855460|P1|Base Period|Excluded medication|0
259149|NCT01217073|855453|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
259150|NCT01217073|855454|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
259151|NCT01217073|855455|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
259152|NCT01217073|855456|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
259153|NCT01217073|855457|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
259154|NCT01217073|855458|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
259155|NCT01217073|855459|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
259156|NCT01217073|855460|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
259157|NCT01217073|855453|P8|Base Period|Adverse Event|0
259158|NCT01217073|855454|P7|Base Period|Adverse Event|0
259159|NCT01217073|855455|P6|Base Period|Adverse Event|1
259160|NCT01217073|855456|P5|Base Period|Adverse Event|4
259161|NCT01217073|855457|P4|Base Period|Adverse Event|0
259162|NCT01217073|855458|P3|Base Period|Adverse Event|1
259163|NCT01217073|855459|P2|Base Period|Adverse Event|0
259164|NCT01217073|855460|P1|Base Period|Adverse Event|1
259165|NCT01216319|855649|P1|Overall Study|Unanticipated chemo for breast cancer|2
259166|NCT01216319|855649|P1|Overall Study|Lost to Follow-up|2
259167|NCT01216163|855666|P3|Overall Study|Withdrawal by Subject|0
259168|NCT01216163|855667|P2|Overall Study|Withdrawal by Subject|1
259169|NCT01216163|855668|P1|Overall Study|Withdrawal by Subject|1
259170|NCT01216072|855720|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
259171|NCT01216072|855721|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
259172|NCT01216072|855720|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
259173|NCT01216072|855721|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
259174|NCT01216072|855720|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
259175|NCT01216072|855721|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
259176|NCT01216072|855720|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
259177|NCT01216072|855721|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
259178|NCT01216072|855720|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
259179|NCT01216072|855721|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
259180|NCT01216072|855720|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
259181|NCT01216072|855721|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
259182|NCT01216072|855720|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
259183|NCT01216072|855721|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
259184|NCT01216072|855720|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
259185|NCT01216072|855721|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
259186|NCT01216072|855720|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
259187|NCT01216072|855721|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
259188|NCT01216072|855720|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
259189|NCT01216072|855721|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
259190|NCT01215981|855749|P2|Overall Study|Withdrawal by Subject|0
259191|NCT01215981|855750|P1|Overall Study|Withdrawal by Subject|1
259192|NCT01215981|855749|P2|Overall Study|Protocol Violation|0
259193|NCT01215981|855750|P1|Overall Study|Protocol Violation|1
259194|NCT01215981|855749|P2|Overall Study|Physician Decision|1
259195|NCT01215981|855750|P1|Overall Study|Physician Decision|0
259196|NCT01215968|855760|P2|Overall Study|Not received study drug|1
259197|NCT01215968|855761|P1|Overall Study|Not received study drug|0
259198|NCT01215968|855760|P2|Overall Study|Protocol Violation|4
259199|NCT01215968|855761|P1|Overall Study|Protocol Violation|2
259200|NCT01215968|855760|P2|Overall Study|Adverse Event|2
259201|NCT01215968|855761|P1|Overall Study|Adverse Event|0
259202|NCT01215955|855781|P4|Overall Study|Quality Issues|2
259203|NCT01215955|855782|P3|Overall Study|Quality Issues|3
259204|NCT01215955|855783|P2|Overall Study|Quality Issues|0
259205|NCT01215955|855784|P1|Overall Study|Quality Issues|0
259206|NCT01215955|855781|P4|Overall Study|Withdrawal by Subject|9
259207|NCT01215955|855782|P3|Overall Study|Withdrawal by Subject|13
259208|NCT01215955|855783|P2|Overall Study|Withdrawal by Subject|15
259209|NCT01215955|855784|P1|Overall Study|Withdrawal by Subject|14
259210|NCT01215955|855781|P4|Overall Study|Sponsor Decision|1
259211|NCT01215955|855782|P3|Overall Study|Sponsor Decision|0
259212|NCT01215955|855783|P2|Overall Study|Sponsor Decision|2
259213|NCT01215955|855784|P1|Overall Study|Sponsor Decision|1
259214|NCT01215955|855781|P4|Overall Study|Protocol Violation|8
259215|NCT01215955|855782|P3|Overall Study|Protocol Violation|8
259216|NCT01215955|855783|P2|Overall Study|Protocol Violation|13
259217|NCT01215955|855784|P1|Overall Study|Protocol Violation|17
259218|NCT01215955|855781|P4|Overall Study|Physician Decision|11
259219|NCT01215955|855782|P3|Overall Study|Physician Decision|8
259220|NCT01215955|855783|P2|Overall Study|Physician Decision|10
259221|NCT01215955|855784|P1|Overall Study|Physician Decision|4
259222|NCT01215955|855781|P4|Overall Study|Lost to Follow-up|9
259223|NCT01215955|855782|P3|Overall Study|Lost to Follow-up|8
259224|NCT01215955|855783|P2|Overall Study|Lost to Follow-up|4
259225|NCT01215955|855784|P1|Overall Study|Lost to Follow-up|4
259226|NCT01215955|855781|P4|Overall Study|Lack of Efficacy|0
259227|NCT01215955|855782|P3|Overall Study|Lack of Efficacy|1
259228|NCT01215955|855783|P2|Overall Study|Lack of Efficacy|2
259229|NCT01215955|855784|P1|Overall Study|Lack of Efficacy|1
259230|NCT01215955|855781|P4|Overall Study|Entry Criteria Not Met|7
259231|NCT01215955|855782|P3|Overall Study|Entry Criteria Not Met|4
259232|NCT01215955|855783|P2|Overall Study|Entry Criteria Not Met|3
259233|NCT01215955|855784|P1|Overall Study|Entry Criteria Not Met|1
259234|NCT01215955|855781|P4|Overall Study|Death|3
259235|NCT01215955|855782|P3|Overall Study|Death|1
259236|NCT01215955|855783|P2|Overall Study|Death|0
259237|NCT01215955|855784|P1|Overall Study|Death|2
259238|NCT01215955|855781|P4|Overall Study|Adverse Event|3
259239|NCT01215955|855782|P3|Overall Study|Adverse Event|2
259240|NCT01215955|855783|P2|Overall Study|Adverse Event|4
259241|NCT01215955|855784|P1|Overall Study|Adverse Event|1
259242|NCT01215851|855865|P6|Follow up Period|Lost to Follow-up|1
259243|NCT01215851|855866|P5|Follow up Period|Lost to Follow-up|0
259244|NCT01215851|855867|P4|Follow up Period|Lost to Follow-up|0
259245|NCT01215851|855868|P3|Follow up Period|Lost to Follow-up|0
259246|NCT01215851|855869|P2|Follow up Period|Lost to Follow-up|0
259247|NCT01215851|855870|P1|Follow up Period|Lost to Follow-up|0
259248|NCT01215851|855865|P6|Treatment Period|Adverse Event|1
259249|NCT01215851|855866|P5|Treatment Period|Adverse Event|0
259250|NCT01215851|855867|P4|Treatment Period|Adverse Event|3
259251|NCT01215851|855868|P3|Treatment Period|Adverse Event|1
259252|NCT01215851|855869|P2|Treatment Period|Adverse Event|1
259253|NCT01215851|855870|P1|Treatment Period|Adverse Event|1
259254|NCT01215734|855929|P2|Overall Study|Death|1
259255|NCT01215734|855930|P1|Overall Study|Death|0
259256|NCT01215721|855938|P1|Overall Study|Adverse Event|2
259257|NCT01215513|856053|P1|Overall Study|Miscellaneous reasons (CS42A)|2
259258|NCT01215513|856053|P1|Overall Study|Withdrawal by subject (CS42A)|5
259259|NCT01215513|856053|P1|Overall Study|Physician decision (CS42A)|6
259260|NCT01215513|856053|P1|Overall Study|Adverse event (CS42A)|2
259261|NCT01215513|856053|P1|Overall Study|Not enrolled from CS42 to CS42A|21
259262|NCT01215513|856053|P1|Overall Study|Not completed CS42|9
259263|NCT01215435|856062|P2|Overall Study|Unclassified|5
259264|NCT01215435|856063|P1|Overall Study|Unclassified|5
259265|NCT01215435|856062|P2|Overall Study|Lost to Follow-up|0
259266|NCT01215435|856063|P1|Overall Study|Lost to Follow-up|3
259267|NCT01215435|856062|P2|Overall Study|Withdrawal Criteria|11
259268|NCT01215435|856063|P1|Overall Study|Withdrawal Criteria|8
259269|NCT01215435|856062|P2|Overall Study|Protocol Violation|0
259270|NCT01215435|856063|P1|Overall Study|Protocol Violation|2
259271|NCT01215435|856062|P2|Overall Study|Adverse Event|0
259272|NCT01215435|856063|P1|Overall Study|Adverse Event|1
259273|NCT01215422|856077|P4|Overall Study|Did not complete all intubations|0
259274|NCT01215422|856078|P3|Overall Study|Did not complete all intubations|0
259275|NCT01215422|856079|P2|Overall Study|Did not complete all intubations|0
259276|NCT01215422|856080|P1|Overall Study|Did not complete all intubations|7
259277|NCT01215422|856077|P4|Overall Study|Failed intubations|8
259278|NCT01215422|856078|P3|Overall Study|Failed intubations|3
259279|NCT01215422|856079|P2|Overall Study|Failed intubations|0
259280|NCT01215422|856080|P1|Overall Study|Failed intubations|0
259281|NCT01215422|856077|P4|Overall Study|Relocation|0
259282|NCT01215422|856078|P3|Overall Study|Relocation|0
259283|NCT01215422|856079|P2|Overall Study|Relocation|0
259284|NCT01215422|856080|P1|Overall Study|Relocation|1
259285|NCT01215357|856102|P1|Overall Study|Protocol Violation|9
259286|NCT01215357|856102|P1|Overall Study|Withdrawal by Subject|3
259287|NCT01215227|856210|P6|Overall Study|Randomized but not treated|1
259288|NCT01215227|856211|P5|Overall Study|Randomized but not treated|0
259289|NCT01215227|856212|P4|Overall Study|Randomized but not treated|1
259290|NCT01215227|856213|P3|Overall Study|Randomized but not treated|1
259291|NCT01215227|856214|P2|Overall Study|Randomized but not treated|0
259292|NCT01215227|856215|P1|Overall Study|Randomized but not treated|0
259293|NCT01215227|856210|P6|Overall Study|Missing Status|0
259294|NCT01215227|856211|P5|Overall Study|Missing Status|0
259295|NCT01215227|856212|P4|Overall Study|Missing Status|0
259296|NCT01215227|856213|P3|Overall Study|Missing Status|0
259297|NCT01215227|856214|P2|Overall Study|Missing Status|1
259298|NCT01215227|856215|P1|Overall Study|Missing Status|0
259299|NCT01215227|856210|P6|Overall Study|Administrative|40
259300|NCT01215227|856211|P5|Overall Study|Administrative|28
259301|NCT01215227|856212|P4|Overall Study|Administrative|24
259302|NCT01215227|856213|P3|Overall Study|Administrative|42
259303|NCT01215227|856214|P2|Overall Study|Administrative|73
259304|NCT01215227|856215|P1|Overall Study|Administrative|83
259305|NCT01215227|856210|P6|Overall Study|Non-Compliance With Protocol|0
259306|NCT01215227|856211|P5|Overall Study|Non-Compliance With Protocol|0
259307|NCT01215227|856212|P4|Overall Study|Non-Compliance With Protocol|0
259308|NCT01215227|856213|P3|Overall Study|Non-Compliance With Protocol|1
259309|NCT01215227|856214|P2|Overall Study|Non-Compliance With Protocol|6
259310|NCT01215227|856215|P1|Overall Study|Non-Compliance With Protocol|2
259311|NCT01215227|856210|P6|Overall Study|Subject Withdrew Consent|8
259312|NCT01215227|856211|P5|Overall Study|Subject Withdrew Consent|11
259313|NCT01215227|856212|P4|Overall Study|Subject Withdrew Consent|10
259314|NCT01215227|856213|P3|Overall Study|Subject Withdrew Consent|7
259315|NCT01215227|856214|P2|Overall Study|Subject Withdrew Consent|20
259316|NCT01215227|856215|P1|Overall Study|Subject Withdrew Consent|16
259317|NCT01215227|856210|P6|Overall Study|Lost to Follow-up|2
259318|NCT01215227|856211|P5|Overall Study|Lost to Follow-up|1
259319|NCT01215227|856212|P4|Overall Study|Lost to Follow-up|1
259320|NCT01215227|856213|P3|Overall Study|Lost to Follow-up|1
259321|NCT01215227|856214|P2|Overall Study|Lost to Follow-up|4
259322|NCT01215227|856215|P1|Overall Study|Lost to Follow-up|1
259323|NCT01215227|856210|P6|Overall Study|Treatment Failure|1
259324|NCT01215227|856211|P5|Overall Study|Treatment Failure|1
259325|NCT01215227|856212|P4|Overall Study|Treatment Failure|5
259326|NCT01215227|856213|P3|Overall Study|Treatment Failure|1
259327|NCT01215227|856214|P2|Overall Study|Treatment Failure|4
259328|NCT01215227|856215|P1|Overall Study|Treatment Failure|8
259329|NCT01215227|856210|P6|Overall Study|Adverse Event|6
259330|NCT01215227|856211|P5|Overall Study|Adverse Event|7
259331|NCT01215227|856212|P4|Overall Study|Adverse Event|8
259332|NCT01215227|856213|P3|Overall Study|Adverse Event|4
259333|NCT01215227|856214|P2|Overall Study|Adverse Event|11
259334|NCT01215227|856215|P1|Overall Study|Adverse Event|11
259335|NCT01215097|856334|P2|Overall Study|patient's private reason|1
259336|NCT01215097|856335|P1|Overall Study|patient's private reason|1
259337|NCT01215097|856334|P2|Overall Study|patient's refusal to come|2
259338|NCT01215097|856335|P1|Overall Study|patient's refusal to come|2
259339|NCT01215097|856334|P2|Overall Study|Lack of Efficacy|3
259340|NCT01215097|856335|P1|Overall Study|Lack of Efficacy|0
259341|NCT01215097|856334|P2|Overall Study|Withdrawal by Subject|3
259342|NCT01215097|856335|P1|Overall Study|Withdrawal by Subject|6
259343|NCT01215097|856334|P2|Overall Study|Lost to Follow-up|0
259344|NCT01215097|856335|P1|Overall Study|Lost to Follow-up|2
259345|NCT01215097|856334|P2|Overall Study|Protocol Violation|2
259346|NCT01215097|856335|P1|Overall Study|Protocol Violation|0
259347|NCT01215097|856334|P2|Overall Study|Adverse Event|3
259348|NCT01215097|856335|P1|Overall Study|Adverse Event|1
259349|NCT01215032|856367|P1|Overall Study|Lack of Efficacy|17
259350|NCT01215032|856367|P1|Overall Study|Adverse Event|3
259351|NCT01214915|856392|P1|Overall Study|Lack of Efficacy|3
259352|NCT01214915|856392|P1|Overall Study|Adverse Event|8
259353|NCT01214850|856403|P3|Overall Study|Unable to classify|1
259354|NCT01214850|856404|P2|Overall Study|Unable to classify|1
259355|NCT01214850|856405|P1|Overall Study|Unable to classify|2
259356|NCT01214850|856403|P3|Overall Study|Administrative reason|0
259357|NCT01214850|856404|P2|Overall Study|Administrative reason|0
259358|NCT01214850|856405|P1|Overall Study|Administrative reason|1
259359|NCT01214850|856403|P3|Overall Study|Inappropriate enrollment|0
259360|NCT01214850|856404|P2|Overall Study|Inappropriate enrollment|1
259361|NCT01214850|856405|P1|Overall Study|Inappropriate enrollment|2
259362|NCT01214850|856403|P3|Overall Study|Adverse event or death|3
259363|NCT01214850|856404|P2|Overall Study|Adverse event or death|8
259364|NCT01214850|856405|P1|Overall Study|Adverse event or death|11
259365|NCT01214850|856403|P3|Overall Study|Protocol Violation|6
259366|NCT01214850|856404|P2|Overall Study|Protocol Violation|5
259367|NCT01214850|856405|P1|Overall Study|Protocol Violation|5
259368|NCT01214850|856403|P3|Overall Study|Lost to Follow-up|123
259369|NCT01214850|856404|P2|Overall Study|Lost to Follow-up|98
259370|NCT01214850|856405|P1|Overall Study|Lost to Follow-up|124
259371|NCT01214850|856403|P3|Overall Study|Withdrawal by Subject|28
259372|NCT01214850|856404|P2|Overall Study|Withdrawal by Subject|31
259373|NCT01214850|856405|P1|Overall Study|Withdrawal by Subject|38
259374|NCT01214837|856489|P3|Overall Study|Unable to Classify|0
259375|NCT01214837|856490|P2|Overall Study|Unable to Classify|3
259376|NCT01214837|856491|P1|Overall Study|Unable to Classify|1
259377|NCT01214837|856489|P3|Overall Study|Protocol Violation|5
259378|NCT01214837|856490|P2|Overall Study|Protocol Violation|1
259379|NCT01214837|856491|P1|Overall Study|Protocol Violation|3
259380|NCT01214837|856489|P3|Overall Study|Administrative Reason|4
259381|NCT01214837|856490|P2|Overall Study|Administrative Reason|6
259382|NCT01214837|856491|P1|Overall Study|Administrative Reason|2
259383|NCT01214837|856489|P3|Overall Study|Inappropriate Enrolment|2
259384|NCT01214837|856490|P2|Overall Study|Inappropriate Enrolment|1
259385|NCT01214837|856491|P1|Overall Study|Inappropriate Enrolment|0
259386|NCT01214837|856489|P3|Overall Study|Lost to Follow-up|21
259387|NCT01214837|856490|P2|Overall Study|Lost to Follow-up|15
259388|NCT01214837|856491|P1|Overall Study|Lost to Follow-up|20
259389|NCT01214837|856489|P3|Overall Study|Withdrawal by Subject|28
259390|NCT01214837|856490|P2|Overall Study|Withdrawal by Subject|36
259391|NCT01214837|856491|P1|Overall Study|Withdrawal by Subject|27
259392|NCT01214837|856489|P3|Overall Study|Adverse Event|1
259393|NCT01214837|856490|P2|Overall Study|Adverse Event|2
259394|NCT01214837|856491|P1|Overall Study|Adverse Event|1
259395|NCT01214837|856489|P3|Overall Study|Death|1
259396|NCT01214837|856490|P2|Overall Study|Death|0
259397|NCT01214837|856491|P1|Overall Study|Death|0
259398|NCT01214720|856547|P2|Overall Study|Lost to Follow-up|2
259399|NCT01214720|856548|P1|Overall Study|Lost to Follow-up|6
259400|NCT01214720|856547|P2|Overall Study|Alive and in follow-up|48
259401|NCT01214720|856548|P1|Overall Study|Alive and in follow-up|45
259402|NCT01214720|856547|P2|Overall Study|Alive and still on treatment|18
259403|NCT01214720|856548|P1|Overall Study|Alive and still on treatment|34
259404|NCT01214616|856569|P4|Overall Study|Withdrawal by Subject|1
259405|NCT01214616|856570|P3|Overall Study|Withdrawal by Subject|0
259406|NCT01214616|856571|P2|Overall Study|Withdrawal by Subject|0
259407|NCT01214616|856572|P1|Overall Study|Withdrawal by Subject|1
259408|NCT01214616|856569|P4|Overall Study|Other adverse events|1
259409|NCT01214616|856570|P3|Overall Study|Other adverse events|1
259410|NCT01214616|856571|P2|Overall Study|Other adverse events|1
259411|NCT01214616|856572|P1|Overall Study|Other adverse events|0
259412|NCT01214616|856569|P4|Overall Study|Dose limiting toxicity|0
259413|NCT01214616|856570|P3|Overall Study|Dose limiting toxicity|0
259414|NCT01214616|856571|P2|Overall Study|Dose limiting toxicity|2
259415|NCT01214616|856572|P1|Overall Study|Dose limiting toxicity|0
259416|NCT01214616|856569|P4|Overall Study|Progressive disease|4
259417|NCT01214616|856570|P3|Overall Study|Progressive disease|2
259418|NCT01214616|856571|P2|Overall Study|Progressive disease|2
259419|NCT01214616|856572|P1|Overall Study|Progressive disease|2
259420|NCT01214434|856608|P2|Overall Study|Site error|0
259421|NCT01214434|856609|P1|Overall Study|Site error|1
259422|NCT01214434|856608|P2|Overall Study|Lost to Follow-up|2
259423|NCT01214434|856609|P1|Overall Study|Lost to Follow-up|2
259424|NCT01214434|856608|P2|Overall Study|Withdrawal by Subject|0
259425|NCT01214434|856609|P1|Overall Study|Withdrawal by Subject|1
259426|NCT01214395|856625|P1|Overall Study|All patients had infection|5
259427|NCT01214252|856634|P1|Overall Study|Not eligible per protocol|82
259428|NCT01214239|856642|P2|Overall Study|patient's private reason|1
259429|NCT01214239|856643|P1|Overall Study|patient's private reason|1
259430|NCT01214239|856642|P2|Overall Study|Lack of Efficacy|2
259431|NCT01214239|856643|P1|Overall Study|Lack of Efficacy|1
259432|NCT01214239|856642|P2|Overall Study|Withdrawal by Subject|9
259433|NCT01214239|856643|P1|Overall Study|Withdrawal by Subject|4
259434|NCT01214239|856642|P2|Overall Study|Lost to Follow-up|1
259435|NCT01214239|856643|P1|Overall Study|Lost to Follow-up|1
259436|NCT01214239|856642|P2|Overall Study|Protocol Violation|1
259437|NCT01214239|856643|P1|Overall Study|Protocol Violation|2
259438|NCT01214239|856642|P2|Overall Study|Adverse Event|4
259439|NCT01214239|856643|P1|Overall Study|Adverse Event|3
259440|NCT01214187|856677|P2|Overall Study|Withdrawal by Subject|3
259441|NCT01214187|856678|P1|Overall Study|Withdrawal by Subject|0
259442|NCT01214187|856677|P2|Overall Study|Death|1
259443|NCT01214187|856678|P1|Overall Study|Death|1
259444|NCT01214187|856677|P2|Overall Study|Adverse Event|2
259445|NCT01214187|856678|P1|Overall Study|Adverse Event|6
259446|NCT01214174|856695|P3|Overall Study|Withdrawal by Subject|1
259447|NCT01214174|856696|P2|Overall Study|Withdrawal by Subject|0
259448|NCT01214174|856697|P1|Overall Study|Withdrawal by Subject|0
259449|NCT01213966|856851|P4|Overall Study|Protocol Violation|1
259450|NCT01213966|856852|P3|Overall Study|Protocol Violation|3
259451|NCT01213966|856853|P2|Overall Study|Protocol Violation|0
259452|NCT01213966|856854|P1|Overall Study|Protocol Violation|1
259453|NCT01213836|856866|P2|Period 1, First Intervention|Withdrawal by Subject|1
259454|NCT01213836|856867|P1|Period 1, First Intervention|Withdrawal by Subject|1
259455|NCT01213836|856866|P2|Period 1, First Intervention|Protocol Violation|1
259456|NCT01213836|856867|P1|Period 1, First Intervention|Protocol Violation|0
259457|NCT01213836|856866|P2|Period 1, First Intervention|Adverse Event|1
259458|NCT01213836|856867|P1|Period 1, First Intervention|Adverse Event|2
259459|NCT01213264|856980|P3|Overall Study|Lost to Follow-up|6
259460|NCT01213264|856981|P2|Overall Study|Lost to Follow-up|2
259461|NCT01213264|856982|P1|Overall Study|Lost to Follow-up|1
259462|NCT01213264|856980|P3|Overall Study|Adverse Event|0
259463|NCT01213264|856981|P2|Overall Study|Adverse Event|0
259464|NCT01213264|856982|P1|Overall Study|Adverse Event|1
259465|NCT01213251|857002|P3|Overall Study|Missed 18-Month Follow-up|1
259466|NCT01213251|857003|P2|Overall Study|Missed 18-Month Follow-up|0
259467|NCT01213251|857004|P1|Overall Study|Missed 18-Month Follow-up|0
259468|NCT01213251|857002|P3|Overall Study|Protocol Violation|0
259469|NCT01213251|857003|P2|Overall Study|Protocol Violation|1
259470|NCT01213251|857004|P1|Overall Study|Protocol Violation|1
259471|NCT01213251|857002|P3|Overall Study|Exit|8
259472|NCT01213251|857003|P2|Overall Study|Exit|2
259473|NCT01213251|857004|P1|Overall Study|Exit|3
259474|NCT01213251|857002|P3|Overall Study|Death|2
259475|NCT01213251|857003|P2|Overall Study|Death|1
259476|NCT01213251|857004|P1|Overall Study|Death|2
259477|NCT01213173|857031|P2|Overall Study|Incorrect Enrollment|3
259478|NCT01213173|857032|P1|Overall Study|Incorrect Enrollment|1
259479|NCT01213173|857031|P2|Overall Study|Withdrawal by Subject|5
259480|NCT01213173|857032|P1|Overall Study|Withdrawal by Subject|5
259481|NCT01213173|857031|P2|Overall Study|Adverse Event|8
259482|NCT01213173|857032|P1|Overall Study|Adverse Event|4
259483|NCT01213173|857031|P2|Overall Study|Protocol Violation|0
259484|NCT01213173|857032|P1|Overall Study|Protocol Violation|2
259485|NCT01212991|857093|P2|Overall Study|Continuing Treatment|61
259486|NCT01212991|857094|P1|Overall Study|Continuing Treatment|367
259487|NCT01212991|857093|P2|Overall Study|Withdrawal by Subject|14
259488|NCT01212991|857094|P1|Overall Study|Withdrawal by Subject|4
259489|NCT01212991|857093|P2|Overall Study|Death|299
259490|NCT01212991|857094|P1|Overall Study|Death|241
259491|NCT01212991|857093|P2|Overall Study|Lost to Follow-up|0
259492|NCT01212991|857094|P1|Overall Study|Lost to Follow-up|1
259493|NCT01212770|857126|P7|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259494|NCT01212770|857127|P6|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259495|NCT01212770|857128|P5|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259496|NCT01212770|857129|P4|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
259497|NCT01212770|857130|P3|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
259498|NCT01212770|857131|P2|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259499|NCT01212770|857132|P1|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259500|NCT01212770|857126|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
259501|NCT01212770|857127|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
259502|NCT01212770|857128|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
259503|NCT01212770|857129|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
259504|NCT01212770|857130|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
259505|NCT01212770|857131|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
259506|NCT01212770|857132|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
259507|NCT01212770|857126|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259508|NCT01212770|857127|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259509|NCT01212770|857128|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259510|NCT01212770|857129|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259511|NCT01212770|857130|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
259512|NCT01212770|857131|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259513|NCT01212770|857132|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259514|NCT01212770|857126|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
259515|NCT01212770|857127|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
259516|NCT01212770|857128|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
259517|NCT01212770|857129|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
259518|NCT01212770|857130|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
259519|NCT01212770|857131|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
259520|NCT01212770|857132|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
259521|NCT01212770|857126|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
259522|NCT01212770|857127|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
259523|NCT01212770|857128|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
259524|NCT01212770|857129|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
259525|NCT01212770|857130|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
259526|NCT01212770|857131|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
259527|NCT01212770|857132|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
259528|NCT01212770|857126|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
259529|NCT01212770|857127|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
259530|NCT01212770|857128|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
259531|NCT01212770|857129|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
259532|NCT01212770|857130|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
259533|NCT01212770|857131|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
259534|NCT01212770|857132|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
259535|NCT01212770|857126|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
259536|NCT01212770|857127|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
259537|NCT01212770|857128|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
259538|NCT01212770|857129|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
259539|NCT01212770|857130|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
259540|NCT01212770|857131|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
259541|NCT01212770|857132|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|3
259542|NCT01212770|857126|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259543|NCT01212770|857127|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259544|NCT01212770|857128|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259545|NCT01212770|857129|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259546|NCT01212770|857130|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
259547|NCT01212770|857131|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259548|NCT01212770|857132|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259549|NCT01212770|857126|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
259550|NCT01212770|857127|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
259551|NCT01212770|857128|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
259552|NCT01212770|857129|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
259553|NCT01212770|857130|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
259554|NCT01212770|857131|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
259555|NCT01212770|857132|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
259556|NCT01212770|857126|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
259557|NCT01212770|857127|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
259558|NCT01212770|857128|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
259559|NCT01212770|857129|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
259560|NCT01212770|857130|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
259561|NCT01212770|857131|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
259562|NCT01212770|857132|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
259563|NCT01212770|857126|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
259564|NCT01212770|857127|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
259565|NCT01212770|857128|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
259566|NCT01212770|857129|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
259567|NCT01212770|857130|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
259568|NCT01212770|857131|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
259569|NCT01212770|857132|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
259570|NCT01212770|857126|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
259571|NCT01212770|857127|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
259572|NCT01212770|857128|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
259573|NCT01212770|857129|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
259574|NCT01212770|857130|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
259575|NCT01212770|857131|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
259576|NCT01212770|857132|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
259577|NCT01212757|857322|P7|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259578|NCT01212757|857323|P6|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259579|NCT01212757|857324|P5|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259580|NCT01212757|857325|P4|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259581|NCT01212757|857326|P3|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
259582|NCT01212757|857327|P2|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
259583|NCT01212757|857328|P1|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
259584|NCT01212757|857322|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259585|NCT01212757|857323|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259586|NCT01212757|857324|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
259587|NCT01212757|857325|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259588|NCT01212757|857326|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259589|NCT01212757|857327|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
259590|NCT01212757|857328|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
259591|NCT01212757|857322|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
259592|NCT01212757|857323|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
259593|NCT01212757|857324|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
259594|NCT01212757|857325|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
259595|NCT01212757|857326|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|7
259596|NCT01212757|857327|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
259597|NCT01212757|857328|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
259598|NCT01212757|857322|P7|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
259599|NCT01212757|857323|P6|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
259754|NCT01210807|857862|P1|Overall Study|Not implanted bilaterally|2
259600|NCT01212757|857324|P5|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
259601|NCT01212757|857325|P4|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
259602|NCT01212757|857326|P3|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|2
259603|NCT01212757|857327|P2|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
259604|NCT01212757|857328|P1|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
259605|NCT01212757|857322|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
259606|NCT01212757|857323|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
259607|NCT01212757|857324|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
259608|NCT01212757|857325|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
259609|NCT01212757|857326|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
259610|NCT01212757|857327|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
259611|NCT01212757|857328|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
259612|NCT01212757|857322|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
259613|NCT01212757|857323|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
259614|NCT01212757|857324|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
259615|NCT01212757|857325|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
259616|NCT01212757|857326|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|3
259617|NCT01212757|857327|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
259618|NCT01212757|857328|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
259619|NCT01212757|857322|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
259620|NCT01212757|857323|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
259621|NCT01212757|857324|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
259622|NCT01212757|857325|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
259623|NCT01212757|857326|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
259624|NCT01212757|857327|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
259625|NCT01212757|857328|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
259626|NCT01212757|857322|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259627|NCT01212757|857323|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259628|NCT01212757|857324|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259629|NCT01212757|857325|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259630|NCT01212757|857326|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
259631|NCT01212757|857327|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
259632|NCT01212757|857328|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
259633|NCT01212757|857322|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
259634|NCT01212757|857323|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
259635|NCT01212757|857324|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
259636|NCT01212757|857325|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
259637|NCT01212757|857326|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
259638|NCT01212757|857327|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
259639|NCT01212757|857328|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
259640|NCT01212757|857322|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
259641|NCT01212757|857323|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
259642|NCT01212757|857324|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
259643|NCT01212757|857325|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
259644|NCT01212757|857326|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
259645|NCT01212757|857327|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
259646|NCT01212757|857328|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
259647|NCT01212757|857322|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
259728|NCT01211184|857789|P1|Overall Study|Withdrawal by Subject|0
259648|NCT01212757|857323|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
259649|NCT01212757|857324|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
259650|NCT01212757|857325|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
259651|NCT01212757|857326|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
259652|NCT01212757|857327|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
259653|NCT01212757|857328|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
259654|NCT01212757|857322|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
259655|NCT01212757|857323|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
259656|NCT01212757|857324|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
259657|NCT01212757|857325|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
259658|NCT01212757|857326|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
259659|NCT01212757|857327|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
259660|NCT01212757|857328|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
259661|NCT01212757|857322|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
259662|NCT01212757|857323|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
259663|NCT01212757|857324|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
259664|NCT01212757|857325|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
259665|NCT01212757|857326|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
259666|NCT01212757|857327|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
259667|NCT01212757|857328|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
259668|NCT01212185|857560|P2|Overall Study|Protocol Violation|1
259669|NCT01212185|857561|P1|Overall Study|Protocol Violation|2
259670|NCT01212159|857580|P2|Overall Study|Withdrawal by Subject|12
259671|NCT01212159|857581|P1|Overall Study|Withdrawal by Subject|12
259672|NCT01212094|857594|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
259673|NCT01212094|857595|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
259674|NCT01212094|857596|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
259675|NCT01212094|857594|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
259676|NCT01212094|857595|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
259677|NCT01212094|857596|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
259678|NCT01212094|857594|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
259679|NCT01212094|857595|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
259680|NCT01212094|857596|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
259681|NCT01212094|857594|P3|Year 1: Baseline Monitoring|Started on DMT|0
259682|NCT01212094|857595|P2|Year 1: Baseline Monitoring|Started on DMT|0
259683|NCT01212094|857596|P1|Year 1: Baseline Monitoring|Started on DMT|2
259684|NCT01212094|857594|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
259685|NCT01212094|857595|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
259686|NCT01212094|857596|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
259687|NCT01212094|857594|P3|Year 1: Baseline Monitoring|Study terminated|0
259688|NCT01212094|857595|P2|Year 1: Baseline Monitoring|Study terminated|0
259689|NCT01212094|857596|P1|Year 1: Baseline Monitoring|Study terminated|7
259690|NCT01211769|857643|P4|Overall Study|Adverse Event|1
259691|NCT01211769|857644|P3|Overall Study|Adverse Event|1
259692|NCT01211769|857645|P2|Overall Study|Adverse Event|1
259693|NCT01211769|857646|P1|Overall Study|Adverse Event|0
259694|NCT01211769|857643|P4|Overall Study|Physician Decision|1
259695|NCT01211769|857644|P3|Overall Study|Physician Decision|2
259696|NCT01211769|857645|P2|Overall Study|Physician Decision|0
259697|NCT01211769|857646|P1|Overall Study|Physician Decision|2
259698|NCT01211769|857643|P4|Overall Study|Lost to Follow-up|9
259699|NCT01211769|857644|P3|Overall Study|Lost to Follow-up|5
259700|NCT01211769|857645|P2|Overall Study|Lost to Follow-up|9
259701|NCT01211769|857646|P1|Overall Study|Lost to Follow-up|7
259702|NCT01211665|857685|P2|Overall Study|Death|0
259703|NCT01211665|857686|P1|Overall Study|Death|1
259704|NCT01211665|857685|P2|Overall Study|Withdrawal by Subject|0
259705|NCT01211665|857686|P1|Overall Study|Withdrawal by Subject|1
259706|NCT01211613|857713|P3|Overall Study|Withdrawal by Subject|0
259707|NCT01211613|857714|P2|Overall Study|Withdrawal by Subject|0
259708|NCT01211613|857715|P1|Overall Study|Withdrawal by Subject|1
259709|NCT01211613|857713|P3|Overall Study|Lost to Follow-up|2
259710|NCT01211613|857714|P2|Overall Study|Lost to Follow-up|2
259711|NCT01211613|857715|P1|Overall Study|Lost to Follow-up|2
259712|NCT01211535|857728|P2|Overall Study|Adverse Event|1
259713|NCT01211535|857729|P1|Overall Study|Adverse Event|0
259714|NCT01211197|857735|P6|Washout Period 2 (7 Days)|Adverse Event|0
259715|NCT01211197|857736|P5|Washout Period 2 (7 Days)|Adverse Event|0
259716|NCT01211197|857737|P4|Washout Period 2 (7 Days)|Adverse Event|0
259717|NCT01211197|857738|P3|Washout Period 2 (7 Days)|Adverse Event|0
259718|NCT01211197|857739|P2|Washout Period 2 (7 Days)|Adverse Event|0
259719|NCT01211197|857740|P1|Washout Period 2 (7 Days)|Adverse Event|1
259720|NCT01211197|857735|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
259721|NCT01211197|857736|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
259722|NCT01211197|857737|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
259723|NCT01211197|857738|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
259724|NCT01211197|857739|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
259725|NCT01211197|857740|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
259726|NCT01211184|857787|P3|Overall Study|Withdrawal by Subject|1
259727|NCT01211184|857788|P2|Overall Study|Withdrawal by Subject|2
259729|NCT01211145|857804|P4|Overall Study|Patient decision|2
259730|NCT01211145|857805|P3|Overall Study|Patient decision|0
259731|NCT01211145|857806|P2|Overall Study|Patient decision|1
259732|NCT01211145|857807|P1|Overall Study|Patient decision|2
259733|NCT01211145|857804|P4|Overall Study|Eligibility criteria not fulfilled|15
259734|NCT01211145|857805|P3|Overall Study|Eligibility criteria not fulfilled|10
259735|NCT01211145|857806|P2|Overall Study|Eligibility criteria not fulfilled|12
259736|NCT01211145|857807|P1|Overall Study|Eligibility criteria not fulfilled|16
259737|NCT01211145|857804|P4|Overall Study|Severe noncompliance to protocol|0
259738|NCT01211145|857805|P3|Overall Study|Severe noncompliance to protocol|0
259739|NCT01211145|857806|P2|Overall Study|Severe noncompliance to protocol|0
259740|NCT01211145|857807|P1|Overall Study|Severe noncompliance to protocol|1
259741|NCT01211145|857804|P4|Overall Study|Study-specific withdrawal criteria|0
259742|NCT01211145|857805|P3|Overall Study|Study-specific withdrawal criteria|0
259743|NCT01211145|857806|P2|Overall Study|Study-specific withdrawal criteria|0
259744|NCT01211145|857807|P1|Overall Study|Study-specific withdrawal criteria|1
259745|NCT01211145|857804|P4|Overall Study|Lost to Follow-up|2
259746|NCT01211145|857805|P3|Overall Study|Lost to Follow-up|1
259747|NCT01211145|857806|P2|Overall Study|Lost to Follow-up|2
259748|NCT01211145|857807|P1|Overall Study|Lost to Follow-up|3
259749|NCT01211145|857804|P4|Overall Study|Reason not specified|1
259750|NCT01211145|857805|P3|Overall Study|Reason not specified|2
259751|NCT01211145|857806|P2|Overall Study|Reason not specified|2
259752|NCT01211145|857807|P1|Overall Study|Reason not specified|3
259753|NCT01210807|857861|P2|Overall Study|Not implanted bilaterally|1
259755|NCT01210807|857861|P2|Overall Study|Lost to Follow-up|2
259756|NCT01210807|857862|P1|Overall Study|Lost to Follow-up|1
259757|NCT01210690|857877|P1|Overall Study|Patient could not take glucose|1
259758|NCT01210690|857877|P1|Overall Study|Patient refused to swallow|1
259759|NCT01210690|857877|P1|Overall Study|Withdrawal by Subject|1
259760|NCT01210690|857877|P1|Overall Study|Disease Remission|1
259761|NCT01210690|857877|P1|Overall Study|Lost to Follow-up|3
259762|NCT01210690|857877|P1|Overall Study|Lack of Efficacy|12
259763|NCT01210690|857877|P1|Overall Study|Adverse Event|7
259764|NCT01210651|857892|P2|Overall Study|Injury outside study|0
259765|NCT01210651|857893|P1|Overall Study|Injury outside study|2
259766|NCT01210651|857892|P2|Overall Study|Withdrawal by Subject|1
259767|NCT01210651|857893|P1|Overall Study|Withdrawal by Subject|1
259768|NCT01210651|857892|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
259769|NCT01210651|857893|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
259770|NCT01210651|857892|P2|Overall Study|schedule conflicts|5
259771|NCT01210651|857893|P1|Overall Study|schedule conflicts|1
259772|NCT01210651|857892|P2|Overall Study|Lost to Follow-up|1
259773|NCT01210651|857893|P1|Overall Study|Lost to Follow-up|1
259774|NCT01210495|857911|P4|Overall Study|Lost to Follow-up|0
259775|NCT01210495|857912|P3|Overall Study|Lost to Follow-up|1
259776|NCT01210495|857913|P2|Overall Study|Lost to Follow-up|0
259777|NCT01210495|857914|P1|Overall Study|Lost to Follow-up|0
259778|NCT01210495|857911|P4|Overall Study|Ongoing on Treatment|1
259779|NCT01210495|857912|P3|Overall Study|Ongoing on Treatment|7
259780|NCT01210495|857913|P2|Overall Study|Ongoing on Treatment|0
259781|NCT01210495|857914|P1|Overall Study|Ongoing on Treatment|0
259782|NCT01210495|857911|P4|Overall Study|Ongoing in Follow-up|13
259783|NCT01210495|857912|P3|Overall Study|Ongoing in Follow-up|14
259784|NCT01210495|857913|P2|Overall Study|Ongoing in Follow-up|1
259785|NCT01210495|857914|P1|Overall Study|Ongoing in Follow-up|0
259786|NCT01210495|857911|P4|Overall Study|Death|52
259787|NCT01210495|857912|P3|Overall Study|Death|101
259788|NCT01210495|857913|P2|Overall Study|Death|6
259789|NCT01210495|857914|P1|Overall Study|Death|14
259790|NCT01210495|857911|P4|Overall Study|Participant Refused Further Follow-Up|2
259791|NCT01210495|857912|P3|Overall Study|Participant Refused Further Follow-Up|11
259792|NCT01210495|857913|P2|Overall Study|Participant Refused Further Follow-Up|0
259793|NCT01210495|857914|P1|Overall Study|Participant Refused Further Follow-Up|1
259794|NCT01210443|857976|P1|Overall Study|Study terminated by sponsor|2
259795|NCT01210144|858000|P2|Overall Study|No transfer|0
259796|NCT01210144|858001|P1|Overall Study|No transfer|1
259797|NCT01210144|858000|P2|Overall Study|No fertilization|0
259798|NCT01210144|858001|P1|Overall Study|No fertilization|1
259799|NCT01210144|858000|P2|Overall Study|Lack of ovarian response|0
259800|NCT01210144|858001|P1|Overall Study|Lack of ovarian response|1
259801|NCT01210118|858023|P2|Overall Study|Spontaneous abortion|3
259802|NCT01210118|858024|P1|Overall Study|Spontaneous abortion|1
259803|NCT01210118|858023|P2|Overall Study|Protocol Violation|1
259804|NCT01210118|858024|P1|Overall Study|Protocol Violation|1
259805|NCT01210118|858023|P2|Overall Study|Lost to Follow-up|1
259806|NCT01210118|858024|P1|Overall Study|Lost to Follow-up|1
259807|NCT01210001|858048|P3|Overall Study|Other reason not defined above|1
259808|NCT01210001|858049|P2|Overall Study|Other reason not defined above|2
259809|NCT01210001|858050|P1|Overall Study|Other reason not defined above|2
259810|NCT01210001|858048|P3|Overall Study|Patient refusal to continue,not due toAE|1
259811|NCT01210001|858049|P2|Overall Study|Patient refusal to continue,not due toAE|2
259812|NCT01210001|858050|P1|Overall Study|Patient refusal to continue,not due toAE|6
259813|NCT01210001|858048|P3|Overall Study|Lost to Follow-up|2
259814|NCT01210001|858049|P2|Overall Study|Lost to Follow-up|3
259815|NCT01210001|858050|P1|Overall Study|Lost to Follow-up|4
259816|NCT01210001|858048|P3|Overall Study|Non compliant with protocol|3
259817|NCT01210001|858049|P2|Overall Study|Non compliant with protocol|2
259818|NCT01210001|858050|P1|Overall Study|Non compliant with protocol|2
259819|NCT01210001|858048|P3|Overall Study|Adverse Event|5
259820|NCT01210001|858049|P2|Overall Study|Adverse Event|2
259821|NCT01210001|858050|P1|Overall Study|Adverse Event|4
259822|NCT01210001|858048|P3|Overall Study|Not treated|0
259823|NCT01210001|858049|P2|Overall Study|Not treated|0
259824|NCT01210001|858050|P1|Overall Study|Not treated|1
259825|NCT01209949|858070|P1|Overall Study|Lost to Follow-up|3
259826|NCT01209780|858080|P5|Overall Study|Inappropriate enrollment|1
259827|NCT01209780|858081|P4|Overall Study|Inappropriate enrollment|0
259828|NCT01209780|858082|P3|Overall Study|Inappropriate enrollment|0
259829|NCT01209780|858083|P2|Overall Study|Inappropriate enrollment|2
259830|NCT01209780|858084|P1|Overall Study|Inappropriate enrollment|0
259831|NCT01209780|858080|P5|Overall Study|Protocol Violation|0
259832|NCT01209780|858081|P4|Overall Study|Protocol Violation|0
259833|NCT01209780|858082|P3|Overall Study|Protocol Violation|0
259834|NCT01209780|858083|P2|Overall Study|Protocol Violation|1
259835|NCT01209780|858084|P1|Overall Study|Protocol Violation|0
259836|NCT01209780|858080|P5|Overall Study|Lost to Follow-up|4
259837|NCT01209780|858081|P4|Overall Study|Lost to Follow-up|9
259838|NCT01209780|858082|P3|Overall Study|Lost to Follow-up|3
259839|NCT01209780|858083|P2|Overall Study|Lost to Follow-up|12
259840|NCT01209780|858084|P1|Overall Study|Lost to Follow-up|17
259841|NCT01209780|858080|P5|Overall Study|Withdrawal by Subject|0
259842|NCT01209780|858081|P4|Overall Study|Withdrawal by Subject|1
259843|NCT01209780|858082|P3|Overall Study|Withdrawal by Subject|1
259844|NCT01209780|858083|P2|Overall Study|Withdrawal by Subject|2
259845|NCT01209780|858084|P1|Overall Study|Withdrawal by Subject|9
259846|NCT01209780|858080|P5|Overall Study|Adverse Event|0
259847|NCT01209780|858081|P4|Overall Study|Adverse Event|0
259848|NCT01209780|858082|P3|Overall Study|Adverse Event|0
259849|NCT01209780|858083|P2|Overall Study|Adverse Event|1
259850|NCT01209780|858084|P1|Overall Study|Adverse Event|0
259851|NCT01209767|858110|P1|Overall Study|Lost to Follow-up|3
259852|NCT01209767|858110|P1|Overall Study|Withdrawal by Subject|1
259853|NCT01209689|858179|P2|Overall Study|Sponsor's Decision to Stop the Study|17
259854|NCT01209689|858180|P1|Overall Study|Sponsor's Decision to Stop the Study|68
259855|NCT01209689|858179|P2|Overall Study|Failure to Return|0
259856|NCT01209689|858180|P1|Overall Study|Failure to Return|3
259857|NCT01209689|858179|P2|Overall Study|Violation of Selection Criteria at Entry|0
259858|NCT01209689|858180|P1|Overall Study|Violation of Selection Criteria at Entry|1
259859|NCT01209689|858179|P2|Overall Study|Adverse Event|0
259860|NCT01209689|858180|P1|Overall Study|Adverse Event|4
259861|NCT01209689|858179|P2|Overall Study|Refused Treatment|3
259862|NCT01209689|858180|P1|Overall Study|Refused Treatment|8
259863|NCT01209689|858179|P2|Overall Study|Insufficient Therapeutic Response|2
259864|NCT01209689|858180|P1|Overall Study|Insufficient Therapeutic Response|7
259865|NCT01209624|858186|P1|Overall Study|Unspecified|4
259866|NCT01209624|858186|P1|Overall Study|Lost to Follow-up|290
259867|NCT01209624|858186|P1|Overall Study|Lack of Efficacy|17
259868|NCT01209624|858186|P1|Overall Study|Adverse Event|13
259869|NCT01209624|858186|P1|Overall Study|Death|2
259870|NCT01209520|858217|P1|Overall Study|Withdrawal by Subject|3
259871|NCT01209286|858225|P3|Overall Study|Other|0
259872|NCT01209286|858226|P2|Overall Study|Other|1
259873|NCT01209286|858227|P1|Overall Study|Other|0
259874|NCT01209286|858225|P3|Overall Study|Physician Decision|0
259875|NCT01209286|858226|P2|Overall Study|Physician Decision|2
259876|NCT01209286|858227|P1|Overall Study|Physician Decision|0
259877|NCT01209286|858225|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
259878|NCT01209286|858226|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
259879|NCT01209286|858227|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
259880|NCT01209286|858225|P3|Overall Study|Hematological Relapse After Remission|1
259881|NCT01209286|858226|P2|Overall Study|Hematological Relapse After Remission|1
259882|NCT01209286|858227|P1|Overall Study|Hematological Relapse After Remission|0
259883|NCT01209286|858225|P3|Overall Study|Adverse Event|1
259884|NCT01209286|858226|P2|Overall Study|Adverse Event|3
259885|NCT01209286|858227|P1|Overall Study|Adverse Event|4
259886|NCT01208402|858336|P2|Overall Study|Withdrawal by Subject|0
259887|NCT01208402|858337|P1|Overall Study|Withdrawal by Subject|1
259888|NCT01208337|858353|P1|Overall Study|Death|3
259889|NCT01209143|858363|P2|Overall Study|Disease progression|16
259890|NCT01209143|858364|P1|Overall Study|Disease progression|11
259891|NCT01209143|858363|P2|Overall Study|Withdrawal by Subject|1
259892|NCT01209143|858364|P1|Overall Study|Withdrawal by Subject|2
259893|NCT01209143|858363|P2|Overall Study|Lost to Follow-up|0
259894|NCT01209143|858364|P1|Overall Study|Lost to Follow-up|1
259895|NCT01209143|858363|P2|Overall Study|Physician Decision|1
259896|NCT01209143|858364|P1|Overall Study|Physician Decision|3
259897|NCT01209143|858363|P2|Overall Study|Death|1
259898|NCT01209143|858364|P1|Overall Study|Death|0
259899|NCT01209143|858363|P2|Overall Study|Adverse Event|1
259900|NCT01209143|858364|P1|Overall Study|Adverse Event|2
259901|NCT01208961|858372|P2|High-Fat Period III|Protocol Violation|0
259902|NCT01208961|858373|P1|High-Fat Period III|Protocol Violation|1
259903|NCT01208233|858388|P6|Overall Study|Withdrawal by Subject|2
259904|NCT01208233|858389|P5|Overall Study|Withdrawal by Subject|4
259905|NCT01208233|858390|P4|Overall Study|Withdrawal by Subject|1
259906|NCT01208233|858391|P3|Overall Study|Withdrawal by Subject|1
259907|NCT01208233|858392|P2|Overall Study|Withdrawal by Subject|0
259908|NCT01208233|858393|P1|Overall Study|Withdrawal by Subject|1
259909|NCT01208233|858388|P6|Overall Study|Unspecified|1
259910|NCT01208233|858389|P5|Overall Study|Unspecified|0
259911|NCT01208233|858390|P4|Overall Study|Unspecified|0
259912|NCT01208233|858391|P3|Overall Study|Unspecified|0
259913|NCT01208233|858392|P2|Overall Study|Unspecified|1
259914|NCT01208233|858393|P1|Overall Study|Unspecified|2
259915|NCT01208233|858388|P6|Overall Study|Protocol Violation|0
259916|NCT01208233|858389|P5|Overall Study|Protocol Violation|3
259917|NCT01208233|858390|P4|Overall Study|Protocol Violation|0
259918|NCT01208233|858391|P3|Overall Study|Protocol Violation|0
259919|NCT01208233|858392|P2|Overall Study|Protocol Violation|0
259920|NCT01208233|858393|P1|Overall Study|Protocol Violation|0
259921|NCT01208233|858388|P6|Overall Study|Study terminated by sponsor|7
259922|NCT01208233|858389|P5|Overall Study|Study terminated by sponsor|10
259923|NCT01208233|858390|P4|Overall Study|Study terminated by sponsor|0
259924|NCT01208233|858391|P3|Overall Study|Study terminated by sponsor|0
259925|NCT01208233|858392|P2|Overall Study|Study terminated by sponsor|0
259926|NCT01208233|858393|P1|Overall Study|Study terminated by sponsor|0
259927|NCT01208233|858388|P6|Overall Study|Medication error without adverse event|1
259928|NCT01208233|858389|P5|Overall Study|Medication error without adverse event|0
259929|NCT01208233|858390|P4|Overall Study|Medication error without adverse event|0
259930|NCT01208233|858391|P3|Overall Study|Medication error without adverse event|0
259931|NCT01208233|858392|P2|Overall Study|Medication error without adverse event|0
259932|NCT01208233|858393|P1|Overall Study|Medication error without adverse event|0
259933|NCT01208233|858388|P6|Overall Study|Did not meet entrance criteria|0
259934|NCT01208233|858389|P5|Overall Study|Did not meet entrance criteria|1
259935|NCT01208233|858390|P4|Overall Study|Did not meet entrance criteria|0
259936|NCT01208233|858391|P3|Overall Study|Did not meet entrance criteria|1
259937|NCT01208233|858392|P2|Overall Study|Did not meet entrance criteria|1
259938|NCT01208233|858393|P1|Overall Study|Did not meet entrance criteria|2
259939|NCT01208233|858388|P6|Overall Study|Death|5
259940|NCT01208233|858389|P5|Overall Study|Death|3
259941|NCT01208233|858390|P4|Overall Study|Death|0
259942|NCT01208233|858391|P3|Overall Study|Death|0
259943|NCT01208233|858392|P2|Overall Study|Death|0
259944|NCT01208233|858393|P1|Overall Study|Death|0
259945|NCT01208233|858388|P6|Overall Study|Adverse Event|5
259946|NCT01208233|858389|P5|Overall Study|Adverse Event|3
259947|NCT01208233|858390|P4|Overall Study|Adverse Event|0
259948|NCT01208233|858391|P3|Overall Study|Adverse Event|2
259949|NCT01208233|858392|P2|Overall Study|Adverse Event|1
259950|NCT01208233|858393|P1|Overall Study|Adverse Event|0
259951|NCT01208207|858518|P7|Part II|Technical Problems|0
259952|NCT01208207|858519|P6|Part II|Technical Problems|1
259953|NCT01208207|858520|P5|Part II|Technical Problems|0
259954|NCT01208207|858521|P4|Part II|Technical Problems|1
259955|NCT01208207|858522|P3|Part II|Technical Problems|0
259956|NCT01208207|858523|P2|Part II|Technical Problems|0
259957|NCT01208207|858524|P1|Part II|Technical Problems|0
259958|NCT01208207|858518|P7|Part II|Protocol Violation|0
259959|NCT01208207|858519|P6|Part II|Protocol Violation|0
259960|NCT01208207|858520|P5|Part II|Protocol Violation|0
259961|NCT01208207|858521|P4|Part II|Protocol Violation|1
259962|NCT01208207|858522|P3|Part II|Protocol Violation|0
259963|NCT01208207|858523|P2|Part II|Protocol Violation|0
259964|NCT01208207|858524|P1|Part II|Protocol Violation|0
259965|NCT01208207|858518|P7|Part II|Physician Decision|0
259966|NCT01208207|858519|P6|Part II|Physician Decision|2
259967|NCT01208207|858520|P5|Part II|Physician Decision|0
259968|NCT01208207|858521|P4|Part II|Physician Decision|1
259969|NCT01208207|858522|P3|Part II|Physician Decision|0
259970|NCT01208207|858523|P2|Part II|Physician Decision|0
259971|NCT01208207|858524|P1|Part II|Physician Decision|0
259972|NCT01208207|858518|P7|Part II|Non-Compliance With Study Drug|0
259973|NCT01208207|858519|P6|Part II|Non-Compliance With Study Drug|1
259974|NCT01208207|858520|P5|Part II|Non-Compliance With Study Drug|1
259975|NCT01208207|858521|P4|Part II|Non-Compliance With Study Drug|4
259976|NCT01208207|858522|P3|Part II|Non-Compliance With Study Drug|0
259977|NCT01208207|858523|P2|Part II|Non-Compliance With Study Drug|0
259978|NCT01208207|858524|P1|Part II|Non-Compliance With Study Drug|0
259979|NCT01208207|858518|P7|Part II|Lost to Follow-up|1
259980|NCT01208207|858519|P6|Part II|Lost to Follow-up|2
259981|NCT01208207|858520|P5|Part II|Lost to Follow-up|0
259982|NCT01208207|858521|P4|Part II|Lost to Follow-up|4
259983|NCT01208207|858522|P3|Part II|Lost to Follow-up|0
259984|NCT01208207|858523|P2|Part II|Lost to Follow-up|0
259985|NCT01208207|858524|P1|Part II|Lost to Follow-up|0
259986|NCT01208207|858518|P7|Part II|Lack of Efficacy|3
259987|NCT01208207|858519|P6|Part II|Lack of Efficacy|3
259988|NCT01208207|858520|P5|Part II|Lack of Efficacy|4
259989|NCT01208207|858521|P4|Part II|Lack of Efficacy|6
259990|NCT01208207|858522|P3|Part II|Lack of Efficacy|0
259991|NCT01208207|858523|P2|Part II|Lack of Efficacy|0
259992|NCT01208207|858524|P1|Part II|Lack of Efficacy|0
259993|NCT01208207|858518|P7|Part II|Adverse Event|2
259994|NCT01208207|858519|P6|Part II|Adverse Event|4
259995|NCT01208207|858520|P5|Part II|Adverse Event|9
259996|NCT01208207|858521|P4|Part II|Adverse Event|5
259997|NCT01208207|858522|P3|Part II|Adverse Event|0
259998|NCT01208207|858523|P2|Part II|Adverse Event|0
259999|NCT01208207|858524|P1|Part II|Adverse Event|0
260000|NCT01208207|858518|P7|Part II|Withdrawal by Subject|5
260001|NCT01208207|858519|P6|Part II|Withdrawal by Subject|3
260002|NCT01208207|858520|P5|Part II|Withdrawal by Subject|9
260003|NCT01208207|858521|P4|Part II|Withdrawal by Subject|10
260004|NCT01208207|858522|P3|Part II|Withdrawal by Subject|0
260005|NCT01208207|858523|P2|Part II|Withdrawal by Subject|0
260006|NCT01208207|858524|P1|Part II|Withdrawal by Subject|0
260007|NCT01208207|858518|P7|Part I|Withdrawal by Subject|0
260008|NCT01208207|858519|P6|Part I|Withdrawal by Subject|0
260009|NCT01208207|858520|P5|Part I|Withdrawal by Subject|0
260010|NCT01208207|858521|P4|Part I|Withdrawal by Subject|0
260011|NCT01208207|858522|P3|Part I|Withdrawal by Subject|4
260012|NCT01208207|858523|P2|Part I|Withdrawal by Subject|4
260013|NCT01208207|858524|P1|Part I|Withdrawal by Subject|14
260014|NCT01208207|858518|P7|Part I|Protocol Violation|0
260015|NCT01208207|858519|P6|Part I|Protocol Violation|0
260016|NCT01208207|858520|P5|Part I|Protocol Violation|0
260017|NCT01208207|858521|P4|Part I|Protocol Violation|0
260018|NCT01208207|858522|P3|Part I|Protocol Violation|2
260019|NCT01208207|858523|P2|Part I|Protocol Violation|0
260020|NCT01208207|858524|P1|Part I|Protocol Violation|8
260021|NCT01208207|858518|P7|Part I|Progressive Disease|0
260022|NCT01208207|858519|P6|Part I|Progressive Disease|0
260023|NCT01208207|858520|P5|Part I|Progressive Disease|0
260024|NCT01208207|858521|P4|Part I|Progressive Disease|0
260025|NCT01208207|858522|P3|Part I|Progressive Disease|0
260026|NCT01208207|858523|P2|Part I|Progressive Disease|0
260027|NCT01208207|858524|P1|Part I|Progressive Disease|1
260028|NCT01208207|858518|P7|Part I|Physician Decision|0
260029|NCT01208207|858519|P6|Part I|Physician Decision|0
260030|NCT01208207|858520|P5|Part I|Physician Decision|0
260031|NCT01208207|858521|P4|Part I|Physician Decision|0
260032|NCT01208207|858522|P3|Part I|Physician Decision|0
260033|NCT01208207|858523|P2|Part I|Physician Decision|1
260034|NCT01208207|858524|P1|Part I|Physician Decision|0
260035|NCT01208207|858518|P7|Part I|Non-Compliance With Study Drug|0
260036|NCT01208207|858519|P6|Part I|Non-Compliance With Study Drug|0
260037|NCT01208207|858520|P5|Part I|Non-Compliance With Study Drug|0
260038|NCT01208207|858521|P4|Part I|Non-Compliance With Study Drug|0
260039|NCT01208207|858522|P3|Part I|Non-Compliance With Study Drug|1
260040|NCT01208207|858523|P2|Part I|Non-Compliance With Study Drug|0
260041|NCT01208207|858524|P1|Part I|Non-Compliance With Study Drug|1
260042|NCT01208207|858518|P7|Part I|Lost to Follow-up|0
260043|NCT01208207|858519|P6|Part I|Lost to Follow-up|0
260044|NCT01208207|858520|P5|Part I|Lost to Follow-up|0
260045|NCT01208207|858521|P4|Part I|Lost to Follow-up|0
260046|NCT01208207|858522|P3|Part I|Lost to Follow-up|0
260047|NCT01208207|858523|P2|Part I|Lost to Follow-up|1
260048|NCT01208207|858524|P1|Part I|Lost to Follow-up|6
260049|NCT01208207|858518|P7|Part I|Lack of Efficacy|0
260050|NCT01208207|858519|P6|Part I|Lack of Efficacy|0
260051|NCT01208207|858520|P5|Part I|Lack of Efficacy|0
260052|NCT01208207|858521|P4|Part I|Lack of Efficacy|0
260053|NCT01208207|858522|P3|Part I|Lack of Efficacy|2
260054|NCT01208207|858523|P2|Part I|Lack of Efficacy|3
260055|NCT01208207|858524|P1|Part I|Lack of Efficacy|21
260056|NCT01208207|858518|P7|Part I|Adverse Event|0
260057|NCT01208207|858519|P6|Part I|Adverse Event|0
260058|NCT01208207|858520|P5|Part I|Adverse Event|0
260059|NCT01208207|858521|P4|Part I|Adverse Event|0
260060|NCT01208207|858522|P3|Part I|Adverse Event|6
260061|NCT01208207|858523|P2|Part I|Adverse Event|2
260062|NCT01208207|858524|P1|Part I|Adverse Event|19
260063|NCT01208181|858551|P5|Part 2|Lack of Efficacy|0
260064|NCT01208181|858552|P4|Part 2|Lack of Efficacy|7
260065|NCT01208181|858553|P3|Part 2|Lack of Efficacy|5
260066|NCT01208181|858554|P2|Part 2|Lack of Efficacy|0
260067|NCT01208181|858555|P1|Part 2|Lack of Efficacy|0
260068|NCT01208181|858551|P5|Part 2|Lost to Follow-up|0
260069|NCT01208181|858552|P4|Part 2|Lost to Follow-up|2
260070|NCT01208181|858553|P3|Part 2|Lost to Follow-up|1
260071|NCT01208181|858554|P2|Part 2|Lost to Follow-up|0
260072|NCT01208181|858555|P1|Part 2|Lost to Follow-up|0
260073|NCT01208181|858551|P5|Part 2|Non-compliance with study drug|0
260074|NCT01208181|858552|P4|Part 2|Non-compliance with study drug|1
260075|NCT01208181|858553|P3|Part 2|Non-compliance with study drug|1
260076|NCT01208181|858554|P2|Part 2|Non-compliance with study drug|0
260077|NCT01208181|858555|P1|Part 2|Non-compliance with study drug|0
260078|NCT01208181|858551|P5|Part 2|Physician Decision|0
260079|NCT01208181|858552|P4|Part 2|Physician Decision|2
260080|NCT01208181|858553|P3|Part 2|Physician Decision|1
260081|NCT01208181|858554|P2|Part 2|Physician Decision|0
260082|NCT01208181|858555|P1|Part 2|Physician Decision|0
260083|NCT01208181|858551|P5|Part 2|Protocol Violation|0
260084|NCT01208181|858552|P4|Part 2|Protocol Violation|0
260085|NCT01208181|858553|P3|Part 2|Protocol Violation|1
260086|NCT01208181|858554|P2|Part 2|Protocol Violation|0
260087|NCT01208181|858555|P1|Part 2|Protocol Violation|0
260088|NCT01208181|858551|P5|Part 2|Withdrawal by Subject|0
260089|NCT01208181|858552|P4|Part 2|Withdrawal by Subject|1
260090|NCT01208181|858553|P3|Part 2|Withdrawal by Subject|1
260091|NCT01208181|858554|P2|Part 2|Withdrawal by Subject|0
260092|NCT01208181|858555|P1|Part 2|Withdrawal by Subject|0
260093|NCT01208181|858551|P5|Part 2|Adverse Event|0
260094|NCT01208181|858552|P4|Part 2|Adverse Event|7
260095|NCT01208181|858553|P3|Part 2|Adverse Event|6
260096|NCT01208181|858554|P2|Part 2|Adverse Event|0
260097|NCT01208181|858555|P1|Part 2|Adverse Event|0
260098|NCT01208181|858551|P5|Part 1|Adverse Event|4
260099|NCT01208181|858552|P4|Part 1|Adverse Event|0
260100|NCT01208181|858553|P3|Part 1|Adverse Event|0
260101|NCT01208181|858554|P2|Part 1|Adverse Event|24
260102|NCT01208181|858555|P1|Part 1|Adverse Event|26
260103|NCT01208181|858551|P5|Part 1|Lack of Efficacy|17
260104|NCT01208181|858552|P4|Part 1|Lack of Efficacy|0
260105|NCT01208181|858553|P3|Part 1|Lack of Efficacy|0
260106|NCT01208181|858554|P2|Part 1|Lack of Efficacy|12
260107|NCT01208181|858555|P1|Part 1|Lack of Efficacy|37
260108|NCT01208181|858551|P5|Part 1|Lost to Follow-up|1
260109|NCT01208181|858552|P4|Part 1|Lost to Follow-up|0
260110|NCT01208181|858553|P3|Part 1|Lost to Follow-up|0
260111|NCT01208181|858554|P2|Part 1|Lost to Follow-up|3
260112|NCT01208181|858555|P1|Part 1|Lost to Follow-up|5
260113|NCT01208181|858551|P5|Part 1|Non-compliance with study drug|0
260114|NCT01208181|858552|P4|Part 1|Non-compliance with study drug|0
260115|NCT01208181|858553|P3|Part 1|Non-compliance with study drug|0
260116|NCT01208181|858554|P2|Part 1|Non-compliance with study drug|1
260117|NCT01208181|858555|P1|Part 1|Non-compliance with study drug|1
260118|NCT01208181|858551|P5|Part 1|Physician Decision|0
260119|NCT01208181|858552|P4|Part 1|Physician Decision|0
260120|NCT01208181|858553|P3|Part 1|Physician Decision|0
260121|NCT01208181|858554|P2|Part 1|Physician Decision|0
260122|NCT01208181|858555|P1|Part 1|Physician Decision|4
260123|NCT01208181|858551|P5|Part 1|Protocol Violation|0
260124|NCT01208181|858552|P4|Part 1|Protocol Violation|0
260125|NCT01208181|858553|P3|Part 1|Protocol Violation|0
260126|NCT01208181|858554|P2|Part 1|Protocol Violation|5
260127|NCT01208181|858555|P1|Part 1|Protocol Violation|10
260128|NCT01208181|858551|P5|Part 1|Technical problem|0
260129|NCT01208181|858552|P4|Part 1|Technical problem|0
260130|NCT01208181|858553|P3|Part 1|Technical problem|0
260131|NCT01208181|858554|P2|Part 1|Technical problem|0
260132|NCT01208181|858555|P1|Part 1|Technical problem|5
260133|NCT01208181|858551|P5|Part 1|Withdrawal by Subject|0
260134|NCT01208181|858552|P4|Part 1|Withdrawal by Subject|0
260135|NCT01208181|858553|P3|Part 1|Withdrawal by Subject|0
260136|NCT01208181|858554|P2|Part 1|Withdrawal by Subject|10
260137|NCT01208181|858555|P1|Part 1|Withdrawal by Subject|11
260138|NCT01207596|858620|P1|Overall Study|Withdrawal by Subject|1
260139|NCT01207596|858620|P1|Overall Study|Adverse Event|3
260140|NCT01207596|858620|P1|Overall Study|Lack of Efficacy|1
260141|NCT01207596|858620|P1|Overall Study|Physician Decision|4
260142|NCT01207583|858633|P3|Overall Study|Lost to Follow-up|0
260143|NCT01207583|858634|P2|Overall Study|Lost to Follow-up|2
260144|NCT01207583|858635|P1|Overall Study|Lost to Follow-up|0
260145|NCT01207583|858633|P3|Overall Study|Participant failed to return|0
260146|NCT01207583|858634|P2|Overall Study|Participant failed to return|0
260147|NCT01207583|858635|P1|Overall Study|Participant failed to return|1
260148|NCT01207583|858633|P3|Overall Study|Withdrawal by Subject|1
260149|NCT01207583|858634|P2|Overall Study|Withdrawal by Subject|3
260150|NCT01207583|858635|P1|Overall Study|Withdrawal by Subject|0
260151|NCT01207492|858688|P1|Overall Study|Toxicity|1
260152|NCT01207492|858688|P1|Overall Study|Progressive disease|3
260153|NCT01207492|858688|P1|Overall Study|Physician Decision|1
260154|NCT01207492|858688|P1|Overall Study|Withdrawal by Subject|9
260155|NCT01207492|858688|P1|Overall Study|Still on study|1
260156|NCT01207453|858703|P2|2nd Intervention|Lost to Follow-up|0
260157|NCT01207453|858704|P1|2nd Intervention|Lost to Follow-up|1
260158|NCT01207453|858703|P2|2nd Intervention|Adverse Event|2
260159|NCT01207453|858704|P1|2nd Intervention|Adverse Event|1
260160|NCT01207453|858703|P2|Washout|Lost to Follow-up|0
260161|NCT01207453|858704|P1|Washout|Lost to Follow-up|1
260162|NCT01207453|858703|P2|Washout|Adverse Event|0
260163|NCT01207453|858704|P1|Washout|Adverse Event|1
260164|NCT01207453|858703|P2|First Intervention|Adverse Event|1
260165|NCT01207453|858704|P1|First Intervention|Adverse Event|2
260166|NCT01207427|858726|P3|Double-blind Treatment Period|Withdrawal by Subject|0
260167|NCT01207427|858727|P2|Double-blind Treatment Period|Withdrawal by Subject|0
260168|NCT01207427|858728|P1|Double-blind Treatment Period|Withdrawal by Subject|1
260169|NCT01207427|858726|P3|Double-blind Treatment Period|Protocol Violation|1
260170|NCT01207427|858727|P2|Double-blind Treatment Period|Protocol Violation|1
260171|NCT01207427|858728|P1|Double-blind Treatment Period|Protocol Violation|2
260172|NCT01207427|858726|P3|Double-blind Treatment Period|Lost to Follow-up|1
260173|NCT01207427|858727|P2|Double-blind Treatment Period|Lost to Follow-up|0
260174|NCT01207427|858728|P1|Double-blind Treatment Period|Lost to Follow-up|0
260175|NCT01207427|858726|P3|Double-blind Treatment Period|Adverse Event|0
260176|NCT01207427|858727|P2|Double-blind Treatment Period|Adverse Event|1
260177|NCT01207427|858728|P1|Double-blind Treatment Period|Adverse Event|0
260178|NCT01207414|858738|P2|Overall Study|Randomized in error|0
260179|NCT01207414|858739|P1|Overall Study|Randomized in error|1
260180|NCT01207414|858738|P2|Overall Study|Protocol deviation|9
260181|NCT01207414|858739|P1|Overall Study|Protocol deviation|12
260182|NCT01207414|858738|P2|Overall Study|Administrative problems|1
260183|NCT01207414|858739|P1|Overall Study|Administrative problems|1
260184|NCT01207414|858738|P2|Overall Study|Lost to Follow-up|17
260185|NCT01207414|858739|P1|Overall Study|Lost to Follow-up|15
260186|NCT01207414|858738|P2|Overall Study|Patient withdrew consent|11
260187|NCT01207414|858739|P1|Overall Study|Patient withdrew consent|14
260188|NCT01207414|858738|P2|Overall Study|Unsatisfactory therapeutic effect|4
260189|NCT01207414|858739|P1|Overall Study|Unsatisfactory therapeutic effect|5
260190|NCT01207414|858738|P2|Overall Study|Abnormal test procedure results|1
260191|NCT01207414|858739|P1|Overall Study|Abnormal test procedure results|0
260192|NCT01207414|858738|P2|Overall Study|Adverse Event|39
260193|NCT01207414|858739|P1|Overall Study|Adverse Event|25
260194|NCT01207388|858764|P1|Overall Study|Other|1
260195|NCT01207388|858764|P1|Overall Study|Physician Decision|2
260196|NCT01207388|858764|P1|Overall Study|Disease Relapse|10
260197|NCT01207388|858764|P1|Overall Study|Adverse Event|20
260198|NCT01207219|858787|P3|Overall Study|Lost to Follow-up|6
260199|NCT01207219|858788|P2|Overall Study|Lost to Follow-up|8
260200|NCT01207219|858789|P1|Overall Study|Lost to Follow-up|6
260201|NCT01207219|858787|P3|Overall Study|changed diagnosis during study period|1
260202|NCT01207219|858788|P2|Overall Study|changed diagnosis during study period|3
260203|NCT01207219|858789|P1|Overall Study|changed diagnosis during study period|5
260204|NCT01207102|858809|P1|Overall Study|Withdrawal by Treating Physician|1
260205|NCT01207102|858809|P1|Overall Study|progression|2
260206|NCT01207102|858809|P1|Overall Study|Adverse Event|2
260207|NCT01207102|858809|P1|Overall Study|Withdrawal by Subject|5
260208|NCT01206777|858814|P1|Overall Study|Adverse Event|1
260209|NCT01206777|858814|P1|Overall Study|Death|1
260210|NCT01206582|858870|P2|Overall Study|Discontinued intervention before week 8|2
260211|NCT01206582|858871|P1|Overall Study|Discontinued intervention before week 8|1
260212|NCT01206582|858870|P2|Overall Study|Withdrew prior to study|0
260213|NCT01206582|858871|P1|Overall Study|Withdrew prior to study|1
260214|NCT01206517|858903|P6|Overall Study|Withdrawal by Subject|0
260215|NCT01206517|858904|P5|Overall Study|Withdrawal by Subject|1
260216|NCT01206517|858905|P4|Overall Study|Withdrawal by Subject|0
260217|NCT01206517|858906|P3|Overall Study|Withdrawal by Subject|2
260218|NCT01206517|858907|P2|Overall Study|Withdrawal by Subject|0
260219|NCT01206517|858908|P1|Overall Study|Withdrawal by Subject|0
260220|NCT01206439|858965|P1|Overall Study|subject did not meet inclusion criteria|1
260221|NCT01206322|858988|P4|Overall Study|Adverse Event|1
260222|NCT01206322|858989|P3|Overall Study|Adverse Event|0
260223|NCT01206322|858990|P2|Overall Study|Adverse Event|0
260224|NCT01206322|858991|P1|Overall Study|Adverse Event|0
260225|NCT01206140|859007|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
260226|NCT01206140|859008|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
260227|NCT01206101|859020|P2|Overall Study|Unclassified|0
260228|NCT01206101|859021|P1|Overall Study|Unclassified|1
260229|NCT01206101|859020|P2|Overall Study|Physician Decision|1
260230|NCT01206101|859021|P1|Overall Study|Physician Decision|0
260231|NCT01206101|859020|P2|Overall Study|Adverse Event|0
260232|NCT01206101|859021|P1|Overall Study|Adverse Event|1
260233|NCT01205685|859045|P1|Overall Study|Withdrawal by Subject|1
260234|NCT01205685|859045|P1|Overall Study|Disease Progression|10
260235|NCT01205581|859062|P6|Overall Study|Withdrawal by Subject|0
260236|NCT01205581|859063|P5|Overall Study|Withdrawal by Subject|0
260237|NCT01205581|859064|P4|Overall Study|Withdrawal by Subject|0
260238|NCT01205581|859065|P3|Overall Study|Withdrawal by Subject|0
260239|NCT01205581|859066|P2|Overall Study|Withdrawal by Subject|0
260240|NCT01205581|859067|P1|Overall Study|Withdrawal by Subject|1
260241|NCT01205451|859150|P2|Overall Study|Withdrawal by Subject|9
260242|NCT01205451|859151|P1|Overall Study|Withdrawal by Subject|5
260243|NCT01205451|859150|P2|Overall Study|Lost to Follow-up|1
260244|NCT01205451|859151|P1|Overall Study|Lost to Follow-up|1
260245|NCT01205269|859199|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
260246|NCT01205269|859200|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
260247|NCT01205269|859201|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
260248|NCT01205269|859202|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
260249|NCT01205269|859203|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
260250|NCT01205269|859204|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
260251|NCT01205230|859244|P2|Overall Study|Physician Decision|0
260252|NCT01205230|859245|P1|Overall Study|Physician Decision|1
260253|NCT01205230|859244|P2|Overall Study|Adverse Event|0
260254|NCT01205230|859245|P1|Overall Study|Adverse Event|4
260255|NCT01205126|859290|P2|Maintenance Phase|Withdrawal by Subject|11
260256|NCT01205126|859291|P1|Maintenance Phase|Withdrawal by Subject|8
260257|NCT01205126|859290|P2|Maintenance Phase|Lost to Follow-up|5
260258|NCT01205126|859291|P1|Maintenance Phase|Lost to Follow-up|5
260259|NCT01205126|859290|P2|Maintenance Phase|Unspecified|8
260260|NCT01205126|859291|P1|Maintenance Phase|Unspecified|11
260261|NCT01205126|859290|P2|Maintenance Phase|Prohibited drugs used|0
260262|NCT01205126|859291|P1|Maintenance Phase|Prohibited drugs used|1
260263|NCT01205126|859290|P2|Maintenance Phase|More than the maximum dosage required|5
260264|NCT01205126|859291|P1|Maintenance Phase|More than the maximum dosage required|5
260265|NCT01205126|859290|P2|Maintenance Phase|Death|4
260266|NCT01205126|859291|P1|Maintenance Phase|Death|4
260267|NCT01205126|859290|P2|Maintenance Phase|Adverse Event|7
260268|NCT01205126|859291|P1|Maintenance Phase|Adverse Event|3
260269|NCT01205126|859290|P2|Between Titration & Maintenance Phase|Unspecified|4
260270|NCT01205126|859291|P1|Between Titration & Maintenance Phase|Unspecified|0
260271|NCT01205126|859290|P2|Titration Phase|Unspecified|6
260272|NCT01205126|859291|P1|Titration Phase|Unspecified|8
260273|NCT01205126|859290|P2|Titration Phase|More than maximum dosage required|3
260274|NCT01205126|859291|P1|Titration Phase|More than maximum dosage required|2
260275|NCT01205126|859290|P2|Titration Phase|No stable titration dose|0
260276|NCT01205126|859291|P1|Titration Phase|No stable titration dose|1
260277|NCT01205126|859290|P2|Titration Phase|Lost to Follow-up|2
260278|NCT01205126|859291|P1|Titration Phase|Lost to Follow-up|2
260279|NCT01205126|859290|P2|Titration Phase|Withdrawal by Subject|5
260280|NCT01205126|859291|P1|Titration Phase|Withdrawal by Subject|5
260281|NCT01205126|859290|P2|Titration Phase|Adverse Event|3
260282|NCT01205126|859291|P1|Titration Phase|Adverse Event|5
260283|NCT01205035|859309|P2|Overall Study|Physician Decision|0
260284|NCT01205035|859310|P1|Overall Study|Physician Decision|1
260285|NCT01205035|859309|P2|Overall Study|Withdrawal by Subject|0
260286|NCT01205035|859310|P1|Overall Study|Withdrawal by Subject|1
260287|NCT01204775|859345|P2|Overall Study|Withdrawal by Subject|0
260288|NCT01204775|859346|P1|Overall Study|Withdrawal by Subject|1
260289|NCT01204775|859345|P2|Overall Study|Poor/non-compliance|1
260290|NCT01204775|859346|P1|Overall Study|Poor/non-compliance|0
260291|NCT01204697|859371|P2|Overall Study|Randomized, but not treated|1
260292|NCT01204697|859372|P1|Overall Study|Randomized, but not treated|0
260293|NCT01204697|859371|P2|Overall Study|Withdrawal by Subject|4
260294|NCT01204697|859372|P1|Overall Study|Withdrawal by Subject|2
260295|NCT01204697|859371|P2|Overall Study|Lost to Follow-up|4
260296|NCT01204697|859372|P1|Overall Study|Lost to Follow-up|3
260297|NCT01204697|859371|P2|Overall Study|Death|27
260298|NCT01204697|859372|P1|Overall Study|Death|26
260299|NCT01204671|859393|P5|Overall Study|Physician Decision|0
260300|NCT01204671|859394|P4|Overall Study|Physician Decision|1
260301|NCT01204671|859395|P3|Overall Study|Physician Decision|0
260302|NCT01204671|859396|P2|Overall Study|Physician Decision|0
260303|NCT01204671|859397|P1|Overall Study|Physician Decision|0
260304|NCT01204671|859393|P5|Overall Study|Unknown Completion Status|0
260305|NCT01204671|859394|P4|Overall Study|Unknown Completion Status|0
260306|NCT01204671|859395|P3|Overall Study|Unknown Completion Status|0
260307|NCT01204671|859396|P2|Overall Study|Unknown Completion Status|1
260308|NCT01204671|859397|P1|Overall Study|Unknown Completion Status|1
260309|NCT01204671|859393|P5|Overall Study|Lost to Follow-up|0
260310|NCT01204671|859394|P4|Overall Study|Lost to Follow-up|4
260311|NCT01204671|859395|P3|Overall Study|Lost to Follow-up|6
260312|NCT01204671|859396|P2|Overall Study|Lost to Follow-up|8
260313|NCT01204671|859397|P1|Overall Study|Lost to Follow-up|7
260314|NCT01204671|859393|P5|Overall Study|Withdrawal by Subject|3
260315|NCT01204671|859394|P4|Overall Study|Withdrawal by Subject|5
260316|NCT01204671|859395|P3|Overall Study|Withdrawal by Subject|4
260317|NCT01204671|859396|P2|Overall Study|Withdrawal by Subject|3
260318|NCT01204671|859397|P1|Overall Study|Withdrawal by Subject|2
260319|NCT01204671|859393|P5|Overall Study|Adverse Event|1
260320|NCT01204671|859394|P4|Overall Study|Adverse Event|3
260321|NCT01204671|859395|P3|Overall Study|Adverse Event|3
260322|NCT01204671|859396|P2|Overall Study|Adverse Event|3
260323|NCT01204671|859397|P1|Overall Study|Adverse Event|4
260324|NCT01204658|859459|P4|Primary Phase|Adverse Event|0
260325|NCT01204658|859460|P3|Primary Phase|Adverse Event|1
260326|NCT01204658|859461|P2|Primary Phase|Adverse Event|0
260327|NCT01204658|859462|P1|Primary Phase|Adverse Event|0
260328|NCT01204398|859572|P1|Overall Study|Adverse Event|1
260329|NCT01204294|859589|P7|Overall Study|Other (house moving)|0
260330|NCT01204294|859590|P6|Overall Study|Other (house moving)|0
260331|NCT01204294|859591|P5|Overall Study|Other (house moving)|0
260332|NCT01204294|859592|P4|Overall Study|Other (house moving)|0
260333|NCT01204294|859593|P3|Overall Study|Other (house moving)|1
260334|NCT01204294|859594|P2|Overall Study|Other (house moving)|0
260335|NCT01204294|859595|P1|Overall Study|Other (house moving)|0
260336|NCT01204294|859589|P7|Overall Study|Lack of Efficacy|0
260337|NCT01204294|859590|P6|Overall Study|Lack of Efficacy|0
260338|NCT01204294|859591|P5|Overall Study|Lack of Efficacy|0
260339|NCT01204294|859592|P4|Overall Study|Lack of Efficacy|2
260340|NCT01204294|859593|P3|Overall Study|Lack of Efficacy|0
260341|NCT01204294|859594|P2|Overall Study|Lack of Efficacy|0
260342|NCT01204294|859595|P1|Overall Study|Lack of Efficacy|0
260343|NCT01204294|859589|P7|Overall Study|Withdrawal by Subject|2
260344|NCT01204294|859590|P6|Overall Study|Withdrawal by Subject|1
260345|NCT01204294|859591|P5|Overall Study|Withdrawal by Subject|1
260346|NCT01204294|859592|P4|Overall Study|Withdrawal by Subject|1
260347|NCT01204294|859593|P3|Overall Study|Withdrawal by Subject|2
260348|NCT01204294|859594|P2|Overall Study|Withdrawal by Subject|2
260349|NCT01204294|859595|P1|Overall Study|Withdrawal by Subject|0
260350|NCT01204294|859589|P7|Overall Study|Protocol Violation|0
260351|NCT01204294|859590|P6|Overall Study|Protocol Violation|0
260352|NCT01204294|859591|P5|Overall Study|Protocol Violation|0
260353|NCT01204294|859592|P4|Overall Study|Protocol Violation|1
260354|NCT01204294|859593|P3|Overall Study|Protocol Violation|2
260355|NCT01204294|859594|P2|Overall Study|Protocol Violation|0
260356|NCT01204294|859595|P1|Overall Study|Protocol Violation|1
260357|NCT01204294|859589|P7|Overall Study|Adverse Event|0
260358|NCT01204294|859590|P6|Overall Study|Adverse Event|4
260359|NCT01204294|859591|P5|Overall Study|Adverse Event|1
260360|NCT01204294|859592|P4|Overall Study|Adverse Event|7
260361|NCT01204294|859593|P3|Overall Study|Adverse Event|0
260362|NCT01204294|859594|P2|Overall Study|Adverse Event|6
260363|NCT01204294|859595|P1|Overall Study|Adverse Event|2
260364|NCT01203956|859628|P2|Second Two-week Period|Non-compliant: no evaluable results|6
260365|NCT01203956|859629|P1|Second Two-week Period|Non-compliant: no evaluable results|5
260366|NCT01203930|859638|P2|Overall Study|Adverse Event|5
260367|NCT01203930|859639|P1|Overall Study|Adverse Event|17
260368|NCT01203930|859638|P2|Overall Study|Poor tolerance of study drug|1
260369|NCT01203930|859639|P1|Overall Study|Poor tolerance of study drug|0
260370|NCT01203930|859638|P2|Overall Study|Study Terminated by Sponsor|12
260371|NCT01203930|859639|P1|Overall Study|Study Terminated by Sponsor|0
260372|NCT01203930|859638|P2|Overall Study|Investigator Request|8
260373|NCT01203930|859639|P1|Overall Study|Investigator Request|0
260374|NCT01203930|859638|P2|Overall Study|Withdrew Consent|10
260375|NCT01203930|859639|P1|Overall Study|Withdrew Consent|1
260376|NCT01203930|859638|P2|Overall Study|Death|1
260377|NCT01203930|859639|P1|Overall Study|Death|3
260378|NCT01203930|859638|P2|Overall Study|Disease Progression|4
260379|NCT01203930|859639|P1|Overall Study|Disease Progression|0
260380|NCT01203917|859661|P1|Overall Study|Due to EGFR M+I patient|1
260381|NCT01203917|859661|P1|Overall Study|Due to objective disease progression|1
260382|NCT01203917|859661|P1|Overall Study|Withdrawal by Subject|3
260383|NCT01203917|859661|P1|Overall Study|Lost to Follow-up|2
260384|NCT01203917|859661|P1|Overall Study|Death|29
260385|NCT01203878|859674|P3|Overall Study|Adverse Event|2
260386|NCT01203878|859675|P2|Overall Study|Adverse Event|0
260387|NCT01203878|859676|P1|Overall Study|Adverse Event|0
260388|NCT01203878|859674|P3|Overall Study|Withdrawal by Subject|1
260389|NCT01203878|859675|P2|Overall Study|Withdrawal by Subject|0
260390|NCT01203878|859676|P1|Overall Study|Withdrawal by Subject|0
260391|NCT01203852|859687|P1|Washout 2 Weeks|Physician Decision|46
260392|NCT01203852|859687|P1|Metoprolol 8 Weeks|Physician Decision|470
260393|NCT01203787|859696|P2|Overall Study|Adverse Event|15
260394|NCT01203787|859697|P1|Overall Study|Adverse Event|11
260395|NCT01203787|859696|P2|Overall Study|Lost to Follow-up|0
260396|NCT01203787|859697|P1|Overall Study|Lost to Follow-up|2
260397|NCT01203787|859696|P2|Overall Study|Withdrawal by Subject|2
260398|NCT01203787|859697|P1|Overall Study|Withdrawal by Subject|6
260399|NCT01203787|859696|P2|Overall Study|Death|10
260400|NCT01203787|859697|P1|Overall Study|Death|12
260401|NCT01203098|859749|P3|Overall Study|Withdrawal by Subject|3
260402|NCT01203098|859750|P2|Overall Study|Withdrawal by Subject|1
260403|NCT01203098|859751|P1|Overall Study|Withdrawal by Subject|1
260404|NCT01203098|859749|P3|Overall Study|Physician Decision|0
260405|NCT01203098|859750|P2|Overall Study|Physician Decision|2
260406|NCT01203098|859751|P1|Overall Study|Physician Decision|2
260407|NCT01203098|859749|P3|Overall Study|Lost to Follow-up|1
260408|NCT01203098|859750|P2|Overall Study|Lost to Follow-up|0
260409|NCT01203098|859751|P1|Overall Study|Lost to Follow-up|0
260410|NCT01203098|859749|P3|Overall Study|Adverse Event|7
260411|NCT01203098|859750|P2|Overall Study|Adverse Event|1
260412|NCT01203098|859751|P1|Overall Study|Adverse Event|3
260413|NCT01203072|859767|P5|Overall Study|Withdrawal by Subject|3
260414|NCT01203072|859768|P4|Overall Study|Withdrawal by Subject|2
260415|NCT01203072|859769|P3|Overall Study|Withdrawal by Subject|1
260416|NCT01203072|859770|P2|Overall Study|Withdrawal by Subject|2
260417|NCT01203072|859771|P1|Overall Study|Withdrawal by Subject|2
260418|NCT01203072|859767|P5|Overall Study|Protocol Violation|1
260419|NCT01203072|859768|P4|Overall Study|Protocol Violation|0
260420|NCT01203072|859769|P3|Overall Study|Protocol Violation|0
260421|NCT01203072|859770|P2|Overall Study|Protocol Violation|0
260422|NCT01203072|859771|P1|Overall Study|Protocol Violation|2
260423|NCT01203072|859767|P5|Overall Study|Lost to Follow-up|0
260424|NCT01203072|859768|P4|Overall Study|Lost to Follow-up|0
260425|NCT01203072|859769|P3|Overall Study|Lost to Follow-up|0
260426|NCT01203072|859770|P2|Overall Study|Lost to Follow-up|1
260427|NCT01203072|859771|P1|Overall Study|Lost to Follow-up|0
260428|NCT01203072|859767|P5|Overall Study|Lack of Efficacy|0
260429|NCT01203072|859768|P4|Overall Study|Lack of Efficacy|0
260430|NCT01203072|859769|P3|Overall Study|Lack of Efficacy|0
260431|NCT01203072|859770|P2|Overall Study|Lack of Efficacy|0
260432|NCT01203072|859771|P1|Overall Study|Lack of Efficacy|1
260433|NCT01203072|859767|P5|Overall Study|Adverse Event|2
260434|NCT01203072|859768|P4|Overall Study|Adverse Event|4
260435|NCT01203072|859769|P3|Overall Study|Adverse Event|2
260436|NCT01203072|859770|P2|Overall Study|Adverse Event|3
260437|NCT01203072|859771|P1|Overall Study|Adverse Event|5
260438|NCT01202955|859801|P2|Period 1: 10 Days|Withdrawal by Subject|2
260439|NCT01202955|859802|P1|Period 1: 10 Days|Withdrawal by Subject|0
260440|NCT01202903|859814|P2|Overall Study|Withdrawal by Subject|4
260441|NCT01202903|859815|P1|Overall Study|Withdrawal by Subject|4
260442|NCT01202903|859814|P2|Overall Study|Adverse Event|3
260443|NCT01202903|859815|P1|Overall Study|Adverse Event|3
260444|NCT01202903|859814|P2|Overall Study|Lack of Efficacy|3
260445|NCT01202903|859815|P1|Overall Study|Lack of Efficacy|1
260446|NCT01202903|859814|P2|Overall Study|Lost to Follow-up|1
260447|NCT01202903|859815|P1|Overall Study|Lost to Follow-up|1
260448|NCT01202903|859814|P2|Overall Study|Death|0
260449|NCT01202903|859815|P1|Overall Study|Death|1
260450|NCT01202903|859814|P2|Overall Study|Protocol Violation|1
260451|NCT01202903|859815|P1|Overall Study|Protocol Violation|0
260452|NCT01202903|859814|P2|Overall Study|Administrative Probelms|4
260453|NCT01202903|859815|P1|Overall Study|Administrative Probelms|1
260454|NCT01202877|859842|P3|Overall Study|Death|1
260455|NCT01202877|859843|P2|Overall Study|Death|0
260456|NCT01202877|859844|P1|Overall Study|Death|0
260457|NCT01202877|859842|P3|Overall Study|Withdrawal by Subject|1
260458|NCT01202877|859843|P2|Overall Study|Withdrawal by Subject|0
260459|NCT01202877|859844|P1|Overall Study|Withdrawal by Subject|0
260460|NCT01202877|859842|P3|Overall Study|Adverse Event|2
260461|NCT01202877|859843|P2|Overall Study|Adverse Event|0
260462|NCT01202877|859844|P1|Overall Study|Adverse Event|0
260463|NCT01202877|859842|P3|Overall Study|Disease Progression|2
260464|NCT01202877|859843|P2|Overall Study|Disease Progression|1
260465|NCT01202877|859844|P1|Overall Study|Disease Progression|0
260466|NCT01202747|859853|P1|Overall Study|Withdrawal by Subject|1
260467|NCT01202591|859885|P6|Overall Study|Objective Disease Progression|0
260468|NCT01202591|859886|P5|Overall Study|Objective Disease Progression|2
260469|NCT01202591|859887|P4|Overall Study|Objective Disease Progression|0
260470|NCT01202591|859888|P3|Overall Study|Objective Disease Progression|0
260471|NCT01202591|859889|P2|Overall Study|Objective Disease Progression|0
260472|NCT01202591|859890|P1|Overall Study|Objective Disease Progression|0
260473|NCT01202591|859885|P6|Overall Study|Withdrawal by Subject|1
260474|NCT01202591|859886|P5|Overall Study|Withdrawal by Subject|2
260475|NCT01202591|859887|P4|Overall Study|Withdrawal by Subject|0
260476|NCT01202591|859888|P3|Overall Study|Withdrawal by Subject|0
260477|NCT01202591|859889|P2|Overall Study|Withdrawal by Subject|0
260478|NCT01202591|859890|P1|Overall Study|Withdrawal by Subject|0
260479|NCT01202591|859885|P6|Overall Study|Other reason as per investigator|3
260480|NCT01202591|859886|P5|Overall Study|Other reason as per investigator|1
260481|NCT01202591|859887|P4|Overall Study|Other reason as per investigator|3
260482|NCT01202591|859888|P3|Overall Study|Other reason as per investigator|7
260483|NCT01202591|859889|P2|Overall Study|Other reason as per investigator|4
260484|NCT01202591|859890|P1|Overall Study|Other reason as per investigator|3
260485|NCT01202591|859885|P6|Overall Study|Adverse Event|0
260486|NCT01202591|859886|P5|Overall Study|Adverse Event|0
260487|NCT01202591|859887|P4|Overall Study|Adverse Event|4
260488|NCT01202591|859888|P3|Overall Study|Adverse Event|4
260489|NCT01202591|859889|P2|Overall Study|Adverse Event|1
260490|NCT01202591|859890|P1|Overall Study|Adverse Event|2
260491|NCT01202279|859936|P2|Overall Study|study compliance|2
260492|NCT01202279|859937|P1|Overall Study|study compliance|5
260493|NCT01202279|859936|P2|Overall Study|Protocol Violation|1
260494|NCT01202279|859937|P1|Overall Study|Protocol Violation|1
260495|NCT01202279|859936|P2|Overall Study|Lost to Follow-up|7
260496|NCT01202279|859937|P1|Overall Study|Lost to Follow-up|10
260497|NCT01202279|859936|P2|Overall Study|Physician Decision|1
260498|NCT01202279|859937|P1|Overall Study|Physician Decision|0
260499|NCT01202279|859936|P2|Overall Study|Withdrawal by Subject|10
260500|NCT01202279|859937|P1|Overall Study|Withdrawal by Subject|13
260501|NCT01202279|859936|P2|Overall Study|Adverse Event|6
260502|NCT01202279|859937|P1|Overall Study|Adverse Event|8
260503|NCT01202227|859989|P1|Overall Study|Lack of Efficacy|1
260504|NCT01202227|859989|P1|Overall Study|Withdrawal by Subject|2
260505|NCT01202227|859989|P1|Overall Study|Adverse Event|16
260506|NCT01202188|860013|P5|Overall Study|Abnormal test procedure result (s)|0
260507|NCT01202188|860014|P4|Overall Study|Abnormal test procedure result (s)|0
260508|NCT01202188|860015|P3|Overall Study|Abnormal test procedure result (s)|2
260509|NCT01202188|860016|P2|Overall Study|Abnormal test procedure result (s)|0
260510|NCT01202188|860017|P1|Overall Study|Abnormal test procedure result (s)|0
260511|NCT01202188|860013|P5|Overall Study|Death|0
260512|NCT01202188|860014|P4|Overall Study|Death|1
260513|NCT01202188|860015|P3|Overall Study|Death|1
260514|NCT01202188|860016|P2|Overall Study|Death|1
260515|NCT01202188|860017|P1|Overall Study|Death|1
260516|NCT01202188|860013|P5|Overall Study|Lost to Follow-up|1
260517|NCT01202188|860014|P4|Overall Study|Lost to Follow-up|4
260518|NCT01202188|860015|P3|Overall Study|Lost to Follow-up|0
260519|NCT01202188|860016|P2|Overall Study|Lost to Follow-up|1
260520|NCT01202188|860017|P1|Overall Study|Lost to Follow-up|1
260521|NCT01202188|860013|P5|Overall Study|Unsatisfactory therapeutic effect|8
260522|NCT01202188|860014|P4|Overall Study|Unsatisfactory therapeutic effect|5
260523|NCT01202188|860015|P3|Overall Study|Unsatisfactory therapeutic effect|2
260524|NCT01202188|860016|P2|Overall Study|Unsatisfactory therapeutic effect|8
260525|NCT01202188|860017|P1|Overall Study|Unsatisfactory therapeutic effect|2
260526|NCT01202188|860013|P5|Overall Study|Administrative problems|2
260527|NCT01202188|860014|P4|Overall Study|Administrative problems|1
260528|NCT01202188|860015|P3|Overall Study|Administrative problems|1
260529|NCT01202188|860016|P2|Overall Study|Administrative problems|2
260530|NCT01202188|860017|P1|Overall Study|Administrative problems|3
260531|NCT01202188|860013|P5|Overall Study|Adverse Event|10
260532|NCT01202188|860014|P4|Overall Study|Adverse Event|10
260533|NCT01202188|860015|P3|Overall Study|Adverse Event|13
260534|NCT01202188|860016|P2|Overall Study|Adverse Event|23
260535|NCT01202188|860017|P1|Overall Study|Adverse Event|5
260536|NCT01202188|860013|P5|Overall Study|Subject withdrew consent|13
260537|NCT01202188|860014|P4|Overall Study|Subject withdrew consent|11
260538|NCT01202188|860015|P3|Overall Study|Subject withdrew consent|22
260539|NCT01202188|860016|P2|Overall Study|Subject withdrew consent|13
260540|NCT01202188|860017|P1|Overall Study|Subject withdrew consent|12
260541|NCT01202188|860013|P5|Overall Study|Protocol deviation|11
260542|NCT01202188|860014|P4|Overall Study|Protocol deviation|10
260543|NCT01202188|860015|P3|Overall Study|Protocol deviation|12
260544|NCT01202188|860016|P2|Overall Study|Protocol deviation|8
260545|NCT01202188|860017|P1|Overall Study|Protocol deviation|14
260546|NCT01201967|860164|P2|Overall Study|Lost to Follow-up|5
260547|NCT01201967|860165|P1|Overall Study|Lost to Follow-up|6
260548|NCT01201915|860190|P3|Overall Study|Target Lesion Progression|0
260549|NCT01201915|860191|P2|Overall Study|Target Lesion Progression|3
260550|NCT01201915|860192|P1|Overall Study|Target Lesion Progression|0
260551|NCT01201915|860190|P3|Overall Study|Subject Decision|5
260552|NCT01201915|860191|P2|Overall Study|Subject Decision|3
260553|NCT01201915|860192|P1|Overall Study|Subject Decision|3
260554|NCT01201915|860190|P3|Overall Study|Physician Decision|0
260555|NCT01201915|860191|P2|Overall Study|Physician Decision|0
260556|NCT01201915|860192|P1|Overall Study|Physician Decision|3
260557|NCT01201915|860190|P3|Overall Study|Lost to Follow-up|0
260558|NCT01201915|860191|P2|Overall Study|Lost to Follow-up|4
260559|NCT01201915|860192|P1|Overall Study|Lost to Follow-up|0
260560|NCT01201915|860190|P3|Overall Study|Adverse Event|1
260561|NCT01201915|860191|P2|Overall Study|Adverse Event|1
260562|NCT01201915|860192|P1|Overall Study|Adverse Event|2
260563|NCT01200810|860205|P2|Overall Study|Sponsor stopped making study drug|3
260564|NCT01200810|860206|P1|Overall Study|Sponsor stopped making study drug|3
260565|NCT01200810|860205|P2|Overall Study|Withdrawal by Subject|2
260566|NCT01200810|860206|P1|Overall Study|Withdrawal by Subject|1
260567|NCT01200810|860205|P2|Overall Study|Physician Decision|0
260568|NCT01200810|860206|P1|Overall Study|Physician Decision|1
260569|NCT01200797|860224|P1|Overall Study|Disease Progression|13
260570|NCT01200797|860224|P1|Overall Study|Adverse Event|4
260571|NCT01200797|860224|P1|Overall Study|symptomatic deterioration|2
260572|NCT01200758|860234|P4|Stage 2|Ongoing Treatment Period|108
260573|NCT01200758|860235|P3|Stage 2|Ongoing Treatment Period|117
260574|NCT01200758|860236|P2|Stage 2|Ongoing Treatment Period|0
260575|NCT01200758|860237|P1|Stage 2|Ongoing Treatment Period|0
260576|NCT01200758|860234|P4|Stage 2|Death|4
260577|NCT01200758|860235|P3|Stage 2|Death|1
260578|NCT01200758|860236|P2|Stage 2|Death|0
260579|NCT01200758|860237|P1|Stage 2|Death|0
260580|NCT01200758|860234|P4|Stage 2|Protocol Violation|4
260581|NCT01200758|860235|P3|Stage 2|Protocol Violation|1
260582|NCT01200758|860236|P2|Stage 2|Protocol Violation|0
260583|NCT01200758|860237|P1|Stage 2|Protocol Violation|0
260584|NCT01200758|860234|P4|Stage 2|Lost to Follow-up|0
260585|NCT01200758|860235|P3|Stage 2|Lost to Follow-up|1
260586|NCT01200758|860236|P2|Stage 2|Lost to Follow-up|0
260587|NCT01200758|860237|P1|Stage 2|Lost to Follow-up|0
260588|NCT01200758|860234|P4|Stage 2|Withdrawal by Subject|1
260589|NCT01200758|860235|P3|Stage 2|Withdrawal by Subject|2
260590|NCT01200758|860236|P2|Stage 2|Withdrawal by Subject|0
260591|NCT01200758|860237|P1|Stage 2|Withdrawal by Subject|0
260592|NCT01200758|860234|P4|Stage 2|Adverse Event|2
260593|NCT01200758|860235|P3|Stage 2|Adverse Event|3
260594|NCT01200758|860236|P2|Stage 2|Adverse Event|0
260595|NCT01200758|860237|P1|Stage 2|Adverse Event|0
260596|NCT01200758|860234|P4|Stage 2|Investigator's Judgement|5
260597|NCT01200758|860235|P3|Stage 2|Investigator's Judgement|4
260598|NCT01200758|860236|P2|Stage 2|Investigator's Judgement|0
260599|NCT01200758|860237|P1|Stage 2|Investigator's Judgement|0
260600|NCT01200758|860234|P4|Stage 2|Lack of Efficacy|2
260601|NCT01200758|860235|P3|Stage 2|Lack of Efficacy|4
260602|NCT01200758|860236|P2|Stage 2|Lack of Efficacy|0
260603|NCT01200758|860237|P1|Stage 2|Lack of Efficacy|0
260604|NCT01200758|860234|P4|Stage 2|Disease Progression|16
260605|NCT01200758|860235|P3|Stage 2|Disease Progression|8
260606|NCT01200758|860236|P2|Stage 2|Disease Progression|0
260607|NCT01200758|860237|P1|Stage 2|Disease Progression|0
260608|NCT01200758|860234|P4|Stage I|Ongoing Treatment Period|0
260609|NCT01200758|860235|P3|Stage I|Ongoing Treatment Period|0
260610|NCT01200758|860236|P2|Stage I|Ongoing Treatment Period|32
260611|NCT01200758|860237|P1|Stage I|Ongoing Treatment Period|30
260612|NCT01200758|860234|P4|Stage I|Disease Progression|0
260613|NCT01200758|860235|P3|Stage I|Disease Progression|0
260614|NCT01200758|860236|P2|Stage I|Disease Progression|7
260615|NCT01200758|860237|P1|Stage I|Disease Progression|9
260616|NCT01200758|860234|P4|Stage I|Withdrawal by Subject|0
260617|NCT01200758|860235|P3|Stage I|Withdrawal by Subject|0
260618|NCT01200758|860236|P2|Stage I|Withdrawal by Subject|2
260619|NCT01200758|860237|P1|Stage I|Withdrawal by Subject|0
260620|NCT01200758|860234|P4|Stage I|Adverse Event|0
260621|NCT01200758|860235|P3|Stage I|Adverse Event|0
260622|NCT01200758|860236|P2|Stage I|Adverse Event|3
260623|NCT01200758|860237|P1|Stage I|Adverse Event|5
260624|NCT01200758|860234|P4|Stage I|Lack of Efficacy|0
260625|NCT01200758|860235|P3|Stage I|Lack of Efficacy|0
260626|NCT01200758|860236|P2|Stage I|Lack of Efficacy|0
260627|NCT01200758|860237|P1|Stage I|Lack of Efficacy|2
260628|NCT01200758|860234|P4|Stage I|Investigator's judgement|0
260629|NCT01200758|860235|P3|Stage I|Investigator's judgement|0
260630|NCT01200758|860236|P2|Stage I|Investigator's judgement|2
260631|NCT01200758|860237|P1|Stage I|Investigator's judgement|1
260632|NCT01200758|860234|P4|Stage I|Death|0
260633|NCT01200758|860235|P3|Stage I|Death|0
260634|NCT01200758|860236|P2|Stage I|Death|1
260635|NCT01200758|860237|P1|Stage I|Death|0
260636|NCT01201811|860281|P1|Overall Study|Physician Decision|1
260637|NCT01201811|860281|P1|Overall Study|Treatment Failure|2
260638|NCT01201811|860281|P1|Overall Study|Death|4
260639|NCT01201811|860281|P1|Overall Study|Withdrawal by Subject|3
260640|NCT01201811|860281|P1|Overall Study|Disease progression|3
260641|NCT01201811|860281|P1|Overall Study|Adverse Event|6
260642|NCT01201798|860303|P2|Overall Study|Treatment Failure|8
260643|NCT01201798|860304|P1|Overall Study|Treatment Failure|1
260644|NCT01201798|860303|P2|Overall Study|Protocol Violation|1
260645|NCT01201798|860304|P1|Overall Study|Protocol Violation|1
260646|NCT01201798|860303|P2|Overall Study|Noncompliance|0
260647|NCT01201798|860304|P1|Overall Study|Noncompliance|1
260648|NCT01201798|860303|P2|Overall Study|Decision Unrelated to an Adverse Event|1
260649|NCT01201798|860304|P1|Overall Study|Decision Unrelated to an Adverse Event|1
260650|NCT01201798|860303|P2|Overall Study|Lost to Follow-up|5
260651|NCT01201798|860304|P1|Overall Study|Lost to Follow-up|3
260652|NCT01201798|860303|P2|Overall Study|Adverse Event|0
260653|NCT01201798|860304|P1|Overall Study|Adverse Event|2
260654|NCT01201785|860328|P1|Overall Study|Lost to Follow-up|16
260655|NCT01201759|860345|P2|Visit 4 Crossover|Lost to Follow-up|1
260656|NCT01201759|860346|P1|Visit 4 Crossover|Lost to Follow-up|0
260657|NCT01201759|860345|P2|Visit 3 - Washout|Lost to Follow-up|0
260658|NCT01201759|860346|P1|Visit 3 - Washout|Lost to Follow-up|1
260659|NCT01201759|860345|P2|Visit 3 - Washout|Adverse Event|3
260660|NCT01201759|860346|P1|Visit 3 - Washout|Adverse Event|0
260661|NCT01201759|860345|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
260662|NCT01201759|860346|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
260663|NCT01201343|860375|P1|Overall Study|Randomized, not treated|3
260664|NCT01201343|860375|P1|Overall Study|Participant wrongly included in trial|1
260665|NCT01201343|860375|P1|Overall Study|Lack of Efficacy|2
260666|NCT01201343|860375|P1|Overall Study|Lost to Follow-up|2
260667|NCT01201343|860375|P1|Overall Study|Withdrawal by Subject|5
260668|NCT01201343|860375|P1|Overall Study|Adverse Event|6
260669|NCT01201317|860389|P3|Overall Study|Safety, possible history of tuberculosis|1
260670|NCT01201317|860390|P2|Overall Study|Safety, possible history of tuberculosis|0
260671|NCT01201317|860391|P1|Overall Study|Safety, possible history of tuberculosis|0
260672|NCT01201317|860389|P3|Overall Study|Lack of Efficacy|0
260673|NCT01201317|860390|P2|Overall Study|Lack of Efficacy|0
260674|NCT01201317|860391|P1|Overall Study|Lack of Efficacy|1
260675|NCT01201317|860389|P3|Overall Study|Decrease in renal function|0
260676|NCT01201317|860390|P2|Overall Study|Decrease in renal function|1
260677|NCT01201317|860391|P1|Overall Study|Decrease in renal function|0
260678|NCT01201317|860389|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
260679|NCT01201317|860390|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
260680|NCT01201317|860391|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
260681|NCT01201317|860389|P3|Overall Study|Study-specific withdrawal criteria|1
260682|NCT01201317|860390|P2|Overall Study|Study-specific withdrawal criteria|0
260683|NCT01201317|860391|P1|Overall Study|Study-specific withdrawal criteria|0
260684|NCT01201317|860389|P3|Overall Study|Death|0
260685|NCT01201317|860390|P2|Overall Study|Death|1
260686|NCT01201317|860391|P1|Overall Study|Death|0
260687|NCT01201317|860389|P3|Overall Study|Protocol Violation|1
260688|NCT01201317|860390|P2|Overall Study|Protocol Violation|1
260689|NCT01201317|860391|P1|Overall Study|Protocol Violation|0
260690|NCT01201317|860389|P3|Overall Study|Screen failure|0
260691|NCT01201317|860390|P2|Overall Study|Screen failure|1
260692|NCT01201317|860391|P1|Overall Study|Screen failure|1
260693|NCT01201317|860389|P3|Overall Study|Adverse Event|2
260694|NCT01201317|860390|P2|Overall Study|Adverse Event|2
260695|NCT01201317|860391|P1|Overall Study|Adverse Event|2
260696|NCT01201317|860389|P3|Overall Study|Withdrawal by Subject|3
260697|NCT01201317|860390|P2|Overall Study|Withdrawal by Subject|0
260698|NCT01201317|860391|P1|Overall Study|Withdrawal by Subject|5
260699|NCT01201265|860411|P1|Overall Study|Disease Progression|4
260700|NCT01201265|860411|P1|Overall Study|Withdrawal by Subject|7
260701|NCT01201265|860411|P1|Overall Study|Lost to Follow-up|10
260702|NCT01201265|860411|P1|Overall Study|Insufficient Therapeutic Response|3
260703|NCT01201265|860411|P1|Overall Study|Death|14
260704|NCT01200992|860425|P2|Overall Study|Randomized but not treated|0
260705|NCT01200992|860426|P1|Overall Study|Randomized but not treated|2
260706|NCT01200992|860425|P2|Overall Study|Study terminated early|41
260707|NCT01200992|860426|P1|Overall Study|Study terminated early|35
260708|NCT01200524|860456|P3|Overall Study|Non availability of study nurse|1
260709|NCT01200524|860457|P2|Overall Study|Non availability of study nurse|0
260710|NCT01200524|860458|P1|Overall Study|Non availability of study nurse|0
260711|NCT01200524|860456|P3|Overall Study|Adverse Event|0
260712|NCT01200524|860457|P2|Overall Study|Adverse Event|0
260713|NCT01200524|860458|P1|Overall Study|Adverse Event|1
260714|NCT01200524|860456|P3|Overall Study|Withdrawal by Subject|3
260715|NCT01200524|860457|P2|Overall Study|Withdrawal by Subject|1
260716|NCT01200524|860458|P1|Overall Study|Withdrawal by Subject|1
260717|NCT01200511|860478|P1|Overall Study|Adverse Event|1
260718|NCT01200511|860478|P1|Overall Study|Withdrawal by Subject|1
260719|NCT01200511|860478|P1|Overall Study|Lost to Follow-up|3
260720|NCT01200368|860516|P3|Toddler Dose|Adverse Event|1
260721|NCT01200368|860517|P2|Toddler Dose|Adverse Event|3
260722|NCT01200368|860518|P1|Toddler Dose|Adverse Event|0
260723|NCT01200368|860516|P3|After Infant Series|Unspecified|2
260724|NCT01200368|860517|P2|After Infant Series|Unspecified|2
260725|NCT01200368|860518|P1|After Infant Series|Unspecified|1
260726|NCT01200368|860516|P3|After Infant Series|Lost to Follow-up|0
260727|NCT01200368|860517|P2|After Infant Series|Lost to Follow-up|0
260728|NCT01200368|860518|P1|After Infant Series|Lost to Follow-up|1
260729|NCT01200368|860516|P3|After Infant Series|Withdrawal by Subject|4
260730|NCT01200368|860517|P2|After Infant Series|Withdrawal by Subject|8
260731|NCT01200368|860518|P1|After Infant Series|Withdrawal by Subject|10
260732|NCT01200368|860516|P3|After Infant Series|Adverse Event|3
260733|NCT01200368|860517|P2|After Infant Series|Adverse Event|6
260734|NCT01200368|860518|P1|After Infant Series|Adverse Event|6
260735|NCT01200368|860516|P3|Infant Series|Unspecified|0
260736|NCT01200368|860517|P2|Infant Series|Unspecified|0
260737|NCT01200368|860518|P1|Infant Series|Unspecified|1
260738|NCT01200368|860516|P3|Infant Series|Randomized, not vaccinated|1
260739|NCT01200368|860517|P2|Infant Series|Randomized, not vaccinated|1
260740|NCT01200368|860518|P1|Infant Series|Randomized, not vaccinated|0
260741|NCT01200368|860516|P3|Infant Series|Did not meet entrance criteria|0
260742|NCT01200368|860517|P2|Infant Series|Did not meet entrance criteria|1
260743|NCT01200368|860518|P1|Infant Series|Did not meet entrance criteria|0
260744|NCT01200368|860516|P3|Infant Series|Withdrawal by Subject|2
260745|NCT01200368|860517|P2|Infant Series|Withdrawal by Subject|2
260746|NCT01200368|860518|P1|Infant Series|Withdrawal by Subject|0
260747|NCT01200368|860516|P3|Infant Series|Adverse Event|3
260748|NCT01200368|860517|P2|Infant Series|Adverse Event|2
260749|NCT01200368|860518|P1|Infant Series|Adverse Event|2
260750|NCT01200342|860582|P1|Overall Study|Disease Progression|1
260751|NCT01200069|860593|P2|Overall Study|Withdrawal by Subject|1
260752|NCT01200069|860594|P1|Overall Study|Withdrawal by Subject|0
260753|NCT01199939|860663|P1|Overall Study|Reached a virologic endpoint|4
260754|NCT01199939|860663|P1|Overall Study|Lost to Follow-up|2
260755|NCT01199939|860663|P1|Overall Study|Protocol Violation|3
260756|NCT01199939|860663|P1|Overall Study|Adverse Event|4
260757|NCT01199861|860695|P2|Overall Study|Adverse Event|0
260758|NCT01199861|860696|P1|Overall Study|Adverse Event|1
260759|NCT01199861|860695|P2|Overall Study|Administrative problems|0
260760|NCT01199861|860696|P1|Overall Study|Administrative problems|1
260761|NCT01199822|860717|P3|Overall Study|Investigator discontinued therapy|0
260762|NCT01199822|860718|P2|Overall Study|Investigator discontinued therapy|1
260763|NCT01199822|860719|P1|Overall Study|Investigator discontinued therapy|0
260764|NCT01199705|860765|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
260765|NCT01199601|860797|P2|Overall Study|Insecurity prevented staff interviewing.|9
260766|NCT01199601|860798|P1|Overall Study|Insecurity prevented staff interviewing.|7
260767|NCT01199601|860797|P2|Overall Study|Withdrawal by Subject|3
260768|NCT01199601|860798|P1|Overall Study|Withdrawal by Subject|15
260769|NCT01199601|860797|P2|Overall Study|Lost to Follow-up|66
260770|NCT01199601|860798|P1|Overall Study|Lost to Follow-up|47
260771|NCT01199471|860808|P1|Overall Study|Physician Decision|1
260772|NCT01199471|860808|P1|Overall Study|Withdrawal by Subject|1
260773|NCT01199471|860808|P1|Overall Study|Protocol Violation|4
260774|NCT01199042|860834|P1|At Home (3 Months)|Lost to Follow-up|1
260775|NCT01199042|860834|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
260776|NCT01199016|860843|P1|Overall Study|Lost to Follow-up|25
260777|NCT01199016|860843|P1|Overall Study|Withdrawal by Subject|21
260778|NCT01199016|860843|P1|Overall Study|Other|13
260779|NCT01199016|860843|P1|Overall Study|Protocol Violation|9
260780|NCT01199016|860843|P1|Overall Study|Entrance criteria|5
260781|NCT01199016|860843|P1|Overall Study|No longer meets eligibility criteria|4
260782|NCT01198977|860852|P2|Overall Study|Lost to Follow-up|0
260783|NCT01198977|860853|P1|Overall Study|Lost to Follow-up|1
260784|NCT01198873|860865|P2|Overall Study|Other than above|2
260785|NCT01198873|860866|P1|Overall Study|Other than above|4
260786|NCT01198873|860865|P2|Overall Study|Study closure|23
260787|NCT01198873|860866|P1|Overall Study|Study closure|29
260788|NCT01198873|860865|P2|Overall Study|Adverse Event|7
260789|NCT01198873|860866|P1|Overall Study|Adverse Event|4
260790|NCT01198795|860880|P1|Overall Study|Other Reason|4
260791|NCT01198795|860880|P1|Overall Study|Protocol Violation|2
260792|NCT01198795|860880|P1|Overall Study|Lack of Efficacy|5
260793|NCT01198795|860880|P1|Overall Study|Adverse Event|9
260794|NCT01198795|860880|P1|Overall Study|Lost to Follow-up|15
260795|NCT01198795|860880|P1|Overall Study|Withdrawal by Subject|17
260796|NCT01198795|860880|P1|Overall Study|Did not meet InclusionExclusion criteria|30
260797|NCT01198756|860897|P4|Overall Study|Lost to Follow-up|18
260798|NCT01198756|860898|P3|Overall Study|Lost to Follow-up|23
260799|NCT01198756|860899|P2|Overall Study|Lost to Follow-up|36
260800|NCT01198756|860900|P1|Overall Study|Lost to Follow-up|29
260801|NCT01198756|860897|P4|Overall Study|Withdrawal by Subject|5
260802|NCT01198756|860898|P3|Overall Study|Withdrawal by Subject|7
260803|NCT01198756|860899|P2|Overall Study|Withdrawal by Subject|4
260804|NCT01198756|860900|P1|Overall Study|Withdrawal by Subject|9
260805|NCT01198756|860897|P4|Overall Study|Protocol Violation|2
260806|NCT01198756|860898|P3|Overall Study|Protocol Violation|0
260807|NCT01198756|860899|P2|Overall Study|Protocol Violation|0
260808|NCT01198756|860900|P1|Overall Study|Protocol Violation|0
260809|NCT01198756|860897|P4|Overall Study|Adverse Event|1
260810|NCT01198756|860898|P3|Overall Study|Adverse Event|0
260811|NCT01198756|860899|P2|Overall Study|Adverse Event|0
260812|NCT01198756|860900|P1|Overall Study|Adverse Event|0
260813|NCT01198600|861011|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
260814|NCT01198600|861012|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
260815|NCT01198600|861013|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
260816|NCT01198600|861014|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
260817|NCT01198600|861011|P4|Phase 2: 56 Days of Wear|Relocation|0
260818|NCT01198600|861012|P3|Phase 2: 56 Days of Wear|Relocation|2
260819|NCT01198600|861013|P2|Phase 2: 56 Days of Wear|Relocation|0
260820|NCT01198600|861014|P1|Phase 2: 56 Days of Wear|Relocation|0
260821|NCT01198600|861011|P4|Phase 2: 56 Days of Wear|Inconvenience|0
260822|NCT01198600|861012|P3|Phase 2: 56 Days of Wear|Inconvenience|2
260823|NCT01198600|861013|P2|Phase 2: 56 Days of Wear|Inconvenience|0
260824|NCT01198600|861014|P1|Phase 2: 56 Days of Wear|Inconvenience|0
260825|NCT01198600|861011|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
260826|NCT01198600|861012|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
260827|NCT01198600|861013|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
260828|NCT01198600|861014|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
260829|NCT01198600|861011|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
260830|NCT01198600|861012|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
260831|NCT01198600|861013|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
260832|NCT01198600|861014|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
260833|NCT01198600|861011|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
260834|NCT01198600|861012|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
260835|NCT01198600|861013|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
260836|NCT01198600|861014|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
260837|NCT01198600|861011|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
260838|NCT01198600|861012|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
260839|NCT01198600|861013|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
260840|NCT01198600|861014|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
260841|NCT01198574|861040|P4|Overall Study|Resigned from schools|4
260842|NCT01198574|861041|P3|Overall Study|Resigned from schools|1
260843|NCT01198574|861042|P2|Overall Study|Resigned from schools|1
260844|NCT01198574|861043|P1|Overall Study|Resigned from schools|4
260845|NCT01198548|861061|P1|Overall Study|Administrative Decision|1
260846|NCT01198548|861061|P1|Overall Study|Disease Progression|9
260847|NCT01198509|861076|P6|Overall Study|Withdrawal by Subject|0
260848|NCT01198509|861077|P5|Overall Study|Withdrawal by Subject|0
260849|NCT01198509|861078|P4|Overall Study|Withdrawal by Subject|0
260850|NCT01198509|861079|P3|Overall Study|Withdrawal by Subject|0
260851|NCT01198509|861080|P2|Overall Study|Withdrawal by Subject|0
260852|NCT01198509|861081|P1|Overall Study|Withdrawal by Subject|1
260853|NCT01198275|861157|P2|Overall Study|spontaneous return to sinus rhythm|2
260854|NCT01198275|861158|P1|Overall Study|spontaneous return to sinus rhythm|4
260855|NCT01198275|861157|P2|Overall Study|Adverse Event|3
260856|NCT01198275|861158|P1|Overall Study|Adverse Event|2
260857|NCT01198145|861166|P2|Overall Study|Withdrawal by Subject|1
260858|NCT01198145|861167|P1|Overall Study|Withdrawal by Subject|1
260859|NCT01197911|861190|P3|Overall Study|Adverse Event|1
260860|NCT01197911|861191|P2|Overall Study|Adverse Event|0
260861|NCT01197911|861192|P1|Overall Study|Adverse Event|0
260862|NCT01197794|861307|P7|Overall Study|Other|4
260863|NCT01197794|861308|P6|Overall Study|Other|2
260864|NCT01197794|861309|P5|Overall Study|Other|2
260865|NCT01197794|861310|P4|Overall Study|Other|0
260866|NCT01197794|861311|P3|Overall Study|Other|3
260867|NCT01197794|861312|P2|Overall Study|Other|1
260868|NCT01197794|861313|P1|Overall Study|Other|1
260869|NCT01197794|861307|P7|Overall Study|Lost to Follow-up|0
260870|NCT01197794|861308|P6|Overall Study|Lost to Follow-up|1
260871|NCT01197794|861309|P5|Overall Study|Lost to Follow-up|0
260872|NCT01197794|861310|P4|Overall Study|Lost to Follow-up|1
260873|NCT01197794|861311|P3|Overall Study|Lost to Follow-up|0
260874|NCT01197794|861312|P2|Overall Study|Lost to Follow-up|1
260875|NCT01197794|861313|P1|Overall Study|Lost to Follow-up|1
260876|NCT01197794|861307|P7|Overall Study|Withdrawal by Subject|6
260877|NCT01197794|861308|P6|Overall Study|Withdrawal by Subject|5
260878|NCT01197794|861309|P5|Overall Study|Withdrawal by Subject|1
260879|NCT01197794|861310|P4|Overall Study|Withdrawal by Subject|1
260880|NCT01197794|861311|P3|Overall Study|Withdrawal by Subject|4
260881|NCT01197794|861312|P2|Overall Study|Withdrawal by Subject|3
260882|NCT01197794|861313|P1|Overall Study|Withdrawal by Subject|3
260883|NCT01197794|861307|P7|Overall Study|Eligibility criteria not fulfilled|6
260884|NCT01197794|861308|P6|Overall Study|Eligibility criteria not fulfilled|9
260885|NCT01197794|861309|P5|Overall Study|Eligibility criteria not fulfilled|5
260886|NCT01197794|861310|P4|Overall Study|Eligibility criteria not fulfilled|5
260887|NCT01197794|861311|P3|Overall Study|Eligibility criteria not fulfilled|2
260888|NCT01197794|861312|P2|Overall Study|Eligibility criteria not fulfilled|8
260889|NCT01197794|861313|P1|Overall Study|Eligibility criteria not fulfilled|5
260890|NCT01197794|861307|P7|Overall Study|Development of study withdrawal criteria|1
260891|NCT01197794|861308|P6|Overall Study|Development of study withdrawal criteria|0
260892|NCT01197794|861309|P5|Overall Study|Development of study withdrawal criteria|0
260893|NCT01197794|861310|P4|Overall Study|Development of study withdrawal criteria|1
260894|NCT01197794|861311|P3|Overall Study|Development of study withdrawal criteria|0
260895|NCT01197794|861312|P2|Overall Study|Development of study withdrawal criteria|0
260896|NCT01197794|861313|P1|Overall Study|Development of study withdrawal criteria|3
260897|NCT01197794|861307|P7|Overall Study|Protocol Violation|1
260898|NCT01197794|861308|P6|Overall Study|Protocol Violation|0
260899|NCT01197794|861309|P5|Overall Study|Protocol Violation|2
260900|NCT01197794|861310|P4|Overall Study|Protocol Violation|0
260901|NCT01197794|861311|P3|Overall Study|Protocol Violation|0
260902|NCT01197794|861312|P2|Overall Study|Protocol Violation|0
260903|NCT01197794|861313|P1|Overall Study|Protocol Violation|0
260904|NCT01197794|861307|P7|Overall Study|Adverse Event|3
260905|NCT01197794|861308|P6|Overall Study|Adverse Event|2
260906|NCT01197794|861309|P5|Overall Study|Adverse Event|4
260907|NCT01197794|861310|P4|Overall Study|Adverse Event|4
260908|NCT01197794|861311|P3|Overall Study|Adverse Event|4
260909|NCT01197794|861312|P2|Overall Study|Adverse Event|2
260910|NCT01197794|861313|P1|Overall Study|Adverse Event|3
260911|NCT01197755|861395|P3|Overall Study|eg, change in circumstances|2
260912|NCT01197755|861396|P2|Overall Study|eg, change in circumstances|3
260913|NCT01197755|861397|P1|Overall Study|eg, change in circumstances|7
260914|NCT01197755|861395|P3|Overall Study|Lost to Follow-up|1
260915|NCT01197755|861396|P2|Overall Study|Lost to Follow-up|0
260916|NCT01197755|861397|P1|Overall Study|Lost to Follow-up|0
260917|NCT01197755|861395|P3|Overall Study|Withdrawal by Subject|0
260918|NCT01197755|861396|P2|Overall Study|Withdrawal by Subject|0
260919|NCT01197755|861397|P1|Overall Study|Withdrawal by Subject|1
260920|NCT01197755|861395|P3|Overall Study|Severe non-compliance to the protocol|2
260921|NCT01197755|861396|P2|Overall Study|Severe non-compliance to the protocol|1
260922|NCT01197755|861397|P1|Overall Study|Severe non-compliance to the protocol|2
260923|NCT01197755|861395|P3|Overall Study|Lack of therapeutic response|4
260924|NCT01197755|861396|P2|Overall Study|Lack of therapeutic response|7
260925|NCT01197755|861397|P1|Overall Study|Lack of therapeutic response|0
260926|NCT01197755|861395|P3|Overall Study|Entered the long-term extension study|35
260927|NCT01197755|861396|P2|Overall Study|Entered the long-term extension study|21
260928|NCT01197755|861397|P1|Overall Study|Entered the long-term extension study|18
260929|NCT01197755|861395|P3|Overall Study|Study-specific discontinuation criteria|0
260930|NCT01197755|861396|P2|Overall Study|Study-specific discontinuation criteria|1
260931|NCT01197755|861397|P1|Overall Study|Study-specific discontinuation criteria|2
260932|NCT01197755|861395|P3|Overall Study|Adverse Event|10
260933|NCT01197755|861396|P2|Overall Study|Adverse Event|10
260934|NCT01197755|861397|P1|Overall Study|Adverse Event|8
260935|NCT01197560|861439|P2|Overall Study|Missing|1
260936|NCT01197560|861440|P1|Overall Study|Missing|0
260937|NCT01197560|861439|P2|Overall Study|Elected to discontinue before cycle end|2
260938|NCT01197560|861440|P1|Overall Study|Elected to discontinue before cycle end|0
260939|NCT01197560|861439|P2|Overall Study|Proceeded to transplant|1
260940|NCT01197560|861440|P1|Overall Study|Proceeded to transplant|1
260941|NCT01197560|861439|P2|Overall Study|Disease progression|35
260942|NCT01197560|861440|P1|Overall Study|Disease progression|39
260943|NCT01197560|861439|P2|Overall Study|Withdrawal by Subject|1
260944|NCT01197560|861440|P1|Overall Study|Withdrawal by Subject|1
260945|NCT01197560|861439|P2|Overall Study|Death|5
260946|NCT01197560|861440|P1|Overall Study|Death|1
260947|NCT01197560|861439|P2|Overall Study|Adverse Event|8
260948|NCT01197560|861440|P1|Overall Study|Adverse Event|4
260949|NCT01197534|861473|P3|Overall Study|Adverse Event|24
260950|NCT01197534|861474|P2|Overall Study|Adverse Event|36
260951|NCT01197534|861475|P1|Overall Study|Adverse Event|35
260952|NCT01197534|861473|P3|Overall Study|Lost to Follow-up|2
260953|NCT01197534|861474|P2|Overall Study|Lost to Follow-up|4
260954|NCT01197534|861475|P1|Overall Study|Lost to Follow-up|1
260955|NCT01197534|861473|P3|Overall Study|Dev. of study specific discont. criteria|2
260956|NCT01197534|861474|P2|Overall Study|Dev. of study specific discont. criteria|6
260957|NCT01197534|861475|P1|Overall Study|Dev. of study specific discont. criteria|13
260958|NCT01197534|861473|P3|Overall Study|Lack of therapeutic response|9
260959|NCT01197534|861474|P2|Overall Study|Lack of therapeutic response|4
260960|NCT01197534|861475|P1|Overall Study|Lack of therapeutic response|9
260961|NCT01197534|861473|P3|Overall Study|Severe non-compliance to protocol|1
260962|NCT01197534|861474|P2|Overall Study|Severe non-compliance to protocol|4
260963|NCT01197534|861475|P1|Overall Study|Severe non-compliance to protocol|3
260964|NCT01197534|861473|P3|Overall Study|Enrolment in long term extension|119
260965|NCT01197534|861474|P2|Overall Study|Enrolment in long term extension|66
260966|NCT01197534|861475|P1|Overall Study|Enrolment in long term extension|57
260967|NCT01197534|861473|P3|Overall Study|Not reported|16
260968|NCT01197534|861474|P2|Overall Study|Not reported|10
260969|NCT01197534|861475|P1|Overall Study|Not reported|16
260970|NCT01197521|861519|P3|Overall Study|Adverse Event|24
260971|NCT01197521|861520|P2|Overall Study|Adverse Event|28
260972|NCT01197521|861521|P1|Overall Study|Adverse Event|25
260973|NCT01197521|861519|P3|Overall Study|Lost to Follow-up|2
260974|NCT01197521|861520|P2|Overall Study|Lost to Follow-up|2
260975|NCT01197521|861521|P1|Overall Study|Lost to Follow-up|3
260976|NCT01197521|861519|P3|Overall Study|Dev. of study specific discont. criteria|2
260977|NCT01197521|861520|P2|Overall Study|Dev. of study specific discont. criteria|16
260978|NCT01197521|861521|P1|Overall Study|Dev. of study specific discont. criteria|6
260979|NCT01197521|861519|P3|Overall Study|Lack of therapeutic response|4
260980|NCT01197521|861520|P2|Overall Study|Lack of therapeutic response|3
260981|NCT01197521|861521|P1|Overall Study|Lack of therapeutic response|2
260982|NCT01197521|861519|P3|Overall Study|Severe non-compliance to protocol|3
260983|NCT01197521|861520|P2|Overall Study|Severe non-compliance to protocol|3
260984|NCT01197521|861521|P1|Overall Study|Severe non-compliance to protocol|1
260985|NCT01197521|861519|P3|Overall Study|Enrolment in long term extension|87
260986|NCT01197521|861520|P2|Overall Study|Enrolment in long term extension|36
260987|NCT01197521|861521|P1|Overall Study|Enrolment in long term extension|42
260988|NCT01197521|861519|P3|Overall Study|Not reported|21
260989|NCT01197521|861520|P2|Overall Study|Not reported|25
260990|NCT01197521|861521|P1|Overall Study|Not reported|24
260991|NCT01197508|861566|P4|Overall Study|Not specified|2
260992|NCT01197508|861567|P3|Overall Study|Not specified|2
260993|NCT01197508|861568|P2|Overall Study|Not specified|3
260994|NCT01197508|861569|P1|Overall Study|Not specified|2
260995|NCT01197508|861566|P4|Overall Study|Lost to Follow-up|0
260996|NCT01197508|861567|P3|Overall Study|Lost to Follow-up|2
260997|NCT01197508|861568|P2|Overall Study|Lost to Follow-up|1
260998|NCT01197508|861569|P1|Overall Study|Lost to Follow-up|1
260999|NCT01197508|861566|P4|Overall Study|Study-specific withdrawal criteria|2
261000|NCT01197508|861567|P3|Overall Study|Study-specific withdrawal criteria|1
261001|NCT01197508|861568|P2|Overall Study|Study-specific withdrawal criteria|0
261002|NCT01197508|861569|P1|Overall Study|Study-specific withdrawal criteria|0
261003|NCT01197508|861566|P4|Overall Study|Lack of Efficacy|1
261004|NCT01197508|861567|P3|Overall Study|Lack of Efficacy|2
261005|NCT01197508|861568|P2|Overall Study|Lack of Efficacy|2
261006|NCT01197508|861569|P1|Overall Study|Lack of Efficacy|1
261007|NCT01197508|861566|P4|Overall Study|Condition under investigation worsened|1
261008|NCT01197508|861567|P3|Overall Study|Condition under investigation worsened|1
261009|NCT01197508|861568|P2|Overall Study|Condition under investigation worsened|1
261010|NCT01197508|861569|P1|Overall Study|Condition under investigation worsened|1
261011|NCT01197508|861566|P4|Overall Study|Severe non-compliance to protocol|3
261012|NCT01197508|861567|P3|Overall Study|Severe non-compliance to protocol|1
261013|NCT01197508|861568|P2|Overall Study|Severe non-compliance to protocol|3
261014|NCT01197508|861569|P1|Overall Study|Severe non-compliance to protocol|0
261015|NCT01197508|861566|P4|Overall Study|Adverse Event|3
261016|NCT01197508|861567|P3|Overall Study|Adverse Event|23
261017|NCT01197508|861568|P2|Overall Study|Adverse Event|13
261018|NCT01197508|861569|P1|Overall Study|Adverse Event|10
261019|NCT01197508|861566|P4|Overall Study|Eligiblity criteria not fulfilled|0
261020|NCT01197508|861567|P3|Overall Study|Eligiblity criteria not fulfilled|2
261021|NCT01197508|861568|P2|Overall Study|Eligiblity criteria not fulfilled|0
261022|NCT01197508|861569|P1|Overall Study|Eligiblity criteria not fulfilled|0
261023|NCT01197508|861566|P4|Overall Study|Withdrawal by Subject|4
261024|NCT01197508|861567|P3|Overall Study|Withdrawal by Subject|15
261025|NCT01197508|861568|P2|Overall Study|Withdrawal by Subject|7
261026|NCT01197508|861569|P1|Overall Study|Withdrawal by Subject|8
261027|NCT01197417|861679|P2|Overall Study|No 25-hour magnesium level|2
261028|NCT01197417|861680|P1|Overall Study|No 25-hour magnesium level|0
261029|NCT01197417|861679|P2|Overall Study|Found to be ineligible|5
261030|NCT01197417|861680|P1|Overall Study|Found to be ineligible|2
261031|NCT01197417|861679|P2|Overall Study|Hypotension|2
261032|NCT01197417|861680|P1|Overall Study|Hypotension|1
261033|NCT01197417|861679|P2|Overall Study|Not consented in time to receive drug|1
261034|NCT01197417|861680|P1|Overall Study|Not consented in time to receive drug|0
261035|NCT01197417|861679|P2|Overall Study|Subject transferred to intensive care|1
261036|NCT01197417|861680|P1|Overall Study|Subject transferred to intensive care|0
261037|NCT01197417|861679|P2|Overall Study|Site miscommunication|1
261038|NCT01197417|861680|P1|Overall Study|Site miscommunication|0
261039|NCT01197417|861679|P2|Overall Study|Withdrawal by Subject|4
261040|NCT01197417|861680|P1|Overall Study|Withdrawal by Subject|2
261041|NCT01197417|861679|P2|Overall Study|Physician Decision|2
261042|NCT01197417|861680|P1|Overall Study|Physician Decision|3
261043|NCT01196988|861713|P4|Overall Study|Unspecified|0
261044|NCT01196988|861714|P3|Overall Study|Unspecified|0
261045|NCT01196988|861715|P2|Overall Study|Unspecified|0
261046|NCT01196988|861716|P1|Overall Study|Unspecified|2
261047|NCT01196988|861713|P4|Overall Study|Lost to Follow-up|1
261048|NCT01196988|861714|P3|Overall Study|Lost to Follow-up|21
261049|NCT01196988|861715|P2|Overall Study|Lost to Follow-up|29
261050|NCT01196988|861716|P1|Overall Study|Lost to Follow-up|16
261051|NCT01196988|861713|P4|Overall Study|Withdrawal by Subject|0
261052|NCT01196988|861714|P3|Overall Study|Withdrawal by Subject|4
261053|NCT01196988|861715|P2|Overall Study|Withdrawal by Subject|1
261054|NCT01196988|861716|P1|Overall Study|Withdrawal by Subject|5
261055|NCT01196988|861713|P4|Overall Study|Adverse Event|0
261056|NCT01196988|861714|P3|Overall Study|Adverse Event|0
261057|NCT01196988|861715|P2|Overall Study|Adverse Event|2
261058|NCT01196988|861716|P1|Overall Study|Adverse Event|1
261059|NCT01196975|861810|P5|Overall Study|Lost to Follow-up|11
261060|NCT01196975|861811|P4|Overall Study|Lost to Follow-up|5
261061|NCT01196975|861812|P3|Overall Study|Lost to Follow-up|5
261062|NCT01196975|861813|P2|Overall Study|Lost to Follow-up|6
261063|NCT01196975|861814|P1|Overall Study|Lost to Follow-up|11
261064|NCT01196975|861810|P5|Overall Study|Withdrawal by Subject|0
261065|NCT01196975|861811|P4|Overall Study|Withdrawal by Subject|1
261066|NCT01196975|861812|P3|Overall Study|Withdrawal by Subject|0
261067|NCT01196975|861813|P2|Overall Study|Withdrawal by Subject|1
261068|NCT01196975|861814|P1|Overall Study|Withdrawal by Subject|2
261069|NCT01196975|861810|P5|Overall Study|Adverse Event|2
261070|NCT01196975|861811|P4|Overall Study|Adverse Event|0
261071|NCT01196975|861812|P3|Overall Study|Adverse Event|0
261072|NCT01196975|861813|P2|Overall Study|Adverse Event|2
261073|NCT01196975|861814|P1|Overall Study|Adverse Event|2
261074|NCT01196741|861952|P2|Overall Study|Protocol Violation|1
261075|NCT01196741|861953|P1|Overall Study|Protocol Violation|2
261076|NCT01196741|861952|P2|Overall Study|Other|2
261077|NCT01196741|861953|P1|Overall Study|Other|3
261078|NCT01196741|861952|P2|Overall Study|Other reason|3
261079|NCT01196741|861953|P1|Overall Study|Other reason|3
261080|NCT01196741|861952|P2|Overall Study|Withdrawal by Subject|0
261081|NCT01196741|861953|P1|Overall Study|Withdrawal by Subject|3
261082|NCT01196741|861952|P2|Overall Study|Dose limiting Adverse Event|1
261083|NCT01196741|861953|P1|Overall Study|Dose limiting Adverse Event|2
261084|NCT01196741|861952|P2|Overall Study|Serious Adverse Event|1
261085|NCT01196741|861953|P1|Overall Study|Serious Adverse Event|3
261086|NCT01196741|861952|P2|Overall Study|Adverse Event|6
261087|NCT01196741|861953|P1|Overall Study|Adverse Event|10
261088|NCT01196741|861952|P2|Overall Study|Disease progression|14
261089|NCT01196741|861953|P1|Overall Study|Disease progression|34
261090|NCT01196429|861979|P2|Overall Study|Refused – Never Treated|0
261091|NCT01196429|861980|P1|Overall Study|Refused – Never Treated|1
261092|NCT01196429|861979|P2|Overall Study|Ineligible - wrong cell type|0
261093|NCT01196429|861980|P1|Overall Study|Ineligible - wrong cell type|1
261094|NCT01196429|861979|P2|Overall Study|Ineligible - inadequate pathology|0
261095|NCT01196429|861980|P1|Overall Study|Ineligible - inadequate pathology|1
261096|NCT01196104|861998|P2|Overall Study|Various|1
261097|NCT01196104|861999|P1|Overall Study|Various|0
261098|NCT01196104|861998|P2|Overall Study|Withdrawal by Subject|3
261099|NCT01196104|861999|P1|Overall Study|Withdrawal by Subject|3
261100|NCT01196104|861998|P2|Overall Study|Physician Decision|1
261101|NCT01196104|861999|P1|Overall Study|Physician Decision|0
261102|NCT01196104|861998|P2|Overall Study|Lost to Follow-up|0
261103|NCT01196104|861999|P1|Overall Study|Lost to Follow-up|1
261104|NCT01196078|862041|P2|Overall Study|Death|4
261105|NCT01196078|862042|P1|Overall Study|Death|6
261106|NCT01196078|862041|P2|Overall Study|Lost to Follow-up|0
261107|NCT01196078|862042|P1|Overall Study|Lost to Follow-up|1
261108|NCT01196078|862041|P2|Overall Study|Lack of Efficacy|23
261109|NCT01196078|862042|P1|Overall Study|Lack of Efficacy|17
261110|NCT01196078|862041|P2|Overall Study|Protocol Violation|1
261111|NCT01196078|862042|P1|Overall Study|Protocol Violation|2
261112|NCT01196078|862041|P2|Overall Study|Adverse Event|4
261113|NCT01196078|862042|P1|Overall Study|Adverse Event|4
261114|NCT01196078|862041|P2|Overall Study|Withdrawal by Subject|5
261115|NCT01196078|862042|P1|Overall Study|Withdrawal by Subject|3
261116|NCT01196052|862070|P1|Overall Study|Withdrawal by Subject|6
261117|NCT01196052|862070|P1|Overall Study|Reason not Specified|5
261118|NCT01196052|862070|P1|Overall Study|Noncompliance to Protocol Requirements|2
261119|NCT01196052|862070|P1|Overall Study|Lost to Follow-up|1
261120|NCT01196052|862070|P1|Overall Study|Adverse Event|9
261121|NCT01196026|862087|P6|Overall Study|Unspecified|0
261122|NCT01196026|862088|P5|Overall Study|Unspecified|0
261123|NCT01196026|862089|P4|Overall Study|Unspecified|0
261124|NCT01196026|862090|P3|Overall Study|Unspecified|0
261125|NCT01196026|862091|P2|Overall Study|Unspecified|1
261126|NCT01196026|862092|P1|Overall Study|Unspecified|0
261127|NCT01196026|862087|P6|Overall Study|Lost to Follow-up|0
261128|NCT01196026|862088|P5|Overall Study|Lost to Follow-up|1
261129|NCT01196026|862089|P4|Overall Study|Lost to Follow-up|0
261130|NCT01196026|862090|P3|Overall Study|Lost to Follow-up|0
261131|NCT01196026|862091|P2|Overall Study|Lost to Follow-up|3
261132|NCT01196026|862092|P1|Overall Study|Lost to Follow-up|0
261133|NCT01196026|862087|P6|Overall Study|Withdrawal by Subject|0
261134|NCT01196026|862088|P5|Overall Study|Withdrawal by Subject|0
261135|NCT01196026|862089|P4|Overall Study|Withdrawal by Subject|0
261136|NCT01196026|862090|P3|Overall Study|Withdrawal by Subject|0
261137|NCT01196026|862091|P2|Overall Study|Withdrawal by Subject|4
261138|NCT01196026|862092|P1|Overall Study|Withdrawal by Subject|1
261139|NCT01195948|862328|P3|Overall Study|Lost to Follow-up|2
261140|NCT01195948|862329|P2|Overall Study|Lost to Follow-up|1
261141|NCT01195948|862330|P1|Overall Study|Lost to Follow-up|0
261142|NCT01195844|862362|P1|Overall Study|Fecal sample not collected|40
261143|NCT01195831|862379|P2|Overall Study|Protocol Violation|2
261144|NCT01195831|862380|P1|Overall Study|Protocol Violation|0
261145|NCT01195831|862379|P2|Overall Study|Adverse Event|2
261146|NCT01195831|862380|P1|Overall Study|Adverse Event|4
261147|NCT01195831|862379|P2|Overall Study|Withdrawal by Subject|2
261148|NCT01195831|862380|P1|Overall Study|Withdrawal by Subject|2
261149|NCT01195831|862379|P2|Overall Study|Lost to Follow-up|4
261150|NCT01195831|862380|P1|Overall Study|Lost to Follow-up|2
261151|NCT01195675|862620|P1|Overall Study|Withdrawal by Subject|2
261152|NCT01195675|862620|P1|Overall Study|Adverse Event|1
261153|NCT01195662|862653|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
261154|NCT01195662|862654|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
261155|NCT01195662|862655|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
261156|NCT01195662|862653|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
261157|NCT01195662|862654|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
261158|NCT01195662|862655|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
261159|NCT01195662|862653|P3|Double Blind Treatment Period|Missing disposition information|1
261160|NCT01195662|862654|P2|Double Blind Treatment Period|Missing disposition information|1
261161|NCT01195662|862655|P1|Double Blind Treatment Period|Missing disposition information|0
261162|NCT01195662|862653|P3|Double Blind Treatment Period|Non-specified|0
261163|NCT01195662|862654|P2|Double Blind Treatment Period|Non-specified|0
261164|NCT01195662|862655|P1|Double Blind Treatment Period|Non-specified|3
261165|NCT01195662|862653|P3|Double Blind Treatment Period|Lack of Efficacy|0
261166|NCT01195662|862654|P2|Double Blind Treatment Period|Lack of Efficacy|0
261167|NCT01195662|862655|P1|Double Blind Treatment Period|Lack of Efficacy|2
261168|NCT01195662|862653|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
261169|NCT01195662|862654|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
261170|NCT01195662|862655|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
261171|NCT01195662|862653|P3|Double Blind Treatment Period|Requested discontinue treatment|1
261172|NCT01195662|862654|P2|Double Blind Treatment Period|Requested discontinue treatment|0
261173|NCT01195662|862655|P1|Double Blind Treatment Period|Requested discontinue treatment|1
261174|NCT01195662|862653|P3|Double Blind Treatment Period|Administrative reason|1
261175|NCT01195662|862654|P2|Double Blind Treatment Period|Administrative reason|1
261176|NCT01195662|862655|P1|Double Blind Treatment Period|Administrative reason|2
261177|NCT01195662|862653|P3|Double Blind Treatment Period|Lost to Follow-up|3
261178|NCT01195662|862654|P2|Double Blind Treatment Period|Lost to Follow-up|2
261179|NCT01195662|862655|P1|Double Blind Treatment Period|Lost to Follow-up|3
261180|NCT01195662|862653|P3|Double Blind Treatment Period|Withdrawal by Subject|4
261181|NCT01195662|862654|P2|Double Blind Treatment Period|Withdrawal by Subject|4
261182|NCT01195662|862655|P1|Double Blind Treatment Period|Withdrawal by Subject|6
261183|NCT01195662|862653|P3|Double Blind Treatment Period|Adverse Event|2
261184|NCT01195662|862654|P2|Double Blind Treatment Period|Adverse Event|1
261185|NCT01195662|862655|P1|Double Blind Treatment Period|Adverse Event|4
261186|NCT01195636|862685|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
261187|NCT01195636|862686|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
261188|NCT01195636|862685|P2|Second Intervention (3 Weeks)|Adverse Event|1
261189|NCT01195636|862686|P1|Second Intervention (3 Weeks)|Adverse Event|1
261190|NCT01195636|862685|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
261191|NCT01195636|862686|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
261192|NCT01195636|862685|P2|Washout Period (2 Weeks)|Adverse Event|1
261193|NCT01195636|862686|P1|Washout Period (2 Weeks)|Adverse Event|1
261194|NCT01195636|862685|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
261195|NCT01195636|862686|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
261196|NCT01195636|862685|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
261197|NCT01195636|862686|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
261198|NCT01195636|862685|P2|First Intervention (3 Weeks)|Protocol Violation|0
261199|NCT01195636|862686|P1|First Intervention (3 Weeks)|Protocol Violation|1
261200|NCT01195636|862685|P2|First Intervention (3 Weeks)|Adverse Event|3
261201|NCT01195636|862686|P1|First Intervention (3 Weeks)|Adverse Event|2
261202|NCT01195623|862712|P2|Overall Study|Lost to Follow-up|37
261203|NCT01195623|862713|P1|Overall Study|Lost to Follow-up|35
261204|NCT01195415|862747|P1|Overall Study|No repeat biopsy due to progression|2
261205|NCT01195363|862754|P2|Overall Study|incarceration|0
261206|NCT01195363|862755|P1|Overall Study|incarceration|1
261207|NCT01195363|862754|P2|Overall Study|Lack of Efficacy|4
261208|NCT01195363|862755|P1|Overall Study|Lack of Efficacy|0
261209|NCT01195363|862754|P2|Overall Study|Adverse Event|1
261210|NCT01195363|862755|P1|Overall Study|Adverse Event|3
261211|NCT01195363|862754|P2|Overall Study|Lost to Follow-up|4
261212|NCT01195363|862755|P1|Overall Study|Lost to Follow-up|7
261213|NCT01195272|862761|P1|Overall Study|Lack of Efficacy|3
261214|NCT01195272|862761|P1|Overall Study|Adverse Event|1
261215|NCT01195103|862790|P3|Overall Study|Withdrawal by Subject|0
261216|NCT01195103|862791|P2|Overall Study|Withdrawal by Subject|0
261217|NCT01195103|862792|P1|Overall Study|Withdrawal by Subject|1
261218|NCT01195090|862802|P2|Overall Study|Protocol Violation|4
261219|NCT01195090|862803|P1|Overall Study|Protocol Violation|3
261220|NCT01195090|862802|P2|Overall Study|Lost to Follow-up|2
261221|NCT01195090|862803|P1|Overall Study|Lost to Follow-up|2
261222|NCT01195090|862802|P2|Overall Study|Adverse Event|2
261223|NCT01195090|862803|P1|Overall Study|Adverse Event|1
261224|NCT01194999|862872|P1|Overall Study|Lost to Follow-up|17
261225|NCT01194973|862876|P1|26 Week Treatment Period|Pregnancy|1
261226|NCT01194973|862876|P1|26 Week Treatment Period|Lack of Efficacy|1
261227|NCT01194973|862876|P1|26 Week Treatment Period|Adverse Event|1
261228|NCT01194973|862876|P1|Screening Period|Screen Failure|3
261229|NCT01194869|862896|P1|Overall Study|Toxicity|2
261230|NCT01194869|862896|P1|Overall Study|Disease Progression|2
261231|NCT01194830|862904|P2|Overall Study|Other Reason|8
261232|NCT01194830|862905|P1|Overall Study|Other Reason|12
261233|NCT01194830|862904|P2|Overall Study|Non-compliance issues|4
261234|NCT01194830|862905|P1|Overall Study|Non-compliance issues|4
261235|NCT01194830|862904|P2|Overall Study|Lack of Efficacy|1
261236|NCT01194830|862905|P1|Overall Study|Lack of Efficacy|1
261237|NCT01194830|862904|P2|Overall Study|Withdrawal by Subject|1
261238|NCT01194830|862905|P1|Overall Study|Withdrawal by Subject|2
261239|NCT01194830|862904|P2|Overall Study|Lost to Follow-up|7
261240|NCT01194830|862905|P1|Overall Study|Lost to Follow-up|9
261241|NCT01194830|862904|P2|Overall Study|Protocol Violation|4
261242|NCT01194830|862905|P1|Overall Study|Protocol Violation|5
261243|NCT01194830|862904|P2|Overall Study|Adverse Event|2
261244|NCT01194830|862905|P1|Overall Study|Adverse Event|3
261245|NCT01194531|862936|P2|Overall Study|Physician Decision|2
261246|NCT01194531|862937|P1|Overall Study|Physician Decision|0
261247|NCT01194531|862936|P2|Overall Study|Protocol Violation|1
261248|NCT01194531|862937|P1|Overall Study|Protocol Violation|4
261249|NCT01194531|862936|P2|Overall Study|Withdrawal by Subject|0
261250|NCT01194531|862937|P1|Overall Study|Withdrawal by Subject|1
261251|NCT01194440|862981|P1|Overall Study|Lost to Follow-up|1
261252|NCT01194440|862981|P1|Overall Study|Withdrawal by Subject|2
261253|NCT01194440|862981|P1|Overall Study|Adverse Event|9
261254|NCT01194414|862991|P4|72 Weeks Open Label Extension|Death|2
261255|NCT01194414|862992|P3|72 Weeks Open Label Extension|Death|0
261256|NCT01194414|862993|P2|72 Weeks Open Label Extension|Death|2
261257|NCT01194414|862994|P1|72 Weeks Open Label Extension|Death|1
261258|NCT01194414|862991|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
261259|NCT01194414|862992|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
261260|NCT01194414|862993|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
261261|NCT01194414|862994|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
261262|NCT01194414|862991|P4|72 Weeks Open Label Extension|Adverse Event|12
261263|NCT01194414|862992|P3|72 Weeks Open Label Extension|Adverse Event|2
261264|NCT01194414|862993|P2|72 Weeks Open Label Extension|Adverse Event|21
261265|NCT01194414|862994|P1|72 Weeks Open Label Extension|Adverse Event|35
261266|NCT01194414|862991|P4|72 Weeks Open Label Extension|Protocol Violation|1
261267|NCT01194414|862992|P3|72 Weeks Open Label Extension|Protocol Violation|0
261268|NCT01194414|862993|P2|72 Weeks Open Label Extension|Protocol Violation|0
261269|NCT01194414|862994|P1|72 Weeks Open Label Extension|Protocol Violation|0
261270|NCT01194414|862991|P4|72 Weeks Open Label Extension|Other|0
261271|NCT01194414|862992|P3|72 Weeks Open Label Extension|Other|0
261272|NCT01194414|862993|P2|72 Weeks Open Label Extension|Other|1
261273|NCT01194414|862994|P1|72 Weeks Open Label Extension|Other|2
261274|NCT01194414|862991|P4|72 Weeks Open Label Extension|Pregnancy|1
261275|NCT01194414|862992|P3|72 Weeks Open Label Extension|Pregnancy|1
261276|NCT01194414|862993|P2|72 Weeks Open Label Extension|Pregnancy|3
261277|NCT01194414|862994|P1|72 Weeks Open Label Extension|Pregnancy|1
261278|NCT01194414|862991|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
261279|NCT01194414|862992|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
261280|NCT01194414|862993|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
261281|NCT01194414|862994|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
261282|NCT01194414|862991|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
261283|NCT01194414|862992|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
261284|NCT01194414|862993|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
261285|NCT01194414|862994|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
261286|NCT01194414|862991|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
261287|NCT01194414|862992|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
261288|NCT01194414|862993|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
261289|NCT01194414|862994|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
261290|NCT01194414|862991|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
261291|NCT01194414|862992|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
261292|NCT01194414|862993|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
261293|NCT01194414|862994|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
261294|NCT01194414|862991|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
261295|NCT01194414|862992|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
261296|NCT01194414|862993|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
261297|NCT01194414|862994|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
261298|NCT01194414|862991|P4|24 Weeks Double Blind Period|Death|0
261299|NCT01194414|862992|P3|24 Weeks Double Blind Period|Death|0
261300|NCT01194414|862993|P2|24 Weeks Double Blind Period|Death|1
261301|NCT01194414|862994|P1|24 Weeks Double Blind Period|Death|0
261302|NCT01194414|862991|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
261303|NCT01194414|862992|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
261304|NCT01194414|862993|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
261305|NCT01194414|862994|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
261306|NCT01194414|862991|P4|24 Weeks Double Blind Period|Adverse Event|0
261307|NCT01194414|862992|P3|24 Weeks Double Blind Period|Adverse Event|0
261308|NCT01194414|862993|P2|24 Weeks Double Blind Period|Adverse Event|40
261309|NCT01194414|862994|P1|24 Weeks Double Blind Period|Adverse Event|28
261310|NCT01194414|862991|P4|24 Weeks Double Blind Period|Other|0
261311|NCT01194414|862992|P3|24 Weeks Double Blind Period|Other|0
261312|NCT01194414|862993|P2|24 Weeks Double Blind Period|Other|1
261313|NCT01194414|862994|P1|24 Weeks Double Blind Period|Other|0
261314|NCT01194414|862991|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
261315|NCT01194414|862992|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
261316|NCT01194414|862993|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
261317|NCT01194414|862994|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
261318|NCT01194414|862991|P4|24 Weeks Double Blind Period|Pregnancy|0
261319|NCT01194414|862992|P3|24 Weeks Double Blind Period|Pregnancy|0
261320|NCT01194414|862993|P2|24 Weeks Double Blind Period|Pregnancy|2
261321|NCT01194414|862994|P1|24 Weeks Double Blind Period|Pregnancy|2
261322|NCT01194414|862991|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
261323|NCT01194414|862992|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
261324|NCT01194414|862993|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
261325|NCT01194414|862994|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
261326|NCT01194414|862991|P4|24 Weeks Double Blind Period|Protocol Violation|0
261327|NCT01194414|862992|P3|24 Weeks Double Blind Period|Protocol Violation|0
261328|NCT01194414|862993|P2|24 Weeks Double Blind Period|Protocol Violation|3
261329|NCT01194414|862994|P1|24 Weeks Double Blind Period|Protocol Violation|5
261330|NCT01194414|862991|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
261331|NCT01194414|862992|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
261332|NCT01194414|862993|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
261333|NCT01194414|862994|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
261334|NCT01194414|862991|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
261335|NCT01194414|862992|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
261336|NCT01194414|862993|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
261337|NCT01194414|862994|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
261338|NCT01194258|863065|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
261339|NCT01194258|863066|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
261340|NCT01194258|863067|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
261341|NCT01194258|863068|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
261342|NCT01194258|863069|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
261343|NCT01194258|863065|P5|Period 2 (12 Weeks)|Adverse Event|0
261344|NCT01194258|863066|P4|Period 2 (12 Weeks)|Adverse Event|0
261345|NCT01194258|863067|P3|Period 2 (12 Weeks)|Adverse Event|0
261346|NCT01194258|863068|P2|Period 2 (12 Weeks)|Adverse Event|1
261347|NCT01194258|863069|P1|Period 2 (12 Weeks)|Adverse Event|0
261348|NCT01194258|863065|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
261349|NCT01194258|863066|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
261350|NCT01194258|863067|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
261351|NCT01194258|863068|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
261352|NCT01194258|863069|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
261353|NCT01194258|863065|P5|Period 1 (12 Weeks)|Death|1
261354|NCT01194258|863066|P4|Period 1 (12 Weeks)|Death|0
261355|NCT01194258|863067|P3|Period 1 (12 Weeks)|Death|0
261356|NCT01194258|863068|P2|Period 1 (12 Weeks)|Death|0
261357|NCT01194258|863069|P1|Period 1 (12 Weeks)|Death|0
261358|NCT01194258|863065|P5|Titration Period|Titration failure|0
261359|NCT01194258|863066|P4|Titration Period|Titration failure|0
261360|NCT01194258|863067|P3|Titration Period|Titration failure|0
261361|NCT01194258|863068|P2|Titration Period|Titration failure|0
261362|NCT01194258|863069|P1|Titration Period|Titration failure|3
261363|NCT01194258|863065|P5|Titration Period|Lost to Follow-up|0
261364|NCT01194258|863066|P4|Titration Period|Lost to Follow-up|0
261365|NCT01194258|863067|P3|Titration Period|Lost to Follow-up|0
261366|NCT01194258|863068|P2|Titration Period|Lost to Follow-up|0
261367|NCT01194258|863069|P1|Titration Period|Lost to Follow-up|2
261368|NCT01194258|863065|P5|Titration Period|Withdrawal by Subject|0
261369|NCT01194258|863066|P4|Titration Period|Withdrawal by Subject|0
261370|NCT01194258|863067|P3|Titration Period|Withdrawal by Subject|0
261371|NCT01194258|863068|P2|Titration Period|Withdrawal by Subject|0
261372|NCT01194258|863069|P1|Titration Period|Withdrawal by Subject|6
261373|NCT01194245|863093|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
261374|NCT01194245|863094|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
261375|NCT01194245|863095|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
261376|NCT01194245|863096|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
261377|NCT01194245|863097|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
261378|NCT01194245|863093|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
261379|NCT01194245|863094|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
261380|NCT01194245|863095|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
261381|NCT01194245|863096|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
261382|NCT01194245|863097|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
261383|NCT01194245|863093|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
261384|NCT01194245|863094|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
261385|NCT01194245|863095|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
261386|NCT01194245|863096|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
261387|NCT01194245|863097|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
261388|NCT01194245|863093|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
261389|NCT01194245|863094|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
261390|NCT01194245|863095|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
261391|NCT01194245|863096|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
261392|NCT01194245|863097|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
261393|NCT01194245|863093|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
261394|NCT01194245|863094|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
261395|NCT01194245|863095|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
261396|NCT01194245|863096|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
261397|NCT01194245|863097|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
261398|NCT01194245|863093|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
261399|NCT01194245|863094|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
261400|NCT01194245|863095|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
261401|NCT01194245|863096|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
261402|NCT01194245|863097|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
261403|NCT01194219|863118|P8|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
261404|NCT01194219|863119|P7|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|1
261405|NCT01194219|863120|P6|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
261406|NCT01194219|863121|P5|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
261407|NCT01194219|863122|P4|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
261408|NCT01194219|863123|P3|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
261409|NCT01194219|863124|P2|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
261410|NCT01194219|863125|P1|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
261411|NCT01194219|863118|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
261412|NCT01194219|863119|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
261413|NCT01194219|863120|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
261414|NCT01194219|863121|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
261415|NCT01194219|863122|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
261416|NCT01194219|863123|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
261417|NCT01194219|863124|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
261418|NCT01194219|863125|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
261419|NCT01194219|863118|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
261420|NCT01194219|863119|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|5
261421|NCT01194219|863120|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
261422|NCT01194219|863121|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
261423|NCT01194219|863122|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
261424|NCT01194219|863123|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
261425|NCT01194219|863124|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
261426|NCT01194219|863125|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
261427|NCT01194219|863118|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|6
261428|NCT01194219|863119|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|12
261429|NCT01194219|863120|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
261430|NCT01194219|863121|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|1
261431|NCT01194219|863122|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
261432|NCT01194219|863123|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
261433|NCT01194219|863124|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
261434|NCT01194219|863125|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
261435|NCT01194219|863118|P8|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
261436|NCT01194219|863119|P7|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|2
261437|NCT01194219|863120|P6|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
261438|NCT01194219|863121|P5|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|1
261439|NCT01194219|863122|P4|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
261440|NCT01194219|863123|P3|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
261441|NCT01194219|863124|P2|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
261442|NCT01194219|863125|P1|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
261443|NCT01194219|863118|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|33
261444|NCT01194219|863119|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|35
261445|NCT01194219|863120|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|1
261446|NCT01194219|863121|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|1
261447|NCT01194219|863122|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
261448|NCT01194219|863123|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
261449|NCT01194219|863124|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
261450|NCT01194219|863125|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
261451|NCT01194219|863118|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|5
261452|NCT01194219|863119|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|6
261453|NCT01194219|863120|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
261454|NCT01194219|863121|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
261455|NCT01194219|863122|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
261456|NCT01194219|863123|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
261457|NCT01194219|863124|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
261458|NCT01194219|863125|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
261459|NCT01194219|863118|P8|Maintenance Phase (Weeks16-32)|Unspecified|0
261460|NCT01194219|863119|P7|Maintenance Phase (Weeks16-32)|Unspecified|0
261461|NCT01194219|863120|P6|Maintenance Phase (Weeks16-32)|Unspecified|0
261462|NCT01194219|863121|P5|Maintenance Phase (Weeks16-32)|Unspecified|0
261463|NCT01194219|863122|P4|Maintenance Phase (Weeks16-32)|Unspecified|1
261464|NCT01194219|863123|P3|Maintenance Phase (Weeks16-32)|Unspecified|2
261465|NCT01194219|863124|P2|Maintenance Phase (Weeks16-32)|Unspecified|0
261466|NCT01194219|863125|P1|Maintenance Phase (Weeks16-32)|Unspecified|0
261467|NCT01194219|863118|P8|Maintenance Phase (Weeks16-32)|Protocol Violation|0
261468|NCT01194219|863119|P7|Maintenance Phase (Weeks16-32)|Protocol Violation|0
261469|NCT01194219|863120|P6|Maintenance Phase (Weeks16-32)|Protocol Violation|0
261470|NCT01194219|863121|P5|Maintenance Phase (Weeks16-32)|Protocol Violation|0
261471|NCT01194219|863122|P4|Maintenance Phase (Weeks16-32)|Protocol Violation|1
261472|NCT01194219|863123|P3|Maintenance Phase (Weeks16-32)|Protocol Violation|0
261473|NCT01194219|863124|P2|Maintenance Phase (Weeks16-32)|Protocol Violation|0
261474|NCT01194219|863125|P1|Maintenance Phase (Weeks16-32)|Protocol Violation|0
261475|NCT01194219|863118|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
261476|NCT01194219|863119|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
261477|NCT01194219|863120|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
261478|NCT01194219|863121|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
261479|NCT01194219|863122|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
261480|NCT01194219|863123|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|9
261481|NCT01194219|863124|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
261482|NCT01194219|863125|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
261483|NCT01194219|863118|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
261484|NCT01194219|863119|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
261485|NCT01194219|863120|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
261486|NCT01194219|863121|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
261487|NCT01194219|863122|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|3
261488|NCT01194219|863123|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|12
261489|NCT01194219|863124|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
261490|NCT01194219|863125|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
261491|NCT01194219|863118|P8|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
261492|NCT01194219|863119|P7|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
261493|NCT01194219|863120|P6|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
261494|NCT01194219|863121|P5|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
261495|NCT01194219|863122|P4|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|1
261496|NCT01194219|863123|P3|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|2
261497|NCT01194219|863124|P2|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
261498|NCT01194219|863125|P1|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
261499|NCT01194219|863118|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
261500|NCT01194219|863119|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
261501|NCT01194219|863120|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
261502|NCT01194219|863121|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
261503|NCT01194219|863122|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|15
261504|NCT01194219|863123|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|37
261505|NCT01194219|863124|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
261506|NCT01194219|863125|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
261507|NCT01194219|863118|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
261508|NCT01194219|863119|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
261509|NCT01194219|863120|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
261510|NCT01194219|863121|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
261511|NCT01194219|863122|P4|Maintenance Phase (Weeks16-32)|Adverse Event|9
261512|NCT01194219|863123|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
261513|NCT01194219|863124|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
261514|NCT01194219|863125|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
261515|NCT01194219|863118|P8|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
261516|NCT01194219|863119|P7|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
261517|NCT01194219|863120|P6|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
261518|NCT01194219|863121|P5|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
261519|NCT01194219|863122|P4|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
261520|NCT01194219|863123|P3|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
261521|NCT01194219|863124|P2|Placebo Controlled Phase (Weeks 0-16)|Unspecified|1
261522|NCT01194219|863125|P1|Placebo Controlled Phase (Weeks 0-16)|Unspecified|1
261523|NCT01194219|863118|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
261524|NCT01194219|863119|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
261525|NCT01194219|863120|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
261526|NCT01194219|863121|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
261527|NCT01194219|863122|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
261528|NCT01194219|863123|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
261529|NCT01194219|863124|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|1
261530|NCT01194219|863125|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|7
261531|NCT01194219|863118|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
261532|NCT01194219|863119|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
261533|NCT01194219|863120|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
261534|NCT01194219|863121|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
261535|NCT01194219|863122|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
261536|NCT01194219|863123|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
261537|NCT01194219|863124|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|9
261538|NCT01194219|863125|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|7
261539|NCT01194219|863118|P8|Placebo Controlled Phase (Weeks 0-16)|Death|0
261540|NCT01194219|863119|P7|Placebo Controlled Phase (Weeks 0-16)|Death|0
261541|NCT01194219|863120|P6|Placebo Controlled Phase (Weeks 0-16)|Death|0
261542|NCT01194219|863121|P5|Placebo Controlled Phase (Weeks 0-16)|Death|0
261543|NCT01194219|863122|P4|Placebo Controlled Phase (Weeks 0-16)|Death|0
261544|NCT01194219|863123|P3|Placebo Controlled Phase (Weeks 0-16)|Death|0
261545|NCT01194219|863124|P2|Placebo Controlled Phase (Weeks 0-16)|Death|1
261546|NCT01194219|863125|P1|Placebo Controlled Phase (Weeks 0-16)|Death|0
261547|NCT01194219|863118|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
261548|NCT01194219|863119|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
261549|NCT01194219|863120|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
261550|NCT01194219|863121|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
261551|NCT01194219|863122|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
261552|NCT01194219|863123|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
261553|NCT01194219|863124|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
261554|NCT01194219|863125|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|12
261555|NCT01194219|863118|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
261556|NCT01194219|863119|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
261557|NCT01194219|863120|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
261558|NCT01194219|863121|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
261559|NCT01194219|863122|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
261560|NCT01194219|863123|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
261561|NCT01194219|863124|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
261562|NCT01194219|863125|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|7
261563|NCT01194219|863118|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
261564|NCT01194219|863119|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
261565|NCT01194219|863120|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
261566|NCT01194219|863121|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
261567|NCT01194219|863122|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
261568|NCT01194219|863123|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
261569|NCT01194219|863124|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|7
261570|NCT01194219|863125|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
261571|NCT01194219|863118|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
261572|NCT01194219|863119|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
261573|NCT01194219|863120|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
261574|NCT01194219|863121|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
261575|NCT01194219|863122|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
261576|NCT01194219|863123|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
261577|NCT01194219|863124|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|5
261578|NCT01194219|863125|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|23
261579|NCT01194154|863157|P2|Overall Study|Did not receive study medication|4
261580|NCT01194154|863158|P1|Overall Study|Did not receive study medication|2
261581|NCT01194154|863157|P2|Overall Study|Unspecified|0
261582|NCT01194154|863158|P1|Overall Study|Unspecified|4
261583|NCT01194154|863157|P2|Overall Study|Treatment with prohibited medication|5
261584|NCT01194154|863158|P1|Overall Study|Treatment with prohibited medication|4
261585|NCT01194154|863157|P2|Overall Study|Skipping of CERA treatment at two visits|0
261586|NCT01194154|863158|P1|Overall Study|Skipping of CERA treatment at two visits|3
261587|NCT01194154|863157|P2|Overall Study|Hemoglobin increase|3
261588|NCT01194154|863158|P1|Overall Study|Hemoglobin increase|12
261589|NCT01194154|863157|P2|Overall Study|Hemoglobin decrease|1
261590|NCT01194154|863158|P1|Overall Study|Hemoglobin decrease|0
261591|NCT01194154|863157|P2|Overall Study|Blood pressure increase|3
261592|NCT01194154|863158|P1|Overall Study|Blood pressure increase|5
261593|NCT01194154|863157|P2|Overall Study|Withdrawal by Subject|6
261594|NCT01194154|863158|P1|Overall Study|Withdrawal by Subject|5
261595|NCT01194154|863157|P2|Overall Study|Protocol Violation|1
261596|NCT01194154|863158|P1|Overall Study|Protocol Violation|0
261597|NCT01194154|863157|P2|Overall Study|Lost to Follow-up|3
261598|NCT01194154|863158|P1|Overall Study|Lost to Follow-up|2
261599|NCT01194154|863157|P2|Overall Study|Adverse Event|7
261600|NCT01194154|863158|P1|Overall Study|Adverse Event|12
261601|NCT01193920|863199|P10|Overall Study|Unable to classify|0
261602|NCT01193920|863200|P9|Overall Study|Unable to classify|0
261603|NCT01193920|863201|P8|Overall Study|Unable to classify|1
261604|NCT01193920|863202|P7|Overall Study|Unable to classify|0
261605|NCT01193920|863203|P6|Overall Study|Unable to classify|0
261606|NCT01193920|863204|P5|Overall Study|Unable to classify|0
261607|NCT01193920|863205|P4|Overall Study|Unable to classify|1
261608|NCT01193920|863206|P3|Overall Study|Unable to classify|0
261609|NCT01193920|863207|P2|Overall Study|Unable to classify|0
261610|NCT01193920|863208|P1|Overall Study|Unable to classify|0
261611|NCT01193920|863199|P10|Overall Study|Death|4
261612|NCT01193920|863200|P9|Overall Study|Death|2
261613|NCT01193920|863201|P8|Overall Study|Death|3
261614|NCT01193920|863202|P7|Overall Study|Death|2
261615|NCT01193920|863203|P6|Overall Study|Death|0
261616|NCT01193920|863204|P5|Overall Study|Death|0
261617|NCT01193920|863205|P4|Overall Study|Death|1
261618|NCT01193920|863206|P3|Overall Study|Death|0
261619|NCT01193920|863207|P2|Overall Study|Death|0
261620|NCT01193920|863208|P1|Overall Study|Death|0
261621|NCT01193920|863199|P10|Overall Study|Protocol Violation|0
261622|NCT01193920|863200|P9|Overall Study|Protocol Violation|0
261623|NCT01193920|863201|P8|Overall Study|Protocol Violation|0
261624|NCT01193920|863202|P7|Overall Study|Protocol Violation|0
261625|NCT01193920|863203|P6|Overall Study|Protocol Violation|0
261626|NCT01193920|863204|P5|Overall Study|Protocol Violation|0
261627|NCT01193920|863205|P4|Overall Study|Protocol Violation|0
261628|NCT01193920|863206|P3|Overall Study|Protocol Violation|0
261629|NCT01193920|863207|P2|Overall Study|Protocol Violation|0
261630|NCT01193920|863208|P1|Overall Study|Protocol Violation|1
261631|NCT01193920|863199|P10|Overall Study|Lost to Follow-up|3
261632|NCT01193920|863200|P9|Overall Study|Lost to Follow-up|2
261633|NCT01193920|863201|P8|Overall Study|Lost to Follow-up|0
261634|NCT01193920|863202|P7|Overall Study|Lost to Follow-up|1
261635|NCT01193920|863203|P6|Overall Study|Lost to Follow-up|3
261636|NCT01193920|863204|P5|Overall Study|Lost to Follow-up|3
261637|NCT01193920|863205|P4|Overall Study|Lost to Follow-up|1
261638|NCT01193920|863206|P3|Overall Study|Lost to Follow-up|1
261639|NCT01193920|863207|P2|Overall Study|Lost to Follow-up|0
261640|NCT01193920|863208|P1|Overall Study|Lost to Follow-up|1
261641|NCT01193920|863199|P10|Overall Study|Withdrawal by Subject|0
261642|NCT01193920|863200|P9|Overall Study|Withdrawal by Subject|1
261643|NCT01193920|863201|P8|Overall Study|Withdrawal by Subject|0
261644|NCT01193920|863202|P7|Overall Study|Withdrawal by Subject|3
261645|NCT01193920|863203|P6|Overall Study|Withdrawal by Subject|1
261646|NCT01193920|863204|P5|Overall Study|Withdrawal by Subject|3
261647|NCT01193920|863205|P4|Overall Study|Withdrawal by Subject|1
261648|NCT01193920|863206|P3|Overall Study|Withdrawal by Subject|5
261649|NCT01193920|863207|P2|Overall Study|Withdrawal by Subject|0
261650|NCT01193920|863208|P1|Overall Study|Withdrawal by Subject|1
261651|NCT01193686|863301|P2|Overall Study|Removed by Investigators; unable to matc|0
261652|NCT01193686|863302|P1|Overall Study|Removed by Investigators; unable to matc|3
261653|NCT01193686|863301|P2|Overall Study|Withdrawal by Subject|1
261654|NCT01193686|863302|P1|Overall Study|Withdrawal by Subject|4
261655|NCT01193660|863319|P3|Overall Study|Physician Decision|1
261656|NCT01193660|863320|P2|Overall Study|Physician Decision|0
261657|NCT01193660|863321|P1|Overall Study|Physician Decision|1
261658|NCT01193660|863319|P3|Overall Study|Death|0
261659|NCT01193660|863320|P2|Overall Study|Death|0
261660|NCT01193660|863321|P1|Overall Study|Death|1
261661|NCT01193660|863319|P3|Overall Study|Withdrawal by Subject|1
261662|NCT01193660|863320|P2|Overall Study|Withdrawal by Subject|3
261663|NCT01193660|863321|P1|Overall Study|Withdrawal by Subject|2
261664|NCT01193608|863365|P6|Overall Study|Adverse Event|0
261665|NCT01193608|863366|P5|Overall Study|Adverse Event|1
261666|NCT01193608|863367|P4|Overall Study|Adverse Event|0
261667|NCT01193608|863368|P3|Overall Study|Adverse Event|0
261668|NCT01193608|863369|P2|Overall Study|Adverse Event|0
261669|NCT01193608|863370|P1|Overall Study|Adverse Event|0
261670|NCT01193608|863365|P6|Overall Study|Lost to Follow-up|2
261671|NCT01193608|863366|P5|Overall Study|Lost to Follow-up|1
261672|NCT01193608|863367|P4|Overall Study|Lost to Follow-up|0
261673|NCT01193608|863368|P3|Overall Study|Lost to Follow-up|0
261674|NCT01193608|863369|P2|Overall Study|Lost to Follow-up|0
261675|NCT01193608|863370|P1|Overall Study|Lost to Follow-up|0
261676|NCT01193608|863365|P6|Overall Study|Withdrawal by Subject|0
261677|NCT01193608|863366|P5|Overall Study|Withdrawal by Subject|3
261678|NCT01193608|863367|P4|Overall Study|Withdrawal by Subject|3
261679|NCT01193608|863368|P3|Overall Study|Withdrawal by Subject|2
261680|NCT01193608|863369|P2|Overall Study|Withdrawal by Subject|1
261681|NCT01193608|863370|P1|Overall Study|Withdrawal by Subject|0
261682|NCT01193608|863365|P6|Overall Study|Unspecified|0
261683|NCT01193608|863366|P5|Overall Study|Unspecified|0
261684|NCT01193608|863367|P4|Overall Study|Unspecified|0
261685|NCT01193608|863368|P3|Overall Study|Unspecified|0
261686|NCT01193608|863369|P2|Overall Study|Unspecified|1
261687|NCT01193608|863370|P1|Overall Study|Unspecified|0
261688|NCT01193582|863607|P4|12 Month Follow-up|Withdrawal by Subject|11
261689|NCT01193582|863608|P3|12 Month Follow-up|Withdrawal by Subject|3
261690|NCT01193582|863609|P2|12 Month Follow-up|Withdrawal by Subject|0
261691|NCT01193582|863610|P1|12 Month Follow-up|Withdrawal by Subject|6
261692|NCT01193582|863607|P4|12 Month Follow-up|Death|0
261693|NCT01193582|863608|P3|12 Month Follow-up|Death|1
261694|NCT01193582|863609|P2|12 Month Follow-up|Death|0
261695|NCT01193582|863610|P1|12 Month Follow-up|Death|0
261696|NCT01193582|863607|P4|Vaccination Series|Withdrawal by Subject|3
261697|NCT01193582|863608|P3|Vaccination Series|Withdrawal by Subject|8
261698|NCT01193582|863609|P2|Vaccination Series|Withdrawal by Subject|13
261699|NCT01193582|863610|P1|Vaccination Series|Withdrawal by Subject|11
261700|NCT01193556|863640|P2|Overall Study|Study termination|25
261701|NCT01193556|863641|P1|Overall Study|Study termination|26
261702|NCT01193348|863649|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
261703|NCT01193348|863649|P1|Extension Treatment Period|Physician Decision|1
261704|NCT01193348|863649|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
261705|NCT01193348|863649|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
261706|NCT01193348|863649|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
261707|NCT01193348|863649|P1|Screening Period|Screen Failure|5
261708|NCT01193335|863669|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
261709|NCT01193335|863670|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
261710|NCT01193335|863669|P2|2-Year Follow-up|No Longer Willing to Participate|6
261711|NCT01193335|863670|P1|2-Year Follow-up|No Longer Willing to Participate|5
261712|NCT01193335|863669|P2|1-Year Follow-up|Lost to Follow-up|0
261713|NCT01193335|863670|P1|1-Year Follow-up|Lost to Follow-up|4
261714|NCT01193335|863669|P2|1-Year Follow-up|No Longer Willing to Participate|9
261715|NCT01193335|863670|P1|1-Year Follow-up|No Longer Willing to Participate|7
261716|NCT01193335|863669|P2|After Infant Series|No Longer Met Eligibility Criteria|1
261717|NCT01193335|863670|P1|After Infant Series|No Longer Met Eligibility Criteria|0
261718|NCT01193335|863669|P2|After Infant Series|Lost to Follow-up|2
261719|NCT01193335|863670|P1|After Infant Series|Lost to Follow-up|1
261720|NCT01193283|863765|P1|Overall Study|Death|1
261721|NCT01193244|863771|P2|Overall Study|Lost to Follow-up|15
261722|NCT01193244|863772|P1|Overall Study|Lost to Follow-up|6
261723|NCT01193244|863771|P2|Overall Study|Other|278
261724|NCT01193244|863772|P1|Overall Study|Other|303
261725|NCT01193244|863771|P2|Overall Study|Withdrawal by Subject|97
261726|NCT01193244|863772|P1|Overall Study|Withdrawal by Subject|79
261727|NCT01193218|863827|P8|12-52 Weeks|Other reason than above|0
261728|NCT01193218|863828|P7|12-52 Weeks|Other reason than above|0
261729|NCT01193218|863829|P6|12-52 Weeks|Other reason than above|0
261730|NCT01193218|863830|P5|12-52 Weeks|Other reason than above|1
261731|NCT01193218|863831|P4|12-52 Weeks|Other reason than above|1
261732|NCT01193218|863832|P3|12-52 Weeks|Other reason than above|0
261733|NCT01193218|863833|P2|12-52 Weeks|Other reason than above|0
261734|NCT01193218|863834|P1|12-52 Weeks|Other reason than above|1
261735|NCT01193218|863827|P8|12-52 Weeks|Withdrawal by Subject|2
261736|NCT01193218|863828|P7|12-52 Weeks|Withdrawal by Subject|1
261737|NCT01193218|863829|P6|12-52 Weeks|Withdrawal by Subject|2
261738|NCT01193218|863830|P5|12-52 Weeks|Withdrawal by Subject|0
261739|NCT01193218|863831|P4|12-52 Weeks|Withdrawal by Subject|0
261740|NCT01193218|863832|P3|12-52 Weeks|Withdrawal by Subject|3
261741|NCT01193218|863833|P2|12-52 Weeks|Withdrawal by Subject|0
261742|NCT01193218|863834|P1|12-52 Weeks|Withdrawal by Subject|3
261743|NCT01193218|863827|P8|12-52 Weeks|Lack of Efficacy|0
261744|NCT01193218|863828|P7|12-52 Weeks|Lack of Efficacy|1
261745|NCT01193218|863829|P6|12-52 Weeks|Lack of Efficacy|0
261746|NCT01193218|863830|P5|12-52 Weeks|Lack of Efficacy|0
261747|NCT01193218|863831|P4|12-52 Weeks|Lack of Efficacy|0
261748|NCT01193218|863832|P3|12-52 Weeks|Lack of Efficacy|0
261749|NCT01193218|863833|P2|12-52 Weeks|Lack of Efficacy|0
261750|NCT01193218|863834|P1|12-52 Weeks|Lack of Efficacy|0
261751|NCT01193218|863827|P8|12-52 Weeks|Adverse Event|2
261752|NCT01193218|863828|P7|12-52 Weeks|Adverse Event|1
261753|NCT01193218|863829|P6|12-52 Weeks|Adverse Event|3
261754|NCT01193218|863830|P5|12-52 Weeks|Adverse Event|3
261755|NCT01193218|863831|P4|12-52 Weeks|Adverse Event|2
261756|NCT01193218|863832|P3|12-52 Weeks|Adverse Event|1
261757|NCT01193218|863833|P2|12-52 Weeks|Adverse Event|0
261758|NCT01193218|863834|P1|12-52 Weeks|Adverse Event|1
261759|NCT01193218|863827|P8|0-12 Weeks|Withdrawal by Subject|0
261760|NCT01193218|863828|P7|0-12 Weeks|Withdrawal by Subject|1
261761|NCT01193218|863829|P6|0-12 Weeks|Withdrawal by Subject|0
261762|NCT01193218|863830|P5|0-12 Weeks|Withdrawal by Subject|0
261763|NCT01193218|863831|P4|0-12 Weeks|Withdrawal by Subject|0
261764|NCT01193218|863832|P3|0-12 Weeks|Withdrawal by Subject|2
261765|NCT01193218|863833|P2|0-12 Weeks|Withdrawal by Subject|0
261766|NCT01193218|863834|P1|0-12 Weeks|Withdrawal by Subject|3
261767|NCT01193218|863827|P8|0-12 Weeks|Protocol Violation|0
261768|NCT01193218|863828|P7|0-12 Weeks|Protocol Violation|0
261769|NCT01193218|863829|P6|0-12 Weeks|Protocol Violation|1
261770|NCT01193218|863830|P5|0-12 Weeks|Protocol Violation|1
261771|NCT01193218|863831|P4|0-12 Weeks|Protocol Violation|0
261772|NCT01193218|863832|P3|0-12 Weeks|Protocol Violation|0
261773|NCT01193218|863833|P2|0-12 Weeks|Protocol Violation|0
261774|NCT01193218|863834|P1|0-12 Weeks|Protocol Violation|0
261775|NCT01193218|863827|P8|0-12 Weeks|Adverse Event|0
261776|NCT01193218|863828|P7|0-12 Weeks|Adverse Event|2
261777|NCT01193218|863829|P6|0-12 Weeks|Adverse Event|2
261778|NCT01193218|863830|P5|0-12 Weeks|Adverse Event|0
261779|NCT01193218|863831|P4|0-12 Weeks|Adverse Event|0
261780|NCT01193218|863832|P3|0-12 Weeks|Adverse Event|1
261781|NCT01193218|863833|P2|0-12 Weeks|Adverse Event|0
261782|NCT01193218|863834|P1|0-12 Weeks|Adverse Event|6
261783|NCT01193153|863865|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
261784|NCT01193153|863866|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
261785|NCT01193153|863865|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
261786|NCT01193153|863866|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
261787|NCT01193153|863865|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
261788|NCT01193153|863866|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
261789|NCT01193153|863865|P2|Double Blind Relapse Prevention Period|Pregnancy|0
261790|NCT01193153|863866|P1|Double Blind Relapse Prevention Period|Pregnancy|1
261791|NCT01193153|863865|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
261792|NCT01193153|863866|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
261793|NCT01193153|863865|P2|Double Blind Relapse Prevention Period|Death|0
261794|NCT01193153|863866|P1|Double Blind Relapse Prevention Period|Death|2
261795|NCT01193153|863865|P2|Double Blind Relapse Prevention Period|Adverse Event|3
261796|NCT01193153|863866|P1|Double Blind Relapse Prevention Period|Adverse Event|12
261797|NCT01193153|863865|P2|Double Blind Relapse Prevention Period|Unspecified|3
261798|NCT01193153|863866|P1|Double Blind Relapse Prevention Period|Unspecified|2
261799|NCT01193153|863865|P2|Open-label Stabilization Period|Unspecified|0
261800|NCT01193153|863866|P1|Open-label Stabilization Period|Unspecified|8
261801|NCT01193153|863865|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
261802|NCT01193153|863866|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
261803|NCT01193153|863865|P2|Open-label Stabilization Period|Withdrawal by Subject|0
261804|NCT01193153|863866|P1|Open-label Stabilization Period|Withdrawal by Subject|29
261805|NCT01193153|863865|P2|Open-label Stabilization Period|Lack of Efficacy|0
261806|NCT01193153|863866|P1|Open-label Stabilization Period|Lack of Efficacy|5
261807|NCT01193153|863865|P2|Open-label Stabilization Period|Lost to Follow-up|0
261808|NCT01193153|863866|P1|Open-label Stabilization Period|Lost to Follow-up|10
261809|NCT01193153|863865|P2|Open-label Stabilization Period|Death|0
261810|NCT01193153|863866|P1|Open-label Stabilization Period|Death|2
261811|NCT01193153|863865|P2|Open-label Stabilization Period|Adverse Event|0
261812|NCT01193153|863866|P1|Open-label Stabilization Period|Adverse Event|9
261813|NCT01193153|863865|P2|Open-label Lead in Period|Lack of Efficacy|0
261814|NCT01193153|863866|P1|Open-label Lead in Period|Lack of Efficacy|26
261815|NCT01193153|863865|P2|Open-label Lead in Period|Death|0
261816|NCT01193153|863866|P1|Open-label Lead in Period|Death|1
261817|NCT01193153|863865|P2|Open-label Lead in Period|Adverse Event|0
261818|NCT01193153|863866|P1|Open-label Lead in Period|Adverse Event|41
261819|NCT01193153|863865|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
261820|NCT01193153|863866|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
261821|NCT01193153|863865|P2|Open-label Lead in Period|Unspecified|0
261822|NCT01193153|863866|P1|Open-label Lead in Period|Unspecified|14
261823|NCT01193153|863865|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
261824|NCT01193153|863866|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
261825|NCT01193153|863865|P2|Open-label Lead in Period|Withdrawal by Subject|0
261826|NCT01193153|863866|P1|Open-label Lead in Period|Withdrawal by Subject|69
261827|NCT01193153|863865|P2|Open-label Lead in Period|Pregnancy|0
261828|NCT01193153|863866|P1|Open-label Lead in Period|Pregnancy|1
261829|NCT01193153|863865|P2|Open-label Lead in Period|Lost to Follow-up|0
261830|NCT01193153|863866|P1|Open-label Lead in Period|Lost to Follow-up|32
261831|NCT01193127|863901|P4|Treated|Withdrawal by Subject|1
261832|NCT01193127|863902|P3|Treated|Withdrawal by Subject|0
261833|NCT01193127|863903|P2|Treated|Withdrawal by Subject|0
261834|NCT01193127|863904|P1|Treated|Withdrawal by Subject|0
261835|NCT01193127|863901|P4|Randomized|Surgery Cancelled|1
261836|NCT01193127|863902|P3|Randomized|Surgery Cancelled|0
261837|NCT01193127|863903|P2|Randomized|Surgery Cancelled|0
261838|NCT01193127|863904|P1|Randomized|Surgery Cancelled|0
261839|NCT01193101|864229|P4|Overall Study|Abnormal test procedure results|0
261840|NCT01193101|864230|P3|Overall Study|Abnormal test procedure results|0
261841|NCT01193101|864231|P2|Overall Study|Abnormal test procedure results|1
261842|NCT01193101|864232|P1|Overall Study|Abnormal test procedure results|0
261843|NCT01193101|864229|P4|Overall Study|Administrative problems|0
261844|NCT01193101|864230|P3|Overall Study|Administrative problems|1
261845|NCT01193101|864231|P2|Overall Study|Administrative problems|0
261846|NCT01193101|864232|P1|Overall Study|Administrative problems|0
261847|NCT01193101|864229|P4|Overall Study|Withdrawal by Subject|1
261848|NCT01193101|864230|P3|Overall Study|Withdrawal by Subject|1
261849|NCT01193101|864231|P2|Overall Study|Withdrawal by Subject|4
261850|NCT01193101|864232|P1|Overall Study|Withdrawal by Subject|2
261851|NCT01193101|864229|P4|Overall Study|Lack of Efficacy|8
261852|NCT01193101|864230|P3|Overall Study|Lack of Efficacy|0
261853|NCT01193101|864231|P2|Overall Study|Lack of Efficacy|1
261854|NCT01193101|864232|P1|Overall Study|Lack of Efficacy|3
261855|NCT01193101|864229|P4|Overall Study|Adverse Event|3
261856|NCT01193101|864230|P3|Overall Study|Adverse Event|1
261857|NCT01193101|864231|P2|Overall Study|Adverse Event|1
261858|NCT01193101|864232|P1|Overall Study|Adverse Event|0
261859|NCT01192516|864334|P3|Overall Study|Unable to follow Actiwatch instructions|0
261860|NCT01192516|864335|P2|Overall Study|Unable to follow Actiwatch instructions|2
261861|NCT01192516|864336|P1|Overall Study|Unable to follow Actiwatch instructions|4
261862|NCT01192516|864334|P3|Overall Study|started new treatment|0
261863|NCT01192516|864335|P2|Overall Study|started new treatment|1
261864|NCT01192516|864336|P1|Overall Study|started new treatment|5
261865|NCT01192516|864334|P3|Overall Study|Withdrawal by Subject|1
261866|NCT01192516|864335|P2|Overall Study|Withdrawal by Subject|4
261867|NCT01192516|864336|P1|Overall Study|Withdrawal by Subject|4
261868|NCT01192516|864334|P3|Overall Study|Lost to Follow-up|7
261869|NCT01192516|864335|P2|Overall Study|Lost to Follow-up|10
261870|NCT01192516|864336|P1|Overall Study|Lost to Follow-up|7
261871|NCT01192412|864370|P2|Overall Study|Withdrawal by Subject|1
261872|NCT01192412|864371|P1|Overall Study|Withdrawal by Subject|2
261873|NCT01192412|864370|P2|Overall Study|Lost to Follow-up|1
261874|NCT01192412|864371|P1|Overall Study|Lost to Follow-up|2
261875|NCT01192347|864379|P1|Overall Study|Patient did not show up for visits|1
261876|NCT01192347|864379|P1|Overall Study|Patient not visiting hospital regularly|1
261877|NCT01192347|864379|P1|Overall Study|Patient seen in different hospital|1
261878|NCT01192347|864379|P1|Overall Study|Suspected serious adverse drug reaction|1
261879|NCT01192347|864379|P1|Overall Study|Adverse Event|1
261880|NCT01192347|864379|P1|Overall Study|Withdrawal by Subject|1
261881|NCT01192347|864379|P1|Overall Study|Lost to Follow-up|3
261882|NCT01192347|864379|P1|Overall Study|Death|3
261883|NCT01192295|864402|P2|Overall Study|Administrative|6
261884|NCT01192295|864403|P1|Overall Study|Administrative|4
261885|NCT01192295|864402|P2|Overall Study|Lack of Efficacy|5
261886|NCT01192295|864403|P1|Overall Study|Lack of Efficacy|0
261887|NCT01192295|864402|P2|Overall Study|Lost to Follow-up|1
261888|NCT01192295|864403|P1|Overall Study|Lost to Follow-up|0
261889|NCT01192295|864402|P2|Overall Study|Withdrawal by Subject|4
261890|NCT01192295|864403|P1|Overall Study|Withdrawal by Subject|3
261891|NCT01192295|864402|P2|Overall Study|Adverse Event|7
261892|NCT01192295|864403|P1|Overall Study|Adverse Event|3
261893|NCT01192204|864437|P2|Overall Study|could not keep recall appointments|0
261894|NCT01192204|864438|P1|Overall Study|could not keep recall appointments|1
261895|NCT01192191|864450|P2|Overall Study|Withdrawal by Subject|6
261896|NCT01192191|864451|P1|Overall Study|Withdrawal by Subject|1
261897|NCT01192191|864450|P2|Overall Study|Lost to Follow-up|1
261898|NCT01192191|864451|P1|Overall Study|Lost to Follow-up|0
261899|NCT01192191|864450|P2|Overall Study|Participants Reached Stopping Criteria|2
261900|NCT01192191|864451|P1|Overall Study|Participants Reached Stopping Criteria|3
261901|NCT01192191|864450|P2|Overall Study|Adverse Event|12
261902|NCT01192191|864451|P1|Overall Study|Adverse Event|7
261903|NCT01192178|864477|P2|Overall Study|Lack of Efficacy|2
261904|NCT01192178|864478|P1|Overall Study|Lack of Efficacy|1
261905|NCT01192178|864477|P2|Overall Study|Adverse Event|1
261906|NCT01192178|864478|P1|Overall Study|Adverse Event|2
261907|NCT01192178|864477|P2|Overall Study|Lost to Follow-up|3
261908|NCT01192178|864478|P1|Overall Study|Lost to Follow-up|3
261909|NCT01192178|864477|P2|Overall Study|Physician Decision|4
261910|NCT01192178|864478|P1|Overall Study|Physician Decision|2
261911|NCT01192178|864477|P2|Overall Study|Protocol Violation|3
261912|NCT01192178|864478|P1|Overall Study|Protocol Violation|10
261913|NCT01192178|864477|P2|Overall Study|Withdrawal by Subject|10
261914|NCT01192178|864478|P1|Overall Study|Withdrawal by Subject|6
261915|NCT01192152|864498|P2|Period 3|family emergency|0
261916|NCT01192152|864499|P1|Period 3|family emergency|1
261917|NCT01192152|864498|P2|Period 1|left prematurely (while on treatment B)|1
261918|NCT01192152|864499|P1|Period 1|left prematurely (while on treatment B)|0
261919|NCT01192126|864670|P2|First Intervention (1 Week)|Lost to Follow-up|1
261920|NCT01192126|864671|P1|First Intervention (1 Week)|Lost to Follow-up|1
261921|NCT01192126|864670|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
261922|NCT01192126|864671|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
261923|NCT01192022|864683|P5|Overall Study|Parents did not allow all follow up|0
261924|NCT01192022|864684|P4|Overall Study|Parents did not allow all follow up|1
261925|NCT01192022|864685|P3|Overall Study|Parents did not allow all follow up|0
261926|NCT01192022|864686|P2|Overall Study|Parents did not allow all follow up|0
261927|NCT01192022|864687|P1|Overall Study|Parents did not allow all follow up|0
261928|NCT01192022|864683|P5|Overall Study|Patient needed surgery|0
261929|NCT01192022|864684|P4|Overall Study|Patient needed surgery|0
261930|NCT01192022|864685|P3|Overall Study|Patient needed surgery|0
261931|NCT01192022|864686|P2|Overall Study|Patient needed surgery|1
261932|NCT01192022|864687|P1|Overall Study|Patient needed surgery|0
261933|NCT01192022|864683|P5|Overall Study|Patient too sick from chemotherapy|0
261934|NCT01192022|864684|P4|Overall Study|Patient too sick from chemotherapy|0
261935|NCT01192022|864685|P3|Overall Study|Patient too sick from chemotherapy|0
261936|NCT01192022|864686|P2|Overall Study|Patient too sick from chemotherapy|1
261937|NCT01192022|864687|P1|Overall Study|Patient too sick from chemotherapy|0
261938|NCT01192022|864683|P5|Overall Study|Physician withdrew-patient hardship|0
261939|NCT01192022|864684|P4|Overall Study|Physician withdrew-patient hardship|0
261940|NCT01192022|864685|P3|Overall Study|Physician withdrew-patient hardship|0
261941|NCT01192022|864686|P2|Overall Study|Physician withdrew-patient hardship|0
261942|NCT01192022|864687|P1|Overall Study|Physician withdrew-patient hardship|1
261943|NCT01192022|864683|P5|Overall Study|Fatal Adverse Event|1
261944|NCT01192022|864684|P4|Overall Study|Fatal Adverse Event|0
261945|NCT01192022|864685|P3|Overall Study|Fatal Adverse Event|0
261946|NCT01192022|864686|P2|Overall Study|Fatal Adverse Event|6
261947|NCT01192022|864687|P1|Overall Study|Fatal Adverse Event|4
261948|NCT01192022|864683|P5|Overall Study|Adverse Event|0
261949|NCT01192022|864684|P4|Overall Study|Adverse Event|0
261950|NCT01192022|864685|P3|Overall Study|Adverse Event|0
261951|NCT01192022|864686|P2|Overall Study|Adverse Event|0
261952|NCT01192022|864687|P1|Overall Study|Adverse Event|1
261953|NCT01192022|864683|P5|Overall Study|Lost to Follow-up|0
261954|NCT01192022|864684|P4|Overall Study|Lost to Follow-up|1
261955|NCT01192022|864685|P3|Overall Study|Lost to Follow-up|1
261956|NCT01192022|864686|P2|Overall Study|Lost to Follow-up|2
261957|NCT01192022|864687|P1|Overall Study|Lost to Follow-up|4
261958|NCT01192022|864683|P5|Overall Study|Withdrawal of Consent|0
261959|NCT01192022|864684|P4|Overall Study|Withdrawal of Consent|0
261960|NCT01192022|864685|P3|Overall Study|Withdrawal of Consent|0
261961|NCT01192022|864686|P2|Overall Study|Withdrawal of Consent|1
261962|NCT01192022|864687|P1|Overall Study|Withdrawal of Consent|3
261963|NCT01191944|864710|P2|Overall Study|Other|3
261964|NCT01191944|864711|P1|Overall Study|Other|1
261965|NCT01191944|864710|P2|Overall Study|Withdrawal by Subject|2
261966|NCT01191944|864711|P1|Overall Study|Withdrawal by Subject|4
261967|NCT01191944|864710|P2|Overall Study|Protocol Violation|2
261968|NCT01191944|864711|P1|Overall Study|Protocol Violation|1
261969|NCT01191944|864710|P2|Overall Study|Adverse Event|12
261970|NCT01191944|864711|P1|Overall Study|Adverse Event|11
261971|NCT01191801|864766|P2|Overall Study|Not Provided|27
261972|NCT01191801|864767|P1|Overall Study|Not Provided|45
261973|NCT01191801|864766|P2|Overall Study|Withdrawal by Subject|4
261974|NCT01191801|864767|P1|Overall Study|Withdrawal by Subject|1
261975|NCT01191801|864766|P2|Overall Study|Physician Decision|24
261976|NCT01191801|864767|P1|Overall Study|Physician Decision|47
261977|NCT01191801|864766|P2|Overall Study|Protocol Violation|4
261978|NCT01191801|864767|P1|Overall Study|Protocol Violation|2
261979|NCT01191801|864766|P2|Overall Study|Adverse Event|8
261980|NCT01191801|864767|P1|Overall Study|Adverse Event|9
261981|NCT01191801|864766|P2|Overall Study|Lack of Efficacy|258
261982|NCT01191801|864767|P1|Overall Study|Lack of Efficacy|176
261983|NCT01191801|864766|P2|Overall Study|Death|12
261984|NCT01191801|864767|P1|Overall Study|Death|36
261985|NCT01191788|864787|P2|Overall Study|Lost to Follow-up|22
261986|NCT01191788|864788|P1|Overall Study|Lost to Follow-up|21
261987|NCT01191762|864798|P2|Overall Study|Adverse Event|0
261988|NCT01191762|864799|P1|Overall Study|Adverse Event|1
261989|NCT01191268|864938|P3|Overall Study|Sponsor Decision|0
261990|NCT01191268|864939|P2|Overall Study|Sponsor Decision|2
261991|NCT01191268|864940|P1|Overall Study|Sponsor Decision|0
261992|NCT01191268|864938|P3|Overall Study|Protocol Violation|1
261993|NCT01191268|864939|P2|Overall Study|Protocol Violation|0
261994|NCT01191268|864940|P1|Overall Study|Protocol Violation|1
261995|NCT01191268|864938|P3|Overall Study|Death|3
261996|NCT01191268|864939|P2|Overall Study|Death|1
261997|NCT01191268|864940|P1|Overall Study|Death|0
261998|NCT01191268|864938|P3|Overall Study|Entry Criteria Not Met|1
261999|NCT01191268|864939|P2|Overall Study|Entry Criteria Not Met|1
262000|NCT01191268|864940|P1|Overall Study|Entry Criteria Not Met|3
262001|NCT01191268|864938|P3|Overall Study|Lost to Follow-up|9
262002|NCT01191268|864939|P2|Overall Study|Lost to Follow-up|5
262003|NCT01191268|864940|P1|Overall Study|Lost to Follow-up|8
262004|NCT01191268|864938|P3|Overall Study|Physician Decision|9
262005|NCT01191268|864939|P2|Overall Study|Physician Decision|8
262006|NCT01191268|864940|P1|Overall Study|Physician Decision|6
262007|NCT01191268|864938|P3|Overall Study|Adverse Event|8
262008|NCT01191268|864939|P2|Overall Study|Adverse Event|13
262009|NCT01191268|864940|P1|Overall Study|Adverse Event|21
262010|NCT01191268|864938|P3|Overall Study|Withdrawal by Subject|21
262011|NCT01191268|864939|P2|Overall Study|Withdrawal by Subject|25
262012|NCT01191268|864940|P1|Overall Study|Withdrawal by Subject|19
262013|NCT01191190|865081|P1|Overall Study|Withdrawal by Subject|1
262014|NCT01191086|865094|P1|Overall Study|Other|1
262015|NCT01191086|865094|P1|Overall Study|Discontinuation criterion met|1
262016|NCT01191086|865094|P1|Overall Study|Withdrawal by Subject|24
262017|NCT01191086|865094|P1|Overall Study|Physician Decision|2
262018|NCT01191086|865094|P1|Overall Study|Lost to Follow-up|4
262019|NCT01191086|865094|P1|Overall Study|Lack of Efficacy|10
262020|NCT01191086|865094|P1|Overall Study|Adverse Event|20
262021|NCT01190891|865100|P2|Overall Study|Withdrawal by Subject|0
262022|NCT01190891|865101|P1|Overall Study|Withdrawal by Subject|5
262023|NCT01190891|865100|P2|Overall Study|Protocol Violation|0
262024|NCT01190891|865101|P1|Overall Study|Protocol Violation|1
262025|NCT01190865|865126|P1|Overall Study|Non-compliance|2
262026|NCT01190865|865126|P1|Overall Study|Withdrawal by Subject|1
262027|NCT01190839|865133|P2|Overall Study|Randomized but not treated|4
262028|NCT01190839|865134|P1|Overall Study|Randomized but not treated|2
262029|NCT01190839|865133|P2|Overall Study|Undefined|31
262030|NCT01190839|865134|P1|Overall Study|Undefined|35
262031|NCT01190839|865133|P2|Overall Study|Trial stopped by Sponsor|68
262032|NCT01190839|865134|P1|Overall Study|Trial stopped by Sponsor|71
262033|NCT01190839|865133|P2|Overall Study|Death|0
262034|NCT01190839|865134|P1|Overall Study|Death|1
262035|NCT01190839|865133|P2|Overall Study|Lost to Follow-up|1
262036|NCT01190839|865134|P1|Overall Study|Lost to Follow-up|7
262037|NCT01190839|865133|P2|Overall Study|Protocol Violation|2
262038|NCT01190839|865134|P1|Overall Study|Protocol Violation|2
262039|NCT01190839|865133|P2|Overall Study|Adverse Event|41
262040|NCT01190839|865134|P1|Overall Study|Adverse Event|32
262041|NCT01190813|865148|P2|Overall Study|Adverse Event|1
262042|NCT01190813|865149|P1|Overall Study|Adverse Event|0
262043|NCT01190813|865148|P2|Overall Study|Refused study treatment after randomized|0
262044|NCT01190813|865149|P1|Overall Study|Refused study treatment after randomized|1
262045|NCT01190813|865148|P2|Overall Study|Withdrawal by Subject|1
262046|NCT01190813|865149|P1|Overall Study|Withdrawal by Subject|2
262047|NCT01190813|865148|P2|Overall Study|Lost to Follow-up|2
262048|NCT01190813|865149|P1|Overall Study|Lost to Follow-up|1
262049|NCT01190514|865270|P4|Third Intervention (Period 3)|Adverse Event|0
262050|NCT01190514|865271|P3|Third Intervention (Period 3)|Adverse Event|0
262051|NCT01190514|865272|P2|Third Intervention (Period 3)|Adverse Event|0
262052|NCT01190514|865273|P1|Third Intervention (Period 3)|Adverse Event|1
262053|NCT01190514|865270|P4|First Intervention (Period 1)|Adverse Event|0
262054|NCT01190514|865271|P3|First Intervention (Period 1)|Adverse Event|0
262055|NCT01190514|865272|P2|First Intervention (Period 1)|Adverse Event|0
262056|NCT01190514|865273|P1|First Intervention (Period 1)|Adverse Event|1
262057|NCT01190436|865303|P1|Overall Study|Unspecified|4
262058|NCT01190436|865303|P1|Overall Study|Lost to Follow-up|35
262059|NCT01190267|865328|P2|Overall Study|Protocol Violation|1
262060|NCT01190267|865329|P1|Overall Study|Protocol Violation|8
262061|NCT01190267|865328|P2|Overall Study|Withdrawal by Subject|1
262062|NCT01190267|865329|P1|Overall Study|Withdrawal by Subject|13
262063|NCT01190267|865328|P2|Overall Study|Lost to Follow-up|0
262064|NCT01190267|865329|P1|Overall Study|Lost to Follow-up|2
262065|NCT01190267|865328|P2|Overall Study|Treatment Failure|2
262066|NCT01190267|865329|P1|Overall Study|Treatment Failure|8
262067|NCT01190267|865328|P2|Overall Study|Adverse Event|0
262068|NCT01190267|865329|P1|Overall Study|Adverse Event|10
262069|NCT01190254|865340|P3|Overall Study|Did not meet protocol eligibility|0
262070|NCT01190254|865341|P2|Overall Study|Did not meet protocol eligibility|0
262071|NCT01190254|865342|P1|Overall Study|Did not meet protocol eligibility|1
262072|NCT01190254|865340|P3|Overall Study|Protocol Violation|2
262073|NCT01190254|865341|P2|Overall Study|Protocol Violation|0
262074|NCT01190254|865342|P1|Overall Study|Protocol Violation|2
262075|NCT01190254|865340|P3|Overall Study|Withdrawal by Subject|7
262076|NCT01190254|865341|P2|Overall Study|Withdrawal by Subject|5
262077|NCT01190254|865342|P1|Overall Study|Withdrawal by Subject|4
262078|NCT01190254|865340|P3|Overall Study|Lost to Follow-up|0
262079|NCT01190254|865341|P2|Overall Study|Lost to Follow-up|2
262080|NCT01190254|865342|P1|Overall Study|Lost to Follow-up|4
262081|NCT01190254|865340|P3|Overall Study|Lack of Efficacy|5
262082|NCT01190254|865341|P2|Overall Study|Lack of Efficacy|4
262083|NCT01190254|865342|P1|Overall Study|Lack of Efficacy|7
262084|NCT01190254|865340|P3|Overall Study|Adverse Event|8
262085|NCT01190254|865341|P2|Overall Study|Adverse Event|6
262086|NCT01190254|865342|P1|Overall Study|Adverse Event|3
262087|NCT01190215|865406|P2|Up to Month 6|Lost to Follow-up|0
262088|NCT01190215|865407|P1|Up to Month 6|Lost to Follow-up|2
262089|NCT01190150|865477|P2|Washout|Difficulty in adherence|1
262090|NCT01190150|865478|P1|Washout|Difficulty in adherence|0
262091|NCT01190150|865477|P2|Washout|Withdrawal by Subject|1
262092|NCT01190150|865478|P1|Washout|Withdrawal by Subject|0
262093|NCT01190150|865477|P2|First Treatment|Withdrawal by Subject|0
262094|NCT01190150|865478|P1|First Treatment|Withdrawal by Subject|1
262095|NCT01190124|865505|P3|Overall Study|Lost to Follow-up|0
262096|NCT01190124|865506|P2|Overall Study|Lost to Follow-up|0
262097|NCT01190124|865507|P1|Overall Study|Lost to Follow-up|2
262098|NCT01190124|865505|P3|Overall Study|Therapeutic Failure|1
262099|NCT01190124|865506|P2|Overall Study|Therapeutic Failure|0
262100|NCT01190124|865507|P1|Overall Study|Therapeutic Failure|12
262101|NCT01190124|865505|P3|Overall Study|Death|0
262102|NCT01190124|865506|P2|Overall Study|Death|0
262103|NCT01190124|865507|P1|Overall Study|Death|3
262104|NCT01190098|865545|P2|Overall Study|Other|1
262105|NCT01190098|865546|P1|Overall Study|Other|0
262106|NCT01190098|865545|P2|Overall Study|Lack of transportation|0
262107|NCT01190098|865546|P1|Overall Study|Lack of transportation|1
262108|NCT01190098|865545|P2|Overall Study|Patient coomorbidity|1
262109|NCT01190098|865546|P1|Overall Study|Patient coomorbidity|0
262110|NCT01190098|865545|P2|Overall Study|Adverse Event|0
262111|NCT01190098|865546|P1|Overall Study|Adverse Event|2
262112|NCT01190007|865585|P1|Overall Study|Participant was arrested|1
262113|NCT01190007|865585|P1|Overall Study|Difficulty of visit for complications|1
262114|NCT01190007|865585|P1|Overall Study|Adverse Event|8
262115|NCT01190007|865585|P1|Overall Study|Withdrawal by Subject|4
262116|NCT01189890|865602|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
262117|NCT01189890|865603|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
262118|NCT01189890|865602|P2|Overall Study|Physician Decision|4
262119|NCT01189890|865603|P1|Overall Study|Physician Decision|5
262120|NCT01189890|865602|P2|Overall Study|Non Compliance|1
262121|NCT01189890|865603|P1|Overall Study|Non Compliance|0
262122|NCT01189890|865602|P2|Overall Study|Withdrawal by Subject|11
262123|NCT01189890|865603|P1|Overall Study|Withdrawal by Subject|15
262124|NCT01189890|865602|P2|Overall Study|Protocol Violation|5
262125|NCT01189890|865603|P1|Overall Study|Protocol Violation|1
262126|NCT01189890|865602|P2|Overall Study|Lost to Follow-up|7
262127|NCT01189890|865603|P1|Overall Study|Lost to Follow-up|1
262128|NCT01189890|865602|P2|Overall Study|Lack of Efficacy|2
262129|NCT01189890|865603|P1|Overall Study|Lack of Efficacy|7
262130|NCT01189890|865602|P2|Overall Study|Adverse Event|4
262131|NCT01189890|865603|P1|Overall Study|Adverse Event|3
262132|NCT01189812|865625|P2|Overall Study|Moved out of State|2
262133|NCT01189812|865626|P1|Overall Study|Moved out of State|1
262134|NCT01189812|865625|P2|Overall Study|Out of Window|3
262135|NCT01189812|865626|P1|Overall Study|Out of Window|4
262136|NCT01189812|865625|P2|Overall Study|Adverse Event|0
262137|NCT01189812|865626|P1|Overall Study|Adverse Event|1
262138|NCT01189812|865625|P2|Overall Study|Withdrawal by Subject|3
262139|NCT01189812|865626|P1|Overall Study|Withdrawal by Subject|2
262140|NCT01189604|865710|P7|Overall Study|Withdrawal by Subject|0
262141|NCT01189604|865711|P6|Overall Study|Withdrawal by Subject|0
262142|NCT01189604|865712|P5|Overall Study|Withdrawal by Subject|0
262143|NCT01189604|865713|P4|Overall Study|Withdrawal by Subject|0
262144|NCT01189604|865714|P3|Overall Study|Withdrawal by Subject|0
262145|NCT01189604|865715|P2|Overall Study|Withdrawal by Subject|0
262146|NCT01189604|865716|P1|Overall Study|Withdrawal by Subject|1
262147|NCT01189604|865710|P7|Overall Study|Adverse Event|1
262148|NCT01189604|865711|P6|Overall Study|Adverse Event|0
262149|NCT01189604|865712|P5|Overall Study|Adverse Event|2
262150|NCT01189604|865713|P4|Overall Study|Adverse Event|0
262151|NCT01189604|865714|P3|Overall Study|Adverse Event|0
262152|NCT01189604|865715|P2|Overall Study|Adverse Event|1
262153|NCT01189604|865716|P1|Overall Study|Adverse Event|0
262154|NCT01189604|865710|P7|Overall Study|Impossible to visit|0
262155|NCT01189604|865711|P6|Overall Study|Impossible to visit|1
262156|NCT01189604|865712|P5|Overall Study|Impossible to visit|0
262157|NCT01189604|865713|P4|Overall Study|Impossible to visit|0
262158|NCT01189604|865714|P3|Overall Study|Impossible to visit|0
262159|NCT01189604|865715|P2|Overall Study|Impossible to visit|0
262160|NCT01189604|865716|P1|Overall Study|Impossible to visit|0
262161|NCT01189500|865760|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
262162|NCT01189500|865760|P1|Period 1: TAMOX Alone|Adverse Event|1
262163|NCT01189487|865821|P1|Overall Study|Adverse Event|1
262164|NCT01189487|865821|P1|Overall Study|Lack of Efficacy|2
262165|NCT01189461|865829|P1|Overall Study|Unspecified|8
262166|NCT01189461|865829|P1|Overall Study|Did not meet entrance criteria|3
262167|NCT01189461|865829|P1|Overall Study|Adverse Event|2
262168|NCT01189461|865829|P1|Overall Study|Protocol Violation|1
262169|NCT01189461|865829|P1|Overall Study|Withdrawal by Subject|6
262170|NCT01189461|865829|P1|Overall Study|Lost to Follow-up|1
262171|NCT01189461|865829|P1|Overall Study|Lack of Efficacy|13
262172|NCT01189435|865836|P1|Overall Study|Physician Decision|1
262173|NCT01189435|865836|P1|Overall Study|Withdrawal by Subject|1
262174|NCT01189227|865918|P2|Overall Study|Study terminated due to low accrual|3
262175|NCT01189227|865919|P1|Overall Study|Study terminated due to low accrual|6
262176|NCT01189201|865925|P1|Overall Study|Adverse Event|1
262177|NCT01189032|866028|P3|Overall Study|Protocol Violation|1
262178|NCT01189032|866029|P2|Overall Study|Protocol Violation|1
262179|NCT01189032|866030|P1|Overall Study|Protocol Violation|1
262180|NCT01189032|866028|P3|Overall Study|Withdrawal by Subject|1
262181|NCT01189032|866029|P2|Overall Study|Withdrawal by Subject|0
262182|NCT01189032|866030|P1|Overall Study|Withdrawal by Subject|1
262183|NCT01189032|866028|P3|Overall Study|Lack of Efficacy|0
262184|NCT01189032|866029|P2|Overall Study|Lack of Efficacy|3
262185|NCT01189032|866030|P1|Overall Study|Lack of Efficacy|2
262186|NCT01189032|866028|P3|Overall Study|Adverse Event|4
262187|NCT01189032|866029|P2|Overall Study|Adverse Event|3
262188|NCT01189032|866030|P1|Overall Study|Adverse Event|1
262189|NCT01188967|866040|P2|Overall Study|Lost to Follow-up|2
262190|NCT01188967|866041|P1|Overall Study|Lost to Follow-up|3
262191|NCT01188967|866040|P2|Overall Study|Physician Decision|1
262192|NCT01188967|866041|P1|Overall Study|Physician Decision|1
262193|NCT01188967|866040|P2|Overall Study|Withdrawal by Subject|1
262194|NCT01188967|866041|P1|Overall Study|Withdrawal by Subject|1
262195|NCT01188811|866084|P2|Overall Study|Adverse Event|0
262196|NCT01188811|866085|P1|Overall Study|Adverse Event|6
262197|NCT01188811|866084|P2|Overall Study|Withdrawal by Subject|2
262198|NCT01188811|866085|P1|Overall Study|Withdrawal by Subject|0
262199|NCT01188798|866097|P2|Overall Study|Protocol closure|1
262200|NCT01188798|866098|P1|Overall Study|Protocol closure|1
262201|NCT01188798|866097|P2|Overall Study|Required additional transplant|1
262202|NCT01188798|866098|P1|Overall Study|Required additional transplant|1
262203|NCT01188798|866097|P2|Overall Study|Death|1
262204|NCT01188798|866098|P1|Overall Study|Death|0
262205|NCT01188772|866110|P4|Overall Study|Withdrawal by Subject|0
262206|NCT01188772|866111|P3|Overall Study|Withdrawal by Subject|2
262207|NCT01188772|866112|P2|Overall Study|Withdrawal by Subject|0
262208|NCT01188772|866113|P1|Overall Study|Withdrawal by Subject|0
262209|NCT01188772|866110|P4|Overall Study|Virologic Failure|0
262210|NCT01188772|866111|P3|Overall Study|Virologic Failure|0
262211|NCT01188772|866112|P2|Overall Study|Virologic Failure|0
262212|NCT01188772|866113|P1|Overall Study|Virologic Failure|1
262213|NCT01188772|866110|P4|Overall Study|Treatment Failure|0
262214|NCT01188772|866111|P3|Overall Study|Treatment Failure|1
262215|NCT01188772|866112|P2|Overall Study|Treatment Failure|0
262216|NCT01188772|866113|P1|Overall Study|Treatment Failure|0
262217|NCT01188772|866110|P4|Overall Study|Terminated by Sponsor|0
262218|NCT01188772|866111|P3|Overall Study|Terminated by Sponsor|1
262219|NCT01188772|866112|P2|Overall Study|Terminated by Sponsor|0
262220|NCT01188772|866113|P1|Overall Study|Terminated by Sponsor|0
262221|NCT01188772|866110|P4|Overall Study|Physician Decision|0
262222|NCT01188772|866111|P3|Overall Study|Physician Decision|1
262223|NCT01188772|866112|P2|Overall Study|Physician Decision|0
262224|NCT01188772|866113|P1|Overall Study|Physician Decision|0
262225|NCT01188772|866110|P4|Overall Study|Non-responder|0
262226|NCT01188772|866111|P3|Overall Study|Non-responder|3
262227|NCT01188772|866112|P2|Overall Study|Non-responder|0
262228|NCT01188772|866113|P1|Overall Study|Non-responder|0
262229|NCT01188772|866110|P4|Overall Study|Lost to Follow-up|1
262230|NCT01188772|866111|P3|Overall Study|Lost to Follow-up|1
262231|NCT01188772|866112|P2|Overall Study|Lost to Follow-up|1
262232|NCT01188772|866113|P1|Overall Study|Lost to Follow-up|4
262233|NCT01188772|866110|P4|Overall Study|Adverse Event|0
262234|NCT01188772|866111|P3|Overall Study|Adverse Event|2
262235|NCT01188772|866112|P2|Overall Study|Adverse Event|1
262236|NCT01188772|866113|P1|Overall Study|Adverse Event|0
262237|NCT01188772|866110|P4|Overall Study|Randomized but Not Treated|0
262238|NCT01188772|866111|P3|Overall Study|Randomized but Not Treated|0
262239|NCT01188772|866112|P2|Overall Study|Randomized but Not Treated|1
262240|NCT01188772|866113|P1|Overall Study|Randomized but Not Treated|0
262249|NCT01188668|866202|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
262250|NCT01188668|866202|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
262251|NCT01188668|866202|P1|Period 1: ARIP Alone|Protocol Violation|2
262252|NCT01188655|866235|P1|Overall Study|Unspecified|11
262253|NCT01188655|866235|P1|Overall Study|Lost to Follow-up|1
262254|NCT01188655|866235|P1|Overall Study|Lack of Efficacy|1
262255|NCT01188564|866279|P2|Double-blind Phase|randomized not treated|0
262256|NCT01188564|866280|P1|Double-blind Phase|randomized not treated|1
262257|NCT01188551|866292|P4|Overall Study|Pharmacy issues|0
262258|NCT01188551|866293|P3|Overall Study|Pharmacy issues|0
262259|NCT01188551|866294|P2|Overall Study|Pharmacy issues|0
262260|NCT01188551|866295|P1|Overall Study|Pharmacy issues|1
262261|NCT01188538|866311|P2|Overall Study|Lost to Follow-up|1
262262|NCT01188538|866312|P1|Overall Study|Lost to Follow-up|0
262263|NCT01188343|866349|P3|Overall Study|Withdrawal by Subject|0
262264|NCT01188343|866350|P2|Overall Study|Withdrawal by Subject|24
262265|NCT01188343|866351|P1|Overall Study|Withdrawal by Subject|1
262266|NCT01188343|866349|P3|Overall Study|Not vaccinated|1
262267|NCT01188343|866350|P2|Overall Study|Not vaccinated|2
262268|NCT01188343|866351|P1|Overall Study|Not vaccinated|0
262269|NCT01188226|866377|P1|Overall Study|Withdrawal by Subject|4
262270|NCT01187953|866423|P2|Overall Study|Withdrawal by Subject|3
262271|NCT01187953|866424|P1|Overall Study|Withdrawal by Subject|3
262272|NCT01187953|866423|P2|Overall Study|Lost to Follow-up|3
262273|NCT01187953|866424|P1|Overall Study|Lost to Follow-up|0
262274|NCT01187953|866423|P2|Overall Study|Adverse Event|2
262275|NCT01187953|866424|P1|Overall Study|Adverse Event|1
262276|NCT01187953|866423|P2|Overall Study|Death|13
262277|NCT01187953|866424|P1|Overall Study|Death|11
262278|NCT01187901|866438|P2|Overall Study|Pregnancy|2
262279|NCT01187901|866439|P1|Overall Study|Pregnancy|0
262280|NCT01187901|866438|P2|Overall Study|No Endpoint due to Early Study Halt|3
262281|NCT01187901|866439|P1|Overall Study|No Endpoint due to Early Study Halt|2
262282|NCT01187901|866438|P2|Overall Study|Adverse Event|0
262283|NCT01187901|866439|P1|Overall Study|Adverse Event|3
262284|NCT01187901|866438|P2|Overall Study|Suspected Allergic Reaction|1
262285|NCT01187901|866439|P1|Overall Study|Suspected Allergic Reaction|1
262286|NCT01187901|866438|P2|Overall Study|Unrelated Health Reasons|2
262287|NCT01187901|866439|P1|Overall Study|Unrelated Health Reasons|1
262288|NCT01187901|866438|P2|Overall Study|Lost to Follow-up|2
262289|NCT01187901|866439|P1|Overall Study|Lost to Follow-up|1
262290|NCT01187901|866438|P2|Overall Study|Protocol Violation|0
262291|NCT01187901|866439|P1|Overall Study|Protocol Violation|1
262292|NCT01187550|866457|P2|Overall Study|Randomized but not treated|0
262293|NCT01187550|866458|P1|Overall Study|Randomized but not treated|8
262294|NCT01187550|866457|P2|Overall Study|Unspecified|0
262295|NCT01187550|866458|P1|Overall Study|Unspecified|3
262296|NCT01187550|866457|P2|Overall Study|Protocol Violation|1
262297|NCT01187550|866458|P1|Overall Study|Protocol Violation|3
262298|NCT01187433|866614|P2|Overall Study|Withdrawal by Subject|2
262299|NCT01187433|866615|P1|Overall Study|Withdrawal by Subject|5
262300|NCT01187433|866614|P2|Overall Study|Protocol Violation|2
262301|NCT01187433|866615|P1|Overall Study|Protocol Violation|6
262302|NCT01187043|866659|P5|Overall Study|Unable to make scheduled visits|1
262303|NCT01187043|866660|P4|Overall Study|Unable to make scheduled visits|0
262304|NCT01187043|866661|P3|Overall Study|Unable to make scheduled visits|4
262305|NCT01187043|866662|P2|Overall Study|Unable to make scheduled visits|0
262306|NCT01187043|866663|P1|Overall Study|Unable to make scheduled visits|1
262307|NCT01187043|866659|P5|Overall Study|Adverse Event|1
262308|NCT01187043|866660|P4|Overall Study|Adverse Event|0
262309|NCT01187043|866661|P3|Overall Study|Adverse Event|0
262310|NCT01187043|866662|P2|Overall Study|Adverse Event|0
262311|NCT01187043|866663|P1|Overall Study|Adverse Event|0
262312|NCT01186939|866689|P1|Overall Study|Transformation to AML|1
262313|NCT01186939|866689|P1|Overall Study|Bone marrow transplant|1
262314|NCT01186939|866689|P1|Overall Study|Myocardial infarction|1
262315|NCT01186939|866689|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
262316|NCT01186939|866689|P1|Overall Study|Started additional treatment|1
262317|NCT01186939|866689|P1|Overall Study|Sponsor decision|4
262318|NCT01186939|866689|P1|Overall Study|Program closed|5
262319|NCT01186939|866689|P1|Overall Study|No longer receiving clinical benefit|17
262320|NCT01186939|866689|P1|Overall Study|Withdrawal by Subject|2
262321|NCT01186939|866689|P1|Overall Study|Death|7
262322|NCT01186848|866693|P1|Overall Study|Adverse Event|2
262323|NCT01186848|866693|P1|Overall Study|Withdrawal by Subject|2
262324|NCT01186848|866693|P1|Overall Study|Lost to Follow-up|4
262325|NCT01186796|866701|P2|Overall Study|Protocol Violation|1
262326|NCT01186796|866702|P1|Overall Study|Protocol Violation|0
262327|NCT01186796|866701|P2|Overall Study|Withdrawal by Subject|1
262328|NCT01186796|866702|P1|Overall Study|Withdrawal by Subject|1
262329|NCT01186796|866701|P2|Overall Study|Adverse Event|0
262330|NCT01186796|866702|P1|Overall Study|Adverse Event|3
262331|NCT01186744|866722|P6|Overall Study|Death|0
262332|NCT01186744|866723|P5|Overall Study|Death|0
262333|NCT01186744|866724|P4|Overall Study|Death|0
262334|NCT01186744|866725|P3|Overall Study|Death|0
262335|NCT01186744|866726|P2|Overall Study|Death|0
262336|NCT01186744|866727|P1|Overall Study|Death|1
262337|NCT01186744|866722|P6|Overall Study|Adverse Event|4
262338|NCT01186744|866723|P5|Overall Study|Adverse Event|1
262339|NCT01186744|866724|P4|Overall Study|Adverse Event|0
262340|NCT01186744|866725|P3|Overall Study|Adverse Event|1
262341|NCT01186744|866726|P2|Overall Study|Adverse Event|14
262342|NCT01186744|866727|P1|Overall Study|Adverse Event|10
262343|NCT01186744|866722|P6|Overall Study|Not specified|5
262344|NCT01186744|866723|P5|Overall Study|Not specified|1
262345|NCT01186744|866724|P4|Overall Study|Not specified|2
262346|NCT01186744|866725|P3|Overall Study|Not specified|1
262347|NCT01186744|866726|P2|Overall Study|Not specified|10
262348|NCT01186744|866727|P1|Overall Study|Not specified|9
262349|NCT01186744|866722|P6|Overall Study|Study terminated by Sponsor|0
262350|NCT01186744|866723|P5|Overall Study|Study terminated by Sponsor|0
262351|NCT01186744|866724|P4|Overall Study|Study terminated by Sponsor|0
262352|NCT01186744|866725|P3|Overall Study|Study terminated by Sponsor|0
262353|NCT01186744|866726|P2|Overall Study|Study terminated by Sponsor|0
262354|NCT01186744|866727|P1|Overall Study|Study terminated by Sponsor|1
262355|NCT01186744|866722|P6|Overall Study|Withdrawal by Subject|6
262356|NCT01186744|866723|P5|Overall Study|Withdrawal by Subject|0
262357|NCT01186744|866724|P4|Overall Study|Withdrawal by Subject|5
262358|NCT01186744|866725|P3|Overall Study|Withdrawal by Subject|2
262359|NCT01186744|866726|P2|Overall Study|Withdrawal by Subject|10
262360|NCT01186744|866727|P1|Overall Study|Withdrawal by Subject|14
262361|NCT01186744|866722|P6|Overall Study|Screen failure|0
262362|NCT01186744|866723|P5|Overall Study|Screen failure|0
262363|NCT01186744|866724|P4|Overall Study|Screen failure|1
262364|NCT01186744|866725|P3|Overall Study|Screen failure|0
262365|NCT01186744|866726|P2|Overall Study|Screen failure|1
262366|NCT01186744|866727|P1|Overall Study|Screen failure|1
262367|NCT01186744|866722|P6|Overall Study|Lost to Follow-up|4
262368|NCT01186744|866723|P5|Overall Study|Lost to Follow-up|1
262369|NCT01186744|866724|P4|Overall Study|Lost to Follow-up|1
262370|NCT01186744|866725|P3|Overall Study|Lost to Follow-up|2
262371|NCT01186744|866726|P2|Overall Study|Lost to Follow-up|16
262372|NCT01186744|866727|P1|Overall Study|Lost to Follow-up|15
262373|NCT01186744|866722|P6|Overall Study|Protocol Violation|2
262374|NCT01186744|866723|P5|Overall Study|Protocol Violation|1
262375|NCT01186744|866724|P4|Overall Study|Protocol Violation|1
262376|NCT01186744|866725|P3|Overall Study|Protocol Violation|0
262377|NCT01186744|866726|P2|Overall Study|Protocol Violation|2
262378|NCT01186744|866727|P1|Overall Study|Protocol Violation|1
262379|NCT01186744|866722|P6|Overall Study|Lack of Efficacy|5
262380|NCT01186744|866723|P5|Overall Study|Lack of Efficacy|2
262381|NCT01186744|866724|P4|Overall Study|Lack of Efficacy|2
262382|NCT01186744|866725|P3|Overall Study|Lack of Efficacy|0
262383|NCT01186744|866726|P2|Overall Study|Lack of Efficacy|99
262384|NCT01186744|866727|P1|Overall Study|Lack of Efficacy|156
262385|NCT01186692|867147|P1|Overall Study|Adverse Event|2
262386|NCT01186692|867147|P1|Overall Study|Futher testing contraindicated implant|19
262387|NCT01186692|867147|P1|Overall Study|Not Catheterized|11
262388|NCT01186458|867174|P1|Overall Study|Adverse Event|1
262389|NCT01186419|867183|P2|Overall Study|Not specified|1
262390|NCT01186419|867184|P1|Overall Study|Not specified|1
262391|NCT01186419|867183|P2|Overall Study|Physician Decision|3
262392|NCT01186419|867184|P1|Overall Study|Physician Decision|0
262393|NCT01186419|867183|P2|Overall Study|Adverse Event|2
262394|NCT01186419|867184|P1|Overall Study|Adverse Event|1
262395|NCT01186419|867183|P2|Overall Study|Withdrawal by Subject|3
262396|NCT01186419|867184|P1|Overall Study|Withdrawal by Subject|5
262397|NCT01185964|867222|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
262398|NCT01185964|867223|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
262399|NCT01185964|867224|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
262400|NCT01185964|867225|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
262401|NCT01185964|867222|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
262402|NCT01185964|867223|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
262403|NCT01185964|867224|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
262404|NCT01185964|867225|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
262405|NCT01185964|867222|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
262406|NCT01185964|867223|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
262407|NCT01185964|867224|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
262408|NCT01185964|867225|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
262409|NCT01185964|867222|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
262410|NCT01185964|867223|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
262411|NCT01185964|867224|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
262412|NCT01185964|867225|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
262413|NCT01185964|867222|P4|Phase 1b and Phase 2|Adverse Event|0
262414|NCT01185964|867223|P3|Phase 1b and Phase 2|Adverse Event|2
262415|NCT01185964|867224|P2|Phase 1b and Phase 2|Adverse Event|0
262416|NCT01185964|867225|P1|Phase 1b and Phase 2|Adverse Event|1
262417|NCT01185964|867222|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
262418|NCT01185964|867223|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
262419|NCT01185964|867224|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
262420|NCT01185964|867225|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
262421|NCT01185964|867222|P4|Phase 1b and Phase 2|Other Therapy Started|0
262422|NCT01185964|867223|P3|Phase 1b and Phase 2|Other Therapy Started|3
262423|NCT01185964|867224|P2|Phase 1b and Phase 2|Other Therapy Started|3
262424|NCT01185964|867225|P1|Phase 1b and Phase 2|Other Therapy Started|0
262425|NCT01185964|867222|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
262426|NCT01185964|867223|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
262427|NCT01185964|867224|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
262428|NCT01185964|867225|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
262429|NCT01185834|867251|P1|Overall Study|Early exit - Site error|2
262430|NCT01185834|867251|P1|Overall Study|Time/Job Conflict|2
262431|NCT01185834|867251|P1|Overall Study|Biomicroscopy|4
262432|NCT01185834|867251|P1|Overall Study|Discomfort|4
262433|NCT01185834|867251|P1|Overall Study|Lost to Follow-up|2
262434|NCT01185782|867258|P2|Overall Study|Randomized but not treated|4
262435|NCT01185782|867259|P1|Overall Study|Randomized but not treated|0
262436|NCT01185782|867258|P2|Overall Study|Unspecified|5
262437|NCT01185782|867259|P1|Overall Study|Unspecified|2
262438|NCT01185782|867258|P2|Overall Study|Poor Response to Treatment|1
262439|NCT01185782|867259|P1|Overall Study|Poor Response to Treatment|3
262440|NCT01185782|867258|P2|Overall Study|Protocol Violation|0
262441|NCT01185782|867259|P1|Overall Study|Protocol Violation|1
262442|NCT01185782|867258|P2|Overall Study|Adverse Event|1
262443|NCT01185782|867259|P1|Overall Study|Adverse Event|0
262444|NCT01185704|867287|P2|Overall Study|Ectopic pregnancy|1
262445|NCT01185704|867288|P1|Overall Study|Ectopic pregnancy|0
262446|NCT01185704|867287|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
262447|NCT01185704|867288|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
262448|NCT01185704|867287|P2|Overall Study|Lack of ovarian response|1
262449|NCT01185704|867288|P1|Overall Study|Lack of ovarian response|5
262450|NCT01185704|867287|P2|Overall Study|Randomized but not treated|3
262451|NCT01185704|867288|P1|Overall Study|Randomized but not treated|3
262452|NCT01185600|867324|P2|Overall Study|Hold by DSMB|2
262453|NCT01185600|867325|P1|Overall Study|Hold by DSMB|1
262454|NCT01185600|867324|P2|Overall Study|Withdrawal by Subject|1
262455|NCT01185600|867325|P1|Overall Study|Withdrawal by Subject|1
262456|NCT01185600|867324|P2|Overall Study|Physician Decision|35
262457|NCT01185600|867325|P1|Overall Study|Physician Decision|29
262458|NCT01185600|867324|P2|Overall Study|Lost to Follow-up|5
262459|NCT01185600|867325|P1|Overall Study|Lost to Follow-up|0
262460|NCT01185600|867324|P2|Overall Study|Death|1
262461|NCT01185600|867325|P1|Overall Study|Death|0
262462|NCT01185600|867324|P2|Overall Study|Adverse Event|1
262463|NCT01185600|867325|P1|Overall Study|Adverse Event|1
262464|NCT01185561|867347|P2|Overall Study|Withdrawal by Subject|8
262465|NCT01185561|867348|P1|Overall Study|Withdrawal by Subject|2
262466|NCT01185561|867347|P2|Overall Study|Lost to Follow-up|4
262467|NCT01185561|867348|P1|Overall Study|Lost to Follow-up|0
262468|NCT01185522|867360|P1|Overall Study|Other reasons|12
262469|NCT01185522|867360|P1|Overall Study|Poor tolerance|39
262470|NCT01185522|867360|P1|Overall Study|Withdrawal by Subject|10
262471|NCT01185522|867360|P1|Overall Study|Lost to Follow-up|19
262472|NCT01185522|867360|P1|Overall Study|Lack of Efficacy|28
262473|NCT01185509|867386|P2|Overall Study|Intercurrent Illness|1
262474|NCT01185509|867387|P1|Overall Study|Intercurrent Illness|0
262475|NCT01185509|867386|P2|Overall Study|Death|1
262476|NCT01185509|867387|P1|Overall Study|Death|0
262477|NCT01185509|867386|P2|Overall Study|Withdrawal by Subject|1
262478|NCT01185509|867387|P1|Overall Study|Withdrawal by Subject|0
262479|NCT01185509|867386|P2|Overall Study|Physician Decision|2
262480|NCT01185509|867387|P1|Overall Study|Physician Decision|2
262481|NCT01185509|867386|P2|Overall Study|Progression/Relapse|15
262482|NCT01185509|867387|P1|Overall Study|Progression/Relapse|9
262483|NCT01185353|867402|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
262484|NCT01185353|867403|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
262485|NCT01185353|867404|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
262486|NCT01185353|867405|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
262487|NCT01185353|867406|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
262488|NCT01185353|867407|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
262489|NCT01185353|867408|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
262490|NCT01185353|867409|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
262491|NCT01185353|867410|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
262492|NCT01185353|867411|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
262493|NCT01185353|867402|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
262494|NCT01185353|867403|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
262495|NCT01185353|867404|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
262496|NCT01185353|867405|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
262497|NCT01185353|867406|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
262498|NCT01185353|867407|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
262499|NCT01185353|867408|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
262500|NCT01185353|867409|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
262501|NCT01185353|867410|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
262502|NCT01185353|867411|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
262503|NCT01185353|867402|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
262504|NCT01185353|867403|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
262505|NCT01185353|867404|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
262506|NCT01185353|867405|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
262507|NCT01185353|867406|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
262508|NCT01185353|867407|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
262509|NCT01185353|867408|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
262510|NCT01185353|867409|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
262511|NCT01185353|867410|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
262512|NCT01185353|867411|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
262513|NCT01185353|867402|P10|Part C (Weeks 24 Through 76)|Reason missing|0
262514|NCT01185353|867403|P9|Part C (Weeks 24 Through 76)|Reason missing|1
262515|NCT01185353|867404|P8|Part C (Weeks 24 Through 76)|Reason missing|0
262516|NCT01185353|867405|P7|Part C (Weeks 24 Through 76)|Reason missing|0
262517|NCT01185353|867406|P6|Part C (Weeks 24 Through 76)|Reason missing|0
262518|NCT01185353|867407|P5|Part C (Weeks 24 Through 76)|Reason missing|0
262519|NCT01185353|867408|P4|Part C (Weeks 24 Through 76)|Reason missing|0
262520|NCT01185353|867409|P3|Part C (Weeks 24 Through 76)|Reason missing|0
262521|NCT01185353|867410|P2|Part C (Weeks 24 Through 76)|Reason missing|0
262522|NCT01185353|867411|P1|Part C (Weeks 24 Through 76)|Reason missing|0
262523|NCT01185353|867402|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
262524|NCT01185353|867403|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
262525|NCT01185353|867404|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
262526|NCT01185353|867405|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
262527|NCT01185353|867406|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
262528|NCT01185353|867407|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
262529|NCT01185353|867408|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
262530|NCT01185353|867409|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
262531|NCT01185353|867410|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
262532|NCT01185353|867411|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
262533|NCT01185353|867402|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
262534|NCT01185353|867403|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
262535|NCT01185353|867404|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
262536|NCT01185353|867405|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
262537|NCT01185353|867406|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
262538|NCT01185353|867407|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
262539|NCT01185353|867408|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
262540|NCT01185353|867409|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
262541|NCT01185353|867410|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
262542|NCT01185353|867411|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
262543|NCT01185353|867402|P10|Part C (Weeks 24 Through 76)|Death|1
262544|NCT01185353|867403|P9|Part C (Weeks 24 Through 76)|Death|0
262545|NCT01185353|867404|P8|Part C (Weeks 24 Through 76)|Death|0
262546|NCT01185353|867405|P7|Part C (Weeks 24 Through 76)|Death|0
262547|NCT01185353|867406|P6|Part C (Weeks 24 Through 76)|Death|0
262548|NCT01185353|867407|P5|Part C (Weeks 24 Through 76)|Death|0
262549|NCT01185353|867408|P4|Part C (Weeks 24 Through 76)|Death|0
262550|NCT01185353|867409|P3|Part C (Weeks 24 Through 76)|Death|0
262551|NCT01185353|867410|P2|Part C (Weeks 24 Through 76)|Death|0
262552|NCT01185353|867411|P1|Part C (Weeks 24 Through 76)|Death|0
262553|NCT01185353|867402|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
262554|NCT01185353|867403|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
262555|NCT01185353|867404|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
262556|NCT01185353|867405|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
262557|NCT01185353|867406|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
262558|NCT01185353|867407|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
262559|NCT01185353|867408|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
262560|NCT01185353|867409|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
262561|NCT01185353|867410|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
262562|NCT01185353|867411|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
262563|NCT01185353|867402|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
262564|NCT01185353|867403|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
262565|NCT01185353|867404|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
262566|NCT01185353|867405|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
262567|NCT01185353|867406|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
262568|NCT01185353|867407|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
262569|NCT01185353|867408|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
262570|NCT01185353|867409|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
262571|NCT01185353|867410|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
262572|NCT01185353|867411|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
262573|NCT01185353|867402|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
262574|NCT01185353|867403|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
262575|NCT01185353|867404|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
262576|NCT01185353|867405|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
262577|NCT01185353|867406|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
262578|NCT01185353|867407|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
262579|NCT01185353|867408|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
262580|NCT01185353|867409|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
262581|NCT01185353|867410|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
262582|NCT01185353|867411|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
262583|NCT01185353|867402|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
262584|NCT01185353|867403|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
262585|NCT01185353|867404|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
262586|NCT01185353|867405|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
262587|NCT01185353|867406|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
262588|NCT01185353|867407|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
262589|NCT01185353|867408|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
262590|NCT01185353|867409|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
262591|NCT01185353|867410|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
262592|NCT01185353|867411|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
262593|NCT01185353|867402|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
262594|NCT01185353|867403|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
262595|NCT01185353|867404|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
262596|NCT01185353|867405|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
262597|NCT01185353|867406|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
262598|NCT01185353|867407|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
262599|NCT01185353|867408|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
262600|NCT01185353|867409|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
262601|NCT01185353|867410|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
262602|NCT01185353|867411|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
262603|NCT01185353|867402|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
262604|NCT01185353|867403|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
262605|NCT01185353|867404|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
262606|NCT01185353|867405|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
262607|NCT01185353|867406|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
262608|NCT01185353|867407|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
262609|NCT01185353|867408|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
262610|NCT01185353|867409|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
262611|NCT01185353|867410|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
262612|NCT01185353|867411|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
262613|NCT01185353|867402|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
262614|NCT01185353|867403|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
262615|NCT01185353|867404|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
262616|NCT01185353|867405|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
262617|NCT01185353|867406|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
262618|NCT01185353|867407|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
262619|NCT01185353|867408|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
262620|NCT01185353|867409|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
262621|NCT01185353|867410|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
262622|NCT01185353|867411|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
262623|NCT01185353|867402|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
262624|NCT01185353|867403|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
262625|NCT01185353|867404|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
262626|NCT01185353|867405|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
262627|NCT01185353|867406|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
262628|NCT01185353|867407|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
262629|NCT01185353|867408|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
262630|NCT01185353|867409|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
262631|NCT01185353|867410|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
262632|NCT01185353|867411|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
262633|NCT01185353|867402|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
262634|NCT01185353|867403|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
262635|NCT01185353|867404|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
262636|NCT01185353|867405|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
262637|NCT01185353|867406|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
262638|NCT01185353|867407|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
262639|NCT01185353|867408|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
262640|NCT01185353|867409|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
262641|NCT01185353|867410|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
262642|NCT01185353|867411|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
262643|NCT01185353|867402|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
262644|NCT01185353|867403|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
262645|NCT01185353|867404|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
262646|NCT01185353|867405|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
262647|NCT01185353|867406|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
262648|NCT01185353|867407|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
262649|NCT01185353|867408|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
262650|NCT01185353|867409|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
262651|NCT01185353|867410|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
262652|NCT01185353|867411|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
262653|NCT01185353|867402|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
262654|NCT01185353|867403|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
262655|NCT01185353|867404|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
262656|NCT01185353|867405|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
262657|NCT01185353|867406|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
262658|NCT01185353|867407|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
262659|NCT01185353|867408|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
262660|NCT01185353|867409|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
262661|NCT01185353|867410|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
262662|NCT01185353|867411|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
262663|NCT01185353|867402|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
262664|NCT01185353|867403|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
262665|NCT01185353|867404|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
262666|NCT01185353|867405|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
262667|NCT01185353|867406|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
262668|NCT01185353|867407|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
262669|NCT01185353|867408|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
262670|NCT01185353|867409|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
262671|NCT01185353|867410|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
262672|NCT01185353|867411|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
262673|NCT01185353|867402|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
262674|NCT01185353|867403|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
262675|NCT01185353|867404|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
262676|NCT01185353|867405|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
262677|NCT01185353|867406|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
262678|NCT01185353|867407|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
262679|NCT01185353|867408|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
262680|NCT01185353|867409|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
262681|NCT01185353|867410|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
262682|NCT01185353|867411|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
262683|NCT01185353|867402|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
262684|NCT01185353|867403|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
262685|NCT01185353|867404|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
262686|NCT01185353|867405|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
262687|NCT01185353|867406|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
262688|NCT01185353|867407|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
262689|NCT01185353|867408|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
262690|NCT01185353|867409|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
262691|NCT01185353|867410|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
262692|NCT01185353|867411|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
262693|NCT01185353|867402|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
262694|NCT01185353|867403|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
262695|NCT01185353|867404|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
262696|NCT01185353|867405|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
262697|NCT01185353|867406|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
262698|NCT01185353|867407|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
262699|NCT01185353|867408|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
262700|NCT01185353|867409|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
262701|NCT01185353|867410|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
262702|NCT01185353|867411|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
262703|NCT01185301|867573|P4|Overall Study|Other Reason|2
262704|NCT01185301|867574|P3|Overall Study|Other Reason|2
262705|NCT01185301|867575|P2|Overall Study|Other Reason|2
262706|NCT01185301|867576|P1|Overall Study|Other Reason|3
262707|NCT01185301|867573|P4|Overall Study|Lost to Follow-up|1
262708|NCT01185301|867574|P3|Overall Study|Lost to Follow-up|0
262709|NCT01185301|867575|P2|Overall Study|Lost to Follow-up|0
262710|NCT01185301|867576|P1|Overall Study|Lost to Follow-up|2
262711|NCT01185301|867573|P4|Overall Study|Withdrawal by Subject|3
262712|NCT01185301|867574|P3|Overall Study|Withdrawal by Subject|2
262713|NCT01185301|867575|P2|Overall Study|Withdrawal by Subject|5
262714|NCT01185301|867576|P1|Overall Study|Withdrawal by Subject|7
262715|NCT01185301|867573|P4|Overall Study|Adverse Event|3
262716|NCT01185301|867574|P3|Overall Study|Adverse Event|2
262717|NCT01185301|867575|P2|Overall Study|Adverse Event|0
262718|NCT01185301|867576|P1|Overall Study|Adverse Event|3
262719|NCT01185288|867636|P2|Overall Study|Noncompliance|1
262720|NCT01185288|867637|P1|Overall Study|Noncompliance|0
262721|NCT01185288|867636|P2|Overall Study|Did not meet inclusion criteria|0
262722|NCT01185288|867637|P1|Overall Study|Did not meet inclusion criteria|1
262723|NCT01185288|867636|P2|Overall Study|Investigator discretion|0
262724|NCT01185288|867637|P1|Overall Study|Investigator discretion|1
262725|NCT01185288|867636|P2|Overall Study|Lack of Efficacy|0
262726|NCT01185288|867637|P1|Overall Study|Lack of Efficacy|2
262727|NCT01185288|867636|P2|Overall Study|Lost to Follow-up|5
262728|NCT01185288|867637|P1|Overall Study|Lost to Follow-up|2
262729|NCT01185288|867636|P2|Overall Study|Withdrawal by Subject|4
262730|NCT01185288|867637|P1|Overall Study|Withdrawal by Subject|6
262731|NCT01185288|867636|P2|Overall Study|Adverse Event|6
262732|NCT01185288|867637|P1|Overall Study|Adverse Event|7
262733|NCT01185249|867655|P1|Overall Study|Patients discharged or change in status|42
262734|NCT01185080|867663|P3|Overall Study|Personal reasons|1
262735|NCT01185080|867664|P2|Overall Study|Personal reasons|0
262736|NCT01185080|867665|P1|Overall Study|Personal reasons|0
262737|NCT01185080|867663|P3|Overall Study|Adverse Event|0
262738|NCT01185080|867664|P2|Overall Study|Adverse Event|1
262739|NCT01185080|867665|P1|Overall Study|Adverse Event|1
262740|NCT01184989|867717|P1|Overall Study|Withdrawal by Subject|1
262741|NCT01184989|867717|P1|Overall Study|Adverse Event|11
262742|NCT01184872|867737|P2|Overall Study|Protocol deviation|0
262743|NCT01184872|867738|P1|Overall Study|Protocol deviation|1
262744|NCT01184872|867737|P2|Overall Study|Administrative problems|1
262745|NCT01184872|867738|P1|Overall Study|Administrative problems|1
262746|NCT01184872|867737|P2|Overall Study|Lost to Follow-up|1
262747|NCT01184872|867738|P1|Overall Study|Lost to Follow-up|0
262748|NCT01184872|867737|P2|Overall Study|Withdrawal by Subject|0
262749|NCT01184872|867738|P1|Overall Study|Withdrawal by Subject|2
262750|NCT01184872|867737|P2|Overall Study|Unsatisfactory therapeutic effect|2
262751|NCT01184872|867738|P1|Overall Study|Unsatisfactory therapeutic effect|3
262752|NCT01184872|867737|P2|Overall Study|Adverse Event|4
262753|NCT01184872|867738|P1|Overall Study|Adverse Event|3
262754|NCT01184859|867757|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
262755|NCT01184859|867758|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
262756|NCT01184859|867759|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
262757|NCT01184859|867760|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
262758|NCT01184859|867761|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
262759|NCT01184859|867757|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
262760|NCT01184859|867758|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
262761|NCT01184859|867759|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
262762|NCT01184859|867760|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
262763|NCT01184859|867761|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
262764|NCT01184859|867757|P5|Period 1: Single Dose|Adverse Event|1
262765|NCT01184859|867758|P4|Period 1: Single Dose|Adverse Event|0
262766|NCT01184859|867759|P3|Period 1: Single Dose|Adverse Event|0
262767|NCT01184859|867760|P2|Period 1: Single Dose|Adverse Event|0
262768|NCT01184859|867761|P1|Period 1: Single Dose|Adverse Event|0
262769|NCT01184859|867757|P5|Period 1: Single Dose|Protocol Violation|0
262770|NCT01184859|867758|P4|Period 1: Single Dose|Protocol Violation|0
262771|NCT01184859|867759|P3|Period 1: Single Dose|Protocol Violation|0
262772|NCT01184859|867760|P2|Period 1: Single Dose|Protocol Violation|1
262773|NCT01184859|867761|P1|Period 1: Single Dose|Protocol Violation|0
262774|NCT01184859|867757|P5|Period 1: Single Dose|Insufficient urine production|0
262775|NCT01184859|867758|P4|Period 1: Single Dose|Insufficient urine production|0
262776|NCT01184859|867759|P3|Period 1: Single Dose|Insufficient urine production|0
262777|NCT01184859|867760|P2|Period 1: Single Dose|Insufficient urine production|1
262778|NCT01184859|867761|P1|Period 1: Single Dose|Insufficient urine production|0
262779|NCT01184846|867853|P1|Overall Study|Insufficient response|1
262780|NCT01184846|867853|P1|Overall Study|Adverse Event|2
262781|NCT01184118|867907|P1|Overall Study|Withdrawal by Subject|5
262782|NCT01184118|867907|P1|Overall Study|Exclusionary medical condition|2
262783|NCT01184118|867907|P1|Overall Study|FEV1 <60% predicted|2
262784|NCT01184118|867907|P1|Overall Study|No physiologic confirmation of asthma|8
262785|NCT01184118|867907|P1|Overall Study|Only asthma step 1 - screen fail|1
262786|NCT01184079|867915|P2|Overall Study|Lost to Follow-up|2
262787|NCT01184079|867916|P1|Overall Study|Lost to Follow-up|14
262788|NCT01184053|867926|P1|Overall Study|progression while on treatment|3
262789|NCT01183975|867942|P1|Overall Study|Lost to Follow-up|73
262790|NCT01183858|867949|P2|Overall Study|Lost to Follow-up|1
262791|NCT01183858|867950|P1|Overall Study|Lost to Follow-up|1
262792|NCT01183858|867949|P2|Overall Study|Death related to Progressive Disease|5
262793|NCT01183858|867950|P1|Overall Study|Death related to Progressive Disease|4
262794|NCT01183858|867949|P2|Overall Study|Progressive Disease|115
262795|NCT01183858|867950|P1|Overall Study|Progressive Disease|112
262796|NCT01183858|867949|P2|Overall Study|Administrative/Other|6
262797|NCT01183858|867950|P1|Overall Study|Administrative/Other|6
262798|NCT01183858|867949|P2|Overall Study|Protocol Violation|0
262799|NCT01183858|867950|P1|Overall Study|Protocol Violation|1
262800|NCT01183858|867949|P2|Overall Study|Discontinued Smoking|1
262801|NCT01183858|867950|P1|Overall Study|Discontinued Smoking|3
262802|NCT01183858|867949|P2|Overall Study|Withdrew Consent|4
262803|NCT01183858|867950|P1|Overall Study|Withdrew Consent|4
262804|NCT01183858|867949|P2|Overall Study|Refused Treatment|4
262805|NCT01183858|867950|P1|Overall Study|Refused Treatment|1
262806|NCT01183858|867949|P2|Overall Study|Insufficient Therapeutic Response|0
262807|NCT01183858|867950|P1|Overall Study|Insufficient Therapeutic Response|2
262808|NCT01183858|867949|P2|Overall Study|Investigator's Decision|3
262809|NCT01183858|867950|P1|Overall Study|Investigator's Decision|0
262810|NCT01183858|867949|P2|Overall Study|Adverse Event|11
262811|NCT01183858|867950|P1|Overall Study|Adverse Event|14
262812|NCT01183858|867949|P2|Overall Study|Death not related to Progressive Disease|6
262813|NCT01183858|867950|P1|Overall Study|Death not related to Progressive Disease|5
262814|NCT01183780|867972|P2|Overall Study|On treatment|16
262815|NCT01183780|867973|P1|Overall Study|On treatment|17
262816|NCT01183780|867972|P2|Overall Study|Lost to Follow-up|11
262817|NCT01183780|867973|P1|Overall Study|Lost to Follow-up|6
262818|NCT01183780|867972|P2|Overall Study|Withdrawal by Subject|13
262819|NCT01183780|867973|P1|Overall Study|Withdrawal by Subject|20
262820|NCT01183468|868033|P4|Overall Study|Withdrawal by Subject|0
262821|NCT01183468|868034|P3|Overall Study|Withdrawal by Subject|0
262822|NCT01183468|868035|P2|Overall Study|Withdrawal by Subject|1
262823|NCT01183468|868036|P1|Overall Study|Withdrawal by Subject|0
262824|NCT01183468|868033|P4|Overall Study|Physician Decision|0
262825|NCT01183468|868034|P3|Overall Study|Physician Decision|0
262826|NCT01183468|868035|P2|Overall Study|Physician Decision|0
262827|NCT01183468|868036|P1|Overall Study|Physician Decision|1
262828|NCT01183468|868033|P4|Overall Study|Lost to Follow-up|0
262829|NCT01183468|868034|P3|Overall Study|Lost to Follow-up|0
262830|NCT01183468|868035|P2|Overall Study|Lost to Follow-up|1
262831|NCT01183468|868036|P1|Overall Study|Lost to Follow-up|2
262832|NCT01183390|868046|P2|First Intervention|Adverse Event|1
262833|NCT01183390|868047|P1|First Intervention|Adverse Event|0
262834|NCT01183234|868078|P2|First Intervention|Adverse Event|0
262835|NCT01183234|868079|P1|First Intervention|Adverse Event|1
262836|NCT01183104|868173|P2|Overall Study|Did not receive study drug|9
262837|NCT01183104|868174|P1|Overall Study|Did not receive study drug|5
262838|NCT01183104|868173|P2|Overall Study|Nonparticipation in Extension Study|50
262839|NCT01183104|868174|P1|Overall Study|Nonparticipation in Extension Study|39
262840|NCT01183104|868173|P2|Overall Study|Withdrawal by Subject|11
262841|NCT01183104|868174|P1|Overall Study|Withdrawal by Subject|6
262842|NCT01183104|868173|P2|Overall Study|Physician Decision|8
262843|NCT01183104|868174|P1|Overall Study|Physician Decision|5
262844|NCT01183104|868173|P2|Overall Study|Lost to Follow-up|7
262845|NCT01183104|868174|P1|Overall Study|Lost to Follow-up|14
262846|NCT01183104|868173|P2|Overall Study|Death|1
262847|NCT01183104|868174|P1|Overall Study|Death|0
262848|NCT01183104|868173|P2|Overall Study|Adverse Event|6
262849|NCT01183104|868174|P1|Overall Study|Adverse Event|8
262850|NCT01183065|868190|P1|Overall Study|Patient no longer fits eligibility crite|1
262851|NCT01183013|868201|P7|Overall Study|Reasons other than stated above|13
262852|NCT01183013|868202|P6|Overall Study|Reasons other than stated above|15
262853|NCT01183013|868203|P5|Overall Study|Reasons other than stated above|12
262854|NCT01183013|868204|P4|Overall Study|Reasons other than stated above|12
262855|NCT01183013|868205|P3|Overall Study|Reasons other than stated above|17
262856|NCT01183013|868206|P2|Overall Study|Reasons other than stated above|11
262857|NCT01183013|868207|P1|Overall Study|Reasons other than stated above|15
262858|NCT01183013|868201|P7|Overall Study|Withdrawal by Subject|10
262859|NCT01183013|868202|P6|Overall Study|Withdrawal by Subject|9
262860|NCT01183013|868203|P5|Overall Study|Withdrawal by Subject|7
262861|NCT01183013|868204|P4|Overall Study|Withdrawal by Subject|8
262862|NCT01183013|868205|P3|Overall Study|Withdrawal by Subject|10
262863|NCT01183013|868206|P2|Overall Study|Withdrawal by Subject|13
262864|NCT01183013|868207|P1|Overall Study|Withdrawal by Subject|9
262865|NCT01183013|868201|P7|Overall Study|Lost to Follow-up|5
262866|NCT01183013|868202|P6|Overall Study|Lost to Follow-up|6
262867|NCT01183013|868203|P5|Overall Study|Lost to Follow-up|2
262868|NCT01183013|868204|P4|Overall Study|Lost to Follow-up|3
262869|NCT01183013|868205|P3|Overall Study|Lost to Follow-up|4
262870|NCT01183013|868206|P2|Overall Study|Lost to Follow-up|3
262871|NCT01183013|868207|P1|Overall Study|Lost to Follow-up|7
262872|NCT01183013|868201|P7|Overall Study|Protocol Violation|3
262873|NCT01183013|868202|P6|Overall Study|Protocol Violation|3
262874|NCT01183013|868203|P5|Overall Study|Protocol Violation|4
262875|NCT01183013|868204|P4|Overall Study|Protocol Violation|0
262876|NCT01183013|868205|P3|Overall Study|Protocol Violation|4
262877|NCT01183013|868206|P2|Overall Study|Protocol Violation|2
262878|NCT01183013|868207|P1|Overall Study|Protocol Violation|5
262879|NCT01183013|868201|P7|Overall Study|Lack of Efficacy|0
262880|NCT01183013|868202|P6|Overall Study|Lack of Efficacy|2
262881|NCT01183013|868203|P5|Overall Study|Lack of Efficacy|1
262882|NCT01183013|868204|P4|Overall Study|Lack of Efficacy|2
262883|NCT01183013|868205|P3|Overall Study|Lack of Efficacy|1
262884|NCT01183013|868206|P2|Overall Study|Lack of Efficacy|2
262885|NCT01183013|868207|P1|Overall Study|Lack of Efficacy|3
262886|NCT01183013|868201|P7|Overall Study|Adverse Event|6
262887|NCT01183013|868202|P6|Overall Study|Adverse Event|10
262888|NCT01183013|868203|P5|Overall Study|Adverse Event|10
262889|NCT01183013|868204|P4|Overall Study|Adverse Event|5
262890|NCT01183013|868205|P3|Overall Study|Adverse Event|5
262891|NCT01183013|868206|P2|Overall Study|Adverse Event|8
262892|NCT01183013|868207|P1|Overall Study|Adverse Event|6
262893|NCT01182428|868331|P2|Overall Study|Withdrawal by Subject|0
262894|NCT01182428|868332|P1|Overall Study|Withdrawal by Subject|1
262895|NCT01182428|868331|P2|Overall Study|Lost to Follow-up|1
262896|NCT01182428|868332|P1|Overall Study|Lost to Follow-up|9
262897|NCT01182428|868331|P2|Overall Study|Physician Decision|0
262898|NCT01182428|868332|P1|Overall Study|Physician Decision|1
262899|NCT01182337|868407|P2|Overall Study|Lost to Follow-up|1
262900|NCT01182337|868408|P1|Overall Study|Lost to Follow-up|0
262901|NCT01182337|868407|P2|Overall Study|Withdrawal by Subject|1
262902|NCT01182337|868408|P1|Overall Study|Withdrawal by Subject|3
262903|NCT01182298|868426|P1|Overall Study|Withdrawal by Subject|2
262904|NCT01182298|868426|P1|Overall Study|Lack of Efficacy|4
262905|NCT01182285|868430|P3|Third Intervention Week 11-52|Other|2
262906|NCT01182285|868431|P2|Third Intervention Week 11-52|Other|0
262907|NCT01182285|868432|P1|Third Intervention Week 11-52|Other|0
262908|NCT01182285|868430|P3|Third Intervention Week 11-52|Disease Progression|6
262909|NCT01182285|868431|P2|Third Intervention Week 11-52|Disease Progression|0
262910|NCT01182285|868432|P1|Third Intervention Week 11-52|Disease Progression|0
262911|NCT01182285|868430|P3|First Intervention Week 1-10|Non-compliance|0
262912|NCT01182285|868431|P2|First Intervention Week 1-10|Non-compliance|0
262913|NCT01182285|868432|P1|First Intervention Week 1-10|Non-compliance|1
262914|NCT01182285|868430|P3|First Intervention Week 1-10|Adverse Event|0
262915|NCT01182285|868431|P2|First Intervention Week 1-10|Adverse Event|0
262916|NCT01182285|868432|P1|First Intervention Week 1-10|Adverse Event|1
262917|NCT01182285|868430|P3|First Intervention Week 1-10|Disease progression|0
262918|NCT01182285|868431|P2|First Intervention Week 1-10|Disease progression|0
262919|NCT01182285|868432|P1|First Intervention Week 1-10|Disease progression|1
262920|NCT01182207|868442|P2|Second Intervention|Emeses within 1 hour of dosing|0
262921|NCT01182207|868443|P1|Second Intervention|Emeses within 1 hour of dosing|1
262922|NCT01182207|868442|P2|First Intervention|Positive Hepatitis Results|1
262923|NCT01182207|868443|P1|First Intervention|Positive Hepatitis Results|0
262924|NCT01182194|868461|P2|Washout of 28 Days|Withdrawal by Subject|0
262925|NCT01182194|868462|P1|Washout of 28 Days|Withdrawal by Subject|1
262926|NCT01182181|868480|P2|Washout of 21 Days|Withdrawal by Subject|1
262927|NCT01182181|868481|P1|Washout of 21 Days|Withdrawal by Subject|0
262928|NCT01182181|868480|P2|First Intervention|Adverse Event|0
262929|NCT01182181|868481|P1|First Intervention|Adverse Event|1
262930|NCT01181986|868506|P3|Phase 2|Medical condition|0
262931|NCT01181986|868507|P2|Phase 2|Medical condition|1
262932|NCT01181986|868508|P1|Phase 2|Medical condition|0
262933|NCT01181986|868506|P3|Phase 2|Adverse Event|0
262934|NCT01181986|868507|P2|Phase 2|Adverse Event|3
262935|NCT01181986|868508|P1|Phase 2|Adverse Event|0
262936|NCT01181986|868506|P3|Phase 1|Protocol Violation|0
262937|NCT01181986|868507|P2|Phase 1|Protocol Violation|0
262938|NCT01181986|868508|P1|Phase 1|Protocol Violation|1
262939|NCT01181986|868506|P3|Phase 1|Adverse Event|1
262940|NCT01181986|868507|P2|Phase 1|Adverse Event|0
262941|NCT01181986|868508|P1|Phase 1|Adverse Event|0
262942|NCT01181986|868506|P3|Phase 1|Lost to Follow-up|1
262943|NCT01181986|868507|P2|Phase 1|Lost to Follow-up|1
262944|NCT01181986|868508|P1|Phase 1|Lost to Follow-up|0
262945|NCT01181921|868529|P1|Overall Study|Lost to Follow-up|1
262946|NCT01181895|868536|P3|Overall Study|Withdrawal by Subject|5
262947|NCT01181895|868537|P2|Overall Study|Withdrawal by Subject|0
262948|NCT01181895|868538|P1|Overall Study|Withdrawal by Subject|3
262949|NCT01181895|868536|P3|Overall Study|Investigator Discretion|1
262950|NCT01181895|868537|P2|Overall Study|Investigator Discretion|2
262951|NCT01181895|868538|P1|Overall Study|Investigator Discretion|1
262952|NCT01181895|868536|P3|Overall Study|Lost to Follow-up|2
262953|NCT01181895|868537|P2|Overall Study|Lost to Follow-up|1
262954|NCT01181895|868538|P1|Overall Study|Lost to Follow-up|0
262955|NCT01181895|868536|P3|Overall Study|Protocol Violation|0
262956|NCT01181895|868537|P2|Overall Study|Protocol Violation|1
262957|NCT01181895|868538|P1|Overall Study|Protocol Violation|2
262958|NCT01181895|868536|P3|Overall Study|Lack of Efficacy|9
262959|NCT01181895|868537|P2|Overall Study|Lack of Efficacy|9
262960|NCT01181895|868538|P1|Overall Study|Lack of Efficacy|8
262961|NCT01181895|868536|P3|Overall Study|Adverse Event|1
262962|NCT01181895|868537|P2|Overall Study|Adverse Event|1
262963|NCT01181895|868538|P1|Overall Study|Adverse Event|3
262964|NCT01181778|868596|P1|Overall Study|Physician Decision|48
262965|NCT01181726|868604|P2|First Intervention|Adverse Event|0
262966|NCT01181726|868605|P1|First Intervention|Adverse Event|1
262967|NCT01181609|868651|P1|Overall Study|Death|50
262968|NCT01181609|868651|P1|Overall Study|Lost to Follow-up|1
262969|NCT01181609|868651|P1|Overall Study|Withdrawal by Subject|1
262970|NCT01181609|868651|P1|Overall Study|Adverse Event|1
262971|NCT01181531|868664|P2|Overall Study|Adverse Event|1
262972|NCT01181531|868665|P1|Overall Study|Adverse Event|0
262973|NCT01181531|868664|P2|Overall Study|Death|12
262974|NCT01181531|868665|P1|Overall Study|Death|9
262975|NCT01181531|868664|P2|Overall Study|Protocol Violation|6
262976|NCT01181531|868665|P1|Overall Study|Protocol Violation|6
262977|NCT01181531|868664|P2|Overall Study|Withdrawal by Subject|7
262978|NCT01181531|868665|P1|Overall Study|Withdrawal by Subject|8
262979|NCT01181531|868664|P2|Overall Study|Pregnancy|1
262980|NCT01181531|868665|P1|Overall Study|Pregnancy|0
262981|NCT01181531|868664|P2|Overall Study|Protocol Specified Criteria|8
262982|NCT01181531|868665|P1|Overall Study|Protocol Specified Criteria|15
262983|NCT01181531|868664|P2|Overall Study|Ineligibility determined|2
262984|NCT01181531|868665|P1|Overall Study|Ineligibility determined|1
262985|NCT01181531|868664|P2|Overall Study|Noncompliance|2
262986|NCT01181531|868665|P1|Overall Study|Noncompliance|2
262987|NCT01181531|868664|P2|Overall Study|Physician Decision|1
262988|NCT01181531|868665|P1|Overall Study|Physician Decision|3
262989|NCT01181531|868664|P2|Overall Study|Partial consent by subject withdrawn|1
262990|NCT01181531|868665|P1|Overall Study|Partial consent by subject withdrawn|0
262991|NCT01181531|868664|P2|Overall Study|Not known|12
262992|NCT01181531|868665|P1|Overall Study|Not known|17
262993|NCT01181271|868788|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
262994|NCT01181271|868788|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
262995|NCT01181271|868788|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
262996|NCT01181271|868788|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
262997|NCT01181167|868812|P2|Overall Study|Withdrawal by Subject|8
262998|NCT01181167|868813|P1|Overall Study|Withdrawal by Subject|6
262999|NCT01181167|868812|P2|Overall Study|Protocol Violation|0
263000|NCT01181167|868813|P1|Overall Study|Protocol Violation|3
263001|NCT01181167|868812|P2|Overall Study|Physician Decision|3
263002|NCT01181167|868813|P1|Overall Study|Physician Decision|2
263003|NCT01181167|868812|P2|Overall Study|Lost to Follow-up|0
263004|NCT01181167|868813|P1|Overall Study|Lost to Follow-up|1
263005|NCT01181167|868812|P2|Overall Study|Adverse Event|21
263006|NCT01181167|868813|P1|Overall Study|Adverse Event|11
263007|NCT01181141|868823|P2|Overall Study|Withdrawal by Subject|1
263008|NCT01181141|868824|P1|Overall Study|Withdrawal by Subject|3
263009|NCT01181141|868823|P2|Overall Study|Protocol Violation|1
263010|NCT01181141|868824|P1|Overall Study|Protocol Violation|3
263011|NCT01181141|868823|P2|Overall Study|Physician Decision|0
263012|NCT01181141|868824|P1|Overall Study|Physician Decision|2
263013|NCT01181141|868823|P2|Overall Study|Lost to Follow-up|1
263014|NCT01181141|868824|P1|Overall Study|Lost to Follow-up|1
263015|NCT01181141|868823|P2|Overall Study|Lack of Efficacy|0
263016|NCT01181141|868824|P1|Overall Study|Lack of Efficacy|1
263017|NCT01181141|868823|P2|Overall Study|Adverse Event|1
263018|NCT01181141|868824|P1|Overall Study|Adverse Event|2
263019|NCT01181128|868833|P3|Overall Study|Not Specified|1
263020|NCT01181128|868834|P2|Overall Study|Not Specified|1
263021|NCT01181128|868835|P1|Overall Study|Not Specified|1
263022|NCT01181128|868833|P3|Overall Study|Adverse Event|0
263023|NCT01181128|868834|P2|Overall Study|Adverse Event|2
263024|NCT01181128|868835|P1|Overall Study|Adverse Event|0
263025|NCT01181128|868833|P3|Overall Study|Physician Decision|0
263026|NCT01181128|868834|P2|Overall Study|Physician Decision|0
263027|NCT01181128|868835|P1|Overall Study|Physician Decision|2
263028|NCT01181128|868833|P3|Overall Study|Death|0
263029|NCT01181128|868834|P2|Overall Study|Death|0
263030|NCT01181128|868835|P1|Overall Study|Death|1
263031|NCT01181128|868833|P3|Overall Study|Withdrawal by Subject|0
263032|NCT01181128|868834|P2|Overall Study|Withdrawal by Subject|2
263033|NCT01181128|868835|P1|Overall Study|Withdrawal by Subject|2
263034|NCT01181102|868923|P2|Overall Study|Withdrawal by Subject|12
263035|NCT01181102|868924|P1|Overall Study|Withdrawal by Subject|10
263036|NCT01181102|868923|P2|Overall Study|Protocol Violation|6
263037|NCT01181102|868924|P1|Overall Study|Protocol Violation|5
263038|NCT01181102|868923|P2|Overall Study|Physician Decision|1
263039|NCT01181102|868924|P1|Overall Study|Physician Decision|3
263040|NCT01181102|868923|P2|Overall Study|Lost to Follow-up|0
263041|NCT01181102|868924|P1|Overall Study|Lost to Follow-up|2
263042|NCT01181102|868923|P2|Overall Study|Lack of Efficacy|1
263043|NCT01181102|868924|P1|Overall Study|Lack of Efficacy|3
263044|NCT01181102|868923|P2|Overall Study|Adverse Event|26
263045|NCT01181102|868924|P1|Overall Study|Adverse Event|28
263046|NCT01181011|868945|P1|Overall Study|Lost to Follow-up|1
263047|NCT01181011|868945|P1|Overall Study|Adverse Event|2
263048|NCT01180998|868995|P3|Overall Study|Poor lens handling|2
263049|NCT01180998|868996|P2|Overall Study|Poor lens handling|0
263050|NCT01180998|868997|P1|Overall Study|Poor lens handling|0
263051|NCT01180998|868995|P3|Overall Study|Poor comfort|4
263052|NCT01180998|868996|P2|Overall Study|Poor comfort|0
263053|NCT01180998|868997|P1|Overall Study|Poor comfort|3
263054|NCT01180998|868995|P3|Overall Study|Withdrawal by Subject|1
263055|NCT01180998|868996|P2|Overall Study|Withdrawal by Subject|0
263056|NCT01180998|868997|P1|Overall Study|Withdrawal by Subject|0
263057|NCT01180998|868995|P3|Overall Study|Protocol Violation|0
263058|NCT01180998|868996|P2|Overall Study|Protocol Violation|2
263059|NCT01180998|868997|P1|Overall Study|Protocol Violation|1
263060|NCT01180998|868995|P3|Overall Study|Lost to Follow-up|1
263061|NCT01180998|868996|P2|Overall Study|Lost to Follow-up|0
263062|NCT01180998|868997|P1|Overall Study|Lost to Follow-up|0
263063|NCT01180998|868995|P3|Overall Study|Poor Vision|2
263064|NCT01180998|868996|P2|Overall Study|Poor Vision|2
263065|NCT01180998|868997|P1|Overall Study|Poor Vision|0
263066|NCT01180985|869011|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
263067|NCT01180985|869012|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
263068|NCT01180790|869051|P7|Overall Study|Severe coronary atherosclerosis (death)|0
263069|NCT01180790|869052|P6|Overall Study|Severe coronary atherosclerosis (death)|0
263070|NCT01180790|869053|P5|Overall Study|Severe coronary atherosclerosis (death)|0
263071|NCT01180790|869054|P4|Overall Study|Severe coronary atherosclerosis (death)|0
263072|NCT01180790|869055|P3|Overall Study|Severe coronary atherosclerosis (death)|1
263073|NCT01180790|869056|P2|Overall Study|Severe coronary atherosclerosis (death)|0
263074|NCT01180790|869057|P1|Overall Study|Severe coronary atherosclerosis (death)|0
263075|NCT01180790|869051|P7|Overall Study|compliance|0
263076|NCT01180790|869052|P6|Overall Study|compliance|0
263077|NCT01180790|869053|P5|Overall Study|compliance|0
263078|NCT01180790|869054|P4|Overall Study|compliance|0
263079|NCT01180790|869055|P3|Overall Study|compliance|0
263080|NCT01180790|869056|P2|Overall Study|compliance|1
263081|NCT01180790|869057|P1|Overall Study|compliance|0
263082|NCT01180790|869051|P7|Overall Study|Lack of Efficacy|0
263083|NCT01180790|869052|P6|Overall Study|Lack of Efficacy|3
263084|NCT01180790|869053|P5|Overall Study|Lack of Efficacy|1
263085|NCT01180790|869054|P4|Overall Study|Lack of Efficacy|6
263086|NCT01180790|869055|P3|Overall Study|Lack of Efficacy|5
263087|NCT01180790|869056|P2|Overall Study|Lack of Efficacy|2
263088|NCT01180790|869057|P1|Overall Study|Lack of Efficacy|1
263089|NCT01180790|869051|P7|Overall Study|Physician Decision|0
263090|NCT01180790|869052|P6|Overall Study|Physician Decision|0
263091|NCT01180790|869053|P5|Overall Study|Physician Decision|0
263092|NCT01180790|869054|P4|Overall Study|Physician Decision|1
263093|NCT01180790|869055|P3|Overall Study|Physician Decision|0
263094|NCT01180790|869056|P2|Overall Study|Physician Decision|0
263095|NCT01180790|869057|P1|Overall Study|Physician Decision|1
263096|NCT01180790|869051|P7|Overall Study|Lost to Follow-up|1
263097|NCT01180790|869052|P6|Overall Study|Lost to Follow-up|0
263098|NCT01180790|869053|P5|Overall Study|Lost to Follow-up|1
263099|NCT01180790|869054|P4|Overall Study|Lost to Follow-up|2
263100|NCT01180790|869055|P3|Overall Study|Lost to Follow-up|0
263101|NCT01180790|869056|P2|Overall Study|Lost to Follow-up|1
263102|NCT01180790|869057|P1|Overall Study|Lost to Follow-up|3
263103|NCT01180790|869051|P7|Overall Study|Withdrawal by Subject|0
263104|NCT01180790|869052|P6|Overall Study|Withdrawal by Subject|1
263105|NCT01180790|869053|P5|Overall Study|Withdrawal by Subject|2
263106|NCT01180790|869054|P4|Overall Study|Withdrawal by Subject|0
263107|NCT01180790|869055|P3|Overall Study|Withdrawal by Subject|5
263108|NCT01180790|869056|P2|Overall Study|Withdrawal by Subject|0
263109|NCT01180790|869057|P1|Overall Study|Withdrawal by Subject|3
263110|NCT01180790|869051|P7|Overall Study|Adverse Event|0
263111|NCT01180790|869052|P6|Overall Study|Adverse Event|3
263112|NCT01180790|869053|P5|Overall Study|Adverse Event|1
263113|NCT01180790|869054|P4|Overall Study|Adverse Event|0
263114|NCT01180790|869055|P3|Overall Study|Adverse Event|2
263115|NCT01180790|869056|P2|Overall Study|Adverse Event|1
263116|NCT01180790|869057|P1|Overall Study|Adverse Event|1
263117|NCT01180777|869122|P1|Overall Study|Adverse Event|1
263118|NCT01180777|869122|P1|Overall Study|Lost to Follow-up|1
263119|NCT01180777|869122|P1|Overall Study|Poor lens fit|4
263120|NCT01180777|869122|P1|Overall Study|Protocol Violation|6
263121|NCT01180660|869136|P2|Overall Study|Changed to open surgery|0
263122|NCT01180660|869137|P1|Overall Study|Changed to open surgery|1
263123|NCT01180647|869147|P2|Overall Study|Lost to Follow-up|6
263124|NCT01180647|869148|P1|Overall Study|Lost to Follow-up|5
263125|NCT01180400|869166|P2|Overall Study|Not specified|1
263126|NCT01180400|869167|P1|Overall Study|Not specified|0
263127|NCT01180400|869166|P2|Overall Study|Lost to Follow-up|3
263128|NCT01180400|869167|P1|Overall Study|Lost to Follow-up|2
263129|NCT01180400|869166|P2|Overall Study|Study-specific withdrawal criteria|2
263130|NCT01180400|869167|P1|Overall Study|Study-specific withdrawal criteria|1
263131|NCT01180400|869166|P2|Overall Study|Lack of Efficacy|0
263132|NCT01180400|869167|P1|Overall Study|Lack of Efficacy|2
263133|NCT01180400|869166|P2|Overall Study|Condition under investigation worsened|1
263134|NCT01180400|869167|P1|Overall Study|Condition under investigation worsened|2
263135|NCT01180400|869166|P2|Overall Study|Severe non-compliance to protocol|2
263136|NCT01180400|869167|P1|Overall Study|Severe non-compliance to protocol|1
263137|NCT01180400|869166|P2|Overall Study|Adverse Event|10
263138|NCT01180400|869167|P1|Overall Study|Adverse Event|12
263139|NCT01180400|869166|P2|Overall Study|Eligibility criteria not fulfilled|2
263140|NCT01180400|869167|P1|Overall Study|Eligibility criteria not fulfilled|0
263141|NCT01180400|869166|P2|Overall Study|Withdrawal by Subject|6
263142|NCT01180400|869167|P1|Overall Study|Withdrawal by Subject|5
263143|NCT01180296|869215|P2|Overall Study|Protocol Violation|2
263144|NCT01180296|869216|P1|Overall Study|Protocol Violation|1
263145|NCT01180244|869224|P2|Overall Study|Lost to Follow-up|0
263146|NCT01180244|869225|P1|Overall Study|Lost to Follow-up|1
263147|NCT01180244|869224|P2|Overall Study|Protocol Violation|0
263148|NCT01180244|869225|P1|Overall Study|Protocol Violation|1
263149|NCT01180244|869224|P2|Overall Study|Withdrawal by Subject|1
263150|NCT01180244|869225|P1|Overall Study|Withdrawal by Subject|0
263151|NCT01180244|869224|P2|Overall Study|Adverse Event|0
263152|NCT01180244|869225|P1|Overall Study|Adverse Event|1
263153|NCT01180244|869224|P2|Overall Study|Physician Decision|0
263154|NCT01180244|869225|P1|Overall Study|Physician Decision|3
263155|NCT01180244|869224|P2|Overall Study|Lack of Efficacy|7
263156|NCT01180244|869225|P1|Overall Study|Lack of Efficacy|0
263157|NCT01180049|869270|P2|Overall Study|Ongoing on treatment|10
263158|NCT01180049|869271|P1|Overall Study|Ongoing on treatment|18
263159|NCT01180049|869270|P2|Overall Study|Death|28
263160|NCT01180049|869271|P1|Overall Study|Death|23
263161|NCT01180049|869270|P2|Overall Study|Lost to Follow-up|1
263162|NCT01180049|869271|P1|Overall Study|Lost to Follow-up|0
263163|NCT01180049|869270|P2|Overall Study|Participant Refused Follow Up|3
263164|NCT01180049|869271|P1|Overall Study|Participant Refused Follow Up|5
263165|NCT01180049|869270|P2|Overall Study|Enrolled to Another Clinical Trial|1
263166|NCT01180049|869271|P1|Overall Study|Enrolled to Another Clinical Trial|1
263167|NCT01179919|869297|P1|Overall Study|Adverse Event|1
263168|NCT01179919|869297|P1|Overall Study|Protocol Violation|1
263169|NCT01179737|869306|P4|Extension|The study was terminated|0
263170|NCT01179737|869307|P3|Extension|The study was terminated|0
263171|NCT01179737|869308|P2|Extension|The study was terminated|0
263172|NCT01179737|869309|P1|Extension|The study was terminated|3
263173|NCT01179737|869306|P4|Cohort 1 & Cohort 2 Expansion|Death|0
263174|NCT01179737|869307|P3|Cohort 1 & Cohort 2 Expansion|Death|0
263175|NCT01179737|869308|P2|Cohort 1 & Cohort 2 Expansion|Death|0
263176|NCT01179737|869309|P1|Cohort 1 & Cohort 2 Expansion|Death|1
263177|NCT01179737|869306|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
263178|NCT01179737|869307|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
263179|NCT01179737|869308|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
263180|NCT01179737|869309|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
263181|NCT01179737|869306|P4|Cohort 1 & Cohort 2|Death|0
263182|NCT01179737|869307|P3|Cohort 1 & Cohort 2|Death|1
263183|NCT01179737|869308|P2|Cohort 1 & Cohort 2|Death|0
263184|NCT01179737|869309|P1|Cohort 1 & Cohort 2|Death|0
263185|NCT01179737|869306|P4|Cohort 1 & Cohort 2|Administrative problems|4
263186|NCT01179737|869307|P3|Cohort 1 & Cohort 2|Administrative problems|2
263187|NCT01179737|869308|P2|Cohort 1 & Cohort 2|Administrative problems|0
263188|NCT01179737|869309|P1|Cohort 1 & Cohort 2|Administrative problems|0
263189|NCT01179737|869306|P4|Cohort 1 & Cohort 2|Withdrew consent|0
263190|NCT01179737|869307|P3|Cohort 1 & Cohort 2|Withdrew consent|0
263191|NCT01179737|869308|P2|Cohort 1 & Cohort 2|Withdrew consent|0
263192|NCT01179737|869309|P1|Cohort 1 & Cohort 2|Withdrew consent|2
263193|NCT01179737|869306|P4|Cohort 1 & Cohort 2|Adverse Event|0
263194|NCT01179737|869307|P3|Cohort 1 & Cohort 2|Adverse Event|1
263195|NCT01179737|869308|P2|Cohort 1 & Cohort 2|Adverse Event|1
263196|NCT01179737|869309|P1|Cohort 1 & Cohort 2|Adverse Event|3
263197|NCT01179672|869320|P2|Overall Study|Physician Decision|1
263198|NCT01179672|869321|P1|Overall Study|Physician Decision|1
263199|NCT01179672|869320|P2|Overall Study|Protocol Violation|2
263200|NCT01179672|869321|P1|Overall Study|Protocol Violation|2
263201|NCT01179672|869320|P2|Overall Study|Lost to Follow-up|1
263202|NCT01179672|869321|P1|Overall Study|Lost to Follow-up|0
263203|NCT01179672|869320|P2|Overall Study|Entry Criteria Not Met|2
263204|NCT01179672|869321|P1|Overall Study|Entry Criteria Not Met|0
263205|NCT01179672|869320|P2|Overall Study|Withdrawal by Subject|12
263206|NCT01179672|869321|P1|Overall Study|Withdrawal by Subject|10
263207|NCT01179672|869320|P2|Overall Study|Adverse Event|8
263208|NCT01179672|869321|P1|Overall Study|Adverse Event|17
263209|NCT01179516|869377|P3|Overall Study|Other|2
263210|NCT01179516|869378|P2|Overall Study|Other|0
263211|NCT01179516|869379|P1|Overall Study|Other|2
263212|NCT01179516|869377|P3|Overall Study|Lost to Follow-up|3
263213|NCT01179516|869378|P2|Overall Study|Lost to Follow-up|7
263214|NCT01179516|869379|P1|Overall Study|Lost to Follow-up|7
263215|NCT01179516|869377|P3|Overall Study|Withdrawal of Consent|10
263216|NCT01179516|869378|P2|Overall Study|Withdrawal of Consent|6
263217|NCT01179516|869379|P1|Overall Study|Withdrawal of Consent|2
263218|NCT01179516|869377|P3|Overall Study|Protocol Deviations|3
263219|NCT01179516|869378|P2|Overall Study|Protocol Deviations|3
263220|NCT01179516|869379|P1|Overall Study|Protocol Deviations|4
263221|NCT01179516|869377|P3|Overall Study|Noncompliance with Study Drug|1
263222|NCT01179516|869378|P2|Overall Study|Noncompliance with Study Drug|0
263223|NCT01179516|869379|P1|Overall Study|Noncompliance with Study Drug|2
263224|NCT01179516|869377|P3|Overall Study|Lack of Efficacy|0
263225|NCT01179516|869378|P2|Overall Study|Lack of Efficacy|2
263226|NCT01179516|869379|P1|Overall Study|Lack of Efficacy|4
263227|NCT01179516|869377|P3|Overall Study|Pretreatment Event or Adverse Event|12
263228|NCT01179516|869378|P2|Overall Study|Pretreatment Event or Adverse Event|8
263229|NCT01179516|869379|P1|Overall Study|Pretreatment Event or Adverse Event|6
263230|NCT01179399|869423|P1|Overall Study|Withdrawal by Subject|1
263231|NCT01179399|869423|P1|Overall Study|Lack of Efficacy|30
263232|NCT01179399|869423|P1|Overall Study|Adverse Event|1
263233|NCT01179347|869429|P2|Open-label Period (12 Weeks)|Other|4
263234|NCT01179347|869430|P1|Open-label Period (12 Weeks)|Other|7
263235|NCT01179347|869429|P2|Open-label Period (12 Weeks)|Protocol Violation|0
263236|NCT01179347|869430|P1|Open-label Period (12 Weeks)|Protocol Violation|1
263237|NCT01179347|869429|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
263238|NCT01179347|869430|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
263239|NCT01179347|869429|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
263240|NCT01179347|869430|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
263241|NCT01179347|869429|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
263242|NCT01179347|869430|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
263243|NCT01179347|869429|P2|Open-label Period (12 Weeks)|Adverse Event|9
263244|NCT01179347|869430|P1|Open-label Period (12 Weeks)|Adverse Event|5
263245|NCT01179347|869429|P2|Double-blind Period (12 Weeks)|Other|4
263246|NCT01179347|869430|P1|Double-blind Period (12 Weeks)|Other|2
263247|NCT01179347|869429|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
263248|NCT01179347|869430|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
263249|NCT01179347|869429|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
263250|NCT01179347|869430|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
263251|NCT01179347|869429|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
263252|NCT01179347|869430|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
263253|NCT01179347|869429|P2|Double-blind Period (12 Weeks)|Adverse Event|6
263254|NCT01179347|869430|P1|Double-blind Period (12 Weeks)|Adverse Event|2
263255|NCT01179334|869452|P2|Long-term Extension (LTE) Period|Adverse Event|4
263256|NCT01179334|869453|P1|Long-term Extension (LTE) Period|Adverse Event|2
263257|NCT01179334|869452|P2|Long-term Extension (LTE) Period|Death|0
263258|NCT01179334|869453|P1|Long-term Extension (LTE) Period|Death|3
263259|NCT01179334|869452|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
263260|NCT01179334|869453|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
263261|NCT01179334|869452|P2|Treatment Period|Adverse Event|0
263262|NCT01179334|869453|P1|Treatment Period|Adverse Event|1
263263|NCT01179191|869481|P1|Maintenance Phase (8 Weeks)|Unspecified|66
263264|NCT01179191|869481|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
263265|NCT01179191|869481|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
263266|NCT01179191|869481|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
263267|NCT01179191|869481|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
263268|NCT01179191|869481|P1|Titration Phase (up to 6 Weeks)|Unspecified|62
263269|NCT01179191|869481|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
263270|NCT01179191|869481|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
263271|NCT01179191|869481|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
263272|NCT01179191|869481|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
263273|NCT01179191|869481|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
263274|NCT01179048|869513|P2|Overall Study|Alive|142
263275|NCT01179048|869514|P1|Overall Study|Alive|127
263276|NCT01179048|869513|P2|Overall Study|Lost to Follow-up|9
263277|NCT01179048|869514|P1|Overall Study|Lost to Follow-up|8
263278|NCT01179048|869513|P2|Overall Study|Withdrawn - does not allow contact|8
263279|NCT01179048|869514|P1|Overall Study|Withdrawn - does not allow contact|4
263280|NCT01178853|869532|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
263281|NCT01178853|869533|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
263282|NCT01178853|869532|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
263283|NCT01178853|869533|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
263284|NCT01178853|869532|P2|Period 3 (Warfarin Titration)|Adverse Event|0
263285|NCT01178853|869533|P1|Period 3 (Warfarin Titration)|Adverse Event|1
263286|NCT01178853|869532|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
263287|NCT01178853|869533|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
263288|NCT01178853|869532|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
263289|NCT01178853|869533|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
263290|NCT01178762|869573|P1|Overall Study|Lost to Follow-up|15
263291|NCT01178671|869579|P2|Overall Study|Physician Decision|6
263292|NCT01178671|869580|P1|Overall Study|Physician Decision|4
263293|NCT01178671|869579|P2|Overall Study|Lost to Follow-up|1
263294|NCT01178671|869580|P1|Overall Study|Lost to Follow-up|3
263295|NCT01178671|869579|P2|Overall Study|Lack of Efficacy|1
263296|NCT01178671|869580|P1|Overall Study|Lack of Efficacy|0
263297|NCT01178671|869579|P2|Overall Study|Protocol Violation|1
263298|NCT01178671|869580|P1|Overall Study|Protocol Violation|1
263299|NCT01178671|869579|P2|Overall Study|Adverse Event|6
263300|NCT01178671|869580|P1|Overall Study|Adverse Event|4
263301|NCT01178385|869628|P2|Overall Study|Withdrawal by Subject|0
263302|NCT01178385|869629|P1|Overall Study|Withdrawal by Subject|2
263303|NCT01178294|869698|P1|Overall Study|Completion status could not be verified|1
263304|NCT01178294|869698|P1|Overall Study|Subject status is terminal|1
263305|NCT01178294|869698|P1|Overall Study|Development of inhibitors to OBI-1|1
263306|NCT01178294|869698|P1|Overall Study|Death|1
263307|NCT01178294|869698|P1|Overall Study|Lack of Efficacy|1
263308|NCT01178294|869698|P1|Overall Study|Lost to Follow-up|2
263309|NCT01178294|869698|P1|Overall Study|Adverse Event|4
263310|NCT01178281|869721|P2|Overall Study|Prohibited Medications|2
263311|NCT01178281|869722|P1|Overall Study|Prohibited Medications|0
263312|NCT01178281|869721|P2|Overall Study|Adverse Event|9
263313|NCT01178281|869722|P1|Overall Study|Adverse Event|39
263314|NCT01178281|869721|P2|Overall Study|Withdrawal by Subject|7
263315|NCT01178281|869722|P1|Overall Study|Withdrawal by Subject|18
263316|NCT01178281|869721|P2|Overall Study|Death|5
263317|NCT01178281|869722|P1|Overall Study|Death|4
263318|NCT01178281|869721|P2|Overall Study|Disease Progression|6
263319|NCT01178281|869722|P1|Overall Study|Disease Progression|18
263320|NCT01178281|869721|P2|Overall Study|Non-compliance to study drug|0
263321|NCT01178281|869722|P1|Overall Study|Non-compliance to study drug|1
263322|NCT01178281|869721|P2|Overall Study|Lack of Efficacy|38
263323|NCT01178281|869722|P1|Overall Study|Lack of Efficacy|60
263324|NCT01178281|869721|P2|Overall Study|Loss of Clinical Benefit|7
263325|NCT01178281|869722|P1|Overall Study|Loss of Clinical Benefit|5
263326|NCT01178281|869721|P2|Overall Study|Physician Decision|3
263327|NCT01178281|869722|P1|Overall Study|Physician Decision|4
263328|NCT01178138|869948|P1|Overall Study|Physician Decision|8
263329|NCT01178138|869948|P1|Overall Study|Withdrawal by Subject|7
263330|NCT01178138|869948|P1|Overall Study|Lost to Follow-up|8
263331|NCT01178125|869969|P1|Overall Study|Investigator Decision|5
263332|NCT01178125|869969|P1|Overall Study|Protocol Violation|17
263333|NCT01178125|869969|P1|Overall Study|Sponsor Decision|28
263334|NCT01178125|869969|P1|Overall Study|Other Reason|39
263335|NCT01178125|869969|P1|Overall Study|Pregnancy|55
263336|NCT01178125|869969|P1|Overall Study|Noncompliance|184
263337|NCT01178125|869969|P1|Overall Study|Withdrawal by Subject|209
263338|NCT01178125|869969|P1|Overall Study|Adverse Event|244
263339|NCT01178125|869969|P1|Overall Study|Lost to Follow-up|397
263340|NCT01178099|870000|P2|Overall Study|Physician Decision|1
263341|NCT01178099|870001|P1|Overall Study|Physician Decision|0
263342|NCT01178073|870042|P3|Overall Study|Missing Completion Status|0
263343|NCT01178073|870043|P2|Overall Study|Missing Completion Status|0
263344|NCT01178073|870044|P1|Overall Study|Missing Completion Status|1
263345|NCT01178073|870042|P3|Overall Study|Withdrawal by Subject|8
263346|NCT01178073|870043|P2|Overall Study|Withdrawal by Subject|6
263347|NCT01178073|870044|P1|Overall Study|Withdrawal by Subject|10
263348|NCT01178073|870042|P3|Overall Study|Physician Decision|10
263349|NCT01178073|870043|P2|Overall Study|Physician Decision|10
263350|NCT01178073|870044|P1|Overall Study|Physician Decision|14
263351|NCT01178073|870042|P3|Overall Study|Lost to Follow-up|3
263352|NCT01178073|870043|P2|Overall Study|Lost to Follow-up|0
263353|NCT01178073|870044|P1|Overall Study|Lost to Follow-up|2
263354|NCT01178073|870042|P3|Overall Study|Protocol Violation|1
263355|NCT01178073|870043|P2|Overall Study|Protocol Violation|1
263356|NCT01178073|870044|P1|Overall Study|Protocol Violation|1
263357|NCT01178073|870042|P3|Overall Study|Adverse Event|24
263358|NCT01178073|870043|P2|Overall Study|Adverse Event|27
263359|NCT01178073|870044|P1|Overall Study|Adverse Event|34
263360|NCT01177969|870075|P2|Overall Study|Withdrawal by Subject|2
263361|NCT01177969|870076|P1|Overall Study|Withdrawal by Subject|1
263362|NCT01177969|870075|P2|Overall Study|Protocol Violation|1
263363|NCT01177969|870076|P1|Overall Study|Protocol Violation|2
263364|NCT01177943|870099|P2|First Intervention|Withdrawal by Subject|0
263365|NCT01177943|870100|P1|First Intervention|Withdrawal by Subject|2
263366|NCT01177813|870113|P5|Overall Study|Other reason not defined above|2
263367|NCT01177813|870114|P4|Overall Study|Other reason not defined above|3
263368|NCT01177813|870115|P3|Overall Study|Other reason not defined above|2
263369|NCT01177813|870116|P2|Overall Study|Other reason not defined above|2
263370|NCT01177813|870117|P1|Overall Study|Other reason not defined above|5
263371|NCT01177813|870113|P5|Overall Study|Withdrawal by Subject|3
263372|NCT01177813|870114|P4|Overall Study|Withdrawal by Subject|5
263373|NCT01177813|870115|P3|Overall Study|Withdrawal by Subject|6
263374|NCT01177813|870116|P2|Overall Study|Withdrawal by Subject|7
263375|NCT01177813|870117|P1|Overall Study|Withdrawal by Subject|12
263376|NCT01177813|870113|P5|Overall Study|Lost to Follow-up|0
263377|NCT01177813|870114|P4|Overall Study|Lost to Follow-up|3
263378|NCT01177813|870115|P3|Overall Study|Lost to Follow-up|6
263379|NCT01177813|870116|P2|Overall Study|Lost to Follow-up|5
263380|NCT01177813|870117|P1|Overall Study|Lost to Follow-up|12
263381|NCT01177813|870113|P5|Overall Study|Protocol Violation|1
263382|NCT01177813|870114|P4|Overall Study|Protocol Violation|0
263383|NCT01177813|870115|P3|Overall Study|Protocol Violation|2
263384|NCT01177813|870116|P2|Overall Study|Protocol Violation|2
263385|NCT01177813|870117|P1|Overall Study|Protocol Violation|3
263386|NCT01177813|870113|P5|Overall Study|Lack of Efficacy|0
263387|NCT01177813|870114|P4|Overall Study|Lack of Efficacy|0
263388|NCT01177813|870115|P3|Overall Study|Lack of Efficacy|0
263389|NCT01177813|870116|P2|Overall Study|Lack of Efficacy|0
263390|NCT01177813|870117|P1|Overall Study|Lack of Efficacy|1
263391|NCT01177813|870113|P5|Overall Study|Adverse Event|3
263392|NCT01177813|870114|P4|Overall Study|Adverse Event|6
263393|NCT01177813|870115|P3|Overall Study|Adverse Event|4
263394|NCT01177813|870116|P2|Overall Study|Adverse Event|2
263395|NCT01177813|870117|P1|Overall Study|Adverse Event|8
263396|NCT01177800|870146|P2|Overall Study|Withdrawal of informed consent|1
263397|NCT01177800|870147|P1|Overall Study|Withdrawal of informed consent|0
263398|NCT01177800|870146|P2|Overall Study|Physician Decision|0
263399|NCT01177800|870147|P1|Overall Study|Physician Decision|1
263400|NCT01177800|870146|P2|Overall Study|Protocol Violation|1
263401|NCT01177800|870147|P1|Overall Study|Protocol Violation|0
263402|NCT01177800|870146|P2|Overall Study|Adverse Event|3
263403|NCT01177800|870147|P1|Overall Study|Adverse Event|9
263404|NCT01177722|870169|P4|Overall Study|Withdrawal by Subject|6
263405|NCT01177722|870170|P3|Overall Study|Withdrawal by Subject|4
263406|NCT01177722|870171|P2|Overall Study|Withdrawal by Subject|6
263407|NCT01177722|870172|P1|Overall Study|Withdrawal by Subject|10
263408|NCT01177722|870169|P4|Overall Study|Lost to Follow-up|1
263409|NCT01177722|870170|P3|Overall Study|Lost to Follow-up|3
263410|NCT01177722|870171|P2|Overall Study|Lost to Follow-up|4
263411|NCT01177722|870172|P1|Overall Study|Lost to Follow-up|3
263412|NCT01177722|870169|P4|Overall Study|Protocol Violation|0
263413|NCT01177722|870170|P3|Overall Study|Protocol Violation|1
263414|NCT01177722|870171|P2|Overall Study|Protocol Violation|0
263415|NCT01177722|870172|P1|Overall Study|Protocol Violation|0
263416|NCT01177722|870169|P4|Overall Study|Serious Adverse Event|0
263417|NCT01177722|870170|P3|Overall Study|Serious Adverse Event|1
263418|NCT01177722|870171|P2|Overall Study|Serious Adverse Event|0
263419|NCT01177722|870172|P1|Overall Study|Serious Adverse Event|0
263420|NCT01177670|870204|P1|Overall Study|Withdrawal by Subject|4
263421|NCT01177670|870204|P1|Overall Study|Physician Decision|50
263422|NCT01177670|870204|P1|Overall Study|Study Terminated|115
263423|NCT01177553|870211|P2|Overall Study|babies not yet 6 months of age|0
263424|NCT01177553|870212|P1|Overall Study|babies not yet 6 months of age|1
263425|NCT01177410|870221|P3|Overall Study|Lost to Follow-up|0
263426|NCT01177410|870222|P2|Overall Study|Lost to Follow-up|1
263427|NCT01177410|870223|P1|Overall Study|Lost to Follow-up|0
263428|NCT01177410|870221|P3|Overall Study|Withdrawal by Subject|3
263429|NCT01177410|870222|P2|Overall Study|Withdrawal by Subject|4
263430|NCT01177410|870223|P1|Overall Study|Withdrawal by Subject|1
263431|NCT01177410|870221|P3|Overall Study|Adverse Event|2
263432|NCT01177410|870222|P2|Overall Study|Adverse Event|2
263433|NCT01177410|870223|P1|Overall Study|Adverse Event|0
263434|NCT01177384|870236|P2|Overall Study|Withdrawal by Subject|12
263435|NCT01177384|870237|P1|Overall Study|Withdrawal by Subject|5
263436|NCT01177384|870236|P2|Overall Study|Protocol Violation|2
263437|NCT01177384|870237|P1|Overall Study|Protocol Violation|0
263438|NCT01177384|870236|P2|Overall Study|Physician Decision|3
263439|NCT01177384|870237|P1|Overall Study|Physician Decision|0
263440|NCT01177384|870236|P2|Overall Study|Lost to Follow-up|4
263441|NCT01177384|870237|P1|Overall Study|Lost to Follow-up|3
263442|NCT01177384|870236|P2|Overall Study|Lack of Efficacy|1
263443|NCT01177384|870237|P1|Overall Study|Lack of Efficacy|0
263444|NCT01177384|870236|P2|Overall Study|Adverse Event|4
263445|NCT01177384|870237|P1|Overall Study|Adverse Event|6
263446|NCT01177293|870249|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
263447|NCT01177293|870250|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
263448|NCT01177228|870268|P4|Overall Study|Withdrawal by Subject|0
263449|NCT01177228|870269|P3|Overall Study|Withdrawal by Subject|0
263450|NCT01177228|870270|P2|Overall Study|Withdrawal by Subject|1
263451|NCT01177228|870271|P1|Overall Study|Withdrawal by Subject|0
263452|NCT01177228|870268|P4|Overall Study|Worsening disease activity|0
263453|NCT01177228|870269|P3|Overall Study|Worsening disease activity|0
263454|NCT01177228|870270|P2|Overall Study|Worsening disease activity|0
263455|NCT01177228|870271|P1|Overall Study|Worsening disease activity|1
263456|NCT01177228|870268|P4|Overall Study|Positive tuberculosis test|0
263457|NCT01177228|870269|P3|Overall Study|Positive tuberculosis test|0
263458|NCT01177228|870270|P2|Overall Study|Positive tuberculosis test|1
263459|NCT01177228|870271|P1|Overall Study|Positive tuberculosis test|0
263460|NCT01176968|870330|P2|Overall Study|Reason not defined|3
263461|NCT01176968|870331|P1|Overall Study|Reason not defined|5
263462|NCT01176968|870330|P2|Overall Study|Study terminated by sponsor|1
263463|NCT01176968|870331|P1|Overall Study|Study terminated by sponsor|0
263464|NCT01176968|870330|P2|Overall Study|Did Not Meet Entrance Criteria|0
263465|NCT01176968|870331|P1|Overall Study|Did Not Meet Entrance Criteria|1
263466|NCT01176968|870330|P2|Overall Study|Protocol Violation|1
263467|NCT01176968|870331|P1|Overall Study|Protocol Violation|2
263468|NCT01176968|870330|P2|Overall Study|Withdrawal by Subject|48
263469|NCT01176968|870331|P1|Overall Study|Withdrawal by Subject|48
263470|NCT01176968|870330|P2|Overall Study|Lost to Follow-up|14
263471|NCT01176968|870331|P1|Overall Study|Lost to Follow-up|16
263472|NCT01176968|870330|P2|Overall Study|Lack of Efficacy|1
263473|NCT01176968|870331|P1|Overall Study|Lack of Efficacy|0
263474|NCT01176968|870330|P2|Overall Study|Death|3
263475|NCT01176968|870331|P1|Overall Study|Death|2
263476|NCT01176968|870330|P2|Overall Study|Adverse Event|11
263477|NCT01176968|870331|P1|Overall Study|Adverse Event|10
263478|NCT01176773|870381|P1|Overall Study|Withdrew consent|1
263479|NCT01176773|870381|P1|Overall Study|Screen Failure|2
263480|NCT01176565|870392|P2|Overall Study|Not Analyzed (any other reason)|2
263481|NCT01176565|870393|P1|Overall Study|Not Analyzed (any other reason)|1
263482|NCT01176565|870392|P2|Overall Study|Withdrawal by Subject|1
263483|NCT01176565|870393|P1|Overall Study|Withdrawal by Subject|7
263484|NCT01176565|870392|P2|Overall Study|Lost to Follow-up|16
263485|NCT01176565|870393|P1|Overall Study|Lost to Follow-up|12
263486|NCT01176513|870411|P1|Overall Study|Withdrew subjects prior to dosing|3
263487|NCT01176292|870426|P2|Overall Study|Has not scheduled one-year visit yet|2
263488|NCT01176292|870427|P1|Overall Study|Has not scheduled one-year visit yet|2
263489|NCT01176292|870426|P2|Overall Study|Physician Decision|2
263490|NCT01176292|870427|P1|Overall Study|Physician Decision|0
263491|NCT01176292|870426|P2|Overall Study|Adverse Event|1
263492|NCT01176292|870427|P1|Overall Study|Adverse Event|1
263493|NCT01176292|870426|P2|Overall Study|Lost to Follow-up|4
263494|NCT01176292|870427|P1|Overall Study|Lost to Follow-up|2
263495|NCT01176240|870449|P2|Study 306B|withdrew prior to dosing|1
263496|NCT01176240|870450|P1|Study 306B|withdrew prior to dosing|2
263497|NCT01176240|870449|P2|Study 306B|Lost to Follow-up|1
263498|NCT01176240|870450|P1|Study 306B|Lost to Follow-up|0
263499|NCT01176240|870449|P2|Study 306B|Supine Hypertension|2
263500|NCT01176240|870450|P1|Study 306B|Supine Hypertension|1
263501|NCT01176240|870449|P2|Study 306B|Physician Decision|1
263502|NCT01176240|870450|P1|Study 306B|Physician Decision|2
263503|NCT01176240|870449|P2|Study 306B|Withdrawal by Subject|1
263504|NCT01176240|870450|P1|Study 306B|Withdrawal by Subject|4
263505|NCT01176240|870449|P2|Study 306B|Protocol Violation|3
263506|NCT01176240|870450|P1|Study 306B|Protocol Violation|2
263507|NCT01176240|870449|P2|Study 306B|Adverse Event|5
263508|NCT01176240|870450|P1|Study 306B|Adverse Event|10
263509|NCT01176240|870449|P2|Study 306B|Lack of Efficacy|3
263510|NCT01176240|870450|P1|Study 306B|Lack of Efficacy|5
263511|NCT01176240|870449|P2|Study 306A|Stop due to diverse problems|0
263512|NCT01176240|870450|P1|Study 306A|Stop due to diverse problems|1
263513|NCT01176240|870449|P2|Study 306A|Withdrawal by Subject|1
263514|NCT01176240|870450|P1|Study 306A|Withdrawal by Subject|0
263515|NCT01176240|870449|P2|Study 306A|Protocol Violation|1
263516|NCT01176240|870450|P1|Study 306A|Protocol Violation|0
263517|NCT01176240|870449|P2|Study 306A|Lack of Efficacy|1
263518|NCT01176240|870450|P1|Study 306A|Lack of Efficacy|2
263519|NCT01176058|870476|P2|Overall Study|Withdrawal by Subject|0
263520|NCT01176058|870477|P1|Overall Study|Withdrawal by Subject|1
263521|NCT01176058|870476|P2|Overall Study|Insufficient mycological response|1
263522|NCT01176058|870477|P1|Overall Study|Insufficient mycological response|0
263523|NCT01176058|870476|P2|Overall Study|Insufficient clinical response|2
263524|NCT01176058|870477|P1|Overall Study|Insufficient clinical response|2
263525|NCT01176058|870476|P2|Overall Study|Adverse Event|0
263526|NCT01176058|870477|P1|Overall Study|Adverse Event|1
263527|NCT01176032|870501|P2|Overall Study|Not available|0
263528|NCT01176032|870502|P1|Overall Study|Not available|1
263529|NCT01176032|870501|P2|Overall Study|Informed consent withdrawn|0
263530|NCT01176032|870502|P1|Overall Study|Informed consent withdrawn|3
263531|NCT01176032|870501|P2|Overall Study|Protocol Violation|0
263532|NCT01176032|870502|P1|Overall Study|Protocol Violation|1
263533|NCT01176032|870501|P2|Overall Study|Unsatisfactory therapeutic effect|1
263534|NCT01176032|870502|P1|Overall Study|Unsatisfactory therapeutic effect|0
263535|NCT01176032|870501|P2|Overall Study|Adverse Event|0
263536|NCT01176032|870502|P1|Overall Study|Adverse Event|1
263537|NCT01175824|870626|P2|Overall Study|Entry Criteria Not Met|4
263538|NCT01175824|870627|P1|Overall Study|Entry Criteria Not Met|6
263539|NCT01175824|870626|P2|Overall Study|Sponsor Decision|0
263540|NCT01175824|870627|P1|Overall Study|Sponsor Decision|1
263541|NCT01175824|870626|P2|Overall Study|Withdrawal by Subject|7
263542|NCT01175824|870627|P1|Overall Study|Withdrawal by Subject|3
263543|NCT01175824|870626|P2|Overall Study|Protocol Violation|5
263544|NCT01175824|870627|P1|Overall Study|Protocol Violation|2
263545|NCT01175824|870626|P2|Overall Study|Physician Decision|4
263546|NCT01175824|870627|P1|Overall Study|Physician Decision|0
263547|NCT01175824|870626|P2|Overall Study|Lost to Follow-up|1
263548|NCT01175824|870627|P1|Overall Study|Lost to Follow-up|0
263549|NCT01175824|870626|P2|Overall Study|Lack of Efficacy|0
263550|NCT01175824|870627|P1|Overall Study|Lack of Efficacy|2
263551|NCT01175824|870626|P2|Overall Study|Adverse Event|1
263552|NCT01175824|870627|P1|Overall Study|Adverse Event|2
263553|NCT01175811|870661|P2|Overall Study|Withdrawal by Subject|7
263554|NCT01175811|870662|P1|Overall Study|Withdrawal by Subject|6
263555|NCT01175811|870661|P2|Overall Study|Protocol Violation|2
263556|NCT01175811|870662|P1|Overall Study|Protocol Violation|1
263557|NCT01175811|870661|P2|Overall Study|Physician Decision|1
263558|NCT01175811|870662|P1|Overall Study|Physician Decision|1
263559|NCT01175811|870661|P2|Overall Study|Lost to Follow-up|2
263560|NCT01175811|870662|P1|Overall Study|Lost to Follow-up|3
263561|NCT01175811|870661|P2|Overall Study|Lack of Efficacy|0
263562|NCT01175811|870662|P1|Overall Study|Lack of Efficacy|1
263563|NCT01175811|870661|P2|Overall Study|Entry criteria not met|1
263564|NCT01175811|870662|P1|Overall Study|Entry criteria not met|3
263565|NCT01175811|870661|P2|Overall Study|Adverse Event|1
263566|NCT01175811|870662|P1|Overall Study|Adverse Event|1
263567|NCT01175707|870697|P2|Overall Study|Adverse Event|6
263568|NCT01175707|870698|P1|Overall Study|Adverse Event|4
263569|NCT01175668|870734|P2|Overall Study|Withdrawal by Subject|0
263570|NCT01175668|870735|P1|Overall Study|Withdrawal by Subject|2
263571|NCT01175590|870745|P2|Overall Study|Protocol Violation|1
263572|NCT01175590|870746|P1|Overall Study|Protocol Violation|0
263573|NCT01175590|870745|P2|Overall Study|Herpes Simplex Dermatitis|0
263574|NCT01175590|870746|P1|Overall Study|Herpes Simplex Dermatitis|1
263575|NCT01175590|870745|P2|Overall Study|Treated not as randomized|2
263576|NCT01175590|870746|P1|Overall Study|Treated not as randomized|3
263577|NCT01175590|870745|P2|Overall Study|Residual Bacterial Conjunctivitis|0
263578|NCT01175590|870746|P1|Overall Study|Residual Bacterial Conjunctivitis|1
263579|NCT01175590|870745|P2|Overall Study|Lack of Efficacy|1
263580|NCT01175590|870746|P1|Overall Study|Lack of Efficacy|1
263581|NCT01175590|870745|P2|Overall Study|Physician Decision|4
263582|NCT01175590|870746|P1|Overall Study|Physician Decision|1
263583|NCT01175590|870745|P2|Overall Study|Adverse Event|0
263584|NCT01175590|870746|P1|Overall Study|Adverse Event|4
263585|NCT01175590|870745|P2|Overall Study|Withdrawal by Subject|2
263586|NCT01175590|870746|P1|Overall Study|Withdrawal by Subject|0
263587|NCT01175590|870745|P2|Overall Study|Lost to Follow-up|0
263588|NCT01175590|870746|P1|Overall Study|Lost to Follow-up|1
263589|NCT01175473|870780|P2|Overall Study|Adverse Event|2
263590|NCT01175473|870781|P1|Overall Study|Adverse Event|2
263591|NCT01175382|870822|P3|Overall Study|Unable to tolerate study meds|1
263592|NCT01175382|870823|P2|Overall Study|Unable to tolerate study meds|1
263593|NCT01175382|870824|P1|Overall Study|Unable to tolerate study meds|0
263594|NCT01175382|870822|P3|Overall Study|Unwilling to follow protocol|0
263595|NCT01175382|870823|P2|Overall Study|Unwilling to follow protocol|1
263596|NCT01175382|870824|P1|Overall Study|Unwilling to follow protocol|0
263597|NCT01175382|870822|P3|Overall Study|Unable/unwilling to attend visits|2
263598|NCT01175382|870823|P2|Overall Study|Unable/unwilling to attend visits|1
263599|NCT01175382|870824|P1|Overall Study|Unable/unwilling to attend visits|3
263600|NCT01175382|870822|P3|Overall Study|No longer having problem|1
263601|NCT01175382|870823|P2|Overall Study|No longer having problem|0
263602|NCT01175382|870824|P1|Overall Study|No longer having problem|1
263603|NCT01175382|870822|P3|Overall Study|Withdrawal by Subject|1
263604|NCT01175382|870823|P2|Overall Study|Withdrawal by Subject|0
263605|NCT01175382|870824|P1|Overall Study|Withdrawal by Subject|0
263606|NCT01175382|870822|P3|Overall Study|Physician Decision|0
263607|NCT01175382|870823|P2|Overall Study|Physician Decision|1
263608|NCT01175382|870824|P1|Overall Study|Physician Decision|0
263609|NCT01175382|870822|P3|Overall Study|Lost to Follow-up|1
263610|NCT01175382|870823|P2|Overall Study|Lost to Follow-up|3
263611|NCT01175382|870824|P1|Overall Study|Lost to Follow-up|4
263612|NCT01175213|870944|P2|Safety Follow-up|Adverse Event|0
263613|NCT01175213|870945|P1|Safety Follow-up|Adverse Event|1
263614|NCT01175213|870944|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
263615|NCT01175213|870945|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
263616|NCT01175213|870944|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
263617|NCT01175213|870945|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
263618|NCT01175213|870944|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
263619|NCT01175213|870945|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
263620|NCT01175213|870944|P2|IGSC, 10%/rHuPH20|Death|0
263621|NCT01175213|870945|P1|IGSC, 10%/rHuPH20|Death|1
263622|NCT01175213|870944|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
263623|NCT01175213|870945|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
263624|NCT01175018|871008|P2|Overall Study|Adverse Event|1
263625|NCT01175018|871009|P1|Overall Study|Adverse Event|3
263626|NCT01174550|871098|P2|Overall Study|Withdrawal by Subject|289
263627|NCT01174550|871099|P1|Overall Study|Withdrawal by Subject|543
263628|NCT01174550|871098|P2|Overall Study|Lost to Follow-up|510
263629|NCT01174550|871099|P1|Overall Study|Lost to Follow-up|652
263630|NCT01174550|871098|P2|Overall Study|Death|74
263631|NCT01174550|871099|P1|Overall Study|Death|75
263632|NCT01174459|871127|P1|Overall Study|case report form (CRF) not collected|5
263633|NCT01174446|871132|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
263634|NCT01174446|871133|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
263635|NCT01174446|871134|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
263636|NCT01174446|871135|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
263637|NCT01174446|871132|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
263638|NCT01174446|871133|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
263639|NCT01174446|871134|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
263640|NCT01174446|871135|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
263641|NCT01174446|871132|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
263642|NCT01174446|871133|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
263643|NCT01174446|871134|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
263644|NCT01174446|871135|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
263645|NCT01174446|871132|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
263646|NCT01174446|871133|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
263647|NCT01174446|871134|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
263648|NCT01174446|871135|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
263649|NCT01174342|871322|P1|Overall Study|Conversion to cesarean section|4
263650|NCT01174264|871329|P3|Steady-state Pharmacokinetics|Not evaluable|2
263651|NCT01174264|871330|P2|Steady-state Pharmacokinetics|Not evaluable|0
263652|NCT01174264|871331|P1|Steady-state Pharmacokinetics|Not evaluable|6
263653|NCT01174264|871329|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
263654|NCT01174264|871330|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
263655|NCT01174264|871331|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
263656|NCT01174264|871329|P3|Single Dose Pharmacokinetics|Early progressive disease|1
263657|NCT01174264|871330|P2|Single Dose Pharmacokinetics|Early progressive disease|0
263658|NCT01174264|871331|P1|Single Dose Pharmacokinetics|Early progressive disease|1
263659|NCT01174186|871365|P2|Overall Study|Withdrawal by Subject|2
263660|NCT01174186|871366|P1|Overall Study|Withdrawal by Subject|0
263661|NCT01174186|871365|P2|Overall Study|Lost to Follow-up|1
263662|NCT01174186|871366|P1|Overall Study|Lost to Follow-up|0
263663|NCT01174173|871373|P1|Overall Study|drug-drug interaction|1
263664|NCT01174160|871383|P2|Overall Study|Withdrawal by Subject|0
263665|NCT01174160|871384|P1|Overall Study|Withdrawal by Subject|1
263666|NCT01174160|871383|P2|Overall Study|Protocol Violation|6
263667|NCT01174160|871384|P1|Overall Study|Protocol Violation|4
263668|NCT01174160|871383|P2|Overall Study|Physician Decision|0
263669|NCT01174160|871384|P1|Overall Study|Physician Decision|1
263670|NCT01174160|871383|P2|Overall Study|Lost to Follow-up|0
263671|NCT01174160|871384|P1|Overall Study|Lost to Follow-up|1
263672|NCT01174160|871383|P2|Overall Study|Adverse Event|0
263673|NCT01174160|871384|P1|Overall Study|Adverse Event|1
263674|NCT01174043|871390|P1|Overall Study|Withdrawal by Subject|2
263675|NCT01174043|871390|P1|Overall Study|Death|1
263676|NCT01174043|871390|P1|Overall Study|Adverse Event|3
263677|NCT01174043|871390|P1|Overall Study|Disease progression|5
263678|NCT01174004|871429|P2|Overall Study|Physician Decision|0
263679|NCT01174004|871430|P1|Overall Study|Physician Decision|1
263680|NCT01174004|871429|P2|Overall Study|Protocol Violation|1
263681|NCT01174004|871430|P1|Overall Study|Protocol Violation|0
263682|NCT01174004|871429|P2|Overall Study|At Discretion of Sponsor|2
263683|NCT01174004|871430|P1|Overall Study|At Discretion of Sponsor|2
263684|NCT01174004|871429|P2|Overall Study|Withdrawal by Subject|3
263685|NCT01174004|871430|P1|Overall Study|Withdrawal by Subject|2
263686|NCT01174004|871429|P2|Overall Study|Adverse Event|10
263687|NCT01174004|871430|P1|Overall Study|Adverse Event|2
263688|NCT01173718|871461|P1|Overall Study|Abandonment of study graft|27
263689|NCT01173718|871461|P1|Overall Study|Death|17
263690|NCT01173679|871470|P1|Overall Study|Death|1
263691|NCT01173653|871478|P2|Overall Study|Pts unwilling to provide follow-up|41
263692|NCT01173653|871479|P1|Overall Study|Pts unwilling to provide follow-up|53
263693|NCT01173523|871487|P2|Overall Study|Other|3
263694|NCT01173523|871488|P1|Overall Study|Other|2
263695|NCT01173523|871487|P2|Overall Study|Progressive Disease|8
263696|NCT01173523|871488|P1|Overall Study|Progressive Disease|10
263697|NCT01173523|871487|P2|Overall Study|Clinical Progression|1
263698|NCT01173523|871488|P1|Overall Study|Clinical Progression|1
263699|NCT01173471|871504|P4|Overall Study|Reason given as Other|0
263700|NCT01173471|871505|P3|Overall Study|Reason given as Other|1
263701|NCT01173471|871506|P2|Overall Study|Reason given as Other|0
263702|NCT01173471|871507|P1|Overall Study|Reason given as Other|0
263703|NCT01173471|871504|P4|Overall Study|Lost to Follow-up|0
263704|NCT01173471|871505|P3|Overall Study|Lost to Follow-up|1
263705|NCT01173471|871506|P2|Overall Study|Lost to Follow-up|0
263706|NCT01173471|871507|P1|Overall Study|Lost to Follow-up|0
263707|NCT01173471|871504|P4|Overall Study|Condition under investigation worsened|0
263708|NCT01173471|871505|P3|Overall Study|Condition under investigation worsened|0
263709|NCT01173471|871506|P2|Overall Study|Condition under investigation worsened|0
263710|NCT01173471|871507|P1|Overall Study|Condition under investigation worsened|2
263711|NCT01173471|871504|P4|Overall Study|Eligibility criteria not fulfilled|1
263712|NCT01173471|871505|P3|Overall Study|Eligibility criteria not fulfilled|1
263713|NCT01173471|871506|P2|Overall Study|Eligibility criteria not fulfilled|0
263714|NCT01173471|871507|P1|Overall Study|Eligibility criteria not fulfilled|0
263715|NCT01173120|871637|P1|Overall Study|Switch-Difficulty With Device|12
263716|NCT01173120|871637|P1|Overall Study|Switch-Participant Decision|12
263717|NCT01173120|871637|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
263718|NCT01173120|871637|P1|Overall Study|Participant Decision|2
263719|NCT01173120|871637|P1|Overall Study|Lost to Follow-up|1
263720|NCT01173120|871637|P1|Overall Study|Lack of Efficacy|2
263721|NCT01173055|871655|P2|Period 2 - Day 64 to 112|Adverse Event|1
263722|NCT01173055|871656|P1|Period 2 - Day 64 to 112|Adverse Event|0
263723|NCT01173055|871655|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
263724|NCT01173055|871656|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
263725|NCT01172938|871695|P7|Active Treatment Phase (Weeks 25 - 52)|Not specified|1
263726|NCT01172938|871696|P6|Active Treatment Phase (Weeks 25 - 52)|Not specified|1
263727|NCT01172938|871697|P5|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
263728|NCT01172938|871698|P4|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
263729|NCT01172938|871699|P3|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
263730|NCT01172938|871700|P2|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
263731|NCT01172938|871701|P1|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
263890|NCT01171976|872303|P3|Overall Study|Protocol Violation|1
263732|NCT01172938|871695|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
263733|NCT01172938|871696|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
263734|NCT01172938|871697|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
263735|NCT01172938|871698|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
263736|NCT01172938|871699|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
263737|NCT01172938|871700|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
263738|NCT01172938|871701|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
263739|NCT01172938|871695|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
263740|NCT01172938|871696|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|9
263741|NCT01172938|871697|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|2
263742|NCT01172938|871698|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|2
263743|NCT01172938|871699|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
263744|NCT01172938|871700|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|5
263745|NCT01172938|871701|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
263746|NCT01172938|871695|P7|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
263747|NCT01172938|871696|P6|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
263748|NCT01172938|871697|P5|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
263749|NCT01172938|871698|P4|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
263750|NCT01172938|871699|P3|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|1
263751|NCT01172938|871700|P2|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
263752|NCT01172938|871701|P1|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
263753|NCT01172938|871695|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
263754|NCT01172938|871696|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|3
263755|NCT01172938|871697|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
263756|NCT01172938|871698|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|3
263757|NCT01172938|871699|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
263758|NCT01172938|871700|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
263759|NCT01172938|871701|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
263760|NCT01172938|871695|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
263761|NCT01172938|871696|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
263762|NCT01172938|871697|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
263763|NCT01172938|871698|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
263764|NCT01172938|871699|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|5
263765|NCT01172938|871700|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
263766|NCT01172938|871701|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
263767|NCT01172938|871695|P7|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
263768|NCT01172938|871696|P6|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
263769|NCT01172938|871697|P5|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
263770|NCT01172938|871698|P4|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
263771|NCT01172938|871699|P3|Placebo-controlled Phase (Week 0 - 24)|Not specified|1
263772|NCT01172938|871700|P2|Placebo-controlled Phase (Week 0 - 24)|Not specified|2
263773|NCT01172938|871701|P1|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
263774|NCT01172938|871695|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
263775|NCT01172938|871696|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
263776|NCT01172938|871697|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
263777|NCT01172938|871698|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
263778|NCT01172938|871699|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
263779|NCT01172938|871700|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
263780|NCT01172938|871701|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
263781|NCT01172938|871695|P7|Placebo-controlled Phase (Week 0 - 24)|Death|0
263782|NCT01172938|871696|P6|Placebo-controlled Phase (Week 0 - 24)|Death|0
263783|NCT01172938|871697|P5|Placebo-controlled Phase (Week 0 - 24)|Death|0
263784|NCT01172938|871698|P4|Placebo-controlled Phase (Week 0 - 24)|Death|0
263785|NCT01172938|871699|P3|Placebo-controlled Phase (Week 0 - 24)|Death|0
263786|NCT01172938|871700|P2|Placebo-controlled Phase (Week 0 - 24)|Death|1
263787|NCT01172938|871701|P1|Placebo-controlled Phase (Week 0 - 24)|Death|0
263788|NCT01172938|871695|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
263789|NCT01172938|871696|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
263790|NCT01172938|871697|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
263791|NCT01172938|871698|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
263792|NCT01172938|871699|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
263793|NCT01172938|871700|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|5
263794|NCT01172938|871701|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|2
263795|NCT01172938|871695|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
263796|NCT01172938|871696|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
263797|NCT01172938|871697|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
263798|NCT01172938|871698|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
263799|NCT01172938|871699|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|2
263800|NCT01172938|871700|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
263801|NCT01172938|871701|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
263802|NCT01172938|871695|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
263803|NCT01172938|871696|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
263804|NCT01172938|871697|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
263805|NCT01172938|871698|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
263806|NCT01172938|871699|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|4
263807|NCT01172938|871700|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
263808|NCT01172938|871701|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|4
263809|NCT01172938|871695|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
263810|NCT01172938|871696|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
263811|NCT01172938|871697|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
263812|NCT01172938|871698|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
263813|NCT01172938|871699|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
263814|NCT01172938|871700|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
263815|NCT01172938|871701|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|11
263816|NCT01172873|871880|P2|Overall Study|Withdrawal by Subject|2
263817|NCT01172873|871881|P1|Overall Study|Withdrawal by Subject|3
263818|NCT01172847|871891|P1|Overall Study|Withdrawal by Subject|3
263819|NCT01172821|871920|P4|Overall Study|Other|3
263820|NCT01172821|871921|P3|Overall Study|Other|5
263821|NCT01172821|871922|P2|Overall Study|Other|4
263822|NCT01172821|871923|P1|Overall Study|Other|3
263823|NCT01172821|871920|P4|Overall Study|Withdrawal by Subject|3
263824|NCT01172821|871921|P3|Overall Study|Withdrawal by Subject|3
263825|NCT01172821|871922|P2|Overall Study|Withdrawal by Subject|3
263826|NCT01172821|871923|P1|Overall Study|Withdrawal by Subject|2
263827|NCT01172821|871920|P4|Overall Study|Lost to Follow-up|2
263828|NCT01172821|871921|P3|Overall Study|Lost to Follow-up|2
263829|NCT01172821|871922|P2|Overall Study|Lost to Follow-up|1
263830|NCT01172821|871923|P1|Overall Study|Lost to Follow-up|4
263831|NCT01172821|871920|P4|Overall Study|Protocol Violation|2
263832|NCT01172821|871921|P3|Overall Study|Protocol Violation|1
263833|NCT01172821|871922|P2|Overall Study|Protocol Violation|2
263834|NCT01172821|871923|P1|Overall Study|Protocol Violation|0
263835|NCT01172821|871920|P4|Overall Study|Adverse Event|7
263836|NCT01172821|871921|P3|Overall Study|Adverse Event|2
263837|NCT01172821|871922|P2|Overall Study|Adverse Event|2
263838|NCT01172821|871923|P1|Overall Study|Adverse Event|5
263839|NCT01172808|872013|P4|Overall Study|Other|7
263840|NCT01172808|872014|P3|Overall Study|Other|9
263841|NCT01172808|872015|P2|Overall Study|Other|5
263842|NCT01172808|872016|P1|Overall Study|Other|6
263843|NCT01172808|872013|P4|Overall Study|Withdrawal by Subject|2
263844|NCT01172808|872014|P3|Overall Study|Withdrawal by Subject|3
263845|NCT01172808|872015|P2|Overall Study|Withdrawal by Subject|1
263846|NCT01172808|872016|P1|Overall Study|Withdrawal by Subject|4
263847|NCT01172808|872013|P4|Overall Study|Lost to Follow-up|3
263848|NCT01172808|872014|P3|Overall Study|Lost to Follow-up|1
263849|NCT01172808|872015|P2|Overall Study|Lost to Follow-up|1
263850|NCT01172808|872016|P1|Overall Study|Lost to Follow-up|0
263851|NCT01172808|872013|P4|Overall Study|Protocol Violation|0
263852|NCT01172808|872014|P3|Overall Study|Protocol Violation|2
263853|NCT01172808|872015|P2|Overall Study|Protocol Violation|2
263854|NCT01172808|872016|P1|Overall Study|Protocol Violation|2
263855|NCT01172808|872013|P4|Overall Study|Lack of Efficacy|0
263856|NCT01172808|872014|P3|Overall Study|Lack of Efficacy|0
263857|NCT01172808|872015|P2|Overall Study|Lack of Efficacy|0
263858|NCT01172808|872016|P1|Overall Study|Lack of Efficacy|1
263859|NCT01172808|872013|P4|Overall Study|Adverse Event|3
263860|NCT01172808|872014|P3|Overall Study|Adverse Event|8
263861|NCT01172808|872015|P2|Overall Study|Adverse Event|4
263862|NCT01172808|872016|P1|Overall Study|Adverse Event|8
263863|NCT01172535|872135|P1|Overall Study|Unwilling to adhere to study requirement|1
263864|NCT01172535|872135|P1|Overall Study|Ineligible at study entry|1
263865|NCT01172535|872135|P1|Overall Study|Lost to Follow-up|1
263866|NCT01172535|872135|P1|Overall Study|Withdrawal by Subject|2
263867|NCT01172535|872135|P1|Overall Study|Death|3
263868|NCT01172288|872180|P2|Overall Study|Protocol Violation|1
263869|NCT01172288|872181|P1|Overall Study|Protocol Violation|0
263870|NCT01172288|872180|P2|Overall Study|Adverse Event|0
263871|NCT01172288|872181|P1|Overall Study|Adverse Event|1
263872|NCT01171989|872227|P3|Overall Study|Lost to Follow-up|1
263873|NCT01171989|872228|P2|Overall Study|Lost to Follow-up|0
263874|NCT01171989|872229|P1|Overall Study|Lost to Follow-up|0
263875|NCT01171976|872303|P3|Overall Study|Adverse Event|5
263876|NCT01171976|872304|P2|Overall Study|Adverse Event|2
263877|NCT01171976|872305|P1|Overall Study|Adverse Event|6
263878|NCT01171976|872303|P3|Overall Study|Abnormal test result|0
263879|NCT01171976|872304|P2|Overall Study|Abnormal test result|0
263880|NCT01171976|872305|P1|Overall Study|Abnormal test result|1
263881|NCT01171976|872303|P3|Overall Study|Withdrawal by Subject|6
263882|NCT01171976|872304|P2|Overall Study|Withdrawal by Subject|5
263883|NCT01171976|872305|P1|Overall Study|Withdrawal by Subject|1
263884|NCT01171976|872303|P3|Overall Study|Lost to Follow-up|2
263885|NCT01171976|872304|P2|Overall Study|Lost to Follow-up|0
263886|NCT01171976|872305|P1|Overall Study|Lost to Follow-up|4
263887|NCT01171976|872303|P3|Overall Study|Death|1
263888|NCT01171976|872304|P2|Overall Study|Death|4
263889|NCT01171976|872305|P1|Overall Study|Death|2
263891|NCT01171976|872304|P2|Overall Study|Protocol Violation|0
263892|NCT01171976|872305|P1|Overall Study|Protocol Violation|0
263893|NCT01171963|872342|P2|Overall Study|Withdrawal by Subject|129
263894|NCT01171963|872343|P1|Overall Study|Withdrawal by Subject|114
263895|NCT01171963|872342|P2|Overall Study|Other - diarrhoea|0
263896|NCT01171963|872343|P1|Overall Study|Other - diarrhoea|1
263897|NCT01171963|872342|P2|Overall Study|Lost to Follow-up|24
263898|NCT01171963|872343|P1|Overall Study|Lost to Follow-up|23
263899|NCT01171963|872342|P2|Overall Study|Adverse Event|15
263900|NCT01171963|872343|P1|Overall Study|Adverse Event|10
263901|NCT01171820|872410|P2|Overall Study|1-Year Missed Visit|1
263902|NCT01171820|872411|P1|Overall Study|1-Year Missed Visit|1
263903|NCT01171820|872410|P2|Overall Study|Physician Decision|1
263904|NCT01171820|872411|P1|Overall Study|Physician Decision|0
263905|NCT01171820|872410|P2|Overall Study|Withdrawal by Subject|0
263906|NCT01171820|872411|P1|Overall Study|Withdrawal by Subject|2
263907|NCT01171820|872410|P2|Overall Study|Lost to Follow-up|1
263908|NCT01171820|872411|P1|Overall Study|Lost to Follow-up|0
263909|NCT01171820|872410|P2|Overall Study|Death|3
263910|NCT01171820|872411|P1|Overall Study|Death|3
263911|NCT01171677|872489|P2|Overall Study|completed <70% IntenSati classes|0
263912|NCT01171677|872490|P1|Overall Study|completed <70% IntenSati classes|5
263913|NCT01171677|872489|P2|Overall Study|Adverse Event|0
263914|NCT01171677|872490|P1|Overall Study|Adverse Event|1
263915|NCT01171677|872489|P2|Overall Study|Withdrawal by Subject|3
263916|NCT01171677|872490|P1|Overall Study|Withdrawal by Subject|0
263917|NCT01171612|872522|P1|Overall Study|Lost to Follow-up|51
263918|NCT01171534|872532|P2|Overall Study|screen failure|1
263919|NCT01171534|872533|P1|Overall Study|screen failure|0
263920|NCT01171534|872532|P2|Overall Study|Lost to Follow-up|2
263921|NCT01171534|872533|P1|Overall Study|Lost to Follow-up|0
263922|NCT01171521|872541|P1|Overall Study|screen failure|1
263923|NCT01171521|872541|P1|Overall Study|Lost to Follow-up|5
263924|NCT01171183|872548|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
263925|NCT01171183|872549|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
263926|NCT01171183|872548|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
263927|NCT01171183|872549|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
263928|NCT01171183|872548|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
263929|NCT01171183|872549|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
263930|NCT01171183|872548|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
263931|NCT01171183|872549|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
263932|NCT01171183|872548|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
263933|NCT01171183|872549|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
263934|NCT01171183|872548|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
263935|NCT01171183|872549|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
263936|NCT01170962|872570|P3|Follow up Period|Others|3
263937|NCT01170962|872571|P2|Follow up Period|Others|7
263938|NCT01170962|872572|P1|Follow up Period|Others|10
263939|NCT01170962|872570|P3|Follow up Period|Death|0
263940|NCT01170962|872571|P2|Follow up Period|Death|2
263941|NCT01170962|872572|P1|Follow up Period|Death|2
263942|NCT01170962|872570|P3|Follow up Period|Lost to Follow-up|1
263943|NCT01170962|872571|P2|Follow up Period|Lost to Follow-up|8
263944|NCT01170962|872572|P1|Follow up Period|Lost to Follow-up|13
263945|NCT01170962|872570|P3|Follow up Period|Withdrawal by Subject|2
263946|NCT01170962|872571|P2|Follow up Period|Withdrawal by Subject|10
263947|NCT01170962|872572|P1|Follow up Period|Withdrawal by Subject|14
263948|NCT01170962|872570|P3|Treatment Period|Completed 24 Week treatment period only|0
263949|NCT01170962|872571|P2|Treatment Period|Completed 24 Week treatment period only|2
263950|NCT01170962|872572|P1|Treatment Period|Completed 24 Week treatment period only|10
263951|NCT01170962|872570|P3|Treatment Period|Request to discontinue treatment|1
263952|NCT01170962|872571|P2|Treatment Period|Request to discontinue treatment|3
263953|NCT01170962|872572|P1|Treatment Period|Request to discontinue treatment|7
263954|NCT01170962|872570|P3|Treatment Period|Participant no longer meets criteria|0
263955|NCT01170962|872571|P2|Treatment Period|Participant no longer meets criteria|1
263956|NCT01170962|872572|P1|Treatment Period|Participant no longer meets criteria|0
263957|NCT01170962|872570|P3|Treatment Period|Lost to Follow-up|1
263958|NCT01170962|872571|P2|Treatment Period|Lost to Follow-up|1
263959|NCT01170962|872572|P1|Treatment Period|Lost to Follow-up|1
263960|NCT01170962|872570|P3|Treatment Period|Withdrawal by Subject|0
263961|NCT01170962|872571|P2|Treatment Period|Withdrawal by Subject|1
263962|NCT01170962|872572|P1|Treatment Period|Withdrawal by Subject|2
263963|NCT01170962|872570|P3|Treatment Period|Adverse Event|3
263964|NCT01170962|872571|P2|Treatment Period|Adverse Event|12
263965|NCT01170962|872572|P1|Treatment Period|Adverse Event|11
263966|NCT01170962|872570|P3|Treatment Period|Lack of Efficacy|7
263967|NCT01170962|872571|P2|Treatment Period|Lack of Efficacy|91
263968|NCT01170962|872572|P1|Treatment Period|Lack of Efficacy|96
263969|NCT01170663|872645|P2|Overall Study|Withdrawal of consent without follow-up|11
263970|NCT01170663|872646|P1|Overall Study|Withdrawal of consent without follow-up|8
263971|NCT01170663|872645|P2|Overall Study|Lost to Follow-up|9
263972|NCT01170663|872646|P1|Overall Study|Lost to Follow-up|3
263973|NCT01170663|872645|P2|Overall Study|Alive on treatment at data cut-off date|7
263974|NCT01170663|872646|P1|Overall Study|Alive on treatment at data cut-off date|13
263975|NCT01170598|872674|P1|Overall Study|Refused|1
263976|NCT01170598|872674|P1|Overall Study|Lost to Follow-up|1
263977|NCT01170598|872674|P1|Overall Study|Death|3
263978|NCT01170598|872674|P1|Overall Study|Withdrawal by Subject|1
263979|NCT01170273|872737|P2|Overall Study|Adverse Event|1
263980|NCT01170273|872738|P1|Overall Study|Adverse Event|0
263981|NCT01170273|872737|P2|Overall Study|Death|0
263982|NCT01170273|872738|P1|Overall Study|Death|1
263983|NCT01170273|872737|P2|Overall Study|Protocol Violation|0
263984|NCT01170273|872738|P1|Overall Study|Protocol Violation|1
263985|NCT01170273|872737|P2|Overall Study|Lost to Follow-up|8
263986|NCT01170273|872738|P1|Overall Study|Lost to Follow-up|6
263987|NCT01170221|872746|P2|Overall Study|Randomized but not treated|0
263988|NCT01170221|872747|P1|Overall Study|Randomized but not treated|1
263989|NCT01170221|872746|P2|Overall Study|Subject completed only screening and LFU|0
263990|NCT01170221|872747|P1|Overall Study|Subject completed only screening and LFU|1
263991|NCT01170221|872746|P2|Overall Study|Withdrawal by Subject|7
263992|NCT01170221|872747|P1|Overall Study|Withdrawal by Subject|9
263993|NCT01170221|872746|P2|Overall Study|Lost to Follow-up|21
263994|NCT01170221|872747|P1|Overall Study|Lost to Follow-up|22
263995|NCT01170208|872770|P3|Overall Study|Protocol Violation|1
263996|NCT01170208|872771|P2|Overall Study|Protocol Violation|0
263997|NCT01170208|872772|P1|Overall Study|Protocol Violation|1
263998|NCT01170208|872770|P3|Overall Study|Withdrawal by Subject|1
263999|NCT01170208|872771|P2|Overall Study|Withdrawal by Subject|0
264000|NCT01170208|872772|P1|Overall Study|Withdrawal by Subject|5
264001|NCT01170091|872780|P1|Overall Study|Treatment duration is less than 4 weeks|21
264002|NCT01170091|872780|P1|Overall Study|Missing efficacy evaluation|3
264003|NCT01170039|872789|P2|Overall Study|Lack of funding, drug not available|3
264004|NCT01170039|872790|P1|Overall Study|Lack of funding, drug not available|3
264005|NCT01170039|872789|P2|Overall Study|Withdrawal by Subject|3
264006|NCT01170039|872790|P1|Overall Study|Withdrawal by Subject|5
264007|NCT01169987|872802|P1|Overall Study|Not Specified|4
264008|NCT01169987|872802|P1|Overall Study|Lost to Follow-up|24
264009|NCT01169987|872802|P1|Overall Study|Withdrawal by Subject|3
264010|NCT01169779|872868|P2|Overall Study|Familial and personal reasons|3
264011|NCT01169779|872869|P1|Overall Study|Familial and personal reasons|3
264012|NCT01169779|872868|P2|Overall Study|Withdrawal by Subject|2
264013|NCT01169779|872869|P1|Overall Study|Withdrawal by Subject|3
264014|NCT01169779|872868|P2|Overall Study|Protocol Violation|1
264015|NCT01169779|872869|P1|Overall Study|Protocol Violation|1
264016|NCT01169779|872868|P2|Overall Study|Lack of Efficacy|0
264017|NCT01169779|872869|P1|Overall Study|Lack of Efficacy|1
264018|NCT01169779|872868|P2|Overall Study|Adverse Event|11
264019|NCT01169779|872869|P1|Overall Study|Adverse Event|3
264020|NCT01169701|872904|P2|Overall Study|Sponsor decision|1
264021|NCT01169701|872905|P1|Overall Study|Sponsor decision|0
264022|NCT01169701|872904|P2|Overall Study|Serious adverse event|1
264023|NCT01169701|872905|P1|Overall Study|Serious adverse event|0
264024|NCT01169701|872904|P2|Overall Study|Administrative problems|1
264025|NCT01169701|872905|P1|Overall Study|Administrative problems|0
264026|NCT01169701|872904|P2|Overall Study|Death|1
264027|NCT01169701|872905|P1|Overall Study|Death|0
264028|NCT01169701|872904|P2|Overall Study|Exclusion criteria|0
264029|NCT01169701|872905|P1|Overall Study|Exclusion criteria|2
264030|NCT01169701|872904|P2|Overall Study|Adverse Event|2
264031|NCT01169701|872905|P1|Overall Study|Adverse Event|1
264032|NCT01169701|872904|P2|Overall Study|Withdrawal by Subject|3
264033|NCT01169701|872905|P1|Overall Study|Withdrawal by Subject|1
264034|NCT01169701|872904|P2|Overall Study|Lost to Follow-up|1
264035|NCT01169701|872905|P1|Overall Study|Lost to Follow-up|1
264036|NCT01169675|872942|P5|Overall Study|Other Reason Not Defined Above|1
264037|NCT01169675|872943|P4|Overall Study|Other Reason Not Defined Above|1
264038|NCT01169675|872944|P3|Overall Study|Other Reason Not Defined Above|0
264039|NCT01169675|872945|P2|Overall Study|Other Reason Not Defined Above|0
264040|NCT01169675|872946|P1|Overall Study|Other Reason Not Defined Above|0
264041|NCT01169675|872942|P5|Overall Study|Withdrawal by Subject|2
264042|NCT01169675|872943|P4|Overall Study|Withdrawal by Subject|1
264043|NCT01169675|872944|P3|Overall Study|Withdrawal by Subject|0
264044|NCT01169675|872945|P2|Overall Study|Withdrawal by Subject|0
264045|NCT01169675|872946|P1|Overall Study|Withdrawal by Subject|1
264046|NCT01169675|872942|P5|Overall Study|Adverse Event|0
264047|NCT01169675|872943|P4|Overall Study|Adverse Event|0
264048|NCT01169675|872944|P3|Overall Study|Adverse Event|2
264049|NCT01169675|872945|P2|Overall Study|Adverse Event|1
264050|NCT01169675|872946|P1|Overall Study|Adverse Event|5
264051|NCT01169675|872942|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
264052|NCT01169675|872943|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
264053|NCT01169675|872944|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
264054|NCT01169675|872945|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
264055|NCT01169675|872946|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
264056|NCT01169675|872942|P5|Overall Study|Progressive disease|1
264057|NCT01169675|872943|P4|Overall Study|Progressive disease|15
264058|NCT01169675|872944|P3|Overall Study|Progressive disease|5
264059|NCT01169675|872945|P2|Overall Study|Progressive disease|2
264060|NCT01169675|872946|P1|Overall Study|Progressive disease|13
264061|NCT01169649|872983|P1|Overall Study|Patient Not Treated|3
264062|NCT01169558|872995|P1|Overall Study|Partial response|2
264063|NCT01169558|872995|P1|Overall Study|Protocol Violation|2
264064|NCT01169558|872995|P1|Overall Study|Non-compliance|2
264065|NCT01169558|872995|P1|Overall Study|Need for Surgery|4
264066|NCT01169558|872995|P1|Overall Study|Lost to Follow-up|4
264067|NCT01169558|872995|P1|Overall Study|Stable Disease|4
264068|NCT01169558|872995|P1|Overall Study|Medical Decision|7
264069|NCT01169558|872995|P1|Overall Study|Withdrawal of Consent|8
264070|NCT01169558|872995|P1|Overall Study|Adverse Event|25
264071|NCT01169558|872995|P1|Overall Study|Disease progression|98
264072|NCT01169493|873020|P6|Period 3 (6 Months)|Physician Decision|0
264073|NCT01169493|873021|P5|Period 3 (6 Months)|Physician Decision|0
264074|NCT01169493|873022|P4|Period 3 (6 Months)|Physician Decision|0
264075|NCT01169493|873023|P3|Period 3 (6 Months)|Physician Decision|1
264076|NCT01169493|873024|P2|Period 3 (6 Months)|Physician Decision|1
264077|NCT01169493|873025|P1|Period 3 (6 Months)|Physician Decision|0
264078|NCT01169493|873020|P6|Period 3 (6 Months)|Adverse Event|0
264079|NCT01169493|873021|P5|Period 3 (6 Months)|Adverse Event|0
264080|NCT01169493|873022|P4|Period 3 (6 Months)|Adverse Event|0
264081|NCT01169493|873023|P3|Period 3 (6 Months)|Adverse Event|0
264082|NCT01169493|873024|P2|Period 3 (6 Months)|Adverse Event|1
264083|NCT01169493|873025|P1|Period 3 (6 Months)|Adverse Event|0
264084|NCT01169493|873020|P6|Period 1 (6 Months)|Withdrawal by Subject|3
264085|NCT01169493|873021|P5|Period 1 (6 Months)|Withdrawal by Subject|0
264086|NCT01169493|873022|P4|Period 1 (6 Months)|Withdrawal by Subject|0
264087|NCT01169493|873023|P3|Period 1 (6 Months)|Withdrawal by Subject|2
264088|NCT01169493|873024|P2|Period 1 (6 Months)|Withdrawal by Subject|1
264089|NCT01169493|873025|P1|Period 1 (6 Months)|Withdrawal by Subject|0
264090|NCT01169103|873085|P2|Overall Study|Withdrawal by Subject|1
264091|NCT01169103|873086|P1|Overall Study|Withdrawal by Subject|3
264092|NCT01169103|873085|P2|Overall Study|Lost to Follow-up|3
264093|NCT01169103|873086|P1|Overall Study|Lost to Follow-up|3
264094|NCT01169038|873113|P1|Overall Study|Required antibiotic administration|1
264095|NCT01169038|873113|P1|Overall Study|Adverse Event|5
264096|NCT01169038|873113|P1|Overall Study|Death|1
264097|NCT01168999|873121|P4|Overall Study|Lost to Follow-up|0
264098|NCT01168999|873122|P3|Overall Study|Lost to Follow-up|0
264099|NCT01168999|873123|P2|Overall Study|Lost to Follow-up|1
264100|NCT01168999|873124|P1|Overall Study|Lost to Follow-up|2
264101|NCT01168973|873190|P2|Overall Study|Withdrawal of consent without follow-up|14
264102|NCT01168973|873191|P1|Overall Study|Withdrawal of consent without follow-up|13
264103|NCT01168973|873190|P2|Overall Study|Lost to Follow-up|9
264104|NCT01168973|873191|P1|Overall Study|Lost to Follow-up|10
264105|NCT01168973|873190|P2|Overall Study|Alive on treatment after data-cutoff|10
264106|NCT01168973|873191|P1|Overall Study|Alive on treatment after data-cutoff|11
264107|NCT01168856|873247|P2|Overall Study|Protocol Violation|6
264108|NCT01168856|873248|P1|Overall Study|Protocol Violation|4
264109|NCT01168856|873247|P2|Overall Study|Unspecified|291
264110|NCT01168856|873248|P1|Overall Study|Unspecified|1
264111|NCT01168856|873247|P2|Overall Study|Death|2
264112|NCT01168856|873248|P1|Overall Study|Death|0
264113|NCT01168856|873247|P2|Overall Study|Participant received anti-HCV treatment|0
264114|NCT01168856|873248|P1|Overall Study|Participant received anti-HCV treatment|1
264115|NCT01168856|873247|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
264116|NCT01168856|873248|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
264117|NCT01168856|873247|P2|Overall Study|Physician Decision|1
264118|NCT01168856|873248|P1|Overall Study|Physician Decision|2
264119|NCT01168856|873247|P2|Overall Study|Withdrawal by Subject|8
264120|NCT01168856|873248|P1|Overall Study|Withdrawal by Subject|6
264121|NCT01168856|873247|P2|Overall Study|Lost to Follow-up|34
264122|NCT01168856|873248|P1|Overall Study|Lost to Follow-up|4
264123|NCT01168596|873346|P2|Overall Study|Withdrawal by Subject|1
264124|NCT01168596|873347|P1|Overall Study|Withdrawal by Subject|3
264125|NCT01168427|873391|P1|Overall Study|Patient exited prior to implant|1
264126|NCT01168349|873396|P1|Overall Study|Protocol Violation|76
264127|NCT01168349|873396|P1|Overall Study|Unspecified|22
264128|NCT01168349|873396|P1|Overall Study|Kidney transplantation|3
264129|NCT01168349|873396|P1|Overall Study|Withdrawal by Subject|9
264130|NCT01168349|873396|P1|Overall Study|Lost to Follow-up|34
264131|NCT01168349|873396|P1|Overall Study|Death|157
264132|NCT01168232|873502|P1|Overall Study|Ineligible-Inadequate pathology|1
264133|NCT01168232|873502|P1|Overall Study|Ineligible- Wrong cell type|6
264134|NCT01168232|873502|P1|Overall Study|Ineligible-Second primary cancer site|1
264135|NCT01167881|873526|P2|Overall Study|Other not defined above|55
264136|NCT01167881|873527|P1|Overall Study|Other not defined above|31
264137|NCT01167881|873526|P2|Overall Study|Not treated|0
264138|NCT01167881|873527|P1|Overall Study|Not treated|4
264139|NCT01167881|873526|P2|Overall Study|Patient refusal to cont., not due to AE|40
264140|NCT01167881|873527|P1|Overall Study|Patient refusal to cont., not due to AE|45
264141|NCT01167881|873526|P2|Overall Study|Lost to Follow-up|20
264142|NCT01167881|873527|P1|Overall Study|Lost to Follow-up|19
264143|NCT01167881|873526|P2|Overall Study|Non compliant with protocol|18
264144|NCT01167881|873527|P1|Overall Study|Non compliant with protocol|9
264145|NCT01167881|873526|P2|Overall Study|Lack of Efficacy|7
264146|NCT01167881|873527|P1|Overall Study|Lack of Efficacy|4
264147|NCT01167881|873526|P2|Overall Study|Adverse Event|51
264148|NCT01167881|873527|P1|Overall Study|Adverse Event|47
264149|NCT01167582|873575|P2|Overall Study|Lost to Follow-up|1
264150|NCT01167582|873576|P1|Overall Study|Lost to Follow-up|0
264151|NCT01167426|873598|P1|Overall Study|Sponsor Decision|1
264152|NCT01167426|873598|P1|Overall Study|Withdrawal by Subject|2
264153|NCT01167426|873598|P1|Overall Study|Protocol Violation|1
264154|NCT01167426|873598|P1|Overall Study|Lost to Follow-up|6
264155|NCT01167257|873606|P2|Overall Study|Withdrew consent|1
264156|NCT01167257|873607|P1|Overall Study|Withdrew consent|1
264157|NCT01167257|873606|P2|Overall Study|Lost to Follow-up|2
264158|NCT01167257|873607|P1|Overall Study|Lost to Follow-up|2
264159|NCT01167192|873629|P1|Overall Study|Insurance denial|1
264160|NCT01167192|873629|P1|Overall Study|Withdrawal by Subject|1
264161|NCT01167192|873629|P1|Overall Study|Death|1
264162|NCT01167192|873629|P1|Overall Study|Adverse Event|1
264163|NCT01167153|873646|P2|Overall Study|Subject initiation withdrawal, Other|8
264164|NCT01167153|873647|P1|Overall Study|Subject initiation withdrawal, Other|5
264165|NCT01167153|873646|P2|Overall Study|Withdrawal consent|1
264166|NCT01167153|873647|P1|Overall Study|Withdrawal consent|1
264167|NCT01167153|873646|P2|Overall Study|Investigator initiation withdrawal,Other|1
264168|NCT01167153|873647|P1|Overall Study|Investigator initiation withdrawal,Other|1
264169|NCT01167153|873646|P2|Overall Study|Non-compliance to concomitant medication|2
264170|NCT01167153|873647|P1|Overall Study|Non-compliance to concomitant medication|0
264171|NCT01167153|873646|P2|Overall Study|Lost to Follow-up|9
264172|NCT01167153|873647|P1|Overall Study|Lost to Follow-up|7
264173|NCT01167153|873646|P2|Overall Study|Hypotension|0
264174|NCT01167153|873647|P1|Overall Study|Hypotension|1
264175|NCT01167153|873646|P2|Overall Study|AE including clinical laboratory AE|8
264176|NCT01167153|873647|P1|Overall Study|AE including clinical laboratory AE|2
264177|NCT01167153|873646|P2|Overall Study|Non-effective therapy|4
264178|NCT01167153|873647|P1|Overall Study|Non-effective therapy|1
264179|NCT01167140|873665|P1|Overall Study|Withdrawal by Subject|1
264180|NCT01167023|873673|P3|Overall Study|Withdrawal by Subject|1
264181|NCT01167023|873674|P2|Overall Study|Withdrawal by Subject|0
264182|NCT01167023|873675|P1|Overall Study|Withdrawal by Subject|0
264183|NCT01167023|873673|P3|Overall Study|Sponsor Decision|0
264184|NCT01167023|873674|P2|Overall Study|Sponsor Decision|1
264185|NCT01167023|873675|P1|Overall Study|Sponsor Decision|0
264186|NCT01167023|873673|P3|Overall Study|Screen Failure|0
264187|NCT01167023|873674|P2|Overall Study|Screen Failure|1
264188|NCT01167023|873675|P1|Overall Study|Screen Failure|0
264189|NCT01167023|873673|P3|Overall Study|Lost to Follow-up|1
264190|NCT01167023|873674|P2|Overall Study|Lost to Follow-up|1
264191|NCT01167023|873675|P1|Overall Study|Lost to Follow-up|0
264192|NCT01166958|873715|P2|Overall Study|Withdrawal by Subject|0
264193|NCT01166958|873716|P1|Overall Study|Withdrawal by Subject|1
264194|NCT01166763|873730|P1|Overall Study|Withdrawal by Subject|3
264195|NCT01166750|873738|P2|Overall Study|Lost to Follow-up|0
264196|NCT01166750|873739|P1|Overall Study|Lost to Follow-up|1
264197|NCT01166659|873756|P1|Overall Study|Study Closed at Site|1
264198|NCT01166659|873756|P1|Overall Study|Lost to Follow-up|1
264199|NCT01166659|873756|P1|Overall Study|Death|1
264200|NCT01166659|873756|P1|Overall Study|Investigator Decision|2
264201|NCT01166659|873756|P1|Overall Study|Subject Decision|8
264202|NCT01166646|873765|P2|Overall Study|Adverse Event|0
264203|NCT01166646|873766|P1|Overall Study|Adverse Event|1
264204|NCT01166646|873765|P2|Overall Study|Protocol Violation|1
264205|NCT01166646|873766|P1|Overall Study|Protocol Violation|0
264206|NCT01166282|873784|P3|Open-label Period|Irregular Compliance|1
264207|NCT01166282|873785|P2|Open-label Period|Irregular Compliance|0
264208|NCT01166282|873786|P1|Open-label Period|Irregular Compliance|0
264209|NCT01166282|873784|P3|Open-label Period|Remission|4
264210|NCT01166282|873785|P2|Open-label Period|Remission|0
264211|NCT01166282|873786|P1|Open-label Period|Remission|0
264212|NCT01166282|873784|P3|Open-label Period|Lack of Efficacy|2
264213|NCT01166282|873785|P2|Open-label Period|Lack of Efficacy|0
264214|NCT01166282|873786|P1|Open-label Period|Lack of Efficacy|0
264215|NCT01166282|873784|P3|Open-label Period|Withdrawal by Subject|4
264216|NCT01166282|873785|P2|Open-label Period|Withdrawal by Subject|0
264217|NCT01166282|873786|P1|Open-label Period|Withdrawal by Subject|0
264218|NCT01166282|873784|P3|Open-label Period|Adverse Event|6
264219|NCT01166282|873785|P2|Open-label Period|Adverse Event|0
264220|NCT01166282|873786|P1|Open-label Period|Adverse Event|0
264221|NCT01166178|873825|P2|Overall Study|Study was terminated|8
264222|NCT01166178|873826|P1|Overall Study|Study was terminated|20
264223|NCT01166178|873825|P2|Overall Study|Withdrawal by Subject|0
264224|NCT01166178|873826|P1|Overall Study|Withdrawal by Subject|1
264225|NCT01165996|873859|P1|Overall Study|Physician Decision|1
264226|NCT01165996|873859|P1|Overall Study|Death|1
264227|NCT01165684|873926|P2|Overall Study|Unclassified|22
264228|NCT01165684|873927|P1|Overall Study|Unclassified|16
264229|NCT01165684|873926|P2|Overall Study|Withdrawal Criteria|13
264230|NCT01165684|873927|P1|Overall Study|Withdrawal Criteria|2
264231|NCT01165684|873926|P2|Overall Study|Protocol Violation|15
264232|NCT01165684|873927|P1|Overall Study|Protocol Violation|7
264233|NCT01165684|873926|P2|Overall Study|Lack of Efficacy|1
264234|NCT01165684|873927|P1|Overall Study|Lack of Efficacy|2
264235|NCT01165684|873926|P2|Overall Study|Adverse Event|1
264236|NCT01165684|873927|P1|Overall Study|Adverse Event|1
264237|NCT01165554|873961|P1|Overall Study|Withdrawal by Subject|23
264238|NCT01165424|873984|P1|Overall Study|Participant moved (relocated)|1
264239|NCT01165424|873984|P1|Overall Study|Did not meet entry criteria|1
264240|NCT01165424|873984|P1|Overall Study|Laboratory adverse experiences|1
264241|NCT01165424|873984|P1|Overall Study|Clinical adverse experiences|1
264242|NCT01165320|873991|P3|Overall Study|Reason unknown|0
264243|NCT01165320|873992|P2|Overall Study|Reason unknown|1
264244|NCT01165320|873993|P1|Overall Study|Reason unknown|0
264245|NCT01165320|873991|P3|Overall Study|Lack of Efficacy|0
264246|NCT01165320|873992|P2|Overall Study|Lack of Efficacy|2
264247|NCT01165320|873993|P1|Overall Study|Lack of Efficacy|0
264248|NCT01165320|873991|P3|Overall Study|Laboratory adverse experience|0
264249|NCT01165320|873992|P2|Overall Study|Laboratory adverse experience|0
264250|NCT01165320|873993|P1|Overall Study|Laboratory adverse experience|1
264251|NCT01165320|873991|P3|Overall Study|Clinical adverse experience|0
264252|NCT01165320|873992|P2|Overall Study|Clinical adverse experience|1
264253|NCT01165320|873993|P1|Overall Study|Clinical adverse experience|2
264254|NCT01165307|874003|P2|Overall Study|Subject not available for contact|0
264255|NCT01165307|874004|P1|Overall Study|Subject not available for contact|1
264256|NCT01165307|874003|P2|Overall Study|Withdrawal by Subject|0
264257|NCT01165307|874004|P1|Overall Study|Withdrawal by Subject|2
264258|NCT01165307|874003|P2|Overall Study|Lost to Follow-up|3
264259|NCT01165307|874004|P1|Overall Study|Lost to Follow-up|11
264260|NCT01165281|874034|P2|Overall Study|Other|0
264261|NCT01165281|874035|P1|Overall Study|Other|6
264262|NCT01165281|874034|P2|Overall Study|Progressive Disease|14
264263|NCT01165281|874035|P1|Overall Study|Progressive Disease|10
264264|NCT01165281|874034|P2|Overall Study|Noncompliance with Study Drug|4
264265|NCT01165281|874035|P1|Overall Study|Noncompliance with Study Drug|1
264266|NCT01165281|874034|P2|Overall Study|Withdrawal by Subject|7
264267|NCT01165281|874035|P1|Overall Study|Withdrawal by Subject|8
264268|NCT01165281|874034|P2|Overall Study|Protocol Violation|5
264269|NCT01165281|874035|P1|Overall Study|Protocol Violation|6
264270|NCT01165281|874034|P2|Overall Study|Physician Decision|1
264271|NCT01165281|874035|P1|Overall Study|Physician Decision|8
264272|NCT01165281|874034|P2|Overall Study|Lost to Follow-up|1
264273|NCT01165281|874035|P1|Overall Study|Lost to Follow-up|0
264274|NCT01165281|874034|P2|Overall Study|Lack of Efficacy|1
264275|NCT01165281|874035|P1|Overall Study|Lack of Efficacy|4
264276|NCT01165281|874034|P2|Overall Study|Death|4
264277|NCT01165281|874035|P1|Overall Study|Death|3
264278|NCT01165281|874034|P2|Overall Study|Adverse Event|14
264279|NCT01165281|874035|P1|Overall Study|Adverse Event|12
264280|NCT01165242|874056|P3|Overall Study|Lost to Follow-up|10
264281|NCT01165242|874057|P2|Overall Study|Lost to Follow-up|7
264282|NCT01165242|874058|P1|Overall Study|Lost to Follow-up|9
264283|NCT01165242|874056|P3|Overall Study|Extended Holiday|1
264284|NCT01165242|874057|P2|Overall Study|Extended Holiday|0
264285|NCT01165242|874058|P1|Overall Study|Extended Holiday|0
264286|NCT01165242|874056|P3|Overall Study|Withdrawal by Subject|2
264287|NCT01165242|874057|P2|Overall Study|Withdrawal by Subject|2
264288|NCT01165242|874058|P1|Overall Study|Withdrawal by Subject|0
264289|NCT01165242|874056|P3|Overall Study|Visit 2 Declined by Subject|1
264290|NCT01165242|874057|P2|Overall Study|Visit 2 Declined by Subject|0
264291|NCT01165242|874058|P1|Overall Study|Visit 2 Declined by Subject|0
264292|NCT01165242|874056|P3|Overall Study|Incarcerated Subjects|0
264293|NCT01165242|874057|P2|Overall Study|Incarcerated Subjects|1
264294|NCT01165242|874058|P1|Overall Study|Incarcerated Subjects|0
264295|NCT01165242|874056|P3|Overall Study|Unreachable Subjects|0
264296|NCT01165242|874057|P2|Overall Study|Unreachable Subjects|0
264297|NCT01165242|874058|P1|Overall Study|Unreachable Subjects|1
264298|NCT01165216|874092|P2|Overall Study|Disease progression|3
264299|NCT01165216|874093|P1|Overall Study|Disease progression|1
264300|NCT01165216|874092|P2|Overall Study|Withdrawal by Subject|1
264301|NCT01165216|874093|P1|Overall Study|Withdrawal by Subject|1
264302|NCT01165216|874092|P2|Overall Study|Adverse Event|3
264303|NCT01165216|874093|P1|Overall Study|Adverse Event|6
264304|NCT01165203|874115|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
264305|NCT01165203|874116|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
264306|NCT01165203|874115|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
264307|NCT01165203|874116|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
264308|NCT01165203|874115|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
264309|NCT01165203|874116|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
264310|NCT01165203|874115|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
264311|NCT01165203|874116|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
264312|NCT01165203|874115|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
264313|NCT01165203|874116|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
264314|NCT01165203|874115|P2|Active Phase|Lost to Follow-up|0
264315|NCT01165203|874116|P1|Active Phase|Lost to Follow-up|2
264316|NCT01165203|874115|P2|Active Phase|Migrated/moved from study area|1
264317|NCT01165203|874116|P1|Active Phase|Migrated/moved from study area|0
264318|NCT01165203|874115|P2|Active Phase|Withdrawal by Subject|1
264319|NCT01165203|874116|P1|Active Phase|Withdrawal by Subject|2
264320|NCT01165203|874115|P2|Active Phase|Serious Adverse Event|0
264321|NCT01165203|874116|P1|Active Phase|Serious Adverse Event|1
264322|NCT01165177|874206|P2|Overall Study|Death|1
264323|NCT01165177|874207|P1|Overall Study|Death|0
264324|NCT01165177|874206|P2|Overall Study|Personal Reasons|4
264325|NCT01165177|874207|P1|Overall Study|Personal Reasons|1
264326|NCT01165177|874206|P2|Overall Study|Physician Decision|1
264327|NCT01165177|874207|P1|Overall Study|Physician Decision|0
264328|NCT01165177|874206|P2|Overall Study|Non-serious Adverse Event|20
264329|NCT01165177|874207|P1|Overall Study|Non-serious Adverse Event|32
264330|NCT01165177|874206|P2|Overall Study|Migrated/moved from study area|43
264331|NCT01165177|874207|P1|Overall Study|Migrated/moved from study area|48
264332|NCT01165177|874206|P2|Overall Study|Subject missed visit|2
264333|NCT01165177|874207|P1|Overall Study|Subject missed visit|5
264334|NCT01165177|874206|P2|Overall Study|Previous health issues worsening|11
264335|NCT01165177|874207|P1|Overall Study|Previous health issues worsening|9
264336|NCT01165177|874206|P2|Overall Study|Subject non-compliant with procedures|2
264337|NCT01165177|874207|P1|Overall Study|Subject non-compliant with procedures|12
264338|NCT01165177|874206|P2|Overall Study|Site closure|5
264339|NCT01165177|874207|P1|Overall Study|Site closure|7
264340|NCT01165177|874206|P2|Overall Study|Protocol Violation|22
264341|NCT01165177|874207|P1|Overall Study|Protocol Violation|19
264342|NCT01165177|874206|P2|Overall Study|Lost to Follow-up|195
264343|NCT01165177|874207|P1|Overall Study|Lost to Follow-up|188
264344|NCT01165177|874206|P2|Overall Study|Serious Adverse Event|240
264345|NCT01165177|874207|P1|Overall Study|Serious Adverse Event|229
264346|NCT01165177|874206|P2|Overall Study|Withdrawal by Subject|356
264347|NCT01165177|874207|P1|Overall Study|Withdrawal by Subject|372
264348|NCT01165138|874332|P4|Overall Study|Withdrawal by Subject|3
264349|NCT01165138|874333|P3|Overall Study|Withdrawal by Subject|6
264350|NCT01165138|874334|P2|Overall Study|Withdrawal by Subject|6
264351|NCT01165138|874335|P1|Overall Study|Withdrawal by Subject|0
264352|NCT01165138|874332|P4|Overall Study|Physician Decision|6
264353|NCT01165138|874333|P3|Overall Study|Physician Decision|7
264354|NCT01165138|874334|P2|Overall Study|Physician Decision|6
264355|NCT01165138|874335|P1|Overall Study|Physician Decision|0
264356|NCT01165138|874332|P4|Overall Study|Lost to Follow-up|2
264357|NCT01165138|874333|P3|Overall Study|Lost to Follow-up|1
264358|NCT01165138|874334|P2|Overall Study|Lost to Follow-up|0
264359|NCT01165138|874335|P1|Overall Study|Lost to Follow-up|0
264360|NCT01165138|874332|P4|Overall Study|Protocol Violation|2
264361|NCT01165138|874333|P3|Overall Study|Protocol Violation|0
264362|NCT01165138|874334|P2|Overall Study|Protocol Violation|7
264363|NCT01165138|874335|P1|Overall Study|Protocol Violation|0
264364|NCT01165138|874332|P4|Overall Study|Lack of Efficacy|7
264365|NCT01165138|874333|P3|Overall Study|Lack of Efficacy|6
264366|NCT01165138|874334|P2|Overall Study|Lack of Efficacy|32
264367|NCT01165138|874335|P1|Overall Study|Lack of Efficacy|0
264368|NCT01165138|874332|P4|Overall Study|Adverse Event|2
264369|NCT01165138|874333|P3|Overall Study|Adverse Event|0
264370|NCT01165138|874334|P2|Overall Study|Adverse Event|1
264371|NCT01165138|874335|P1|Overall Study|Adverse Event|0
264372|NCT01165021|874405|P1|Overall Study|Death|1
264373|NCT01164891|874413|P1|Overall Study|Adverse Event|1
264374|NCT01164891|874413|P1|Overall Study|Disease Progression|5
264375|NCT01164865|874433|P2|Overall Study|Lost to Follow-up|1
264376|NCT01164865|874434|P1|Overall Study|Lost to Follow-up|2
264377|NCT01164722|874444|P2|Overall Study|enrolled on other study, concomitant med|3
264378|NCT01164722|874445|P1|Overall Study|enrolled on other study, concomitant med|1
264379|NCT01164722|874444|P2|Overall Study|met protocol criteria for non-treatment|1
264380|NCT01164722|874445|P1|Overall Study|met protocol criteria for non-treatment|11
264381|NCT01164722|874444|P2|Overall Study|Lost to Follow-up|6
264382|NCT01164722|874445|P1|Overall Study|Lost to Follow-up|3
264383|NCT01164722|874444|P2|Overall Study|Withdrawal by Subject|4
264384|NCT01164722|874445|P1|Overall Study|Withdrawal by Subject|3
264385|NCT01164722|874444|P2|Overall Study|Adverse Event|1
264386|NCT01164722|874445|P1|Overall Study|Adverse Event|0
264387|NCT01164579|874475|P3|Overall Study|Reason not specified|0
264388|NCT01164579|874476|P2|Overall Study|Reason not specified|0
264389|NCT01164579|874477|P1|Overall Study|Reason not specified|1
264390|NCT01164579|874475|P3|Overall Study|Adverse Event|5
264391|NCT01164579|874476|P2|Overall Study|Adverse Event|2
264392|NCT01164579|874477|P1|Overall Study|Adverse Event|4
264393|NCT01164579|874475|P3|Overall Study|Protocol Violation|2
264394|NCT01164579|874476|P2|Overall Study|Protocol Violation|1
264395|NCT01164579|874477|P1|Overall Study|Protocol Violation|0
264396|NCT01164579|874475|P3|Overall Study|Withdrawal by Subject|3
264397|NCT01164579|874476|P2|Overall Study|Withdrawal by Subject|5
264398|NCT01164579|874477|P1|Overall Study|Withdrawal by Subject|2
264399|NCT01164579|874475|P3|Overall Study|Lost to Follow-up|0
264400|NCT01164579|874476|P2|Overall Study|Lost to Follow-up|1
264401|NCT01164579|874477|P1|Overall Study|Lost to Follow-up|1
264402|NCT01164579|874475|P3|Overall Study|Lack of Efficacy|6
264403|NCT01164579|874476|P2|Overall Study|Lack of Efficacy|0
264404|NCT01164579|874477|P1|Overall Study|Lack of Efficacy|0
264405|NCT01164501|874557|P3|Overall Study|Other reason not defined above|4
264406|NCT01164501|874558|P2|Overall Study|Other reason not defined above|1
264407|NCT01164501|874559|P1|Overall Study|Other reason not defined above|9
264408|NCT01164501|874557|P3|Overall Study|Patient refusal to continue,not due toAE|8
264409|NCT01164501|874558|P2|Overall Study|Patient refusal to continue,not due toAE|4
264410|NCT01164501|874559|P1|Overall Study|Patient refusal to continue,not due toAE|10
264411|NCT01164501|874557|P3|Overall Study|Lost to Follow-up|3
264412|NCT01164501|874558|P2|Overall Study|Lost to Follow-up|0
264413|NCT01164501|874559|P1|Overall Study|Lost to Follow-up|3
264414|NCT01164501|874557|P3|Overall Study|Non compliant with protocol|4
264415|NCT01164501|874558|P2|Overall Study|Non compliant with protocol|1
264416|NCT01164501|874559|P1|Overall Study|Non compliant with protocol|1
264417|NCT01164501|874557|P3|Overall Study|Lack of Efficacy|1
264418|NCT01164501|874558|P2|Overall Study|Lack of Efficacy|0
264419|NCT01164501|874559|P1|Overall Study|Lack of Efficacy|0
264420|NCT01164501|874557|P3|Overall Study|Adverse Event|21
264421|NCT01164501|874558|P2|Overall Study|Adverse Event|4
264422|NCT01164501|874559|P1|Overall Study|Adverse Event|18
264423|NCT01164501|874557|P3|Overall Study|Not treated|1
264424|NCT01164501|874558|P2|Overall Study|Not treated|0
264425|NCT01164501|874559|P1|Overall Study|Not treated|2
264426|NCT01164475|874576|P2|Overall Study|Protocol Violation|0
264427|NCT01164475|874577|P1|Overall Study|Protocol Violation|1
264428|NCT01164475|874576|P2|Overall Study|Progressive disease|1
264429|NCT01164475|874577|P1|Overall Study|Progressive disease|0
264430|NCT01164475|874576|P2|Overall Study|Other|1
264431|NCT01164475|874577|P1|Overall Study|Other|0
264432|NCT01164475|874576|P2|Overall Study|Lack of Efficacy|0
264433|NCT01164475|874577|P1|Overall Study|Lack of Efficacy|1
264434|NCT01164007|874618|P1|Overall Study|Medical Decision|3
264435|NCT01164007|874618|P1|Overall Study|Withdrawal by Subject|1
264436|NCT01164007|874618|P1|Overall Study|Protocol Violation|1
264437|NCT01164007|874618|P1|Overall Study|Progression of Disease|30
264438|NCT01164007|874618|P1|Overall Study|Adverse Event|5
264439|NCT01163916|874644|P3|Overall Study|Other|16
264440|NCT01163916|874645|P2|Overall Study|Other|4
264441|NCT01163916|874646|P1|Overall Study|Other|24
264442|NCT01163916|874644|P3|Overall Study|Lack of Efficacy|1
264443|NCT01163916|874645|P2|Overall Study|Lack of Efficacy|0
264444|NCT01163916|874646|P1|Overall Study|Lack of Efficacy|2
264445|NCT01163916|874644|P3|Overall Study|Adverse Event|1
264446|NCT01163916|874645|P2|Overall Study|Adverse Event|0
264447|NCT01163916|874646|P1|Overall Study|Adverse Event|2
264448|NCT01163916|874644|P3|Overall Study|Withdrawal by Subject|2
264449|NCT01163916|874645|P2|Overall Study|Withdrawal by Subject|0
264450|NCT01163916|874646|P1|Overall Study|Withdrawal by Subject|2
264451|NCT01163851|874684|P2|Overall Study|Randomized but not treated|0
264452|NCT01163851|874685|P1|Overall Study|Randomized but not treated|1
264453|NCT01163851|874684|P2|Overall Study|Ongoing|1
264454|NCT01163851|874685|P1|Overall Study|Ongoing|0
264455|NCT01163747|874776|P2|Overall Study|Refused Treatment|4
264456|NCT01163747|874777|P1|Overall Study|Refused Treatment|6
264457|NCT01163747|874776|P2|Overall Study|Protocol Violation|1
264458|NCT01163747|874777|P1|Overall Study|Protocol Violation|0
264459|NCT01163747|874776|P2|Overall Study|Insufficient Therapeutic Response|1
264460|NCT01163747|874777|P1|Overall Study|Insufficient Therapeutic Response|0
264461|NCT01163747|874776|P2|Overall Study|Adverse Event|5
264462|NCT01163747|874777|P1|Overall Study|Adverse Event|0
264463|NCT01163721|874797|P2|Overall Study|Physician Decision|1
264464|NCT01163721|874798|P1|Overall Study|Physician Decision|0
264465|NCT01163721|874797|P2|Overall Study|Lost to Follow-up|1
264466|NCT01163721|874798|P1|Overall Study|Lost to Follow-up|0
264467|NCT01163721|874797|P2|Overall Study|Withdrawal by Subject|4
264468|NCT01163721|874798|P1|Overall Study|Withdrawal by Subject|3
264469|NCT01163721|874797|P2|Overall Study|Adverse Event|6
264470|NCT01163721|874798|P1|Overall Study|Adverse Event|5
264471|NCT01163617|874817|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
264472|NCT01163617|874818|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
264473|NCT01163617|874819|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
264474|NCT01163617|874820|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
264475|NCT01163617|874821|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
264476|NCT01163617|874822|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
264477|NCT01163617|874823|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
264478|NCT01163617|874824|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
264479|NCT01163617|874817|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
264480|NCT01163617|874818|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
264481|NCT01163617|874819|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
264482|NCT01163617|874820|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
264483|NCT01163617|874821|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
264484|NCT01163617|874822|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
264485|NCT01163617|874823|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
264486|NCT01163617|874824|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
264487|NCT01163617|874817|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
264488|NCT01163617|874818|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
264489|NCT01163617|874819|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
264490|NCT01163617|874820|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
264491|NCT01163617|874821|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
264492|NCT01163617|874822|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
264493|NCT01163617|874823|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
264494|NCT01163617|874824|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
264495|NCT01163474|874853|P1|Overall Study|Lost to Follow-up|3
264496|NCT01163474|874853|P1|Overall Study|Tech barriers to videoteleconference vis|12
264497|NCT01163474|874853|P1|Overall Study|Withdrawal by Subject|1
264498|NCT01163318|874864|P1|Overall Study|Multiple Reasons Per Participant|224
264499|NCT01163318|874864|P1|Overall Study|Participants Without Case Report Form|7
264500|NCT01163318|874864|P1|Overall Study|History/comorbidity of malignant tumor|3
264501|NCT01163318|874864|P1|Overall Study|Did Not Continue Use of Adalimumab|26
264502|NCT01163318|874864|P1|Overall Study|Off-Label Use of Adalimumab|8
264503|NCT01163292|874873|P2|Overall Study|No further visits|7
264504|NCT01163292|874874|P1|Overall Study|No further visits|5
264505|NCT01163292|874873|P2|Overall Study|Economic reasons|0
264506|NCT01163292|874874|P1|Overall Study|Economic reasons|6
264507|NCT01163292|874873|P2|Overall Study|Refusal to receive adalimumab|0
264508|NCT01163292|874874|P1|Overall Study|Refusal to receive adalimumab|7
264509|NCT01163292|874873|P2|Overall Study|Sufficient response to adalimumab|0
264510|NCT01163292|874874|P1|Overall Study|Sufficient response to adalimumab|8
264511|NCT01163292|874873|P2|Overall Study|Initiation of biological therapy|15
264512|NCT01163292|874874|P1|Overall Study|Initiation of biological therapy|0
264513|NCT01163292|874873|P2|Overall Study|Adverse Event|0
264514|NCT01163292|874874|P1|Overall Study|Adverse Event|6
264515|NCT01163292|874873|P2|Overall Study|Lack of Efficacy|0
264516|NCT01163292|874874|P1|Overall Study|Lack of Efficacy|9
264517|NCT01163279|874890|P2|Overall Study|Withdrawal by Subject|0
264518|NCT01163279|874891|P1|Overall Study|Withdrawal by Subject|2
264519|NCT01163266|874920|P3|Overall Study|Other|2
264520|NCT01163266|874921|P2|Overall Study|Other|1
264521|NCT01163266|874922|P1|Overall Study|Other|1
264522|NCT01163266|874920|P3|Overall Study|Lost to Follow-up|10
264523|NCT01163266|874921|P2|Overall Study|Lost to Follow-up|7
264524|NCT01163266|874922|P1|Overall Study|Lost to Follow-up|7
264525|NCT01163266|874920|P3|Overall Study|Withdrawal of Consent|3
264526|NCT01163266|874921|P2|Overall Study|Withdrawal of Consent|7
264527|NCT01163266|874922|P1|Overall Study|Withdrawal of Consent|5
264528|NCT01163266|874920|P3|Overall Study|Protocol Deviations|5
264529|NCT01163266|874921|P2|Overall Study|Protocol Deviations|2
264530|NCT01163266|874922|P1|Overall Study|Protocol Deviations|2
264531|NCT01163266|874920|P3|Overall Study|Noncompliance with Study Drug|0
264532|NCT01163266|874921|P2|Overall Study|Noncompliance with Study Drug|2
264533|NCT01163266|874922|P1|Overall Study|Noncompliance with Study Drug|0
264534|NCT01163266|874920|P3|Overall Study|Lack of Efficacy|1
264535|NCT01163266|874921|P2|Overall Study|Lack of Efficacy|3
264536|NCT01163266|874922|P1|Overall Study|Lack of Efficacy|1
264537|NCT01163266|874920|P3|Overall Study|Pretreatment Event or Adverse Event|7
264538|NCT01163266|874921|P2|Overall Study|Pretreatment Event or Adverse Event|9
264539|NCT01163266|874922|P1|Overall Study|Pretreatment Event or Adverse Event|2
264540|NCT01163032|875028|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
264541|NCT01163032|875029|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
264542|NCT01163032|875030|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
264543|NCT01163032|875028|P3|Open Label Extension Phase|Study Termination|7
264544|NCT01163032|875029|P2|Open Label Extension Phase|Study Termination|0
264545|NCT01163032|875030|P1|Open Label Extension Phase|Study Termination|0
264546|NCT01163032|875028|P3|Open Label Extension Phase|Protocol Violation|1
264547|NCT01163032|875029|P2|Open Label Extension Phase|Protocol Violation|0
264548|NCT01163032|875030|P1|Open Label Extension Phase|Protocol Violation|0
264549|NCT01163032|875028|P3|Open Label Extension Phase|Withdrawal by Subject|3
264550|NCT01163032|875029|P2|Open Label Extension Phase|Withdrawal by Subject|0
264551|NCT01163032|875030|P1|Open Label Extension Phase|Withdrawal by Subject|0
264552|NCT01163032|875028|P3|Open Label Extension Phase|Adverse Event|3
264553|NCT01163032|875029|P2|Open Label Extension Phase|Adverse Event|0
264554|NCT01163032|875030|P1|Open Label Extension Phase|Adverse Event|0
264555|NCT01163032|875028|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
264556|NCT01163032|875029|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
264557|NCT01163032|875030|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
264558|NCT01163032|875028|P3|Randomization Phase|Various*|0
264559|NCT01163032|875029|P2|Randomization Phase|Various*|4
264560|NCT01163032|875030|P1|Randomization Phase|Various*|5
264561|NCT01163032|875028|P3|Randomization Phase|Protocol Violation|0
264562|NCT01163032|875029|P2|Randomization Phase|Protocol Violation|1
264563|NCT01163032|875030|P1|Randomization Phase|Protocol Violation|0
264564|NCT01163032|875028|P3|Randomization Phase|Adverse Event|0
264565|NCT01163032|875029|P2|Randomization Phase|Adverse Event|3
264566|NCT01163032|875030|P1|Randomization Phase|Adverse Event|3
264567|NCT01163032|875028|P3|Randomization Phase|Withdrawal by Subject|0
264568|NCT01163032|875029|P2|Randomization Phase|Withdrawal by Subject|3
264569|NCT01163032|875030|P1|Randomization Phase|Withdrawal by Subject|2
264570|NCT01162863|875063|P3|Overall Study|Adverse Event|0
264571|NCT01162863|875064|P2|Overall Study|Adverse Event|1
264572|NCT01162863|875065|P1|Overall Study|Adverse Event|0
264573|NCT01162863|875063|P3|Overall Study|Lack of Efficacy|0
264574|NCT01162863|875064|P2|Overall Study|Lack of Efficacy|0
264575|NCT01162863|875065|P1|Overall Study|Lack of Efficacy|1
264576|NCT01162499|875090|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
264577|NCT01162499|875091|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
264578|NCT01162473|875113|P2|Overall Study|Withdrawal by Subject|4
264579|NCT01162473|875114|P1|Overall Study|Withdrawal by Subject|0
264580|NCT01162473|875113|P2|Overall Study|Adverse Event|1
264581|NCT01162473|875114|P1|Overall Study|Adverse Event|2
264582|NCT01162421|875122|P2|Overall Study|Not specified|3
264583|NCT01162421|875123|P1|Overall Study|Not specified|2
264584|NCT01162421|875122|P2|Overall Study|Lack of Efficacy|2
264585|NCT01162421|875123|P1|Overall Study|Lack of Efficacy|2
264586|NCT01162421|875122|P2|Overall Study|Lost to Follow-up|2
264587|NCT01162421|875123|P1|Overall Study|Lost to Follow-up|0
264588|NCT01162421|875122|P2|Overall Study|Adverse Event|5
264589|NCT01162421|875123|P1|Overall Study|Adverse Event|2
264590|NCT01162421|875122|P2|Overall Study|Did not receive study drug|1
264591|NCT01162421|875123|P1|Overall Study|Did not receive study drug|2
264592|NCT01162304|875212|P1|Overall Study|Beck scale to high|11
264593|NCT01162135|875226|P1|Overall Study|Ineligible|1
264594|NCT01162135|875226|P1|Overall Study|Severe back pain|1
264595|NCT01162135|875226|P1|Overall Study|Withdrawal by Subject|1
264596|NCT01162122|875232|P2|Overall Study|Missing primary reason|0
264597|NCT01162122|875233|P1|Overall Study|Missing primary reason|1
264598|NCT01162122|875232|P2|Overall Study|Unable to classify|7
264599|NCT01162122|875233|P1|Overall Study|Unable to classify|3
264600|NCT01162122|875232|P2|Overall Study|Administrative reason|1
264601|NCT01162122|875233|P1|Overall Study|Administrative reason|1
264602|NCT01162122|875232|P2|Overall Study|Inappropriate enrollment|4
264603|NCT01162122|875233|P1|Overall Study|Inappropriate enrollment|5
264604|NCT01162122|875232|P2|Overall Study|Protocol Violation|2
264605|NCT01162122|875233|P1|Overall Study|Protocol Violation|2
264606|NCT01162122|875232|P2|Overall Study|Death|46
264607|NCT01162122|875233|P1|Overall Study|Death|51
264608|NCT01162122|875232|P2|Overall Study|Adverse Event|2
264609|NCT01162122|875233|P1|Overall Study|Adverse Event|3
264610|NCT01162122|875232|P2|Overall Study|Lost to Follow-up|91
264611|NCT01162122|875233|P1|Overall Study|Lost to Follow-up|73
264612|NCT01162122|875232|P2|Overall Study|Withdrawal by Subject|43
264613|NCT01162122|875233|P1|Overall Study|Withdrawal by Subject|52
264614|NCT01161628|875303|P1|Overall Study|Lack of Efficacy|2
264615|NCT01161628|875303|P1|Overall Study|Death|6
264616|NCT01161537|875326|P1|Part B|Withdrawal by Subject|2
264617|NCT01161498|875344|P2|Overall Study|Disease Progression|1
264618|NCT01161498|875345|P1|Overall Study|Disease Progression|0
264619|NCT01161472|875369|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
264620|NCT01161472|875370|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
264621|NCT01161472|875371|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
264622|NCT01161472|875372|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
264623|NCT01161446|875428|P2|Overall Study|Withdrawal by Subject|1
264624|NCT01161446|875429|P1|Overall Study|Withdrawal by Subject|0
264625|NCT01161446|875428|P2|Overall Study|Lost to Follow-up|14
264626|NCT01161446|875429|P1|Overall Study|Lost to Follow-up|18
264627|NCT01161407|875455|P2|Overall Study|Protocol Violation|1
264628|NCT01161407|875456|P1|Overall Study|Protocol Violation|3
264629|NCT01161173|875511|P1|Overall Study|Reasons Not Specified|23
264630|NCT01161173|875511|P1|Overall Study|End of Study|2
264631|NCT01161173|875511|P1|Overall Study|Death|194
264632|NCT01161173|875511|P1|Overall Study|Unacceptable Toxicity|21
264633|NCT01161173|875511|P1|Overall Study|Withdrawal of Consent|5
264634|NCT01161173|875511|P1|Overall Study|Progressive Disease|82
264635|NCT01161173|875511|P1|Overall Study|Lost to Follow-up|7
264636|NCT01161173|875511|P1|Overall Study|Protocol Violation|13
264637|NCT01160822|875552|P7|Overall Study|Protocol deviation|0
264638|NCT01160822|875553|P6|Overall Study|Protocol deviation|0
264639|NCT01160822|875554|P5|Overall Study|Protocol deviation|2
264640|NCT01160822|875555|P4|Overall Study|Protocol deviation|0
264641|NCT01160822|875556|P3|Overall Study|Protocol deviation|0
264642|NCT01160822|875557|P2|Overall Study|Protocol deviation|0
264643|NCT01160822|875558|P1|Overall Study|Protocol deviation|0
264644|NCT01160822|875552|P7|Overall Study|Administrative problems|0
264645|NCT01160822|875553|P6|Overall Study|Administrative problems|0
264646|NCT01160822|875554|P5|Overall Study|Administrative problems|1
264647|NCT01160822|875555|P4|Overall Study|Administrative problems|0
264648|NCT01160822|875556|P3|Overall Study|Administrative problems|0
264649|NCT01160822|875557|P2|Overall Study|Administrative problems|0
264650|NCT01160822|875558|P1|Overall Study|Administrative problems|0
264651|NCT01160822|875552|P7|Overall Study|Lost to Follow-up|0
264652|NCT01160822|875553|P6|Overall Study|Lost to Follow-up|0
264653|NCT01160822|875554|P5|Overall Study|Lost to Follow-up|1
264654|NCT01160822|875555|P4|Overall Study|Lost to Follow-up|0
264655|NCT01160822|875556|P3|Overall Study|Lost to Follow-up|0
264656|NCT01160822|875557|P2|Overall Study|Lost to Follow-up|0
264657|NCT01160822|875558|P1|Overall Study|Lost to Follow-up|0
264658|NCT01160822|875552|P7|Overall Study|Withdrawal by Subject|1
264659|NCT01160822|875553|P6|Overall Study|Withdrawal by Subject|0
264660|NCT01160822|875554|P5|Overall Study|Withdrawal by Subject|0
264661|NCT01160822|875555|P4|Overall Study|Withdrawal by Subject|0
264662|NCT01160822|875556|P3|Overall Study|Withdrawal by Subject|0
264663|NCT01160822|875557|P2|Overall Study|Withdrawal by Subject|0
264664|NCT01160822|875558|P1|Overall Study|Withdrawal by Subject|0
264665|NCT01160822|875552|P7|Overall Study|Unsatisfactory therapeutic effect|3
264666|NCT01160822|875553|P6|Overall Study|Unsatisfactory therapeutic effect|5
264667|NCT01160822|875554|P5|Overall Study|Unsatisfactory therapeutic effect|4
264668|NCT01160822|875555|P4|Overall Study|Unsatisfactory therapeutic effect|0
264669|NCT01160822|875556|P3|Overall Study|Unsatisfactory therapeutic effect|0
264670|NCT01160822|875557|P2|Overall Study|Unsatisfactory therapeutic effect|0
264671|NCT01160822|875558|P1|Overall Study|Unsatisfactory therapeutic effect|0
264672|NCT01160822|875552|P7|Overall Study|Adverse Event|5
264673|NCT01160822|875553|P6|Overall Study|Adverse Event|2
264674|NCT01160822|875554|P5|Overall Study|Adverse Event|1
264675|NCT01160822|875555|P4|Overall Study|Adverse Event|0
264676|NCT01160822|875556|P3|Overall Study|Adverse Event|0
264677|NCT01160822|875557|P2|Overall Study|Adverse Event|0
264678|NCT01160822|875558|P1|Overall Study|Adverse Event|0
264679|NCT01160770|875647|P1|Overall Study|Other Reasons|1
264680|NCT01160770|875647|P1|Overall Study|Lack of Efficacy|15
264681|NCT01160770|875647|P1|Overall Study|Death|9
264682|NCT01160770|875647|P1|Overall Study|Study termination or sponsor request|1
264683|NCT01160770|875647|P1|Overall Study|Lost to Follow-up|7
264684|NCT01160770|875647|P1|Overall Study|Physician Decision|1
264685|NCT01160770|875647|P1|Overall Study|Subject/parent/caregiver request|33
264686|NCT01160770|875647|P1|Overall Study|Protocol Violation|2
264687|NCT01160770|875647|P1|Overall Study|Adverse Event|10
264688|NCT01160744|875660|P4|Overall Study|Alive and Still on Treatment|14
264689|NCT01160744|875661|P3|Overall Study|Alive and Still on Treatment|8
264690|NCT01160744|875662|P2|Overall Study|Alive and Still on Treatment|11
264691|NCT01160744|875663|P1|Overall Study|Alive and Still on Treatment|9
264692|NCT01160744|875660|P4|Overall Study|Not Specified|4
264693|NCT01160744|875661|P3|Overall Study|Not Specified|5
264694|NCT01160744|875662|P2|Overall Study|Not Specified|9
264695|NCT01160744|875663|P1|Overall Study|Not Specified|5
264696|NCT01160744|875660|P4|Overall Study|Not meet inclusion/exclusion criteria|0
264697|NCT01160744|875661|P3|Overall Study|Not meet inclusion/exclusion criteria|1
264698|NCT01160744|875662|P2|Overall Study|Not meet inclusion/exclusion criteria|0
264699|NCT01160744|875663|P1|Overall Study|Not meet inclusion/exclusion criteria|0
264700|NCT01160744|875660|P4|Overall Study|Withdrawal by Subject|4
264701|NCT01160744|875661|P3|Overall Study|Withdrawal by Subject|6
264702|NCT01160744|875662|P2|Overall Study|Withdrawal by Subject|5
264703|NCT01160744|875663|P1|Overall Study|Withdrawal by Subject|6
264704|NCT01160640|875699|P2|Overall Study|Withdrawal by Subject|3
264705|NCT01160640|875700|P1|Overall Study|Withdrawal by Subject|0
264706|NCT01160640|875699|P2|Overall Study|Incarceration|0
264707|NCT01160640|875700|P1|Overall Study|Incarceration|1
264708|NCT01160640|875699|P2|Overall Study|Physician Decision|3
264709|NCT01160640|875700|P1|Overall Study|Physician Decision|3
264710|NCT01160614|875716|P2|Overall Study|Withdrawal by Subject|2
264711|NCT01160614|875717|P1|Overall Study|Withdrawal by Subject|0
264712|NCT01160484|875765|P1|Overall Study|inclusion/exclusion criteria failure|1
264713|NCT01160484|875765|P1|Overall Study|Withdrawal by Subject|2
264714|NCT01160484|875765|P1|Overall Study|Adverse Event|6
264715|NCT01160484|875765|P1|Overall Study|Lack of Efficacy|9
264716|NCT01159938|875846|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
264717|NCT01159938|875847|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
264718|NCT01159938|875848|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
264719|NCT01159938|875849|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
264720|NCT01159938|875850|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
264721|NCT01159912|875913|P3|Overall Study|Withdrawal by Subject|3
264722|NCT01159912|875914|P2|Overall Study|Withdrawal by Subject|3
264723|NCT01159912|875915|P1|Overall Study|Withdrawal by Subject|10
264724|NCT01159912|875913|P3|Overall Study|Physician Decision|3
264725|NCT01159912|875914|P2|Overall Study|Physician Decision|0
264726|NCT01159912|875915|P1|Overall Study|Physician Decision|0
264727|NCT01159912|875913|P3|Overall Study|Lost to Follow-up|0
264728|NCT01159912|875914|P2|Overall Study|Lost to Follow-up|0
264729|NCT01159912|875915|P1|Overall Study|Lost to Follow-up|4
264730|NCT01159912|875913|P3|Overall Study|Protocol Violation|3
264731|NCT01159912|875914|P2|Overall Study|Protocol Violation|2
264732|NCT01159912|875915|P1|Overall Study|Protocol Violation|1
264733|NCT01159912|875913|P3|Overall Study|Lack of Efficacy|14
264734|NCT01159912|875914|P2|Overall Study|Lack of Efficacy|15
264735|NCT01159912|875915|P1|Overall Study|Lack of Efficacy|23
264736|NCT01159912|875913|P3|Overall Study|Adverse Event|3
264737|NCT01159912|875914|P2|Overall Study|Adverse Event|2
264738|NCT01159912|875915|P1|Overall Study|Adverse Event|2
264739|NCT01159769|875938|P1|Overall Study|Adverse Event|1
264740|NCT01159691|875958|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
264741|NCT01159691|875958|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
264742|NCT01159691|875958|P1|Overall Study|Disc. Neupro other & unknown reasons|7
264743|NCT01159691|875958|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
264744|NCT01159691|875958|P1|Overall Study|Discontinued Neupro due to other reasons|1
264745|NCT01159691|875958|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
264746|NCT01159691|875958|P1|Overall Study|Unknown reasons|1
264747|NCT01159691|875958|P1|Overall Study|Lost to Follow-up|2
264748|NCT01159665|875971|P6|Overall Study|Withdrawal by Subject|0
264749|NCT01159665|875972|P5|Overall Study|Withdrawal by Subject|0
264750|NCT01159665|875973|P4|Overall Study|Withdrawal by Subject|0
264751|NCT01159665|875974|P3|Overall Study|Withdrawal by Subject|0
264752|NCT01159665|875975|P2|Overall Study|Withdrawal by Subject|1
264753|NCT01159665|875976|P1|Overall Study|Withdrawal by Subject|0
264754|NCT01159600|876004|P8|Overall Study|Other reason not defined above|3
264755|NCT01159600|876005|P7|Overall Study|Other reason not defined above|3
264756|NCT01159600|876006|P6|Overall Study|Other reason not defined above|7
264757|NCT01159600|876007|P5|Overall Study|Other reason not defined above|5
264758|NCT01159600|876008|P4|Overall Study|Other reason not defined above|2
264759|NCT01159600|876009|P3|Overall Study|Other reason not defined above|4
264760|NCT01159600|876010|P2|Overall Study|Other reason not defined above|0
264761|NCT01159600|876011|P1|Overall Study|Other reason not defined above|3
264762|NCT01159600|876004|P8|Overall Study|Patient refusal to continue,not due toAE|5
264763|NCT01159600|876005|P7|Overall Study|Patient refusal to continue,not due toAE|2
264764|NCT01159600|876006|P6|Overall Study|Patient refusal to continue,not due toAE|4
264765|NCT01159600|876007|P5|Overall Study|Patient refusal to continue,not due toAE|4
264766|NCT01159600|876008|P4|Overall Study|Patient refusal to continue,not due toAE|5
264767|NCT01159600|876009|P3|Overall Study|Patient refusal to continue,not due toAE|4
264768|NCT01159600|876010|P2|Overall Study|Patient refusal to continue,not due toAE|2
264769|NCT01159600|876011|P1|Overall Study|Patient refusal to continue,not due toAE|7
264770|NCT01159600|876004|P8|Overall Study|Lost to Follow-up|2
264771|NCT01159600|876005|P7|Overall Study|Lost to Follow-up|3
264772|NCT01159600|876006|P6|Overall Study|Lost to Follow-up|0
264773|NCT01159600|876007|P5|Overall Study|Lost to Follow-up|3
264774|NCT01159600|876008|P4|Overall Study|Lost to Follow-up|3
264775|NCT01159600|876009|P3|Overall Study|Lost to Follow-up|4
264776|NCT01159600|876010|P2|Overall Study|Lost to Follow-up|3
264777|NCT01159600|876011|P1|Overall Study|Lost to Follow-up|2
264778|NCT01159600|876004|P8|Overall Study|Non compliant with protocol|0
264779|NCT01159600|876005|P7|Overall Study|Non compliant with protocol|2
264780|NCT01159600|876006|P6|Overall Study|Non compliant with protocol|0
264781|NCT01159600|876007|P5|Overall Study|Non compliant with protocol|2
264782|NCT01159600|876008|P4|Overall Study|Non compliant with protocol|0
264783|NCT01159600|876009|P3|Overall Study|Non compliant with protocol|0
264784|NCT01159600|876010|P2|Overall Study|Non compliant with protocol|1
264785|NCT01159600|876011|P1|Overall Study|Non compliant with protocol|2
264786|NCT01159600|876004|P8|Overall Study|Lack of Efficacy|1
264787|NCT01159600|876005|P7|Overall Study|Lack of Efficacy|0
264788|NCT01159600|876006|P6|Overall Study|Lack of Efficacy|0
264789|NCT01159600|876007|P5|Overall Study|Lack of Efficacy|2
264790|NCT01159600|876008|P4|Overall Study|Lack of Efficacy|0
264791|NCT01159600|876009|P3|Overall Study|Lack of Efficacy|0
264792|NCT01159600|876010|P2|Overall Study|Lack of Efficacy|0
264793|NCT01159600|876011|P1|Overall Study|Lack of Efficacy|0
264794|NCT01159600|876004|P8|Overall Study|Adverse Event|5
264795|NCT01159600|876005|P7|Overall Study|Adverse Event|7
264796|NCT01159600|876006|P6|Overall Study|Adverse Event|6
264797|NCT01159600|876007|P5|Overall Study|Adverse Event|8
264798|NCT01159600|876008|P4|Overall Study|Adverse Event|1
264799|NCT01159600|876009|P3|Overall Study|Adverse Event|5
264800|NCT01159600|876010|P2|Overall Study|Adverse Event|2
264801|NCT01159600|876011|P1|Overall Study|Adverse Event|7
264802|NCT01159600|876004|P8|Overall Study|Not treated|2
264803|NCT01159600|876005|P7|Overall Study|Not treated|2
264804|NCT01159600|876006|P6|Overall Study|Not treated|1
264805|NCT01159600|876007|P5|Overall Study|Not treated|0
264806|NCT01159600|876008|P4|Overall Study|Not treated|0
264807|NCT01159600|876009|P3|Overall Study|Not treated|1
264808|NCT01159600|876010|P2|Overall Study|Not treated|0
264809|NCT01159600|876011|P1|Overall Study|Not treated|0
264810|NCT01159574|876053|P1|Follow Up Phase|still being followed for overall surviva|18
264811|NCT01159574|876053|P1|Follow Up Phase|Lost to Follow-up|2
264812|NCT01159574|876053|P1|Treatment Phase|still on treatment|2
264813|NCT01159574|876053|P1|Treatment Phase|Withdrawal by Subject|7
264814|NCT01159574|876053|P1|Treatment Phase|Physician Decision|2
264815|NCT01159574|876053|P1|Treatment Phase|Death|6
264816|NCT01159574|876053|P1|Treatment Phase|Adverse Event|3
264817|NCT01159574|876053|P1|Treatment Phase|non-evaluable/not included in analysis|1
264818|NCT01159431|876072|P2|Overall Study|Lack of Efficacy|3
264819|NCT01159431|876073|P1|Overall Study|Lack of Efficacy|0
264820|NCT01159431|876072|P2|Overall Study|non-compliance|1
264821|NCT01159431|876073|P1|Overall Study|non-compliance|1
264822|NCT01159431|876072|P2|Overall Study|Adverse Event|2
264823|NCT01159431|876073|P1|Overall Study|Adverse Event|1
264824|NCT01159171|876126|P1|Overall Study|Death|1
264825|NCT01159171|876126|P1|Overall Study|Medical Decision|4
264826|NCT01159171|876126|P1|Overall Study|Need for Surgery|5
264827|NCT01159171|876126|P1|Overall Study|Protocol Violation|1
264828|NCT01159171|876126|P1|Overall Study|Progression of Disease|28
264829|NCT01159171|876126|P1|Overall Study|Adverse Event|11
264830|NCT01157845|876141|P1|Overall Study|Device malfunction|1
264831|NCT01157845|876141|P1|Overall Study|Study was ended|1
264832|NCT01157845|876141|P1|Overall Study|Protocol Violation|13
264833|NCT01157845|876141|P1|Overall Study|Physician Decision|3
264834|NCT01157845|876141|P1|Overall Study|Withdrawal by Subject|12
264835|NCT01157845|876141|P1|Overall Study|Lost to Follow-up|5
264836|NCT01158924|876148|P2|Overall Study|Lost to Follow-up|1
264837|NCT01158924|876149|P1|Overall Study|Lost to Follow-up|0
264838|NCT01158924|876148|P2|Overall Study|Withdrawal by Subject|2
264839|NCT01158924|876149|P1|Overall Study|Withdrawal by Subject|1
264840|NCT01158534|876191|P1|Overall Study|Other|1
264841|NCT01158534|876191|P1|Overall Study|Death|1
264842|NCT01158534|876191|P1|Overall Study|Withdrawal by Subject|1
264843|NCT01158378|876201|P2|Overall Study|Withdrawal by Subject|0
264844|NCT01158378|876202|P1|Overall Study|Withdrawal by Subject|4
264845|NCT01158378|876201|P2|Overall Study|Lost to Follow-up|4
264846|NCT01158378|876202|P1|Overall Study|Lost to Follow-up|2
264847|NCT01158378|876201|P2|Overall Study|Death|5
264848|NCT01158378|876202|P1|Overall Study|Death|4
264849|NCT01158261|876214|P1|Overall Study|Withdrawal by Subject|1
264850|NCT01158261|876214|P1|Overall Study|Death|7
264851|NCT01158261|876214|P1|Overall Study|Lost to Follow-up|9
264852|NCT01158118|876220|P2|Overall Study|Death|1
264853|NCT01158118|876221|P1|Overall Study|Death|0
264854|NCT01158118|876220|P2|Overall Study|Suffered stroke prior to transplant|1
264855|NCT01158118|876221|P1|Overall Study|Suffered stroke prior to transplant|0
264856|NCT01158118|876220|P2|Overall Study|Donor match was a screen failure|1
264857|NCT01158118|876221|P1|Overall Study|Donor match was a screen failure|0
264858|NCT01158118|876220|P2|Overall Study|Screen failure|0
264859|NCT01158118|876221|P1|Overall Study|Screen failure|1
264860|NCT01157377|876266|P7|Overall Study|Other Miscellaneous Reasons|1
264861|NCT01157377|876267|P6|Overall Study|Other Miscellaneous Reasons|1
264862|NCT01157377|876268|P5|Overall Study|Other Miscellaneous Reasons|1
264863|NCT01157377|876269|P4|Overall Study|Other Miscellaneous Reasons|0
264864|NCT01157377|876270|P3|Overall Study|Other Miscellaneous Reasons|0
264865|NCT01157377|876271|P2|Overall Study|Other Miscellaneous Reasons|2
264866|NCT01157377|876272|P1|Overall Study|Other Miscellaneous Reasons|0
264867|NCT01157377|876266|P7|Overall Study|Lack of Efficacy|1
264868|NCT01157377|876267|P6|Overall Study|Lack of Efficacy|0
264869|NCT01157377|876268|P5|Overall Study|Lack of Efficacy|0
264870|NCT01157377|876269|P4|Overall Study|Lack of Efficacy|0
264871|NCT01157377|876270|P3|Overall Study|Lack of Efficacy|0
264872|NCT01157377|876271|P2|Overall Study|Lack of Efficacy|0
264873|NCT01157377|876272|P1|Overall Study|Lack of Efficacy|0
264874|NCT01157377|876266|P7|Overall Study|Protocol Violation|0
264875|NCT01157377|876267|P6|Overall Study|Protocol Violation|1
264876|NCT01157377|876268|P5|Overall Study|Protocol Violation|0
264877|NCT01157377|876269|P4|Overall Study|Protocol Violation|0
264878|NCT01157377|876270|P3|Overall Study|Protocol Violation|0
264879|NCT01157377|876271|P2|Overall Study|Protocol Violation|0
264880|NCT01157377|876272|P1|Overall Study|Protocol Violation|0
264881|NCT01157377|876266|P7|Overall Study|Personal Reasons|0
264882|NCT01157377|876267|P6|Overall Study|Personal Reasons|0
264883|NCT01157377|876268|P5|Overall Study|Personal Reasons|0
264884|NCT01157377|876269|P4|Overall Study|Personal Reasons|1
264885|NCT01157377|876270|P3|Overall Study|Personal Reasons|0
264886|NCT01157377|876271|P2|Overall Study|Personal Reasons|1
264887|NCT01157377|876272|P1|Overall Study|Personal Reasons|2
264888|NCT01157377|876266|P7|Overall Study|Lost to Follow-up|0
264889|NCT01157377|876267|P6|Overall Study|Lost to Follow-up|1
264890|NCT01157377|876268|P5|Overall Study|Lost to Follow-up|1
264891|NCT01157377|876269|P4|Overall Study|Lost to Follow-up|0
264892|NCT01157377|876270|P3|Overall Study|Lost to Follow-up|1
264893|NCT01157377|876271|P2|Overall Study|Lost to Follow-up|0
264894|NCT01157377|876272|P1|Overall Study|Lost to Follow-up|0
264895|NCT01157351|876290|P2|Overall Study|Randomized but not Treated|2
264896|NCT01157351|876291|P1|Overall Study|Randomized but not Treated|4
264897|NCT01157351|876290|P2|Overall Study|Noncompliance with Study Drug|3
264898|NCT01157351|876291|P1|Overall Study|Noncompliance with Study Drug|0
264899|NCT01157351|876290|P2|Overall Study|Unspecified|36
264900|NCT01157351|876291|P1|Overall Study|Unspecified|32
264901|NCT01157351|876290|P2|Overall Study|Protocol Violation|1
264902|NCT01157351|876291|P1|Overall Study|Protocol Violation|0
264903|NCT01157351|876290|P2|Overall Study|Physician Decision|4
264904|NCT01157351|876291|P1|Overall Study|Physician Decision|5
264905|NCT01157351|876290|P2|Overall Study|Withdrawal by Subject|27
264906|NCT01157351|876291|P1|Overall Study|Withdrawal by Subject|37
264907|NCT01157351|876290|P2|Overall Study|Lost to Follow-up|55
264908|NCT01157351|876291|P1|Overall Study|Lost to Follow-up|53
264909|NCT01157351|876290|P2|Overall Study|Death|0
264910|NCT01157351|876291|P1|Overall Study|Death|1
264911|NCT01157351|876290|P2|Overall Study|Adverse Event|4
264912|NCT01157351|876291|P1|Overall Study|Adverse Event|5
264913|NCT01157234|876309|P2|Overall Study|Withdrawal by Subject|0
264914|NCT01157234|876310|P1|Overall Study|Withdrawal by Subject|1
264915|NCT01157182|876342|P2|Washout of 28 Days|Adverse Event|0
264916|NCT01157182|876343|P1|Washout of 28 Days|Adverse Event|2
264917|NCT01157169|876391|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
264918|NCT01157169|876392|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
264919|NCT01157169|876391|P2|First Intervention|Emesis Within 4 hrs of Administration|2
264920|NCT01157169|876392|P1|First Intervention|Emesis Within 4 hrs of Administration|4
264921|NCT01157169|876391|P2|First Intervention|Protocol Violation|0
264922|NCT01157169|876392|P1|First Intervention|Protocol Violation|0
264923|NCT01157117|876411|P3|Overall Study|Unknown (Pending Final Form Submission)|13
264924|NCT01157117|876412|P2|Overall Study|Unknown (Pending Final Form Submission)|5
264925|NCT01157117|876413|P1|Overall Study|Unknown (Pending Final Form Submission)|4
264926|NCT01157117|876411|P3|Overall Study|Lost to Follow-up|1
264927|NCT01157117|876412|P2|Overall Study|Lost to Follow-up|0
264928|NCT01157117|876413|P1|Overall Study|Lost to Follow-up|0
264929|NCT01157117|876411|P3|Overall Study|Lack of Efficacy|0
264930|NCT01157117|876412|P2|Overall Study|Lack of Efficacy|1
264931|NCT01157117|876413|P1|Overall Study|Lack of Efficacy|1
264932|NCT01157117|876411|P3|Overall Study|Withdrawal by Subject|1
264933|NCT01157117|876412|P2|Overall Study|Withdrawal by Subject|1
264934|NCT01157117|876413|P1|Overall Study|Withdrawal by Subject|4
264935|NCT01157117|876411|P3|Overall Study|Dosing Symptoms|0
264936|NCT01157117|876412|P2|Overall Study|Dosing Symptoms|4
264937|NCT01157117|876413|P1|Overall Study|Dosing Symptoms|0
264938|NCT01157078|876454|P2|Overall Study|Not specified|4
264939|NCT01157078|876455|P1|Overall Study|Not specified|2
264940|NCT01157078|876454|P2|Overall Study|Lost to Follow-up|5
264941|NCT01157078|876455|P1|Overall Study|Lost to Follow-up|7
264942|NCT01157078|876454|P2|Overall Study|Study-specific withdrawal criteria|2
264943|NCT01157078|876455|P1|Overall Study|Study-specific withdrawal criteria|2
264944|NCT01157078|876454|P2|Overall Study|Lack of Efficacy|0
264945|NCT01157078|876455|P1|Overall Study|Lack of Efficacy|2
264946|NCT01157078|876454|P2|Overall Study|Condition under investigation worsened|1
264947|NCT01157078|876455|P1|Overall Study|Condition under investigation worsened|0
264948|NCT01157078|876454|P2|Overall Study|Severe non-compliance to protocol|4
264949|NCT01157078|876455|P1|Overall Study|Severe non-compliance to protocol|2
264950|NCT01157078|876454|P2|Overall Study|Adverse Event|6
264951|NCT01157078|876455|P1|Overall Study|Adverse Event|6
264952|NCT01157078|876454|P2|Overall Study|Eligibility criteria not fulfilled|0
264953|NCT01157078|876455|P1|Overall Study|Eligibility criteria not fulfilled|2
264954|NCT01157078|876454|P2|Overall Study|Withdrawal by Subject|14
264955|NCT01157078|876455|P1|Overall Study|Withdrawal by Subject|12
264956|NCT01157065|876505|P2|Overall Study|Death|1
264957|NCT01157065|876506|P1|Overall Study|Death|0
264958|NCT01156844|876527|P4|Overall Study|Protocol deviation|0
264959|NCT01156844|876528|P3|Overall Study|Protocol deviation|0
264960|NCT01156844|876529|P2|Overall Study|Protocol deviation|0
264961|NCT01156844|876530|P1|Overall Study|Protocol deviation|2
264962|NCT01156844|876527|P4|Overall Study|Administrative problems|1
264963|NCT01156844|876528|P3|Overall Study|Administrative problems|0
264964|NCT01156844|876529|P2|Overall Study|Administrative problems|1
264965|NCT01156844|876530|P1|Overall Study|Administrative problems|0
264966|NCT01156844|876527|P4|Overall Study|Lost to Follow-up|0
264967|NCT01156844|876528|P3|Overall Study|Lost to Follow-up|1
264968|NCT01156844|876529|P2|Overall Study|Lost to Follow-up|0
264969|NCT01156844|876530|P1|Overall Study|Lost to Follow-up|0
264970|NCT01156844|876527|P4|Overall Study|Withdrawal by Subject|2
264971|NCT01156844|876528|P3|Overall Study|Withdrawal by Subject|2
264972|NCT01156844|876529|P2|Overall Study|Withdrawal by Subject|0
264973|NCT01156844|876530|P1|Overall Study|Withdrawal by Subject|0
264974|NCT01156844|876527|P4|Overall Study|Abnormal test procedure result(s)|2
264975|NCT01156844|876528|P3|Overall Study|Abnormal test procedure result(s)|2
264976|NCT01156844|876529|P2|Overall Study|Abnormal test procedure result(s)|1
264977|NCT01156844|876530|P1|Overall Study|Abnormal test procedure result(s)|0
264978|NCT01156844|876527|P4|Overall Study|Adverse Event|1
264979|NCT01156844|876528|P3|Overall Study|Adverse Event|1
264980|NCT01156844|876529|P2|Overall Study|Adverse Event|0
264981|NCT01156844|876530|P1|Overall Study|Adverse Event|0
264982|NCT01156792|876549|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
264983|NCT01156792|876549|P1|Overall Study|Withdrawal by Subject|9
264984|NCT01156792|876549|P1|Overall Study|Physician Decision|3
264985|NCT01156792|876549|P1|Overall Study|Lost to Follow-up|3
264986|NCT01156792|876549|P1|Overall Study|Protocol Violation|6
264987|NCT01156792|876549|P1|Overall Study|Lack of Efficacy|36
264988|NCT01156792|876549|P1|Overall Study|Adverse Event|1
264989|NCT01156532|876677|P1|Overall Study|Lost to Follow-up|1
264990|NCT01156532|876677|P1|Overall Study|Family Reasons|1
264991|NCT01156480|876689|P2|Overall Study|change in diagnosis|1
264992|NCT01156480|876690|P1|Overall Study|change in diagnosis|0
264993|NCT01156376|876701|P3|Overall Study|Withdrawal by Subject|3
264994|NCT01156376|876702|P2|Overall Study|Withdrawal by Subject|0
264995|NCT01156376|876703|P1|Overall Study|Withdrawal by Subject|0
264996|NCT01156376|876701|P3|Overall Study|Adverse Event|1
264997|NCT01156376|876702|P2|Overall Study|Adverse Event|0
264998|NCT01156376|876703|P1|Overall Study|Adverse Event|1
264999|NCT01156363|876924|P1|Overall Study|Unspecified|6
265000|NCT01156363|876924|P1|Overall Study|Refused Treatment|4
265001|NCT01156363|876924|P1|Overall Study|Failure to Return|1
265002|NCT01156363|876924|P1|Overall Study|Insufficient Therapeutic Response|5
265003|NCT01156363|876924|P1|Overall Study|Adverse Event|6
265004|NCT01156311|876946|P4|6-month Add-on Therapy Period|Not Specified|2
265005|NCT01156311|876947|P3|6-month Add-on Therapy Period|Not Specified|1
265006|NCT01156311|876948|P2|6-month Add-on Therapy Period|Not Specified|0
265007|NCT01156311|876949|P1|6-month Add-on Therapy Period|Not Specified|0
265008|NCT01156311|876946|P4|6-month Add-on Therapy Period|Physician Decision|0
265009|NCT01156311|876947|P3|6-month Add-on Therapy Period|Physician Decision|1
265010|NCT01156311|876948|P2|6-month Add-on Therapy Period|Physician Decision|0
265011|NCT01156311|876949|P1|6-month Add-on Therapy Period|Physician Decision|0
265012|NCT01156311|876946|P4|6-month Add-on Therapy Period|Disease Activity|2
265013|NCT01156311|876947|P3|6-month Add-on Therapy Period|Disease Activity|1
265014|NCT01156311|876948|P2|6-month Add-on Therapy Period|Disease Activity|0
265015|NCT01156311|876949|P1|6-month Add-on Therapy Period|Disease Activity|0
265016|NCT01156311|876946|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
265017|NCT01156311|876947|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
265018|NCT01156311|876948|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
265019|NCT01156311|876949|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
265020|NCT01156311|876946|P4|6-month Add-on Therapy Period|Adverse Event|6
265021|NCT01156311|876947|P3|6-month Add-on Therapy Period|Adverse Event|7
265022|NCT01156311|876948|P2|6-month Add-on Therapy Period|Adverse Event|0
265023|NCT01156311|876949|P1|6-month Add-on Therapy Period|Adverse Event|0
265024|NCT01156311|876946|P4|2-Month Monotherapy Period|Not specified|0
265025|NCT01156311|876947|P3|2-Month Monotherapy Period|Not specified|0
265026|NCT01156311|876948|P2|2-Month Monotherapy Period|Not specified|0
265027|NCT01156311|876949|P1|2-Month Monotherapy Period|Not specified|1
265028|NCT01156311|876946|P4|2-Month Monotherapy Period|Physician Decision|0
265029|NCT01156311|876947|P3|2-Month Monotherapy Period|Physician Decision|0
265030|NCT01156311|876948|P2|2-Month Monotherapy Period|Physician Decision|1
265031|NCT01156311|876949|P1|2-Month Monotherapy Period|Physician Decision|0
265032|NCT01156311|876946|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
265033|NCT01156311|876947|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
265034|NCT01156311|876948|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
265035|NCT01156311|876949|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
265036|NCT01156142|876973|P2|Overall Study|Ineligible|1
265037|NCT01156142|876974|P1|Overall Study|Ineligible|0
265038|NCT01156142|876973|P2|Overall Study|Withdrawal by Subject|6
265039|NCT01156142|876974|P1|Overall Study|Withdrawal by Subject|8
265040|NCT01156116|876992|P2|Overall Study|CPAP intolerance|0
265041|NCT01156116|876993|P1|Overall Study|CPAP intolerance|2
265042|NCT01156116|876992|P2|Overall Study|Withdrawal by Subject|1
265043|NCT01156116|876993|P1|Overall Study|Withdrawal by Subject|3
265044|NCT01156051|877007|P2|Overall Study|patient not compliant with protocol|1
265045|NCT01156051|877008|P1|Overall Study|patient not compliant with protocol|0
265046|NCT01156051|877007|P2|Overall Study|Lost to Follow-up|0
265047|NCT01156051|877008|P1|Overall Study|Lost to Follow-up|1
265048|NCT01156012|877022|P2|Overall Study|Non respect of one of inclusion criteria|1
265049|NCT01156012|877023|P1|Overall Study|Non respect of one of inclusion criteria|2
265050|NCT01156012|877022|P2|Overall Study|use of commercial drug instead of study|1
265051|NCT01156012|877023|P1|Overall Study|use of commercial drug instead of study|0
265052|NCT01156012|877022|P2|Overall Study|Withdrawal by Subject|0
265053|NCT01156012|877023|P1|Overall Study|Withdrawal by Subject|1
265054|NCT01156012|877022|P2|Overall Study|Lost to Follow-up|0
265055|NCT01156012|877023|P1|Overall Study|Lost to Follow-up|1
265056|NCT01156012|877022|P2|Overall Study|Adverse Event|1
265057|NCT01156012|877023|P1|Overall Study|Adverse Event|3
265058|NCT01155869|877040|P2|Overall Study|Lost to Follow-up|1
265059|NCT01155869|877041|P1|Overall Study|Lost to Follow-up|3
265060|NCT01155726|877065|P4|Period 1, 3 Days (Masked)|Inconvenience|0
265061|NCT01155726|877066|P3|Period 1, 3 Days (Masked)|Inconvenience|2
265062|NCT01155726|877067|P2|Period 1, 3 Days (Masked)|Inconvenience|0
265063|NCT01155726|877068|P1|Period 1, 3 Days (Masked)|Inconvenience|1
265064|NCT01155570|877090|P1|Overall Study|Other Reasons|23
265065|NCT01155570|877090|P1|Overall Study|Participant's Economic Reasons + Other|1
265066|NCT01155570|877090|P1|Overall Study|Adverse Event + Other Reasons|7
265067|NCT01155570|877090|P1|Overall Study|Adverse Event + Lack of Efficacy|2
265068|NCT01155570|877090|P1|Overall Study|No Hospital Visits|7
265069|NCT01155570|877090|P1|Overall Study|Participant's Economic Reasons|17
265070|NCT01155570|877090|P1|Overall Study|Lack of Efficacy|46
265071|NCT01155570|877090|P1|Overall Study|Adverse Event|39
265072|NCT01155531|877124|P4|Overall Study|Withdrawal by Subject|0
265073|NCT01155531|877125|P3|Overall Study|Withdrawal by Subject|1
265074|NCT01155531|877126|P2|Overall Study|Withdrawal by Subject|0
265075|NCT01155531|877127|P1|Overall Study|Withdrawal by Subject|1
265076|NCT01155531|877124|P4|Overall Study|Lost to Follow-up|1
265077|NCT01155531|877125|P3|Overall Study|Lost to Follow-up|0
265078|NCT01155531|877126|P2|Overall Study|Lost to Follow-up|0
265079|NCT01155531|877127|P1|Overall Study|Lost to Follow-up|0
265080|NCT01155531|877124|P4|Overall Study|Adverse Event|0
265081|NCT01155531|877125|P3|Overall Study|Adverse Event|1
265082|NCT01155531|877126|P2|Overall Study|Adverse Event|0
265083|NCT01155531|877127|P1|Overall Study|Adverse Event|0
265084|NCT01155479|877150|P5|Part II|Non-Compliance with Protocol|0
265085|NCT01155479|877151|P4|Part II|Non-Compliance with Protocol|2
265086|NCT01155479|877152|P3|Part II|Non-Compliance with Protocol|0
265087|NCT01155479|877153|P2|Part II|Non-Compliance with Protocol|1
265088|NCT01155479|877154|P1|Part II|Non-Compliance with Protocol|0
265089|NCT01155479|877150|P5|Part II|Treatment Failure|1
265090|NCT01155479|877151|P4|Part II|Treatment Failure|0
265091|NCT01155479|877152|P3|Part II|Treatment Failure|2
265092|NCT01155479|877153|P2|Part II|Treatment Failure|1
265093|NCT01155479|877154|P1|Part II|Treatment Failure|0
265094|NCT01155479|877150|P5|Part II|Lost to Follow-up|1
265095|NCT01155479|877151|P4|Part II|Lost to Follow-up|0
265096|NCT01155479|877152|P3|Part II|Lost to Follow-up|0
265097|NCT01155479|877153|P2|Part II|Lost to Follow-up|0
265098|NCT01155479|877154|P1|Part II|Lost to Follow-up|1
265099|NCT01155479|877150|P5|Part II|Withdrawal by Subject|3
265100|NCT01155479|877151|P4|Part II|Withdrawal by Subject|7
265101|NCT01155479|877152|P3|Part II|Withdrawal by Subject|12
265102|NCT01155479|877153|P2|Part II|Withdrawal by Subject|4
265103|NCT01155479|877154|P1|Part II|Withdrawal by Subject|8
265104|NCT01155479|877150|P5|Part II|Administrative|46
265105|NCT01155479|877151|P4|Part II|Administrative|38
265106|NCT01155479|877152|P3|Part II|Administrative|36
265107|NCT01155479|877153|P2|Part II|Administrative|49
265108|NCT01155479|877154|P1|Part II|Administrative|43
265109|NCT01155479|877150|P5|Part II|Adverse Event|4
265110|NCT01155479|877151|P4|Part II|Adverse Event|3
265111|NCT01155479|877152|P3|Part II|Adverse Event|8
265112|NCT01155479|877153|P2|Part II|Adverse Event|6
265113|NCT01155479|877154|P1|Part II|Adverse Event|7
265114|NCT01155479|877150|P5|Part I|Non-Compliance with Protocol|2
265115|NCT01155479|877151|P4|Part I|Non-Compliance with Protocol|3
265116|NCT01155479|877152|P3|Part I|Non-Compliance with Protocol|3
265117|NCT01155479|877153|P2|Part I|Non-Compliance with Protocol|1
265118|NCT01155479|877154|P1|Part I|Non-Compliance with Protocol|2
265119|NCT01155479|877150|P5|Part I|Did Not Receive Treatment|1
265120|NCT01155479|877151|P4|Part I|Did Not Receive Treatment|6
265121|NCT01155479|877152|P3|Part I|Did Not Receive Treatment|2
265122|NCT01155479|877153|P2|Part I|Did Not Receive Treatment|2
265123|NCT01155479|877154|P1|Part I|Did Not Receive Treatment|4
265124|NCT01155479|877150|P5|Part I|Treatment Failure|2
265125|NCT01155479|877151|P4|Part I|Treatment Failure|1
265126|NCT01155479|877152|P3|Part I|Treatment Failure|3
265127|NCT01155479|877153|P2|Part I|Treatment Failure|0
265128|NCT01155479|877154|P1|Part I|Treatment Failure|3
265129|NCT01155479|877150|P5|Part I|Lost to Follow-up|0
265130|NCT01155479|877151|P4|Part I|Lost to Follow-up|1
265131|NCT01155479|877152|P3|Part I|Lost to Follow-up|1
265132|NCT01155479|877153|P2|Part I|Lost to Follow-up|0
265133|NCT01155479|877154|P1|Part I|Lost to Follow-up|0
265134|NCT01155479|877150|P5|Part I|Withdrawal by Subject|9
265135|NCT01155479|877151|P4|Part I|Withdrawal by Subject|8
265136|NCT01155479|877152|P3|Part I|Withdrawal by Subject|8
265137|NCT01155479|877153|P2|Part I|Withdrawal by Subject|13
265138|NCT01155479|877154|P1|Part I|Withdrawal by Subject|11
265139|NCT01155479|877150|P5|Part I|Did Not Meet Protocol Eligibility|3
265140|NCT01155479|877151|P4|Part I|Did Not Meet Protocol Eligibility|1
265141|NCT01155479|877152|P3|Part I|Did Not Meet Protocol Eligibility|2
265142|NCT01155479|877153|P2|Part I|Did Not Meet Protocol Eligibility|1
265143|NCT01155479|877154|P1|Part I|Did Not Meet Protocol Eligibility|3
265144|NCT01155479|877150|P5|Part I|Administrative|0
265145|NCT01155479|877151|P4|Part I|Administrative|0
265146|NCT01155479|877152|P3|Part I|Administrative|2
265147|NCT01155479|877153|P2|Part I|Administrative|2
265148|NCT01155479|877154|P1|Part I|Administrative|2
265149|NCT01155479|877150|P5|Part I|Adverse Event|6
265150|NCT01155479|877151|P4|Part I|Adverse Event|7
265151|NCT01155479|877152|P3|Part I|Adverse Event|18
265152|NCT01155479|877153|P2|Part I|Adverse Event|8
265153|NCT01155479|877154|P1|Part I|Adverse Event|13
265154|NCT01155466|877206|P5|Overall Study|Randomized not treated|2
265155|NCT01155466|877207|P4|Overall Study|Randomized not treated|0
265156|NCT01155466|877208|P3|Overall Study|Randomized not treated|3
265157|NCT01155466|877209|P2|Overall Study|Randomized not treated|2
265158|NCT01155466|877210|P1|Overall Study|Randomized not treated|2
265159|NCT01155466|877206|P5|Overall Study|Administrative|0
265160|NCT01155466|877207|P4|Overall Study|Administrative|0
265161|NCT01155466|877208|P3|Overall Study|Administrative|0
265162|NCT01155466|877209|P2|Overall Study|Administrative|3
265163|NCT01155466|877210|P1|Overall Study|Administrative|0
265164|NCT01155466|877206|P5|Overall Study|Protocol Violation|1
265165|NCT01155466|877207|P4|Overall Study|Protocol Violation|0
265166|NCT01155466|877208|P3|Overall Study|Protocol Violation|2
265167|NCT01155466|877209|P2|Overall Study|Protocol Violation|0
265168|NCT01155466|877210|P1|Overall Study|Protocol Violation|0
265169|NCT01155466|877206|P5|Overall Study|Withdrawal by Subject|4
265170|NCT01155466|877207|P4|Overall Study|Withdrawal by Subject|4
265171|NCT01155466|877208|P3|Overall Study|Withdrawal by Subject|9
265172|NCT01155466|877209|P2|Overall Study|Withdrawal by Subject|5
265173|NCT01155466|877210|P1|Overall Study|Withdrawal by Subject|7
265174|NCT01155466|877206|P5|Overall Study|Lost to Follow-up|2
265175|NCT01155466|877207|P4|Overall Study|Lost to Follow-up|0
265176|NCT01155466|877208|P3|Overall Study|Lost to Follow-up|0
265177|NCT01155466|877209|P2|Overall Study|Lost to Follow-up|0
265178|NCT01155466|877210|P1|Overall Study|Lost to Follow-up|0
265179|NCT01155466|877206|P5|Overall Study|Adverse Event|18
265180|NCT01155466|877207|P4|Overall Study|Adverse Event|17
265181|NCT01155466|877208|P3|Overall Study|Adverse Event|6
265182|NCT01155466|877209|P2|Overall Study|Adverse Event|15
265183|NCT01155466|877210|P1|Overall Study|Adverse Event|13
265184|NCT01155323|877271|P2|Second Intervention|Lost to Follow-up|1
265185|NCT01155323|877272|P1|Second Intervention|Lost to Follow-up|1
265186|NCT01155323|877271|P2|First Intervention|exclusion criteria|1
265187|NCT01155323|877272|P1|First Intervention|exclusion criteria|1
265188|NCT01155219|877290|P2|Overall Study|non-medical reason|2
265189|NCT01155219|877291|P1|Overall Study|non-medical reason|1
265190|NCT01155219|877290|P2|Overall Study|Adverse Event|1
265191|NCT01155219|877291|P1|Overall Study|Adverse Event|3
265192|NCT01155167|877308|P2|Overall Study|Access site changed to femoral artery|0
265193|NCT01155167|877309|P1|Overall Study|Access site changed to femoral artery|1
265194|NCT01155167|877308|P2|Overall Study|Insufficient ultrasound data|0
265195|NCT01155167|877309|P1|Overall Study|Insufficient ultrasound data|2
265196|NCT01155141|877332|P1|Overall Study|Screen Failure|1
265197|NCT01155141|877332|P1|Overall Study|Withdrawal by Subject|1
265198|NCT01155063|877344|P1|Overall Study|Study terminated by sponsor|87
265199|NCT01155063|877344|P1|Overall Study|Withdrawal by Subject|1
265200|NCT01155063|877344|P1|Overall Study|Adverse Event|1
265201|NCT01155024|877354|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
265202|NCT01155024|877355|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
265203|NCT01155024|877354|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
265204|NCT01155024|877355|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
265205|NCT01155024|877354|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
265206|NCT01155024|877355|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
265207|NCT01154816|877394|P12|Overall Study|Adverse Event|0
265208|NCT01154816|877395|P11|Overall Study|Adverse Event|0
265209|NCT01154816|877396|P10|Overall Study|Adverse Event|0
265210|NCT01154816|877397|P9|Overall Study|Adverse Event|0
265211|NCT01154816|877398|P8|Overall Study|Adverse Event|1
265212|NCT01154816|877399|P7|Overall Study|Adverse Event|1
265213|NCT01154816|877400|P6|Overall Study|Adverse Event|0
265214|NCT01154816|877401|P5|Overall Study|Adverse Event|0
265215|NCT01154816|877402|P4|Overall Study|Adverse Event|0
265216|NCT01154816|877403|P3|Overall Study|Adverse Event|0
265217|NCT01154816|877404|P2|Overall Study|Adverse Event|2
265218|NCT01154816|877405|P1|Overall Study|Adverse Event|5
265219|NCT01154816|877394|P12|Overall Study|Physician Decision|1
265220|NCT01154816|877395|P11|Overall Study|Physician Decision|1
265221|NCT01154816|877396|P10|Overall Study|Physician Decision|1
265222|NCT01154816|877397|P9|Overall Study|Physician Decision|0
265223|NCT01154816|877398|P8|Overall Study|Physician Decision|0
265224|NCT01154816|877399|P7|Overall Study|Physician Decision|0
265225|NCT01154816|877400|P6|Overall Study|Physician Decision|0
265226|NCT01154816|877401|P5|Overall Study|Physician Decision|2
265227|NCT01154816|877402|P4|Overall Study|Physician Decision|0
265228|NCT01154816|877403|P3|Overall Study|Physician Decision|1
265229|NCT01154816|877404|P2|Overall Study|Physician Decision|0
265230|NCT01154816|877405|P1|Overall Study|Physician Decision|1
265231|NCT01154816|877394|P12|Overall Study|Progressive Disease|3
265232|NCT01154816|877395|P11|Overall Study|Progressive Disease|10
265233|NCT01154816|877396|P10|Overall Study|Progressive Disease|6
265234|NCT01154816|877397|P9|Overall Study|Progressive Disease|8
265235|NCT01154816|877398|P8|Overall Study|Progressive Disease|6
265236|NCT01154816|877399|P7|Overall Study|Progressive Disease|5
265237|NCT01154816|877400|P6|Overall Study|Progressive Disease|8
265238|NCT01154816|877401|P5|Overall Study|Progressive Disease|8
265239|NCT01154816|877402|P4|Overall Study|Progressive Disease|9
265240|NCT01154816|877403|P3|Overall Study|Progressive Disease|9
265241|NCT01154816|877404|P2|Overall Study|Progressive Disease|8
265242|NCT01154816|877405|P1|Overall Study|Progressive Disease|13
265243|NCT01154816|877394|P12|Overall Study|Withdrawal by Subject|0
265244|NCT01154816|877395|P11|Overall Study|Withdrawal by Subject|0
265245|NCT01154816|877396|P10|Overall Study|Withdrawal by Subject|3
265246|NCT01154816|877397|P9|Overall Study|Withdrawal by Subject|1
265247|NCT01154816|877398|P8|Overall Study|Withdrawal by Subject|0
265248|NCT01154816|877399|P7|Overall Study|Withdrawal by Subject|0
265249|NCT01154816|877400|P6|Overall Study|Withdrawal by Subject|0
265250|NCT01154816|877401|P5|Overall Study|Withdrawal by Subject|0
265251|NCT01154816|877402|P4|Overall Study|Withdrawal by Subject|1
265252|NCT01154816|877403|P3|Overall Study|Withdrawal by Subject|0
265253|NCT01154816|877404|P2|Overall Study|Withdrawal by Subject|0
265254|NCT01154816|877405|P1|Overall Study|Withdrawal by Subject|1
265255|NCT01154673|877459|P2|Overall Study|moved out of province|0
265256|NCT01154673|877460|P1|Overall Study|moved out of province|1
265257|NCT01154673|877459|P2|Overall Study|Lost to Follow-up|0
265258|NCT01154673|877460|P1|Overall Study|Lost to Follow-up|1
265259|NCT01154452|877515|P4|Phase II|Adverse Event|4
265260|NCT01154452|877516|P3|Phase II|Adverse Event|4
265261|NCT01154452|877517|P2|Phase II|Adverse Event|0
265262|NCT01154452|877518|P1|Phase II|Adverse Event|0
265263|NCT01154452|877515|P4|Phase II|Withdrawal by Subject|2
265264|NCT01154452|877516|P3|Phase II|Withdrawal by Subject|1
265265|NCT01154452|877517|P2|Phase II|Withdrawal by Subject|0
265266|NCT01154452|877518|P1|Phase II|Withdrawal by Subject|0
265267|NCT01154452|877515|P4|Phase Ib|Adverse Event|0
265268|NCT01154452|877516|P3|Phase Ib|Adverse Event|0
265269|NCT01154452|877517|P2|Phase Ib|Adverse Event|1
265270|NCT01154452|877518|P1|Phase Ib|Adverse Event|2
265271|NCT01154452|877515|P4|Phase Ib|Not Treated|0
265272|NCT01154452|877516|P3|Phase Ib|Not Treated|0
265273|NCT01154452|877517|P2|Phase Ib|Not Treated|0
265274|NCT01154452|877518|P1|Phase Ib|Not Treated|1
265275|NCT01154296|877548|P2|6-month Follow-up|Declined by Study Coordinator|4
265276|NCT01154296|877549|P1|6-month Follow-up|Declined by Study Coordinator|5
265277|NCT01154296|877548|P2|6-month Follow-up|Death|2
265278|NCT01154296|877549|P1|6-month Follow-up|Death|3
265279|NCT01154296|877548|P2|6-month Follow-up|Withdrew consent|15
265280|NCT01154296|877549|P1|6-month Follow-up|Withdrew consent|14
265281|NCT01154296|877548|P2|6-month Follow-up|Incarcerated|32
265282|NCT01154296|877549|P1|6-month Follow-up|Incarcerated|37
265283|NCT01154296|877548|P2|6-month Follow-up|Lost contact|275
265284|NCT01154296|877549|P1|6-month Follow-up|Lost contact|269
265285|NCT01154296|877548|P2|Randomization and Intervention|Left clinic early|0
265286|NCT01154296|877549|P1|Randomization and Intervention|Left clinic early|2
265287|NCT01154296|877548|P2|Randomization and Intervention|Left before test|1
265288|NCT01154296|877549|P1|Randomization and Intervention|Left before test|0
265289|NCT01154296|877548|P2|Randomization and Intervention|Did not return|0
265290|NCT01154296|877549|P1|Randomization and Intervention|Did not return|1
265291|NCT01154296|877548|P2|Randomization and Intervention|Declined by staff|0
265292|NCT01154296|877549|P1|Randomization and Intervention|Declined by staff|1
265293|NCT01154296|877548|P2|Randomization and Intervention|Decided to decline|1
265294|NCT01154296|877549|P1|Randomization and Intervention|Decided to decline|1
265295|NCT01154283|877567|P2|7-12 Weeks|Withdrawal by Subject|1
265296|NCT01154283|877568|P1|7-12 Weeks|Withdrawal by Subject|0
265297|NCT01154283|877567|P2|7-12 Weeks|Death|0
265298|NCT01154283|877568|P1|7-12 Weeks|Death|1
265299|NCT01154283|877567|P2|0-6 Weeks|Death|1
265300|NCT01154283|877568|P1|0-6 Weeks|Death|0
265301|NCT01154283|877567|P2|0-6 Weeks|Withdrawal by Subject|2
265302|NCT01154283|877568|P1|0-6 Weeks|Withdrawal by Subject|7
265303|NCT01154231|877580|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
265304|NCT01154231|877580|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
265305|NCT01154218|877586|P4|Fourth Intervention Period|Withdrawal by Subject|0
265306|NCT01154218|877587|P3|Fourth Intervention Period|Withdrawal by Subject|0
265307|NCT01154218|877588|P2|Fourth Intervention Period|Withdrawal by Subject|0
265308|NCT01154218|877589|P1|Fourth Intervention Period|Withdrawal by Subject|1
265309|NCT01154218|877586|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
265310|NCT01154218|877587|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
265311|NCT01154218|877588|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
265312|NCT01154218|877589|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
265313|NCT01154218|877586|P4|Third Intervention Period|Adverse Event|0
265314|NCT01154218|877587|P3|Third Intervention Period|Adverse Event|0
265315|NCT01154218|877588|P2|Third Intervention Period|Adverse Event|1
265316|NCT01154218|877589|P1|Third Intervention Period|Adverse Event|0
265317|NCT01154166|877641|P2|Overall Study|Poor Compliance|0
265318|NCT01154166|877642|P1|Overall Study|Poor Compliance|1
265319|NCT01154166|877641|P2|Overall Study|Disease Progression|0
265320|NCT01154166|877642|P1|Overall Study|Disease Progression|1
265321|NCT01154166|877641|P2|Overall Study|Lack of Efficacy|0
265322|NCT01154166|877642|P1|Overall Study|Lack of Efficacy|3
265323|NCT01154166|877641|P2|Overall Study|Withdrawal by Subject|1
265324|NCT01154166|877642|P1|Overall Study|Withdrawal by Subject|10
265325|NCT01154166|877641|P2|Overall Study|Protocol Violation|1
265326|NCT01154166|877642|P1|Overall Study|Protocol Violation|4
265327|NCT01154166|877641|P2|Overall Study|Lost to Follow-up|1
265328|NCT01154166|877642|P1|Overall Study|Lost to Follow-up|1
265329|NCT01154166|877641|P2|Overall Study|Adverse Event|9
265330|NCT01154166|877642|P1|Overall Study|Adverse Event|14
265331|NCT01154153|877674|P2|Overall Study|Withdrew consent|0
265332|NCT01154153|877675|P1|Overall Study|Withdrew consent|1
265333|NCT01154153|877674|P2|Overall Study|Unable to use labs|3
265334|NCT01154153|877675|P1|Overall Study|Unable to use labs|2
265335|NCT01154153|877674|P2|Overall Study|Poor compliance to protocol|0
265336|NCT01154153|877675|P1|Overall Study|Poor compliance to protocol|2
265337|NCT01154140|877693|P2|Overall Study|Randomized but not treated|2
265338|NCT01154140|877694|P1|Overall Study|Randomized but not treated|1
265339|NCT01154140|877693|P2|Overall Study|Ongoing at date of cut-off|115
265340|NCT01154140|877694|P1|Overall Study|Ongoing at date of cut-off|119
265341|NCT01154140|877693|P2|Overall Study|Not specified|1
265342|NCT01154140|877694|P1|Overall Study|Not specified|1
265343|NCT01154140|877693|P2|Overall Study|Withdrawal by Subject|5
265344|NCT01154140|877694|P1|Overall Study|Withdrawal by Subject|7
265345|NCT01154140|877693|P2|Overall Study|Lost to Follow-up|2
265346|NCT01154140|877694|P1|Overall Study|Lost to Follow-up|0
265347|NCT01154140|877693|P2|Overall Study|Death|46
265348|NCT01154140|877694|P1|Overall Study|Death|44
265349|NCT01154127|877743|P2|Period 2 (21 Days)|Protocol Deviation|1
265350|NCT01154127|877744|P1|Period 2 (21 Days)|Protocol Deviation|0
265351|NCT01154127|877743|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
265352|NCT01154127|877744|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
265353|NCT01154127|877743|P2|Washout (14 - 28 Days)|Adverse Event|0
265354|NCT01154127|877744|P1|Washout (14 - 28 Days)|Adverse Event|2
265355|NCT01154127|877743|P2|Period 1 (21 Days)|Withdrawal by Subject|2
265356|NCT01154127|877744|P1|Period 1 (21 Days)|Withdrawal by Subject|0
265357|NCT01154127|877743|P2|Period 1 (21 Days)|Adverse Event|4
265358|NCT01154127|877744|P1|Period 1 (21 Days)|Adverse Event|3
265359|NCT01154036|877769|P8|Phase II|Withdrawal by Subject|4
265360|NCT01154036|877770|P7|Phase II|Withdrawal by Subject|5
265361|NCT01154036|877771|P6|Phase II|Withdrawal by Subject|2
265362|NCT01154036|877772|P5|Phase II|Withdrawal by Subject|4
265363|NCT01154036|877773|P4|Phase II|Withdrawal by Subject|0
265364|NCT01154036|877774|P3|Phase II|Withdrawal by Subject|0
265365|NCT01154036|877775|P2|Phase II|Withdrawal by Subject|0
265366|NCT01154036|877776|P1|Phase II|Withdrawal by Subject|0
265367|NCT01154036|877769|P8|Phase II|Protocol Violation|0
265368|NCT01154036|877770|P7|Phase II|Protocol Violation|0
265369|NCT01154036|877771|P6|Phase II|Protocol Violation|2
265370|NCT01154036|877772|P5|Phase II|Protocol Violation|1
265371|NCT01154036|877773|P4|Phase II|Protocol Violation|0
265372|NCT01154036|877774|P3|Phase II|Protocol Violation|0
265373|NCT01154036|877775|P2|Phase II|Protocol Violation|0
265374|NCT01154036|877776|P1|Phase II|Protocol Violation|0
265375|NCT01154036|877769|P8|Phase II|Lost to Follow-up|1
265376|NCT01154036|877770|P7|Phase II|Lost to Follow-up|2
265377|NCT01154036|877771|P6|Phase II|Lost to Follow-up|0
265378|NCT01154036|877772|P5|Phase II|Lost to Follow-up|2
265379|NCT01154036|877773|P4|Phase II|Lost to Follow-up|1
265380|NCT01154036|877774|P3|Phase II|Lost to Follow-up|0
265381|NCT01154036|877775|P2|Phase II|Lost to Follow-up|0
265382|NCT01154036|877776|P1|Phase II|Lost to Follow-up|0
265383|NCT01154036|877769|P8|Phase II|Physician Decision|0
265384|NCT01154036|877770|P7|Phase II|Physician Decision|1
265385|NCT01154036|877771|P6|Phase II|Physician Decision|0
265386|NCT01154036|877772|P5|Phase II|Physician Decision|0
265387|NCT01154036|877773|P4|Phase II|Physician Decision|0
265388|NCT01154036|877774|P3|Phase II|Physician Decision|0
265389|NCT01154036|877775|P2|Phase II|Physician Decision|0
265390|NCT01154036|877776|P1|Phase II|Physician Decision|0
265391|NCT01154036|877769|P8|Phase II|Adverse Event|1
265392|NCT01154036|877770|P7|Phase II|Adverse Event|1
265393|NCT01154036|877771|P6|Phase II|Adverse Event|1
265394|NCT01154036|877772|P5|Phase II|Adverse Event|1
265395|NCT01154036|877773|P4|Phase II|Adverse Event|0
265396|NCT01154036|877774|P3|Phase II|Adverse Event|0
265397|NCT01154036|877775|P2|Phase II|Adverse Event|0
265398|NCT01154036|877776|P1|Phase II|Adverse Event|0
265399|NCT01154036|877769|P8|Phase I|Adverse Event|0
265400|NCT01154036|877770|P7|Phase I|Adverse Event|0
265401|NCT01154036|877771|P6|Phase I|Adverse Event|0
265402|NCT01154036|877772|P5|Phase I|Adverse Event|0
265403|NCT01154036|877773|P4|Phase I|Adverse Event|0
265404|NCT01154036|877774|P3|Phase I|Adverse Event|12
265405|NCT01154036|877775|P2|Phase I|Adverse Event|11
265406|NCT01154036|877776|P1|Phase I|Adverse Event|1
265407|NCT01154036|877769|P8|Phase I|Withdrawal by Subject|0
265408|NCT01154036|877770|P7|Phase I|Withdrawal by Subject|0
265409|NCT01154036|877771|P6|Phase I|Withdrawal by Subject|0
265410|NCT01154036|877772|P5|Phase I|Withdrawal by Subject|0
265411|NCT01154036|877773|P4|Phase I|Withdrawal by Subject|0
265412|NCT01154036|877774|P3|Phase I|Withdrawal by Subject|29
265413|NCT01154036|877775|P2|Phase I|Withdrawal by Subject|10
265414|NCT01154036|877776|P1|Phase I|Withdrawal by Subject|2
265415|NCT01154036|877769|P8|Phase I|Protocol Violation|0
265416|NCT01154036|877770|P7|Phase I|Protocol Violation|0
265417|NCT01154036|877771|P6|Phase I|Protocol Violation|0
265418|NCT01154036|877772|P5|Phase I|Protocol Violation|0
265419|NCT01154036|877773|P4|Phase I|Protocol Violation|0
265420|NCT01154036|877774|P3|Phase I|Protocol Violation|9
265421|NCT01154036|877775|P2|Phase I|Protocol Violation|3
265422|NCT01154036|877776|P1|Phase I|Protocol Violation|0
265423|NCT01154036|877769|P8|Phase I|Lost to Follow-up|0
265424|NCT01154036|877770|P7|Phase I|Lost to Follow-up|0
265425|NCT01154036|877771|P6|Phase I|Lost to Follow-up|0
265426|NCT01154036|877772|P5|Phase I|Lost to Follow-up|0
265427|NCT01154036|877773|P4|Phase I|Lost to Follow-up|0
265428|NCT01154036|877774|P3|Phase I|Lost to Follow-up|6
265429|NCT01154036|877775|P2|Phase I|Lost to Follow-up|3
265430|NCT01154036|877776|P1|Phase I|Lost to Follow-up|0
265431|NCT01154036|877769|P8|Phase I|Physician Decision|0
265432|NCT01154036|877770|P7|Phase I|Physician Decision|0
265433|NCT01154036|877771|P6|Phase I|Physician Decision|0
265434|NCT01154036|877772|P5|Phase I|Physician Decision|0
265435|NCT01154036|877773|P4|Phase I|Physician Decision|0
265436|NCT01154036|877774|P3|Phase I|Physician Decision|0
265437|NCT01154036|877775|P2|Phase I|Physician Decision|1
265438|NCT01154036|877776|P1|Phase I|Physician Decision|0
265439|NCT01154010|877900|P2|Overall Study|Lost to Follow-up|1
265440|NCT01154010|877901|P1|Overall Study|Lost to Follow-up|0
265441|NCT01153984|877907|P1|Overall Study|Adverse Event|1
265442|NCT01153984|877907|P1|Overall Study|Withdrawal by Subject|1
265443|NCT01153971|877918|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
265444|NCT01153971|877918|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
265445|NCT01153971|877918|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
265446|NCT01153971|877918|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
265447|NCT01153971|877918|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
265448|NCT01153971|877918|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
265449|NCT01153971|877918|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
265450|NCT01153958|877941|P2|Overall Study|Study Terminated|32
265451|NCT01153958|877942|P1|Overall Study|Study Terminated|36
265452|NCT01153893|877960|P2|Overall Study|Adverse Event|0
265453|NCT01153893|877961|P1|Overall Study|Adverse Event|1
265454|NCT01153841|877987|P2|Overall Study|Lost to Follow-up|0
265455|NCT01153841|877988|P1|Overall Study|Lost to Follow-up|2
265456|NCT01153841|877987|P2|Overall Study|Protocol Violation|0
265457|NCT01153841|877988|P1|Overall Study|Protocol Violation|2
265458|NCT01153841|877987|P2|Overall Study|Withdrawal by Subject|0
265459|NCT01153841|877988|P1|Overall Study|Withdrawal by Subject|1
265460|NCT01153841|877987|P2|Overall Study|Adverse Event|0
265461|NCT01153841|877988|P1|Overall Study|Adverse Event|1
265466|NCT01153763|878027|P1|Overall Study|Ongoing (In follow-up)|24
265467|NCT01153763|878027|P1|Overall Study|Death|29
265468|NCT01153763|878027|P1|Overall Study|Withdrawal by Subject|2
265469|NCT01153763|878027|P1|Overall Study|Physician Decision|2
265470|NCT01153763|878027|P1|Overall Study|Lost to Follow-up|2
265471|NCT01153724|878038|P1|Treatment Period 2|Other reason not defined above|1
265472|NCT01153724|878038|P1|Treatment Period 2|Adverse Event|1
265473|NCT01153724|878038|P1|Treatment Period 1|Withdrawal by Subject|1
265474|NCT01153698|878078|P1|Overall Study|Not treated with Pradaxa|5
265475|NCT01153698|878078|P1|Overall Study|Other|2
265476|NCT01153698|878078|P1|Overall Study|Switch to other anticoagulants|4
265477|NCT01153698|878078|P1|Overall Study|Withdrawal by Subject|2
265478|NCT01153698|878078|P1|Overall Study|Lost to Follow-up|4
265479|NCT01153698|878078|P1|Overall Study|Adverse Event|12
265480|NCT01153633|878127|P2|Overall Study|Therapeutic failure|3
265481|NCT01153633|878128|P1|Overall Study|Therapeutic failure|3
265482|NCT01153633|878127|P2|Overall Study|Protocol Violation|1
265483|NCT01153633|878128|P1|Overall Study|Protocol Violation|1
265484|NCT01153347|878180|P4|Overall Study|Death|0
265485|NCT01153347|878181|P3|Overall Study|Death|0
265486|NCT01153347|878182|P2|Overall Study|Death|0
265487|NCT01153347|878183|P1|Overall Study|Death|1
265488|NCT01153347|878180|P4|Overall Study|Not specified|0
265489|NCT01153347|878181|P3|Overall Study|Not specified|4
265490|NCT01153347|878182|P2|Overall Study|Not specified|5
265491|NCT01153347|878183|P1|Overall Study|Not specified|5
265492|NCT01153347|878180|P4|Overall Study|Lost to Follow-up|8
265493|NCT01153347|878181|P3|Overall Study|Lost to Follow-up|11
265494|NCT01153347|878182|P2|Overall Study|Lost to Follow-up|9
265495|NCT01153347|878183|P1|Overall Study|Lost to Follow-up|4
265496|NCT01153347|878180|P4|Overall Study|Study-specific withdrawal criteria|2
265497|NCT01153347|878181|P3|Overall Study|Study-specific withdrawal criteria|1
265498|NCT01153347|878182|P2|Overall Study|Study-specific withdrawal criteria|3
265499|NCT01153347|878183|P1|Overall Study|Study-specific withdrawal criteria|4
265500|NCT01153347|878180|P4|Overall Study|Lack of Efficacy|4
265501|NCT01153347|878181|P3|Overall Study|Lack of Efficacy|0
265502|NCT01153347|878182|P2|Overall Study|Lack of Efficacy|2
265503|NCT01153347|878183|P1|Overall Study|Lack of Efficacy|2
265504|NCT01153347|878180|P4|Overall Study|Condition under investigation worsened|0
265505|NCT01153347|878181|P3|Overall Study|Condition under investigation worsened|0
265506|NCT01153347|878182|P2|Overall Study|Condition under investigation worsened|1
265507|NCT01153347|878183|P1|Overall Study|Condition under investigation worsened|1
265508|NCT01153347|878180|P4|Overall Study|Severe non-compliance to protocol|3
265509|NCT01153347|878181|P3|Overall Study|Severe non-compliance to protocol|4
265510|NCT01153347|878182|P2|Overall Study|Severe non-compliance to protocol|7
265511|NCT01153347|878183|P1|Overall Study|Severe non-compliance to protocol|6
265512|NCT01153347|878180|P4|Overall Study|Adverse Event|7
265513|NCT01153347|878181|P3|Overall Study|Adverse Event|21
265514|NCT01153347|878182|P2|Overall Study|Adverse Event|9
265515|NCT01153347|878183|P1|Overall Study|Adverse Event|3
265516|NCT01153347|878180|P4|Overall Study|Eligibility criteria not fulfilled|1
265517|NCT01153347|878181|P3|Overall Study|Eligibility criteria not fulfilled|2
265518|NCT01153347|878182|P2|Overall Study|Eligibility criteria not fulfilled|1
265519|NCT01153347|878183|P1|Overall Study|Eligibility criteria not fulfilled|0
265520|NCT01153347|878180|P4|Overall Study|Withdrawal by Subject|7
265521|NCT01153347|878181|P3|Overall Study|Withdrawal by Subject|7
265522|NCT01153347|878182|P2|Overall Study|Withdrawal by Subject|7
265523|NCT01153347|878183|P1|Overall Study|Withdrawal by Subject|7
265524|NCT01153321|878283|P2|Overall Study|Adverse Event|1
265525|NCT01153321|878284|P1|Overall Study|Adverse Event|1
265526|NCT01153321|878283|P2|Overall Study|Withdrawal by Subject|1
265527|NCT01153321|878284|P1|Overall Study|Withdrawal by Subject|0
265528|NCT01153321|878283|P2|Overall Study|Development of study withdrawal criteria|1
265529|NCT01153321|878284|P1|Overall Study|Development of study withdrawal criteria|0
265530|NCT01153269|878396|P1|Overall Study|Antiretroviral therapy break|1
265531|NCT01153269|878396|P1|Overall Study|Withdrawal by Subject|1
265532|NCT01153009|878459|P4|Overall Study|Other|2
265533|NCT01153009|878460|P3|Overall Study|Other|3
265534|NCT01153009|878461|P2|Overall Study|Other|1
265535|NCT01153009|878462|P1|Overall Study|Other|1
265536|NCT01153009|878459|P4|Overall Study|Lost to Follow-up|15
265537|NCT01153009|878460|P3|Overall Study|Lost to Follow-up|11
265538|NCT01153009|878461|P2|Overall Study|Lost to Follow-up|8
265539|NCT01153009|878462|P1|Overall Study|Lost to Follow-up|8
265540|NCT01153009|878459|P4|Overall Study|Withdrawal of Consent|6
265541|NCT01153009|878460|P3|Overall Study|Withdrawal of Consent|4
265542|NCT01153009|878461|P2|Overall Study|Withdrawal of Consent|5
265543|NCT01153009|878462|P1|Overall Study|Withdrawal of Consent|5
265544|NCT01153009|878459|P4|Overall Study|Protocol Deviations|2
265545|NCT01153009|878460|P3|Overall Study|Protocol Deviations|3
265546|NCT01153009|878461|P2|Overall Study|Protocol Deviations|3
265547|NCT01153009|878462|P1|Overall Study|Protocol Deviations|4
265548|NCT01153009|878459|P4|Overall Study|Noncompliance with Study Medication|1
265549|NCT01153009|878460|P3|Overall Study|Noncompliance with Study Medication|4
265550|NCT01153009|878461|P2|Overall Study|Noncompliance with Study Medication|3
265551|NCT01153009|878462|P1|Overall Study|Noncompliance with Study Medication|1
265552|NCT01153009|878459|P4|Overall Study|Lack of Efficacy|1
265553|NCT01153009|878460|P3|Overall Study|Lack of Efficacy|2
265554|NCT01153009|878461|P2|Overall Study|Lack of Efficacy|0
265555|NCT01153009|878462|P1|Overall Study|Lack of Efficacy|9
265556|NCT01153009|878459|P4|Overall Study|Adverse Event|10
265557|NCT01153009|878460|P3|Overall Study|Adverse Event|14
265558|NCT01153009|878461|P2|Overall Study|Adverse Event|14
265559|NCT01153009|878462|P1|Overall Study|Adverse Event|4
265560|NCT01152996|878492|P1|Overall Study|Elevated liver enzymes|1
265561|NCT01152996|878492|P1|Overall Study|Protocol Violation|22
265562|NCT01152996|878492|P1|Overall Study|Other|36
265563|NCT01152996|878492|P1|Overall Study|Noncompliance|41
265564|NCT01152996|878492|P1|Overall Study|Lack of Efficacy|68
265565|NCT01152996|878492|P1|Overall Study|Lost to Follow-up|112
265566|NCT01152996|878492|P1|Overall Study|Adverse Event|115
265567|NCT01152996|878492|P1|Overall Study|Withdrawal by Subject|142
265568|NCT01152814|878505|P1|Overall Study|Lost to Follow-up|2
265569|NCT01152788|878514|P2|Overall Study|No treatment|1
265570|NCT01152788|878515|P1|Overall Study|No treatment|0
265571|NCT01152788|878514|P2|Overall Study|Withdrawal by Subject|3
265572|NCT01152788|878515|P1|Overall Study|Withdrawal by Subject|0
265573|NCT01152580|878552|P2|Overall Study|Withdrawal by Subject|1
265574|NCT01152580|878553|P1|Overall Study|Withdrawal by Subject|0
265575|NCT01152554|878575|P2|Overall Study|Death|1
265576|NCT01152554|878576|P1|Overall Study|Death|1
265577|NCT01152554|878575|P2|Overall Study|Not specified|8
265578|NCT01152554|878576|P1|Overall Study|Not specified|28
265579|NCT01152554|878575|P2|Overall Study|Lost to Follow-up|32
265580|NCT01152554|878576|P1|Overall Study|Lost to Follow-up|87
265581|NCT01152554|878575|P2|Overall Study|Study-specific withdrawal criteria|8
265582|NCT01152554|878576|P1|Overall Study|Study-specific withdrawal criteria|17
265583|NCT01152554|878575|P2|Overall Study|Lack of Efficacy|3
265584|NCT01152554|878576|P1|Overall Study|Lack of Efficacy|20
265585|NCT01152554|878575|P2|Overall Study|Condition under investigation worsened|2
265586|NCT01152554|878576|P1|Overall Study|Condition under investigation worsened|5
265587|NCT01152554|878575|P2|Overall Study|Severe non-compliance to protocol|14
265588|NCT01152554|878576|P1|Overall Study|Severe non-compliance to protocol|36
265589|NCT01152554|878575|P2|Overall Study|Adverse Event|14
265590|NCT01152554|878576|P1|Overall Study|Adverse Event|67
265591|NCT01152554|878575|P2|Overall Study|Eligiblity criteria not fulfilled|1
265592|NCT01152554|878576|P1|Overall Study|Eligiblity criteria not fulfilled|0
265593|NCT01152554|878575|P2|Overall Study|Withdrawal by Subject|28
265594|NCT01152554|878576|P1|Overall Study|Withdrawal by Subject|73
265595|NCT01152450|878598|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
265596|NCT01152450|878599|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
265597|NCT01152450|878600|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
265598|NCT01152450|878601|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
265599|NCT01152450|878602|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
265600|NCT01152450|878603|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
265601|NCT01152450|878598|P6|Period 1 (4 Weeks)|Protocol Violation|0
265602|NCT01152450|878599|P5|Period 1 (4 Weeks)|Protocol Violation|1
265603|NCT01152450|878600|P4|Period 1 (4 Weeks)|Protocol Violation|0
265604|NCT01152450|878601|P3|Period 1 (4 Weeks)|Protocol Violation|0
265605|NCT01152450|878602|P2|Period 1 (4 Weeks)|Protocol Violation|0
265606|NCT01152450|878603|P1|Period 1 (4 Weeks)|Protocol Violation|0
265607|NCT01152450|878598|P6|Period 1 (4 Weeks)|Adverse Event|1
265608|NCT01152450|878599|P5|Period 1 (4 Weeks)|Adverse Event|1
265609|NCT01152450|878600|P4|Period 1 (4 Weeks)|Adverse Event|0
265610|NCT01152450|878601|P3|Period 1 (4 Weeks)|Adverse Event|0
265611|NCT01152450|878602|P2|Period 1 (4 Weeks)|Adverse Event|0
265612|NCT01152450|878603|P1|Period 1 (4 Weeks)|Adverse Event|0
265613|NCT01152437|878674|P3|Overall Study|Refusal to continue taking trial medicat|2
265614|NCT01152437|878675|P2|Overall Study|Refusal to continue taking trial medicat|0
265615|NCT01152437|878676|P1|Overall Study|Refusal to continue taking trial medicat|1
265616|NCT01152437|878674|P3|Overall Study|Progressive disease|32
265617|NCT01152437|878675|P2|Overall Study|Progressive disease|13
265618|NCT01152437|878676|P1|Overall Study|Progressive disease|27
265619|NCT01152437|878674|P3|Overall Study|Not treated|2
265620|NCT01152437|878675|P2|Overall Study|Not treated|1
265621|NCT01152437|878676|P1|Overall Study|Not treated|0
265622|NCT01152437|878674|P3|Overall Study|Other Adverse Event|7
265623|NCT01152437|878675|P2|Overall Study|Other Adverse Event|1
265624|NCT01152437|878676|P1|Overall Study|Other Adverse Event|8
265625|NCT01152385|878696|P4|Overall Study|Unspecified|3
265626|NCT01152385|878697|P3|Overall Study|Unspecified|2
265627|NCT01152385|878698|P2|Overall Study|Unspecified|3
265628|NCT01152385|878699|P1|Overall Study|Unspecified|4
265629|NCT01152385|878696|P4|Overall Study|Study-specific withdrawal criteria|0
265630|NCT01152385|878697|P3|Overall Study|Study-specific withdrawal criteria|2
265631|NCT01152385|878698|P2|Overall Study|Study-specific withdrawal criteria|1
265632|NCT01152385|878699|P1|Overall Study|Study-specific withdrawal criteria|1
265633|NCT01152385|878696|P4|Overall Study|Adverse Event|0
265634|NCT01152385|878697|P3|Overall Study|Adverse Event|0
265635|NCT01152385|878698|P2|Overall Study|Adverse Event|1
265636|NCT01152385|878699|P1|Overall Study|Adverse Event|1
265637|NCT01152385|878696|P4|Overall Study|Protocol Violation|1
265638|NCT01152385|878697|P3|Overall Study|Protocol Violation|0
265639|NCT01152385|878698|P2|Overall Study|Protocol Violation|0
265640|NCT01152385|878699|P1|Overall Study|Protocol Violation|0
265641|NCT01152385|878696|P4|Overall Study|Withdrawal by Subject|1
265642|NCT01152385|878697|P3|Overall Study|Withdrawal by Subject|1
265643|NCT01152385|878698|P2|Overall Study|Withdrawal by Subject|1
265644|NCT01152385|878699|P1|Overall Study|Withdrawal by Subject|3
265645|NCT01152190|878766|P2|Overall Study|Withdrawal by Subject|3
265646|NCT01152190|878767|P1|Overall Study|Withdrawal by Subject|1
265647|NCT01152190|878766|P2|Overall Study|Protocol Violation|1
265648|NCT01152190|878767|P1|Overall Study|Protocol Violation|1
265649|NCT01152190|878766|P2|Overall Study|Death|0
265650|NCT01152190|878767|P1|Overall Study|Death|1
265651|NCT01152190|878766|P2|Overall Study|Adverse Event|4
265652|NCT01152190|878767|P1|Overall Study|Adverse Event|2
265653|NCT01151579|878817|P2|Overall Study|Not meet inclusion criteria|4
265654|NCT01151579|878818|P1|Overall Study|Not meet inclusion criteria|6
265655|NCT01151579|878817|P2|Overall Study|Withdrawal by Subject|2
265656|NCT01151579|878818|P1|Overall Study|Withdrawal by Subject|3
265657|NCT01151579|878817|P2|Overall Study|Physician Decision|1
265658|NCT01151579|878818|P1|Overall Study|Physician Decision|3
265659|NCT01151410|878872|P2|Overall Study|Abnormal laboratory value(s)|1
265660|NCT01151410|878873|P1|Overall Study|Abnormal laboratory value(s)|0
265661|NCT01151410|878872|P2|Overall Study|Unsatisfactory therapeutic effect|1
265662|NCT01151410|878873|P1|Overall Study|Unsatisfactory therapeutic effect|1
265663|NCT01151410|878872|P2|Overall Study|Administrative problems|1
265664|NCT01151410|878873|P1|Overall Study|Administrative problems|1
265665|NCT01151410|878872|P2|Overall Study|Protocol deviation|1
265666|NCT01151410|878873|P1|Overall Study|Protocol deviation|2
265667|NCT01151410|878872|P2|Overall Study|Adverse Event|2
265668|NCT01151410|878873|P1|Overall Study|Adverse Event|1
265669|NCT01151410|878872|P2|Overall Study|Lost to Follow-up|4
265670|NCT01151410|878873|P1|Overall Study|Lost to Follow-up|3
265671|NCT01151410|878872|P2|Overall Study|Withdrawal by Subject|5
265672|NCT01151410|878873|P1|Overall Study|Withdrawal by Subject|3
265673|NCT01151345|878917|P2|First Intervention Period|Protocol Violation|1
265674|NCT01151345|878918|P1|First Intervention Period|Protocol Violation|0
265675|NCT01151280|878932|P1|Overall Study|Lack of Efficacy|3
265676|NCT01151280|878932|P1|Overall Study|Adverse Event|1
265677|NCT01151215|878945|P3|Overall Study|Safety as judged by the investigator|1
265678|NCT01151215|878946|P2|Overall Study|Safety as judged by the investigator|0
265679|NCT01151215|878947|P1|Overall Study|Safety as judged by the investigator|0
265680|NCT01151215|878945|P3|Overall Study|Disease progression|1
265681|NCT01151215|878946|P2|Overall Study|Disease progression|1
265682|NCT01151215|878947|P1|Overall Study|Disease progression|0
265683|NCT01151215|878945|P3|Overall Study|Withdrawal by Subject|2
265684|NCT01151215|878946|P2|Overall Study|Withdrawal by Subject|1
265685|NCT01151215|878947|P1|Overall Study|Withdrawal by Subject|3
265686|NCT01151215|878945|P3|Overall Study|Lost to Follow-up|3
265687|NCT01151215|878946|P2|Overall Study|Lost to Follow-up|0
265688|NCT01151215|878947|P1|Overall Study|Lost to Follow-up|0
265689|NCT01151215|878945|P3|Overall Study|Death|11
265690|NCT01151215|878946|P2|Overall Study|Death|20
265691|NCT01151215|878947|P1|Overall Study|Death|16
265692|NCT01151215|878945|P3|Overall Study|Worsening of condition under study|1
265693|NCT01151215|878946|P2|Overall Study|Worsening of condition under study|1
265694|NCT01151215|878947|P1|Overall Study|Worsening of condition under study|1
265695|NCT01151137|878985|P2|Overall Study|Lost to Follow-up|1
265696|NCT01151137|878986|P1|Overall Study|Lost to Follow-up|1
265697|NCT01151137|878985|P2|Overall Study|Death|27
265698|NCT01151137|878986|P1|Overall Study|Death|15
265699|NCT01151098|879004|P1|Overall Study|Miscellaneous|13
265700|NCT01151098|879004|P1|Overall Study|Protocol Violation|1
265701|NCT01151098|879004|P1|Overall Study|Lack of Efficacy|15
265702|NCT01151098|879004|P1|Overall Study|Lost to Follow-up|6
265703|NCT01151098|879004|P1|Overall Study|Adverse Event|82
265704|NCT01151085|879008|P1|Overall Study|Protocol Violation|25
265705|NCT01151085|879008|P1|Overall Study|Lost to Follow-up|31
265706|NCT01151020|879039|P1|Overall Study|Still be eligible for follow-up|79
265707|NCT01151020|879039|P1|Overall Study|Patients did not receive the device|2
265708|NCT01151020|879039|P1|Overall Study|Withdrawal by Subject|12
265709|NCT01151020|879039|P1|Overall Study|Lost to Follow-up|1
265710|NCT01151020|879039|P1|Overall Study|Conversion to open repair|1
265711|NCT01151020|879039|P1|Overall Study|Death|15
265712|NCT01150474|879118|P2|Overall Study|Surgery Changed|0
265713|NCT01150474|879119|P1|Overall Study|Surgery Changed|1
265714|NCT01150474|879118|P2|Overall Study|Drug not administered|0
265715|NCT01150474|879119|P1|Overall Study|Drug not administered|1
265716|NCT01150474|879118|P2|Overall Study|Drug did not arrive in time|0
265717|NCT01150474|879119|P1|Overall Study|Drug did not arrive in time|1
265718|NCT01150474|879118|P2|Overall Study|Rectotomy|0
265719|NCT01150474|879119|P1|Overall Study|Rectotomy|1
265720|NCT01150474|879118|P2|Overall Study|Multiple Studies|1
265721|NCT01150474|879119|P1|Overall Study|Multiple Studies|0
265722|NCT01150474|879118|P2|Overall Study|Cancer found|0
265723|NCT01150474|879119|P1|Overall Study|Cancer found|1
265724|NCT01150474|879118|P2|Overall Study|Withdrawal by Subject|2
265725|NCT01150474|879119|P1|Overall Study|Withdrawal by Subject|5
265726|NCT01150357|879164|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
265727|NCT01150357|879165|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
265728|NCT01150357|879166|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
265729|NCT01150357|879164|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
265730|NCT01150357|879165|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
265731|NCT01150357|879166|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
265732|NCT01150357|879164|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
265733|NCT01150357|879165|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
265734|NCT01150357|879166|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
265735|NCT01150357|879164|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
265736|NCT01150357|879165|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
265737|NCT01150357|879166|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
265738|NCT01150357|879164|P3|Dose Response Phase (Phase 1)|Adverse Event|1
265739|NCT01150357|879165|P2|Dose Response Phase (Phase 1)|Adverse Event|0
265740|NCT01150357|879166|P1|Dose Response Phase (Phase 1)|Adverse Event|0
265741|NCT01150357|879164|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
265742|NCT01150357|879165|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
265743|NCT01150357|879166|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
265744|NCT01150357|879164|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
265745|NCT01150357|879165|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
265746|NCT01150357|879166|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
265747|NCT01150123|879246|P18|Overall Study|Lost to Follow-up|0
265748|NCT01150123|879247|P17|Overall Study|Lost to Follow-up|0
265749|NCT01150123|879248|P16|Overall Study|Lost to Follow-up|0
265750|NCT01150123|879249|P15|Overall Study|Lost to Follow-up|0
265751|NCT01150123|879250|P14|Overall Study|Lost to Follow-up|0
265752|NCT01150123|879251|P13|Overall Study|Lost to Follow-up|2
265753|NCT01150123|879252|P12|Overall Study|Lost to Follow-up|1
265754|NCT01150123|879253|P11|Overall Study|Lost to Follow-up|1
265755|NCT01150123|879254|P10|Overall Study|Lost to Follow-up|1
265756|NCT01150123|879255|P9|Overall Study|Lost to Follow-up|3
265757|NCT01150123|879256|P8|Overall Study|Lost to Follow-up|0
265758|NCT01150123|879257|P7|Overall Study|Lost to Follow-up|0
265759|NCT01150123|879258|P6|Overall Study|Lost to Follow-up|5
265760|NCT01150123|879259|P5|Overall Study|Lost to Follow-up|2
265761|NCT01150123|879260|P4|Overall Study|Lost to Follow-up|2
265762|NCT01150123|879261|P3|Overall Study|Lost to Follow-up|2
265763|NCT01150123|879262|P2|Overall Study|Lost to Follow-up|1
265764|NCT01150123|879263|P1|Overall Study|Lost to Follow-up|2
265765|NCT01150123|879246|P18|Overall Study|Withdrawal by Subject|1
265766|NCT01150123|879247|P17|Overall Study|Withdrawal by Subject|0
265767|NCT01150123|879248|P16|Overall Study|Withdrawal by Subject|1
265768|NCT01150123|879249|P15|Overall Study|Withdrawal by Subject|0
265769|NCT01150123|879250|P14|Overall Study|Withdrawal by Subject|0
265770|NCT01150123|879251|P13|Overall Study|Withdrawal by Subject|1
265771|NCT01150123|879252|P12|Overall Study|Withdrawal by Subject|0
265772|NCT01150123|879253|P11|Overall Study|Withdrawal by Subject|1
265773|NCT01150123|879254|P10|Overall Study|Withdrawal by Subject|0
265774|NCT01150123|879255|P9|Overall Study|Withdrawal by Subject|2
265775|NCT01150123|879256|P8|Overall Study|Withdrawal by Subject|3
265776|NCT01150123|879257|P7|Overall Study|Withdrawal by Subject|0
265777|NCT01150123|879258|P6|Overall Study|Withdrawal by Subject|1
265778|NCT01150123|879259|P5|Overall Study|Withdrawal by Subject|1
265779|NCT01150123|879260|P4|Overall Study|Withdrawal by Subject|1
265780|NCT01150123|879261|P3|Overall Study|Withdrawal by Subject|2
265781|NCT01150123|879262|P2|Overall Study|Withdrawal by Subject|1
265782|NCT01150123|879263|P1|Overall Study|Withdrawal by Subject|1
265783|NCT01150097|879439|P3|Months 24 to 48 Post-transplantation|Death|0
265784|NCT01150097|879440|P2|Months 24 to 48 Post-transplantation|Death|0
265785|NCT01150097|879441|P1|Months 24 to 48 Post-transplantation|Death|2
265786|NCT01150097|879439|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
265787|NCT01150097|879440|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
265788|NCT01150097|879441|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
265789|NCT01150097|879439|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
265790|NCT01150097|879440|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
265791|NCT01150097|879441|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
265792|NCT01150097|879439|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
265793|NCT01150097|879440|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
265794|NCT01150097|879441|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
265795|NCT01150097|879439|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
265796|NCT01150097|879440|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
265797|NCT01150097|879441|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
265798|NCT01150097|879439|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
265873|NCT01149486|879612|P2|First Intervention|Adverse Event|1
265799|NCT01150097|879440|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
265800|NCT01150097|879441|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
265801|NCT01150097|879439|P3|Months 24 to 36 Post-transplantation|Death|0
265802|NCT01150097|879440|P2|Months 24 to 36 Post-transplantation|Death|0
265803|NCT01150097|879441|P1|Months 24 to 36 Post-transplantation|Death|2
265804|NCT01149863|879485|P1|Overall Study|Missing data or Not receiveing studydrug|3
265805|NCT01149655|879562|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
265806|NCT01149655|879563|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
265807|NCT01149655|879564|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
265808|NCT01149655|879565|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
265809|NCT01149655|879562|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
265810|NCT01149655|879563|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
265811|NCT01149655|879564|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
265812|NCT01149655|879565|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
265813|NCT01149655|879562|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
265814|NCT01149655|879563|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
265815|NCT01149655|879564|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
265816|NCT01149655|879565|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
265817|NCT01149655|879562|P4|Period 3-DB Maintenance Phase|Physician Decision|0
265818|NCT01149655|879563|P3|Period 3-DB Maintenance Phase|Physician Decision|1
265819|NCT01149655|879564|P2|Period 3-DB Maintenance Phase|Physician Decision|0
265820|NCT01149655|879565|P1|Period 3-DB Maintenance Phase|Physician Decision|0
265821|NCT01149655|879562|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
265822|NCT01149655|879563|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
265823|NCT01149655|879564|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
265824|NCT01149655|879565|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
265825|NCT01149655|879562|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
265826|NCT01149655|879563|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
265827|NCT01149655|879564|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
265828|NCT01149655|879565|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
265829|NCT01149655|879562|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
265830|NCT01149655|879563|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
265831|NCT01149655|879564|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
265832|NCT01149655|879565|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
265833|NCT01149655|879562|P4|Period 2-Stabilization Phase|Physician Decision|0
265834|NCT01149655|879563|P3|Period 2-Stabilization Phase|Physician Decision|0
265835|NCT01149655|879564|P2|Period 2-Stabilization Phase|Physician Decision|3
265836|NCT01149655|879565|P1|Period 2-Stabilization Phase|Physician Decision|0
265837|NCT01149655|879562|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
265838|NCT01149655|879563|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
265839|NCT01149655|879564|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
265840|NCT01149655|879565|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
265841|NCT01149655|879562|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
265842|NCT01149655|879563|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
265843|NCT01149655|879564|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
265844|NCT01149655|879565|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
265845|NCT01149655|879562|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
265846|NCT01149655|879563|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
265847|NCT01149655|879564|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
265848|NCT01149655|879565|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
265849|NCT01149655|879562|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
265850|NCT01149655|879563|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
265851|NCT01149655|879564|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
265852|NCT01149655|879565|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
265853|NCT01149655|879562|P4|Period 1 - Conversion Phase|Physician Decision|0
265854|NCT01149655|879563|P3|Period 1 - Conversion Phase|Physician Decision|0
265855|NCT01149655|879564|P2|Period 1 - Conversion Phase|Physician Decision|0
265856|NCT01149655|879565|P1|Period 1 - Conversion Phase|Physician Decision|2
265857|NCT01149655|879562|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
265858|NCT01149655|879563|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
265859|NCT01149655|879564|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
265860|NCT01149655|879565|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
265861|NCT01149655|879562|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
265862|NCT01149655|879563|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
265863|NCT01149655|879564|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
265864|NCT01149655|879565|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
265865|NCT01149655|879562|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
265866|NCT01149655|879563|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
265867|NCT01149655|879564|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
265868|NCT01149655|879565|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
265869|NCT01149538|879595|P2|Overall Study|Withdrawal by Subject|3
265870|NCT01149538|879596|P1|Overall Study|Withdrawal by Subject|5
265871|NCT01149538|879595|P2|Overall Study|Lost to Follow-up|1
265872|NCT01149538|879596|P1|Overall Study|Lost to Follow-up|0
265874|NCT01149486|879613|P1|First Intervention|Adverse Event|0
265875|NCT01149473|879637|P2|Washout of 7 Days|Withdrawal by Subject|1
265876|NCT01149473|879638|P1|Washout of 7 Days|Withdrawal by Subject|1
265877|NCT01149473|879637|P2|First Intervention|Adverse Event|1
265878|NCT01149473|879638|P1|First Intervention|Adverse Event|1
265879|NCT01149460|879656|P2|Overall Study|Withdrawal by Subject|2
265880|NCT01149460|879657|P1|Overall Study|Withdrawal by Subject|0
265881|NCT01149421|879690|P3|Overall Study|Protocol Violation|6
265882|NCT01149421|879691|P2|Overall Study|Protocol Violation|2
265883|NCT01149421|879692|P1|Overall Study|Protocol Violation|2
265884|NCT01149421|879690|P3|Overall Study|Entry Criteria Not Met|2
265885|NCT01149421|879691|P2|Overall Study|Entry Criteria Not Met|1
265886|NCT01149421|879692|P1|Overall Study|Entry Criteria Not Met|1
265887|NCT01149421|879690|P3|Overall Study|Physician Decision|6
265888|NCT01149421|879691|P2|Overall Study|Physician Decision|3
265889|NCT01149421|879692|P1|Overall Study|Physician Decision|5
265890|NCT01149421|879690|P3|Overall Study|Lost to Follow-up|5
265891|NCT01149421|879691|P2|Overall Study|Lost to Follow-up|4
265892|NCT01149421|879692|P1|Overall Study|Lost to Follow-up|2
265893|NCT01149421|879690|P3|Overall Study|Sponsor Decision|1
265894|NCT01149421|879691|P2|Overall Study|Sponsor Decision|1
265895|NCT01149421|879692|P1|Overall Study|Sponsor Decision|0
265896|NCT01149421|879690|P3|Overall Study|Withdrawal by Subject|13
265897|NCT01149421|879691|P2|Overall Study|Withdrawal by Subject|12
265898|NCT01149421|879692|P1|Overall Study|Withdrawal by Subject|20
265899|NCT01149421|879690|P3|Overall Study|Adverse Event|11
265900|NCT01149421|879691|P2|Overall Study|Adverse Event|6
265901|NCT01149421|879692|P1|Overall Study|Adverse Event|22
265902|NCT01149148|879773|P2|Overall Study|Death|0
265903|NCT01149148|879774|P1|Overall Study|Death|1
265904|NCT01149148|879773|P2|Overall Study|Lost to Follow-up|2
265905|NCT01149148|879774|P1|Overall Study|Lost to Follow-up|1
265906|NCT01149057|879782|P1|Overall Study|Unspecified|6
265907|NCT01149057|879782|P1|Overall Study|High Parathyroid Hormone Value|1
265908|NCT01149057|879782|P1|Overall Study|Lost to Follow-up|1
265909|NCT01149057|879782|P1|Overall Study|Participant Non-Compliance|2
265910|NCT01149057|879782|P1|Overall Study|B Cell Depletion|4
265911|NCT01149057|879782|P1|Overall Study|Positive Hepatitis B Core Antibody|5
265912|NCT01149057|879782|P1|Overall Study|Withdrawal by Subject|9
265913|NCT01149057|879782|P1|Overall Study|Adverse Event|13
265914|NCT01149057|879782|P1|Overall Study|Lack of Efficacy|16
265915|NCT01148979|879809|P2|Overall Study|Lost to Follow-up|1
265916|NCT01148979|879810|P1|Overall Study|Lost to Follow-up|0
265917|NCT01148862|879816|P2|Second Intervention|Withdrawal by Subject|2
265918|NCT01148862|879817|P1|Second Intervention|Withdrawal by Subject|0
265919|NCT01148771|879849|P2|Washout Period|Withdrawal by Subject|1
265920|NCT01148771|879850|P1|Washout Period|Withdrawal by Subject|0
265921|NCT01148693|879870|P2|Overall Study|Attempts for cannulation were failed|10
265922|NCT01148693|879871|P1|Overall Study|Attempts for cannulation were failed|13
265923|NCT01148537|879880|P3|Overall Study|Adverse Event|1
265924|NCT01148537|879881|P2|Overall Study|Adverse Event|0
265925|NCT01148537|879882|P1|Overall Study|Adverse Event|2
265926|NCT01148537|879880|P3|Overall Study|Withdrawal by Subject|2
265927|NCT01148537|879881|P2|Overall Study|Withdrawal by Subject|0
265928|NCT01148537|879882|P1|Overall Study|Withdrawal by Subject|1
265929|NCT01148511|879968|P3|Randomized|Not Specified|1
265930|NCT01148511|879969|P2|Randomized|Not Specified|1
265931|NCT01148511|879970|P1|Randomized|Not Specified|0
265932|NCT01148511|879968|P3|Randomized|Consent withdrawal|3
265933|NCT01148511|879969|P2|Randomized|Consent withdrawal|5
265934|NCT01148511|879970|P1|Randomized|Consent withdrawal|0
265935|NCT01148511|879968|P3|Randomized|Lost to Follow-up|1
265936|NCT01148511|879969|P2|Randomized|Lost to Follow-up|1
265937|NCT01148511|879970|P1|Randomized|Lost to Follow-up|0
265938|NCT01148511|879968|P3|Randomized|Protocol Violation|1
265939|NCT01148511|879969|P2|Randomized|Protocol Violation|2
265940|NCT01148511|879970|P1|Randomized|Protocol Violation|0
265941|NCT01148511|879968|P3|Randomized|Adverse Event|0
265942|NCT01148511|879969|P2|Randomized|Adverse Event|1
265943|NCT01148511|879970|P1|Randomized|Adverse Event|0
265944|NCT01148511|879968|P3|Exposed to Study Drug|Lost to Follow-up|0
265945|NCT01148511|879969|P2|Exposed to Study Drug|Lost to Follow-up|0
265946|NCT01148511|879970|P1|Exposed to Study Drug|Lost to Follow-up|4
265947|NCT01148511|879968|P3|Exposed to Study Drug|Protocol Violation|0
265948|NCT01148511|879969|P2|Exposed to Study Drug|Protocol Violation|0
265949|NCT01148511|879970|P1|Exposed to Study Drug|Protocol Violation|2
265950|NCT01148017|880008|P4|Overall Study|Unable to classify|0
265951|NCT01148017|880009|P3|Overall Study|Unable to classify|0
265952|NCT01148017|880010|P2|Overall Study|Unable to classify|1
265953|NCT01148017|880011|P1|Overall Study|Unable to classify|3
265954|NCT01148017|880008|P4|Overall Study|Administrative reason|0
265955|NCT01148017|880009|P3|Overall Study|Administrative reason|0
265956|NCT01148017|880010|P2|Overall Study|Administrative reason|9
265957|NCT01148017|880011|P1|Overall Study|Administrative reason|22
265958|NCT01148017|880008|P4|Overall Study|Inappropriate enrollment|0
265959|NCT01148017|880009|P3|Overall Study|Inappropriate enrollment|0
265960|NCT01148017|880010|P2|Overall Study|Inappropriate enrollment|0
265961|NCT01148017|880011|P1|Overall Study|Inappropriate enrollment|1
265962|NCT01148017|880008|P4|Overall Study|Lost to Follow-up|0
265963|NCT01148017|880009|P3|Overall Study|Lost to Follow-up|0
265964|NCT01148017|880010|P2|Overall Study|Lost to Follow-up|10
265965|NCT01148017|880011|P1|Overall Study|Lost to Follow-up|23
265966|NCT01148017|880008|P4|Overall Study|Withdrawal by Subject|0
265967|NCT01148017|880009|P3|Overall Study|Withdrawal by Subject|0
265968|NCT01148017|880010|P2|Overall Study|Withdrawal by Subject|14
265969|NCT01148017|880011|P1|Overall Study|Withdrawal by Subject|31
265970|NCT01147926|880050|P2|Overall Study|Colonoscopy result|1
265971|NCT01147926|880051|P1|Overall Study|Colonoscopy result|0
265972|NCT01147926|880050|P2|Overall Study|Went on holiday|1
265973|NCT01147926|880051|P1|Overall Study|Went on holiday|0
265974|NCT01147926|880050|P2|Overall Study|Too busy, no time for study|0
265975|NCT01147926|880051|P1|Overall Study|Too busy, no time for study|1
265976|NCT01147926|880050|P2|Overall Study|Lack of Efficacy|0
265977|NCT01147926|880051|P1|Overall Study|Lack of Efficacy|1
265978|NCT01147926|880050|P2|Overall Study|Sponsor's Decision|1
265979|NCT01147926|880051|P1|Overall Study|Sponsor's Decision|0
265980|NCT01147926|880050|P2|Overall Study|Lost to Follow-up|2
265981|NCT01147926|880051|P1|Overall Study|Lost to Follow-up|0
265982|NCT01147926|880050|P2|Overall Study|Selection criteria not met|1
265983|NCT01147926|880051|P1|Overall Study|Selection criteria not met|3
265984|NCT01147926|880050|P2|Overall Study|Principal investigator left hospital|3
265985|NCT01147926|880051|P1|Overall Study|Principal investigator left hospital|1
265986|NCT01147926|880050|P2|Overall Study|Subject Non-Compliant|4
265987|NCT01147926|880051|P1|Overall Study|Subject Non-Compliant|5
265988|NCT01147926|880050|P2|Overall Study|Adverse Event|6
265989|NCT01147926|880051|P1|Overall Study|Adverse Event|7
265990|NCT01147926|880050|P2|Overall Study|Subject Withdrew Consent|10
265991|NCT01147926|880051|P1|Overall Study|Subject Withdrew Consent|9
265992|NCT01147900|880086|P3|At Year 10|Lost to Follow-up|0
265993|NCT01147900|880087|P2|At Year 10|Lost to Follow-up|1
265994|NCT01147900|880088|P1|At Year 10|Lost to Follow-up|0
265995|NCT01147874|880147|P1|Overall Study|Withdrawal by Subject|24
265996|NCT01147874|880147|P1|Overall Study|Sponsor's Decision|2
265997|NCT01147874|880147|P1|Overall Study|Protocol Violation|5
265998|NCT01147874|880147|P1|Overall Study|Unspecified|5
265999|NCT01147874|880147|P1|Overall Study|Lost to Follow-up|25
266000|NCT01147874|880147|P1|Overall Study|Investigator’s Request|1
266001|NCT01147874|880147|P1|Overall Study|Adverse Event|5
266002|NCT01147848|880155|P3|Randomized Phase|Withdrawal by Subject|9
266003|NCT01147848|880156|P2|Randomized Phase|Withdrawal by Subject|7
266004|NCT01147848|880157|P1|Randomized Phase|Withdrawal by Subject|0
266005|NCT01147848|880155|P3|Randomized Phase|Physician Decision|1
266006|NCT01147848|880156|P2|Randomized Phase|Physician Decision|0
266007|NCT01147848|880157|P1|Randomized Phase|Physician Decision|0
266008|NCT01147848|880155|P3|Randomized Phase|Lost to Follow-up|7
266009|NCT01147848|880156|P2|Randomized Phase|Lost to Follow-up|5
266010|NCT01147848|880157|P1|Randomized Phase|Lost to Follow-up|0
266011|NCT01147848|880155|P3|Randomized Phase|Protocol Violation|10
266012|NCT01147848|880156|P2|Randomized Phase|Protocol Violation|7
266013|NCT01147848|880157|P1|Randomized Phase|Protocol Violation|0
266014|NCT01147848|880155|P3|Randomized Phase|Lack of Efficacy|11
266015|NCT01147848|880156|P2|Randomized Phase|Lack of Efficacy|20
266016|NCT01147848|880157|P1|Randomized Phase|Lack of Efficacy|0
266017|NCT01147848|880155|P3|Randomized Phase|Adverse Event|8
266018|NCT01147848|880156|P2|Randomized Phase|Adverse Event|6
266019|NCT01147848|880157|P1|Randomized Phase|Adverse Event|0
266020|NCT01147848|880155|P3|Run-in Period|Run-in Failure|0
266021|NCT01147848|880156|P2|Run-in Period|Run-in Failure|0
266022|NCT01147848|880157|P1|Run-in Period|Run-in Failure|135
266023|NCT01147848|880155|P3|Run-in Period|Screen Failure|0
266024|NCT01147848|880156|P2|Run-in Period|Screen Failure|0
266025|NCT01147848|880157|P1|Run-in Period|Screen Failure|623
266026|NCT01147822|880189|P2|Overall Study|Not Completed/Ongoing|102
266027|NCT01147822|880190|P1|Overall Study|Not Completed/Ongoing|111
266028|NCT01147822|880189|P2|Overall Study|Withdrawal by Subject|13
266029|NCT01147822|880190|P1|Overall Study|Withdrawal by Subject|8
266030|NCT01147822|880189|P2|Overall Study|Physician Decision|2
266031|NCT01147822|880190|P1|Overall Study|Physician Decision|0
266032|NCT01147822|880189|P2|Overall Study|Lost to Follow-up|2
266033|NCT01147822|880190|P1|Overall Study|Lost to Follow-up|3
266034|NCT01147822|880189|P2|Overall Study|Protocol Violation|1
266035|NCT01147822|880190|P1|Overall Study|Protocol Violation|0
266036|NCT01147822|880189|P2|Overall Study|Death|59
266037|NCT01147822|880190|P1|Overall Study|Death|66
266038|NCT01147809|880210|P6|Phase II (168 Days)|Ongoing|0
266039|NCT01147809|880211|P5|Phase II (168 Days)|Ongoing|1
266040|NCT01147809|880212|P4|Phase II (168 Days)|Ongoing|0
266041|NCT01147809|880213|P3|Phase II (168 Days)|Ongoing|0
266042|NCT01147809|880214|P2|Phase II (168 Days)|Ongoing|0
266043|NCT01147809|880215|P1|Phase II (168 Days)|Ongoing|0
266044|NCT01147809|880210|P6|Phase II (168 Days)|Withdrawal by Subject|15
266045|NCT01147809|880211|P5|Phase II (168 Days)|Withdrawal by Subject|7
266046|NCT01147809|880212|P4|Phase II (168 Days)|Withdrawal by Subject|0
266047|NCT01147809|880213|P3|Phase II (168 Days)|Withdrawal by Subject|0
266048|NCT01147809|880214|P2|Phase II (168 Days)|Withdrawal by Subject|0
266049|NCT01147809|880215|P1|Phase II (168 Days)|Withdrawal by Subject|0
266050|NCT01147809|880210|P6|Phase II (168 Days)|Physician Decision|11
266051|NCT01147809|880211|P5|Phase II (168 Days)|Physician Decision|5
266052|NCT01147809|880212|P4|Phase II (168 Days)|Physician Decision|0
266053|NCT01147809|880213|P3|Phase II (168 Days)|Physician Decision|0
266054|NCT01147809|880214|P2|Phase II (168 Days)|Physician Decision|0
266055|NCT01147809|880215|P1|Phase II (168 Days)|Physician Decision|0
266056|NCT01147809|880210|P6|Phase II (168 Days)|Protocol Violation|1
266057|NCT01147809|880211|P5|Phase II (168 Days)|Protocol Violation|0
266058|NCT01147809|880212|P4|Phase II (168 Days)|Protocol Violation|0
266059|NCT01147809|880213|P3|Phase II (168 Days)|Protocol Violation|0
266060|NCT01147809|880214|P2|Phase II (168 Days)|Protocol Violation|0
266061|NCT01147809|880215|P1|Phase II (168 Days)|Protocol Violation|0
266062|NCT01147809|880210|P6|Phase II (168 Days)|Adverse Event|6
266063|NCT01147809|880211|P5|Phase II (168 Days)|Adverse Event|3
266064|NCT01147809|880212|P4|Phase II (168 Days)|Adverse Event|0
266065|NCT01147809|880213|P3|Phase II (168 Days)|Adverse Event|0
266066|NCT01147809|880214|P2|Phase II (168 Days)|Adverse Event|0
266067|NCT01147809|880215|P1|Phase II (168 Days)|Adverse Event|0
266068|NCT01147809|880210|P6|Phase I (168 Days)|Withdrawal by Subject|0
266069|NCT01147809|880211|P5|Phase I (168 Days)|Withdrawal by Subject|0
266070|NCT01147809|880212|P4|Phase I (168 Days)|Withdrawal by Subject|3
266071|NCT01147809|880213|P3|Phase I (168 Days)|Withdrawal by Subject|0
266072|NCT01147809|880214|P2|Phase I (168 Days)|Withdrawal by Subject|0
266073|NCT01147809|880215|P1|Phase I (168 Days)|Withdrawal by Subject|0
266074|NCT01147809|880210|P6|Phase I (168 Days)|Physician Decision|0
266075|NCT01147809|880211|P5|Phase I (168 Days)|Physician Decision|0
266076|NCT01147809|880212|P4|Phase I (168 Days)|Physician Decision|0
266077|NCT01147809|880213|P3|Phase I (168 Days)|Physician Decision|2
266078|NCT01147809|880214|P2|Phase I (168 Days)|Physician Decision|1
266079|NCT01147809|880215|P1|Phase I (168 Days)|Physician Decision|0
266080|NCT01147809|880210|P6|Phase I (168 Days)|Lost to Follow-up|0
266081|NCT01147809|880211|P5|Phase I (168 Days)|Lost to Follow-up|0
266082|NCT01147809|880212|P4|Phase I (168 Days)|Lost to Follow-up|1
266083|NCT01147809|880213|P3|Phase I (168 Days)|Lost to Follow-up|0
266084|NCT01147809|880214|P2|Phase I (168 Days)|Lost to Follow-up|0
266085|NCT01147809|880215|P1|Phase I (168 Days)|Lost to Follow-up|1
266086|NCT01147809|880210|P6|Phase I (168 Days)|Adverse Event|0
266087|NCT01147809|880211|P5|Phase I (168 Days)|Adverse Event|0
266088|NCT01147809|880212|P4|Phase I (168 Days)|Adverse Event|1
266089|NCT01147809|880213|P3|Phase I (168 Days)|Adverse Event|0
266090|NCT01147809|880214|P2|Phase I (168 Days)|Adverse Event|0
266091|NCT01147809|880215|P1|Phase I (168 Days)|Adverse Event|0
266092|NCT01147653|880331|P2|Year 2|Withdrawal by Subject|3
266093|NCT01147653|880332|P1|Year 2|Withdrawal by Subject|2
266094|NCT01147640|880389|P2|Overall Study|Didn't meet eligibility criteria|0
266095|NCT01147640|880390|P1|Overall Study|Didn't meet eligibility criteria|1
266096|NCT01147640|880389|P2|Overall Study|Lost to Follow-up|1
266097|NCT01147640|880390|P1|Overall Study|Lost to Follow-up|0
266098|NCT01147640|880389|P2|Overall Study|Withdrawal by Subject|0
266099|NCT01147640|880390|P1|Overall Study|Withdrawal by Subject|1
266100|NCT01147640|880389|P2|Overall Study|Physician Decision|0
266101|NCT01147640|880390|P1|Overall Study|Physician Decision|1
266102|NCT01147640|880389|P2|Overall Study|Adverse Event|0
266103|NCT01147640|880390|P1|Overall Study|Adverse Event|2
266104|NCT01147497|880413|P2|Overall Study|failed insertion|0
266105|NCT01147497|880414|P1|Overall Study|failed insertion|2
266106|NCT01147471|880426|P2|6 Month Follow Up|Lost to Follow-up|2
266107|NCT01147471|880427|P1|6 Month Follow Up|Lost to Follow-up|4
266108|NCT01147471|880426|P2|3 Month Follow Up|Physician Decision|1
266109|NCT01147471|880427|P1|3 Month Follow Up|Physician Decision|0
266110|NCT01147471|880426|P2|3 Month Follow Up|Lost to Follow-up|1
266111|NCT01147471|880427|P1|3 Month Follow Up|Lost to Follow-up|1
266112|NCT01147471|880426|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
266113|NCT01147471|880427|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
266114|NCT01147471|880426|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
266115|NCT01147471|880427|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
266116|NCT01147471|880426|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
266117|NCT01147471|880427|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
266118|NCT01147458|880441|P4|Second Intervention|Unspecified|0
266119|NCT01147458|880442|P3|Second Intervention|Unspecified|1
266120|NCT01147458|880443|P2|Second Intervention|Unspecified|0
266121|NCT01147458|880444|P1|Second Intervention|Unspecified|0
266122|NCT01147458|880441|P4|Second Intervention|Adverse Event|1
266123|NCT01147458|880442|P3|Second Intervention|Adverse Event|1
266124|NCT01147458|880443|P2|Second Intervention|Adverse Event|0
266125|NCT01147458|880444|P1|Second Intervention|Adverse Event|2
266126|NCT01147458|880441|P4|Second Intervention|Withdrawal by Subject|0
266127|NCT01147458|880442|P3|Second Intervention|Withdrawal by Subject|0
266128|NCT01147458|880443|P2|Second Intervention|Withdrawal by Subject|1
266129|NCT01147458|880444|P1|Second Intervention|Withdrawal by Subject|0
266130|NCT01147458|880441|P4|Second Intervention|Protocol Violation|0
266131|NCT01147458|880442|P3|Second Intervention|Protocol Violation|1
266132|NCT01147458|880443|P2|Second Intervention|Protocol Violation|1
266133|NCT01147458|880444|P1|Second Intervention|Protocol Violation|0
266134|NCT01147458|880441|P4|Second Intervention|Study terminated by sponsor|3
266135|NCT01147458|880442|P3|Second Intervention|Study terminated by sponsor|5
266136|NCT01147458|880443|P2|Second Intervention|Study terminated by sponsor|5
266137|NCT01147458|880444|P1|Second Intervention|Study terminated by sponsor|7
266138|NCT01147458|880441|P4|First Intervention|Unspecified|0
266139|NCT01147458|880442|P3|First Intervention|Unspecified|0
266140|NCT01147458|880443|P2|First Intervention|Unspecified|2
266141|NCT01147458|880444|P1|First Intervention|Unspecified|1
266142|NCT01147458|880441|P4|First Intervention|Adverse Event|3
266143|NCT01147458|880442|P3|First Intervention|Adverse Event|2
266144|NCT01147458|880443|P2|First Intervention|Adverse Event|3
266145|NCT01147458|880444|P1|First Intervention|Adverse Event|0
266146|NCT01147458|880441|P4|First Intervention|Withdrawal by Subject|0
266147|NCT01147458|880442|P3|First Intervention|Withdrawal by Subject|1
266148|NCT01147458|880443|P2|First Intervention|Withdrawal by Subject|0
266149|NCT01147458|880444|P1|First Intervention|Withdrawal by Subject|3
266150|NCT01147458|880441|P4|First Intervention|Protocol Violation|3
266151|NCT01147458|880442|P3|First Intervention|Protocol Violation|2
266152|NCT01147458|880443|P2|First Intervention|Protocol Violation|3
266153|NCT01147458|880444|P1|First Intervention|Protocol Violation|2
266154|NCT01147458|880441|P4|First Intervention|Study terminated by sponsor|8
266155|NCT01147458|880442|P3|First Intervention|Study terminated by sponsor|7
266156|NCT01147458|880443|P2|First Intervention|Study terminated by sponsor|8
266157|NCT01147458|880444|P1|First Intervention|Study terminated by sponsor|8
266158|NCT01147393|880523|P1|Dose Level -1|Dose Limited Toxicity|1
266159|NCT01147393|880523|P1|Dose Level 1|Dose limiting Toxicity|2
266160|NCT01147341|880544|P2|Open Label Period|Subject moved|0
266161|NCT01147341|880545|P1|Open Label Period|Subject moved|1
266162|NCT01147341|880544|P2|Open Label Period|Lack of Efficacy|0
266163|NCT01147341|880545|P1|Open Label Period|Lack of Efficacy|3
266164|NCT01147341|880544|P2|Double Blind Period|Withdrawal by Subject|1
266165|NCT01147341|880545|P1|Double Blind Period|Withdrawal by Subject|0
266166|NCT01147341|880544|P2|Double Blind Period|Lack of Efficacy|1
266167|NCT01147341|880545|P1|Double Blind Period|Lack of Efficacy|1
266168|NCT01147250|880608|P2|Overall Study|Other than specified|1
266169|NCT01147250|880609|P1|Overall Study|Other than specified|0
266170|NCT01147250|880608|P2|Overall Study|Site termination by sponsor|5
266171|NCT01147250|880609|P1|Overall Study|Site termination by sponsor|13
266172|NCT01147250|880608|P2|Overall Study|Withdrawal by Subject|88
266173|NCT01147250|880609|P1|Overall Study|Withdrawal by Subject|83
266174|NCT01147250|880608|P2|Overall Study|Lost to Follow-up|11
266175|NCT01147250|880609|P1|Overall Study|Lost to Follow-up|14
266176|NCT01147172|880621|P1|Overall Study|Lost to Follow-up|2
266177|NCT01147172|880621|P1|Overall Study|Withdrawal by Subject|2
266178|NCT01147068|880639|P7|Subjects That Completed Safety Follow-up|Ineligible|0
266179|NCT01147068|880640|P6|Subjects That Completed Safety Follow-up|Ineligible|0
266180|NCT01147068|880641|P5|Subjects That Completed Safety Follow-up|Ineligible|0
266181|NCT01147068|880642|P4|Subjects That Completed Safety Follow-up|Ineligible|0
266182|NCT01147068|880643|P3|Subjects That Completed Safety Follow-up|Ineligible|0
266183|NCT01147068|880644|P2|Subjects That Completed Safety Follow-up|Ineligible|1
266184|NCT01147068|880645|P1|Subjects That Completed Safety Follow-up|Ineligible|0
266185|NCT01147068|880639|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
266186|NCT01147068|880640|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
266187|NCT01147068|880641|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
266188|NCT01147068|880642|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
266189|NCT01147068|880643|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
266190|NCT01147068|880644|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
266191|NCT01147068|880645|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
266192|NCT01147068|880639|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
266193|NCT01147068|880640|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
266194|NCT01147068|880641|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
266195|NCT01147068|880642|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
266196|NCT01147068|880643|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
266197|NCT01147068|880644|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
266198|NCT01147068|880645|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
266199|NCT01147068|880639|P7|Subjects That Received 2nd Dose|Other|0
266200|NCT01147068|880640|P6|Subjects That Received 2nd Dose|Other|0
266201|NCT01147068|880641|P5|Subjects That Received 2nd Dose|Other|1
266202|NCT01147068|880642|P4|Subjects That Received 2nd Dose|Other|0
266203|NCT01147068|880643|P3|Subjects That Received 2nd Dose|Other|3
266204|NCT01147068|880644|P2|Subjects That Received 2nd Dose|Other|3
266205|NCT01147068|880645|P1|Subjects That Received 2nd Dose|Other|0
266206|NCT01147068|880639|P7|Subjects That Received 2nd Dose|Did not complete the study|0
266207|NCT01147068|880640|P6|Subjects That Received 2nd Dose|Did not complete the study|1
266208|NCT01147068|880641|P5|Subjects That Received 2nd Dose|Did not complete the study|0
266209|NCT01147068|880642|P4|Subjects That Received 2nd Dose|Did not complete the study|0
266210|NCT01147068|880643|P3|Subjects That Received 2nd Dose|Did not complete the study|0
266211|NCT01147068|880644|P2|Subjects That Received 2nd Dose|Did not complete the study|1
266212|NCT01147068|880645|P1|Subjects That Received 2nd Dose|Did not complete the study|0
266213|NCT01147068|880639|P7|Subjects That Received 2nd Dose|Ineligible|0
266214|NCT01147068|880640|P6|Subjects That Received 2nd Dose|Ineligible|0
266215|NCT01147068|880641|P5|Subjects That Received 2nd Dose|Ineligible|0
266216|NCT01147068|880642|P4|Subjects That Received 2nd Dose|Ineligible|0
266217|NCT01147068|880643|P3|Subjects That Received 2nd Dose|Ineligible|0
266218|NCT01147068|880644|P2|Subjects That Received 2nd Dose|Ineligible|1
266219|NCT01147068|880645|P1|Subjects That Received 2nd Dose|Ineligible|0
266220|NCT01147068|880639|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
266221|NCT01147068|880640|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
266222|NCT01147068|880641|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
266223|NCT01147068|880642|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
266224|NCT01147068|880643|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
266225|NCT01147068|880644|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
266226|NCT01147068|880645|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
266227|NCT01147055|880675|P2|First Intervention Period|Lost to Follow-up|0
266228|NCT01147055|880676|P1|First Intervention Period|Lost to Follow-up|1
266229|NCT01146951|880710|P2|Overall Study|Adverse Event|1
266230|NCT01146951|880711|P1|Overall Study|Adverse Event|4
266231|NCT01146912|880732|P8|Overall Study|Duplicate patient|0
266232|NCT01146912|880733|P7|Overall Study|Duplicate patient|0
266233|NCT01146912|880734|P6|Overall Study|Duplicate patient|0
266234|NCT01146912|880735|P5|Overall Study|Duplicate patient|0
266235|NCT01146912|880736|P4|Overall Study|Duplicate patient|0
266236|NCT01146912|880737|P3|Overall Study|Duplicate patient|1
266237|NCT01146912|880738|P2|Overall Study|Duplicate patient|0
266238|NCT01146912|880739|P1|Overall Study|Duplicate patient|0
266239|NCT01146912|880732|P8|Overall Study|< 14 weeks gestational age|0
266240|NCT01146912|880733|P7|Overall Study|< 14 weeks gestational age|0
266241|NCT01146912|880734|P6|Overall Study|< 14 weeks gestational age|0
266242|NCT01146912|880735|P5|Overall Study|< 14 weeks gestational age|0
266243|NCT01146912|880736|P4|Overall Study|< 14 weeks gestational age|2
266244|NCT01146912|880737|P3|Overall Study|< 14 weeks gestational age|3
266245|NCT01146912|880738|P2|Overall Study|< 14 weeks gestational age|0
266246|NCT01146912|880739|P1|Overall Study|< 14 weeks gestational age|0
266247|NCT01146912|880732|P8|Overall Study|Already received influenza vaccination|0
266248|NCT01146912|880733|P7|Overall Study|Already received influenza vaccination|56
266249|NCT01146912|880734|P6|Overall Study|Already received influenza vaccination|61
266250|NCT01146912|880735|P5|Overall Study|Already received influenza vaccination|41
266251|NCT01146912|880736|P4|Overall Study|Already received influenza vaccination|15
266252|NCT01146912|880737|P3|Overall Study|Already received influenza vaccination|13
266253|NCT01146912|880738|P2|Overall Study|Already received influenza vaccination|822
266254|NCT01146912|880739|P1|Overall Study|Already received influenza vaccination|817
266255|NCT01146873|880761|P2|Overall Study|Transfer out|6
266256|NCT01146873|880762|P1|Overall Study|Transfer out|0
266257|NCT01146860|880778|P2|Overall Study|Withdrawal by Subject|1
266258|NCT01146860|880779|P1|Overall Study|Withdrawal by Subject|0
266259|NCT01146782|880799|P1|Primary Endpoint Cohort|Physician Decision|1
266260|NCT01146782|880799|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
266261|NCT01146782|880799|P1|Safety Cohort|TST <4 hrs|14
266262|NCT01146782|880799|P1|Safety Cohort|Control AHI <5|4
266263|NCT01146782|880799|P1|Safety Cohort|Withdrawal by Subject|4
266264|NCT01146782|880799|P1|Safety Cohort|Screen Failure|61
266265|NCT01146782|880799|P1|Screening Cohort|Withdrawal by Subject|29
266266|NCT01146782|880799|P1|Screening Cohort|Physician Decision|1
266267|NCT01146782|880799|P1|Screening Cohort|Lost to Follow-up|4
266268|NCT01146782|880799|P1|Screening Cohort|Screen Failure|187
266269|NCT01146613|880808|P2|Overall Study|Outpatient detox|0
266270|NCT01146613|880809|P1|Overall Study|Outpatient detox|1
266271|NCT01146613|880808|P2|Overall Study|schedule conflict|0
266272|NCT01146613|880809|P1|Overall Study|schedule conflict|1
266273|NCT01146613|880808|P2|Overall Study|Withdrawal by Subject|3
266274|NCT01146613|880809|P1|Overall Study|Withdrawal by Subject|0
266275|NCT01146613|880808|P2|Overall Study|Physician Decision|0
266276|NCT01146613|880809|P1|Overall Study|Physician Decision|1
266277|NCT01146613|880808|P2|Overall Study|Death|0
266278|NCT01146613|880809|P1|Overall Study|Death|1
266279|NCT01146613|880808|P2|Overall Study|Lack of Efficacy|1
266280|NCT01146613|880809|P1|Overall Study|Lack of Efficacy|0
266281|NCT01146613|880808|P2|Overall Study|Lost to Follow-up|8
266282|NCT01146613|880809|P1|Overall Study|Lost to Follow-up|3
266283|NCT01146288|880900|P2|First Intervention(1 Day)|Adverse Event|1
266284|NCT01146288|880901|P1|First Intervention(1 Day)|Adverse Event|0
266285|NCT01146054|880915|P1|Overall Study|Lost to Follow-up|1
266286|NCT01146054|880915|P1|Overall Study|Other illness precluded treatment|2
266287|NCT01146054|880915|P1|Overall Study|Rapid tumor progression|2
266288|NCT01146054|880915|P1|Overall Study|Did not meet dose constraints for SBRT|5
266289|NCT01145898|880925|P2|3-year Treatment|medication change by treating physician|16
266290|NCT01145898|880926|P1|3-year Treatment|medication change by treating physician|3
266291|NCT01145755|880960|P3|Overall Study|Positive urine ethanol|0
266292|NCT01145755|880961|P2|Overall Study|Positive urine ethanol|1
266293|NCT01145755|880962|P1|Overall Study|Positive urine ethanol|0
266294|NCT01145755|880960|P3|Overall Study|Withdrawal by Subject|1
266295|NCT01145755|880961|P2|Overall Study|Withdrawal by Subject|0
266296|NCT01145755|880962|P1|Overall Study|Withdrawal by Subject|0
266297|NCT01145755|880960|P3|Overall Study|Patient could not swollow medication|1
266298|NCT01145755|880961|P2|Overall Study|Patient could not swollow medication|0
266299|NCT01145755|880962|P1|Overall Study|Patient could not swollow medication|0
266300|NCT01145755|880960|P3|Overall Study|Lack of Efficacy|0
266301|NCT01145755|880961|P2|Overall Study|Lack of Efficacy|1
266302|NCT01145755|880962|P1|Overall Study|Lack of Efficacy|0
266303|NCT01145755|880960|P3|Overall Study|Study Closure|17
266304|NCT01145755|880961|P2|Overall Study|Study Closure|14
266305|NCT01145755|880962|P1|Overall Study|Study Closure|14
266306|NCT01145755|880960|P3|Overall Study|Protocol Violation|1
266307|NCT01145755|880961|P2|Overall Study|Protocol Violation|3
266308|NCT01145755|880962|P1|Overall Study|Protocol Violation|0
266309|NCT01145755|880960|P3|Overall Study|Lost to Follow-up|1
266310|NCT01145755|880961|P2|Overall Study|Lost to Follow-up|3
266311|NCT01145755|880962|P1|Overall Study|Lost to Follow-up|2
266312|NCT01145755|880960|P3|Overall Study|Withdrawal by Subject|2
266313|NCT01145755|880961|P2|Overall Study|Withdrawal by Subject|2
266314|NCT01145755|880962|P1|Overall Study|Withdrawal by Subject|2
266315|NCT01145755|880960|P3|Overall Study|Adverse Event|2
266316|NCT01145755|880961|P2|Overall Study|Adverse Event|4
266317|NCT01145755|880962|P1|Overall Study|Adverse Event|2
266318|NCT01145625|880989|P2|Overall Study|Pregnancy|1
266319|NCT01145625|880990|P1|Overall Study|Pregnancy|0
266320|NCT01145625|880989|P2|Overall Study|Withdrawal by Subject|16
266321|NCT01145625|880990|P1|Overall Study|Withdrawal by Subject|7
266322|NCT01145625|880989|P2|Overall Study|Protocol Violation|1
266323|NCT01145625|880990|P1|Overall Study|Protocol Violation|3
266324|NCT01145625|880989|P2|Overall Study|Adverse Event|4
266325|NCT01145625|880990|P1|Overall Study|Adverse Event|6
266326|NCT01145625|880989|P2|Overall Study|Lost to Follow-up|9
266327|NCT01145625|880990|P1|Overall Study|Lost to Follow-up|8
266328|NCT01145560|881003|P3|Overall Study|Withdrawal of therapy|1
266329|NCT01145560|881004|P2|Overall Study|Withdrawal of therapy|0
266330|NCT01145560|881005|P1|Overall Study|Withdrawal of therapy|0
266331|NCT01145560|881003|P3|Overall Study|False insurance information|0
266332|NCT01145560|881004|P2|Overall Study|False insurance information|1
266333|NCT01145560|881005|P1|Overall Study|False insurance information|0
266334|NCT01145560|881003|P3|Overall Study|Accidental unblinding of study treatment|0
266335|NCT01145560|881004|P2|Overall Study|Accidental unblinding of study treatment|1
266336|NCT01145560|881005|P1|Overall Study|Accidental unblinding of study treatment|0
266337|NCT01145560|881003|P3|Overall Study|No study drug by 24h after organ failure|0
266338|NCT01145560|881004|P2|Overall Study|No study drug by 24h after organ failure|0
266339|NCT01145560|881005|P1|Overall Study|No study drug by 24h after organ failure|1
266340|NCT01145560|881003|P3|Overall Study|Lost to Follow-up|1
266341|NCT01145560|881004|P2|Overall Study|Lost to Follow-up|1
266342|NCT01145560|881005|P1|Overall Study|Lost to Follow-up|1
266343|NCT01145560|881003|P3|Overall Study|Withdrawal by Subject|0
266344|NCT01145560|881004|P2|Overall Study|Withdrawal by Subject|1
266345|NCT01145560|881005|P1|Overall Study|Withdrawal by Subject|2
266346|NCT01145508|881031|P2|Overall Study|Never started treatment|1
266347|NCT01145508|881032|P1|Overall Study|Never started treatment|1
266348|NCT01145508|881031|P2|Overall Study|Physician Decision|1
266349|NCT01145508|881032|P1|Overall Study|Physician Decision|2
266350|NCT01145508|881031|P2|Overall Study|Death|0
266351|NCT01145508|881032|P1|Overall Study|Death|1
266352|NCT01145508|881031|P2|Overall Study|Adverse Event|0
266353|NCT01145508|881032|P1|Overall Study|Adverse Event|1
266354|NCT01145495|881038|P1|Overall Study|Disease progression after respone|1
266355|NCT01145495|881038|P1|Overall Study|Withdrawal by Subject|5
266356|NCT01145495|881038|P1|Overall Study|Adverse Event|6
266357|NCT01145482|881044|P2|First Intervention (1 Day)|Withdrawal by Subject|1
266358|NCT01145482|881045|P1|First Intervention (1 Day)|Withdrawal by Subject|0
266359|NCT01145417|881055|P2|Overall Study|Unspecified|0
266360|NCT01145417|881056|P1|Overall Study|Unspecified|1
266361|NCT01145417|881055|P2|Overall Study|Study terminated by sponsor|43
266362|NCT01145417|881056|P1|Overall Study|Study terminated by sponsor|35
266363|NCT01145417|881055|P2|Overall Study|Adverse Event|1
266364|NCT01145417|881056|P1|Overall Study|Adverse Event|0
266365|NCT01145417|881055|P2|Overall Study|Pregnancy|0
266366|NCT01145417|881056|P1|Overall Study|Pregnancy|1
266367|NCT01145417|881055|P2|Overall Study|Withdrawal by Subject|2
266368|NCT01145417|881056|P1|Overall Study|Withdrawal by Subject|1
266369|NCT01145417|881055|P2|Overall Study|Lost to Follow-up|1
266370|NCT01145417|881056|P1|Overall Study|Lost to Follow-up|2
266371|NCT01145417|881055|P2|Overall Study|Death|0
266372|NCT01145417|881056|P1|Overall Study|Death|1
266373|NCT01145352|881126|P1|Overall Study|Syringe formulation was used|1
266374|NCT01145352|881126|P1|Overall Study|Treated before marketing approval|4
266375|NCT01145352|881126|P1|Overall Study|Found to have been registered twice|6
266376|NCT01145053|881134|P1|Overall Study|Other|18
266377|NCT01145053|881134|P1|Overall Study|Withdrawal by Subject|25
266378|NCT01145053|881134|P1|Overall Study|Lost to Follow-up|28
266379|NCT01145053|881134|P1|Overall Study|Adverse Event|22
266380|NCT01144715|881186|P2|Overall Study|Adverse Event|1
266381|NCT01144715|881187|P1|Overall Study|Adverse Event|0
266382|NCT01144715|881186|P2|Overall Study|Withdrawal by Subject|1
266383|NCT01144715|881187|P1|Overall Study|Withdrawal by Subject|2
266384|NCT01144715|881186|P2|Overall Study|Lost to Follow-up|1
266385|NCT01144715|881187|P1|Overall Study|Lost to Follow-up|2
266386|NCT01144416|881206|P2|Intervention Period|Other|5
266387|NCT01144416|881207|P1|Intervention Period|Other|7
266388|NCT01144416|881206|P2|Intervention Period|No/too few/bad quality embryos|3
266389|NCT01144416|881207|P1|Intervention Period|No/too few/bad quality embryos|3
266390|NCT01144416|881206|P2|Intervention Period|No or abnormal fertilization|10
266391|NCT01144416|881207|P1|Intervention Period|No or abnormal fertilization|25
266392|NCT01144416|881206|P2|Intervention Period|No/too few/bad oocytes|5
266393|NCT01144416|881207|P1|Intervention Period|No/too few/bad oocytes|7
266394|NCT01144416|881206|P2|Intervention Period|Too high ovarian response|2
266395|NCT01144416|881207|P1|Intervention Period|Too high ovarian response|4
266396|NCT01144416|881206|P2|Intervention Period|Risk of OHSS|1
266397|NCT01144416|881207|P1|Intervention Period|Risk of OHSS|0
266398|NCT01144416|881206|P2|Intervention Period|Insufficient ovarian response|17
266399|NCT01144416|881207|P1|Intervention Period|Insufficient ovarian response|11
266400|NCT01144416|881206|P2|Intervention Period|Adverse Event|6
266401|NCT01144416|881207|P1|Intervention Period|Adverse Event|5
266402|NCT01144403|881223|P1|Overall Study|Adverse Event|1
266403|NCT01144403|881223|P1|Overall Study|Death|1
266404|NCT01144403|881223|P1|Overall Study|Lost to Follow-up|3
266405|NCT01144364|881232|P3|Follow-Up/Maintenance Phase|Physician Decision|1
266406|NCT01144364|881233|P2|Follow-Up/Maintenance Phase|Physician Decision|0
266407|NCT01144364|881234|P1|Follow-Up/Maintenance Phase|Physician Decision|0
266408|NCT01144364|881232|P3|Follow-Up/Maintenance Phase|Relapse|5
266409|NCT01144364|881233|P2|Follow-Up/Maintenance Phase|Relapse|5
266410|NCT01144364|881234|P1|Follow-Up/Maintenance Phase|Relapse|0
266411|NCT01144364|881232|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
266412|NCT01144364|881233|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
266413|NCT01144364|881234|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
266414|NCT01144364|881232|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
266415|NCT01144364|881233|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
266416|NCT01144364|881234|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
266417|NCT01144364|881232|P3|Follow-Up/Maintenance Phase|Death|0
266418|NCT01144364|881233|P2|Follow-Up/Maintenance Phase|Death|2
266419|NCT01144364|881234|P1|Follow-Up/Maintenance Phase|Death|0
266420|NCT01144364|881232|P3|Follow-Up/Maintenance Phase|Adverse Event|1
266421|NCT01144364|881233|P2|Follow-Up/Maintenance Phase|Adverse Event|3
266422|NCT01144364|881234|P1|Follow-Up/Maintenance Phase|Adverse Event|0
266423|NCT01144364|881232|P3|Follow-Up/Maintenance Phase|Disease progression|29
266424|NCT01144364|881233|P2|Follow-Up/Maintenance Phase|Disease progression|23
266425|NCT01144364|881234|P1|Follow-Up/Maintenance Phase|Disease progression|0
266426|NCT01144364|881232|P3|Induction Phase|Protocol Violation|0
266427|NCT01144364|881233|P2|Induction Phase|Protocol Violation|0
266428|NCT01144364|881234|P1|Induction Phase|Protocol Violation|1
266429|NCT01144364|881232|P3|Induction Phase|Secondary neoplasia|0
266430|NCT01144364|881233|P2|Induction Phase|Secondary neoplasia|0
266431|NCT01144364|881234|P1|Induction Phase|Secondary neoplasia|1
266432|NCT01144364|881232|P3|Induction Phase|Stable disease|0
266433|NCT01144364|881233|P2|Induction Phase|Stable disease|0
266434|NCT01144364|881234|P1|Induction Phase|Stable disease|2
266435|NCT01144364|881232|P3|Induction Phase|Physician Decision|0
266436|NCT01144364|881233|P2|Induction Phase|Physician Decision|0
266437|NCT01144364|881234|P1|Induction Phase|Physician Decision|1
266438|NCT01144364|881232|P3|Induction Phase|Lost to Follow-up|0
266439|NCT01144364|881233|P2|Induction Phase|Lost to Follow-up|0
266440|NCT01144364|881234|P1|Induction Phase|Lost to Follow-up|2
266441|NCT01144364|881232|P3|Induction Phase|Withdrawal by Subject|0
266442|NCT01144364|881233|P2|Induction Phase|Withdrawal by Subject|0
266443|NCT01144364|881234|P1|Induction Phase|Withdrawal by Subject|1
266444|NCT01144364|881232|P3|Induction Phase|Death|0
266445|NCT01144364|881233|P2|Induction Phase|Death|0
266446|NCT01144364|881234|P1|Induction Phase|Death|1
266447|NCT01144364|881232|P3|Induction Phase|Adverse Event|0
266448|NCT01144364|881233|P2|Induction Phase|Adverse Event|0
266449|NCT01144364|881234|P1|Induction Phase|Adverse Event|9
266450|NCT01144364|881232|P3|Induction Phase|Disease progression|0
266451|NCT01144364|881233|P2|Induction Phase|Disease progression|0
266452|NCT01144364|881234|P1|Induction Phase|Disease progression|14
266453|NCT01144299|881260|P2|Overall Study|Withdrawal by Subject|0
266454|NCT01144299|881261|P1|Overall Study|Withdrawal by Subject|1
266455|NCT01144299|881260|P2|Overall Study|Lost to Follow-up|0
266456|NCT01144299|881261|P1|Overall Study|Lost to Follow-up|1
266457|NCT01144182|881306|P2|Overall Study|Lost to Follow-up|9
266458|NCT01144182|881307|P1|Overall Study|Lost to Follow-up|9
266459|NCT01144182|881306|P2|Overall Study|Withdrawal by Subject|6
266460|NCT01144182|881307|P1|Overall Study|Withdrawal by Subject|3
266461|NCT01144182|881306|P2|Overall Study|Death|6
266462|NCT01144182|881307|P1|Overall Study|Death|5
266463|NCT01144052|881339|P2|Overall Study|Withdrawal by Subject|1
266464|NCT01144052|881340|P1|Overall Study|Withdrawal by Subject|1
266465|NCT01143896|881371|P2|Overall Study|Death|3
266466|NCT01143896|881372|P1|Overall Study|Death|6
266467|NCT01143896|881371|P2|Overall Study|Withdrawal by Subject|5
266468|NCT01143896|881372|P1|Overall Study|Withdrawal by Subject|13
266469|NCT01143896|881371|P2|Overall Study|Lost to Follow-up|13
266470|NCT01143896|881372|P1|Overall Study|Lost to Follow-up|18
266471|NCT01143896|881371|P2|Overall Study|Did not complete Baseline Interview|4
266472|NCT01143896|881372|P1|Overall Study|Did not complete Baseline Interview|5
266473|NCT01143714|881463|P2|Overall Study|wound size increased|0
266474|NCT01143714|881464|P1|Overall Study|wound size increased|1
266475|NCT01143714|881463|P2|Overall Study|wound closed = deemed healed|0
266476|NCT01143714|881464|P1|Overall Study|wound closed = deemed healed|1
266477|NCT01143714|881463|P2|Overall Study|Subject non-compliance|1
266478|NCT01143714|881464|P1|Overall Study|Subject non-compliance|0
266479|NCT01143714|881463|P2|Overall Study|Withdrawal by Subject|0
266480|NCT01143714|881464|P1|Overall Study|Withdrawal by Subject|1
266481|NCT01143714|881463|P2|Overall Study|Adverse Event|2
266482|NCT01143714|881464|P1|Overall Study|Adverse Event|4
266483|NCT01143402|881569|P3|Overall Study|Not Treated|1
266484|NCT01143402|881570|P2|Overall Study|Not Treated|0
266485|NCT01143402|881571|P1|Overall Study|Not Treated|0
266486|NCT01143402|881569|P3|Overall Study|Rapid clinical decline|0
266487|NCT01143402|881570|P2|Overall Study|Rapid clinical decline|1
266488|NCT01143402|881571|P1|Overall Study|Rapid clinical decline|1
266489|NCT01143337|881582|P3|Overall Study|Other reason|5
266490|NCT01143337|881583|P2|Overall Study|Other reason|0
266491|NCT01143337|881584|P1|Overall Study|Other reason|0
266492|NCT01143337|881582|P3|Overall Study|Withdrawal by Subject|1
266493|NCT01143337|881583|P2|Overall Study|Withdrawal by Subject|0
266494|NCT01143337|881584|P1|Overall Study|Withdrawal by Subject|0
266495|NCT01143337|881582|P3|Overall Study|Protocol Violation|0
266496|NCT01143337|881583|P2|Overall Study|Protocol Violation|0
266497|NCT01143337|881584|P1|Overall Study|Protocol Violation|1
266498|NCT01143337|881582|P3|Overall Study|Lack of Efficacy|1
266499|NCT01143337|881583|P2|Overall Study|Lack of Efficacy|2
266500|NCT01143337|881584|P1|Overall Study|Lack of Efficacy|6
266501|NCT01143337|881582|P3|Overall Study|Adverse Event|5
266502|NCT01143337|881583|P2|Overall Study|Adverse Event|9
266503|NCT01143337|881584|P1|Overall Study|Adverse Event|3
266504|NCT01143324|881598|P1|Overall Study|Explant of the device|4
266505|NCT01143324|881598|P1|Overall Study|Withdrawal by Subject|4
266506|NCT01143324|881598|P1|Overall Study|Lost to Follow-up|11
266507|NCT01143259|881637|P2|Overall Study|Screen Failure|9
266508|NCT01143259|881638|P1|Overall Study|Screen Failure|7
266509|NCT01143259|881637|P2|Overall Study|Protocol Violation|9
266510|NCT01143259|881638|P1|Overall Study|Protocol Violation|13
266511|NCT01143259|881637|P2|Overall Study|Withdrawal by Subject|2
266512|NCT01143259|881638|P1|Overall Study|Withdrawal by Subject|3
266513|NCT01143207|881646|P1|Overall Study|Lost to Follow-up|2
266514|NCT01143090|881666|P1|Overall Study|Administrative|1
266515|NCT01143090|881666|P1|Overall Study|Failure to meet eligibility criteria|1
266516|NCT01143090|881666|P1|Overall Study|Non-compliance with study drug|1
266517|NCT01143090|881666|P1|Overall Study|Withdrawal by Subject|18
266518|NCT01143090|881666|P1|Overall Study|Protocol Violation|2
266519|NCT01143090|881666|P1|Overall Study|Lost to Follow-up|9
266520|NCT01143090|881666|P1|Overall Study|Adverse Event|17
266521|NCT01143090|881666|P1|Overall Study|Lack of Efficacy|2
266522|NCT01143077|881673|P3|Overall Study|Principal Investigator Decision|1
266523|NCT01143077|881674|P2|Overall Study|Principal Investigator Decision|0
266524|NCT01143077|881675|P1|Overall Study|Principal Investigator Decision|2
266525|NCT01143077|881673|P3|Overall Study|Administrative|0
266526|NCT01143077|881674|P2|Overall Study|Administrative|0
266527|NCT01143077|881675|P1|Overall Study|Administrative|1
266528|NCT01143077|881673|P3|Overall Study|Non-compliance with study drug|1
266529|NCT01143077|881674|P2|Overall Study|Non-compliance with study drug|1
266530|NCT01143077|881675|P1|Overall Study|Non-compliance with study drug|0
266531|NCT01143077|881673|P3|Overall Study|Withdrawal by Subject|3
266532|NCT01143077|881674|P2|Overall Study|Withdrawal by Subject|3
266533|NCT01143077|881675|P1|Overall Study|Withdrawal by Subject|4
266534|NCT01143077|881673|P3|Overall Study|Protocol Violation|0
266535|NCT01143077|881674|P2|Overall Study|Protocol Violation|0
266536|NCT01143077|881675|P1|Overall Study|Protocol Violation|2
266537|NCT01143077|881673|P3|Overall Study|Lost to Follow-up|4
266538|NCT01143077|881674|P2|Overall Study|Lost to Follow-up|3
266539|NCT01143077|881675|P1|Overall Study|Lost to Follow-up|2
266540|NCT01143077|881673|P3|Overall Study|Adverse Event|5
266541|NCT01143077|881674|P2|Overall Study|Adverse Event|6
266542|NCT01143077|881675|P1|Overall Study|Adverse Event|5
266543|NCT01143077|881673|P3|Overall Study|Lack of Efficacy|1
266544|NCT01143077|881674|P2|Overall Study|Lack of Efficacy|2
266545|NCT01143077|881675|P1|Overall Study|Lack of Efficacy|0
266546|NCT01143051|881692|P6|3-14 Day Washout|Withdrawal by Subject|1
266547|NCT01143051|881693|P5|3-14 Day Washout|Withdrawal by Subject|0
266548|NCT01143051|881694|P4|3-14 Day Washout|Withdrawal by Subject|0
266549|NCT01143051|881695|P3|3-14 Day Washout|Withdrawal by Subject|0
266550|NCT01143051|881696|P2|3-14 Day Washout|Withdrawal by Subject|0
266551|NCT01143051|881697|P1|3-14 Day Washout|Withdrawal by Subject|0
266552|NCT01143051|881692|P6|3-14 Day Washout|Withdrawal by Subject|0
266553|NCT01143051|881693|P5|3-14 Day Washout|Withdrawal by Subject|0
266554|NCT01143051|881694|P4|3-14 Day Washout|Withdrawal by Subject|0
266555|NCT01143051|881695|P3|3-14 Day Washout|Withdrawal by Subject|1
266556|NCT01143051|881696|P2|3-14 Day Washout|Withdrawal by Subject|0
266557|NCT01143051|881697|P1|3-14 Day Washout|Withdrawal by Subject|0
266558|NCT01143038|881720|P1|Overall Study|Death|1
266559|NCT01143038|881720|P1|Overall Study|Protocol Deviation|1
266560|NCT01143038|881720|P1|Overall Study|Lost to Follow-up|2
266561|NCT01143038|881720|P1|Overall Study|Adverse Event|3
266562|NCT01143038|881720|P1|Overall Study|Requirement for alternative therapy|5
266563|NCT01143038|881720|P1|Overall Study|Withdrawal by Subject|4
266564|NCT01142908|881730|P2|Overall Study|Withdrawal by Subject|0
266565|NCT01142908|881731|P1|Overall Study|Withdrawal by Subject|3
266566|NCT01142908|881730|P2|Overall Study|Excluded - did not meet criteria|5
266567|NCT01142908|881731|P1|Overall Study|Excluded - did not meet criteria|9
266568|NCT01142908|881730|P2|Overall Study|Death|4
266569|NCT01142908|881731|P1|Overall Study|Death|1
266570|NCT01142908|881730|P2|Overall Study|Lost to Follow-up|13
266571|NCT01142908|881731|P1|Overall Study|Lost to Follow-up|19
266572|NCT01142726|881780|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
266573|NCT01142726|881781|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
266574|NCT01142726|881782|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
266575|NCT01142726|881780|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
266576|NCT01142726|881781|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
266577|NCT01142726|881782|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
266578|NCT01142726|881780|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
266579|NCT01142726|881781|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
266580|NCT01142726|881782|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
266581|NCT01142726|881780|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
266582|NCT01142726|881781|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
266583|NCT01142726|881782|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
266584|NCT01142726|881780|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
266585|NCT01142726|881781|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
266586|NCT01142726|881782|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
266587|NCT01142726|881780|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
266588|NCT01142726|881781|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
266589|NCT01142726|881782|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
266590|NCT01142726|881780|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
266591|NCT01142726|881781|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
266592|NCT01142726|881782|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
266593|NCT01142726|881780|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
266594|NCT01142726|881781|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
266595|NCT01142726|881782|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
266596|NCT01142726|881780|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
266597|NCT01142726|881781|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
266598|NCT01142726|881782|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
266599|NCT01142726|881780|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
266600|NCT01142726|881781|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
266601|NCT01142726|881782|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
266602|NCT01142726|881780|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
266603|NCT01142726|881781|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
266604|NCT01142726|881782|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
266605|NCT01142726|881780|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
266606|NCT01142726|881781|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
266607|NCT01142726|881782|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
266608|NCT01142726|881780|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
266609|NCT01142726|881781|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
266610|NCT01142726|881782|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
266611|NCT01142726|881780|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
266612|NCT01142726|881781|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
266613|NCT01142726|881782|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
266614|NCT01142726|881780|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
266615|NCT01142726|881781|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
266616|NCT01142726|881782|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
266617|NCT01142726|881780|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
266618|NCT01142726|881781|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
266619|NCT01142726|881782|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
266620|NCT01142661|881845|P1|Overall Study|Physician Decision|1
266621|NCT01142661|881845|P1|Overall Study|Withdrawal by Subject|1
266622|NCT01142661|881845|P1|Overall Study|Adverse Event|2
266623|NCT01142596|881852|P2|Overall Study|Other reason (not specified)|4
266624|NCT01142596|881853|P1|Overall Study|Other reason (not specified)|5
266625|NCT01142596|881852|P2|Overall Study|Lost to Follow-up|3
266626|NCT01142596|881853|P1|Overall Study|Lost to Follow-up|2
266627|NCT01142596|881852|P2|Overall Study|Lack of Efficacy|9
266628|NCT01142596|881853|P1|Overall Study|Lack of Efficacy|5
266629|NCT01142596|881852|P2|Overall Study|Adverse Event|35
266630|NCT01142596|881853|P1|Overall Study|Adverse Event|8
266631|NCT01142596|881852|P2|Overall Study|Withdrawal by Subject|35
266632|NCT01142596|881853|P1|Overall Study|Withdrawal by Subject|9
266633|NCT01142466|881905|P2|Overall Study|Withdrawal by Subject|1
266634|NCT01142466|881906|P1|Overall Study|Withdrawal by Subject|1
266635|NCT01142466|881905|P2|Overall Study|Adverse Event|1
266636|NCT01142466|881906|P1|Overall Study|Adverse Event|2
266637|NCT01142388|881926|P2|Overall Study|Never started therapy|3
266638|NCT01142388|881927|P1|Overall Study|Never started therapy|7
266639|NCT01142388|881926|P2|Overall Study|Other|1
266640|NCT01142388|881927|P1|Overall Study|Other|1
266641|NCT01142388|881926|P2|Overall Study|Other complications|2
266642|NCT01142388|881927|P1|Overall Study|Other complications|0
266643|NCT01142388|881926|P2|Overall Study|Alternative therapy|0
266644|NCT01142388|881927|P1|Overall Study|Alternative therapy|1
266645|NCT01142388|881926|P2|Overall Study|Withdrawal by Subject|3
266646|NCT01142388|881927|P1|Overall Study|Withdrawal by Subject|5
266647|NCT01142388|881926|P2|Overall Study|Death|2
266648|NCT01142388|881927|P1|Overall Study|Death|3
266649|NCT01142388|881926|P2|Overall Study|Adverse Event|5
266650|NCT01142388|881927|P1|Overall Study|Adverse Event|9
266651|NCT01142388|881926|P2|Overall Study|Lack of Efficacy|31
266652|NCT01142388|881927|P1|Overall Study|Lack of Efficacy|21
266653|NCT01142193|881950|P2|Overall Study|Other|2
266654|NCT01142193|881951|P1|Overall Study|Other|1
266655|NCT01142193|881950|P2|Overall Study|Protocol Discontinuation Criterion Met|0
266656|NCT01142193|881951|P1|Overall Study|Protocol Discontinuation Criterion Met|1
266657|NCT01142193|881950|P2|Overall Study|Withdrawal by Subject|3
266658|NCT01142193|881951|P1|Overall Study|Withdrawal by Subject|4
266659|NCT01142193|881950|P2|Overall Study|Physician Decision|1
266660|NCT01142193|881951|P1|Overall Study|Physician Decision|1
266661|NCT01142193|881950|P2|Overall Study|Lack of Efficacy|1
266662|NCT01142193|881951|P1|Overall Study|Lack of Efficacy|2
266663|NCT01142193|881950|P2|Overall Study|Adverse Event|4
266664|NCT01142193|881951|P1|Overall Study|Adverse Event|12
266665|NCT01142128|881979|P1|Overall Study|Withdrawal by Subject|2
266666|NCT01142128|881979|P1|Overall Study|Lost to Follow-up|1
266667|NCT01142128|881979|P1|Overall Study|Physician Decision|1
266668|NCT01142115|881989|P2|First Intervention|Adverse Event|0
266669|NCT01142115|881990|P1|First Intervention|Adverse Event|1
266670|NCT01142115|881989|P2|First Intervention|Lack of Efficacy|1
266671|NCT01142115|881990|P1|First Intervention|Lack of Efficacy|1
266672|NCT01141712|882005|P1|Overall Study|Disease progression|3
266673|NCT01141660|882026|P2|Overall Study|Physician Decision|12
266674|NCT01141660|882027|P1|Overall Study|Physician Decision|0
266675|NCT01141283|882084|P1|Overall Study|Lack of Efficacy|10
266676|NCT01141283|882084|P1|Overall Study|Administrative|4
266677|NCT01141283|882084|P1|Overall Study|Withdrawal by Subject|14
266678|NCT01141283|882084|P1|Overall Study|Lost to Follow-up|4
266679|NCT01141283|882084|P1|Overall Study|Adverse Event|56
266680|NCT01141205|882090|P2|Overall Study|Withdrawal by Subject|1
266681|NCT01141205|882091|P1|Overall Study|Withdrawal by Subject|1
266682|NCT01141205|882090|P2|Overall Study|Lost to Follow-up|0
266683|NCT01141205|882091|P1|Overall Study|Lost to Follow-up|1
266684|NCT01141205|882090|P2|Overall Study|Physician Decision|1
266685|NCT01141205|882091|P1|Overall Study|Physician Decision|1
266686|NCT01140906|882113|P4|Overall Study|Administrative or other reason|2
266687|NCT01140906|882114|P3|Overall Study|Administrative or other reason|3
266688|NCT01140906|882115|P2|Overall Study|Administrative or other reason|5
266689|NCT01140906|882116|P1|Overall Study|Administrative or other reason|0
266690|NCT01140906|882113|P4|Overall Study|Lost to Follow-up|2
266691|NCT01140906|882114|P3|Overall Study|Lost to Follow-up|0
266692|NCT01140906|882115|P2|Overall Study|Lost to Follow-up|1
266693|NCT01140906|882116|P1|Overall Study|Lost to Follow-up|1
266694|NCT01140906|882113|P4|Overall Study|Withdrawal of consent|2
266695|NCT01140906|882114|P3|Overall Study|Withdrawal of consent|2
266696|NCT01140906|882115|P2|Overall Study|Withdrawal of consent|6
266697|NCT01140906|882116|P1|Overall Study|Withdrawal of consent|6
266698|NCT01140906|882113|P4|Overall Study|Protocol Violation|1
266699|NCT01140906|882114|P3|Overall Study|Protocol Violation|2
266700|NCT01140906|882115|P2|Overall Study|Protocol Violation|3
266701|NCT01140906|882116|P1|Overall Study|Protocol Violation|5
266702|NCT01140906|882113|P4|Overall Study|Non-compliance|1
266703|NCT01140906|882114|P3|Overall Study|Non-compliance|0
266704|NCT01140906|882115|P2|Overall Study|Non-compliance|1
266705|NCT01140906|882116|P1|Overall Study|Non-compliance|0
266706|NCT01140906|882113|P4|Overall Study|Lack of Efficacy|1
266707|NCT01140906|882114|P3|Overall Study|Lack of Efficacy|2
266708|NCT01140906|882115|P2|Overall Study|Lack of Efficacy|8
266709|NCT01140906|882116|P1|Overall Study|Lack of Efficacy|6
266710|NCT01140906|882113|P4|Overall Study|Adverse Event|7
266711|NCT01140906|882114|P3|Overall Study|Adverse Event|17
266712|NCT01140906|882115|P2|Overall Study|Adverse Event|10
266713|NCT01140906|882116|P1|Overall Study|Adverse Event|7
266714|NCT01140880|882156|P2|Overall Study|Protocol Violation|30
266715|NCT01140880|882157|P1|Overall Study|Protocol Violation|0
266716|NCT01140880|882156|P2|Overall Study|Lost to Follow-up|10
266717|NCT01140880|882157|P1|Overall Study|Lost to Follow-up|8
266718|NCT01140880|882156|P2|Overall Study|Withdrawal by Subject|3
266719|NCT01140880|882157|P1|Overall Study|Withdrawal by Subject|6
266720|NCT01140880|882156|P2|Overall Study|Death|1
266721|NCT01140880|882157|P1|Overall Study|Death|0
266722|NCT01140867|882169|P1|Overall Study|Medication Noncompliance|2
266723|NCT01140867|882169|P1|Overall Study|Uncooperative patient|2
266724|NCT01140867|882169|P1|Overall Study|Protocol Violation|1
266725|NCT01140867|882169|P1|Overall Study|Withdrawal by Subject|1
266726|NCT01140867|882169|P1|Overall Study|Lost to Follow-up|2
266727|NCT01140867|882169|P1|Overall Study|Lack of Efficacy|3
266728|NCT01140867|882169|P1|Overall Study|Adverse Event|22
266729|NCT01140646|882209|P1|Overall Study|Refused Further Treatment|5
266730|NCT01140646|882209|P1|Overall Study|Adverse Event|4
266731|NCT01140503|882213|P1|Overall Study|Withdrawal by Subject|1
266732|NCT01140477|882221|P2|Overall Study|Subject explanted|1
266733|NCT01140477|882222|P1|Overall Study|Subject explanted|0
266734|NCT01140477|882221|P2|Overall Study|Death|1
266735|NCT01140477|882222|P1|Overall Study|Death|1
266736|NCT01140477|882221|P2|Overall Study|Surgical complication preventing implant|0
266737|NCT01140477|882222|P1|Overall Study|Surgical complication preventing implant|2
266738|NCT01140477|882221|P2|Overall Study|Withdrawal by Subject|4
266739|NCT01140477|882222|P1|Overall Study|Withdrawal by Subject|1
266740|NCT01140477|882221|P2|Overall Study|Lost to Follow-up|0
266741|NCT01140477|882222|P1|Overall Study|Lost to Follow-up|4
266742|NCT01140347|882233|P2|Overall Study|Withdrawal by Subject|8
266743|NCT01140347|882234|P1|Overall Study|Withdrawal by Subject|13
266744|NCT01140347|882233|P2|Overall Study|Lost to Follow-up|6
266745|NCT01140347|882234|P1|Overall Study|Lost to Follow-up|5
266746|NCT01140061|882287|P10|Extension|Laboratory Adverse Event|1
266747|NCT01140061|882288|P9|Extension|Laboratory Adverse Event|0
266748|NCT01140061|882289|P8|Extension|Laboratory Adverse Event|0
266749|NCT01140061|882290|P7|Extension|Laboratory Adverse Event|0
266750|NCT01140061|882291|P6|Extension|Laboratory Adverse Event|0
266751|NCT01140061|882292|P5|Extension|Laboratory Adverse Event|0
266752|NCT01140061|882293|P4|Extension|Laboratory Adverse Event|0
266753|NCT01140061|882294|P3|Extension|Laboratory Adverse Event|0
266754|NCT01140061|882295|P2|Extension|Laboratory Adverse Event|0
266755|NCT01140061|882296|P1|Extension|Laboratory Adverse Event|0
266756|NCT01140061|882287|P10|Part I|Adverse Event|0
266757|NCT01140061|882288|P9|Part I|Adverse Event|0
266758|NCT01140061|882289|P8|Part I|Adverse Event|0
266759|NCT01140061|882290|P7|Part I|Adverse Event|0
266760|NCT01140061|882291|P6|Part I|Adverse Event|0
266761|NCT01140061|882292|P5|Part I|Adverse Event|0
266762|NCT01140061|882293|P4|Part I|Adverse Event|0
266763|NCT01140061|882294|P3|Part I|Adverse Event|0
266764|NCT01140061|882295|P2|Part I|Adverse Event|0
266765|NCT01140061|882296|P1|Part I|Adverse Event|1
266766|NCT01140048|882323|P1|Overall Study|Lost to Follow-up|31
266767|NCT01140048|882323|P1|Overall Study|Withdrawal by Subject|13
266768|NCT01140048|882323|P1|Overall Study|Physician Decision|1
266769|NCT01139762|882345|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
266770|NCT01139762|882346|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
266771|NCT01139762|882347|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
266772|NCT01139762|882345|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
266773|NCT01139762|882346|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
266774|NCT01139762|882347|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
266775|NCT01139762|882345|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
266776|NCT01139762|882346|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
266777|NCT01139762|882347|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
266778|NCT01139762|882345|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
266779|NCT01139762|882346|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
266780|NCT01139762|882347|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
266781|NCT01139762|882345|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
266782|NCT01139762|882346|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
266783|NCT01139762|882347|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
266784|NCT01139762|882345|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
266785|NCT01139762|882346|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
266786|NCT01139762|882347|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
266787|NCT01139762|882345|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
266788|NCT01139762|882346|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
266789|NCT01139762|882347|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
266790|NCT01139762|882345|P3|Double-Blind Randomized Active Treatment|Death|1
266791|NCT01139762|882346|P2|Double-Blind Randomized Active Treatment|Death|1
266792|NCT01139762|882347|P1|Double-Blind Randomized Active Treatment|Death|0
266793|NCT01139762|882345|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
266877|NCT01139021|882548|P6|Overall Study|Lost to Follow-up|0
266794|NCT01139762|882346|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
266795|NCT01139762|882347|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
266796|NCT01139762|882345|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
266797|NCT01139762|882346|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
266798|NCT01139762|882347|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
266799|NCT01139762|882345|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
266800|NCT01139762|882346|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
266801|NCT01139762|882347|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
266802|NCT01139762|882345|P3|Washout and Placebo Lead-In Period|Physician Decision|0
266803|NCT01139762|882346|P2|Washout and Placebo Lead-In Period|Physician Decision|0
266804|NCT01139762|882347|P1|Washout and Placebo Lead-In Period|Physician Decision|12
266805|NCT01139762|882345|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
266806|NCT01139762|882346|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
266807|NCT01139762|882347|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
266808|NCT01139762|882345|P3|Washout and Placebo Lead-In Period|Adverse Event|0
266809|NCT01139762|882346|P2|Washout and Placebo Lead-In Period|Adverse Event|0
266810|NCT01139762|882347|P1|Washout and Placebo Lead-In Period|Adverse Event|1
266811|NCT01139762|882345|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
266812|NCT01139762|882346|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
266813|NCT01139762|882347|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
266814|NCT01139658|882382|P2|Overall Study|Not specified|75
266815|NCT01139658|882383|P1|Overall Study|Not specified|28
266816|NCT01139658|882382|P2|Overall Study|No documentation of treatment|0
266817|NCT01139658|882383|P1|Overall Study|No documentation of treatment|1
266818|NCT01139658|882382|P2|Overall Study|Withdrawal by Subject|4
266819|NCT01139658|882383|P1|Overall Study|Withdrawal by Subject|2
266820|NCT01139658|882382|P2|Overall Study|Lack of Efficacy|7
266821|NCT01139658|882383|P1|Overall Study|Lack of Efficacy|15
266822|NCT01139658|882382|P2|Overall Study|Adverse Event|27
266823|NCT01139658|882383|P1|Overall Study|Adverse Event|10
266824|NCT01139580|882421|P2|Overall Study|Participant Randomization in Error|1
266825|NCT01139580|882422|P1|Overall Study|Participant Randomization in Error|0
266826|NCT01139580|882421|P2|Overall Study|Beginning Study Exclusion Treatment|1
266827|NCT01139580|882422|P1|Overall Study|Beginning Study Exclusion Treatment|0
266828|NCT01139580|882421|P2|Overall Study|Misrandomized|0
266829|NCT01139580|882422|P1|Overall Study|Misrandomized|1
266830|NCT01139580|882421|P2|Overall Study|Did Not Meet Exclusion Criteria|0
266831|NCT01139580|882422|P1|Overall Study|Did Not Meet Exclusion Criteria|1
266832|NCT01139580|882421|P2|Overall Study|Used Excluded Medicine After Enrollment|0
266833|NCT01139580|882422|P1|Overall Study|Used Excluded Medicine After Enrollment|1
266834|NCT01139580|882421|P2|Overall Study|Withdrawal by Subject|9
266835|NCT01139580|882422|P1|Overall Study|Withdrawal by Subject|6
266836|NCT01139580|882421|P2|Overall Study|Lack of Efficacy|2
266837|NCT01139580|882422|P1|Overall Study|Lack of Efficacy|0
266838|NCT01139580|882421|P2|Overall Study|Lost to Follow-up|1
266839|NCT01139580|882422|P1|Overall Study|Lost to Follow-up|9
266840|NCT01139580|882421|P2|Overall Study|Adverse Event|4
266841|NCT01139580|882422|P1|Overall Study|Adverse Event|5
266842|NCT01139450|882470|P3|Overall Study|Adverse Event|3
266843|NCT01139450|882471|P2|Overall Study|Adverse Event|2
266844|NCT01139450|882472|P1|Overall Study|Adverse Event|2
266845|NCT01139450|882470|P3|Overall Study|Administrative|1
266846|NCT01139450|882471|P2|Overall Study|Administrative|0
266847|NCT01139450|882472|P1|Overall Study|Administrative|0
266848|NCT01139450|882470|P3|Overall Study|Lost to Follow-up|11
266849|NCT01139450|882471|P2|Overall Study|Lost to Follow-up|7
266850|NCT01139450|882472|P1|Overall Study|Lost to Follow-up|9
266851|NCT01139450|882470|P3|Overall Study|Protocol Violation|2
266852|NCT01139450|882471|P2|Overall Study|Protocol Violation|5
266853|NCT01139450|882472|P1|Overall Study|Protocol Violation|6
266854|NCT01139450|882470|P3|Overall Study|Lack of Efficacy|8
266855|NCT01139450|882471|P2|Overall Study|Lack of Efficacy|1
266856|NCT01139450|882472|P1|Overall Study|Lack of Efficacy|3
266857|NCT01139450|882470|P3|Overall Study|Withdrawal by Subject|13
266858|NCT01139450|882471|P2|Overall Study|Withdrawal by Subject|10
266859|NCT01139450|882472|P1|Overall Study|Withdrawal by Subject|7
266860|NCT01139164|882513|P3|Overall Study|Withdrawn prior to study start|0
266861|NCT01139164|882514|P2|Overall Study|Withdrawn prior to study start|2
266862|NCT01139164|882515|P1|Overall Study|Withdrawn prior to study start|0
266863|NCT01139125|882529|P1|Overall Study|Withdrawal by Subject|1
266864|NCT01139047|882533|P1|Overall Study|Withdrawal by Subject|1
266865|NCT01139021|882548|P6|Overall Study|Withdrawal by Subject|0
266866|NCT01139021|882549|P5|Overall Study|Withdrawal by Subject|4
266867|NCT01139021|882550|P4|Overall Study|Withdrawal by Subject|1
266868|NCT01139021|882551|P3|Overall Study|Withdrawal by Subject|0
266869|NCT01139021|882552|P2|Overall Study|Withdrawal by Subject|0
266870|NCT01139021|882553|P1|Overall Study|Withdrawal by Subject|0
266871|NCT01139021|882548|P6|Overall Study|Protocol Violation|0
266872|NCT01139021|882549|P5|Overall Study|Protocol Violation|2
266873|NCT01139021|882550|P4|Overall Study|Protocol Violation|0
266874|NCT01139021|882551|P3|Overall Study|Protocol Violation|0
266875|NCT01139021|882552|P2|Overall Study|Protocol Violation|0
266876|NCT01139021|882553|P1|Overall Study|Protocol Violation|1
266878|NCT01139021|882549|P5|Overall Study|Lost to Follow-up|2
266879|NCT01139021|882550|P4|Overall Study|Lost to Follow-up|0
266880|NCT01139021|882551|P3|Overall Study|Lost to Follow-up|0
266881|NCT01139021|882552|P2|Overall Study|Lost to Follow-up|0
266882|NCT01139021|882553|P1|Overall Study|Lost to Follow-up|0
266883|NCT01139021|882548|P6|Overall Study|Adverse Event|0
266884|NCT01139021|882549|P5|Overall Study|Adverse Event|1
266885|NCT01139021|882550|P4|Overall Study|Adverse Event|0
266886|NCT01139021|882551|P3|Overall Study|Adverse Event|0
266887|NCT01139021|882552|P2|Overall Study|Adverse Event|0
266888|NCT01139021|882553|P1|Overall Study|Adverse Event|0
266889|NCT01139008|882589|P1|Overall Study|Non-compliant, lost product|1
266890|NCT01139008|882589|P1|Overall Study|Withdrawal by Subject|5
266891|NCT01138826|882622|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
266892|NCT01138826|882623|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
266893|NCT01138826|882624|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
266894|NCT01138826|882625|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
266895|NCT01138826|882626|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
266896|NCT01138826|882627|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
266897|NCT01138657|882664|P2|Overall Study|Miscellaneous Reasons|4
266898|NCT01138657|882665|P1|Overall Study|Miscellaneous Reasons|3
266899|NCT01138657|882664|P2|Overall Study|Lost to Follow-up|3
266900|NCT01138657|882665|P1|Overall Study|Lost to Follow-up|0
266901|NCT01138657|882664|P2|Overall Study|Lack of Efficacy|1
266902|NCT01138657|882665|P1|Overall Study|Lack of Efficacy|2
266903|NCT01138657|882664|P2|Overall Study|Adverse Event|10
266904|NCT01138657|882665|P1|Overall Study|Adverse Event|3
266905|NCT01138501|882728|P1|Overall Study|Withdrawal by Subject|3
266906|NCT01138501|882728|P1|Overall Study|Protocol Violation|2
266907|NCT01138150|882772|P2|Overall Study|Physician Decision|0
266908|NCT01138150|882773|P1|Overall Study|Physician Decision|1
266909|NCT01138150|882772|P2|Overall Study|blood unable to be processed|1
266910|NCT01138150|882773|P1|Overall Study|blood unable to be processed|0
266911|NCT01138111|882854|P1|Overall Study|Lost to Follow-up|2
266912|NCT01138111|882854|P1|Overall Study|Death|1
266913|NCT01138111|882854|P1|Overall Study|Adverse Event|1
266914|NCT01138111|882854|P1|Overall Study|Withdrawal by Subject|5
266915|NCT01138046|882908|P1|Overall Study|Withdrawal due to death|6
266916|NCT01138007|882928|P3|Overall Study|Withdrawal by Subject|15
266917|NCT01138007|882929|P2|Overall Study|Withdrawal by Subject|6
266918|NCT01138007|882930|P1|Overall Study|Withdrawal by Subject|5
266919|NCT01138007|882928|P3|Overall Study|Physician Decision|3
266920|NCT01138007|882929|P2|Overall Study|Physician Decision|5
266921|NCT01138007|882930|P1|Overall Study|Physician Decision|0
266922|NCT01138007|882928|P3|Overall Study|Lost to Follow-up|5
266923|NCT01138007|882929|P2|Overall Study|Lost to Follow-up|3
266924|NCT01138007|882930|P1|Overall Study|Lost to Follow-up|3
266925|NCT01138007|882928|P3|Overall Study|Protocol-Defined Stopping Criteria|8
266926|NCT01138007|882929|P2|Overall Study|Protocol-Defined Stopping Criteria|1
266927|NCT01138007|882930|P1|Overall Study|Protocol-Defined Stopping Criteria|6
266928|NCT01138007|882928|P3|Overall Study|Protocol Violation|2
266929|NCT01138007|882929|P2|Overall Study|Protocol Violation|3
266930|NCT01138007|882930|P1|Overall Study|Protocol Violation|2
266931|NCT01138007|882928|P3|Overall Study|Lack of Efficacy|6
266932|NCT01138007|882929|P2|Overall Study|Lack of Efficacy|0
266933|NCT01138007|882930|P1|Overall Study|Lack of Efficacy|2
266934|NCT01138007|882928|P3|Overall Study|Adverse Event|9
266935|NCT01138007|882929|P2|Overall Study|Adverse Event|12
266936|NCT01138007|882930|P1|Overall Study|Adverse Event|4
266937|NCT01137812|882964|P2|Overall Study|Not specified|27
266938|NCT01137812|882965|P1|Overall Study|Not specified|19
266939|NCT01137812|882964|P2|Overall Study|Patient met glycemic withdrawal criteria|85
266940|NCT01137812|882965|P1|Overall Study|Patient met glycemic withdrawal criteria|40
266941|NCT01137812|882964|P2|Overall Study|Death|0
266942|NCT01137812|882965|P1|Overall Study|Death|2
266943|NCT01137812|882964|P2|Overall Study|Withdrawal by Subject|13
266944|NCT01137812|882965|P1|Overall Study|Withdrawal by Subject|5
266945|NCT01137812|882964|P2|Overall Study|Protocol Violation|4
266946|NCT01137812|882965|P1|Overall Study|Protocol Violation|5
266947|NCT01137812|882964|P2|Overall Study|Physician Decision|17
266948|NCT01137812|882965|P1|Overall Study|Physician Decision|25
266949|NCT01137812|882964|P2|Overall Study|Lost to Follow-up|8
266950|NCT01137812|882965|P1|Overall Study|Lost to Follow-up|6
266951|NCT01137812|882964|P2|Overall Study|Adverse Event|14
266952|NCT01137812|882965|P1|Overall Study|Adverse Event|21
266953|NCT01137786|882985|P2|Overall Study|Withdrawal by Subject|1
266954|NCT01137786|882986|P1|Overall Study|Withdrawal by Subject|1
266955|NCT01137786|882985|P2|Overall Study|Lost to Follow-up|2
266956|NCT01137786|882986|P1|Overall Study|Lost to Follow-up|0
266957|NCT01137682|882997|P3|Overall Study|Protocol Violation|1
266958|NCT01137682|882998|P2|Overall Study|Protocol Violation|1
266959|NCT01137682|882999|P1|Overall Study|Protocol Violation|0
266960|NCT01137682|882997|P3|Overall Study|Administrative Problems|0
266961|NCT01137682|882998|P2|Overall Study|Administrative Problems|1
266962|NCT01137682|882999|P1|Overall Study|Administrative Problems|2
266963|NCT01137682|882997|P3|Overall Study|Withdrawal by Subject|2
266964|NCT01137682|882998|P2|Overall Study|Withdrawal by Subject|2
266965|NCT01137682|882999|P1|Overall Study|Withdrawal by Subject|2
266966|NCT01137682|882997|P3|Overall Study|Adverse Event|0
266967|NCT01137682|882998|P2|Overall Study|Adverse Event|4
266968|NCT01137682|882999|P1|Overall Study|Adverse Event|2
266969|NCT01137604|883014|P4|Overall Study|Clinical Decline|1
266970|NCT01137604|883015|P3|Overall Study|Clinical Decline|1
266971|NCT01137604|883016|P2|Overall Study|Clinical Decline|0
266972|NCT01137604|883017|P1|Overall Study|Clinical Decline|0
266973|NCT01137604|883014|P4|Overall Study|Participant's Decision|0
266974|NCT01137604|883015|P3|Overall Study|Participant's Decision|0
266975|NCT01137604|883016|P2|Overall Study|Participant's Decision|0
266976|NCT01137604|883017|P1|Overall Study|Participant's Decision|1
266977|NCT01137604|883014|P4|Overall Study|Clinical Progression|0
266978|NCT01137604|883015|P3|Overall Study|Clinical Progression|1
266979|NCT01137604|883016|P2|Overall Study|Clinical Progression|2
266980|NCT01137604|883017|P1|Overall Study|Clinical Progression|0
266981|NCT01137604|883014|P4|Overall Study|Withdrawal by Subject|1
266982|NCT01137604|883015|P3|Overall Study|Withdrawal by Subject|2
266983|NCT01137604|883016|P2|Overall Study|Withdrawal by Subject|2
266984|NCT01137604|883017|P1|Overall Study|Withdrawal by Subject|0
266985|NCT01137604|883014|P4|Overall Study|Adverse Event|9
266986|NCT01137604|883015|P3|Overall Study|Adverse Event|9
266987|NCT01137604|883016|P2|Overall Study|Adverse Event|6
266988|NCT01137604|883017|P1|Overall Study|Adverse Event|1
266989|NCT01137578|883051|P3|Overall Study|Not Specified|6
266990|NCT01137578|883052|P2|Overall Study|Not Specified|2
266991|NCT01137578|883053|P1|Overall Study|Not Specified|12
266992|NCT01137578|883051|P3|Overall Study|Withdrawal by Subject|0
266993|NCT01137578|883052|P2|Overall Study|Withdrawal by Subject|0
266994|NCT01137578|883053|P1|Overall Study|Withdrawal by Subject|1
266995|NCT01137578|883051|P3|Overall Study|Participant requested to Discontinue|0
266996|NCT01137578|883052|P2|Overall Study|Participant requested to Discontinue|0
266997|NCT01137578|883053|P1|Overall Study|Participant requested to Discontinue|3
266998|NCT01137474|883097|P4|Overall Study|Administrative reason by sponsor|0
266999|NCT01137474|883098|P3|Overall Study|Administrative reason by sponsor|0
267000|NCT01137474|883099|P2|Overall Study|Administrative reason by sponsor|1
267001|NCT01137474|883100|P1|Overall Study|Administrative reason by sponsor|0
267002|NCT01137474|883097|P4|Overall Study|Pregnancy|0
267003|NCT01137474|883098|P3|Overall Study|Pregnancy|0
267004|NCT01137474|883099|P2|Overall Study|Pregnancy|1
267005|NCT01137474|883100|P1|Overall Study|Pregnancy|0
267006|NCT01137474|883097|P4|Overall Study|Not specified|0
267007|NCT01137474|883098|P3|Overall Study|Not specified|0
267008|NCT01137474|883099|P2|Overall Study|Not specified|1
267009|NCT01137474|883100|P1|Overall Study|Not specified|3
267010|NCT01137474|883097|P4|Overall Study|Lack of Efficacy|2
267011|NCT01137474|883098|P3|Overall Study|Lack of Efficacy|0
267012|NCT01137474|883099|P2|Overall Study|Lack of Efficacy|0
267013|NCT01137474|883100|P1|Overall Study|Lack of Efficacy|0
267014|NCT01137474|883097|P4|Overall Study|Lost to Follow-up|2
267015|NCT01137474|883098|P3|Overall Study|Lost to Follow-up|0
267016|NCT01137474|883099|P2|Overall Study|Lost to Follow-up|1
267017|NCT01137474|883100|P1|Overall Study|Lost to Follow-up|5
267018|NCT01137474|883097|P4|Overall Study|No longer met study criteria|5
267019|NCT01137474|883098|P3|Overall Study|No longer met study criteria|0
267020|NCT01137474|883099|P2|Overall Study|No longer met study criteria|1
267021|NCT01137474|883100|P1|Overall Study|No longer met study criteria|6
267022|NCT01137474|883097|P4|Overall Study|Withdrawal by Subject|9
267023|NCT01137474|883098|P3|Overall Study|Withdrawal by Subject|6
267024|NCT01137474|883099|P2|Overall Study|Withdrawal by Subject|2
267025|NCT01137474|883100|P1|Overall Study|Withdrawal by Subject|7
267026|NCT01137474|883097|P4|Overall Study|Adverse Event|3
267027|NCT01137474|883098|P3|Overall Study|Adverse Event|1
267028|NCT01137474|883099|P2|Overall Study|Adverse Event|5
267029|NCT01137474|883100|P1|Overall Study|Adverse Event|3
267030|NCT01137435|883118|P1|Overall Study|Off label usage|4
267031|NCT01137435|883118|P1|Overall Study|Lost to Follow-up|24
267032|NCT01137292|883145|P1|Overall Study|Unspecified|7
267033|NCT01137292|883145|P1|Overall Study|Lost to Follow-up|1
267034|NCT01137292|883145|P1|Overall Study|Lack of Efficacy|13
267035|NCT01137292|883145|P1|Overall Study|Adverse Event|3
267036|NCT01137292|883145|P1|Overall Study|Death|30
267037|NCT01137071|883152|P1|Overall Study|Wrongly Included|1
267038|NCT01137071|883152|P1|Overall Study|Withdrawal by Subject|2
267039|NCT01137071|883152|P1|Overall Study|Disease Progression|11
267040|NCT01136967|883221|P2|Overall Study|Diagnosis of Second Primary Cancer|1
267041|NCT01136967|883222|P1|Overall Study|Diagnosis of Second Primary Cancer|0
267042|NCT01136967|883221|P2|Overall Study|Increase in Lesion Size|2
267043|NCT01136967|883222|P1|Overall Study|Increase in Lesion Size|0
267044|NCT01136967|883221|P2|Overall Study|Investigator's Choice|1
267045|NCT01136967|883222|P1|Overall Study|Investigator's Choice|1
267046|NCT01136967|883221|P2|Overall Study|Non Compliance|0
267047|NCT01136967|883222|P1|Overall Study|Non Compliance|1
267048|NCT01136967|883221|P2|Overall Study|Radiation|0
267049|NCT01136967|883222|P1|Overall Study|Radiation|1
267050|NCT01136967|883221|P2|Overall Study|Clinical Progression|5
267051|NCT01136967|883222|P1|Overall Study|Clinical Progression|3
267052|NCT01136967|883221|P2|Overall Study|Withdrawal by Subject|2
267053|NCT01136967|883222|P1|Overall Study|Withdrawal by Subject|1
267054|NCT01136967|883221|P2|Overall Study|Lost to Follow-up|1
267055|NCT01136967|883222|P1|Overall Study|Lost to Follow-up|0
267056|NCT01136967|883221|P2|Overall Study|Participant Choice|3
267057|NCT01136967|883222|P1|Overall Study|Participant Choice|8
267058|NCT01136967|883221|P2|Overall Study|Adverse Event|12
267059|NCT01136967|883222|P1|Overall Study|Adverse Event|9
267060|NCT01136954|883240|P2|Overall Study|Not Specified|3
267061|NCT01136954|883241|P1|Overall Study|Not Specified|1
267062|NCT01136954|883240|P2|Overall Study|Physician Decision|1
267063|NCT01136954|883241|P1|Overall Study|Physician Decision|0
267064|NCT01136954|883240|P2|Overall Study|Lack of Efficacy|13
267065|NCT01136954|883241|P1|Overall Study|Lack of Efficacy|14
267066|NCT01136954|883240|P2|Overall Study|Withdrawal by Subject|2
267067|NCT01136954|883241|P1|Overall Study|Withdrawal by Subject|6
267068|NCT01136954|883240|P2|Overall Study|Adverse Event|2
267069|NCT01136954|883241|P1|Overall Study|Adverse Event|3
267070|NCT01136915|883255|P2|Overall Study|Exclusion criterion met|1
267071|NCT01136915|883256|P1|Overall Study|Exclusion criterion met|0
267072|NCT01136915|883255|P2|Overall Study|Lost to Follow-up|0
267073|NCT01136915|883256|P1|Overall Study|Lost to Follow-up|2
267074|NCT01136876|883266|P2|Overall Study|Physician Decision|5
267075|NCT01136876|883267|P1|Overall Study|Physician Decision|3
267076|NCT01136876|883266|P2|Overall Study|Lost to Follow-up|1
267077|NCT01136876|883267|P1|Overall Study|Lost to Follow-up|0
267078|NCT01136785|883277|P2|Overall Study|Protocol Violation|1
267079|NCT01136785|883278|P1|Overall Study|Protocol Violation|2
267080|NCT01136772|883293|P2|Overall Study|Did not follow up after first injection|2
267081|NCT01136772|883294|P1|Overall Study|Did not follow up after first injection|2
267082|NCT01136772|883293|P2|Overall Study|Did not receive injection|7
267083|NCT01136772|883294|P1|Overall Study|Did not receive injection|10
267084|NCT01136772|883293|P2|Overall Study|Withdrawal by Subject|36
267085|NCT01136772|883294|P1|Overall Study|Withdrawal by Subject|33
267086|NCT01136772|883293|P2|Overall Study|Administrative|12
267087|NCT01136772|883294|P1|Overall Study|Administrative|14
267088|NCT01136772|883293|P2|Overall Study|Lack of Efficacy|39
267089|NCT01136772|883294|P1|Overall Study|Lack of Efficacy|42
267090|NCT01136772|883293|P2|Overall Study|Adverse Event|14
267091|NCT01136772|883294|P1|Overall Study|Adverse Event|15
267092|NCT01136746|883304|P2|Overall Study|Death|0
267093|NCT01136746|883305|P1|Overall Study|Death|1
267094|NCT01136746|883304|P2|Overall Study|Protocol Violation|1
267095|NCT01136746|883305|P1|Overall Study|Protocol Violation|2
267096|NCT01136746|883304|P2|Overall Study|Lost to Follow-up|2
267097|NCT01136746|883305|P1|Overall Study|Lost to Follow-up|0
267098|NCT01136655|883365|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
267099|NCT01136655|883365|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
267100|NCT01136655|883365|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
267101|NCT01136655|883365|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
267102|NCT01136408|883398|P3|Overall Study|Protocol Violation|1
267103|NCT01136408|883399|P2|Overall Study|Protocol Violation|1
267104|NCT01136408|883400|P1|Overall Study|Protocol Violation|1
267105|NCT01136408|883398|P3|Overall Study|Adverse Event|4
267106|NCT01136408|883399|P2|Overall Study|Adverse Event|8
267107|NCT01136408|883400|P1|Overall Study|Adverse Event|4
267108|NCT01136382|883457|P2|Overall Study|Withdrawal by Subject|1
267109|NCT01136382|883458|P1|Overall Study|Withdrawal by Subject|4
267110|NCT01136382|883457|P2|Overall Study|Severe Non-Compliance to Protocol|2
267111|NCT01136382|883458|P1|Overall Study|Severe Non-Compliance to Protocol|0
267112|NCT01136382|883457|P2|Overall Study|Study-Specific Withdrawal Criteria|25
267113|NCT01136382|883458|P1|Overall Study|Study-Specific Withdrawal Criteria|48
267114|NCT01136382|883457|P2|Overall Study|Not Specified|3
267115|NCT01136382|883458|P1|Overall Study|Not Specified|8
267116|NCT01136356|883484|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
267117|NCT01136356|883485|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
267118|NCT01136356|883484|P2|First 18-day Withdrawal|Physician Decision|0
267119|NCT01136356|883485|P1|First 18-day Withdrawal|Physician Decision|1
267120|NCT01136356|883484|P2|First 18-day Withdrawal|Withdrawal by Subject|0
267121|NCT01136356|883485|P1|First 18-day Withdrawal|Withdrawal by Subject|3
267122|NCT01136291|883496|P2|Overall Study|Lost to Follow-up|1
267123|NCT01136291|883497|P1|Overall Study|Lost to Follow-up|1
267124|NCT01136174|883515|P4|Overall Study|Adverse Event|4
267125|NCT01136174|883516|P3|Overall Study|Adverse Event|0
267126|NCT01136174|883517|P2|Overall Study|Adverse Event|0
267127|NCT01136174|883518|P1|Overall Study|Adverse Event|0
267128|NCT01135992|883598|P1|Overall Study|Unclassified|7
267129|NCT01135992|883598|P1|Overall Study|Withdrawal criteria|10
267130|NCT01135992|883598|P1|Overall Study|Protocol Violation|2
267131|NCT01135992|883598|P1|Overall Study|Lack of Efficacy|1
267132|NCT01135992|883598|P1|Overall Study|Adverse Event|1
267133|NCT01135914|883610|P3|Overall Study|Adverse Event|2
267134|NCT01135914|883611|P2|Overall Study|Adverse Event|1
267135|NCT01135914|883612|P1|Overall Study|Adverse Event|0
267136|NCT01135914|883610|P3|Overall Study|Lack of Efficacy|10
267137|NCT01135914|883611|P2|Overall Study|Lack of Efficacy|1
267138|NCT01135914|883612|P1|Overall Study|Lack of Efficacy|2
267139|NCT01135914|883610|P3|Overall Study|Protocol Violation|3
267140|NCT01135914|883611|P2|Overall Study|Protocol Violation|0
267141|NCT01135914|883612|P1|Overall Study|Protocol Violation|0
267142|NCT01135914|883610|P3|Overall Study|Lost to Follow-up|1
267143|NCT01135914|883611|P2|Overall Study|Lost to Follow-up|0
267144|NCT01135914|883612|P1|Overall Study|Lost to Follow-up|1
267145|NCT01135914|883610|P3|Overall Study|Withdrawal by Subject|6
267146|NCT01135914|883611|P2|Overall Study|Withdrawal by Subject|3
267147|NCT01135914|883612|P1|Overall Study|Withdrawal by Subject|1
267148|NCT01135524|883641|P1|Overall Study|Lack of Efficacy|8
267149|NCT01135524|883641|P1|Overall Study|Administrative|151
267150|NCT01135524|883641|P1|Overall Study|Lost to Follow-up|3
267151|NCT01135524|883641|P1|Overall Study|Adverse Event|20
267152|NCT01135524|883641|P1|Overall Study|Withdrawal by Subject|14
267153|NCT01135511|883654|P9|Overall Study|Withdrawal by Subject|1
267154|NCT01135511|883655|P8|Overall Study|Withdrawal by Subject|0
267155|NCT01135511|883656|P7|Overall Study|Withdrawal by Subject|1
267156|NCT01135511|883657|P6|Overall Study|Withdrawal by Subject|0
267157|NCT01135511|883658|P5|Overall Study|Withdrawal by Subject|0
267158|NCT01135511|883659|P4|Overall Study|Withdrawal by Subject|0
267159|NCT01135511|883660|P3|Overall Study|Withdrawal by Subject|0
267160|NCT01135511|883661|P2|Overall Study|Withdrawal by Subject|0
267161|NCT01135511|883662|P1|Overall Study|Withdrawal by Subject|0
267162|NCT01135511|883654|P9|Overall Study|noncompliance with study drug taken|0
267163|NCT01135511|883655|P8|Overall Study|noncompliance with study drug taken|0
267164|NCT01135511|883656|P7|Overall Study|noncompliance with study drug taken|0
267165|NCT01135511|883657|P6|Overall Study|noncompliance with study drug taken|0
267166|NCT01135511|883658|P5|Overall Study|noncompliance with study drug taken|1
267167|NCT01135511|883659|P4|Overall Study|noncompliance with study drug taken|0
267168|NCT01135511|883660|P3|Overall Study|noncompliance with study drug taken|0
267169|NCT01135511|883661|P2|Overall Study|noncompliance with study drug taken|0
267170|NCT01135511|883662|P1|Overall Study|noncompliance with study drug taken|0
267171|NCT01135511|883654|P9|Overall Study|could not visit the clinic|0
267172|NCT01135511|883655|P8|Overall Study|could not visit the clinic|0
267173|NCT01135511|883656|P7|Overall Study|could not visit the clinic|0
267174|NCT01135511|883657|P6|Overall Study|could not visit the clinic|0
267175|NCT01135511|883658|P5|Overall Study|could not visit the clinic|0
267176|NCT01135511|883659|P4|Overall Study|could not visit the clinic|0
267177|NCT01135511|883660|P3|Overall Study|could not visit the clinic|2
267178|NCT01135511|883661|P2|Overall Study|could not visit the clinic|1
267179|NCT01135511|883662|P1|Overall Study|could not visit the clinic|0
267180|NCT01135511|883654|P9|Overall Study|Pregnancy|0
267181|NCT01135511|883655|P8|Overall Study|Pregnancy|0
267182|NCT01135511|883656|P7|Overall Study|Pregnancy|0
267183|NCT01135511|883657|P6|Overall Study|Pregnancy|0
267184|NCT01135511|883658|P5|Overall Study|Pregnancy|0
267185|NCT01135511|883659|P4|Overall Study|Pregnancy|1
267186|NCT01135511|883660|P3|Overall Study|Pregnancy|0
267187|NCT01135511|883661|P2|Overall Study|Pregnancy|0
267188|NCT01135511|883662|P1|Overall Study|Pregnancy|0
267189|NCT01135511|883654|P9|Overall Study|Protocol Violation|0
267190|NCT01135511|883655|P8|Overall Study|Protocol Violation|0
267191|NCT01135511|883656|P7|Overall Study|Protocol Violation|0
267192|NCT01135511|883657|P6|Overall Study|Protocol Violation|0
267193|NCT01135511|883658|P5|Overall Study|Protocol Violation|0
267194|NCT01135511|883659|P4|Overall Study|Protocol Violation|0
267195|NCT01135511|883660|P3|Overall Study|Protocol Violation|3
267196|NCT01135511|883661|P2|Overall Study|Protocol Violation|0
267197|NCT01135511|883662|P1|Overall Study|Protocol Violation|0
267198|NCT01135511|883654|P9|Overall Study|Lack of Efficacy|0
267199|NCT01135511|883655|P8|Overall Study|Lack of Efficacy|0
267200|NCT01135511|883656|P7|Overall Study|Lack of Efficacy|0
267201|NCT01135511|883657|P6|Overall Study|Lack of Efficacy|0
267202|NCT01135511|883658|P5|Overall Study|Lack of Efficacy|0
267203|NCT01135511|883659|P4|Overall Study|Lack of Efficacy|2
267204|NCT01135511|883660|P3|Overall Study|Lack of Efficacy|1
267205|NCT01135511|883661|P2|Overall Study|Lack of Efficacy|1
267206|NCT01135511|883662|P1|Overall Study|Lack of Efficacy|0
267207|NCT01135511|883654|P9|Overall Study|Adverse Event|0
267208|NCT01135511|883655|P8|Overall Study|Adverse Event|1
267209|NCT01135511|883656|P7|Overall Study|Adverse Event|0
267210|NCT01135511|883657|P6|Overall Study|Adverse Event|1
267211|NCT01135511|883658|P5|Overall Study|Adverse Event|0
267212|NCT01135511|883659|P4|Overall Study|Adverse Event|0
267213|NCT01135511|883660|P3|Overall Study|Adverse Event|2
267214|NCT01135511|883661|P2|Overall Study|Adverse Event|1
267215|NCT01135511|883662|P1|Overall Study|Adverse Event|0
267216|NCT01135498|883944|P1|Overall Study|Ongoing at time of analysis|2
267217|NCT01135498|883944|P1|Overall Study|Death|1
267218|NCT01135498|883944|P1|Overall Study|Withdrawal by Subject|4
267219|NCT01135498|883944|P1|Overall Study|Investigator judgement|25
267220|NCT01135498|883944|P1|Overall Study|Progressive disease|38
267221|NCT01135498|883944|P1|Overall Study|Adverse Event|20
267222|NCT01135134|884112|P2|Overall Study|Did not meet protocol eligibility|0
267223|NCT01135134|884113|P1|Overall Study|Did not meet protocol eligibility|1
267224|NCT01135134|884112|P2|Overall Study|Adverse Event|1
267225|NCT01135134|884113|P1|Overall Study|Adverse Event|1
267226|NCT01135017|884136|P2|Overall Study|Other than above|4
267227|NCT01135017|884137|P1|Overall Study|Other than above|3
267228|NCT01135017|884136|P2|Overall Study|Adverse Event|8
267229|NCT01135017|884137|P1|Overall Study|Adverse Event|3
267230|NCT01134939|884175|P8|Overall Study|Termination page not available|0
267231|NCT01134939|884176|P7|Overall Study|Termination page not available|7
267232|NCT01134939|884177|P6|Overall Study|Termination page not available|3
267233|NCT01134939|884178|P5|Overall Study|Termination page not available|0
267234|NCT01134939|884179|P4|Overall Study|Termination page not available|8
267235|NCT01134939|884180|P3|Overall Study|Termination page not available|5
267236|NCT01134939|884181|P2|Overall Study|Termination page not available|6
267237|NCT01134939|884182|P1|Overall Study|Termination page not available|4
267238|NCT01134939|884175|P8|Overall Study|Death|0
267239|NCT01134939|884176|P7|Overall Study|Death|0
267240|NCT01134939|884177|P6|Overall Study|Death|0
267241|NCT01134939|884178|P5|Overall Study|Death|0
267242|NCT01134939|884179|P4|Overall Study|Death|0
267243|NCT01134939|884180|P3|Overall Study|Death|0
267244|NCT01134939|884181|P2|Overall Study|Death|1
267245|NCT01134939|884182|P1|Overall Study|Death|0
267246|NCT01134939|884175|P8|Overall Study|Lost to Follow-up|0
267247|NCT01134939|884176|P7|Overall Study|Lost to Follow-up|0
267248|NCT01134939|884177|P6|Overall Study|Lost to Follow-up|1
267249|NCT01134939|884178|P5|Overall Study|Lost to Follow-up|2
267250|NCT01134939|884179|P4|Overall Study|Lost to Follow-up|1
267251|NCT01134939|884180|P3|Overall Study|Lost to Follow-up|0
267252|NCT01134939|884181|P2|Overall Study|Lost to Follow-up|3
267253|NCT01134939|884182|P1|Overall Study|Lost to Follow-up|2
267254|NCT01134939|884175|P8|Overall Study|Lack of Efficacy|0
267255|NCT01134939|884176|P7|Overall Study|Lack of Efficacy|1
267256|NCT01134939|884177|P6|Overall Study|Lack of Efficacy|0
267257|NCT01134939|884178|P5|Overall Study|Lack of Efficacy|3
267258|NCT01134939|884179|P4|Overall Study|Lack of Efficacy|0
267259|NCT01134939|884180|P3|Overall Study|Lack of Efficacy|1
267260|NCT01134939|884181|P2|Overall Study|Lack of Efficacy|5
267261|NCT01134939|884182|P1|Overall Study|Lack of Efficacy|2
267262|NCT01134939|884175|P8|Overall Study|Adverse Event|0
267263|NCT01134939|884176|P7|Overall Study|Adverse Event|1
267264|NCT01134939|884177|P6|Overall Study|Adverse Event|5
267265|NCT01134939|884178|P5|Overall Study|Adverse Event|5
267266|NCT01134939|884179|P4|Overall Study|Adverse Event|5
267267|NCT01134939|884180|P3|Overall Study|Adverse Event|4
267268|NCT01134939|884181|P2|Overall Study|Adverse Event|3
267269|NCT01134939|884182|P1|Overall Study|Adverse Event|9
267270|NCT01134783|884320|P2|Overall Study|Lost to Follow-up|20
267271|NCT01134783|884321|P1|Overall Study|Lost to Follow-up|5
267272|NCT01134783|884320|P2|Overall Study|Withdrawal by Subject|9
267273|NCT01134783|884321|P1|Overall Study|Withdrawal by Subject|15
267274|NCT01134783|884320|P2|Overall Study|Pregnancy|8
267275|NCT01134783|884321|P1|Overall Study|Pregnancy|16
267276|NCT01134731|884340|P3|Overall Study|Lost to Follow-up|3
267277|NCT01134731|884341|P2|Overall Study|Lost to Follow-up|4
267278|NCT01134731|884342|P1|Overall Study|Lost to Follow-up|5
267279|NCT01134731|884340|P3|Overall Study|Withdrawal by Subject|1
267280|NCT01134731|884341|P2|Overall Study|Withdrawal by Subject|3
267281|NCT01134731|884342|P1|Overall Study|Withdrawal by Subject|3
267282|NCT01134731|884340|P3|Overall Study|Lack of Efficacy|1
267283|NCT01134731|884341|P2|Overall Study|Lack of Efficacy|0
267284|NCT01134731|884342|P1|Overall Study|Lack of Efficacy|0
267285|NCT01134731|884340|P3|Overall Study|Physician Decision|2
267286|NCT01134731|884341|P2|Overall Study|Physician Decision|2
267287|NCT01134731|884342|P1|Overall Study|Physician Decision|2
267288|NCT01134731|884340|P3|Overall Study|Adverse Event|1
267289|NCT01134731|884341|P2|Overall Study|Adverse Event|2
267290|NCT01134731|884342|P1|Overall Study|Adverse Event|3
267291|NCT01134705|884355|P2|Overall Study|Other|6
267292|NCT01134705|884356|P1|Overall Study|Other|1
267293|NCT01134705|884355|P2|Overall Study|Protocol Violation|1
267294|NCT01134705|884356|P1|Overall Study|Protocol Violation|1
267295|NCT01134705|884355|P2|Overall Study|Lost to Follow-up|2
267296|NCT01134705|884356|P1|Overall Study|Lost to Follow-up|5
267297|NCT01134705|884355|P2|Overall Study|Pregnancy|0
267298|NCT01134705|884356|P1|Overall Study|Pregnancy|1
267299|NCT01134705|884355|P2|Overall Study|Withdrawal by Subject|6
267300|NCT01134705|884356|P1|Overall Study|Withdrawal by Subject|6
267301|NCT01134705|884355|P2|Overall Study|Adverse Event|7
267302|NCT01134705|884356|P1|Overall Study|Adverse Event|1
267303|NCT01134627|884368|P2|Overall Study|Unspecified|14
267304|NCT01134627|884369|P1|Overall Study|Unspecified|11
267305|NCT01134627|884368|P2|Overall Study|Planning to become pregnant/pregnancy|0
267306|NCT01134627|884369|P1|Overall Study|Planning to become pregnant/pregnancy|1
267307|NCT01134627|884368|P2|Overall Study|Withdrawal by Subject|3
267308|NCT01134627|884369|P1|Overall Study|Withdrawal by Subject|4
267309|NCT01134627|884368|P2|Overall Study|Lack of Efficacy|12
267310|NCT01134627|884369|P1|Overall Study|Lack of Efficacy|2
267311|NCT01134627|884368|P2|Overall Study|Protocol Violation|5
267312|NCT01134627|884369|P1|Overall Study|Protocol Violation|3
267313|NCT01134627|884368|P2|Overall Study|Lost to Follow-up|2
267314|NCT01134627|884369|P1|Overall Study|Lost to Follow-up|1
267315|NCT01134627|884368|P2|Overall Study|Adverse Event|31
267316|NCT01134627|884369|P1|Overall Study|Adverse Event|47
267341|NCT01134393|884518|P1|Overall Study|Other|6
267342|NCT01134393|884518|P1|Overall Study|Withdrawal by Subject|11
267343|NCT01134393|884518|P1|Overall Study|Lost to Follow-up|3
267344|NCT01134393|884518|P1|Overall Study|Protocol Violation|12
267345|NCT01134393|884518|P1|Overall Study|Lack of Efficacy|2
267346|NCT01134393|884518|P1|Overall Study|Adverse Event|18
267347|NCT01134315|884534|P2|Overall Study|Other Reason|17
267348|NCT01134315|884535|P1|Overall Study|Other Reason|8
267349|NCT01134315|884534|P2|Overall Study|Adverse Event|2
267350|NCT01134315|884535|P1|Overall Study|Adverse Event|1
267351|NCT01134107|884570|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
267352|NCT01134107|884571|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
267353|NCT01134107|884570|P2|Period 2-Second Treatment Intervention|Physician Decision|0
267354|NCT01134107|884571|P1|Period 2-Second Treatment Intervention|Physician Decision|1
267355|NCT01134107|884570|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
267356|NCT01134107|884571|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
267357|NCT01134107|884570|P2|Period 1-First Treatment Intervention|Physician Decision|0
267358|NCT01134107|884571|P1|Period 1-First Treatment Intervention|Physician Decision|1
267359|NCT01134107|884570|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
267360|NCT01134107|884571|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
267361|NCT01134107|884570|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
267362|NCT01134107|884571|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
267363|NCT01134107|884570|P2|Period 1-First Treatment Intervention|Adverse Event|0
267364|NCT01134107|884571|P1|Period 1-First Treatment Intervention|Adverse Event|1
267365|NCT01134042|884606|P3|Overall Study|Withdrawal by Subject|7
267366|NCT01134042|884607|P2|Overall Study|Withdrawal by Subject|4
267367|NCT01134042|884608|P1|Overall Study|Withdrawal by Subject|13
267368|NCT01134042|884606|P3|Overall Study|Physician Decision|1
267369|NCT01134042|884607|P2|Overall Study|Physician Decision|8
267370|NCT01134042|884608|P1|Overall Study|Physician Decision|4
267371|NCT01134042|884606|P3|Overall Study|Lost to Follow-up|1
267372|NCT01134042|884607|P2|Overall Study|Lost to Follow-up|0
267373|NCT01134042|884608|P1|Overall Study|Lost to Follow-up|2
267374|NCT01134042|884606|P3|Overall Study|Protocol Violation|5
267375|NCT01134042|884607|P2|Overall Study|Protocol Violation|3
267376|NCT01134042|884608|P1|Overall Study|Protocol Violation|5
267377|NCT01134042|884606|P3|Overall Study|Lack of Efficacy|18
267378|NCT01134042|884607|P2|Overall Study|Lack of Efficacy|6
267379|NCT01134042|884608|P1|Overall Study|Lack of Efficacy|21
267380|NCT01134042|884606|P3|Overall Study|Adverse Event|2
267381|NCT01134042|884607|P2|Overall Study|Adverse Event|7
267382|NCT01134042|884608|P1|Overall Study|Adverse Event|3
267383|NCT01133977|884684|P5|Overall Study|Withdrawal by Subject|1
267384|NCT01133977|884685|P4|Overall Study|Withdrawal by Subject|5
267385|NCT01133977|884686|P3|Overall Study|Withdrawal by Subject|0
267386|NCT01133977|884687|P2|Overall Study|Withdrawal by Subject|0
267387|NCT01133977|884688|P1|Overall Study|Withdrawal by Subject|0
267388|NCT01133977|884684|P5|Overall Study|Lost to Follow-up|1
267389|NCT01133977|884685|P4|Overall Study|Lost to Follow-up|2
267390|NCT01133977|884686|P3|Overall Study|Lost to Follow-up|0
267391|NCT01133977|884687|P2|Overall Study|Lost to Follow-up|0
267392|NCT01133977|884688|P1|Overall Study|Lost to Follow-up|0
267393|NCT01133977|884684|P5|Overall Study|Started a New Line of Therapy|33
267394|NCT01133977|884685|P4|Overall Study|Started a New Line of Therapy|25
267395|NCT01133977|884686|P3|Overall Study|Started a New Line of Therapy|4
267396|NCT01133977|884687|P2|Overall Study|Started a New Line of Therapy|6
267397|NCT01133977|884688|P1|Overall Study|Started a New Line of Therapy|2
267398|NCT01133977|884684|P5|Overall Study|Death|3
267399|NCT01133977|884685|P4|Overall Study|Death|7
267400|NCT01133977|884686|P3|Overall Study|Death|1
267401|NCT01133977|884687|P2|Overall Study|Death|1
267402|NCT01133977|884688|P1|Overall Study|Death|1
267403|NCT01133977|884684|P5|Overall Study|Adverse Event|0
267404|NCT01133977|884685|P4|Overall Study|Adverse Event|0
267405|NCT01133977|884686|P3|Overall Study|Adverse Event|1
267406|NCT01133977|884687|P2|Overall Study|Adverse Event|0
267407|NCT01133977|884688|P1|Overall Study|Adverse Event|0
267408|NCT01133847|884715|P3|Follow-Up Phase|Lost to Follow-up|7
267409|NCT01133847|884716|P2|Follow-Up Phase|Lost to Follow-up|3
267410|NCT01133847|884717|P1|Follow-Up Phase|Lost to Follow-up|1
267411|NCT01133847|884715|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
267412|NCT01133847|884716|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
267413|NCT01133847|884717|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
267414|NCT01133756|884758|P3|Overall Study|Progression of Disease|1
267415|NCT01133756|884759|P2|Overall Study|Progression of Disease|0
267416|NCT01133756|884760|P1|Overall Study|Progression of Disease|0
267417|NCT01133756|884758|P3|Overall Study|Withdrawal by Subject|0
267418|NCT01133756|884759|P2|Overall Study|Withdrawal by Subject|1
267419|NCT01133756|884760|P1|Overall Study|Withdrawal by Subject|0
267420|NCT01133756|884758|P3|Overall Study|Investigator Decision|0
267421|NCT01133756|884759|P2|Overall Study|Investigator Decision|0
267422|NCT01133756|884760|P1|Overall Study|Investigator Decision|1
267423|NCT01133756|884758|P3|Overall Study|Adverse Event|1
267424|NCT01133756|884759|P2|Overall Study|Adverse Event|2
267425|NCT01133756|884760|P1|Overall Study|Adverse Event|1
267426|NCT01133704|884776|P2|Overall Study|Study Closure|0
267427|NCT01133704|884777|P1|Overall Study|Study Closure|1
267428|NCT01133704|884776|P2|Overall Study|Patient refused to continue|0
267429|NCT01133704|884777|P1|Overall Study|Patient refused to continue|4
267430|NCT01133704|884776|P2|Overall Study|Death|26
267431|NCT01133704|884777|P1|Overall Study|Death|44
267432|NCT01133665|884785|P1|Overall Study|Physician Decision|2
267433|NCT01133626|884829|P3|Overall Study|Not specified|0
267434|NCT01133626|884830|P2|Overall Study|Not specified|2
267435|NCT01133626|884831|P1|Overall Study|Not specified|0
267436|NCT01133626|884829|P3|Overall Study|Withdrawal by Subject|2
267437|NCT01133626|884830|P2|Overall Study|Withdrawal by Subject|2
267438|NCT01133626|884831|P1|Overall Study|Withdrawal by Subject|1
267439|NCT01133626|884829|P3|Overall Study|Adverse Event|0
267440|NCT01133626|884830|P2|Overall Study|Adverse Event|1
267441|NCT01133626|884831|P1|Overall Study|Adverse Event|0
267442|NCT01133522|884849|P10|Overall Study|Physician Decision|0
267443|NCT01133522|884850|P9|Overall Study|Physician Decision|0
267444|NCT01133522|884851|P8|Overall Study|Physician Decision|0
267445|NCT01133522|884852|P7|Overall Study|Physician Decision|0
267446|NCT01133522|884853|P6|Overall Study|Physician Decision|0
267447|NCT01133522|884854|P5|Overall Study|Physician Decision|1
267448|NCT01133522|884855|P4|Overall Study|Physician Decision|0
267449|NCT01133522|884856|P3|Overall Study|Physician Decision|0
267450|NCT01133522|884857|P2|Overall Study|Physician Decision|0
267451|NCT01133522|884858|P1|Overall Study|Physician Decision|0
267452|NCT01133522|884849|P10|Overall Study|Withdrawal by Subject|0
267453|NCT01133522|884850|P9|Overall Study|Withdrawal by Subject|0
267454|NCT01133522|884851|P8|Overall Study|Withdrawal by Subject|0
267455|NCT01133522|884852|P7|Overall Study|Withdrawal by Subject|0
267456|NCT01133522|884853|P6|Overall Study|Withdrawal by Subject|0
267457|NCT01133522|884854|P5|Overall Study|Withdrawal by Subject|0
267458|NCT01133522|884855|P4|Overall Study|Withdrawal by Subject|1
267459|NCT01133522|884856|P3|Overall Study|Withdrawal by Subject|0
267460|NCT01133522|884857|P2|Overall Study|Withdrawal by Subject|1
267461|NCT01133522|884858|P1|Overall Study|Withdrawal by Subject|0
267462|NCT01133418|884926|P2|Overall Study|Lost to Follow-up|6
267463|NCT01133418|884927|P1|Overall Study|Lost to Follow-up|5
267464|NCT01133392|884941|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
267465|NCT01133392|884942|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
267466|NCT01133392|884941|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
267467|NCT01133392|884942|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
267468|NCT01133379|884959|P3|Overall Study|Lost to Follow-up|1
267469|NCT01133379|884960|P2|Overall Study|Lost to Follow-up|1
267470|NCT01133379|884961|P1|Overall Study|Lost to Follow-up|1
267471|NCT01133379|884959|P3|Overall Study|Withdrawal by Subject|1
267472|NCT01133379|884960|P2|Overall Study|Withdrawal by Subject|1
267473|NCT01133379|884961|P1|Overall Study|Withdrawal by Subject|0
267474|NCT01133288|885014|P1|Intervention Allocation|study terminated|2
267475|NCT01133288|885014|P1|Eligibility Assessment|met exclusion criteria|5
267476|NCT01133275|885019|P1|Overall Study|Cerebrovascular accident (CVA)|1
267477|NCT01133275|885019|P1|Overall Study|Withdrawal by Subject|1
267478|NCT01133171|885027|P3|Overall Study|Withdrawal by Subject|0
267479|NCT01133171|885028|P2|Overall Study|Withdrawal by Subject|2
267480|NCT01133171|885029|P1|Overall Study|Withdrawal by Subject|1
267481|NCT01132664|885118|P5|BM Cohort|Withdrawal by Subject|1
267482|NCT01132664|885119|P4|BM Cohort|Withdrawal by Subject|0
267483|NCT01132664|885120|P3|BM Cohort|Withdrawal by Subject|0
267484|NCT01132664|885121|P2|BM Cohort|Withdrawal by Subject|0
267485|NCT01132664|885122|P1|BM Cohort|Withdrawal by Subject|0
267486|NCT01132664|885118|P5|BM Cohort|Adverse Event|1
267487|NCT01132664|885119|P4|BM Cohort|Adverse Event|0
267488|NCT01132664|885120|P3|BM Cohort|Adverse Event|0
267489|NCT01132664|885121|P2|BM Cohort|Adverse Event|0
267490|NCT01132664|885122|P1|BM Cohort|Adverse Event|0
267491|NCT01132664|885118|P5|BM Cohort|Disease progression|4
267492|NCT01132664|885119|P4|BM Cohort|Disease progression|3
267493|NCT01132664|885120|P3|BM Cohort|Disease progression|0
267494|NCT01132664|885121|P2|BM Cohort|Disease progression|0
267495|NCT01132664|885122|P1|BM Cohort|Disease progression|0
267496|NCT01132664|885118|P5|Phase ll|Disease progression|0
267497|NCT01132664|885119|P4|Phase ll|Disease progression|0
267498|NCT01132664|885120|P3|Phase ll|Disease progression|35
267499|NCT01132664|885121|P2|Phase ll|Disease progression|0
267500|NCT01132664|885122|P1|Phase ll|Disease progression|0
267501|NCT01132664|885118|P5|Phase ll|Withdrawal by Subject|0
267502|NCT01132664|885119|P4|Phase ll|Withdrawal by Subject|0
267503|NCT01132664|885120|P3|Phase ll|Withdrawal by Subject|3
267504|NCT01132664|885121|P2|Phase ll|Withdrawal by Subject|0
267505|NCT01132664|885122|P1|Phase ll|Withdrawal by Subject|0
267506|NCT01132664|885118|P5|Phase ll|Adverse Event|0
267507|NCT01132664|885119|P4|Phase ll|Adverse Event|0
267508|NCT01132664|885120|P3|Phase ll|Adverse Event|10
267509|NCT01132664|885121|P2|Phase ll|Adverse Event|0
267510|NCT01132664|885122|P1|Phase ll|Adverse Event|0
267511|NCT01132664|885118|P5|Phase ll|Death|0
267512|NCT01132664|885119|P4|Phase ll|Death|0
267513|NCT01132664|885120|P3|Phase ll|Death|2
267514|NCT01132664|885121|P2|Phase ll|Death|0
267515|NCT01132664|885122|P1|Phase ll|Death|0
267516|NCT01132664|885118|P5|Phase lb|Disease Progression|0
267517|NCT01132664|885119|P4|Phase lb|Disease Progression|0
267518|NCT01132664|885120|P3|Phase lb|Disease Progression|0
267519|NCT01132664|885121|P2|Phase lb|Disease Progression|9
267520|NCT01132664|885122|P1|Phase lb|Disease Progression|4
267521|NCT01132664|885118|P5|Phase lb|Withdrawal by Subject|0
267522|NCT01132664|885119|P4|Phase lb|Withdrawal by Subject|0
267523|NCT01132664|885120|P3|Phase lb|Withdrawal by Subject|0
267524|NCT01132664|885121|P2|Phase lb|Withdrawal by Subject|2
267525|NCT01132664|885122|P1|Phase lb|Withdrawal by Subject|1
267526|NCT01132664|885118|P5|Phase lb|Adverse Event|0
267527|NCT01132664|885119|P4|Phase lb|Adverse Event|0
267528|NCT01132664|885120|P3|Phase lb|Adverse Event|0
267529|NCT01132664|885121|P2|Phase lb|Adverse Event|1
267530|NCT01132664|885122|P1|Phase lb|Adverse Event|0
267531|NCT01132651|885156|P2|Overall Study|Lost to Follow-up|1
267532|NCT01132651|885157|P1|Overall Study|Lost to Follow-up|1
267533|NCT01132547|885167|P2|Overall Study|Death|0
267534|NCT01132547|885168|P1|Overall Study|Death|1
267535|NCT01132547|885167|P2|Overall Study|Withdrawal by Subject|1
267536|NCT01132547|885168|P1|Overall Study|Withdrawal by Subject|3
267537|NCT01132495|885238|P4|Overall Study|Various reasons|12
267538|NCT01132495|885239|P3|Overall Study|Various reasons|20
267539|NCT01132495|885240|P2|Overall Study|Various reasons|38
267540|NCT01132495|885241|P1|Overall Study|Various reasons|40
267541|NCT01132326|885254|P1|Overall Study|Subject Unable to Come To Visits|1
267542|NCT01132326|885254|P1|Overall Study|Death|5
267543|NCT01132326|885254|P1|Overall Study|Caregiver Withdrew Consent|1
267544|NCT01132326|885254|P1|Overall Study|Pregnancy|1
267545|NCT01132326|885254|P1|Overall Study|Declining Health|1
267546|NCT01132326|885254|P1|Overall Study|Study Termination|80
267547|NCT01132326|885254|P1|Overall Study|Physician Decision|10
267548|NCT01132326|885254|P1|Overall Study|Withdrawal by Subject|40
267549|NCT01132326|885254|P1|Overall Study|Lost to Follow-up|16
267550|NCT01132326|885254|P1|Overall Study|Protocol Violation|1
267551|NCT01132326|885254|P1|Overall Study|Adverse Event|37
267552|NCT01132326|885254|P1|Overall Study|Lack of Efficacy|25
267553|NCT01132313|885270|P12|Overall Study|Other reason not defined above|0
267554|NCT01132313|885271|P11|Overall Study|Other reason not defined above|0
267555|NCT01132313|885272|P10|Overall Study|Other reason not defined above|0
267556|NCT01132313|885273|P9|Overall Study|Other reason not defined above|0
267557|NCT01132313|885274|P8|Overall Study|Other reason not defined above|1
267558|NCT01132313|885275|P7|Overall Study|Other reason not defined above|0
267559|NCT01132313|885276|P6|Overall Study|Other reason not defined above|0
267560|NCT01132313|885277|P5|Overall Study|Other reason not defined above|0
267561|NCT01132313|885278|P4|Overall Study|Other reason not defined above|0
267562|NCT01132313|885279|P3|Overall Study|Other reason not defined above|0
267563|NCT01132313|885280|P2|Overall Study|Other reason not defined above|0
267564|NCT01132313|885281|P1|Overall Study|Other reason not defined above|0
267565|NCT01132313|885270|P12|Overall Study|Lack of antiviral response|0
267566|NCT01132313|885271|P11|Overall Study|Lack of antiviral response|1
267567|NCT01132313|885272|P10|Overall Study|Lack of antiviral response|0
267568|NCT01132313|885273|P9|Overall Study|Lack of antiviral response|0
267569|NCT01132313|885274|P8|Overall Study|Lack of antiviral response|0
267570|NCT01132313|885275|P7|Overall Study|Lack of antiviral response|21
267571|NCT01132313|885276|P6|Overall Study|Lack of antiviral response|18
267572|NCT01132313|885277|P5|Overall Study|Lack of antiviral response|18
267573|NCT01132313|885278|P4|Overall Study|Lack of antiviral response|18
267574|NCT01132313|885279|P3|Overall Study|Lack of antiviral response|12
267575|NCT01132313|885280|P2|Overall Study|Lack of antiviral response|0
267576|NCT01132313|885281|P1|Overall Study|Lack of antiviral response|0
267577|NCT01132313|885270|P12|Overall Study|Withdrawal by Subject|0
267578|NCT01132313|885271|P11|Overall Study|Withdrawal by Subject|0
267579|NCT01132313|885272|P10|Overall Study|Withdrawal by Subject|2
267580|NCT01132313|885273|P9|Overall Study|Withdrawal by Subject|0
267581|NCT01132313|885274|P8|Overall Study|Withdrawal by Subject|0
267582|NCT01132313|885275|P7|Overall Study|Withdrawal by Subject|1
267583|NCT01132313|885276|P6|Overall Study|Withdrawal by Subject|0
267584|NCT01132313|885277|P5|Overall Study|Withdrawal by Subject|6
267585|NCT01132313|885278|P4|Overall Study|Withdrawal by Subject|3
267586|NCT01132313|885279|P3|Overall Study|Withdrawal by Subject|3
267587|NCT01132313|885280|P2|Overall Study|Withdrawal by Subject|0
267588|NCT01132313|885281|P1|Overall Study|Withdrawal by Subject|0
267589|NCT01132313|885270|P12|Overall Study|Lost to Follow-up|0
267590|NCT01132313|885271|P11|Overall Study|Lost to Follow-up|0
267591|NCT01132313|885272|P10|Overall Study|Lost to Follow-up|0
267592|NCT01132313|885273|P9|Overall Study|Lost to Follow-up|0
267593|NCT01132313|885274|P8|Overall Study|Lost to Follow-up|1
267594|NCT01132313|885275|P7|Overall Study|Lost to Follow-up|0
267595|NCT01132313|885276|P6|Overall Study|Lost to Follow-up|0
267596|NCT01132313|885277|P5|Overall Study|Lost to Follow-up|0
267597|NCT01132313|885278|P4|Overall Study|Lost to Follow-up|0
267598|NCT01132313|885279|P3|Overall Study|Lost to Follow-up|1
267599|NCT01132313|885280|P2|Overall Study|Lost to Follow-up|0
267600|NCT01132313|885281|P1|Overall Study|Lost to Follow-up|0
267601|NCT01132313|885270|P12|Overall Study|Protocol Violation|0
267602|NCT01132313|885271|P11|Overall Study|Protocol Violation|0
267603|NCT01132313|885272|P10|Overall Study|Protocol Violation|0
267604|NCT01132313|885273|P9|Overall Study|Protocol Violation|0
267605|NCT01132313|885274|P8|Overall Study|Protocol Violation|0
267606|NCT01132313|885275|P7|Overall Study|Protocol Violation|0
267607|NCT01132313|885276|P6|Overall Study|Protocol Violation|0
267608|NCT01132313|885277|P5|Overall Study|Protocol Violation|0
267609|NCT01132313|885278|P4|Overall Study|Protocol Violation|1
267610|NCT01132313|885279|P3|Overall Study|Protocol Violation|0
267611|NCT01132313|885280|P2|Overall Study|Protocol Violation|0
267612|NCT01132313|885281|P1|Overall Study|Protocol Violation|0
267613|NCT01132313|885270|P12|Overall Study|Adverse Event|0
267614|NCT01132313|885271|P11|Overall Study|Adverse Event|0
267615|NCT01132313|885272|P10|Overall Study|Adverse Event|2
267616|NCT01132313|885273|P9|Overall Study|Adverse Event|7
267617|NCT01132313|885274|P8|Overall Study|Adverse Event|3
267618|NCT01132313|885275|P7|Overall Study|Adverse Event|5
267619|NCT01132313|885276|P6|Overall Study|Adverse Event|6
267620|NCT01132313|885277|P5|Overall Study|Adverse Event|19
267621|NCT01132313|885278|P4|Overall Study|Adverse Event|10
267622|NCT01132313|885279|P3|Overall Study|Adverse Event|4
267623|NCT01132313|885280|P2|Overall Study|Adverse Event|0
267624|NCT01132313|885281|P1|Overall Study|Adverse Event|0
267625|NCT01132313|885270|P12|Overall Study|Not treated|0
267626|NCT01132313|885271|P11|Overall Study|Not treated|0
267627|NCT01132313|885272|P10|Overall Study|Not treated|0
267628|NCT01132313|885273|P9|Overall Study|Not treated|0
267629|NCT01132313|885274|P8|Overall Study|Not treated|0
267630|NCT01132313|885275|P7|Overall Study|Not treated|3
267631|NCT01132313|885276|P6|Overall Study|Not treated|1
267632|NCT01132313|885277|P5|Overall Study|Not treated|2
267633|NCT01132313|885278|P4|Overall Study|Not treated|0
267634|NCT01132313|885279|P3|Overall Study|Not treated|0
267635|NCT01132313|885280|P2|Overall Study|Not treated|0
267636|NCT01132313|885281|P1|Overall Study|Not treated|2
267637|NCT01132313|885270|P12|Overall Study|Lack of Efficacy|0
267638|NCT01132313|885271|P11|Overall Study|Lack of Efficacy|0
267639|NCT01132313|885272|P10|Overall Study|Lack of Efficacy|16
267640|NCT01132313|885273|P9|Overall Study|Lack of Efficacy|14
267641|NCT01132313|885274|P8|Overall Study|Lack of Efficacy|3
267642|NCT01132313|885275|P7|Overall Study|Lack of Efficacy|0
267643|NCT01132313|885276|P6|Overall Study|Lack of Efficacy|0
267644|NCT01132313|885277|P5|Overall Study|Lack of Efficacy|0
267645|NCT01132313|885278|P4|Overall Study|Lack of Efficacy|0
267646|NCT01132313|885279|P3|Overall Study|Lack of Efficacy|0
267647|NCT01132313|885280|P2|Overall Study|Lack of Efficacy|0
267648|NCT01132313|885281|P1|Overall Study|Lack of Efficacy|1
267649|NCT01132118|885361|P2|Second Intervention (8 Weeks)|Adverse Event|1
267650|NCT01132118|885362|P1|Second Intervention (8 Weeks)|Adverse Event|0
267651|NCT01132118|885361|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
267652|NCT01132118|885362|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
267653|NCT01132118|885361|P2|First Intervention (8 Weeks)|Adverse Event|0
267654|NCT01132118|885362|P1|First Intervention (8 Weeks)|Adverse Event|1
267655|NCT01131676|885392|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
267656|NCT01131676|885393|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
267657|NCT01131676|885394|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
267658|NCT01131676|885392|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
267659|NCT01131676|885393|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
267660|NCT01131676|885394|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
267661|NCT01131676|885392|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
267662|NCT01131676|885393|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
267663|NCT01131676|885394|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
267664|NCT01131676|885392|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
267665|NCT01131676|885393|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
267666|NCT01131676|885394|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
267667|NCT01131676|885392|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
267668|NCT01131676|885393|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
267669|NCT01131676|885394|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
267670|NCT01131676|885392|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
267671|NCT01131676|885393|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
267672|NCT01131676|885394|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
267673|NCT01131676|885392|P3|Discontinuation From Treatment|Adverse Event|273
267674|NCT01131676|885393|P2|Discontinuation From Treatment|Adverse Event|267
267675|NCT01131676|885394|P1|Discontinuation From Treatment|Adverse Event|303
267676|NCT01131676|885392|P3|Discontinuation From Treatment|Other than those specified|125
267677|NCT01131676|885393|P2|Discontinuation From Treatment|Other than those specified|142
267678|NCT01131676|885394|P1|Discontinuation From Treatment|Other than those specified|162
267679|NCT01131676|885392|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
267680|NCT01131676|885393|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
267681|NCT01131676|885394|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
267682|NCT01131676|885392|P3|Discontinuation From Treatment|Lost to Follow-up|6
267683|NCT01131676|885393|P2|Discontinuation From Treatment|Lost to Follow-up|9
267684|NCT01131676|885394|P1|Discontinuation From Treatment|Lost to Follow-up|15
267685|NCT01131676|885392|P3|Discontinuation From Treatment|Non compliant with protocol|12
267686|NCT01131676|885393|P2|Discontinuation From Treatment|Non compliant with protocol|15
267687|NCT01131676|885394|P1|Discontinuation From Treatment|Non compliant with protocol|15
267688|NCT01131676|885392|P3|Discontinuation From Treatment|Lack of Efficacy|0
267689|NCT01131676|885393|P2|Discontinuation From Treatment|Lack of Efficacy|1
267690|NCT01131676|885394|P1|Discontinuation From Treatment|Lack of Efficacy|11
267691|NCT01131676|885392|P3|Discontinuation From Treatment|Not treated|2
267692|NCT01131676|885393|P2|Discontinuation From Treatment|Not treated|2
267693|NCT01131676|885394|P1|Discontinuation From Treatment|Not treated|4
267694|NCT01131676|885392|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
267695|NCT01131676|885393|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
267696|NCT01131676|885394|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
267697|NCT01131585|885429|P2|Overall Study|Study termination|32
267698|NCT01131585|885430|P1|Overall Study|Study termination|78
267699|NCT01131585|885429|P2|Overall Study|Administrative problems|1
267700|NCT01131585|885430|P1|Overall Study|Administrative problems|1
267701|NCT01131585|885429|P2|Overall Study|Lost to Follow-up|1
267702|NCT01131585|885430|P1|Overall Study|Lost to Follow-up|0
267703|NCT01131585|885429|P2|Overall Study|Withdrawal by Subject|3
267704|NCT01131585|885430|P1|Overall Study|Withdrawal by Subject|3
267705|NCT01131585|885429|P2|Overall Study|Protocol Violation|1
267706|NCT01131585|885430|P1|Overall Study|Protocol Violation|2
267707|NCT01131585|885429|P2|Overall Study|Unsatisfactory therapeutic effect|3
267708|NCT01131585|885430|P1|Overall Study|Unsatisfactory therapeutic effect|0
267709|NCT01131585|885429|P2|Overall Study|Abnormal laboratory value|0
267710|NCT01131585|885430|P1|Overall Study|Abnormal laboratory value|1
267711|NCT01131585|885429|P2|Overall Study|Adverse Event|2
267712|NCT01131585|885430|P1|Overall Study|Adverse Event|0
267713|NCT01131507|885436|P1|Overall Study|Withdrawal by Subject|1
267714|NCT01131507|885436|P1|Overall Study|Lost to Follow-up|1
267715|NCT01131507|885436|P1|Overall Study|Adverse Event|1
267716|NCT01131494|885441|P1|Overall Study|Withdrawal by Subject|2
267717|NCT01131455|885451|P3|Overall Study|Death of PI|0
267718|NCT01131455|885452|P2|Overall Study|Death of PI|4
267719|NCT01131455|885453|P1|Overall Study|Death of PI|6
267720|NCT01131299|885461|P2|Overall Study|Withdrawal by Subject|7
267721|NCT01131299|885462|P1|Overall Study|Withdrawal by Subject|4
267722|NCT01131182|885475|P2|Overall Study|Other Reason|0
267723|NCT01131182|885476|P1|Overall Study|Other Reason|1
267724|NCT01131182|885475|P2|Overall Study|Lost to Follow-up|15
267725|NCT01131182|885476|P1|Overall Study|Lost to Follow-up|14
267726|NCT01131182|885475|P2|Overall Study|Withdrawal by Subject|1
267727|NCT01131182|885476|P1|Overall Study|Withdrawal by Subject|1
267728|NCT01131130|885484|P1|Period 3- Crossover|+ Slit lamp finding|1
267729|NCT01131130|885484|P1|Period 1 - Baseline|Pregnancy|1
267730|NCT01131078|885500|P3|Overall Study|Other|0
267731|NCT01131078|885501|P2|Overall Study|Other|1
267732|NCT01131078|885502|P1|Overall Study|Other|0
267733|NCT01131078|885500|P3|Overall Study|Death|2
267734|NCT01131078|885501|P2|Overall Study|Death|0
267735|NCT01131078|885502|P1|Overall Study|Death|4
267736|NCT01131078|885500|P3|Overall Study|Physician Decision|8
267737|NCT01131078|885501|P2|Overall Study|Physician Decision|6
267738|NCT01131078|885502|P1|Overall Study|Physician Decision|10
267739|NCT01131078|885500|P3|Overall Study|Non-compliance|0
267740|NCT01131078|885501|P2|Overall Study|Non-compliance|0
267741|NCT01131078|885502|P1|Overall Study|Non-compliance|3
267742|NCT01131078|885500|P3|Overall Study|Withdrawal by Subject|3
267743|NCT01131078|885501|P2|Overall Study|Withdrawal by Subject|4
267744|NCT01131078|885502|P1|Overall Study|Withdrawal by Subject|2
267745|NCT01131078|885500|P3|Overall Study|Lost to Follow-up|1
267746|NCT01131078|885501|P2|Overall Study|Lost to Follow-up|1
267747|NCT01131078|885502|P1|Overall Study|Lost to Follow-up|1
267748|NCT01131078|885500|P3|Overall Study|Protocol Violation|0
267749|NCT01131078|885501|P2|Overall Study|Protocol Violation|0
267750|NCT01131078|885502|P1|Overall Study|Protocol Violation|1
267751|NCT01131078|885500|P3|Overall Study|Progressive Disease|71
267752|NCT01131078|885501|P2|Overall Study|Progressive Disease|77
267753|NCT01131078|885502|P1|Overall Study|Progressive Disease|58
267754|NCT01131078|885500|P3|Overall Study|Adverse Event|17
267755|NCT01131078|885501|P2|Overall Study|Adverse Event|12
267756|NCT01131078|885502|P1|Overall Study|Adverse Event|22
267757|NCT01130974|885589|P2|Overall Study|Ineligibility criteria|2
267758|NCT01130974|885590|P1|Overall Study|Ineligibility criteria|5
267759|NCT01130974|885589|P2|Overall Study|Withdrawal by Subject|1
267760|NCT01130974|885590|P1|Overall Study|Withdrawal by Subject|0
267761|NCT01130974|885589|P2|Overall Study|Protocol Violation|10
267762|NCT01130974|885590|P1|Overall Study|Protocol Violation|10
267763|NCT01130883|885610|P1|Overall Study|Adverse Event|3
267764|NCT01130883|885610|P1|Overall Study|Reason Unknown|1
267765|NCT01130883|885610|P1|Overall Study|Patient Noncompliance|6
267766|NCT01130831|885667|P1|Overall Study|Information was missing|3
267767|NCT01130831|885667|P1|Overall Study|Death|4
267768|NCT01130831|885667|P1|Overall Study|Withdrawal by Subject|7
267769|NCT01130597|885706|P1|Overall Study|Protocol Violation|1
267770|NCT01130597|885706|P1|Overall Study|Death|1
267771|NCT01130597|885706|P1|Overall Study|Adverse Event|4
267772|NCT01130597|885706|P1|Overall Study|Protocol-specified (High K+)|1
267773|NCT01130532|885731|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
267774|NCT01130532|885732|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
267775|NCT01130532|885733|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
267776|NCT01130532|885734|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
267777|NCT01130532|885731|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
267778|NCT01130532|885732|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
267779|NCT01130532|885733|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
267780|NCT01130532|885734|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
267781|NCT01130532|885731|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
267782|NCT01130532|885732|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
267783|NCT01130532|885733|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
267784|NCT01130532|885734|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
267785|NCT01130532|885731|P4|Period IV (Weeks 13-16)|Adverse Event|1
267786|NCT01130532|885732|P3|Period IV (Weeks 13-16)|Adverse Event|0
267787|NCT01130532|885733|P2|Period IV (Weeks 13-16)|Adverse Event|0
267788|NCT01130532|885734|P1|Period IV (Weeks 13-16)|Adverse Event|0
267789|NCT01130532|885731|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
267790|NCT01130532|885732|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
267791|NCT01130532|885733|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
267792|NCT01130532|885734|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
267793|NCT01130532|885731|P4|Period III (Weeks 0-12)|Sponsor Decision|0
267794|NCT01130532|885732|P3|Period III (Weeks 0-12)|Sponsor Decision|2
267795|NCT01130532|885733|P2|Period III (Weeks 0-12)|Sponsor Decision|4
267796|NCT01130532|885734|P1|Period III (Weeks 0-12)|Sponsor Decision|3
267797|NCT01130532|885731|P4|Period III (Weeks 0-12)|Protocol Violation|0
267798|NCT01130532|885732|P3|Period III (Weeks 0-12)|Protocol Violation|1
267799|NCT01130532|885733|P2|Period III (Weeks 0-12)|Protocol Violation|0
267800|NCT01130532|885734|P1|Period III (Weeks 0-12)|Protocol Violation|0
267801|NCT01130532|885731|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
267802|NCT01130532|885732|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
267803|NCT01130532|885733|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
267804|NCT01130532|885734|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
267805|NCT01130532|885731|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
267806|NCT01130532|885732|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
267807|NCT01130532|885733|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
267808|NCT01130532|885734|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
267809|NCT01130532|885731|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
267810|NCT01130532|885732|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
267811|NCT01130532|885733|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
267812|NCT01130532|885734|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
267813|NCT01130532|885731|P4|Period III (Weeks 0-12)|Adverse Event|0
267814|NCT01130532|885732|P3|Period III (Weeks 0-12)|Adverse Event|2
267815|NCT01130532|885733|P2|Period III (Weeks 0-12)|Adverse Event|3
267816|NCT01130532|885734|P1|Period III (Weeks 0-12)|Adverse Event|3
267817|NCT01130337|885779|P1|Overall Study|Surgical resection (R2)|1
267818|NCT01130337|885779|P1|Overall Study|Toxicity, AE/intercurrent disease|7
267819|NCT01130337|885779|P1|Overall Study|Disease progression|1
267820|NCT01130337|885779|P1|Overall Study|Death|1
267821|NCT01130337|885779|P1|Overall Study|Principal investigator decision|1
267822|NCT01130337|885779|P1|Overall Study|Withdrawal by Subject|3
267823|NCT01130168|885786|P6|Period 1|Adverse Event|0
267824|NCT01130168|885787|P5|Period 1|Adverse Event|0
267825|NCT01130168|885788|P4|Period 1|Adverse Event|1
267826|NCT01130168|885789|P3|Period 1|Adverse Event|0
267827|NCT01130168|885790|P2|Period 1|Adverse Event|0
267828|NCT01130168|885791|P1|Period 1|Adverse Event|0
267829|NCT01130168|885786|P6|Period 1|Discontinued For Other Reason|0
267830|NCT01130168|885787|P5|Period 1|Discontinued For Other Reason|0
267831|NCT01130168|885788|P4|Period 1|Discontinued For Other Reason|1
267832|NCT01130168|885789|P3|Period 1|Discontinued For Other Reason|1
267833|NCT01130168|885790|P2|Period 1|Discontinued For Other Reason|0
267834|NCT01130168|885791|P1|Period 1|Discontinued For Other Reason|0
267835|NCT01130168|885786|P6|Period 1|Withdrawal by Subject|0
267836|NCT01130168|885787|P5|Period 1|Withdrawal by Subject|0
267837|NCT01130168|885788|P4|Period 1|Withdrawal by Subject|1
267838|NCT01130168|885789|P3|Period 1|Withdrawal by Subject|0
267839|NCT01130168|885790|P2|Period 1|Withdrawal by Subject|1
267840|NCT01130168|885791|P1|Period 1|Withdrawal by Subject|0
267841|NCT01130103|885828|P2|Maintenance Treatment|Withdrawal by Subject|0
267842|NCT01130103|885829|P1|Maintenance Treatment|Withdrawal by Subject|1
267843|NCT01130103|885828|P2|Maintenance Treatment|Lost to Follow-up|1
267844|NCT01130103|885829|P1|Maintenance Treatment|Lost to Follow-up|1
267845|NCT01130103|885828|P2|Maintenance Treatment|Lack of Efficacy|1
267846|NCT01130103|885829|P1|Maintenance Treatment|Lack of Efficacy|0
267847|NCT01130103|885828|P2|Randomized Treatment|Withdrawal by Subject|2
267848|NCT01130103|885829|P1|Randomized Treatment|Withdrawal by Subject|1
267849|NCT01130103|885828|P2|Randomized Treatment|Protocol Violation|2
267850|NCT01130103|885829|P1|Randomized Treatment|Protocol Violation|3
267851|NCT01130103|885828|P2|Randomized Treatment|Lost to Follow-up|0
267852|NCT01130103|885829|P1|Randomized Treatment|Lost to Follow-up|1
267853|NCT01130103|885828|P2|Randomized Treatment|Adverse Event|1
267854|NCT01130103|885829|P1|Randomized Treatment|Adverse Event|1
267855|NCT01130051|885843|P2|Washout Period of 14 Days|Protocol Violation|1
267856|NCT01130051|885844|P1|Washout Period of 14 Days|Protocol Violation|1
267857|NCT01130051|885843|P2|Washout Period of 14 Days|Withdrawal by Subject|1
267858|NCT01130051|885844|P1|Washout Period of 14 Days|Withdrawal by Subject|0
267859|NCT01129960|885858|P4|Overall Study|Pregnancy|0
267860|NCT01129960|885859|P3|Overall Study|Pregnancy|0
267861|NCT01129960|885860|P2|Overall Study|Pregnancy|0
267862|NCT01129960|885861|P1|Overall Study|Pregnancy|1
267863|NCT01129960|885858|P4|Overall Study|Physician Decision|0
267864|NCT01129960|885859|P3|Overall Study|Physician Decision|0
267865|NCT01129960|885860|P2|Overall Study|Physician Decision|0
267866|NCT01129960|885861|P1|Overall Study|Physician Decision|1
267867|NCT01129960|885858|P4|Overall Study|Discontinuation of the study by Sponsor|0
267868|NCT01129960|885859|P3|Overall Study|Discontinuation of the study by Sponsor|0
267869|NCT01129960|885860|P2|Overall Study|Discontinuation of the study by Sponsor|1
267870|NCT01129960|885861|P1|Overall Study|Discontinuation of the study by Sponsor|0
267871|NCT01129960|885858|P4|Overall Study|Lost to Follow-up|3
267872|NCT01129960|885859|P3|Overall Study|Lost to Follow-up|3
267873|NCT01129960|885860|P2|Overall Study|Lost to Follow-up|2
267874|NCT01129960|885861|P1|Overall Study|Lost to Follow-up|0
267875|NCT01129960|885858|P4|Overall Study|Protocol Violation|0
267876|NCT01129960|885859|P3|Overall Study|Protocol Violation|3
267877|NCT01129960|885860|P2|Overall Study|Protocol Violation|2
267878|NCT01129960|885861|P1|Overall Study|Protocol Violation|1
267879|NCT01129960|885858|P4|Overall Study|Adverse Event|7
267880|NCT01129960|885859|P3|Overall Study|Adverse Event|16
267881|NCT01129960|885860|P2|Overall Study|Adverse Event|16
267882|NCT01129960|885861|P1|Overall Study|Adverse Event|23
267883|NCT01129960|885858|P4|Overall Study|Lack of Efficacy|1
267884|NCT01129960|885859|P3|Overall Study|Lack of Efficacy|1
267885|NCT01129960|885860|P2|Overall Study|Lack of Efficacy|1
267886|NCT01129960|885861|P1|Overall Study|Lack of Efficacy|1
267887|NCT01129960|885858|P4|Overall Study|Withdrawal by Subject|2
267888|NCT01129960|885859|P3|Overall Study|Withdrawal by Subject|3
267889|NCT01129960|885860|P2|Overall Study|Withdrawal by Subject|0
267890|NCT01129960|885861|P1|Overall Study|Withdrawal by Subject|3
267891|NCT01129921|885873|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
267892|NCT01129921|885874|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
267893|NCT01129921|885873|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
267894|NCT01129921|885874|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
267895|NCT01129921|885873|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
267896|NCT01129921|885874|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
267897|NCT01129921|885873|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
267898|NCT01129921|885874|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
267899|NCT01129622|885898|P1|Overall Study|Withdrawal by Subject|2
267900|NCT01129583|885905|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
267901|NCT01129583|885906|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
267902|NCT01129583|885905|P2|Overall Study|Lost to Follow-up|1
267903|NCT01129583|885906|P1|Overall Study|Lost to Follow-up|1
267904|NCT01129583|885905|P2|Overall Study|Death|0
267905|NCT01129583|885906|P1|Overall Study|Death|1
267906|NCT01129557|885919|P3|Overall Study|Novartis terminated study early|2
267907|NCT01129557|885920|P2|Overall Study|Novartis terminated study early|3
267908|NCT01129557|885921|P1|Overall Study|Novartis terminated study early|3
267909|NCT01129557|885919|P3|Overall Study|Adverse Event|2
267910|NCT01129557|885920|P2|Overall Study|Adverse Event|2
267911|NCT01129557|885921|P1|Overall Study|Adverse Event|1
267912|NCT01129336|886016|P2|Overall Study|Death|4
267913|NCT01129336|886017|P1|Overall Study|Death|0
267914|NCT01129336|886016|P2|Overall Study|Missing Study Completion Status|3
267915|NCT01129336|886017|P1|Overall Study|Missing Study Completion Status|2
267916|NCT01129336|886016|P2|Overall Study|Adverse Event|1
267917|NCT01129336|886017|P1|Overall Study|Adverse Event|0
267918|NCT01129336|886016|P2|Overall Study|Withdrawal by Subject|4
267919|NCT01129336|886017|P1|Overall Study|Withdrawal by Subject|7
267920|NCT01129336|886016|P2|Overall Study|Lost to Follow-up|0
267921|NCT01129336|886017|P1|Overall Study|Lost to Follow-up|1
267922|NCT01129336|886016|P2|Overall Study|Disease Progression|4
267923|NCT01129336|886017|P1|Overall Study|Disease Progression|1
267924|NCT01129336|886016|P2|Overall Study|Protocol Violation|0
267925|NCT01129336|886017|P1|Overall Study|Protocol Violation|1
267926|NCT01129284|886032|P3|Overall Study|Adverse Event|1
267927|NCT01129284|886033|P2|Overall Study|Adverse Event|0
267928|NCT01129284|886034|P1|Overall Study|Adverse Event|2
267929|NCT01129128|886074|P3|Overall Study|Physician Decision|0
267930|NCT01129128|886075|P2|Overall Study|Physician Decision|0
267931|NCT01129128|886076|P1|Overall Study|Physician Decision|1
267932|NCT01129128|886074|P3|Overall Study|Withdrawal by Subject|3
267933|NCT01129128|886075|P2|Overall Study|Withdrawal by Subject|1
267934|NCT01129128|886076|P1|Overall Study|Withdrawal by Subject|0
267935|NCT01129128|886074|P3|Overall Study|Protocol Violation|0
267936|NCT01129128|886075|P2|Overall Study|Protocol Violation|1
267937|NCT01129128|886076|P1|Overall Study|Protocol Violation|0
267938|NCT01129128|886074|P3|Overall Study|Lost to Follow-up|1
267939|NCT01129128|886075|P2|Overall Study|Lost to Follow-up|2
267940|NCT01129128|886076|P1|Overall Study|Lost to Follow-up|2
267941|NCT01129115|886100|P4|Overall Study|Protocol Violation|2
267942|NCT01129115|886101|P3|Overall Study|Protocol Violation|2
267943|NCT01129115|886102|P2|Overall Study|Protocol Violation|2
267944|NCT01129115|886103|P1|Overall Study|Protocol Violation|0
267945|NCT01129115|886100|P4|Overall Study|Withdrawal by Subject|4
267946|NCT01129115|886101|P3|Overall Study|Withdrawal by Subject|1
267947|NCT01129115|886102|P2|Overall Study|Withdrawal by Subject|3
267948|NCT01129115|886103|P1|Overall Study|Withdrawal by Subject|1
267949|NCT01129115|886100|P4|Overall Study|Adverse Event|3
267950|NCT01129115|886101|P3|Overall Study|Adverse Event|3
267951|NCT01129115|886102|P2|Overall Study|Adverse Event|2
267952|NCT01129115|886103|P1|Overall Study|Adverse Event|1
267953|NCT01129102|886140|P3|Overall Study|Lost to Follow-up|0
267954|NCT01129102|886141|P2|Overall Study|Lost to Follow-up|0
267955|NCT01129102|886142|P1|Overall Study|Lost to Follow-up|2
267956|NCT01129102|886140|P3|Overall Study|Adverse Event|1
267957|NCT01129102|886141|P2|Overall Study|Adverse Event|2
267958|NCT01129102|886142|P1|Overall Study|Adverse Event|2
267959|NCT01129102|886140|P3|Overall Study|Pregnancy|1
267960|NCT01129102|886141|P2|Overall Study|Pregnancy|0
267961|NCT01129102|886142|P1|Overall Study|Pregnancy|0
267962|NCT01129102|886140|P3|Overall Study|Protocol Violation|1
267963|NCT01129102|886141|P2|Overall Study|Protocol Violation|1
267964|NCT01129102|886142|P1|Overall Study|Protocol Violation|0
267965|NCT01129102|886140|P3|Overall Study|Withdrawal by Subject|3
267966|NCT01129102|886141|P2|Overall Study|Withdrawal by Subject|0
267967|NCT01129102|886142|P1|Overall Study|Withdrawal by Subject|2
267968|NCT01129102|886140|P3|Overall Study|No study drug treatment|1
267969|NCT01129102|886141|P2|Overall Study|No study drug treatment|3
267970|NCT01129102|886142|P1|Overall Study|No study drug treatment|2
267971|NCT01129011|886153|P2|Overall Study|misc|4
267972|NCT01129011|886154|P1|Overall Study|misc|7
267973|NCT01129011|886153|P2|Overall Study|Duodenal Ulcer|8
267974|NCT01129011|886154|P1|Overall Study|Duodenal Ulcer|2
267975|NCT01129011|886153|P2|Overall Study|Lost to Follow-up|7
267976|NCT01129011|886154|P1|Overall Study|Lost to Follow-up|6
267977|NCT01129011|886153|P2|Overall Study|Withdrawal by Subject|8
267978|NCT01129011|886154|P1|Overall Study|Withdrawal by Subject|24
267979|NCT01129011|886153|P2|Overall Study|Adverse Event|30
267980|NCT01129011|886154|P1|Overall Study|Adverse Event|20
267981|NCT01128959|886209|P1|Treatment Period|Withdrawal by Subject|1
267982|NCT01128959|886209|P1|Treatment Period|Adverse Event|3
267983|NCT01128959|886209|P1|Lead in Period|Adverse Event|3
267984|NCT01128946|886215|P4|Period III|Protocol Violation|0
267985|NCT01128946|886216|P3|Period III|Protocol Violation|0
267986|NCT01128946|886217|P2|Period III|Protocol Violation|0
267987|NCT01128946|886218|P1|Period III|Protocol Violation|1
267988|NCT01128946|886215|P4|Period II|Withdrawal by Subject|1
267989|NCT01128946|886216|P3|Period II|Withdrawal by Subject|0
267990|NCT01128946|886217|P2|Period II|Withdrawal by Subject|0
267991|NCT01128946|886218|P1|Period II|Withdrawal by Subject|0
267992|NCT01128946|886215|P4|Period II|Protocol Violation|0
267993|NCT01128946|886216|P3|Period II|Protocol Violation|0
267994|NCT01128946|886217|P2|Period II|Protocol Violation|1
267995|NCT01128946|886218|P1|Period II|Protocol Violation|0
267996|NCT01128946|886215|P4|Period I|Withdrawal by Subject|1
267997|NCT01128946|886216|P3|Period I|Withdrawal by Subject|1
267998|NCT01128946|886217|P2|Period I|Withdrawal by Subject|0
267999|NCT01128946|886218|P1|Period I|Withdrawal by Subject|0
268000|NCT01128946|886215|P4|Period I|Protocol Violation|0
268001|NCT01128946|886216|P3|Period I|Protocol Violation|0
268002|NCT01128946|886217|P2|Period I|Protocol Violation|1
268003|NCT01128946|886218|P1|Period I|Protocol Violation|0
268004|NCT01128894|886236|P2|Overall Study|Conflicting HbA1c Results at Screening|0
268005|NCT01128894|886237|P1|Overall Study|Conflicting HbA1c Results at Screening|1
268006|NCT01128894|886236|P2|Overall Study|Physician Decision|1
268007|NCT01128894|886237|P1|Overall Study|Physician Decision|2
268008|NCT01128894|886236|P2|Overall Study|Withdrawal by Subject|12
268009|NCT01128894|886237|P1|Overall Study|Withdrawal by Subject|10
268010|NCT01128894|886236|P2|Overall Study|Lost to Follow-up|8
268011|NCT01128894|886237|P1|Overall Study|Lost to Follow-up|8
268012|NCT01128894|886236|P2|Overall Study|Noncompliance|5
268013|NCT01128894|886237|P1|Overall Study|Noncompliance|4
268014|NCT01128894|886236|P2|Overall Study|Protocol Violation|1
268015|NCT01128894|886237|P1|Overall Study|Protocol Violation|2
268016|NCT01128894|886236|P2|Overall Study|Adverse Event|41
268017|NCT01128894|886237|P1|Overall Study|Adverse Event|31
268018|NCT01128738|886262|P2|Second TP|Withdrawal by Subject|2
268019|NCT01128738|886263|P1|Second TP|Withdrawal by Subject|0
268020|NCT01128738|886262|P2|Second TP|Lost to Follow-up|1
268021|NCT01128738|886263|P1|Second TP|Lost to Follow-up|0
268022|NCT01128738|886262|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
268023|NCT01128738|886263|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
268024|NCT01128738|886262|P2|First Treatment Phase (TP)|Lost to Follow-up|0
268025|NCT01128738|886263|P1|First Treatment Phase (TP)|Lost to Follow-up|1
268026|NCT01128595|886386|P4|Treatment Period 3|Withdrawal by Subject|0
268027|NCT01128595|886387|P3|Treatment Period 3|Withdrawal by Subject|0
268028|NCT01128595|886388|P2|Treatment Period 3|Withdrawal by Subject|1
268029|NCT01128595|886389|P1|Treatment Period 3|Withdrawal by Subject|0
268030|NCT01128569|886419|P6|Treatment Period 2|Withdrawal by Subject|0
268031|NCT01128569|886420|P5|Treatment Period 2|Withdrawal by Subject|0
268032|NCT01128569|886421|P4|Treatment Period 2|Withdrawal by Subject|0
268033|NCT01128569|886422|P3|Treatment Period 2|Withdrawal by Subject|0
268034|NCT01128569|886423|P2|Treatment Period 2|Withdrawal by Subject|1
268035|NCT01128569|886424|P1|Treatment Period 2|Withdrawal by Subject|0
268036|NCT01128569|886419|P6|Washout Period 1|Adverse Event|0
268037|NCT01128569|886420|P5|Washout Period 1|Adverse Event|0
268038|NCT01128569|886421|P4|Washout Period 1|Adverse Event|0
268039|NCT01128569|886422|P3|Washout Period 1|Adverse Event|1
268040|NCT01128569|886423|P2|Washout Period 1|Adverse Event|0
268041|NCT01128569|886424|P1|Washout Period 1|Adverse Event|0
268042|NCT01128543|886441|P1|Overall Study|Protocol Violation|1
268043|NCT01128543|886441|P1|Overall Study|Withdrawal by Subject|3
268044|NCT01128413|886467|P2|Overall Study|Pt made DNR|0
268045|NCT01128413|886468|P1|Overall Study|Pt made DNR|1
268046|NCT01128413|886467|P2|Overall Study|NICOM Monitor Problems|1
268047|NCT01128413|886468|P1|Overall Study|NICOM Monitor Problems|2
268048|NCT01128413|886467|P2|Overall Study|Withdrawal by Subject|0
268049|NCT01128413|886468|P1|Overall Study|Withdrawal by Subject|1
268050|NCT01128400|886477|P3|Overall Study|were not invited to participate on taste|15
268051|NCT01128400|886478|P2|Overall Study|were not invited to participate on taste|0
268052|NCT01128400|886479|P1|Overall Study|were not invited to participate on taste|0
268053|NCT01128400|886477|P3|Overall Study|Screening failure|0
268054|NCT01128400|886478|P2|Overall Study|Screening failure|0
268055|NCT01128400|886479|P1|Overall Study|Screening failure|1
268056|NCT01128400|886477|P3|Overall Study|Lost to Follow-up|1
268057|NCT01128400|886478|P2|Overall Study|Lost to Follow-up|0
268058|NCT01128400|886479|P1|Overall Study|Lost to Follow-up|1
268059|NCT01128361|886492|P2|Overall Study|Withdrawal by Subject|2
268060|NCT01128361|886493|P1|Overall Study|Withdrawal by Subject|5
268061|NCT01128361|886492|P2|Overall Study|Lost to Follow-up|1
268062|NCT01128361|886493|P1|Overall Study|Lost to Follow-up|0
268063|NCT01128244|886518|P1|Overall Study|Scheduling conflict|2
268064|NCT01128244|886518|P1|Overall Study|Adverse Event|1
268065|NCT01128179|886559|P2|Overall Study|Protocol Violation|0
268066|NCT01128179|886560|P1|Overall Study|Protocol Violation|1
268067|NCT01128179|886559|P2|Overall Study|Death|0
268068|NCT01128179|886560|P1|Overall Study|Death|1
268069|NCT01128153|886580|P2|Overall Study|Developed discontinuation criteria|1
268070|NCT01128153|886581|P1|Overall Study|Developed discontinuation criteria|1
268071|NCT01128153|886580|P2|Overall Study|Protocol Violation|0
268072|NCT01128153|886581|P1|Overall Study|Protocol Violation|2
268073|NCT01128153|886580|P2|Overall Study|Incorrect enrolment to study|1
268074|NCT01128153|886581|P1|Overall Study|Incorrect enrolment to study|2
268075|NCT01128153|886580|P2|Overall Study|Withdrawal by Subject|3
268076|NCT01128153|886581|P1|Overall Study|Withdrawal by Subject|2
268077|NCT01128153|886580|P2|Overall Study|Condition under investigation worsened|7
268078|NCT01128153|886581|P1|Overall Study|Condition under investigation worsened|8
268079|NCT01128153|886580|P2|Overall Study|Adverse Event|3
268080|NCT01128153|886581|P1|Overall Study|Adverse Event|1
268081|NCT01128114|886597|P1|Overall Study|Screening Failed|2
268082|NCT01128114|886597|P1|Overall Study|Treatment Withdrawn|6
268083|NCT01127763|886614|P1|Overall Study|Physician Decision|2
268084|NCT01127763|886614|P1|Overall Study|Withdrawal by Subject|1
268085|NCT01127763|886614|P1|Overall Study|Adverse Event|2
268086|NCT01127646|886659|P2|Overall Study|Protocol Violation|1
268087|NCT01127646|886660|P1|Overall Study|Protocol Violation|0
268088|NCT01127646|886659|P2|Overall Study|Entry Criteria Not Met|0
268089|NCT01127646|886660|P1|Overall Study|Entry Criteria Not Met|1
268090|NCT01127607|886694|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
268091|NCT01127607|886695|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
268092|NCT01127607|886694|P2|Phase II (Between Subjects)|Lost to Follow-up|2
268093|NCT01127607|886695|P1|Phase II (Between Subjects)|Lost to Follow-up|0
268094|NCT01127256|886861|P2|Overall Study|Protocol Violation|0
268095|NCT01127256|886862|P1|Overall Study|Protocol Violation|1
268096|NCT01127256|886861|P2|Overall Study|Withdrawal by Subject|9
268097|NCT01127256|886862|P1|Overall Study|Withdrawal by Subject|5
268098|NCT01127256|886861|P2|Overall Study|Lost to Follow-up|17
268099|NCT01127256|886862|P1|Overall Study|Lost to Follow-up|16
268100|NCT01127256|886861|P2|Overall Study|Lack of Efficacy|0
268101|NCT01127256|886862|P1|Overall Study|Lack of Efficacy|4
268102|NCT01127256|886861|P2|Overall Study|Adverse Event|13
268103|NCT01127256|886862|P1|Overall Study|Adverse Event|13
268104|NCT01127165|886874|P2|Overall Study|Protocol Violation|1
268105|NCT01127165|886875|P1|Overall Study|Protocol Violation|0
268106|NCT01127165|886874|P2|Overall Study|Withdrawal by Subject|3
268107|NCT01127165|886875|P1|Overall Study|Withdrawal by Subject|1
268108|NCT01127165|886874|P2|Overall Study|Lost to Follow-up|5
268109|NCT01127165|886875|P1|Overall Study|Lost to Follow-up|3
268110|NCT01127165|886874|P2|Overall Study|Lack of Efficacy|8
268111|NCT01127165|886875|P1|Overall Study|Lack of Efficacy|10
268112|NCT01127165|886874|P2|Overall Study|Adverse Event|2
268113|NCT01127165|886875|P1|Overall Study|Adverse Event|2
268114|NCT01127139|886887|P1|Overall Study|Reason not specified|1
268115|NCT01127139|886887|P1|Overall Study|Lack of Efficacy|4
268116|NCT01127139|886887|P1|Overall Study|Incompliance|12
268117|NCT01127139|886887|P1|Overall Study|Adverse Event|40
268118|NCT01126619|886947|P1|Overall Study|Non-compliance|1
268119|NCT01126619|886947|P1|Overall Study|Withdrawal by Subject|9
268120|NCT01126619|886947|P1|Overall Study|Serious adverse event|1
268121|NCT01126619|886947|P1|Overall Study|Investigator decision|4
268122|NCT01126619|886947|P1|Overall Study|Not eligible for the study|2
268123|NCT01126580|886975|P3|Overall Study|Treatment Non-compliance|3
268124|NCT01126580|886976|P2|Overall Study|Treatment Non-compliance|2
268125|NCT01126580|886977|P1|Overall Study|Treatment Non-compliance|0
268126|NCT01126580|886975|P3|Overall Study|Lost to Follow-up|9
268127|NCT01126580|886976|P2|Overall Study|Lost to Follow-up|13
268128|NCT01126580|886977|P1|Overall Study|Lost to Follow-up|15
268129|NCT01126580|886975|P3|Overall Study|Protocol Violation|2
268130|NCT01126580|886976|P2|Overall Study|Protocol Violation|1
268131|NCT01126580|886977|P1|Overall Study|Protocol Violation|0
268132|NCT01126580|886975|P3|Overall Study|Lack of Efficacy|4
268133|NCT01126580|886976|P2|Overall Study|Lack of Efficacy|3
268134|NCT01126580|886977|P1|Overall Study|Lack of Efficacy|2
268135|NCT01126580|886975|P3|Overall Study|Entry Criteria Not Met|2
268136|NCT01126580|886976|P2|Overall Study|Entry Criteria Not Met|1
268137|NCT01126580|886977|P1|Overall Study|Entry Criteria Not Met|1
268138|NCT01126580|886975|P3|Overall Study|Physician Decision|2
268139|NCT01126580|886976|P2|Overall Study|Physician Decision|1
268140|NCT01126580|886977|P1|Overall Study|Physician Decision|1
268141|NCT01126580|886975|P3|Overall Study|Sponsor Decision|7
268142|NCT01126580|886976|P2|Overall Study|Sponsor Decision|4
268143|NCT01126580|886977|P1|Overall Study|Sponsor Decision|5
268144|NCT01126580|886975|P3|Overall Study|Withdrawal by Subject|14
268145|NCT01126580|886976|P2|Overall Study|Withdrawal by Subject|19
268146|NCT01126580|886977|P1|Overall Study|Withdrawal by Subject|11
268147|NCT01126580|886975|P3|Overall Study|Adverse Event|12
268148|NCT01126580|886976|P2|Overall Study|Adverse Event|8
268149|NCT01126580|886977|P1|Overall Study|Adverse Event|14
268150|NCT01126541|887072|P3|Overall Study|Administrative reason or other|2
268151|NCT01126541|887073|P2|Overall Study|Administrative reason or other|1
268152|NCT01126541|887074|P1|Overall Study|Administrative reason or other|1
268153|NCT01126541|887072|P3|Overall Study|Protocol Violation|1
268154|NCT01126541|887073|P2|Overall Study|Protocol Violation|0
268155|NCT01126541|887074|P1|Overall Study|Protocol Violation|0
268156|NCT01126541|887072|P3|Overall Study|Withdrawal by Subject|6
268157|NCT01126541|887073|P2|Overall Study|Withdrawal by Subject|5
268158|NCT01126541|887074|P1|Overall Study|Withdrawal by Subject|2
268159|NCT01126541|887072|P3|Overall Study|Lost to Follow-up|2
268160|NCT01126541|887073|P2|Overall Study|Lost to Follow-up|2
268161|NCT01126541|887074|P1|Overall Study|Lost to Follow-up|1
268162|NCT01126541|887072|P3|Overall Study|Lack of Efficacy|11
268163|NCT01126541|887073|P2|Overall Study|Lack of Efficacy|1
268164|NCT01126541|887074|P1|Overall Study|Lack of Efficacy|6
268165|NCT01126541|887072|P3|Overall Study|Death|0
268166|NCT01126541|887073|P2|Overall Study|Death|1
268167|NCT01126541|887074|P1|Overall Study|Death|0
268168|NCT01126541|887072|P3|Overall Study|Adverse Event|4
268169|NCT01126541|887073|P2|Overall Study|Adverse Event|2
268170|NCT01126541|887074|P1|Overall Study|Adverse Event|0
268171|NCT01126437|887158|P3|Overall Study|Other reason not specified|178
268172|NCT01126437|887159|P2|Overall Study|Other reason not specified|176
268173|NCT01126437|887160|P1|Overall Study|Other reason not specified|210
268174|NCT01126437|887158|P3|Overall Study|Withdrawal by Subject|319
268175|NCT01126437|887159|P2|Overall Study|Withdrawal by Subject|335
268176|NCT01126437|887160|P1|Overall Study|Withdrawal by Subject|331
268177|NCT01126437|887158|P3|Overall Study|Lost to Follow-up|55
268178|NCT01126437|887159|P2|Overall Study|Lost to Follow-up|63
268179|NCT01126437|887160|P1|Overall Study|Lost to Follow-up|52
268180|NCT01126437|887158|P3|Overall Study|Protocol Violation|41
268181|NCT01126437|887159|P2|Overall Study|Protocol Violation|66
268182|NCT01126437|887160|P1|Overall Study|Protocol Violation|64
268183|NCT01126437|887158|P3|Overall Study|Lack of Efficacy|59
268184|NCT01126437|887159|P2|Overall Study|Lack of Efficacy|60
268185|NCT01126437|887160|P1|Overall Study|Lack of Efficacy|65
268186|NCT01126437|887158|P3|Overall Study|Adverse Event|635
268187|NCT01126437|887159|P2|Overall Study|Adverse Event|606
268188|NCT01126437|887160|P1|Overall Study|Adverse Event|602
268189|NCT01126437|887158|P3|Overall Study|Sites with data irregularities/fraud|7
268190|NCT01126437|887159|P2|Overall Study|Sites with data irregularities/fraud|6
268191|NCT01126437|887160|P1|Overall Study|Sites with data irregularities/fraud|6
268192|NCT01126437|887158|P3|Overall Study|Not treated|19
268193|NCT01126437|887159|P2|Overall Study|Not treated|18
268194|NCT01126437|887160|P1|Overall Study|Not treated|11
268195|NCT01126424|887198|P6|Overall Study|Withdrawal by Subject|0
268196|NCT01126424|887199|P5|Overall Study|Withdrawal by Subject|1
268197|NCT01126424|887200|P4|Overall Study|Withdrawal by Subject|3
268198|NCT01126424|887201|P3|Overall Study|Withdrawal by Subject|1
268199|NCT01126424|887202|P2|Overall Study|Withdrawal by Subject|0
268200|NCT01126424|887203|P1|Overall Study|Withdrawal by Subject|0
268201|NCT01126424|887198|P6|Overall Study|Adverse Event|0
268202|NCT01126424|887199|P5|Overall Study|Adverse Event|1
268203|NCT01126424|887200|P4|Overall Study|Adverse Event|0
268204|NCT01126424|887201|P3|Overall Study|Adverse Event|0
268205|NCT01126424|887202|P2|Overall Study|Adverse Event|0
268206|NCT01126424|887203|P1|Overall Study|Adverse Event|0
268207|NCT01126359|887226|P2|First Intervention (20-minutes)|Physician Decision|1
268208|NCT01126359|887227|P1|First Intervention (20-minutes)|Physician Decision|0
268209|NCT01126268|887239|P1|Overall Study|Adverse Event|1
268210|NCT01126060|887278|P2|Overall Study|Protocol Violation|2
268211|NCT01126060|887279|P1|Overall Study|Protocol Violation|0
268212|NCT01125930|887287|P2|Overall Study|Lost to Follow-up|2
268213|NCT01125930|887288|P1|Overall Study|Lost to Follow-up|0
268214|NCT01125930|887287|P2|Overall Study|Protocol Violation|1
268215|NCT01125930|887288|P1|Overall Study|Protocol Violation|0
268216|NCT01125930|887287|P2|Overall Study|Withdrawal by Subject|6
268217|NCT01125930|887288|P1|Overall Study|Withdrawal by Subject|1
268218|NCT01125930|887287|P2|Overall Study|Adverse Event|1
268219|NCT01125930|887288|P1|Overall Study|Adverse Event|0
268220|NCT01125917|887442|P1|Overall Study|Lack of Efficacy|19
268221|NCT01125917|887442|P1|Overall Study|Administrative|223
268222|NCT01125917|887442|P1|Overall Study|Withdrawal by Subject|31
268223|NCT01125917|887442|P1|Overall Study|Lost to Follow-up|23
268224|NCT01125917|887442|P1|Overall Study|Adverse Event|43
268225|NCT01125813|887446|P1|Overall Study|Screen Failures|4
268226|NCT01125813|887446|P1|Overall Study|Withdrawal by Subject|1
268227|NCT01125813|887446|P1|Overall Study|Death|1
268228|NCT01125800|887456|P5|Phase II|Disease progression|8
268229|NCT01125800|887457|P4|Phase II|Disease progression|1
268230|NCT01125800|887458|P3|Phase II|Disease progression|0
268231|NCT01125800|887459|P2|Phase II|Disease progression|0
268232|NCT01125800|887460|P1|Phase II|Disease progression|0
268233|NCT01125800|887456|P5|Phase II|Adverse Event|2
268234|NCT01125800|887457|P4|Phase II|Adverse Event|0
268235|NCT01125800|887458|P3|Phase II|Adverse Event|0
268236|NCT01125800|887459|P2|Phase II|Adverse Event|0
268237|NCT01125800|887460|P1|Phase II|Adverse Event|0
268238|NCT01125800|887456|P5|Phase II|Protocol Violation|1
268239|NCT01125800|887457|P4|Phase II|Protocol Violation|0
268240|NCT01125800|887458|P3|Phase II|Protocol Violation|0
268241|NCT01125800|887459|P2|Phase II|Protocol Violation|0
268242|NCT01125800|887460|P1|Phase II|Protocol Violation|0
268243|NCT01125800|887456|P5|Phase I|Disease progression|0
268244|NCT01125800|887457|P4|Phase I|Disease progression|3
268245|NCT01125800|887458|P3|Phase I|Disease progression|1
268246|NCT01125800|887459|P2|Phase I|Disease progression|4
268247|NCT01125800|887460|P1|Phase I|Disease progression|5
268248|NCT01125800|887456|P5|Phase I|Withdrawal by Subject|0
268249|NCT01125800|887457|P4|Phase I|Withdrawal by Subject|0
268250|NCT01125800|887458|P3|Phase I|Withdrawal by Subject|1
268251|NCT01125800|887459|P2|Phase I|Withdrawal by Subject|0
268252|NCT01125800|887460|P1|Phase I|Withdrawal by Subject|0
268253|NCT01125800|887456|P5|Phase I|Administrative problems|0
268254|NCT01125800|887457|P4|Phase I|Administrative problems|0
268255|NCT01125800|887458|P3|Phase I|Administrative problems|0
268256|NCT01125800|887459|P2|Phase I|Administrative problems|0
268257|NCT01125800|887460|P1|Phase I|Administrative problems|1
268258|NCT01125800|887456|P5|Phase I|Adverse Event|0
268259|NCT01125800|887457|P4|Phase I|Adverse Event|7
268260|NCT01125800|887458|P3|Phase I|Adverse Event|1
268261|NCT01125800|887459|P2|Phase I|Adverse Event|2
268262|NCT01125800|887460|P1|Phase I|Adverse Event|2
268263|NCT01125800|887456|P5|Phase I|Protocol Violation|0
268264|NCT01125800|887457|P4|Phase I|Protocol Violation|1
268265|NCT01125800|887458|P3|Phase I|Protocol Violation|1
268266|NCT01125800|887459|P2|Phase I|Protocol Violation|3
268267|NCT01125800|887460|P1|Phase I|Protocol Violation|0
268268|NCT01125748|887526|P2|Overall Study|Patient Decision to Withdraw|4
268269|NCT01125748|887527|P1|Overall Study|Patient Decision to Withdraw|2
268270|NCT01125748|887526|P2|Overall Study|Physician Decision|7
268271|NCT01125748|887527|P1|Overall Study|Physician Decision|8
268272|NCT01125748|887526|P2|Overall Study|Lost to Follow-up|1
268273|NCT01125748|887527|P1|Overall Study|Lost to Follow-up|0
268274|NCT01125748|887526|P2|Overall Study|Adverse Event|2
268275|NCT01125748|887527|P1|Overall Study|Adverse Event|0
268276|NCT01125722|887537|P2|Overall Study|Lost to Follow-up|0
268277|NCT01125722|887538|P1|Overall Study|Lost to Follow-up|1
268278|NCT01125722|887537|P2|Overall Study|Withdrawal by Subject|1
268279|NCT01125722|887538|P1|Overall Study|Withdrawal by Subject|2
268280|NCT01125566|887585|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|4
268281|NCT01125566|887586|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
268282|NCT01125566|887587|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
268283|NCT01125566|887585|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|20
268284|NCT01125566|887586|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
268285|NCT01125566|887587|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
268286|NCT01125566|887585|P3|Patients Before the Switch (26Apr2013)|Other than those stated above|0
268287|NCT01125566|887586|P2|Patients Before the Switch (26Apr2013)|Other than those stated above|5
268288|NCT01125566|887587|P1|Patients Before the Switch (26Apr2013)|Other than those stated above|23
268289|NCT01125566|887585|P3|Patients Before the Switch (26Apr2013)|Not treated|0
268290|NCT01125566|887586|P2|Patients Before the Switch (26Apr2013)|Not treated|0
268291|NCT01125566|887587|P1|Patients Before the Switch (26Apr2013)|Not treated|2
268292|NCT01125566|887585|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
268293|NCT01125566|887586|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|21
268294|NCT01125566|887587|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|25
268295|NCT01125566|887585|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
268296|NCT01125566|887586|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|1
268297|NCT01125566|887587|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
268298|NCT01125566|887585|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
268299|NCT01125566|887586|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
268300|NCT01125566|887587|P1|Patients Before the Switch (26Apr2013)|Adverse Event|24
268301|NCT01125566|887585|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
268302|NCT01125566|887586|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|4
268303|NCT01125566|887587|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|5
268304|NCT01125566|887585|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
268305|NCT01125566|887586|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|100
268306|NCT01125566|887587|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|181
268307|NCT01125514|887600|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
268308|NCT01125514|887600|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
268309|NCT01125514|887600|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
268310|NCT01125514|887600|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
268311|NCT01125514|887600|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
268312|NCT01125514|887600|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
268313|NCT01125189|887675|P3|Follow up Period|Other reasons|5
268314|NCT01125189|887676|P2|Follow up Period|Other reasons|4
268315|NCT01125189|887677|P1|Follow up Period|Other reasons|4
268316|NCT01125189|887675|P3|Follow up Period|Lost to Follow-up|6
268317|NCT01125189|887676|P2|Follow up Period|Lost to Follow-up|9
268318|NCT01125189|887677|P1|Follow up Period|Lost to Follow-up|12
268319|NCT01125189|887675|P3|Follow up Period|Death|0
268320|NCT01125189|887676|P2|Follow up Period|Death|0
268321|NCT01125189|887677|P1|Follow up Period|Death|1
268322|NCT01125189|887675|P3|Follow up Period|Withdrawal by Subject|5
268323|NCT01125189|887676|P2|Follow up Period|Withdrawal by Subject|2
268324|NCT01125189|887677|P1|Follow up Period|Withdrawal by Subject|3
268325|NCT01125189|887675|P3|Treatment Period|Completed 24 week treatment period only|2
268326|NCT01125189|887676|P2|Treatment Period|Completed 24 week treatment period only|1
268327|NCT01125189|887677|P1|Treatment Period|Completed 24 week treatment period only|2
268328|NCT01125189|887675|P3|Treatment Period|Other reasons|0
268329|NCT01125189|887676|P2|Treatment Period|Other reasons|1
268330|NCT01125189|887677|P1|Treatment Period|Other reasons|1
268331|NCT01125189|887675|P3|Treatment Period|Participants requested to discontinue|4
268332|NCT01125189|887676|P2|Treatment Period|Participants requested to discontinue|3
268333|NCT01125189|887677|P1|Treatment Period|Participants requested to discontinue|1
268334|NCT01125189|887675|P3|Treatment Period|Poor compliance/noncompliance|0
268335|NCT01125189|887676|P2|Treatment Period|Poor compliance/noncompliance|1
268336|NCT01125189|887677|P1|Treatment Period|Poor compliance/noncompliance|0
268337|NCT01125189|887675|P3|Treatment Period|Lost to Follow-up|1
268338|NCT01125189|887676|P2|Treatment Period|Lost to Follow-up|2
268339|NCT01125189|887677|P1|Treatment Period|Lost to Follow-up|1
268340|NCT01125189|887675|P3|Treatment Period|Death|0
268341|NCT01125189|887676|P2|Treatment Period|Death|0
268342|NCT01125189|887677|P1|Treatment Period|Death|1
268343|NCT01125189|887675|P3|Treatment Period|Withdrawal by Subject|1
268344|NCT01125189|887676|P2|Treatment Period|Withdrawal by Subject|1
268345|NCT01125189|887677|P1|Treatment Period|Withdrawal by Subject|3
268346|NCT01125189|887675|P3|Treatment Period|Adverse Event|8
268347|NCT01125189|887676|P2|Treatment Period|Adverse Event|8
268348|NCT01125189|887677|P1|Treatment Period|Adverse Event|7
268349|NCT01125189|887675|P3|Treatment Period|Lack of Efficacy|25
268350|NCT01125189|887676|P2|Treatment Period|Lack of Efficacy|18
268351|NCT01125189|887677|P1|Treatment Period|Lack of Efficacy|15
268352|NCT01124916|887731|P2|Overall Study|Lost to Follow-up|2
268353|NCT01124916|887732|P1|Overall Study|Lost to Follow-up|3
268354|NCT01124864|887746|P6|Overall Study|Protocol Violation|0
268355|NCT01124864|887747|P5|Overall Study|Protocol Violation|1
268356|NCT01124864|887748|P4|Overall Study|Protocol Violation|0
268357|NCT01124864|887749|P3|Overall Study|Protocol Violation|0
268358|NCT01124864|887750|P2|Overall Study|Protocol Violation|0
268359|NCT01124864|887751|P1|Overall Study|Protocol Violation|1
268360|NCT01124864|887746|P6|Overall Study|Lost to Follow-up|0
268361|NCT01124864|887747|P5|Overall Study|Lost to Follow-up|0
268362|NCT01124864|887748|P4|Overall Study|Lost to Follow-up|1
268363|NCT01124864|887749|P3|Overall Study|Lost to Follow-up|0
268364|NCT01124864|887750|P2|Overall Study|Lost to Follow-up|1
268365|NCT01124864|887751|P1|Overall Study|Lost to Follow-up|1
268366|NCT01124864|887746|P6|Overall Study|Withdrawal by Subject|1
268367|NCT01124864|887747|P5|Overall Study|Withdrawal by Subject|2
268368|NCT01124864|887748|P4|Overall Study|Withdrawal by Subject|0
268369|NCT01124864|887749|P3|Overall Study|Withdrawal by Subject|4
268370|NCT01124864|887750|P2|Overall Study|Withdrawal by Subject|3
268371|NCT01124864|887751|P1|Overall Study|Withdrawal by Subject|2
268372|NCT01124864|887746|P6|Overall Study|Death|0
268373|NCT01124864|887747|P5|Overall Study|Death|1
268374|NCT01124864|887748|P4|Overall Study|Death|2
268375|NCT01124864|887749|P3|Overall Study|Death|6
268376|NCT01124864|887750|P2|Overall Study|Death|9
268377|NCT01124864|887751|P1|Overall Study|Death|6
268378|NCT01124864|887746|P6|Overall Study|Follow up phase competed as per protocol|2
268379|NCT01124864|887747|P5|Overall Study|Follow up phase competed as per protocol|26
268380|NCT01124864|887748|P4|Overall Study|Follow up phase competed as per protocol|18
268381|NCT01124864|887749|P3|Overall Study|Follow up phase competed as per protocol|24
268382|NCT01124864|887750|P2|Overall Study|Follow up phase competed as per protocol|22
268383|NCT01124864|887751|P1|Overall Study|Follow up phase competed as per protocol|18
268384|NCT01124838|887785|P2|Overall Study|Lost to Follow-up|0
268385|NCT01124838|887786|P1|Overall Study|Lost to Follow-up|2
268386|NCT01124838|887785|P2|Overall Study|Withdrawal by Subject|2
268387|NCT01124838|887786|P1|Overall Study|Withdrawal by Subject|3
268388|NCT01124838|887785|P2|Overall Study|Lack of Efficacy|0
268389|NCT01124838|887786|P1|Overall Study|Lack of Efficacy|2
268390|NCT01124838|887785|P2|Overall Study|Adverse Event|11
268391|NCT01124838|887786|P1|Overall Study|Adverse Event|7
268392|NCT01124838|887785|P2|Overall Study|Miscellaneous|2
268393|NCT01124838|887786|P1|Overall Study|Miscellaneous|4
268394|NCT01124643|887853|P1|Overall Study|Death|1
268395|NCT01124617|887867|P2|Overall Study|Unspecified|1
268396|NCT01124617|887868|P1|Overall Study|Unspecified|2
268397|NCT01124617|887867|P2|Overall Study|Withdrawal by Subject|1
268398|NCT01124617|887868|P1|Overall Study|Withdrawal by Subject|9
268399|NCT01124617|887867|P2|Overall Study|Protocol Violation|1
268400|NCT01124617|887868|P1|Overall Study|Protocol Violation|1
268401|NCT01124617|887867|P2|Overall Study|Lack of Efficacy|1
268402|NCT01124617|887868|P1|Overall Study|Lack of Efficacy|2
268403|NCT01124617|887867|P2|Overall Study|Adverse Event|2
268404|NCT01124617|887868|P1|Overall Study|Adverse Event|5
268405|NCT01124604|887900|P2|Overall Study|Disease Progression|1
268406|NCT01124604|887901|P1|Overall Study|Disease Progression|0
268407|NCT01124604|887900|P2|Overall Study|Withdrawal by Subject|0
268408|NCT01124604|887901|P1|Overall Study|Withdrawal by Subject|4
268409|NCT01124604|887900|P2|Overall Study|Lack of Efficacy|0
268410|NCT01124604|887901|P1|Overall Study|Lack of Efficacy|1
268411|NCT01124604|887900|P2|Overall Study|Adverse Event|1
268412|NCT01124604|887901|P1|Overall Study|Adverse Event|10
268413|NCT01124448|887940|P2|Overall Study|Protocol Violation|0
268414|NCT01124448|887941|P1|Overall Study|Protocol Violation|2
268415|NCT01124448|887940|P2|Overall Study|Lost to Follow-up|3
268416|NCT01124448|887941|P1|Overall Study|Lost to Follow-up|0
268417|NCT01124422|887949|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
268418|NCT01124422|887950|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
268419|NCT01124422|887951|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
268420|NCT01124422|887949|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
268421|NCT01124422|887950|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
268422|NCT01124422|887951|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
268423|NCT01124422|887949|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
268424|NCT01124422|887950|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
268425|NCT01124422|887951|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
268426|NCT01124422|887949|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
268427|NCT01124422|887950|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
268428|NCT01124422|887951|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
268429|NCT01124422|887949|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
268430|NCT01124422|887950|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
268431|NCT01124422|887951|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
268432|NCT01124422|887949|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
268433|NCT01124422|887950|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
268434|NCT01124422|887951|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
268435|NCT01124422|887949|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
268436|NCT01124422|887950|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
268437|NCT01124422|887951|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
268438|NCT01124422|887949|P3|4-Week Open-label Run-in Phase|Physician Decision|0
268439|NCT01124422|887950|P2|4-Week Open-label Run-in Phase|Physician Decision|0
268440|NCT01124422|887951|P1|4-Week Open-label Run-in Phase|Physician Decision|4
268441|NCT01124422|887949|P3|4-Week Open-label Run-in Phase|Adverse Event|0
268442|NCT01124422|887950|P2|4-Week Open-label Run-in Phase|Adverse Event|0
268443|NCT01124422|887951|P1|4-Week Open-label Run-in Phase|Adverse Event|7
268444|NCT01124422|887949|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
268445|NCT01124422|887950|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
268446|NCT01124422|887951|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
268447|NCT01124292|888021|P3|Overall Study|piercing track closed|1
268448|NCT01124292|888022|P2|Overall Study|piercing track closed|2
268449|NCT01124292|888023|P1|Overall Study|piercing track closed|0
268450|NCT01124292|888021|P3|Overall Study|medical issue unrelated to the study|2
268451|NCT01124292|888022|P2|Overall Study|medical issue unrelated to the study|0
268452|NCT01124292|888023|P1|Overall Study|medical issue unrelated to the study|0
268453|NCT01124292|888021|P3|Overall Study|Withdrawal by Subject|2
268454|NCT01124292|888022|P2|Overall Study|Withdrawal by Subject|6
268455|NCT01124292|888023|P1|Overall Study|Withdrawal by Subject|0
268456|NCT01124292|888021|P3|Overall Study|Physician Decision|2
268457|NCT01124292|888022|P2|Overall Study|Physician Decision|3
268458|NCT01124292|888023|P1|Overall Study|Physician Decision|0
268459|NCT01124292|888021|P3|Overall Study|Lost to Follow-up|3
268460|NCT01124292|888022|P2|Overall Study|Lost to Follow-up|4
268461|NCT01124292|888023|P1|Overall Study|Lost to Follow-up|2
268462|NCT01124175|888094|P2|Washout of 7 Days|Withdrawal by Subject|2
268463|NCT01124175|888095|P1|Washout of 7 Days|Withdrawal by Subject|0
268464|NCT01124162|888113|P2|Washout of 7 Days|Withdrawal by Subject|0
268465|NCT01124162|888114|P1|Washout of 7 Days|Withdrawal by Subject|1
268466|NCT01124162|888113|P2|First Intervention|Adverse Event|0
268467|NCT01124162|888114|P1|First Intervention|Adverse Event|2
268468|NCT01124149|888130|P1|Maintenance Phase|Non-compliance|1
268469|NCT01124149|888130|P1|Maintenance Phase|Coordinator error|1
268470|NCT01124149|888130|P1|Maintenance Phase|Protocol Violation|5
268471|NCT01124149|888130|P1|Maintenance Phase|Withdrawal by Subject|10
268472|NCT01124149|888130|P1|Maintenance Phase|Lost to Follow-up|15
268473|NCT01124149|888130|P1|Maintenance Phase|Adverse Event|24
268474|NCT01124149|888130|P1|Maintenance Phase|Lack of Efficacy|40
268475|NCT01124149|888130|P1|Acute Phase|Sponsor decision|1
268476|NCT01124149|888130|P1|Acute Phase|Travelling to another country|1
268477|NCT01124149|888130|P1|Acute Phase|Low hemoglobin|1
268478|NCT01124149|888130|P1|Acute Phase|Non-compliance|1
268479|NCT01124149|888130|P1|Acute Phase|UC symptoms not ameliorated|1
268480|NCT01124149|888130|P1|Acute Phase|Sponsor request|1
268481|NCT01124149|888130|P1|Acute Phase|Prolonged antibiotic therapy|1
268482|NCT01124149|888130|P1|Acute Phase|Lost to Follow-up|2
268483|NCT01124149|888130|P1|Acute Phase|Protocol Violation|14
268484|NCT01124149|888130|P1|Acute Phase|Lack of Efficacy|17
268485|NCT01124149|888130|P1|Acute Phase|Adverse Event|21
268486|NCT01124149|888130|P1|Acute Phase|Withdrawal by Subject|22
268487|NCT01124097|888150|P4|Overall Study|Physician Decision|0
268488|NCT01124097|888151|P3|Overall Study|Physician Decision|0
268489|NCT01124097|888152|P2|Overall Study|Physician Decision|1
268490|NCT01124097|888153|P1|Overall Study|Physician Decision|2
268491|NCT01124097|888150|P4|Overall Study|Protocol Violation|1
268492|NCT01124097|888151|P3|Overall Study|Protocol Violation|2
268493|NCT01124097|888152|P2|Overall Study|Protocol Violation|0
268494|NCT01124097|888153|P1|Overall Study|Protocol Violation|2
268495|NCT01124097|888150|P4|Overall Study|Adverse Event|7
268496|NCT01124097|888151|P3|Overall Study|Adverse Event|15
268497|NCT01124097|888152|P2|Overall Study|Adverse Event|15
268498|NCT01124097|888153|P1|Overall Study|Adverse Event|24
268499|NCT01124097|888150|P4|Overall Study|Lack of Efficacy|3
268500|NCT01124097|888151|P3|Overall Study|Lack of Efficacy|1
268501|NCT01124097|888152|P2|Overall Study|Lack of Efficacy|3
268502|NCT01124097|888153|P1|Overall Study|Lack of Efficacy|2
268503|NCT01124097|888150|P4|Overall Study|Withdrawal by Subject|3
268504|NCT01124097|888151|P3|Overall Study|Withdrawal by Subject|2
268505|NCT01124097|888152|P2|Overall Study|Withdrawal by Subject|3
268506|NCT01124097|888153|P1|Overall Study|Withdrawal by Subject|4
268507|NCT01124045|888165|P2|Overall Study|Physician Decision|2
268508|NCT01124045|888166|P1|Overall Study|Physician Decision|0
268509|NCT01124045|888165|P2|Overall Study|Lost to Follow-up|1
268510|NCT01124045|888166|P1|Overall Study|Lost to Follow-up|0
268511|NCT01124006|888199|P3|Overall Study|Other|1
268512|NCT01124006|888200|P2|Overall Study|Other|0
268513|NCT01124006|888201|P1|Overall Study|Other|0
268514|NCT01124006|888199|P3|Overall Study|Lost to Follow-up|1
268515|NCT01124006|888200|P2|Overall Study|Lost to Follow-up|0
268516|NCT01124006|888201|P1|Overall Study|Lost to Follow-up|1
268517|NCT01124006|888199|P3|Overall Study|Withdrawal by Subject|0
268518|NCT01124006|888200|P2|Overall Study|Withdrawal by Subject|2
268519|NCT01124006|888201|P1|Overall Study|Withdrawal by Subject|2
268520|NCT01123980|888229|P2|Overall Study|Unclassified|7
268521|NCT01123980|888230|P1|Overall Study|Unclassified|6
268522|NCT01123980|888229|P2|Overall Study|Withdrawal by Subject|3
268523|NCT01123980|888230|P1|Overall Study|Withdrawal by Subject|5
268524|NCT01123980|888229|P2|Overall Study|Protocol Violation|6
268525|NCT01123980|888230|P1|Overall Study|Protocol Violation|6
268526|NCT01123980|888229|P2|Overall Study|Lost to Follow-up|6
268527|NCT01123980|888230|P1|Overall Study|Lost to Follow-up|0
268528|NCT01123980|888229|P2|Overall Study|Physician Decision|1
268529|NCT01123980|888230|P1|Overall Study|Physician Decision|0
268530|NCT01123980|888229|P2|Overall Study|Lack of Efficacy|0
268531|NCT01123980|888230|P1|Overall Study|Lack of Efficacy|1
268532|NCT01123980|888229|P2|Overall Study|Adverse Event|1
268533|NCT01123980|888230|P1|Overall Study|Adverse Event|1
268534|NCT01123941|888250|P2|Overall Study|Lost to Follow-up|1
268535|NCT01123941|888251|P1|Overall Study|Lost to Follow-up|2
268536|NCT01123889|888286|P2|Overall Study|Lost to Follow-up|1
268537|NCT01123889|888287|P1|Overall Study|Lost to Follow-up|3
268538|NCT01123850|888297|P1|Overall Study|Slow enrollment|45
268539|NCT01123642|888302|P1|Overall Study|ineligible at baseline assessment|36
268540|NCT01123642|888302|P1|Overall Study|Withdrawal by Subject|9
268541|NCT01123642|888302|P1|Overall Study|Lost to Follow-up|23
268542|NCT01123395|888315|P2|Washout Period of 14 Days|Withdrawal by Subject|1
268543|NCT01123395|888316|P1|Washout Period of 14 Days|Withdrawal by Subject|0
268544|NCT01123356|888326|P1|Overall Study|Withdrawal by Subject|1
268545|NCT01123356|888326|P1|Overall Study|Lack of Efficacy|4
268546|NCT01123356|888326|P1|Overall Study|Adverse Event|2
268547|NCT01123200|888334|P1|Overall Study|Withdrawal by Subject|1
268548|NCT01123161|888341|P2|Overall Study|Withdrawal by Subject|0
268549|NCT01123161|888342|P1|Overall Study|Withdrawal by Subject|1
268550|NCT01123161|888341|P2|Overall Study|Lost to Follow-up|0
268551|NCT01123161|888342|P1|Overall Study|Lost to Follow-up|1
268552|NCT01123148|888360|P1|Overall Study|Didn't meet milestone criteria|1
268553|NCT01123148|888360|P1|Overall Study|Coughing caused unacceptable EEG quality|1
268554|NCT01122927|888364|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
268555|NCT01122927|888365|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
268556|NCT01122927|888364|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
268557|NCT01122927|888365|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
268558|NCT01122927|888364|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
268559|NCT01122927|888365|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
268560|NCT01122927|888364|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
268561|NCT01122927|888365|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
268562|NCT01122927|888364|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
268563|NCT01122927|888365|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
268564|NCT01122927|888364|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
268565|NCT01122927|888365|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
268566|NCT01122927|888364|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
268567|NCT01122927|888365|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
268568|NCT01122927|888364|P2|Period 1 - Conversion Phase|Protocol Deviation|0
268569|NCT01122927|888365|P1|Period 1 - Conversion Phase|Protocol Deviation|1
268570|NCT01122927|888364|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
268571|NCT01122927|888365|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
268572|NCT01122927|888364|P2|Period 1 - Conversion Phase|Physician Decision|0
268573|NCT01122927|888365|P1|Period 1 - Conversion Phase|Physician Decision|2
268574|NCT01122927|888364|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
268575|NCT01122927|888365|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
268576|NCT01122927|888364|P2|Period 1 - Conversion Phase|Adverse Event|0
268577|NCT01122927|888365|P1|Period 1 - Conversion Phase|Adverse Event|3
268578|NCT01122862|888417|P3|Period 2|Adverse Event|1
268579|NCT01122862|888418|P2|Period 2|Adverse Event|0
268580|NCT01122862|888419|P1|Period 2|Adverse Event|0
268581|NCT01122862|888417|P3|Period 1|Protocol Violation|0
268582|NCT01122862|888418|P2|Period 1|Protocol Violation|1
268583|NCT01122862|888419|P1|Period 1|Protocol Violation|0
268584|NCT01122680|888437|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
268585|NCT01122680|888438|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
268586|NCT01122680|888439|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
268587|NCT01122680|888440|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
268588|NCT01122680|888437|P4|Period 3 (4 Weeks)|Adverse Event|0
268589|NCT01122680|888438|P3|Period 3 (4 Weeks)|Adverse Event|0
268590|NCT01122680|888439|P2|Period 3 (4 Weeks)|Adverse Event|0
268591|NCT01122680|888440|P1|Period 3 (4 Weeks)|Adverse Event|1
268592|NCT01122680|888437|P4|Period 2 (4 Weeks)|Other|0
268593|NCT01122680|888438|P3|Period 2 (4 Weeks)|Other|0
268594|NCT01122680|888439|P2|Period 2 (4 Weeks)|Other|0
268595|NCT01122680|888440|P1|Period 2 (4 Weeks)|Other|1
268596|NCT01122680|888437|P4|Period 2 (4 Weeks)|Protocol Violation|1
268597|NCT01122680|888438|P3|Period 2 (4 Weeks)|Protocol Violation|0
268598|NCT01122680|888439|P2|Period 2 (4 Weeks)|Protocol Violation|0
268599|NCT01122680|888440|P1|Period 2 (4 Weeks)|Protocol Violation|0
268600|NCT01122680|888437|P4|Period 1 (4 Weeks)|Other|0
268601|NCT01122680|888438|P3|Period 1 (4 Weeks)|Other|0
268602|NCT01122680|888439|P2|Period 1 (4 Weeks)|Other|1
268603|NCT01122680|888440|P1|Period 1 (4 Weeks)|Other|1
268604|NCT01122680|888437|P4|Period 1 (4 Weeks)|Protocol Violation|0
268605|NCT01122680|888438|P3|Period 1 (4 Weeks)|Protocol Violation|0
268606|NCT01122680|888439|P2|Period 1 (4 Weeks)|Protocol Violation|0
268607|NCT01122680|888440|P1|Period 1 (4 Weeks)|Protocol Violation|1
268608|NCT01122680|888437|P4|Period 1 (4 Weeks)|Adverse Event|0
268609|NCT01122680|888438|P3|Period 1 (4 Weeks)|Adverse Event|0
268610|NCT01122680|888439|P2|Period 1 (4 Weeks)|Adverse Event|0
268611|NCT01122680|888440|P1|Period 1 (4 Weeks)|Adverse Event|1
268612|NCT01122576|888505|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
268613|NCT01122576|888506|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
268614|NCT01122576|888507|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
268615|NCT01122576|888505|P3|Post-Cataract Surgery|Central Macular Edema|1
268616|NCT01122576|888506|P2|Post-Cataract Surgery|Central Macular Edema|0
268617|NCT01122576|888507|P1|Post-Cataract Surgery|Central Macular Edema|0
268618|NCT01122576|888505|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
268619|NCT01122576|888506|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
268620|NCT01122576|888507|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
268621|NCT01122394|888661|P2|Overall Study|Adverse Event|1
268622|NCT01122394|888662|P1|Overall Study|Adverse Event|0
268623|NCT01122394|888661|P2|Overall Study|Lost to Follow-up|2
268624|NCT01122394|888662|P1|Overall Study|Lost to Follow-up|2
268625|NCT01122394|888661|P2|Overall Study|Withdrawal by Subject|1
268626|NCT01122394|888662|P1|Overall Study|Withdrawal by Subject|1
268627|NCT01122381|888678|P2|Overall Study|study terminated early|1
268628|NCT01122381|888679|P1|Overall Study|study terminated early|0
268629|NCT01122264|888688|P3|Overall Study|Lack of Efficacy|1
268630|NCT01122264|888689|P2|Overall Study|Lack of Efficacy|1
268631|NCT01122264|888690|P1|Overall Study|Lack of Efficacy|3
268632|NCT01122264|888688|P3|Overall Study|Physician Decision|1
268633|NCT01122264|888689|P2|Overall Study|Physician Decision|1
268634|NCT01122264|888690|P1|Overall Study|Physician Decision|3
268635|NCT01122264|888688|P3|Overall Study|Withdrawal by Subject|16
268636|NCT01122264|888689|P2|Overall Study|Withdrawal by Subject|6
268637|NCT01122264|888690|P1|Overall Study|Withdrawal by Subject|6
268638|NCT01122264|888688|P3|Overall Study|Protocol Violation|9
268639|NCT01122264|888689|P2|Overall Study|Protocol Violation|7
268640|NCT01122264|888690|P1|Overall Study|Protocol Violation|7
268641|NCT01122264|888688|P3|Overall Study|Entry Criteria Not Met|0
268642|NCT01122264|888689|P2|Overall Study|Entry Criteria Not Met|0
268643|NCT01122264|888690|P1|Overall Study|Entry Criteria Not Met|1
268644|NCT01122264|888688|P3|Overall Study|Lost to Follow-up|13
268645|NCT01122264|888689|P2|Overall Study|Lost to Follow-up|9
268646|NCT01122264|888690|P1|Overall Study|Lost to Follow-up|5
268647|NCT01122264|888688|P3|Overall Study|Death|0
268648|NCT01122264|888689|P2|Overall Study|Death|0
268649|NCT01122264|888690|P1|Overall Study|Death|1
268650|NCT01122264|888688|P3|Overall Study|Adverse Event|7
268651|NCT01122264|888689|P2|Overall Study|Adverse Event|5
268652|NCT01122264|888690|P1|Overall Study|Adverse Event|6
268653|NCT01121991|889016|P1|Overall Study|No Fertilization|1
268654|NCT01121991|889016|P1|Overall Study|No Oocytes Retrieved|3
268655|NCT01121991|889016|P1|Overall Study|Lack of Ovarian Response|2
268656|NCT01121926|889041|P2|Washout Period|Positive pregnancy test|1
268657|NCT01121926|889042|P1|Washout Period|Positive pregnancy test|0
268658|NCT01121926|889041|P2|Washout Period|Adverse Event|1
268659|NCT01121926|889042|P1|Washout Period|Adverse Event|0
268660|NCT01121926|889041|P2|First Intervention Period|Adverse Event|0
268661|NCT01121926|889042|P1|First Intervention Period|Adverse Event|1
268662|NCT01121913|889060|P4|Third Washout Period|Adverse Event|0
268663|NCT01121913|889061|P3|Third Washout Period|Adverse Event|0
268664|NCT01121913|889062|P2|Third Washout Period|Adverse Event|0
268665|NCT01121913|889063|P1|Third Washout Period|Adverse Event|1
268666|NCT01121913|889060|P4|Second Washout Period|Withdrawal by Subject|0
268667|NCT01121913|889061|P3|Second Washout Period|Withdrawal by Subject|1
268668|NCT01121913|889062|P2|Second Washout Period|Withdrawal by Subject|0
268669|NCT01121913|889063|P1|Second Washout Period|Withdrawal by Subject|0
268670|NCT01121913|889060|P4|Second Intervention Period|Adverse Event|0
268671|NCT01121913|889061|P3|Second Intervention Period|Adverse Event|1
268672|NCT01121913|889062|P2|Second Intervention Period|Adverse Event|0
268673|NCT01121913|889063|P1|Second Intervention Period|Adverse Event|0
268674|NCT01121913|889060|P4|First Washout Period|Withdrawal by Subject|0
268675|NCT01121913|889061|P3|First Washout Period|Withdrawal by Subject|0
268676|NCT01121913|889062|P2|First Washout Period|Withdrawal by Subject|0
268677|NCT01121913|889063|P1|First Washout Period|Withdrawal by Subject|1
268678|NCT01121913|889060|P4|First Intervention Period|Adverse Event|0
268679|NCT01121913|889061|P3|First Intervention Period|Adverse Event|1
268680|NCT01121913|889062|P2|First Intervention Period|Adverse Event|0
268681|NCT01121913|889063|P1|First Intervention Period|Adverse Event|0
268682|NCT01121900|889093|P2|Washout Period of 7 Days|Withdrawal by Subject|1
268683|NCT01121900|889094|P1|Washout Period of 7 Days|Withdrawal by Subject|0
268684|NCT01121900|889093|P2|First Intervention Period|Adverse Event|1
268685|NCT01121900|889094|P1|First Intervention Period|Adverse Event|1
268686|NCT01121757|889114|P2|Combination|Disease Progression|0
268687|NCT01121757|889115|P1|Combination|Disease Progression|2
268688|NCT01121757|889114|P2|Combination|Physician Decision|1
268689|NCT01121757|889115|P1|Combination|Physician Decision|0
268690|NCT01121757|889114|P2|First Drug|Disease Progression|2
268691|NCT01121757|889115|P1|First Drug|Disease Progression|0
268692|NCT01121757|889114|P2|First Drug|Death|0
268693|NCT01121757|889115|P1|First Drug|Death|1
268694|NCT01121666|889131|P2|Overall Study|Protocol Violation|10
268695|NCT01121666|889132|P1|Overall Study|Protocol Violation|29
268696|NCT01121575|889188|P6|Overall Study|Death|1
268697|NCT01121575|889189|P5|Overall Study|Death|7
268698|NCT01121575|889190|P4|Overall Study|Death|1
268699|NCT01121575|889191|P3|Overall Study|Death|0
268700|NCT01121575|889192|P2|Overall Study|Death|0
268701|NCT01121575|889193|P1|Overall Study|Death|6
268702|NCT01121575|889188|P6|Overall Study|Unspecified Reasons|10
268703|NCT01121575|889189|P5|Overall Study|Unspecified Reasons|13
268704|NCT01121575|889190|P4|Overall Study|Unspecified Reasons|5
268705|NCT01121575|889191|P3|Overall Study|Unspecified Reasons|7
268706|NCT01121575|889192|P2|Overall Study|Unspecified Reasons|6
268707|NCT01121575|889193|P1|Overall Study|Unspecified Reasons|8
268708|NCT01121575|889188|P6|Overall Study|Participant Refused Further Follow-Up|1
268709|NCT01121575|889189|P5|Overall Study|Participant Refused Further Follow-Up|5
268710|NCT01121575|889190|P4|Overall Study|Participant Refused Further Follow-Up|0
268711|NCT01121575|889191|P3|Overall Study|Participant Refused Further Follow-Up|0
268712|NCT01121575|889192|P2|Overall Study|Participant Refused Further Follow-Up|0
268713|NCT01121575|889193|P1|Overall Study|Participant Refused Further Follow-Up|0
268714|NCT01121562|889317|P1|Overall Study|Met study discontinuation criteria|1
268715|NCT01121562|889317|P1|Overall Study|Sponsor Decision|1
268716|NCT01121562|889317|P1|Overall Study|Adverse Event|1
268717|NCT01121562|889317|P1|Overall Study|Withdrawal by Subject|1
268718|NCT01121562|889317|P1|Overall Study|Objective progression or relapse|8
268719|NCT01121549|889326|P1|Overall Study|Unspecified|58
268720|NCT01121549|889326|P1|Overall Study|Withdrawal by Subject|16
268721|NCT01121549|889326|P1|Overall Study|Protocol Violation|33
268722|NCT01121549|889326|P1|Overall Study|Pregnancy|1
268723|NCT01121549|889326|P1|Overall Study|Study terminated by sponsor|197
268724|NCT01121549|889326|P1|Overall Study|Did not meet entrance criteria|9
268725|NCT01121549|889326|P1|Overall Study|Lost to Follow-up|12
268726|NCT01121549|889326|P1|Overall Study|Lack of Efficacy|11
268727|NCT01121549|889326|P1|Overall Study|Adverse Event|10
268728|NCT01121536|889337|P1|Overall Study|Not specified|118
268729|NCT01121536|889337|P1|Overall Study|Lost to Follow-up|39
268730|NCT01121536|889337|P1|Overall Study|Noncompliance with study procedures|9
268731|NCT01121536|889337|P1|Overall Study|Noncompliance with study medication|12
268732|NCT01121536|889337|P1|Overall Study|Protocol Violation|20
268733|NCT01121536|889337|P1|Overall Study|Withdrawal by Subject|65
268734|NCT01121536|889337|P1|Overall Study|Lack of Efficacy|35
268735|NCT01121536|889337|P1|Overall Study|Adverse Event|63
268736|NCT01121484|889358|P2|Overall Study|Randomized, not treated|4
268737|NCT01121484|889359|P1|Overall Study|Randomized, not treated|1
268738|NCT01121484|889358|P2|Overall Study|unspecified|3
268739|NCT01121484|889359|P1|Overall Study|unspecified|3
268740|NCT01121484|889358|P2|Overall Study|Discontinuation of study by sponsor|1
268741|NCT01121484|889359|P1|Overall Study|Discontinuation of study by sponsor|0
268742|NCT01121484|889358|P2|Overall Study|Withdrawal by Subject|7
268743|NCT01121484|889359|P1|Overall Study|Withdrawal by Subject|8
268744|NCT01121484|889358|P2|Overall Study|Protocol Violation|0
268745|NCT01121484|889359|P1|Overall Study|Protocol Violation|1
268746|NCT01121484|889358|P2|Overall Study|Physician Decision|3
268747|NCT01121484|889359|P1|Overall Study|Physician Decision|0
268748|NCT01121484|889358|P2|Overall Study|Lost to Follow-up|9
268749|NCT01121484|889359|P1|Overall Study|Lost to Follow-up|5
268750|NCT01121484|889358|P2|Overall Study|Lack of Efficacy|11
268751|NCT01121484|889359|P1|Overall Study|Lack of Efficacy|3
268752|NCT01121484|889358|P2|Overall Study|Adverse Event|5
268753|NCT01121484|889359|P1|Overall Study|Adverse Event|12
268754|NCT01121406|889377|P2|Overall Study|Not treated|0
268755|NCT01121406|889378|P1|Overall Study|Not treated|1
268756|NCT01121406|889377|P2|Overall Study|Reason other than specified above|6
268757|NCT01121406|889378|P1|Overall Study|Reason other than specified above|2
268758|NCT01121406|889377|P2|Overall Study|Refused continuation of study med.|2
268759|NCT01121406|889378|P1|Overall Study|Refused continuation of study med.|1
268760|NCT01121406|889377|P2|Overall Study|Lost to Follow-up|1
268761|NCT01121406|889378|P1|Overall Study|Lost to Follow-up|0
268762|NCT01121406|889377|P2|Overall Study|Non−compliant with protocol|2
268763|NCT01121406|889378|P1|Overall Study|Non−compliant with protocol|0
268764|NCT01121406|889377|P2|Overall Study|Other AE|10
268765|NCT01121406|889378|P1|Overall Study|Other AE|3
268766|NCT01121406|889377|P2|Overall Study|Wors. or AE of underlying cancer disease|6
268767|NCT01121406|889378|P1|Overall Study|Wors. or AE of underlying cancer disease|4
268768|NCT01121406|889377|P2|Overall Study|Progressive disease RECIST|28
268769|NCT01121406|889378|P1|Overall Study|Progressive disease RECIST|44
268770|NCT01121393|889428|P2|Overall Study|Not treated|9
268771|NCT01121393|889429|P1|Overall Study|Not treated|3
268772|NCT01121393|889428|P2|Overall Study|Refused cont. medication|7
268773|NCT01121393|889429|P1|Overall Study|Refused cont. medication|7
268774|NCT01121393|889428|P2|Overall Study|Lost to Follow-up|0
268775|NCT01121393|889429|P1|Overall Study|Lost to Follow-up|1
268776|NCT01121393|889428|P2|Overall Study|Non-compliant with protocol|3
268777|NCT01121393|889429|P1|Overall Study|Non-compliant with protocol|0
268778|NCT01121393|889428|P2|Overall Study|Other Adverse events|45
268779|NCT01121393|889429|P1|Overall Study|Other Adverse events|22
268780|NCT01121393|889428|P2|Overall Study|Progressive disease|20
268781|NCT01121393|889429|P1|Overall Study|Progressive disease|186
268782|NCT01121263|889474|P2|Overall Study|Withdrawal by Subject|1
268783|NCT01121263|889475|P1|Overall Study|Withdrawal by Subject|0
268784|NCT01121263|889474|P2|Overall Study|Lost to Follow-up|12
268785|NCT01121263|889475|P1|Overall Study|Lost to Follow-up|22
268786|NCT01121263|889474|P2|Overall Study|Death|2
268787|NCT01121263|889475|P1|Overall Study|Death|3
268788|NCT01121185|889496|P2|Overall Study|Not transplanted|0
268789|NCT01121185|889497|P1|Overall Study|Not transplanted|1
268790|NCT01121185|889496|P2|Overall Study|Not infused|1
268791|NCT01121185|889497|P1|Overall Study|Not infused|0
268792|NCT01121146|889531|P2|Overall Study|Lost to Follow-up|16
268793|NCT01121146|889532|P1|Overall Study|Lost to Follow-up|7
268794|NCT01121146|889531|P2|Overall Study|Adverse Event|11
268795|NCT01121146|889532|P1|Overall Study|Adverse Event|2
268796|NCT01121146|889531|P2|Overall Study|Death|15
268797|NCT01121146|889532|P1|Overall Study|Death|17
268798|NCT01120899|889553|P1|Overall Study|Withdrawal by Subject|3
268799|NCT01120782|889581|P1|Overall Study|Test article shipping error|11
268800|NCT01120717|889587|P2|Overall Study|Abnormal Test Procedure Result(s)|0
268801|NCT01120717|889588|P1|Overall Study|Abnormal Test Procedure Result(s)|1
268802|NCT01120717|889587|P2|Overall Study|Death|1
268803|NCT01120717|889588|P1|Overall Study|Death|3
268804|NCT01120717|889587|P2|Overall Study|Lost to Follow-up|3
268805|NCT01120717|889588|P1|Overall Study|Lost to Follow-up|2
268806|NCT01120717|889587|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
268807|NCT01120717|889588|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
268808|NCT01120717|889587|P2|Overall Study|Protocol Deviation|5
268809|NCT01120717|889588|P1|Overall Study|Protocol Deviation|2
268810|NCT01120717|889587|P2|Overall Study|Adverse Event|6
268811|NCT01120717|889588|P1|Overall Study|Adverse Event|10
268812|NCT01120717|889587|P2|Overall Study|Withdrawal by Subject|6
268813|NCT01120717|889588|P1|Overall Study|Withdrawal by Subject|11
268814|NCT01120691|889694|P3|Overall Study|Abnormal laboratory value(s)|4
268815|NCT01120691|889695|P2|Overall Study|Abnormal laboratory value(s)|3
268816|NCT01120691|889696|P1|Overall Study|Abnormal laboratory value(s)|1
268817|NCT01120691|889694|P3|Overall Study|Patient's inability to use the device|0
268818|NCT01120691|889695|P2|Overall Study|Patient's inability to use the device|1
268819|NCT01120691|889696|P1|Overall Study|Patient's inability to use the device|3
268820|NCT01120691|889694|P3|Overall Study|Abnormal test procedure result(s)|1
268821|NCT01120691|889695|P2|Overall Study|Abnormal test procedure result(s)|2
268822|NCT01120691|889696|P1|Overall Study|Abnormal test procedure result(s)|3
268823|NCT01120691|889694|P3|Overall Study|Lost to Follow-up|4
268824|NCT01120691|889695|P2|Overall Study|Lost to Follow-up|6
268825|NCT01120691|889696|P1|Overall Study|Lost to Follow-up|5
268826|NCT01120691|889694|P3|Overall Study|Protocol deviation|12
268827|NCT01120691|889695|P2|Overall Study|Protocol deviation|12
268828|NCT01120691|889696|P1|Overall Study|Protocol deviation|13
268829|NCT01120691|889694|P3|Overall Study|Administrative problems|9
268830|NCT01120691|889695|P2|Overall Study|Administrative problems|8
268831|NCT01120691|889696|P1|Overall Study|Administrative problems|15
268832|NCT01120691|889694|P3|Overall Study|Unsatisfactory therapeutic effect|38
268833|NCT01120691|889695|P2|Overall Study|Unsatisfactory therapeutic effect|32
268834|NCT01120691|889696|P1|Overall Study|Unsatisfactory therapeutic effect|18
268835|NCT01120691|889694|P3|Overall Study|Death|24
268836|NCT01120691|889695|P2|Overall Study|Death|22
268837|NCT01120691|889696|P1|Overall Study|Death|21
268838|NCT01120691|889694|P3|Overall Study|Subject withdrew consent|44
268839|NCT01120691|889695|P2|Overall Study|Subject withdrew consent|50
268840|NCT01120691|889696|P1|Overall Study|Subject withdrew consent|33
268841|NCT01120691|889694|P3|Overall Study|Adverse Event|47
268842|NCT01120691|889695|P2|Overall Study|Adverse Event|67
268843|NCT01120691|889696|P1|Overall Study|Adverse Event|59
268844|NCT01120626|889740|P2|Overall Study|Withdrawal by Subject|0
268845|NCT01120626|889741|P1|Overall Study|Withdrawal by Subject|1
268846|NCT01120379|889780|P1|Four Year Timepoint|Any other reason for early termination|217
268847|NCT01120379|889780|P1|Four Year Timepoint|Physician Decision|5
268848|NCT01120379|889780|P1|Four Year Timepoint|Death|131
268849|NCT01120379|889780|P1|Four Year Timepoint|Lost to Follow-up|10
268850|NCT01120379|889780|P1|Four Year Timepoint|Withdrawal by Subject|5
268851|NCT01120379|889780|P1|Three Year Timepoint|Any other reason for early termination|17
268852|NCT01120379|889780|P1|Three Year Timepoint|Physician Decision|9
268853|NCT01120379|889780|P1|Three Year Timepoint|Death|120
268854|NCT01120379|889780|P1|Three Year Timepoint|Lost to Follow-up|43
268855|NCT01120379|889780|P1|Three Year Timepoint|Withdrawal by Subject|25
268856|NCT01120379|889780|P1|Two Year Timepoint|Any other reason for early termination|4
268857|NCT01120379|889780|P1|Two Year Timepoint|Physician Decision|12
268858|NCT01120379|889780|P1|Two Year Timepoint|Death|123
268859|NCT01120379|889780|P1|Two Year Timepoint|Lost to Follow-up|87
268860|NCT01120379|889780|P1|Two Year Timepoint|Withdrawal by Subject|11
268861|NCT01120379|889780|P1|One Year Timepoint|Any other reason for early termination|5
268862|NCT01120379|889780|P1|One Year Timepoint|Physician Decision|9
268863|NCT01120379|889780|P1|One Year Timepoint|Death|108
268864|NCT01120379|889780|P1|One Year Timepoint|Lost to Follow-up|115
268865|NCT01120379|889780|P1|One Year Timepoint|Withdrawal by Subject|41
268866|NCT01120275|889816|P1|Overall Study|Not specific|1
268867|NCT01120275|889816|P1|Overall Study|Refusal|1
268868|NCT01120275|889816|P1|Overall Study|Withdrawal by Subject|1
268869|NCT01120275|889816|P1|Overall Study|Ineligible|3
268870|NCT01120275|889816|P1|Overall Study|Progression|27
268871|NCT01120275|889816|P1|Overall Study|Adverse Event|3
268872|NCT01120210|889866|P2|MAIN INFUSION|Withdrawal by Subject|1
268873|NCT01120210|889867|P1|MAIN INFUSION|Withdrawal by Subject|0
268874|NCT01120210|889866|P2|MAIN INFUSION|Adverse Event|0
268875|NCT01120210|889867|P1|MAIN INFUSION|Adverse Event|1
268876|NCT01120184|889917|P3|Overall Study|Not Specified|8
268877|NCT01120184|889918|P2|Overall Study|Not Specified|2
268878|NCT01120184|889919|P1|Overall Study|Not Specified|4
268879|NCT01120184|889917|P3|Overall Study|Withdrawal by Subject|22
268880|NCT01120184|889918|P2|Overall Study|Withdrawal by Subject|28
268881|NCT01120184|889919|P1|Overall Study|Withdrawal by Subject|28
268882|NCT01120184|889917|P3|Overall Study|Physician Decision|2
268883|NCT01120184|889918|P2|Overall Study|Physician Decision|2
268884|NCT01120184|889919|P1|Overall Study|Physician Decision|9
268885|NCT01120184|889917|P3|Overall Study|Lost to Follow-up|7
268886|NCT01120184|889918|P2|Overall Study|Lost to Follow-up|6
268887|NCT01120184|889919|P1|Overall Study|Lost to Follow-up|5
268888|NCT01120184|889917|P3|Overall Study|Death|115
268889|NCT01120184|889918|P2|Overall Study|Death|116
268890|NCT01120184|889919|P1|Overall Study|Death|123
268891|NCT01120093|890041|P5|Treatment Period 5|Adverse Event|0
268892|NCT01120093|890042|P4|Treatment Period 5|Adverse Event|1
268893|NCT01120093|890043|P3|Treatment Period 5|Adverse Event|0
268894|NCT01120093|890044|P2|Treatment Period 5|Adverse Event|1
268895|NCT01120093|890045|P1|Treatment Period 5|Adverse Event|0
268896|NCT01120093|890041|P5|Treatment Period 4|Adverse Event|0
268897|NCT01120093|890042|P4|Treatment Period 4|Adverse Event|0
268898|NCT01120093|890043|P3|Treatment Period 4|Adverse Event|0
268899|NCT01120093|890044|P2|Treatment Period 4|Adverse Event|0
268900|NCT01120093|890045|P1|Treatment Period 4|Adverse Event|1
268901|NCT01120093|890041|P5|Treatment Period 3|Withdrawal by Subject|0
268902|NCT01120093|890042|P4|Treatment Period 3|Withdrawal by Subject|0
268903|NCT01120093|890043|P3|Treatment Period 3|Withdrawal by Subject|1
268904|NCT01120093|890044|P2|Treatment Period 3|Withdrawal by Subject|0
268905|NCT01120093|890045|P1|Treatment Period 3|Withdrawal by Subject|0
268906|NCT01120093|890041|P5|Treatment Period 3|Adverse Event|1
268907|NCT01120093|890042|P4|Treatment Period 3|Adverse Event|0
268908|NCT01120093|890043|P3|Treatment Period 3|Adverse Event|0
268909|NCT01120093|890044|P2|Treatment Period 3|Adverse Event|0
268910|NCT01120093|890045|P1|Treatment Period 3|Adverse Event|0
268911|NCT01120093|890041|P5|Treatment Period 3|Lack of Efficacy|0
268912|NCT01120093|890042|P4|Treatment Period 3|Lack of Efficacy|1
268913|NCT01120093|890043|P3|Treatment Period 3|Lack of Efficacy|0
268914|NCT01120093|890044|P2|Treatment Period 3|Lack of Efficacy|0
268915|NCT01120093|890045|P1|Treatment Period 3|Lack of Efficacy|0
268916|NCT01120093|890041|P5|Treatment Period 2|Withdrawal by Subject|1
268917|NCT01120093|890042|P4|Treatment Period 2|Withdrawal by Subject|0
268918|NCT01120093|890043|P3|Treatment Period 2|Withdrawal by Subject|0
268919|NCT01120093|890044|P2|Treatment Period 2|Withdrawal by Subject|0
268920|NCT01120093|890045|P1|Treatment Period 2|Withdrawal by Subject|0
268921|NCT01120093|890041|P5|Treatment Period 2|Adverse Event|0
268922|NCT01120093|890042|P4|Treatment Period 2|Adverse Event|1
268923|NCT01120093|890043|P3|Treatment Period 2|Adverse Event|0
268924|NCT01120093|890044|P2|Treatment Period 2|Adverse Event|0
268925|NCT01120093|890045|P1|Treatment Period 2|Adverse Event|0
268926|NCT01120093|890041|P5|Treatment Period 1|Withdrawal by Subject|0
268927|NCT01120093|890042|P4|Treatment Period 1|Withdrawal by Subject|0
268928|NCT01120093|890043|P3|Treatment Period 1|Withdrawal by Subject|0
268929|NCT01120093|890044|P2|Treatment Period 1|Withdrawal by Subject|1
268930|NCT01120093|890045|P1|Treatment Period 1|Withdrawal by Subject|0
268931|NCT01120093|890041|P5|Treatment Period 1|Adverse Event|1
268932|NCT01120093|890042|P4|Treatment Period 1|Adverse Event|0
268933|NCT01120093|890043|P3|Treatment Period 1|Adverse Event|1
268934|NCT01120093|890044|P2|Treatment Period 1|Adverse Event|0
268935|NCT01120093|890045|P1|Treatment Period 1|Adverse Event|0
268936|NCT01120067|890074|P2|Overall Study|fail to engage >3 sessions|0
268937|NCT01120067|890075|P1|Overall Study|fail to engage >3 sessions|2
268938|NCT01120067|890074|P2|Overall Study|Lost to Follow-up|1
268939|NCT01120067|890075|P1|Overall Study|Lost to Follow-up|3
268940|NCT01119950|890081|P1|Overall Study|Death|1
268941|NCT01119950|890081|P1|Overall Study|Abnormal lab value|1
268942|NCT01119950|890081|P1|Overall Study|Administrative|2
268943|NCT01119950|890081|P1|Overall Study|Lost to Follow-up|4
268944|NCT01119950|890081|P1|Overall Study|Protocol Violation|5
268945|NCT01119950|890081|P1|Overall Study|Withdrawal by Subject|9
268946|NCT01119950|890081|P1|Overall Study|Adverse Event|25
268947|NCT01119937|890328|P2|Overall Study|Withdrawal by Subject|1
268948|NCT01119937|890329|P1|Overall Study|Withdrawal by Subject|2
268949|NCT01119937|890328|P2|Overall Study|Unsatisfactory therapeutic effect|0
268950|NCT01119937|890329|P1|Overall Study|Unsatisfactory therapeutic effect|3
268951|NCT01119937|890328|P2|Overall Study|Protocol deviation|1
268952|NCT01119937|890329|P1|Overall Study|Protocol deviation|3
268953|NCT01119937|890328|P2|Overall Study|Adverse Event|5
268954|NCT01119937|890329|P1|Overall Study|Adverse Event|11
268955|NCT01119859|890357|P2|Overall Study|Failure to return|0
268956|NCT01119859|890358|P1|Overall Study|Failure to return|3
268957|NCT01119859|890357|P2|Overall Study|Refused treatment|6
268958|NCT01119859|890358|P1|Overall Study|Refused treatment|3
268959|NCT01119859|890357|P2|Overall Study|Insufficient therapeutic response|14
268960|NCT01119859|890358|P1|Overall Study|Insufficient therapeutic response|7
268961|NCT01119859|890357|P2|Overall Study|Death|0
268962|NCT01119859|890358|P1|Overall Study|Death|2
268963|NCT01119859|890357|P2|Overall Study|Adverse Event|10
268964|NCT01119859|890358|P1|Overall Study|Adverse Event|9
268965|NCT01119768|890380|P2|Treatment Period|Lack of Efficacy|25
268966|NCT01119768|890381|P1|Treatment Period|Lack of Efficacy|18
268967|NCT01119703|890437|P2|Overall Study|Adverse Event|1
268968|NCT01119703|890438|P1|Overall Study|Adverse Event|0
268969|NCT01119625|890452|P2|Overall Study|Unspecified|1
268970|NCT01119625|890453|P1|Overall Study|Unspecified|0
268971|NCT01119625|890452|P2|Overall Study|Withdrawal by Subject|1
268972|NCT01119625|890453|P1|Overall Study|Withdrawal by Subject|2
268973|NCT01119625|890452|P2|Overall Study|Lost to Follow-up|2
268974|NCT01119625|890453|P1|Overall Study|Lost to Follow-up|1
268975|NCT01119443|890495|P2|Crossover Period 1 (5 Days)|Adverse Event|1
268976|NCT01119443|890496|P1|Crossover Period 1 (5 Days)|Adverse Event|0
268977|NCT01119287|890539|P6|Overall Study|Patient Decision, not related to AE|0
268978|NCT01119287|890540|P5|Overall Study|Patient Decision, not related to AE|1
268979|NCT01119287|890541|P4|Overall Study|Patient Decision, not related to AE|2
268980|NCT01119287|890542|P3|Overall Study|Patient Decision, not related to AE|2
268981|NCT01119287|890543|P2|Overall Study|Patient Decision, not related to AE|0
268982|NCT01119287|890544|P1|Overall Study|Patient Decision, not related to AE|0
268983|NCT01119131|890601|P3|Overall Study|Physician Decision|1
268984|NCT01119131|890602|P2|Overall Study|Physician Decision|0
268985|NCT01119131|890603|P1|Overall Study|Physician Decision|0
268986|NCT01119131|890601|P3|Overall Study|Non-Compliance|4
268987|NCT01119131|890602|P2|Overall Study|Non-Compliance|0
268988|NCT01119131|890603|P1|Overall Study|Non-Compliance|1
268989|NCT01119131|890601|P3|Overall Study|Adverse Event|1
268990|NCT01119131|890602|P2|Overall Study|Adverse Event|1
268991|NCT01119131|890603|P1|Overall Study|Adverse Event|1
268992|NCT01119118|890632|P1|Overall Study|Adverse Event|1
268993|NCT01119001|890644|P1|Overall Study|Withdrawal by Subject|2
268994|NCT01118975|890688|P2|Overall Study|Adverse Event|1
268995|NCT01118975|890689|P1|Overall Study|Adverse Event|0
268996|NCT01118962|890695|P1|Overall Study|Non-compliance with Medicinal Product|1
268997|NCT01118962|890695|P1|Overall Study|Pregnancy|1
268998|NCT01118962|890695|P1|Overall Study|Withdrawal by Subject|4
268999|NCT01118962|890695|P1|Overall Study|Protocol Violation|1
269000|NCT01118962|890695|P1|Overall Study|Lack of Efficacy|1
269001|NCT01118962|890695|P1|Overall Study|Adverse Event|2
269002|NCT01118949|890700|P1|Overall Study|Withdrawal by Subject|4
269003|NCT01118949|890700|P1|Overall Study|Adverse Event|5
269004|NCT01118780|890730|P2|Overall Study|Withdrawal by Subject|8
269005|NCT01118780|890731|P1|Overall Study|Withdrawal by Subject|13
269006|NCT01118780|890730|P2|Overall Study|Protocol Violation|6
269007|NCT01118780|890731|P1|Overall Study|Protocol Violation|3
269008|NCT01118780|890730|P2|Overall Study|Physician Decision|0
269009|NCT01118780|890731|P1|Overall Study|Physician Decision|2
269010|NCT01118780|890730|P2|Overall Study|Lack of Efficacy|6
269011|NCT01118780|890731|P1|Overall Study|Lack of Efficacy|2
269012|NCT01118780|890730|P2|Overall Study|Death|0
269013|NCT01118780|890731|P1|Overall Study|Death|1
269014|NCT01118780|890730|P2|Overall Study|Adverse Event|15
269015|NCT01118780|890731|P1|Overall Study|Adverse Event|15
269016|NCT01118663|890789|P2|Overall Study|Withdrawal by Subject|1
269017|NCT01118663|890790|P1|Overall Study|Withdrawal by Subject|0
269018|NCT01118663|890789|P2|Overall Study|Adverse Event|1
269019|NCT01118663|890790|P1|Overall Study|Adverse Event|2
269020|NCT01118455|890813|P2|Baseline [Visits 1 & 2]|Adverse Event|0
269021|NCT01118455|890814|P1|Baseline [Visits 1 & 2]|Adverse Event|1
269022|NCT01118377|890842|P1|Overall Study|Failure to Return|3
269023|NCT01118377|890842|P1|Overall Study|Death|38
269024|NCT01118377|890842|P1|Overall Study|Did Not Receive Study Medication|1
269025|NCT01118325|890851|P3|Overall Study|Adverse Event|1
269026|NCT01118325|890852|P2|Overall Study|Adverse Event|0
269027|NCT01118325|890853|P1|Overall Study|Adverse Event|1
269028|NCT01118312|890899|P2|Overall Study|Withdrawal by Subject|3
269029|NCT01118312|890900|P1|Overall Study|Withdrawal by Subject|1
269030|NCT01118312|890899|P2|Overall Study|Lost to Follow-up|32
269031|NCT01118312|890900|P1|Overall Study|Lost to Follow-up|33
269032|NCT01118143|891098|P2|Overall Study|Withdrawal by Subject|5
269033|NCT01118143|891099|P1|Overall Study|Withdrawal by Subject|2
269034|NCT01118117|891109|P2|Overall Study|Missed 12 Month Visit|0
269035|NCT01118117|891110|P1|Overall Study|Missed 12 Month Visit|7
269036|NCT01118117|891109|P2|Overall Study|Lost to Follow-up|0
269037|NCT01118117|891110|P1|Overall Study|Lost to Follow-up|6
269038|NCT01118117|891109|P2|Overall Study|Death|0
269039|NCT01118117|891110|P1|Overall Study|Death|8
269040|NCT01117987|891152|P2|Overall Study|Administrative problems|22
269041|NCT01117987|891153|P1|Overall Study|Administrative problems|25
269042|NCT01117987|891152|P2|Overall Study|Adverse Event|26
269043|NCT01117987|891153|P1|Overall Study|Adverse Event|19
269044|NCT01117987|891152|P2|Overall Study|Withdrawal by Subject|10
269045|NCT01117987|891153|P1|Overall Study|Withdrawal by Subject|5
269046|NCT01117987|891152|P2|Overall Study|Death|10
269047|NCT01117987|891153|P1|Overall Study|Death|5
269048|NCT01117987|891152|P2|Overall Study|Lack of Efficacy|4
269049|NCT01117987|891153|P1|Overall Study|Lack of Efficacy|3
269050|NCT01117987|891152|P2|Overall Study|Abnormal test procedure result|0
269051|NCT01117987|891153|P1|Overall Study|Abnormal test procedure result|2
269052|NCT01117987|891152|P2|Overall Study|Lost to Follow-up|1
269053|NCT01117987|891153|P1|Overall Study|Lost to Follow-up|1
269054|NCT01117987|891152|P2|Overall Study|Subject no longer requires study drug|0
269055|NCT01117987|891153|P1|Overall Study|Subject no longer requires study drug|1
269056|NCT01117987|891152|P2|Overall Study|Protocol deviation|1
269057|NCT01117987|891153|P1|Overall Study|Protocol deviation|0
269058|NCT01117870|891174|P2|Overall Study|Inability to place needle|0
269059|NCT01117870|891175|P1|Overall Study|Inability to place needle|1
269060|NCT01117857|891189|P1|Overall Study|Physician Decision|1
269061|NCT01117857|891189|P1|Overall Study|Withdrawal by Subject|4
269062|NCT01117857|891189|P1|Overall Study|Lost to Follow-up|4
269063|NCT01117766|891197|P2|Second Intervention|Withdrawal by Subject|1
269064|NCT01117766|891198|P1|Second Intervention|Withdrawal by Subject|0
269065|NCT01117766|891197|P2|Second Intervention|Adverse Event|2
269066|NCT01117766|891198|P1|Second Intervention|Adverse Event|0
269067|NCT01117766|891197|P2|Second Intervention|Unspecified|2
269068|NCT01117766|891198|P1|Second Intervention|Unspecified|1
269069|NCT01117766|891197|P2|Second Intervention|Lost to Follow-up|0
269070|NCT01117766|891198|P1|Second Intervention|Lost to Follow-up|1
269071|NCT01117766|891197|P2|Washout Period|Protocol Violation|2
269072|NCT01117766|891198|P1|Washout Period|Protocol Violation|0
269073|NCT01117766|891197|P2|First Intervention|Protocol Violation|0
269074|NCT01117766|891198|P1|First Intervention|Protocol Violation|1
269075|NCT01117766|891197|P2|First Intervention|Unspecified|0
269076|NCT01117766|891198|P1|First Intervention|Unspecified|0
269077|NCT01117766|891197|P2|First Intervention|Adverse Event|1
269078|NCT01117766|891198|P1|First Intervention|Adverse Event|0
269079|NCT01117623|891235|P8|Overall Study|Invest. text: completed all planned txs|0
269080|NCT01117623|891236|P7|Overall Study|Invest. text: completed all planned txs|0
269081|NCT01117623|891237|P6|Overall Study|Invest. text: completed all planned txs|1
269082|NCT01117623|891238|P5|Overall Study|Invest. text: completed all planned txs|0
269083|NCT01117623|891239|P4|Overall Study|Invest. text: completed all planned txs|0
269084|NCT01117623|891240|P3|Overall Study|Invest. text: completed all planned txs|0
269085|NCT01117623|891241|P2|Overall Study|Invest. text: completed all planned txs|0
269086|NCT01117623|891242|P1|Overall Study|Invest. text: completed all planned txs|0
269087|NCT01117623|891235|P8|Overall Study|Non-compliance with study medication|1
269088|NCT01117623|891236|P7|Overall Study|Non-compliance with study medication|0
269089|NCT01117623|891237|P6|Overall Study|Non-compliance with study medication|0
269090|NCT01117623|891238|P5|Overall Study|Non-compliance with study medication|0
269091|NCT01117623|891239|P4|Overall Study|Non-compliance with study medication|0
269092|NCT01117623|891240|P3|Overall Study|Non-compliance with study medication|0
269093|NCT01117623|891241|P2|Overall Study|Non-compliance with study medication|0
269094|NCT01117623|891242|P1|Overall Study|Non-compliance with study medication|0
269095|NCT01117623|891235|P8|Overall Study|Withdrawal by Subject|1
269096|NCT01117623|891236|P7|Overall Study|Withdrawal by Subject|1
269097|NCT01117623|891237|P6|Overall Study|Withdrawal by Subject|1
269098|NCT01117623|891238|P5|Overall Study|Withdrawal by Subject|0
269099|NCT01117623|891239|P4|Overall Study|Withdrawal by Subject|0
269100|NCT01117623|891240|P3|Overall Study|Withdrawal by Subject|2
269101|NCT01117623|891241|P2|Overall Study|Withdrawal by Subject|0
269102|NCT01117623|891242|P1|Overall Study|Withdrawal by Subject|0
269103|NCT01117623|891235|P8|Overall Study|Disease progression, recurrence, relapse|22
269104|NCT01117623|891236|P7|Overall Study|Disease progression, recurrence, relapse|5
269105|NCT01117623|891237|P6|Overall Study|Disease progression, recurrence, relapse|14
269106|NCT01117623|891238|P5|Overall Study|Disease progression, recurrence, relapse|8
269107|NCT01117623|891239|P4|Overall Study|Disease progression, recurrence, relapse|6
269108|NCT01117623|891240|P3|Overall Study|Disease progression, recurrence, relapse|5
269109|NCT01117623|891241|P2|Overall Study|Disease progression, recurrence, relapse|6
269110|NCT01117623|891242|P1|Overall Study|Disease progression, recurrence, relapse|3
269111|NCT01117623|891235|P8|Overall Study|Adverse Event|2
269112|NCT01117623|891236|P7|Overall Study|Adverse Event|0
269113|NCT01117623|891237|P6|Overall Study|Adverse Event|0
269114|NCT01117623|891238|P5|Overall Study|Adverse Event|2
269115|NCT01117623|891239|P4|Overall Study|Adverse Event|0
269116|NCT01117623|891240|P3|Overall Study|Adverse Event|4
269117|NCT01117623|891241|P2|Overall Study|Adverse Event|2
269118|NCT01117623|891242|P1|Overall Study|Adverse Event|0
269119|NCT01117480|891394|P1|Overall Study|Did Not Start Adalimumab Therapy|20
269120|NCT01117480|891394|P1|Overall Study|Protocol Violation|8
269121|NCT01117454|891402|P2|Overall Study|Pregnancy|1
269122|NCT01117454|891403|P1|Overall Study|Pregnancy|0
269123|NCT01117350|891411|P2|Extension Period|Prohibited medication|1
269124|NCT01117350|891412|P1|Extension Period|Prohibited medication|0
269125|NCT01117350|891411|P2|Extension Period|Inclusion criteria not respected|1
269126|NCT01117350|891412|P1|Extension Period|Inclusion criteria not respected|0
269127|NCT01117350|891411|P2|Extension Period|Lack of Efficacy|2
269128|NCT01117350|891412|P1|Extension Period|Lack of Efficacy|0
269129|NCT01117350|891411|P2|Extension Period|Withdrawal by Subject|3
269130|NCT01117350|891412|P1|Extension Period|Withdrawal by Subject|0
269131|NCT01117350|891411|P2|Extension Period|Lost to Follow-up|2
269132|NCT01117350|891412|P1|Extension Period|Lost to Follow-up|0
269133|NCT01117350|891411|P2|Extension Period|Protocol Violation|2
269134|NCT01117350|891412|P1|Extension Period|Protocol Violation|0
269135|NCT01117350|891411|P2|Extension Period|Adverse Event|2
269136|NCT01117350|891412|P1|Extension Period|Adverse Event|0
269137|NCT01117350|891411|P2|Extension Period|Not included in extension, not treated|50
269138|NCT01117350|891412|P1|Extension Period|Not included in extension, not treated|0
269139|NCT01117350|891411|P2|Comparative Period|Move to another city/country|1
269140|NCT01117350|891412|P1|Comparative Period|Move to another city/country|2
269141|NCT01117350|891411|P2|Comparative Period|Physician Decision|1
269142|NCT01117350|891412|P1|Comparative Period|Physician Decision|0
269143|NCT01117350|891411|P2|Comparative Period|Lack of Efficacy|0
269144|NCT01117350|891412|P1|Comparative Period|Lack of Efficacy|1
269145|NCT01117350|891411|P2|Comparative Period|Protocol Violation|12
269146|NCT01117350|891412|P1|Comparative Period|Protocol Violation|8
269147|NCT01117350|891411|P2|Comparative Period|Withdrawal by Subject|13
269148|NCT01117350|891412|P1|Comparative Period|Withdrawal by Subject|9
269149|NCT01117350|891411|P2|Comparative Period|Lost to Follow-up|7
269150|NCT01117350|891412|P1|Comparative Period|Lost to Follow-up|11
269151|NCT01117350|891411|P2|Comparative Period|Adverse Event|33
269152|NCT01117350|891412|P1|Comparative Period|Adverse Event|6
269153|NCT01117350|891411|P2|Comparative Period|Not Treated|8
269154|NCT01117350|891412|P1|Comparative Period|Not Treated|5
269155|NCT01117337|891444|P2|Overall Study|Lost to Follow-up|0
269156|NCT01117337|891445|P1|Overall Study|Lost to Follow-up|4
269157|NCT01117181|891466|P2|Overall Study|Withdrawal by Subject|2
269158|NCT01117181|891467|P1|Overall Study|Withdrawal by Subject|0
269159|NCT01117181|891466|P2|Overall Study|Lost to Follow-up|0
269160|NCT01117181|891467|P1|Overall Study|Lost to Follow-up|1
269161|NCT01117051|891498|P2|Overall Study|Convenience issue|0
269162|NCT01117051|891499|P1|Overall Study|Convenience issue|1
269163|NCT01117051|891498|P2|Overall Study|Randomized by mistake|1
269164|NCT01117051|891499|P1|Overall Study|Randomized by mistake|0
269165|NCT01117051|891498|P2|Overall Study|Surgical procedure|1
269166|NCT01117051|891499|P1|Overall Study|Surgical procedure|0
269167|NCT01117051|891498|P2|Overall Study|Sponsor's decision|1
269168|NCT01117051|891499|P1|Overall Study|Sponsor's decision|3
269169|NCT01117051|891498|P2|Overall Study|Did not meet in-/exclusion criteria|1
269170|NCT01117051|891499|P1|Overall Study|Did not meet in-/exclusion criteria|0
269171|NCT01117051|891498|P2|Overall Study|Lost to Follow-up|1
269172|NCT01117051|891499|P1|Overall Study|Lost to Follow-up|0
269173|NCT01117051|891498|P2|Overall Study|Adverse Event|3
269174|NCT01117051|891499|P1|Overall Study|Adverse Event|4
269175|NCT01117051|891498|P2|Overall Study|Withdrawal by Subject|3
269176|NCT01117051|891499|P1|Overall Study|Withdrawal by Subject|5
269177|NCT01117012|891509|P2|Overall Study|Undefined|3
269178|NCT01117012|891510|P1|Overall Study|Undefined|4
269179|NCT01117012|891509|P2|Overall Study|Withdrawal by Subject|0
269180|NCT01117012|891510|P1|Overall Study|Withdrawal by Subject|3
269181|NCT01117012|891509|P2|Overall Study|Death|1
269182|NCT01117012|891510|P1|Overall Study|Death|1
269183|NCT01117012|891509|P2|Overall Study|Adverse Event|1
269184|NCT01117012|891510|P1|Overall Study|Adverse Event|0
269185|NCT01116882|891651|P2|12-month|Withdrawal by Subject|8
269186|NCT01116882|891652|P1|12-month|Withdrawal by Subject|5
269187|NCT01116882|891651|P2|12-month|Other Reasons|49
269188|NCT01116882|891652|P1|12-month|Other Reasons|151
269189|NCT01116882|891651|P2|12-month|Lost to Follow-up|42
269190|NCT01116882|891652|P1|12-month|Lost to Follow-up|111
269191|NCT01116882|891651|P2|30-day|Other Reasons|6
269192|NCT01116882|891652|P1|30-day|Other Reasons|16
269193|NCT01116882|891651|P2|30-day|Withdrawal by Subject|4
269194|NCT01116882|891652|P1|30-day|Withdrawal by Subject|2
269195|NCT01116882|891651|P2|30-day|Lost to Follow-up|21
269196|NCT01116882|891652|P1|30-day|Lost to Follow-up|50
269197|NCT01116687|891690|P1|Overall Study|Withdrawal by Subject|4
269198|NCT01116427|891707|P2|Extension Phase|Not using appropriate birth control|0
269199|NCT01116427|891708|P1|Extension Phase|Not using appropriate birth control|1
269200|NCT01116427|891707|P2|Extension Phase|Withdrawal by Subject|1
269201|NCT01116427|891708|P1|Extension Phase|Withdrawal by Subject|5
269202|NCT01116427|891707|P2|Extension Phase|Lost to Follow-up|0
269203|NCT01116427|891708|P1|Extension Phase|Lost to Follow-up|2
269204|NCT01116427|891707|P2|Extension Phase|Adverse Event|1
269205|NCT01116427|891708|P1|Extension Phase|Adverse Event|1
269206|NCT01116427|891707|P2|Core Phase|Worsening Multiple Sclerosis|0
269207|NCT01116427|891708|P1|Core Phase|Worsening Multiple Sclerosis|1
269208|NCT01116427|891707|P2|Core Phase|Withdrawal by Subject|0
269209|NCT01116427|891708|P1|Core Phase|Withdrawal by Subject|3
269210|NCT01116427|891707|P2|Core Phase|Lost to Follow-up|0
269211|NCT01116427|891708|P1|Core Phase|Lost to Follow-up|1
269212|NCT01116427|891707|P2|Core Phase|Adverse Event|1
269213|NCT01116427|891708|P1|Core Phase|Adverse Event|0
269214|NCT01116232|891744|P1|Overall Study|Progressive diease|1
269215|NCT01115998|891852|P2|Overall Study|Lost to Follow-up|6
269216|NCT01115998|891853|P1|Overall Study|Lost to Follow-up|6
269217|NCT01115933|891863|P1|Overall Study|Did not receive XIENCE PRIME SV|1
269218|NCT01115855|891960|P2|Overall Study|Unspecified|6
269219|NCT01115855|891961|P1|Overall Study|Unspecified|8
269220|NCT01115855|891960|P2|Overall Study|Withdrawal by Subject|5
269221|NCT01115855|891961|P1|Overall Study|Withdrawal by Subject|5
269222|NCT01115855|891960|P2|Overall Study|Protocol Violation|1
269223|NCT01115855|891961|P1|Overall Study|Protocol Violation|0
269224|NCT01115855|891960|P2|Overall Study|Lab Abnormality|1
269225|NCT01115855|891961|P1|Overall Study|Lab Abnormality|1
269226|NCT01115855|891960|P2|Overall Study|Death|5
269227|NCT01115855|891961|P1|Overall Study|Death|6
269228|NCT01115855|891960|P2|Overall Study|Adverse Event|18
269229|NCT01115855|891961|P1|Overall Study|Adverse Event|16
269230|NCT01115738|892012|P3|Overall Study|Withdrawal by Subject|9
269231|NCT01115738|892013|P2|Overall Study|Withdrawal by Subject|6
269232|NCT01115738|892014|P1|Overall Study|Withdrawal by Subject|6
269233|NCT01115738|892012|P3|Overall Study|Physician Decision|17
269234|NCT01115738|892013|P2|Overall Study|Physician Decision|15
269235|NCT01115738|892014|P1|Overall Study|Physician Decision|18
269236|NCT01115738|892012|P3|Overall Study|Lost to Follow-up|1
269237|NCT01115738|892013|P2|Overall Study|Lost to Follow-up|0
269238|NCT01115738|892014|P1|Overall Study|Lost to Follow-up|0
269239|NCT01115738|892012|P3|Overall Study|Death|0
269240|NCT01115738|892013|P2|Overall Study|Death|0
269241|NCT01115738|892014|P1|Overall Study|Death|1
269242|NCT01115569|892212|P2|Maintenance Phase|Administrative|1
269243|NCT01115569|892213|P1|Maintenance Phase|Administrative|0
269244|NCT01115569|892212|P2|Maintenance Phase|Non-Compliance with Study Drug|48
269245|NCT01115569|892213|P1|Maintenance Phase|Non-Compliance with Study Drug|0
269246|NCT01115569|892212|P2|Maintenance Phase|Withdrawal by Subject|27
269247|NCT01115569|892213|P1|Maintenance Phase|Withdrawal by Subject|0
269248|NCT01115569|892212|P2|Maintenance Phase|Protocol Violation|9
269249|NCT01115569|892213|P1|Maintenance Phase|Protocol Violation|0
269250|NCT01115569|892212|P2|Maintenance Phase|Physician Decision|3
269251|NCT01115569|892213|P1|Maintenance Phase|Physician Decision|0
269252|NCT01115569|892212|P2|Maintenance Phase|Lost to Follow-up|8
269253|NCT01115569|892213|P1|Maintenance Phase|Lost to Follow-up|0
269254|NCT01115569|892212|P2|Maintenance Phase|Adverse Event|43
269255|NCT01115569|892213|P1|Maintenance Phase|Adverse Event|0
269256|NCT01115569|892212|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
269257|NCT01115569|892213|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
269258|NCT01115569|892212|P2|Conversion/Titration Phase|Withdrawal by Subject|0
269259|NCT01115569|892213|P1|Conversion/Titration Phase|Withdrawal by Subject|26
269260|NCT01115569|892212|P2|Conversion/Titration Phase|Protocol Violation|0
269261|NCT01115569|892213|P1|Conversion/Titration Phase|Protocol Violation|68
269262|NCT01115569|892212|P2|Conversion/Titration Phase|Physician Decision|0
269263|NCT01115569|892213|P1|Conversion/Titration Phase|Physician Decision|5
269264|NCT01115569|892212|P2|Conversion/Titration Phase|Lost to Follow-up|0
269265|NCT01115569|892213|P1|Conversion/Titration Phase|Lost to Follow-up|3
269266|NCT01115569|892212|P2|Conversion/Titration Phase|Adverse Event|0
269267|NCT01115569|892213|P1|Conversion/Titration Phase|Adverse Event|59
269268|NCT01115491|892231|P1|Overall Study|Physician Decision|1
269269|NCT01115491|892231|P1|Overall Study|Withdrawal by Subject|1
269270|NCT01115491|892231|P1|Overall Study|Lost to Follow-up|3
269271|NCT01115491|892231|P1|Overall Study|Adverse Event|3
269272|NCT01115491|892231|P1|Overall Study|Death|22
269273|NCT01114880|892393|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
269274|NCT01114880|892394|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
269275|NCT01114880|892393|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
269276|NCT01114880|892394|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
269277|NCT01114880|892393|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
269278|NCT01114880|892394|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
269279|NCT01114880|892393|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
269280|NCT01114880|892394|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
269281|NCT01114880|892393|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
269282|NCT01114880|892394|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
269283|NCT01114880|892393|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
269284|NCT01114880|892394|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
269285|NCT01114828|892446|P2|Overall Study|Withdrawal by Subject|1
269286|NCT01114828|892447|P1|Overall Study|Withdrawal by Subject|0
269287|NCT01114828|892446|P2|Overall Study|Protocol Violation|0
269288|NCT01114828|892447|P1|Overall Study|Protocol Violation|2
269289|NCT01114828|892446|P2|Overall Study|Lack of Efficacy|2
269290|NCT01114828|892447|P1|Overall Study|Lack of Efficacy|0
269291|NCT01114828|892446|P2|Overall Study|Adverse Event|1
269292|NCT01114828|892447|P1|Overall Study|Adverse Event|1
269293|NCT01114737|892457|P2|Open-Label Treatment Period|Difficult Personal Events|0
269294|NCT01114737|892458|P1|Open-Label Treatment Period|Difficult Personal Events|1
269295|NCT01114737|892457|P2|Open-Label Treatment Period|Lost to Follow-up|1
269296|NCT01114737|892458|P1|Open-Label Treatment Period|Lost to Follow-up|3
269297|NCT01114737|892457|P2|Open-Label Treatment Period|Withdrawal by Subject|1
269298|NCT01114737|892458|P1|Open-Label Treatment Period|Withdrawal by Subject|1
269299|NCT01114737|892457|P2|Randomized Treatment Period|Pregnancy|0
269300|NCT01114737|892458|P1|Randomized Treatment Period|Pregnancy|1
269301|NCT01114737|892457|P2|Randomized Treatment Period|Lost to Follow-up|1
269302|NCT01114737|892458|P1|Randomized Treatment Period|Lost to Follow-up|1
269303|NCT01114737|892457|P2|Randomized Treatment Period|Withdrawal by Subject|0
269304|NCT01114737|892458|P1|Randomized Treatment Period|Withdrawal by Subject|1
269305|NCT01114724|892506|P1|Overall Study|Withdrawal by Subject|1
269306|NCT01114724|892506|P1|Overall Study|Lost to Follow-up|1
269307|NCT01114724|892506|P1|Overall Study|Death|8
269308|NCT01114672|892526|P2|Overall Study|transplanted|0
269309|NCT01114672|892527|P1|Overall Study|transplanted|1
269310|NCT01114672|892526|P2|Overall Study|Lost to Follow-up|0
269311|NCT01114672|892527|P1|Overall Study|Lost to Follow-up|1
269312|NCT01114672|892526|P2|Overall Study|Withdrawal by Subject|1
269313|NCT01114672|892527|P1|Overall Study|Withdrawal by Subject|2
269314|NCT01114672|892526|P2|Overall Study|Death|1
269315|NCT01114672|892527|P1|Overall Study|Death|0
269316|NCT01114529|892547|P3|Completed Study Phase at Month 24|Missing|0
269317|NCT01114529|892548|P2|Completed Study Phase at Month 24|Missing|0
269318|NCT01114529|892549|P1|Completed Study Phase at Month 24|Missing|2
269319|NCT01114529|892547|P3|Completed Study Phase at Month 24|Other|0
269320|NCT01114529|892548|P2|Completed Study Phase at Month 24|Other|0
269321|NCT01114529|892549|P1|Completed Study Phase at Month 24|Other|2
269322|NCT01114529|892547|P3|Completed Study Phase at Month 24|Death|4
269323|NCT01114529|892548|P2|Completed Study Phase at Month 24|Death|5
269324|NCT01114529|892549|P1|Completed Study Phase at Month 24|Death|8
269325|NCT01114529|892547|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
269326|NCT01114529|892548|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
269327|NCT01114529|892549|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
269328|NCT01114529|892547|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
269329|NCT01114529|892548|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
269330|NCT01114529|892549|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
269331|NCT01114529|892547|P3|Completed Study Medication at Month 24|Missing|0
269332|NCT01114529|892548|P2|Completed Study Medication at Month 24|Missing|0
269333|NCT01114529|892549|P1|Completed Study Medication at Month 24|Missing|2
269334|NCT01114529|892547|P3|Completed Study Medication at Month 24|Protocol Violation|2
269335|NCT01114529|892548|P2|Completed Study Medication at Month 24|Protocol Violation|5
269336|NCT01114529|892549|P1|Completed Study Medication at Month 24|Protocol Violation|0
269337|NCT01114529|892547|P3|Completed Study Medication at Month 24|Graft loss|0
269338|NCT01114529|892548|P2|Completed Study Medication at Month 24|Graft loss|2
269339|NCT01114529|892549|P1|Completed Study Medication at Month 24|Graft loss|0
269340|NCT01114529|892547|P3|Completed Study Medication at Month 24|Death|2
269341|NCT01114529|892548|P2|Completed Study Medication at Month 24|Death|1
269342|NCT01114529|892549|P1|Completed Study Medication at Month 24|Death|2
269343|NCT01114529|892547|P3|Completed Study Medication at Month 24|Administrative problems|2
269344|NCT01114529|892548|P2|Completed Study Medication at Month 24|Administrative problems|1
269345|NCT01114529|892549|P1|Completed Study Medication at Month 24|Administrative problems|2
269346|NCT01114529|892547|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
269347|NCT01114529|892548|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
269348|NCT01114529|892549|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
269349|NCT01114529|892547|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
269350|NCT01114529|892548|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
269351|NCT01114529|892549|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
269352|NCT01114529|892547|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
269353|NCT01114529|892548|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
269354|NCT01114529|892549|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
269355|NCT01114529|892547|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
269356|NCT01114529|892548|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
269357|NCT01114529|892549|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
269358|NCT01114529|892547|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
269359|NCT01114529|892548|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
269360|NCT01114529|892549|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
269361|NCT01114529|892547|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
269362|NCT01114529|892548|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
269363|NCT01114529|892549|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
269364|NCT01114529|892547|P3|Completed Study Medication at Month 24|Adverse Event|17
269365|NCT01114529|892548|P2|Completed Study Medication at Month 24|Adverse Event|18
269366|NCT01114529|892549|P1|Completed Study Medication at Month 24|Adverse Event|87
269367|NCT01114516|892568|P2|Overall Study|Lost to Follow-up|1
269368|NCT01114516|892569|P1|Overall Study|Lost to Follow-up|2
269369|NCT01114438|892583|P1|Overall Study|Withdrawal by Subject|2
269370|NCT01114438|892583|P1|Overall Study|Physician Decision|1
269371|NCT01114438|892583|P1|Overall Study|concomitant medication|1
269372|NCT01114438|892583|P1|Overall Study|Adverse Event|10
269373|NCT01114373|892593|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
269374|NCT01114373|892594|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
269375|NCT01114373|892593|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
269376|NCT01114373|892594|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
269377|NCT01114373|892593|P2|Intervention 1 (4 Weeks)|Incarceration|0
269378|NCT01114373|892594|P1|Intervention 1 (4 Weeks)|Incarceration|1
269379|NCT01114373|892593|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
269380|NCT01114373|892594|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
269381|NCT01114360|892626|P2|Intervention 1 (4 Weeks)|Physician Decision|1
269382|NCT01114360|892627|P1|Intervention 1 (4 Weeks)|Physician Decision|0
269383|NCT01113931|892678|P2|Overall Study|Withdrawal by Subject|0
269384|NCT01113931|892679|P1|Overall Study|Withdrawal by Subject|3
269385|NCT01113931|892678|P2|Overall Study|Various|4
269386|NCT01113931|892679|P1|Overall Study|Various|2
269387|NCT01113931|892678|P2|Overall Study|Lost to Follow-up|9
269388|NCT01113931|892679|P1|Overall Study|Lost to Follow-up|12
269389|NCT01113931|892678|P2|Overall Study|Physician Decision|2
269390|NCT01113931|892679|P1|Overall Study|Physician Decision|0
269391|NCT01113931|892678|P2|Overall Study|Adverse Event|2
269392|NCT01113931|892679|P1|Overall Study|Adverse Event|2
269393|NCT01113749|892693|P2|Overall Study|Lost to Follow-up|2
269394|NCT01113749|892694|P1|Overall Study|Lost to Follow-up|1
269395|NCT01113710|892717|P1|Overall Study|Subject Did Not Receive Neupro|3
269396|NCT01113710|892717|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
269397|NCT01113710|892717|P1|Overall Study|Lack of Patient's Compliance/Other|1
269398|NCT01113710|892717|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
269399|NCT01113710|892717|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
269400|NCT01113710|892717|P1|Overall Study|Compliance/Efficacy/AE/Other|1
269401|NCT01113710|892717|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
269402|NCT01113710|892717|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
269403|NCT01113710|892717|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
269404|NCT01113710|892717|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
269405|NCT01113710|892717|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
269406|NCT01113710|892717|P1|Overall Study|Lack of Efficacy/Adverse Event|3
269407|NCT01113710|892717|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
269408|NCT01113710|892717|P1|Overall Study|Lack of Efficacy/Other|4
269409|NCT01113710|892717|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
269410|NCT01113710|892717|P1|Overall Study|Adverse Event/Other|5
269411|NCT01113710|892717|P1|Overall Study|Other|7
269412|NCT01113710|892717|P1|Overall Study|Lack of Patient's Compliance|8
269413|NCT01113710|892717|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
269414|NCT01113710|892717|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
269415|NCT01113710|892717|P1|Overall Study|Lost to Follow-up|20
269416|NCT01113710|892717|P1|Overall Study|Withdrawal by Subject|28
269417|NCT01113710|892717|P1|Overall Study|No Information Available|40
269418|NCT01113710|892717|P1|Overall Study|Lack of Efficacy|41
269419|NCT01113710|892717|P1|Overall Study|Adverse Event|64
269420|NCT01113580|892745|P2|Overall Study|Protocol Violation|0
269421|NCT01113580|892746|P1|Overall Study|Protocol Violation|1
269422|NCT01113541|892760|P1|Overall Study|Adverse Event|4
269423|NCT01113541|892760|P1|Overall Study|Study Terminated by Sponsor|7
269424|NCT01113541|892760|P1|Overall Study|Protocol Violation|1
269425|NCT01113541|892760|P1|Overall Study|Withdrawal by Subject|1
269426|NCT01113463|892793|P1|Overall Study|Physician Decision|5
269427|NCT01112917|892823|P2|Overall Study|Unable to Convert Filter|0
269428|NCT01112917|892824|P1|Overall Study|Unable to Convert Filter|3
269429|NCT01112917|892823|P2|Overall Study|Withdrawal by Subject|3
269430|NCT01112917|892824|P1|Overall Study|Withdrawal by Subject|1
269431|NCT01112917|892823|P2|Overall Study|Lost to Follow-up|1
269432|NCT01112917|892824|P1|Overall Study|Lost to Follow-up|1
269433|NCT01112917|892823|P2|Overall Study|Death|11
269434|NCT01112917|892824|P1|Overall Study|Death|2
269435|NCT01112579|892900|P2|Overall Study|Death|2
269436|NCT01112579|892901|P1|Overall Study|Death|0
269437|NCT01112579|892900|P2|Overall Study|Missed Visit|1
269438|NCT01112579|892901|P1|Overall Study|Missed Visit|1
269439|NCT01112514|892911|P1|Overall Study|Lost to Follow-up|1
269440|NCT01112267|892917|P2|Overall Study|Participants not receive any study drug|2
269441|NCT01112267|892918|P1|Overall Study|Participants not receive any study drug|1
269442|NCT01112267|892917|P2|Overall Study|Participants not compliant|2
269443|NCT01112267|892918|P1|Overall Study|Participants not compliant|1
269444|NCT01112267|892917|P2|Overall Study|Protocol Violation|3
269445|NCT01112267|892918|P1|Overall Study|Protocol Violation|5
269446|NCT01112267|892917|P2|Overall Study|Withdrawal by Subject|5
269447|NCT01112267|892918|P1|Overall Study|Withdrawal by Subject|3
269448|NCT01112267|892917|P2|Overall Study|Adverse Event|6
269449|NCT01112267|892918|P1|Overall Study|Adverse Event|24
269450|NCT01112059|892951|P2|Overall Study|Withdrawal by Subject|0
269451|NCT01112059|892952|P1|Overall Study|Withdrawal by Subject|1
269452|NCT01111851|892966|P2|Overall Study|All planned PET scans were not obtained.|0
269453|NCT01111851|892967|P1|Overall Study|All planned PET scans were not obtained.|2
269454|NCT01111838|892979|P1|Overall Study|Other Complicating Disease|1
269455|NCT01111838|892979|P1|Overall Study|Clinical deterioration|1
269456|NCT01111838|892979|P1|Overall Study|Not Treated|3
269457|NCT01111838|892979|P1|Overall Study|Patient Ineligible|2
269458|NCT01111526|892983|P3|Overall Study|GVHD Disease Progression|2
269459|NCT01111526|892984|P2|Overall Study|GVHD Disease Progression|1
269460|NCT01111526|892985|P1|Overall Study|GVHD Disease Progression|0
269461|NCT01111461|892997|P1|Overall Study|Not specified|6
269462|NCT01111461|892997|P1|Overall Study|Withdrawal by Subject|1
269463|NCT01111461|892997|P1|Overall Study|Lost to Follow-up|1
269464|NCT01111461|892997|P1|Overall Study|Participant choice|11
269465|NCT01111461|892997|P1|Overall Study|Adverse Event|32
269466|NCT01111292|893177|P2|Treatment|Physician Decision|1
269467|NCT01111292|893178|P1|Treatment|Physician Decision|1
269468|NCT01111240|893184|P1|Overall Study|Not Specified|312
269469|NCT01111240|893184|P1|Overall Study|Lack of Efficacy and Adverse Event|19
269470|NCT01111240|893184|P1|Overall Study|Lack of Efficacy|545
269471|NCT01111240|893184|P1|Overall Study|Adverse Event|190
269472|NCT01111149|893214|P3|Overall Study|Withdrawal by Subject|2
269473|NCT01111149|893215|P2|Overall Study|Withdrawal by Subject|0
269474|NCT01111149|893216|P1|Overall Study|Withdrawal by Subject|1
269475|NCT01111149|893214|P3|Overall Study|Protocol Violation|2
269476|NCT01111149|893215|P2|Overall Study|Protocol Violation|1
269477|NCT01111149|893216|P1|Overall Study|Protocol Violation|1
269478|NCT01111123|893292|P2|Maintenance Phase|Lost to Follow-up|2
269479|NCT01111123|893293|P1|Maintenance Phase|Lost to Follow-up|0
269480|NCT01111123|893292|P2|Open- Label Phase|Failed to be clear or almost cleared|0
269481|NCT01111123|893293|P1|Open- Label Phase|Failed to be clear or almost cleared|14
269482|NCT01110915|893327|P2|Overall Study|Withdrawal by Subject|1
269483|NCT01110915|893328|P1|Overall Study|Withdrawal by Subject|7
269484|NCT01110915|893327|P2|Overall Study|Lost to Follow-up|0
269485|NCT01110915|893328|P1|Overall Study|Lost to Follow-up|1
269486|NCT01110915|893327|P2|Overall Study|Death|1
269487|NCT01110915|893328|P1|Overall Study|Death|2
269488|NCT01110408|893401|P2|Overall Study|Protocol Violation|0
269489|NCT01110408|893402|P1|Overall Study|Protocol Violation|1
269490|NCT01110382|893422|P2|Overall Study|Protocol Violation|1
269491|NCT01110382|893423|P1|Overall Study|Protocol Violation|0
269492|NCT01110382|893422|P2|Overall Study|Withdrawal by Subject|1
269493|NCT01110382|893423|P1|Overall Study|Withdrawal by Subject|0
269494|NCT01110330|893444|P3|Overall Study|Not specified|1
269495|NCT01110330|893445|P2|Overall Study|Not specified|1
269496|NCT01110330|893446|P1|Overall Study|Not specified|1
269497|NCT01110330|893444|P3|Overall Study|Withdrawal by Subject|2
269498|NCT01110330|893445|P2|Overall Study|Withdrawal by Subject|6
269499|NCT01110330|893446|P1|Overall Study|Withdrawal by Subject|0
269500|NCT01110330|893444|P3|Overall Study|Protocol Violation|4
269501|NCT01110330|893445|P2|Overall Study|Protocol Violation|0
269502|NCT01110330|893446|P1|Overall Study|Protocol Violation|2
269503|NCT01110330|893444|P3|Overall Study|Physician Decision|0
269504|NCT01110330|893445|P2|Overall Study|Physician Decision|1
269505|NCT01110330|893446|P1|Overall Study|Physician Decision|0
269506|NCT01110330|893444|P3|Overall Study|Lost to Follow-up|15
269507|NCT01110330|893445|P2|Overall Study|Lost to Follow-up|10
269508|NCT01110330|893446|P1|Overall Study|Lost to Follow-up|9
269509|NCT01110330|893444|P3|Overall Study|Lack of Efficacy|1
269510|NCT01110330|893445|P2|Overall Study|Lack of Efficacy|1
269511|NCT01110330|893446|P1|Overall Study|Lack of Efficacy|3
269512|NCT01110330|893444|P3|Overall Study|Adverse Event|3
269513|NCT01110330|893445|P2|Overall Study|Adverse Event|4
269514|NCT01110330|893446|P1|Overall Study|Adverse Event|0
269515|NCT01110239|893474|P4|7.5 Min Ischemia|Withdrawal by Subject|0
269516|NCT01110239|893475|P3|7.5 Min Ischemia|Withdrawal by Subject|1
269517|NCT01110239|893476|P2|7.5 Min Ischemia|Withdrawal by Subject|0
269518|NCT01110239|893477|P1|7.5 Min Ischemia|Withdrawal by Subject|0
269519|NCT01110239|893474|P4|Sham Preconditioning|Withdrawal by Subject|0
269520|NCT01110239|893475|P3|Sham Preconditioning|Withdrawal by Subject|1
269521|NCT01110239|893476|P2|Sham Preconditioning|Withdrawal by Subject|0
269522|NCT01110239|893477|P1|Sham Preconditioning|Withdrawal by Subject|0
269523|NCT01110200|893493|P2|Overall Study|Lost to Follow-up|7
269524|NCT01110200|893494|P1|Overall Study|Lost to Follow-up|10
269525|NCT01110200|893493|P2|Overall Study|Physician Decision|17
269526|NCT01110200|893494|P1|Overall Study|Physician Decision|13
269527|NCT01110200|893493|P2|Overall Study|Protocol Violation|12
269528|NCT01110200|893494|P1|Overall Study|Protocol Violation|14
269529|NCT01110200|893493|P2|Overall Study|Lack of Efficacy|25
269530|NCT01110200|893494|P1|Overall Study|Lack of Efficacy|16
269531|NCT01110200|893493|P2|Overall Study|Withdrawal by Subject|32
269532|NCT01110200|893494|P1|Overall Study|Withdrawal by Subject|25
269533|NCT01110200|893493|P2|Overall Study|Adverse Event|28
269534|NCT01110200|893494|P1|Overall Study|Adverse Event|28
269535|NCT01110005|893525|P2|Overall Study|Withdrawal by Subject|1
269536|NCT01110005|893526|P1|Overall Study|Withdrawal by Subject|0
269537|NCT01110005|893525|P2|Overall Study|missing consent|2
269538|NCT01110005|893526|P1|Overall Study|missing consent|3
269539|NCT01110005|893525|P2|Overall Study|ineligible|2
269540|NCT01110005|893526|P1|Overall Study|ineligible|1
269541|NCT01109979|893538|P2|Overall Study|Withdrawal by Subject|1
269542|NCT01109979|893539|P1|Overall Study|Withdrawal by Subject|0
269543|NCT01109979|893538|P2|Overall Study|Physician Decision|0
269544|NCT01109979|893539|P1|Overall Study|Physician Decision|2
269545|NCT01109524|893565|P1|Overall Study|Not specified|5
269546|NCT01109524|893565|P1|Overall Study|Participant requested to end treatment|4
269547|NCT01109524|893565|P1|Overall Study|No longer meets criteria|2
269548|NCT01109524|893565|P1|Overall Study|Death|2
269549|NCT01109524|893565|P1|Overall Study|Maximum clinical benefit|3
269550|NCT01109524|893565|P1|Overall Study|Withdrawal by Subject|2
269551|NCT01109524|893565|P1|Overall Study|Adverse Event|4
269552|NCT01109524|893565|P1|Overall Study|Study Drug toxicity|6
269553|NCT01109524|893565|P1|Overall Study|Disease Progression|29
269554|NCT01109316|893587|P3|Study Period 3|Withdrawal by Subject|1
269555|NCT01109316|893588|P2|Study Period 3|Withdrawal by Subject|1
269556|NCT01109316|893589|P1|Study Period 3|Withdrawal by Subject|0
269557|NCT01109316|893587|P3|Study Period 3|Lost to Follow-up|0
269558|NCT01109316|893588|P2|Study Period 3|Lost to Follow-up|1
269559|NCT01109316|893589|P1|Study Period 3|Lost to Follow-up|0
269560|NCT01109316|893587|P3|Study Period 2|Withdrawal by Subject|0
269561|NCT01109316|893588|P2|Study Period 2|Withdrawal by Subject|1
269562|NCT01109316|893589|P1|Study Period 2|Withdrawal by Subject|1
269563|NCT01109316|893587|P3|Study Period 2|Protocol Violation|0
269564|NCT01109316|893588|P2|Study Period 2|Protocol Violation|1
269565|NCT01109316|893589|P1|Study Period 2|Protocol Violation|0
269566|NCT01109316|893587|P3|Study Period 2|Physician Decision|1
269567|NCT01109316|893588|P2|Study Period 2|Physician Decision|0
269568|NCT01109316|893589|P1|Study Period 2|Physician Decision|0
269569|NCT01109316|893587|P3|Study Period 2|Entry Criteria Not Met|1
269570|NCT01109316|893588|P2|Study Period 2|Entry Criteria Not Met|0
269571|NCT01109316|893589|P1|Study Period 2|Entry Criteria Not Met|0
269572|NCT01109316|893587|P3|Study Period 1|Sponsor Decision|2
269573|NCT01109316|893588|P2|Study Period 1|Sponsor Decision|0
269574|NCT01109316|893589|P1|Study Period 1|Sponsor Decision|0
269575|NCT01109316|893587|P3|Study Period 1|Withdrawal by Subject|2
269576|NCT01109316|893588|P2|Study Period 1|Withdrawal by Subject|1
269577|NCT01109316|893589|P1|Study Period 1|Withdrawal by Subject|0
269578|NCT01109316|893587|P3|Study Period 1|Lost to Follow-up|0
269579|NCT01109316|893588|P2|Study Period 1|Lost to Follow-up|2
269580|NCT01109316|893589|P1|Study Period 1|Lost to Follow-up|0
269581|NCT01109316|893587|P3|Study Period 1|Adverse Event|0
269582|NCT01109316|893588|P2|Study Period 1|Adverse Event|1
269583|NCT01109316|893589|P1|Study Period 1|Adverse Event|0
269584|NCT01109173|893637|P4|Overall Study|Not Specifiied|14
269585|NCT01109173|893638|P3|Overall Study|Not Specifiied|9
269586|NCT01109173|893639|P2|Overall Study|Not Specifiied|4
269587|NCT01109173|893640|P1|Overall Study|Not Specifiied|5
269588|NCT01109173|893637|P4|Overall Study|Patient Did Not Use Study Medication|7
269589|NCT01109173|893638|P3|Overall Study|Patient Did Not Use Study Medication|11
269590|NCT01109173|893639|P2|Overall Study|Patient Did Not Use Study Medication|26
269591|NCT01109173|893640|P1|Overall Study|Patient Did Not Use Study Medication|34
269592|NCT01109173|893637|P4|Overall Study|Protocol Violation|2
269593|NCT01109173|893638|P3|Overall Study|Protocol Violation|1
269594|NCT01109173|893639|P2|Overall Study|Protocol Violation|5
269595|NCT01109173|893640|P1|Overall Study|Protocol Violation|4
269596|NCT01109173|893637|P4|Overall Study|Treatment Failure|64
269597|NCT01109173|893638|P3|Overall Study|Treatment Failure|69
269598|NCT01109173|893639|P2|Overall Study|Treatment Failure|32
269599|NCT01109173|893640|P1|Overall Study|Treatment Failure|25
269600|NCT01109173|893637|P4|Overall Study|Noncompliance|0
269601|NCT01109173|893638|P3|Overall Study|Noncompliance|0
269602|NCT01109173|893639|P2|Overall Study|Noncompliance|1
269603|NCT01109173|893640|P1|Overall Study|Noncompliance|0
269604|NCT01109173|893637|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
269605|NCT01109173|893638|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
269606|NCT01109173|893639|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
269607|NCT01109173|893640|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
269608|NCT01109173|893637|P4|Overall Study|Lost to Follow-up|0
269609|NCT01109173|893638|P3|Overall Study|Lost to Follow-up|0
269610|NCT01109173|893639|P2|Overall Study|Lost to Follow-up|1
269611|NCT01109173|893640|P1|Overall Study|Lost to Follow-up|0
269612|NCT01109173|893637|P4|Overall Study|Adverse Event|6
269613|NCT01109173|893638|P3|Overall Study|Adverse Event|9
269614|NCT01109173|893639|P2|Overall Study|Adverse Event|17
269615|NCT01109173|893640|P1|Overall Study|Adverse Event|15
269616|NCT01108809|893706|P1|Overall Study|Lost to Follow-up|1
269617|NCT01108809|893706|P1|Overall Study|Adverse Event|3
269618|NCT01108796|893723|P2|Overall Study|Lost to Follow-up|6
269619|NCT01108796|893724|P1|Overall Study|Lost to Follow-up|7
269620|NCT01108796|893723|P2|Overall Study|Adverse Event|1
269621|NCT01108796|893724|P1|Overall Study|Adverse Event|0
269622|NCT01108731|893758|P2|Overall Study|Adverse Event|3
269623|NCT01108731|893759|P1|Overall Study|Adverse Event|3
269624|NCT01108731|893758|P2|Overall Study|Withdrawal by Subject|1
269625|NCT01108731|893759|P1|Overall Study|Withdrawal by Subject|1
269626|NCT01108718|893771|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
269627|NCT01108718|893772|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
269628|NCT01108523|893777|P1|Overall Study|Protocol Violation|4
269629|NCT01108510|893784|P2|Overall Study|Death|1
269630|NCT01108510|893785|P1|Overall Study|Death|1
269631|NCT01108510|893784|P2|Overall Study|Pregnancy|3
269632|NCT01108510|893785|P1|Overall Study|Pregnancy|0
269633|NCT01108510|893784|P2|Overall Study|Lack of Efficacy|0
269634|NCT01108510|893785|P1|Overall Study|Lack of Efficacy|3
269635|NCT01108510|893784|P2|Overall Study|Participant Noncompliance|7
269636|NCT01108510|893785|P1|Overall Study|Participant Noncompliance|5
269637|NCT01108510|893784|P2|Overall Study|Investigator’s Discretion|10
269638|NCT01108510|893785|P1|Overall Study|Investigator’s Discretion|12
269639|NCT01108510|893784|P2|Overall Study|Withdrew Consent|15
269640|NCT01108510|893785|P1|Overall Study|Withdrew Consent|21
269641|NCT01108510|893784|P2|Overall Study|Lost to Follow-up|17
269642|NCT01108510|893785|P1|Overall Study|Lost to Follow-up|20
269643|NCT01108510|893784|P2|Overall Study|Adverse Event|19
269644|NCT01108510|893785|P1|Overall Study|Adverse Event|26
269645|NCT01108510|893784|P2|Overall Study|Joined Another Gilead-sponsored Study|195
269646|NCT01108510|893785|P1|Overall Study|Joined Another Gilead-sponsored Study|186
269647|NCT01108510|893784|P2|Overall Study|Randomized but Not Treated|1
269648|NCT01108510|893785|P1|Overall Study|Randomized but Not Treated|5
269649|NCT01108458|893805|P1|Overall Study|Withdrawal by Subject|1
269650|NCT01108341|893857|P1|Overall Study|not specified|1
269651|NCT01108341|893857|P1|Overall Study|Lost to Follow-up|1
269652|NCT01108341|893857|P1|Overall Study|Withdrawal by Subject|1
269653|NCT01108341|893857|P1|Overall Study|Death|2
269654|NCT01108263|893864|P2|Overall Study|Adverse Event|1
269655|NCT01108263|893865|P1|Overall Study|Adverse Event|0
269656|NCT01108237|893875|P2|Overall Study|Did not meet criteria for analysis|0
269657|NCT01108237|893876|P1|Overall Study|Did not meet criteria for analysis|7
269658|NCT01108237|893875|P2|Overall Study|No alignment data|17
269659|NCT01108237|893876|P1|Overall Study|No alignment data|2
269660|NCT01108185|893882|P1|Overall Study|Lost to Follow-up|12
269661|NCT01108185|893882|P1|Overall Study|Non-compliance|15
269662|NCT01108055|893916|P1|Overall Study|Not evaluable- didn't complete treatment|4
269663|NCT01108055|893916|P1|Overall Study|Ineligible|11
269664|NCT01107925|893939|P6|Period 2|Withdrawal by Subject|1
269665|NCT01107925|893940|P5|Period 2|Withdrawal by Subject|0
269666|NCT01107925|893941|P4|Period 2|Withdrawal by Subject|0
269667|NCT01107925|893942|P3|Period 2|Withdrawal by Subject|0
269668|NCT01107925|893943|P2|Period 2|Withdrawal by Subject|1
269669|NCT01107925|893944|P1|Period 2|Withdrawal by Subject|0
269670|NCT01107925|893939|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
269671|NCT01107925|893940|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
269672|NCT01107925|893941|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
269673|NCT01107925|893942|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
269674|NCT01107925|893943|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
269675|NCT01107925|893944|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
269676|NCT01107912|893982|P6|Period 3|Withdrawal by Subject|0
269677|NCT01107912|893983|P5|Period 3|Withdrawal by Subject|0
269678|NCT01107912|893984|P4|Period 3|Withdrawal by Subject|1
269679|NCT01107912|893985|P3|Period 3|Withdrawal by Subject|0
269680|NCT01107912|893986|P2|Period 3|Withdrawal by Subject|0
269681|NCT01107912|893987|P1|Period 3|Withdrawal by Subject|0
269682|NCT01107912|893982|P6|Period 3|Adverse Event|0
269683|NCT01107912|893983|P5|Period 3|Adverse Event|0
269684|NCT01107912|893984|P4|Period 3|Adverse Event|0
269685|NCT01107912|893985|P3|Period 3|Adverse Event|1
269686|NCT01107912|893986|P2|Period 3|Adverse Event|1
269687|NCT01107912|893987|P1|Period 3|Adverse Event|0
269688|NCT01107912|893982|P6|Period 2|Physician Decision|0
269689|NCT01107912|893983|P5|Period 2|Physician Decision|0
269690|NCT01107912|893984|P4|Period 2|Physician Decision|0
269691|NCT01107912|893985|P3|Period 2|Physician Decision|1
269692|NCT01107912|893986|P2|Period 2|Physician Decision|0
269693|NCT01107912|893987|P1|Period 2|Physician Decision|0
269694|NCT01107912|893982|P6|Period 1|Withdrawal by Subject|0
269695|NCT01107912|893983|P5|Period 1|Withdrawal by Subject|0
269696|NCT01107912|893984|P4|Period 1|Withdrawal by Subject|0
269697|NCT01107912|893985|P3|Period 1|Withdrawal by Subject|0
269698|NCT01107912|893986|P2|Period 1|Withdrawal by Subject|0
269699|NCT01107912|893987|P1|Period 1|Withdrawal by Subject|1
269700|NCT01107912|893982|P6|Period 1|Physician Decision|0
269701|NCT01107912|893983|P5|Period 1|Physician Decision|1
269702|NCT01107912|893984|P4|Period 1|Physician Decision|0
269703|NCT01107912|893985|P3|Period 1|Physician Decision|0
269704|NCT01107912|893986|P2|Period 1|Physician Decision|0
269705|NCT01107912|893987|P1|Period 1|Physician Decision|0
269706|NCT01107912|893982|P6|Period 1|Adverse Event|0
269707|NCT01107912|893983|P5|Period 1|Adverse Event|2
269708|NCT01107912|893984|P4|Period 1|Adverse Event|0
269709|NCT01107912|893985|P3|Period 1|Adverse Event|0
269710|NCT01107912|893986|P2|Period 1|Adverse Event|0
269711|NCT01107912|893987|P1|Period 1|Adverse Event|0
269712|NCT01107899|894024|P3|Overall Study|Withdrawal by Subject|1
269713|NCT01107899|894025|P2|Overall Study|Withdrawal by Subject|0
269714|NCT01107899|894026|P1|Overall Study|Withdrawal by Subject|0
269715|NCT01107899|894024|P3|Overall Study|Physician Decision|3
269716|NCT01107899|894025|P2|Overall Study|Physician Decision|0
269717|NCT01107899|894026|P1|Overall Study|Physician Decision|5
269718|NCT01107886|894072|P2|Overall Study|Administrative withdrawal of consent|5
269719|NCT01107886|894073|P1|Overall Study|Administrative withdrawal of consent|7
269720|NCT01107886|894072|P2|Overall Study|Withdrawal by Subject|196
269721|NCT01107886|894073|P1|Overall Study|Withdrawal by Subject|180
269722|NCT01107886|894072|P2|Overall Study|Lost to Follow-up|13
269723|NCT01107886|894073|P1|Overall Study|Lost to Follow-up|15
269724|NCT01107743|894102|P1|Overall Study|Protocol Violation|46
269725|NCT01107535|894201|P1|Overall Study|Death|5
269726|NCT01107418|894213|P1|Overall Study|Entered Extension Study|1
269727|NCT01107418|894213|P1|Overall Study|Started Other Therapy|1
269728|NCT01107418|894213|P1|Overall Study|Study Closing|1
269729|NCT01107418|894213|P1|Overall Study|Withdrawal by Subject|1
269730|NCT01107418|894213|P1|Overall Study|Adverse Event|3
269731|NCT01107418|894213|P1|Overall Study|Disease Progression|45
269732|NCT01107405|894286|P5|Overall Study|Protocol Violation|0
269733|NCT01107405|894287|P4|Overall Study|Protocol Violation|1
269734|NCT01107405|894288|P3|Overall Study|Protocol Violation|1
269735|NCT01107405|894289|P2|Overall Study|Protocol Violation|0
269736|NCT01107405|894290|P1|Overall Study|Protocol Violation|0
269737|NCT01107405|894286|P5|Overall Study|Withdrawal by Subject|1
269738|NCT01107405|894287|P4|Overall Study|Withdrawal by Subject|2
269739|NCT01107405|894288|P3|Overall Study|Withdrawal by Subject|1
269740|NCT01107405|894289|P2|Overall Study|Withdrawal by Subject|0
269741|NCT01107405|894290|P1|Overall Study|Withdrawal by Subject|1
269742|NCT01107405|894286|P5|Overall Study|Adverse Event|2
269743|NCT01107405|894287|P4|Overall Study|Adverse Event|0
269744|NCT01107405|894288|P3|Overall Study|Adverse Event|0
269745|NCT01107405|894289|P2|Overall Study|Adverse Event|1
269746|NCT01107405|894290|P1|Overall Study|Adverse Event|1
269747|NCT01107392|894329|P2|Overall Study|Administrative decision|0
269748|NCT01107392|894330|P1|Overall Study|Administrative decision|1
269749|NCT01107392|894329|P2|Overall Study|Personal Reasons|3
269750|NCT01107392|894330|P1|Overall Study|Personal Reasons|2
269751|NCT01107392|894329|P2|Overall Study|Adverse Event|0
269752|NCT01107392|894330|P1|Overall Study|Adverse Event|2
269753|NCT01107379|894342|P1|Overall Study|Lost to Follow-up|3
269754|NCT01107379|894342|P1|Overall Study|Withdrawal by Subject|18
269755|NCT01107353|894353|P2|Overall Study|Positive Drug Screen|0
269756|NCT01107353|894354|P1|Overall Study|Positive Drug Screen|1
269757|NCT01107197|894362|P2|Overall Study|Withdrawal by Subject|5
269758|NCT01107197|894363|P1|Overall Study|Withdrawal by Subject|3
269759|NCT01107197|894362|P2|Overall Study|Lost to Follow-up|8
269760|NCT01107197|894363|P1|Overall Study|Lost to Follow-up|5
269761|NCT01107197|894362|P2|Overall Study|Death|10
269762|NCT01107197|894363|P1|Overall Study|Death|12
269763|NCT01106976|894381|P1|Overall Study|Lost to Follow-up|8
269764|NCT01106911|894395|P1|Overall Study|deemed ineligible after screening|3
269765|NCT01106911|894395|P1|Overall Study|Physician Decision|2
269766|NCT01106846|894440|P2|Overall Study|Change in surgical procedure|1
269767|NCT01106846|894441|P1|Overall Study|Change in surgical procedure|0
269768|NCT01106690|894450|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
269769|NCT01106690|894451|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
269770|NCT01106690|894452|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
269771|NCT01106690|894450|P3|Extension Period: Week 26 to Week 52|Not specified|4
269772|NCT01106690|894451|P2|Extension Period: Week 26 to Week 52|Not specified|3
269773|NCT01106690|894452|P1|Extension Period: Week 26 to Week 52|Not specified|8
269774|NCT01106690|894450|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
269775|NCT01106690|894451|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
269776|NCT01106690|894452|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
269777|NCT01106690|894450|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
269778|NCT01106690|894451|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
269779|NCT01106690|894452|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
269780|NCT01106690|894450|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
269781|NCT01106690|894451|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
269782|NCT01106690|894452|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
269783|NCT01106690|894450|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
269784|NCT01106690|894451|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
269785|NCT01106690|894452|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
269786|NCT01106690|894450|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
269787|NCT01106690|894451|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
269788|NCT01106690|894452|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
269789|NCT01106690|894450|P3|Core Period: Baseline to Week 26|Not specified|6
269790|NCT01106690|894451|P2|Core Period: Baseline to Week 26|Not specified|2
269791|NCT01106690|894452|P1|Core Period: Baseline to Week 26|Not specified|10
269792|NCT01106690|894450|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
269793|NCT01106690|894451|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
269794|NCT01106690|894452|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
269795|NCT01106690|894450|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
269796|NCT01106690|894451|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
269797|NCT01106690|894452|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
269798|NCT01106690|894450|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
269799|NCT01106690|894451|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
269800|NCT01106690|894452|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
269801|NCT01106690|894450|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
269802|NCT01106690|894451|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
269803|NCT01106690|894452|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
269804|NCT01106690|894450|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
269805|NCT01106690|894451|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
269806|NCT01106690|894452|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
269807|NCT01106690|894450|P3|Core Period: Baseline to Week 26|Protocol Violation|0
269808|NCT01106690|894451|P2|Core Period: Baseline to Week 26|Protocol Violation|0
269809|NCT01106690|894452|P1|Core Period: Baseline to Week 26|Protocol Violation|1
269810|NCT01106690|894450|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
269811|NCT01106690|894451|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
269812|NCT01106690|894452|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
269813|NCT01106690|894450|P3|Core Period: Baseline to Week 26|Adverse Event|4
269814|NCT01106690|894451|P2|Core Period: Baseline to Week 26|Adverse Event|1
269815|NCT01106690|894452|P1|Core Period: Baseline to Week 26|Adverse Event|6
269816|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Not specified|5
269817|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Not specified|8
269818|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Not specified|5
269819|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Not specified|6
269820|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
269821|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
269822|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
269823|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
269824|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
269825|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
269826|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
269827|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
269828|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
269829|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
269830|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
269831|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
269832|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
269833|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
269834|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
269835|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
269836|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
269837|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
269838|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
269839|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
269840|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
269841|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
269842|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
269843|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
269844|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
269845|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
269846|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
269847|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
269848|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Death|1
269849|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Death|0
269850|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Death|0
269851|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Death|0
269852|NCT01106677|894488|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
269853|NCT01106677|894489|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
269854|NCT01106677|894490|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
269855|NCT01106677|894491|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
269856|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Pregnancy|0
269857|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Pregnancy|0
269858|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Pregnancy|1
269859|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Pregnancy|0
269860|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Not specified|23
269861|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Not specified|8
269862|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Not specified|14
269863|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Not specified|8
269864|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Product quality complaint|0
269865|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Product quality complaint|1
269866|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Product quality complaint|1
269867|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Product quality complaint|0
269868|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
269869|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
269870|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
269871|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
269872|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
269873|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
269874|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
269875|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
269876|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
269877|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
269878|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
269879|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
269880|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
269881|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
269882|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
269883|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
269884|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Protocol Violation|3
269885|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Protocol Violation|0
269886|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Protocol Violation|1
269887|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Protocol Violation|0
269888|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Physician Decision|1
269889|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Physician Decision|3
269890|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Physician Decision|1
269891|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Physician Decision|2
269892|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
269893|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
269894|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
269895|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
269896|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
269897|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
269898|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
269899|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
269900|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Death|0
269901|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Death|1
269902|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Death|0
269903|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Death|0
269904|NCT01106677|894488|P4|Core Period: Baseline to Week 26|Adverse Event|8
269905|NCT01106677|894489|P3|Core Period: Baseline to Week 26|Adverse Event|6
269906|NCT01106677|894490|P2|Core Period: Baseline to Week 26|Adverse Event|18
269907|NCT01106677|894491|P1|Core Period: Baseline to Week 26|Adverse Event|7
269908|NCT01106651|894554|P3|Overall Study|Death|0
269909|NCT01106651|894555|P2|Overall Study|Death|3
269910|NCT01106651|894556|P1|Overall Study|Death|0
269911|NCT01106651|894554|P3|Overall Study|Not specified|21
269912|NCT01106651|894555|P2|Overall Study|Not specified|31
269913|NCT01106651|894556|P1|Overall Study|Not specified|34
269914|NCT01106651|894554|P3|Overall Study|Noncompliance with study drug|2
269915|NCT01106651|894555|P2|Overall Study|Noncompliance with study drug|0
269916|NCT01106651|894556|P1|Overall Study|Noncompliance with study drug|1
269917|NCT01106651|894554|P3|Overall Study|Withdrawal by Subject|4
269918|NCT01106651|894555|P2|Overall Study|Withdrawal by Subject|7
269919|NCT01106651|894556|P1|Overall Study|Withdrawal by Subject|14
269920|NCT01106651|894554|P3|Overall Study|Protocol Violation|1
269921|NCT01106651|894555|P2|Overall Study|Protocol Violation|2
269922|NCT01106651|894556|P1|Overall Study|Protocol Violation|1
269923|NCT01106651|894554|P3|Overall Study|Physician Decision|1
269924|NCT01106651|894555|P2|Overall Study|Physician Decision|3
269925|NCT01106651|894556|P1|Overall Study|Physician Decision|4
269926|NCT01106651|894554|P3|Overall Study|Lost to Follow-up|6
269927|NCT01106651|894555|P2|Overall Study|Lost to Follow-up|2
269928|NCT01106651|894556|P1|Overall Study|Lost to Follow-up|8
269929|NCT01106651|894554|P3|Overall Study|Adverse Event|23
269930|NCT01106651|894555|P2|Overall Study|Adverse Event|9
269931|NCT01106651|894556|P1|Overall Study|Adverse Event|17
269932|NCT01106625|894609|P3|Extension Period: Week 26 to Week 52|Not specified|4
269933|NCT01106625|894610|P2|Extension Period: Week 26 to Week 52|Not specified|5
269934|NCT01106625|894611|P1|Extension Period: Week 26 to Week 52|Not specified|5
269935|NCT01106625|894609|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
269936|NCT01106625|894610|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
269937|NCT01106625|894611|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
269938|NCT01106625|894609|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
269939|NCT01106625|894610|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
269940|NCT01106625|894611|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
269941|NCT01106625|894609|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
269942|NCT01106625|894610|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
269943|NCT01106625|894611|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
269944|NCT01106625|894609|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
269945|NCT01106625|894610|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
269946|NCT01106625|894611|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
269947|NCT01106625|894609|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
269948|NCT01106625|894610|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
269949|NCT01106625|894611|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
269950|NCT01106625|894609|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
269951|NCT01106625|894610|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
269952|NCT01106625|894611|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
269953|NCT01106625|894609|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
269954|NCT01106625|894610|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
269955|NCT01106625|894611|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
269956|NCT01106625|894609|P3|Core Period: Baseline to Week 26|Not specified|4
269957|NCT01106625|894610|P2|Core Period: Baseline to Week 26|Not specified|7
269958|NCT01106625|894611|P1|Core Period: Baseline to Week 26|Not specified|8
269959|NCT01106625|894609|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
269960|NCT01106625|894610|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
269961|NCT01106625|894611|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
269962|NCT01106625|894609|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
269963|NCT01106625|894610|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
269964|NCT01106625|894611|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
269965|NCT01106625|894609|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
269966|NCT01106625|894610|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
269967|NCT01106625|894611|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
269968|NCT01106625|894609|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
269969|NCT01106625|894610|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
269970|NCT01106625|894611|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
269971|NCT01106625|894609|P3|Core Period: Baseline to Week 26|Protocol Violation|3
269972|NCT01106625|894610|P2|Core Period: Baseline to Week 26|Protocol Violation|1
269973|NCT01106625|894611|P1|Core Period: Baseline to Week 26|Protocol Violation|2
269974|NCT01106625|894609|P3|Core Period: Baseline to Week 26|Physician Decision|0
269975|NCT01106625|894610|P2|Core Period: Baseline to Week 26|Physician Decision|0
269976|NCT01106625|894611|P1|Core Period: Baseline to Week 26|Physician Decision|1
269977|NCT01106625|894609|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
269978|NCT01106625|894610|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
269979|NCT01106625|894611|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
269980|NCT01106625|894609|P3|Core Period: Baseline to Week 26|Adverse Event|8
269981|NCT01106625|894610|P2|Core Period: Baseline to Week 26|Adverse Event|8
269982|NCT01106625|894611|P1|Core Period: Baseline to Week 26|Adverse Event|6
269983|NCT01106586|894642|P2|Overall Study|Participant Transferred to Another Study|197
269984|NCT01106586|894643|P1|Overall Study|Participant Transferred to Another Study|212
269985|NCT01106586|894642|P2|Overall Study|Protocol Violation|0
269986|NCT01106586|894643|P1|Overall Study|Protocol Violation|1
269987|NCT01106586|894642|P2|Overall Study|Participant Noncompliance|10
269988|NCT01106586|894643|P1|Overall Study|Participant Noncompliance|12
269989|NCT01106586|894642|P2|Overall Study|Lost to Follow-up|20
269990|NCT01106586|894643|P1|Overall Study|Lost to Follow-up|24
269991|NCT01106586|894642|P2|Overall Study|Withdrew Consent|30
269992|NCT01106586|894643|P1|Overall Study|Withdrew Consent|18
269993|NCT01106586|894642|P2|Overall Study|Investigator's Discretion|8
269994|NCT01106586|894643|P1|Overall Study|Investigator's Discretion|5
269995|NCT01106586|894642|P2|Overall Study|Lack of Efficacy|0
269996|NCT01106586|894643|P1|Overall Study|Lack of Efficacy|1
269997|NCT01106586|894642|P2|Overall Study|Pregnancy|2
269998|NCT01106586|894643|P1|Overall Study|Pregnancy|2
269999|NCT01106586|894642|P2|Overall Study|Death|3
270000|NCT01106586|894643|P1|Overall Study|Death|1
270001|NCT01106586|894642|P2|Overall Study|Adverse Event|15
270002|NCT01106586|894643|P1|Overall Study|Adverse Event|9
270003|NCT01106534|894661|P1|Overall Study|Physician Decision|1
270004|NCT01106534|894661|P1|Overall Study|Death|16
270005|NCT01106534|894661|P1|Overall Study|Lost to Follow-up|2
270006|NCT01106534|894661|P1|Overall Study|Withdrawal by Subject|18
270007|NCT01106430|894693|P2|Overall Study|Withdrawal by Subject|4
270008|NCT01106430|894694|P1|Overall Study|Withdrawal by Subject|8
270009|NCT01106430|894693|P2|Overall Study|Protocol Violation|2
270010|NCT01106430|894694|P1|Overall Study|Protocol Violation|7
270011|NCT01106430|894693|P2|Overall Study|Previous Use Of Marijuana|0
270012|NCT01106430|894694|P1|Overall Study|Previous Use Of Marijuana|1
270013|NCT01106430|894693|P2|Overall Study|Hard Time Swallowing The Pills|0
270014|NCT01106430|894694|P1|Overall Study|Hard Time Swallowing The Pills|1
270015|NCT01106430|894693|P2|Overall Study|Noncompliance|1
270016|NCT01106430|894694|P1|Overall Study|Noncompliance|0
270017|NCT01106430|894693|P2|Overall Study|Refused To Take Medication|1
270018|NCT01106430|894694|P1|Overall Study|Refused To Take Medication|0
270019|NCT01106430|894693|P2|Overall Study|Moved Out Of State|1
270020|NCT01106430|894694|P1|Overall Study|Moved Out Of State|0
270021|NCT01106430|894693|P2|Overall Study|Early Termination Requested By Sponsor|0
270022|NCT01106430|894694|P1|Overall Study|Early Termination Requested By Sponsor|1
270023|NCT01106430|894693|P2|Overall Study|Lost to Follow-up|1
270024|NCT01106430|894694|P1|Overall Study|Lost to Follow-up|5
270025|NCT01106430|894693|P2|Overall Study|Lack of Efficacy|13
270026|NCT01106430|894694|P1|Overall Study|Lack of Efficacy|2
270027|NCT01106430|894693|P2|Overall Study|Adverse Event|10
270028|NCT01106430|894694|P1|Overall Study|Adverse Event|8
270029|NCT01106404|894716|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
270030|NCT01106404|894717|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
270031|NCT01106404|894716|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
270032|NCT01106404|894717|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
270033|NCT01106404|894716|P2|Period I (First 6 Weeks)|Physician Decision|0
270034|NCT01106404|894717|P1|Period I (First 6 Weeks)|Physician Decision|1
270035|NCT01106404|894716|P2|Period I (First 6 Weeks)|Adverse Event|0
270036|NCT01106404|894717|P1|Period I (First 6 Weeks)|Adverse Event|2
270037|NCT01106352|894740|P5|Overall Study|Home hospice since July 2013|0
270038|NCT01106352|894741|P4|Overall Study|Home hospice since July 2013|1
270039|NCT01106352|894742|P3|Overall Study|Home hospice since July 2013|0
270040|NCT01106352|894743|P2|Overall Study|Home hospice since July 2013|0
270041|NCT01106352|894744|P1|Overall Study|Home hospice since July 2013|0
270042|NCT01106352|894740|P5|Overall Study|Subject entered hospice|0
270043|NCT01106352|894741|P4|Overall Study|Subject entered hospice|1
270044|NCT01106352|894742|P3|Overall Study|Subject entered hospice|0
270045|NCT01106352|894743|P2|Overall Study|Subject entered hospice|0
270046|NCT01106352|894744|P1|Overall Study|Subject entered hospice|0
270047|NCT01106352|894740|P5|Overall Study|Went on hospice|0
270048|NCT01106352|894741|P4|Overall Study|Went on hospice|1
270049|NCT01106352|894742|P3|Overall Study|Went on hospice|0
270050|NCT01106352|894743|P2|Overall Study|Went on hospice|0
270051|NCT01106352|894744|P1|Overall Study|Went on hospice|0
270052|NCT01106352|894740|P5|Overall Study|Withdrawal by Subject|2
270053|NCT01106352|894741|P4|Overall Study|Withdrawal by Subject|3
270054|NCT01106352|894742|P3|Overall Study|Withdrawal by Subject|0
270055|NCT01106352|894743|P2|Overall Study|Withdrawal by Subject|0
270056|NCT01106352|894744|P1|Overall Study|Withdrawal by Subject|0
270057|NCT01106352|894740|P5|Overall Study|Disease progression|0
270058|NCT01106352|894741|P4|Overall Study|Disease progression|1
270059|NCT01106352|894742|P3|Overall Study|Disease progression|0
270060|NCT01106352|894743|P2|Overall Study|Disease progression|0
270061|NCT01106352|894744|P1|Overall Study|Disease progression|0
270062|NCT01106352|894740|P5|Overall Study|Death|1
270063|NCT01106352|894741|P4|Overall Study|Death|3
270064|NCT01106352|894742|P3|Overall Study|Death|1
270065|NCT01106352|894743|P2|Overall Study|Death|0
270066|NCT01106352|894744|P1|Overall Study|Death|0
270067|NCT01106352|894740|P5|Overall Study|Lost to Follow-up|1
270068|NCT01106352|894741|P4|Overall Study|Lost to Follow-up|0
270069|NCT01106352|894742|P3|Overall Study|Lost to Follow-up|0
270070|NCT01106352|894743|P2|Overall Study|Lost to Follow-up|0
270071|NCT01106352|894744|P1|Overall Study|Lost to Follow-up|0
270072|NCT01106352|894740|P5|Overall Study|Too ill to come in for the visit|0
270073|NCT01106352|894741|P4|Overall Study|Too ill to come in for the visit|0
270074|NCT01106352|894742|P3|Overall Study|Too ill to come in for the visit|1
270075|NCT01106352|894743|P2|Overall Study|Too ill to come in for the visit|0
270076|NCT01106352|894744|P1|Overall Study|Too ill to come in for the visit|0
270077|NCT01106352|894740|P5|Overall Study|Sponsor Decision|0
270078|NCT01106352|894741|P4|Overall Study|Sponsor Decision|0
270079|NCT01106352|894742|P3|Overall Study|Sponsor Decision|0
270080|NCT01106352|894743|P2|Overall Study|Sponsor Decision|0
270081|NCT01106352|894744|P1|Overall Study|Sponsor Decision|1
270082|NCT01106352|894740|P5|Overall Study|Subjects untreated|4
270083|NCT01106352|894741|P4|Overall Study|Subjects untreated|3
270084|NCT01106352|894742|P3|Overall Study|Subjects untreated|0
270085|NCT01106352|894743|P2|Overall Study|Subjects untreated|0
270086|NCT01106352|894744|P1|Overall Study|Subjects untreated|0
270087|NCT01106287|894840|P4|Overall Study|Adverse Event|0
270088|NCT01106287|894841|P3|Overall Study|Adverse Event|0
270089|NCT01106287|894842|P2|Overall Study|Adverse Event|0
270090|NCT01106287|894843|P1|Overall Study|Adverse Event|1
270091|NCT01105767|894866|P3|Overall Study|Lost to Follow-up|1184
270092|NCT01105767|894867|P2|Overall Study|Lost to Follow-up|1614
270093|NCT01105767|894868|P1|Overall Study|Lost to Follow-up|1160
270094|NCT01106248|894879|P1|Overall Study|Administrative|2
270095|NCT01106248|894879|P1|Overall Study|Adverse Event|1
270096|NCT01106157|894887|P2|Overall Study|Withdrawal by Subject|0
270097|NCT01106157|894888|P1|Overall Study|Withdrawal by Subject|1
270098|NCT01106092|894916|P4|Overall Study|Withdrawal by Subject|1
270099|NCT01106092|894917|P3|Overall Study|Withdrawal by Subject|0
270100|NCT01106092|894918|P2|Overall Study|Withdrawal by Subject|0
270101|NCT01106092|894919|P1|Overall Study|Withdrawal by Subject|0
270102|NCT01106014|895004|P2|Overall Study|Lost to Follow-up|3
270103|NCT01106014|895005|P1|Overall Study|Lost to Follow-up|2
270104|NCT01106014|895004|P2|Overall Study|Administrative reason|6
270105|NCT01106014|895005|P1|Overall Study|Administrative reason|7
270106|NCT01106014|895004|P2|Overall Study|Withdrawal by Subject|37
270107|NCT01106014|895005|P1|Overall Study|Withdrawal by Subject|43
270108|NCT01106014|895004|P2|Overall Study|Adverse Event|42
270109|NCT01106014|895005|P1|Overall Study|Adverse Event|78
270110|NCT01106014|895004|P2|Overall Study|Morbidity or Mortality primary endpoint|242
270111|NCT01106014|895005|P1|Overall Study|Morbidity or Mortality primary endpoint|155
270112|NCT01105936|895015|P4|Period 3|Protocol Violation|0
270113|NCT01105936|895016|P3|Period 3|Protocol Violation|0
270114|NCT01105936|895017|P2|Period 3|Protocol Violation|2
270115|NCT01105936|895018|P1|Period 3|Protocol Violation|0
270116|NCT01105936|895015|P4|Period 2|Adverse Event|0
270117|NCT01105936|895016|P3|Period 2|Adverse Event|0
270118|NCT01105936|895017|P2|Period 2|Adverse Event|0
270119|NCT01105936|895018|P1|Period 2|Adverse Event|1
270120|NCT01105936|895015|P4|Period 1|Adverse Event|1
270121|NCT01105936|895016|P3|Period 1|Adverse Event|0
270122|NCT01105936|895017|P2|Period 1|Adverse Event|0
270123|NCT01105936|895018|P1|Period 1|Adverse Event|0
270124|NCT01105533|895085|P9|Overall Study|Physician Decision|0
270125|NCT01105533|895086|P8|Overall Study|Physician Decision|1
270126|NCT01105533|895087|P7|Overall Study|Physician Decision|0
270127|NCT01105533|895088|P6|Overall Study|Physician Decision|0
270128|NCT01105533|895089|P5|Overall Study|Physician Decision|0
270129|NCT01105533|895090|P4|Overall Study|Physician Decision|0
270130|NCT01105533|895091|P3|Overall Study|Physician Decision|0
270131|NCT01105533|895092|P2|Overall Study|Physician Decision|0
270132|NCT01105533|895093|P1|Overall Study|Physician Decision|0
270133|NCT01105533|895085|P9|Overall Study|Unspecified|2
270134|NCT01105533|895086|P8|Overall Study|Unspecified|1
270135|NCT01105533|895087|P7|Overall Study|Unspecified|3
270136|NCT01105533|895088|P6|Overall Study|Unspecified|0
270137|NCT01105533|895089|P5|Overall Study|Unspecified|1
270138|NCT01105533|895090|P4|Overall Study|Unspecified|0
270139|NCT01105533|895091|P3|Overall Study|Unspecified|0
270140|NCT01105533|895092|P2|Overall Study|Unspecified|0
270141|NCT01105533|895093|P1|Overall Study|Unspecified|0
270142|NCT01105533|895085|P9|Overall Study|Adverse Event|1
270143|NCT01105533|895086|P8|Overall Study|Adverse Event|0
270144|NCT01105533|895087|P7|Overall Study|Adverse Event|2
270145|NCT01105533|895088|P6|Overall Study|Adverse Event|2
270146|NCT01105533|895089|P5|Overall Study|Adverse Event|1
270147|NCT01105533|895090|P4|Overall Study|Adverse Event|0
270148|NCT01105533|895091|P3|Overall Study|Adverse Event|0
270149|NCT01105533|895092|P2|Overall Study|Adverse Event|0
270150|NCT01105533|895093|P1|Overall Study|Adverse Event|0
270151|NCT01105533|895085|P9|Overall Study|Lack of Efficacy|9
270152|NCT01105533|895086|P8|Overall Study|Lack of Efficacy|2
270153|NCT01105533|895087|P7|Overall Study|Lack of Efficacy|3
270154|NCT01105533|895088|P6|Overall Study|Lack of Efficacy|5
270155|NCT01105533|895089|P5|Overall Study|Lack of Efficacy|4
270156|NCT01105533|895090|P4|Overall Study|Lack of Efficacy|3
270157|NCT01105533|895091|P3|Overall Study|Lack of Efficacy|3
270158|NCT01105533|895092|P2|Overall Study|Lack of Efficacy|1
270159|NCT01105533|895093|P1|Overall Study|Lack of Efficacy|1
270160|NCT01105533|895085|P9|Overall Study|Death|0
270161|NCT01105533|895086|P8|Overall Study|Death|0
270162|NCT01105533|895087|P7|Overall Study|Death|0
270163|NCT01105533|895088|P6|Overall Study|Death|0
270164|NCT01105533|895089|P5|Overall Study|Death|1
270165|NCT01105533|895090|P4|Overall Study|Death|0
270166|NCT01105533|895091|P3|Overall Study|Death|0
270167|NCT01105533|895092|P2|Overall Study|Death|0
270168|NCT01105533|895093|P1|Overall Study|Death|0
270169|NCT01105377|895183|P2|Overall Study|Withdrawal by Subject|1
270170|NCT01105377|895184|P1|Overall Study|Withdrawal by Subject|0
270171|NCT01105130|895211|P3|Overall Study|Multiple Reasons|2
270172|NCT01105130|895212|P2|Overall Study|Multiple Reasons|0
270173|NCT01105130|895213|P1|Overall Study|Multiple Reasons|3
270174|NCT01105130|895211|P3|Overall Study|Toxicity|2
270175|NCT01105130|895212|P2|Overall Study|Toxicity|3
270176|NCT01105130|895213|P1|Overall Study|Toxicity|1
270177|NCT01105130|895211|P3|Overall Study|Never Started|4
270178|NCT01105130|895212|P2|Overall Study|Never Started|2
270179|NCT01105130|895213|P1|Overall Study|Never Started|2
270180|NCT01105130|895211|P3|Overall Study|Withdrawal by Subject|2
270181|NCT01105130|895212|P2|Overall Study|Withdrawal by Subject|6
270182|NCT01105130|895213|P1|Overall Study|Withdrawal by Subject|4
270183|NCT01105091|895243|P2|Overall Study|Death|0
270184|NCT01105091|895244|P1|Overall Study|Death|2
270185|NCT01105065|895268|P1|Overall Study|Technical Problems|1
270186|NCT01105065|895268|P1|Overall Study|Adverse Event|5
270187|NCT01103960|895285|P2|Overall Study|Other|0
270188|NCT01103960|895286|P1|Overall Study|Other|1
270189|NCT01103960|895285|P2|Overall Study|Withdrawal by Subject|1
270190|NCT01103960|895286|P1|Overall Study|Withdrawal by Subject|2
270191|NCT01103960|895285|P2|Overall Study|Adverse Event|1
270192|NCT01103960|895286|P1|Overall Study|Adverse Event|2
270193|NCT01102803|895323|P2|Post to Follow-Up|Lost to Follow-up|3
270194|NCT01102803|895324|P1|Post to Follow-Up|Lost to Follow-up|1
270195|NCT01102803|895323|P2|Baseline to Post-Treatment|Lost to Follow-up|0
270196|NCT01102803|895324|P1|Baseline to Post-Treatment|Lost to Follow-up|3
270197|NCT01102777|895338|P2|Overall Study|Lost to Follow-up|10
270198|NCT01102777|895339|P1|Overall Study|Lost to Follow-up|7
270199|NCT01102777|895338|P2|Overall Study|Death|6
270200|NCT01102777|895339|P1|Overall Study|Death|2
270201|NCT01104870|895379|P3|Overall Study|Withdrawal by Subject|1
270202|NCT01104870|895380|P2|Overall Study|Withdrawal by Subject|0
270203|NCT01104870|895381|P1|Overall Study|Withdrawal by Subject|0
270204|NCT01104870|895379|P3|Overall Study|Death|1
270205|NCT01104870|895380|P2|Overall Study|Death|0
270206|NCT01104870|895381|P1|Overall Study|Death|0
270207|NCT01104870|895379|P3|Overall Study|Adverse Event|0
270208|NCT01104870|895380|P2|Overall Study|Adverse Event|1
270209|NCT01104870|895381|P1|Overall Study|Adverse Event|1
270210|NCT01104701|895414|P4|Overall Study|Physician Decision|0
270211|NCT01104701|895415|P3|Overall Study|Physician Decision|0
270212|NCT01104701|895416|P2|Overall Study|Physician Decision|2
270213|NCT01104701|895417|P1|Overall Study|Physician Decision|0
270214|NCT01104701|895414|P4|Overall Study|Adverse Event|1
270215|NCT01104701|895415|P3|Overall Study|Adverse Event|0
270216|NCT01104701|895416|P2|Overall Study|Adverse Event|0
270217|NCT01104701|895417|P1|Overall Study|Adverse Event|0
270218|NCT01104701|895414|P4|Overall Study|Withdrawal by Subject|1
270219|NCT01104701|895415|P3|Overall Study|Withdrawal by Subject|2
270220|NCT01104701|895416|P2|Overall Study|Withdrawal by Subject|1
270221|NCT01104701|895417|P1|Overall Study|Withdrawal by Subject|0
270222|NCT01104662|895479|P8|Overall Study|Randomized but not treated|0
270223|NCT01104662|895480|P7|Overall Study|Randomized but not treated|0
270224|NCT01104662|895481|P6|Overall Study|Randomized but not treated|1
270225|NCT01104662|895482|P5|Overall Study|Randomized but not treated|0
270226|NCT01104662|895483|P4|Overall Study|Randomized but not treated|0
270227|NCT01104662|895484|P3|Overall Study|Randomized but not treated|1
270228|NCT01104662|895485|P2|Overall Study|Randomized but not treated|4
270229|NCT01104662|895486|P1|Overall Study|Randomized but not treated|3
270230|NCT01104662|895479|P8|Overall Study|Reason not specified|0
270231|NCT01104662|895480|P7|Overall Study|Reason not specified|0
270232|NCT01104662|895481|P6|Overall Study|Reason not specified|1
270233|NCT01104662|895482|P5|Overall Study|Reason not specified|0
270234|NCT01104662|895483|P4|Overall Study|Reason not specified|0
270235|NCT01104662|895484|P3|Overall Study|Reason not specified|0
270236|NCT01104662|895485|P2|Overall Study|Reason not specified|3
270237|NCT01104662|895486|P1|Overall Study|Reason not specified|3
270238|NCT01104662|895479|P8|Overall Study|Participant left investigator’s care|0
270239|NCT01104662|895480|P7|Overall Study|Participant left investigator’s care|0
270240|NCT01104662|895481|P6|Overall Study|Participant left investigator’s care|0
270241|NCT01104662|895482|P5|Overall Study|Participant left investigator’s care|0
270242|NCT01104662|895483|P4|Overall Study|Participant left investigator’s care|0
270243|NCT01104662|895484|P3|Overall Study|Participant left investigator’s care|0
270244|NCT01104662|895485|P2|Overall Study|Participant left investigator’s care|1
270245|NCT01104662|895486|P1|Overall Study|Participant left investigator’s care|1
270246|NCT01104662|895479|P8|Overall Study|Clinical Failure|0
270247|NCT01104662|895480|P7|Overall Study|Clinical Failure|0
270248|NCT01104662|895481|P6|Overall Study|Clinical Failure|1
270249|NCT01104662|895482|P5|Overall Study|Clinical Failure|0
270250|NCT01104662|895483|P4|Overall Study|Clinical Failure|0
270251|NCT01104662|895484|P3|Overall Study|Clinical Failure|0
270252|NCT01104662|895485|P2|Overall Study|Clinical Failure|0
270253|NCT01104662|895486|P1|Overall Study|Clinical Failure|1
270254|NCT01104662|895479|P8|Overall Study|Adverse Event|0
270255|NCT01104662|895480|P7|Overall Study|Adverse Event|0
270256|NCT01104662|895481|P6|Overall Study|Adverse Event|1
270257|NCT01104662|895482|P5|Overall Study|Adverse Event|1
270258|NCT01104662|895483|P4|Overall Study|Adverse Event|1
270259|NCT01104662|895484|P3|Overall Study|Adverse Event|0
270260|NCT01104662|895485|P2|Overall Study|Adverse Event|2
270261|NCT01104662|895486|P1|Overall Study|Adverse Event|2
270262|NCT01104636|895512|P1|Overall Study|Ongoing|21
270263|NCT01104636|895512|P1|Overall Study|Adverse Event|40
270264|NCT01104636|895512|P1|Overall Study|Pregnancy|2
270265|NCT01104636|895512|P1|Overall Study|Study terminated by sponsor|1
270266|NCT01104636|895512|P1|Overall Study|Unspecified|43
270267|NCT01104636|895512|P1|Overall Study|Withdrawal by Subject|4
270268|NCT01104636|895512|P1|Overall Study|Lost to Follow-up|24
270269|NCT01104636|895512|P1|Overall Study|Lack of Efficacy|43
270270|NCT01104584|895517|P1|Overall Study|Study prematurely discontinued|2
270271|NCT01104584|895517|P1|Overall Study|Study drug never administered|21
270272|NCT01104558|895587|P1|Overall Study|Missing of genetic analysis results|1
270273|NCT01104558|895587|P1|Overall Study|Missing of primary efficacy assessment|10
270274|NCT01104558|895587|P1|Overall Study|Protocol Violation|6
270275|NCT01104493|895630|P2|Overall Study|Lost to Follow-up|2
270276|NCT01104493|895631|P1|Overall Study|Lost to Follow-up|0
270277|NCT01104376|895649|P1|Overall Study|Consented but excluded after labs|13
270278|NCT01104376|895649|P1|Overall Study|Withdrawal by Subject|15
270279|NCT01104311|895655|P2|Overall Study|Adverse Event|2
270280|NCT01104311|895656|P1|Overall Study|Adverse Event|1
270281|NCT01104311|895655|P2|Overall Study|low compliance|1
270282|NCT01104311|895656|P1|Overall Study|low compliance|1
270283|NCT01104311|895655|P2|Overall Study|Physician Decision|2
270284|NCT01104311|895656|P1|Overall Study|Physician Decision|2
270285|NCT01104311|895655|P2|Overall Study|Protocol Violation|1
270286|NCT01104311|895656|P1|Overall Study|Protocol Violation|0
270287|NCT01104311|895655|P2|Overall Study|Withdrawal by Subject|6
270288|NCT01104311|895656|P1|Overall Study|Withdrawal by Subject|6
270289|NCT01104246|895683|P1|Overall Study|did not meet inclusion criteria|4
270290|NCT01104246|895683|P1|Overall Study|Withdrawal by Subject|1
270291|NCT01104155|895698|P2|Overall Study|Not specified|4
270292|NCT01104155|895699|P1|Overall Study|Not specified|3
270293|NCT01104155|895698|P2|Overall Study|Withdrawal of consent|1
270294|NCT01104155|895699|P1|Overall Study|Withdrawal of consent|1
270295|NCT01104155|895698|P2|Overall Study|Participant choice|5
270296|NCT01104155|895699|P1|Overall Study|Participant choice|6
270297|NCT01104155|895698|P2|Overall Study|Adverse Event|8
270298|NCT01104155|895699|P1|Overall Study|Adverse Event|15
270299|NCT01103713|895729|P1|Overall Study|Not specified|1
270300|NCT01103713|895729|P1|Overall Study|Study terminated by sponsor|2
270301|NCT01103713|895729|P1|Overall Study|Withdrawal by Subject|8
270302|NCT01103713|895729|P1|Overall Study|Lost to Follow-up|2
270303|NCT01103479|895762|P3|Overall Study|Saw non-study physician|0
270304|NCT01103479|895763|P2|Overall Study|Saw non-study physician|0
270305|NCT01103479|895764|P1|Overall Study|Saw non-study physician|2
270306|NCT01103479|895762|P3|Overall Study|Active cancer|0
270307|NCT01103479|895763|P2|Overall Study|Active cancer|0
270308|NCT01103479|895764|P1|Overall Study|Active cancer|1
270309|NCT01103479|895762|P3|Overall Study|Family history of CRC|2
270310|NCT01103479|895763|P2|Overall Study|Family history of CRC|0
270311|NCT01103479|895764|P1|Overall Study|Family history of CRC|1
270312|NCT01103479|895762|P3|Overall Study|Up to date with CRC screening|12
270313|NCT01103479|895763|P2|Overall Study|Up to date with CRC screening|9
270314|NCT01103479|895764|P1|Overall Study|Up to date with CRC screening|1
270315|NCT01103466|895777|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
270316|NCT01103466|895778|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
270317|NCT01103466|895779|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
270318|NCT01103466|895777|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
270319|NCT01103466|895778|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
270320|NCT01103466|895779|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
270321|NCT01103466|895777|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
270322|NCT01103466|895778|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
270323|NCT01103466|895779|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
270324|NCT01103466|895777|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
270325|NCT01103466|895778|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
270326|NCT01103466|895779|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
270327|NCT01103466|895777|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
270328|NCT01103466|895778|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
270329|NCT01103466|895779|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
270330|NCT01103466|895777|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
270331|NCT01103466|895778|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
270332|NCT01103466|895779|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
270333|NCT01103362|895858|P1|Overall Study|study terminated|596
270334|NCT01103323|895864|P2|Switched From Placebo to Regorafenib|Adverse Event|1
270335|NCT01103323|895865|P1|Switched From Placebo to Regorafenib|Adverse Event|0
270336|NCT01103323|895864|P2|Without/Before Drug Switch|Switch to Regorafenib|4
270337|NCT01103323|895865|P1|Without/Before Drug Switch|Switch to Regorafenib|0
270338|NCT01103323|895864|P2|Without/Before Drug Switch|did not receive study treatment|2
270339|NCT01103323|895865|P1|Without/Before Drug Switch|did not receive study treatment|5
270340|NCT01103323|895864|P2|Without/Before Drug Switch|Physician Decision|0
270341|NCT01103323|895865|P1|Without/Before Drug Switch|Physician Decision|2
270342|NCT01103323|895864|P2|Without/Before Drug Switch|Protocol Violation|0
270343|NCT01103323|895865|P1|Without/Before Drug Switch|Protocol Violation|2
270344|NCT01103323|895864|P2|Without/Before Drug Switch|Withdrawal by Subject|5
270345|NCT01103323|895865|P1|Without/Before Drug Switch|Withdrawal by Subject|17
270346|NCT01103323|895864|P2|Without/Before Drug Switch|Adverse Event|7
270347|NCT01103323|895865|P1|Without/Before Drug Switch|Adverse Event|50
270348|NCT01103284|895882|P2|Overall Study|Missing CRF entries for study completion|2
270349|NCT01103284|895883|P1|Overall Study|Missing CRF entries for study completion|0
270350|NCT01103284|895882|P2|Overall Study|Not described|1
270351|NCT01103284|895883|P1|Overall Study|Not described|2
270352|NCT01103284|895882|P2|Overall Study|Termination by the Sponsor|1
270353|NCT01103284|895883|P1|Overall Study|Termination by the Sponsor|0
270354|NCT01103284|895882|P2|Overall Study|Dermal Hypersensitivity|1
270355|NCT01103284|895883|P1|Overall Study|Dermal Hypersensitivity|0
270356|NCT01103284|895882|P2|Overall Study|Withdrawal by Subject|18
270357|NCT01103284|895883|P1|Overall Study|Withdrawal by Subject|14
270358|NCT01103284|895882|P2|Overall Study|Adverse Event|5
270359|NCT01103284|895883|P1|Overall Study|Adverse Event|0
270360|NCT01103284|895882|P2|Overall Study|Protocol Violation|5
270361|NCT01103284|895883|P1|Overall Study|Protocol Violation|12
270362|NCT01103284|895882|P2|Overall Study|Pregnancy|1
270363|NCT01103284|895883|P1|Overall Study|Pregnancy|3
270364|NCT01103284|895882|P2|Overall Study|Lost to Follow-up|10
270365|NCT01103284|895883|P1|Overall Study|Lost to Follow-up|9
270366|NCT01103284|895882|P2|Overall Study|Death|0
270367|NCT01103284|895883|P1|Overall Study|Death|2
270368|NCT01103232|895909|P2|Overall Study|Protocol Violation|1
270369|NCT01103232|895910|P1|Overall Study|Protocol Violation|0
270370|NCT01103232|895909|P2|Overall Study|Withdrawal by Subject|1
270371|NCT01103232|895910|P1|Overall Study|Withdrawal by Subject|1
270372|NCT01103141|895918|P2|Overall Study|Lost to Follow-up|1
270373|NCT01103141|895919|P1|Overall Study|Lost to Follow-up|2
270374|NCT01103141|895918|P2|Overall Study|Death|1
270375|NCT01103141|895919|P1|Overall Study|Death|0
270376|NCT01103063|895927|P2|Overall Study|Death|1
270377|NCT01103063|895928|P1|Overall Study|Death|3
270378|NCT01103063|895927|P2|Overall Study|Study terminated by Sponsor|342
270379|NCT01103063|895928|P1|Overall Study|Study terminated by Sponsor|326
270380|NCT01103063|895927|P2|Overall Study|Protocol Violation|0
270381|NCT01103063|895928|P1|Overall Study|Protocol Violation|1
270382|NCT01103063|895927|P2|Overall Study|Not specified|11
270383|NCT01103063|895928|P1|Overall Study|Not specified|16
270384|NCT01103063|895927|P2|Overall Study|Withdrawal by Subject|15
270385|NCT01103063|895928|P1|Overall Study|Withdrawal by Subject|60
270386|NCT01103063|895927|P2|Overall Study|Lost to Follow-up|51
270387|NCT01103063|895928|P1|Overall Study|Lost to Follow-up|68
270388|NCT01103063|895927|P2|Overall Study|Adverse Event|1
270389|NCT01103063|895928|P1|Overall Study|Adverse Event|3
270390|NCT01102972|895996|P2|Overall Study|Withdrawal by Subject|6
270391|NCT01102972|895997|P1|Overall Study|Withdrawal by Subject|6
270392|NCT01102972|895996|P2|Overall Study|Investigator Discretion|0
270393|NCT01102972|895997|P1|Overall Study|Investigator Discretion|2
270394|NCT01102972|895996|P2|Overall Study|Lost to Follow-up|5
270395|NCT01102972|895997|P1|Overall Study|Lost to Follow-up|10
270396|NCT01102972|895996|P2|Overall Study|Protocol Violation|0
270397|NCT01102972|895997|P1|Overall Study|Protocol Violation|1
270398|NCT01102972|895996|P2|Overall Study|Lack of Efficacy|1
270399|NCT01102972|895997|P1|Overall Study|Lack of Efficacy|2
270400|NCT01102972|895996|P2|Overall Study|Adverse Event|2
270401|NCT01102972|895997|P1|Overall Study|Adverse Event|8
270402|NCT01102491|896061|P2|Overall Study|Protocol Violation|12
270403|NCT01102491|896062|P1|Overall Study|Protocol Violation|11
270404|NCT01102374|896081|P2|Overall Study|Lost to Follow-up|6
270405|NCT01102374|896082|P1|Overall Study|Lost to Follow-up|7
270406|NCT01102374|896081|P2|Overall Study|Death|13
270407|NCT01102374|896082|P1|Overall Study|Death|9
270408|NCT01102257|896131|P2|Overall Study|Adverse Event|0
270409|NCT01102257|896132|P1|Overall Study|Adverse Event|1
270410|NCT01102257|896131|P2|Overall Study|Adverse Event|0
270411|NCT01102257|896132|P1|Overall Study|Adverse Event|1
270412|NCT01101841|896175|P2|Overall Study|Eligibility Criteria|2
270413|NCT01101841|896176|P1|Overall Study|Eligibility Criteria|1
270414|NCT01101841|896175|P2|Overall Study|Suicidality Tracking Scale|1
270415|NCT01101841|896176|P1|Overall Study|Suicidality Tracking Scale|3
270416|NCT01101841|896175|P2|Overall Study|Not Specified|1
270417|NCT01101841|896176|P1|Overall Study|Not Specified|0
270418|NCT01101841|896175|P2|Overall Study|Lack of Efficacy|2
270419|NCT01101841|896176|P1|Overall Study|Lack of Efficacy|0
270420|NCT01101841|896175|P2|Overall Study|Physician Decision|2
270421|NCT01101841|896176|P1|Overall Study|Physician Decision|0
270422|NCT01101841|896175|P2|Overall Study|Protocol Violation|1
270423|NCT01101841|896176|P1|Overall Study|Protocol Violation|1
270424|NCT01101841|896175|P2|Overall Study|Withdrawal by Subject|40
270425|NCT01101841|896176|P1|Overall Study|Withdrawal by Subject|21
270426|NCT01101841|896175|P2|Overall Study|Lost to Follow-up|3
270427|NCT01101841|896176|P1|Overall Study|Lost to Follow-up|9
270428|NCT01101841|896175|P2|Overall Study|Adverse Event|15
270429|NCT01101841|896176|P1|Overall Study|Adverse Event|15
270430|NCT01101542|896214|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
270431|NCT01101542|896214|P1|Year 6 Surveillance Period|Pregnancy|1
270432|NCT01101542|896214|P1|Year 6 Surveillance Period|Lost to Follow-up|986
270433|NCT01101542|896214|P1|Year 5 Surveillance Period|Pregnancy|1
270434|NCT01101542|896214|P1|Year 5 Surveillance Period|Lost to Follow-up|140
270435|NCT01101542|896214|P1|Year 4 Surveillance Period|Unspecified|287
270436|NCT01101542|896214|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
270437|NCT01101542|896214|P1|Year 3 Surveillance Period|Lost to Follow-up|7
270438|NCT01101477|896233|P3|Overall Study|Protocol Violation|1
270439|NCT01101477|896234|P2|Overall Study|Protocol Violation|3
270440|NCT01101477|896235|P1|Overall Study|Protocol Violation|5
270441|NCT01101321|896256|P2|Period 1|Adverse Event|3
270442|NCT01101321|896257|P1|Period 1|Adverse Event|3
270443|NCT01101321|896256|P2|Period 1|Withdrawal by Subject|1
270444|NCT01101321|896257|P1|Period 1|Withdrawal by Subject|1
270445|NCT01101308|896267|P2|Period 1|Positive for cotinine|0
270446|NCT01101308|896268|P1|Period 1|Positive for cotinine|1
270447|NCT01101308|896267|P2|Period 1|Adverse Event|1
270448|NCT01101308|896268|P1|Period 1|Adverse Event|2
270449|NCT01101191|896279|P2|Period 1|Adverse Event|2
270450|NCT01101191|896280|P1|Period 1|Adverse Event|1
270451|NCT01101191|896279|P2|Period 1|Withdrawal by Subject|0
270452|NCT01101191|896280|P1|Period 1|Withdrawal by Subject|1
270453|NCT01101178|896291|P2|Period 2|Withdrawal by Subject|1
270454|NCT01101178|896292|P1|Period 2|Withdrawal by Subject|0
270455|NCT01101178|896291|P2|Period 1|Adverse Event|1
270456|NCT01101178|896292|P1|Period 1|Adverse Event|2
270457|NCT01101178|896291|P2|Period 1|Positive drug screen|1
270458|NCT01101178|896292|P1|Period 1|Positive drug screen|1
270459|NCT01101178|896291|P2|Period 1|Withdrawal by Subject|2
270460|NCT01101178|896292|P1|Period 1|Withdrawal by Subject|1
270461|NCT01101165|896303|P2|Period 2|Adverse Event|0
270462|NCT01101165|896304|P1|Period 2|Adverse Event|1
270463|NCT01101165|896303|P2|Period 2|Withdrawal by Subject|1
270464|NCT01101165|896304|P1|Period 2|Withdrawal by Subject|3
270465|NCT01101165|896303|P2|Period 1|Lost to Follow-up|0
270466|NCT01101165|896304|P1|Period 1|Lost to Follow-up|1
270467|NCT01101165|896303|P2|Period 1|Positive Drug Screen|1
270468|NCT01101165|896304|P1|Period 1|Positive Drug Screen|0
270469|NCT01101165|896303|P2|Period 1|Withdrawal by Subject|2
270470|NCT01101165|896304|P1|Period 1|Withdrawal by Subject|0
270471|NCT01101165|896303|P2|Period 1|Adverse Event|2
270472|NCT01101165|896304|P1|Period 1|Adverse Event|1
270473|NCT01101022|896316|P2|Overall Study|Vacation|1
270474|NCT01101022|896317|P1|Overall Study|Vacation|0
270475|NCT01101022|896316|P2|Overall Study|Work schedule|1
270476|NCT01101022|896317|P1|Overall Study|Work schedule|1
270477|NCT01101022|896316|P2|Overall Study|Non-compliance|0
270478|NCT01101022|896317|P1|Overall Study|Non-compliance|1
270479|NCT01101022|896316|P2|Overall Study|Sponsor decision|1
270480|NCT01101022|896317|P1|Overall Study|Sponsor decision|1
270481|NCT01101022|896316|P2|Overall Study|Lack of Efficacy|7
270482|NCT01101022|896317|P1|Overall Study|Lack of Efficacy|0
270483|NCT01101022|896316|P2|Overall Study|Lost to Follow-up|4
270484|NCT01101022|896317|P1|Overall Study|Lost to Follow-up|1
270485|NCT01101022|896316|P2|Overall Study|Withdrawal by Subject|8
270486|NCT01101022|896317|P1|Overall Study|Withdrawal by Subject|3
270487|NCT01101022|896316|P2|Overall Study|Protocol Violation|3
270488|NCT01101022|896317|P1|Overall Study|Protocol Violation|4
270489|NCT01101022|896316|P2|Overall Study|Adverse Event|2
270490|NCT01101022|896317|P1|Overall Study|Adverse Event|6
270491|NCT01100944|896351|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
270492|NCT01100944|896352|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
270493|NCT01100944|896353|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
270494|NCT01100944|896351|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
270495|NCT01100944|896352|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
270496|NCT01100944|896353|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
270497|NCT01100944|896351|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
270498|NCT01100944|896352|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
270499|NCT01100944|896353|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
270500|NCT01100944|896351|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
270501|NCT01100944|896352|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
270502|NCT01100944|896353|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
270503|NCT01100853|896411|P2|Overall Study|Withdrawal by Subject|4
270504|NCT01100853|896412|P1|Overall Study|Withdrawal by Subject|6
270505|NCT01100853|896411|P2|Overall Study|Received <4 study injections|13
270506|NCT01100853|896412|P1|Overall Study|Received <4 study injections|10
270507|NCT01100853|896411|P2|Overall Study|Lost to Follow-up|6
270508|NCT01100853|896412|P1|Overall Study|Lost to Follow-up|11
270509|NCT01100658|896458|P1|Overall Study|Withdrawal by Subject|1
270510|NCT01100567|896490|P2|Overall Study|Deemed ineligible after consent|1
270511|NCT01100567|896491|P1|Overall Study|Deemed ineligible after consent|0
270512|NCT01100567|896490|P2|Overall Study|Physician Decision|1
270513|NCT01100567|896491|P1|Overall Study|Physician Decision|0
270514|NCT01100567|896490|P2|Overall Study|Lost to Follow-up|2
270515|NCT01100567|896491|P1|Overall Study|Lost to Follow-up|1
270516|NCT01100567|896490|P2|Overall Study|Early Hospital Discharge|4
270517|NCT01100567|896491|P1|Overall Study|Early Hospital Discharge|6
270518|NCT01100567|896490|P2|Overall Study|Withdrawal by Subject|8
270519|NCT01100567|896491|P1|Overall Study|Withdrawal by Subject|5
270520|NCT01100502|896501|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
270521|NCT01100502|896502|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
270522|NCT01100502|896501|P2|Long-Term Follow-up|Lost to Follow-up|2
270523|NCT01100502|896502|P1|Long-Term Follow-up|Lost to Follow-up|5
270524|NCT01100502|896501|P2|Long-Term Follow-up|Withdrawal by Subject|8
270525|NCT01100502|896502|P1|Long-Term Follow-up|Withdrawal by Subject|10
270526|NCT01100502|896501|P2|Treatment Period|Progressive Disease|69
270527|NCT01100502|896502|P1|Treatment Period|Progressive Disease|24
270528|NCT01100502|896501|P2|Treatment Period|Withdrawal by Subject|4
270529|NCT01100502|896502|P1|Treatment Period|Withdrawal by Subject|9
270530|NCT01100502|896501|P2|Treatment Period|Adverse Event|10
270531|NCT01100502|896502|P1|Treatment Period|Adverse Event|54
270532|NCT01100437|896512|P3|Maintenance|Sponsor termination of study|1
270533|NCT01100437|896513|P2|Maintenance|Sponsor termination of study|0
270534|NCT01100437|896514|P1|Maintenance|Sponsor termination of study|0
270535|NCT01100437|896512|P3|Maintenance|Withdrawal by Subject|1
270536|NCT01100437|896513|P2|Maintenance|Withdrawal by Subject|0
270537|NCT01100437|896514|P1|Maintenance|Withdrawal by Subject|0
270538|NCT01100437|896512|P3|Titration/Stabilization|Sponsor canceled study|1
270539|NCT01100437|896513|P2|Titration/Stabilization|Sponsor canceled study|0
270540|NCT01100437|896514|P1|Titration/Stabilization|Sponsor canceled study|0
270541|NCT01100437|896512|P3|Titration/Stabilization|Non-compliance|1
270542|NCT01100437|896513|P2|Titration/Stabilization|Non-compliance|0
270543|NCT01100437|896514|P1|Titration/Stabilization|Non-compliance|0
270544|NCT01100437|896512|P3|Titration/Stabilization|Adverse Event|4
270545|NCT01100437|896513|P2|Titration/Stabilization|Adverse Event|0
270546|NCT01100437|896514|P1|Titration/Stabilization|Adverse Event|0
270547|NCT01100320|896551|P2|Period 2|Withdrawal by Subject|1
270548|NCT01100320|896552|P1|Period 2|Withdrawal by Subject|1
270549|NCT01100320|896551|P2|Period 1|Adverse Event|2
270550|NCT01100320|896552|P1|Period 1|Adverse Event|2
270551|NCT01100320|896551|P2|Period 1|Positive Drug Screen|1
270552|NCT01100320|896552|P1|Period 1|Positive Drug Screen|1
270553|NCT01100320|896551|P2|Period 1|Withdrawal by Subject|4
270554|NCT01100320|896552|P1|Period 1|Withdrawal by Subject|2
270555|NCT01100307|896564|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
270556|NCT01100307|896565|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
270557|NCT01100307|896564|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
270558|NCT01100307|896565|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
270559|NCT01100307|896564|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
270560|NCT01100307|896565|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
270561|NCT01100307|896564|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
270562|NCT01100307|896565|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
270563|NCT01100307|896564|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
270564|NCT01100307|896565|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
270565|NCT01100307|896564|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
270566|NCT01100307|896565|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
270567|NCT01100086|896634|P2|Period 1|Withdrawal by Subject|0
270568|NCT01100086|896635|P1|Period 1|Withdrawal by Subject|1
270569|NCT01100073|896645|P1|Overall Study|Missing|5
270570|NCT01100073|896645|P1|Overall Study|not known|8
270571|NCT01100073|896645|P1|Overall Study|Insufficient tolerability +patients wish|8
270572|NCT01100073|896645|P1|Overall Study|Lack of effect + patient's wish|2
270573|NCT01100073|896645|P1|Overall Study|Lost to Follow-up|39
270574|NCT01100073|896645|P1|Overall Study|Withdrawal by Subject|13
270575|NCT01100073|896645|P1|Overall Study|Insufficient Tolerability|21
270576|NCT01100073|896645|P1|Overall Study|Lack of Efficacy|4
270577|NCT01099917|896660|P1|Overall Study|Not Treated|24
270578|NCT01099917|896660|P1|Overall Study|Adverse Event|3
270579|NCT01099709|896722|P2|Period 1|Adverse Event|0
270580|NCT01099709|896723|P1|Period 1|Adverse Event|1
270581|NCT01099709|896722|P2|Period 1|Positive cotinine test|1
270582|NCT01099709|896723|P1|Period 1|Positive cotinine test|0
270583|NCT01099709|896722|P2|Period 1|Withdrawal by Subject|1
270584|NCT01099709|896723|P1|Period 1|Withdrawal by Subject|0
270585|NCT01099579|896749|P3|Stage 2 (ATV Capsules )|Ongoing treatment|15
270586|NCT01099579|896750|P2|Stage 2 (ATV Capsules )|Ongoing treatment|13
270587|NCT01099579|896751|P1|Stage 2 (ATV Capsules )|Ongoing treatment|14
270588|NCT01099579|896749|P3|Stage 2 (ATV Capsules )|Lost to Follow-up|0
270589|NCT01099579|896750|P2|Stage 2 (ATV Capsules )|Lost to Follow-up|1
270590|NCT01099579|896751|P1|Stage 2 (ATV Capsules )|Lost to Follow-up|0
270591|NCT01099579|896749|P3|Stage 2 (ATV Capsules )|No longer met study criteria|0
270592|NCT01099579|896750|P2|Stage 2 (ATV Capsules )|No longer met study criteria|0
270593|NCT01099579|896751|P1|Stage 2 (ATV Capsules )|No longer met study criteria|2
270594|NCT01099579|896749|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
270595|NCT01099579|896750|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
270596|NCT01099579|896751|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
270597|NCT01099579|896749|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
270598|NCT01099579|896750|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
270599|NCT01099579|896751|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
270600|NCT01099579|896749|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
270601|NCT01099579|896750|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
270602|NCT01099579|896751|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
270603|NCT01099579|896749|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
270604|NCT01099579|896750|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
270605|NCT01099579|896751|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
270606|NCT01099397|896820|P1|Overall Study|Withdrawal by Subject|5
270607|NCT01099397|896820|P1|Overall Study|Protocol Violation|4
270608|NCT01099397|896820|P1|Overall Study|Lost to Follow-up|4
270609|NCT01099267|896847|P1|MDS-003 Study|Secondary Malign Disease|1
270610|NCT01099267|896847|P1|MDS-003 Study|Loss of Response|1
270611|NCT01099267|896847|P1|MDS-003 Study|Non-Compliance|2
270612|NCT01099267|896847|P1|MDS-003 Study|Investigator Decision|2
270613|NCT01099267|896847|P1|MDS-003 Study|Disease Progression|7
270614|NCT01099267|896847|P1|MDS-003 Study|Study Closed by Sponsor|2
270615|NCT01099267|896847|P1|MDS-003 Study|Death|11
270616|NCT01099267|896847|P1|MDS-003 Study|Lost to Follow-up|1
270617|NCT01099267|896847|P1|MDS-003 Study|Withdrawal by Subject|8
270618|NCT01099267|896847|P1|MDS-003 Study|Lack of Efficacy|52
270619|NCT01099267|896847|P1|MDS-003 Study|Adverse Event|37
270620|NCT01099215|896857|P2|Overall Study|Adverse Event|1
270621|NCT01099215|896858|P1|Overall Study|Adverse Event|0
270622|NCT01099215|896857|P2|Overall Study|Withdrawal by Subject|0
270623|NCT01099215|896858|P1|Overall Study|Withdrawal by Subject|1
270624|NCT01098851|896928|P2|Overall Study|Equipment failure|0
270625|NCT01098851|896929|P1|Overall Study|Equipment failure|1
270626|NCT01098812|896940|P3|Overall Study|Lost to Follow-up|0
270627|NCT01098812|896941|P2|Overall Study|Lost to Follow-up|1
270628|NCT01098812|896942|P1|Overall Study|Lost to Follow-up|0
270629|NCT01098812|896940|P3|Overall Study|Death|1
270630|NCT01098812|896941|P2|Overall Study|Death|0
270631|NCT01098812|896942|P1|Overall Study|Death|2
270632|NCT01098539|897018|P2|Overall Study|Physician Decision|3
270633|NCT01098539|897019|P1|Overall Study|Physician Decision|5
270634|NCT01098539|897018|P2|Overall Study|Withdrawal by Subject|26
270635|NCT01098539|897019|P1|Overall Study|Withdrawal by Subject|12
270636|NCT01098539|897018|P2|Overall Study|Lost to Follow-up|4
270637|NCT01098539|897019|P1|Overall Study|Lost to Follow-up|4
270638|NCT01098539|897018|P2|Overall Study|Noncompliance|5
270639|NCT01098539|897019|P1|Overall Study|Noncompliance|3
270640|NCT01098539|897018|P2|Overall Study|Protocol Violation|4
270641|NCT01098539|897019|P1|Overall Study|Protocol Violation|1
270642|NCT01098539|897018|P2|Overall Study|Adverse Event|26
270643|NCT01098539|897019|P1|Overall Study|Adverse Event|26
270644|NCT01098487|897070|P1|Overall Study|Physician Decision|1
270645|NCT01098487|897070|P1|Overall Study|Lost to Follow-up|3
270646|NCT01098487|897070|P1|Overall Study|Withdrawal by Subject|7
270647|NCT01098487|897070|P1|Overall Study|Lack of Efficacy|11
270648|NCT01098487|897070|P1|Overall Study|Adverse Event|22
270649|NCT01098461|897086|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
270650|NCT01098461|897087|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
270651|NCT01098461|897088|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
270652|NCT01098461|897089|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
270653|NCT01098461|897086|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
270654|NCT01098461|897087|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
270655|NCT01098461|897088|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
270656|NCT01098461|897089|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
270657|NCT01098461|897086|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
270658|NCT01098461|897087|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
270659|NCT01098461|897088|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
270660|NCT01098461|897089|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
270661|NCT01098461|897086|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
270662|NCT01098461|897087|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
270663|NCT01098461|897088|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
270664|NCT01098461|897089|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
270665|NCT01098461|897086|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
270666|NCT01098461|897087|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
270667|NCT01098461|897088|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
270668|NCT01098461|897089|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
270669|NCT01098461|897086|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
270670|NCT01098461|897087|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
270671|NCT01098461|897088|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
270672|NCT01098461|897089|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
270673|NCT01098461|897086|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
270674|NCT01098461|897087|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
270675|NCT01098461|897088|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
270676|NCT01098461|897089|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
270677|NCT01098305|897134|P2|Overall Study|Lost to Follow-up|33
270678|NCT01098305|897135|P1|Overall Study|Lost to Follow-up|31
270679|NCT01098240|897154|P3|Double-Blind Phase|Adverse Event|3
270680|NCT01098240|897155|P2|Double-Blind Phase|Adverse Event|3
270681|NCT01098240|897156|P1|Double-Blind Phase|Adverse Event|0
270682|NCT01098240|897154|P3|Double-Blind Phase|Withdrawal by Subject|3
270683|NCT01098240|897155|P2|Double-Blind Phase|Withdrawal by Subject|1
270684|NCT01098240|897156|P1|Double-Blind Phase|Withdrawal by Subject|0
270685|NCT01098240|897154|P3|Double-Blind Phase|Insufficient Clinical Response|2
270686|NCT01098240|897155|P2|Double-Blind Phase|Insufficient Clinical Response|1
270687|NCT01098240|897156|P1|Double-Blind Phase|Insufficient Clinical Response|0
270688|NCT01098240|897154|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
270689|NCT01098240|897155|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
270690|NCT01098240|897156|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
270691|NCT01098240|897154|P3|Double-Blind Phase|Unspecified|2
270692|NCT01098240|897155|P2|Double-Blind Phase|Unspecified|2
270693|NCT01098240|897156|P1|Double-Blind Phase|Unspecified|0
270694|NCT01098240|897154|P3|Double-Blind Phase|Lost to Follow-up|0
270695|NCT01098240|897155|P2|Double-Blind Phase|Lost to Follow-up|2
270696|NCT01098240|897156|P1|Double-Blind Phase|Lost to Follow-up|0
270697|NCT01098240|897154|P3|Double-Blind Phase|Protocol Violation|4
270698|NCT01098240|897155|P2|Double-Blind Phase|Protocol Violation|2
270699|NCT01098240|897156|P1|Double-Blind Phase|Protocol Violation|0
270700|NCT01098240|897154|P3|Double-Blind Phase|Study Terminated by Sponsor|8
270701|NCT01098240|897155|P2|Double-Blind Phase|Study Terminated by Sponsor|5
270702|NCT01098240|897156|P1|Double-Blind Phase|Study Terminated by Sponsor|0
270703|NCT01098240|897154|P3|Open-Label Phase|Adverse Event|0
270704|NCT01098240|897155|P2|Open-Label Phase|Adverse Event|0
270705|NCT01098240|897156|P1|Open-Label Phase|Adverse Event|12
270706|NCT01098240|897154|P3|Open-Label Phase|Withdrawal by Subject|0
270707|NCT01098240|897155|P2|Open-Label Phase|Withdrawal by Subject|0
270708|NCT01098240|897156|P1|Open-Label Phase|Withdrawal by Subject|9
270709|NCT01098240|897154|P3|Open-Label Phase|Pregnancy|0
270710|NCT01098240|897155|P2|Open-Label Phase|Pregnancy|0
270711|NCT01098240|897156|P1|Open-Label Phase|Pregnancy|1
270712|NCT01098240|897154|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
270713|NCT01098240|897155|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
270714|NCT01098240|897156|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
270715|NCT01098240|897154|P3|Open-Label Phase|Unspecified|0
270716|NCT01098240|897155|P2|Open-Label Phase|Unspecified|0
270717|NCT01098240|897156|P1|Open-Label Phase|Unspecified|19
270718|NCT01098240|897154|P3|Open-Label Phase|Lost to Follow-up|0
270719|NCT01098240|897155|P2|Open-Label Phase|Lost to Follow-up|0
270720|NCT01098240|897156|P1|Open-Label Phase|Lost to Follow-up|13
270721|NCT01098240|897154|P3|Open-Label Phase|Protocol Violation|0
270722|NCT01098240|897155|P2|Open-Label Phase|Protocol Violation|0
270723|NCT01098240|897156|P1|Open-Label Phase|Protocol Violation|4
270724|NCT01098240|897154|P3|Open-Label Phase|Study Terminated by Sponsor|0
270725|NCT01098240|897155|P2|Open-Label Phase|Study Terminated by Sponsor|0
270726|NCT01098240|897156|P1|Open-Label Phase|Study Terminated by Sponsor|27
270727|NCT01098162|897186|P1|Overall Study|Reason Unknown|26
270728|NCT01098162|897186|P1|Overall Study|Other Reason|1
270729|NCT01098162|897186|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
270730|NCT01098162|897186|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
270731|NCT01098162|897186|P1|Overall Study|Adverse Event & Lost to Follow-up|2
270732|NCT01098162|897186|P1|Overall Study|Adverse Event & Wish of Patient|13
270733|NCT01098162|897186|P1|Overall Study|Adverse Event & Lack of Efficacy|6
270734|NCT01098162|897186|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
270735|NCT01098162|897186|P1|Overall Study|Lost to Follow-up|9
270736|NCT01098162|897186|P1|Overall Study|Wish of Patient|7
270737|NCT01098162|897186|P1|Overall Study|Lack of Efficacy|4
270738|NCT01098162|897186|P1|Overall Study|Adverse Event|37
270739|NCT01098110|897198|P3|Overall Study|Untreated|0
270740|NCT01098110|897199|P2|Overall Study|Untreated|1
270741|NCT01098110|897200|P1|Overall Study|Untreated|1
270742|NCT01098110|897198|P3|Overall Study|Not Specified|5
270743|NCT01098110|897199|P2|Overall Study|Not Specified|7
270744|NCT01098110|897200|P1|Overall Study|Not Specified|4
270745|NCT01098110|897198|P3|Overall Study|Lack of Efficacy|27
270746|NCT01098110|897199|P2|Overall Study|Lack of Efficacy|9
270747|NCT01098110|897200|P1|Overall Study|Lack of Efficacy|13
270748|NCT01098110|897198|P3|Overall Study|Adverse Event|43
270749|NCT01098110|897199|P2|Overall Study|Adverse Event|32
270750|NCT01098110|897200|P1|Overall Study|Adverse Event|30
270751|NCT01098110|897198|P3|Overall Study|Withdrawal by Subject|19
270752|NCT01098110|897199|P2|Overall Study|Withdrawal by Subject|24
270753|NCT01098110|897200|P1|Overall Study|Withdrawal by Subject|14
270754|NCT01098097|897241|P1|Overall Study|No reason reported|31
270755|NCT01098097|897241|P1|Overall Study|Status unknown|16
270756|NCT01098097|897241|P1|Overall Study|Lost to Follow-up|18
270757|NCT01098097|897241|P1|Overall Study|Adverse Event|17
270758|NCT01098071|897250|P1|Overall Study|Lost to Follow-up|13
270759|NCT01098071|897250|P1|Overall Study|Surgery (adenoidectomy)|2
270760|NCT01098032|897263|P2|Overall Study|Withdrawal by Subject|1
270761|NCT01098032|897264|P1|Overall Study|Withdrawal by Subject|1
270762|NCT01097863|897292|P3|Overall Study|Did not return for final visit|1
270763|NCT01097863|897293|P2|Overall Study|Did not return for final visit|0
270764|NCT01097863|897294|P1|Overall Study|Did not return for final visit|0
270765|NCT01097863|897292|P3|Overall Study|Discomfort|1
270766|NCT01097863|897293|P2|Overall Study|Discomfort|0
270767|NCT01097863|897294|P1|Overall Study|Discomfort|1
270768|NCT01097694|897315|P2|Overall Study|Withdrawal by Subject|1
270769|NCT01097694|897316|P1|Overall Study|Withdrawal by Subject|3
270770|NCT01097694|897315|P2|Overall Study|Lost to Follow-up|3
270771|NCT01097694|897316|P1|Overall Study|Lost to Follow-up|0
270772|NCT01097694|897315|P2|Overall Study|Adverse Event|0
270773|NCT01097694|897316|P1|Overall Study|Adverse Event|5
270774|NCT01097668|897378|P2|Overall Study|Lost to Follow-up|0
270775|NCT01097668|897379|P1|Overall Study|Lost to Follow-up|1
270776|NCT01097668|897378|P2|Overall Study|Withdrawal by Subject|2
270777|NCT01097668|897379|P1|Overall Study|Withdrawal by Subject|1
270778|NCT01097655|897389|P1|Overall Study|Did Not Meet Inclusion Criteria|8
270779|NCT01097655|897389|P1|Overall Study|Subject Documented Twice|1
270780|NCT01097655|897389|P1|Overall Study|Withdrawal by Subject|1
270781|NCT01097629|897399|P8|DB RO Phase|Lost to Follow-up|0
270782|NCT01097629|897400|P7|DB RO Phase|Lost to Follow-up|2
270783|NCT01097629|897401|P6|DB RO Phase|Lost to Follow-up|0
270784|NCT01097629|897402|P5|DB RO Phase|Lost to Follow-up|0
270785|NCT01097629|897403|P4|DB RO Phase|Lost to Follow-up|0
270786|NCT01097629|897404|P3|DB RO Phase|Lost to Follow-up|0
270787|NCT01097629|897405|P2|DB RO Phase|Lost to Follow-up|0
270788|NCT01097629|897406|P1|DB RO Phase|Lost to Follow-up|0
270789|NCT01097629|897399|P8|DB RO Phase|Protocol Violation|0
270790|NCT01097629|897400|P7|DB RO Phase|Protocol Violation|1
270791|NCT01097629|897401|P6|DB RO Phase|Protocol Violation|1
270792|NCT01097629|897402|P5|DB RO Phase|Protocol Violation|0
270793|NCT01097629|897403|P4|DB RO Phase|Protocol Violation|1
270794|NCT01097629|897404|P3|DB RO Phase|Protocol Violation|0
270795|NCT01097629|897405|P2|DB RO Phase|Protocol Violation|0
270796|NCT01097629|897406|P1|DB RO Phase|Protocol Violation|0
270797|NCT01097629|897399|P8|DB RO Phase|Withdrawal by Subject|1
270798|NCT01097629|897400|P7|DB RO Phase|Withdrawal by Subject|0
270799|NCT01097629|897401|P6|DB RO Phase|Withdrawal by Subject|0
270800|NCT01097629|897402|P5|DB RO Phase|Withdrawal by Subject|0
270801|NCT01097629|897403|P4|DB RO Phase|Withdrawal by Subject|0
270802|NCT01097629|897404|P3|DB RO Phase|Withdrawal by Subject|0
270803|NCT01097629|897405|P2|DB RO Phase|Withdrawal by Subject|0
270804|NCT01097629|897406|P1|DB RO Phase|Withdrawal by Subject|0
270805|NCT01097629|897399|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270806|NCT01097629|897400|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270807|NCT01097629|897401|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270808|NCT01097629|897402|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270809|NCT01097629|897403|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270810|NCT01097629|897404|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
270811|NCT01097629|897405|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
270812|NCT01097629|897406|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
270813|NCT01097629|897399|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270814|NCT01097629|897400|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270815|NCT01097629|897401|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270816|NCT01097629|897402|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270817|NCT01097629|897403|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270818|NCT01097629|897404|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270819|NCT01097629|897405|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
270820|NCT01097629|897406|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
270821|NCT01097629|897399|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270822|NCT01097629|897400|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270823|NCT01097629|897401|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270824|NCT01097629|897402|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270825|NCT01097629|897403|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270826|NCT01097629|897404|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
270827|NCT01097629|897405|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
270828|NCT01097629|897406|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
270829|NCT01097629|897399|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270830|NCT01097629|897400|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270831|NCT01097629|897401|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270832|NCT01097629|897402|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270833|NCT01097629|897403|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270834|NCT01097629|897404|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
270835|NCT01097629|897405|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
270836|NCT01097629|897406|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
270837|NCT01097629|897399|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270838|NCT01097629|897400|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270839|NCT01097629|897401|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270840|NCT01097629|897402|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270841|NCT01097629|897403|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270842|NCT01097629|897404|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
270843|NCT01097629|897405|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
270844|NCT01097629|897406|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
270845|NCT01097629|897399|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270846|NCT01097629|897400|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270847|NCT01097629|897401|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270848|NCT01097629|897402|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270849|NCT01097629|897403|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270850|NCT01097629|897404|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
270851|NCT01097629|897405|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
270852|NCT01097629|897406|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
270853|NCT01097629|897399|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
270854|NCT01097629|897400|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
270855|NCT01097629|897401|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
270856|NCT01097629|897402|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
270857|NCT01097629|897403|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
270858|NCT01097629|897404|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
270859|NCT01097629|897405|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
270860|NCT01097629|897406|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
270861|NCT01097616|897457|P8|DB RO Phase|Not Treated in RO|0
270862|NCT01097616|897458|P7|DB RO Phase|Not Treated in RO|0
270863|NCT01097616|897459|P6|DB RO Phase|Not Treated in RO|1
270864|NCT01097616|897460|P5|DB RO Phase|Not Treated in RO|0
270865|NCT01097616|897461|P4|DB RO Phase|Not Treated in RO|0
270866|NCT01097616|897462|P3|DB RO Phase|Not Treated in RO|0
270867|NCT01097616|897463|P2|DB RO Phase|Not Treated in RO|0
270868|NCT01097616|897464|P1|DB RO Phase|Not Treated in RO|0
270869|NCT01097616|897457|P8|DB RO Phase|Lost to Follow-up|1
270870|NCT01097616|897458|P7|DB RO Phase|Lost to Follow-up|0
270871|NCT01097616|897459|P6|DB RO Phase|Lost to Follow-up|0
270872|NCT01097616|897460|P5|DB RO Phase|Lost to Follow-up|1
270873|NCT01097616|897461|P4|DB RO Phase|Lost to Follow-up|1
270874|NCT01097616|897462|P3|DB RO Phase|Lost to Follow-up|0
270875|NCT01097616|897463|P2|DB RO Phase|Lost to Follow-up|0
270876|NCT01097616|897464|P1|DB RO Phase|Lost to Follow-up|0
270877|NCT01097616|897457|P8|DB RO Phase|Withdrawal by Subject|0
270878|NCT01097616|897458|P7|DB RO Phase|Withdrawal by Subject|0
270879|NCT01097616|897459|P6|DB RO Phase|Withdrawal by Subject|1
270880|NCT01097616|897460|P5|DB RO Phase|Withdrawal by Subject|0
270881|NCT01097616|897461|P4|DB RO Phase|Withdrawal by Subject|0
270882|NCT01097616|897462|P3|DB RO Phase|Withdrawal by Subject|0
270883|NCT01097616|897463|P2|DB RO Phase|Withdrawal by Subject|0
270884|NCT01097616|897464|P1|DB RO Phase|Withdrawal by Subject|0
270885|NCT01097616|897457|P8|DB RO Phase|Adverse Event|0
270886|NCT01097616|897458|P7|DB RO Phase|Adverse Event|1
270887|NCT01097616|897459|P6|DB RO Phase|Adverse Event|0
270888|NCT01097616|897460|P5|DB RO Phase|Adverse Event|0
270889|NCT01097616|897461|P4|DB RO Phase|Adverse Event|0
270890|NCT01097616|897462|P3|DB RO Phase|Adverse Event|0
270891|NCT01097616|897463|P2|DB RO Phase|Adverse Event|0
270892|NCT01097616|897464|P1|DB RO Phase|Adverse Event|0
270893|NCT01097616|897457|P8|Optional DB EXT Phase|Physician Decision|0
270894|NCT01097616|897458|P7|Optional DB EXT Phase|Physician Decision|0
270895|NCT01097616|897459|P6|Optional DB EXT Phase|Physician Decision|0
270896|NCT01097616|897460|P5|Optional DB EXT Phase|Physician Decision|0
270897|NCT01097616|897461|P4|Optional DB EXT Phase|Physician Decision|0
270898|NCT01097616|897462|P3|Optional DB EXT Phase|Physician Decision|0
270899|NCT01097616|897463|P2|Optional DB EXT Phase|Physician Decision|0
270900|NCT01097616|897464|P1|Optional DB EXT Phase|Physician Decision|1
270901|NCT01097616|897457|P8|Optional DB EXT Phase|Lack of Efficacy|0
270902|NCT01097616|897458|P7|Optional DB EXT Phase|Lack of Efficacy|0
270903|NCT01097616|897459|P6|Optional DB EXT Phase|Lack of Efficacy|0
270904|NCT01097616|897460|P5|Optional DB EXT Phase|Lack of Efficacy|0
270905|NCT01097616|897461|P4|Optional DB EXT Phase|Lack of Efficacy|0
270906|NCT01097616|897462|P3|Optional DB EXT Phase|Lack of Efficacy|1
270907|NCT01097616|897463|P2|Optional DB EXT Phase|Lack of Efficacy|1
270908|NCT01097616|897464|P1|Optional DB EXT Phase|Lack of Efficacy|1
270909|NCT01097616|897457|P8|Optional DB EXT Phase|Lost to Follow-up|0
270910|NCT01097616|897458|P7|Optional DB EXT Phase|Lost to Follow-up|0
270911|NCT01097616|897459|P6|Optional DB EXT Phase|Lost to Follow-up|0
270912|NCT01097616|897460|P5|Optional DB EXT Phase|Lost to Follow-up|0
270913|NCT01097616|897461|P4|Optional DB EXT Phase|Lost to Follow-up|0
270914|NCT01097616|897462|P3|Optional DB EXT Phase|Lost to Follow-up|1
270915|NCT01097616|897463|P2|Optional DB EXT Phase|Lost to Follow-up|5
270916|NCT01097616|897464|P1|Optional DB EXT Phase|Lost to Follow-up|1
270917|NCT01097616|897457|P8|Optional DB EXT Phase|Protocol Violation|0
270918|NCT01097616|897458|P7|Optional DB EXT Phase|Protocol Violation|0
270919|NCT01097616|897459|P6|Optional DB EXT Phase|Protocol Violation|0
270920|NCT01097616|897460|P5|Optional DB EXT Phase|Protocol Violation|0
270921|NCT01097616|897461|P4|Optional DB EXT Phase|Protocol Violation|0
270922|NCT01097616|897462|P3|Optional DB EXT Phase|Protocol Violation|3
270923|NCT01097616|897463|P2|Optional DB EXT Phase|Protocol Violation|2
270924|NCT01097616|897464|P1|Optional DB EXT Phase|Protocol Violation|0
270925|NCT01097616|897457|P8|Optional DB EXT Phase|Withdrawal by Subject|0
270926|NCT01097616|897458|P7|Optional DB EXT Phase|Withdrawal by Subject|0
270927|NCT01097616|897459|P6|Optional DB EXT Phase|Withdrawal by Subject|0
270928|NCT01097616|897460|P5|Optional DB EXT Phase|Withdrawal by Subject|0
270929|NCT01097616|897461|P4|Optional DB EXT Phase|Withdrawal by Subject|0
270930|NCT01097616|897462|P3|Optional DB EXT Phase|Withdrawal by Subject|3
270931|NCT01097616|897463|P2|Optional DB EXT Phase|Withdrawal by Subject|6
270932|NCT01097616|897464|P1|Optional DB EXT Phase|Withdrawal by Subject|12
270933|NCT01097616|897457|P8|Optional DB EXT Phase|Adverse Event|0
270934|NCT01097616|897458|P7|Optional DB EXT Phase|Adverse Event|0
270935|NCT01097616|897459|P6|Optional DB EXT Phase|Adverse Event|0
270936|NCT01097616|897460|P5|Optional DB EXT Phase|Adverse Event|0
270937|NCT01097616|897461|P4|Optional DB EXT Phase|Adverse Event|0
270938|NCT01097616|897462|P3|Optional DB EXT Phase|Adverse Event|2
270939|NCT01097616|897463|P2|Optional DB EXT Phase|Adverse Event|7
270940|NCT01097616|897464|P1|Optional DB EXT Phase|Adverse Event|0
270941|NCT01097616|897457|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270942|NCT01097616|897458|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270943|NCT01097616|897459|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270944|NCT01097616|897460|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270945|NCT01097616|897461|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270946|NCT01097616|897462|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
270947|NCT01097616|897463|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270948|NCT01097616|897464|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
270949|NCT01097616|897457|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270950|NCT01097616|897458|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270951|NCT01097616|897459|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270952|NCT01097616|897460|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270953|NCT01097616|897461|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270954|NCT01097616|897462|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
270955|NCT01097616|897463|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
270956|NCT01097616|897464|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
270957|NCT01097616|897457|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
270958|NCT01097616|897458|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
270959|NCT01097616|897459|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
270960|NCT01097616|897460|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
270961|NCT01097616|897461|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
270962|NCT01097616|897462|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
270963|NCT01097616|897463|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
270964|NCT01097616|897464|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
270965|NCT01097616|897457|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270966|NCT01097616|897458|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270967|NCT01097616|897459|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270968|NCT01097616|897460|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270969|NCT01097616|897461|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
270970|NCT01097616|897462|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
270971|NCT01097616|897463|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
270972|NCT01097616|897464|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
270973|NCT01097616|897457|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270974|NCT01097616|897458|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270975|NCT01097616|897459|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270976|NCT01097616|897460|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270977|NCT01097616|897461|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270978|NCT01097616|897462|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
270979|NCT01097616|897463|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
270980|NCT01097616|897464|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
270981|NCT01097616|897457|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270982|NCT01097616|897458|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270983|NCT01097616|897459|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270984|NCT01097616|897460|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270985|NCT01097616|897461|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
270986|NCT01097616|897462|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
270987|NCT01097616|897463|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
270988|NCT01097616|897464|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
270989|NCT01097616|897457|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270990|NCT01097616|897458|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270991|NCT01097616|897459|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270992|NCT01097616|897460|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270993|NCT01097616|897461|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
270994|NCT01097616|897462|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
270995|NCT01097616|897463|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
270996|NCT01097616|897464|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
270997|NCT01097616|897457|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
270998|NCT01097616|897458|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
270999|NCT01097616|897459|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
271000|NCT01097616|897460|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
271001|NCT01097616|897461|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
271002|NCT01097616|897462|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
271003|NCT01097616|897463|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
271004|NCT01097616|897464|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
271005|NCT01096589|897539|P4|Overall Study|found treatment exhausting|1
271006|NCT01096589|897540|P3|Overall Study|found treatment exhausting|0
271007|NCT01096589|897541|P2|Overall Study|found treatment exhausting|0
271008|NCT01096589|897542|P1|Overall Study|found treatment exhausting|0
271009|NCT01096589|897539|P4|Overall Study|Compliance with protocol|0
271010|NCT01096589|897540|P3|Overall Study|Compliance with protocol|1
271011|NCT01096589|897541|P2|Overall Study|Compliance with protocol|0
271012|NCT01096589|897542|P1|Overall Study|Compliance with protocol|0
271013|NCT01096589|897539|P4|Overall Study|Withdrawal by Subject|1
271014|NCT01096589|897540|P3|Overall Study|Withdrawal by Subject|1
271015|NCT01096589|897541|P2|Overall Study|Withdrawal by Subject|1
271016|NCT01096589|897542|P1|Overall Study|Withdrawal by Subject|2
271017|NCT01096589|897539|P4|Overall Study|Adverse Event|1
271018|NCT01096589|897540|P3|Overall Study|Adverse Event|2
271019|NCT01096589|897541|P2|Overall Study|Adverse Event|1
271020|NCT01096589|897542|P1|Overall Study|Adverse Event|2
271021|NCT01096550|897554|P2|Overall Study|Lost to Follow-up|9
271022|NCT01096550|897555|P1|Overall Study|Lost to Follow-up|12
271023|NCT01096550|897554|P2|Overall Study|non-African American participant|6
271024|NCT01096550|897555|P1|Overall Study|non-African American participant|13
271025|NCT01096550|897554|P2|Overall Study|Withdrawal by Subject|1
271026|NCT01096550|897555|P1|Overall Study|Withdrawal by Subject|0
271027|NCT01096550|897554|P2|Overall Study|clinic readmission|1
271028|NCT01096550|897555|P1|Overall Study|clinic readmission|1
271029|NCT01096550|897554|P2|Overall Study|non-regular treatment track at clinic|1
271030|NCT01096550|897555|P1|Overall Study|non-regular treatment track at clinic|1
271031|NCT01096550|897554|P2|Overall Study|discontinued site|11
271032|NCT01096550|897555|P1|Overall Study|discontinued site|10
271033|NCT01097421|897565|P1|Overall Study|Withdrawal by Subject|3
271034|NCT01097421|897565|P1|Overall Study|Lost to Follow-up|1
271035|NCT01097421|897565|P1|Overall Study|Protocol Violation|2
271036|NCT01097421|897565|P1|Overall Study|Adverse Event|8
271037|NCT01097005|897586|P1|Overall Study|Discontinuance by complication|50
271038|NCT01097005|897586|P1|Overall Study|Adverse Event|14
271039|NCT01097005|897586|P1|Overall Study|Deviation from exclusion criteria|37
271040|NCT01097005|897586|P1|Overall Study|No examination data available|244
271041|NCT01097005|897586|P1|Overall Study|Poor medication compliance|1
271042|NCT01097005|897586|P1|Overall Study|Subjects cannot visit the hospital|1
271043|NCT01097005|897586|P1|Overall Study|Case Report Form not collected|18
271044|NCT01096784|897630|P2|Overall Study|Other Unspecified|1
271045|NCT01096784|897631|P1|Overall Study|Other Unspecified|0
271046|NCT01096784|897630|P2|Overall Study|Administrative Decision|1
271047|NCT01096784|897631|P1|Overall Study|Administrative Decision|0
271048|NCT01096784|897630|P2|Overall Study|Protocol Deviation|2
271049|NCT01096784|897631|P1|Overall Study|Protocol Deviation|2
271050|NCT01096784|897630|P2|Overall Study|Adverse Event|9
271051|NCT01096784|897631|P1|Overall Study|Adverse Event|11
271052|NCT01096784|897630|P2|Overall Study|Withdrawal by Subject|1
271053|NCT01096784|897631|P1|Overall Study|Withdrawal by Subject|2
271054|NCT01096446|897733|P2|Overall Study|Protocol Violation|0
271055|NCT01096446|897734|P1|Overall Study|Protocol Violation|2
271056|NCT01096446|897733|P2|Overall Study|Death|0
271057|NCT01096446|897734|P1|Overall Study|Death|1
271058|NCT01096342|897739|P1|Overall Study|Protocol Violation|1
271059|NCT01096316|897747|P2|Overall Study|Lost to Follow-up|9
271060|NCT01096316|897748|P1|Overall Study|Lost to Follow-up|15
271061|NCT01096186|897758|P1|Overall Study|Noncompliance with study drug|1
271062|NCT01096186|897758|P1|Overall Study|Physician Decision|1
271063|NCT01096186|897758|P1|Overall Study|Withdrawal by Subject|22
271064|NCT01096186|897758|P1|Overall Study|Lost to Follow-up|2
271065|NCT01096186|897758|P1|Overall Study|Lack of Efficacy|4
271066|NCT01096186|897758|P1|Overall Study|Death|4
271067|NCT01096186|897758|P1|Overall Study|Adverse Event|16
271068|NCT01096056|897766|P2|Overall Study|Lost to Follow-up|1
271069|NCT01096056|897767|P1|Overall Study|Lost to Follow-up|0
271070|NCT01096017|897799|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
271071|NCT01096017|897800|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
271072|NCT01095978|897828|P1|Overall Study|Adverse Event|1
271073|NCT01095978|897828|P1|Overall Study|Did not take Klacid SR|2
271074|NCT01095835|897862|P3|Overall Study|Protocol Violation|0
271075|NCT01095835|897863|P2|Overall Study|Protocol Violation|2
271076|NCT01095835|897864|P1|Overall Study|Protocol Violation|1
271077|NCT01095835|897862|P3|Overall Study|Non study compliance|1
271078|NCT01095835|897863|P2|Overall Study|Non study compliance|0
271079|NCT01095835|897864|P1|Overall Study|Non study compliance|0
271080|NCT01095835|897862|P3|Overall Study|Withdrawal by Subject|0
271081|NCT01095835|897863|P2|Overall Study|Withdrawal by Subject|3
271082|NCT01095835|897864|P1|Overall Study|Withdrawal by Subject|1
271083|NCT01095835|897862|P3|Overall Study|Physician Decision|1
271084|NCT01095835|897863|P2|Overall Study|Physician Decision|0
271085|NCT01095835|897864|P1|Overall Study|Physician Decision|0
271086|NCT01095835|897862|P3|Overall Study|Lack of Efficacy|0
271087|NCT01095835|897863|P2|Overall Study|Lack of Efficacy|1
271088|NCT01095835|897864|P1|Overall Study|Lack of Efficacy|0
271089|NCT01095835|897862|P3|Overall Study|Adverse Event|6
271090|NCT01095835|897863|P2|Overall Study|Adverse Event|6
271091|NCT01095835|897864|P1|Overall Study|Adverse Event|8
271092|NCT01095796|897902|P2|Overall Study|Participant Transferred to Another Study|200
271093|NCT01095796|897903|P1|Overall Study|Participant Transferred to Another Study|215
271094|NCT01095796|897902|P2|Overall Study|Protocol Violation|0
271095|NCT01095796|897903|P1|Overall Study|Protocol Violation|1
271096|NCT01095796|897902|P2|Overall Study|Participant Noncompliance|10
271097|NCT01095796|897903|P1|Overall Study|Participant Noncompliance|5
271098|NCT01095796|897902|P2|Overall Study|Lost to Follow-up|29
271099|NCT01095796|897903|P1|Overall Study|Lost to Follow-up|27
271100|NCT01095796|897902|P2|Overall Study|Withdrew Consent|22
271101|NCT01095796|897903|P1|Overall Study|Withdrew Consent|16
271102|NCT01095796|897902|P2|Overall Study|Investigator's Discretion|2
271103|NCT01095796|897903|P1|Overall Study|Investigator's Discretion|7
271104|NCT01095796|897902|P2|Overall Study|Lack of Efficacy|3
271105|NCT01095796|897903|P1|Overall Study|Lack of Efficacy|5
271106|NCT01095796|897902|P2|Overall Study|Pregnancy|0
271107|NCT01095796|897903|P1|Overall Study|Pregnancy|2
271108|NCT01095796|897902|P2|Overall Study|Death|2
271109|NCT01095796|897903|P1|Overall Study|Death|3
271110|NCT01095796|897902|P2|Overall Study|Adverse Event|19
271111|NCT01095796|897903|P1|Overall Study|Adverse Event|9
271112|NCT01095796|897902|P2|Overall Study|Randomized but Not Treated|2
271113|NCT01095796|897903|P1|Overall Study|Randomized but Not Treated|5
271114|NCT01095653|897933|P3|Overall Study|non-compliance, not met criteria, etc.|5
271115|NCT01095653|897934|P2|Overall Study|non-compliance, not met criteria, etc.|6
271116|NCT01095653|897935|P1|Overall Study|non-compliance, not met criteria, etc.|10
271117|NCT01095653|897933|P3|Overall Study|Withdrawal by Subject|3
271118|NCT01095653|897934|P2|Overall Study|Withdrawal by Subject|5
271119|NCT01095653|897935|P1|Overall Study|Withdrawal by Subject|4
271120|NCT01095653|897933|P3|Overall Study|Lost to Follow-up|4
271121|NCT01095653|897934|P2|Overall Study|Lost to Follow-up|0
271122|NCT01095653|897935|P1|Overall Study|Lost to Follow-up|1
271123|NCT01095653|897933|P3|Overall Study|Adverse Event|4
271124|NCT01095653|897934|P2|Overall Study|Adverse Event|4
271125|NCT01095653|897935|P1|Overall Study|Adverse Event|1
271126|NCT01095653|897933|P3|Overall Study|Lack of Efficacy|0
271127|NCT01095653|897934|P2|Overall Study|Lack of Efficacy|0
271128|NCT01095653|897935|P1|Overall Study|Lack of Efficacy|3
271129|NCT01095250|897993|P4|Overall Study|Withdrawal by Subject|0
271130|NCT01095250|897994|P3|Overall Study|Withdrawal by Subject|1
271131|NCT01095250|897995|P2|Overall Study|Withdrawal by Subject|0
271132|NCT01095250|897996|P1|Overall Study|Withdrawal by Subject|0
271133|NCT01095250|897993|P4|Overall Study|administrative reasons|5
271134|NCT01095250|897994|P3|Overall Study|administrative reasons|7
271135|NCT01095250|897995|P2|Overall Study|administrative reasons|10
271136|NCT01095250|897996|P1|Overall Study|administrative reasons|8
271137|NCT01095094|898026|P1|Overall Study|Physician Decision|1
271138|NCT01095094|898026|P1|Overall Study|Death|1
271139|NCT01095094|898026|P1|Overall Study|Withdrawal by Subject|1
271140|NCT01094886|898031|P1|Overall Study|Withdrawal by Subject|5
271141|NCT01094886|898031|P1|Overall Study|Adverse Event|2
271142|NCT01094808|898041|P3|Overall Study|Withdrawal by Subject|0
271143|NCT01094808|898042|P2|Overall Study|Withdrawal by Subject|1
271144|NCT01094808|898043|P1|Overall Study|Withdrawal by Subject|1
271145|NCT01094743|898078|P1|Period 1|Unsatisfactory comfort at lens fitting|2
271146|NCT01094730|898095|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
271147|NCT01094730|898096|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
271148|NCT01094730|898095|P2|Period 2 (14 Days)|Adverse Event|1
271149|NCT01094730|898096|P1|Period 2 (14 Days)|Adverse Event|0
271150|NCT01094730|898095|P2|Period 2 (14 Days)|No time for the follow-up visit|0
271151|NCT01094730|898096|P1|Period 2 (14 Days)|No time for the follow-up visit|1
271152|NCT01094730|898095|P2|Period 2 (14 Days)|Protocol Violation|0
271153|NCT01094730|898096|P1|Period 2 (14 Days)|Protocol Violation|2
271154|NCT01094730|898095|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
271155|NCT01094730|898096|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
271156|NCT01094730|898095|P2|Period 1 (14 Days)|No time for the follow-up visit|0
271157|NCT01094730|898096|P1|Period 1 (14 Days)|No time for the follow-up visit|1
271158|NCT01094730|898095|P2|Period 1 (14 Days)|Withdrawal by Subject|1
271159|NCT01094730|898096|P1|Period 1 (14 Days)|Withdrawal by Subject|0
271160|NCT01094730|898095|P2|Period 1 (14 Days)|Lost to Follow-up|1
271161|NCT01094730|898096|P1|Period 1 (14 Days)|Lost to Follow-up|0
271162|NCT01093222|898200|P1|Overall Study|Not protocol specified|1
271163|NCT01093222|898200|P1|Overall Study|Death|2
271164|NCT01093222|898200|P1|Overall Study|Progression/relapse|24
271165|NCT01093222|898200|P1|Overall Study|Adverse Event|7
271166|NCT01093222|898200|P1|Overall Study|Ineligible|6
271167|NCT01094171|898207|P1|Overall Study|Unspecified|1
271168|NCT01094171|898207|P1|Overall Study|Migration from the study area|3
271169|NCT01094171|898207|P1|Overall Study|Informed consent withdrawal|4
271170|NCT01094171|898207|P1|Overall Study|Lost to Follow-up|2
271171|NCT01094119|898216|P2|Overall Study|Lack of Efficacy|4
271172|NCT01094119|898217|P1|Overall Study|Lack of Efficacy|2
271173|NCT01093846|898232|P3|Overall Study|Administrative Problems|15
271174|NCT01093846|898233|P2|Overall Study|Administrative Problems|17
271175|NCT01093846|898234|P1|Overall Study|Administrative Problems|18
271176|NCT01093846|898232|P3|Overall Study|Condition no longer required study drug|1
271177|NCT01093846|898233|P2|Overall Study|Condition no longer required study drug|1
271178|NCT01093846|898234|P1|Overall Study|Condition no longer required study drug|1
271179|NCT01093846|898232|P3|Overall Study|Lack of Efficacy|4
271180|NCT01093846|898233|P2|Overall Study|Lack of Efficacy|0
271181|NCT01093846|898234|P1|Overall Study|Lack of Efficacy|0
271182|NCT01093846|898232|P3|Overall Study|Adverse Event|1
271183|NCT01093846|898233|P2|Overall Study|Adverse Event|0
271184|NCT01093846|898234|P1|Overall Study|Adverse Event|0
271185|NCT01093755|898259|P2|Overall Study|Withdrawal by Subject|4
271186|NCT01093755|898260|P1|Overall Study|Withdrawal by Subject|3
271187|NCT01093625|898300|P2|1-Year Visit|Lost to Follow-up|3
271188|NCT01093625|898301|P1|1-Year Visit|Lost to Follow-up|5
271189|NCT01093625|898300|P2|6-Month Visit|Lost to Follow-up|2
271190|NCT01093625|898301|P1|6-Month Visit|Lost to Follow-up|2
271191|NCT01093625|898300|P2|6-Month Visit|Withdrawal by Subject|7
271192|NCT01093625|898301|P1|6-Month Visit|Withdrawal by Subject|6
271193|NCT01093625|898300|P2|3-Month Visit|Lost to Follow-up|0
271194|NCT01093625|898301|P1|3-Month Visit|Lost to Follow-up|2
271195|NCT01093625|898300|P2|1-Month Visit|Lost to Follow-up|0
271196|NCT01093625|898301|P1|1-Month Visit|Lost to Follow-up|2
271197|NCT01093625|898300|P2|2-Week Visit|Withdrawal by Subject|0
271198|NCT01093625|898301|P1|2-Week Visit|Withdrawal by Subject|1
271199|NCT01093625|898300|P2|Baseline and Dispensed|Withdrawal by Subject|0
271200|NCT01093625|898301|P1|Baseline and Dispensed|Withdrawal by Subject|2
271201|NCT01093599|898321|P2|Overall Study|Lost to Follow-up|46
271202|NCT01093599|898322|P1|Overall Study|Lost to Follow-up|32
271203|NCT01093534|898331|P3|Overall Study|Other|4
271204|NCT01093534|898332|P2|Overall Study|Other|3
271205|NCT01093534|898333|P1|Overall Study|Other|1
271206|NCT01093534|898331|P3|Overall Study|Withdrawal by Subject|2
271207|NCT01093534|898332|P2|Overall Study|Withdrawal by Subject|7
271208|NCT01093534|898333|P1|Overall Study|Withdrawal by Subject|5
271209|NCT01093534|898331|P3|Overall Study|Lack of Efficacy|1
271210|NCT01093534|898332|P2|Overall Study|Lack of Efficacy|1
271211|NCT01093534|898333|P1|Overall Study|Lack of Efficacy|2
271212|NCT01093534|898331|P3|Overall Study|Adverse Event|2
271213|NCT01093534|898332|P2|Overall Study|Adverse Event|5
271214|NCT01093534|898333|P1|Overall Study|Adverse Event|2
271215|NCT01092832|898534|P2|Overall Study|Not specified|0
271216|NCT01092832|898535|P1|Overall Study|Not specified|1
271217|NCT01092780|898547|P4|Washout Period 2|Adverse Event|0
271218|NCT01092780|898548|P3|Washout Period 2|Adverse Event|1
271219|NCT01092780|898549|P2|Washout Period 2|Adverse Event|1
271220|NCT01092780|898550|P1|Washout Period 2|Adverse Event|0
271221|NCT01092780|898547|P4|Washout Period 1|Noncompliance with nCPAP|0
271222|NCT01092780|898548|P3|Washout Period 1|Noncompliance with nCPAP|0
271223|NCT01092780|898549|P2|Washout Period 1|Noncompliance with nCPAP|0
271224|NCT01092780|898550|P1|Washout Period 1|Noncompliance with nCPAP|1
271225|NCT01092780|898547|P4|Washout Period 1|Adverse Event|0
271226|NCT01092780|898548|P3|Washout Period 1|Adverse Event|0
271227|NCT01092780|898549|P2|Washout Period 1|Adverse Event|1
271228|NCT01092780|898550|P1|Washout Period 1|Adverse Event|0
271229|NCT01092728|898586|P2|Overall Study|Prohibited Concomitant Medications|0
271230|NCT01092728|898587|P1|Overall Study|Prohibited Concomitant Medications|1
271231|NCT01092728|898586|P2|Overall Study|Disease Progression|13
271232|NCT01092728|898587|P1|Overall Study|Disease Progression|1
271233|NCT01092728|898586|P2|Overall Study|Adverse Event|1
271234|NCT01092728|898587|P1|Overall Study|Adverse Event|0
271235|NCT01092728|898586|P2|Overall Study|Withdrawal by Subject|0
271236|NCT01092728|898587|P1|Overall Study|Withdrawal by Subject|2
271237|NCT01092702|898595|P1|Overall Study|Lost to Follow-up|2
271238|NCT01092702|898595|P1|Overall Study|Withdrawal by Subject|7
271239|NCT01092663|898601|P2|Overall Study|Protocol Violation|1
271240|NCT01092663|898602|P1|Overall Study|Protocol Violation|0
271241|NCT01092663|898601|P2|Overall Study|Adverse Event|1
271242|NCT01092663|898602|P1|Overall Study|Adverse Event|1
271243|NCT01092663|898601|P2|Overall Study|High fasting triglyceride|0
271244|NCT01092663|898602|P1|Overall Study|High fasting triglyceride|2
271245|NCT01092663|898601|P2|Overall Study|Glucose >300mg/dL|0
271246|NCT01092663|898602|P1|Overall Study|Glucose >300mg/dL|1
271247|NCT01092663|898601|P2|Overall Study|Withdrawal by Subject|2
271248|NCT01092663|898602|P1|Overall Study|Withdrawal by Subject|3
271249|NCT01092637|898650|P2|Overall Study|Death|49
271250|NCT01092637|898651|P1|Overall Study|Death|47
271251|NCT01092546|898666|P1|Overall Study|Subjects withdrawn prior to dosing|4
271252|NCT01092507|898673|P2|Overall Study|Withdrawal by Subject|0
271253|NCT01092507|898674|P1|Overall Study|Withdrawal by Subject|2
271254|NCT01092416|898709|P1|12-Month Follow-up|Data collected after close of 1Y window|2
271255|NCT01092416|898709|P1|12-Month Follow-up|Missed 1-year follow-up|1
271256|NCT01092416|898709|P1|12-Month Follow-up|Withdrawal by Subject|2
271257|NCT01092416|898709|P1|12-Month Follow-up|Lost to Follow-up|4
271258|NCT01092416|898709|P1|12-Month Follow-up|Death|16
271259|NCT01092416|898709|P1|30-Day Follow-up|Data collected after close of 30D window|5
271260|NCT01092416|898709|P1|30-Day Follow-up|Missed 30-day follow-up|3
271261|NCT01092416|898709|P1|30-Day Follow-up|Death|2
271262|NCT01092416|898709|P1|Enrollment|Atherectomy device not inserted|3
271263|NCT01091974|898733|P4|Overall Study|side-effects|2
271264|NCT01091974|898734|P3|Overall Study|side-effects|0
271265|NCT01091974|898735|P2|Overall Study|side-effects|1
271266|NCT01091974|898736|P1|Overall Study|side-effects|1
271267|NCT01091974|898733|P4|Overall Study|Withdrawal by Subject|2
271268|NCT01091974|898734|P3|Overall Study|Withdrawal by Subject|2
271269|NCT01091974|898735|P2|Overall Study|Withdrawal by Subject|3
271270|NCT01091974|898736|P1|Overall Study|Withdrawal by Subject|1
271271|NCT01091974|898733|P4|Overall Study|resumed sleep medication|2
271272|NCT01091974|898734|P3|Overall Study|resumed sleep medication|1
271273|NCT01091974|898735|P2|Overall Study|resumed sleep medication|0
271274|NCT01091974|898736|P1|Overall Study|resumed sleep medication|0
271275|NCT01091974|898733|P4|Overall Study|Did not start intervention|1
271276|NCT01091974|898734|P3|Overall Study|Did not start intervention|3
271277|NCT01091974|898735|P2|Overall Study|Did not start intervention|1
271278|NCT01091974|898736|P1|Overall Study|Did not start intervention|3
271279|NCT01091675|898771|P1|Overall Study|Lack of Efficacy|27
271280|NCT01091675|898771|P1|Overall Study|Adverse Event|7
271281|NCT01091662|898777|P2|Overall Study|unable to swallow capsule|1
271282|NCT01091662|898778|P1|Overall Study|unable to swallow capsule|0
271283|NCT01091662|898777|P2|Overall Study|Protocol Violation|2
271284|NCT01091662|898778|P1|Overall Study|Protocol Violation|0
271285|NCT01091662|898777|P2|Overall Study|Pregnancy|1
271286|NCT01091662|898778|P1|Overall Study|Pregnancy|0
271287|NCT01091662|898777|P2|Overall Study|Lost to Follow-up|1
271288|NCT01091662|898778|P1|Overall Study|Lost to Follow-up|0
271289|NCT01091662|898777|P2|Overall Study|met exclusion criteria|0
271290|NCT01091662|898778|P1|Overall Study|met exclusion criteria|1
271291|NCT01091662|898777|P2|Overall Study|met exit criteria|13
271292|NCT01091662|898778|P1|Overall Study|met exit criteria|7
271293|NCT01091662|898777|P2|Overall Study|Withdrawal by Subject|6
271294|NCT01091662|898778|P1|Overall Study|Withdrawal by Subject|7
271295|NCT01091662|898777|P2|Overall Study|Physician Decision|1
271296|NCT01091662|898778|P1|Overall Study|Physician Decision|1
271297|NCT01091662|898777|P2|Overall Study|Adverse Event|9
271298|NCT01091662|898778|P1|Overall Study|Adverse Event|1
271299|NCT01091519|898816|P2|Overall Study|Randomized not treated|4
271300|NCT01091519|898817|P1|Overall Study|Randomized not treated|4
271301|NCT01091519|898816|P2|Overall Study|Unspecified|8
271302|NCT01091519|898817|P1|Overall Study|Unspecified|6
271303|NCT01091519|898816|P2|Overall Study|Withdrawal by Subject|2
271304|NCT01091519|898817|P1|Overall Study|Withdrawal by Subject|2
271305|NCT01091519|898816|P2|Overall Study|Lost to Follow-up|24
271306|NCT01091519|898817|P1|Overall Study|Lost to Follow-up|14
271307|NCT01091519|898816|P2|Overall Study|Lack of Efficacy|19
271308|NCT01091519|898817|P1|Overall Study|Lack of Efficacy|16
271309|NCT01091519|898816|P2|Overall Study|Death|0
271310|NCT01091519|898817|P1|Overall Study|Death|1
271311|NCT01091519|898816|P2|Overall Study|Adverse Event|16
271312|NCT01091519|898817|P1|Overall Study|Adverse Event|12
271313|NCT01091454|898829|P1|Overall Study|Ineligible|1
271314|NCT01091259|898838|P1|Overall Study|Lack of Efficacy|2
271315|NCT01091259|898838|P1|Overall Study|Adverse Event|3
271316|NCT01091246|898849|P3|Overall Study|Subject not dosed|1
271317|NCT01091246|898850|P2|Overall Study|Subject not dosed|0
271318|NCT01091246|898851|P1|Overall Study|Subject not dosed|2
271319|NCT01091246|898849|P3|Overall Study|Withdrawal by Subject|4
271320|NCT01091246|898850|P2|Overall Study|Withdrawal by Subject|5
271321|NCT01091246|898851|P1|Overall Study|Withdrawal by Subject|9
271322|NCT01091246|898849|P3|Overall Study|Adverse Event|1
271323|NCT01091246|898850|P2|Overall Study|Adverse Event|0
271324|NCT01091246|898851|P1|Overall Study|Adverse Event|1
271325|NCT01091246|898849|P3|Overall Study|Lost to Follow-up|7
271326|NCT01091246|898850|P2|Overall Study|Lost to Follow-up|11
271327|NCT01091246|898851|P1|Overall Study|Lost to Follow-up|23
271328|NCT01091103|898990|P1|Overall Study|Progressive Disease|3
271329|NCT01091103|898990|P1|Overall Study|Adverse Event|1
271330|NCT01090973|899010|P1|Overall Study|Disease progression|1
271331|NCT01090765|899026|P6|Overall Study|Vasovagal reaction with first infusion|0
271332|NCT01090765|899027|P5|Overall Study|Vasovagal reaction with first infusion|1
271333|NCT01090765|899028|P4|Overall Study|Vasovagal reaction with first infusion|0
271334|NCT01090765|899029|P3|Overall Study|Vasovagal reaction with first infusion|0
271335|NCT01090765|899030|P2|Overall Study|Vasovagal reaction with first infusion|0
271336|NCT01090765|899031|P1|Overall Study|Vasovagal reaction with first infusion|0
271337|NCT01090765|899026|P6|Overall Study|Developed a DVT, needed anticoagulation|0
271338|NCT01090765|899027|P5|Overall Study|Developed a DVT, needed anticoagulation|0
271339|NCT01090765|899028|P4|Overall Study|Developed a DVT, needed anticoagulation|1
271340|NCT01090765|899029|P3|Overall Study|Developed a DVT, needed anticoagulation|0
271341|NCT01090765|899030|P2|Overall Study|Developed a DVT, needed anticoagulation|0
271342|NCT01090765|899031|P1|Overall Study|Developed a DVT, needed anticoagulation|0
271343|NCT01090765|899026|P6|Overall Study|Patient withdrew consent|1
271344|NCT01090765|899027|P5|Overall Study|Patient withdrew consent|1
271345|NCT01090765|899028|P4|Overall Study|Patient withdrew consent|0
271346|NCT01090765|899029|P3|Overall Study|Patient withdrew consent|0
271347|NCT01090765|899030|P2|Overall Study|Patient withdrew consent|0
271348|NCT01090765|899031|P1|Overall Study|Patient withdrew consent|0
271349|NCT01090739|899059|P1|36 Month Follow-up|Visit still pending|17
271350|NCT01090739|899059|P1|36 Month Follow-up|Withdrawal by Subject|6
271351|NCT01090739|899059|P1|24 Month Follow-up|Death|1
271352|NCT01090739|899059|P1|24 Month Follow-up|Lost to Follow-up|1
271353|NCT01090739|899059|P1|24 Month Follow-up|Withdrawal by Subject|7
271354|NCT01090739|899059|P1|12 Month Follow-up|Death|1
271355|NCT01090739|899059|P1|12 Month Follow-up|Physician Decision|1
271356|NCT01090739|899059|P1|12 Month Follow-up|Lost to Follow-up|1
271357|NCT01090739|899059|P1|12 Month Follow-up|Withdrawal by Subject|2
271358|NCT01090739|899059|P1|Enrollment|Adverse Event|1
271359|NCT01090739|899059|P1|Enrollment|Study implant limit reached|2
271360|NCT01090739|899059|P1|Enrollment|Sponsor termination of site|4
271361|NCT01090739|899059|P1|Enrollment|Physician Decision|5
271362|NCT01090739|899059|P1|Enrollment|Lost to Follow-up|5
271363|NCT01090739|899059|P1|Enrollment|Protocol Violation|14
271364|NCT01090739|899059|P1|Enrollment|Withdrawal by Subject|24
271365|NCT01090453|899087|P2|Overall Study|Eligibility Criteria|1
271366|NCT01090453|899088|P1|Overall Study|Eligibility Criteria|0
271367|NCT01090453|899087|P2|Overall Study|Unspecified|4
271368|NCT01090453|899088|P1|Overall Study|Unspecified|2
271369|NCT01090453|899087|P2|Overall Study|Protocol Violation|0
271370|NCT01090453|899088|P1|Overall Study|Protocol Violation|2
271371|NCT01090453|899087|P2|Overall Study|Non serious AEs|0
271372|NCT01090453|899088|P1|Overall Study|Non serious AEs|1
271373|NCT01090453|899087|P2|Overall Study|Lost to Follow-up|7
271374|NCT01090453|899088|P1|Overall Study|Lost to Follow-up|7
271375|NCT01090453|899087|P2|Overall Study|Withdrawal by Subject|2
271376|NCT01090453|899088|P1|Overall Study|Withdrawal by Subject|1
271377|NCT01090427|899135|P7|After Controlled Period|Adverse Event|0
271378|NCT01090427|899136|P6|After Controlled Period|Adverse Event|1
271379|NCT01090427|899137|P5|After Controlled Period|Adverse Event|0
271380|NCT01090427|899138|P4|After Controlled Period|Adverse Event|2
271381|NCT01090427|899139|P3|After Controlled Period|Adverse Event|0
271382|NCT01090427|899140|P2|After Controlled Period|Adverse Event|0
271383|NCT01090427|899141|P1|After Controlled Period|Adverse Event|0
271384|NCT01090427|899135|P7|After Controlled Period|Lack of Efficacy|2
271385|NCT01090427|899136|P6|After Controlled Period|Lack of Efficacy|3
271386|NCT01090427|899137|P5|After Controlled Period|Lack of Efficacy|0
271387|NCT01090427|899138|P4|After Controlled Period|Lack of Efficacy|0
271388|NCT01090427|899139|P3|After Controlled Period|Lack of Efficacy|0
271389|NCT01090427|899140|P2|After Controlled Period|Lack of Efficacy|0
271390|NCT01090427|899141|P1|After Controlled Period|Lack of Efficacy|0
271391|NCT01090427|899135|P7|After Controlled Period|Death|0
271392|NCT01090427|899136|P6|After Controlled Period|Death|1
271393|NCT01090427|899137|P5|After Controlled Period|Death|0
271394|NCT01090427|899138|P4|After Controlled Period|Death|0
271395|NCT01090427|899139|P3|After Controlled Period|Death|0
271396|NCT01090427|899140|P2|After Controlled Period|Death|0
271397|NCT01090427|899141|P1|After Controlled Period|Death|0
271398|NCT01090323|899176|P2|Overall Study|Stopped end of extension 1#|1
271399|NCT01090323|899177|P1|Overall Study|Stopped end of extension 1#|3
271400|NCT01090323|899176|P2|Overall Study|Stopped end of core|0
271401|NCT01090323|899177|P1|Overall Study|Stopped end of core|7
271402|NCT01090323|899176|P2|Overall Study|Death|2
271403|NCT01090323|899177|P1|Overall Study|Death|1
271404|NCT01090323|899176|P2|Overall Study|Administrative problems|4
271405|NCT01090323|899177|P1|Overall Study|Administrative problems|6
271406|NCT01090323|899176|P2|Overall Study|Lost to Follow-up|6
271407|NCT01090323|899177|P1|Overall Study|Lost to Follow-up|11
271408|NCT01090323|899176|P2|Overall Study|Withdrew consent|11
271409|NCT01090323|899177|P1|Overall Study|Withdrew consent|33
271410|NCT01090323|899176|P2|Overall Study|Protocol Violation|1
271411|NCT01090323|899177|P1|Overall Study|Protocol Violation|2
271412|NCT01090323|899176|P2|Overall Study|Condition no longer requires drug|4
271413|NCT01090323|899177|P1|Overall Study|Condition no longer requires drug|5
271414|NCT01090323|899176|P2|Overall Study|Unsatisfactory therapeutic effect|2
271415|NCT01090323|899177|P1|Overall Study|Unsatisfactory therapeutic effect|4
271416|NCT01090323|899176|P2|Overall Study|Abnormal Test Procedure Results|0
271417|NCT01090323|899177|P1|Overall Study|Abnormal Test Procedure Results|2
271418|NCT01090323|899176|P2|Overall Study|Abnormal Lab Values|1
271419|NCT01090323|899177|P1|Overall Study|Abnormal Lab Values|3
271420|NCT01090323|899176|P2|Overall Study|Adverse Event|2
271421|NCT01090323|899177|P1|Overall Study|Adverse Event|12
271422|NCT01090310|899189|P4|Extension Study|Subject withdrew consent|0
271423|NCT01090310|899190|P3|Extension Study|Subject withdrew consent|0
271424|NCT01090310|899191|P2|Extension Study|Subject withdrew consent|1
271425|NCT01090310|899192|P1|Extension Study|Subject withdrew consent|0
271426|NCT01090310|899189|P4|Extension Study|Unsatisfactory therapeutic effect|1
271427|NCT01090310|899190|P3|Extension Study|Unsatisfactory therapeutic effect|1
271428|NCT01090310|899191|P2|Extension Study|Unsatisfactory therapeutic effect|0
271429|NCT01090310|899192|P1|Extension Study|Unsatisfactory therapeutic effect|1
271430|NCT01090310|899189|P4|Extension Study|Adverse Event|1
271431|NCT01090310|899190|P3|Extension Study|Adverse Event|0
271432|NCT01090310|899191|P2|Extension Study|Adverse Event|0
271433|NCT01090310|899192|P1|Extension Study|Adverse Event|0
271434|NCT01090310|899189|P4|Extension Study|Aministrative problems|18
271435|NCT01090310|899190|P3|Extension Study|Aministrative problems|14
271436|NCT01090310|899191|P2|Extension Study|Aministrative problems|15
271437|NCT01090310|899192|P1|Extension Study|Aministrative problems|13
271438|NCT01090310|899189|P4|Core Study|Protocol deviation|1
271439|NCT01090310|899190|P3|Core Study|Protocol deviation|0
271440|NCT01090310|899191|P2|Core Study|Protocol deviation|0
271441|NCT01090310|899192|P1|Core Study|Protocol deviation|1
271442|NCT01090310|899189|P4|Core Study|Administrative reasons|4
271443|NCT01090310|899190|P3|Core Study|Administrative reasons|4
271444|NCT01090310|899191|P2|Core Study|Administrative reasons|6
271445|NCT01090310|899192|P1|Core Study|Administrative reasons|5
271446|NCT01090310|899189|P4|Core Study|Abnormal test procedure result|0
271447|NCT01090310|899190|P3|Core Study|Abnormal test procedure result|1
271448|NCT01090310|899191|P2|Core Study|Abnormal test procedure result|0
271449|NCT01090310|899192|P1|Core Study|Abnormal test procedure result|0
271450|NCT01090310|899189|P4|Core Study|Subject withdrew consent|1
271451|NCT01090310|899190|P3|Core Study|Subject withdrew consent|1
271452|NCT01090310|899191|P2|Core Study|Subject withdrew consent|3
271453|NCT01090310|899192|P1|Core Study|Subject withdrew consent|0
271454|NCT01090310|899189|P4|Core Study|Adverse Event|1
271455|NCT01090310|899190|P3|Core Study|Adverse Event|1
271456|NCT01090310|899191|P2|Core Study|Adverse Event|2
271457|NCT01090310|899192|P1|Core Study|Adverse Event|2
271458|NCT01090102|899231|P2|Second 12 Weeks|Withdrawal by Subject|1
271459|NCT01090102|899232|P1|Second 12 Weeks|Withdrawal by Subject|0
271460|NCT01090102|899231|P2|First 12 Weeks|Death|1
271461|NCT01090102|899232|P1|First 12 Weeks|Death|1
271462|NCT01090102|899231|P2|First 12 Weeks|Adverse Event|0
271463|NCT01090102|899232|P1|First 12 Weeks|Adverse Event|2
271464|NCT01090102|899231|P2|First 12 Weeks|Withdrawal by Subject|1
271465|NCT01090102|899232|P1|First 12 Weeks|Withdrawal by Subject|1
271466|NCT01090076|899242|P2|Overall Study|Withdrawal by Subject|1
271467|NCT01090076|899243|P1|Overall Study|Withdrawal by Subject|0
271468|NCT01090076|899242|P2|Overall Study|Death|1
271469|NCT01090076|899243|P1|Overall Study|Death|1
271470|NCT01090063|899253|P1|Treatment|Withdrawal by Subject|4
271471|NCT01090063|899253|P1|Screen|Screen Failed|4
271472|NCT01090050|899269|P2|Overall Study|Physician Decision|1
271473|NCT01090050|899270|P1|Overall Study|Physician Decision|0
271474|NCT01090050|899269|P2|Overall Study|Lack of Efficacy|5
271475|NCT01090050|899270|P1|Overall Study|Lack of Efficacy|1
271476|NCT01090050|899269|P2|Overall Study|Lost to Follow-up|1
271477|NCT01090050|899270|P1|Overall Study|Lost to Follow-up|0
271478|NCT01090011|899290|P1|Overall Study|Other reason not defined above|5
271479|NCT01090011|899290|P1|Overall Study|Refusal to start/continue medication|5
271480|NCT01090011|899290|P1|Overall Study|Protocol Violation|1
271481|NCT01090011|899290|P1|Overall Study|Adverse Event|32
271482|NCT01090011|899290|P1|Overall Study|Progressive disease|128
271483|NCT01089608|899383|P2|Overall Study|Lost to Follow-up|2
271484|NCT01089608|899384|P1|Overall Study|Lost to Follow-up|0
271485|NCT01089608|899383|P2|Overall Study|Adverse Event|4
271486|NCT01089608|899384|P1|Overall Study|Adverse Event|0
271487|NCT01089582|899401|P1|Overall Study|Withdrawal by Subject|1
271488|NCT01089582|899401|P1|Overall Study|Unspecified|4
271489|NCT01089582|899401|P1|Overall Study|Lost to Follow-up|8
271490|NCT01089582|899401|P1|Overall Study|Adverse Event|15
271491|NCT01089582|899401|P1|Overall Study|Death|2
271492|NCT01089556|899444|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
271493|NCT01089556|899445|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
271494|NCT01089556|899446|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
271495|NCT01089556|899447|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
271496|NCT01089556|899448|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
271497|NCT01089556|899449|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
271498|NCT01089556|899444|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
271499|NCT01089556|899445|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
271500|NCT01089556|899446|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
271501|NCT01089556|899447|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
271502|NCT01089556|899448|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
271503|NCT01089556|899449|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
271504|NCT01089556|899444|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
271505|NCT01089556|899445|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
271506|NCT01089556|899446|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
271507|NCT01089556|899447|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
271508|NCT01089556|899448|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
271509|NCT01089556|899449|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
271510|NCT01089556|899444|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
271511|NCT01089556|899445|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
271512|NCT01089556|899446|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
271513|NCT01089556|899447|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
271514|NCT01089556|899448|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
271515|NCT01089556|899449|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
271516|NCT01089556|899444|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
271517|NCT01089556|899445|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
271518|NCT01089556|899446|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
271519|NCT01089556|899447|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
271520|NCT01089556|899448|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
271521|NCT01089556|899449|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
271522|NCT01089556|899444|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
271523|NCT01089556|899445|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
271524|NCT01089556|899446|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
271525|NCT01089556|899447|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
271526|NCT01089556|899448|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
271527|NCT01089556|899449|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
271528|NCT01089556|899444|P6|Study Period III (Weeks 9-16)|Adverse Event|3
271529|NCT01089556|899445|P5|Study Period III (Weeks 9-16)|Adverse Event|4
271530|NCT01089556|899446|P4|Study Period III (Weeks 9-16)|Adverse Event|2
271531|NCT01089556|899447|P3|Study Period III (Weeks 9-16)|Adverse Event|4
271532|NCT01089556|899448|P2|Study Period III (Weeks 9-16)|Adverse Event|0
271533|NCT01089556|899449|P1|Study Period III (Weeks 9-16)|Adverse Event|0
271534|NCT01089556|899444|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
271535|NCT01089556|899445|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
271536|NCT01089556|899446|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
271537|NCT01089556|899447|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
271538|NCT01089556|899448|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
271539|NCT01089556|899449|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
271540|NCT01089556|899444|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
271541|NCT01089556|899445|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
271542|NCT01089556|899446|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
271543|NCT01089556|899447|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
271544|NCT01089556|899448|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
271545|NCT01089556|899449|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
271546|NCT01089556|899444|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
271547|NCT01089556|899445|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
271548|NCT01089556|899446|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
271549|NCT01089556|899447|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
271550|NCT01089556|899448|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
271551|NCT01089556|899449|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
271552|NCT01089556|899444|P6|Study Period II (Weeks 1-8)|Physician Decision|0
271553|NCT01089556|899445|P5|Study Period II (Weeks 1-8)|Physician Decision|0
271554|NCT01089556|899446|P4|Study Period II (Weeks 1-8)|Physician Decision|0
271555|NCT01089556|899447|P3|Study Period II (Weeks 1-8)|Physician Decision|0
271556|NCT01089556|899448|P2|Study Period II (Weeks 1-8)|Physician Decision|0
271557|NCT01089556|899449|P1|Study Period II (Weeks 1-8)|Physician Decision|4
271558|NCT01089556|899444|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
271559|NCT01089556|899445|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
271560|NCT01089556|899446|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
271561|NCT01089556|899447|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
271562|NCT01089556|899448|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
271563|NCT01089556|899449|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
271564|NCT01089556|899444|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
271565|NCT01089556|899445|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
271566|NCT01089556|899446|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
271567|NCT01089556|899447|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
271568|NCT01089556|899448|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
271569|NCT01089556|899449|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
271570|NCT01089556|899444|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
271571|NCT01089556|899445|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
271572|NCT01089556|899446|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
271573|NCT01089556|899447|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
271574|NCT01089556|899448|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
271575|NCT01089556|899449|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
271576|NCT01089556|899444|P6|Study Period II (Weeks 1-8)|Adverse Event|0
271577|NCT01089556|899445|P5|Study Period II (Weeks 1-8)|Adverse Event|0
271578|NCT01089556|899446|P4|Study Period II (Weeks 1-8)|Adverse Event|0
271579|NCT01089556|899447|P3|Study Period II (Weeks 1-8)|Adverse Event|0
271580|NCT01089556|899448|P2|Study Period II (Weeks 1-8)|Adverse Event|39
271581|NCT01089556|899449|P1|Study Period II (Weeks 1-8)|Adverse Event|35
271582|NCT01089543|899523|P4|Overall Study|Adverse Event|0
271583|NCT01089543|899524|P3|Overall Study|Adverse Event|0
271584|NCT01089543|899525|P2|Overall Study|Adverse Event|1
271585|NCT01089543|899526|P1|Overall Study|Adverse Event|0
271586|NCT01089543|899523|P4|Overall Study|Physician Decision|1
271587|NCT01089543|899524|P3|Overall Study|Physician Decision|0
271588|NCT01089543|899525|P2|Overall Study|Physician Decision|0
271589|NCT01089543|899526|P1|Overall Study|Physician Decision|1
271590|NCT01089543|899523|P4|Overall Study|Withdrawal by Subject|1
271591|NCT01089543|899524|P3|Overall Study|Withdrawal by Subject|3
271592|NCT01089543|899525|P2|Overall Study|Withdrawal by Subject|3
271593|NCT01089543|899526|P1|Overall Study|Withdrawal by Subject|2
271594|NCT01089504|899561|P2|Overall Study|Withdrawal by Subject|0
271595|NCT01089504|899562|P1|Overall Study|Withdrawal by Subject|2
271596|NCT01089504|899561|P2|Overall Study|Lost to Follow-up|1
271597|NCT01089504|899562|P1|Overall Study|Lost to Follow-up|1
271598|NCT01089413|899575|P1|Overall Study|Unspecified|71
271599|NCT01089413|899575|P1|Overall Study|Metastasectomy|13
271600|NCT01089413|899575|P1|Overall Study|Death|10
271601|NCT01089413|899575|P1|Overall Study|Unacceptable Toxicity|12
271602|NCT01089413|899575|P1|Overall Study|Participant Withdrew Consent|1
271603|NCT01089413|899575|P1|Overall Study|Progressive Disease|93
271604|NCT01089413|899575|P1|Overall Study|Lost to Follow-up|1
271605|NCT01089127|899623|P6|Overall Study|Protocol deviation|0
271606|NCT01089127|899624|P5|Overall Study|Protocol deviation|1
271607|NCT01089127|899625|P4|Overall Study|Protocol deviation|0
271608|NCT01089127|899626|P3|Overall Study|Protocol deviation|0
271609|NCT01089127|899627|P2|Overall Study|Protocol deviation|1
271610|NCT01089127|899628|P1|Overall Study|Protocol deviation|0
271611|NCT01089127|899623|P6|Overall Study|Lost to Follow-up|0
271612|NCT01089127|899624|P5|Overall Study|Lost to Follow-up|1
271613|NCT01089127|899625|P4|Overall Study|Lost to Follow-up|0
271614|NCT01089127|899626|P3|Overall Study|Lost to Follow-up|0
271615|NCT01089127|899627|P2|Overall Study|Lost to Follow-up|1
271616|NCT01089127|899628|P1|Overall Study|Lost to Follow-up|1
271617|NCT01089127|899623|P6|Overall Study|Abnormal test procedure result(s)|0
271618|NCT01089127|899624|P5|Overall Study|Abnormal test procedure result(s)|0
271619|NCT01089127|899625|P4|Overall Study|Abnormal test procedure result(s)|0
271620|NCT01089127|899626|P3|Overall Study|Abnormal test procedure result(s)|0
271621|NCT01089127|899627|P2|Overall Study|Abnormal test procedure result(s)|1
271622|NCT01089127|899628|P1|Overall Study|Abnormal test procedure result(s)|2
271623|NCT01089127|899623|P6|Overall Study|Subject withdrew consent|2
271624|NCT01089127|899624|P5|Overall Study|Subject withdrew consent|0
271625|NCT01089127|899625|P4|Overall Study|Subject withdrew consent|1
271626|NCT01089127|899626|P3|Overall Study|Subject withdrew consent|1
271627|NCT01089127|899627|P2|Overall Study|Subject withdrew consent|1
271628|NCT01089127|899628|P1|Overall Study|Subject withdrew consent|0
271629|NCT01089127|899623|P6|Overall Study|Adverse Event|1
271630|NCT01089127|899624|P5|Overall Study|Adverse Event|0
271631|NCT01089127|899625|P4|Overall Study|Adverse Event|0
271632|NCT01089127|899626|P3|Overall Study|Adverse Event|1
271633|NCT01089127|899627|P2|Overall Study|Adverse Event|1
271634|NCT01089127|899628|P1|Overall Study|Adverse Event|5
271635|NCT01089023|899682|P1|Overall Study|Lack of Efficacy|1
271636|NCT01089023|899682|P1|Overall Study|Protocol Violation|1
271637|NCT01089023|899682|P1|Overall Study|Withdrawal by Subject|1
271638|NCT01089023|899682|P1|Overall Study|Adverse Event|1
271639|NCT01089023|899682|P1|Overall Study|Lost to Follow-up|3
271640|NCT01088997|899696|P2|Overall Study|Excluded prior to receiving drug|1
271641|NCT01088997|899697|P1|Overall Study|Excluded prior to receiving drug|1
271642|NCT01088997|899696|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
271643|NCT01088997|899697|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
271644|NCT01088997|899696|P2|Overall Study|Physician Decision|1
271645|NCT01088997|899697|P1|Overall Study|Physician Decision|1
271646|NCT01088984|899708|P2|Phase 2|Not Specified|1
271647|NCT01088984|899709|P1|Phase 2|Not Specified|0
271648|NCT01088984|899708|P2|Phase 2|DIsease Progression|25
271649|NCT01088984|899709|P1|Phase 2|DIsease Progression|0
271650|NCT01088984|899708|P2|Phase 2|Withdrawal by Subject|1
271651|NCT01088984|899709|P1|Phase 2|Withdrawal by Subject|0
271652|NCT01088984|899708|P2|Phase 2|Death|5
271653|NCT01088984|899709|P1|Phase 2|Death|0
271654|NCT01088984|899708|P2|Phase 1|Not Specified|1
271655|NCT01088984|899709|P1|Phase 1|Not Specified|1
271656|NCT01088984|899708|P2|Phase 1|Disease Progression|4
271657|NCT01088984|899709|P1|Phase 1|Disease Progression|2
271658|NCT01088984|899708|P2|Phase 1|Death|1
271659|NCT01088984|899709|P1|Phase 1|Death|2
271660|NCT01088529|899770|P2|Overall Study|Did not receive study treatment|1
271661|NCT01088529|899771|P1|Overall Study|Did not receive study treatment|0
271662|NCT01088503|899784|P3|Overall Study|Death|7
271663|NCT01088503|899785|P2|Overall Study|Death|358
271664|NCT01088503|899786|P1|Overall Study|Death|64
271665|NCT01088503|899784|P3|Overall Study|Withdrawal by Subject|10
271666|NCT01088503|899785|P2|Overall Study|Withdrawal by Subject|327
271667|NCT01088503|899786|P1|Overall Study|Withdrawal by Subject|118
271668|NCT01088438|899864|P2|Overall Study|Lost to Follow-up|30
271669|NCT01088438|899865|P1|Overall Study|Lost to Follow-up|18
271670|NCT01088438|899864|P2|Overall Study|Withdrawal by Subject|6
271671|NCT01088438|899865|P1|Overall Study|Withdrawal by Subject|11
271672|NCT01088399|899878|P3|Overall Study|Study summary visit not completed|80
271673|NCT01088399|899879|P2|Overall Study|Study summary visit not completed|283
271674|NCT01088399|899880|P1|Overall Study|Study summary visit not completed|2398
271675|NCT01088399|899878|P3|Overall Study|Enrollment criteria not met|70
271676|NCT01088399|899879|P2|Overall Study|Enrollment criteria not met|119
271677|NCT01088399|899880|P1|Overall Study|Enrollment criteria not met|48
271678|NCT01088399|899878|P3|Overall Study|Protocol Violation|0
271679|NCT01088399|899879|P2|Overall Study|Protocol Violation|1
271680|NCT01088399|899880|P1|Overall Study|Protocol Violation|10
271681|NCT01088399|899878|P3|Overall Study|Sponsor decision|7
271682|NCT01088399|899879|P2|Overall Study|Sponsor decision|298
271683|NCT01088399|899880|P1|Overall Study|Sponsor decision|1573
271684|NCT01088399|899878|P3|Overall Study|Change to or start of somatropin therapy|12
271685|NCT01088399|899879|P2|Overall Study|Change to or start of somatropin therapy|17
271686|NCT01088399|899880|P1|Overall Study|Change to or start of somatropin therapy|234
271687|NCT01088399|899878|P3|Overall Study|Withdrawal by Subject|33
271688|NCT01088399|899879|P2|Overall Study|Withdrawal by Subject|195
271689|NCT01088399|899880|P1|Overall Study|Withdrawal by Subject|544
271690|NCT01088399|899878|P3|Overall Study|Physician Decision|16
271691|NCT01088399|899879|P2|Overall Study|Physician Decision|88
271692|NCT01088399|899880|P1|Overall Study|Physician Decision|531
271693|NCT01088399|899878|P3|Overall Study|Lost to Follow-up|58
271694|NCT01088399|899879|P2|Overall Study|Lost to Follow-up|278
271695|NCT01088399|899880|P1|Overall Study|Lost to Follow-up|1070
271696|NCT01088399|899878|P3|Overall Study|Lack of Efficacy|5
271697|NCT01088399|899879|P2|Overall Study|Lack of Efficacy|7
271698|NCT01088399|899880|P1|Overall Study|Lack of Efficacy|298
271699|NCT01088399|899878|P3|Overall Study|Death|0
271700|NCT01088399|899879|P2|Overall Study|Death|45
271701|NCT01088399|899880|P1|Overall Study|Death|204
271702|NCT01088399|899878|P3|Overall Study|Adverse Event|0
271703|NCT01088399|899879|P2|Overall Study|Adverse Event|16
271704|NCT01088399|899880|P1|Overall Study|Adverse Event|211
271705|NCT01087970|899932|P1|Overall Study|Protocol Violation|2
271706|NCT01087957|899944|P2|Overall Study|Physician Decision|9
271707|NCT01087957|899945|P1|Overall Study|Physician Decision|5
271708|NCT01087957|899944|P2|Overall Study|Withdrawal by Subject|15
271709|NCT01087957|899945|P1|Overall Study|Withdrawal by Subject|18
271710|NCT01087957|899944|P2|Overall Study|Protocol Violation|25
271711|NCT01087957|899945|P1|Overall Study|Protocol Violation|13
271712|NCT01087957|899944|P2|Overall Study|Lost to Follow-up|4
271713|NCT01087957|899945|P1|Overall Study|Lost to Follow-up|3
271714|NCT01087957|899944|P2|Overall Study|Death|2
271715|NCT01087957|899945|P1|Overall Study|Death|2
271716|NCT01087944|899971|P2|Period 2 (Week 4-6)|Adverse Event|2
271717|NCT01087944|899972|P1|Period 2 (Week 4-6)|Adverse Event|0
271718|NCT01087944|899971|P2|Period 1 (Week 1-3)|Adverse Event|0
271719|NCT01087944|899972|P1|Period 1 (Week 1-3)|Adverse Event|1
271720|NCT01087905|900037|P8|Overall Study|Withdrawal by Subject|5
271721|NCT01087905|900038|P7|Overall Study|Withdrawal by Subject|3
271722|NCT01087905|900039|P6|Overall Study|Withdrawal by Subject|3
271723|NCT01087905|900040|P5|Overall Study|Withdrawal by Subject|4
271724|NCT01087905|900041|P4|Overall Study|Withdrawal by Subject|5
271725|NCT01087905|900042|P3|Overall Study|Withdrawal by Subject|4
271726|NCT01087905|900043|P2|Overall Study|Withdrawal by Subject|4
271727|NCT01087905|900044|P1|Overall Study|Withdrawal by Subject|5
271728|NCT01087905|900037|P8|Overall Study|Lost to Follow-up|24
271729|NCT01087905|900038|P7|Overall Study|Lost to Follow-up|20
271730|NCT01087905|900039|P6|Overall Study|Lost to Follow-up|25
271731|NCT01087905|900040|P5|Overall Study|Lost to Follow-up|27
271732|NCT01087905|900041|P4|Overall Study|Lost to Follow-up|31
271733|NCT01087905|900042|P3|Overall Study|Lost to Follow-up|18
271734|NCT01087905|900043|P2|Overall Study|Lost to Follow-up|28
271735|NCT01087905|900044|P1|Overall Study|Lost to Follow-up|24
271736|NCT01087814|900066|P2|Second Intervention (5 Days)|Physician Decision|0
271737|NCT01087814|900067|P1|Second Intervention (5 Days)|Physician Decision|1
271738|NCT01087814|900066|P2|First Intervention (5 Days)|Withdrawal by Subject|1
271739|NCT01087814|900067|P1|First Intervention (5 Days)|Withdrawal by Subject|3
271740|NCT01087788|900085|P3|Open-Label Period (OL-P)|Personal reasons|1
271741|NCT01087788|900086|P2|Open-Label Period (OL-P)|Personal reasons|0
271742|NCT01087788|900087|P1|Open-Label Period (OL-P)|Personal reasons|0
271743|NCT01087788|900085|P3|Open-Label Period (OL-P)|No participation in study extension|1
271744|NCT01087788|900086|P2|Open-Label Period (OL-P)|No participation in study extension|0
271745|NCT01087788|900087|P1|Open-Label Period (OL-P)|No participation in study extension|0
271746|NCT01087788|900085|P3|Open-Label Period (OL-P)|Principal investigator decision|2
271747|NCT01087788|900086|P2|Open-Label Period (OL-P)|Principal investigator decision|1
271748|NCT01087788|900087|P1|Open-Label Period (OL-P)|Principal investigator decision|0
271749|NCT01087788|900085|P3|Open-Label Period (OL-P)|Sponsor request|0
271750|NCT01087788|900086|P2|Open-Label Period (OL-P)|Sponsor request|0
271751|NCT01087788|900087|P1|Open-Label Period (OL-P)|Sponsor request|1
271752|NCT01087788|900085|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
271753|NCT01087788|900086|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
271754|NCT01087788|900087|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
271755|NCT01087788|900085|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
271756|NCT01087788|900086|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
271757|NCT01087788|900087|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
271758|NCT01087788|900085|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
271759|NCT01087788|900086|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
271760|NCT01087788|900087|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
271761|NCT01087788|900085|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
271762|NCT01087788|900086|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
271763|NCT01087788|900087|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
271764|NCT01087788|900085|P3|Open-Label Period (OL-P)|AE, serious fatal|1
271765|NCT01087788|900086|P2|Open-Label Period (OL-P)|AE, serious fatal|0
271766|NCT01087788|900087|P1|Open-Label Period (OL-P)|AE, serious fatal|2
271767|NCT01087788|900085|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
271768|NCT01087788|900086|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
271769|NCT01087788|900087|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
271770|NCT01087788|900085|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
271771|NCT01087788|900086|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
271772|NCT01087788|900087|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
271773|NCT01087788|900085|P3|Open-Label Period (OL-P)|Protocol Violation|0
271774|NCT01087788|900086|P2|Open-Label Period (OL-P)|Protocol Violation|1
271775|NCT01087788|900087|P1|Open-Label Period (OL-P)|Protocol Violation|2
271776|NCT01087788|900085|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
271777|NCT01087788|900086|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
271778|NCT01087788|900087|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
271779|NCT01087788|900085|P3|24-weeks Dose-blind Period|Patient moved|1
271780|NCT01087788|900086|P2|24-weeks Dose-blind Period|Patient moved|0
271781|NCT01087788|900087|P1|24-weeks Dose-blind Period|Patient moved|0
271782|NCT01087788|900085|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
271783|NCT01087788|900086|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
271784|NCT01087788|900087|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
271785|NCT01087788|900085|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
271786|NCT01087788|900086|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
271787|NCT01087788|900087|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
271788|NCT01087788|900085|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
271789|NCT01087788|900086|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
271790|NCT01087788|900087|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
271791|NCT01087788|900085|P3|24-weeks Dose-blind Period|AE, serious fatal|0
271792|NCT01087788|900086|P2|24-weeks Dose-blind Period|AE, serious fatal|1
271793|NCT01087788|900087|P1|24-weeks Dose-blind Period|AE, serious fatal|0
271794|NCT01087788|900085|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
271795|NCT01087788|900086|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
271796|NCT01087788|900087|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
271797|NCT01087788|900085|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
271798|NCT01087788|900086|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
271799|NCT01087788|900087|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
271800|NCT01087788|900085|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
271801|NCT01087788|900086|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
271802|NCT01087788|900087|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
271953|NCT01086969|900263|P2|Overall Study|Withdrawal by Subject|2
271803|NCT01087788|900085|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
271804|NCT01087788|900086|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
271805|NCT01087788|900087|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
271806|NCT01087788|900085|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
271807|NCT01087788|900086|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
271808|NCT01087788|900087|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
271809|NCT01087788|900085|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
271810|NCT01087788|900086|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
271811|NCT01087788|900087|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
271812|NCT01087788|900085|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
271813|NCT01087788|900086|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
271814|NCT01087788|900087|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
271815|NCT01087788|900085|P3|24-weeks Double-blind Period|AE, unknown type|1
271816|NCT01087788|900086|P2|24-weeks Double-blind Period|AE, unknown type|0
271817|NCT01087788|900087|P1|24-weeks Double-blind Period|AE, unknown type|0
271818|NCT01087788|900085|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
271819|NCT01087788|900086|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
271820|NCT01087788|900087|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
271821|NCT01087788|900085|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
271822|NCT01087788|900086|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
271823|NCT01087788|900087|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
271824|NCT01087788|900085|P3|24-weeks Double-blind Period|AE, serious fatal|1
271825|NCT01087788|900086|P2|24-weeks Double-blind Period|AE, serious fatal|1
271826|NCT01087788|900087|P1|24-weeks Double-blind Period|AE, serious fatal|0
271827|NCT01087788|900085|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
271828|NCT01087788|900086|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
271829|NCT01087788|900087|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
271830|NCT01087788|900085|P3|24-weeks Double-blind Period|Lost to Follow-up|1
271831|NCT01087788|900086|P2|24-weeks Double-blind Period|Lost to Follow-up|1
271832|NCT01087788|900087|P1|24-weeks Double-blind Period|Lost to Follow-up|4
271833|NCT01087788|900085|P3|24-weeks Double-blind Period|Protocol Violation|0
271834|NCT01087788|900086|P2|24-weeks Double-blind Period|Protocol Violation|1
271835|NCT01087788|900087|P1|24-weeks Double-blind Period|Protocol Violation|0
271836|NCT01087788|900085|P3|24-weeks Double-blind Period|Lack of Efficacy|1
271837|NCT01087788|900086|P2|24-weeks Double-blind Period|Lack of Efficacy|0
271838|NCT01087788|900087|P1|24-weeks Double-blind Period|Lack of Efficacy|2
271839|NCT01087762|900117|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
271840|NCT01087762|900118|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
271841|NCT01087762|900119|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
271842|NCT01087762|900120|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
271843|NCT01087762|900121|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
271844|NCT01087762|900117|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
271845|NCT01087762|900118|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
271846|NCT01087762|900119|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
271847|NCT01087762|900120|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
271848|NCT01087762|900121|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
271849|NCT01087762|900117|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
271850|NCT01087762|900118|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
271851|NCT01087762|900119|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
271852|NCT01087762|900120|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
271853|NCT01087762|900121|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
271854|NCT01087762|900117|P5|Open-Label Period (Weeks 48-204)|Unspecified|4
271855|NCT01087762|900118|P4|Open-Label Period (Weeks 48-204)|Unspecified|2
271856|NCT01087762|900119|P3|Open-Label Period (Weeks 48-204)|Unspecified|0
271857|NCT01087762|900120|P2|Open-Label Period (Weeks 48-204)|Unspecified|0
271858|NCT01087762|900121|P1|Open-Label Period (Weeks 48-204)|Unspecified|0
271859|NCT01087762|900117|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
271860|NCT01087762|900118|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
271861|NCT01087762|900119|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
271862|NCT01087762|900120|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
271863|NCT01087762|900121|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
271864|NCT01087762|900117|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
271865|NCT01087762|900118|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
271866|NCT01087762|900119|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
271867|NCT01087762|900120|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
271868|NCT01087762|900121|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
271869|NCT01087762|900117|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
271870|NCT01087762|900118|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
271871|NCT01087762|900119|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
271872|NCT01087762|900120|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
271873|NCT01087762|900121|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
271874|NCT01087762|900117|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
271875|NCT01087762|900118|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
271876|NCT01087762|900119|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
271877|NCT01087762|900120|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
271878|NCT01087762|900121|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
271879|NCT01087762|900117|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
271880|NCT01087762|900118|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
271881|NCT01087762|900119|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
271882|NCT01087762|900120|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
271883|NCT01087762|900121|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
271884|NCT01087762|900117|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
271885|NCT01087762|900118|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
271886|NCT01087762|900119|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
271887|NCT01087762|900120|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
271888|NCT01087762|900121|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
271889|NCT01087762|900117|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
271890|NCT01087762|900118|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
271891|NCT01087762|900119|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
271892|NCT01087762|900120|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
271893|NCT01087762|900121|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
271894|NCT01087762|900117|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
271895|NCT01087762|900118|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
271896|NCT01087762|900119|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
271897|NCT01087762|900120|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
271898|NCT01087762|900121|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
271899|NCT01087762|900117|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
271900|NCT01087762|900118|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
271901|NCT01087762|900119|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
271902|NCT01087762|900120|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
271903|NCT01087762|900121|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
271904|NCT01087736|900169|P2|Overall Study|Withdrawal by Subject|1
271905|NCT01087736|900170|P1|Overall Study|Withdrawal by Subject|0
271906|NCT01087736|900169|P2|Overall Study|Death|1
271907|NCT01087736|900170|P1|Overall Study|Death|0
271908|NCT01087736|900169|P2|Overall Study|Lost to Follow-up|0
271909|NCT01087736|900170|P1|Overall Study|Lost to Follow-up|1
271910|NCT01087723|900180|P2|Overall Study|Reason Not Specified|2
271911|NCT01087723|900181|P1|Overall Study|Reason Not Specified|1
271912|NCT01087723|900180|P2|Overall Study|Lost to Follow-up|4
271913|NCT01087723|900181|P1|Overall Study|Lost to Follow-up|1
271914|NCT01087723|900180|P2|Overall Study|Physician Decision|0
271915|NCT01087723|900181|P1|Overall Study|Physician Decision|2
271916|NCT01087723|900180|P2|Overall Study|Withdrawal by Subject|13
271917|NCT01087723|900181|P1|Overall Study|Withdrawal by Subject|10
271918|NCT01087723|900180|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
271919|NCT01087723|900181|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
271920|NCT01087528|900222|P1|Overall Study|Incomplete CE procedure|6
271921|NCT01087528|900222|P1|Overall Study|Withdrawal by Subject|1
271922|NCT01087502|900228|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
271923|NCT01087502|900229|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
271924|NCT01087502|900228|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
271925|NCT01087502|900229|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
271926|NCT01087502|900228|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
271927|NCT01087502|900229|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
271928|NCT01087502|900228|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
271929|NCT01087502|900229|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
271930|NCT01087502|900228|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
271931|NCT01087502|900229|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
271932|NCT01087502|900228|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
271933|NCT01087502|900229|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
271934|NCT01087502|900228|P2|Up to Final Analysis (Week 52)|Adverse Event|10
271935|NCT01087502|900229|P1|Up to Final Analysis (Week 52)|Adverse Event|17
271936|NCT01087502|900228|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
271937|NCT01087502|900229|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
271938|NCT01087502|900228|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
271939|NCT01087502|900229|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
271940|NCT01087502|900228|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
271941|NCT01087502|900229|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
271942|NCT01087502|900228|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
271943|NCT01087502|900229|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
271944|NCT01087502|900228|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
271945|NCT01087502|900229|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
271946|NCT01087489|900248|P2|Overall Study|unable to survey by telephone|1
271947|NCT01087489|900249|P1|Overall Study|unable to survey by telephone|0
271948|NCT01087489|900248|P2|Overall Study|Death|1
271949|NCT01087489|900249|P1|Overall Study|Death|0
271950|NCT01087489|900248|P2|Overall Study|enrolled in another VA study|1
271951|NCT01087489|900249|P1|Overall Study|enrolled in another VA study|0
271952|NCT01086969|900262|P3|Overall Study|Withdrawal by Subject|0
271954|NCT01086969|900264|P1|Overall Study|Withdrawal by Subject|1
271955|NCT01086423|900374|P3|Overall Study|Lost to Follow-up|1
271956|NCT01086423|900375|P2|Overall Study|Lost to Follow-up|0
271957|NCT01086423|900376|P1|Overall Study|Lost to Follow-up|0
271958|NCT01086423|900374|P3|Overall Study|Withdrawal by Subject|3
271959|NCT01086423|900375|P2|Overall Study|Withdrawal by Subject|1
271960|NCT01086423|900376|P1|Overall Study|Withdrawal by Subject|5
271961|NCT01086423|900374|P3|Overall Study|Adverse event, non-fatal|0
271962|NCT01086423|900375|P2|Overall Study|Adverse event, non-fatal|1
271963|NCT01086423|900376|P1|Overall Study|Adverse event, non-fatal|2
271964|NCT01086423|900374|P3|Overall Study|Adverse event, fatal|0
271965|NCT01086423|900375|P2|Overall Study|Adverse event, fatal|1
271966|NCT01086423|900376|P1|Overall Study|Adverse event, fatal|1
271967|NCT01086423|900374|P3|Overall Study|Migrated/moved from study area|4
271968|NCT01086423|900375|P2|Overall Study|Migrated/moved from study area|0
271969|NCT01086423|900376|P1|Overall Study|Migrated/moved from study area|2
271970|NCT01086423|900374|P3|Overall Study|Protocol Violation|1
271971|NCT01086423|900375|P2|Overall Study|Protocol Violation|0
271972|NCT01086423|900376|P1|Overall Study|Protocol Violation|0
271973|NCT01086410|900421|P4|Overall Study|Lost to Follow-up|0
271974|NCT01086410|900422|P3|Overall Study|Lost to Follow-up|1
271975|NCT01086410|900423|P2|Overall Study|Lost to Follow-up|0
271976|NCT01086410|900424|P1|Overall Study|Lost to Follow-up|0
271977|NCT01086410|900421|P4|Overall Study|Protocol Violation|0
271978|NCT01086410|900422|P3|Overall Study|Protocol Violation|0
271979|NCT01086410|900423|P2|Overall Study|Protocol Violation|1
271980|NCT01086410|900424|P1|Overall Study|Protocol Violation|1
271981|NCT01086410|900421|P4|Overall Study|Lack of Efficacy|0
271982|NCT01086410|900422|P3|Overall Study|Lack of Efficacy|0
271983|NCT01086410|900423|P2|Overall Study|Lack of Efficacy|1
271984|NCT01086410|900424|P1|Overall Study|Lack of Efficacy|1
271985|NCT01086410|900421|P4|Overall Study|Adverse Event|2
271986|NCT01086410|900422|P3|Overall Study|Adverse Event|0
271987|NCT01086410|900423|P2|Overall Study|Adverse Event|0
271988|NCT01086410|900424|P1|Overall Study|Adverse Event|1
271989|NCT01086384|900520|P3|Treatment Period|Received Treatment in Error|0
271990|NCT01086384|900521|P2|Treatment Period|Received Treatment in Error|1
271991|NCT01086384|900522|P1|Treatment Period|Received Treatment in Error|0
271992|NCT01086384|900520|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
271993|NCT01086384|900521|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
271994|NCT01086384|900522|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
271995|NCT01086384|900520|P3|Treatment Period|Study Closed/Terminated|8
271996|NCT01086384|900521|P2|Treatment Period|Study Closed/Terminated|7
271997|NCT01086384|900522|P1|Treatment Period|Study Closed/Terminated|0
271998|NCT01086384|900520|P3|Treatment Period|Physician Decision|6
271999|NCT01086384|900521|P2|Treatment Period|Physician Decision|9
272000|NCT01086384|900522|P1|Treatment Period|Physician Decision|0
272001|NCT01086384|900520|P3|Treatment Period|Lost to Follow-up|9
272002|NCT01086384|900521|P2|Treatment Period|Lost to Follow-up|11
272003|NCT01086384|900522|P1|Treatment Period|Lost to Follow-up|0
272004|NCT01086384|900520|P3|Treatment Period|Adverse Event|15
272005|NCT01086384|900521|P2|Treatment Period|Adverse Event|19
272006|NCT01086384|900522|P1|Treatment Period|Adverse Event|0
272007|NCT01086384|900520|P3|Treatment Period|Lack of Efficacy|13
272008|NCT01086384|900521|P2|Treatment Period|Lack of Efficacy|22
272009|NCT01086384|900522|P1|Treatment Period|Lack of Efficacy|0
272010|NCT01086384|900520|P3|Treatment Period|Protocol Violation|17
272011|NCT01086384|900521|P2|Treatment Period|Protocol Violation|26
272012|NCT01086384|900522|P1|Treatment Period|Protocol Violation|0
272013|NCT01086384|900520|P3|Treatment Period|Withdrawal by Subject|55
272014|NCT01086384|900521|P2|Treatment Period|Withdrawal by Subject|53
272015|NCT01086384|900522|P1|Treatment Period|Withdrawal by Subject|0
272016|NCT01086384|900520|P3|2-week Run-in Period|Randomized in Error|0
272017|NCT01086384|900521|P2|2-week Run-in Period|Randomized in Error|0
272018|NCT01086384|900522|P1|2-week Run-in Period|Randomized in Error|1
272019|NCT01086384|900520|P3|2-week Run-in Period|Continuation Criteria Not Met|0
272020|NCT01086384|900521|P2|2-week Run-in Period|Continuation Criteria Not Met|0
272021|NCT01086384|900522|P1|2-week Run-in Period|Continuation Criteria Not Met|92
272022|NCT01086384|900520|P3|2-week Run-in Period|Study Closed/Terminated|0
272023|NCT01086384|900521|P2|2-week Run-in Period|Study Closed/Terminated|0
272024|NCT01086384|900522|P1|2-week Run-in Period|Study Closed/Terminated|42
272025|NCT01086384|900520|P3|2-week Run-in Period|Withdrawal by Subject|0
272026|NCT01086384|900521|P2|2-week Run-in Period|Withdrawal by Subject|0
272027|NCT01086384|900522|P1|2-week Run-in Period|Withdrawal by Subject|19
272028|NCT01086384|900520|P3|2-week Run-in Period|Physician Decision|0
272029|NCT01086384|900521|P2|2-week Run-in Period|Physician Decision|0
272030|NCT01086384|900522|P1|2-week Run-in Period|Physician Decision|6
272031|NCT01086384|900520|P3|2-week Run-in Period|Lost to Follow-up|0
272032|NCT01086384|900521|P2|2-week Run-in Period|Lost to Follow-up|0
272033|NCT01086384|900522|P1|2-week Run-in Period|Lost to Follow-up|1
272034|NCT01086384|900520|P3|2-week Run-in Period|Protocol Violation|0
272035|NCT01086384|900521|P2|2-week Run-in Period|Protocol Violation|0
272036|NCT01086384|900522|P1|2-week Run-in Period|Protocol Violation|1
272037|NCT01086384|900520|P3|2-week Run-in Period|Adverse Event|0
272038|NCT01086384|900521|P2|2-week Run-in Period|Adverse Event|0
272039|NCT01086384|900522|P1|2-week Run-in Period|Adverse Event|1
272040|NCT01086215|900536|P4|Overall Study|Lost to Follow-up|2
272041|NCT01086215|900537|P3|Overall Study|Lost to Follow-up|18
272042|NCT01086215|900538|P2|Overall Study|Lost to Follow-up|39
272043|NCT01086215|900539|P1|Overall Study|Lost to Follow-up|22
272044|NCT01086215|900536|P4|Overall Study|Death|1
272045|NCT01086215|900537|P3|Overall Study|Death|8
272046|NCT01086215|900538|P2|Overall Study|Death|8
272047|NCT01086215|900539|P1|Overall Study|Death|14
272137|NCT01085136|900850|P3|Part A|Lost to Follow-up|0
272048|NCT01086033|900557|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
272049|NCT01086033|900557|P1|Overall Study|AE and Other Reason|1
272050|NCT01086033|900557|P1|Overall Study|AE and Lost to Follow-up|1
272051|NCT01086033|900557|P1|Overall Study|Death|1
272052|NCT01086033|900557|P1|Overall Study|AE and Lack of Efficacy|4
272053|NCT01086033|900557|P1|Overall Study|Withdrew consent and Other Reason|4
272054|NCT01086033|900557|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
272055|NCT01086033|900557|P1|Overall Study|AE and Withdrew Consent|5
272056|NCT01086033|900557|P1|Overall Study|Other|13
272057|NCT01086033|900557|P1|Overall Study|Other|14
272058|NCT01086033|900557|P1|Overall Study|Withdrawal by Subject|41
272059|NCT01086033|900557|P1|Overall Study|Adverse Event|42
272060|NCT01086033|900557|P1|Overall Study|Lost to Follow-up|86
272061|NCT01086033|900557|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
272062|NCT01085734|900663|P2|Overall Study|Withdrawal by Subject|1
272063|NCT01085734|900664|P1|Overall Study|Withdrawal by Subject|0
272064|NCT01085734|900663|P2|Overall Study|Lost to Follow-up|1
272065|NCT01085734|900664|P1|Overall Study|Lost to Follow-up|0
272066|NCT01085734|900663|P2|Overall Study|Death|0
272067|NCT01085734|900664|P1|Overall Study|Death|1
272068|NCT01085734|900663|P2|Overall Study|Adverse Event|2
272069|NCT01085734|900664|P1|Overall Study|Adverse Event|0
272070|NCT01085682|900676|P2|Overall Study|Withdrawal by Subject|25
272071|NCT01085682|900677|P1|Overall Study|Withdrawal by Subject|25
272072|NCT01085591|900695|P3|Overall Study|Not Properly Consented|0
272073|NCT01085591|900696|P2|Overall Study|Not Properly Consented|0
272074|NCT01085591|900697|P1|Overall Study|Not Properly Consented|1
272075|NCT01085591|900695|P3|Overall Study|Other|0
272076|NCT01085591|900696|P2|Overall Study|Other|1
272077|NCT01085591|900697|P1|Overall Study|Other|0
272078|NCT01085591|900695|P3|Overall Study|Protocol Violation|1
272079|NCT01085591|900696|P2|Overall Study|Protocol Violation|1
272080|NCT01085591|900697|P1|Overall Study|Protocol Violation|1
272081|NCT01085591|900695|P3|Overall Study|Lost to Follow-up|1
272082|NCT01085591|900696|P2|Overall Study|Lost to Follow-up|1
272083|NCT01085591|900697|P1|Overall Study|Lost to Follow-up|0
272084|NCT01085591|900695|P3|Overall Study|Withdrawal by Subject|1
272085|NCT01085591|900696|P2|Overall Study|Withdrawal by Subject|2
272086|NCT01085591|900697|P1|Overall Study|Withdrawal by Subject|0
272087|NCT01085591|900695|P3|Overall Study|Physician Decision|1
272088|NCT01085591|900696|P2|Overall Study|Physician Decision|0
272089|NCT01085591|900697|P1|Overall Study|Physician Decision|1
272090|NCT01085591|900695|P3|Overall Study|Adverse Event|3
272091|NCT01085591|900696|P2|Overall Study|Adverse Event|1
272092|NCT01085591|900697|P1|Overall Study|Adverse Event|0
272093|NCT01085357|900748|P2|Overall Study|Lost to Follow-up|0
272094|NCT01085357|900749|P1|Overall Study|Lost to Follow-up|2
272095|NCT01085357|900748|P2|Overall Study|Death|1
272096|NCT01085357|900749|P1|Overall Study|Death|11
272097|NCT01085357|900748|P2|Overall Study|Investigator Decision|1
272098|NCT01085357|900749|P1|Overall Study|Investigator Decision|1
272099|NCT01085357|900748|P2|Overall Study|Subject Decision|3
272100|NCT01085357|900749|P1|Overall Study|Subject Decision|4
272101|NCT01085357|900748|P2|Overall Study|Adverse Event|1
272102|NCT01085357|900749|P1|Overall Study|Adverse Event|1
272103|NCT01085214|900812|P1|Overall Study|Alternate treatment required|1
272104|NCT01085201|900824|P5|Overall Study|Fond ineligible after consent|0
272105|NCT01085201|900825|P4|Overall Study|Fond ineligible after consent|0
272106|NCT01085201|900826|P3|Overall Study|Fond ineligible after consent|1
272107|NCT01085201|900827|P2|Overall Study|Fond ineligible after consent|1
272108|NCT01085201|900828|P1|Overall Study|Fond ineligible after consent|0
272109|NCT01085201|900824|P5|Overall Study|Unknown- no study drug|0
272110|NCT01085201|900825|P4|Overall Study|Unknown- no study drug|0
272111|NCT01085201|900826|P3|Overall Study|Unknown- no study drug|0
272112|NCT01085201|900827|P2|Overall Study|Unknown- no study drug|0
272113|NCT01085201|900828|P1|Overall Study|Unknown- no study drug|2
272114|NCT01085201|900824|P5|Overall Study|Scheduling conflict|0
272115|NCT01085201|900825|P4|Overall Study|Scheduling conflict|0
272116|NCT01085201|900826|P3|Overall Study|Scheduling conflict|1
272117|NCT01085201|900827|P2|Overall Study|Scheduling conflict|0
272118|NCT01085201|900828|P1|Overall Study|Scheduling conflict|1
272119|NCT01085136|900850|P3|Part B|Other reason not defined above|3
272120|NCT01085136|900851|P2|Part B|Other reason not defined above|6
272121|NCT01085136|900852|P1|Part B|Other reason not defined above|0
272122|NCT01085136|900850|P3|Part B|Not treated|8
272123|NCT01085136|900851|P2|Part B|Not treated|4
272124|NCT01085136|900852|P1|Part B|Not treated|0
272125|NCT01085136|900850|P3|Part B|Refusal to continue trial medication|7
272126|NCT01085136|900851|P2|Part B|Refusal to continue trial medication|12
272127|NCT01085136|900852|P1|Part B|Refusal to continue trial medication|0
272128|NCT01085136|900850|P3|Part B|Other AE|8
272129|NCT01085136|900851|P2|Part B|Other AE|29
272130|NCT01085136|900852|P1|Part B|Other AE|0
272131|NCT01085136|900850|P3|Part A|Other reason not defined above|0
272132|NCT01085136|900851|P2|Part A|Other reason not defined above|0
272133|NCT01085136|900852|P1|Part A|Other reason not defined above|30
272134|NCT01085136|900850|P3|Part A|Refusal to continue trial medication|0
272135|NCT01085136|900851|P2|Part A|Refusal to continue trial medication|0
272136|NCT01085136|900852|P1|Part A|Refusal to continue trial medication|64
272138|NCT01085136|900851|P2|Part A|Lost to Follow-up|0
272139|NCT01085136|900852|P1|Part A|Lost to Follow-up|3
272140|NCT01085136|900850|P3|Part A|Protocol Violation|0
272141|NCT01085136|900851|P2|Part A|Protocol Violation|0
272142|NCT01085136|900852|P1|Part A|Protocol Violation|3
272143|NCT01085136|900850|P3|Part A|Other Adverse event|0
272144|NCT01085136|900851|P2|Part A|Other Adverse event|0
272145|NCT01085136|900852|P1|Part A|Other Adverse event|223
272146|NCT01085045|900868|P1|Part B|Adverse Event|6
272147|NCT01085045|900868|P1|Part B|Lost to Follow-up|1
272148|NCT01085045|900868|P1|Part B|Protocol Specified Criteria|6
272149|NCT01085045|900868|P1|Part B|Withdrawal by Subject|2
272150|NCT01085045|900868|P1|Part A|Protocol Specified Criteria|7
272151|NCT01085045|900868|P1|Part A|Protocol Violation|1
272152|NCT01085045|900868|P1|Part A|Adverse Event|6
272153|NCT01085045|900868|P1|Part A|Withdrawal by Subject|4
272154|NCT01084707|900983|P1|Overall Study|Withdrawal by Subject|6
272155|NCT01084668|901017|P1|Overall Study|Non-compliance|1
272156|NCT01084668|901017|P1|Overall Study|Pregnancy|1
272157|NCT01084668|901017|P1|Overall Study|Withdrawal by Subject|2
272158|NCT01084668|901017|P1|Overall Study|Lack of Efficacy|5
272159|NCT01084603|901026|P1|Washout Period 4|Adverse Event|1
272160|NCT01084603|901026|P1|Oral Nicotine 1|Withdrawal by Subject|1
272161|NCT01084603|901026|P1|Nicorette® Gum|Withdrawal by Subject|1
272162|NCT01084603|901026|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
272163|NCT01084603|901026|P1|Baseline|Withdrawal by Subject|2
272164|NCT01084551|901062|P3|Overall Study|Physician Decision|0
272165|NCT01084551|901063|P2|Overall Study|Physician Decision|0
272166|NCT01084551|901064|P1|Overall Study|Physician Decision|1
272167|NCT01084551|901062|P3|Overall Study|Lost to Follow-up|3
272168|NCT01084551|901063|P2|Overall Study|Lost to Follow-up|0
272169|NCT01084551|901064|P1|Overall Study|Lost to Follow-up|0
272170|NCT01084551|901062|P3|Overall Study|Protocol Violation|0
272171|NCT01084551|901063|P2|Overall Study|Protocol Violation|4
272172|NCT01084551|901064|P1|Overall Study|Protocol Violation|2
272173|NCT01084551|901062|P3|Overall Study|Withdrawal by Subject|0
272174|NCT01084551|901063|P2|Overall Study|Withdrawal by Subject|1
272175|NCT01084551|901064|P1|Overall Study|Withdrawal by Subject|2
272176|NCT01084551|901062|P3|Overall Study|Lack of Efficacy|1
272177|NCT01084551|901063|P2|Overall Study|Lack of Efficacy|0
272178|NCT01084551|901064|P1|Overall Study|Lack of Efficacy|2
272179|NCT01084551|901062|P3|Overall Study|Adverse Event|4
272180|NCT01084551|901063|P2|Overall Study|Adverse Event|9
272181|NCT01084551|901064|P1|Overall Study|Adverse Event|2
272182|NCT01084538|901102|P1|Overall Study|Reason unknown|8
272183|NCT01084538|901102|P1|Overall Study|Over-suppression of parathyroid gland|2
272184|NCT01084538|901102|P1|Overall Study|Change of residence|2
272185|NCT01084538|901102|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
272186|NCT01084538|901102|P1|Overall Study|Hyperphosphatemia|2
272187|NCT01084538|901102|P1|Overall Study|Patient noncompliance|2
272188|NCT01084538|901102|P1|Overall Study|Lack of effectiveness|2
272189|NCT01084538|901102|P1|Overall Study|Serious Adverse Event|3
272190|NCT01084538|901102|P1|Overall Study|Kidney transplant|6
272191|NCT01084538|901102|P1|Overall Study|Adverse Event|9
272192|NCT01084538|901102|P1|Overall Study|Drug not available|30
272193|NCT01084239|901213|P2|28-Day Follow-up|Lost to Follow-up|9
272194|NCT01084239|901214|P1|28-Day Follow-up|Lost to Follow-up|4
272195|NCT01084174|901232|P2|Overall Study|Participant noncompliance|1
272196|NCT01084174|901233|P1|Overall Study|Participant noncompliance|0
272197|NCT01084174|901232|P2|Overall Study|Anaphylaxis|1
272198|NCT01084174|901233|P1|Overall Study|Anaphylaxis|0
272199|NCT01084174|901232|P2|Overall Study|Eosinophilic esophagitis|1
272200|NCT01084174|901233|P1|Overall Study|Eosinophilic esophagitis|0
272201|NCT01084174|901232|P2|Overall Study|gastrointestinal symptoms|1
272202|NCT01084174|901233|P1|Overall Study|gastrointestinal symptoms|1
272203|NCT01084135|901264|P2|20 Week|Physician Decision|1
272204|NCT01084135|901265|P1|20 Week|Physician Decision|0
272205|NCT01084083|901275|P1|Overall Study|Never started assigned therapy|1
272206|NCT01084083|901275|P1|Overall Study|Other|2
272207|NCT01084083|901275|P1|Overall Study|Complicating disease|1
272208|NCT01084083|901275|P1|Overall Study|Withdrawal by Subject|2
272209|NCT01084083|901275|P1|Overall Study|Death|1
272210|NCT01084083|901275|P1|Overall Study|Adverse Event|5
272211|NCT01084005|901283|P2|Overall Study|Withdrawal by Subject|1
272212|NCT01084005|901284|P1|Overall Study|Withdrawal by Subject|1
272213|NCT01084005|901283|P2|Overall Study|Protocol Violation|7
272214|NCT01084005|901284|P1|Overall Study|Protocol Violation|3
272215|NCT01084005|901283|P2|Overall Study|Adverse Event|8
272216|NCT01084005|901284|P1|Overall Study|Adverse Event|1
272217|NCT01083810|901365|P3|Overall Study|Virologic failure|0
272218|NCT01083810|901366|P2|Overall Study|Virologic failure|8
272219|NCT01083810|901367|P1|Overall Study|Virologic failure|1
272220|NCT01083810|901365|P3|Overall Study|Therapy break|2
272221|NCT01083810|901366|P2|Overall Study|Therapy break|2
272222|NCT01083810|901367|P1|Overall Study|Therapy break|1
272223|NCT01083810|901365|P3|Overall Study|Participation in study|0
272224|NCT01083810|901366|P2|Overall Study|Participation in study|0
272225|NCT01083810|901367|P1|Overall Study|Participation in study|1
272226|NCT01083810|901365|P3|Overall Study|Co-morbidities|0
272227|NCT01083810|901366|P2|Overall Study|Co-morbidities|0
272228|NCT01083810|901367|P1|Overall Study|Co-morbidities|1
272229|NCT01083810|901365|P3|Overall Study|Death|3
272230|NCT01083810|901366|P2|Overall Study|Death|2
272231|NCT01083810|901367|P1|Overall Study|Death|2
272232|NCT01083810|901365|P3|Overall Study|Simplification|0
272233|NCT01083810|901366|P2|Overall Study|Simplification|1
272234|NCT01083810|901367|P1|Overall Study|Simplification|4
272235|NCT01083810|901365|P3|Overall Study|Non-compliance|2
272236|NCT01083810|901366|P2|Overall Study|Non-compliance|7
272237|NCT01083810|901367|P1|Overall Study|Non-compliance|4
272238|NCT01083810|901365|P3|Overall Study|Reason not reported|1
272239|NCT01083810|901366|P2|Overall Study|Reason not reported|1
272240|NCT01083810|901367|P1|Overall Study|Reason not reported|6
272241|NCT01083810|901365|P3|Overall Study|Withdrawal by Subject|4
272242|NCT01083810|901366|P2|Overall Study|Withdrawal by Subject|2
272243|NCT01083810|901367|P1|Overall Study|Withdrawal by Subject|7
272244|NCT01083810|901365|P3|Overall Study|Adverse Event|4
272245|NCT01083810|901366|P2|Overall Study|Adverse Event|11
272246|NCT01083810|901367|P1|Overall Study|Adverse Event|15
272247|NCT01083810|901365|P3|Overall Study|Lost to Follow-up|4
272248|NCT01083810|901366|P2|Overall Study|Lost to Follow-up|11
272249|NCT01083810|901367|P1|Overall Study|Lost to Follow-up|23
272250|NCT01083771|901388|P1|Overall Study|Withdrawal by Subject|3
272251|NCT01083771|901388|P1|Overall Study|non-compliant|2
272252|NCT01083693|901489|P3|Overall Study|Reason unknown|1
272253|NCT01083693|901490|P2|Overall Study|Reason unknown|0
272254|NCT01083693|901491|P1|Overall Study|Reason unknown|0
272255|NCT01083693|901489|P3|Overall Study|Withdrawal by Subject|2
272256|NCT01083693|901490|P2|Overall Study|Withdrawal by Subject|0
272257|NCT01083693|901491|P1|Overall Study|Withdrawal by Subject|3
272258|NCT01083693|901489|P3|Overall Study|Other medical condition/surgery|0
272259|NCT01083693|901490|P2|Overall Study|Other medical condition/surgery|1
272260|NCT01083693|901491|P1|Overall Study|Other medical condition/surgery|1
272261|NCT01083693|901489|P3|Overall Study|Complete remission|0
272262|NCT01083693|901490|P2|Overall Study|Complete remission|1
272263|NCT01083693|901491|P1|Overall Study|Complete remission|0
272264|NCT01083693|901489|P3|Overall Study|Patient Moved|0
272265|NCT01083693|901490|P2|Overall Study|Patient Moved|1
272266|NCT01083693|901491|P1|Overall Study|Patient Moved|0
272267|NCT01083693|901489|P3|Overall Study|Lack of effectiveness|2
272268|NCT01083693|901490|P2|Overall Study|Lack of effectiveness|2
272269|NCT01083693|901491|P1|Overall Study|Lack of effectiveness|13
272270|NCT01083693|901489|P3|Overall Study|Lost to Follow-up|2
272271|NCT01083693|901490|P2|Overall Study|Lost to Follow-up|0
272272|NCT01083693|901491|P1|Overall Study|Lost to Follow-up|2
272273|NCT01083693|901489|P3|Overall Study|Adverse Event|0
272274|NCT01083693|901490|P2|Overall Study|Adverse Event|1
272275|NCT01083693|901491|P1|Overall Study|Adverse Event|1
272276|NCT01083680|901526|P1|Overall Study|Withdrawal by Subject|1086
272277|NCT01083680|901526|P1|Overall Study|Lost to Follow-up|2758
272278|NCT01083641|901544|P1|Overall Study|Withdrawal by Subject|2
272279|NCT01083602|901551|P1|Overall Study|Lack of Efficacy|36
272280|NCT01083602|901551|P1|Overall Study|Withdrawal by Subject|5
272281|NCT01083602|901551|P1|Overall Study|Death|1
272282|NCT01083602|901551|P1|Overall Study|New Cancer Therapy|2
272283|NCT01083602|901551|P1|Overall Study|Adverse Event|11
272284|NCT01083576|901562|P2|Overall Study|Treatment Failure|1
272285|NCT01083576|901563|P1|Overall Study|Treatment Failure|6
272286|NCT01083485|901593|P2|Overall Study|Other|0
272287|NCT01083485|901594|P1|Overall Study|Other|1
272288|NCT01083485|901593|P2|Overall Study|Withdrawal by Subject|2
272289|NCT01083485|901594|P1|Overall Study|Withdrawal by Subject|5
272290|NCT01083485|901593|P2|Overall Study|Protocol Violation|0
272291|NCT01083485|901594|P1|Overall Study|Protocol Violation|1
272292|NCT01083485|901593|P2|Overall Study|Adverse Event|1
272293|NCT01083485|901594|P1|Overall Study|Adverse Event|0
272294|NCT01083316|901611|P1|Overall Study|Withdrawal by Subject|1
272295|NCT01083316|901611|P1|Overall Study|Adverse Event|2
272296|NCT01083186|901622|P1|Overall Study|Non-compliance to Study Treatment|1
272297|NCT01083186|901622|P1|Overall Study|Administrative Reasons|2
272298|NCT01083186|901622|P1|Overall Study|Hemodialysis Initiation|28
272299|NCT01083186|901622|P1|Overall Study|Lack of Efficacy|2
272300|NCT01083186|901622|P1|Overall Study|Adverse Event|3
272301|NCT01083186|901622|P1|Overall Study|Death|3
272302|NCT01083186|901622|P1|Overall Study|Consent Withdrawal|7
272303|NCT01083186|901622|P1|Overall Study|Lost to Follow-up|48
272304|NCT01083173|901663|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
272305|NCT01083173|901664|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
272306|NCT01083173|901663|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
272307|NCT01083173|901664|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
272389|NCT01081951|901943|P2|Overall Study|Withdrawal by Subject|6
272308|NCT01083173|901663|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
272309|NCT01083173|901664|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
272310|NCT01083173|901663|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
272311|NCT01083173|901664|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
272312|NCT01083173|901663|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
272313|NCT01083173|901664|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
272314|NCT01083173|901663|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
272315|NCT01083173|901664|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
272316|NCT01083173|901663|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
272317|NCT01083173|901664|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
272318|NCT01083173|901663|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
272319|NCT01083173|901664|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
272320|NCT01083173|901663|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
272321|NCT01083173|901664|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
272322|NCT01083173|901663|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
272323|NCT01083173|901664|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
272324|NCT01083173|901663|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
272325|NCT01083173|901664|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
272326|NCT01083160|901682|P1|Overall Study|Adverse Event|1
272327|NCT01083121|901689|P1|Overall Study|Use of Humira outside the approved label|81
272328|NCT01082965|901699|P2|Overall Study|Unspecified|1
272329|NCT01082965|901700|P1|Overall Study|Unspecified|1
272330|NCT01082965|901699|P2|Overall Study|Protocol Violation|1
272331|NCT01082965|901700|P1|Overall Study|Protocol Violation|0
272332|NCT01082874|901737|P4|Overall Study|Withdrawal by Subject|3
272333|NCT01082874|901738|P3|Overall Study|Withdrawal by Subject|5
272334|NCT01082874|901739|P2|Overall Study|Withdrawal by Subject|2
272335|NCT01082874|901740|P1|Overall Study|Withdrawal by Subject|1
272336|NCT01082874|901737|P4|Overall Study|Lost to Follow-up|10
272337|NCT01082874|901738|P3|Overall Study|Lost to Follow-up|6
272338|NCT01082874|901739|P2|Overall Study|Lost to Follow-up|10
272339|NCT01082874|901740|P1|Overall Study|Lost to Follow-up|10
272340|NCT01082640|901753|P3|Overall Study|Other|3
272341|NCT01082640|901754|P2|Overall Study|Other|1
272342|NCT01082640|901755|P1|Overall Study|Other|2
272343|NCT01082640|901753|P3|Overall Study|Lost to Follow-up|0
272344|NCT01082640|901754|P2|Overall Study|Lost to Follow-up|3
272345|NCT01082640|901755|P1|Overall Study|Lost to Follow-up|0
272346|NCT01082640|901753|P3|Overall Study|Major protocol deviation|0
272347|NCT01082640|901754|P2|Overall Study|Major protocol deviation|3
272348|NCT01082640|901755|P1|Overall Study|Major protocol deviation|3
272349|NCT01082640|901753|P3|Overall Study|Withdrawal by Subject|2
272350|NCT01082640|901754|P2|Overall Study|Withdrawal by Subject|3
272351|NCT01082640|901755|P1|Overall Study|Withdrawal by Subject|3
272352|NCT01082640|901753|P3|Overall Study|Adverse Event|3
272353|NCT01082640|901754|P2|Overall Study|Adverse Event|5
272354|NCT01082640|901755|P1|Overall Study|Adverse Event|9
272355|NCT01082614|901777|P2|Overall Study|Physician Decision|0
272356|NCT01082614|901778|P1|Overall Study|Physician Decision|2
272357|NCT01082614|901777|P2|Overall Study|Equipment Malfunction|1
272358|NCT01082614|901778|P1|Overall Study|Equipment Malfunction|0
272359|NCT01082614|901777|P2|Overall Study|Adverse Event|4
272360|NCT01082614|901778|P1|Overall Study|Adverse Event|1
272361|NCT01082367|901845|P2|Follow-up (F-U) Period|Adverse Event|1
272362|NCT01082367|901846|P1|Follow-up (F-U) Period|Adverse Event|0
272363|NCT01082367|901845|P2|Follow-up (F-U) Period|Abnormal lab values|0
272364|NCT01082367|901846|P1|Follow-up (F-U) Period|Abnormal lab values|1
272365|NCT01082367|901845|P2|Follow-up (F-U) Period|Administrative problems|0
272366|NCT01082367|901846|P1|Follow-up (F-U) Period|Administrative problems|1
272367|NCT01082367|901845|P2|Double-blind Period|Adverse Event|1
272368|NCT01082367|901846|P1|Double-blind Period|Adverse Event|0
272369|NCT01082367|901845|P2|Double-blind Period|Lack of Efficacy|11
272370|NCT01082367|901846|P1|Double-blind Period|Lack of Efficacy|5
272371|NCT01082367|901845|P2|Double-blind Period|Administrative problems|1
272372|NCT01082367|901846|P1|Double-blind Period|Administrative problems|0
272373|NCT01082328|901860|P1|Overall Study|Adverse Event|1
272374|NCT01082211|901869|P1|Overall Study|No protocol treatment received|3
272375|NCT01082211|901869|P1|Overall Study|Protocol Violation|4
272376|NCT01082081|901889|P3|Overall Study|Other Reason|0
272377|NCT01082081|901890|P2|Overall Study|Other Reason|1
272378|NCT01082081|901891|P1|Overall Study|Other Reason|0
272379|NCT01082081|901889|P3|Overall Study|Withdrawal by Subject|1
272380|NCT01082081|901890|P2|Overall Study|Withdrawal by Subject|0
272381|NCT01082081|901891|P1|Overall Study|Withdrawal by Subject|0
272382|NCT01082081|901889|P3|Overall Study|Lost to Follow-up|1
272383|NCT01082081|901890|P2|Overall Study|Lost to Follow-up|0
272384|NCT01082081|901891|P1|Overall Study|Lost to Follow-up|0
272385|NCT01081951|901943|P2|Overall Study|Lost to Follow-up|1
272386|NCT01081951|901944|P1|Overall Study|Lost to Follow-up|0
272387|NCT01081951|901943|P2|Overall Study|Allocated treatment but did not take it|1
272388|NCT01081951|901944|P1|Overall Study|Allocated treatment but did not take it|0
272390|NCT01081951|901944|P1|Overall Study|Withdrawal by Subject|2
272391|NCT01081951|901943|P2|Overall Study|Death|47
272392|NCT01081951|901944|P1|Overall Study|Death|54
272393|NCT01081912|901954|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
272394|NCT01081912|901955|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
272395|NCT01081912|901956|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
272396|NCT01081912|901954|P3|Maintenance Treatment|Non-Compliance|7
272397|NCT01081912|901955|P2|Maintenance Treatment|Non-Compliance|4
272398|NCT01081912|901956|P1|Maintenance Treatment|Non-Compliance|0
272399|NCT01081912|901954|P3|Maintenance Treatment|Withdrawal by Subject|5
272400|NCT01081912|901955|P2|Maintenance Treatment|Withdrawal by Subject|5
272401|NCT01081912|901956|P1|Maintenance Treatment|Withdrawal by Subject|0
272402|NCT01081912|901954|P3|Maintenance Treatment|Protocol Violation|2
272403|NCT01081912|901955|P2|Maintenance Treatment|Protocol Violation|1
272404|NCT01081912|901956|P1|Maintenance Treatment|Protocol Violation|0
272405|NCT01081912|901954|P3|Maintenance Treatment|Physician Decision|1
272406|NCT01081912|901955|P2|Maintenance Treatment|Physician Decision|0
272407|NCT01081912|901956|P1|Maintenance Treatment|Physician Decision|0
272408|NCT01081912|901954|P3|Maintenance Treatment|Lost to Follow-up|0
272409|NCT01081912|901955|P2|Maintenance Treatment|Lost to Follow-up|1
272410|NCT01081912|901956|P1|Maintenance Treatment|Lost to Follow-up|0
272411|NCT01081912|901954|P3|Maintenance Treatment|Lack of Efficacy|64
272412|NCT01081912|901955|P2|Maintenance Treatment|Lack of Efficacy|14
272413|NCT01081912|901956|P1|Maintenance Treatment|Lack of Efficacy|0
272414|NCT01081912|901954|P3|Maintenance Treatment|Adverse Event|12
272415|NCT01081912|901955|P2|Maintenance Treatment|Adverse Event|2
272416|NCT01081912|901956|P1|Maintenance Treatment|Adverse Event|0
272417|NCT01081912|901954|P3|Conversion/Titration|Non-Compliance|0
272418|NCT01081912|901955|P2|Conversion/Titration|Non-Compliance|0
272419|NCT01081912|901956|P1|Conversion/Titration|Non-Compliance|47
272420|NCT01081912|901954|P3|Conversion/Titration|Withdrawal by Subject|0
272421|NCT01081912|901955|P2|Conversion/Titration|Withdrawal by Subject|0
272422|NCT01081912|901956|P1|Conversion/Titration|Withdrawal by Subject|23
272423|NCT01081912|901954|P3|Conversion/Titration|Protocol Violation|0
272424|NCT01081912|901955|P2|Conversion/Titration|Protocol Violation|0
272425|NCT01081912|901956|P1|Conversion/Titration|Protocol Violation|67
272426|NCT01081912|901954|P3|Conversion/Titration|Physician Decision|0
272427|NCT01081912|901955|P2|Conversion/Titration|Physician Decision|0
272428|NCT01081912|901956|P1|Conversion/Titration|Physician Decision|2
272429|NCT01081912|901954|P3|Conversion/Titration|Lost to Follow-up|0
272430|NCT01081912|901955|P2|Conversion/Titration|Lost to Follow-up|0
272431|NCT01081912|901956|P1|Conversion/Titration|Lost to Follow-up|5
272432|NCT01081912|901954|P3|Conversion/Titration|Lack of Efficacy|0
272433|NCT01081912|901955|P2|Conversion/Titration|Lack of Efficacy|0
272434|NCT01081912|901956|P1|Conversion/Titration|Lack of Efficacy|17
272435|NCT01081912|901954|P3|Conversion/Titration|Adverse Event|0
272436|NCT01081912|901955|P2|Conversion/Titration|Adverse Event|0
272437|NCT01081912|901956|P1|Conversion/Titration|Adverse Event|47
272438|NCT01081886|901965|P2|Overall Study|Study termination|13
272439|NCT01081886|901966|P1|Overall Study|Study termination|11
272440|NCT01081873|901974|P1|Overall Study|Other|47
272441|NCT01081873|901974|P1|Overall Study|Progression of prostate cancer|13
272442|NCT01081873|901974|P1|Overall Study|Lost to Follow-up|142
272443|NCT01081873|901974|P1|Overall Study|Withdrawal by Subject|10
272444|NCT01081873|901974|P1|Overall Study|Death|86
272445|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
272446|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
272447|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
272448|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
272449|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
272450|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
272451|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
272452|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
272453|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
272454|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
272455|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Not specified|0
272456|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Not specified|0
272457|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Not specified|4
272458|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Not specified|5
272459|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Not specified|4
272460|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
272461|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
272462|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
272463|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
272464|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
272465|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
272466|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
272467|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
272468|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
272469|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
272470|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
272471|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
272472|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
272473|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
272796|NCT01079936|902815|P5|Phase II|Adverse Event|0
272474|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
272475|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
272476|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
272477|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
272478|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
272479|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
272480|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
272481|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
272482|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
272483|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
272484|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
272485|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Death|0
272486|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Death|0
272487|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Death|0
272488|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Death|0
272489|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Death|1
272490|NCT01081834|902046|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
272491|NCT01081834|902047|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
272492|NCT01081834|902048|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
272493|NCT01081834|902049|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
272494|NCT01081834|902050|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
272495|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
272496|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
272497|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
272498|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
272499|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
272500|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Not specified|0
272501|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Not specified|1
272502|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Not specified|3
272503|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Not specified|4
272504|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Not specified|4
272505|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
272506|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
272507|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
272508|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
272509|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
272510|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
272511|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
272512|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
272513|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
272514|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
272515|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
272516|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
272517|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
272518|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
272519|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
272520|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Protocol Violation|2
272521|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Protocol Violation|0
272522|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Protocol Violation|0
272523|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Protocol Violation|4
272524|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Protocol Violation|0
272525|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
272526|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
272527|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
272528|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
272529|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
272530|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Death|0
272531|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Death|0
272532|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Death|0
272533|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Death|0
272534|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Death|1
272535|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Adverse Event|1
272536|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Adverse Event|1
272537|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Adverse Event|3
272538|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Adverse Event|5
272539|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Adverse Event|2
272540|NCT01081834|902046|P5|Core Period: Baseline to Week 26|Pregnancy|0
272541|NCT01081834|902047|P4|Core Period: Baseline to Week 26|Pregnancy|0
272542|NCT01081834|902048|P3|Core Period: Baseline to Week 26|Pregnancy|0
272543|NCT01081834|902049|P2|Core Period: Baseline to Week 26|Pregnancy|0
272544|NCT01081834|902050|P1|Core Period: Baseline to Week 26|Pregnancy|1
272545|NCT01081795|902111|P3|Overall Study|Unspecified|0
272546|NCT01081795|902112|P2|Overall Study|Unspecified|2
272547|NCT01081795|902113|P1|Overall Study|Unspecified|1
272548|NCT01081795|902111|P3|Overall Study|Using drug with restricted days of use|2
272549|NCT01081795|902112|P2|Overall Study|Using drug with restricted days of use|3
272550|NCT01081795|902113|P1|Overall Study|Using drug with restricted days of use|2
272551|NCT01081795|902111|P3|Overall Study|Use of a prohibited concomitant drug|1
272552|NCT01081795|902112|P2|Overall Study|Use of a prohibited concomitant drug|1
272553|NCT01081795|902113|P1|Overall Study|Use of a prohibited concomitant drug|1
272554|NCT01081795|902111|P3|Overall Study|Ineligible for participation|0
272555|NCT01081795|902112|P2|Overall Study|Ineligible for participation|0
272556|NCT01081795|902113|P1|Overall Study|Ineligible for participation|1
272557|NCT01081795|902111|P3|Overall Study|Revocation of informed consent|0
272558|NCT01081795|902112|P2|Overall Study|Revocation of informed consent|0
272559|NCT01081795|902113|P1|Overall Study|Revocation of informed consent|2
272560|NCT01081795|902111|P3|Overall Study|Subject’s schedule|2
272561|NCT01081795|902112|P2|Overall Study|Subject’s schedule|1
272562|NCT01081795|902113|P1|Overall Study|Subject’s schedule|1
272563|NCT01081795|902111|P3|Overall Study|Lack of Efficacy|19
272564|NCT01081795|902112|P2|Overall Study|Lack of Efficacy|5
272565|NCT01081795|902113|P1|Overall Study|Lack of Efficacy|7
272566|NCT01081795|902111|P3|Overall Study|Adverse Event|6
272567|NCT01081795|902112|P2|Overall Study|Adverse Event|23
272568|NCT01081795|902113|P1|Overall Study|Adverse Event|18
272569|NCT01081769|902150|P2|CORE Intent-To-Treat|Patient Moved|2
272570|NCT01081769|902151|P1|CORE Intent-To-Treat|Patient Moved|2
272571|NCT01081769|902150|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
272572|NCT01081769|902151|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
272573|NCT01081769|902150|P2|CORE Intent-To-Treat|Ineligibility|4
272574|NCT01081769|902151|P1|CORE Intent-To-Treat|Ineligibility|3
272575|NCT01081769|902150|P2|CORE Intent-To-Treat|Other|1
272576|NCT01081769|902151|P1|CORE Intent-To-Treat|Other|0
272577|NCT01081769|902150|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
272578|NCT01081769|902151|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
272579|NCT01081769|902150|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
272580|NCT01081769|902151|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
272581|NCT01081769|902150|P2|CORE Intent-To-Treat|Pregnancy|0
272582|NCT01081769|902151|P1|CORE Intent-To-Treat|Pregnancy|1
272583|NCT01081769|902150|P2|CORE Intent-To-Treat|Lost to Follow-up|5
272584|NCT01081769|902151|P1|CORE Intent-To-Treat|Lost to Follow-up|4
272585|NCT01081769|902150|P2|CORE Intent-To-Treat|Lack of Efficacy|6
272586|NCT01081769|902151|P1|CORE Intent-To-Treat|Lack of Efficacy|2
272587|NCT01081769|902150|P2|CORE Intent-To-Treat|Death|1
272588|NCT01081769|902151|P1|CORE Intent-To-Treat|Death|1
272589|NCT01081769|902150|P2|CORE Intent-To-Treat|Adverse Event|11
272590|NCT01081769|902151|P1|CORE Intent-To-Treat|Adverse Event|14
272591|NCT01081769|902150|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
272592|NCT01081769|902151|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
272593|NCT01081769|902150|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
272594|NCT01081769|902151|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
272595|NCT01081769|902150|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
272596|NCT01081769|902151|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
272597|NCT01081769|902150|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
272598|NCT01081769|902151|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
272599|NCT01081665|902185|P1|Overall Study|Lack of Efficacy|1
272600|NCT01081665|902185|P1|Overall Study|Adverse Event|1
272601|NCT01081665|902185|P1|Overall Study|Change in renal replacement therapy|2
272602|NCT01081665|902185|P1|Overall Study|Regulation of iPTH|5
272603|NCT01081665|902185|P1|Overall Study|Change of dialysis unit|10
272604|NCT01081665|902185|P1|Overall Study|Withdrawal by Subject|17
272605|NCT01081665|902185|P1|Overall Study|Lost to Follow-up|18
272606|NCT01081665|902185|P1|Overall Study|Death|41
272607|NCT01081626|902197|P2|Overall Study|Unspecified|30
272608|NCT01081626|902198|P1|Overall Study|Unspecified|33
272609|NCT01081626|902197|P2|Overall Study|Lost to Follow-up|1
272610|NCT01081626|902198|P1|Overall Study|Lost to Follow-up|0
272611|NCT01081626|902197|P2|Overall Study|Overstimulation|1
272612|NCT01081626|902198|P1|Overall Study|Overstimulation|0
272613|NCT01081626|902197|P2|Overall Study|Low antral follicle count|0
272614|NCT01081626|902198|P1|Overall Study|Low antral follicle count|1
272615|NCT01081626|902197|P2|Overall Study|Missing Estradiol|28
272616|NCT01081626|902198|P1|Overall Study|Missing Estradiol|25
272617|NCT01081626|902197|P2|Overall Study|Dosing error|1
272618|NCT01081626|902198|P1|Overall Study|Dosing error|1
272619|NCT01081301|902224|P1|Overall Study|Lost to Follow-up|4
272620|NCT01081301|902224|P1|Overall Study|Patient too ill|2
272621|NCT01081301|902224|P1|Overall Study|Too busy|5
272622|NCT01081301|902224|P1|Overall Study|Bereaved|3
272623|NCT01081249|902262|P2|Overall Study|Diagnosed with Bipolar Disorder|1
272624|NCT01081249|902263|P1|Overall Study|Diagnosed with Bipolar Disorder|0
272625|NCT01081145|902269|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
272626|NCT01081145|902270|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
272627|NCT01081145|902269|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
272628|NCT01081145|902270|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
272629|NCT01081145|902269|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
272797|NCT01079936|902816|P4|Phase II|Adverse Event|0
272630|NCT01081145|902270|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
272631|NCT01081145|902269|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
272632|NCT01081145|902270|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
272633|NCT01081145|902269|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
272634|NCT01081145|902270|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
272635|NCT01081145|902269|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
272636|NCT01081145|902270|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
272637|NCT01081145|902269|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
272638|NCT01081145|902270|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
272639|NCT01081145|902269|P2|Open-Label Phase|Protocol Violation|0
272640|NCT01081145|902270|P1|Open-Label Phase|Protocol Violation|4
272641|NCT01081145|902269|P2|Open-Label Phase|Lost to Follow-up|0
272642|NCT01081145|902270|P1|Open-Label Phase|Lost to Follow-up|11
272643|NCT01081145|902269|P2|Open-Label Phase|Not specified|0
272644|NCT01081145|902270|P1|Open-Label Phase|Not specified|12
272645|NCT01081145|902269|P2|Open-Label Phase|Withdrawal by Subject|0
272646|NCT01081145|902270|P1|Open-Label Phase|Withdrawal by Subject|41
272647|NCT01081145|902269|P2|Open-Label Phase|Adverse Event|0
272648|NCT01081145|902270|P1|Open-Label Phase|Adverse Event|42
272649|NCT01081145|902269|P2|Open-Label Phase|Response criteria not met|0
272650|NCT01081145|902270|P1|Open-Label Phase|Response criteria not met|46
272651|NCT01081145|902269|P2|Open-Label Phase|Lack of Efficacy|0
272652|NCT01081145|902270|P1|Open-Label Phase|Lack of Efficacy|56
272653|NCT01081132|902298|P2|Overall Study|Protocol Violation|1
272654|NCT01081132|902299|P1|Overall Study|Protocol Violation|3
272655|NCT01081132|902298|P2|Overall Study|Declined Taper Phase|1
272656|NCT01081132|902299|P1|Overall Study|Declined Taper Phase|0
272657|NCT01081132|902298|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
272658|NCT01081132|902299|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
272659|NCT01081132|902298|P2|Overall Study|Stopped Taking Meds|0
272660|NCT01081132|902299|P1|Overall Study|Stopped Taking Meds|2
272661|NCT01081132|902298|P2|Overall Study|Missed Visits|1
272662|NCT01081132|902299|P1|Overall Study|Missed Visits|1
272663|NCT01081132|902298|P2|Overall Study|Lack Of Compliance|1
272664|NCT01081132|902299|P1|Overall Study|Lack Of Compliance|0
272665|NCT01081132|902298|P2|Overall Study|Non Compliance|2
272666|NCT01081132|902299|P1|Overall Study|Non Compliance|4
272667|NCT01081132|902298|P2|Overall Study|Adverse Event|9
272668|NCT01081132|902299|P1|Overall Study|Adverse Event|3
272669|NCT01081132|902298|P2|Overall Study|Lost to Follow-up|11
272670|NCT01081132|902299|P1|Overall Study|Lost to Follow-up|4
272671|NCT01081132|902298|P2|Overall Study|Withdrawal by Subject|16
272672|NCT01081132|902299|P1|Overall Study|Withdrawal by Subject|13
272673|NCT01081132|902298|P2|Overall Study|Lack of Efficacy|9
272674|NCT01081132|902299|P1|Overall Study|Lack of Efficacy|25
272675|NCT01080807|902372|P2|Overall Study|Moved away without notifying center|0
272676|NCT01080807|902373|P1|Overall Study|Moved away without notifying center|1
272677|NCT01080807|902372|P2|Overall Study|Switched to first shift|0
272678|NCT01080807|902373|P1|Overall Study|Switched to first shift|1
272679|NCT01080807|902372|P2|Overall Study|Work schedule and travel|1
272680|NCT01080807|902373|P1|Overall Study|Work schedule and travel|0
272681|NCT01080807|902372|P2|Overall Study|Work schedule changing|1
272682|NCT01080807|902373|P1|Overall Study|Work schedule changing|1
272683|NCT01080807|902372|P2|Overall Study|Stopped working consistent night shifts|1
272684|NCT01080807|902373|P1|Overall Study|Stopped working consistent night shifts|0
272685|NCT01080807|902372|P2|Overall Study|Laid off or terminated from job|2
272686|NCT01080807|902373|P1|Overall Study|Laid off or terminated from job|1
272687|NCT01080807|902372|P2|Overall Study|Began working day shift|2
272688|NCT01080807|902373|P1|Overall Study|Began working day shift|0
272689|NCT01080807|902372|P2|Overall Study|Noncompliance to study procedures|1
272690|NCT01080807|902373|P1|Overall Study|Noncompliance to study procedures|1
272691|NCT01080807|902372|P2|Overall Study|Noncompliance with drug administration|1
272692|NCT01080807|902373|P1|Overall Study|Noncompliance with drug administration|1
272693|NCT01080807|902372|P2|Overall Study|Lost to Follow-up|4
272694|NCT01080807|902373|P1|Overall Study|Lost to Follow-up|6
272695|NCT01080807|902372|P2|Overall Study|Protocol Violation|6
272696|NCT01080807|902373|P1|Overall Study|Protocol Violation|7
272697|NCT01080807|902372|P2|Overall Study|Withdrawal by Subject|2
272698|NCT01080807|902373|P1|Overall Study|Withdrawal by Subject|7
272699|NCT01080807|902372|P2|Overall Study|Lack of Efficacy|1
272700|NCT01080807|902373|P1|Overall Study|Lack of Efficacy|0
272701|NCT01080807|902372|P2|Overall Study|Adverse Event|1
272702|NCT01080807|902373|P1|Overall Study|Adverse Event|9
272703|NCT01080768|902482|P2|Overall Study|Protocol Deviation|1
272704|NCT01080768|902483|P1|Overall Study|Protocol Deviation|2
272705|NCT01080625|902514|P3|Overall Study|Physician Decision|1
272706|NCT01080625|902515|P2|Overall Study|Physician Decision|2
272707|NCT01080625|902516|P1|Overall Study|Physician Decision|0
272708|NCT01080391|902526|P2|Overall Study|Withdrawal by Subject|10
272709|NCT01080391|902527|P1|Overall Study|Withdrawal by Subject|19
272710|NCT01080391|902526|P2|Overall Study|Lost to Follow-up|3
272711|NCT01080391|902527|P1|Overall Study|Lost to Follow-up|4
272712|NCT01080326|902545|P1|Overall Study|Surgeon decision|1
272713|NCT01080326|902545|P1|Overall Study|Patient deterioration prior to procedure|3
272714|NCT01080300|902551|P2|Overall Study|Reasons not specified|6
272715|NCT01080300|902552|P1|Overall Study|Reasons not specified|4
272716|NCT01080300|902551|P2|Overall Study|Withdrawal by Subject|28
272717|NCT01080300|902552|P1|Overall Study|Withdrawal by Subject|12
272718|NCT01080300|902551|P2|Overall Study|Death|1
272719|NCT01080300|902552|P1|Overall Study|Death|0
272720|NCT01080300|902551|P2|Overall Study|Lost to Follow-up|6
272721|NCT01080300|902552|P1|Overall Study|Lost to Follow-up|10
272722|NCT01080300|902551|P2|Overall Study|Protocol Violation|13
272723|NCT01080300|902552|P1|Overall Study|Protocol Violation|7
272724|NCT01080300|902551|P2|Overall Study|Lack of Efficacy|15
272725|NCT01080300|902552|P1|Overall Study|Lack of Efficacy|12
272726|NCT01080300|902551|P2|Overall Study|Adverse Event|35
272727|NCT01080300|902552|P1|Overall Study|Adverse Event|49
272728|NCT01080131|902620|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
272729|NCT01080131|902621|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
272730|NCT01080131|902620|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
272731|NCT01080131|902621|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
272732|NCT01080131|902620|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
272733|NCT01080131|902621|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
272734|NCT01080131|902620|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
272735|NCT01080131|902621|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
272736|NCT01080131|902620|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
272737|NCT01080131|902621|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
272738|NCT01080131|902620|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
272739|NCT01080131|902621|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
272740|NCT01080131|902620|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
272741|NCT01080131|902621|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
272742|NCT01080131|902620|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
272743|NCT01080131|902621|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
272744|NCT01080131|902620|P2|Core Study (0- 12 Weeks)|Death|0
272745|NCT01080131|902621|P1|Core Study (0- 12 Weeks)|Death|1
272746|NCT01080131|902620|P2|Core Study (0- 12 Weeks)|Administrative problems|1
272747|NCT01080131|902621|P1|Core Study (0- 12 Weeks)|Administrative problems|0
272748|NCT01080131|902620|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
272749|NCT01080131|902621|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
272750|NCT01080131|902620|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
272751|NCT01080131|902621|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
272752|NCT01080131|902620|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
272753|NCT01080131|902621|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
272754|NCT01079988|902716|P5|Overall Study|Other|1
272755|NCT01079988|902717|P4|Overall Study|Other|2
272756|NCT01079988|902718|P3|Overall Study|Other|0
272757|NCT01079988|902719|P2|Overall Study|Other|0
272758|NCT01079988|902720|P1|Overall Study|Other|0
272759|NCT01079988|902716|P5|Overall Study|Lack of Efficacy|0
272760|NCT01079988|902717|P4|Overall Study|Lack of Efficacy|0
272761|NCT01079988|902718|P3|Overall Study|Lack of Efficacy|0
272762|NCT01079988|902719|P2|Overall Study|Lack of Efficacy|0
272763|NCT01079988|902720|P1|Overall Study|Lack of Efficacy|1
272764|NCT01079988|902716|P5|Overall Study|Lost to Follow-up|0
272765|NCT01079988|902717|P4|Overall Study|Lost to Follow-up|1
272766|NCT01079988|902718|P3|Overall Study|Lost to Follow-up|0
272767|NCT01079988|902719|P2|Overall Study|Lost to Follow-up|0
272768|NCT01079988|902720|P1|Overall Study|Lost to Follow-up|0
272769|NCT01079962|902739|P2|Overall Study|Due to arrhythmia/bradycardia|1
272770|NCT01079962|902740|P1|Overall Study|Due to arrhythmia/bradycardia|1
272771|NCT01079962|902739|P2|Overall Study|Participant not returning for next visit|0
272772|NCT01079962|902740|P1|Overall Study|Participant not returning for next visit|1
272773|NCT01079962|902739|P2|Overall Study|Inclusion/exclusion criteria|3
272774|NCT01079962|902740|P1|Overall Study|Inclusion/exclusion criteria|1
272775|NCT01079962|902739|P2|Overall Study|No blood pressure (BP) control|0
272776|NCT01079962|902740|P1|Overall Study|No blood pressure (BP) control|3
272777|NCT01079962|902739|P2|Overall Study|Protocol Violation|2
272778|NCT01079962|902740|P1|Overall Study|Protocol Violation|2
272779|NCT01079962|902739|P2|Overall Study|Withdrawal by Subject|7
272780|NCT01079962|902740|P1|Overall Study|Withdrawal by Subject|5
272781|NCT01079962|902739|P2|Overall Study|Adverse Event|2
272782|NCT01079962|902740|P1|Overall Study|Adverse Event|2
272783|NCT01079949|902768|P2|Overall Study|Randomized but not treated|0
272784|NCT01079949|902769|P1|Overall Study|Randomized but not treated|1
272785|NCT01079949|902768|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
272786|NCT01079949|902769|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
272787|NCT01079949|902768|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
272788|NCT01079949|902769|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
272789|NCT01079949|902768|P2|Overall Study|Withdrawal before r-hCG administration|3
272790|NCT01079949|902769|P1|Overall Study|Withdrawal before r-hCG administration|2
272791|NCT01079936|902815|P5|Phase II|Insurance Issue|1
272792|NCT01079936|902816|P4|Phase II|Insurance Issue|0
272793|NCT01079936|902817|P3|Phase II|Insurance Issue|0
272794|NCT01079936|902818|P2|Phase II|Insurance Issue|0
272795|NCT01079936|902819|P1|Phase II|Insurance Issue|0
272798|NCT01079936|902817|P3|Phase II|Adverse Event|1
272799|NCT01079936|902818|P2|Phase II|Adverse Event|0
272800|NCT01079936|902819|P1|Phase II|Adverse Event|0
272801|NCT01079936|902815|P5|Phase I: MTD|No Stem Cell Transplantation|0
272802|NCT01079936|902816|P4|Phase I: MTD|No Stem Cell Transplantation|0
272803|NCT01079936|902817|P3|Phase I: MTD|No Stem Cell Transplantation|0
272804|NCT01079936|902818|P2|Phase I: MTD|No Stem Cell Transplantation|0
272805|NCT01079936|902819|P1|Phase I: MTD|No Stem Cell Transplantation|2
272806|NCT01079936|902815|P5|Phase I: MTD|First Remission Status|0
272807|NCT01079936|902816|P4|Phase I: MTD|First Remission Status|0
272808|NCT01079936|902817|P3|Phase I: MTD|First Remission Status|0
272809|NCT01079936|902818|P2|Phase I: MTD|First Remission Status|0
272810|NCT01079936|902819|P1|Phase I: MTD|First Remission Status|2
272811|NCT01079832|902838|P1|Overall Study|Withdrawal by Subject|1
272812|NCT01079806|902848|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|2
272813|NCT01079806|902849|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|0
272814|NCT01079806|902848|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
272815|NCT01079806|902849|P1|Day 1 to Week 96|Poor compliance or noncompliance|1
272816|NCT01079806|902848|P2|Day 1 to Week 96|Pregnancy|1
272817|NCT01079806|902849|P1|Day 1 to Week 96|Pregnancy|0
272818|NCT01079806|902848|P2|Day 1 to Week 96|Withdrawal by Subject|1
272819|NCT01079806|902849|P1|Day 1 to Week 96|Withdrawal by Subject|3
272820|NCT01079806|902848|P2|Day 1 to Week 96|Adverse Event|2
272821|NCT01079806|902849|P1|Day 1 to Week 96|Adverse Event|0
272822|NCT01079234|902888|P4|Extension: Week 27 to 52|Unclassified|7
272823|NCT01079234|902889|P3|Extension: Week 27 to 52|Unclassified|4
272824|NCT01079234|902890|P2|Extension: Week 27 to 52|Unclassified|0
272825|NCT01079234|902891|P1|Extension: Week 27 to 52|Unclassified|0
272826|NCT01079234|902888|P4|Extension: Week 27 to 52|Withdrawal criteria|2
272827|NCT01079234|902889|P3|Extension: Week 27 to 52|Withdrawal criteria|4
272828|NCT01079234|902890|P2|Extension: Week 27 to 52|Withdrawal criteria|0
272829|NCT01079234|902891|P1|Extension: Week 27 to 52|Withdrawal criteria|0
272830|NCT01079234|902888|P4|Extension: Week 27 to 52|Protocol Violation|5
272831|NCT01079234|902889|P3|Extension: Week 27 to 52|Protocol Violation|2
272832|NCT01079234|902890|P2|Extension: Week 27 to 52|Protocol Violation|0
272833|NCT01079234|902891|P1|Extension: Week 27 to 52|Protocol Violation|0
272834|NCT01079234|902888|P4|Extension: Week 27 to 52|Lack of Efficacy|2
272835|NCT01079234|902889|P3|Extension: Week 27 to 52|Lack of Efficacy|0
272836|NCT01079234|902890|P2|Extension: Week 27 to 52|Lack of Efficacy|0
272837|NCT01079234|902891|P1|Extension: Week 27 to 52|Lack of Efficacy|0
272838|NCT01079234|902888|P4|Extension: Week 27 to 52|Adverse Event|0
272839|NCT01079234|902889|P3|Extension: Week 27 to 52|Adverse Event|1
272840|NCT01079234|902890|P2|Extension: Week 27 to 52|Adverse Event|0
272841|NCT01079234|902891|P1|Extension: Week 27 to 52|Adverse Event|0
272842|NCT01079234|902888|P4|Main: Week 0 to 26|Unclassified|0
272843|NCT01079234|902889|P3|Main: Week 0 to 26|Unclassified|4
272844|NCT01079234|902890|P2|Main: Week 0 to 26|Unclassified|13
272845|NCT01079234|902891|P1|Main: Week 0 to 26|Unclassified|7
272846|NCT01079234|902888|P4|Main: Week 0 to 26|Withdrawal criteria|0
272847|NCT01079234|902889|P3|Main: Week 0 to 26|Withdrawal criteria|2
272848|NCT01079234|902890|P2|Main: Week 0 to 26|Withdrawal criteria|6
272849|NCT01079234|902891|P1|Main: Week 0 to 26|Withdrawal criteria|6
272850|NCT01079234|902888|P4|Main: Week 0 to 26|Protocol Violation|0
272851|NCT01079234|902889|P3|Main: Week 0 to 26|Protocol Violation|4
272852|NCT01079234|902890|P2|Main: Week 0 to 26|Protocol Violation|2
272853|NCT01079234|902891|P1|Main: Week 0 to 26|Protocol Violation|6
272854|NCT01079234|902888|P4|Main: Week 0 to 26|Lack of Efficacy|0
272855|NCT01079234|902889|P3|Main: Week 0 to 26|Lack of Efficacy|1
272856|NCT01079234|902890|P2|Main: Week 0 to 26|Lack of Efficacy|1
272857|NCT01079234|902891|P1|Main: Week 0 to 26|Lack of Efficacy|2
272858|NCT01079234|902888|P4|Main: Week 0 to 26|Adverse Event|0
272859|NCT01079234|902889|P3|Main: Week 0 to 26|Adverse Event|1
272860|NCT01079234|902890|P2|Main: Week 0 to 26|Adverse Event|4
272861|NCT01079234|902891|P1|Main: Week 0 to 26|Adverse Event|5
272862|NCT01079195|902909|P1|Overall Study|Non-compliance|2
272863|NCT01079195|902909|P1|Overall Study|No Follow-up Documentation Available|4
272864|NCT01079195|902909|P1|Overall Study|Improved Status of Participant|4
272865|NCT01079195|902909|P1|Overall Study|Physician Decision|4
272866|NCT01079195|902909|P1|Overall Study|Lack of Effectiveness|12
272867|NCT01079195|902909|P1|Overall Study|Financial Reasons|15
272868|NCT01079195|902909|P1|Overall Study|Withdrawal by Subject|18
272869|NCT01079195|902909|P1|Overall Study|Reason Unknown|39
272870|NCT01079195|902909|P1|Overall Study|Adverse Event|157
272871|NCT01079195|902909|P1|Overall Study|No Documentation Available|437
272872|NCT01079195|902909|P1|Overall Study|No Documentation of Tarka Therapy|739
272873|NCT01079182|902915|P1|Overall Study|Reasons not Evaluated|271
272874|NCT01079182|902915|P1|Overall Study|ADR and Lack of Effectiveness|39
272875|NCT01079182|902915|P1|Overall Study|Lack of Efficacy|514
272876|NCT01079182|902915|P1|Overall Study|Adverse Drug Reaction (ADR)|261
272877|NCT01079182|902915|P1|Overall Study|Lost to Follow-up|1634
272878|NCT01079130|903023|P6|Overall Study|Lost to Follow-up|0
272879|NCT01079130|903024|P5|Overall Study|Lost to Follow-up|1
272880|NCT01079130|903025|P4|Overall Study|Lost to Follow-up|0
272881|NCT01079130|903026|P3|Overall Study|Lost to Follow-up|0
272882|NCT01079130|903027|P2|Overall Study|Lost to Follow-up|0
272883|NCT01079130|903028|P1|Overall Study|Lost to Follow-up|0
272884|NCT01079130|903023|P6|Overall Study|Unsatisfactory therapeutic effect|0
272885|NCT01079130|903024|P5|Overall Study|Unsatisfactory therapeutic effect|0
272886|NCT01079130|903025|P4|Overall Study|Unsatisfactory therapeutic effect|2
272887|NCT01079130|903026|P3|Overall Study|Unsatisfactory therapeutic effect|0
272888|NCT01079130|903027|P2|Overall Study|Unsatisfactory therapeutic effect|0
272889|NCT01079130|903028|P1|Overall Study|Unsatisfactory therapeutic effect|0
272890|NCT01079130|903023|P6|Overall Study|Abnormal test procedure result(s)|0
272891|NCT01079130|903024|P5|Overall Study|Abnormal test procedure result(s)|1
272892|NCT01079130|903025|P4|Overall Study|Abnormal test procedure result(s)|0
272893|NCT01079130|903026|P3|Overall Study|Abnormal test procedure result(s)|0
272894|NCT01079130|903027|P2|Overall Study|Abnormal test procedure result(s)|0
272895|NCT01079130|903028|P1|Overall Study|Abnormal test procedure result(s)|0
272896|NCT01079130|903023|P6|Overall Study|Protocol deviation|0
272897|NCT01079130|903024|P5|Overall Study|Protocol deviation|0
272898|NCT01079130|903025|P4|Overall Study|Protocol deviation|2
272899|NCT01079130|903026|P3|Overall Study|Protocol deviation|1
272900|NCT01079130|903027|P2|Overall Study|Protocol deviation|2
272901|NCT01079130|903028|P1|Overall Study|Protocol deviation|0
272902|NCT01079130|903023|P6|Overall Study|Withdrawal by Subject|3
272903|NCT01079130|903024|P5|Overall Study|Withdrawal by Subject|1
272904|NCT01079130|903025|P4|Overall Study|Withdrawal by Subject|0
272905|NCT01079130|903026|P3|Overall Study|Withdrawal by Subject|0
272906|NCT01079130|903027|P2|Overall Study|Withdrawal by Subject|1
272907|NCT01079130|903028|P1|Overall Study|Withdrawal by Subject|0
272908|NCT01079130|903023|P6|Overall Study|Administrative problems|1
272909|NCT01079130|903024|P5|Overall Study|Administrative problems|0
272910|NCT01079130|903025|P4|Overall Study|Administrative problems|0
272911|NCT01079130|903026|P3|Overall Study|Administrative problems|0
272912|NCT01079130|903027|P2|Overall Study|Administrative problems|3
272913|NCT01079130|903028|P1|Overall Study|Administrative problems|1
272914|NCT01079130|903023|P6|Overall Study|Adverse Event|1
272915|NCT01079130|903024|P5|Overall Study|Adverse Event|5
272916|NCT01079130|903025|P4|Overall Study|Adverse Event|1
272917|NCT01079130|903026|P3|Overall Study|Adverse Event|0
272918|NCT01079130|903027|P2|Overall Study|Adverse Event|1
272919|NCT01079130|903028|P1|Overall Study|Adverse Event|1
272920|NCT01078974|903048|P1|Overall Study|Adverse Event|3
272921|NCT01078922|903053|P1|Overall Study|Adverse Event|1
272922|NCT01078805|903084|P1|Overall Study|Didn't take study drug|82
272923|NCT01078805|903084|P1|Overall Study|Other|173
272924|NCT01078805|903084|P1|Overall Study|Withdrawal by Subject|739
272925|NCT01078805|903084|P1|Overall Study|Sponsor decision|46
272926|NCT01078805|903084|P1|Overall Study|Serious adverse event|26
272927|NCT01078805|903084|P1|Overall Study|Physician Decision|169
272928|NCT01078805|903084|P1|Overall Study|Lost to Follow-up|676
272929|NCT01078805|903084|P1|Overall Study|Death|134
272930|NCT01078805|903084|P1|Overall Study|Clinically significant abnormal lab|5
272931|NCT01078675|903111|P2|Overall Study|Adverse Event|0
272932|NCT01078675|903112|P1|Overall Study|Adverse Event|3
272933|NCT01078675|903111|P2|Overall Study|Provided in CRF for specific reasons|3
272934|NCT01078675|903112|P1|Overall Study|Provided in CRF for specific reasons|2
272935|NCT01078675|903111|P2|Overall Study|Protocol Violation|0
272936|NCT01078675|903112|P1|Overall Study|Protocol Violation|56
272937|NCT01078675|903111|P2|Overall Study|Withdrawal by Subject|3
272938|NCT01078675|903112|P1|Overall Study|Withdrawal by Subject|7
272939|NCT01078662|903134|P5|Overall Study|Lost to Follow-up|0
272940|NCT01078662|903135|P4|Overall Study|Lost to Follow-up|0
272941|NCT01078662|903136|P3|Overall Study|Lost to Follow-up|0
272942|NCT01078662|903137|P2|Overall Study|Lost to Follow-up|0
272943|NCT01078662|903138|P1|Overall Study|Lost to Follow-up|1
272944|NCT01078662|903134|P5|Overall Study|Protocol Violation|0
272945|NCT01078662|903135|P4|Overall Study|Protocol Violation|0
272946|NCT01078662|903136|P3|Overall Study|Protocol Violation|0
272947|NCT01078662|903137|P2|Overall Study|Protocol Violation|1
272948|NCT01078662|903138|P1|Overall Study|Protocol Violation|0
272949|NCT01078662|903134|P5|Overall Study|Withdrawal by Subject|0
272950|NCT01078662|903135|P4|Overall Study|Withdrawal by Subject|0
272951|NCT01078662|903136|P3|Overall Study|Withdrawal by Subject|1
272952|NCT01078662|903137|P2|Overall Study|Withdrawal by Subject|11
272953|NCT01078662|903138|P1|Overall Study|Withdrawal by Subject|4
272954|NCT01078662|903134|P5|Overall Study|Patients reached data cut-off|3
272955|NCT01078662|903135|P4|Overall Study|Patients reached data cut-off|2
272956|NCT01078662|903136|P3|Overall Study|Patients reached data cut-off|2
272957|NCT01078662|903137|P2|Overall Study|Patients reached data cut-off|53
272958|NCT01078662|903138|P1|Overall Study|Patients reached data cut-off|12
272959|NCT01078662|903134|P5|Overall Study|Death|8
272960|NCT01078662|903135|P4|Overall Study|Death|5
272961|NCT01078662|903136|P3|Overall Study|Death|18
272962|NCT01078662|903137|P2|Overall Study|Death|103
272963|NCT01078662|903138|P1|Overall Study|Death|41
272964|NCT01078623|903177|P20|Treatment Period 4|Withdrawal by Subject|0
272965|NCT01078623|903178|P19|Treatment Period 4|Withdrawal by Subject|0
272966|NCT01078623|903179|P18|Treatment Period 4|Withdrawal by Subject|0
272967|NCT01078623|903180|P17|Treatment Period 4|Withdrawal by Subject|0
272968|NCT01078623|903181|P16|Treatment Period 4|Withdrawal by Subject|1
272969|NCT01078623|903182|P15|Treatment Period 4|Withdrawal by Subject|0
272970|NCT01078623|903183|P14|Treatment Period 4|Withdrawal by Subject|0
272971|NCT01078623|903184|P13|Treatment Period 4|Withdrawal by Subject|0
272972|NCT01078623|903185|P12|Treatment Period 4|Withdrawal by Subject|0
272973|NCT01078623|903186|P11|Treatment Period 4|Withdrawal by Subject|0
272974|NCT01078623|903187|P10|Treatment Period 4|Withdrawal by Subject|0
272975|NCT01078623|903188|P9|Treatment Period 4|Withdrawal by Subject|0
272976|NCT01078623|903189|P8|Treatment Period 4|Withdrawal by Subject|0
272977|NCT01078623|903190|P7|Treatment Period 4|Withdrawal by Subject|0
272978|NCT01078623|903191|P6|Treatment Period 4|Withdrawal by Subject|0
272979|NCT01078623|903192|P5|Treatment Period 4|Withdrawal by Subject|0
272980|NCT01078623|903193|P4|Treatment Period 4|Withdrawal by Subject|0
272981|NCT01078623|903194|P3|Treatment Period 4|Withdrawal by Subject|0
272982|NCT01078623|903195|P2|Treatment Period 4|Withdrawal by Subject|0
272983|NCT01078623|903196|P1|Treatment Period 4|Withdrawal by Subject|0
272984|NCT01078623|903177|P20|Treatment Period 4|Adverse Event|0
272985|NCT01078623|903178|P19|Treatment Period 4|Adverse Event|0
272986|NCT01078623|903179|P18|Treatment Period 4|Adverse Event|0
272987|NCT01078623|903180|P17|Treatment Period 4|Adverse Event|0
272988|NCT01078623|903181|P16|Treatment Period 4|Adverse Event|0
272989|NCT01078623|903182|P15|Treatment Period 4|Adverse Event|0
272990|NCT01078623|903183|P14|Treatment Period 4|Adverse Event|0
272991|NCT01078623|903184|P13|Treatment Period 4|Adverse Event|0
272992|NCT01078623|903185|P12|Treatment Period 4|Adverse Event|0
272993|NCT01078623|903186|P11|Treatment Period 4|Adverse Event|0
272994|NCT01078623|903187|P10|Treatment Period 4|Adverse Event|0
272995|NCT01078623|903188|P9|Treatment Period 4|Adverse Event|0
272996|NCT01078623|903189|P8|Treatment Period 4|Adverse Event|0
272997|NCT01078623|903190|P7|Treatment Period 4|Adverse Event|0
272998|NCT01078623|903191|P6|Treatment Period 4|Adverse Event|0
272999|NCT01078623|903192|P5|Treatment Period 4|Adverse Event|0
273000|NCT01078623|903193|P4|Treatment Period 4|Adverse Event|0
273001|NCT01078623|903194|P3|Treatment Period 4|Adverse Event|1
273002|NCT01078623|903195|P2|Treatment Period 4|Adverse Event|0
273003|NCT01078623|903196|P1|Treatment Period 4|Adverse Event|0
273004|NCT01078623|903177|P20|Treatment Period 3|Adverse Event|0
273005|NCT01078623|903178|P19|Treatment Period 3|Adverse Event|0
273006|NCT01078623|903179|P18|Treatment Period 3|Adverse Event|0
273007|NCT01078623|903180|P17|Treatment Period 3|Adverse Event|0
273008|NCT01078623|903181|P16|Treatment Period 3|Adverse Event|0
273009|NCT01078623|903182|P15|Treatment Period 3|Adverse Event|0
273010|NCT01078623|903183|P14|Treatment Period 3|Adverse Event|1
273011|NCT01078623|903184|P13|Treatment Period 3|Adverse Event|0
273012|NCT01078623|903185|P12|Treatment Period 3|Adverse Event|0
273013|NCT01078623|903186|P11|Treatment Period 3|Adverse Event|0
273014|NCT01078623|903187|P10|Treatment Period 3|Adverse Event|0
273015|NCT01078623|903188|P9|Treatment Period 3|Adverse Event|0
273016|NCT01078623|903189|P8|Treatment Period 3|Adverse Event|0
273017|NCT01078623|903190|P7|Treatment Period 3|Adverse Event|0
273018|NCT01078623|903191|P6|Treatment Period 3|Adverse Event|0
273019|NCT01078623|903192|P5|Treatment Period 3|Adverse Event|1
273020|NCT01078623|903193|P4|Treatment Period 3|Adverse Event|0
273021|NCT01078623|903194|P3|Treatment Period 3|Adverse Event|0
273022|NCT01078623|903195|P2|Treatment Period 3|Adverse Event|0
273023|NCT01078623|903196|P1|Treatment Period 3|Adverse Event|0
273024|NCT01078623|903177|P20|Treatment Period 2|Withdrawal by Subject|0
273025|NCT01078623|903178|P19|Treatment Period 2|Withdrawal by Subject|0
273026|NCT01078623|903179|P18|Treatment Period 2|Withdrawal by Subject|0
273027|NCT01078623|903180|P17|Treatment Period 2|Withdrawal by Subject|0
273028|NCT01078623|903181|P16|Treatment Period 2|Withdrawal by Subject|0
273029|NCT01078623|903182|P15|Treatment Period 2|Withdrawal by Subject|0
273030|NCT01078623|903183|P14|Treatment Period 2|Withdrawal by Subject|0
273031|NCT01078623|903184|P13|Treatment Period 2|Withdrawal by Subject|0
273032|NCT01078623|903185|P12|Treatment Period 2|Withdrawal by Subject|0
273033|NCT01078623|903186|P11|Treatment Period 2|Withdrawal by Subject|0
273034|NCT01078623|903187|P10|Treatment Period 2|Withdrawal by Subject|0
273035|NCT01078623|903188|P9|Treatment Period 2|Withdrawal by Subject|0
273036|NCT01078623|903189|P8|Treatment Period 2|Withdrawal by Subject|0
273037|NCT01078623|903190|P7|Treatment Period 2|Withdrawal by Subject|0
273038|NCT01078623|903191|P6|Treatment Period 2|Withdrawal by Subject|1
273039|NCT01078623|903192|P5|Treatment Period 2|Withdrawal by Subject|0
273040|NCT01078623|903193|P4|Treatment Period 2|Withdrawal by Subject|0
273041|NCT01078623|903194|P3|Treatment Period 2|Withdrawal by Subject|0
273042|NCT01078623|903195|P2|Treatment Period 2|Withdrawal by Subject|0
273043|NCT01078623|903196|P1|Treatment Period 2|Withdrawal by Subject|0
273044|NCT01078623|903177|P20|Treatment Period 2|Adverse Event|0
273045|NCT01078623|903178|P19|Treatment Period 2|Adverse Event|1
273046|NCT01078623|903179|P18|Treatment Period 2|Adverse Event|0
273047|NCT01078623|903180|P17|Treatment Period 2|Adverse Event|0
273048|NCT01078623|903181|P16|Treatment Period 2|Adverse Event|0
273049|NCT01078623|903182|P15|Treatment Period 2|Adverse Event|0
273050|NCT01078623|903183|P14|Treatment Period 2|Adverse Event|0
273051|NCT01078623|903184|P13|Treatment Period 2|Adverse Event|0
273052|NCT01078623|903185|P12|Treatment Period 2|Adverse Event|0
273053|NCT01078623|903186|P11|Treatment Period 2|Adverse Event|0
273054|NCT01078623|903187|P10|Treatment Period 2|Adverse Event|0
273055|NCT01078623|903188|P9|Treatment Period 2|Adverse Event|0
273056|NCT01078623|903189|P8|Treatment Period 2|Adverse Event|0
273057|NCT01078623|903190|P7|Treatment Period 2|Adverse Event|1
273058|NCT01078623|903191|P6|Treatment Period 2|Adverse Event|0
273059|NCT01078623|903192|P5|Treatment Period 2|Adverse Event|0
273060|NCT01078623|903193|P4|Treatment Period 2|Adverse Event|0
273061|NCT01078623|903194|P3|Treatment Period 2|Adverse Event|0
273062|NCT01078623|903195|P2|Treatment Period 2|Adverse Event|0
273063|NCT01078623|903196|P1|Treatment Period 2|Adverse Event|0
273064|NCT01078623|903177|P20|Treatment Period 1|Protocol Violation|0
273065|NCT01078623|903178|P19|Treatment Period 1|Protocol Violation|0
273066|NCT01078623|903179|P18|Treatment Period 1|Protocol Violation|0
273067|NCT01078623|903180|P17|Treatment Period 1|Protocol Violation|0
273068|NCT01078623|903181|P16|Treatment Period 1|Protocol Violation|0
273069|NCT01078623|903182|P15|Treatment Period 1|Protocol Violation|0
273070|NCT01078623|903183|P14|Treatment Period 1|Protocol Violation|0
273071|NCT01078623|903184|P13|Treatment Period 1|Protocol Violation|0
273072|NCT01078623|903185|P12|Treatment Period 1|Protocol Violation|0
273073|NCT01078623|903186|P11|Treatment Period 1|Protocol Violation|0
273074|NCT01078623|903187|P10|Treatment Period 1|Protocol Violation|0
273075|NCT01078623|903188|P9|Treatment Period 1|Protocol Violation|0
273076|NCT01078623|903189|P8|Treatment Period 1|Protocol Violation|0
273077|NCT01078623|903190|P7|Treatment Period 1|Protocol Violation|0
273078|NCT01078623|903191|P6|Treatment Period 1|Protocol Violation|1
273079|NCT01078623|903192|P5|Treatment Period 1|Protocol Violation|0
273080|NCT01078623|903193|P4|Treatment Period 1|Protocol Violation|0
273081|NCT01078623|903194|P3|Treatment Period 1|Protocol Violation|0
273082|NCT01078623|903195|P2|Treatment Period 1|Protocol Violation|0
273083|NCT01078623|903196|P1|Treatment Period 1|Protocol Violation|0
273084|NCT01078623|903177|P20|Treatment Period 1|Withdrawal by Subject|0
273085|NCT01078623|903178|P19|Treatment Period 1|Withdrawal by Subject|0
273086|NCT01078623|903179|P18|Treatment Period 1|Withdrawal by Subject|0
273087|NCT01078623|903180|P17|Treatment Period 1|Withdrawal by Subject|0
273088|NCT01078623|903181|P16|Treatment Period 1|Withdrawal by Subject|0
273089|NCT01078623|903182|P15|Treatment Period 1|Withdrawal by Subject|0
273090|NCT01078623|903183|P14|Treatment Period 1|Withdrawal by Subject|0
273091|NCT01078623|903184|P13|Treatment Period 1|Withdrawal by Subject|0
273092|NCT01078623|903185|P12|Treatment Period 1|Withdrawal by Subject|0
273093|NCT01078623|903186|P11|Treatment Period 1|Withdrawal by Subject|1
273094|NCT01078623|903187|P10|Treatment Period 1|Withdrawal by Subject|0
273095|NCT01078623|903188|P9|Treatment Period 1|Withdrawal by Subject|0
273096|NCT01078623|903189|P8|Treatment Period 1|Withdrawal by Subject|1
273097|NCT01078623|903190|P7|Treatment Period 1|Withdrawal by Subject|0
273098|NCT01078623|903191|P6|Treatment Period 1|Withdrawal by Subject|0
273099|NCT01078623|903192|P5|Treatment Period 1|Withdrawal by Subject|0
273100|NCT01078623|903193|P4|Treatment Period 1|Withdrawal by Subject|0
273101|NCT01078623|903194|P3|Treatment Period 1|Withdrawal by Subject|0
273102|NCT01078623|903195|P2|Treatment Period 1|Withdrawal by Subject|0
273103|NCT01078623|903196|P1|Treatment Period 1|Withdrawal by Subject|0
273104|NCT01078623|903177|P20|Treatment Period 1|Adverse Event|0
273105|NCT01078623|903178|P19|Treatment Period 1|Adverse Event|0
273106|NCT01078623|903179|P18|Treatment Period 1|Adverse Event|0
273107|NCT01078623|903180|P17|Treatment Period 1|Adverse Event|0
273108|NCT01078623|903181|P16|Treatment Period 1|Adverse Event|0
273109|NCT01078623|903182|P15|Treatment Period 1|Adverse Event|0
273110|NCT01078623|903183|P14|Treatment Period 1|Adverse Event|0
273111|NCT01078623|903184|P13|Treatment Period 1|Adverse Event|0
273112|NCT01078623|903185|P12|Treatment Period 1|Adverse Event|0
273113|NCT01078623|903186|P11|Treatment Period 1|Adverse Event|0
273114|NCT01078623|903187|P10|Treatment Period 1|Adverse Event|1
273115|NCT01078623|903188|P9|Treatment Period 1|Adverse Event|1
273116|NCT01078623|903189|P8|Treatment Period 1|Adverse Event|0
273117|NCT01078623|903190|P7|Treatment Period 1|Adverse Event|1
273118|NCT01078623|903191|P6|Treatment Period 1|Adverse Event|0
273119|NCT01078623|903192|P5|Treatment Period 1|Adverse Event|0
273120|NCT01078623|903193|P4|Treatment Period 1|Adverse Event|0
273121|NCT01078623|903194|P3|Treatment Period 1|Adverse Event|1
273122|NCT01078623|903195|P2|Treatment Period 1|Adverse Event|1
273123|NCT01078623|903196|P1|Treatment Period 1|Adverse Event|1
273124|NCT01078584|903218|P1|Overall Study|Multiple Reasons|2
273125|NCT01078584|903218|P1|Overall Study|Serious Adverse Event|27
273126|NCT01078584|903218|P1|Overall Study|Protocol Violation|75
273127|NCT01078584|903218|P1|Overall Study|Lack of Efficacy|98
273128|NCT01078584|903218|P1|Overall Study|Physician Discontinued Patient|12
273129|NCT01078584|903218|P1|Overall Study|Physician Switched Medication|26
273130|NCT01078584|903218|P1|Overall Study|Blood Pressure Controlled|49
273131|NCT01078584|903218|P1|Overall Study|Non-compliance|67
273132|NCT01078584|903218|P1|Overall Study|Physician Withdrew from Study|90
273133|NCT01078584|903218|P1|Overall Study|Withdrawal of Consent|244
273134|NCT01078584|903218|P1|Overall Study|Non-serious Adverse Event|577
273135|NCT01078584|903218|P1|Overall Study|Lost to Follow-up|670
273136|NCT01078584|903218|P1|Overall Study|Final Status Unknown|1073
273137|NCT01078571|903299|P1|Overall Study|Protocol Violation|2
273138|NCT01078571|903299|P1|Overall Study|Lost to Follow-up|8
273139|NCT01078571|903299|P1|Overall Study|Withdrawal by Subject|12
273140|NCT01078571|903299|P1|Overall Study|Reason not reported|21
273141|NCT01078571|903299|P1|Overall Study|Lack of effectiveness|36
273142|NCT01078571|903299|P1|Overall Study|Adverse Event|36
273143|NCT01078545|903315|P1|Overall Study|Participant moved to another physician|1
273144|NCT01078545|903315|P1|Overall Study|Death|3
273145|NCT01078545|903315|P1|Overall Study|Withdrawal by Subject|3
273146|NCT01078545|903315|P1|Overall Study|Physician Decision|6
273147|NCT01078545|903315|P1|Overall Study|Lost to Follow-up|13
273148|NCT01078454|903325|P2|Overall Study|Death|1
273149|NCT01078454|903326|P1|Overall Study|Death|0
273150|NCT01078454|903325|P2|Overall Study|Adverse Event|1
273151|NCT01078454|903326|P1|Overall Study|Adverse Event|1
273152|NCT01078441|903332|P1|Overall Study|Withdrawal by Subject|1
273153|NCT01078389|903372|P2|Overall Study|Other|2
273154|NCT01078389|903373|P1|Overall Study|Other|9
273155|NCT01078389|903372|P2|Overall Study|Voluntary Withdrawal|36
273156|NCT01078389|903373|P1|Overall Study|Voluntary Withdrawal|20
273157|NCT01078389|903372|P2|Overall Study|Lost to Follow-up|23
273158|NCT01078389|903373|P1|Overall Study|Lost to Follow-up|23
273159|NCT01078389|903372|P2|Overall Study|Major Protocol Deviation|0
273160|NCT01078389|903373|P1|Overall Study|Major Protocol Deviation|2
273161|NCT01078389|903372|P2|Overall Study|Adverse Event|6
273162|NCT01078389|903373|P1|Overall Study|Adverse Event|10
273163|NCT01078298|903534|P2|Overall Study|Unspecified|32
273164|NCT01078298|903535|P1|Overall Study|Unspecified|24
273165|NCT01078298|903534|P2|Overall Study|Did not meet entrance criteria|1
273166|NCT01078298|903535|P1|Overall Study|Did not meet entrance criteria|0
273167|NCT01078298|903534|P2|Overall Study|Death|0
273168|NCT01078298|903535|P1|Overall Study|Death|2
273169|NCT01078298|903534|P2|Overall Study|Adverse Event|5
273170|NCT01078298|903535|P1|Overall Study|Adverse Event|6
273171|NCT01078298|903534|P2|Overall Study|Protocol Violation|6
273172|NCT01078298|903535|P1|Overall Study|Protocol Violation|6
273173|NCT01078298|903534|P2|Overall Study|Withdrawal by Subject|33
273174|NCT01078298|903535|P1|Overall Study|Withdrawal by Subject|31
273175|NCT01078298|903534|P2|Overall Study|Lost to Follow-up|13
273176|NCT01078298|903535|P1|Overall Study|Lost to Follow-up|12
273177|NCT01078155|903643|P1|Overall Study|Lost to Follow-up|15
273178|NCT01078155|903643|P1|Overall Study|Participant's Decision|6
273179|NCT01078155|903643|P1|Overall Study|Lack of Efficacy|16
273180|NCT01078155|903643|P1|Overall Study|Adverse Event|7
273181|NCT01078116|903659|P1|Overall Study|Case report form not completed|3
273182|NCT01078116|903659|P1|Overall Study|Lack of effectiveness|15
273183|NCT01078116|903659|P1|Overall Study|Withdrawal by Subject|8
273184|NCT01078116|903659|P1|Overall Study|Adverse Event|5
273185|NCT01078116|903659|P1|Overall Study|Lost to Follow-up|17
273186|NCT01078090|903667|P1|Overall Study|Other|523
273187|NCT01078090|903667|P1|Overall Study|ADR and lack of efficacy|61
273188|NCT01078090|903667|P1|Overall Study|Lack of Efficacy|1193
273189|NCT01078090|903667|P1|Overall Study|Adverse drug reaction (ADR)|453
273190|NCT01078090|903667|P1|Overall Study|Lost to Follow-up|2363
273191|NCT01077960|903761|P1|Overall Study|Reason unspecified|1
273192|NCT01077960|903761|P1|Overall Study|Subject decision|1
273193|NCT01077960|903761|P1|Overall Study|Lost to Follow-up|5
273194|NCT01077960|903761|P1|Overall Study|Protocol Violation|3
273195|NCT01077960|903761|P1|Overall Study|Adverse Event|6
273196|NCT01077804|904011|P1|Overall Study|Other|18
273197|NCT01077804|904011|P1|Overall Study|Refused to continue|79
273198|NCT01077804|904011|P1|Overall Study|Unreachable|102
273199|NCT01077739|904020|P2|Overall Study|Not specified|2
273200|NCT01077739|904021|P1|Overall Study|Not specified|2
273201|NCT01077739|904020|P2|Overall Study|Unacceptable toxicity|2
273202|NCT01077739|904021|P1|Overall Study|Unacceptable toxicity|1
273203|NCT01077739|904020|P2|Overall Study|Death|3
273204|NCT01077739|904021|P1|Overall Study|Death|0
273205|NCT01077739|904020|P2|Overall Study|Withdrawal by Subject|0
273206|NCT01077739|904021|P1|Overall Study|Withdrawal by Subject|1
273207|NCT01077739|904020|P2|Overall Study|Premature withdrawal|3
273208|NCT01077739|904021|P1|Overall Study|Premature withdrawal|1
273209|NCT01077713|904035|P2|Overall Study|Unspecified|2
273210|NCT01077713|904036|P1|Overall Study|Unspecified|4
273211|NCT01077713|904035|P2|Overall Study|Adverse Event|1
273212|NCT01077713|904036|P1|Overall Study|Adverse Event|2
273213|NCT01077713|904035|P2|Overall Study|Lost to Follow-up|1
273214|NCT01077713|904036|P1|Overall Study|Lost to Follow-up|1
273215|NCT01077713|904035|P2|Overall Study|Death|29
273216|NCT01077713|904036|P1|Overall Study|Death|28
273217|NCT01077713|904035|P2|Overall Study|Progressive Disease (PD)|1
273218|NCT01077713|904036|P1|Overall Study|Progressive Disease (PD)|0
273219|NCT01077713|904035|P2|Overall Study|Withdrawal by Subject|2
273220|NCT01077713|904036|P1|Overall Study|Withdrawal by Subject|1
273221|NCT01077622|904060|P1|Overall Study|Withdrawal by Subject|1
273222|NCT01077622|904060|P1|Overall Study|Physician Decision|2
273223|NCT01077544|904180|P2|Overall Study|Disease Progression|1
273224|NCT01077544|904181|P1|Overall Study|Disease Progression|0
273225|NCT01077544|904180|P2|Overall Study|Adverse Event|1
273226|NCT01077544|904181|P1|Overall Study|Adverse Event|0
273227|NCT01077544|904180|P2|Overall Study|New Cancer Therapy|3
273228|NCT01077544|904181|P1|Overall Study|New Cancer Therapy|3
273229|NCT01077375|904222|P2|Overall Study|Other Reason|1
273230|NCT01077375|904223|P1|Overall Study|Other Reason|0
273231|NCT01077375|904222|P2|Overall Study|Lost to Follow-up|5
273232|NCT01077375|904223|P1|Overall Study|Lost to Follow-up|2
273233|NCT01077375|904222|P2|Overall Study|Withdrawal by Subject|6
273234|NCT01077375|904223|P1|Overall Study|Withdrawal by Subject|0
273235|NCT01077375|904222|P2|Overall Study|Lack of Efficacy|8
273236|NCT01077375|904223|P1|Overall Study|Lack of Efficacy|6
273237|NCT01077375|904222|P2|Overall Study|Adverse Event|15
273238|NCT01077375|904223|P1|Overall Study|Adverse Event|2
273239|NCT01077362|904234|P3|Overall Study|Not Specified|2
273240|NCT01077362|904235|P2|Overall Study|Not Specified|1
273241|NCT01077362|904236|P1|Overall Study|Not Specified|0
273242|NCT01077362|904234|P3|Overall Study|Withdrawal by Subject|5
273243|NCT01077362|904235|P2|Overall Study|Withdrawal by Subject|3
273244|NCT01077362|904236|P1|Overall Study|Withdrawal by Subject|5
273245|NCT01077362|904234|P3|Overall Study|Adverse Event|4
273246|NCT01077362|904235|P2|Overall Study|Adverse Event|7
273247|NCT01077362|904236|P1|Overall Study|Adverse Event|12
273248|NCT01077362|904234|P3|Overall Study|Lost to Follow-up|3
273249|NCT01077362|904235|P2|Overall Study|Lost to Follow-up|0
273250|NCT01077362|904236|P1|Overall Study|Lost to Follow-up|1
273251|NCT01077362|904234|P3|Overall Study|Lack of Efficacy|10
273252|NCT01077362|904235|P2|Overall Study|Lack of Efficacy|8
273253|NCT01077362|904236|P1|Overall Study|Lack of Efficacy|13
273254|NCT01077323|904272|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
273255|NCT01077323|904273|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
273256|NCT01077323|904274|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
273257|NCT01077323|904272|P3|Overall Study|Dispensing of drug in baseline period|256446
273258|NCT01077323|904273|P2|Overall Study|Dispensing of drug in baseline period|120229
273259|NCT01077323|904274|P1|Overall Study|Dispensing of drug in baseline period|0
273260|NCT01077323|904272|P3|Overall Study|<9 months enroll before drug dispensed|11655523
273261|NCT01077323|904273|P2|Overall Study|<9 months enroll before drug dispensed|263954
273262|NCT01077323|904274|P1|Overall Study|<9 months enroll before drug dispensed|11226
273263|NCT01077284|904317|P3|Overall Study|Other|1
273264|NCT01077284|904318|P2|Overall Study|Other|0
273265|NCT01077284|904319|P1|Overall Study|Other|0
273266|NCT01077284|904317|P3|Overall Study|Withdrawal by Subject|1
273267|NCT01077284|904318|P2|Overall Study|Withdrawal by Subject|3
273268|NCT01077284|904319|P1|Overall Study|Withdrawal by Subject|2
273269|NCT01077284|904317|P3|Overall Study|Lost to Follow-up|0
273270|NCT01077284|904318|P2|Overall Study|Lost to Follow-up|2
273271|NCT01077284|904319|P1|Overall Study|Lost to Follow-up|1
273272|NCT01077284|904317|P3|Overall Study|Adverse Event|1
273273|NCT01077284|904318|P2|Overall Study|Adverse Event|0
273274|NCT01077284|904319|P1|Overall Study|Adverse Event|2
273275|NCT01077271|904340|P1|Overall Study|Mother unconvinced of the necessity|1
273276|NCT01077271|904340|P1|Overall Study|End of RSV season nearly reached|1
273277|NCT01077271|904340|P1|Overall Study|Parents thought too many injections|2
273278|NCT01077271|904340|P1|Overall Study|Changed doctors|2
273279|NCT01077271|904340|P1|Overall Study|Quota used up (insurance reimb issue)|2
273280|NCT01077271|904340|P1|Overall Study|Noncompliance|2
273281|NCT01077271|904340|P1|Overall Study|Screen failure, did not take palivizumab|4
273282|NCT01077271|904340|P1|Overall Study|Parental desire|8
273283|NCT01077258|904378|P1|Overall Study|Other reasons|260
273284|NCT01077258|904378|P1|Overall Study|Clinical remission|37
273285|NCT01077258|904378|P1|Overall Study|Lack of Efficacy|663
273286|NCT01077258|904378|P1|Overall Study|Adverse drug reaction|218
273287|NCT01077258|904378|P1|Overall Study|Lost to Follow-up|1390
273288|NCT01077193|904414|P1|Overall Study|Study Terminated by Sponsor|40
273289|NCT01077193|904414|P1|Overall Study|Lack of Efficacy|1
273290|NCT01077193|904414|P1|Overall Study|Withdrawal by Subject|2
273291|NCT01077193|904414|P1|Overall Study|Lost to Follow-up|1
273292|NCT01077128|904418|P1|Overall Study|Not available|54
273293|NCT01077128|904418|P1|Overall Study|Lack of efficacy/disease exacerbation|1
273294|NCT01077128|904418|P1|Overall Study|Adverse event and disease exacerbation|1
273295|NCT01077128|904418|P1|Overall Study|Adverse event and consent withdrawal|1
273296|NCT01077128|904418|P1|Overall Study|Disease exacerbation|1
273297|NCT01077128|904418|P1|Overall Study|Lack of Efficacy|1
273298|NCT01077128|904418|P1|Overall Study|Adverse Event|8
273299|NCT01077076|904476|P6|Third Intervention|Death in the participant's family|1
273300|NCT01077076|904477|P5|Third Intervention|Death in the participant's family|0
273301|NCT01077076|904478|P4|Third Intervention|Death in the participant's family|0
273302|NCT01077076|904479|P3|Third Intervention|Death in the participant's family|0
273303|NCT01077076|904480|P2|Third Intervention|Death in the participant's family|0
273304|NCT01077076|904481|P1|Third Intervention|Death in the participant's family|0
273305|NCT01077076|904476|P6|First Intervention|Withdrawal by Subject|0
273306|NCT01077076|904477|P5|First Intervention|Withdrawal by Subject|0
273307|NCT01077076|904478|P4|First Intervention|Withdrawal by Subject|0
273308|NCT01077076|904479|P3|First Intervention|Withdrawal by Subject|0
273309|NCT01077076|904480|P2|First Intervention|Withdrawal by Subject|0
273310|NCT01077076|904481|P1|First Intervention|Withdrawal by Subject|1
273311|NCT01077063|904491|P2|Overall Study|Withdrawal by Subject|2
273312|NCT01077063|904492|P1|Overall Study|Withdrawal by Subject|0
273313|NCT01077063|904491|P2|Overall Study|Death|1
273314|NCT01077063|904492|P1|Overall Study|Death|1
273315|NCT01077063|904491|P2|Overall Study|Adverse Event|0
273316|NCT01077063|904492|P1|Overall Study|Adverse Event|3
273317|NCT01077050|904498|P1|Overall Study|Screen failure|8
273318|NCT01077050|904498|P1|Overall Study|Subjects signed ICF could not be located|1
273319|NCT01077024|904504|P2|Overall Study|unspecified|4
273320|NCT01077024|904505|P1|Overall Study|unspecified|4
273321|NCT01077024|904504|P2|Overall Study|Incarcerated|8
273322|NCT01077024|904505|P1|Overall Study|Incarcerated|7
273323|NCT01077024|904504|P2|Overall Study|Withdrawal by Subject|2
273324|NCT01077024|904505|P1|Overall Study|Withdrawal by Subject|0
273325|NCT01077024|904504|P2|Overall Study|Lost to Follow-up|14
273326|NCT01077024|904505|P1|Overall Study|Lost to Follow-up|20
273327|NCT01076959|904544|P1|Overall Study|Other|119
273328|NCT01076959|904544|P1|Overall Study|Lost to Follow-up|241
273329|NCT01076959|904544|P1|Overall Study|Non-compliance|274
273330|NCT01076959|904544|P1|Overall Study|Lack of Efficacy|849
273331|NCT01076959|904544|P1|Overall Study|Adverse Event|767
273332|NCT01076647|904580|P2|Overall Study|Unclassified|12
273333|NCT01076647|904581|P1|Overall Study|Unclassified|12
273334|NCT01076647|904580|P2|Overall Study|Withdrawal criteria|2
273335|NCT01076647|904581|P1|Overall Study|Withdrawal criteria|2
273336|NCT01076647|904580|P2|Overall Study|Protocol Violation|9
273337|NCT01076647|904581|P1|Overall Study|Protocol Violation|7
273338|NCT01076647|904580|P2|Overall Study|Lack of Efficacy|1
273339|NCT01076647|904581|P1|Overall Study|Lack of Efficacy|0
273340|NCT01076647|904580|P2|Overall Study|Adverse Event|1
273341|NCT01076647|904581|P1|Overall Study|Adverse Event|4
273342|NCT01076361|904612|P1|Overall Study|22 leads were excluded from analysis|21
273343|NCT01076335|904620|P1|Overall Study|Withdrawal without treatment|1
273344|NCT01076335|904620|P1|Overall Study|Withdrawal by Subject|3
273345|NCT01076192|904672|P1|Overall Study|Not specified|197
273346|NCT01076179|904687|P1|Overall Study|Withdrawal by Subject|1
273347|NCT01076166|904710|P1|Overall Study|Symptoms improved/resolved|6
273348|NCT01076166|904710|P1|Overall Study|Adverse Event|3
273349|NCT01076153|904717|P1|Overall Study|Adverse Event|1
273350|NCT01076153|904717|P1|Overall Study|Symptoms improved/resolved|10
273351|NCT01076088|904731|P6|Overall Study|Other protocol specified criteria|1
273352|NCT01076088|904732|P5|Overall Study|Other protocol specified criteria|0
273353|NCT01076088|904733|P4|Overall Study|Other protocol specified criteria|0
273354|NCT01076088|904734|P3|Overall Study|Other protocol specified criteria|0
273355|NCT01076088|904735|P2|Overall Study|Other protocol specified criteria|0
273356|NCT01076088|904736|P1|Overall Study|Other protocol specified criteria|0
273357|NCT01076088|904731|P6|Overall Study|Withdrawal by Subject|17
273358|NCT01076088|904732|P5|Overall Study|Withdrawal by Subject|11
273359|NCT01076088|904733|P4|Overall Study|Withdrawal by Subject|10
273360|NCT01076088|904734|P3|Overall Study|Withdrawal by Subject|14
273361|NCT01076088|904735|P2|Overall Study|Withdrawal by Subject|8
273362|NCT01076088|904736|P1|Overall Study|Withdrawal by Subject|8
273363|NCT01076088|904731|P6|Overall Study|Physician Decision|0
273364|NCT01076088|904732|P5|Overall Study|Physician Decision|1
273365|NCT01076088|904733|P4|Overall Study|Physician Decision|1
273366|NCT01076088|904734|P3|Overall Study|Physician Decision|0
273367|NCT01076088|904735|P2|Overall Study|Physician Decision|3
273368|NCT01076088|904736|P1|Overall Study|Physician Decision|1
273369|NCT01076088|904731|P6|Overall Study|Non-compliance with study drug|0
273370|NCT01076088|904732|P5|Overall Study|Non-compliance with study drug|0
273371|NCT01076088|904733|P4|Overall Study|Non-compliance with study drug|1
273372|NCT01076088|904734|P3|Overall Study|Non-compliance with study drug|0
273373|NCT01076088|904735|P2|Overall Study|Non-compliance with study drug|0
273374|NCT01076088|904736|P1|Overall Study|Non-compliance with study drug|0
273375|NCT01076088|904731|P6|Overall Study|Lost to Follow-up|2
273376|NCT01076088|904732|P5|Overall Study|Lost to Follow-up|1
273377|NCT01076088|904733|P4|Overall Study|Lost to Follow-up|1
273378|NCT01076088|904734|P3|Overall Study|Lost to Follow-up|0
273379|NCT01076088|904735|P2|Overall Study|Lost to Follow-up|1
273380|NCT01076088|904736|P1|Overall Study|Lost to Follow-up|1
273381|NCT01076088|904731|P6|Overall Study|Adverse Event|3
273382|NCT01076088|904732|P5|Overall Study|Adverse Event|3
273383|NCT01076088|904733|P4|Overall Study|Adverse Event|2
273384|NCT01076088|904734|P3|Overall Study|Adverse Event|3
273385|NCT01076088|904735|P2|Overall Study|Adverse Event|6
273386|NCT01076088|904736|P1|Overall Study|Adverse Event|1
273387|NCT01076075|904764|P2|Overall Study|Withdrawal by Subject|19
273388|NCT01076075|904765|P1|Overall Study|Withdrawal by Subject|8
273389|NCT01076075|904764|P2|Overall Study|Protocol Violation|1
273390|NCT01076075|904765|P1|Overall Study|Protocol Violation|0
273391|NCT01076075|904764|P2|Overall Study|other|9
273392|NCT01076075|904765|P1|Overall Study|other|19
273393|NCT01076075|904764|P2|Overall Study|Lost to Follow-up|5
273394|NCT01076075|904765|P1|Overall Study|Lost to Follow-up|6
273395|NCT01076075|904764|P2|Overall Study|Lack of Efficacy|4
273396|NCT01076075|904765|P1|Overall Study|Lack of Efficacy|5
273397|NCT01076075|904764|P2|Overall Study|Adverse Event|9
273398|NCT01076075|904765|P1|Overall Study|Adverse Event|3
273399|NCT01076036|904779|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
273400|NCT01075984|904789|P5|Follow-up Phase|Treatment failure|4
273401|NCT01075984|904790|P4|Follow-up Phase|Treatment failure|0
273402|NCT01075984|904791|P3|Follow-up Phase|Treatment failure|0
273403|NCT01075984|904792|P2|Follow-up Phase|Treatment failure|0
273404|NCT01075984|904793|P1|Follow-up Phase|Treatment failure|0
273405|NCT01075984|904789|P5|Follow-up Phase|Progression of disease|2
273406|NCT01075984|904790|P4|Follow-up Phase|Progression of disease|0
273407|NCT01075984|904791|P3|Follow-up Phase|Progression of disease|0
273408|NCT01075984|904792|P2|Follow-up Phase|Progression of disease|0
273409|NCT01075984|904793|P1|Follow-up Phase|Progression of disease|0
273410|NCT01075984|904789|P5|Follow-up Phase|Withdrawal by Subject|10
273411|NCT01075984|904790|P4|Follow-up Phase|Withdrawal by Subject|0
273412|NCT01075984|904791|P3|Follow-up Phase|Withdrawal by Subject|0
273413|NCT01075984|904792|P2|Follow-up Phase|Withdrawal by Subject|0
273414|NCT01075984|904793|P1|Follow-up Phase|Withdrawal by Subject|0
273415|NCT01075984|904789|P5|Follow-up Phase|Administrative|1
273416|NCT01075984|904790|P4|Follow-up Phase|Administrative|0
273417|NCT01075984|904791|P3|Follow-up Phase|Administrative|0
273418|NCT01075984|904792|P2|Follow-up Phase|Administrative|0
273419|NCT01075984|904793|P1|Follow-up Phase|Administrative|0
273420|NCT01075984|904789|P5|Follow-up Phase|Adverse Event|27
273421|NCT01075984|904790|P4|Follow-up Phase|Adverse Event|2
273422|NCT01075984|904791|P3|Follow-up Phase|Adverse Event|0
273423|NCT01075984|904792|P2|Follow-up Phase|Adverse Event|0
273424|NCT01075984|904793|P1|Follow-up Phase|Adverse Event|0
273425|NCT01075984|904789|P5|Follow-up Phase|Protocol Violation|3
273426|NCT01075984|904790|P4|Follow-up Phase|Protocol Violation|0
273427|NCT01075984|904791|P3|Follow-up Phase|Protocol Violation|1
273428|NCT01075984|904792|P2|Follow-up Phase|Protocol Violation|0
273429|NCT01075984|904793|P1|Follow-up Phase|Protocol Violation|0
273430|NCT01075984|904789|P5|Treatment Phase|Progression of disease|2
273431|NCT01075984|904790|P4|Treatment Phase|Progression of disease|0
273432|NCT01075984|904791|P3|Treatment Phase|Progression of disease|0
273433|NCT01075984|904792|P2|Treatment Phase|Progression of disease|0
273434|NCT01075984|904793|P1|Treatment Phase|Progression of disease|0
273435|NCT01075984|904789|P5|Treatment Phase|Treatment Failure|5
273436|NCT01075984|904790|P4|Treatment Phase|Treatment Failure|0
273437|NCT01075984|904791|P3|Treatment Phase|Treatment Failure|1
273438|NCT01075984|904792|P2|Treatment Phase|Treatment Failure|0
273439|NCT01075984|904793|P1|Treatment Phase|Treatment Failure|0
273440|NCT01075984|904789|P5|Treatment Phase|Withdrawal by Subject|15
273441|NCT01075984|904790|P4|Treatment Phase|Withdrawal by Subject|0
273442|NCT01075984|904791|P3|Treatment Phase|Withdrawal by Subject|2
273443|NCT01075984|904792|P2|Treatment Phase|Withdrawal by Subject|0
273444|NCT01075984|904793|P1|Treatment Phase|Withdrawal by Subject|0
273445|NCT01075984|904789|P5|Treatment Phase|Protocol Violation|3
273446|NCT01075984|904790|P4|Treatment Phase|Protocol Violation|0
273447|NCT01075984|904791|P3|Treatment Phase|Protocol Violation|1
273448|NCT01075984|904792|P2|Treatment Phase|Protocol Violation|0
273449|NCT01075984|904793|P1|Treatment Phase|Protocol Violation|0
273450|NCT01075984|904789|P5|Treatment Phase|Adverse Event|35
273451|NCT01075984|904790|P4|Treatment Phase|Adverse Event|7
273452|NCT01075984|904791|P3|Treatment Phase|Adverse Event|3
273453|NCT01075984|904792|P2|Treatment Phase|Adverse Event|1
273454|NCT01075984|904793|P1|Treatment Phase|Adverse Event|0
273455|NCT01075958|904851|P1|Overall Study|Blood sample could not be obtained|44
273456|NCT01075815|904867|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
273457|NCT01075815|904868|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
273458|NCT01075815|904867|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
273459|NCT01075815|904868|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
273460|NCT01075815|904867|P2|Overall Study|Withdrawal before r-hCG administration|1
273461|NCT01075815|904868|P1|Overall Study|Withdrawal before r-hCG administration|6
273462|NCT01075763|904906|P2|Overall Study|Withdrawal by Subject|2
273463|NCT01075763|904907|P1|Overall Study|Withdrawal by Subject|2
273464|NCT01075763|904906|P2|Overall Study|Lack of Efficacy|1
273465|NCT01075763|904907|P1|Overall Study|Lack of Efficacy|0
273466|NCT01075763|904906|P2|Overall Study|Lost to Follow-up|1
273467|NCT01075763|904907|P1|Overall Study|Lost to Follow-up|2
273468|NCT01075685|904931|P2|Overall Study|Lost to Follow-up|220
273469|NCT01075685|904932|P1|Overall Study|Lost to Follow-up|563
273470|NCT01075685|904931|P2|Overall Study|Withdrawal by Subject|5
273471|NCT01075685|904932|P1|Overall Study|Withdrawal by Subject|20
273472|NCT01075685|904931|P2|Overall Study|Protocol Violation|1
273473|NCT01075685|904932|P1|Overall Study|Protocol Violation|9
273474|NCT01075646|904948|P4|Overall Study|Lost to Follow-up|2
273475|NCT01075646|904949|P3|Overall Study|Lost to Follow-up|1
273476|NCT01075646|904950|P2|Overall Study|Lost to Follow-up|3
273477|NCT01075646|904951|P1|Overall Study|Lost to Follow-up|4
273478|NCT01075282|904999|P3|Overall Study|Death|2
273479|NCT01075282|905000|P2|Overall Study|Death|1
273480|NCT01075282|905001|P1|Overall Study|Death|0
273481|NCT01075282|904999|P3|Overall Study|Protocol Violation|1
273482|NCT01075282|905000|P2|Overall Study|Protocol Violation|2
273483|NCT01075282|905001|P1|Overall Study|Protocol Violation|0
273484|NCT01075282|904999|P3|Overall Study|Treatment Non-compliance|2
273485|NCT01075282|905000|P2|Overall Study|Treatment Non-compliance|2
273486|NCT01075282|905001|P1|Overall Study|Treatment Non-compliance|1
273487|NCT01075282|904999|P3|Overall Study|Lack of Efficacy|0
273488|NCT01075282|905000|P2|Overall Study|Lack of Efficacy|1
273489|NCT01075282|905001|P1|Overall Study|Lack of Efficacy|1
273490|NCT01075282|904999|P3|Overall Study|Physician Decision|3
273491|NCT01075282|905000|P2|Overall Study|Physician Decision|3
273492|NCT01075282|905001|P1|Overall Study|Physician Decision|3
273493|NCT01075282|904999|P3|Overall Study|Lost to Follow-up|3
273494|NCT01075282|905000|P2|Overall Study|Lost to Follow-up|3
273495|NCT01075282|905001|P1|Overall Study|Lost to Follow-up|3
273496|NCT01075282|904999|P3|Overall Study|Entry Criteria Not Met|0
273497|NCT01075282|905000|P2|Overall Study|Entry Criteria Not Met|2
273498|NCT01075282|905001|P1|Overall Study|Entry Criteria Not Met|3
273499|NCT01075282|904999|P3|Overall Study|Adverse Event|5
273500|NCT01075282|905000|P2|Overall Study|Adverse Event|8
273501|NCT01075282|905001|P1|Overall Study|Adverse Event|9
273502|NCT01075282|904999|P3|Overall Study|Withdrawal by Subject|11
273503|NCT01075282|905000|P2|Overall Study|Withdrawal by Subject|7
273504|NCT01075282|905001|P1|Overall Study|Withdrawal by Subject|11
273505|NCT01075256|905084|P3|Overall Study|Withdrawal by Subject|0
273506|NCT01075256|905085|P2|Overall Study|Withdrawal by Subject|0
273507|NCT01075256|905086|P1|Overall Study|Withdrawal by Subject|1
273508|NCT01075243|905118|P3|Overall Study|Withdrawal by Subject|0
273509|NCT01075243|905119|P2|Overall Study|Withdrawal by Subject|1
273510|NCT01075243|905120|P1|Overall Study|Withdrawal by Subject|1
273511|NCT01075243|905118|P3|Overall Study|Lost to Follow-up|0
273512|NCT01075243|905119|P2|Overall Study|Lost to Follow-up|2
273513|NCT01075243|905120|P1|Overall Study|Lost to Follow-up|5
273514|NCT01075217|905172|P2|Overall Study|Physician Decision|0
273515|NCT01075217|905173|P1|Overall Study|Physician Decision|1
273516|NCT01075217|905172|P2|Overall Study|Adverse Event|1
273517|NCT01075217|905173|P1|Overall Study|Adverse Event|1
273518|NCT01075191|905206|P1|Overall Study|Unknown Reasons|1
273519|NCT01075191|905206|P1|Overall Study|Patient's Wish|2
273520|NCT01075191|905206|P1|Overall Study|Therapy Break|3
273521|NCT01075191|905206|P1|Overall Study|Noncompliance|3
273522|NCT01075191|905206|P1|Overall Study|Adverse Event|4
273523|NCT01075191|905206|P1|Overall Study|Co-morbidities|1
273524|NCT01075191|905206|P1|Overall Study|Intensification|3
273525|NCT01075191|905206|P1|Overall Study|Death|1
273526|NCT01075178|905217|P2|Subject Chart Review|matched partner excluded (reasons above)|3
273527|NCT01075178|905218|P1|Subject Chart Review|matched partner excluded (reasons above)|6
273528|NCT01075178|905217|P2|Subject Chart Review|no data collected due to site closure|4
273529|NCT01075178|905218|P1|Subject Chart Review|no data collected due to site closure|3
273530|NCT01075178|905217|P2|Subject Chart Review|died before chart review period|2
273531|NCT01075178|905218|P1|Subject Chart Review|died before chart review period|0
273532|NCT01075178|905217|P2|Subject Matching|eligible but not matched|403
273533|NCT01075178|905218|P1|Subject Matching|eligible but not matched|130
273534|NCT01075152|905232|P2|Overall Study|Withdrawal by Subject|0
273535|NCT01075152|905233|P1|Overall Study|Withdrawal by Subject|1
273536|NCT01075100|905259|P2|Overall Study|Other|1
273537|NCT01075100|905260|P1|Overall Study|Other|3
273538|NCT01075100|905259|P2|Overall Study|Disease Progression|29
273539|NCT01075100|905260|P1|Overall Study|Disease Progression|25
273540|NCT01075100|905259|P2|Overall Study|Investigator Request|1
273541|NCT01075100|905260|P1|Overall Study|Investigator Request|2
273542|NCT01075100|905259|P2|Overall Study|Patient Request|4
273543|NCT01075100|905260|P1|Overall Study|Patient Request|4
273544|NCT01075100|905259|P2|Overall Study|Adverse Event|18
273545|NCT01075100|905260|P1|Overall Study|Adverse Event|15
273546|NCT01075074|905290|P3|Overall Study|Surgeon changed to open incisional case|2
273547|NCT01075074|905291|P2|Overall Study|Surgeon changed to open incisional case|2
273548|NCT01075074|905292|P1|Overall Study|Surgeon changed to open incisional case|1
273549|NCT01074944|905309|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
273550|NCT01074944|905310|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
273551|NCT01074944|905311|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
273552|NCT01074944|905312|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
273553|NCT01074944|905313|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
273554|NCT01074944|905309|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
273555|NCT01074944|905310|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
273556|NCT01074944|905311|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
273557|NCT01074944|905312|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
273558|NCT01074944|905313|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
273559|NCT01074944|905309|P5|Long Term Treatment|Withdrawal by Subject|0
273560|NCT01074944|905310|P4|Long Term Treatment|Withdrawal by Subject|2
273561|NCT01074944|905311|P3|Long Term Treatment|Withdrawal by Subject|0
273562|NCT01074944|905312|P2|Long Term Treatment|Withdrawal by Subject|0
273563|NCT01074944|905313|P1|Long Term Treatment|Withdrawal by Subject|0
273564|NCT01074944|905309|P5|Long Term Treatment|Entered in Period, But Not Treated|0
273565|NCT01074944|905310|P4|Long Term Treatment|Entered in Period, But Not Treated|1
273566|NCT01074944|905311|P3|Long Term Treatment|Entered in Period, But Not Treated|0
273567|NCT01074944|905312|P2|Long Term Treatment|Entered in Period, But Not Treated|0
273568|NCT01074944|905313|P1|Long Term Treatment|Entered in Period, But Not Treated|0
273569|NCT01074944|905309|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
273570|NCT01074944|905310|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
273571|NCT01074944|905311|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
273572|NCT01074944|905312|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
273573|NCT01074944|905313|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
273574|NCT01074944|905309|P5|Long Term Treatment|Lost to Follow-up|0
273575|NCT01074944|905310|P4|Long Term Treatment|Lost to Follow-up|2
273576|NCT01074944|905311|P3|Long Term Treatment|Lost to Follow-up|0
273577|NCT01074944|905312|P2|Long Term Treatment|Lost to Follow-up|0
273578|NCT01074944|905313|P1|Long Term Treatment|Lost to Follow-up|0
273579|NCT01074944|905309|P5|Long Term Treatment|Adverse Event|0
273580|NCT01074944|905310|P4|Long Term Treatment|Adverse Event|3
273581|NCT01074944|905311|P3|Long Term Treatment|Adverse Event|0
273582|NCT01074944|905312|P2|Long Term Treatment|Adverse Event|0
273583|NCT01074944|905313|P1|Long Term Treatment|Adverse Event|0
273584|NCT01074944|905309|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
273585|NCT01074944|905310|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
273586|NCT01074944|905311|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
273587|NCT01074944|905312|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
273588|NCT01074944|905313|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
273589|NCT01074944|905309|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
273590|NCT01074944|905310|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
273591|NCT01074944|905311|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
273592|NCT01074944|905312|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
273593|NCT01074944|905313|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
273594|NCT01074944|905309|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
273595|NCT01074944|905310|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
273596|NCT01074944|905311|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
273597|NCT01074944|905312|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
273598|NCT01074944|905313|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
273599|NCT01074944|905309|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
273600|NCT01074944|905310|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
273601|NCT01074944|905311|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
273602|NCT01074944|905312|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
273603|NCT01074944|905313|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
273604|NCT01074944|905309|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
273605|NCT01074944|905310|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
273606|NCT01074944|905311|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
273607|NCT01074944|905312|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
273608|NCT01074944|905313|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
273609|NCT01074944|905309|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
273610|NCT01074944|905310|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
273611|NCT01074944|905311|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
273612|NCT01074944|905312|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
273613|NCT01074944|905313|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
273614|NCT01074944|905309|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
273615|NCT01074944|905310|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
273616|NCT01074944|905311|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
273617|NCT01074944|905312|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
273618|NCT01074944|905313|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
273619|NCT01074944|905309|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
273620|NCT01074944|905310|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
273621|NCT01074944|905311|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
273622|NCT01074944|905312|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
273623|NCT01074944|905313|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
273624|NCT01074944|905309|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
273625|NCT01074944|905310|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
273626|NCT01074944|905311|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
273627|NCT01074944|905312|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
273628|NCT01074944|905313|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
273629|NCT01074931|905367|P1|Overall Study|Death|5
273630|NCT01074931|905367|P1|Overall Study|Economic reasons|1
273631|NCT01074658|905379|P1|Overall Study|No implant attempted|19
273632|NCT01074554|905387|P2|Overall Study|Lost to Follow-up|1
273633|NCT01074554|905388|P1|Overall Study|Lost to Follow-up|0
273634|NCT01074554|905387|P2|Overall Study|Adverse Event|3
273635|NCT01074554|905388|P1|Overall Study|Adverse Event|3
273636|NCT01074502|905398|P1|Overall Study|Withdrawal by Subject|1
273637|NCT01074450|905422|P2|Second Intervention|Physician Decision|1
273638|NCT01074450|905423|P1|Second Intervention|Physician Decision|0
273639|NCT01074450|905422|P2|Second Intervention|Protocol Violation|0
273640|NCT01074450|905423|P1|Second Intervention|Protocol Violation|1
273641|NCT01074450|905422|P2|First Intervention|Emesis in Dosing Interval|2
273642|NCT01074450|905423|P1|First Intervention|Emesis in Dosing Interval|0
273643|NCT01074307|905444|P2|Overall Study|Protocol Violation|5
273644|NCT01074307|905445|P1|Overall Study|Protocol Violation|8
273645|NCT01074307|905444|P2|Overall Study|Exclusion criterion|1
273646|NCT01074307|905445|P1|Overall Study|Exclusion criterion|0
273647|NCT01074307|905444|P2|Overall Study|No primary endpoint evaluation|6
273648|NCT01074307|905445|P1|Overall Study|No primary endpoint evaluation|14
273649|NCT01074268|905467|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
273650|NCT01074268|905468|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
273651|NCT01074268|905467|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
273652|NCT01074268|905468|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
273653|NCT01074268|905467|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
273654|NCT01074268|905468|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
273655|NCT01074268|905467|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
273656|NCT01074268|905468|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
273657|NCT01074268|905467|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
273658|NCT01074268|905468|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
273659|NCT01074268|905467|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
273660|NCT01074268|905468|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
273661|NCT01074268|905467|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
273662|NCT01074268|905468|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
273663|NCT01074268|905467|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
273664|NCT01074268|905468|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
273665|NCT01074268|905467|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
273666|NCT01074268|905468|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
273667|NCT01074255|905494|P1|Overall Study|Did not receive EMEND|2
273668|NCT01074242|905498|P1|Overall Study|Duplicate Case Report Form|5
273669|NCT01074242|905498|P1|Overall Study|Violation of vaccine dose or dosage|351
273670|NCT01074242|905498|P1|Overall Study|Case report unclear|6
273671|NCT01074242|905498|P1|Overall Study|Lost to Follow-up|1
273672|NCT01074242|905498|P1|Overall Study|Case report before date of contract|40
273673|NCT01074229|905506|P3|Overall Study|Change to open surgical procedure|4
273674|NCT01074229|905507|P2|Overall Study|Change to open surgical procedure|3
273675|NCT01074229|905508|P1|Overall Study|Change to open surgical procedure|1
273676|NCT01074229|905506|P3|Overall Study|Lost to Follow-up|0
273677|NCT01074229|905507|P2|Overall Study|Lost to Follow-up|0
273678|NCT01074229|905508|P1|Overall Study|Lost to Follow-up|1
273679|NCT01074216|905519|P1|Overall Study|Not Treated|12
273680|NCT01074216|905519|P1|Overall Study|Physician Decision|1
273681|NCT01074047|905576|P2|Survival Follow-Up Phase|Those who remain alive at study closure|3
273682|NCT01074047|905577|P1|Survival Follow-Up Phase|Those who remain alive at study closure|1
273683|NCT01074047|905576|P2|Survival Follow-Up Phase|Death|124
273684|NCT01074047|905577|P1|Survival Follow-Up Phase|Death|116
273685|NCT01074047|905576|P2|Survival Follow-Up Phase|Lost to Follow-up|1
273686|NCT01074047|905577|P1|Survival Follow-Up Phase|Lost to Follow-up|2
273687|NCT01074047|905576|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
273688|NCT01074047|905577|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
273689|NCT01074047|905576|P2|Treatment Phase|Unspecified|39
273690|NCT01074047|905577|P1|Treatment Phase|Unspecified|32
273691|NCT01074047|905576|P2|Treatment Phase|Protocol Violation|1
273692|NCT01074047|905577|P1|Treatment Phase|Protocol Violation|0
273693|NCT01074047|905576|P2|Treatment Phase|Study closure|13
273694|NCT01074047|905577|P1|Treatment Phase|Study closure|24
273695|NCT01074047|905576|P2|Treatment Phase|Lost to Follow-up|1
273696|NCT01074047|905577|P1|Treatment Phase|Lost to Follow-up|0
273697|NCT01074047|905576|P2|Treatment Phase|Death|58
273698|NCT01074047|905577|P1|Treatment Phase|Death|53
273699|NCT01074047|905576|P2|Treatment Phase|Withdrawal by Subject|48
273700|NCT01074047|905577|P1|Treatment Phase|Withdrawal by Subject|27
273701|NCT01074047|905576|P2|Treatment Phase|Disease progression|21
273702|NCT01074047|905577|P1|Treatment Phase|Disease progression|16
273703|NCT01074047|905576|P2|Treatment Phase|Adverse Event|66
273704|NCT01074047|905577|P1|Treatment Phase|Adverse Event|89
273705|NCT01074008|905663|P9|Overall Study|Lost to Follow-up|4
273706|NCT01074008|905664|P8|Overall Study|Lost to Follow-up|0
273707|NCT01074008|905665|P7|Overall Study|Lost to Follow-up|1
273708|NCT01074008|905666|P6|Overall Study|Lost to Follow-up|0
273709|NCT01074008|905667|P5|Overall Study|Lost to Follow-up|1
273710|NCT01074008|905668|P4|Overall Study|Lost to Follow-up|1
273711|NCT01074008|905669|P3|Overall Study|Lost to Follow-up|1
273712|NCT01074008|905670|P2|Overall Study|Lost to Follow-up|1
273713|NCT01074008|905671|P1|Overall Study|Lost to Follow-up|0
273714|NCT01074008|905663|P9|Overall Study|Withdrawal by Subject|0
273715|NCT01074008|905664|P8|Overall Study|Withdrawal by Subject|0
273716|NCT01074008|905665|P7|Overall Study|Withdrawal by Subject|0
273717|NCT01074008|905666|P6|Overall Study|Withdrawal by Subject|0
273718|NCT01074008|905667|P5|Overall Study|Withdrawal by Subject|1
273719|NCT01074008|905668|P4|Overall Study|Withdrawal by Subject|0
273720|NCT01074008|905669|P3|Overall Study|Withdrawal by Subject|1
273721|NCT01074008|905670|P2|Overall Study|Withdrawal by Subject|1
273722|NCT01074008|905671|P1|Overall Study|Withdrawal by Subject|1
273723|NCT01074008|905663|P9|Overall Study|Adverse Event|0
273724|NCT01074008|905664|P8|Overall Study|Adverse Event|0
273725|NCT01074008|905665|P7|Overall Study|Adverse Event|0
273726|NCT01074008|905666|P6|Overall Study|Adverse Event|0
273727|NCT01074008|905667|P5|Overall Study|Adverse Event|0
273728|NCT01074008|905668|P4|Overall Study|Adverse Event|0
273729|NCT01074008|905669|P3|Overall Study|Adverse Event|0
273730|NCT01074008|905670|P2|Overall Study|Adverse Event|1
273731|NCT01074008|905671|P1|Overall Study|Adverse Event|0
273732|NCT01073943|905781|P2|Overall Study|Could not tolerate prep|0
273733|NCT01073943|905782|P1|Overall Study|Could not tolerate prep|1
273734|NCT01073943|905781|P2|Overall Study|Unable to return for follow-up|1
273735|NCT01073943|905782|P1|Overall Study|Unable to return for follow-up|0
273736|NCT01073943|905781|P2|Overall Study|Subject forgot|1
273737|NCT01073943|905782|P1|Overall Study|Subject forgot|0
273738|NCT01073943|905781|P2|Overall Study|Power outage; colonoscopy not done|0
273739|NCT01073943|905782|P1|Overall Study|Power outage; colonoscopy not done|1
273740|NCT01073943|905781|P2|Overall Study|Lost to Follow-up|2
273741|NCT01073943|905782|P1|Overall Study|Lost to Follow-up|0
273742|NCT01073943|905781|P2|Overall Study|Adverse Event|1
273743|NCT01073943|905782|P1|Overall Study|Adverse Event|1
273744|NCT01073943|905781|P2|Overall Study|Protocol Violation|1
273745|NCT01073943|905782|P1|Overall Study|Protocol Violation|2
273746|NCT01073943|905781|P2|Overall Study|Withdrawal by Subject|2
273747|NCT01073943|905782|P1|Overall Study|Withdrawal by Subject|8
273748|NCT01073930|905808|P2|Overall Study|Inadequate prep; unable to do procedure|1
273749|NCT01073930|905809|P1|Overall Study|Inadequate prep; unable to do procedure|0
273750|NCT01073930|905808|P2|Overall Study|Noncompliance with study drug|1
273751|NCT01073930|905809|P1|Overall Study|Noncompliance with study drug|0
273752|NCT01073930|905808|P2|Overall Study|Adverse Event|1
273753|NCT01073930|905809|P1|Overall Study|Adverse Event|0
273754|NCT01073930|905808|P2|Overall Study|Lost to Follow-up|1
273755|NCT01073930|905809|P1|Overall Study|Lost to Follow-up|0
273756|NCT01073930|905808|P2|Overall Study|Withdrawal by Subject|2
273757|NCT01073930|905809|P1|Overall Study|Withdrawal by Subject|3
273758|NCT01073865|905833|P2|Overall Study|Withdrawal by Subject|5
273759|NCT01073865|905834|P1|Overall Study|Withdrawal by Subject|5
273760|NCT01073865|905833|P2|Overall Study|Death|2
273761|NCT01073865|905834|P1|Overall Study|Death|3
273762|NCT01073865|905833|P2|Overall Study|Lost to Follow-up|1
273763|NCT01073865|905834|P1|Overall Study|Lost to Follow-up|1
273764|NCT01073865|905833|P2|Overall Study|Reasons other than below|31
273765|NCT01073865|905834|P1|Overall Study|Reasons other than below|19
273766|NCT01073631|905853|P1|Overall Study|Unspecified|63
273767|NCT01073631|905853|P1|Overall Study|Adverse Event|24
273768|NCT01073631|905853|P1|Overall Study|Death|82
273769|NCT01073618|905858|P1|Overall Study|Unspecified|80
273770|NCT01073618|905858|P1|Overall Study|Adverse Event|19
273771|NCT01073618|905858|P1|Overall Study|Death|208
273772|NCT01073605|905866|P3|Overall Study|Randomized But Not Treated|1
273773|NCT01073605|905867|P2|Overall Study|Randomized But Not Treated|1
273774|NCT01073605|905868|P1|Overall Study|Randomized But Not Treated|0
273775|NCT01073605|905866|P3|Overall Study|Withdrawal by Subject|22
273776|NCT01073605|905867|P2|Overall Study|Withdrawal by Subject|39
273777|NCT01073605|905868|P1|Overall Study|Withdrawal by Subject|31
273778|NCT01073605|905866|P3|Overall Study|Other|29
273779|NCT01073605|905867|P2|Overall Study|Other|21
273780|NCT01073605|905868|P1|Overall Study|Other|25
273781|NCT01073605|905866|P3|Overall Study|Lost to Follow-up|9
273782|NCT01073605|905867|P2|Overall Study|Lost to Follow-up|4
273783|NCT01073605|905868|P1|Overall Study|Lost to Follow-up|3
273784|NCT01073605|905866|P3|Overall Study|Adverse Event|0
273785|NCT01073605|905867|P2|Overall Study|Adverse Event|1
273786|NCT01073605|905868|P1|Overall Study|Adverse Event|2
273787|NCT01073605|905866|P3|Overall Study|Ongoing at Cutoff Date|0
273788|NCT01073605|905867|P2|Overall Study|Ongoing at Cutoff Date|1
273789|NCT01073605|905868|P1|Overall Study|Ongoing at Cutoff Date|1
273790|NCT01073566|905914|P2|Period 2 (6 Weeks)|Adverse Event|0
273791|NCT01073566|905915|P1|Period 2 (6 Weeks)|Adverse Event|1
273792|NCT01073462|905927|P1|Overall Study|Lost to Follow-up|7
273793|NCT01073462|905927|P1|Overall Study|Serious adverse event|2
273794|NCT01073462|905927|P1|Overall Study|Low parathyroid hormone levels|8
273795|NCT01073462|905927|P1|Overall Study|Kidney transplant|10
273796|NCT01073462|905927|P1|Overall Study|Death|14
273797|NCT01073293|905946|P2|Overall Study|Withdrawal by Subject|10
273798|NCT01073293|905947|P1|Overall Study|Withdrawal by Subject|5
273799|NCT01073293|905946|P2|Overall Study|Lost to Follow-up|1
273800|NCT01073293|905947|P1|Overall Study|Lost to Follow-up|0
273801|NCT01073267|905969|P1|Overall Study|Disease Progression|3
273802|NCT01073163|905973|P1|Overall Study|Early termination|1
273803|NCT01073163|905973|P1|Overall Study|Disease Progression|1
273804|NCT01073163|905973|P1|Overall Study|Adverse Event|1
273805|NCT01072929|905996|P3|Overall Study|Not specified|0
273806|NCT01072929|905997|P2|Overall Study|Not specified|3
273807|NCT01072929|905998|P1|Overall Study|Not specified|0
273808|NCT01072929|905996|P3|Overall Study|Noncompliance with study procedures|1
273809|NCT01072929|905997|P2|Overall Study|Noncompliance with study procedures|0
273810|NCT01072929|905998|P1|Overall Study|Noncompliance with study procedures|1
273811|NCT01072929|905996|P3|Overall Study|Noncompliance with study medication|0
273812|NCT01072929|905997|P2|Overall Study|Noncompliance with study medication|3
273813|NCT01072929|905998|P1|Overall Study|Noncompliance with study medication|0
273814|NCT01072929|905996|P3|Overall Study|Lost to Follow-up|1
273815|NCT01072929|905997|P2|Overall Study|Lost to Follow-up|4
273816|NCT01072929|905998|P1|Overall Study|Lost to Follow-up|8
273817|NCT01072929|905996|P3|Overall Study|Protocol Violation|2
273818|NCT01072929|905997|P2|Overall Study|Protocol Violation|11
273819|NCT01072929|905998|P1|Overall Study|Protocol Violation|13
273820|NCT01072929|905996|P3|Overall Study|Withdrawal by Subject|3
273821|NCT01072929|905997|P2|Overall Study|Withdrawal by Subject|15
273822|NCT01072929|905998|P1|Overall Study|Withdrawal by Subject|7
273823|NCT01072929|905996|P3|Overall Study|Lack of Efficacy|0
273824|NCT01072929|905997|P2|Overall Study|Lack of Efficacy|4
273825|NCT01072929|905998|P1|Overall Study|Lack of Efficacy|7
273826|NCT01072929|905996|P3|Overall Study|Adverse Event|2
273827|NCT01072929|905997|P2|Overall Study|Adverse Event|11
273828|NCT01072929|905998|P1|Overall Study|Adverse Event|8
273829|NCT01072877|906077|P5|Overall Study|Lost to Follow-up|0
273830|NCT01072877|906078|P4|Overall Study|Lost to Follow-up|2
273831|NCT01072877|906079|P3|Overall Study|Lost to Follow-up|0
273832|NCT01072877|906080|P2|Overall Study|Lost to Follow-up|1
273833|NCT01072877|906081|P1|Overall Study|Lost to Follow-up|1
273834|NCT01072630|906144|P3|Overall Study|Not specified|1
273835|NCT01072630|906145|P2|Overall Study|Not specified|2
273836|NCT01072630|906146|P1|Overall Study|Not specified|3
273837|NCT01072630|906144|P3|Overall Study|Noncompliance with study procedures|1
273838|NCT01072630|906145|P2|Overall Study|Noncompliance with study procedures|2
273839|NCT01072630|906146|P1|Overall Study|Noncompliance with study procedures|1
273840|NCT01072630|906144|P3|Overall Study|Noncompliance with study medication|1
273841|NCT01072630|906145|P2|Overall Study|Noncompliance with study medication|1
273842|NCT01072630|906146|P1|Overall Study|Noncompliance with study medication|1
273843|NCT01072630|906144|P3|Overall Study|Lost to Follow-up|1
273844|NCT01072630|906145|P2|Overall Study|Lost to Follow-up|11
273845|NCT01072630|906146|P1|Overall Study|Lost to Follow-up|11
273846|NCT01072630|906144|P3|Overall Study|Protocol Violation|4
273847|NCT01072630|906145|P2|Overall Study|Protocol Violation|8
273848|NCT01072630|906146|P1|Overall Study|Protocol Violation|10
273849|NCT01072630|906144|P3|Overall Study|Withdrawal by Subject|2
273850|NCT01072630|906145|P2|Overall Study|Withdrawal by Subject|7
273851|NCT01072630|906146|P1|Overall Study|Withdrawal by Subject|8
273852|NCT01072630|906144|P3|Overall Study|Lack of Efficacy|1
273853|NCT01072630|906145|P2|Overall Study|Lack of Efficacy|10
273854|NCT01072630|906146|P1|Overall Study|Lack of Efficacy|10
273855|NCT01072630|906144|P3|Overall Study|Adverse Event|2
273856|NCT01072630|906145|P2|Overall Study|Adverse Event|19
273857|NCT01072630|906146|P1|Overall Study|Adverse Event|11
273858|NCT01072539|906227|P1|Overall Study|Protocol Violation|2
273859|NCT01072539|906227|P1|Overall Study|Treated prior to the Site Initiation|1
273860|NCT01072500|906251|P2|Overall Study|Withdrawal by Subject|10
273861|NCT01072500|906252|P1|Overall Study|Withdrawal by Subject|17
273862|NCT01072500|906251|P2|Overall Study|Lost to Follow-up|2
273863|NCT01072500|906252|P1|Overall Study|Lost to Follow-up|5
273864|NCT01072500|906251|P2|Overall Study|Death|2
273865|NCT01072500|906252|P1|Overall Study|Death|2
273866|NCT01072448|906262|P2|Overall Study|Death|2
273867|NCT01072448|906263|P1|Overall Study|Death|0
273868|NCT01072448|906262|P2|Overall Study|Abnormal laboratory value(s)|1
273869|NCT01072448|906263|P1|Overall Study|Abnormal laboratory value(s)|0
273870|NCT01072448|906262|P2|Overall Study|Lost to Follow-up|1
273871|NCT01072448|906263|P1|Overall Study|Lost to Follow-up|1
273872|NCT01072448|906262|P2|Overall Study|Unsatisfactory therapeutic effect|3
273873|NCT01072448|906263|P1|Overall Study|Unsatisfactory therapeutic effect|1
273874|NCT01072448|906262|P2|Overall Study|Abnormal test procedure result(s)|0
273875|NCT01072448|906263|P1|Overall Study|Abnormal test procedure result(s)|1
273876|NCT01072448|906262|P2|Overall Study|Protocol deviation|4
273877|NCT01072448|906263|P1|Overall Study|Protocol deviation|3
273878|NCT01072448|906262|P2|Overall Study|Subject withdrew consent|9
273879|NCT01072448|906263|P1|Overall Study|Subject withdrew consent|4
273880|NCT01072448|906262|P2|Overall Study|Adverse Event|10
273881|NCT01072448|906263|P1|Overall Study|Adverse Event|9
273882|NCT01072396|906277|P2|Period Two|Lost to Follow-up|0
273883|NCT01072396|906278|P1|Period Two|Lost to Follow-up|1
273884|NCT01072396|906277|P2|Period Two|Adverse Event|3
273885|NCT01072396|906278|P1|Period Two|Adverse Event|0
273886|NCT01072396|906277|P2|Washout Period|Missing termination information|1
273887|NCT01072396|906278|P1|Washout Period|Missing termination information|0
273888|NCT01072396|906277|P2|Period One|Withdrawal by Subject|0
273889|NCT01072396|906278|P1|Period One|Withdrawal by Subject|2
273890|NCT01072396|906277|P2|Period One|Protocol Violation|1
273891|NCT01072396|906278|P1|Period One|Protocol Violation|2
273892|NCT01072396|906277|P2|Period One|Adverse Event|1
273893|NCT01072396|906278|P1|Period One|Adverse Event|1
273894|NCT01072357|906290|P2|Overall Study|Lost to Follow-up|1
273895|NCT01072357|906291|P1|Overall Study|Lost to Follow-up|0
273896|NCT01072201|906323|P2|Overall Study|Lost to Follow-up|1
273897|NCT01072201|906324|P1|Overall Study|Lost to Follow-up|0
273898|NCT01072175|906357|P13|Part D (HPMC Capsules)|Ongoing|34
273899|NCT01072175|906358|P12|Part D (HPMC Capsules)|Ongoing|34
273900|NCT01072175|906359|P11|Part D (HPMC Capsules)|Ongoing|12
273901|NCT01072175|906360|P10|Part D (HPMC Capsules)|Ongoing|10
273902|NCT01072175|906361|P9|Part D (HPMC Capsules)|Ongoing|0
273903|NCT01072175|906362|P8|Part D (HPMC Capsules)|Ongoing|0
273904|NCT01072175|906363|P7|Part D (HPMC Capsules)|Ongoing|0
273905|NCT01072175|906364|P6|Part D (HPMC Capsules)|Ongoing|0
273906|NCT01072175|906365|P5|Part D (HPMC Capsules)|Ongoing|0
273907|NCT01072175|906366|P4|Part D (HPMC Capsules)|Ongoing|0
273908|NCT01072175|906367|P3|Part D (HPMC Capsules)|Ongoing|0
273909|NCT01072175|906368|P2|Part D (HPMC Capsules)|Ongoing|0
273910|NCT01072175|906369|P1|Part D (HPMC Capsules)|Ongoing|0
273911|NCT01072175|906357|P13|Part D (HPMC Capsules)|Death|5
273912|NCT01072175|906358|P12|Part D (HPMC Capsules)|Death|6
273913|NCT01072175|906359|P11|Part D (HPMC Capsules)|Death|4
273914|NCT01072175|906360|P10|Part D (HPMC Capsules)|Death|2
273915|NCT01072175|906361|P9|Part D (HPMC Capsules)|Death|0
273916|NCT01072175|906362|P8|Part D (HPMC Capsules)|Death|0
273917|NCT01072175|906363|P7|Part D (HPMC Capsules)|Death|0
273918|NCT01072175|906364|P6|Part D (HPMC Capsules)|Death|0
273919|NCT01072175|906365|P5|Part D (HPMC Capsules)|Death|0
273920|NCT01072175|906366|P4|Part D (HPMC Capsules)|Death|0
273921|NCT01072175|906367|P3|Part D (HPMC Capsules)|Death|0
273922|NCT01072175|906368|P2|Part D (HPMC Capsules)|Death|0
273923|NCT01072175|906369|P1|Part D (HPMC Capsules)|Death|0
273924|NCT01072175|906357|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
273925|NCT01072175|906358|P12|Part D (HPMC Capsules)|Withdrawal by Subject|1
273926|NCT01072175|906359|P11|Part D (HPMC Capsules)|Withdrawal by Subject|0
273927|NCT01072175|906360|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
273928|NCT01072175|906361|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
273929|NCT01072175|906362|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
273930|NCT01072175|906363|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
273931|NCT01072175|906364|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
273932|NCT01072175|906365|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
273933|NCT01072175|906366|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
273934|NCT01072175|906367|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
273935|NCT01072175|906368|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
273936|NCT01072175|906369|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
273937|NCT01072175|906357|P13|Part D (HPMC Capsules)|Lost to Follow-up|0
273938|NCT01072175|906358|P12|Part D (HPMC Capsules)|Lost to Follow-up|2
273939|NCT01072175|906359|P11|Part D (HPMC Capsules)|Lost to Follow-up|0
273940|NCT01072175|906360|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
273941|NCT01072175|906361|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
273942|NCT01072175|906362|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
273943|NCT01072175|906363|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
273944|NCT01072175|906364|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
273945|NCT01072175|906365|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
273946|NCT01072175|906366|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
273947|NCT01072175|906367|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
273948|NCT01072175|906368|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
273949|NCT01072175|906369|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
273950|NCT01072175|906357|P13|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273951|NCT01072175|906358|P12|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273952|NCT01072175|906359|P11|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273953|NCT01072175|906360|P10|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273954|NCT01072175|906361|P9|Part C (Phase II: Crossover Phase [CP])|Ongoing|28
273955|NCT01072175|906362|P8|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273956|NCT01072175|906363|P7|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273957|NCT01072175|906364|P6|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273958|NCT01072175|906365|P5|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273959|NCT01072175|906366|P4|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273960|NCT01072175|906367|P3|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273961|NCT01072175|906368|P2|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273962|NCT01072175|906369|P1|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
273963|NCT01072175|906357|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
273964|NCT01072175|906358|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
273965|NCT01072175|906359|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
273966|NCT01072175|906360|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
273967|NCT01072175|906361|P9|Part C (Phase II: Crossover Phase [CP])|Death|15
273968|NCT01072175|906362|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
273969|NCT01072175|906363|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
273970|NCT01072175|906364|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
273971|NCT01072175|906365|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
273972|NCT01072175|906366|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
273973|NCT01072175|906367|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
273974|NCT01072175|906368|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
273975|NCT01072175|906369|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
273976|NCT01072175|906357|P13|Part C (Phase II: Randomized Phase)|Ongoing|0
273977|NCT01072175|906358|P12|Part C (Phase II: Randomized Phase)|Ongoing|0
273978|NCT01072175|906359|P11|Part C (Phase II: Randomized Phase)|Ongoing|0
273979|NCT01072175|906360|P10|Part C (Phase II: Randomized Phase)|Ongoing|0
273980|NCT01072175|906361|P9|Part C (Phase II: Randomized Phase)|Ongoing|0
273981|NCT01072175|906362|P8|Part C (Phase II: Randomized Phase)|Ongoing|40
273982|NCT01072175|906363|P7|Part C (Phase II: Randomized Phase)|Ongoing|32
273983|NCT01072175|906364|P6|Part C (Phase II: Randomized Phase)|Ongoing|35
273984|NCT01072175|906365|P5|Part C (Phase II: Randomized Phase)|Ongoing|0
273985|NCT01072175|906366|P4|Part C (Phase II: Randomized Phase)|Ongoing|0
273986|NCT01072175|906367|P3|Part C (Phase II: Randomized Phase)|Ongoing|0
273987|NCT01072175|906368|P2|Part C (Phase II: Randomized Phase)|Ongoing|0
273988|NCT01072175|906369|P1|Part C (Phase II: Randomized Phase)|Ongoing|0
273989|NCT01072175|906357|P13|Part C (Phase II: Randomized Phase)|Death|0
273990|NCT01072175|906358|P12|Part C (Phase II: Randomized Phase)|Death|0
273991|NCT01072175|906359|P11|Part C (Phase II: Randomized Phase)|Death|0
273992|NCT01072175|906360|P10|Part C (Phase II: Randomized Phase)|Death|0
273993|NCT01072175|906361|P9|Part C (Phase II: Randomized Phase)|Death|0
273994|NCT01072175|906362|P8|Part C (Phase II: Randomized Phase)|Death|14
273995|NCT01072175|906363|P7|Part C (Phase II: Randomized Phase)|Death|18
273996|NCT01072175|906364|P6|Part C (Phase II: Randomized Phase)|Death|19
273997|NCT01072175|906365|P5|Part C (Phase II: Randomized Phase)|Death|0
273998|NCT01072175|906366|P4|Part C (Phase II: Randomized Phase)|Death|0
273999|NCT01072175|906367|P3|Part C (Phase II: Randomized Phase)|Death|0
274000|NCT01072175|906368|P2|Part C (Phase II: Randomized Phase)|Death|0
274001|NCT01072175|906369|P1|Part C (Phase II: Randomized Phase)|Death|0
274002|NCT01072175|906357|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274003|NCT01072175|906358|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274004|NCT01072175|906359|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274005|NCT01072175|906360|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274006|NCT01072175|906361|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274007|NCT01072175|906362|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274008|NCT01072175|906363|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|4
274009|NCT01072175|906364|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274010|NCT01072175|906365|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274011|NCT01072175|906366|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274012|NCT01072175|906367|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274013|NCT01072175|906368|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274014|NCT01072175|906369|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
274015|NCT01072175|906357|P13|Part B (Dose Escalation and Expansion)|Ongoing|0
274016|NCT01072175|906358|P12|Part B (Dose Escalation and Expansion)|Ongoing|0
274017|NCT01072175|906359|P11|Part B (Dose Escalation and Expansion)|Ongoing|0
274018|NCT01072175|906360|P10|Part B (Dose Escalation and Expansion)|Ongoing|0
274019|NCT01072175|906361|P9|Part B (Dose Escalation and Expansion)|Ongoing|0
274020|NCT01072175|906362|P8|Part B (Dose Escalation and Expansion)|Ongoing|0
274021|NCT01072175|906363|P7|Part B (Dose Escalation and Expansion)|Ongoing|0
274022|NCT01072175|906364|P6|Part B (Dose Escalation and Expansion)|Ongoing|0
274023|NCT01072175|906365|P5|Part B (Dose Escalation and Expansion)|Ongoing|28
274024|NCT01072175|906366|P4|Part B (Dose Escalation and Expansion)|Ongoing|9
274025|NCT01072175|906367|P3|Part B (Dose Escalation and Expansion)|Ongoing|10
274026|NCT01072175|906368|P2|Part B (Dose Escalation and Expansion)|Ongoing|2
274027|NCT01072175|906369|P1|Part B (Dose Escalation and Expansion)|Ongoing|0
274028|NCT01072175|906357|P13|Part B (Dose Escalation and Expansion)|Death|0
274029|NCT01072175|906358|P12|Part B (Dose Escalation and Expansion)|Death|0
274030|NCT01072175|906359|P11|Part B (Dose Escalation and Expansion)|Death|0
274031|NCT01072175|906360|P10|Part B (Dose Escalation and Expansion)|Death|0
274032|NCT01072175|906361|P9|Part B (Dose Escalation and Expansion)|Death|0
274033|NCT01072175|906362|P8|Part B (Dose Escalation and Expansion)|Death|0
274034|NCT01072175|906363|P7|Part B (Dose Escalation and Expansion)|Death|0
274035|NCT01072175|906364|P6|Part B (Dose Escalation and Expansion)|Death|0
274036|NCT01072175|906365|P5|Part B (Dose Escalation and Expansion)|Death|36
274037|NCT01072175|906366|P4|Part B (Dose Escalation and Expansion)|Death|12
274038|NCT01072175|906367|P3|Part B (Dose Escalation and Expansion)|Death|10
274039|NCT01072175|906368|P2|Part B (Dose Escalation and Expansion)|Death|3
274040|NCT01072175|906369|P1|Part B (Dose Escalation and Expansion)|Death|0
274041|NCT01072175|906357|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274042|NCT01072175|906358|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274043|NCT01072175|906359|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274044|NCT01072175|906360|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274045|NCT01072175|906361|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274046|NCT01072175|906362|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274047|NCT01072175|906363|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274048|NCT01072175|906364|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274049|NCT01072175|906365|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
274050|NCT01072175|906366|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
274051|NCT01072175|906367|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274052|NCT01072175|906368|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274053|NCT01072175|906369|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
274054|NCT01072175|906357|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
274055|NCT01072175|906358|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
274056|NCT01072175|906359|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
274057|NCT01072175|906360|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
274058|NCT01072175|906361|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
274059|NCT01072175|906362|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
274060|NCT01072175|906363|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
274061|NCT01072175|906364|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
274062|NCT01072175|906365|P5|Part B (Dose Escalation and Expansion)|Physician Decision|13
274063|NCT01072175|906366|P4|Part B (Dose Escalation and Expansion)|Physician Decision|4
274064|NCT01072175|906367|P3|Part B (Dose Escalation and Expansion)|Physician Decision|3
274065|NCT01072175|906368|P2|Part B (Dose Escalation and Expansion)|Physician Decision|1
274066|NCT01072175|906369|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
274067|NCT01072175|906357|P13|Part A (Drug-Drug Interaction)|Death|0
274068|NCT01072175|906358|P12|Part A (Drug-Drug Interaction)|Death|0
274069|NCT01072175|906359|P11|Part A (Drug-Drug Interaction)|Death|0
274070|NCT01072175|906360|P10|Part A (Drug-Drug Interaction)|Death|0
274071|NCT01072175|906361|P9|Part A (Drug-Drug Interaction)|Death|0
274072|NCT01072175|906362|P8|Part A (Drug-Drug Interaction)|Death|0
274073|NCT01072175|906363|P7|Part A (Drug-Drug Interaction)|Death|0
274074|NCT01072175|906364|P6|Part A (Drug-Drug Interaction)|Death|0
274075|NCT01072175|906365|P5|Part A (Drug-Drug Interaction)|Death|0
274076|NCT01072175|906366|P4|Part A (Drug-Drug Interaction)|Death|0
274077|NCT01072175|906367|P3|Part A (Drug-Drug Interaction)|Death|0
274078|NCT01072175|906368|P2|Part A (Drug-Drug Interaction)|Death|0
274079|NCT01072175|906369|P1|Part A (Drug-Drug Interaction)|Death|1
274080|NCT01072175|906357|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274081|NCT01072175|906358|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274082|NCT01072175|906359|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274083|NCT01072175|906360|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274084|NCT01072175|906361|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274085|NCT01072175|906362|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274086|NCT01072175|906363|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274087|NCT01072175|906364|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274088|NCT01072175|906365|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274089|NCT01072175|906366|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274090|NCT01072175|906367|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274091|NCT01072175|906368|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
274092|NCT01072175|906369|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
274093|NCT01072175|906357|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
274094|NCT01072175|906358|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
274095|NCT01072175|906359|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
274096|NCT01072175|906360|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
274097|NCT01072175|906361|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
274098|NCT01072175|906362|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
274099|NCT01072175|906363|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
274100|NCT01072175|906364|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
274101|NCT01072175|906365|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
274102|NCT01072175|906366|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
274103|NCT01072175|906367|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
274104|NCT01072175|906368|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
274105|NCT01072175|906369|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
274106|NCT01072149|906552|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274107|NCT01072149|906553|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274108|NCT01072149|906554|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274109|NCT01072149|906555|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274110|NCT01072149|906556|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
274111|NCT01072149|906557|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274112|NCT01072149|906558|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274113|NCT01072149|906559|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274114|NCT01072149|906560|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274115|NCT01072149|906561|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274116|NCT01072149|906562|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274117|NCT01072149|906563|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274118|NCT01072149|906564|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274119|NCT01072149|906565|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274120|NCT01072149|906566|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274121|NCT01072149|906567|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
274122|NCT01072149|906568|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274123|NCT01072149|906569|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
274124|NCT01072149|906552|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
274125|NCT01072149|906553|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
274126|NCT01072149|906554|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
274127|NCT01072149|906555|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
274128|NCT01072149|906556|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
274129|NCT01072149|906557|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
274130|NCT01072149|906558|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
274131|NCT01072149|906559|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
274132|NCT01072149|906560|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
274133|NCT01072149|906561|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
274134|NCT01072149|906562|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
274135|NCT01072149|906563|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
274136|NCT01072149|906564|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
274137|NCT01072149|906565|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
274138|NCT01072149|906566|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
274139|NCT01072149|906567|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
274140|NCT01072149|906568|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
274141|NCT01072149|906569|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
274142|NCT01072149|906552|P18|Washout Period 2 (14 Days)|Adverse Event|0
274143|NCT01072149|906553|P17|Washout Period 2 (14 Days)|Adverse Event|0
274144|NCT01072149|906554|P16|Washout Period 2 (14 Days)|Adverse Event|1
274145|NCT01072149|906555|P15|Washout Period 2 (14 Days)|Adverse Event|0
274146|NCT01072149|906556|P14|Washout Period 2 (14 Days)|Adverse Event|0
274147|NCT01072149|906557|P13|Washout Period 2 (14 Days)|Adverse Event|0
274148|NCT01072149|906558|P12|Washout Period 2 (14 Days)|Adverse Event|0
274149|NCT01072149|906559|P11|Washout Period 2 (14 Days)|Adverse Event|0
274150|NCT01072149|906560|P10|Washout Period 2 (14 Days)|Adverse Event|0
274151|NCT01072149|906561|P9|Washout Period 2 (14 Days)|Adverse Event|0
274152|NCT01072149|906562|P8|Washout Period 2 (14 Days)|Adverse Event|0
274153|NCT01072149|906563|P7|Washout Period 2 (14 Days)|Adverse Event|0
274154|NCT01072149|906564|P6|Washout Period 2 (14 Days)|Adverse Event|0
274155|NCT01072149|906565|P5|Washout Period 2 (14 Days)|Adverse Event|0
274156|NCT01072149|906566|P4|Washout Period 2 (14 Days)|Adverse Event|0
274157|NCT01072149|906567|P3|Washout Period 2 (14 Days)|Adverse Event|0
274158|NCT01072149|906568|P2|Washout Period 2 (14 Days)|Adverse Event|0
274159|NCT01072149|906569|P1|Washout Period 2 (14 Days)|Adverse Event|0
274160|NCT01072149|906552|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274161|NCT01072149|906553|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274162|NCT01072149|906554|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
274163|NCT01072149|906555|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274164|NCT01072149|906556|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274165|NCT01072149|906557|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274166|NCT01072149|906558|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274167|NCT01072149|906559|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274168|NCT01072149|906560|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274169|NCT01072149|906561|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274170|NCT01072149|906562|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274171|NCT01072149|906563|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274172|NCT01072149|906564|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274173|NCT01072149|906565|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274174|NCT01072149|906566|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274175|NCT01072149|906567|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274176|NCT01072149|906568|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274177|NCT01072149|906569|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
274178|NCT01072149|906552|P18|Washout Period 2 (14 Days)|Physician Decision|0
274179|NCT01072149|906553|P17|Washout Period 2 (14 Days)|Physician Decision|0
274180|NCT01072149|906554|P16|Washout Period 2 (14 Days)|Physician Decision|0
274181|NCT01072149|906555|P15|Washout Period 2 (14 Days)|Physician Decision|0
274182|NCT01072149|906556|P14|Washout Period 2 (14 Days)|Physician Decision|0
274183|NCT01072149|906557|P13|Washout Period 2 (14 Days)|Physician Decision|0
274184|NCT01072149|906558|P12|Washout Period 2 (14 Days)|Physician Decision|0
274185|NCT01072149|906559|P11|Washout Period 2 (14 Days)|Physician Decision|0
274186|NCT01072149|906560|P10|Washout Period 2 (14 Days)|Physician Decision|0
274187|NCT01072149|906561|P9|Washout Period 2 (14 Days)|Physician Decision|0
274188|NCT01072149|906562|P8|Washout Period 2 (14 Days)|Physician Decision|0
274189|NCT01072149|906563|P7|Washout Period 2 (14 Days)|Physician Decision|0
274190|NCT01072149|906564|P6|Washout Period 2 (14 Days)|Physician Decision|0
274191|NCT01072149|906565|P5|Washout Period 2 (14 Days)|Physician Decision|0
274192|NCT01072149|906566|P4|Washout Period 2 (14 Days)|Physician Decision|0
274193|NCT01072149|906567|P3|Washout Period 2 (14 Days)|Physician Decision|0
274194|NCT01072149|906568|P2|Washout Period 2 (14 Days)|Physician Decision|0
274195|NCT01072149|906569|P1|Washout Period 2 (14 Days)|Physician Decision|1
274196|NCT01072149|906552|P18|Treatment Period 2 (28 Days)|Physician Decision|0
274197|NCT01072149|906553|P17|Treatment Period 2 (28 Days)|Physician Decision|0
274198|NCT01072149|906554|P16|Treatment Period 2 (28 Days)|Physician Decision|0
274199|NCT01072149|906555|P15|Treatment Period 2 (28 Days)|Physician Decision|0
274200|NCT01072149|906556|P14|Treatment Period 2 (28 Days)|Physician Decision|0
274201|NCT01072149|906557|P13|Treatment Period 2 (28 Days)|Physician Decision|0
274202|NCT01072149|906558|P12|Treatment Period 2 (28 Days)|Physician Decision|0
274203|NCT01072149|906559|P11|Treatment Period 2 (28 Days)|Physician Decision|0
274204|NCT01072149|906560|P10|Treatment Period 2 (28 Days)|Physician Decision|0
274205|NCT01072149|906561|P9|Treatment Period 2 (28 Days)|Physician Decision|0
274206|NCT01072149|906562|P8|Treatment Period 2 (28 Days)|Physician Decision|1
274207|NCT01072149|906563|P7|Treatment Period 2 (28 Days)|Physician Decision|0
274208|NCT01072149|906564|P6|Treatment Period 2 (28 Days)|Physician Decision|0
274209|NCT01072149|906565|P5|Treatment Period 2 (28 Days)|Physician Decision|0
274210|NCT01072149|906566|P4|Treatment Period 2 (28 Days)|Physician Decision|0
274211|NCT01072149|906567|P3|Treatment Period 2 (28 Days)|Physician Decision|0
274212|NCT01072149|906568|P2|Treatment Period 2 (28 Days)|Physician Decision|0
274213|NCT01072149|906569|P1|Treatment Period 2 (28 Days)|Physician Decision|0
274214|NCT01072149|906552|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274215|NCT01072149|906553|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274216|NCT01072149|906554|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274217|NCT01072149|906555|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274218|NCT01072149|906556|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274219|NCT01072149|906557|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274220|NCT01072149|906558|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274221|NCT01072149|906559|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274222|NCT01072149|906560|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274223|NCT01072149|906561|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274224|NCT01072149|906562|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274225|NCT01072149|906563|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274226|NCT01072149|906564|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274227|NCT01072149|906565|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274228|NCT01072149|906566|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274229|NCT01072149|906567|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
274230|NCT01072149|906568|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274231|NCT01072149|906569|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
274232|NCT01072149|906552|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274233|NCT01072149|906553|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274234|NCT01072149|906554|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274235|NCT01072149|906555|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274236|NCT01072149|906556|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274237|NCT01072149|906557|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274238|NCT01072149|906558|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274239|NCT01072149|906559|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274240|NCT01072149|906560|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274241|NCT01072149|906561|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274242|NCT01072149|906562|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274243|NCT01072149|906563|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274244|NCT01072149|906564|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274245|NCT01072149|906565|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274246|NCT01072149|906566|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274247|NCT01072149|906567|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274248|NCT01072149|906568|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
274249|NCT01072149|906569|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
274250|NCT01072149|906552|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274251|NCT01072149|906553|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274252|NCT01072149|906554|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274253|NCT01072149|906555|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274254|NCT01072149|906556|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274255|NCT01072149|906557|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274256|NCT01072149|906558|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274257|NCT01072149|906559|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
274258|NCT01072149|906560|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274259|NCT01072149|906561|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274260|NCT01072149|906562|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274261|NCT01072149|906563|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274262|NCT01072149|906564|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274263|NCT01072149|906565|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274264|NCT01072149|906566|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274265|NCT01072149|906567|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274266|NCT01072149|906568|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274267|NCT01072149|906569|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
274268|NCT01072149|906552|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
274269|NCT01072149|906553|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
274270|NCT01072149|906554|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
274271|NCT01072149|906555|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
274272|NCT01072149|906556|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
274273|NCT01072149|906557|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
274274|NCT01072149|906558|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
274275|NCT01072149|906559|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
274276|NCT01072149|906560|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
274277|NCT01072149|906561|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
274278|NCT01072149|906562|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
274279|NCT01072149|906563|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
274280|NCT01072149|906564|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
274281|NCT01072149|906565|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
274282|NCT01072149|906566|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
274283|NCT01072149|906567|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
274284|NCT01072149|906568|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
274285|NCT01072149|906569|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
274286|NCT01072149|906552|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274287|NCT01072149|906553|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274288|NCT01072149|906554|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274289|NCT01072149|906555|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274290|NCT01072149|906556|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274291|NCT01072149|906557|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274292|NCT01072149|906558|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274293|NCT01072149|906559|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274294|NCT01072149|906560|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274295|NCT01072149|906561|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274296|NCT01072149|906562|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274297|NCT01072149|906563|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274298|NCT01072149|906564|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274299|NCT01072149|906565|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274300|NCT01072149|906566|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274301|NCT01072149|906567|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
274302|NCT01072149|906568|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274303|NCT01072149|906569|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
274304|NCT01071915|906649|P1|Overall Study|Miscellaneous Reasons|2
274305|NCT01071915|906649|P1|Overall Study|Withdrawal by Subject|2
274306|NCT01071915|906649|P1|Overall Study|Physician Decision|2
274307|NCT01071915|906649|P1|Overall Study|Adverse Event|3
274308|NCT01071798|906659|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
274309|NCT01071798|906659|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
274310|NCT01071798|906659|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
274311|NCT01071798|906659|P1|Subpopulation Who Received Two Cycles|Remission|1
274312|NCT01071798|906659|P1|Participants Who Received One Cycle|Severe concomitant disease|2
274313|NCT01071798|906659|P1|Participants Who Received One Cycle|Change of therapy|6
274314|NCT01071798|906659|P1|Participants Who Received One Cycle|Death|5
274315|NCT01071798|906659|P1|Participants Who Received One Cycle|Patient requirement|20
274316|NCT01071798|906659|P1|Participants Who Received One Cycle|Lack of tolerability|14
274317|NCT01071798|906659|P1|Participants Who Received One Cycle|Lack of Efficacy|18
274318|NCT01071395|906691|P2|Overall Study|Adverse Event|1
274319|NCT01071395|906692|P1|Overall Study|Adverse Event|3
274320|NCT01071395|906691|P2|Overall Study|Withdrawal by Subject|1
274321|NCT01071395|906692|P1|Overall Study|Withdrawal by Subject|2
274322|NCT01071278|906698|P1|Overall Study|Completion Status Unknown|459
274323|NCT01071278|906698|P1|Overall Study|Premature Discontinuation|254
274324|NCT01071252|906709|P5|Overall Study|Death|1
274325|NCT01071252|906710|P4|Overall Study|Death|0
274326|NCT01071252|906711|P3|Overall Study|Death|0
274327|NCT01071252|906712|P2|Overall Study|Death|0
274328|NCT01071252|906713|P1|Overall Study|Death|0
274329|NCT01071252|906709|P5|Overall Study|Adverse Event|0
274330|NCT01071252|906710|P4|Overall Study|Adverse Event|1
274331|NCT01071252|906711|P3|Overall Study|Adverse Event|0
274332|NCT01071252|906712|P2|Overall Study|Adverse Event|1
274333|NCT01071252|906713|P1|Overall Study|Adverse Event|1
274334|NCT01071252|906709|P5|Overall Study|Lost to Follow-up|0
274335|NCT01071252|906710|P4|Overall Study|Lost to Follow-up|2
274336|NCT01071252|906711|P3|Overall Study|Lost to Follow-up|1
274337|NCT01071252|906712|P2|Overall Study|Lost to Follow-up|0
274338|NCT01071252|906713|P1|Overall Study|Lost to Follow-up|1
274339|NCT01071252|906709|P5|Overall Study|administrative problems|1
274340|NCT01071252|906710|P4|Overall Study|administrative problems|2
274341|NCT01071252|906711|P3|Overall Study|administrative problems|0
274342|NCT01071252|906712|P2|Overall Study|administrative problems|1
274343|NCT01071252|906713|P1|Overall Study|administrative problems|1
274344|NCT01071252|906709|P5|Overall Study|Withdrawal by Subject|3
274345|NCT01071252|906710|P4|Overall Study|Withdrawal by Subject|2
274346|NCT01071252|906711|P3|Overall Study|Withdrawal by Subject|1
274347|NCT01071252|906712|P2|Overall Study|Withdrawal by Subject|2
274348|NCT01071252|906713|P1|Overall Study|Withdrawal by Subject|8
274349|NCT01071252|906709|P5|Overall Study|unsatisfactory therapeutic effect|6
274350|NCT01071252|906710|P4|Overall Study|unsatisfactory therapeutic effect|0
274351|NCT01071252|906711|P3|Overall Study|unsatisfactory therapeutic effect|2
274352|NCT01071252|906712|P2|Overall Study|unsatisfactory therapeutic effect|6
274353|NCT01071252|906713|P1|Overall Study|unsatisfactory therapeutic effect|4
274354|NCT01071200|906741|P2|Overall Study|No viable embryos|1
274355|NCT01071200|906742|P1|Overall Study|No viable embryos|0
274356|NCT01071200|906741|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
274357|NCT01071200|906742|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
274358|NCT01071200|906741|P2|Overall Study|No oocytes retrieved|1
274359|NCT01071200|906742|P1|Overall Study|No oocytes retrieved|1
274360|NCT01071200|906741|P2|Overall Study|No fertilization|0
274361|NCT01071200|906742|P1|Overall Study|No fertilization|4
274362|NCT01071200|906741|P2|Overall Study|Lack of ovarian response|1
274363|NCT01071200|906742|P1|Overall Study|Lack of ovarian response|1
274364|NCT01071096|906774|P2|First Intervention (90 Days)|Lost to Follow-up|0
274365|NCT01071096|906775|P1|First Intervention (90 Days)|Lost to Follow-up|1
274366|NCT01071083|906799|P5|Overall Study|Subject Refused to Continue|0
274367|NCT01071083|906800|P4|Overall Study|Subject Refused to Continue|0
274368|NCT01071083|906801|P3|Overall Study|Subject Refused to Continue|0
274369|NCT01071083|906802|P2|Overall Study|Subject Refused to Continue|0
274370|NCT01071083|906803|P1|Overall Study|Subject Refused to Continue|1
274371|NCT01071083|906799|P5|Overall Study|Did Not Want Per Protocol Treatment|1
274372|NCT01071083|906800|P4|Overall Study|Did Not Want Per Protocol Treatment|0
274373|NCT01071083|906801|P3|Overall Study|Did Not Want Per Protocol Treatment|1
274374|NCT01071083|906802|P2|Overall Study|Did Not Want Per Protocol Treatment|0
274375|NCT01071083|906803|P1|Overall Study|Did Not Want Per Protocol Treatment|0
274376|NCT01071083|906799|P5|Overall Study|Did Not Meet Eligibility Criteria|1
274377|NCT01071083|906800|P4|Overall Study|Did Not Meet Eligibility Criteria|1
274378|NCT01071083|906801|P3|Overall Study|Did Not Meet Eligibility Criteria|1
274379|NCT01071083|906802|P2|Overall Study|Did Not Meet Eligibility Criteria|0
274380|NCT01071083|906803|P1|Overall Study|Did Not Meet Eligibility Criteria|0
274381|NCT01071083|906799|P5|Overall Study|Images Not Usable (Motion)|0
274382|NCT01071083|906800|P4|Overall Study|Images Not Usable (Motion)|0
274383|NCT01071083|906801|P3|Overall Study|Images Not Usable (Motion)|0
274384|NCT01071083|906802|P2|Overall Study|Images Not Usable (Motion)|1
274385|NCT01071083|906803|P1|Overall Study|Images Not Usable (Motion)|0
274386|NCT01071083|906799|P5|Overall Study|Subject Moved|0
274387|NCT01071083|906800|P4|Overall Study|Subject Moved|0
274388|NCT01071083|906801|P3|Overall Study|Subject Moved|0
274389|NCT01071083|906802|P2|Overall Study|Subject Moved|1
274390|NCT01071083|906803|P1|Overall Study|Subject Moved|0
274391|NCT01071083|906799|P5|Overall Study|Early Rescue|1
274392|NCT01071083|906800|P4|Overall Study|Early Rescue|0
274393|NCT01071083|906801|P3|Overall Study|Early Rescue|0
274394|NCT01071083|906802|P2|Overall Study|Early Rescue|0
274395|NCT01071083|906803|P1|Overall Study|Early Rescue|1
274396|NCT01071083|906799|P5|Overall Study|Physician Decision|1
274397|NCT01071083|906800|P4|Overall Study|Physician Decision|1
274398|NCT01071083|906801|P3|Overall Study|Physician Decision|0
274399|NCT01071083|906802|P2|Overall Study|Physician Decision|0
274400|NCT01071083|906803|P1|Overall Study|Physician Decision|1
274401|NCT01071083|906799|P5|Overall Study|Withdrawal by Subject|3
274402|NCT01071083|906800|P4|Overall Study|Withdrawal by Subject|0
274403|NCT01071083|906801|P3|Overall Study|Withdrawal by Subject|2
274404|NCT01071083|906802|P2|Overall Study|Withdrawal by Subject|0
274405|NCT01071083|906803|P1|Overall Study|Withdrawal by Subject|3
274406|NCT01071083|906799|P5|Overall Study|Adverse Event|1
274407|NCT01071083|906800|P4|Overall Study|Adverse Event|0
274408|NCT01071083|906801|P3|Overall Study|Adverse Event|1
274409|NCT01071083|906802|P2|Overall Study|Adverse Event|0
274410|NCT01071083|906803|P1|Overall Study|Adverse Event|1
274411|NCT01071070|906822|P2|Overall Study|Hypercalcemia|0
274412|NCT01071070|906823|P1|Overall Study|Hypercalcemia|1
274413|NCT01071070|906822|P2|Overall Study|Missed 3 consecutive doses of study drug|0
274414|NCT01071070|906823|P1|Overall Study|Missed 3 consecutive doses of study drug|2
274415|NCT01071070|906822|P2|Overall Study|Withdrawal by Subject|0
274416|NCT01071070|906823|P1|Overall Study|Withdrawal by Subject|1
274417|NCT01071070|906822|P2|Overall Study|Adverse Event|3
274418|NCT01071070|906823|P1|Overall Study|Adverse Event|0
274419|NCT01070979|906869|P3|Overall Study|No study drug taken|0
274420|NCT01070979|906870|P2|Overall Study|No study drug taken|1
274421|NCT01070979|906871|P1|Overall Study|No study drug taken|0
274422|NCT01070979|906869|P3|Overall Study|Withdrawal by Subject|1
274423|NCT01070979|906870|P2|Overall Study|Withdrawal by Subject|1
274424|NCT01070979|906871|P1|Overall Study|Withdrawal by Subject|3
274425|NCT01070979|906869|P3|Overall Study|Surgery, moving, personal, abn. labs|2
274426|NCT01070979|906870|P2|Overall Study|Surgery, moving, personal, abn. labs|4
274427|NCT01070979|906871|P1|Overall Study|Surgery, moving, personal, abn. labs|4
274428|NCT01070979|906869|P3|Overall Study|Protocol Violation|6
274429|NCT01070979|906870|P2|Overall Study|Protocol Violation|2
274430|NCT01070979|906871|P1|Overall Study|Protocol Violation|0
274431|NCT01070979|906869|P3|Overall Study|Lost to Follow-up|1
274432|NCT01070979|906870|P2|Overall Study|Lost to Follow-up|1
274433|NCT01070979|906871|P1|Overall Study|Lost to Follow-up|2
274434|NCT01070979|906869|P3|Overall Study|Adverse Event|3
274435|NCT01070979|906870|P2|Overall Study|Adverse Event|3
274436|NCT01070979|906871|P1|Overall Study|Adverse Event|2
274437|NCT01070966|906897|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
274438|NCT01070966|906897|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
274439|NCT01070966|906897|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
274440|NCT01070966|906897|P1|Participants for Safety Evaluation|TMT given before date of contract|3
274441|NCT01070966|906897|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
274442|NCT01070966|906897|P1|Participants for Safety Evaluation|Duplicate Participants|4
274443|NCT01070966|906897|P1|Participants for Safety Evaluation|Off-label use|9
274444|NCT01070966|906897|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
274445|NCT01070953|906908|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
274446|NCT01070953|906908|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
274447|NCT01070953|906908|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
274448|NCT01070953|906908|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
274449|NCT01070953|906908|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
274450|NCT01070953|906908|P1|Participants for Safety Evaluation|Uncontracted participants|4
274451|NCT01070953|906908|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
274540|NCT01070550|907057|P5|Overall Study|Relapse|0
274452|NCT01070953|906908|P1|Participants for Safety Evaluation|Duplicated participants|22
274453|NCT01070953|906908|P1|Participants for Safety Evaluation|Off-label use|283
274454|NCT01070953|906908|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
274455|NCT01070888|906921|P2|Washout (14 Days)|Physician Decision|0
274456|NCT01070888|906922|P1|Washout (14 Days)|Physician Decision|1
274457|NCT01070888|906921|P2|First Intervention (14 Days)|Lost to Follow-up|1
274458|NCT01070888|906922|P1|First Intervention (14 Days)|Lost to Follow-up|0
274459|NCT01070888|906921|P2|First Intervention (14 Days)|Adverse Event|1
274460|NCT01070888|906922|P1|First Intervention (14 Days)|Adverse Event|0
274461|NCT01070784|906947|P2|Overall Study|Adverse Event|9
274462|NCT01070784|906948|P1|Overall Study|Adverse Event|14
274463|NCT01070784|906947|P2|Overall Study|Withdrawal by Subject|9
274464|NCT01070784|906948|P1|Overall Study|Withdrawal by Subject|6
274465|NCT01070771|907036|P1|Overall Study|Protocol Violation|1
274466|NCT01070771|907036|P1|Overall Study|Adverse Event|2
274467|NCT01070550|907056|P6|Overall Study|Withdrawal by Subject|0
274468|NCT01070550|907057|P5|Overall Study|Withdrawal by Subject|0
274469|NCT01070550|907058|P4|Overall Study|Withdrawal by Subject|0
274470|NCT01070550|907059|P3|Overall Study|Withdrawal by Subject|3
274471|NCT01070550|907060|P2|Overall Study|Withdrawal by Subject|0
274472|NCT01070550|907061|P1|Overall Study|Withdrawal by Subject|35
274473|NCT01070550|907056|P6|Overall Study|Other|0
274474|NCT01070550|907057|P5|Overall Study|Other|0
274475|NCT01070550|907058|P4|Overall Study|Other|1
274476|NCT01070550|907059|P3|Overall Study|Other|0
274477|NCT01070550|907060|P2|Overall Study|Other|0
274478|NCT01070550|907061|P1|Overall Study|Other|5
274479|NCT01070550|907056|P6|Overall Study|Treatment was stopped early|0
274480|NCT01070550|907057|P5|Overall Study|Treatment was stopped early|0
274481|NCT01070550|907058|P4|Overall Study|Treatment was stopped early|0
274482|NCT01070550|907059|P3|Overall Study|Treatment was stopped early|0
274483|NCT01070550|907060|P2|Overall Study|Treatment was stopped early|0
274484|NCT01070550|907061|P1|Overall Study|Treatment was stopped early|7
274485|NCT01070550|907056|P6|Overall Study|Treatment unavailable|0
274486|NCT01070550|907057|P5|Overall Study|Treatment unavailable|0
274487|NCT01070550|907058|P4|Overall Study|Treatment unavailable|0
274488|NCT01070550|907059|P3|Overall Study|Treatment unavailable|0
274489|NCT01070550|907060|P2|Overall Study|Treatment unavailable|0
274490|NCT01070550|907061|P1|Overall Study|Treatment unavailable|1
274491|NCT01070550|907056|P6|Overall Study|Treatment stopped|0
274492|NCT01070550|907057|P5|Overall Study|Treatment stopped|0
274493|NCT01070550|907058|P4|Overall Study|Treatment stopped|0
274494|NCT01070550|907059|P3|Overall Study|Treatment stopped|0
274495|NCT01070550|907060|P2|Overall Study|Treatment stopped|0
274496|NCT01070550|907061|P1|Overall Study|Treatment stopped|3
274497|NCT01070550|907056|P6|Overall Study|Treatment restarted|0
274498|NCT01070550|907057|P5|Overall Study|Treatment restarted|0
274499|NCT01070550|907058|P4|Overall Study|Treatment restarted|0
274500|NCT01070550|907059|P3|Overall Study|Treatment restarted|0
274501|NCT01070550|907060|P2|Overall Study|Treatment restarted|1
274502|NCT01070550|907061|P1|Overall Study|Treatment restarted|0
274503|NCT01070550|907056|P6|Overall Study|Treatment not started|0
274504|NCT01070550|907057|P5|Overall Study|Treatment not started|0
274505|NCT01070550|907058|P4|Overall Study|Treatment not started|0
274506|NCT01070550|907059|P3|Overall Study|Treatment not started|4
274507|NCT01070550|907060|P2|Overall Study|Treatment not started|2
274508|NCT01070550|907061|P1|Overall Study|Treatment not started|14
274509|NCT01070550|907056|P6|Overall Study|Treatment interrupted|0
274510|NCT01070550|907057|P5|Overall Study|Treatment interrupted|0
274511|NCT01070550|907058|P4|Overall Study|Treatment interrupted|1
274512|NCT01070550|907059|P3|Overall Study|Treatment interrupted|1
274513|NCT01070550|907060|P2|Overall Study|Treatment interrupted|0
274514|NCT01070550|907061|P1|Overall Study|Treatment interrupted|7
274515|NCT01070550|907056|P6|Overall Study|Treatment duration shortened|0
274516|NCT01070550|907057|P5|Overall Study|Treatment duration shortened|0
274517|NCT01070550|907058|P4|Overall Study|Treatment duration shortened|0
274518|NCT01070550|907059|P3|Overall Study|Treatment duration shortened|0
274519|NCT01070550|907060|P2|Overall Study|Treatment duration shortened|0
274520|NCT01070550|907061|P1|Overall Study|Treatment duration shortened|1
274521|NCT01070550|907056|P6|Overall Study|Sponsor decision|0
274522|NCT01070550|907057|P5|Overall Study|Sponsor decision|0
274523|NCT01070550|907058|P4|Overall Study|Sponsor decision|0
274524|NCT01070550|907059|P3|Overall Study|Sponsor decision|0
274525|NCT01070550|907060|P2|Overall Study|Sponsor decision|0
274526|NCT01070550|907061|P1|Overall Study|Sponsor decision|1
274527|NCT01070550|907056|P6|Overall Study|Screen failure|0
274528|NCT01070550|907057|P5|Overall Study|Screen failure|0
274529|NCT01070550|907058|P4|Overall Study|Screen failure|0
274530|NCT01070550|907059|P3|Overall Study|Screen failure|0
274531|NCT01070550|907060|P2|Overall Study|Screen failure|0
274532|NCT01070550|907061|P1|Overall Study|Screen failure|1
274533|NCT01070550|907056|P6|Overall Study|Result not available|0
274534|NCT01070550|907057|P5|Overall Study|Result not available|0
274535|NCT01070550|907058|P4|Overall Study|Result not available|0
274536|NCT01070550|907059|P3|Overall Study|Result not available|3
274537|NCT01070550|907060|P2|Overall Study|Result not available|1
274538|NCT01070550|907061|P1|Overall Study|Result not available|3
274539|NCT01070550|907056|P6|Overall Study|Relapse|0
274541|NCT01070550|907058|P4|Overall Study|Relapse|4
274542|NCT01070550|907059|P3|Overall Study|Relapse|14
274543|NCT01070550|907060|P2|Overall Study|Relapse|5
274544|NCT01070550|907061|P1|Overall Study|Relapse|44
274545|NCT01070550|907056|P6|Overall Study|Protocol Violation|0
274546|NCT01070550|907057|P5|Overall Study|Protocol Violation|0
274547|NCT01070550|907058|P4|Overall Study|Protocol Violation|1
274548|NCT01070550|907059|P3|Overall Study|Protocol Violation|1
274549|NCT01070550|907060|P2|Overall Study|Protocol Violation|1
274550|NCT01070550|907061|P1|Overall Study|Protocol Violation|15
274551|NCT01070550|907056|P6|Overall Study|Not categorized|1
274552|NCT01070550|907057|P5|Overall Study|Not categorized|0
274553|NCT01070550|907058|P4|Overall Study|Not categorized|1
274554|NCT01070550|907059|P3|Overall Study|Not categorized|6
274555|NCT01070550|907060|P2|Overall Study|Not categorized|2
274556|NCT01070550|907061|P1|Overall Study|Not categorized|33
274557|NCT01070550|907056|P6|Overall Study|Non-responders|2
274558|NCT01070550|907057|P5|Overall Study|Non-responders|0
274559|NCT01070550|907058|P4|Overall Study|Non-responders|20
274560|NCT01070550|907059|P3|Overall Study|Non-responders|21
274561|NCT01070550|907060|P2|Overall Study|Non-responders|4
274562|NCT01070550|907061|P1|Overall Study|Non-responders|493
274563|NCT01070550|907056|P6|Overall Study|New treatment started|0
274564|NCT01070550|907057|P5|Overall Study|New treatment started|0
274565|NCT01070550|907058|P4|Overall Study|New treatment started|2
274566|NCT01070550|907059|P3|Overall Study|New treatment started|0
274567|NCT01070550|907060|P2|Overall Study|New treatment started|1
274568|NCT01070550|907061|P1|Overall Study|New treatment started|3
274569|NCT01070550|907056|P6|Overall Study|Miscellaneous|0
274570|NCT01070550|907057|P5|Overall Study|Miscellaneous|0
274571|NCT01070550|907058|P4|Overall Study|Miscellaneous|1
274572|NCT01070550|907059|P3|Overall Study|Miscellaneous|3
274573|NCT01070550|907060|P2|Overall Study|Miscellaneous|2
274574|NCT01070550|907061|P1|Overall Study|Miscellaneous|12
274575|NCT01070550|907056|P6|Overall Study|Lack of Efficacy|1
274576|NCT01070550|907057|P5|Overall Study|Lack of Efficacy|0
274577|NCT01070550|907058|P4|Overall Study|Lack of Efficacy|5
274578|NCT01070550|907059|P3|Overall Study|Lack of Efficacy|5
274579|NCT01070550|907060|P2|Overall Study|Lack of Efficacy|1
274580|NCT01070550|907061|P1|Overall Study|Lack of Efficacy|65
274581|NCT01070550|907056|P6|Overall Study|Lab test not done|1
274582|NCT01070550|907057|P5|Overall Study|Lab test not done|0
274583|NCT01070550|907058|P4|Overall Study|Lab test not done|1
274584|NCT01070550|907059|P3|Overall Study|Lab test not done|4
274585|NCT01070550|907060|P2|Overall Study|Lab test not done|3
274586|NCT01070550|907061|P1|Overall Study|Lab test not done|22
274587|NCT01070550|907056|P6|Overall Study|Incomplete treatment|0
274588|NCT01070550|907057|P5|Overall Study|Incomplete treatment|0
274589|NCT01070550|907058|P4|Overall Study|Incomplete treatment|0
274590|NCT01070550|907059|P3|Overall Study|Incomplete treatment|0
274591|NCT01070550|907060|P2|Overall Study|Incomplete treatment|0
274592|NCT01070550|907061|P1|Overall Study|Incomplete treatment|2
274593|NCT01070550|907056|P6|Overall Study|Failed to return|2
274594|NCT01070550|907057|P5|Overall Study|Failed to return|1
274595|NCT01070550|907058|P4|Overall Study|Failed to return|40
274596|NCT01070550|907059|P3|Overall Study|Failed to return|144
274597|NCT01070550|907060|P2|Overall Study|Failed to return|33
274598|NCT01070550|907061|P1|Overall Study|Failed to return|450
274599|NCT01070550|907056|P6|Overall Study|Early termination|0
274600|NCT01070550|907057|P5|Overall Study|Early termination|0
274601|NCT01070550|907058|P4|Overall Study|Early termination|0
274602|NCT01070550|907059|P3|Overall Study|Early termination|0
274603|NCT01070550|907060|P2|Overall Study|Early termination|0
274604|NCT01070550|907061|P1|Overall Study|Early termination|3
274605|NCT01070550|907056|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
274606|NCT01070550|907057|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
274607|NCT01070550|907058|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
274608|NCT01070550|907059|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
274609|NCT01070550|907060|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
274610|NCT01070550|907061|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
274611|NCT01070550|907056|P6|Overall Study|Death|0
274612|NCT01070550|907057|P5|Overall Study|Death|0
274613|NCT01070550|907058|P4|Overall Study|Death|0
274614|NCT01070550|907059|P3|Overall Study|Death|3
274615|NCT01070550|907060|P2|Overall Study|Death|4
274616|NCT01070550|907061|P1|Overall Study|Death|20
274617|NCT01070550|907056|P6|Overall Study|Adverse Event|0
274618|NCT01070550|907057|P5|Overall Study|Adverse Event|0
274619|NCT01070550|907058|P4|Overall Study|Adverse Event|0
274620|NCT01070550|907059|P3|Overall Study|Adverse Event|3
274621|NCT01070550|907060|P2|Overall Study|Adverse Event|1
274622|NCT01070550|907061|P1|Overall Study|Adverse Event|43
274623|NCT01070394|907201|P1|Overall Study|Withdrawal by Subject|1
274624|NCT01070394|907201|P1|Overall Study|Adverse Event|6
274625|NCT01070381|907212|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
274626|NCT01070381|907213|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
274627|NCT01070381|907212|P2|Period 2, 1 Week of Wear|Handling|1
274628|NCT01070381|907213|P1|Period 2, 1 Week of Wear|Handling|0
274629|NCT01070329|907221|P2|Overall Study|Sponsor Decision|1
274630|NCT01070329|907222|P1|Overall Study|Sponsor Decision|0
274631|NCT01070329|907221|P2|Overall Study|Entry Criteria Not Met|0
274632|NCT01070329|907222|P1|Overall Study|Entry Criteria Not Met|1
274633|NCT01070329|907221|P2|Overall Study|Physician Decision|1
274634|NCT01070329|907222|P1|Overall Study|Physician Decision|2
274635|NCT01070329|907221|P2|Overall Study|Lack of Efficacy|6
274636|NCT01070329|907222|P1|Overall Study|Lack of Efficacy|2
274637|NCT01070329|907221|P2|Overall Study|Protocol Violation|8
274638|NCT01070329|907222|P1|Overall Study|Protocol Violation|3
274639|NCT01070329|907221|P2|Overall Study|Withdrawal by Subject|11
274640|NCT01070329|907222|P1|Overall Study|Withdrawal by Subject|9
274641|NCT01070329|907221|P2|Overall Study|Lost to Follow-up|12
274642|NCT01070329|907222|P1|Overall Study|Lost to Follow-up|22
274643|NCT01070329|907221|P2|Overall Study|Adverse Event|10
274644|NCT01070329|907222|P1|Overall Study|Adverse Event|13
274645|NCT01070316|907254|P1|Extension Phase|Withdrawal by Subject|1
274646|NCT01070316|907254|P1|Extension Phase|Lack of Efficacy|3
274647|NCT01070303|907261|P1|Overall Study|Other|18
274648|NCT01070303|907261|P1|Overall Study|Administrative Reason|1
274649|NCT01070303|907261|P1|Overall Study|Lack of Efficacy|2
274650|NCT01070303|907261|P1|Overall Study|Protocol Violation|0
274651|NCT01070303|907261|P1|Overall Study|Lost to Follow-up|9
274652|NCT01070303|907261|P1|Overall Study|Withdrawal by Subject|20
274653|NCT01070303|907261|P1|Overall Study|Adverse Event|39
274654|NCT01070043|907335|P3|Double-Blind Treatment|Adverse Event|2
274655|NCT01070043|907336|P2|Double-Blind Treatment|Adverse Event|0
274656|NCT01070043|907337|P1|Double-Blind Treatment|Adverse Event|0
274657|NCT01070043|907335|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
274658|NCT01070043|907336|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
274659|NCT01070043|907337|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
274660|NCT01069939|907353|P2|Randomised and Included in the Analyses|Removal|0
274661|NCT01069939|907354|P1|Randomised and Included in the Analyses|Removal|1
274662|NCT01069939|907353|P2|Randomised and Included in the Analyses|Physician Decision|2
274663|NCT01069939|907354|P1|Randomised and Included in the Analyses|Physician Decision|0
274664|NCT01069939|907353|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
274665|NCT01069939|907354|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
274666|NCT01069939|907353|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
274667|NCT01069939|907354|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
274668|NCT01069939|907353|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
274669|NCT01069939|907354|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
274670|NCT01069939|907353|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
274671|NCT01069939|907354|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
274672|NCT01069939|907353|P2|Randomised and Included in the Analyses|Protocol Violation|1
274673|NCT01069939|907354|P1|Randomised and Included in the Analyses|Protocol Violation|0
274674|NCT01069939|907353|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
274675|NCT01069939|907354|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
274676|NCT01069939|907353|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
274677|NCT01069939|907354|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
274678|NCT01069939|907353|P2|Randomised and Included in the Analyses|Adverse Event|22
274679|NCT01069939|907354|P1|Randomised and Included in the Analyses|Adverse Event|17
274680|NCT01069900|907380|P2|Overall Study|Insufficient Therapeutic effect|0
274681|NCT01069900|907381|P1|Overall Study|Insufficient Therapeutic effect|1
274682|NCT01069900|907380|P2|Overall Study|Protocol Violation|1
274683|NCT01069900|907381|P1|Overall Study|Protocol Violation|4
274684|NCT01069900|907380|P2|Overall Study|Withdrawal by Subject|1
274685|NCT01069900|907381|P1|Overall Study|Withdrawal by Subject|6
274686|NCT01069900|907380|P2|Overall Study|Lost to Follow-up|1
274687|NCT01069900|907381|P1|Overall Study|Lost to Follow-up|7
274688|NCT01069900|907380|P2|Overall Study|Technical problems|1
274689|NCT01069900|907381|P1|Overall Study|Technical problems|0
274690|NCT01069861|907425|P1|Overall Study|Did not meet entrance criteria|1
274691|NCT01069861|907425|P1|Overall Study|Adverse Event|1
274692|NCT01069861|907425|P1|Overall Study|Death|1
274693|NCT01069627|907438|P1|Overall Study|Protocol Violation|1
274694|NCT01069627|907438|P1|Overall Study|Adverse Event|12
274695|NCT01069627|907438|P1|Overall Study|Disease progression|7
274696|NCT01069523|907488|P2|Overall Study|Withdrawal by Subject|7
274697|NCT01069523|907489|P1|Overall Study|Withdrawal by Subject|4
274698|NCT01069484|907499|P2|Overall Study|Illness mother or child|1
274699|NCT01069484|907500|P1|Overall Study|Illness mother or child|3
274700|NCT01069484|907499|P2|Overall Study|No specific reason|2
274701|NCT01069484|907500|P1|Overall Study|No specific reason|8
274702|NCT01069484|907499|P2|Overall Study|Death-in-near-family|0
274703|NCT01069484|907500|P1|Overall Study|Death-in-near-family|1
274704|NCT01069419|907508|P1|Overall Study|Missing termination information|13
274705|NCT01069419|907508|P1|Overall Study|Other Reason|43
274706|NCT01069419|907508|P1|Overall Study|Withdrawal by Subject|34
274707|NCT01069419|907508|P1|Overall Study|Remission of disease|11
274708|NCT01069419|907508|P1|Overall Study|Lost to Follow-up|49
274709|NCT01069419|907508|P1|Overall Study|Lack of Efficacy|332
274710|NCT01069419|907508|P1|Overall Study|Adverse Event|233
274711|NCT01069341|907515|P1|Overall Study|Lost to Follow-up|1
274712|NCT01069289|907528|P2|Overall Study|Due to deteriorating health condition|0
274713|NCT01069289|907529|P1|Overall Study|Due to deteriorating health condition|1
274714|NCT01069289|907528|P2|Overall Study|Severe non-compliance to protocol|2
274715|NCT01069289|907529|P1|Overall Study|Severe non-compliance to protocol|3
274716|NCT01069289|907528|P2|Overall Study|Eligibility criteria not fulfilled|0
274717|NCT01069289|907529|P1|Overall Study|Eligibility criteria not fulfilled|2
274718|NCT01069289|907528|P2|Overall Study|Adverse Event|28
274719|NCT01069289|907529|P1|Overall Study|Adverse Event|21
274720|NCT01069289|907528|P2|Overall Study|Withdrawal by Subject|26
274721|NCT01069289|907529|P1|Overall Study|Withdrawal by Subject|15
274722|NCT01069172|907567|P2|Overall Study|Withdrawal by Subject|0
274723|NCT01069172|907568|P1|Overall Study|Withdrawal by Subject|1
274724|NCT01069120|907578|P1|Overall Study|Study prematurely terminated|27
274725|NCT01068912|907615|P3|Overall Study|other underlying illness|3
274726|NCT01068912|907616|P2|Overall Study|other underlying illness|3
274727|NCT01068912|907617|P1|Overall Study|other underlying illness|0
274728|NCT01068912|907615|P3|Overall Study|aggravation influenza|1
274729|NCT01068912|907616|P2|Overall Study|aggravation influenza|1
274730|NCT01068912|907617|P1|Overall Study|aggravation influenza|1
274731|NCT01068912|907615|P3|Overall Study|Protocol Violation|0
274732|NCT01068912|907616|P2|Overall Study|Protocol Violation|2
274733|NCT01068912|907617|P1|Overall Study|Protocol Violation|0
274734|NCT01068912|907615|P3|Overall Study|Lost to Follow-up|3
274735|NCT01068912|907616|P2|Overall Study|Lost to Follow-up|7
274736|NCT01068912|907617|P1|Overall Study|Lost to Follow-up|3
274737|NCT01068912|907615|P3|Overall Study|Withdrawal by Subject|6
274738|NCT01068912|907616|P2|Overall Study|Withdrawal by Subject|6
274739|NCT01068912|907617|P1|Overall Study|Withdrawal by Subject|5
274740|NCT01068912|907615|P3|Overall Study|Adverse Event|2
274741|NCT01068912|907616|P2|Overall Study|Adverse Event|3
274742|NCT01068912|907617|P1|Overall Study|Adverse Event|2
274743|NCT01068860|907635|P10|Overall Study|Lost to Follow-up|0
274744|NCT01068860|907636|P9|Overall Study|Lost to Follow-up|0
274745|NCT01068860|907637|P8|Overall Study|Lost to Follow-up|0
274746|NCT01068860|907638|P7|Overall Study|Lost to Follow-up|0
274747|NCT01068860|907639|P6|Overall Study|Lost to Follow-up|0
274748|NCT01068860|907640|P5|Overall Study|Lost to Follow-up|0
274749|NCT01068860|907641|P4|Overall Study|Lost to Follow-up|0
274750|NCT01068860|907642|P3|Overall Study|Lost to Follow-up|0
274751|NCT01068860|907643|P2|Overall Study|Lost to Follow-up|1
274752|NCT01068860|907644|P1|Overall Study|Lost to Follow-up|0
274753|NCT01068860|907635|P10|Overall Study|Administrative problems; misrandomized|1
274754|NCT01068860|907636|P9|Overall Study|Administrative problems; misrandomized|0
274755|NCT01068860|907637|P8|Overall Study|Administrative problems; misrandomized|0
274756|NCT01068860|907638|P7|Overall Study|Administrative problems; misrandomized|0
274757|NCT01068860|907639|P6|Overall Study|Administrative problems; misrandomized|0
274758|NCT01068860|907640|P5|Overall Study|Administrative problems; misrandomized|0
274759|NCT01068860|907641|P4|Overall Study|Administrative problems; misrandomized|1
274760|NCT01068860|907642|P3|Overall Study|Administrative problems; misrandomized|0
274761|NCT01068860|907643|P2|Overall Study|Administrative problems; misrandomized|0
274762|NCT01068860|907644|P1|Overall Study|Administrative problems; misrandomized|0
274763|NCT01068860|907635|P10|Overall Study|Withdrawal by Subject|3
274764|NCT01068860|907636|P9|Overall Study|Withdrawal by Subject|0
274765|NCT01068860|907637|P8|Overall Study|Withdrawal by Subject|0
274766|NCT01068860|907638|P7|Overall Study|Withdrawal by Subject|0
274767|NCT01068860|907639|P6|Overall Study|Withdrawal by Subject|2
274768|NCT01068860|907640|P5|Overall Study|Withdrawal by Subject|0
274769|NCT01068860|907641|P4|Overall Study|Withdrawal by Subject|0
274770|NCT01068860|907642|P3|Overall Study|Withdrawal by Subject|0
274771|NCT01068860|907643|P2|Overall Study|Withdrawal by Subject|0
274772|NCT01068860|907644|P1|Overall Study|Withdrawal by Subject|0
274773|NCT01068769|907827|P1|Overall Study|Ineligible|1
274774|NCT01068743|907832|P4|Period 3|Adverse Event|0
274775|NCT01068743|907833|P3|Period 3|Adverse Event|0
274776|NCT01068743|907834|P2|Period 3|Adverse Event|1
274777|NCT01068743|907835|P1|Period 3|Adverse Event|0
274778|NCT01068730|907909|P4|Period 4|Family emergency|0
274779|NCT01068730|907910|P3|Period 4|Family emergency|0
274780|NCT01068730|907911|P2|Period 4|Family emergency|1
274781|NCT01068730|907912|P1|Period 4|Family emergency|0
274782|NCT01068730|907909|P4|Period 3|Personal reason|0
274783|NCT01068730|907910|P3|Period 3|Personal reason|0
274784|NCT01068730|907911|P2|Period 3|Personal reason|0
274785|NCT01068730|907912|P1|Period 3|Personal reason|1
274786|NCT01068717|907966|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
274787|NCT01068717|907967|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
274788|NCT01068717|907968|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
274789|NCT01068717|907969|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
274790|NCT01068678|908025|P2|Overall Study|Unclassified|15
274791|NCT01068678|908026|P1|Overall Study|Unclassified|18
274792|NCT01068678|908025|P2|Overall Study|Withdrawal criteria|6
274793|NCT01068678|908026|P1|Overall Study|Withdrawal criteria|12
274794|NCT01068678|908025|P2|Overall Study|Protocol Violation|1
274795|NCT01068678|908026|P1|Overall Study|Protocol Violation|5
274796|NCT01068678|908025|P2|Overall Study|Lack of Efficacy|2
274797|NCT01068678|908026|P1|Overall Study|Lack of Efficacy|3
274798|NCT01068665|908036|P2|Overall Study|Other|12
274799|NCT01068665|908037|P1|Overall Study|Other|17
274800|NCT01068665|908036|P2|Overall Study|Withdrawal Criteria|9
274801|NCT01068665|908037|P1|Overall Study|Withdrawal Criteria|3
274802|NCT01068665|908036|P2|Overall Study|Protocol Violation|2
274803|NCT01068665|908037|P1|Overall Study|Protocol Violation|5
274804|NCT01068665|908036|P2|Overall Study|Lack of Efficacy|2
274805|NCT01068665|908037|P1|Overall Study|Lack of Efficacy|0
274806|NCT01068665|908036|P2|Overall Study|Adverse Event|4
274807|NCT01068665|908037|P1|Overall Study|Adverse Event|5
274808|NCT01068652|908047|P2|Overall Study|Unclassified|4
274809|NCT01068652|908048|P1|Overall Study|Unclassified|7
274810|NCT01068652|908047|P2|Overall Study|Patient was not eligible|0
274811|NCT01068652|908048|P1|Overall Study|Patient was not eligible|1
274812|NCT01068652|908047|P2|Overall Study|Withdrawal criteria|2
274813|NCT01068652|908048|P1|Overall Study|Withdrawal criteria|1
274814|NCT01068652|908047|P2|Overall Study|Protocol Violation|6
274815|NCT01068652|908048|P1|Overall Study|Protocol Violation|3
274816|NCT01068652|908047|P2|Overall Study|Lost to Follow-up|1
274817|NCT01068652|908048|P1|Overall Study|Lost to Follow-up|2
274818|NCT01068652|908047|P2|Overall Study|Lack of Efficacy|2
274819|NCT01068652|908048|P1|Overall Study|Lack of Efficacy|0
274820|NCT01068652|908047|P2|Overall Study|Adverse Event|0
274821|NCT01068652|908048|P1|Overall Study|Adverse Event|4
274822|NCT01068626|908088|P2|Overall Study|Withdrawal by Subject|2
274823|NCT01068626|908089|P1|Overall Study|Withdrawal by Subject|0
274824|NCT01068626|908088|P2|Overall Study|Adverse Event|0
274825|NCT01068626|908089|P1|Overall Study|Adverse Event|3
274826|NCT01068600|908107|P2|Overall Study|Administrative problems|1
274827|NCT01068600|908108|P1|Overall Study|Administrative problems|0
274828|NCT01068600|908107|P2|Overall Study|Unsatisfactory therapeutic effect|4
274829|NCT01068600|908108|P1|Overall Study|Unsatisfactory therapeutic effect|0
274830|NCT01068600|908107|P2|Overall Study|Protocol deviation|1
274831|NCT01068600|908108|P1|Overall Study|Protocol deviation|1
274832|NCT01068600|908107|P2|Overall Study|Lost to Follow-up|2
274833|NCT01068600|908108|P1|Overall Study|Lost to Follow-up|1
274834|NCT01068600|908107|P2|Overall Study|Abnormal laboratory value(s)|0
274835|NCT01068600|908108|P1|Overall Study|Abnormal laboratory value(s)|1
274836|NCT01068600|908107|P2|Overall Study|Adverse Event|3
274837|NCT01068600|908108|P1|Overall Study|Adverse Event|3
274838|NCT01068600|908107|P2|Overall Study|Withdrawal by Subject|6
274839|NCT01068600|908108|P1|Overall Study|Withdrawal by Subject|5
274840|NCT01068509|908128|P3|Overall Study|Reason Not Specified|0
274841|NCT01068509|908129|P2|Overall Study|Reason Not Specified|1
274842|NCT01068509|908130|P1|Overall Study|Reason Not Specified|0
274843|NCT01068509|908128|P3|Overall Study|Withdrew Consent|2
274844|NCT01068509|908129|P2|Overall Study|Withdrew Consent|1
274845|NCT01068509|908130|P1|Overall Study|Withdrew Consent|0
274846|NCT01068509|908128|P3|Overall Study|Lost to Follow-up|0
274847|NCT01068509|908129|P2|Overall Study|Lost to Follow-up|0
274848|NCT01068509|908130|P1|Overall Study|Lost to Follow-up|1
274849|NCT01068509|908128|P3|Overall Study|Disease Progression|18
274850|NCT01068509|908129|P2|Overall Study|Disease Progression|20
274851|NCT01068509|908130|P1|Overall Study|Disease Progression|5
274852|NCT01068509|908128|P3|Overall Study|Death|1
274853|NCT01068509|908129|P2|Overall Study|Death|0
274854|NCT01068509|908130|P1|Overall Study|Death|0
274855|NCT01068418|908143|P1|Overall Study|Physician Decision|12
274856|NCT01068262|908152|P4|Overall Study|Withdrawal by Subject|0
274857|NCT01068262|908153|P3|Overall Study|Withdrawal by Subject|0
274858|NCT01068262|908154|P2|Overall Study|Withdrawal by Subject|1
274859|NCT01068262|908155|P1|Overall Study|Withdrawal by Subject|0
274860|NCT01068262|908152|P4|Overall Study|Protocol Violation|0
274861|NCT01068262|908153|P3|Overall Study|Protocol Violation|0
274862|NCT01068262|908154|P2|Overall Study|Protocol Violation|0
274863|NCT01068262|908155|P1|Overall Study|Protocol Violation|1
274864|NCT01068262|908152|P4|Overall Study|Adverse Event|0
274865|NCT01068262|908153|P3|Overall Study|Adverse Event|1
274866|NCT01068262|908154|P2|Overall Study|Adverse Event|0
274867|NCT01068262|908155|P1|Overall Study|Adverse Event|2
274868|NCT01068158|908185|P2|Overall Study|Protocol Violation|2
274869|NCT01068158|908186|P1|Overall Study|Protocol Violation|0
274870|NCT01068158|908185|P2|Overall Study|Lost to Follow-up|0
274871|NCT01068158|908186|P1|Overall Study|Lost to Follow-up|7
274872|NCT01068158|908185|P2|Overall Study|Withdrawal by Subject|2
274873|NCT01068158|908186|P1|Overall Study|Withdrawal by Subject|1
274874|NCT01067976|908198|P1|Overall Study|Study prematurely discontinued|2
274875|NCT01067976|908198|P1|Overall Study|Study drug never administered|20
274876|NCT01067846|908259|P2|Overall Study|participation in other tx study|0
274877|NCT01067846|908260|P1|Overall Study|participation in other tx study|1
274878|NCT01067846|908259|P2|Overall Study|Withdrawal by Subject|0
274879|NCT01067846|908260|P1|Overall Study|Withdrawal by Subject|1
274880|NCT01067846|908259|P2|Overall Study|Lost to Follow-up|19
274881|NCT01067846|908260|P1|Overall Study|Lost to Follow-up|17
274882|NCT01067352|908328|P3|Overall Study|Physician Decision|0
274883|NCT01067352|908329|P2|Overall Study|Physician Decision|1
274884|NCT01067352|908330|P1|Overall Study|Physician Decision|0
274885|NCT01067352|908328|P3|Overall Study|Withdrawal by Subject|1
274886|NCT01067352|908329|P2|Overall Study|Withdrawal by Subject|2
274887|NCT01067352|908330|P1|Overall Study|Withdrawal by Subject|1
274888|NCT01067339|908346|P2|Overall Study|Withdrawal by Subject|5
274889|NCT01067339|908347|P1|Overall Study|Withdrawal by Subject|6
274890|NCT01067326|908357|P2|Overall Study|Early Study Termination|1
274891|NCT01067326|908358|P1|Overall Study|Early Study Termination|1
274892|NCT01067326|908357|P2|Overall Study|Withdrawal by Subject|0
274893|NCT01067326|908358|P1|Overall Study|Withdrawal by Subject|1
274894|NCT01067326|908357|P2|Overall Study|Adverse Event|2
274895|NCT01067326|908358|P1|Overall Study|Adverse Event|0
274896|NCT01067105|908370|P1|Overall Study|Other|31
274897|NCT01067105|908370|P1|Overall Study|Physician Decision|6
274898|NCT01067105|908370|P1|Overall Study|Lost to Follow-up|6
274899|NCT01067105|908370|P1|Overall Study|Withdrawal by Subject|36
274900|NCT01067105|908370|P1|Overall Study|Protocol Violation|48
274901|NCT01067105|908370|P1|Overall Study|Adverse Event|14
274902|NCT01066923|908391|P4|Overall Study|Withdrawal by Subject|8
274903|NCT01066923|908392|P3|Overall Study|Withdrawal by Subject|8
274904|NCT01066923|908393|P2|Overall Study|Withdrawal by Subject|3
274905|NCT01066923|908394|P1|Overall Study|Withdrawal by Subject|3
274906|NCT01066897|908410|P2|Overall Study|stopped study after developing the flu.|0
274907|NCT01066897|908411|P1|Overall Study|stopped study after developing the flu.|1
274908|NCT01066897|908410|P2|Overall Study|Withdrawal by Subject|0
274909|NCT01066897|908411|P1|Overall Study|Withdrawal by Subject|1
274910|NCT01066871|908425|P4|Overall Study|Unspecified|2
274911|NCT01066871|908426|P3|Overall Study|Unspecified|1
274912|NCT01066871|908427|P2|Overall Study|Unspecified|2
274913|NCT01066871|908428|P1|Overall Study|Unspecified|0
274914|NCT01066871|908425|P4|Overall Study|Withdrawal by Subject|0
274915|NCT01066871|908426|P3|Overall Study|Withdrawal by Subject|0
274916|NCT01066871|908427|P2|Overall Study|Withdrawal by Subject|1
274917|NCT01066871|908428|P1|Overall Study|Withdrawal by Subject|3
274918|NCT01066871|908425|P4|Overall Study|Lack of Efficacy|1
274919|NCT01066871|908426|P3|Overall Study|Lack of Efficacy|0
274920|NCT01066871|908427|P2|Overall Study|Lack of Efficacy|0
274921|NCT01066871|908428|P1|Overall Study|Lack of Efficacy|0
274922|NCT01066871|908425|P4|Overall Study|Protocol Violation|2
274923|NCT01066871|908426|P3|Overall Study|Protocol Violation|3
274924|NCT01066871|908427|P2|Overall Study|Protocol Violation|0
274925|NCT01066871|908428|P1|Overall Study|Protocol Violation|1
274926|NCT01066871|908425|P4|Overall Study|Lost to Follow-up|0
274927|NCT01066871|908426|P3|Overall Study|Lost to Follow-up|2
274928|NCT01066871|908427|P2|Overall Study|Lost to Follow-up|2
274929|NCT01066871|908428|P1|Overall Study|Lost to Follow-up|0
274930|NCT01066819|908492|P6|Overall Study|Other|0
274931|NCT01066819|908493|P5|Overall Study|Other|0
274932|NCT01066819|908494|P4|Overall Study|Other|0
274933|NCT01066819|908495|P3|Overall Study|Other|1
274934|NCT01066819|908496|P2|Overall Study|Other|1
274935|NCT01066819|908497|P1|Overall Study|Other|5
274936|NCT01066819|908492|P6|Overall Study|Treatment stopped|0
274937|NCT01066819|908493|P5|Overall Study|Treatment stopped|0
274938|NCT01066819|908494|P4|Overall Study|Treatment stopped|1
274939|NCT01066819|908495|P3|Overall Study|Treatment stopped|2
274940|NCT01066819|908496|P2|Overall Study|Treatment stopped|1
274941|NCT01066819|908497|P1|Overall Study|Treatment stopped|12
274942|NCT01066819|908492|P6|Overall Study|Treatment never started|2
274943|NCT01066819|908493|P5|Overall Study|Treatment never started|2
274944|NCT01066819|908494|P4|Overall Study|Treatment never started|3
274945|NCT01066819|908495|P3|Overall Study|Treatment never started|19
274946|NCT01066819|908496|P2|Overall Study|Treatment never started|19
274947|NCT01066819|908497|P1|Overall Study|Treatment never started|85
274948|NCT01066819|908492|P6|Overall Study|Spontaneous cure|0
274949|NCT01066819|908493|P5|Overall Study|Spontaneous cure|0
274950|NCT01066819|908494|P4|Overall Study|Spontaneous cure|0
274951|NCT01066819|908495|P3|Overall Study|Spontaneous cure|0
274952|NCT01066819|908496|P2|Overall Study|Spontaneous cure|0
274953|NCT01066819|908497|P1|Overall Study|Spontaneous cure|1
274954|NCT01066819|908492|P6|Overall Study|Screen failure|0
274955|NCT01066819|908493|P5|Overall Study|Screen failure|0
274956|NCT01066819|908494|P4|Overall Study|Screen failure|0
274957|NCT01066819|908495|P3|Overall Study|Screen failure|0
274958|NCT01066819|908496|P2|Overall Study|Screen failure|0
274959|NCT01066819|908497|P1|Overall Study|Screen failure|1
274960|NCT01066819|908492|P6|Overall Study|Results not available|0
274961|NCT01066819|908493|P5|Overall Study|Results not available|0
274962|NCT01066819|908494|P4|Overall Study|Results not available|0
274963|NCT01066819|908495|P3|Overall Study|Results not available|0
274964|NCT01066819|908496|P2|Overall Study|Results not available|0
274965|NCT01066819|908497|P1|Overall Study|Results not available|1
274966|NCT01066819|908492|P6|Overall Study|Relapse|0
274967|NCT01066819|908493|P5|Overall Study|Relapse|0
274968|NCT01066819|908494|P4|Overall Study|Relapse|0
274969|NCT01066819|908495|P3|Overall Study|Relapse|3
274970|NCT01066819|908496|P2|Overall Study|Relapse|4
274971|NCT01066819|908497|P1|Overall Study|Relapse|16
274972|NCT01066819|908492|P6|Overall Study|Not categorised|0
274973|NCT01066819|908493|P5|Overall Study|Not categorised|0
274974|NCT01066819|908494|P4|Overall Study|Not categorised|1
274975|NCT01066819|908495|P3|Overall Study|Not categorised|6
274976|NCT01066819|908496|P2|Overall Study|Not categorised|2
274977|NCT01066819|908497|P1|Overall Study|Not categorised|9
274978|NCT01066819|908492|P6|Overall Study|Non responders|1
274979|NCT01066819|908493|P5|Overall Study|Non responders|0
274980|NCT01066819|908494|P4|Overall Study|Non responders|2
274981|NCT01066819|908495|P3|Overall Study|Non responders|7
274982|NCT01066819|908496|P2|Overall Study|Non responders|2
274983|NCT01066819|908497|P1|Overall Study|Non responders|123
274984|NCT01066819|908492|P6|Overall Study|Miscellaneous|0
274985|NCT01066819|908493|P5|Overall Study|Miscellaneous|0
274986|NCT01066819|908494|P4|Overall Study|Miscellaneous|1
274987|NCT01066819|908495|P3|Overall Study|Miscellaneous|18
274988|NCT01066819|908496|P2|Overall Study|Miscellaneous|10
274989|NCT01066819|908497|P1|Overall Study|Miscellaneous|28
274990|NCT01066819|908492|P6|Overall Study|Lab test not done|0
274991|NCT01066819|908493|P5|Overall Study|Lab test not done|0
274992|NCT01066819|908494|P4|Overall Study|Lab test not done|1
274993|NCT01066819|908495|P3|Overall Study|Lab test not done|2
274994|NCT01066819|908496|P2|Overall Study|Lab test not done|0
274995|NCT01066819|908497|P1|Overall Study|Lab test not done|9
274996|NCT01066819|908492|P6|Overall Study|Failed to return|3
274997|NCT01066819|908493|P5|Overall Study|Failed to return|2
274998|NCT01066819|908494|P4|Overall Study|Failed to return|7
274999|NCT01066819|908495|P3|Overall Study|Failed to return|68
275000|NCT01066819|908496|P2|Overall Study|Failed to return|107
275001|NCT01066819|908497|P1|Overall Study|Failed to return|298
275002|NCT01066819|908492|P6|Overall Study|Early termination|0
275003|NCT01066819|908493|P5|Overall Study|Early termination|0
275004|NCT01066819|908494|P4|Overall Study|Early termination|0
275005|NCT01066819|908495|P3|Overall Study|Early termination|0
275006|NCT01066819|908496|P2|Overall Study|Early termination|0
275007|NCT01066819|908497|P1|Overall Study|Early termination|2
275008|NCT01066819|908492|P6|Overall Study|Not met inclusion/exclusion criteria|0
275009|NCT01066819|908493|P5|Overall Study|Not met inclusion/exclusion criteria|0
275010|NCT01066819|908494|P4|Overall Study|Not met inclusion/exclusion criteria|0
275011|NCT01066819|908495|P3|Overall Study|Not met inclusion/exclusion criteria|0
275012|NCT01066819|908496|P2|Overall Study|Not met inclusion/exclusion criteria|0
275013|NCT01066819|908497|P1|Overall Study|Not met inclusion/exclusion criteria|1
275014|NCT01066819|908492|P6|Overall Study|Administrative|0
275015|NCT01066819|908493|P5|Overall Study|Administrative|0
275016|NCT01066819|908494|P4|Overall Study|Administrative|0
275017|NCT01066819|908495|P3|Overall Study|Administrative|2
275018|NCT01066819|908496|P2|Overall Study|Administrative|4
275019|NCT01066819|908497|P1|Overall Study|Administrative|6
275020|NCT01066819|908492|P6|Overall Study|Withdrawal by Subject|0
275021|NCT01066819|908493|P5|Overall Study|Withdrawal by Subject|0
275022|NCT01066819|908494|P4|Overall Study|Withdrawal by Subject|0
275023|NCT01066819|908495|P3|Overall Study|Withdrawal by Subject|6
275024|NCT01066819|908496|P2|Overall Study|Withdrawal by Subject|11
275025|NCT01066819|908497|P1|Overall Study|Withdrawal by Subject|29
275026|NCT01066819|908492|P6|Overall Study|Protocol Violation|0
275027|NCT01066819|908493|P5|Overall Study|Protocol Violation|0
275028|NCT01066819|908494|P4|Overall Study|Protocol Violation|0
275029|NCT01066819|908495|P3|Overall Study|Protocol Violation|0
275030|NCT01066819|908496|P2|Overall Study|Protocol Violation|6
275031|NCT01066819|908497|P1|Overall Study|Protocol Violation|12
275032|NCT01066819|908492|P6|Overall Study|Physician Decision|0
275033|NCT01066819|908493|P5|Overall Study|Physician Decision|0
275034|NCT01066819|908494|P4|Overall Study|Physician Decision|0
275035|NCT01066819|908495|P3|Overall Study|Physician Decision|3
275036|NCT01066819|908496|P2|Overall Study|Physician Decision|2
275037|NCT01066819|908497|P1|Overall Study|Physician Decision|6
275038|NCT01066819|908492|P6|Overall Study|Lack of Efficacy|0
275039|NCT01066819|908493|P5|Overall Study|Lack of Efficacy|0
275040|NCT01066819|908494|P4|Overall Study|Lack of Efficacy|1
275041|NCT01066819|908495|P3|Overall Study|Lack of Efficacy|2
275042|NCT01066819|908496|P2|Overall Study|Lack of Efficacy|1
275043|NCT01066819|908497|P1|Overall Study|Lack of Efficacy|22
275044|NCT01066819|908492|P6|Overall Study|Death|0
275045|NCT01066819|908493|P5|Overall Study|Death|0
275046|NCT01066819|908494|P4|Overall Study|Death|0
275047|NCT01066819|908495|P3|Overall Study|Death|1
275048|NCT01066819|908496|P2|Overall Study|Death|0
275049|NCT01066819|908497|P1|Overall Study|Death|5
275050|NCT01066819|908492|P6|Overall Study|Adverse Event|0
275051|NCT01066819|908493|P5|Overall Study|Adverse Event|0
275052|NCT01066819|908494|P4|Overall Study|Adverse Event|0
275053|NCT01066819|908495|P3|Overall Study|Adverse Event|6
275054|NCT01066819|908496|P2|Overall Study|Adverse Event|1
275055|NCT01066819|908497|P1|Overall Study|Adverse Event|18
275056|NCT01066793|908638|P6|Overall Study|Treatment Stopped|0
275057|NCT01066793|908639|P5|Overall Study|Treatment Stopped|0
275058|NCT01066793|908640|P4|Overall Study|Treatment Stopped|1
275059|NCT01066793|908641|P3|Overall Study|Treatment Stopped|0
275060|NCT01066793|908642|P2|Overall Study|Treatment Stopped|1
275061|NCT01066793|908643|P1|Overall Study|Treatment Stopped|2
275062|NCT01066793|908638|P6|Overall Study|Treatment Never Started|0
275063|NCT01066793|908639|P5|Overall Study|Treatment Never Started|0
275064|NCT01066793|908640|P4|Overall Study|Treatment Never Started|1
275065|NCT01066793|908641|P3|Overall Study|Treatment Never Started|4
275066|NCT01066793|908642|P2|Overall Study|Treatment Never Started|5
275067|NCT01066793|908643|P1|Overall Study|Treatment Never Started|18
275068|NCT01066793|908638|P6|Overall Study|Treatment Interrupted|0
275069|NCT01066793|908639|P5|Overall Study|Treatment Interrupted|0
275070|NCT01066793|908640|P4|Overall Study|Treatment Interrupted|0
275071|NCT01066793|908641|P3|Overall Study|Treatment Interrupted|0
275072|NCT01066793|908642|P2|Overall Study|Treatment Interrupted|1
275073|NCT01066793|908643|P1|Overall Study|Treatment Interrupted|1
275074|NCT01066793|908638|P6|Overall Study|Result Not Available|0
275075|NCT01066793|908639|P5|Overall Study|Result Not Available|0
275076|NCT01066793|908640|P4|Overall Study|Result Not Available|0
275077|NCT01066793|908641|P3|Overall Study|Result Not Available|0
275078|NCT01066793|908642|P2|Overall Study|Result Not Available|0
275079|NCT01066793|908643|P1|Overall Study|Result Not Available|1
275080|NCT01066793|908638|P6|Overall Study|Relapse|0
275081|NCT01066793|908639|P5|Overall Study|Relapse|0
275082|NCT01066793|908640|P4|Overall Study|Relapse|3
275083|NCT01066793|908641|P3|Overall Study|Relapse|2
275084|NCT01066793|908642|P2|Overall Study|Relapse|8
275085|NCT01066793|908643|P1|Overall Study|Relapse|20
275086|NCT01066793|908638|P6|Overall Study|Other|0
275087|NCT01066793|908639|P5|Overall Study|Other|0
275088|NCT01066793|908640|P4|Overall Study|Other|2
275089|NCT01066793|908641|P3|Overall Study|Other|6
275090|NCT01066793|908642|P2|Overall Study|Other|5
275091|NCT01066793|908643|P1|Overall Study|Other|15
275092|NCT01066793|908638|P6|Overall Study|Non-responders|0
275093|NCT01066793|908639|P5|Overall Study|Non-responders|0
275094|NCT01066793|908640|P4|Overall Study|Non-responders|25
275095|NCT01066793|908641|P3|Overall Study|Non-responders|11
275096|NCT01066793|908642|P2|Overall Study|Non-responders|5
275097|NCT01066793|908643|P1|Overall Study|Non-responders|104
275098|NCT01066793|908638|P6|Overall Study|Miscellaneous|0
275099|NCT01066793|908639|P5|Overall Study|Miscellaneous|0
275100|NCT01066793|908640|P4|Overall Study|Miscellaneous|0
275101|NCT01066793|908641|P3|Overall Study|Miscellaneous|6
275102|NCT01066793|908642|P2|Overall Study|Miscellaneous|5
275103|NCT01066793|908643|P1|Overall Study|Miscellaneous|4
275104|NCT01066793|908638|P6|Overall Study|Lab test not done|0
275105|NCT01066793|908639|P5|Overall Study|Lab test not done|0
275106|NCT01066793|908640|P4|Overall Study|Lab test not done|1
275107|NCT01066793|908641|P3|Overall Study|Lab test not done|0
275108|NCT01066793|908642|P2|Overall Study|Lab test not done|0
275109|NCT01066793|908643|P1|Overall Study|Lab test not done|7
275110|NCT01066793|908638|P6|Overall Study|Early Termination|0
275111|NCT01066793|908639|P5|Overall Study|Early Termination|0
275112|NCT01066793|908640|P4|Overall Study|Early Termination|0
275113|NCT01066793|908641|P3|Overall Study|Early Termination|0
275114|NCT01066793|908642|P2|Overall Study|Early Termination|0
275115|NCT01066793|908643|P1|Overall Study|Early Termination|3
275116|NCT01066793|908638|P6|Overall Study|Withdrawal by Subject|0
275117|NCT01066793|908639|P5|Overall Study|Withdrawal by Subject|0
275118|NCT01066793|908640|P4|Overall Study|Withdrawal by Subject|0
275119|NCT01066793|908641|P3|Overall Study|Withdrawal by Subject|1
275120|NCT01066793|908642|P2|Overall Study|Withdrawal by Subject|4
275121|NCT01066793|908643|P1|Overall Study|Withdrawal by Subject|7
275122|NCT01066793|908638|P6|Overall Study|Protocol Violation|0
275123|NCT01066793|908639|P5|Overall Study|Protocol Violation|0
275124|NCT01066793|908640|P4|Overall Study|Protocol Violation|0
275125|NCT01066793|908641|P3|Overall Study|Protocol Violation|2
275126|NCT01066793|908642|P2|Overall Study|Protocol Violation|2
275127|NCT01066793|908643|P1|Overall Study|Protocol Violation|3
275128|NCT01066793|908638|P6|Overall Study|Physician Decision|0
275129|NCT01066793|908639|P5|Overall Study|Physician Decision|0
275130|NCT01066793|908640|P4|Overall Study|Physician Decision|0
275131|NCT01066793|908641|P3|Overall Study|Physician Decision|0
275132|NCT01066793|908642|P2|Overall Study|Physician Decision|0
275133|NCT01066793|908643|P1|Overall Study|Physician Decision|3
275134|NCT01066793|908638|P6|Overall Study|Lost to Follow-up|1
275135|NCT01066793|908639|P5|Overall Study|Lost to Follow-up|0
275136|NCT01066793|908640|P4|Overall Study|Lost to Follow-up|16
275137|NCT01066793|908641|P3|Overall Study|Lost to Follow-up|82
275138|NCT01066793|908642|P2|Overall Study|Lost to Follow-up|39
275139|NCT01066793|908643|P1|Overall Study|Lost to Follow-up|180
275140|NCT01066793|908638|P6|Overall Study|Lack of Efficacy|0
275141|NCT01066793|908639|P5|Overall Study|Lack of Efficacy|0
275142|NCT01066793|908640|P4|Overall Study|Lack of Efficacy|0
275143|NCT01066793|908641|P3|Overall Study|Lack of Efficacy|0
275144|NCT01066793|908642|P2|Overall Study|Lack of Efficacy|1
275145|NCT01066793|908643|P1|Overall Study|Lack of Efficacy|2
275146|NCT01066793|908638|P6|Overall Study|Death|0
275147|NCT01066793|908639|P5|Overall Study|Death|0
275148|NCT01066793|908640|P4|Overall Study|Death|0
275149|NCT01066793|908641|P3|Overall Study|Death|1
275150|NCT01066793|908642|P2|Overall Study|Death|1
275151|NCT01066793|908643|P1|Overall Study|Death|4
275152|NCT01066780|908783|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
275153|NCT01066780|908784|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
275154|NCT01066585|908803|P2|Overall Study|Withdrawal by Subject|3
275155|NCT01066585|908804|P1|Overall Study|Withdrawal by Subject|0
275156|NCT01066585|908803|P2|Overall Study|Protocol Violation|0
275157|NCT01066585|908804|P1|Overall Study|Protocol Violation|1
275158|NCT01066546|908816|P1|Overall Study|Study terminated by sponsor|5
275159|NCT01066156|908846|P1|Overall Study|Withdrawal by Subject|1
275160|NCT01066156|908846|P1|Overall Study|Lost to Follow-up|7
275161|NCT01066156|908846|P1|Overall Study|ineligible|2
275162|NCT01066143|908850|P1|Overall Study|ineligible for the study|8
275163|NCT01066104|908856|P2|Overall Study|Protocol Violation|0
275164|NCT01066104|908857|P1|Overall Study|Protocol Violation|1
275165|NCT01066104|908856|P2|Overall Study|Adverse Event|1
275166|NCT01066104|908857|P1|Overall Study|Adverse Event|1
275167|NCT01066039|908865|P1|Overall Study|Drug/Dose Adjustment Required|1
275168|NCT01066039|908865|P1|Overall Study|Failure to Control Blood Pressure|1
275169|NCT01066039|908865|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
275170|NCT01066039|908865|P1|Overall Study|Additional Antihypertensive Required|4
275171|NCT01066039|908865|P1|Overall Study|Dropout due to Insulin Administration|1
275172|NCT01066039|908865|P1|Overall Study|Investigator’s Request|1
275173|NCT01066039|908865|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
275174|NCT01066039|908865|P1|Overall Study|Protocol Violation|2
275175|NCT01066039|908865|P1|Overall Study|Withdrawal by Subject|17
275176|NCT01066039|908865|P1|Overall Study|Adverse Event|6
275177|NCT01066000|908878|P1|Overall Study|Adverse Event|1
275178|NCT01066000|908878|P1|Overall Study|Withdrawal by Subject|1
275179|NCT01066000|908878|P1|Overall Study|Death|3
275180|NCT01066000|908878|P1|Overall Study|Protocol Violation|4
275181|NCT01065844|908889|P1|Overall Study|Adverse Event|5
275182|NCT01065779|908893|P1|Overall Study|Inclusion Criteria Violation|7
275183|NCT01065779|908893|P1|Overall Study|Failed to Follow-up|10
275184|NCT01065779|908893|P1|Overall Study|Not Administered With Study Drug|17
275185|NCT01065779|908893|P1|Overall Study|Non-enrollment Period Administration|10
275186|NCT01065779|908893|P1|Overall Study|Investigation Before Contract Date|37
275187|NCT01065779|908893|P1|Overall Study|Duplicate Investigation|1
275188|NCT01065766|908904|P1|Overall Study|Violated dosage/administration|25
275189|NCT01065766|908904|P1|Overall Study|Contraindication to administration|6
275190|NCT01065766|908904|P1|Overall Study|Assessed before the contracted date|1
275191|NCT01065597|908923|P1|Overall Study|Adverse Event|1
275192|NCT01065454|908948|P4|Follow up|study ongoing|41
275193|NCT01065454|908949|P3|Follow up|study ongoing|15
275194|NCT01065454|908950|P2|Follow up|study ongoing|22
275195|NCT01065454|908951|P1|Follow up|study ongoing|37
275196|NCT01065454|908948|P4|Follow up|Withdrawal by Subject|0
275197|NCT01065454|908949|P3|Follow up|Withdrawal by Subject|1
275198|NCT01065454|908950|P2|Follow up|Withdrawal by Subject|1
275199|NCT01065454|908951|P1|Follow up|Withdrawal by Subject|1
275200|NCT01065454|908948|P4|Follow up|Progressive disease|1
275201|NCT01065454|908949|P3|Follow up|Progressive disease|0
275202|NCT01065454|908950|P2|Follow up|Progressive disease|0
275203|NCT01065454|908951|P1|Follow up|Progressive disease|0
275204|NCT01065454|908948|P4|Follow up|Lost to Follow-up|1
275205|NCT01065454|908949|P3|Follow up|Lost to Follow-up|0
275206|NCT01065454|908950|P2|Follow up|Lost to Follow-up|0
275207|NCT01065454|908951|P1|Follow up|Lost to Follow-up|0
275208|NCT01065454|908948|P4|Follow up|Death|0
275209|NCT01065454|908949|P3|Follow up|Death|1
275210|NCT01065454|908950|P2|Follow up|Death|1
275211|NCT01065454|908951|P1|Follow up|Death|0
275212|NCT01065454|908948|P4|Follow up|Adverse Event|1
275213|NCT01065454|908949|P3|Follow up|Adverse Event|0
275214|NCT01065454|908950|P2|Follow up|Adverse Event|0
275215|NCT01065454|908951|P1|Follow up|Adverse Event|1
275216|NCT01065454|908948|P4|Treatment|Withdrawal by Subject|3
275217|NCT01065454|908949|P3|Treatment|Withdrawal by Subject|2
275218|NCT01065454|908950|P2|Treatment|Withdrawal by Subject|1
275219|NCT01065454|908951|P1|Treatment|Withdrawal by Subject|3
275220|NCT01065454|908948|P4|Treatment|Protocol Violation|0
275221|NCT01065454|908949|P3|Treatment|Protocol Violation|1
275222|NCT01065454|908950|P2|Treatment|Protocol Violation|0
275223|NCT01065454|908951|P1|Treatment|Protocol Violation|1
275224|NCT01065454|908948|P4|Treatment|Protocol Decision|2
275225|NCT01065454|908949|P3|Treatment|Protocol Decision|3
275226|NCT01065454|908950|P2|Treatment|Protocol Decision|0
275227|NCT01065454|908951|P1|Treatment|Protocol Decision|0
275228|NCT01065454|908948|P4|Treatment|Non-compliance|1
275229|NCT01065454|908949|P3|Treatment|Non-compliance|0
275230|NCT01065454|908950|P2|Treatment|Non-compliance|0
275231|NCT01065454|908951|P1|Treatment|Non-compliance|1
275232|NCT01065454|908948|P4|Treatment|Death|0
275233|NCT01065454|908949|P3|Treatment|Death|0
275234|NCT01065454|908950|P2|Treatment|Death|0
275235|NCT01065454|908951|P1|Treatment|Death|1
275236|NCT01065454|908948|P4|Treatment|Adverse Event|6
275237|NCT01065454|908949|P3|Treatment|Adverse Event|3
275238|NCT01065454|908950|P2|Treatment|Adverse Event|4
275239|NCT01065454|908951|P1|Treatment|Adverse Event|7
275240|NCT01065350|909074|P2|Overall Study|Received incorrect drug allocation|1
275241|NCT01065350|909075|P1|Overall Study|Received incorrect drug allocation|0
275242|NCT01064947|909136|P1|Overall Study|negative culture|41
275243|NCT01064856|909177|P4|Open-label (OL) Period|Not specified|7
275244|NCT01064856|909178|P3|Open-label (OL) Period|Not specified|7
275245|NCT01064856|909179|P2|Open-label (OL) Period|Not specified|0
275246|NCT01064856|909180|P1|Open-label (OL) Period|Not specified|0
275247|NCT01064856|909177|P4|Open-label (OL) Period|Lost to Follow-up|1
275248|NCT01064856|909178|P3|Open-label (OL) Period|Lost to Follow-up|2
275249|NCT01064856|909179|P2|Open-label (OL) Period|Lost to Follow-up|0
275250|NCT01064856|909180|P1|Open-label (OL) Period|Lost to Follow-up|0
275251|NCT01064856|909177|P4|Open-label (OL) Period|Consent withdrawn by participant|6
275252|NCT01064856|909178|P3|Open-label (OL) Period|Consent withdrawn by participant|5
275253|NCT01064856|909179|P2|Open-label (OL) Period|Consent withdrawn by participant|0
275254|NCT01064856|909180|P1|Open-label (OL) Period|Consent withdrawn by participant|0
275255|NCT01064856|909177|P4|Open-label (OL) Period|Adverse Event|6
275256|NCT01064856|909178|P3|Open-label (OL) Period|Adverse Event|12
275257|NCT01064856|909179|P2|Open-label (OL) Period|Adverse Event|0
275258|NCT01064856|909180|P1|Open-label (OL) Period|Adverse Event|0
275259|NCT01064856|909177|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
275260|NCT01064856|909178|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
275261|NCT01064856|909179|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
275262|NCT01064856|909180|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
275263|NCT01064856|909177|P4|Double-blind (DB) Period|Adverse Event|0
275264|NCT01064856|909178|P3|Double-blind (DB) Period|Adverse Event|0
275265|NCT01064856|909179|P2|Double-blind (DB) Period|Adverse Event|0
275266|NCT01064856|909180|P1|Double-blind (DB) Period|Adverse Event|1
275267|NCT01064817|909224|P2|Study Completion|Withdrawal by Subject|0
275268|NCT01064817|909225|P1|Study Completion|Withdrawal by Subject|1
275269|NCT01064817|909224|P2|Study Completion|Physician Decision|0
275270|NCT01064817|909225|P1|Study Completion|Physician Decision|1
275271|NCT01064739|909237|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
275272|NCT01064687|909297|P4|Overall Study|Treatment Noncompliance|0
275273|NCT01064687|909298|P3|Overall Study|Treatment Noncompliance|1
275274|NCT01064687|909299|P2|Overall Study|Treatment Noncompliance|1
275275|NCT01064687|909300|P1|Overall Study|Treatment Noncompliance|1
275276|NCT01064687|909297|P4|Overall Study|Withdrawal by Subject|5
275277|NCT01064687|909298|P3|Overall Study|Withdrawal by Subject|12
275278|NCT01064687|909299|P2|Overall Study|Withdrawal by Subject|7
275279|NCT01064687|909300|P1|Overall Study|Withdrawal by Subject|9
275280|NCT01064687|909297|P4|Overall Study|Sponsor Decision|0
275281|NCT01064687|909298|P3|Overall Study|Sponsor Decision|3
275282|NCT01064687|909299|P2|Overall Study|Sponsor Decision|0
275283|NCT01064687|909300|P1|Overall Study|Sponsor Decision|0
275284|NCT01064687|909297|P4|Overall Study|Protocol Violation|1
275285|NCT01064687|909298|P3|Overall Study|Protocol Violation|0
275286|NCT01064687|909299|P2|Overall Study|Protocol Violation|1
275287|NCT01064687|909300|P1|Overall Study|Protocol Violation|1
275288|NCT01064687|909297|P4|Overall Study|Physician Decision|0
275289|NCT01064687|909298|P3|Overall Study|Physician Decision|0
275290|NCT01064687|909299|P2|Overall Study|Physician Decision|2
275291|NCT01064687|909300|P1|Overall Study|Physician Decision|2
275292|NCT01064687|909297|P4|Overall Study|Lost to Follow-up|5
275293|NCT01064687|909298|P3|Overall Study|Lost to Follow-up|13
275294|NCT01064687|909299|P2|Overall Study|Lost to Follow-up|10
275295|NCT01064687|909300|P1|Overall Study|Lost to Follow-up|7
275296|NCT01064687|909297|P4|Overall Study|Lack of Efficacy|3
275297|NCT01064687|909298|P3|Overall Study|Lack of Efficacy|2
275298|NCT01064687|909299|P2|Overall Study|Lack of Efficacy|0
275299|NCT01064687|909300|P1|Overall Study|Lack of Efficacy|1
275300|NCT01064687|909297|P4|Overall Study|Entry Criteria Not Met|0
275301|NCT01064687|909298|P3|Overall Study|Entry Criteria Not Met|0
275302|NCT01064687|909299|P2|Overall Study|Entry Criteria Not Met|0
275303|NCT01064687|909300|P1|Overall Study|Entry Criteria Not Met|3
275304|NCT01064687|909297|P4|Overall Study|Death|0
275305|NCT01064687|909298|P3|Overall Study|Death|0
275306|NCT01064687|909299|P2|Overall Study|Death|1
275307|NCT01064687|909300|P1|Overall Study|Death|1
275308|NCT01064687|909297|P4|Overall Study|Adverse Event|3
275309|NCT01064687|909298|P3|Overall Study|Adverse Event|10
275310|NCT01064687|909299|P2|Overall Study|Adverse Event|4
275311|NCT01064687|909300|P1|Overall Study|Adverse Event|9
275312|NCT01064622|909480|P2|Randomized Phase II|Protocol Violation|1
275313|NCT01064622|909481|P1|Randomized Phase II|Protocol Violation|0
275314|NCT01064622|909480|P2|Randomized Phase II|Withdrawal by Subject|2
275315|NCT01064622|909481|P1|Randomized Phase II|Withdrawal by Subject|2
275316|NCT01064414|909505|P3|Extension Period: Week 26 to Week 52|Not specified|1
275317|NCT01064414|909506|P2|Extension Period: Week 26 to Week 52|Not specified|2
275318|NCT01064414|909507|P1|Extension Period: Week 26 to Week 52|Not specified|5
275319|NCT01064414|909505|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
275320|NCT01064414|909506|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
275321|NCT01064414|909507|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
275322|NCT01064414|909505|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
275323|NCT01064414|909506|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
275324|NCT01064414|909507|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
275325|NCT01064414|909505|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
275326|NCT01064414|909506|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
275327|NCT01064414|909507|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
275328|NCT01064414|909505|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
275329|NCT01064414|909506|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
275330|NCT01064414|909507|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
275331|NCT01064414|909505|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
275332|NCT01064414|909506|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
275333|NCT01064414|909507|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
275334|NCT01064414|909505|P3|Extension Period: Week 26 to Week 52|Death|0
275335|NCT01064414|909506|P2|Extension Period: Week 26 to Week 52|Death|1
275336|NCT01064414|909507|P1|Extension Period: Week 26 to Week 52|Death|0
275337|NCT01064414|909505|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
275338|NCT01064414|909506|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
275339|NCT01064414|909507|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
275340|NCT01064414|909505|P3|Core Period: Baseline to Week 26|Not specified|2
275341|NCT01064414|909506|P2|Core Period: Baseline to Week 26|Not specified|7
275342|NCT01064414|909507|P1|Core Period: Baseline to Week 26|Not specified|4
275343|NCT01064414|909505|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
275344|NCT01064414|909506|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
275345|NCT01064414|909507|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
275346|NCT01064414|909505|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
275347|NCT01064414|909506|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
275348|NCT01064414|909507|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
275349|NCT01064414|909505|P3|Core Period: Baseline to Week 26|Protocol Violation|1
275350|NCT01064414|909506|P2|Core Period: Baseline to Week 26|Protocol Violation|0
275351|NCT01064414|909507|P1|Core Period: Baseline to Week 26|Protocol Violation|1
275352|NCT01064414|909505|P3|Core Period: Baseline to Week 26|Death|0
275353|NCT01064414|909506|P2|Core Period: Baseline to Week 26|Death|1
275354|NCT01064414|909507|P1|Core Period: Baseline to Week 26|Death|0
275355|NCT01064414|909505|P3|Core Period: Baseline to Week 26|Adverse Event|2
275356|NCT01064414|909506|P2|Core Period: Baseline to Week 26|Adverse Event|4
275357|NCT01064414|909507|P1|Core Period: Baseline to Week 26|Adverse Event|4
275358|NCT01064401|909526|P2|Overall Study|Not Specified|1
275359|NCT01064401|909527|P1|Overall Study|Not Specified|2
275360|NCT01064401|909526|P2|Overall Study|Site Closure|5
275361|NCT01064401|909527|P1|Overall Study|Site Closure|4
275362|NCT01064401|909526|P2|Overall Study|Noncompliance|8
275363|NCT01064401|909527|P1|Overall Study|Noncompliance|7
275364|NCT01064401|909526|P2|Overall Study|Pregnancy|7
275365|NCT01064401|909527|P1|Overall Study|Pregnancy|4
275366|NCT01064401|909526|P2|Overall Study|Death|0
275367|NCT01064401|909527|P1|Overall Study|Death|4
275368|NCT01064401|909526|P2|Overall Study|Investigator Decision|6
275369|NCT01064401|909527|P1|Overall Study|Investigator Decision|4
275370|NCT01064401|909526|P2|Overall Study|Consent Withdrawn|80
275371|NCT01064401|909527|P1|Overall Study|Consent Withdrawn|98
275372|NCT01064401|909526|P2|Overall Study|Lost to Follow-up|9
275373|NCT01064401|909527|P1|Overall Study|Lost to Follow-up|12
275374|NCT01064401|909526|P2|Overall Study|Lack of Efficacy|23
275375|NCT01064401|909527|P1|Overall Study|Lack of Efficacy|46
275376|NCT01064401|909526|P2|Overall Study|Adverse Event|56
275377|NCT01064401|909527|P1|Overall Study|Adverse Event|47
275378|NCT01064310|909554|P3|Open Label Pazopinib|Physician Decision|20
275379|NCT01064310|909555|P2|Open Label Pazopinib|Physician Decision|0
275380|NCT01064310|909556|P1|Open Label Pazopinib|Physician Decision|0
275381|NCT01064310|909554|P3|Open Label Pazopinib|Lack of Efficacy|51
275382|NCT01064310|909555|P2|Open Label Pazopinib|Lack of Efficacy|0
275383|NCT01064310|909556|P1|Open Label Pazopinib|Lack of Efficacy|0
275384|NCT01064310|909554|P3|Open Label Pazopinib|Adverse Event|12
275385|NCT01064310|909555|P2|Open Label Pazopinib|Adverse Event|0
275386|NCT01064310|909556|P1|Open Label Pazopinib|Adverse Event|0
275387|NCT01064310|909554|P3|Open Label Pazopinib|Withdrawal by Subject|1
275388|NCT01064310|909555|P2|Open Label Pazopinib|Withdrawal by Subject|0
275389|NCT01064310|909556|P1|Open Label Pazopinib|Withdrawal by Subject|0
275390|NCT01064310|909554|P3|Period 2|Lack of Efficacy|0
275391|NCT01064310|909555|P2|Period 2|Lack of Efficacy|4
275392|NCT01064310|909556|P1|Period 2|Lack of Efficacy|1
275393|NCT01064310|909554|P3|Period 2|Entered Open-label Period|0
275394|NCT01064310|909555|P2|Period 2|Entered Open-label Period|0
275395|NCT01064310|909556|P1|Period 2|Entered Open-label Period|1
275396|NCT01064310|909554|P3|Period 2|Physician Decision|0
275397|NCT01064310|909555|P2|Period 2|Physician Decision|1
275398|NCT01064310|909556|P1|Period 2|Physician Decision|0
275399|NCT01064310|909554|P3|Period 2|Adverse Event|0
275400|NCT01064310|909555|P2|Period 2|Adverse Event|1
275401|NCT01064310|909556|P1|Period 2|Adverse Event|2
275402|NCT01064310|909554|P3|Period 1|Entered Open-label Period|0
275403|NCT01064310|909555|P2|Period 1|Entered Open-label Period|1
275404|NCT01064310|909556|P1|Period 1|Entered Open-label Period|1
275405|NCT01064310|909554|P3|Period 1|Lack of Efficacy|0
275406|NCT01064310|909555|P2|Period 1|Lack of Efficacy|5
275407|NCT01064310|909556|P1|Period 1|Lack of Efficacy|3
275408|NCT01064310|909554|P3|Period 1|Withdrawal by Subject|0
275409|NCT01064310|909555|P2|Period 1|Withdrawal by Subject|2
275410|NCT01064310|909556|P1|Period 1|Withdrawal by Subject|2
275411|NCT01064310|909554|P3|Period 1|Physician Decision|0
275412|NCT01064310|909555|P2|Period 1|Physician Decision|0
275413|NCT01064310|909556|P1|Period 1|Physician Decision|1
275414|NCT01064310|909554|P3|Period 1|Adverse Event|0
275415|NCT01064310|909555|P2|Period 1|Adverse Event|10
275416|NCT01064310|909556|P1|Period 1|Adverse Event|7
275417|NCT01064297|909586|P3|Overall Study|Lost to Follow-up|133
275418|NCT01064297|909587|P2|Overall Study|Lost to Follow-up|48
275419|NCT01064297|909588|P1|Overall Study|Lost to Follow-up|791
275420|NCT01064167|909657|P2|Overall Study|Protocol Violation|15
275421|NCT01064167|909658|P1|Overall Study|Protocol Violation|14
275422|NCT01063881|909705|P3|Overall Study|Reason for not completed not specified|0
275423|NCT01063881|909706|P2|Overall Study|Reason for not completed not specified|1
275424|NCT01063881|909707|P1|Overall Study|Reason for not completed not specified|5
275425|NCT01063881|909705|P3|Overall Study|Withdrawal by Subject|0
275426|NCT01063881|909706|P2|Overall Study|Withdrawal by Subject|1
275427|NCT01063881|909707|P1|Overall Study|Withdrawal by Subject|25
275428|NCT01063881|909705|P3|Overall Study|Lost to Follow-up|1
275429|NCT01063881|909706|P2|Overall Study|Lost to Follow-up|7
275430|NCT01063881|909707|P1|Overall Study|Lost to Follow-up|13
275431|NCT01063881|909705|P3|Overall Study|Adverse Event|0
275432|NCT01063881|909706|P2|Overall Study|Adverse Event|2
275433|NCT01063881|909707|P1|Overall Study|Adverse Event|12
275434|NCT01063868|909731|P2|Overall Study|Study Terminated By Sponsor|4
275435|NCT01063868|909732|P1|Overall Study|Study Terminated By Sponsor|23
275436|NCT01063868|909731|P2|Overall Study|Withdrawal by Subject|1
275437|NCT01063868|909732|P1|Overall Study|Withdrawal by Subject|3
275438|NCT01063868|909731|P2|Overall Study|Adverse Event|7
275439|NCT01063868|909732|P1|Overall Study|Adverse Event|9
275440|NCT01063855|909740|P2|Overall Study|Reason not specified|11
275441|NCT01063855|909741|P1|Overall Study|Reason not specified|13
275442|NCT01063855|909740|P2|Overall Study|Withdrawal by Subject|8
275443|NCT01063855|909741|P1|Overall Study|Withdrawal by Subject|11
275444|NCT01063855|909740|P2|Overall Study|Lack of Efficacy|1
275445|NCT01063855|909741|P1|Overall Study|Lack of Efficacy|0
275446|NCT01063855|909740|P2|Overall Study|Pregnancy|0
275447|NCT01063855|909741|P1|Overall Study|Pregnancy|1
275448|NCT01063855|909740|P2|Overall Study|Lost to Follow-up|4
275449|NCT01063855|909741|P1|Overall Study|Lost to Follow-up|8
275450|NCT01063855|909740|P2|Overall Study|Death|1
275451|NCT01063855|909741|P1|Overall Study|Death|0
275452|NCT01063855|909740|P2|Overall Study|Adverse Event|4
275453|NCT01063855|909741|P1|Overall Study|Adverse Event|4
275454|NCT01063764|909763|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
275455|NCT01063764|909763|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
275456|NCT01063764|909763|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
275457|NCT01063764|909763|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
275458|NCT01063764|909763|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
275459|NCT01063764|909763|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
275460|NCT01063764|909763|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
275461|NCT01063595|909782|P2|First Intervention|Reason not Specified|1
275462|NCT01063595|909783|P1|First Intervention|Reason not Specified|0
275463|NCT01063595|909782|P2|First Intervention|Withdrawal by Subject|0
275464|NCT01063595|909783|P1|First Intervention|Withdrawal by Subject|1
275465|NCT01063595|909782|P2|First Intervention|Adverse Event|4
275466|NCT01063595|909783|P1|First Intervention|Adverse Event|1
275467|NCT01063595|909782|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
275468|NCT01063595|909783|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
275469|NCT01063595|909782|P2|Enrolled in Study and Randomized|Adverse Event|1
275470|NCT01063595|909783|P1|Enrolled in Study and Randomized|Adverse Event|0
275471|NCT01063595|909782|P2|Enrolled in Study and Randomized|Reason not Specified|0
275472|NCT01063595|909783|P1|Enrolled in Study and Randomized|Reason not Specified|1
275473|NCT01063517|909795|P2|Overall Study|Death|48
275474|NCT01063517|909796|P1|Overall Study|Death|33
275475|NCT01063517|909795|P2|Overall Study|Withdrawal by Subject|2
275476|NCT01063517|909796|P1|Overall Study|Withdrawal by Subject|1
275477|NCT01063517|909795|P2|Overall Study|Lost to Follow-up|3
275478|NCT01063517|909796|P1|Overall Study|Lost to Follow-up|4
275479|NCT01063517|909795|P2|Overall Study|Study reached data cut-off|7
275480|NCT01063517|909796|P1|Overall Study|Study reached data cut-off|19
275481|NCT01063517|909795|P2|Overall Study|Consent withdrawal|0
275482|NCT01063517|909796|P1|Overall Study|Consent withdrawal|1
275483|NCT01063348|909836|P2|Overall Study|Lost to Follow-up|10
275484|NCT01063348|909837|P1|Overall Study|Lost to Follow-up|3
275485|NCT01063153|909847|P2|Overall Study|Physician Decision|4
275486|NCT01063153|909848|P1|Overall Study|Physician Decision|0
275487|NCT01063153|909847|P2|Overall Study|Withdrawal by Subject|1
275488|NCT01063153|909848|P1|Overall Study|Withdrawal by Subject|0
275489|NCT01063153|909847|P2|Overall Study|Lost to Follow-up|7
275490|NCT01063153|909848|P1|Overall Study|Lost to Follow-up|0
275491|NCT01063153|909847|P2|Overall Study|Found Ineligible During Screening|0
275492|NCT01063153|909848|P1|Overall Study|Found Ineligible During Screening|2
275493|NCT01063062|909879|P2|Overall Study|Miscellaneous reason|1
275494|NCT01063062|909880|P1|Overall Study|Miscellaneous reason|0
275495|NCT01063062|909879|P2|Overall Study|Lost to Follow-up|2
275496|NCT01063062|909880|P1|Overall Study|Lost to Follow-up|0
275497|NCT01063062|909879|P2|Overall Study|Investigator's request|0
275498|NCT01063062|909880|P1|Overall Study|Investigator's request|1
275499|NCT01063062|909879|P2|Overall Study|Protocol Violation|4
275500|NCT01063062|909880|P1|Overall Study|Protocol Violation|5
275501|NCT01063062|909879|P2|Overall Study|Adverse Event|4
275502|NCT01063062|909880|P1|Overall Study|Adverse Event|2
275503|NCT01063062|909879|P2|Overall Study|Patient withdrew consent|1
275504|NCT01063062|909880|P1|Overall Study|Patient withdrew consent|0
275505|NCT01063036|909934|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
275506|NCT01063036|909934|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
275507|NCT01063036|909934|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
275508|NCT01063036|909934|P1|Participants Treated With Study Drug|Pregnancy|1
275509|NCT01063036|909934|P1|Participants Treated With Study Drug|Lost to Follow-up|1
275510|NCT01063036|909934|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
275511|NCT01063036|909934|P1|Participants Treated With Study Drug|Protocol Violation|1
275512|NCT01063036|909934|P1|Participants Treated With Study Drug|Adverse Event|1
275513|NCT01062841|909950|P2|Overall Study|Withdrawal by Study|0
275514|NCT01062841|909951|P1|Overall Study|Withdrawal by Study|3
275515|NCT01062841|909950|P2|Overall Study|Withdrawal by Subject|0
275516|NCT01062841|909951|P1|Overall Study|Withdrawal by Subject|2
275517|NCT01062841|909950|P2|Overall Study|Death|5
275518|NCT01062841|909951|P1|Overall Study|Death|3
275519|NCT01062841|909950|P2|Overall Study|Indwelling Device Removed|48
275520|NCT01062841|909951|P1|Overall Study|Indwelling Device Removed|41
275521|NCT01062763|909981|P2|Overall Study|Adverse Event|4
275522|NCT01062763|909982|P1|Overall Study|Adverse Event|3
275523|NCT01062425|909994|P2|Overall Study|Protocol Violation|6
275524|NCT01062425|909995|P1|Overall Study|Protocol Violation|3
275525|NCT01062256|910032|P3|Overall Study|Administrative|0
275526|NCT01062256|910033|P2|Overall Study|Administrative|2
275527|NCT01062256|910034|P1|Overall Study|Administrative|0
275528|NCT01062256|910032|P3|Overall Study|Ineligible|3
275529|NCT01062256|910033|P2|Overall Study|Ineligible|4
275530|NCT01062256|910034|P1|Overall Study|Ineligible|1
275531|NCT01062256|910032|P3|Overall Study|Withdrawal by Subject|1
275532|NCT01062256|910033|P2|Overall Study|Withdrawal by Subject|1
275533|NCT01062256|910034|P1|Overall Study|Withdrawal by Subject|1
275534|NCT01062256|910032|P3|Overall Study|Adverse Event|0
275535|NCT01062256|910033|P2|Overall Study|Adverse Event|0
275536|NCT01062256|910034|P1|Overall Study|Adverse Event|1
275537|NCT01062113|910068|P3|Overall Study|Withdrawal by Subject|0
275538|NCT01062113|910069|P2|Overall Study|Withdrawal by Subject|0
275539|NCT01062113|910070|P1|Overall Study|Withdrawal by Subject|1
275540|NCT01062113|910068|P3|Overall Study|Lack of Efficacy|31
275541|NCT01062113|910069|P2|Overall Study|Lack of Efficacy|22
275542|NCT01062113|910070|P1|Overall Study|Lack of Efficacy|38
275543|NCT01062113|910068|P3|Overall Study|Adverse Event|0
275544|NCT01062113|910069|P2|Overall Study|Adverse Event|0
275545|NCT01062113|910070|P1|Overall Study|Adverse Event|1
275546|NCT01062061|910088|P1|Overall Study|Failed to meet inclusion criteria|2
275547|NCT01062061|910088|P1|Overall Study|Outside chief indications|10
275548|NCT01062061|910088|P1|Overall Study|Investigated before study start|13
275549|NCT01062061|910088|P1|Overall Study|Enrolled more than once|2
275550|NCT01061866|910102|P1|Overall Study|Adverse Event|2
275551|NCT01061775|910106|P1|Overall Study|Lost to Follow-up|1
275552|NCT01061775|910106|P1|Overall Study|Physician Decision|2
275553|NCT01061710|910113|P1|Overall Study|Protocol Violation|14
275554|NCT01061671|910123|P2|Overall Study|Death|30
275555|NCT01061671|910124|P1|Overall Study|Death|28
275556|NCT01061671|910123|P2|Overall Study|Lost to Follow-up|5
275557|NCT01061671|910124|P1|Overall Study|Lost to Follow-up|3
275558|NCT01061671|910123|P2|Overall Study|Withdrawal by Subject|20
275559|NCT01061671|910124|P1|Overall Study|Withdrawal by Subject|16
275560|NCT01061606|910136|P1|Overall Study|alternative therapy|2
275561|NCT01061606|910136|P1|Overall Study|Disease Progression|4
275562|NCT01061606|910136|P1|Overall Study|Death|1
275563|NCT01061606|910136|P1|Overall Study|Adverse Event|1
275564|NCT01061567|910145|P1|Overall Study|Other reason than stated above|3
275565|NCT01061567|910145|P1|Overall Study|Withdrawal by Subject|11
275566|NCT01061567|910145|P1|Overall Study|Protocol Violation|1
275567|NCT01061567|910145|P1|Overall Study|Lost to Follow-up|24
275568|NCT01061567|910145|P1|Overall Study|Lack of Efficacy|3
275569|NCT01061567|910145|P1|Overall Study|Death|2
275570|NCT01061567|910145|P1|Overall Study|Adverse Event|32
275571|NCT01061385|910160|P2|Overall Study|subject decision not related to AE|1
275572|NCT01061385|910161|P1|Overall Study|subject decision not related to AE|0
275573|NCT01061385|910160|P2|Overall Study|Lost to Follow-up|0
275574|NCT01061385|910161|P1|Overall Study|Lost to Follow-up|1
275575|NCT01061359|910169|P1|Overall Study|Secondary neoplasm|11
275576|NCT01061359|910169|P1|Overall Study|Relapse|187
275577|NCT01061359|910169|P1|Overall Study|Lost to Follow-up|1072
275578|NCT01061359|910169|P1|Overall Study|Death|32
275579|NCT01061333|910175|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
275580|NCT01061333|910176|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
275581|NCT01061177|910214|P1|Overall Study|Death|4
275582|NCT01061177|910214|P1|Overall Study|Administratie problems|4
275583|NCT01061177|910214|P1|Overall Study|Abnormal test procedure results|4
275584|NCT01061177|910214|P1|Overall Study|Abnormal laboratory values|6
275585|NCT01061177|910214|P1|Overall Study|New cancer therapy|9
275586|NCT01061177|910214|P1|Overall Study|Lost to Follow-up|9
275587|NCT01061177|910214|P1|Overall Study|Protocol Violation|11
275588|NCT01061177|910214|P1|Overall Study|Disease progression|17
275589|NCT01061177|910214|P1|Overall Study|Withdrawal by Subject|27
275590|NCT01061177|910214|P1|Overall Study|Adverse Event|117
275591|NCT01061008|910240|P2|Overall Study|Adverse Event|1
275592|NCT01061008|910241|P1|Overall Study|Adverse Event|0
275593|NCT01061008|910240|P2|Overall Study|Unable to exercise following surgery|0
275594|NCT01061008|910241|P1|Overall Study|Unable to exercise following surgery|1
275595|NCT01061008|910240|P2|Overall Study|Withdrawal by Subject|3
275596|NCT01061008|910241|P1|Overall Study|Withdrawal by Subject|1
275597|NCT01061008|910240|P2|Overall Study|Death|0
275598|NCT01061008|910241|P1|Overall Study|Death|1
275599|NCT01061008|910240|P2|Overall Study|Badiocephalic fistula failed|2
275600|NCT01061008|910241|P1|Overall Study|Badiocephalic fistula failed|3
275601|NCT01060670|910249|P2|Run In|screen failure|238
275602|NCT01060670|910250|P1|Run In|screen failure|0
275603|NCT01060553|910285|P2|Overall Study|Lack of Efficacy|0
275604|NCT01060553|910286|P1|Overall Study|Lack of Efficacy|1
275605|NCT01060553|910285|P2|Overall Study|Withdrawal by Subject|5
275606|NCT01060553|910286|P1|Overall Study|Withdrawal by Subject|5
275607|NCT01060553|910285|P2|Overall Study|Lost to Follow-up|5
275608|NCT01060553|910286|P1|Overall Study|Lost to Follow-up|3
275609|NCT01060540|910293|P2|Overall Study|Physician Decision|1
275610|NCT01060540|910294|P1|Overall Study|Physician Decision|0
275611|NCT01060540|910293|P2|Overall Study|Death|1
275612|NCT01060540|910294|P1|Overall Study|Death|2
275613|NCT01060540|910293|P2|Overall Study|Lost to Follow-up|43
275614|NCT01060540|910294|P1|Overall Study|Lost to Follow-up|52
275615|NCT01060540|910293|P2|Overall Study|Withdrawal by Subject|20
275616|NCT01060540|910294|P1|Overall Study|Withdrawal by Subject|10
275617|NCT01060150|910308|P1|Overall Study|Enrolled, but not treated|2
275618|NCT01060150|910308|P1|Overall Study|Withdrawal by Subject|8
275619|NCT01060150|910308|P1|Overall Study|Protocol Violation|6
275620|NCT01060150|910308|P1|Overall Study|Lost to Follow-up|1
275621|NCT01060150|910308|P1|Overall Study|Adverse Event|6
275622|NCT01060124|910323|P1|Overall Study|Withdrawal by Subject|7
275623|NCT01060124|910323|P1|Overall Study|Adverse Event|14
275624|NCT01060124|910323|P1|Overall Study|Unspecified|16
275625|NCT01060111|910334|P3|Overall Study|Unspecified|4
275626|NCT01060111|910335|P2|Overall Study|Unspecified|3
275627|NCT01060111|910336|P1|Overall Study|Unspecified|2
275628|NCT01060111|910334|P3|Overall Study|Participants' non-cooperation|0
275629|NCT01060111|910335|P2|Overall Study|Participants' non-cooperation|0
275630|NCT01060111|910336|P1|Overall Study|Participants' non-cooperation|1
275631|NCT01060111|910334|P3|Overall Study|Adverse event and insufficient effect|0
275632|NCT01060111|910335|P2|Overall Study|Adverse event and insufficient effect|1
275633|NCT01060111|910336|P1|Overall Study|Adverse event and insufficient effect|0
275634|NCT01060111|910334|P3|Overall Study|Participants' non-cooperation|6
275635|NCT01060111|910335|P2|Overall Study|Participants' non-cooperation|6
275636|NCT01060111|910336|P1|Overall Study|Participants' non-cooperation|8
275637|NCT01060111|910334|P3|Overall Study|Participants' evasion for hospital visit|2
275638|NCT01060111|910335|P2|Overall Study|Participants' evasion for hospital visit|3
275639|NCT01060111|910336|P1|Overall Study|Participants' evasion for hospital visit|0
275640|NCT01060111|910334|P3|Overall Study|Inappropriate participant|5
275641|NCT01060111|910335|P2|Overall Study|Inappropriate participant|4
275642|NCT01060111|910336|P1|Overall Study|Inappropriate participant|5
275643|NCT01060111|910334|P3|Overall Study|Lack of Efficacy|0
275644|NCT01060111|910335|P2|Overall Study|Lack of Efficacy|1
275645|NCT01060111|910336|P1|Overall Study|Lack of Efficacy|2
275646|NCT01060111|910334|P3|Overall Study|Adverse Event|18
275647|NCT01060111|910335|P2|Overall Study|Adverse Event|5
275648|NCT01060111|910336|P1|Overall Study|Adverse Event|9
275649|NCT01060072|910355|P2|Overall Study|Excluded Medications|1
275650|NCT01060072|910356|P1|Overall Study|Excluded Medications|0
275651|NCT01060072|910355|P2|Overall Study|Acute cholecystitis|0
275652|NCT01060072|910356|P1|Overall Study|Acute cholecystitis|1
275653|NCT01060072|910355|P2|Overall Study|Protocol Violation|1
275654|NCT01060072|910356|P1|Overall Study|Protocol Violation|0
275655|NCT01060072|910355|P2|Overall Study|Physician Decision|2
275656|NCT01060072|910356|P1|Overall Study|Physician Decision|0
275657|NCT01060072|910355|P2|Overall Study|Adverse Event|1
275658|NCT01060072|910356|P1|Overall Study|Adverse Event|1
275659|NCT01060059|910372|P2|Overall Study|lack of compliance|2
275660|NCT01060059|910373|P1|Overall Study|lack of compliance|5
275661|NCT01060059|910372|P2|Overall Study|lack of glycemic control|1
275662|NCT01060059|910373|P1|Overall Study|lack of glycemic control|2
275663|NCT01060059|910372|P2|Overall Study|Withdrawal by Subject|23
275664|NCT01060059|910373|P1|Overall Study|Withdrawal by Subject|35
275665|NCT01060059|910372|P2|Overall Study|entry criteria not met|3
275666|NCT01060059|910373|P1|Overall Study|entry criteria not met|4
275667|NCT01060059|910372|P2|Overall Study|Lost to Follow-up|34
275668|NCT01060059|910373|P1|Overall Study|Lost to Follow-up|18
275669|NCT01060059|910372|P2|Overall Study|Death|3
275670|NCT01060059|910373|P1|Overall Study|Death|2
275671|NCT01060059|910372|P2|Overall Study|Adverse Event|1
275672|NCT01060059|910373|P1|Overall Study|Adverse Event|1
275673|NCT01060007|910423|P1|Overall Study|Inevaluable for response at surgery|3
275674|NCT01060007|910423|P1|Overall Study|Withdrawal by Subject|1
275675|NCT01059903|910460|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
275676|NCT01059903|910461|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
275677|NCT01059864|910495|P3|Double-Blind Treatment Phase|Adverse Event|3
275678|NCT01059864|910496|P2|Double-Blind Treatment Phase|Adverse Event|3
275679|NCT01059864|910497|P1|Double-Blind Treatment Phase|Adverse Event|0
275680|NCT01059864|910495|P3|Open-Label Run-In Phase|Protocol Violation|0
275681|NCT01059864|910496|P2|Open-Label Run-In Phase|Protocol Violation|0
275682|NCT01059864|910497|P1|Open-Label Run-In Phase|Protocol Violation|2
275683|NCT01059864|910495|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
275684|NCT01059864|910496|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
275685|NCT01059864|910497|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
275686|NCT01059864|910495|P3|Open-Label Run-In Phase|Lost to Follow-up|0
275687|NCT01059864|910496|P2|Open-Label Run-In Phase|Lost to Follow-up|0
275688|NCT01059864|910497|P1|Open-Label Run-In Phase|Lost to Follow-up|2
275689|NCT01059864|910495|P3|Open-Label Run-In Phase|Lack of Efficacy|0
275690|NCT01059864|910496|P2|Open-Label Run-In Phase|Lack of Efficacy|0
275691|NCT01059864|910497|P1|Open-Label Run-In Phase|Lack of Efficacy|1
275692|NCT01059864|910495|P3|Open-Label Run-In Phase|Adverse Event|0
275693|NCT01059864|910496|P2|Open-Label Run-In Phase|Adverse Event|0
275694|NCT01059864|910497|P1|Open-Label Run-In Phase|Adverse Event|7
275695|NCT01059812|910567|P2|Overall Study|Unclassified|4
275696|NCT01059812|910568|P1|Overall Study|Unclassified|14
275697|NCT01059812|910567|P2|Overall Study|Withdrawal Criteria|4
275698|NCT01059812|910568|P1|Overall Study|Withdrawal Criteria|9
275699|NCT01059812|910567|P2|Overall Study|Protocol Violation|1
275700|NCT01059812|910568|P1|Overall Study|Protocol Violation|3
275701|NCT01059812|910567|P2|Overall Study|Lack of Efficacy|2
275702|NCT01059812|910568|P1|Overall Study|Lack of Efficacy|2
275703|NCT01059812|910567|P2|Overall Study|Adverse Event|5
275704|NCT01059812|910568|P1|Overall Study|Adverse Event|9
275705|NCT01059799|910584|P2|Overall Study|Other|3
275706|NCT01059799|910585|P1|Overall Study|Other|12
275707|NCT01059799|910584|P2|Overall Study|Withdrawal criteria|2
275708|NCT01059799|910585|P1|Overall Study|Withdrawal criteria|13
275709|NCT01059799|910584|P2|Overall Study|Protocol Violation|2
275710|NCT01059799|910585|P1|Overall Study|Protocol Violation|3
275711|NCT01059799|910584|P2|Overall Study|Lack of Efficacy|0
275712|NCT01059799|910585|P1|Overall Study|Lack of Efficacy|1
275713|NCT01059799|910584|P2|Overall Study|Adverse Event|3
275714|NCT01059799|910585|P1|Overall Study|Adverse Event|2
275715|NCT01059773|910599|P2|Overall Study|Other|3
275716|NCT01059773|910600|P1|Overall Study|Other|1
275717|NCT01059773|910599|P2|Overall Study|Ineligible follow TB screening criteria|1
275718|NCT01059773|910600|P1|Overall Study|Ineligible follow TB screening criteria|0
275719|NCT01059773|910599|P2|Overall Study|Malignancy including squamous cell skin|1
275720|NCT01059773|910600|P1|Overall Study|Malignancy including squamous cell skin|0
275721|NCT01059773|910599|P2|Overall Study|Death|1
275722|NCT01059773|910600|P1|Overall Study|Death|0
275723|NCT01059773|910599|P2|Overall Study|Lack of Efficacy|3
275724|NCT01059773|910600|P1|Overall Study|Lack of Efficacy|3
275725|NCT01059773|910599|P2|Overall Study|Physician Decision|4
275726|NCT01059773|910600|P1|Overall Study|Physician Decision|5
275727|NCT01059773|910599|P2|Overall Study|Protocol Violation|2
275728|NCT01059773|910600|P1|Overall Study|Protocol Violation|6
275729|NCT01059773|910599|P2|Overall Study|Pregnancy|1
275730|NCT01059773|910600|P1|Overall Study|Pregnancy|1
275731|NCT01059773|910599|P2|Overall Study|Lost to Follow-up|1
275732|NCT01059773|910600|P1|Overall Study|Lost to Follow-up|1
275733|NCT01059773|910599|P2|Overall Study|Withdrawal by Subject|5
275734|NCT01059773|910600|P1|Overall Study|Withdrawal by Subject|1
275735|NCT01059773|910599|P2|Overall Study|Adverse Event|2
275736|NCT01059773|910600|P1|Overall Study|Adverse Event|2
275737|NCT01059630|910632|P2|Maintenance Period (up to 2 Years)|Unspecified|3
275738|NCT01059630|910633|P1|Maintenance Period (up to 2 Years)|Unspecified|0
275739|NCT01059630|910632|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
275740|NCT01059630|910633|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
275741|NCT01059630|910632|P2|Maintenance Period (up to 2 Years)|Death|2
275742|NCT01059630|910633|P1|Maintenance Period (up to 2 Years)|Death|0
275743|NCT01059630|910632|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
275744|NCT01059630|910633|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
275745|NCT01059630|910632|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
275746|NCT01059630|910633|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
275747|NCT01059630|910632|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
275748|NCT01059630|910633|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
275749|NCT01059630|910632|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
275750|NCT01059630|910633|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
275751|NCT01059630|910632|P2|Induction Period (6 Months)|Randomized but not Treated|0
275752|NCT01059630|910633|P1|Induction Period (6 Months)|Randomized but not Treated|4
275753|NCT01059630|910632|P2|Induction Period (6 Months)|Unspecified|0
275754|NCT01059630|910633|P1|Induction Period (6 Months)|Unspecified|1
275755|NCT01059630|910632|P2|Induction Period (6 Months)|Physician Decision|4
275756|NCT01059630|910633|P1|Induction Period (6 Months)|Physician Decision|2
275757|NCT01059630|910632|P2|Induction Period (6 Months)|Death|2
275758|NCT01059630|910633|P1|Induction Period (6 Months)|Death|2
275759|NCT01059630|910632|P2|Induction Period (6 Months)|Withdrawal by Subject|2
275760|NCT01059630|910633|P1|Induction Period (6 Months)|Withdrawal by Subject|7
275761|NCT01059630|910632|P2|Induction Period (6 Months)|Progressive Disease|9
275762|NCT01059630|910633|P1|Induction Period (6 Months)|Progressive Disease|14
275763|NCT01059630|910632|P2|Induction Period (6 Months)|Adverse Event|15
275764|NCT01059630|910633|P1|Induction Period (6 Months)|Adverse Event|30
275765|NCT01059630|910632|P2|Induction Period (6 Months)|Induction ongoing|6
275766|NCT01059630|910633|P1|Induction Period (6 Months)|Induction ongoing|13
275767|NCT01059617|910693|P4|Overall Study|Unspecified|6
275768|NCT01059617|910694|P3|Overall Study|Unspecified|8
275769|NCT01059617|910695|P2|Overall Study|Unspecified|1
275770|NCT01059617|910696|P1|Overall Study|Unspecified|7
275771|NCT01059565|910866|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
275772|NCT01059565|910867|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
275773|NCT01059565|910866|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
275774|NCT01059565|910867|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
275775|NCT01059565|910866|P2|24-Week Open-Label Phase|Subject noncompliance|0
275776|NCT01059565|910867|P1|24-Week Open-Label Phase|Subject noncompliance|1
275777|NCT01059565|910866|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
275778|NCT01059565|910867|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
275779|NCT01059565|910866|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
275780|NCT01059565|910867|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
275781|NCT01059565|910866|P2|24-Week Open-Label Phase|Adverse Event|0
275782|NCT01059565|910867|P1|24-Week Open-Label Phase|Adverse Event|2
275783|NCT01059565|910866|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
275784|NCT01059565|910867|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
275785|NCT01059565|910866|P2|24-Week Randomized Phase|Lost to Follow-up|1
275786|NCT01059565|910867|P1|24-Week Randomized Phase|Lost to Follow-up|0
275787|NCT01059565|910866|P2|24-Week Randomized Phase|Withdrawal by Subject|1
275788|NCT01059565|910867|P1|24-Week Randomized Phase|Withdrawal by Subject|3
275789|NCT01059565|910866|P2|24-Week Randomized Phase|Adverse Event|0
275790|NCT01059565|910867|P1|24-Week Randomized Phase|Adverse Event|5
275791|NCT01059565|910866|P2|24-Week Randomized Phase|Randomized but not treated|0
275792|NCT01059565|910867|P1|24-Week Randomized Phase|Randomized but not treated|1
275793|NCT01059526|910903|P2|Overall Study|Patient found to be dermatographic|0
275794|NCT01059526|910904|P1|Overall Study|Patient found to be dermatographic|1
275795|NCT01059526|910903|P2|Overall Study|Lost to Follow-up|1
275796|NCT01059526|910904|P1|Overall Study|Lost to Follow-up|4
275797|NCT01059526|910903|P2|Overall Study|Withdrawal by Subject|1
275798|NCT01059526|910904|P1|Overall Study|Withdrawal by Subject|3
275799|NCT01059526|910903|P2|Overall Study|Protocol Violation|1
275800|NCT01059526|910904|P1|Overall Study|Protocol Violation|0
275801|NCT01059526|910903|P2|Overall Study|Adverse Event|2
275802|NCT01059526|910904|P1|Overall Study|Adverse Event|2
275803|NCT01059526|910903|P2|Overall Study|Patient enrolled but not treated|17
275804|NCT01059526|910904|P1|Overall Study|Patient enrolled but not treated|20
275805|NCT01059344|910914|P2|Overall Study|Other|6
275806|NCT01059344|910915|P1|Overall Study|Other|3
275807|NCT01059344|910914|P2|Overall Study|Lost to Follow-up|1
275808|NCT01059344|910915|P1|Overall Study|Lost to Follow-up|1
275809|NCT01059344|910914|P2|Overall Study|Withdrawal by Subject|9
275810|NCT01059344|910915|P1|Overall Study|Withdrawal by Subject|6
275811|NCT01059344|910914|P2|Overall Study|Adverse Event|30
275812|NCT01059344|910915|P1|Overall Study|Adverse Event|12
275813|NCT01059175|910939|P2|Overall Study|Lost to Follow-up|1
275814|NCT01059175|910940|P1|Overall Study|Lost to Follow-up|0
275815|NCT01059175|910939|P2|Overall Study|Adverse Event|2
275816|NCT01059175|910940|P1|Overall Study|Adverse Event|4
275817|NCT01059175|910939|P2|Overall Study|Death|17
275818|NCT01059175|910940|P1|Overall Study|Death|17
275819|NCT01059071|910962|P4|Overall Study|Physician Decision|1
275820|NCT01059071|910963|P3|Overall Study|Physician Decision|0
275821|NCT01059071|910964|P2|Overall Study|Physician Decision|0
275822|NCT01059071|910965|P1|Overall Study|Physician Decision|0
275823|NCT01059071|910962|P4|Overall Study|Withdrawal by Subject|2
275824|NCT01059071|910963|P3|Overall Study|Withdrawal by Subject|0
275825|NCT01059071|910964|P2|Overall Study|Withdrawal by Subject|0
275826|NCT01059071|910965|P1|Overall Study|Withdrawal by Subject|1
275827|NCT01059071|910962|P4|Overall Study|Lack of Efficacy|3
275828|NCT01059071|910963|P3|Overall Study|Lack of Efficacy|2
275829|NCT01059071|910964|P2|Overall Study|Lack of Efficacy|4
275830|NCT01059071|910965|P1|Overall Study|Lack of Efficacy|1
275831|NCT01058863|910992|P1|Overall Study|Randomized in error|1
275832|NCT01058863|910992|P1|Overall Study|Sponsor requested withdrawal|1
275833|NCT01058863|910992|P1|Overall Study|Withdrawal by Subject|1
275834|NCT01058863|910992|P1|Overall Study|Lost to Follow-up|1
275835|NCT01058668|911013|P3|Double-blind Treatment Phase|Other Unspecified|0
275836|NCT01058668|911014|P2|Double-blind Treatment Phase|Other Unspecified|1
275837|NCT01058668|911015|P1|Double-blind Treatment Phase|Other Unspecified|1
275838|NCT01058668|911013|P3|Double-blind Treatment Phase|Lost to Follow-up|1
275839|NCT01058668|911014|P2|Double-blind Treatment Phase|Lost to Follow-up|1
275840|NCT01058668|911015|P1|Double-blind Treatment Phase|Lost to Follow-up|0
275841|NCT01058668|911013|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
275842|NCT01058668|911014|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
275843|NCT01058668|911015|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
275844|NCT01058668|911013|P3|Double-blind Treatment Phase|Protocol Violation|2
275845|NCT01058668|911014|P2|Double-blind Treatment Phase|Protocol Violation|1
275846|NCT01058668|911015|P1|Double-blind Treatment Phase|Protocol Violation|1
275847|NCT01058668|911013|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
275848|NCT01058668|911014|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
275849|NCT01058668|911015|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
275850|NCT01058668|911013|P3|Double-blind Treatment Phase|Adverse Event|25
275851|NCT01058668|911014|P2|Double-blind Treatment Phase|Adverse Event|15
275852|NCT01058668|911015|P1|Double-blind Treatment Phase|Adverse Event|8
275853|NCT01058655|911030|P4|Overall Study|Other|4
275854|NCT01058655|911031|P3|Overall Study|Other|0
275855|NCT01058655|911032|P2|Overall Study|Other|0
275856|NCT01058655|911033|P1|Overall Study|Other|0
275857|NCT01058655|911030|P4|Overall Study|Disease Progression|24
275858|NCT01058655|911031|P3|Overall Study|Disease Progression|4
275859|NCT01058655|911032|P2|Overall Study|Disease Progression|2
275860|NCT01058655|911033|P1|Overall Study|Disease Progression|1
275861|NCT01058655|911030|P4|Overall Study|Death|0
275862|NCT01058655|911031|P3|Overall Study|Death|1
275863|NCT01058655|911032|P2|Overall Study|Death|1
275864|NCT01058655|911033|P1|Overall Study|Death|0
275865|NCT01058655|911030|P4|Overall Study|Clinical Progression (non-RECIST)|7
275866|NCT01058655|911031|P3|Overall Study|Clinical Progression (non-RECIST)|0
275867|NCT01058655|911032|P2|Overall Study|Clinical Progression (non-RECIST)|0
275868|NCT01058655|911033|P1|Overall Study|Clinical Progression (non-RECIST)|1
275869|NCT01058655|911030|P4|Overall Study|Symptomatic Deterioration|1
275870|NCT01058655|911031|P3|Overall Study|Symptomatic Deterioration|0
275871|NCT01058655|911032|P2|Overall Study|Symptomatic Deterioration|0
275872|NCT01058655|911033|P1|Overall Study|Symptomatic Deterioration|0
275873|NCT01058655|911030|P4|Overall Study|Prolonged Treatment Delay|2
275874|NCT01058655|911031|P3|Overall Study|Prolonged Treatment Delay|0
275875|NCT01058655|911032|P2|Overall Study|Prolonged Treatment Delay|0
275876|NCT01058655|911033|P1|Overall Study|Prolonged Treatment Delay|0
275877|NCT01058655|911030|P4|Overall Study|Withdrawal by Subject|4
275878|NCT01058655|911031|P3|Overall Study|Withdrawal by Subject|3
275879|NCT01058655|911032|P2|Overall Study|Withdrawal by Subject|0
275880|NCT01058655|911033|P1|Overall Study|Withdrawal by Subject|1
275881|NCT01058642|911051|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
275882|NCT01058642|911052|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
275883|NCT01058642|911053|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
275884|NCT01058642|911054|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
275885|NCT01058642|911051|P4|Treatment Period 1|Protocol Violation|1
275886|NCT01058642|911052|P3|Treatment Period 1|Protocol Violation|0
275887|NCT01058642|911053|P2|Treatment Period 1|Protocol Violation|0
275888|NCT01058642|911054|P1|Treatment Period 1|Protocol Violation|0
275889|NCT01058642|911051|P4|Treatment Period 1|Lack of Efficacy|1
275890|NCT01058642|911052|P3|Treatment Period 1|Lack of Efficacy|0
275891|NCT01058642|911053|P2|Treatment Period 1|Lack of Efficacy|0
275892|NCT01058642|911054|P1|Treatment Period 1|Lack of Efficacy|0
275893|NCT01058642|911051|P4|Treatment Period 1|Withdrawal by Subject|0
275894|NCT01058642|911052|P3|Treatment Period 1|Withdrawal by Subject|0
275895|NCT01058642|911053|P2|Treatment Period 1|Withdrawal by Subject|0
275896|NCT01058642|911054|P1|Treatment Period 1|Withdrawal by Subject|1
275897|NCT01058642|911051|P4|Treatment Period 1|Physician Decision|0
275898|NCT01058642|911052|P3|Treatment Period 1|Physician Decision|1
275899|NCT01058642|911053|P2|Treatment Period 1|Physician Decision|0
275900|NCT01058642|911054|P1|Treatment Period 1|Physician Decision|0
275901|NCT01058642|911051|P4|Treatment Period 1|Adverse Event|0
275902|NCT01058642|911052|P3|Treatment Period 1|Adverse Event|1
275903|NCT01058642|911053|P2|Treatment Period 1|Adverse Event|1
275904|NCT01058642|911054|P1|Treatment Period 1|Adverse Event|0
275905|NCT01058421|911064|P2|6 Month Outcomes|Remained in Other Facility|3
275906|NCT01058421|911065|P1|6 Month Outcomes|Remained in Other Facility|1
275907|NCT01058421|911064|P2|6 Month Outcomes|Lost to Follow-up|21
275908|NCT01058421|911065|P1|6 Month Outcomes|Lost to Follow-up|16
275909|NCT01058421|911064|P2|6 Month Outcomes|Death|2
275910|NCT01058421|911065|P1|6 Month Outcomes|Death|2
275911|NCT01058421|911064|P2|3 Month Outcomes|Remained in Other Facility|8
275912|NCT01058421|911065|P1|3 Month Outcomes|Remained in Other Facility|5
275913|NCT01058421|911064|P2|3 Month Outcomes|Remained in Hospital|2
275914|NCT01058421|911065|P1|3 Month Outcomes|Remained in Hospital|0
275915|NCT01058421|911064|P2|3 Month Outcomes|Lost to Follow-up|11
275916|NCT01058421|911065|P1|3 Month Outcomes|Lost to Follow-up|12
275917|NCT01058421|911064|P2|3 Month Outcomes|Death|5
275918|NCT01058421|911065|P1|3 Month Outcomes|Death|3
275919|NCT01058421|911064|P2|1 Month Outcomes|Remained in Other Facility|17
275920|NCT01058421|911065|P1|1 Month Outcomes|Remained in Other Facility|16
275921|NCT01058421|911064|P2|1 Month Outcomes|Remained in Hospital|12
275922|NCT01058421|911065|P1|1 Month Outcomes|Remained in Hospital|5
275923|NCT01058421|911064|P2|1 Month Outcomes|Lost to Follow-up|7
275924|NCT01058421|911065|P1|1 Month Outcomes|Lost to Follow-up|8
275925|NCT01058421|911064|P2|1 Month Outcomes|Death|6
275926|NCT01058421|911065|P1|1 Month Outcomes|Death|10
275927|NCT01058356|911087|P1|Overall Study|Lost to Follow-up|4
275928|NCT01058356|911087|P1|Overall Study|Withdrawal by Subject|21
275929|NCT01058356|911087|P1|Overall Study|Administration of contraindicated drugs|12
275930|NCT01058356|911087|P1|Overall Study|Adverse Event|5
275931|NCT01058304|911094|P2|Overall Study|Developed exclusion criterion|12
275932|NCT01058304|911095|P1|Overall Study|Developed exclusion criterion|6
275933|NCT01058304|911094|P2|Overall Study|Lost to Follow-up|16
275934|NCT01058304|911095|P1|Overall Study|Lost to Follow-up|13
275935|NCT01058304|911094|P2|Overall Study|Withdrawal by Subject|5
275936|NCT01058304|911095|P1|Overall Study|Withdrawal by Subject|8
275937|NCT01058265|911105|P2|Overall Study|Lost to Follow-up|12
275938|NCT01058265|911106|P1|Overall Study|Lost to Follow-up|11
275939|NCT01058096|911116|P2|Double-blind Treatment Phase|Other Unspecified|0
275940|NCT01058096|911117|P1|Double-blind Treatment Phase|Other Unspecified|2
275941|NCT01058096|911116|P2|Double-blind Treatment Phase|Lost to Follow-up|1
275942|NCT01058096|911117|P1|Double-blind Treatment Phase|Lost to Follow-up|0
275943|NCT01058096|911116|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
275944|NCT01058096|911117|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
275945|NCT01058096|911116|P2|Double-blind Treatment Phase|Protocol Violation|1
275946|NCT01058096|911117|P1|Double-blind Treatment Phase|Protocol Violation|2
275947|NCT01058096|911116|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
275948|NCT01058096|911117|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
275949|NCT01058096|911116|P2|Double-blind Treatment Phase|Adverse Event|15
275950|NCT01058096|911117|P1|Double-blind Treatment Phase|Adverse Event|11
275951|NCT01058005|911133|P3|Overall Study|Reason Missing|1
275952|NCT01058005|911134|P2|Overall Study|Reason Missing|3
275953|NCT01058005|911135|P1|Overall Study|Reason Missing|5
275954|NCT01058005|911133|P3|Overall Study|Withdrawn Due to Study Termination|7
275955|NCT01058005|911134|P2|Overall Study|Withdrawn Due to Study Termination|13
275956|NCT01058005|911135|P1|Overall Study|Withdrawn Due to Study Termination|27
275957|NCT01058005|911133|P3|Overall Study|Withdrawal by Subject|11
275958|NCT01058005|911134|P2|Overall Study|Withdrawal by Subject|5
275959|NCT01058005|911135|P1|Overall Study|Withdrawal by Subject|4
275960|NCT01058005|911133|P3|Overall Study|Physician Decision|0
275961|NCT01058005|911134|P2|Overall Study|Physician Decision|2
275962|NCT01058005|911135|P1|Overall Study|Physician Decision|2
275963|NCT01058005|911133|P3|Overall Study|Adverse Event|1
275964|NCT01058005|911134|P2|Overall Study|Adverse Event|2
275965|NCT01058005|911135|P1|Overall Study|Adverse Event|0
275966|NCT01057810|911170|P2|Overall Study|Unspecified|14
275967|NCT01057810|911171|P1|Overall Study|Unspecified|7
275968|NCT01057810|911170|P2|Overall Study|No longer met study criteria|1
275969|NCT01057810|911171|P1|Overall Study|No longer met study criteria|0
275970|NCT01057810|911170|P2|Overall Study|Poor/non-compliance|1
275971|NCT01057810|911171|P1|Overall Study|Poor/non-compliance|0
275972|NCT01057810|911170|P2|Overall Study|Maximum clinical benefit|5
275973|NCT01057810|911171|P1|Overall Study|Maximum clinical benefit|5
275974|NCT01057810|911170|P2|Overall Study|Death|12
275975|NCT01057810|911171|P1|Overall Study|Death|2
275976|NCT01057810|911170|P2|Overall Study|Withdrawal by Subject|25
275977|NCT01057810|911171|P1|Overall Study|Withdrawal by Subject|10
275978|NCT01057810|911170|P2|Overall Study|Adverse event unrelated to study drug|29
275979|NCT01057810|911171|P1|Overall Study|Adverse event unrelated to study drug|13
275980|NCT01057810|911170|P2|Overall Study|Study drug toxicity|114
275981|NCT01057810|911171|P1|Overall Study|Study drug toxicity|5
275982|NCT01057810|911170|P2|Overall Study|Disease progression|197
275983|NCT01057810|911171|P1|Overall Study|Disease progression|156
275984|NCT01057693|911187|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
275985|NCT01057693|911188|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
275986|NCT01057693|911189|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
275987|NCT01057693|911187|P3|Double-Blind Phase (Week 7 to Week 19)|Unspecified|0
275988|NCT01057693|911188|P2|Double-Blind Phase (Week 7 to Week 19)|Unspecified|1
275989|NCT01057693|911189|P1|Double-Blind Phase (Week 7 to Week 19)|Unspecified|0
275990|NCT01057693|911187|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
275991|NCT01057693|911188|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
275992|NCT01057693|911189|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
275993|NCT01057693|911187|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
275994|NCT01057693|911188|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
275995|NCT01057693|911189|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
275996|NCT01057693|911187|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
275997|NCT01057693|911188|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
275998|NCT01057693|911189|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
275999|NCT01057693|911187|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
276000|NCT01057693|911188|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
276001|NCT01057693|911189|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
276002|NCT01057693|911187|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
276003|NCT01057693|911188|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
276086|NCT01056523|911456|P3|Overall Study|Death|2
276004|NCT01057693|911189|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
276005|NCT01057693|911187|P3|Between Single-Blind and Double-Blind|Unspecified|0
276006|NCT01057693|911188|P2|Between Single-Blind and Double-Blind|Unspecified|0
276007|NCT01057693|911189|P1|Between Single-Blind and Double-Blind|Unspecified|6
276008|NCT01057693|911187|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
276009|NCT01057693|911188|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
276010|NCT01057693|911189|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
276011|NCT01057693|911187|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
276012|NCT01057693|911188|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
276013|NCT01057693|911189|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
276014|NCT01057693|911187|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
276015|NCT01057693|911188|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
276016|NCT01057693|911189|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
276017|NCT01057693|911187|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
276018|NCT01057693|911188|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
276019|NCT01057693|911189|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
276020|NCT01057693|911187|P3|Between Single-Blind and Double-Blind|Adverse Event|0
276021|NCT01057693|911188|P2|Between Single-Blind and Double-Blind|Adverse Event|0
276022|NCT01057693|911189|P1|Between Single-Blind and Double-Blind|Adverse Event|5
276023|NCT01057693|911187|P3|Single-Blind Phase (Up to Week 6)|Unspecified|0
276024|NCT01057693|911188|P2|Single-Blind Phase (Up to Week 6)|Unspecified|0
276025|NCT01057693|911189|P1|Single-Blind Phase (Up to Week 6)|Unspecified|2
276026|NCT01057693|911187|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
276027|NCT01057693|911188|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
276028|NCT01057693|911189|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
276029|NCT01057693|911187|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
276030|NCT01057693|911188|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
276031|NCT01057693|911189|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
276032|NCT01057693|911187|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
276033|NCT01057693|911188|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
276034|NCT01057693|911189|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
276035|NCT01057693|911187|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
276036|NCT01057693|911188|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
276037|NCT01057693|911189|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
276038|NCT01057693|911187|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
276039|NCT01057693|911188|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
276040|NCT01057693|911189|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
276041|NCT01057589|911235|P1|Overall Study|Lost to Follow-up|1
276042|NCT01057589|911235|P1|Overall Study|Death|8
276043|NCT01057589|911235|P1|Overall Study|Sponsor Decision|1
276044|NCT01057589|911235|P1|Overall Study|Withdrawal by Subject|3
276045|NCT01057589|911235|P1|Overall Study|Physician Decision|8
276046|NCT01057589|911235|P1|Overall Study|Adverse Event|10
276047|NCT01057589|911235|P1|Overall Study|Disease Progression|35
276048|NCT01057433|911244|P1|Overall Study|Adverse Event|1
276049|NCT01057394|911248|P2|Overall Study|Not eligible|2
276050|NCT01057394|911249|P1|Overall Study|Not eligible|0
276051|NCT01057251|911259|P2|Overall Study|Other Reason|1
276052|NCT01057251|911260|P1|Overall Study|Other Reason|1
276053|NCT01057251|911259|P2|Overall Study|Lost to Follow-up|6
276054|NCT01057251|911260|P1|Overall Study|Lost to Follow-up|7
276055|NCT01057251|911259|P2|Overall Study|Withdrawal by Subject|5
276056|NCT01057251|911260|P1|Overall Study|Withdrawal by Subject|4
276057|NCT01057251|911259|P2|Overall Study|Protocol Violation|2
276058|NCT01057251|911260|P1|Overall Study|Protocol Violation|6
276059|NCT01057251|911259|P2|Overall Study|Lack of Efficacy|11
276060|NCT01057251|911260|P1|Overall Study|Lack of Efficacy|2
276061|NCT01057251|911259|P2|Overall Study|Adverse Event|2
276062|NCT01057251|911260|P1|Overall Study|Adverse Event|4
276063|NCT01057251|911259|P2|Overall Study|Did not meet InclusionExclusion criteria|2
276064|NCT01057251|911260|P1|Overall Study|Did not meet InclusionExclusion criteria|4
276065|NCT01056822|911338|P2|Overall Study|Lost to Follow-up|0
276066|NCT01056822|911339|P1|Overall Study|Lost to Follow-up|1
276067|NCT01056822|911338|P2|Overall Study|Withdrawal by Subject|1
276068|NCT01056822|911339|P1|Overall Study|Withdrawal by Subject|1
276069|NCT01056822|911338|P2|Overall Study|Protocol Violation|5
276070|NCT01056822|911339|P1|Overall Study|Protocol Violation|6
276071|NCT01056822|911338|P2|Overall Study|Adverse Event|1
276072|NCT01056822|911339|P1|Overall Study|Adverse Event|0
276073|NCT01056718|911388|P1|Overall Study|Ischemia on baseline stress test|1
276074|NCT01056718|911388|P1|Overall Study|Withdrawal by Subject|2
276075|NCT01056653|911421|P3|Overall Study|Lost to Follow-up|2
276076|NCT01056653|911422|P2|Overall Study|Lost to Follow-up|0
276077|NCT01056653|911423|P1|Overall Study|Lost to Follow-up|0
276078|NCT01056640|911439|P2|Overall Study|Death|4
276079|NCT01056640|911440|P1|Overall Study|Death|15
276080|NCT01056640|911439|P2|Overall Study|Withdrawal by Subject|8
276081|NCT01056640|911440|P1|Overall Study|Withdrawal by Subject|11
276082|NCT01056523|911452|P7|Overall Study|Death|1
276083|NCT01056523|911453|P6|Overall Study|Death|0
276084|NCT01056523|911454|P5|Overall Study|Death|0
276085|NCT01056523|911455|P4|Overall Study|Death|3
276087|NCT01056523|911457|P2|Overall Study|Death|0
276088|NCT01056523|911458|P1|Overall Study|Death|1
276089|NCT01056510|911468|P2|Overall Study|Missing|1
276090|NCT01056510|911469|P1|Overall Study|Missing|0
276091|NCT01056510|911468|P2|Overall Study|Not Specified|12
276092|NCT01056510|911469|P1|Overall Study|Not Specified|10
276093|NCT01056510|911468|P2|Overall Study|Lost to Follow-up|6
276094|NCT01056510|911469|P1|Overall Study|Lost to Follow-up|5
276095|NCT01056510|911468|P2|Overall Study|Physician Decision|5
276096|NCT01056510|911469|P1|Overall Study|Physician Decision|4
276097|NCT01056510|911468|P2|Overall Study|Noncompliance|3
276098|NCT01056510|911469|P1|Overall Study|Noncompliance|1
276099|NCT01056510|911468|P2|Overall Study|Death|34
276100|NCT01056510|911469|P1|Overall Study|Death|29
276101|NCT01056510|911468|P2|Overall Study|Withdrawal by Subject|2
276102|NCT01056510|911469|P1|Overall Study|Withdrawal by Subject|4
276103|NCT01056510|911468|P2|Overall Study|Dropout Before Start of Treatment|1
276104|NCT01056510|911469|P1|Overall Study|Dropout Before Start of Treatment|1
276105|NCT01056484|911515|P2|Follow up - Non-randomized|Withdrawal by Subject|2
276106|NCT01056484|911516|P1|Follow up - Non-randomized|Withdrawal by Subject|0
276107|NCT01056484|911515|P2|Randomized Controlled Trial|Physician Decision|0
276108|NCT01056484|911516|P1|Randomized Controlled Trial|Physician Decision|1
276109|NCT01056484|911515|P2|Randomized Controlled Trial|Withdrawal by Subject|1
276110|NCT01056484|911516|P1|Randomized Controlled Trial|Withdrawal by Subject|6
276111|NCT01056341|911535|P5|Overall Study|Other reasons|5
276112|NCT01056341|911536|P4|Overall Study|Other reasons|9
276113|NCT01056341|911537|P3|Overall Study|Other reasons|8
276114|NCT01056341|911538|P2|Overall Study|Other reasons|4
276115|NCT01056341|911539|P1|Overall Study|Other reasons|4
276116|NCT01056341|911535|P5|Overall Study|Lack of Efficacy|9
276117|NCT01056341|911536|P4|Overall Study|Lack of Efficacy|25
276118|NCT01056341|911537|P3|Overall Study|Lack of Efficacy|7
276119|NCT01056341|911538|P2|Overall Study|Lack of Efficacy|30
276120|NCT01056341|911539|P1|Overall Study|Lack of Efficacy|32
276121|NCT01056341|911535|P5|Overall Study|Treatment Intolerance|0
276122|NCT01056341|911536|P4|Overall Study|Treatment Intolerance|2
276123|NCT01056341|911537|P3|Overall Study|Treatment Intolerance|0
276124|NCT01056341|911538|P2|Overall Study|Treatment Intolerance|2
276125|NCT01056341|911539|P1|Overall Study|Treatment Intolerance|0
276126|NCT01056289|911612|P4|Double-blind Phase|Physician Decision|0
276127|NCT01056289|911613|P3|Double-blind Phase|Physician Decision|1
276128|NCT01056289|911614|P2|Double-blind Phase|Physician Decision|0
276129|NCT01056289|911615|P1|Double-blind Phase|Physician Decision|0
276130|NCT01056289|911612|P4|Double-blind Phase|Discontinuation symptom|2
276131|NCT01056289|911613|P3|Double-blind Phase|Discontinuation symptom|2
276132|NCT01056289|911614|P2|Double-blind Phase|Discontinuation symptom|1
276133|NCT01056289|911615|P1|Double-blind Phase|Discontinuation symptom|0
276134|NCT01056289|911612|P4|Double-blind Phase|Withdrawal by Subject|2
276135|NCT01056289|911613|P3|Double-blind Phase|Withdrawal by Subject|4
276136|NCT01056289|911614|P2|Double-blind Phase|Withdrawal by Subject|0
276137|NCT01056289|911615|P1|Double-blind Phase|Withdrawal by Subject|0
276138|NCT01056289|911612|P4|Double-blind Phase|Protocol Violation|1
276139|NCT01056289|911613|P3|Double-blind Phase|Protocol Violation|1
276140|NCT01056289|911614|P2|Double-blind Phase|Protocol Violation|0
276141|NCT01056289|911615|P1|Double-blind Phase|Protocol Violation|0
276142|NCT01056289|911612|P4|Double-blind Phase|Unspecified|2
276143|NCT01056289|911613|P3|Double-blind Phase|Unspecified|1
276144|NCT01056289|911614|P2|Double-blind Phase|Unspecified|0
276145|NCT01056289|911615|P1|Double-blind Phase|Unspecified|0
276146|NCT01056289|911612|P4|Double-blind Phase|Lost to Follow-up|2
276147|NCT01056289|911613|P3|Double-blind Phase|Lost to Follow-up|2
276148|NCT01056289|911614|P2|Double-blind Phase|Lost to Follow-up|2
276149|NCT01056289|911615|P1|Double-blind Phase|Lost to Follow-up|0
276150|NCT01056289|911612|P4|Double-blind Phase|Adverse Event|1
276151|NCT01056289|911613|P3|Double-blind Phase|Adverse Event|2
276152|NCT01056289|911614|P2|Double-blind Phase|Adverse Event|1
276153|NCT01056289|911615|P1|Double-blind Phase|Adverse Event|0
276154|NCT01056289|911612|P4|Open-label Phase|Not randomized to Double-blind phase|0
276155|NCT01056289|911613|P3|Open-label Phase|Not randomized to Double-blind phase|0
276156|NCT01056289|911614|P2|Open-label Phase|Not randomized to Double-blind phase|0
276157|NCT01056289|911615|P1|Open-label Phase|Not randomized to Double-blind phase|1
276158|NCT01056289|911612|P4|Open-label Phase|Lack of Efficacy|0
276159|NCT01056289|911613|P3|Open-label Phase|Lack of Efficacy|0
276160|NCT01056289|911614|P2|Open-label Phase|Lack of Efficacy|0
276161|NCT01056289|911615|P1|Open-label Phase|Lack of Efficacy|18
276162|NCT01056289|911612|P4|Open-label Phase|Withdrawal by Subject|0
276163|NCT01056289|911613|P3|Open-label Phase|Withdrawal by Subject|0
276164|NCT01056289|911614|P2|Open-label Phase|Withdrawal by Subject|0
276165|NCT01056289|911615|P1|Open-label Phase|Withdrawal by Subject|26
276166|NCT01056289|911612|P4|Open-label Phase|Protocol Violation|0
276167|NCT01056289|911613|P3|Open-label Phase|Protocol Violation|0
276168|NCT01056289|911614|P2|Open-label Phase|Protocol Violation|0
276169|NCT01056289|911615|P1|Open-label Phase|Protocol Violation|6
276170|NCT01056289|911612|P4|Open-label Phase|Unspecified|0
276171|NCT01056289|911613|P3|Open-label Phase|Unspecified|0
276172|NCT01056289|911614|P2|Open-label Phase|Unspecified|0
276173|NCT01056289|911615|P1|Open-label Phase|Unspecified|9
276174|NCT01056289|911612|P4|Open-label Phase|Lost to Follow-up|0
276175|NCT01056289|911613|P3|Open-label Phase|Lost to Follow-up|0
276176|NCT01056289|911614|P2|Open-label Phase|Lost to Follow-up|0
276177|NCT01056289|911615|P1|Open-label Phase|Lost to Follow-up|30
276178|NCT01056289|911612|P4|Open-label Phase|Adverse Event|0
276179|NCT01056289|911613|P3|Open-label Phase|Adverse Event|0
276180|NCT01056289|911614|P2|Open-label Phase|Adverse Event|0
276181|NCT01056289|911615|P1|Open-label Phase|Adverse Event|29
276182|NCT01056276|911632|P2|Maintenance Therapy|Continuing maintenance therapy|14
276183|NCT01056276|911633|P1|Maintenance Therapy|Continuing maintenance therapy|0
276184|NCT01056276|911632|P2|Maintenance Therapy|Intercurrent Illness|1
276185|NCT01056276|911633|P1|Maintenance Therapy|Intercurrent Illness|0
276186|NCT01056276|911632|P2|Maintenance Therapy|Withdrawal by Subject|1
276187|NCT01056276|911633|P1|Maintenance Therapy|Withdrawal by Subject|0
276188|NCT01056276|911632|P2|Maintenance Therapy|Physician Decision|1
276189|NCT01056276|911633|P1|Maintenance Therapy|Physician Decision|0
276190|NCT01056276|911632|P2|Maintenance Therapy|Progressive Disease|9
276191|NCT01056276|911633|P1|Maintenance Therapy|Progressive Disease|0
276192|NCT01056276|911632|P2|Maintenance Therapy|Toxicity|2
276193|NCT01056276|911633|P1|Maintenance Therapy|Toxicity|0
276194|NCT01056276|911632|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
276195|NCT01056276|911633|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
276196|NCT01056276|911632|P2|Treatment Period-Cycles 1-8|Death|1
276197|NCT01056276|911633|P1|Treatment Period-Cycles 1-8|Death|3
276198|NCT01056276|911632|P2|Treatment Period-Cycles 1-8|Physician Decision|0
276199|NCT01056276|911633|P1|Treatment Period-Cycles 1-8|Physician Decision|3
276200|NCT01056276|911632|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
276201|NCT01056276|911633|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
276202|NCT01056276|911632|P2|Treatment Period-Cycles 1-8|Disease Progression|2
276203|NCT01056276|911633|P1|Treatment Period-Cycles 1-8|Disease Progression|2
276204|NCT01056276|911632|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
276205|NCT01056276|911633|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
276206|NCT01056276|911632|P2|Treatment Period-Cycles 1-8|Toxicity|1
276207|NCT01056276|911633|P1|Treatment Period-Cycles 1-8|Toxicity|2
276208|NCT01056263|911647|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
276209|NCT01056263|911647|P1|Overall Study|Objective progression or relapse|1
276210|NCT01056263|911647|P1|Overall Study|Neoplasm progression|1
276211|NCT01056263|911647|P1|Overall Study|Progressive disease|2
276212|NCT01056263|911647|P1|Overall Study|Lack of Efficacy|29
276213|NCT01056263|911647|P1|Overall Study|Withdrawal by Subject|1
276214|NCT01056263|911647|P1|Overall Study|Death|1
276215|NCT01056263|911647|P1|Overall Study|Adverse Event|12
276216|NCT01056107|911670|P4|Overall Study|Withdrawal by Subject|0
276217|NCT01056107|911671|P3|Overall Study|Withdrawal by Subject|3
276218|NCT01056107|911672|P2|Overall Study|Withdrawal by Subject|1
276219|NCT01056107|911673|P1|Overall Study|Withdrawal by Subject|0
276220|NCT01055886|911730|P2|Overall Study|Withdrawal by PI|1
276221|NCT01055886|911731|P1|Overall Study|Withdrawal by PI|0
276222|NCT01055886|911730|P2|Overall Study|Lost to Follow-up|1
276223|NCT01055886|911731|P1|Overall Study|Lost to Follow-up|1
276224|NCT01055886|911730|P2|Overall Study|Withdrawal by Subject|9
276225|NCT01055886|911731|P1|Overall Study|Withdrawal by Subject|4
276226|NCT01055834|911743|P2|Treatment Period I|Adverse Event|0
276227|NCT01055834|911744|P1|Treatment Period I|Adverse Event|1
276228|NCT01055639|911829|P2|Overall Study|Withdrawal by Subject|11
276229|NCT01055639|911830|P1|Overall Study|Withdrawal by Subject|8
276230|NCT01055639|911829|P2|Overall Study|Protocol Violation|5
276231|NCT01055639|911830|P1|Overall Study|Protocol Violation|5
276232|NCT01055639|911829|P2|Overall Study|Lost to Follow-up|11
276233|NCT01055639|911830|P1|Overall Study|Lost to Follow-up|8
276234|NCT01055639|911829|P2|Overall Study|Lack of Efficacy|1
276235|NCT01055639|911830|P1|Overall Study|Lack of Efficacy|0
276236|NCT01055639|911829|P2|Overall Study|Adverse Event|1
276237|NCT01055639|911830|P1|Overall Study|Adverse Event|0
276238|NCT01055613|911854|P2|Overall Study|Subject Disinterest|1
276239|NCT01055613|911855|P1|Overall Study|Subject Disinterest|1
276240|NCT01055613|911854|P2|Overall Study|Protocol Violation|1
276241|NCT01055613|911855|P1|Overall Study|Protocol Violation|1
276242|NCT01055613|911854|P2|Overall Study|Lost to Follow-up|1
276243|NCT01055613|911855|P1|Overall Study|Lost to Follow-up|1
276244|NCT01055613|911854|P2|Overall Study|Discomfort|1
276245|NCT01055613|911855|P1|Overall Study|Discomfort|2
276246|NCT01055613|911854|P2|Overall Study|Unacceptable lens fit|0
276247|NCT01055613|911855|P1|Overall Study|Unacceptable lens fit|1
276248|NCT01055613|911854|P2|Overall Study|No Longer Meets Eligibility Criteria|0
276249|NCT01055613|911855|P1|Overall Study|No Longer Meets Eligibility Criteria|3
276250|NCT01055457|911863|P10|Overall Study|Adverse Event|0
276251|NCT01055457|911864|P9|Overall Study|Adverse Event|0
276252|NCT01055457|911865|P8|Overall Study|Adverse Event|0
276253|NCT01055457|911866|P7|Overall Study|Adverse Event|0
276254|NCT01055457|911867|P6|Overall Study|Adverse Event|0
276255|NCT01055457|911868|P5|Overall Study|Adverse Event|0
276256|NCT01055457|911869|P4|Overall Study|Adverse Event|1
276257|NCT01055457|911870|P3|Overall Study|Adverse Event|0
276258|NCT01055457|911871|P2|Overall Study|Adverse Event|0
276259|NCT01055457|911872|P1|Overall Study|Adverse Event|0
276260|NCT01055457|911863|P10|Overall Study|Pregnancy|0
276261|NCT01055457|911864|P9|Overall Study|Pregnancy|0
276262|NCT01055457|911865|P8|Overall Study|Pregnancy|0
276263|NCT01055457|911866|P7|Overall Study|Pregnancy|0
276264|NCT01055457|911867|P6|Overall Study|Pregnancy|0
276265|NCT01055457|911868|P5|Overall Study|Pregnancy|0
276266|NCT01055457|911869|P4|Overall Study|Pregnancy|1
276267|NCT01055457|911870|P3|Overall Study|Pregnancy|0
276268|NCT01055457|911871|P2|Overall Study|Pregnancy|0
276269|NCT01055457|911872|P1|Overall Study|Pregnancy|0
276270|NCT01055457|911863|P10|Overall Study|Discomfort|0
276271|NCT01055457|911864|P9|Overall Study|Discomfort|0
276272|NCT01055457|911865|P8|Overall Study|Discomfort|0
276273|NCT01055457|911866|P7|Overall Study|Discomfort|0
276274|NCT01055457|911867|P6|Overall Study|Discomfort|0
276275|NCT01055457|911868|P5|Overall Study|Discomfort|1
276276|NCT01055457|911869|P4|Overall Study|Discomfort|0
276277|NCT01055457|911870|P3|Overall Study|Discomfort|0
276278|NCT01055457|911871|P2|Overall Study|Discomfort|0
276279|NCT01055457|911872|P1|Overall Study|Discomfort|0
276280|NCT01055457|911863|P10|Overall Study|Subject Ineligible|0
276281|NCT01055457|911864|P9|Overall Study|Subject Ineligible|0
276282|NCT01055457|911865|P8|Overall Study|Subject Ineligible|0
276283|NCT01055457|911866|P7|Overall Study|Subject Ineligible|0
276284|NCT01055457|911867|P6|Overall Study|Subject Ineligible|0
276285|NCT01055457|911868|P5|Overall Study|Subject Ineligible|1
276286|NCT01055457|911869|P4|Overall Study|Subject Ineligible|0
276287|NCT01055457|911870|P3|Overall Study|Subject Ineligible|1
276288|NCT01055457|911871|P2|Overall Study|Subject Ineligible|0
276289|NCT01055457|911872|P1|Overall Study|Subject Ineligible|1
276290|NCT01055457|911863|P10|Overall Study|Subject Disinterest|0
276291|NCT01055457|911864|P9|Overall Study|Subject Disinterest|0
276292|NCT01055457|911865|P8|Overall Study|Subject Disinterest|1
276293|NCT01055457|911866|P7|Overall Study|Subject Disinterest|0
276294|NCT01055457|911867|P6|Overall Study|Subject Disinterest|0
276295|NCT01055457|911868|P5|Overall Study|Subject Disinterest|0
276296|NCT01055457|911869|P4|Overall Study|Subject Disinterest|0
276297|NCT01055457|911870|P3|Overall Study|Subject Disinterest|0
276298|NCT01055457|911871|P2|Overall Study|Subject Disinterest|0
276299|NCT01055457|911872|P1|Overall Study|Subject Disinterest|0
276300|NCT01055457|911863|P10|Overall Study|Protocol Violation|1
276301|NCT01055457|911864|P9|Overall Study|Protocol Violation|0
276302|NCT01055457|911865|P8|Overall Study|Protocol Violation|0
276303|NCT01055457|911866|P7|Overall Study|Protocol Violation|1
276304|NCT01055457|911867|P6|Overall Study|Protocol Violation|2
276305|NCT01055457|911868|P5|Overall Study|Protocol Violation|1
276306|NCT01055457|911869|P4|Overall Study|Protocol Violation|1
276307|NCT01055457|911870|P3|Overall Study|Protocol Violation|1
276308|NCT01055457|911871|P2|Overall Study|Protocol Violation|0
276309|NCT01055457|911872|P1|Overall Study|Protocol Violation|0
276310|NCT01055457|911863|P10|Overall Study|Lost to Follow-up|0
276311|NCT01055457|911864|P9|Overall Study|Lost to Follow-up|0
276312|NCT01055457|911865|P8|Overall Study|Lost to Follow-up|0
276313|NCT01055457|911866|P7|Overall Study|Lost to Follow-up|0
276314|NCT01055457|911867|P6|Overall Study|Lost to Follow-up|1
276315|NCT01055457|911868|P5|Overall Study|Lost to Follow-up|0
276316|NCT01055457|911869|P4|Overall Study|Lost to Follow-up|0
276317|NCT01055457|911870|P3|Overall Study|Lost to Follow-up|0
276318|NCT01055457|911871|P2|Overall Study|Lost to Follow-up|1
276319|NCT01055457|911872|P1|Overall Study|Lost to Follow-up|0
276320|NCT01055262|911904|P1|Overall Study|Uncooperativeness|1
276321|NCT01055262|911904|P1|Overall Study|Protocol Violation|3
276322|NCT01055262|911904|P1|Overall Study|Adverse Event|5
276323|NCT01055197|911945|P2|Overall Study|Withdrawal by Subject|0
276324|NCT01055197|911946|P1|Overall Study|Withdrawal by Subject|2
276325|NCT01055197|911945|P2|Overall Study|Protocol Violation|2
276326|NCT01055197|911946|P1|Overall Study|Protocol Violation|7
276327|NCT01055132|911973|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
276328|NCT01055132|911974|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
276329|NCT01055132|911973|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
276330|NCT01055132|911974|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
276331|NCT01054976|911985|P1|Overall Study|Not specified|8
276332|NCT01054976|911985|P1|Overall Study|Withdrawal by Subject|4
276333|NCT01054976|911985|P1|Overall Study|Uncooperative participations to study|7
276334|NCT01054976|911985|P1|Overall Study|Adverse Event|16
276335|NCT01054885|912006|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
276336|NCT01054885|912007|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
276337|NCT01054885|912008|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
276338|NCT01054885|912009|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
276339|NCT01054885|912010|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
276340|NCT01054885|912011|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
276341|NCT01054885|912012|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
276342|NCT01054885|912006|P7|24-week, Double-blind Treatment Period|Physician Decision|1
276343|NCT01054885|912007|P6|24-week, Double-blind Treatment Period|Physician Decision|1
276344|NCT01054885|912008|P5|24-week, Double-blind Treatment Period|Physician Decision|3
276345|NCT01054885|912009|P4|24-week, Double-blind Treatment Period|Physician Decision|6
276346|NCT01054885|912010|P3|24-week, Double-blind Treatment Period|Physician Decision|1
276347|NCT01054885|912011|P2|24-week, Double-blind Treatment Period|Physician Decision|4
276348|NCT01054885|912012|P1|24-week, Double-blind Treatment Period|Physician Decision|0
276349|NCT01054885|912006|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
276350|NCT01054885|912007|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
276351|NCT01054885|912008|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
276352|NCT01054885|912009|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
276353|NCT01054885|912010|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
276354|NCT01054885|912011|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
276355|NCT01054885|912012|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
276356|NCT01054885|912006|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
276357|NCT01054885|912007|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
276358|NCT01054885|912008|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
276359|NCT01054885|912009|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
276360|NCT01054885|912010|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
276361|NCT01054885|912011|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
276362|NCT01054885|912012|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
276363|NCT01054885|912006|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
276364|NCT01054885|912007|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
276365|NCT01054885|912008|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
276366|NCT01054885|912009|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
276367|NCT01054885|912010|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
276368|NCT01054885|912011|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
276369|NCT01054885|912012|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
276370|NCT01054885|912006|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
276371|NCT01054885|912007|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
276372|NCT01054885|912008|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
276373|NCT01054885|912009|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
276374|NCT01054885|912010|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
276375|NCT01054885|912011|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
276376|NCT01054885|912012|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
276377|NCT01054885|912006|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
276378|NCT01054885|912007|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
276379|NCT01054885|912008|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
276380|NCT01054885|912009|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
276381|NCT01054885|912010|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
276382|NCT01054885|912011|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
276383|NCT01054885|912012|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
276384|NCT01054885|912006|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
276385|NCT01054885|912007|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
276386|NCT01054885|912008|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
276387|NCT01054885|912009|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
276388|NCT01054885|912010|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
276389|NCT01054885|912011|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
276390|NCT01054885|912012|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
276391|NCT01054885|912006|P7|24-week, Double-blind Treatment Period|Adverse Event|19
276392|NCT01054885|912007|P6|24-week, Double-blind Treatment Period|Adverse Event|17
276393|NCT01054885|912008|P5|24-week, Double-blind Treatment Period|Adverse Event|15
276394|NCT01054885|912009|P4|24-week, Double-blind Treatment Period|Adverse Event|15
276395|NCT01054885|912010|P3|24-week, Double-blind Treatment Period|Adverse Event|12
276396|NCT01054885|912011|P2|24-week, Double-blind Treatment Period|Adverse Event|18
276397|NCT01054885|912012|P1|24-week, Double-blind Treatment Period|Adverse Event|0
276398|NCT01054885|912006|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276399|NCT01054885|912007|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276400|NCT01054885|912008|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276401|NCT01054885|912009|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276402|NCT01054885|912010|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276403|NCT01054885|912011|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276404|NCT01054885|912012|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
276405|NCT01054885|912006|P7|2-week, Single-blind Run-In Period|Adverse Event|0
276406|NCT01054885|912007|P6|2-week, Single-blind Run-In Period|Adverse Event|0
276407|NCT01054885|912008|P5|2-week, Single-blind Run-In Period|Adverse Event|0
276408|NCT01054885|912009|P4|2-week, Single-blind Run-In Period|Adverse Event|0
276409|NCT01054885|912010|P3|2-week, Single-blind Run-In Period|Adverse Event|0
276410|NCT01054885|912011|P2|2-week, Single-blind Run-In Period|Adverse Event|0
276411|NCT01054885|912012|P1|2-week, Single-blind Run-In Period|Adverse Event|7
276412|NCT01054885|912006|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276413|NCT01054885|912007|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276414|NCT01054885|912008|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276415|NCT01054885|912009|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276416|NCT01054885|912010|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276417|NCT01054885|912011|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276418|NCT01054885|912012|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
276419|NCT01054885|912006|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276420|NCT01054885|912007|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276421|NCT01054885|912008|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276422|NCT01054885|912009|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276423|NCT01054885|912010|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276424|NCT01054885|912011|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276425|NCT01054885|912012|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
276426|NCT01054885|912006|P7|2-week, Single-blind Run-In Period|Physician Decision|0
276427|NCT01054885|912007|P6|2-week, Single-blind Run-In Period|Physician Decision|0
276428|NCT01054885|912008|P5|2-week, Single-blind Run-In Period|Physician Decision|0
276429|NCT01054885|912009|P4|2-week, Single-blind Run-In Period|Physician Decision|0
276430|NCT01054885|912010|P3|2-week, Single-blind Run-In Period|Physician Decision|0
276431|NCT01054885|912011|P2|2-week, Single-blind Run-In Period|Physician Decision|0
276432|NCT01054885|912012|P1|2-week, Single-blind Run-In Period|Physician Decision|6
276433|NCT01054885|912006|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276434|NCT01054885|912007|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276435|NCT01054885|912008|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276436|NCT01054885|912009|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276437|NCT01054885|912010|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276438|NCT01054885|912011|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276439|NCT01054885|912012|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
276440|NCT01054846|912052|P2|Overall Study|Lost to Follow-up|17
276441|NCT01054846|912053|P1|Overall Study|Lost to Follow-up|76
276442|NCT01054820|912060|P1|Overall Study|Withdrawal by Subject|2
276443|NCT01054729|912082|P4|Overall Study|Lack of Efficacy|1
276444|NCT01054729|912083|P3|Overall Study|Lack of Efficacy|0
276445|NCT01054729|912084|P2|Overall Study|Lack of Efficacy|0
276446|NCT01054729|912085|P1|Overall Study|Lack of Efficacy|0
276447|NCT01054729|912082|P4|Overall Study|Subject moved|0
276448|NCT01054729|912083|P3|Overall Study|Subject moved|1
276449|NCT01054729|912084|P2|Overall Study|Subject moved|0
276450|NCT01054729|912085|P1|Overall Study|Subject moved|0
276451|NCT01054729|912082|P4|Overall Study|Personal/Obligations|0
276452|NCT01054729|912083|P3|Overall Study|Personal/Obligations|0
276453|NCT01054729|912084|P2|Overall Study|Personal/Obligations|1
276454|NCT01054729|912085|P1|Overall Study|Personal/Obligations|0
276455|NCT01054729|912082|P4|Overall Study|PEG/RBV Non-responder|0
276456|NCT01054729|912083|P3|Overall Study|PEG/RBV Non-responder|1
276457|NCT01054729|912084|P2|Overall Study|PEG/RBV Non-responder|0
276458|NCT01054729|912085|P1|Overall Study|PEG/RBV Non-responder|1
276459|NCT01054729|912082|P4|Overall Study|Non-responder|1
276460|NCT01054729|912083|P3|Overall Study|Non-responder|1
276461|NCT01054729|912084|P2|Overall Study|Non-responder|0
276462|NCT01054729|912085|P1|Overall Study|Non-responder|1
276463|NCT01054729|912082|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
276464|NCT01054729|912083|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
276465|NCT01054729|912084|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
276466|NCT01054729|912085|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
276467|NCT01054729|912082|P4|Overall Study|Lost to Follow-up|0
276468|NCT01054729|912083|P3|Overall Study|Lost to Follow-up|0
276469|NCT01054729|912084|P2|Overall Study|Lost to Follow-up|1
276470|NCT01054729|912085|P1|Overall Study|Lost to Follow-up|0
276471|NCT01054729|912082|P4|Overall Study|Withdrawal by Subject|0
276472|NCT01054729|912083|P3|Overall Study|Withdrawal by Subject|1
276473|NCT01054729|912084|P2|Overall Study|Withdrawal by Subject|0
276474|NCT01054729|912085|P1|Overall Study|Withdrawal by Subject|1
276475|NCT01054729|912082|P4|Overall Study|Adverse Event|1
276476|NCT01054729|912083|P3|Overall Study|Adverse Event|2
276477|NCT01054729|912084|P2|Overall Study|Adverse Event|1
276478|NCT01054729|912085|P1|Overall Study|Adverse Event|1
276479|NCT01054729|912082|P4|Overall Study|Randomized but Not Treated|0
276480|NCT01054729|912083|P3|Overall Study|Randomized but Not Treated|0
276481|NCT01054729|912084|P2|Overall Study|Randomized but Not Treated|1
276482|NCT01054729|912085|P1|Overall Study|Randomized but Not Treated|0
276483|NCT01054573|912280|P4|Overall Study|Withdrawal by Subject|1
276484|NCT01054573|912281|P3|Overall Study|Withdrawal by Subject|2
276485|NCT01054573|912282|P2|Overall Study|Withdrawal by Subject|2
276486|NCT01054573|912283|P1|Overall Study|Withdrawal by Subject|0
276487|NCT01054573|912280|P4|Overall Study|Lost to Follow-up|0
276488|NCT01054573|912281|P3|Overall Study|Lost to Follow-up|0
276489|NCT01054573|912282|P2|Overall Study|Lost to Follow-up|2
276490|NCT01054573|912283|P1|Overall Study|Lost to Follow-up|0
276491|NCT01054573|912280|P4|Overall Study|Adverse Event|1
276492|NCT01054573|912281|P3|Overall Study|Adverse Event|1
276493|NCT01054573|912282|P2|Overall Study|Adverse Event|0
276494|NCT01054573|912283|P1|Overall Study|Adverse Event|1
276495|NCT01054560|912329|P2|Overall Study|Physician Decision|0
276496|NCT01054560|912330|P1|Overall Study|Physician Decision|1
276497|NCT01054560|912329|P2|Overall Study|Withdrawal by Subject|2
276498|NCT01054560|912330|P1|Overall Study|Withdrawal by Subject|0
276499|NCT01054560|912329|P2|Overall Study|Lost to Follow-up|5
276500|NCT01054560|912330|P1|Overall Study|Lost to Follow-up|2
276501|NCT01054560|912329|P2|Overall Study|Death|21
276502|NCT01054560|912330|P1|Overall Study|Death|10
276503|NCT01054222|912380|P1|Overall Study|Withdrawal by Subject|6
276504|NCT01054222|912380|P1|Overall Study|Lost to Follow-up|4
276505|NCT01054222|912380|P1|Overall Study|Lack of Efficacy|1
276506|NCT01054170|912412|P2|Overall Study|Adverse Event|4
276507|NCT01054170|912413|P1|Overall Study|Adverse Event|0
276508|NCT01054170|912412|P2|Overall Study|Withdrawal by Subject|2
276509|NCT01054170|912413|P1|Overall Study|Withdrawal by Subject|3
276510|NCT01054170|912412|P2|Overall Study|Protocol Violation|0
276511|NCT01054170|912413|P1|Overall Study|Protocol Violation|1
276512|NCT01053988|912474|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
276513|NCT01053988|912475|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
276514|NCT01053988|912476|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
276515|NCT01053988|912477|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
276516|NCT01053988|912478|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
276517|NCT01053988|912479|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
276518|NCT01053988|912474|P6|24-week, Double-blind Treatment Period|Physician Decision|4
276519|NCT01053988|912475|P5|24-week, Double-blind Treatment Period|Physician Decision|5
276520|NCT01053988|912476|P4|24-week, Double-blind Treatment Period|Physician Decision|5
276521|NCT01053988|912477|P3|24-week, Double-blind Treatment Period|Physician Decision|2
276522|NCT01053988|912478|P2|24-week, Double-blind Treatment Period|Physician Decision|5
276523|NCT01053988|912479|P1|24-week, Double-blind Treatment Period|Physician Decision|0
276524|NCT01053988|912474|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
276525|NCT01053988|912475|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
276526|NCT01053988|912476|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
276527|NCT01053988|912477|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
276528|NCT01053988|912478|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
276529|NCT01053988|912479|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
276530|NCT01053988|912474|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
276531|NCT01053988|912475|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
276532|NCT01053988|912476|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
276533|NCT01053988|912477|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
276534|NCT01053988|912478|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
276535|NCT01053988|912479|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
276536|NCT01053988|912474|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
276537|NCT01053988|912475|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
276538|NCT01053988|912476|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
276539|NCT01053988|912477|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
276540|NCT01053988|912478|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
276541|NCT01053988|912479|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
276542|NCT01053988|912474|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
276543|NCT01053988|912475|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
276544|NCT01053988|912476|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
276545|NCT01053988|912477|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
276546|NCT01053988|912478|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
276547|NCT01053988|912479|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
276548|NCT01053988|912474|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
276549|NCT01053988|912475|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
276550|NCT01053988|912476|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
276551|NCT01053988|912477|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
276552|NCT01053988|912478|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
276553|NCT01053988|912479|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
276554|NCT01053988|912474|P6|24-week, Double-blind Treatment Period|Adverse Event|14
276555|NCT01053988|912475|P5|24-week, Double-blind Treatment Period|Adverse Event|17
276556|NCT01053988|912476|P4|24-week, Double-blind Treatment Period|Adverse Event|24
276557|NCT01053988|912477|P3|24-week, Double-blind Treatment Period|Adverse Event|23
276558|NCT01053988|912478|P2|24-week, Double-blind Treatment Period|Adverse Event|15
276559|NCT01053988|912479|P1|24-week, Double-blind Treatment Period|Adverse Event|0
276560|NCT01053988|912474|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276561|NCT01053988|912475|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276562|NCT01053988|912476|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276563|NCT01053988|912477|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276564|NCT01053988|912478|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
276565|NCT01053988|912479|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
276566|NCT01053988|912474|P6|2-week, Single-blind Run-In Period|Physician Decision|0
276567|NCT01053988|912475|P5|2-week, Single-blind Run-In Period|Physician Decision|0
276568|NCT01053988|912476|P4|2-week, Single-blind Run-In Period|Physician Decision|0
276569|NCT01053988|912477|P3|2-week, Single-blind Run-In Period|Physician Decision|0
276570|NCT01053988|912478|P2|2-week, Single-blind Run-In Period|Physician Decision|0
276571|NCT01053988|912479|P1|2-week, Single-blind Run-In Period|Physician Decision|5
276572|NCT01053988|912474|P6|2-week, Single-blind Run-In Period|Adverse Event|0
276573|NCT01053988|912475|P5|2-week, Single-blind Run-In Period|Adverse Event|0
276574|NCT01053988|912476|P4|2-week, Single-blind Run-In Period|Adverse Event|0
276575|NCT01053988|912477|P3|2-week, Single-blind Run-In Period|Adverse Event|0
276576|NCT01053988|912478|P2|2-week, Single-blind Run-In Period|Adverse Event|0
276577|NCT01053988|912479|P1|2-week, Single-blind Run-In Period|Adverse Event|6
276578|NCT01053988|912474|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276579|NCT01053988|912475|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276580|NCT01053988|912476|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276581|NCT01053988|912477|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276582|NCT01053988|912478|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
276583|NCT01053988|912479|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
276584|NCT01053988|912474|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276585|NCT01053988|912475|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276586|NCT01053988|912476|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276587|NCT01053988|912477|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276588|NCT01053988|912478|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
276589|NCT01053988|912479|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
276590|NCT01053988|912474|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276591|NCT01053988|912475|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276592|NCT01053988|912476|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276593|NCT01053988|912477|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276594|NCT01053988|912478|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
276595|NCT01053988|912479|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
276596|NCT01053741|912529|P2|2nd Study Intervention|Physician Decision|1
276597|NCT01053741|912530|P1|2nd Study Intervention|Physician Decision|0
276598|NCT01053663|912539|P1|Overall Study|Negative Influenza Diagnosis|1
276599|NCT01053663|912539|P1|Overall Study|Transferred to Another Hospital|1
276600|NCT01053663|912539|P1|Overall Study|Poor IV Access|1
276601|NCT01053663|912539|P1|Overall Study|Lost to Follow-up|1
276602|NCT01053663|912539|P1|Overall Study|Death|2
276603|NCT01053429|912597|P1|Overall Study|Unspecified|309
276604|NCT01053429|912597|P1|Overall Study|Adverse Event|64
276605|NCT01053247|912627|P3|Overall Study|Adverse Event|3
276606|NCT01053247|912628|P2|Overall Study|Adverse Event|9
276607|NCT01053247|912629|P1|Overall Study|Adverse Event|0
276608|NCT01053247|912627|P3|Overall Study|Lost to Follow-up|7
276609|NCT01053247|912628|P2|Overall Study|Lost to Follow-up|5
276610|NCT01053247|912629|P1|Overall Study|Lost to Follow-up|8
276611|NCT01053247|912627|P3|Overall Study|Protocol Violation|2
276612|NCT01053247|912628|P2|Overall Study|Protocol Violation|1
276613|NCT01053247|912629|P1|Overall Study|Protocol Violation|2
276614|NCT01053247|912627|P3|Overall Study|Lack of Efficacy|1
276615|NCT01053247|912628|P2|Overall Study|Lack of Efficacy|0
276616|NCT01053247|912629|P1|Overall Study|Lack of Efficacy|1
276617|NCT01053247|912627|P3|Overall Study|Withdrawal by Subject|15
276618|NCT01053247|912628|P2|Overall Study|Withdrawal by Subject|4
276619|NCT01053247|912629|P1|Overall Study|Withdrawal by Subject|9
276620|NCT01052844|912723|P2|Overall Study|Adverse Event|1
276621|NCT01052844|912724|P1|Overall Study|Adverse Event|0
276622|NCT01052662|912757|P3|Overall Study|Administrative|0
276623|NCT01052662|912758|P2|Overall Study|Administrative|3
276624|NCT01052662|912759|P1|Overall Study|Administrative|0
276625|NCT01052662|912757|P3|Overall Study|Legal Problem|0
276626|NCT01052662|912758|P2|Overall Study|Legal Problem|0
276627|NCT01052662|912759|P1|Overall Study|Legal Problem|2
276628|NCT01052662|912757|P3|Overall Study|Adverse Event|0
276629|NCT01052662|912758|P2|Overall Study|Adverse Event|1
276630|NCT01052662|912759|P1|Overall Study|Adverse Event|1
276631|NCT01052662|912757|P3|Overall Study|Pharmacy issue|3
276632|NCT01052662|912758|P2|Overall Study|Pharmacy issue|3
276633|NCT01052662|912759|P1|Overall Study|Pharmacy issue|1
276634|NCT01052662|912757|P3|Overall Study|Withdrawal by Subject|1
276635|NCT01052662|912758|P2|Overall Study|Withdrawal by Subject|2
276636|NCT01052662|912759|P1|Overall Study|Withdrawal by Subject|3
276637|NCT01052662|912757|P3|Overall Study|Lost to Follow-up|18
276638|NCT01052662|912758|P2|Overall Study|Lost to Follow-up|13
276639|NCT01052662|912759|P1|Overall Study|Lost to Follow-up|15
276640|NCT01052480|912790|P2|Overall Study|Death|5
276641|NCT01052480|912791|P1|Overall Study|Death|1
276642|NCT01052480|912790|P2|Overall Study|Physician Decision|2
276643|NCT01052480|912791|P1|Overall Study|Physician Decision|0
276644|NCT01052480|912790|P2|Overall Study|Withdrawal by Subject|7
276645|NCT01052480|912791|P1|Overall Study|Withdrawal by Subject|3
276646|NCT01052480|912790|P2|Overall Study|Protocol Violation|0
276647|NCT01052480|912791|P1|Overall Study|Protocol Violation|1
276648|NCT01052480|912790|P2|Overall Study|Lost to Follow-up|3
276649|NCT01052480|912791|P1|Overall Study|Lost to Follow-up|3
276650|NCT01052428|912841|P2|Overall Study|Withdrawal by Subject|1
276651|NCT01052428|912842|P1|Overall Study|Withdrawal by Subject|0
276652|NCT01052428|912841|P2|Overall Study|Death|0
276653|NCT01052428|912842|P1|Overall Study|Death|1
276654|NCT01052272|912864|P4|Overall Study|decline in health|0
276655|NCT01052272|912865|P3|Overall Study|decline in health|1
276656|NCT01052272|912866|P2|Overall Study|decline in health|0
276657|NCT01052272|912867|P1|Overall Study|decline in health|0
276658|NCT01052272|912864|P4|Overall Study|placed in long-term care|0
276659|NCT01052272|912865|P3|Overall Study|placed in long-term care|1
276660|NCT01052272|912866|P2|Overall Study|placed in long-term care|0
276661|NCT01052272|912867|P1|Overall Study|placed in long-term care|0
276662|NCT01052272|912864|P4|Overall Study|Withdrawal by Subject|2
276663|NCT01052272|912865|P3|Overall Study|Withdrawal by Subject|3
276664|NCT01052272|912866|P2|Overall Study|Withdrawal by Subject|2
276665|NCT01052272|912867|P1|Overall Study|Withdrawal by Subject|0
276666|NCT01052272|912864|P4|Overall Study|patient refuses follow-up|4
276667|NCT01052272|912865|P3|Overall Study|patient refuses follow-up|2
276668|NCT01052272|912866|P2|Overall Study|patient refuses follow-up|4
276669|NCT01052272|912867|P1|Overall Study|patient refuses follow-up|5
276670|NCT01052272|912864|P4|Overall Study|Physician Decision|0
276671|NCT01052272|912865|P3|Overall Study|Physician Decision|0
276672|NCT01052272|912866|P2|Overall Study|Physician Decision|1
276673|NCT01052272|912867|P1|Overall Study|Physician Decision|0
276674|NCT01052272|912864|P4|Overall Study|Death|1
276675|NCT01052272|912865|P3|Overall Study|Death|1
276676|NCT01052272|912866|P2|Overall Study|Death|0
276677|NCT01052272|912867|P1|Overall Study|Death|0
276678|NCT01052116|912912|P2|Overall Study|Spirometry not performed|4
276679|NCT01052116|912913|P1|Overall Study|Spirometry not performed|0
276680|NCT01052116|912912|P2|Overall Study|Withdrawal by Subject|6
276681|NCT01052116|912913|P1|Overall Study|Withdrawal by Subject|3
276682|NCT01052116|912912|P2|Overall Study|Lost to Follow-up|17
276683|NCT01052116|912913|P1|Overall Study|Lost to Follow-up|11
276684|NCT01052077|912921|P4|Phase A+|Withdrawal by Subject|7
276685|NCT01052077|912922|P3|Phase A+|Withdrawal by Subject|0
276686|NCT01052077|912923|P2|Phase A+|Withdrawal by Subject|0
276687|NCT01052077|912924|P1|Phase A+|Withdrawal by Subject|0
276688|NCT01052077|912921|P4|Phase A+|Met Withdrawal Criteria|2
276689|NCT01052077|912922|P3|Phase A+|Met Withdrawal Criteria|0
276690|NCT01052077|912923|P2|Phase A+|Met Withdrawal Criteria|0
276691|NCT01052077|912924|P1|Phase A+|Met Withdrawal Criteria|0
276692|NCT01052077|912921|P4|Phase A+|Adverse Event|4
276693|NCT01052077|912922|P3|Phase A+|Adverse Event|0
276694|NCT01052077|912923|P2|Phase A+|Adverse Event|0
276695|NCT01052077|912924|P1|Phase A+|Adverse Event|0
276696|NCT01052077|912921|P4|Phase A+|Lost to Follow-up|8
276697|NCT01052077|912922|P3|Phase A+|Lost to Follow-up|0
276698|NCT01052077|912923|P2|Phase A+|Lost to Follow-up|0
276699|NCT01052077|912924|P1|Phase A+|Lost to Follow-up|0
276700|NCT01052077|912921|P4|Phase B|Lack of Efficacy|0
276701|NCT01052077|912922|P3|Phase B|Lack of Efficacy|0
276702|NCT01052077|912923|P2|Phase B|Lack of Efficacy|1
276703|NCT01052077|912924|P1|Phase B|Lack of Efficacy|0
276704|NCT01052077|912921|P4|Phase B|Protocol Deviation|0
276705|NCT01052077|912922|P3|Phase B|Protocol Deviation|4
276706|NCT01052077|912923|P2|Phase B|Protocol Deviation|3
276707|NCT01052077|912924|P1|Phase B|Protocol Deviation|0
276708|NCT01052077|912921|P4|Phase B|Withdrawal by Subject|0
276709|NCT01052077|912922|P3|Phase B|Withdrawal by Subject|5
276710|NCT01052077|912923|P2|Phase B|Withdrawal by Subject|0
276711|NCT01052077|912924|P1|Phase B|Withdrawal by Subject|0
276712|NCT01052077|912921|P4|Phase B|Physician Decision|0
276713|NCT01052077|912922|P3|Phase B|Physician Decision|1
276714|NCT01052077|912923|P2|Phase B|Physician Decision|1
276715|NCT01052077|912924|P1|Phase B|Physician Decision|0
276716|NCT01052077|912921|P4|Phase B|Met Withdrawal Criteria|0
276717|NCT01052077|912922|P3|Phase B|Met Withdrawal Criteria|1
276718|NCT01052077|912923|P2|Phase B|Met Withdrawal Criteria|2
276719|NCT01052077|912924|P1|Phase B|Met Withdrawal Criteria|0
276720|NCT01052077|912921|P4|Phase B|Adverse Event|0
276721|NCT01052077|912922|P3|Phase B|Adverse Event|2
276722|NCT01052077|912923|P2|Phase B|Adverse Event|9
276723|NCT01052077|912924|P1|Phase B|Adverse Event|0
276724|NCT01052077|912921|P4|Phase B|Lost to Follow-up|0
276725|NCT01052077|912922|P3|Phase B|Lost to Follow-up|3
276726|NCT01052077|912923|P2|Phase B|Lost to Follow-up|2
276727|NCT01052077|912924|P1|Phase B|Lost to Follow-up|0
276728|NCT01052077|912921|P4|Phase A|Protocol Deviation|0
276729|NCT01052077|912922|P3|Phase A|Protocol Deviation|0
276730|NCT01052077|912923|P2|Phase A|Protocol Deviation|0
276731|NCT01052077|912924|P1|Phase A|Protocol Deviation|27
276732|NCT01052077|912921|P4|Phase A|Withdrawal by Subject|0
276733|NCT01052077|912922|P3|Phase A|Withdrawal by Subject|0
276734|NCT01052077|912923|P2|Phase A|Withdrawal by Subject|0
276735|NCT01052077|912924|P1|Phase A|Withdrawal by Subject|29
276736|NCT01052077|912921|P4|Phase A|Physician Decision|0
276737|NCT01052077|912922|P3|Phase A|Physician Decision|0
276738|NCT01052077|912923|P2|Phase A|Physician Decision|0
276739|NCT01052077|912924|P1|Phase A|Physician Decision|10
276740|NCT01052077|912921|P4|Phase A|Met Withdrawal Criteria|0
276741|NCT01052077|912922|P3|Phase A|Met Withdrawal Criteria|0
276742|NCT01052077|912923|P2|Phase A|Met Withdrawal Criteria|0
276743|NCT01052077|912924|P1|Phase A|Met Withdrawal Criteria|26
276744|NCT01052077|912921|P4|Phase A|Adverse Event|0
276745|NCT01052077|912922|P3|Phase A|Adverse Event|0
276746|NCT01052077|912923|P2|Phase A|Adverse Event|0
276747|NCT01052077|912924|P1|Phase A|Adverse Event|32
276748|NCT01052077|912921|P4|Phase A|Lost to Follow-up|0
276749|NCT01052077|912922|P3|Phase A|Lost to Follow-up|0
276750|NCT01052077|912923|P2|Phase A|Lost to Follow-up|0
276751|NCT01052077|912924|P1|Phase A|Lost to Follow-up|22
276752|NCT01052038|912951|P3|Overall Study|Protocol Violation|3
276753|NCT01052038|912952|P2|Overall Study|Protocol Violation|3
276754|NCT01052038|912953|P1|Overall Study|Protocol Violation|2
276755|NCT01052038|912951|P3|Overall Study|Lost to Follow-up|1
276756|NCT01052038|912952|P2|Overall Study|Lost to Follow-up|3
276757|NCT01052038|912953|P1|Overall Study|Lost to Follow-up|2
276758|NCT01051986|912975|P2|Overall Study|Protocol Violation|3
276759|NCT01051986|912976|P1|Overall Study|Protocol Violation|2
276760|NCT01051986|912975|P2|Overall Study|Withdrawal by Subject|1
276761|NCT01051986|912976|P1|Overall Study|Withdrawal by Subject|2
276762|NCT01051986|912975|P2|Overall Study|Death|0
276763|NCT01051986|912976|P1|Overall Study|Death|1
276764|NCT01051921|912990|P1|Overall Study|patient moved|1
276765|NCT01051921|912990|P1|Overall Study|virological failure|1
276766|NCT01051921|912990|P1|Overall Study|Lost to Follow-up|4
276767|NCT01051921|912990|P1|Overall Study|Withdrawal by Subject|7
276768|NCT01051921|912990|P1|Overall Study|Adverse Event|8
276769|NCT01051921|912990|P1|Overall Study|Physician Decision|9
276770|NCT01051856|912997|P2|Overall Study|Withdrawal by Subject|0
276771|NCT01051856|912998|P1|Overall Study|Withdrawal by Subject|1
276772|NCT01051817|913008|P2|Overall Study|Protocol Violation|1
276773|NCT01051817|913009|P1|Overall Study|Protocol Violation|0
276774|NCT01051817|913008|P2|Overall Study|Withdrawal by Subject|5
276775|NCT01051817|913009|P1|Overall Study|Withdrawal by Subject|3
276776|NCT01051817|913008|P2|Overall Study|Abnormal Test Proceedure reults|1
276777|NCT01051817|913009|P1|Overall Study|Abnormal Test Proceedure reults|0
276778|NCT01051817|913008|P2|Overall Study|Adverse Event|2
276779|NCT01051817|913009|P1|Overall Study|Adverse Event|0
276780|NCT01051739|913030|P2|Overall Study|Withdrawal by Subject|10
276781|NCT01051739|913031|P1|Overall Study|Withdrawal by Subject|25
276782|NCT01051739|913030|P2|Overall Study|Death|3
276783|NCT01051739|913031|P1|Overall Study|Death|3
276784|NCT01051557|913048|P7|Overall Study|Adverse Event|4
276785|NCT01051557|913049|P6|Overall Study|Adverse Event|3
276786|NCT01051557|913050|P5|Overall Study|Adverse Event|1
276787|NCT01051557|913051|P4|Overall Study|Adverse Event|1
276788|NCT01051557|913052|P3|Overall Study|Adverse Event|0
276789|NCT01051557|913053|P2|Overall Study|Adverse Event|0
276790|NCT01051557|913054|P1|Overall Study|Adverse Event|0
276791|NCT01051557|913048|P7|Overall Study|Withdrawal by Subject|1
276792|NCT01051557|913049|P6|Overall Study|Withdrawal by Subject|0
276793|NCT01051557|913050|P5|Overall Study|Withdrawal by Subject|2
276794|NCT01051557|913051|P4|Overall Study|Withdrawal by Subject|0
276795|NCT01051557|913052|P3|Overall Study|Withdrawal by Subject|1
276796|NCT01051557|913053|P2|Overall Study|Withdrawal by Subject|0
276797|NCT01051557|913054|P1|Overall Study|Withdrawal by Subject|0
276798|NCT01051557|913048|P7|Overall Study|disease progression|1
276799|NCT01051557|913049|P6|Overall Study|disease progression|3
276800|NCT01051557|913050|P5|Overall Study|disease progression|4
276801|NCT01051557|913051|P4|Overall Study|disease progression|2
276802|NCT01051557|913052|P3|Overall Study|disease progression|5
276803|NCT01051557|913053|P2|Overall Study|disease progression|3
276804|NCT01051557|913054|P1|Overall Study|disease progression|3
276805|NCT01051557|913048|P7|Overall Study|Physician Decision|0
276806|NCT01051557|913049|P6|Overall Study|Physician Decision|0
276807|NCT01051557|913050|P5|Overall Study|Physician Decision|0
276808|NCT01051557|913051|P4|Overall Study|Physician Decision|0
276809|NCT01051557|913052|P3|Overall Study|Physician Decision|0
276810|NCT01051557|913053|P2|Overall Study|Physician Decision|0
276811|NCT01051557|913054|P1|Overall Study|Physician Decision|1
276812|NCT01051466|913066|P2|Overall Study|Physician Decision|0
276813|NCT01051466|913067|P1|Overall Study|Physician Decision|1
276814|NCT01051466|913066|P2|Overall Study|Entry Criteria Not Met|3
276815|NCT01051466|913067|P1|Overall Study|Entry Criteria Not Met|0
276816|NCT01051466|913066|P2|Overall Study|Withdrawal by Subject|1
276817|NCT01051466|913067|P1|Overall Study|Withdrawal by Subject|5
276818|NCT01051466|913066|P2|Overall Study|Lost to Follow-up|1
276819|NCT01051466|913067|P1|Overall Study|Lost to Follow-up|1
276820|NCT01051466|913066|P2|Overall Study|Adverse Event|0
276821|NCT01051466|913067|P1|Overall Study|Adverse Event|1
276822|NCT01051323|913114|P1|Overall Study|Missing|37
276823|NCT01051323|913114|P1|Overall Study|Unspecified|148
276824|NCT01051323|913114|P1|Overall Study|Hospitalization|28
276825|NCT01051323|913114|P1|Overall Study|Death|129
276826|NCT01051323|913114|P1|Overall Study|Lost to Follow-up|31
276827|NCT01051323|913114|P1|Overall Study|Withdrawal by Subject|13
276828|NCT01051323|913114|P1|Overall Study|Dialysis dependency|22
276829|NCT01051323|913114|P1|Overall Study|Transplantation|28
276830|NCT01051323|913114|P1|Overall Study|Discontinuation of treatment|103
276831|NCT01050998|913141|P5|Overall Study|Data integrity issues|4
276832|NCT01050998|913142|P4|Overall Study|Data integrity issues|1
276833|NCT01050998|913143|P3|Overall Study|Data integrity issues|1
276834|NCT01050998|913144|P2|Overall Study|Data integrity issues|0
276835|NCT01050998|913145|P1|Overall Study|Data integrity issues|0
276836|NCT01050998|913141|P5|Overall Study|Unspecified|5
276837|NCT01050998|913142|P4|Overall Study|Unspecified|1
276838|NCT01050998|913143|P3|Overall Study|Unspecified|1
276839|NCT01050998|913144|P2|Overall Study|Unspecified|2
276840|NCT01050998|913145|P1|Overall Study|Unspecified|3
276841|NCT01050998|913141|P5|Overall Study|Withdrawal by Subject|3
276842|NCT01050998|913142|P4|Overall Study|Withdrawal by Subject|1
276843|NCT01050998|913143|P3|Overall Study|Withdrawal by Subject|0
276844|NCT01050998|913144|P2|Overall Study|Withdrawal by Subject|0
276845|NCT01050998|913145|P1|Overall Study|Withdrawal by Subject|0
276846|NCT01050998|913141|P5|Overall Study|Adverse Event|2
276847|NCT01050998|913142|P4|Overall Study|Adverse Event|0
276848|NCT01050998|913143|P3|Overall Study|Adverse Event|1
276849|NCT01050998|913144|P2|Overall Study|Adverse Event|0
276850|NCT01050998|913145|P1|Overall Study|Adverse Event|1
276851|NCT01050816|913479|P1|Overall Study|patient's refusal|2
276852|NCT01050816|913479|P1|Overall Study|Lost to Follow-up|2
276853|NCT01050790|913485|P1|Overall Study|Adverse Event|1
276854|NCT01050764|913495|P1|Overall Study|Death, after HSCT|1
276855|NCT01050764|913495|P1|Overall Study|Donor mobilization failure, death|1
276856|NCT01050764|913495|P1|Overall Study|Death, before HSCT|1
276857|NCT01050673|913506|P2|Overall Study|Physician Decision|5
276858|NCT01050673|913507|P1|Overall Study|Physician Decision|4
276859|NCT01050634|913556|P1|Overall Study|Ongoing at Date of Cut-Off|5
276860|NCT01050634|913556|P1|Overall Study|Other|21
276861|NCT01050634|913556|P1|Overall Study|Lost to Follow-up|2
276862|NCT01050634|913556|P1|Overall Study|Adverse Event|42
276863|NCT01050634|913556|P1|Overall Study|Death|2
276864|NCT01050634|913556|P1|Overall Study|Enrolled, but Not Treated|56
276865|NCT01050569|913580|P3|Overall Study|Physician Decision|3
276866|NCT01050569|913581|P2|Overall Study|Physician Decision|3
276867|NCT01050569|913582|P1|Overall Study|Physician Decision|3
276868|NCT01050569|913580|P3|Overall Study|Adverse Event|0
276869|NCT01050569|913581|P2|Overall Study|Adverse Event|0
276870|NCT01050569|913582|P1|Overall Study|Adverse Event|1
276871|NCT01050569|913580|P3|Overall Study|Lack of Efficacy|3
276872|NCT01050569|913581|P2|Overall Study|Lack of Efficacy|4
276873|NCT01050569|913582|P1|Overall Study|Lack of Efficacy|5
276874|NCT01050569|913580|P3|Overall Study|Withdrawal by Subject|11
276875|NCT01050569|913581|P2|Overall Study|Withdrawal by Subject|3
276876|NCT01050569|913582|P1|Overall Study|Withdrawal by Subject|9
276877|NCT01050569|913580|P3|Overall Study|Lost to Follow-up|16
276878|NCT01050569|913581|P2|Overall Study|Lost to Follow-up|14
276879|NCT01050569|913582|P1|Overall Study|Lost to Follow-up|20
276880|NCT01050543|913601|P2|Overall Study|Administrative|1
276881|NCT01050543|913602|P1|Overall Study|Administrative|4
276882|NCT01050543|913601|P2|Overall Study|Protocol Violation|1
276883|NCT01050543|913602|P1|Overall Study|Protocol Violation|0
276884|NCT01050543|913601|P2|Overall Study|Withdrawal by Subject|2
276885|NCT01050543|913602|P1|Overall Study|Withdrawal by Subject|0
276886|NCT01050530|913610|P2|Overall Study|Protocol Violation|0
276887|NCT01050530|913611|P1|Overall Study|Protocol Violation|1
276888|NCT01050530|913610|P2|Overall Study|Withdrawal by Subject|3
276889|NCT01050530|913611|P1|Overall Study|Withdrawal by Subject|0
276890|NCT01050530|913610|P2|Overall Study|Lack of Efficacy|4
276891|NCT01050530|913611|P1|Overall Study|Lack of Efficacy|1
276892|NCT01050530|913610|P2|Overall Study|Adverse Event|3
276893|NCT01050530|913611|P1|Overall Study|Adverse Event|6
276894|NCT01050257|913622|P3|Overall Study|Death|1
276895|NCT01050257|913623|P2|Overall Study|Death|0
276896|NCT01050257|913624|P1|Overall Study|Death|0
276897|NCT01050257|913622|P3|Overall Study|Failure to return|0
276898|NCT01050257|913623|P2|Overall Study|Failure to return|2
276899|NCT01050257|913624|P1|Overall Study|Failure to return|0
276900|NCT01050257|913622|P3|Overall Study|Violation criteria|0
276901|NCT01050257|913623|P2|Overall Study|Violation criteria|1
276902|NCT01050257|913624|P1|Overall Study|Violation criteria|0
276903|NCT01050257|913622|P3|Overall Study|Refused treatment/ Did not Cooperate|0
276904|NCT01050257|913623|P2|Overall Study|Refused treatment/ Did not Cooperate|1
276905|NCT01050257|913624|P1|Overall Study|Refused treatment/ Did not Cooperate|1
276906|NCT01050257|913622|P3|Overall Study|No reason specified|2
276907|NCT01050257|913623|P2|Overall Study|No reason specified|0
276908|NCT01050257|913624|P1|Overall Study|No reason specified|0
276909|NCT01050257|913622|P3|Overall Study|Withdrawal by Subject|0
276910|NCT01050257|913623|P2|Overall Study|Withdrawal by Subject|3
276911|NCT01050257|913624|P1|Overall Study|Withdrawal by Subject|0
276912|NCT01050257|913622|P3|Overall Study|Admin/Other (did not switch to oral)|2
276913|NCT01050257|913623|P2|Overall Study|Admin/Other (did not switch to oral)|2
276914|NCT01050257|913624|P1|Overall Study|Admin/Other (did not switch to oral)|6
276915|NCT01050257|913622|P3|Overall Study|Adverse Event|2
276916|NCT01050257|913623|P2|Overall Study|Adverse Event|4
276917|NCT01050257|913624|P1|Overall Study|Adverse Event|4
276918|NCT01050218|913659|P1|Overall Study|Family emergency|1
276919|NCT01050218|913659|P1|Overall Study|Serious Adverse Event|1
276920|NCT01050218|913659|P1|Overall Study|Failed to return|7
276921|NCT01050218|913659|P1|Overall Study|Compliance|2
276922|NCT01050218|913659|P1|Overall Study|Discontinued by sponsor|18
276923|NCT01050218|913659|P1|Overall Study|Withdrawal by Subject|18
276924|NCT01050218|913659|P1|Overall Study|Protocol Violation|3
276925|NCT01050218|913659|P1|Overall Study|Lack of Efficacy|8
276926|NCT01050218|913659|P1|Overall Study|Adverse Event|37
276927|NCT01050062|913692|P2|Overall Study|Others|11
276928|NCT01050062|913693|P1|Overall Study|Others|17
276929|NCT01050062|913692|P2|Overall Study|Physician Decision|9
276930|NCT01050062|913693|P1|Overall Study|Physician Decision|74
276931|NCT01050062|913692|P2|Overall Study|Lack of Efficacy|35
276932|NCT01050062|913693|P1|Overall Study|Lack of Efficacy|22
276933|NCT01050062|913692|P2|Overall Study|Lost to Follow-up|35
276934|NCT01050062|913693|P1|Overall Study|Lost to Follow-up|83
276935|NCT01050062|913692|P2|Overall Study|Adverse Event|22
276936|NCT01050062|913693|P1|Overall Study|Adverse Event|75
276937|NCT01049984|913715|P2|Overall Study|Treatment failure|2
276938|NCT01049984|913716|P1|Overall Study|Treatment failure|0
276939|NCT01049984|913715|P2|Overall Study|Adverse Event|7
276940|NCT01049984|913716|P1|Overall Study|Adverse Event|13
276941|NCT01049984|913715|P2|Overall Study|Lost to Follow-up|1
276942|NCT01049984|913716|P1|Overall Study|Lost to Follow-up|2
276943|NCT01049984|913715|P2|Overall Study|Protocol Violation|4
276944|NCT01049984|913716|P1|Overall Study|Protocol Violation|3
276945|NCT01049984|913715|P2|Overall Study|Withdrawal by Subject|5
276946|NCT01049984|913716|P1|Overall Study|Withdrawal by Subject|1
276947|NCT01049581|913776|P2|Overall Study|Lost to Follow-up|1
276948|NCT01049581|913777|P1|Overall Study|Lost to Follow-up|2
276949|NCT01049503|913792|P6|Overall Study|Lost to Follow-up|8
276950|NCT01049503|913793|P5|Overall Study|Lost to Follow-up|27
276951|NCT01049503|913794|P4|Overall Study|Lost to Follow-up|26
276952|NCT01049503|913795|P3|Overall Study|Lost to Follow-up|24
276953|NCT01049503|913796|P2|Overall Study|Lost to Follow-up|12
276954|NCT01049503|913797|P1|Overall Study|Lost to Follow-up|11
276955|NCT01049373|913828|P2|Overall Study|Non-cooperation|1
276956|NCT01049373|913829|P1|Overall Study|Non-cooperation|0
276957|NCT01049373|913828|P2|Overall Study|Not specified|1
276958|NCT01049373|913829|P1|Overall Study|Not specified|1
276959|NCT01049373|913828|P2|Overall Study|no evaluable study values|21
276960|NCT01049373|913829|P1|Overall Study|no evaluable study values|9
276961|NCT01049373|913828|P2|Overall Study|Lost to Follow-up|4
276962|NCT01049373|913829|P1|Overall Study|Lost to Follow-up|9
276963|NCT01049373|913828|P2|Overall Study|Adverse Event|3
276964|NCT01049373|913829|P1|Overall Study|Adverse Event|3
276965|NCT01049373|913828|P2|Overall Study|Withdrawal by Subject|5
276966|NCT01049373|913829|P1|Overall Study|Withdrawal by Subject|8
276967|NCT01049373|913828|P2|Overall Study|Protocol Violation|9
276968|NCT01049373|913829|P1|Overall Study|Protocol Violation|9
276969|NCT01049360|913843|P20|Period 4|Withdrawal by Subject|0
276970|NCT01049360|913844|P19|Period 4|Withdrawal by Subject|0
276971|NCT01049360|913845|P18|Period 4|Withdrawal by Subject|0
276972|NCT01049360|913846|P17|Period 4|Withdrawal by Subject|0
276973|NCT01049360|913847|P16|Period 4|Withdrawal by Subject|0
276974|NCT01049360|913848|P15|Period 4|Withdrawal by Subject|0
276975|NCT01049360|913849|P14|Period 4|Withdrawal by Subject|0
276976|NCT01049360|913850|P13|Period 4|Withdrawal by Subject|0
276977|NCT01049360|913851|P12|Period 4|Withdrawal by Subject|0
276978|NCT01049360|913852|P11|Period 4|Withdrawal by Subject|0
276979|NCT01049360|913853|P10|Period 4|Withdrawal by Subject|0
276980|NCT01049360|913854|P9|Period 4|Withdrawal by Subject|0
276981|NCT01049360|913855|P8|Period 4|Withdrawal by Subject|0
276982|NCT01049360|913856|P7|Period 4|Withdrawal by Subject|0
276983|NCT01049360|913857|P6|Period 4|Withdrawal by Subject|0
276984|NCT01049360|913858|P5|Period 4|Withdrawal by Subject|0
276985|NCT01049360|913859|P4|Period 4|Withdrawal by Subject|1
276986|NCT01049360|913860|P3|Period 4|Withdrawal by Subject|0
276987|NCT01049360|913861|P2|Period 4|Withdrawal by Subject|0
276988|NCT01049360|913862|P1|Period 4|Withdrawal by Subject|0
276989|NCT01049360|913843|P20|Period 4|Protocol Violation|0
276990|NCT01049360|913844|P19|Period 4|Protocol Violation|0
276991|NCT01049360|913845|P18|Period 4|Protocol Violation|1
276992|NCT01049360|913846|P17|Period 4|Protocol Violation|0
276993|NCT01049360|913847|P16|Period 4|Protocol Violation|0
276994|NCT01049360|913848|P15|Period 4|Protocol Violation|0
276995|NCT01049360|913849|P14|Period 4|Protocol Violation|0
276996|NCT01049360|913850|P13|Period 4|Protocol Violation|0
276997|NCT01049360|913851|P12|Period 4|Protocol Violation|0
276998|NCT01049360|913852|P11|Period 4|Protocol Violation|0
276999|NCT01049360|913853|P10|Period 4|Protocol Violation|0
277000|NCT01049360|913854|P9|Period 4|Protocol Violation|0
277001|NCT01049360|913855|P8|Period 4|Protocol Violation|0
277002|NCT01049360|913856|P7|Period 4|Protocol Violation|0
277003|NCT01049360|913857|P6|Period 4|Protocol Violation|0
277004|NCT01049360|913858|P5|Period 4|Protocol Violation|0
277005|NCT01049360|913859|P4|Period 4|Protocol Violation|0
277006|NCT01049360|913860|P3|Period 4|Protocol Violation|0
277007|NCT01049360|913861|P2|Period 4|Protocol Violation|0
277008|NCT01049360|913862|P1|Period 4|Protocol Violation|0
277009|NCT01049360|913843|P20|Period 2|Lack of Efficacy|0
277010|NCT01049360|913844|P19|Period 2|Lack of Efficacy|0
277011|NCT01049360|913845|P18|Period 2|Lack of Efficacy|0
277012|NCT01049360|913846|P17|Period 2|Lack of Efficacy|0
277013|NCT01049360|913847|P16|Period 2|Lack of Efficacy|0
277014|NCT01049360|913848|P15|Period 2|Lack of Efficacy|0
277015|NCT01049360|913849|P14|Period 2|Lack of Efficacy|0
277016|NCT01049360|913850|P13|Period 2|Lack of Efficacy|0
277017|NCT01049360|913851|P12|Period 2|Lack of Efficacy|0
277018|NCT01049360|913852|P11|Period 2|Lack of Efficacy|0
277019|NCT01049360|913853|P10|Period 2|Lack of Efficacy|0
277020|NCT01049360|913854|P9|Period 2|Lack of Efficacy|0
277021|NCT01049360|913855|P8|Period 2|Lack of Efficacy|0
277022|NCT01049360|913856|P7|Period 2|Lack of Efficacy|0
277023|NCT01049360|913857|P6|Period 2|Lack of Efficacy|1
277024|NCT01049360|913858|P5|Period 2|Lack of Efficacy|0
277025|NCT01049360|913859|P4|Period 2|Lack of Efficacy|0
277026|NCT01049360|913860|P3|Period 2|Lack of Efficacy|0
277027|NCT01049360|913861|P2|Period 2|Lack of Efficacy|0
277028|NCT01049360|913862|P1|Period 2|Lack of Efficacy|0
277029|NCT01049360|913843|P20|Period 2|Withdrawal by Subject|1
277030|NCT01049360|913844|P19|Period 2|Withdrawal by Subject|0
277031|NCT01049360|913845|P18|Period 2|Withdrawal by Subject|0
277032|NCT01049360|913846|P17|Period 2|Withdrawal by Subject|0
277033|NCT01049360|913847|P16|Period 2|Withdrawal by Subject|0
277034|NCT01049360|913848|P15|Period 2|Withdrawal by Subject|1
277035|NCT01049360|913849|P14|Period 2|Withdrawal by Subject|0
277036|NCT01049360|913850|P13|Period 2|Withdrawal by Subject|0
277037|NCT01049360|913851|P12|Period 2|Withdrawal by Subject|0
277038|NCT01049360|913852|P11|Period 2|Withdrawal by Subject|0
277039|NCT01049360|913853|P10|Period 2|Withdrawal by Subject|0
277040|NCT01049360|913854|P9|Period 2|Withdrawal by Subject|0
277041|NCT01049360|913855|P8|Period 2|Withdrawal by Subject|0
277042|NCT01049360|913856|P7|Period 2|Withdrawal by Subject|0
277043|NCT01049360|913857|P6|Period 2|Withdrawal by Subject|0
277044|NCT01049360|913858|P5|Period 2|Withdrawal by Subject|0
277045|NCT01049360|913859|P4|Period 2|Withdrawal by Subject|1
277046|NCT01049360|913860|P3|Period 2|Withdrawal by Subject|0
277047|NCT01049360|913861|P2|Period 2|Withdrawal by Subject|0
277048|NCT01049360|913862|P1|Period 2|Withdrawal by Subject|0
277049|NCT01049360|913843|P20|Period 2|Adverse Event|1
277050|NCT01049360|913844|P19|Period 2|Adverse Event|0
277051|NCT01049360|913845|P18|Period 2|Adverse Event|0
277052|NCT01049360|913846|P17|Period 2|Adverse Event|0
277053|NCT01049360|913847|P16|Period 2|Adverse Event|0
277054|NCT01049360|913848|P15|Period 2|Adverse Event|0
277055|NCT01049360|913849|P14|Period 2|Adverse Event|0
277056|NCT01049360|913850|P13|Period 2|Adverse Event|0
277057|NCT01049360|913851|P12|Period 2|Adverse Event|0
277058|NCT01049360|913852|P11|Period 2|Adverse Event|0
277059|NCT01049360|913853|P10|Period 2|Adverse Event|0
277060|NCT01049360|913854|P9|Period 2|Adverse Event|1
277061|NCT01049360|913855|P8|Period 2|Adverse Event|0
277062|NCT01049360|913856|P7|Period 2|Adverse Event|0
277063|NCT01049360|913857|P6|Period 2|Adverse Event|0
277064|NCT01049360|913858|P5|Period 2|Adverse Event|0
277065|NCT01049360|913859|P4|Period 2|Adverse Event|0
277066|NCT01049360|913860|P3|Period 2|Adverse Event|0
277067|NCT01049360|913861|P2|Period 2|Adverse Event|1
277068|NCT01049360|913862|P1|Period 2|Adverse Event|0
277069|NCT01049360|913843|P20|Period 2|Protocol Violation|0
277070|NCT01049360|913844|P19|Period 2|Protocol Violation|0
277071|NCT01049360|913845|P18|Period 2|Protocol Violation|0
277072|NCT01049360|913846|P17|Period 2|Protocol Violation|0
277073|NCT01049360|913847|P16|Period 2|Protocol Violation|1
277074|NCT01049360|913848|P15|Period 2|Protocol Violation|1
277075|NCT01049360|913849|P14|Period 2|Protocol Violation|0
277076|NCT01049360|913850|P13|Period 2|Protocol Violation|0
277077|NCT01049360|913851|P12|Period 2|Protocol Violation|0
277078|NCT01049360|913852|P11|Period 2|Protocol Violation|0
277079|NCT01049360|913853|P10|Period 2|Protocol Violation|0
277080|NCT01049360|913854|P9|Period 2|Protocol Violation|0
277081|NCT01049360|913855|P8|Period 2|Protocol Violation|0
277082|NCT01049360|913856|P7|Period 2|Protocol Violation|0
277083|NCT01049360|913857|P6|Period 2|Protocol Violation|0
277084|NCT01049360|913858|P5|Period 2|Protocol Violation|0
277085|NCT01049360|913859|P4|Period 2|Protocol Violation|1
277086|NCT01049360|913860|P3|Period 2|Protocol Violation|0
277087|NCT01049360|913861|P2|Period 2|Protocol Violation|0
277088|NCT01049360|913862|P1|Period 2|Protocol Violation|0
277089|NCT01049360|913843|P20|Period 1|Withdrawal by Subject|0
277090|NCT01049360|913844|P19|Period 1|Withdrawal by Subject|0
277091|NCT01049360|913845|P18|Period 1|Withdrawal by Subject|0
277092|NCT01049360|913846|P17|Period 1|Withdrawal by Subject|0
277093|NCT01049360|913847|P16|Period 1|Withdrawal by Subject|0
277094|NCT01049360|913848|P15|Period 1|Withdrawal by Subject|0
277095|NCT01049360|913849|P14|Period 1|Withdrawal by Subject|0
277096|NCT01049360|913850|P13|Period 1|Withdrawal by Subject|1
277097|NCT01049360|913851|P12|Period 1|Withdrawal by Subject|0
277098|NCT01049360|913852|P11|Period 1|Withdrawal by Subject|1
277099|NCT01049360|913853|P10|Period 1|Withdrawal by Subject|0
277100|NCT01049360|913854|P9|Period 1|Withdrawal by Subject|1
277101|NCT01049360|913855|P8|Period 1|Withdrawal by Subject|0
277102|NCT01049360|913856|P7|Period 1|Withdrawal by Subject|0
277103|NCT01049360|913857|P6|Period 1|Withdrawal by Subject|0
277104|NCT01049360|913858|P5|Period 1|Withdrawal by Subject|0
277105|NCT01049360|913859|P4|Period 1|Withdrawal by Subject|0
277106|NCT01049360|913860|P3|Period 1|Withdrawal by Subject|0
277107|NCT01049360|913861|P2|Period 1|Withdrawal by Subject|0
277108|NCT01049360|913862|P1|Period 1|Withdrawal by Subject|0
277109|NCT01049360|913843|P20|Period 1|Did not meet inc/exc criteria|0
277110|NCT01049360|913844|P19|Period 1|Did not meet inc/exc criteria|0
277111|NCT01049360|913845|P18|Period 1|Did not meet inc/exc criteria|0
277112|NCT01049360|913846|P17|Period 1|Did not meet inc/exc criteria|0
277113|NCT01049360|913847|P16|Period 1|Did not meet inc/exc criteria|0
277114|NCT01049360|913848|P15|Period 1|Did not meet inc/exc criteria|0
277115|NCT01049360|913849|P14|Period 1|Did not meet inc/exc criteria|0
277116|NCT01049360|913850|P13|Period 1|Did not meet inc/exc criteria|0
277117|NCT01049360|913851|P12|Period 1|Did not meet inc/exc criteria|0
277118|NCT01049360|913852|P11|Period 1|Did not meet inc/exc criteria|0
277119|NCT01049360|913853|P10|Period 1|Did not meet inc/exc criteria|0
277120|NCT01049360|913854|P9|Period 1|Did not meet inc/exc criteria|1
277121|NCT01049360|913855|P8|Period 1|Did not meet inc/exc criteria|1
277122|NCT01049360|913856|P7|Period 1|Did not meet inc/exc criteria|0
277123|NCT01049360|913857|P6|Period 1|Did not meet inc/exc criteria|0
277124|NCT01049360|913858|P5|Period 1|Did not meet inc/exc criteria|0
277125|NCT01049360|913859|P4|Period 1|Did not meet inc/exc criteria|0
277126|NCT01049360|913860|P3|Period 1|Did not meet inc/exc criteria|0
277127|NCT01049360|913861|P2|Period 1|Did not meet inc/exc criteria|0
277128|NCT01049360|913862|P1|Period 1|Did not meet inc/exc criteria|0
277129|NCT01049360|913843|P20|Period 1|Adverse Event|0
277130|NCT01049360|913844|P19|Period 1|Adverse Event|1
277131|NCT01049360|913845|P18|Period 1|Adverse Event|0
277132|NCT01049360|913846|P17|Period 1|Adverse Event|1
277133|NCT01049360|913847|P16|Period 1|Adverse Event|0
277134|NCT01049360|913848|P15|Period 1|Adverse Event|0
277135|NCT01049360|913849|P14|Period 1|Adverse Event|1
277136|NCT01049360|913850|P13|Period 1|Adverse Event|1
277137|NCT01049360|913851|P12|Period 1|Adverse Event|0
277138|NCT01049360|913852|P11|Period 1|Adverse Event|0
277139|NCT01049360|913853|P10|Period 1|Adverse Event|0
277140|NCT01049360|913854|P9|Period 1|Adverse Event|0
277141|NCT01049360|913855|P8|Period 1|Adverse Event|1
277142|NCT01049360|913856|P7|Period 1|Adverse Event|0
277143|NCT01049360|913857|P6|Period 1|Adverse Event|0
277144|NCT01049360|913858|P5|Period 1|Adverse Event|0
277145|NCT01049360|913859|P4|Period 1|Adverse Event|1
277146|NCT01049360|913860|P3|Period 1|Adverse Event|0
277147|NCT01049360|913861|P2|Period 1|Adverse Event|1
277148|NCT01049360|913862|P1|Period 1|Adverse Event|0
277149|NCT01049308|913884|P1|Pill Counts|Withdrawal by Subject|83
277150|NCT01049217|913897|P2|Overall Study|Randomized but not Treated|2
277151|NCT01049217|913898|P1|Overall Study|Randomized but not Treated|0
277152|NCT01049217|913897|P2|Overall Study|Unspecified|2
277153|NCT01049217|913898|P1|Overall Study|Unspecified|1
277154|NCT01049217|913897|P2|Overall Study|Study Terminated by Sponsor|43
277155|NCT01049217|913898|P1|Overall Study|Study Terminated by Sponsor|43
277156|NCT01049217|913897|P2|Overall Study|Pregnancy|0
277157|NCT01049217|913898|P1|Overall Study|Pregnancy|1
277158|NCT01049217|913897|P2|Overall Study|Protocol Violation|3
277159|NCT01049217|913898|P1|Overall Study|Protocol Violation|1
277160|NCT01049217|913897|P2|Overall Study|Withdrawal by Subject|3
277161|NCT01049217|913898|P1|Overall Study|Withdrawal by Subject|4
277162|NCT01049217|913897|P2|Overall Study|Lost to Follow-up|8
277163|NCT01049217|913898|P1|Overall Study|Lost to Follow-up|3
277164|NCT01049217|913897|P2|Overall Study|Lack of Efficacy|1
277165|NCT01049217|913898|P1|Overall Study|Lack of Efficacy|1
277166|NCT01049217|913897|P2|Overall Study|Adverse Event|1
277167|NCT01049217|913898|P1|Overall Study|Adverse Event|2
277168|NCT01049009|913970|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
277169|NCT01049009|913971|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
277170|NCT01049009|913970|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
277171|NCT01049009|913971|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
277172|NCT01049009|913970|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
277173|NCT01049009|913971|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
277174|NCT01049009|913970|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
277175|NCT01049009|913971|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
277176|NCT01048944|913983|P4|Overall Study|Protocol Violation|2
277177|NCT01048944|913984|P3|Overall Study|Protocol Violation|10
277178|NCT01048944|913985|P2|Overall Study|Protocol Violation|10
277179|NCT01048944|913986|P1|Overall Study|Protocol Violation|8
277180|NCT01048788|914019|P3|Overall Study|Withdrawal by Subject|0
277181|NCT01048788|914020|P2|Overall Study|Withdrawal by Subject|1
277182|NCT01048788|914021|P1|Overall Study|Withdrawal by Subject|0
277183|NCT01048788|914019|P3|Overall Study|Lack of Efficacy|1
277184|NCT01048788|914020|P2|Overall Study|Lack of Efficacy|0
277185|NCT01048788|914021|P1|Overall Study|Lack of Efficacy|0
277186|NCT01048788|914019|P3|Overall Study|Adverse Event|1
277187|NCT01048788|914020|P2|Overall Study|Adverse Event|1
277188|NCT01048788|914021|P1|Overall Study|Adverse Event|5
277189|NCT01048671|914043|P3|Overall Study|Protocol Violation|1
277190|NCT01048671|914044|P2|Overall Study|Protocol Violation|1
277191|NCT01048671|914045|P1|Overall Study|Protocol Violation|0
277192|NCT01048541|914096|P2|Overall Study|Withdrawal by Subject|0
277193|NCT01048541|914097|P1|Overall Study|Withdrawal by Subject|1
277194|NCT01048502|914107|P4|Overall Study|Physician Decision|1
277195|NCT01048502|914108|P3|Overall Study|Physician Decision|0
277196|NCT01048502|914109|P2|Overall Study|Physician Decision|3
277197|NCT01048502|914110|P1|Overall Study|Physician Decision|0
277198|NCT01048502|914107|P4|Overall Study|Withdrawal by Subject|3
277199|NCT01048502|914108|P3|Overall Study|Withdrawal by Subject|5
277200|NCT01048502|914109|P2|Overall Study|Withdrawal by Subject|4
277201|NCT01048502|914110|P1|Overall Study|Withdrawal by Subject|1
277202|NCT01048502|914107|P4|Overall Study|Adverse Event|0
277203|NCT01048502|914108|P3|Overall Study|Adverse Event|0
277204|NCT01048502|914109|P2|Overall Study|Adverse Event|0
277205|NCT01048502|914110|P1|Overall Study|Adverse Event|1
277206|NCT01048502|914107|P4|Overall Study|Lost to Follow-up|0
277207|NCT01048502|914108|P3|Overall Study|Lost to Follow-up|0
277208|NCT01048502|914109|P2|Overall Study|Lost to Follow-up|0
277209|NCT01048502|914110|P1|Overall Study|Lost to Follow-up|2
277210|NCT01048333|914146|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
277211|NCT01048333|914147|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
277212|NCT01048333|914148|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
277213|NCT01048333|914149|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
277214|NCT01048333|914150|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
277215|NCT01048333|914151|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
277216|NCT01048242|914173|P2|Overall Study|See study flow chart|2
277217|NCT01048242|914174|P1|Overall Study|See study flow chart|4
277218|NCT01048099|914189|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
277219|NCT01048099|914189|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
277220|NCT01047553|914219|P2|Overall Study|PI's decision|1
277221|NCT01047553|914220|P1|Overall Study|PI's decision|0
277222|NCT01047553|914219|P2|Overall Study|Sever Non-Compliance to Protocol|0
277223|NCT01047553|914220|P1|Overall Study|Sever Non-Compliance to Protocol|1
277224|NCT01047553|914219|P2|Overall Study|Lost to Follow-up|0
277225|NCT01047553|914220|P1|Overall Study|Lost to Follow-up|1
277226|NCT01047553|914219|P2|Overall Study|Development of Study-Specific Withdrawal|1
277227|NCT01047553|914220|P1|Overall Study|Development of Study-Specific Withdrawal|1
277228|NCT01047553|914219|P2|Overall Study|Withdrawal by Subject|2
277229|NCT01047553|914220|P1|Overall Study|Withdrawal by Subject|4
277230|NCT01047553|914219|P2|Overall Study|Adverse Event|5
277231|NCT01047553|914220|P1|Overall Study|Adverse Event|10
277232|NCT01047436|914327|P2|Overall Study|Protocol Violation|0
277233|NCT01047436|914328|P1|Overall Study|Protocol Violation|1
277234|NCT01047345|914353|P3|Extension|Lost to Follow-up|5
277235|NCT01047345|914354|P2|Extension|Lost to Follow-up|0
277236|NCT01047345|914355|P1|Extension|Lost to Follow-up|0
277237|NCT01047345|914353|P3|Extension|Withdrawal by Subject|1
277238|NCT01047345|914354|P2|Extension|Withdrawal by Subject|0
277239|NCT01047345|914355|P1|Extension|Withdrawal by Subject|0
277240|NCT01047345|914353|P3|Base Study|Withdrawal by Subject|0
277241|NCT01047345|914354|P2|Base Study|Withdrawal by Subject|4
277242|NCT01047345|914355|P1|Base Study|Withdrawal by Subject|12
277243|NCT01047345|914353|P3|Base Study|Protocol Violation|0
277244|NCT01047345|914354|P2|Base Study|Protocol Violation|1
277245|NCT01047345|914355|P1|Base Study|Protocol Violation|3
277246|NCT01047345|914353|P3|Base Study|Lost to Follow-up|0
277247|NCT01047345|914354|P2|Base Study|Lost to Follow-up|1
277248|NCT01047345|914355|P1|Base Study|Lost to Follow-up|4
277249|NCT01047345|914353|P3|Base Study|Adverse Event|0
277250|NCT01047345|914354|P2|Base Study|Adverse Event|0
277251|NCT01047345|914355|P1|Base Study|Adverse Event|3
277252|NCT01047332|914377|P2|Overall Study|Lost to Follow-up|3
277253|NCT01047332|914378|P1|Overall Study|Lost to Follow-up|8
277254|NCT01047332|914377|P2|Overall Study|Died Unobstructed|41
277255|NCT01047332|914378|P1|Overall Study|Died Unobstructed|38
277256|NCT01047332|914377|P2|Overall Study|SEMS Obstruction|20
277257|NCT01047332|914378|P1|Overall Study|SEMS Obstruction|11
277258|NCT01047306|914392|P2|Overall Study|Lost to Follow-up|0
277259|NCT01047306|914393|P1|Overall Study|Lost to Follow-up|1
277260|NCT01047306|914392|P2|Overall Study|Withdrawal by Subject|0
277261|NCT01047306|914393|P1|Overall Study|Withdrawal by Subject|2
277262|NCT01047293|914467|P4|Overall Study|DLT criteria not fulfilled|0
277263|NCT01047293|914468|P3|Overall Study|DLT criteria not fulfilled|0
277264|NCT01047293|914469|P2|Overall Study|DLT criteria not fulfilled|1
277265|NCT01047293|914470|P1|Overall Study|DLT criteria not fulfilled|1
277266|NCT01046903|914497|P1|Overall Study|Unspecified|5
277267|NCT01046903|914497|P1|Overall Study|Withdrawal by Subject|3
277268|NCT01046903|914497|P1|Overall Study|Adverse Event|4
277269|NCT01046903|914497|P1|Overall Study|Lost to Follow-up|16
277270|NCT01046877|914510|P1|Overall Study|Exited voluntarily after tube extrusion|11
277271|NCT01046877|914510|P1|Overall Study|Exited voluntarily before tube extrusion|7
277272|NCT01046695|914526|P2|Overall Study|TENS interfered with the cardiac monitor|1
277273|NCT01046695|914527|P1|Overall Study|TENS interfered with the cardiac monitor|0
277274|NCT01046695|914526|P2|Overall Study|Subject had a pacemaker|1
277275|NCT01046695|914527|P1|Overall Study|Subject had a pacemaker|0
277276|NCT01046682|914539|P2|Overall Study|Adverse Event|0
277277|NCT01046682|914540|P1|Overall Study|Adverse Event|2
277278|NCT01046643|914548|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
277279|NCT01046643|914549|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
277280|NCT01046643|914550|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
277281|NCT01046643|914551|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
277282|NCT01046565|914573|P1|Overall Study|Withdrawal by Subject|7
277283|NCT01046565|914573|P1|Overall Study|Adverse Event|2
277284|NCT01046396|914582|P1|Overall Study|Withdrawal by Subject|5
277285|NCT01046253|914593|P2|Second Intervention|Protocol Violation|1
277286|NCT01046253|914594|P1|Second Intervention|Protocol Violation|0
277287|NCT01046253|914593|P2|Second Intervention|Adverse Event|1
277288|NCT01046253|914594|P1|Second Intervention|Adverse Event|0
277289|NCT01046136|914606|P2|Overall Study|Lost to Follow-up|3
277290|NCT01046136|914607|P1|Overall Study|Lost to Follow-up|3
277291|NCT01046136|914606|P2|Overall Study|Physician Decision|1
277292|NCT01046136|914607|P1|Overall Study|Physician Decision|1
277293|NCT01046136|914606|P2|Overall Study|Withdrawal by Subject|4
277294|NCT01046136|914607|P1|Overall Study|Withdrawal by Subject|0
277295|NCT01046110|914619|P2|Overall Study|Unclassified|35
277296|NCT01046110|914620|P1|Overall Study|Unclassified|36
277297|NCT01046110|914619|P2|Overall Study|Withdrawal Criteria|5
277298|NCT01046110|914620|P1|Overall Study|Withdrawal Criteria|3
277299|NCT01046110|914619|P2|Overall Study|Protocol Violation|12
277300|NCT01046110|914620|P1|Overall Study|Protocol Violation|7
277301|NCT01046110|914619|P2|Overall Study|Lack of Efficacy|1
277302|NCT01046110|914620|P1|Overall Study|Lack of Efficacy|0
277303|NCT01046110|914619|P2|Overall Study|Adverse Event|2
277304|NCT01046110|914620|P1|Overall Study|Adverse Event|9
277305|NCT01046084|914630|P2|Third Washout of 7 Days|Withdrawal by Subject|0
277306|NCT01046084|914631|P1|Third Washout of 7 Days|Withdrawal by Subject|2
277307|NCT01045993|914645|P4|Overall Study|Treated-later found eligibility not met|0
277308|NCT01045993|914646|P3|Overall Study|Treated-later found eligibility not met|0
277309|NCT01045993|914647|P2|Overall Study|Treated-later found eligibility not met|1
277310|NCT01045993|914648|P1|Overall Study|Treated-later found eligibility not met|0
277311|NCT01045967|914724|P2|Second Intervention|Protocol Violation|1
277312|NCT01045967|914725|P1|Second Intervention|Protocol Violation|0
277313|NCT01045798|914737|P2|Overall Study|Received Systemic Antifungal Prestudy|1
277314|NCT01045798|914738|P1|Overall Study|Received Systemic Antifungal Prestudy|0
277315|NCT01045798|914737|P2|Overall Study|Changed to Other Antifungal Therapy|2
277316|NCT01045798|914738|P1|Overall Study|Changed to Other Antifungal Therapy|1
277317|NCT01045798|914737|P2|Overall Study|Invasive Fungal Infection at Baseline|1
277318|NCT01045798|914738|P1|Overall Study|Invasive Fungal Infection at Baseline|0
277319|NCT01045798|914737|P2|Overall Study|Changed to Open-Label Caspofungin|0
277320|NCT01045798|914738|P1|Overall Study|Changed to Open-Label Caspofungin|1
277321|NCT01045707|914746|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
277322|NCT01045707|914747|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
277323|NCT01045707|914746|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
277324|NCT01045707|914747|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
277325|NCT01045707|914746|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
277326|NCT01045707|914747|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
277327|NCT01045707|914746|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
277328|NCT01045707|914747|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
277329|NCT01045707|914746|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
277330|NCT01045707|914747|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
277331|NCT01045707|914746|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
277332|NCT01045707|914747|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
277333|NCT01045707|914746|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
277334|NCT01045707|914747|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
277335|NCT01045707|914746|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
277336|NCT01045707|914747|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
277337|NCT01045707|914746|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
277338|NCT01045707|914747|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
277339|NCT01045447|914773|P2|Overall Study|Unclassified|13
277340|NCT01045447|914774|P1|Overall Study|Unclassified|17
277341|NCT01045447|914773|P2|Overall Study|Withdrawal Criteria|10
277342|NCT01045447|914774|P1|Overall Study|Withdrawal Criteria|10
277343|NCT01045447|914773|P2|Overall Study|Protocol Violation|3
277344|NCT01045447|914774|P1|Overall Study|Protocol Violation|6
277345|NCT01045447|914773|P2|Overall Study|Lack of Efficacy|1
277346|NCT01045447|914774|P1|Overall Study|Lack of Efficacy|3
277347|NCT01045447|914773|P2|Overall Study|Adverse Event|1
277348|NCT01045447|914774|P1|Overall Study|Adverse Event|0
277349|NCT01045421|914788|P11|Phase 2|Other|1
277350|NCT01045421|914789|P10|Phase 2|Other|0
277351|NCT01045421|914790|P9|Phase 2|Other|0
277352|NCT01045421|914791|P8|Phase 2|Other|3
277353|NCT01045421|914792|P7|Phase 2|Other|0
277354|NCT01045421|914793|P6|Phase 2|Other|0
277355|NCT01045421|914794|P5|Phase 2|Other|0
277356|NCT01045421|914795|P4|Phase 2|Other|0
277357|NCT01045421|914796|P3|Phase 2|Other|0
277358|NCT01045421|914797|P2|Phase 2|Other|0
277359|NCT01045421|914798|P1|Phase 2|Other|0
277360|NCT01045421|914788|P11|Phase 2|Death|0
277361|NCT01045421|914789|P10|Phase 2|Death|2
277362|NCT01045421|914790|P9|Phase 2|Death|1
277363|NCT01045421|914791|P8|Phase 2|Death|1
277364|NCT01045421|914792|P7|Phase 2|Death|0
277365|NCT01045421|914793|P6|Phase 2|Death|0
277366|NCT01045421|914794|P5|Phase 2|Death|0
277367|NCT01045421|914795|P4|Phase 2|Death|0
277368|NCT01045421|914796|P3|Phase 2|Death|0
277369|NCT01045421|914797|P2|Phase 2|Death|0
277370|NCT01045421|914798|P1|Phase 2|Death|0
277371|NCT01045421|914788|P11|Phase 2|Progressive Disease|1
277372|NCT01045421|914789|P10|Phase 2|Progressive Disease|1
277373|NCT01045421|914790|P9|Phase 2|Progressive Disease|1
277374|NCT01045421|914791|P8|Phase 2|Progressive Disease|1
277375|NCT01045421|914792|P7|Phase 2|Progressive Disease|0
277376|NCT01045421|914793|P6|Phase 2|Progressive Disease|0
277377|NCT01045421|914794|P5|Phase 2|Progressive Disease|0
277378|NCT01045421|914795|P4|Phase 2|Progressive Disease|0
277379|NCT01045421|914796|P3|Phase 2|Progressive Disease|0
277380|NCT01045421|914797|P2|Phase 2|Progressive Disease|0
277381|NCT01045421|914798|P1|Phase 2|Progressive Disease|0
277382|NCT01045421|914788|P11|Phase 1|Withdrawal by Subject|0
277383|NCT01045421|914789|P10|Phase 1|Withdrawal by Subject|0
277384|NCT01045421|914790|P9|Phase 1|Withdrawal by Subject|0
277385|NCT01045421|914791|P8|Phase 1|Withdrawal by Subject|0
277386|NCT01045421|914792|P7|Phase 1|Withdrawal by Subject|0
277387|NCT01045421|914793|P6|Phase 1|Withdrawal by Subject|0
277388|NCT01045421|914794|P5|Phase 1|Withdrawal by Subject|0
277389|NCT01045421|914795|P4|Phase 1|Withdrawal by Subject|1
277390|NCT01045421|914796|P3|Phase 1|Withdrawal by Subject|0
277391|NCT01045421|914797|P2|Phase 1|Withdrawal by Subject|0
277392|NCT01045421|914798|P1|Phase 1|Withdrawal by Subject|0
277393|NCT01045421|914788|P11|Phase 1|Progressive Disease|0
277394|NCT01045421|914789|P10|Phase 1|Progressive Disease|0
277395|NCT01045421|914790|P9|Phase 1|Progressive Disease|0
277396|NCT01045421|914791|P8|Phase 1|Progressive Disease|0
277397|NCT01045421|914792|P7|Phase 1|Progressive Disease|0
277398|NCT01045421|914793|P6|Phase 1|Progressive Disease|0
277399|NCT01045421|914794|P5|Phase 1|Progressive Disease|1
277400|NCT01045421|914795|P4|Phase 1|Progressive Disease|0
277401|NCT01045421|914796|P3|Phase 1|Progressive Disease|0
277402|NCT01045421|914797|P2|Phase 1|Progressive Disease|0
277403|NCT01045421|914798|P1|Phase 1|Progressive Disease|0
277404|NCT01045161|914892|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
277405|NCT01045161|914893|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
277406|NCT01045161|914894|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
277407|NCT01045161|914892|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
277408|NCT01045161|914893|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
277409|NCT01045161|914894|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
277410|NCT01045161|914892|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
277411|NCT01045161|914893|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
277412|NCT01045161|914894|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
277413|NCT01045161|914892|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
277414|NCT01045161|914893|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
277415|NCT01045161|914894|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
277416|NCT01045161|914892|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
277417|NCT01045161|914893|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
277418|NCT01045161|914894|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
277419|NCT01045161|914892|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
277420|NCT01045161|914893|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
277421|NCT01045161|914894|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
277422|NCT01045161|914892|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
277423|NCT01045161|914893|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
277424|NCT01045161|914894|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
277425|NCT01045161|914892|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
277426|NCT01045161|914893|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
277427|NCT01045161|914894|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
277428|NCT01045161|914892|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
277429|NCT01045161|914893|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
277430|NCT01045161|914894|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
277431|NCT01045161|914892|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
277432|NCT01045161|914893|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
277433|NCT01045161|914894|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
277434|NCT01045161|914892|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
277435|NCT01045161|914893|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
277436|NCT01045161|914894|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
277437|NCT01045161|914892|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
277438|NCT01045161|914893|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
277439|NCT01045161|914894|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
277440|NCT01045161|914892|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
277441|NCT01045161|914893|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
277442|NCT01045161|914894|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
277443|NCT01045161|914892|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
277444|NCT01045161|914893|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
277445|NCT01045161|914894|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
277446|NCT01045096|914924|P3|Overall Study|Other|0
277447|NCT01045096|914925|P2|Overall Study|Other|0
277448|NCT01045096|914926|P1|Overall Study|Other|1
277449|NCT01045096|914924|P3|Overall Study|Withdrawal by Subject|0
277450|NCT01045096|914925|P2|Overall Study|Withdrawal by Subject|0
277451|NCT01045096|914926|P1|Overall Study|Withdrawal by Subject|2
277452|NCT01044732|915001|P2|Overall Study|Technical error or malfunction|14
277453|NCT01044732|915002|P1|Overall Study|Technical error or malfunction|15
277454|NCT01044732|915001|P2|Overall Study|Inability to reach cecum|2
277455|NCT01044732|915002|P1|Overall Study|Inability to reach cecum|5
277456|NCT01044732|915001|P2|Overall Study|Inadequate bowel preparation|17
277457|NCT01044732|915002|P1|Overall Study|Inadequate bowel preparation|11
277458|NCT01044732|915001|P2|Overall Study|Withdrawal by Subject|1
277459|NCT01044732|915002|P1|Overall Study|Withdrawal by Subject|0
277460|NCT01044732|915001|P2|Overall Study|Protocol Violation|12
277461|NCT01044732|915002|P1|Overall Study|Protocol Violation|11
277462|NCT01044732|915001|P2|Overall Study|Physician Decision|3
277463|NCT01044732|915002|P1|Overall Study|Physician Decision|5
277464|NCT01044732|915001|P2|Overall Study|Lost to Follow-up|1
277465|NCT01044732|915002|P1|Overall Study|Lost to Follow-up|2
277466|NCT01044498|915180|P2|Overall Study|Not specified|0
277467|NCT01044498|915181|P1|Overall Study|Not specified|1
277468|NCT01044498|915180|P2|Overall Study|Adverse Event|1
277469|NCT01044498|915181|P1|Overall Study|Adverse Event|1
277470|NCT01044498|915180|P2|Overall Study|Withdrew consent|1
277471|NCT01044498|915181|P1|Overall Study|Withdrew consent|1
277472|NCT01044459|915207|P2|Overall Study|Lost to Follow-up|12
277473|NCT01044459|915208|P1|Overall Study|Lost to Follow-up|18
277474|NCT01044459|915207|P2|Overall Study|COPD exacerbation|8
277475|NCT01044459|915208|P1|Overall Study|COPD exacerbation|9
277476|NCT01044459|915207|P2|Overall Study|Other Reason|14
277477|NCT01044459|915208|P1|Overall Study|Other Reason|7
277478|NCT01044459|915207|P2|Overall Study|Protocol Violation|16
277479|NCT01044459|915208|P1|Overall Study|Protocol Violation|11
277480|NCT01044459|915207|P2|Overall Study|Lack of Efficacy|12
277481|NCT01044459|915208|P1|Overall Study|Lack of Efficacy|23
277482|NCT01044459|915207|P2|Overall Study|Adverse Event|20
277483|NCT01044459|915208|P1|Overall Study|Adverse Event|22
277484|NCT01044459|915207|P2|Overall Study|Terminated by Sponsor|21
277485|NCT01044459|915208|P1|Overall Study|Terminated by Sponsor|22
277486|NCT01044459|915207|P2|Overall Study|Withdrawal by Subject|28
277487|NCT01044459|915208|P1|Overall Study|Withdrawal by Subject|21
277488|NCT01044303|915216|P1|Overall Study|Lost to Follow-up|2
277489|NCT01044290|915226|P3|Follow-Up 2|Withdrawal by Subject|1
277490|NCT01044290|915227|P2|Follow-Up 2|Withdrawal by Subject|1
277491|NCT01044290|915228|P1|Follow-Up 2|Withdrawal by Subject|0
277492|NCT01044290|915226|P3|Follow-Up 2|Death|1
277493|NCT01044290|915227|P2|Follow-Up 2|Death|1
277494|NCT01044290|915228|P1|Follow-Up 2|Death|0
277495|NCT01044290|915226|P3|Follow-up 1|Withdrawal by Subject|0
277496|NCT01044290|915227|P2|Follow-up 1|Withdrawal by Subject|2
277497|NCT01044290|915228|P1|Follow-up 1|Withdrawal by Subject|2
277498|NCT01044290|915226|P3|Follow-up 1|Death|1
277499|NCT01044290|915227|P2|Follow-up 1|Death|3
277500|NCT01044290|915228|P1|Follow-up 1|Death|3
277501|NCT01043874|915344|P1|Overall Study|Administrative Problems|1
277502|NCT01043874|915344|P1|Overall Study|Lack of Efficacy|1
277503|NCT01043874|915344|P1|Overall Study|Withdrawal by Subject|1
277504|NCT01043874|915344|P1|Overall Study|Adverse Event|3
277505|NCT01043705|915354|P3|Overall Study|Unspecified|25
277506|NCT01043705|915355|P2|Overall Study|Unspecified|19
277507|NCT01043705|915356|P1|Overall Study|Unspecified|0
277508|NCT01043705|915354|P3|Overall Study|Screen Fail|0
277509|NCT01043705|915355|P2|Overall Study|Screen Fail|0
277510|NCT01043705|915356|P1|Overall Study|Screen Fail|21
277511|NCT01043705|915354|P3|Overall Study|Adverse Event|0
277512|NCT01043705|915355|P2|Overall Study|Adverse Event|2
277513|NCT01043705|915356|P1|Overall Study|Adverse Event|0
277514|NCT01043705|915354|P3|Overall Study|Subsequent Procedure|29
277515|NCT01043705|915355|P2|Overall Study|Subsequent Procedure|24
277516|NCT01043705|915356|P1|Overall Study|Subsequent Procedure|9
277517|NCT01043705|915354|P3|Overall Study|Site Closure|0
277518|NCT01043705|915355|P2|Overall Study|Site Closure|0
277519|NCT01043705|915356|P1|Overall Study|Site Closure|8
277520|NCT01043705|915354|P3|Overall Study|Withdrawal by Subject|0
277521|NCT01043705|915355|P2|Overall Study|Withdrawal by Subject|6
277522|NCT01043705|915356|P1|Overall Study|Withdrawal by Subject|8
277523|NCT01043705|915354|P3|Overall Study|Protocol Violation|0
277524|NCT01043705|915355|P2|Overall Study|Protocol Violation|1
277525|NCT01043705|915356|P1|Overall Study|Protocol Violation|2
277526|NCT01043705|915354|P3|Overall Study|Multiple Reasons|0
277527|NCT01043705|915355|P2|Overall Study|Multiple Reasons|7
277528|NCT01043705|915356|P1|Overall Study|Multiple Reasons|4
277529|NCT01043705|915354|P3|Overall Study|Lost to Follow-up|0
277530|NCT01043705|915355|P2|Overall Study|Lost to Follow-up|12
277531|NCT01043705|915356|P1|Overall Study|Lost to Follow-up|27
277532|NCT01043705|915354|P3|Overall Study|Death|26
277533|NCT01043705|915355|P2|Overall Study|Death|60
277534|NCT01043705|915356|P1|Overall Study|Death|28
277535|NCT01043185|915438|P10|Period 6 - Third Washout Period|Protocol Violation|0
277536|NCT01043185|915439|P9|Period 6 - Third Washout Period|Protocol Violation|1
277537|NCT01043185|915440|P8|Period 6 - Third Washout Period|Protocol Violation|0
277538|NCT01043185|915441|P7|Period 6 - Third Washout Period|Protocol Violation|0
277539|NCT01043185|915442|P6|Period 6 - Third Washout Period|Protocol Violation|0
277540|NCT01043185|915443|P5|Period 6 - Third Washout Period|Protocol Violation|0
277541|NCT01043185|915444|P4|Period 6 - Third Washout Period|Protocol Violation|0
277542|NCT01043185|915445|P3|Period 6 - Third Washout Period|Protocol Violation|0
277543|NCT01043185|915446|P2|Period 6 - Third Washout Period|Protocol Violation|0
277544|NCT01043185|915447|P1|Period 6 - Third Washout Period|Protocol Violation|0
277545|NCT01042977|915523|P2|Overall Study|Various|0
277546|NCT01042977|915524|P1|Overall Study|Various|3
277547|NCT01042977|915523|P2|Overall Study|Administrative reason by sponsor|1
277548|NCT01042977|915524|P1|Overall Study|Administrative reason by sponsor|0
277549|NCT01042977|915523|P2|Overall Study|Safety|2
277550|NCT01042977|915524|P1|Overall Study|Safety|0
277551|NCT01042977|915523|P2|Overall Study|Incorrect enrollment|4
277552|NCT01042977|915524|P1|Overall Study|Incorrect enrollment|6
277553|NCT01042977|915523|P2|Overall Study|Subject no longer meets study criteria|13
277554|NCT01042977|915524|P1|Overall Study|Subject no longer meets study criteria|15
277555|NCT01042977|915523|P2|Overall Study|Poor/non-compliance|4
277556|NCT01042977|915524|P1|Overall Study|Poor/non-compliance|3
277557|NCT01042977|915523|P2|Overall Study|Lost to Follow-up|2
277558|NCT01042977|915524|P1|Overall Study|Lost to Follow-up|0
277559|NCT01042977|915523|P2|Overall Study|Withdrawal by Subject|16
277560|NCT01042977|915524|P1|Overall Study|Withdrawal by Subject|8
277561|NCT01042977|915523|P2|Overall Study|Death|1
277562|NCT01042977|915524|P1|Overall Study|Death|2
277563|NCT01042977|915523|P2|Overall Study|Adverse Event|12
277564|NCT01042977|915524|P1|Overall Study|Adverse Event|4
277565|NCT01042938|915544|P2|Overall Study|Ineligible: RTOG study conflict|0
277566|NCT01042938|915545|P1|Overall Study|Ineligible: RTOG study conflict|1
277567|NCT01042938|915544|P2|Overall Study|Protocol Violation|1
277568|NCT01042938|915545|P1|Overall Study|Protocol Violation|1
277569|NCT01042938|915544|P2|Overall Study|Withdrawal by Subject|1
277570|NCT01042938|915545|P1|Overall Study|Withdrawal by Subject|1
277571|NCT01042678|915560|P6|Overall Study|Physician Decision|0
277572|NCT01042678|915561|P5|Overall Study|Physician Decision|0
277573|NCT01042678|915562|P4|Overall Study|Physician Decision|0
277574|NCT01042678|915563|P3|Overall Study|Physician Decision|0
277575|NCT01042678|915564|P2|Overall Study|Physician Decision|0
277576|NCT01042678|915565|P1|Overall Study|Physician Decision|1
277577|NCT01042600|915603|P2|Overall Study|Ineligible|0
277578|NCT01042600|915604|P1|Overall Study|Ineligible|1
277579|NCT01042535|915612|P1|Overall Study|complications from other disease|2
277580|NCT01042535|915612|P1|Overall Study|disease progression during treatment|3
277581|NCT01042535|915612|P1|Overall Study|disease progression prior to treatment|3
277582|NCT01042392|915646|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
277583|NCT01042392|915647|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
277584|NCT01042392|915648|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
277585|NCT01042392|915649|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
277586|NCT01042392|915646|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
277587|NCT01042392|915647|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
277588|NCT01042392|915648|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
277589|NCT01042392|915649|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
277590|NCT01042392|915646|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
277591|NCT01042392|915647|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
277592|NCT01042392|915648|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
277593|NCT01042392|915649|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
277594|NCT01042392|915646|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
277595|NCT01042392|915647|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
277596|NCT01042392|915648|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
277597|NCT01042392|915649|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
277598|NCT01042392|915646|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
277599|NCT01042392|915647|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
277600|NCT01042392|915648|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
277601|NCT01042392|915649|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
277602|NCT01042392|915646|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
277603|NCT01042392|915647|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
277604|NCT01042392|915648|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
277605|NCT01042392|915649|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
277606|NCT01042392|915646|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
277607|NCT01042392|915647|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
277608|NCT01042392|915648|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
277609|NCT01042392|915649|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
277610|NCT01042392|915646|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
277611|NCT01042392|915647|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
277612|NCT01042392|915648|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
277613|NCT01042392|915649|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
277614|NCT01042392|915646|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
277615|NCT01042392|915647|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
277616|NCT01042392|915648|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
277617|NCT01042392|915649|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
277618|NCT01042236|915683|P6|Treatment Period 3|Protocol Violation|0
277619|NCT01042236|915684|P5|Treatment Period 3|Protocol Violation|0
277620|NCT01042236|915685|P4|Treatment Period 3|Protocol Violation|1
277621|NCT01042236|915686|P3|Treatment Period 3|Protocol Violation|0
277622|NCT01042236|915687|P2|Treatment Period 3|Protocol Violation|0
277623|NCT01042236|915688|P1|Treatment Period 3|Protocol Violation|0
277624|NCT01042236|915683|P6|Treatment Period 3|Adverse Event|0
277625|NCT01042236|915684|P5|Treatment Period 3|Adverse Event|0
277626|NCT01042236|915685|P4|Treatment Period 3|Adverse Event|1
277627|NCT01042236|915686|P3|Treatment Period 3|Adverse Event|0
277628|NCT01042236|915687|P2|Treatment Period 3|Adverse Event|0
277629|NCT01042236|915688|P1|Treatment Period 3|Adverse Event|0
277630|NCT01042236|915683|P6|Treatment Period 1|Adverse Event|0
277631|NCT01042236|915684|P5|Treatment Period 1|Adverse Event|1
277632|NCT01042236|915685|P4|Treatment Period 1|Adverse Event|0
277633|NCT01042236|915686|P3|Treatment Period 1|Adverse Event|0
277634|NCT01042236|915687|P2|Treatment Period 1|Adverse Event|1
277635|NCT01042236|915688|P1|Treatment Period 1|Adverse Event|0
277636|NCT01042093|915748|P4|Overall Study|Withdrawal by Subject|1
277637|NCT01042093|915749|P3|Overall Study|Withdrawal by Subject|0
277638|NCT01042093|915750|P2|Overall Study|Withdrawal by Subject|0
277639|NCT01042093|915751|P1|Overall Study|Withdrawal by Subject|0
277640|NCT01042093|915748|P4|Overall Study|Protocol Violation|3
277641|NCT01042093|915749|P3|Overall Study|Protocol Violation|2
277642|NCT01042093|915750|P2|Overall Study|Protocol Violation|2
277643|NCT01042093|915751|P1|Overall Study|Protocol Violation|2
277644|NCT01041976|915771|P2|Overall Study|Death|4
277645|NCT01041976|915772|P1|Overall Study|Death|0
277646|NCT01041976|915771|P2|Overall Study|Incarceration|0
277647|NCT01041976|915772|P1|Overall Study|Incarceration|2
277648|NCT01041976|915771|P2|Overall Study|Withdrawal by Subject|0
277649|NCT01041976|915772|P1|Overall Study|Withdrawal by Subject|3
277650|NCT01041859|915782|P3|Double-Blind Maintenance|Withdrawal by Subject|9
277651|NCT01041859|915783|P2|Double-Blind Maintenance|Withdrawal by Subject|8
277652|NCT01041859|915784|P1|Double-Blind Maintenance|Withdrawal by Subject|0
277653|NCT01041859|915782|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
277654|NCT01041859|915783|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
277655|NCT01041859|915784|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
277656|NCT01041859|915782|P3|Double-Blind Maintenance|Other|2
277657|NCT01041859|915783|P2|Double-Blind Maintenance|Other|6
277658|NCT01041859|915784|P1|Double-Blind Maintenance|Other|0
277659|NCT01041859|915782|P3|Double-Blind Maintenance|Protocol Violation|3
277660|NCT01041859|915783|P2|Double-Blind Maintenance|Protocol Violation|1
277661|NCT01041859|915784|P1|Double-Blind Maintenance|Protocol Violation|0
277662|NCT01041859|915782|P3|Double-Blind Maintenance|Physician Decision|1
277663|NCT01041859|915783|P2|Double-Blind Maintenance|Physician Decision|2
277664|NCT01041859|915784|P1|Double-Blind Maintenance|Physician Decision|0
277665|NCT01041859|915782|P3|Double-Blind Maintenance|Lost to Follow-up|0
277666|NCT01041859|915783|P2|Double-Blind Maintenance|Lost to Follow-up|1
277667|NCT01041859|915784|P1|Double-Blind Maintenance|Lost to Follow-up|0
277668|NCT01041859|915782|P3|Double-Blind Maintenance|Lack of Efficacy|11
277669|NCT01041859|915783|P2|Double-Blind Maintenance|Lack of Efficacy|3
277670|NCT01041859|915784|P1|Double-Blind Maintenance|Lack of Efficacy|0
277671|NCT01041859|915782|P3|Double-Blind Maintenance|Adverse Event|13
277672|NCT01041859|915783|P2|Double-Blind Maintenance|Adverse Event|23
277673|NCT01041859|915784|P1|Double-Blind Maintenance|Adverse Event|0
277674|NCT01041859|915782|P3|Open-Label Titration|Withdrawal by Subject|0
277675|NCT01041859|915783|P2|Open-Label Titration|Withdrawal by Subject|0
277676|NCT01041859|915784|P1|Open-Label Titration|Withdrawal by Subject|11
277677|NCT01041859|915782|P3|Open-Label Titration|Noncompliance With Study Drug|0
277678|NCT01041859|915783|P2|Open-Label Titration|Noncompliance With Study Drug|0
277679|NCT01041859|915784|P1|Open-Label Titration|Noncompliance With Study Drug|8
277680|NCT01041859|915782|P3|Open-Label Titration|Other|0
277681|NCT01041859|915783|P2|Open-Label Titration|Other|0
277682|NCT01041859|915784|P1|Open-Label Titration|Other|7
277683|NCT01041859|915782|P3|Open-Label Titration|Protocol Violation|0
277684|NCT01041859|915783|P2|Open-Label Titration|Protocol Violation|0
277685|NCT01041859|915784|P1|Open-Label Titration|Protocol Violation|1
277686|NCT01041859|915782|P3|Open-Label Titration|Physician Decision|0
277687|NCT01041859|915783|P2|Open-Label Titration|Physician Decision|0
277688|NCT01041859|915784|P1|Open-Label Titration|Physician Decision|1
277689|NCT01041859|915782|P3|Open-Label Titration|Lost to Follow-up|0
277690|NCT01041859|915783|P2|Open-Label Titration|Lost to Follow-up|0
277691|NCT01041859|915784|P1|Open-Label Titration|Lost to Follow-up|1
277692|NCT01041859|915782|P3|Open-Label Titration|Lack of Efficacy|0
277693|NCT01041859|915783|P2|Open-Label Titration|Lack of Efficacy|0
277694|NCT01041859|915784|P1|Open-Label Titration|Lack of Efficacy|3
277695|NCT01041859|915782|P3|Open-Label Titration|Adverse Event|0
277696|NCT01041859|915783|P2|Open-Label Titration|Adverse Event|0
277697|NCT01041859|915784|P1|Open-Label Titration|Adverse Event|69
277698|NCT01041638|915799|P1|Overall Study|Withdrawal by Subject|11
277699|NCT01041638|915799|P1|Overall Study|Physician Decision|4
277700|NCT01041638|915799|P1|Overall Study|Lack of Efficacy|7
277701|NCT01041638|915799|P1|Overall Study|Death|1
277702|NCT01041638|915799|P1|Overall Study|Adverse Event|4
277703|NCT01041573|915807|P4|Overall Study|positive to anti-HCV|0
277704|NCT01041573|915808|P3|Overall Study|positive to anti-HCV|0
277705|NCT01041573|915809|P2|Overall Study|positive to anti-HCV|0
277706|NCT01041573|915810|P1|Overall Study|positive to anti-HCV|1
277707|NCT01041573|915807|P4|Overall Study|further blood extraction|0
277708|NCT01041573|915808|P3|Overall Study|further blood extraction|0
277709|NCT01041573|915809|P2|Overall Study|further blood extraction|1
277710|NCT01041573|915810|P1|Overall Study|further blood extraction|0
277711|NCT01041573|915807|P4|Overall Study|relocation|1
277712|NCT01041573|915808|P3|Overall Study|relocation|3
277713|NCT01041573|915809|P2|Overall Study|relocation|4
277714|NCT01041573|915810|P1|Overall Study|relocation|1
277715|NCT01041573|915807|P4|Overall Study|Adverse Event|0
277716|NCT01041573|915808|P3|Overall Study|Adverse Event|0
277717|NCT01041573|915809|P2|Overall Study|Adverse Event|2
277718|NCT01041573|915810|P1|Overall Study|Adverse Event|0
277719|NCT01041573|915807|P4|Overall Study|Lost to Follow-up|1
277720|NCT01041573|915808|P3|Overall Study|Lost to Follow-up|2
277721|NCT01041573|915809|P2|Overall Study|Lost to Follow-up|1
277722|NCT01041573|915810|P1|Overall Study|Lost to Follow-up|0
277723|NCT01041573|915807|P4|Overall Study|Death|0
277724|NCT01041573|915808|P3|Overall Study|Death|0
277725|NCT01041573|915809|P2|Overall Study|Death|0
277726|NCT01041573|915810|P1|Overall Study|Death|1
277727|NCT01041573|915807|P4|Overall Study|Withdrawal by Subject|0
277728|NCT01041573|915808|P3|Overall Study|Withdrawal by Subject|2
277729|NCT01041573|915809|P2|Overall Study|Withdrawal by Subject|5
277730|NCT01041573|915810|P1|Overall Study|Withdrawal by Subject|2
277731|NCT01041417|915822|P2|Overall Study|Death|0
277732|NCT01041417|915823|P1|Overall Study|Death|1
277733|NCT01041417|915822|P2|Overall Study|Lost to Follow-up|1
277734|NCT01041417|915823|P1|Overall Study|Lost to Follow-up|1
277735|NCT01041417|915822|P2|Overall Study|Adverse Event|2
277736|NCT01041417|915823|P1|Overall Study|Adverse Event|5
277737|NCT01041404|915861|P2|Overall Study|Not Specified|23
277738|NCT01041404|915862|P1|Overall Study|Not Specified|11
277739|NCT01041404|915861|P2|Overall Study|Failure to Return|2
277740|NCT01041404|915862|P1|Overall Study|Failure to Return|1
277741|NCT01041404|915861|P2|Overall Study|Withdrawal by Subject|23
277742|NCT01041404|915862|P1|Overall Study|Withdrawal by Subject|29
277743|NCT01041404|915861|P2|Overall Study|Protocol Violation|0
277744|NCT01041404|915862|P1|Overall Study|Protocol Violation|4
277745|NCT01041404|915861|P2|Overall Study|Violation of Selection Criteria|1
277746|NCT01041404|915862|P1|Overall Study|Violation of Selection Criteria|0
277747|NCT01041404|915861|P2|Overall Study|Lack of Efficacy|210
277748|NCT01041404|915862|P1|Overall Study|Lack of Efficacy|200
277749|NCT01041404|915861|P2|Overall Study|Adverse Event|35
277750|NCT01041404|915862|P1|Overall Study|Adverse Event|45
277751|NCT01041287|915903|P2|Treatment Period 2 (3 Months)|Adverse Event|2
277752|NCT01041287|915904|P1|Treatment Period 2 (3 Months)|Adverse Event|0
277753|NCT01041287|915903|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
277754|NCT01041287|915904|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
277755|NCT01040871|915927|P2|Overall Study|Randomized and Not Treated|1
277756|NCT01040871|915928|P1|Overall Study|Randomized and Not Treated|2
277757|NCT01040871|915927|P2|Overall Study|drug supply issue|0
277758|NCT01040871|915928|P1|Overall Study|drug supply issue|1
277759|NCT01040871|915927|P2|Overall Study|Lack of Efficacy|1
277760|NCT01040871|915928|P1|Overall Study|Lack of Efficacy|1
277761|NCT01040871|915927|P2|Overall Study|Death|3
277762|NCT01040871|915928|P1|Overall Study|Death|1
277763|NCT01040871|915927|P2|Overall Study|Withdrawal by Subject|0
277764|NCT01040871|915928|P1|Overall Study|Withdrawal by Subject|2
277765|NCT01040871|915927|P2|Overall Study|Adverse Event|2
277766|NCT01040871|915928|P1|Overall Study|Adverse Event|6
277767|NCT01040845|915979|P2|Overall Study|Physician Decision|0
277768|NCT01040845|915980|P1|Overall Study|Physician Decision|1
277769|NCT01040845|915979|P2|Overall Study|Withdrawal by Subject|1
277770|NCT01040845|915980|P1|Overall Study|Withdrawal by Subject|1
277771|NCT01040832|915995|P2|Overall Study|Unspecified|1
277772|NCT01040832|915996|P1|Overall Study|Unspecified|2
277773|NCT01040832|915995|P2|Overall Study|Symptomatic deterioration|5
277774|NCT01040832|915996|P1|Overall Study|Symptomatic deterioration|2
277775|NCT01040832|915995|P2|Overall Study|Progressive disease|17
277776|NCT01040832|915996|P1|Overall Study|Progressive disease|32
277777|NCT01040832|915995|P2|Overall Study|Withdrawal by Subject|3
277778|NCT01040832|915996|P1|Overall Study|Withdrawal by Subject|2
277779|NCT01040832|915995|P2|Overall Study|Death|6
277780|NCT01040832|915996|P1|Overall Study|Death|4
277781|NCT01040832|915995|P2|Overall Study|Adverse Event|5
277782|NCT01040832|915996|P1|Overall Study|Adverse Event|4
277783|NCT01040793|916019|P6|Overall Study|Other reasons not listed above|0
277784|NCT01040793|916020|P5|Overall Study|Other reasons not listed above|1
277785|NCT01040793|916021|P4|Overall Study|Other reasons not listed above|0
277786|NCT01040793|916022|P3|Overall Study|Other reasons not listed above|1
277787|NCT01040793|916023|P2|Overall Study|Other reasons not listed above|0
277788|NCT01040793|916024|P1|Overall Study|Other reasons not listed above|0
277789|NCT01040793|916019|P6|Overall Study|Withdrawal by Subject|0
277790|NCT01040793|916020|P5|Overall Study|Withdrawal by Subject|0
277791|NCT01040793|916021|P4|Overall Study|Withdrawal by Subject|2
277792|NCT01040793|916022|P3|Overall Study|Withdrawal by Subject|0
277793|NCT01040793|916023|P2|Overall Study|Withdrawal by Subject|0
277794|NCT01040793|916024|P1|Overall Study|Withdrawal by Subject|0
277795|NCT01040793|916019|P6|Overall Study|Lost to Follow-up|0
277796|NCT01040793|916020|P5|Overall Study|Lost to Follow-up|0
277797|NCT01040793|916021|P4|Overall Study|Lost to Follow-up|0
277798|NCT01040793|916022|P3|Overall Study|Lost to Follow-up|1
277799|NCT01040793|916023|P2|Overall Study|Lost to Follow-up|1
277800|NCT01040793|916024|P1|Overall Study|Lost to Follow-up|0
277801|NCT01040793|916019|P6|Overall Study|Protocol Violation|0
277802|NCT01040793|916020|P5|Overall Study|Protocol Violation|1
277803|NCT01040793|916021|P4|Overall Study|Protocol Violation|0
277804|NCT01040793|916022|P3|Overall Study|Protocol Violation|1
277805|NCT01040793|916023|P2|Overall Study|Protocol Violation|1
277806|NCT01040793|916024|P1|Overall Study|Protocol Violation|1
277807|NCT01040793|916019|P6|Overall Study|Adverse Event|1
277808|NCT01040793|916020|P5|Overall Study|Adverse Event|2
277809|NCT01040793|916021|P4|Overall Study|Adverse Event|2
277810|NCT01040793|916022|P3|Overall Study|Adverse Event|0
277811|NCT01040793|916023|P2|Overall Study|Adverse Event|3
277812|NCT01040793|916024|P1|Overall Study|Adverse Event|5
277813|NCT01040780|916103|P2|Overall Study|Protocol Violation|3
277814|NCT01040780|916104|P1|Overall Study|Protocol Violation|1
277815|NCT01040728|916118|P4|Overall Study|Other reasons not listed above|0
277816|NCT01040728|916119|P3|Overall Study|Other reasons not listed above|0
277817|NCT01040728|916120|P2|Overall Study|Other reasons not listed above|1
277818|NCT01040728|916121|P1|Overall Study|Other reasons not listed above|0
277819|NCT01040728|916118|P4|Overall Study|Lack of Efficacy|1
277820|NCT01040728|916119|P3|Overall Study|Lack of Efficacy|0
277821|NCT01040728|916120|P2|Overall Study|Lack of Efficacy|1
277822|NCT01040728|916121|P1|Overall Study|Lack of Efficacy|0
277823|NCT01040728|916118|P4|Overall Study|Protocol Violation|1
277824|NCT01040728|916119|P3|Overall Study|Protocol Violation|0
277825|NCT01040728|916120|P2|Overall Study|Protocol Violation|0
277826|NCT01040728|916121|P1|Overall Study|Protocol Violation|0
277827|NCT01040728|916118|P4|Overall Study|Withdrawal by Subject|0
277828|NCT01040728|916119|P3|Overall Study|Withdrawal by Subject|1
277829|NCT01040728|916120|P2|Overall Study|Withdrawal by Subject|1
277830|NCT01040728|916121|P1|Overall Study|Withdrawal by Subject|0
277831|NCT01040728|916118|P4|Overall Study|Adverse Event|4
277832|NCT01040728|916119|P3|Overall Study|Adverse Event|0
277833|NCT01040728|916120|P2|Overall Study|Adverse Event|8
277834|NCT01040728|916121|P1|Overall Study|Adverse Event|4
277835|NCT01040689|916191|P4|Overall Study|Other reasons not listed above|0
277836|NCT01040689|916192|P3|Overall Study|Other reasons not listed above|0
277837|NCT01040689|916193|P2|Overall Study|Other reasons not listed above|1
277838|NCT01040689|916194|P1|Overall Study|Other reasons not listed above|0
277839|NCT01040689|916191|P4|Overall Study|Withdrawal by Subject|0
277840|NCT01040689|916192|P3|Overall Study|Withdrawal by Subject|1
277841|NCT01040689|916193|P2|Overall Study|Withdrawal by Subject|1
277842|NCT01040689|916194|P1|Overall Study|Withdrawal by Subject|2
277843|NCT01040689|916191|P4|Overall Study|Lost to Follow-up|0
277844|NCT01040689|916192|P3|Overall Study|Lost to Follow-up|0
277845|NCT01040689|916193|P2|Overall Study|Lost to Follow-up|0
277846|NCT01040689|916194|P1|Overall Study|Lost to Follow-up|1
277847|NCT01040689|916191|P4|Overall Study|Lack of Efficacy|0
277848|NCT01040689|916192|P3|Overall Study|Lack of Efficacy|1
277849|NCT01040689|916193|P2|Overall Study|Lack of Efficacy|0
277850|NCT01040689|916194|P1|Overall Study|Lack of Efficacy|0
277851|NCT01040689|916191|P4|Overall Study|Adverse Event|4
277852|NCT01040689|916192|P3|Overall Study|Adverse Event|2
277853|NCT01040689|916193|P2|Overall Study|Adverse Event|0
277854|NCT01040689|916194|P1|Overall Study|Adverse Event|0
277855|NCT01040403|916273|P1|Overall Study|Other reason not defined above|6
277856|NCT01040403|916273|P1|Overall Study|Not treated|1
277857|NCT01040403|916273|P1|Overall Study|Lost to Follow-up|1
277858|NCT01040403|916273|P1|Overall Study|Protocol Violation|2
277859|NCT01040403|916273|P1|Overall Study|Adverse Event|10
277860|NCT01040351|916461|P2|Overall Study|poor ovarian response|2
277861|NCT01040351|916462|P1|Overall Study|poor ovarian response|1
277862|NCT01040169|916500|P2|Overall Study|Lost to Follow-up|8
277863|NCT01040169|916501|P1|Overall Study|Lost to Follow-up|3
277864|NCT01040130|916509|P6|Overall Study|Other reasons not listed above|0
277865|NCT01040130|916510|P5|Overall Study|Other reasons not listed above|0
277866|NCT01040130|916511|P4|Overall Study|Other reasons not listed above|0
277867|NCT01040130|916512|P3|Overall Study|Other reasons not listed above|0
277868|NCT01040130|916513|P2|Overall Study|Other reasons not listed above|0
277869|NCT01040130|916514|P1|Overall Study|Other reasons not listed above|2
277870|NCT01040130|916509|P6|Overall Study|Withdrawal by Subject|1
277871|NCT01040130|916510|P5|Overall Study|Withdrawal by Subject|0
277872|NCT01040130|916511|P4|Overall Study|Withdrawal by Subject|0
277873|NCT01040130|916512|P3|Overall Study|Withdrawal by Subject|0
277874|NCT01040130|916513|P2|Overall Study|Withdrawal by Subject|2
277875|NCT01040130|916514|P1|Overall Study|Withdrawal by Subject|0
277876|NCT01040130|916509|P6|Overall Study|Protocol Violation|0
277877|NCT01040130|916510|P5|Overall Study|Protocol Violation|0
277878|NCT01040130|916511|P4|Overall Study|Protocol Violation|0
277879|NCT01040130|916512|P3|Overall Study|Protocol Violation|2
277880|NCT01040130|916513|P2|Overall Study|Protocol Violation|0
277881|NCT01040130|916514|P1|Overall Study|Protocol Violation|0
277882|NCT01040130|916509|P6|Overall Study|Adverse Event|3
277883|NCT01040130|916510|P5|Overall Study|Adverse Event|0
277884|NCT01040130|916511|P4|Overall Study|Adverse Event|5
277885|NCT01040130|916512|P3|Overall Study|Adverse Event|0
277886|NCT01040130|916513|P2|Overall Study|Adverse Event|1
277887|NCT01040130|916514|P1|Overall Study|Adverse Event|1
277888|NCT01039675|916606|P2|Overall Study|Physician Decision|1
277889|NCT01039675|916607|P1|Overall Study|Physician Decision|0
277890|NCT01039675|916606|P2|Overall Study|Lost to Follow-up|1
277891|NCT01039675|916607|P1|Overall Study|Lost to Follow-up|0
277892|NCT01039675|916606|P2|Overall Study|Withdrawal by Subject|1
277893|NCT01039675|916607|P1|Overall Study|Withdrawal by Subject|0
277894|NCT01039675|916606|P2|Overall Study|Lack of Efficacy|2
277895|NCT01039675|916607|P1|Overall Study|Lack of Efficacy|0
277896|NCT01039675|916606|P2|Overall Study|Adverse Event|2
277897|NCT01039675|916607|P1|Overall Study|Adverse Event|0
277898|NCT01039584|916620|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
277899|NCT01039584|916621|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
277900|NCT01039584|916622|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
277901|NCT01039584|916620|P3|Overall Study|Pap smear with significant pathology|3
277902|NCT01039584|916621|P2|Overall Study|Pap smear with significant pathology|10
277903|NCT01039584|916622|P1|Overall Study|Pap smear with significant pathology|10
277904|NCT01039584|916620|P3|Overall Study|other|1
277905|NCT01039584|916621|P2|Overall Study|other|3
277906|NCT01039584|916622|P1|Overall Study|other|1
277907|NCT01039584|916620|P3|Overall Study|Lack of Efficacy|10
277908|NCT01039584|916621|P2|Overall Study|Lack of Efficacy|6
277909|NCT01039584|916622|P1|Overall Study|Lack of Efficacy|7
277910|NCT01039584|916620|P3|Overall Study|Negative Baseline culture for Candida|24
277911|NCT01039584|916621|P2|Overall Study|Negative Baseline culture for Candida|59
277912|NCT01039584|916622|P1|Overall Study|Negative Baseline culture for Candida|59
277913|NCT01039584|916620|P3|Overall Study|Lost to Follow-up|4
277914|NCT01039584|916621|P2|Overall Study|Lost to Follow-up|3
277915|NCT01039584|916622|P1|Overall Study|Lost to Follow-up|5
277916|NCT01039584|916620|P3|Overall Study|Protocol Violation|6
277917|NCT01039584|916621|P2|Overall Study|Protocol Violation|4
277918|NCT01039584|916622|P1|Overall Study|Protocol Violation|10
277919|NCT01039584|916620|P3|Overall Study|Withdrawal by Subject|1
277920|NCT01039584|916621|P2|Overall Study|Withdrawal by Subject|2
277921|NCT01039584|916622|P1|Overall Study|Withdrawal by Subject|4
277922|NCT01039519|916636|P1|Survival Follow-up|Sponsor decision|4
277923|NCT01039519|916636|P1|Survival Follow-up|Death|23
277924|NCT01039519|916636|P1|Treatment|Physician Decision|2
277925|NCT01039519|916636|P1|Treatment|Adverse Event|3
277926|NCT01039519|916636|P1|Treatment|Treatment failure|2
277927|NCT01039519|916636|P1|Treatment|Progressive disease|20
277928|NCT01039428|916647|P2|Overall Study|Withdrawal by Subject|0
277929|NCT01039428|916648|P1|Overall Study|Withdrawal by Subject|1
277930|NCT01039428|916647|P2|Overall Study|Protocol Violation|0
277931|NCT01039428|916648|P1|Overall Study|Protocol Violation|1
277932|NCT01039376|916672|P2|Overall Study|Ongoing|182
277933|NCT01039376|916673|P1|Overall Study|Ongoing|189
277934|NCT01039376|916672|P2|Overall Study|Withdrawal by Subject|17
277935|NCT01039376|916673|P1|Overall Study|Withdrawal by Subject|11
277936|NCT01039376|916672|P2|Overall Study|Physician Decision|2
277937|NCT01039376|916673|P1|Overall Study|Physician Decision|4
277938|NCT01039376|916672|P2|Overall Study|Lost to Follow-up|1
277939|NCT01039376|916673|P1|Overall Study|Lost to Follow-up|2
277940|NCT01038921|916897|P2|Overall Study|Physician Decision|0
277941|NCT01038921|916898|P1|Overall Study|Physician Decision|1
277942|NCT01038921|916897|P2|Overall Study|Withdrawal by Subject|0
277943|NCT01038921|916898|P1|Overall Study|Withdrawal by Subject|1
277944|NCT01038869|916904|P1|Overall Study|Lost to Follow-up|6
277945|NCT01038869|916904|P1|Overall Study|Withdrawal by Subject|1
277946|NCT01038752|916914|P2|Overall Study|Lost to Follow-up|3
277947|NCT01038752|916915|P1|Overall Study|Lost to Follow-up|3
277948|NCT01038752|916914|P2|Overall Study|Tumor Progression|2
277949|NCT01038752|916915|P1|Overall Study|Tumor Progression|2
277950|NCT01038713|916938|P3|Overall Study|Autoimmune Pancreatitis|0
277951|NCT01038713|916939|P2|Overall Study|Autoimmune Pancreatitis|0
277952|NCT01038713|916940|P1|Overall Study|Autoimmune Pancreatitis|1
277953|NCT01038713|916938|P3|Overall Study|died from PEP|0
277954|NCT01038713|916939|P2|Overall Study|died from PEP|1
277955|NCT01038713|916940|P1|Overall Study|died from PEP|0
277956|NCT01038713|916938|P3|Overall Study|Neuroendocrine Tumor|0
277957|NCT01038713|916939|P2|Overall Study|Neuroendocrine Tumor|1
277958|NCT01038713|916940|P1|Overall Study|Neuroendocrine Tumor|0
277959|NCT01038713|916938|P3|Overall Study|Lost to Follow-up|0
277960|NCT01038713|916939|P2|Overall Study|Lost to Follow-up|0
277961|NCT01038713|916940|P1|Overall Study|Lost to Follow-up|3
277962|NCT01038713|916938|P3|Overall Study|Patient to hospice|1
277963|NCT01038713|916939|P2|Overall Study|Patient to hospice|1
277964|NCT01038713|916940|P1|Overall Study|Patient to hospice|1
277965|NCT01038635|916969|P9|Overall Study|Death|2
277966|NCT01038635|916970|P8|Overall Study|Death|1
277967|NCT01038635|916971|P7|Overall Study|Death|1
277968|NCT01038635|916972|P6|Overall Study|Death|0
277969|NCT01038635|916973|P5|Overall Study|Death|1
277970|NCT01038635|916974|P4|Overall Study|Death|0
277971|NCT01038635|916975|P3|Overall Study|Death|0
277972|NCT01038635|916976|P2|Overall Study|Death|0
277973|NCT01038635|916977|P1|Overall Study|Death|0
277974|NCT01038635|916969|P9|Overall Study|Disease Progression|0
277975|NCT01038635|916970|P8|Overall Study|Disease Progression|4
277976|NCT01038635|916971|P7|Overall Study|Disease Progression|1
277977|NCT01038635|916972|P6|Overall Study|Disease Progression|0
277978|NCT01038635|916973|P5|Overall Study|Disease Progression|0
277979|NCT01038635|916974|P4|Overall Study|Disease Progression|0
277980|NCT01038635|916975|P3|Overall Study|Disease Progression|0
277981|NCT01038635|916976|P2|Overall Study|Disease Progression|0
277982|NCT01038635|916977|P1|Overall Study|Disease Progression|2
277983|NCT01038609|917003|P5|Overall Study|Refusal of Blood Draws|0
277984|NCT01038609|917004|P4|Overall Study|Refusal of Blood Draws|0
277985|NCT01038609|917005|P3|Overall Study|Refusal of Blood Draws|0
277986|NCT01038609|917006|P2|Overall Study|Refusal of Blood Draws|1
277987|NCT01038609|917007|P1|Overall Study|Refusal of Blood Draws|0
277988|NCT01038609|917003|P5|Overall Study|Death in the Family|0
277989|NCT01038609|917004|P4|Overall Study|Death in the Family|0
277990|NCT01038609|917005|P3|Overall Study|Death in the Family|0
277991|NCT01038609|917006|P2|Overall Study|Death in the Family|0
277992|NCT01038609|917007|P1|Overall Study|Death in the Family|1
277993|NCT01038609|917003|P5|Overall Study|Dosing Error|1
277994|NCT01038609|917004|P4|Overall Study|Dosing Error|1
277995|NCT01038609|917005|P3|Overall Study|Dosing Error|0
277996|NCT01038609|917006|P2|Overall Study|Dosing Error|0
277997|NCT01038609|917007|P1|Overall Study|Dosing Error|0
277998|NCT01038609|917003|P5|Overall Study|Adverse Event|0
277999|NCT01038609|917004|P4|Overall Study|Adverse Event|0
278000|NCT01038609|917005|P3|Overall Study|Adverse Event|1
278001|NCT01038609|917006|P2|Overall Study|Adverse Event|0
278002|NCT01038609|917007|P1|Overall Study|Adverse Event|0
278003|NCT01038323|917086|P3|Overall Study|Withdrawal by Subject|4
278004|NCT01038323|917087|P2|Overall Study|Withdrawal by Subject|2
278005|NCT01038323|917088|P1|Overall Study|Withdrawal by Subject|3
278006|NCT01038128|917102|P1|Overall Study|Withdrawal by Subject|2
278007|NCT01038128|917102|P1|Overall Study|Lost to Follow-up|1
278008|NCT01038128|917102|P1|Overall Study|Lack of Efficacy|1
278009|NCT01035255|917167|P2|Overall Study|patient's request|13
278010|NCT01035255|917168|P1|Overall Study|patient's request|15
278011|NCT01035255|917167|P2|Overall Study|Lost to Follow-up|5
278012|NCT01035255|917168|P1|Overall Study|Lost to Follow-up|2
278013|NCT01035255|917167|P2|Overall Study|Death|844
278014|NCT01035255|917168|P1|Overall Study|Death|724
278015|NCT01035229|917186|P2|Overall Study|Disease Progression|152
278016|NCT01035229|917187|P1|Overall Study|Disease Progression|261
278017|NCT01035229|917186|P2|Overall Study|Sponsor's decision to end study|3
278018|NCT01035229|917187|P1|Overall Study|Sponsor's decision to end study|3
278019|NCT01035229|917186|P2|Overall Study|Protocol Violation|2
278020|NCT01035229|917187|P1|Overall Study|Protocol Violation|0
278021|NCT01035229|917186|P2|Overall Study|New cancer therapy|0
278022|NCT01035229|917187|P1|Overall Study|New cancer therapy|2
278023|NCT01035229|917186|P2|Overall Study|Death|5
278024|NCT01035229|917187|P1|Overall Study|Death|13
278025|NCT01035229|917186|P2|Overall Study|Administrative problems|1
278026|NCT01035229|917187|P1|Overall Study|Administrative problems|1
278027|NCT01035229|917186|P2|Overall Study|Lost to Follow-up|0
278028|NCT01035229|917187|P1|Overall Study|Lost to Follow-up|1
278029|NCT01035229|917186|P2|Overall Study|Withdrawal by Subject|7
278030|NCT01035229|917187|P1|Overall Study|Withdrawal by Subject|20
278031|NCT01035229|917186|P2|Overall Study|Adverse Event|14
278032|NCT01035229|917187|P1|Overall Study|Adverse Event|61
278033|NCT01037244|917252|P4|Overall Study|Various|1
278034|NCT01037244|917253|P3|Overall Study|Various|1
278035|NCT01037244|917254|P2|Overall Study|Various|2
278036|NCT01037244|917255|P1|Overall Study|Various|3
278037|NCT01037244|917252|P4|Overall Study|Partner Withdrew Consent|0
278038|NCT01037244|917253|P3|Overall Study|Partner Withdrew Consent|0
278039|NCT01037244|917254|P2|Overall Study|Partner Withdrew Consent|1
278040|NCT01037244|917255|P1|Overall Study|Partner Withdrew Consent|2
278041|NCT01037244|917252|P4|Overall Study|Withdrawal by Subject|5
278042|NCT01037244|917253|P3|Overall Study|Withdrawal by Subject|3
278043|NCT01037244|917254|P2|Overall Study|Withdrawal by Subject|5
278044|NCT01037244|917255|P1|Overall Study|Withdrawal by Subject|1
278045|NCT01037244|917252|P4|Overall Study|Lost to Follow-up|4
278046|NCT01037244|917253|P3|Overall Study|Lost to Follow-up|4
278047|NCT01037244|917254|P2|Overall Study|Lost to Follow-up|3
278048|NCT01037244|917255|P1|Overall Study|Lost to Follow-up|3
278049|NCT01037244|917252|P4|Overall Study|Lack of Efficacy|1
278050|NCT01037244|917253|P3|Overall Study|Lack of Efficacy|0
278051|NCT01037244|917254|P2|Overall Study|Lack of Efficacy|1
278052|NCT01037244|917255|P1|Overall Study|Lack of Efficacy|1
278053|NCT01037244|917252|P4|Overall Study|Adverse Event|3
278054|NCT01037244|917253|P3|Overall Study|Adverse Event|6
278055|NCT01037244|917254|P2|Overall Study|Adverse Event|2
278056|NCT01037244|917255|P1|Overall Study|Adverse Event|3
278057|NCT01037218|917317|P4|Overall Study|Various|1
278058|NCT01037218|917318|P3|Overall Study|Various|3
278059|NCT01037218|917319|P2|Overall Study|Various|2
278060|NCT01037218|917320|P1|Overall Study|Various|3
278061|NCT01037218|917317|P4|Overall Study|Protocol Violation|2
278062|NCT01037218|917318|P3|Overall Study|Protocol Violation|2
278063|NCT01037218|917319|P2|Overall Study|Protocol Violation|0
278064|NCT01037218|917320|P1|Overall Study|Protocol Violation|0
278065|NCT01037218|917317|P4|Overall Study|Partner Withdrew Consent|1
278066|NCT01037218|917318|P3|Overall Study|Partner Withdrew Consent|2
278067|NCT01037218|917319|P2|Overall Study|Partner Withdrew Consent|3
278068|NCT01037218|917320|P1|Overall Study|Partner Withdrew Consent|0
278069|NCT01037218|917317|P4|Overall Study|Withdrawal by Subject|4
278070|NCT01037218|917318|P3|Overall Study|Withdrawal by Subject|7
278071|NCT01037218|917319|P2|Overall Study|Withdrawal by Subject|7
278072|NCT01037218|917320|P1|Overall Study|Withdrawal by Subject|6
278073|NCT01037218|917317|P4|Overall Study|Lost to Follow-up|2
278074|NCT01037218|917318|P3|Overall Study|Lost to Follow-up|4
278075|NCT01037218|917319|P2|Overall Study|Lost to Follow-up|5
278076|NCT01037218|917320|P1|Overall Study|Lost to Follow-up|3
278077|NCT01037218|917317|P4|Overall Study|Lack of Efficacy|5
278078|NCT01037218|917318|P3|Overall Study|Lack of Efficacy|1
278079|NCT01037218|917319|P2|Overall Study|Lack of Efficacy|2
278080|NCT01037218|917320|P1|Overall Study|Lack of Efficacy|0
278081|NCT01037218|917317|P4|Overall Study|Adverse Event|1
278082|NCT01037218|917318|P3|Overall Study|Adverse Event|2
278083|NCT01037218|917319|P2|Overall Study|Adverse Event|2
278084|NCT01037218|917320|P1|Overall Study|Adverse Event|4
278085|NCT01037127|917391|P2|Overall Study|Study Closed Terminated|17
278086|NCT01037127|917392|P1|Overall Study|Study Closed Terminated|2
278087|NCT01037127|917391|P2|Overall Study|Physician Decision|0
278088|NCT01037127|917392|P1|Overall Study|Physician Decision|1
278089|NCT01037127|917391|P2|Overall Study|Lost to Follow-up|4
278090|NCT01037127|917392|P1|Overall Study|Lost to Follow-up|2
278091|NCT01037114|917424|P1|Year 20|Others|1
278092|NCT01037088|917437|P1|Overall Study|Withdrawal by Subject|3
278093|NCT01036763|917466|P1|Overall Study|Other reason (not specified)|40
278094|NCT01036763|917466|P1|Overall Study|Lost to Follow-up|28
278095|NCT01036763|917466|P1|Overall Study|Adverse Event|25
278096|NCT01036724|917478|P2|Overall Study|Protocol Violation|5
278097|NCT01036724|917479|P1|Overall Study|Protocol Violation|4
278098|NCT01036724|917478|P2|Overall Study|Lack of Efficacy|1
278099|NCT01036724|917479|P1|Overall Study|Lack of Efficacy|1
278100|NCT01036724|917478|P2|Overall Study|Adverse Event|2
278101|NCT01036724|917479|P1|Overall Study|Adverse Event|1
278102|NCT01036529|917489|P2|Overall Study|Sponsor study termination|12
278103|NCT01036529|917490|P1|Overall Study|Sponsor study termination|11
278104|NCT01036529|917489|P2|Overall Study|Withdrawal by Subject|1
278105|NCT01036529|917490|P1|Overall Study|Withdrawal by Subject|1
278106|NCT01036529|917489|P2|Overall Study|Physician Decision|0
278107|NCT01036529|917490|P1|Overall Study|Physician Decision|1
278108|NCT01036529|917489|P2|Overall Study|Lost to Follow-up|1
278109|NCT01036529|917490|P1|Overall Study|Lost to Follow-up|0
278110|NCT01036529|917489|P2|Overall Study|Adverse Event|1
278111|NCT01036529|917490|P1|Overall Study|Adverse Event|0
278112|NCT01036438|917517|P2|Overall Study|No effect of study treatment|1
278113|NCT01036438|917518|P1|Overall Study|No effect of study treatment|3
278114|NCT01036438|917517|P2|Overall Study|Death|1
278115|NCT01036438|917518|P1|Overall Study|Death|0
278116|NCT01036438|917517|P2|Overall Study|Adverse Event|8
278117|NCT01036438|917518|P1|Overall Study|Adverse Event|7
278118|NCT01036321|917526|P2|Overall Study|Adverse Event|1
278119|NCT01036321|917527|P1|Overall Study|Adverse Event|2
278120|NCT01036321|917526|P2|Overall Study|Withdrawal by Subject|2
278121|NCT01036321|917527|P1|Overall Study|Withdrawal by Subject|3
278122|NCT01036321|917526|P2|Overall Study|Ineligible after randomization|1
278123|NCT01036321|917527|P1|Overall Study|Ineligible after randomization|0
278124|NCT01036165|917551|P1|Overall Study|Problems finding proper area to inject|1
278125|NCT01036165|917551|P1|Overall Study|Device Related Issues|3
278126|NCT01036165|917551|P1|Overall Study|Withdrawal by Subject|3
278127|NCT01036165|917551|P1|Overall Study|Lost to Follow-up|2
278128|NCT01036165|917551|P1|Overall Study|Adverse Event|6
278129|NCT01035905|917592|P2|Overall Study|Lack of Efficacy|1
278130|NCT01035905|917593|P1|Overall Study|Lack of Efficacy|1
278131|NCT01035138|917602|P3|Overall Study|Lost to Follow-up|1
278132|NCT01035138|917603|P2|Overall Study|Lost to Follow-up|0
278133|NCT01035138|917604|P1|Overall Study|Lost to Follow-up|0
278134|NCT01035138|917602|P3|Overall Study|Sponsor Decision|42
278135|NCT01035138|917603|P2|Overall Study|Sponsor Decision|60
278136|NCT01035138|917604|P1|Overall Study|Sponsor Decision|66
278137|NCT01035138|917602|P3|Overall Study|Physician Decision|1
278138|NCT01035138|917603|P2|Overall Study|Physician Decision|0
278139|NCT01035138|917604|P1|Overall Study|Physician Decision|0
278140|NCT01035138|917602|P3|Overall Study|Withdrawal by Subject|0
278141|NCT01035138|917603|P2|Overall Study|Withdrawal by Subject|0
278142|NCT01035138|917604|P1|Overall Study|Withdrawal by Subject|1
278143|NCT01035138|917602|P3|Overall Study|Caregiver Decision|1
278144|NCT01035138|917603|P2|Overall Study|Caregiver Decision|0
278145|NCT01035138|917604|P1|Overall Study|Caregiver Decision|2
278146|NCT01035138|917602|P3|Overall Study|Adverse Event|2
278147|NCT01035138|917603|P2|Overall Study|Adverse Event|0
278148|NCT01035138|917604|P1|Overall Study|Adverse Event|4
278149|NCT01035060|917660|P2|Overall Study|Physician Decision|0
278150|NCT01035060|917661|P1|Overall Study|Physician Decision|2
278151|NCT01035060|917660|P2|Overall Study|Withdrawal by Subject|6
278152|NCT01035060|917661|P1|Overall Study|Withdrawal by Subject|8
278153|NCT01035060|917660|P2|Overall Study|Did not quality after 2nd screening|1
278154|NCT01035060|917661|P1|Overall Study|Did not quality after 2nd screening|14
278155|NCT01035060|917660|P2|Overall Study|Lost to Follow-up|7
278156|NCT01035060|917661|P1|Overall Study|Lost to Follow-up|0
278157|NCT01034709|917686|P2|Overall Study|Protocol Violation|16
278158|NCT01034709|917687|P1|Overall Study|Protocol Violation|9
278159|NCT01034657|917693|P3|Randomized Phase|Adverse Event|1
278160|NCT01034657|917694|P2|Randomized Phase|Adverse Event|2
278161|NCT01034657|917695|P1|Randomized Phase|Adverse Event|0
278162|NCT01034657|917693|P3|Randomized Phase|Abnormal laboratory value|0
278163|NCT01034657|917694|P2|Randomized Phase|Abnormal laboratory value|1
278164|NCT01034657|917695|P1|Randomized Phase|Abnormal laboratory value|0
278165|NCT01034657|917693|P3|Randomized Phase|Lack of Efficacy|0
278166|NCT01034657|917694|P2|Randomized Phase|Lack of Efficacy|1
278167|NCT01034657|917695|P1|Randomized Phase|Lack of Efficacy|5
278168|NCT01034657|917693|P3|Randomized Phase|Withdrawal by Subject|0
278169|NCT01034657|917694|P2|Randomized Phase|Withdrawal by Subject|2
278170|NCT01034657|917695|P1|Randomized Phase|Withdrawal by Subject|0
278171|NCT01034657|917693|P3|Core Phase|Protocol Violation|0
278172|NCT01034657|917694|P2|Core Phase|Protocol Violation|0
278173|NCT01034657|917695|P1|Core Phase|Protocol Violation|2
278174|NCT01034657|917693|P3|Core Phase|Adverse Event|0
278175|NCT01034657|917694|P2|Core Phase|Adverse Event|0
278176|NCT01034657|917695|P1|Core Phase|Adverse Event|8
278177|NCT01034657|917693|P3|Core Phase|Abnormal laboratory value|0
278178|NCT01034657|917694|P2|Core Phase|Abnormal laboratory value|0
278179|NCT01034657|917695|P1|Core Phase|Abnormal laboratory value|1
278180|NCT01034657|917693|P3|Core Phase|Lack of Efficacy|0
278181|NCT01034657|917694|P2|Core Phase|Lack of Efficacy|0
278182|NCT01034657|917695|P1|Core Phase|Lack of Efficacy|2
278183|NCT01034657|917693|P3|Core Phase|Withdrawal by Subject|0
278184|NCT01034657|917694|P2|Core Phase|Withdrawal by Subject|0
278185|NCT01034657|917695|P1|Core Phase|Withdrawal by Subject|1
278186|NCT01034631|917736|P3|Phase II|Determined Ineligible per protocol|0
278187|NCT01034631|917737|P2|Phase II|Determined Ineligible per protocol|1
278188|NCT01034631|917738|P1|Phase II|Determined Ineligible per protocol|0
278189|NCT01034631|917736|P3|Phase II|Not Evaluable per protocol|2
278190|NCT01034631|917737|P2|Phase II|Not Evaluable per protocol|0
278191|NCT01034631|917738|P1|Phase II|Not Evaluable per protocol|0
278192|NCT01034631|917736|P3|Phase I|Symptomatic Deterioration before Treatme|0
278193|NCT01034631|917737|P2|Phase I|Symptomatic Deterioration before Treatme|0
278194|NCT01034631|917738|P1|Phase I|Symptomatic Deterioration before Treatme|3
278195|NCT01034540|917805|P2|Overall Study|Adverse Event|1
278196|NCT01034540|917806|P1|Overall Study|Adverse Event|0
278197|NCT01034462|917816|P2|Overall Study|Other reasons|2
278198|NCT01034462|917817|P1|Overall Study|Other reasons|1
278199|NCT01034462|917816|P2|Overall Study|Lost to Follow-up|16
278200|NCT01034462|917817|P1|Overall Study|Lost to Follow-up|14
278201|NCT01034462|917816|P2|Overall Study|Withdrawal by Subject|8
278202|NCT01034462|917817|P1|Overall Study|Withdrawal by Subject|9
278203|NCT01034462|917816|P2|Overall Study|Protocol Violation|7
278204|NCT01034462|917817|P1|Overall Study|Protocol Violation|10
278205|NCT01034462|917816|P2|Overall Study|Lack of Efficacy|4
278206|NCT01034462|917817|P1|Overall Study|Lack of Efficacy|4
278207|NCT01034462|917816|P2|Overall Study|Adverse Event|17
278208|NCT01034462|917817|P1|Overall Study|Adverse Event|7
278209|NCT01034397|917827|P2|Overall Study|Not specified|1
278210|NCT01034397|917828|P1|Overall Study|Not specified|0
278211|NCT01034397|917827|P2|Overall Study|Adverse Event|0
278212|NCT01034397|917828|P1|Overall Study|Adverse Event|4
278213|NCT01034397|917827|P2|Overall Study|Lack of Efficacy|0
278214|NCT01034397|917828|P1|Overall Study|Lack of Efficacy|3
278215|NCT01034397|917827|P2|Overall Study|Lack of compliance|1
278216|NCT01034397|917828|P1|Overall Study|Lack of compliance|0
278217|NCT01034358|917977|P1|Overall Study|Protocol Violation|1
278218|NCT01034358|917977|P1|Overall Study|Withdrawal by Subject|1
278219|NCT01034306|917983|P2|Overall Study|Noncomplience|0
278220|NCT01034306|917984|P1|Overall Study|Noncomplience|1
278221|NCT01034306|917983|P2|Overall Study|hospitalized and decided to stop|0
278222|NCT01034306|917984|P1|Overall Study|hospitalized and decided to stop|1
278223|NCT01034306|917983|P2|Overall Study|Withdrawal by Subject|2
278224|NCT01034306|917984|P1|Overall Study|Withdrawal by Subject|2
278225|NCT01034306|917983|P2|Overall Study|Lost to Follow-up|1
278226|NCT01034306|917984|P1|Overall Study|Lost to Follow-up|0
278227|NCT01034306|917983|P2|Overall Study|Adverse Event|0
278228|NCT01034306|917984|P1|Overall Study|Adverse Event|1
278229|NCT01034176|917992|P2|Overall Study|Lost to Follow-up|1
278230|NCT01034176|917993|P1|Overall Study|Lost to Follow-up|0
278231|NCT01034176|917992|P2|Overall Study|Withdrawal by Subject|1
278232|NCT01034176|917993|P1|Overall Study|Withdrawal by Subject|0
278233|NCT01034176|917992|P2|Overall Study|Physician Decision|0
278234|NCT01034176|917993|P1|Overall Study|Physician Decision|2
278235|NCT01034163|918003|P2|Overall Study|Abnormal laboratory value|0
278236|NCT01034163|918004|P1|Overall Study|Abnormal laboratory value|1
278237|NCT01034163|918003|P2|Overall Study|Administrative problems|1
278238|NCT01034163|918004|P1|Overall Study|Administrative problems|0
278239|NCT01034163|918003|P2|Overall Study|Adverse Event|0
278240|NCT01034163|918004|P1|Overall Study|Adverse Event|6
278241|NCT01034163|918003|P2|Overall Study|Disease progression|4
278242|NCT01034163|918004|P1|Overall Study|Disease progression|3
278243|NCT01034163|918003|P2|Overall Study|Protocol deviation|0
278244|NCT01034163|918004|P1|Overall Study|Protocol deviation|1
278245|NCT01034163|918003|P2|Overall Study|Withdrawal by Subject|2
278246|NCT01034163|918004|P1|Overall Study|Withdrawal by Subject|8
278247|NCT01034163|918003|P2|Overall Study|Treatment completed as per protocol|7
278248|NCT01034163|918004|P1|Overall Study|Treatment completed as per protocol|8
278249|NCT01034137|918013|P3|Overall Study|Administrative or other|4
278250|NCT01034137|918014|P2|Overall Study|Administrative or other|3
278251|NCT01034137|918015|P1|Overall Study|Administrative or other|2
278252|NCT01034137|918013|P3|Overall Study|Refused treatment or did not cooperate|1
278253|NCT01034137|918014|P2|Overall Study|Refused treatment or did not cooperate|0
278254|NCT01034137|918015|P1|Overall Study|Refused treatment or did not cooperate|2
278255|NCT01034137|918013|P3|Overall Study|Protocol Violation|1
278256|NCT01034137|918014|P2|Overall Study|Protocol Violation|2
278257|NCT01034137|918015|P1|Overall Study|Protocol Violation|2
278258|NCT01034137|918013|P3|Overall Study|Lack of Efficacy|13
278259|NCT01034137|918014|P2|Overall Study|Lack of Efficacy|4
278260|NCT01034137|918015|P1|Overall Study|Lack of Efficacy|9
278261|NCT01034137|918013|P3|Overall Study|Withdrawal by Subject|3
278262|NCT01034137|918014|P2|Overall Study|Withdrawal by Subject|3
278263|NCT01034137|918015|P1|Overall Study|Withdrawal by Subject|4
278264|NCT01034137|918013|P3|Overall Study|Adverse Event|8
278265|NCT01034137|918014|P2|Overall Study|Adverse Event|10
278266|NCT01034137|918015|P1|Overall Study|Adverse Event|9
278267|NCT01033942|918154|P3|Overall Study|Enrolled in Extension Study|0
278268|NCT01033942|918155|P2|Overall Study|Enrolled in Extension Study|3
278269|NCT01033942|918156|P1|Overall Study|Enrolled in Extension Study|0
278270|NCT01033942|918154|P3|Overall Study|Lost to Follow-up|0
278271|NCT01033942|918155|P2|Overall Study|Lost to Follow-up|0
278272|NCT01033942|918156|P1|Overall Study|Lost to Follow-up|1
278273|NCT01033942|918154|P3|Overall Study|Withdrawal by Subject|1
278274|NCT01033942|918155|P2|Overall Study|Withdrawal by Subject|1
278275|NCT01033942|918156|P1|Overall Study|Withdrawal by Subject|1
278276|NCT01033851|918454|P2|Overall Study|Withdrawal by Subject|7
278277|NCT01033851|918455|P1|Overall Study|Withdrawal by Subject|3
278278|NCT01033825|918470|P7|Overall Study|Other|0
278279|NCT01033825|918471|P6|Overall Study|Other|0
278280|NCT01033825|918472|P5|Overall Study|Other|1
278281|NCT01033825|918473|P4|Overall Study|Other|0
278282|NCT01033825|918474|P3|Overall Study|Other|0
278283|NCT01033825|918475|P2|Overall Study|Other|0
278284|NCT01033825|918476|P1|Overall Study|Other|0
278285|NCT01033825|918470|P7|Overall Study|Protocol Violation|0
278286|NCT01033825|918471|P6|Overall Study|Protocol Violation|0
278287|NCT01033825|918472|P5|Overall Study|Protocol Violation|0
278288|NCT01033825|918473|P4|Overall Study|Protocol Violation|0
278289|NCT01033825|918474|P3|Overall Study|Protocol Violation|0
278290|NCT01033825|918475|P2|Overall Study|Protocol Violation|0
278291|NCT01033825|918476|P1|Overall Study|Protocol Violation|1
278292|NCT01033825|918470|P7|Overall Study|Adverse Event|0
278293|NCT01033825|918471|P6|Overall Study|Adverse Event|0
278294|NCT01033825|918472|P5|Overall Study|Adverse Event|0
278295|NCT01033825|918473|P4|Overall Study|Adverse Event|1
278296|NCT01033825|918474|P3|Overall Study|Adverse Event|0
278297|NCT01033825|918475|P2|Overall Study|Adverse Event|0
278298|NCT01033825|918476|P1|Overall Study|Adverse Event|0
278299|NCT01033825|918470|P7|Overall Study|Withdrawal by Subject|0
278300|NCT01033825|918471|P6|Overall Study|Withdrawal by Subject|0
278301|NCT01033825|918472|P5|Overall Study|Withdrawal by Subject|1
278302|NCT01033825|918473|P4|Overall Study|Withdrawal by Subject|1
278303|NCT01033825|918474|P3|Overall Study|Withdrawal by Subject|2
278304|NCT01033825|918475|P2|Overall Study|Withdrawal by Subject|3
278305|NCT01033825|918476|P1|Overall Study|Withdrawal by Subject|2
278306|NCT01033747|918697|P2|Overall Study|Stopped at end of Extension 1|0
278307|NCT01033747|918698|P1|Overall Study|Stopped at end of Extension 1|2
278308|NCT01033747|918697|P2|Overall Study|Stopped at end of prolongation visit 1|0
278309|NCT01033747|918698|P1|Overall Study|Stopped at end of prolongation visit 1|1
278310|NCT01033747|918697|P2|Overall Study|Withdrawal by Subject|6
278311|NCT01033747|918698|P1|Overall Study|Withdrawal by Subject|9
278312|NCT01033747|918697|P2|Overall Study|Protocol Violation|0
278313|NCT01033747|918698|P1|Overall Study|Protocol Violation|1
278314|NCT01033747|918697|P2|Overall Study|Unsatisfactory therapeutic effect|4
278315|NCT01033747|918698|P1|Overall Study|Unsatisfactory therapeutic effect|14
278316|NCT01033747|918697|P2|Overall Study|Abnormal test procedure|1
278317|NCT01033747|918698|P1|Overall Study|Abnormal test procedure|0
278318|NCT01033747|918697|P2|Overall Study|Abnormal Laboratory Value|0
278319|NCT01033747|918698|P1|Overall Study|Abnormal Laboratory Value|1
278320|NCT01033747|918697|P2|Overall Study|Adverse Event|4
278321|NCT01033747|918698|P1|Overall Study|Adverse Event|9
278322|NCT01033734|918706|P1|Overall Study|Withdrawal by Subject|1
278323|NCT01033487|918762|P10|Fourth Intervention Period|Adverse Event|0
278324|NCT01033487|918763|P9|Fourth Intervention Period|Adverse Event|1
278325|NCT01033487|918764|P8|Fourth Intervention Period|Adverse Event|0
278326|NCT01033487|918765|P7|Fourth Intervention Period|Adverse Event|0
278327|NCT01033487|918766|P6|Fourth Intervention Period|Adverse Event|0
278328|NCT01033487|918767|P5|Fourth Intervention Period|Adverse Event|0
278329|NCT01033487|918768|P4|Fourth Intervention Period|Adverse Event|0
278330|NCT01033487|918769|P3|Fourth Intervention Period|Adverse Event|0
278331|NCT01033487|918770|P2|Fourth Intervention Period|Adverse Event|0
278332|NCT01033487|918771|P1|Fourth Intervention Period|Adverse Event|0
278333|NCT01033071|918862|P3|Overall Study|Other|3
278334|NCT01033071|918863|P2|Overall Study|Other|4
278335|NCT01033071|918864|P1|Overall Study|Other|6
278336|NCT01033071|918862|P3|Overall Study|Lack of Efficacy|1
278337|NCT01033071|918863|P2|Overall Study|Lack of Efficacy|1
278338|NCT01033071|918864|P1|Overall Study|Lack of Efficacy|0
278339|NCT01033071|918862|P3|Overall Study|Withdrawal by Subject|11
278340|NCT01033071|918863|P2|Overall Study|Withdrawal by Subject|14
278341|NCT01033071|918864|P1|Overall Study|Withdrawal by Subject|17
278342|NCT01033071|918862|P3|Overall Study|Lost to Follow-up|5
278343|NCT01033071|918863|P2|Overall Study|Lost to Follow-up|5
278344|NCT01033071|918864|P1|Overall Study|Lost to Follow-up|4
278345|NCT01033071|918862|P3|Overall Study|Protocol Violation|1
278346|NCT01033071|918863|P2|Overall Study|Protocol Violation|2
278347|NCT01033071|918864|P1|Overall Study|Protocol Violation|0
278348|NCT01033071|918862|P3|Overall Study|Adverse Event|26
278349|NCT01033071|918863|P2|Overall Study|Adverse Event|51
278350|NCT01033071|918864|P1|Overall Study|Adverse Event|28
278351|NCT01033019|918935|P2|Overall Study|Withdrawal by Subject|0
278352|NCT01033019|918936|P1|Overall Study|Withdrawal by Subject|1
278353|NCT01032915|918974|P4|Overall Study|Protocol Violation|1
278354|NCT01032915|918975|P3|Overall Study|Protocol Violation|0
278355|NCT01032915|918976|P2|Overall Study|Protocol Violation|0
278356|NCT01032915|918977|P1|Overall Study|Protocol Violation|1
278357|NCT01032915|918974|P4|Overall Study|Administrative reasons|4
278358|NCT01032915|918975|P3|Overall Study|Administrative reasons|4
278359|NCT01032915|918976|P2|Overall Study|Administrative reasons|6
278360|NCT01032915|918977|P1|Overall Study|Administrative reasons|5
278361|NCT01032915|918974|P4|Overall Study|Withdrawal by Subject|1
278362|NCT01032915|918975|P3|Overall Study|Withdrawal by Subject|1
278363|NCT01032915|918976|P2|Overall Study|Withdrawal by Subject|3
278364|NCT01032915|918977|P1|Overall Study|Withdrawal by Subject|0
278365|NCT01032915|918974|P4|Overall Study|Abnormal test procedure result|0
278366|NCT01032915|918975|P3|Overall Study|Abnormal test procedure result|1
278367|NCT01032915|918976|P2|Overall Study|Abnormal test procedure result|0
278368|NCT01032915|918977|P1|Overall Study|Abnormal test procedure result|0
278369|NCT01032915|918974|P4|Overall Study|Adverse Event|1
278370|NCT01032915|918975|P3|Overall Study|Adverse Event|1
278371|NCT01032915|918976|P2|Overall Study|Adverse Event|2
278372|NCT01032915|918977|P1|Overall Study|Adverse Event|2
278373|NCT01032889|919002|P3|Overall Study|Miscellaneous Reasons|1
278374|NCT01032889|919003|P2|Overall Study|Miscellaneous Reasons|1
278375|NCT01032889|919004|P1|Overall Study|Miscellaneous Reasons|2
278376|NCT01032889|919002|P3|Overall Study|Lack of Submental Fat|1
278377|NCT01032889|919003|P2|Overall Study|Lack of Submental Fat|8
278378|NCT01032889|919004|P1|Overall Study|Lack of Submental Fat|2
278379|NCT01032889|919002|P3|Overall Study|Lost to Follow-up|0
278380|NCT01032889|919003|P2|Overall Study|Lost to Follow-up|1
278381|NCT01032889|919004|P1|Overall Study|Lost to Follow-up|1
278382|NCT01032889|919002|P3|Overall Study|Patient Request|0
278383|NCT01032889|919003|P2|Overall Study|Patient Request|1
278384|NCT01032889|919004|P1|Overall Study|Patient Request|0
278385|NCT01032889|919002|P3|Overall Study|Withdrawal of Consent|1
278386|NCT01032889|919003|P2|Overall Study|Withdrawal of Consent|2
278387|NCT01032889|919004|P1|Overall Study|Withdrawal of Consent|1
278388|NCT01032889|919002|P3|Overall Study|Adverse Event|0
278389|NCT01032889|919003|P2|Overall Study|Adverse Event|2
278390|NCT01032889|919004|P1|Overall Study|Adverse Event|2
278391|NCT01032837|919035|P4|Overall Study|Refused treatment|1
278392|NCT01032837|919036|P3|Overall Study|Refused treatment|0
278393|NCT01032837|919037|P2|Overall Study|Refused treatment|0
278394|NCT01032837|919038|P1|Overall Study|Refused treatment|0
278395|NCT01032837|919035|P4|Overall Study|Failed to return|0
278396|NCT01032837|919036|P3|Overall Study|Failed to return|1
278397|NCT01032837|919037|P2|Overall Study|Failed to return|0
278398|NCT01032837|919038|P1|Overall Study|Failed to return|0
278399|NCT01032837|919035|P4|Overall Study|Withdrew consent|1
278400|NCT01032837|919036|P3|Overall Study|Withdrew consent|0
278401|NCT01032837|919037|P2|Overall Study|Withdrew consent|2
278402|NCT01032837|919038|P1|Overall Study|Withdrew consent|0
278403|NCT01032837|919035|P4|Overall Study|Adverse event/internal illness|1
278404|NCT01032837|919036|P3|Overall Study|Adverse event/internal illness|0
278405|NCT01032837|919037|P2|Overall Study|Adverse event/internal illness|1
278406|NCT01032837|919038|P1|Overall Study|Adverse event/internal illness|0
278407|NCT01032382|919143|P2|Overall Study|Index lesion relapse|3
278408|NCT01032382|919144|P1|Overall Study|Index lesion relapse|1
278409|NCT01032382|919143|P2|Overall Study|Treatment failure|1
278410|NCT01032382|919144|P1|Overall Study|Treatment failure|3
278411|NCT01032382|919143|P2|Overall Study|Disease dissemination|1
278412|NCT01032382|919144|P1|Overall Study|Disease dissemination|1
278413|NCT01032291|919173|P3|Proof of Concept|Never Received Study Drug|0
278414|NCT01032291|919174|P2|Proof of Concept|Never Received Study Drug|1
278415|NCT01032291|919175|P1|Proof of Concept|Never Received Study Drug|0
278416|NCT01032291|919173|P3|Proof of Concept|Lack of Efficacy|0
278417|NCT01032291|919174|P2|Proof of Concept|Lack of Efficacy|1
278418|NCT01032291|919175|P1|Proof of Concept|Lack of Efficacy|0
278419|NCT01032291|919173|P3|Proof of Concept|Death|2
278420|NCT01032291|919174|P2|Proof of Concept|Death|1
278421|NCT01032291|919175|P1|Proof of Concept|Death|0
278422|NCT01032291|919173|P3|Proof of Concept|Adverse Event|1
278423|NCT01032291|919174|P2|Proof of Concept|Adverse Event|5
278424|NCT01032291|919175|P1|Proof of Concept|Adverse Event|0
278425|NCT01032291|919173|P3|Safety Lead-in|Death|0
278426|NCT01032291|919174|P2|Safety Lead-in|Death|0
278427|NCT01032291|919175|P1|Safety Lead-in|Death|1
278428|NCT01032291|919173|P3|Safety Lead-in|Adverse Event|0
278429|NCT01032291|919174|P2|Safety Lead-in|Adverse Event|0
278430|NCT01032291|919175|P1|Safety Lead-in|Adverse Event|1
278431|NCT01032200|919222|P2|Overall Study|Multiple|1
278432|NCT01032200|919223|P1|Overall Study|Multiple|1
278433|NCT01032200|919222|P2|Overall Study|Progression|0
278434|NCT01032200|919223|P1|Overall Study|Progression|1
278435|NCT01032200|919222|P2|Overall Study|Toxicity|2
278436|NCT01032200|919223|P1|Overall Study|Toxicity|0
278437|NCT01032200|919222|P2|Overall Study|Withdrawal by Subject|3
278438|NCT01032200|919223|P1|Overall Study|Withdrawal by Subject|1
278439|NCT01032200|919222|P2|Overall Study|Death|1
278440|NCT01032200|919223|P1|Overall Study|Death|1
278441|NCT01032174|919239|P2|Overall Study|Adverse Event|1
278442|NCT01032174|919240|P1|Overall Study|Adverse Event|0
278443|NCT01032070|919480|P2|Overall Study|Withdrawal by Subject|2
278444|NCT01032070|919481|P1|Overall Study|Withdrawal by Subject|0
278445|NCT01032070|919480|P2|Overall Study|Medical or ethical reasons|2
278446|NCT01032070|919481|P1|Overall Study|Medical or ethical reasons|0
278447|NCT01032070|919480|P2|Overall Study|Disease progression|8
278448|NCT01032070|919481|P1|Overall Study|Disease progression|13
278449|NCT01032044|919510|P2|Overall Study|Lost to Follow-up|11
278450|NCT01032044|919511|P1|Overall Study|Lost to Follow-up|11
278451|NCT01032044|919510|P2|Overall Study|Adverse Event|1
278452|NCT01032044|919511|P1|Overall Study|Adverse Event|0
278453|NCT01032044|919510|P2|Overall Study|Protocol Violation|8
278454|NCT01032044|919511|P1|Overall Study|Protocol Violation|14
278455|NCT01032018|919519|P2|Overall Study|Death|1
278456|NCT01032018|919520|P1|Overall Study|Death|0
278457|NCT01032018|919519|P2|Overall Study|Lost to Follow-up|5
278458|NCT01032018|919520|P1|Overall Study|Lost to Follow-up|6
278459|NCT01031979|919530|P2|Overall Study|Lost to Follow-up|4
278460|NCT01031979|919531|P1|Overall Study|Lost to Follow-up|5
278461|NCT01031706|919569|P2|Overall Study|Withdrawal by Subject|1
278462|NCT01031706|919570|P1|Overall Study|Withdrawal by Subject|1
278463|NCT01031706|919569|P2|Overall Study|Adverse Event|0
278464|NCT01031706|919570|P1|Overall Study|Adverse Event|1
278465|NCT01031680|919580|P2|Overall Study|Various|2
278466|NCT01031680|919581|P1|Overall Study|Various|0
278467|NCT01031680|919580|P2|Overall Study|Administrative Reason by Sponsor|1
278468|NCT01031680|919581|P1|Overall Study|Administrative Reason by Sponsor|0
278469|NCT01031680|919580|P2|Overall Study|Incorrect Enrolment|2
278470|NCT01031680|919581|P1|Overall Study|Incorrect Enrolment|1
278471|NCT01031680|919580|P2|Overall Study|Safety|0
278472|NCT01031680|919581|P1|Overall Study|Safety|1
278473|NCT01031680|919580|P2|Overall Study|Poor/Non-compliance|6
278474|NCT01031680|919581|P1|Overall Study|Poor/Non-compliance|5
278475|NCT01031680|919580|P2|Overall Study|Subject No Longer Meets Study Criteria|17
278476|NCT01031680|919581|P1|Overall Study|Subject No Longer Meets Study Criteria|26
278477|NCT01031680|919580|P2|Overall Study|Death|1
278478|NCT01031680|919581|P1|Overall Study|Death|2
278479|NCT01031680|919580|P2|Overall Study|Withdrawal by Subject|16
278480|NCT01031680|919581|P1|Overall Study|Withdrawal by Subject|12
278481|NCT01031680|919580|P2|Overall Study|Lost to Follow-up|10
278482|NCT01031680|919581|P1|Overall Study|Lost to Follow-up|2
278483|NCT01031680|919580|P2|Overall Study|Adverse Event|3
278484|NCT01031680|919581|P1|Overall Study|Adverse Event|8
278485|NCT01031628|919601|P4|Overall Study|Study terminated early|0
278486|NCT01031628|919602|P3|Overall Study|Study terminated early|3
278487|NCT01031628|919603|P2|Overall Study|Study terminated early|1
278488|NCT01031628|919604|P1|Overall Study|Study terminated early|0
278489|NCT01031446|919642|P1|Overall Study|Still on treatment|1
278490|NCT01031446|919642|P1|Overall Study|Withdrawal by Subject|3
278491|NCT01031446|919642|P1|Overall Study|Physician Decision|4
278492|NCT01031446|919642|P1|Overall Study|Adverse Event|9
278493|NCT01031446|919642|P1|Overall Study|Disease Progression|38
278494|NCT01031381|919651|P1|Overall Study|Withdrawal by Subject|6
278495|NCT01031381|919651|P1|Overall Study|Physician Decision|3
278496|NCT01031004|919682|P2|Overall Study|Lost to Follow-up|0
278497|NCT01031004|919683|P1|Overall Study|Lost to Follow-up|1
278498|NCT01031004|919682|P2|Overall Study|Protocol Violation|1
278499|NCT01031004|919683|P1|Overall Study|Protocol Violation|0
278500|NCT01030965|919727|P4|Overall Study|Withdrawal by Subject|2
278501|NCT01030965|919728|P3|Overall Study|Withdrawal by Subject|0
278502|NCT01030965|919729|P2|Overall Study|Withdrawal by Subject|1
278503|NCT01030965|919730|P1|Overall Study|Withdrawal by Subject|0
278504|NCT01030965|919727|P4|Overall Study|Protocol-defined Stopping Criteria|0
278505|NCT01030965|919728|P3|Overall Study|Protocol-defined Stopping Criteria|1
278506|NCT01030965|919729|P2|Overall Study|Protocol-defined Stopping Criteria|1
278507|NCT01030965|919730|P1|Overall Study|Protocol-defined Stopping Criteria|0
278508|NCT01030965|919727|P4|Overall Study|Adverse Event|1
278509|NCT01030965|919728|P3|Overall Study|Adverse Event|2
278510|NCT01030965|919729|P2|Overall Study|Adverse Event|1
278511|NCT01030965|919730|P1|Overall Study|Adverse Event|0
278512|NCT01030965|919727|P4|Overall Study|Protocol Violation|1
278513|NCT01030965|919728|P3|Overall Study|Protocol Violation|1
278514|NCT01030965|919729|P2|Overall Study|Protocol Violation|1
278515|NCT01030965|919730|P1|Overall Study|Protocol Violation|1
278516|NCT01030965|919727|P4|Overall Study|Lack of Efficacy|3
278517|NCT01030965|919728|P3|Overall Study|Lack of Efficacy|0
278518|NCT01030965|919729|P2|Overall Study|Lack of Efficacy|2
278519|NCT01030965|919730|P1|Overall Study|Lack of Efficacy|3
278520|NCT01030952|919750|P2|Overall Study|Unexplained|1
278521|NCT01030952|919751|P1|Overall Study|Unexplained|1
278522|NCT01030952|919750|P2|Overall Study|Lost to Follow-up|1
278523|NCT01030952|919751|P1|Overall Study|Lost to Follow-up|0
278524|NCT01030952|919750|P2|Overall Study|Informed consent withdrawal|0
278525|NCT01030952|919751|P1|Overall Study|Informed consent withdrawal|1
278526|NCT01030952|919750|P2|Overall Study|Protocol Violation|1
278527|NCT01030952|919751|P1|Overall Study|Protocol Violation|0
278528|NCT01030822|919788|P3|Overall Study|Lost to Follow-up|7
278529|NCT01030822|919789|P2|Overall Study|Lost to Follow-up|4
278530|NCT01030822|919790|P1|Overall Study|Lost to Follow-up|9
278531|NCT01030822|919788|P3|Overall Study|Withdrawal by Subject|16
278532|NCT01030822|919789|P2|Overall Study|Withdrawal by Subject|13
278533|NCT01030822|919790|P1|Overall Study|Withdrawal by Subject|16
278534|NCT01030822|919788|P3|Overall Study|Moved/migrated from study area|3
278535|NCT01030822|919789|P2|Overall Study|Moved/migrated from study area|7
278536|NCT01030822|919790|P1|Overall Study|Moved/migrated from study area|6
278537|NCT01030718|919845|P3|Study CA180-036 Only|Other Reasons|0
278538|NCT01030718|919846|P2|Study CA180-036 Only|Other Reasons|2
278539|NCT01030718|919847|P1|Study CA180-036 Only|Other Reasons|0
278540|NCT01030718|919845|P3|Study CA180-036 Only|Death|0
278541|NCT01030718|919846|P2|Study CA180-036 Only|Death|1
278542|NCT01030718|919847|P1|Study CA180-036 Only|Death|0
278543|NCT01030718|919845|P3|Study CA180-036 Only|Adverse Event|0
278544|NCT01030718|919846|P2|Study CA180-036 Only|Adverse Event|3
278545|NCT01030718|919847|P1|Study CA180-036 Only|Adverse Event|2
278546|NCT01030718|919845|P3|Study CA180-036 Only|insufficient effect|5
278547|NCT01030718|919846|P2|Study CA180-036 Only|insufficient effect|1
278548|NCT01030718|919847|P1|Study CA180-036 Only|insufficient effect|1
278549|NCT01030718|919845|P3|Studies CA180-031 and -036 Combined|other reasons|0
278550|NCT01030718|919846|P2|Studies CA180-031 and -036 Combined|other reasons|2
278551|NCT01030718|919847|P1|Studies CA180-031 and -036 Combined|other reasons|0
278552|NCT01030718|919845|P3|Studies CA180-031 and -036 Combined|Death|0
278553|NCT01030718|919846|P2|Studies CA180-031 and -036 Combined|Death|1
278554|NCT01030718|919847|P1|Studies CA180-031 and -036 Combined|Death|0
278555|NCT01030718|919845|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
278556|NCT01030718|919846|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
278557|NCT01030718|919847|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
278558|NCT01030718|919845|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
278559|NCT01030718|919846|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
278560|NCT01030718|919847|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
278561|NCT01030666|919908|P2|Overall Study|Lost to Follow-up|2
278562|NCT01030666|919909|P1|Overall Study|Lost to Follow-up|3
278563|NCT01030458|919931|P2|Overall Study|Side effect of medication|1
278564|NCT01030458|919932|P1|Overall Study|Side effect of medication|1
278565|NCT01030458|919931|P2|Overall Study|Moved or changed job|13
278566|NCT01030458|919932|P1|Overall Study|Moved or changed job|6
278567|NCT01030458|919931|P2|Overall Study|Logistical reasons|5
278568|NCT01030458|919932|P1|Overall Study|Logistical reasons|9
278569|NCT01030458|919931|P2|Overall Study|Withdrawal by Subject|3
278570|NCT01030458|919932|P1|Overall Study|Withdrawal by Subject|2
278571|NCT01030458|919931|P2|Overall Study|Lost to Follow-up|10
278572|NCT01030458|919932|P1|Overall Study|Lost to Follow-up|9
278573|NCT01029925|919944|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
278574|NCT01029925|919944|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
278575|NCT01029925|919944|P1|Completion of Cycle 1 (28 Days)|Death|2
278576|NCT01029886|919950|P2|Overall Study|Loss Glucose Control|1
278577|NCT01029886|919951|P1|Overall Study|Loss Glucose Control|7
278578|NCT01029886|919950|P2|Overall Study|Sponsor Decision|0
278579|NCT01029886|919951|P1|Overall Study|Sponsor Decision|1
278580|NCT01029886|919950|P2|Overall Study|Entry Criteria Not Met|5
278581|NCT01029886|919951|P1|Overall Study|Entry Criteria Not Met|13
278582|NCT01029886|919950|P2|Overall Study|Withdrawal by Subject|18
278583|NCT01029886|919951|P1|Overall Study|Withdrawal by Subject|8
278584|NCT01029886|919950|P2|Overall Study|Protocol Violation|5
278585|NCT01029886|919951|P1|Overall Study|Protocol Violation|17
278586|NCT01029886|919950|P2|Overall Study|Physician Decision|6
278587|NCT01029886|919951|P1|Overall Study|Physician Decision|2
278588|NCT01029886|919950|P2|Overall Study|Lost to Follow-up|0
278589|NCT01029886|919951|P1|Overall Study|Lost to Follow-up|1
278590|NCT01029886|919950|P2|Overall Study|Adverse Event|25
278591|NCT01029886|919951|P1|Overall Study|Adverse Event|12
278592|NCT01029795|919979|P2|Overall Study|Withdrawal by Subject|3
278593|NCT01029795|919980|P1|Overall Study|Withdrawal by Subject|1
278594|NCT01029795|919979|P2|Overall Study|Sponsor Decision|17
278595|NCT01029795|919980|P1|Overall Study|Sponsor Decision|11
278596|NCT01029795|919979|P2|Overall Study|Physician Decision|1
278597|NCT01029795|919980|P1|Overall Study|Physician Decision|2
278598|NCT01029795|919979|P2|Overall Study|Entry Criteria Not Met|1
278599|NCT01029795|919980|P1|Overall Study|Entry Criteria Not Met|2
278600|NCT01029652|920077|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
278601|NCT01029652|920078|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
278602|NCT01029652|920077|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
278603|NCT01029652|920078|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
278604|NCT01029652|920077|P2|Extension Study 2 (25-72 Weeks)|Death|1
278605|NCT01029652|920078|P1|Extension Study 2 (25-72 Weeks)|Death|1
278606|NCT01029652|920077|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
278607|NCT01029652|920078|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
278608|NCT01029652|920077|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
278609|NCT01029652|920078|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
278610|NCT01029652|920077|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
278611|NCT01029652|920078|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
278612|NCT01029652|920077|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
278613|NCT01029652|920078|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
278614|NCT01029652|920077|P2|Core Study (0-12 Weeks)|Death|1
278615|NCT01029652|920078|P1|Core Study (0-12 Weeks)|Death|0
278616|NCT01029652|920077|P2|Core Study (0-12 Weeks)|Administrative problems|1
278617|NCT01029652|920078|P1|Core Study (0-12 Weeks)|Administrative problems|2
278618|NCT01029652|920077|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
278619|NCT01029652|920078|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
278620|NCT01029652|920077|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
278621|NCT01029652|920078|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
278622|NCT01029652|920077|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
278623|NCT01029652|920078|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
278624|NCT01029535|920156|P1|Overall Study|Death|1
278625|NCT01029535|920156|P1|Overall Study|Use of Another Treatment|1
278626|NCT01029535|920156|P1|Overall Study|Adverse Event|1
278627|NCT01029535|920156|P1|Overall Study|Participant Withdrew Consent|2
278628|NCT01029535|920156|P1|Overall Study|Protocol Violation|2
278629|NCT01029535|920156|P1|Overall Study|Lost to Follow-up|24
278630|NCT01029405|920185|P4|Overall Study|Unspecified|1
278631|NCT01029405|920186|P3|Overall Study|Unspecified|0
278632|NCT01029405|920187|P2|Overall Study|Unspecified|1
278633|NCT01029405|920188|P1|Overall Study|Unspecified|0
278634|NCT01029405|920185|P4|Overall Study|Lost to Follow-up|2
278635|NCT01029405|920186|P3|Overall Study|Lost to Follow-up|1
278636|NCT01029405|920187|P2|Overall Study|Lost to Follow-up|1
278637|NCT01029405|920188|P1|Overall Study|Lost to Follow-up|2
278638|NCT01029405|920185|P4|Overall Study|Adverse Event|1
278639|NCT01029405|920186|P3|Overall Study|Adverse Event|1
278640|NCT01029405|920187|P2|Overall Study|Adverse Event|0
278641|NCT01029405|920188|P1|Overall Study|Adverse Event|0
278642|NCT01029405|920185|P4|Overall Study|Protocol Violation|1
278643|NCT01029405|920186|P3|Overall Study|Protocol Violation|0
278644|NCT01029405|920187|P2|Overall Study|Protocol Violation|0
278645|NCT01029405|920188|P1|Overall Study|Protocol Violation|0
278646|NCT01029405|920185|P4|Overall Study|Withdrawal by Subject|0
278647|NCT01029405|920186|P3|Overall Study|Withdrawal by Subject|2
278648|NCT01029405|920187|P2|Overall Study|Withdrawal by Subject|1
278649|NCT01029405|920188|P1|Overall Study|Withdrawal by Subject|0
278650|NCT01029392|920200|P2|Overall Study|Physician Decision|0
278651|NCT01029392|920201|P1|Overall Study|Physician Decision|2
278652|NCT01029392|920200|P2|Overall Study|Withdrawal by Subject|11
278653|NCT01029392|920201|P1|Overall Study|Withdrawal by Subject|18
278654|NCT01029366|920211|P2|Overall Study|manufacturing failure|1
278655|NCT01029366|920212|P1|Overall Study|manufacturing failure|0
278656|NCT01029366|920211|P2|Overall Study|disease progression|0
278657|NCT01029366|920212|P1|Overall Study|disease progression|2
278658|NCT01029366|920211|P2|Overall Study|Death|1
278659|NCT01029366|920212|P1|Overall Study|Death|1
278660|NCT01029366|920211|P2|Overall Study|Withdrawal by Subject|0
278661|NCT01029366|920212|P1|Overall Study|Withdrawal by Subject|1
278662|NCT01029340|920224|P6|Extension Period|Physician Decision|1
278663|NCT01029340|920225|P5|Extension Period|Physician Decision|0
278664|NCT01029340|920226|P4|Extension Period|Physician Decision|0
278665|NCT01029340|920227|P3|Extension Period|Physician Decision|0
278666|NCT01029340|920228|P2|Extension Period|Physician Decision|0
278667|NCT01029340|920229|P1|Extension Period|Physician Decision|0
278668|NCT01029340|920224|P6|Extension Period|Withdrawal by Subject|1
278669|NCT01029340|920225|P5|Extension Period|Withdrawal by Subject|0
278670|NCT01029340|920226|P4|Extension Period|Withdrawal by Subject|0
278671|NCT01029340|920227|P3|Extension Period|Withdrawal by Subject|0
278672|NCT01029340|920228|P2|Extension Period|Withdrawal by Subject|0
278673|NCT01029340|920229|P1|Extension Period|Withdrawal by Subject|0
278674|NCT01029340|920224|P6|Extension Period|non-compliance|1
278675|NCT01029340|920225|P5|Extension Period|non-compliance|0
278676|NCT01029340|920226|P4|Extension Period|non-compliance|0
278677|NCT01029340|920227|P3|Extension Period|non-compliance|0
278678|NCT01029340|920228|P2|Extension Period|non-compliance|0
278679|NCT01029340|920229|P1|Extension Period|non-compliance|0
278680|NCT01029340|920224|P6|Extension Period|starting another study|8
278681|NCT01029340|920225|P5|Extension Period|starting another study|0
278682|NCT01029340|920226|P4|Extension Period|starting another study|0
278683|NCT01029340|920227|P3|Extension Period|starting another study|0
278684|NCT01029340|920228|P2|Extension Period|starting another study|0
278685|NCT01029340|920229|P1|Extension Period|starting another study|0
278686|NCT01029340|920224|P6|Extension Period|Adverse Event|1
278687|NCT01029340|920225|P5|Extension Period|Adverse Event|0
278688|NCT01029340|920226|P4|Extension Period|Adverse Event|0
278689|NCT01029340|920227|P3|Extension Period|Adverse Event|0
278690|NCT01029340|920228|P2|Extension Period|Adverse Event|0
278691|NCT01029340|920229|P1|Extension Period|Adverse Event|0
278692|NCT01029340|920224|P6|Part B Treatment Period|Protocol Violation|0
278693|NCT01029340|920225|P5|Part B Treatment Period|Protocol Violation|0
278694|NCT01029340|920226|P4|Part B Treatment Period|Protocol Violation|0
278695|NCT01029340|920227|P3|Part B Treatment Period|Protocol Violation|1
278696|NCT01029340|920228|P2|Part B Treatment Period|Protocol Violation|0
278697|NCT01029340|920229|P1|Part B Treatment Period|Protocol Violation|0
278698|NCT01029340|920224|P6|Part B Treatment Period|Withdrawal by Subject|0
278699|NCT01029340|920225|P5|Part B Treatment Period|Withdrawal by Subject|0
278700|NCT01029340|920226|P4|Part B Treatment Period|Withdrawal by Subject|0
278701|NCT01029340|920227|P3|Part B Treatment Period|Withdrawal by Subject|1
278702|NCT01029340|920228|P2|Part B Treatment Period|Withdrawal by Subject|0
278703|NCT01029340|920229|P1|Part B Treatment Period|Withdrawal by Subject|0
278704|NCT01028053|920279|P1|Overall Study|Various reasons|4
278705|NCT01028053|920279|P1|Overall Study|Terminated by Sponsor|1
278706|NCT01028053|920279|P1|Overall Study|Technical Problem|1
278707|NCT01028053|920279|P1|Overall Study|Physician Decision|2
278708|NCT01028053|920279|P1|Overall Study|Protocol Violation|1
278709|NCT01028053|920279|P1|Overall Study|Patient Request|11
278710|NCT01028053|920279|P1|Overall Study|Screen Failure|113
278711|NCT01028027|920287|P2|Overall Study|Lack of Efficacy|1
278712|NCT01028027|920288|P1|Overall Study|Lack of Efficacy|0
278713|NCT01028027|920287|P2|Overall Study|Protocol Violation|1
278714|NCT01028027|920288|P1|Overall Study|Protocol Violation|3
278715|NCT01028027|920287|P2|Overall Study|Adverse Event|7
278716|NCT01028027|920288|P1|Overall Study|Adverse Event|4
278717|NCT01028027|920287|P2|Overall Study|Withdrawal by Subject|3
278718|NCT01028027|920288|P1|Overall Study|Withdrawal by Subject|5
278719|NCT01028027|920287|P2|Overall Study|Lost to Follow-up|1
278720|NCT01028027|920288|P1|Overall Study|Lost to Follow-up|4
278721|NCT01028014|920310|P6|Overall Study|Lost to Follow-up|2
278722|NCT01028014|920311|P5|Overall Study|Lost to Follow-up|1
278723|NCT01028014|920312|P4|Overall Study|Lost to Follow-up|1
278724|NCT01028014|920313|P3|Overall Study|Lost to Follow-up|0
278725|NCT01028014|920314|P2|Overall Study|Lost to Follow-up|2
278726|NCT01028014|920315|P1|Overall Study|Lost to Follow-up|1
278727|NCT01029262|920343|P2|Overall Study|Unspecified|5
278728|NCT01029262|920344|P1|Overall Study|Unspecified|1
278729|NCT01029262|920343|P2|Overall Study|Protocol Violation|3
278730|NCT01029262|920344|P1|Overall Study|Protocol Violation|2
278731|NCT01029262|920343|P2|Overall Study|Withdrawal by Subject|16
278732|NCT01029262|920344|P1|Overall Study|Withdrawal by Subject|10
278733|NCT01029262|920343|P2|Overall Study|Lack of therapeutic effect|69
278734|NCT01029262|920344|P1|Overall Study|Lack of therapeutic effect|56
278735|NCT01029262|920343|P2|Overall Study|Adverse Event|52
278736|NCT01029262|920344|P1|Overall Study|Adverse Event|9
278737|NCT01028651|920502|P1|Overall Study|Adverse Event|1
278738|NCT01028651|920502|P1|Overall Study|Death|2
278739|NCT01028391|920525|P2|Overall Study|Needed excluded medication|1
278740|NCT01028391|920526|P1|Overall Study|Needed excluded medication|1
278741|NCT01028391|920525|P2|Overall Study|Withdrawal by Subject|3
278742|NCT01028391|920526|P1|Overall Study|Withdrawal by Subject|6
278743|NCT01028391|920525|P2|Overall Study|Physician Decision|1
278744|NCT01028391|920526|P1|Overall Study|Physician Decision|0
278745|NCT01028391|920525|P2|Overall Study|Lost to Follow-up|4
278746|NCT01028391|920526|P1|Overall Study|Lost to Follow-up|3
278747|NCT01028391|920525|P2|Overall Study|Lack of Efficacy|2
278748|NCT01028391|920526|P1|Overall Study|Lack of Efficacy|0
278749|NCT01028391|920525|P2|Overall Study|Adverse Event|0
278750|NCT01028391|920526|P1|Overall Study|Adverse Event|4
278751|NCT01028378|920534|P1|Overall Study|Adminstrative Reasons|4
278752|NCT01028378|920534|P1|Overall Study|Withdrawal by Subject|1
278753|NCT01028378|920534|P1|Overall Study|Lost to Follow-up|12
278754|NCT01028352|920546|P1|Overall Study|Withdrawal by Subject|1
278755|NCT01028352|920546|P1|Overall Study|Ineligible due to baseline average pain|5
278756|NCT01028300|920551|P1|Overall Study|Study Terminated|4
278757|NCT01028222|920560|P2|Overall Study|Adverse Event|0
278758|NCT01028222|920561|P1|Overall Study|Adverse Event|2
278759|NCT01028222|920560|P2|Overall Study|Crossover to nilotinib w/out progression|2
278760|NCT01028222|920561|P1|Overall Study|Crossover to nilotinib w/out progression|0
278761|NCT01028222|920560|P2|Overall Study|Withdrawal by Subject|0
278762|NCT01028222|920561|P1|Overall Study|Withdrawal by Subject|1
278763|NCT01028222|920560|P2|Overall Study|Lost to Follow-up|1
278764|NCT01028222|920561|P1|Overall Study|Lost to Follow-up|0
278765|NCT01028222|920560|P2|Overall Study|Administrative problems|1
278766|NCT01028222|920561|P1|Overall Study|Administrative problems|1
278767|NCT01028222|920560|P2|Overall Study|Disease progression|9
278768|NCT01028222|920561|P1|Overall Study|Disease progression|33
278769|NCT01028222|920560|P2|Overall Study|Protocol deviation|0
278770|NCT01028222|920561|P1|Overall Study|Protocol deviation|1
278771|NCT01027897|920597|P1|Overall Study|Withdrawal by Subject|1
278772|NCT01027897|920597|P1|Overall Study|Protocol Violation|1
278773|NCT01027884|920605|P2|Overall Study|Spinal fixation surgery|3
278774|NCT01027884|920606|P1|Overall Study|Spinal fixation surgery|0
278775|NCT01027884|920605|P2|Overall Study|Lost to Follow-up|1
278776|NCT01027884|920606|P1|Overall Study|Lost to Follow-up|0
278777|NCT01027884|920605|P2|Overall Study|Withdrawal by Subject|1
278778|NCT01027884|920606|P1|Overall Study|Withdrawal by Subject|0
278779|NCT01027884|920605|P2|Overall Study|Non-compliance|1
278780|NCT01027884|920606|P1|Overall Study|Non-compliance|1
278781|NCT01027884|920605|P2|Overall Study|Protocol Violation|0
278782|NCT01027884|920606|P1|Overall Study|Protocol Violation|1
278783|NCT01027884|920605|P2|Overall Study|Adverse Event|1
278784|NCT01027884|920606|P1|Overall Study|Adverse Event|2
278785|NCT01027650|920650|P8|Overall Study|Lack of Efficacy|0
278786|NCT01027650|920651|P7|Overall Study|Lack of Efficacy|0
278787|NCT01027650|920652|P6|Overall Study|Lack of Efficacy|1
278788|NCT01027650|920653|P5|Overall Study|Lack of Efficacy|0
278789|NCT01027650|920654|P4|Overall Study|Lack of Efficacy|0
278790|NCT01027650|920655|P3|Overall Study|Lack of Efficacy|0
278791|NCT01027650|920656|P2|Overall Study|Lack of Efficacy|0
278792|NCT01027650|920657|P1|Overall Study|Lack of Efficacy|0
278793|NCT01027650|920650|P8|Overall Study|Lost to Follow-up|0
278794|NCT01027650|920651|P7|Overall Study|Lost to Follow-up|1
278795|NCT01027650|920652|P6|Overall Study|Lost to Follow-up|0
278796|NCT01027650|920653|P5|Overall Study|Lost to Follow-up|0
278797|NCT01027650|920654|P4|Overall Study|Lost to Follow-up|0
278798|NCT01027650|920655|P3|Overall Study|Lost to Follow-up|0
278799|NCT01027650|920656|P2|Overall Study|Lost to Follow-up|0
278800|NCT01027650|920657|P1|Overall Study|Lost to Follow-up|0
278801|NCT01027650|920650|P8|Overall Study|Personal Reasons|0
278802|NCT01027650|920651|P7|Overall Study|Personal Reasons|0
278803|NCT01027650|920652|P6|Overall Study|Personal Reasons|1
278804|NCT01027650|920653|P5|Overall Study|Personal Reasons|2
278805|NCT01027650|920654|P4|Overall Study|Personal Reasons|0
278806|NCT01027650|920655|P3|Overall Study|Personal Reasons|0
278807|NCT01027650|920656|P2|Overall Study|Personal Reasons|0
278808|NCT01027650|920657|P1|Overall Study|Personal Reasons|0
278809|NCT01027364|920720|P4|Overall Study|Withdrawal by Subject|0
278810|NCT01027364|920721|P3|Overall Study|Withdrawal by Subject|0
278811|NCT01027364|920722|P2|Overall Study|Withdrawal by Subject|2
278812|NCT01027364|920723|P1|Overall Study|Withdrawal by Subject|1
278813|NCT01027364|920720|P4|Overall Study|Protocol Violation|1
278814|NCT01027364|920721|P3|Overall Study|Protocol Violation|0
278815|NCT01027364|920722|P2|Overall Study|Protocol Violation|0
278816|NCT01027364|920723|P1|Overall Study|Protocol Violation|1
278817|NCT01027364|920720|P4|Overall Study|Lost to Follow-up|0
278818|NCT01027364|920721|P3|Overall Study|Lost to Follow-up|0
278819|NCT01027364|920722|P2|Overall Study|Lost to Follow-up|0
278820|NCT01027364|920723|P1|Overall Study|Lost to Follow-up|1
278821|NCT01027364|920720|P4|Overall Study|Adverse Event|0
278822|NCT01027364|920721|P3|Overall Study|Adverse Event|1
278823|NCT01027364|920722|P2|Overall Study|Adverse Event|0
278824|NCT01027364|920723|P1|Overall Study|Adverse Event|1
278825|NCT01027351|920818|P6|Overall Study|Protocol Violation|0
278826|NCT01027351|920819|P5|Overall Study|Protocol Violation|1
278827|NCT01027351|920820|P4|Overall Study|Protocol Violation|1
278828|NCT01027351|920821|P3|Overall Study|Protocol Violation|0
278829|NCT01027351|920822|P2|Overall Study|Protocol Violation|0
278830|NCT01027351|920823|P1|Overall Study|Protocol Violation|1
278831|NCT01027351|920818|P6|Overall Study|Inappropriate enrollment|0
278832|NCT01027351|920819|P5|Overall Study|Inappropriate enrollment|1
278833|NCT01027351|920820|P4|Overall Study|Inappropriate enrollment|0
278834|NCT01027351|920821|P3|Overall Study|Inappropriate enrollment|0
278835|NCT01027351|920822|P2|Overall Study|Inappropriate enrollment|0
278836|NCT01027351|920823|P1|Overall Study|Inappropriate enrollment|0
278837|NCT01027351|920818|P6|Overall Study|Lost to Follow-up|0
278838|NCT01027351|920819|P5|Overall Study|Lost to Follow-up|6
278839|NCT01027351|920820|P4|Overall Study|Lost to Follow-up|1
278840|NCT01027351|920821|P3|Overall Study|Lost to Follow-up|0
278841|NCT01027351|920822|P2|Overall Study|Lost to Follow-up|1
278842|NCT01027351|920823|P1|Overall Study|Lost to Follow-up|1
278843|NCT01027351|920818|P6|Overall Study|Withdrawal by Subject|5
278844|NCT01027351|920819|P5|Overall Study|Withdrawal by Subject|3
278845|NCT01027351|920820|P4|Overall Study|Withdrawal by Subject|0
278846|NCT01027351|920821|P3|Overall Study|Withdrawal by Subject|1
278847|NCT01027351|920822|P2|Overall Study|Withdrawal by Subject|0
278848|NCT01027351|920823|P1|Overall Study|Withdrawal by Subject|1
278849|NCT01027286|920907|P2|Overall Study|Lost to Follow-up|1
278850|NCT01027286|920908|P1|Overall Study|Lost to Follow-up|0
278851|NCT01027286|920907|P2|Overall Study|Unable to Obtain Required Blood Volume|0
278852|NCT01027286|920908|P1|Overall Study|Unable to Obtain Required Blood Volume|1
278853|NCT01027273|920928|P2|Overall Study|Death|2
278854|NCT01027273|920929|P1|Overall Study|Death|2
278855|NCT01027273|920928|P2|Overall Study|Lost to Follow-up|31
278856|NCT01027273|920929|P1|Overall Study|Lost to Follow-up|57
278857|NCT01026974|920976|P4|Overall Study|Inappropriate enrollment|0
278858|NCT01026974|920977|P3|Overall Study|Inappropriate enrollment|1
278859|NCT01026974|920978|P2|Overall Study|Inappropriate enrollment|0
278860|NCT01026974|920979|P1|Overall Study|Inappropriate enrollment|0
278861|NCT01026974|920976|P4|Overall Study|Adverse Event|1
278862|NCT01026974|920977|P3|Overall Study|Adverse Event|0
278863|NCT01026974|920978|P2|Overall Study|Adverse Event|0
278864|NCT01026974|920979|P1|Overall Study|Adverse Event|0
278865|NCT01026974|920976|P4|Overall Study|Lost to Follow-up|0
278866|NCT01026974|920977|P3|Overall Study|Lost to Follow-up|4
278867|NCT01026974|920978|P2|Overall Study|Lost to Follow-up|1
278868|NCT01026974|920979|P1|Overall Study|Lost to Follow-up|1
278869|NCT01026974|920976|P4|Overall Study|Withdrawal by Subject|2
278870|NCT01026974|920977|P3|Overall Study|Withdrawal by Subject|7
278871|NCT01026974|920978|P2|Overall Study|Withdrawal by Subject|1
278872|NCT01026974|920979|P1|Overall Study|Withdrawal by Subject|0
278873|NCT01026948|921036|P1|Overall Study|Physician Decision|8
278874|NCT01026831|921069|P2|Overall Study|Withdrawal by Subject|5
278875|NCT01026831|921070|P1|Overall Study|Withdrawal by Subject|7
278876|NCT01026831|921069|P2|Overall Study|Protocol Violation|2
278877|NCT01026831|921070|P1|Overall Study|Protocol Violation|0
278878|NCT01026831|921069|P2|Overall Study|Physician Decision|1
278879|NCT01026831|921070|P1|Overall Study|Physician Decision|1
278880|NCT01026831|921069|P2|Overall Study|Lost to Follow-up|0
278881|NCT01026831|921070|P1|Overall Study|Lost to Follow-up|2
278882|NCT01026831|921069|P2|Overall Study|Adverse Event|3
278883|NCT01026831|921070|P1|Overall Study|Adverse Event|4
278884|NCT01026818|921081|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
278885|NCT01026818|921082|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
278886|NCT01026818|921083|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
278887|NCT01026818|921084|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
278888|NCT01026818|921081|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
278889|NCT01026818|921082|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
278890|NCT01026818|921083|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
278891|NCT01026818|921084|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
278892|NCT01026818|921081|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
278893|NCT01026818|921082|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
278894|NCT01026818|921083|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
278895|NCT01026818|921084|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
278896|NCT01026818|921081|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
278897|NCT01026818|921082|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
278898|NCT01026818|921083|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
278899|NCT01026818|921084|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
278900|NCT01026818|921081|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
278901|NCT01026818|921082|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
278902|NCT01026818|921083|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
278903|NCT01026818|921084|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
278904|NCT01026818|921081|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
278905|NCT01026818|921082|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
278906|NCT01026818|921083|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
278907|NCT01026818|921084|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
278908|NCT01026818|921081|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
278909|NCT01026818|921082|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
278910|NCT01026818|921083|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
278911|NCT01026818|921084|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
278912|NCT01026818|921081|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
278913|NCT01026818|921082|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
278914|NCT01026818|921083|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
278915|NCT01026818|921084|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
279076|NCT01025817|921786|P2|Completed Study Medication|Adverse Event|39
278916|NCT01026818|921081|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
278917|NCT01026818|921082|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
278918|NCT01026818|921083|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
278919|NCT01026818|921084|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
278920|NCT01026818|921081|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
278921|NCT01026818|921082|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
278922|NCT01026818|921083|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
278923|NCT01026818|921084|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
278924|NCT01026818|921081|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
278925|NCT01026818|921082|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
278926|NCT01026818|921083|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
278927|NCT01026818|921084|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
278928|NCT01026818|921081|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
278929|NCT01026818|921082|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
278930|NCT01026818|921083|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
278931|NCT01026818|921084|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
278932|NCT01026818|921081|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
278933|NCT01026818|921082|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
278934|NCT01026818|921083|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
278935|NCT01026818|921084|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
278936|NCT01026818|921081|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
278937|NCT01026818|921082|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
278938|NCT01026818|921083|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
278939|NCT01026818|921084|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
278940|NCT01026818|921081|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
278941|NCT01026818|921082|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
278942|NCT01026818|921083|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
278943|NCT01026818|921084|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
278944|NCT01026818|921081|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
278945|NCT01026818|921082|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
278946|NCT01026818|921083|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
278947|NCT01026818|921084|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
278948|NCT01026818|921081|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
278949|NCT01026818|921082|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
278950|NCT01026818|921083|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
278951|NCT01026818|921084|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
278952|NCT01026818|921081|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
278953|NCT01026818|921082|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
278954|NCT01026818|921083|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
278955|NCT01026818|921084|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
278956|NCT01026818|921081|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
278957|NCT01026818|921082|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
278958|NCT01026818|921083|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
278959|NCT01026818|921084|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
278960|NCT01026818|921081|P4|Screening Period|Physician Decision|0
278961|NCT01026818|921082|P3|Screening Period|Physician Decision|0
278962|NCT01026818|921083|P2|Screening Period|Physician Decision|0
278963|NCT01026818|921084|P1|Screening Period|Physician Decision|1
278964|NCT01026818|921081|P4|Screening Period|Adverse Event|0
278965|NCT01026818|921082|P3|Screening Period|Adverse Event|0
278966|NCT01026818|921083|P2|Screening Period|Adverse Event|0
278967|NCT01026818|921084|P1|Screening Period|Adverse Event|2
278968|NCT01026818|921081|P4|Screening Period|Protocol Deviation|0
278969|NCT01026818|921082|P3|Screening Period|Protocol Deviation|0
278970|NCT01026818|921083|P2|Screening Period|Protocol Deviation|0
278971|NCT01026818|921084|P1|Screening Period|Protocol Deviation|3
278972|NCT01026818|921081|P4|Screening Period|Withdrawal by Subject|0
278973|NCT01026818|921082|P3|Screening Period|Withdrawal by Subject|0
278974|NCT01026818|921083|P2|Screening Period|Withdrawal by Subject|0
278975|NCT01026818|921084|P1|Screening Period|Withdrawal by Subject|49
278976|NCT01026818|921081|P4|Screening Period|Entry Criteria Not Met|0
278977|NCT01026818|921082|P3|Screening Period|Entry Criteria Not Met|0
278978|NCT01026818|921083|P2|Screening Period|Entry Criteria Not Met|0
278979|NCT01026818|921084|P1|Screening Period|Entry Criteria Not Met|105
278980|NCT01026792|921172|P1|Overall Study|Protocol Violation|1
278981|NCT01026454|921178|P2|Second Intervention|Pregnancy|1
278982|NCT01026454|921179|P1|Second Intervention|Pregnancy|1
278983|NCT01026389|921528|P2|Overall Study|change of treatment, patient moved|2
278984|NCT01026389|921529|P1|Overall Study|change of treatment, patient moved|4
278985|NCT01026389|921528|P2|Overall Study|Withdrawal by Subject|3
278986|NCT01026389|921529|P1|Overall Study|Withdrawal by Subject|1
278987|NCT01026324|921544|P3|Follow up/Survival|Withdrawal by Subject|0
278988|NCT01026324|921545|P2|Follow up/Survival|Withdrawal by Subject|0
278989|NCT01026324|921546|P1|Follow up/Survival|Withdrawal by Subject|1
278990|NCT01026220|921556|P3|Consolidation Maintenance|Withdrawal by Subject|6
278991|NCT01026220|921557|P2|Consolidation Maintenance|Withdrawal by Subject|2
278992|NCT01026220|921558|P1|Consolidation Maintenance|Withdrawal by Subject|0
278993|NCT01026220|921556|P3|Consolidation Maintenance|Physician Decision|7
278994|NCT01026220|921557|P2|Consolidation Maintenance|Physician Decision|2
278995|NCT01026220|921558|P1|Consolidation Maintenance|Physician Decision|0
278996|NCT01026220|921556|P3|Consolidation Maintenance|Lack of Efficacy|1
278997|NCT01026220|921557|P2|Consolidation Maintenance|Lack of Efficacy|1
278998|NCT01026220|921558|P1|Consolidation Maintenance|Lack of Efficacy|0
278999|NCT01026220|921556|P3|Consolidation Maintenance|Death|0
279000|NCT01026220|921557|P2|Consolidation Maintenance|Death|1
279001|NCT01026220|921558|P1|Consolidation Maintenance|Death|0
279002|NCT01026220|921556|P3|Induction|Ineligible|0
279003|NCT01026220|921557|P2|Induction|Ineligible|0
279004|NCT01026220|921558|P1|Induction|Ineligible|1
279005|NCT01026220|921556|P3|Induction|Withdrawal by Subject|0
279006|NCT01026220|921557|P2|Induction|Withdrawal by Subject|0
279007|NCT01026220|921558|P1|Induction|Withdrawal by Subject|9
279008|NCT01026220|921556|P3|Induction|Physician Decision|0
279009|NCT01026220|921557|P2|Induction|Physician Decision|0
279010|NCT01026220|921558|P1|Induction|Physician Decision|12
279011|NCT01026220|921556|P3|Induction|Lack of Efficacy|0
279012|NCT01026220|921557|P2|Induction|Lack of Efficacy|0
279013|NCT01026220|921558|P1|Induction|Lack of Efficacy|2
279014|NCT01026220|921556|P3|Induction|Death|0
279015|NCT01026220|921557|P2|Induction|Death|0
279016|NCT01026220|921558|P1|Induction|Death|1
279017|NCT01026194|921582|P2|Period 2：Open-label Period|Withdrawal by Subject|4
279018|NCT01026194|921583|P1|Period 2：Open-label Period|Withdrawal by Subject|0
279019|NCT01026194|921582|P2|Period 2：Open-label Period|Physician Decision|1
279020|NCT01026194|921583|P1|Period 2：Open-label Period|Physician Decision|3
279021|NCT01026194|921582|P2|Period 2：Open-label Period|Adverse Event|5
279022|NCT01026194|921583|P1|Period 2：Open-label Period|Adverse Event|4
279023|NCT01026194|921582|P2|Period 1：Double Blind Period|Physician Decision|4
279024|NCT01026194|921583|P1|Period 1：Double Blind Period|Physician Decision|0
279025|NCT01026194|921582|P2|Period 1：Double Blind Period|Lack of Efficacy|0
279026|NCT01026194|921583|P1|Period 1：Double Blind Period|Lack of Efficacy|1
279027|NCT01026194|921582|P2|Period 1：Double Blind Period|Adverse Event|1
279028|NCT01026194|921583|P1|Period 1：Double Blind Period|Adverse Event|2
279029|NCT01026142|921599|P2|Overall Study|Reasons not specified|23
279030|NCT01026142|921600|P1|Overall Study|Reasons not specified|25
279031|NCT01026142|921599|P2|Overall Study|Death|98
279032|NCT01026142|921600|P1|Overall Study|Death|114
279033|NCT01026103|921622|P1|Overall Study|did not receive study device bc of error|1
279034|NCT01026103|921622|P1|Overall Study|Physician Decision|1
279035|NCT01026038|921632|P3|Overall Study|Lost to Follow-up|0
279036|NCT01026038|921633|P2|Overall Study|Lost to Follow-up|1
279037|NCT01026038|921634|P1|Overall Study|Lost to Follow-up|1
279038|NCT01025843|921683|P10|Washout 4|Withdrawal by Subject|0
279039|NCT01025843|921684|P9|Washout 4|Withdrawal by Subject|0
279040|NCT01025843|921685|P8|Washout 4|Withdrawal by Subject|0
279041|NCT01025843|921686|P7|Washout 4|Withdrawal by Subject|0
279042|NCT01025843|921687|P6|Washout 4|Withdrawal by Subject|0
279043|NCT01025843|921688|P5|Washout 4|Withdrawal by Subject|0
279044|NCT01025843|921689|P4|Washout 4|Withdrawal by Subject|1
279045|NCT01025843|921690|P3|Washout 4|Withdrawal by Subject|1
279046|NCT01025843|921691|P2|Washout 4|Withdrawal by Subject|0
279047|NCT01025843|921692|P1|Washout 4|Withdrawal by Subject|0
279048|NCT01025817|921786|P2|Completed Study|Lost to Follow-up|1
279049|NCT01025817|921787|P1|Completed Study|Lost to Follow-up|0
279050|NCT01025817|921786|P2|Completed Study|Missing|0
279051|NCT01025817|921787|P1|Completed Study|Missing|2
279052|NCT01025817|921786|P2|Completed Study|Death|5
279053|NCT01025817|921787|P1|Completed Study|Death|6
279054|NCT01025817|921786|P2|Completed Study|Withdrawal by Subject|16
279055|NCT01025817|921787|P1|Completed Study|Withdrawal by Subject|8
279056|NCT01025817|921786|P2|Completed Study Medication|Lost to Follow-up|1
279057|NCT01025817|921787|P1|Completed Study Medication|Lost to Follow-up|0
279058|NCT01025817|921786|P2|Completed Study Medication|Subject no longer required study drug|1
279059|NCT01025817|921787|P1|Completed Study Medication|Subject no longer required study drug|0
279060|NCT01025817|921786|P2|Completed Study Medication|Abnormal lab values|2
279061|NCT01025817|921787|P1|Completed Study Medication|Abnormal lab values|0
279062|NCT01025817|921786|P2|Completed Study Medication|Death|2
279063|NCT01025817|921787|P1|Completed Study Medication|Death|2
279064|NCT01025817|921786|P2|Completed Study Medication|Graft loss|5
279065|NCT01025817|921787|P1|Completed Study Medication|Graft loss|2
279066|NCT01025817|921786|P2|Completed Study Medication|Abnormal test procedure|0
279067|NCT01025817|921787|P1|Completed Study Medication|Abnormal test procedure|4
279068|NCT01025817|921786|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
279069|NCT01025817|921787|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
279070|NCT01025817|921786|P2|Completed Study Medication|Administrative problems|5
279071|NCT01025817|921787|P1|Completed Study Medication|Administrative problems|7
279072|NCT01025817|921786|P2|Completed Study Medication|Withdrawal by Subject|9
279073|NCT01025817|921787|P1|Completed Study Medication|Withdrawal by Subject|8
279074|NCT01025817|921786|P2|Completed Study Medication|Protocol Deviation|8
279075|NCT01025817|921787|P1|Completed Study Medication|Protocol Deviation|9
279077|NCT01025817|921787|P1|Completed Study Medication|Adverse Event|66
279078|NCT01025635|921807|P2|Overall Study|Reason not known|2
279079|NCT01025635|921808|P1|Overall Study|Reason not known|4
279080|NCT01025635|921807|P2|Overall Study|Lost to Follow-up|13
279081|NCT01025635|921808|P1|Overall Study|Lost to Follow-up|9
279082|NCT01025635|921807|P2|Overall Study|Lack of Efficacy|1
279083|NCT01025635|921808|P1|Overall Study|Lack of Efficacy|0
279084|NCT01025635|921807|P2|Overall Study|Protocol Violation|2
279085|NCT01025635|921808|P1|Overall Study|Protocol Violation|4
279086|NCT01025635|921807|P2|Overall Study|Withdrawal by Subject|7
279087|NCT01025635|921808|P1|Overall Study|Withdrawal by Subject|6
279088|NCT01025336|921829|P5|Overall Study|Protocol Violation|0
279089|NCT01025336|921830|P4|Overall Study|Protocol Violation|2
279090|NCT01025336|921831|P3|Overall Study|Protocol Violation|0
279091|NCT01025336|921832|P2|Overall Study|Protocol Violation|0
279092|NCT01025336|921833|P1|Overall Study|Protocol Violation|0
279093|NCT01025232|921892|P2|Overall Study|Study drug no longer available|6
279094|NCT01025232|921893|P1|Overall Study|Study drug no longer available|3
279095|NCT01025193|921911|P1|Overall Study|Adverse Event|3
279096|NCT01025193|921911|P1|Overall Study|Protocol Violation|1
279097|NCT01025154|921921|P1|Overall Study|Withdrawal by Subject|1
279098|NCT01025154|921921|P1|Overall Study|Lost to Follow-up|1
279099|NCT01025037|921930|P1|Overall Study|Withdrawal by Subject|1
279100|NCT01025037|921930|P1|Overall Study|Lost to Follow-up|7
279101|NCT01025037|921930|P1|Overall Study|Adverse Event|3
279102|NCT01024959|921952|P1|Overall Study|missing results required for analysis|17
279103|NCT01024959|921952|P1|Overall Study|results not evaluable|12
279104|NCT01024959|921952|P1|Overall Study|ineligible|12
279105|NCT01024946|921961|P1|Overall Study|Adverse Event|1
279106|NCT01024946|921961|P1|Overall Study|Withdrawal by Subject|1
279107|NCT01024946|921961|P1|Overall Study|Screen Failure|3
279108|NCT01024855|921965|P1|Overall Study|Inclusion/exclusion criteria|1
279109|NCT01024751|921972|P2|Eligible Participants|Ineligible|1
279110|NCT01024751|921973|P1|Eligible Participants|Ineligible|0
279111|NCT01024751|921972|P2|Eligible Participants|Lost to Follow-up|1
279112|NCT01024751|921973|P1|Eligible Participants|Lost to Follow-up|0
279113|NCT01024751|921972|P2|Eligible Participants|Withdrawal by Subject|1
279114|NCT01024751|921973|P1|Eligible Participants|Withdrawal by Subject|0
279115|NCT01024751|921972|P2|Enrolled Participants|Ineligible at baseline|4
279116|NCT01024751|921973|P1|Enrolled Participants|Ineligible at baseline|3
279117|NCT01024608|921996|P2|Overall Study|Never received study treatment|0
279118|NCT01024608|921997|P1|Overall Study|Never received study treatment|2
279119|NCT01024608|921996|P2|Overall Study|Protocol Violation|3
279120|NCT01024608|921997|P1|Overall Study|Protocol Violation|0
279121|NCT01024608|921996|P2|Overall Study|Lost to Follow-up|1
279122|NCT01024608|921997|P1|Overall Study|Lost to Follow-up|0
279123|NCT01024608|921996|P2|Overall Study|Withdrawal by Subject|0
279124|NCT01024608|921997|P1|Overall Study|Withdrawal by Subject|1
279125|NCT01024608|921996|P2|Overall Study|Adverse Event|0
279126|NCT01024608|921997|P1|Overall Study|Adverse Event|1
279127|NCT01024465|922009|P1|Overall Study|Physician Decision|1
279128|NCT01024465|922009|P1|Overall Study|Adverse Event|2
279129|NCT01024309|922026|P2|Overall Study|Withdrawal by Subject|4
279130|NCT01024309|922027|P1|Overall Study|Withdrawal by Subject|4
279131|NCT01024309|922026|P2|Overall Study|Physician Decision|0
279132|NCT01024309|922027|P1|Overall Study|Physician Decision|4
279133|NCT01024244|922054|P5|Overall Study|Withdrawal by Subject|0
279134|NCT01024244|922055|P4|Overall Study|Withdrawal by Subject|0
279135|NCT01024244|922056|P3|Overall Study|Withdrawal by Subject|0
279136|NCT01024244|922057|P2|Overall Study|Withdrawal by Subject|1
279137|NCT01024244|922058|P1|Overall Study|Withdrawal by Subject|0
279138|NCT01024244|922054|P5|Overall Study|Sponsor Decision|10
279139|NCT01024244|922055|P4|Overall Study|Sponsor Decision|12
279140|NCT01024244|922056|P3|Overall Study|Sponsor Decision|14
279141|NCT01024244|922057|P2|Overall Study|Sponsor Decision|7
279142|NCT01024244|922058|P1|Overall Study|Sponsor Decision|14
279143|NCT01024244|922054|P5|Overall Study|Protocol Violation|2
279144|NCT01024244|922055|P4|Overall Study|Protocol Violation|0
279145|NCT01024244|922056|P3|Overall Study|Protocol Violation|0
279146|NCT01024244|922057|P2|Overall Study|Protocol Violation|0
279147|NCT01024244|922058|P1|Overall Study|Protocol Violation|1
279148|NCT01024244|922054|P5|Overall Study|Lack of Efficacy|0
279149|NCT01024244|922055|P4|Overall Study|Lack of Efficacy|0
279150|NCT01024244|922056|P3|Overall Study|Lack of Efficacy|0
279151|NCT01024244|922057|P2|Overall Study|Lack of Efficacy|0
279152|NCT01024244|922058|P1|Overall Study|Lack of Efficacy|1
279153|NCT01024244|922054|P5|Overall Study|Entry Criteria Not Met|0
279154|NCT01024244|922055|P4|Overall Study|Entry Criteria Not Met|0
279155|NCT01024244|922056|P3|Overall Study|Entry Criteria Not Met|0
279156|NCT01024244|922057|P2|Overall Study|Entry Criteria Not Met|1
279157|NCT01024244|922058|P1|Overall Study|Entry Criteria Not Met|0
279158|NCT01024244|922054|P5|Overall Study|Adverse Event|2
279159|NCT01024244|922055|P4|Overall Study|Adverse Event|1
279160|NCT01024244|922056|P3|Overall Study|Adverse Event|0
279161|NCT01024244|922057|P2|Overall Study|Adverse Event|2
279162|NCT01024244|922058|P1|Overall Study|Adverse Event|1
279163|NCT01024036|922172|P2|Unblinded Treatment|Lack of Efficacy|0
279164|NCT01024036|922173|P1|Unblinded Treatment|Lack of Efficacy|2
279165|NCT01024036|922172|P2|Unblinded Treatment|Adverse Event|0
279166|NCT01024036|922173|P1|Unblinded Treatment|Adverse Event|1
279167|NCT01024036|922172|P2|Blinded Treatment|Withdrawal by Subject|3
279168|NCT01024036|922173|P1|Blinded Treatment|Withdrawal by Subject|4
279169|NCT01024036|922172|P2|Blinded Treatment|Death|2
279170|NCT01024036|922173|P1|Blinded Treatment|Death|0
279171|NCT01024036|922172|P2|Blinded Treatment|Physician Decision|0
279172|NCT01024036|922173|P1|Blinded Treatment|Physician Decision|1
279173|NCT01024036|922172|P2|Blinded Treatment|Lack of Efficacy|14
279174|NCT01024036|922173|P1|Blinded Treatment|Lack of Efficacy|16
279175|NCT01024036|922172|P2|Blinded Treatment|Adverse Event|1
279176|NCT01024036|922173|P1|Blinded Treatment|Adverse Event|1
279177|NCT01023815|922222|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
279178|NCT01023815|922223|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
279179|NCT01023815|922224|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
279180|NCT01023815|922225|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
279181|NCT01023815|922222|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
279182|NCT01023815|922223|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
279183|NCT01023815|922224|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
279184|NCT01023815|922225|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
279185|NCT01023815|922222|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
279186|NCT01023815|922223|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
279187|NCT01023815|922224|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
279188|NCT01023815|922225|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
279189|NCT01023815|922222|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
279190|NCT01023815|922223|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
279191|NCT01023815|922224|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
279192|NCT01023815|922225|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
279193|NCT01023815|922222|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
279194|NCT01023815|922223|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
279195|NCT01023815|922224|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
279196|NCT01023815|922225|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
279197|NCT01023672|922263|P1|Overall Study|Death|1
279198|NCT01023672|922263|P1|Overall Study|Worsening disease|2
279199|NCT01023659|922270|P3|Overall Study|Lost to Follow-up|99
279200|NCT01023659|922271|P2|Overall Study|Lost to Follow-up|228
279201|NCT01023659|922272|P1|Overall Study|Lost to Follow-up|73
279202|NCT01023581|922288|P7|Overall Study|Other|0
279203|NCT01023581|922289|P6|Overall Study|Other|0
279204|NCT01023581|922290|P5|Overall Study|Other|1
279205|NCT01023581|922291|P4|Overall Study|Other|0
279206|NCT01023581|922292|P3|Overall Study|Other|1
279207|NCT01023581|922293|P2|Overall Study|Other|0
279208|NCT01023581|922294|P1|Overall Study|Other|1
279209|NCT01023581|922288|P7|Overall Study|Physician Decision|1
279210|NCT01023581|922289|P6|Overall Study|Physician Decision|1
279211|NCT01023581|922290|P5|Overall Study|Physician Decision|1
279212|NCT01023581|922291|P4|Overall Study|Physician Decision|1
279213|NCT01023581|922292|P3|Overall Study|Physician Decision|2
279214|NCT01023581|922293|P2|Overall Study|Physician Decision|0
279215|NCT01023581|922294|P1|Overall Study|Physician Decision|2
279216|NCT01023581|922288|P7|Overall Study|Lack of Efficacy|1
279217|NCT01023581|922289|P6|Overall Study|Lack of Efficacy|2
279218|NCT01023581|922290|P5|Overall Study|Lack of Efficacy|1
279219|NCT01023581|922291|P4|Overall Study|Lack of Efficacy|2
279220|NCT01023581|922292|P3|Overall Study|Lack of Efficacy|6
279221|NCT01023581|922293|P2|Overall Study|Lack of Efficacy|3
279222|NCT01023581|922294|P1|Overall Study|Lack of Efficacy|9
279223|NCT01023581|922288|P7|Overall Study|Pregnancy|0
279224|NCT01023581|922289|P6|Overall Study|Pregnancy|1
279225|NCT01023581|922290|P5|Overall Study|Pregnancy|0
279226|NCT01023581|922291|P4|Overall Study|Pregnancy|2
279227|NCT01023581|922292|P3|Overall Study|Pregnancy|0
279228|NCT01023581|922293|P2|Overall Study|Pregnancy|0
279229|NCT01023581|922294|P1|Overall Study|Pregnancy|0
279230|NCT01023581|922288|P7|Overall Study|Withdrawal by Subject|5
279231|NCT01023581|922289|P6|Overall Study|Withdrawal by Subject|8
279232|NCT01023581|922290|P5|Overall Study|Withdrawal by Subject|6
279233|NCT01023581|922291|P4|Overall Study|Withdrawal by Subject|10
279234|NCT01023581|922292|P3|Overall Study|Withdrawal by Subject|16
279235|NCT01023581|922293|P2|Overall Study|Withdrawal by Subject|8
279236|NCT01023581|922294|P1|Overall Study|Withdrawal by Subject|13
279237|NCT01023581|922288|P7|Overall Study|Lost to Follow-up|2
279238|NCT01023581|922289|P6|Overall Study|Lost to Follow-up|2
279239|NCT01023581|922290|P5|Overall Study|Lost to Follow-up|5
279240|NCT01023581|922291|P4|Overall Study|Lost to Follow-up|2
279241|NCT01023581|922292|P3|Overall Study|Lost to Follow-up|7
279242|NCT01023581|922293|P2|Overall Study|Lost to Follow-up|8
279243|NCT01023581|922294|P1|Overall Study|Lost to Follow-up|4
279244|NCT01023581|922288|P7|Overall Study|Major protocol deviation|0
279245|NCT01023581|922289|P6|Overall Study|Major protocol deviation|0
279246|NCT01023581|922290|P5|Overall Study|Major protocol deviation|0
279247|NCT01023581|922291|P4|Overall Study|Major protocol deviation|0
279248|NCT01023581|922292|P3|Overall Study|Major protocol deviation|3
279249|NCT01023581|922293|P2|Overall Study|Major protocol deviation|0
279250|NCT01023581|922294|P1|Overall Study|Major protocol deviation|2
279251|NCT01023581|922288|P7|Overall Study|Adverse Event|11
279252|NCT01023581|922289|P6|Overall Study|Adverse Event|5
279253|NCT01023581|922290|P5|Overall Study|Adverse Event|2
279254|NCT01023581|922291|P4|Overall Study|Adverse Event|3
279255|NCT01023581|922292|P3|Overall Study|Adverse Event|7
279256|NCT01023581|922293|P2|Overall Study|Adverse Event|4
279257|NCT01023581|922294|P1|Overall Study|Adverse Event|4
279258|NCT01023516|922351|P2|Overall Study|Incorrect enrolment|2
279259|NCT01023516|922352|P1|Overall Study|Incorrect enrolment|4
279260|NCT01023516|922351|P2|Overall Study|Study-specific criteria|2
279261|NCT01023516|922352|P1|Overall Study|Study-specific criteria|4
279262|NCT01023516|922351|P2|Overall Study|Safety reason|3
279263|NCT01023516|922352|P1|Overall Study|Safety reason|0
279264|NCT01023516|922351|P2|Overall Study|Adverse Event|6
279265|NCT01023516|922352|P1|Overall Study|Adverse Event|9
279266|NCT01023516|922351|P2|Overall Study|Voluntary discontinuation|5
279267|NCT01023516|922352|P1|Overall Study|Voluntary discontinuation|7
279268|NCT01023308|922434|P2|Overall Study|Withdrawal by Subject|18
279269|NCT01023308|922435|P1|Overall Study|Withdrawal by Subject|34
279270|NCT01023308|922434|P2|Overall Study|Lost to Follow-up|0
279271|NCT01023308|922435|P1|Overall Study|Lost to Follow-up|1
279272|NCT01023308|922434|P2|Overall Study|Untreated|5
279273|NCT01023308|922435|P1|Overall Study|Untreated|5
279274|NCT01023308|922434|P2|Overall Study|Protocol Violation|4
279275|NCT01023308|922435|P1|Overall Study|Protocol Violation|3
279276|NCT01023308|922434|P2|Overall Study|New Cancer therapy|7
279277|NCT01023308|922435|P1|Overall Study|New Cancer therapy|4
279278|NCT01023308|922434|P2|Overall Study|Disease progression|153
279279|NCT01023308|922435|P1|Overall Study|Disease progression|82
279280|NCT01023308|922434|P2|Overall Study|Death|17
279281|NCT01023308|922435|P1|Overall Study|Death|21
279282|NCT01023308|922434|P2|Overall Study|Adverse Event|66
279283|NCT01023308|922435|P1|Overall Study|Adverse Event|130
279284|NCT01023308|922434|P2|Overall Study|Administrative problems|1
279285|NCT01023308|922435|P1|Overall Study|Administrative problems|2
279286|NCT01023308|922434|P2|Overall Study|Abnormal test proceedure results|8
279287|NCT01023308|922435|P1|Overall Study|Abnormal test proceedure results|3
279288|NCT01023256|922465|P4|Overall Study|Withdrawal by Subject|2
279289|NCT01023256|922466|P3|Overall Study|Withdrawal by Subject|0
279290|NCT01023256|922467|P2|Overall Study|Withdrawal by Subject|0
279291|NCT01023256|922468|P1|Overall Study|Withdrawal by Subject|0
279292|NCT01023256|922465|P4|Overall Study|Adverse Event|1
279293|NCT01023256|922466|P3|Overall Study|Adverse Event|0
279294|NCT01023256|922467|P2|Overall Study|Adverse Event|0
279295|NCT01023256|922468|P1|Overall Study|Adverse Event|0
279296|NCT01023256|922465|P4|Overall Study|Not specified|2
279297|NCT01023256|922466|P3|Overall Study|Not specified|0
279298|NCT01023256|922467|P2|Overall Study|Not specified|0
279299|NCT01023256|922468|P1|Overall Study|Not specified|1
279300|NCT01023256|922465|P4|Overall Study|Randomized but not treated|0
279301|NCT01023256|922466|P3|Overall Study|Randomized but not treated|1
279302|NCT01023256|922467|P2|Overall Study|Randomized but not treated|0
279303|NCT01023256|922468|P1|Overall Study|Randomized but not treated|1
279304|NCT01023256|922465|P4|Overall Study|Protocol Violation|0
279305|NCT01023256|922466|P3|Overall Study|Protocol Violation|0
279306|NCT01023256|922467|P2|Overall Study|Protocol Violation|3
279307|NCT01023256|922468|P1|Overall Study|Protocol Violation|2
279308|NCT01023217|922510|P2|Overall Study|Withdrawal by Subject|0
279309|NCT01023217|922511|P1|Overall Study|Withdrawal by Subject|1
279310|NCT01023061|922549|P1|Overall Study|Withdrawal prior to treatment|2
279311|NCT01023035|922558|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
279312|NCT01023035|922559|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
279313|NCT01023035|922560|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
279314|NCT01023035|922558|P3|Follow-up Period (up to Week 72)|Adverse Event|1
279315|NCT01023035|922559|P2|Follow-up Period (up to Week 72)|Adverse Event|0
279316|NCT01023035|922560|P1|Follow-up Period (up to Week 72)|Adverse Event|2
279317|NCT01023035|922558|P3|Treatment Period|Treatment Failure|24
279318|NCT01023035|922559|P2|Treatment Period|Treatment Failure|31
279319|NCT01023035|922560|P1|Treatment Period|Treatment Failure|26
279320|NCT01023035|922558|P3|Treatment Period|Non-Medical Reasons|44
279321|NCT01023035|922559|P2|Treatment Period|Non-Medical Reasons|22
279322|NCT01023035|922560|P1|Treatment Period|Non-Medical Reasons|19
279323|NCT01023035|922558|P3|Treatment Period|Adverse Event|50
279324|NCT01023035|922559|P2|Treatment Period|Adverse Event|32
279325|NCT01023035|922560|P1|Treatment Period|Adverse Event|27
279326|NCT01023022|922570|P1|Overall Study|due to technical issues|2
279327|NCT01023022|922570|P1|Overall Study|Lost to Follow-up|7
279328|NCT01023022|922570|P1|Overall Study|Death|5
279329|NCT01022996|922576|P1|Overall Study|Protocol Violation|1
279330|NCT01022996|922576|P1|Overall Study|Disease Progression|32
279331|NCT01022996|922576|P1|Overall Study|Administrative problems|6
279332|NCT01022996|922576|P1|Overall Study|Lost to Follow-up|1
279333|NCT01022996|922576|P1|Overall Study|Withdrawal by Subject|3
279334|NCT01022996|922576|P1|Overall Study|Adverse Event|14
279335|NCT01022762|922587|P2|Overall Study|Unclassified|20
279336|NCT01022762|922588|P1|Overall Study|Unclassified|12
279337|NCT01022762|922587|P2|Overall Study|Protocol Violation|6
279338|NCT01022762|922588|P1|Overall Study|Protocol Violation|7
279339|NCT01022762|922587|P2|Overall Study|Lack of Efficacy|1
279340|NCT01022762|922588|P1|Overall Study|Lack of Efficacy|0
279341|NCT01022762|922587|P2|Overall Study|Adverse Event|1
279342|NCT01022762|922588|P1|Overall Study|Adverse Event|3
279343|NCT01022502|922623|P1|Overall Study|Withdrawal by Subject|1
279344|NCT01022502|922623|P1|Overall Study|employment related reasons|1
279345|NCT01022502|922623|P1|Overall Study|Adverse Event|1
279346|NCT01022398|922639|P2|Overall Study|Study terminated|2
279347|NCT01022398|922640|P1|Overall Study|Study terminated|2
279348|NCT01022203|922665|P2|Follow-Up Assessment|Lost to Follow-up|2
279349|NCT01022203|922666|P1|Follow-Up Assessment|Lost to Follow-up|2
279350|NCT01022203|922665|P2|Post Treatment Assessment|Adverse Event|2
279351|NCT01022203|922666|P1|Post Treatment Assessment|Adverse Event|0
279352|NCT01022203|922665|P2|Post Treatment Assessment|Physician Decision|0
279353|NCT01022203|922666|P1|Post Treatment Assessment|Physician Decision|2
279354|NCT01022203|922665|P2|Post Treatment Assessment|Withdrawal by Subject|12
279355|NCT01022203|922666|P1|Post Treatment Assessment|Withdrawal by Subject|12
279356|NCT01022112|922685|P5|Overall Study|Fasting plasma glucose level increased|7
279357|NCT01022112|922686|P4|Overall Study|Fasting plasma glucose level increased|0
279358|NCT01022112|922687|P3|Overall Study|Fasting plasma glucose level increased|0
279359|NCT01022112|922688|P2|Overall Study|Fasting plasma glucose level increased|0
279360|NCT01022112|922689|P1|Overall Study|Fasting plasma glucose level increased|1
279361|NCT01022112|922685|P5|Overall Study|Withdrawal by Subject|1
279362|NCT01022112|922686|P4|Overall Study|Withdrawal by Subject|2
279363|NCT01022112|922687|P3|Overall Study|Withdrawal by Subject|2
279364|NCT01022112|922688|P2|Overall Study|Withdrawal by Subject|1
279365|NCT01022112|922689|P1|Overall Study|Withdrawal by Subject|0
279366|NCT01022112|922685|P5|Overall Study|Physician Decision|1
279367|NCT01022112|922686|P4|Overall Study|Physician Decision|0
279368|NCT01022112|922687|P3|Overall Study|Physician Decision|1
279369|NCT01022112|922688|P2|Overall Study|Physician Decision|0
279370|NCT01022112|922689|P1|Overall Study|Physician Decision|0
279371|NCT01022112|922685|P5|Overall Study|Lack of Efficacy|1
279372|NCT01022112|922686|P4|Overall Study|Lack of Efficacy|0
279373|NCT01022112|922687|P3|Overall Study|Lack of Efficacy|0
279374|NCT01022112|922688|P2|Overall Study|Lack of Efficacy|0
279375|NCT01022112|922689|P1|Overall Study|Lack of Efficacy|1
279376|NCT01022112|922685|P5|Overall Study|Adverse Event|0
279377|NCT01022112|922686|P4|Overall Study|Adverse Event|1
279378|NCT01022112|922687|P3|Overall Study|Adverse Event|0
279379|NCT01022112|922688|P2|Overall Study|Adverse Event|2
279380|NCT01022112|922689|P1|Overall Study|Adverse Event|1
279381|NCT01021878|922712|P2|Overall Study|Transplantation|1
279382|NCT01021878|922713|P1|Overall Study|Transplantation|6
279383|NCT01021878|922712|P2|Overall Study|Adverse Event|5
279384|NCT01021878|922713|P1|Overall Study|Adverse Event|6
279385|NCT01021878|922712|P2|Overall Study|Death|1
279386|NCT01021878|922713|P1|Overall Study|Death|0
279387|NCT01021878|922712|P2|Overall Study|Lost to Follow-up|3
279388|NCT01021878|922713|P1|Overall Study|Lost to Follow-up|4
279389|NCT01021852|922735|P8|Treatment Period 2|Withdrawal by Subject|2
279390|NCT01021852|922736|P7|Treatment Period 2|Withdrawal by Subject|1
279391|NCT01021852|922737|P6|Treatment Period 2|Withdrawal by Subject|0
279392|NCT01021852|922738|P5|Treatment Period 2|Withdrawal by Subject|0
279393|NCT01021852|922739|P4|Treatment Period 2|Withdrawal by Subject|0
279394|NCT01021852|922740|P3|Treatment Period 2|Withdrawal by Subject|0
279395|NCT01021852|922741|P2|Treatment Period 2|Withdrawal by Subject|0
279396|NCT01021852|922742|P1|Treatment Period 2|Withdrawal by Subject|0
279397|NCT01021852|922735|P8|Treatment Period 2|Protocol Violation|0
279398|NCT01021852|922736|P7|Treatment Period 2|Protocol Violation|1
279399|NCT01021852|922737|P6|Treatment Period 2|Protocol Violation|0
279400|NCT01021852|922738|P5|Treatment Period 2|Protocol Violation|1
279401|NCT01021852|922739|P4|Treatment Period 2|Protocol Violation|0
279402|NCT01021852|922740|P3|Treatment Period 2|Protocol Violation|0
279403|NCT01021852|922741|P2|Treatment Period 2|Protocol Violation|0
279404|NCT01021852|922742|P1|Treatment Period 2|Protocol Violation|0
279405|NCT01021852|922735|P8|Treatment Period 2|Physician Decision|0
279406|NCT01021852|922736|P7|Treatment Period 2|Physician Decision|0
279407|NCT01021852|922737|P6|Treatment Period 2|Physician Decision|0
279408|NCT01021852|922738|P5|Treatment Period 2|Physician Decision|0
279409|NCT01021852|922739|P4|Treatment Period 2|Physician Decision|0
279410|NCT01021852|922740|P3|Treatment Period 2|Physician Decision|1
279411|NCT01021852|922741|P2|Treatment Period 2|Physician Decision|0
279412|NCT01021852|922742|P1|Treatment Period 2|Physician Decision|0
279413|NCT01021852|922735|P8|Treatment Period 2|Lack of Efficacy|0
279414|NCT01021852|922736|P7|Treatment Period 2|Lack of Efficacy|0
279415|NCT01021852|922737|P6|Treatment Period 2|Lack of Efficacy|1
279416|NCT01021852|922738|P5|Treatment Period 2|Lack of Efficacy|0
279417|NCT01021852|922739|P4|Treatment Period 2|Lack of Efficacy|0
279418|NCT01021852|922740|P3|Treatment Period 2|Lack of Efficacy|0
279419|NCT01021852|922741|P2|Treatment Period 2|Lack of Efficacy|0
279420|NCT01021852|922742|P1|Treatment Period 2|Lack of Efficacy|0
279421|NCT01021852|922735|P8|Treatment Period 2|Adverse Event|0
279422|NCT01021852|922736|P7|Treatment Period 2|Adverse Event|1
279423|NCT01021852|922737|P6|Treatment Period 2|Adverse Event|0
279424|NCT01021852|922738|P5|Treatment Period 2|Adverse Event|1
279425|NCT01021852|922739|P4|Treatment Period 2|Adverse Event|0
279426|NCT01021852|922740|P3|Treatment Period 2|Adverse Event|0
279427|NCT01021852|922741|P2|Treatment Period 2|Adverse Event|1
279428|NCT01021852|922742|P1|Treatment Period 2|Adverse Event|0
279429|NCT01021852|922735|P8|Washout Period-No Drug|Adverse Event|0
279430|NCT01021852|922736|P7|Washout Period-No Drug|Adverse Event|0
279431|NCT01021852|922737|P6|Washout Period-No Drug|Adverse Event|1
279432|NCT01021852|922738|P5|Washout Period-No Drug|Adverse Event|0
279433|NCT01021852|922739|P4|Washout Period-No Drug|Adverse Event|0
279434|NCT01021852|922740|P3|Washout Period-No Drug|Adverse Event|0
279435|NCT01021852|922741|P2|Washout Period-No Drug|Adverse Event|0
279436|NCT01021852|922742|P1|Washout Period-No Drug|Adverse Event|1
279437|NCT01021852|922735|P8|Washout Period-Placebo|Protocol Violation|0
279438|NCT01021852|922736|P7|Washout Period-Placebo|Protocol Violation|1
279439|NCT01021852|922737|P6|Washout Period-Placebo|Protocol Violation|0
279440|NCT01021852|922738|P5|Washout Period-Placebo|Protocol Violation|0
279441|NCT01021852|922739|P4|Washout Period-Placebo|Protocol Violation|0
279442|NCT01021852|922740|P3|Washout Period-Placebo|Protocol Violation|0
279443|NCT01021852|922741|P2|Washout Period-Placebo|Protocol Violation|0
279444|NCT01021852|922742|P1|Washout Period-Placebo|Protocol Violation|0
279445|NCT01021852|922735|P8|Washout Period-Placebo|Lost to Follow-up|0
279446|NCT01021852|922736|P7|Washout Period-Placebo|Lost to Follow-up|0
279447|NCT01021852|922737|P6|Washout Period-Placebo|Lost to Follow-up|0
279448|NCT01021852|922738|P5|Washout Period-Placebo|Lost to Follow-up|1
279449|NCT01021852|922739|P4|Washout Period-Placebo|Lost to Follow-up|0
279450|NCT01021852|922740|P3|Washout Period-Placebo|Lost to Follow-up|0
279451|NCT01021852|922741|P2|Washout Period-Placebo|Lost to Follow-up|0
279452|NCT01021852|922742|P1|Washout Period-Placebo|Lost to Follow-up|0
279453|NCT01021852|922735|P8|Washout Period-Placebo|Adverse Event|0
279454|NCT01021852|922736|P7|Washout Period-Placebo|Adverse Event|0
279455|NCT01021852|922737|P6|Washout Period-Placebo|Adverse Event|1
279456|NCT01021852|922738|P5|Washout Period-Placebo|Adverse Event|0
279457|NCT01021852|922739|P4|Washout Period-Placebo|Adverse Event|1
279458|NCT01021852|922740|P3|Washout Period-Placebo|Adverse Event|0
279459|NCT01021852|922741|P2|Washout Period-Placebo|Adverse Event|0
279460|NCT01021852|922742|P1|Washout Period-Placebo|Adverse Event|0
279461|NCT01021852|922735|P8|Treatment Period 1|Not Treated|0
279462|NCT01021852|922736|P7|Treatment Period 1|Not Treated|0
279463|NCT01021852|922737|P6|Treatment Period 1|Not Treated|0
279464|NCT01021852|922738|P5|Treatment Period 1|Not Treated|0
279465|NCT01021852|922739|P4|Treatment Period 1|Not Treated|2
279466|NCT01021852|922740|P3|Treatment Period 1|Not Treated|0
279467|NCT01021852|922741|P2|Treatment Period 1|Not Treated|0
279468|NCT01021852|922742|P1|Treatment Period 1|Not Treated|0
279469|NCT01021852|922735|P8|Treatment Period 1|Withdrawal by Subject|1
279470|NCT01021852|922736|P7|Treatment Period 1|Withdrawal by Subject|0
279471|NCT01021852|922737|P6|Treatment Period 1|Withdrawal by Subject|0
279472|NCT01021852|922738|P5|Treatment Period 1|Withdrawal by Subject|1
279473|NCT01021852|922739|P4|Treatment Period 1|Withdrawal by Subject|0
279474|NCT01021852|922740|P3|Treatment Period 1|Withdrawal by Subject|0
279475|NCT01021852|922741|P2|Treatment Period 1|Withdrawal by Subject|0
279476|NCT01021852|922742|P1|Treatment Period 1|Withdrawal by Subject|0
279477|NCT01021852|922735|P8|Treatment Period 1|Pregnancy|0
279478|NCT01021852|922736|P7|Treatment Period 1|Pregnancy|0
279479|NCT01021852|922737|P6|Treatment Period 1|Pregnancy|0
279480|NCT01021852|922738|P5|Treatment Period 1|Pregnancy|0
279481|NCT01021852|922739|P4|Treatment Period 1|Pregnancy|0
279482|NCT01021852|922740|P3|Treatment Period 1|Pregnancy|1
279483|NCT01021852|922741|P2|Treatment Period 1|Pregnancy|0
279484|NCT01021852|922742|P1|Treatment Period 1|Pregnancy|0
279485|NCT01021852|922735|P8|Treatment Period 1|Adverse Event|0
279486|NCT01021852|922736|P7|Treatment Period 1|Adverse Event|0
279487|NCT01021852|922737|P6|Treatment Period 1|Adverse Event|2
279488|NCT01021852|922738|P5|Treatment Period 1|Adverse Event|2
279489|NCT01021852|922739|P4|Treatment Period 1|Adverse Event|0
279490|NCT01021852|922740|P3|Treatment Period 1|Adverse Event|1
279491|NCT01021852|922741|P2|Treatment Period 1|Adverse Event|1
279492|NCT01021852|922742|P1|Treatment Period 1|Adverse Event|3
279493|NCT01021813|922778|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
279494|NCT01021813|922779|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
279495|NCT01021813|922780|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
279496|NCT01021813|922781|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
279497|NCT01021813|922782|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
279498|NCT01021813|922778|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
279499|NCT01021813|922779|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
279500|NCT01021813|922780|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
279501|NCT01021813|922781|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
279502|NCT01021813|922782|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
279503|NCT01021813|922778|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
279504|NCT01021813|922779|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
279505|NCT01021813|922780|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
279506|NCT01021813|922781|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
279507|NCT01021813|922782|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
279508|NCT01021813|922778|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
279509|NCT01021813|922779|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
279510|NCT01021813|922780|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
279511|NCT01021813|922781|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
279512|NCT01021813|922782|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
279513|NCT01021813|922778|P5|DB Randomized Discontinuation Phase|Adverse Event|1
279514|NCT01021813|922779|P4|DB Randomized Discontinuation Phase|Adverse Event|3
279515|NCT01021813|922780|P3|DB Randomized Discontinuation Phase|Adverse Event|0
279516|NCT01021813|922781|P2|DB Randomized Discontinuation Phase|Adverse Event|0
279517|NCT01021813|922782|P1|DB Randomized Discontinuation Phase|Adverse Event|0
279518|NCT01021813|922778|P5|DB Treatment Phase|Withdrawal by Subject|0
279519|NCT01021813|922779|P4|DB Treatment Phase|Withdrawal by Subject|0
279520|NCT01021813|922780|P3|DB Treatment Phase|Withdrawal by Subject|0
279521|NCT01021813|922781|P2|DB Treatment Phase|Withdrawal by Subject|24
279522|NCT01021813|922782|P1|DB Treatment Phase|Withdrawal by Subject|60
279523|NCT01021813|922778|P5|DB Treatment Phase|Protocol Violation|0
279524|NCT01021813|922779|P4|DB Treatment Phase|Protocol Violation|0
279525|NCT01021813|922780|P3|DB Treatment Phase|Protocol Violation|0
279526|NCT01021813|922781|P2|DB Treatment Phase|Protocol Violation|3
279527|NCT01021813|922782|P1|DB Treatment Phase|Protocol Violation|4
279528|NCT01021813|922778|P5|DB Treatment Phase|Pregnancy|0
279529|NCT01021813|922779|P4|DB Treatment Phase|Pregnancy|0
279530|NCT01021813|922780|P3|DB Treatment Phase|Pregnancy|0
279531|NCT01021813|922781|P2|DB Treatment Phase|Pregnancy|0
279532|NCT01021813|922782|P1|DB Treatment Phase|Pregnancy|1
279533|NCT01021813|922778|P5|DB Treatment Phase|Physician Decision|0
279534|NCT01021813|922779|P4|DB Treatment Phase|Physician Decision|0
279535|NCT01021813|922780|P3|DB Treatment Phase|Physician Decision|0
279536|NCT01021813|922781|P2|DB Treatment Phase|Physician Decision|8
279537|NCT01021813|922782|P1|DB Treatment Phase|Physician Decision|17
279538|NCT01021813|922778|P5|DB Treatment Phase|Lost to Follow-up|0
279539|NCT01021813|922779|P4|DB Treatment Phase|Lost to Follow-up|0
279540|NCT01021813|922780|P3|DB Treatment Phase|Lost to Follow-up|0
279541|NCT01021813|922781|P2|DB Treatment Phase|Lost to Follow-up|12
279542|NCT01021813|922782|P1|DB Treatment Phase|Lost to Follow-up|14
279543|NCT01021813|922778|P5|DB Treatment Phase|Lack of Efficacy|0
279544|NCT01021813|922779|P4|DB Treatment Phase|Lack of Efficacy|0
279545|NCT01021813|922780|P3|DB Treatment Phase|Lack of Efficacy|0
279546|NCT01021813|922781|P2|DB Treatment Phase|Lack of Efficacy|28
279547|NCT01021813|922782|P1|DB Treatment Phase|Lack of Efficacy|44
279548|NCT01021813|922778|P5|DB Treatment Phase|Adverse Event|0
279549|NCT01021813|922779|P4|DB Treatment Phase|Adverse Event|0
279550|NCT01021813|922780|P3|DB Treatment Phase|Adverse Event|0
279551|NCT01021813|922781|P2|DB Treatment Phase|Adverse Event|22
279552|NCT01021813|922782|P1|DB Treatment Phase|Adverse Event|60
279553|NCT01021683|922834|P1|Overall Study|unspecified|8
279554|NCT01021683|922834|P1|Overall Study|Recovery of neutrophil count|51
279555|NCT01021683|922834|P1|Overall Study|Lack of Efficacy|12
279556|NCT01020526|922857|P1|Overall Study|Adverse Event|2
279557|NCT01020526|922857|P1|Overall Study|Lost to Follow-up|1
279558|NCT01020526|922857|P1|Overall Study|Insufficient clinical response|3
279559|NCT01020526|922857|P1|Overall Study|Other reasons|3
279560|NCT01020526|922857|P1|Overall Study|Withdrawal by Subject|5
279561|NCT01021423|922863|P2|Overall Study|Study terminated|5
279562|NCT01021423|922864|P1|Overall Study|Study terminated|4
279563|NCT01021332|922880|P1|Overall Study|Miscellaneous|3
279564|NCT01021332|922880|P1|Overall Study|Protocol Violation|9
279565|NCT01021332|922880|P1|Overall Study|Lost to Follow-up|4
279566|NCT01021332|922880|P1|Overall Study|Withdrawal of Consent|23
279567|NCT01021332|922880|P1|Overall Study|Lack of Efficacy|19
279568|NCT01021332|922880|P1|Overall Study|Adverse Event|43
279569|NCT01021332|922880|P1|Overall Study|Not fulfilling incl./excl.criteria|5
279570|NCT01021293|922941|P2|Overall Study|Lost to Follow-up|1
279571|NCT01021293|922942|P1|Overall Study|Lost to Follow-up|1
279572|NCT01021293|922941|P2|Overall Study|Migrated/moved from study area|18
279573|NCT01021293|922942|P1|Overall Study|Migrated/moved from study area|6
279574|NCT01021293|922941|P2|Overall Study|Withdrawal by Subject|3
279575|NCT01021293|922942|P1|Overall Study|Withdrawal by Subject|1
279576|NCT01021293|922941|P2|Overall Study|Adverse Event|1
279577|NCT01021293|922942|P1|Overall Study|Adverse Event|2
279578|NCT01021293|922941|P2|Overall Study|Serious Adverse Event|1
279579|NCT01021293|922942|P1|Overall Study|Serious Adverse Event|2
279580|NCT01021215|922961|P2|Overall Study|Lost to Follow-up|0
279581|NCT01021215|922962|P1|Overall Study|Lost to Follow-up|3
279582|NCT01021020|922977|P1|14 Day Washout Period A|Physician Decision|1
279583|NCT01021020|922977|P1|Period I|Withdrawal by Subject|1
279584|NCT01021020|922977|P1|Period I|Protocol Violation|1
279585|NCT01021007|922993|P2|Overall Study|Adverse Event|3
279586|NCT01021007|922994|P1|Overall Study|Adverse Event|1
279587|NCT01021007|922993|P2|Overall Study|Lost to Follow-up|1
279588|NCT01021007|922994|P1|Overall Study|Lost to Follow-up|1
279589|NCT01020981|923006|P2|Overall Study|Participant declined to complete survey|0
279590|NCT01020981|923007|P1|Overall Study|Participant declined to complete survey|2
279591|NCT01020981|923006|P2|Overall Study|Survey returned undeliverable|32
279592|NCT01020981|923007|P1|Overall Study|Survey returned undeliverable|8
279593|NCT01020981|923006|P2|Overall Study|Did not return mailed survey|58
279594|NCT01020981|923007|P1|Overall Study|Did not return mailed survey|74
279595|NCT01020877|923028|P2|Second Intervention|Withdrawal by Subject|0
279596|NCT01020877|923029|P1|Second Intervention|Withdrawal by Subject|1
279597|NCT01020838|923039|P1|Overall Study|Most common: Study ended by sponsor|77
279598|NCT01020838|923039|P1|Overall Study|Lost to Follow-up|6
279599|NCT01020838|923039|P1|Overall Study|Withdrawal by Subject|9
279600|NCT01020838|923039|P1|Overall Study|Adverse Event|1
279601|NCT01020838|923039|P1|Overall Study|Death|90
279602|NCT01020812|923054|P1|Overall Study|Protocol Violation|1
279603|NCT01020812|923054|P1|Overall Study|Withdrawal by Subject|1
279604|NCT01020812|923054|P1|Overall Study|Physician Decision|1
279605|NCT01020799|923064|P3|Overall Study|Lost to Follow-up|2
279606|NCT01020799|923065|P2|Overall Study|Lost to Follow-up|4
279607|NCT01020799|923066|P1|Overall Study|Lost to Follow-up|6
279608|NCT01020799|923064|P3|Overall Study|Withdrawal by Subject|3
279609|NCT01020799|923065|P2|Overall Study|Withdrawal by Subject|2
279610|NCT01020799|923066|P1|Overall Study|Withdrawal by Subject|2
279611|NCT01020799|923064|P3|Overall Study|Protocol Violation|0
279612|NCT01020799|923065|P2|Overall Study|Protocol Violation|2
279613|NCT01020799|923066|P1|Overall Study|Protocol Violation|3
279614|NCT01020799|923064|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
279615|NCT01020799|923065|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
279616|NCT01020799|923066|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
279617|NCT01020799|923064|P3|Overall Study|Adverse Event|2
279618|NCT01020799|923065|P2|Overall Study|Adverse Event|3
279619|NCT01020799|923066|P1|Overall Study|Adverse Event|4
279620|NCT01020786|923089|P1|Maintenance Period|Sponsor Decision|1
279621|NCT01020786|923089|P1|Maintenance Period|Withdrawal by Subject|8
279622|NCT01020786|923089|P1|Maintenance Period|Progressive Disease|43
279623|NCT01020786|923089|P1|Maintenance Period|Adverse Event|8
279624|NCT01020786|923089|P1|Induction Period|Withdrawal by Subject|3
279625|NCT01020786|923089|P1|Induction Period|Investigator Decision|3
279626|NCT01020786|923089|P1|Induction Period|Progressive Disease|31
279627|NCT01020786|923089|P1|Induction Period|Adverse Event|10
279628|NCT01020786|923089|P1|Induction Period|Entry Criteria Not Met|2
279629|NCT01020773|923103|P2|Overall Study|Withdrawal by Subject|3
279630|NCT01020773|923104|P1|Overall Study|Withdrawal by Subject|4
279631|NCT01020747|923110|P1|Overall Study|Withdrawal by Subject|1
279632|NCT01020487|923129|P3|Part 2 Open-label Period|Adverse Event|1
279633|NCT01020487|923130|P2|Part 2 Open-label Period|Adverse Event|4
279634|NCT01020487|923131|P1|Part 2 Open-label Period|Adverse Event|0
279635|NCT01020487|923129|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
279636|NCT01020487|923130|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
279637|NCT01020487|923131|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
279638|NCT01020487|923129|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
279639|NCT01020487|923130|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
279640|NCT01020487|923131|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
279641|NCT01020487|923129|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
279642|NCT01020487|923130|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
279643|NCT01020487|923131|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
279644|NCT01020487|923129|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
279645|NCT01020487|923130|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
279646|NCT01020487|923131|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
279647|NCT01020474|923154|P2|Overall Study|Insufficient Clinical Response|3
279648|NCT01020474|923155|P1|Overall Study|Insufficient Clinical Response|0
279649|NCT01020474|923154|P2|Overall Study|Other Reasons|1
279650|NCT01020474|923155|P1|Overall Study|Other Reasons|1
279651|NCT01020474|923154|P2|Overall Study|Withdrawal by Subject|7
279652|NCT01020474|923155|P1|Overall Study|Withdrawal by Subject|5
279653|NCT01020474|923154|P2|Overall Study|Protocol Violation|2
279654|NCT01020474|923155|P1|Overall Study|Protocol Violation|0
279655|NCT01020474|923154|P2|Overall Study|Adverse Event|4
279656|NCT01020474|923155|P1|Overall Study|Adverse Event|4
279657|NCT01020448|923175|P1|Treatment|Lost to Follow-up|2
279658|NCT01020448|923175|P1|Treatment|Lack of Efficacy|8
279659|NCT01020448|923175|P1|Treatment|Disease Progression|2
279660|NCT01020448|923175|P1|Treatment|Consent Withdrawn|3
279661|NCT01020448|923175|P1|Treatment|Adverse Event|11
279662|NCT01020448|923175|P1|Pre-assignment|Does Not Meet Entry Criteria|2
279663|NCT01020448|923175|P1|Pre-assignment|Withdrawal by Subject|5
279664|NCT01020448|923175|P1|Pre-assignment|Adverse Event|6
279665|NCT01020305|923184|P1|Overall Study|Adverse Event|2
279666|NCT01020123|923195|P7|Extention Period|Lost to Follow-up|0
279667|NCT01020123|923196|P6|Extention Period|Lost to Follow-up|2
279668|NCT01020123|923197|P5|Extention Period|Lost to Follow-up|0
279669|NCT01020123|923198|P4|Extention Period|Lost to Follow-up|0
279670|NCT01020123|923199|P3|Extention Period|Lost to Follow-up|0
279671|NCT01020123|923200|P2|Extention Period|Lost to Follow-up|0
279672|NCT01020123|923201|P1|Extention Period|Lost to Follow-up|0
279673|NCT01020123|923195|P7|Extention Period|Protocol Violation|1
279674|NCT01020123|923196|P6|Extention Period|Protocol Violation|0
279675|NCT01020123|923197|P5|Extention Period|Protocol Violation|0
279676|NCT01020123|923198|P4|Extention Period|Protocol Violation|0
279677|NCT01020123|923199|P3|Extention Period|Protocol Violation|1
279678|NCT01020123|923200|P2|Extention Period|Protocol Violation|1
279679|NCT01020123|923201|P1|Extention Period|Protocol Violation|1
279680|NCT01020123|923195|P7|Extention Period|Adverse Event|0
279681|NCT01020123|923196|P6|Extention Period|Adverse Event|0
279682|NCT01020123|923197|P5|Extention Period|Adverse Event|0
279683|NCT01020123|923198|P4|Extention Period|Adverse Event|1
279684|NCT01020123|923199|P3|Extention Period|Adverse Event|0
279685|NCT01020123|923200|P2|Extention Period|Adverse Event|0
279686|NCT01020123|923201|P1|Extention Period|Adverse Event|0
279687|NCT01020123|923195|P7|Extention Period|Withdrawal by Subject|0
279688|NCT01020123|923196|P6|Extention Period|Withdrawal by Subject|0
279689|NCT01020123|923197|P5|Extention Period|Withdrawal by Subject|0
279690|NCT01020123|923198|P4|Extention Period|Withdrawal by Subject|0
279691|NCT01020123|923199|P3|Extention Period|Withdrawal by Subject|1
279692|NCT01020123|923200|P2|Extention Period|Withdrawal by Subject|1
279693|NCT01020123|923201|P1|Extention Period|Withdrawal by Subject|2
279694|NCT01020123|923195|P7|Main Period|Unclasified|6
279695|NCT01020123|923196|P6|Main Period|Unclasified|3
279696|NCT01020123|923197|P5|Main Period|Unclasified|1
279697|NCT01020123|923198|P4|Main Period|Unclasified|0
279698|NCT01020123|923199|P3|Main Period|Unclasified|1
279699|NCT01020123|923200|P2|Main Period|Unclasified|0
279700|NCT01020123|923201|P1|Main Period|Unclasified|2
279701|NCT01020123|923195|P7|Main Period|Lost to Follow-up|0
279702|NCT01020123|923196|P6|Main Period|Lost to Follow-up|0
279703|NCT01020123|923197|P5|Main Period|Lost to Follow-up|0
279704|NCT01020123|923198|P4|Main Period|Lost to Follow-up|0
279705|NCT01020123|923199|P3|Main Period|Lost to Follow-up|0
279706|NCT01020123|923200|P2|Main Period|Lost to Follow-up|2
279707|NCT01020123|923201|P1|Main Period|Lost to Follow-up|0
279708|NCT01020123|923195|P7|Main Period|Protocol Violation|2
279709|NCT01020123|923196|P6|Main Period|Protocol Violation|3
279710|NCT01020123|923197|P5|Main Period|Protocol Violation|2
279711|NCT01020123|923198|P4|Main Period|Protocol Violation|5
279712|NCT01020123|923199|P3|Main Period|Protocol Violation|2
279713|NCT01020123|923200|P2|Main Period|Protocol Violation|4
279714|NCT01020123|923201|P1|Main Period|Protocol Violation|4
279715|NCT01020123|923195|P7|Main Period|Adverse Event|1
279716|NCT01020123|923196|P6|Main Period|Adverse Event|2
279717|NCT01020123|923197|P5|Main Period|Adverse Event|1
279718|NCT01020123|923198|P4|Main Period|Adverse Event|1
279719|NCT01020123|923199|P3|Main Period|Adverse Event|2
279720|NCT01020123|923200|P2|Main Period|Adverse Event|2
279721|NCT01020123|923201|P1|Main Period|Adverse Event|5
279722|NCT01020123|923195|P7|Main Period|Eligibility Criteria not fullfilled|0
279723|NCT01020123|923196|P6|Main Period|Eligibility Criteria not fullfilled|0
279724|NCT01020123|923197|P5|Main Period|Eligibility Criteria not fullfilled|1
279725|NCT01020123|923198|P4|Main Period|Eligibility Criteria not fullfilled|0
279726|NCT01020123|923199|P3|Main Period|Eligibility Criteria not fullfilled|0
279727|NCT01020123|923200|P2|Main Period|Eligibility Criteria not fullfilled|1
279728|NCT01020123|923201|P1|Main Period|Eligibility Criteria not fullfilled|0
279729|NCT01020123|923195|P7|Main Period|Withdrawal by Subject|2
279730|NCT01020123|923196|P6|Main Period|Withdrawal by Subject|3
279731|NCT01020123|923197|P5|Main Period|Withdrawal by Subject|6
279732|NCT01020123|923198|P4|Main Period|Withdrawal by Subject|1
279733|NCT01020123|923199|P3|Main Period|Withdrawal by Subject|3
279734|NCT01020123|923200|P2|Main Period|Withdrawal by Subject|5
279735|NCT01020123|923201|P1|Main Period|Withdrawal by Subject|6
279736|NCT01020019|923396|P2|Overall Study|moving|2
279737|NCT01020019|923397|P1|Overall Study|moving|0
279738|NCT01020019|923396|P2|Overall Study|not interested in treatment|4
279739|NCT01020019|923397|P1|Overall Study|not interested in treatment|4
279740|NCT01020019|923396|P2|Overall Study|Adverse Event|5
279741|NCT01020019|923397|P1|Overall Study|Adverse Event|1
279742|NCT01020019|923396|P2|Overall Study|Lost to Follow-up|18
279743|NCT01020019|923397|P1|Overall Study|Lost to Follow-up|21
279744|NCT01019980|923418|P2|Overall Study|Drug not available.|0
279745|NCT01019980|923419|P1|Overall Study|Drug not available.|2
279746|NCT01019694|923482|P3|Overall Study|Other reason (not specified)|6
279747|NCT01019694|923483|P2|Overall Study|Other reason (not specified)|5
279748|NCT01019694|923484|P1|Overall Study|Other reason (not specified)|1
279749|NCT01019694|923482|P3|Overall Study|Not treated|3
279750|NCT01019694|923483|P2|Overall Study|Not treated|2
279751|NCT01019694|923484|P1|Overall Study|Not treated|0
279752|NCT01019694|923482|P3|Overall Study|Withdrawal by Subject|12
279753|NCT01019694|923483|P2|Overall Study|Withdrawal by Subject|6
279754|NCT01019694|923484|P1|Overall Study|Withdrawal by Subject|4
279755|NCT01019694|923482|P3|Overall Study|Lost to Follow-up|3
279756|NCT01019694|923483|P2|Overall Study|Lost to Follow-up|3
279757|NCT01019694|923484|P1|Overall Study|Lost to Follow-up|5
279758|NCT01019694|923482|P3|Overall Study|Protocol Violation|4
279759|NCT01019694|923483|P2|Overall Study|Protocol Violation|6
279760|NCT01019694|923484|P1|Overall Study|Protocol Violation|2
279761|NCT01019694|923482|P3|Overall Study|Adverse Event|19
279762|NCT01019694|923483|P2|Overall Study|Adverse Event|16
279763|NCT01019694|923484|P1|Overall Study|Adverse Event|12
279764|NCT01019486|923609|P3|Overall Study|Withdrawal by Subject|1
279765|NCT01019486|923610|P2|Overall Study|Withdrawal by Subject|1
279766|NCT01019486|923611|P1|Overall Study|Withdrawal by Subject|1
279767|NCT01019369|923625|P2|Overall Study|Withdrawal by Subject|1
279768|NCT01019369|923626|P1|Overall Study|Withdrawal by Subject|0
279769|NCT01019369|923625|P2|Overall Study|Lost to Follow-up|6
279770|NCT01019369|923626|P1|Overall Study|Lost to Follow-up|10
279771|NCT01019317|923632|P1|Overall Study|Not Eligible|4
279772|NCT01019135|923639|P3|Overall Study|Did not attend CR|6
279773|NCT01019135|923640|P2|Overall Study|Did not attend CR|13
279774|NCT01019135|923641|P1|Overall Study|Did not attend CR|8
279775|NCT01019135|923639|P3|Overall Study|Did not receive allocated intervention|25
279776|NCT01019135|923640|P2|Overall Study|Did not receive allocated intervention|6
279777|NCT01019135|923641|P1|Overall Study|Did not receive allocated intervention|12
279778|NCT01018992|923669|P2|Overall Study|Lost to Follow-up|1
279779|NCT01018992|923670|P1|Overall Study|Lost to Follow-up|5
279780|NCT01018992|923669|P2|Overall Study|Protocol Violation|4
279781|NCT01018992|923670|P1|Overall Study|Protocol Violation|0
279782|NCT01018992|923669|P2|Overall Study|Withdrawal by Subject|8
279783|NCT01018992|923670|P1|Overall Study|Withdrawal by Subject|3
279784|NCT01018992|923669|P2|Overall Study|Adverse Event|3
279785|NCT01018992|923670|P1|Overall Study|Adverse Event|8
279786|NCT01018979|923684|P2|Overall Study|Not received at least one dose|1
279787|NCT01018979|923685|P1|Overall Study|Not received at least one dose|0
279788|NCT01018979|923684|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
279789|NCT01018979|923685|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
279790|NCT01018953|923715|P1|Overall Study|Study termination by sponsor|5
279791|NCT01018953|923715|P1|Overall Study|Withdrawal by Subject|1
279792|NCT01018953|923715|P1|Overall Study|Adverse Event|2
279793|NCT01018862|923728|P3|Overall Study|administrative problems|4
279794|NCT01018862|923729|P2|Overall Study|administrative problems|4
279795|NCT01018862|923730|P1|Overall Study|administrative problems|5
279796|NCT01018862|923728|P3|Overall Study|Withdrawal by Subject|1
279797|NCT01018862|923729|P2|Overall Study|Withdrawal by Subject|2
279798|NCT01018862|923730|P1|Overall Study|Withdrawal by Subject|1
279799|NCT01018862|923728|P3|Overall Study|Protocol Violation|3
279800|NCT01018862|923729|P2|Overall Study|Protocol Violation|3
279801|NCT01018862|923730|P1|Overall Study|Protocol Violation|1
279802|NCT01018862|923728|P3|Overall Study|Lost to Follow-up|0
279803|NCT01018862|923729|P2|Overall Study|Lost to Follow-up|1
279804|NCT01018862|923730|P1|Overall Study|Lost to Follow-up|3
279805|NCT01018862|923728|P3|Overall Study|Lack of Efficacy|2
279806|NCT01018862|923729|P2|Overall Study|Lack of Efficacy|0
279807|NCT01018862|923730|P1|Overall Study|Lack of Efficacy|1
279808|NCT01018862|923728|P3|Overall Study|Adverse Event|6
279809|NCT01018862|923729|P2|Overall Study|Adverse Event|0
279810|NCT01018862|923730|P1|Overall Study|Adverse Event|2
279811|NCT01018810|923752|P5|Overall Study|Sponsor Decision|1
279812|NCT01018810|923753|P4|Overall Study|Sponsor Decision|1
279813|NCT01018810|923754|P3|Overall Study|Sponsor Decision|1
279814|NCT01018810|923755|P2|Overall Study|Sponsor Decision|0
279815|NCT01018810|923756|P1|Overall Study|Sponsor Decision|2
279816|NCT01018810|923752|P5|Overall Study|Withdrawal by Subject|0
279817|NCT01018810|923753|P4|Overall Study|Withdrawal by Subject|0
279818|NCT01018810|923754|P3|Overall Study|Withdrawal by Subject|0
279819|NCT01018810|923755|P2|Overall Study|Withdrawal by Subject|1
279820|NCT01018810|923756|P1|Overall Study|Withdrawal by Subject|0
279821|NCT01018732|923816|P3|Overall Study|Unable to Classify|1
279822|NCT01018732|923817|P2|Overall Study|Unable to Classify|0
279823|NCT01018732|923818|P1|Overall Study|Unable to Classify|0
279824|NCT01018732|923816|P3|Overall Study|Inappropriate Enrollment|0
279825|NCT01018732|923817|P2|Overall Study|Inappropriate Enrollment|1
279826|NCT01018732|923818|P1|Overall Study|Inappropriate Enrollment|0
279827|NCT01018732|923816|P3|Overall Study|Protocol Violation|0
279828|NCT01018732|923817|P2|Overall Study|Protocol Violation|1
279829|NCT01018732|923818|P1|Overall Study|Protocol Violation|1
279830|NCT01018732|923816|P3|Overall Study|Lost to Follow-up|3
279831|NCT01018732|923817|P2|Overall Study|Lost to Follow-up|0
279832|NCT01018732|923818|P1|Overall Study|Lost to Follow-up|0
279833|NCT01018680|923852|P2|Overall Study|Physician Decision|1
279834|NCT01018680|923853|P1|Overall Study|Physician Decision|3
279835|NCT01018680|923852|P2|Overall Study|Entry Criteria Not Met|4
279836|NCT01018680|923853|P1|Overall Study|Entry Criteria Not Met|1
279837|NCT01018680|923852|P2|Overall Study|Lost to Follow-up|3
279838|NCT01018680|923853|P1|Overall Study|Lost to Follow-up|5
279839|NCT01018680|923852|P2|Overall Study|Lack of Efficacy|2
279840|NCT01018680|923853|P1|Overall Study|Lack of Efficacy|8
279841|NCT01018680|923852|P2|Overall Study|Sponsor Decision|7
279842|NCT01018680|923853|P1|Overall Study|Sponsor Decision|6
279843|NCT01018680|923852|P2|Overall Study|Protocol Violation|8
279844|NCT01018680|923853|P1|Overall Study|Protocol Violation|5
279845|NCT01018680|923852|P2|Overall Study|Withdrawal by Subject|10
279846|NCT01018680|923853|P1|Overall Study|Withdrawal by Subject|10
279847|NCT01018680|923852|P2|Overall Study|Adverse Event|40
279848|NCT01018680|923853|P1|Overall Study|Adverse Event|23
279849|NCT01018511|923897|P4|Overall Study|Miscellaneous|0
279850|NCT01018511|923898|P3|Overall Study|Miscellaneous|0
279851|NCT01018511|923899|P2|Overall Study|Miscellaneous|2
279852|NCT01018511|923900|P1|Overall Study|Miscellaneous|0
279853|NCT01018511|923897|P4|Overall Study|Protocol Violation|9
279854|NCT01018511|923898|P3|Overall Study|Protocol Violation|7
279855|NCT01018511|923899|P2|Overall Study|Protocol Violation|8
279856|NCT01018511|923900|P1|Overall Study|Protocol Violation|5
279857|NCT01018511|923897|P4|Overall Study|Lost to Follow-up|0
279858|NCT01018511|923898|P3|Overall Study|Lost to Follow-up|1
279859|NCT01018511|923899|P2|Overall Study|Lost to Follow-up|0
279860|NCT01018511|923900|P1|Overall Study|Lost to Follow-up|0
279861|NCT01018511|923897|P4|Overall Study|Withdrawal by Subject|9
279862|NCT01018511|923898|P3|Overall Study|Withdrawal by Subject|11
279863|NCT01018511|923899|P2|Overall Study|Withdrawal by Subject|5
279864|NCT01018511|923900|P1|Overall Study|Withdrawal by Subject|6
279865|NCT01018511|923897|P4|Overall Study|Lack of Efficacy|2
279866|NCT01018511|923898|P3|Overall Study|Lack of Efficacy|1
279867|NCT01018511|923899|P2|Overall Study|Lack of Efficacy|1
279868|NCT01018511|923900|P1|Overall Study|Lack of Efficacy|4
279869|NCT01018511|923897|P4|Overall Study|Adverse Event|10
279870|NCT01018511|923898|P3|Overall Study|Adverse Event|13
279871|NCT01018511|923899|P2|Overall Study|Adverse Event|9
279872|NCT01018511|923900|P1|Overall Study|Adverse Event|5
279873|NCT01018511|923897|P4|Overall Study|Not fulfilling eligibility criteria|3
279874|NCT01018511|923898|P3|Overall Study|Not fulfilling eligibility criteria|7
279875|NCT01018511|923899|P2|Overall Study|Not fulfilling eligibility criteria|7
279876|NCT01018511|923900|P1|Overall Study|Not fulfilling eligibility criteria|6
279877|NCT01018394|924097|P2|Overall Study|Lost to Follow-up|3
279878|NCT01018394|924098|P1|Overall Study|Lost to Follow-up|4
279879|NCT01018394|924097|P2|Overall Study|Withdrawal by Subject|5
279880|NCT01018394|924098|P1|Overall Study|Withdrawal by Subject|5
279881|NCT01018264|924108|P2|Overall Study|Lost to Follow-up|1
279882|NCT01018264|924109|P1|Overall Study|Lost to Follow-up|0
279883|NCT01018264|924108|P2|Overall Study|Withdrawal by Subject|0
279884|NCT01018264|924109|P1|Overall Study|Withdrawal by Subject|1
279885|NCT01018186|924126|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
279886|NCT01018186|924127|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
279887|NCT01018186|924128|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
279888|NCT01018186|924129|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
279889|NCT01018186|924126|P4|52-week Double-blind Treatment Period|Physician Decision|3
279890|NCT01018186|924127|P3|52-week Double-blind Treatment Period|Physician Decision|0
279891|NCT01018186|924128|P2|52-week Double-blind Treatment Period|Physician Decision|1
279892|NCT01018186|924129|P1|52-week Double-blind Treatment Period|Physician Decision|0
279893|NCT01018186|924126|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
279894|NCT01018186|924127|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
279895|NCT01018186|924128|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
279896|NCT01018186|924129|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
279897|NCT01018186|924126|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
279898|NCT01018186|924127|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
279899|NCT01018186|924128|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
279900|NCT01018186|924129|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
279901|NCT01018186|924126|P4|52-week Double-blind Treatment Period|Protocol Violation|2
279902|NCT01018186|924127|P3|52-week Double-blind Treatment Period|Protocol Violation|8
279903|NCT01018186|924128|P2|52-week Double-blind Treatment Period|Protocol Violation|8
279904|NCT01018186|924129|P1|52-week Double-blind Treatment Period|Protocol Violation|0
279905|NCT01018186|924126|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
279906|NCT01018186|924127|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
279907|NCT01018186|924128|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
279908|NCT01018186|924129|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
279909|NCT01018186|924126|P4|52-week Double-blind Treatment Period|Adverse Event|6
279910|NCT01018186|924127|P3|52-week Double-blind Treatment Period|Adverse Event|3
279911|NCT01018186|924128|P2|52-week Double-blind Treatment Period|Adverse Event|5
279912|NCT01018186|924129|P1|52-week Double-blind Treatment Period|Adverse Event|0
279913|NCT01018186|924126|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
279914|NCT01018186|924127|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
279915|NCT01018186|924128|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
279916|NCT01018186|924129|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
279917|NCT01018186|924126|P4|2-week Run-in Period|Withdrawal by Subject|0
279918|NCT01018186|924127|P3|2-week Run-in Period|Withdrawal by Subject|0
279919|NCT01018186|924128|P2|2-week Run-in Period|Withdrawal by Subject|0
279920|NCT01018186|924129|P1|2-week Run-in Period|Withdrawal by Subject|11
279921|NCT01018186|924126|P4|2-week Run-in Period|Physician Decision|0
279922|NCT01018186|924127|P3|2-week Run-in Period|Physician Decision|0
279923|NCT01018186|924128|P2|2-week Run-in Period|Physician Decision|0
279924|NCT01018186|924129|P1|2-week Run-in Period|Physician Decision|3
279925|NCT01018186|924126|P4|2-week Run-in Period|Lost to Follow-up|0
279926|NCT01018186|924127|P3|2-week Run-in Period|Lost to Follow-up|0
279927|NCT01018186|924128|P2|2-week Run-in Period|Lost to Follow-up|0
279928|NCT01018186|924129|P1|2-week Run-in Period|Lost to Follow-up|2
279929|NCT01018186|924126|P4|2-week Run-in Period|Protocol Violation|0
279930|NCT01018186|924127|P3|2-week Run-in Period|Protocol Violation|0
279931|NCT01018186|924128|P2|2-week Run-in Period|Protocol Violation|0
279932|NCT01018186|924129|P1|2-week Run-in Period|Protocol Violation|1
279933|NCT01018030|924315|P3|Overall Study|Did Not Receive Study Drug|0
279934|NCT01018030|924316|P2|Overall Study|Did Not Receive Study Drug|3
279935|NCT01018030|924317|P1|Overall Study|Did Not Receive Study Drug|1
279936|NCT01018030|924315|P3|Overall Study|Lack of Efficacy|0
279937|NCT01018030|924316|P2|Overall Study|Lack of Efficacy|0
279938|NCT01018030|924317|P1|Overall Study|Lack of Efficacy|1
279939|NCT01018030|924315|P3|Overall Study|Physician Decision|1
279940|NCT01018030|924316|P2|Overall Study|Physician Decision|0
279941|NCT01018030|924317|P1|Overall Study|Physician Decision|1
279942|NCT01018030|924315|P3|Overall Study|Protocol Violation|0
279943|NCT01018030|924316|P2|Overall Study|Protocol Violation|1
279944|NCT01018030|924317|P1|Overall Study|Protocol Violation|2
279945|NCT01018030|924315|P3|Overall Study|Lost to Follow-up|3
279946|NCT01018030|924316|P2|Overall Study|Lost to Follow-up|0
279947|NCT01018030|924317|P1|Overall Study|Lost to Follow-up|2
279948|NCT01018030|924315|P3|Overall Study|Withdrawal by Subject|4
279949|NCT01018030|924316|P2|Overall Study|Withdrawal by Subject|2
279950|NCT01018030|924317|P1|Overall Study|Withdrawal by Subject|2
279951|NCT01018030|924315|P3|Overall Study|Adverse Event|5
279952|NCT01018030|924316|P2|Overall Study|Adverse Event|5
279953|NCT01018030|924317|P1|Overall Study|Adverse Event|10
279954|NCT01017952|924368|P5|52-week, Double-blind Treatment Period|Physician Decision|7
279955|NCT01017952|924369|P4|52-week, Double-blind Treatment Period|Physician Decision|9
279956|NCT01017952|924370|P3|52-week, Double-blind Treatment Period|Physician Decision|8
279957|NCT01017952|924371|P2|52-week, Double-blind Treatment Period|Physician Decision|10
279958|NCT01017952|924372|P1|52-week, Double-blind Treatment Period|Physician Decision|0
279959|NCT01017952|924368|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
279960|NCT01017952|924369|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
279961|NCT01017952|924370|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
279962|NCT01017952|924371|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
279963|NCT01017952|924372|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
279964|NCT01017952|924368|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
279965|NCT01017952|924369|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
279966|NCT01017952|924370|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
279967|NCT01017952|924371|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
279968|NCT01017952|924372|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
279969|NCT01017952|924368|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
279970|NCT01017952|924369|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
279971|NCT01017952|924370|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
279972|NCT01017952|924371|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
279973|NCT01017952|924372|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
279974|NCT01017952|924368|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
279975|NCT01017952|924369|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
279976|NCT01017952|924370|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
279977|NCT01017952|924371|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
279978|NCT01017952|924372|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
279979|NCT01017952|924368|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
279980|NCT01017952|924369|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
279981|NCT01017952|924370|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
279982|NCT01017952|924371|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
279983|NCT01017952|924372|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
279984|NCT01017952|924368|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
279985|NCT01017952|924369|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
279986|NCT01017952|924370|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
279987|NCT01017952|924371|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
279988|NCT01017952|924372|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
279989|NCT01017952|924368|P5|52-week, Double-blind Treatment Period|Adverse Event|30
279990|NCT01017952|924369|P4|52-week, Double-blind Treatment Period|Adverse Event|35
279991|NCT01017952|924370|P3|52-week, Double-blind Treatment Period|Adverse Event|32
279992|NCT01017952|924371|P2|52-week, Double-blind Treatment Period|Adverse Event|25
279993|NCT01017952|924372|P1|52-week, Double-blind Treatment Period|Adverse Event|0
279994|NCT01017952|924368|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
279995|NCT01017952|924369|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
279996|NCT01017952|924370|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
279997|NCT01017952|924371|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
279998|NCT01017952|924372|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
279999|NCT01017952|924368|P5|4-week, Open-label Run-In Period|Physician Decision|0
280000|NCT01017952|924369|P4|4-week, Open-label Run-In Period|Physician Decision|0
280001|NCT01017952|924370|P3|4-week, Open-label Run-In Period|Physician Decision|0
280002|NCT01017952|924371|P2|4-week, Open-label Run-In Period|Physician Decision|0
280003|NCT01017952|924372|P1|4-week, Open-label Run-In Period|Physician Decision|10
280004|NCT01017952|924368|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
280005|NCT01017952|924369|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
280006|NCT01017952|924370|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
280007|NCT01017952|924371|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
280008|NCT01017952|924372|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
280009|NCT01017952|924368|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
280010|NCT01017952|924369|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
280011|NCT01017952|924370|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
280012|NCT01017952|924371|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
280013|NCT01017952|924372|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
280014|NCT01017952|924368|P5|4-week, Open-label Run-In Period|Adverse Event|0
280015|NCT01017952|924369|P4|4-week, Open-label Run-In Period|Adverse Event|0
280016|NCT01017952|924370|P3|4-week, Open-label Run-In Period|Adverse Event|0
280017|NCT01017952|924371|P2|4-week, Open-label Run-In Period|Adverse Event|0
280018|NCT01017952|924372|P1|4-week, Open-label Run-In Period|Adverse Event|23
280019|NCT01017952|924368|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
280020|NCT01017952|924369|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
280021|NCT01017952|924370|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
280022|NCT01017952|924371|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
280023|NCT01017952|924372|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
280024|NCT01017874|924396|P2|Overall Study|Physician Decision|3
280025|NCT01017874|924397|P1|Overall Study|Physician Decision|1
280026|NCT01017874|924396|P2|Overall Study|Lost to Follow-up|2
280027|NCT01017874|924397|P1|Overall Study|Lost to Follow-up|3
280028|NCT01017874|924396|P2|Overall Study|Sponsor decision|1
280029|NCT01017874|924397|P1|Overall Study|Sponsor decision|3
280030|NCT01017874|924396|P2|Overall Study|Withdrawal by Subject|20
280031|NCT01017874|924397|P1|Overall Study|Withdrawal by Subject|23
280032|NCT01017731|924415|P1|Overall Study|Adverse Event|1
280033|NCT01017731|924415|P1|Overall Study|Physician Decision|2
280034|NCT01017731|924415|P1|Overall Study|Withdrawal by Subject|3
280035|NCT01017731|924415|P1|Overall Study|Lost to Follow-up|2
280036|NCT01017601|924444|P2|Overall Study|Withdrawal by Subject|1
280037|NCT01017601|924445|P1|Overall Study|Withdrawal by Subject|0
280038|NCT01017601|924444|P2|Overall Study|Disease Progression|12
280039|NCT01017601|924445|P1|Overall Study|Disease Progression|12
280040|NCT01017575|924472|P5|Overall Study|Withdrawal by Subject|0
280041|NCT01017575|924473|P4|Overall Study|Withdrawal by Subject|0
280042|NCT01017575|924474|P3|Overall Study|Withdrawal by Subject|0
280043|NCT01017575|924475|P2|Overall Study|Withdrawal by Subject|0
280044|NCT01017575|924476|P1|Overall Study|Withdrawal by Subject|1
280045|NCT01017575|924472|P5|Overall Study|Adverse Event|2
280046|NCT01017575|924473|P4|Overall Study|Adverse Event|0
280047|NCT01017575|924474|P3|Overall Study|Adverse Event|0
280048|NCT01017575|924475|P2|Overall Study|Adverse Event|1
280049|NCT01017575|924476|P1|Overall Study|Adverse Event|0
280050|NCT01017575|924472|P5|Overall Study|Lack of Efficacy|1
280051|NCT01017575|924473|P4|Overall Study|Lack of Efficacy|1
280052|NCT01017575|924474|P3|Overall Study|Lack of Efficacy|0
280053|NCT01017575|924475|P2|Overall Study|Lack of Efficacy|1
280054|NCT01017575|924476|P1|Overall Study|Lack of Efficacy|0
280055|NCT01017549|924513|P1|One-year Follow-up|Withdrawal by Subject|5
280056|NCT01017549|924513|P1|One-year Follow-up|Lost to Follow-up|2
280057|NCT01017549|924513|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
280058|NCT01017263|924544|P1|Overall Study|not eligible|12
280059|NCT01017146|924625|P2|Overall Study|Change in Work Situation|0
280060|NCT01017146|924626|P1|Overall Study|Change in Work Situation|1
280061|NCT01017146|924625|P2|Overall Study|Did Not Meet Eligibility Criteria|2
280062|NCT01017146|924626|P1|Overall Study|Did Not Meet Eligibility Criteria|1
280063|NCT01017146|924625|P2|Overall Study|Took Excluded Medication|0
280064|NCT01017146|924626|P1|Overall Study|Took Excluded Medication|2
280065|NCT01017146|924625|P2|Overall Study|Protocol Violation|0
280066|NCT01017146|924626|P1|Overall Study|Protocol Violation|2
280067|NCT01017146|924625|P2|Overall Study|Pregnancy|1
280068|NCT01017146|924626|P1|Overall Study|Pregnancy|2
280069|NCT01017146|924625|P2|Overall Study|Relocation|4
280070|NCT01017146|924626|P1|Overall Study|Relocation|0
280071|NCT01017146|924625|P2|Overall Study|Withdrawal by Subject|16
280072|NCT01017146|924626|P1|Overall Study|Withdrawal by Subject|32
280073|NCT01017146|924625|P2|Overall Study|Noncompliance with Study Product|1
280074|NCT01017146|924626|P1|Overall Study|Noncompliance with Study Product|1
280075|NCT01017146|924625|P2|Overall Study|Lost to Follow-up|14
280076|NCT01017146|924626|P1|Overall Study|Lost to Follow-up|14
280077|NCT01017146|924625|P2|Overall Study|Adverse Event|1
280078|NCT01017146|924626|P1|Overall Study|Adverse Event|11
280079|NCT01017120|924664|P2|Overall Study|Parent Unable to Provide Transportation|0
280080|NCT01017120|924665|P1|Overall Study|Parent Unable to Provide Transportation|1
280081|NCT01017120|924664|P2|Overall Study|Protocol Violation|0
280082|NCT01017120|924665|P1|Overall Study|Protocol Violation|1
280083|NCT01017120|924664|P2|Overall Study|Relocated Out of Town|2
280084|NCT01017120|924665|P1|Overall Study|Relocated Out of Town|0
280085|NCT01017120|924664|P2|Overall Study|Did Not Meet Eligibility Criteria|0
280086|NCT01017120|924665|P1|Overall Study|Did Not Meet Eligibility Criteria|1
280087|NCT01017120|924664|P2|Overall Study|Pregnancy|1
280088|NCT01017120|924665|P1|Overall Study|Pregnancy|1
280089|NCT01017120|924664|P2|Overall Study|Withdrawal by Subject|21
280090|NCT01017120|924665|P1|Overall Study|Withdrawal by Subject|39
280091|NCT01017120|924664|P2|Overall Study|Lack of Efficacy|0
280092|NCT01017120|924665|P1|Overall Study|Lack of Efficacy|1
280093|NCT01017120|924664|P2|Overall Study|Lost to Follow-up|11
280094|NCT01017120|924665|P1|Overall Study|Lost to Follow-up|13
280095|NCT01017120|924664|P2|Overall Study|Adverse Event|0
280096|NCT01017120|924665|P1|Overall Study|Adverse Event|9
280097|NCT01017029|924726|P2|Overall Study|Death|1
280098|NCT01017029|924727|P1|Overall Study|Death|3
280099|NCT01017029|924726|P2|Overall Study|Administrative problem|1
280100|NCT01017029|924727|P1|Overall Study|Administrative problem|0
280101|NCT01017029|924726|P2|Overall Study|Lost to Follow-up|0
280102|NCT01017029|924727|P1|Overall Study|Lost to Follow-up|1
280103|NCT01016977|924755|P2|Overall Study|Withdrawal by Subject|2
280104|NCT01016977|924756|P1|Overall Study|Withdrawal by Subject|2
280105|NCT01016977|924755|P2|Overall Study|Lost to Follow-up|0
280106|NCT01016977|924756|P1|Overall Study|Lost to Follow-up|1
280107|NCT01016964|924792|P2|Overall Study|Lost to Follow-up|3
280108|NCT01016964|924793|P1|Overall Study|Lost to Follow-up|3
280109|NCT01016912|924809|P5|Follow-up Period|Other reason|0
280110|NCT01016912|924810|P4|Follow-up Period|Other reason|1
280111|NCT01016912|924811|P3|Follow-up Period|Other reason|1
280112|NCT01016912|924812|P2|Follow-up Period|Other reason|0
280113|NCT01016912|924813|P1|Follow-up Period|Other reason|0
280114|NCT01016912|924809|P5|End of Treatment Period|Completed double-blind period only|0
280115|NCT01016912|924810|P4|End of Treatment Period|Completed double-blind period only|0
280116|NCT01016912|924811|P3|End of Treatment Period|Completed double-blind period only|0
280117|NCT01016912|924812|P2|End of Treatment Period|Completed double-blind period only|1
280118|NCT01016912|924813|P1|End of Treatment Period|Completed double-blind period only|0
280119|NCT01016912|924809|P5|End of Treatment Period|Adverse Event|0
280120|NCT01016912|924810|P4|End of Treatment Period|Adverse Event|0
280121|NCT01016912|924811|P3|End of Treatment Period|Adverse Event|1
280122|NCT01016912|924812|P2|End of Treatment Period|Adverse Event|1
280123|NCT01016912|924813|P1|End of Treatment Period|Adverse Event|0
280124|NCT01016912|924809|P5|End of Treatment Period|Lack of Efficacy|4
280125|NCT01016912|924810|P4|End of Treatment Period|Lack of Efficacy|4
280126|NCT01016912|924811|P3|End of Treatment Period|Lack of Efficacy|0
280127|NCT01016912|924812|P2|End of Treatment Period|Lack of Efficacy|1
280128|NCT01016912|924813|P1|End of Treatment Period|Lack of Efficacy|0
280129|NCT01016600|924974|P4|Overall Study|Did not start treatment|0
280130|NCT01016600|924975|P3|Overall Study|Did not start treatment|0
280131|NCT01016600|924976|P2|Overall Study|Did not start treatment|0
280132|NCT01016600|924977|P1|Overall Study|Did not start treatment|1
280133|NCT01016132|925040|P1|Overall Study|Discomfort|1
280134|NCT01016067|925055|P2|Overall Study|Withdrew due to Relocation|1
280135|NCT01016067|925056|P1|Overall Study|Withdrew due to Relocation|0
280136|NCT01016067|925055|P2|Overall Study|Physician Decision|1
280137|NCT01016067|925056|P1|Overall Study|Physician Decision|1
280138|NCT01016067|925055|P2|Overall Study|Lost to Follow-up|2
280139|NCT01016067|925056|P1|Overall Study|Lost to Follow-up|1
280140|NCT01016015|925074|P1|Overall Study|Adverse Event|15
280141|NCT01016015|925074|P1|Overall Study|Withdrawal by Subject|1
280142|NCT01016015|925074|P1|Overall Study|Not Treated|3
280143|NCT01015820|925085|P2|Overall Study|Suboptimal measurements|0
280144|NCT01015820|925086|P1|Overall Study|Suboptimal measurements|1
280145|NCT01015703|925121|P5|Overall Study|Protocol Violation|0
280146|NCT01015703|925122|P4|Overall Study|Protocol Violation|0
280147|NCT01015703|925123|P3|Overall Study|Protocol Violation|0
280148|NCT01015703|925124|P2|Overall Study|Protocol Violation|0
280149|NCT01015703|925125|P1|Overall Study|Protocol Violation|1
280150|NCT01015703|925121|P5|Overall Study|Adverse Event|0
280151|NCT01015703|925122|P4|Overall Study|Adverse Event|0
280152|NCT01015703|925123|P3|Overall Study|Adverse Event|0
280153|NCT01015703|925124|P2|Overall Study|Adverse Event|0
280154|NCT01015703|925125|P1|Overall Study|Adverse Event|1
280155|NCT01015703|925121|P5|Overall Study|Withdrawal by Subject|0
280156|NCT01015703|925122|P4|Overall Study|Withdrawal by Subject|0
280157|NCT01015703|925123|P3|Overall Study|Withdrawal by Subject|0
280158|NCT01015703|925124|P2|Overall Study|Withdrawal by Subject|1
280159|NCT01015703|925125|P1|Overall Study|Withdrawal by Subject|0
280160|NCT01015677|925140|P3|Overall Study|Withdrawal by Subject|0
280161|NCT01015677|925141|P2|Overall Study|Withdrawal by Subject|1
280162|NCT01015677|925142|P1|Overall Study|Withdrawal by Subject|1
280163|NCT01015677|925140|P3|Overall Study|Protocol Violation|0
280164|NCT01015677|925141|P2|Overall Study|Protocol Violation|1
280165|NCT01015677|925142|P1|Overall Study|Protocol Violation|0
280166|NCT01015677|925140|P3|Overall Study|Lack of Efficacy|0
280167|NCT01015677|925141|P2|Overall Study|Lack of Efficacy|1
280168|NCT01015677|925142|P1|Overall Study|Lack of Efficacy|0
280169|NCT01015677|925140|P3|Overall Study|Adverse Event|0
280170|NCT01015677|925141|P2|Overall Study|Adverse Event|1
280171|NCT01015677|925142|P1|Overall Study|Adverse Event|0
280172|NCT01015638|925164|P2|Overall Study|Withdrawal by Subject|0
280173|NCT01015638|925165|P1|Overall Study|Withdrawal by Subject|1
280174|NCT01015560|925193|P1|Overall Study|Withdrawal by Subject|1
280175|NCT01015560|925193|P1|Overall Study|Not protocol specified|1
280176|NCT01015560|925193|P1|Overall Study|Adverse Event|1
280177|NCT01015287|925242|P2|Overall Study|Protocol Violation|1
280178|NCT01015287|925243|P1|Overall Study|Protocol Violation|1
280179|NCT01015287|925242|P2|Overall Study|Lost to Follow-up|1
280180|NCT01015287|925243|P1|Overall Study|Lost to Follow-up|2
280181|NCT01015287|925242|P2|Overall Study|Entry Criteria not Met|14
280182|NCT01015287|925243|P1|Overall Study|Entry Criteria not Met|11
280183|NCT01015287|925242|P2|Overall Study|Withdrawal by Subject|19
280184|NCT01015287|925243|P1|Overall Study|Withdrawal by Subject|14
280185|NCT01015287|925242|P2|Overall Study|Physician Decision|21
280186|NCT01015287|925243|P1|Overall Study|Physician Decision|19
280187|NCT01015287|925242|P2|Overall Study|Sponsor Decision|7
280188|NCT01015287|925243|P1|Overall Study|Sponsor Decision|3
280189|NCT01015287|925242|P2|Overall Study|Adverse Event|0
280190|NCT01015287|925243|P1|Overall Study|Adverse Event|1
280191|NCT01015287|925242|P2|Overall Study|Death|16
280192|NCT01015287|925243|P1|Overall Study|Death|21
280193|NCT01015131|925275|P1|Overall Study|Other Protocol Specified Criteria|4
280194|NCT01015131|925275|P1|Overall Study|Withdrawal by Subject|2
280195|NCT01015131|925275|P1|Overall Study|Protocol Violation|1
280196|NCT01015131|925275|P1|Overall Study|Physician Decision|1
280197|NCT01015118|925291|P2|Overall Study|Other than stated above|17
280198|NCT01015118|925292|P1|Overall Study|Other than stated above|32
280199|NCT01015118|925291|P2|Overall Study|Not treated|5
280200|NCT01015118|925292|P1|Overall Study|Not treated|9
280201|NCT01015118|925291|P2|Overall Study|Progressive disease|225
280202|NCT01015118|925292|P1|Overall Study|Progressive disease|354
280203|NCT01015118|925291|P2|Overall Study|Other Adverse Event|32
280204|NCT01015118|925292|P1|Overall Study|Other Adverse Event|138
280205|NCT01015118|925291|P2|Overall Study|Withdrawal by Subject|26
280206|NCT01015118|925292|P1|Overall Study|Withdrawal by Subject|98
280207|NCT01015118|925291|P2|Overall Study|Lost to Follow-up|0
280208|NCT01015118|925292|P1|Overall Study|Lost to Follow-up|1
280209|NCT01015118|925291|P2|Overall Study|Protocol Violation|5
280210|NCT01015118|925292|P1|Overall Study|Protocol Violation|4
280211|NCT01015118|925291|P2|Overall Study|Worsening or AE of underlying disease|4
280212|NCT01015118|925292|P1|Overall Study|Worsening or AE of underlying disease|5
280213|NCT01014988|925316|P6|Overall Study|Withdrawal by Subject|0
280214|NCT01014988|925317|P5|Overall Study|Withdrawal by Subject|0
280215|NCT01014988|925318|P4|Overall Study|Withdrawal by Subject|0
280216|NCT01014988|925319|P3|Overall Study|Withdrawal by Subject|0
280217|NCT01014988|925320|P2|Overall Study|Withdrawal by Subject|0
280218|NCT01014988|925321|P1|Overall Study|Withdrawal by Subject|1
280219|NCT01014988|925316|P6|Overall Study|Physician Decision|0
280220|NCT01014988|925317|P5|Overall Study|Physician Decision|0
280221|NCT01014988|925318|P4|Overall Study|Physician Decision|0
280222|NCT01014988|925319|P3|Overall Study|Physician Decision|0
280223|NCT01014988|925320|P2|Overall Study|Physician Decision|0
280224|NCT01014988|925321|P1|Overall Study|Physician Decision|1
280225|NCT01014988|925316|P6|Overall Study|Lost to Follow-up|0
280226|NCT01014988|925317|P5|Overall Study|Lost to Follow-up|0
280227|NCT01014988|925318|P4|Overall Study|Lost to Follow-up|0
280228|NCT01014988|925319|P3|Overall Study|Lost to Follow-up|1
280229|NCT01014988|925320|P2|Overall Study|Lost to Follow-up|0
280230|NCT01014988|925321|P1|Overall Study|Lost to Follow-up|1
280231|NCT01014988|925316|P6|Overall Study|Adverse Event|3
280232|NCT01014988|925317|P5|Overall Study|Adverse Event|1
280233|NCT01014988|925318|P4|Overall Study|Adverse Event|0
280234|NCT01014988|925319|P3|Overall Study|Adverse Event|1
280235|NCT01014988|925320|P2|Overall Study|Adverse Event|0
280236|NCT01014988|925321|P1|Overall Study|Adverse Event|20
280237|NCT01014975|925493|P3|Overall Study|Lost to Follow-up|1
280238|NCT01014975|925494|P2|Overall Study|Lost to Follow-up|0
280239|NCT01014975|925495|P1|Overall Study|Lost to Follow-up|0
280240|NCT01014975|925493|P3|Overall Study|Death|4
280241|NCT01014975|925494|P2|Overall Study|Death|3
280242|NCT01014975|925495|P1|Overall Study|Death|3
280243|NCT01014975|925493|P3|Overall Study|Withdrawal by Subject|1
280244|NCT01014975|925494|P2|Overall Study|Withdrawal by Subject|0
280245|NCT01014975|925495|P1|Overall Study|Withdrawal by Subject|1
280246|NCT01014910|926000|P2|Overall Study|Withdrawal by Subject|2
280247|NCT01014910|926001|P1|Overall Study|Withdrawal by Subject|0
280248|NCT01014689|926045|P2|Overall Study|Pregnancy|0
280249|NCT01014689|926046|P1|Overall Study|Pregnancy|1
280250|NCT01014689|926045|P2|Overall Study|Lost to Follow-up|7
280251|NCT01014689|926046|P1|Overall Study|Lost to Follow-up|3
280252|NCT01014689|926045|P2|Overall Study|Protocol Violation|1
280253|NCT01014689|926046|P1|Overall Study|Protocol Violation|1
280254|NCT01014689|926045|P2|Overall Study|Withdrawal by Subject|4
280255|NCT01014689|926046|P1|Overall Study|Withdrawal by Subject|5
280256|NCT01014689|926045|P2|Overall Study|Adverse Event|0
280257|NCT01014689|926046|P1|Overall Study|Adverse Event|3
280258|NCT01014689|926045|P2|Overall Study|Lack of Efficacy|1
280259|NCT01014689|926046|P1|Overall Study|Lack of Efficacy|0
280260|NCT01014585|926081|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
280261|NCT01014585|926082|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
280262|NCT01014585|926083|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
280263|NCT01014585|926084|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
280264|NCT01014585|926081|P4|Overall Study|Lost to Follow-up|2
280265|NCT01014585|926082|P3|Overall Study|Lost to Follow-up|0
280266|NCT01014585|926083|P2|Overall Study|Lost to Follow-up|0
280267|NCT01014585|926084|P1|Overall Study|Lost to Follow-up|0
280268|NCT01014585|926081|P4|Overall Study|Withdrawal by Subject|3
280269|NCT01014585|926082|P3|Overall Study|Withdrawal by Subject|1
280270|NCT01014585|926083|P2|Overall Study|Withdrawal by Subject|0
280271|NCT01014585|926084|P1|Overall Study|Withdrawal by Subject|2
280272|NCT01014585|926081|P4|Overall Study|Adverse Event|3
280273|NCT01014585|926082|P3|Overall Study|Adverse Event|0
280274|NCT01014585|926083|P2|Overall Study|Adverse Event|2
280275|NCT01014585|926084|P1|Overall Study|Adverse Event|0
280276|NCT01014442|926113|P2|Overall Study|Unspecified Reason|1
280277|NCT01014442|926114|P1|Overall Study|Unspecified Reason|1
280278|NCT01014442|926113|P2|Overall Study|Lack of Compliance|1
280279|NCT01014442|926114|P1|Overall Study|Lack of Compliance|0
280280|NCT01014442|926113|P2|Overall Study|Protocol Violation|5
280281|NCT01014442|926114|P1|Overall Study|Protocol Violation|2
280282|NCT01014442|926113|P2|Overall Study|Withdrawal by Subject|4
280283|NCT01014442|926114|P1|Overall Study|Withdrawal by Subject|4
280284|NCT01014442|926113|P2|Overall Study|Adverse Event|8
280285|NCT01014442|926114|P1|Overall Study|Adverse Event|0
280286|NCT01014208|926234|P2|Overall Study|Study Closed/terminated|83
280287|NCT01014208|926235|P1|Overall Study|Study Closed/terminated|78
280288|NCT01014208|926234|P2|Overall Study|Did Not Receive Study Drug|0
280289|NCT01014208|926235|P1|Overall Study|Did Not Receive Study Drug|2
280290|NCT01014208|926234|P2|Overall Study|Participant Withdrew Consent|12
280291|NCT01014208|926235|P1|Overall Study|Participant Withdrew Consent|12
280292|NCT01014208|926234|P2|Overall Study|Lost to Follow-up|5
280293|NCT01014208|926235|P1|Overall Study|Lost to Follow-up|2
280294|NCT01014143|926277|P3|Second Intervention|Lost to Follow-up|0
280295|NCT01014143|926278|P2|Second Intervention|Lost to Follow-up|0
280296|NCT01014143|926279|P1|Second Intervention|Lost to Follow-up|2
280297|NCT01014013|926374|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
280298|NCT01014013|926375|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
280299|NCT01014013|926374|P2|Overall Study|Appendectomy|0
280300|NCT01014013|926375|P1|Overall Study|Appendectomy|1
280301|NCT01014013|926374|P2|Overall Study|Another antibiotic therapy required|1
280302|NCT01014013|926375|P1|Overall Study|Another antibiotic therapy required|0
280303|NCT01014013|926374|P2|Overall Study|Physician Decision|1
280304|NCT01014013|926375|P1|Overall Study|Physician Decision|0
280305|NCT01014013|926374|P2|Overall Study|Pathogen resistant|4
280306|NCT01014013|926375|P1|Overall Study|Pathogen resistant|7
280307|NCT01014013|926374|P2|Overall Study|Negative urine culture|0
280308|NCT01014013|926375|P1|Overall Study|Negative urine culture|2
280309|NCT01014013|926374|P2|Overall Study|Pathogen culture = no growth|34
280310|NCT01014013|926375|P1|Overall Study|Pathogen culture = no growth|26
280311|NCT01014013|926374|P2|Overall Study|Clinical/microbiologic failure|2
280312|NCT01014013|926375|P1|Overall Study|Clinical/microbiologic failure|1
280313|NCT01014013|926374|P2|Overall Study|Withdrawal by Subject|4
280314|NCT01014013|926375|P1|Overall Study|Withdrawal by Subject|7
280315|NCT01014013|926374|P2|Overall Study|Protocol Violation|3
280316|NCT01014013|926375|P1|Overall Study|Protocol Violation|1
280317|NCT01014013|926374|P2|Overall Study|Laboratory adverse experience|1
280318|NCT01014013|926375|P1|Overall Study|Laboratory adverse experience|1
280319|NCT01014013|926374|P2|Overall Study|Clinical adverse experience|2
280320|NCT01014013|926375|P1|Overall Study|Clinical adverse experience|4
280321|NCT01014013|926374|P2|Overall Study|Inclusion/Exclusion criteria not met|3
280322|NCT01014013|926375|P1|Overall Study|Inclusion/Exclusion criteria not met|1
280323|NCT01013961|926387|P2|Overall Study|Physician Decision|1
280324|NCT01013961|926388|P1|Overall Study|Physician Decision|0
280325|NCT01013961|926387|P2|Overall Study|Withdrawal by Subject|0
280326|NCT01013961|926388|P1|Overall Study|Withdrawal by Subject|1
280327|NCT01013961|926387|P2|Overall Study|Adverse Event|2
280328|NCT01013961|926388|P1|Overall Study|Adverse Event|2
280329|NCT01013883|926406|P2|Overall Study|Lost to Follow-up|2
280330|NCT01013883|926407|P1|Overall Study|Lost to Follow-up|2
280331|NCT01013870|926419|P2|Overall Study|Lost to Follow-up|3
280332|NCT01013870|926420|P1|Overall Study|Lost to Follow-up|1
280333|NCT01013792|926469|P2|Overall Study|Lost to Follow-up|1
280334|NCT01013792|926470|P1|Overall Study|Lost to Follow-up|0
280335|NCT01013792|926469|P2|Overall Study|Adverse Event|3
280336|NCT01013792|926470|P1|Overall Study|Adverse Event|0
280337|NCT01013792|926469|P2|Overall Study|Study suspended|1
280338|NCT01013792|926470|P1|Overall Study|Study suspended|2
280339|NCT01013753|926476|P1|Overall Study|Other|2
280340|NCT01013753|926476|P1|Overall Study|Withdrawal by Subject|2
280341|NCT01013753|926476|P1|Overall Study|Lost to Follow-up|1
280342|NCT01013753|926476|P1|Overall Study|Protocol Violation|3
280343|NCT01013753|926476|P1|Overall Study|Adverse Event|8
280344|NCT01013740|926672|P2|Overall Study|Ongoing: Study records not completed|2
280345|NCT01013740|926673|P1|Overall Study|Ongoing: Study records not completed|0
280346|NCT01013740|926672|P2|Overall Study|Missing|1
280347|NCT01013740|926673|P1|Overall Study|Missing|2
280348|NCT01013740|926672|P2|Overall Study|study close / terminated : done in error|1
280349|NCT01013740|926673|P1|Overall Study|study close / terminated : done in error|2
280350|NCT01013740|926672|P2|Overall Study|Withdrawal by Subject|10
280351|NCT01013740|926673|P1|Overall Study|Withdrawal by Subject|2
280352|NCT01013740|926672|P2|Overall Study|Physician Decision|0
280353|NCT01013740|926673|P1|Overall Study|Physician Decision|2
280354|NCT01013740|926672|P2|Overall Study|Lost to Follow-up|5
280355|NCT01013740|926673|P1|Overall Study|Lost to Follow-up|3
280356|NCT01013597|926697|P1|Overall Study|Withdrawal by Subject|1
280357|NCT01013207|926707|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
280358|NCT01012973|926727|P2|Overall Study|Withdrawal by Subject|6
280359|NCT01012973|926728|P1|Overall Study|Withdrawal by Subject|4
280360|NCT01012973|926727|P2|Overall Study|Protocol Violation|2
280361|NCT01012973|926728|P1|Overall Study|Protocol Violation|5
280362|NCT01012973|926727|P2|Overall Study|Increase in vis. acuity, never injected|1
280363|NCT01012973|926728|P1|Overall Study|Increase in vis. acuity, never injected|0
280364|NCT01012973|926727|P2|Overall Study|(Overseas travel - indefinite period)|0
280365|NCT01012973|926728|P1|Overall Study|(Overseas travel - indefinite period)|1
280366|NCT01012973|926727|P2|Overall Study|Lost to Follow-up|0
280367|NCT01012973|926728|P1|Overall Study|Lost to Follow-up|1
280368|NCT01012973|926727|P2|Overall Study|Lack of Efficacy|5
280369|NCT01012973|926728|P1|Overall Study|Lack of Efficacy|0
280370|NCT01012973|926727|P2|Overall Study|Adverse Event|5
280371|NCT01012973|926728|P1|Overall Study|Adverse Event|5
280372|NCT01012947|926753|P5|Overall Study|Lost to Follow-up|142
280373|NCT01012947|926754|P4|Overall Study|Lost to Follow-up|118
280374|NCT01012947|926755|P3|Overall Study|Lost to Follow-up|130
280375|NCT01012947|926756|P2|Overall Study|Lost to Follow-up|135
280376|NCT01012947|926757|P1|Overall Study|Lost to Follow-up|131
280377|NCT01012765|926769|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
280378|NCT01012765|926770|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
280379|NCT01012765|926771|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
280380|NCT01012765|926772|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
280381|NCT01012765|926773|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
280382|NCT01012765|926774|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
280383|NCT01012765|926769|P6|Treatment Period 2|Adverse Event|0
280384|NCT01012765|926770|P5|Treatment Period 2|Adverse Event|0
280385|NCT01012765|926771|P4|Treatment Period 2|Adverse Event|0
280386|NCT01012765|926772|P3|Treatment Period 2|Adverse Event|1
280387|NCT01012765|926773|P2|Treatment Period 2|Adverse Event|1
280388|NCT01012765|926774|P1|Treatment Period 2|Adverse Event|0
280389|NCT01012765|926769|P6|Treatment Period 2|Abnormal laboratory value(s)|1
280390|NCT01012765|926770|P5|Treatment Period 2|Abnormal laboratory value(s)|0
280391|NCT01012765|926771|P4|Treatment Period 2|Abnormal laboratory value(s)|0
280392|NCT01012765|926772|P3|Treatment Period 2|Abnormal laboratory value(s)|0
280393|NCT01012765|926773|P2|Treatment Period 2|Abnormal laboratory value(s)|0
280394|NCT01012765|926774|P1|Treatment Period 2|Abnormal laboratory value(s)|0
280395|NCT01012765|926769|P6|Treatment Period 2|Withdrawal by Subject|0
280396|NCT01012765|926770|P5|Treatment Period 2|Withdrawal by Subject|1
280397|NCT01012765|926771|P4|Treatment Period 2|Withdrawal by Subject|0
280398|NCT01012765|926772|P3|Treatment Period 2|Withdrawal by Subject|1
280399|NCT01012765|926773|P2|Treatment Period 2|Withdrawal by Subject|0
280400|NCT01012765|926774|P1|Treatment Period 2|Withdrawal by Subject|1
280401|NCT01012765|926769|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
280402|NCT01012765|926770|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
280403|NCT01012765|926771|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
280404|NCT01012765|926772|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
280405|NCT01012765|926773|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
280406|NCT01012765|926774|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
280407|NCT01012765|926769|P6|Treatment Period 1|Protocol Violation|0
280408|NCT01012765|926770|P5|Treatment Period 1|Protocol Violation|1
280409|NCT01012765|926771|P4|Treatment Period 1|Protocol Violation|2
280410|NCT01012765|926772|P3|Treatment Period 1|Protocol Violation|0
280411|NCT01012765|926773|P2|Treatment Period 1|Protocol Violation|0
280412|NCT01012765|926774|P1|Treatment Period 1|Protocol Violation|0
280413|NCT01012765|926769|P6|Treatment Period 1|Administrative problems|0
280414|NCT01012765|926770|P5|Treatment Period 1|Administrative problems|1
280415|NCT01012765|926771|P4|Treatment Period 1|Administrative problems|1
280416|NCT01012765|926772|P3|Treatment Period 1|Administrative problems|1
280417|NCT01012765|926773|P2|Treatment Period 1|Administrative problems|0
280418|NCT01012765|926774|P1|Treatment Period 1|Administrative problems|0
280419|NCT01012765|926769|P6|Treatment Period 1|Withdrawal by Subject|0
280420|NCT01012765|926770|P5|Treatment Period 1|Withdrawal by Subject|0
280421|NCT01012765|926771|P4|Treatment Period 1|Withdrawal by Subject|0
280422|NCT01012765|926772|P3|Treatment Period 1|Withdrawal by Subject|0
280423|NCT01012765|926773|P2|Treatment Period 1|Withdrawal by Subject|0
280424|NCT01012765|926774|P1|Treatment Period 1|Withdrawal by Subject|2
280425|NCT01012765|926769|P6|Treatment Period 1|Adverse Event|0
280426|NCT01012765|926770|P5|Treatment Period 1|Adverse Event|0
280427|NCT01012765|926771|P4|Treatment Period 1|Adverse Event|0
280428|NCT01012765|926772|P3|Treatment Period 1|Adverse Event|1
280429|NCT01012765|926773|P2|Treatment Period 1|Adverse Event|0
280430|NCT01012765|926774|P1|Treatment Period 1|Adverse Event|1
280431|NCT01012739|926803|P4|Treatment Period 2|Abnormal test procedure results|1
280432|NCT01012739|926804|P3|Treatment Period 2|Abnormal test procedure results|0
280433|NCT01012739|926805|P2|Treatment Period 2|Abnormal test procedure results|0
280434|NCT01012739|926806|P1|Treatment Period 2|Abnormal test procedure results|0
280435|NCT01012739|926803|P4|Treatment Period 1|Adverse Event|1
280436|NCT01012739|926804|P3|Treatment Period 1|Adverse Event|0
280437|NCT01012739|926805|P2|Treatment Period 1|Adverse Event|0
280438|NCT01012739|926806|P1|Treatment Period 1|Adverse Event|0
280439|NCT01012713|926834|P1|Overall Study|Lack of Efficacy|3
280440|NCT01012622|926860|P1|Overall Study|withdrawal of consent by a parent|2
280441|NCT01012622|926860|P1|Overall Study|screening failure|1
280442|NCT01012622|926860|P1|Overall Study|unspecified|1
280443|NCT01012622|926860|P1|Overall Study|non-compliance with the drug|9
280444|NCT01012622|926860|P1|Overall Study|Adverse Event|7
280445|NCT01012622|926860|P1|Overall Study|Lost to Follow-up|5
280446|NCT01012622|926860|P1|Overall Study|Withdrawal by Subject|6
280447|NCT01012440|926879|P1|Overall Study|Withdrawal by Subject|2
280448|NCT01012414|926883|P1|Overall Study|Trial was stopped before completed|7
280449|NCT01012414|926883|P1|Overall Study|Lost to Follow-up|1
280450|NCT01012414|926883|P1|Overall Study|Withdrawal by Subject|2
280451|NCT01012323|926899|P1|Overall Study|Investigator Judgment|1
280452|NCT01012258|926921|P1|Overall Study|Ongoing|29
280453|NCT01012258|926921|P1|Overall Study|Another Tumor Discovered|1
280454|NCT01012258|926921|P1|Overall Study|Another Anti-cancer Drug Received|1
280455|NCT01012258|926921|P1|Overall Study|Symptomatic Deterioration|1
280456|NCT01012258|926921|P1|Overall Study|Progressive Disease (PD)|18
280457|NCT01012258|926921|P1|Overall Study|Adverse Event|1
280458|NCT01012258|926921|P1|Overall Study|Lost to Follow-up|1
280459|NCT01012258|926921|P1|Overall Study|Death|14
280460|NCT01012219|926968|P1|Period 2|Withdrawal by Subject|1
280461|NCT01012219|926968|P1|Period 1|Withdrawal by Subject|1
280462|NCT01012037|927237|P3|Overall Study|Other reason (not specified)|1
280463|NCT01012037|927238|P2|Overall Study|Other reason (not specified)|1
280464|NCT01012037|927239|P1|Overall Study|Other reason (not specified)|1
280465|NCT01012037|927237|P3|Overall Study|Withdrawal by Subject|1
280466|NCT01012037|927238|P2|Overall Study|Withdrawal by Subject|4
280467|NCT01012037|927239|P1|Overall Study|Withdrawal by Subject|0
280468|NCT01012037|927237|P3|Overall Study|Protocol Violation|5
280469|NCT01012037|927238|P2|Overall Study|Protocol Violation|3
280470|NCT01012037|927239|P1|Overall Study|Protocol Violation|0
280471|NCT01012037|927237|P3|Overall Study|Adverse Event|3
280472|NCT01012037|927238|P2|Overall Study|Adverse Event|8
280473|NCT01012037|927239|P1|Overall Study|Adverse Event|0
280474|NCT01011946|927274|P1|Overall Study|No pathological lab value|1
280475|NCT01011946|927274|P1|Overall Study|Transferred to another hospital|2
280476|NCT01011933|927278|P1|Overall Study|Never treated|1
280477|NCT01011933|927278|P1|Overall Study|Inadequate pathology|1
280478|NCT01011933|927278|P1|Overall Study|Improper pre-protocol Rx|1
280479|NCT01011933|927278|P1|Overall Study|Wrong cell type|1
280480|NCT01011907|927287|P2|Overall Study|Adverse Event|4
280481|NCT01011907|927288|P1|Overall Study|Adverse Event|1
280482|NCT01011907|927287|P2|Overall Study|Withdrawal by Subject|11
280483|NCT01011907|927288|P1|Overall Study|Withdrawal by Subject|13
280484|NCT01011868|927305|P3|After Week 78 Follow-up|Other reason not defined above|16
280485|NCT01011868|927306|P2|After Week 78 Follow-up|Other reason not defined above|5
280486|NCT01011868|927307|P1|After Week 78 Follow-up|Other reason not defined above|5
280487|NCT01011868|927305|P3|After Week 78 Follow-up|Withdrawal by Subject|1
280488|NCT01011868|927306|P2|After Week 78 Follow-up|Withdrawal by Subject|8
280489|NCT01011868|927307|P1|After Week 78 Follow-up|Withdrawal by Subject|9
280490|NCT01011868|927305|P3|After Week 78 Follow-up|Lost to Follow-up|4
280491|NCT01011868|927306|P2|After Week 78 Follow-up|Lost to Follow-up|6
280492|NCT01011868|927307|P1|After Week 78 Follow-up|Lost to Follow-up|11
280493|NCT01011868|927305|P3|After Week 78 Follow-up|Protocol Violation|2
280494|NCT01011868|927306|P2|After Week 78 Follow-up|Protocol Violation|1
280495|NCT01011868|927307|P1|After Week 78 Follow-up|Protocol Violation|9
280496|NCT01011868|927305|P3|After Week 78 Follow-up|Lack of Efficacy|0
280497|NCT01011868|927306|P2|After Week 78 Follow-up|Lack of Efficacy|0
280498|NCT01011868|927307|P1|After Week 78 Follow-up|Lack of Efficacy|4
280499|NCT01011868|927305|P3|After Week 78 Follow-up|Adverse Event|21
280500|NCT01011868|927306|P2|After Week 78 Follow-up|Adverse Event|18
280501|NCT01011868|927307|P1|After Week 78 Follow-up|Adverse Event|14
280502|NCT01011868|927305|P3|After Week 18 Follow-up|Other reason not defined above|12
280503|NCT01011868|927306|P2|After Week 18 Follow-up|Other reason not defined above|3
280504|NCT01011868|927307|P1|After Week 18 Follow-up|Other reason not defined above|2
280505|NCT01011868|927305|P3|After Week 18 Follow-up|Withdrawal by Subject|0
280506|NCT01011868|927306|P2|After Week 18 Follow-up|Withdrawal by Subject|3
280507|NCT01011868|927307|P1|After Week 18 Follow-up|Withdrawal by Subject|6
280508|NCT01011868|927305|P3|After Week 18 Follow-up|Lost to Follow-up|0
280509|NCT01011868|927306|P2|After Week 18 Follow-up|Lost to Follow-up|3
280510|NCT01011868|927307|P1|After Week 18 Follow-up|Lost to Follow-up|5
280511|NCT01011868|927305|P3|After Week 18 Follow-up|Protocol Violation|1
280512|NCT01011868|927306|P2|After Week 18 Follow-up|Protocol Violation|1
280513|NCT01011868|927307|P1|After Week 18 Follow-up|Protocol Violation|1
280514|NCT01011868|927305|P3|After Week 18 Follow-up|Lack of Efficacy|0
280515|NCT01011868|927306|P2|After Week 18 Follow-up|Lack of Efficacy|0
280516|NCT01011868|927307|P1|After Week 18 Follow-up|Lack of Efficacy|1
280517|NCT01011868|927305|P3|After Week 18 Follow-up|Adverse Event|13
280518|NCT01011868|927306|P2|After Week 18 Follow-up|Adverse Event|6
280519|NCT01011868|927307|P1|After Week 18 Follow-up|Adverse Event|8
280520|NCT01011738|927369|P3|Overall Study|Unknown reasons|17
280521|NCT01011738|927370|P2|Overall Study|Unknown reasons|291
280522|NCT01011738|927371|P1|Overall Study|Unknown reasons|312
280523|NCT01011738|927369|P3|Overall Study|Death|0
280524|NCT01011738|927370|P2|Overall Study|Death|3
280525|NCT01011738|927371|P1|Overall Study|Death|12
280526|NCT01011673|927411|P2|24 Hour Follow-up|Lost to Follow-up|3
280527|NCT01011673|927412|P1|24 Hour Follow-up|Lost to Follow-up|3
280528|NCT01011673|927411|P2|Randomized|Secondary headache|1
280529|NCT01011673|927412|P1|Randomized|Secondary headache|2
280530|NCT01011556|927435|P4|Overall Study|Inclusion/exclusion criteria not met|5
280531|NCT01011556|927436|P3|Overall Study|Inclusion/exclusion criteria not met|3
280532|NCT01011556|927437|P2|Overall Study|Inclusion/exclusion criteria not met|1
280533|NCT01011556|927438|P1|Overall Study|Inclusion/exclusion criteria not met|2
280534|NCT01011556|927435|P4|Overall Study|Sponsor decision|2
280535|NCT01011556|927436|P3|Overall Study|Sponsor decision|1
280536|NCT01011556|927437|P2|Overall Study|Sponsor decision|1
280537|NCT01011556|927438|P1|Overall Study|Sponsor decision|0
280538|NCT01011556|927435|P4|Overall Study|Withdrawal by Subject|4
280539|NCT01011556|927436|P3|Overall Study|Withdrawal by Subject|4
280540|NCT01011556|927437|P2|Overall Study|Withdrawal by Subject|2
280541|NCT01011556|927438|P1|Overall Study|Withdrawal by Subject|1
280542|NCT01011556|927435|P4|Overall Study|Protocol Violation|0
280543|NCT01011556|927436|P3|Overall Study|Protocol Violation|0
280544|NCT01011556|927437|P2|Overall Study|Protocol Violation|1
280545|NCT01011556|927438|P1|Overall Study|Protocol Violation|0
280546|NCT01011556|927435|P4|Overall Study|Physician Decision|1
280547|NCT01011556|927436|P3|Overall Study|Physician Decision|0
280548|NCT01011556|927437|P2|Overall Study|Physician Decision|0
280549|NCT01011556|927438|P1|Overall Study|Physician Decision|1
280550|NCT01011556|927435|P4|Overall Study|Lost to Follow-up|0
280551|NCT01011556|927436|P3|Overall Study|Lost to Follow-up|0
280552|NCT01011556|927437|P2|Overall Study|Lost to Follow-up|0
280553|NCT01011556|927438|P1|Overall Study|Lost to Follow-up|1
280554|NCT01011556|927435|P4|Overall Study|Adverse Event|1
280555|NCT01011556|927436|P3|Overall Study|Adverse Event|2
280556|NCT01011556|927437|P2|Overall Study|Adverse Event|3
280557|NCT01011556|927438|P1|Overall Study|Adverse Event|1
280558|NCT01011465|927516|P8|Overall Study|Withdrawal by Subject|0
280559|NCT01011465|927517|P7|Overall Study|Withdrawal by Subject|1
280560|NCT01011465|927518|P6|Overall Study|Withdrawal by Subject|0
280561|NCT01011465|927519|P5|Overall Study|Withdrawal by Subject|1
280562|NCT01011465|927520|P4|Overall Study|Withdrawal by Subject|0
280563|NCT01011465|927521|P3|Overall Study|Withdrawal by Subject|0
280564|NCT01011465|927522|P2|Overall Study|Withdrawal by Subject|1
280565|NCT01011465|927523|P1|Overall Study|Withdrawal by Subject|2
280566|NCT01011387|927551|P1|Overall Study|Protocol Violation|1
280567|NCT01011387|927551|P1|Overall Study|Adverse Event|2
280568|NCT01011387|927551|P1|Overall Study|Withdrawal by Subject|3
280569|NCT01011309|927558|P3|Overall Study|Protocol Violation|3
280570|NCT01011309|927559|P2|Overall Study|Protocol Violation|1
280571|NCT01011309|927560|P1|Overall Study|Protocol Violation|0
280572|NCT01011309|927558|P3|Overall Study|Lack of Efficacy|0
280573|NCT01011309|927559|P2|Overall Study|Lack of Efficacy|1
280574|NCT01011309|927560|P1|Overall Study|Lack of Efficacy|0
280575|NCT01011309|927558|P3|Overall Study|Adverse Event|2
280576|NCT01011309|927559|P2|Overall Study|Adverse Event|1
280577|NCT01011309|927560|P1|Overall Study|Adverse Event|2
280578|NCT01011283|927576|P2|Overall Study|Not Specified|2
280579|NCT01011283|927577|P1|Overall Study|Not Specified|2
280580|NCT01011283|927576|P2|Overall Study|Terminated by Sponsor|5
280581|NCT01011283|927577|P1|Overall Study|Terminated by Sponsor|5
280582|NCT01011283|927576|P2|Overall Study|Progressive Disease|2
280583|NCT01011283|927577|P1|Overall Study|Progressive Disease|0
280584|NCT01011283|927576|P2|Overall Study|Adverse Event|2
280585|NCT01011283|927577|P1|Overall Study|Adverse Event|4
280586|NCT01011153|927597|P3|Overall Study|Less than 78 cases completed|9
280587|NCT01011153|927598|P2|Overall Study|Less than 78 cases completed|11
280588|NCT01011153|927599|P1|Overall Study|Less than 78 cases completed|8
280589|NCT01011049|927628|P4|Overall Study|Withdrawal by Subject|0
280590|NCT01011049|927629|P3|Overall Study|Withdrawal by Subject|1
280591|NCT01011049|927630|P2|Overall Study|Withdrawal by Subject|0
280592|NCT01011049|927631|P1|Overall Study|Withdrawal by Subject|0
280593|NCT01011049|927628|P4|Overall Study|Lost to Follow-up|0
280594|NCT01011049|927629|P3|Overall Study|Lost to Follow-up|1
280595|NCT01011049|927630|P2|Overall Study|Lost to Follow-up|2
280596|NCT01011049|927631|P1|Overall Study|Lost to Follow-up|1
280597|NCT01011049|927628|P4|Overall Study|Protocol Violation|0
280598|NCT01011049|927629|P3|Overall Study|Protocol Violation|2
280599|NCT01011049|927630|P2|Overall Study|Protocol Violation|0
280600|NCT01011049|927631|P1|Overall Study|Protocol Violation|0
280601|NCT01010971|927656|P3|Overall Study|Other|2
280602|NCT01010971|927657|P2|Overall Study|Other|0
280603|NCT01010971|927658|P1|Overall Study|Other|1
280604|NCT01010971|927656|P3|Overall Study|Lost to Follow-up|3
280605|NCT01010971|927657|P2|Overall Study|Lost to Follow-up|2
280606|NCT01010971|927658|P1|Overall Study|Lost to Follow-up|0
280607|NCT01010971|927656|P3|Overall Study|Withdrawal by Subject|5
280608|NCT01010971|927657|P2|Overall Study|Withdrawal by Subject|2
280609|NCT01010971|927658|P1|Overall Study|Withdrawal by Subject|0
280610|NCT01010971|927656|P3|Overall Study|Adverse Event|3
280611|NCT01010971|927657|P2|Overall Study|Adverse Event|4
280612|NCT01010971|927658|P1|Overall Study|Adverse Event|2
280613|NCT01010776|927786|P1|Extension Phase|Not specified|3
280614|NCT01010776|927786|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
280615|NCT01010776|927786|P1|Main Phase|Did not received study medication|5
280616|NCT01010776|927786|P1|Main Phase|Not specified|1
280617|NCT01010776|927786|P1|Main Phase|Inform consent withdrawal|1
280618|NCT01010776|927786|P1|Main Phase|Selection failure|2
280619|NCT01010776|927786|P1|Main Phase|Non-compliance to study medication|5
280620|NCT01010776|927786|P1|Main Phase|Lost to Follow-up|6
280621|NCT01010776|927786|P1|Main Phase|Adverse Event|7
280622|NCT01010776|927786|P1|Main Phase|Lack of Efficacy|8
280623|NCT01010776|927786|P1|Main Phase|Withdrawal by Subject|14
280624|NCT01010750|927814|P6|Second Intervention|Adverse Event|0
280625|NCT01010750|927815|P5|Second Intervention|Adverse Event|0
280626|NCT01010750|927816|P4|Second Intervention|Adverse Event|0
280627|NCT01010750|927817|P3|Second Intervention|Adverse Event|0
280628|NCT01010750|927818|P2|Second Intervention|Adverse Event|1
280629|NCT01010750|927819|P1|Second Intervention|Adverse Event|0
280630|NCT01010633|927844|P2|Overall Study|Investigator decision|1
280631|NCT01010633|927845|P1|Overall Study|Investigator decision|0
280632|NCT01010633|927844|P2|Overall Study|Withdrawal by Subject|1
280633|NCT01010633|927845|P1|Overall Study|Withdrawal by Subject|2
280634|NCT01010633|927844|P2|Overall Study|Protocol Violation|2
280635|NCT01010633|927845|P1|Overall Study|Protocol Violation|1
280636|NCT01010633|927844|P2|Overall Study|Adverse Event|1
280637|NCT01010633|927845|P1|Overall Study|Adverse Event|1
280638|NCT01010503|927872|P1|Overall Study|Death|1
280639|NCT01010503|927872|P1|Overall Study|Adverse Event|1
280640|NCT01010230|927931|P2|Overall Study|Lost to Follow-up|2
280641|NCT01010230|927932|P1|Overall Study|Lost to Follow-up|4
280642|NCT01010230|927931|P2|Overall Study|Withdrawal by Subject|5
280643|NCT01010230|927932|P1|Overall Study|Withdrawal by Subject|6
280644|NCT01010204|927964|P2|Overall Study|psychiatric hospitalization|1
280645|NCT01010204|927965|P1|Overall Study|psychiatric hospitalization|2
280646|NCT01010204|927964|P2|Overall Study|Withdrawal by Subject|3
280647|NCT01010204|927965|P1|Overall Study|Withdrawal by Subject|2
280648|NCT01010204|927964|P2|Overall Study|Adverse Event|3
280649|NCT01010204|927965|P1|Overall Study|Adverse Event|1
280650|NCT01010204|927964|P2|Overall Study|Lost to Follow-up|2
280651|NCT01010204|927965|P1|Overall Study|Lost to Follow-up|2
280652|NCT01010061|927975|P2|Overall Study|Failure to Return|2
280653|NCT01010061|927976|P1|Overall Study|Failure to Return|3
280654|NCT01010061|927975|P2|Overall Study|Refused Treatment/Did Not Cooperate|1
280655|NCT01010061|927976|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
280656|NCT01010061|927975|P2|Overall Study|Administrative/Other|14
280657|NCT01010061|927976|P1|Overall Study|Administrative/Other|19
280658|NCT01010061|927975|P2|Overall Study|Death|7
280659|NCT01010061|927976|P1|Overall Study|Death|23
280660|NCT01010061|927975|P2|Overall Study|Withdrew Consent|4
280661|NCT01010061|927976|P1|Overall Study|Withdrew Consent|9
280662|NCT01010061|927975|P2|Overall Study|Progression of Disease|63
280663|NCT01010061|927976|P1|Overall Study|Progression of Disease|71
280664|NCT01010061|927975|P2|Overall Study|Adverse Events or Intercurrent Illness|4
280665|NCT01010061|927976|P1|Overall Study|Adverse Events or Intercurrent Illness|7
280666|NCT01009983|928026|P1|Overall Study|necessary scans not completed|1
280667|NCT01009840|928036|P1|Overall Study|Subject Withdrew Consent to Participate|1
280668|NCT01009840|928036|P1|Overall Study|Subject was Withdrawn by Investigator|1
280669|NCT01009840|928036|P1|Overall Study|Subject Met Withdrawal Criteria|7
280670|NCT01009840|928036|P1|Overall Study|Adverse Event|4
280671|NCT01009840|928036|P1|Overall Study|Lost to Follow-up|1
280672|NCT01009645|928066|P4|Overall Study|Lost to Follow-up|5
280673|NCT01009645|928067|P3|Overall Study|Lost to Follow-up|4
280674|NCT01009645|928068|P2|Overall Study|Lost to Follow-up|8
280675|NCT01009645|928069|P1|Overall Study|Lost to Follow-up|2
280676|NCT01009580|928106|P2|Overall Study|Unclassified|21
280677|NCT01009580|928107|P1|Overall Study|Unclassified|17
280678|NCT01009580|928106|P2|Overall Study|Withdrawal Criteria|6
280679|NCT01009580|928107|P1|Overall Study|Withdrawal Criteria|4
280680|NCT01009580|928106|P2|Overall Study|Protocol Violation|3
280681|NCT01009580|928107|P1|Overall Study|Protocol Violation|2
280682|NCT01009580|928106|P2|Overall Study|Lack of Efficacy|1
280683|NCT01009580|928107|P1|Overall Study|Lack of Efficacy|0
280684|NCT01009580|928106|P2|Overall Study|Adverse Event|4
280685|NCT01009580|928107|P1|Overall Study|Adverse Event|4
280686|NCT01009554|928121|P2|Overall Study|Noncompliant with Study Product|3
280687|NCT01009554|928122|P1|Overall Study|Noncompliant with Study Product|0
280688|NCT01009554|928121|P2|Overall Study|Withdrawal by Subject|3
280689|NCT01009554|928122|P1|Overall Study|Withdrawal by Subject|1
280690|NCT01009554|928121|P2|Overall Study|Adverse Event|1
280691|NCT01009554|928122|P1|Overall Study|Adverse Event|1
280692|NCT01009515|928254|P1|Overall Study|Withdrawal by Subject|3
280693|NCT01009463|928265|P5|52-week, Double-blind Treatment Period|Physician Decision|8
280694|NCT01009463|928266|P4|52-week, Double-blind Treatment Period|Physician Decision|6
280695|NCT01009463|928267|P3|52-week, Double-blind Treatment Period|Physician Decision|6
280696|NCT01009463|928268|P2|52-week, Double-blind Treatment Period|Physician Decision|4
280697|NCT01009463|928269|P1|52-week, Double-blind Treatment Period|Physician Decision|0
280698|NCT01009463|928265|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
280699|NCT01009463|928266|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
280700|NCT01009463|928267|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
280701|NCT01009463|928268|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
280702|NCT01009463|928269|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
280703|NCT01009463|928265|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
280704|NCT01009463|928266|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
280705|NCT01009463|928267|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
280706|NCT01009463|928268|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
280707|NCT01009463|928269|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
280708|NCT01009463|928265|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
280709|NCT01009463|928266|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
280710|NCT01009463|928267|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
280711|NCT01009463|928268|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
280712|NCT01009463|928269|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
280713|NCT01009463|928265|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
280714|NCT01009463|928266|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
280715|NCT01009463|928267|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
280716|NCT01009463|928268|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
280717|NCT01009463|928269|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
280718|NCT01009463|928265|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
280719|NCT01009463|928266|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
280720|NCT01009463|928267|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
280721|NCT01009463|928268|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
280722|NCT01009463|928269|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
280723|NCT01009463|928265|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
280724|NCT01009463|928266|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
280725|NCT01009463|928267|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
280726|NCT01009463|928268|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
280727|NCT01009463|928269|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
280728|NCT01009463|928265|P5|52-week, Double-blind Treatment Period|Adverse Event|31
280729|NCT01009463|928266|P4|52-week, Double-blind Treatment Period|Adverse Event|29
280730|NCT01009463|928267|P3|52-week, Double-blind Treatment Period|Adverse Event|25
280731|NCT01009463|928268|P2|52-week, Double-blind Treatment Period|Adverse Event|22
280732|NCT01009463|928269|P1|52-week, Double-blind Treatment Period|Adverse Event|0
280733|NCT01009463|928265|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
280734|NCT01009463|928266|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
280735|NCT01009463|928267|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
280736|NCT01009463|928268|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
280737|NCT01009463|928269|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
280738|NCT01009463|928265|P5|4-week, Open-label Run-In Period|Physician Decision|0
280739|NCT01009463|928266|P4|4-week, Open-label Run-In Period|Physician Decision|0
280740|NCT01009463|928267|P3|4-week, Open-label Run-In Period|Physician Decision|0
280741|NCT01009463|928268|P2|4-week, Open-label Run-In Period|Physician Decision|0
280742|NCT01009463|928269|P1|4-week, Open-label Run-In Period|Physician Decision|10
280743|NCT01009463|928265|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
280744|NCT01009463|928266|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
280745|NCT01009463|928267|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
280746|NCT01009463|928268|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
280747|NCT01009463|928269|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
280748|NCT01009463|928265|P5|4-week, Open-label Run-In Period|Adverse Event|0
280749|NCT01009463|928266|P4|4-week, Open-label Run-In Period|Adverse Event|0
280750|NCT01009463|928267|P3|4-week, Open-label Run-In Period|Adverse Event|0
280751|NCT01009463|928268|P2|4-week, Open-label Run-In Period|Adverse Event|0
280752|NCT01009463|928269|P1|4-week, Open-label Run-In Period|Adverse Event|10
280753|NCT01009463|928265|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
280754|NCT01009463|928266|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
280755|NCT01009463|928267|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
280756|NCT01009463|928268|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
280757|NCT01009463|928269|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
280758|NCT01009203|928314|P1|Overall Study|Treatment-unrelated death|1
280759|NCT01009203|928314|P1|Overall Study|Adverse Event|5
280760|NCT01009203|928314|P1|Overall Study|Withdrawal by Subject|1
280761|NCT01009099|928354|P2|Overall Study|Death|1
280762|NCT01009099|928355|P1|Overall Study|Death|0
280763|NCT01009099|928354|P2|Overall Study|Withdrawal by Subject|1
280764|NCT01009099|928355|P1|Overall Study|Withdrawal by Subject|1
280765|NCT01009099|928354|P2|Overall Study|Physician Decision|2
280766|NCT01009099|928355|P1|Overall Study|Physician Decision|3
280767|NCT01009099|928354|P2|Overall Study|Lost to Follow-up|0
280768|NCT01009099|928355|P1|Overall Study|Lost to Follow-up|1
280769|NCT01009086|928364|P3|Overall Study|Unspecified|1
280770|NCT01009086|928365|P2|Overall Study|Unspecified|5
280771|NCT01009086|928366|P1|Overall Study|Unspecified|3
280772|NCT01009086|928364|P3|Overall Study|Withdrawal by Subject|13
280773|NCT01009086|928365|P2|Overall Study|Withdrawal by Subject|11
280774|NCT01009086|928366|P1|Overall Study|Withdrawal by Subject|9
280775|NCT01009086|928364|P3|Overall Study|Adverse Event|8
280776|NCT01009086|928365|P2|Overall Study|Adverse Event|11
280777|NCT01009086|928366|P1|Overall Study|Adverse Event|12
280778|NCT01009086|928364|P3|Overall Study|Lost to Follow-up|3
280779|NCT01009086|928365|P2|Overall Study|Lost to Follow-up|5
280780|NCT01009086|928366|P1|Overall Study|Lost to Follow-up|4
280781|NCT01009086|928364|P3|Overall Study|Lack of Efficacy|9
280782|NCT01009086|928365|P2|Overall Study|Lack of Efficacy|15
280783|NCT01009086|928366|P1|Overall Study|Lack of Efficacy|16
280784|NCT01009047|928401|P2|Overall Study|Unspecified|2
280785|NCT01009047|928402|P1|Overall Study|Unspecified|3
280786|NCT01009047|928401|P2|Overall Study|Withdrawal by consent|11
280787|NCT01009047|928402|P1|Overall Study|Withdrawal by consent|16
280788|NCT01009047|928401|P2|Overall Study|Lack of Efficacy|11
280789|NCT01009047|928402|P1|Overall Study|Lack of Efficacy|4
280790|NCT01009047|928401|P2|Overall Study|Lost to Follow-up|2
280791|NCT01009047|928402|P1|Overall Study|Lost to Follow-up|0
280792|NCT01009047|928401|P2|Overall Study|Adverse Event|0
280793|NCT01009047|928402|P1|Overall Study|Adverse Event|5
280794|NCT01009034|928424|P1|Overall Study|Withdrawal by Subject|2
280795|NCT01009034|928424|P1|Overall Study|Lost to Follow-up|2
280796|NCT01008995|928432|P4|After Controlled Period|Not specified|0
280797|NCT01008995|928433|P3|After Controlled Period|Not specified|1
280798|NCT01008995|928434|P2|After Controlled Period|Not specified|0
280799|NCT01008995|928435|P1|After Controlled Period|Not specified|0
280800|NCT01008995|928432|P4|After Controlled Period|Adverse Event|1
280801|NCT01008995|928433|P3|After Controlled Period|Adverse Event|1
280802|NCT01008995|928434|P2|After Controlled Period|Adverse Event|0
280803|NCT01008995|928435|P1|After Controlled Period|Adverse Event|0
280804|NCT01008995|928432|P4|Controlled Period|Not specified|0
280805|NCT01008995|928433|P3|Controlled Period|Not specified|0
280806|NCT01008995|928434|P2|Controlled Period|Not specified|1
280807|NCT01008995|928435|P1|Controlled Period|Not specified|2
280808|NCT01008995|928432|P4|Controlled Period|Adverse Event|0
280809|NCT01008995|928433|P3|Controlled Period|Adverse Event|0
280810|NCT01008995|928434|P2|Controlled Period|Adverse Event|2
280811|NCT01008995|928435|P1|Controlled Period|Adverse Event|1
280812|NCT01008943|928452|P1|Overall Study|Withdrawal by Subject|1
280813|NCT01008904|928459|P1|Overall Study|unexpected unrelated surgery|1
280814|NCT01008904|928459|P1|Overall Study|Adverse Event|2
280815|NCT01008904|928459|P1|Overall Study|Lost to Follow-up|1
280816|NCT01008696|928477|P2|Overall Study|Other|2
280817|NCT01008696|928478|P1|Overall Study|Other|0
280818|NCT01008696|928477|P2|Overall Study|Unspecified|3
280819|NCT01008696|928478|P1|Overall Study|Unspecified|2
280820|NCT01008696|928477|P2|Overall Study|Participants' non-cooperation|3
280821|NCT01008696|928478|P1|Overall Study|Participants' non-cooperation|2
280822|NCT01008696|928477|P2|Overall Study|Adverse Event|0
280823|NCT01008696|928478|P1|Overall Study|Adverse Event|1
280824|NCT01008696|928477|P2|Overall Study|Physician Decision|1
280825|NCT01008696|928478|P1|Overall Study|Physician Decision|5
280826|NCT01008696|928477|P2|Overall Study|Withdrawal by Subject|4
280827|NCT01008696|928478|P1|Overall Study|Withdrawal by Subject|2
280828|NCT01008696|928477|P2|Overall Study|Participant's evasion of hospital visit|4
280829|NCT01008696|928478|P1|Overall Study|Participant's evasion of hospital visit|5
280830|NCT01008618|928488|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
280831|NCT01008618|928489|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
280832|NCT01008618|928490|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
280833|NCT01008618|928488|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
280834|NCT01008618|928489|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
280835|NCT01008618|928490|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
280836|NCT01008618|928488|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
280837|NCT01008618|928489|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
280838|NCT01008618|928490|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
280839|NCT01008618|928488|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
280840|NCT01008618|928489|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
280841|NCT01008618|928490|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
280842|NCT01008618|928488|P3|Period 2 (Double-Blind Period)|Physician Decision|0
280843|NCT01008618|928489|P2|Period 2 (Double-Blind Period)|Physician Decision|1
280844|NCT01008618|928490|P1|Period 2 (Double-Blind Period)|Physician Decision|0
280845|NCT01008618|928488|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
280846|NCT01008618|928489|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
280847|NCT01008618|928490|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
280848|NCT01008618|928488|P3|Period 2 (Double-Blind Period)|Adverse Event|2
280849|NCT01008618|928489|P2|Period 2 (Double-Blind Period)|Adverse Event|11
280850|NCT01008618|928490|P1|Period 2 (Double-Blind Period)|Adverse Event|0
280851|NCT01008618|928488|P3|Period 1 (Titration Period)|Aggravated symptom|0
280852|NCT01008618|928489|P2|Period 1 (Titration Period)|Aggravated symptom|0
280853|NCT01008618|928490|P1|Period 1 (Titration Period)|Aggravated symptom|2
280854|NCT01008618|928488|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
280855|NCT01008618|928489|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
280856|NCT01008618|928490|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
280857|NCT01008618|928488|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
280858|NCT01008618|928489|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
280859|NCT01008618|928490|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
280860|NCT01008618|928488|P3|Period 1 (Titration Period)|Adverse Event|0
280861|NCT01008618|928489|P2|Period 1 (Titration Period)|Adverse Event|0
280862|NCT01008618|928490|P1|Period 1 (Titration Period)|Adverse Event|33
280863|NCT01008618|928488|P3|Period 1 (Titration Period)|Physician Decision|0
280864|NCT01008618|928489|P2|Period 1 (Titration Period)|Physician Decision|0
280865|NCT01008618|928490|P1|Period 1 (Titration Period)|Physician Decision|2
280866|NCT01008553|928539|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
280867|NCT01008553|928540|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
280868|NCT01008553|928541|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
280869|NCT01008553|928539|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
280870|NCT01008553|928540|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
280871|NCT01008553|928541|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
280872|NCT01008553|928539|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
280873|NCT01008553|928540|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
280874|NCT01008553|928541|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
280875|NCT01008553|928539|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
280876|NCT01008553|928540|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
280877|NCT01008553|928541|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
280878|NCT01008553|928539|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
280879|NCT01008553|928540|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
280880|NCT01008553|928541|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
280881|NCT01008553|928539|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
280882|NCT01008553|928540|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
280883|NCT01008553|928541|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
280884|NCT01008553|928539|P3|Period 2 (Double-Blind Period)|Adverse Event|4
280885|NCT01008553|928540|P2|Period 2 (Double-Blind Period)|Adverse Event|14
280886|NCT01008553|928541|P1|Period 2 (Double-Blind Period)|Adverse Event|0
280887|NCT01008553|928539|P3|Period 2 (Double-Blind Period)|Physician Decision|2
280888|NCT01008553|928540|P2|Period 2 (Double-Blind Period)|Physician Decision|1
280889|NCT01008553|928541|P1|Period 2 (Double-Blind Period)|Physician Decision|0
280890|NCT01008553|928539|P3|Period 1 (Titration Period)|Not appropriate for this study|0
280891|NCT01008553|928540|P2|Period 1 (Titration Period)|Not appropriate for this study|0
280892|NCT01008553|928541|P1|Period 1 (Titration Period)|Not appropriate for this study|1
280893|NCT01008553|928539|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
280894|NCT01008553|928540|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
280895|NCT01008553|928541|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
280896|NCT01008553|928539|P3|Period 1 (Titration Period)|Determined to increase dosage|0
280897|NCT01008553|928540|P2|Period 1 (Titration Period)|Determined to increase dosage|0
280898|NCT01008553|928541|P1|Period 1 (Titration Period)|Determined to increase dosage|3
280899|NCT01008553|928539|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
280900|NCT01008553|928540|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
280901|NCT01008553|928541|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
280902|NCT01008553|928539|P3|Period 1 (Titration Period)|Adverse Event|0
280903|NCT01008553|928540|P2|Period 1 (Titration Period)|Adverse Event|0
280904|NCT01008553|928541|P1|Period 1 (Titration Period)|Adverse Event|33
280905|NCT01008553|928539|P3|Period 1 (Titration Period)|Physician Decision|0
280906|NCT01008553|928540|P2|Period 1 (Titration Period)|Physician Decision|0
280907|NCT01008553|928541|P1|Period 1 (Titration Period)|Physician Decision|2
280908|NCT01008475|928573|P7|Overall Study|Ongoing treatment at data cut-off date|4
280909|NCT01008475|928574|P6|Overall Study|Ongoing treatment at data cut-off date|6
280910|NCT01008475|928575|P5|Overall Study|Ongoing treatment at data cut-off date|5
280911|NCT01008475|928576|P4|Overall Study|Ongoing treatment at data cut-off date|0
280912|NCT01008475|928577|P3|Overall Study|Ongoing treatment at data cut-off date|0
280913|NCT01008475|928578|P2|Overall Study|Ongoing treatment at data cut-off date|0
280914|NCT01008475|928579|P1|Overall Study|Ongoing treatment at data cut-off date|0
280915|NCT01008449|928609|P2|Overall Study|Lost to Follow-up|19
280916|NCT01008449|928610|P1|Overall Study|Lost to Follow-up|29
280917|NCT01007942|928645|P2|Overall Study|Patients untreated|3
280918|NCT01007942|928646|P1|Overall Study|Patients untreated|4
280919|NCT01007942|928645|P2|Overall Study|Death|2
280920|NCT01007942|928646|P1|Overall Study|Death|3
280921|NCT01007942|928645|P2|Overall Study|Administrative problems|0
280922|NCT01007942|928646|P1|Overall Study|Administrative problems|2
280923|NCT01007942|928645|P2|Overall Study|Lost to Follow-up|0
280924|NCT01007942|928646|P1|Overall Study|Lost to Follow-up|1
280925|NCT01007942|928645|P2|Overall Study|Withdrawal by Subject|14
280926|NCT01007942|928646|P1|Overall Study|Withdrawal by Subject|19
280927|NCT01007942|928645|P2|Overall Study|Protocol Violation|1
280928|NCT01007942|928646|P1|Overall Study|Protocol Violation|1
280929|NCT01007942|928645|P2|Overall Study|New cancer therapy|1
280930|NCT01007942|928646|P1|Overall Study|New cancer therapy|5
280931|NCT01007942|928645|P2|Overall Study|Disease progression|242
280932|NCT01007942|928646|P1|Overall Study|Disease progression|217
280933|NCT01007942|928645|P2|Overall Study|Abnormal test procedure|1
280934|NCT01007942|928646|P1|Overall Study|Abnormal test procedure|0
280935|NCT01007942|928645|P2|Overall Study|Adverse Event|14
280936|NCT01007942|928646|P1|Overall Study|Adverse Event|29
280937|NCT01007916|928668|P2|Period 2, 4 Weeks of Wear|Relocation|0
280938|NCT01007916|928669|P1|Period 2, 4 Weeks of Wear|Relocation|1
280939|NCT01007916|928668|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
280940|NCT01007916|928669|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
280941|NCT01007838|928679|P4|Overall Study|Started home haemodialysis|0
280942|NCT01007838|928680|P3|Overall Study|Started home haemodialysis|0
280943|NCT01007838|928681|P2|Overall Study|Started home haemodialysis|0
280944|NCT01007838|928682|P1|Overall Study|Started home haemodialysis|1
280945|NCT01007838|928679|P4|Overall Study|Physician Decision|0
280946|NCT01007838|928680|P3|Overall Study|Physician Decision|0
280947|NCT01007838|928681|P2|Overall Study|Physician Decision|0
280948|NCT01007838|928682|P1|Overall Study|Physician Decision|1
280949|NCT01007838|928679|P4|Overall Study|Withdrawal by Subject|0
280950|NCT01007838|928680|P3|Overall Study|Withdrawal by Subject|0
280951|NCT01007838|928681|P2|Overall Study|Withdrawal by Subject|0
280952|NCT01007838|928682|P1|Overall Study|Withdrawal by Subject|1
280953|NCT01007812|928692|P2|Period 1, One Week|Discomfort|0
280954|NCT01007812|928693|P1|Period 1, One Week|Discomfort|1
280955|NCT01007812|928692|P2|Period 1, One Week|Lost to Follow-up|1
280956|NCT01007812|928693|P1|Period 1, One Week|Lost to Follow-up|0
280957|NCT01007552|928726|P1|Overall Study|Withdrawal by Subject|1
280958|NCT01007435|928740|P4|Overall Study|Reason not Specified|1
280959|NCT01007435|928741|P3|Overall Study|Reason not Specified|2
280960|NCT01007435|928742|P2|Overall Study|Reason not Specified|1
280961|NCT01007435|928743|P1|Overall Study|Reason not Specified|1
280962|NCT01007435|928740|P4|Overall Study|Failure to Return|6
280963|NCT01007435|928741|P3|Overall Study|Failure to Return|3
280964|NCT01007435|928742|P2|Overall Study|Failure to Return|4
280965|NCT01007435|928743|P1|Overall Study|Failure to Return|5
280966|NCT01007435|928740|P4|Overall Study|Refused Treatment|8
280967|NCT01007435|928741|P3|Overall Study|Refused Treatment|5
280968|NCT01007435|928742|P2|Overall Study|Refused Treatment|13
280969|NCT01007435|928743|P1|Overall Study|Refused Treatment|13
280970|NCT01007435|928740|P4|Overall Study|Other Protocol Violation|0
280971|NCT01007435|928741|P3|Overall Study|Other Protocol Violation|1
280972|NCT01007435|928742|P2|Overall Study|Other Protocol Violation|0
280973|NCT01007435|928743|P1|Overall Study|Other Protocol Violation|2
280974|NCT01007435|928740|P4|Overall Study|Violation of Selection Criteria at Entry|0
280975|NCT01007435|928741|P3|Overall Study|Violation of Selection Criteria at Entry|2
280976|NCT01007435|928742|P2|Overall Study|Violation of Selection Criteria at Entry|5
280977|NCT01007435|928743|P1|Overall Study|Violation of Selection Criteria at Entry|3
280978|NCT01007435|928740|P4|Overall Study|Insufficient Therapeutic Response|9
280979|NCT01007435|928741|P3|Overall Study|Insufficient Therapeutic Response|2
280980|NCT01007435|928742|P2|Overall Study|Insufficient Therapeutic Response|7
280981|NCT01007435|928743|P1|Overall Study|Insufficient Therapeutic Response|21
280982|NCT01007435|928740|P4|Overall Study|Death|1
280983|NCT01007435|928741|P3|Overall Study|Death|2
280984|NCT01007435|928742|P2|Overall Study|Death|4
280985|NCT01007435|928743|P1|Overall Study|Death|2
280986|NCT01007435|928740|P4|Overall Study|Adverse Event|31
280987|NCT01007435|928741|P3|Overall Study|Adverse Event|47
280988|NCT01007435|928742|P2|Overall Study|Adverse Event|25
280989|NCT01007435|928743|P1|Overall Study|Adverse Event|16
280990|NCT01007396|928785|P1|Overall Study|Lost to Follow-up|47
280991|NCT01007253|928790|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
280992|NCT01007253|928791|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
280993|NCT01007253|928792|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
280994|NCT01007253|928793|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
280995|NCT01007149|928825|P2|Overall Study|Administrative problems|1
280996|NCT01007149|928826|P1|Overall Study|Administrative problems|0
280997|NCT01007123|928852|P4|Overall Study|Lost to Follow-up|0
280998|NCT01007123|928853|P3|Overall Study|Lost to Follow-up|0
280999|NCT01007123|928854|P2|Overall Study|Lost to Follow-up|1
281000|NCT01007123|928855|P1|Overall Study|Lost to Follow-up|0
281001|NCT01007123|928852|P4|Overall Study|Withdrawal by Subject|0
281002|NCT01007123|928853|P3|Overall Study|Withdrawal by Subject|1
281003|NCT01007123|928854|P2|Overall Study|Withdrawal by Subject|0
281004|NCT01007123|928855|P1|Overall Study|Withdrawal by Subject|1
281005|NCT01007123|928852|P4|Overall Study|Protocol Violation|1
281006|NCT01007123|928853|P3|Overall Study|Protocol Violation|2
281007|NCT01007123|928854|P2|Overall Study|Protocol Violation|1
281008|NCT01007123|928855|P1|Overall Study|Protocol Violation|1
281009|NCT01007123|928852|P4|Overall Study|Lack of Efficacy|4
281010|NCT01007123|928853|P3|Overall Study|Lack of Efficacy|1
281011|NCT01007123|928854|P2|Overall Study|Lack of Efficacy|0
281012|NCT01007123|928855|P1|Overall Study|Lack of Efficacy|1
281013|NCT01007123|928852|P4|Overall Study|Adverse Event|1
281014|NCT01007123|928853|P3|Overall Study|Adverse Event|7
281015|NCT01007123|928854|P2|Overall Study|Adverse Event|4
281016|NCT01007123|928855|P1|Overall Study|Adverse Event|3
281017|NCT01006980|928903|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
281018|NCT01006980|928904|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
281019|NCT01006980|928903|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
281020|NCT01006980|928904|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
281021|NCT01006980|928903|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
281022|NCT01006980|928904|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
281023|NCT01006980|928903|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
281024|NCT01006980|928904|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
281025|NCT01006980|928903|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
281026|NCT01006980|928904|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
281027|NCT01006980|928903|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
281028|NCT01006980|928904|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
281029|NCT01006980|928903|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
281030|NCT01006980|928904|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
281031|NCT01006980|928903|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
281032|NCT01006980|928904|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
281033|NCT01006980|928903|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
281034|NCT01006980|928904|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
281035|NCT01006980|928903|P2|Vemurafenib and Dacarbazine|Progression|218
281036|NCT01006980|928904|P1|Vemurafenib and Dacarbazine|Progression|257
281037|NCT01006980|928903|P2|Vemurafenib and Dacarbazine|Death|12
281038|NCT01006980|928904|P1|Vemurafenib and Dacarbazine|Death|13
281039|NCT01006980|928903|P2|Vemurafenib and Dacarbazine|Adverse Event|5
281040|NCT01006980|928904|P1|Vemurafenib and Dacarbazine|Adverse Event|25
281041|NCT01006980|928903|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
281042|NCT01006980|928904|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
281043|NCT01006889|928924|P1|Overall Study|Withdrawal by Subject|3
281044|NCT01006629|928944|P1|Overall Study|Parent unable to perform site visit|4
281045|NCT01006629|928944|P1|Overall Study|Parent refused to continue participation|1
281046|NCT01006629|928944|P1|Overall Study|Adverse Event|1
281047|NCT01006616|928959|P4|Period 2 (18 Months)|Study Terminated|70
281048|NCT01006616|928960|P3|Period 2 (18 Months)|Study Terminated|44
281049|NCT01006616|928961|P2|Period 2 (18 Months)|Study Terminated|46
281050|NCT01006616|928962|P1|Period 2 (18 Months)|Study Terminated|63
281051|NCT01006616|928959|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
281052|NCT01006616|928960|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
281053|NCT01006616|928961|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
281054|NCT01006616|928962|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
281055|NCT01006616|928959|P4|Period 2 (18 Months)|Withdrawal by Subject|1
281056|NCT01006616|928960|P3|Period 2 (18 Months)|Withdrawal by Subject|0
281057|NCT01006616|928961|P2|Period 2 (18 Months)|Withdrawal by Subject|4
281058|NCT01006616|928962|P1|Period 2 (18 Months)|Withdrawal by Subject|1
281059|NCT01006616|928959|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
281060|NCT01006616|928960|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
281061|NCT01006616|928961|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
281062|NCT01006616|928962|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
281063|NCT01006616|928959|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
281064|NCT01006616|928960|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
281065|NCT01006616|928961|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
281066|NCT01006616|928962|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
281067|NCT01006616|928959|P4|Period 2 (18 Months)|Lost to Follow-up|0
281068|NCT01006616|928960|P3|Period 2 (18 Months)|Lost to Follow-up|0
281069|NCT01006616|928961|P2|Period 2 (18 Months)|Lost to Follow-up|0
281070|NCT01006616|928962|P1|Period 2 (18 Months)|Lost to Follow-up|2
281071|NCT01006616|928959|P4|Period 2 (18 Months)|Lack of Efficacy|2
281072|NCT01006616|928960|P3|Period 2 (18 Months)|Lack of Efficacy|1
281073|NCT01006616|928961|P2|Period 2 (18 Months)|Lack of Efficacy|0
281074|NCT01006616|928962|P1|Period 2 (18 Months)|Lack of Efficacy|0
281075|NCT01006616|928959|P4|Period 2 (18 Months)|Adverse Event|4
281076|NCT01006616|928960|P3|Period 2 (18 Months)|Adverse Event|6
281077|NCT01006616|928961|P2|Period 2 (18 Months)|Adverse Event|6
281078|NCT01006616|928962|P1|Period 2 (18 Months)|Adverse Event|6
281079|NCT01006616|928959|P4|Period 1 (6 Months)|Not Treated|1
281080|NCT01006616|928960|P3|Period 1 (6 Months)|Not Treated|1
281081|NCT01006616|928961|P2|Period 1 (6 Months)|Not Treated|0
281082|NCT01006616|928962|P1|Period 1 (6 Months)|Not Treated|0
281083|NCT01006616|928959|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
281084|NCT01006616|928960|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
281085|NCT01006616|928961|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
281086|NCT01006616|928962|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
281087|NCT01006616|928959|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
281088|NCT01006616|928960|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
281089|NCT01006616|928961|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
281090|NCT01006616|928962|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
281091|NCT01006616|928959|P4|Period 1 (6 Months)|Withdrawal by Subject|0
281092|NCT01006616|928960|P3|Period 1 (6 Months)|Withdrawal by Subject|2
281093|NCT01006616|928961|P2|Period 1 (6 Months)|Withdrawal by Subject|2
281094|NCT01006616|928962|P1|Period 1 (6 Months)|Withdrawal by Subject|2
281095|NCT01006616|928959|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
281096|NCT01006616|928960|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
281097|NCT01006616|928961|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
281098|NCT01006616|928962|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
281099|NCT01006616|928959|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
281100|NCT01006616|928960|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
281101|NCT01006616|928961|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
281102|NCT01006616|928962|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
281103|NCT01006616|928959|P4|Period 1 (6 Months)|Lost to Follow-up|0
281104|NCT01006616|928960|P3|Period 1 (6 Months)|Lost to Follow-up|1
281105|NCT01006616|928961|P2|Period 1 (6 Months)|Lost to Follow-up|0
281106|NCT01006616|928962|P1|Period 1 (6 Months)|Lost to Follow-up|0
281107|NCT01006616|928959|P4|Period 1 (6 Months)|Lack of Efficacy|4
281108|NCT01006616|928960|P3|Period 1 (6 Months)|Lack of Efficacy|0
281109|NCT01006616|928961|P2|Period 1 (6 Months)|Lack of Efficacy|4
281110|NCT01006616|928962|P1|Period 1 (6 Months)|Lack of Efficacy|3
281111|NCT01006616|928959|P4|Period 1 (6 Months)|Adverse Event|9
281112|NCT01006616|928960|P3|Period 1 (6 Months)|Adverse Event|37
281113|NCT01006616|928961|P2|Period 1 (6 Months)|Adverse Event|31
281114|NCT01006616|928962|P1|Period 1 (6 Months)|Adverse Event|10
281115|NCT01006603|929098|P2|Overall Study|Other|7
281116|NCT01006603|929099|P1|Overall Study|Other|3
281117|NCT01006603|929098|P2|Overall Study|Study specific discontinuation criteria|34
281118|NCT01006603|929099|P1|Overall Study|Study specific discontinuation criteria|33
281119|NCT01006603|929098|P2|Overall Study|Death|1
281120|NCT01006603|929099|P1|Overall Study|Death|1
281121|NCT01006603|929098|P2|Overall Study|Adverse Event|7
281122|NCT01006603|929099|P1|Overall Study|Adverse Event|15
281123|NCT01006603|929098|P2|Overall Study|Incorrect enrolment|2
281124|NCT01006603|929099|P1|Overall Study|Incorrect enrolment|0
281125|NCT01006603|929098|P2|Overall Study|Protocol Violation|3
281126|NCT01006603|929099|P1|Overall Study|Protocol Violation|1
281127|NCT01006603|929098|P2|Overall Study|Safety reason|1
281128|NCT01006603|929099|P1|Overall Study|Safety reason|1
281129|NCT01006603|929098|P2|Overall Study|Lost to Follow-up|1
281130|NCT01006603|929099|P1|Overall Study|Lost to Follow-up|0
281131|NCT01006603|929098|P2|Overall Study|Withdrawal by Subject|19
281132|NCT01006603|929099|P1|Overall Study|Withdrawal by Subject|17
281133|NCT01006590|929119|P2|Overall Study|Not specified|2
281134|NCT01006590|929120|P1|Overall Study|Not specified|3
281135|NCT01006590|929119|P2|Overall Study|Study specific discontinuation criteria|23
281136|NCT01006590|929120|P1|Overall Study|Study specific discontinuation criteria|16
281137|NCT01006590|929119|P2|Overall Study|Withdrawal by Subject|2
281138|NCT01006590|929120|P1|Overall Study|Withdrawal by Subject|4
281139|NCT01006590|929119|P2|Overall Study|Protocol Violation|0
281140|NCT01006590|929120|P1|Overall Study|Protocol Violation|1
281141|NCT01006590|929119|P2|Overall Study|Lost to Follow-up|1
281142|NCT01006590|929120|P1|Overall Study|Lost to Follow-up|1
281143|NCT01006590|929119|P2|Overall Study|Death|1
281144|NCT01006590|929120|P1|Overall Study|Death|1
281145|NCT01006590|929119|P2|Overall Study|Adverse Event|3
281146|NCT01006590|929120|P1|Overall Study|Adverse Event|2
281147|NCT01006356|929136|P1|Overall Study|unspecified|23
281148|NCT01006356|929136|P1|Overall Study|Protocol Violation|3
281149|NCT01006356|929136|P1|Overall Study|Choice by participants|2
281150|NCT01006356|929136|P1|Overall Study|Withdrawal by Subject|1
281151|NCT01006356|929136|P1|Overall Study|Paticipants did not cooperate|6
281152|NCT01006356|929136|P1|Overall Study|Physician Decision|1
281153|NCT01006356|929136|P1|Overall Study|Adverse Event|6
281154|NCT01006291|929151|P3|Overall Study|Other|17
281155|NCT01006291|929152|P2|Overall Study|Other|14
281156|NCT01006291|929153|P1|Overall Study|Other|14
281157|NCT01006291|929151|P3|Overall Study|Withdrawal criteria|4
281158|NCT01006291|929152|P2|Overall Study|Withdrawal criteria|4
281159|NCT01006291|929153|P1|Overall Study|Withdrawal criteria|5
281160|NCT01006291|929151|P3|Overall Study|Protocol Violation|3
281161|NCT01006291|929152|P2|Overall Study|Protocol Violation|3
281162|NCT01006291|929153|P1|Overall Study|Protocol Violation|3
281163|NCT01006291|929151|P3|Overall Study|Lack of Efficacy|1
281164|NCT01006291|929152|P2|Overall Study|Lack of Efficacy|2
281165|NCT01006291|929153|P1|Overall Study|Lack of Efficacy|2
281166|NCT01006291|929151|P3|Overall Study|Adverse Event|2
281167|NCT01006291|929152|P2|Overall Study|Adverse Event|1
281168|NCT01006291|929153|P1|Overall Study|Adverse Event|2
281169|NCT01006135|929170|P1|Overall Study|Other|72
281170|NCT01006135|929170|P1|Overall Study|Lost to Follow-up|32
281171|NCT01006135|929170|P1|Overall Study|Protocol Violation|14
281172|NCT01006135|929170|P1|Overall Study|Adverse Event|22
281173|NCT01006122|929177|P2|Second Double-blind Intervention Period|Death|1
281174|NCT01006122|929178|P1|Second Double-blind Intervention Period|Death|0
281175|NCT01006122|929177|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
281176|NCT01006122|929178|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
281177|NCT01006122|929177|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
281178|NCT01006122|929178|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
281179|NCT01006122|929177|P2|Second Double-blind Intervention Period|Protocol Violation|0
281180|NCT01006122|929178|P1|Second Double-blind Intervention Period|Protocol Violation|1
281181|NCT01006122|929177|P2|Second Double-blind Intervention Period|Adverse Event|1
281182|NCT01006122|929178|P1|Second Double-blind Intervention Period|Adverse Event|1
281183|NCT01006122|929177|P2|First Double-blind Intervention Period|Adverse Event|4
281184|NCT01006122|929178|P1|First Double-blind Intervention Period|Adverse Event|0
281185|NCT01006122|929177|P2|First Double-blind Intervention Period|Unspecified|0
281186|NCT01006122|929178|P1|First Double-blind Intervention Period|Unspecified|3
281187|NCT01006122|929177|P2|First Double-blind Intervention Period|Lack of Efficacy|1
281188|NCT01006122|929178|P1|First Double-blind Intervention Period|Lack of Efficacy|2
281189|NCT01006122|929177|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
281190|NCT01006122|929178|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
281191|NCT01006122|929177|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
281192|NCT01006122|929178|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
281193|NCT01006122|929177|P2|First Double-blind Intervention Period|Pregnancy|1
281194|NCT01006122|929178|P1|First Double-blind Intervention Period|Pregnancy|0
281195|NCT01006122|929177|P2|First Double-blind Intervention Period|Protocol Violation|1
281196|NCT01006122|929178|P1|First Double-blind Intervention Period|Protocol Violation|1
281197|NCT01006122|929177|P2|First Double-blind Intervention Period|Lost to Follow-up|2
281198|NCT01006122|929178|P1|First Double-blind Intervention Period|Lost to Follow-up|0
281199|NCT01005966|929229|P5|Treatment Period 4 (14 Days)|Other Reason|1
281200|NCT01005966|929230|P4|Treatment Period 4 (14 Days)|Other Reason|0
281201|NCT01005966|929231|P3|Treatment Period 4 (14 Days)|Other Reason|0
281202|NCT01005966|929232|P2|Treatment Period 4 (14 Days)|Other Reason|0
281203|NCT01005966|929233|P1|Treatment Period 4 (14 Days)|Other Reason|0
281204|NCT01005966|929229|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
281205|NCT01005966|929230|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
281206|NCT01005966|929231|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
281207|NCT01005966|929232|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
281208|NCT01005966|929233|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
281209|NCT01005966|929229|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
281210|NCT01005966|929230|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
281211|NCT01005966|929231|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
281212|NCT01005966|929232|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
281213|NCT01005966|929233|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
281214|NCT01005966|929229|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
281215|NCT01005966|929230|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
281216|NCT01005966|929231|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
281217|NCT01005966|929232|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
281218|NCT01005966|929233|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
281219|NCT01005966|929229|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
281220|NCT01005966|929230|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
281221|NCT01005966|929231|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
281222|NCT01005966|929232|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
281223|NCT01005966|929233|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
281224|NCT01005966|929229|P5|Treatment Period 2 (14 Days)|Adverse Event|0
281225|NCT01005966|929230|P4|Treatment Period 2 (14 Days)|Adverse Event|0
281226|NCT01005966|929231|P3|Treatment Period 2 (14 Days)|Adverse Event|1
281227|NCT01005966|929232|P2|Treatment Period 2 (14 Days)|Adverse Event|1
281228|NCT01005966|929233|P1|Treatment Period 2 (14 Days)|Adverse Event|0
281229|NCT01005966|929229|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
281230|NCT01005966|929230|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
281231|NCT01005966|929231|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
281232|NCT01005966|929232|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
281233|NCT01005966|929233|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
281234|NCT01005966|929229|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
281235|NCT01005966|929230|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
281236|NCT01005966|929231|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
281237|NCT01005966|929232|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
281238|NCT01005966|929233|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
281239|NCT01005966|929229|P5|Treatment Period 1 (14 Days)|Adverse Event|0
281240|NCT01005966|929230|P4|Treatment Period 1 (14 Days)|Adverse Event|0
281241|NCT01005966|929231|P3|Treatment Period 1 (14 Days)|Adverse Event|0
281242|NCT01005966|929232|P2|Treatment Period 1 (14 Days)|Adverse Event|0
281243|NCT01005966|929233|P1|Treatment Period 1 (14 Days)|Adverse Event|1
281244|NCT01005914|929253|P1|Overall Study|Withdrawal by Subject|1
281245|NCT01005914|929253|P1|Overall Study|Lack of Efficacy|1
281246|NCT01005914|929253|P1|Overall Study|Death|4
281247|NCT01005914|929253|P1|Overall Study|Adverse Event|4
281248|NCT01005901|929259|P2|Overall Study|No longer requires study drug|1
281249|NCT01005901|929260|P1|Overall Study|No longer requires study drug|0
281250|NCT01005901|929259|P2|Overall Study|Patient's inability to use the device|1
281251|NCT01005901|929260|P1|Overall Study|Patient's inability to use the device|1
281252|NCT01005901|929259|P2|Overall Study|Lost to Follow-up|2
281253|NCT01005901|929260|P1|Overall Study|Lost to Follow-up|1
281254|NCT01005901|929259|P2|Overall Study|Death|3
281255|NCT01005901|929260|P1|Overall Study|Death|2
281256|NCT01005901|929259|P2|Overall Study|Protocol Violation|3
281257|NCT01005901|929260|P1|Overall Study|Protocol Violation|4
281258|NCT01005901|929259|P2|Overall Study|Unsatisfactory therapeutic effect|5
281259|NCT01005901|929260|P1|Overall Study|Unsatisfactory therapeutic effect|5
281260|NCT01005901|929259|P2|Overall Study|Administrative problems|13
281261|NCT01005901|929260|P1|Overall Study|Administrative problems|21
281262|NCT01005901|929259|P2|Overall Study|Adverse Event|16
281263|NCT01005901|929260|P1|Overall Study|Adverse Event|30
281264|NCT01005901|929259|P2|Overall Study|Withdrawal by Subject|14
281265|NCT01005901|929260|P1|Overall Study|Withdrawal by Subject|38
281266|NCT01005875|929323|P1|Overall Study|Death|3
281267|NCT01005745|929331|P1|Overall Study|Inappropriate antidiuretic hormone|1
281268|NCT01005745|929331|P1|Overall Study|Death prior to treatment|1
281269|NCT01005745|929331|P1|Overall Study|Disease progressed during TIL growth|3
281270|NCT01005745|929331|P1|Overall Study|No TIL growth|1
281271|NCT01005732|929336|P1|Overall Study|Death|1
281272|NCT01005732|929336|P1|Overall Study|Lost to Follow-up|10
281273|NCT01005719|929352|P6|Period 2|Adverse Event|1
281274|NCT01005719|929353|P5|Period 2|Adverse Event|1
281275|NCT01005719|929354|P4|Period 2|Adverse Event|0
281276|NCT01005719|929355|P3|Period 2|Adverse Event|0
281277|NCT01005719|929356|P2|Period 2|Adverse Event|0
281278|NCT01005719|929357|P1|Period 2|Adverse Event|0
281279|NCT01005719|929352|P6|Period 1|Delay in completing study procedures|1
281280|NCT01005719|929353|P5|Period 1|Delay in completing study procedures|0
281281|NCT01005719|929354|P4|Period 1|Delay in completing study procedures|0
281282|NCT01005719|929355|P3|Period 1|Delay in completing study procedures|0
281283|NCT01005719|929356|P2|Period 1|Delay in completing study procedures|0
281284|NCT01005719|929357|P1|Period 1|Delay in completing study procedures|0
281285|NCT01005719|929352|P6|Period 1|Adverse Event|0
281286|NCT01005719|929353|P5|Period 1|Adverse Event|0
281287|NCT01005719|929354|P4|Period 1|Adverse Event|1
281288|NCT01005719|929355|P3|Period 1|Adverse Event|0
281289|NCT01005719|929356|P2|Period 1|Adverse Event|0
281290|NCT01005719|929357|P1|Period 1|Adverse Event|0
281291|NCT01005680|929424|P2|Overall Study|Physician Decision|1
281292|NCT01005680|929425|P1|Overall Study|Physician Decision|1
281293|NCT01005680|929424|P2|Overall Study|Withdrawal by Subject|4
281294|NCT01005680|929425|P1|Overall Study|Withdrawal by Subject|1
281295|NCT01005680|929424|P2|Overall Study|Lost to Follow-up|6
281296|NCT01005680|929425|P1|Overall Study|Lost to Follow-up|4
281297|NCT01005602|929449|P2|Overall Study|Excluded due to unreliable clinical data|0
281298|NCT01005602|929450|P1|Overall Study|Excluded due to unreliable clinical data|1
281299|NCT01005329|929510|P1|Overall Study|Ineligible or received no protocol trt.|4
281300|NCT01005316|929517|P4|Overall Study|Retransplanted|0
281301|NCT01005316|929518|P3|Overall Study|Retransplanted|0
281302|NCT01005316|929519|P2|Overall Study|Retransplanted|1
281303|NCT01005316|929520|P1|Overall Study|Retransplanted|0
281304|NCT01005316|929517|P4|Overall Study|Transferred Care|3
281305|NCT01005316|929518|P3|Overall Study|Transferred Care|1
281306|NCT01005316|929519|P2|Overall Study|Transferred Care|0
281307|NCT01005316|929520|P1|Overall Study|Transferred Care|1
281308|NCT01005316|929517|P4|Overall Study|Delisted|0
281309|NCT01005316|929518|P3|Overall Study|Delisted|0
281310|NCT01005316|929519|P2|Overall Study|Delisted|0
281311|NCT01005316|929520|P1|Overall Study|Delisted|8
281312|NCT01005316|929517|P4|Overall Study|Consented to Another Study|0
281313|NCT01005316|929518|P3|Overall Study|Consented to Another Study|0
281314|NCT01005316|929519|P2|Overall Study|Consented to Another Study|0
281315|NCT01005316|929520|P1|Overall Study|Consented to Another Study|2
281316|NCT01005316|929517|P4|Overall Study|Withdrawal by Subject|2
281317|NCT01005316|929518|P3|Overall Study|Withdrawal by Subject|0
281318|NCT01005316|929519|P2|Overall Study|Withdrawal by Subject|1
281319|NCT01005316|929520|P1|Overall Study|Withdrawal by Subject|1
281320|NCT01005316|929517|P4|Overall Study|Sponsor Decision|0
281321|NCT01005316|929518|P3|Overall Study|Sponsor Decision|0
281322|NCT01005316|929519|P2|Overall Study|Sponsor Decision|3
281323|NCT01005316|929520|P1|Overall Study|Sponsor Decision|6
281324|NCT01005316|929517|P4|Overall Study|Physician Decision|0
281325|NCT01005316|929518|P3|Overall Study|Physician Decision|0
281326|NCT01005316|929519|P2|Overall Study|Physician Decision|0
281327|NCT01005316|929520|P1|Overall Study|Physician Decision|6
281328|NCT01005316|929517|P4|Overall Study|Lost to Follow-up|2
281329|NCT01005316|929518|P3|Overall Study|Lost to Follow-up|0
281330|NCT01005316|929519|P2|Overall Study|Lost to Follow-up|3
281331|NCT01005316|929520|P1|Overall Study|Lost to Follow-up|1
281332|NCT01005316|929517|P4|Overall Study|Study Termination|85
281333|NCT01005316|929518|P3|Overall Study|Study Termination|9
281334|NCT01005316|929519|P2|Overall Study|Study Termination|63
281335|NCT01005316|929520|P1|Overall Study|Study Termination|5
281336|NCT01005316|929517|P4|Overall Study|Death|15
281337|NCT01005316|929518|P3|Overall Study|Death|1
281338|NCT01005316|929519|P2|Overall Study|Death|5
281339|NCT01005316|929520|P1|Overall Study|Death|20
281340|NCT01005316|929517|P4|Overall Study|Adverse Event|1
281341|NCT01005316|929518|P3|Overall Study|Adverse Event|0
281342|NCT01005316|929519|P2|Overall Study|Adverse Event|0
281343|NCT01005316|929520|P1|Overall Study|Adverse Event|0
281344|NCT01005251|929587|P5|Overall Study|Lack of Efficacy|0
281345|NCT01005251|929588|P4|Overall Study|Lack of Efficacy|1
281346|NCT01005251|929589|P3|Overall Study|Lack of Efficacy|1
281347|NCT01005251|929590|P2|Overall Study|Lack of Efficacy|0
281348|NCT01005251|929591|P1|Overall Study|Lack of Efficacy|0
281349|NCT01005251|929587|P5|Overall Study|Randomized in error|0
281350|NCT01005251|929588|P4|Overall Study|Randomized in error|1
281351|NCT01005251|929589|P3|Overall Study|Randomized in error|1
281352|NCT01005251|929590|P2|Overall Study|Randomized in error|0
281353|NCT01005251|929591|P1|Overall Study|Randomized in error|0
281354|NCT01005251|929587|P5|Overall Study|Wrong drug dispensed|0
281355|NCT01005251|929588|P4|Overall Study|Wrong drug dispensed|0
281356|NCT01005251|929589|P3|Overall Study|Wrong drug dispensed|0
281357|NCT01005251|929590|P2|Overall Study|Wrong drug dispensed|1
281358|NCT01005251|929591|P1|Overall Study|Wrong drug dispensed|0
281359|NCT01005251|929587|P5|Overall Study|Patient moved|0
281360|NCT01005251|929588|P4|Overall Study|Patient moved|0
281361|NCT01005251|929589|P3|Overall Study|Patient moved|0
281362|NCT01005251|929590|P2|Overall Study|Patient moved|0
281363|NCT01005251|929591|P1|Overall Study|Patient moved|1
281364|NCT01005251|929587|P5|Overall Study|Physician Decision|2
281365|NCT01005251|929588|P4|Overall Study|Physician Decision|0
281366|NCT01005251|929589|P3|Overall Study|Physician Decision|0
281367|NCT01005251|929590|P2|Overall Study|Physician Decision|0
281368|NCT01005251|929591|P1|Overall Study|Physician Decision|0
281369|NCT01005251|929587|P5|Overall Study|Lost to Follow-up|0
281370|NCT01005251|929588|P4|Overall Study|Lost to Follow-up|0
281371|NCT01005251|929589|P3|Overall Study|Lost to Follow-up|2
281372|NCT01005251|929590|P2|Overall Study|Lost to Follow-up|4
281373|NCT01005251|929591|P1|Overall Study|Lost to Follow-up|1
281374|NCT01005251|929587|P5|Overall Study|Developed study-specific withdrawal crit|1
281375|NCT01005251|929588|P4|Overall Study|Developed study-specific withdrawal crit|0
281376|NCT01005251|929589|P3|Overall Study|Developed study-specific withdrawal crit|3
281377|NCT01005251|929590|P2|Overall Study|Developed study-specific withdrawal crit|0
281378|NCT01005251|929591|P1|Overall Study|Developed study-specific withdrawal crit|2
281379|NCT01005251|929587|P5|Overall Study|Protocol Violation|2
281380|NCT01005251|929588|P4|Overall Study|Protocol Violation|0
281381|NCT01005251|929589|P3|Overall Study|Protocol Violation|0
281382|NCT01005251|929590|P2|Overall Study|Protocol Violation|0
281383|NCT01005251|929591|P1|Overall Study|Protocol Violation|1
281384|NCT01005251|929587|P5|Overall Study|Adverse Event|4
281385|NCT01005251|929588|P4|Overall Study|Adverse Event|5
281386|NCT01005251|929589|P3|Overall Study|Adverse Event|8
281387|NCT01005251|929590|P2|Overall Study|Adverse Event|6
281388|NCT01005251|929591|P1|Overall Study|Adverse Event|2
281389|NCT01005251|929587|P5|Overall Study|Eligibility criteria not fulfilled|0
281390|NCT01005251|929588|P4|Overall Study|Eligibility criteria not fulfilled|1
281391|NCT01005251|929589|P3|Overall Study|Eligibility criteria not fulfilled|4
281392|NCT01005251|929590|P2|Overall Study|Eligibility criteria not fulfilled|0
281393|NCT01005251|929591|P1|Overall Study|Eligibility criteria not fulfilled|4
281394|NCT01005251|929587|P5|Overall Study|Withdrawal by Subject|9
281395|NCT01005251|929588|P4|Overall Study|Withdrawal by Subject|4
281396|NCT01005251|929589|P3|Overall Study|Withdrawal by Subject|3
281397|NCT01005251|929590|P2|Overall Study|Withdrawal by Subject|5
281398|NCT01005251|929591|P1|Overall Study|Withdrawal by Subject|2
281399|NCT01004848|929664|P2|Overall Study|Lost to Follow-up|45
281400|NCT01004848|929665|P1|Overall Study|Lost to Follow-up|55
281401|NCT01004822|929703|P8|Overall Study|Unspecified|0
281402|NCT01004822|929704|P7|Overall Study|Unspecified|0
281403|NCT01004822|929705|P6|Overall Study|Unspecified|1
281404|NCT01004822|929706|P5|Overall Study|Unspecified|0
281405|NCT01004822|929707|P4|Overall Study|Unspecified|1
281406|NCT01004822|929708|P3|Overall Study|Unspecified|4
281407|NCT01004822|929709|P2|Overall Study|Unspecified|0
281408|NCT01004822|929710|P1|Overall Study|Unspecified|0
281409|NCT01004822|929703|P8|Overall Study|Adverse Event|1
281410|NCT01004822|929704|P7|Overall Study|Adverse Event|1
281411|NCT01004822|929705|P6|Overall Study|Adverse Event|0
281412|NCT01004822|929706|P5|Overall Study|Adverse Event|0
281413|NCT01004822|929707|P4|Overall Study|Adverse Event|0
281414|NCT01004822|929708|P3|Overall Study|Adverse Event|0
281415|NCT01004822|929709|P2|Overall Study|Adverse Event|0
281416|NCT01004822|929710|P1|Overall Study|Adverse Event|0
281417|NCT01004822|929703|P8|Overall Study|No longer willing to continue|0
281418|NCT01004822|929704|P7|Overall Study|No longer willing to continue|1
281419|NCT01004822|929705|P6|Overall Study|No longer willing to continue|1
281420|NCT01004822|929706|P5|Overall Study|No longer willing to continue|2
281421|NCT01004822|929707|P4|Overall Study|No longer willing to continue|1
281422|NCT01004822|929708|P3|Overall Study|No longer willing to continue|0
281423|NCT01004822|929709|P2|Overall Study|No longer willing to continue|0
281424|NCT01004822|929710|P1|Overall Study|No longer willing to continue|0
281425|NCT01004822|929703|P8|Overall Study|Global deterioration of health status|0
281426|NCT01004822|929704|P7|Overall Study|Global deterioration of health status|1
281427|NCT01004822|929705|P6|Overall Study|Global deterioration of health status|0
281428|NCT01004822|929706|P5|Overall Study|Global deterioration of health status|0
281429|NCT01004822|929707|P4|Overall Study|Global deterioration of health status|1
281430|NCT01004822|929708|P3|Overall Study|Global deterioration of health status|0
281431|NCT01004822|929709|P2|Overall Study|Global deterioration of health status|0
281432|NCT01004822|929710|P1|Overall Study|Global deterioration of health status|0
281433|NCT01004822|929703|P8|Overall Study|Objective progression or relapse|4
281434|NCT01004822|929704|P7|Overall Study|Objective progression or relapse|1
281435|NCT01004822|929705|P6|Overall Study|Objective progression or relapse|2
281436|NCT01004822|929706|P5|Overall Study|Objective progression or relapse|2
281437|NCT01004822|929707|P4|Overall Study|Objective progression or relapse|1
281438|NCT01004822|929708|P3|Overall Study|Objective progression or relapse|0
281439|NCT01004822|929709|P2|Overall Study|Objective progression or relapse|3
281440|NCT01004822|929710|P1|Overall Study|Objective progression or relapse|3
281441|NCT01004614|929875|P4|Washout|Withdrawal by Subject|0
281442|NCT01004614|929876|P3|Washout|Withdrawal by Subject|0
281443|NCT01004614|929877|P2|Washout|Withdrawal by Subject|1
281444|NCT01004614|929878|P1|Washout|Withdrawal by Subject|0
281445|NCT01004510|929912|P1|Overall Study|Adverse Event|1
281446|NCT01004432|929916|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
281447|NCT01004432|929917|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
281448|NCT01004432|929918|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
281449|NCT01004432|929919|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
281450|NCT01004432|929920|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
281451|NCT01004432|929916|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
281452|NCT01004432|929917|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
281453|NCT01004432|929918|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
281454|NCT01004432|929919|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
281455|NCT01004432|929920|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
281456|NCT01004432|929916|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
281457|NCT01004432|929917|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
281458|NCT01004432|929918|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
281459|NCT01004432|929919|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
281460|NCT01004432|929920|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
281461|NCT01004432|929916|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
281462|NCT01004432|929917|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
281463|NCT01004432|929918|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
281464|NCT01004432|929919|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
281465|NCT01004432|929920|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
281466|NCT01004432|929916|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
281467|NCT01004432|929917|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
281468|NCT01004432|929918|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
281469|NCT01004432|929919|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
281470|NCT01004432|929920|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
281471|NCT01004432|929916|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
281472|NCT01004432|929917|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
281473|NCT01004432|929918|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
281474|NCT01004432|929919|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
281475|NCT01004432|929920|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
281476|NCT01004432|929916|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
281477|NCT01004432|929917|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
281478|NCT01004432|929918|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
281479|NCT01004432|929919|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
281480|NCT01004432|929920|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
281481|NCT01004432|929916|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
281482|NCT01004432|929917|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
281483|NCT01004432|929918|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
281484|NCT01004432|929919|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
281485|NCT01004432|929920|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
281486|NCT01004432|929916|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
281487|NCT01004432|929917|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
281488|NCT01004432|929918|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
281489|NCT01004432|929919|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
281490|NCT01004432|929920|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
281491|NCT01004432|929916|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
281492|NCT01004432|929917|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
281493|NCT01004432|929918|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
281494|NCT01004432|929919|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
281495|NCT01004432|929920|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
281496|NCT01004432|929916|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
281497|NCT01004432|929917|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
281498|NCT01004432|929918|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
281499|NCT01004432|929919|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
281500|NCT01004432|929920|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
281501|NCT01004432|929916|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
281502|NCT01004432|929917|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
281503|NCT01004432|929918|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
281504|NCT01004432|929919|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
281505|NCT01004432|929920|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
281506|NCT01004432|929916|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
281507|NCT01004432|929917|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
281508|NCT01004432|929918|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
281509|NCT01004432|929919|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
281510|NCT01004432|929920|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
281511|NCT01004432|929916|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
281512|NCT01004432|929917|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
281513|NCT01004432|929918|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
281514|NCT01004432|929919|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
281515|NCT01004432|929920|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
281516|NCT01004432|929916|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
281517|NCT01004432|929917|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
281518|NCT01004432|929918|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
281519|NCT01004432|929919|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
281520|NCT01004432|929920|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
281521|NCT01004263|929955|P1|Overall Study|Lack of Qualifying Event|2
281522|NCT01004263|929955|P1|Overall Study|Physician Decision|15
281523|NCT01004263|929955|P1|Overall Study|Pregnancy|2
281524|NCT01004263|929955|P1|Overall Study|Lack of Efficacy|13
281525|NCT01004263|929955|P1|Overall Study|Lost to Follow-up|64
281526|NCT01004263|929955|P1|Overall Study|Protocol Violation|10
281527|NCT01004263|929955|P1|Overall Study|Withdrawal by Subject|58
281528|NCT01004263|929955|P1|Overall Study|Adverse Event|15
281529|NCT01004250|929963|P1|Follow-Up (FU) Period|Lost to Follow-up|1
281530|NCT01004250|929963|P1|Maintenance Therapy Period|Physician Decision|4
281531|NCT01004250|929963|P1|Maintenance Therapy Period|Withdrawal by Subject|5
281532|NCT01004250|929963|P1|Maintenance Therapy Period|Protocol Violation|1
281533|NCT01004250|929963|P1|Maintenance Therapy Period|Lost to Follow-up|1
281534|NCT01004250|929963|P1|Maintenance Therapy Period|Adverse Event|15
281535|NCT01004250|929963|P1|Induction Therapy Period|Physician Decision|2
281536|NCT01004250|929963|P1|Induction Therapy Period|Withdrawal by Subject|2
281537|NCT01004250|929963|P1|Induction Therapy Period|Entry Criteria Not Met|1
281538|NCT01004250|929963|P1|Induction Therapy Period|Adverse Event|10
281539|NCT01004185|929975|P2|Overall Study|Withdrawal by Subject|1
281540|NCT01004185|929976|P1|Overall Study|Withdrawal by Subject|2
281541|NCT01004185|929975|P2|Overall Study|Sponsor Terminated Study|5
281542|NCT01004185|929976|P1|Overall Study|Sponsor Terminated Study|4
281543|NCT01004185|929975|P2|Overall Study|Lack of Efficacy|1
281544|NCT01004185|929976|P1|Overall Study|Lack of Efficacy|2
281545|NCT01004185|929975|P2|Overall Study|Lost to Follow-up|1
281546|NCT01004185|929976|P1|Overall Study|Lost to Follow-up|0
281547|NCT01004185|929975|P2|Overall Study|Adverse Event|1
281548|NCT01004185|929976|P1|Overall Study|Adverse Event|1
281549|NCT01004172|929984|P1|Overall Study|Symptomatic Deterioration|2
281550|NCT01004172|929984|P1|Overall Study|Physician Decision|1
281551|NCT01004172|929984|P1|Overall Study|Adverse Event|1
281552|NCT01004172|929984|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
281553|NCT01004172|929984|P1|Overall Study|Progressive Disease in Non-CNS Only|16
281554|NCT01004172|929984|P1|Overall Study|Progressive Disease in CNS Only|16
281555|NCT01004159|929990|P1|Overall Study|Disease Progression|18
281556|NCT01004159|929990|P1|Overall Study|Adverse Event|2
281557|NCT01004146|929997|P2|Overall Study|Withdrawal by Subject|5
281558|NCT01004146|929998|P1|Overall Study|Withdrawal by Subject|4
281559|NCT01004003|930013|P9|Overall Study|Other|0
281560|NCT01004003|930014|P8|Overall Study|Other|0
281561|NCT01004003|930015|P7|Overall Study|Other|0
281562|NCT01004003|930016|P6|Overall Study|Other|1
281563|NCT01004003|930017|P5|Overall Study|Other|0
281564|NCT01004003|930018|P4|Overall Study|Other|0
281565|NCT01004003|930019|P3|Overall Study|Other|0
281566|NCT01004003|930020|P2|Overall Study|Other|0
281567|NCT01004003|930021|P1|Overall Study|Other|0
281568|NCT01004003|930013|P9|Overall Study|Refused to continue taking trial med.|2
281569|NCT01004003|930014|P8|Overall Study|Refused to continue taking trial med.|0
281570|NCT01004003|930015|P7|Overall Study|Refused to continue taking trial med.|0
281571|NCT01004003|930016|P6|Overall Study|Refused to continue taking trial med.|0
281572|NCT01004003|930017|P5|Overall Study|Refused to continue taking trial med.|0
281573|NCT01004003|930018|P4|Overall Study|Refused to continue taking trial med.|0
281574|NCT01004003|930019|P3|Overall Study|Refused to continue taking trial med.|0
281575|NCT01004003|930020|P2|Overall Study|Refused to continue taking trial med.|0
281576|NCT01004003|930021|P1|Overall Study|Refused to continue taking trial med.|0
281577|NCT01004003|930013|P9|Overall Study|Adverse Event|6
281578|NCT01004003|930014|P8|Overall Study|Adverse Event|21
281579|NCT01004003|930015|P7|Overall Study|Adverse Event|7
281580|NCT01004003|930016|P6|Overall Study|Adverse Event|2
281581|NCT01004003|930017|P5|Overall Study|Adverse Event|2
281582|NCT01004003|930018|P4|Overall Study|Adverse Event|3
281583|NCT01004003|930019|P3|Overall Study|Adverse Event|3
281584|NCT01004003|930020|P2|Overall Study|Adverse Event|2
281585|NCT01004003|930021|P1|Overall Study|Adverse Event|4
281586|NCT01004003|930013|P9|Overall Study|Progressive disease|22
281587|NCT01004003|930014|P8|Overall Study|Progressive disease|39
281588|NCT01004003|930015|P7|Overall Study|Progressive disease|1
281589|NCT01004003|930016|P6|Overall Study|Progressive disease|1
281590|NCT01004003|930017|P5|Overall Study|Progressive disease|2
281591|NCT01004003|930018|P4|Overall Study|Progressive disease|0
281592|NCT01004003|930019|P3|Overall Study|Progressive disease|1
281593|NCT01004003|930020|P2|Overall Study|Progressive disease|1
281594|NCT01004003|930021|P1|Overall Study|Progressive disease|2
281595|NCT01003990|930052|P3|Overall Study|Subject Withdrew Consent|7
281596|NCT01003990|930053|P2|Overall Study|Subject Withdrew Consent|5
281597|NCT01003990|930054|P1|Overall Study|Subject Withdrew Consent|12
281598|NCT01003990|930052|P3|Overall Study|No Longer Met Study Criteria|0
281599|NCT01003990|930053|P2|Overall Study|No Longer Met Study Criteria|1
281600|NCT01003990|930054|P1|Overall Study|No Longer Met Study Criteria|4
281601|NCT01003990|930052|P3|Overall Study|Pregnancy|4
281602|NCT01003990|930053|P2|Overall Study|Pregnancy|2
281603|NCT01003990|930054|P1|Overall Study|Pregnancy|10
281604|NCT01003990|930052|P3|Overall Study|Poor/Non-compliance|2
281605|NCT01003990|930053|P2|Overall Study|Poor/Non-compliance|3
281606|NCT01003990|930054|P1|Overall Study|Poor/Non-compliance|4
281607|NCT01003990|930052|P3|Overall Study|Reasons Not Identified|8
281608|NCT01003990|930053|P2|Overall Study|Reasons Not Identified|13
281609|NCT01003990|930054|P1|Overall Study|Reasons Not Identified|14
281610|NCT01003990|930052|P3|Overall Study|Lost to Follow-up|7
281611|NCT01003990|930053|P2|Overall Study|Lost to Follow-up|12
281612|NCT01003990|930054|P1|Overall Study|Lost to Follow-up|30
281613|NCT01003990|930052|P3|Overall Study|Lack of Efficacy|3
281614|NCT01003990|930053|P2|Overall Study|Lack of Efficacy|2
281615|NCT01003990|930054|P1|Overall Study|Lack of Efficacy|10
281616|NCT01003990|930052|P3|Overall Study|Death|1
281617|NCT01003990|930053|P2|Overall Study|Death|8
281618|NCT01003990|930054|P1|Overall Study|Death|0
281619|NCT01003990|930052|P3|Overall Study|Adverse Event|11
281620|NCT01003990|930053|P2|Overall Study|Adverse Event|5
281621|NCT01003990|930054|P1|Overall Study|Adverse Event|8
281622|NCT01003899|930071|P1|Overall Study|Progressive disease|34
281623|NCT01003899|930071|P1|Overall Study|Not treated|1
281624|NCT01003899|930071|P1|Overall Study|Not entered|4
281625|NCT01003899|930071|P1|Overall Study|Other Adverse Event|8
281626|NCT01003886|930080|P1|Overall Study|Adverse Event|3
281627|NCT01003886|930080|P1|Overall Study|Unspecified|14
281628|NCT01003886|930080|P1|Overall Study|Withdrawal by Subject|39
281629|NCT01003886|930080|P1|Overall Study|Lost to Follow-up|169
281630|NCT01003886|930080|P1|Overall Study|Lack of Efficacy|5
281631|NCT01002742|930091|P2|Overall Study|Determined to be ineligible|1
281632|NCT01002742|930092|P1|Overall Study|Determined to be ineligible|0
281633|NCT01003210|930153|P2|Overall Study|Lost to Follow-up|3
281634|NCT01003210|930154|P1|Overall Study|Lost to Follow-up|1
281635|NCT01003184|930164|P2|Overall Study|Physician Decision|0
281636|NCT01003184|930165|P1|Overall Study|Physician Decision|1
281637|NCT01003184|930164|P2|Overall Study|Withdrawal by Subject|6
281638|NCT01003184|930165|P1|Overall Study|Withdrawal by Subject|1
281639|NCT01003184|930164|P2|Overall Study|Protocol Violation|0
281640|NCT01003184|930165|P1|Overall Study|Protocol Violation|3
281641|NCT01003184|930164|P2|Overall Study|Loss of glucose control|1
281642|NCT01003184|930165|P1|Overall Study|Loss of glucose control|1
281643|NCT01003184|930164|P2|Overall Study|Lost to Follow-up|0
281644|NCT01003184|930165|P1|Overall Study|Lost to Follow-up|1
281645|NCT01003184|930164|P2|Overall Study|Adverse Event|5
281646|NCT01003184|930165|P1|Overall Study|Adverse Event|12
281647|NCT01002989|930248|P1|Overall Study|exclusion criteria, no consent|5
281648|NCT01002573|930257|P2|Overall Study|Subject did not receive at least 1 dose|7
281649|NCT01002573|930258|P1|Overall Study|Subject did not receive at least 1 dose|11
281650|NCT01002482|930278|P2|Overall Study|Included twice|0
281651|NCT01002482|930279|P1|Overall Study|Included twice|1
281652|NCT01002482|930278|P2|Overall Study|Withdrawal by Subject|21
281653|NCT01002482|930279|P1|Overall Study|Withdrawal by Subject|14
281654|NCT01002339|930313|P3|Overall Study|Randomized. Not transplanted|1
281655|NCT01002339|930314|P2|Overall Study|Randomized. Not transplanted|0
281656|NCT01002339|930315|P1|Overall Study|Randomized. Not transplanted|0
281657|NCT01002339|930313|P3|Overall Study|Lung cancer detected before transplant|1
281658|NCT01002339|930314|P2|Overall Study|Lung cancer detected before transplant|0
281659|NCT01002339|930315|P1|Overall Study|Lung cancer detected before transplant|0
281660|NCT01002339|930313|P3|Overall Study|Protocol Violation|2
281661|NCT01002339|930314|P2|Overall Study|Protocol Violation|0
281662|NCT01002339|930315|P1|Overall Study|Protocol Violation|0
281663|NCT01002339|930313|P3|Overall Study|Incorrect treatment assignment|1
281664|NCT01002339|930314|P2|Overall Study|Incorrect treatment assignment|0
281665|NCT01002339|930315|P1|Overall Study|Incorrect treatment assignment|0
281666|NCT01002339|930313|P3|Overall Study|Withdrawal by Subject|0
281667|NCT01002339|930314|P2|Overall Study|Withdrawal by Subject|1
281668|NCT01002339|930315|P1|Overall Study|Withdrawal by Subject|0
281669|NCT01002105|930385|P2|Overall Study|condition worsened|2
281670|NCT01002105|930386|P1|Overall Study|condition worsened|4
281671|NCT01002105|930385|P2|Overall Study|non compliance|3
281672|NCT01002105|930386|P1|Overall Study|non compliance|5
281673|NCT01002105|930385|P2|Overall Study|Lost to Follow-up|16
281674|NCT01002105|930386|P1|Overall Study|Lost to Follow-up|10
281675|NCT01001832|930415|P2|Follow-up Period|Not specified|1
281676|NCT01001832|930416|P1|Follow-up Period|Not specified|2
281677|NCT01001832|930415|P2|Follow-up Period|Follow-up no longer required /protocol|20
281678|NCT01001832|930416|P1|Follow-up Period|Follow-up no longer required /protocol|15
281679|NCT01001832|930415|P2|Follow-up Period|Withdrawal by Subject|0
281680|NCT01001832|930416|P1|Follow-up Period|Withdrawal by Subject|1
281681|NCT01001832|930415|P2|Long-term Period|Not specified|2
281682|NCT01001832|930416|P1|Long-term Period|Not specified|1
281683|NCT01001832|930415|P2|Long-term Period|Lack of Efficacy|2
281684|NCT01001832|930416|P1|Long-term Period|Lack of Efficacy|0
281685|NCT01001832|930415|P2|Long-term Period|Withdrawal by Subject|0
281686|NCT01001832|930416|P1|Long-term Period|Withdrawal by Subject|1
281687|NCT01001832|930415|P2|Long-term Period|Adverse Event|1
281688|NCT01001832|930416|P1|Long-term Period|Adverse Event|2
281689|NCT01001832|930415|P2|Short-term Period|Adverse Event|3
281690|NCT01001832|930416|P1|Short-term Period|Adverse Event|2
281691|NCT01001767|930474|P2|Overall Study|Physician Decision|0
281692|NCT01001767|930475|P1|Overall Study|Physician Decision|1
281693|NCT01001767|930474|P2|Overall Study|Lost to Follow-up|0
281694|NCT01001767|930475|P1|Overall Study|Lost to Follow-up|1
281695|NCT01001767|930474|P2|Overall Study|Protocol Violation|0
281696|NCT01001767|930475|P1|Overall Study|Protocol Violation|1
281697|NCT01001767|930474|P2|Overall Study|no baseline study performed|0
281698|NCT01001767|930475|P1|Overall Study|no baseline study performed|1
281699|NCT01001702|930481|P1|Overall Study|Lack of Efficacy per Investigator|3
281700|NCT01001702|930481|P1|Overall Study|Withdrawal by Subject|19
281701|NCT01001702|930481|P1|Overall Study|Investigator withdrew Subject|10
281702|NCT01001702|930481|P1|Overall Study|Subject met Withdrawal Criteria|22
281703|NCT01001702|930481|P1|Overall Study|Sponsor Discontinued Study|4
281704|NCT01001702|930481|P1|Overall Study|Adverse Event|7
281705|NCT01001702|930481|P1|Overall Study|Lost to Follow-up|7
281706|NCT01001572|930494|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
281707|NCT01001572|930495|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
281708|NCT01001572|930496|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
281709|NCT01001572|930494|P3|Double-Blind Treatment Phase|Protocol deviation|1
281710|NCT01001572|930495|P2|Double-Blind Treatment Phase|Protocol deviation|0
281711|NCT01001572|930496|P1|Double-Blind Treatment Phase|Protocol deviation|0
281712|NCT01001572|930494|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
281713|NCT01001572|930495|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
281714|NCT01001572|930496|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
281715|NCT01001572|930494|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
281716|NCT01001572|930495|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
281717|NCT01001572|930496|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
281718|NCT01001572|930494|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
281719|NCT01001572|930495|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
281720|NCT01001572|930496|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
281721|NCT01001572|930494|P3|Double-Blind Treatment Phase|Adverse Event|2
281722|NCT01001572|930495|P2|Double-Blind Treatment Phase|Adverse Event|2
281723|NCT01001572|930496|P1|Double-Blind Treatment Phase|Adverse Event|0
281724|NCT01001572|930494|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
281725|NCT01001572|930495|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
281726|NCT01001572|930496|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
281727|NCT01001572|930494|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
281728|NCT01001572|930495|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
281729|NCT01001572|930496|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
281730|NCT01001572|930494|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
281731|NCT01001572|930495|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
281732|NCT01001572|930496|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
281733|NCT01001572|930494|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
281734|NCT01001572|930495|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
281735|NCT01001572|930496|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
281736|NCT01001572|930494|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
281737|NCT01001572|930495|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
281907|NCT01001104|931023|P2|Overall Study|Adverse Event|1
281738|NCT01001572|930496|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
281739|NCT01001572|930494|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
281740|NCT01001572|930495|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
281741|NCT01001572|930496|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
281742|NCT01001572|930494|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
281743|NCT01001572|930495|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
281744|NCT01001572|930496|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
281745|NCT01001572|930494|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
281746|NCT01001572|930495|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
281747|NCT01001572|930496|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
281748|NCT01001520|930534|P2|Medication Period 2|Withdrawal by Subject|3
281749|NCT01001520|930535|P1|Medication Period 2|Withdrawal by Subject|0
281750|NCT01001520|930534|P2|Washout Period|Withdrawal by Subject|1
281751|NCT01001520|930535|P1|Washout Period|Withdrawal by Subject|2
281752|NCT01001520|930534|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
281753|NCT01001520|930535|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
281754|NCT01001520|930534|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
281755|NCT01001520|930535|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
281756|NCT01001520|930534|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
281757|NCT01001520|930535|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
281758|NCT01001520|930534|P2|Medication Period 1|Withdrawal by Subject|2
281759|NCT01001520|930535|P1|Medication Period 1|Withdrawal by Subject|2
281760|NCT01001494|930562|P3|Overall Study|Other|3
281761|NCT01001494|930563|P2|Overall Study|Other|1
281762|NCT01001494|930564|P1|Overall Study|Other|0
281763|NCT01001494|930562|P3|Overall Study|Lack of Efficacy|8
281764|NCT01001494|930563|P2|Overall Study|Lack of Efficacy|0
281765|NCT01001494|930564|P1|Overall Study|Lack of Efficacy|2
281766|NCT01001494|930562|P3|Overall Study|COPD exacerbation|5
281767|NCT01001494|930563|P2|Overall Study|COPD exacerbation|4
281768|NCT01001494|930564|P1|Overall Study|COPD exacerbation|3
281769|NCT01001494|930562|P3|Overall Study|Withdrawal by Subject|17
281770|NCT01001494|930563|P2|Overall Study|Withdrawal by Subject|7
281771|NCT01001494|930564|P1|Overall Study|Withdrawal by Subject|9
281772|NCT01001494|930562|P3|Overall Study|Lost to Follow-up|1
281773|NCT01001494|930563|P2|Overall Study|Lost to Follow-up|0
281774|NCT01001494|930564|P1|Overall Study|Lost to Follow-up|2
281775|NCT01001494|930562|P3|Overall Study|Protocol Violation|1
281776|NCT01001494|930563|P2|Overall Study|Protocol Violation|1
281777|NCT01001494|930564|P1|Overall Study|Protocol Violation|0
281778|NCT01001494|930562|P3|Overall Study|Adverse Event|6
281779|NCT01001494|930563|P2|Overall Study|Adverse Event|4
281780|NCT01001494|930564|P1|Overall Study|Adverse Event|8
281781|NCT01001390|930593|P2|Overall Study|Failure to wear AFO device|0
281782|NCT01001390|930594|P1|Overall Study|Failure to wear AFO device|2
281783|NCT01001377|930602|P2|Overall Study|Death|384
281784|NCT01001377|930603|P1|Overall Study|Death|391
281785|NCT01001377|930602|P2|Overall Study|Lost to Follow-up|17
281786|NCT01001377|930603|P1|Overall Study|Lost to Follow-up|14
281787|NCT01001377|930602|P2|Overall Study|Withdrawal by Subject|20
281788|NCT01001377|930603|P1|Overall Study|Withdrawal by Subject|19
281789|NCT01001377|930602|P2|Overall Study|Ineligibility determined|0
281790|NCT01001377|930603|P1|Overall Study|Ineligibility determined|2
281791|NCT01001325|930633|P2|Overall Study|Protocol Violation|0
281792|NCT01001325|930634|P1|Overall Study|Protocol Violation|2
281793|NCT01001325|930633|P2|Overall Study|Lost to Follow-up|10
281794|NCT01001325|930634|P1|Overall Study|Lost to Follow-up|16
281795|NCT01001299|930640|P1|Overall Study|Withdrew Consent|1
281796|NCT01001299|930640|P1|Overall Study|Began Taking Commercially Available Drug|2
281797|NCT01001299|930640|P1|Overall Study|Death|1
281798|NCT01001299|930640|P1|Overall Study|Adverse event or Intercurrent Illness|1
281799|NCT01001299|930640|P1|Overall Study|Insufficient Therapeutic Response|20
281800|NCT01001234|930669|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
281801|NCT01001234|930670|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
281802|NCT01001234|930671|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
281803|NCT01001234|930672|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
281804|NCT01001234|930673|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
281805|NCT01001234|930669|P5|Overall Study|Not Treated: Physician Decision|0
281806|NCT01001234|930670|P4|Overall Study|Not Treated: Physician Decision|0
281807|NCT01001234|930671|P3|Overall Study|Not Treated: Physician Decision|0
281808|NCT01001234|930672|P2|Overall Study|Not Treated: Physician Decision|4
281809|NCT01001234|930673|P1|Overall Study|Not Treated: Physician Decision|37
281810|NCT01001234|930669|P5|Overall Study|Not Treated: Pregnancy|0
281811|NCT01001234|930670|P4|Overall Study|Not Treated: Pregnancy|0
281812|NCT01001234|930671|P3|Overall Study|Not Treated: Pregnancy|0
281813|NCT01001234|930672|P2|Overall Study|Not Treated: Pregnancy|0
281814|NCT01001234|930673|P1|Overall Study|Not Treated: Pregnancy|3
281815|NCT01001234|930669|P5|Overall Study|Not Treated: Lost to Follow-up|0
281816|NCT01001234|930670|P4|Overall Study|Not Treated: Lost to Follow-up|5
281817|NCT01001234|930671|P3|Overall Study|Not Treated: Lost to Follow-up|7
281818|NCT01001234|930672|P2|Overall Study|Not Treated: Lost to Follow-up|4
281819|NCT01001234|930673|P1|Overall Study|Not Treated: Lost to Follow-up|53
281820|NCT01001234|930669|P5|Overall Study|Not Treated: Protocol Violation|0
281821|NCT01001234|930670|P4|Overall Study|Not Treated: Protocol Violation|0
281822|NCT01001234|930671|P3|Overall Study|Not Treated: Protocol Violation|0
281823|NCT01001234|930672|P2|Overall Study|Not Treated: Protocol Violation|0
281824|NCT01001234|930673|P1|Overall Study|Not Treated: Protocol Violation|3
281825|NCT01001234|930669|P5|Overall Study|Not Treated: Withdrawal by Subject|0
281826|NCT01001234|930670|P4|Overall Study|Not Treated: Withdrawal by Subject|0
281827|NCT01001234|930671|P3|Overall Study|Not Treated: Withdrawal by Subject|2
281828|NCT01001234|930672|P2|Overall Study|Not Treated: Withdrawal by Subject|2
281829|NCT01001234|930673|P1|Overall Study|Not Treated: Withdrawal by Subject|23
281830|NCT01001234|930669|P5|Overall Study|Not Treated: Adverse Event|0
281831|NCT01001234|930670|P4|Overall Study|Not Treated: Adverse Event|0
281832|NCT01001234|930671|P3|Overall Study|Not Treated: Adverse Event|0
281833|NCT01001234|930672|P2|Overall Study|Not Treated: Adverse Event|0
281834|NCT01001234|930673|P1|Overall Study|Not Treated: Adverse Event|1
281835|NCT01001234|930669|P5|Overall Study|Physician Decision|0
281836|NCT01001234|930670|P4|Overall Study|Physician Decision|0
281837|NCT01001234|930671|P3|Overall Study|Physician Decision|0
281838|NCT01001234|930672|P2|Overall Study|Physician Decision|0
281839|NCT01001234|930673|P1|Overall Study|Physician Decision|1
281840|NCT01001234|930669|P5|Overall Study|Lost to Follow-up|0
281841|NCT01001234|930670|P4|Overall Study|Lost to Follow-up|2
281842|NCT01001234|930671|P3|Overall Study|Lost to Follow-up|1
281843|NCT01001234|930672|P2|Overall Study|Lost to Follow-up|0
281844|NCT01001234|930673|P1|Overall Study|Lost to Follow-up|0
281845|NCT01001234|930669|P5|Overall Study|Protocol Violation|0
281846|NCT01001234|930670|P4|Overall Study|Protocol Violation|18
281847|NCT01001234|930671|P3|Overall Study|Protocol Violation|19
281848|NCT01001234|930672|P2|Overall Study|Protocol Violation|3
281849|NCT01001234|930673|P1|Overall Study|Protocol Violation|34
281850|NCT01001234|930669|P5|Overall Study|Withdrawal by Subject|0
281851|NCT01001234|930670|P4|Overall Study|Withdrawal by Subject|0
281852|NCT01001234|930671|P3|Overall Study|Withdrawal by Subject|3
281853|NCT01001234|930672|P2|Overall Study|Withdrawal by Subject|0
281854|NCT01001234|930673|P1|Overall Study|Withdrawal by Subject|2
281855|NCT01001221|930689|P5|Overall Study|Not treated; protocol exclusion|0
281856|NCT01001221|930690|P4|Overall Study|Not treated; protocol exclusion|0
281857|NCT01001221|930691|P3|Overall Study|Not treated; protocol exclusion|1
281858|NCT01001221|930692|P2|Overall Study|Not treated; protocol exclusion|0
281859|NCT01001221|930693|P1|Overall Study|Not treated; protocol exclusion|0
281860|NCT01001221|930689|P5|Overall Study|Not specified|0
281861|NCT01001221|930690|P4|Overall Study|Not specified|0
281862|NCT01001221|930691|P3|Overall Study|Not specified|0
281863|NCT01001221|930692|P2|Overall Study|Not specified|1
281864|NCT01001221|930693|P1|Overall Study|Not specified|1
281865|NCT01001221|930689|P5|Overall Study|Disease progression|0
281866|NCT01001221|930690|P4|Overall Study|Disease progression|4
281867|NCT01001221|930691|P3|Overall Study|Disease progression|2
281868|NCT01001221|930692|P2|Overall Study|Disease progression|2
281869|NCT01001221|930693|P1|Overall Study|Disease progression|3
281870|NCT01001221|930689|P5|Overall Study|Adverse Event|0
281871|NCT01001221|930690|P4|Overall Study|Adverse Event|2
281872|NCT01001221|930691|P3|Overall Study|Adverse Event|0
281873|NCT01001221|930692|P2|Overall Study|Adverse Event|2
281874|NCT01001221|930693|P1|Overall Study|Adverse Event|1
281875|NCT01001208|930868|P2|Overall Study|Other|2
281876|NCT01001208|930869|P1|Overall Study|Other|0
281877|NCT01001208|930868|P2|Overall Study|Disease Progression|3
281878|NCT01001208|930869|P1|Overall Study|Disease Progression|0
281879|NCT01001208|930868|P2|Overall Study|Noncompliance|7
281880|NCT01001208|930869|P1|Overall Study|Noncompliance|4
281881|NCT01001208|930868|P2|Overall Study|Ineligibility Determined|2
281882|NCT01001208|930869|P1|Overall Study|Ineligibility Determined|4
281883|NCT01001208|930868|P2|Overall Study|Withdrawal by Subject|5
281884|NCT01001208|930869|P1|Overall Study|Withdrawal by Subject|4
281885|NCT01001208|930868|P2|Overall Study|Physician Decision|0
281886|NCT01001208|930869|P1|Overall Study|Physician Decision|1
281887|NCT01001208|930868|P2|Overall Study|Lost to Follow-up|9
281888|NCT01001208|930869|P1|Overall Study|Lost to Follow-up|5
281889|NCT01001208|930868|P2|Overall Study|Adverse Event|5
281890|NCT01001208|930869|P1|Overall Study|Adverse Event|10
281891|NCT01001169|930912|P2|Overall Study|Withdrawal by Subject|1
281892|NCT01001169|930913|P1|Overall Study|Withdrawal by Subject|2
281893|NCT01001104|931021|P4|Overall Study|Withdrawal by Subject|2
281894|NCT01001104|931022|P3|Overall Study|Withdrawal by Subject|0
281895|NCT01001104|931023|P2|Overall Study|Withdrawal by Subject|0
281896|NCT01001104|931024|P1|Overall Study|Withdrawal by Subject|0
281897|NCT01001104|931021|P4|Overall Study|Entry Criteria Not Met|1
281898|NCT01001104|931022|P3|Overall Study|Entry Criteria Not Met|0
281899|NCT01001104|931023|P2|Overall Study|Entry Criteria Not Met|0
281900|NCT01001104|931024|P1|Overall Study|Entry Criteria Not Met|0
281901|NCT01001104|931021|P4|Overall Study|Lost to Follow-up|0
281902|NCT01001104|931022|P3|Overall Study|Lost to Follow-up|1
281903|NCT01001104|931023|P2|Overall Study|Lost to Follow-up|0
281904|NCT01001104|931024|P1|Overall Study|Lost to Follow-up|0
281905|NCT01001104|931021|P4|Overall Study|Adverse Event|0
281906|NCT01001104|931022|P3|Overall Study|Adverse Event|0
281908|NCT01001104|931024|P1|Overall Study|Adverse Event|2
281909|NCT01000974|931102|P3|Booster Vaccination Phase|Unspecified|4
281910|NCT01000974|931103|P2|Booster Vaccination Phase|Unspecified|6
281911|NCT01000974|931104|P1|Booster Vaccination Phase|Unspecified|24
281912|NCT01000974|931102|P3|Booster Vaccination Phase|Lost to Follow-up|7
281913|NCT01000974|931103|P2|Booster Vaccination Phase|Lost to Follow-up|5
281914|NCT01000974|931104|P1|Booster Vaccination Phase|Lost to Follow-up|40
281915|NCT01000974|931102|P3|Booster Vaccination Phase|Withdrawal by Subject|1
281916|NCT01000974|931103|P2|Booster Vaccination Phase|Withdrawal by Subject|1
281917|NCT01000974|931104|P1|Booster Vaccination Phase|Withdrawal by Subject|3
281918|NCT01000974|931102|P3|Booster Vaccination Phase|Protocol Violation|2
281919|NCT01000974|931103|P2|Booster Vaccination Phase|Protocol Violation|0
281920|NCT01000974|931104|P1|Booster Vaccination Phase|Protocol Violation|0
281921|NCT01000974|931102|P3|Primary Vaccination Phase|Unspecified|12
281922|NCT01000974|931103|P2|Primary Vaccination Phase|Unspecified|9
281923|NCT01000974|931104|P1|Primary Vaccination Phase|Unspecified|4
281924|NCT01000974|931102|P3|Primary Vaccination Phase|Adverse Event|2
281925|NCT01000974|931103|P2|Primary Vaccination Phase|Adverse Event|2
281926|NCT01000974|931104|P1|Primary Vaccination Phase|Adverse Event|14
281927|NCT01000974|931102|P3|Primary Vaccination Phase|Protocol Violation|2
281928|NCT01000974|931103|P2|Primary Vaccination Phase|Protocol Violation|3
281929|NCT01000974|931104|P1|Primary Vaccination Phase|Protocol Violation|40
281930|NCT01000974|931102|P3|Primary Vaccination Phase|Lost to Follow-up|26
281931|NCT01000974|931103|P2|Primary Vaccination Phase|Lost to Follow-up|19
281932|NCT01000974|931104|P1|Primary Vaccination Phase|Lost to Follow-up|171
281933|NCT01000974|931102|P3|Primary Vaccination Phase|Withdrawal by Subject|21
281934|NCT01000974|931103|P2|Primary Vaccination Phase|Withdrawal by Subject|17
281935|NCT01000974|931104|P1|Primary Vaccination Phase|Withdrawal by Subject|109
281936|NCT01000961|931181|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
281937|NCT01000961|931182|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
281938|NCT01000961|931181|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
281939|NCT01000961|931182|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
281940|NCT01000805|931205|P2|Overall Study|Sponsor Decision|1
281941|NCT01000805|931206|P1|Overall Study|Sponsor Decision|0
281942|NCT01000805|931205|P2|Overall Study|Withdrawal by Subject|6
281943|NCT01000805|931206|P1|Overall Study|Withdrawal by Subject|16
281944|NCT01000805|931205|P2|Overall Study|Protocol Violation|8
281945|NCT01000805|931206|P1|Overall Study|Protocol Violation|12
281946|NCT01000805|931205|P2|Overall Study|Physician Decision|1
281947|NCT01000805|931206|P1|Overall Study|Physician Decision|0
281948|NCT01000805|931205|P2|Overall Study|Lost to Follow-up|21
281949|NCT01000805|931206|P1|Overall Study|Lost to Follow-up|16
281950|NCT01000805|931205|P2|Overall Study|Lack of Efficacy|16
281951|NCT01000805|931206|P1|Overall Study|Lack of Efficacy|5
281952|NCT01000805|931205|P2|Overall Study|Adverse Event|9
281953|NCT01000805|931206|P1|Overall Study|Adverse Event|21
281954|NCT01000649|931251|P4|Overall Study|Lost to Follow-up|2
281955|NCT01000649|931252|P3|Overall Study|Lost to Follow-up|0
281956|NCT01000649|931253|P2|Overall Study|Lost to Follow-up|2
281957|NCT01000649|931254|P1|Overall Study|Lost to Follow-up|0
281958|NCT01000649|931251|P4|Overall Study|Adverse Event|4
281959|NCT01000649|931252|P3|Overall Study|Adverse Event|2
281960|NCT01000649|931253|P2|Overall Study|Adverse Event|1
281961|NCT01000649|931254|P1|Overall Study|Adverse Event|5
281962|NCT01000610|931335|P1|Overall Study|Treatment failure|1
281963|NCT01000610|931335|P1|Overall Study|Lost to Follow-up|4
281964|NCT01000610|931335|P1|Overall Study|Adverse Event|1
281965|NCT01000506|931346|P4|Overall Study|Withdrawal by Subject|7
281966|NCT01000506|931347|P3|Overall Study|Withdrawal by Subject|2
281967|NCT01000506|931348|P2|Overall Study|Withdrawal by Subject|8
281968|NCT01000506|931349|P1|Overall Study|Withdrawal by Subject|11
281969|NCT01000506|931346|P4|Overall Study|Physician Decision|3
281970|NCT01000506|931347|P3|Overall Study|Physician Decision|3
281971|NCT01000506|931348|P2|Overall Study|Physician Decision|3
281972|NCT01000506|931349|P1|Overall Study|Physician Decision|1
281973|NCT01000506|931346|P4|Overall Study|Lost to Follow-up|0
281974|NCT01000506|931347|P3|Overall Study|Lost to Follow-up|4
281975|NCT01000506|931348|P2|Overall Study|Lost to Follow-up|1
281976|NCT01000506|931349|P1|Overall Study|Lost to Follow-up|1
281977|NCT01000506|931346|P4|Overall Study|Protocol Violation|0
281978|NCT01000506|931347|P3|Overall Study|Protocol Violation|0
281979|NCT01000506|931348|P2|Overall Study|Protocol Violation|1
281980|NCT01000506|931349|P1|Overall Study|Protocol Violation|1
281981|NCT01000506|931346|P4|Overall Study|Lack of Efficacy|4
281982|NCT01000506|931347|P3|Overall Study|Lack of Efficacy|4
281983|NCT01000506|931348|P2|Overall Study|Lack of Efficacy|6
281984|NCT01000506|931349|P1|Overall Study|Lack of Efficacy|8
281985|NCT01000506|931346|P4|Overall Study|Adverse Event|9
281986|NCT01000506|931347|P3|Overall Study|Adverse Event|8
281987|NCT01000506|931348|P2|Overall Study|Adverse Event|5
281988|NCT01000506|931349|P1|Overall Study|Adverse Event|6
281989|NCT01000480|931391|P1|Concurrent Therapy Phase|Physician Decision|1
281990|NCT01000480|931391|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
281991|NCT01000480|931391|P1|Concurrent Therapy Phase|Protocol Violation|2
281992|NCT01000480|931391|P1|Concurrent Therapy Phase|Adverse Event|4
281993|NCT01000480|931391|P1|Induction Phase|Entry Criteria Not Met|3
281994|NCT01000480|931391|P1|Induction Phase|Physician Decision|1
281995|NCT01000480|931391|P1|Induction Phase|Lost to Follow-up|1
281996|NCT01000480|931391|P1|Induction Phase|Adverse Event|2
281997|NCT01000376|931399|P2|Cycle 1 Day 1|Progressive Disease|0
281998|NCT01000376|931400|P1|Cycle 1 Day 1|Progressive Disease|1
281999|NCT01000376|931399|P2|Cycle 1 Day 1|Adverse Event|0
282000|NCT01000376|931400|P1|Cycle 1 Day 1|Adverse Event|1
282001|NCT01000337|931410|P2|Overall Study|Lost to Follow-up|3
282002|NCT01000337|931411|P1|Overall Study|Lost to Follow-up|4
282003|NCT01000311|931429|P2|Overall Study|Administrative reason|15
282004|NCT01000311|931430|P1|Overall Study|Administrative reason|9
282005|NCT01000311|931429|P2|Overall Study|Inappropriate enrollment|0
282006|NCT01000311|931430|P1|Overall Study|Inappropriate enrollment|2
282007|NCT01000311|931429|P2|Overall Study|Protocol Violation|2
282008|NCT01000311|931430|P1|Overall Study|Protocol Violation|1
282009|NCT01000311|931429|P2|Overall Study|Lost to Follow-up|24
282010|NCT01000311|931430|P1|Overall Study|Lost to Follow-up|15
282011|NCT01000311|931429|P2|Overall Study|Withdrawal by Subject|24
282012|NCT01000311|931430|P1|Overall Study|Withdrawal by Subject|16
282013|NCT01000311|931429|P2|Overall Study|Adverse Event|5
282014|NCT01000311|931430|P1|Overall Study|Adverse Event|2
282015|NCT01000155|931480|P1|Overall Study|Adverse Event|1
282016|NCT01000155|931480|P1|Overall Study|Withdrawal by Subject|1
282017|NCT01000064|931484|P2|Overall Study|Withdrawal by Subject|1
282018|NCT01000064|931485|P1|Overall Study|Withdrawal by Subject|1
282019|NCT01000025|931508|P2|Overall Study|Intercurrent Illness|7
282020|NCT01000025|931509|P1|Overall Study|Intercurrent Illness|26
282021|NCT01000025|931508|P2|Overall Study|Lack of Efficacy|208
282022|NCT01000025|931509|P1|Overall Study|Lack of Efficacy|363
282023|NCT01000025|931508|P2|Overall Study|Death|13
282024|NCT01000025|931509|P1|Overall Study|Death|23
282025|NCT01000025|931508|P2|Overall Study|Withdrawal by Subject|8
282026|NCT01000025|931509|P1|Overall Study|Withdrawal by Subject|13
282027|NCT01000025|931508|P2|Overall Study|Adverse Event|2
282028|NCT01000025|931509|P1|Overall Study|Adverse Event|43
282029|NCT00999921|931527|P2|Overall Study|Lost to Follow-up|19
282030|NCT00999921|931528|P1|Overall Study|Lost to Follow-up|10
282031|NCT00999908|931538|P3|Treatment Period 2|Protocol Violation|0
282032|NCT00999908|931539|P2|Treatment Period 2|Protocol Violation|0
282033|NCT00999908|931540|P1|Treatment Period 2|Protocol Violation|1
282034|NCT00999908|931538|P3|Treatment Period 1|Subject withdrew consent|0
282035|NCT00999908|931539|P2|Treatment Period 1|Subject withdrew consent|0
282036|NCT00999908|931540|P1|Treatment Period 1|Subject withdrew consent|2
282037|NCT00999804|931569|P2|Overall Study|Ineligible|0
282038|NCT00999804|931570|P1|Overall Study|Ineligible|3
282039|NCT00999804|931569|P2|Overall Study|Death|0
282040|NCT00999804|931570|P1|Overall Study|Death|1
282041|NCT00999804|931569|P2|Overall Study|Withdrawal by Subject|0
282042|NCT00999804|931570|P1|Overall Study|Withdrawal by Subject|4
282043|NCT00999804|931569|P2|Overall Study|Adverse Event|3
282044|NCT00999804|931570|P1|Overall Study|Adverse Event|4
282045|NCT00999804|931569|P2|Overall Study|Lack of Efficacy|2
282046|NCT00999804|931570|P1|Overall Study|Lack of Efficacy|9
282047|NCT00999687|931582|P1|Second Intervention|Lack of Efficacy|1
282048|NCT00999687|931582|P1|Second Intervention|Withdrawal by Subject|2
282049|NCT00999687|931582|P1|First Intervention|Withdrawal by Subject|1
282050|NCT00999661|931589|P1|Overall Study|Not meeting eligibility criteria|9
282051|NCT00999661|931589|P1|Overall Study|Withdrawal by Subject|1
282052|NCT00999661|931589|P1|Overall Study|Adverse Event|1
282053|NCT00999661|931589|P1|Overall Study|Lost to Follow-up|59
282054|NCT00999596|931595|P1|Overall Study|Statistical population not required|101
282055|NCT00999544|931600|P1|Overall Study|Withdrawal by Subject|1
282056|NCT00999466|931621|P3|Main Part|Adverse Event|2
282057|NCT00999466|931622|P2|Main Part|Adverse Event|4
282058|NCT00999466|931623|P1|Main Part|Adverse Event|0
282059|NCT00999466|931621|P3|Main Part|Withdrawal by Subject|2
282060|NCT00999466|931622|P2|Main Part|Withdrawal by Subject|0
282061|NCT00999466|931623|P1|Main Part|Withdrawal by Subject|0
282062|NCT00999167|931900|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
282063|NCT00999167|931901|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
282064|NCT00999167|931902|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
282065|NCT00999167|931900|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
282066|NCT00999167|931901|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
282067|NCT00999167|931902|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
282068|NCT00999167|931900|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
282069|NCT00999167|931901|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
282070|NCT00999167|931902|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
282071|NCT00999167|931900|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
282072|NCT00999167|931901|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
282073|NCT00999167|931902|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
282074|NCT00999167|931900|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
282075|NCT00999167|931901|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
282076|NCT00999167|931902|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
282077|NCT00999167|931900|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
282078|NCT00999167|931901|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
282079|NCT00999167|931902|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
282080|NCT00999167|931900|P3|Part A: Open Label Safety run-in|Adverse Event|0
282081|NCT00999167|931901|P2|Part A: Open Label Safety run-in|Adverse Event|0
282082|NCT00999167|931902|P1|Part A: Open Label Safety run-in|Adverse Event|3
282083|NCT00999167|931900|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
282084|NCT00999167|931901|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
282085|NCT00999167|931902|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
282086|NCT00998985|932025|P14|Overall Study|Protocol Violation|0
282087|NCT00998985|932026|P13|Overall Study|Protocol Violation|0
282088|NCT00998985|932027|P12|Overall Study|Protocol Violation|0
282089|NCT00998985|932028|P11|Overall Study|Protocol Violation|0
282090|NCT00998985|932029|P10|Overall Study|Protocol Violation|0
282091|NCT00998985|932030|P9|Overall Study|Protocol Violation|0
282092|NCT00998985|932031|P8|Overall Study|Protocol Violation|0
282093|NCT00998985|932032|P7|Overall Study|Protocol Violation|0
282094|NCT00998985|932033|P6|Overall Study|Protocol Violation|1
282095|NCT00998985|932034|P5|Overall Study|Protocol Violation|0
282096|NCT00998985|932035|P4|Overall Study|Protocol Violation|0
282097|NCT00998985|932036|P3|Overall Study|Protocol Violation|0
282098|NCT00998985|932037|P2|Overall Study|Protocol Violation|0
282099|NCT00998985|932038|P1|Overall Study|Protocol Violation|0
282100|NCT00998985|932025|P14|Overall Study|Withdrawal by Subject|0
282101|NCT00998985|932026|P13|Overall Study|Withdrawal by Subject|0
282102|NCT00998985|932027|P12|Overall Study|Withdrawal by Subject|0
282103|NCT00998985|932028|P11|Overall Study|Withdrawal by Subject|0
282104|NCT00998985|932029|P10|Overall Study|Withdrawal by Subject|0
282105|NCT00998985|932030|P9|Overall Study|Withdrawal by Subject|1
282106|NCT00998985|932031|P8|Overall Study|Withdrawal by Subject|0
282107|NCT00998985|932032|P7|Overall Study|Withdrawal by Subject|0
282108|NCT00998985|932033|P6|Overall Study|Withdrawal by Subject|0
282109|NCT00998985|932034|P5|Overall Study|Withdrawal by Subject|0
282110|NCT00998985|932035|P4|Overall Study|Withdrawal by Subject|0
282111|NCT00998985|932036|P3|Overall Study|Withdrawal by Subject|0
282112|NCT00998985|932037|P2|Overall Study|Withdrawal by Subject|0
282113|NCT00998985|932038|P1|Overall Study|Withdrawal by Subject|0
282114|NCT00998881|932106|P2|Overall Study|Personal matter|0
282115|NCT00998881|932107|P1|Overall Study|Personal matter|1
282116|NCT00998881|932106|P2|Overall Study|Withdrawal by Subject|0
282117|NCT00998881|932107|P1|Overall Study|Withdrawal by Subject|1
282118|NCT00998881|932106|P2|Overall Study|Physician Decision|0
282119|NCT00998881|932107|P1|Overall Study|Physician Decision|3
282120|NCT00998881|932106|P2|Overall Study|Lack of Efficacy|0
282121|NCT00998881|932107|P1|Overall Study|Lack of Efficacy|1
282122|NCT00998881|932106|P2|Overall Study|Adverse Event|2
282123|NCT00998881|932107|P1|Overall Study|Adverse Event|2
282124|NCT00998764|932128|P2|Overall Study|Recurrent Episode of vasogenic edema|0
282125|NCT00998764|932129|P1|Overall Study|Recurrent Episode of vasogenic edema|1
282126|NCT00998764|932128|P2|Overall Study|Not specified|4
282127|NCT00998764|932129|P1|Overall Study|Not specified|4
282128|NCT00998764|932128|P2|Overall Study|Loss of Caregiver|3
282129|NCT00998764|932129|P1|Overall Study|Loss of Caregiver|0
282130|NCT00998764|932128|P2|Overall Study|Lost to Follow-up|1
282131|NCT00998764|932129|P1|Overall Study|Lost to Follow-up|1
282132|NCT00998764|932128|P2|Overall Study|Failed to Return|1
282133|NCT00998764|932129|P1|Overall Study|Failed to Return|1
282134|NCT00998764|932128|P2|Overall Study|Protocol Violation|1
282135|NCT00998764|932129|P1|Overall Study|Protocol Violation|0
282136|NCT00998764|932128|P2|Overall Study|Discontinuation of Study by Sponsor|217
282137|NCT00998764|932129|P1|Overall Study|Discontinuation of Study by Sponsor|164
282138|NCT00998764|932128|P2|Overall Study|Death|1
282139|NCT00998764|932129|P1|Overall Study|Death|3
282140|NCT00998764|932128|P2|Overall Study|Physician Decision|3
282141|NCT00998764|932129|P1|Overall Study|Physician Decision|3
282142|NCT00998764|932128|P2|Overall Study|Withdrawal by Subject|25
282143|NCT00998764|932129|P1|Overall Study|Withdrawal by Subject|19
282144|NCT00998764|932128|P2|Overall Study|Adverse Event|12
282145|NCT00998764|932129|P1|Overall Study|Adverse Event|17
282146|NCT00998764|932128|P2|Overall Study|Lack of Efficacy|6
282147|NCT00998764|932129|P1|Overall Study|Lack of Efficacy|3
282148|NCT00998738|932151|P1|Overall Study|Uknown|1
282149|NCT00998335|932234|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
282150|NCT00998335|932235|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
282151|NCT00998309|932263|P1|Overall Study|Protocol Violation|4
282152|NCT00998296|932330|P11|Overall Study|Reason other than those specified above|0
282153|NCT00998296|932331|P10|Overall Study|Reason other than those specified above|1
282154|NCT00998296|932332|P9|Overall Study|Reason other than those specified above|0
282155|NCT00998296|932333|P8|Overall Study|Reason other than those specified above|0
282156|NCT00998296|932334|P7|Overall Study|Reason other than those specified above|0
282157|NCT00998296|932335|P6|Overall Study|Reason other than those specified above|0
282158|NCT00998296|932336|P5|Overall Study|Reason other than those specified above|0
282159|NCT00998296|932337|P4|Overall Study|Reason other than those specified above|0
282160|NCT00998296|932338|P3|Overall Study|Reason other than those specified above|0
282161|NCT00998296|932339|P2|Overall Study|Reason other than those specified above|0
282162|NCT00998296|932340|P1|Overall Study|Reason other than those specified above|0
282163|NCT00998296|932330|P11|Overall Study|Refused to continue taking trial med.|0
282164|NCT00998296|932331|P10|Overall Study|Refused to continue taking trial med.|2
282165|NCT00998296|932332|P9|Overall Study|Refused to continue taking trial med.|0
282166|NCT00998296|932333|P8|Overall Study|Refused to continue taking trial med.|0
282167|NCT00998296|932334|P7|Overall Study|Refused to continue taking trial med.|0
282168|NCT00998296|932335|P6|Overall Study|Refused to continue taking trial med.|0
282169|NCT00998296|932336|P5|Overall Study|Refused to continue taking trial med.|0
282170|NCT00998296|932337|P4|Overall Study|Refused to continue taking trial med.|0
282171|NCT00998296|932338|P3|Overall Study|Refused to continue taking trial med.|0
282172|NCT00998296|932339|P2|Overall Study|Refused to continue taking trial med.|0
282173|NCT00998296|932340|P1|Overall Study|Refused to continue taking trial med.|0
282174|NCT00998296|932330|P11|Overall Study|Other adverse event|2
282175|NCT00998296|932331|P10|Overall Study|Other adverse event|1
282176|NCT00998296|932332|P9|Overall Study|Other adverse event|0
282177|NCT00998296|932333|P8|Overall Study|Other adverse event|0
282178|NCT00998296|932334|P7|Overall Study|Other adverse event|0
282179|NCT00998296|932335|P6|Overall Study|Other adverse event|0
282180|NCT00998296|932336|P5|Overall Study|Other adverse event|1
282181|NCT00998296|932337|P4|Overall Study|Other adverse event|0
282182|NCT00998296|932338|P3|Overall Study|Other adverse event|0
282183|NCT00998296|932339|P2|Overall Study|Other adverse event|0
282184|NCT00998296|932340|P1|Overall Study|Other adverse event|0
282185|NCT00998296|932330|P11|Overall Study|Dose limiting or dose reducing toxicity|0
282186|NCT00998296|932331|P10|Overall Study|Dose limiting or dose reducing toxicity|0
282187|NCT00998296|932332|P9|Overall Study|Dose limiting or dose reducing toxicity|2
282188|NCT00998296|932333|P8|Overall Study|Dose limiting or dose reducing toxicity|2
282189|NCT00998296|932334|P7|Overall Study|Dose limiting or dose reducing toxicity|0
282190|NCT00998296|932335|P6|Overall Study|Dose limiting or dose reducing toxicity|0
282191|NCT00998296|932336|P5|Overall Study|Dose limiting or dose reducing toxicity|1
282192|NCT00998296|932337|P4|Overall Study|Dose limiting or dose reducing toxicity|0
282193|NCT00998296|932338|P3|Overall Study|Dose limiting or dose reducing toxicity|0
282194|NCT00998296|932339|P2|Overall Study|Dose limiting or dose reducing toxicity|0
282195|NCT00998296|932340|P1|Overall Study|Dose limiting or dose reducing toxicity|0
282196|NCT00998296|932330|P11|Overall Study|Progressive disease|5
282197|NCT00998296|932331|P10|Overall Study|Progressive disease|14
282198|NCT00998296|932332|P9|Overall Study|Progressive disease|0
282199|NCT00998296|932333|P8|Overall Study|Progressive disease|0
282200|NCT00998296|932334|P7|Overall Study|Progressive disease|1
282201|NCT00998296|932335|P6|Overall Study|Progressive disease|0
282202|NCT00998296|932336|P5|Overall Study|Progressive disease|0
282203|NCT00998296|932337|P4|Overall Study|Progressive disease|0
282204|NCT00998296|932338|P3|Overall Study|Progressive disease|0
282205|NCT00998296|932339|P2|Overall Study|Progressive disease|1
282206|NCT00998296|932340|P1|Overall Study|Progressive disease|0
282207|NCT00997984|932435|P3|Overall Study|Work schedule|2
282208|NCT00997984|932436|P2|Overall Study|Work schedule|0
282209|NCT00997984|932437|P1|Overall Study|Work schedule|0
282210|NCT00997984|932435|P3|Overall Study|Suicidal ideation|1
282211|NCT00997984|932436|P2|Overall Study|Suicidal ideation|0
282212|NCT00997984|932437|P1|Overall Study|Suicidal ideation|0
282213|NCT00997984|932435|P3|Overall Study|Wrong medication dispensed|0
282214|NCT00997984|932436|P2|Overall Study|Wrong medication dispensed|1
282215|NCT00997984|932437|P1|Overall Study|Wrong medication dispensed|0
282216|NCT00997984|932435|P3|Overall Study|non-compliance|3
282217|NCT00997984|932436|P2|Overall Study|non-compliance|2
282218|NCT00997984|932437|P1|Overall Study|non-compliance|0
282219|NCT00997984|932435|P3|Overall Study|Met exclusion criteria|0
282220|NCT00997984|932436|P2|Overall Study|Met exclusion criteria|0
282221|NCT00997984|932437|P1|Overall Study|Met exclusion criteria|1
282222|NCT00997984|932435|P3|Overall Study|Lack of Efficacy|3
282223|NCT00997984|932436|P2|Overall Study|Lack of Efficacy|6
282224|NCT00997984|932437|P1|Overall Study|Lack of Efficacy|20
282225|NCT00997984|932435|P3|Overall Study|Lost to Follow-up|4
282226|NCT00997984|932436|P2|Overall Study|Lost to Follow-up|5
282227|NCT00997984|932437|P1|Overall Study|Lost to Follow-up|8
282228|NCT00997984|932435|P3|Overall Study|Withdrawal by Subject|5
282229|NCT00997984|932436|P2|Overall Study|Withdrawal by Subject|9
282230|NCT00997984|932437|P1|Overall Study|Withdrawal by Subject|6
282231|NCT00997984|932435|P3|Overall Study|Protocol Violation|0
282232|NCT00997984|932436|P2|Overall Study|Protocol Violation|3
282233|NCT00997984|932437|P1|Overall Study|Protocol Violation|1
282234|NCT00997984|932435|P3|Overall Study|Adverse Event|8
282235|NCT00997984|932436|P2|Overall Study|Adverse Event|8
282236|NCT00997984|932437|P1|Overall Study|Adverse Event|1
282237|NCT00997503|932576|P1|Overall Study|Other reason|13
282238|NCT00997503|932576|P1|Overall Study|Missed 12-month follow-up|85
282239|NCT00997503|932576|P1|Overall Study|Physician Decision|10
282240|NCT00997503|932576|P1|Overall Study|Adverse Event|3
282241|NCT00997503|932576|P1|Overall Study|Lost to Follow-up|33
282242|NCT00997503|932576|P1|Overall Study|Withdrawal by Subject|76
282243|NCT00997503|932576|P1|Overall Study|Death|53
282244|NCT00997438|932619|P3|Overall Study|Exclusion criteria at visit 1|3
282245|NCT00997438|932620|P2|Overall Study|Exclusion criteria at visit 1|2
282246|NCT00997438|932621|P1|Overall Study|Exclusion criteria at visit 1|2
282247|NCT00997438|932619|P3|Overall Study|Withdrawal by Subject|0
282248|NCT00997438|932620|P2|Overall Study|Withdrawal by Subject|1
282249|NCT00997438|932621|P1|Overall Study|Withdrawal by Subject|1
282250|NCT00997438|932619|P3|Overall Study|Blood draw difficulty|1
282251|NCT00997438|932620|P2|Overall Study|Blood draw difficulty|0
282252|NCT00997438|932621|P1|Overall Study|Blood draw difficulty|2
282253|NCT00997373|932663|P2|Overall Study|could not have hysterectomy|0
282254|NCT00997373|932664|P1|Overall Study|could not have hysterectomy|6
282255|NCT00997373|932663|P2|Overall Study|wrong tumor type|0
282256|NCT00997373|932664|P1|Overall Study|wrong tumor type|4
282257|NCT00997373|932663|P2|Overall Study|Withdrawal by Subject|0
282258|NCT00997373|932664|P1|Overall Study|Withdrawal by Subject|5
282259|NCT00997334|932670|P1|Overall Study|Ineligible|1
282260|NCT00997334|932670|P1|Overall Study|No lesion amenable|1
282261|NCT00997334|932670|P1|Overall Study|Urgent Palliative Care|2
282262|NCT00997334|932670|P1|Overall Study|Death|2
282263|NCT00997334|932670|P1|Overall Study|Withdrawal by Subject|3
282264|NCT00997334|932670|P1|Overall Study|Patient non-compliance|1
282265|NCT00997334|932670|P1|Overall Study|Adverse Event|3
282266|NCT00997334|932670|P1|Overall Study|still on therapy|12
282267|NCT00997321|932679|P2|Overall Study|did not undergo sedation after enrollmen|3
282268|NCT00997321|932680|P1|Overall Study|did not undergo sedation after enrollmen|0
282269|NCT00997243|932692|P1|Overall Study|Early termination of study by sponsor|7
282270|NCT00997126|932724|P2|Overall Study|Physician Decision|11
282271|NCT00997126|932725|P1|Overall Study|Physician Decision|7
282272|NCT00997035|932754|P2|3-month Follow-up Visit|Lost to Follow-up|6
282273|NCT00997035|932755|P1|3-month Follow-up Visit|Lost to Follow-up|12
282274|NCT00997035|932754|P2|3-week Followup Visit|Lost to Follow-up|6
282275|NCT00997035|932755|P1|3-week Followup Visit|Lost to Follow-up|9
282276|NCT00996996|932775|P1|Overall Study|Did Not Receive Study Medications|1
282277|NCT00996996|932775|P1|Overall Study|Death|5
282278|NCT00996996|932775|P1|Overall Study|Lost to Follow-up|9
282279|NCT00996996|932775|P1|Overall Study|Non-compliance|8
282280|NCT00996996|932775|P1|Overall Study|Progressive Disease|10
282281|NCT00996944|932809|P2|Long-term Treatment Period|Study Closed/Terminated|5
282282|NCT00996944|932810|P1|Long-term Treatment Period|Study Closed/Terminated|12
282283|NCT00996944|932809|P2|Double-blind Treatment Period|Withdrawal by Subject|1
282284|NCT00996944|932810|P1|Double-blind Treatment Period|Withdrawal by Subject|1
282285|NCT00996944|932809|P2|Double-blind Treatment Period|Study Closed/Terminated|5
282286|NCT00996944|932810|P1|Double-blind Treatment Period|Study Closed/Terminated|6
282287|NCT00996944|932809|P2|Double-blind Treatment Period|Protocol Violation|0
282288|NCT00996944|932810|P1|Double-blind Treatment Period|Protocol Violation|1
282289|NCT00996944|932809|P2|Double-blind Treatment Period|Adverse Event|1
282290|NCT00996944|932810|P1|Double-blind Treatment Period|Adverse Event|2
282291|NCT00996918|932862|P5|Overall Study|Not Specified|0
282292|NCT00996918|932863|P4|Overall Study|Not Specified|0
282293|NCT00996918|932864|P3|Overall Study|Not Specified|0
282294|NCT00996918|932865|P2|Overall Study|Not Specified|1
282295|NCT00996918|932866|P1|Overall Study|Not Specified|3
282296|NCT00996918|932862|P5|Overall Study|Loss of Caregiver|0
282297|NCT00996918|932863|P4|Overall Study|Loss of Caregiver|0
282298|NCT00996918|932864|P3|Overall Study|Loss of Caregiver|0
282299|NCT00996918|932865|P2|Overall Study|Loss of Caregiver|1
282300|NCT00996918|932866|P1|Overall Study|Loss of Caregiver|0
282301|NCT00996918|932862|P5|Overall Study|Discontinuation of Study by Sponsor|2
282302|NCT00996918|932863|P4|Overall Study|Discontinuation of Study by Sponsor|45
282303|NCT00996918|932864|P3|Overall Study|Discontinuation of Study by Sponsor|30
282304|NCT00996918|932865|P2|Overall Study|Discontinuation of Study by Sponsor|54
282305|NCT00996918|932866|P1|Overall Study|Discontinuation of Study by Sponsor|31
282306|NCT00996918|932862|P5|Overall Study|Physician Decision|0
282307|NCT00996918|932863|P4|Overall Study|Physician Decision|0
282308|NCT00996918|932864|P3|Overall Study|Physician Decision|0
282309|NCT00996918|932865|P2|Overall Study|Physician Decision|0
282310|NCT00996918|932866|P1|Overall Study|Physician Decision|1
282311|NCT00996918|932862|P5|Overall Study|Withdrawal by Subject|2
282312|NCT00996918|932863|P4|Overall Study|Withdrawal by Subject|3
282313|NCT00996918|932864|P3|Overall Study|Withdrawal by Subject|3
282314|NCT00996918|932865|P2|Overall Study|Withdrawal by Subject|4
282315|NCT00996918|932866|P1|Overall Study|Withdrawal by Subject|1
282316|NCT00996918|932862|P5|Overall Study|Adverse Event|0
282317|NCT00996918|932863|P4|Overall Study|Adverse Event|6
282318|NCT00996918|932864|P3|Overall Study|Adverse Event|2
282319|NCT00996918|932865|P2|Overall Study|Adverse Event|5
282320|NCT00996918|932866|P1|Overall Study|Adverse Event|2
282321|NCT00996918|932862|P5|Overall Study|Lack of Efficacy|0
282322|NCT00996918|932863|P4|Overall Study|Lack of Efficacy|2
282323|NCT00996918|932864|P3|Overall Study|Lack of Efficacy|2
282324|NCT00996918|932865|P2|Overall Study|Lack of Efficacy|1
282325|NCT00996918|932866|P1|Overall Study|Lack of Efficacy|1
282326|NCT00996892|932910|P20|Expansion Stage 2A|Disease Progression|31
282327|NCT00996892|932911|P19|Expansion Stage 2A|Disease Progression|0
282328|NCT00996892|932912|P18|Expansion Stage 2A|Disease Progression|0
282329|NCT00996892|932913|P17|Expansion Stage 2A|Disease Progression|0
282330|NCT00996892|932914|P16|Expansion Stage 2A|Disease Progression|0
282331|NCT00996892|932915|P15|Expansion Stage 2A|Disease Progression|0
282332|NCT00996892|932916|P14|Expansion Stage 2A|Disease Progression|0
282333|NCT00996892|932917|P13|Expansion Stage 2A|Disease Progression|0
282334|NCT00996892|932918|P12|Expansion Stage 2A|Disease Progression|0
282335|NCT00996892|932919|P11|Expansion Stage 2A|Disease Progression|0
282336|NCT00996892|932920|P10|Expansion Stage 2A|Disease Progression|0
282337|NCT00996892|932921|P9|Expansion Stage 2A|Disease Progression|0
282338|NCT00996892|932922|P8|Expansion Stage 2A|Disease Progression|0
282339|NCT00996892|932923|P7|Expansion Stage 2A|Disease Progression|0
282340|NCT00996892|932924|P6|Expansion Stage 2A|Disease Progression|0
282341|NCT00996892|932925|P5|Expansion Stage 2A|Disease Progression|0
282342|NCT00996892|932926|P4|Expansion Stage 2A|Disease Progression|0
282343|NCT00996892|932927|P3|Expansion Stage 2A|Disease Progression|0
282344|NCT00996892|932928|P2|Expansion Stage 2A|Disease Progression|0
282345|NCT00996892|932929|P1|Expansion Stage 2A|Disease Progression|0
282346|NCT00996892|932910|P20|Expansion Stage 2A|Withdrawal by Subject|4
282347|NCT00996892|932911|P19|Expansion Stage 2A|Withdrawal by Subject|0
282348|NCT00996892|932912|P18|Expansion Stage 2A|Withdrawal by Subject|0
282349|NCT00996892|932913|P17|Expansion Stage 2A|Withdrawal by Subject|0
282350|NCT00996892|932914|P16|Expansion Stage 2A|Withdrawal by Subject|0
282351|NCT00996892|932915|P15|Expansion Stage 2A|Withdrawal by Subject|0
282352|NCT00996892|932916|P14|Expansion Stage 2A|Withdrawal by Subject|0
282353|NCT00996892|932917|P13|Expansion Stage 2A|Withdrawal by Subject|0
282354|NCT00996892|932918|P12|Expansion Stage 2A|Withdrawal by Subject|0
282355|NCT00996892|932919|P11|Expansion Stage 2A|Withdrawal by Subject|0
282356|NCT00996892|932920|P10|Expansion Stage 2A|Withdrawal by Subject|0
282357|NCT00996892|932921|P9|Expansion Stage 2A|Withdrawal by Subject|0
282358|NCT00996892|932922|P8|Expansion Stage 2A|Withdrawal by Subject|0
282359|NCT00996892|932923|P7|Expansion Stage 2A|Withdrawal by Subject|0
282360|NCT00996892|932924|P6|Expansion Stage 2A|Withdrawal by Subject|0
282361|NCT00996892|932925|P5|Expansion Stage 2A|Withdrawal by Subject|0
282362|NCT00996892|932926|P4|Expansion Stage 2A|Withdrawal by Subject|0
282363|NCT00996892|932927|P3|Expansion Stage 2A|Withdrawal by Subject|0
282364|NCT00996892|932928|P2|Expansion Stage 2A|Withdrawal by Subject|0
282365|NCT00996892|932929|P1|Expansion Stage 2A|Withdrawal by Subject|0
282366|NCT00996892|932910|P20|Expansion Stage 2A|Physician Decision|2
282367|NCT00996892|932911|P19|Expansion Stage 2A|Physician Decision|0
282368|NCT00996892|932912|P18|Expansion Stage 2A|Physician Decision|0
282369|NCT00996892|932913|P17|Expansion Stage 2A|Physician Decision|0
282370|NCT00996892|932914|P16|Expansion Stage 2A|Physician Decision|0
282371|NCT00996892|932915|P15|Expansion Stage 2A|Physician Decision|0
282372|NCT00996892|932916|P14|Expansion Stage 2A|Physician Decision|0
282373|NCT00996892|932917|P13|Expansion Stage 2A|Physician Decision|0
282374|NCT00996892|932918|P12|Expansion Stage 2A|Physician Decision|0
282375|NCT00996892|932919|P11|Expansion Stage 2A|Physician Decision|0
282376|NCT00996892|932920|P10|Expansion Stage 2A|Physician Decision|0
282377|NCT00996892|932921|P9|Expansion Stage 2A|Physician Decision|0
282378|NCT00996892|932922|P8|Expansion Stage 2A|Physician Decision|0
282379|NCT00996892|932923|P7|Expansion Stage 2A|Physician Decision|0
282380|NCT00996892|932924|P6|Expansion Stage 2A|Physician Decision|0
282381|NCT00996892|932925|P5|Expansion Stage 2A|Physician Decision|0
282382|NCT00996892|932926|P4|Expansion Stage 2A|Physician Decision|0
282383|NCT00996892|932927|P3|Expansion Stage 2A|Physician Decision|0
282384|NCT00996892|932928|P2|Expansion Stage 2A|Physician Decision|0
282385|NCT00996892|932929|P1|Expansion Stage 2A|Physician Decision|0
282386|NCT00996892|932910|P20|Expansion Stage 2A|Adverse Event|8
282387|NCT00996892|932911|P19|Expansion Stage 2A|Adverse Event|0
282388|NCT00996892|932912|P18|Expansion Stage 2A|Adverse Event|0
282389|NCT00996892|932913|P17|Expansion Stage 2A|Adverse Event|0
282390|NCT00996892|932914|P16|Expansion Stage 2A|Adverse Event|0
282391|NCT00996892|932915|P15|Expansion Stage 2A|Adverse Event|0
282392|NCT00996892|932916|P14|Expansion Stage 2A|Adverse Event|0
282393|NCT00996892|932917|P13|Expansion Stage 2A|Adverse Event|0
282394|NCT00996892|932918|P12|Expansion Stage 2A|Adverse Event|0
282395|NCT00996892|932919|P11|Expansion Stage 2A|Adverse Event|0
282396|NCT00996892|932920|P10|Expansion Stage 2A|Adverse Event|0
282397|NCT00996892|932921|P9|Expansion Stage 2A|Adverse Event|0
282398|NCT00996892|932922|P8|Expansion Stage 2A|Adverse Event|0
282399|NCT00996892|932923|P7|Expansion Stage 2A|Adverse Event|0
282400|NCT00996892|932924|P6|Expansion Stage 2A|Adverse Event|0
282401|NCT00996892|932925|P5|Expansion Stage 2A|Adverse Event|0
282402|NCT00996892|932926|P4|Expansion Stage 2A|Adverse Event|0
282403|NCT00996892|932927|P3|Expansion Stage 2A|Adverse Event|0
282404|NCT00996892|932928|P2|Expansion Stage 2A|Adverse Event|0
282405|NCT00996892|932929|P1|Expansion Stage 2A|Adverse Event|0
282406|NCT00996892|932910|P20|Expansion Stage 2|Disease Progression|0
282407|NCT00996892|932911|P19|Expansion Stage 2|Disease Progression|28
282408|NCT00996892|932912|P18|Expansion Stage 2|Disease Progression|0
282409|NCT00996892|932913|P17|Expansion Stage 2|Disease Progression|0
282410|NCT00996892|932914|P16|Expansion Stage 2|Disease Progression|0
282411|NCT00996892|932915|P15|Expansion Stage 2|Disease Progression|0
282412|NCT00996892|932916|P14|Expansion Stage 2|Disease Progression|0
282413|NCT00996892|932917|P13|Expansion Stage 2|Disease Progression|0
282414|NCT00996892|932918|P12|Expansion Stage 2|Disease Progression|0
282415|NCT00996892|932919|P11|Expansion Stage 2|Disease Progression|0
282416|NCT00996892|932920|P10|Expansion Stage 2|Disease Progression|0
282417|NCT00996892|932921|P9|Expansion Stage 2|Disease Progression|0
282418|NCT00996892|932922|P8|Expansion Stage 2|Disease Progression|0
282419|NCT00996892|932923|P7|Expansion Stage 2|Disease Progression|0
282420|NCT00996892|932924|P6|Expansion Stage 2|Disease Progression|0
282421|NCT00996892|932925|P5|Expansion Stage 2|Disease Progression|0
282422|NCT00996892|932926|P4|Expansion Stage 2|Disease Progression|0
282423|NCT00996892|932927|P3|Expansion Stage 2|Disease Progression|0
282424|NCT00996892|932928|P2|Expansion Stage 2|Disease Progression|0
282425|NCT00996892|932929|P1|Expansion Stage 2|Disease Progression|0
282426|NCT00996892|932910|P20|Expansion Stage 2|Withdrawal by Subject|0
282427|NCT00996892|932911|P19|Expansion Stage 2|Withdrawal by Subject|1
282428|NCT00996892|932912|P18|Expansion Stage 2|Withdrawal by Subject|0
282429|NCT00996892|932913|P17|Expansion Stage 2|Withdrawal by Subject|0
282430|NCT00996892|932914|P16|Expansion Stage 2|Withdrawal by Subject|0
282431|NCT00996892|932915|P15|Expansion Stage 2|Withdrawal by Subject|0
282432|NCT00996892|932916|P14|Expansion Stage 2|Withdrawal by Subject|0
282433|NCT00996892|932917|P13|Expansion Stage 2|Withdrawal by Subject|0
282434|NCT00996892|932918|P12|Expansion Stage 2|Withdrawal by Subject|0
282435|NCT00996892|932919|P11|Expansion Stage 2|Withdrawal by Subject|0
282436|NCT00996892|932920|P10|Expansion Stage 2|Withdrawal by Subject|0
282437|NCT00996892|932921|P9|Expansion Stage 2|Withdrawal by Subject|0
282438|NCT00996892|932922|P8|Expansion Stage 2|Withdrawal by Subject|0
282439|NCT00996892|932923|P7|Expansion Stage 2|Withdrawal by Subject|0
282440|NCT00996892|932924|P6|Expansion Stage 2|Withdrawal by Subject|0
282441|NCT00996892|932925|P5|Expansion Stage 2|Withdrawal by Subject|0
282442|NCT00996892|932926|P4|Expansion Stage 2|Withdrawal by Subject|0
282443|NCT00996892|932927|P3|Expansion Stage 2|Withdrawal by Subject|0
282444|NCT00996892|932928|P2|Expansion Stage 2|Withdrawal by Subject|0
282445|NCT00996892|932929|P1|Expansion Stage 2|Withdrawal by Subject|0
282446|NCT00996892|932910|P20|Expansion Stage 2|Physician Decision|0
282447|NCT00996892|932911|P19|Expansion Stage 2|Physician Decision|1
282448|NCT00996892|932912|P18|Expansion Stage 2|Physician Decision|0
282449|NCT00996892|932913|P17|Expansion Stage 2|Physician Decision|0
282450|NCT00996892|932914|P16|Expansion Stage 2|Physician Decision|0
282451|NCT00996892|932915|P15|Expansion Stage 2|Physician Decision|0
282452|NCT00996892|932916|P14|Expansion Stage 2|Physician Decision|0
282453|NCT00996892|932917|P13|Expansion Stage 2|Physician Decision|0
282454|NCT00996892|932918|P12|Expansion Stage 2|Physician Decision|0
282455|NCT00996892|932919|P11|Expansion Stage 2|Physician Decision|0
282456|NCT00996892|932920|P10|Expansion Stage 2|Physician Decision|0
282457|NCT00996892|932921|P9|Expansion Stage 2|Physician Decision|0
282458|NCT00996892|932922|P8|Expansion Stage 2|Physician Decision|0
282459|NCT00996892|932923|P7|Expansion Stage 2|Physician Decision|0
282460|NCT00996892|932924|P6|Expansion Stage 2|Physician Decision|0
282461|NCT00996892|932925|P5|Expansion Stage 2|Physician Decision|0
282462|NCT00996892|932926|P4|Expansion Stage 2|Physician Decision|0
282463|NCT00996892|932927|P3|Expansion Stage 2|Physician Decision|0
282464|NCT00996892|932928|P2|Expansion Stage 2|Physician Decision|0
282465|NCT00996892|932929|P1|Expansion Stage 2|Physician Decision|0
282466|NCT00996892|932910|P20|Expansion Stage 2|Death|0
282467|NCT00996892|932911|P19|Expansion Stage 2|Death|2
282468|NCT00996892|932912|P18|Expansion Stage 2|Death|0
282469|NCT00996892|932913|P17|Expansion Stage 2|Death|0
282470|NCT00996892|932914|P16|Expansion Stage 2|Death|0
282471|NCT00996892|932915|P15|Expansion Stage 2|Death|0
282472|NCT00996892|932916|P14|Expansion Stage 2|Death|0
282473|NCT00996892|932917|P13|Expansion Stage 2|Death|0
282474|NCT00996892|932918|P12|Expansion Stage 2|Death|0
282475|NCT00996892|932919|P11|Expansion Stage 2|Death|0
282476|NCT00996892|932920|P10|Expansion Stage 2|Death|0
282477|NCT00996892|932921|P9|Expansion Stage 2|Death|0
282478|NCT00996892|932922|P8|Expansion Stage 2|Death|0
282479|NCT00996892|932923|P7|Expansion Stage 2|Death|0
282480|NCT00996892|932924|P6|Expansion Stage 2|Death|0
282481|NCT00996892|932925|P5|Expansion Stage 2|Death|0
282482|NCT00996892|932926|P4|Expansion Stage 2|Death|0
282483|NCT00996892|932927|P3|Expansion Stage 2|Death|0
282484|NCT00996892|932928|P2|Expansion Stage 2|Death|0
282485|NCT00996892|932929|P1|Expansion Stage 2|Death|0
282486|NCT00996892|932910|P20|Expansion Stage 2|Adverse Event|0
282487|NCT00996892|932911|P19|Expansion Stage 2|Adverse Event|3
282488|NCT00996892|932912|P18|Expansion Stage 2|Adverse Event|0
282489|NCT00996892|932913|P17|Expansion Stage 2|Adverse Event|0
282490|NCT00996892|932914|P16|Expansion Stage 2|Adverse Event|0
282491|NCT00996892|932915|P15|Expansion Stage 2|Adverse Event|0
282492|NCT00996892|932916|P14|Expansion Stage 2|Adverse Event|0
282493|NCT00996892|932917|P13|Expansion Stage 2|Adverse Event|0
282494|NCT00996892|932918|P12|Expansion Stage 2|Adverse Event|0
282495|NCT00996892|932919|P11|Expansion Stage 2|Adverse Event|0
282496|NCT00996892|932920|P10|Expansion Stage 2|Adverse Event|0
282497|NCT00996892|932921|P9|Expansion Stage 2|Adverse Event|0
282498|NCT00996892|932922|P8|Expansion Stage 2|Adverse Event|0
282499|NCT00996892|932923|P7|Expansion Stage 2|Adverse Event|0
282500|NCT00996892|932924|P6|Expansion Stage 2|Adverse Event|0
282501|NCT00996892|932925|P5|Expansion Stage 2|Adverse Event|0
282502|NCT00996892|932926|P4|Expansion Stage 2|Adverse Event|0
282503|NCT00996892|932927|P3|Expansion Stage 2|Adverse Event|0
282504|NCT00996892|932928|P2|Expansion Stage 2|Adverse Event|0
282505|NCT00996892|932929|P1|Expansion Stage 2|Adverse Event|0
282506|NCT00996892|932910|P20|Dose-Escalation Stage 1B|Disease Progression|0
282507|NCT00996892|932911|P19|Dose-Escalation Stage 1B|Disease Progression|0
282508|NCT00996892|932912|P18|Dose-Escalation Stage 1B|Disease Progression|3
282509|NCT00996892|932913|P17|Dose-Escalation Stage 1B|Disease Progression|3
282510|NCT00996892|932914|P16|Dose-Escalation Stage 1B|Disease Progression|3
282511|NCT00996892|932915|P15|Dose-Escalation Stage 1B|Disease Progression|4
282512|NCT00996892|932916|P14|Dose-Escalation Stage 1B|Disease Progression|0
282513|NCT00996892|932917|P13|Dose-Escalation Stage 1B|Disease Progression|0
282514|NCT00996892|932918|P12|Dose-Escalation Stage 1B|Disease Progression|0
282515|NCT00996892|932919|P11|Dose-Escalation Stage 1B|Disease Progression|0
282516|NCT00996892|932920|P10|Dose-Escalation Stage 1B|Disease Progression|0
282517|NCT00996892|932921|P9|Dose-Escalation Stage 1B|Disease Progression|0
282518|NCT00996892|932922|P8|Dose-Escalation Stage 1B|Disease Progression|0
282519|NCT00996892|932923|P7|Dose-Escalation Stage 1B|Disease Progression|0
282520|NCT00996892|932924|P6|Dose-Escalation Stage 1B|Disease Progression|0
282521|NCT00996892|932925|P5|Dose-Escalation Stage 1B|Disease Progression|0
282522|NCT00996892|932926|P4|Dose-Escalation Stage 1B|Disease Progression|0
282523|NCT00996892|932927|P3|Dose-Escalation Stage 1B|Disease Progression|0
282524|NCT00996892|932928|P2|Dose-Escalation Stage 1B|Disease Progression|0
282525|NCT00996892|932929|P1|Dose-Escalation Stage 1B|Disease Progression|0
282526|NCT00996892|932910|P20|Dose-Escalation Stage 1B|Physician Decision|0
282527|NCT00996892|932911|P19|Dose-Escalation Stage 1B|Physician Decision|0
282528|NCT00996892|932912|P18|Dose-Escalation Stage 1B|Physician Decision|2
282529|NCT00996892|932913|P17|Dose-Escalation Stage 1B|Physician Decision|0
282530|NCT00996892|932914|P16|Dose-Escalation Stage 1B|Physician Decision|0
282531|NCT00996892|932915|P15|Dose-Escalation Stage 1B|Physician Decision|0
282532|NCT00996892|932916|P14|Dose-Escalation Stage 1B|Physician Decision|0
282533|NCT00996892|932917|P13|Dose-Escalation Stage 1B|Physician Decision|0
282534|NCT00996892|932918|P12|Dose-Escalation Stage 1B|Physician Decision|0
282535|NCT00996892|932919|P11|Dose-Escalation Stage 1B|Physician Decision|0
282536|NCT00996892|932920|P10|Dose-Escalation Stage 1B|Physician Decision|0
282537|NCT00996892|932921|P9|Dose-Escalation Stage 1B|Physician Decision|0
282538|NCT00996892|932922|P8|Dose-Escalation Stage 1B|Physician Decision|0
282539|NCT00996892|932923|P7|Dose-Escalation Stage 1B|Physician Decision|0
282540|NCT00996892|932924|P6|Dose-Escalation Stage 1B|Physician Decision|0
282541|NCT00996892|932925|P5|Dose-Escalation Stage 1B|Physician Decision|0
282542|NCT00996892|932926|P4|Dose-Escalation Stage 1B|Physician Decision|0
282543|NCT00996892|932927|P3|Dose-Escalation Stage 1B|Physician Decision|0
282544|NCT00996892|932928|P2|Dose-Escalation Stage 1B|Physician Decision|0
282545|NCT00996892|932929|P1|Dose-Escalation Stage 1B|Physician Decision|0
282546|NCT00996892|932910|P20|Dose-Escalation Stage 1A|Disease Progression|0
282547|NCT00996892|932911|P19|Dose-Escalation Stage 1A|Disease Progression|0
282548|NCT00996892|932912|P18|Dose-Escalation Stage 1A|Disease Progression|0
282549|NCT00996892|932913|P17|Dose-Escalation Stage 1A|Disease Progression|0
282550|NCT00996892|932914|P16|Dose-Escalation Stage 1A|Disease Progression|0
282551|NCT00996892|932915|P15|Dose-Escalation Stage 1A|Disease Progression|0
282552|NCT00996892|932916|P14|Dose-Escalation Stage 1A|Disease Progression|4
282553|NCT00996892|932917|P13|Dose-Escalation Stage 1A|Disease Progression|6
282554|NCT00996892|932918|P12|Dose-Escalation Stage 1A|Disease Progression|7
282555|NCT00996892|932919|P11|Dose-Escalation Stage 1A|Disease Progression|5
282556|NCT00996892|932920|P10|Dose-Escalation Stage 1A|Disease Progression|1
282557|NCT00996892|932921|P9|Dose-Escalation Stage 1A|Disease Progression|3
282558|NCT00996892|932922|P8|Dose-Escalation Stage 1A|Disease Progression|2
282559|NCT00996892|932923|P7|Dose-Escalation Stage 1A|Disease Progression|0
282560|NCT00996892|932924|P6|Dose-Escalation Stage 1A|Disease Progression|0
282561|NCT00996892|932925|P5|Dose-Escalation Stage 1A|Disease Progression|0
282562|NCT00996892|932926|P4|Dose-Escalation Stage 1A|Disease Progression|0
282563|NCT00996892|932927|P3|Dose-Escalation Stage 1A|Disease Progression|0
282564|NCT00996892|932928|P2|Dose-Escalation Stage 1A|Disease Progression|0
282565|NCT00996892|932929|P1|Dose-Escalation Stage 1A|Disease Progression|0
282566|NCT00996892|932910|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282567|NCT00996892|932911|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282568|NCT00996892|932912|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282569|NCT00996892|932913|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282570|NCT00996892|932914|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282571|NCT00996892|932915|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282572|NCT00996892|932916|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282573|NCT00996892|932917|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
282574|NCT00996892|932918|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
282575|NCT00996892|932919|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
282576|NCT00996892|932920|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
282577|NCT00996892|932921|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282578|NCT00996892|932922|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282579|NCT00996892|932923|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282580|NCT00996892|932924|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282581|NCT00996892|932925|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282582|NCT00996892|932926|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282583|NCT00996892|932927|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282584|NCT00996892|932928|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282585|NCT00996892|932929|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
282586|NCT00996892|932910|P20|Dose-Escalation Stage 1A|Physician Decision|0
282587|NCT00996892|932911|P19|Dose-Escalation Stage 1A|Physician Decision|0
282588|NCT00996892|932912|P18|Dose-Escalation Stage 1A|Physician Decision|0
282589|NCT00996892|932913|P17|Dose-Escalation Stage 1A|Physician Decision|0
282590|NCT00996892|932914|P16|Dose-Escalation Stage 1A|Physician Decision|0
282591|NCT00996892|932915|P15|Dose-Escalation Stage 1A|Physician Decision|0
282592|NCT00996892|932916|P14|Dose-Escalation Stage 1A|Physician Decision|0
282593|NCT00996892|932917|P13|Dose-Escalation Stage 1A|Physician Decision|0
282594|NCT00996892|932918|P12|Dose-Escalation Stage 1A|Physician Decision|0
282595|NCT00996892|932919|P11|Dose-Escalation Stage 1A|Physician Decision|0
282596|NCT00996892|932920|P10|Dose-Escalation Stage 1A|Physician Decision|0
282597|NCT00996892|932921|P9|Dose-Escalation Stage 1A|Physician Decision|0
282598|NCT00996892|932922|P8|Dose-Escalation Stage 1A|Physician Decision|1
282599|NCT00996892|932923|P7|Dose-Escalation Stage 1A|Physician Decision|0
282600|NCT00996892|932924|P6|Dose-Escalation Stage 1A|Physician Decision|0
282601|NCT00996892|932925|P5|Dose-Escalation Stage 1A|Physician Decision|0
282602|NCT00996892|932926|P4|Dose-Escalation Stage 1A|Physician Decision|0
282603|NCT00996892|932927|P3|Dose-Escalation Stage 1A|Physician Decision|0
282604|NCT00996892|932928|P2|Dose-Escalation Stage 1A|Physician Decision|0
282605|NCT00996892|932929|P1|Dose-Escalation Stage 1A|Physician Decision|0
282606|NCT00996892|932910|P20|Dose-Escalation Stage 1A|Death|0
282607|NCT00996892|932911|P19|Dose-Escalation Stage 1A|Death|0
282608|NCT00996892|932912|P18|Dose-Escalation Stage 1A|Death|0
282609|NCT00996892|932913|P17|Dose-Escalation Stage 1A|Death|0
282610|NCT00996892|932914|P16|Dose-Escalation Stage 1A|Death|0
282611|NCT00996892|932915|P15|Dose-Escalation Stage 1A|Death|0
282612|NCT00996892|932916|P14|Dose-Escalation Stage 1A|Death|0
282613|NCT00996892|932917|P13|Dose-Escalation Stage 1A|Death|1
282614|NCT00996892|932918|P12|Dose-Escalation Stage 1A|Death|1
282615|NCT00996892|932919|P11|Dose-Escalation Stage 1A|Death|0
282616|NCT00996892|932920|P10|Dose-Escalation Stage 1A|Death|2
282617|NCT00996892|932921|P9|Dose-Escalation Stage 1A|Death|0
282618|NCT00996892|932922|P8|Dose-Escalation Stage 1A|Death|0
282619|NCT00996892|932923|P7|Dose-Escalation Stage 1A|Death|0
282620|NCT00996892|932924|P6|Dose-Escalation Stage 1A|Death|0
282621|NCT00996892|932925|P5|Dose-Escalation Stage 1A|Death|0
282622|NCT00996892|932926|P4|Dose-Escalation Stage 1A|Death|0
282623|NCT00996892|932927|P3|Dose-Escalation Stage 1A|Death|0
282624|NCT00996892|932928|P2|Dose-Escalation Stage 1A|Death|0
282625|NCT00996892|932929|P1|Dose-Escalation Stage 1A|Death|0
282626|NCT00996892|932910|P20|Dose-Escalation Stage 1A|Adverse Event|0
282627|NCT00996892|932911|P19|Dose-Escalation Stage 1A|Adverse Event|0
282628|NCT00996892|932912|P18|Dose-Escalation Stage 1A|Adverse Event|0
282629|NCT00996892|932913|P17|Dose-Escalation Stage 1A|Adverse Event|0
282630|NCT00996892|932914|P16|Dose-Escalation Stage 1A|Adverse Event|0
282631|NCT00996892|932915|P15|Dose-Escalation Stage 1A|Adverse Event|0
282632|NCT00996892|932916|P14|Dose-Escalation Stage 1A|Adverse Event|1
282633|NCT00996892|932917|P13|Dose-Escalation Stage 1A|Adverse Event|0
282634|NCT00996892|932918|P12|Dose-Escalation Stage 1A|Adverse Event|0
282635|NCT00996892|932919|P11|Dose-Escalation Stage 1A|Adverse Event|1
282636|NCT00996892|932920|P10|Dose-Escalation Stage 1A|Adverse Event|0
282637|NCT00996892|932921|P9|Dose-Escalation Stage 1A|Adverse Event|0
282638|NCT00996892|932922|P8|Dose-Escalation Stage 1A|Adverse Event|0
282639|NCT00996892|932923|P7|Dose-Escalation Stage 1A|Adverse Event|0
282640|NCT00996892|932924|P6|Dose-Escalation Stage 1A|Adverse Event|0
282641|NCT00996892|932925|P5|Dose-Escalation Stage 1A|Adverse Event|0
282642|NCT00996892|932926|P4|Dose-Escalation Stage 1A|Adverse Event|0
282643|NCT00996892|932927|P3|Dose-Escalation Stage 1A|Adverse Event|0
282644|NCT00996892|932928|P2|Dose-Escalation Stage 1A|Adverse Event|0
282645|NCT00996892|932929|P1|Dose-Escalation Stage 1A|Adverse Event|0
282646|NCT00996892|932910|P20|Dose-Escalation Stage 1|Disease Progression|0
282647|NCT00996892|932911|P19|Dose-Escalation Stage 1|Disease Progression|0
282648|NCT00996892|932912|P18|Dose-Escalation Stage 1|Disease Progression|0
282649|NCT00996892|932913|P17|Dose-Escalation Stage 1|Disease Progression|0
282650|NCT00996892|932914|P16|Dose-Escalation Stage 1|Disease Progression|0
282651|NCT00996892|932915|P15|Dose-Escalation Stage 1|Disease Progression|0
282652|NCT00996892|932916|P14|Dose-Escalation Stage 1|Disease Progression|0
282653|NCT00996892|932917|P13|Dose-Escalation Stage 1|Disease Progression|0
282654|NCT00996892|932918|P12|Dose-Escalation Stage 1|Disease Progression|0
282655|NCT00996892|932919|P11|Dose-Escalation Stage 1|Disease Progression|0
282656|NCT00996892|932920|P10|Dose-Escalation Stage 1|Disease Progression|0
282657|NCT00996892|932921|P9|Dose-Escalation Stage 1|Disease Progression|0
282658|NCT00996892|932922|P8|Dose-Escalation Stage 1|Disease Progression|0
282659|NCT00996892|932923|P7|Dose-Escalation Stage 1|Disease Progression|0
282660|NCT00996892|932924|P6|Dose-Escalation Stage 1|Disease Progression|7
282661|NCT00996892|932925|P5|Dose-Escalation Stage 1|Disease Progression|10
282662|NCT00996892|932926|P4|Dose-Escalation Stage 1|Disease Progression|4
282663|NCT00996892|932927|P3|Dose-Escalation Stage 1|Disease Progression|3
282664|NCT00996892|932928|P2|Dose-Escalation Stage 1|Disease Progression|2
282665|NCT00996892|932929|P1|Dose-Escalation Stage 1|Disease Progression|2
282666|NCT00996892|932910|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
282667|NCT00996892|932911|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
282668|NCT00996892|932912|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
282669|NCT00996892|932913|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
282670|NCT00996892|932914|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
282671|NCT00996892|932915|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
282672|NCT00996892|932916|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
282673|NCT00996892|932917|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
282674|NCT00996892|932918|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
282675|NCT00996892|932919|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
282676|NCT00996892|932920|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
282677|NCT00996892|932921|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
282678|NCT00996892|932922|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
282679|NCT00996892|932923|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
282680|NCT00996892|932924|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
282681|NCT00996892|932925|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
282682|NCT00996892|932926|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
282683|NCT00996892|932927|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
282684|NCT00996892|932928|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
282685|NCT00996892|932929|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
282686|NCT00996892|932910|P20|Dose-Escalation Stage 1|Physician Decision|0
282687|NCT00996892|932911|P19|Dose-Escalation Stage 1|Physician Decision|0
282688|NCT00996892|932912|P18|Dose-Escalation Stage 1|Physician Decision|0
282689|NCT00996892|932913|P17|Dose-Escalation Stage 1|Physician Decision|0
282690|NCT00996892|932914|P16|Dose-Escalation Stage 1|Physician Decision|0
282691|NCT00996892|932915|P15|Dose-Escalation Stage 1|Physician Decision|0
282692|NCT00996892|932916|P14|Dose-Escalation Stage 1|Physician Decision|0
282693|NCT00996892|932917|P13|Dose-Escalation Stage 1|Physician Decision|0
282694|NCT00996892|932918|P12|Dose-Escalation Stage 1|Physician Decision|0
282695|NCT00996892|932919|P11|Dose-Escalation Stage 1|Physician Decision|0
282696|NCT00996892|932920|P10|Dose-Escalation Stage 1|Physician Decision|0
282697|NCT00996892|932921|P9|Dose-Escalation Stage 1|Physician Decision|0
282698|NCT00996892|932922|P8|Dose-Escalation Stage 1|Physician Decision|0
282699|NCT00996892|932923|P7|Dose-Escalation Stage 1|Physician Decision|2
282700|NCT00996892|932924|P6|Dose-Escalation Stage 1|Physician Decision|1
282701|NCT00996892|932925|P5|Dose-Escalation Stage 1|Physician Decision|0
282702|NCT00996892|932926|P4|Dose-Escalation Stage 1|Physician Decision|1
282703|NCT00996892|932927|P3|Dose-Escalation Stage 1|Physician Decision|0
282704|NCT00996892|932928|P2|Dose-Escalation Stage 1|Physician Decision|0
282705|NCT00996892|932929|P1|Dose-Escalation Stage 1|Physician Decision|1
282706|NCT00996892|932910|P20|Dose-Escalation Stage 1|Death|0
282707|NCT00996892|932911|P19|Dose-Escalation Stage 1|Death|0
282708|NCT00996892|932912|P18|Dose-Escalation Stage 1|Death|0
282709|NCT00996892|932913|P17|Dose-Escalation Stage 1|Death|0
282710|NCT00996892|932914|P16|Dose-Escalation Stage 1|Death|0
282711|NCT00996892|932915|P15|Dose-Escalation Stage 1|Death|0
282712|NCT00996892|932916|P14|Dose-Escalation Stage 1|Death|0
282713|NCT00996892|932917|P13|Dose-Escalation Stage 1|Death|0
282714|NCT00996892|932918|P12|Dose-Escalation Stage 1|Death|0
282715|NCT00996892|932919|P11|Dose-Escalation Stage 1|Death|0
282716|NCT00996892|932920|P10|Dose-Escalation Stage 1|Death|0
282717|NCT00996892|932921|P9|Dose-Escalation Stage 1|Death|0
282718|NCT00996892|932922|P8|Dose-Escalation Stage 1|Death|0
282719|NCT00996892|932923|P7|Dose-Escalation Stage 1|Death|0
282720|NCT00996892|932924|P6|Dose-Escalation Stage 1|Death|1
282721|NCT00996892|932925|P5|Dose-Escalation Stage 1|Death|0
282722|NCT00996892|932926|P4|Dose-Escalation Stage 1|Death|0
282723|NCT00996892|932927|P3|Dose-Escalation Stage 1|Death|0
282724|NCT00996892|932928|P2|Dose-Escalation Stage 1|Death|0
282725|NCT00996892|932929|P1|Dose-Escalation Stage 1|Death|1
282726|NCT00996892|932910|P20|Dose-Escalation Stage 1|Adverse Event|0
282727|NCT00996892|932911|P19|Dose-Escalation Stage 1|Adverse Event|0
282728|NCT00996892|932912|P18|Dose-Escalation Stage 1|Adverse Event|0
282729|NCT00996892|932913|P17|Dose-Escalation Stage 1|Adverse Event|0
282730|NCT00996892|932914|P16|Dose-Escalation Stage 1|Adverse Event|0
282731|NCT00996892|932915|P15|Dose-Escalation Stage 1|Adverse Event|0
282732|NCT00996892|932916|P14|Dose-Escalation Stage 1|Adverse Event|0
282733|NCT00996892|932917|P13|Dose-Escalation Stage 1|Adverse Event|0
282734|NCT00996892|932918|P12|Dose-Escalation Stage 1|Adverse Event|0
282735|NCT00996892|932919|P11|Dose-Escalation Stage 1|Adverse Event|0
282736|NCT00996892|932920|P10|Dose-Escalation Stage 1|Adverse Event|0
282737|NCT00996892|932921|P9|Dose-Escalation Stage 1|Adverse Event|0
282738|NCT00996892|932922|P8|Dose-Escalation Stage 1|Adverse Event|0
282739|NCT00996892|932923|P7|Dose-Escalation Stage 1|Adverse Event|1
282740|NCT00996892|932924|P6|Dose-Escalation Stage 1|Adverse Event|0
282741|NCT00996892|932925|P5|Dose-Escalation Stage 1|Adverse Event|0
282742|NCT00996892|932926|P4|Dose-Escalation Stage 1|Adverse Event|2
282743|NCT00996892|932927|P3|Dose-Escalation Stage 1|Adverse Event|0
282744|NCT00996892|932928|P2|Dose-Escalation Stage 1|Adverse Event|0
282745|NCT00996892|932929|P1|Dose-Escalation Stage 1|Adverse Event|0
282746|NCT00996801|933524|P6|Overall Study|Withdrawal by Subject|9
282747|NCT00996801|933525|P5|Overall Study|Withdrawal by Subject|5
282748|NCT00996801|933526|P4|Overall Study|Withdrawal by Subject|5
282749|NCT00996801|933527|P3|Overall Study|Withdrawal by Subject|9
282750|NCT00996801|933528|P2|Overall Study|Withdrawal by Subject|6
282751|NCT00996801|933529|P1|Overall Study|Withdrawal by Subject|8
282752|NCT00996801|933524|P6|Overall Study|Study Terminated by Sponsor|0
282753|NCT00996801|933525|P5|Overall Study|Study Terminated by Sponsor|46
282754|NCT00996801|933526|P4|Overall Study|Study Terminated by Sponsor|0
282755|NCT00996801|933527|P3|Overall Study|Study Terminated by Sponsor|0
282756|NCT00996801|933528|P2|Overall Study|Study Terminated by Sponsor|1
282757|NCT00996801|933529|P1|Overall Study|Study Terminated by Sponsor|0
282758|NCT00996801|933524|P6|Overall Study|Protocol Violation|4
282759|NCT00996801|933525|P5|Overall Study|Protocol Violation|3
282760|NCT00996801|933526|P4|Overall Study|Protocol Violation|2
282761|NCT00996801|933527|P3|Overall Study|Protocol Violation|1
282762|NCT00996801|933528|P2|Overall Study|Protocol Violation|4
282763|NCT00996801|933529|P1|Overall Study|Protocol Violation|3
282764|NCT00996801|933524|P6|Overall Study|Progressive Disease|0
282765|NCT00996801|933525|P5|Overall Study|Progressive Disease|0
282766|NCT00996801|933526|P4|Overall Study|Progressive Disease|0
282767|NCT00996801|933527|P3|Overall Study|Progressive Disease|0
282768|NCT00996801|933528|P2|Overall Study|Progressive Disease|1
282769|NCT00996801|933529|P1|Overall Study|Progressive Disease|0
282770|NCT00996801|933524|P6|Overall Study|Physician Decision|0
282771|NCT00996801|933525|P5|Overall Study|Physician Decision|0
282772|NCT00996801|933526|P4|Overall Study|Physician Decision|1
282773|NCT00996801|933527|P3|Overall Study|Physician Decision|0
282774|NCT00996801|933528|P2|Overall Study|Physician Decision|0
282775|NCT00996801|933529|P1|Overall Study|Physician Decision|0
282776|NCT00996801|933524|P6|Overall Study|Lost to Follow-up|2
282777|NCT00996801|933525|P5|Overall Study|Lost to Follow-up|3
282778|NCT00996801|933526|P4|Overall Study|Lost to Follow-up|3
282779|NCT00996801|933527|P3|Overall Study|Lost to Follow-up|0
282780|NCT00996801|933528|P2|Overall Study|Lost to Follow-up|0
282781|NCT00996801|933529|P1|Overall Study|Lost to Follow-up|0
282782|NCT00996801|933524|P6|Overall Study|Lack of Efficacy|1
282783|NCT00996801|933525|P5|Overall Study|Lack of Efficacy|0
282784|NCT00996801|933526|P4|Overall Study|Lack of Efficacy|3
282785|NCT00996801|933527|P3|Overall Study|Lack of Efficacy|1
282786|NCT00996801|933528|P2|Overall Study|Lack of Efficacy|0
282787|NCT00996801|933529|P1|Overall Study|Lack of Efficacy|3
282788|NCT00996801|933524|P6|Overall Study|Adverse Event|3
282789|NCT00996801|933525|P5|Overall Study|Adverse Event|31
282790|NCT00996801|933526|P4|Overall Study|Adverse Event|17
282791|NCT00996801|933527|P3|Overall Study|Adverse Event|12
282792|NCT00996801|933528|P2|Overall Study|Adverse Event|4
282793|NCT00996801|933529|P1|Overall Study|Adverse Event|6
282794|NCT00996736|933641|P2|Overall Study|Visit not within 3-month window|3
282795|NCT00996736|933642|P1|Overall Study|Visit not within 3-month window|5
282796|NCT00996736|933641|P2|Overall Study|Lost to Follow-up|14
282797|NCT00996736|933642|P1|Overall Study|Lost to Follow-up|15
282798|NCT00996736|933641|P2|Overall Study|Death|1
282799|NCT00996736|933642|P1|Overall Study|Death|1
282800|NCT00996658|933662|P2|Overall Study|Other|7
282801|NCT00996658|933663|P1|Overall Study|Other|9
282802|NCT00996658|933662|P2|Overall Study|Non-compliance issues|3
282803|NCT00996658|933663|P1|Overall Study|Non-compliance issues|3
282804|NCT00996658|933662|P2|Overall Study|Lost to Follow-up|5
282805|NCT00996658|933663|P1|Overall Study|Lost to Follow-up|2
282806|NCT00996658|933662|P2|Overall Study|Protocol Violation|1
282807|NCT00996658|933663|P1|Overall Study|Protocol Violation|0
282808|NCT00996658|933662|P2|Overall Study|Adverse Event|5
282809|NCT00996658|933663|P1|Overall Study|Adverse Event|2
282810|NCT00996632|933691|P2|Overall Study|Physician Decision|0
282811|NCT00996632|933692|P1|Overall Study|Physician Decision|0
282812|NCT00996606|933700|P1|Overall Study|Withdrawal by Subject|3
282813|NCT00996606|933700|P1|Overall Study|Protocol Violation|1
282814|NCT00996606|933700|P1|Overall Study|Insufficient Therapeutic Response|2
282815|NCT00996606|933700|P1|Overall Study|Adverse Event or Intercurrent Illness|2
282816|NCT00996593|933794|P1|Long-Term Follow-Up|Site Closed|1
282817|NCT00996593|933794|P1|Long-Term Follow-Up|Withdrawal by Subject|2
282818|NCT00996593|933794|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
282819|NCT00996593|933794|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
282820|NCT00996593|933794|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
282821|NCT00996593|933794|P1|Dosimetric and Therapeutic Treatment|Death|1
282822|NCT00996593|933794|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
282823|NCT00996593|933794|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
282824|NCT00996593|933794|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
282825|NCT00996580|933822|P1|Overall Study|Not specified|29
282826|NCT00996580|933822|P1|Overall Study|Withdrawal by Subject|217
282827|NCT00996580|933822|P1|Overall Study|Sponsor requested participant withdrawal|35
282828|NCT00996580|933822|P1|Overall Study|Protocol Violation|16
282829|NCT00996580|933822|P1|Overall Study|Pregnancy|68
282830|NCT00996580|933822|P1|Overall Study|Physician Decision|5
282831|NCT00996580|933822|P1|Overall Study|Noncompliance with the protocol|137
282832|NCT00996580|933822|P1|Overall Study|Lost to Follow-up|480
282833|NCT00996580|933822|P1|Overall Study|Adverse Event|466
282834|NCT00996476|933859|P5|Overall Study|Adverse Event|1
282835|NCT00996476|933860|P4|Overall Study|Adverse Event|0
282836|NCT00996476|933861|P3|Overall Study|Adverse Event|0
282837|NCT00996476|933862|P2|Overall Study|Adverse Event|1
282838|NCT00996476|933863|P1|Overall Study|Adverse Event|0
282839|NCT00996476|933859|P5|Overall Study|Withdrawal by Subject|1
282840|NCT00996476|933860|P4|Overall Study|Withdrawal by Subject|0
282841|NCT00996476|933861|P3|Overall Study|Withdrawal by Subject|1
282842|NCT00996476|933862|P2|Overall Study|Withdrawal by Subject|2
282843|NCT00996476|933863|P1|Overall Study|Withdrawal by Subject|1
282844|NCT00996437|933931|P2|Overall Study|Missed|5
282845|NCT00996437|933932|P1|Overall Study|Missed|2
282846|NCT00996437|933931|P2|Overall Study|Dropped|2
282847|NCT00996437|933932|P1|Overall Study|Dropped|2
282848|NCT00996437|933931|P2|Overall Study|Death|0
282849|NCT00996437|933932|P1|Overall Study|Death|1
282850|NCT00996333|933977|P1|Overall Study|Other|5
282851|NCT00996333|933977|P1|Overall Study|Physician Decision|1
282852|NCT00996333|933977|P1|Overall Study|Adverse Event|1
282853|NCT00996333|933977|P1|Overall Study|Death|4
282854|NCT00996333|933977|P1|Overall Study|Withdrawal by Subject|1
282855|NCT00996333|933977|P1|Overall Study|Screen failure|1
282856|NCT00996307|933987|P4|Overall Study|Unable to classify|1
282857|NCT00996307|933988|P3|Overall Study|Unable to classify|2
282858|NCT00996307|933989|P2|Overall Study|Unable to classify|0
282859|NCT00996307|933990|P1|Overall Study|Unable to classify|4
282860|NCT00996307|933987|P4|Overall Study|Administrative reason|0
282861|NCT00996307|933988|P3|Overall Study|Administrative reason|0
282862|NCT00996307|933989|P2|Overall Study|Administrative reason|1
282863|NCT00996307|933990|P1|Overall Study|Administrative reason|0
282864|NCT00996307|933987|P4|Overall Study|Lost to Follow-up|15
282865|NCT00996307|933988|P3|Overall Study|Lost to Follow-up|7
282866|NCT00996307|933989|P2|Overall Study|Lost to Follow-up|13
282867|NCT00996307|933990|P1|Overall Study|Lost to Follow-up|13
282868|NCT00996307|933987|P4|Overall Study|Withdrawal by Subject|5
282869|NCT00996307|933988|P3|Overall Study|Withdrawal by Subject|5
282870|NCT00996307|933989|P2|Overall Study|Withdrawal by Subject|2
282871|NCT00996307|933990|P1|Overall Study|Withdrawal by Subject|3
282872|NCT00996307|933987|P4|Overall Study|Adverse Event|0
282873|NCT00996307|933988|P3|Overall Study|Adverse Event|0
282874|NCT00996307|933989|P2|Overall Study|Adverse Event|1
282875|NCT00996307|933990|P1|Overall Study|Adverse Event|0
282876|NCT00996281|934050|P2|Overall Study|Other|7
282877|NCT00996281|934051|P1|Overall Study|Other|5
282878|NCT00996281|934050|P2|Overall Study|Lack of Efficacy|2
282879|NCT00996281|934051|P1|Overall Study|Lack of Efficacy|0
282880|NCT00996281|934050|P2|Overall Study|Withdrawal by Subject|20
282881|NCT00996281|934051|P1|Overall Study|Withdrawal by Subject|31
282882|NCT00996281|934050|P2|Overall Study|Lost to Follow-up|16
282883|NCT00996281|934051|P1|Overall Study|Lost to Follow-up|14
282884|NCT00996281|934050|P2|Overall Study|Major Protocol Deviation|7
282885|NCT00996281|934051|P1|Overall Study|Major Protocol Deviation|6
282886|NCT00996281|934050|P2|Overall Study|Adverse Event|37
282887|NCT00996281|934051|P1|Overall Study|Adverse Event|75
282888|NCT00996216|934059|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
282889|NCT00996216|934059|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
282890|NCT00996216|934059|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
282891|NCT00996203|934075|P1|Overall Study|Protocol Violation|2
282892|NCT00996203|934075|P1|Overall Study|Lack of Efficacy|1
282893|NCT00996203|934075|P1|Overall Study|Lost to Follow-up|1
282894|NCT00996203|934075|P1|Overall Study|Adverse Event|3
282895|NCT00996125|934107|P2|Overall Study|Withdrawal by Subject|3
282896|NCT00996125|934108|P1|Overall Study|Withdrawal by Subject|4
282897|NCT00996125|934107|P2|Overall Study|Lost to Follow-up|6
282898|NCT00996125|934108|P1|Overall Study|Lost to Follow-up|1
282899|NCT00996125|934107|P2|Overall Study|Adverse Event|2
282900|NCT00996125|934108|P1|Overall Study|Adverse Event|0
282901|NCT00996034|934128|P1|Overall Study|withdrawn by PI|1
282902|NCT00996034|934128|P1|Overall Study|Lost to Follow-up|2
282903|NCT00995930|934134|P2|Overall Study|Adverse Event|14
282904|NCT00995930|934135|P1|Overall Study|Adverse Event|11
282905|NCT00995930|934134|P2|Overall Study|Withdrawal by Subject|4
282906|NCT00995930|934135|P1|Overall Study|Withdrawal by Subject|3
282907|NCT00995930|934134|P2|Overall Study|Lost to Follow-up|2
282908|NCT00995930|934135|P1|Overall Study|Lost to Follow-up|1
282909|NCT00995930|934134|P2|Overall Study|Administrative problems|2
282910|NCT00995930|934135|P1|Overall Study|Administrative problems|4
282911|NCT00995930|934134|P2|Overall Study|Death|1
282912|NCT00995930|934135|P1|Overall Study|Death|0
282913|NCT00995930|934134|P2|Overall Study|Protocol deviation|5
282914|NCT00995930|934135|P1|Overall Study|Protocol deviation|2
282915|NCT00995865|934186|P3|Overall Study|Lost to Follow-up|1
282916|NCT00995865|934187|P2|Overall Study|Lost to Follow-up|0
282917|NCT00995865|934188|P1|Overall Study|Lost to Follow-up|0
282918|NCT00995865|934186|P3|Overall Study|Protocol Violation|0
282919|NCT00995865|934187|P2|Overall Study|Protocol Violation|0
282920|NCT00995865|934188|P1|Overall Study|Protocol Violation|2
282921|NCT00995774|934210|P2|Training Period 2|Withdrawal by Subject|0
282922|NCT00995774|934211|P1|Training Period 2|Withdrawal by Subject|2
282923|NCT00995709|934243|P3|Overall Study|Protocol Violation|0
282924|NCT00995709|934244|P2|Overall Study|Protocol Violation|1
282925|NCT00995709|934245|P1|Overall Study|Protocol Violation|2
282926|NCT00995709|934243|P3|Overall Study|Death|0
282927|NCT00995709|934244|P2|Overall Study|Death|1
282928|NCT00995709|934245|P1|Overall Study|Death|0
282929|NCT00995709|934243|P3|Overall Study|Lost to Follow-up|0
282930|NCT00995709|934244|P2|Overall Study|Lost to Follow-up|0
282931|NCT00995709|934245|P1|Overall Study|Lost to Follow-up|1
282932|NCT00995709|934243|P3|Overall Study|Withdrawal by Subject|1
282933|NCT00995709|934244|P2|Overall Study|Withdrawal by Subject|4
282934|NCT00995709|934245|P1|Overall Study|Withdrawal by Subject|0
282935|NCT00995709|934243|P3|Overall Study|Lack of Efficacy|4
282936|NCT00995709|934244|P2|Overall Study|Lack of Efficacy|1
282937|NCT00995709|934245|P1|Overall Study|Lack of Efficacy|0
282938|NCT00995709|934243|P3|Overall Study|Adverse Event|0
282939|NCT00995709|934244|P2|Overall Study|Adverse Event|2
282940|NCT00995709|934245|P1|Overall Study|Adverse Event|4
282941|NCT00995670|934271|P3|Overall Study|Failed arterial cannulation|3
282942|NCT00995670|934272|P2|Overall Study|Failed arterial cannulation|0
282943|NCT00995670|934273|P1|Overall Study|Failed arterial cannulation|1
282944|NCT00995566|934281|P1|Overall Study|Early study termination|52
282945|NCT00995566|934281|P1|Overall Study|Adverse Event|2
282946|NCT00995553|934295|P2|Overall Study|Withdrawal by Subject|6
282947|NCT00995553|934296|P1|Overall Study|Withdrawal by Subject|2
282948|NCT00995488|934345|P1|Overall Study|Withdrawal by Subject|1
282949|NCT00995436|934368|P3|Overall Study|Withdrawal by Subject|0
282950|NCT00995436|934369|P2|Overall Study|Withdrawal by Subject|5
282951|NCT00995436|934370|P1|Overall Study|Withdrawal by Subject|2
282952|NCT00995410|934378|P1|Overall Study|Misc|28
282953|NCT00995410|934378|P1|Overall Study|Lost to Follow-up|2
282954|NCT00995410|934378|P1|Overall Study|Withdrawal by Subject|7
282955|NCT00995410|934378|P1|Overall Study|Adverse Event|51
282956|NCT00995371|934385|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
282957|NCT00995371|934386|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
282958|NCT00995345|934404|P5|Overall Study|all other reasons combined|3
282959|NCT00995345|934405|P4|Overall Study|all other reasons combined|1
282960|NCT00995345|934406|P3|Overall Study|all other reasons combined|2
282961|NCT00995345|934407|P2|Overall Study|all other reasons combined|2
282962|NCT00995345|934408|P1|Overall Study|all other reasons combined|2
282963|NCT00995345|934404|P5|Overall Study|Lost to Follow-up|0
282964|NCT00995345|934405|P4|Overall Study|Lost to Follow-up|1
282965|NCT00995345|934406|P3|Overall Study|Lost to Follow-up|2
282966|NCT00995345|934407|P2|Overall Study|Lost to Follow-up|2
282967|NCT00995345|934408|P1|Overall Study|Lost to Follow-up|2
282968|NCT00995345|934404|P5|Overall Study|Adverse Event|1
282969|NCT00995345|934405|P4|Overall Study|Adverse Event|0
282970|NCT00995345|934406|P3|Overall Study|Adverse Event|2
282971|NCT00995345|934407|P2|Overall Study|Adverse Event|1
282972|NCT00995345|934408|P1|Overall Study|Adverse Event|3
282973|NCT00995345|934404|P5|Overall Study|Withdrawal by Subject|1
282974|NCT00995345|934405|P4|Overall Study|Withdrawal by Subject|3
282975|NCT00995345|934406|P3|Overall Study|Withdrawal by Subject|1
282976|NCT00995345|934407|P2|Overall Study|Withdrawal by Subject|2
282977|NCT00995345|934408|P1|Overall Study|Withdrawal by Subject|4
282978|NCT00995085|934435|P1|Overall Study|Withdrawal by Subject|5
282979|NCT00995020|934441|P2|Overall Study|specimen fragmentation, thermal damage|2
282980|NCT00995020|934442|P1|Overall Study|specimen fragmentation, thermal damage|1
282981|NCT00995020|934441|P2|Overall Study|margin analysis not performed|5
282982|NCT00995020|934442|P1|Overall Study|margin analysis not performed|2
282983|NCT00995007|934452|P2|Overall Study|Toxicity|0
282984|NCT00995007|934453|P1|Overall Study|Toxicity|8
282985|NCT00995007|934452|P2|Overall Study|Refused further treatment|2
282986|NCT00995007|934453|P1|Overall Study|Refused further treatment|8
282987|NCT00995007|934452|P2|Overall Study|Withdrew consent|0
282988|NCT00995007|934453|P1|Overall Study|Withdrew consent|1
282989|NCT00994682|934516|P2|Pioglitazone Open Label|Physician Decision|1
282990|NCT00994682|934517|P1|Pioglitazone Open Label|Physician Decision|6
282991|NCT00994682|934516|P2|Pioglitazone Open Label|Lost to Follow-up|2
282992|NCT00994682|934517|P1|Pioglitazone Open Label|Lost to Follow-up|3
282993|NCT00994682|934516|P2|Pioglitazone Open Label|Withdrawal by Subject|4
282994|NCT00994682|934517|P1|Pioglitazone Open Label|Withdrawal by Subject|4
282995|NCT00994682|934516|P2|Double Bilnd|Adverse Event|0
282996|NCT00994682|934517|P1|Double Bilnd|Adverse Event|1
282997|NCT00994682|934516|P2|Double Bilnd|Lost to Follow-up|3
282998|NCT00994682|934517|P1|Double Bilnd|Lost to Follow-up|3
282999|NCT00994682|934516|P2|Double Bilnd|Withdrawal by Subject|6
283000|NCT00994682|934517|P1|Double Bilnd|Withdrawal by Subject|5
283001|NCT00994461|934571|P3|Overall Study|Adverse Event|0
283002|NCT00994461|934572|P2|Overall Study|Adverse Event|1
283003|NCT00994461|934573|P1|Overall Study|Adverse Event|2
283004|NCT00994448|934601|P2|Overall Study|Physician Decision|0
283005|NCT00994448|934602|P1|Overall Study|Physician Decision|1
283006|NCT00994448|934601|P2|Overall Study|Withdrawal by Subject|1
283007|NCT00994448|934602|P1|Overall Study|Withdrawal by Subject|1
283008|NCT00994448|934601|P2|Overall Study|Lost to Follow-up|1
283009|NCT00994448|934602|P1|Overall Study|Lost to Follow-up|5
283010|NCT00994448|934601|P2|Overall Study|Adverse Event|0
283011|NCT00994448|934602|P1|Overall Study|Adverse Event|1
283012|NCT00994422|934610|P2|Overall Study|Lost to Follow-up|1
283013|NCT00994422|934611|P1|Overall Study|Lost to Follow-up|7
283014|NCT00994279|934636|P2|Overall Study|Multiple reasons|3
283015|NCT00994279|934637|P1|Overall Study|Multiple reasons|1
283016|NCT00994279|934636|P2|Overall Study|Toxicity|0
283017|NCT00994279|934637|P1|Overall Study|Toxicity|1
283018|NCT00994279|934636|P2|Overall Study|Withdrawal by Subject|2
283019|NCT00994279|934637|P1|Overall Study|Withdrawal by Subject|2
283020|NCT00994240|934656|P2|Overall Study|study termination|3
283021|NCT00994240|934657|P1|Overall Study|study termination|2
283022|NCT00994240|934656|P2|Overall Study|Withdrawal by Subject|0
283023|NCT00994240|934657|P1|Overall Study|Withdrawal by Subject|1
283024|NCT00994240|934656|P2|Overall Study|Lost to Follow-up|2
283025|NCT00994240|934657|P1|Overall Study|Lost to Follow-up|3
283026|NCT00994214|934667|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
283027|NCT00994214|934668|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
283028|NCT00994214|934669|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
283029|NCT00994214|934670|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
283030|NCT00994214|934667|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
283031|NCT00994214|934668|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
283032|NCT00994214|934669|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
283033|NCT00994214|934670|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
283034|NCT00994214|934667|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
283035|NCT00994214|934668|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
283036|NCT00994214|934669|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
283037|NCT00994214|934670|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
283038|NCT00994214|934667|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
283039|NCT00994214|934668|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
283040|NCT00994214|934669|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
283041|NCT00994214|934670|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
283042|NCT00994214|934667|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
283043|NCT00994214|934668|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
283044|NCT00994214|934669|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
283045|NCT00994214|934670|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
283046|NCT00994214|934667|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
283047|NCT00994214|934668|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
283048|NCT00994214|934669|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
283049|NCT00994214|934670|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
283050|NCT00994110|934740|P2|Overall Study|Pt not eligible|5
283051|NCT00994110|934741|P1|Overall Study|Pt not eligible|10
283052|NCT00994110|934740|P2|Overall Study|Patient not resected|52
283053|NCT00994110|934741|P1|Overall Study|Patient not resected|41
283054|NCT00994110|934740|P2|Overall Study|Adverse Event|0
283055|NCT00994110|934741|P1|Overall Study|Adverse Event|1
283056|NCT00994110|934740|P2|Overall Study|Not Treated|8
283057|NCT00994110|934741|P1|Overall Study|Not Treated|4
283058|NCT00994110|934740|P2|Overall Study|Withdrawal by Subject|9
283059|NCT00994110|934741|P1|Overall Study|Withdrawal by Subject|9
283060|NCT00993954|934749|P2|Overall Study|Protocol Violation|2
283061|NCT00993954|934750|P1|Overall Study|Protocol Violation|21
283062|NCT00993928|934763|P2|Overall Study|ineligible|0
283063|NCT00993928|934764|P1|Overall Study|ineligible|1
283064|NCT00993928|934763|P2|Overall Study|Withdrawal by Subject|7
283065|NCT00993928|934764|P1|Overall Study|Withdrawal by Subject|4
283066|NCT00993915|934778|P1|Overall Study|Ongoing|3
283067|NCT00993915|934778|P1|Overall Study|Not specified|1
283068|NCT00993915|934778|P1|Overall Study|Withdrawal by Subject|2
283069|NCT00993915|934778|P1|Overall Study|Insufficient clinical response|3
283070|NCT00993668|934804|P2|Open-Label Period|Lost to Follow-up|1
283071|NCT00993668|934805|P1|Open-Label Period|Lost to Follow-up|6
283072|NCT00993668|934804|P2|Open-Label Period|Withdrawal by Subject|3
283073|NCT00993668|934805|P1|Open-Label Period|Withdrawal by Subject|4
283074|NCT00993668|934804|P2|Open-Label Period|Lack of Efficacy|3
283075|NCT00993668|934805|P1|Open-Label Period|Lack of Efficacy|4
283076|NCT00993668|934804|P2|Open-Label Period|Adverse Event|8
283077|NCT00993668|934805|P1|Open-Label Period|Adverse Event|9
283078|NCT00993668|934804|P2|Single-Blind Period|Lost to Follow-up|1
283079|NCT00993668|934805|P1|Single-Blind Period|Lost to Follow-up|3
283080|NCT00993668|934804|P2|Single-Blind Period|Lack of Efficacy|1
283081|NCT00993668|934805|P1|Single-Blind Period|Lack of Efficacy|0
283082|NCT00993668|934804|P2|Single-Blind Period|Adverse Event|1
283083|NCT00993668|934805|P1|Single-Blind Period|Adverse Event|1
283084|NCT00993616|934830|P1|Overall Study|Never treated|1
283085|NCT00993616|934830|P1|Overall Study|No tumor at entry|1
283086|NCT00993499|934840|P6|Discontinued After Starting Course 3|Other adverse event|0
283087|NCT00993499|934841|P5|Discontinued After Starting Course 3|Other adverse event|0
283088|NCT00993499|934842|P4|Discontinued After Starting Course 3|Other adverse event|0
283089|NCT00993499|934843|P3|Discontinued After Starting Course 3|Other adverse event|1
283090|NCT00993499|934844|P2|Discontinued After Starting Course 3|Other adverse event|0
283091|NCT00993499|934845|P1|Discontinued After Starting Course 3|Other adverse event|1
283092|NCT00993499|934840|P6|Discontinued After Starting Course 3|DLT|0
283093|NCT00993499|934841|P5|Discontinued After Starting Course 3|DLT|0
283094|NCT00993499|934842|P4|Discontinued After Starting Course 3|DLT|1
283095|NCT00993499|934843|P3|Discontinued After Starting Course 3|DLT|2
283096|NCT00993499|934844|P2|Discontinued After Starting Course 3|DLT|0
283097|NCT00993499|934845|P1|Discontinued After Starting Course 3|DLT|1
283098|NCT00993499|934840|P6|Discontinued After Starting Course 3|Progressive Disease|3
283099|NCT00993499|934841|P5|Discontinued After Starting Course 3|Progressive Disease|3
283100|NCT00993499|934842|P4|Discontinued After Starting Course 3|Progressive Disease|1
283101|NCT00993499|934843|P3|Discontinued After Starting Course 3|Progressive Disease|3
283102|NCT00993499|934844|P2|Discontinued After Starting Course 3|Progressive Disease|4
283103|NCT00993499|934845|P1|Discontinued After Starting Course 3|Progressive Disease|6
283104|NCT00993499|934840|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
283105|NCT00993499|934841|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
283106|NCT00993499|934842|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
283107|NCT00993499|934843|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
283108|NCT00993499|934844|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
283109|NCT00993499|934845|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
283110|NCT00993499|934840|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
283111|NCT00993499|934841|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
283112|NCT00993499|934842|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
283113|NCT00993499|934843|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
283114|NCT00993499|934844|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
283115|NCT00993499|934845|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
283116|NCT00993499|934840|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
283117|NCT00993499|934841|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
283118|NCT00993499|934842|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
283119|NCT00993499|934843|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
283120|NCT00993499|934844|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
283121|NCT00993499|934845|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
283122|NCT00993499|934840|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
283123|NCT00993499|934841|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
283124|NCT00993499|934842|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
283125|NCT00993499|934843|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
283126|NCT00993499|934844|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
283127|NCT00993499|934845|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
283128|NCT00993499|934840|P6|Discontinued Before Starting Course 3|Progressive Disease|0
283129|NCT00993499|934841|P5|Discontinued Before Starting Course 3|Progressive Disease|0
283130|NCT00993499|934842|P4|Discontinued Before Starting Course 3|Progressive Disease|0
283131|NCT00993499|934843|P3|Discontinued Before Starting Course 3|Progressive Disease|0
283132|NCT00993499|934844|P2|Discontinued Before Starting Course 3|Progressive Disease|2
283133|NCT00993499|934845|P1|Discontinued Before Starting Course 3|Progressive Disease|2
283134|NCT00993499|934840|P6|Run-in Period (8 Days)|Progressive disease|0
283135|NCT00993499|934841|P5|Run-in Period (8 Days)|Progressive disease|0
283136|NCT00993499|934842|P4|Run-in Period (8 Days)|Progressive disease|0
283137|NCT00993499|934843|P3|Run-in Period (8 Days)|Progressive disease|1
283138|NCT00993499|934844|P2|Run-in Period (8 Days)|Progressive disease|1
283139|NCT00993499|934845|P1|Run-in Period (8 Days)|Progressive disease|0
283140|NCT00993499|934840|P6|Run-in Period (8 Days)|Consent withdrawn|0
283141|NCT00993499|934841|P5|Run-in Period (8 Days)|Consent withdrawn|0
283142|NCT00993499|934842|P4|Run-in Period (8 Days)|Consent withdrawn|0
283143|NCT00993499|934843|P3|Run-in Period (8 Days)|Consent withdrawn|0
283144|NCT00993499|934844|P2|Run-in Period (8 Days)|Consent withdrawn|1
283145|NCT00993499|934845|P1|Run-in Period (8 Days)|Consent withdrawn|0
283146|NCT00993499|934840|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
283147|NCT00993499|934841|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
283148|NCT00993499|934842|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
283149|NCT00993499|934843|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
283150|NCT00993499|934844|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
283151|NCT00993499|934845|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
283152|NCT00993499|934840|P6|Run-in Period (8 Days)|Adverse Event|0
283153|NCT00993499|934841|P5|Run-in Period (8 Days)|Adverse Event|0
283154|NCT00993499|934842|P4|Run-in Period (8 Days)|Adverse Event|0
283155|NCT00993499|934843|P3|Run-in Period (8 Days)|Adverse Event|0
283156|NCT00993499|934844|P2|Run-in Period (8 Days)|Adverse Event|1
283157|NCT00993499|934845|P1|Run-in Period (8 Days)|Adverse Event|0
283158|NCT00993473|934927|P2|Overall Study|Family event|0
283159|NCT00993473|934928|P1|Overall Study|Family event|1
283160|NCT00993473|934927|P2|Overall Study|Technical problem with CGM device|1
283161|NCT00993473|934928|P1|Overall Study|Technical problem with CGM device|0
283162|NCT00993473|934927|P2|Overall Study|Withdrawal by Subject|5
283163|NCT00993473|934928|P1|Overall Study|Withdrawal by Subject|1
283164|NCT00993473|934927|P2|Overall Study|Lost to Follow-up|0
283165|NCT00993473|934928|P1|Overall Study|Lost to Follow-up|1
283166|NCT00993473|934927|P2|Overall Study|Protocol Violation|2
283167|NCT00993473|934928|P1|Overall Study|Protocol Violation|1
283168|NCT00993473|934927|P2|Overall Study|Adverse Event|2
283169|NCT00993473|934928|P1|Overall Study|Adverse Event|0
283170|NCT00993447|934966|P2|Overall Study|Adverse Event|0
283171|NCT00993447|934967|P1|Overall Study|Adverse Event|1
283172|NCT00993447|934966|P2|Overall Study|Lost to Follow-up|3
283173|NCT00993447|934967|P1|Overall Study|Lost to Follow-up|1
283174|NCT00993447|934966|P2|Overall Study|Protocol Violation|8
283175|NCT00993447|934967|P1|Overall Study|Protocol Violation|12
283176|NCT00993447|934966|P2|Overall Study|Withdrawal by Subject|8
283177|NCT00993447|934967|P1|Overall Study|Withdrawal by Subject|23
283178|NCT00993421|935004|P7|Overall Study|Protocol Violation|1
283179|NCT00993421|935005|P6|Overall Study|Protocol Violation|2
283180|NCT00993421|935006|P5|Overall Study|Protocol Violation|0
283181|NCT00993421|935007|P4|Overall Study|Protocol Violation|0
283182|NCT00993421|935008|P3|Overall Study|Protocol Violation|0
283183|NCT00993421|935009|P2|Overall Study|Protocol Violation|0
283184|NCT00993421|935010|P1|Overall Study|Protocol Violation|0
283185|NCT00993421|935004|P7|Overall Study|Physician Decision|1
283186|NCT00993421|935005|P6|Overall Study|Physician Decision|1
283187|NCT00993421|935006|P5|Overall Study|Physician Decision|0
283188|NCT00993421|935007|P4|Overall Study|Physician Decision|0
283189|NCT00993421|935008|P3|Overall Study|Physician Decision|0
283190|NCT00993421|935009|P2|Overall Study|Physician Decision|0
283191|NCT00993421|935010|P1|Overall Study|Physician Decision|0
283192|NCT00993421|935004|P7|Overall Study|Entry Criteria Exclusion|0
283193|NCT00993421|935005|P6|Overall Study|Entry Criteria Exclusion|1
283194|NCT00993421|935006|P5|Overall Study|Entry Criteria Exclusion|0
283195|NCT00993421|935007|P4|Overall Study|Entry Criteria Exclusion|3
283196|NCT00993421|935008|P3|Overall Study|Entry Criteria Exclusion|1
283197|NCT00993421|935009|P2|Overall Study|Entry Criteria Exclusion|0
283198|NCT00993421|935010|P1|Overall Study|Entry Criteria Exclusion|0
283199|NCT00993421|935004|P7|Overall Study|Death|1
283200|NCT00993421|935005|P6|Overall Study|Death|0
283201|NCT00993421|935006|P5|Overall Study|Death|0
283202|NCT00993421|935007|P4|Overall Study|Death|0
283203|NCT00993421|935008|P3|Overall Study|Death|0
283204|NCT00993421|935009|P2|Overall Study|Death|0
283205|NCT00993421|935010|P1|Overall Study|Death|0
283206|NCT00993421|935004|P7|Overall Study|Withdrawal by Subject|3
283207|NCT00993421|935005|P6|Overall Study|Withdrawal by Subject|5
283208|NCT00993421|935006|P5|Overall Study|Withdrawal by Subject|3
283209|NCT00993421|935007|P4|Overall Study|Withdrawal by Subject|3
283210|NCT00993421|935008|P3|Overall Study|Withdrawal by Subject|3
283211|NCT00993421|935009|P2|Overall Study|Withdrawal by Subject|2
283212|NCT00993421|935010|P1|Overall Study|Withdrawal by Subject|3
283213|NCT00993421|935004|P7|Overall Study|Lost to Follow-up|6
283214|NCT00993421|935005|P6|Overall Study|Lost to Follow-up|0
283215|NCT00993421|935006|P5|Overall Study|Lost to Follow-up|0
283216|NCT00993421|935007|P4|Overall Study|Lost to Follow-up|0
283217|NCT00993421|935008|P3|Overall Study|Lost to Follow-up|5
283218|NCT00993421|935009|P2|Overall Study|Lost to Follow-up|5
283219|NCT00993421|935010|P1|Overall Study|Lost to Follow-up|3
283220|NCT00993421|935004|P7|Overall Study|Sponsor Decision|29
283221|NCT00993421|935005|P6|Overall Study|Sponsor Decision|30
283222|NCT00993421|935006|P5|Overall Study|Sponsor Decision|38
283223|NCT00993421|935007|P4|Overall Study|Sponsor Decision|30
283224|NCT00993421|935008|P3|Overall Study|Sponsor Decision|28
283225|NCT00993421|935009|P2|Overall Study|Sponsor Decision|31
283226|NCT00993421|935010|P1|Overall Study|Sponsor Decision|36
283227|NCT00993421|935004|P7|Overall Study|Adverse Event|1
283228|NCT00993421|935005|P6|Overall Study|Adverse Event|7
283229|NCT00993421|935006|P5|Overall Study|Adverse Event|5
283230|NCT00993421|935007|P4|Overall Study|Adverse Event|9
283231|NCT00993421|935008|P3|Overall Study|Adverse Event|6
283232|NCT00993421|935009|P2|Overall Study|Adverse Event|7
283233|NCT00993421|935010|P1|Overall Study|Adverse Event|2
283234|NCT00993317|935161|P2|Overall Study|Early study termination at the site|0
283235|NCT00993317|935162|P1|Overall Study|Early study termination at the site|1
283236|NCT00993317|935161|P2|Overall Study|Investigator's opinion|1
283237|NCT00993317|935162|P1|Overall Study|Investigator's opinion|0
283238|NCT00993317|935161|P2|Overall Study|Withdrawal by Subject|2
283239|NCT00993317|935162|P1|Overall Study|Withdrawal by Subject|0
283240|NCT00993317|935161|P2|Overall Study|Lack of Efficacy|18
283241|NCT00993317|935162|P1|Overall Study|Lack of Efficacy|18
283242|NCT00993317|935161|P2|Overall Study|Adverse Event|4
283243|NCT00993317|935162|P1|Overall Study|Adverse Event|2
283244|NCT00993291|935180|P1|Overall Study|Withdrawal by Subject|1
283245|NCT00993265|935186|P2|Overall Study|Non-compliant with study medication|0
283246|NCT00993265|935187|P1|Overall Study|Non-compliant with study medication|1
283247|NCT00993265|935186|P2|Overall Study|Changed dose of concomitant drug|0
283248|NCT00993265|935187|P1|Overall Study|Changed dose of concomitant drug|2
283249|NCT00993265|935186|P2|Overall Study|Adverse Event|0
283250|NCT00993265|935187|P1|Overall Study|Adverse Event|1
283251|NCT00993148|935239|P1|Overall Study|never initiated treatment|1
283252|NCT00993148|935239|P1|Overall Study|Lost to Follow-up|2
283253|NCT00993044|935251|P1|Irinotecan 50 mg|Physician Decision|1
283254|NCT00992992|935256|P1|Overall Study|Sponsor Closed the Study|4
283255|NCT00992992|935256|P1|Overall Study|GlaxoSmithKline Closed the Study|2
283256|NCT00992992|935256|P1|Overall Study|Death|16
283257|NCT00992992|935256|P1|Overall Study|Lost to Follow-up|3
283258|NCT00992836|935287|P1|Overall Study|Protocol Violation|2
283259|NCT00992836|935287|P1|Overall Study|Withdrawal by Subject|2
283260|NCT00992836|935287|P1|Overall Study|Lost to Follow-up|1
283261|NCT00992784|935302|P3|Overall Study|Withdrawal by Subject|1
283262|NCT00992784|935303|P2|Overall Study|Withdrawal by Subject|1
283263|NCT00992784|935304|P1|Overall Study|Withdrawal by Subject|1
283264|NCT00992784|935302|P3|Overall Study|Adverse Event|0
283265|NCT00992784|935303|P2|Overall Study|Adverse Event|1
283266|NCT00992784|935304|P1|Overall Study|Adverse Event|2
283267|NCT00992589|935411|P4|Double-Blind Phase|Not specified|3
283268|NCT00992589|935412|P3|Double-Blind Phase|Not specified|6
283269|NCT00992589|935413|P2|Double-Blind Phase|Not specified|1
283270|NCT00992589|935414|P1|Double-Blind Phase|Not specified|0
283271|NCT00992589|935411|P4|Double-Blind Phase|Lost to Follow-up|2
283272|NCT00992589|935412|P3|Double-Blind Phase|Lost to Follow-up|0
283273|NCT00992589|935413|P2|Double-Blind Phase|Lost to Follow-up|0
283274|NCT00992589|935414|P1|Double-Blind Phase|Lost to Follow-up|0
283275|NCT00992589|935411|P4|Double-Blind Phase|Withdrawal by Subject|2
283276|NCT00992589|935412|P3|Double-Blind Phase|Withdrawal by Subject|5
283277|NCT00992589|935413|P2|Double-Blind Phase|Withdrawal by Subject|6
283278|NCT00992589|935414|P1|Double-Blind Phase|Withdrawal by Subject|0
283279|NCT00992589|935411|P4|Double-Blind Phase|Adverse Event|3
283280|NCT00992589|935412|P3|Double-Blind Phase|Adverse Event|2
283281|NCT00992589|935413|P2|Double-Blind Phase|Adverse Event|6
283282|NCT00992589|935414|P1|Double-Blind Phase|Adverse Event|0
283283|NCT00992589|935411|P4|Open-Label Phase|Not specified|0
283284|NCT00992589|935412|P3|Open-Label Phase|Not specified|0
283285|NCT00992589|935413|P2|Open-Label Phase|Not specified|0
283286|NCT00992589|935414|P1|Open-Label Phase|Not specified|45
283287|NCT00992589|935411|P4|Open-Label Phase|Physician Decision|0
283288|NCT00992589|935412|P3|Open-Label Phase|Physician Decision|0
283289|NCT00992589|935413|P2|Open-Label Phase|Physician Decision|0
283290|NCT00992589|935414|P1|Open-Label Phase|Physician Decision|4
283291|NCT00992589|935411|P4|Open-Label Phase|Protocol Violation|0
283292|NCT00992589|935412|P3|Open-Label Phase|Protocol Violation|0
283293|NCT00992589|935413|P2|Open-Label Phase|Protocol Violation|0
283294|NCT00992589|935414|P1|Open-Label Phase|Protocol Violation|3
283295|NCT00992589|935411|P4|Open-Label Phase|Lost to Follow-up|0
283296|NCT00992589|935412|P3|Open-Label Phase|Lost to Follow-up|0
283297|NCT00992589|935413|P2|Open-Label Phase|Lost to Follow-up|0
283298|NCT00992589|935414|P1|Open-Label Phase|Lost to Follow-up|1
283299|NCT00992589|935411|P4|Open-Label Phase|Withdrawal by Subject|0
283300|NCT00992589|935412|P3|Open-Label Phase|Withdrawal by Subject|0
283301|NCT00992589|935413|P2|Open-Label Phase|Withdrawal by Subject|0
283302|NCT00992589|935414|P1|Open-Label Phase|Withdrawal by Subject|20
283303|NCT00992589|935411|P4|Open-Label Phase|Adverse Event|0
283304|NCT00992589|935412|P3|Open-Label Phase|Adverse Event|0
283305|NCT00992589|935413|P2|Open-Label Phase|Adverse Event|0
283306|NCT00992589|935414|P1|Open-Label Phase|Adverse Event|4
283307|NCT00992459|935458|P2|Overall Study|Adverse Event|0
283308|NCT00992459|935459|P1|Overall Study|Adverse Event|1
283309|NCT00992459|935458|P2|Overall Study|Withdrawal by Subject|1
283310|NCT00992459|935459|P1|Overall Study|Withdrawal by Subject|0
283311|NCT00992446|935483|P1|Overall Study|Maintenance Therapy Screen Fail|5
283312|NCT00992446|935483|P1|Overall Study|Withdrawal by Subject|2
283313|NCT00992446|935483|P1|Overall Study|Disease Progression|1
283314|NCT00992407|935555|P2|Overall Study|Study medication not administered|13
283315|NCT00992407|935556|P1|Overall Study|Study medication not administered|17
283316|NCT00992407|935555|P2|Overall Study|Loss of follow-up & Adverse events|1
283317|NCT00992407|935556|P1|Overall Study|Loss of follow-up & Adverse events|2
283318|NCT00992407|935555|P2|Overall Study|Unspecified|0
283319|NCT00992407|935556|P1|Overall Study|Unspecified|2
283320|NCT00992407|935555|P2|Overall Study|protocol Violation & Adverse events|4
283321|NCT00992407|935556|P1|Overall Study|protocol Violation & Adverse events|2
283322|NCT00992407|935555|P2|Overall Study|Adverse Event|2
283323|NCT00992407|935556|P1|Overall Study|Adverse Event|3
283324|NCT00992407|935555|P2|Overall Study|Lost to Follow-up|3
283325|NCT00992407|935556|P1|Overall Study|Lost to Follow-up|3
283326|NCT00992407|935555|P2|Overall Study|Protocol Violation|1
283327|NCT00992407|935556|P1|Overall Study|Protocol Violation|2
283328|NCT00992394|935606|P2|Overall Study|Other event|0
283329|NCT00992394|935607|P1|Overall Study|Other event|1
283330|NCT00992394|935606|P2|Overall Study|Lost to Follow-up|0
283331|NCT00992394|935607|P1|Overall Study|Lost to Follow-up|2
283332|NCT00992394|935606|P2|Overall Study|Protocol Violation|4
283333|NCT00992394|935607|P1|Overall Study|Protocol Violation|2
283334|NCT00992394|935606|P2|Overall Study|Physician Decision|0
283335|NCT00992394|935607|P1|Overall Study|Physician Decision|1
283336|NCT00992394|935606|P2|Overall Study|Withdrawal by Subject|2
283337|NCT00992394|935607|P1|Overall Study|Withdrawal by Subject|8
283338|NCT00992394|935606|P2|Overall Study|Adverse Event|5
283339|NCT00992394|935607|P1|Overall Study|Adverse Event|4
283340|NCT00992394|935606|P2|Overall Study|Lack of Efficacy|3
283341|NCT00992394|935607|P1|Overall Study|Lack of Efficacy|6
283342|NCT00992186|935694|P1|Overall Study|Refusal To Receive Study Agent|3
283343|NCT00992186|935694|P1|Overall Study|Progressive Disease|30
283344|NCT00992186|935694|P1|Overall Study|Adverse Event|9
283345|NCT00992186|935694|P1|Overall Study|Physician Decision|1
283346|NCT00992186|935694|P1|Overall Study|Protocol Violation|1
283347|NCT00992186|935694|P1|Overall Study|Withdrawal by Subject|2
283348|NCT00992108|935713|P2|Overall Study|Lost to Follow-up|1
283349|NCT00992108|935714|P1|Overall Study|Lost to Follow-up|0
283350|NCT00992056|935728|P2|Washout Period (2 Weeks)|Physician Decision|0
283351|NCT00992056|935729|P1|Washout Period (2 Weeks)|Physician Decision|1
283352|NCT00992056|935728|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
283353|NCT00992056|935729|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
283354|NCT00992017|935735|P1|Overall Study|Not adhere to study requirements|1
283355|NCT00992017|935735|P1|Overall Study|Unable to get to clinic|5
283356|NCT00992017|935735|P1|Overall Study|Withdrawal by Subject|2
283357|NCT00992017|935735|P1|Overall Study|Lost to Follow-up|2
283358|NCT00991952|935750|P2|Overall Study|Adverse Event|1
283359|NCT00991952|935751|P1|Overall Study|Adverse Event|0
283360|NCT00991939|935759|P2|Overall Study|Entire study terminated|1
283361|NCT00991939|935760|P1|Overall Study|Entire study terminated|4
283362|NCT00991939|935759|P2|Overall Study|Withdrawal by Subject|0
283363|NCT00991939|935760|P1|Overall Study|Withdrawal by Subject|1
283364|NCT00991939|935759|P2|Overall Study|Lost to Follow-up|1
283365|NCT00991939|935760|P1|Overall Study|Lost to Follow-up|0
283366|NCT00991510|935803|P2|Period III (Days 29-112)|Adverse Event|1
283367|NCT00991510|935804|P1|Period III (Days 29-112)|Adverse Event|1
283368|NCT00991510|935803|P2|Period I (Days 1-14)|Adverse Event|0
283369|NCT00991510|935804|P1|Period I (Days 1-14)|Adverse Event|1
283370|NCT00991341|935850|P2|Overall Study|Withdrawal by Subject|4
283371|NCT00991341|935851|P1|Overall Study|Withdrawal by Subject|3
283372|NCT00991341|935850|P2|Overall Study|Physician Decision|2
283373|NCT00991341|935851|P1|Overall Study|Physician Decision|1
283374|NCT00991341|935850|P2|Overall Study|no RBCs received 96hrs after randomized|155
283375|NCT00991341|935851|P1|Overall Study|no RBCs received 96hrs after randomized|186
283376|NCT00991341|935850|P2|Overall Study|Death|0
283377|NCT00991341|935851|P1|Overall Study|Death|3
283378|NCT00991341|935850|P2|Overall Study|no surgery w/in 30 days of randomization|18
283379|NCT00991341|935851|P1|Overall Study|no surgery w/in 30 days of randomization|11
283380|NCT00991302|935889|P2|Overall Study|Lost to Follow-up|12
283381|NCT00991302|935890|P1|Overall Study|Lost to Follow-up|14
283382|NCT00991302|935889|P2|Overall Study|Death|1
283383|NCT00991302|935890|P1|Overall Study|Death|0
283384|NCT00991289|935906|P1|Overall Study|Protocol Violation|2
283385|NCT00991289|935906|P1|Overall Study|Lost to Follow-up|4
283386|NCT00991289|935906|P1|Overall Study|Withdrawal by Subject|3
283387|NCT00991289|935906|P1|Overall Study|Physician Decision|2
283388|NCT00991289|935906|P1|Overall Study|Adverse Event|1
283389|NCT00991276|935926|P6|Third Intervention Period|Withdrawal by Subject|0
283390|NCT00991276|935927|P5|Third Intervention Period|Withdrawal by Subject|0
283391|NCT00991276|935928|P4|Third Intervention Period|Withdrawal by Subject|1
283392|NCT00991276|935929|P3|Third Intervention Period|Withdrawal by Subject|0
283393|NCT00991276|935930|P2|Third Intervention Period|Withdrawal by Subject|0
283394|NCT00991276|935931|P1|Third Intervention Period|Withdrawal by Subject|0
283395|NCT00991276|935926|P6|Third Intervention Period|Adverse Event|0
283396|NCT00991276|935927|P5|Third Intervention Period|Adverse Event|0
283397|NCT00991276|935928|P4|Third Intervention Period|Adverse Event|0
283398|NCT00991276|935929|P3|Third Intervention Period|Adverse Event|1
283399|NCT00991276|935930|P2|Third Intervention Period|Adverse Event|0
283400|NCT00991276|935931|P1|Third Intervention Period|Adverse Event|0
283401|NCT00991276|935926|P6|Third Intervention Period|Unspecified|1
283402|NCT00991276|935927|P5|Third Intervention Period|Unspecified|0
283403|NCT00991276|935928|P4|Third Intervention Period|Unspecified|0
283404|NCT00991276|935929|P3|Third Intervention Period|Unspecified|0
283405|NCT00991276|935930|P2|Third Intervention Period|Unspecified|0
283406|NCT00991276|935931|P1|Third Intervention Period|Unspecified|0
283407|NCT00991276|935926|P6|Third Intervention Period|Protocol Violation|0
283408|NCT00991276|935927|P5|Third Intervention Period|Protocol Violation|0
283409|NCT00991276|935928|P4|Third Intervention Period|Protocol Violation|0
283410|NCT00991276|935929|P3|Third Intervention Period|Protocol Violation|0
283411|NCT00991276|935930|P2|Third Intervention Period|Protocol Violation|0
283412|NCT00991276|935931|P1|Third Intervention Period|Protocol Violation|1
283413|NCT00991276|935926|P6|Second Intervention Period|Unspecified|1
283414|NCT00991276|935927|P5|Second Intervention Period|Unspecified|0
283415|NCT00991276|935928|P4|Second Intervention Period|Unspecified|1
283416|NCT00991276|935929|P3|Second Intervention Period|Unspecified|0
283417|NCT00991276|935930|P2|Second Intervention Period|Unspecified|0
283418|NCT00991276|935931|P1|Second Intervention Period|Unspecified|0
283419|NCT00991276|935926|P6|Second Intervention Period|Protocol Violation|0
283420|NCT00991276|935927|P5|Second Intervention Period|Protocol Violation|0
283421|NCT00991276|935928|P4|Second Intervention Period|Protocol Violation|0
283422|NCT00991276|935929|P3|Second Intervention Period|Protocol Violation|0
283423|NCT00991276|935930|P2|Second Intervention Period|Protocol Violation|0
283424|NCT00991276|935931|P1|Second Intervention Period|Protocol Violation|1
283425|NCT00991276|935926|P6|Second Intervention Period|Adverse Event|0
283426|NCT00991276|935927|P5|Second Intervention Period|Adverse Event|1
283427|NCT00991276|935928|P4|Second Intervention Period|Adverse Event|1
283428|NCT00991276|935929|P3|Second Intervention Period|Adverse Event|0
283429|NCT00991276|935930|P2|Second Intervention Period|Adverse Event|2
283430|NCT00991276|935931|P1|Second Intervention Period|Adverse Event|0
283431|NCT00991276|935926|P6|First Intervention Period|Lost to Follow-up|0
283432|NCT00991276|935927|P5|First Intervention Period|Lost to Follow-up|0
283433|NCT00991276|935928|P4|First Intervention Period|Lost to Follow-up|1
283434|NCT00991276|935929|P3|First Intervention Period|Lost to Follow-up|0
283435|NCT00991276|935930|P2|First Intervention Period|Lost to Follow-up|1
283436|NCT00991276|935931|P1|First Intervention Period|Lost to Follow-up|0
283437|NCT00991276|935926|P6|First Intervention Period|Withdrawal by Subject|1
283438|NCT00991276|935927|P5|First Intervention Period|Withdrawal by Subject|0
283439|NCT00991276|935928|P4|First Intervention Period|Withdrawal by Subject|1
283440|NCT00991276|935929|P3|First Intervention Period|Withdrawal by Subject|0
283441|NCT00991276|935930|P2|First Intervention Period|Withdrawal by Subject|1
283442|NCT00991276|935931|P1|First Intervention Period|Withdrawal by Subject|0
283443|NCT00991276|935926|P6|First Intervention Period|Unspecified|0
283444|NCT00991276|935927|P5|First Intervention Period|Unspecified|1
283445|NCT00991276|935928|P4|First Intervention Period|Unspecified|1
283446|NCT00991276|935929|P3|First Intervention Period|Unspecified|0
283447|NCT00991276|935930|P2|First Intervention Period|Unspecified|0
283448|NCT00991276|935931|P1|First Intervention Period|Unspecified|0
283449|NCT00991276|935926|P6|First Intervention Period|Insufficient clinical response|0
283450|NCT00991276|935927|P5|First Intervention Period|Insufficient clinical response|1
283451|NCT00991276|935928|P4|First Intervention Period|Insufficient clinical response|0
283452|NCT00991276|935929|P3|First Intervention Period|Insufficient clinical response|0
283453|NCT00991276|935930|P2|First Intervention Period|Insufficient clinical response|0
283454|NCT00991276|935931|P1|First Intervention Period|Insufficient clinical response|0
283455|NCT00991276|935926|P6|First Intervention Period|Protocol Violation|0
283456|NCT00991276|935927|P5|First Intervention Period|Protocol Violation|2
283457|NCT00991276|935928|P4|First Intervention Period|Protocol Violation|0
283458|NCT00991276|935929|P3|First Intervention Period|Protocol Violation|0
283459|NCT00991276|935930|P2|First Intervention Period|Protocol Violation|0
283460|NCT00991276|935931|P1|First Intervention Period|Protocol Violation|0
283461|NCT00991276|935926|P6|First Intervention Period|Adverse Event|0
283462|NCT00991276|935927|P5|First Intervention Period|Adverse Event|0
283463|NCT00991276|935928|P4|First Intervention Period|Adverse Event|1
283464|NCT00991276|935929|P3|First Intervention Period|Adverse Event|0
283465|NCT00991276|935930|P2|First Intervention Period|Adverse Event|1
283466|NCT00991276|935931|P1|First Intervention Period|Adverse Event|0
283467|NCT00990821|936088|P14|Overall Study|Withdrawal by Subject|1
283468|NCT00990821|936089|P13|Overall Study|Withdrawal by Subject|2
283469|NCT00990821|936090|P12|Overall Study|Withdrawal by Subject|5
283470|NCT00990821|936091|P11|Overall Study|Withdrawal by Subject|3
283471|NCT00990821|936092|P10|Overall Study|Withdrawal by Subject|1
283472|NCT00990821|936093|P9|Overall Study|Withdrawal by Subject|0
283473|NCT00990821|936094|P8|Overall Study|Withdrawal by Subject|0
283474|NCT00990821|936095|P7|Overall Study|Withdrawal by Subject|1
283475|NCT00990821|936096|P6|Overall Study|Withdrawal by Subject|3
283476|NCT00990821|936097|P5|Overall Study|Withdrawal by Subject|3
283477|NCT00990821|936098|P4|Overall Study|Withdrawal by Subject|0
283478|NCT00990821|936099|P3|Overall Study|Withdrawal by Subject|0
283479|NCT00990821|936100|P2|Overall Study|Withdrawal by Subject|2
283480|NCT00990821|936101|P1|Overall Study|Withdrawal by Subject|0
283481|NCT00990704|936133|P2|Overall Study|Physician Decision|1
283482|NCT00990704|936134|P1|Overall Study|Physician Decision|0
283483|NCT00990704|936133|P2|Overall Study|Adverse Event|1
283484|NCT00990704|936134|P1|Overall Study|Adverse Event|1
283485|NCT00990652|936154|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
283486|NCT00990652|936154|P1|Pre-surgical Bortezomib|Adverse Event|1
283487|NCT00990340|936188|P2|First 14-day Treatment|Protocol Violation|2
283488|NCT00990340|936189|P1|First 14-day Treatment|Protocol Violation|2
283489|NCT00990340|936188|P2|First 14-day Treatment|Lost to Follow-up|1
283490|NCT00990340|936189|P1|First 14-day Treatment|Lost to Follow-up|2
283491|NCT00990340|936188|P2|First 14-day Treatment|Not Compliant|1
283492|NCT00990340|936189|P1|First 14-day Treatment|Not Compliant|2
283493|NCT00990184|936203|P1|Overall Study|Physician Decision|1
283494|NCT00990106|936211|P2|Overall Study|scheduling conflicts|2
283495|NCT00990106|936212|P1|Overall Study|scheduling conflicts|0
283496|NCT00990106|936211|P2|Overall Study|planned major surgery|1
283497|NCT00990106|936212|P1|Overall Study|planned major surgery|0
283498|NCT00990106|936211|P2|Overall Study|started exclusionary medication|1
283499|NCT00990106|936212|P1|Overall Study|started exclusionary medication|0
283500|NCT00990106|936211|P2|Overall Study|relocation/deployment|1
283501|NCT00990106|936212|P1|Overall Study|relocation/deployment|4
283502|NCT00990106|936211|P2|Overall Study|opted for open label prazosin|1
283503|NCT00990106|936212|P1|Overall Study|opted for open label prazosin|1
283504|NCT00990106|936211|P2|Overall Study|Withdrawal by Subject|1
283505|NCT00990106|936212|P1|Overall Study|Withdrawal by Subject|2
283506|NCT00990106|936211|P2|Overall Study|Lost to Follow-up|3
283507|NCT00990106|936212|P1|Overall Study|Lost to Follow-up|1
283508|NCT00990106|936211|P2|Overall Study|"too busy to continue"|2
283509|NCT00990106|936212|P1|Overall Study|"too busy to continue"|1
283510|NCT00990093|936222|P2|Test Period 2 (15-28 Days)|Not specified|1
283511|NCT00990093|936223|P1|Test Period 2 (15-28 Days)|Not specified|0
283512|NCT00990093|936222|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
283513|NCT00990093|936223|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
283514|NCT00990093|936222|P2|Test Period 2 (15-28 Days)|Adverse Event|0
283515|NCT00990093|936223|P1|Test Period 2 (15-28 Days)|Adverse Event|1
283516|NCT00990093|936222|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
283517|NCT00990093|936223|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
283518|NCT00990093|936222|P2|Test Period 1 (1-14 Days)|Not Specified|0
283519|NCT00990093|936223|P1|Test Period 1 (1-14 Days)|Not Specified|1
283520|NCT00990093|936222|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
283521|NCT00990093|936223|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
283522|NCT00990093|936222|P2|Test Period 1 (1-14 Days)|Adverse Event|0
283523|NCT00990093|936223|P1|Test Period 1 (1-14 Days)|Adverse Event|1
283524|NCT00989950|936276|P4|Randomized Phase|Adverse Event|0
283525|NCT00989950|936277|P3|Randomized Phase|Adverse Event|0
283526|NCT00989950|936278|P2|Randomized Phase|Adverse Event|1
283527|NCT00989950|936279|P1|Randomized Phase|Adverse Event|0
283528|NCT00989950|936276|P4|Randomized Phase|Protocol Violation|0
283529|NCT00989950|936277|P3|Randomized Phase|Protocol Violation|0
283530|NCT00989950|936278|P2|Randomized Phase|Protocol Violation|0
283531|NCT00989950|936279|P1|Randomized Phase|Protocol Violation|1
283532|NCT00989833|936296|P3|Overall Study|Incorrectly randomized|0
283533|NCT00989833|936297|P2|Overall Study|Incorrectly randomized|0
283534|NCT00989833|936298|P1|Overall Study|Incorrectly randomized|1
283535|NCT00989833|936296|P3|Overall Study|Withdrawal by Subject|1
283536|NCT00989833|936297|P2|Overall Study|Withdrawal by Subject|0
283537|NCT00989833|936298|P1|Overall Study|Withdrawal by Subject|0
283538|NCT00989833|936296|P3|Overall Study|Protocol Violation|1
283539|NCT00989833|936297|P2|Overall Study|Protocol Violation|2
283540|NCT00989833|936298|P1|Overall Study|Protocol Violation|1
283541|NCT00989833|936296|P3|Overall Study|Lost to Follow-up|0
283542|NCT00989833|936297|P2|Overall Study|Lost to Follow-up|1
283543|NCT00989833|936298|P1|Overall Study|Lost to Follow-up|0
283544|NCT00989664|936338|P1|Long-Term Follow-Up|Death|3
283545|NCT00989664|936338|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
283546|NCT00989664|936338|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
283547|NCT00989664|936338|P1|Dosimetric and Therapeutic Treatment|Death|1
283548|NCT00989664|936338|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
283549|NCT00989664|936338|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
283550|NCT00989664|936338|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
283551|NCT00989235|936384|P2|Overall Study|Lost to Follow-up|1
283552|NCT00989235|936385|P1|Overall Study|Lost to Follow-up|0
283553|NCT00989235|936384|P2|Overall Study|Randomized by Mistake|2
283554|NCT00989235|936385|P1|Overall Study|Randomized by Mistake|0
283555|NCT00989235|936384|P2|Overall Study|Desire to Become Pregnant|0
283556|NCT00989235|936385|P1|Overall Study|Desire to Become Pregnant|1
283557|NCT00989235|936384|P2|Overall Study|Withdrawal of Consent|1
283558|NCT00989235|936385|P1|Overall Study|Withdrawal of Consent|1
283559|NCT00989235|936384|P2|Overall Study|Lack of Efficacy|0
283560|NCT00989235|936385|P1|Overall Study|Lack of Efficacy|1
283561|NCT00989235|936384|P2|Overall Study|Adverse Event|1
283562|NCT00989235|936385|P1|Overall Study|Adverse Event|0
283563|NCT00989235|936384|P2|Overall Study|Death|1
283564|NCT00989235|936385|P1|Overall Study|Death|0
283565|NCT00989196|936430|P2|Treatment Period|Lost to Follow-up|0
283566|NCT00989196|936431|P1|Treatment Period|Lost to Follow-up|1
283567|NCT00989092|936469|P2|Overall Study|Did not receive study drug|0
283568|NCT00989092|936470|P1|Overall Study|Did not receive study drug|2
283569|NCT00989092|936469|P2|Overall Study|Erythropoietin therapy initiated|0
283570|NCT00989092|936470|P1|Overall Study|Erythropoietin therapy initiated|2
283571|NCT00989092|936469|P2|Overall Study|Protocol deviation|0
283572|NCT00989092|936470|P1|Overall Study|Protocol deviation|2
283573|NCT00989092|936469|P2|Overall Study|Other|1
283574|NCT00989092|936470|P1|Overall Study|Other|3
283575|NCT00989092|936469|P2|Overall Study|Lost to Follow-up|2
283576|NCT00989092|936470|P1|Overall Study|Lost to Follow-up|6
283577|NCT00989092|936469|P2|Overall Study|Ineligibility determined|3
283578|NCT00989092|936470|P1|Overall Study|Ineligibility determined|3
283579|NCT00989092|936469|P2|Overall Study|Death|2
283580|NCT00989092|936470|P1|Overall Study|Death|14
283581|NCT00989092|936469|P2|Overall Study|Withdrawal by Subject|9
283582|NCT00989092|936470|P1|Overall Study|Withdrawal by Subject|17
283583|NCT00989092|936469|P2|Overall Study|Chemotherapy initiated|4
283584|NCT00989092|936470|P1|Overall Study|Chemotherapy initiated|12
283585|NCT00989092|936469|P2|Overall Study|Adverse Event|1
283586|NCT00989092|936470|P1|Overall Study|Adverse Event|20
283587|NCT00989092|936469|P2|Overall Study|Physician Decision|6
283588|NCT00989092|936470|P1|Overall Study|Physician Decision|9
283589|NCT00988884|936522|P2|Overall Study|Withdrawal by Subject|18
283590|NCT00988884|936523|P1|Overall Study|Withdrawal by Subject|15
283591|NCT00988884|936522|P2|Overall Study|Protocol Violation|1
283592|NCT00988884|936523|P1|Overall Study|Protocol Violation|0
283593|NCT00988884|936522|P2|Overall Study|Lost to Follow-up|16
283594|NCT00988884|936523|P1|Overall Study|Lost to Follow-up|20
283595|NCT00988884|936522|P2|Overall Study|Adverse Event|1
283596|NCT00988884|936523|P1|Overall Study|Adverse Event|0
283597|NCT00988637|936582|P2|Overall Study|non-compliance with study drug|1
283598|NCT00988637|936583|P1|Overall Study|non-compliance with study drug|0
283599|NCT00988637|936582|P2|Overall Study|Withdrawal by Subject|1
283600|NCT00988637|936583|P1|Overall Study|Withdrawal by Subject|1
283601|NCT00988637|936582|P2|Overall Study|Lost to Follow-up|1
283602|NCT00988637|936583|P1|Overall Study|Lost to Follow-up|2
283603|NCT00988533|936613|P1|Overall Study|Lost to Follow-up|3
283604|NCT00988429|936628|P3|Overall Study|other reasons|1
283605|NCT00988429|936629|P2|Overall Study|other reasons|8
283606|NCT00988429|936630|P1|Overall Study|other reasons|8
283607|NCT00988429|936628|P3|Overall Study|Administrative Reasons|1
283608|NCT00988429|936629|P2|Overall Study|Administrative Reasons|2
283609|NCT00988429|936630|P1|Overall Study|Administrative Reasons|1
283610|NCT00988429|936628|P3|Overall Study|Withdrawal by Subject|12
283611|NCT00988429|936629|P2|Overall Study|Withdrawal by Subject|7
283612|NCT00988429|936630|P1|Overall Study|Withdrawal by Subject|7
283613|NCT00988429|936628|P3|Overall Study|Protocol Violation|3
283614|NCT00988429|936629|P2|Overall Study|Protocol Violation|3
283615|NCT00988429|936630|P1|Overall Study|Protocol Violation|4
283616|NCT00988429|936628|P3|Overall Study|Pregnancy|0
283617|NCT00988429|936629|P2|Overall Study|Pregnancy|1
283618|NCT00988429|936630|P1|Overall Study|Pregnancy|2
283619|NCT00988429|936628|P3|Overall Study|Physician Decision|3
283620|NCT00988429|936629|P2|Overall Study|Physician Decision|0
283621|NCT00988429|936630|P1|Overall Study|Physician Decision|1
283622|NCT00988429|936628|P3|Overall Study|Non-Compliance with Study Drug|3
283623|NCT00988429|936629|P2|Overall Study|Non-Compliance with Study Drug|1
283624|NCT00988429|936630|P1|Overall Study|Non-Compliance with Study Drug|5
283625|NCT00988429|936628|P3|Overall Study|Lack of Efficacy|1
283626|NCT00988429|936629|P2|Overall Study|Lack of Efficacy|0
283627|NCT00988429|936630|P1|Overall Study|Lack of Efficacy|0
283628|NCT00988429|936628|P3|Overall Study|Adverse Event|45
283629|NCT00988429|936629|P2|Overall Study|Adverse Event|21
283630|NCT00988429|936630|P1|Overall Study|Adverse Event|9
283631|NCT00988351|936643|P2|Overall Study|not using CPAP|3
283632|NCT00988351|936644|P1|Overall Study|not using CPAP|5
283633|NCT00988351|936643|P2|Overall Study|Lost to Follow-up|9
283634|NCT00988351|936644|P1|Overall Study|Lost to Follow-up|6
283635|NCT00988351|936643|P2|Overall Study|Withdrawal by Subject|0
283636|NCT00988351|936644|P1|Overall Study|Withdrawal by Subject|8
283637|NCT00988247|936721|P2|Overall Study|Not specified|0
283638|NCT00988247|936722|P1|Overall Study|Not specified|3
283639|NCT00988247|936721|P2|Overall Study|Sponsor requested withdrawal|1
283640|NCT00988247|936722|P1|Overall Study|Sponsor requested withdrawal|3
283641|NCT00988247|936721|P2|Overall Study|Protocol Violation|5
283642|NCT00988247|936722|P1|Overall Study|Protocol Violation|4
283643|NCT00988247|936721|P2|Overall Study|Lost to Follow-up|2
283644|NCT00988247|936722|P1|Overall Study|Lost to Follow-up|11
283645|NCT00988247|936721|P2|Overall Study|Pregnancy|2
283646|NCT00988247|936722|P1|Overall Study|Pregnancy|1
283647|NCT00988247|936721|P2|Overall Study|Withdrawal by Subject|13
283648|NCT00988247|936722|P1|Overall Study|Withdrawal by Subject|44
283649|NCT00988247|936721|P2|Overall Study|Adverse Event|3
283650|NCT00988247|936722|P1|Overall Study|Adverse Event|17
283651|NCT00988221|936741|P4|Part III|Refused Treatment|0
283652|NCT00988221|936742|P3|Part III|Refused Treatment|1
283653|NCT00988221|936743|P2|Part III|Refused Treatment|0
283654|NCT00988221|936744|P1|Part III|Refused Treatment|0
283655|NCT00988221|936741|P4|Part III|Insufficient Therapeutic Response|0
283656|NCT00988221|936742|P3|Part III|Insufficient Therapeutic Response|1
283657|NCT00988221|936743|P2|Part III|Insufficient Therapeutic Response|1
283658|NCT00988221|936744|P1|Part III|Insufficient Therapeutic Response|0
283659|NCT00988221|936741|P4|Part III|Adverse Event|0
283660|NCT00988221|936742|P3|Part III|Adverse Event|1
283661|NCT00988221|936743|P2|Part III|Adverse Event|0
283662|NCT00988221|936744|P1|Part III|Adverse Event|1
283663|NCT00988221|936741|P4|Part II|Reason not Specified|0
283664|NCT00988221|936742|P3|Part II|Reason not Specified|1
283665|NCT00988221|936743|P2|Part II|Reason not Specified|0
283666|NCT00988221|936744|P1|Part II|Reason not Specified|0
283667|NCT00988221|936741|P4|Part II|Withdrawal by Subject|2
283668|NCT00988221|936742|P3|Part II|Withdrawal by Subject|2
283669|NCT00988221|936743|P2|Part II|Withdrawal by Subject|0
283670|NCT00988221|936744|P1|Part II|Withdrawal by Subject|0
283671|NCT00988221|936741|P4|Part II|Adverse Event|1
283672|NCT00988221|936742|P3|Part II|Adverse Event|0
283673|NCT00988221|936743|P2|Part II|Adverse Event|0
283674|NCT00988221|936744|P1|Part II|Adverse Event|1
283675|NCT00988221|936741|P4|Part I|Lost to Follow-up|0
283676|NCT00988221|936742|P3|Part I|Lost to Follow-up|0
283677|NCT00988221|936743|P2|Part I|Lost to Follow-up|1
283678|NCT00988221|936744|P1|Part I|Lost to Follow-up|0
283679|NCT00988221|936741|P4|Part I|Refused Treatment|0
283680|NCT00988221|936742|P3|Part I|Refused Treatment|1
283681|NCT00988221|936743|P2|Part I|Refused Treatment|2
283682|NCT00988221|936744|P1|Part I|Refused Treatment|0
283683|NCT00988221|936741|P4|Part I|Insufficient Therapeutic Response|0
283684|NCT00988221|936742|P3|Part I|Insufficient Therapeutic Response|5
283685|NCT00988221|936743|P2|Part I|Insufficient Therapeutic Response|6
283686|NCT00988221|936744|P1|Part I|Insufficient Therapeutic Response|4
283687|NCT00988221|936741|P4|Part I|Adverse Event|0
283688|NCT00988221|936742|P3|Part I|Adverse Event|2
283689|NCT00988221|936743|P2|Part I|Adverse Event|1
283690|NCT00988221|936744|P1|Part I|Adverse Event|0
283691|NCT00988208|936917|P2|Overall Study|Unspecified|3
283692|NCT00988208|936918|P1|Overall Study|Unspecified|8
283693|NCT00988208|936917|P2|Overall Study|Subject decision/investigator discretion|32
283694|NCT00988208|936918|P1|Overall Study|Subject decision/investigator discretion|32
283695|NCT00988208|936917|P2|Overall Study|Clinical Deterioration|14
283696|NCT00988208|936918|P1|Overall Study|Clinical Deterioration|7
283697|NCT00988208|936917|P2|Overall Study|Biochemical Progression|7
283698|NCT00988208|936918|P1|Overall Study|Biochemical Progression|21
283699|NCT00988208|936917|P2|Overall Study|Clinical Progression|16
283700|NCT00988208|936918|P1|Overall Study|Clinical Progression|17
283701|NCT00988208|936917|P2|Overall Study|Sponsor Decision|78
283702|NCT00988208|936918|P1|Overall Study|Sponsor Decision|102
283703|NCT00988208|936917|P2|Overall Study|Protocol Violation|2
283704|NCT00988208|936918|P1|Overall Study|Protocol Violation|9
283705|NCT00988208|936917|P2|Overall Study|Lost to Follow-up|3
283706|NCT00988208|936918|P1|Overall Study|Lost to Follow-up|2
283707|NCT00988208|936917|P2|Overall Study|Death|15
283708|NCT00988208|936918|P1|Overall Study|Death|9
283709|NCT00988208|936917|P2|Overall Study|Withdrawal by Subject|57
283710|NCT00988208|936918|P1|Overall Study|Withdrawal by Subject|50
283711|NCT00988208|936917|P2|Overall Study|Disease Progression|89
283712|NCT00988208|936918|P1|Overall Study|Disease Progression|103
283713|NCT00988208|936917|P2|Overall Study|Adverse Event|122
283714|NCT00988208|936918|P1|Overall Study|Adverse Event|71
283715|NCT00988169|936930|P1|Overall Study|Withdrawal by Subject|1
283716|NCT00988117|936982|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
283717|NCT00988117|936982|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
283718|NCT00988091|936991|P2|Open-label Period|Not specified|3
283719|NCT00988091|936992|P1|Open-label Period|Not specified|2
283720|NCT00988091|936991|P2|Open-label Period|Lost to Follow-up|5
283721|NCT00988091|936992|P1|Open-label Period|Lost to Follow-up|3
283722|NCT00988091|936991|P2|Open-label Period|Withdrawal by Subject|16
283723|NCT00988091|936992|P1|Open-label Period|Withdrawal by Subject|10
283724|NCT00988091|936991|P2|Open-label Period|Protocol Violation|1
283725|NCT00988091|936992|P1|Open-label Period|Protocol Violation|1
283726|NCT00988091|936991|P2|Open-label Period|Use of exclusionary medication|1
283727|NCT00988091|936992|P1|Open-label Period|Use of exclusionary medication|1
283728|NCT00988091|936991|P2|Open-label Period|Adverse Event|7
283729|NCT00988091|936992|P1|Open-label Period|Adverse Event|4
283730|NCT00988091|936991|P2|Double-blind Period|Use of exclusionary medication|3
283731|NCT00988091|936992|P1|Double-blind Period|Use of exclusionary medication|2
283732|NCT00988091|936991|P2|Double-blind Period|Adverse Event|9
283733|NCT00988091|936992|P1|Double-blind Period|Adverse Event|6
283734|NCT00988091|936991|P2|Double-blind Period|Not specified|8
283735|NCT00988091|936992|P1|Double-blind Period|Not specified|8
283736|NCT00988091|936991|P2|Double-blind Period|Lost to Follow-up|14
283737|NCT00988091|936992|P1|Double-blind Period|Lost to Follow-up|12
283738|NCT00988091|936991|P2|Double-blind Period|Withdrawal by Subject|13
283739|NCT00988091|936992|P1|Double-blind Period|Withdrawal by Subject|15
283740|NCT00988065|937014|P3|Overall Study|Noncompliance with protocol|9
283741|NCT00988065|937015|P2|Overall Study|Noncompliance with protocol|6
283742|NCT00988065|937016|P1|Overall Study|Noncompliance with protocol|5
283743|NCT00988065|937014|P3|Overall Study|Subject withdrew consent|2
283744|NCT00988065|937015|P2|Overall Study|Subject withdrew consent|5
283745|NCT00988065|937016|P1|Overall Study|Subject withdrew consent|3
283746|NCT00988065|937014|P3|Overall Study|Lost to Follow-up|2
283747|NCT00988065|937015|P2|Overall Study|Lost to Follow-up|2
283748|NCT00988065|937016|P1|Overall Study|Lost to Follow-up|1
283749|NCT00988065|937014|P3|Overall Study|Adverse Event|2
283750|NCT00988065|937015|P2|Overall Study|Adverse Event|10
283751|NCT00988065|937016|P1|Overall Study|Adverse Event|4
283752|NCT00987935|937050|P9|Overall Study|Reason other than those specified above|1
283753|NCT00987935|937051|P8|Overall Study|Reason other than those specified above|0
283754|NCT00987935|937052|P7|Overall Study|Reason other than those specified above|0
283755|NCT00987935|937053|P6|Overall Study|Reason other than those specified above|0
283756|NCT00987935|937054|P5|Overall Study|Reason other than those specified above|0
283757|NCT00987935|937055|P4|Overall Study|Reason other than those specified above|0
283758|NCT00987935|937056|P3|Overall Study|Reason other than those specified above|0
283759|NCT00987935|937057|P2|Overall Study|Reason other than those specified above|0
283760|NCT00987935|937058|P1|Overall Study|Reason other than those specified above|0
283761|NCT00987935|937050|P9|Overall Study|Refused to continue taking trial med.|2
283850|NCT00986674|937326|P1|Overall Study|Death|5
283762|NCT00987935|937051|P8|Overall Study|Refused to continue taking trial med.|4
283763|NCT00987935|937052|P7|Overall Study|Refused to continue taking trial med.|4
283764|NCT00987935|937053|P6|Overall Study|Refused to continue taking trial med.|0
283765|NCT00987935|937054|P5|Overall Study|Refused to continue taking trial med.|1
283766|NCT00987935|937055|P4|Overall Study|Refused to continue taking trial med.|0
283767|NCT00987935|937056|P3|Overall Study|Refused to continue taking trial med.|0
283768|NCT00987935|937057|P2|Overall Study|Refused to continue taking trial med.|0
283769|NCT00987935|937058|P1|Overall Study|Refused to continue taking trial med.|1
283770|NCT00987935|937050|P9|Overall Study|Adverse Event|6
283771|NCT00987935|937051|P8|Overall Study|Adverse Event|10
283772|NCT00987935|937052|P7|Overall Study|Adverse Event|2
283773|NCT00987935|937053|P6|Overall Study|Adverse Event|0
283774|NCT00987935|937054|P5|Overall Study|Adverse Event|1
283775|NCT00987935|937055|P4|Overall Study|Adverse Event|1
283776|NCT00987935|937056|P3|Overall Study|Adverse Event|0
283777|NCT00987935|937057|P2|Overall Study|Adverse Event|1
283778|NCT00987935|937058|P1|Overall Study|Adverse Event|0
283779|NCT00987935|937050|P9|Overall Study|Progressive disease|23
283780|NCT00987935|937051|P8|Overall Study|Progressive disease|48
283781|NCT00987935|937052|P7|Overall Study|Progressive disease|9
283782|NCT00987935|937053|P6|Overall Study|Progressive disease|3
283783|NCT00987935|937054|P5|Overall Study|Progressive disease|5
283784|NCT00987935|937055|P4|Overall Study|Progressive disease|2
283785|NCT00987935|937056|P3|Overall Study|Progressive disease|3
283786|NCT00987935|937057|P2|Overall Study|Progressive disease|2
283787|NCT00987935|937058|P1|Overall Study|Progressive disease|3
283788|NCT00987831|937114|P3|Overall Study|Lost to Follow-up|0
283789|NCT00987831|937115|P2|Overall Study|Lost to Follow-up|3
283790|NCT00987831|937116|P1|Overall Study|Lost to Follow-up|0
283791|NCT00987831|937114|P3|Overall Study|Never flared in 12 months|0
283792|NCT00987831|937115|P2|Overall Study|Never flared in 12 months|0
283793|NCT00987831|937116|P1|Overall Study|Never flared in 12 months|1
283794|NCT00987623|937138|P2|Overall Study|Influenza|1
283795|NCT00987623|937139|P1|Overall Study|Influenza|0
283796|NCT00987623|937138|P2|Overall Study|Biomicroscopy|1
283797|NCT00987623|937139|P1|Overall Study|Biomicroscopy|0
283798|NCT00987623|937138|P2|Overall Study|Discomfort|0
283799|NCT00987623|937139|P1|Overall Study|Discomfort|1
283800|NCT00987623|937138|P2|Overall Study|Time/job conflict|0
283801|NCT00987623|937139|P1|Overall Study|Time/job conflict|2
283802|NCT00987623|937138|P2|Overall Study|Lost to Follow-up|1
283803|NCT00987623|937139|P1|Overall Study|Lost to Follow-up|2
283804|NCT00987467|937159|P1|Overall Study|Lost to Follow-up|2
283805|NCT00987402|937183|P2|Overall Study|Insufficient data entry|98
283806|NCT00987402|937184|P1|Overall Study|Insufficient data entry|86
283807|NCT00987337|937193|P3|Overall Study|Participant Relapsed|5
283808|NCT00987337|937194|P2|Overall Study|Participant Relapsed|20
283809|NCT00987337|937195|P1|Overall Study|Participant Relapsed|18
283810|NCT00987337|937193|P3|Overall Study|Protocol Violation|2
283811|NCT00987337|937194|P2|Overall Study|Protocol Violation|0
283812|NCT00987337|937195|P1|Overall Study|Protocol Violation|1
283813|NCT00987337|937193|P3|Overall Study|Unspecified|5
283814|NCT00987337|937194|P2|Overall Study|Unspecified|2
283815|NCT00987337|937195|P1|Overall Study|Unspecified|0
283816|NCT00987337|937193|P3|Overall Study|Withdrawal by Subject|9
283817|NCT00987337|937194|P2|Overall Study|Withdrawal by Subject|9
283818|NCT00987337|937195|P1|Overall Study|Withdrawal by Subject|6
283819|NCT00987337|937193|P3|Overall Study|Lost to Follow-up|2
283820|NCT00987337|937194|P2|Overall Study|Lost to Follow-up|6
283821|NCT00987337|937195|P1|Overall Study|Lost to Follow-up|10
283822|NCT00987337|937193|P3|Overall Study|Virologic Breakthrough|8
283823|NCT00987337|937194|P2|Overall Study|Virologic Breakthrough|2
283824|NCT00987337|937195|P1|Overall Study|Virologic Breakthrough|2
283825|NCT00987337|937193|P3|Overall Study|Insufficient Virologic Response|12
283826|NCT00987337|937194|P2|Overall Study|Insufficient Virologic Response|7
283827|NCT00987337|937195|P1|Overall Study|Insufficient Virologic Response|10
283828|NCT00987337|937193|P3|Overall Study|Adverse Event|8
283829|NCT00987337|937194|P2|Overall Study|Adverse Event|9
283830|NCT00987337|937195|P1|Overall Study|Adverse Event|10
283831|NCT00986986|937250|P2|Overall Study|Lost to Follow-up|1
283832|NCT00986986|937251|P1|Overall Study|Lost to Follow-up|0
283833|NCT00986973|937261|P1|Overall Study|Withdrawn by study team|1
283834|NCT00986921|937287|P2|Overall Study|Physician Decision|0
283835|NCT00986921|937288|P1|Overall Study|Physician Decision|1
283836|NCT00986674|937324|P3|Overall Study|unknown/not specify|9
283837|NCT00986674|937325|P2|Overall Study|unknown/not specify|7
283838|NCT00986674|937326|P1|Overall Study|unknown/not specify|0
283839|NCT00986674|937324|P3|Overall Study|not start protocol therapy|1
283840|NCT00986674|937325|P2|Overall Study|not start protocol therapy|3
283841|NCT00986674|937326|P1|Overall Study|not start protocol therapy|4
283842|NCT00986674|937324|P3|Overall Study|alternative therapy|1
283843|NCT00986674|937325|P2|Overall Study|alternative therapy|0
283844|NCT00986674|937326|P1|Overall Study|alternative therapy|0
283845|NCT00986674|937324|P3|Overall Study|Withdrawal by Subject|1
283846|NCT00986674|937325|P2|Overall Study|Withdrawal by Subject|2
283847|NCT00986674|937326|P1|Overall Study|Withdrawal by Subject|6
283848|NCT00986674|937324|P3|Overall Study|Death|4
283849|NCT00986674|937325|P2|Overall Study|Death|0
283851|NCT00986674|937324|P3|Overall Study|Adverse Event|9
283852|NCT00986674|937325|P2|Overall Study|Adverse Event|8
283853|NCT00986674|937326|P1|Overall Study|Adverse Event|4
283854|NCT00986674|937324|P3|Overall Study|Lack of Efficacy|23
283855|NCT00986674|937325|P2|Overall Study|Lack of Efficacy|25
283856|NCT00986674|937326|P1|Overall Study|Lack of Efficacy|28
283857|NCT00986570|937359|P1|Overall Study|Potential bias for objective assessment|1
283858|NCT00986570|937359|P1|Overall Study|Lost to Follow-up|6
283859|NCT00986479|937376|P2|Period 1|Administrative reasons|0
283860|NCT00986479|937377|P1|Period 1|Administrative reasons|1
283861|NCT00986479|937376|P2|Period 1|Improved mood|0
283862|NCT00986479|937377|P1|Period 1|Improved mood|1
283863|NCT00986427|937423|P2|Overall Study|Withdrawal by Subject|0
283864|NCT00986427|937424|P1|Overall Study|Withdrawal by Subject|1
283865|NCT00986427|937423|P2|Overall Study|Lack of Efficacy|0
283866|NCT00986427|937424|P1|Overall Study|Lack of Efficacy|1
283867|NCT00986427|937423|P2|Overall Study|Lost to Follow-up|0
283868|NCT00986427|937424|P1|Overall Study|Lost to Follow-up|2
283869|NCT00986362|937452|P2|Overall Study|Lost to Follow-up|1
283870|NCT00986362|937453|P1|Overall Study|Lost to Follow-up|0
283871|NCT00986362|937452|P2|Overall Study|Death|0
283872|NCT00986362|937453|P1|Overall Study|Death|2
283873|NCT00986349|937459|P1|Overall Study|device migration|1
283874|NCT00986349|937459|P1|Overall Study|Physician Decision|1
283875|NCT00986349|937459|P1|Overall Study|Adverse Event|2
283876|NCT00986349|937459|P1|Overall Study|Unsuccessful implant procedure|3
283877|NCT00986258|937472|P1|Maintenance Period|Withdrawal by Subject|2
283878|NCT00986258|937472|P1|Maintenance Period|Lack of Efficacy|2
283879|NCT00986258|937472|P1|Maintenance Period|Adverse Event|5
283880|NCT00986258|937472|P1|Titration and Optimal Dose Period|Other|1
283881|NCT00986258|937472|P1|Titration and Optimal Dose Period|Non-Compliance|1
283882|NCT00986258|937472|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
283883|NCT00986258|937472|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
283884|NCT00986258|937472|P1|Titration and Optimal Dose Period|Adverse Event|15
283885|NCT00986258|937472|P1|Observation Period|Not eligible to be dosed|11
283886|NCT00986245|937500|P2|Second Intervention|Protocol Violation|1
283887|NCT00986245|937501|P1|Second Intervention|Protocol Violation|0
283888|NCT00986245|937500|P2|Second Intervention|Lost to Follow-up|0
283889|NCT00986245|937501|P1|Second Intervention|Lost to Follow-up|1
283890|NCT00986245|937500|P2|Second Intervention|Poor compliance|0
283891|NCT00986245|937501|P1|Second Intervention|Poor compliance|1
283892|NCT00986245|937500|P2|First Intervention|Out of indication|0
283893|NCT00986245|937501|P1|First Intervention|Out of indication|1
283894|NCT00986245|937500|P2|First Intervention|Protocol Violation|1
283895|NCT00986245|937501|P1|First Intervention|Protocol Violation|0
283896|NCT00986245|937500|P2|First Intervention|Withdrawal by Subject|1
283897|NCT00986245|937501|P1|First Intervention|Withdrawal by Subject|0
283898|NCT00986245|937500|P2|First Intervention|Lack of Efficacy|2
283899|NCT00986245|937501|P1|First Intervention|Lack of Efficacy|1
283900|NCT00986245|937500|P2|First Intervention|Poor compliance|4
283901|NCT00986245|937501|P1|First Intervention|Poor compliance|8
283902|NCT00986232|937538|P4|Overall Study|Incomplete safety follow-up|2
283903|NCT00986232|937539|P3|Overall Study|Incomplete safety follow-up|2
283904|NCT00986232|937540|P2|Overall Study|Incomplete safety follow-up|7
283905|NCT00986232|937541|P1|Overall Study|Incomplete safety follow-up|3
283906|NCT00986232|937538|P4|Overall Study|Missed one or more bleeds|7
283907|NCT00986232|937539|P3|Overall Study|Missed one or more bleeds|6
283908|NCT00986232|937540|P2|Overall Study|Missed one or more bleeds|10
283909|NCT00986232|937541|P1|Overall Study|Missed one or more bleeds|13
283910|NCT00986232|937538|P4|Overall Study|Withdrawal by Subject|3
283911|NCT00986232|937539|P3|Overall Study|Withdrawal by Subject|12
283912|NCT00986232|937540|P2|Overall Study|Withdrawal by Subject|16
283913|NCT00986232|937541|P1|Overall Study|Withdrawal by Subject|13
283914|NCT00986232|937538|P4|Overall Study|Protocol Violation|1
283915|NCT00986232|937539|P3|Overall Study|Protocol Violation|0
283916|NCT00986232|937540|P2|Overall Study|Protocol Violation|3
283917|NCT00986232|937541|P1|Overall Study|Protocol Violation|2
283918|NCT00986232|937538|P4|Overall Study|Lost to Follow-up|7
283919|NCT00986232|937539|P3|Overall Study|Lost to Follow-up|12
283920|NCT00986232|937540|P2|Overall Study|Lost to Follow-up|12
283921|NCT00986232|937541|P1|Overall Study|Lost to Follow-up|19
283922|NCT00986232|937538|P4|Overall Study|Adverse Event|0
283923|NCT00986232|937539|P3|Overall Study|Adverse Event|3
283924|NCT00986232|937540|P2|Overall Study|Adverse Event|2
283925|NCT00986232|937541|P1|Overall Study|Adverse Event|1
283926|NCT00986180|937615|P2|Overall Study|Miscellanies|11
283927|NCT00986180|937616|P1|Overall Study|Miscellanies|10
283928|NCT00986180|937615|P2|Overall Study|Withdrawal by Subject|9
283929|NCT00986180|937616|P1|Overall Study|Withdrawal by Subject|1
283930|NCT00986180|937615|P2|Overall Study|Protocol Violation|0
283931|NCT00986180|937616|P1|Overall Study|Protocol Violation|2
283932|NCT00986180|937615|P2|Overall Study|Physician Decision|3
283933|NCT00986180|937616|P1|Overall Study|Physician Decision|1
283934|NCT00986180|937615|P2|Overall Study|Lost to Follow-up|7
283935|NCT00986180|937616|P1|Overall Study|Lost to Follow-up|5
283936|NCT00986180|937615|P2|Overall Study|Lack of Efficacy|3
283937|NCT00986180|937616|P1|Overall Study|Lack of Efficacy|4
283938|NCT00986180|937615|P2|Overall Study|Adverse Event|23
283939|NCT00986180|937616|P1|Overall Study|Adverse Event|21
283940|NCT00986154|937694|P2|Overall Study|never received study drug|27
283941|NCT00986154|937695|P1|Overall Study|never received study drug|25
283942|NCT00986154|937694|P2|Overall Study|investigator/subject decide not continue|3
283943|NCT00986154|937695|P1|Overall Study|investigator/subject decide not continue|6
283944|NCT00986154|937694|P2|Overall Study|Withdrawal by Subject|33
283945|NCT00986154|937695|P1|Overall Study|Withdrawal by Subject|32
283946|NCT00986154|937694|P2|Overall Study|Lost to Follow-up|4
283947|NCT00986154|937695|P1|Overall Study|Lost to Follow-up|7
283948|NCT00986154|937694|P2|Overall Study|Death|127
283949|NCT00986154|937695|P1|Overall Study|Death|136
283950|NCT00986102|937709|P4|Overall Study|Withdrawal by Subject|0
283951|NCT00986102|937710|P3|Overall Study|Withdrawal by Subject|0
283952|NCT00986102|937711|P2|Overall Study|Withdrawal by Subject|1
283953|NCT00986102|937712|P1|Overall Study|Withdrawal by Subject|1
283954|NCT00986102|937709|P4|Overall Study|Lost to Follow-up|1
283955|NCT00986102|937710|P3|Overall Study|Lost to Follow-up|0
283956|NCT00986102|937711|P2|Overall Study|Lost to Follow-up|1
283957|NCT00986102|937712|P1|Overall Study|Lost to Follow-up|0
283958|NCT00985985|937762|P4|Overall Study|Other Reason|2
283959|NCT00985985|937763|P3|Overall Study|Other Reason|4
283960|NCT00985985|937764|P2|Overall Study|Other Reason|1
283961|NCT00985985|937765|P1|Overall Study|Other Reason|6
283962|NCT00985985|937762|P4|Overall Study|Withdrawal by Subject|2
283963|NCT00985985|937763|P3|Overall Study|Withdrawal by Subject|2
283964|NCT00985985|937764|P2|Overall Study|Withdrawal by Subject|2
283965|NCT00985985|937765|P1|Overall Study|Withdrawal by Subject|4
283966|NCT00985985|937762|P4|Overall Study|Lack of Efficacy|3
283967|NCT00985985|937763|P3|Overall Study|Lack of Efficacy|1
283968|NCT00985985|937764|P2|Overall Study|Lack of Efficacy|6
283969|NCT00985985|937765|P1|Overall Study|Lack of Efficacy|5
283970|NCT00985985|937762|P4|Overall Study|Protocol Violation|1
283971|NCT00985985|937763|P3|Overall Study|Protocol Violation|0
283972|NCT00985985|937764|P2|Overall Study|Protocol Violation|2
283973|NCT00985985|937765|P1|Overall Study|Protocol Violation|1
283974|NCT00985985|937762|P4|Overall Study|Lost to Follow-up|3
283975|NCT00985985|937763|P3|Overall Study|Lost to Follow-up|2
283976|NCT00985985|937764|P2|Overall Study|Lost to Follow-up|11
283977|NCT00985985|937765|P1|Overall Study|Lost to Follow-up|4
283978|NCT00985985|937762|P4|Overall Study|Adverse Event|2
283979|NCT00985985|937763|P3|Overall Study|Adverse Event|2
283980|NCT00985985|937764|P2|Overall Study|Adverse Event|2
283981|NCT00985985|937765|P1|Overall Study|Adverse Event|4
283982|NCT00985959|937806|P3|Overall Study|Unspecified|11
283983|NCT00985959|937807|P2|Overall Study|Unspecified|0
283984|NCT00985959|937808|P1|Overall Study|Unspecified|0
283985|NCT00985959|937806|P3|Overall Study|Complete response observed over 2 cycles|4
283986|NCT00985959|937807|P2|Overall Study|Complete response observed over 2 cycles|1
283987|NCT00985959|937808|P1|Overall Study|Complete response observed over 2 cycles|0
283988|NCT00985959|937806|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
283989|NCT00985959|937807|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
283990|NCT00985959|937808|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
283991|NCT00985959|937806|P3|Overall Study|Unrecovered toxicity|7
283992|NCT00985959|937807|P2|Overall Study|Unrecovered toxicity|0
283993|NCT00985959|937808|P1|Overall Study|Unrecovered toxicity|0
283994|NCT00985959|937806|P3|Overall Study|Progressive disease|8
283995|NCT00985959|937807|P2|Overall Study|Progressive disease|2
283996|NCT00985959|937808|P1|Overall Study|Progressive disease|1
283997|NCT00985959|937806|P3|Overall Study|Withdrawal by Subject|8
283998|NCT00985959|937807|P2|Overall Study|Withdrawal by Subject|0
283999|NCT00985959|937808|P1|Overall Study|Withdrawal by Subject|0
284000|NCT00985959|937806|P3|Overall Study|Adverse Event|19
284001|NCT00985959|937807|P2|Overall Study|Adverse Event|0
284002|NCT00985959|937808|P1|Overall Study|Adverse Event|0
284003|NCT00985790|937842|P2|Overall Study|Lost to Follow-up|7
284004|NCT00985790|937843|P1|Overall Study|Lost to Follow-up|6
284005|NCT00985790|937842|P2|Overall Study|Withdrawal by Subject|1
284006|NCT00985790|937843|P1|Overall Study|Withdrawal by Subject|1
284007|NCT00985738|937881|P2|Overall Study|Study closed prematurely|8
284008|NCT00985738|937882|P1|Overall Study|Study closed prematurely|8
284009|NCT00985725|937890|P2|Overall Study|Out-of-window visits|1
284010|NCT00985725|937891|P1|Overall Study|Out-of-window visits|0
284011|NCT00985725|937890|P2|Overall Study|Non-compliance|2
284012|NCT00985725|937891|P1|Overall Study|Non-compliance|1
284013|NCT00985725|937890|P2|Overall Study|Lack of Efficacy|1
284014|NCT00985725|937891|P1|Overall Study|Lack of Efficacy|0
284015|NCT00985725|937890|P2|Overall Study|Lost to Follow-up|1
284016|NCT00985725|937891|P1|Overall Study|Lost to Follow-up|1
284017|NCT00985725|937890|P2|Overall Study|Withdrawal by Subject|4
284018|NCT00985725|937891|P1|Overall Study|Withdrawal by Subject|4
284019|NCT00985725|937890|P2|Overall Study|Protocol Violation|3
284020|NCT00985725|937891|P1|Overall Study|Protocol Violation|1
284021|NCT00985725|937890|P2|Overall Study|Adverse Event|1
284022|NCT00985725|937891|P1|Overall Study|Adverse Event|4
284023|NCT00985712|937927|P2|Overall Study|Sponsor decision|2
284024|NCT00985712|937928|P1|Overall Study|Sponsor decision|0
284025|NCT00985712|937927|P2|Overall Study|Withdrawal by Subject|1
284026|NCT00985712|937928|P1|Overall Study|Withdrawal by Subject|4
284027|NCT00985712|937927|P2|Overall Study|Protocol Violation|1
284028|NCT00985712|937928|P1|Overall Study|Protocol Violation|0
284029|NCT00985712|937927|P2|Overall Study|Lost to Follow-up|2
284030|NCT00985712|937928|P1|Overall Study|Lost to Follow-up|2
284031|NCT00985712|937927|P2|Overall Study|Adverse Event|1
284032|NCT00985712|937928|P1|Overall Study|Adverse Event|0
284033|NCT00985686|937946|P4|Overall Study|Lost to Follow-up|2
284034|NCT00985686|937947|P3|Overall Study|Lost to Follow-up|0
284035|NCT00985686|937948|P2|Overall Study|Lost to Follow-up|1
284036|NCT00985686|937949|P1|Overall Study|Lost to Follow-up|1
284037|NCT00985673|937963|P6|Overall Study|Unspecified|0
284038|NCT00985673|937964|P5|Overall Study|Unspecified|1
284039|NCT00985673|937965|P4|Overall Study|Unspecified|0
284040|NCT00985673|937966|P3|Overall Study|Unspecified|1
284041|NCT00985673|937967|P2|Overall Study|Unspecified|0
284042|NCT00985673|937968|P1|Overall Study|Unspecified|1
284043|NCT00985673|937963|P6|Overall Study|Withdrawal by Subject|3
284044|NCT00985673|937964|P5|Overall Study|Withdrawal by Subject|2
284045|NCT00985673|937965|P4|Overall Study|Withdrawal by Subject|2
284046|NCT00985673|937966|P3|Overall Study|Withdrawal by Subject|5
284047|NCT00985673|937967|P2|Overall Study|Withdrawal by Subject|4
284048|NCT00985673|937968|P1|Overall Study|Withdrawal by Subject|0
284049|NCT00985673|937963|P6|Overall Study|Lost to Follow-up|3
284050|NCT00985673|937964|P5|Overall Study|Lost to Follow-up|5
284051|NCT00985673|937965|P4|Overall Study|Lost to Follow-up|10
284052|NCT00985673|937966|P3|Overall Study|Lost to Follow-up|6
284053|NCT00985673|937967|P2|Overall Study|Lost to Follow-up|7
284054|NCT00985673|937968|P1|Overall Study|Lost to Follow-up|6
284055|NCT00985504|938230|P2|Optimization Period|Withdrawal by Subject|8
284056|NCT00985504|938231|P1|Optimization Period|Withdrawal by Subject|10
284057|NCT00985504|938230|P2|Optimization Period|Protocol Violation|1
284058|NCT00985504|938231|P1|Optimization Period|Protocol Violation|3
284059|NCT00985504|938230|P2|Optimization Period|Physician Decision|0
284060|NCT00985504|938231|P1|Optimization Period|Physician Decision|1
284061|NCT00985504|938230|P2|Optimization Period|Lost to Follow-up|1
284062|NCT00985504|938231|P1|Optimization Period|Lost to Follow-up|0
284063|NCT00985504|938230|P2|Optimization Period|Lack of Efficacy|3
284064|NCT00985504|938231|P1|Optimization Period|Lack of Efficacy|5
284065|NCT00985504|938230|P2|Optimization Period|Death|1
284066|NCT00985504|938231|P1|Optimization Period|Death|0
284067|NCT00985504|938230|P2|Optimization Period|Adverse Event|9
284068|NCT00985504|938231|P1|Optimization Period|Adverse Event|7
284069|NCT00985504|938230|P2|Acute Treatment Period|Withdrawal by Subject|5
284070|NCT00985504|938231|P1|Acute Treatment Period|Withdrawal by Subject|9
284071|NCT00985504|938230|P2|Acute Treatment Period|Sponsor Decision|1
284072|NCT00985504|938231|P1|Acute Treatment Period|Sponsor Decision|0
284073|NCT00985504|938230|P2|Acute Treatment Period|Protocol Violation|0
284074|NCT00985504|938231|P1|Acute Treatment Period|Protocol Violation|2
284075|NCT00985504|938230|P2|Acute Treatment Period|Entry Criteria Not Met|2
284076|NCT00985504|938231|P1|Acute Treatment Period|Entry Criteria Not Met|1
284077|NCT00985504|938230|P2|Acute Treatment Period|Adverse Event|4
284078|NCT00985504|938231|P1|Acute Treatment Period|Adverse Event|3
284079|NCT00985491|938257|P1|Overall Study|implant failure|3
284080|NCT00985491|938257|P1|Overall Study|Withdrawal by Subject|1
284081|NCT00985491|938257|P1|Overall Study|device migration|7
284082|NCT00985491|938257|P1|Overall Study|Adverse Event|8
284083|NCT00985439|938266|P4|Overall Study|Adverse Event|0
284084|NCT00985439|938267|P3|Overall Study|Adverse Event|1
284085|NCT00985439|938268|P2|Overall Study|Adverse Event|0
284086|NCT00985439|938269|P1|Overall Study|Adverse Event|0
284087|NCT00985231|938285|P2|Overall Study|Study related symptoms & complaints|2
284088|NCT00985231|938286|P1|Overall Study|Study related symptoms & complaints|0
284089|NCT00985231|938285|P2|Overall Study|Lost to Follow-up|1
284090|NCT00985231|938286|P1|Overall Study|Lost to Follow-up|0
284091|NCT00985231|938285|P2|Overall Study|Withdrawal by Subject|0
284092|NCT00985231|938286|P1|Overall Study|Withdrawal by Subject|1
284093|NCT00985231|938285|P2|Overall Study|Protocol Violation|0
284094|NCT00985231|938286|P1|Overall Study|Protocol Violation|1
284095|NCT00985231|938285|P2|Overall Study|ineligible|0
284096|NCT00985231|938286|P1|Overall Study|ineligible|1
284097|NCT00985192|938294|P1|Overall Study|Determined to be Ineligible During Trial|2
284098|NCT00985192|938294|P1|Overall Study|Disease Progression|1
284099|NCT00985192|938294|P1|Overall Study|Withdrawal by Subject|1
284100|NCT00985166|938306|P3|Overall Study|Unspecified|1
284101|NCT00985166|938307|P2|Overall Study|Unspecified|0
284102|NCT00985166|938308|P1|Overall Study|Unspecified|1
284103|NCT00985166|938306|P3|Overall Study|Test not done|4
284104|NCT00985166|938307|P2|Overall Study|Test not done|0
284105|NCT00985166|938308|P1|Overall Study|Test not done|2
284106|NCT00985166|938306|P3|Overall Study|Withdrawal by Subject|0
284107|NCT00985166|938307|P2|Overall Study|Withdrawal by Subject|2
284108|NCT00985166|938308|P1|Overall Study|Withdrawal by Subject|3
284109|NCT00985166|938306|P3|Overall Study|Lost to Follow-up|2
284110|NCT00985166|938307|P2|Overall Study|Lost to Follow-up|2
284111|NCT00985166|938308|P1|Overall Study|Lost to Follow-up|3
284112|NCT00985153|938328|P4|Overall Study|Incomplete Safety Follow-up|4
284113|NCT00985153|938329|P3|Overall Study|Incomplete Safety Follow-up|4
284114|NCT00985153|938330|P2|Overall Study|Incomplete Safety Follow-up|5
284115|NCT00985153|938331|P1|Overall Study|Incomplete Safety Follow-up|3
284116|NCT00985153|938328|P4|Overall Study|Missed One or More Bleeds|10
284117|NCT00985153|938329|P3|Overall Study|Missed One or More Bleeds|8
284118|NCT00985153|938330|P2|Overall Study|Missed One or More Bleeds|7
284119|NCT00985153|938331|P1|Overall Study|Missed One or More Bleeds|7
284120|NCT00985153|938328|P4|Overall Study|Withdrawal by Subject|10
284121|NCT00985153|938329|P3|Overall Study|Withdrawal by Subject|11
284122|NCT00985153|938330|P2|Overall Study|Withdrawal by Subject|11
284123|NCT00985153|938331|P1|Overall Study|Withdrawal by Subject|6
284124|NCT00985153|938328|P4|Overall Study|Protocol Violation|3
284125|NCT00985153|938329|P3|Overall Study|Protocol Violation|4
284126|NCT00985153|938330|P2|Overall Study|Protocol Violation|2
284127|NCT00985153|938331|P1|Overall Study|Protocol Violation|3
284128|NCT00985153|938328|P4|Overall Study|Lost to Follow-up|20
284129|NCT00985153|938329|P3|Overall Study|Lost to Follow-up|17
284130|NCT00985153|938330|P2|Overall Study|Lost to Follow-up|19
284131|NCT00985153|938331|P1|Overall Study|Lost to Follow-up|16
284132|NCT00985114|938379|P2|Overall Study|Withdrawal by Subject|2
284133|NCT00985114|938380|P1|Overall Study|Withdrawal by Subject|0
284134|NCT00985114|938379|P2|Overall Study|Adverse Event|0
284135|NCT00985114|938380|P1|Overall Study|Adverse Event|1
284136|NCT00984867|938399|P2|Overall Study|lack of efficacy and subject compliance|0
284137|NCT00984867|938400|P1|Overall Study|lack of efficacy and subject compliance|1
284138|NCT00984867|938399|P2|Overall Study|site closing|0
284139|NCT00984867|938400|P1|Overall Study|site closing|1
284140|NCT00984867|938399|P2|Overall Study|Subject no longer meets study criteria|1
284141|NCT00984867|938400|P1|Overall Study|Subject no longer meets study criteria|1
284142|NCT00984867|938399|P2|Overall Study|Poor/non-compliance|1
284143|NCT00984867|938400|P1|Overall Study|Poor/non-compliance|0
284144|NCT00984867|938399|P2|Overall Study|Lost to Follow-up|4
284145|NCT00984867|938400|P1|Overall Study|Lost to Follow-up|3
284146|NCT00984867|938399|P2|Overall Study|Withdrawal by Subject|4
284147|NCT00984867|938400|P1|Overall Study|Withdrawal by Subject|13
284148|NCT00984867|938399|P2|Overall Study|Death|0
284149|NCT00984867|938400|P1|Overall Study|Death|1
284150|NCT00984867|938399|P2|Overall Study|Adverse Event|7
284151|NCT00984867|938400|P1|Overall Study|Adverse Event|3
284152|NCT00984659|938440|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
284153|NCT00984659|938441|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
284154|NCT00984659|938442|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
284155|NCT00984659|938443|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
284156|NCT00984659|938440|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
284157|NCT00984659|938441|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
284158|NCT00984659|938442|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
284159|NCT00984659|938443|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
284160|NCT00984659|938440|P4|6-week Double-blind Treatment Period|Protocol Violation|4
284161|NCT00984659|938441|P3|6-week Double-blind Treatment Period|Protocol Violation|0
284162|NCT00984659|938442|P2|6-week Double-blind Treatment Period|Protocol Violation|0
284163|NCT00984659|938443|P1|6-week Double-blind Treatment Period|Protocol Violation|0
284164|NCT00984659|938440|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
284165|NCT00984659|938441|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
284166|NCT00984659|938442|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
284167|NCT00984659|938443|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
284168|NCT00984659|938440|P4|6-week Double-blind Treatment Period|Adverse Event|7
284169|NCT00984659|938441|P3|6-week Double-blind Treatment Period|Adverse Event|3
284170|NCT00984659|938442|P2|6-week Double-blind Treatment Period|Adverse Event|3
284171|NCT00984659|938443|P1|6-week Double-blind Treatment Period|Adverse Event|0
284172|NCT00984659|938440|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
284173|NCT00984659|938441|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
284174|NCT00984659|938442|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
284175|NCT00984659|938443|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
284176|NCT00984659|938440|P4|2-week Run-in Period|Withdrawal by Subject|0
284177|NCT00984659|938441|P3|2-week Run-in Period|Withdrawal by Subject|0
284178|NCT00984659|938442|P2|2-week Run-in Period|Withdrawal by Subject|0
284179|NCT00984659|938443|P1|2-week Run-in Period|Withdrawal by Subject|10
284180|NCT00984659|938440|P4|2-week Run-in Period|Physician Decision|0
284181|NCT00984659|938441|P3|2-week Run-in Period|Physician Decision|0
284182|NCT00984659|938442|P2|2-week Run-in Period|Physician Decision|0
284183|NCT00984659|938443|P1|2-week Run-in Period|Physician Decision|10
284184|NCT00984659|938440|P4|2-week Run-in Period|Lost to Follow-up|0
284185|NCT00984659|938441|P3|2-week Run-in Period|Lost to Follow-up|0
284186|NCT00984659|938442|P2|2-week Run-in Period|Lost to Follow-up|0
284187|NCT00984659|938443|P1|2-week Run-in Period|Lost to Follow-up|3
284188|NCT00984659|938440|P4|2-week Run-in Period|Study Closed/Terminated|0
284189|NCT00984659|938441|P3|2-week Run-in Period|Study Closed/Terminated|0
284190|NCT00984659|938442|P2|2-week Run-in Period|Study Closed/Terminated|0
284191|NCT00984659|938443|P1|2-week Run-in Period|Study Closed/Terminated|2
284192|NCT00984659|938440|P4|2-week Run-in Period|Protocol Violation|0
284193|NCT00984659|938441|P3|2-week Run-in Period|Protocol Violation|0
284194|NCT00984659|938442|P2|2-week Run-in Period|Protocol Violation|0
284195|NCT00984659|938443|P1|2-week Run-in Period|Protocol Violation|5
284196|NCT00984659|938440|P4|2-week Run-in Period|Adverse Event|0
284197|NCT00984659|938441|P3|2-week Run-in Period|Adverse Event|0
284198|NCT00984659|938442|P2|2-week Run-in Period|Adverse Event|0
284199|NCT00984659|938443|P1|2-week Run-in Period|Adverse Event|8
284200|NCT00984620|938470|P2|Overall Study|reason other than listed above|4
284201|NCT00984620|938471|P1|Overall Study|reason other than listed above|0
284202|NCT00984620|938470|P2|Overall Study|Withdrawal by Subject|2
284203|NCT00984620|938471|P1|Overall Study|Withdrawal by Subject|0
284204|NCT00984620|938470|P2|Overall Study|Lost to Follow-up|1
284205|NCT00984620|938471|P1|Overall Study|Lost to Follow-up|1
284206|NCT00984620|938470|P2|Overall Study|Adverse Event|5
284207|NCT00984620|938471|P1|Overall Study|Adverse Event|5
284208|NCT00984594|938509|P2|Overall Study|Withdrawal by Subject|1
284209|NCT00984594|938510|P1|Overall Study|Withdrawal by Subject|0
284210|NCT00984594|938509|P2|Overall Study|Lost to Follow-up|0
284211|NCT00984594|938510|P1|Overall Study|Lost to Follow-up|1
284212|NCT00984568|938526|P2|Overall Study|Unknown Reason|3
284213|NCT00984568|938527|P1|Overall Study|Unknown Reason|1
284214|NCT00984568|938526|P2|Overall Study|Opportunistic Infection|0
284215|NCT00984568|938527|P1|Overall Study|Opportunistic Infection|1
284216|NCT00984568|938526|P2|Overall Study|Lost to Follow-up|1
284217|NCT00984568|938527|P1|Overall Study|Lost to Follow-up|0
284218|NCT00984568|938526|P2|Overall Study|Did Not Meet Randomization Criteria|0
284219|NCT00984568|938527|P1|Overall Study|Did Not Meet Randomization Criteria|1
284220|NCT00984568|938526|P2|Overall Study|Adverse Event|0
284221|NCT00984568|938527|P1|Overall Study|Adverse Event|2
284222|NCT00984568|938526|P2|Overall Study|Lack of Efficacy|0
284223|NCT00984568|938527|P1|Overall Study|Lack of Efficacy|2
284224|NCT00984568|938526|P2|Overall Study|Withdrawal by Subject|2
284225|NCT00984568|938527|P1|Overall Study|Withdrawal by Subject|1
284226|NCT00984542|938535|P1|Overall Study|clinical deterioration|2
284227|NCT00984542|938535|P1|Overall Study|Withdrawal by Subject|3
284228|NCT00984542|938535|P1|Overall Study|complicating disease|3
284229|NCT00984542|938535|P1|Overall Study|Death|7
284230|NCT00984542|938535|P1|Overall Study|toxicity|7
284231|NCT00984542|938535|P1|Overall Study|disease progression|19
284232|NCT00984295|938585|P3|Overall Study|Incomplete safety follow-up|3
284233|NCT00984295|938586|P2|Overall Study|Incomplete safety follow-up|2
284234|NCT00984295|938587|P1|Overall Study|Incomplete safety follow-up|11
284235|NCT00984295|938585|P3|Overall Study|Missed one or more blood samplings|2
284236|NCT00984295|938586|P2|Overall Study|Missed one or more blood samplings|7
284237|NCT00984295|938587|P1|Overall Study|Missed one or more blood samplings|3
284238|NCT00984295|938585|P3|Overall Study|CAE – discontinued test vaccine|3
284239|NCT00984295|938586|P2|Overall Study|CAE – discontinued test vaccine|1
284240|NCT00984295|938587|P1|Overall Study|CAE – discontinued test vaccine|0
284241|NCT00984295|938585|P3|Overall Study|Withdrawal by Subject|12
284242|NCT00984295|938586|P2|Overall Study|Withdrawal by Subject|9
284243|NCT00984295|938587|P1|Overall Study|Withdrawal by Subject|18
284244|NCT00984295|938585|P3|Overall Study|Protocol Violation|4
284245|NCT00984295|938586|P2|Overall Study|Protocol Violation|1
284246|NCT00984295|938587|P1|Overall Study|Protocol Violation|2
284247|NCT00984295|938585|P3|Overall Study|Lost to Follow-up|13
284248|NCT00984295|938586|P2|Overall Study|Lost to Follow-up|12
284249|NCT00984295|938587|P1|Overall Study|Lost to Follow-up|31
284250|NCT00984282|938654|P2|Long Term Follow-up|Ongoing with treatment|26
284251|NCT00984282|938655|P1|Long Term Follow-up|Ongoing with treatment|33
284252|NCT00984282|938654|P2|Long Term Follow-up|Lost to Follow-up|4
284253|NCT00984282|938655|P1|Long Term Follow-up|Lost to Follow-up|8
284254|NCT00984282|938654|P2|Long Term Follow-up|Death|72
284255|NCT00984282|938655|P1|Long Term Follow-up|Death|55
284256|NCT00984282|938654|P2|Long Term Follow-up|Withdrawal by Subject|15
284257|NCT00984282|938655|P1|Long Term Follow-up|Withdrawal by Subject|18
284258|NCT00984282|938654|P2|Open-label Treatment|Target lesion removed|1
284259|NCT00984282|938655|P1|Open-label Treatment|Target lesion removed|0
284260|NCT00984282|938654|P2|Open-label Treatment|Non-compliant with study medication|0
284261|NCT00984282|938655|P1|Open-label Treatment|Non-compliant with study medication|1
284262|NCT00984282|938654|P2|Open-label Treatment|Ongoing with treatment|18
284263|NCT00984282|938655|P1|Open-label Treatment|Ongoing with treatment|19
284264|NCT00984282|938654|P2|Open-label Treatment|Lost to Follow-up|0
284265|NCT00984282|938655|P1|Open-label Treatment|Lost to Follow-up|1
284266|NCT00984282|938654|P2|Open-label Treatment|Progression, recurrence or relapse|77
284267|NCT00984282|938655|P1|Open-label Treatment|Progression, recurrence or relapse|37
284268|NCT00984282|938654|P2|Open-label Treatment|Death|15
284269|NCT00984282|938655|P1|Open-label Treatment|Death|5
284270|NCT00984282|938654|P2|Open-label Treatment|Withdrawal by Subject|21
284271|NCT00984282|938655|P1|Open-label Treatment|Withdrawal by Subject|6
284272|NCT00984282|938654|P2|Open-label Treatment|Adverse Event|29
284273|NCT00984282|938655|P1|Open-label Treatment|Adverse Event|17
284274|NCT00984282|938654|P2|Double Blind Treatment|Switched to follow-up|4
284275|NCT00984282|938655|P1|Double Blind Treatment|Switched to follow-up|12
284276|NCT00984282|938654|P2|Double Blind Treatment|Not treated|1
284277|NCT00984282|938655|P1|Double Blind Treatment|Not treated|0
284278|NCT00984282|938654|P2|Double Blind Treatment|Death|4
284279|NCT00984282|938655|P1|Double Blind Treatment|Death|8
284280|NCT00984282|938654|P2|Double Blind Treatment|Lost to Follow-up|0
284281|NCT00984282|938655|P1|Double Blind Treatment|Lost to Follow-up|3
284282|NCT00984282|938654|P2|Double Blind Treatment|Withdrawal by Subject|18
284283|NCT00984282|938655|P1|Double Blind Treatment|Withdrawal by Subject|14
284284|NCT00984282|938654|P2|Double Blind Treatment|Progression by clinical judgment|0
284285|NCT00984282|938655|P1|Double Blind Treatment|Progression by clinical judgment|1
284286|NCT00984282|938654|P2|Double Blind Treatment|Noncompliance with study medication|0
284287|NCT00984282|938655|P1|Double Blind Treatment|Noncompliance with study medication|3
284288|NCT00984282|938654|P2|Double Blind Treatment|Physician Decision|2
284289|NCT00984282|938655|P1|Double Blind Treatment|Physician Decision|1
284290|NCT00984282|938654|P2|Double Blind Treatment|Progression, recurrence or relapse|3
284291|NCT00984282|938655|P1|Double Blind Treatment|Progression, recurrence or relapse|24
284292|NCT00984282|938654|P2|Double Blind Treatment|Adverse Event|6
284293|NCT00984282|938655|P1|Double Blind Treatment|Adverse Event|38
284294|NCT00984256|938678|P2|Overall Study|Withdrawal by Subject|1
284295|NCT00984256|938679|P1|Overall Study|Withdrawal by Subject|0
284296|NCT00984204|938699|P1|Overall Study|Lack of Efficacy|10
284297|NCT00984204|938699|P1|Overall Study|Lost to Follow-up|4
284298|NCT00984204|938699|P1|Overall Study|Death|1
284299|NCT00984165|938709|P4|Overall Study|removed with a pair recipient|1
284300|NCT00984165|938710|P3|Overall Study|removed with a pair recipient|0
284301|NCT00984165|938711|P2|Overall Study|removed with a pair recipient|0
284302|NCT00984165|938712|P1|Overall Study|removed with a pair recipient|0
284303|NCT00984165|938709|P4|Overall Study|P+/donor pair removed from protocol|1
284304|NCT00984165|938710|P3|Overall Study|P+/donor pair removed from protocol|0
284305|NCT00984165|938711|P2|Overall Study|P+/donor pair removed from protocol|0
284306|NCT00984165|938712|P1|Overall Study|P+/donor pair removed from protocol|0
284307|NCT00984165|938709|P4|Overall Study|New protocol|1
284308|NCT00984165|938710|P3|Overall Study|New protocol|0
284309|NCT00984165|938711|P2|Overall Study|New protocol|0
284310|NCT00984165|938712|P1|Overall Study|New protocol|0
284311|NCT00984165|938709|P4|Overall Study|Death of recipient|1
284312|NCT00984165|938710|P3|Overall Study|Death of recipient|0
284313|NCT00984165|938711|P2|Overall Study|Death of recipient|0
284314|NCT00984165|938712|P1|Overall Study|Death of recipient|0
284315|NCT00984165|938709|P4|Overall Study|Disease progression on study|0
284316|NCT00984165|938710|P3|Overall Study|Disease progression on study|0
284317|NCT00984165|938711|P2|Overall Study|Disease progression on study|1
284318|NCT00984165|938712|P1|Overall Study|Disease progression on study|5
284319|NCT00984165|938709|P4|Overall Study|Death on study|0
284320|NCT00984165|938710|P3|Overall Study|Death on study|0
284321|NCT00984165|938711|P2|Overall Study|Death on study|0
284322|NCT00984165|938712|P1|Overall Study|Death on study|2
284323|NCT00984061|938737|P1|Clarithromycin Alone|Protocol Violation|1
284324|NCT00984022|938750|P2|Overall Study|Lost to Follow-up|14
284325|NCT00984022|938751|P1|Overall Study|Lost to Follow-up|10
284326|NCT00984009|938761|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
284327|NCT00983957|938794|P1|Overall Study|Personal Reasons|1
284328|NCT00983957|938794|P1|Overall Study|Adverse Event|1
284329|NCT00983931|938828|P1|14 Day Washout Period|Physician Decision|1
284330|NCT00983918|938842|P4|Overall Study|conversion to open cholecystectomy|2
284331|NCT00983918|938843|P3|Overall Study|conversion to open cholecystectomy|2
284332|NCT00983918|938844|P2|Overall Study|conversion to open cholecystectomy|2
284333|NCT00983918|938845|P1|Overall Study|conversion to open cholecystectomy|0
284334|NCT00983905|938855|P1|Colchicine Alone|Adverse Event|2
284335|NCT00983905|938855|P1|Theophylline Alone|Adverse Event|1
284336|NCT00983892|938868|P2|Overall Study|Withdrawal by Subject|12
284337|NCT00983892|938869|P1|Overall Study|Withdrawal by Subject|10
284338|NCT00983853|938881|P6|Overall Study|Unable to come to study follow-up visits|0
284339|NCT00983853|938882|P5|Overall Study|Unable to come to study follow-up visits|0
284340|NCT00983853|938883|P4|Overall Study|Unable to come to study follow-up visits|0
284341|NCT00983853|938884|P3|Overall Study|Unable to come to study follow-up visits|0
284342|NCT00983853|938885|P2|Overall Study|Unable to come to study follow-up visits|1
284343|NCT00983853|938886|P1|Overall Study|Unable to come to study follow-up visits|0
284344|NCT00983853|938881|P6|Overall Study|Withdrawal by Subject|0
284345|NCT00983853|938882|P5|Overall Study|Withdrawal by Subject|1
284346|NCT00983853|938883|P4|Overall Study|Withdrawal by Subject|0
284347|NCT00983853|938884|P3|Overall Study|Withdrawal by Subject|1
284348|NCT00983853|938885|P2|Overall Study|Withdrawal by Subject|0
284349|NCT00983853|938886|P1|Overall Study|Withdrawal by Subject|0
284350|NCT00983853|938881|P6|Overall Study|Lost to Follow-up|1
284351|NCT00983853|938882|P5|Overall Study|Lost to Follow-up|2
284352|NCT00983853|938883|P4|Overall Study|Lost to Follow-up|2
284353|NCT00983853|938884|P3|Overall Study|Lost to Follow-up|2
284354|NCT00983853|938885|P2|Overall Study|Lost to Follow-up|1
284355|NCT00983853|938886|P1|Overall Study|Lost to Follow-up|1
284356|NCT00983827|938914|P1|Overall Study|Withdrawal by Subject|1
284357|NCT00983749|938932|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
284358|NCT00983749|938933|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
284359|NCT00983515|938966|P1|Colchicine With Ritonavir|Lost to Follow-up|1
284360|NCT00983515|938966|P1|Ritonavir Alone|liver panel out of range|6
284361|NCT00983476|938993|P3|Overall Study|Did not receive intervention|0
284362|NCT00983476|938994|P2|Overall Study|Did not receive intervention|22
284363|NCT00983476|938995|P1|Overall Study|Did not receive intervention|17
284364|NCT00983437|939027|P1|Overall Study|Other Reason|26
284365|NCT00983437|939027|P1|Overall Study|Lost to Follow-up|2
284366|NCT00983437|939027|P1|Overall Study|Noncompliance to Study Procedures|1
284367|NCT00983437|939027|P1|Overall Study|Withdrawal by Subject|8
284368|NCT00983437|939027|P1|Overall Study|Lack of Efficacy|1
284369|NCT00983437|939027|P1|Overall Study|Adverse Event|9
284370|NCT00983385|939046|P1|Observation Period|Not Evaluable due to Non Compliance|12
284371|NCT00983385|939046|P1|Observation Period|Not eligible to be dosed|20
284372|NCT00983372|939091|P1|Diltiazem ER Alone|Adverse Event|1
284373|NCT00983372|939091|P1|Diltiazem ER Alone|missed diltiazem dose|2
284374|NCT00983372|939091|P1|14 Day Washout Period|Withdrawal by Subject|1
284375|NCT00983294|939114|P1|Colchicine With Azithromycin|Adverse Event|1
284376|NCT00983294|939114|P1|14 Day Washout Period|Withdrawal by Subject|2
284377|NCT00983073|939156|P1|Maintenance Period|Other Reason|7
284378|NCT00983073|939156|P1|Maintenance Period|Lack of Efficacy|2
284379|NCT00983073|939156|P1|Maintenance Period|Withdrawal by Subject|2
284380|NCT00983073|939156|P1|Maintenance Period|Adverse Event|5
284381|NCT00983073|939156|P1|Titration and Optimal Dose Period|Other reason|4
284382|NCT00983073|939156|P1|Titration and Optimal Dose Period|Non-Compliance|1
284383|NCT00983073|939156|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
284384|NCT00983073|939156|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
284385|NCT00983073|939156|P1|Titration and Optimal Dose Period|Adverse Event|19
284386|NCT00982735|939182|P1|Overall Study|Patient ineligible for trial|224
284387|NCT00982735|939182|P1|Overall Study|Lost to Follow-up|6
284388|NCT00982657|939192|P4|Overall Study|On going at date of cut-off|1
284389|NCT00982657|939193|P3|Overall Study|On going at date of cut-off|0
284390|NCT00982657|939194|P2|Overall Study|On going at date of cut-off|0
284391|NCT00982657|939195|P1|Overall Study|On going at date of cut-off|0
284392|NCT00982657|939192|P4|Overall Study|Unspecified|4
284393|NCT00982657|939193|P3|Overall Study|Unspecified|0
284394|NCT00982657|939194|P2|Overall Study|Unspecified|0
284395|NCT00982657|939195|P1|Overall Study|Unspecified|0
284396|NCT00982657|939192|P4|Overall Study|Withdrawal by Subject|3
284397|NCT00982657|939193|P3|Overall Study|Withdrawal by Subject|1
284398|NCT00982657|939194|P2|Overall Study|Withdrawal by Subject|0
284399|NCT00982657|939195|P1|Overall Study|Withdrawal by Subject|0
284400|NCT00982657|939192|P4|Overall Study|Death|1
284401|NCT00982657|939193|P3|Overall Study|Death|1
284402|NCT00982657|939194|P2|Overall Study|Death|0
284403|NCT00982657|939195|P1|Overall Study|Death|1
284404|NCT00982644|939236|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
284405|NCT00982644|939237|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
284406|NCT00982644|939236|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
284407|NCT00982644|939237|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
284408|NCT00982644|939236|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
284409|NCT00982644|939237|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
284410|NCT00982644|939236|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
284411|NCT00982644|939237|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
284412|NCT00982644|939236|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
284413|NCT00982644|939237|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
284414|NCT00982644|939236|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
284415|NCT00982644|939237|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
284416|NCT00982644|939236|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
284417|NCT00982644|939237|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
284418|NCT00982644|939236|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
284419|NCT00982644|939237|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
284420|NCT00982644|939236|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
284421|NCT00982644|939237|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
284422|NCT00982644|939236|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
284423|NCT00982644|939237|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
284424|NCT00982488|939288|P5|Overall Study|Withdrawal by Subject|0
284425|NCT00982488|939289|P4|Overall Study|Withdrawal by Subject|0
284426|NCT00982488|939290|P3|Overall Study|Withdrawal by Subject|1
284427|NCT00982488|939291|P2|Overall Study|Withdrawal by Subject|1
284428|NCT00982488|939292|P1|Overall Study|Withdrawal by Subject|5
284429|NCT00982488|939288|P5|Overall Study|Study drug toxicity|0
284430|NCT00982488|939289|P4|Overall Study|Study drug toxicity|0
284431|NCT00982488|939290|P3|Overall Study|Study drug toxicity|6
284432|NCT00982488|939291|P2|Overall Study|Study drug toxicity|1
284433|NCT00982488|939292|P1|Overall Study|Study drug toxicity|34
284434|NCT00982488|939288|P5|Overall Study|Stem cell transplant|0
284435|NCT00982488|939289|P4|Overall Study|Stem cell transplant|1
284436|NCT00982488|939290|P3|Overall Study|Stem cell transplant|0
284437|NCT00982488|939291|P2|Overall Study|Stem cell transplant|0
284438|NCT00982488|939292|P1|Overall Study|Stem cell transplant|2
284439|NCT00982488|939288|P5|Overall Study|Poor compliance/noncompliance|0
284440|NCT00982488|939289|P4|Overall Study|Poor compliance/noncompliance|0
284441|NCT00982488|939290|P3|Overall Study|Poor compliance/noncompliance|0
284442|NCT00982488|939291|P2|Overall Study|Poor compliance/noncompliance|1
284443|NCT00982488|939292|P1|Overall Study|Poor compliance/noncompliance|0
284444|NCT00982488|939288|P5|Overall Study|Not specified|0
284445|NCT00982488|939289|P4|Overall Study|Not specified|1
284446|NCT00982488|939290|P3|Overall Study|Not specified|3
284447|NCT00982488|939291|P2|Overall Study|Not specified|1
284448|NCT00982488|939292|P1|Overall Study|Not specified|15
284449|NCT00982488|939288|P5|Overall Study|Maximum clinical benefit|0
284450|NCT00982488|939289|P4|Overall Study|Maximum clinical benefit|0
284451|NCT00982488|939290|P3|Overall Study|Maximum clinical benefit|1
284452|NCT00982488|939291|P2|Overall Study|Maximum clinical benefit|1
284453|NCT00982488|939292|P1|Overall Study|Maximum clinical benefit|1
284454|NCT00982488|939288|P5|Overall Study|Lost to Follow-up|0
284455|NCT00982488|939289|P4|Overall Study|Lost to Follow-up|0
284456|NCT00982488|939290|P3|Overall Study|Lost to Follow-up|0
284457|NCT00982488|939291|P2|Overall Study|Lost to Follow-up|0
284458|NCT00982488|939292|P1|Overall Study|Lost to Follow-up|1
284459|NCT00982488|939288|P5|Overall Study|Disease progression|1
284460|NCT00982488|939289|P4|Overall Study|Disease progression|1
284461|NCT00982488|939290|P3|Overall Study|Disease progression|10
284462|NCT00982488|939291|P2|Overall Study|Disease progression|5
284463|NCT00982488|939292|P1|Overall Study|Disease progression|30
284464|NCT00982488|939288|P5|Overall Study|Death|0
284465|NCT00982488|939289|P4|Overall Study|Death|0
284466|NCT00982488|939290|P3|Overall Study|Death|2
284467|NCT00982488|939291|P2|Overall Study|Death|0
284468|NCT00982488|939292|P1|Overall Study|Death|11
284469|NCT00982488|939288|P5|Overall Study|Adverse event unrelated to study drug|0
284470|NCT00982488|939289|P4|Overall Study|Adverse event unrelated to study drug|0
284471|NCT00982488|939290|P3|Overall Study|Adverse event unrelated to study drug|0
284472|NCT00982488|939291|P2|Overall Study|Adverse event unrelated to study drug|1
284473|NCT00982488|939292|P1|Overall Study|Adverse event unrelated to study drug|5
284474|NCT00982488|939288|P5|Overall Study|Administrative reason by sponsor|0
284475|NCT00982488|939289|P4|Overall Study|Administrative reason by sponsor|0
284476|NCT00982488|939290|P3|Overall Study|Administrative reason by sponsor|11
284477|NCT00982488|939291|P2|Overall Study|Administrative reason by sponsor|3
284478|NCT00982488|939292|P1|Overall Study|Administrative reason by sponsor|81
284479|NCT00982410|939325|P2|12-month Follow-up Assessment|scheduled, no-show|0
284480|NCT00982410|939326|P1|12-month Follow-up Assessment|scheduled, no-show|1
284481|NCT00982410|939325|P2|12-month Follow-up Assessment|incarceration|1
284482|NCT00982410|939326|P1|12-month Follow-up Assessment|incarceration|2
284483|NCT00982410|939325|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
284484|NCT00982410|939326|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
284485|NCT00982410|939325|P2|12-month Follow-up Assessment|could not reach to schedule|5
284486|NCT00982410|939326|P1|12-month Follow-up Assessment|could not reach to schedule|6
284487|NCT00982410|939325|P2|12-month Follow-up Assessment|Death|2
284488|NCT00982410|939326|P1|12-month Follow-up Assessment|Death|0
284489|NCT00982410|939325|P2|6-month Follow-up Assessment|scheduled, no-show|1
284490|NCT00982410|939326|P1|6-month Follow-up Assessment|scheduled, no-show|0
284491|NCT00982410|939325|P2|6-month Follow-up Assessment|patent surgery|1
284492|NCT00982410|939326|P1|6-month Follow-up Assessment|patent surgery|0
284493|NCT00982410|939325|P2|6-month Follow-up Assessment|incarceration|2
284494|NCT00982410|939326|P1|6-month Follow-up Assessment|incarceration|0
284495|NCT00982410|939325|P2|6-month Follow-up Assessment|participant no transportation|0
284496|NCT00982410|939326|P1|6-month Follow-up Assessment|participant no transportation|1
284497|NCT00982410|939325|P2|6-month Follow-up Assessment|Could not reach to schedule|7
284498|NCT00982410|939326|P1|6-month Follow-up Assessment|Could not reach to schedule|5
284499|NCT00982410|939325|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
284500|NCT00982410|939326|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
284501|NCT00982410|939325|P2|3-month Follow-up Assessment|Scheduled, no-show|2
284502|NCT00982410|939326|P1|3-month Follow-up Assessment|Scheduled, no-show|1
284503|NCT00982410|939325|P2|3-month Follow-up Assessment|Could not reach to schedule|9
284504|NCT00982410|939326|P1|3-month Follow-up Assessment|Could not reach to schedule|8
284505|NCT00982280|939352|P1|Maintenance Period|Adverse Event|1
284506|NCT00982280|939352|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
284507|NCT00982280|939352|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
284508|NCT00982280|939352|P1|Titration and Optimal Dose Period|Adverse Event|5
284509|NCT00982280|939352|P1|Observation Period|Not eligible to be dosed|19
284510|NCT00982228|939377|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
284511|NCT00982228|939378|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
284512|NCT00982228|939377|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
284513|NCT00982228|939378|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
284514|NCT00982228|939377|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
284515|NCT00982228|939378|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
284516|NCT00982228|939377|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
284517|NCT00982228|939378|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
284518|NCT00982228|939377|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
284519|NCT00982228|939378|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
284520|NCT00982228|939377|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
284521|NCT00982228|939378|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
284522|NCT00982228|939377|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
284523|NCT00982228|939378|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
284524|NCT00982228|939377|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
284525|NCT00982228|939378|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
284526|NCT00982228|939377|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
284527|NCT00982228|939378|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
284528|NCT00982228|939377|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
284529|NCT00982228|939378|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
284530|NCT00982137|939431|P4|Overall Study|Withdrawal by Subject|0
284531|NCT00982137|939432|P3|Overall Study|Withdrawal by Subject|0
284532|NCT00982137|939433|P2|Overall Study|Withdrawal by Subject|1
284533|NCT00982137|939434|P1|Overall Study|Withdrawal by Subject|0
284534|NCT00982137|939431|P4|Overall Study|Lost to Follow-up|1
284535|NCT00982137|939432|P3|Overall Study|Lost to Follow-up|0
284536|NCT00982137|939433|P2|Overall Study|Lost to Follow-up|0
284537|NCT00982137|939434|P1|Overall Study|Lost to Follow-up|0
284538|NCT00982111|939466|P2|Overall Study|Withdrawal by Subject|17
284539|NCT00982111|939467|P1|Overall Study|Withdrawal by Subject|16
284540|NCT00982111|939466|P2|Overall Study|On Study Treatment at Conclusion|0
284541|NCT00982111|939467|P1|Overall Study|On Study Treatment at Conclusion|7
284542|NCT00982111|939466|P2|Overall Study|New Anti-Cancer Therapy|5
284543|NCT00982111|939467|P1|Overall Study|New Anti-Cancer Therapy|5
284544|NCT00982111|939466|P2|Overall Study|Lost to Follow-up|6
284545|NCT00982111|939467|P1|Overall Study|Lost to Follow-up|9
284546|NCT00982111|939466|P2|Overall Study|Progressive Disease|37
284547|NCT00982111|939467|P1|Overall Study|Progressive Disease|37
284548|NCT00982111|939466|P2|Overall Study|Adverse Event|1
284549|NCT00982111|939467|P1|Overall Study|Adverse Event|1
284550|NCT00982020|939500|P2|Overall Study|Clinical Relapse|1
284551|NCT00982020|939501|P1|Overall Study|Clinical Relapse|0
284552|NCT00982020|939500|P2|Overall Study|Protocol Violation|2
284553|NCT00982020|939501|P1|Overall Study|Protocol Violation|0
284554|NCT00982020|939500|P2|Overall Study|Entry Criteria Not Met|1
284555|NCT00982020|939501|P1|Overall Study|Entry Criteria Not Met|2
284556|NCT00982020|939500|P2|Overall Study|Physician Decision|5
284557|NCT00982020|939501|P1|Overall Study|Physician Decision|2
284558|NCT00982020|939500|P2|Overall Study|Treatment Non-compliance|6
284559|NCT00982020|939501|P1|Overall Study|Treatment Non-compliance|3
284560|NCT00982020|939500|P2|Overall Study|Parent/Caregiver Decision|5
284561|NCT00982020|939501|P1|Overall Study|Parent/Caregiver Decision|5
284562|NCT00982020|939500|P2|Overall Study|Lack of Efficacy|4
284563|NCT00982020|939501|P1|Overall Study|Lack of Efficacy|10
284564|NCT00982020|939500|P2|Overall Study|Lost to Follow-up|11
284565|NCT00982020|939501|P1|Overall Study|Lost to Follow-up|5
284566|NCT00982020|939500|P2|Overall Study|Withdrawal by Subject|14
284567|NCT00982020|939501|P1|Overall Study|Withdrawal by Subject|11
284568|NCT00982020|939500|P2|Overall Study|Adverse Event|15
284569|NCT00982020|939501|P1|Overall Study|Adverse Event|19
284570|NCT00981461|939601|P2|Overall Study|Lost to Follow-up|2
284571|NCT00981461|939602|P1|Overall Study|Lost to Follow-up|5
284572|NCT00981409|939626|P2|Overall Study|Prostate Cancer Treatment before Trial|0
284573|NCT00981409|939627|P1|Overall Study|Prostate Cancer Treatment before Trial|2
284574|NCT00981409|939626|P2|Overall Study|Protocol Violation|1
284575|NCT00981409|939627|P1|Overall Study|Protocol Violation|0
284576|NCT00981409|939626|P2|Overall Study|Adverse Event|0
284577|NCT00981409|939627|P1|Overall Study|Adverse Event|4
284578|NCT00981292|939666|P6|Day 3|Protocol Violation|1
284579|NCT00981292|939667|P5|Day 3|Protocol Violation|0
284580|NCT00981292|939668|P4|Day 3|Protocol Violation|0
284581|NCT00981292|939669|P3|Day 3|Protocol Violation|0
284582|NCT00981292|939670|P2|Day 3|Protocol Violation|0
284583|NCT00981292|939671|P1|Day 3|Protocol Violation|0
284584|NCT00981292|939666|P6|Day 2|Protocol Violation|0
284585|NCT00981292|939667|P5|Day 2|Protocol Violation|0
284586|NCT00981292|939668|P4|Day 2|Protocol Violation|0
284587|NCT00981292|939669|P3|Day 2|Protocol Violation|0
284588|NCT00981292|939670|P2|Day 2|Protocol Violation|0
284589|NCT00981292|939671|P1|Day 2|Protocol Violation|2
284590|NCT00981292|939666|P6|Day 1|Protocol Violation|2
284591|NCT00981292|939667|P5|Day 1|Protocol Violation|0
284592|NCT00981292|939668|P4|Day 1|Protocol Violation|0
284593|NCT00981292|939669|P3|Day 1|Protocol Violation|0
284594|NCT00981292|939670|P2|Day 1|Protocol Violation|0
284595|NCT00981292|939671|P1|Day 1|Protocol Violation|1
284596|NCT00981175|939734|P2|Booster Dose Vaccination|Lost to Follow-up|3
284597|NCT00981175|939735|P1|Booster Dose Vaccination|Lost to Follow-up|2
284598|NCT00981175|939734|P2|Primary Dose Vaccination|Lost to Follow-up|1
284599|NCT00981175|939735|P1|Primary Dose Vaccination|Lost to Follow-up|2
284600|NCT00981175|939734|P2|Primary Dose Vaccination|Protocol Violation|1
284601|NCT00981175|939735|P1|Primary Dose Vaccination|Protocol Violation|0
284602|NCT00981175|939734|P2|Primary Dose Vaccination|Adverse Event|0
284603|NCT00981175|939735|P1|Primary Dose Vaccination|Adverse Event|1
284604|NCT00981084|939760|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
284605|NCT00981084|939761|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
284606|NCT00981084|939760|P2|Post Intervention (Data Analysis)|poor effort|1
284607|NCT00981084|939761|P1|Post Intervention (Data Analysis)|poor effort|1
284608|NCT00981058|939777|P2|Overall Study|On study treatment at conclusion|0
284609|NCT00981058|939778|P1|Overall Study|On study treatment at conclusion|9
284610|NCT00981058|939777|P2|Overall Study|Withdrawal by Subject|23
284611|NCT00981058|939778|P1|Overall Study|Withdrawal by Subject|25
284612|NCT00981058|939777|P2|Overall Study|Randomization Error|2
284613|NCT00981058|939778|P1|Overall Study|Randomization Error|1
284614|NCT00981058|939777|P2|Overall Study|Radiologist Error|1
284615|NCT00981058|939778|P1|Overall Study|Radiologist Error|0
284616|NCT00981058|939777|P2|Overall Study|Noncompliance|0
284617|NCT00981058|939778|P1|Overall Study|Noncompliance|1
284618|NCT00981058|939777|P2|Overall Study|New Anticancer Therapy|6
284619|NCT00981058|939778|P1|Overall Study|New Anticancer Therapy|6
284620|NCT00981058|939777|P2|Overall Study|Lost to Follow-up|15
284621|NCT00981058|939778|P1|Overall Study|Lost to Follow-up|16
284622|NCT00981058|939777|P2|Overall Study|Progressive Disease|49
284623|NCT00981058|939778|P1|Overall Study|Progressive Disease|61
284624|NCT00981058|939777|P2|Overall Study|Adverse Event|1
284625|NCT00981058|939778|P1|Overall Study|Adverse Event|1
284626|NCT00981019|939809|P1|Overall Study|Hit the survey after closure|79
284627|NCT00981019|939809|P1|Overall Study|Inadvertent exclusion|239
284628|NCT00981019|939809|P1|Overall Study|Did not match target population|94
284629|NCT00981019|939809|P1|Overall Study|Did not respond|65
284630|NCT00980980|939816|P3|Overall Study|Withdrawal by Hospital|0
284631|NCT00980980|939817|P2|Overall Study|Withdrawal by Hospital|1
284632|NCT00980980|939818|P1|Overall Study|Withdrawal by Hospital|0
284633|NCT00980798|939849|P2|Overall Study|Other|1
284634|NCT00980798|939850|P1|Overall Study|Other|0
284635|NCT00980798|939849|P2|Overall Study|Withdrawal by Subject|11
284636|NCT00980798|939850|P1|Overall Study|Withdrawal by Subject|8
284637|NCT00980798|939849|P2|Overall Study|Physician Decision|1
284638|NCT00980798|939850|P1|Overall Study|Physician Decision|2
284639|NCT00980798|939849|P2|Overall Study|Lost to Follow-up|1
284640|NCT00980798|939850|P1|Overall Study|Lost to Follow-up|0
284641|NCT00980798|939849|P2|Overall Study|Lack of Efficacy|5
284642|NCT00980798|939850|P1|Overall Study|Lack of Efficacy|16
284643|NCT00980798|939849|P2|Overall Study|Adverse Event|36
284644|NCT00980798|939850|P1|Overall Study|Adverse Event|7
284645|NCT00980655|939891|P2|Overall Study|Unspecified|1
284646|NCT00980655|939892|P1|Overall Study|Unspecified|0
284647|NCT00980655|939891|P2|Overall Study|Parent/legal guardian request|0
284648|NCT00980655|939892|P1|Overall Study|Parent/legal guardian request|1
284649|NCT00980655|939891|P2|Overall Study|Lost to Follow-up|1
284650|NCT00980655|939892|P1|Overall Study|Lost to Follow-up|0
284651|NCT00980655|939891|P2|Overall Study|Withdrawal by Subject|4
284652|NCT00980655|939892|P1|Overall Study|Withdrawal by Subject|0
284653|NCT00980655|939891|P2|Overall Study|Protocol Violation|7
284654|NCT00980655|939892|P1|Overall Study|Protocol Violation|2
284655|NCT00980655|939891|P2|Overall Study|Death|7
284656|NCT00980655|939892|P1|Overall Study|Death|0
284657|NCT00980655|939891|P2|Overall Study|Adverse Event|31
284658|NCT00980655|939892|P1|Overall Study|Adverse Event|13
284659|NCT00980330|939973|P7|Overall Study|(not specified)|0
284660|NCT00980330|939974|P6|Overall Study|(not specified)|1
284661|NCT00980330|939975|P5|Overall Study|(not specified)|1
284662|NCT00980330|939976|P4|Overall Study|(not specified)|1
284663|NCT00980330|939977|P3|Overall Study|(not specified)|0
284664|NCT00980330|939978|P2|Overall Study|(not specified)|0
284665|NCT00980330|939979|P1|Overall Study|(not specified)|2
284666|NCT00980330|939973|P7|Overall Study|Withdrawal by Subject|5
284667|NCT00980330|939974|P6|Overall Study|Withdrawal by Subject|2
284668|NCT00980330|939975|P5|Overall Study|Withdrawal by Subject|3
284669|NCT00980330|939976|P4|Overall Study|Withdrawal by Subject|1
284670|NCT00980330|939977|P3|Overall Study|Withdrawal by Subject|4
284671|NCT00980330|939978|P2|Overall Study|Withdrawal by Subject|4
284672|NCT00980330|939979|P1|Overall Study|Withdrawal by Subject|2
284673|NCT00980330|939973|P7|Overall Study|Lost to Follow-up|2
284674|NCT00980330|939974|P6|Overall Study|Lost to Follow-up|1
284675|NCT00980330|939975|P5|Overall Study|Lost to Follow-up|1
284676|NCT00980330|939976|P4|Overall Study|Lost to Follow-up|2
284677|NCT00980330|939977|P3|Overall Study|Lost to Follow-up|4
284678|NCT00980330|939978|P2|Overall Study|Lost to Follow-up|1
284679|NCT00980330|939979|P1|Overall Study|Lost to Follow-up|1
284680|NCT00980330|939973|P7|Overall Study|Adverse Event|0
284681|NCT00980330|939974|P6|Overall Study|Adverse Event|0
284682|NCT00980330|939975|P5|Overall Study|Adverse Event|0
284683|NCT00980330|939976|P4|Overall Study|Adverse Event|1
284684|NCT00980330|939977|P3|Overall Study|Adverse Event|0
284685|NCT00980330|939978|P2|Overall Study|Adverse Event|0
284686|NCT00980330|939979|P1|Overall Study|Adverse Event|0
284687|NCT00980200|940094|P5|7-day Treatment Period 3|Lack of Efficacy|1
284688|NCT00980200|940095|P4|7-day Treatment Period 3|Lack of Efficacy|0
284689|NCT00980200|940096|P3|7-day Treatment Period 3|Lack of Efficacy|0
284690|NCT00980200|940097|P2|7-day Treatment Period 3|Lack of Efficacy|1
284691|NCT00980200|940098|P1|7-day Treatment Period 3|Lack of Efficacy|0
284692|NCT00980200|940094|P5|7-day Treatment Period 1|Withdrawal by Subject|0
284693|NCT00980200|940095|P4|7-day Treatment Period 1|Withdrawal by Subject|0
284694|NCT00980200|940096|P3|7-day Treatment Period 1|Withdrawal by Subject|0
284695|NCT00980200|940097|P2|7-day Treatment Period 1|Withdrawal by Subject|1
284696|NCT00980200|940098|P1|7-day Treatment Period 1|Withdrawal by Subject|0
284697|NCT00980174|940117|P2|Overall Study|Other|1
284698|NCT00980174|940118|P1|Overall Study|Other|0
284699|NCT00980174|940117|P2|Overall Study|Death|1
284700|NCT00980174|940118|P1|Overall Study|Death|1
284701|NCT00980174|940117|P2|Overall Study|Ineligibility determined|1
284702|NCT00980174|940118|P1|Overall Study|Ineligibility determined|2
284703|NCT00980174|940117|P2|Overall Study|Adverse Event|3
284704|NCT00980174|940118|P1|Overall Study|Adverse Event|0
284705|NCT00980174|940117|P2|Overall Study|Withdrawal by Subject|4
284706|NCT00980174|940118|P1|Overall Study|Withdrawal by Subject|1
284707|NCT00980148|940136|P2|Overall Study|Various other reasons|9
284708|NCT00980148|940137|P1|Overall Study|Various other reasons|8
284709|NCT00980148|940136|P2|Overall Study|Negative for chlamydia at enrollment|9
284710|NCT00980148|940137|P1|Overall Study|Negative for chlamydia at enrollment|12
284711|NCT00980148|940136|P2|Overall Study|Received other antichlamydia treatment|14
284712|NCT00980148|940137|P1|Overall Study|Received other antichlamydia treatment|20
284713|NCT00980148|940136|P2|Overall Study|Discharged from facility|96
284714|NCT00980148|940137|P1|Overall Study|Discharged from facility|89
284715|NCT00980044|940146|P3|Overall Study|Protocol Violation|2
284716|NCT00980044|940147|P2|Overall Study|Protocol Violation|0
284717|NCT00980044|940148|P1|Overall Study|Protocol Violation|0
284718|NCT00980044|940146|P3|Overall Study|Withdrawal by Subject|3
284719|NCT00980044|940147|P2|Overall Study|Withdrawal by Subject|7
284720|NCT00980044|940148|P1|Overall Study|Withdrawal by Subject|5
284721|NCT00980005|940167|P2|Overall Study|Unspecified|3
284722|NCT00980005|940168|P1|Overall Study|Unspecified|4
284723|NCT00980005|940167|P2|Overall Study|Lost to Follow-up|43
284724|NCT00980005|940168|P1|Overall Study|Lost to Follow-up|37
284725|NCT00980005|940167|P2|Overall Study|Withdrawal by Subject|17
284726|NCT00980005|940168|P1|Overall Study|Withdrawal by Subject|6
284727|NCT00979953|940212|P4|Overall Study|Protocol Violation|2
284728|NCT00979953|940213|P3|Overall Study|Protocol Violation|2
284729|NCT00979953|940214|P2|Overall Study|Protocol Violation|0
284730|NCT00979953|940215|P1|Overall Study|Protocol Violation|1
284731|NCT00979953|940212|P4|Overall Study|Withdrawal by Subject|1
284732|NCT00979953|940213|P3|Overall Study|Withdrawal by Subject|2
284733|NCT00979953|940214|P2|Overall Study|Withdrawal by Subject|0
284734|NCT00979953|940215|P1|Overall Study|Withdrawal by Subject|0
284735|NCT00979953|940212|P4|Overall Study|Lost to Follow-up|0
284736|NCT00979953|940213|P3|Overall Study|Lost to Follow-up|1
284737|NCT00979953|940214|P2|Overall Study|Lost to Follow-up|1
284738|NCT00979953|940215|P1|Overall Study|Lost to Follow-up|1
284739|NCT00979953|940212|P4|Overall Study|Lack of Efficacy|0
284740|NCT00979953|940213|P3|Overall Study|Lack of Efficacy|0
284741|NCT00979953|940214|P2|Overall Study|Lack of Efficacy|2
284742|NCT00979953|940215|P1|Overall Study|Lack of Efficacy|1
284743|NCT00979953|940212|P4|Overall Study|Adverse Event|4
284744|NCT00979953|940213|P3|Overall Study|Adverse Event|17
284745|NCT00979953|940214|P2|Overall Study|Adverse Event|2
284746|NCT00979953|940215|P1|Overall Study|Adverse Event|5
284747|NCT00979901|940238|P4|Overall Study|Treatment Group Terminated by Sponsor|112
284748|NCT00979901|940239|P3|Overall Study|Treatment Group Terminated by Sponsor|0
284749|NCT00979901|940240|P2|Overall Study|Treatment Group Terminated by Sponsor|0
284750|NCT00979901|940241|P1|Overall Study|Treatment Group Terminated by Sponsor|0
284751|NCT00979901|940238|P4|Overall Study|Left Country|0
284752|NCT00979901|940239|P3|Overall Study|Left Country|1
284753|NCT00979901|940240|P2|Overall Study|Left Country|0
284754|NCT00979901|940241|P1|Overall Study|Left Country|0
284755|NCT00979901|940238|P4|Overall Study|Discontinued in Error|0
284756|NCT00979901|940239|P3|Overall Study|Discontinued in Error|0
284757|NCT00979901|940240|P2|Overall Study|Discontinued in Error|1
284758|NCT00979901|940241|P1|Overall Study|Discontinued in Error|0
284759|NCT00979901|940238|P4|Overall Study|elevated lab values pre-randomization|0
284760|NCT00979901|940239|P3|Overall Study|elevated lab values pre-randomization|0
284761|NCT00979901|940240|P2|Overall Study|elevated lab values pre-randomization|0
284762|NCT00979901|940241|P1|Overall Study|elevated lab values pre-randomization|1
284763|NCT00979901|940238|P4|Overall Study|vacation|0
284764|NCT00979901|940239|P3|Overall Study|vacation|0
284765|NCT00979901|940240|P2|Overall Study|vacation|0
284766|NCT00979901|940241|P1|Overall Study|vacation|1
284767|NCT00979901|940238|P4|Overall Study|out-of-state|0
284768|NCT00979901|940239|P3|Overall Study|out-of-state|0
284769|NCT00979901|940240|P2|Overall Study|out-of-state|0
284770|NCT00979901|940241|P1|Overall Study|out-of-state|1
284771|NCT00979901|940238|P4|Overall Study|Noncompliance|0
284772|NCT00979901|940239|P3|Overall Study|Noncompliance|0
284773|NCT00979901|940240|P2|Overall Study|Noncompliance|0
284774|NCT00979901|940241|P1|Overall Study|Noncompliance|1
284775|NCT00979901|940238|P4|Overall Study|Withdrawal by Subject|1
284776|NCT00979901|940239|P3|Overall Study|Withdrawal by Subject|1
284777|NCT00979901|940240|P2|Overall Study|Withdrawal by Subject|1
284778|NCT00979901|940241|P1|Overall Study|Withdrawal by Subject|2
284779|NCT00979901|940238|P4|Overall Study|Protocol Violation|1
284780|NCT00979901|940239|P3|Overall Study|Protocol Violation|7
284781|NCT00979901|940240|P2|Overall Study|Protocol Violation|2
284782|NCT00979901|940241|P1|Overall Study|Protocol Violation|2
284783|NCT00979901|940238|P4|Overall Study|Lost to Follow-up|0
284784|NCT00979901|940239|P3|Overall Study|Lost to Follow-up|2
284785|NCT00979901|940240|P2|Overall Study|Lost to Follow-up|1
284786|NCT00979901|940241|P1|Overall Study|Lost to Follow-up|1
284787|NCT00979901|940238|P4|Overall Study|Lack of Efficacy|0
284788|NCT00979901|940239|P3|Overall Study|Lack of Efficacy|9
284789|NCT00979901|940240|P2|Overall Study|Lack of Efficacy|4
284790|NCT00979901|940241|P1|Overall Study|Lack of Efficacy|8
284791|NCT00979901|940238|P4|Overall Study|Adverse Event|2
284792|NCT00979901|940239|P3|Overall Study|Adverse Event|9
284793|NCT00979901|940240|P2|Overall Study|Adverse Event|3
284794|NCT00979901|940241|P1|Overall Study|Adverse Event|1
284795|NCT00979654|940314|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
284796|NCT00979654|940314|P1|Overall Study|Serious Adverse Event|1
284797|NCT00979654|940314|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
284798|NCT00979654|940314|P1|Overall Study|Per Principal Investigator’s Discretion|1
284799|NCT00979654|940314|P1|Overall Study|Adverse Event of Diverticulitis|1
284800|NCT00979654|940314|P1|Overall Study|Adverse Event|1
284801|NCT00979654|940314|P1|Overall Study|Lack of Efficacy|6
284802|NCT00979654|940314|P1|Overall Study|Death|1
284803|NCT00979654|940314|P1|Overall Study|Withdrawal by Subject|22
284804|NCT00979654|940314|P1|Overall Study|Lost to Follow-up|1
284805|NCT00979628|940329|P3|Overall Study|transferred to ICU|1
284806|NCT00979628|940330|P2|Overall Study|transferred to ICU|2
284807|NCT00979628|940331|P1|Overall Study|transferred to ICU|1
284808|NCT00979628|940329|P3|Overall Study|received steroids|0
284809|NCT00979628|940330|P2|Overall Study|received steroids|1
284810|NCT00979628|940331|P1|Overall Study|received steroids|1
284811|NCT00979628|940329|P3|Overall Study|received regimen < 24 hours|5
284812|NCT00979628|940330|P2|Overall Study|received regimen < 24 hours|6
284813|NCT00979628|940331|P1|Overall Study|received regimen < 24 hours|7
284814|NCT00979576|940359|P3|Combination Followed by Monotherapy|Progressive Disease|1
284815|NCT00979576|940360|P2|Combination Followed by Monotherapy|Progressive Disease|2
284816|NCT00979576|940361|P1|Combination Followed by Monotherapy|Progressive Disease|0
284817|NCT00979576|940359|P3|Combination Treatment Phase|Adverse Event|2
284818|NCT00979576|940360|P2|Combination Treatment Phase|Adverse Event|2
284819|NCT00979576|940361|P1|Combination Treatment Phase|Adverse Event|0
284820|NCT00979576|940359|P3|Combination Treatment Phase|Dose limiting toxicity|2
284821|NCT00979576|940360|P2|Combination Treatment Phase|Dose limiting toxicity|3
284822|NCT00979576|940361|P1|Combination Treatment Phase|Dose limiting toxicity|0
284823|NCT00979576|940359|P3|Combination Treatment Phase|Progressive disease|5
284824|NCT00979576|940360|P2|Combination Treatment Phase|Progressive disease|1
284825|NCT00979576|940361|P1|Combination Treatment Phase|Progressive disease|3
284826|NCT00979420|940409|P4|Overall Study|Other reasons not related to Viramune|1
284827|NCT00979420|940410|P3|Overall Study|Other reasons not related to Viramune|0
284828|NCT00979420|940411|P2|Overall Study|Other reasons not related to Viramune|0
284829|NCT00979420|940412|P1|Overall Study|Other reasons not related to Viramune|3
284830|NCT00979420|940409|P4|Overall Study|Lack of Efficacy|1
284831|NCT00979420|940410|P3|Overall Study|Lack of Efficacy|1
284832|NCT00979420|940411|P2|Overall Study|Lack of Efficacy|0
284833|NCT00979420|940412|P1|Overall Study|Lack of Efficacy|3
284834|NCT00979420|940409|P4|Overall Study|Adverse Event|0
284835|NCT00979420|940410|P3|Overall Study|Adverse Event|0
284836|NCT00979420|940411|P2|Overall Study|Adverse Event|0
284837|NCT00979420|940412|P1|Overall Study|Adverse Event|1
284838|NCT00979212|940482|P2|Overall Study|No protocol therapy received|0
284839|NCT00979212|940483|P1|Overall Study|No protocol therapy received|1
284840|NCT00979212|940482|P2|Overall Study|Protocol Violation|8
284841|NCT00979212|940483|P1|Overall Study|Protocol Violation|1
284842|NCT00978757|940543|P2|Overall Study|Physician Decision|3
284843|NCT00978757|940544|P1|Overall Study|Physician Decision|1
284844|NCT00978731|940554|P4|Overall Study|No response|0
284845|NCT00978731|940555|P3|Overall Study|No response|0
284846|NCT00978731|940556|P2|Overall Study|No response|0
284847|NCT00978731|940557|P1|Overall Study|No response|1
284848|NCT00978731|940554|P4|Overall Study|Study closure|1
284849|NCT00978731|940555|P3|Overall Study|Study closure|1
284850|NCT00978731|940556|P2|Overall Study|Study closure|4
284851|NCT00978731|940557|P1|Overall Study|Study closure|3
284852|NCT00978731|940554|P4|Overall Study|Disease progression/relapse|2
284853|NCT00978731|940555|P3|Overall Study|Disease progression/relapse|2
284854|NCT00978731|940556|P2|Overall Study|Disease progression/relapse|4
284855|NCT00978731|940557|P1|Overall Study|Disease progression/relapse|5
284856|NCT00978731|940554|P4|Overall Study|Deterioration without progression|0
284857|NCT00978731|940555|P3|Overall Study|Deterioration without progression|0
284858|NCT00978731|940556|P2|Overall Study|Deterioration without progression|1
284859|NCT00978731|940557|P1|Overall Study|Deterioration without progression|0
284860|NCT00978731|940554|P4|Overall Study|Administrative reason|0
284861|NCT00978731|940555|P3|Overall Study|Administrative reason|1
284862|NCT00978731|940556|P2|Overall Study|Administrative reason|3
284863|NCT00978731|940557|P1|Overall Study|Administrative reason|3
284864|NCT00978731|940554|P4|Overall Study|Participant's request|0
284865|NCT00978731|940555|P3|Overall Study|Participant's request|0
284866|NCT00978731|940556|P2|Overall Study|Participant's request|0
284867|NCT00978731|940557|P1|Overall Study|Participant's request|1
284868|NCT00978731|940554|P4|Overall Study|Adverse Event|0
284869|NCT00978731|940555|P3|Overall Study|Adverse Event|0
284870|NCT00978731|940556|P2|Overall Study|Adverse Event|2
284871|NCT00978731|940557|P1|Overall Study|Adverse Event|5
284872|NCT00978731|940554|P4|Overall Study|Lost to Follow-up|1
284873|NCT00978731|940555|P3|Overall Study|Lost to Follow-up|0
284874|NCT00978731|940556|P2|Overall Study|Lost to Follow-up|0
284875|NCT00978731|940557|P1|Overall Study|Lost to Follow-up|0
284876|NCT00978731|940554|P4|Overall Study|Death|0
284877|NCT00978731|940555|P3|Overall Study|Death|1
284878|NCT00978731|940556|P2|Overall Study|Death|1
284879|NCT00978731|940557|P1|Overall Study|Death|4
284880|NCT00978627|940597|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
284881|NCT00978627|940598|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
284882|NCT00978627|940597|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
284883|NCT00978627|940598|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
284884|NCT00978627|940597|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
284885|NCT00978627|940598|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
284886|NCT00978627|940597|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
284887|NCT00978627|940598|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
284888|NCT00978627|940597|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
284889|NCT00978627|940598|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
284890|NCT00978627|940597|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
284891|NCT00978627|940598|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
284892|NCT00978627|940597|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
284893|NCT00978627|940598|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
284894|NCT00978627|940597|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
284895|NCT00978627|940598|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
284896|NCT00978627|940597|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
284897|NCT00978627|940598|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
284898|NCT00978432|940636|P3|Overall Study|Adverse Event|1
284899|NCT00978432|940637|P2|Overall Study|Adverse Event|0
284900|NCT00978432|940638|P1|Overall Study|Adverse Event|2
284901|NCT00978432|940636|P3|Overall Study|Lack of Efficacy|3
284902|NCT00978432|940637|P2|Overall Study|Lack of Efficacy|1
284903|NCT00978432|940638|P1|Overall Study|Lack of Efficacy|1
284904|NCT00978432|940636|P3|Overall Study|Withdrawal by Subject|1
284905|NCT00978432|940637|P2|Overall Study|Withdrawal by Subject|0
284906|NCT00978432|940638|P1|Overall Study|Withdrawal by Subject|0
284907|NCT00978380|940658|P1|Overall Study|Unclassified|8
284908|NCT00978380|940658|P1|Overall Study|Withdrawal criteria|9
284909|NCT00978380|940658|P1|Overall Study|Protocol Violation|2
284910|NCT00978341|940664|P2|Washout Period of 2 Weeks|Adverse Event|0
284911|NCT00978341|940665|P1|Washout Period of 2 Weeks|Adverse Event|1
284912|NCT00978120|940687|P4|Overall Study|Moved out of state|1
284913|NCT00978120|940688|P3|Overall Study|Moved out of state|0
284914|NCT00978120|940689|P2|Overall Study|Moved out of state|0
284915|NCT00978120|940690|P1|Overall Study|Moved out of state|0
284916|NCT00978120|940687|P4|Overall Study|Withdrawal by Subject|0
284917|NCT00978120|940688|P3|Overall Study|Withdrawal by Subject|0
284918|NCT00978120|940689|P2|Overall Study|Withdrawal by Subject|0
284919|NCT00978120|940690|P1|Overall Study|Withdrawal by Subject|2
284920|NCT00978120|940687|P4|Overall Study|Lost to Follow-up|0
284921|NCT00978120|940688|P3|Overall Study|Lost to Follow-up|3
284922|NCT00978120|940689|P2|Overall Study|Lost to Follow-up|0
284923|NCT00978120|940690|P1|Overall Study|Lost to Follow-up|0
284924|NCT00978120|940687|P4|Overall Study|Death|1
284925|NCT00978120|940688|P3|Overall Study|Death|0
284926|NCT00978120|940689|P2|Overall Study|Death|0
284927|NCT00978120|940690|P1|Overall Study|Death|0
284928|NCT00978042|940742|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
284929|NCT00978042|940743|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
284930|NCT00978042|940742|P2|Initial Treatment Period|Consent withdrawn|9
284931|NCT00978042|940743|P1|Initial Treatment Period|Consent withdrawn|22
284932|NCT00978042|940742|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
284933|NCT00978042|940743|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
284934|NCT00978042|940742|P2|Initial Treatment Period|Adverse Event|0
284935|NCT00978042|940743|P1|Initial Treatment Period|Adverse Event|2
284936|NCT00978042|940742|P2|Initial Treatment Period|Lost to Follow-up|3
284937|NCT00978042|940743|P1|Initial Treatment Period|Lost to Follow-up|21
284938|NCT00978042|940742|P2|Initial Treatment Period|Ineligibility|0
284939|NCT00978042|940743|P1|Initial Treatment Period|Ineligibility|1
284940|NCT00978042|940742|P2|Initial Treatment Period|Treated in Error|3
284941|NCT00978042|940743|P1|Initial Treatment Period|Treated in Error|0
284942|NCT00978029|940756|P3|Overall Study|Protocol Violation|0
284943|NCT00978029|940757|P2|Overall Study|Protocol Violation|1
284944|NCT00978029|940758|P1|Overall Study|Protocol Violation|0
284945|NCT00978029|940756|P3|Overall Study|Withdrawal by Subject|1
284946|NCT00978029|940757|P2|Overall Study|Withdrawal by Subject|0
284947|NCT00978029|940758|P1|Overall Study|Withdrawal by Subject|0
284948|NCT00978029|940756|P3|Overall Study|Adverse Event|5
284949|NCT00978029|940757|P2|Overall Study|Adverse Event|2
284950|NCT00978029|940758|P1|Overall Study|Adverse Event|1
284951|NCT00977938|940785|P4|Observation (30-33 mo. Post Procedure)|Other|0
284952|NCT00977938|940786|P3|Observation (30-33 mo. Post Procedure)|Other|0
284953|NCT00977938|940787|P2|Observation (30-33 mo. Post Procedure)|Other|4
284954|NCT00977938|940788|P1|Observation (30-33 mo. Post Procedure)|Other|8
284955|NCT00977938|940785|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
284956|NCT00977938|940786|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
284957|NCT00977938|940787|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
284958|NCT00977938|940788|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
284959|NCT00977938|940785|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
284960|NCT00977938|940786|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
284961|NCT00977938|940787|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
284962|NCT00977938|940788|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
284963|NCT00977938|940785|P4|Treatment (12-30 mo. Post Procedure)|Other|4
284964|NCT00977938|940786|P3|Treatment (12-30 mo. Post Procedure)|Other|3
284965|NCT00977938|940787|P2|Treatment (12-30 mo. Post Procedure)|Other|18
284966|NCT00977938|940788|P1|Treatment (12-30 mo. Post Procedure)|Other|17
284967|NCT00977938|940785|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
284968|NCT00977938|940786|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
284969|NCT00977938|940787|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
284970|NCT00977938|940788|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
284971|NCT00977938|940785|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
284972|NCT00977938|940786|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
284973|NCT00977938|940787|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
284974|NCT00977938|940788|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
284975|NCT00977665|940852|P2|Overall Study|Treatment failure|1
284976|NCT00977665|940853|P1|Overall Study|Treatment failure|0
284977|NCT00977665|940852|P2|Overall Study|Adverse Event|7
284978|NCT00977665|940853|P1|Overall Study|Adverse Event|14
284979|NCT00977665|940852|P2|Overall Study|Death|2
284980|NCT00977665|940853|P1|Overall Study|Death|3
284981|NCT00977665|940852|P2|Overall Study|Lost to Follow-up|0
284982|NCT00977665|940853|P1|Overall Study|Lost to Follow-up|1
284983|NCT00977665|940852|P2|Overall Study|Sponsor requested withdrawal|1
284984|NCT00977665|940853|P1|Overall Study|Sponsor requested withdrawal|0
284985|NCT00977665|940852|P2|Overall Study|Physician Decision|1
284986|NCT00977665|940853|P1|Overall Study|Physician Decision|2
284987|NCT00977665|940852|P2|Overall Study|Withdrawal by Subject|3
284988|NCT00977665|940853|P1|Overall Study|Withdrawal by Subject|1
284989|NCT00977613|940885|P1|Overall Study|Lost to Follow-up|16
284990|NCT00977561|940891|P2|Overall Study|Unspecified|0
284991|NCT00977561|940892|P1|Overall Study|Unspecified|2
284992|NCT00977561|940891|P2|Overall Study|Study terminated|2
284993|NCT00977561|940892|P1|Overall Study|Study terminated|0
284994|NCT00977561|940891|P2|Overall Study|Death|2
284995|NCT00977561|940892|P1|Overall Study|Death|3
284996|NCT00977548|940919|P1|Overall Study|Withdrawal by Subject|1
284997|NCT00977548|940919|P1|Overall Study|Adverse Event|8
284998|NCT00977548|940919|P1|Overall Study|Ineligible|4
284999|NCT00977470|940928|P2|Overall Study|Still on-study|0
285000|NCT00977470|940929|P1|Overall Study|Still on-study|2
285001|NCT00977470|940928|P2|Overall Study|prolonged recovery post-surgery|1
285002|NCT00977470|940929|P1|Overall Study|prolonged recovery post-surgery|0
285003|NCT00977470|940928|P2|Overall Study|clinical decline|1
285004|NCT00977470|940929|P1|Overall Study|clinical decline|0
285005|NCT00977470|940928|P2|Overall Study|Death|2
285006|NCT00977470|940929|P1|Overall Study|Death|0
285007|NCT00977470|940928|P2|Overall Study|Withdrawal by Subject|2
285008|NCT00977470|940929|P1|Overall Study|Withdrawal by Subject|0
285009|NCT00977470|940928|P2|Overall Study|Protocol Violation|0
285010|NCT00977470|940929|P1|Overall Study|Protocol Violation|1
285011|NCT00977470|940928|P2|Overall Study|Adverse Event|2
285012|NCT00977470|940929|P1|Overall Study|Adverse Event|1
285013|NCT00977470|940928|P2|Overall Study|Physician Decision|0
285014|NCT00977470|940929|P1|Overall Study|Physician Decision|2
285015|NCT00977470|940928|P2|Overall Study|Lack of Efficacy|30
285016|NCT00977470|940929|P1|Overall Study|Lack of Efficacy|32
285017|NCT00977379|940949|P2|Overall Study|Randomization Error|1
285018|NCT00977379|940950|P1|Overall Study|Randomization Error|0
285019|NCT00977379|940949|P2|Overall Study|Participant Moving House|1
285020|NCT00977379|940950|P1|Overall Study|Participant Moving House|0
285021|NCT00977379|940949|P2|Overall Study|Premature Study Termination|0
285022|NCT00977379|940950|P1|Overall Study|Premature Study Termination|4
285023|NCT00977379|940949|P2|Overall Study|Death|9
285024|NCT00977379|940950|P1|Overall Study|Death|7
285025|NCT00977379|940949|P2|Overall Study|Withdrawal by Subject|1
285026|NCT00977379|940950|P1|Overall Study|Withdrawal by Subject|1
285027|NCT00977314|940986|P2|Overall Study|Physician Decision|0
285028|NCT00977314|940987|P1|Overall Study|Physician Decision|1
285029|NCT00977314|940986|P2|Overall Study|Withdrawal by Subject|0
285030|NCT00977314|940987|P1|Overall Study|Withdrawal by Subject|1
285031|NCT00977197|940995|P2|Overall Study|Nonadherence|1
285032|NCT00977197|940996|P1|Overall Study|Nonadherence|1
285033|NCT00977197|940995|P2|Overall Study|Lost to Follow-up|3
285034|NCT00977197|940996|P1|Overall Study|Lost to Follow-up|1
285035|NCT00977197|940995|P2|Overall Study|Lack of Efficacy|0
285036|NCT00977197|940996|P1|Overall Study|Lack of Efficacy|1
285037|NCT00977197|940995|P2|Overall Study|Adverse Event|1
285038|NCT00977197|940996|P1|Overall Study|Adverse Event|3
285039|NCT00977197|940995|P2|Overall Study|Withdrawal by Subject|4
285040|NCT00977197|940996|P1|Overall Study|Withdrawal by Subject|3
285041|NCT00977106|941059|P2|Overall Study|Not specified|0
285042|NCT00977106|941060|P1|Overall Study|Not specified|1
285043|NCT00977106|941059|P2|Overall Study|Protocol Violation|1
285044|NCT00977106|941060|P1|Overall Study|Protocol Violation|0
285045|NCT00977106|941059|P2|Overall Study|Lack of Efficacy|2
285046|NCT00977106|941060|P1|Overall Study|Lack of Efficacy|2
285047|NCT00977106|941059|P2|Overall Study|Withdrawal by Subject|2
285048|NCT00977106|941060|P1|Overall Study|Withdrawal by Subject|2
285049|NCT00977106|941059|P2|Overall Study|Adverse Event|6
285050|NCT00977106|941060|P1|Overall Study|Adverse Event|5
285051|NCT00977080|941152|P4|Overall Study|Travel for family reasons|0
285052|NCT00977080|941153|P3|Overall Study|Travel for family reasons|0
285053|NCT00977080|941154|P2|Overall Study|Travel for family reasons|0
285054|NCT00977080|941155|P1|Overall Study|Travel for family reasons|1
285055|NCT00977080|941152|P4|Overall Study|Required kidney transplantation|1
285056|NCT00977080|941153|P3|Overall Study|Required kidney transplantation|3
285057|NCT00977080|941154|P2|Overall Study|Required kidney transplantation|3
285058|NCT00977080|941155|P1|Overall Study|Required kidney transplantation|1
285059|NCT00977080|941152|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
285060|NCT00977080|941153|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
285061|NCT00977080|941154|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
285062|NCT00977080|941155|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
285063|NCT00977080|941152|P4|Overall Study|Noncompliance|0
285064|NCT00977080|941153|P3|Overall Study|Noncompliance|1
285065|NCT00977080|941154|P2|Overall Study|Noncompliance|2
285066|NCT00977080|941155|P1|Overall Study|Noncompliance|0
285067|NCT00977080|941152|P4|Overall Study|Protocol Violation|3
285068|NCT00977080|941153|P3|Overall Study|Protocol Violation|4
285069|NCT00977080|941154|P2|Overall Study|Protocol Violation|3
285070|NCT00977080|941155|P1|Overall Study|Protocol Violation|7
285071|NCT00977080|941152|P4|Overall Study|Withdrawal by Subject|5
285072|NCT00977080|941153|P3|Overall Study|Withdrawal by Subject|1
285073|NCT00977080|941154|P2|Overall Study|Withdrawal by Subject|5
285074|NCT00977080|941155|P1|Overall Study|Withdrawal by Subject|1
285075|NCT00977080|941152|P4|Overall Study|Adverse Event|7
285076|NCT00977080|941153|P3|Overall Study|Adverse Event|7
285077|NCT00977080|941154|P2|Overall Study|Adverse Event|7
285078|NCT00977080|941155|P1|Overall Study|Adverse Event|2
285079|NCT00976989|941188|P3|Overall Study|Unspecified|1
285080|NCT00976989|941189|P2|Overall Study|Unspecified|0
285081|NCT00976989|941190|P1|Overall Study|Unspecified|1
285082|NCT00976989|941188|P3|Overall Study|Recurrence of Disease|0
285083|NCT00976989|941189|P2|Overall Study|Recurrence of Disease|1
285084|NCT00976989|941190|P1|Overall Study|Recurrence of Disease|0
285085|NCT00976989|941188|P3|Overall Study|Failure to Return|0
285086|NCT00976989|941189|P2|Overall Study|Failure to Return|1
285087|NCT00976989|941190|P1|Overall Study|Failure to Return|2
285088|NCT00976989|941188|P3|Overall Study|Refused Treatment|5
285089|NCT00976989|941189|P2|Overall Study|Refused Treatment|3
285090|NCT00976989|941190|P1|Overall Study|Refused Treatment|4
285091|NCT00976989|941188|P3|Overall Study|Death|10
285092|NCT00976989|941189|P2|Overall Study|Death|7
285093|NCT00976989|941190|P1|Overall Study|Death|5
285094|NCT00976989|941188|P3|Overall Study|Violation of Selection Criteria at Entry|1
285095|NCT00976989|941189|P2|Overall Study|Violation of Selection Criteria at Entry|0
285096|NCT00976989|941190|P1|Overall Study|Violation of Selection Criteria at Entry|1
285097|NCT00976950|941231|P1|Overall Study|Events with no relationship to Aptivus|3
285098|NCT00976950|941231|P1|Overall Study|Adverse Event|3
285099|NCT00976937|941239|P2|Overall Study|Personal and Familial Reason|2
285100|NCT00976937|941240|P1|Overall Study|Personal and Familial Reason|2
285101|NCT00976937|941239|P2|Overall Study|Poor compliance to protocol|0
285102|NCT00976937|941240|P1|Overall Study|Poor compliance to protocol|3
285103|NCT00976937|941239|P2|Overall Study|Withdrawal by Subject|3
285104|NCT00976937|941240|P1|Overall Study|Withdrawal by Subject|5
285105|NCT00976937|941239|P2|Overall Study|Lost to Follow-up|1
285106|NCT00976937|941240|P1|Overall Study|Lost to Follow-up|2
285107|NCT00976937|941239|P2|Overall Study|Adverse Event|5
285108|NCT00976937|941240|P1|Overall Study|Adverse Event|4
285109|NCT00976911|941282|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
285110|NCT00976911|941283|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
285111|NCT00976911|941282|P2|Overall Study|Not Specified|9
285112|NCT00976911|941283|P1|Overall Study|Not Specified|8
285113|NCT00976911|941282|P2|Overall Study|Protocol Violation|0
285114|NCT00976911|941283|P1|Overall Study|Protocol Violation|2
285115|NCT00976911|941282|P2|Overall Study|Adverse Event|1
285116|NCT00976911|941283|P1|Overall Study|Adverse Event|0
285117|NCT00976911|941282|P2|Overall Study|Death|126
285118|NCT00976911|941283|P1|Overall Study|Death|138
285119|NCT00976911|941282|P2|Overall Study|Withdrawal by Subject|6
285120|NCT00976911|941283|P1|Overall Study|Withdrawal by Subject|4
285121|NCT00976716|941301|P1|Overall Study|Adverse Event|1
285122|NCT00976703|941319|P2|Overall Study|ineligible for study|2
285123|NCT00976703|941320|P1|Overall Study|ineligible for study|2
285124|NCT00976703|941319|P2|Overall Study|Physician Decision|1
285125|NCT00976703|941320|P1|Overall Study|Physician Decision|1
285126|NCT00976677|941334|P2|Overall Study|Unknown/Missing|0
285127|NCT00976677|941335|P1|Overall Study|Unknown/Missing|1
285128|NCT00976677|941334|P2|Overall Study|Trial unblinded|2
285129|NCT00976677|941335|P1|Overall Study|Trial unblinded|2
285130|NCT00976677|941334|P2|Overall Study|Disease progression|1
285131|NCT00976677|941335|P1|Overall Study|Disease progression|1
285132|NCT00976677|941334|P2|Overall Study|Withdrawal by Subject|2
285133|NCT00976677|941335|P1|Overall Study|Withdrawal by Subject|0
285134|NCT00976677|941334|P2|Overall Study|Adverse Event|0
285135|NCT00976677|941335|P1|Overall Study|Adverse Event|1
285136|NCT00976573|941543|P2|Overall Study|Cancel prior to receiving treatment|2
285137|NCT00976573|941544|P1|Overall Study|Cancel prior to receiving treatment|4
285138|NCT00976573|941543|P2|Overall Study|Ineligible|1
285139|NCT00976573|941544|P1|Overall Study|Ineligible|0
285140|NCT00976508|941577|P2|Overall Study|Terminated by the Sponsor|1
285141|NCT00976508|941578|P1|Overall Study|Terminated by the Sponsor|0
285142|NCT00976508|941577|P2|Overall Study|Subject Enrolled in Hospice|0
285143|NCT00976508|941578|P1|Overall Study|Subject Enrolled in Hospice|1
285144|NCT00976508|941577|P2|Overall Study|Disease Progression|4
285145|NCT00976508|941578|P1|Overall Study|Disease Progression|4
285146|NCT00976508|941577|P2|Overall Study|Withdrawal by Subject|0
285147|NCT00976508|941578|P1|Overall Study|Withdrawal by Subject|1
285148|NCT00976508|941577|P2|Overall Study|Lost to Follow-up|0
285149|NCT00976508|941578|P1|Overall Study|Lost to Follow-up|1
285150|NCT00976508|941577|P2|Overall Study|Death|1
285151|NCT00976508|941578|P1|Overall Study|Death|7
285152|NCT00976495|941611|P3|Overall Study|Withdrawal by Subject|0
285153|NCT00976495|941612|P2|Overall Study|Withdrawal by Subject|1
285154|NCT00976495|941613|P1|Overall Study|Withdrawal by Subject|0
285155|NCT00976482|941630|P1|Overall Study|Protocol Violation|5
285156|NCT00976482|941630|P1|Overall Study|Center terminated|1
285157|NCT00976482|941630|P1|Overall Study|Withdrawal by Subject|45
285158|NCT00976482|941630|P1|Overall Study|Death|208
285159|NCT00976456|941636|P2|Overall Study|screening failure, unknown|4
285160|NCT00976456|941637|P1|Overall Study|screening failure, unknown|11
285161|NCT00976456|941636|P2|Overall Study|Withdrawal by Subject|1
285162|NCT00976456|941637|P1|Overall Study|Withdrawal by Subject|3
285163|NCT00976456|941636|P2|Overall Study|Lack of Efficacy|2
285164|NCT00976456|941637|P1|Overall Study|Lack of Efficacy|5
285165|NCT00976456|941636|P2|Overall Study|Death|9
285166|NCT00976456|941637|P1|Overall Study|Death|7
285167|NCT00976456|941636|P2|Overall Study|Adverse Event|22
285168|NCT00976456|941637|P1|Overall Study|Adverse Event|17
285169|NCT00976391|941664|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
285170|NCT00976391|941665|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
285171|NCT00976391|941664|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
285172|NCT00976391|941665|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
285173|NCT00976391|941664|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
285174|NCT00976391|941665|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
285175|NCT00976391|941664|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
285176|NCT00976391|941665|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
285177|NCT00976391|941664|P2|Follow-up Period (8 Weeks)|Noncompliance|2
285178|NCT00976391|941665|P1|Follow-up Period (8 Weeks)|Noncompliance|2
285179|NCT00976391|941664|P2|Follow-up Period (8 Weeks)|Adverse Event|1
285180|NCT00976391|941665|P1|Follow-up Period (8 Weeks)|Adverse Event|3
285181|NCT00976391|941664|P2|Treatment Period (52 Weeks)|Pregnancy|0
285182|NCT00976391|941665|P1|Treatment Period (52 Weeks)|Pregnancy|1
285183|NCT00976391|941664|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
285184|NCT00976391|941665|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
285185|NCT00976391|941664|P2|Treatment Period (52 Weeks)|Physician Decision|1
285186|NCT00976391|941665|P1|Treatment Period (52 Weeks)|Physician Decision|1
285187|NCT00976391|941664|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
285188|NCT00976391|941665|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
285189|NCT00976391|941664|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
285190|NCT00976391|941665|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
285191|NCT00976391|941664|P2|Treatment Period (52 Weeks)|Noncompliance|4
285192|NCT00976391|941665|P1|Treatment Period (52 Weeks)|Noncompliance|4
285193|NCT00976391|941664|P2|Treatment Period (52 Weeks)|Protocol Violation|1
285194|NCT00976391|941665|P1|Treatment Period (52 Weeks)|Protocol Violation|1
285195|NCT00976391|941664|P2|Treatment Period (52 Weeks)|Adverse Event|2
285196|NCT00976391|941665|P1|Treatment Period (52 Weeks)|Adverse Event|16
285197|NCT00976274|941691|P2|Overall Study|Physician Decision|2
285198|NCT00976274|941692|P1|Overall Study|Physician Decision|1
285199|NCT00976274|941691|P2|Overall Study|Withdrawal by Subject|1
285200|NCT00976274|941692|P1|Overall Study|Withdrawal by Subject|1
285201|NCT00976274|941691|P2|Overall Study|Lost to Follow-up|5
285202|NCT00976274|941692|P1|Overall Study|Lost to Follow-up|5
285203|NCT00976209|941708|P2|Treatment Period 2|Lost to Follow-up|1
285204|NCT00976209|941709|P1|Treatment Period 2|Lost to Follow-up|0
285205|NCT00976209|941708|P2|Treatment Period 2|Withdrawal by Subject|1
285206|NCT00976209|941709|P1|Treatment Period 2|Withdrawal by Subject|0
285207|NCT00976209|941708|P2|Wash-out Period|Unspecified|0
285208|NCT00976209|941709|P1|Wash-out Period|Unspecified|1
285209|NCT00976209|941708|P2|Wash-out Period|Protocol Violation|0
285210|NCT00976209|941709|P1|Wash-out Period|Protocol Violation|1
285211|NCT00976209|941708|P2|Wash-out Period|Lost to Follow-up|0
285212|NCT00976209|941709|P1|Wash-out Period|Lost to Follow-up|1
285213|NCT00976209|941708|P2|Wash-out Period|Adverse Event|2
285214|NCT00976209|941709|P1|Wash-out Period|Adverse Event|1
285215|NCT00976209|941708|P2|Treatment Period 1|Unspecified|1
285216|NCT00976209|941709|P1|Treatment Period 1|Unspecified|0
285217|NCT00976209|941708|P2|Treatment Period 1|Lost to Follow-up|0
285218|NCT00976209|941709|P1|Treatment Period 1|Lost to Follow-up|2
285219|NCT00976209|941708|P2|Treatment Period 1|Protocol Violation|0
285220|NCT00976209|941709|P1|Treatment Period 1|Protocol Violation|1
285221|NCT00976027|941722|P2|Overall Study|Withdrawal by Subject|66
285222|NCT00976027|941723|P1|Overall Study|Withdrawal by Subject|107
285223|NCT00976027|941722|P2|Overall Study|Lost to Follow-up|103
285224|NCT00976027|941723|P1|Overall Study|Lost to Follow-up|208
285225|NCT00976027|941722|P2|Overall Study|Protocol Violation|27
285226|NCT00976027|941723|P1|Overall Study|Protocol Violation|60
285227|NCT00976027|941722|P2|Overall Study|Adverse Event|2
285228|NCT00976027|941723|P1|Overall Study|Adverse Event|0
285229|NCT00976027|941722|P2|Overall Study|Serious Adverse Event|17
285230|NCT00976027|941723|P1|Overall Study|Serious Adverse Event|36
285231|NCT00975975|941735|P1|Overall Study|Death|6
285232|NCT00975923|941743|P2|Overall Study|Withdrawal by Subject|1
285233|NCT00975923|941744|P1|Overall Study|Withdrawal by Subject|0
285234|NCT00975806|941755|P3|Overall Study|Physician decision and disease related|1
285235|NCT00975806|941756|P2|Overall Study|Physician decision and disease related|0
285236|NCT00975806|941757|P1|Overall Study|Physician decision and disease related|1
285237|NCT00975806|941755|P3|Overall Study|Death|0
285238|NCT00975806|941756|P2|Overall Study|Death|1
285239|NCT00975806|941757|P1|Overall Study|Death|0
285240|NCT00975806|941755|P3|Overall Study|Withdrawal by Subject|0
285241|NCT00975806|941756|P2|Overall Study|Withdrawal by Subject|0
285242|NCT00975806|941757|P1|Overall Study|Withdrawal by Subject|1
285243|NCT00975806|941755|P3|Overall Study|Disease Progression|1
285244|NCT00975806|941756|P2|Overall Study|Disease Progression|5
285245|NCT00975806|941757|P1|Overall Study|Disease Progression|1
285246|NCT00975806|941755|P3|Overall Study|Adverse Event|2
285247|NCT00975806|941756|P2|Overall Study|Adverse Event|1
285248|NCT00975806|941757|P1|Overall Study|Adverse Event|2
285249|NCT00975780|941781|P2|Follow Up|Discharged from Facility|12
285250|NCT00975780|941782|P1|Follow Up|Discharged from Facility|7
285251|NCT00975780|941781|P2|Follow Up|Facility Withdrawal|23
285252|NCT00975780|941782|P1|Follow Up|Facility Withdrawal|7
285253|NCT00975780|941781|P2|Follow Up|Death|122
285254|NCT00975780|941782|P1|Follow Up|Death|88
285255|NCT00975715|941792|P2|Maintenance Period|Adverse Event|1
285256|NCT00975715|941793|P1|Maintenance Period|Adverse Event|2
285257|NCT00975715|941792|P2|Titration Period|Protocol Violation|0
285258|NCT00975715|941793|P1|Titration Period|Protocol Violation|1
285259|NCT00975715|941792|P2|Titration Period|Adverse Event|0
285260|NCT00975715|941793|P1|Titration Period|Adverse Event|6
285261|NCT00975689|941809|P2|Overall Study|Physician Decision|0
285262|NCT00975689|941810|P1|Overall Study|Physician Decision|1
285263|NCT00975689|941809|P2|Overall Study|Withdrawal by Subject|0
285264|NCT00975689|941810|P1|Overall Study|Withdrawal by Subject|1
285265|NCT00975689|941809|P2|Overall Study|Adverse Event|3
285266|NCT00975689|941810|P1|Overall Study|Adverse Event|0
285267|NCT00975611|941842|P1|Overall Study|Physician Decision|1
285268|NCT00975611|941842|P1|Overall Study|Screen Fail|16
285269|NCT00975585|941848|P2|Overall Study|Lens issue|2
285270|NCT00975585|941849|P1|Overall Study|Lens issue|2
285271|NCT00975585|941848|P2|Overall Study|Withdrawal by Subject|1
285272|NCT00975585|941849|P1|Overall Study|Withdrawal by Subject|2
285273|NCT00975585|941848|P2|Overall Study|Lost to Follow-up|5
285274|NCT00975585|941849|P1|Overall Study|Lost to Follow-up|3
285275|NCT00975585|941848|P2|Overall Study|Adverse Event|4
285276|NCT00975585|941849|P1|Overall Study|Adverse Event|0
285277|NCT00975507|941869|P2|Overall Study|Withdrawal by Subject|3
285278|NCT00975507|941870|P1|Overall Study|Withdrawal by Subject|10
285279|NCT00975507|941869|P2|Overall Study|Protocol Violation|0
285280|NCT00975507|941870|P1|Overall Study|Protocol Violation|2
285281|NCT00975507|941869|P2|Overall Study|Lost to Follow-up|1
285282|NCT00975507|941870|P1|Overall Study|Lost to Follow-up|7
285283|NCT00975507|941869|P2|Overall Study|Adverse Event|0
285284|NCT00975507|941870|P1|Overall Study|Adverse Event|1
285285|NCT00975481|941890|P6|Fifth Intervention Period|Withdrawal by Subject|0
285286|NCT00975481|941891|P5|Fifth Intervention Period|Withdrawal by Subject|1
285287|NCT00975481|941892|P4|Fifth Intervention Period|Withdrawal by Subject|0
285288|NCT00975481|941893|P3|Fifth Intervention Period|Withdrawal by Subject|0
285289|NCT00975481|941894|P2|Fifth Intervention Period|Withdrawal by Subject|0
285290|NCT00975481|941895|P1|Fifth Intervention Period|Withdrawal by Subject|0
285291|NCT00975481|941890|P6|Fourth Intervention Period|Withdrawal by Subject|0
285292|NCT00975481|941891|P5|Fourth Intervention Period|Withdrawal by Subject|0
285293|NCT00975481|941892|P4|Fourth Intervention Period|Withdrawal by Subject|1
285294|NCT00975481|941893|P3|Fourth Intervention Period|Withdrawal by Subject|1
285295|NCT00975481|941894|P2|Fourth Intervention Period|Withdrawal by Subject|0
285296|NCT00975481|941895|P1|Fourth Intervention Period|Withdrawal by Subject|0
285297|NCT00975481|941890|P6|Second Intervention Period|Withdrawal by Subject|0
285382|NCT00975130|942141|P2|Study Part 2|Adverse Event|14
285298|NCT00975481|941891|P5|Second Intervention Period|Withdrawal by Subject|0
285299|NCT00975481|941892|P4|Second Intervention Period|Withdrawal by Subject|0
285300|NCT00975481|941893|P3|Second Intervention Period|Withdrawal by Subject|1
285301|NCT00975481|941894|P2|Second Intervention Period|Withdrawal by Subject|0
285302|NCT00975481|941895|P1|Second Intervention Period|Withdrawal by Subject|0
285303|NCT00975481|941890|P6|Second Intervention Period|Adverse Event|0
285304|NCT00975481|941891|P5|Second Intervention Period|Adverse Event|0
285305|NCT00975481|941892|P4|Second Intervention Period|Adverse Event|0
285306|NCT00975481|941893|P3|Second Intervention Period|Adverse Event|0
285307|NCT00975481|941894|P2|Second Intervention Period|Adverse Event|1
285308|NCT00975481|941895|P1|Second Intervention Period|Adverse Event|2
285309|NCT00975416|941995|P2|Overall Study|early discharge from tx|5
285310|NCT00975416|941996|P1|Overall Study|early discharge from tx|3
285311|NCT00975286|942005|P2|Overall Study|Sponsor Decision|2
285312|NCT00975286|942006|P1|Overall Study|Sponsor Decision|0
285313|NCT00975286|942005|P2|Overall Study|Poor Compliance to Protocol|2
285314|NCT00975286|942006|P1|Overall Study|Poor Compliance to Protocol|0
285315|NCT00975286|942005|P2|Overall Study|Familial and Personal Reasons|2
285316|NCT00975286|942006|P1|Overall Study|Familial and Personal Reasons|2
285317|NCT00975286|942005|P2|Overall Study|Withdrawal by Subject|2
285318|NCT00975286|942006|P1|Overall Study|Withdrawal by Subject|0
285319|NCT00975286|942005|P2|Overall Study|Protocol Violation|2
285320|NCT00975286|942006|P1|Overall Study|Protocol Violation|1
285321|NCT00975286|942005|P2|Overall Study|Adverse Event|19
285322|NCT00975286|942006|P1|Overall Study|Adverse Event|9
285323|NCT00975221|942038|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
285324|NCT00975221|942039|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
285325|NCT00975221|942038|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
285326|NCT00975221|942039|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
285327|NCT00975221|942038|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
285328|NCT00975221|942039|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
285329|NCT00975221|942038|P2|Titration Phase (Weeks 1-12)|Other|1
285330|NCT00975221|942039|P1|Titration Phase (Weeks 1-12)|Other|0
285331|NCT00975221|942038|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
285332|NCT00975221|942039|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
285333|NCT00975221|942038|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
285334|NCT00975221|942039|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
285335|NCT00975195|942055|P2|Overall Study|Not treated|2
285336|NCT00975195|942056|P1|Overall Study|Not treated|1
285337|NCT00975195|942055|P2|Overall Study|Other reason not defined above|33
285338|NCT00975195|942056|P1|Overall Study|Other reason not defined above|29
285339|NCT00975195|942055|P2|Overall Study|Withdrawal by Subject|61
285340|NCT00975195|942056|P1|Overall Study|Withdrawal by Subject|48
285341|NCT00975195|942055|P2|Overall Study|Lost to Follow-up|7
285342|NCT00975195|942056|P1|Overall Study|Lost to Follow-up|9
285343|NCT00975195|942055|P2|Overall Study|Protocol Violation|23
285344|NCT00975195|942056|P1|Overall Study|Protocol Violation|27
285345|NCT00975195|942055|P2|Overall Study|Lack of Efficacy|6
285346|NCT00975195|942056|P1|Overall Study|Lack of Efficacy|6
285347|NCT00975195|942055|P2|Overall Study|Adverse Event|101
285348|NCT00975195|942056|P1|Overall Study|Adverse Event|108
285349|NCT00975156|942116|P2|Overall Study|Protocol Violation|1
285350|NCT00975156|942117|P1|Overall Study|Protocol Violation|0
285351|NCT00975143|942129|P2|Overall Study|Details not available|4
285352|NCT00975143|942130|P1|Overall Study|Details not available|10
285353|NCT00975143|942129|P2|Overall Study|Physician Decision|2
285354|NCT00975143|942130|P1|Overall Study|Physician Decision|1
285355|NCT00975143|942129|P2|Overall Study|Non-compliance|8
285356|NCT00975143|942130|P1|Overall Study|Non-compliance|5
285357|NCT00975143|942129|P2|Overall Study|Lost to Follow-up|16
285358|NCT00975143|942130|P1|Overall Study|Lost to Follow-up|20
285359|NCT00975143|942129|P2|Overall Study|Withdrawal by Subject|15
285360|NCT00975143|942130|P1|Overall Study|Withdrawal by Subject|15
285361|NCT00975143|942129|P2|Overall Study|Adverse Event|15
285362|NCT00975143|942130|P1|Overall Study|Adverse Event|19
285363|NCT00975130|942140|P3|Study Part 2|Protocol Violation|1
285364|NCT00975130|942141|P2|Study Part 2|Protocol Violation|0
285365|NCT00975130|942142|P1|Study Part 2|Protocol Violation|0
285366|NCT00975130|942140|P3|Study Part 2|Administrative|0
285367|NCT00975130|942141|P2|Study Part 2|Administrative|1
285368|NCT00975130|942142|P1|Study Part 2|Administrative|0
285369|NCT00975130|942140|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
285370|NCT00975130|942141|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
285371|NCT00975130|942142|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
285372|NCT00975130|942140|P3|Study Part 2|Withdrew Consent|2
285373|NCT00975130|942141|P2|Study Part 2|Withdrew Consent|6
285374|NCT00975130|942142|P1|Study Part 2|Withdrew Consent|0
285375|NCT00975130|942140|P3|Study Part 2|Withdrawal by Subject|5
285376|NCT00975130|942141|P2|Study Part 2|Withdrawal by Subject|13
285377|NCT00975130|942142|P1|Study Part 2|Withdrawal by Subject|0
285378|NCT00975130|942140|P3|Study Part 2|Lost to Follow-up|1
285379|NCT00975130|942141|P2|Study Part 2|Lost to Follow-up|0
285380|NCT00975130|942142|P1|Study Part 2|Lost to Follow-up|0
285381|NCT00975130|942140|P3|Study Part 2|Adverse Event|7
285383|NCT00975130|942142|P1|Study Part 2|Adverse Event|0
285384|NCT00975130|942140|P3|Study Part 1|Withdrew Consent|0
285385|NCT00975130|942141|P2|Study Part 1|Withdrew Consent|0
285386|NCT00975130|942142|P1|Study Part 1|Withdrew Consent|24
285387|NCT00975130|942140|P3|Study Part 1|Administrative|0
285388|NCT00975130|942141|P2|Study Part 1|Administrative|0
285389|NCT00975130|942142|P1|Study Part 1|Administrative|4
285390|NCT00975130|942140|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
285391|NCT00975130|942141|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
285392|NCT00975130|942142|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
285393|NCT00975130|942140|P3|Study Part 1|Protocol Violation|0
285394|NCT00975130|942141|P2|Study Part 1|Protocol Violation|0
285395|NCT00975130|942142|P1|Study Part 1|Protocol Violation|13
285396|NCT00975130|942140|P3|Study Part 1|Withdrawal by Subject|0
285397|NCT00975130|942141|P2|Study Part 1|Withdrawal by Subject|0
285398|NCT00975130|942142|P1|Study Part 1|Withdrawal by Subject|61
285399|NCT00975130|942140|P3|Study Part 1|Lost to Follow-up|0
285400|NCT00975130|942141|P2|Study Part 1|Lost to Follow-up|0
285401|NCT00975130|942142|P1|Study Part 1|Lost to Follow-up|19
285402|NCT00975130|942140|P3|Study Part 1|Adverse Event|0
285403|NCT00975130|942141|P2|Study Part 1|Adverse Event|0
285404|NCT00975130|942142|P1|Study Part 1|Adverse Event|150
285405|NCT00975000|942326|P2|Overall Study|Non-compliance|1
285406|NCT00975000|942327|P1|Overall Study|Non-compliance|0
285407|NCT00975000|942326|P2|Overall Study|Protocol-specified Criteria|0
285408|NCT00975000|942327|P1|Overall Study|Protocol-specified Criteria|1
285409|NCT00975000|942326|P2|Overall Study|Lost to Follow-up|1
285410|NCT00975000|942327|P1|Overall Study|Lost to Follow-up|0
285411|NCT00975000|942326|P2|Overall Study|Withdrawal by Subject|2
285412|NCT00975000|942327|P1|Overall Study|Withdrawal by Subject|2
285413|NCT00975000|942326|P2|Overall Study|Adverse Event|1
285414|NCT00975000|942327|P1|Overall Study|Adverse Event|1
285415|NCT00975000|942326|P2|Overall Study|Other|0
285416|NCT00975000|942327|P1|Overall Study|Other|1
285417|NCT00974974|942351|P2|Maintenance - Double Blind Treatment|Various|0
285418|NCT00974974|942352|P1|Maintenance - Double Blind Treatment|Various|4
285419|NCT00974974|942351|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
285420|NCT00974974|942352|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
285421|NCT00974974|942351|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
285422|NCT00974974|942352|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
285423|NCT00974974|942351|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
285424|NCT00974974|942352|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
285425|NCT00974974|942351|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
285426|NCT00974974|942352|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
285427|NCT00974974|942351|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
285428|NCT00974974|942352|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
285429|NCT00974974|942351|P2|Maintenance - Double Blind Treatment|Adverse Event|3
285430|NCT00974974|942352|P1|Maintenance - Double Blind Treatment|Adverse Event|3
285431|NCT00974974|942351|P2|IPX066 Dose Conversion|Protocol Violation|0
285432|NCT00974974|942352|P1|IPX066 Dose Conversion|Protocol Violation|4
285433|NCT00974974|942351|P2|IPX066 Dose Conversion|Various|0
285434|NCT00974974|942352|P1|IPX066 Dose Conversion|Various|3
285435|NCT00974974|942351|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
285436|NCT00974974|942352|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
285437|NCT00974974|942351|P2|IPX066 Dose Conversion|Lack of Efficacy|0
285438|NCT00974974|942352|P1|IPX066 Dose Conversion|Lack of Efficacy|13
285439|NCT00974974|942351|P2|IPX066 Dose Conversion|Death|0
285440|NCT00974974|942352|P1|IPX066 Dose Conversion|Death|2
285441|NCT00974974|942351|P2|IPX066 Dose Conversion|Adverse Event|0
285442|NCT00974974|942352|P1|IPX066 Dose Conversion|Adverse Event|23
285443|NCT00974974|942351|P2|IR CD-LD Dose Adjustment|Various|9
285444|NCT00974974|942352|P1|IR CD-LD Dose Adjustment|Various|0
285445|NCT00974974|942351|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
285446|NCT00974974|942352|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
285447|NCT00974974|942351|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
285448|NCT00974974|942352|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
285449|NCT00974974|942351|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
285450|NCT00974974|942352|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
285451|NCT00974974|942351|P2|IR CD-LD Dose Adjustment|Adverse Event|3
285452|NCT00974974|942352|P1|IR CD-LD Dose Adjustment|Adverse Event|0
285453|NCT00974675|942375|P4|Overall Study|Participant on holiday; unable to attend|1
285454|NCT00974675|942376|P3|Overall Study|Participant on holiday; unable to attend|0
285455|NCT00974675|942377|P2|Overall Study|Participant on holiday; unable to attend|0
285456|NCT00974675|942378|P1|Overall Study|Participant on holiday; unable to attend|0
285457|NCT00974675|942375|P4|Overall Study|Physician Decision|0
285458|NCT00974675|942376|P3|Overall Study|Physician Decision|1
285459|NCT00974675|942377|P2|Overall Study|Physician Decision|0
285460|NCT00974675|942378|P1|Overall Study|Physician Decision|0
285461|NCT00974675|942375|P4|Overall Study|Adverse Event|1
285462|NCT00974675|942376|P3|Overall Study|Adverse Event|1
285463|NCT00974675|942377|P2|Overall Study|Adverse Event|1
285464|NCT00974675|942378|P1|Overall Study|Adverse Event|2
285465|NCT00974571|942427|P3|Overall Study|Unspecified|10
285466|NCT00974571|942428|P2|Overall Study|Unspecified|0
285467|NCT00974571|942429|P1|Overall Study|Unspecified|4
285468|NCT00974571|942427|P3|Overall Study|Patient Moved|1
285469|NCT00974571|942428|P2|Overall Study|Patient Moved|0
285470|NCT00974571|942429|P1|Overall Study|Patient Moved|1
285471|NCT00974571|942427|P3|Overall Study|Withdrawal by Subject|16
285472|NCT00974571|942428|P2|Overall Study|Withdrawal by Subject|5
285473|NCT00974571|942429|P1|Overall Study|Withdrawal by Subject|14
285474|NCT00974571|942427|P3|Overall Study|Protocol Violation|18
285475|NCT00974571|942428|P2|Overall Study|Protocol Violation|4
285476|NCT00974571|942429|P1|Overall Study|Protocol Violation|13
285477|NCT00974571|942427|P3|Overall Study|Lost to Follow-up|2
285478|NCT00974571|942428|P2|Overall Study|Lost to Follow-up|1
285479|NCT00974571|942429|P1|Overall Study|Lost to Follow-up|2
285480|NCT00974571|942427|P3|Overall Study|Lack of Efficacy|9
285481|NCT00974571|942428|P2|Overall Study|Lack of Efficacy|2
285482|NCT00974571|942429|P1|Overall Study|Lack of Efficacy|3
285483|NCT00974571|942427|P3|Overall Study|Adverse Event|27
285484|NCT00974571|942428|P2|Overall Study|Adverse Event|4
285485|NCT00974571|942429|P1|Overall Study|Adverse Event|31
285486|NCT00974311|942526|P2|Overall Study|Continuing Treatment|19
285487|NCT00974311|942527|P1|Overall Study|Continuing Treatment|231
285488|NCT00974311|942526|P2|Overall Study|Withdrawal of consent|5
285489|NCT00974311|942527|P1|Overall Study|Withdrawal of consent|9
285490|NCT00974311|942526|P2|Overall Study|Death|211
285491|NCT00974311|942527|P1|Overall Study|Death|305
285492|NCT00974311|942526|P2|Overall Study|Lost to Follow-up|1
285493|NCT00974311|942527|P1|Overall Study|Lost to Follow-up|1
285494|NCT00974220|942555|P2|Treatment Period 1|noncompliant subjects|1
285495|NCT00974220|942556|P1|Treatment Period 1|noncompliant subjects|0
285496|NCT00974220|942555|P2|Treatment Period 1|Adverse Event|1
285497|NCT00974220|942556|P1|Treatment Period 1|Adverse Event|2
285498|NCT00974090|942566|P2|Period 2: Open-label Period|Withdrawal by Subject|0
285499|NCT00974090|942567|P1|Period 2: Open-label Period|Withdrawal by Subject|1
285500|NCT00974090|942566|P2|Period 2: Open-label Period|Physician Decision|3
285501|NCT00974090|942567|P1|Period 2: Open-label Period|Physician Decision|0
285502|NCT00974090|942566|P2|Period 2: Open-label Period|Lack of Efficacy|1
285503|NCT00974090|942567|P1|Period 2: Open-label Period|Lack of Efficacy|3
285504|NCT00974090|942566|P2|Period 2: Open-label Period|Adverse Event|6
285505|NCT00974090|942567|P1|Period 2: Open-label Period|Adverse Event|4
285506|NCT00974090|942566|P2|Period 1: Double Blind Period|Physician Decision|0
285507|NCT00974090|942567|P1|Period 1: Double Blind Period|Physician Decision|1
285508|NCT00974090|942566|P2|Period 1: Double Blind Period|Adverse Event|1
285509|NCT00974090|942567|P1|Period 1: Double Blind Period|Adverse Event|2
285510|NCT00973921|942601|P1|Overall Study|IVUS results were not available|9
285511|NCT00973765|942610|P2|Overall Study|Lost to Follow-up|14
285512|NCT00973765|942611|P1|Overall Study|Lost to Follow-up|8
285513|NCT00973700|942633|P5|Overall Study|Unable to Classify|1
285514|NCT00973700|942634|P4|Overall Study|Unable to Classify|2
285515|NCT00973700|942635|P3|Overall Study|Unable to Classify|1
285516|NCT00973700|942636|P2|Overall Study|Unable to Classify|0
285517|NCT00973700|942637|P1|Overall Study|Unable to Classify|0
285518|NCT00973700|942633|P5|Overall Study|Inappropriate enrolment|0
285519|NCT00973700|942634|P4|Overall Study|Inappropriate enrolment|4
285520|NCT00973700|942635|P3|Overall Study|Inappropriate enrolment|0
285521|NCT00973700|942636|P2|Overall Study|Inappropriate enrolment|0
285522|NCT00973700|942637|P1|Overall Study|Inappropriate enrolment|0
285523|NCT00973700|942633|P5|Overall Study|Lost to Follow-up|5
285524|NCT00973700|942634|P4|Overall Study|Lost to Follow-up|8
285525|NCT00973700|942635|P3|Overall Study|Lost to Follow-up|1
285526|NCT00973700|942636|P2|Overall Study|Lost to Follow-up|0
285527|NCT00973700|942637|P1|Overall Study|Lost to Follow-up|5
285528|NCT00973700|942633|P5|Overall Study|Withdrawal by Subject|4
285529|NCT00973700|942634|P4|Overall Study|Withdrawal by Subject|4
285530|NCT00973700|942635|P3|Overall Study|Withdrawal by Subject|8
285531|NCT00973700|942636|P2|Overall Study|Withdrawal by Subject|2
285532|NCT00973700|942637|P1|Overall Study|Withdrawal by Subject|2
285533|NCT00973622|942686|P2|Overall Study|did not complete rTMS sessions|2
285534|NCT00973622|942687|P1|Overall Study|did not complete rTMS sessions|11
285535|NCT00973622|942686|P2|Overall Study|did not pass MRI screen|0
285536|NCT00973622|942687|P1|Overall Study|did not pass MRI screen|6
285537|NCT00973622|942686|P2|Overall Study|did not attend MRI|3
285538|NCT00973622|942687|P1|Overall Study|did not attend MRI|14
285539|NCT00973479|942695|P2|Overall Study|Not Specified|7
285540|NCT00973479|942696|P1|Overall Study|Not Specified|1
285541|NCT00973479|942695|P2|Overall Study|Protocol Violation|2
285542|NCT00973479|942696|P1|Overall Study|Protocol Violation|2
285543|NCT00973479|942695|P2|Overall Study|Adverse Event|32
285544|NCT00973479|942696|P1|Overall Study|Adverse Event|12
285545|NCT00973479|942695|P2|Overall Study|Lack of Efficacy|7
285546|NCT00973479|942696|P1|Overall Study|Lack of Efficacy|5
285547|NCT00973479|942695|P2|Overall Study|Withdrawal by Subject|16
285548|NCT00973479|942696|P1|Overall Study|Withdrawal by Subject|15
285549|NCT00973479|942695|P2|Overall Study|Death|2
285550|NCT00973479|942696|P1|Overall Study|Death|2
285551|NCT00973479|942695|P2|Overall Study|Lost to Follow-up|3
285552|NCT00973479|942696|P1|Overall Study|Lost to Follow-up|0
285553|NCT00973362|942714|P2|3-Year Follow-up|Lost to Follow-up|0
285554|NCT00973362|942715|P1|3-Year Follow-up|Lost to Follow-up|17
285555|NCT00973362|942714|P2|Baseline Evaluation|Inevaluable|223
285556|NCT00973362|942715|P1|Baseline Evaluation|Inevaluable|686
285557|NCT00973362|942714|P2|Baseline Evaluation|No colposcopy visit|0
285558|NCT00973362|942715|P1|Baseline Evaluation|No colposcopy visit|62
285559|NCT00973362|942714|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
285560|NCT00973362|942715|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
285561|NCT00973349|942740|P16|Overall Study|Unable to classify|0
285562|NCT00973349|942741|P15|Overall Study|Unable to classify|0
285563|NCT00973349|942742|P14|Overall Study|Unable to classify|0
285564|NCT00973349|942743|P13|Overall Study|Unable to classify|0
285565|NCT00973349|942744|P12|Overall Study|Unable to classify|0
285566|NCT00973349|942745|P11|Overall Study|Unable to classify|0
285567|NCT00973349|942746|P10|Overall Study|Unable to classify|1
285568|NCT00973349|942747|P9|Overall Study|Unable to classify|0
285569|NCT00973349|942748|P8|Overall Study|Unable to classify|0
285570|NCT00973349|942749|P7|Overall Study|Unable to classify|0
285571|NCT00973349|942750|P6|Overall Study|Unable to classify|1
285572|NCT00973349|942751|P5|Overall Study|Unable to classify|1
285573|NCT00973349|942752|P4|Overall Study|Unable to classify|0
285574|NCT00973349|942753|P3|Overall Study|Unable to classify|0
285575|NCT00973349|942754|P2|Overall Study|Unable to classify|0
285576|NCT00973349|942755|P1|Overall Study|Unable to classify|0
285577|NCT00973349|942740|P16|Overall Study|Protocol Violation|0
285578|NCT00973349|942741|P15|Overall Study|Protocol Violation|0
285579|NCT00973349|942742|P14|Overall Study|Protocol Violation|0
285580|NCT00973349|942743|P13|Overall Study|Protocol Violation|0
285581|NCT00973349|942744|P12|Overall Study|Protocol Violation|0
285582|NCT00973349|942745|P11|Overall Study|Protocol Violation|0
285583|NCT00973349|942746|P10|Overall Study|Protocol Violation|0
285584|NCT00973349|942747|P9|Overall Study|Protocol Violation|1
285585|NCT00973349|942748|P8|Overall Study|Protocol Violation|0
285586|NCT00973349|942749|P7|Overall Study|Protocol Violation|0
285587|NCT00973349|942750|P6|Overall Study|Protocol Violation|0
285588|NCT00973349|942751|P5|Overall Study|Protocol Violation|0
285589|NCT00973349|942752|P4|Overall Study|Protocol Violation|0
285590|NCT00973349|942753|P3|Overall Study|Protocol Violation|0
285591|NCT00973349|942754|P2|Overall Study|Protocol Violation|0
285592|NCT00973349|942755|P1|Overall Study|Protocol Violation|0
285593|NCT00973349|942740|P16|Overall Study|Inappropriate enrolment|1
285594|NCT00973349|942741|P15|Overall Study|Inappropriate enrolment|1
285595|NCT00973349|942742|P14|Overall Study|Inappropriate enrolment|0
285596|NCT00973349|942743|P13|Overall Study|Inappropriate enrolment|1
285597|NCT00973349|942744|P12|Overall Study|Inappropriate enrolment|0
285598|NCT00973349|942745|P11|Overall Study|Inappropriate enrolment|0
285599|NCT00973349|942746|P10|Overall Study|Inappropriate enrolment|2
285600|NCT00973349|942747|P9|Overall Study|Inappropriate enrolment|0
285601|NCT00973349|942748|P8|Overall Study|Inappropriate enrolment|0
285602|NCT00973349|942749|P7|Overall Study|Inappropriate enrolment|0
285603|NCT00973349|942750|P6|Overall Study|Inappropriate enrolment|0
285604|NCT00973349|942751|P5|Overall Study|Inappropriate enrolment|0
285605|NCT00973349|942752|P4|Overall Study|Inappropriate enrolment|0
285606|NCT00973349|942753|P3|Overall Study|Inappropriate enrolment|1
285607|NCT00973349|942754|P2|Overall Study|Inappropriate enrolment|0
285608|NCT00973349|942755|P1|Overall Study|Inappropriate enrolment|0
285609|NCT00973349|942740|P16|Overall Study|Lost to Follow-up|1
285610|NCT00973349|942741|P15|Overall Study|Lost to Follow-up|0
285611|NCT00973349|942742|P14|Overall Study|Lost to Follow-up|0
285612|NCT00973349|942743|P13|Overall Study|Lost to Follow-up|0
285613|NCT00973349|942744|P12|Overall Study|Lost to Follow-up|1
285614|NCT00973349|942745|P11|Overall Study|Lost to Follow-up|0
285615|NCT00973349|942746|P10|Overall Study|Lost to Follow-up|1
285616|NCT00973349|942747|P9|Overall Study|Lost to Follow-up|2
285617|NCT00973349|942748|P8|Overall Study|Lost to Follow-up|1
285618|NCT00973349|942749|P7|Overall Study|Lost to Follow-up|0
285619|NCT00973349|942750|P6|Overall Study|Lost to Follow-up|3
285620|NCT00973349|942751|P5|Overall Study|Lost to Follow-up|1
285621|NCT00973349|942752|P4|Overall Study|Lost to Follow-up|2
285622|NCT00973349|942753|P3|Overall Study|Lost to Follow-up|2
285623|NCT00973349|942754|P2|Overall Study|Lost to Follow-up|1
285624|NCT00973349|942755|P1|Overall Study|Lost to Follow-up|3
285625|NCT00973349|942740|P16|Overall Study|Withdrawal by Subject|0
285626|NCT00973349|942741|P15|Overall Study|Withdrawal by Subject|0
285627|NCT00973349|942742|P14|Overall Study|Withdrawal by Subject|0
285628|NCT00973349|942743|P13|Overall Study|Withdrawal by Subject|0
285629|NCT00973349|942744|P12|Overall Study|Withdrawal by Subject|1
285630|NCT00973349|942745|P11|Overall Study|Withdrawal by Subject|0
285631|NCT00973349|942746|P10|Overall Study|Withdrawal by Subject|2
285632|NCT00973349|942747|P9|Overall Study|Withdrawal by Subject|0
285633|NCT00973349|942748|P8|Overall Study|Withdrawal by Subject|2
285634|NCT00973349|942749|P7|Overall Study|Withdrawal by Subject|2
285635|NCT00973349|942750|P6|Overall Study|Withdrawal by Subject|0
285636|NCT00973349|942751|P5|Overall Study|Withdrawal by Subject|2
285637|NCT00973349|942752|P4|Overall Study|Withdrawal by Subject|3
285638|NCT00973349|942753|P3|Overall Study|Withdrawal by Subject|2
285639|NCT00973349|942754|P2|Overall Study|Withdrawal by Subject|2
285640|NCT00973349|942755|P1|Overall Study|Withdrawal by Subject|1
285641|NCT00973349|942740|P16|Overall Study|Adverse Event|0
285642|NCT00973349|942741|P15|Overall Study|Adverse Event|1
285643|NCT00973349|942742|P14|Overall Study|Adverse Event|0
285644|NCT00973349|942743|P13|Overall Study|Adverse Event|0
285645|NCT00973349|942744|P12|Overall Study|Adverse Event|0
285646|NCT00973349|942745|P11|Overall Study|Adverse Event|0
285647|NCT00973349|942746|P10|Overall Study|Adverse Event|0
285648|NCT00973349|942747|P9|Overall Study|Adverse Event|1
285649|NCT00973349|942748|P8|Overall Study|Adverse Event|0
285650|NCT00973349|942749|P7|Overall Study|Adverse Event|0
285651|NCT00973349|942750|P6|Overall Study|Adverse Event|0
285652|NCT00973349|942751|P5|Overall Study|Adverse Event|1
285653|NCT00973349|942752|P4|Overall Study|Adverse Event|0
285654|NCT00973349|942753|P3|Overall Study|Adverse Event|0
285655|NCT00973349|942754|P2|Overall Study|Adverse Event|0
285656|NCT00973349|942755|P1|Overall Study|Adverse Event|0
285657|NCT00972816|942876|P8|Overall Study|Unable to classify|0
285658|NCT00972816|942877|P7|Overall Study|Unable to classify|0
285659|NCT00972816|942878|P6|Overall Study|Unable to classify|0
285660|NCT00972816|942879|P5|Overall Study|Unable to classify|1
285661|NCT00972816|942880|P4|Overall Study|Unable to classify|0
285662|NCT00972816|942881|P3|Overall Study|Unable to classify|0
285663|NCT00972816|942882|P2|Overall Study|Unable to classify|0
285664|NCT00972816|942883|P1|Overall Study|Unable to classify|2
285665|NCT00972816|942876|P8|Overall Study|Inappropriate enrolment|0
285666|NCT00972816|942877|P7|Overall Study|Inappropriate enrolment|2
285667|NCT00972816|942878|P6|Overall Study|Inappropriate enrolment|0
285668|NCT00972816|942879|P5|Overall Study|Inappropriate enrolment|0
285669|NCT00972816|942880|P4|Overall Study|Inappropriate enrolment|0
285670|NCT00972816|942881|P3|Overall Study|Inappropriate enrolment|0
285671|NCT00972816|942882|P2|Overall Study|Inappropriate enrolment|0
285672|NCT00972816|942883|P1|Overall Study|Inappropriate enrolment|0
285673|NCT00972816|942876|P8|Overall Study|Lost to Follow-up|7
285674|NCT00972816|942877|P7|Overall Study|Lost to Follow-up|7
285675|NCT00972816|942878|P6|Overall Study|Lost to Follow-up|10
285676|NCT00972816|942879|P5|Overall Study|Lost to Follow-up|11
285677|NCT00972816|942880|P4|Overall Study|Lost to Follow-up|5
285678|NCT00972816|942881|P3|Overall Study|Lost to Follow-up|7
285679|NCT00972816|942882|P2|Overall Study|Lost to Follow-up|9
285680|NCT00972816|942883|P1|Overall Study|Lost to Follow-up|11
285681|NCT00972816|942876|P8|Overall Study|Withdrawal by Subject|2
285682|NCT00972816|942877|P7|Overall Study|Withdrawal by Subject|1
285683|NCT00972816|942878|P6|Overall Study|Withdrawal by Subject|1
285684|NCT00972816|942879|P5|Overall Study|Withdrawal by Subject|0
285685|NCT00972816|942880|P4|Overall Study|Withdrawal by Subject|3
285686|NCT00972816|942881|P3|Overall Study|Withdrawal by Subject|1
285687|NCT00972816|942882|P2|Overall Study|Withdrawal by Subject|2
285688|NCT00972816|942883|P1|Overall Study|Withdrawal by Subject|4
285689|NCT00972816|942876|P8|Overall Study|Adverse Event|0
285690|NCT00972816|942877|P7|Overall Study|Adverse Event|0
285691|NCT00972816|942878|P6|Overall Study|Adverse Event|0
285692|NCT00972816|942879|P5|Overall Study|Adverse Event|0
285693|NCT00972816|942880|P4|Overall Study|Adverse Event|0
285694|NCT00972816|942881|P3|Overall Study|Adverse Event|1
285695|NCT00972816|942882|P2|Overall Study|Adverse Event|0
285696|NCT00972816|942883|P1|Overall Study|Adverse Event|0
285697|NCT00972777|942967|P2|Overall Study|Missed visit|0
285698|NCT00972777|942968|P1|Overall Study|Missed visit|1
285699|NCT00972777|942967|P2|Overall Study|Screening Failure|1
285700|NCT00972777|942968|P1|Overall Study|Screening Failure|2
285701|NCT00972777|942967|P2|Overall Study|Protocol Violation|2
285702|NCT00972777|942968|P1|Overall Study|Protocol Violation|0
285703|NCT00972777|942967|P2|Overall Study|Physician Decision|0
285704|NCT00972777|942968|P1|Overall Study|Physician Decision|4
285705|NCT00972777|942967|P2|Overall Study|Withdrawal by Subject|5
285706|NCT00972777|942968|P1|Overall Study|Withdrawal by Subject|4
285707|NCT00972777|942967|P2|Overall Study|Lost to Follow-up|4
285708|NCT00972777|942968|P1|Overall Study|Lost to Follow-up|0
285709|NCT00972777|942967|P2|Overall Study|Adverse Event|2
285710|NCT00972777|942968|P1|Overall Study|Adverse Event|3
285711|NCT00972738|942983|P3|Overall Study|Unspecified|1
285712|NCT00972738|942984|P2|Overall Study|Unspecified|2
285713|NCT00972738|942985|P1|Overall Study|Unspecified|1
285714|NCT00972738|942983|P3|Overall Study|Moved|1
285715|NCT00972738|942984|P2|Overall Study|Moved|0
285716|NCT00972738|942985|P1|Overall Study|Moved|0
285717|NCT00972738|942983|P3|Overall Study|Withdrawal by Subject|4
285718|NCT00972738|942984|P2|Overall Study|Withdrawal by Subject|1
285719|NCT00972738|942985|P1|Overall Study|Withdrawal by Subject|5
285720|NCT00972738|942983|P3|Overall Study|Lack of Efficacy|11
285721|NCT00972738|942984|P2|Overall Study|Lack of Efficacy|1
285722|NCT00972738|942985|P1|Overall Study|Lack of Efficacy|5
285723|NCT00972738|942983|P3|Overall Study|Lost to Follow-up|1
285724|NCT00972738|942984|P2|Overall Study|Lost to Follow-up|0
285725|NCT00972738|942985|P1|Overall Study|Lost to Follow-up|1
285726|NCT00972738|942983|P3|Overall Study|Protocol Violation|3
285727|NCT00972738|942984|P2|Overall Study|Protocol Violation|1
285728|NCT00972738|942985|P1|Overall Study|Protocol Violation|2
285729|NCT00972738|942983|P3|Overall Study|Adverse Event|8
285730|NCT00972738|942984|P2|Overall Study|Adverse Event|1
285731|NCT00972738|942985|P1|Overall Study|Adverse Event|7
285732|NCT00972595|943102|P2|Period 1|Adverse Event|0
285733|NCT00972595|943103|P1|Period 1|Adverse Event|1
285734|NCT00972543|943113|P2|Overall Study|Early study termination by sponsor|1
285735|NCT00972543|943114|P1|Overall Study|Early study termination by sponsor|4
285736|NCT00972543|943113|P2|Overall Study|Adverse Event|0
285737|NCT00972543|943114|P1|Overall Study|Adverse Event|1
285738|NCT00972478|943199|P2|Overall Study|Not start protocol treatment|2
285739|NCT00972478|943200|P1|Overall Study|Not start protocol treatment|1
285740|NCT00972478|943199|P2|Overall Study|Ineligible|7
285741|NCT00972478|943200|P1|Overall Study|Ineligible|1
285742|NCT00972478|943199|P2|Overall Study|Not protocol specified|1
285743|NCT00972478|943200|P1|Overall Study|Not protocol specified|1
285744|NCT00972478|943199|P2|Overall Study|Death|2
285745|NCT00972478|943200|P1|Overall Study|Death|0
285746|NCT00972478|943199|P2|Overall Study|Progression/Relapse|2
285747|NCT00972478|943200|P1|Overall Study|Progression/Relapse|0
285748|NCT00972478|943199|P2|Overall Study|Withdrawal by Subject|8
285749|NCT00972478|943200|P1|Overall Study|Withdrawal by Subject|1
285750|NCT00972478|943199|P2|Overall Study|Adverse Event|16
285751|NCT00972478|943200|P1|Overall Study|Adverse Event|3
285752|NCT00972322|943236|P2|Overall Study|Consistently high glucose values|0
285753|NCT00972322|943237|P1|Overall Study|Consistently high glucose values|1
285754|NCT00972322|943236|P2|Overall Study|Lost to Follow-up|1
285755|NCT00972322|943237|P1|Overall Study|Lost to Follow-up|0
285756|NCT00972322|943236|P2|Overall Study|Positive drug screen|1
285757|NCT00972322|943237|P1|Overall Study|Positive drug screen|0
285758|NCT00972322|943236|P2|Overall Study|Adverse Event|1
285759|NCT00972322|943237|P1|Overall Study|Adverse Event|2
285760|NCT00972283|943249|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
285761|NCT00972283|943250|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
285762|NCT00972283|943249|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
285763|NCT00972283|943250|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
285764|NCT00972283|943249|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
285765|NCT00972283|943250|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
285766|NCT00972283|943249|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
285767|NCT00972283|943250|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
285768|NCT00972283|943249|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
285769|NCT00972283|943250|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
285770|NCT00972283|943249|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
285771|NCT00972283|943250|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
285772|NCT00972283|943249|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
285773|NCT00972283|943250|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
285774|NCT00972283|943249|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
285775|NCT00972283|943250|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
285776|NCT00972283|943249|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
285777|NCT00972283|943250|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
285778|NCT00972283|943249|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
285779|NCT00972283|943250|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
285780|NCT00972244|943277|P5|Overall Study|Various|2
285781|NCT00972244|943278|P4|Overall Study|Various|0
285782|NCT00972244|943279|P3|Overall Study|Various|0
285783|NCT00972244|943280|P2|Overall Study|Various|0
285784|NCT00972244|943281|P1|Overall Study|Various|0
285785|NCT00972244|943277|P5|Overall Study|Death|0
285786|NCT00972244|943278|P4|Overall Study|Death|0
285787|NCT00972244|943279|P3|Overall Study|Death|0
285788|NCT00972244|943280|P2|Overall Study|Death|0
285789|NCT00972244|943281|P1|Overall Study|Death|1
285790|NCT00972244|943277|P5|Overall Study|Safety|1
285791|NCT00972244|943278|P4|Overall Study|Safety|0
285792|NCT00972244|943279|P3|Overall Study|Safety|0
285793|NCT00972244|943280|P2|Overall Study|Safety|0
285794|NCT00972244|943281|P1|Overall Study|Safety|0
285795|NCT00972244|943277|P5|Overall Study|Withdrawal by Subject|1
285796|NCT00972244|943278|P4|Overall Study|Withdrawal by Subject|0
285797|NCT00972244|943279|P3|Overall Study|Withdrawal by Subject|1
285798|NCT00972244|943280|P2|Overall Study|Withdrawal by Subject|2
285799|NCT00972244|943281|P1|Overall Study|Withdrawal by Subject|1
285800|NCT00972244|943277|P5|Overall Study|Subject No Longer Meets Study Criteria|5
285801|NCT00972244|943278|P4|Overall Study|Subject No Longer Meets Study Criteria|0
285802|NCT00972244|943279|P3|Overall Study|Subject No Longer Meets Study Criteria|0
285803|NCT00972244|943280|P2|Overall Study|Subject No Longer Meets Study Criteria|2
285804|NCT00972244|943281|P1|Overall Study|Subject No Longer Meets Study Criteria|2
285805|NCT00972244|943277|P5|Overall Study|Adverse Event|0
285806|NCT00972244|943278|P4|Overall Study|Adverse Event|0
285807|NCT00972244|943279|P3|Overall Study|Adverse Event|1
285808|NCT00972244|943280|P2|Overall Study|Adverse Event|1
285809|NCT00972244|943281|P1|Overall Study|Adverse Event|0
285810|NCT00972244|943277|P5|Overall Study|Incorrect Enrolment|0
285811|NCT00972244|943278|P4|Overall Study|Incorrect Enrolment|0
285812|NCT00972244|943279|P3|Overall Study|Incorrect Enrolment|0
285813|NCT00972244|943280|P2|Overall Study|Incorrect Enrolment|0
285814|NCT00972244|943281|P1|Overall Study|Incorrect Enrolment|1
285815|NCT00972153|943313|P3|Overall Study|Equipment malfunction during case|0
285816|NCT00972153|943314|P2|Overall Study|Equipment malfunction during case|1
285817|NCT00972153|943315|P1|Overall Study|Equipment malfunction during case|0
285818|NCT00972023|943330|P1|Overall Study|Withdrawal by Subject|1
285819|NCT00971997|943337|P1|Overall Study|Physician Decision|7
285820|NCT00971997|943337|P1|Overall Study|Withdrawal by Subject|5
285821|NCT00971997|943337|P1|Overall Study|Protocol Violation|4
285822|NCT00971997|943337|P1|Overall Study|Death|1
285823|NCT00971997|943337|P1|Overall Study|Adverse Event|2
285824|NCT00971932|943355|P1|Overall Study|Ongoing|4
285825|NCT00971932|943355|P1|Overall Study|Investigator's decision|2
285826|NCT00971932|943355|P1|Overall Study|Withdrawal by Subject|1
285827|NCT00971425|943435|P2|Overall Study|Withdrawal by Subject|1
285828|NCT00971425|943436|P1|Overall Study|Withdrawal by Subject|0
285829|NCT00971425|943435|P2|Overall Study|Adverse Event|1
285830|NCT00971425|943436|P1|Overall Study|Adverse Event|1
285831|NCT00971243|943500|P5|Open-label Period|Other reason|2
285832|NCT00971243|943501|P4|Open-label Period|Other reason|0
285833|NCT00971243|943502|P3|Open-label Period|Other reason|0
285834|NCT00971243|943503|P2|Open-label Period|Other reason|0
285835|NCT00971243|943504|P1|Open-label Period|Other reason|0
285836|NCT00971243|943500|P5|Open-label Period|Withdrawal by Subject|1
285837|NCT00971243|943501|P4|Open-label Period|Withdrawal by Subject|2
285838|NCT00971243|943502|P3|Open-label Period|Withdrawal by Subject|0
285839|NCT00971243|943503|P2|Open-label Period|Withdrawal by Subject|0
285840|NCT00971243|943504|P1|Open-label Period|Withdrawal by Subject|1
285841|NCT00971243|943500|P5|Open-label Period|Protocol Violation|1
285842|NCT00971243|943501|P4|Open-label Period|Protocol Violation|0
285843|NCT00971243|943502|P3|Open-label Period|Protocol Violation|1
285844|NCT00971243|943503|P2|Open-label Period|Protocol Violation|1
285845|NCT00971243|943504|P1|Open-label Period|Protocol Violation|1
285846|NCT00971243|943500|P5|Open-label Period|Physician Decision|2
285847|NCT00971243|943501|P4|Open-label Period|Physician Decision|7
285848|NCT00971243|943502|P3|Open-label Period|Physician Decision|3
285849|NCT00971243|943503|P2|Open-label Period|Physician Decision|9
285850|NCT00971243|943504|P1|Open-label Period|Physician Decision|5
285851|NCT00971243|943500|P5|Open-label Period|Adverse Event|0
285852|NCT00971243|943501|P4|Open-label Period|Adverse Event|1
285853|NCT00971243|943502|P3|Open-label Period|Adverse Event|1
285854|NCT00971243|943503|P2|Open-label Period|Adverse Event|0
285855|NCT00971243|943504|P1|Open-label Period|Adverse Event|1
285856|NCT00971243|943500|P5|Double Blind Period|Other reasons|1
285857|NCT00971243|943501|P4|Double Blind Period|Other reasons|0
285858|NCT00971243|943502|P3|Double Blind Period|Other reasons|2
285859|NCT00971243|943503|P2|Double Blind Period|Other reasons|0
285860|NCT00971243|943504|P1|Double Blind Period|Other reasons|1
285861|NCT00971243|943500|P5|Double Blind Period|Withdrawal by Subject|4
285862|NCT00971243|943501|P4|Double Blind Period|Withdrawal by Subject|4
285863|NCT00971243|943502|P3|Double Blind Period|Withdrawal by Subject|4
285864|NCT00971243|943503|P2|Double Blind Period|Withdrawal by Subject|1
285865|NCT00971243|943504|P1|Double Blind Period|Withdrawal by Subject|4
285866|NCT00971243|943500|P5|Double Blind Period|Protocol Violation|2
285867|NCT00971243|943501|P4|Double Blind Period|Protocol Violation|2
285868|NCT00971243|943502|P3|Double Blind Period|Protocol Violation|3
285869|NCT00971243|943503|P2|Double Blind Period|Protocol Violation|0
285870|NCT00971243|943504|P1|Double Blind Period|Protocol Violation|2
285871|NCT00971243|943500|P5|Double Blind Period|Physician Decision|7
285872|NCT00971243|943501|P4|Double Blind Period|Physician Decision|6
285873|NCT00971243|943502|P3|Double Blind Period|Physician Decision|7
285874|NCT00971243|943503|P2|Double Blind Period|Physician Decision|6
285875|NCT00971243|943504|P1|Double Blind Period|Physician Decision|10
285876|NCT00971243|943500|P5|Double Blind Period|Lost to Follow-up|1
285877|NCT00971243|943501|P4|Double Blind Period|Lost to Follow-up|0
285878|NCT00971243|943502|P3|Double Blind Period|Lost to Follow-up|1
285879|NCT00971243|943503|P2|Double Blind Period|Lost to Follow-up|1
285880|NCT00971243|943504|P1|Double Blind Period|Lost to Follow-up|0
285881|NCT00971243|943500|P5|Double Blind Period|Adverse Event|3
285882|NCT00971243|943501|P4|Double Blind Period|Adverse Event|2
285883|NCT00971243|943502|P3|Double Blind Period|Adverse Event|2
285884|NCT00971243|943503|P2|Double Blind Period|Adverse Event|3
285885|NCT00971243|943504|P1|Double Blind Period|Adverse Event|2
285886|NCT00971204|943521|P1|Overall Study|Lost to Follow-up|10
285887|NCT00971204|943521|P1|Overall Study|Did not meet all criteria-not treated|14
285888|NCT00971048|943529|P4|Overall Study|Physician Decision|1
285889|NCT00971048|943530|P3|Overall Study|Physician Decision|0
285890|NCT00971048|943531|P2|Overall Study|Physician Decision|0
285891|NCT00971048|943532|P1|Overall Study|Physician Decision|0
285892|NCT00971048|943529|P4|Overall Study|Adverse Event|0
285893|NCT00971048|943530|P3|Overall Study|Adverse Event|1
285894|NCT00971048|943531|P2|Overall Study|Adverse Event|0
285895|NCT00971048|943532|P1|Overall Study|Adverse Event|0
285896|NCT00971048|943529|P4|Overall Study|Protocol Violation|1
285897|NCT00971048|943530|P3|Overall Study|Protocol Violation|0
285898|NCT00971048|943531|P2|Overall Study|Protocol Violation|2
285899|NCT00971048|943532|P1|Overall Study|Protocol Violation|1
285900|NCT00970944|943556|P2|Overall Study|Physician Decision|2
285901|NCT00970944|943557|P1|Overall Study|Physician Decision|0
285902|NCT00970944|943556|P2|Overall Study|Death|0
285903|NCT00970944|943557|P1|Overall Study|Death|1
285904|NCT00970684|943609|P1|Overall Study|Withdrawal by Subject|1
285905|NCT00970684|943609|P1|Overall Study|Adverse Event|4
285906|NCT00970684|943609|P1|Overall Study|Lack of Efficacy|5
285907|NCT00970632|943618|P3|Overall Study|Sponsor decision|1
285908|NCT00970632|943619|P2|Overall Study|Sponsor decision|0
285909|NCT00970632|943620|P1|Overall Study|Sponsor decision|1
285910|NCT00970632|943618|P3|Overall Study|Entry criteria not met|2
285911|NCT00970632|943619|P2|Overall Study|Entry criteria not met|2
285912|NCT00970632|943620|P1|Overall Study|Entry criteria not met|0
285913|NCT00970632|943618|P3|Overall Study|Withdrawal by Subject|4
285914|NCT00970632|943619|P2|Overall Study|Withdrawal by Subject|6
285915|NCT00970632|943620|P1|Overall Study|Withdrawal by Subject|7
285916|NCT00970632|943618|P3|Overall Study|Protocol Violation|8
285917|NCT00970632|943619|P2|Overall Study|Protocol Violation|5
285918|NCT00970632|943620|P1|Overall Study|Protocol Violation|8
285919|NCT00970632|943618|P3|Overall Study|Lost to Follow-up|2
285920|NCT00970632|943619|P2|Overall Study|Lost to Follow-up|0
285921|NCT00970632|943620|P1|Overall Study|Lost to Follow-up|3
285922|NCT00970632|943618|P3|Overall Study|Lack of Efficacy|0
285923|NCT00970632|943619|P2|Overall Study|Lack of Efficacy|0
285924|NCT00970632|943620|P1|Overall Study|Lack of Efficacy|3
285925|NCT00970632|943618|P3|Overall Study|Adverse Event|1
285926|NCT00970632|943619|P2|Overall Study|Adverse Event|2
285927|NCT00970632|943620|P1|Overall Study|Adverse Event|2
285928|NCT00970502|943685|P1|Overall Study|Withdrawal by Subject|1
285929|NCT00970489|943696|P2|Overall Study|Death/Withdrew/Criteria Violation|41
285930|NCT00970489|943697|P1|Overall Study|Death/Withdrew/Criteria Violation|54
285931|NCT00970359|943709|P1|Overall Study|Not Treated|4
285932|NCT00970307|943739|P3|Overall Study|Withdrawal by Subject|2
285933|NCT00970307|943740|P2|Overall Study|Withdrawal by Subject|3
285934|NCT00970307|943741|P1|Overall Study|Withdrawal by Subject|2
285935|NCT00970307|943739|P3|Overall Study|Serious Adverse Event|0
285936|NCT00970307|943740|P2|Overall Study|Serious Adverse Event|0
285937|NCT00970307|943741|P1|Overall Study|Serious Adverse Event|1
285938|NCT00970294|943815|P1|Overall Study|Withdrawal by Subject|1
285939|NCT00970294|943815|P1|Overall Study|Physician Decision|4
285940|NCT00970281|943823|P2|Overall Study|Physician Decision|1
285941|NCT00970281|943824|P1|Overall Study|Physician Decision|1
285942|NCT00970281|943823|P2|Overall Study|Withdrawal by Subject|1
285943|NCT00970281|943824|P1|Overall Study|Withdrawal by Subject|0
285944|NCT00970281|943823|P2|Overall Study|Lack of Efficacy|14
285945|NCT00970281|943824|P1|Overall Study|Lack of Efficacy|1
285946|NCT00970268|943842|P2|Overall Study|Inclusion/Exclusion Criteria|0
285947|NCT00970268|943843|P1|Overall Study|Inclusion/Exclusion Criteria|1
285948|NCT00970268|943842|P2|Overall Study|Lost to Follow-up|2
285949|NCT00970268|943843|P1|Overall Study|Lost to Follow-up|1
285950|NCT00970268|943842|P2|Overall Study|COPD Exacerbation|2
285951|NCT00970268|943843|P1|Overall Study|COPD Exacerbation|4
285952|NCT00970268|943842|P2|Overall Study|Other Reason|1
285953|NCT00970268|943843|P1|Overall Study|Other Reason|3
285954|NCT00970268|943842|P2|Overall Study|Protocol Violation|7
285955|NCT00970268|943843|P1|Overall Study|Protocol Violation|4
285956|NCT00970268|943842|P2|Overall Study|Lack of Efficacy|6
285957|NCT00970268|943843|P1|Overall Study|Lack of Efficacy|3
285958|NCT00970268|943842|P2|Overall Study|Adverse Event|12
285959|NCT00970268|943843|P1|Overall Study|Adverse Event|15
285960|NCT00970268|943842|P2|Overall Study|Withdrawal by Subject|19
285961|NCT00970268|943843|P1|Overall Study|Withdrawal by Subject|12
285962|NCT00969280|943859|P2|Overall Study|infection of influenza A(H1N1)|1
285963|NCT00969280|943860|P1|Overall Study|infection of influenza A(H1N1)|0
285964|NCT00969280|943859|P2|Overall Study|Withdrawal by Subject|1
285965|NCT00969280|943860|P1|Overall Study|Withdrawal by Subject|0
285966|NCT00969280|943859|P2|Overall Study|Protocol Violation|1
285967|NCT00969280|943860|P1|Overall Study|Protocol Violation|2
285968|NCT00969228|943868|P2|Overall Study|Porcine circovirus detection in vaccine|14
285969|NCT00969228|943869|P1|Overall Study|Porcine circovirus detection in vaccine|38
285970|NCT00969228|943868|P2|Overall Study|Withdrawal by Subject|0
285971|NCT00969228|943869|P1|Overall Study|Withdrawal by Subject|4
285972|NCT00969228|943868|P2|Overall Study|Adverse Event|0
285973|NCT00969228|943869|P1|Overall Study|Adverse Event|1
285974|NCT00969709|943904|P4|Overall Study|Other reasons|0
285975|NCT00969709|943905|P3|Overall Study|Other reasons|3
285976|NCT00969709|943906|P2|Overall Study|Other reasons|0
285977|NCT00969709|943907|P1|Overall Study|Other reasons|0
285978|NCT00969709|943904|P4|Overall Study|Lost to Follow-up|15
285979|NCT00969709|943905|P3|Overall Study|Lost to Follow-up|8
285980|NCT00969709|943906|P2|Overall Study|Lost to Follow-up|14
285981|NCT00969709|943907|P1|Overall Study|Lost to Follow-up|10
285982|NCT00969709|943904|P4|Overall Study|Withdrawal by Subject|23
285983|NCT00969709|943905|P3|Overall Study|Withdrawal by Subject|11
285984|NCT00969709|943906|P2|Overall Study|Withdrawal by Subject|12
285985|NCT00969709|943907|P1|Overall Study|Withdrawal by Subject|9
285986|NCT00969709|943904|P4|Overall Study|Protocol Violation|10
285987|NCT00969709|943905|P3|Overall Study|Protocol Violation|9
285988|NCT00969709|943906|P2|Overall Study|Protocol Violation|5
285989|NCT00969709|943907|P1|Overall Study|Protocol Violation|9
285990|NCT00969709|943904|P4|Overall Study|Lack of Efficacy|3
285991|NCT00969709|943905|P3|Overall Study|Lack of Efficacy|1
285992|NCT00969709|943906|P2|Overall Study|Lack of Efficacy|4
285993|NCT00969709|943907|P1|Overall Study|Lack of Efficacy|7
285994|NCT00969709|943904|P4|Overall Study|Adverse Event|12
285995|NCT00969709|943905|P3|Overall Study|Adverse Event|26
285996|NCT00969709|943906|P2|Overall Study|Adverse Event|13
285997|NCT00969709|943907|P1|Overall Study|Adverse Event|3
285998|NCT00969618|943921|P1|Overall Study|Withdrawal by Subject|27
285999|NCT00969618|943921|P1|Overall Study|Protocol Violation|9
286000|NCT00969618|943921|P1|Overall Study|Physician Decision|1
286001|NCT00969618|943921|P1|Overall Study|Lost to Follow-up|7
286002|NCT00969618|943921|P1|Overall Study|Lack of Efficacy|2
286003|NCT00969618|943921|P1|Overall Study|Entry Criteria Not Met|3
286004|NCT00969618|943921|P1|Overall Study|Adverse Event|29
286005|NCT00969540|943934|P2|Overall Study|Lost to Follow-up|1
286006|NCT00969540|943935|P1|Overall Study|Lost to Follow-up|1
286007|NCT00969150|943959|P2|Overall Study|Other reasons|0
286008|NCT00969150|943960|P1|Overall Study|Other reasons|1
286009|NCT00969150|943959|P2|Overall Study|Lost to Follow-up|4
286010|NCT00969150|943960|P1|Overall Study|Lost to Follow-up|5
286011|NCT00969150|943959|P2|Overall Study|Withdrawal by Subject|9
286012|NCT00969150|943960|P1|Overall Study|Withdrawal by Subject|13
286013|NCT00969150|943959|P2|Overall Study|Protocol Violation|12
286014|NCT00969150|943960|P1|Overall Study|Protocol Violation|9
286015|NCT00969150|943959|P2|Overall Study|Lack of Efficacy|1
286016|NCT00969150|943960|P1|Overall Study|Lack of Efficacy|1
286017|NCT00969150|943959|P2|Overall Study|Adverse Event|14
286018|NCT00969150|943960|P1|Overall Study|Adverse Event|4
286019|NCT00968981|943971|P3|Overall Study|Withdrawal by Subject|3
286020|NCT00968981|943972|P2|Overall Study|Withdrawal by Subject|3
286021|NCT00968981|943973|P1|Overall Study|Withdrawal by Subject|1
286022|NCT00968981|943971|P3|Overall Study|Physician Decision|5
286023|NCT00968981|943972|P2|Overall Study|Physician Decision|3
286024|NCT00968981|943973|P1|Overall Study|Physician Decision|5
286025|NCT00968981|943971|P3|Overall Study|Lost to Follow-up|1
286026|NCT00968981|943972|P2|Overall Study|Lost to Follow-up|0
286027|NCT00968981|943973|P1|Overall Study|Lost to Follow-up|0
286028|NCT00968981|943971|P3|Overall Study|Disease Progression|13
286029|NCT00968981|943972|P2|Overall Study|Disease Progression|16
286030|NCT00968981|943973|P1|Overall Study|Disease Progression|14
286031|NCT00968981|943971|P3|Overall Study|Adverse Event|0
286032|NCT00968981|943972|P2|Overall Study|Adverse Event|0
286033|NCT00968981|943973|P1|Overall Study|Adverse Event|2
286034|NCT00968812|944052|P3|Overall Study|Not specified|40
286035|NCT00968812|944053|P2|Overall Study|Not specified|37
286036|NCT00968812|944054|P1|Overall Study|Not specified|25
286037|NCT00968812|944052|P3|Overall Study|Unable to take rescue therapy|17
286038|NCT00968812|944053|P2|Overall Study|Unable to take rescue therapy|12
286039|NCT00968812|944054|P1|Overall Study|Unable to take rescue therapy|12
286040|NCT00968812|944052|P3|Overall Study|Noncompliance with study drug|6
286041|NCT00968812|944053|P2|Overall Study|Noncompliance with study drug|1
286042|NCT00968812|944054|P1|Overall Study|Noncompliance with study drug|4
286043|NCT00968812|944052|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
286044|NCT00968812|944053|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
286045|NCT00968812|944054|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
286046|NCT00968812|944052|P3|Overall Study|Withdrawal by Subject|25
286047|NCT00968812|944053|P2|Overall Study|Withdrawal by Subject|23
286048|NCT00968812|944054|P1|Overall Study|Withdrawal by Subject|17
286049|NCT00968812|944052|P3|Overall Study|Protocol Violation|3
286050|NCT00968812|944053|P2|Overall Study|Protocol Violation|4
286051|NCT00968812|944054|P1|Overall Study|Protocol Violation|7
286052|NCT00968812|944052|P3|Overall Study|Physician Decision|9
286053|NCT00968812|944053|P2|Overall Study|Physician Decision|5
286054|NCT00968812|944054|P1|Overall Study|Physician Decision|8
286055|NCT00968812|944052|P3|Overall Study|Lost to Follow-up|11
286056|NCT00968812|944053|P2|Overall Study|Lost to Follow-up|12
286057|NCT00968812|944054|P1|Overall Study|Lost to Follow-up|17
286058|NCT00968812|944052|P3|Overall Study|Lack of Efficacy|16
286059|NCT00968812|944053|P2|Overall Study|Lack of Efficacy|7
286060|NCT00968812|944054|P1|Overall Study|Lack of Efficacy|9
286061|NCT00968812|944052|P3|Overall Study|Death|1
286062|NCT00968812|944053|P2|Overall Study|Death|2
286063|NCT00968812|944054|P1|Overall Study|Death|2
286064|NCT00968812|944052|P3|Overall Study|Adverse Event|33
286065|NCT00968812|944053|P2|Overall Study|Adverse Event|46
286066|NCT00968812|944054|P1|Overall Study|Adverse Event|30
286067|NCT00968799|944074|P1|Overall Study|Advanced disease, HIPEC not applicable|2
286068|NCT00968708|944084|P2|Overall Study|Other|34
286069|NCT00968708|944085|P1|Overall Study|Other|26
286070|NCT00968708|944084|P2|Overall Study|Investigator Discretion|1
286071|NCT00968708|944085|P1|Overall Study|Investigator Discretion|0
286072|NCT00968708|944084|P2|Overall Study|Voluntary Withdrawal|101
286073|NCT00968708|944085|P1|Overall Study|Voluntary Withdrawal|104
286074|NCT00968708|944084|P2|Overall Study|Lost to Follow-up|11
286075|NCT00968708|944085|P1|Overall Study|Lost to Follow-up|19
286076|NCT00968708|944084|P2|Overall Study|Major Protocol Deviation|1
286077|NCT00968708|944085|P1|Overall Study|Major Protocol Deviation|0
286078|NCT00968708|944084|P2|Overall Study|Adverse Event|150
286079|NCT00968708|944085|P1|Overall Study|Adverse Event|169
286080|NCT00968669|944097|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
286081|NCT00968669|944098|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
286082|NCT00968669|944099|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
286083|NCT00968669|944100|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
286084|NCT00968669|944097|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
286085|NCT00968669|944098|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
286086|NCT00968669|944099|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
286087|NCT00968669|944100|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
286088|NCT00968669|944097|P4|Overall Study|SUBJECT INCARCERATED|0
286089|NCT00968669|944098|P3|Overall Study|SUBJECT INCARCERATED|0
286090|NCT00968669|944099|P2|Overall Study|SUBJECT INCARCERATED|1
286091|NCT00968669|944100|P1|Overall Study|SUBJECT INCARCERATED|0
286092|NCT00968669|944097|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
286093|NCT00968669|944098|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
286094|NCT00968669|944099|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
286095|NCT00968669|944100|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
286096|NCT00968669|944097|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
286097|NCT00968669|944098|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
286098|NCT00968669|944099|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
286099|NCT00968669|944100|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
286100|NCT00968669|944097|P4|Overall Study|SPONSOR DECISION|0
286101|NCT00968669|944098|P3|Overall Study|SPONSOR DECISION|0
286102|NCT00968669|944099|P2|Overall Study|SPONSOR DECISION|1
286103|NCT00968669|944100|P1|Overall Study|SPONSOR DECISION|0
286104|NCT00968669|944097|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
286105|NCT00968669|944098|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
286106|NCT00968669|944099|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
286107|NCT00968669|944100|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
286108|NCT00968669|944097|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
286109|NCT00968669|944098|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
286110|NCT00968669|944099|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
286111|NCT00968669|944100|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
286112|NCT00968669|944097|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
286113|NCT00968669|944098|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
286114|NCT00968669|944099|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
286115|NCT00968669|944100|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
286116|NCT00968669|944097|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
286117|NCT00968669|944098|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
286118|NCT00968669|944099|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
286119|NCT00968669|944100|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
286120|NCT00968669|944097|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
286121|NCT00968669|944098|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
286122|NCT00968669|944099|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
286123|NCT00968669|944100|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
286124|NCT00968669|944097|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
286125|NCT00968669|944098|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
286126|NCT00968669|944099|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
286127|NCT00968669|944100|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
286128|NCT00968669|944097|P4|Overall Study|EARLY WITHDRAWAL|0
286129|NCT00968669|944098|P3|Overall Study|EARLY WITHDRAWAL|0
286130|NCT00968669|944099|P2|Overall Study|EARLY WITHDRAWAL|1
286131|NCT00968669|944100|P1|Overall Study|EARLY WITHDRAWAL|0
286132|NCT00968669|944097|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
286133|NCT00968669|944098|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
286134|NCT00968669|944099|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
286135|NCT00968669|944100|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
286136|NCT00968669|944097|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
286137|NCT00968669|944098|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
286138|NCT00968669|944099|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
286139|NCT00968669|944100|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
286140|NCT00968669|944097|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
286141|NCT00968669|944098|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
286142|NCT00968669|944099|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
286143|NCT00968669|944100|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
286144|NCT00968669|944097|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
286145|NCT00968669|944098|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
286146|NCT00968669|944099|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
286147|NCT00968669|944100|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
286148|NCT00968669|944097|P4|Overall Study|AE|0
286149|NCT00968669|944098|P3|Overall Study|AE|0
286150|NCT00968669|944099|P2|Overall Study|AE|0
286151|NCT00968669|944100|P1|Overall Study|AE|1
286152|NCT00968669|944097|P4|Overall Study|Pregnancy|0
286153|NCT00968669|944098|P3|Overall Study|Pregnancy|2
286154|NCT00968669|944099|P2|Overall Study|Pregnancy|0
286155|NCT00968669|944100|P1|Overall Study|Pregnancy|0
286156|NCT00968669|944097|P4|Overall Study|Withdrawal by Subject|3
286157|NCT00968669|944098|P3|Overall Study|Withdrawal by Subject|5
286158|NCT00968669|944099|P2|Overall Study|Withdrawal by Subject|7
286159|NCT00968669|944100|P1|Overall Study|Withdrawal by Subject|9
286160|NCT00968669|944097|P4|Overall Study|Lost to Follow-up|4
286161|NCT00968669|944098|P3|Overall Study|Lost to Follow-up|1
286162|NCT00968669|944099|P2|Overall Study|Lost to Follow-up|2
286163|NCT00968669|944100|P1|Overall Study|Lost to Follow-up|5
286164|NCT00968617|944190|P1|Overall Study|Study terminated by sponsor|6
286165|NCT00968201|944209|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
286166|NCT00968201|944210|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
286167|NCT00968201|944211|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
286168|NCT00968201|944209|P3|Extension Study - (Period III)|Not Specified|2
286169|NCT00968201|944210|P2|Extension Study - (Period III)|Not Specified|0
286170|NCT00968201|944211|P1|Extension Study - (Period III)|Not Specified|0
286171|NCT00968201|944209|P3|Extension Study - (Period III)|Noncompliance|3
286172|NCT00968201|944210|P2|Extension Study - (Period III)|Noncompliance|0
286173|NCT00968201|944211|P1|Extension Study - (Period III)|Noncompliance|0
286174|NCT00968201|944209|P3|Extension Study - (Period III)|Patient Relocated|1
286175|NCT00968201|944210|P2|Extension Study - (Period III)|Patient Relocated|1
286176|NCT00968201|944211|P1|Extension Study - (Period III)|Patient Relocated|0
286177|NCT00968201|944209|P3|Extension Study - (Period III)|Withdrawal by Subject|40
286178|NCT00968201|944210|P2|Extension Study - (Period III)|Withdrawal by Subject|20
286179|NCT00968201|944211|P1|Extension Study - (Period III)|Withdrawal by Subject|0
286180|NCT00968201|944209|P3|Extension Study - (Period III)|Protocol Violation|14
286181|NCT00968201|944210|P2|Extension Study - (Period III)|Protocol Violation|17
286182|NCT00968201|944211|P1|Extension Study - (Period III)|Protocol Violation|0
286183|NCT00968201|944209|P3|Extension Study - (Period III)|Lost to Follow-up|13
286184|NCT00968201|944210|P2|Extension Study - (Period III)|Lost to Follow-up|7
286185|NCT00968201|944211|P1|Extension Study - (Period III)|Lost to Follow-up|0
286186|NCT00968201|944209|P3|Extension Study - (Period III)|Adverse Event|22
286187|NCT00968201|944210|P2|Extension Study - (Period III)|Adverse Event|5
286188|NCT00968201|944211|P1|Extension Study - (Period III)|Adverse Event|0
286189|NCT00968201|944209|P3|Base Study - (Period II)|Site Error|1
286190|NCT00968201|944210|P2|Base Study - (Period II)|Site Error|0
286191|NCT00968201|944211|P1|Base Study - (Period II)|Site Error|0
286192|NCT00968201|944209|P3|Base Study - (Period II)|Withdrawal by Subject|8
286193|NCT00968201|944210|P2|Base Study - (Period II)|Withdrawal by Subject|0
286194|NCT00968201|944211|P1|Base Study - (Period II)|Withdrawal by Subject|4
286195|NCT00968201|944209|P3|Base Study - (Period II)|Protocol Violation|12
286196|NCT00968201|944210|P2|Base Study - (Period II)|Protocol Violation|0
286197|NCT00968201|944211|P1|Base Study - (Period II)|Protocol Violation|12
286198|NCT00968201|944209|P3|Base Study - (Period II)|Lost to Follow-up|7
286199|NCT00968201|944210|P2|Base Study - (Period II)|Lost to Follow-up|0
286200|NCT00968201|944211|P1|Base Study - (Period II)|Lost to Follow-up|2
286201|NCT00968201|944209|P3|Base Study - (Period II)|Lack of Efficacy|1
286202|NCT00968201|944210|P2|Base Study - (Period II)|Lack of Efficacy|0
286203|NCT00968201|944211|P1|Base Study - (Period II)|Lack of Efficacy|0
286204|NCT00968201|944209|P3|Base Study - (Period II)|Adverse Event|16
286205|NCT00968201|944210|P2|Base Study - (Period II)|Adverse Event|0
286206|NCT00968201|944211|P1|Base Study - (Period II)|Adverse Event|8
286207|NCT00968149|944272|P2|Overall Study|Withdrawal by Subject|0
286208|NCT00968149|944273|P1|Overall Study|Withdrawal by Subject|2
286209|NCT00968149|944272|P2|Overall Study|Protocol Violation|0
286210|NCT00968149|944273|P1|Overall Study|Protocol Violation|4
286211|NCT00968149|944272|P2|Overall Study|Lost to Follow-up|1
286212|NCT00968149|944273|P1|Overall Study|Lost to Follow-up|0
286213|NCT00968149|944272|P2|Overall Study|Lack of Efficacy|4
286214|NCT00968149|944273|P1|Overall Study|Lack of Efficacy|0
286215|NCT00968149|944272|P2|Overall Study|Adverse Event|1
286216|NCT00968149|944273|P1|Overall Study|Adverse Event|5
286217|NCT00967694|944326|P1|Overall Study|Withdrawal by Subject|6
286218|NCT00967668|944333|P3|Overall Study|Pregnancy|0
286219|NCT00967668|944334|P2|Overall Study|Pregnancy|0
286220|NCT00967668|944335|P1|Overall Study|Pregnancy|1
286221|NCT00967668|944333|P3|Overall Study|Refused 12-mo assessment|9
286222|NCT00967668|944334|P2|Overall Study|Refused 12-mo assessment|1
286223|NCT00967668|944335|P1|Overall Study|Refused 12-mo assessment|3
286224|NCT00967668|944333|P3|Overall Study|Lost to Follow-up|16
286225|NCT00967668|944334|P2|Overall Study|Lost to Follow-up|9
286226|NCT00967668|944335|P1|Overall Study|Lost to Follow-up|15
286227|NCT00967668|944333|P3|Overall Study|Lost to follow-up at 12-mo|26
286228|NCT00967668|944334|P2|Overall Study|Lost to follow-up at 12-mo|29
286229|NCT00967668|944335|P1|Overall Study|Lost to follow-up at 12-mo|27
286230|NCT00967668|944333|P3|Overall Study|Refused Year 2|4
286231|NCT00967668|944334|P2|Overall Study|Refused Year 2|6
286232|NCT00967668|944335|P1|Overall Study|Refused Year 2|11
286233|NCT00967668|944333|P3|Overall Study|Removed due to behavior|2
286234|NCT00967668|944334|P2|Overall Study|Removed due to behavior|1
286235|NCT00967668|944335|P1|Overall Study|Removed due to behavior|1
286236|NCT00967668|944333|P3|Overall Study|Death|4
286237|NCT00967668|944334|P2|Overall Study|Death|2
286238|NCT00967668|944335|P1|Overall Study|Death|0
286239|NCT00967668|944333|P3|Overall Study|Withdrawal by Subject|8
286240|NCT00967668|944334|P2|Overall Study|Withdrawal by Subject|8
286241|NCT00967668|944335|P1|Overall Study|Withdrawal by Subject|13
286242|NCT00967330|944381|P2|Overall Study|Severe protocol deviation|1
286243|NCT00967330|944382|P1|Overall Study|Severe protocol deviation|0
286244|NCT00967330|944381|P2|Overall Study|Death|51
286245|NCT00967330|944382|P1|Overall Study|Death|102
286246|NCT00967330|944381|P2|Overall Study|Lost to Follow-up|1
286247|NCT00967330|944382|P1|Overall Study|Lost to Follow-up|1
286248|NCT00967330|944381|P2|Overall Study|Withdrawal by Subject|0
286249|NCT00967330|944382|P1|Overall Study|Withdrawal by Subject|6
286250|NCT00967330|944381|P2|Overall Study|Regular|3
286251|NCT00967330|944382|P1|Overall Study|Regular|10
286252|NCT00967330|944381|P2|Overall Study|Protocol Violation|4
286253|NCT00967330|944382|P1|Overall Study|Protocol Violation|3
286254|NCT00967226|944412|P2|Overall Study|Physician Decision|1
286255|NCT00967226|944413|P1|Overall Study|Physician Decision|0
286256|NCT00967226|944412|P2|Overall Study|Protocol Violation|0
286257|NCT00967226|944413|P1|Overall Study|Protocol Violation|2
286258|NCT00967226|944412|P2|Overall Study|Adverse Event|5
286259|NCT00967226|944413|P1|Overall Study|Adverse Event|0
286260|NCT00967018|944447|P1|Overall Study|Miscellaneous Reasons|9
286261|NCT00967018|944447|P1|Overall Study|Withdrawal by Subject|1
286262|NCT00967018|944447|P1|Overall Study|Lost to Follow-up|2
286263|NCT00967018|944447|P1|Overall Study|Physician Decision|7
286264|NCT00967018|944447|P1|Overall Study|Adverse Event|2
286265|NCT00966940|944488|P2|Period 1, First 6 Weeks|Protocol Violation|0
286266|NCT00966940|944489|P1|Period 1, First 6 Weeks|Protocol Violation|1
286267|NCT00966940|944488|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
286268|NCT00966940|944489|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
286269|NCT00966875|944516|P9|Part B|Entry Criteria|1
286270|NCT00966875|944517|P8|Part B|Entry Criteria|0
286271|NCT00966875|944518|P7|Part B|Entry Criteria|1
286272|NCT00966875|944519|P6|Part B|Entry Criteria|0
286273|NCT00966875|944520|P5|Part B|Entry Criteria|0
286274|NCT00966875|944521|P4|Part B|Entry Criteria|0
286275|NCT00966875|944522|P3|Part B|Entry Criteria|0
286276|NCT00966875|944523|P2|Part B|Entry Criteria|0
286277|NCT00966875|944524|P1|Part B|Entry Criteria|0
286278|NCT00966875|944516|P9|Part B|Withdrawal by Subject|5
286279|NCT00966875|944517|P8|Part B|Withdrawal by Subject|5
286280|NCT00966875|944518|P7|Part B|Withdrawal by Subject|4
286281|NCT00966875|944519|P6|Part B|Withdrawal by Subject|1
286282|NCT00966875|944520|P5|Part B|Withdrawal by Subject|2
286283|NCT00966875|944521|P4|Part B|Withdrawal by Subject|1
286284|NCT00966875|944522|P3|Part B|Withdrawal by Subject|2
286285|NCT00966875|944523|P2|Part B|Withdrawal by Subject|1
286286|NCT00966875|944524|P1|Part B|Withdrawal by Subject|2
286287|NCT00966875|944516|P9|Part B|Sponsor Decision|1
286288|NCT00966875|944517|P8|Part B|Sponsor Decision|2
286289|NCT00966875|944518|P7|Part B|Sponsor Decision|0
286290|NCT00966875|944519|P6|Part B|Sponsor Decision|1
286291|NCT00966875|944520|P5|Part B|Sponsor Decision|0
286292|NCT00966875|944521|P4|Part B|Sponsor Decision|0
286293|NCT00966875|944522|P3|Part B|Sponsor Decision|0
286294|NCT00966875|944523|P2|Part B|Sponsor Decision|0
286295|NCT00966875|944524|P1|Part B|Sponsor Decision|1
286296|NCT00966875|944516|P9|Part B|Physician Decision|2
286297|NCT00966875|944517|P8|Part B|Physician Decision|0
286298|NCT00966875|944518|P7|Part B|Physician Decision|0
286299|NCT00966875|944519|P6|Part B|Physician Decision|1
286300|NCT00966875|944520|P5|Part B|Physician Decision|2
286301|NCT00966875|944521|P4|Part B|Physician Decision|0
286302|NCT00966875|944522|P3|Part B|Physician Decision|1
286303|NCT00966875|944523|P2|Part B|Physician Decision|0
286304|NCT00966875|944524|P1|Part B|Physician Decision|0
286305|NCT00966875|944516|P9|Part B|Lost to Follow-up|1
286306|NCT00966875|944517|P8|Part B|Lost to Follow-up|0
286307|NCT00966875|944518|P7|Part B|Lost to Follow-up|0
286308|NCT00966875|944519|P6|Part B|Lost to Follow-up|0
286309|NCT00966875|944520|P5|Part B|Lost to Follow-up|0
286310|NCT00966875|944521|P4|Part B|Lost to Follow-up|1
286311|NCT00966875|944522|P3|Part B|Lost to Follow-up|0
286312|NCT00966875|944523|P2|Part B|Lost to Follow-up|0
286313|NCT00966875|944524|P1|Part B|Lost to Follow-up|0
286314|NCT00966875|944516|P9|Part B|Lack of Efficacy|6
286315|NCT00966875|944517|P8|Part B|Lack of Efficacy|9
286316|NCT00966875|944518|P7|Part B|Lack of Efficacy|12
286317|NCT00966875|944519|P6|Part B|Lack of Efficacy|3
286318|NCT00966875|944520|P5|Part B|Lack of Efficacy|2
286319|NCT00966875|944521|P4|Part B|Lack of Efficacy|1
286320|NCT00966875|944522|P3|Part B|Lack of Efficacy|1
286321|NCT00966875|944523|P2|Part B|Lack of Efficacy|1
286322|NCT00966875|944524|P1|Part B|Lack of Efficacy|2
286323|NCT00966875|944516|P9|Part B|Death|0
286324|NCT00966875|944517|P8|Part B|Death|1
286325|NCT00966875|944518|P7|Part B|Death|0
286326|NCT00966875|944519|P6|Part B|Death|0
286327|NCT00966875|944520|P5|Part B|Death|0
286328|NCT00966875|944521|P4|Part B|Death|0
286329|NCT00966875|944522|P3|Part B|Death|1
286330|NCT00966875|944523|P2|Part B|Death|0
286331|NCT00966875|944524|P1|Part B|Death|0
286332|NCT00966875|944516|P9|Part B|Adverse Event|2
286333|NCT00966875|944517|P8|Part B|Adverse Event|2
286334|NCT00966875|944518|P7|Part B|Adverse Event|5
286335|NCT00966875|944519|P6|Part B|Adverse Event|0
286336|NCT00966875|944520|P5|Part B|Adverse Event|1
286337|NCT00966875|944521|P4|Part B|Adverse Event|0
286338|NCT00966875|944522|P3|Part B|Adverse Event|1
286339|NCT00966875|944523|P2|Part B|Adverse Event|1
286340|NCT00966875|944524|P1|Part B|Adverse Event|0
286341|NCT00966875|944516|P9|Part A|Protocol Violation|1
286342|NCT00966875|944517|P8|Part A|Protocol Violation|1
286343|NCT00966875|944518|P7|Part A|Protocol Violation|2
286344|NCT00966875|944519|P6|Part A|Protocol Violation|0
286345|NCT00966875|944520|P5|Part A|Protocol Violation|0
286346|NCT00966875|944521|P4|Part A|Protocol Violation|0
286347|NCT00966875|944522|P3|Part A|Protocol Violation|0
286348|NCT00966875|944523|P2|Part A|Protocol Violation|0
286349|NCT00966875|944524|P1|Part A|Protocol Violation|0
286350|NCT00966875|944516|P9|Part A|Withdrawal by Subject|1
286351|NCT00966875|944517|P8|Part A|Withdrawal by Subject|1
286352|NCT00966875|944518|P7|Part A|Withdrawal by Subject|5
286353|NCT00966875|944519|P6|Part A|Withdrawal by Subject|0
286354|NCT00966875|944520|P5|Part A|Withdrawal by Subject|3
286355|NCT00966875|944521|P4|Part A|Withdrawal by Subject|1
286356|NCT00966875|944522|P3|Part A|Withdrawal by Subject|1
286357|NCT00966875|944523|P2|Part A|Withdrawal by Subject|2
286358|NCT00966875|944524|P1|Part A|Withdrawal by Subject|2
286359|NCT00966875|944516|P9|Part A|Sponsor Decision|1
286360|NCT00966875|944517|P8|Part A|Sponsor Decision|2
286361|NCT00966875|944518|P7|Part A|Sponsor Decision|0
286362|NCT00966875|944519|P6|Part A|Sponsor Decision|0
286363|NCT00966875|944520|P5|Part A|Sponsor Decision|1
286364|NCT00966875|944521|P4|Part A|Sponsor Decision|0
286365|NCT00966875|944522|P3|Part A|Sponsor Decision|1
286366|NCT00966875|944523|P2|Part A|Sponsor Decision|0
286367|NCT00966875|944524|P1|Part A|Sponsor Decision|0
286368|NCT00966875|944516|P9|Part A|Physician Decision|2
286369|NCT00966875|944517|P8|Part A|Physician Decision|0
286370|NCT00966875|944518|P7|Part A|Physician Decision|1
286371|NCT00966875|944519|P6|Part A|Physician Decision|0
286372|NCT00966875|944520|P5|Part A|Physician Decision|1
286373|NCT00966875|944521|P4|Part A|Physician Decision|0
286374|NCT00966875|944522|P3|Part A|Physician Decision|0
286375|NCT00966875|944523|P2|Part A|Physician Decision|0
286376|NCT00966875|944524|P1|Part A|Physician Decision|0
286377|NCT00966875|944516|P9|Part A|Parent/Caregiver Decision|0
286378|NCT00966875|944517|P8|Part A|Parent/Caregiver Decision|0
286379|NCT00966875|944518|P7|Part A|Parent/Caregiver Decision|0
286380|NCT00966875|944519|P6|Part A|Parent/Caregiver Decision|0
286381|NCT00966875|944520|P5|Part A|Parent/Caregiver Decision|0
286382|NCT00966875|944521|P4|Part A|Parent/Caregiver Decision|1
286383|NCT00966875|944522|P3|Part A|Parent/Caregiver Decision|0
286384|NCT00966875|944523|P2|Part A|Parent/Caregiver Decision|0
286385|NCT00966875|944524|P1|Part A|Parent/Caregiver Decision|0
286386|NCT00966875|944516|P9|Part A|Lost to Follow-up|0
286387|NCT00966875|944517|P8|Part A|Lost to Follow-up|0
286388|NCT00966875|944518|P7|Part A|Lost to Follow-up|0
286389|NCT00966875|944519|P6|Part A|Lost to Follow-up|1
286390|NCT00966875|944520|P5|Part A|Lost to Follow-up|0
286391|NCT00966875|944521|P4|Part A|Lost to Follow-up|0
286392|NCT00966875|944522|P3|Part A|Lost to Follow-up|0
286393|NCT00966875|944523|P2|Part A|Lost to Follow-up|0
286394|NCT00966875|944524|P1|Part A|Lost to Follow-up|2
286395|NCT00966875|944516|P9|Part A|Lack of Efficacy|0
286396|NCT00966875|944517|P8|Part A|Lack of Efficacy|0
286397|NCT00966875|944518|P7|Part A|Lack of Efficacy|4
286398|NCT00966875|944519|P6|Part A|Lack of Efficacy|0
286399|NCT00966875|944520|P5|Part A|Lack of Efficacy|0
286400|NCT00966875|944521|P4|Part A|Lack of Efficacy|0
286401|NCT00966875|944522|P3|Part A|Lack of Efficacy|0
286402|NCT00966875|944523|P2|Part A|Lack of Efficacy|1
286403|NCT00966875|944524|P1|Part A|Lack of Efficacy|0
286404|NCT00966875|944516|P9|Part A|Entry Criteria|0
286405|NCT00966875|944517|P8|Part A|Entry Criteria|0
286406|NCT00966875|944518|P7|Part A|Entry Criteria|0
286407|NCT00966875|944519|P6|Part A|Entry Criteria|2
286408|NCT00966875|944520|P5|Part A|Entry Criteria|0
286409|NCT00966875|944521|P4|Part A|Entry Criteria|0
286410|NCT00966875|944522|P3|Part A|Entry Criteria|0
286411|NCT00966875|944523|P2|Part A|Entry Criteria|0
286412|NCT00966875|944524|P1|Part A|Entry Criteria|0
286413|NCT00966875|944516|P9|Part A|Adverse Event|3
286414|NCT00966875|944517|P8|Part A|Adverse Event|3
286415|NCT00966875|944518|P7|Part A|Adverse Event|0
286416|NCT00966875|944519|P6|Part A|Adverse Event|1
286417|NCT00966875|944520|P5|Part A|Adverse Event|0
286418|NCT00966875|944521|P4|Part A|Adverse Event|1
286419|NCT00966875|944522|P3|Part A|Adverse Event|0
286420|NCT00966875|944523|P2|Part A|Adverse Event|1
286421|NCT00966875|944524|P1|Part A|Adverse Event|2
286422|NCT00966277|944888|P2|Overall Study|Treatment Plan Changed|1
286423|NCT00966277|944889|P1|Overall Study|Treatment Plan Changed|0
286424|NCT00966277|944888|P2|Overall Study|Ineligible|3
286425|NCT00966277|944889|P1|Overall Study|Ineligible|1
286426|NCT00966277|944888|P2|Overall Study|Withdrawal by Subject|0
286427|NCT00966277|944889|P1|Overall Study|Withdrawal by Subject|3
286428|NCT00966264|944897|P2|Overall Study|Lost to Follow-up|3
286429|NCT00966264|944898|P1|Overall Study|Lost to Follow-up|4
286430|NCT00965848|944944|P3|Overall Study|Unspecified|1
286431|NCT00965848|944945|P2|Overall Study|Unspecified|0
286432|NCT00965848|944946|P1|Overall Study|Unspecified|5
286433|NCT00965848|944944|P3|Overall Study|Not Clinically Evaluable|1
286434|NCT00965848|944945|P2|Overall Study|Not Clinically Evaluable|1
286435|NCT00965848|944946|P1|Overall Study|Not Clinically Evaluable|7
286436|NCT00965848|944944|P3|Overall Study|Indeterminate Clinical Outcome|1
286437|NCT00965848|944945|P2|Overall Study|Indeterminate Clinical Outcome|0
286438|NCT00965848|944946|P1|Overall Study|Indeterminate Clinical Outcome|2
286439|NCT00965848|944944|P3|Overall Study|Withdrawal by Subject|0
286440|NCT00965848|944945|P2|Overall Study|Withdrawal by Subject|0
286441|NCT00965848|944946|P1|Overall Study|Withdrawal by Subject|1
286442|NCT00965848|944944|P3|Overall Study|Lost to Follow-up|1
286443|NCT00965848|944945|P2|Overall Study|Lost to Follow-up|0
286444|NCT00965848|944946|P1|Overall Study|Lost to Follow-up|0
286445|NCT00965848|944944|P3|Overall Study|Death|5
286446|NCT00965848|944945|P2|Overall Study|Death|1
286447|NCT00965848|944946|P1|Overall Study|Death|11
286448|NCT00965848|944944|P3|Overall Study|Protocol Violation|1
286449|NCT00965848|944945|P2|Overall Study|Protocol Violation|0
286450|NCT00965848|944946|P1|Overall Study|Protocol Violation|3
286451|NCT00965757|944965|P4|Extension Phase|Not Specified|1
286452|NCT00965757|944966|P3|Extension Phase|Not Specified|2
286453|NCT00965757|944967|P2|Extension Phase|Not Specified|0
286454|NCT00965757|944968|P1|Extension Phase|Not Specified|0
286455|NCT00965757|944965|P4|Extension Phase|Protocol Violation|1
286456|NCT00965757|944966|P3|Extension Phase|Protocol Violation|0
286457|NCT00965757|944967|P2|Extension Phase|Protocol Violation|0
286458|NCT00965757|944968|P1|Extension Phase|Protocol Violation|0
286459|NCT00965757|944965|P4|Extension Phase|Ineligible after Taking Study Drug|3
286460|NCT00965757|944966|P3|Extension Phase|Ineligible after Taking Study Drug|3
286461|NCT00965757|944967|P2|Extension Phase|Ineligible after Taking Study Drug|0
286462|NCT00965757|944968|P1|Extension Phase|Ineligible after Taking Study Drug|0
286463|NCT00965757|944965|P4|Extension Phase|Lost to Follow-up|1
286464|NCT00965757|944966|P3|Extension Phase|Lost to Follow-up|0
286465|NCT00965757|944967|P2|Extension Phase|Lost to Follow-up|0
286466|NCT00965757|944968|P1|Extension Phase|Lost to Follow-up|0
286467|NCT00965757|944965|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
286468|NCT00965757|944966|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
286469|NCT00965757|944967|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
286470|NCT00965757|944968|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
286471|NCT00965757|944965|P4|Extension Phase|Lack of Efficacy|12
286472|NCT00965757|944966|P3|Extension Phase|Lack of Efficacy|8
286473|NCT00965757|944967|P2|Extension Phase|Lack of Efficacy|0
286474|NCT00965757|944968|P1|Extension Phase|Lack of Efficacy|0
286475|NCT00965757|944965|P4|Extension Phase|Abnormal Laboratory Value|1
286476|NCT00965757|944966|P3|Extension Phase|Abnormal Laboratory Value|6
286477|NCT00965757|944967|P2|Extension Phase|Abnormal Laboratory Value|0
286478|NCT00965757|944968|P1|Extension Phase|Abnormal Laboratory Value|0
286479|NCT00965757|944965|P4|Extension Phase|Adverse drug reaction|3
286480|NCT00965757|944966|P3|Extension Phase|Adverse drug reaction|6
286481|NCT00965757|944967|P2|Extension Phase|Adverse drug reaction|0
286482|NCT00965757|944968|P1|Extension Phase|Adverse drug reaction|0
286483|NCT00965757|944965|P4|Extension Phase|Progression of concomitant disease|2
286484|NCT00965757|944966|P3|Extension Phase|Progression of concomitant disease|4
286485|NCT00965757|944967|P2|Extension Phase|Progression of concomitant disease|0
286486|NCT00965757|944968|P1|Extension Phase|Progression of concomitant disease|0
286487|NCT00965757|944965|P4|Double-blind Phase|Not specified|0
286488|NCT00965757|944966|P3|Double-blind Phase|Not specified|0
286489|NCT00965757|944967|P2|Double-blind Phase|Not specified|0
286490|NCT00965757|944968|P1|Double-blind Phase|Not specified|1
286491|NCT00965757|944965|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
286492|NCT00965757|944966|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
286493|NCT00965757|944967|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
286494|NCT00965757|944968|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
286495|NCT00965757|944965|P4|Double-blind Phase|Lost to Follow-up|0
286496|NCT00965757|944966|P3|Double-blind Phase|Lost to Follow-up|0
286497|NCT00965757|944967|P2|Double-blind Phase|Lost to Follow-up|1
286498|NCT00965757|944968|P1|Double-blind Phase|Lost to Follow-up|0
286499|NCT00965757|944965|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
286500|NCT00965757|944966|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
286501|NCT00965757|944967|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
286502|NCT00965757|944968|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
286503|NCT00965757|944965|P4|Double-blind Phase|Lack of Efficacy|0
286504|NCT00965757|944966|P3|Double-blind Phase|Lack of Efficacy|0
286505|NCT00965757|944967|P2|Double-blind Phase|Lack of Efficacy|11
286506|NCT00965757|944968|P1|Double-blind Phase|Lack of Efficacy|7
286507|NCT00965757|944965|P4|Double-blind Phase|Abnormal Laboratory Value|0
286508|NCT00965757|944966|P3|Double-blind Phase|Abnormal Laboratory Value|0
286509|NCT00965757|944967|P2|Double-blind Phase|Abnormal Laboratory Value|0
286510|NCT00965757|944968|P1|Double-blind Phase|Abnormal Laboratory Value|2
286511|NCT00965757|944965|P4|Double-blind Phase|Adverse drug reaction|0
286512|NCT00965757|944966|P3|Double-blind Phase|Adverse drug reaction|0
286513|NCT00965757|944967|P2|Double-blind Phase|Adverse drug reaction|1
286514|NCT00965757|944968|P1|Double-blind Phase|Adverse drug reaction|2
286515|NCT00965757|944965|P4|Double-blind Phase|Progression of concomitant disease|0
286516|NCT00965757|944966|P3|Double-blind Phase|Progression of concomitant disease|0
286517|NCT00965757|944967|P2|Double-blind Phase|Progression of concomitant disease|2
286518|NCT00965757|944968|P1|Double-blind Phase|Progression of concomitant disease|1
286519|NCT00965731|945002|P2|Overall Study|Not specified|15
286520|NCT00965731|945003|P1|Overall Study|Not specified|7
286521|NCT00965731|945002|P2|Overall Study|Withdrawal by Subject|1
286522|NCT00965731|945003|P1|Overall Study|Withdrawal by Subject|0
286523|NCT00965731|945002|P2|Overall Study|Death|4
286524|NCT00965731|945003|P1|Overall Study|Death|0
286525|NCT00965718|945067|P1|Overall Study|Withdrawal by Subject|4
286526|NCT00965562|945080|P3|Overall Study|Withdrawal by Subject|0
286527|NCT00965562|945081|P2|Overall Study|Withdrawal by Subject|2
286528|NCT00965562|945082|P1|Overall Study|Withdrawal by Subject|2
286529|NCT00965562|945080|P3|Overall Study|Lost to Follow-up|3
286530|NCT00965562|945081|P2|Overall Study|Lost to Follow-up|2
286531|NCT00965562|945082|P1|Overall Study|Lost to Follow-up|1
286532|NCT00965523|945120|P1|Study 224|Physician Decision|1
286533|NCT00965523|945120|P1|Study 224|Progressive Disease|5
286534|NCT00965523|945120|P1|Study 221|Physician Decision|3
286535|NCT00965523|945120|P1|Study 221|Progressive Disease|4
286536|NCT00965497|945125|P1|Overall Study|Physician Decision|1
286537|NCT00965484|945130|P1|Overall Study|Withdrawal by Subject|1
286538|NCT00965484|945130|P1|Overall Study|Protocol Violation|1
286539|NCT00965458|945139|P2|Overall Study|Withdrawal by Subject|1
286540|NCT00965458|945140|P1|Overall Study|Withdrawal by Subject|0
286541|NCT00965458|945139|P2|Overall Study|Lost to Follow-up|3
286542|NCT00965458|945140|P1|Overall Study|Lost to Follow-up|1
286543|NCT00965458|945139|P2|Overall Study|Adverse Event|0
286544|NCT00965458|945140|P1|Overall Study|Adverse Event|1
286545|NCT00965341|945158|P2|Overall Study|Transportation issues|3
286546|NCT00965341|945159|P1|Overall Study|Transportation issues|4
286547|NCT00965341|945158|P2|Overall Study|Lost to Follow-up|0
286548|NCT00965341|945159|P1|Overall Study|Lost to Follow-up|1
286549|NCT00965341|945158|P2|Overall Study|Withdrew consent|5
286550|NCT00965341|945159|P1|Overall Study|Withdrew consent|1
286551|NCT00965185|945197|P2|Overall Study|Withdrawal by Subject|1
286552|NCT00965185|945198|P1|Overall Study|Withdrawal by Subject|0
286553|NCT00965185|945197|P2|Overall Study|Lost to Follow-up|0
286554|NCT00965185|945198|P1|Overall Study|Lost to Follow-up|2
286555|NCT00965146|945214|P1|Overall Study|Overall Study Termination|145
286556|NCT00965146|945214|P1|Overall Study|Revision / Removal of Study Implant|6
286557|NCT00965146|945214|P1|Overall Study|Intercurrent illness|1
286558|NCT00965146|945214|P1|Overall Study|Unwilling to return|11
286559|NCT00965146|945214|P1|Overall Study|Unable to return|1
286560|NCT00965146|945214|P1|Overall Study|Withdrawal by Subject|17
286561|NCT00965146|945214|P1|Overall Study|Lost to Follow-up|22
286562|NCT00965146|945214|P1|Overall Study|Death|7
286563|NCT00965094|945220|P2|Overall Study|Lost to Follow-up|1
286564|NCT00965094|945221|P1|Overall Study|Lost to Follow-up|0
286565|NCT00965094|945220|P2|Overall Study|Adverse Event|0
286566|NCT00965094|945221|P1|Overall Study|Adverse Event|5
286567|NCT00965081|945237|P2|Overall Study|Switched to Rescue Arm|12
286568|NCT00965081|945238|P1|Overall Study|Switched to Rescue Arm|5
286569|NCT00965081|945237|P2|Overall Study|Withdrawal by Subject|7
286570|NCT00965081|945238|P1|Overall Study|Withdrawal by Subject|4
286571|NCT00965081|945237|P2|Overall Study|Sponsor Decision|0
286572|NCT00965081|945238|P1|Overall Study|Sponsor Decision|1
286573|NCT00965081|945237|P2|Overall Study|Protocol Violation|5
286574|NCT00965081|945238|P1|Overall Study|Protocol Violation|2
286575|NCT00965081|945237|P2|Overall Study|Physician Decision|0
286576|NCT00965081|945238|P1|Overall Study|Physician Decision|2
286577|NCT00965081|945237|P2|Overall Study|Lost to Follow-up|5
286578|NCT00965081|945238|P1|Overall Study|Lost to Follow-up|4
286579|NCT00965081|945237|P2|Overall Study|Lack of Efficacy|5
286580|NCT00965081|945238|P1|Overall Study|Lack of Efficacy|2
286581|NCT00965081|945237|P2|Overall Study|Adverse Event|9
286582|NCT00965081|945238|P1|Overall Study|Adverse Event|14
286583|NCT00964886|945265|P4|Overall Study|Protocol Violation|0
286584|NCT00964886|945266|P3|Overall Study|Protocol Violation|0
286585|NCT00964886|945267|P2|Overall Study|Protocol Violation|2
286586|NCT00964886|945268|P1|Overall Study|Protocol Violation|0
286587|NCT00964886|945265|P4|Overall Study|Adverse Event|2
286588|NCT00964886|945266|P3|Overall Study|Adverse Event|5
286589|NCT00964886|945267|P2|Overall Study|Adverse Event|1
286590|NCT00964886|945268|P1|Overall Study|Adverse Event|3
286591|NCT00964886|945265|P4|Overall Study|Withdrawal by Subject|3
286592|NCT00964886|945266|P3|Overall Study|Withdrawal by Subject|5
286593|NCT00964886|945267|P2|Overall Study|Withdrawal by Subject|2
286594|NCT00964886|945268|P1|Overall Study|Withdrawal by Subject|6
286595|NCT00964886|945265|P4|Overall Study|Lost to Follow-up|4
286596|NCT00964886|945266|P3|Overall Study|Lost to Follow-up|6
286597|NCT00964886|945267|P2|Overall Study|Lost to Follow-up|2
286598|NCT00964886|945268|P1|Overall Study|Lost to Follow-up|2
286599|NCT00964860|945284|P2|Overall Study|Withdrawal by Subject|1
286600|NCT00964860|945285|P1|Overall Study|Withdrawal by Subject|0
286601|NCT00964795|945293|P1|Overall Study|Other|23
286602|NCT00964795|945293|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
286603|NCT00964795|945293|P1|Overall Study|Termination of Study by Sponsor|169
286604|NCT00964795|945293|P1|Overall Study|Lost to Follow-up|7
286605|NCT00964795|945293|P1|Overall Study|Death|14
286606|NCT00964795|945293|P1|Overall Study|Adverse Event|12
286607|NCT00964795|945293|P1|Overall Study|Withdrawal by Subject|79
286608|NCT00964743|945300|P1|Overall Study|Neither patient completed 8 weeks of tre|2
286609|NCT00964678|945308|P1|Overall Study|Physician Decision|4
286610|NCT00964392|945372|P2|Overall Study|Not completed|168
286611|NCT00964392|945373|P1|Overall Study|Not completed|44
286612|NCT00964392|945372|P2|Overall Study|Early Termination, non-study arrhythmia|6
286613|NCT00964392|945373|P1|Overall Study|Early Termination, non-study arrhythmia|1
286614|NCT00964392|945372|P2|Overall Study|Lost to Follow-up|10
286615|NCT00964392|945373|P1|Overall Study|Lost to Follow-up|4
286616|NCT00964392|945372|P2|Overall Study|Withdrawal by Subject|6
286617|NCT00964392|945373|P1|Overall Study|Withdrawal by Subject|4
286618|NCT00964366|945383|P2|Overall Study|Withdrawal by Subject|1
286619|NCT00964366|945384|P1|Overall Study|Withdrawal by Subject|0
286620|NCT00964366|945383|P2|Overall Study|Did not qualify at Day 1|0
286621|NCT00964366|945384|P1|Overall Study|Did not qualify at Day 1|1
286622|NCT00964223|945398|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
286623|NCT00964028|945469|P2|Overall Study|Withdrawal by Subject|1
286624|NCT00964028|945470|P1|Overall Study|Withdrawal by Subject|0
286625|NCT00963937|945485|P3|Overall Study|Physician Decision|4
286626|NCT00963937|945486|P2|Overall Study|Physician Decision|10
286627|NCT00963937|945487|P1|Overall Study|Physician Decision|18
286628|NCT00963937|945485|P3|Overall Study|Protocol Violation|0
286629|NCT00963937|945486|P2|Overall Study|Protocol Violation|1
286630|NCT00963937|945487|P1|Overall Study|Protocol Violation|1
286631|NCT00963924|945525|P2|Overall Study|Lost to Follow-up|1
286632|NCT00963924|945526|P1|Overall Study|Lost to Follow-up|0
286633|NCT00963924|945525|P2|Overall Study|Changed antipsychotic|1
286634|NCT00963924|945526|P1|Overall Study|Changed antipsychotic|0
286635|NCT00963924|945525|P2|Overall Study|Withdrawal by Subject|1
286636|NCT00963924|945526|P1|Overall Study|Withdrawal by Subject|0
286637|NCT00963924|945525|P2|Overall Study|Adverse Event|0
286638|NCT00963924|945526|P1|Overall Study|Adverse Event|1
286639|NCT00963820|945594|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
286640|NCT00963820|945595|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
286641|NCT00963820|945596|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
286642|NCT00963820|945597|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
286643|NCT00963820|945598|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
286644|NCT00963820|945599|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
286645|NCT00963820|945600|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
286646|NCT00963820|945601|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
286647|NCT00963820|945602|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
286648|NCT00963820|945603|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
286649|NCT00963820|945604|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
286650|NCT00963820|945605|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
286651|NCT00963820|945594|P12|Expansion Phase|Withdrawal by Subject|1
286652|NCT00963820|945595|P11|Expansion Phase|Withdrawal by Subject|1
286653|NCT00963820|945596|P10|Expansion Phase|Withdrawal by Subject|0
286654|NCT00963820|945597|P9|Expansion Phase|Withdrawal by Subject|1
286655|NCT00963820|945598|P8|Expansion Phase|Withdrawal by Subject|0
286656|NCT00963820|945599|P7|Expansion Phase|Withdrawal by Subject|0
286657|NCT00963820|945600|P6|Expansion Phase|Withdrawal by Subject|0
286658|NCT00963820|945601|P5|Expansion Phase|Withdrawal by Subject|0
286659|NCT00963820|945602|P4|Expansion Phase|Withdrawal by Subject|0
286660|NCT00963820|945603|P3|Expansion Phase|Withdrawal by Subject|0
286661|NCT00963820|945604|P2|Expansion Phase|Withdrawal by Subject|0
286662|NCT00963820|945605|P1|Expansion Phase|Withdrawal by Subject|0
286663|NCT00963820|945594|P12|Expansion Phase|Adverse Event|0
286664|NCT00963820|945595|P11|Expansion Phase|Adverse Event|0
286665|NCT00963820|945596|P10|Expansion Phase|Adverse Event|3
286666|NCT00963820|945597|P9|Expansion Phase|Adverse Event|1
286667|NCT00963820|945598|P8|Expansion Phase|Adverse Event|0
286668|NCT00963820|945599|P7|Expansion Phase|Adverse Event|0
286669|NCT00963820|945600|P6|Expansion Phase|Adverse Event|0
286670|NCT00963820|945601|P5|Expansion Phase|Adverse Event|0
286671|NCT00963820|945602|P4|Expansion Phase|Adverse Event|0
286672|NCT00963820|945603|P3|Expansion Phase|Adverse Event|0
286673|NCT00963820|945604|P2|Expansion Phase|Adverse Event|0
286674|NCT00963820|945605|P1|Expansion Phase|Adverse Event|0
286675|NCT00963820|945594|P12|Expansion Phase|Progressive Disease|2
286676|NCT00963820|945595|P11|Expansion Phase|Progressive Disease|4
286677|NCT00963820|945596|P10|Expansion Phase|Progressive Disease|6
286678|NCT00963820|945597|P9|Expansion Phase|Progressive Disease|8
286679|NCT00963820|945598|P8|Expansion Phase|Progressive Disease|0
286680|NCT00963820|945599|P7|Expansion Phase|Progressive Disease|0
286681|NCT00963820|945600|P6|Expansion Phase|Progressive Disease|0
286682|NCT00963820|945601|P5|Expansion Phase|Progressive Disease|0
286683|NCT00963820|945602|P4|Expansion Phase|Progressive Disease|0
286684|NCT00963820|945603|P3|Expansion Phase|Progressive Disease|0
286685|NCT00963820|945604|P2|Expansion Phase|Progressive Disease|0
286686|NCT00963820|945605|P1|Expansion Phase|Progressive Disease|0
286687|NCT00963820|945594|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286688|NCT00963820|945595|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286689|NCT00963820|945596|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286690|NCT00963820|945597|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286691|NCT00963820|945598|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286692|NCT00963820|945599|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
286693|NCT00963820|945600|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286694|NCT00963820|945601|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286695|NCT00963820|945602|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286696|NCT00963820|945603|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286697|NCT00963820|945604|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286698|NCT00963820|945605|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
286699|NCT00963820|945594|P12|Dose Escalation Phase|Withdrawal by Subject|0
286700|NCT00963820|945595|P11|Dose Escalation Phase|Withdrawal by Subject|0
286701|NCT00963820|945596|P10|Dose Escalation Phase|Withdrawal by Subject|0
286702|NCT00963820|945597|P9|Dose Escalation Phase|Withdrawal by Subject|0
286703|NCT00963820|945598|P8|Dose Escalation Phase|Withdrawal by Subject|2
286704|NCT00963820|945599|P7|Dose Escalation Phase|Withdrawal by Subject|1
286705|NCT00963820|945600|P6|Dose Escalation Phase|Withdrawal by Subject|0
286706|NCT00963820|945601|P5|Dose Escalation Phase|Withdrawal by Subject|0
286707|NCT00963820|945602|P4|Dose Escalation Phase|Withdrawal by Subject|0
286708|NCT00963820|945603|P3|Dose Escalation Phase|Withdrawal by Subject|0
286709|NCT00963820|945604|P2|Dose Escalation Phase|Withdrawal by Subject|0
286710|NCT00963820|945605|P1|Dose Escalation Phase|Withdrawal by Subject|0
286711|NCT00963820|945594|P12|Dose Escalation Phase|Adverse Event|0
286712|NCT00963820|945595|P11|Dose Escalation Phase|Adverse Event|0
286713|NCT00963820|945596|P10|Dose Escalation Phase|Adverse Event|0
286714|NCT00963820|945597|P9|Dose Escalation Phase|Adverse Event|0
286715|NCT00963820|945598|P8|Dose Escalation Phase|Adverse Event|1
286716|NCT00963820|945599|P7|Dose Escalation Phase|Adverse Event|3
286717|NCT00963820|945600|P6|Dose Escalation Phase|Adverse Event|0
286718|NCT00963820|945601|P5|Dose Escalation Phase|Adverse Event|0
286719|NCT00963820|945602|P4|Dose Escalation Phase|Adverse Event|0
286720|NCT00963820|945603|P3|Dose Escalation Phase|Adverse Event|0
286721|NCT00963820|945604|P2|Dose Escalation Phase|Adverse Event|0
286722|NCT00963820|945605|P1|Dose Escalation Phase|Adverse Event|0
286723|NCT00963820|945594|P12|Dose Escalation Phase|Progressive Disease|0
286724|NCT00963820|945595|P11|Dose Escalation Phase|Progressive Disease|0
286725|NCT00963820|945596|P10|Dose Escalation Phase|Progressive Disease|0
286726|NCT00963820|945597|P9|Dose Escalation Phase|Progressive Disease|0
286727|NCT00963820|945598|P8|Dose Escalation Phase|Progressive Disease|2
286728|NCT00963820|945599|P7|Dose Escalation Phase|Progressive Disease|3
286729|NCT00963820|945600|P6|Dose Escalation Phase|Progressive Disease|3
286730|NCT00963820|945601|P5|Dose Escalation Phase|Progressive Disease|4
286731|NCT00963820|945602|P4|Dose Escalation Phase|Progressive Disease|3
286732|NCT00963820|945603|P3|Dose Escalation Phase|Progressive Disease|3
286733|NCT00963820|945604|P2|Dose Escalation Phase|Progressive Disease|3
286734|NCT00963820|945605|P1|Dose Escalation Phase|Progressive Disease|3
286735|NCT00963807|945741|P1|Overall Study|Disease progression|15
286736|NCT00963807|945741|P1|Overall Study|Reaction to study chemotherapy regimen|1
286737|NCT00963807|945741|P1|Overall Study|Physician Decision|2
286738|NCT00963599|945774|P4|Overall Study|Withdrawal by Subject|3
286739|NCT00963599|945775|P3|Overall Study|Withdrawal by Subject|3
286740|NCT00963599|945776|P2|Overall Study|Withdrawal by Subject|1
286741|NCT00963599|945777|P1|Overall Study|Withdrawal by Subject|2
286742|NCT00963599|945774|P4|Overall Study|Protocol Violation|4
286743|NCT00963599|945775|P3|Overall Study|Protocol Violation|3
286744|NCT00963599|945776|P2|Overall Study|Protocol Violation|2
286745|NCT00963599|945777|P1|Overall Study|Protocol Violation|2
286746|NCT00963599|945774|P4|Overall Study|Lost to Follow-up|1
286747|NCT00963599|945775|P3|Overall Study|Lost to Follow-up|1
286748|NCT00963599|945776|P2|Overall Study|Lost to Follow-up|1
286749|NCT00963599|945777|P1|Overall Study|Lost to Follow-up|0
286750|NCT00963599|945774|P4|Overall Study|Lack of Efficacy|4
286751|NCT00963599|945775|P3|Overall Study|Lack of Efficacy|1
286752|NCT00963599|945776|P2|Overall Study|Lack of Efficacy|2
286753|NCT00963599|945777|P1|Overall Study|Lack of Efficacy|0
286754|NCT00963599|945774|P4|Overall Study|Adverse Event|2
286755|NCT00963599|945775|P3|Overall Study|Adverse Event|1
286756|NCT00963599|945776|P2|Overall Study|Adverse Event|0
286757|NCT00963599|945777|P1|Overall Study|Adverse Event|2
286758|NCT00963469|945867|P3|Overall Study|Site closed (local pollen Season ended)|3
286759|NCT00963469|945868|P2|Overall Study|Site closed (local pollen Season ended)|1
286760|NCT00963469|945869|P1|Overall Study|Site closed (local pollen Season ended)|4
286761|NCT00963469|945867|P3|Overall Study|Moved|0
286762|NCT00963469|945868|P2|Overall Study|Moved|0
286763|NCT00963469|945869|P1|Overall Study|Moved|1
286764|NCT00963469|945867|P3|Overall Study|Pre-randomization Adverse Event|0
286765|NCT00963469|945868|P2|Overall Study|Pre-randomization Adverse Event|2
286766|NCT00963469|945869|P1|Overall Study|Pre-randomization Adverse Event|1
286767|NCT00963469|945867|P3|Overall Study|Withdrawal by Subject|1
286768|NCT00963469|945868|P2|Overall Study|Withdrawal by Subject|1
286769|NCT00963469|945869|P1|Overall Study|Withdrawal by Subject|4
286770|NCT00963469|945867|P3|Overall Study|Protocol Violation|3
286771|NCT00963469|945868|P2|Overall Study|Protocol Violation|5
286772|NCT00963469|945869|P1|Overall Study|Protocol Violation|5
286773|NCT00963469|945867|P3|Overall Study|Lost to Follow-up|0
286774|NCT00963469|945868|P2|Overall Study|Lost to Follow-up|1
286775|NCT00963469|945869|P1|Overall Study|Lost to Follow-up|1
286776|NCT00963469|945867|P3|Overall Study|Lack of Efficacy|2
286777|NCT00963469|945868|P2|Overall Study|Lack of Efficacy|7
286778|NCT00963469|945869|P1|Overall Study|Lack of Efficacy|10
286779|NCT00963469|945867|P3|Overall Study|Adverse Event|1
286780|NCT00963469|945868|P2|Overall Study|Adverse Event|11
286781|NCT00963469|945869|P1|Overall Study|Adverse Event|15
286782|NCT00963235|945936|P1|Overall Study|Unspecified|1
286783|NCT00963235|945936|P1|Overall Study|Physician Decision|2
286784|NCT00963235|945936|P1|Overall Study|Adverse Event|5
286785|NCT00963235|945936|P1|Overall Study|Protocol Violation|7
286786|NCT00963235|945936|P1|Overall Study|Failed to return|9
286787|NCT00963235|945936|P1|Overall Study|Lost to Follow-up|14
286788|NCT00963235|945936|P1|Overall Study|Withdrawal by Subject|22
286789|NCT00962780|946179|P2|Overall Study|Unspecified|1
286790|NCT00962780|946180|P1|Overall Study|Unspecified|0
286791|NCT00962780|946179|P2|Overall Study|Withdrawal by Subject|8
286792|NCT00962780|946180|P1|Overall Study|Withdrawal by Subject|1
286793|NCT00962780|946179|P2|Overall Study|Protocol Violation|4
286794|NCT00962780|946180|P1|Overall Study|Protocol Violation|9
286795|NCT00962780|946179|P2|Overall Study|Death|1
286796|NCT00962780|946180|P1|Overall Study|Death|0
286797|NCT00962741|946255|P1|Overall Study|drug ineffective+prohibited drug taken|1
286798|NCT00962741|946255|P1|Overall Study|Lack of Efficacy|1
286799|NCT00962741|946255|P1|Overall Study|Withdrawal by Subject|1
286800|NCT00962741|946255|P1|Overall Study|Lost to Follow-up|2
286801|NCT00962741|946255|P1|Overall Study|Failed to return|3
286802|NCT00962650|946346|P1|Overall Study|Transgastric DP was not completed|2
286803|NCT00962598|946352|P2|Overall Study|discontinued prior to getting treatment|3
286804|NCT00962598|946353|P1|Overall Study|discontinued prior to getting treatment|0
286805|NCT00962598|946352|P2|Overall Study|Pregnancy|0
286806|NCT00962598|946353|P1|Overall Study|Pregnancy|1
286807|NCT00962598|946352|P2|Overall Study|Withdrawal by Subject|3
286808|NCT00962598|946353|P1|Overall Study|Withdrawal by Subject|1
286809|NCT00962598|946352|P2|Overall Study|Physician Decision|0
286810|NCT00962598|946353|P1|Overall Study|Physician Decision|1
286811|NCT00962598|946352|P2|Overall Study|Lost to Follow-up|0
286812|NCT00962598|946353|P1|Overall Study|Lost to Follow-up|2
286813|NCT00962598|946352|P2|Overall Study|Adverse Event|0
286814|NCT00962598|946353|P1|Overall Study|Adverse Event|1
286815|NCT00962585|946365|P4|Overall Study|Withdrew Consent|0
286816|NCT00962585|946366|P3|Overall Study|Withdrew Consent|0
286817|NCT00962585|946367|P2|Overall Study|Withdrew Consent|0
286818|NCT00962585|946368|P1|Overall Study|Withdrew Consent|2
286819|NCT00962585|946365|P4|Overall Study|Withdrawal by Subject|0
286820|NCT00962585|946366|P3|Overall Study|Withdrawal by Subject|0
286821|NCT00962585|946367|P2|Overall Study|Withdrawal by Subject|0
286822|NCT00962585|946368|P1|Overall Study|Withdrawal by Subject|1
286823|NCT00962585|946365|P4|Overall Study|Protocol Violation|0
286824|NCT00962585|946366|P3|Overall Study|Protocol Violation|1
286825|NCT00962585|946367|P2|Overall Study|Protocol Violation|0
286826|NCT00962585|946368|P1|Overall Study|Protocol Violation|0
286827|NCT00962585|946365|P4|Overall Study|Lost to Follow-up|0
286828|NCT00962585|946366|P3|Overall Study|Lost to Follow-up|1
286829|NCT00962585|946367|P2|Overall Study|Lost to Follow-up|0
286830|NCT00962585|946368|P1|Overall Study|Lost to Follow-up|3
286831|NCT00962585|946365|P4|Overall Study|Adverse Event|0
286832|NCT00962585|946366|P3|Overall Study|Adverse Event|1
286833|NCT00962585|946367|P2|Overall Study|Adverse Event|2
286834|NCT00962585|946368|P1|Overall Study|Adverse Event|0
286835|NCT00962390|946430|P4|Overall Study|Withdrawal by Subject|0
286836|NCT00962390|946431|P3|Overall Study|Withdrawal by Subject|1
286837|NCT00962390|946432|P2|Overall Study|Withdrawal by Subject|1
286838|NCT00962390|946433|P1|Overall Study|Withdrawal by Subject|1
286839|NCT00962390|946430|P4|Overall Study|Protocol Violation|0
286840|NCT00962390|946431|P3|Overall Study|Protocol Violation|0
286841|NCT00962390|946432|P2|Overall Study|Protocol Violation|0
286842|NCT00962390|946433|P1|Overall Study|Protocol Violation|1
286843|NCT00962390|946430|P4|Overall Study|Lost to Follow-up|0
286844|NCT00962390|946431|P3|Overall Study|Lost to Follow-up|0
286845|NCT00962390|946432|P2|Overall Study|Lost to Follow-up|2
286846|NCT00962390|946433|P1|Overall Study|Lost to Follow-up|2
286847|NCT00962390|946430|P4|Overall Study|Adverse Event|1
286848|NCT00962390|946431|P3|Overall Study|Adverse Event|3
286849|NCT00962390|946432|P2|Overall Study|Adverse Event|0
286850|NCT00962390|946433|P1|Overall Study|Adverse Event|0
286851|NCT00962208|946497|P2|Overall Study|Lost to Follow-up|9
286852|NCT00962208|946498|P1|Overall Study|Lost to Follow-up|0
286853|NCT00962208|946497|P2|Overall Study|Contraindicated to continue study|1
286854|NCT00962208|946498|P1|Overall Study|Contraindicated to continue study|5
286855|NCT00962208|946497|P2|Overall Study|Could not achieve good vision|0
286856|NCT00962208|946498|P1|Overall Study|Could not achieve good vision|9
286857|NCT00962104|946506|P2|Overall Study|Other|0
286858|NCT00962104|946507|P1|Overall Study|Other|2
286859|NCT00962104|946506|P2|Overall Study|Withdrawal by Subject|6
286860|NCT00962104|946507|P1|Overall Study|Withdrawal by Subject|10
286861|NCT00962104|946506|P2|Overall Study|Sponsor Decision|1
286862|NCT00962104|946507|P1|Overall Study|Sponsor Decision|0
286863|NCT00962104|946506|P2|Overall Study|Protocol Violation|8
286864|NCT00962104|946507|P1|Overall Study|Protocol Violation|6
286865|NCT00962104|946506|P2|Overall Study|Physician Decision|0
286866|NCT00962104|946507|P1|Overall Study|Physician Decision|1
286867|NCT00962104|946506|P2|Overall Study|Lost to Follow-up|4
286868|NCT00962104|946507|P1|Overall Study|Lost to Follow-up|10
286869|NCT00962104|946506|P2|Overall Study|Lack of Efficacy|1
286870|NCT00962104|946507|P1|Overall Study|Lack of Efficacy|0
286871|NCT00962104|946506|P2|Overall Study|Entry Criteria Not Met|2
286872|NCT00962104|946507|P1|Overall Study|Entry Criteria Not Met|1
286873|NCT00962104|946506|P2|Overall Study|Adverse Event|3
286874|NCT00962104|946507|P1|Overall Study|Adverse Event|10
286875|NCT00962013|946561|P1|Overall Study|No 5 year evaluation|6
286876|NCT00962013|946561|P1|Overall Study|Site Termination|24
286877|NCT00962013|946561|P1|Overall Study|Removal of study device|3
286878|NCT00962013|946561|P1|Overall Study|Withdrawal by Subject|8
286879|NCT00962013|946561|P1|Overall Study|Unable/Unwilling to return|6
286880|NCT00962013|946561|P1|Overall Study|Lost to Follow-up|12
286881|NCT00962013|946561|P1|Overall Study|Death|8
286882|NCT00962013|946561|P1|Overall Study|Did not have surgery|1
286883|NCT00961896|946584|P3|Overall Study|Abnormal laboratory value|1
286884|NCT00961896|946585|P2|Overall Study|Abnormal laboratory value|0
286885|NCT00961896|946586|P1|Overall Study|Abnormal laboratory value|0
286886|NCT00961649|946653|P4|Overall Study|Study terminated by sponsor|1
286887|NCT00961649|946654|P3|Overall Study|Study terminated by sponsor|4
286888|NCT00961649|946655|P2|Overall Study|Study terminated by sponsor|4
286889|NCT00961649|946656|P1|Overall Study|Study terminated by sponsor|4
286890|NCT00961649|946653|P4|Overall Study|Patient left to Mexico-family emergency|0
286891|NCT00961649|946654|P3|Overall Study|Patient left to Mexico-family emergency|0
286892|NCT00961649|946655|P2|Overall Study|Patient left to Mexico-family emergency|0
286893|NCT00961649|946656|P1|Overall Study|Patient left to Mexico-family emergency|1
286894|NCT00961649|946653|P4|Overall Study|Patient has travel plans during holidays|0
286895|NCT00961649|946654|P3|Overall Study|Patient has travel plans during holidays|1
286896|NCT00961649|946655|P2|Overall Study|Patient has travel plans during holidays|0
286897|NCT00961649|946656|P1|Overall Study|Patient has travel plans during holidays|0
286898|NCT00961649|946653|P4|Overall Study|Inadequate control of IOP|1
286899|NCT00961649|946654|P3|Overall Study|Inadequate control of IOP|0
286900|NCT00961649|946655|P2|Overall Study|Inadequate control of IOP|0
286901|NCT00961649|946656|P1|Overall Study|Inadequate control of IOP|0
286902|NCT00961649|946653|P4|Overall Study|Adverse Event|2
286903|NCT00961649|946654|P3|Overall Study|Adverse Event|0
286904|NCT00961649|946655|P2|Overall Study|Adverse Event|0
286905|NCT00961649|946656|P1|Overall Study|Adverse Event|4
286906|NCT00961636|946670|P3|Overall Study|Withdrawal by Subject|13
286907|NCT00961636|946671|P2|Overall Study|Withdrawal by Subject|22
286908|NCT00961636|946672|P1|Overall Study|Withdrawal by Subject|29
286909|NCT00961636|946670|P3|Overall Study|Protocol Violation|1
286910|NCT00961636|946671|P2|Overall Study|Protocol Violation|5
286911|NCT00961636|946672|P1|Overall Study|Protocol Violation|9
286912|NCT00961636|946670|P3|Overall Study|Physician Decision|1
286913|NCT00961636|946671|P2|Overall Study|Physician Decision|1
286914|NCT00961636|946672|P1|Overall Study|Physician Decision|3
286915|NCT00961636|946670|P3|Overall Study|Lost to Follow-up|1
286916|NCT00961636|946671|P2|Overall Study|Lost to Follow-up|3
286917|NCT00961636|946672|P1|Overall Study|Lost to Follow-up|2
286918|NCT00961636|946670|P3|Overall Study|Flushing Symptoms|3
286919|NCT00961636|946671|P2|Overall Study|Flushing Symptoms|46
286920|NCT00961636|946672|P1|Overall Study|Flushing Symptoms|29
286921|NCT00961636|946670|P3|Overall Study|Adverse Event|13
286922|NCT00961636|946671|P2|Overall Study|Adverse Event|54
286923|NCT00961636|946672|P1|Overall Study|Adverse Event|35
286924|NCT00961571|946683|P1|Overall Study|Physician Decision|39
286925|NCT00961415|946711|P3|Maintenance Treatment Phase|Other reason|3
286926|NCT00961415|946712|P2|Maintenance Treatment Phase|Other reason|1
286927|NCT00961415|946713|P1|Maintenance Treatment Phase|Other reason|0
286928|NCT00961415|946711|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
286929|NCT00961415|946712|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
286930|NCT00961415|946713|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
286931|NCT00961415|946711|P3|Maintenance Treatment Phase|Investigators decision|0
286932|NCT00961415|946712|P2|Maintenance Treatment Phase|Investigators decision|2
286933|NCT00961415|946713|P1|Maintenance Treatment Phase|Investigators decision|0
286934|NCT00961415|946711|P3|Maintenance Treatment Phase|Death|34
286935|NCT00961415|946712|P2|Maintenance Treatment Phase|Death|42
286936|NCT00961415|946713|P1|Maintenance Treatment Phase|Death|0
286937|NCT00961415|946711|P3|Induction Treatment Phase|Other Reason|0
286938|NCT00961415|946712|P2|Induction Treatment Phase|Other Reason|0
286939|NCT00961415|946713|P1|Induction Treatment Phase|Other Reason|5
286940|NCT00961415|946711|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
286941|NCT00961415|946712|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
286942|NCT00961415|946713|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
286943|NCT00961415|946711|P3|Induction Treatment Phase|Physician Decision|0
286944|NCT00961415|946712|P2|Induction Treatment Phase|Physician Decision|0
286945|NCT00961415|946713|P1|Induction Treatment Phase|Physician Decision|2
286946|NCT00961415|946711|P3|Induction Treatment Phase|Protocol Violation|0
286947|NCT00961415|946712|P2|Induction Treatment Phase|Protocol Violation|0
286948|NCT00961415|946713|P1|Induction Treatment Phase|Protocol Violation|1
286949|NCT00961415|946711|P3|Induction Treatment Phase|Death|0
286950|NCT00961415|946712|P2|Induction Treatment Phase|Death|0
286951|NCT00961415|946713|P1|Induction Treatment Phase|Death|77
286952|NCT00961415|946711|P3|Induction Treatment Phase|Withdrawal by Subject|0
286953|NCT00961415|946712|P2|Induction Treatment Phase|Withdrawal by Subject|0
286954|NCT00961415|946713|P1|Induction Treatment Phase|Withdrawal by Subject|11
286955|NCT00961350|946753|P2|Overall Study|Misc|21
286956|NCT00961350|946754|P1|Overall Study|Misc|16
286957|NCT00961350|946753|P2|Overall Study|Lost to Follow-up|3
286958|NCT00961350|946754|P1|Overall Study|Lost to Follow-up|3
286959|NCT00961350|946753|P2|Overall Study|Withdrawal by Subject|10
286960|NCT00961350|946754|P1|Overall Study|Withdrawal by Subject|10
286961|NCT00961350|946753|P2|Overall Study|Adverse Event|33
286962|NCT00961350|946754|P1|Overall Study|Adverse Event|18
286963|NCT00961298|946775|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
286964|NCT00961298|946775|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
286965|NCT00961298|946775|P1|Two Week Placebo Run in|Withdrawal by Subject|1
286966|NCT00961259|946782|P3|Washout Period of 7 Days|due to concomitant medication used|0
286967|NCT00961259|946783|P2|Washout Period of 7 Days|due to concomitant medication used|1
286968|NCT00961259|946784|P1|Washout Period of 7 Days|due to concomitant medication used|0
286969|NCT00961220|946812|P1|Overall Study|Complete Response prior to 12 courses|1
286970|NCT00961220|946812|P1|Overall Study|O6BG no longer supplied|1
286971|NCT00961220|946812|P1|Overall Study|No IV access for O6BG|1
286972|NCT00961220|946812|P1|Overall Study|Lack of Efficacy|1
286973|NCT00961220|946812|P1|Overall Study|Adverse Event|3
286974|NCT00961181|946828|P1|Overall Study|Lost to Follow-up|1
286975|NCT00961181|946828|P1|Overall Study|Withdrawal by Subject|2
286976|NCT00961181|946828|P1|Overall Study|Death|2
286977|NCT00961116|946841|P2|Washout Period of 7 Days|Protocol Violation|1
286978|NCT00961116|946842|P1|Washout Period of 7 Days|Protocol Violation|0
286979|NCT00961116|946841|P2|Washout Period of 7 Days|Withdrawal by Subject|1
286980|NCT00961116|946842|P1|Washout Period of 7 Days|Withdrawal by Subject|1
286981|NCT00961116|946841|P2|Washout Period of 7 Days|Adverse Event|1
286982|NCT00961116|946842|P1|Washout Period of 7 Days|Adverse Event|1
286983|NCT00960999|946865|P2|Overall Study|RT dose constraints not met|0
286984|NCT00960999|946866|P1|Overall Study|RT dose constraints not met|2
286985|NCT00960999|946865|P2|Overall Study|Protocol Violation|2
286986|NCT00960999|946866|P1|Overall Study|Protocol Violation|5
286987|NCT00960999|946865|P2|Overall Study|Withdrawal by Subject|0
286988|NCT00960999|946866|P1|Overall Study|Withdrawal by Subject|1
286989|NCT00960986|946876|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
286990|NCT00960986|946877|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
286991|NCT00960986|946878|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
286992|NCT00960986|946879|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
286993|NCT00960986|946876|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
286994|NCT00960986|946877|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
286995|NCT00960986|946878|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
286996|NCT00960986|946879|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
286997|NCT00960986|946876|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
286998|NCT00960986|946877|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
286999|NCT00960986|946878|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
287000|NCT00960986|946879|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
287001|NCT00960986|946876|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
287002|NCT00960986|946877|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
287003|NCT00960986|946878|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
287004|NCT00960986|946879|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
287005|NCT00960986|946876|P4|Period 3 (7-week Therapy Period)|Death|0
287006|NCT00960986|946877|P3|Period 3 (7-week Therapy Period)|Death|1
287007|NCT00960986|946878|P2|Period 3 (7-week Therapy Period)|Death|0
287008|NCT00960986|946879|P1|Period 3 (7-week Therapy Period)|Death|0
287009|NCT00960986|946876|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
287010|NCT00960986|946877|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
287011|NCT00960986|946878|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
287012|NCT00960986|946879|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
287013|NCT00960986|946876|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
287014|NCT00960986|946877|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
287015|NCT00960986|946878|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
287016|NCT00960986|946879|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
287017|NCT00960986|946876|P4|Period 1 (Screening and Washout)|Protocol Violation|0
287018|NCT00960986|946877|P3|Period 1 (Screening and Washout)|Protocol Violation|0
287019|NCT00960986|946878|P2|Period 1 (Screening and Washout)|Protocol Violation|0
287020|NCT00960986|946879|P1|Period 1 (Screening and Washout)|Protocol Violation|1
287021|NCT00960986|946876|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
287022|NCT00960986|946877|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
287023|NCT00960986|946878|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
287024|NCT00960986|946879|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
287025|NCT00960986|946876|P4|Period 1 (Screening and Washout)|Adverse Event|1
287026|NCT00960986|946877|P3|Period 1 (Screening and Washout)|Adverse Event|1
287027|NCT00960986|946878|P2|Period 1 (Screening and Washout)|Adverse Event|2
287028|NCT00960986|946879|P1|Period 1 (Screening and Washout)|Adverse Event|1
287029|NCT00960934|946955|P6|Overall Study|Study Terminated by Sponsor|49
287030|NCT00960934|946956|P5|Overall Study|Study Terminated by Sponsor|49
287031|NCT00960934|946957|P4|Overall Study|Study Terminated by Sponsor|50
287032|NCT00960934|946958|P3|Overall Study|Study Terminated by Sponsor|52
287033|NCT00960934|946959|P2|Overall Study|Study Terminated by Sponsor|46
287034|NCT00960934|946960|P1|Overall Study|Study Terminated by Sponsor|50
287035|NCT00960934|946955|P6|Overall Study|Withdrawal by Subject|7
287036|NCT00960934|946956|P5|Overall Study|Withdrawal by Subject|5
287037|NCT00960934|946957|P4|Overall Study|Withdrawal by Subject|5
287038|NCT00960934|946958|P3|Overall Study|Withdrawal by Subject|4
287039|NCT00960934|946959|P2|Overall Study|Withdrawal by Subject|6
287040|NCT00960934|946960|P1|Overall Study|Withdrawal by Subject|5
287041|NCT00960934|946955|P6|Overall Study|Protocol Violation|2
287042|NCT00960934|946956|P5|Overall Study|Protocol Violation|3
287043|NCT00960934|946957|P4|Overall Study|Protocol Violation|3
287044|NCT00960934|946958|P3|Overall Study|Protocol Violation|0
287045|NCT00960934|946959|P2|Overall Study|Protocol Violation|4
287046|NCT00960934|946960|P1|Overall Study|Protocol Violation|3
287047|NCT00960934|946955|P6|Overall Study|Progressive Disease|1
287048|NCT00960934|946956|P5|Overall Study|Progressive Disease|1
287049|NCT00960934|946957|P4|Overall Study|Progressive Disease|0
287050|NCT00960934|946958|P3|Overall Study|Progressive Disease|0
287051|NCT00960934|946959|P2|Overall Study|Progressive Disease|1
287052|NCT00960934|946960|P1|Overall Study|Progressive Disease|1
287053|NCT00960934|946955|P6|Overall Study|Physician Decision|0
287054|NCT00960934|946956|P5|Overall Study|Physician Decision|0
287055|NCT00960934|946957|P4|Overall Study|Physician Decision|0
287056|NCT00960934|946958|P3|Overall Study|Physician Decision|0
287057|NCT00960934|946959|P2|Overall Study|Physician Decision|1
287058|NCT00960934|946960|P1|Overall Study|Physician Decision|0
287059|NCT00960934|946955|P6|Overall Study|Not Specified|2
287060|NCT00960934|946956|P5|Overall Study|Not Specified|2
287061|NCT00960934|946957|P4|Overall Study|Not Specified|4
287062|NCT00960934|946958|P3|Overall Study|Not Specified|5
287063|NCT00960934|946959|P2|Overall Study|Not Specified|1
287064|NCT00960934|946960|P1|Overall Study|Not Specified|2
287065|NCT00960934|946955|P6|Overall Study|Lost to Follow-up|0
287066|NCT00960934|946956|P5|Overall Study|Lost to Follow-up|0
287067|NCT00960934|946957|P4|Overall Study|Lost to Follow-up|0
287068|NCT00960934|946958|P3|Overall Study|Lost to Follow-up|0
287069|NCT00960934|946959|P2|Overall Study|Lost to Follow-up|1
287070|NCT00960934|946960|P1|Overall Study|Lost to Follow-up|0
287071|NCT00960934|946955|P6|Overall Study|Lack of Efficacy|0
287072|NCT00960934|946956|P5|Overall Study|Lack of Efficacy|0
287073|NCT00960934|946957|P4|Overall Study|Lack of Efficacy|0
287074|NCT00960934|946958|P3|Overall Study|Lack of Efficacy|0
287075|NCT00960934|946959|P2|Overall Study|Lack of Efficacy|0
287076|NCT00960934|946960|P1|Overall Study|Lack of Efficacy|1
287077|NCT00960934|946955|P6|Overall Study|Adverse Event|3
287078|NCT00960934|946956|P5|Overall Study|Adverse Event|4
287079|NCT00960934|946957|P4|Overall Study|Adverse Event|2
287080|NCT00960934|946958|P3|Overall Study|Adverse Event|3
287081|NCT00960934|946959|P2|Overall Study|Adverse Event|3
287082|NCT00960934|946960|P1|Overall Study|Adverse Event|2
287083|NCT00960869|947072|P2|Overall Study|Misc|18
287084|NCT00960869|947073|P1|Overall Study|Misc|19
287085|NCT00960869|947072|P2|Overall Study|Lost to Follow-up|4
287086|NCT00960869|947073|P1|Overall Study|Lost to Follow-up|1
287087|NCT00960869|947072|P2|Overall Study|Withdrawal by Subject|14
287088|NCT00960869|947073|P1|Overall Study|Withdrawal by Subject|16
287089|NCT00960869|947072|P2|Overall Study|Adverse Event|26
287090|NCT00960869|947073|P1|Overall Study|Adverse Event|17
287091|NCT00960856|947087|P4|Washout Period of 7 Days|Adverse Event|0
287092|NCT00960856|947088|P3|Washout Period of 7 Days|Adverse Event|1
287093|NCT00960856|947089|P2|Washout Period of 7 Days|Adverse Event|0
287094|NCT00960856|947090|P1|Washout Period of 7 Days|Adverse Event|0
287095|NCT00960856|947087|P4|Washout Period of 7 Days|Withdrawal by Subject|0
287096|NCT00960856|947088|P3|Washout Period of 7 Days|Withdrawal by Subject|0
287097|NCT00960856|947089|P2|Washout Period of 7 Days|Withdrawal by Subject|2
287098|NCT00960856|947090|P1|Washout Period of 7 Days|Withdrawal by Subject|0
287099|NCT00960843|947110|P2|Overall Study|Repeated needle dislodgment|1
287100|NCT00960843|947111|P1|Overall Study|Repeated needle dislodgment|0
287101|NCT00960843|947110|P2|Overall Study|Protocol Violation|4
287102|NCT00960843|947111|P1|Overall Study|Protocol Violation|0
287103|NCT00960843|947110|P2|Overall Study|Lost to Follow-up|0
287104|NCT00960843|947111|P1|Overall Study|Lost to Follow-up|2
287105|NCT00960687|947121|P2|Washout Period of 7 Days|Withdrawal by Subject|1
287106|NCT00960687|947122|P1|Washout Period of 7 Days|Withdrawal by Subject|1
287107|NCT00960687|947121|P2|Washout Period of 7 Days|Adverse Event|2
287108|NCT00960687|947122|P1|Washout Period of 7 Days|Adverse Event|3
287109|NCT00960661|947134|P3|Interventional Phase|Lack of Efficacy|0
287110|NCT00960661|947135|P2|Interventional Phase|Lack of Efficacy|2
287111|NCT00960661|947136|P1|Interventional Phase|Lack of Efficacy|0
287112|NCT00960661|947134|P3|Interventional Phase|sponsor decision|0
287113|NCT00960661|947135|P2|Interventional Phase|sponsor decision|1
287114|NCT00960661|947136|P1|Interventional Phase|sponsor decision|0
287115|NCT00960661|947134|P3|Interventional Phase|Physician Decision|5
287116|NCT00960661|947135|P2|Interventional Phase|Physician Decision|3
287117|NCT00960661|947136|P1|Interventional Phase|Physician Decision|0
287118|NCT00960661|947134|P3|Interventional Phase|Withdrawal by Subject|29
287119|NCT00960661|947135|P2|Interventional Phase|Withdrawal by Subject|18
287120|NCT00960661|947136|P1|Interventional Phase|Withdrawal by Subject|0
287121|NCT00960661|947134|P3|Interventional Phase|Protocol Violation|2
287122|NCT00960661|947135|P2|Interventional Phase|Protocol Violation|7
287123|NCT00960661|947136|P1|Interventional Phase|Protocol Violation|0
287124|NCT00960661|947134|P3|Interventional Phase|entry criteria not met|0
287125|NCT00960661|947135|P2|Interventional Phase|entry criteria not met|3
287126|NCT00960661|947136|P1|Interventional Phase|entry criteria not met|0
287127|NCT00960661|947134|P3|Interventional Phase|Lost to Follow-up|2
287128|NCT00960661|947135|P2|Interventional Phase|Lost to Follow-up|0
287129|NCT00960661|947136|P1|Interventional Phase|Lost to Follow-up|0
287130|NCT00960661|947134|P3|Interventional Phase|Death|0
287131|NCT00960661|947135|P2|Interventional Phase|Death|1
287132|NCT00960661|947136|P1|Interventional Phase|Death|0
287133|NCT00960661|947134|P3|Interventional Phase|Adverse Event|8
287134|NCT00960661|947135|P2|Interventional Phase|Adverse Event|17
287135|NCT00960661|947136|P1|Interventional Phase|Adverse Event|0
287136|NCT00960661|947134|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
287137|NCT00960661|947135|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
287138|NCT00960661|947136|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
287139|NCT00960661|947134|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
287140|NCT00960661|947135|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
287141|NCT00960661|947136|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
287142|NCT00960661|947134|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
287143|NCT00960661|947135|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
287144|NCT00960661|947136|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
287145|NCT00960661|947134|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
287146|NCT00960661|947135|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
287147|NCT00960661|947136|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
287148|NCT00960661|947134|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
287149|NCT00960661|947135|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
287150|NCT00960661|947136|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
287151|NCT00960661|947134|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
287152|NCT00960661|947135|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
287153|NCT00960661|947136|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
287154|NCT00960570|947175|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
287155|NCT00960570|947175|P1|1 Day Period Between Dosing|Adverse Event|2
287156|NCT00960570|947175|P1|21 Day Washout Period|Withdrawal by Subject|1
287157|NCT00960570|947175|P1|21 Day Washout Period|Adverse Event|1
287158|NCT00960531|947196|P10|Overall Study|Reason not Specified|1
287159|NCT00960531|947197|P9|Overall Study|Reason not Specified|8
287160|NCT00960531|947198|P8|Overall Study|Reason not Specified|0
287161|NCT00960531|947199|P7|Overall Study|Reason not Specified|16
287162|NCT00960531|947200|P6|Overall Study|Reason not Specified|0
287163|NCT00960531|947201|P5|Overall Study|Reason not Specified|2
287164|NCT00960531|947202|P4|Overall Study|Reason not Specified|1
287165|NCT00960531|947203|P3|Overall Study|Reason not Specified|13
287166|NCT00960531|947204|P2|Overall Study|Reason not Specified|1
287167|NCT00960531|947205|P1|Overall Study|Reason not Specified|2
287168|NCT00960531|947196|P10|Overall Study|Adverse Event (AE)|0
287169|NCT00960531|947197|P9|Overall Study|Adverse Event (AE)|2
287170|NCT00960531|947198|P8|Overall Study|Adverse Event (AE)|0
287171|NCT00960531|947199|P7|Overall Study|Adverse Event (AE)|2
287172|NCT00960531|947200|P6|Overall Study|Adverse Event (AE)|1
287173|NCT00960531|947201|P5|Overall Study|Adverse Event (AE)|0
287174|NCT00960531|947202|P4|Overall Study|Adverse Event (AE)|0
287175|NCT00960531|947203|P3|Overall Study|Adverse Event (AE)|0
287176|NCT00960531|947204|P2|Overall Study|Adverse Event (AE)|0
287177|NCT00960531|947205|P1|Overall Study|Adverse Event (AE)|2
287178|NCT00960531|947196|P10|Overall Study|Failed to Return|0
287179|NCT00960531|947197|P9|Overall Study|Failed to Return|0
287180|NCT00960531|947198|P8|Overall Study|Failed to Return|2
287181|NCT00960531|947199|P7|Overall Study|Failed to Return|0
287182|NCT00960531|947200|P6|Overall Study|Failed to Return|0
287183|NCT00960531|947201|P5|Overall Study|Failed to Return|0
287184|NCT00960531|947202|P4|Overall Study|Failed to Return|0
287185|NCT00960531|947203|P3|Overall Study|Failed to Return|0
287186|NCT00960531|947204|P2|Overall Study|Failed to Return|0
287187|NCT00960531|947205|P1|Overall Study|Failed to Return|2
287188|NCT00960531|947196|P10|Overall Study|Lost to Follow-up|0
287189|NCT00960531|947197|P9|Overall Study|Lost to Follow-up|0
287190|NCT00960531|947198|P8|Overall Study|Lost to Follow-up|0
287191|NCT00960531|947199|P7|Overall Study|Lost to Follow-up|1
287192|NCT00960531|947200|P6|Overall Study|Lost to Follow-up|0
287193|NCT00960531|947201|P5|Overall Study|Lost to Follow-up|0
287194|NCT00960531|947202|P4|Overall Study|Lost to Follow-up|0
287195|NCT00960531|947203|P3|Overall Study|Lost to Follow-up|1
287196|NCT00960531|947204|P2|Overall Study|Lost to Follow-up|0
287197|NCT00960531|947205|P1|Overall Study|Lost to Follow-up|0
287198|NCT00960531|947196|P10|Overall Study|Discontinuation of Study by Sponsor|0
287199|NCT00960531|947197|P9|Overall Study|Discontinuation of Study by Sponsor|0
287200|NCT00960531|947198|P8|Overall Study|Discontinuation of Study by Sponsor|1
287201|NCT00960531|947199|P7|Overall Study|Discontinuation of Study by Sponsor|0
287202|NCT00960531|947200|P6|Overall Study|Discontinuation of Study by Sponsor|0
287203|NCT00960531|947201|P5|Overall Study|Discontinuation of Study by Sponsor|0
287204|NCT00960531|947202|P4|Overall Study|Discontinuation of Study by Sponsor|0
287205|NCT00960531|947203|P3|Overall Study|Discontinuation of Study by Sponsor|0
287206|NCT00960531|947204|P2|Overall Study|Discontinuation of Study by Sponsor|0
287207|NCT00960531|947205|P1|Overall Study|Discontinuation of Study by Sponsor|0
287208|NCT00960531|947196|P10|Overall Study|Investigator Request|0
287209|NCT00960531|947197|P9|Overall Study|Investigator Request|0
287210|NCT00960531|947198|P8|Overall Study|Investigator Request|0
287211|NCT00960531|947199|P7|Overall Study|Investigator Request|0
287212|NCT00960531|947200|P6|Overall Study|Investigator Request|0
287213|NCT00960531|947201|P5|Overall Study|Investigator Request|0
287214|NCT00960531|947202|P4|Overall Study|Investigator Request|0
287215|NCT00960531|947203|P3|Overall Study|Investigator Request|1
287216|NCT00960531|947204|P2|Overall Study|Investigator Request|0
287217|NCT00960531|947205|P1|Overall Study|Investigator Request|0
287218|NCT00960531|947196|P10|Overall Study|Caregiver Request|0
287219|NCT00960531|947197|P9|Overall Study|Caregiver Request|3
287220|NCT00960531|947198|P8|Overall Study|Caregiver Request|1
287221|NCT00960531|947199|P7|Overall Study|Caregiver Request|3
287222|NCT00960531|947200|P6|Overall Study|Caregiver Request|2
287223|NCT00960531|947201|P5|Overall Study|Caregiver Request|0
287224|NCT00960531|947202|P4|Overall Study|Caregiver Request|5
287225|NCT00960531|947203|P3|Overall Study|Caregiver Request|6
287226|NCT00960531|947204|P2|Overall Study|Caregiver Request|0
287227|NCT00960531|947205|P1|Overall Study|Caregiver Request|2
287228|NCT00960531|947196|P10|Overall Study|Withdrawal by Subject|0
287229|NCT00960531|947197|P9|Overall Study|Withdrawal by Subject|1
287230|NCT00960531|947198|P8|Overall Study|Withdrawal by Subject|0
287231|NCT00960531|947199|P7|Overall Study|Withdrawal by Subject|2
287232|NCT00960531|947200|P6|Overall Study|Withdrawal by Subject|0
287233|NCT00960531|947201|P5|Overall Study|Withdrawal by Subject|0
287234|NCT00960531|947202|P4|Overall Study|Withdrawal by Subject|2
287235|NCT00960531|947203|P3|Overall Study|Withdrawal by Subject|5
287236|NCT00960531|947204|P2|Overall Study|Withdrawal by Subject|0
287237|NCT00960531|947205|P1|Overall Study|Withdrawal by Subject|1
287238|NCT00960531|947196|P10|Overall Study|Lack of Efficacy|0
287239|NCT00960531|947197|P9|Overall Study|Lack of Efficacy|0
287240|NCT00960531|947198|P8|Overall Study|Lack of Efficacy|0
287241|NCT00960531|947199|P7|Overall Study|Lack of Efficacy|0
287242|NCT00960531|947200|P6|Overall Study|Lack of Efficacy|0
287243|NCT00960531|947201|P5|Overall Study|Lack of Efficacy|0
287244|NCT00960531|947202|P4|Overall Study|Lack of Efficacy|0
287245|NCT00960531|947203|P3|Overall Study|Lack of Efficacy|0
287246|NCT00960531|947204|P2|Overall Study|Lack of Efficacy|0
287247|NCT00960531|947205|P1|Overall Study|Lack of Efficacy|1
287248|NCT00960440|947253|P4|Overall Study|Unspecified|0
287249|NCT00960440|947254|P3|Overall Study|Unspecified|1
287250|NCT00960440|947255|P2|Overall Study|Unspecified|1
287251|NCT00960440|947256|P1|Overall Study|Unspecified|1
287252|NCT00960440|947253|P4|Overall Study|Withdrawal by Subject|1
287253|NCT00960440|947254|P3|Overall Study|Withdrawal by Subject|2
287254|NCT00960440|947255|P2|Overall Study|Withdrawal by Subject|5
287255|NCT00960440|947256|P1|Overall Study|Withdrawal by Subject|9
287256|NCT00960440|947253|P4|Overall Study|Protocol Violation|4
287257|NCT00960440|947254|P3|Overall Study|Protocol Violation|3
287258|NCT00960440|947255|P2|Overall Study|Protocol Violation|8
287259|NCT00960440|947256|P1|Overall Study|Protocol Violation|2
287260|NCT00960440|947253|P4|Overall Study|Lack of Efficacy|8
287261|NCT00960440|947254|P3|Overall Study|Lack of Efficacy|3
287262|NCT00960440|947255|P2|Overall Study|Lack of Efficacy|5
287263|NCT00960440|947256|P1|Overall Study|Lack of Efficacy|2
287264|NCT00960440|947253|P4|Overall Study|Adverse Event|4
287265|NCT00960440|947254|P3|Overall Study|Adverse Event|4
287266|NCT00960440|947255|P2|Overall Study|Adverse Event|12
287267|NCT00960440|947256|P1|Overall Study|Adverse Event|12
287268|NCT00960440|947253|P4|Overall Study|Death|1
287269|NCT00960440|947254|P3|Overall Study|Death|0
287270|NCT00960440|947255|P2|Overall Study|Death|0
287271|NCT00960440|947256|P1|Overall Study|Death|0
287272|NCT00960375|947428|P2|Overall Study|Lost to Follow-up|22
287273|NCT00960375|947429|P1|Overall Study|Lost to Follow-up|20
287274|NCT00960323|947437|P1|Atorvastatin Alone|Withdrawal by Subject|1
287275|NCT00960297|947448|P1|Overall Study|Disease progression|1
287276|NCT00960297|947448|P1|Overall Study|Venous port infection|1
287277|NCT00960297|947448|P1|Overall Study|Physician Decision|1
287278|NCT00960206|947455|P3|Overall Study|Missing 10 year data|1
287279|NCT00960206|947456|P2|Overall Study|Missing 10 year data|1
287280|NCT00960206|947457|P1|Overall Study|Missing 10 year data|20
287281|NCT00960206|947455|P3|Overall Study|Revision of study component|2
287282|NCT00960206|947456|P2|Overall Study|Revision of study component|2
287283|NCT00960206|947457|P1|Overall Study|Revision of study component|2
287284|NCT00960206|947455|P3|Overall Study|Withdrawal by Subject|0
287285|NCT00960206|947456|P2|Overall Study|Withdrawal by Subject|4
287286|NCT00960206|947457|P1|Overall Study|Withdrawal by Subject|2
287287|NCT00960206|947455|P3|Overall Study|Lost to Follow-up|8
287288|NCT00960206|947456|P2|Overall Study|Lost to Follow-up|14
287289|NCT00960206|947457|P1|Overall Study|Lost to Follow-up|8
287290|NCT00960206|947455|P3|Overall Study|Unwilling/Unable to return|0
287291|NCT00960206|947456|P2|Overall Study|Unwilling/Unable to return|2
287292|NCT00960206|947457|P1|Overall Study|Unwilling/Unable to return|1
287293|NCT00960206|947455|P3|Overall Study|Death|1
287294|NCT00960206|947456|P2|Overall Study|Death|4
287295|NCT00960206|947457|P1|Overall Study|Death|7
287296|NCT00960193|947475|P1|14 Day Washout Period|Withdrawal by Subject|1
287297|NCT00960154|947488|P2|Overall Study|Study termination|25
287298|NCT00960154|947489|P1|Overall Study|Study termination|25
287299|NCT00960141|947500|P3|Overall Study|Withdrawal by Subject|1
287300|NCT00960141|947501|P2|Overall Study|Withdrawal by Subject|2
287301|NCT00960141|947502|P1|Overall Study|Withdrawal by Subject|1
287302|NCT00960141|947500|P3|Overall Study|Protocol Violation|2
287303|NCT00960141|947501|P2|Overall Study|Protocol Violation|3
287304|NCT00960141|947502|P1|Overall Study|Protocol Violation|1
287305|NCT00960141|947500|P3|Overall Study|Lost to Follow-up|0
287306|NCT00960141|947501|P2|Overall Study|Lost to Follow-up|0
287307|NCT00960141|947502|P1|Overall Study|Lost to Follow-up|1
287308|NCT00960141|947500|P3|Overall Study|Lack of Efficacy|2
287309|NCT00960141|947501|P2|Overall Study|Lack of Efficacy|4
287310|NCT00960141|947502|P1|Overall Study|Lack of Efficacy|3
287311|NCT00960141|947500|P3|Overall Study|Adverse Event|2
287312|NCT00960141|947501|P2|Overall Study|Adverse Event|8
287313|NCT00960141|947502|P1|Overall Study|Adverse Event|4
287314|NCT00960115|947527|P2|Overall Study|Ongoing treatment at data cut-off date|15
287315|NCT00960115|947528|P1|Overall Study|Ongoing treatment at data cut-off date|19
287316|NCT00960076|947542|P2|Overall Study|Did not attend the termination visit|1
287317|NCT00960076|947543|P1|Overall Study|Did not attend the termination visit|0
287318|NCT00960076|947542|P2|Overall Study|Hyperglycemia|5
287319|NCT00960076|947543|P1|Overall Study|Hyperglycemia|1
287320|NCT00960076|947542|P2|Overall Study|Severe non-compliance to protocol|2
287321|NCT00960076|947543|P1|Overall Study|Severe non-compliance to protocol|1
287322|NCT00960076|947542|P2|Overall Study|Lost to Follow-up|3
287323|NCT00960076|947543|P1|Overall Study|Lost to Follow-up|3
287324|NCT00960076|947542|P2|Overall Study|Withdrawal by Subject|2
287325|NCT00960076|947543|P1|Overall Study|Withdrawal by Subject|1
287326|NCT00960076|947542|P2|Overall Study|No longer met study criteria|5
287327|NCT00960076|947543|P1|Overall Study|No longer met study criteria|1
287328|NCT00960076|947542|P2|Overall Study|Adverse Event|7
287329|NCT00960076|947543|P1|Overall Study|Adverse Event|1
287330|NCT00960063|947558|P3|Overall Study|Progression of Disease|3
287331|NCT00960063|947559|P2|Overall Study|Progression of Disease|0
287332|NCT00960063|947560|P1|Overall Study|Progression of Disease|0
287333|NCT00960063|947558|P3|Overall Study|Adverse Event|0
287334|NCT00960063|947559|P2|Overall Study|Adverse Event|0
287335|NCT00960063|947560|P1|Overall Study|Adverse Event|1
287336|NCT00959946|947651|P8|Overall Study|Withdrawal by Subject|0
287337|NCT00959946|947652|P7|Overall Study|Withdrawal by Subject|0
287338|NCT00959946|947653|P6|Overall Study|Withdrawal by Subject|1
287339|NCT00959946|947654|P5|Overall Study|Withdrawal by Subject|0
287340|NCT00959946|947655|P4|Overall Study|Withdrawal by Subject|0
287341|NCT00959946|947656|P3|Overall Study|Withdrawal by Subject|0
287342|NCT00959946|947657|P2|Overall Study|Withdrawal by Subject|0
287343|NCT00959946|947658|P1|Overall Study|Withdrawal by Subject|0
287344|NCT00959946|947651|P8|Overall Study|Disease Progression|2
287345|NCT00959946|947652|P7|Overall Study|Disease Progression|2
287346|NCT00959946|947653|P6|Overall Study|Disease Progression|6
287347|NCT00959946|947654|P5|Overall Study|Disease Progression|4
287348|NCT00959946|947655|P4|Overall Study|Disease Progression|4
287349|NCT00959946|947656|P3|Overall Study|Disease Progression|2
287350|NCT00959946|947657|P2|Overall Study|Disease Progression|4
287351|NCT00959946|947658|P1|Overall Study|Disease Progression|2
287352|NCT00959946|947651|P8|Overall Study|Death|0
287353|NCT00959946|947652|P7|Overall Study|Death|0
287354|NCT00959946|947653|P6|Overall Study|Death|1
287355|NCT00959946|947654|P5|Overall Study|Death|0
287356|NCT00959946|947655|P4|Overall Study|Death|0
287357|NCT00959946|947656|P3|Overall Study|Death|0
287358|NCT00959946|947657|P2|Overall Study|Death|0
287359|NCT00959946|947658|P1|Overall Study|Death|0
287360|NCT00959946|947651|P8|Overall Study|Adverse Event|0
287361|NCT00959946|947652|P7|Overall Study|Adverse Event|0
287362|NCT00959946|947653|P6|Overall Study|Adverse Event|1
287363|NCT00959946|947654|P5|Overall Study|Adverse Event|0
287364|NCT00959946|947655|P4|Overall Study|Adverse Event|1
287365|NCT00959946|947656|P3|Overall Study|Adverse Event|2
287366|NCT00959946|947657|P2|Overall Study|Adverse Event|0
287367|NCT00959946|947658|P1|Overall Study|Adverse Event|0
287368|NCT00959907|947722|P2|Overall Study|Withdrawal by Subject|0
287369|NCT00959907|947723|P1|Overall Study|Withdrawal by Subject|2
287370|NCT00959907|947722|P2|Overall Study|Adverse Event|0
287371|NCT00959907|947723|P1|Overall Study|Adverse Event|1
287372|NCT00959907|947722|P2|Overall Study|Protocol Violation|1
287373|NCT00959907|947723|P1|Overall Study|Protocol Violation|0
287374|NCT00959894|947733|P1|Overall Study|Subject moved out of town|1
287375|NCT00959894|947733|P1|Overall Study|Need for contraindicated medication|1
287376|NCT00959894|947733|P1|Overall Study|Withdrawal by Subject|1
287377|NCT00959894|947733|P1|Overall Study|Adverse Event|3
287378|NCT00959894|947733|P1|Overall Study|Lost to Follow-up|10
287379|NCT00959751|947782|P2|Overall Study|No migraine headache without aura|7
287380|NCT00959751|947783|P1|Overall Study|No migraine headache without aura|7
287381|NCT00959751|947782|P2|Overall Study|Non-compliance to Study Procedures|1
287382|NCT00959751|947783|P1|Overall Study|Non-compliance to Study Procedures|0
287383|NCT00959751|947782|P2|Overall Study|Consent Withdrawn|1
287384|NCT00959751|947783|P1|Overall Study|Consent Withdrawn|0
287385|NCT00959751|947782|P2|Overall Study|Lost to Follow-up|3
287386|NCT00959751|947783|P1|Overall Study|Lost to Follow-up|2
287387|NCT00959699|947805|P2|Follow-up Period|Withdrawal by Subject|4
287388|NCT00959699|947806|P1|Follow-up Period|Withdrawal by Subject|3
287389|NCT00959699|947805|P2|Follow-up Period|Lost to Follow-up|2
287390|NCT00959699|947806|P1|Follow-up Period|Lost to Follow-up|3
287391|NCT00959699|947805|P2|Treatment Period|Futility/crossover to boceprevir|0
287392|NCT00959699|947806|P1|Treatment Period|Futility/crossover to boceprevir|4
287393|NCT00959699|947805|P2|Treatment Period|Did not receive treatment|1
287394|NCT00959699|947806|P1|Treatment Period|Did not receive treatment|0
287395|NCT00959699|947805|P2|Treatment Period|Non-Compliance with Protocol|1
287396|NCT00959699|947806|P1|Treatment Period|Non-Compliance with Protocol|0
287397|NCT00959699|947805|P2|Treatment Period|Withdrawal by Subject|3
287398|NCT00959699|947806|P1|Treatment Period|Withdrawal by Subject|1
287399|NCT00959699|947805|P2|Treatment Period|Lost to Follow-up|1
287400|NCT00959699|947806|P1|Treatment Period|Lost to Follow-up|0
287401|NCT00959699|947805|P2|Treatment Period|Lack of Efficacy|6
287402|NCT00959699|947806|P1|Treatment Period|Lack of Efficacy|15
287403|NCT00959699|947805|P2|Treatment Period|Adverse Event|13
287404|NCT00959699|947806|P1|Treatment Period|Adverse Event|3
287405|NCT00959647|947823|P1|Overall Study|Withdrawal by Subject|7
287406|NCT00959647|947823|P1|Overall Study|Study terminated by sponsor|4
287407|NCT00959647|947823|P1|Overall Study|Progressive disease|6
287408|NCT00959647|947823|P1|Overall Study|Adverse Event|2
287409|NCT00959374|947828|P1|Overall Study|Physician Decision|1
287410|NCT00959374|947828|P1|Overall Study|Implant Removed/Not Replaced|4
287411|NCT00959374|947828|P1|Overall Study|Protocol Violation|1
287412|NCT00959374|947828|P1|Overall Study|Death|1
287413|NCT00959374|947828|P1|Overall Study|Lost to Follow-up|14
287414|NCT00959374|947828|P1|Overall Study|Withdrawal by Subject|2
287415|NCT00959192|947842|P4|Overall Study|Caregiver Request|1
287416|NCT00959192|947843|P3|Overall Study|Caregiver Request|2
287417|NCT00959192|947844|P2|Overall Study|Caregiver Request|0
287418|NCT00959192|947845|P1|Overall Study|Caregiver Request|0
287419|NCT00959192|947842|P4|Overall Study|Investigator Request|0
287420|NCT00959192|947843|P3|Overall Study|Investigator Request|0
287421|NCT00959192|947844|P2|Overall Study|Investigator Request|0
287422|NCT00959192|947845|P1|Overall Study|Investigator Request|1
287423|NCT00959192|947842|P4|Overall Study|Adverse Event|0
287424|NCT00959192|947843|P3|Overall Study|Adverse Event|1
287425|NCT00959192|947844|P2|Overall Study|Adverse Event|1
287426|NCT00959192|947845|P1|Overall Study|Adverse Event|1
287427|NCT00959049|947893|P6|Overall Study|Withdrawal by Subject|0
287428|NCT00959049|947894|P5|Overall Study|Withdrawal by Subject|0
287429|NCT00959049|947895|P4|Overall Study|Withdrawal by Subject|0
287430|NCT00959049|947896|P3|Overall Study|Withdrawal by Subject|0
287431|NCT00959049|947897|P2|Overall Study|Withdrawal by Subject|2
287432|NCT00959049|947898|P1|Overall Study|Withdrawal by Subject|0
287433|NCT00959049|947893|P6|Overall Study|Contraindicated medication|0
287434|NCT00959049|947894|P5|Overall Study|Contraindicated medication|0
287435|NCT00959049|947895|P4|Overall Study|Contraindicated medication|1
287436|NCT00959049|947896|P3|Overall Study|Contraindicated medication|0
287437|NCT00959049|947897|P2|Overall Study|Contraindicated medication|0
287438|NCT00959049|947898|P1|Overall Study|Contraindicated medication|0
287439|NCT00959049|947893|P6|Overall Study|Lost to Follow-up|1
287440|NCT00959049|947894|P5|Overall Study|Lost to Follow-up|9
287441|NCT00959049|947895|P4|Overall Study|Lost to Follow-up|10
287442|NCT00959049|947896|P3|Overall Study|Lost to Follow-up|1
287443|NCT00959049|947897|P2|Overall Study|Lost to Follow-up|5
287444|NCT00959049|947898|P1|Overall Study|Lost to Follow-up|17
287445|NCT00959049|947893|P6|Overall Study|Adverse Event|0
287446|NCT00959049|947894|P5|Overall Study|Adverse Event|0
287447|NCT00959049|947895|P4|Overall Study|Adverse Event|0
287448|NCT00959049|947896|P3|Overall Study|Adverse Event|0
287449|NCT00959049|947897|P2|Overall Study|Adverse Event|0
287450|NCT00959049|947898|P1|Overall Study|Adverse Event|1
287451|NCT00958893|947963|P1|Overall Study|Study prematurely terminated|4
287452|NCT00958880|947969|P2|Overall Study|Lost to Follow-up|2
287453|NCT00958880|947970|P1|Overall Study|Lost to Follow-up|2
287454|NCT00958841|947978|P1|Overall Study|Discontinued prior to M*|28
287455|NCT00958841|947978|P1|Overall Study|Completed M6/did not enter extension|27
287456|NCT00958841|947978|P1|Overall Study|Unsatisfactory therapeutic effect|22
287457|NCT00958841|947978|P1|Overall Study|Withdrawal by Subject|1
287458|NCT00958841|947978|P1|Overall Study|New cancer therapy|5
287459|NCT00958841|947978|P1|Overall Study|Adverse Event|8
287460|NCT00958841|947978|P1|Overall Study|Administrative problems|1
287461|NCT00958841|947978|P1|Overall Study|Abnormal test procedure result(s)|3
287462|NCT00958841|947978|P1|Overall Study|Abnormal laboratory value(s)|1
287463|NCT00958828|947996|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
287464|NCT00958828|947997|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
287465|NCT00958828|947996|P2|Period 1, 1 Week of Wear|Randomization break|1
287466|NCT00958828|947997|P1|Period 1, 1 Week of Wear|Randomization break|0
287467|NCT00958789|948003|P1|Overall Study|Revision|8
287468|NCT00958789|948003|P1|Overall Study|Subject terminated|3
287469|NCT00958789|948003|P1|Overall Study|2 yr. Knee Society Score not calculable|2
287470|NCT00958789|948003|P1|Overall Study|No 2 yr. Knee Society Score data|12
287471|NCT00958789|948003|P1|Overall Study|Withdrawal by Subject|16
287472|NCT00958789|948003|P1|Overall Study|Lost to Follow-up|7
287473|NCT00958789|948003|P1|Overall Study|Death|3
287474|NCT00958776|948009|P2|Overall Study|Missing|1
287475|NCT00958776|948010|P1|Overall Study|Missing|1
287476|NCT00958776|948009|P2|Overall Study|Noncompliance; Protocol Deviations|3
287477|NCT00958776|948010|P1|Overall Study|Noncompliance; Protocol Deviations|2
287478|NCT00958776|948009|P2|Overall Study|Death|1
287479|NCT00958776|948010|P1|Overall Study|Death|2
287480|NCT00958776|948009|P2|Overall Study|Protocol Violation|1
287481|NCT00958776|948010|P1|Overall Study|Protocol Violation|1
287482|NCT00958776|948009|P2|Overall Study|Withdrawal by Subject|16
287483|NCT00958776|948010|P1|Overall Study|Withdrawal by Subject|7
287484|NCT00958776|948009|P2|Overall Study|Lost to Follow-up|6
287485|NCT00958776|948010|P1|Overall Study|Lost to Follow-up|2
287486|NCT00958776|948009|P2|Overall Study|Physician Decision|0
287487|NCT00958776|948010|P1|Overall Study|Physician Decision|1
287488|NCT00958776|948009|P2|Overall Study|Adverse Event|1
287489|NCT00958776|948010|P1|Overall Study|Adverse Event|0
287490|NCT00958568|948040|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
287491|NCT00958568|948041|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
287492|NCT00958568|948042|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
287493|NCT00958568|948043|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
287494|NCT00958568|948040|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
287495|NCT00958568|948041|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
287496|NCT00958568|948042|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
287497|NCT00958568|948043|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
287498|NCT00958568|948040|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
287499|NCT00958568|948041|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
287500|NCT00958568|948042|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
287501|NCT00958568|948043|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
287502|NCT00958568|948040|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
287503|NCT00958568|948041|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
287504|NCT00958568|948042|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
287505|NCT00958568|948043|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
287506|NCT00958568|948040|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
287507|NCT00958568|948041|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
287508|NCT00958568|948042|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
287509|NCT00958568|948043|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
287510|NCT00958568|948040|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
287511|NCT00958568|948041|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
287512|NCT00958568|948042|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
287513|NCT00958568|948043|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
287514|NCT00958568|948040|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
287515|NCT00958568|948041|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
287516|NCT00958568|948042|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
287517|NCT00958568|948043|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
287518|NCT00958568|948040|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
287519|NCT00958568|948041|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
287520|NCT00958568|948042|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
287521|NCT00958568|948043|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
287522|NCT00958568|948040|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
287523|NCT00958568|948041|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
287524|NCT00958568|948042|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
287525|NCT00958568|948043|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
287526|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
287527|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
287528|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
287529|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
287530|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
287531|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
287532|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
287533|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
287534|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
287535|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
287536|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
287537|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
287538|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
287539|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
287540|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
287541|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
287542|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
287543|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
287544|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
287545|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
287546|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
287547|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
287548|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
287549|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
287550|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
287551|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
287552|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
287553|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
287554|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
287555|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
287556|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
287557|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
287558|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
287559|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
287560|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
287561|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
287562|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
287563|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
287564|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
287565|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
287566|NCT00958568|948040|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
287567|NCT00958568|948041|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
287568|NCT00958568|948042|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
287569|NCT00958568|948043|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
287570|NCT00958568|948040|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
287571|NCT00958568|948041|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
287572|NCT00958568|948042|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
287573|NCT00958568|948043|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
287574|NCT00958568|948040|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
287575|NCT00958568|948041|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
287576|NCT00958568|948042|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
287577|NCT00958568|948043|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
287578|NCT00958568|948040|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
287579|NCT00958568|948041|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
287580|NCT00958568|948042|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
287581|NCT00958568|948043|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
287582|NCT00958568|948040|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
287583|NCT00958568|948041|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
287584|NCT00958568|948042|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
287585|NCT00958568|948043|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
287586|NCT00958568|948040|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
287587|NCT00958568|948041|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
287588|NCT00958568|948042|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
287589|NCT00958568|948043|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
287590|NCT00958568|948040|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
287591|NCT00958568|948041|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
287592|NCT00958568|948042|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
287593|NCT00958568|948043|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
287594|NCT00958568|948040|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
287595|NCT00958568|948041|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
287596|NCT00958568|948042|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
287597|NCT00958568|948043|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
287598|NCT00958568|948040|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
287599|NCT00958568|948041|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
287600|NCT00958568|948042|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
287601|NCT00958568|948043|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
287602|NCT00958568|948040|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
287603|NCT00958568|948041|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
287604|NCT00958568|948042|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
287605|NCT00958568|948043|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
287606|NCT00958438|948127|P3|Overall Study|Other than specified above|2
287607|NCT00958438|948128|P2|Overall Study|Other than specified above|3
287608|NCT00958438|948129|P1|Overall Study|Other than specified above|2
287609|NCT00958438|948127|P3|Overall Study|Physician Decision|1
287610|NCT00958438|948128|P2|Overall Study|Physician Decision|0
287611|NCT00958438|948129|P1|Overall Study|Physician Decision|1
287612|NCT00958438|948127|P3|Overall Study|Adverse Event|0
287613|NCT00958438|948128|P2|Overall Study|Adverse Event|3
287614|NCT00958438|948129|P1|Overall Study|Adverse Event|0
287615|NCT00958438|948127|P3|Overall Study|Withdrawal by Subject|1
287616|NCT00958438|948128|P2|Overall Study|Withdrawal by Subject|2
287617|NCT00958438|948129|P1|Overall Study|Withdrawal by Subject|4
287618|NCT00958438|948127|P3|Overall Study|Protocol Violation|2
287619|NCT00958438|948128|P2|Overall Study|Protocol Violation|2
287620|NCT00958438|948129|P1|Overall Study|Protocol Violation|3
287621|NCT00958360|948154|P2|Overall Study|Lost to Follow-up|1
287622|NCT00958360|948155|P1|Overall Study|Lost to Follow-up|0
287623|NCT00958360|948154|P2|Overall Study|Physician Decision|1
287624|NCT00958360|948155|P1|Overall Study|Physician Decision|2
287625|NCT00958360|948154|P2|Overall Study|Death|7
287626|NCT00958360|948155|P1|Overall Study|Death|6
287627|NCT00958360|948154|P2|Overall Study|Withdrawal by Subject|1
287628|NCT00958360|948155|P1|Overall Study|Withdrawal by Subject|3
287629|NCT00958347|948169|P1|Overall Study|study termination|135
287630|NCT00958347|948169|P1|Overall Study|revision/removal|10
287631|NCT00958347|948169|P1|Overall Study|Lost to Follow-up|15
287632|NCT00958347|948169|P1|Overall Study|Withdrawal by Subject|23
287633|NCT00958347|948169|P1|Overall Study|Death|43
287634|NCT00958256|948210|P1|Overall Study|Adverse Event|3
287635|NCT00958243|948220|P6|Overall Study|Lost to Follow-up|5
287636|NCT00958243|948221|P5|Overall Study|Lost to Follow-up|8
287637|NCT00958243|948222|P4|Overall Study|Lost to Follow-up|2
287638|NCT00958243|948223|P3|Overall Study|Lost to Follow-up|11
287639|NCT00958243|948224|P2|Overall Study|Lost to Follow-up|5
287640|NCT00958243|948225|P1|Overall Study|Lost to Follow-up|2
287641|NCT00958243|948220|P6|Overall Study|Withdrawal by Subject|5
287642|NCT00958243|948221|P5|Overall Study|Withdrawal by Subject|1
287643|NCT00958243|948222|P4|Overall Study|Withdrawal by Subject|1
287644|NCT00958243|948223|P3|Overall Study|Withdrawal by Subject|3
287645|NCT00958243|948224|P2|Overall Study|Withdrawal by Subject|1
287646|NCT00958243|948225|P1|Overall Study|Withdrawal by Subject|0
287647|NCT00958217|948283|P2|Overall Study|Inpatient hospitalization|1
287648|NCT00958217|948284|P1|Overall Study|Inpatient hospitalization|0
287649|NCT00958217|948283|P2|Overall Study|Moved out of area|1
287650|NCT00958217|948284|P1|Overall Study|Moved out of area|1
287651|NCT00958217|948283|P2|Overall Study|Lost to Follow-up|19
287652|NCT00958217|948284|P1|Overall Study|Lost to Follow-up|17
287653|NCT00958217|948283|P2|Overall Study|Withdrawal by Subject|3
287654|NCT00958217|948284|P1|Overall Study|Withdrawal by Subject|4
287655|NCT00958217|948283|P2|Overall Study|Death|1
287656|NCT00958217|948284|P1|Overall Study|Death|2
287657|NCT00958191|948295|P1|Overall Study|No 5 yr x-rays|56
287658|NCT00958191|948295|P1|Overall Study|Site termination|11
287659|NCT00958191|948295|P1|Overall Study|Revision of study device|4
287660|NCT00958191|948295|P1|Overall Study|Did not receive study device|1
287661|NCT00958191|948295|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
287662|NCT00958191|948295|P1|Overall Study|Inadequate 5 yr x-ray quality|10
287663|NCT00958191|948295|P1|Overall Study|Lost to Follow-up|5
287664|NCT00958191|948295|P1|Overall Study|Death|4
287665|NCT00958165|948308|P1|Overall Study|Not eligible|9
287666|NCT00958165|948308|P1|Overall Study|Lost to Follow-up|5
287667|NCT00958126|948320|P8|Overall Study|Other Reason|0
287668|NCT00958126|948321|P7|Overall Study|Other Reason|0
287669|NCT00958126|948322|P6|Overall Study|Other Reason|1
287670|NCT00958126|948323|P5|Overall Study|Other Reason|0
287671|NCT00958126|948324|P4|Overall Study|Other Reason|1
287672|NCT00958126|948325|P3|Overall Study|Other Reason|0
287673|NCT00958126|948326|P2|Overall Study|Other Reason|0
287674|NCT00958126|948327|P1|Overall Study|Other Reason|0
287675|NCT00958126|948320|P8|Overall Study|Sponsor/Investigator decision|0
287676|NCT00958126|948321|P7|Overall Study|Sponsor/Investigator decision|0
287677|NCT00958126|948322|P6|Overall Study|Sponsor/Investigator decision|0
287678|NCT00958126|948323|P5|Overall Study|Sponsor/Investigator decision|0
287679|NCT00958126|948324|P4|Overall Study|Sponsor/Investigator decision|1
287680|NCT00958126|948325|P3|Overall Study|Sponsor/Investigator decision|0
287681|NCT00958126|948326|P2|Overall Study|Sponsor/Investigator decision|0
287682|NCT00958126|948327|P1|Overall Study|Sponsor/Investigator decision|0
287683|NCT00958126|948320|P8|Overall Study|Lost to Follow-up|0
287684|NCT00958126|948321|P7|Overall Study|Lost to Follow-up|0
287685|NCT00958126|948322|P6|Overall Study|Lost to Follow-up|0
287686|NCT00958126|948323|P5|Overall Study|Lost to Follow-up|0
287687|NCT00958126|948324|P4|Overall Study|Lost to Follow-up|8
287688|NCT00958126|948325|P3|Overall Study|Lost to Follow-up|9
287689|NCT00958126|948326|P2|Overall Study|Lost to Follow-up|5
287690|NCT00958126|948327|P1|Overall Study|Lost to Follow-up|1
287691|NCT00958126|948320|P8|Overall Study|Moved away from study area|0
287692|NCT00958126|948321|P7|Overall Study|Moved away from study area|0
287693|NCT00958126|948322|P6|Overall Study|Moved away from study area|0
287694|NCT00958126|948323|P5|Overall Study|Moved away from study area|0
287695|NCT00958126|948324|P4|Overall Study|Moved away from study area|1
287696|NCT00958126|948325|P3|Overall Study|Moved away from study area|1
287697|NCT00958126|948326|P2|Overall Study|Moved away from study area|0
287698|NCT00958126|948327|P1|Overall Study|Moved away from study area|0
287699|NCT00958126|948320|P8|Overall Study|Withdrawal by Subject|0
287700|NCT00958126|948321|P7|Overall Study|Withdrawal by Subject|0
287701|NCT00958126|948322|P6|Overall Study|Withdrawal by Subject|0
287702|NCT00958126|948323|P5|Overall Study|Withdrawal by Subject|0
287703|NCT00958126|948324|P4|Overall Study|Withdrawal by Subject|0
287704|NCT00958126|948325|P3|Overall Study|Withdrawal by Subject|0
287705|NCT00958126|948326|P2|Overall Study|Withdrawal by Subject|2
287706|NCT00958126|948327|P1|Overall Study|Withdrawal by Subject|0
287707|NCT00958126|948320|P8|Overall Study|Serious Adverse Event|0
287708|NCT00958126|948321|P7|Overall Study|Serious Adverse Event|1
287709|NCT00958126|948322|P6|Overall Study|Serious Adverse Event|0
287710|NCT00958126|948323|P5|Overall Study|Serious Adverse Event|0
287711|NCT00958126|948324|P4|Overall Study|Serious Adverse Event|0
287712|NCT00958126|948325|P3|Overall Study|Serious Adverse Event|0
287713|NCT00958126|948326|P2|Overall Study|Serious Adverse Event|2
287714|NCT00958126|948327|P1|Overall Study|Serious Adverse Event|0
287715|NCT00958074|948399|P2|Overall Study|Withdrawal by Subject|1
287716|NCT00958074|948400|P1|Overall Study|Withdrawal by Subject|0
287717|NCT00958009|948415|P1|Overall Study|Subject found device difficult to use|1
287718|NCT00958009|948415|P1|Overall Study|Adverse Event|1
287719|NCT00957996|948422|P2|Overall Study|Noncompliance; Protocol Deviations|6
287720|NCT00957996|948423|P1|Overall Study|Noncompliance; Protocol Deviations|5
287721|NCT00957996|948422|P2|Overall Study|Missing|0
287722|NCT00957996|948423|P1|Overall Study|Missing|1
287723|NCT00957996|948422|P2|Overall Study|Influenza-related complication|1
287724|NCT00957996|948423|P1|Overall Study|Influenza-related complication|0
287725|NCT00957996|948422|P2|Overall Study|Physician Decision|1
287726|NCT00957996|948423|P1|Overall Study|Physician Decision|1
287727|NCT00957996|948422|P2|Overall Study|Adverse Event|1
287728|NCT00957996|948423|P1|Overall Study|Adverse Event|2
287729|NCT00957996|948422|P2|Overall Study|Withdrawal by Subject|2
287730|NCT00957996|948423|P1|Overall Study|Withdrawal by Subject|9
287731|NCT00957996|948422|P2|Overall Study|Lost to Follow-up|7
287732|NCT00957996|948423|P1|Overall Study|Lost to Follow-up|4
287733|NCT00957996|948422|P2|Overall Study|Death|10
287734|NCT00957996|948423|P1|Overall Study|Death|4
287735|NCT00957944|948455|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
287736|NCT00957944|948456|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
287737|NCT00957905|948492|P2|Part B|Protocol Violation|1
287738|NCT00957905|948493|P1|Part B|Protocol Violation|0
287739|NCT00957905|948492|P2|Part B|Death|1
287740|NCT00957905|948493|P1|Part B|Death|0
287741|NCT00957905|948492|P2|Part B|Physician Decision|1
287742|NCT00957905|948493|P1|Part B|Physician Decision|0
287743|NCT00957905|948492|P2|Part B|Not Treated|1
287744|NCT00957905|948493|P1|Part B|Not Treated|0
287745|NCT00957723|948499|P1|Overall Study|2yr ROM Data Not Evaluable|25
287746|NCT00957723|948499|P1|Overall Study|Intercurrent Illness|2
287747|NCT00957723|948499|P1|Overall Study|Investigative Site Terminated|55
287748|NCT00957723|948499|P1|Overall Study|Did not undergo surgery|3
287749|NCT00957723|948499|P1|Overall Study|Withdrawal by Subject|23
287750|NCT00957723|948499|P1|Overall Study|Lost to Follow-up|7
287751|NCT00957723|948499|P1|Overall Study|Revision/ Removal of Study Implant|3
287752|NCT00957723|948499|P1|Overall Study|Death|3
287753|NCT00957658|948528|P1|Overall Study|Protocol Violation|5
287754|NCT00957658|948528|P1|Overall Study|surgery cancelled|2
287755|NCT00957658|948528|P1|Overall Study|unwilling/unable to return|2
287756|NCT00957658|948528|P1|Overall Study|Site termination|10
287757|NCT00957658|948528|P1|Overall Study|Incomplete 2 yr data|28
287758|NCT00957658|948528|P1|Overall Study|Revision|1
287759|NCT00957658|948528|P1|Overall Study|Withdrawal by Subject|12
287760|NCT00957658|948528|P1|Overall Study|Lost to Follow-up|4
287761|NCT00957658|948528|P1|Overall Study|Death|1
287762|NCT00957580|948553|P3|Overall Study|Enrolled but not treated|0
287763|NCT00957580|948554|P2|Overall Study|Enrolled but not treated|1
287764|NCT00957580|948555|P1|Overall Study|Enrolled but not treated|0
287765|NCT00957580|948553|P3|Overall Study|Ongoing at data cut-off|0
287766|NCT00957580|948554|P2|Overall Study|Ongoing at data cut-off|1
287767|NCT00957580|948555|P1|Overall Study|Ongoing at data cut-off|0
287768|NCT00957528|948702|P3|Overall Study|Withdrawal by Subject|1
287769|NCT00957528|948703|P2|Overall Study|Withdrawal by Subject|0
287770|NCT00957528|948704|P1|Overall Study|Withdrawal by Subject|0
287771|NCT00957528|948702|P3|Overall Study|Protocol Violation|0
287772|NCT00957528|948703|P2|Overall Study|Protocol Violation|1
287773|NCT00957528|948704|P1|Overall Study|Protocol Violation|0
287774|NCT00957424|948727|P1|Overall Study|Withdrawal by Subject|1
287775|NCT00957424|948727|P1|Overall Study|Protocol Violation|3
287776|NCT00957424|948727|P1|Overall Study|Lost to Follow-up|19
287777|NCT00957372|948737|P4|PART II|Patient non-compliance|4
287778|NCT00957372|948738|P3|PART II|Patient non-compliance|0
287779|NCT00957372|948739|P2|PART II|Patient non-compliance|0
287780|NCT00957372|948740|P1|PART II|Patient non-compliance|0
287781|NCT00957372|948737|P4|PART II|Adverse Event|10
287782|NCT00957372|948738|P3|PART II|Adverse Event|0
287783|NCT00957372|948739|P2|PART II|Adverse Event|0
287784|NCT00957372|948740|P1|PART II|Adverse Event|0
287785|NCT00957372|948737|P4|PART II|Not Know|20
287786|NCT00957372|948738|P3|PART II|Not Know|0
287787|NCT00957372|948739|P2|PART II|Not Know|0
287788|NCT00957372|948740|P1|PART II|Not Know|0
287789|NCT00957372|948737|P4|PART II|Pregnancy|1
287790|NCT00957372|948738|P3|PART II|Pregnancy|0
287791|NCT00957372|948739|P2|PART II|Pregnancy|0
287792|NCT00957372|948740|P1|PART II|Pregnancy|0
287793|NCT00957372|948737|P4|PART II|Physician Decision|1
287794|NCT00957372|948738|P3|PART II|Physician Decision|0
287795|NCT00957372|948739|P2|PART II|Physician Decision|0
287796|NCT00957372|948740|P1|PART II|Physician Decision|0
287797|NCT00957372|948737|P4|PART II|Withdrawal by Subject|8
287798|NCT00957372|948738|P3|PART II|Withdrawal by Subject|0
287799|NCT00957372|948739|P2|PART II|Withdrawal by Subject|0
287800|NCT00957372|948740|P1|PART II|Withdrawal by Subject|0
287801|NCT00957372|948737|P4|PART I|Lost to Follow-up|0
287802|NCT00957372|948738|P3|PART I|Lost to Follow-up|1
287803|NCT00957372|948739|P2|PART I|Lost to Follow-up|0
287804|NCT00957372|948740|P1|PART I|Lost to Follow-up|0
287805|NCT00957268|948765|P5|Overall Study|Voluntary Withdrawal|0
287806|NCT00957268|948766|P4|Overall Study|Voluntary Withdrawal|0
287807|NCT00957268|948767|P3|Overall Study|Voluntary Withdrawal|1
287808|NCT00957268|948768|P2|Overall Study|Voluntary Withdrawal|0
287809|NCT00957268|948769|P1|Overall Study|Voluntary Withdrawal|0
287810|NCT00957034|948891|P3|Overall Study|Withdrawal by Subject|0
287811|NCT00957034|948892|P2|Overall Study|Withdrawal by Subject|2
287812|NCT00957034|948893|P1|Overall Study|Withdrawal by Subject|0
287813|NCT00957034|948891|P3|Overall Study|Sponsor Terminated Study|5
287814|NCT00957034|948892|P2|Overall Study|Sponsor Terminated Study|1
287815|NCT00957034|948893|P1|Overall Study|Sponsor Terminated Study|6
287816|NCT00957034|948891|P3|Overall Study|Adverse Event|1
287817|NCT00957034|948892|P2|Overall Study|Adverse Event|1
287818|NCT00957034|948893|P1|Overall Study|Adverse Event|0
287819|NCT00957021|948916|P1|Overall Study|Termination due to language issue|2
287820|NCT00957021|948916|P1|Overall Study|Surgery Cancelled|9
287821|NCT00957021|948916|P1|Overall Study|Site Termination by the 2 yr visit|16
287822|NCT00957021|948916|P1|Overall Study|Revised study component by 2 yr visit|8
287823|NCT00957021|948916|P1|Overall Study|No 2 yr ROM data|35
287824|NCT00957021|948916|P1|Overall Study|Withdrawal by Subject|34
287825|NCT00957021|948916|P1|Overall Study|Lost to Follow-up|8
287826|NCT00957021|948916|P1|Overall Study|Death|5
287827|NCT00957008|948929|P4|Overall Study|Relocated; Family conflict|3
287828|NCT00957008|948930|P3|Overall Study|Relocated; Family conflict|1
287829|NCT00957008|948931|P2|Overall Study|Relocated; Family conflict|1
287830|NCT00957008|948932|P1|Overall Study|Relocated; Family conflict|4
287831|NCT00957008|948929|P4|Overall Study|Physician Decision|1
287832|NCT00957008|948930|P3|Overall Study|Physician Decision|1
287833|NCT00957008|948931|P2|Overall Study|Physician Decision|0
287834|NCT00957008|948932|P1|Overall Study|Physician Decision|1
287835|NCT00957008|948929|P4|Overall Study|Lost to Follow-up|4
287836|NCT00957008|948930|P3|Overall Study|Lost to Follow-up|3
287837|NCT00957008|948931|P2|Overall Study|Lost to Follow-up|1
287838|NCT00957008|948932|P1|Overall Study|Lost to Follow-up|3
287839|NCT00957008|948929|P4|Overall Study|Withdrawal by Subject|16
287840|NCT00957008|948930|P3|Overall Study|Withdrawal by Subject|12
287841|NCT00957008|948931|P2|Overall Study|Withdrawal by Subject|10
287842|NCT00957008|948932|P1|Overall Study|Withdrawal by Subject|13
287843|NCT00956943|948948|P2|Overall Study|Lost to Follow-up|10
287844|NCT00956943|948949|P1|Overall Study|Lost to Follow-up|9
287845|NCT00956839|948960|P3|Overall Study|Lost to Follow-up|3
287846|NCT00956839|948961|P2|Overall Study|Lost to Follow-up|0
287847|NCT00956839|948962|P1|Overall Study|Lost to Follow-up|3
287848|NCT00956813|948975|P2|Flaxseed and Placebo|Ineligible|1
287849|NCT00956813|948976|P1|Flaxseed and Placebo|Ineligible|3
287850|NCT00956813|948975|P2|Flaxseed and Placebo|Withdrawal by Subject|4
287851|NCT00956813|948976|P1|Flaxseed and Placebo|Withdrawal by Subject|5
287852|NCT00956592|949028|P2|Overall Study|Protocol Violation|3
287853|NCT00956592|949029|P1|Overall Study|Protocol Violation|1
287854|NCT00956293|949054|P3|Follow-up Period|Follow-up period was terminated.|0
287855|NCT00956293|949055|P2|Follow-up Period|Follow-up period was terminated.|32
287856|NCT00956293|949056|P1|Follow-up Period|Follow-up period was terminated.|20
287857|NCT00956293|949054|P3|Main Period (Randomization)|Adverse Event|0
287858|NCT00956293|949055|P2|Main Period (Randomization)|Adverse Event|15
287859|NCT00956293|949056|P1|Main Period (Randomization)|Adverse Event|0
287860|NCT00956293|949054|P3|Main Period (Randomization)|Lack of Efficacy|0
287861|NCT00956293|949055|P2|Main Period (Randomization)|Lack of Efficacy|10
287862|NCT00956293|949056|P1|Main Period (Randomization)|Lack of Efficacy|1
287863|NCT00956293|949054|P3|Main Period (Randomization)|Abnormal laboratory value|0
287864|NCT00956293|949055|P2|Main Period (Randomization)|Abnormal laboratory value|2
287865|NCT00956293|949056|P1|Main Period (Randomization)|Abnormal laboratory value|0
287866|NCT00956293|949054|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
287867|NCT00956293|949055|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
287868|NCT00956293|949056|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
287869|NCT00956293|949054|P3|Main Period (Pre-randomization)|Adverse Event|36
287870|NCT00956293|949055|P2|Main Period (Pre-randomization)|Adverse Event|0
287871|NCT00956293|949056|P1|Main Period (Pre-randomization)|Adverse Event|0
287872|NCT00956293|949054|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
287873|NCT00956293|949055|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
287874|NCT00956293|949056|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
287875|NCT00956293|949054|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
287876|NCT00956293|949055|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
287877|NCT00956293|949056|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
287878|NCT00956293|949054|P3|Main Period (Pre-randomization)|Graft loss|7
287879|NCT00956293|949055|P2|Main Period (Pre-randomization)|Graft loss|0
287880|NCT00956293|949056|P1|Main Period (Pre-randomization)|Graft loss|0
287881|NCT00956293|949054|P3|Main Period (Pre-randomization)|Administrative problems|6
287882|NCT00956293|949055|P2|Main Period (Pre-randomization)|Administrative problems|0
287883|NCT00956293|949056|P1|Main Period (Pre-randomization)|Administrative problems|0
287884|NCT00956293|949054|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
287885|NCT00956293|949055|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
287886|NCT00956293|949056|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
287887|NCT00956293|949054|P3|Main Period (Pre-randomization)|Protocol Violation|1
287888|NCT00956293|949055|P2|Main Period (Pre-randomization)|Protocol Violation|0
287889|NCT00956293|949056|P1|Main Period (Pre-randomization)|Protocol Violation|0
287890|NCT00956293|949054|P3|Main Period (Pre-randomization)|Death|1
287891|NCT00956293|949055|P2|Main Period (Pre-randomization)|Death|0
287892|NCT00956293|949056|P1|Main Period (Pre-randomization)|Death|0
287893|NCT00956293|949054|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
287894|NCT00956293|949055|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
287895|NCT00956293|949056|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
287896|NCT00955955|949112|P3|Overall Study|Lost to Follow-up|0
287897|NCT00955955|949113|P2|Overall Study|Lost to Follow-up|0
287898|NCT00955955|949114|P1|Overall Study|Lost to Follow-up|2
287899|NCT00955825|949136|P2|Overall Study|Any other reason not above-mentioned|9
287900|NCT00955825|949137|P1|Overall Study|Any other reason not above-mentioned|7
287901|NCT00955825|949136|P2|Overall Study|Withdrawal by Subject|6
287902|NCT00955825|949137|P1|Overall Study|Withdrawal by Subject|4
287903|NCT00955825|949136|P2|Overall Study|Adverse Event|2
287904|NCT00955825|949137|P1|Overall Study|Adverse Event|15
287905|NCT00955721|949154|P2|Overall Study|Withdrawal by Subject|0
287906|NCT00955721|949155|P1|Overall Study|Withdrawal by Subject|1
287907|NCT00955721|949154|P2|Overall Study|Death|0
287908|NCT00955721|949155|P1|Overall Study|Death|1
287909|NCT00955721|949154|P2|Overall Study|Physician Decision|0
287910|NCT00955721|949155|P1|Overall Study|Physician Decision|1
287911|NCT00955617|949163|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
287912|NCT00955617|949164|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
287913|NCT00955617|949163|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
287914|NCT00955617|949164|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
287915|NCT00955617|949163|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
287916|NCT00955617|949164|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
287917|NCT00955617|949163|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
287918|NCT00955617|949164|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
287919|NCT00955474|949228|P2|Overall Study|Physician Decision|5
287920|NCT00955474|949229|P1|Overall Study|Physician Decision|7
287921|NCT00955357|949265|P2|Maintenance Phase|Non compliance to study procedures|0
287922|NCT00955357|949266|P1|Maintenance Phase|Non compliance to study procedures|1
287923|NCT00955357|949265|P2|Maintenance Phase|Patient moving out of area|1
287924|NCT00955357|949266|P1|Maintenance Phase|Patient moving out of area|0
287925|NCT00955357|949265|P2|Maintenance Phase|Withdrawal by Subject|4
287926|NCT00955357|949266|P1|Maintenance Phase|Withdrawal by Subject|4
287927|NCT00955357|949265|P2|Maintenance Phase|Lost to Follow-up|7
287928|NCT00955357|949266|P1|Maintenance Phase|Lost to Follow-up|2
287929|NCT00955357|949265|P2|Maintenance Phase|Protocol Violation|6
287930|NCT00955357|949266|P1|Maintenance Phase|Protocol Violation|2
287931|NCT00955357|949265|P2|Maintenance Phase|Lack of Efficacy|4
287932|NCT00955357|949266|P1|Maintenance Phase|Lack of Efficacy|0
287933|NCT00955357|949265|P2|Maintenance Phase|Adverse Event|23
287934|NCT00955357|949266|P1|Maintenance Phase|Adverse Event|3
287935|NCT00955357|949265|P2|Titration Phase|Non compliance to study procedures|1
287936|NCT00955357|949266|P1|Titration Phase|Non compliance to study procedures|0
287937|NCT00955357|949265|P2|Titration Phase|Study medication not tolerated|1
287938|NCT00955357|949266|P1|Titration Phase|Study medication not tolerated|0
287939|NCT00955357|949265|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
287940|NCT00955357|949266|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
287941|NCT00955357|949265|P2|Titration Phase|Withdrawal by Subject|5
287942|NCT00955357|949266|P1|Titration Phase|Withdrawal by Subject|3
287943|NCT00955357|949265|P2|Titration Phase|Lost to Follow-up|3
287944|NCT00955357|949266|P1|Titration Phase|Lost to Follow-up|1
287945|NCT00955357|949265|P2|Titration Phase|Protocol Violation|7
287946|NCT00955357|949266|P1|Titration Phase|Protocol Violation|3
287947|NCT00955357|949265|P2|Titration Phase|Lack of Efficacy|2
287948|NCT00955357|949266|P1|Titration Phase|Lack of Efficacy|0
287949|NCT00955357|949265|P2|Titration Phase|Adverse Event|46
287950|NCT00955357|949266|P1|Titration Phase|Adverse Event|9
287951|NCT00955305|949274|P2|Overall Study|Ineligible|7
287952|NCT00955305|949275|P1|Overall Study|Ineligible|5
287953|NCT00955305|949274|P2|Overall Study|Never started protocol treatment|5
287954|NCT00955305|949275|P1|Overall Study|Never started protocol treatment|5
287955|NCT00955305|949274|P2|Overall Study|No off-treatment reason submitted|0
287956|NCT00955305|949275|P1|Overall Study|No off-treatment reason submitted|1
287957|NCT00955305|949274|P2|Overall Study|Lost to Follow-up|1
287958|NCT00955305|949275|P1|Overall Study|Lost to Follow-up|0
287959|NCT00955305|949274|P2|Overall Study|Maximum response achieved|1
287960|NCT00955305|949275|P1|Overall Study|Maximum response achieved|0
287961|NCT00955305|949274|P2|Overall Study|Functional decline|0
287962|NCT00955305|949275|P1|Overall Study|Functional decline|2
287963|NCT00955305|949274|P2|Overall Study|Continued presence of residual disease|1
287964|NCT00955305|949275|P1|Overall Study|Continued presence of residual disease|0
287965|NCT00955305|949274|P2|Overall Study|Physician Decision|0
287966|NCT00955305|949275|P1|Overall Study|Physician Decision|1
287967|NCT00955305|949274|P2|Overall Study|Other complicating disease|4
287968|NCT00955305|949275|P1|Overall Study|Other complicating disease|2
287969|NCT00955305|949274|P2|Overall Study|Alternative therapy|0
287970|NCT00955305|949275|P1|Overall Study|Alternative therapy|4
287971|NCT00955305|949274|P2|Overall Study|Withdrawal by Subject|4
287972|NCT00955305|949275|P1|Overall Study|Withdrawal by Subject|5
287973|NCT00955305|949274|P2|Overall Study|Death|1
287974|NCT00955305|949275|P1|Overall Study|Death|2
287975|NCT00955305|949274|P2|Overall Study|Adverse Event|22
287976|NCT00955305|949275|P1|Overall Study|Adverse Event|22
287977|NCT00955305|949274|P2|Overall Study|Disease progression|41
287978|NCT00955305|949275|P1|Overall Study|Disease progression|39
287979|NCT00955279|949288|P3|Overall Study|Withdrawal by Subject|3
287980|NCT00955279|949289|P2|Overall Study|Withdrawal by Subject|0
287981|NCT00955279|949290|P1|Overall Study|Withdrawal by Subject|2
287982|NCT00955279|949288|P3|Overall Study|Lost to Follow-up|1
287983|NCT00955279|949289|P2|Overall Study|Lost to Follow-up|3
287984|NCT00955279|949290|P1|Overall Study|Lost to Follow-up|0
287985|NCT00955279|949288|P3|Overall Study|Death|1
287986|NCT00955279|949289|P2|Overall Study|Death|1
287987|NCT00955279|949290|P1|Overall Study|Death|1
287988|NCT00955279|949288|P3|Overall Study|Unspecified|3
287989|NCT00955279|949289|P2|Overall Study|Unspecified|0
287990|NCT00955279|949290|P1|Overall Study|Unspecified|0
287991|NCT00955110|949327|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
287992|NCT00955110|949327|P1|Treatment Phase|Non-compliance with study restrictions|1
287993|NCT00955110|949327|P1|Treatment Phase|Administrative reasons|2
287994|NCT00955110|949327|P1|Treatment Phase|Adverse Event|2
287995|NCT00955110|949327|P1|Qualification Phase|Did not meet eligibility criteria|24
287996|NCT00954941|949374|P2|Overall Study|Adverse Event|1
287997|NCT00954941|949375|P1|Overall Study|Adverse Event|0
287998|NCT00954941|949374|P2|Overall Study|Ineligible|2
287999|NCT00954941|949375|P1|Overall Study|Ineligible|2
288000|NCT00954941|949374|P2|Overall Study|Physician Decision|2
288001|NCT00954941|949375|P1|Overall Study|Physician Decision|2
288002|NCT00954941|949374|P2|Overall Study|Insurance Denial|2
288003|NCT00954941|949375|P1|Overall Study|Insurance Denial|2
288004|NCT00954941|949374|P2|Overall Study|Withdrawal by Subject|0
288005|NCT00954941|949375|P1|Overall Study|Withdrawal by Subject|1
288006|NCT00954941|949374|P2|Overall Study|Received treatment at home|0
288007|NCT00954941|949375|P1|Overall Study|Received treatment at home|1
288008|NCT00954733|949391|P1|Overall Study|blood gas machine did not work|1
288009|NCT00954707|949395|P1|Overall Study|Lost to Follow-up|33
288010|NCT00954707|949395|P1|Overall Study|Withdrawal by Subject|100
288011|NCT00954707|949395|P1|Overall Study|Death|34
288012|NCT00954538|949413|P6|Part III|Withdrawal by Subject|0
288013|NCT00954538|949414|P5|Part III|Withdrawal by Subject|1
288014|NCT00954538|949415|P4|Part III|Withdrawal by Subject|0
288015|NCT00954538|949416|P3|Part III|Withdrawal by Subject|0
288016|NCT00954538|949417|P2|Part III|Withdrawal by Subject|0
288017|NCT00954538|949418|P1|Part III|Withdrawal by Subject|0
288018|NCT00954512|949435|P6|Overall Study|Progression of Disease|1
288019|NCT00954512|949436|P5|Overall Study|Progression of Disease|1
288020|NCT00954512|949437|P4|Overall Study|Progression of Disease|1
288021|NCT00954512|949438|P3|Overall Study|Progression of Disease|0
288022|NCT00954512|949439|P2|Overall Study|Progression of Disease|1
288023|NCT00954512|949440|P1|Overall Study|Progression of Disease|2
288024|NCT00954512|949435|P6|Overall Study|Symptomatic Deterioration|0
288025|NCT00954512|949436|P5|Overall Study|Symptomatic Deterioration|2
288026|NCT00954512|949437|P4|Overall Study|Symptomatic Deterioration|0
288027|NCT00954512|949438|P3|Overall Study|Symptomatic Deterioration|0
288028|NCT00954512|949439|P2|Overall Study|Symptomatic Deterioration|1
288029|NCT00954512|949440|P1|Overall Study|Symptomatic Deterioration|0
288030|NCT00954512|949435|P6|Overall Study|Physician Decision|0
288031|NCT00954512|949436|P5|Overall Study|Physician Decision|0
288032|NCT00954512|949437|P4|Overall Study|Physician Decision|1
288033|NCT00954512|949438|P3|Overall Study|Physician Decision|0
288034|NCT00954512|949439|P2|Overall Study|Physician Decision|1
288035|NCT00954512|949440|P1|Overall Study|Physician Decision|0
288036|NCT00954512|949435|P6|Overall Study|Adverse Event|2
288037|NCT00954512|949436|P5|Overall Study|Adverse Event|1
288038|NCT00954512|949437|P4|Overall Study|Adverse Event|0
288039|NCT00954512|949438|P3|Overall Study|Adverse Event|0
288040|NCT00954512|949439|P2|Overall Study|Adverse Event|0
288041|NCT00954512|949440|P1|Overall Study|Adverse Event|0
288042|NCT00954512|949435|P6|Overall Study|Withdrawal by Subject|1
288043|NCT00954512|949436|P5|Overall Study|Withdrawal by Subject|0
288044|NCT00954512|949437|P4|Overall Study|Withdrawal by Subject|0
288045|NCT00954512|949438|P3|Overall Study|Withdrawal by Subject|0
288046|NCT00954512|949439|P2|Overall Study|Withdrawal by Subject|0
288047|NCT00954512|949440|P1|Overall Study|Withdrawal by Subject|0
288048|NCT00954447|949461|P2|Overall Study|Other|18
288049|NCT00954447|949462|P1|Overall Study|Other|21
288050|NCT00954447|949461|P2|Overall Study|Withdrawal by Subject|21
288051|NCT00954447|949462|P1|Overall Study|Withdrawal by Subject|26
288052|NCT00954447|949461|P2|Overall Study|Lost to Follow-up|14
288053|NCT00954447|949462|P1|Overall Study|Lost to Follow-up|8
288054|NCT00954447|949461|P2|Overall Study|Protocol Violation|7
288055|NCT00954447|949462|P1|Overall Study|Protocol Violation|5
288056|NCT00954447|949461|P2|Overall Study|Lack of Efficacy|3
288057|NCT00954447|949462|P1|Overall Study|Lack of Efficacy|17
288058|NCT00954447|949461|P2|Overall Study|Adverse Event|25
288059|NCT00954447|949462|P1|Overall Study|Adverse Event|33
288060|NCT00954421|949498|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
288061|NCT00954421|949498|P1|6 Months of DBS|Withdrawal by Subject|1
288062|NCT00954421|949498|P1|Screening|screen failures|3
288063|NCT00954122|949544|P1|Overall Study|Safety Reason|1
288064|NCT00954122|949544|P1|Overall Study|Adverse Event|1
288065|NCT00954122|949544|P1|Overall Study|Withdrawal by Subject|5
288066|NCT00953927|949561|P2|Overall Study|Other study discontinuation|1
288067|NCT00953927|949562|P1|Overall Study|Other study discontinuation|1
288068|NCT00953927|949561|P2|Overall Study|Death|4
288069|NCT00953927|949562|P1|Overall Study|Death|7
288070|NCT00953927|949561|P2|Overall Study|Withdrawal by Subject|25
288071|NCT00953927|949562|P1|Overall Study|Withdrawal by Subject|36
288072|NCT00953927|949561|P2|Overall Study|Lost to Follow-up|65
288073|NCT00953927|949562|P1|Overall Study|Lost to Follow-up|61
288074|NCT00953706|949640|P4|Part B (96-Week Open-Label Extension)|Unspecified|2
288075|NCT00953706|949641|P3|Part B (96-Week Open-Label Extension)|Unspecified|0
288076|NCT00953706|949642|P2|Part B (96-Week Open-Label Extension)|Unspecified|0
288077|NCT00953706|949643|P1|Part B (96-Week Open-Label Extension)|Unspecified|0
288078|NCT00953706|949640|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
288079|NCT00953706|949641|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
288080|NCT00953706|949642|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
288081|NCT00953706|949643|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
288082|NCT00953706|949640|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
288083|NCT00953706|949641|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
288084|NCT00953706|949642|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
288085|NCT00953706|949643|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
288086|NCT00953706|949640|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
288087|NCT00953706|949641|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
288088|NCT00953706|949642|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
288089|NCT00953706|949643|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
288090|NCT00953706|949640|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
288091|NCT00953706|949641|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
288092|NCT00953706|949642|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
288093|NCT00953706|949643|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
288094|NCT00953706|949640|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
288095|NCT00953706|949641|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
288096|NCT00953706|949642|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
288097|NCT00953706|949643|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
288098|NCT00953706|949640|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
288099|NCT00953706|949641|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
288100|NCT00953706|949642|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
288101|NCT00953706|949643|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
288102|NCT00953706|949640|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
288103|NCT00953706|949641|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
288104|NCT00953706|949642|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
288105|NCT00953706|949643|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
288106|NCT00953706|949640|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
288107|NCT00953706|949641|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
288108|NCT00953706|949642|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
288109|NCT00953706|949643|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
288110|NCT00953706|949640|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
288111|NCT00953706|949641|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
288112|NCT00953706|949642|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
288113|NCT00953706|949643|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
288114|NCT00953706|949640|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
288115|NCT00953706|949641|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
288116|NCT00953706|949642|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
288117|NCT00953706|949643|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
288118|NCT00953680|949675|P2|Period 1|Withdrawal by Subject|1
288119|NCT00953680|949676|P1|Period 1|Withdrawal by Subject|0
288120|NCT00953667|949688|P1|Overall Study|poor venous access,unable to draw blood|4
288121|NCT00953667|949688|P1|Overall Study|Adverse Event|10
288122|NCT00953667|949688|P1|Overall Study|Withdrawal by Subject|63
288123|NCT00953667|949688|P1|Overall Study|Physician Decision|35
288124|NCT00953667|949688|P1|Overall Study|Lost to Follow-up|11
288125|NCT00953615|949709|P1|Overall Study|Adverse Event|1
288126|NCT00953524|949720|P4|Overall Study|Withdrawal by Subject|0
288127|NCT00953524|949721|P3|Overall Study|Withdrawal by Subject|1
288128|NCT00953524|949722|P2|Overall Study|Withdrawal by Subject|4
288129|NCT00953524|949723|P1|Overall Study|Withdrawal by Subject|2
288130|NCT00953524|949720|P4|Overall Study|Lost to Follow-up|0
288131|NCT00953524|949721|P3|Overall Study|Lost to Follow-up|1
288132|NCT00953524|949722|P2|Overall Study|Lost to Follow-up|1
288133|NCT00953524|949723|P1|Overall Study|Lost to Follow-up|0
288134|NCT00953524|949720|P4|Overall Study|Protocol Violation|6
288135|NCT00953524|949721|P3|Overall Study|Protocol Violation|11
288136|NCT00953524|949722|P2|Overall Study|Protocol Violation|10
288137|NCT00953524|949723|P1|Overall Study|Protocol Violation|18
288138|NCT00953524|949720|P4|Overall Study|Adverse Event|2
288139|NCT00953524|949721|P3|Overall Study|Adverse Event|1
288140|NCT00953524|949722|P2|Overall Study|Adverse Event|0
288141|NCT00953524|949723|P1|Overall Study|Adverse Event|2
288142|NCT00953407|949766|P5|Overall Study|Lost to Follow-up|0
288143|NCT00953407|949767|P4|Overall Study|Lost to Follow-up|1
288144|NCT00953407|949768|P3|Overall Study|Lost to Follow-up|0
288145|NCT00953407|949769|P2|Overall Study|Lost to Follow-up|0
288146|NCT00953407|949770|P1|Overall Study|Lost to Follow-up|0
288147|NCT00953407|949766|P5|Overall Study|Failed inclusion criteria|1
288148|NCT00953407|949767|P4|Overall Study|Failed inclusion criteria|1
288149|NCT00953407|949768|P3|Overall Study|Failed inclusion criteria|1
288150|NCT00953407|949769|P2|Overall Study|Failed inclusion criteria|1
288151|NCT00953407|949770|P1|Overall Study|Failed inclusion criteria|1
288152|NCT00953329|949782|P1|Overall Study|Lack of Efficacy|1
288153|NCT00953225|949795|P2|Overall Study|Withdrawal by Subject|0
288154|NCT00953225|949796|P1|Overall Study|Withdrawal by Subject|2
288155|NCT00953160|949804|P1|Overall Study|Withdrawal by Subject|4
288156|NCT00953160|949804|P1|Overall Study|Lost to Follow-up|23
288157|NCT00953147|949813|P3|Overall Study|Other|13
288158|NCT00953147|949814|P2|Overall Study|Other|11
288159|NCT00953147|949815|P1|Overall Study|Other|4
288160|NCT00953147|949813|P3|Overall Study|Physician Decision|3
288161|NCT00953147|949814|P2|Overall Study|Physician Decision|7
288162|NCT00953147|949815|P1|Overall Study|Physician Decision|2
288163|NCT00953147|949813|P3|Overall Study|Lost to Follow-up|4
288164|NCT00953147|949814|P2|Overall Study|Lost to Follow-up|9
288165|NCT00953147|949815|P1|Overall Study|Lost to Follow-up|8
288166|NCT00953147|949813|P3|Overall Study|Withdrawal by Subject|12
288167|NCT00953147|949814|P2|Overall Study|Withdrawal by Subject|15
288168|NCT00953147|949815|P1|Overall Study|Withdrawal by Subject|13
288169|NCT00953147|949813|P3|Overall Study|Protocol Violation|4
288170|NCT00953147|949814|P2|Overall Study|Protocol Violation|8
288171|NCT00953147|949815|P1|Overall Study|Protocol Violation|2
288172|NCT00953147|949813|P3|Overall Study|Adverse Event|6
288173|NCT00953147|949814|P2|Overall Study|Adverse Event|16
288174|NCT00953147|949815|P1|Overall Study|Adverse Event|8
288175|NCT00953056|949893|P6|Overall Study|Serious Adverse Event|1
288176|NCT00953056|949894|P5|Overall Study|Serious Adverse Event|0
288177|NCT00953056|949895|P4|Overall Study|Serious Adverse Event|0
288178|NCT00953056|949896|P3|Overall Study|Serious Adverse Event|0
288179|NCT00953056|949897|P2|Overall Study|Serious Adverse Event|0
288180|NCT00953056|949898|P1|Overall Study|Serious Adverse Event|0
288181|NCT00953056|949893|P6|Overall Study|Withdrew Consent|3
288182|NCT00953056|949894|P5|Overall Study|Withdrew Consent|2
288183|NCT00953056|949895|P4|Overall Study|Withdrew Consent|0
288184|NCT00953056|949896|P3|Overall Study|Withdrew Consent|0
288185|NCT00953056|949897|P2|Overall Study|Withdrew Consent|0
288186|NCT00953056|949898|P1|Overall Study|Withdrew Consent|0
288187|NCT00953043|949922|P2|Overall Study|Physician Decision|2
288188|NCT00953043|949923|P1|Overall Study|Physician Decision|0
288189|NCT00953043|949922|P2|Overall Study|Withdrawal by Subject|0
288190|NCT00953043|949923|P1|Overall Study|Withdrawal by Subject|4
288191|NCT00953017|949947|P4|Overall Study|Brown stool prior to procedure|0
288192|NCT00953017|949948|P3|Overall Study|Brown stool prior to procedure|1
288193|NCT00953017|949949|P2|Overall Study|Brown stool prior to procedure|0
288194|NCT00953017|949950|P1|Overall Study|Brown stool prior to procedure|0
288195|NCT00953017|949947|P4|Overall Study|Procedure incomplete due to pain/looping|1
288196|NCT00953017|949948|P3|Overall Study|Procedure incomplete due to pain/looping|0
288197|NCT00953017|949949|P2|Overall Study|Procedure incomplete due to pain/looping|1
288198|NCT00953017|949950|P1|Overall Study|Procedure incomplete due to pain/looping|0
288199|NCT00953017|949947|P4|Overall Study|Incomplete data|0
288200|NCT00953017|949948|P3|Overall Study|Incomplete data|0
288201|NCT00953017|949949|P2|Overall Study|Incomplete data|1
288202|NCT00953017|949950|P1|Overall Study|Incomplete data|1
288203|NCT00953017|949947|P4|Overall Study|DId not show up for colonoscopy|4
288204|NCT00953017|949948|P3|Overall Study|DId not show up for colonoscopy|5
288205|NCT00953017|949949|P2|Overall Study|DId not show up for colonoscopy|4
288206|NCT00953017|949950|P1|Overall Study|DId not show up for colonoscopy|4
288207|NCT00952848|949972|P1|Overall Study|Withdrawal by Subject|4
288208|NCT00952822|949979|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
288209|NCT00952822|949980|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
288210|NCT00952822|949981|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
288211|NCT00952822|949982|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
288212|NCT00952822|949979|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
288213|NCT00952822|949980|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
288214|NCT00952822|949981|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
288215|NCT00952822|949982|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
288216|NCT00952731|950014|P2|Overall Study|Drug supply expired|0
288217|NCT00952731|950015|P1|Overall Study|Drug supply expired|1
288218|NCT00952705|950034|P3|Overall Study|Exclusion criteria not met pre dose|0
288219|NCT00952705|950035|P2|Overall Study|Exclusion criteria not met pre dose|1
288220|NCT00952705|950036|P1|Overall Study|Exclusion criteria not met pre dose|0
288221|NCT00952705|950034|P3|Overall Study|Incarcerated post dose|0
288222|NCT00952705|950035|P2|Overall Study|Incarcerated post dose|0
288223|NCT00952705|950036|P1|Overall Study|Incarcerated post dose|5
288224|NCT00952705|950034|P3|Overall Study|Death|0
288225|NCT00952705|950035|P2|Overall Study|Death|0
288226|NCT00952705|950036|P1|Overall Study|Death|2
288227|NCT00952705|950034|P3|Overall Study|Withdrawal by Subject|1
288228|NCT00952705|950035|P2|Overall Study|Withdrawal by Subject|1
288229|NCT00952705|950036|P1|Overall Study|Withdrawal by Subject|2
288230|NCT00952705|950034|P3|Overall Study|Lost to Follow-up|9
288231|NCT00952705|950035|P2|Overall Study|Lost to Follow-up|8
288232|NCT00952705|950036|P1|Overall Study|Lost to Follow-up|24
288233|NCT00952614|950123|P1|Overall Study|other reason|1
288234|NCT00952614|950123|P1|Overall Study|Lost to Follow-up|3
288235|NCT00952614|950123|P1|Overall Study|Death|3
288236|NCT00952588|950130|P2|Overall Study|Lack of Efficacy|2
288237|NCT00952588|950131|P1|Overall Study|Lack of Efficacy|2
288238|NCT00952588|950130|P2|Overall Study|Physician Decision|1
288239|NCT00952588|950131|P1|Overall Study|Physician Decision|0
288240|NCT00952588|950130|P2|Overall Study|Lost to Follow-up|0
288241|NCT00952588|950131|P1|Overall Study|Lost to Follow-up|2
288242|NCT00952588|950130|P2|Overall Study|Adverse Event|3
288243|NCT00952588|950131|P1|Overall Study|Adverse Event|2
288244|NCT00952588|950130|P2|Overall Study|Withdrawal by Subject|5
288245|NCT00952588|950131|P1|Overall Study|Withdrawal by Subject|2
288246|NCT00952588|950130|P2|Overall Study|Death|13
288247|NCT00952588|950131|P1|Overall Study|Death|28
288248|NCT00952523|950149|P1|Overall Study|Withdrawal by Subject|7
288249|NCT00952484|950158|P3|Overall Study|Withdrawal by Subject|0
288250|NCT00952484|950159|P2|Overall Study|Withdrawal by Subject|1
288251|NCT00952484|950160|P1|Overall Study|Withdrawal by Subject|0
288252|NCT00952419|950187|P3|Overall Study|Withdrawal by Subject|0
288253|NCT00952419|950188|P2|Overall Study|Withdrawal by Subject|3
288254|NCT00952419|950189|P1|Overall Study|Withdrawal by Subject|1
288255|NCT00952419|950187|P3|Overall Study|Protocol Violation|0
288256|NCT00952419|950188|P2|Overall Study|Protocol Violation|7
288257|NCT00952419|950189|P1|Overall Study|Protocol Violation|3
288258|NCT00952419|950187|P3|Overall Study|Adverse Event|0
288259|NCT00952419|950188|P2|Overall Study|Adverse Event|0
288260|NCT00952419|950189|P1|Overall Study|Adverse Event|2
288261|NCT00952367|950225|P1|Overall Study|Protocol Violation|3
288262|NCT00952367|950225|P1|Overall Study|Noncoordination|1
288263|NCT00952367|950225|P1|Overall Study|Withdrawal by Subject|2
288264|NCT00952341|950240|P2|Cycle 2|Progressive Disease|1
288265|NCT00952341|950241|P1|Cycle 2|Progressive Disease|0
288266|NCT00952341|950240|P2|Cycle 2|Physician Decision|1
288267|NCT00952341|950241|P1|Cycle 2|Physician Decision|1
288268|NCT00952341|950240|P2|Cycle 2|Lost to Follow-up|9
288269|NCT00952341|950241|P1|Cycle 2|Lost to Follow-up|6
288270|NCT00952341|950240|P2|Cycle 2|Protocol Violation|0
288271|NCT00952341|950241|P1|Cycle 2|Protocol Violation|1
288272|NCT00952341|950240|P2|Cycle 2|Withdrawal by Subject|1
288273|NCT00952341|950241|P1|Cycle 2|Withdrawal by Subject|1
288274|NCT00952341|950240|P2|Cycle 1|Physician Decision|1
288275|NCT00952341|950241|P1|Cycle 1|Physician Decision|0
288276|NCT00952341|950240|P2|Cycle 1|Lost to Follow-up|2
288277|NCT00952341|950241|P1|Cycle 1|Lost to Follow-up|11
288278|NCT00952341|950240|P2|Cycle 1|Protocol Violation|1
288279|NCT00952341|950241|P1|Cycle 1|Protocol Violation|2
288280|NCT00952341|950240|P2|Cycle 1|Withdrawal by Subject|8
288281|NCT00952341|950241|P1|Cycle 1|Withdrawal by Subject|3
288282|NCT00952341|950240|P2|Cycle 1|Adverse Event|1
288283|NCT00952341|950241|P1|Cycle 1|Adverse Event|4
288284|NCT00952289|950263|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
288285|NCT00952289|950264|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
288286|NCT00952289|950263|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
288377|NCT00951665|950496|P6|Phase 1b|Disease Progression|0
288287|NCT00952289|950264|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
288288|NCT00952289|950263|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
288289|NCT00952289|950264|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
288290|NCT00952289|950263|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
288291|NCT00952289|950264|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
288292|NCT00952289|950263|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
288293|NCT00952289|950264|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
288294|NCT00952289|950263|P2|All Participants|Data lost during site relocation|1
288295|NCT00952289|950264|P1|All Participants|Data lost during site relocation|0
288296|NCT00952289|950263|P2|All Participants|Withdrawal by Subject|10
288297|NCT00952289|950264|P1|All Participants|Withdrawal by Subject|1
288298|NCT00952289|950263|P2|All Participants|Disease progression|12
288299|NCT00952289|950264|P1|All Participants|Disease progression|3
288300|NCT00952289|950263|P2|All Participants|Adverse Event|8
288301|NCT00952289|950264|P1|All Participants|Adverse Event|8
288302|NCT00952289|950263|P2|All Participants|Death|9
288303|NCT00952289|950264|P1|All Participants|Death|9
288304|NCT00952276|950293|P5|Overall Study|Withdrawal by Subject|0
288305|NCT00952276|950294|P4|Overall Study|Withdrawal by Subject|1
288306|NCT00952276|950295|P3|Overall Study|Withdrawal by Subject|0
288307|NCT00952276|950296|P2|Overall Study|Withdrawal by Subject|0
288308|NCT00952276|950297|P1|Overall Study|Withdrawal by Subject|1
288309|NCT00952068|950383|P1|Overall Study|Withdrawal by Subject|4
288310|NCT00952068|950383|P1|Overall Study|Adverse Event|3
288311|NCT00951912|950394|P3|Overall Study|Other: Stroke|0
288312|NCT00951912|950395|P2|Overall Study|Other: Stroke|1
288313|NCT00951912|950396|P1|Overall Study|Other: Stroke|0
288314|NCT00951912|950394|P3|Overall Study|Other: Colon cancer|0
288315|NCT00951912|950395|P2|Overall Study|Other: Colon cancer|0
288316|NCT00951912|950396|P1|Overall Study|Other: Colon cancer|1
288317|NCT00951912|950394|P3|Overall Study|Other:Depression|0
288318|NCT00951912|950395|P2|Overall Study|Other:Depression|0
288319|NCT00951912|950396|P1|Overall Study|Other:Depression|1
288320|NCT00951912|950394|P3|Overall Study|Withdrawal by Subject|0
288321|NCT00951912|950395|P2|Overall Study|Withdrawal by Subject|1
288322|NCT00951912|950396|P1|Overall Study|Withdrawal by Subject|1
288323|NCT00951912|950394|P3|Overall Study|Physician Decision|1
288324|NCT00951912|950395|P2|Overall Study|Physician Decision|0
288325|NCT00951912|950396|P1|Overall Study|Physician Decision|1
288326|NCT00951912|950394|P3|Overall Study|Lost to Follow-up|0
288327|NCT00951912|950395|P2|Overall Study|Lost to Follow-up|2
288328|NCT00951912|950396|P1|Overall Study|Lost to Follow-up|2
288329|NCT00951912|950394|P3|Overall Study|Adverse Event|1
288330|NCT00951912|950395|P2|Overall Study|Adverse Event|1
288331|NCT00951912|950396|P1|Overall Study|Adverse Event|0
288332|NCT00951912|950394|P3|Overall Study|Lack of Efficacy|0
288333|NCT00951912|950395|P2|Overall Study|Lack of Efficacy|0
288334|NCT00951912|950396|P1|Overall Study|Lack of Efficacy|1
288335|NCT00951665|950496|P6|Phase 2a|Disease Progression|5
288336|NCT00951665|950497|P5|Phase 2a|Disease Progression|6
288337|NCT00951665|950498|P4|Phase 2a|Disease Progression|0
288338|NCT00951665|950499|P3|Phase 2a|Disease Progression|0
288339|NCT00951665|950500|P2|Phase 2a|Disease Progression|0
288340|NCT00951665|950501|P1|Phase 2a|Disease Progression|0
288341|NCT00951665|950496|P6|Phase 2a|Withdrawal by Subject|0
288342|NCT00951665|950497|P5|Phase 2a|Withdrawal by Subject|2
288343|NCT00951665|950498|P4|Phase 2a|Withdrawal by Subject|0
288344|NCT00951665|950499|P3|Phase 2a|Withdrawal by Subject|0
288345|NCT00951665|950500|P2|Phase 2a|Withdrawal by Subject|0
288346|NCT00951665|950501|P1|Phase 2a|Withdrawal by Subject|0
288347|NCT00951665|950496|P6|Phase 2a|Physician Decision|1
288348|NCT00951665|950497|P5|Phase 2a|Physician Decision|0
288349|NCT00951665|950498|P4|Phase 2a|Physician Decision|0
288350|NCT00951665|950499|P3|Phase 2a|Physician Decision|0
288351|NCT00951665|950500|P2|Phase 2a|Physician Decision|0
288352|NCT00951665|950501|P1|Phase 2a|Physician Decision|0
288353|NCT00951665|950496|P6|Phase 2a|Lost to Follow-up|0
288354|NCT00951665|950497|P5|Phase 2a|Lost to Follow-up|1
288355|NCT00951665|950498|P4|Phase 2a|Lost to Follow-up|0
288356|NCT00951665|950499|P3|Phase 2a|Lost to Follow-up|0
288357|NCT00951665|950500|P2|Phase 2a|Lost to Follow-up|0
288358|NCT00951665|950501|P1|Phase 2a|Lost to Follow-up|0
288359|NCT00951665|950496|P6|Phase 2a|Death|1
288360|NCT00951665|950497|P5|Phase 2a|Death|1
288361|NCT00951665|950498|P4|Phase 2a|Death|0
288362|NCT00951665|950499|P3|Phase 2a|Death|0
288363|NCT00951665|950500|P2|Phase 2a|Death|0
288364|NCT00951665|950501|P1|Phase 2a|Death|0
288365|NCT00951665|950496|P6|Phase 2a|Adverse Event|0
288366|NCT00951665|950497|P5|Phase 2a|Adverse Event|2
288367|NCT00951665|950498|P4|Phase 2a|Adverse Event|0
288368|NCT00951665|950499|P3|Phase 2a|Adverse Event|0
288369|NCT00951665|950500|P2|Phase 2a|Adverse Event|0
288370|NCT00951665|950501|P1|Phase 2a|Adverse Event|0
288371|NCT00951665|950496|P6|Phase 1b|Protocol Violation|0
288372|NCT00951665|950497|P5|Phase 1b|Protocol Violation|0
288373|NCT00951665|950498|P4|Phase 1b|Protocol Violation|0
288374|NCT00951665|950499|P3|Phase 1b|Protocol Violation|0
288375|NCT00951665|950500|P2|Phase 1b|Protocol Violation|0
288376|NCT00951665|950501|P1|Phase 1b|Protocol Violation|2
288378|NCT00951665|950497|P5|Phase 1b|Disease Progression|0
288379|NCT00951665|950498|P4|Phase 1b|Disease Progression|0
288380|NCT00951665|950499|P3|Phase 1b|Disease Progression|14
288381|NCT00951665|950500|P2|Phase 1b|Disease Progression|2
288382|NCT00951665|950501|P1|Phase 1b|Disease Progression|13
288383|NCT00951665|950496|P6|Phase 1b|Withdrawal by Subject|0
288384|NCT00951665|950497|P5|Phase 1b|Withdrawal by Subject|0
288385|NCT00951665|950498|P4|Phase 1b|Withdrawal by Subject|0
288386|NCT00951665|950499|P3|Phase 1b|Withdrawal by Subject|0
288387|NCT00951665|950500|P2|Phase 1b|Withdrawal by Subject|1
288388|NCT00951665|950501|P1|Phase 1b|Withdrawal by Subject|0
288389|NCT00951665|950496|P6|Phase 1b|Physician Decision|0
288390|NCT00951665|950497|P5|Phase 1b|Physician Decision|0
288391|NCT00951665|950498|P4|Phase 1b|Physician Decision|0
288392|NCT00951665|950499|P3|Phase 1b|Physician Decision|1
288393|NCT00951665|950500|P2|Phase 1b|Physician Decision|0
288394|NCT00951665|950501|P1|Phase 1b|Physician Decision|4
288395|NCT00951665|950496|P6|Phase 1b|Death|0
288396|NCT00951665|950497|P5|Phase 1b|Death|0
288397|NCT00951665|950498|P4|Phase 1b|Death|0
288398|NCT00951665|950499|P3|Phase 1b|Death|2
288399|NCT00951665|950500|P2|Phase 1b|Death|0
288400|NCT00951665|950501|P1|Phase 1b|Death|1
288401|NCT00951665|950496|P6|Phase 1b|Adverse Event|0
288402|NCT00951665|950497|P5|Phase 1b|Adverse Event|0
288403|NCT00951665|950498|P4|Phase 1b|Adverse Event|1
288404|NCT00951665|950499|P3|Phase 1b|Adverse Event|0
288405|NCT00951665|950500|P2|Phase 1b|Adverse Event|1
288406|NCT00951665|950501|P1|Phase 1b|Adverse Event|2
288407|NCT00951509|950610|P1|Overall Study|Withdrawal by Subject|2
288408|NCT00951483|950620|P2|Overall Study|Withdrawal by Subject|0
288409|NCT00951483|950621|P1|Overall Study|Withdrawal by Subject|15
288410|NCT00951483|950620|P2|Overall Study|Physician Decision|0
288411|NCT00951483|950621|P1|Overall Study|Physician Decision|4
288412|NCT00951379|950641|P2|Overall Study|Disease Progression|1
288413|NCT00951379|950642|P1|Overall Study|Disease Progression|0
288414|NCT00951379|950641|P2|Overall Study|Noncompliance|0
288415|NCT00951379|950642|P1|Overall Study|Noncompliance|1
288416|NCT00951379|950641|P2|Overall Study|Withdrawal by Subject|0
288417|NCT00951379|950642|P1|Overall Study|Withdrawal by Subject|1
288418|NCT00951379|950641|P2|Overall Study|Adverse Event|1
288419|NCT00951379|950642|P1|Overall Study|Adverse Event|4
288420|NCT00951275|950684|P1|Overall Study|Protocol Violation|1
288421|NCT00951275|950684|P1|Overall Study|Withdrawal by Subject|4
288422|NCT00951275|950684|P1|Overall Study|Adverse Event|7
288423|NCT00951275|950684|P1|Overall Study|Administrative Reason|1
288424|NCT00951171|950716|P2|Overall Study|Adverse Event|0
288425|NCT00951171|950717|P1|Overall Study|Adverse Event|2
288426|NCT00951015|950751|P4|Overall Study|Ongoing|8
288427|NCT00951015|950752|P3|Overall Study|Ongoing|46
288428|NCT00951015|950753|P2|Overall Study|Ongoing|45
288429|NCT00951015|950754|P1|Overall Study|Ongoing|47
288430|NCT00951015|950751|P4|Overall Study|Withdrawal by Subject|2
288431|NCT00951015|950752|P3|Overall Study|Withdrawal by Subject|1
288432|NCT00951015|950753|P2|Overall Study|Withdrawal by Subject|1
288433|NCT00951015|950754|P1|Overall Study|Withdrawal by Subject|3
288434|NCT00951015|950751|P4|Overall Study|Lost to Follow-up|2
288435|NCT00951015|950752|P3|Overall Study|Lost to Follow-up|1
288436|NCT00951015|950753|P2|Overall Study|Lost to Follow-up|2
288437|NCT00951015|950754|P1|Overall Study|Lost to Follow-up|0
288438|NCT00951015|950751|P4|Overall Study|Protocol-Defined Stopping Criteria|1
288439|NCT00951015|950752|P3|Overall Study|Protocol-Defined Stopping Criteria|0
288440|NCT00951015|950753|P2|Overall Study|Protocol-Defined Stopping Criteria|0
288441|NCT00951015|950754|P1|Overall Study|Protocol-Defined Stopping Criteria|0
288442|NCT00951015|950751|P4|Overall Study|Protocol Violation|0
288443|NCT00951015|950752|P3|Overall Study|Protocol Violation|1
288444|NCT00951015|950753|P2|Overall Study|Protocol Violation|1
288445|NCT00951015|950754|P1|Overall Study|Protocol Violation|1
288446|NCT00951015|950751|P4|Overall Study|Lack of Efficacy|0
288447|NCT00951015|950752|P3|Overall Study|Lack of Efficacy|0
288448|NCT00951015|950753|P2|Overall Study|Lack of Efficacy|1
288449|NCT00951015|950754|P1|Overall Study|Lack of Efficacy|1
288450|NCT00951015|950751|P4|Overall Study|Adverse Event|5
288451|NCT00951015|950752|P3|Overall Study|Adverse Event|2
288452|NCT00951015|950753|P2|Overall Study|Adverse Event|1
288453|NCT00951015|950754|P1|Overall Study|Adverse Event|1
288454|NCT00950963|950850|P2|Overall Study|Lost to Follow-up|24
288455|NCT00950963|950851|P1|Overall Study|Lost to Follow-up|29
288456|NCT00950911|950886|P2|Overall Study|Poor performance status|1
288457|NCT00950911|950887|P1|Overall Study|Poor performance status|0
288458|NCT00950911|950886|P2|Overall Study|Noncompliance|0
288459|NCT00950911|950887|P1|Overall Study|Noncompliance|1
288460|NCT00950911|950886|P2|Overall Study|Ineligibility determined|0
288461|NCT00950911|950887|P1|Overall Study|Ineligibility determined|1
288462|NCT00950911|950886|P2|Overall Study|Administrative decision|1
288463|NCT00950911|950887|P1|Overall Study|Administrative decision|3
288464|NCT00950911|950886|P2|Overall Study|Consent withdrawn|3
288465|NCT00950911|950887|P1|Overall Study|Consent withdrawn|1
288466|NCT00950911|950886|P2|Overall Study|Disease progression|2
288467|NCT00950911|950887|P1|Overall Study|Disease progression|2
288468|NCT00950911|950886|P2|Overall Study|Death|6
288469|NCT00950911|950887|P1|Overall Study|Death|4
288470|NCT00950911|950886|P2|Overall Study|Adverse Event|2
288471|NCT00950911|950887|P1|Overall Study|Adverse Event|0
288472|NCT00950872|950893|P1|Overall Study|Did not have surgery|2
288473|NCT00950872|950893|P1|Overall Study|Withdrawal by Subject|1
288474|NCT00950859|950902|P2|Overall Study|Lost to Follow-up|3
288475|NCT00950859|950903|P1|Overall Study|Lost to Follow-up|0
288476|NCT00950859|950902|P2|Overall Study|Protocol Violation|1
288477|NCT00950859|950903|P1|Overall Study|Protocol Violation|1
288478|NCT00950859|950902|P2|Overall Study|Insufficient Viral Load Response|3
288479|NCT00950859|950903|P1|Overall Study|Insufficient Viral Load Response|12
288480|NCT00950859|950902|P2|Overall Study|Adverse Event|3
288481|NCT00950859|950903|P1|Overall Study|Adverse Event|3
288482|NCT00950807|950943|P10|Treatment Period 3|Adverse Event|0
288483|NCT00950807|950944|P9|Treatment Period 3|Adverse Event|0
288484|NCT00950807|950945|P8|Treatment Period 3|Adverse Event|0
288485|NCT00950807|950946|P7|Treatment Period 3|Adverse Event|1
288486|NCT00950807|950947|P6|Treatment Period 3|Adverse Event|0
288487|NCT00950807|950948|P5|Treatment Period 3|Adverse Event|0
288488|NCT00950807|950949|P4|Treatment Period 3|Adverse Event|0
288489|NCT00950807|950950|P3|Treatment Period 3|Adverse Event|0
288490|NCT00950807|950951|P2|Treatment Period 3|Adverse Event|0
288491|NCT00950807|950952|P1|Treatment Period 3|Adverse Event|0
288492|NCT00950807|950943|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
288493|NCT00950807|950944|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
288494|NCT00950807|950945|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
288495|NCT00950807|950946|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
288496|NCT00950807|950947|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
288497|NCT00950807|950948|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
288498|NCT00950807|950949|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
288499|NCT00950807|950950|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
288500|NCT00950807|950951|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
288501|NCT00950807|950952|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
288502|NCT00950807|950943|P10|Treatment Period 3|Withdrawal by Subject|1
288503|NCT00950807|950944|P9|Treatment Period 3|Withdrawal by Subject|0
288504|NCT00950807|950945|P8|Treatment Period 3|Withdrawal by Subject|0
288505|NCT00950807|950946|P7|Treatment Period 3|Withdrawal by Subject|0
288506|NCT00950807|950947|P6|Treatment Period 3|Withdrawal by Subject|0
288507|NCT00950807|950948|P5|Treatment Period 3|Withdrawal by Subject|0
288508|NCT00950807|950949|P4|Treatment Period 3|Withdrawal by Subject|0
288509|NCT00950807|950950|P3|Treatment Period 3|Withdrawal by Subject|0
288510|NCT00950807|950951|P2|Treatment Period 3|Withdrawal by Subject|0
288511|NCT00950807|950952|P1|Treatment Period 3|Withdrawal by Subject|0
288512|NCT00950807|950943|P10|Washout Period 2|Adverse Event|0
288513|NCT00950807|950944|P9|Washout Period 2|Adverse Event|0
288514|NCT00950807|950945|P8|Washout Period 2|Adverse Event|0
288515|NCT00950807|950946|P7|Washout Period 2|Adverse Event|0
288516|NCT00950807|950947|P6|Washout Period 2|Adverse Event|0
288517|NCT00950807|950948|P5|Washout Period 2|Adverse Event|0
288518|NCT00950807|950949|P4|Washout Period 2|Adverse Event|1
288519|NCT00950807|950950|P3|Washout Period 2|Adverse Event|0
288520|NCT00950807|950951|P2|Washout Period 2|Adverse Event|0
288521|NCT00950807|950952|P1|Washout Period 2|Adverse Event|3
288522|NCT00950807|950943|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
288523|NCT00950807|950944|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
288524|NCT00950807|950945|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
288525|NCT00950807|950946|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
288526|NCT00950807|950947|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
288527|NCT00950807|950948|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
288528|NCT00950807|950949|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
288529|NCT00950807|950950|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
288530|NCT00950807|950951|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
288531|NCT00950807|950952|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
288532|NCT00950807|950943|P10|Washout Period 2|Lack of Efficacy|0
288533|NCT00950807|950944|P9|Washout Period 2|Lack of Efficacy|0
288534|NCT00950807|950945|P8|Washout Period 2|Lack of Efficacy|0
288535|NCT00950807|950946|P7|Washout Period 2|Lack of Efficacy|0
288536|NCT00950807|950947|P6|Washout Period 2|Lack of Efficacy|0
288537|NCT00950807|950948|P5|Washout Period 2|Lack of Efficacy|0
288538|NCT00950807|950949|P4|Washout Period 2|Lack of Efficacy|0
288539|NCT00950807|950950|P3|Washout Period 2|Lack of Efficacy|0
288540|NCT00950807|950951|P2|Washout Period 2|Lack of Efficacy|0
288541|NCT00950807|950952|P1|Washout Period 2|Lack of Efficacy|1
288542|NCT00950807|950943|P10|Treatment Period 2|Adverse Event|0
288543|NCT00950807|950944|P9|Treatment Period 2|Adverse Event|0
288544|NCT00950807|950945|P8|Treatment Period 2|Adverse Event|1
288545|NCT00950807|950946|P7|Treatment Period 2|Adverse Event|0
288546|NCT00950807|950947|P6|Treatment Period 2|Adverse Event|1
288547|NCT00950807|950948|P5|Treatment Period 2|Adverse Event|0
288548|NCT00950807|950949|P4|Treatment Period 2|Adverse Event|1
288549|NCT00950807|950950|P3|Treatment Period 2|Adverse Event|0
288550|NCT00950807|950951|P2|Treatment Period 2|Adverse Event|1
288551|NCT00950807|950952|P1|Treatment Period 2|Adverse Event|0
288552|NCT00950807|950943|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
288553|NCT00950807|950944|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
288554|NCT00950807|950945|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
288555|NCT00950807|950946|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
288556|NCT00950807|950947|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
288557|NCT00950807|950948|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
288558|NCT00950807|950949|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
288559|NCT00950807|950950|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
288560|NCT00950807|950951|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
288561|NCT00950807|950952|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
288562|NCT00950807|950943|P10|Treatment Period 2|Withdrawal by Subject|0
288563|NCT00950807|950944|P9|Treatment Period 2|Withdrawal by Subject|0
288564|NCT00950807|950945|P8|Treatment Period 2|Withdrawal by Subject|2
288565|NCT00950807|950946|P7|Treatment Period 2|Withdrawal by Subject|1
288566|NCT00950807|950947|P6|Treatment Period 2|Withdrawal by Subject|0
288567|NCT00950807|950948|P5|Treatment Period 2|Withdrawal by Subject|0
288568|NCT00950807|950949|P4|Treatment Period 2|Withdrawal by Subject|0
288569|NCT00950807|950950|P3|Treatment Period 2|Withdrawal by Subject|0
288570|NCT00950807|950951|P2|Treatment Period 2|Withdrawal by Subject|0
288571|NCT00950807|950952|P1|Treatment Period 2|Withdrawal by Subject|0
288572|NCT00950807|950943|P10|Treatment Period 2|Lack of Efficacy|0
288573|NCT00950807|950944|P9|Treatment Period 2|Lack of Efficacy|0
288574|NCT00950807|950945|P8|Treatment Period 2|Lack of Efficacy|0
288575|NCT00950807|950946|P7|Treatment Period 2|Lack of Efficacy|0
288576|NCT00950807|950947|P6|Treatment Period 2|Lack of Efficacy|0
288577|NCT00950807|950948|P5|Treatment Period 2|Lack of Efficacy|0
288578|NCT00950807|950949|P4|Treatment Period 2|Lack of Efficacy|0
288579|NCT00950807|950950|P3|Treatment Period 2|Lack of Efficacy|0
288580|NCT00950807|950951|P2|Treatment Period 2|Lack of Efficacy|0
288581|NCT00950807|950952|P1|Treatment Period 2|Lack of Efficacy|1
288582|NCT00950807|950943|P10|Washout Period 1|Adverse Event|0
288583|NCT00950807|950944|P9|Washout Period 1|Adverse Event|0
288584|NCT00950807|950945|P8|Washout Period 1|Adverse Event|0
288585|NCT00950807|950946|P7|Washout Period 1|Adverse Event|0
288586|NCT00950807|950947|P6|Washout Period 1|Adverse Event|0
288587|NCT00950807|950948|P5|Washout Period 1|Adverse Event|1
288588|NCT00950807|950949|P4|Washout Period 1|Adverse Event|1
288589|NCT00950807|950950|P3|Washout Period 1|Adverse Event|0
288590|NCT00950807|950951|P2|Washout Period 1|Adverse Event|0
288591|NCT00950807|950952|P1|Washout Period 1|Adverse Event|2
288592|NCT00950807|950943|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
288593|NCT00950807|950944|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
288594|NCT00950807|950945|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
288595|NCT00950807|950946|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
288596|NCT00950807|950947|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
288597|NCT00950807|950948|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
288598|NCT00950807|950949|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
288599|NCT00950807|950950|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
288600|NCT00950807|950951|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
288601|NCT00950807|950952|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
288602|NCT00950807|950943|P10|Washout Period 1|Withdrawal by Subject|0
288603|NCT00950807|950944|P9|Washout Period 1|Withdrawal by Subject|1
288604|NCT00950807|950945|P8|Washout Period 1|Withdrawal by Subject|0
288605|NCT00950807|950946|P7|Washout Period 1|Withdrawal by Subject|0
288606|NCT00950807|950947|P6|Washout Period 1|Withdrawal by Subject|0
288607|NCT00950807|950948|P5|Washout Period 1|Withdrawal by Subject|0
288608|NCT00950807|950949|P4|Washout Period 1|Withdrawal by Subject|0
288609|NCT00950807|950950|P3|Washout Period 1|Withdrawal by Subject|0
288610|NCT00950807|950951|P2|Washout Period 1|Withdrawal by Subject|0
288611|NCT00950807|950952|P1|Washout Period 1|Withdrawal by Subject|0
288612|NCT00950807|950943|P10|Washout Period 1|Lack of Efficacy|0
288613|NCT00950807|950944|P9|Washout Period 1|Lack of Efficacy|0
288614|NCT00950807|950945|P8|Washout Period 1|Lack of Efficacy|0
288615|NCT00950807|950946|P7|Washout Period 1|Lack of Efficacy|1
288616|NCT00950807|950947|P6|Washout Period 1|Lack of Efficacy|0
288617|NCT00950807|950948|P5|Washout Period 1|Lack of Efficacy|0
288618|NCT00950807|950949|P4|Washout Period 1|Lack of Efficacy|0
288619|NCT00950807|950950|P3|Washout Period 1|Lack of Efficacy|0
288620|NCT00950807|950951|P2|Washout Period 1|Lack of Efficacy|0
288621|NCT00950807|950952|P1|Washout Period 1|Lack of Efficacy|0
288622|NCT00950807|950943|P10|Treatment Period 1|Adverse Event|0
288623|NCT00950807|950944|P9|Treatment Period 1|Adverse Event|0
288624|NCT00950807|950945|P8|Treatment Period 1|Adverse Event|0
288625|NCT00950807|950946|P7|Treatment Period 1|Adverse Event|0
288626|NCT00950807|950947|P6|Treatment Period 1|Adverse Event|1
288627|NCT00950807|950948|P5|Treatment Period 1|Adverse Event|0
288628|NCT00950807|950949|P4|Treatment Period 1|Adverse Event|0
288629|NCT00950807|950950|P3|Treatment Period 1|Adverse Event|0
288630|NCT00950807|950951|P2|Treatment Period 1|Adverse Event|0
288631|NCT00950807|950952|P1|Treatment Period 1|Adverse Event|0
288632|NCT00950807|950943|P10|Treatment Period 1|Withdrawal by Subject|0
288633|NCT00950807|950944|P9|Treatment Period 1|Withdrawal by Subject|1
288634|NCT00950807|950945|P8|Treatment Period 1|Withdrawal by Subject|0
288635|NCT00950807|950946|P7|Treatment Period 1|Withdrawal by Subject|0
288636|NCT00950807|950947|P6|Treatment Period 1|Withdrawal by Subject|0
288637|NCT00950807|950948|P5|Treatment Period 1|Withdrawal by Subject|1
288638|NCT00950807|950949|P4|Treatment Period 1|Withdrawal by Subject|0
288639|NCT00950807|950950|P3|Treatment Period 1|Withdrawal by Subject|0
288640|NCT00950807|950951|P2|Treatment Period 1|Withdrawal by Subject|0
288641|NCT00950807|950952|P1|Treatment Period 1|Withdrawal by Subject|1
288642|NCT00950807|950943|P10|Treatment Period 1|Lost to Follow-up|0
288643|NCT00950807|950944|P9|Treatment Period 1|Lost to Follow-up|0
288644|NCT00950807|950945|P8|Treatment Period 1|Lost to Follow-up|0
288645|NCT00950807|950946|P7|Treatment Period 1|Lost to Follow-up|0
288646|NCT00950807|950947|P6|Treatment Period 1|Lost to Follow-up|0
288647|NCT00950807|950948|P5|Treatment Period 1|Lost to Follow-up|0
288648|NCT00950807|950949|P4|Treatment Period 1|Lost to Follow-up|0
288649|NCT00950807|950950|P3|Treatment Period 1|Lost to Follow-up|1
288650|NCT00950807|950951|P2|Treatment Period 1|Lost to Follow-up|0
288651|NCT00950807|950952|P1|Treatment Period 1|Lost to Follow-up|0
288652|NCT00950807|950943|P10|Treatment Period 1|Protocol Violation|0
288653|NCT00950807|950944|P9|Treatment Period 1|Protocol Violation|0
288654|NCT00950807|950945|P8|Treatment Period 1|Protocol Violation|0
288655|NCT00950807|950946|P7|Treatment Period 1|Protocol Violation|0
288656|NCT00950807|950947|P6|Treatment Period 1|Protocol Violation|0
288657|NCT00950807|950948|P5|Treatment Period 1|Protocol Violation|0
288658|NCT00950807|950949|P4|Treatment Period 1|Protocol Violation|0
288659|NCT00950807|950950|P3|Treatment Period 1|Protocol Violation|0
288660|NCT00950807|950951|P2|Treatment Period 1|Protocol Violation|0
288661|NCT00950807|950952|P1|Treatment Period 1|Protocol Violation|1
288662|NCT00950807|950943|P10|Treatment Period 1|Lack of Efficacy|0
288663|NCT00950807|950944|P9|Treatment Period 1|Lack of Efficacy|0
288664|NCT00950807|950945|P8|Treatment Period 1|Lack of Efficacy|0
288665|NCT00950807|950946|P7|Treatment Period 1|Lack of Efficacy|0
288666|NCT00950807|950947|P6|Treatment Period 1|Lack of Efficacy|1
288667|NCT00950807|950948|P5|Treatment Period 1|Lack of Efficacy|0
288668|NCT00950807|950949|P4|Treatment Period 1|Lack of Efficacy|0
288669|NCT00950807|950950|P3|Treatment Period 1|Lack of Efficacy|0
288670|NCT00950807|950951|P2|Treatment Period 1|Lack of Efficacy|0
288671|NCT00950807|950952|P1|Treatment Period 1|Lack of Efficacy|1
288672|NCT00950755|950994|P1|Long-Term Follow-Up|Death|8
288673|NCT00950755|950994|P1|Long-Term Follow-Up|Lost to Follow-up|1
288674|NCT00950755|950994|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
288675|NCT00950755|950994|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
288676|NCT00950755|950994|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
288677|NCT00950755|950994|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
288678|NCT00950755|950994|P1|Dosimetric and Therapeutic Treatment|Death|1
288679|NCT00950755|950994|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
288680|NCT00950755|950994|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
288681|NCT00950755|950994|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
288682|NCT00950742|951020|P2|Overall Study|Dose limiting toxicity|0
288683|NCT00950742|951021|P1|Overall Study|Dose limiting toxicity|6
288684|NCT00950742|951020|P2|Overall Study|Progressive Disease|2
288685|NCT00950742|951021|P1|Overall Study|Progressive Disease|6
288686|NCT00950742|951020|P2|Overall Study|Withdrawal by Subject|0
288687|NCT00950742|951021|P1|Overall Study|Withdrawal by Subject|3
288688|NCT00950742|951020|P2|Overall Study|Other Adverse Event|0
288689|NCT00950742|951021|P1|Overall Study|Other Adverse Event|1
288690|NCT00950690|951042|P1|Overall Study|Not known|163
288691|NCT00950690|951042|P1|Overall Study|Lost to Follow-up|40
288692|NCT00950690|951042|P1|Overall Study|Lack of Efficacy|22
288693|NCT00950690|951042|P1|Overall Study|Adverse Event|15
288694|NCT00950690|951042|P1|Overall Study|Death|4
288695|NCT00950664|951049|P2|First Intervention|Withdrawal by Subject|2
288696|NCT00950664|951050|P1|First Intervention|Withdrawal by Subject|2
288697|NCT00950664|951049|P2|First Intervention|Lost to Follow-up|3
288698|NCT00950664|951050|P1|First Intervention|Lost to Follow-up|1
288699|NCT00950651|951070|P2|Overall Study|Withdrawal by Subject|9
288700|NCT00950651|951071|P1|Overall Study|Withdrawal by Subject|8
288701|NCT00950651|951070|P2|Overall Study|Protocol Violation|4
288702|NCT00950651|951071|P1|Overall Study|Protocol Violation|3
288703|NCT00950651|951070|P2|Overall Study|Lack of Efficacy|2
288704|NCT00950651|951071|P1|Overall Study|Lack of Efficacy|2
288705|NCT00950651|951070|P2|Overall Study|Death|0
288706|NCT00950651|951071|P1|Overall Study|Death|1
288707|NCT00950651|951070|P2|Overall Study|Adverse Event|20
288708|NCT00950651|951071|P1|Overall Study|Adverse Event|17
288709|NCT00950599|951164|P10|Follow-Up Period|Subject withdrew Consent|1
288710|NCT00950599|951165|P9|Follow-Up Period|Subject withdrew Consent|2
288711|NCT00950599|951166|P8|Follow-Up Period|Subject withdrew Consent|0
288712|NCT00950599|951167|P7|Follow-Up Period|Subject withdrew Consent|0
288713|NCT00950599|951168|P6|Follow-Up Period|Subject withdrew Consent|0
288714|NCT00950599|951169|P5|Follow-Up Period|Subject withdrew Consent|0
288715|NCT00950599|951170|P4|Follow-Up Period|Subject withdrew Consent|0
288716|NCT00950599|951171|P3|Follow-Up Period|Subject withdrew Consent|0
288717|NCT00950599|951172|P2|Follow-Up Period|Subject withdrew Consent|0
288718|NCT00950599|951173|P1|Follow-Up Period|Subject withdrew Consent|0
288719|NCT00950599|951164|P10|Follow-Up Period|Poor/Noncompliance|0
288720|NCT00950599|951165|P9|Follow-Up Period|Poor/Noncompliance|1
288721|NCT00950599|951166|P8|Follow-Up Period|Poor/Noncompliance|0
288722|NCT00950599|951167|P7|Follow-Up Period|Poor/Noncompliance|0
288723|NCT00950599|951168|P6|Follow-Up Period|Poor/Noncompliance|0
288724|NCT00950599|951169|P5|Follow-Up Period|Poor/Noncompliance|0
288725|NCT00950599|951170|P4|Follow-Up Period|Poor/Noncompliance|0
288726|NCT00950599|951171|P3|Follow-Up Period|Poor/Noncompliance|0
288727|NCT00950599|951172|P2|Follow-Up Period|Poor/Noncompliance|0
288728|NCT00950599|951173|P1|Follow-Up Period|Poor/Noncompliance|0
288729|NCT00950599|951164|P10|Follow-Up Period|Physician Decision|0
288730|NCT00950599|951165|P9|Follow-Up Period|Physician Decision|1
288731|NCT00950599|951166|P8|Follow-Up Period|Physician Decision|0
288732|NCT00950599|951167|P7|Follow-Up Period|Physician Decision|0
288733|NCT00950599|951168|P6|Follow-Up Period|Physician Decision|0
288734|NCT00950599|951169|P5|Follow-Up Period|Physician Decision|0
288735|NCT00950599|951170|P4|Follow-Up Period|Physician Decision|0
288736|NCT00950599|951171|P3|Follow-Up Period|Physician Decision|0
288737|NCT00950599|951172|P2|Follow-Up Period|Physician Decision|0
288738|NCT00950599|951173|P1|Follow-Up Period|Physician Decision|0
288739|NCT00950599|951164|P10|Follow-Up Period|Lost to Follow-up|1
288740|NCT00950599|951165|P9|Follow-Up Period|Lost to Follow-up|5
288741|NCT00950599|951166|P8|Follow-Up Period|Lost to Follow-up|0
288742|NCT00950599|951167|P7|Follow-Up Period|Lost to Follow-up|0
288743|NCT00950599|951168|P6|Follow-Up Period|Lost to Follow-up|0
288744|NCT00950599|951169|P5|Follow-Up Period|Lost to Follow-up|0
288745|NCT00950599|951170|P4|Follow-Up Period|Lost to Follow-up|0
288746|NCT00950599|951171|P3|Follow-Up Period|Lost to Follow-up|0
288747|NCT00950599|951172|P2|Follow-Up Period|Lost to Follow-up|0
288748|NCT00950599|951173|P1|Follow-Up Period|Lost to Follow-up|0
288749|NCT00950599|951164|P10|Follow-Up Period|Lack of Efficacy|0
288750|NCT00950599|951165|P9|Follow-Up Period|Lack of Efficacy|3
288751|NCT00950599|951166|P8|Follow-Up Period|Lack of Efficacy|0
288752|NCT00950599|951167|P7|Follow-Up Period|Lack of Efficacy|0
288753|NCT00950599|951168|P6|Follow-Up Period|Lack of Efficacy|0
288754|NCT00950599|951169|P5|Follow-Up Period|Lack of Efficacy|0
288755|NCT00950599|951170|P4|Follow-Up Period|Lack of Efficacy|0
288756|NCT00950599|951171|P3|Follow-Up Period|Lack of Efficacy|0
288757|NCT00950599|951172|P2|Follow-Up Period|Lack of Efficacy|0
288758|NCT00950599|951173|P1|Follow-Up Period|Lack of Efficacy|0
288759|NCT00950599|951164|P10|Follow-Up Period|Adverse Event|0
288760|NCT00950599|951165|P9|Follow-Up Period|Adverse Event|1
288761|NCT00950599|951166|P8|Follow-Up Period|Adverse Event|0
288762|NCT00950599|951167|P7|Follow-Up Period|Adverse Event|0
288763|NCT00950599|951168|P6|Follow-Up Period|Adverse Event|0
288764|NCT00950599|951169|P5|Follow-Up Period|Adverse Event|0
288765|NCT00950599|951170|P4|Follow-Up Period|Adverse Event|0
288766|NCT00950599|951171|P3|Follow-Up Period|Adverse Event|0
288767|NCT00950599|951172|P2|Follow-Up Period|Adverse Event|0
288768|NCT00950599|951173|P1|Follow-Up Period|Adverse Event|0
288769|NCT00950599|951164|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
288770|NCT00950599|951165|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
288771|NCT00950599|951166|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
288772|NCT00950599|951167|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
288773|NCT00950599|951168|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
288774|NCT00950599|951169|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
288775|NCT00950599|951170|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
288776|NCT00950599|951171|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
288777|NCT00950599|951172|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
288778|NCT00950599|951173|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
288779|NCT00950599|951164|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
288780|NCT00950599|951165|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
288781|NCT00950599|951166|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
288782|NCT00950599|951167|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
288783|NCT00950599|951168|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
288784|NCT00950599|951169|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
288785|NCT00950599|951170|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
288786|NCT00950599|951171|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
288787|NCT00950599|951172|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
288788|NCT00950599|951173|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
288789|NCT00950599|951164|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
288790|NCT00950599|951165|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
288791|NCT00950599|951166|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
288792|NCT00950599|951167|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
288793|NCT00950599|951168|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
288794|NCT00950599|951169|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
288795|NCT00950599|951170|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
288796|NCT00950599|951171|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
288797|NCT00950599|951172|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
288798|NCT00950599|951173|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
288799|NCT00950599|951164|P10|Double-Blind Treatment Period|Lost to Follow-up|0
288800|NCT00950599|951165|P9|Double-Blind Treatment Period|Lost to Follow-up|0
288801|NCT00950599|951166|P8|Double-Blind Treatment Period|Lost to Follow-up|1
288802|NCT00950599|951167|P7|Double-Blind Treatment Period|Lost to Follow-up|0
288803|NCT00950599|951168|P6|Double-Blind Treatment Period|Lost to Follow-up|2
288804|NCT00950599|951169|P5|Double-Blind Treatment Period|Lost to Follow-up|1
288805|NCT00950599|951170|P4|Double-Blind Treatment Period|Lost to Follow-up|1
288806|NCT00950599|951171|P3|Double-Blind Treatment Period|Lost to Follow-up|0
288807|NCT00950599|951172|P2|Double-Blind Treatment Period|Lost to Follow-up|0
288808|NCT00950599|951173|P1|Double-Blind Treatment Period|Lost to Follow-up|0
288809|NCT00950599|951164|P10|Double-Blind Treatment Period|Lack of Efficacy|0
288810|NCT00950599|951165|P9|Double-Blind Treatment Period|Lack of Efficacy|0
288811|NCT00950599|951166|P8|Double-Blind Treatment Period|Lack of Efficacy|1
288812|NCT00950599|951167|P7|Double-Blind Treatment Period|Lack of Efficacy|0
288813|NCT00950599|951168|P6|Double-Blind Treatment Period|Lack of Efficacy|6
288814|NCT00950599|951169|P5|Double-Blind Treatment Period|Lack of Efficacy|3
288815|NCT00950599|951170|P4|Double-Blind Treatment Period|Lack of Efficacy|7
288816|NCT00950599|951171|P3|Double-Blind Treatment Period|Lack of Efficacy|5
288817|NCT00950599|951172|P2|Double-Blind Treatment Period|Lack of Efficacy|5
288818|NCT00950599|951173|P1|Double-Blind Treatment Period|Lack of Efficacy|2
288819|NCT00950599|951164|P10|Double-Blind Treatment Period|Adverse Event|0
288820|NCT00950599|951165|P9|Double-Blind Treatment Period|Adverse Event|0
288821|NCT00950599|951166|P8|Double-Blind Treatment Period|Adverse Event|0
288822|NCT00950599|951167|P7|Double-Blind Treatment Period|Adverse Event|0
288823|NCT00950599|951168|P6|Double-Blind Treatment Period|Adverse Event|1
288824|NCT00950599|951169|P5|Double-Blind Treatment Period|Adverse Event|1
288825|NCT00950599|951170|P4|Double-Blind Treatment Period|Adverse Event|1
288826|NCT00950599|951171|P3|Double-Blind Treatment Period|Adverse Event|1
288827|NCT00950599|951172|P2|Double-Blind Treatment Period|Adverse Event|1
288828|NCT00950599|951173|P1|Double-Blind Treatment Period|Adverse Event|0
288829|NCT00950599|951164|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
288830|NCT00950599|951165|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
288831|NCT00950599|951166|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
288832|NCT00950599|951167|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
288833|NCT00950599|951168|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
288834|NCT00950599|951169|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
288835|NCT00950599|951170|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
288836|NCT00950599|951171|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
288837|NCT00950599|951172|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
288838|NCT00950599|951173|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
288839|NCT00950300|951746|P2|SFU Period|Participant Refusal/Withdrawal|6
288840|NCT00950300|951747|P1|SFU Period|Participant Refusal/Withdrawal|2
288841|NCT00950300|951746|P2|SFU Period|Lost to Follow-up|9
288842|NCT00950300|951747|P1|SFU Period|Lost to Follow-up|11
288843|NCT00950300|951746|P2|SFU Period|Death|21
288844|NCT00950300|951747|P1|SFU Period|Death|28
288845|NCT00950300|951746|P2|SFU Period|Ongoing in SFU|18
288846|NCT00950300|951747|P1|SFU Period|Ongoing in SFU|12
288847|NCT00950300|951746|P2|TFFU Period|Not Specified|1
288848|NCT00950300|951747|P1|TFFU Period|Not Specified|1
288849|NCT00950300|951746|P2|TFFU Period|Recurrence of Disease|55
288850|NCT00950300|951747|P1|TFFU Period|Recurrence of Disease|48
288851|NCT00950300|951746|P2|TFFU Period|Lost to Follow-up|4
288852|NCT00950300|951747|P1|TFFU Period|Lost to Follow-up|6
288853|NCT00950300|951746|P2|TFFU Period|Participant Refusal/Withdrawal|8
288854|NCT00950300|951747|P1|TFFU Period|Participant Refusal/Withdrawal|5
288855|NCT00950300|951746|P2|TFFU Period|Death|0
288856|NCT00950300|951747|P1|TFFU Period|Death|1
288857|NCT00950300|951746|P2|TFFU Period|Adverse Event or Intercurrent Illness|1
288858|NCT00950300|951747|P1|TFFU Period|Adverse Event or Intercurrent Illness|1
288859|NCT00950300|951746|P2|TFFU Period|Ongoing in TFFU|183
288860|NCT00950300|951747|P1|TFFU Period|Ongoing in TFFU|192
288861|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
288862|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
288863|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
288864|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
288865|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
288866|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
288867|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
288868|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
288869|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
288870|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
288871|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
288872|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
288873|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
288874|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
288875|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
288876|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
288877|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
288878|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
288879|NCT00950300|951746|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
288880|NCT00950300|951747|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
288881|NCT00949975|951825|P4|Overall Study|Other|0
288882|NCT00949975|951826|P3|Overall Study|Other|0
288883|NCT00949975|951827|P2|Overall Study|Other|0
288884|NCT00949975|951828|P1|Overall Study|Other|1
288885|NCT00949975|951825|P4|Overall Study|Lost to Follow-up|3
288886|NCT00949975|951826|P3|Overall Study|Lost to Follow-up|1
288887|NCT00949975|951827|P2|Overall Study|Lost to Follow-up|0
288888|NCT00949975|951828|P1|Overall Study|Lost to Follow-up|1
288889|NCT00949975|951825|P4|Overall Study|Severe non-compliance|2
288890|NCT00949975|951826|P3|Overall Study|Severe non-compliance|0
288891|NCT00949975|951827|P2|Overall Study|Severe non-compliance|1
288892|NCT00949975|951828|P1|Overall Study|Severe non-compliance|3
288893|NCT00949975|951825|P4|Overall Study|Incorrect enrolment|7
288894|NCT00949975|951826|P3|Overall Study|Incorrect enrolment|4
288895|NCT00949975|951827|P2|Overall Study|Incorrect enrolment|10
288896|NCT00949975|951828|P1|Overall Study|Incorrect enrolment|5
288897|NCT00949975|951825|P4|Overall Study|Study-specific criteria|0
288898|NCT00949975|951826|P3|Overall Study|Study-specific criteria|1
288899|NCT00949975|951827|P2|Overall Study|Study-specific criteria|1
288900|NCT00949975|951828|P1|Overall Study|Study-specific criteria|0
288901|NCT00949975|951825|P4|Overall Study|Safety reason|0
288902|NCT00949975|951826|P3|Overall Study|Safety reason|0
288903|NCT00949975|951827|P2|Overall Study|Safety reason|1
288904|NCT00949975|951828|P1|Overall Study|Safety reason|0
288905|NCT00949975|951825|P4|Overall Study|Adverse Event|10
288906|NCT00949975|951826|P3|Overall Study|Adverse Event|10
288907|NCT00949975|951827|P2|Overall Study|Adverse Event|11
288908|NCT00949975|951828|P1|Overall Study|Adverse Event|11
288909|NCT00949975|951825|P4|Overall Study|Voluntary discontinuation|6
288910|NCT00949975|951826|P3|Overall Study|Voluntary discontinuation|3
288911|NCT00949975|951827|P2|Overall Study|Voluntary discontinuation|5
288912|NCT00949975|951828|P1|Overall Study|Voluntary discontinuation|6
288913|NCT00949910|951946|P1|Overall Study|No Data|9
288914|NCT00949910|951946|P1|Overall Study|Other|4
288915|NCT00949910|951946|P1|Overall Study|Physician/Participant Decision|7
288916|NCT00949910|951946|P1|Overall Study|Serious Adverse Event|6
288917|NCT00949910|951946|P1|Overall Study|Adverse Event|83
288918|NCT00949910|951946|P1|Overall Study|Prolonged Dosing Interruption|4
288919|NCT00949910|951946|P1|Overall Study|Non-Compliance|10
288920|NCT00949910|951946|P1|Overall Study|Logistical Reasons|13
288921|NCT00949910|951946|P1|Overall Study|Violation of Eligibility|23
288922|NCT00949910|951946|P1|Overall Study|Switched to Commercial Treatment|4
288923|NCT00949910|951946|P1|Overall Study|Switched to Compassionate/Other Use|174
288924|NCT00949910|951946|P1|Overall Study|Unspecified Progression/Deterioration|13
288925|NCT00949910|951946|P1|Overall Study|Death from Unknown Cause|5
288926|NCT00949910|951946|P1|Overall Study|Death Due to Toxicity|3
288927|NCT00949910|951946|P1|Overall Study|Death Due to Adverse Event|115
288928|NCT00949910|951946|P1|Overall Study|Death Due to Progression/Deterioration|4
288929|NCT00949910|951946|P1|Overall Study|Death Due to Malignant Disease|456
288930|NCT00949910|951946|P1|Overall Study|Participant Refusal|390
288931|NCT00949910|951946|P1|Overall Study|Study Drug-Related Adverse Event|315
288932|NCT00949910|951946|P1|Overall Study|Lost to Follow-up|100
288933|NCT00949910|951946|P1|Overall Study|Symptomatic Deterioration|1088
288934|NCT00949910|951946|P1|Overall Study|Progressive Disease|3750
288935|NCT00949884|951959|P3|Overall Study|Study terminated by sponsor|1
288936|NCT00949884|951960|P2|Overall Study|Study terminated by sponsor|0
288937|NCT00949884|951961|P1|Overall Study|Study terminated by sponsor|0
288938|NCT00949884|951959|P3|Overall Study|Lack of Efficacy|7
288939|NCT00949884|951960|P2|Overall Study|Lack of Efficacy|2
288940|NCT00949884|951961|P1|Overall Study|Lack of Efficacy|4
288941|NCT00949884|951959|P3|Overall Study|Withdrawal by Subject|16
288942|NCT00949884|951960|P2|Overall Study|Withdrawal by Subject|4
288943|NCT00949884|951961|P1|Overall Study|Withdrawal by Subject|13
288944|NCT00949884|951959|P3|Overall Study|Treatment non-compliance|8
288945|NCT00949884|951960|P2|Overall Study|Treatment non-compliance|0
288946|NCT00949884|951961|P1|Overall Study|Treatment non-compliance|5
288947|NCT00949884|951959|P3|Overall Study|Physician Decision|6
288948|NCT00949884|951960|P2|Overall Study|Physician Decision|0
288949|NCT00949884|951961|P1|Overall Study|Physician Decision|5
288950|NCT00949884|951959|P3|Overall Study|Lost to Follow-up|5
288951|NCT00949884|951960|P2|Overall Study|Lost to Follow-up|5
288952|NCT00949884|951961|P1|Overall Study|Lost to Follow-up|7
288953|NCT00949884|951959|P3|Overall Study|Did not meet inclusion/exclusion|3
288954|NCT00949884|951960|P2|Overall Study|Did not meet inclusion/exclusion|1
288955|NCT00949884|951961|P1|Overall Study|Did not meet inclusion/exclusion|2
288956|NCT00949884|951959|P3|Overall Study|Adverse Event|12
288957|NCT00949884|951960|P2|Overall Study|Adverse Event|3
288958|NCT00949884|951961|P1|Overall Study|Adverse Event|14
288959|NCT00949715|952016|P2|Overall Study|Missing 24 month LVEF measurement|0
288960|NCT00949715|952017|P1|Overall Study|Missing 24 month LVEF measurement|2
288961|NCT00949715|952016|P2|Overall Study|Lost to Follow-up|0
288962|NCT00949715|952017|P1|Overall Study|Lost to Follow-up|1
288963|NCT00949715|952016|P2|Overall Study|Physician Decision|0
288964|NCT00949715|952017|P1|Overall Study|Physician Decision|1
288965|NCT00949702|952028|P1|Overall Study|Withdrawal of consent|1
288966|NCT00949702|952028|P1|Overall Study|Disease progression|7
288967|NCT00949702|952028|P1|Overall Study|Death|40
288968|NCT00949650|952045|P2|Overall Study|Other|0
288969|NCT00949650|952046|P1|Overall Study|Other|1
288970|NCT00949650|952045|P2|Overall Study|Not treated|4
288971|NCT00949650|952046|P1|Overall Study|Not treated|1
288972|NCT00949650|952045|P2|Overall Study|Withdrawal by Subject|11
288973|NCT00949650|952046|P1|Overall Study|Withdrawal by Subject|6
288974|NCT00949650|952045|P2|Overall Study|Protocol Violation|4
288975|NCT00949650|952046|P1|Overall Study|Protocol Violation|1
288976|NCT00949650|952045|P2|Overall Study|Other Adverse Event|17
288977|NCT00949650|952046|P1|Overall Study|Other Adverse Event|23
288978|NCT00949650|952045|P2|Overall Study|Progressive disease|19
288979|NCT00949650|952046|P1|Overall Study|Progressive disease|133
288980|NCT00949533|952084|P2|Overall Study|Lost to Follow-up|1
288981|NCT00949533|952085|P1|Overall Study|Lost to Follow-up|0
288982|NCT00949117|952099|P2|Overall Study|Adverse Event|1
288983|NCT00949117|952100|P1|Overall Study|Adverse Event|0
288984|NCT00949117|952099|P2|Overall Study|Protocol Violation|1
288985|NCT00949117|952100|P1|Overall Study|Protocol Violation|1
288986|NCT00949117|952099|P2|Overall Study|Lack of Efficacy|3
288987|NCT00949117|952100|P1|Overall Study|Lack of Efficacy|2
288988|NCT00948896|952122|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
288989|NCT00948896|952123|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
288990|NCT00948896|952124|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
288991|NCT00948896|952125|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
288992|NCT00948896|952126|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
288993|NCT00948896|952127|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
288994|NCT00948896|952128|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
288995|NCT00948896|952129|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
288996|NCT00948896|952122|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
288997|NCT00948896|952123|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
288998|NCT00948896|952124|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
288999|NCT00948896|952125|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
289000|NCT00948896|952126|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
289001|NCT00948896|952127|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
289002|NCT00948896|952128|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
289003|NCT00948896|952129|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
289004|NCT00948896|952122|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
289005|NCT00948896|952123|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
289006|NCT00948896|952124|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
289007|NCT00948896|952125|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
289008|NCT00948896|952126|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
289009|NCT00948896|952127|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
289010|NCT00948896|952128|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
289011|NCT00948896|952129|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
289012|NCT00948896|952122|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
289013|NCT00948896|952123|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
289014|NCT00948896|952124|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
289015|NCT00948896|952125|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
289016|NCT00948896|952126|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
289017|NCT00948896|952127|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
289018|NCT00948896|952128|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
289019|NCT00948896|952129|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
289020|NCT00948896|952122|P8|24 Months of Age to 36 Months of Age|Death|0
289021|NCT00948896|952123|P7|24 Months of Age to 36 Months of Age|Death|0
289022|NCT00948896|952124|P6|24 Months of Age to 36 Months of Age|Death|1
289023|NCT00948896|952125|P5|24 Months of Age to 36 Months of Age|Death|0
289024|NCT00948896|952126|P4|24 Months of Age to 36 Months of Age|Death|0
289025|NCT00948896|952127|P3|24 Months of Age to 36 Months of Age|Death|2
289026|NCT00948896|952128|P2|24 Months of Age to 36 Months of Age|Death|2
289027|NCT00948896|952129|P1|24 Months of Age to 36 Months of Age|Death|0
289028|NCT00948896|952122|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
289029|NCT00948896|952123|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
289030|NCT00948896|952124|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
289031|NCT00948896|952125|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
289032|NCT00948896|952126|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
289033|NCT00948896|952127|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
289034|NCT00948896|952128|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
289035|NCT00948896|952129|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
289036|NCT00948896|952122|P8|Randomization to 24 Months of Age|Protocol Violation|1
289037|NCT00948896|952123|P7|Randomization to 24 Months of Age|Protocol Violation|1
289038|NCT00948896|952124|P6|Randomization to 24 Months of Age|Protocol Violation|0
289039|NCT00948896|952125|P5|Randomization to 24 Months of Age|Protocol Violation|0
289040|NCT00948896|952126|P4|Randomization to 24 Months of Age|Protocol Violation|1
289041|NCT00948896|952127|P3|Randomization to 24 Months of Age|Protocol Violation|0
289042|NCT00948896|952128|P2|Randomization to 24 Months of Age|Protocol Violation|1
289043|NCT00948896|952129|P1|Randomization to 24 Months of Age|Protocol Violation|0
289044|NCT00948896|952122|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
289045|NCT00948896|952123|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
289046|NCT00948896|952124|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
289047|NCT00948896|952125|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
289048|NCT00948896|952126|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
289049|NCT00948896|952127|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
289050|NCT00948896|952128|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
289051|NCT00948896|952129|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
289052|NCT00948896|952122|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
289053|NCT00948896|952123|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
289054|NCT00948896|952124|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
289055|NCT00948896|952125|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
289056|NCT00948896|952126|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
289057|NCT00948896|952127|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
289058|NCT00948896|952128|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
289059|NCT00948896|952129|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
289060|NCT00948896|952122|P8|Randomization to 24 Months of Age|Death|1
289061|NCT00948896|952123|P7|Randomization to 24 Months of Age|Death|2
289062|NCT00948896|952124|P6|Randomization to 24 Months of Age|Death|1
289063|NCT00948896|952125|P5|Randomization to 24 Months of Age|Death|2
289064|NCT00948896|952126|P4|Randomization to 24 Months of Age|Death|0
289065|NCT00948896|952127|P3|Randomization to 24 Months of Age|Death|0
289066|NCT00948896|952128|P2|Randomization to 24 Months of Age|Death|0
289067|NCT00948896|952129|P1|Randomization to 24 Months of Age|Death|1
289068|NCT00948857|952165|P2|Overall Study|Lost to Follow-up|0
289069|NCT00948857|952166|P1|Overall Study|Lost to Follow-up|1
289070|NCT00948818|952174|P2|Overall Study|Other Reason|5
289071|NCT00948818|952175|P1|Overall Study|Other Reason|4
289072|NCT00948818|952174|P2|Overall Study|Lack of Efficacy|5
289073|NCT00948818|952175|P1|Overall Study|Lack of Efficacy|4
289074|NCT00948818|952174|P2|Overall Study|Lost to Follow-up|17
289075|NCT00948818|952175|P1|Overall Study|Lost to Follow-up|10
289076|NCT00948818|952174|P2|Overall Study|Withdrawal by Subject|25
289077|NCT00948818|952175|P1|Overall Study|Withdrawal by Subject|25
289078|NCT00948818|952174|P2|Overall Study|Protocol Violation|10
289079|NCT00948818|952175|P1|Overall Study|Protocol Violation|9
289080|NCT00948818|952174|P2|Overall Study|Adverse Event|32
289081|NCT00948818|952175|P1|Overall Study|Adverse Event|10
289082|NCT00948766|952222|P2|Extension Study|Death|0
289083|NCT00948766|952223|P1|Extension Study|Death|4
289084|NCT00948766|952222|P2|Extension Study|Administrative Problems|0
289085|NCT00948766|952223|P1|Extension Study|Administrative Problems|1
289086|NCT00948766|952222|P2|Extension Study|Lost to Follow-up|0
289087|NCT00948766|952223|P1|Extension Study|Lost to Follow-up|8
289088|NCT00948766|952222|P2|Extension Study|Patient Withdrew Consent|0
289089|NCT00948766|952223|P1|Extension Study|Patient Withdrew Consent|32
289090|NCT00948766|952222|P2|Extension Study|Study Drug No Longer Required|0
289091|NCT00948766|952223|P1|Extension Study|Study Drug No Longer Required|1
289092|NCT00948766|952222|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
289093|NCT00948766|952223|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
289094|NCT00948766|952222|P2|Extension Study|Adverse Event|0
289095|NCT00948766|952223|P1|Extension Study|Adverse Event|43
289096|NCT00948766|952222|P2|Core Study|Protocol Deviation|10
289097|NCT00948766|952223|P1|Core Study|Protocol Deviation|8
289098|NCT00948766|952222|P2|Core Study|Death|1
289099|NCT00948766|952223|P1|Core Study|Death|1
289100|NCT00948766|952222|P2|Core Study|Administrative Problems|2
289101|NCT00948766|952223|P1|Core Study|Administrative Problems|2
289102|NCT00948766|952222|P2|Core Study|Lost to Follow-up|2
289103|NCT00948766|952223|P1|Core Study|Lost to Follow-up|3
289104|NCT00948766|952222|P2|Core Study|Patient Withdrew Consent|46
289105|NCT00948766|952223|P1|Core Study|Patient Withdrew Consent|27
289106|NCT00948766|952222|P2|Core Study|Unsatisfactory Therapeutic Effect|14
289107|NCT00948766|952223|P1|Core Study|Unsatisfactory Therapeutic Effect|13
289108|NCT00948766|952222|P2|Core Study|Adverse Event|51
289109|NCT00948766|952223|P1|Core Study|Adverse Event|73
289110|NCT00948688|952239|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
289111|NCT00948688|952240|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
289112|NCT00948688|952239|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
289113|NCT00948688|952240|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
289114|NCT00948688|952239|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
289115|NCT00948688|952240|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
289116|NCT00948675|952254|P2|Overall Study|Treatment ongoing|4
289117|NCT00948675|952255|P1|Overall Study|Treatment ongoing|5
289118|NCT00948675|952254|P2|Overall Study|Lost to Follow-up|0
289119|NCT00948675|952255|P1|Overall Study|Lost to Follow-up|2
289120|NCT00948506|952271|P2|Overall Study|Withdrawal by Subject|1
289121|NCT00948506|952272|P1|Overall Study|Withdrawal by Subject|3
289122|NCT00948441|952283|P2|Overall Study|no longer meet inclusion criteria|4
289123|NCT00948441|952284|P1|Overall Study|no longer meet inclusion criteria|1
289124|NCT00948389|952297|P5|Overall Study|Both Progression and Toxicity|0
289125|NCT00948389|952298|P4|Overall Study|Both Progression and Toxicity|0
289126|NCT00948389|952299|P3|Overall Study|Both Progression and Toxicity|0
289127|NCT00948389|952300|P2|Overall Study|Both Progression and Toxicity|0
289128|NCT00948389|952301|P1|Overall Study|Both Progression and Toxicity|1
289129|NCT00948389|952297|P5|Overall Study|Thrombocytopenia, Grade 4|0
289130|NCT00948389|952298|P4|Overall Study|Thrombocytopenia, Grade 4|1
289131|NCT00948389|952299|P3|Overall Study|Thrombocytopenia, Grade 4|0
289132|NCT00948389|952300|P2|Overall Study|Thrombocytopenia, Grade 4|0
289133|NCT00948389|952301|P1|Overall Study|Thrombocytopenia, Grade 4|2
289134|NCT00948389|952297|P5|Overall Study|Disease Progression/Relapse/Death|1
289135|NCT00948389|952298|P4|Overall Study|Disease Progression/Relapse/Death|8
289136|NCT00948389|952299|P3|Overall Study|Disease Progression/Relapse/Death|7
289137|NCT00948389|952300|P2|Overall Study|Disease Progression/Relapse/Death|3
289138|NCT00948389|952301|P1|Overall Study|Disease Progression/Relapse/Death|3
289139|NCT00948246|952338|P1|Overall Study|Withdrawal by Subject|1
289140|NCT00948246|952338|P1|Overall Study|Death|1
289141|NCT00948246|952338|P1|Overall Study|Adverse Event|11
289142|NCT00948246|952338|P1|Overall Study|Lost to Follow-up|11
289143|NCT00948155|952347|P2|Washout 14 Days|Lost to Follow-up|2
289144|NCT00948155|952348|P1|Washout 14 Days|Lost to Follow-up|1
289145|NCT00948155|952347|P2|First Intervention 21 Days|Lost to Follow-up|2
289146|NCT00948155|952348|P1|First Intervention 21 Days|Lost to Follow-up|2
289147|NCT00948064|952395|P3|Phase II|Withdrawal by Subject|0
289148|NCT00948064|952396|P2|Phase II|Withdrawal by Subject|1
289149|NCT00948064|952397|P1|Phase II|Withdrawal by Subject|0
289150|NCT00948064|952395|P3|Phase II|Physician Decision|1
289151|NCT00948064|952396|P2|Phase II|Physician Decision|0
289152|NCT00948064|952397|P1|Phase II|Physician Decision|0
289153|NCT00948064|952395|P3|Phase I|No treatment received|0
289154|NCT00948064|952396|P2|Phase I|No treatment received|0
289155|NCT00948064|952397|P1|Phase I|No treatment received|1
289156|NCT00947882|952412|P4|Overall Study|Trial Terminated by Sponsor|70
289157|NCT00947882|952413|P3|Overall Study|Trial Terminated by Sponsor|62
289158|NCT00947882|952414|P2|Overall Study|Trial Terminated by Sponsor|61
289159|NCT00947882|952415|P1|Overall Study|Trial Terminated by Sponsor|62
289160|NCT00947882|952412|P4|Overall Study|Other/Unknown|6
289161|NCT00947882|952413|P3|Overall Study|Other/Unknown|3
289162|NCT00947882|952414|P2|Overall Study|Other/Unknown|13
289163|NCT00947882|952415|P1|Overall Study|Other/Unknown|10
289164|NCT00947882|952412|P4|Overall Study|Lost to Follow-up|0
289165|NCT00947882|952413|P3|Overall Study|Lost to Follow-up|1
289166|NCT00947882|952414|P2|Overall Study|Lost to Follow-up|2
289167|NCT00947882|952415|P1|Overall Study|Lost to Follow-up|0
289168|NCT00947882|952412|P4|Overall Study|Protocol Violation|0
289169|NCT00947882|952413|P3|Overall Study|Protocol Violation|1
289170|NCT00947882|952414|P2|Overall Study|Protocol Violation|0
289171|NCT00947882|952415|P1|Overall Study|Protocol Violation|0
289172|NCT00947882|952412|P4|Overall Study|Withdrawal by Subject|2
289173|NCT00947882|952413|P3|Overall Study|Withdrawal by Subject|8
289174|NCT00947882|952414|P2|Overall Study|Withdrawal by Subject|0
289175|NCT00947882|952415|P1|Overall Study|Withdrawal by Subject|2
289176|NCT00947882|952412|P4|Overall Study|Adverse Event|4
289177|NCT00947882|952413|P3|Overall Study|Adverse Event|4
289178|NCT00947882|952414|P2|Overall Study|Adverse Event|1
289179|NCT00947882|952415|P1|Overall Study|Adverse Event|0
289180|NCT00947856|952443|P2|Follow-up Period|Withdrawal by Subject|0
289181|NCT00947856|952444|P1|Follow-up Period|Withdrawal by Subject|1
289182|NCT00947856|952443|P2|Follow-up Period|Patient unavailable for site visits|0
289183|NCT00947856|952444|P1|Follow-up Period|Patient unavailable for site visits|1
289184|NCT00947856|952443|P2|Follow-up Period|Lost to Follow-up|0
289185|NCT00947856|952444|P1|Follow-up Period|Lost to Follow-up|7
289186|NCT00947856|952443|P2|Follow-up Period|Re-enrolled for Retreatment|3
289187|NCT00947856|952444|P1|Follow-up Period|Re-enrolled for Retreatment|2
289188|NCT00947856|952443|P2|Follow-up Period|Study Stopped by Sponsor|20
289189|NCT00947856|952444|P1|Follow-up Period|Study Stopped by Sponsor|40
289190|NCT00947856|952443|P2|Treatment Period|Withdrawal by Subject|1
289191|NCT00947856|952444|P1|Treatment Period|Withdrawal by Subject|12
289192|NCT00947856|952443|P2|Treatment Period|Study Stopped by Sponsor|4
289193|NCT00947856|952444|P1|Treatment Period|Study Stopped by Sponsor|4
289194|NCT00947856|952443|P2|Treatment Period|Physician Decision|6
289195|NCT00947856|952444|P1|Treatment Period|Physician Decision|14
289196|NCT00947856|952443|P2|Treatment Period|Adverse Event|9
289197|NCT00947856|952444|P1|Treatment Period|Adverse Event|15
289198|NCT00947856|952443|P2|Treatment Period|Progressive Disease|12
289199|NCT00947856|952444|P1|Treatment Period|Progressive Disease|33
289200|NCT00947544|952533|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
289201|NCT00947544|952534|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
289202|NCT00947531|952560|P2|Overall Study|Other|1
289203|NCT00947531|952561|P1|Overall Study|Other|1
289204|NCT00947531|952560|P2|Overall Study|Lack of Efficacy|0
289205|NCT00947531|952561|P1|Overall Study|Lack of Efficacy|1
289206|NCT00947531|952560|P2|Overall Study|Adverse Event|2
289207|NCT00947531|952561|P1|Overall Study|Adverse Event|2
289208|NCT00947531|952560|P2|Overall Study|Administrative Reason|1
289209|NCT00947531|952561|P1|Overall Study|Administrative Reason|0
289210|NCT00947531|952560|P2|Overall Study|Withdrawal by Subject|7
289211|NCT00947531|952561|P1|Overall Study|Withdrawal by Subject|10
289212|NCT00947427|952594|P2|Overall Study|Protocol Violation|1
289213|NCT00947427|952595|P1|Overall Study|Protocol Violation|0
289214|NCT00947427|952594|P2|Overall Study|Withdrawal by Subject|3
289215|NCT00947427|952595|P1|Overall Study|Withdrawal by Subject|1
289216|NCT00947349|952605|P4|Overall Study Standard of Care|not specified|1
289217|NCT00947349|952606|P3|Overall Study Standard of Care|not specified|0
289218|NCT00947349|952607|P2|Overall Study Standard of Care|not specified|0
289219|NCT00947349|952608|P1|Overall Study Standard of Care|not specified|0
289220|NCT00947349|952605|P4|Overall Study Standard of Care|Withdrawal by Subject|0
289221|NCT00947349|952606|P3|Overall Study Standard of Care|Withdrawal by Subject|1
289222|NCT00947349|952607|P2|Overall Study Standard of Care|Withdrawal by Subject|0
289223|NCT00947349|952608|P1|Overall Study Standard of Care|Withdrawal by Subject|0
289224|NCT00947349|952605|P4|Overall Study Standard of Care|Lack of Efficacy|1
289225|NCT00947349|952606|P3|Overall Study Standard of Care|Lack of Efficacy|1
289226|NCT00947349|952607|P2|Overall Study Standard of Care|Lack of Efficacy|0
289227|NCT00947349|952608|P1|Overall Study Standard of Care|Lack of Efficacy|0
289228|NCT00947349|952605|P4|Triple Treatment Combination Period|Adverse Event|0
289229|NCT00947349|952606|P3|Triple Treatment Combination Period|Adverse Event|0
289230|NCT00947349|952607|P2|Triple Treatment Combination Period|Adverse Event|1
289231|NCT00947349|952608|P1|Triple Treatment Combination Period|Adverse Event|0
289232|NCT00947154|952822|P1|Overall Study|Lost to Follow-up|1
289233|NCT00947115|952832|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
289234|NCT00947115|952833|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
289235|NCT00947115|952834|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
289236|NCT00947115|952832|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
289237|NCT00947115|952833|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
289238|NCT00947115|952834|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
289239|NCT00947115|952832|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
289240|NCT00947115|952833|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
289241|NCT00947115|952834|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
289242|NCT00947115|952832|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
289243|NCT00947115|952833|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
289244|NCT00947115|952834|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
289245|NCT00947115|952832|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
289246|NCT00947115|952833|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
289247|NCT00947115|952834|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
289248|NCT00947115|952832|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
289249|NCT00947115|952833|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
289250|NCT00947115|952834|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
289251|NCT00946985|952896|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
289252|NCT00946985|952896|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
289253|NCT00946985|952896|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
289254|NCT00946985|952896|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
289255|NCT00946985|952896|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
289256|NCT00946985|952896|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
289257|NCT00946985|952896|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
289258|NCT00946985|952896|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
289259|NCT00946985|952896|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
289260|NCT00946920|952902|P2|Overall Study|Miscellaneous reasons|3
289261|NCT00946920|952903|P1|Overall Study|Miscellaneous reasons|18
289262|NCT00946920|952902|P2|Overall Study|Protocol Violation|8
289263|NCT00946920|952903|P1|Overall Study|Protocol Violation|16
289264|NCT00946920|952902|P2|Overall Study|Adverse Event|14
289265|NCT00946920|952903|P1|Overall Study|Adverse Event|41
289266|NCT00946920|952902|P2|Overall Study|Physician Decision|2
289267|NCT00946920|952903|P1|Overall Study|Physician Decision|5
289268|NCT00946920|952902|P2|Overall Study|Lost to Follow-up|2
289269|NCT00946920|952903|P1|Overall Study|Lost to Follow-up|2
289270|NCT00946920|952902|P2|Overall Study|Withdrawal by Subject|15
289271|NCT00946920|952903|P1|Overall Study|Withdrawal by Subject|28
289272|NCT00946530|952922|P4|Overall Study|Physician Decision|1
289273|NCT00946530|952923|P3|Overall Study|Physician Decision|1
289274|NCT00946530|952924|P2|Overall Study|Physician Decision|1
289275|NCT00946530|952925|P1|Overall Study|Physician Decision|1
289276|NCT00946530|952922|P4|Overall Study|Withdrawal by Subject|3
289277|NCT00946530|952923|P3|Overall Study|Withdrawal by Subject|0
289278|NCT00946530|952924|P2|Overall Study|Withdrawal by Subject|3
289279|NCT00946530|952925|P1|Overall Study|Withdrawal by Subject|0
289369|NCT00944034|953650|P11|Overall Study|Administrative reason|0
289280|NCT00946322|952957|P1|Post-treatment|participant failure to follow up|2
289281|NCT00946322|952957|P1|Pre-treatment|participant failure to follow up|1
289282|NCT00946309|952970|P2|Overall Study|Procedure cancelled/discontinued|3
289283|NCT00946309|952971|P1|Overall Study|Procedure cancelled/discontinued|0
289284|NCT00946309|952970|P2|Overall Study|Lost to Follow-up|1
289285|NCT00946309|952971|P1|Overall Study|Lost to Follow-up|0
289286|NCT00946309|952970|P2|Overall Study|Protocol Violation|0
289287|NCT00946309|952971|P1|Overall Study|Protocol Violation|1
289288|NCT00946296|952989|P2|Overall Study|Physician Decision|0
289289|NCT00946296|952990|P1|Overall Study|Physician Decision|3
289290|NCT00946114|952998|P2|Overall Study|Withdrawal by Subject|0
289291|NCT00946114|952999|P1|Overall Study|Withdrawal by Subject|2
289292|NCT00946114|952998|P2|Overall Study|Unspecified|0
289293|NCT00946114|952999|P1|Overall Study|Unspecified|1
289294|NCT00946114|952998|P2|Overall Study|Death|2
289295|NCT00946114|952999|P1|Overall Study|Death|5
289296|NCT00946101|953007|P2|Overall Study|Physician Decision|1
289297|NCT00946101|953008|P1|Overall Study|Physician Decision|0
289298|NCT00946101|953007|P2|Overall Study|Withdrawal of consent|0
289299|NCT00946101|953008|P1|Overall Study|Withdrawal of consent|2
289300|NCT00946101|953007|P2|Overall Study|Lost to Follow-up|1
289301|NCT00946101|953008|P1|Overall Study|Lost to Follow-up|2
289302|NCT00946088|953074|P2|Overall Study|Withdrawal by Subject|1
289303|NCT00946088|953075|P1|Overall Study|Withdrawal by Subject|0
289304|NCT00945945|953104|P2|Overall Study|Entry Criteria Not Met|1
289305|NCT00945945|953105|P1|Overall Study|Entry Criteria Not Met|0
289306|NCT00945945|953104|P2|Overall Study|Protocol Violation|2
289307|NCT00945945|953105|P1|Overall Study|Protocol Violation|4
289308|NCT00945945|953104|P2|Overall Study|Lack of Efficacy|2
289309|NCT00945945|953105|P1|Overall Study|Lack of Efficacy|6
289310|NCT00945945|953104|P2|Overall Study|Lost to Follow-up|5
289311|NCT00945945|953105|P1|Overall Study|Lost to Follow-up|4
289312|NCT00945945|953104|P2|Overall Study|Withdrawal by Subject|10
289313|NCT00945945|953105|P1|Overall Study|Withdrawal by Subject|7
289314|NCT00945945|953104|P2|Overall Study|Adverse Event|35
289315|NCT00945945|953105|P1|Overall Study|Adverse Event|15
289316|NCT00945906|953131|P1|Overall Study|Moved to another country|2
289317|NCT00945906|953131|P1|Overall Study|Unable to return for last visit|2
289318|NCT00945906|953131|P1|Overall Study|Did not want to return for last visit|2
289319|NCT00945906|953131|P1|Overall Study|Withdrawal by Subject|1
289320|NCT00945893|953142|P2|Overall Study|Withdrawal of consent|2
289321|NCT00945893|953143|P1|Overall Study|Withdrawal of consent|1
289322|NCT00945893|953142|P2|Overall Study|Lost to Follow-up|8
289323|NCT00945893|953143|P1|Overall Study|Lost to Follow-up|2
289324|NCT00945815|953220|P1|Overall Study|Did not begin protocol therapy|1
289325|NCT00945815|953220|P1|Overall Study|Ineligible|3
289326|NCT00945815|953220|P1|Overall Study|Not protocol specified|1
289327|NCT00945815|953220|P1|Overall Study|Death|3
289328|NCT00945555|953249|P1|Overall Study|Other|1
289329|NCT00945555|953249|P1|Overall Study|Death|18
289330|NCT00945555|953249|P1|Overall Study|Participant continued treatment at home|1
289331|NCT00945555|953249|P1|Overall Study|Withdrawal by Subject|2
289332|NCT00945555|953249|P1|Overall Study|Worsening condition, intensive care unit|1
289333|NCT00945555|953249|P1|Overall Study|Referred to another hospital|5
289334|NCT00945477|953260|P1|Overall Study|Withdrawal by Subject|1
289335|NCT00945477|953260|P1|Overall Study|Lack of Efficacy|2
289336|NCT00945477|953260|P1|Overall Study|Adverse Event|3
289337|NCT00945321|953276|P6|Period 4|Lost to Follow-up|1
289338|NCT00945321|953277|P5|Period 4|Lost to Follow-up|0
289339|NCT00945321|953278|P4|Period 4|Lost to Follow-up|0
289340|NCT00945321|953279|P3|Period 4|Lost to Follow-up|0
289341|NCT00945321|953280|P2|Period 4|Lost to Follow-up|0
289342|NCT00945321|953281|P1|Period 4|Lost to Follow-up|0
289343|NCT00945321|953276|P6|Period 1|Adverse Event|0
289344|NCT00945321|953277|P5|Period 1|Adverse Event|1
289345|NCT00945321|953278|P4|Period 1|Adverse Event|0
289346|NCT00945321|953279|P3|Period 1|Adverse Event|0
289347|NCT00945321|953280|P2|Period 1|Adverse Event|0
289348|NCT00945321|953281|P1|Period 1|Adverse Event|0
289349|NCT00945243|953333|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
289350|NCT00944697|953490|P2|Overall Study|Administrative|1
289351|NCT00944697|953491|P1|Overall Study|Administrative|1
289352|NCT00944697|953490|P2|Overall Study|Adverse Event|3
289353|NCT00944697|953491|P1|Overall Study|Adverse Event|0
289354|NCT00944697|953490|P2|Overall Study|Withdrawal by Subject|1
289355|NCT00944697|953491|P1|Overall Study|Withdrawal by Subject|1
289356|NCT00944645|953521|P2|Period 2|Withdrawal by Subject|6
289357|NCT00944645|953522|P1|Period 2|Withdrawal by Subject|7
289358|NCT00944645|953521|P2|Period 2|Lost to Follow-up|3
289359|NCT00944645|953522|P1|Period 2|Lost to Follow-up|0
289360|NCT00944645|953521|P2|Period 2|Adverse Event|0
289361|NCT00944645|953522|P1|Period 2|Adverse Event|1
289362|NCT00944229|953543|P1|Overall Study|Physician Decision|14
289363|NCT00944229|953543|P1|Overall Study|Withdrawal by Subject|11
289364|NCT00944125|953549|P2|6 Months to Study Completion|Withdrawal by Subject|2
289365|NCT00944125|953550|P1|6 Months to Study Completion|Withdrawal by Subject|0
289366|NCT00944125|953549|P2|3 to 6 Months|Withdrawal by Subject|2
289367|NCT00944125|953550|P1|3 to 6 Months|Withdrawal by Subject|0
289368|NCT00944034|953649|P12|Overall Study|Administrative reason|0
289370|NCT00944034|953651|P10|Overall Study|Administrative reason|0
289371|NCT00944034|953652|P9|Overall Study|Administrative reason|0
289372|NCT00944034|953653|P8|Overall Study|Administrative reason|0
289373|NCT00944034|953654|P7|Overall Study|Administrative reason|1
289374|NCT00944034|953655|P6|Overall Study|Administrative reason|0
289375|NCT00944034|953656|P5|Overall Study|Administrative reason|0
289376|NCT00944034|953657|P4|Overall Study|Administrative reason|0
289377|NCT00944034|953658|P3|Overall Study|Administrative reason|0
289378|NCT00944034|953659|P2|Overall Study|Administrative reason|0
289379|NCT00944034|953660|P1|Overall Study|Administrative reason|0
289380|NCT00944034|953649|P12|Overall Study|Unable to classify|0
289381|NCT00944034|953650|P11|Overall Study|Unable to classify|0
289382|NCT00944034|953651|P10|Overall Study|Unable to classify|0
289383|NCT00944034|953652|P9|Overall Study|Unable to classify|0
289384|NCT00944034|953653|P8|Overall Study|Unable to classify|1
289385|NCT00944034|953654|P7|Overall Study|Unable to classify|1
289386|NCT00944034|953655|P6|Overall Study|Unable to classify|1
289387|NCT00944034|953656|P5|Overall Study|Unable to classify|0
289388|NCT00944034|953657|P4|Overall Study|Unable to classify|0
289389|NCT00944034|953658|P3|Overall Study|Unable to classify|0
289390|NCT00944034|953659|P2|Overall Study|Unable to classify|0
289391|NCT00944034|953660|P1|Overall Study|Unable to classify|0
289392|NCT00944034|953649|P12|Overall Study|Protocol Violation|0
289393|NCT00944034|953650|P11|Overall Study|Protocol Violation|0
289394|NCT00944034|953651|P10|Overall Study|Protocol Violation|4
289395|NCT00944034|953652|P9|Overall Study|Protocol Violation|1
289396|NCT00944034|953653|P8|Overall Study|Protocol Violation|1
289397|NCT00944034|953654|P7|Overall Study|Protocol Violation|0
289398|NCT00944034|953655|P6|Overall Study|Protocol Violation|3
289399|NCT00944034|953656|P5|Overall Study|Protocol Violation|2
289400|NCT00944034|953657|P4|Overall Study|Protocol Violation|1
289401|NCT00944034|953658|P3|Overall Study|Protocol Violation|0
289402|NCT00944034|953659|P2|Overall Study|Protocol Violation|0
289403|NCT00944034|953660|P1|Overall Study|Protocol Violation|2
289404|NCT00944034|953649|P12|Overall Study|Death|0
289405|NCT00944034|953650|P11|Overall Study|Death|0
289406|NCT00944034|953651|P10|Overall Study|Death|0
289407|NCT00944034|953652|P9|Overall Study|Death|0
289408|NCT00944034|953653|P8|Overall Study|Death|0
289409|NCT00944034|953654|P7|Overall Study|Death|0
289410|NCT00944034|953655|P6|Overall Study|Death|0
289411|NCT00944034|953656|P5|Overall Study|Death|0
289412|NCT00944034|953657|P4|Overall Study|Death|0
289413|NCT00944034|953658|P3|Overall Study|Death|1
289414|NCT00944034|953659|P2|Overall Study|Death|0
289415|NCT00944034|953660|P1|Overall Study|Death|0
289416|NCT00944034|953649|P12|Overall Study|Lost to Follow-up|0
289417|NCT00944034|953650|P11|Overall Study|Lost to Follow-up|1
289418|NCT00944034|953651|P10|Overall Study|Lost to Follow-up|1
289419|NCT00944034|953652|P9|Overall Study|Lost to Follow-up|5
289420|NCT00944034|953653|P8|Overall Study|Lost to Follow-up|1
289421|NCT00944034|953654|P7|Overall Study|Lost to Follow-up|0
289422|NCT00944034|953655|P6|Overall Study|Lost to Follow-up|7
289423|NCT00944034|953656|P5|Overall Study|Lost to Follow-up|5
289424|NCT00944034|953657|P4|Overall Study|Lost to Follow-up|0
289425|NCT00944034|953658|P3|Overall Study|Lost to Follow-up|2
289426|NCT00944034|953659|P2|Overall Study|Lost to Follow-up|4
289427|NCT00944034|953660|P1|Overall Study|Lost to Follow-up|0
289428|NCT00944034|953649|P12|Overall Study|Withdrawal by Subject|4
289429|NCT00944034|953650|P11|Overall Study|Withdrawal by Subject|0
289430|NCT00944034|953651|P10|Overall Study|Withdrawal by Subject|4
289431|NCT00944034|953652|P9|Overall Study|Withdrawal by Subject|3
289432|NCT00944034|953653|P8|Overall Study|Withdrawal by Subject|2
289433|NCT00944034|953654|P7|Overall Study|Withdrawal by Subject|2
289434|NCT00944034|953655|P6|Overall Study|Withdrawal by Subject|8
289435|NCT00944034|953656|P5|Overall Study|Withdrawal by Subject|5
289436|NCT00944034|953657|P4|Overall Study|Withdrawal by Subject|2
289437|NCT00944034|953658|P3|Overall Study|Withdrawal by Subject|6
289438|NCT00944034|953659|P2|Overall Study|Withdrawal by Subject|2
289439|NCT00944034|953660|P1|Overall Study|Withdrawal by Subject|3
289440|NCT00944034|953649|P12|Overall Study|Inappropriate enrollment|0
289441|NCT00944034|953650|P11|Overall Study|Inappropriate enrollment|0
289442|NCT00944034|953651|P10|Overall Study|Inappropriate enrollment|1
289443|NCT00944034|953652|P9|Overall Study|Inappropriate enrollment|1
289444|NCT00944034|953653|P8|Overall Study|Inappropriate enrollment|0
289445|NCT00944034|953654|P7|Overall Study|Inappropriate enrollment|0
289446|NCT00944034|953655|P6|Overall Study|Inappropriate enrollment|1
289447|NCT00944034|953656|P5|Overall Study|Inappropriate enrollment|2
289448|NCT00944034|953657|P4|Overall Study|Inappropriate enrollment|1
289449|NCT00944034|953658|P3|Overall Study|Inappropriate enrollment|0
289450|NCT00944034|953659|P2|Overall Study|Inappropriate enrollment|1
289451|NCT00944034|953660|P1|Overall Study|Inappropriate enrollment|0
289452|NCT00943917|953806|P15|Stage II Continuation|A1C elevation|0
289453|NCT00943917|953807|P14|Stage II Continuation|A1C elevation|1
289454|NCT00943917|953808|P13|Stage II Continuation|A1C elevation|0
289455|NCT00943917|953809|P12|Stage II Continuation|A1C elevation|0
289456|NCT00943917|953810|P11|Stage II Continuation|A1C elevation|0
289457|NCT00943917|953811|P10|Stage II Continuation|A1C elevation|0
289458|NCT00943917|953812|P9|Stage II Continuation|A1C elevation|0
289459|NCT00943917|953813|P8|Stage II Continuation|A1C elevation|0
289460|NCT00943917|953814|P7|Stage II Continuation|A1C elevation|0
289461|NCT00943917|953815|P6|Stage II Continuation|A1C elevation|0
289462|NCT00943917|953816|P5|Stage II Continuation|A1C elevation|0
289463|NCT00943917|953817|P4|Stage II Continuation|A1C elevation|0
289464|NCT00943917|953818|P3|Stage II Continuation|A1C elevation|0
289465|NCT00943917|953819|P2|Stage II Continuation|A1C elevation|0
289466|NCT00943917|953820|P1|Stage II Continuation|A1C elevation|0
289467|NCT00943917|953806|P15|Stage II Continuation|hypoglycemia|0
289468|NCT00943917|953807|P14|Stage II Continuation|hypoglycemia|0
289469|NCT00943917|953808|P13|Stage II Continuation|hypoglycemia|1
289470|NCT00943917|953809|P12|Stage II Continuation|hypoglycemia|0
289471|NCT00943917|953810|P11|Stage II Continuation|hypoglycemia|0
289472|NCT00943917|953811|P10|Stage II Continuation|hypoglycemia|0
289473|NCT00943917|953812|P9|Stage II Continuation|hypoglycemia|0
289474|NCT00943917|953813|P8|Stage II Continuation|hypoglycemia|0
289475|NCT00943917|953814|P7|Stage II Continuation|hypoglycemia|0
289476|NCT00943917|953815|P6|Stage II Continuation|hypoglycemia|0
289477|NCT00943917|953816|P5|Stage II Continuation|hypoglycemia|0
289478|NCT00943917|953817|P4|Stage II Continuation|hypoglycemia|0
289479|NCT00943917|953818|P3|Stage II Continuation|hypoglycemia|0
289480|NCT00943917|953819|P2|Stage II Continuation|hypoglycemia|0
289481|NCT00943917|953820|P1|Stage II Continuation|hypoglycemia|0
289482|NCT00943917|953806|P15|Stage II Continuation|Protocol Violation|0
289483|NCT00943917|953807|P14|Stage II Continuation|Protocol Violation|0
289484|NCT00943917|953808|P13|Stage II Continuation|Protocol Violation|0
289485|NCT00943917|953809|P12|Stage II Continuation|Protocol Violation|1
289486|NCT00943917|953810|P11|Stage II Continuation|Protocol Violation|0
289487|NCT00943917|953811|P10|Stage II Continuation|Protocol Violation|1
289488|NCT00943917|953812|P9|Stage II Continuation|Protocol Violation|0
289489|NCT00943917|953813|P8|Stage II Continuation|Protocol Violation|0
289490|NCT00943917|953814|P7|Stage II Continuation|Protocol Violation|0
289491|NCT00943917|953815|P6|Stage II Continuation|Protocol Violation|0
289492|NCT00943917|953816|P5|Stage II Continuation|Protocol Violation|0
289493|NCT00943917|953817|P4|Stage II Continuation|Protocol Violation|0
289494|NCT00943917|953818|P3|Stage II Continuation|Protocol Violation|0
289495|NCT00943917|953819|P2|Stage II Continuation|Protocol Violation|0
289496|NCT00943917|953820|P1|Stage II Continuation|Protocol Violation|0
289497|NCT00943917|953806|P15|Stage II Continuation|Withdrawal by Subject|3
289498|NCT00943917|953807|P14|Stage II Continuation|Withdrawal by Subject|1
289499|NCT00943917|953808|P13|Stage II Continuation|Withdrawal by Subject|0
289500|NCT00943917|953809|P12|Stage II Continuation|Withdrawal by Subject|0
289501|NCT00943917|953810|P11|Stage II Continuation|Withdrawal by Subject|0
289502|NCT00943917|953811|P10|Stage II Continuation|Withdrawal by Subject|0
289503|NCT00943917|953812|P9|Stage II Continuation|Withdrawal by Subject|0
289504|NCT00943917|953813|P8|Stage II Continuation|Withdrawal by Subject|0
289505|NCT00943917|953814|P7|Stage II Continuation|Withdrawal by Subject|0
289506|NCT00943917|953815|P6|Stage II Continuation|Withdrawal by Subject|0
289507|NCT00943917|953816|P5|Stage II Continuation|Withdrawal by Subject|0
289508|NCT00943917|953817|P4|Stage II Continuation|Withdrawal by Subject|0
289509|NCT00943917|953818|P3|Stage II Continuation|Withdrawal by Subject|0
289510|NCT00943917|953819|P2|Stage II Continuation|Withdrawal by Subject|0
289511|NCT00943917|953820|P1|Stage II Continuation|Withdrawal by Subject|0
289512|NCT00943917|953806|P15|Stage II Continuation|Adverse Event|1
289513|NCT00943917|953807|P14|Stage II Continuation|Adverse Event|1
289514|NCT00943917|953808|P13|Stage II Continuation|Adverse Event|2
289515|NCT00943917|953809|P12|Stage II Continuation|Adverse Event|1
289516|NCT00943917|953810|P11|Stage II Continuation|Adverse Event|0
289517|NCT00943917|953811|P10|Stage II Continuation|Adverse Event|0
289518|NCT00943917|953812|P9|Stage II Continuation|Adverse Event|0
289519|NCT00943917|953813|P8|Stage II Continuation|Adverse Event|0
289520|NCT00943917|953814|P7|Stage II Continuation|Adverse Event|0
289521|NCT00943917|953815|P6|Stage II Continuation|Adverse Event|0
289522|NCT00943917|953816|P5|Stage II Continuation|Adverse Event|0
289523|NCT00943917|953817|P4|Stage II Continuation|Adverse Event|0
289524|NCT00943917|953818|P3|Stage II Continuation|Adverse Event|0
289525|NCT00943917|953819|P2|Stage II Continuation|Adverse Event|0
289526|NCT00943917|953820|P1|Stage II Continuation|Adverse Event|0
289527|NCT00943917|953806|P15|Stage II|Pregnancy|0
289528|NCT00943917|953807|P14|Stage II|Pregnancy|0
289529|NCT00943917|953808|P13|Stage II|Pregnancy|0
289530|NCT00943917|953809|P12|Stage II|Pregnancy|0
289531|NCT00943917|953810|P11|Stage II|Pregnancy|0
289532|NCT00943917|953811|P10|Stage II|Pregnancy|0
289533|NCT00943917|953812|P9|Stage II|Pregnancy|0
289534|NCT00943917|953813|P8|Stage II|Pregnancy|0
289535|NCT00943917|953814|P7|Stage II|Pregnancy|0
289536|NCT00943917|953815|P6|Stage II|Pregnancy|1
289537|NCT00943917|953816|P5|Stage II|Pregnancy|0
289538|NCT00943917|953817|P4|Stage II|Pregnancy|0
289539|NCT00943917|953818|P3|Stage II|Pregnancy|0
289540|NCT00943917|953819|P2|Stage II|Pregnancy|0
289541|NCT00943917|953820|P1|Stage II|Pregnancy|0
289542|NCT00943917|953806|P15|Stage II|Withdrawal by Subject|0
289543|NCT00943917|953807|P14|Stage II|Withdrawal by Subject|0
289544|NCT00943917|953808|P13|Stage II|Withdrawal by Subject|0
289545|NCT00943917|953809|P12|Stage II|Withdrawal by Subject|0
289546|NCT00943917|953810|P11|Stage II|Withdrawal by Subject|0
289547|NCT00943917|953811|P10|Stage II|Withdrawal by Subject|0
289548|NCT00943917|953812|P9|Stage II|Withdrawal by Subject|0
289549|NCT00943917|953813|P8|Stage II|Withdrawal by Subject|0
289550|NCT00943917|953814|P7|Stage II|Withdrawal by Subject|0
289551|NCT00943917|953815|P6|Stage II|Withdrawal by Subject|1
289552|NCT00943917|953816|P5|Stage II|Withdrawal by Subject|0
289553|NCT00943917|953817|P4|Stage II|Withdrawal by Subject|0
289554|NCT00943917|953818|P3|Stage II|Withdrawal by Subject|0
289555|NCT00943917|953819|P2|Stage II|Withdrawal by Subject|0
289556|NCT00943917|953820|P1|Stage II|Withdrawal by Subject|0
289557|NCT00943917|953806|P15|Stage II|Adverse Event|0
289558|NCT00943917|953807|P14|Stage II|Adverse Event|0
289559|NCT00943917|953808|P13|Stage II|Adverse Event|0
289560|NCT00943917|953809|P12|Stage II|Adverse Event|0
289561|NCT00943917|953810|P11|Stage II|Adverse Event|0
289562|NCT00943917|953811|P10|Stage II|Adverse Event|0
289563|NCT00943917|953812|P9|Stage II|Adverse Event|1
289564|NCT00943917|953813|P8|Stage II|Adverse Event|0
289565|NCT00943917|953814|P7|Stage II|Adverse Event|3
289566|NCT00943917|953815|P6|Stage II|Adverse Event|1
289567|NCT00943917|953816|P5|Stage II|Adverse Event|0
289568|NCT00943917|953817|P4|Stage II|Adverse Event|0
289569|NCT00943917|953818|P3|Stage II|Adverse Event|0
289570|NCT00943917|953819|P2|Stage II|Adverse Event|0
289571|NCT00943917|953820|P1|Stage II|Adverse Event|0
289572|NCT00943917|953806|P15|Stage I|Withdrawal by Subject|0
289573|NCT00943917|953807|P14|Stage I|Withdrawal by Subject|0
289574|NCT00943917|953808|P13|Stage I|Withdrawal by Subject|0
289575|NCT00943917|953809|P12|Stage I|Withdrawal by Subject|0
289576|NCT00943917|953810|P11|Stage I|Withdrawal by Subject|0
289577|NCT00943917|953811|P10|Stage I|Withdrawal by Subject|0
289578|NCT00943917|953812|P9|Stage I|Withdrawal by Subject|0
289579|NCT00943917|953813|P8|Stage I|Withdrawal by Subject|0
289580|NCT00943917|953814|P7|Stage I|Withdrawal by Subject|0
289581|NCT00943917|953815|P6|Stage I|Withdrawal by Subject|0
289582|NCT00943917|953816|P5|Stage I|Withdrawal by Subject|0
289583|NCT00943917|953817|P4|Stage I|Withdrawal by Subject|0
289584|NCT00943917|953818|P3|Stage I|Withdrawal by Subject|2
289585|NCT00943917|953819|P2|Stage I|Withdrawal by Subject|1
289586|NCT00943917|953820|P1|Stage I|Withdrawal by Subject|2
289587|NCT00943917|953806|P15|Stage I|A1C elevation|0
289588|NCT00943917|953807|P14|Stage I|A1C elevation|0
289589|NCT00943917|953808|P13|Stage I|A1C elevation|0
289590|NCT00943917|953809|P12|Stage I|A1C elevation|0
289591|NCT00943917|953810|P11|Stage I|A1C elevation|0
289592|NCT00943917|953811|P10|Stage I|A1C elevation|0
289593|NCT00943917|953812|P9|Stage I|A1C elevation|0
289594|NCT00943917|953813|P8|Stage I|A1C elevation|0
289595|NCT00943917|953814|P7|Stage I|A1C elevation|0
289596|NCT00943917|953815|P6|Stage I|A1C elevation|0
289597|NCT00943917|953816|P5|Stage I|A1C elevation|0
289598|NCT00943917|953817|P4|Stage I|A1C elevation|0
289599|NCT00943917|953818|P3|Stage I|A1C elevation|0
289600|NCT00943917|953819|P2|Stage I|A1C elevation|0
289601|NCT00943917|953820|P1|Stage I|A1C elevation|1
289602|NCT00943917|953806|P15|Stage I|hyperglycemia|0
289603|NCT00943917|953807|P14|Stage I|hyperglycemia|0
289604|NCT00943917|953808|P13|Stage I|hyperglycemia|0
289605|NCT00943917|953809|P12|Stage I|hyperglycemia|0
289606|NCT00943917|953810|P11|Stage I|hyperglycemia|0
289607|NCT00943917|953811|P10|Stage I|hyperglycemia|0
289608|NCT00943917|953812|P9|Stage I|hyperglycemia|0
289609|NCT00943917|953813|P8|Stage I|hyperglycemia|0
289610|NCT00943917|953814|P7|Stage I|hyperglycemia|0
289611|NCT00943917|953815|P6|Stage I|hyperglycemia|0
289612|NCT00943917|953816|P5|Stage I|hyperglycemia|0
289613|NCT00943917|953817|P4|Stage I|hyperglycemia|0
289614|NCT00943917|953818|P3|Stage I|hyperglycemia|1
289615|NCT00943917|953819|P2|Stage I|hyperglycemia|0
289616|NCT00943917|953820|P1|Stage I|hyperglycemia|0
289617|NCT00943917|953806|P15|Stage I|Lost to Follow-up|0
289618|NCT00943917|953807|P14|Stage I|Lost to Follow-up|0
289619|NCT00943917|953808|P13|Stage I|Lost to Follow-up|0
289620|NCT00943917|953809|P12|Stage I|Lost to Follow-up|0
289621|NCT00943917|953810|P11|Stage I|Lost to Follow-up|0
289622|NCT00943917|953811|P10|Stage I|Lost to Follow-up|0
289623|NCT00943917|953812|P9|Stage I|Lost to Follow-up|0
289624|NCT00943917|953813|P8|Stage I|Lost to Follow-up|0
289625|NCT00943917|953814|P7|Stage I|Lost to Follow-up|0
289626|NCT00943917|953815|P6|Stage I|Lost to Follow-up|0
289627|NCT00943917|953816|P5|Stage I|Lost to Follow-up|0
289628|NCT00943917|953817|P4|Stage I|Lost to Follow-up|0
289629|NCT00943917|953818|P3|Stage I|Lost to Follow-up|1
289630|NCT00943917|953819|P2|Stage I|Lost to Follow-up|0
289631|NCT00943917|953820|P1|Stage I|Lost to Follow-up|0
289632|NCT00943917|953806|P15|Stage I|Adverse Event|0
289633|NCT00943917|953807|P14|Stage I|Adverse Event|0
289634|NCT00943917|953808|P13|Stage I|Adverse Event|0
289635|NCT00943917|953809|P12|Stage I|Adverse Event|0
289636|NCT00943917|953810|P11|Stage I|Adverse Event|0
289637|NCT00943917|953811|P10|Stage I|Adverse Event|0
289638|NCT00943917|953812|P9|Stage I|Adverse Event|0
289639|NCT00943917|953813|P8|Stage I|Adverse Event|0
289640|NCT00943917|953814|P7|Stage I|Adverse Event|0
289641|NCT00943917|953815|P6|Stage I|Adverse Event|0
289642|NCT00943917|953816|P5|Stage I|Adverse Event|0
289643|NCT00943917|953817|P4|Stage I|Adverse Event|0
289644|NCT00943917|953818|P3|Stage I|Adverse Event|2
289645|NCT00943917|953819|P2|Stage I|Adverse Event|2
289646|NCT00943917|953820|P1|Stage I|Adverse Event|1
289647|NCT00943852|953996|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
289648|NCT00943852|953997|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
289649|NCT00943852|953998|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
289650|NCT00943852|953999|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
289651|NCT00943852|954000|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
289652|NCT00943852|954001|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
289653|NCT00943852|954002|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
289654|NCT00943852|954003|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
289655|NCT00943852|954004|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
289656|NCT00943852|954005|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
289657|NCT00943852|953996|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
289658|NCT00943852|953997|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
289659|NCT00943852|953998|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
289660|NCT00943852|953999|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
289661|NCT00943852|954000|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
289662|NCT00943852|954001|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
289663|NCT00943852|954002|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
289664|NCT00943852|954003|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
289665|NCT00943852|954004|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
289666|NCT00943852|954005|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
289667|NCT00943852|953996|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
289668|NCT00943852|953997|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
289669|NCT00943852|953998|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
289670|NCT00943852|953999|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
289671|NCT00943852|954000|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
289672|NCT00943852|954001|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
289673|NCT00943852|954002|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
289674|NCT00943852|954003|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
289675|NCT00943852|954004|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
289676|NCT00943852|954005|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
289677|NCT00943852|953996|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
289678|NCT00943852|953997|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
289679|NCT00943852|953998|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
289680|NCT00943852|953999|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
289681|NCT00943852|954000|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
289682|NCT00943852|954001|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
289683|NCT00943852|954002|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
289684|NCT00943852|954003|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
289685|NCT00943852|954004|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
289686|NCT00943852|954005|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
289687|NCT00943852|953996|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
289688|NCT00943852|953997|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
289689|NCT00943852|953998|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
289690|NCT00943852|953999|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
289691|NCT00943852|954000|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
289692|NCT00943852|954001|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
289693|NCT00943852|954002|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
289694|NCT00943852|954003|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
289695|NCT00943852|954004|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
289696|NCT00943852|954005|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
289697|NCT00943826|954018|P2|Monotherapy Phase|Failure to return|1
289698|NCT00943826|954019|P1|Monotherapy Phase|Failure to return|2
289699|NCT00943826|954018|P2|Monotherapy Phase|Withdrew Consent|3
289700|NCT00943826|954019|P1|Monotherapy Phase|Withdrew Consent|3
289701|NCT00943826|954018|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
289702|NCT00943826|954019|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|5
289703|NCT00943826|954018|P2|Monotherapy Phase|Administrative reasons|4
289704|NCT00943826|954019|P1|Monotherapy Phase|Administrative reasons|8
289705|NCT00943826|954018|P2|Monotherapy Phase|Adverse Event|3
289706|NCT00943826|954019|P1|Monotherapy Phase|Adverse Event|33
289707|NCT00943826|954018|P2|Maintenance Phase|Failure to return|1
289708|NCT00943826|954019|P1|Maintenance Phase|Failure to return|0
289709|NCT00943826|954018|P2|Maintenance Phase|Administrative reasons|2
289710|NCT00943826|954019|P1|Maintenance Phase|Administrative reasons|4
289711|NCT00943826|954018|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
289712|NCT00943826|954019|P1|Maintenance Phase|Refused treatment/Did not cooperate|4
289713|NCT00943826|954018|P2|Maintenance Phase|Withdrew consent|5
289714|NCT00943826|954019|P1|Maintenance Phase|Withdrew consent|4
289715|NCT00943826|954018|P2|Maintenance Phase|Adverse Event|30
289716|NCT00943826|954019|P1|Maintenance Phase|Adverse Event|31
289717|NCT00943826|954018|P2|Concurrent Phase|Protocol Violation|0
289718|NCT00943826|954019|P1|Concurrent Phase|Protocol Violation|1
289719|NCT00943826|954018|P2|Concurrent Phase|Administrative reasons|1
289720|NCT00943826|954019|P1|Concurrent Phase|Administrative reasons|2
289721|NCT00943826|954018|P2|Concurrent Phase|Refused treatment/Did not cooperate|6
289722|NCT00943826|954019|P1|Concurrent Phase|Refused treatment/Did not cooperate|4
289723|NCT00943826|954018|P2|Concurrent Phase|Withdrew consent|8
289724|NCT00943826|954019|P1|Concurrent Phase|Withdrew consent|4
289725|NCT00943826|954018|P2|Concurrent Phase|Adverse Event|27
289726|NCT00943826|954019|P1|Concurrent Phase|Adverse Event|50
289727|NCT00943787|954033|P1|Overall Study|Withdrawal by Subject|3
289728|NCT00943787|954033|P1|Overall Study|Physician Decision|4
289729|NCT00943761|954040|P2|Overall Study|Withdrawal by Subject|1
289730|NCT00943761|954041|P1|Overall Study|Withdrawal by Subject|2
289731|NCT00943761|954040|P2|Overall Study|Lost to Follow-up|0
289732|NCT00943761|954041|P1|Overall Study|Lost to Follow-up|2
289733|NCT00943735|954053|P1|Overall Study|Other|3
289734|NCT00943735|954053|P1|Overall Study|Unspecified|8
289735|NCT00943735|954053|P1|Overall Study|Death|1
289736|NCT00943735|954053|P1|Overall Study|Withdrawal by Subject|8
289737|NCT00943735|954053|P1|Overall Study|Adverse Event|12
289738|NCT00943722|954091|P5|Overall Study|Withdrawal by Subject|8
289739|NCT00943722|954092|P4|Overall Study|Withdrawal by Subject|13
289740|NCT00943722|954093|P3|Overall Study|Withdrawal by Subject|2
289741|NCT00943722|954094|P2|Overall Study|Withdrawal by Subject|13
289742|NCT00943722|954095|P1|Overall Study|Withdrawal by Subject|12
289743|NCT00943722|954091|P5|Overall Study|Protocol Violation|2
289744|NCT00943722|954092|P4|Overall Study|Protocol Violation|0
289745|NCT00943722|954093|P3|Overall Study|Protocol Violation|0
289746|NCT00943722|954094|P2|Overall Study|Protocol Violation|1
289747|NCT00943722|954095|P1|Overall Study|Protocol Violation|0
289748|NCT00943722|954091|P5|Overall Study|Pregnancy|0
289749|NCT00943722|954092|P4|Overall Study|Pregnancy|0
289750|NCT00943722|954093|P3|Overall Study|Pregnancy|1
289751|NCT00943722|954094|P2|Overall Study|Pregnancy|0
289752|NCT00943722|954095|P1|Overall Study|Pregnancy|0
289753|NCT00943722|954091|P5|Overall Study|Physician Decision|1
289754|NCT00943722|954092|P4|Overall Study|Physician Decision|0
289755|NCT00943722|954093|P3|Overall Study|Physician Decision|0
289756|NCT00943722|954094|P2|Overall Study|Physician Decision|0
289757|NCT00943722|954095|P1|Overall Study|Physician Decision|1
289758|NCT00943722|954091|P5|Overall Study|Lost to Follow-up|11
289759|NCT00943722|954092|P4|Overall Study|Lost to Follow-up|8
289760|NCT00943722|954093|P3|Overall Study|Lost to Follow-up|10
289761|NCT00943722|954094|P2|Overall Study|Lost to Follow-up|8
289762|NCT00943722|954095|P1|Overall Study|Lost to Follow-up|12
289763|NCT00943722|954091|P5|Overall Study|Adverse Event|0
289764|NCT00943722|954092|P4|Overall Study|Adverse Event|1
289765|NCT00943722|954093|P3|Overall Study|Adverse Event|0
289766|NCT00943722|954094|P2|Overall Study|Adverse Event|0
289767|NCT00943722|954095|P1|Overall Study|Adverse Event|0
289768|NCT00943683|954125|P2|Overall Study|Patient Moved|0
289769|NCT00943683|954126|P1|Overall Study|Patient Moved|1
289770|NCT00943683|954125|P2|Overall Study|Withdrawal by Subject|0
289771|NCT00943683|954126|P1|Overall Study|Withdrawal by Subject|1
289772|NCT00943683|954125|P2|Overall Study|Protocol Violation|2
289773|NCT00943683|954126|P1|Overall Study|Protocol Violation|1
289774|NCT00943683|954125|P2|Overall Study|Lost to Follow-up|1
289775|NCT00943683|954126|P1|Overall Study|Lost to Follow-up|1
289776|NCT00943683|954125|P2|Overall Study|Adverse Event|3
289777|NCT00943683|954126|P1|Overall Study|Adverse Event|3
289778|NCT00943670|954132|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
289779|NCT00943670|954132|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
289780|NCT00943670|954132|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
289781|NCT00943670|954132|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
289782|NCT00943670|954132|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
289783|NCT00943670|954132|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
289784|NCT00943670|954132|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
289785|NCT00943670|954132|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
289786|NCT00943670|954132|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
289787|NCT00943670|954132|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
289788|NCT00943605|954221|P2|Overall Study|Study termination|30
289789|NCT00943605|954222|P1|Overall Study|Study termination|30
289790|NCT00943592|954232|P1|Overall Study|Death|3
289791|NCT00943579|954245|P2|Overall Study|Lack of Efficacy|2
289792|NCT00943579|954246|P1|Overall Study|Lack of Efficacy|2
289793|NCT00943579|954245|P2|Overall Study|Adverse Event|3
289794|NCT00943579|954246|P1|Overall Study|Adverse Event|4
289795|NCT00943397|954340|P2|Overall Study|Site terminated and other|56
289796|NCT00943397|954341|P1|Overall Study|Site terminated and other|12
289797|NCT00943397|954340|P2|Overall Study|Withdrawal by Subject|1
289798|NCT00943397|954341|P1|Overall Study|Withdrawal by Subject|1
289799|NCT00943397|954340|P2|Overall Study|Protocol Violation|5
289800|NCT00943397|954341|P1|Overall Study|Protocol Violation|2
289801|NCT00943397|954340|P2|Overall Study|Lost to Follow-up|4
289802|NCT00943397|954341|P1|Overall Study|Lost to Follow-up|0
289803|NCT00943397|954340|P2|Overall Study|Adverse Event|6
289804|NCT00943397|954341|P1|Overall Study|Adverse Event|0
289805|NCT00943384|954347|P1|Overall Study|Withdrawal by Subject|5
289806|NCT00943384|954347|P1|Overall Study|Lost to Follow-up|16
289807|NCT00943384|954347|P1|Overall Study|Treated off protocol-protocol violation|5
289808|NCT00943384|954347|P1|Overall Study|Dispositioned prior to treatment|23
289809|NCT00943124|954606|P2|Period 1|Personal Reasons|1
289810|NCT00943124|954607|P1|Period 1|Personal Reasons|0
289811|NCT00943124|954606|P2|Period 1|Did Not Follow Study Procedures|0
289812|NCT00943124|954607|P1|Period 1|Did Not Follow Study Procedures|1
289813|NCT00943124|954606|P2|Period 1|Withdrawal by Subject|1
289814|NCT00943124|954607|P1|Period 1|Withdrawal by Subject|1
289815|NCT00943111|954629|P3|5 Years Long-term Treatment Period|Other than specified above|2
289816|NCT00943111|954630|P2|5 Years Long-term Treatment Period|Other than specified above|0
289817|NCT00943111|954631|P1|5 Years Long-term Treatment Period|Other than specified above|0
289818|NCT00943111|954629|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
289819|NCT00943111|954630|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
289820|NCT00943111|954631|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
289821|NCT00943111|954629|P3|5 Years Long-term Treatment Period|Pregnancy|4
289822|NCT00943111|954630|P2|5 Years Long-term Treatment Period|Pregnancy|0
289823|NCT00943111|954631|P1|5 Years Long-term Treatment Period|Pregnancy|0
289824|NCT00943111|954629|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
289825|NCT00943111|954630|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
289826|NCT00943111|954631|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
289827|NCT00943111|954629|P3|5 Years Long-term Treatment Period|Adverse Event|9
289828|NCT00943111|954630|P2|5 Years Long-term Treatment Period|Adverse Event|0
289829|NCT00943111|954631|P1|5 Years Long-term Treatment Period|Adverse Event|0
289830|NCT00943111|954629|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
289831|NCT00943111|954630|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
289832|NCT00943111|954631|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
289833|NCT00943111|954629|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
289834|NCT00943111|954630|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
289835|NCT00943111|954631|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
289836|NCT00943111|954629|P3|52-Weeks Primary Analysis Period|Adverse Event|0
289837|NCT00943111|954630|P2|52-Weeks Primary Analysis Period|Adverse Event|1
289838|NCT00943111|954631|P1|52-Weeks Primary Analysis Period|Adverse Event|2
289839|NCT00943072|954699|P2|Overall Study|Other|1
289840|NCT00943072|954700|P1|Overall Study|Other|1
289841|NCT00943072|954699|P2|Overall Study|Lack of Efficacy|4
289842|NCT00943072|954700|P1|Overall Study|Lack of Efficacy|0
289843|NCT00943072|954699|P2|Overall Study|Lost to Follow-up|2
289844|NCT00943072|954700|P1|Overall Study|Lost to Follow-up|1
289845|NCT00943072|954699|P2|Overall Study|Protocol Violation|1
289846|NCT00943072|954700|P1|Overall Study|Protocol Violation|0
289847|NCT00943072|954699|P2|Overall Study|Withdrawal by Subject|1
289848|NCT00943072|954700|P1|Overall Study|Withdrawal by Subject|3
289849|NCT00943072|954699|P2|Overall Study|Death|2
289850|NCT00943072|954700|P1|Overall Study|Death|0
289851|NCT00943072|954699|P2|Overall Study|Adverse Event|3
289852|NCT00943072|954700|P1|Overall Study|Adverse Event|0
289853|NCT00942994|954718|P2|Overall Study|Protocol deviation|2
289854|NCT00942994|954719|P1|Overall Study|Protocol deviation|1
289855|NCT00942994|954718|P2|Overall Study|Lost to Follow-up|4
289856|NCT00942994|954719|P1|Overall Study|Lost to Follow-up|1
289857|NCT00942994|954718|P2|Overall Study|Patient withdrew consent|8
289858|NCT00942994|954719|P1|Overall Study|Patient withdrew consent|5
289859|NCT00942994|954718|P2|Overall Study|Unsatisfactory therapeutic effect|1
289860|NCT00942994|954719|P1|Overall Study|Unsatisfactory therapeutic effect|1
289861|NCT00942994|954718|P2|Overall Study|Abnormal laboratory value(s)|0
289862|NCT00942994|954719|P1|Overall Study|Abnormal laboratory value(s)|1
289863|NCT00942994|954718|P2|Overall Study|Adverse Event|4
289864|NCT00942994|954719|P1|Overall Study|Adverse Event|7
289865|NCT00942968|954735|P1|Overall Study|Deep vein thrombosis (DVT)|2
289866|NCT00942968|954735|P1|Overall Study|Participant required pancreatic biopsy|1
289867|NCT00942968|954735|P1|Overall Study|Pulmonary embolism (PE)|1
289868|NCT00942968|954735|P1|Overall Study|Inferior vena cava filter placement|4
289869|NCT00942968|954735|P1|Overall Study|Progression of disease|12
289870|NCT00942968|954735|P1|Overall Study|Physician Decision|11
289871|NCT00942968|954735|P1|Overall Study|Sponsor request|5
289872|NCT00942968|954735|P1|Overall Study|Withdrawal by Subject|44
289873|NCT00942968|954735|P1|Overall Study|Lost to Follow-up|4
289874|NCT00942968|954735|P1|Overall Study|Protocol Violation|9
289875|NCT00942968|954735|P1|Overall Study|Death|76
289876|NCT00942968|954735|P1|Overall Study|Adverse Event|60
289877|NCT00942734|954790|P1|Overall Study|Physician Decision|1
289878|NCT00942734|954790|P1|Overall Study|Disease Progression|2
289879|NCT00942734|954790|P1|Overall Study|Protocol Violation|3
289880|NCT00942734|954790|P1|Overall Study|Adverse Event|2
289881|NCT00942604|954796|P2|Overall Study|Patient relocation|1
289882|NCT00942604|954797|P1|Overall Study|Patient relocation|1
289883|NCT00942604|954796|P2|Overall Study|Withdrawal by Subject|1
289884|NCT00942604|954797|P1|Overall Study|Withdrawal by Subject|0
289885|NCT00942604|954796|P2|Overall Study|Adverse Event|1
289886|NCT00942604|954797|P1|Overall Study|Adverse Event|0
289887|NCT00942604|954796|P2|Overall Study|Protocol Violation|1
289888|NCT00942604|954797|P1|Overall Study|Protocol Violation|1
289889|NCT00942422|954874|P1|Overall Study|Progressive diease|1
289890|NCT00942422|954874|P1|Overall Study|Death|1
289891|NCT00942422|954874|P1|Overall Study|Withdrawal by Subject|1
289892|NCT00942409|954878|P1|Overall Study|study drug unavailable|2
289893|NCT00942409|954878|P1|Overall Study|Lack of Efficacy|1
289894|NCT00942266|954884|P2|Overall Study|medical deterioration (pneumonia)|1
289895|NCT00942266|954885|P1|Overall Study|medical deterioration (pneumonia)|0
289896|NCT00942266|954884|P2|Overall Study|Physician Decision|0
289897|NCT00942266|954885|P1|Overall Study|Physician Decision|2
289898|NCT00942266|954884|P2|Overall Study|Intercurrent illness|1
289899|NCT00942266|954885|P1|Overall Study|Intercurrent illness|0
289900|NCT00942266|954884|P2|Overall Study|Failure to thrive and pt withdrawal|1
289901|NCT00942266|954885|P1|Overall Study|Failure to thrive and pt withdrawal|0
289902|NCT00942266|954884|P2|Overall Study|Disease Progression|11
289903|NCT00942266|954885|P1|Overall Study|Disease Progression|38
289904|NCT00942266|954884|P2|Overall Study|Adverse Event|1
289905|NCT00942266|954885|P1|Overall Study|Adverse Event|2
289906|NCT00942266|954884|P2|Overall Study|Withdrawal by Subject|0
289907|NCT00942266|954885|P1|Overall Study|Withdrawal by Subject|1
289908|NCT00942175|954907|P4|Overall Study|Low Platelet Count|0
289909|NCT00942175|954908|P3|Overall Study|Low Platelet Count|0
289910|NCT00942175|954909|P2|Overall Study|Low Platelet Count|2
289911|NCT00942175|954910|P1|Overall Study|Low Platelet Count|0
289912|NCT00942175|954907|P4|Overall Study|Elevated Alanine Amino Transferase|1
289913|NCT00942175|954908|P3|Overall Study|Elevated Alanine Amino Transferase|0
289914|NCT00942175|954909|P2|Overall Study|Elevated Alanine Amino Transferase|0
289915|NCT00942175|954910|P1|Overall Study|Elevated Alanine Amino Transferase|0
289916|NCT00942175|954907|P4|Overall Study|Pregnancy|1
289917|NCT00942175|954908|P3|Overall Study|Pregnancy|0
289918|NCT00942175|954909|P2|Overall Study|Pregnancy|0
289919|NCT00942175|954910|P1|Overall Study|Pregnancy|0
289920|NCT00942175|954907|P4|Overall Study|Protocol Violation|0
289921|NCT00942175|954908|P3|Overall Study|Protocol Violation|2
289922|NCT00942175|954909|P2|Overall Study|Protocol Violation|1
289923|NCT00942175|954910|P1|Overall Study|Protocol Violation|0
289924|NCT00942175|954907|P4|Overall Study|Adverse Event|0
289925|NCT00942175|954908|P3|Overall Study|Adverse Event|0
289926|NCT00942175|954909|P2|Overall Study|Adverse Event|1
289927|NCT00942175|954910|P1|Overall Study|Adverse Event|2
289928|NCT00942084|954964|P1|Overall Study|Death|2
289929|NCT00941928|954981|P1|Overall Study|Disease Progression|1
289930|NCT00941928|954981|P1|Overall Study|Withdrawal by Subject|1
289931|NCT00941863|954999|P5|Continued After PCD|Disease progression, recurrence, relapse|18
289932|NCT00941863|955000|P4|Continued After PCD|Disease progression, recurrence, relapse|0
289933|NCT00941863|955001|P3|Continued After PCD|Disease progression, recurrence, relapse|0
289934|NCT00941863|955002|P2|Continued After PCD|Disease progression, recurrence, relapse|0
289935|NCT00941863|955003|P1|Continued After PCD|Disease progression, recurrence, relapse|0
289936|NCT00941863|954999|P5|Continued After PCD|Withdrawal by Subject|1
289937|NCT00941863|955000|P4|Continued After PCD|Withdrawal by Subject|0
289938|NCT00941863|955001|P3|Continued After PCD|Withdrawal by Subject|0
289939|NCT00941863|955002|P2|Continued After PCD|Withdrawal by Subject|0
289940|NCT00941863|955003|P1|Continued After PCD|Withdrawal by Subject|0
289941|NCT00941863|954999|P5|Until Primary Completion Date (PCD)|Disease progression|73
289942|NCT00941863|955000|P4|Until Primary Completion Date (PCD)|Disease progression|14
289943|NCT00941863|955001|P3|Until Primary Completion Date (PCD)|Disease progression|8
289944|NCT00941863|955002|P2|Until Primary Completion Date (PCD)|Disease progression|1
289945|NCT00941863|955003|P1|Until Primary Completion Date (PCD)|Disease progression|6
289946|NCT00941863|954999|P5|Until Primary Completion Date (PCD)|Death|7
289947|NCT00941863|955000|P4|Until Primary Completion Date (PCD)|Death|2
289948|NCT00941863|955001|P3|Until Primary Completion Date (PCD)|Death|1
289949|NCT00941863|955002|P2|Until Primary Completion Date (PCD)|Death|0
289950|NCT00941863|955003|P1|Until Primary Completion Date (PCD)|Death|0
289951|NCT00941863|954999|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
289952|NCT00941863|955000|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
289953|NCT00941863|955001|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
289954|NCT00941863|955002|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
289955|NCT00941863|955003|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
289956|NCT00941863|954999|P5|Until Primary Completion Date (PCD)|Physician Decision|1
289957|NCT00941863|955000|P4|Until Primary Completion Date (PCD)|Physician Decision|0
289958|NCT00941863|955001|P3|Until Primary Completion Date (PCD)|Physician Decision|0
289959|NCT00941863|955002|P2|Until Primary Completion Date (PCD)|Physician Decision|0
289960|NCT00941863|955003|P1|Until Primary Completion Date (PCD)|Physician Decision|0
289961|NCT00941863|954999|P5|Until Primary Completion Date (PCD)|Adverse Event|5
289962|NCT00941863|955000|P4|Until Primary Completion Date (PCD)|Adverse Event|1
289963|NCT00941863|955001|P3|Until Primary Completion Date (PCD)|Adverse Event|2
289964|NCT00941863|955002|P2|Until Primary Completion Date (PCD)|Adverse Event|2
289965|NCT00941863|955003|P1|Until Primary Completion Date (PCD)|Adverse Event|1
289966|NCT00941798|955030|P2|Overall Study|Death|1
289967|NCT00941798|955031|P1|Overall Study|Death|0
289968|NCT00941798|955030|P2|Overall Study|Abnormal laboratory values|2
289969|NCT00941798|955031|P1|Overall Study|Abnormal laboratory values|1
289970|NCT00941798|955030|P2|Overall Study|Abnormal test procedure results|1
289971|NCT00941798|955031|P1|Overall Study|Abnormal test procedure results|3
289972|NCT00941798|955030|P2|Overall Study|Patient's inability to use device|1
289973|NCT00941798|955031|P1|Overall Study|Patient's inability to use device|6
289974|NCT00941798|955030|P2|Overall Study|Lack of Efficacy|17
289975|NCT00941798|955031|P1|Overall Study|Lack of Efficacy|10
289976|NCT00941798|955030|P2|Overall Study|Administrative problems|23
289977|NCT00941798|955031|P1|Overall Study|Administrative problems|13
289978|NCT00941798|955030|P2|Overall Study|Protocol Violation|20
289979|NCT00941798|955031|P1|Overall Study|Protocol Violation|17
289980|NCT00941798|955030|P2|Overall Study|Lost to Follow-up|23
289981|NCT00941798|955031|P1|Overall Study|Lost to Follow-up|29
289982|NCT00941798|955030|P2|Overall Study|Adverse Event|23
289983|NCT00941798|955031|P1|Overall Study|Adverse Event|43
289984|NCT00941798|955030|P2|Overall Study|Withdrawal by Subject|74
289985|NCT00941798|955031|P1|Overall Study|Withdrawal by Subject|72
289986|NCT00941733|955061|P2|Overall Study|Protocol Violation|6
289987|NCT00941733|955062|P1|Overall Study|Protocol Violation|15
289988|NCT00941733|955061|P2|Overall Study|Lost to Follow-up|2
289989|NCT00941733|955062|P1|Overall Study|Lost to Follow-up|1
289990|NCT00941733|955061|P2|Overall Study|Adverse Event|4
289991|NCT00941733|955062|P1|Overall Study|Adverse Event|20
289992|NCT00941733|955061|P2|Overall Study|Withdrawal by Subject|6
289993|NCT00941733|955062|P1|Overall Study|Withdrawal by Subject|14
289994|NCT00941733|955061|P2|Overall Study|Death|10
289995|NCT00941733|955062|P1|Overall Study|Death|24
289996|NCT00941720|955102|P1|Overall Study|ineligible|2
289997|NCT00941720|955102|P1|Overall Study|Insurance denied participation|11
289998|NCT00941720|955102|P1|Overall Study|Withdrawal by Subject|1
289999|NCT00941655|955149|P2|Overall Study|off study prior to trmt/noncompliance|1
290000|NCT00941655|955150|P1|Overall Study|off study prior to trmt/noncompliance|0
290001|NCT00941655|955149|P2|Overall Study|withdrew consent|3
290002|NCT00941655|955150|P1|Overall Study|withdrew consent|0
290003|NCT00941655|955149|P2|Overall Study|stopped chemo/decided to have surgery|1
290004|NCT00941655|955150|P1|Overall Study|stopped chemo/decided to have surgery|0
290005|NCT00941655|955149|P2|Overall Study|progressed while on chemo|2
290006|NCT00941655|955150|P1|Overall Study|progressed while on chemo|0
290007|NCT00941655|955149|P2|Overall Study|not meet criteria for chemo foll surgery|0
290008|NCT00941655|955150|P1|Overall Study|not meet criteria for chemo foll surgery|4
290009|NCT00941655|955149|P2|Overall Study|received some chemo, 4 and 9 cycles|0
290010|NCT00941655|955150|P1|Overall Study|received some chemo, 4 and 9 cycles|2
290011|NCT00941603|955164|P6|Overall Study|Did not meet protocol eligibility|0
290012|NCT00941603|955165|P5|Overall Study|Did not meet protocol eligibility|0
290013|NCT00941603|955166|P4|Overall Study|Did not meet protocol eligibility|0
290014|NCT00941603|955167|P3|Overall Study|Did not meet protocol eligibility|0
290015|NCT00941603|955168|P2|Overall Study|Did not meet protocol eligibility|0
290016|NCT00941603|955169|P1|Overall Study|Did not meet protocol eligibility|1
290017|NCT00941603|955164|P6|Overall Study|Protocol Violation|0
290018|NCT00941603|955165|P5|Overall Study|Protocol Violation|0
290019|NCT00941603|955166|P4|Overall Study|Protocol Violation|0
290020|NCT00941603|955167|P3|Overall Study|Protocol Violation|0
290021|NCT00941603|955168|P2|Overall Study|Protocol Violation|1
290022|NCT00941603|955169|P1|Overall Study|Protocol Violation|0
290023|NCT00941603|955164|P6|Overall Study|Withdrawal by Subject|1
290024|NCT00941603|955165|P5|Overall Study|Withdrawal by Subject|0
290025|NCT00941603|955166|P4|Overall Study|Withdrawal by Subject|2
290026|NCT00941603|955167|P3|Overall Study|Withdrawal by Subject|0
290027|NCT00941603|955168|P2|Overall Study|Withdrawal by Subject|0
290028|NCT00941603|955169|P1|Overall Study|Withdrawal by Subject|0
290029|NCT00941603|955164|P6|Overall Study|Lost to Follow-up|2
290030|NCT00941603|955165|P5|Overall Study|Lost to Follow-up|0
290031|NCT00941603|955166|P4|Overall Study|Lost to Follow-up|1
290032|NCT00941603|955167|P3|Overall Study|Lost to Follow-up|0
290033|NCT00941603|955168|P2|Overall Study|Lost to Follow-up|0
290034|NCT00941603|955169|P1|Overall Study|Lost to Follow-up|0
290035|NCT00941603|955164|P6|Overall Study|Adverse Event|0
290036|NCT00941603|955165|P5|Overall Study|Adverse Event|4
290037|NCT00941603|955166|P4|Overall Study|Adverse Event|1
290038|NCT00941603|955167|P3|Overall Study|Adverse Event|5
290039|NCT00941603|955168|P2|Overall Study|Adverse Event|15
290040|NCT00941603|955169|P1|Overall Study|Adverse Event|10
290041|NCT00941330|955191|P2|Overall Study|Physician Decision|2
290042|NCT00941330|955192|P1|Overall Study|Physician Decision|0
290043|NCT00941330|955191|P2|Overall Study|Other|0
290044|NCT00941330|955192|P1|Overall Study|Other|1
290045|NCT00941304|955205|P5|Overall Study|Lost to Follow-up|0
290046|NCT00941304|955206|P4|Overall Study|Lost to Follow-up|0
290047|NCT00941304|955207|P3|Overall Study|Lost to Follow-up|0
290048|NCT00941304|955208|P2|Overall Study|Lost to Follow-up|0
290049|NCT00941304|955209|P1|Overall Study|Lost to Follow-up|1
290050|NCT00941070|955271|P1|Overall Study|Patient non-compliant|1
290051|NCT00941031|955289|P7|Maintenance Period|Lack of Efficacy|13
290052|NCT00941031|955290|P6|Maintenance Period|Lack of Efficacy|0
290053|NCT00941031|955291|P5|Maintenance Period|Lack of Efficacy|0
290054|NCT00941031|955292|P4|Maintenance Period|Lack of Efficacy|0
290055|NCT00941031|955293|P3|Maintenance Period|Lack of Efficacy|0
290056|NCT00941031|955294|P2|Maintenance Period|Lack of Efficacy|0
290057|NCT00941031|955295|P1|Maintenance Period|Lack of Efficacy|0
290058|NCT00941031|955289|P7|Maintenance Period|Lost to Follow-up|7
290059|NCT00941031|955290|P6|Maintenance Period|Lost to Follow-up|2
290060|NCT00941031|955291|P5|Maintenance Period|Lost to Follow-up|2
290061|NCT00941031|955292|P4|Maintenance Period|Lost to Follow-up|0
290062|NCT00941031|955293|P3|Maintenance Period|Lost to Follow-up|0
290063|NCT00941031|955294|P2|Maintenance Period|Lost to Follow-up|0
290064|NCT00941031|955295|P1|Maintenance Period|Lost to Follow-up|0
290065|NCT00941031|955289|P7|Maintenance Period|Adverse Event|8
290066|NCT00941031|955290|P6|Maintenance Period|Adverse Event|2
290067|NCT00941031|955291|P5|Maintenance Period|Adverse Event|0
290068|NCT00941031|955292|P4|Maintenance Period|Adverse Event|0
290069|NCT00941031|955293|P3|Maintenance Period|Adverse Event|0
290070|NCT00941031|955294|P2|Maintenance Period|Adverse Event|0
290071|NCT00941031|955295|P1|Maintenance Period|Adverse Event|0
290072|NCT00941031|955289|P7|Maintenance Period|Protocol Violation|1
290073|NCT00941031|955290|P6|Maintenance Period|Protocol Violation|0
290074|NCT00941031|955291|P5|Maintenance Period|Protocol Violation|0
290075|NCT00941031|955292|P4|Maintenance Period|Protocol Violation|0
290076|NCT00941031|955293|P3|Maintenance Period|Protocol Violation|0
290077|NCT00941031|955294|P2|Maintenance Period|Protocol Violation|0
290078|NCT00941031|955295|P1|Maintenance Period|Protocol Violation|0
290079|NCT00941031|955289|P7|Maintenance Period|Administrative Problems|1
290080|NCT00941031|955290|P6|Maintenance Period|Administrative Problems|0
290081|NCT00941031|955291|P5|Maintenance Period|Administrative Problems|1
290082|NCT00941031|955292|P4|Maintenance Period|Administrative Problems|0
290083|NCT00941031|955293|P3|Maintenance Period|Administrative Problems|0
290084|NCT00941031|955294|P2|Maintenance Period|Administrative Problems|0
290085|NCT00941031|955295|P1|Maintenance Period|Administrative Problems|0
290086|NCT00941031|955289|P7|Maintenance Period|Withdrawal by Subject|13
290087|NCT00941031|955290|P6|Maintenance Period|Withdrawal by Subject|2
290088|NCT00941031|955291|P5|Maintenance Period|Withdrawal by Subject|6
290089|NCT00941031|955292|P4|Maintenance Period|Withdrawal by Subject|0
290090|NCT00941031|955293|P3|Maintenance Period|Withdrawal by Subject|0
290091|NCT00941031|955294|P2|Maintenance Period|Withdrawal by Subject|0
290092|NCT00941031|955295|P1|Maintenance Period|Withdrawal by Subject|0
290093|NCT00941031|955289|P7|Induction Period|Adverse Event|0
290094|NCT00941031|955290|P6|Induction Period|Adverse Event|0
290095|NCT00941031|955291|P5|Induction Period|Adverse Event|0
290096|NCT00941031|955292|P4|Induction Period|Adverse Event|2
290097|NCT00941031|955293|P3|Induction Period|Adverse Event|3
290098|NCT00941031|955294|P2|Induction Period|Adverse Event|0
290099|NCT00941031|955295|P1|Induction Period|Adverse Event|1
290100|NCT00941031|955289|P7|Induction Period|Adminstative Problems|0
290101|NCT00941031|955290|P6|Induction Period|Adminstative Problems|0
290102|NCT00941031|955291|P5|Induction Period|Adminstative Problems|0
290103|NCT00941031|955292|P4|Induction Period|Adminstative Problems|0
290104|NCT00941031|955293|P3|Induction Period|Adminstative Problems|1
290105|NCT00941031|955294|P2|Induction Period|Adminstative Problems|1
290106|NCT00941031|955295|P1|Induction Period|Adminstative Problems|1
290107|NCT00941031|955289|P7|Induction Period|Withdrawal by Subject|0
290108|NCT00941031|955290|P6|Induction Period|Withdrawal by Subject|0
290109|NCT00941031|955291|P5|Induction Period|Withdrawal by Subject|0
290110|NCT00941031|955292|P4|Induction Period|Withdrawal by Subject|2
290111|NCT00941031|955293|P3|Induction Period|Withdrawal by Subject|2
290112|NCT00941031|955294|P2|Induction Period|Withdrawal by Subject|2
290113|NCT00941031|955295|P1|Induction Period|Withdrawal by Subject|1
290114|NCT00941031|955289|P7|Induction Period|Lack of Efficacy|0
290115|NCT00941031|955290|P6|Induction Period|Lack of Efficacy|0
290116|NCT00941031|955291|P5|Induction Period|Lack of Efficacy|0
290117|NCT00941031|955292|P4|Induction Period|Lack of Efficacy|5
290118|NCT00941031|955293|P3|Induction Period|Lack of Efficacy|0
290119|NCT00941031|955294|P2|Induction Period|Lack of Efficacy|1
290120|NCT00941031|955295|P1|Induction Period|Lack of Efficacy|2
290121|NCT00940992|955321|P3|Overall Study|Lost to Follow-up|1
290122|NCT00940992|955322|P2|Overall Study|Lost to Follow-up|1
290123|NCT00940992|955323|P1|Overall Study|Lost to Follow-up|0
290124|NCT00940992|955321|P3|Overall Study|subject request|0
290125|NCT00940992|955322|P2|Overall Study|subject request|1
290126|NCT00940992|955323|P1|Overall Study|subject request|2
290127|NCT00940992|955321|P3|Overall Study|Adverse Event|1
290128|NCT00940992|955322|P2|Overall Study|Adverse Event|0
290129|NCT00940992|955323|P1|Overall Study|Adverse Event|2
290130|NCT00940875|955354|P2|Post-Study Treatment|Disease Progression|2
290131|NCT00940875|955355|P1|Post-Study Treatment|Disease Progression|0
290132|NCT00940875|955354|P2|Post-Study Treatment|Death|1
290133|NCT00940875|955355|P1|Post-Study Treatment|Death|0
290134|NCT00940875|955354|P2|Treatment Phase|Physician Decision|0
290135|NCT00940875|955355|P1|Treatment Phase|Physician Decision|1
290136|NCT00940875|955354|P2|Treatment Phase|Disease progression|11
290137|NCT00940875|955355|P1|Treatment Phase|Disease progression|9
290138|NCT00940875|955354|P2|Treatment Phase|Withdrawal by Subject|0
290139|NCT00940875|955355|P1|Treatment Phase|Withdrawal by Subject|3
290140|NCT00940875|955354|P2|Treatment Phase|Lack of Efficacy|0
290141|NCT00940875|955355|P1|Treatment Phase|Lack of Efficacy|1
290142|NCT00940875|955354|P2|Treatment Phase|Death|5
290143|NCT00940875|955355|P1|Treatment Phase|Death|3
290144|NCT00940875|955354|P2|Treatment Phase|Adverse Event|3
290145|NCT00940875|955355|P1|Treatment Phase|Adverse Event|9
290146|NCT00940485|955395|P2|Overall Study|Others|1
290147|NCT00940485|955396|P1|Overall Study|Others|1
290148|NCT00940485|955395|P2|Overall Study|Withdrawal by Subject|1
290149|NCT00940485|955396|P1|Overall Study|Withdrawal by Subject|1
290150|NCT00940485|955395|P2|Overall Study|Adverse Event|0
290151|NCT00940485|955396|P1|Overall Study|Adverse Event|8
290152|NCT00940485|955395|P2|Overall Study|Lost to Follow-up|3
290153|NCT00940485|955396|P1|Overall Study|Lost to Follow-up|2
290154|NCT00940485|955395|P2|Overall Study|HBeAb positive at Baseline|2
290155|NCT00940485|955396|P1|Overall Study|HBeAb positive at Baseline|3
290156|NCT00940108|955441|P4|Overall Study|Diagnosed with H1N1|1
290157|NCT00940108|955442|P3|Overall Study|Diagnosed with H1N1|0
290158|NCT00940108|955443|P2|Overall Study|Diagnosed with H1N1|0
290159|NCT00940108|955444|P1|Overall Study|Diagnosed with H1N1|0
290160|NCT00940108|955441|P4|Overall Study|Viral illness after Dose 1|0
290161|NCT00940108|955442|P3|Overall Study|Viral illness after Dose 1|0
290162|NCT00940108|955443|P2|Overall Study|Viral illness after Dose 1|1
290163|NCT00940108|955444|P1|Overall Study|Viral illness after Dose 1|0
290164|NCT00940108|955441|P4|Overall Study|Refused - pyrexia after Dose 1|0
290165|NCT00940108|955442|P3|Overall Study|Refused - pyrexia after Dose 1|0
290166|NCT00940108|955443|P2|Overall Study|Refused - pyrexia after Dose 1|1
290167|NCT00940108|955444|P1|Overall Study|Refused - pyrexia after Dose 1|0
290168|NCT00940108|955441|P4|Overall Study|Declined further vaccination|0
290169|NCT00940108|955442|P3|Overall Study|Declined further vaccination|3
290170|NCT00940108|955443|P2|Overall Study|Declined further vaccination|1
290171|NCT00940108|955444|P1|Overall Study|Declined further vaccination|0
290172|NCT00940108|955441|P4|Overall Study|Dose 2 contraindicated|1
290173|NCT00940108|955442|P3|Overall Study|Dose 2 contraindicated|0
290174|NCT00940108|955443|P2|Overall Study|Dose 2 contraindicated|1
290175|NCT00940108|955444|P1|Overall Study|Dose 2 contraindicated|1
290176|NCT00940108|955441|P4|Overall Study|Withdrew Consent|1
290177|NCT00940108|955442|P3|Overall Study|Withdrew Consent|0
290178|NCT00940108|955443|P2|Overall Study|Withdrew Consent|1
290179|NCT00940108|955444|P1|Overall Study|Withdrew Consent|2
290180|NCT00940108|955441|P4|Overall Study|Adverse Event|2
290181|NCT00940108|955442|P3|Overall Study|Adverse Event|0
290182|NCT00940108|955443|P2|Overall Study|Adverse Event|4
290183|NCT00940108|955444|P1|Overall Study|Adverse Event|2
290184|NCT00940017|955494|P1|Overall Study|Adverse Event|1
290185|NCT00940017|955494|P1|Overall Study|did not meet entrance criteria|3
290186|NCT00939809|955550|P1|Overall Study|Death|1
290187|NCT00939809|955550|P1|Overall Study|Adverse Event|2
290188|NCT00939783|955564|P1|Overall Study|Enrolled but not treated|1
290189|NCT00939783|955564|P1|Overall Study|Protocol Violation|3
290190|NCT00939783|955564|P1|Overall Study|Lost to Follow-up|8
290191|NCT00939783|955564|P1|Overall Study|Unspecified|16
290192|NCT00939783|955564|P1|Overall Study|Withdrawal by Subject|78
290193|NCT00939783|955564|P1|Overall Study|Study Terminated by Sponsor|498
290194|NCT00939783|955564|P1|Overall Study|Adverse Event|39
290195|NCT00939783|955564|P1|Overall Study|Death|6
290196|NCT00939692|955605|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
290197|NCT00939692|955606|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
290198|NCT00939692|955605|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
290199|NCT00939692|955606|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
290200|NCT00939627|955618|P3|Overall Study|No off-tx reason given|0
290201|NCT00939627|955619|P2|Overall Study|No off-tx reason given|2
290202|NCT00939627|955620|P1|Overall Study|No off-tx reason given|0
290203|NCT00939627|955618|P3|Overall Study|Not compliant|0
290204|NCT00939627|955619|P2|Overall Study|Not compliant|0
290205|NCT00939627|955620|P1|Overall Study|Not compliant|2
290206|NCT00939627|955618|P3|Overall Study|Other complicating disease|0
290207|NCT00939627|955619|P2|Overall Study|Other complicating disease|1
290208|NCT00939627|955620|P1|Overall Study|Other complicating disease|1
290209|NCT00939627|955618|P3|Overall Study|Withdrawal by Subject|0
290210|NCT00939627|955619|P2|Overall Study|Withdrawal by Subject|4
290211|NCT00939627|955620|P1|Overall Study|Withdrawal by Subject|2
290212|NCT00939627|955618|P3|Overall Study|Death|0
290213|NCT00939627|955619|P2|Overall Study|Death|2
290214|NCT00939627|955620|P1|Overall Study|Death|0
290215|NCT00939627|955618|P3|Overall Study|Adverse Event|0
290216|NCT00939627|955619|P2|Overall Study|Adverse Event|7
290217|NCT00939627|955620|P1|Overall Study|Adverse Event|6
290218|NCT00939627|955618|P3|Overall Study|Disease Progression|0
290219|NCT00939627|955619|P2|Overall Study|Disease Progression|12
290220|NCT00939627|955620|P1|Overall Study|Disease Progression|16
290221|NCT00939510|955656|P1|Overall Study|Withdrawal by Subject|1
290222|NCT00939484|955665|P3|Overall Study|Progression/Relapse|3
290223|NCT00939484|955666|P2|Overall Study|Progression/Relapse|20
290224|NCT00939484|955667|P1|Overall Study|Progression/Relapse|8
290225|NCT00939393|955693|P2|Overall Study|Lost to Follow-up|0
290226|NCT00939393|955694|P1|Overall Study|Lost to Follow-up|3
290227|NCT00939393|955693|P2|Overall Study|Withdrawal by Subject|0
290228|NCT00939393|955694|P1|Overall Study|Withdrawal by Subject|1
290229|NCT00939341|955725|P1|Overall Study|Incorrect enrolment|8
290230|NCT00939341|955725|P1|Overall Study|Protocol Violation|6
290231|NCT00939341|955725|P1|Overall Study|Withdrawal by Subject|13
290232|NCT00939341|955725|P1|Overall Study|Lost to Follow-up|23
290233|NCT00939341|955725|P1|Overall Study|Pregnancy|1
290234|NCT00939341|955725|P1|Overall Study|Adverse Event|15
290235|NCT00939185|955807|P1|Overall Study|Randomized But Did Not Receive Treatment|10
290236|NCT00939185|955807|P1|Overall Study|Withdrawal by Subject|2
290237|NCT00939185|955807|P1|Overall Study|Unspecified|3
290238|NCT00939185|955807|P1|Overall Study|Lost to Follow-up|6
290239|NCT00939185|955807|P1|Overall Study|Lack of Efficacy|1
290240|NCT00939185|955807|P1|Overall Study|Adverse Event|3
290241|NCT00939107|955845|P2|Overall Study|Lost to Follow-up|12
290242|NCT00939107|955846|P1|Overall Study|Lost to Follow-up|14
290243|NCT00939094|955860|P2|Overall Study|Abnormal ECG findings|0
290244|NCT00939094|955861|P1|Overall Study|Abnormal ECG findings|1
290245|NCT00939094|955860|P2|Overall Study|Study stopped by sponsor|2
290246|NCT00939094|955861|P1|Overall Study|Study stopped by sponsor|0
290247|NCT00939094|955860|P2|Overall Study|Severe non-compliance to protocol|1
290248|NCT00939094|955861|P1|Overall Study|Severe non-compliance to protocol|0
290249|NCT00939094|955860|P2|Overall Study|Eligibility criteria not fulfilled|0
290250|NCT00939094|955861|P1|Overall Study|Eligibility criteria not fulfilled|2
290251|NCT00939094|955860|P2|Overall Study|Lost to Follow-up|1
290252|NCT00939094|955861|P1|Overall Study|Lost to Follow-up|1
290253|NCT00939094|955860|P2|Overall Study|Withdrawal by Subject|6
290254|NCT00939094|955861|P1|Overall Study|Withdrawal by Subject|1
290255|NCT00939094|955860|P2|Overall Study|Adverse Event|0
290256|NCT00939094|955861|P1|Overall Study|Adverse Event|9
290257|NCT00939055|955883|P2|Overall Study|Discontinuation prior to procedure|0
290258|NCT00939055|955884|P1|Overall Study|Discontinuation prior to procedure|4
290259|NCT00939029|955894|P2|Overall Study|Adverse Event|1
290260|NCT00939029|955895|P1|Overall Study|Adverse Event|0
290261|NCT00939029|955894|P2|Overall Study|Lost to Follow-up|4
290262|NCT00939029|955895|P1|Overall Study|Lost to Follow-up|3
290263|NCT00939029|955894|P2|Overall Study|Withdrawal by Subject|7
290264|NCT00939029|955895|P1|Overall Study|Withdrawal by Subject|3
290265|NCT00939003|955907|P2|Open-label Treatment Period|Site Closure|4
290266|NCT00939003|955908|P1|Open-label Treatment Period|Site Closure|3
290267|NCT00939003|955907|P2|Open-label Treatment Period|Exclusion Criteria|0
290268|NCT00939003|955908|P1|Open-label Treatment Period|Exclusion Criteria|1
290269|NCT00939003|955907|P2|Open-label Treatment Period|Pregnancy|1
290270|NCT00939003|955908|P1|Open-label Treatment Period|Pregnancy|1
290271|NCT00939003|955907|P2|Open-label Treatment Period|Lack of Efficacy|9
290272|NCT00939003|955908|P1|Open-label Treatment Period|Lack of Efficacy|6
290273|NCT00939003|955907|P2|Open-label Treatment Period|Withdrawal by Subject|7
290274|NCT00939003|955908|P1|Open-label Treatment Period|Withdrawal by Subject|14
290275|NCT00939003|955907|P2|Open-label Treatment Period|Adverse Event|8
290276|NCT00939003|955908|P1|Open-label Treatment Period|Adverse Event|4
290277|NCT00939003|955907|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
290278|NCT00939003|955908|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
290279|NCT00939003|955907|P2|Double-blind Treatment Period|Pregnancy|1
290280|NCT00939003|955908|P1|Double-blind Treatment Period|Pregnancy|0
290281|NCT00939003|955907|P2|Double-blind Treatment Period|Lack of Efficacy|1
290282|NCT00939003|955908|P1|Double-blind Treatment Period|Lack of Efficacy|0
290283|NCT00939003|955907|P2|Double-blind Treatment Period|Adverse Event|1
290284|NCT00939003|955908|P1|Double-blind Treatment Period|Adverse Event|1
290285|NCT00938886|955945|P2|Overall Study|Lost to Follow-up|2
290286|NCT00938886|955946|P1|Overall Study|Lost to Follow-up|3
290287|NCT00938886|955945|P2|Overall Study|Withdrawal by Subject|7
290288|NCT00938886|955946|P1|Overall Study|Withdrawal by Subject|4
290289|NCT00938886|955945|P2|Overall Study|Death|1
290290|NCT00938886|955946|P1|Overall Study|Death|0
290291|NCT00938860|955956|P2|Overall Study|Protocol Violation|1
290292|NCT00938860|955957|P1|Overall Study|Protocol Violation|3
290293|NCT00938860|955956|P2|Overall Study|Death|1
290294|NCT00938860|955957|P1|Overall Study|Death|1
290295|NCT00938860|955956|P2|Overall Study|Administration problems|0
290296|NCT00938860|955957|P1|Overall Study|Administration problems|2
290297|NCT00938860|955956|P2|Overall Study|Lost to Follow-up|4
290298|NCT00938860|955957|P1|Overall Study|Lost to Follow-up|4
290299|NCT00938860|955956|P2|Overall Study|Withdrawal by Subject|8
290300|NCT00938860|955957|P1|Overall Study|Withdrawal by Subject|11
290301|NCT00938860|955956|P2|Overall Study|Abnormal laboratory values|2
290302|NCT00938860|955957|P1|Overall Study|Abnormal laboratory values|2
290303|NCT00938860|955956|P2|Overall Study|Adverse Event|1
290304|NCT00938860|955957|P1|Overall Study|Adverse Event|2
290305|NCT00938717|955990|P2|Overall Study|Other reason|2
290306|NCT00938717|955991|P1|Overall Study|Other reason|5
290307|NCT00938717|955990|P2|Overall Study|Lack of Efficacy|15
290308|NCT00938717|955991|P1|Overall Study|Lack of Efficacy|33
290309|NCT00938717|955990|P2|Overall Study|Lost to Follow-up|18
290310|NCT00938717|955991|P1|Overall Study|Lost to Follow-up|13
290311|NCT00938717|955990|P2|Overall Study|Withdrawal by Subject|24
290312|NCT00938717|955991|P1|Overall Study|Withdrawal by Subject|26
290313|NCT00938717|955990|P2|Overall Study|Protocol Violation|8
290314|NCT00938717|955991|P1|Overall Study|Protocol Violation|11
290315|NCT00938717|955990|P2|Overall Study|Adverse Event|41
290316|NCT00938717|955991|P1|Overall Study|Adverse Event|10
290317|NCT00938639|956042|P2|Overall Study|Participant noncompliance|0
290318|NCT00938639|956043|P1|Overall Study|Participant noncompliance|1
290319|NCT00938639|956042|P2|Overall Study|Family issues|1
290320|NCT00938639|956043|P1|Overall Study|Family issues|1
290321|NCT00938639|956042|P2|Overall Study|Lost to Follow-up|2
290322|NCT00938639|956043|P1|Overall Study|Lost to Follow-up|1
290323|NCT00938639|956042|P2|Overall Study|Moved away from study area|1
290324|NCT00938639|956043|P1|Overall Study|Moved away from study area|0
290325|NCT00938470|956126|P2|Overall Study|Other Reason|1
290326|NCT00938470|956127|P1|Overall Study|Other Reason|0
290327|NCT00938470|956126|P2|Overall Study|Death|2
290328|NCT00938470|956127|P1|Overall Study|Death|3
290329|NCT00938470|956126|P2|Overall Study|Alternate Treatment|0
290330|NCT00938470|956127|P1|Overall Study|Alternate Treatment|1
290331|NCT00938470|956126|P2|Overall Study|Disease Progression|0
290332|NCT00938470|956127|P1|Overall Study|Disease Progression|3
290333|NCT00938431|956157|P3|Overall Study|Reached maximum dose early|1
290334|NCT00938431|956158|P2|Overall Study|Reached maximum dose early|0
290335|NCT00938431|956159|P1|Overall Study|Reached maximum dose early|0
290336|NCT00938431|956157|P3|Overall Study|Dosing compliance issue|1
290337|NCT00938431|956158|P2|Overall Study|Dosing compliance issue|0
290338|NCT00938431|956159|P1|Overall Study|Dosing compliance issue|0
290339|NCT00938431|956157|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
290340|NCT00938431|956158|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
290341|NCT00938431|956159|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
290342|NCT00938431|956157|P3|Overall Study|Lack of Efficacy|0
290343|NCT00938431|956158|P2|Overall Study|Lack of Efficacy|1
290344|NCT00938431|956159|P1|Overall Study|Lack of Efficacy|0
290345|NCT00938431|956157|P3|Overall Study|Adverse Event|6
290346|NCT00938431|956158|P2|Overall Study|Adverse Event|8
290347|NCT00938431|956159|P1|Overall Study|Adverse Event|5
290348|NCT00938392|956186|P2|Overall Study|Lost to Follow-up|2
290349|NCT00938392|956187|P1|Overall Study|Lost to Follow-up|2
290350|NCT00938392|956186|P2|Overall Study|Withdrawal by Subject|1
290351|NCT00938392|956187|P1|Overall Study|Withdrawal by Subject|0
290352|NCT00938392|956186|P2|Overall Study|Adverse Event|1
290353|NCT00938392|956187|P1|Overall Study|Adverse Event|0
290354|NCT00938366|956213|P2|Overall Study|Withdrawal by Subject|0
290355|NCT00938366|956214|P1|Overall Study|Withdrawal by Subject|1
290356|NCT00938327|956234|P1|Overall Study|Vaccine not received as out of stock|9
290357|NCT00938327|956234|P1|Overall Study|2nd dose received outside of the study|7
290358|NCT00938327|956234|P1|Overall Study|Lost to Follow-up|37
290359|NCT00938327|956234|P1|Overall Study|Withdrawal by Subject|4
290360|NCT00938327|956234|P1|Overall Study|Protocol Violation|1
290361|NCT00938327|956234|P1|Overall Study|Adverse Event|2
290362|NCT00938041|956302|P1|Overall Study|Adrenal Insufficiency|3
290363|NCT00938041|956302|P1|Overall Study|Death|12
290364|NCT00938041|956302|P1|Overall Study|Progressive Disease|5
290365|NCT00938041|956302|P1|Overall Study|Received Alternative Therapy|1
290366|NCT00938041|956302|P1|Overall Study|Lost to Follow-up|6
290367|NCT00938015|956311|P1|Overall Study|Reason not related to Etanercept|29
290368|NCT00938015|956311|P1|Overall Study|Non-responder|52
290369|NCT00938015|956311|P1|Overall Study|Adverse Event|32
290370|NCT00938015|956311|P1|Overall Study|Lost to Follow-up|32
290371|NCT00938015|956311|P1|Overall Study|Death|2
290372|NCT00937950|956327|P1|Overall Study|Others|18
290373|NCT00937950|956327|P1|Overall Study|Missing confirmed|4
290374|NCT00937950|956327|P1|Overall Study|Lost to Follow-up|144
290375|NCT00937950|956327|P1|Overall Study|Migrated/moved from study area|27
290376|NCT00937950|956327|P1|Overall Study|Withdrawal by Subject|23
290377|NCT00937937|956343|P1|Overall Study|Not specified|2
290378|NCT00937937|956343|P1|Overall Study|Death|1
290379|NCT00937937|956343|P1|Overall Study|Progression/relapse|61
290380|NCT00937937|956343|P1|Overall Study|Withdrawal by Subject|2
290381|NCT00937937|956343|P1|Overall Study|Adverse Event|6
290382|NCT00937833|956352|P2|Overall Study|Withdrawal by Subject|6
290383|NCT00937833|956353|P1|Overall Study|Withdrawal by Subject|4
290384|NCT00937833|956352|P2|Overall Study|Lost to Follow-up|8
290385|NCT00937833|956353|P1|Overall Study|Lost to Follow-up|10
290386|NCT00937833|956352|P2|Overall Study|Procedure delayed; enrollment closed|1
290387|NCT00937833|956353|P1|Overall Study|Procedure delayed; enrollment closed|0
290388|NCT00937833|956352|P2|Overall Study|Protocol Violation|2
290389|NCT00937833|956353|P1|Overall Study|Protocol Violation|1
290390|NCT00937768|956366|P2|Overall Study|No Further Funding|4
290391|NCT00937768|956367|P1|Overall Study|No Further Funding|4
290392|NCT00937768|956366|P2|Overall Study|Alternate Treatment|1
290393|NCT00937768|956367|P1|Overall Study|Alternate Treatment|0
290394|NCT00937768|956366|P2|Overall Study|Disease Progression|1
290395|NCT00937768|956367|P1|Overall Study|Disease Progression|1
290396|NCT00937768|956366|P2|Overall Study|Refused Further Treatment|2
290397|NCT00937768|956367|P1|Overall Study|Refused Further Treatment|3
290398|NCT00937560|956373|P1|Maintenance Treatment|According to protocol|1
290399|NCT00937560|956373|P1|Maintenance Treatment|Withdraw consent|5
290400|NCT00937560|956373|P1|Maintenance Treatment|Death|12
290401|NCT00937560|956373|P1|Initial Treatment|No end of study page|10
290402|NCT00937560|956373|P1|Initial Treatment|Lost to Follow-up|1
290403|NCT00937560|956373|P1|Initial Treatment|Adverse Event|1
290404|NCT00937560|956373|P1|Initial Treatment|Withdraw consent|3
290405|NCT00937560|956373|P1|Initial Treatment|Death|6
290406|NCT00937547|956384|P3|Overall Study|misdiagnosis|7
290407|NCT00937547|956385|P2|Overall Study|misdiagnosis|6
290408|NCT00937547|956386|P1|Overall Study|misdiagnosis|1
290409|NCT00937521|956423|P8|Booster Phase|Protocol Deviation|0
290410|NCT00937521|956424|P7|Booster Phase|Protocol Deviation|1
290411|NCT00937521|956425|P6|Booster Phase|Protocol Deviation|0
290412|NCT00937521|956426|P5|Booster Phase|Protocol Deviation|0
290413|NCT00937521|956427|P4|Booster Phase|Protocol Deviation|0
290414|NCT00937521|956428|P3|Booster Phase|Protocol Deviation|0
290415|NCT00937521|956429|P2|Booster Phase|Protocol Deviation|0
290416|NCT00937521|956430|P1|Booster Phase|Protocol Deviation|0
290417|NCT00937521|956423|P8|Booster Phase|Administrative Reason|0
290418|NCT00937521|956424|P7|Booster Phase|Administrative Reason|0
290419|NCT00937521|956425|P6|Booster Phase|Administrative Reason|1
290420|NCT00937521|956426|P5|Booster Phase|Administrative Reason|1
290421|NCT00937521|956427|P4|Booster Phase|Administrative Reason|0
290422|NCT00937521|956428|P3|Booster Phase|Administrative Reason|1
290423|NCT00937521|956429|P2|Booster Phase|Administrative Reason|0
290424|NCT00937521|956430|P1|Booster Phase|Administrative Reason|0
290425|NCT00937521|956423|P8|Booster Phase|Lost to Follow-up|0
290426|NCT00937521|956424|P7|Booster Phase|Lost to Follow-up|3
290427|NCT00937521|956425|P6|Booster Phase|Lost to Follow-up|4
290428|NCT00937521|956426|P5|Booster Phase|Lost to Follow-up|4
290429|NCT00937521|956427|P4|Booster Phase|Lost to Follow-up|2
290430|NCT00937521|956428|P3|Booster Phase|Lost to Follow-up|4
290431|NCT00937521|956429|P2|Booster Phase|Lost to Follow-up|2
290432|NCT00937521|956430|P1|Booster Phase|Lost to Follow-up|2
290433|NCT00937521|956423|P8|Booster Phase|Withdrawal by Subject|2
290434|NCT00937521|956424|P7|Booster Phase|Withdrawal by Subject|0
290435|NCT00937521|956425|P6|Booster Phase|Withdrawal by Subject|0
290436|NCT00937521|956426|P5|Booster Phase|Withdrawal by Subject|0
290437|NCT00937521|956427|P4|Booster Phase|Withdrawal by Subject|1
290438|NCT00937521|956428|P3|Booster Phase|Withdrawal by Subject|0
290439|NCT00937521|956429|P2|Booster Phase|Withdrawal by Subject|0
290440|NCT00937521|956430|P1|Booster Phase|Withdrawal by Subject|1
290441|NCT00937521|956423|P8|Booster Phase|Adverse Event|0
290442|NCT00937521|956424|P7|Booster Phase|Adverse Event|1
290443|NCT00937521|956425|P6|Booster Phase|Adverse Event|0
290444|NCT00937521|956426|P5|Booster Phase|Adverse Event|0
290445|NCT00937521|956427|P4|Booster Phase|Adverse Event|0
290446|NCT00937521|956428|P3|Booster Phase|Adverse Event|0
290447|NCT00937521|956429|P2|Booster Phase|Adverse Event|0
290448|NCT00937521|956430|P1|Booster Phase|Adverse Event|0
290449|NCT00937521|956423|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
290450|NCT00937521|956424|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
290451|NCT00937521|956425|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
290452|NCT00937521|956426|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
290453|NCT00937521|956427|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
290454|NCT00937521|956428|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
290455|NCT00937521|956429|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
290456|NCT00937521|956430|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
290457|NCT00937521|956423|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
290458|NCT00937521|956424|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
290459|NCT00937521|956425|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
290460|NCT00937521|956426|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
290461|NCT00937521|956427|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
290462|NCT00937521|956428|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
290463|NCT00937521|956429|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
290464|NCT00937521|956430|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
290465|NCT00937521|956423|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
290466|NCT00937521|956424|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
290467|NCT00937521|956425|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
290468|NCT00937521|956426|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
290469|NCT00937521|956427|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
290470|NCT00937521|956428|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
290471|NCT00937521|956429|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
290472|NCT00937521|956430|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
290473|NCT00937521|956423|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
290474|NCT00937521|956424|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
290475|NCT00937521|956425|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
290476|NCT00937521|956426|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
290477|NCT00937521|956427|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
290478|NCT00937521|956428|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
290565|NCT00935818|956991|P2|Overall Study|Adverse Event|7
290479|NCT00937521|956429|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
290480|NCT00937521|956430|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
290481|NCT00937521|956423|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
290482|NCT00937521|956424|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
290483|NCT00937521|956425|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
290484|NCT00937521|956426|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
290485|NCT00937521|956427|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
290486|NCT00937521|956428|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
290487|NCT00937521|956429|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
290488|NCT00937521|956430|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
290489|NCT00937495|956536|P1|Overall Study|Protocol Violation|2
290490|NCT00937391|956544|P1|Stage 2|Withdrawal by Subject|1
290491|NCT00937157|956595|P1|Overall Study|Lost to Follow-up|3
290492|NCT00937157|956595|P1|Overall Study|Pregnancy|1
290493|NCT00937040|956626|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
290494|NCT00937040|956627|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
290495|NCT00937040|956626|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
290496|NCT00937040|956627|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
290497|NCT00937040|956626|P2|Overall Study|Withdrawal by Subject|7
290498|NCT00937040|956627|P1|Overall Study|Withdrawal by Subject|13
290499|NCT00937040|956626|P2|Overall Study|Protocol Violation|0
290500|NCT00937040|956627|P1|Overall Study|Protocol Violation|3
290501|NCT00937040|956626|P2|Overall Study|Lost to Follow-up|12
290502|NCT00937040|956627|P1|Overall Study|Lost to Follow-up|12
290503|NCT00937040|956626|P2|Overall Study|Adverse Event|8
290504|NCT00937040|956627|P1|Overall Study|Adverse Event|5
290505|NCT00936975|956669|P1|Overall Study|Post-Tx scan uninterpretable|2
290506|NCT00936975|956669|P1|Overall Study|Disease progression|3
290507|NCT00936975|956669|P1|Overall Study|Withdrawal by Subject|1
290508|NCT00936897|956680|P2|Overall Study|Death|1
290509|NCT00936897|956681|P1|Overall Study|Death|0
290510|NCT00936897|956680|P2|Overall Study|Noncompliance|2
290511|NCT00936897|956681|P1|Overall Study|Noncompliance|0
290512|NCT00936897|956680|P2|Overall Study|Ineligibility Determined|3
290513|NCT00936897|956681|P1|Overall Study|Ineligibility Determined|0
290514|NCT00936897|956680|P2|Overall Study|Protocol Violation|1
290515|NCT00936897|956681|P1|Overall Study|Protocol Violation|1
290516|NCT00936897|956680|P2|Overall Study|Administrative Decision|2
290517|NCT00936897|956681|P1|Overall Study|Administrative Decision|1
290518|NCT00936897|956680|P2|Overall Study|Lost to Follow-up|10
290519|NCT00936897|956681|P1|Overall Study|Lost to Follow-up|1
290520|NCT00936897|956680|P2|Overall Study|Other|9
290521|NCT00936897|956681|P1|Overall Study|Other|3
290522|NCT00936897|956680|P2|Overall Study|Adverse Event|13
290523|NCT00936897|956681|P1|Overall Study|Adverse Event|4
290524|NCT00936897|956680|P2|Overall Study|Withdrawal by Subject|19
290525|NCT00936897|956681|P1|Overall Study|Withdrawal by Subject|9
290526|NCT00936715|956698|P1|Overall Study|Safety or Tolerability Reasons|4
290527|NCT00936715|956698|P1|Overall Study|Protocol Violation|1
290528|NCT00936715|956698|P1|Overall Study|Investigators Discretion|1
290529|NCT00936702|956702|P1|Overall Study|Unspecified|1
290530|NCT00936702|956702|P1|Overall Study|Alternative Treatment|1
290531|NCT00936702|956702|P1|Overall Study|Withdrawal by Subject|2
290532|NCT00936702|956702|P1|Overall Study|Adverse Event|8
290533|NCT00936702|956702|P1|Overall Study|Disease progression|34
290534|NCT00936598|956712|P2|Overall Study|Ineligible after consent|0
290535|NCT00936598|956713|P1|Overall Study|Ineligible after consent|1
290536|NCT00936598|956712|P2|Overall Study|Withdrawal by Subject|0
290537|NCT00936598|956713|P1|Overall Study|Withdrawal by Subject|1
290538|NCT00936221|956802|P2|Overall Study|Withdrawal by Subject|1
290539|NCT00936221|956803|P1|Overall Study|Withdrawal by Subject|1
290540|NCT00936208|956817|P2|Overall Study|Protocol Violation|22
290541|NCT00936208|956818|P1|Overall Study|Protocol Violation|37
290542|NCT00936117|956836|P1|Overall Study|Unable to continue oral medication|3
290543|NCT00936117|956836|P1|Overall Study|Adverse Event|7
290544|NCT00936065|956844|P3|Overall Study|Withdrawal by Subject|4
290545|NCT00936065|956845|P2|Overall Study|Withdrawal by Subject|2
290546|NCT00936065|956846|P1|Overall Study|Withdrawal by Subject|0
290547|NCT00936065|956844|P3|Overall Study|Protocol Violation|1
290548|NCT00936065|956845|P2|Overall Study|Protocol Violation|2
290549|NCT00936065|956846|P1|Overall Study|Protocol Violation|1
290550|NCT00936065|956844|P3|Overall Study|Lost to Follow-up|0
290551|NCT00936065|956845|P2|Overall Study|Lost to Follow-up|0
290552|NCT00936065|956846|P1|Overall Study|Lost to Follow-up|1
290553|NCT00936065|956844|P3|Overall Study|Lack of Efficacy|1
290554|NCT00936065|956845|P2|Overall Study|Lack of Efficacy|0
290555|NCT00936065|956846|P1|Overall Study|Lack of Efficacy|1
290556|NCT00936065|956844|P3|Overall Study|Adverse Event|1
290557|NCT00936065|956845|P2|Overall Study|Adverse Event|0
290558|NCT00936065|956846|P1|Overall Study|Adverse Event|1
290559|NCT00935883|956963|P2|Treatment Period|Withdrawal by Subject|2
290560|NCT00935883|956964|P1|Treatment Period|Withdrawal by Subject|0
290561|NCT00935883|956963|P2|Treatment Period|Physician Decision|0
290562|NCT00935883|956964|P1|Treatment Period|Physician Decision|1
290563|NCT00935818|956991|P2|Overall Study|Physician Decision|1
290564|NCT00935818|956992|P1|Overall Study|Physician Decision|0
290566|NCT00935818|956992|P1|Overall Study|Adverse Event|6
290567|NCT00935818|956991|P2|Overall Study|Lost to Follow-up|42
290568|NCT00935818|956992|P1|Overall Study|Lost to Follow-up|40
290569|NCT00935818|956991|P2|Overall Study|Withdrawal by Subject|50
290570|NCT00935818|956992|P1|Overall Study|Withdrawal by Subject|45
290571|NCT00935701|957043|P1|Overall Study|Failure to Transition to Acupuncture|1
290572|NCT00935584|957060|P2|Overall Study|Provider dropped out of study|4
290573|NCT00935584|957061|P1|Overall Study|Provider dropped out of study|14
290574|NCT00935584|957060|P2|Overall Study|Patient changed provider|0
290575|NCT00935584|957061|P1|Overall Study|Patient changed provider|3
290576|NCT00935584|957060|P2|Overall Study|Relocated|0
290577|NCT00935584|957061|P1|Overall Study|Relocated|3
290578|NCT00935584|957060|P2|Overall Study|No show|0
290579|NCT00935584|957061|P1|Overall Study|No show|9
290580|NCT00935584|957060|P2|Overall Study|Lost to Follow-up|0
290581|NCT00935584|957061|P1|Overall Study|Lost to Follow-up|8
290582|NCT00935584|957060|P2|Overall Study|Death|0
290583|NCT00935584|957061|P1|Overall Study|Death|3
290584|NCT00935584|957060|P2|Overall Study|Withdrawal by Subject|0
290585|NCT00935584|957061|P1|Overall Study|Withdrawal by Subject|9
290586|NCT00935532|957073|P2|Overall Study|Loss Glucose Control|0
290587|NCT00935532|957074|P1|Overall Study|Loss Glucose Control|4
290588|NCT00935532|957073|P2|Overall Study|Sponsor Decision|1
290589|NCT00935532|957074|P1|Overall Study|Sponsor Decision|0
290590|NCT00935532|957073|P2|Overall Study|Subject Decision|1
290591|NCT00935532|957074|P1|Overall Study|Subject Decision|2
290592|NCT00935532|957073|P2|Overall Study|Protocol Violation|1
290593|NCT00935532|957074|P1|Overall Study|Protocol Violation|2
290594|NCT00935532|957073|P2|Overall Study|Physician Decision|2
290595|NCT00935532|957074|P1|Overall Study|Physician Decision|1
290596|NCT00935532|957073|P2|Overall Study|Lost to Follow-up|0
290597|NCT00935532|957074|P1|Overall Study|Lost to Follow-up|1
290598|NCT00935532|957073|P2|Overall Study|Death|0
290599|NCT00935532|957074|P1|Overall Study|Death|1
290600|NCT00935532|957073|P2|Overall Study|Adverse Event|6
290601|NCT00935532|957074|P1|Overall Study|Adverse Event|11
290602|NCT00935493|957103|P3|Overall Study|Treatment Discontinued|0
290603|NCT00935493|957104|P2|Overall Study|Treatment Discontinued|1
290604|NCT00935493|957105|P1|Overall Study|Treatment Discontinued|0
290605|NCT00935493|957103|P3|Overall Study|Lost to Follow-up|1
290606|NCT00935493|957104|P2|Overall Study|Lost to Follow-up|1
290607|NCT00935493|957105|P1|Overall Study|Lost to Follow-up|1
290608|NCT00935272|957143|P2|Overall Study|Protocol Violation|1
290609|NCT00935272|957144|P1|Overall Study|Protocol Violation|0
290610|NCT00935272|957143|P2|Overall Study|Physician Decision|0
290611|NCT00935272|957144|P1|Overall Study|Physician Decision|1
290612|NCT00935272|957143|P2|Overall Study|Withdrawal by Subject|2
290613|NCT00935272|957144|P1|Overall Study|Withdrawal by Subject|8
290614|NCT00935272|957143|P2|Overall Study|Lost to Follow-up|3
290615|NCT00935272|957144|P1|Overall Study|Lost to Follow-up|10
290616|NCT00935259|957153|P2|Period 1|Administrative (scheduling conflict)|1
290617|NCT00935259|957154|P1|Period 1|Administrative (scheduling conflict)|1
290618|NCT00935220|957168|P1|Overall Study|Other reason (not specified)|1
290619|NCT00935220|957168|P1|Overall Study|Adverse Event|1
290620|NCT00934947|957199|P2|Overall Study|Adverse Event|2
290621|NCT00934947|957200|P1|Overall Study|Adverse Event|0
290622|NCT00934856|957212|P6|Extension Part|Non-compliance with drug|1
290623|NCT00934856|957213|P5|Extension Part|Non-compliance with drug|0
290624|NCT00934856|957214|P4|Extension Part|Non-compliance with drug|0
290625|NCT00934856|957215|P3|Extension Part|Non-compliance with drug|0
290626|NCT00934856|957216|P2|Extension Part|Non-compliance with drug|0
290627|NCT00934856|957217|P1|Extension Part|Non-compliance with drug|0
290628|NCT00934856|957212|P6|Extension Part|Progressive disease|0
290629|NCT00934856|957213|P5|Extension Part|Progressive disease|0
290630|NCT00934856|957214|P4|Extension Part|Progressive disease|1
290631|NCT00934856|957215|P3|Extension Part|Progressive disease|0
290632|NCT00934856|957216|P2|Extension Part|Progressive disease|0
290633|NCT00934856|957217|P1|Extension Part|Progressive disease|0
290634|NCT00934856|957212|P6|Extension Part|Adverse Event|4
290635|NCT00934856|957213|P5|Extension Part|Adverse Event|4
290636|NCT00934856|957214|P4|Extension Part|Adverse Event|1
290637|NCT00934856|957215|P3|Extension Part|Adverse Event|0
290638|NCT00934856|957216|P2|Extension Part|Adverse Event|0
290639|NCT00934856|957217|P1|Extension Part|Adverse Event|0
290640|NCT00934856|957212|P6|Feasibility Part|Withdrawal by Subject|1
290641|NCT00934856|957213|P5|Feasibility Part|Withdrawal by Subject|0
290642|NCT00934856|957214|P4|Feasibility Part|Withdrawal by Subject|1
290643|NCT00934856|957215|P3|Feasibility Part|Withdrawal by Subject|0
290644|NCT00934856|957216|P2|Feasibility Part|Withdrawal by Subject|0
290645|NCT00934856|957217|P1|Feasibility Part|Withdrawal by Subject|0
290646|NCT00934856|957212|P6|Feasibility Part|Adverse Event|2
290647|NCT00934856|957213|P5|Feasibility Part|Adverse Event|0
290648|NCT00934856|957214|P4|Feasibility Part|Adverse Event|1
290649|NCT00934856|957215|P3|Feasibility Part|Adverse Event|0
290650|NCT00934856|957216|P2|Feasibility Part|Adverse Event|1
290651|NCT00934856|957217|P1|Feasibility Part|Adverse Event|1
290652|NCT00934856|957212|P6|Feasibility Part|Physician Decision|0
290653|NCT00934856|957213|P5|Feasibility Part|Physician Decision|0
290654|NCT00934856|957214|P4|Feasibility Part|Physician Decision|0
290655|NCT00934856|957215|P3|Feasibility Part|Physician Decision|1
290656|NCT00934856|957216|P2|Feasibility Part|Physician Decision|0
290657|NCT00934856|957217|P1|Feasibility Part|Physician Decision|0
290658|NCT00934856|957212|P6|Feasibility Part|Progressive disease|0
290659|NCT00934856|957213|P5|Feasibility Part|Progressive disease|0
290660|NCT00934856|957214|P4|Feasibility Part|Progressive disease|3
290661|NCT00934856|957215|P3|Feasibility Part|Progressive disease|2
290662|NCT00934856|957216|P2|Feasibility Part|Progressive disease|4
290663|NCT00934856|957217|P1|Feasibility Part|Progressive disease|4
290664|NCT00934843|957315|P2|Overall Study|Protocol Violation|1
290665|NCT00934843|957316|P1|Overall Study|Protocol Violation|0
290666|NCT00934791|957332|P2|Overall Study|Withdrawal by Subject|0
290667|NCT00934791|957333|P1|Overall Study|Withdrawal by Subject|1
290668|NCT00934648|957339|P1|Overall Study|Withdrawal by Subject|1
290669|NCT00934648|957339|P1|Overall Study|Failure to return|8
290670|NCT00934622|957383|P1|Overall Study|2nd Intraoperative exclusion criteria|1
290671|NCT00934622|957383|P1|Overall Study|Lost to Follow-up|7
290672|NCT00934544|957421|P2|Overall Study|Entered Extension phase INC424|18
290673|NCT00934544|957422|P1|Overall Study|Entered Extension phase INC424|29
290674|NCT00934544|957421|P2|Overall Study|Other Reasons|7
290675|NCT00934544|957422|P1|Overall Study|Other Reasons|7
290676|NCT00934544|957421|P2|Overall Study|Non-compliance with study procedures|1
290677|NCT00934544|957422|P1|Overall Study|Non-compliance with study procedures|0
290678|NCT00934544|957421|P2|Overall Study|Non-compliance with study Medication|0
290679|NCT00934544|957422|P1|Overall Study|Non-compliance with study Medication|2
290680|NCT00934544|957421|P2|Overall Study|Disease Progression|3
290681|NCT00934544|957422|P1|Overall Study|Disease Progression|1
290682|NCT00934544|957421|P2|Overall Study|Protocol Violation|0
290683|NCT00934544|957422|P1|Overall Study|Protocol Violation|2
290684|NCT00934544|957421|P2|Overall Study|Withdrawal by Subject|9
290685|NCT00934544|957422|P1|Overall Study|Withdrawal by Subject|2
290686|NCT00934544|957421|P2|Overall Study|Adverse Event|4
290687|NCT00934544|957422|P1|Overall Study|Adverse Event|12
290688|NCT00934440|957436|P1|Overall Study|Lost to Follow-up|1
290689|NCT00934362|957452|P2|Overall Study|Adverse Event|0
290690|NCT00934362|957453|P1|Overall Study|Adverse Event|1
290691|NCT00934128|957503|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
290692|NCT00934128|957504|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
290693|NCT00934128|957503|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
290694|NCT00934128|957504|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
290695|NCT00934128|957503|P2|Washout Period (1 Hour)|Too tired|0
290696|NCT00934128|957504|P1|Washout Period (1 Hour)|Too tired|1
290697|NCT00934128|957503|P2|Washout Period (1 Hour)|Pain|0
290698|NCT00934128|957504|P1|Washout Period (1 Hour)|Pain|1
290699|NCT00934128|957503|P2|Washout Period (1 Hour)|Patient preference|3
290700|NCT00934128|957504|P1|Washout Period (1 Hour)|Patient preference|1
290701|NCT00934128|957503|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
290702|NCT00934128|957504|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
290703|NCT00934128|957503|P2|First Intervention (2 Hours)|Adverse Event|1
290704|NCT00934128|957504|P1|First Intervention (2 Hours)|Adverse Event|4
290705|NCT00934128|957503|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
290706|NCT00934128|957504|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
290707|NCT00934102|957512|P3|Period 1, One Night of Wear|Personal Reasons|0
290708|NCT00934102|957513|P2|Period 1, One Night of Wear|Personal Reasons|0
290709|NCT00934102|957514|P1|Period 1, One Night of Wear|Personal Reasons|1
290710|NCT00934050|957528|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
290711|NCT00934050|957529|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
290712|NCT00934050|957530|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
290713|NCT00934050|957531|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
290714|NCT00934050|957532|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
290715|NCT00934050|957533|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
290716|NCT00934050|957528|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
290717|NCT00934050|957529|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
290718|NCT00934050|957530|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
290719|NCT00934050|957531|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
290720|NCT00934050|957532|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
290721|NCT00934050|957533|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
290722|NCT00934050|957528|P6|Enrolled After 15 Dec 2009|Death|1
290723|NCT00934050|957529|P5|Enrolled After 15 Dec 2009|Death|0
290724|NCT00934050|957530|P4|Enrolled After 15 Dec 2009|Death|0
290725|NCT00934050|957531|P3|Enrolled After 15 Dec 2009|Death|0
290726|NCT00934050|957532|P2|Enrolled After 15 Dec 2009|Death|0
290727|NCT00934050|957533|P1|Enrolled After 15 Dec 2009|Death|0
290728|NCT00934050|957528|P6|Enrolled After 15 Dec 2009|Adverse Event|0
290729|NCT00934050|957529|P5|Enrolled After 15 Dec 2009|Adverse Event|3
290730|NCT00934050|957530|P4|Enrolled After 15 Dec 2009|Adverse Event|0
290731|NCT00934050|957531|P3|Enrolled After 15 Dec 2009|Adverse Event|0
290732|NCT00934050|957532|P2|Enrolled After 15 Dec 2009|Adverse Event|0
290733|NCT00934050|957533|P1|Enrolled After 15 Dec 2009|Adverse Event|0
290734|NCT00934050|957528|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
290735|NCT00934050|957529|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
290736|NCT00934050|957530|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
290737|NCT00934050|957531|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
290738|NCT00934050|957532|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
290739|NCT00934050|957533|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
290740|NCT00934050|957528|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
290741|NCT00934050|957529|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
290742|NCT00934050|957530|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
290743|NCT00934050|957531|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
290744|NCT00934050|957532|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
290745|NCT00934050|957533|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
290746|NCT00934050|957528|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
290747|NCT00934050|957529|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
290748|NCT00934050|957530|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
290749|NCT00934050|957531|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
290750|NCT00934050|957532|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
290751|NCT00934050|957533|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
290752|NCT00933933|957548|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
290753|NCT00933933|957549|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
290754|NCT00933933|957550|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
290755|NCT00933933|957548|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
290756|NCT00933933|957549|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
290757|NCT00933933|957550|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
290758|NCT00933686|957568|P2|Overall Study|Failure to show up at endpoint visits|2
290759|NCT00933686|957569|P1|Overall Study|Failure to show up at endpoint visits|0
290760|NCT00933686|957568|P2|Overall Study|Physician Decision|0
290761|NCT00933686|957569|P1|Overall Study|Physician Decision|1
290762|NCT00933686|957568|P2|Overall Study|Adverse Event|1
290763|NCT00933686|957569|P1|Overall Study|Adverse Event|1
290764|NCT00933686|957568|P2|Overall Study|Withdrawal by Subject|5
290765|NCT00933686|957569|P1|Overall Study|Withdrawal by Subject|6
290766|NCT00933686|957568|P2|Overall Study|Lost to Follow-up|2
290767|NCT00933686|957569|P1|Overall Study|Lost to Follow-up|2
290768|NCT00933686|957568|P2|Overall Study|Protocol Violation|1
290769|NCT00933686|957569|P1|Overall Study|Protocol Violation|0
290770|NCT00933608|957589|P2|Overall Study|Physician Decision|0
290771|NCT00933608|957590|P1|Overall Study|Physician Decision|1
290772|NCT00933608|957589|P2|Overall Study|Adverse Event|2
290773|NCT00933608|957590|P1|Overall Study|Adverse Event|4
290774|NCT00933543|957598|P2|Overall Study|Not known|1
290775|NCT00933543|957599|P1|Overall Study|Not known|1
290776|NCT00933543|957598|P2|Overall Study|Lack of Efficacy|3
290777|NCT00933543|957599|P1|Overall Study|Lack of Efficacy|0
290778|NCT00933543|957598|P2|Overall Study|Withdrawal by Subject|1
290779|NCT00933543|957599|P1|Overall Study|Withdrawal by Subject|0
290780|NCT00933543|957598|P2|Overall Study|Lost to Follow-up|1
290781|NCT00933543|957599|P1|Overall Study|Lost to Follow-up|0
290782|NCT00933543|957598|P2|Overall Study|Adverse Event|1
290783|NCT00933543|957599|P1|Overall Study|Adverse Event|2
290784|NCT00933335|957668|P2|Overall Study|Co-morbid Illness|0
290785|NCT00933335|957669|P1|Overall Study|Co-morbid Illness|1
290786|NCT00933335|957668|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
290787|NCT00933335|957669|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
290788|NCT00933335|957668|P2|Overall Study|Progressive Disease|11
290789|NCT00933335|957669|P1|Overall Study|Progressive Disease|0
290790|NCT00933335|957668|P2|Overall Study|Withdrawal by Subject|1
290791|NCT00933335|957669|P1|Overall Study|Withdrawal by Subject|0
290792|NCT00933335|957668|P2|Overall Study|Lost to Follow-up|3
290793|NCT00933335|957669|P1|Overall Study|Lost to Follow-up|1
290794|NCT00933270|957739|P1|Overall Study|Moved or would not return|10
290795|NCT00933270|957739|P1|Overall Study|Death|24
290796|NCT00933270|957739|P1|Overall Study|Missed Visit|2
290797|NCT00933270|957739|P1|Overall Study|Adverse Event|1
290798|NCT00933270|957739|P1|Overall Study|Lost to Follow-up|14
290799|NCT00933270|957739|P1|Overall Study|Insufficient Follow-up|10
290800|NCT00933270|957739|P1|Overall Study|Withdrawal by Subject|26
290801|NCT00933244|957833|P3|Overall Study|Withdrawal by Subject|3
290802|NCT00933244|957834|P2|Overall Study|Withdrawal by Subject|1
290803|NCT00933244|957835|P1|Overall Study|Withdrawal by Subject|5
290804|NCT00933166|957852|P1|Overall Study|Withdrawal by Subject|1
290805|NCT00933166|957852|P1|Overall Study|Unavailable|4
290806|NCT00933166|957852|P1|Overall Study|Lack of Efficacy|9
290807|NCT00933166|957852|P1|Overall Study|Lost to Follow-up|4
290808|NCT00932893|957858|P2|Overall Study|Unspecified|144
290809|NCT00932893|957859|P1|Overall Study|Unspecified|5
290810|NCT00932893|957858|P2|Overall Study|Withdrawal by Subject|2
290811|NCT00932893|957859|P1|Overall Study|Withdrawal by Subject|5
290812|NCT00932893|957858|P2|Overall Study|Lost to Follow-up|0
290813|NCT00932893|957859|P1|Overall Study|Lost to Follow-up|8
290814|NCT00932893|957858|P2|Overall Study|Death|24
290815|NCT00932893|957859|P1|Overall Study|Death|115
290816|NCT00932646|957895|P4|Overall Study|Withdrawal by Subject|0
290817|NCT00932646|957896|P3|Overall Study|Withdrawal by Subject|3
290818|NCT00932646|957897|P2|Overall Study|Withdrawal by Subject|1
290819|NCT00932646|957898|P1|Overall Study|Withdrawal by Subject|1
290820|NCT00932646|957895|P4|Overall Study|Lost to Follow-up|0
290821|NCT00932646|957896|P3|Overall Study|Lost to Follow-up|0
290822|NCT00932646|957897|P2|Overall Study|Lost to Follow-up|1
290823|NCT00932646|957898|P1|Overall Study|Lost to Follow-up|2
290824|NCT00932646|957895|P4|Overall Study|Adverse Event|1
290825|NCT00932646|957896|P3|Overall Study|Adverse Event|1
290826|NCT00932646|957897|P2|Overall Study|Adverse Event|1
290827|NCT00932646|957898|P1|Overall Study|Adverse Event|2
290828|NCT00932451|957985|P1|Overall Study|Other reasons|5
290829|NCT00932451|957985|P1|Overall Study|Death|726
290830|NCT00932451|957985|P1|Overall Study|Lost to Follow-up|22
290831|NCT00932451|957985|P1|Overall Study|Withdrawal by Subject|69
290832|NCT00932425|958009|P2|Overall Study|Withdrawal by Subject|1
290833|NCT00932425|958010|P1|Overall Study|Withdrawal by Subject|0
290834|NCT00932425|958009|P2|Overall Study|Lost to Follow-up|1
290835|NCT00932425|958010|P1|Overall Study|Lost to Follow-up|0
290836|NCT00932373|958043|P11|Overall Study|Lack of Efficacy|0
290837|NCT00932373|958044|P10|Overall Study|Lack of Efficacy|1
290838|NCT00932373|958045|P9|Overall Study|Lack of Efficacy|0
290839|NCT00932373|958046|P8|Overall Study|Lack of Efficacy|0
290840|NCT00932373|958047|P7|Overall Study|Lack of Efficacy|0
290841|NCT00932373|958048|P6|Overall Study|Lack of Efficacy|0
290842|NCT00932373|958049|P5|Overall Study|Lack of Efficacy|0
290843|NCT00932373|958050|P4|Overall Study|Lack of Efficacy|0
290844|NCT00932373|958051|P3|Overall Study|Lack of Efficacy|0
290845|NCT00932373|958052|P2|Overall Study|Lack of Efficacy|0
290846|NCT00932373|958053|P1|Overall Study|Lack of Efficacy|0
290847|NCT00932373|958043|P11|Overall Study|Clinical progression|0
290848|NCT00932373|958044|P10|Overall Study|Clinical progression|0
290849|NCT00932373|958045|P9|Overall Study|Clinical progression|0
290850|NCT00932373|958046|P8|Overall Study|Clinical progression|0
290851|NCT00932373|958047|P7|Overall Study|Clinical progression|1
290852|NCT00932373|958048|P6|Overall Study|Clinical progression|0
290853|NCT00932373|958049|P5|Overall Study|Clinical progression|0
290854|NCT00932373|958050|P4|Overall Study|Clinical progression|0
290855|NCT00932373|958051|P3|Overall Study|Clinical progression|0
290856|NCT00932373|958052|P2|Overall Study|Clinical progression|0
290857|NCT00932373|958053|P1|Overall Study|Clinical progression|0
290858|NCT00932373|958043|P11|Overall Study|Withdrawal by Subject|0
290859|NCT00932373|958044|P10|Overall Study|Withdrawal by Subject|0
290860|NCT00932373|958045|P9|Overall Study|Withdrawal by Subject|1
290861|NCT00932373|958046|P8|Overall Study|Withdrawal by Subject|0
290862|NCT00932373|958047|P7|Overall Study|Withdrawal by Subject|0
290863|NCT00932373|958048|P6|Overall Study|Withdrawal by Subject|0
290864|NCT00932373|958049|P5|Overall Study|Withdrawal by Subject|0
290865|NCT00932373|958050|P4|Overall Study|Withdrawal by Subject|0
290866|NCT00932373|958051|P3|Overall Study|Withdrawal by Subject|0
290867|NCT00932373|958052|P2|Overall Study|Withdrawal by Subject|0
290868|NCT00932373|958053|P1|Overall Study|Withdrawal by Subject|0
290869|NCT00932373|958043|P11|Overall Study|Dose limiting toxicity|0
290870|NCT00932373|958044|P10|Overall Study|Dose limiting toxicity|0
290871|NCT00932373|958045|P9|Overall Study|Dose limiting toxicity|0
290872|NCT00932373|958046|P8|Overall Study|Dose limiting toxicity|0
290873|NCT00932373|958047|P7|Overall Study|Dose limiting toxicity|0
290874|NCT00932373|958048|P6|Overall Study|Dose limiting toxicity|1
290875|NCT00932373|958049|P5|Overall Study|Dose limiting toxicity|0
290876|NCT00932373|958050|P4|Overall Study|Dose limiting toxicity|0
290877|NCT00932373|958051|P3|Overall Study|Dose limiting toxicity|0
290878|NCT00932373|958052|P2|Overall Study|Dose limiting toxicity|0
290879|NCT00932373|958053|P1|Overall Study|Dose limiting toxicity|0
290880|NCT00932373|958043|P11|Overall Study|Physician Decision|0
290881|NCT00932373|958044|P10|Overall Study|Physician Decision|1
290882|NCT00932373|958045|P9|Overall Study|Physician Decision|0
290883|NCT00932373|958046|P8|Overall Study|Physician Decision|0
290884|NCT00932373|958047|P7|Overall Study|Physician Decision|0
290885|NCT00932373|958048|P6|Overall Study|Physician Decision|0
290886|NCT00932373|958049|P5|Overall Study|Physician Decision|2
290887|NCT00932373|958050|P4|Overall Study|Physician Decision|0
290888|NCT00932373|958051|P3|Overall Study|Physician Decision|1
290889|NCT00932373|958052|P2|Overall Study|Physician Decision|0
290890|NCT00932373|958053|P1|Overall Study|Physician Decision|0
290891|NCT00932373|958043|P11|Overall Study|Adverse Event|1
290892|NCT00932373|958044|P10|Overall Study|Adverse Event|2
290893|NCT00932373|958045|P9|Overall Study|Adverse Event|0
290894|NCT00932373|958046|P8|Overall Study|Adverse Event|1
290895|NCT00932373|958047|P7|Overall Study|Adverse Event|0
290896|NCT00932373|958048|P6|Overall Study|Adverse Event|1
290897|NCT00932373|958049|P5|Overall Study|Adverse Event|2
290898|NCT00932373|958050|P4|Overall Study|Adverse Event|0
290899|NCT00932373|958051|P3|Overall Study|Adverse Event|0
290900|NCT00932373|958052|P2|Overall Study|Adverse Event|0
290901|NCT00932373|958053|P1|Overall Study|Adverse Event|0
290902|NCT00932373|958043|P11|Overall Study|Progressive disease|2
290903|NCT00932373|958044|P10|Overall Study|Progressive disease|9
290904|NCT00932373|958045|P9|Overall Study|Progressive disease|1
290905|NCT00932373|958046|P8|Overall Study|Progressive disease|2
290906|NCT00932373|958047|P7|Overall Study|Progressive disease|0
290907|NCT00932373|958048|P6|Overall Study|Progressive disease|1
290908|NCT00932373|958049|P5|Overall Study|Progressive disease|10
290909|NCT00932373|958050|P4|Overall Study|Progressive disease|0
290910|NCT00932373|958051|P3|Overall Study|Progressive disease|0
290911|NCT00932373|958052|P2|Overall Study|Progressive disease|1
290912|NCT00932373|958053|P1|Overall Study|Progressive disease|3
290913|NCT00932165|958164|P1|Overall Study|Lost to Follow-up|1
290914|NCT00932126|958182|P8|Overall Study|Other|2
290915|NCT00932126|958183|P7|Overall Study|Other|1
290916|NCT00932126|958184|P6|Overall Study|Other|0
290917|NCT00932126|958185|P5|Overall Study|Other|1
290918|NCT00932126|958186|P4|Overall Study|Other|0
290919|NCT00932126|958187|P3|Overall Study|Other|0
290920|NCT00932126|958188|P2|Overall Study|Other|0
290921|NCT00932126|958189|P1|Overall Study|Other|0
290922|NCT00932126|958182|P8|Overall Study|Objective progression or relapse|5
290923|NCT00932126|958183|P7|Overall Study|Objective progression or relapse|3
290924|NCT00932126|958184|P6|Overall Study|Objective progression or relapse|3
290925|NCT00932126|958185|P5|Overall Study|Objective progression or relapse|3
290926|NCT00932126|958186|P4|Overall Study|Objective progression or relapse|3
290927|NCT00932126|958187|P3|Overall Study|Objective progression or relapse|2
290928|NCT00932126|958188|P2|Overall Study|Objective progression or relapse|3
290929|NCT00932126|958189|P1|Overall Study|Objective progression or relapse|3
290930|NCT00932126|958182|P8|Overall Study|Withdrawal by Subject|1
290931|NCT00932126|958183|P7|Overall Study|Withdrawal by Subject|0
290932|NCT00932126|958184|P6|Overall Study|Withdrawal by Subject|0
290933|NCT00932126|958185|P5|Overall Study|Withdrawal by Subject|0
290934|NCT00932126|958186|P4|Overall Study|Withdrawal by Subject|0
290935|NCT00932126|958187|P3|Overall Study|Withdrawal by Subject|1
290936|NCT00932126|958188|P2|Overall Study|Withdrawal by Subject|0
290937|NCT00932126|958189|P1|Overall Study|Withdrawal by Subject|0
290938|NCT00932126|958182|P8|Overall Study|Protocol Violation|0
290939|NCT00932126|958183|P7|Overall Study|Protocol Violation|0
290940|NCT00932126|958184|P6|Overall Study|Protocol Violation|0
290941|NCT00932126|958185|P5|Overall Study|Protocol Violation|1
290942|NCT00932126|958186|P4|Overall Study|Protocol Violation|0
290943|NCT00932126|958187|P3|Overall Study|Protocol Violation|0
290944|NCT00932126|958188|P2|Overall Study|Protocol Violation|0
290945|NCT00932126|958189|P1|Overall Study|Protocol Violation|0
290946|NCT00932126|958182|P8|Overall Study|Adverse Event|2
290947|NCT00932126|958183|P7|Overall Study|Adverse Event|1
290948|NCT00932126|958184|P6|Overall Study|Adverse Event|0
290949|NCT00932126|958185|P5|Overall Study|Adverse Event|0
290950|NCT00932126|958186|P4|Overall Study|Adverse Event|0
290951|NCT00932126|958187|P3|Overall Study|Adverse Event|0
290952|NCT00932126|958188|P2|Overall Study|Adverse Event|0
290953|NCT00932126|958189|P1|Overall Study|Adverse Event|0
290954|NCT00931918|958261|P2|Overall Study|Did not receive study drug|2
290955|NCT00931918|958262|P1|Overall Study|Did not receive study drug|3
290956|NCT00931918|958261|P2|Overall Study|Other Reason not Specified|4
290957|NCT00931918|958262|P1|Overall Study|Other Reason not Specified|4
290958|NCT00931918|958261|P2|Overall Study|Withdrawal by Patient|4
290959|NCT00931918|958262|P1|Overall Study|Withdrawal by Patient|3
290960|NCT00931918|958261|P2|Overall Study|Symptomatic Deterioration|0
290961|NCT00931918|958262|P1|Overall Study|Symptomatic Deterioration|1
290962|NCT00931918|958261|P2|Overall Study|Progressive Disease|1
290963|NCT00931918|958262|P1|Overall Study|Progressive Disease|2
290964|NCT00931918|958261|P2|Overall Study|Adverse Event|6
290965|NCT00931918|958262|P1|Overall Study|Adverse Event|4
290966|NCT00931801|958314|P3|Overall Study|Confirmed Virologic Failure|3
290967|NCT00931801|958315|P2|Overall Study|Confirmed Virologic Failure|0
290968|NCT00931801|958316|P1|Overall Study|Confirmed Virologic Failure|0
290969|NCT00931801|958314|P3|Overall Study|Withdrawal by Subject|0
290970|NCT00931801|958315|P2|Overall Study|Withdrawal by Subject|0
290971|NCT00931801|958316|P1|Overall Study|Withdrawal by Subject|1
290972|NCT00931801|958314|P3|Overall Study|Lost to Follow-up|0
290973|NCT00931801|958315|P2|Overall Study|Lost to Follow-up|1
290974|NCT00931801|958316|P1|Overall Study|Lost to Follow-up|0
290975|NCT00931801|958314|P3|Overall Study|Adverse Event|1
290976|NCT00931801|958315|P2|Overall Study|Adverse Event|0
290977|NCT00931801|958316|P1|Overall Study|Adverse Event|0
290978|NCT00931723|958339|P2|Overall Study|Late hospital discharge|0
290979|NCT00931723|958340|P1|Overall Study|Late hospital discharge|1
290980|NCT00931723|958339|P2|Overall Study|Sponsor decision|0
290981|NCT00931723|958340|P1|Overall Study|Sponsor decision|1
290982|NCT00931723|958339|P2|Overall Study|Lack or insufficient theraputic response|5
290983|NCT00931723|958340|P1|Overall Study|Lack or insufficient theraputic response|2
290984|NCT00931723|958339|P2|Overall Study|Took prohibited concomitant medication|1
290985|NCT00931723|958340|P1|Overall Study|Took prohibited concomitant medication|0
290986|NCT00931723|958339|P2|Overall Study|Safety reasons|1
290987|NCT00931723|958340|P1|Overall Study|Safety reasons|0
290988|NCT00931723|958339|P2|Overall Study|Severe non-compliance to protocol|0
290989|NCT00931723|958340|P1|Overall Study|Severe non-compliance to protocol|2
290990|NCT00931723|958339|P2|Overall Study|Study-specific discontinuation criteria|1
290991|NCT00931723|958340|P1|Overall Study|Study-specific discontinuation criteria|1
290992|NCT00931723|958339|P2|Overall Study|Lost to Follow-up|2
290993|NCT00931723|958340|P1|Overall Study|Lost to Follow-up|1
290994|NCT00931723|958339|P2|Overall Study|Condition under investigation worsened|2
290995|NCT00931723|958340|P1|Overall Study|Condition under investigation worsened|1
290996|NCT00931723|958339|P2|Overall Study|Lithium found in blood|1
290997|NCT00931723|958340|P1|Overall Study|Lithium found in blood|0
290998|NCT00931723|958339|P2|Overall Study|Adverse Event|13
290999|NCT00931723|958340|P1|Overall Study|Adverse Event|6
291000|NCT00931723|958339|P2|Overall Study|Withdrawal by Subject|13
291001|NCT00931723|958340|P1|Overall Study|Withdrawal by Subject|11
291002|NCT00931710|958388|P2|Overall Study|Protocol deviation|2
291003|NCT00931710|958389|P1|Overall Study|Protocol deviation|1
291004|NCT00931710|958388|P2|Overall Study|Lost to Follow-up|5
291005|NCT00931710|958389|P1|Overall Study|Lost to Follow-up|6
291006|NCT00931710|958388|P2|Overall Study|Patient withdrew consent|9
291007|NCT00931710|958389|P1|Overall Study|Patient withdrew consent|4
291008|NCT00931710|958388|P2|Overall Study|Unsatisfactory therapeutic effects|12
291009|NCT00931710|958389|P1|Overall Study|Unsatisfactory therapeutic effects|5
291010|NCT00931710|958388|P2|Overall Study|Abnormal test procedure results|0
291011|NCT00931710|958389|P1|Overall Study|Abnormal test procedure results|2
291012|NCT00931710|958388|P2|Overall Study|Adverse Event|10
291013|NCT00931710|958389|P1|Overall Study|Adverse Event|16
291014|NCT00931632|958407|P2|Overall Study|Adverse Event|15
291015|NCT00931632|958408|P1|Overall Study|Adverse Event|19
291016|NCT00931632|958407|P2|Overall Study|Withdrawal by Subject|3
291017|NCT00931632|958408|P1|Overall Study|Withdrawal by Subject|2
291018|NCT00931528|958416|P2|Overall Study|Assessment outside of Time Frame|23
291019|NCT00931528|958417|P1|Overall Study|Assessment outside of Time Frame|22
291020|NCT00931528|958416|P2|Overall Study|Lost to Follow-up|13
291021|NCT00931528|958417|P1|Overall Study|Lost to Follow-up|6
291022|NCT00931528|958416|P2|Overall Study|Withdrawal by Subject|12
291023|NCT00931528|958417|P1|Overall Study|Withdrawal by Subject|4
291024|NCT00931528|958416|P2|Overall Study|Protocol Violation|12
291025|NCT00931528|958417|P1|Overall Study|Protocol Violation|9
291026|NCT00931515|958425|P2|Overall Study|Lost to Follow-up|5
291027|NCT00931515|958426|P1|Overall Study|Lost to Follow-up|2
291028|NCT00931463|958434|P2|Overall Study|Lost to Follow-up|1
291029|NCT00931463|958435|P1|Overall Study|Lost to Follow-up|4
291030|NCT00931463|958434|P2|Overall Study|Withdrawal by Subject|0
291031|NCT00931463|958435|P1|Overall Study|Withdrawal by Subject|5
291032|NCT00931463|958434|P2|Overall Study|Death|4
291033|NCT00931463|958435|P1|Overall Study|Death|8
291034|NCT00931411|958451|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
291035|NCT00931411|958452|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
291036|NCT00931411|958451|P2|First Intervention - 42 Days|Lost to Follow-up|0
291037|NCT00931411|958452|P1|First Intervention - 42 Days|Lost to Follow-up|2
291038|NCT00931411|958451|P2|First Intervention - 42 Days|Adverse Event|3
291039|NCT00931411|958452|P1|First Intervention - 42 Days|Adverse Event|2
291040|NCT00931385|958473|P4|Overall Study|Lost to Follow-up|1
291041|NCT00931385|958474|P3|Overall Study|Lost to Follow-up|0
291042|NCT00931385|958475|P2|Overall Study|Lost to Follow-up|0
291043|NCT00931385|958476|P1|Overall Study|Lost to Follow-up|0
291044|NCT00931385|958473|P4|Overall Study|Withdrawal by Subject|1
291045|NCT00931385|958474|P3|Overall Study|Withdrawal by Subject|0
291046|NCT00931385|958475|P2|Overall Study|Withdrawal by Subject|1
291047|NCT00931385|958476|P1|Overall Study|Withdrawal by Subject|0
291048|NCT00931385|958473|P4|Overall Study|Protocol Violation|0
291049|NCT00931385|958474|P3|Overall Study|Protocol Violation|1
291050|NCT00931385|958475|P2|Overall Study|Protocol Violation|0
291051|NCT00931385|958476|P1|Overall Study|Protocol Violation|0
291052|NCT00931385|958473|P4|Overall Study|Adverse Event|3
291053|NCT00931385|958474|P3|Overall Study|Adverse Event|0
291054|NCT00931385|958475|P2|Overall Study|Adverse Event|1
291055|NCT00931385|958476|P1|Overall Study|Adverse Event|2
291056|NCT00931307|958545|P1|Overall Study|Biomicroscopy|1
291057|NCT00931307|958545|P1|Overall Study|Lack of Efficacy|12
291058|NCT00931268|958549|P1|Overall Study|Lost to Follow-up|6
291059|NCT00930982|958574|P2|Overall Study|Withdrawal by Subject|1
291060|NCT00930982|958575|P1|Overall Study|Withdrawal by Subject|1
291061|NCT00930982|958574|P2|Overall Study|Protocol Violation|5
291062|NCT00930982|958575|P1|Overall Study|Protocol Violation|1
291063|NCT00930982|958574|P2|Overall Study|Adverse Event|23
291064|NCT00930982|958575|P1|Overall Study|Adverse Event|19
291065|NCT00930969|958609|P1|Overall Study|Withdrawal by Subject|19
291066|NCT00930969|958609|P1|Overall Study|Physician Decision|13
291067|NCT00930969|958609|P1|Overall Study|Lost to Follow-up|1
291068|NCT00930969|958609|P1|Overall Study|Death|5
291069|NCT00930930|958619|P2|Overall Study|patients not compliant|1
291070|NCT00930930|958620|P1|Overall Study|patients not compliant|1
291071|NCT00930930|958619|P2|Overall Study|excessive lapse btw txs, not eligible|1
291072|NCT00930930|958620|P1|Overall Study|excessive lapse btw txs, not eligible|0
291073|NCT00930930|958619|P2|Overall Study|Disease progression|3
291074|NCT00930930|958620|P1|Overall Study|Disease progression|2
291075|NCT00930930|958619|P2|Overall Study|Withdrawal by Subject|1
291076|NCT00930930|958620|P1|Overall Study|Withdrawal by Subject|3
291077|NCT00930930|958619|P2|Overall Study|Adverse Event|3
291078|NCT00930930|958620|P1|Overall Study|Adverse Event|13
291079|NCT00930930|958619|P2|Overall Study|Physician Decision|0
291080|NCT00930930|958620|P1|Overall Study|Physician Decision|1
291081|NCT00930930|958619|P2|Overall Study|Death|0
291082|NCT00930930|958620|P1|Overall Study|Death|1
291083|NCT00930813|958634|P2|Overall Study|Lost to Follow-up|4
291084|NCT00930813|958635|P1|Overall Study|Lost to Follow-up|2
291085|NCT00930813|958634|P2|Overall Study|Withdrawal by Subject|5
291086|NCT00930813|958635|P1|Overall Study|Withdrawal by Subject|2
291087|NCT00930813|958634|P2|Overall Study|Death|5
291088|NCT00930813|958635|P1|Overall Study|Death|4
291089|NCT00930774|958656|P4|Overall Study|Withdrawal by Subject|0
291090|NCT00930774|958657|P3|Overall Study|Withdrawal by Subject|2
291091|NCT00930774|958658|P2|Overall Study|Withdrawal by Subject|9
291092|NCT00930774|958659|P1|Overall Study|Withdrawal by Subject|1
291093|NCT00930761|958699|P2|Overall Study|less than 3 music therapy sessions|3
291094|NCT00930761|958700|P1|Overall Study|less than 3 music therapy sessions|0
291095|NCT00930761|958699|P2|Overall Study|3 newborns died; 1 mother quit the study|0
291096|NCT00930761|958700|P1|Overall Study|3 newborns died; 1 mother quit the study|4
291097|NCT00930722|958712|P1|Overall Study|Study terminated by sponsor|2
291098|NCT00930722|958712|P1|Overall Study|No longer willing to participate|9
291099|NCT00930722|958712|P1|Overall Study|Lost to Follow-up|16
291100|NCT00930644|958727|P1|Overall Study|Adverse Event|16
291101|NCT00930644|958727|P1|Overall Study|Death|1
291102|NCT00930644|958727|P1|Overall Study|Physician Decision|2
291103|NCT00930644|958727|P1|Overall Study|Withdrawal by Subject|4
291104|NCT00930553|958740|P1|Overall Study|Other than specified above|28
291105|NCT00930553|958740|P1|Overall Study|Study terminated by sponsor|24
291106|NCT00930553|958740|P1|Overall Study|Death|9
291107|NCT00930553|958740|P1|Overall Study|Lost to Follow-up|25
291108|NCT00930553|958740|P1|Overall Study|Withdrawal by Subject|88
291109|NCT00930553|958740|P1|Overall Study|Pregnancy|1
291110|NCT00930553|958740|P1|Overall Study|Protocol Violation|1
291111|NCT00930553|958740|P1|Overall Study|Physician Decision|39
291112|NCT00930553|958740|P1|Overall Study|Lack of Efficacy|7
291113|NCT00930553|958740|P1|Overall Study|Adverse Event|1
291114|NCT00930176|958817|P1|Overall Study|Death|1
291115|NCT00929864|958834|P2|Overall Study|Non-specified|7
291116|NCT00929864|958835|P1|Overall Study|Non-specified|2
291117|NCT00929864|958834|P2|Overall Study|Administrative reason by Sponsor|1
291118|NCT00929864|958835|P1|Overall Study|Administrative reason by Sponsor|1
291119|NCT00929864|958834|P2|Overall Study|Pregnancy|3
291120|NCT00929864|958835|P1|Overall Study|Pregnancy|0
291121|NCT00929864|958834|P2|Overall Study|Poor or non-compliance|3
291122|NCT00929864|958835|P1|Overall Study|Poor or non-compliance|3
291123|NCT00929864|958834|P2|Overall Study|No longer met criteria|1
291124|NCT00929864|958835|P1|Overall Study|No longer met criteria|2
291125|NCT00929864|958834|P2|Overall Study|Withdrawal by Subject|9
291126|NCT00929864|958835|P1|Overall Study|Withdrawal by Subject|20
291127|NCT00929864|958834|P2|Overall Study|Lost to Follow-up|12
291128|NCT00929864|958835|P1|Overall Study|Lost to Follow-up|7
291129|NCT00929864|958834|P2|Overall Study|Lack of Efficacy|16
291130|NCT00929864|958835|P1|Overall Study|Lack of Efficacy|19
291131|NCT00929864|958834|P2|Overall Study|Adverse Event|30
291132|NCT00929864|958835|P1|Overall Study|Adverse Event|11
291133|NCT00929864|958834|P2|Overall Study|Death|1
291134|NCT00929864|958835|P1|Overall Study|Death|1
291135|NCT00929734|958874|P2|Overall Study|Withdrawal by Subject|2
291136|NCT00929734|958875|P1|Overall Study|Withdrawal by Subject|0
291137|NCT00929734|958874|P2|Overall Study|Lost to Follow-up|1
291138|NCT00929734|958875|P1|Overall Study|Lost to Follow-up|2
291139|NCT00929708|958892|P5|Overall Study|Lost to Follow-up|0
291140|NCT00929708|958893|P4|Overall Study|Lost to Follow-up|1
291141|NCT00929708|958894|P3|Overall Study|Lost to Follow-up|0
291142|NCT00929708|958895|P2|Overall Study|Lost to Follow-up|0
291143|NCT00929708|958896|P1|Overall Study|Lost to Follow-up|0
291144|NCT00929708|958892|P5|Overall Study|Physician Decision|1
291145|NCT00929708|958893|P4|Overall Study|Physician Decision|2
291146|NCT00929708|958894|P3|Overall Study|Physician Decision|2
291147|NCT00929708|958895|P2|Overall Study|Physician Decision|2
291148|NCT00929708|958896|P1|Overall Study|Physician Decision|0
291149|NCT00929708|958892|P5|Overall Study|Adverse Event|3
291150|NCT00929708|958893|P4|Overall Study|Adverse Event|0
291151|NCT00929708|958894|P3|Overall Study|Adverse Event|0
291152|NCT00929708|958895|P2|Overall Study|Adverse Event|0
291153|NCT00929708|958896|P1|Overall Study|Adverse Event|0
291154|NCT00929708|958892|P5|Overall Study|Withdrawal by Subject|1
291155|NCT00929708|958893|P4|Overall Study|Withdrawal by Subject|2
291156|NCT00929708|958894|P3|Overall Study|Withdrawal by Subject|0
291157|NCT00929708|958895|P2|Overall Study|Withdrawal by Subject|0
291158|NCT00929708|958896|P1|Overall Study|Withdrawal by Subject|2
291159|NCT00929708|958892|P5|Overall Study|Protocol Violation|1
291160|NCT00929708|958893|P4|Overall Study|Protocol Violation|1
291161|NCT00929708|958894|P3|Overall Study|Protocol Violation|1
291162|NCT00929708|958895|P2|Overall Study|Protocol Violation|1
291163|NCT00929708|958896|P1|Overall Study|Protocol Violation|2
291164|NCT00929695|958950|P2|Overall Study|incorrect stratification|0
291165|NCT00929695|958951|P1|Overall Study|incorrect stratification|2
291166|NCT00929695|958950|P2|Overall Study|discharge home|3
291167|NCT00929695|958951|P1|Overall Study|discharge home|4
291168|NCT00929695|958950|P2|Overall Study|Withdrawal by Subject|2
291169|NCT00929695|958951|P1|Overall Study|Withdrawal by Subject|0
291170|NCT00929695|958950|P2|Overall Study|Death|1
291171|NCT00929695|958951|P1|Overall Study|Death|2
291172|NCT00929643|958981|P1|Overall Study|Protocol Violation|2
291173|NCT00929526|959003|P2|Overall Study|Unspecified|6
291174|NCT00929526|959004|P1|Overall Study|Unspecified|8
291175|NCT00929526|959003|P2|Overall Study|Lost to Follow-up|12
291176|NCT00929526|959004|P1|Overall Study|Lost to Follow-up|8
291177|NCT00929526|959003|P2|Overall Study|Withdrawal by Subject|11
291178|NCT00929526|959004|P1|Overall Study|Withdrawal by Subject|1
291179|NCT00929240|959143|P3|Maintenance Phase|Participant not treated|0
291180|NCT00929240|959144|P2|Maintenance Phase|Participant not treated|2
291181|NCT00929240|959145|P1|Maintenance Phase|Participant not treated|0
291182|NCT00929240|959143|P3|Maintenance Phase|Treatment ongoing at study closure|10
291183|NCT00929240|959144|P2|Maintenance Phase|Treatment ongoing at study closure|0
291184|NCT00929240|959145|P1|Maintenance Phase|Treatment ongoing at study closure|0
291185|NCT00929240|959143|P3|Maintenance Phase|Change of treatment|0
291186|NCT00929240|959144|P2|Maintenance Phase|Change of treatment|4
291187|NCT00929240|959145|P1|Maintenance Phase|Change of treatment|0
291188|NCT00929240|959143|P3|Maintenance Phase|Physician Decision|1
291189|NCT00929240|959144|P2|Maintenance Phase|Physician Decision|2
291190|NCT00929240|959145|P1|Maintenance Phase|Physician Decision|0
291191|NCT00929240|959143|P3|Maintenance Phase|Health authority/Study termination|2
291192|NCT00929240|959144|P2|Maintenance Phase|Health authority/Study termination|1
291193|NCT00929240|959145|P1|Maintenance Phase|Health authority/Study termination|0
291194|NCT00929240|959143|P3|Maintenance Phase|Protocol Violation|0
291195|NCT00929240|959144|P2|Maintenance Phase|Protocol Violation|1
291196|NCT00929240|959145|P1|Maintenance Phase|Protocol Violation|0
291197|NCT00929240|959143|P3|Maintenance Phase|Withdrawal by Subject|6
291198|NCT00929240|959144|P2|Maintenance Phase|Withdrawal by Subject|2
291199|NCT00929240|959145|P1|Maintenance Phase|Withdrawal by Subject|0
291200|NCT00929240|959143|P3|Maintenance Phase|Adverse Event|12
291201|NCT00929240|959144|P2|Maintenance Phase|Adverse Event|9
291202|NCT00929240|959145|P1|Maintenance Phase|Adverse Event|0
291203|NCT00929240|959143|P3|Maintenance Phase|Disease progression|60
291204|NCT00929240|959144|P2|Maintenance Phase|Disease progression|73
291205|NCT00929240|959145|P1|Maintenance Phase|Disease progression|0
291206|NCT00929240|959143|P3|Initial Treatment Phase|Physician Decision|0
291207|NCT00929240|959144|P2|Initial Treatment Phase|Physician Decision|0
291208|NCT00929240|959145|P1|Initial Treatment Phase|Physician Decision|4
291209|NCT00929240|959143|P3|Initial Treatment Phase|Health authority/Study termination|0
291210|NCT00929240|959144|P2|Initial Treatment Phase|Health authority/Study termination|0
291211|NCT00929240|959145|P1|Initial Treatment Phase|Health authority/Study termination|3
291212|NCT00929240|959143|P3|Initial Treatment Phase|Death|0
291213|NCT00929240|959144|P2|Initial Treatment Phase|Death|0
291214|NCT00929240|959145|P1|Initial Treatment Phase|Death|2
291215|NCT00929240|959143|P3|Initial Treatment Phase|Protocol Violation|0
291216|NCT00929240|959144|P2|Initial Treatment Phase|Protocol Violation|0
291217|NCT00929240|959145|P1|Initial Treatment Phase|Protocol Violation|5
291218|NCT00929240|959143|P3|Initial Treatment Phase|Withdrawal by Subject|0
291219|NCT00929240|959144|P2|Initial Treatment Phase|Withdrawal by Subject|0
291220|NCT00929240|959145|P1|Initial Treatment Phase|Withdrawal by Subject|13
291221|NCT00929240|959143|P3|Initial Treatment Phase|Disease progression|0
291222|NCT00929240|959144|P2|Initial Treatment Phase|Disease progression|0
291223|NCT00929240|959145|P1|Initial Treatment Phase|Disease progression|41
291224|NCT00929240|959143|P3|Initial Treatment Phase|Adverse Event|0
291225|NCT00929240|959144|P2|Initial Treatment Phase|Adverse Event|0
291226|NCT00929240|959145|P1|Initial Treatment Phase|Adverse Event|31
291227|NCT00929201|959172|P2|Period 1|Withdrawal by Subject|1
291228|NCT00929201|959173|P1|Period 1|Withdrawal by Subject|0
291229|NCT00929162|959183|P2|Overall Study|Other termination reason|6
291230|NCT00929162|959184|P1|Overall Study|Other termination reason|5
291231|NCT00929162|959183|P2|Overall Study|Protocol Violation|30
291232|NCT00929162|959184|P1|Overall Study|Protocol Violation|32
291233|NCT00929162|959183|P2|Overall Study|Withdrawal by Subject|1
291234|NCT00929162|959184|P1|Overall Study|Withdrawal by Subject|3
291235|NCT00929162|959183|P2|Overall Study|Adverse Event|5
291236|NCT00929162|959184|P1|Overall Study|Adverse Event|8
291237|NCT00929110|959197|P3|Overall Study|Patient inability to use the device|0
291238|NCT00929110|959198|P2|Overall Study|Patient inability to use the device|1
291239|NCT00929110|959199|P1|Overall Study|Patient inability to use the device|0
291240|NCT00929110|959197|P3|Overall Study|Abnormal test procedure result(s)|1
291241|NCT00929110|959198|P2|Overall Study|Abnormal test procedure result(s)|1
291242|NCT00929110|959199|P1|Overall Study|Abnormal test procedure result(s)|0
291243|NCT00929110|959197|P3|Overall Study|Abnormal laboratory value(s)|0
291244|NCT00929110|959198|P2|Overall Study|Abnormal laboratory value(s)|1
291245|NCT00929110|959199|P1|Overall Study|Abnormal laboratory value(s)|0
291246|NCT00929110|959197|P3|Overall Study|Death|2
291247|NCT00929110|959198|P2|Overall Study|Death|2
291248|NCT00929110|959199|P1|Overall Study|Death|2
291249|NCT00929110|959197|P3|Overall Study|Administrative problems|2
291250|NCT00929110|959198|P2|Overall Study|Administrative problems|1
291251|NCT00929110|959199|P1|Overall Study|Administrative problems|4
291252|NCT00929110|959197|P3|Overall Study|Protocol deviation|4
291253|NCT00929110|959198|P2|Overall Study|Protocol deviation|2
291254|NCT00929110|959199|P1|Overall Study|Protocol deviation|5
291255|NCT00929110|959197|P3|Overall Study|Lost to Follow-up|3
291256|NCT00929110|959198|P2|Overall Study|Lost to Follow-up|7
291257|NCT00929110|959199|P1|Overall Study|Lost to Follow-up|7
291258|NCT00929110|959197|P3|Overall Study|Unsatisfactory therapeutic effect|6
291259|NCT00929110|959198|P2|Overall Study|Unsatisfactory therapeutic effect|9
291260|NCT00929110|959199|P1|Overall Study|Unsatisfactory therapeutic effect|20
291261|NCT00929110|959197|P3|Overall Study|Subject withdrew consent|26
291262|NCT00929110|959198|P2|Overall Study|Subject withdrew consent|23
291263|NCT00929110|959199|P1|Overall Study|Subject withdrew consent|40
291264|NCT00929110|959197|P3|Overall Study|Adverse Event|18
291265|NCT00929110|959198|P2|Overall Study|Adverse Event|29
291266|NCT00929110|959199|P1|Overall Study|Adverse Event|40
291267|NCT00928889|959282|P2|Overall Study|Other|0
291268|NCT00928889|959283|P1|Overall Study|Other|1
291269|NCT00928889|959282|P2|Overall Study|Adverse Event|0
291270|NCT00928889|959283|P1|Overall Study|Adverse Event|1
291271|NCT00928889|959282|P2|Overall Study|Protocol Violation|1
291272|NCT00928889|959283|P1|Overall Study|Protocol Violation|0
291273|NCT00928889|959282|P2|Overall Study|Lost to Follow-up|1
291274|NCT00928889|959283|P1|Overall Study|Lost to Follow-up|3
291275|NCT00928746|959329|P1|Overall Study|Other|2
291276|NCT00928746|959329|P1|Overall Study|Withdrawal by Subject|1
291277|NCT00928746|959329|P1|Overall Study|Protocol Violation|1
291278|NCT00928746|959329|P1|Overall Study|Adverse Event|2
291279|NCT00928668|959371|P5|Overall Study|Other reasons not listed above|0
291280|NCT00928668|959372|P4|Overall Study|Other reasons not listed above|1
291281|NCT00928668|959373|P3|Overall Study|Other reasons not listed above|0
291282|NCT00928668|959374|P2|Overall Study|Other reasons not listed above|0
291283|NCT00928668|959375|P1|Overall Study|Other reasons not listed above|0
291284|NCT00928668|959371|P5|Overall Study|Withdrawal by Subject|0
291285|NCT00928668|959372|P4|Overall Study|Withdrawal by Subject|0
291286|NCT00928668|959373|P3|Overall Study|Withdrawal by Subject|1
291287|NCT00928668|959374|P2|Overall Study|Withdrawal by Subject|1
291288|NCT00928668|959375|P1|Overall Study|Withdrawal by Subject|0
291289|NCT00928668|959371|P5|Overall Study|Protocol Violation|1
291290|NCT00928668|959372|P4|Overall Study|Protocol Violation|0
291291|NCT00928668|959373|P3|Overall Study|Protocol Violation|0
291292|NCT00928668|959374|P2|Overall Study|Protocol Violation|0
291293|NCT00928668|959375|P1|Overall Study|Protocol Violation|0
291294|NCT00928668|959371|P5|Overall Study|Adverse Event|0
291295|NCT00928668|959372|P4|Overall Study|Adverse Event|0
291296|NCT00928668|959373|P3|Overall Study|Adverse Event|0
291297|NCT00928668|959374|P2|Overall Study|Adverse Event|0
291298|NCT00928668|959375|P1|Overall Study|Adverse Event|1
291299|NCT00928512|959431|P5|Overall Study|Administrative Problems|0
291300|NCT00928512|959432|P4|Overall Study|Administrative Problems|0
291301|NCT00928512|959433|P3|Overall Study|Administrative Problems|0
291302|NCT00928512|959434|P2|Overall Study|Administrative Problems|1
291303|NCT00928512|959435|P1|Overall Study|Administrative Problems|0
291304|NCT00928512|959431|P5|Overall Study|Lost to Follow-up|3
291305|NCT00928512|959432|P4|Overall Study|Lost to Follow-up|1
291306|NCT00928512|959433|P3|Overall Study|Lost to Follow-up|2
291307|NCT00928512|959434|P2|Overall Study|Lost to Follow-up|1
291308|NCT00928512|959435|P1|Overall Study|Lost to Follow-up|1
291309|NCT00928512|959431|P5|Overall Study|Withdrawal by Subject|0
291310|NCT00928512|959432|P4|Overall Study|Withdrawal by Subject|4
291311|NCT00928512|959433|P3|Overall Study|Withdrawal by Subject|3
291312|NCT00928512|959434|P2|Overall Study|Withdrawal by Subject|0
291313|NCT00928512|959435|P1|Overall Study|Withdrawal by Subject|3
291314|NCT00928512|959431|P5|Overall Study|Protocol Violation|3
291315|NCT00928512|959432|P4|Overall Study|Protocol Violation|1
291316|NCT00928512|959433|P3|Overall Study|Protocol Violation|0
291317|NCT00928512|959434|P2|Overall Study|Protocol Violation|1
291318|NCT00928512|959435|P1|Overall Study|Protocol Violation|0
291319|NCT00928512|959431|P5|Overall Study|Lack of Efficacy|3
291320|NCT00928512|959432|P4|Overall Study|Lack of Efficacy|7
291321|NCT00928512|959433|P3|Overall Study|Lack of Efficacy|4
291322|NCT00928512|959434|P2|Overall Study|Lack of Efficacy|0
291323|NCT00928512|959435|P1|Overall Study|Lack of Efficacy|2
291324|NCT00928512|959431|P5|Overall Study|Adverse Event|6
291325|NCT00928512|959432|P4|Overall Study|Adverse Event|8
291326|NCT00928512|959433|P3|Overall Study|Adverse Event|2
291327|NCT00928512|959434|P2|Overall Study|Adverse Event|3
291328|NCT00928512|959435|P1|Overall Study|Adverse Event|4
291329|NCT00928486|959536|P1|Overall Study|Withdrawal by Subject|1
291330|NCT00928486|959536|P1|Overall Study|Disease Progression|7
291331|NCT00928486|959536|P1|Overall Study|Adverse Event|2
291332|NCT00928434|959545|P3|Overall Study|Other (not meeting above criteria)|2
291333|NCT00928434|959546|P2|Overall Study|Other (not meeting above criteria)|1
291334|NCT00928434|959547|P1|Overall Study|Other (not meeting above criteria)|5
291335|NCT00928434|959545|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
291336|NCT00928434|959546|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
291337|NCT00928434|959547|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
291338|NCT00928434|959545|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
291339|NCT00928434|959546|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
291340|NCT00928434|959547|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
291341|NCT00928434|959545|P3|Overall Study|Withdrawal by Subject|2
291342|NCT00928434|959546|P2|Overall Study|Withdrawal by Subject|3
291343|NCT00928434|959547|P1|Overall Study|Withdrawal by Subject|5
291344|NCT00928434|959545|P3|Overall Study|Lost to Follow-up|3
291345|NCT00928434|959546|P2|Overall Study|Lost to Follow-up|0
291346|NCT00928434|959547|P1|Overall Study|Lost to Follow-up|1
291347|NCT00928434|959545|P3|Overall Study|Physician Decision|3
291348|NCT00928434|959546|P2|Overall Study|Physician Decision|0
291349|NCT00928434|959547|P1|Overall Study|Physician Decision|2
291350|NCT00928434|959545|P3|Overall Study|Protocol Violation|8
291351|NCT00928434|959546|P2|Overall Study|Protocol Violation|0
291352|NCT00928434|959547|P1|Overall Study|Protocol Violation|5
291353|NCT00928434|959545|P3|Overall Study|Adverse Event|18
291354|NCT00928434|959546|P2|Overall Study|Adverse Event|5
291355|NCT00928434|959547|P1|Overall Study|Adverse Event|14
291356|NCT00928408|959623|P1|Overall Study|Lost to Follow-up|12
291357|NCT00928408|959623|P1|Overall Study|Death|5
291358|NCT00928408|959623|P1|Overall Study|Withdrawal by Subject|4
291359|NCT00928408|959623|P1|Overall Study|Other|2
291360|NCT00928187|959672|P3|Overall Study|Protocol Violation|0
291361|NCT00928187|959673|P2|Overall Study|Protocol Violation|1
291362|NCT00928187|959674|P1|Overall Study|Protocol Violation|0
291363|NCT00928187|959672|P3|Overall Study|Withdrawal by Subject|1
291364|NCT00928187|959673|P2|Overall Study|Withdrawal by Subject|1
291365|NCT00928187|959674|P1|Overall Study|Withdrawal by Subject|0
291366|NCT00928187|959672|P3|Overall Study|Lost to Follow-up|1
291367|NCT00928187|959673|P2|Overall Study|Lost to Follow-up|2
291368|NCT00928187|959674|P1|Overall Study|Lost to Follow-up|1
291369|NCT00928187|959672|P3|Overall Study|Death|3
291370|NCT00928187|959673|P2|Overall Study|Death|2
291371|NCT00928187|959674|P1|Overall Study|Death|1
291372|NCT00928070|959844|P2|Overall Study|Unspecified|5
291373|NCT00928070|959845|P1|Overall Study|Unspecified|5
291374|NCT00928070|959844|P2|Overall Study|Randomized but not treated|2
291375|NCT00928070|959845|P1|Overall Study|Randomized but not treated|2
291376|NCT00928070|959844|P2|Overall Study|Protocol Violation|5
291377|NCT00928070|959845|P1|Overall Study|Protocol Violation|6
291378|NCT00928070|959844|P2|Overall Study|Did not meet entrance criteria|9
291379|NCT00928070|959845|P1|Overall Study|Did not meet entrance criteria|16
291380|NCT00928070|959844|P2|Overall Study|Lack of Efficacy|5
291381|NCT00928070|959845|P1|Overall Study|Lack of Efficacy|9
291382|NCT00928070|959844|P2|Overall Study|Adverse Event|26
291383|NCT00928070|959845|P1|Overall Study|Adverse Event|14
291384|NCT00928070|959844|P2|Overall Study|Withdrawal by Subject|3
291385|NCT00928070|959845|P1|Overall Study|Withdrawal by Subject|10
291386|NCT00928070|959844|P2|Overall Study|Lost to Follow-up|2
291387|NCT00928070|959845|P1|Overall Study|Lost to Follow-up|1
291388|NCT00928057|959903|P2|Overall Study|Protocol Violation|1
291389|NCT00928057|959904|P1|Overall Study|Protocol Violation|0
291390|NCT00928057|959903|P2|Overall Study|Lost to Follow-up|1
291391|NCT00928057|959904|P1|Overall Study|Lost to Follow-up|0
291392|NCT00928057|959903|P2|Overall Study|Withdrawal by Subject|0
291393|NCT00928057|959904|P1|Overall Study|Withdrawal by Subject|1
291394|NCT00928057|959903|P2|Overall Study|Adverse Event|2
291395|NCT00928057|959904|P1|Overall Study|Adverse Event|1
291396|NCT00928018|959929|P2|Overall Study|Withdrawal by Subject|0
291397|NCT00928018|959930|P1|Overall Study|Withdrawal by Subject|1
291398|NCT00927953|959960|P2|Overall Study|Death|1
291399|NCT00927953|959961|P1|Overall Study|Death|2
291400|NCT00927940|959975|P1|Overall Study|Death|1
291401|NCT00927927|959995|P15|Overall Study|Withdrawal by Subject|0
291402|NCT00927927|959996|P14|Overall Study|Withdrawal by Subject|0
291403|NCT00927927|959997|P13|Overall Study|Withdrawal by Subject|0
291404|NCT00927927|959998|P12|Overall Study|Withdrawal by Subject|2
291405|NCT00927927|959999|P11|Overall Study|Withdrawal by Subject|0
291406|NCT00927927|960000|P10|Overall Study|Withdrawal by Subject|0
291407|NCT00927927|960001|P9|Overall Study|Withdrawal by Subject|0
291408|NCT00927927|960002|P8|Overall Study|Withdrawal by Subject|2
291409|NCT00927927|960003|P7|Overall Study|Withdrawal by Subject|0
291410|NCT00927927|960004|P6|Overall Study|Withdrawal by Subject|0
291411|NCT00927927|960005|P5|Overall Study|Withdrawal by Subject|0
291412|NCT00927927|960006|P4|Overall Study|Withdrawal by Subject|0
291413|NCT00927927|960007|P3|Overall Study|Withdrawal by Subject|0
291414|NCT00927927|960008|P2|Overall Study|Withdrawal by Subject|0
291415|NCT00927927|960009|P1|Overall Study|Withdrawal by Subject|0
291416|NCT00927901|960056|P4|Treatment Period 4|Subject withdrew consent|0
291417|NCT00927901|960057|P3|Treatment Period 4|Subject withdrew consent|1
291418|NCT00927901|960058|P2|Treatment Period 4|Subject withdrew consent|0
291419|NCT00927901|960059|P1|Treatment Period 4|Subject withdrew consent|0
291420|NCT00927901|960056|P4|Treatment Period 4|Adverse Event|1
291421|NCT00927901|960057|P3|Treatment Period 4|Adverse Event|0
291422|NCT00927901|960058|P2|Treatment Period 4|Adverse Event|0
291423|NCT00927901|960059|P1|Treatment Period 4|Adverse Event|0
291424|NCT00927901|960056|P4|Treatment Period 1|Subject withdrew consent|0
291425|NCT00927901|960057|P3|Treatment Period 1|Subject withdrew consent|1
291426|NCT00927901|960058|P2|Treatment Period 1|Subject withdrew consent|0
291427|NCT00927901|960059|P1|Treatment Period 1|Subject withdrew consent|0
291428|NCT00927862|960100|P2|Overall Study|Missing data needed for endpt analyses|45
291429|NCT00927862|960101|P1|Overall Study|Missing data needed for endpt analyses|27
291430|NCT00927823|960136|P4|Continuous Dosing Period|Unspecified|3
291431|NCT00927823|960137|P3|Continuous Dosing Period|Unspecified|9
291432|NCT00927823|960138|P2|Continuous Dosing Period|Unspecified|2
291433|NCT00927823|960139|P1|Continuous Dosing Period|Unspecified|1
291434|NCT00927823|960136|P4|Continuous Dosing Period|Withdrawal by Subject|2
291435|NCT00927823|960137|P3|Continuous Dosing Period|Withdrawal by Subject|2
291436|NCT00927823|960138|P2|Continuous Dosing Period|Withdrawal by Subject|0
291437|NCT00927823|960139|P1|Continuous Dosing Period|Withdrawal by Subject|1
291438|NCT00927823|960136|P4|Continuous Dosing Period|Lost to Follow-up|0
291439|NCT00927823|960137|P3|Continuous Dosing Period|Lost to Follow-up|9
291440|NCT00927823|960138|P2|Continuous Dosing Period|Lost to Follow-up|1
291441|NCT00927823|960139|P1|Continuous Dosing Period|Lost to Follow-up|1
291442|NCT00927823|960136|P4|Continuous Dosing Period|Death|0
291443|NCT00927823|960137|P3|Continuous Dosing Period|Death|6
291444|NCT00927823|960138|P2|Continuous Dosing Period|Death|0
291445|NCT00927823|960139|P1|Continuous Dosing Period|Death|0
291446|NCT00927758|960203|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
291447|NCT00927758|960204|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
291448|NCT00927758|960205|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
291449|NCT00927758|960206|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
291450|NCT00927758|960207|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
291451|NCT00927758|960208|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
291452|NCT00927758|960203|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
291453|NCT00927758|960204|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
291454|NCT00927758|960205|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
291455|NCT00927758|960206|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
291456|NCT00927758|960207|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
291457|NCT00927758|960208|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
291458|NCT00927589|960216|P1|Overall Study|Non-compliance|1
291459|NCT00927589|960216|P1|Overall Study|Disease Progression|8
291460|NCT00927589|960216|P1|Overall Study|Adverse Event|2
291461|NCT00927589|960216|P1|Overall Study|Withdrawal by Subject|3
291462|NCT00927589|960216|P1|Overall Study|Physician Decision|1
291463|NCT00927589|960216|P1|Overall Study|Death|1
291464|NCT00927563|960246|P1|Overall Study|Withdrawal by Subject|1
291465|NCT00927563|960246|P1|Overall Study|Lost to Follow-up|1
291466|NCT00927472|960254|P2|Overall Study|Post treatment Assessment out of window|4
291467|NCT00927472|960255|P1|Overall Study|Post treatment Assessment out of window|0
291468|NCT00927472|960254|P2|Overall Study|Protocol Violation|1
291469|NCT00927472|960255|P1|Overall Study|Protocol Violation|0
291470|NCT00927472|960254|P2|Overall Study|Lost to Follow-up|6
291471|NCT00927472|960255|P1|Overall Study|Lost to Follow-up|1
291472|NCT00927472|960254|P2|Overall Study|Withdrawal by Subject|11
291473|NCT00927472|960255|P1|Overall Study|Withdrawal by Subject|10
291474|NCT00927394|960281|P2|Overall Study|Randomized in error|1
291475|NCT00927394|960282|P1|Overall Study|Randomized in error|0
291476|NCT00927394|960281|P2|Overall Study|Protocol deviation|13
291477|NCT00927394|960282|P1|Overall Study|Protocol deviation|16
291478|NCT00927394|960281|P2|Overall Study|Death|1
291479|NCT00927394|960282|P1|Overall Study|Death|1
291480|NCT00927394|960281|P2|Overall Study|Administrative Problem|0
291481|NCT00927394|960282|P1|Overall Study|Administrative Problem|1
291482|NCT00927394|960281|P2|Overall Study|Lost to Follow-up|14
291483|NCT00927394|960282|P1|Overall Study|Lost to Follow-up|8
291484|NCT00927394|960281|P2|Overall Study|Withdrawal by Subject|24
291485|NCT00927394|960282|P1|Overall Study|Withdrawal by Subject|20
291486|NCT00927394|960281|P2|Overall Study|Unsatisfactory therapeutic effect|23
291487|NCT00927394|960282|P1|Overall Study|Unsatisfactory therapeutic effect|17
291488|NCT00927394|960281|P2|Overall Study|Adverse Event|9
291489|NCT00927394|960282|P1|Overall Study|Adverse Event|14
291490|NCT00927368|960313|P3|Overall Study|cancellation of surgery|2
291491|NCT00927368|960314|P2|Overall Study|cancellation of surgery|1
291492|NCT00927368|960315|P1|Overall Study|cancellation of surgery|0
291493|NCT00927368|960313|P3|Overall Study|ineligible post randomization|1
291494|NCT00927368|960314|P2|Overall Study|ineligible post randomization|3
291495|NCT00927368|960315|P1|Overall Study|ineligible post randomization|0
291496|NCT00927368|960313|P3|Overall Study|equipment failure|0
291497|NCT00927368|960314|P2|Overall Study|equipment failure|0
291498|NCT00927368|960315|P1|Overall Study|equipment failure|1
291499|NCT00927368|960313|P3|Overall Study|Lost to Follow-up|0
291500|NCT00927368|960314|P2|Overall Study|Lost to Follow-up|0
291501|NCT00927368|960315|P1|Overall Study|Lost to Follow-up|4
291502|NCT00927368|960313|P3|Overall Study|enrollment in another study|2
291503|NCT00927368|960314|P2|Overall Study|enrollment in another study|1
291504|NCT00927368|960315|P1|Overall Study|enrollment in another study|1
291505|NCT00927355|960334|P2|Overall Study|Adverse Event|1
291506|NCT00927355|960335|P1|Overall Study|Adverse Event|1
291507|NCT00927251|960353|P1|Overall Study|Patients not implanted with 4296 lead|8
291508|NCT00927186|960359|P2|12 Months Primary Study|Withdrawal by Subject|1
291509|NCT00927186|960360|P1|12 Months Primary Study|Withdrawal by Subject|1
291510|NCT00927186|960359|P2|12 Months Primary Study|Protocol Violation|1
291511|NCT00927186|960360|P1|12 Months Primary Study|Protocol Violation|0
291512|NCT00927186|960359|P2|12 Months Primary Study|Lost to Follow-up|0
291513|NCT00927186|960360|P1|12 Months Primary Study|Lost to Follow-up|1
291514|NCT00927186|960359|P2|12 Months Primary Study|Adverse Event|2
291515|NCT00927186|960360|P1|12 Months Primary Study|Adverse Event|5
291516|NCT00927095|960490|P3|Overall Study|Physician Decision|1
291517|NCT00927095|960491|P2|Overall Study|Physician Decision|2
291518|NCT00927095|960492|P1|Overall Study|Physician Decision|1
291519|NCT00927095|960490|P3|Overall Study|Withdrawal by Subject|1
291520|NCT00927095|960491|P2|Overall Study|Withdrawal by Subject|1
291521|NCT00927095|960492|P1|Overall Study|Withdrawal by Subject|2
291522|NCT00927095|960490|P3|Overall Study|Adverse Event|0
291523|NCT00927095|960491|P2|Overall Study|Adverse Event|1
291524|NCT00927095|960492|P1|Overall Study|Adverse Event|3
291525|NCT00927082|960504|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
291526|NCT00927082|960505|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
291527|NCT00927082|960506|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
291528|NCT00927082|960507|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
291529|NCT00927082|960504|P4|Overall Study|Death|0
291530|NCT00927082|960505|P3|Overall Study|Death|1
291531|NCT00927082|960506|P2|Overall Study|Death|0
291532|NCT00927082|960507|P1|Overall Study|Death|0
291533|NCT00927082|960504|P4|Overall Study|Withdrawal by Subject|2
291534|NCT00927082|960505|P3|Overall Study|Withdrawal by Subject|7
291535|NCT00927082|960506|P2|Overall Study|Withdrawal by Subject|2
291536|NCT00927082|960507|P1|Overall Study|Withdrawal by Subject|3
291537|NCT00927082|960504|P4|Overall Study|Lost to Follow-up|16
291538|NCT00927082|960505|P3|Overall Study|Lost to Follow-up|12
291539|NCT00927082|960506|P2|Overall Study|Lost to Follow-up|8
291540|NCT00927082|960507|P1|Overall Study|Lost to Follow-up|9
291541|NCT00927069|960571|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
291542|NCT00927069|960572|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
291543|NCT00927069|960573|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
291544|NCT00927069|960574|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
291545|NCT00927069|960571|P4|Week 12 to Week 24|Withdrawal by Subject|0
291546|NCT00927069|960572|P3|Week 12 to Week 24|Withdrawal by Subject|0
291547|NCT00927069|960573|P2|Week 12 to Week 24|Withdrawal by Subject|0
291548|NCT00927069|960574|P1|Week 12 to Week 24|Withdrawal by Subject|1
291549|NCT00927069|960571|P4|Week 12 to Week 24|Lost to Follow-up|0
291550|NCT00927069|960572|P3|Week 12 to Week 24|Lost to Follow-up|1
291551|NCT00927069|960573|P2|Week 12 to Week 24|Lost to Follow-up|0
291552|NCT00927069|960574|P1|Week 12 to Week 24|Lost to Follow-up|0
291553|NCT00927069|960571|P4|Week 12 to Week 24|Lack of Efficacy|3
291554|NCT00927069|960572|P3|Week 12 to Week 24|Lack of Efficacy|2
291555|NCT00927069|960573|P2|Week 12 to Week 24|Lack of Efficacy|0
291556|NCT00927069|960574|P1|Week 12 to Week 24|Lack of Efficacy|0
291557|NCT00927069|960571|P4|Week 0 to Week 12|Worsening of psoriasis|0
291558|NCT00927069|960572|P3|Week 0 to Week 12|Worsening of psoriasis|0
291559|NCT00927069|960573|P2|Week 0 to Week 12|Worsening of psoriasis|1
291560|NCT00927069|960574|P1|Week 0 to Week 12|Worsening of psoriasis|1
291561|NCT00926796|960611|P2|Overall Study|Withdrawal by Subject|0
291562|NCT00926796|960612|P1|Overall Study|Withdrawal by Subject|1
291563|NCT00926796|960611|P2|Overall Study|Protocol Violation|11
291564|NCT00926796|960612|P1|Overall Study|Protocol Violation|15
291565|NCT00926796|960611|P2|Overall Study|Lost to Follow-up|13
291566|NCT00926796|960612|P1|Overall Study|Lost to Follow-up|22
291567|NCT00926796|960611|P2|Overall Study|Adverse Event|14
291568|NCT00926796|960612|P1|Overall Study|Adverse Event|7
291569|NCT00926796|960611|P2|Overall Study|Ineligible, but positive for gonorrhea|1
291570|NCT00926796|960612|P1|Overall Study|Ineligible, but positive for gonorrhea|1
291571|NCT00926796|960611|P2|Overall Study|Ineligible, negative for gonorrhea|60
291572|NCT00926796|960612|P1|Overall Study|Ineligible, negative for gonorrhea|57
291573|NCT00926796|960611|P2|Overall Study|Did not receive randomized treatment|7
291574|NCT00926796|960612|P1|Overall Study|Did not receive randomized treatment|4
291575|NCT00926783|960633|P2|Overall Study|Incomplete CFAE Procedures|3
291576|NCT00926783|960634|P1|Overall Study|Incomplete CFAE Procedures|3
291577|NCT00926575|960661|P2|Overall Study|Withdrawal by Subject|9
291578|NCT00926575|960662|P1|Overall Study|Withdrawal by Subject|8
291579|NCT00926575|960661|P2|Overall Study|Protocol Violation|0
291580|NCT00926575|960662|P1|Overall Study|Protocol Violation|1
291581|NCT00926575|960661|P2|Overall Study|Physician Decision|2
291582|NCT00926575|960662|P1|Overall Study|Physician Decision|1
291583|NCT00926575|960661|P2|Overall Study|Lost to Follow-up|1
291584|NCT00926575|960662|P1|Overall Study|Lost to Follow-up|1
291585|NCT00926575|960661|P2|Overall Study|Death|4
291586|NCT00926575|960662|P1|Overall Study|Death|4
291587|NCT00926575|960661|P2|Overall Study|Adverse Event|1
291588|NCT00926575|960662|P1|Overall Study|Adverse Event|1
291589|NCT00926536|960674|P2|Overall Study|Physician Decision|2
291590|NCT00926536|960675|P1|Overall Study|Physician Decision|1
291591|NCT00926393|960696|P2|Overall Study|Adverse Event|1
291592|NCT00926393|960697|P1|Overall Study|Adverse Event|1
291593|NCT00926393|960696|P2|Overall Study|Withdrawal by Subject|2
291594|NCT00926393|960697|P1|Overall Study|Withdrawal by Subject|1
291595|NCT00926367|960729|P2|Overall Study|Skin Irritation|2
291596|NCT00926367|960730|P1|Overall Study|Skin Irritation|1
291597|NCT00926367|960729|P2|Overall Study|Lost to Follow-up|0
291598|NCT00926367|960730|P1|Overall Study|Lost to Follow-up|1
291599|NCT00926367|960729|P2|Overall Study|Withdrawal by Subject|1
291600|NCT00926367|960730|P1|Overall Study|Withdrawal by Subject|0
291601|NCT00926328|960772|P2|Overall Study|Lost to Follow-up|14
291602|NCT00926328|960773|P1|Overall Study|Lost to Follow-up|12
291603|NCT00926289|960783|P2|Overall Study|not specified|3
291604|NCT00926289|960784|P1|Overall Study|not specified|1
291605|NCT00926289|960783|P2|Overall Study|Withdrawal by Subject|4
291606|NCT00926289|960784|P1|Overall Study|Withdrawal by Subject|4
291607|NCT00926289|960783|P2|Overall Study|Lost to Follow-up|6
291608|NCT00926289|960784|P1|Overall Study|Lost to Follow-up|3
291609|NCT00926289|960783|P2|Overall Study|Protocol Violation|12
291610|NCT00926289|960784|P1|Overall Study|Protocol Violation|8
291611|NCT00926289|960783|P2|Overall Study|Adverse Event|11
291612|NCT00926289|960784|P1|Overall Study|Adverse Event|9
291613|NCT00926211|960852|P1|Overall Study|Lost to Follow-up|1
291614|NCT00926029|960883|P3|Overall Study|Lost to Follow-up|1
291615|NCT00926029|960884|P2|Overall Study|Lost to Follow-up|1
291616|NCT00926029|960885|P1|Overall Study|Lost to Follow-up|2
291617|NCT00925990|960898|P2|Overall Study|moved out of state, missed medication|2
291618|NCT00925990|960899|P1|Overall Study|moved out of state, missed medication|0
291619|NCT00925990|960898|P2|Overall Study|Physician Decision|1
291620|NCT00925990|960899|P1|Overall Study|Physician Decision|1
291621|NCT00925990|960898|P2|Overall Study|Lost to Follow-up|3
291622|NCT00925990|960899|P1|Overall Study|Lost to Follow-up|1
291623|NCT00925990|960898|P2|Overall Study|Withdrawal by Subject|2
291624|NCT00925990|960899|P1|Overall Study|Withdrawal by Subject|2
291625|NCT00925990|960898|P2|Overall Study|Adverse Event|3
291626|NCT00925990|960899|P1|Overall Study|Adverse Event|1
291627|NCT00925899|960934|P2|Part 1|Withdrawal by Subject|9
291628|NCT00925899|960935|P1|Part 1|Withdrawal by Subject|10
291629|NCT00925899|960934|P2|Part 1|Death|2
291630|NCT00925899|960935|P1|Part 1|Death|1
291631|NCT00925769|960963|P6|Overall Study|Adverse Event|0
291632|NCT00925769|960964|P5|Overall Study|Adverse Event|1
291633|NCT00925769|960965|P4|Overall Study|Adverse Event|0
291634|NCT00925769|960966|P3|Overall Study|Adverse Event|0
291635|NCT00925769|960967|P2|Overall Study|Adverse Event|0
291636|NCT00925769|960968|P1|Overall Study|Adverse Event|0
291637|NCT00925769|960963|P6|Overall Study|Participant is unable to swallow drug|0
291638|NCT00925769|960964|P5|Overall Study|Participant is unable to swallow drug|0
291639|NCT00925769|960965|P4|Overall Study|Participant is unable to swallow drug|1
291640|NCT00925769|960966|P3|Overall Study|Participant is unable to swallow drug|0
291641|NCT00925769|960967|P2|Overall Study|Participant is unable to swallow drug|0
291642|NCT00925769|960968|P1|Overall Study|Participant is unable to swallow drug|0
291643|NCT00925769|960963|P6|Overall Study|End of study visit not done|0
291644|NCT00925769|960964|P5|Overall Study|End of study visit not done|0
291645|NCT00925769|960965|P4|Overall Study|End of study visit not done|0
291646|NCT00925769|960966|P3|Overall Study|End of study visit not done|1
291647|NCT00925769|960967|P2|Overall Study|End of study visit not done|0
291648|NCT00925769|960968|P1|Overall Study|End of study visit not done|0
291649|NCT00925769|960963|P6|Overall Study|Missing documentation|0
291650|NCT00925769|960964|P5|Overall Study|Missing documentation|0
291651|NCT00925769|960965|P4|Overall Study|Missing documentation|0
291652|NCT00925769|960966|P3|Overall Study|Missing documentation|0
291653|NCT00925769|960967|P2|Overall Study|Missing documentation|1
291654|NCT00925769|960968|P1|Overall Study|Missing documentation|0
291655|NCT00925769|960963|P6|Overall Study|Physician Decision|0
291656|NCT00925769|960964|P5|Overall Study|Physician Decision|0
291657|NCT00925769|960965|P4|Overall Study|Physician Decision|0
291658|NCT00925769|960966|P3|Overall Study|Physician Decision|0
291659|NCT00925769|960967|P2|Overall Study|Physician Decision|0
291660|NCT00925769|960968|P1|Overall Study|Physician Decision|1
291661|NCT00925769|960963|P6|Overall Study|Death|0
291662|NCT00925769|960964|P5|Overall Study|Death|0
291663|NCT00925769|960965|P4|Overall Study|Death|0
291664|NCT00925769|960966|P3|Overall Study|Death|1
291665|NCT00925769|960967|P2|Overall Study|Death|0
291666|NCT00925769|960968|P1|Overall Study|Death|0
291667|NCT00925769|960963|P6|Overall Study|Disease progression|3
291668|NCT00925769|960964|P5|Overall Study|Disease progression|2
291669|NCT00925769|960965|P4|Overall Study|Disease progression|4
291670|NCT00925769|960966|P3|Overall Study|Disease progression|3
291671|NCT00925769|960967|P2|Overall Study|Disease progression|5
291672|NCT00925769|960968|P1|Overall Study|Disease progression|4
291673|NCT00925769|960963|P6|Overall Study|Major toxicity|0
291674|NCT00925769|960964|P5|Overall Study|Major toxicity|0
291675|NCT00925769|960965|P4|Overall Study|Major toxicity|1
291676|NCT00925769|960966|P3|Overall Study|Major toxicity|1
291677|NCT00925769|960967|P2|Overall Study|Major toxicity|0
291678|NCT00925769|960968|P1|Overall Study|Major toxicity|1
291679|NCT00925704|961036|P6|Third Intervention|Withdrew consent|1
291680|NCT00925704|961037|P5|Third Intervention|Withdrew consent|0
291681|NCT00925704|961038|P4|Third Intervention|Withdrew consent|0
291682|NCT00925704|961039|P3|Third Intervention|Withdrew consent|0
291683|NCT00925704|961040|P2|Third Intervention|Withdrew consent|0
291684|NCT00925704|961041|P1|Third Intervention|Withdrew consent|0
291685|NCT00925704|961036|P6|Second Intervention|Withdrawal by Subject|0
291686|NCT00925704|961037|P5|Second Intervention|Withdrawal by Subject|1
291687|NCT00925704|961038|P4|Second Intervention|Withdrawal by Subject|0
291688|NCT00925704|961039|P3|Second Intervention|Withdrawal by Subject|0
291689|NCT00925704|961040|P2|Second Intervention|Withdrawal by Subject|0
291690|NCT00925704|961041|P1|Second Intervention|Withdrawal by Subject|1
291691|NCT00925704|961036|P6|First Intervention|Withdrew consent|0
291692|NCT00925704|961037|P5|First Intervention|Withdrew consent|1
291693|NCT00925704|961038|P4|First Intervention|Withdrew consent|1
291694|NCT00925704|961039|P3|First Intervention|Withdrew consent|0
291695|NCT00925704|961040|P2|First Intervention|Withdrew consent|0
291696|NCT00925704|961041|P1|First Intervention|Withdrew consent|0
291697|NCT00925600|961054|P2|Overall Study|Adverse Event|2
291698|NCT00925600|961055|P1|Overall Study|Adverse Event|1
291699|NCT00925600|961054|P2|Overall Study|Other|1
291700|NCT00925600|961055|P1|Overall Study|Other|3
291701|NCT00925600|961054|P2|Overall Study|Requirement for Alternative Therapy|1
291702|NCT00925600|961055|P1|Overall Study|Requirement for Alternative Therapy|0
291703|NCT00925600|961054|P2|Overall Study|Protocol Deviation|1
291704|NCT00925600|961055|P1|Overall Study|Protocol Deviation|0
291705|NCT00925600|961054|P2|Overall Study|Ineligibility Determined|0
291706|NCT00925600|961055|P1|Overall Study|Ineligibility Determined|2
291707|NCT00925600|961054|P2|Overall Study|Noncompliance|0
291708|NCT00925600|961055|P1|Overall Study|Noncompliance|2
291709|NCT00925600|961054|P2|Overall Study|Administrative Decision|1
291710|NCT00925600|961055|P1|Overall Study|Administrative Decision|1
291711|NCT00925600|961054|P2|Overall Study|Disease Progression|3
291712|NCT00925600|961055|P1|Overall Study|Disease Progression|1
291713|NCT00925600|961054|P2|Overall Study|Lost to Follow-up|2
291714|NCT00925600|961055|P1|Overall Study|Lost to Follow-up|2
291715|NCT00925600|961054|P2|Overall Study|Death|3
291716|NCT00925600|961055|P1|Overall Study|Death|4
291717|NCT00925600|961054|P2|Overall Study|Withdrawal by Subject|14
291718|NCT00925600|961055|P1|Overall Study|Withdrawal by Subject|16
291719|NCT00925587|961077|P2|Overall Study|Lost to Follow-up|1
291720|NCT00925587|961078|P1|Overall Study|Lost to Follow-up|0
291721|NCT00925587|961077|P2|Overall Study|Adverse Event|2
291722|NCT00925587|961078|P1|Overall Study|Adverse Event|6
291723|NCT00925587|961077|P2|Overall Study|Death|5
291724|NCT00925587|961078|P1|Overall Study|Death|5
291725|NCT00925587|961077|P2|Overall Study|Withdrawal by Subject|6
291726|NCT00925587|961078|P1|Overall Study|Withdrawal by Subject|9
291727|NCT00925587|961077|P2|Overall Study|Protocol Violation|4
291728|NCT00925587|961078|P1|Overall Study|Protocol Violation|6
291729|NCT00925587|961077|P2|Overall Study|Physician Decision|1
291730|NCT00925587|961078|P1|Overall Study|Physician Decision|4
291731|NCT00925587|961077|P2|Overall Study|Protocol Specified Criteria|6
291732|NCT00925587|961078|P1|Overall Study|Protocol Specified Criteria|6
291733|NCT00925548|961192|P2|Overall Study|Discontinuation of trial by sponsor|5
291734|NCT00925548|961193|P1|Overall Study|Discontinuation of trial by sponsor|10
291735|NCT00925353|961223|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
291736|NCT00925288|961229|P2|Overall Study|Lost to Follow-up|7
291737|NCT00925288|961230|P1|Overall Study|Lost to Follow-up|9
291738|NCT00924950|961242|P1|Overall Study|Lost to Follow-up|2
291739|NCT00924898|961247|P1|Overall Study|Withdrawal by Subject|2
291740|NCT00924781|961283|P2|Overall Study|Study terminated by sponsor|10
291741|NCT00924781|961284|P1|Overall Study|Study terminated by sponsor|12
291742|NCT00924729|961318|P2|Overall Study|Protocol Violation|0
291743|NCT00924729|961319|P1|Overall Study|Protocol Violation|1
291744|NCT00924729|961318|P2|Overall Study|insufficient volume for analysis|0
291745|NCT00924729|961319|P1|Overall Study|insufficient volume for analysis|1
291746|NCT00924638|961327|P2|Overall Study|Physician Decision|3
291747|NCT00924638|961328|P1|Overall Study|Physician Decision|3
291748|NCT00924638|961327|P2|Overall Study|Withdrawal by Subject|7
291749|NCT00924638|961328|P1|Overall Study|Withdrawal by Subject|5
291750|NCT00924638|961327|P2|Overall Study|Lost to Follow-up|1
291751|NCT00924638|961328|P1|Overall Study|Lost to Follow-up|1
291752|NCT00924638|961327|P2|Overall Study|Death|2
291753|NCT00924638|961328|P1|Overall Study|Death|3
291754|NCT00924560|961350|P3|Overall Study|Miscellaneous Reasons|10
291755|NCT00924560|961351|P2|Overall Study|Miscellaneous Reasons|10
291756|NCT00924560|961352|P1|Overall Study|Miscellaneous Reasons|13
291757|NCT00924560|961350|P3|Overall Study|Lost to Follow-up|45
291758|NCT00924560|961351|P2|Overall Study|Lost to Follow-up|94
291759|NCT00924560|961352|P1|Overall Study|Lost to Follow-up|78
291760|NCT00924560|961350|P3|Overall Study|Pregnancy|1
291761|NCT00924560|961351|P2|Overall Study|Pregnancy|7
291762|NCT00924560|961352|P1|Overall Study|Pregnancy|5
291763|NCT00924560|961350|P3|Overall Study|Adverse Event|0
291764|NCT00924560|961351|P2|Overall Study|Adverse Event|33
291765|NCT00924560|961352|P1|Overall Study|Adverse Event|39
291766|NCT00924560|961350|P3|Overall Study|Withdrawal by Subject|18
291767|NCT00924560|961351|P2|Overall Study|Withdrawal by Subject|44
291768|NCT00924560|961352|P1|Overall Study|Withdrawal by Subject|50
291769|NCT00924560|961350|P3|Overall Study|Physician Decision|4
291770|NCT00924560|961351|P2|Overall Study|Physician Decision|3
291771|NCT00924560|961352|P1|Overall Study|Physician Decision|2
291772|NCT00924560|961350|P3|Overall Study|Non Compliance with the Protocol|4
291773|NCT00924560|961351|P2|Overall Study|Non Compliance with the Protocol|15
291774|NCT00924560|961352|P1|Overall Study|Non Compliance with the Protocol|20
291775|NCT00924560|961350|P3|Overall Study|Did Not Meet Protocol Requirements|1
291776|NCT00924560|961351|P2|Overall Study|Did Not Meet Protocol Requirements|2
291777|NCT00924560|961352|P1|Overall Study|Did Not Meet Protocol Requirements|4
291778|NCT00924508|961396|P1|Overall Study|Withdrawal by Subject|3
291779|NCT00924469|961410|P2|Overall Study|Lost to Follow-up|1
291780|NCT00924469|961411|P1|Overall Study|Lost to Follow-up|0
291781|NCT00924469|961410|P2|Overall Study|Withdrawal by Subject|1
291782|NCT00924469|961411|P1|Overall Study|Withdrawal by Subject|0
291783|NCT00924469|961410|P2|Overall Study|Adverse Event|0
291784|NCT00924469|961411|P1|Overall Study|Adverse Event|2
291785|NCT00924443|961433|P1|Overall Study|Protocol Violation|1
291786|NCT00924443|961433|P1|Overall Study|Physician Decision|2
291787|NCT00924313|961455|P1|Overall Study|not imaged due to failed tracer imaging|1
291788|NCT00924287|961460|P1|Overall Study|Death|1
291789|NCT00923975|961547|P1|Overall Study|Did not meet inclusion criteria|1
291790|NCT00923936|961566|P2|Overall Study|Continuing in follow up period|1
291791|NCT00923936|961567|P1|Overall Study|Continuing in follow up period|2
291792|NCT00923936|961566|P2|Overall Study|Lost to follow up|0
291793|NCT00923936|961567|P1|Overall Study|Lost to follow up|2
291794|NCT00923936|961566|P2|Overall Study|Adverse Event|1
291795|NCT00923936|961567|P1|Overall Study|Adverse Event|2
291796|NCT00923936|961566|P2|Overall Study|progressive disease on study|1
291797|NCT00923936|961567|P1|Overall Study|progressive disease on study|2
291798|NCT00923845|961596|P2|Induction Therapy|Poor performance status|2
291799|NCT00923845|961597|P1|Induction Therapy|Poor performance status|0
291800|NCT00923351|961611|P3|Overall Study|no apheresis/adequate tumor sample|12
291801|NCT00923351|961612|P2|Overall Study|no apheresis/adequate tumor sample|0
291802|NCT00923351|961613|P1|Overall Study|no apheresis/adequate tumor sample|0
291803|NCT00923273|961626|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
291804|NCT00923273|961627|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
291805|NCT00923273|961628|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
291806|NCT00923273|961629|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
291807|NCT00923273|961630|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
291808|NCT00923273|961626|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
291809|NCT00923273|961627|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
291810|NCT00923273|961628|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
291811|NCT00923273|961629|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
291812|NCT00923273|961630|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
291813|NCT00923260|961655|P2|Overall Study|Lost to Follow-up|1
291814|NCT00923260|961656|P1|Overall Study|Lost to Follow-up|1
291815|NCT00923195|961819|P2|Overall Study|Death|1
291816|NCT00923195|961820|P1|Overall Study|Death|0
291817|NCT00923156|961831|P3|Overall Study|Lack of Efficacy|1
291818|NCT00923156|961832|P2|Overall Study|Lack of Efficacy|0
291819|NCT00923156|961833|P1|Overall Study|Lack of Efficacy|0
291820|NCT00923156|961831|P3|Overall Study|Death|0
291821|NCT00923156|961832|P2|Overall Study|Death|1
291822|NCT00923156|961833|P1|Overall Study|Death|0
291823|NCT00923156|961831|P3|Overall Study|Withdrawal by Subject|0
291824|NCT00923156|961832|P2|Overall Study|Withdrawal by Subject|1
291825|NCT00923156|961833|P1|Overall Study|Withdrawal by Subject|0
291826|NCT00923156|961831|P3|Overall Study|Abnormal laboratory values|1
291827|NCT00923156|961832|P2|Overall Study|Abnormal laboratory values|0
291828|NCT00923156|961833|P1|Overall Study|Abnormal laboratory values|0
291829|NCT00923156|961831|P3|Overall Study|Adverse Event|1
291830|NCT00923156|961832|P2|Overall Study|Adverse Event|2
291831|NCT00923156|961833|P1|Overall Study|Adverse Event|0
291832|NCT00923091|961878|P13|Period VI (Open-Label)|Other Reason|0
291833|NCT00923091|961879|P12|Period VI (Open-Label)|Other Reason|0
291834|NCT00923091|961880|P11|Period VI (Open-Label)|Other Reason|0
291835|NCT00923091|961881|P10|Period VI (Open-Label)|Other Reason|0
291836|NCT00923091|961882|P9|Period VI (Open-Label)|Other Reason|0
291837|NCT00923091|961883|P8|Period VI (Open-Label)|Other Reason|0
291838|NCT00923091|961884|P7|Period VI (Open-Label)|Other Reason|0
291839|NCT00923091|961885|P6|Period VI (Open-Label)|Other Reason|0
291840|NCT00923091|961886|P5|Period VI (Open-Label)|Other Reason|1
291841|NCT00923091|961887|P4|Period VI (Open-Label)|Other Reason|1
291842|NCT00923091|961888|P3|Period VI (Open-Label)|Other Reason|0
291843|NCT00923091|961889|P2|Period VI (Open-Label)|Other Reason|0
291844|NCT00923091|961890|P1|Period VI (Open-Label)|Other Reason|0
291845|NCT00923091|961878|P13|Period VI (Open-Label)|Lost to Follow-up|0
291846|NCT00923091|961879|P12|Period VI (Open-Label)|Lost to Follow-up|0
291847|NCT00923091|961880|P11|Period VI (Open-Label)|Lost to Follow-up|0
291848|NCT00923091|961881|P10|Period VI (Open-Label)|Lost to Follow-up|0
291849|NCT00923091|961882|P9|Period VI (Open-Label)|Lost to Follow-up|0
291850|NCT00923091|961883|P8|Period VI (Open-Label)|Lost to Follow-up|0
291851|NCT00923091|961884|P7|Period VI (Open-Label)|Lost to Follow-up|0
291852|NCT00923091|961885|P6|Period VI (Open-Label)|Lost to Follow-up|0
291853|NCT00923091|961886|P5|Period VI (Open-Label)|Lost to Follow-up|0
291854|NCT00923091|961887|P4|Period VI (Open-Label)|Lost to Follow-up|0
291855|NCT00923091|961888|P3|Period VI (Open-Label)|Lost to Follow-up|1
291856|NCT00923091|961889|P2|Period VI (Open-Label)|Lost to Follow-up|0
291857|NCT00923091|961890|P1|Period VI (Open-Label)|Lost to Follow-up|1
291858|NCT00923091|961878|P13|Period VI (Open-Label)|Protocol Violation|0
291859|NCT00923091|961879|P12|Period VI (Open-Label)|Protocol Violation|0
291860|NCT00923091|961880|P11|Period VI (Open-Label)|Protocol Violation|0
291861|NCT00923091|961881|P10|Period VI (Open-Label)|Protocol Violation|0
291862|NCT00923091|961882|P9|Period VI (Open-Label)|Protocol Violation|0
291863|NCT00923091|961883|P8|Period VI (Open-Label)|Protocol Violation|0
291864|NCT00923091|961884|P7|Period VI (Open-Label)|Protocol Violation|0
291865|NCT00923091|961885|P6|Period VI (Open-Label)|Protocol Violation|0
291866|NCT00923091|961886|P5|Period VI (Open-Label)|Protocol Violation|4
291867|NCT00923091|961887|P4|Period VI (Open-Label)|Protocol Violation|1
291868|NCT00923091|961888|P3|Period VI (Open-Label)|Protocol Violation|3
291869|NCT00923091|961889|P2|Period VI (Open-Label)|Protocol Violation|1
291870|NCT00923091|961890|P1|Period VI (Open-Label)|Protocol Violation|6
291871|NCT00923091|961878|P13|Period VI (Open-Label)|Withdrawal by Subject|0
291872|NCT00923091|961879|P12|Period VI (Open-Label)|Withdrawal by Subject|0
291873|NCT00923091|961880|P11|Period VI (Open-Label)|Withdrawal by Subject|0
291874|NCT00923091|961881|P10|Period VI (Open-Label)|Withdrawal by Subject|0
291875|NCT00923091|961882|P9|Period VI (Open-Label)|Withdrawal by Subject|0
291876|NCT00923091|961883|P8|Period VI (Open-Label)|Withdrawal by Subject|0
291877|NCT00923091|961884|P7|Period VI (Open-Label)|Withdrawal by Subject|0
291878|NCT00923091|961885|P6|Period VI (Open-Label)|Withdrawal by Subject|0
291879|NCT00923091|961886|P5|Period VI (Open-Label)|Withdrawal by Subject|1
291880|NCT00923091|961887|P4|Period VI (Open-Label)|Withdrawal by Subject|0
291881|NCT00923091|961888|P3|Period VI (Open-Label)|Withdrawal by Subject|5
291882|NCT00923091|961889|P2|Period VI (Open-Label)|Withdrawal by Subject|7
291883|NCT00923091|961890|P1|Period VI (Open-Label)|Withdrawal by Subject|15
291884|NCT00923091|961878|P13|Period VI (Open-Label)|Adverse Event|0
291885|NCT00923091|961879|P12|Period VI (Open-Label)|Adverse Event|0
291886|NCT00923091|961880|P11|Period VI (Open-Label)|Adverse Event|0
291887|NCT00923091|961881|P10|Period VI (Open-Label)|Adverse Event|0
291888|NCT00923091|961882|P9|Period VI (Open-Label)|Adverse Event|0
291889|NCT00923091|961883|P8|Period VI (Open-Label)|Adverse Event|0
291890|NCT00923091|961884|P7|Period VI (Open-Label)|Adverse Event|0
291891|NCT00923091|961885|P6|Period VI (Open-Label)|Adverse Event|0
291892|NCT00923091|961886|P5|Period VI (Open-Label)|Adverse Event|1
291893|NCT00923091|961887|P4|Period VI (Open-Label)|Adverse Event|1
291894|NCT00923091|961888|P3|Period VI (Open-Label)|Adverse Event|4
291895|NCT00923091|961889|P2|Period VI (Open-Label)|Adverse Event|0
291896|NCT00923091|961890|P1|Period VI (Open-Label)|Adverse Event|17
291897|NCT00923091|961878|P13|Period V (Double -Blind)|Lost to Follow-up|0
291898|NCT00923091|961879|P12|Period V (Double -Blind)|Lost to Follow-up|0
291899|NCT00923091|961880|P11|Period V (Double -Blind)|Lost to Follow-up|1
291900|NCT00923091|961881|P10|Period V (Double -Blind)|Lost to Follow-up|0
291901|NCT00923091|961882|P9|Period V (Double -Blind)|Lost to Follow-up|0
291902|NCT00923091|961883|P8|Period V (Double -Blind)|Lost to Follow-up|0
291903|NCT00923091|961884|P7|Period V (Double -Blind)|Lost to Follow-up|0
291904|NCT00923091|961885|P6|Period V (Double -Blind)|Lost to Follow-up|0
291905|NCT00923091|961886|P5|Period V (Double -Blind)|Lost to Follow-up|0
291906|NCT00923091|961887|P4|Period V (Double -Blind)|Lost to Follow-up|0
291907|NCT00923091|961888|P3|Period V (Double -Blind)|Lost to Follow-up|0
291908|NCT00923091|961889|P2|Period V (Double -Blind)|Lost to Follow-up|0
291909|NCT00923091|961890|P1|Period V (Double -Blind)|Lost to Follow-up|0
291910|NCT00923091|961878|P13|Period V (Double -Blind)|Protocol Violation|1
291911|NCT00923091|961879|P12|Period V (Double -Blind)|Protocol Violation|0
291912|NCT00923091|961880|P11|Period V (Double -Blind)|Protocol Violation|0
291913|NCT00923091|961881|P10|Period V (Double -Blind)|Protocol Violation|0
291914|NCT00923091|961882|P9|Period V (Double -Blind)|Protocol Violation|0
291915|NCT00923091|961883|P8|Period V (Double -Blind)|Protocol Violation|0
291916|NCT00923091|961884|P7|Period V (Double -Blind)|Protocol Violation|0
291917|NCT00923091|961885|P6|Period V (Double -Blind)|Protocol Violation|0
291918|NCT00923091|961886|P5|Period V (Double -Blind)|Protocol Violation|0
291919|NCT00923091|961887|P4|Period V (Double -Blind)|Protocol Violation|0
291920|NCT00923091|961888|P3|Period V (Double -Blind)|Protocol Violation|0
291921|NCT00923091|961889|P2|Period V (Double -Blind)|Protocol Violation|0
291922|NCT00923091|961890|P1|Period V (Double -Blind)|Protocol Violation|0
291923|NCT00923091|961878|P13|Period V (Double -Blind)|Withdrawal by Subject|1
291924|NCT00923091|961879|P12|Period V (Double -Blind)|Withdrawal by Subject|0
291925|NCT00923091|961880|P11|Period V (Double -Blind)|Withdrawal by Subject|0
291926|NCT00923091|961881|P10|Period V (Double -Blind)|Withdrawal by Subject|0
291927|NCT00923091|961882|P9|Period V (Double -Blind)|Withdrawal by Subject|1
291928|NCT00923091|961883|P8|Period V (Double -Blind)|Withdrawal by Subject|0
291929|NCT00923091|961884|P7|Period V (Double -Blind)|Withdrawal by Subject|0
291930|NCT00923091|961885|P6|Period V (Double -Blind)|Withdrawal by Subject|0
291931|NCT00923091|961886|P5|Period V (Double -Blind)|Withdrawal by Subject|0
291932|NCT00923091|961887|P4|Period V (Double -Blind)|Withdrawal by Subject|0
291933|NCT00923091|961888|P3|Period V (Double -Blind)|Withdrawal by Subject|0
291934|NCT00923091|961889|P2|Period V (Double -Blind)|Withdrawal by Subject|0
291935|NCT00923091|961890|P1|Period V (Double -Blind)|Withdrawal by Subject|0
291936|NCT00923091|961878|P13|Period IV (Double-Blind)|Protocol Violation|0
291937|NCT00923091|961879|P12|Period IV (Double-Blind)|Protocol Violation|0
291938|NCT00923091|961880|P11|Period IV (Double-Blind)|Protocol Violation|0
291939|NCT00923091|961881|P10|Period IV (Double-Blind)|Protocol Violation|0
291940|NCT00923091|961882|P9|Period IV (Double-Blind)|Protocol Violation|0
291941|NCT00923091|961883|P8|Period IV (Double-Blind)|Protocol Violation|0
291942|NCT00923091|961884|P7|Period IV (Double-Blind)|Protocol Violation|0
291943|NCT00923091|961885|P6|Period IV (Double-Blind)|Protocol Violation|0
291944|NCT00923091|961886|P5|Period IV (Double-Blind)|Protocol Violation|0
291945|NCT00923091|961887|P4|Period IV (Double-Blind)|Protocol Violation|0
291946|NCT00923091|961888|P3|Period IV (Double-Blind)|Protocol Violation|0
291947|NCT00923091|961889|P2|Period IV (Double-Blind)|Protocol Violation|1
291948|NCT00923091|961890|P1|Period IV (Double-Blind)|Protocol Violation|0
291949|NCT00923091|961878|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
291950|NCT00923091|961879|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
291951|NCT00923091|961880|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
291952|NCT00923091|961881|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
291953|NCT00923091|961882|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
291954|NCT00923091|961883|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
291955|NCT00923091|961884|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
291956|NCT00923091|961885|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
291957|NCT00923091|961886|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
291958|NCT00923091|961887|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
291959|NCT00923091|961888|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
291960|NCT00923091|961889|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
291961|NCT00923091|961890|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
291962|NCT00923091|961878|P13|Period IV (Double-Blind)|Adverse Event|0
291963|NCT00923091|961879|P12|Period IV (Double-Blind)|Adverse Event|0
291964|NCT00923091|961880|P11|Period IV (Double-Blind)|Adverse Event|0
291965|NCT00923091|961881|P10|Period IV (Double-Blind)|Adverse Event|0
291966|NCT00923091|961882|P9|Period IV (Double-Blind)|Adverse Event|0
291967|NCT00923091|961883|P8|Period IV (Double-Blind)|Adverse Event|0
291968|NCT00923091|961884|P7|Period IV (Double-Blind)|Adverse Event|0
291969|NCT00923091|961885|P6|Period IV (Double-Blind)|Adverse Event|0
291970|NCT00923091|961886|P5|Period IV (Double-Blind)|Adverse Event|0
291971|NCT00923091|961887|P4|Period IV (Double-Blind)|Adverse Event|0
291972|NCT00923091|961888|P3|Period IV (Double-Blind)|Adverse Event|0
291973|NCT00923091|961889|P2|Period IV (Double-Blind)|Adverse Event|0
291974|NCT00923091|961890|P1|Period IV (Double-Blind)|Adverse Event|2
291975|NCT00923091|961878|P13|Period III (Single-Blind)|Lost to Follow-up|0
291976|NCT00923091|961879|P12|Period III (Single-Blind)|Lost to Follow-up|0
291977|NCT00923091|961880|P11|Period III (Single-Blind)|Lost to Follow-up|0
291978|NCT00923091|961881|P10|Period III (Single-Blind)|Lost to Follow-up|0
291979|NCT00923091|961882|P9|Period III (Single-Blind)|Lost to Follow-up|0
291980|NCT00923091|961883|P8|Period III (Single-Blind)|Lost to Follow-up|0
291981|NCT00923091|961884|P7|Period III (Single-Blind)|Lost to Follow-up|0
291982|NCT00923091|961885|P6|Period III (Single-Blind)|Lost to Follow-up|0
291983|NCT00923091|961886|P5|Period III (Single-Blind)|Lost to Follow-up|0
291984|NCT00923091|961887|P4|Period III (Single-Blind)|Lost to Follow-up|0
291985|NCT00923091|961888|P3|Period III (Single-Blind)|Lost to Follow-up|0
291986|NCT00923091|961889|P2|Period III (Single-Blind)|Lost to Follow-up|0
291987|NCT00923091|961890|P1|Period III (Single-Blind)|Lost to Follow-up|2
291988|NCT00923091|961878|P13|Period III (Single-Blind)|Protocol Violation|0
291989|NCT00923091|961879|P12|Period III (Single-Blind)|Protocol Violation|0
291990|NCT00923091|961880|P11|Period III (Single-Blind)|Protocol Violation|0
291991|NCT00923091|961881|P10|Period III (Single-Blind)|Protocol Violation|0
291992|NCT00923091|961882|P9|Period III (Single-Blind)|Protocol Violation|0
291993|NCT00923091|961883|P8|Period III (Single-Blind)|Protocol Violation|0
291994|NCT00923091|961884|P7|Period III (Single-Blind)|Protocol Violation|0
291995|NCT00923091|961885|P6|Period III (Single-Blind)|Protocol Violation|0
291996|NCT00923091|961886|P5|Period III (Single-Blind)|Protocol Violation|0
291997|NCT00923091|961887|P4|Period III (Single-Blind)|Protocol Violation|0
291998|NCT00923091|961888|P3|Period III (Single-Blind)|Protocol Violation|0
291999|NCT00923091|961889|P2|Period III (Single-Blind)|Protocol Violation|0
292000|NCT00923091|961890|P1|Period III (Single-Blind)|Protocol Violation|3
292001|NCT00923091|961878|P13|Period III (Single-Blind)|Withdrawal by Subject|0
292002|NCT00923091|961879|P12|Period III (Single-Blind)|Withdrawal by Subject|0
292003|NCT00923091|961880|P11|Period III (Single-Blind)|Withdrawal by Subject|0
292004|NCT00923091|961881|P10|Period III (Single-Blind)|Withdrawal by Subject|0
292005|NCT00923091|961882|P9|Period III (Single-Blind)|Withdrawal by Subject|0
292006|NCT00923091|961883|P8|Period III (Single-Blind)|Withdrawal by Subject|0
292007|NCT00923091|961884|P7|Period III (Single-Blind)|Withdrawal by Subject|0
292008|NCT00923091|961885|P6|Period III (Single-Blind)|Withdrawal by Subject|0
292009|NCT00923091|961886|P5|Period III (Single-Blind)|Withdrawal by Subject|0
292010|NCT00923091|961887|P4|Period III (Single-Blind)|Withdrawal by Subject|0
292011|NCT00923091|961888|P3|Period III (Single-Blind)|Withdrawal by Subject|0
292012|NCT00923091|961889|P2|Period III (Single-Blind)|Withdrawal by Subject|0
292013|NCT00923091|961890|P1|Period III (Single-Blind)|Withdrawal by Subject|10
292014|NCT00923091|961878|P13|Period III (Single-Blind)|Adverse Event|0
292015|NCT00923091|961879|P12|Period III (Single-Blind)|Adverse Event|0
292016|NCT00923091|961880|P11|Period III (Single-Blind)|Adverse Event|0
292017|NCT00923091|961881|P10|Period III (Single-Blind)|Adverse Event|0
292018|NCT00923091|961882|P9|Period III (Single-Blind)|Adverse Event|0
292019|NCT00923091|961883|P8|Period III (Single-Blind)|Adverse Event|0
292020|NCT00923091|961884|P7|Period III (Single-Blind)|Adverse Event|0
292021|NCT00923091|961885|P6|Period III (Single-Blind)|Adverse Event|0
292022|NCT00923091|961886|P5|Period III (Single-Blind)|Adverse Event|0
292023|NCT00923091|961887|P4|Period III (Single-Blind)|Adverse Event|0
292024|NCT00923091|961888|P3|Period III (Single-Blind)|Adverse Event|0
292025|NCT00923091|961889|P2|Period III (Single-Blind)|Adverse Event|0
292026|NCT00923091|961890|P1|Period III (Single-Blind)|Adverse Event|5
292027|NCT00923091|961878|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292028|NCT00923091|961879|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292029|NCT00923091|961880|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292030|NCT00923091|961881|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292031|NCT00923091|961882|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292032|NCT00923091|961883|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292033|NCT00923091|961884|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292034|NCT00923091|961885|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
292035|NCT00923091|961886|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292036|NCT00923091|961887|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
292037|NCT00923091|961888|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292038|NCT00923091|961889|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
292039|NCT00923091|961890|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
292040|NCT00923091|961878|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292041|NCT00923091|961879|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292042|NCT00923091|961880|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292043|NCT00923091|961881|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292044|NCT00923091|961882|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292045|NCT00923091|961883|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292046|NCT00923091|961884|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292047|NCT00923091|961885|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
292048|NCT00923091|961886|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292049|NCT00923091|961887|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292050|NCT00923091|961888|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292051|NCT00923091|961889|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292052|NCT00923091|961890|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
292053|NCT00923091|961878|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
292054|NCT00923091|961879|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
292055|NCT00923091|961880|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
292056|NCT00923091|961881|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
292057|NCT00923091|961882|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
292058|NCT00923091|961883|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
292059|NCT00923091|961884|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
292060|NCT00923091|961885|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
292061|NCT00923091|961886|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
292062|NCT00923091|961887|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
292063|NCT00923091|961888|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
292064|NCT00923091|961889|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
292065|NCT00923091|961890|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
292066|NCT00923091|961878|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
292067|NCT00923091|961879|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
292068|NCT00923091|961880|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
292069|NCT00923091|961881|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
292070|NCT00923091|961882|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
292071|NCT00923091|961883|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
292072|NCT00923091|961884|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
292073|NCT00923091|961885|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
292074|NCT00923091|961886|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
292075|NCT00923091|961887|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
292076|NCT00923091|961888|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
292077|NCT00923091|961889|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
292078|NCT00923091|961890|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
292079|NCT00923091|961878|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
292080|NCT00923091|961879|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
292081|NCT00923091|961880|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
292082|NCT00923091|961881|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
292083|NCT00923091|961882|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
292084|NCT00923091|961883|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
292085|NCT00923091|961884|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
292086|NCT00923091|961885|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
292087|NCT00923091|961886|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
292088|NCT00923091|961887|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
292089|NCT00923091|961888|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
292090|NCT00923091|961889|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
292091|NCT00923091|961890|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
292092|NCT00922987|961937|P1|Overall Study|Adverse Event|1
292093|NCT00922987|961937|P1|Overall Study|Protocol Violation|2
292094|NCT00922987|961937|P1|Overall Study|Insufficient clinical response|1
292095|NCT00922935|961952|P3|Overall Study|Lost to Follow-up|0
292096|NCT00922935|961953|P2|Overall Study|Lost to Follow-up|1
292097|NCT00922935|961954|P1|Overall Study|Lost to Follow-up|0
292098|NCT00922935|961952|P3|Overall Study|Physician Decision|0
292099|NCT00922935|961953|P2|Overall Study|Physician Decision|1
292100|NCT00922935|961954|P1|Overall Study|Physician Decision|1
292101|NCT00922935|961952|P3|Overall Study|Protocol Violation|0
292102|NCT00922935|961953|P2|Overall Study|Protocol Violation|3
292103|NCT00922935|961954|P1|Overall Study|Protocol Violation|0
292104|NCT00922779|961962|P1|Overall Study|Missing|1874
292105|NCT00922779|961962|P1|Overall Study|Unspecified|27
292106|NCT00922779|961962|P1|Overall Study|Lost to Follow-up|44
292107|NCT00922779|961962|P1|Overall Study|Withdrawal by Subject|308
292108|NCT00922779|961962|P1|Overall Study|Pregnancy|7
292109|NCT00922779|961962|P1|Overall Study|Adverse Event|67
292110|NCT00922766|961969|P1|Overall Study|Adverse Event|1
292111|NCT00922766|961969|P1|Overall Study|Unspecified|1
292112|NCT00922766|961969|P1|Overall Study|Withdrawal by Subject|2
292113|NCT00922766|961969|P1|Overall Study|Death|3
292114|NCT00922636|961987|P5|Overall Study|Lost to Follow-up|4
292115|NCT00922636|961988|P4|Overall Study|Lost to Follow-up|2
292116|NCT00922636|961989|P3|Overall Study|Lost to Follow-up|2
292117|NCT00922636|961990|P2|Overall Study|Lost to Follow-up|2
292118|NCT00922636|961991|P1|Overall Study|Lost to Follow-up|1
292119|NCT00922636|961987|P5|Overall Study|Parent/Caregiver Decision|2
292120|NCT00922636|961988|P4|Overall Study|Parent/Caregiver Decision|5
292121|NCT00922636|961989|P3|Overall Study|Parent/Caregiver Decision|3
292122|NCT00922636|961990|P2|Overall Study|Parent/Caregiver Decision|4
292123|NCT00922636|961991|P1|Overall Study|Parent/Caregiver Decision|2
292124|NCT00922636|961987|P5|Overall Study|Entry Criteria Not Met|0
292125|NCT00922636|961988|P4|Overall Study|Entry Criteria Not Met|1
292126|NCT00922636|961989|P3|Overall Study|Entry Criteria Not Met|1
292127|NCT00922636|961990|P2|Overall Study|Entry Criteria Not Met|0
292128|NCT00922636|961991|P1|Overall Study|Entry Criteria Not Met|0
292129|NCT00922636|961987|P5|Overall Study|Protocol Violation|0
292130|NCT00922636|961988|P4|Overall Study|Protocol Violation|2
292131|NCT00922636|961989|P3|Overall Study|Protocol Violation|2
292132|NCT00922636|961990|P2|Overall Study|Protocol Violation|0
292133|NCT00922636|961991|P1|Overall Study|Protocol Violation|0
292134|NCT00922636|961987|P5|Overall Study|Withdrawal by Subject|4
292135|NCT00922636|961988|P4|Overall Study|Withdrawal by Subject|2
292136|NCT00922636|961989|P3|Overall Study|Withdrawal by Subject|5
292137|NCT00922636|961990|P2|Overall Study|Withdrawal by Subject|0
292138|NCT00922636|961991|P1|Overall Study|Withdrawal by Subject|0
292139|NCT00922636|961987|P5|Overall Study|Sponsor Decision|0
292140|NCT00922636|961988|P4|Overall Study|Sponsor Decision|0
292141|NCT00922636|961989|P3|Overall Study|Sponsor Decision|2
292142|NCT00922636|961990|P2|Overall Study|Sponsor Decision|0
292143|NCT00922636|961991|P1|Overall Study|Sponsor Decision|0
292144|NCT00922636|961987|P5|Overall Study|Lack of Efficacy|4
292145|NCT00922636|961988|P4|Overall Study|Lack of Efficacy|2
292146|NCT00922636|961989|P3|Overall Study|Lack of Efficacy|3
292147|NCT00922636|961990|P2|Overall Study|Lack of Efficacy|7
292148|NCT00922636|961991|P1|Overall Study|Lack of Efficacy|1
292149|NCT00922636|961987|P5|Overall Study|Adverse Event|2
292150|NCT00922636|961988|P4|Overall Study|Adverse Event|3
292151|NCT00922636|961989|P3|Overall Study|Adverse Event|2
292152|NCT00922636|961990|P2|Overall Study|Adverse Event|3
292153|NCT00922636|961991|P1|Overall Study|Adverse Event|3
292154|NCT00922623|962138|P1|Overall Study|Lost to Follow-up|1
292155|NCT00922623|962138|P1|Overall Study|Other|4
292156|NCT00922428|962144|P1|Overall Study|no medication use or questionable use|13
292157|NCT00922428|962144|P1|Overall Study|retrospective/extremely implausible data|2
292158|NCT00922272|962173|P2|Double-blind Phase|Positive urine drug screen|1
292159|NCT00922272|962174|P1|Double-blind Phase|Positive urine drug screen|1
292160|NCT00922272|962173|P2|Double-blind Phase|Noncompliance|1
292161|NCT00922272|962174|P1|Double-blind Phase|Noncompliance|1
292162|NCT00922272|962173|P2|Double-blind Phase|Withdrawal criteria met|1
292163|NCT00922272|962174|P1|Double-blind Phase|Withdrawal criteria met|1
292164|NCT00922272|962173|P2|Double-blind Phase|Lost to Follow-up|1
292165|NCT00922272|962174|P1|Double-blind Phase|Lost to Follow-up|2
292166|NCT00922272|962173|P2|Double-blind Phase|Withdrawal by Subject|1
292167|NCT00922272|962174|P1|Double-blind Phase|Withdrawal by Subject|1
292168|NCT00922272|962173|P2|Double-blind Phase|Adverse Event|1
292169|NCT00922272|962174|P1|Double-blind Phase|Adverse Event|1
292170|NCT00922272|962173|P2|Open-label Phase|Withdrawal criteria met|0
292171|NCT00922272|962174|P1|Open-label Phase|Withdrawal criteria met|5
292172|NCT00922272|962173|P2|Open-label Phase|Failure to meet randomization criteria|0
292173|NCT00922272|962174|P1|Open-label Phase|Failure to meet randomization criteria|1
292174|NCT00922272|962173|P2|Open-label Phase|Withdrawal by Subject|0
292175|NCT00922272|962174|P1|Open-label Phase|Withdrawal by Subject|11
292176|NCT00922272|962173|P2|Open-label Phase|Protocol Violation|0
292177|NCT00922272|962174|P1|Open-label Phase|Protocol Violation|1
292178|NCT00922272|962173|P2|Open-label Phase|Adverse Event|0
292179|NCT00922272|962174|P1|Open-label Phase|Adverse Event|5
292180|NCT00922207|962239|P3|Overall Study|Abnormality of Laboratory Test|1
292181|NCT00922207|962240|P2|Overall Study|Abnormality of Laboratory Test|1
292182|NCT00922207|962241|P1|Overall Study|Abnormality of Laboratory Test|0
292183|NCT00922207|962239|P3|Overall Study|Withdrew Consent|2
292184|NCT00922207|962240|P2|Overall Study|Withdrew Consent|5
292185|NCT00922207|962241|P1|Overall Study|Withdrew Consent|2
292186|NCT00922207|962239|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
292187|NCT00922207|962240|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
292188|NCT00922207|962241|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
292189|NCT00922207|962239|P3|Overall Study|Violation of Selection Criteria at Entry|0
292190|NCT00922207|962240|P2|Overall Study|Violation of Selection Criteria at Entry|1
292191|NCT00922207|962241|P1|Overall Study|Violation of Selection Criteria at Entry|0
292192|NCT00922207|962239|P3|Overall Study|Insufficient Therapeutic Response|1
292193|NCT00922207|962240|P2|Overall Study|Insufficient Therapeutic Response|0
292194|NCT00922207|962241|P1|Overall Study|Insufficient Therapeutic Response|0
292195|NCT00922207|962239|P3|Overall Study|Adverse Event/Intercurrent Illness|0
292196|NCT00922207|962240|P2|Overall Study|Adverse Event/Intercurrent Illness|0
292197|NCT00922207|962241|P1|Overall Study|Adverse Event/Intercurrent Illness|3
292198|NCT00922116|962277|P1|Overall Study|Unspecified|5
292199|NCT00922116|962277|P1|Overall Study|Withdrawal by Subject|4
292200|NCT00922116|962277|P1|Overall Study|Lost to Follow-up|1
292201|NCT00922116|962277|P1|Overall Study|Death|1
292202|NCT00922116|962277|P1|Overall Study|Adverse Event|4
292203|NCT00921557|962322|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
292204|NCT00921557|962323|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
292205|NCT00921557|962324|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
292206|NCT00921557|962322|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
292207|NCT00921557|962323|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
292208|NCT00921557|962324|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
292209|NCT00921557|962322|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
292210|NCT00921557|962323|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
292211|NCT00921557|962324|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
292212|NCT00921557|962322|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
292213|NCT00921557|962323|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
292214|NCT00921557|962324|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
292215|NCT00921557|962322|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
292216|NCT00921557|962323|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
292217|NCT00921557|962324|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
292218|NCT00921024|962426|P2|Overall Study|Withdrawal by Subject|3
292219|NCT00921024|962427|P1|Overall Study|Withdrawal by Subject|0
292220|NCT00921024|962426|P2|Overall Study|Received concomittant therapy|0
292221|NCT00921024|962427|P1|Overall Study|Received concomittant therapy|2
292222|NCT00921024|962426|P2|Overall Study|Lost to Follow-up|0
292223|NCT00921024|962427|P1|Overall Study|Lost to Follow-up|2
292224|NCT00920907|962437|P2|Maintenance Period|Adverse Event|1
292225|NCT00920907|962438|P1|Maintenance Period|Adverse Event|0
292226|NCT00920907|962437|P2|Maintenance Period|Withdrawal by Subject|0
292227|NCT00920907|962438|P1|Maintenance Period|Withdrawal by Subject|1
292228|NCT00920907|962437|P2|Maintenance Period|Death|1
292229|NCT00920907|962438|P1|Maintenance Period|Death|1
292230|NCT00920907|962437|P2|Maintenance Period|Study Drug Toxicity|2
292231|NCT00920907|962438|P1|Maintenance Period|Study Drug Toxicity|0
292232|NCT00920907|962437|P2|Maintenance Period|Administrative (study closure)|2
292233|NCT00920907|962438|P1|Maintenance Period|Administrative (study closure)|7
292234|NCT00920907|962437|P2|Maintenance Period|Disease Progression|7
292235|NCT00920907|962438|P1|Maintenance Period|Disease Progression|3
292236|NCT00920907|962437|P2|Induction Period|Withdrawal by Subject|1
292237|NCT00920907|962438|P1|Induction Period|Withdrawal by Subject|1
292238|NCT00920907|962437|P2|Induction Period|No longer meets study criteria|1
292239|NCT00920907|962438|P1|Induction Period|No longer meets study criteria|0
292240|NCT00920907|962437|P2|Induction Period|Study Drug Toxicity|6
292241|NCT00920907|962438|P1|Induction Period|Study Drug Toxicity|8
292242|NCT00920907|962437|P2|Induction Period|Disease Progression|11
292243|NCT00920907|962438|P1|Induction Period|Disease Progression|12
292244|NCT00920907|962437|P2|Induction Period|Death|1
292245|NCT00920907|962438|P1|Induction Period|Death|1
292246|NCT00920907|962437|P2|Induction Period|Adverse Event|2
292247|NCT00920907|962438|P1|Induction Period|Adverse Event|0
292248|NCT00920855|962479|P3|Overall Study|Response plateau; started maintenance|1
292249|NCT00920855|962480|P2|Overall Study|Response plateau; started maintenance|0
292250|NCT00920855|962481|P1|Overall Study|Response plateau; started maintenance|0
292251|NCT00920855|962479|P3|Overall Study|Noncompliance to study medication|1
292252|NCT00920855|962480|P2|Overall Study|Noncompliance to study medication|0
292253|NCT00920855|962481|P1|Overall Study|Noncompliance to study medication|0
292254|NCT00920855|962479|P3|Overall Study|Disease progression|10
292255|NCT00920855|962480|P2|Overall Study|Disease progression|1
292256|NCT00920855|962481|P1|Overall Study|Disease progression|2
292257|NCT00920855|962479|P3|Overall Study|Withdrawal by Subject|6
292258|NCT00920855|962480|P2|Overall Study|Withdrawal by Subject|1
292259|NCT00920855|962481|P1|Overall Study|Withdrawal by Subject|2
292260|NCT00920855|962479|P3|Overall Study|Adverse Event|4
292261|NCT00920855|962480|P2|Overall Study|Adverse Event|1
292262|NCT00920855|962481|P1|Overall Study|Adverse Event|1
292263|NCT00920816|962507|P4|Overall Study|Ongoing|36
292264|NCT00920816|962508|P3|Overall Study|Ongoing|70
292265|NCT00920816|962509|P2|Overall Study|Ongoing|56
292266|NCT00920816|962510|P1|Overall Study|Ongoing|106
292267|NCT00920816|962507|P4|Overall Study|Withdrawal by Subject|1
292268|NCT00920816|962508|P3|Overall Study|Withdrawal by Subject|1
292269|NCT00920816|962509|P2|Overall Study|Withdrawal by Subject|2
292270|NCT00920816|962510|P1|Overall Study|Withdrawal by Subject|7
292271|NCT00920816|962507|P4|Overall Study|Objective progression or relapse|0
292272|NCT00920816|962508|P3|Overall Study|Objective progression or relapse|2
292273|NCT00920816|962509|P2|Overall Study|Objective progression or relapse|0
292274|NCT00920816|962510|P1|Overall Study|Objective progression or relapse|0
292275|NCT00920816|962507|P4|Overall Study|Lost to Follow-up|4
292276|NCT00920816|962508|P3|Overall Study|Lost to Follow-up|3
292277|NCT00920816|962509|P2|Overall Study|Lost to Follow-up|2
292278|NCT00920816|962510|P1|Overall Study|Lost to Follow-up|1
292279|NCT00920816|962507|P4|Overall Study|Adverse Event|0
292280|NCT00920816|962508|P3|Overall Study|Adverse Event|1
292281|NCT00920816|962509|P2|Overall Study|Adverse Event|0
292282|NCT00920816|962510|P1|Overall Study|Adverse Event|1
292283|NCT00920816|962507|P4|Overall Study|Death|28
292284|NCT00920816|962508|P3|Overall Study|Death|58
292285|NCT00920816|962509|P2|Overall Study|Death|36
292286|NCT00920816|962510|P1|Overall Study|Death|77
292287|NCT00920790|962548|P1|Overall Study|aggravation of general condition|14
292288|NCT00920686|962560|P3|Overall Study|Study drug dosing criteria not met|12
292289|NCT00920686|962561|P2|Overall Study|Study drug dosing criteria not met|19
292290|NCT00920686|962562|P1|Overall Study|Study drug dosing criteria not met|17
292291|NCT00920686|962560|P3|Overall Study|Lost to Follow-up|1
292292|NCT00920686|962561|P2|Overall Study|Lost to Follow-up|3
292293|NCT00920686|962562|P1|Overall Study|Lost to Follow-up|2
292294|NCT00920140|962691|P5|Phase 2|Withdrawal by Subject|1
292295|NCT00920140|962692|P4|Phase 2|Withdrawal by Subject|2
292296|NCT00920140|962693|P3|Phase 2|Withdrawal by Subject|4
292297|NCT00920140|962694|P2|Phase 2|Withdrawal by Subject|0
292298|NCT00920140|962695|P1|Phase 2|Withdrawal by Subject|0
292299|NCT00920140|962691|P5|Phase 2|Physician Decision|2
292300|NCT00920140|962692|P4|Phase 2|Physician Decision|3
292301|NCT00920140|962693|P3|Phase 2|Physician Decision|3
292302|NCT00920140|962694|P2|Phase 2|Physician Decision|0
292303|NCT00920140|962695|P1|Phase 2|Physician Decision|0
292304|NCT00920140|962691|P5|Phase 2|Lost to Follow-up|0
292305|NCT00920140|962692|P4|Phase 2|Lost to Follow-up|1
292306|NCT00920140|962693|P3|Phase 2|Lost to Follow-up|0
292307|NCT00920140|962694|P2|Phase 2|Lost to Follow-up|0
292308|NCT00920140|962695|P1|Phase 2|Lost to Follow-up|0
292309|NCT00920140|962691|P5|Phase 2|Lack of Efficacy|5
292310|NCT00920140|962692|P4|Phase 2|Lack of Efficacy|14
292311|NCT00920140|962693|P3|Phase 2|Lack of Efficacy|29
292312|NCT00920140|962694|P2|Phase 2|Lack of Efficacy|0
292313|NCT00920140|962695|P1|Phase 2|Lack of Efficacy|0
292314|NCT00920140|962691|P5|Phase 2|Adverse Event|3
292315|NCT00920140|962692|P4|Phase 2|Adverse Event|2
292316|NCT00920140|962693|P3|Phase 2|Adverse Event|14
292317|NCT00920140|962694|P2|Phase 2|Adverse Event|0
292318|NCT00920140|962695|P1|Phase 2|Adverse Event|0
292319|NCT00920140|962691|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
292320|NCT00920140|962692|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
292321|NCT00920140|962693|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
292322|NCT00920140|962694|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
292323|NCT00920140|962695|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
292324|NCT00920140|962691|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
292325|NCT00920140|962692|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
292326|NCT00920140|962693|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
292327|NCT00920140|962694|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
292328|NCT00920140|962695|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
292329|NCT00920140|962691|P5|Phase 1 (Dose Escalation)|Adverse Event|0
292330|NCT00920140|962692|P4|Phase 1 (Dose Escalation)|Adverse Event|0
292331|NCT00920140|962693|P3|Phase 1 (Dose Escalation)|Adverse Event|0
292332|NCT00920140|962694|P2|Phase 1 (Dose Escalation)|Adverse Event|3
292333|NCT00920140|962695|P1|Phase 1 (Dose Escalation)|Adverse Event|3
292334|NCT00919893|962752|P2|Overall Study|Protocol Violation|9
292335|NCT00919893|962753|P1|Overall Study|Protocol Violation|19
292336|NCT00919867|962765|P6|First Intervention|Physician Decision|1
292337|NCT00919867|962766|P5|First Intervention|Physician Decision|0
292338|NCT00919867|962767|P4|First Intervention|Physician Decision|0
292339|NCT00919867|962768|P3|First Intervention|Physician Decision|0
292340|NCT00919867|962769|P2|First Intervention|Physician Decision|0
292341|NCT00919867|962770|P1|First Intervention|Physician Decision|0
292342|NCT00919867|962765|P6|First Intervention|Withdrawal by Subject|0
292343|NCT00919867|962766|P5|First Intervention|Withdrawal by Subject|0
292344|NCT00919867|962767|P4|First Intervention|Withdrawal by Subject|0
292345|NCT00919867|962768|P3|First Intervention|Withdrawal by Subject|1
292346|NCT00919867|962769|P2|First Intervention|Withdrawal by Subject|0
292347|NCT00919867|962770|P1|First Intervention|Withdrawal by Subject|0
292348|NCT00919854|962791|P1|Overall Study|Adverse Event|1
292349|NCT00919711|962829|P2|Overall Study|Noncompliance|0
292350|NCT00919711|962830|P1|Overall Study|Noncompliance|1
292351|NCT00919711|962829|P2|Overall Study|Death|0
292352|NCT00919711|962830|P1|Overall Study|Death|1
292353|NCT00919711|962829|P2|Overall Study|Lost to Follow-up|0
292354|NCT00919711|962830|P1|Overall Study|Lost to Follow-up|2
292355|NCT00919711|962829|P2|Overall Study|Administrative Decision|1
292356|NCT00919711|962830|P1|Overall Study|Administrative Decision|0
292357|NCT00919711|962829|P2|Overall Study|Other|2
292358|NCT00919711|962830|P1|Overall Study|Other|1
292359|NCT00919711|962829|P2|Overall Study|Adverse Event|3
292360|NCT00919711|962830|P1|Overall Study|Adverse Event|13
292361|NCT00919711|962829|P2|Overall Study|Withdrawal by Subject|7
292362|NCT00919711|962830|P1|Overall Study|Withdrawal by Subject|15
292363|NCT00916617|962853|P4|Overall Study|Not specified|2
292364|NCT00916617|962854|P3|Overall Study|Not specified|0
292365|NCT00916617|962855|P2|Overall Study|Not specified|0
292366|NCT00916617|962856|P1|Overall Study|Not specified|2
292367|NCT00916617|962853|P4|Overall Study|Lack of Efficacy|0
292368|NCT00916617|962854|P3|Overall Study|Lack of Efficacy|0
292369|NCT00916617|962855|P2|Overall Study|Lack of Efficacy|0
292370|NCT00916617|962856|P1|Overall Study|Lack of Efficacy|1
292371|NCT00916617|962853|P4|Overall Study|Lost to Follow-up|0
292372|NCT00916617|962854|P3|Overall Study|Lost to Follow-up|0
292373|NCT00916617|962855|P2|Overall Study|Lost to Follow-up|1
292374|NCT00916617|962856|P1|Overall Study|Lost to Follow-up|2
292375|NCT00916617|962853|P4|Overall Study|Discontinuation of Study by Sponsor|1
292376|NCT00916617|962854|P3|Overall Study|Discontinuation of Study by Sponsor|3
292377|NCT00916617|962855|P2|Overall Study|Discontinuation of Study by Sponsor|13
292378|NCT00916617|962856|P1|Overall Study|Discontinuation of Study by Sponsor|8
292379|NCT00916617|962853|P4|Overall Study|Physician Decision|0
292380|NCT00916617|962854|P3|Overall Study|Physician Decision|0
292381|NCT00916617|962855|P2|Overall Study|Physician Decision|1
292382|NCT00916617|962856|P1|Overall Study|Physician Decision|1
292383|NCT00916617|962853|P4|Overall Study|Caregiver Request|0
292384|NCT00916617|962854|P3|Overall Study|Caregiver Request|1
292385|NCT00916617|962855|P2|Overall Study|Caregiver Request|2
292386|NCT00916617|962856|P1|Overall Study|Caregiver Request|3
292387|NCT00916617|962853|P4|Overall Study|Withdrawal by Subject|1
292388|NCT00916617|962854|P3|Overall Study|Withdrawal by Subject|0
292389|NCT00916617|962855|P2|Overall Study|Withdrawal by Subject|2
292390|NCT00916617|962856|P1|Overall Study|Withdrawal by Subject|3
292391|NCT00916617|962853|P4|Overall Study|Adverse Event|3
292392|NCT00916617|962854|P3|Overall Study|Adverse Event|6
292393|NCT00916617|962855|P2|Overall Study|Adverse Event|2
292394|NCT00916617|962856|P1|Overall Study|Adverse Event|3
292395|NCT00919633|962899|P4|Overall Study|Viral rebound outside protocol timepoint|0
292396|NCT00919633|962900|P3|Overall Study|Viral rebound outside protocol timepoint|1
292397|NCT00919633|962901|P2|Overall Study|Viral rebound outside protocol timepoint|0
292398|NCT00919633|962902|P1|Overall Study|Viral rebound outside protocol timepoint|0
292399|NCT00919633|962899|P4|Overall Study|Request of withdrawal w/o future contact|0
292400|NCT00919633|962900|P3|Overall Study|Request of withdrawal w/o future contact|1
292401|NCT00919633|962901|P2|Overall Study|Request of withdrawal w/o future contact|0
292402|NCT00919633|962902|P1|Overall Study|Request of withdrawal w/o future contact|0
292403|NCT00919633|962899|P4|Overall Study|Physician Decision|1
292404|NCT00919633|962900|P3|Overall Study|Physician Decision|0
292405|NCT00919633|962901|P2|Overall Study|Physician Decision|0
292406|NCT00919633|962902|P1|Overall Study|Physician Decision|0
292407|NCT00919633|962899|P4|Overall Study|Protocol Violation|1
292408|NCT00919633|962900|P3|Overall Study|Protocol Violation|0
292409|NCT00919633|962901|P2|Overall Study|Protocol Violation|0
292410|NCT00919633|962902|P1|Overall Study|Protocol Violation|0
292411|NCT00919633|962899|P4|Overall Study|Withdraw consent post transition to SOC|1
292412|NCT00919633|962900|P3|Overall Study|Withdraw consent post transition to SOC|1
292413|NCT00919633|962901|P2|Overall Study|Withdraw consent post transition to SOC|0
292414|NCT00919633|962902|P1|Overall Study|Withdraw consent post transition to SOC|0
292415|NCT00919633|962899|P4|Overall Study|Lost to Follow-up|2
292416|NCT00919633|962900|P3|Overall Study|Lost to Follow-up|0
292417|NCT00919633|962901|P2|Overall Study|Lost to Follow-up|1
292418|NCT00919633|962902|P1|Overall Study|Lost to Follow-up|3
292419|NCT00919633|962899|P4|Overall Study|Withdrawal by Subject|3
292420|NCT00919633|962900|P3|Overall Study|Withdrawal by Subject|4
292421|NCT00919633|962901|P2|Overall Study|Withdrawal by Subject|2
292422|NCT00919633|962902|P1|Overall Study|Withdrawal by Subject|1
292423|NCT00919633|962899|P4|Overall Study|Lack of Efficacy|3
292424|NCT00919633|962900|P3|Overall Study|Lack of Efficacy|2
292425|NCT00919633|962901|P2|Overall Study|Lack of Efficacy|3
292426|NCT00919633|962902|P1|Overall Study|Lack of Efficacy|17
292427|NCT00919633|962899|P4|Overall Study|Death|0
292428|NCT00919633|962900|P3|Overall Study|Death|2
292429|NCT00919633|962901|P2|Overall Study|Death|0
292430|NCT00919633|962902|P1|Overall Study|Death|0
292431|NCT00919633|962899|P4|Overall Study|Adverse Event|10
292432|NCT00919633|962900|P3|Overall Study|Adverse Event|12
292433|NCT00919633|962901|P2|Overall Study|Adverse Event|9
292434|NCT00919633|962902|P1|Overall Study|Adverse Event|1
292435|NCT00919061|962987|P1|Overall Study|Withdrawal by Subject|1
292436|NCT00919061|962987|P1|Overall Study|Adverse Event|1
292437|NCT00918957|963000|P2|Overall Study|Withdrawal by Subject|0
292438|NCT00918957|963001|P1|Overall Study|Withdrawal by Subject|1
292439|NCT00918957|963000|P2|Overall Study|Adverse Event|0
292440|NCT00918957|963001|P1|Overall Study|Adverse Event|2
292441|NCT00918879|963034|P2|Overall Study|Severe non-compliance to protocol|1
292442|NCT00918879|963035|P1|Overall Study|Severe non-compliance to protocol|1
292443|NCT00918879|963034|P2|Overall Study|Lost to Follow-up|1
292444|NCT00918879|963035|P1|Overall Study|Lost to Follow-up|1
292445|NCT00918879|963034|P2|Overall Study|Withdrawal by Subject|4
292446|NCT00918879|963035|P1|Overall Study|Withdrawal by Subject|4
292447|NCT00918749|963067|P3|Overall Study|No Study Medication Taken|0
292448|NCT00918749|963068|P2|Overall Study|No Study Medication Taken|0
292449|NCT00918749|963069|P1|Overall Study|No Study Medication Taken|1
292450|NCT00918749|963067|P3|Overall Study|Withdrawal by Subject|5
292451|NCT00918749|963068|P2|Overall Study|Withdrawal by Subject|3
292452|NCT00918749|963069|P1|Overall Study|Withdrawal by Subject|5
292453|NCT00918749|963067|P3|Overall Study|Lost to Follow-up|1
292454|NCT00918749|963068|P2|Overall Study|Lost to Follow-up|0
292455|NCT00918749|963069|P1|Overall Study|Lost to Follow-up|0
292456|NCT00918749|963067|P3|Overall Study|Adverse Event|1
292457|NCT00918749|963068|P2|Overall Study|Adverse Event|0
292458|NCT00918749|963069|P1|Overall Study|Adverse Event|1
292459|NCT00918736|963101|P1|Overall Study|Withdrawal by Subject|4
292460|NCT00918684|963105|P1|Treatment Phase|Withdrawal by Subject|8
292461|NCT00918684|963105|P1|Treatment Phase|Protocol Violation|1
292462|NCT00918684|963105|P1|Treatment Phase|Physician Decision|8
292463|NCT00918684|963105|P1|Treatment Phase|Lost to Follow-up|2
292464|NCT00918684|963105|P1|Treatment Phase|Lack of Efficacy|6
292465|NCT00918684|963105|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
292466|NCT00918580|963116|P1|After 6-month FU to 1-year FU|Failed to Return|2
292467|NCT00918580|963116|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
292468|NCT00918580|963116|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
292469|NCT00918580|963116|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
292470|NCT00918580|963116|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
292471|NCT00918580|963116|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
292472|NCT00918580|963116|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
292473|NCT00918385|963136|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
292474|NCT00918385|963137|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
292475|NCT00918385|963136|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
292476|NCT00918385|963137|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
292477|NCT00918385|963136|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
292478|NCT00918385|963137|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
292479|NCT00918385|963136|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
292480|NCT00918385|963137|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
292481|NCT00918385|963136|P2|Monotherapy|Complicating illness|0
292482|NCT00918385|963137|P1|Monotherapy|Complicating illness|1
292483|NCT00918385|963136|P2|Monotherapy|Adverse Event|6
292484|NCT00918385|963137|P1|Monotherapy|Adverse Event|1
292485|NCT00918346|963146|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
292486|NCT00918346|963147|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
292487|NCT00918281|963161|P1|Overall Study|Physician Decision|29
292488|NCT00918255|963171|P3|Overall Study|Investigator discretion|0
292489|NCT00918255|963172|P2|Overall Study|Investigator discretion|0
292490|NCT00918255|963173|P1|Overall Study|Investigator discretion|1
292491|NCT00918255|963171|P3|Overall Study|Non-compliance|0
292492|NCT00918255|963172|P2|Overall Study|Non-compliance|0
292493|NCT00918255|963173|P1|Overall Study|Non-compliance|1
292494|NCT00918255|963171|P3|Overall Study|Exceeded allowed number of interventions|1
292495|NCT00918255|963172|P2|Overall Study|Exceeded allowed number of interventions|0
292496|NCT00918255|963173|P1|Overall Study|Exceeded allowed number of interventions|0
292497|NCT00918255|963171|P3|Overall Study|Lost to Follow-up|2
292498|NCT00918255|963172|P2|Overall Study|Lost to Follow-up|0
292499|NCT00918255|963173|P1|Overall Study|Lost to Follow-up|1
292500|NCT00918255|963171|P3|Overall Study|Lack of Efficacy|0
292501|NCT00918255|963172|P2|Overall Study|Lack of Efficacy|0
292502|NCT00918255|963173|P1|Overall Study|Lack of Efficacy|1
292503|NCT00918255|963171|P3|Overall Study|Withdrawal by Subject|2
292504|NCT00918255|963172|P2|Overall Study|Withdrawal by Subject|0
292505|NCT00918255|963173|P1|Overall Study|Withdrawal by Subject|1
292506|NCT00918255|963171|P3|Overall Study|Adverse Event|0
292507|NCT00918255|963172|P2|Overall Study|Adverse Event|0
292508|NCT00918255|963173|P1|Overall Study|Adverse Event|1
292509|NCT00918203|963201|P3|Crossover to Olaratumab Monotherapy|Other Therapy Started|1
292510|NCT00918203|963202|P2|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
292511|NCT00918203|963203|P1|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
292512|NCT00918203|963201|P3|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|2
292513|NCT00918203|963202|P2|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
292514|NCT00918203|963203|P1|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
292515|NCT00918203|963201|P3|Treatment With or Without Olaratumab|On Treatment|0
292516|NCT00918203|963202|P2|Treatment With or Without Olaratumab|On Treatment|0
292517|NCT00918203|963203|P1|Treatment With or Without Olaratumab|On Treatment|1
292518|NCT00918203|963201|P3|Treatment With or Without Olaratumab|Physician Decision|0
292519|NCT00918203|963202|P2|Treatment With or Without Olaratumab|Physician Decision|1
292520|NCT00918203|963203|P1|Treatment With or Without Olaratumab|Physician Decision|0
292521|NCT00918203|963201|P3|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
292522|NCT00918203|963202|P2|Treatment With or Without Olaratumab|Off Study Treatment/Alive|1
292523|NCT00918203|963203|P1|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
292524|NCT00918203|963201|P3|Treatment With or Without Olaratumab|Never Treated|0
292525|NCT00918203|963202|P2|Treatment With or Without Olaratumab|Never Treated|1
292526|NCT00918203|963203|P1|Treatment With or Without Olaratumab|Never Treated|2
292527|NCT00918203|963201|P3|Treatment With or Without Olaratumab|Adverse Event|0
292528|NCT00918203|963202|P2|Treatment With or Without Olaratumab|Adverse Event|1
292529|NCT00918203|963203|P1|Treatment With or Without Olaratumab|Adverse Event|1
292530|NCT00918203|963201|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
292531|NCT00918203|963202|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
292532|NCT00918203|963203|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
292533|NCT00918203|963201|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
292534|NCT00918203|963202|P2|Treatment With or Without Olaratumab|Lost to Follow-up|0
292535|NCT00918203|963203|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
292536|NCT00918203|963201|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
292537|NCT00918203|963202|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|9
292538|NCT00918203|963203|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|0
292539|NCT00918138|963234|P2|Overall Study|Death|0
292540|NCT00918138|963235|P1|Overall Study|Death|1
292541|NCT00918138|963234|P2|Overall Study|Subject withdrew consent|1
292542|NCT00918138|963235|P1|Overall Study|Subject withdrew consent|1
292543|NCT00917852|963274|P1|Overall Study|Death|6
292544|NCT00917644|963291|P2|Period 2: Second Intervention|family emergency|0
292545|NCT00917644|963292|P1|Period 2: Second Intervention|family emergency|1
292546|NCT00917644|963291|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
292547|NCT00917644|963292|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
292548|NCT00917644|963291|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
292549|NCT00917644|963292|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
292550|NCT00917579|963306|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
292551|NCT00917579|963307|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
292552|NCT00917579|963306|P2|Washout >= 2 Weeks|Adverse Event|0
292553|NCT00917579|963307|P1|Washout >= 2 Weeks|Adverse Event|1
292554|NCT00917501|963323|P2|Overall Study|trouble swollowing capsules|1
292555|NCT00917501|963324|P1|Overall Study|trouble swollowing capsules|0
292556|NCT00917501|963323|P2|Overall Study|Lack of Efficacy|2
292557|NCT00917501|963324|P1|Overall Study|Lack of Efficacy|1
292558|NCT00917501|963323|P2|Overall Study|Withdrawal by Subject|1
292559|NCT00917501|963324|P1|Overall Study|Withdrawal by Subject|3
292560|NCT00917501|963323|P2|Overall Study|Lost to Follow-up|1
292561|NCT00917501|963324|P1|Overall Study|Lost to Follow-up|4
292562|NCT00917384|963332|P2|Overall Study|Withdrawal by Subject|2
292563|NCT00917384|963333|P1|Overall Study|Withdrawal by Subject|10
292564|NCT00917384|963332|P2|Overall Study|Lost to Follow-up|2
292565|NCT00917384|963333|P1|Overall Study|Lost to Follow-up|4
292566|NCT00917267|963357|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
292567|NCT00917267|963358|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
292568|NCT00917267|963357|P2|Overall Study|Sponsor Decision|5
292569|NCT00917267|963358|P1|Overall Study|Sponsor Decision|5
292570|NCT00917267|963357|P2|Overall Study|Entry Criteria Not Met|0
292571|NCT00917267|963358|P1|Overall Study|Entry Criteria Not Met|1
292572|NCT00917267|963357|P2|Overall Study|Lost to follow up|2
292573|NCT00917267|963358|P1|Overall Study|Lost to follow up|0
292574|NCT00917267|963357|P2|Overall Study|Withdrawal by Subject|12
292575|NCT00917267|963358|P1|Overall Study|Withdrawal by Subject|5
292576|NCT00917267|963357|P2|Overall Study|Protocol Violation|18
292577|NCT00917267|963358|P1|Overall Study|Protocol Violation|9
292578|NCT00917267|963357|P2|Overall Study|Physician Decision|4
292579|NCT00917267|963358|P1|Overall Study|Physician Decision|2
292580|NCT00917267|963357|P2|Overall Study|Adverse Event|36
292581|NCT00917267|963358|P1|Overall Study|Adverse Event|15
292582|NCT00917124|963386|P2|Overall Study|Protocol Violation|6
292583|NCT00917124|963387|P1|Overall Study|Protocol Violation|4
292584|NCT00916929|963397|P2|Overall Study|Device unable to process impedance data|7
292585|NCT00916929|963398|P1|Overall Study|Device unable to process impedance data|0
292586|NCT00916929|963397|P2|Overall Study|Moved to another state|1
292587|NCT00916929|963398|P1|Overall Study|Moved to another state|0
292588|NCT00916929|963397|P2|Overall Study|System explant|0
292589|NCT00916929|963398|P1|Overall Study|System explant|1
292590|NCT00916929|963397|P2|Overall Study|Transferred to hospice care|1
292591|NCT00916929|963398|P1|Overall Study|Transferred to hospice care|1
292592|NCT00916929|963397|P2|Overall Study|Left ventricular epicardial lead|2
292593|NCT00916929|963398|P1|Overall Study|Left ventricular epicardial lead|1
292594|NCT00916929|963397|P2|Overall Study|Withdrawal by Subject|5
292595|NCT00916929|963398|P1|Overall Study|Withdrawal by Subject|1
292596|NCT00916929|963397|P2|Overall Study|Death|10
292597|NCT00916929|963398|P1|Overall Study|Death|5
292598|NCT00916929|963397|P2|Overall Study|Lost to Follow-up|3
292599|NCT00916929|963398|P1|Overall Study|Lost to Follow-up|1
292600|NCT00916721|963408|P2|Overall Study|Protocol Violation|4
292601|NCT00916721|963409|P1|Overall Study|Protocol Violation|2
292602|NCT00916721|963408|P2|Overall Study|Withdrawal by Subject|2
292603|NCT00916721|963409|P1|Overall Study|Withdrawal by Subject|2
292604|NCT00916721|963408|P2|Overall Study|Adverse Event|3
292605|NCT00916721|963409|P1|Overall Study|Adverse Event|6
292606|NCT00916721|963408|P2|Overall Study|Lost to Follow-up|1
292607|NCT00916721|963409|P1|Overall Study|Lost to Follow-up|0
292608|NCT00916383|963421|P1|Overall Study|Protocol Violation|1
292609|NCT00916383|963421|P1|Overall Study|Death|1
292610|NCT00916383|963421|P1|Overall Study|Adverse Event|1
292611|NCT00916370|963449|P2|Overall Study|Physician Decision|1
292612|NCT00916370|963450|P1|Overall Study|Physician Decision|0
292613|NCT00916370|963449|P2|Overall Study|Withdrawal by Subject|0
292614|NCT00916370|963450|P1|Overall Study|Withdrawal by Subject|2
292615|NCT00916370|963449|P2|Overall Study|Death|1
292616|NCT00916370|963450|P1|Overall Study|Death|3
292617|NCT00916357|963624|P6|Period 2|Weight loss > 3 kilograms (kg)|0
292618|NCT00916357|963625|P5|Period 2|Weight loss > 3 kilograms (kg)|0
292619|NCT00916357|963626|P4|Period 2|Weight loss > 3 kilograms (kg)|1
292620|NCT00916357|963627|P3|Period 2|Weight loss > 3 kilograms (kg)|0
292621|NCT00916357|963628|P2|Period 2|Weight loss > 3 kilograms (kg)|0
292622|NCT00916357|963629|P1|Period 2|Weight loss > 3 kilograms (kg)|0
292623|NCT00916357|963624|P6|Period 1|Withdrawal by Subject|0
292624|NCT00916357|963625|P5|Period 1|Withdrawal by Subject|0
292625|NCT00916357|963626|P4|Period 1|Withdrawal by Subject|0
292626|NCT00916357|963627|P3|Period 1|Withdrawal by Subject|0
292627|NCT00916357|963628|P2|Period 1|Withdrawal by Subject|0
292628|NCT00916357|963629|P1|Period 1|Withdrawal by Subject|1
292629|NCT00916344|963667|P1|Overall Study|Drop-out|5
292630|NCT00916344|963667|P1|Overall Study|ICD upgrade|1
292631|NCT00916344|963667|P1|Overall Study|Death|2
292632|NCT00916305|963674|P2|Overall Study|Withdrawal by Subject|1
292633|NCT00916305|963675|P1|Overall Study|Withdrawal by Subject|0
292634|NCT00916305|963674|P2|Overall Study|Lost to Follow-up|27
292635|NCT00916305|963675|P1|Overall Study|Lost to Follow-up|21
292636|NCT00916279|963683|P1|Overall Study|Lost to Follow-up|2
292637|NCT00916279|963683|P1|Overall Study|Death|2
292638|NCT00916006|963745|P2|Overall Study|Protocol Violation|1
292639|NCT00916006|963746|P1|Overall Study|Protocol Violation|0
292640|NCT00916006|963745|P2|Overall Study|Withdrawal by Subject|5
292641|NCT00916006|963746|P1|Overall Study|Withdrawal by Subject|2
292642|NCT00916006|963745|P2|Overall Study|Adverse Event|1
292643|NCT00916006|963746|P1|Overall Study|Adverse Event|1
292644|NCT00915876|963767|P2|Overall Study|Adverse Event|1
292645|NCT00915876|963768|P1|Overall Study|Adverse Event|0
292646|NCT00915772|963804|P3|Overall Study|Any other reason|7
292647|NCT00915772|963805|P2|Overall Study|Any other reason|7
292648|NCT00915772|963806|P1|Overall Study|Any other reason|4
292649|NCT00915772|963804|P3|Overall Study|Refused to continue trial medication|4
292650|NCT00915772|963805|P2|Overall Study|Refused to continue trial medication|8
292651|NCT00915772|963806|P1|Overall Study|Refused to continue trial medication|6
292652|NCT00915772|963804|P3|Overall Study|Lack of Efficacy|3
292653|NCT00915772|963805|P2|Overall Study|Lack of Efficacy|15
292654|NCT00915772|963806|P1|Overall Study|Lack of Efficacy|9
292655|NCT00915772|963804|P3|Overall Study|Lost to Follow-up|2
292656|NCT00915772|963805|P2|Overall Study|Lost to Follow-up|2
292657|NCT00915772|963806|P1|Overall Study|Lost to Follow-up|1
292658|NCT00915772|963804|P3|Overall Study|Protocol Violation|2
292659|NCT00915772|963805|P2|Overall Study|Protocol Violation|1
292660|NCT00915772|963806|P1|Overall Study|Protocol Violation|4
292661|NCT00915772|963804|P3|Overall Study|Adverse Event|11
292662|NCT00915772|963805|P2|Overall Study|Adverse Event|13
292663|NCT00915772|963806|P1|Overall Study|Adverse Event|12
292664|NCT00915551|963905|P2|Overall Study|Withdrawal by Subject|1
292665|NCT00915551|963906|P1|Overall Study|Withdrawal by Subject|0
292666|NCT00915525|963916|P2|Overall Study|Patient Moved|9
292667|NCT00915525|963917|P1|Overall Study|Patient Moved|15
292668|NCT00915525|963916|P2|Overall Study|Non-Compliance|1
292669|NCT00915525|963917|P1|Overall Study|Non-Compliance|3
292670|NCT00915525|963916|P2|Overall Study|Study Burden|12
292671|NCT00915525|963917|P1|Overall Study|Study Burden|28
292672|NCT00915525|963916|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
292673|NCT00915525|963917|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
292674|NCT00915525|963916|P2|Overall Study|Site Closed|9
292675|NCT00915525|963917|P1|Overall Study|Site Closed|27
292676|NCT00915525|963916|P2|Overall Study|Other Reason|12
292677|NCT00915525|963917|P1|Overall Study|Other Reason|35
292678|NCT00915525|963916|P2|Overall Study|Missing|1
292679|NCT00915525|963917|P1|Overall Study|Missing|12
292680|NCT00915525|963916|P2|Overall Study|Adverse Event|13
292681|NCT00915525|963917|P1|Overall Study|Adverse Event|29
292682|NCT00915525|963916|P2|Overall Study|Lack of Efficacy|32
292683|NCT00915525|963917|P1|Overall Study|Lack of Efficacy|15
292684|NCT00915525|963916|P2|Overall Study|Pregnancy|0
292685|NCT00915525|963917|P1|Overall Study|Pregnancy|2
292686|NCT00915525|963916|P2|Overall Study|Lost to Follow-up|16
292687|NCT00915525|963917|P1|Overall Study|Lost to Follow-up|27
292688|NCT00915525|963916|P2|Overall Study|Withdrawal by Subject|21
292689|NCT00915525|963917|P1|Overall Study|Withdrawal by Subject|59
292690|NCT00915525|963916|P2|Overall Study|Protocol Violation|4
292691|NCT00915525|963917|P1|Overall Study|Protocol Violation|9
292692|NCT00915473|964031|P2|4-week Follow Up|Lost to Follow-up|5
292693|NCT00915473|964032|P1|4-week Follow Up|Lost to Follow-up|1
292694|NCT00915473|964031|P2|Screening|Withdrawal by Subject|0
292695|NCT00915473|964032|P1|Screening|Withdrawal by Subject|1
292696|NCT00915356|964049|P5|Overall Study|Withdrawal by Subject|0
292697|NCT00915356|964050|P4|Overall Study|Withdrawal by Subject|0
292698|NCT00915356|964051|P3|Overall Study|Withdrawal by Subject|0
292699|NCT00915356|964052|P2|Overall Study|Withdrawal by Subject|0
292700|NCT00915356|964053|P1|Overall Study|Withdrawal by Subject|1
292701|NCT00915343|964115|P3|Part B - Open Label Period|Did not attend the last visit|1
292702|NCT00915343|964116|P2|Part B - Open Label Period|Did not attend the last visit|0
292703|NCT00915343|964117|P1|Part B - Open Label Period|Did not attend the last visit|0
292704|NCT00915343|964115|P3|Part B - Open Label Period|Treatment switch|1
292705|NCT00915343|964116|P2|Part B - Open Label Period|Treatment switch|0
292706|NCT00915343|964117|P1|Part B - Open Label Period|Treatment switch|0
292707|NCT00915278|964202|P6|Overall Study|Admission to hospice|0
292708|NCT00915278|964203|P5|Overall Study|Admission to hospice|0
292709|NCT00915278|964204|P4|Overall Study|Admission to hospice|0
292710|NCT00915278|964205|P3|Overall Study|Admission to hospice|1
292711|NCT00915278|964206|P2|Overall Study|Admission to hospice|0
292712|NCT00915278|964207|P1|Overall Study|Admission to hospice|0
292713|NCT00915278|964202|P6|Overall Study|Infusion related AEs|2
292714|NCT00915278|964203|P5|Overall Study|Infusion related AEs|0
292715|NCT00915278|964204|P4|Overall Study|Infusion related AEs|0
292716|NCT00915278|964205|P3|Overall Study|Infusion related AEs|0
292717|NCT00915278|964206|P2|Overall Study|Infusion related AEs|0
292718|NCT00915278|964207|P1|Overall Study|Infusion related AEs|0
292719|NCT00915278|964202|P6|Overall Study|Progressive disease/clinical progression|2
292720|NCT00915278|964203|P5|Overall Study|Progressive disease/clinical progression|1
292721|NCT00915278|964204|P4|Overall Study|Progressive disease/clinical progression|3
292722|NCT00915278|964205|P3|Overall Study|Progressive disease/clinical progression|0
292723|NCT00915278|964206|P2|Overall Study|Progressive disease/clinical progression|0
292724|NCT00915278|964207|P1|Overall Study|Progressive disease/clinical progression|0
292725|NCT00915278|964202|P6|Overall Study|Adverse Event|0
292726|NCT00915278|964203|P5|Overall Study|Adverse Event|0
292727|NCT00915278|964204|P4|Overall Study|Adverse Event|0
292728|NCT00915278|964205|P3|Overall Study|Adverse Event|0
292729|NCT00915278|964206|P2|Overall Study|Adverse Event|1
292730|NCT00915278|964207|P1|Overall Study|Adverse Event|4
292731|NCT00915278|964202|P6|Overall Study|Withdrawal by Subject|4
292732|NCT00915278|964203|P5|Overall Study|Withdrawal by Subject|1
292733|NCT00915278|964204|P4|Overall Study|Withdrawal by Subject|0
292734|NCT00915278|964205|P3|Overall Study|Withdrawal by Subject|0
292735|NCT00915278|964206|P2|Overall Study|Withdrawal by Subject|1
292736|NCT00915278|964207|P1|Overall Study|Withdrawal by Subject|0
292737|NCT00915278|964202|P6|Overall Study|Lost to Follow-up|0
292738|NCT00915278|964203|P5|Overall Study|Lost to Follow-up|0
292739|NCT00915278|964204|P4|Overall Study|Lost to Follow-up|0
292740|NCT00915278|964205|P3|Overall Study|Lost to Follow-up|0
292741|NCT00915278|964206|P2|Overall Study|Lost to Follow-up|1
292742|NCT00915278|964207|P1|Overall Study|Lost to Follow-up|0
292743|NCT00915278|964202|P6|Overall Study|Death|0
292744|NCT00915278|964203|P5|Overall Study|Death|0
292745|NCT00915278|964204|P4|Overall Study|Death|0
292746|NCT00915278|964205|P3|Overall Study|Death|0
292747|NCT00915278|964206|P2|Overall Study|Death|0
292748|NCT00915278|964207|P1|Overall Study|Death|1
292749|NCT00914966|964358|P1|Step 2: 2000 Units|Withdrawal by Subject|1
292750|NCT00914966|964358|P1|Step 1: 1500 Units|Physician Decision|1
292751|NCT00914966|964358|P1|Step 1: 1500 Units|Withdrawal by Subject|1
292752|NCT00914849|964453|P2|Overall Study|Not eligible|1
292753|NCT00914849|964454|P1|Overall Study|Not eligible|0
292754|NCT00914849|964453|P2|Overall Study|Withdrawal by Subject|0
292755|NCT00914849|964454|P1|Overall Study|Withdrawal by Subject|1
292756|NCT00914810|964488|P2|Overall Study|Hospitalized and unable to follow up.|1
292757|NCT00914810|964489|P1|Overall Study|Hospitalized and unable to follow up.|0
292758|NCT00914810|964488|P2|Overall Study|Relocated out of state|0
292759|NCT00914810|964489|P1|Overall Study|Relocated out of state|1
292760|NCT00914810|964488|P2|Overall Study|Withdrawal by Subject|0
292761|NCT00914810|964489|P1|Overall Study|Withdrawal by Subject|1
292762|NCT00914589|964500|P3|Overall Study|Death|1
292763|NCT00914589|964501|P2|Overall Study|Death|1
292764|NCT00914589|964502|P1|Overall Study|Death|0
292765|NCT00914589|964500|P3|Overall Study|unclassified|7
292766|NCT00914589|964501|P2|Overall Study|unclassified|9
292767|NCT00914589|964502|P1|Overall Study|unclassified|16
292768|NCT00914589|964500|P3|Overall Study|Protocol Violation|3
292769|NCT00914589|964501|P2|Overall Study|Protocol Violation|6
292770|NCT00914589|964502|P1|Overall Study|Protocol Violation|8
292771|NCT00914589|964500|P3|Overall Study|Adverse Event|1
292772|NCT00914589|964501|P2|Overall Study|Adverse Event|0
292773|NCT00914589|964502|P1|Overall Study|Adverse Event|1
292774|NCT00914459|964528|P2|Overall Study|Parent/Legal guardian request|0
292775|NCT00914459|964529|P1|Overall Study|Parent/Legal guardian request|1
292776|NCT00914459|964528|P2|Overall Study|Protocol Violation|1
292777|NCT00914459|964529|P1|Overall Study|Protocol Violation|0
292778|NCT00913835|964620|P2|Lip Dox: Olaratumab Monotherapy|Not Specified|3
292779|NCT00913835|964621|P1|Lip Dox: Olaratumab Monotherapy|Not Specified|0
292780|NCT00913835|964620|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
292781|NCT00913835|964621|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
292782|NCT00913835|964620|P2|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|3
292783|NCT00913835|964621|P1|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|4
292784|NCT00913835|964620|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
292785|NCT00913835|964621|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
292786|NCT00913835|964620|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
292787|NCT00913835|964621|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
292788|NCT00913770|964660|P3|Overall Study|Refused|8
292789|NCT00913770|964661|P2|Overall Study|Refused|10
292790|NCT00913770|964662|P1|Overall Study|Refused|11
292791|NCT00913770|964660|P3|Overall Study|Unable to contact|13
292792|NCT00913770|964661|P2|Overall Study|Unable to contact|19
292793|NCT00913770|964662|P1|Overall Study|Unable to contact|24
292794|NCT00913744|964675|P2|Overall Study|Death|0
292795|NCT00913744|964676|P1|Overall Study|Death|1
292796|NCT00913744|964675|P2|Overall Study|Withdrawal by Subject|1
292797|NCT00913744|964676|P1|Overall Study|Withdrawal by Subject|2
292798|NCT00913744|964675|P2|Overall Study|Adverse Event|0
292799|NCT00913744|964676|P1|Overall Study|Adverse Event|2
292800|NCT00913692|964682|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
292801|NCT00913692|964682|P1|Screening (4 Months)|Not eligible after screening phase.|6
292802|NCT00913692|964682|P1|Screening (4 Months)|Physician Decision|3
292803|NCT00913523|964695|P3|Overall Study|Inadequate Number of Tampons Used|3
292804|NCT00913523|964696|P2|Overall Study|Inadequate Number of Tampons Used|2
292805|NCT00913523|964697|P1|Overall Study|Inadequate Number of Tampons Used|7
292806|NCT00913523|964695|P3|Overall Study|Pregnancy|0
292807|NCT00913523|964696|P2|Overall Study|Pregnancy|3
292808|NCT00913523|964697|P1|Overall Study|Pregnancy|1
292809|NCT00913523|964695|P3|Overall Study|Protocol Violation|8
292810|NCT00913523|964696|P2|Overall Study|Protocol Violation|8
292811|NCT00913523|964697|P1|Overall Study|Protocol Violation|5
292812|NCT00913523|964695|P3|Overall Study|Adverse Event|0
292813|NCT00913523|964696|P2|Overall Study|Adverse Event|0
292814|NCT00913523|964697|P1|Overall Study|Adverse Event|1
292815|NCT00913523|964695|P3|Overall Study|Lost to Follow-up|1
292816|NCT00913523|964696|P2|Overall Study|Lost to Follow-up|1
292817|NCT00913523|964697|P1|Overall Study|Lost to Follow-up|1
292818|NCT00913523|964695|P3|Overall Study|Withdrawal by Subject|2
292819|NCT00913523|964696|P2|Overall Study|Withdrawal by Subject|2
292820|NCT00913523|964697|P1|Overall Study|Withdrawal by Subject|3
292821|NCT00913458|964729|P7|Phase 3|Unsatisfactory Response per Investigator|4
292822|NCT00913458|964730|P6|Phase 3|Unsatisfactory Response per Investigator|11
292823|NCT00913458|964731|P5|Phase 3|Unsatisfactory Response per Investigator|14
292824|NCT00913458|964732|P4|Phase 3|Unsatisfactory Response per Investigator|0
292825|NCT00913458|964733|P3|Phase 3|Unsatisfactory Response per Investigator|0
292826|NCT00913458|964734|P2|Phase 3|Unsatisfactory Response per Investigator|0
292827|NCT00913458|964735|P1|Phase 3|Unsatisfactory Response per Investigator|0
292828|NCT00913458|964729|P7|Phase 3|Withdrawal by Subject|0
292829|NCT00913458|964730|P6|Phase 3|Withdrawal by Subject|2
292830|NCT00913458|964731|P5|Phase 3|Withdrawal by Subject|1
292831|NCT00913458|964732|P4|Phase 3|Withdrawal by Subject|0
292832|NCT00913458|964733|P3|Phase 3|Withdrawal by Subject|0
292833|NCT00913458|964734|P2|Phase 3|Withdrawal by Subject|0
292834|NCT00913458|964735|P1|Phase 3|Withdrawal by Subject|0
292835|NCT00913458|964729|P7|Phase 3|Non-Responder|3
292836|NCT00913458|964730|P6|Phase 3|Non-Responder|1
292837|NCT00913458|964731|P5|Phase 3|Non-Responder|0
292838|NCT00913458|964732|P4|Phase 3|Non-Responder|0
292839|NCT00913458|964733|P3|Phase 3|Non-Responder|0
292840|NCT00913458|964734|P2|Phase 3|Non-Responder|0
292841|NCT00913458|964735|P1|Phase 3|Non-Responder|0
292842|NCT00913458|964729|P7|Phase 3|Lost to Follow-up|0
292843|NCT00913458|964730|P6|Phase 3|Lost to Follow-up|0
292844|NCT00913458|964731|P5|Phase 3|Lost to Follow-up|2
292845|NCT00913458|964732|P4|Phase 3|Lost to Follow-up|0
292846|NCT00913458|964733|P3|Phase 3|Lost to Follow-up|0
292847|NCT00913458|964734|P2|Phase 3|Lost to Follow-up|0
292848|NCT00913458|964735|P1|Phase 3|Lost to Follow-up|0
292849|NCT00913458|964729|P7|Phase 3|Adverse Event|1
292850|NCT00913458|964730|P6|Phase 3|Adverse Event|4
292851|NCT00913458|964731|P5|Phase 3|Adverse Event|5
292852|NCT00913458|964732|P4|Phase 3|Adverse Event|0
292853|NCT00913458|964733|P3|Phase 3|Adverse Event|0
292854|NCT00913458|964734|P2|Phase 3|Adverse Event|0
292855|NCT00913458|964735|P1|Phase 3|Adverse Event|0
292856|NCT00913458|964729|P7|Phase 2|Unsatisfactory Response per Investigator|0
292857|NCT00913458|964730|P6|Phase 2|Unsatisfactory Response per Investigator|0
292858|NCT00913458|964731|P5|Phase 2|Unsatisfactory Response per Investigator|0
292859|NCT00913458|964732|P4|Phase 2|Unsatisfactory Response per Investigator|17
292860|NCT00913458|964733|P3|Phase 2|Unsatisfactory Response per Investigator|11
292861|NCT00913458|964734|P2|Phase 2|Unsatisfactory Response per Investigator|0
292862|NCT00913458|964735|P1|Phase 2|Unsatisfactory Response per Investigator|0
292863|NCT00913458|964729|P7|Phase 2|Protocol Violation|0
292864|NCT00913458|964730|P6|Phase 2|Protocol Violation|0
292865|NCT00913458|964731|P5|Phase 2|Protocol Violation|0
292866|NCT00913458|964732|P4|Phase 2|Protocol Violation|0
292867|NCT00913458|964733|P3|Phase 2|Protocol Violation|0
292868|NCT00913458|964734|P2|Phase 2|Protocol Violation|2
292869|NCT00913458|964735|P1|Phase 2|Protocol Violation|0
292870|NCT00913458|964729|P7|Phase 2|Lost to Follow-up|0
292871|NCT00913458|964730|P6|Phase 2|Lost to Follow-up|0
292872|NCT00913458|964731|P5|Phase 2|Lost to Follow-up|0
292873|NCT00913458|964732|P4|Phase 2|Lost to Follow-up|1
292874|NCT00913458|964733|P3|Phase 2|Lost to Follow-up|0
292875|NCT00913458|964734|P2|Phase 2|Lost to Follow-up|0
292876|NCT00913458|964735|P1|Phase 2|Lost to Follow-up|0
292877|NCT00913458|964729|P7|Phase 2|Adverse Event|0
292878|NCT00913458|964730|P6|Phase 2|Adverse Event|0
292879|NCT00913458|964731|P5|Phase 2|Adverse Event|0
292880|NCT00913458|964732|P4|Phase 2|Adverse Event|1
292881|NCT00913458|964733|P3|Phase 2|Adverse Event|0
292882|NCT00913458|964734|P2|Phase 2|Adverse Event|3
292883|NCT00913458|964735|P1|Phase 2|Adverse Event|0
292884|NCT00913458|964729|P7|Phase 2|Subject Request|0
292885|NCT00913458|964730|P6|Phase 2|Subject Request|0
292886|NCT00913458|964731|P5|Phase 2|Subject Request|0
292887|NCT00913458|964732|P4|Phase 2|Subject Request|2
292888|NCT00913458|964733|P3|Phase 2|Subject Request|1
292889|NCT00913458|964734|P2|Phase 2|Subject Request|0
292890|NCT00913458|964735|P1|Phase 2|Subject Request|0
292891|NCT00913458|964729|P7|Phase 2|Non-Responder|0
292892|NCT00913458|964730|P6|Phase 2|Non-Responder|0
292893|NCT00913458|964731|P5|Phase 2|Non-Responder|0
292894|NCT00913458|964732|P4|Phase 2|Non-Responder|12
292895|NCT00913458|964733|P3|Phase 2|Non-Responder|7
292896|NCT00913458|964734|P2|Phase 2|Non-Responder|5
292897|NCT00913458|964735|P1|Phase 2|Non-Responder|0
292898|NCT00913458|964729|P7|Phase 1|Unsatisfactory Response per Investigator|0
292899|NCT00913458|964730|P6|Phase 1|Unsatisfactory Response per Investigator|0
292900|NCT00913458|964731|P5|Phase 1|Unsatisfactory Response per Investigator|0
292901|NCT00913458|964732|P4|Phase 1|Unsatisfactory Response per Investigator|0
292902|NCT00913458|964733|P3|Phase 1|Unsatisfactory Response per Investigator|0
292903|NCT00913458|964734|P2|Phase 1|Unsatisfactory Response per Investigator|0
292904|NCT00913458|964735|P1|Phase 1|Unsatisfactory Response per Investigator|7
292905|NCT00913458|964729|P7|Phase 1|Sponsor|0
292906|NCT00913458|964730|P6|Phase 1|Sponsor|0
292907|NCT00913458|964731|P5|Phase 1|Sponsor|0
292908|NCT00913458|964732|P4|Phase 1|Sponsor|0
292909|NCT00913458|964733|P3|Phase 1|Sponsor|0
292910|NCT00913458|964734|P2|Phase 1|Sponsor|0
292911|NCT00913458|964735|P1|Phase 1|Sponsor|2
292912|NCT00913458|964729|P7|Phase 1|Protocol Violation|0
292913|NCT00913458|964730|P6|Phase 1|Protocol Violation|0
292914|NCT00913458|964731|P5|Phase 1|Protocol Violation|0
292915|NCT00913458|964732|P4|Phase 1|Protocol Violation|0
292916|NCT00913458|964733|P3|Phase 1|Protocol Violation|0
292917|NCT00913458|964734|P2|Phase 1|Protocol Violation|0
292918|NCT00913458|964735|P1|Phase 1|Protocol Violation|10
292919|NCT00913458|964729|P7|Phase 1|Lost to Follow-up|0
292920|NCT00913458|964730|P6|Phase 1|Lost to Follow-up|0
292921|NCT00913458|964731|P5|Phase 1|Lost to Follow-up|0
292922|NCT00913458|964732|P4|Phase 1|Lost to Follow-up|0
292923|NCT00913458|964733|P3|Phase 1|Lost to Follow-up|0
292924|NCT00913458|964734|P2|Phase 1|Lost to Follow-up|0
292925|NCT00913458|964735|P1|Phase 1|Lost to Follow-up|2
292926|NCT00913458|964729|P7|Phase 1|Adverse Event|0
292927|NCT00913458|964730|P6|Phase 1|Adverse Event|0
292928|NCT00913458|964731|P5|Phase 1|Adverse Event|0
292929|NCT00913458|964732|P4|Phase 1|Adverse Event|0
292930|NCT00913458|964733|P3|Phase 1|Adverse Event|0
292931|NCT00913458|964734|P2|Phase 1|Adverse Event|0
292932|NCT00913458|964735|P1|Phase 1|Adverse Event|20
292933|NCT00913458|964729|P7|Phase 1|Subject Request|0
292934|NCT00913458|964730|P6|Phase 1|Subject Request|0
292935|NCT00913458|964731|P5|Phase 1|Subject Request|0
292936|NCT00913458|964732|P4|Phase 1|Subject Request|0
292937|NCT00913458|964733|P3|Phase 1|Subject Request|0
292938|NCT00913458|964734|P2|Phase 1|Subject Request|0
292939|NCT00913458|964735|P1|Phase 1|Subject Request|17
292940|NCT00913458|964729|P7|Phase 1|Non-Responder|0
292941|NCT00913458|964730|P6|Phase 1|Non-Responder|0
292942|NCT00913458|964731|P5|Phase 1|Non-Responder|0
292943|NCT00913458|964732|P4|Phase 1|Non-Responder|0
292944|NCT00913458|964733|P3|Phase 1|Non-Responder|0
292945|NCT00913458|964734|P2|Phase 1|Non-Responder|0
292946|NCT00913458|964735|P1|Phase 1|Non-Responder|54
292947|NCT00913380|964828|P2|Clinical Outcomes|Lost to Follow-up|6
292948|NCT00913380|964829|P1|Clinical Outcomes|Lost to Follow-up|6
292949|NCT00912964|964895|P3|Overall Study|Randomized but never received study drug|0
292950|NCT00912964|964896|P2|Overall Study|Randomized but never received study drug|1
292951|NCT00912964|964897|P1|Overall Study|Randomized but never received study drug|0
292952|NCT00912964|964895|P3|Overall Study|Violation of exclusion criterion|2
292953|NCT00912964|964896|P2|Overall Study|Violation of exclusion criterion|0
292954|NCT00912964|964897|P1|Overall Study|Violation of exclusion criterion|0
292955|NCT00912964|964895|P3|Overall Study|Non-compliance with study procedures|0
292956|NCT00912964|964896|P2|Overall Study|Non-compliance with study procedures|0
292957|NCT00912964|964897|P1|Overall Study|Non-compliance with study procedures|2
292958|NCT00912964|964895|P3|Overall Study|Medical History|0
292959|NCT00912964|964896|P2|Overall Study|Medical History|0
292960|NCT00912964|964897|P1|Overall Study|Medical History|1
292961|NCT00912964|964895|P3|Overall Study|Taking exclusionary medications|8
292962|NCT00912964|964896|P2|Overall Study|Taking exclusionary medications|4
292963|NCT00912964|964897|P1|Overall Study|Taking exclusionary medications|7
292964|NCT00912964|964895|P3|Overall Study|Protocol Violation|8
292965|NCT00912964|964896|P2|Overall Study|Protocol Violation|3
292966|NCT00912964|964897|P1|Overall Study|Protocol Violation|5
292967|NCT00912964|964895|P3|Overall Study|Lost to Follow-up|3
292968|NCT00912964|964896|P2|Overall Study|Lost to Follow-up|3
292969|NCT00912964|964897|P1|Overall Study|Lost to Follow-up|4
292970|NCT00912964|964895|P3|Overall Study|Withdrawal by Subject|18
292971|NCT00912964|964896|P2|Overall Study|Withdrawal by Subject|12
292972|NCT00912964|964897|P1|Overall Study|Withdrawal by Subject|20
292973|NCT00912964|964895|P3|Overall Study|Lack of Efficacy|3
292974|NCT00912964|964896|P2|Overall Study|Lack of Efficacy|4
292975|NCT00912964|964897|P1|Overall Study|Lack of Efficacy|11
292976|NCT00912964|964895|P3|Overall Study|Adverse Event|12
292977|NCT00912964|964896|P2|Overall Study|Adverse Event|18
292978|NCT00912964|964897|P1|Overall Study|Adverse Event|15
292979|NCT00912964|964895|P3|Overall Study|Eligibility criterion not met|0
292980|NCT00912964|964896|P2|Overall Study|Eligibility criterion not met|1
292981|NCT00912964|964897|P1|Overall Study|Eligibility criterion not met|1
292982|NCT00912912|965040|P1|Overall Study|Disease Progression|3
292983|NCT00912912|965040|P1|Overall Study|Withdrawal by Subject|1
292984|NCT00912782|965072|P2|Overall Study|Relocated before study completion|1
292985|NCT00912782|965073|P1|Overall Study|Relocated before study completion|0
292986|NCT00912782|965072|P2|Overall Study|Did not receive vascular access type|2
292987|NCT00912782|965073|P1|Overall Study|Did not receive vascular access type|1
292988|NCT00912782|965072|P2|Overall Study|Lost to Follow-up|1
292989|NCT00912782|965073|P1|Overall Study|Lost to Follow-up|0
292990|NCT00912782|965072|P2|Overall Study|Death|1
292991|NCT00912782|965073|P1|Overall Study|Death|2
292992|NCT00912743|965083|P2|Overall Study|End of treatment form was not collected|0
292993|NCT00912743|965084|P1|Overall Study|End of treatment form was not collected|1
292994|NCT00912743|965083|P2|Overall Study|Toxicity|1
292995|NCT00912743|965084|P1|Overall Study|Toxicity|0
292996|NCT00912743|965083|P2|Overall Study|Lack of Efficacy|18
292997|NCT00912743|965084|P1|Overall Study|Lack of Efficacy|9
292998|NCT00912743|965083|P2|Overall Study|Adverse Event|1
292999|NCT00912743|965084|P1|Overall Study|Adverse Event|3
293000|NCT00912509|965096|P2|Overall Study|Lack of Efficacy|3
293001|NCT00912509|965097|P1|Overall Study|Lack of Efficacy|4
293002|NCT00912509|965096|P2|Overall Study|Lost to Follow-up|0
293003|NCT00912509|965097|P1|Overall Study|Lost to Follow-up|1
293004|NCT00912405|965103|P1|Overall Study|Lost to Follow-up|5
293005|NCT00912288|965137|P2|Overall Study|Unspecified|0
293006|NCT00912288|965138|P1|Overall Study|Unspecified|1
293007|NCT00912288|965137|P2|Overall Study|Study terminated by sponsor|35
293008|NCT00912288|965138|P1|Overall Study|Study terminated by sponsor|34
293009|NCT00912288|965137|P2|Overall Study|Withdrawal by Subject|3
293010|NCT00912288|965138|P1|Overall Study|Withdrawal by Subject|3
293011|NCT00912288|965137|P2|Overall Study|Protocol Violation|0
293012|NCT00912288|965138|P1|Overall Study|Protocol Violation|1
293013|NCT00912288|965137|P2|Overall Study|Lost to Follow-up|0
293014|NCT00912288|965138|P1|Overall Study|Lost to Follow-up|1
293015|NCT00912288|965137|P2|Overall Study|Adverse Event|1
293016|NCT00912288|965138|P1|Overall Study|Adverse Event|1
293017|NCT00912288|965137|P2|Overall Study|Death|1
293018|NCT00912288|965138|P1|Overall Study|Death|0
293019|NCT00912223|965160|P1|Overall Study|Transformed disease|1
293020|NCT00912223|965160|P1|Overall Study|Not transplanted|1
293021|NCT00912223|965160|P1|Overall Study|Withdrawal by Subject|1
293022|NCT00912093|965191|P5|The Controlled Phase|Lost to Follow-up|1
293023|NCT00912093|965192|P4|The Controlled Phase|Lost to Follow-up|0
293024|NCT00912093|965193|P3|The Controlled Phase|Lost to Follow-up|0
293025|NCT00912093|965194|P2|The Controlled Phase|Lost to Follow-up|0
293026|NCT00912093|965195|P1|The Controlled Phase|Lost to Follow-up|0
293027|NCT00912093|965191|P5|The Controlled Phase|Medical Condition|0
293028|NCT00912093|965192|P4|The Controlled Phase|Medical Condition|0
293029|NCT00912093|965193|P3|The Controlled Phase|Medical Condition|0
293030|NCT00912093|965194|P2|The Controlled Phase|Medical Condition|1
293031|NCT00912093|965195|P1|The Controlled Phase|Medical Condition|0
293032|NCT00912093|965191|P5|The Controlled Phase|Death|0
293033|NCT00912093|965192|P4|The Controlled Phase|Death|0
293034|NCT00912093|965193|P3|The Controlled Phase|Death|0
293035|NCT00912093|965194|P2|The Controlled Phase|Death|1
293036|NCT00912093|965195|P1|The Controlled Phase|Death|0
293037|NCT00912028|965214|P5|Overall Study|Withdrawal by Subject|0
293038|NCT00912028|965215|P4|Overall Study|Withdrawal by Subject|0
293039|NCT00912028|965216|P3|Overall Study|Withdrawal by Subject|0
293040|NCT00912028|965217|P2|Overall Study|Withdrawal by Subject|0
293041|NCT00912028|965218|P1|Overall Study|Withdrawal by Subject|3
293042|NCT00912028|965214|P5|Overall Study|Lost to Follow-up|3
293043|NCT00912028|965215|P4|Overall Study|Lost to Follow-up|1
293044|NCT00912028|965216|P3|Overall Study|Lost to Follow-up|0
293045|NCT00912028|965217|P2|Overall Study|Lost to Follow-up|3
293046|NCT00912028|965218|P1|Overall Study|Lost to Follow-up|2
293047|NCT00912015|965247|P4|Overall Study|Adverse Event|1
293048|NCT00912015|965248|P3|Overall Study|Adverse Event|0
293049|NCT00912015|965249|P2|Overall Study|Adverse Event|0
293050|NCT00912015|965250|P1|Overall Study|Adverse Event|6
293051|NCT00912015|965247|P4|Overall Study|Protocol Violation|1
293052|NCT00912015|965248|P3|Overall Study|Protocol Violation|0
293053|NCT00912015|965249|P2|Overall Study|Protocol Violation|0
293054|NCT00912015|965250|P1|Overall Study|Protocol Violation|1
293055|NCT00912015|965247|P4|Overall Study|Withdrawal by Subject|0
293056|NCT00912015|965248|P3|Overall Study|Withdrawal by Subject|3
293057|NCT00912015|965249|P2|Overall Study|Withdrawal by Subject|8
293058|NCT00912015|965250|P1|Overall Study|Withdrawal by Subject|8
293059|NCT00912015|965247|P4|Overall Study|Lack of Efficacy|0
293060|NCT00912015|965248|P3|Overall Study|Lack of Efficacy|0
293061|NCT00912015|965249|P2|Overall Study|Lack of Efficacy|0
293062|NCT00912015|965250|P1|Overall Study|Lack of Efficacy|1
293063|NCT00911989|965266|P1|Overall Study|Adverse Event|1
293064|NCT00911937|965272|P2|Overall Study|Unspecified|5
293065|NCT00911937|965273|P1|Overall Study|Unspecified|9
293066|NCT00911937|965272|P2|Overall Study|Randomized but not treated|13
293067|NCT00911937|965273|P1|Overall Study|Randomized but not treated|13
293068|NCT00911937|965272|P2|Overall Study|Protocol Violation|23
293069|NCT00911937|965273|P1|Overall Study|Protocol Violation|14
293070|NCT00911937|965272|P2|Overall Study|Did not meet inclusion criteria|11
293071|NCT00911937|965273|P1|Overall Study|Did not meet inclusion criteria|9
293072|NCT00911937|965272|P2|Overall Study|Lack of Efficacy|6
293073|NCT00911937|965273|P1|Overall Study|Lack of Efficacy|11
293074|NCT00911937|965272|P2|Overall Study|Adverse Event|25
293075|NCT00911937|965273|P1|Overall Study|Adverse Event|11
293076|NCT00911937|965272|P2|Overall Study|Withdrawn due to pregnancy|0
293077|NCT00911937|965273|P1|Overall Study|Withdrawn due to pregnancy|1
293078|NCT00911937|965272|P2|Overall Study|Withdrawal by Subject|7
293079|NCT00911937|965273|P1|Overall Study|Withdrawal by Subject|10
293080|NCT00911937|965272|P2|Overall Study|Lost to Follow-up|5
293081|NCT00911937|965273|P1|Overall Study|Lost to Follow-up|8
293082|NCT00911937|965272|P2|Overall Study|Death|0
293083|NCT00911937|965273|P1|Overall Study|Death|1
293084|NCT00911859|965340|P3|Follow-up Period|Study terminated by sponsor|27
293085|NCT00911859|965341|P2|Follow-up Period|Study terminated by sponsor|33
293086|NCT00911859|965342|P1|Follow-up Period|Study terminated by sponsor|5
293087|NCT00911859|965340|P3|Follow-up Period|Withdrawal by Subject|4
293088|NCT00911859|965341|P2|Follow-up Period|Withdrawal by Subject|4
293089|NCT00911859|965342|P1|Follow-up Period|Withdrawal by Subject|0
293090|NCT00911859|965340|P3|Follow-up Period|Lost to Follow-up|0
293091|NCT00911859|965341|P2|Follow-up Period|Lost to Follow-up|1
293092|NCT00911859|965342|P1|Follow-up Period|Lost to Follow-up|1
293093|NCT00911859|965340|P3|Follow-up Period|Death|10
293094|NCT00911859|965341|P2|Follow-up Period|Death|8
293095|NCT00911859|965342|P1|Follow-up Period|Death|5
293096|NCT00911859|965340|P3|Maintainance Period|Withdrawal by Subject|3
293097|NCT00911859|965341|P2|Maintainance Period|Withdrawal by Subject|0
293098|NCT00911859|965342|P1|Maintainance Period|Withdrawal by Subject|0
293099|NCT00911859|965340|P3|Maintainance Period|Physician Decision|9
293100|NCT00911859|965341|P2|Maintainance Period|Physician Decision|0
293101|NCT00911859|965342|P1|Maintainance Period|Physician Decision|0
293102|NCT00911859|965340|P3|Maintainance Period|Lack of Efficacy|9
293103|NCT00911859|965341|P2|Maintainance Period|Lack of Efficacy|0
293104|NCT00911859|965342|P1|Maintainance Period|Lack of Efficacy|0
293105|NCT00911859|965340|P3|Treatment Period|Did not receive study treatment|0
293106|NCT00911859|965341|P2|Treatment Period|Did not receive study treatment|1
293107|NCT00911859|965342|P1|Treatment Period|Did not receive study treatment|0
293108|NCT00911859|965340|P3|Treatment Period|Withdrawal by Subject|5
293109|NCT00911859|965341|P2|Treatment Period|Withdrawal by Subject|4
293110|NCT00911859|965342|P1|Treatment Period|Withdrawal by Subject|0
293111|NCT00911859|965340|P3|Treatment Period|Physician Decision|3
293112|NCT00911859|965341|P2|Treatment Period|Physician Decision|3
293113|NCT00911859|965342|P1|Treatment Period|Physician Decision|3
293114|NCT00911859|965340|P3|Treatment Period|Lack of Efficacy|5
293115|NCT00911859|965341|P2|Treatment Period|Lack of Efficacy|7
293116|NCT00911859|965342|P1|Treatment Period|Lack of Efficacy|1
293117|NCT00911859|965340|P3|Treatment Period|Death|5
293118|NCT00911859|965341|P2|Treatment Period|Death|3
293119|NCT00911859|965342|P1|Treatment Period|Death|1
293120|NCT00911859|965340|P3|Treatment Period|Adverse Event|7
293121|NCT00911859|965341|P2|Treatment Period|Adverse Event|3
293122|NCT00911859|965342|P1|Treatment Period|Adverse Event|3
293123|NCT00911807|965369|P3|Overall Study|Organizational reasons|1
293124|NCT00911807|965370|P2|Overall Study|Organizational reasons|3
293125|NCT00911807|965371|P1|Overall Study|Organizational reasons|1
293126|NCT00911807|965369|P3|Overall Study|Withdrawal by Subject|7
293127|NCT00911807|965370|P2|Overall Study|Withdrawal by Subject|10
293128|NCT00911807|965371|P1|Overall Study|Withdrawal by Subject|8
293129|NCT00911807|965369|P3|Overall Study|Protocol Violation|9
293130|NCT00911807|965370|P2|Overall Study|Protocol Violation|4
293131|NCT00911807|965371|P1|Overall Study|Protocol Violation|6
293132|NCT00911807|965369|P3|Overall Study|Death|1
293133|NCT00911807|965370|P2|Overall Study|Death|0
293134|NCT00911807|965371|P1|Overall Study|Death|0
293135|NCT00911807|965369|P3|Overall Study|Adverse Event|5
293136|NCT00911807|965370|P2|Overall Study|Adverse Event|1
293137|NCT00911807|965371|P1|Overall Study|Adverse Event|2
293138|NCT00911768|965381|P2|Overall Study|Withdrawal by Subject|0
293139|NCT00911768|965382|P1|Overall Study|Withdrawal by Subject|1
293140|NCT00911768|965381|P2|Overall Study|Protocol Violation|4
293141|NCT00911768|965382|P1|Overall Study|Protocol Violation|5
293142|NCT00911625|965411|P2|Overall Study|Lost to Follow-up|0
293143|NCT00911625|965412|P1|Overall Study|Lost to Follow-up|7
293144|NCT00911547|965441|P4|Overall Study|Withdrawal by Subject|8
293145|NCT00911547|965442|P3|Overall Study|Withdrawal by Subject|4
293146|NCT00911547|965443|P2|Overall Study|Withdrawal by Subject|10
293147|NCT00911547|965444|P1|Overall Study|Withdrawal by Subject|3
293148|NCT00911547|965441|P4|Overall Study|Protocol Violation|1
293149|NCT00911547|965442|P3|Overall Study|Protocol Violation|5
293150|NCT00911547|965443|P2|Overall Study|Protocol Violation|5
293151|NCT00911547|965444|P1|Overall Study|Protocol Violation|0
293152|NCT00911547|965441|P4|Overall Study|Lost to Follow-up|1
293153|NCT00911547|965442|P3|Overall Study|Lost to Follow-up|2
293154|NCT00911547|965443|P2|Overall Study|Lost to Follow-up|0
293155|NCT00911547|965444|P1|Overall Study|Lost to Follow-up|0
293156|NCT00911547|965441|P4|Overall Study|Adverse Event|6
293157|NCT00911547|965442|P3|Overall Study|Adverse Event|11
293158|NCT00911547|965443|P2|Overall Study|Adverse Event|27
293159|NCT00911547|965444|P1|Overall Study|Adverse Event|8
293160|NCT00911534|965472|P2|Overall Study|Not specified|2
293161|NCT00911534|965473|P1|Overall Study|Not specified|2
293162|NCT00911534|965472|P2|Overall Study|Withdrawal of consent|4
293163|NCT00911534|965473|P1|Overall Study|Withdrawal of consent|1
293164|NCT00911534|965472|P2|Overall Study|Lack of Efficacy|1
293165|NCT00911534|965473|P1|Overall Study|Lack of Efficacy|4
293166|NCT00911534|965472|P2|Overall Study|Withdrawal by Subject|1
293167|NCT00911534|965473|P1|Overall Study|Withdrawal by Subject|2
293168|NCT00911534|965472|P2|Overall Study|Lost to Follow-up|4
293169|NCT00911534|965473|P1|Overall Study|Lost to Follow-up|2
293170|NCT00911534|965472|P2|Overall Study|Adverse Event|4
293171|NCT00911534|965473|P1|Overall Study|Adverse Event|4
293172|NCT00911300|965528|P2|Overall Study|Randomized; No Study Medication Received|2
293173|NCT00911300|965529|P1|Overall Study|Randomized; No Study Medication Received|0
293174|NCT00911300|965528|P2|Overall Study|Treatment Stopped by Mistake|1
293175|NCT00911300|965529|P1|Overall Study|Treatment Stopped by Mistake|0
293176|NCT00911300|965528|P2|Overall Study|Physician Decision|1
293177|NCT00911300|965529|P1|Overall Study|Physician Decision|0
293178|NCT00911300|965528|P2|Overall Study|Underlying Disease (Myocarditis)|1
293179|NCT00911300|965529|P1|Overall Study|Underlying Disease (Myocarditis)|0
293180|NCT00911300|965528|P2|Overall Study|Participant Refused Hospital Consulation|1
293181|NCT00911300|965529|P1|Overall Study|Participant Refused Hospital Consulation|0
293182|NCT00911300|965528|P2|Overall Study|International Normalized Ratio Too High|1
293183|NCT00911300|965529|P1|Overall Study|International Normalized Ratio Too High|0
293184|NCT00911300|965528|P2|Overall Study|Investigator's Decision; New AF Episode|1
293185|NCT00911300|965529|P1|Overall Study|Investigator's Decision; New AF Episode|0
293186|NCT00911300|965528|P2|Overall Study|Participant Could Not Stay in Hospital|1
293187|NCT00911300|965529|P1|Overall Study|Participant Could Not Stay in Hospital|0
293188|NCT00911300|965528|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
293189|NCT00911300|965529|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
293190|NCT00911300|965528|P2|Overall Study|Nurse Unavailable in Participant's City|0
293191|NCT00911300|965529|P1|Overall Study|Nurse Unavailable in Participant's City|1
293192|NCT00911300|965528|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
293193|NCT00911300|965529|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
293194|NCT00911300|965528|P2|Overall Study|Recurrent Tachyarrhythmia|1
293195|NCT00911300|965529|P1|Overall Study|Recurrent Tachyarrhythmia|1
293196|NCT00911300|965528|P2|Overall Study|Received Commercial Treatment|0
293197|NCT00911300|965529|P1|Overall Study|Received Commercial Treatment|1
293198|NCT00911300|965528|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
293199|NCT00911300|965529|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
293200|NCT00911300|965528|P2|Overall Study|Coronary Angiography Performed|0
293201|NCT00911300|965529|P1|Overall Study|Coronary Angiography Performed|1
293202|NCT00911300|965528|P2|Overall Study|Consent Withdrawn|12
293203|NCT00911300|965529|P1|Overall Study|Consent Withdrawn|4
293204|NCT00911300|965528|P2|Overall Study|Protocol Violation|2
293205|NCT00911300|965529|P1|Overall Study|Protocol Violation|3
293206|NCT00911300|965528|P2|Overall Study|Adverse Event|6
293207|NCT00911300|965529|P1|Overall Study|Adverse Event|14
293208|NCT00911300|965528|P2|Overall Study|Thrombus Persistant in Second TEE|7
293209|NCT00911300|965529|P1|Overall Study|Thrombus Persistant in Second TEE|3
293210|NCT00911300|965528|P2|Overall Study|Death|0
293211|NCT00911300|965529|P1|Overall Study|Death|1
293212|NCT00911300|965528|P2|Overall Study|Primary Endpoint Component Occurred|2
293213|NCT00911300|965529|P1|Overall Study|Primary Endpoint Component Occurred|1
293214|NCT00911170|965566|P2|Long Term Follow-Up|Death|121
293215|NCT00911170|965567|P1|Long Term Follow-Up|Death|116
293216|NCT00911170|965566|P2|Long Term Follow-Up|Lost to Follow-up|7
293217|NCT00911170|965567|P1|Long Term Follow-Up|Lost to Follow-up|8
293218|NCT00911170|965566|P2|Long Term Follow-Up|Physician Decision|4
293219|NCT00911170|965567|P1|Long Term Follow-Up|Physician Decision|5
293220|NCT00911170|965566|P2|Long Term Follow-Up|Withdrawal by Subject|21
293221|NCT00911170|965567|P1|Long Term Follow-Up|Withdrawal by Subject|20
293222|NCT00911170|965566|P2|Long Term Follow-Up|Continuing in study|269
293223|NCT00911170|965567|P1|Long Term Follow-Up|Continuing in study|274
293224|NCT00911170|965566|P2|Treatment Period|Death|9
293225|NCT00911170|965567|P1|Treatment Period|Death|6
293226|NCT00911170|965566|P2|Treatment Period|Lost to Follow-up|1
293227|NCT00911170|965567|P1|Treatment Period|Lost to Follow-up|0
293228|NCT00911170|965566|P2|Treatment Period|Physician Decision|5
293229|NCT00911170|965567|P1|Treatment Period|Physician Decision|5
293230|NCT00911170|965566|P2|Treatment Period|Disease progression|2
293231|NCT00911170|965567|P1|Treatment Period|Disease progression|0
293232|NCT00911170|965566|P2|Treatment Period|Withdrawal by Subject|4
293233|NCT00911170|965567|P1|Treatment Period|Withdrawal by Subject|4
293234|NCT00911170|965566|P2|Treatment Period|Adverse Event|10
293235|NCT00911170|965567|P1|Treatment Period|Adverse Event|9
293236|NCT00911170|965566|P2|Treatment Period|Protocol deviation|2
293237|NCT00911170|965567|P1|Treatment Period|Protocol deviation|1
293238|NCT00911170|965566|P2|Treatment Period|Ineligibility determined|3
293239|NCT00911170|965567|P1|Treatment Period|Ineligibility determined|1
293240|NCT00911170|965566|P2|Treatment Period|Randomized in error|1
293241|NCT00911170|965567|P1|Treatment Period|Randomized in error|1
293242|NCT00911157|965591|P2|Overall Study|Need to treat for lung cancer|0
293243|NCT00911157|965592|P1|Overall Study|Need to treat for lung cancer|1
293244|NCT00911157|965591|P2|Overall Study|Need for prohibited drug (heparin)|0
293245|NCT00911157|965592|P1|Overall Study|Need for prohibited drug (heparin)|1
293246|NCT00911157|965591|P2|Overall Study|Withdrawal by Subject|1
293247|NCT00911157|965592|P1|Overall Study|Withdrawal by Subject|1
293248|NCT00911157|965591|P2|Overall Study|Adverse Event|1
293249|NCT00911157|965592|P1|Overall Study|Adverse Event|4
293250|NCT00911144|965608|P2|Overall Study|Withdrawal by Subject|5
293251|NCT00911144|965609|P1|Overall Study|Withdrawal by Subject|16
293252|NCT00910988|965637|P4|Overall Study|Lost to Follow-up|0
293253|NCT00910988|965638|P3|Overall Study|Lost to Follow-up|3
293254|NCT00910988|965639|P2|Overall Study|Lost to Follow-up|4
293255|NCT00910988|965640|P1|Overall Study|Lost to Follow-up|2
293256|NCT00910910|965684|P2|Overall Study|Untreated before cycle 1|2
293257|NCT00910910|965685|P1|Overall Study|Untreated before cycle 1|1
293258|NCT00910910|965684|P2|Overall Study|Unspecified|32
293259|NCT00910910|965685|P1|Overall Study|Unspecified|114
293260|NCT00910910|965684|P2|Overall Study|Completed 13 cycles of treatment|118
293261|NCT00910910|965685|P1|Overall Study|Completed 13 cycles of treatment|0
293262|NCT00910910|965684|P2|Overall Study|Protocol Violation|2
293263|NCT00910910|965685|P1|Overall Study|Protocol Violation|2
293264|NCT00910910|965684|P2|Overall Study|Death|3
293265|NCT00910910|965685|P1|Overall Study|Death|9
293266|NCT00910910|965684|P2|Overall Study|Lost to Follow-up|2
293267|NCT00910910|965685|P1|Overall Study|Lost to Follow-up|2
293268|NCT00910910|965684|P2|Overall Study|Withdrawal by Subject|5
293269|NCT00910910|965685|P1|Overall Study|Withdrawal by Subject|7
293270|NCT00910910|965684|P2|Overall Study|PD with histologic change|2
293271|NCT00910910|965685|P1|Overall Study|PD with histologic change|0
293272|NCT00910910|965684|P2|Overall Study|PD without histologic change|23
293273|NCT00910910|965685|P1|Overall Study|PD without histologic change|27
293274|NCT00910910|965684|P2|Overall Study|Adverse Event|35
293275|NCT00910910|965685|P1|Overall Study|Adverse Event|63
293276|NCT00910871|965719|P1|Overall Study|Undefined|1
293277|NCT00910871|965719|P1|Overall Study|Subject didn’t meet eligibility criteria|5
293278|NCT00910871|965719|P1|Overall Study|Withdrawal by Subject|12
293279|NCT00910871|965719|P1|Overall Study|Protocol Violation|11
293280|NCT00910871|965719|P1|Overall Study|Lost to Follow-up|8
293281|NCT00910871|965719|P1|Overall Study|Death|12
293282|NCT00910871|965719|P1|Overall Study|Adverse Event|5
293283|NCT00910858|965727|P3|Combined Treatment Phase|Other|1
293284|NCT00910858|965728|P2|Combined Treatment Phase|Other|2
293285|NCT00910858|965729|P1|Combined Treatment Phase|Other|0
293286|NCT00910858|965727|P3|Combined Treatment Phase|Protocol Violation|0
293287|NCT00910858|965728|P2|Combined Treatment Phase|Protocol Violation|0
293288|NCT00910858|965729|P1|Combined Treatment Phase|Protocol Violation|1
293289|NCT00910858|965727|P3|Combined Treatment Phase|Withdrawal by Subject|0
293290|NCT00910858|965728|P2|Combined Treatment Phase|Withdrawal by Subject|2
293291|NCT00910858|965729|P1|Combined Treatment Phase|Withdrawal by Subject|0
293292|NCT00910858|965727|P3|Combined Treatment Phase|Lack of therapeutic effect|3
293293|NCT00910858|965728|P2|Combined Treatment Phase|Lack of therapeutic effect|6
293294|NCT00910858|965729|P1|Combined Treatment Phase|Lack of therapeutic effect|8
293295|NCT00910858|965727|P3|Monotherapy Phase|Other|2
293296|NCT00910858|965728|P2|Monotherapy Phase|Other|4
293297|NCT00910858|965729|P1|Monotherapy Phase|Other|3
293298|NCT00910858|965727|P3|Monotherapy Phase|Protocol Violation|0
293299|NCT00910858|965728|P2|Monotherapy Phase|Protocol Violation|0
293300|NCT00910858|965729|P1|Monotherapy Phase|Protocol Violation|1
293301|NCT00910858|965727|P3|Monotherapy Phase|Withdrawal by Subject|1
293302|NCT00910858|965728|P2|Monotherapy Phase|Withdrawal by Subject|3
293303|NCT00910858|965729|P1|Monotherapy Phase|Withdrawal by Subject|1
293304|NCT00910858|965727|P3|Monotherapy Phase|Lack of therapeutic effect|4
293305|NCT00910858|965728|P2|Monotherapy Phase|Lack of therapeutic effect|6
293306|NCT00910858|965729|P1|Monotherapy Phase|Lack of therapeutic effect|9
293307|NCT00910858|965727|P3|Monotherapy Phase|Adverse Event|0
293308|NCT00910858|965728|P2|Monotherapy Phase|Adverse Event|2
293309|NCT00910858|965729|P1|Monotherapy Phase|Adverse Event|3
293310|NCT00910858|965727|P3|Pharmacokinetic Phase|Adverse Event|0
293311|NCT00910858|965728|P2|Pharmacokinetic Phase|Adverse Event|0
293312|NCT00910858|965729|P1|Pharmacokinetic Phase|Adverse Event|1
293313|NCT00910728|965774|P9|Overall Study|Adverse Event|1
293314|NCT00910728|965775|P8|Overall Study|Adverse Event|1
293315|NCT00910728|965776|P7|Overall Study|Adverse Event|2
293316|NCT00910728|965777|P6|Overall Study|Adverse Event|0
293317|NCT00910728|965778|P5|Overall Study|Adverse Event|0
293318|NCT00910728|965779|P4|Overall Study|Adverse Event|1
293319|NCT00910728|965780|P3|Overall Study|Adverse Event|1
293320|NCT00910728|965781|P2|Overall Study|Adverse Event|0
293321|NCT00910728|965782|P1|Overall Study|Adverse Event|2
293322|NCT00910728|965774|P9|Overall Study|(not specified)|0
293323|NCT00910728|965775|P8|Overall Study|(not specified)|0
293324|NCT00910728|965776|P7|Overall Study|(not specified)|0
293325|NCT00910728|965777|P6|Overall Study|(not specified)|0
293326|NCT00910728|965778|P5|Overall Study|(not specified)|1
293327|NCT00910728|965779|P4|Overall Study|(not specified)|0
293328|NCT00910728|965780|P3|Overall Study|(not specified)|1
293329|NCT00910728|965781|P2|Overall Study|(not specified)|0
293330|NCT00910728|965782|P1|Overall Study|(not specified)|2
293331|NCT00910728|965774|P9|Overall Study|Withdrawal by Subject|0
293332|NCT00910728|965775|P8|Overall Study|Withdrawal by Subject|0
293333|NCT00910728|965776|P7|Overall Study|Withdrawal by Subject|2
293334|NCT00910728|965777|P6|Overall Study|Withdrawal by Subject|1
293335|NCT00910728|965778|P5|Overall Study|Withdrawal by Subject|3
293336|NCT00910728|965779|P4|Overall Study|Withdrawal by Subject|0
293337|NCT00910728|965780|P3|Overall Study|Withdrawal by Subject|0
293338|NCT00910728|965781|P2|Overall Study|Withdrawal by Subject|0
293339|NCT00910728|965782|P1|Overall Study|Withdrawal by Subject|0
293340|NCT00910728|965774|P9|Overall Study|Lack of Efficacy|2
293341|NCT00910728|965775|P8|Overall Study|Lack of Efficacy|2
293342|NCT00910728|965776|P7|Overall Study|Lack of Efficacy|2
293343|NCT00910728|965777|P6|Overall Study|Lack of Efficacy|0
293344|NCT00910728|965778|P5|Overall Study|Lack of Efficacy|1
293345|NCT00910728|965779|P4|Overall Study|Lack of Efficacy|2
293346|NCT00910728|965780|P3|Overall Study|Lack of Efficacy|1
293347|NCT00910728|965781|P2|Overall Study|Lack of Efficacy|3
293348|NCT00910728|965782|P1|Overall Study|Lack of Efficacy|2
293349|NCT00910715|965904|P3|Overall Study|Lost to Follow-up|0
293350|NCT00910715|965905|P2|Overall Study|Lost to Follow-up|26
293351|NCT00910715|965906|P1|Overall Study|Lost to Follow-up|22
293352|NCT00910689|965920|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
293353|NCT00910689|965921|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
293354|NCT00910689|965922|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
293355|NCT00910689|965923|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
293356|NCT00910689|965920|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
293357|NCT00910689|965921|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
293358|NCT00910689|965922|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
293359|NCT00910689|965923|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
293360|NCT00910689|965920|P4|Months 11- 16: Evaluation Period II|Time Demands|0
293361|NCT00910689|965921|P3|Months 11- 16: Evaluation Period II|Time Demands|0
293362|NCT00910689|965922|P2|Months 11- 16: Evaluation Period II|Time Demands|1
293363|NCT00910689|965923|P1|Months 11- 16: Evaluation Period II|Time Demands|2
293364|NCT00910689|965920|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
293365|NCT00910689|965921|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
293366|NCT00910689|965922|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
293367|NCT00910689|965923|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
293368|NCT00910689|965920|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
293369|NCT00910689|965921|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
293370|NCT00910689|965922|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
293371|NCT00910689|965923|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
293372|NCT00910689|965920|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
293373|NCT00910689|965921|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
293374|NCT00910689|965922|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
293375|NCT00910689|965923|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
293376|NCT00910689|965920|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
293377|NCT00910689|965921|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
293378|NCT00910689|965922|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
293379|NCT00910689|965923|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
293380|NCT00910689|965920|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
293381|NCT00910689|965921|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
293382|NCT00910689|965922|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
293383|NCT00910689|965923|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
293384|NCT00910689|965920|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
293385|NCT00910689|965921|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
293386|NCT00910689|965922|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
293387|NCT00910689|965923|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
293388|NCT00910689|965920|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
293389|NCT00910689|965921|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
293390|NCT00910689|965922|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
293391|NCT00910689|965923|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
293392|NCT00910689|965920|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
293393|NCT00910689|965921|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
293394|NCT00910689|965922|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
293395|NCT00910689|965923|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
293396|NCT00910689|965920|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
293397|NCT00910689|965921|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
293398|NCT00910689|965922|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
293399|NCT00910689|965923|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
293400|NCT00910689|965920|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
293401|NCT00910689|965921|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
293402|NCT00910689|965922|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
293403|NCT00910689|965923|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
293404|NCT00910689|965920|P4|Month 2- 4: Treatment Period|Protocol Violation|0
293405|NCT00910689|965921|P3|Month 2- 4: Treatment Period|Protocol Violation|0
293406|NCT00910689|965922|P2|Month 2- 4: Treatment Period|Protocol Violation|0
293407|NCT00910689|965923|P1|Month 2- 4: Treatment Period|Protocol Violation|1
293408|NCT00910689|965920|P4|Month 2- 4: Treatment Period|Pregnancy|0
293409|NCT00910689|965921|P3|Month 2- 4: Treatment Period|Pregnancy|0
293410|NCT00910689|965922|P2|Month 2- 4: Treatment Period|Pregnancy|2
293411|NCT00910689|965923|P1|Month 2- 4: Treatment Period|Pregnancy|0
293412|NCT00910689|965920|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
293413|NCT00910689|965921|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
293414|NCT00910689|965922|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
293415|NCT00910689|965923|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
293416|NCT00910689|965920|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
293417|NCT00910689|965921|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
293418|NCT00910689|965922|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
293419|NCT00910689|965923|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
293420|NCT00910689|965920|P4|Month 2- 4: Treatment Period|Time Demands|8
293421|NCT00910689|965921|P3|Month 2- 4: Treatment Period|Time Demands|4
293422|NCT00910689|965922|P2|Month 2- 4: Treatment Period|Time Demands|0
293423|NCT00910689|965923|P1|Month 2- 4: Treatment Period|Time Demands|1
293424|NCT00910689|965920|P4|Month 2- 4: Treatment Period|Adverse Event|0
293425|NCT00910689|965921|P3|Month 2- 4: Treatment Period|Adverse Event|2
293426|NCT00910689|965922|P2|Month 2- 4: Treatment Period|Adverse Event|3
293427|NCT00910689|965923|P1|Month 2- 4: Treatment Period|Adverse Event|2
293428|NCT00910689|965920|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
293429|NCT00910689|965921|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
293430|NCT00910689|965922|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
293431|NCT00910689|965923|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
293432|NCT00910689|965920|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
293433|NCT00910689|965921|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
293434|NCT00910689|965922|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
293435|NCT00910689|965923|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
293436|NCT00910663|965955|P2|Period 1|Withdrawal by Subject|1
293437|NCT00910663|965956|P1|Period 1|Withdrawal by Subject|0
293438|NCT00910624|965970|P4|Follow-Up Phase|Administrative|0
293439|NCT00910624|965971|P3|Follow-Up Phase|Administrative|1
293440|NCT00910624|965972|P2|Follow-Up Phase|Administrative|1
293441|NCT00910624|965973|P1|Follow-Up Phase|Administrative|0
293442|NCT00910624|965970|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
293443|NCT00910624|965971|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
293444|NCT00910624|965972|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
293445|NCT00910624|965973|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
293446|NCT00910624|965970|P4|Follow-Up Phase|Withdrawal by Subject|0
293447|NCT00910624|965971|P3|Follow-Up Phase|Withdrawal by Subject|0
293448|NCT00910624|965972|P2|Follow-Up Phase|Withdrawal by Subject|0
293449|NCT00910624|965973|P1|Follow-Up Phase|Withdrawal by Subject|1
293450|NCT00910624|965970|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
293451|NCT00910624|965971|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
293452|NCT00910624|965972|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
293453|NCT00910624|965973|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
293454|NCT00910624|965970|P4|Follow-Up Phase|Lost to Follow-up|0
293455|NCT00910624|965971|P3|Follow-Up Phase|Lost to Follow-up|2
293456|NCT00910624|965972|P2|Follow-Up Phase|Lost to Follow-up|1
293457|NCT00910624|965973|P1|Follow-Up Phase|Lost to Follow-up|3
293458|NCT00910624|965970|P4|Follow-Up Phase|Adverse Event|0
293459|NCT00910624|965971|P3|Follow-Up Phase|Adverse Event|1
293460|NCT00910624|965972|P2|Follow-Up Phase|Adverse Event|0
293461|NCT00910624|965973|P1|Follow-Up Phase|Adverse Event|0
293462|NCT00910624|965970|P4|Treatment Phase|Non-Compliance With Protocol|0
293463|NCT00910624|965971|P3|Treatment Phase|Non-Compliance With Protocol|1
293464|NCT00910624|965972|P2|Treatment Phase|Non-Compliance With Protocol|1
293465|NCT00910624|965973|P1|Treatment Phase|Non-Compliance With Protocol|0
293466|NCT00910624|965970|P4|Treatment Phase|Withdrawal by Subject|0
293467|NCT00910624|965971|P3|Treatment Phase|Withdrawal by Subject|0
293468|NCT00910624|965972|P2|Treatment Phase|Withdrawal by Subject|1
293469|NCT00910624|965973|P1|Treatment Phase|Withdrawal by Subject|2
293470|NCT00910624|965970|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
293471|NCT00910624|965971|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
293472|NCT00910624|965972|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
293473|NCT00910624|965973|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
293474|NCT00910624|965970|P4|Treatment Phase|Lost to Follow-up|0
293475|NCT00910624|965971|P3|Treatment Phase|Lost to Follow-up|1
293476|NCT00910624|965972|P2|Treatment Phase|Lost to Follow-up|0
293477|NCT00910624|965973|P1|Treatment Phase|Lost to Follow-up|0
293478|NCT00910624|965970|P4|Treatment Phase|Treatment Failure|0
293479|NCT00910624|965971|P3|Treatment Phase|Treatment Failure|0
293480|NCT00910624|965972|P2|Treatment Phase|Treatment Failure|10
293481|NCT00910624|965973|P1|Treatment Phase|Treatment Failure|23
293482|NCT00910624|965970|P4|Treatment Phase|Adverse Event|0
293483|NCT00910624|965971|P3|Treatment Phase|Adverse Event|6
293484|NCT00910624|965972|P2|Treatment Phase|Adverse Event|6
293485|NCT00910624|965973|P1|Treatment Phase|Adverse Event|2
293486|NCT00910299|966000|P2|Overall Study|Didn't receive any study drug|1
293487|NCT00910299|966001|P1|Overall Study|Didn't receive any study drug|2
293488|NCT00910299|966000|P2|Overall Study|Sponsor Decision|60
293489|NCT00910299|966001|P1|Overall Study|Sponsor Decision|58
293490|NCT00910299|966000|P2|Overall Study|Withdrawal by Subject|13
293491|NCT00910299|966001|P1|Overall Study|Withdrawal by Subject|16
293492|NCT00910273|966013|P2|Overall Study|Lost to Follow-up|1
293493|NCT00910273|966014|P1|Overall Study|Lost to Follow-up|1
293494|NCT00910273|966013|P2|Overall Study|Protocol Violation|0
293495|NCT00910273|966014|P1|Overall Study|Protocol Violation|1
293496|NCT00910273|966013|P2|Overall Study|Discontinuation of study by sponsor|2
293497|NCT00910273|966014|P1|Overall Study|Discontinuation of study by sponsor|8
293498|NCT00910273|966013|P2|Overall Study|Withdrawal by Subject|0
293499|NCT00910273|966014|P1|Overall Study|Withdrawal by Subject|1
293500|NCT00910273|966013|P2|Overall Study|Adverse Event|1
293501|NCT00910273|966014|P1|Overall Study|Adverse Event|1
293502|NCT00910273|966013|P2|Overall Study|Lack of Efficacy|9
293503|NCT00910273|966014|P1|Overall Study|Lack of Efficacy|6
293504|NCT00910091|966066|P2|Treatment and Survival|Adverse Event|0
293505|NCT00910091|966067|P1|Treatment and Survival|Adverse Event|1
293506|NCT00910091|966066|P2|Treatment and Survival|Withdrawal by Subject|4
293507|NCT00910091|966067|P1|Treatment and Survival|Withdrawal by Subject|3
293508|NCT00910091|966066|P2|Pre-assignment|Withdrawal by Subject|2
293509|NCT00910091|966067|P1|Pre-assignment|Withdrawal by Subject|0
293510|NCT00910039|966095|P1|Overall Study|Physician Decision|1
293511|NCT00910000|966112|P6|Overall Study|Withdrawal by Subject|0
293512|NCT00910000|966113|P5|Overall Study|Withdrawal by Subject|1
293513|NCT00910000|966114|P4|Overall Study|Withdrawal by Subject|0
293514|NCT00910000|966115|P3|Overall Study|Withdrawal by Subject|1
293515|NCT00910000|966116|P2|Overall Study|Withdrawal by Subject|0
293516|NCT00910000|966117|P1|Overall Study|Withdrawal by Subject|0
293517|NCT00910000|966112|P6|Overall Study|Adverse Event|1
293518|NCT00910000|966113|P5|Overall Study|Adverse Event|0
293519|NCT00910000|966114|P4|Overall Study|Adverse Event|2
293520|NCT00910000|966115|P3|Overall Study|Adverse Event|2
293521|NCT00910000|966116|P2|Overall Study|Adverse Event|3
293522|NCT00910000|966117|P1|Overall Study|Adverse Event|0
293523|NCT00909870|966135|P2|Overall Study|Other|5
293524|NCT00909870|966136|P1|Overall Study|Other|1
293525|NCT00909870|966135|P2|Overall Study|Physician Decision|2
293526|NCT00909870|966136|P1|Overall Study|Physician Decision|0
293527|NCT00909870|966135|P2|Overall Study|Lost to Follow-up|3
293528|NCT00909870|966136|P1|Overall Study|Lost to Follow-up|3
293529|NCT00909870|966135|P2|Overall Study|Withdrawal by Subject|8
293530|NCT00909870|966136|P1|Overall Study|Withdrawal by Subject|5
293531|NCT00909870|966135|P2|Overall Study|Protocol Violation|2
293532|NCT00909870|966136|P1|Overall Study|Protocol Violation|1
293533|NCT00909870|966135|P2|Overall Study|Adverse Event|7
293534|NCT00909870|966136|P1|Overall Study|Adverse Event|13
293535|NCT00909857|966148|P2|Overall Study|Did not receive study medication|24
293536|NCT00909857|966149|P1|Overall Study|Did not receive study medication|19
293537|NCT00909857|966148|P2|Overall Study|Other|0
293538|NCT00909857|966149|P1|Overall Study|Other|1
293539|NCT00909857|966148|P2|Overall Study|Pregnancy|0
293540|NCT00909857|966149|P1|Overall Study|Pregnancy|1
293541|NCT00909857|966148|P2|Overall Study|Protocol Violation|1
293542|NCT00909857|966149|P1|Overall Study|Protocol Violation|2
293543|NCT00909857|966148|P2|Overall Study|Lost to Follow-up|5
293544|NCT00909857|966149|P1|Overall Study|Lost to Follow-up|2
293545|NCT00909857|966148|P2|Overall Study|Adverse Event|5
293546|NCT00909857|966149|P1|Overall Study|Adverse Event|5
293547|NCT00909857|966148|P2|Overall Study|Withdrawal by Subject|10
293548|NCT00909857|966149|P1|Overall Study|Withdrawal by Subject|6
293549|NCT00909844|966289|P1|Overall Study|Lost to Follow-up|2
293550|NCT00909844|966289|P1|Overall Study|Withdrawal by Subject|1
293551|NCT00909844|966289|P1|Overall Study|Adverse Event|1
293552|NCT00909792|966307|P2|Period 2|Lost to Follow-up|1
293553|NCT00909792|966308|P1|Period 2|Lost to Follow-up|0
293554|NCT00909792|966307|P2|Period 2|Biomicroscopy|0
293555|NCT00909792|966308|P1|Period 2|Biomicroscopy|1
293556|NCT00909792|966307|P2|Period 1|Did not meet inclusion criteria|1
293557|NCT00909792|966308|P1|Period 1|Did not meet inclusion criteria|0
293558|NCT00909779|966316|P2|Overall Study|Randomized in error|1
293559|NCT00909779|966317|P1|Overall Study|Randomized in error|1
293560|NCT00909779|966316|P2|Overall Study|Noncompliance|1
293561|NCT00909779|966317|P1|Overall Study|Noncompliance|1
293562|NCT00909779|966316|P2|Overall Study|Medical Monitor Decision|0
293563|NCT00909779|966317|P1|Overall Study|Medical Monitor Decision|1
293564|NCT00909779|966316|P2|Overall Study|Site Ceasing Operation|2
293565|NCT00909779|966317|P1|Overall Study|Site Ceasing Operation|2
293566|NCT00909779|966316|P2|Overall Study|Withdrawal by Subject|80
293567|NCT00909779|966317|P1|Overall Study|Withdrawal by Subject|116
293568|NCT00909779|966316|P2|Overall Study|Protocol Violation|5
293569|NCT00909779|966317|P1|Overall Study|Protocol Violation|2
293570|NCT00909779|966316|P2|Overall Study|Physician Decision|2
293571|NCT00909779|966317|P1|Overall Study|Physician Decision|8
293572|NCT00909779|966316|P2|Overall Study|Lost to Follow-up|15
293573|NCT00909779|966317|P1|Overall Study|Lost to Follow-up|19
293574|NCT00909779|966316|P2|Overall Study|Lack of Efficacy|4
293575|NCT00909779|966317|P1|Overall Study|Lack of Efficacy|7
293576|NCT00909779|966316|P2|Overall Study|Adverse Event|55
293577|NCT00909779|966317|P1|Overall Study|Adverse Event|53
293578|NCT00909753|966341|P2|Period: Second Intervention|Protocol Violation|0
293579|NCT00909753|966342|P1|Period: Second Intervention|Protocol Violation|1
293580|NCT00909753|966341|P2|Period: Washout of 28 Days|Protocol Violation|3
293581|NCT00909753|966342|P1|Period: Washout of 28 Days|Protocol Violation|2
293582|NCT00909727|966362|P2|Overall Study|Prohibited Medication|0
293583|NCT00909727|966363|P1|Overall Study|Prohibited Medication|1
293584|NCT00909727|966362|P2|Overall Study|Withdrawal of Consent|0
293585|NCT00909727|966363|P1|Overall Study|Withdrawal of Consent|1
293586|NCT00909727|966362|P2|Overall Study|Wrong Genotype|0
293587|NCT00909727|966363|P1|Overall Study|Wrong Genotype|1
293588|NCT00909727|966362|P2|Overall Study|Adverse Event|0
293589|NCT00909727|966363|P1|Overall Study|Adverse Event|1
293590|NCT00909610|966386|P2|Period: Second Intervention|Adverse Event|0
293591|NCT00909610|966387|P1|Period: Second Intervention|Adverse Event|1
293592|NCT00909610|966386|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
293593|NCT00909610|966387|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
293594|NCT00909610|966386|P2|Period: First Intervention|Adverse Event|1
293595|NCT00909610|966387|P1|Period: First Intervention|Adverse Event|0
293596|NCT00909532|966548|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
293597|NCT00909532|966549|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
293598|NCT00909532|966548|P2|Overall Study|Wrong Genotype|0
293599|NCT00909532|966549|P1|Overall Study|Wrong Genotype|1
293600|NCT00909532|966548|P2|Overall Study|Physician Decision|0
293601|NCT00909532|966549|P1|Overall Study|Physician Decision|1
293602|NCT00909532|966548|P2|Overall Study|Noncompliance with Study Requirements|2
293603|NCT00909532|966549|P1|Overall Study|Noncompliance with Study Requirements|0
293604|NCT00909532|966548|P2|Overall Study|Withdrawal of Consent|1
293605|NCT00909532|966549|P1|Overall Study|Withdrawal of Consent|1
293606|NCT00909532|966548|P2|Overall Study|Prohibited Medication|1
293607|NCT00909532|966549|P1|Overall Study|Prohibited Medication|2
293608|NCT00909532|966548|P2|Overall Study|Pregnancy|1
293609|NCT00909532|966549|P1|Overall Study|Pregnancy|0
293610|NCT00909532|966548|P2|Overall Study|Adverse Event|1
293611|NCT00909532|966549|P1|Overall Study|Adverse Event|4
293612|NCT00909480|966567|P2|Overall Study|Unclassified|19
293613|NCT00909480|966568|P1|Overall Study|Unclassified|18
293614|NCT00909480|966567|P2|Overall Study|Withdrawal criteria|11
293615|NCT00909480|966568|P1|Overall Study|Withdrawal criteria|9
293616|NCT00909480|966567|P2|Overall Study|Protocol Violation|8
293617|NCT00909480|966568|P1|Overall Study|Protocol Violation|6
293618|NCT00909480|966567|P2|Overall Study|Adverse Event|3
293619|NCT00909480|966568|P1|Overall Study|Adverse Event|5
293620|NCT00909428|966603|P3|Overall Study|Lost to Follow-up|9
293621|NCT00909428|966604|P2|Overall Study|Lost to Follow-up|10
293622|NCT00909428|966605|P1|Overall Study|Lost to Follow-up|13
293623|NCT00909389|966612|P1|Overall Study|No Information|103
293624|NCT00909389|966612|P1|Overall Study|Lost to Follow-up|4
293625|NCT00909389|966612|P1|Overall Study|Poor Compliance|16
293626|NCT00909389|966612|P1|Overall Study|Death|4
293627|NCT00909389|966612|P1|Overall Study|Adverse Event|6
293628|NCT00909181|966632|P3|Overall Study|Lost to Follow-up|33
293629|NCT00909181|966633|P2|Overall Study|Lost to Follow-up|18
293630|NCT00909181|966634|P1|Overall Study|Lost to Follow-up|39
293631|NCT00909038|966661|P1|Overall Study|Non-evaluable Subjects|230
293632|NCT00909038|966661|P1|Overall Study|Protocol Violation|187
293633|NCT00908960|966673|P3|Overall Study|excluded from analysis|2
293634|NCT00908960|966674|P2|Overall Study|excluded from analysis|1
293635|NCT00908960|966675|P1|Overall Study|excluded from analysis|1
293636|NCT00908895|966691|P2|Overall Study|Adverse Event|1
293637|NCT00908895|966692|P1|Overall Study|Adverse Event|1
293638|NCT00908895|966691|P2|Overall Study|algodystrophy|2
293639|NCT00908895|966692|P1|Overall Study|algodystrophy|2
293640|NCT00908895|966691|P2|Overall Study|Lost to Follow-up|3
293641|NCT00908895|966692|P1|Overall Study|Lost to Follow-up|1
293642|NCT00908596|966765|P4|Overall Study|Withdrawal by Subject|1
293643|NCT00908596|966766|P3|Overall Study|Withdrawal by Subject|3
293644|NCT00908596|966767|P2|Overall Study|Withdrawal by Subject|1
293645|NCT00908596|966768|P1|Overall Study|Withdrawal by Subject|0
293646|NCT00908596|966765|P4|Overall Study|Protocol Violation|0
293647|NCT00908596|966766|P3|Overall Study|Protocol Violation|0
293648|NCT00908596|966767|P2|Overall Study|Protocol Violation|0
293649|NCT00908596|966768|P1|Overall Study|Protocol Violation|1
293650|NCT00908596|966765|P4|Overall Study|Death|32
293651|NCT00908596|966766|P3|Overall Study|Death|57
293652|NCT00908596|966767|P2|Overall Study|Death|5
293653|NCT00908596|966768|P1|Overall Study|Death|0
293654|NCT00908596|966765|P4|Overall Study|Lost to Follow-up|4
293655|NCT00908596|966766|P3|Overall Study|Lost to Follow-up|12
293656|NCT00908596|966767|P2|Overall Study|Lost to Follow-up|1
293657|NCT00908596|966768|P1|Overall Study|Lost to Follow-up|0
293658|NCT00908596|966765|P4|Overall Study|Other reasons|0
293659|NCT00908596|966766|P3|Overall Study|Other reasons|2
293660|NCT00908596|966767|P2|Overall Study|Other reasons|6
293661|NCT00908596|966768|P1|Overall Study|Other reasons|46
293662|NCT00908583|966798|P1|Phase 5|Adverse Event|3
293663|NCT00908583|966798|P1|Phase 4|Physician Decision|1
293664|NCT00908583|966798|P1|Phase 4|Adverse Event|1
293665|NCT00908583|966798|P1|Phase 3|Adverse Event|2
293666|NCT00908583|966798|P1|Phase 2|Adverse Event|1
293667|NCT00908583|966798|P1|Phase 2|Physician Decision|1
293668|NCT00908583|966798|P1|Phase 1|Adverse Event|4
293669|NCT00908583|966798|P1|Phase 1|Withdrawal by Subject|1
293670|NCT00908375|966826|P2|Overall Study|Lost to Follow-up|6
293671|NCT00908375|966827|P1|Overall Study|Lost to Follow-up|8
293672|NCT00908375|966826|P2|Overall Study|Withdrawal by Subject|4
293673|NCT00908375|966827|P1|Overall Study|Withdrawal by Subject|2
293674|NCT00908349|966837|P1|Overall Study|Various|6
293675|NCT00908349|966837|P1|Overall Study|Lost to Follow-up|5
293676|NCT00908349|966837|P1|Overall Study|Physician Decision|5
293677|NCT00908349|966837|P1|Overall Study|Withdrawal by Subject|9
293678|NCT00908349|966837|P1|Overall Study|Adverse Event|10
293679|NCT00908310|966841|P1|Overall Study|Other reasons|4
293680|NCT00908310|966841|P1|Overall Study|Screening failure|5
293681|NCT00908310|966841|P1|Overall Study|Lost to Follow-up|7
293682|NCT00908310|966841|P1|Overall Study|Withdrawal by Subject|7
293683|NCT00908310|966841|P1|Overall Study|Death|37
293684|NCT00908232|966845|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
293685|NCT00908232|966846|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
293686|NCT00908232|966847|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
293687|NCT00908232|966848|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
293688|NCT00908232|966845|P4|Randomization (Cycle 5) to Cycle 8|Other|0
293689|NCT00908232|966846|P3|Randomization (Cycle 5) to Cycle 8|Other|0
293690|NCT00908232|966847|P2|Randomization (Cycle 5) to Cycle 8|Other|1
293691|NCT00908232|966848|P1|Randomization (Cycle 5) to Cycle 8|Other|3
293692|NCT00908232|966845|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
293693|NCT00908232|966846|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
293694|NCT00908232|966847|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
293695|NCT00908232|966848|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
293696|NCT00908232|966845|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
293697|NCT00908232|966846|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
293698|NCT00908232|966847|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
293699|NCT00908232|966848|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
293700|NCT00908232|966845|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
293701|NCT00908232|966846|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
293702|NCT00908232|966847|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
293703|NCT00908232|966848|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
293704|NCT00908232|966845|P4|Randomization (Cycle 5) to Cycle 8|Death|0
293705|NCT00908232|966846|P3|Randomization (Cycle 5) to Cycle 8|Death|0
293706|NCT00908232|966847|P2|Randomization (Cycle 5) to Cycle 8|Death|0
293707|NCT00908232|966848|P1|Randomization (Cycle 5) to Cycle 8|Death|2
293708|NCT00908232|966845|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
293709|NCT00908232|966846|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
293710|NCT00908232|966847|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
293711|NCT00908232|966848|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
293712|NCT00908232|966845|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
293713|NCT00908232|966846|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
293714|NCT00908232|966847|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
293715|NCT00908232|966848|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
293716|NCT00908232|966845|P4|Cycle 1 to 4|not specified|0
293717|NCT00908232|966846|P3|Cycle 1 to 4|not specified|0
293718|NCT00908232|966847|P2|Cycle 1 to 4|not specified|0
293719|NCT00908232|966848|P1|Cycle 1 to 4|not specified|1
293720|NCT00908232|966845|P4|Cycle 1 to 4|Adverse Event|0
293721|NCT00908232|966846|P3|Cycle 1 to 4|Adverse Event|0
293722|NCT00908232|966847|P2|Cycle 1 to 4|Adverse Event|0
293723|NCT00908232|966848|P1|Cycle 1 to 4|Adverse Event|12
293724|NCT00908232|966845|P4|Cycle 1 to 4|Progressive Disease|0
293725|NCT00908232|966846|P3|Cycle 1 to 4|Progressive Disease|0
293726|NCT00908232|966847|P2|Cycle 1 to 4|Progressive Disease|0
293727|NCT00908232|966848|P1|Cycle 1 to 4|Progressive Disease|6
293728|NCT00908232|966845|P4|Cycle 1 to 4|Withdrawal by Subject|0
293729|NCT00908232|966846|P3|Cycle 1 to 4|Withdrawal by Subject|0
293730|NCT00908232|966847|P2|Cycle 1 to 4|Withdrawal by Subject|0
293731|NCT00908232|966848|P1|Cycle 1 to 4|Withdrawal by Subject|4
293732|NCT00908232|966845|P4|Cycle 1 to 4|Death|0
293733|NCT00908232|966846|P3|Cycle 1 to 4|Death|0
293734|NCT00908232|966847|P2|Cycle 1 to 4|Death|0
293735|NCT00908232|966848|P1|Cycle 1 to 4|Death|5
293736|NCT00908141|966866|P2|Overall Study|Withdrawal by Subject|1
293737|NCT00908141|966867|P1|Overall Study|Withdrawal by Subject|0
293738|NCT00908115|966884|P1|Overall Study|Unspecified|14
293739|NCT00908076|966892|P2|Overall Study|Lack of Efficacy|1
293740|NCT00908076|966893|P1|Overall Study|Lack of Efficacy|1
293741|NCT00908037|966906|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293742|NCT00908037|966907|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
293743|NCT00908037|966908|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293744|NCT00908037|966909|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293745|NCT00908037|966910|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293746|NCT00908037|966911|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293747|NCT00908037|966912|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293748|NCT00908037|966913|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293749|NCT00908037|966914|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293750|NCT00908037|966915|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293751|NCT00908037|966916|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293752|NCT00908037|966917|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
293753|NCT00908037|966906|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293754|NCT00908037|966907|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293755|NCT00908037|966908|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
293756|NCT00908037|966909|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293757|NCT00908037|966910|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293758|NCT00908037|966911|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293759|NCT00908037|966912|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293760|NCT00908037|966913|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293761|NCT00908037|966914|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293762|NCT00908037|966915|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293763|NCT00908037|966916|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293764|NCT00908037|966917|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
293765|NCT00908037|966906|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293766|NCT00908037|966907|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
293767|NCT00908037|966908|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293768|NCT00908037|966909|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293769|NCT00908037|966910|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293770|NCT00908037|966911|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293771|NCT00908037|966912|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293772|NCT00908037|966913|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293773|NCT00908037|966914|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293774|NCT00908037|966915|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293775|NCT00908037|966916|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293776|NCT00908037|966917|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
293777|NCT00908037|966906|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293778|NCT00908037|966907|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293779|NCT00908037|966908|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
293780|NCT00908037|966909|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293781|NCT00908037|966910|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293782|NCT00908037|966911|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293783|NCT00908037|966912|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293784|NCT00908037|966913|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293785|NCT00908037|966914|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293786|NCT00908037|966915|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293787|NCT00908037|966916|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293788|NCT00908037|966917|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
293789|NCT00908037|966906|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
293790|NCT00908037|966907|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293791|NCT00908037|966908|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
293792|NCT00908037|966909|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293793|NCT00908037|966910|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293794|NCT00908037|966911|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293795|NCT00908037|966912|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293796|NCT00908037|966913|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293797|NCT00908037|966914|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293798|NCT00908037|966915|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293799|NCT00908037|966916|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293800|NCT00908037|966917|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
293801|NCT00908037|966906|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
293802|NCT00908037|966907|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293803|NCT00908037|966908|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293804|NCT00908037|966909|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293805|NCT00908037|966910|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293806|NCT00908037|966911|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293807|NCT00908037|966912|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293808|NCT00908037|966913|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293809|NCT00908037|966914|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293810|NCT00908037|966915|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293811|NCT00908037|966916|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293812|NCT00908037|966917|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
293813|NCT00908037|966906|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293814|NCT00908037|966907|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293815|NCT00908037|966908|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293816|NCT00908037|966909|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293817|NCT00908037|966910|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293818|NCT00908037|966911|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
293819|NCT00908037|966912|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293820|NCT00908037|966913|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293821|NCT00908037|966914|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
293822|NCT00908037|966915|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293823|NCT00908037|966916|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293824|NCT00908037|966917|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
293825|NCT00908037|966906|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293826|NCT00908037|966907|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293827|NCT00908037|966908|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293828|NCT00908037|966909|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
293829|NCT00908037|966910|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293830|NCT00908037|966911|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293831|NCT00908037|966912|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293832|NCT00908037|966913|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
293833|NCT00908037|966914|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293834|NCT00908037|966915|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293835|NCT00908037|966916|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293836|NCT00908037|966917|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
293837|NCT00908037|966906|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
293838|NCT00908037|966907|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
293839|NCT00908037|966908|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
293840|NCT00908037|966909|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
293841|NCT00908037|966910|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
293842|NCT00908037|966911|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
293843|NCT00908037|966912|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
293844|NCT00908037|966913|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
293845|NCT00908037|966914|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
293846|NCT00908037|966915|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
293847|NCT00908037|966916|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
293848|NCT00908037|966917|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
293849|NCT00908011|967066|P2|Overall Study|Withdrawal by Subject|2
293850|NCT00908011|967067|P1|Overall Study|Withdrawal by Subject|2
293851|NCT00907881|967084|P1|Overall Study|Missing discontinuation information|15
293852|NCT00907881|967084|P1|Overall Study|Protocol Violation|1
293853|NCT00907881|967084|P1|Overall Study|Withdrawal by Subject|5
293854|NCT00907881|967084|P1|Overall Study|Noncompliance|5
293855|NCT00907881|967084|P1|Overall Study|Lost to Follow-up|59
293856|NCT00907803|967094|P3|Overall Study|Protocol Violation|0
293857|NCT00907803|967095|P2|Overall Study|Protocol Violation|1
293858|NCT00907803|967096|P1|Overall Study|Protocol Violation|0
293859|NCT00907803|967094|P3|Overall Study|Lost to Follow-up|0
293860|NCT00907803|967095|P2|Overall Study|Lost to Follow-up|1
293861|NCT00907803|967096|P1|Overall Study|Lost to Follow-up|0
293862|NCT00907803|967094|P3|Overall Study|Withdrawal by Subject|0
293863|NCT00907803|967095|P2|Overall Study|Withdrawal by Subject|1
293864|NCT00907803|967096|P1|Overall Study|Withdrawal by Subject|0
293865|NCT00907803|967094|P3|Overall Study|Adverse Event|0
293866|NCT00907803|967095|P2|Overall Study|Adverse Event|0
293867|NCT00907803|967096|P1|Overall Study|Adverse Event|2
293868|NCT00907803|967094|P3|Overall Study|Withdrawal of consent - long commute|0
293869|NCT00907803|967095|P2|Overall Study|Withdrawal of consent - long commute|0
293870|NCT00907803|967096|P1|Overall Study|Withdrawal of consent - long commute|1
293871|NCT00907777|967127|P2|Overall Study|Withdrawal by Subject|1
293872|NCT00907777|967128|P1|Overall Study|Withdrawal by Subject|0
293873|NCT00907738|967155|P5|Overall Study|Disease progression|2
293874|NCT00907738|967156|P4|Overall Study|Disease progression|4
293875|NCT00907738|967157|P3|Overall Study|Disease progression|6
293876|NCT00907738|967158|P2|Overall Study|Disease progression|1
293877|NCT00907738|967159|P1|Overall Study|Disease progression|8
293878|NCT00907738|967155|P5|Overall Study|not specified or withdrew consent|0
293879|NCT00907738|967156|P4|Overall Study|not specified or withdrew consent|0
293880|NCT00907738|967157|P3|Overall Study|not specified or withdrew consent|0
293881|NCT00907738|967158|P2|Overall Study|not specified or withdrew consent|0
293882|NCT00907738|967159|P1|Overall Study|not specified or withdrew consent|3
293883|NCT00907738|967155|P5|Overall Study|Adverse Event|0
293884|NCT00907738|967156|P4|Overall Study|Adverse Event|0
293885|NCT00907738|967157|P3|Overall Study|Adverse Event|1
293886|NCT00907738|967158|P2|Overall Study|Adverse Event|0
293887|NCT00907738|967159|P1|Overall Study|Adverse Event|2
293888|NCT00907621|967177|P2|Overall Study|intercurrent febrile illness|1
293889|NCT00907621|967178|P1|Overall Study|intercurrent febrile illness|1
293890|NCT00907621|967177|P2|Overall Study|Lost to Follow-up|3
293891|NCT00907621|967178|P1|Overall Study|Lost to Follow-up|6
293892|NCT00907517|967191|P5|Overall Study|Symptomatic Deterioration|1
293893|NCT00907517|967192|P4|Overall Study|Symptomatic Deterioration|0
293894|NCT00907517|967193|P3|Overall Study|Symptomatic Deterioration|0
293895|NCT00907517|967194|P2|Overall Study|Symptomatic Deterioration|0
293896|NCT00907517|967195|P1|Overall Study|Symptomatic Deterioration|0
293897|NCT00907517|967191|P5|Overall Study|Progressive Disease|4
293898|NCT00907517|967192|P4|Overall Study|Progressive Disease|4
293899|NCT00907517|967193|P3|Overall Study|Progressive Disease|4
293900|NCT00907517|967194|P2|Overall Study|Progressive Disease|3
293901|NCT00907517|967195|P1|Overall Study|Progressive Disease|3
293902|NCT00907478|967220|P3|Overall Study|Other|1
293903|NCT00907478|967221|P2|Overall Study|Other|0
293904|NCT00907478|967222|P1|Overall Study|Other|3
293905|NCT00907478|967220|P3|Overall Study|Lost to Follow-up|0
293906|NCT00907478|967221|P2|Overall Study|Lost to Follow-up|0
293907|NCT00907478|967222|P1|Overall Study|Lost to Follow-up|1
293908|NCT00907478|967220|P3|Overall Study|Pregnancy|1
293909|NCT00907478|967221|P2|Overall Study|Pregnancy|1
293910|NCT00907478|967222|P1|Overall Study|Pregnancy|0
293911|NCT00907478|967220|P3|Overall Study|Protocol-specified criteria|3
293912|NCT00907478|967221|P2|Overall Study|Protocol-specified criteria|2
293913|NCT00907478|967222|P1|Overall Study|Protocol-specified criteria|5
293914|NCT00907478|967220|P3|Overall Study|Death|1
293915|NCT00907478|967221|P2|Overall Study|Death|2
293916|NCT00907478|967222|P1|Overall Study|Death|4
293917|NCT00907478|967220|P3|Overall Study|Physician Decision|3
293918|NCT00907478|967221|P2|Overall Study|Physician Decision|0
293919|NCT00907478|967222|P1|Overall Study|Physician Decision|2
293920|NCT00907478|967220|P3|Overall Study|Requirement for alternative therapy|3
293921|NCT00907478|967221|P2|Overall Study|Requirement for alternative therapy|2
293922|NCT00907478|967222|P1|Overall Study|Requirement for alternative therapy|1
293923|NCT00907478|967220|P3|Overall Study|Withdrawal by Subject|6
293924|NCT00907478|967221|P2|Overall Study|Withdrawal by Subject|9
293925|NCT00907478|967222|P1|Overall Study|Withdrawal by Subject|8
293926|NCT00907478|967220|P3|Overall Study|Adverse Event|2
293927|NCT00907478|967221|P2|Overall Study|Adverse Event|1
293928|NCT00907478|967222|P1|Overall Study|Adverse Event|3
293929|NCT00907478|967220|P3|Overall Study|Noncompliance|1
293930|NCT00907478|967221|P2|Overall Study|Noncompliance|0
293931|NCT00907478|967222|P1|Overall Study|Noncompliance|0
293932|NCT00907478|967220|P3|Overall Study|Ineligibility determined|1
293933|NCT00907478|967221|P2|Overall Study|Ineligibility determined|0
293934|NCT00907478|967222|P1|Overall Study|Ineligibility determined|0
293935|NCT00907374|967272|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
293936|NCT00907374|967273|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
293937|NCT00907335|967287|P2|Overall Study|Lost to Follow-up|0
293938|NCT00907335|967288|P1|Overall Study|Lost to Follow-up|2
293939|NCT00907335|967287|P2|Overall Study|Adverse Event|1
293940|NCT00907335|967288|P1|Overall Study|Adverse Event|4
293941|NCT00907335|967287|P2|Overall Study|Withdrawal by Subject|0
293942|NCT00907335|967288|P1|Overall Study|Withdrawal by Subject|2
293943|NCT00907257|967306|P2|Overall Study|Personal Reasons|1
293944|NCT00907257|967307|P1|Overall Study|Personal Reasons|6
293945|NCT00907257|967306|P2|Overall Study|Moved|0
293946|NCT00907257|967307|P1|Overall Study|Moved|1
293947|NCT00907257|967306|P2|Overall Study|Per IRB-Subject became vulnerable|0
293948|NCT00907257|967307|P1|Overall Study|Per IRB-Subject became vulnerable|1
293949|NCT00907257|967306|P2|Overall Study|Withdrawal by Subject|2
293950|NCT00907257|967307|P1|Overall Study|Withdrawal by Subject|1
293951|NCT00907257|967306|P2|Overall Study|Lost to Follow-up|3
293952|NCT00907257|967307|P1|Overall Study|Lost to Follow-up|3
293953|NCT00907257|967306|P2|Overall Study|Protocol Violation|2
293954|NCT00907257|967307|P1|Overall Study|Protocol Violation|1
293955|NCT00907257|967306|P2|Overall Study|Adverse Event|4
293956|NCT00907257|967307|P1|Overall Study|Adverse Event|0
293957|NCT00906971|967340|P2|Overall Study|Lost to Follow-up|1
293958|NCT00906971|967341|P1|Overall Study|Lost to Follow-up|0
293959|NCT00906971|967340|P2|Overall Study|Withdrawal by Subject|2
293960|NCT00906971|967341|P1|Overall Study|Withdrawal by Subject|8
293961|NCT00906945|967354|P6|Overall Study|Physician Decision|1
293962|NCT00906945|967355|P5|Overall Study|Physician Decision|0
293963|NCT00906945|967356|P4|Overall Study|Physician Decision|0
293964|NCT00906945|967357|P3|Overall Study|Physician Decision|0
293965|NCT00906945|967358|P2|Overall Study|Physician Decision|0
293966|NCT00906945|967359|P1|Overall Study|Physician Decision|0
293967|NCT00906945|967354|P6|Overall Study|Found to be not eligible|1
293968|NCT00906945|967355|P5|Overall Study|Found to be not eligible|1
293969|NCT00906945|967356|P4|Overall Study|Found to be not eligible|1
293970|NCT00906945|967357|P3|Overall Study|Found to be not eligible|0
293971|NCT00906945|967358|P2|Overall Study|Found to be not eligible|0
293972|NCT00906945|967359|P1|Overall Study|Found to be not eligible|0
293973|NCT00906698|967419|P6|Overall Study|incl. non compliance, lost to follow-up|0
293974|NCT00906698|967420|P5|Overall Study|incl. non compliance, lost to follow-up|0
293975|NCT00906698|967421|P4|Overall Study|incl. non compliance, lost to follow-up|0
293976|NCT00906698|967422|P3|Overall Study|incl. non compliance, lost to follow-up|0
293977|NCT00906698|967423|P2|Overall Study|incl. non compliance, lost to follow-up|1
293978|NCT00906698|967424|P1|Overall Study|incl. non compliance, lost to follow-up|0
293979|NCT00906698|967419|P6|Overall Study|Withdrawal by Subject|0
293980|NCT00906698|967420|P5|Overall Study|Withdrawal by Subject|1
293981|NCT00906698|967421|P4|Overall Study|Withdrawal by Subject|0
293982|NCT00906698|967422|P3|Overall Study|Withdrawal by Subject|0
293983|NCT00906698|967423|P2|Overall Study|Withdrawal by Subject|0
293984|NCT00906698|967424|P1|Overall Study|Withdrawal by Subject|0
293985|NCT00906698|967419|P6|Overall Study|Disease progression|4
293986|NCT00906698|967420|P5|Overall Study|Disease progression|12
293987|NCT00906698|967421|P4|Overall Study|Disease progression|4
293988|NCT00906698|967422|P3|Overall Study|Disease progression|4
293989|NCT00906698|967423|P2|Overall Study|Disease progression|12
293990|NCT00906698|967424|P1|Overall Study|Disease progression|3
293991|NCT00906698|967419|P6|Overall Study|Adverse Event|1
293992|NCT00906698|967420|P5|Overall Study|Adverse Event|4
293993|NCT00906698|967421|P4|Overall Study|Adverse Event|0
293994|NCT00906698|967422|P3|Overall Study|Adverse Event|2
293995|NCT00906698|967423|P2|Overall Study|Adverse Event|0
293996|NCT00906698|967424|P1|Overall Study|Adverse Event|0
293997|NCT00906698|967419|P6|Overall Study|Dose-limiting toxicity (DLT)|0
293998|NCT00906698|967420|P5|Overall Study|Dose-limiting toxicity (DLT)|1
293999|NCT00906698|967421|P4|Overall Study|Dose-limiting toxicity (DLT)|0
294000|NCT00906698|967422|P3|Overall Study|Dose-limiting toxicity (DLT)|0
294001|NCT00906698|967423|P2|Overall Study|Dose-limiting toxicity (DLT)|6
294002|NCT00906698|967424|P1|Overall Study|Dose-limiting toxicity (DLT)|0
294003|NCT00906399|967526|P7|Year 2|Not specified|0
294004|NCT00906399|967527|P6|Year 2|Not specified|1
294005|NCT00906399|967528|P5|Year 2|Not specified|3
294006|NCT00906399|967529|P4|Year 2|Not specified|2
294007|NCT00906399|967530|P3|Year 2|Not specified|0
294008|NCT00906399|967531|P2|Year 2|Not specified|0
294009|NCT00906399|967532|P1|Year 2|Not specified|0
294010|NCT00906399|967526|P7|Year 2|Death|3
294011|NCT00906399|967527|P6|Year 2|Death|0
294012|NCT00906399|967528|P5|Year 2|Death|0
294013|NCT00906399|967529|P4|Year 2|Death|1
294014|NCT00906399|967530|P3|Year 2|Death|0
294015|NCT00906399|967531|P2|Year 2|Death|0
294016|NCT00906399|967532|P1|Year 2|Death|0
294017|NCT00906399|967526|P7|Year 2|Physician Decision|3
294018|NCT00906399|967527|P6|Year 2|Physician Decision|6
294019|NCT00906399|967528|P5|Year 2|Physician Decision|2
294020|NCT00906399|967529|P4|Year 2|Physician Decision|0
294021|NCT00906399|967530|P3|Year 2|Physician Decision|0
294022|NCT00906399|967531|P2|Year 2|Physician Decision|0
294023|NCT00906399|967532|P1|Year 2|Physician Decision|0
294024|NCT00906399|967526|P7|Year 2|Withdrawal by Subject|13
294025|NCT00906399|967527|P6|Year 2|Withdrawal by Subject|27
294026|NCT00906399|967528|P5|Year 2|Withdrawal by Subject|18
294027|NCT00906399|967529|P4|Year 2|Withdrawal by Subject|17
294028|NCT00906399|967530|P3|Year 2|Withdrawal by Subject|0
294029|NCT00906399|967531|P2|Year 2|Withdrawal by Subject|0
294030|NCT00906399|967532|P1|Year 2|Withdrawal by Subject|0
294031|NCT00906399|967526|P7|Year 2|Lost to Follow-up|4
294032|NCT00906399|967527|P6|Year 2|Lost to Follow-up|2
294033|NCT00906399|967528|P5|Year 2|Lost to Follow-up|4
294034|NCT00906399|967529|P4|Year 2|Lost to Follow-up|1
294035|NCT00906399|967530|P3|Year 2|Lost to Follow-up|0
294036|NCT00906399|967531|P2|Year 2|Lost to Follow-up|0
294037|NCT00906399|967532|P1|Year 2|Lost to Follow-up|0
294038|NCT00906399|967526|P7|Year 2|Adverse Event|6
294039|NCT00906399|967527|P6|Year 2|Adverse Event|11
294040|NCT00906399|967528|P5|Year 2|Adverse Event|8
294041|NCT00906399|967529|P4|Year 2|Adverse Event|9
294042|NCT00906399|967530|P3|Year 2|Adverse Event|0
294043|NCT00906399|967531|P2|Year 2|Adverse Event|0
294044|NCT00906399|967532|P1|Year 2|Adverse Event|0
294045|NCT00906399|967526|P7|Year 1|Not specified|0
294046|NCT00906399|967527|P6|Year 1|Not specified|0
294047|NCT00906399|967528|P5|Year 1|Not specified|0
294048|NCT00906399|967529|P4|Year 1|Not specified|0
294049|NCT00906399|967530|P3|Year 1|Not specified|7
294050|NCT00906399|967531|P2|Year 1|Not specified|2
294051|NCT00906399|967532|P1|Year 1|Not specified|4
294052|NCT00906399|967526|P7|Year 1|Death|0
294053|NCT00906399|967527|P6|Year 1|Death|0
294054|NCT00906399|967528|P5|Year 1|Death|0
294055|NCT00906399|967529|P4|Year 1|Death|0
294056|NCT00906399|967530|P3|Year 1|Death|1
294057|NCT00906399|967531|P2|Year 1|Death|1
294058|NCT00906399|967532|P1|Year 1|Death|2
294059|NCT00906399|967526|P7|Year 1|Physician Decision|0
294060|NCT00906399|967527|P6|Year 1|Physician Decision|0
294061|NCT00906399|967528|P5|Year 1|Physician Decision|0
294062|NCT00906399|967529|P4|Year 1|Physician Decision|0
294063|NCT00906399|967530|P3|Year 1|Physician Decision|3
294064|NCT00906399|967531|P2|Year 1|Physician Decision|1
294065|NCT00906399|967532|P1|Year 1|Physician Decision|0
294066|NCT00906399|967526|P7|Year 1|Withdrawal by Subject|0
294067|NCT00906399|967527|P6|Year 1|Withdrawal by Subject|0
294068|NCT00906399|967528|P5|Year 1|Withdrawal by Subject|0
294069|NCT00906399|967529|P4|Year 1|Withdrawal by Subject|0
294070|NCT00906399|967530|P3|Year 1|Withdrawal by Subject|36
294071|NCT00906399|967531|P2|Year 1|Withdrawal by Subject|32
294072|NCT00906399|967532|P1|Year 1|Withdrawal by Subject|30
294073|NCT00906399|967526|P7|Year 1|Lost to Follow-up|0
294074|NCT00906399|967527|P6|Year 1|Lost to Follow-up|0
294075|NCT00906399|967528|P5|Year 1|Lost to Follow-up|0
294076|NCT00906399|967529|P4|Year 1|Lost to Follow-up|0
294077|NCT00906399|967530|P3|Year 1|Lost to Follow-up|2
294078|NCT00906399|967531|P2|Year 1|Lost to Follow-up|4
294079|NCT00906399|967532|P1|Year 1|Lost to Follow-up|4
294080|NCT00906399|967526|P7|Year 1|Adverse Event|0
294081|NCT00906399|967527|P6|Year 1|Adverse Event|0
294082|NCT00906399|967528|P5|Year 1|Adverse Event|0
294083|NCT00906399|967529|P4|Year 1|Adverse Event|0
294084|NCT00906399|967530|P3|Year 1|Adverse Event|24
294085|NCT00906399|967531|P2|Year 1|Adverse Event|22
294086|NCT00906399|967532|P1|Year 1|Adverse Event|4
294087|NCT00906399|967526|P7|Year 1|Randomized But Not Treated|0
294088|NCT00906399|967527|P6|Year 1|Randomized But Not Treated|0
294089|NCT00906399|967528|P5|Year 1|Randomized But Not Treated|0
294090|NCT00906399|967529|P4|Year 1|Randomized But Not Treated|0
294091|NCT00906399|967530|P3|Year 1|Randomized But Not Treated|3
294092|NCT00906399|967531|P2|Year 1|Randomized But Not Treated|1
294093|NCT00906399|967532|P1|Year 1|Randomized But Not Treated|0
294094|NCT00906347|967555|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
294095|NCT00906347|967556|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
294096|NCT00906347|967555|P2|Received Study Drug|Refused study drug|0
294097|NCT00906347|967556|P1|Received Study Drug|Refused study drug|1
294098|NCT00906347|967555|P2|Received Study Drug|Nonreassuring fetal heart rate|1
294099|NCT00906347|967556|P1|Received Study Drug|Nonreassuring fetal heart rate|13
294100|NCT00906347|967555|P2|Received Study Drug|8 cm prior to initiation of study drug|30
294101|NCT00906347|967556|P1|Received Study Drug|8 cm prior to initiation of study drug|18
294102|NCT00906282|967576|P1|Preoperative Chemotherapy|Toxicity|1
294103|NCT00906282|967576|P1|Preoperative Chemotherapy|Progressive disease|6
294104|NCT00906282|967576|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
294105|NCT00906282|967576|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
294106|NCT00906204|967590|P2|Secondary Endpoints (Long-term Safety)|Death|1
294107|NCT00906204|967591|P1|Secondary Endpoints (Long-term Safety)|Death|0
294108|NCT00906204|967590|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
294109|NCT00906204|967591|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
294110|NCT00906204|967590|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
294111|NCT00906204|967591|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
294112|NCT00906204|967590|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
294113|NCT00906204|967591|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
294114|NCT00906204|967590|P2|Primary Endpoint (Early Safety)|Physician Decision|0
294115|NCT00906204|967591|P1|Primary Endpoint (Early Safety)|Physician Decision|1
294116|NCT00906087|967622|P1|Initial Washout|Physician Decision|1
294117|NCT00906087|967622|P1|Initial Washout|Withdrawal by Subject|1
294118|NCT00905164|967658|P2|Period 1|Protocol Violation|1
294119|NCT00905164|967659|P1|Period 1|Protocol Violation|0
294120|NCT00905034|967706|P1|Overall Study|Withdrawal by Subject|1
294121|NCT00905021|967710|P1|Overall Study|Adverse Event|2
294122|NCT00904982|967728|P4|Overall Study|Withdrawal by Subject|0
294123|NCT00904982|967729|P3|Overall Study|Withdrawal by Subject|0
294124|NCT00904982|967730|P2|Overall Study|Withdrawal by Subject|0
294125|NCT00904982|967731|P1|Overall Study|Withdrawal by Subject|2
294126|NCT00905840|967741|P1|Overall Study|Adverse Event|1
294127|NCT00905840|967741|P1|Overall Study|Withdrawal by Subject|1
294128|NCT00905840|967741|P1|Overall Study|Death|3
294129|NCT00905840|967741|P1|Overall Study|Lost to Follow-up|11
294130|NCT00905632|967772|P7|Overall Study|Adverse Event|4
294131|NCT00905632|967773|P6|Overall Study|Adverse Event|1
294132|NCT00905632|967774|P5|Overall Study|Adverse Event|0
294133|NCT00905632|967775|P4|Overall Study|Adverse Event|0
294134|NCT00905632|967776|P3|Overall Study|Adverse Event|0
294135|NCT00905632|967777|P2|Overall Study|Adverse Event|0
294136|NCT00905632|967778|P1|Overall Study|Adverse Event|0
294137|NCT00905606|967916|P2|Washout|Withdrawal by Subject|0
294138|NCT00905606|967917|P1|Washout|Withdrawal by Subject|1
294139|NCT00905606|967916|P2|Period 1|Adverse Event|1
294140|NCT00905606|967917|P1|Period 1|Adverse Event|0
294141|NCT00905567|967942|P2|Washout|Withdrawal by Subject|1
294142|NCT00905567|967943|P1|Washout|Withdrawal by Subject|0
294143|NCT00905489|967975|P1|Optional Extension Phase (OEP)|Adverse Event|1
294144|NCT00905489|967975|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
294145|NCT00905489|967975|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
294146|NCT00905437|968024|P2|Overall Study|Unspecified|6
294147|NCT00905437|968025|P1|Overall Study|Unspecified|5
294148|NCT00905437|968024|P2|Overall Study|Withdrawal by Subject|1
294149|NCT00905437|968025|P1|Overall Study|Withdrawal by Subject|0
294150|NCT00905437|968024|P2|Overall Study|Lost to Follow-up|1
294151|NCT00905437|968025|P1|Overall Study|Lost to Follow-up|0
294152|NCT00905437|968024|P2|Overall Study|Adverse Event|2
294153|NCT00905437|968025|P1|Overall Study|Adverse Event|3
294154|NCT00905424|968045|P2|Overall Study|Non-adherence to visit schedule|1
294155|NCT00905424|968046|P1|Overall Study|Non-adherence to visit schedule|0
294156|NCT00905424|968045|P2|Overall Study|Positive urine drug screen|1
294157|NCT00905424|968046|P1|Overall Study|Positive urine drug screen|0
294158|NCT00905424|968045|P2|Overall Study|Sponsor decision|0
294159|NCT00905424|968046|P1|Overall Study|Sponsor decision|1
294160|NCT00905424|968045|P2|Overall Study|Non-compliance with study medication|0
294161|NCT00905424|968046|P1|Overall Study|Non-compliance with study medication|2
294162|NCT00905424|968045|P2|Overall Study|Adverse Event|2
294163|NCT00905424|968046|P1|Overall Study|Adverse Event|4
294164|NCT00905424|968045|P2|Overall Study|Withdrawal by Subject|2
294165|NCT00905424|968046|P1|Overall Study|Withdrawal by Subject|1
294166|NCT00905424|968045|P2|Overall Study|Lost to Follow-up|3
294167|NCT00905424|968046|P1|Overall Study|Lost to Follow-up|3
294168|NCT00905359|968088|P2|Overall Study|Withdrawal consent|6
294169|NCT00905359|968089|P1|Overall Study|Withdrawal consent|5
294170|NCT00905359|968088|P2|Overall Study|Death|0
294171|NCT00905359|968089|P1|Overall Study|Death|2
294172|NCT00905359|968088|P2|Overall Study|Lost to Follow-up|10
294173|NCT00905359|968089|P1|Overall Study|Lost to Follow-up|17
294174|NCT00905346|968125|P2|Period 1|Withdrawal by Subject|0
294175|NCT00905346|968126|P1|Period 1|Withdrawal by Subject|1
294176|NCT00905307|968140|P6|Overall Study|Lack of Efficacy|8
294177|NCT00905307|968141|P5|Overall Study|Lack of Efficacy|4
294178|NCT00905307|968142|P4|Overall Study|Lack of Efficacy|4
294179|NCT00905307|968143|P3|Overall Study|Lack of Efficacy|5
294180|NCT00905307|968144|P2|Overall Study|Lack of Efficacy|3
294181|NCT00905307|968145|P1|Overall Study|Lack of Efficacy|6
294182|NCT00905307|968140|P6|Overall Study|Protocol Violation|0
294183|NCT00905307|968141|P5|Overall Study|Protocol Violation|0
294184|NCT00905307|968142|P4|Overall Study|Protocol Violation|0
294185|NCT00905307|968143|P3|Overall Study|Protocol Violation|1
294186|NCT00905307|968144|P2|Overall Study|Protocol Violation|0
294187|NCT00905307|968145|P1|Overall Study|Protocol Violation|1
294188|NCT00905307|968140|P6|Overall Study|Withdrawal by Subject|13
294189|NCT00905307|968141|P5|Overall Study|Withdrawal by Subject|4
294190|NCT00905307|968142|P4|Overall Study|Withdrawal by Subject|11
294191|NCT00905307|968143|P3|Overall Study|Withdrawal by Subject|15
294192|NCT00905307|968144|P2|Overall Study|Withdrawal by Subject|13
294193|NCT00905307|968145|P1|Overall Study|Withdrawal by Subject|5
294194|NCT00905307|968140|P6|Overall Study|Adverse Event|5
294195|NCT00905307|968141|P5|Overall Study|Adverse Event|3
294196|NCT00905307|968142|P4|Overall Study|Adverse Event|11
294197|NCT00905307|968143|P3|Overall Study|Adverse Event|5
294198|NCT00905307|968144|P2|Overall Study|Adverse Event|4
294199|NCT00905307|968145|P1|Overall Study|Adverse Event|3
294200|NCT00905307|968140|P6|Overall Study|Lost to Follow-up|1
294201|NCT00905307|968141|P5|Overall Study|Lost to Follow-up|1
294202|NCT00905307|968142|P4|Overall Study|Lost to Follow-up|0
294203|NCT00905307|968143|P3|Overall Study|Lost to Follow-up|0
294204|NCT00905307|968144|P2|Overall Study|Lost to Follow-up|0
294205|NCT00905307|968145|P1|Overall Study|Lost to Follow-up|0
294206|NCT00905307|968140|P6|Overall Study|Switched to Open Label Rescue|15
294207|NCT00905307|968141|P5|Overall Study|Switched to Open Label Rescue|4
294208|NCT00905307|968142|P4|Overall Study|Switched to Open Label Rescue|11
294209|NCT00905307|968143|P3|Overall Study|Switched to Open Label Rescue|11
294210|NCT00905307|968144|P2|Overall Study|Switched to Open Label Rescue|17
294211|NCT00905307|968145|P1|Overall Study|Switched to Open Label Rescue|7
294212|NCT00905255|968240|P2|Overall Study|Familial and Personal Reasons|0
294213|NCT00905255|968241|P1|Overall Study|Familial and Personal Reasons|1
294214|NCT00905255|968240|P2|Overall Study|Withdrawal by Subject|4
294215|NCT00905255|968241|P1|Overall Study|Withdrawal by Subject|5
294216|NCT00905255|968240|P2|Overall Study|Adverse Event|5
294217|NCT00905255|968241|P1|Overall Study|Adverse Event|7
294218|NCT00904917|968272|P4|Overall Study|Lost to Follow-up|2
294219|NCT00904917|968273|P3|Overall Study|Lost to Follow-up|2
294220|NCT00904917|968274|P2|Overall Study|Lost to Follow-up|2
294221|NCT00904917|968275|P1|Overall Study|Lost to Follow-up|2
294222|NCT00904839|968293|P3|Overall Study|Other than above|7
294223|NCT00904839|968294|P2|Overall Study|Other than above|9
294224|NCT00904839|968295|P1|Overall Study|Other than above|0
294225|NCT00904839|968293|P3|Overall Study|Not treated|1
294226|NCT00904839|968294|P2|Overall Study|Not treated|0
294227|NCT00904839|968295|P1|Overall Study|Not treated|1
294228|NCT00904839|968293|P3|Overall Study|Withdrawal by Subject|0
294229|NCT00904839|968294|P2|Overall Study|Withdrawal by Subject|2
294230|NCT00904839|968295|P1|Overall Study|Withdrawal by Subject|0
294231|NCT00904839|968293|P3|Overall Study|Lost to Follow-up|2
294232|NCT00904839|968294|P2|Overall Study|Lost to Follow-up|1
294233|NCT00904839|968295|P1|Overall Study|Lost to Follow-up|0
294234|NCT00904839|968293|P3|Overall Study|Protocol Violation|1
294235|NCT00904839|968294|P2|Overall Study|Protocol Violation|1
294236|NCT00904839|968295|P1|Overall Study|Protocol Violation|0
294237|NCT00904839|968293|P3|Overall Study|Adverse Event|4
294238|NCT00904839|968294|P2|Overall Study|Adverse Event|5
294239|NCT00904839|968295|P1|Overall Study|Adverse Event|0
294240|NCT00904748|968341|P6|Overall Study|Adverse Event|0
294241|NCT00904748|968342|P5|Overall Study|Adverse Event|1
294242|NCT00904748|968343|P4|Overall Study|Adverse Event|0
294243|NCT00904748|968344|P3|Overall Study|Adverse Event|0
294244|NCT00904748|968345|P2|Overall Study|Adverse Event|0
294245|NCT00904748|968346|P1|Overall Study|Adverse Event|0
294246|NCT00904748|968341|P6|Overall Study|Withdrawal by Subject|0
294247|NCT00904748|968342|P5|Overall Study|Withdrawal by Subject|0
294248|NCT00904748|968343|P4|Overall Study|Withdrawal by Subject|2
294249|NCT00904748|968344|P3|Overall Study|Withdrawal by Subject|1
294250|NCT00904748|968345|P2|Overall Study|Withdrawal by Subject|1
294251|NCT00904748|968346|P1|Overall Study|Withdrawal by Subject|1
294252|NCT00904722|968370|P1|Overall Study|Physician Decision|1
294253|NCT00904670|968375|P2|Open Label Phase|Lost to Follow-up|0
294254|NCT00904670|968376|P1|Open Label Phase|Lost to Follow-up|1
294255|NCT00904670|968375|P2|Open Label Phase|Lack of Efficacy|0
294256|NCT00904670|968376|P1|Open Label Phase|Lack of Efficacy|1
294257|NCT00904670|968375|P2|Open Label Phase|Adverse Event|0
294258|NCT00904670|968376|P1|Open Label Phase|Adverse Event|2
294259|NCT00904670|968375|P2|Open Label Phase|Withdrawal by Subject|0
294260|NCT00904670|968376|P1|Open Label Phase|Withdrawal by Subject|2
294261|NCT00904371|968413|P1|Overall Study|Continued with Tritace|1
294262|NCT00904371|968413|P1|Overall Study|Discontinued at target blood pressure|2
294263|NCT00904371|968413|P1|Overall Study|Lost to Follow-up|4
294264|NCT00904371|968413|P1|Overall Study|Adverse Event|2
294265|NCT00904215|968427|P1|Overall Study|Other|28
294266|NCT00904215|968427|P1|Overall Study|Withdrawal by Subject|9
294267|NCT00904215|968427|P1|Overall Study|Lost to Follow-up|63
294268|NCT00904215|968427|P1|Overall Study|Protocol Violation|10
294269|NCT00904215|968427|P1|Overall Study|Adverse Event|25
294270|NCT00904150|968441|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
294271|NCT00904150|968442|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
294272|NCT00904150|968441|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
294273|NCT00904150|968442|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
294274|NCT00903929|968469|P4|Overall Study|Adverse Event|1
294275|NCT00903929|968470|P3|Overall Study|Adverse Event|0
294276|NCT00903929|968471|P2|Overall Study|Adverse Event|0
294277|NCT00903929|968472|P1|Overall Study|Adverse Event|0
294278|NCT00903929|968469|P4|Overall Study|Withdrawal by Subject|2
294279|NCT00903929|968470|P3|Overall Study|Withdrawal by Subject|1
294280|NCT00903929|968471|P2|Overall Study|Withdrawal by Subject|0
294281|NCT00903929|968472|P1|Overall Study|Withdrawal by Subject|0
294282|NCT00902850|968480|P2|Overall Study|Physician Decision|2
294283|NCT00902850|968481|P1|Overall Study|Physician Decision|2
294284|NCT00903695|968489|P2|Overall Study|lung cancer|0
294285|NCT00903695|968490|P1|Overall Study|lung cancer|1
294286|NCT00903695|968489|P2|Overall Study|medical exclusion after 1st testing|0
294287|NCT00903695|968490|P1|Overall Study|medical exclusion after 1st testing|1
294288|NCT00903682|968512|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
294289|NCT00903682|968513|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
294290|NCT00903682|968512|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
294291|NCT00903682|968513|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
294292|NCT00903682|968512|P2|Overall Study|Subject Non-Compliant|0
294293|NCT00903682|968513|P1|Overall Study|Subject Non-Compliant|1
294294|NCT00903682|968512|P2|Overall Study|Subject Reached A Virologic Endpoint|1
294295|NCT00903682|968513|P1|Overall Study|Subject Reached A Virologic Endpoint|1
294296|NCT00903682|968512|P2|Overall Study|Pregnancy|1
294297|NCT00903682|968513|P1|Overall Study|Pregnancy|0
294298|NCT00903682|968512|P2|Overall Study|Withdrawal by Subject|0
294299|NCT00903682|968513|P1|Overall Study|Withdrawal by Subject|5
294300|NCT00903682|968512|P2|Overall Study|Lost to Follow-up|0
294301|NCT00903682|968513|P1|Overall Study|Lost to Follow-up|1
294302|NCT00903682|968512|P2|Overall Study|Adverse Event|13
294303|NCT00903682|968513|P1|Overall Study|Adverse Event|6
294304|NCT00903630|968534|P3|Phase 2|Adverse Event|1
294305|NCT00903630|968535|P2|Phase 2|Adverse Event|0
294306|NCT00903630|968536|P1|Phase 2|Adverse Event|0
294307|NCT00903409|968559|P2|Overall Study|Lost to Follow-up|6
294308|NCT00903409|968560|P1|Overall Study|Lost to Follow-up|2
294309|NCT00903409|968559|P2|Overall Study|Not specified|3
294310|NCT00903409|968560|P1|Overall Study|Not specified|2
294311|NCT00903409|968559|P2|Overall Study|Withdrawal by Subject|8
294312|NCT00903409|968560|P1|Overall Study|Withdrawal by Subject|8
294313|NCT00903409|968559|P2|Overall Study|Laboratory Abnormality|0
294314|NCT00903409|968560|P1|Overall Study|Laboratory Abnormality|2
294315|NCT00903409|968559|P2|Overall Study|Non-compliance with Protocol|1
294316|NCT00903409|968560|P1|Overall Study|Non-compliance with Protocol|1
294317|NCT00903409|968559|P2|Overall Study|Adverse Event|9
294318|NCT00903409|968560|P1|Overall Study|Adverse Event|11
294319|NCT00903383|968611|P4|Overall Study|Patient Decision|1
294320|NCT00903383|968612|P3|Overall Study|Patient Decision|0
294321|NCT00903383|968613|P2|Overall Study|Patient Decision|0
294322|NCT00903383|968614|P1|Overall Study|Patient Decision|0
294323|NCT00903383|968611|P4|Overall Study|Patient Decision - Lack of Efficacy|0
294324|NCT00903383|968612|P3|Overall Study|Patient Decision - Lack of Efficacy|0
294325|NCT00903383|968613|P2|Overall Study|Patient Decision - Lack of Efficacy|1
294326|NCT00903383|968614|P1|Overall Study|Patient Decision - Lack of Efficacy|0
294327|NCT00903383|968611|P4|Overall Study|Withdrawal by Subject|2
294328|NCT00903383|968612|P3|Overall Study|Withdrawal by Subject|0
294329|NCT00903383|968613|P2|Overall Study|Withdrawal by Subject|1
294330|NCT00903383|968614|P1|Overall Study|Withdrawal by Subject|4
294331|NCT00903383|968611|P4|Overall Study|Decision of Sponsor|0
294332|NCT00903383|968612|P3|Overall Study|Decision of Sponsor|0
294333|NCT00903383|968613|P2|Overall Study|Decision of Sponsor|0
294334|NCT00903383|968614|P1|Overall Study|Decision of Sponsor|1
294335|NCT00903383|968611|P4|Overall Study|Lost to Follow-up|1
294336|NCT00903383|968612|P3|Overall Study|Lost to Follow-up|0
294337|NCT00903383|968613|P2|Overall Study|Lost to Follow-up|0
294338|NCT00903383|968614|P1|Overall Study|Lost to Follow-up|0
294339|NCT00903383|968611|P4|Overall Study|Physician Decision|0
294340|NCT00903383|968612|P3|Overall Study|Physician Decision|0
294341|NCT00903383|968613|P2|Overall Study|Physician Decision|2
294342|NCT00903383|968614|P1|Overall Study|Physician Decision|1
294343|NCT00903383|968611|P4|Overall Study|Adverse Event|1
294344|NCT00903383|968612|P3|Overall Study|Adverse Event|3
294345|NCT00903383|968613|P2|Overall Study|Adverse Event|2
294346|NCT00903383|968614|P1|Overall Study|Adverse Event|1
294347|NCT00903370|968646|P2|Overall Study|Lost to Follow-up|8
294348|NCT00903370|968647|P1|Overall Study|Lost to Follow-up|6
294349|NCT00903370|968646|P2|Overall Study|Withdrawal by Subject|6
294350|NCT00903370|968647|P1|Overall Study|Withdrawal by Subject|9
294351|NCT00903370|968646|P2|Overall Study|Death|10
294352|NCT00903370|968647|P1|Overall Study|Death|13
294353|NCT00903357|968655|P2|Second Intervention|Lost to Follow-up|0
294354|NCT00903357|968656|P1|Second Intervention|Lost to Follow-up|1
294355|NCT00903357|968655|P2|Wash Out Period of 2 Weeks|Flu|1
294356|NCT00903357|968656|P1|Wash Out Period of 2 Weeks|Flu|0
294357|NCT00903357|968655|P2|First Intervention|Flu|1
294358|NCT00903357|968656|P1|First Intervention|Flu|0
294359|NCT00903357|968655|P2|First Intervention|Withdrawal by Subject|3
294360|NCT00903357|968656|P1|First Intervention|Withdrawal by Subject|5
294361|NCT00903344|968668|P2|Overall Study|Lost to Follow-up|0
294362|NCT00903344|968669|P1|Overall Study|Lost to Follow-up|3
294363|NCT00903344|968668|P2|Overall Study|Pregnancy|3
294364|NCT00903344|968669|P1|Overall Study|Pregnancy|2
294365|NCT00903331|968687|P2|Overall Study|Lung transplant|2
294366|NCT00903331|968688|P1|Overall Study|Lung transplant|0
294367|NCT00903331|968687|P2|Overall Study|Withdrawal of consent|8
294368|NCT00903331|968688|P1|Overall Study|Withdrawal of consent|1
294369|NCT00903331|968687|P2|Overall Study|Death|8
294370|NCT00903331|968688|P1|Overall Study|Death|4
294371|NCT00903175|968698|P2|Period 2 - Second Line|Death|2
294372|NCT00903175|968699|P1|Period 2 - Second Line|Death|5
294373|NCT00903175|968698|P2|Period 2 - Second Line|Administrative problems|9
294374|NCT00903175|968699|P1|Period 2 - Second Line|Administrative problems|19
294375|NCT00903175|968698|P2|Period 2 - Second Line|Lost to Follow-up|0
294376|NCT00903175|968699|P1|Period 2 - Second Line|Lost to Follow-up|1
294377|NCT00903175|968698|P2|Period 2 - Second Line|Withdrawal by Subject|5
294378|NCT00903175|968699|P1|Period 2 - Second Line|Withdrawal by Subject|7
294379|NCT00903175|968698|P2|Period 2 - Second Line|Adverse Event|20
294380|NCT00903175|968699|P1|Period 2 - Second Line|Adverse Event|16
294381|NCT00903175|968698|P2|Period 2 - Second Line|Missing|0
294382|NCT00903175|968699|P1|Period 2 - Second Line|Missing|1
294383|NCT00903175|968698|P2|Period 1 - First Line|Death|10
294384|NCT00903175|968699|P1|Period 1 - First Line|Death|17
294385|NCT00903175|968698|P2|Period 1 - First Line|Administrative problems|13
294386|NCT00903175|968699|P1|Period 1 - First Line|Administrative problems|12
294387|NCT00903175|968698|P2|Period 1 - First Line|Withdrawal by Subject|12
294388|NCT00903175|968699|P1|Period 1 - First Line|Withdrawal by Subject|8
294389|NCT00903175|968698|P2|Period 1 - First Line|Protocol Violation|3
294390|NCT00903175|968699|P1|Period 1 - First Line|Protocol Violation|3
294391|NCT00903175|968698|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
294392|NCT00903175|968699|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
294393|NCT00903175|968698|P2|Period 1 - First Line|Abnormal lab value(s)|1
294394|NCT00903175|968699|P1|Period 1 - First Line|Abnormal lab value(s)|0
294395|NCT00903175|968698|P2|Period 1 - First Line|Adverse Event|50
294396|NCT00903175|968699|P1|Period 1 - First Line|Adverse Event|36
294397|NCT00903032|968737|P2|Overall Study|Lost to Follow-up|2
294398|NCT00903032|968738|P1|Overall Study|Lost to Follow-up|2
294399|NCT00903032|968737|P2|Overall Study|Withdrawal by Subject|3
294400|NCT00903032|968738|P1|Overall Study|Withdrawal by Subject|5
294401|NCT00903006|968748|P4|Overall Study|Progressive Disease|0
294402|NCT00903006|968749|P3|Overall Study|Progressive Disease|1
294403|NCT00903006|968750|P2|Overall Study|Progressive Disease|3
294404|NCT00903006|968751|P1|Overall Study|Progressive Disease|0
294405|NCT00903006|968748|P4|Overall Study|Withdrawal by Subject|0
294406|NCT00903006|968749|P3|Overall Study|Withdrawal by Subject|0
294407|NCT00903006|968750|P2|Overall Study|Withdrawal by Subject|0
294408|NCT00903006|968751|P1|Overall Study|Withdrawal by Subject|2
294409|NCT00902746|968761|P1|Overall Study|Physician Decision|2
294410|NCT00902746|968761|P1|Overall Study|Lost to Follow-up|3
294411|NCT00902746|968761|P1|Overall Study|Adverse Event|8
294412|NCT00902746|968761|P1|Overall Study|Withdrawal by Subject|16
294413|NCT00902746|968761|P1|Overall Study|Protocol Violation|7
294414|NCT00902668|968766|P1|Overall Study|Protocol stopped due to slow accrual.|3
294415|NCT00902564|968770|P1|Overall Study|Withdrawal by Subject|2
294416|NCT00902538|968785|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
294417|NCT00902538|968786|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
294418|NCT00902538|968787|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
294419|NCT00902538|968788|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
294420|NCT00902538|968789|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
294421|NCT00902538|968790|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
294422|NCT00902538|968785|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
294423|NCT00902538|968786|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
294424|NCT00902538|968787|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
294425|NCT00902538|968788|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
294426|NCT00902538|968789|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
294427|NCT00902538|968790|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
294428|NCT00902538|968785|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
294429|NCT00902538|968786|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
294430|NCT00902538|968787|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
294431|NCT00902538|968788|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
294432|NCT00902538|968789|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
294433|NCT00902538|968790|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
294434|NCT00902538|968785|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
294435|NCT00902538|968786|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
294436|NCT00902538|968787|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
294437|NCT00902538|968788|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
294438|NCT00902538|968789|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
294439|NCT00902538|968790|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
294440|NCT00902538|968785|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
294441|NCT00902538|968786|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
294442|NCT00902538|968787|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
294443|NCT00902538|968788|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
294444|NCT00902538|968789|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
294445|NCT00902538|968790|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
294446|NCT00902538|968785|P6|3-Single-blind, Single Treatment|Protocol Violation|0
294447|NCT00902538|968786|P5|3-Single-blind, Single Treatment|Protocol Violation|0
294448|NCT00902538|968787|P4|3-Single-blind, Single Treatment|Protocol Violation|0
294449|NCT00902538|968788|P3|3-Single-blind, Single Treatment|Protocol Violation|0
294450|NCT00902538|968789|P2|3-Single-blind, Single Treatment|Protocol Violation|5
294451|NCT00902538|968790|P1|3-Single-blind, Single Treatment|Protocol Violation|0
294452|NCT00902538|968785|P6|3-Single-blind, Single Treatment|Adverse Event|0
294453|NCT00902538|968786|P5|3-Single-blind, Single Treatment|Adverse Event|0
294454|NCT00902538|968787|P4|3-Single-blind, Single Treatment|Adverse Event|0
294455|NCT00902538|968788|P3|3-Single-blind, Single Treatment|Adverse Event|0
294456|NCT00902538|968789|P2|3-Single-blind, Single Treatment|Adverse Event|5
294457|NCT00902538|968790|P1|3-Single-blind, Single Treatment|Adverse Event|0
294458|NCT00902538|968785|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
294459|NCT00902538|968786|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
294460|NCT00902538|968787|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
294461|NCT00902538|968788|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
294462|NCT00902538|968789|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
294463|NCT00902538|968790|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
294464|NCT00902538|968785|P6|2-Randomized Double-blind 3 Treatments|Other|0
294465|NCT00902538|968786|P5|2-Randomized Double-blind 3 Treatments|Other|0
294466|NCT00902538|968787|P4|2-Randomized Double-blind 3 Treatments|Other|0
294467|NCT00902538|968788|P3|2-Randomized Double-blind 3 Treatments|Other|0
294468|NCT00902538|968789|P2|2-Randomized Double-blind 3 Treatments|Other|1
294469|NCT00902538|968790|P1|2-Randomized Double-blind 3 Treatments|Other|2
294470|NCT00902538|968785|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
294471|NCT00902538|968786|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
294472|NCT00902538|968787|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
294473|NCT00902538|968788|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
294474|NCT00902538|968789|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
294475|NCT00902538|968790|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
294476|NCT00902538|968785|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
294477|NCT00902538|968786|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
294478|NCT00902538|968787|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
294479|NCT00902538|968788|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
294480|NCT00902538|968789|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
294481|NCT00902538|968790|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
294482|NCT00902538|968785|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
294483|NCT00902538|968786|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
294484|NCT00902538|968787|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
294485|NCT00902538|968788|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
294486|NCT00902538|968789|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
294487|NCT00902538|968790|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
294488|NCT00902538|968785|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
294489|NCT00902538|968786|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
294490|NCT00902538|968787|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
294491|NCT00902538|968788|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
294492|NCT00902538|968789|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
294493|NCT00902538|968790|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
294494|NCT00902538|968785|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
294495|NCT00902538|968786|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
294496|NCT00902538|968787|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
294497|NCT00902538|968788|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
294498|NCT00902538|968789|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
294499|NCT00902538|968790|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
294500|NCT00902538|968785|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
294501|NCT00902538|968786|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
294502|NCT00902538|968787|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
294503|NCT00902538|968788|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
294504|NCT00902538|968789|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
294505|NCT00902538|968790|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
294506|NCT00902538|968785|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
294507|NCT00902538|968786|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
294508|NCT00902538|968787|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
294509|NCT00902538|968788|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
294510|NCT00902538|968789|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
294511|NCT00902538|968790|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
294512|NCT00902538|968785|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
294513|NCT00902538|968786|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
294514|NCT00902538|968787|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
294515|NCT00902538|968788|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
294516|NCT00902538|968789|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
294517|NCT00902538|968790|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
294518|NCT00902330|968822|P2|Overall Study|No post baseline data|0
294519|NCT00902330|968823|P1|Overall Study|No post baseline data|1
294520|NCT00902330|968822|P2|Overall Study|Adverse Event|0
294521|NCT00902330|968823|P1|Overall Study|Adverse Event|1
294522|NCT00902330|968822|P2|Overall Study|Too overwhelmed by treatment|5
294523|NCT00902330|968823|P1|Overall Study|Too overwhelmed by treatment|2
294524|NCT00902304|968860|P3|Overall Study|includes pregnancy|2
294525|NCT00902304|968861|P2|Overall Study|includes pregnancy|9
294526|NCT00902304|968862|P1|Overall Study|includes pregnancy|3
294527|NCT00902304|968860|P3|Overall Study|Withdrawal by Subject|43
294528|NCT00902304|968861|P2|Overall Study|Withdrawal by Subject|22
294529|NCT00902304|968862|P1|Overall Study|Withdrawal by Subject|32
294530|NCT00902304|968860|P3|Overall Study|Protocol Violation|20
294531|NCT00902304|968861|P2|Overall Study|Protocol Violation|18
294532|NCT00902304|968862|P1|Overall Study|Protocol Violation|9
294533|NCT00902304|968860|P3|Overall Study|Lost to Follow-up|7
294534|NCT00902304|968861|P2|Overall Study|Lost to Follow-up|7
294535|NCT00902304|968862|P1|Overall Study|Lost to Follow-up|7
294536|NCT00902304|968860|P3|Overall Study|Investigator discretion|13
294537|NCT00902304|968861|P2|Overall Study|Investigator discretion|5
294538|NCT00902304|968862|P1|Overall Study|Investigator discretion|3
294539|NCT00902304|968860|P3|Overall Study|Adverse Event|25
294540|NCT00902304|968861|P2|Overall Study|Adverse Event|10
294541|NCT00902304|968862|P1|Overall Study|Adverse Event|4
294542|NCT00902265|968907|P1|Overall Study|Protocol Violation|1
294543|NCT00902265|968907|P1|Overall Study|Lack of Efficacy|2
294544|NCT00902265|968907|P1|Overall Study|Adverse Event|2
294545|NCT00902265|968907|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
294546|NCT00902174|968931|P2|Overall Study|Administration problem|1
294547|NCT00902174|968932|P1|Overall Study|Administration problem|0
294548|NCT00902174|968931|P2|Overall Study|Protocol Violation|1
294549|NCT00902174|968932|P1|Overall Study|Protocol Violation|1
294550|NCT00902174|968931|P2|Overall Study|Abnormal labs|1
294551|NCT00902174|968932|P1|Overall Study|Abnormal labs|1
294552|NCT00902174|968931|P2|Overall Study|Withdrawal by Subject|1
294553|NCT00902174|968932|P1|Overall Study|Withdrawal by Subject|2
294554|NCT00902174|968931|P2|Overall Study|Death|2
294555|NCT00902174|968932|P1|Overall Study|Death|2
294556|NCT00902174|968931|P2|Overall Study|Lack of Efficacy|5
294557|NCT00902174|968932|P1|Overall Study|Lack of Efficacy|1
294558|NCT00902174|968931|P2|Overall Study|Adverse Event|7
294559|NCT00902174|968932|P1|Overall Study|Adverse Event|27
294560|NCT00901901|968989|P2|Follow-up Period|Lost to Follow-up|8
294561|NCT00901901|968990|P1|Follow-up Period|Lost to Follow-up|12
294562|NCT00901901|968989|P2|Follow-up Period|Withdrawal by Subject|9
294563|NCT00901901|968990|P1|Follow-up Period|Withdrawal by Subject|6
294564|NCT00901901|968989|P2|Follow-up Period|Protocol driven decision point|35
294565|NCT00901901|968990|P1|Follow-up Period|Protocol driven decision point|47
294566|NCT00901901|968989|P2|Follow-up Period|Death|207
294567|NCT00901901|968990|P1|Follow-up Period|Death|181
294568|NCT00901901|968989|P2|Treatment Period|Never treated|3
294569|NCT00901901|968990|P1|Treatment Period|Never treated|0
294570|NCT00901901|968989|P2|Treatment Period|Missing|1
294571|NCT00901901|968990|P1|Treatment Period|Missing|1
294572|NCT00901901|968989|P2|Treatment Period|Protocol Violation|9
294573|NCT00901901|968990|P1|Treatment Period|Protocol Violation|4
294574|NCT00901901|968989|P2|Treatment Period|Noncompliance with study medication|1
294575|NCT00901901|968990|P1|Treatment Period|Noncompliance with study medication|4
294576|NCT00901901|968989|P2|Treatment Period|Lost to Follow-up|5
294577|NCT00901901|968990|P1|Treatment Period|Lost to Follow-up|3
294578|NCT00901901|968989|P2|Treatment Period|Physician Decision|2
294579|NCT00901901|968990|P1|Treatment Period|Physician Decision|2
294580|NCT00901901|968989|P2|Treatment Period|Withdrawal by Subject|24
294581|NCT00901901|968990|P1|Treatment Period|Withdrawal by Subject|26
294582|NCT00901901|968989|P2|Treatment Period|Adverse Event|123
294583|NCT00901901|968990|P1|Treatment Period|Adverse Event|117
294584|NCT00901628|969096|P2|Overall Study|peroneal nerve palsy|1
294585|NCT00901628|969097|P1|Overall Study|peroneal nerve palsy|0
294586|NCT00901628|969096|P2|Overall Study|disconnection of drain|1
294587|NCT00901628|969097|P1|Overall Study|disconnection of drain|0
294588|NCT00901628|969096|P2|Overall Study|disconnection of catheter|8
294589|NCT00901628|969097|P1|Overall Study|disconnection of catheter|4
294590|NCT00901576|969119|P6|Second Intervention|Physician Decision|0
294591|NCT00901576|969120|P5|Second Intervention|Physician Decision|0
294592|NCT00901576|969121|P4|Second Intervention|Physician Decision|0
294593|NCT00901576|969122|P3|Second Intervention|Physician Decision|0
294594|NCT00901576|969123|P2|Second Intervention|Physician Decision|0
294595|NCT00901576|969124|P1|Second Intervention|Physician Decision|1
294596|NCT00901576|969119|P6|Second Intervention|Withdrawal by Subject|1
294597|NCT00901576|969120|P5|Second Intervention|Withdrawal by Subject|0
294598|NCT00901576|969121|P4|Second Intervention|Withdrawal by Subject|1
294599|NCT00901576|969122|P3|Second Intervention|Withdrawal by Subject|0
294600|NCT00901576|969123|P2|Second Intervention|Withdrawal by Subject|0
294601|NCT00901576|969124|P1|Second Intervention|Withdrawal by Subject|0
294602|NCT00901459|969145|P1|Overall Study|Withdrawal by Subject|6
294603|NCT00901342|969156|P1|Overall Study|Withdrawal by Subject|9
294604|NCT00901342|969156|P1|Overall Study|Disease progression|1
294605|NCT00901342|969156|P1|Overall Study|Death|4
294606|NCT00901342|969156|P1|Overall Study|Adverse Event|1
294607|NCT00901186|969180|P2|Overall Study|Protocol deviations|4
294608|NCT00901186|969181|P1|Overall Study|Protocol deviations|5
294609|NCT00901186|969180|P2|Overall Study|Administration problems|1
294610|NCT00901186|969181|P1|Overall Study|Administration problems|0
294611|NCT00901186|969180|P2|Overall Study|Adverse Event|4
294612|NCT00901186|969181|P1|Overall Study|Adverse Event|2
294613|NCT00901186|969180|P2|Overall Study|Lost to Follow-up|0
294614|NCT00901186|969181|P1|Overall Study|Lost to Follow-up|2
294615|NCT00901186|969180|P2|Overall Study|Abnormal laboratory values|1
294616|NCT00901186|969181|P1|Overall Study|Abnormal laboratory values|0
294617|NCT00901186|969180|P2|Overall Study|Lack of Efficacy|1
294618|NCT00901186|969181|P1|Overall Study|Lack of Efficacy|0
294619|NCT00900796|969221|P1|Phase 2|Lost to Follow-up|5
294620|NCT00900796|969221|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
294621|NCT00900796|969221|P1|Phase 1|Missing information at Week 16|7
294622|NCT00900796|969221|P1|Phase 1|Lacked sufficient information|4
294623|NCT00900757|969231|P1|Overall Study|screen failure|19
294624|NCT00900731|969241|P2|Overall Study|Death|2
294625|NCT00900731|969242|P1|Overall Study|Death|0
294626|NCT00900731|969241|P2|Overall Study|Lack of Efficacy|3
294627|NCT00900731|969242|P1|Overall Study|Lack of Efficacy|1
294628|NCT00900731|969241|P2|Overall Study|Lost to Follow-up|3
294629|NCT00900731|969242|P1|Overall Study|Lost to Follow-up|2
294630|NCT00900731|969241|P2|Overall Study|Abnormal Laboratory Value(s)|4
294631|NCT00900731|969242|P1|Overall Study|Abnormal Laboratory Value(s)|2
294632|NCT00900731|969241|P2|Overall Study|Abnormal Test Procedure Result(s)|0
294633|NCT00900731|969242|P1|Overall Study|Abnormal Test Procedure Result(s)|3
294634|NCT00900731|969241|P2|Overall Study|Administrative Problems|4
294635|NCT00900731|969242|P1|Overall Study|Administrative Problems|5
294636|NCT00900731|969241|P2|Overall Study|Protocol Deviation|11
294637|NCT00900731|969242|P1|Overall Study|Protocol Deviation|8
294638|NCT00900731|969241|P2|Overall Study|Withdrawal by Subject|7
294639|NCT00900731|969242|P1|Overall Study|Withdrawal by Subject|8
294640|NCT00900731|969241|P2|Overall Study|Adverse Event|27
294641|NCT00900731|969242|P1|Overall Study|Adverse Event|31
294642|NCT00899392|969264|P2|Overall Study|Subject didn't finish/partial pilot data|24
294643|NCT00899392|969265|P1|Overall Study|Subject didn't finish/partial pilot data|21
294644|NCT00899379|969282|P5|Overall Study|Inc/Exc Criteria Not Met|0
294645|NCT00899379|969283|P4|Overall Study|Inc/Exc Criteria Not Met|0
294646|NCT00899379|969284|P3|Overall Study|Inc/Exc Criteria Not Met|1
294647|NCT00899379|969285|P2|Overall Study|Inc/Exc Criteria Not Met|0
294648|NCT00899379|969286|P1|Overall Study|Inc/Exc Criteria Not Met|0
294649|NCT00899379|969282|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
294650|NCT00899379|969283|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
294651|NCT00899379|969284|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
294652|NCT00899379|969285|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
294653|NCT00899379|969286|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
294654|NCT00899379|969282|P5|Overall Study|No Attack Pretreatment|4
294655|NCT00899379|969283|P4|Overall Study|No Attack Pretreatment|6
294656|NCT00899379|969284|P3|Overall Study|No Attack Pretreatment|5
294657|NCT00899379|969285|P2|Overall Study|No Attack Pretreatment|5
294658|NCT00899379|969286|P1|Overall Study|No Attack Pretreatment|3
294659|NCT00899379|969282|P5|Overall Study|Abnormal Baseline ECG|0
294660|NCT00899379|969283|P4|Overall Study|Abnormal Baseline ECG|1
294661|NCT00899379|969284|P3|Overall Study|Abnormal Baseline ECG|1
294662|NCT00899379|969285|P2|Overall Study|Abnormal Baseline ECG|0
294663|NCT00899379|969286|P1|Overall Study|Abnormal Baseline ECG|0
294664|NCT00899379|969282|P5|Overall Study|Abnormal Prestudy Labs|2
294665|NCT00899379|969283|P4|Overall Study|Abnormal Prestudy Labs|0
294666|NCT00899379|969284|P3|Overall Study|Abnormal Prestudy Labs|0
294667|NCT00899379|969285|P2|Overall Study|Abnormal Prestudy Labs|0
294668|NCT00899379|969286|P1|Overall Study|Abnormal Prestudy Labs|0
294669|NCT00899379|969282|P5|Overall Study|Patient Uncooperative|0
294670|NCT00899379|969283|P4|Overall Study|Patient Uncooperative|1
294671|NCT00899379|969284|P3|Overall Study|Patient Uncooperative|0
294672|NCT00899379|969285|P2|Overall Study|Patient Uncooperative|0
294673|NCT00899379|969286|P1|Overall Study|Patient Uncooperative|0
294674|NCT00899379|969282|P5|Overall Study|Pregnancy|0
294675|NCT00899379|969283|P4|Overall Study|Pregnancy|0
294676|NCT00899379|969284|P3|Overall Study|Pregnancy|0
294677|NCT00899379|969285|P2|Overall Study|Pregnancy|0
294678|NCT00899379|969286|P1|Overall Study|Pregnancy|1
294679|NCT00899379|969282|P5|Overall Study|Withdrawal by Subject|2
294680|NCT00899379|969283|P4|Overall Study|Withdrawal by Subject|7
294681|NCT00899379|969284|P3|Overall Study|Withdrawal by Subject|4
294682|NCT00899379|969285|P2|Overall Study|Withdrawal by Subject|7
294683|NCT00899379|969286|P1|Overall Study|Withdrawal by Subject|4
294684|NCT00899379|969282|P5|Overall Study|Lost to Follow-up|5
294685|NCT00899379|969283|P4|Overall Study|Lost to Follow-up|2
294686|NCT00899379|969284|P3|Overall Study|Lost to Follow-up|0
294687|NCT00899379|969285|P2|Overall Study|Lost to Follow-up|1
294688|NCT00899379|969286|P1|Overall Study|Lost to Follow-up|3
294689|NCT00899379|969282|P5|Overall Study|Study Terminated|1
294690|NCT00899379|969283|P4|Overall Study|Study Terminated|3
294691|NCT00899379|969284|P3|Overall Study|Study Terminated|3
294692|NCT00899379|969285|P2|Overall Study|Study Terminated|0
294693|NCT00899379|969286|P1|Overall Study|Study Terminated|3
294694|NCT00899379|969282|P5|Overall Study|Not Completed/Entered Extn|3
294695|NCT00899379|969283|P4|Overall Study|Not Completed/Entered Extn|4
294696|NCT00899379|969284|P3|Overall Study|Not Completed/Entered Extn|6
294697|NCT00899379|969285|P2|Overall Study|Not Completed/Entered Extn|1
294698|NCT00899379|969286|P1|Overall Study|Not Completed/Entered Extn|5
294699|NCT00899379|969282|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
294700|NCT00899379|969283|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
294701|NCT00899379|969284|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
294702|NCT00899379|969285|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
294703|NCT00899379|969286|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
294704|NCT00899379|969282|P5|Overall Study|Abnormal Baseline ECG|0
294705|NCT00899379|969283|P4|Overall Study|Abnormal Baseline ECG|1
294706|NCT00899379|969284|P3|Overall Study|Abnormal Baseline ECG|0
294707|NCT00899379|969285|P2|Overall Study|Abnormal Baseline ECG|0
294708|NCT00899379|969286|P1|Overall Study|Abnormal Baseline ECG|0
294709|NCT00899379|969282|P5|Overall Study|Patient Uncooperative|2
294710|NCT00899379|969283|P4|Overall Study|Patient Uncooperative|1
294711|NCT00899379|969284|P3|Overall Study|Patient Uncooperative|0
294712|NCT00899379|969285|P2|Overall Study|Patient Uncooperative|1
294713|NCT00899379|969286|P1|Overall Study|Patient Uncooperative|0
294714|NCT00899379|969282|P5|Overall Study|Pregnancy|1
294715|NCT00899379|969283|P4|Overall Study|Pregnancy|0
294716|NCT00899379|969284|P3|Overall Study|Pregnancy|1
294717|NCT00899379|969285|P2|Overall Study|Pregnancy|0
294718|NCT00899379|969286|P1|Overall Study|Pregnancy|0
294719|NCT00899379|969282|P5|Overall Study|Withdrawal by Subject|6
294720|NCT00899379|969283|P4|Overall Study|Withdrawal by Subject|3
294721|NCT00899379|969284|P3|Overall Study|Withdrawal by Subject|2
294722|NCT00899379|969285|P2|Overall Study|Withdrawal by Subject|4
294723|NCT00899379|969286|P1|Overall Study|Withdrawal by Subject|2
294724|NCT00899379|969282|P5|Overall Study|Protocol Violation|0
294725|NCT00899379|969283|P4|Overall Study|Protocol Violation|1
294726|NCT00899379|969284|P3|Overall Study|Protocol Violation|1
294727|NCT00899379|969285|P2|Overall Study|Protocol Violation|0
294728|NCT00899379|969286|P1|Overall Study|Protocol Violation|0
294729|NCT00899379|969282|P5|Overall Study|Lost to Follow-up|2
294730|NCT00899379|969283|P4|Overall Study|Lost to Follow-up|6
294731|NCT00899379|969284|P3|Overall Study|Lost to Follow-up|0
294732|NCT00899379|969285|P2|Overall Study|Lost to Follow-up|3
294733|NCT00899379|969286|P1|Overall Study|Lost to Follow-up|9
294734|NCT00899379|969282|P5|Overall Study|Lack of Efficacy|1
294735|NCT00899379|969283|P4|Overall Study|Lack of Efficacy|0
294736|NCT00899379|969284|P3|Overall Study|Lack of Efficacy|3
294737|NCT00899379|969285|P2|Overall Study|Lack of Efficacy|4
294738|NCT00899379|969286|P1|Overall Study|Lack of Efficacy|0
294739|NCT00899379|969282|P5|Overall Study|Adverse Event|2
294740|NCT00899379|969283|P4|Overall Study|Adverse Event|1
294741|NCT00899379|969284|P3|Overall Study|Adverse Event|1
294742|NCT00899379|969285|P2|Overall Study|Adverse Event|2
294743|NCT00899379|969286|P1|Overall Study|Adverse Event|2
294744|NCT00900627|969315|P6|Overall Study|Death|24
294745|NCT00900627|969316|P5|Overall Study|Death|28
294746|NCT00900627|969317|P4|Overall Study|Death|0
294747|NCT00900627|969318|P3|Overall Study|Death|0
294748|NCT00900627|969319|P2|Overall Study|Death|0
294749|NCT00900627|969320|P1|Overall Study|Death|0
294750|NCT00900627|969315|P6|Overall Study|Adverse Event|0
294751|NCT00900627|969316|P5|Overall Study|Adverse Event|0
294752|NCT00900627|969317|P4|Overall Study|Adverse Event|3
294753|NCT00900627|969318|P3|Overall Study|Adverse Event|0
294754|NCT00900627|969319|P2|Overall Study|Adverse Event|2
294755|NCT00900627|969320|P1|Overall Study|Adverse Event|1
294756|NCT00900627|969315|P6|Overall Study|Withdrawal by Subject|2
294757|NCT00900627|969316|P5|Overall Study|Withdrawal by Subject|1
294758|NCT00900627|969317|P4|Overall Study|Withdrawal by Subject|0
294759|NCT00900627|969318|P3|Overall Study|Withdrawal by Subject|1
294760|NCT00900627|969319|P2|Overall Study|Withdrawal by Subject|0
294761|NCT00900627|969320|P1|Overall Study|Withdrawal by Subject|1
294762|NCT00900627|969315|P6|Overall Study|Condition under investigation worsened|0
294763|NCT00900627|969316|P5|Overall Study|Condition under investigation worsened|0
294764|NCT00900627|969317|P4|Overall Study|Condition under investigation worsened|3
294765|NCT00900627|969318|P3|Overall Study|Condition under investigation worsened|5
294766|NCT00900627|969319|P2|Overall Study|Condition under investigation worsened|0
294767|NCT00900627|969320|P1|Overall Study|Condition under investigation worsened|4
294768|NCT00900146|969354|P5|Intermediate: Period III|Administrative problems|163
294769|NCT00900146|969355|P4|Intermediate: Period III|Administrative problems|90
294770|NCT00900146|969356|P3|Intermediate: Period III|Administrative problems|84
294771|NCT00900146|969357|P2|Intermediate: Period III|Administrative problems|92
294772|NCT00900146|969358|P1|Intermediate: Period III|Administrative problems|85
294773|NCT00900146|969354|P5|Intermediate: Period III|Lost to Follow-up|1
294774|NCT00900146|969355|P4|Intermediate: Period III|Lost to Follow-up|0
294775|NCT00900146|969356|P3|Intermediate: Period III|Lost to Follow-up|0
294776|NCT00900146|969357|P2|Intermediate: Period III|Lost to Follow-up|0
294777|NCT00900146|969358|P1|Intermediate: Period III|Lost to Follow-up|2
294778|NCT00900146|969354|P5|Intermediate: Period III|Withdrawal by Subject|3
294779|NCT00900146|969355|P4|Intermediate: Period III|Withdrawal by Subject|0
294780|NCT00900146|969356|P3|Intermediate: Period III|Withdrawal by Subject|0
294781|NCT00900146|969357|P2|Intermediate: Period III|Withdrawal by Subject|1
294782|NCT00900146|969358|P1|Intermediate: Period III|Withdrawal by Subject|0
294783|NCT00900146|969354|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
294784|NCT00900146|969355|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
294785|NCT00900146|969356|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
294786|NCT00900146|969357|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
294787|NCT00900146|969358|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
294788|NCT00900146|969354|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
294789|NCT00900146|969355|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
294790|NCT00900146|969356|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
294791|NCT00900146|969357|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
294792|NCT00900146|969358|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
294793|NCT00900146|969354|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
294794|NCT00900146|969355|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
294795|NCT00900146|969356|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
294796|NCT00900146|969357|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
294797|NCT00900146|969358|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
294798|NCT00900029|969475|P5|Overall Study|Death|0
294799|NCT00900029|969476|P4|Overall Study|Death|1
294800|NCT00900029|969477|P3|Overall Study|Death|0
294801|NCT00900029|969478|P2|Overall Study|Death|0
294802|NCT00900029|969479|P1|Overall Study|Death|1
294803|NCT00900029|969475|P5|Overall Study|Adverse Event|1
294804|NCT00900029|969476|P4|Overall Study|Adverse Event|1
294805|NCT00900029|969477|P3|Overall Study|Adverse Event|1
294806|NCT00900029|969478|P2|Overall Study|Adverse Event|0
294807|NCT00900029|969479|P1|Overall Study|Adverse Event|0
294808|NCT00900029|969475|P5|Overall Study|Withdrawal by Subject|1
294809|NCT00900029|969476|P4|Overall Study|Withdrawal by Subject|1
294810|NCT00900029|969477|P3|Overall Study|Withdrawal by Subject|1
294811|NCT00900029|969478|P2|Overall Study|Withdrawal by Subject|2
294812|NCT00900029|969479|P1|Overall Study|Withdrawal by Subject|2
294813|NCT00900029|969475|P5|Overall Study|Lost to Follow-up|4
294814|NCT00900029|969476|P4|Overall Study|Lost to Follow-up|4
294815|NCT00900029|969477|P3|Overall Study|Lost to Follow-up|1
294816|NCT00900029|969478|P2|Overall Study|Lost to Follow-up|2
294817|NCT00900029|969479|P1|Overall Study|Lost to Follow-up|0
294818|NCT00899678|969516|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
294819|NCT00899678|969517|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
294820|NCT00899678|969518|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
294821|NCT00899678|969516|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
294822|NCT00899678|969517|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
294823|NCT00899678|969518|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
294824|NCT00899678|969516|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
294825|NCT00899678|969517|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
294826|NCT00899678|969518|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
294827|NCT00899678|969516|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
294828|NCT00899678|969517|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
294829|NCT00899678|969518|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
294830|NCT00899678|969516|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
294831|NCT00899678|969517|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
294832|NCT00899678|969518|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
294833|NCT00899678|969516|P3|Induction Period (Weeks 0 to 6)|Other reason|0
294834|NCT00899678|969517|P2|Induction Period (Weeks 0 to 6)|Other reason|0
294835|NCT00899678|969518|P1|Induction Period (Weeks 0 to 6)|Other reason|1
294836|NCT00899678|969516|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
294837|NCT00899678|969517|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
294838|NCT00899678|969518|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
294839|NCT00899678|969516|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
294840|NCT00899678|969517|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
294841|NCT00899678|969518|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
294842|NCT00899678|969516|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
294843|NCT00899678|969517|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
294844|NCT00899678|969518|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
294845|NCT00899353|969555|P1|Overall Study|Withdrawal by Subject|2
294846|NCT00899353|969555|P1|Overall Study|Lost to Follow-up|1
294847|NCT00899353|969555|P1|Overall Study|Adverse Event|2
294848|NCT00898807|969578|P2|Overall Study|Death|1
294849|NCT00898807|969579|P1|Overall Study|Death|0
294850|NCT00898807|969578|P2|Overall Study|Lost to Follow-up|3
294851|NCT00898807|969579|P1|Overall Study|Lost to Follow-up|1
294852|NCT00898807|969578|P2|Overall Study|Family pressure to discontinue|2
294853|NCT00898807|969579|P1|Overall Study|Family pressure to discontinue|2
294854|NCT00898807|969578|P2|Overall Study|Withdrawal by Subject|3
294855|NCT00898807|969579|P1|Overall Study|Withdrawal by Subject|5
294856|NCT00898677|969595|P4|Overall Study|Not Treated: Other (Not Specified)|0
294857|NCT00898677|969596|P3|Overall Study|Not Treated: Other (Not Specified)|2
294858|NCT00898677|969597|P2|Overall Study|Not Treated: Other (Not Specified)|0
294859|NCT00898677|969598|P1|Overall Study|Not Treated: Other (Not Specified)|0
294860|NCT00898677|969595|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
294861|NCT00898677|969596|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
294862|NCT00898677|969597|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
294863|NCT00898677|969598|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
294864|NCT00898677|969595|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
294865|NCT00898677|969596|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
294866|NCT00898677|969597|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
294867|NCT00898677|969598|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
294868|NCT00898677|969595|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
294869|NCT00898677|969596|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
294870|NCT00898677|969597|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
294871|NCT00898677|969598|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
294872|NCT00898677|969595|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
294873|NCT00898677|969596|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
294874|NCT00898677|969597|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
294875|NCT00898677|969598|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
294876|NCT00898677|969595|P4|Overall Study|Not Treated: Patient uncooperative|0
294877|NCT00898677|969596|P3|Overall Study|Not Treated: Patient uncooperative|1
294878|NCT00898677|969597|P2|Overall Study|Not Treated: Patient uncooperative|3
294879|NCT00898677|969598|P1|Overall Study|Not Treated: Patient uncooperative|2
294880|NCT00898677|969595|P4|Overall Study|Not Treated: Withdraw by Subject|3
294881|NCT00898677|969596|P3|Overall Study|Not Treated: Withdraw by Subject|11
294882|NCT00898677|969597|P2|Overall Study|Not Treated: Withdraw by Subject|16
294883|NCT00898677|969598|P1|Overall Study|Not Treated: Withdraw by Subject|2
294884|NCT00898677|969595|P4|Overall Study|Not Treated: Protocol Violation|0
294885|NCT00898677|969596|P3|Overall Study|Not Treated: Protocol Violation|2
294886|NCT00898677|969597|P2|Overall Study|Not Treated: Protocol Violation|0
294887|NCT00898677|969598|P1|Overall Study|Not Treated: Protocol Violation|2
294888|NCT00898677|969595|P4|Overall Study|Not Treated: Pregnancy|0
294889|NCT00898677|969596|P3|Overall Study|Not Treated: Pregnancy|1
294890|NCT00898677|969597|P2|Overall Study|Not Treated: Pregnancy|0
294891|NCT00898677|969598|P1|Overall Study|Not Treated: Pregnancy|0
294892|NCT00898677|969595|P4|Overall Study|Not Treated: Lost to Follow-Up|2
294893|NCT00898677|969596|P3|Overall Study|Not Treated: Lost to Follow-Up|5
294894|NCT00898677|969597|P2|Overall Study|Not Treated: Lost to Follow-Up|5
294895|NCT00898677|969598|P1|Overall Study|Not Treated: Lost to Follow-Up|0
294896|NCT00898677|969595|P4|Overall Study|Not Treated: Adverse Event|0
294897|NCT00898677|969596|P3|Overall Study|Not Treated: Adverse Event|1
294898|NCT00898677|969597|P2|Overall Study|Not Treated: Adverse Event|2
294899|NCT00898677|969598|P1|Overall Study|Not Treated: Adverse Event|0
294900|NCT00898677|969595|P4|Overall Study|Withdrawal by Subject|1
294901|NCT00898677|969596|P3|Overall Study|Withdrawal by Subject|0
294902|NCT00898677|969597|P2|Overall Study|Withdrawal by Subject|0
294903|NCT00898677|969598|P1|Overall Study|Withdrawal by Subject|0
294904|NCT00898677|969595|P4|Overall Study|Protocol Violation|0
294905|NCT00898677|969596|P3|Overall Study|Protocol Violation|2
294906|NCT00898677|969597|P2|Overall Study|Protocol Violation|1
294907|NCT00898677|969598|P1|Overall Study|Protocol Violation|1
294908|NCT00898677|969595|P4|Overall Study|Lost to Follow-up|0
294909|NCT00898677|969596|P3|Overall Study|Lost to Follow-up|2
294910|NCT00898677|969597|P2|Overall Study|Lost to Follow-up|0
294911|NCT00898677|969598|P1|Overall Study|Lost to Follow-up|0
294912|NCT00898677|969595|P4|Overall Study|Adverse Event|0
294913|NCT00898677|969596|P3|Overall Study|Adverse Event|1
294914|NCT00898677|969597|P2|Overall Study|Adverse Event|0
294915|NCT00898677|969598|P1|Overall Study|Adverse Event|0
294916|NCT00898443|969636|P2|Overall Study|Withdrawal by Subject|0
294917|NCT00898443|969637|P1|Overall Study|Withdrawal by Subject|1
294918|NCT00897949|969652|P3|Overall Study|Did not take study drug|4
294919|NCT00897949|969653|P2|Overall Study|Did not take study drug|3
294920|NCT00897949|969654|P1|Overall Study|Did not take study drug|9
294921|NCT00897949|969652|P3|Overall Study|Lack of Migraine Attack|19
294922|NCT00897949|969653|P2|Overall Study|Lack of Migraine Attack|30
294923|NCT00897949|969654|P1|Overall Study|Lack of Migraine Attack|29
294924|NCT00897949|969652|P3|Overall Study|Need for Concom. Med.|1
294925|NCT00897949|969653|P2|Overall Study|Need for Concom. Med.|1
294926|NCT00897949|969654|P1|Overall Study|Need for Concom. Med.|0
294927|NCT00897949|969652|P3|Overall Study|Abnormal Baseline ECG|4
294928|NCT00897949|969653|P2|Overall Study|Abnormal Baseline ECG|2
294929|NCT00897949|969654|P1|Overall Study|Abnormal Baseline ECG|2
294930|NCT00897949|969652|P3|Overall Study|Abnormal Prestudy Labs|4
294931|NCT00897949|969653|P2|Overall Study|Abnormal Prestudy Labs|3
294932|NCT00897949|969654|P1|Overall Study|Abnormal Prestudy Labs|2
294933|NCT00897949|969652|P3|Overall Study|Withdrawal by Subject|17
294934|NCT00897949|969653|P2|Overall Study|Withdrawal by Subject|31
294935|NCT00897949|969654|P1|Overall Study|Withdrawal by Subject|24
294936|NCT00897949|969652|P3|Overall Study|Lost to Follow-up|17
294937|NCT00897949|969653|P2|Overall Study|Lost to Follow-up|23
294938|NCT00897949|969654|P1|Overall Study|Lost to Follow-up|30
294939|NCT00897949|969652|P3|Overall Study|Patient Uncoorperative|1
294940|NCT00897949|969653|P2|Overall Study|Patient Uncoorperative|2
294941|NCT00897949|969654|P1|Overall Study|Patient Uncoorperative|0
294942|NCT00897949|969652|P3|Overall Study|Withdrawal by Subject|0
294943|NCT00897949|969653|P2|Overall Study|Withdrawal by Subject|2
294944|NCT00897949|969654|P1|Overall Study|Withdrawal by Subject|1
294945|NCT00897949|969652|P3|Overall Study|Protocol Violation|1
294946|NCT00897949|969653|P2|Overall Study|Protocol Violation|3
294947|NCT00897949|969654|P1|Overall Study|Protocol Violation|6
294948|NCT00897949|969652|P3|Overall Study|Lost to Follow-up|1
294949|NCT00897949|969653|P2|Overall Study|Lost to Follow-up|2
294950|NCT00897949|969654|P1|Overall Study|Lost to Follow-up|0
294951|NCT00897949|969652|P3|Overall Study|Adverse Event|0
294952|NCT00897949|969653|P2|Overall Study|Adverse Event|1
294953|NCT00897949|969654|P1|Overall Study|Adverse Event|1
294954|NCT00897715|969688|P2|Overall Study|increased risk of infection|0
294955|NCT00897715|969689|P1|Overall Study|increased risk of infection|1
294956|NCT00897715|969688|P2|Overall Study|Physician Decision|0
294957|NCT00897715|969689|P1|Overall Study|Physician Decision|1
294958|NCT00897715|969688|P2|Overall Study|Lost to Follow-up|1
294959|NCT00897715|969689|P1|Overall Study|Lost to Follow-up|0
294960|NCT00897390|969697|P1|Overall Study|Did not Return for the Clinic Visit|2
294961|NCT00897390|969697|P1|Overall Study|Personal Reasons|1
294962|NCT00897390|969697|P1|Overall Study|No Longer Met Study Criteria|1
294963|NCT00897390|969697|P1|Overall Study|Adverse Event|2
294964|NCT00897104|969787|P3|Overall Study|Withdrawal by Subject|1
294965|NCT00897104|969788|P2|Overall Study|Withdrawal by Subject|0
294966|NCT00897104|969789|P1|Overall Study|Withdrawal by Subject|0
294967|NCT00897104|969787|P3|Overall Study|Protocol Violation|0
294968|NCT00897104|969788|P2|Overall Study|Protocol Violation|0
294969|NCT00897104|969789|P1|Overall Study|Protocol Violation|1
294970|NCT00897104|969787|P3|Overall Study|Not Specified|0
294971|NCT00897104|969788|P2|Overall Study|Not Specified|0
294972|NCT00897104|969789|P1|Overall Study|Not Specified|3
294973|NCT00897104|969787|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
294974|NCT00897104|969788|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
294975|NCT00897104|969789|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
294976|NCT00897104|969787|P3|Overall Study|Lack of Migraine Attack|1
294977|NCT00897104|969788|P2|Overall Study|Lack of Migraine Attack|22
294978|NCT00897104|969789|P1|Overall Study|Lack of Migraine Attack|20
294979|NCT00897104|969787|P3|Overall Study|Need for Concom. Med.|1
294980|NCT00897104|969788|P2|Overall Study|Need for Concom. Med.|1
294981|NCT00897104|969789|P1|Overall Study|Need for Concom. Med.|0
294982|NCT00897104|969787|P3|Overall Study|Abnormal Baseline ECG|0
294983|NCT00897104|969788|P2|Overall Study|Abnormal Baseline ECG|2
294984|NCT00897104|969789|P1|Overall Study|Abnormal Baseline ECG|2
294985|NCT00897104|969787|P3|Overall Study|Abnormal Prestudy Labs|0
294986|NCT00897104|969788|P2|Overall Study|Abnormal Prestudy Labs|0
294987|NCT00897104|969789|P1|Overall Study|Abnormal Prestudy Labs|2
294988|NCT00897104|969787|P3|Overall Study|Withdrawal by Subject|3
294989|NCT00897104|969788|P2|Overall Study|Withdrawal by Subject|27
294990|NCT00897104|969789|P1|Overall Study|Withdrawal by Subject|23
294991|NCT00897104|969787|P3|Overall Study|Protocol Violation|0
294992|NCT00897104|969788|P2|Overall Study|Protocol Violation|1
294993|NCT00897104|969789|P1|Overall Study|Protocol Violation|0
294994|NCT00897104|969787|P3|Overall Study|Pregnancy|0
294995|NCT00897104|969788|P2|Overall Study|Pregnancy|1
294996|NCT00897104|969789|P1|Overall Study|Pregnancy|0
294997|NCT00897104|969787|P3|Overall Study|Lost to Follow-up|2
294998|NCT00897104|969788|P2|Overall Study|Lost to Follow-up|17
294999|NCT00897104|969789|P1|Overall Study|Lost to Follow-up|12
295000|NCT00896649|969824|P1|Overall Study|technical difficulties|2
295001|NCT00896649|969824|P1|Overall Study|missing documentation|1
295002|NCT00896649|969824|P1|Overall Study|Pregnancy|1
295003|NCT00896649|969824|P1|Overall Study|Physician Decision|1
295004|NCT00896454|969829|P1|Overall Study|Withdrawal by Subject|1
295005|NCT00896454|969829|P1|Overall Study|Ongoing in study|2
295006|NCT00896454|969829|P1|Overall Study|Requirement for alternative therapy|3
295007|NCT00896454|969829|P1|Overall Study|Other|4
295008|NCT00896454|969829|P1|Overall Study|Disease Progression|5
295009|NCT00896454|969829|P1|Overall Study|Adverse Event|8
295010|NCT00896454|969829|P1|Overall Study|Death|10
295011|NCT00896337|969841|P1|Overall Study|Lost to Follow-up|11
295012|NCT00896337|969841|P1|Overall Study|Withdrawal by Subject|7
295013|NCT00896337|969841|P1|Overall Study|Death|7
295014|NCT00896233|969908|P1|Overall Study|Claustrophobia during MRI|1
295015|NCT00896168|969921|P2|Overall Study|Unspecified|1
295016|NCT00896168|969922|P1|Overall Study|Unspecified|1
295017|NCT00896168|969921|P2|Overall Study|Lost to Follow-up|1
295018|NCT00896168|969922|P1|Overall Study|Lost to Follow-up|1
295019|NCT00896168|969921|P2|Overall Study|Treatment failure|10
295020|NCT00896168|969922|P1|Overall Study|Treatment failure|8
295021|NCT00896168|969921|P2|Overall Study|Adverse Event|7
295022|NCT00896168|969922|P1|Overall Study|Adverse Event|4
295023|NCT00896051|969952|P2|Overall Study|Not specified|1
295024|NCT00896051|969953|P1|Overall Study|Not specified|1
295025|NCT00896051|969952|P2|Overall Study|Subject noncompliant|3
295026|NCT00896051|969953|P1|Overall Study|Subject noncompliant|1
295027|NCT00896051|969952|P2|Overall Study|Withdrawal by Subject|2
295028|NCT00896051|969953|P1|Overall Study|Withdrawal by Subject|3
295029|NCT00896051|969952|P2|Overall Study|Lost to Follow-up|2
295030|NCT00896051|969953|P1|Overall Study|Lost to Follow-up|3
295031|NCT00896051|969952|P2|Overall Study|Adverse Event|1
295032|NCT00896051|969953|P1|Overall Study|Adverse Event|2
295033|NCT00895947|970040|P2|Overall Study|Withdrawal by Subject|0
295034|NCT00895947|970041|P1|Overall Study|Withdrawal by Subject|2
295035|NCT00895947|970040|P2|Overall Study|Protocol Violation|2
295036|NCT00895947|970041|P1|Overall Study|Protocol Violation|4
295037|NCT00895947|970040|P2|Overall Study|Lost to Follow-up|4
295038|NCT00895947|970041|P1|Overall Study|Lost to Follow-up|3
295039|NCT00895947|970040|P2|Overall Study|Adverse Event|4
295040|NCT00895947|970041|P1|Overall Study|Adverse Event|3
295041|NCT00895934|970059|P2|Overall Study|ineligible|0
295042|NCT00895934|970060|P1|Overall Study|ineligible|1
295043|NCT00895934|970059|P2|Overall Study|Death|1
295044|NCT00895934|970060|P1|Overall Study|Death|0
295045|NCT00895934|970059|P2|Overall Study|Lack of Efficacy|24
295046|NCT00895934|970060|P1|Overall Study|Lack of Efficacy|5
295047|NCT00895895|970071|P5|Period 2|unsatisfactory response-efficacy|0
295048|NCT00895895|970072|P4|Period 2|unsatisfactory response-efficacy|0
295049|NCT00895895|970073|P3|Period 2|unsatisfactory response-efficacy|0
295050|NCT00895895|970074|P2|Period 2|unsatisfactory response-efficacy|1
295051|NCT00895895|970075|P1|Period 2|unsatisfactory response-efficacy|2
295052|NCT00895895|970071|P5|Period 2|Withdrawal by Subject|5
295053|NCT00895895|970072|P4|Period 2|Withdrawal by Subject|3
295054|NCT00895895|970073|P3|Period 2|Withdrawal by Subject|0
295055|NCT00895895|970074|P2|Period 2|Withdrawal by Subject|2
295056|NCT00895895|970075|P1|Period 2|Withdrawal by Subject|0
295057|NCT00895895|970071|P5|Period 2|Protocol Violation|1
295058|NCT00895895|970072|P4|Period 2|Protocol Violation|1
295059|NCT00895895|970073|P3|Period 2|Protocol Violation|1
295060|NCT00895895|970074|P2|Period 2|Protocol Violation|0
295061|NCT00895895|970075|P1|Period 2|Protocol Violation|1
295062|NCT00895895|970071|P5|Period 2|unspecified|1
295063|NCT00895895|970072|P4|Period 2|unspecified|1
295064|NCT00895895|970073|P3|Period 2|unspecified|3
295065|NCT00895895|970074|P2|Period 2|unspecified|1
295066|NCT00895895|970075|P1|Period 2|unspecified|1
295067|NCT00895895|970071|P5|Period 2|Lost to Follow-up|0
295068|NCT00895895|970072|P4|Period 2|Lost to Follow-up|1
295069|NCT00895895|970073|P3|Period 2|Lost to Follow-up|1
295070|NCT00895895|970074|P2|Period 2|Lost to Follow-up|2
295071|NCT00895895|970075|P1|Period 2|Lost to Follow-up|1
295072|NCT00895895|970071|P5|Period 2|investigator request|0
295073|NCT00895895|970072|P4|Period 2|investigator request|0
295074|NCT00895895|970073|P3|Period 2|investigator request|0
295075|NCT00895895|970074|P2|Period 2|investigator request|0
295076|NCT00895895|970075|P1|Period 2|investigator request|2
295077|NCT00895895|970071|P5|Period 2|failed to return|0
295078|NCT00895895|970072|P4|Period 2|failed to return|0
295079|NCT00895895|970073|P3|Period 2|failed to return|0
295080|NCT00895895|970074|P2|Period 2|failed to return|0
295081|NCT00895895|970075|P1|Period 2|failed to return|2
295082|NCT00895895|970071|P5|Period 2|discontinued by sponsor|37
295083|NCT00895895|970072|P4|Period 2|discontinued by sponsor|46
295084|NCT00895895|970073|P3|Period 2|discontinued by sponsor|38
295085|NCT00895895|970074|P2|Period 2|discontinued by sponsor|44
295086|NCT00895895|970075|P1|Period 2|discontinued by sponsor|44
295087|NCT00895895|970071|P5|Period 2|Death|0
295088|NCT00895895|970072|P4|Period 2|Death|0
295089|NCT00895895|970073|P3|Period 2|Death|1
295090|NCT00895895|970074|P2|Period 2|Death|0
295091|NCT00895895|970075|P1|Period 2|Death|0
295092|NCT00895895|970071|P5|Period 2|Adverse Event|5
295093|NCT00895895|970072|P4|Period 2|Adverse Event|2
295094|NCT00895895|970073|P3|Period 2|Adverse Event|5
295095|NCT00895895|970074|P2|Period 2|Adverse Event|3
295096|NCT00895895|970075|P1|Period 2|Adverse Event|3
295097|NCT00895895|970071|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
295098|NCT00895895|970072|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
295099|NCT00895895|970073|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
295100|NCT00895895|970074|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
295101|NCT00895895|970075|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
295102|NCT00895895|970071|P5|After Period 1, Prior to Period 2|Protocol Violation|1
295103|NCT00895895|970072|P4|After Period 1, Prior to Period 2|Protocol Violation|0
295104|NCT00895895|970073|P3|After Period 1, Prior to Period 2|Protocol Violation|0
295105|NCT00895895|970074|P2|After Period 1, Prior to Period 2|Protocol Violation|0
295106|NCT00895895|970075|P1|After Period 1, Prior to Period 2|Protocol Violation|0
295107|NCT00895895|970071|P5|After Period 1, Prior to Period 2|unspecified|0
295108|NCT00895895|970072|P4|After Period 1, Prior to Period 2|unspecified|0
295109|NCT00895895|970073|P3|After Period 1, Prior to Period 2|unspecified|1
295110|NCT00895895|970074|P2|After Period 1, Prior to Period 2|unspecified|0
295111|NCT00895895|970075|P1|After Period 1, Prior to Period 2|unspecified|0
295112|NCT00895895|970071|P5|After Period 1, Prior to Period 2|Adverse Event|0
295113|NCT00895895|970072|P4|After Period 1, Prior to Period 2|Adverse Event|0
295114|NCT00895895|970073|P3|After Period 1, Prior to Period 2|Adverse Event|1
295115|NCT00895895|970074|P2|After Period 1, Prior to Period 2|Adverse Event|0
295116|NCT00895895|970075|P1|After Period 1, Prior to Period 2|Adverse Event|0
295117|NCT00895895|970071|P5|Period 1|randomized and not treated|2
295118|NCT00895895|970072|P4|Period 1|randomized and not treated|1
295119|NCT00895895|970073|P3|Period 1|randomized and not treated|1
295120|NCT00895895|970074|P2|Period 1|randomized and not treated|3
295121|NCT00895895|970075|P1|Period 1|randomized and not treated|1
295122|NCT00895895|970071|P5|Period 1|unsatisfactory response-efficacy|0
295123|NCT00895895|970072|P4|Period 1|unsatisfactory response-efficacy|0
295124|NCT00895895|970073|P3|Period 1|unsatisfactory response-efficacy|0
295125|NCT00895895|970074|P2|Period 1|unsatisfactory response-efficacy|0
295126|NCT00895895|970075|P1|Period 1|unsatisfactory response-efficacy|2
295127|NCT00895895|970071|P5|Period 1|Withdrawal by Subject|4
295128|NCT00895895|970072|P4|Period 1|Withdrawal by Subject|2
295129|NCT00895895|970073|P3|Period 1|Withdrawal by Subject|8
295130|NCT00895895|970074|P2|Period 1|Withdrawal by Subject|6
295131|NCT00895895|970075|P1|Period 1|Withdrawal by Subject|6
295132|NCT00895895|970071|P5|Period 1|Protocol Violation|0
295133|NCT00895895|970072|P4|Period 1|Protocol Violation|0
295134|NCT00895895|970073|P3|Period 1|Protocol Violation|0
295135|NCT00895895|970074|P2|Period 1|Protocol Violation|1
295136|NCT00895895|970075|P1|Period 1|Protocol Violation|0
295137|NCT00895895|970071|P5|Period 1|unspecified|1
295138|NCT00895895|970072|P4|Period 1|unspecified|1
295139|NCT00895895|970073|P3|Period 1|unspecified|1
295140|NCT00895895|970074|P2|Period 1|unspecified|2
295141|NCT00895895|970075|P1|Period 1|unspecified|1
295142|NCT00895895|970071|P5|Period 1|Lost to Follow-up|3
295143|NCT00895895|970072|P4|Period 1|Lost to Follow-up|2
295144|NCT00895895|970073|P3|Period 1|Lost to Follow-up|3
295145|NCT00895895|970074|P2|Period 1|Lost to Follow-up|1
295146|NCT00895895|970075|P1|Period 1|Lost to Follow-up|2
295147|NCT00895895|970071|P5|Period 1|investigator request|0
295148|NCT00895895|970072|P4|Period 1|investigator request|0
295149|NCT00895895|970073|P3|Period 1|investigator request|0
295150|NCT00895895|970074|P2|Period 1|investigator request|1
295151|NCT00895895|970075|P1|Period 1|investigator request|0
295152|NCT00895895|970071|P5|Period 1|failed to return|1
295153|NCT00895895|970072|P4|Period 1|failed to return|0
295154|NCT00895895|970073|P3|Period 1|failed to return|1
295155|NCT00895895|970074|P2|Period 1|failed to return|0
295156|NCT00895895|970075|P1|Period 1|failed to return|0
295157|NCT00895895|970071|P5|Period 1|discontinued by sponsor|1
295158|NCT00895895|970072|P4|Period 1|discontinued by sponsor|1
295159|NCT00895895|970073|P3|Period 1|discontinued by sponsor|2
295160|NCT00895895|970074|P2|Period 1|discontinued by sponsor|1
295161|NCT00895895|970075|P1|Period 1|discontinued by sponsor|2
295162|NCT00895895|970071|P5|Period 1|Death|1
295163|NCT00895895|970072|P4|Period 1|Death|0
295164|NCT00895895|970073|P3|Period 1|Death|0
295165|NCT00895895|970074|P2|Period 1|Death|0
295166|NCT00895895|970075|P1|Period 1|Death|0
295167|NCT00895895|970071|P5|Period 1|Adverse Event|7
295168|NCT00895895|970072|P4|Period 1|Adverse Event|6
295169|NCT00895895|970073|P3|Period 1|Adverse Event|4
295170|NCT00895895|970074|P2|Period 1|Adverse Event|6
295171|NCT00895895|970075|P1|Period 1|Adverse Event|7
295172|NCT00895843|970189|P2|Overall Study|Protocol Violation|12
295173|NCT00895843|970190|P1|Overall Study|Protocol Violation|12
295174|NCT00895661|970237|P1|Overall Study|reason unknown|2
295175|NCT00895661|970237|P1|Overall Study|Death|1
295176|NCT00895583|970246|P2|Overall Study|Not specified|1
295177|NCT00895583|970247|P1|Overall Study|Not specified|0
295178|NCT00895583|970246|P2|Overall Study|Lack of Efficacy|0
295179|NCT00895583|970247|P1|Overall Study|Lack of Efficacy|5
295180|NCT00895583|970246|P2|Overall Study|Withdrawal by Subject|2
295181|NCT00895583|970247|P1|Overall Study|Withdrawal by Subject|4
295182|NCT00895583|970246|P2|Overall Study|Protocol Violation|0
295183|NCT00895583|970247|P1|Overall Study|Protocol Violation|1
295184|NCT00895583|970246|P2|Overall Study|Lost to Follow-up|3
295185|NCT00895583|970247|P1|Overall Study|Lost to Follow-up|1
295186|NCT00895583|970246|P2|Overall Study|Physician Decision|1
295187|NCT00895583|970247|P1|Overall Study|Physician Decision|3
295188|NCT00895583|970246|P2|Overall Study|Death|1
295189|NCT00895583|970247|P1|Overall Study|Death|2
295190|NCT00895583|970246|P2|Overall Study|Adverse Event|4
295191|NCT00895583|970247|P1|Overall Study|Adverse Event|28
295192|NCT00895453|970328|P3|Overall Study|Lost to Follow-up|23
295193|NCT00895453|970329|P2|Overall Study|Lost to Follow-up|25
295194|NCT00895453|970330|P1|Overall Study|Lost to Follow-up|25
295195|NCT00895310|970338|P1|Overall Study|Withdrawal by Subject|1
295196|NCT00895245|970354|P1|Overall Study|Lack of Efficacy|6
295197|NCT00895011|970433|P3|Overall Study|schedule conflict|0
295198|NCT00895011|970434|P2|Overall Study|schedule conflict|0
295199|NCT00895011|970435|P1|Overall Study|schedule conflict|1
295200|NCT00895011|970433|P3|Overall Study|Adverse Event|2
295201|NCT00895011|970434|P2|Overall Study|Adverse Event|2
295202|NCT00895011|970435|P1|Overall Study|Adverse Event|1
295203|NCT00895011|970433|P3|Overall Study|Protocol Violation|3
295204|NCT00895011|970434|P2|Overall Study|Protocol Violation|1
295205|NCT00895011|970435|P1|Overall Study|Protocol Violation|3
295206|NCT00895011|970433|P3|Overall Study|Lost to Follow-up|1
295207|NCT00895011|970434|P2|Overall Study|Lost to Follow-up|4
295208|NCT00895011|970435|P1|Overall Study|Lost to Follow-up|5
295209|NCT00895011|970433|P3|Overall Study|Withdrawal by Subject|2
295210|NCT00895011|970434|P2|Overall Study|Withdrawal by Subject|7
295211|NCT00895011|970435|P1|Overall Study|Withdrawal by Subject|14
295212|NCT00894933|970449|P1|Overall Study|Did not meeting incl/excl criteria|1
295213|NCT00894933|970449|P1|Overall Study|Cancelled Procedure|1
295214|NCT00894933|970449|P1|Overall Study|Lost to Follow-up|2
295215|NCT00894803|970467|P2|Overall Study|Lost to Follow-up|1
295216|NCT00894803|970468|P1|Overall Study|Lost to Follow-up|0
295217|NCT00894803|970467|P2|Overall Study|Death|4
295218|NCT00894803|970468|P1|Overall Study|Death|20
295219|NCT00894790|970504|P2|Overall Study|Did not meet entrance criteria|0
295220|NCT00894790|970505|P1|Overall Study|Did not meet entrance criteria|1
295221|NCT00894790|970504|P2|Overall Study|Lost to Follow-up|1
295222|NCT00894790|970505|P1|Overall Study|Lost to Follow-up|0
295223|NCT00894790|970504|P2|Overall Study|Protocol Violation|1
295224|NCT00894790|970505|P1|Overall Study|Protocol Violation|0
295225|NCT00894647|970538|P2|Overall Study|Other, not due to AE|2
295226|NCT00894647|970539|P1|Overall Study|Other, not due to AE|1
295227|NCT00894647|970538|P2|Overall Study|Non-compliance with study procedures|2
295228|NCT00894647|970539|P1|Overall Study|Non-compliance with study procedures|0
295229|NCT00894647|970538|P2|Overall Study|Lost to Follow-up|2
295230|NCT00894647|970539|P1|Overall Study|Lost to Follow-up|0
295231|NCT00894647|970538|P2|Overall Study|Withdrawal by Subject|4
295232|NCT00894647|970539|P1|Overall Study|Withdrawal by Subject|4
295233|NCT00894647|970538|P2|Overall Study|Adverse Event|4
295234|NCT00894647|970539|P1|Overall Study|Adverse Event|5
295235|NCT00894556|970552|P4|Treatment Phase|Lack of Qualifying Event|0
295236|NCT00894556|970553|P3|Treatment Phase|Lack of Qualifying Event|0
295237|NCT00894556|970554|P2|Treatment Phase|Lack of Qualifying Event|1
295238|NCT00894556|970555|P1|Treatment Phase|Lack of Qualifying Event|2
295239|NCT00894556|970552|P4|Treatment Phase|Lost to Follow-up|0
295240|NCT00894556|970553|P3|Treatment Phase|Lost to Follow-up|1
295241|NCT00894556|970554|P2|Treatment Phase|Lost to Follow-up|3
295242|NCT00894556|970555|P1|Treatment Phase|Lost to Follow-up|2
295243|NCT00894556|970552|P4|Baseline Phase|Did not meet Randomization Criteria|85
295244|NCT00894556|970553|P3|Baseline Phase|Did not meet Randomization Criteria|0
295245|NCT00894556|970554|P2|Baseline Phase|Did not meet Randomization Criteria|0
295246|NCT00894556|970555|P1|Baseline Phase|Did not meet Randomization Criteria|0
295247|NCT00894543|970566|P2|Week 4 to Week 8|No diary or lost or withdrew|2
295248|NCT00894543|970567|P1|Week 4 to Week 8|No diary or lost or withdrew|4
295249|NCT00894543|970566|P2|Baseline to Week 4|No diary or lost or withdrew|2
295250|NCT00894543|970567|P1|Baseline to Week 4|No diary or lost or withdrew|3
295251|NCT00894387|970633|P2|Overall Study|GCP non-compliance|2
295252|NCT00894387|970634|P1|Overall Study|GCP non-compliance|0
295253|NCT00894387|970633|P2|Overall Study|Mis-randomized|9
295254|NCT00894387|970634|P1|Overall Study|Mis-randomized|13
295255|NCT00894387|970633|P2|Overall Study|Other (Missing)|3
295256|NCT00894387|970634|P1|Overall Study|Other (Missing)|5
295257|NCT00894387|970633|P2|Overall Study|Patient's request|30
295258|NCT00894387|970634|P1|Overall Study|Patient's request|25
295259|NCT00894387|970633|P2|Overall Study|Protocol Deviation|0
295260|NCT00894387|970634|P1|Overall Study|Protocol Deviation|4
295261|NCT00894387|970633|P2|Overall Study|Death|76
295262|NCT00894387|970634|P1|Overall Study|Death|77
295263|NCT00894387|970633|P2|Overall Study|Administrative problems|2
295264|NCT00894387|970634|P1|Overall Study|Administrative problems|2
295265|NCT00894387|970633|P2|Overall Study|Lost to Follow-up|5
295266|NCT00894387|970634|P1|Overall Study|Lost to Follow-up|3
295267|NCT00894387|970633|P2|Overall Study|Unsatisfactory therapeutic effect|1
295268|NCT00894387|970634|P1|Overall Study|Unsatisfactory therapeutic effect|0
295269|NCT00894387|970633|P2|Overall Study|Abnormal Laboratory values|2
295270|NCT00894387|970634|P1|Overall Study|Abnormal Laboratory values|2
295271|NCT00894387|970633|P2|Overall Study|Adverse Event|45
295272|NCT00894387|970634|P1|Overall Study|Adverse Event|44
295273|NCT00894361|970654|P2|Overall Study|deaths and less than 2 yr followup|64
295274|NCT00894361|970655|P1|Overall Study|deaths and less than 2 yr followup|24
295275|NCT00894322|970664|P3|Overall Study|Withdrawal by Subject|0
295276|NCT00894322|970665|P2|Overall Study|Withdrawal by Subject|0
295277|NCT00894322|970666|P1|Overall Study|Withdrawal by Subject|1
295278|NCT00894166|970717|P8|Overall Study|Death|0
295279|NCT00894166|970718|P7|Overall Study|Death|0
295280|NCT00894166|970719|P6|Overall Study|Death|0
295281|NCT00894166|970720|P5|Overall Study|Death|0
295282|NCT00894166|970721|P4|Overall Study|Death|1
295283|NCT00894166|970722|P3|Overall Study|Death|0
295284|NCT00894166|970723|P2|Overall Study|Death|0
295285|NCT00894166|970724|P1|Overall Study|Death|0
295286|NCT00894166|970717|P8|Overall Study|Withdrew or Lost to Follow-Up|34
295287|NCT00894166|970718|P7|Overall Study|Withdrew or Lost to Follow-Up|16
295288|NCT00894166|970719|P6|Overall Study|Withdrew or Lost to Follow-Up|16
295289|NCT00894166|970720|P5|Overall Study|Withdrew or Lost to Follow-Up|24
295290|NCT00894166|970721|P4|Overall Study|Withdrew or Lost to Follow-Up|68
295291|NCT00894166|970722|P3|Overall Study|Withdrew or Lost to Follow-Up|62
295292|NCT00894166|970723|P2|Overall Study|Withdrew or Lost to Follow-Up|63
295293|NCT00894166|970724|P1|Overall Study|Withdrew or Lost to Follow-Up|61
295294|NCT00893971|970763|P1|Overall Study|Physician Decision|3
295295|NCT00893789|970881|P4|Overall Study|Lost to Follow-up|1
295296|NCT00893789|970882|P3|Overall Study|Lost to Follow-up|0
295297|NCT00893789|970883|P2|Overall Study|Lost to Follow-up|0
295298|NCT00893789|970884|P1|Overall Study|Lost to Follow-up|0
295299|NCT00893789|970881|P4|Overall Study|Protocol Violation|4
295300|NCT00893789|970882|P3|Overall Study|Protocol Violation|1
295301|NCT00893789|970883|P2|Overall Study|Protocol Violation|1
295302|NCT00893789|970884|P1|Overall Study|Protocol Violation|0
295303|NCT00893789|970881|P4|Overall Study|Adverse Event|5
295304|NCT00893789|970882|P3|Overall Study|Adverse Event|1
295305|NCT00893789|970883|P2|Overall Study|Adverse Event|2
295306|NCT00893789|970884|P1|Overall Study|Adverse Event|0
295307|NCT00893789|970881|P4|Overall Study|Taking Excluded Concomitant Medication|0
295308|NCT00893789|970882|P3|Overall Study|Taking Excluded Concomitant Medication|1
295309|NCT00893789|970883|P2|Overall Study|Taking Excluded Concomitant Medication|0
295310|NCT00893789|970884|P1|Overall Study|Taking Excluded Concomitant Medication|1
295311|NCT00893789|970881|P4|Overall Study|Noncompliance With Study Procedures|0
295312|NCT00893789|970882|P3|Overall Study|Noncompliance With Study Procedures|0
295313|NCT00893789|970883|P2|Overall Study|Noncompliance With Study Procedures|0
295314|NCT00893789|970884|P1|Overall Study|Noncompliance With Study Procedures|1
295315|NCT00893789|970881|P4|Overall Study|Noncompliance With Study Drug|2
295316|NCT00893789|970882|P3|Overall Study|Noncompliance With Study Drug|1
295317|NCT00893789|970883|P2|Overall Study|Noncompliance With Study Drug|0
295318|NCT00893789|970884|P1|Overall Study|Noncompliance With Study Drug|1
295319|NCT00893789|970881|P4|Overall Study|Withdrawal by Subject|1
295320|NCT00893789|970882|P3|Overall Study|Withdrawal by Subject|3
295321|NCT00893789|970883|P2|Overall Study|Withdrawal by Subject|1
295322|NCT00893789|970884|P1|Overall Study|Withdrawal by Subject|3
295323|NCT00893763|970968|P2|Overall Study|extubated|110
295324|NCT00893763|970969|P1|Overall Study|extubated|110
295325|NCT00893737|970977|P1|Overall Study|Lost to Follow-up|6
295326|NCT00893737|970977|P1|Overall Study|Withdrawal by Subject|2
295327|NCT00893737|970977|P1|Overall Study|Adverse Event|4
295328|NCT00893464|970991|P8|Overall Study|Did not complete therapy/experience PD|2
295329|NCT00893464|970992|P7|Overall Study|Did not complete therapy/experience PD|2
295330|NCT00893464|970993|P6|Overall Study|Did not complete therapy/experience PD|0
295331|NCT00893464|970994|P5|Overall Study|Did not complete therapy/experience PD|0
295332|NCT00893464|970995|P4|Overall Study|Did not complete therapy/experience PD|0
295333|NCT00893464|970996|P3|Overall Study|Did not complete therapy/experience PD|0
295334|NCT00893464|970997|P2|Overall Study|Did not complete therapy/experience PD|0
295335|NCT00893464|970998|P1|Overall Study|Did not complete therapy/experience PD|0
295336|NCT00893113|971125|P2|Overall Study|Withdrew Consent|7
295337|NCT00893113|971126|P1|Overall Study|Withdrew Consent|8
295338|NCT00893113|971125|P2|Overall Study|Early Termination|1
295339|NCT00893113|971126|P1|Overall Study|Early Termination|1
295340|NCT00893113|971125|P2|Overall Study|Lost to Follow-up|8
295341|NCT00893113|971126|P1|Overall Study|Lost to Follow-up|4
295342|NCT00892957|971138|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
295343|NCT00892957|971139|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
295344|NCT00892957|971138|P2|Between Postoperative Day 1 and Day 14|Death|2
295345|NCT00892957|971139|P1|Between Postoperative Day 1 and Day 14|Death|0
295346|NCT00892723|971228|P3|Overall Study|Withdrawal by Subject|1
295347|NCT00892723|971229|P2|Overall Study|Withdrawal by Subject|1
295348|NCT00892723|971230|P1|Overall Study|Withdrawal by Subject|1
295349|NCT00892723|971228|P3|Overall Study|Lost to Follow-up|1
295350|NCT00892723|971229|P2|Overall Study|Lost to Follow-up|3
295351|NCT00892723|971230|P1|Overall Study|Lost to Follow-up|1
295352|NCT00892437|971319|P2|Open-Label Extension Phase|Withdrew Consent|1
295353|NCT00892437|971320|P1|Open-Label Extension Phase|Withdrew Consent|3
295354|NCT00892437|971319|P2|Open-Label Extension Phase|Investigator's Discretion|0
295355|NCT00892437|971320|P1|Open-Label Extension Phase|Investigator's Discretion|1
295356|NCT00892437|971319|P2|Open-Label Extension Phase|Lost to Follow-up|1
295357|NCT00892437|971320|P1|Open-Label Extension Phase|Lost to Follow-up|3
295358|NCT00892437|971319|P2|Open-Label Extension Phase|Lack of Efficacy|0
295359|NCT00892437|971320|P1|Open-Label Extension Phase|Lack of Efficacy|1
295360|NCT00892437|971319|P2|Open-Label Extension Phase|Adverse Event|2
295361|NCT00892437|971320|P1|Open-Label Extension Phase|Adverse Event|4
295362|NCT00892437|971319|P2|Randomized Phase|Withdrew Consent|0
295363|NCT00892437|971320|P1|Randomized Phase|Withdrew Consent|1
295364|NCT00892437|971319|P2|Randomized Phase|Investigator’s Discretion|0
295365|NCT00892437|971320|P1|Randomized Phase|Investigator’s Discretion|1
295366|NCT00892437|971319|P2|Randomized Phase|Lost to Follow-up|3
295367|NCT00892437|971320|P1|Randomized Phase|Lost to Follow-up|1
295368|NCT00892437|971319|P2|Randomized Phase|Adverse Event|2
295369|NCT00892437|971320|P1|Randomized Phase|Adverse Event|2
295370|NCT00892437|971319|P2|Randomized Phase|Randomized but not treated|0
295371|NCT00892437|971320|P1|Randomized Phase|Randomized but not treated|6
295372|NCT00892281|971339|P2|Overall Study|Visit 4 date out of window|0
295373|NCT00892281|971340|P1|Overall Study|Visit 4 date out of window|1
295374|NCT00892281|971339|P2|Overall Study|Rash on hand|0
295375|NCT00892281|971340|P1|Overall Study|Rash on hand|1
295376|NCT00892281|971339|P2|Overall Study|Subject had history of drug abuse|0
295377|NCT00892281|971340|P1|Overall Study|Subject had history of drug abuse|1
295378|NCT00892281|971339|P2|Overall Study|Non-compliant with visits as scheduled|0
295379|NCT00892281|971340|P1|Overall Study|Non-compliant with visits as scheduled|1
295380|NCT00892281|971339|P2|Overall Study|Missed visits rescheduled out of window|0
295381|NCT00892281|971340|P1|Overall Study|Missed visits rescheduled out of window|1
295382|NCT00892281|971339|P2|Overall Study|Missed multiple visits|0
295383|NCT00892281|971340|P1|Overall Study|Missed multiple visits|1
295384|NCT00892281|971339|P2|Overall Study|No show Visit 2; prescription not filled|0
295385|NCT00892281|971340|P1|Overall Study|No show Visit 2; prescription not filled|1
295386|NCT00892281|971339|P2|Overall Study|Subject not seen by PI at final visit|0
295387|NCT00892281|971340|P1|Overall Study|Subject not seen by PI at final visit|1
295388|NCT00892281|971339|P2|Overall Study|Lack of efficacy of study product|0
295389|NCT00892281|971340|P1|Overall Study|Lack of efficacy of study product|2
295390|NCT00892281|971339|P2|Overall Study|Death in family|0
295391|NCT00892281|971340|P1|Overall Study|Death in family|1
295392|NCT00892281|971339|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
295393|NCT00892281|971340|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
295394|NCT00892281|971339|P2|Overall Study|Subject lost interest in program|1
295395|NCT00892281|971340|P1|Overall Study|Subject lost interest in program|0
295396|NCT00892281|971339|P2|Overall Study|PI complained of inadequate compensation|0
295397|NCT00892281|971340|P1|Overall Study|PI complained of inadequate compensation|3
295398|NCT00892281|971339|P2|Overall Study|Scheduled for knee replacement|1
295399|NCT00892281|971340|P1|Overall Study|Scheduled for knee replacement|0
295400|NCT00892281|971339|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
295401|NCT00892281|971340|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
295402|NCT00892281|971339|P2|Overall Study|Subject missed several visits/lost meds|0
295403|NCT00892281|971340|P1|Overall Study|Subject missed several visits/lost meds|1
295404|NCT00892281|971339|P2|Overall Study|Subject did not return for any visits|0
295405|NCT00892281|971340|P1|Overall Study|Subject did not return for any visits|1
295406|NCT00892281|971339|P2|Overall Study|Subject not good candidate for study|0
295407|NCT00892281|971340|P1|Overall Study|Subject not good candidate for study|1
295408|NCT00892281|971339|P2|Overall Study|Unable to redeem the drug voucher|0
295409|NCT00892281|971340|P1|Overall Study|Unable to redeem the drug voucher|1
295410|NCT00892281|971339|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
295411|NCT00892281|971340|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
295412|NCT00892281|971339|P2|Overall Study|Did not meet incl/excl criteria|0
295413|NCT00892281|971340|P1|Overall Study|Did not meet incl/excl criteria|1
295414|NCT00892281|971339|P2|Overall Study|Last visit not done - death in family|0
295415|NCT00892281|971340|P1|Overall Study|Last visit not done - death in family|1
295416|NCT00892281|971339|P2|Overall Study|Family emergency|0
295417|NCT00892281|971340|P1|Overall Study|Family emergency|1
295418|NCT00892281|971339|P2|Overall Study|Subject completed day after study closed|0
295419|NCT00892281|971340|P1|Overall Study|Subject completed day after study closed|1
295420|NCT00892281|971339|P2|Overall Study|Final visit completed 4 weeks late|1
295421|NCT00892281|971340|P1|Overall Study|Final visit completed 4 weeks late|0
295422|NCT00892281|971339|P2|Overall Study|Subject unable to keep follow-up visits|0
295423|NCT00892281|971340|P1|Overall Study|Subject unable to keep follow-up visits|1
295424|NCT00892281|971339|P2|Overall Study|Subject failed to return for final visit|0
295425|NCT00892281|971340|P1|Overall Study|Subject failed to return for final visit|2
295426|NCT00892281|971339|P2|Overall Study|Withdrawal by Subject|14
295427|NCT00892281|971340|P1|Overall Study|Withdrawal by Subject|86
295428|NCT00892281|971339|P2|Overall Study|Protocol Violation|2
295429|NCT00892281|971340|P1|Overall Study|Protocol Violation|7
295430|NCT00892281|971339|P2|Overall Study|Pregnancy|0
295431|NCT00892281|971340|P1|Overall Study|Pregnancy|1
295432|NCT00892281|971339|P2|Overall Study|Lost to Follow-up|8
295433|NCT00892281|971340|P1|Overall Study|Lost to Follow-up|81
295434|NCT00892281|971339|P2|Overall Study|Adverse Event|8
295435|NCT00892281|971340|P1|Overall Study|Adverse Event|65
295436|NCT00892151|971350|P1|Overall Study|Protocol Violation|1
295437|NCT00892099|971359|P3|Overall Study|Lost to Follow-up|1
295438|NCT00892099|971360|P2|Overall Study|Lost to Follow-up|0
295439|NCT00892099|971361|P1|Overall Study|Lost to Follow-up|0
295440|NCT00892099|971359|P3|Overall Study|investigator decision|1
295441|NCT00892099|971360|P2|Overall Study|investigator decision|0
295442|NCT00892099|971361|P1|Overall Study|investigator decision|0
295443|NCT00892099|971359|P3|Overall Study|kidney function recovered|0
295444|NCT00892099|971360|P2|Overall Study|kidney function recovered|1
295445|NCT00892099|971361|P1|Overall Study|kidney function recovered|0
295446|NCT00892099|971359|P3|Overall Study|no further details|1
295447|NCT00892099|971360|P2|Overall Study|no further details|0
295448|NCT00892099|971361|P1|Overall Study|no further details|1
295449|NCT00892099|971359|P3|Overall Study|Prolonged hospitalization|1
295450|NCT00892099|971360|P2|Overall Study|Prolonged hospitalization|0
295451|NCT00892099|971361|P1|Overall Study|Prolonged hospitalization|1
295452|NCT00892099|971359|P3|Overall Study|replocated|2
295453|NCT00892099|971360|P2|Overall Study|replocated|0
295454|NCT00892099|971361|P1|Overall Study|replocated|1
295455|NCT00892099|971359|P3|Overall Study|Adverse Event|0
295456|NCT00892099|971360|P2|Overall Study|Adverse Event|0
295457|NCT00892099|971361|P1|Overall Study|Adverse Event|1
295458|NCT00892099|971359|P3|Overall Study|Death|1
295459|NCT00892099|971360|P2|Overall Study|Death|0
295460|NCT00892099|971361|P1|Overall Study|Death|1
295461|NCT00892047|971371|P2|Overall Study|Lack of Efficacy|2
295462|NCT00892047|971372|P1|Overall Study|Lack of Efficacy|0
295463|NCT00892047|971371|P2|Overall Study|subject burden|3
295464|NCT00892047|971372|P1|Overall Study|subject burden|2
295465|NCT00892047|971371|P2|Overall Study|Adverse Event|2
295466|NCT00892047|971372|P1|Overall Study|Adverse Event|2
295467|NCT00892008|971388|P1|Overall Study|Adverse Event|37
295468|NCT00892008|971388|P1|Overall Study|unspecified|378
295469|NCT00892008|971388|P1|Overall Study|Lost to Follow-up|142
295470|NCT00892008|971388|P1|Overall Study|Lack of Efficacy|3
295471|NCT00892008|971388|P1|Overall Study|Death|5
295472|NCT00891930|971474|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
295473|NCT00891930|971474|P1|Part 2: Panitumumab + Ganitumab|Death|30
295474|NCT00891930|971474|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
295475|NCT00891930|971474|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
295476|NCT00891930|971474|P1|Part 1: Panitumumab +Irinotecan|Death|38
295477|NCT00891904|971495|P1|Overall Study|Adverse Event|1
295478|NCT00891904|971495|P1|Overall Study|Death|1
295479|NCT00891839|971502|P1|Overall Study|Disease progression|3
295480|NCT00891839|971502|P1|Overall Study|Withdrawal by Subject|2
295481|NCT00891839|971502|P1|Overall Study|Adverse Event|2
295482|NCT00891813|971511|P1|Overall Study|Protocol Violation|2
295483|NCT00891813|971511|P1|Overall Study|Patient Noncompliance|6
295484|NCT00891813|971511|P1|Overall Study|Withdrawal by Subject|1
295485|NCT00891813|971511|P1|Overall Study|Adverse Event|3
295486|NCT00891774|971517|P1|Overall Study|Protocol Violation|4
295487|NCT00891774|971517|P1|Overall Study|Withdrawal by Subject|2
295488|NCT00891774|971517|P1|Overall Study|Illness (Self/Mother)|3
295489|NCT00891774|971517|P1|Overall Study|Lost to Follow-up|5
295490|NCT00891735|971525|P4|Overall Study|Patient's decision to withdraw|8
295491|NCT00891735|971526|P3|Overall Study|Patient's decision to withdraw|4
295492|NCT00891735|971527|P2|Overall Study|Patient's decision to withdraw|9
295493|NCT00891735|971528|P1|Overall Study|Patient's decision to withdraw|4
295494|NCT00891735|971525|P4|Overall Study|Physician's decision to withdraw patient|0
295495|NCT00891735|971526|P3|Overall Study|Physician's decision to withdraw patient|0
295496|NCT00891735|971527|P2|Overall Study|Physician's decision to withdraw patient|0
295497|NCT00891735|971528|P1|Overall Study|Physician's decision to withdraw patient|1
295498|NCT00891735|971525|P4|Overall Study|Lost to Follow-up|2
295499|NCT00891735|971526|P3|Overall Study|Lost to Follow-up|2
295500|NCT00891735|971527|P2|Overall Study|Lost to Follow-up|2
295501|NCT00891735|971528|P1|Overall Study|Lost to Follow-up|2
295502|NCT00891735|971525|P4|Overall Study|Death|5
295503|NCT00891735|971526|P3|Overall Study|Death|4
295504|NCT00891735|971527|P2|Overall Study|Death|5
295505|NCT00891735|971528|P1|Overall Study|Death|8
295506|NCT00891735|971525|P4|Overall Study|Adverse Event|0
295507|NCT00891735|971526|P3|Overall Study|Adverse Event|2
295508|NCT00891735|971527|P2|Overall Study|Adverse Event|0
295509|NCT00891735|971528|P1|Overall Study|Adverse Event|2
295510|NCT00891657|971568|P2|Overall Study|Withdrawal by Subject|1
295511|NCT00891657|971569|P1|Overall Study|Withdrawal by Subject|1
295512|NCT00891618|971581|P1|Overall Study|Withdrawal by Subject|1
295513|NCT00891527|971585|P1|Overall Study|Withdrawal by Subject|2
295514|NCT00891462|971594|P3|Overall Study|Lost to Follow-up|0
295515|NCT00891462|971595|P2|Overall Study|Lost to Follow-up|2
295516|NCT00891462|971596|P1|Overall Study|Lost to Follow-up|0
295517|NCT00891462|971594|P3|Overall Study|Inclusion/exclusion criteria|2
295518|NCT00891462|971595|P2|Overall Study|Inclusion/exclusion criteria|2
295519|NCT00891462|971596|P1|Overall Study|Inclusion/exclusion criteria|0
295520|NCT00891462|971594|P3|Overall Study|Protocol Violation|3
295521|NCT00891462|971595|P2|Overall Study|Protocol Violation|1
295522|NCT00891462|971596|P1|Overall Study|Protocol Violation|2
295523|NCT00891462|971594|P3|Overall Study|Other Reason|3
295524|NCT00891462|971595|P2|Overall Study|Other Reason|5
295525|NCT00891462|971596|P1|Overall Study|Other Reason|2
295526|NCT00891462|971594|P3|Overall Study|COPD exacerbation|1
295527|NCT00891462|971595|P2|Overall Study|COPD exacerbation|4
295528|NCT00891462|971596|P1|Overall Study|COPD exacerbation|7
295529|NCT00891462|971594|P3|Overall Study|Lack of Efficacy|1
295530|NCT00891462|971595|P2|Overall Study|Lack of Efficacy|5
295531|NCT00891462|971596|P1|Overall Study|Lack of Efficacy|10
295532|NCT00891462|971594|P3|Overall Study|Adverse Event|7
295533|NCT00891462|971595|P2|Overall Study|Adverse Event|8
295534|NCT00891462|971596|P1|Overall Study|Adverse Event|7
295535|NCT00891462|971594|P3|Overall Study|Withdrawal by Subject|7
295536|NCT00891462|971595|P2|Overall Study|Withdrawal by Subject|6
295537|NCT00891462|971596|P1|Overall Study|Withdrawal by Subject|9
295538|NCT00891371|971618|P1|Treatment|Lost to Follow-up|1
295539|NCT00891371|971618|P1|Treatment|Death|1
295540|NCT00891371|971618|P1|Treatment|Adverse Event|2
295541|NCT00891371|971618|P1|Treatment|Lack of Efficacy|5
295542|NCT00891371|971618|P1|Pre-assignment|Consent withdrawal|1
295543|NCT00891371|971618|P1|Pre-assignment|Inclusion/exclusion|5
295544|NCT00891293|971627|P1|Overall Study|Sponsor termination|62
295545|NCT00891293|971627|P1|Overall Study|Subject withdrew consent|7
295546|NCT00891293|971627|P1|Overall Study|Lost to Follow-up|7
295547|NCT00891293|971627|P1|Overall Study|Laboratory abnormality|4
295548|NCT00891293|971627|P1|Overall Study|Protocol Violation|2
295549|NCT00891293|971627|P1|Overall Study|Adverse Event|2
295550|NCT00891202|971641|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
295551|NCT00891202|971642|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
295552|NCT00891202|971643|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
295553|NCT00891202|971644|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
295554|NCT00891202|971641|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
295555|NCT00891202|971642|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
295556|NCT00891202|971643|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
295557|NCT00891202|971644|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
295558|NCT00891202|971641|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
295559|NCT00891202|971642|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
295560|NCT00891202|971643|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
295561|NCT00891202|971644|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
295562|NCT00891202|971641|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
295563|NCT00891202|971642|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
295564|NCT00891202|971643|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
295565|NCT00891202|971644|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
295566|NCT00891046|971804|P5|Overall Study|Lost to Follow-up|1
295567|NCT00891046|971805|P4|Overall Study|Lost to Follow-up|0
295568|NCT00891046|971806|P3|Overall Study|Lost to Follow-up|0
295569|NCT00891046|971807|P2|Overall Study|Lost to Follow-up|0
295570|NCT00891046|971808|P1|Overall Study|Lost to Follow-up|0
295571|NCT00891046|971804|P5|Overall Study|Withdrawal by Subject|1
295572|NCT00891046|971805|P4|Overall Study|Withdrawal by Subject|1
295573|NCT00891046|971806|P3|Overall Study|Withdrawal by Subject|2
295574|NCT00891046|971807|P2|Overall Study|Withdrawal by Subject|1
295575|NCT00891046|971808|P1|Overall Study|Withdrawal by Subject|2
295576|NCT00891046|971804|P5|Overall Study|Adverse Event|14
295577|NCT00891046|971805|P4|Overall Study|Adverse Event|0
295578|NCT00891046|971806|P3|Overall Study|Adverse Event|2
295579|NCT00891046|971807|P2|Overall Study|Adverse Event|3
295580|NCT00891046|971808|P1|Overall Study|Adverse Event|4
295581|NCT00891046|971804|P5|Overall Study|Participant no longer required drug|1
295582|NCT00891046|971805|P4|Overall Study|Participant no longer required drug|0
295583|NCT00891046|971806|P3|Overall Study|Participant no longer required drug|0
295584|NCT00891046|971807|P2|Overall Study|Participant no longer required drug|2
295585|NCT00891046|971808|P1|Overall Study|Participant no longer required drug|0
295586|NCT00891046|971804|P5|Overall Study|Administrative problems|1
295587|NCT00891046|971805|P4|Overall Study|Administrative problems|0
295588|NCT00891046|971806|P3|Overall Study|Administrative problems|0
295589|NCT00891046|971807|P2|Overall Study|Administrative problems|0
295590|NCT00891046|971808|P1|Overall Study|Administrative problems|0
295591|NCT00891046|971804|P5|Overall Study|Unsatisfactory therapeutic effect|20
295592|NCT00891046|971805|P4|Overall Study|Unsatisfactory therapeutic effect|2
295593|NCT00891046|971806|P3|Overall Study|Unsatisfactory therapeutic effect|19
295594|NCT00891046|971807|P2|Overall Study|Unsatisfactory therapeutic effect|2
295595|NCT00891046|971808|P1|Overall Study|Unsatisfactory therapeutic effect|5
295596|NCT00891046|971804|P5|Overall Study|Protocol Violation|1
295597|NCT00891046|971805|P4|Overall Study|Protocol Violation|0
295598|NCT00891046|971806|P3|Overall Study|Protocol Violation|0
295599|NCT00891046|971807|P2|Overall Study|Protocol Violation|1
295600|NCT00891046|971808|P1|Overall Study|Protocol Violation|1
295601|NCT00891020|971884|P3|Long-term Extension Period|Administrative|2
295602|NCT00891020|971885|P2|Long-term Extension Period|Administrative|2
295603|NCT00891020|971886|P1|Long-term Extension Period|Administrative|1
295604|NCT00891020|971884|P3|Long-term Extension Period|Failure to return|3
295605|NCT00891020|971885|P2|Long-term Extension Period|Failure to return|2
295606|NCT00891020|971886|P1|Long-term Extension Period|Failure to return|0
295607|NCT00891020|971884|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
295608|NCT00891020|971885|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
295609|NCT00891020|971886|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
295610|NCT00891020|971884|P3|Long-term Extension Period|Protocol Violation|1
295611|NCT00891020|971885|P2|Long-term Extension Period|Protocol Violation|1
295612|NCT00891020|971886|P1|Long-term Extension Period|Protocol Violation|0
295613|NCT00891020|971884|P3|Long-term Extension Period|Insufficient therapeutic response|2
295614|NCT00891020|971885|P2|Long-term Extension Period|Insufficient therapeutic response|2
295615|NCT00891020|971886|P1|Long-term Extension Period|Insufficient therapeutic response|3
295616|NCT00891020|971884|P3|Long-term Extension Period|Death|1
295617|NCT00891020|971885|P2|Long-term Extension Period|Death|0
295618|NCT00891020|971886|P1|Long-term Extension Period|Death|0
295619|NCT00891020|971884|P3|Long-term Extension Period|Adverse Event|10
295620|NCT00891020|971885|P2|Long-term Extension Period|Adverse Event|11
295621|NCT00891020|971886|P1|Long-term Extension Period|Adverse Event|1
295622|NCT00891020|971884|P3|24 Week Treatment Period|Administrative/Other|1
295623|NCT00891020|971885|P2|24 Week Treatment Period|Administrative/Other|6
295624|NCT00891020|971886|P1|24 Week Treatment Period|Administrative/Other|5
295625|NCT00891020|971884|P3|24 Week Treatment Period|Withdrew consent|15
295626|NCT00891020|971885|P2|24 Week Treatment Period|Withdrew consent|3
295627|NCT00891020|971886|P1|24 Week Treatment Period|Withdrew consent|6
295628|NCT00891020|971884|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
295629|NCT00891020|971885|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
295630|NCT00891020|971886|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
295631|NCT00891020|971884|P3|24 Week Treatment Period|Other protocol violation|2
295632|NCT00891020|971885|P2|24 Week Treatment Period|Other protocol violation|1
295633|NCT00891020|971886|P1|24 Week Treatment Period|Other protocol violation|1
295634|NCT00891020|971884|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
295635|NCT00891020|971885|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
295636|NCT00891020|971886|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
295637|NCT00891020|971884|P3|24 Week Treatment Period|Failure to return|5
295638|NCT00891020|971885|P2|24 Week Treatment Period|Failure to return|5
295639|NCT00891020|971886|P1|24 Week Treatment Period|Failure to return|4
295640|NCT00891020|971884|P3|24 Week Treatment Period|Insufficient therapeutic response|15
295641|NCT00891020|971885|P2|24 Week Treatment Period|Insufficient therapeutic response|9
295642|NCT00891020|971886|P1|24 Week Treatment Period|Insufficient therapeutic response|6
295643|NCT00891020|971884|P3|24 Week Treatment Period|Death|0
295644|NCT00891020|971885|P2|24 Week Treatment Period|Death|2
295645|NCT00891020|971886|P1|24 Week Treatment Period|Death|0
295646|NCT00891020|971884|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
295647|NCT00891020|971885|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
295648|NCT00891020|971886|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
295649|NCT00890929|971950|P1|Overall Study|Physician Decision|1
295650|NCT00890929|971950|P1|Overall Study|Withdrawal by Subject|3
295651|NCT00890929|971950|P1|Overall Study|Death before treatment|2
295652|NCT00890695|971977|P2|Overall Study|Protocol Violation|0
295653|NCT00890695|971978|P1|Overall Study|Protocol Violation|1
295654|NCT00890591|972007|P1|Overall Study|Lack of Efficacy|20
295655|NCT00890552|972013|P1|On-treatment|Early prog disease/ death|10
295656|NCT00890552|972013|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
295657|NCT00890409|972022|P2|Overall Study|Lost to Follow-up|21
295658|NCT00890409|972023|P1|Overall Study|Lost to Follow-up|20
295659|NCT00890201|972033|P2|Overall Study|Protocol Violation|56
295660|NCT00890201|972034|P1|Overall Study|Protocol Violation|5
295661|NCT00890097|972043|P3|Overall Study|Protocol Deviation|1
295662|NCT00890097|972044|P2|Overall Study|Protocol Deviation|1
295663|NCT00890097|972045|P1|Overall Study|Protocol Deviation|1
295664|NCT00890097|972043|P3|Overall Study|Subject Moved|0
295665|NCT00890097|972044|P2|Overall Study|Subject Moved|4
295666|NCT00890097|972045|P1|Overall Study|Subject Moved|0
295667|NCT00890097|972043|P3|Overall Study|Transportation|0
295668|NCT00890097|972044|P2|Overall Study|Transportation|2
295669|NCT00890097|972045|P1|Overall Study|Transportation|0
295670|NCT00890097|972043|P3|Overall Study|Failed inclusion criteria|0
295671|NCT00890097|972044|P2|Overall Study|Failed inclusion criteria|4
295672|NCT00890097|972045|P1|Overall Study|Failed inclusion criteria|3
295673|NCT00890097|972043|P3|Overall Study|Randomization Error|0
295674|NCT00890097|972044|P2|Overall Study|Randomization Error|0
295675|NCT00890097|972045|P1|Overall Study|Randomization Error|2
295676|NCT00890097|972043|P3|Overall Study|Subject Decision|6
295677|NCT00890097|972044|P2|Overall Study|Subject Decision|2
295678|NCT00890097|972045|P1|Overall Study|Subject Decision|3
295679|NCT00890097|972043|P3|Overall Study|Did not attend final visit|0
295680|NCT00890097|972044|P2|Overall Study|Did not attend final visit|3
295681|NCT00890097|972045|P1|Overall Study|Did not attend final visit|2
295682|NCT00890097|972043|P3|Overall Study|Sponsor Decision|7
295683|NCT00890097|972044|P2|Overall Study|Sponsor Decision|11
295684|NCT00890097|972045|P1|Overall Study|Sponsor Decision|7
295685|NCT00890097|972043|P3|Overall Study|Noncompliance|4
295686|NCT00890097|972044|P2|Overall Study|Noncompliance|4
295687|NCT00890097|972045|P1|Overall Study|Noncompliance|0
295688|NCT00890097|972043|P3|Overall Study|Lost to Follow-up|5
295689|NCT00890097|972044|P2|Overall Study|Lost to Follow-up|5
295690|NCT00890097|972045|P1|Overall Study|Lost to Follow-up|5
295691|NCT00890097|972043|P3|Overall Study|Withdrew Consent|9
295692|NCT00890097|972044|P2|Overall Study|Withdrew Consent|6
295693|NCT00890097|972045|P1|Overall Study|Withdrew Consent|9
295694|NCT00890097|972043|P3|Overall Study|Decision Unrelated to an Adverse Event|17
295695|NCT00890097|972044|P2|Overall Study|Decision Unrelated to an Adverse Event|12
295696|NCT00890097|972045|P1|Overall Study|Decision Unrelated to an Adverse Event|15
295697|NCT00890097|972043|P3|Overall Study|Adverse Event|28
295698|NCT00890097|972044|P2|Overall Study|Adverse Event|32
295699|NCT00890097|972045|P1|Overall Study|Adverse Event|21
295700|NCT00890084|972053|P1|Overall Study|Lost to Follow-up|126
295701|NCT00890084|972053|P1|Overall Study|Adverse Event|16
295702|NCT00889863|972093|P2|Part II: Randomized Double Blind|Protocol deviation|1
295703|NCT00889863|972094|P1|Part II: Randomized Double Blind|Protocol deviation|0
295704|NCT00889863|972093|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
295705|NCT00889863|972094|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
295706|NCT00889863|972093|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
295707|NCT00889863|972094|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
295708|NCT00889863|972093|P2|Part II: Randomized Double Blind|Adverse Event|4
295709|NCT00889863|972094|P1|Part II: Randomized Double Blind|Adverse Event|0
295710|NCT00889863|972093|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
295711|NCT00889863|972094|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
295712|NCT00889863|972093|P2|Part I: Open Label|Adverse Event|0
295713|NCT00889863|972094|P1|Part I: Open Label|Adverse Event|4
295714|NCT00889863|972093|P2|Part I: Open Label|Death|0
295715|NCT00889863|972094|P1|Part I: Open Label|Death|1
295716|NCT00888940|972122|P2|Overall Study|Randomized Not Treated|13
295717|NCT00888940|972123|P1|Overall Study|Randomized Not Treated|11
295718|NCT00888940|972122|P2|Overall Study|Lost to Follow-up|5
295719|NCT00888940|972123|P1|Overall Study|Lost to Follow-up|5
295720|NCT00888940|972122|P2|Overall Study|Adverse Event|3
295721|NCT00888940|972123|P1|Overall Study|Adverse Event|12
295722|NCT00888849|972133|P2|Overall Study|Lost to Follow-up|2
295723|NCT00888849|972134|P1|Overall Study|Lost to Follow-up|1
295724|NCT00888849|972133|P2|Overall Study|Death|7
295725|NCT00888849|972134|P1|Overall Study|Death|4
295726|NCT00889720|972144|P1|Overall Study|Unspecified|4
295727|NCT00889720|972144|P1|Overall Study|Withdrawal by Subject|4
295728|NCT00889707|972171|P2|Overall Study|Lack of Efficacy|5
295729|NCT00889707|972172|P1|Overall Study|Lack of Efficacy|2
295730|NCT00889707|972171|P2|Overall Study|Lost to Follow-up|2
295731|NCT00889707|972172|P1|Overall Study|Lost to Follow-up|0
295732|NCT00889707|972171|P2|Overall Study|Withdrawal by Subject|3
295733|NCT00889707|972172|P1|Overall Study|Withdrawal by Subject|4
295734|NCT00889707|972171|P2|Overall Study|Adverse Event|0
295735|NCT00889707|972172|P1|Overall Study|Adverse Event|1
295736|NCT00889681|972180|P1|Overall Study|Insurance disapproval|1
295737|NCT00889681|972180|P1|Overall Study|Not meeting qualification Criteria|2
295738|NCT00889603|972187|P1|Overall Study|Not Specified|4
295739|NCT00889603|972187|P1|Overall Study|No longer willing to participant in stud|4
295740|NCT00889603|972187|P1|Overall Study|Lost to Follow-up|19
295741|NCT00889603|972187|P1|Overall Study|Death|3
295742|NCT00889603|972187|P1|Overall Study|Adverse Event|7
295743|NCT00889421|972209|P1|Overall Study|Lack of Efficacy|3
295744|NCT00889265|972250|P1|Overall Study|Protocol Violation|1
295745|NCT00889265|972250|P1|Overall Study|Lost to Follow-up|5
295746|NCT00889265|972250|P1|Overall Study|Adverse Event|1
295747|NCT00889252|972257|P2|Overall Study|Protocol Violation|0
295748|NCT00889252|972258|P1|Overall Study|Protocol Violation|2
295749|NCT00889252|972257|P2|Overall Study|Withdrawal by Subject|0
295750|NCT00889252|972258|P1|Overall Study|Withdrawal by Subject|3
295751|NCT00889252|972257|P2|Overall Study|Adverse Event|4
295752|NCT00889252|972258|P1|Overall Study|Adverse Event|2
295753|NCT00888654|972310|P1|Overall Study|Stopped meds due to headaches|1
295754|NCT00888654|972310|P1|Overall Study|Change in surg date|1
295755|NCT00888654|972310|P1|Overall Study|Inelig. due to contraindication of med|1
295756|NCT00888654|972310|P1|Overall Study|Withdrawal by Subject|1
295757|NCT00888654|972310|P1|Overall Study|Surgery aborted|2
295758|NCT00888654|972310|P1|Overall Study|Not enough oral meds before surgery|3
295759|NCT00888654|972310|P1|Overall Study|Problems swallowing oral meds.|1
295760|NCT00888433|972331|P2|Overall Study|Missed Visit|1
295761|NCT00888433|972332|P1|Overall Study|Missed Visit|2
295762|NCT00888433|972331|P2|Overall Study|Withdrawal by Subject|2
295763|NCT00888433|972332|P1|Overall Study|Withdrawal by Subject|1
295764|NCT00888381|972340|P2|Overall Study|Lost to Follow-up|1
295765|NCT00888381|972341|P1|Overall Study|Lost to Follow-up|0
295766|NCT00888355|972361|P4|Overall Study|Withdrawal by Subject|3
295767|NCT00888355|972362|P3|Overall Study|Withdrawal by Subject|1
295768|NCT00888355|972363|P2|Overall Study|Withdrawal by Subject|3
295769|NCT00888355|972364|P1|Overall Study|Withdrawal by Subject|0
295770|NCT00888355|972361|P4|Overall Study|Protocol Violation|2
295771|NCT00888355|972362|P3|Overall Study|Protocol Violation|1
295772|NCT00888355|972363|P2|Overall Study|Protocol Violation|2
295773|NCT00888355|972364|P1|Overall Study|Protocol Violation|3
295774|NCT00888355|972361|P4|Overall Study|Lost to Follow-up|0
295775|NCT00888355|972362|P3|Overall Study|Lost to Follow-up|2
295776|NCT00888355|972363|P2|Overall Study|Lost to Follow-up|2
295777|NCT00888355|972364|P1|Overall Study|Lost to Follow-up|0
295778|NCT00888355|972361|P4|Overall Study|Lack of Efficacy|2
295779|NCT00888355|972362|P3|Overall Study|Lack of Efficacy|5
295780|NCT00888355|972363|P2|Overall Study|Lack of Efficacy|2
295781|NCT00888355|972364|P1|Overall Study|Lack of Efficacy|9
295782|NCT00888355|972361|P4|Overall Study|Adverse Event|3
295783|NCT00888355|972362|P3|Overall Study|Adverse Event|3
295784|NCT00888355|972363|P2|Overall Study|Adverse Event|0
295785|NCT00888355|972364|P1|Overall Study|Adverse Event|10
295786|NCT00888329|972420|P2|Overall Study|Physician Decision|9
295787|NCT00888329|972421|P1|Overall Study|Physician Decision|6
295788|NCT00888238|972427|P3|Washout Period After Period 2|Adverse Event|1
295789|NCT00888238|972428|P2|Washout Period After Period 2|Adverse Event|0
295790|NCT00888238|972429|P1|Washout Period After Period 2|Adverse Event|0
295791|NCT00888134|972437|P1|Follow-up|being followed for long-term survival|1
295792|NCT00888134|972437|P1|Treatment With Study Drug|Withdrawal by Subject|1
295793|NCT00887978|972447|P2|Overall Study|Lost to Follow-up|1
295794|NCT00887978|972448|P1|Overall Study|Lost to Follow-up|0
295795|NCT00887978|972447|P2|Overall Study|Withdrawal by Subject|2
295796|NCT00887978|972448|P1|Overall Study|Withdrawal by Subject|1
295797|NCT00887978|972447|P2|Overall Study|Death|3
295798|NCT00887978|972448|P1|Overall Study|Death|2
295799|NCT00887978|972447|P2|Overall Study|Clinical Worsening|4
295800|NCT00887978|972448|P1|Overall Study|Clinical Worsening|4
295801|NCT00887978|972447|P2|Overall Study|Adverse Event|5
295802|NCT00887978|972448|P1|Overall Study|Adverse Event|18
295803|NCT00887913|972514|P1|Overall Study|Withdrawal by Subject|6
295804|NCT00887822|972522|P2|Overall Study|Randomized but not treated|1
295805|NCT00887822|972523|P1|Overall Study|Randomized but not treated|0
295806|NCT00887822|972522|P2|Overall Study|Protocol Violation|1
295807|NCT00887822|972523|P1|Overall Study|Protocol Violation|0
295808|NCT00887822|972522|P2|Overall Study|Death|3
295809|NCT00887822|972523|P1|Overall Study|Death|2
295810|NCT00887822|972522|P2|Overall Study|Administrative/Other than specified|4
295811|NCT00887822|972523|P1|Overall Study|Administrative/Other than specified|5
295812|NCT00887822|972522|P2|Overall Study|Refused treatment/Did not cooperate|10
295813|NCT00887822|972523|P1|Overall Study|Refused treatment/Did not cooperate|12
295814|NCT00887822|972522|P2|Overall Study|Failure to return|11
295815|NCT00887822|972523|P1|Overall Study|Failure to return|11
295816|NCT00887822|972522|P2|Overall Study|Adverse Event|17
295817|NCT00887822|972523|P1|Overall Study|Adverse Event|14
295818|NCT00887822|972522|P2|Overall Study|Insufficient therapeutic response|55
295819|NCT00887822|972523|P1|Overall Study|Insufficient therapeutic response|53
295820|NCT00887809|972555|P2|Overall Study|Death|0
295821|NCT00887809|972556|P1|Overall Study|Death|1
295822|NCT00887809|972555|P2|Overall Study|Patient Not Treated|0
295823|NCT00887809|972556|P1|Overall Study|Patient Not Treated|3
295824|NCT00887744|972562|P1|Overall Study|Various reasons|9
295825|NCT00887744|972562|P1|Overall Study|Withdrawal by Subject|18
295826|NCT00887744|972562|P1|Overall Study|Lost to Follow-up|3
295827|NCT00887744|972562|P1|Overall Study|Death|1
295828|NCT00887744|972562|P1|Overall Study|Adverse Event|3
295829|NCT00887679|972571|P1|Overall Study|Physician Decision|5
295830|NCT00887679|972571|P1|Overall Study|Lost to Follow-up|4
295831|NCT00887679|972571|P1|Overall Study|Withdrawal by Subject|1
295832|NCT00887588|972601|P2|Extension Period|Lost to Follow-up|0
295833|NCT00887588|972602|P1|Extension Period|Lost to Follow-up|1
295834|NCT00887588|972601|P2|Extension Period|Protocol deviation|0
295835|NCT00887588|972602|P1|Extension Period|Protocol deviation|1
295836|NCT00887588|972601|P2|Extension Period|Death|1
295837|NCT00887588|972602|P1|Extension Period|Death|0
295838|NCT00887588|972601|P2|Extension Period|Adverse Event|4
295839|NCT00887588|972602|P1|Extension Period|Adverse Event|4
295840|NCT00887588|972601|P2|Core Period|Adverse Event|11
295841|NCT00887588|972602|P1|Core Period|Adverse Event|9
295842|NCT00887588|972601|P2|Core Period|Withdrawal by Subject|8
295843|NCT00887588|972602|P1|Core Period|Withdrawal by Subject|6
295844|NCT00887588|972601|P2|Core Period|Lost to Follow-up|1
295845|NCT00887588|972602|P1|Core Period|Lost to Follow-up|3
295846|NCT00887588|972601|P2|Core Period|Death|1
295847|NCT00887588|972602|P1|Core Period|Death|1
295848|NCT00887549|972683|P1|Maintenance Therapy|Death due to adverse event|1
295849|NCT00887549|972683|P1|Maintenance Therapy|Progressive Disease|25
295850|NCT00887549|972683|P1|Maintenance Therapy|Physician Decision|1
295851|NCT00887549|972683|P1|Maintenance Therapy|Adverse Event|16
295852|NCT00887549|972683|P1|Induction Therapy|Death due to Study Drug Toxicity|1
295853|NCT00887549|972683|P1|Induction Therapy|Death due to Study Disease|4
295854|NCT00887549|972683|P1|Induction Therapy|Progressive Disease|13
295855|NCT00887549|972683|P1|Induction Therapy|Physician Decision|1
295856|NCT00887549|972683|P1|Induction Therapy|Adverse Event|8
295857|NCT00887484|972701|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
295858|NCT00887484|972701|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
295859|NCT00887484|972701|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
295860|NCT00887354|972787|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
295861|NCT00887354|972788|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
295862|NCT00887354|972787|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
295863|NCT00887354|972788|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
295864|NCT00887354|972787|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
295865|NCT00887354|972788|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
295866|NCT00887354|972787|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
295867|NCT00887354|972788|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
295868|NCT00887354|972787|P2|Open Label Phase (Week 26 to Week 78)|Death|2
295869|NCT00887354|972788|P1|Open Label Phase (Week 26 to Week 78)|Death|0
295870|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
295871|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
295872|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
295873|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
295874|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
295875|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
295876|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
295877|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
295878|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
295879|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
295880|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
295881|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
295882|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
295883|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
295884|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
295885|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
295886|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
295887|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
295888|NCT00887354|972787|P2|Treatment Phase (Week 0 to Week 26)|Death|1
295889|NCT00887354|972788|P1|Treatment Phase (Week 0 to Week 26)|Death|0
295890|NCT00887341|972808|P2|Overall Study|Lost to Follow-up|1
295891|NCT00887341|972809|P1|Overall Study|Lost to Follow-up|0
295892|NCT00887341|972808|P2|Overall Study|Adverse Event|1
295893|NCT00887341|972809|P1|Overall Study|Adverse Event|0
295894|NCT00887341|972808|P2|Overall Study|Withdrawal by Subject|1
295895|NCT00887341|972809|P1|Overall Study|Withdrawal by Subject|1
295896|NCT00887341|972808|P2|Overall Study|Refused treatment|0
295897|NCT00887341|972809|P1|Overall Study|Refused treatment|1
295898|NCT00887315|972845|P2|Overall Study|Study termination|4
295899|NCT00887315|972846|P1|Overall Study|Study termination|7
295900|NCT00887289|972854|P1|Overall Study|not specified|20
295901|NCT00887289|972854|P1|Overall Study|Lost to Follow-up|8
295902|NCT00887289|972854|P1|Overall Study|Withdrawal by Subject|26
295903|NCT00887289|972854|P1|Overall Study|Adverse Event|27
295904|NCT00887289|972854|P1|Overall Study|Lack of Efficacy|14
295905|NCT00887250|972866|P3|Overall Study|Patient uncooperative|1
295906|NCT00887250|972867|P2|Overall Study|Patient uncooperative|0
295907|NCT00887250|972868|P1|Overall Study|Patient uncooperative|0
295908|NCT00887250|972866|P3|Overall Study|Withdrawal by Subject|2
295909|NCT00887250|972867|P2|Overall Study|Withdrawal by Subject|1
295910|NCT00887250|972868|P1|Overall Study|Withdrawal by Subject|2
295911|NCT00887250|972866|P3|Overall Study|Protocol Violation|1
295912|NCT00887250|972867|P2|Overall Study|Protocol Violation|2
295913|NCT00887250|972868|P1|Overall Study|Protocol Violation|2
295914|NCT00887250|972866|P3|Overall Study|Lost to Follow-up|1
295915|NCT00887250|972867|P2|Overall Study|Lost to Follow-up|3
295916|NCT00887250|972868|P1|Overall Study|Lost to Follow-up|2
295917|NCT00887250|972866|P3|Overall Study|Lack of Efficacy|1
295918|NCT00887250|972867|P2|Overall Study|Lack of Efficacy|6
295919|NCT00887250|972868|P1|Overall Study|Lack of Efficacy|9
295920|NCT00887250|972866|P3|Overall Study|Adverse Event|7
295921|NCT00887250|972867|P2|Overall Study|Adverse Event|0
295922|NCT00887250|972868|P1|Overall Study|Adverse Event|3
295923|NCT00887224|972891|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
295924|NCT00887224|972892|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
295925|NCT00887224|972893|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
295926|NCT00887224|972891|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
295927|NCT00887224|972892|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
295928|NCT00887224|972893|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
295929|NCT00887224|972891|P3|DB Taper Phase / Post Study Follow Up|Unspecified|12
295930|NCT00887224|972892|P2|DB Taper Phase / Post Study Follow Up|Unspecified|11
295931|NCT00887224|972893|P1|DB Taper Phase / Post Study Follow Up|Unspecified|0
295932|NCT00887224|972891|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
295933|NCT00887224|972892|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
295934|NCT00887224|972893|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
295935|NCT00887224|972891|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
295936|NCT00887224|972892|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
295937|NCT00887224|972893|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
295938|NCT00887224|972891|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
295939|NCT00887224|972892|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
295940|NCT00887224|972893|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
295941|NCT00887224|972891|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
295942|NCT00887224|972892|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
295943|NCT00887224|972893|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
295944|NCT00887224|972891|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
295945|NCT00887224|972892|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
295946|NCT00887224|972893|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
295947|NCT00887224|972891|P3|Double-blind (DB) Phase|Protocol Violation|5
295948|NCT00887224|972892|P2|Double-blind (DB) Phase|Protocol Violation|8
295949|NCT00887224|972893|P1|Double-blind (DB) Phase|Protocol Violation|0
295950|NCT00887224|972891|P3|Double-blind (DB) Phase|Unspecified|0
295951|NCT00887224|972892|P2|Double-blind (DB) Phase|Unspecified|2
295952|NCT00887224|972893|P1|Double-blind (DB) Phase|Unspecified|0
295953|NCT00887224|972891|P3|Double-blind (DB) Phase|Lost to Follow-up|8
295954|NCT00887224|972892|P2|Double-blind (DB) Phase|Lost to Follow-up|8
295955|NCT00887224|972893|P1|Double-blind (DB) Phase|Lost to Follow-up|0
295956|NCT00887224|972891|P3|Double-blind (DB) Phase|Lack of Efficacy|33
295957|NCT00887224|972892|P2|Double-blind (DB) Phase|Lack of Efficacy|67
295958|NCT00887224|972893|P1|Double-blind (DB) Phase|Lack of Efficacy|0
295959|NCT00887224|972891|P3|Double-blind (DB) Phase|Failed to return|2
295960|NCT00887224|972892|P2|Double-blind (DB) Phase|Failed to return|2
295961|NCT00887224|972893|P1|Double-blind (DB) Phase|Failed to return|0
295962|NCT00887224|972891|P3|Double-blind (DB) Phase|Adverse Event|2
295963|NCT00887224|972892|P2|Double-blind (DB) Phase|Adverse Event|7
295964|NCT00887224|972893|P1|Double-blind (DB) Phase|Adverse Event|0
295965|NCT00887224|972891|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
295966|NCT00887224|972892|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
295967|NCT00887224|972893|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
295968|NCT00887224|972891|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
295969|NCT00887224|972892|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
295970|NCT00887224|972893|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
295971|NCT00887224|972891|P3|OL Taper Phase / OL Follow Up|Unspecified|0
295972|NCT00887224|972892|P2|OL Taper Phase / OL Follow Up|Unspecified|0
295973|NCT00887224|972893|P1|OL Taper Phase / OL Follow Up|Unspecified|30
295974|NCT00887224|972891|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
295975|NCT00887224|972892|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
295976|NCT00887224|972893|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
295977|NCT00887224|972891|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
295978|NCT00887224|972892|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
295979|NCT00887224|972893|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
295980|NCT00887224|972891|P3|OL Taper Phase / OL Follow Up|Failed to return|0
295981|NCT00887224|972892|P2|OL Taper Phase / OL Follow Up|Failed to return|0
295982|NCT00887224|972893|P1|OL Taper Phase / OL Follow Up|Failed to return|17
295983|NCT00887224|972891|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
295984|NCT00887224|972892|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
295985|NCT00887224|972893|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
295986|NCT00887224|972891|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
295987|NCT00887224|972892|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
295988|NCT00887224|972893|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
295989|NCT00887224|972891|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
295990|NCT00887224|972892|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
295991|NCT00887224|972893|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
295992|NCT00887224|972891|P3|Open-label Stability (OLS) Phase|Unspecified|0
295993|NCT00887224|972892|P2|Open-label Stability (OLS) Phase|Unspecified|0
295994|NCT00887224|972893|P1|Open-label Stability (OLS) Phase|Unspecified|1
295995|NCT00887224|972891|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
295996|NCT00887224|972892|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
295997|NCT00887224|972893|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
295998|NCT00887224|972891|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
295999|NCT00887224|972892|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
296000|NCT00887224|972893|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
296001|NCT00887224|972891|P3|Open-label Stability (OLS) Phase|Failed to return|0
296002|NCT00887224|972892|P2|Open-label Stability (OLS) Phase|Failed to return|0
296003|NCT00887224|972893|P1|Open-label Stability (OLS) Phase|Failed to return|3
296004|NCT00887224|972891|P3|Open-label Stability (OLS) Phase|Adverse Event|0
296005|NCT00887224|972892|P2|Open-label Stability (OLS) Phase|Adverse Event|0
296006|NCT00887224|972893|P1|Open-label Stability (OLS) Phase|Adverse Event|22
296007|NCT00887224|972891|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
296008|NCT00887224|972892|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
296009|NCT00887224|972893|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
296010|NCT00887224|972891|P3|Open-label Response (OLR) Phase|Protocol Violation|0
296011|NCT00887224|972892|P2|Open-label Response (OLR) Phase|Protocol Violation|0
296012|NCT00887224|972893|P1|Open-label Response (OLR) Phase|Protocol Violation|12
296013|NCT00887224|972891|P3|Open-label Response (OLR) Phase|Unspecified|0
296014|NCT00887224|972892|P2|Open-label Response (OLR) Phase|Unspecified|0
296015|NCT00887224|972893|P1|Open-label Response (OLR) Phase|Unspecified|1
296016|NCT00887224|972891|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
296017|NCT00887224|972892|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
296018|NCT00887224|972893|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
296019|NCT00887224|972891|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
296020|NCT00887224|972892|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
296021|NCT00887224|972893|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
296022|NCT00887224|972891|P3|Open-label Response (OLR) Phase|Failed to return|0
296023|NCT00887224|972892|P2|Open-label Response (OLR) Phase|Failed to return|0
296024|NCT00887224|972893|P1|Open-label Response (OLR) Phase|Failed to return|6
296025|NCT00887224|972891|P3|Open-label Response (OLR) Phase|Adverse Event|0
296026|NCT00887224|972892|P2|Open-label Response (OLR) Phase|Adverse Event|0
296027|NCT00887224|972893|P1|Open-label Response (OLR) Phase|Adverse Event|46
296028|NCT00887198|972920|P2|Overall Study|Lost to Follow-up|3
296029|NCT00887198|972921|P1|Overall Study|Lost to Follow-up|4
296030|NCT00887198|972920|P2|Overall Study|Withdrawal by Subject|41
296031|NCT00887198|972921|P1|Overall Study|Withdrawal by Subject|28
296032|NCT00887198|972920|P2|Overall Study|Death|387
296033|NCT00887198|972921|P1|Overall Study|Death|352
296034|NCT00887159|972952|P3|Overall Study|Never started assigned therapy|4
296035|NCT00887159|972953|P2|Overall Study|Never started assigned therapy|3
296036|NCT00887159|972954|P1|Overall Study|Never started assigned therapy|3
296037|NCT00887159|972952|P3|Overall Study|Ineligible|0
296038|NCT00887159|972953|P2|Overall Study|Ineligible|1
296039|NCT00887159|972954|P1|Overall Study|Ineligible|5
296040|NCT00887159|972952|P3|Overall Study|Received more tx instead of observation|0
296041|NCT00887159|972953|P2|Overall Study|Received more tx instead of observation|0
296042|NCT00887159|972954|P1|Overall Study|Received more tx instead of observation|1
296043|NCT00887159|972952|P3|Overall Study|Pt had PD but was SD when re-measured|0
296044|NCT00887159|972953|P2|Overall Study|Pt had PD but was SD when re-measured|1
296045|NCT00887159|972954|P1|Overall Study|Pt had PD but was SD when re-measured|0
296046|NCT00887159|972952|P3|Overall Study|Treatment delayed|0
296047|NCT00887159|972953|P2|Overall Study|Treatment delayed|1
296048|NCT00887159|972954|P1|Overall Study|Treatment delayed|1
296049|NCT00887159|972952|P3|Overall Study|Sympomatic deterioration|0
296050|NCT00887159|972953|P2|Overall Study|Sympomatic deterioration|0
296051|NCT00887159|972954|P1|Overall Study|Sympomatic deterioration|1
296052|NCT00887159|972952|P3|Overall Study|Physician Decision|0
296053|NCT00887159|972953|P2|Overall Study|Physician Decision|1
296054|NCT00887159|972954|P1|Overall Study|Physician Decision|1
296055|NCT00887159|972952|P3|Overall Study|Alternative therapy|0
296056|NCT00887159|972953|P2|Overall Study|Alternative therapy|0
296057|NCT00887159|972954|P1|Overall Study|Alternative therapy|2
296058|NCT00887159|972952|P3|Overall Study|Withdrawal by Subject|2
296059|NCT00887159|972953|P2|Overall Study|Withdrawal by Subject|4
296060|NCT00887159|972954|P1|Overall Study|Withdrawal by Subject|4
296061|NCT00887159|972952|P3|Overall Study|Death|0
296062|NCT00887159|972953|P2|Overall Study|Death|2
296063|NCT00887159|972954|P1|Overall Study|Death|2
296064|NCT00887159|972952|P3|Overall Study|Adverse Event|17
296065|NCT00887159|972953|P2|Overall Study|Adverse Event|4
296066|NCT00887159|972954|P1|Overall Study|Adverse Event|3
296067|NCT00887159|972952|P3|Overall Study|Disease progression|33
296068|NCT00887159|972953|P2|Overall Study|Disease progression|39
296069|NCT00887159|972954|P1|Overall Study|Disease progression|6
296070|NCT00886938|972970|P1|Overall Study|Withdrawal by Subject|1
296071|NCT00886938|972970|P1|Overall Study|Adverse Event|1
296072|NCT00886834|972983|P2|Overall Study|Protocol Violation|3
296073|NCT00886834|972984|P1|Overall Study|Protocol Violation|0
296074|NCT00886821|973006|P14|Stage 2|Lost to Follow-up|1
296075|NCT00886821|973007|P13|Stage 2|Lost to Follow-up|2
296076|NCT00886821|973008|P12|Stage 2|Lost to Follow-up|0
296077|NCT00886821|973009|P11|Stage 2|Lost to Follow-up|0
296078|NCT00886821|973010|P10|Stage 2|Lost to Follow-up|0
296079|NCT00886821|973011|P9|Stage 2|Lost to Follow-up|0
296080|NCT00886821|973012|P8|Stage 2|Lost to Follow-up|0
296081|NCT00886821|973013|P7|Stage 2|Lost to Follow-up|0
296082|NCT00886821|973014|P6|Stage 2|Lost to Follow-up|0
296083|NCT00886821|973015|P5|Stage 2|Lost to Follow-up|0
296084|NCT00886821|973016|P4|Stage 2|Lost to Follow-up|0
296085|NCT00886821|973017|P3|Stage 2|Lost to Follow-up|0
296086|NCT00886821|973018|P2|Stage 2|Lost to Follow-up|0
296087|NCT00886821|973019|P1|Stage 2|Lost to Follow-up|0
296088|NCT00886821|973006|P14|Stage 2|Adverse Event|0
296089|NCT00886821|973007|P13|Stage 2|Adverse Event|3
296090|NCT00886821|973008|P12|Stage 2|Adverse Event|1
296091|NCT00886821|973009|P11|Stage 2|Adverse Event|0
296092|NCT00886821|973010|P10|Stage 2|Adverse Event|0
296093|NCT00886821|973011|P9|Stage 2|Adverse Event|0
296094|NCT00886821|973012|P8|Stage 2|Adverse Event|0
296095|NCT00886821|973013|P7|Stage 2|Adverse Event|0
296096|NCT00886821|973014|P6|Stage 2|Adverse Event|0
296097|NCT00886821|973015|P5|Stage 2|Adverse Event|0
296098|NCT00886821|973016|P4|Stage 2|Adverse Event|0
296099|NCT00886821|973017|P3|Stage 2|Adverse Event|0
296100|NCT00886821|973018|P2|Stage 2|Adverse Event|0
296101|NCT00886821|973019|P1|Stage 2|Adverse Event|0
296102|NCT00886795|973244|P1|Overall Study|Lack of Efficacy|1
296103|NCT00886769|973251|P2|Overall Study|Unsatisfactory therapeutic effect|37
296104|NCT00886769|973252|P1|Overall Study|Unsatisfactory therapeutic effect|6
296105|NCT00886743|973276|P1|Overall Study|Unspecified|1
296106|NCT00886743|973276|P1|Overall Study|Adverse Event|3
296107|NCT00886639|973295|P1|Overall Study|non-compliance|2
296108|NCT00886639|973295|P1|Overall Study|acute exacerbation|14
296109|NCT00886613|973309|P3|Overall Study|Subject withdrew consent (Part A)|2
296110|NCT00886613|973310|P2|Overall Study|Subject withdrew consent (Part A)|0
296111|NCT00886613|973311|P1|Overall Study|Subject withdrew consent (Part A)|0
296112|NCT00886613|973309|P3|Overall Study|Lost to follow-up (Part B)|1
296113|NCT00886613|973310|P2|Overall Study|Lost to follow-up (Part B)|0
296114|NCT00886613|973311|P1|Overall Study|Lost to follow-up (Part B)|1
296115|NCT00886613|973309|P3|Overall Study|Protocol deviation (Part B)|0
296116|NCT00886613|973310|P2|Overall Study|Protocol deviation (Part B)|0
296117|NCT00886613|973311|P1|Overall Study|Protocol deviation (Part B)|1
296118|NCT00886600|973333|P4|Combination Therapy Period|Protocol Violation|0
296119|NCT00886600|973334|P3|Combination Therapy Period|Protocol Violation|1
296120|NCT00886600|973335|P2|Combination Therapy Period|Protocol Violation|0
296121|NCT00886600|973336|P1|Combination Therapy Period|Protocol Violation|0
296122|NCT00886600|973333|P4|Combination Therapy Period|Adverse Event|0
296123|NCT00886600|973334|P3|Combination Therapy Period|Adverse Event|1
296124|NCT00886600|973335|P2|Combination Therapy Period|Adverse Event|0
296125|NCT00886600|973336|P1|Combination Therapy Period|Adverse Event|0
296126|NCT00886600|973333|P4|Double-blind Monotherapy|Withdrawal by Subject|0
296127|NCT00886600|973334|P3|Double-blind Monotherapy|Withdrawal by Subject|0
296128|NCT00886600|973335|P2|Double-blind Monotherapy|Withdrawal by Subject|0
296129|NCT00886600|973336|P1|Double-blind Monotherapy|Withdrawal by Subject|1
296130|NCT00886600|973333|P4|Double-blind Monotherapy|Protocol Violation|1
296131|NCT00886600|973334|P3|Double-blind Monotherapy|Protocol Violation|0
296132|NCT00886600|973335|P2|Double-blind Monotherapy|Protocol Violation|0
296133|NCT00886600|973336|P1|Double-blind Monotherapy|Protocol Violation|0
296134|NCT00886600|973333|P4|Double-blind Monotherapy|Adverse Event|1
296135|NCT00886600|973334|P3|Double-blind Monotherapy|Adverse Event|1
296136|NCT00886600|973335|P2|Double-blind Monotherapy|Adverse Event|1
296137|NCT00886600|973336|P1|Double-blind Monotherapy|Adverse Event|1
296138|NCT00886587|973360|P2|Overall Study|Withdrawal by Subject|1
296139|NCT00886587|973361|P1|Overall Study|Withdrawal by Subject|0
296140|NCT00886587|973360|P2|Overall Study|Protocol Violation|0
296141|NCT00886587|973361|P1|Overall Study|Protocol Violation|2
296142|NCT00886587|973360|P2|Overall Study|Adverse Event|1
296143|NCT00886587|973361|P1|Overall Study|Adverse Event|2
296144|NCT00886483|973375|P2|Overall Study|Distance to center, poor grades|0
296145|NCT00886483|973376|P1|Overall Study|Distance to center, poor grades|1
296146|NCT00886483|973375|P2|Overall Study|Pursue medications|2
296147|NCT00886483|973376|P1|Overall Study|Pursue medications|1
296148|NCT00886483|973375|P2|Overall Study|Lost to Follow-up|1
296149|NCT00886483|973376|P1|Overall Study|Lost to Follow-up|0
296150|NCT00886340|973394|P2|Overall Study|Withdrawal by Subject|7
296151|NCT00886340|973395|P1|Overall Study|Withdrawal by Subject|0
296152|NCT00886288|973403|P2|Overall Study|Lost to Follow-up|0
296153|NCT00886288|973404|P1|Overall Study|Lost to Follow-up|86
296154|NCT00886288|973403|P2|Overall Study|no respect of the 12 weeks period|227
296155|NCT00886288|973404|P1|Overall Study|no respect of the 12 weeks period|657
296156|NCT00886119|973426|P2|Period 1|Did not meet inclusion criteria|0
296157|NCT00886119|973427|P1|Period 1|Did not meet inclusion criteria|1
296158|NCT00886015|973435|P2|Overall Study|Death|2
296159|NCT00886015|973436|P1|Overall Study|Death|0
296160|NCT00885846|973455|P3|Overall Study|Withdrawal by Subject|2
296161|NCT00885846|973456|P2|Overall Study|Withdrawal by Subject|5
296162|NCT00885846|973457|P1|Overall Study|Withdrawal by Subject|2
296163|NCT00885755|973472|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
296164|NCT00885755|973473|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
296165|NCT00885755|973474|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
296166|NCT00885755|973472|P3|Part I: Trastuzumab+Taxane|Death|1
296167|NCT00885755|973473|P2|Part I: Trastuzumab+Taxane|Death|0
296168|NCT00885755|973474|P1|Part I: Trastuzumab+Taxane|Death|0
296169|NCT00885755|973472|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
296170|NCT00885755|973473|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
296171|NCT00885755|973474|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
296172|NCT00885755|973472|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
296173|NCT00885755|973473|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
296174|NCT00885755|973474|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
296175|NCT00885755|973472|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
296176|NCT00885755|973473|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
296177|NCT00885755|973474|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
296178|NCT00885677|973512|P2|Overall Study|Inclusion/exclusion not met|27
296179|NCT00885677|973513|P1|Overall Study|Inclusion/exclusion not met|25
296180|NCT00885677|973512|P2|Overall Study|Heart transplantation|0
296181|NCT00885677|973513|P1|Overall Study|Heart transplantation|1
296182|NCT00885677|973512|P2|Overall Study|device/lead revision or replacement|6
296183|NCT00885677|973513|P1|Overall Study|device/lead revision or replacement|7
296184|NCT00885677|973512|P2|Overall Study|premature study closure|44
296185|NCT00885677|973513|P1|Overall Study|premature study closure|41
296186|NCT00885677|973512|P2|Overall Study|Protocol Violation|54
296187|NCT00885677|973513|P1|Overall Study|Protocol Violation|54
296188|NCT00885677|973512|P2|Overall Study|Lost to Follow-up|13
296189|NCT00885677|973513|P1|Overall Study|Lost to Follow-up|15
296190|NCT00885677|973512|P2|Overall Study|Death|34
296191|NCT00885677|973513|P1|Overall Study|Death|40
296192|NCT00885534|973529|P1|Overall Study|Patient deemed ineligible|1
296193|NCT00885482|973533|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
296194|NCT00885482|973533|P1|Overall Study|Death|1
296195|NCT00885482|973533|P1|Overall Study|Lack of Efficacy|1
296196|NCT00885482|973533|P1|Overall Study|Pregnancy|1
296197|NCT00885378|973539|P2|Overall Study|Protocol Violation|0
296198|NCT00885378|973540|P1|Overall Study|Protocol Violation|2
296199|NCT00885378|973539|P2|Overall Study|Poor/Noncompliance|2
296200|NCT00885378|973540|P1|Overall Study|Poor/Noncompliance|2
296201|NCT00885378|973539|P2|Overall Study|Lost to Follow-up|2
296202|NCT00885378|973540|P1|Overall Study|Lost to Follow-up|1
296203|NCT00885378|973539|P2|Overall Study|Withdrawal by Subject|2
296204|NCT00885378|973540|P1|Overall Study|Withdrawal by Subject|1
296205|NCT00885378|973539|P2|Overall Study|Lack of Efficacy|2
296206|NCT00885378|973540|P1|Overall Study|Lack of Efficacy|2
296207|NCT00885365|973570|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
296208|NCT00885365|973571|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
296209|NCT00885365|973570|P2|4 Weeks ON Treatment|Protocol Violation|2
296210|NCT00885365|973571|P1|4 Weeks ON Treatment|Protocol Violation|1
296211|NCT00885365|973570|P2|4 Weeks ON Treatment|Adverse Event|4
296212|NCT00885365|973571|P1|4 Weeks ON Treatment|Adverse Event|2
296213|NCT00885352|973607|P2|Overall Study|Lab abnormalities|1
296214|NCT00885352|973608|P1|Overall Study|Lab abnormalities|1
296215|NCT00885352|973607|P2|Overall Study|Excluded medication|2
296216|NCT00885352|973608|P1|Overall Study|Excluded medication|2
296217|NCT00885352|973607|P2|Overall Study|Contradiction to study medication|2
296218|NCT00885352|973608|P1|Overall Study|Contradiction to study medication|0
296219|NCT00885352|973607|P2|Overall Study|Withdrawal by Subject|5
296220|NCT00885352|973608|P1|Overall Study|Withdrawal by Subject|1
296221|NCT00885352|973607|P2|Overall Study|Protocol Violation|2
296222|NCT00885352|973608|P1|Overall Study|Protocol Violation|0
296223|NCT00885352|973607|P2|Overall Study|Physician Decision|3
296224|NCT00885352|973608|P1|Overall Study|Physician Decision|0
296225|NCT00885352|973607|P2|Overall Study|Lost to Follow-up|2
296226|NCT00885352|973608|P1|Overall Study|Lost to Follow-up|2
296227|NCT00885352|973607|P2|Overall Study|Adverse Event|3
296228|NCT00885352|973608|P1|Overall Study|Adverse Event|2
296229|NCT00885170|973620|P2|Overall Study|Withdrawal by Subject|13
296230|NCT00885170|973621|P1|Overall Study|Withdrawal by Subject|13
296231|NCT00885170|973620|P2|Overall Study|Protocol Violation|1
296232|NCT00885170|973621|P1|Overall Study|Protocol Violation|3
296233|NCT00885170|973620|P2|Overall Study|Physician Decision|1
296234|NCT00885170|973621|P1|Overall Study|Physician Decision|2
296235|NCT00885170|973620|P2|Overall Study|Lost to Follow-up|1
296236|NCT00885170|973621|P1|Overall Study|Lost to Follow-up|2
296237|NCT00885170|973620|P2|Overall Study|Excessive bone loss|3
296238|NCT00885170|973621|P1|Overall Study|Excessive bone loss|6
296239|NCT00885170|973620|P2|Overall Study|Adverse Event|4
296240|NCT00885170|973621|P1|Overall Study|Adverse Event|12
296241|NCT00885118|973680|P5|Overall Study|Other reason not defined above|0
296242|NCT00885118|973681|P4|Overall Study|Other reason not defined above|0
296243|NCT00885118|973682|P3|Overall Study|Other reason not defined above|1
296244|NCT00885118|973683|P2|Overall Study|Other reason not defined above|0
296245|NCT00885118|973684|P1|Overall Study|Other reason not defined above|0
296246|NCT00885118|973680|P5|Overall Study|Withdrawal by Subject|1
296247|NCT00885118|973681|P4|Overall Study|Withdrawal by Subject|0
296248|NCT00885118|973682|P3|Overall Study|Withdrawal by Subject|0
296249|NCT00885118|973683|P2|Overall Study|Withdrawal by Subject|0
296250|NCT00885118|973684|P1|Overall Study|Withdrawal by Subject|0
296251|NCT00885118|973680|P5|Overall Study|Adverse Event|0
296252|NCT00885118|973681|P4|Overall Study|Adverse Event|0
296253|NCT00885118|973682|P3|Overall Study|Adverse Event|0
296254|NCT00885118|973683|P2|Overall Study|Adverse Event|0
296255|NCT00885118|973684|P1|Overall Study|Adverse Event|1
296256|NCT00885105|973823|P2|Overall Study|Protocol Violation|2
296257|NCT00885105|973824|P1|Overall Study|Protocol Violation|0
296258|NCT00885105|973823|P2|Overall Study|Adverse Event|0
296259|NCT00885105|973824|P1|Overall Study|Adverse Event|1
296260|NCT00885105|973823|P2|Overall Study|Withdrawal by Subject|8
296261|NCT00885105|973824|P1|Overall Study|Withdrawal by Subject|0
296262|NCT00884949|973864|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
296263|NCT00884949|973864|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
296264|NCT00884832|973899|P2|Overall Study|Withdrawal by Subject|1
296265|NCT00884832|973900|P1|Overall Study|Withdrawal by Subject|0
296266|NCT00884793|973935|P1|Overall Study|Withdrawal by Subject|1
296267|NCT00884741|973954|P4|Randomization|Protocol Violation|8
296268|NCT00884741|973955|P3|Randomization|Protocol Violation|8
296269|NCT00884741|973956|P2|Randomization|Protocol Violation|0
296270|NCT00884741|973957|P1|Randomization|Protocol Violation|0
296271|NCT00884741|973954|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
296272|NCT00884741|973955|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
296273|NCT00884741|973956|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
296274|NCT00884741|973957|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
296275|NCT00884741|973954|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
296276|NCT00884741|973955|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
296277|NCT00884741|973956|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
296278|NCT00884741|973957|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
296279|NCT00884741|973954|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
296280|NCT00884741|973955|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
296281|NCT00884741|973956|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
296282|NCT00884741|973957|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
296283|NCT00884741|973954|P4|Step 2 Registration: Tissue Analysis|Death|0
296284|NCT00884741|973955|P3|Step 2 Registration: Tissue Analysis|Death|0
296285|NCT00884741|973956|P2|Step 2 Registration: Tissue Analysis|Death|1
296286|NCT00884741|973957|P1|Step 2 Registration: Tissue Analysis|Death|0
296287|NCT00884741|973954|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
296288|NCT00884741|973955|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
296289|NCT00884741|973956|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
296290|NCT00884741|973957|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
296291|NCT00884741|973954|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
296292|NCT00884741|973955|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
296293|NCT00884741|973956|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
296294|NCT00884741|973957|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
296295|NCT00884741|973954|P4|Step 1 Registration: Tissue Screening|Disease progression|0
296296|NCT00884741|973955|P3|Step 1 Registration: Tissue Screening|Disease progression|0
296297|NCT00884741|973956|P2|Step 1 Registration: Tissue Screening|Disease progression|0
296298|NCT00884741|973957|P1|Step 1 Registration: Tissue Screening|Disease progression|12
296299|NCT00884741|973954|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
296300|NCT00884741|973955|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
296301|NCT00884741|973956|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
296302|NCT00884741|973957|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
296303|NCT00884741|973954|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
296304|NCT00884741|973955|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
296305|NCT00884741|973956|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
296306|NCT00884741|973957|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
296307|NCT00884741|973954|P4|Step 1 Registration: Tissue Screening|Death|0
296308|NCT00884741|973955|P3|Step 1 Registration: Tissue Screening|Death|0
296309|NCT00884741|973956|P2|Step 1 Registration: Tissue Screening|Death|0
296310|NCT00884741|973957|P1|Step 1 Registration: Tissue Screening|Death|3
296311|NCT00884741|973954|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
296312|NCT00884741|973955|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
296313|NCT00884741|973956|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
296314|NCT00884741|973957|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
296315|NCT00884390|973985|P2|Overall Study|Not specified|1
296316|NCT00884390|973986|P1|Overall Study|Not specified|11
296317|NCT00884390|973985|P2|Overall Study|Discontinuation of Study by Sponsor|2
296318|NCT00884390|973986|P1|Overall Study|Discontinuation of Study by Sponsor|2
296319|NCT00884390|973985|P2|Overall Study|Withdrawal by Subject|1
296320|NCT00884390|973986|P1|Overall Study|Withdrawal by Subject|4
296321|NCT00884390|973985|P2|Overall Study|Protocol Violation|1
296322|NCT00884390|973986|P1|Overall Study|Protocol Violation|4
296323|NCT00884390|973985|P2|Overall Study|Physician Decision|1
296324|NCT00884390|973986|P1|Overall Study|Physician Decision|2
296325|NCT00884390|973985|P2|Overall Study|Lost to Follow-up|1
296326|NCT00884390|973986|P1|Overall Study|Lost to Follow-up|0
296327|NCT00884390|973985|P2|Overall Study|Adverse Event|1
296328|NCT00884390|973986|P1|Overall Study|Adverse Event|0
296329|NCT00884325|974004|P2|Overall Study|Not provided|0
296330|NCT00884325|974005|P1|Overall Study|Not provided|1
296331|NCT00884325|974004|P2|Overall Study|Withdrawal by Subject|1
296332|NCT00884325|974005|P1|Overall Study|Withdrawal by Subject|1
296333|NCT00884325|974004|P2|Overall Study|Lack of Efficacy|1
296334|NCT00884325|974005|P1|Overall Study|Lack of Efficacy|0
296335|NCT00884325|974004|P2|Overall Study|Lost to Follow-up|2
296336|NCT00884325|974005|P1|Overall Study|Lost to Follow-up|1
296337|NCT00884273|974015|P2|Overall Study|Practical reasons|0
296338|NCT00884273|974016|P1|Overall Study|Practical reasons|1
296339|NCT00884273|974015|P2|Overall Study|Protocol Violation|3
296340|NCT00884273|974016|P1|Overall Study|Protocol Violation|1
296341|NCT00884273|974015|P2|Overall Study|Adverse Event|2
296342|NCT00884273|974016|P1|Overall Study|Adverse Event|0
296343|NCT00884221|974042|P2|Overall Study|Cancellation of Cycle and Other Reason|13
296344|NCT00884221|974043|P1|Overall Study|Cancellation of Cycle and Other Reason|12
296345|NCT00884221|974042|P2|Overall Study|Protocol Violation|13
296346|NCT00884221|974043|P1|Overall Study|Protocol Violation|16
296347|NCT00884221|974042|P2|Overall Study|Adverse Event|3
296348|NCT00884221|974043|P1|Overall Study|Adverse Event|6
296349|NCT00884221|974042|P2|Overall Study|Withdrawal by Subject|3
296350|NCT00884221|974043|P1|Overall Study|Withdrawal by Subject|0
296351|NCT00884117|974079|P1|Overall Study|Not Specified|12
296352|NCT00884117|974079|P1|Overall Study|Lost to Follow-up|143
296353|NCT00884117|974079|P1|Overall Study|Death|3
296354|NCT00884117|974079|P1|Overall Study|Withdrawal by Subject|89
296355|NCT00884117|974079|P1|Overall Study|Adverse Event|2
296356|NCT00884039|974142|P2|Overall Study|Lack of Efficacy|0
296357|NCT00884039|974143|P1|Overall Study|Lack of Efficacy|2
296358|NCT00884039|974142|P2|Overall Study|Withdrawal by Subject|1
296359|NCT00884039|974143|P1|Overall Study|Withdrawal by Subject|0
296360|NCT00883779|974151|P2|Off-study Phase|Unspecified|21
296361|NCT00883779|974152|P1|Off-study Phase|Unspecified|18
296362|NCT00883779|974151|P2|Off-study Phase|Failure to return|6
296363|NCT00883779|974152|P1|Off-study Phase|Failure to return|5
296364|NCT00883779|974151|P2|Off-study Phase|Refused treatment|1
296365|NCT00883779|974152|P1|Off-study Phase|Refused treatment|1
296366|NCT00883779|974151|P2|Off-study Phase|Death|174
296367|NCT00883779|974152|P1|Off-study Phase|Death|185
296368|NCT00883779|974151|P2|Post-Study Treatment Phase|Ongoing in the study|6
296369|NCT00883779|974152|P1|Post-Study Treatment Phase|Ongoing in the study|0
296370|NCT00883779|974151|P2|Post-Study Treatment Phase|Unspecified|0
296371|NCT00883779|974152|P1|Post-Study Treatment Phase|Unspecified|3
296372|NCT00883779|974151|P2|Post-Study Treatment Phase|Disease progression|122
296373|NCT00883779|974152|P1|Post-Study Treatment Phase|Disease progression|103
296374|NCT00883779|974151|P2|Post-Study Treatment Phase|Refused Treatment|0
296375|NCT00883779|974152|P1|Post-Study Treatment Phase|Refused Treatment|3
296376|NCT00883779|974151|P2|Post-Study Treatment Phase|Protocol Violation|1
296377|NCT00883779|974152|P1|Post-Study Treatment Phase|Protocol Violation|0
296378|NCT00883779|974151|P2|Post-Study Treatment Phase|Death|3
296379|NCT00883779|974152|P1|Post-Study Treatment Phase|Death|1
296380|NCT00883779|974151|P2|Post-Study Treatment Phase|Adverse Event|3
296381|NCT00883779|974152|P1|Post-Study Treatment Phase|Adverse Event|2
296382|NCT00883779|974151|P2|Primary Study Treatment Phase|Unspecified|0
296383|NCT00883779|974152|P1|Primary Study Treatment Phase|Unspecified|3
296384|NCT00883779|974151|P2|Primary Study Treatment Phase|Refused Treatment|4
296385|NCT00883779|974152|P1|Primary Study Treatment Phase|Refused Treatment|5
296386|NCT00883779|974151|P2|Primary Study Treatment Phase|Death|3
296387|NCT00883779|974152|P1|Primary Study Treatment Phase|Death|2
296388|NCT00883779|974151|P2|Primary Study Treatment Phase|Adverse Event|16
296389|NCT00883779|974152|P1|Primary Study Treatment Phase|Adverse Event|16
296390|NCT00883779|974151|P2|Primary Study Treatment Phase|Disease progression|59
296391|NCT00883779|974152|P1|Primary Study Treatment Phase|Disease progression|75
296392|NCT00883779|974151|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
296393|NCT00883779|974152|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
296394|NCT00883753|974188|P1|Overall Study|Administrative/Other|8
296395|NCT00883753|974188|P1|Overall Study|Investigator's decision|17
296396|NCT00883753|974188|P1|Overall Study|Withdrew consent|10
296397|NCT00883753|974188|P1|Overall Study|Refused treatment|4
296398|NCT00883753|974188|P1|Overall Study|Protocol Violation|2
296399|NCT00883753|974188|P1|Overall Study|Violation of selection criteria at entry|7
296400|NCT00883753|974188|P1|Overall Study|Lost to Follow-up|4
296401|NCT00883753|974188|P1|Overall Study|Insufficient therapeutic response|16
296402|NCT00883753|974188|P1|Overall Study|Death|2
296403|NCT00883753|974188|P1|Overall Study|Adverse Event|37
296404|NCT00883740|974228|P2|Second Intervention|No longer willing to participate|1
296405|NCT00883740|974229|P1|Second Intervention|No longer willing to participate|0
296406|NCT00883740|974228|P2|Second Intervention|Protocol Violation|0
296407|NCT00883740|974229|P1|Second Intervention|Protocol Violation|1
296408|NCT00883740|974228|P2|First Intervention|Adverse Event|2
296409|NCT00883740|974229|P1|First Intervention|Adverse Event|1
296410|NCT00883740|974228|P2|First Intervention|Protocol Violation|6
296411|NCT00883740|974229|P1|First Intervention|Protocol Violation|3
296412|NCT00883740|974228|P2|First Intervention|No longer willing to participate|0
296413|NCT00883740|974229|P1|First Intervention|No longer willing to participate|2
296414|NCT00883740|974228|P2|First Intervention|Lost to Follow-up|0
296415|NCT00883740|974229|P1|First Intervention|Lost to Follow-up|1
296416|NCT00883558|974273|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
296417|NCT00883558|974274|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
296418|NCT00883558|974275|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
296419|NCT00883558|974273|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
296420|NCT00883558|974274|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
296421|NCT00883558|974275|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
296422|NCT00883558|974273|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
296423|NCT00883558|974274|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
296424|NCT00883558|974275|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
296425|NCT00883558|974273|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
296426|NCT00883558|974274|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
296427|NCT00883558|974275|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
296428|NCT00883558|974273|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
296429|NCT00883558|974274|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
296430|NCT00883558|974275|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
296431|NCT00883493|974287|P2|Overall Study|Not specified|3
296432|NCT00883493|974288|P1|Overall Study|Not specified|5
296433|NCT00883493|974287|P2|Overall Study|Study specific disc. criteria|0
296434|NCT00883493|974288|P1|Overall Study|Study specific disc. criteria|2
296435|NCT00883493|974287|P2|Overall Study|Eligibility Criteria not fullfilled|6
296436|NCT00883493|974288|P1|Overall Study|Eligibility Criteria not fullfilled|6
296437|NCT00883493|974287|P2|Overall Study|Withdrawal by Subject|20
296438|NCT00883493|974288|P1|Overall Study|Withdrawal by Subject|11
296439|NCT00883493|974287|P2|Overall Study|Lost to Follow-up|6
296440|NCT00883493|974288|P1|Overall Study|Lost to Follow-up|7
296441|NCT00883493|974287|P2|Overall Study|Lack of Efficacy|3
296442|NCT00883493|974288|P1|Overall Study|Lack of Efficacy|4
296443|NCT00883493|974287|P2|Overall Study|Adverse Event|12
296444|NCT00883493|974288|P1|Overall Study|Adverse Event|11
296445|NCT00883337|974319|P3|Extension Treatment Period|Other than above|5
296446|NCT00883337|974320|P2|Extension Treatment Period|Other than above|9
296447|NCT00883337|974321|P1|Extension Treatment Period|Other than above|10
296448|NCT00883337|974319|P3|Extension Treatment Period|Lost to Follow-up|0
296449|NCT00883337|974320|P2|Extension Treatment Period|Lost to Follow-up|0
296450|NCT00883337|974321|P1|Extension Treatment Period|Lost to Follow-up|1
296451|NCT00883337|974319|P3|Extension Treatment Period|Poor compliance to protocol|1
296452|NCT00883337|974320|P2|Extension Treatment Period|Poor compliance to protocol|1
296453|NCT00883337|974321|P1|Extension Treatment Period|Poor compliance to protocol|1
296454|NCT00883337|974319|P3|Extension Treatment Period|Lack of Efficacy|8
296455|NCT00883337|974320|P2|Extension Treatment Period|Lack of Efficacy|8
296456|NCT00883337|974321|P1|Extension Treatment Period|Lack of Efficacy|8
296457|NCT00883337|974319|P3|Extension Treatment Period|Adverse Event|5
296458|NCT00883337|974320|P2|Extension Treatment Period|Adverse Event|5
296459|NCT00883337|974321|P1|Extension Treatment Period|Adverse Event|8
296460|NCT00883337|974319|P3|Core Treatment Period|Other than above|1
296461|NCT00883337|974320|P2|Core Treatment Period|Other than above|1
296462|NCT00883337|974321|P1|Core Treatment Period|Other than above|0
296463|NCT00883337|974319|P3|Core Treatment Period|Poor compliance to protocol|1
296464|NCT00883337|974320|P2|Core Treatment Period|Poor compliance to protocol|0
296465|NCT00883337|974321|P1|Core Treatment Period|Poor compliance to protocol|0
296466|NCT00883337|974319|P3|Core Treatment Period|Wish to be pregnant|1
296467|NCT00883337|974320|P2|Core Treatment Period|Wish to be pregnant|2
296468|NCT00883337|974321|P1|Core Treatment Period|Wish to be pregnant|1
296469|NCT00883337|974319|P3|Core Treatment Period|Withdrawal by Subject|6
296470|NCT00883337|974320|P2|Core Treatment Period|Withdrawal by Subject|2
296471|NCT00883337|974321|P1|Core Treatment Period|Withdrawal by Subject|2
296472|NCT00883337|974319|P3|Core Treatment Period|Lost to Follow-up|0
296473|NCT00883337|974320|P2|Core Treatment Period|Lost to Follow-up|1
296474|NCT00883337|974321|P1|Core Treatment Period|Lost to Follow-up|1
296475|NCT00883337|974319|P3|Core Treatment Period|Lack of Efficacy|2
296476|NCT00883337|974320|P2|Core Treatment Period|Lack of Efficacy|4
296477|NCT00883337|974321|P1|Core Treatment Period|Lack of Efficacy|7
296478|NCT00883337|974319|P3|Core Treatment Period|Adverse Event|22
296479|NCT00883337|974320|P2|Core Treatment Period|Adverse Event|12
296480|NCT00883337|974321|P1|Core Treatment Period|Adverse Event|9
296481|NCT00883181|974388|P1|Overall Study|Noncompliance|3
296482|NCT00883181|974388|P1|Overall Study|Protocol Deviation|3
296483|NCT00883181|974388|P1|Overall Study|Other|38
296484|NCT00883181|974388|P1|Overall Study|Death|31
296485|NCT00883181|974388|P1|Overall Study|Withdrawal by Subject|4
296486|NCT00883181|974388|P1|Overall Study|Administrative Reason|24
296487|NCT00883181|974388|P1|Overall Study|Disease Progression|94
296488|NCT00883181|974388|P1|Overall Study|Non-hematological Adverse Event|55
296489|NCT00883181|974388|P1|Overall Study|Hematological Adverse Event|26
296490|NCT00883129|974624|P2|Overall Study|Defined Treatment Failure|2
296491|NCT00883129|974625|P1|Overall Study|Defined Treatment Failure|0
296492|NCT00883129|974624|P2|Overall Study|Death|2
296493|NCT00883129|974625|P1|Overall Study|Death|1
296494|NCT00883129|974624|P2|Overall Study|Lost to Follow-up|2
296495|NCT00883129|974625|P1|Overall Study|Lost to Follow-up|1
296496|NCT00883129|974624|P2|Overall Study|Non-compliance|6
296497|NCT00883129|974625|P1|Overall Study|Non-compliance|3
296498|NCT00883129|974624|P2|Overall Study|Withdrawal by Subject|9
296499|NCT00883129|974625|P1|Overall Study|Withdrawal by Subject|8
296500|NCT00883129|974624|P2|Overall Study|Adverse Event|15
296501|NCT00883129|974625|P1|Overall Study|Adverse Event|7
296502|NCT00883116|974649|P2|Overall Study|No longer meets study criteria|2
296503|NCT00883116|974650|P1|Overall Study|No longer meets study criteria|2
296504|NCT00883116|974649|P2|Overall Study|Withdrawal by Subject|8
296505|NCT00883116|974650|P1|Overall Study|Withdrawal by Subject|14
296506|NCT00883116|974649|P2|Overall Study|Study drug toxicity|16
296507|NCT00883116|974650|P1|Overall Study|Study drug toxicity|36
296508|NCT00883116|974649|P2|Overall Study|Not identified|6
296509|NCT00883116|974650|P1|Overall Study|Not identified|3
296510|NCT00883116|974649|P2|Overall Study|Maximum clinical benefit|46
296511|NCT00883116|974650|P1|Overall Study|Maximum clinical benefit|13
296512|NCT00883116|974649|P2|Overall Study|Lost to Follow-up|1
296513|NCT00883116|974650|P1|Overall Study|Lost to Follow-up|0
296514|NCT00883116|974649|P2|Overall Study|Disease progression|128
296515|NCT00883116|974650|P1|Overall Study|Disease progression|130
296516|NCT00883116|974649|P2|Overall Study|Death|2
296517|NCT00883116|974650|P1|Overall Study|Death|6
296518|NCT00883116|974649|P2|Overall Study|Adverse event unrelated to study drug|10
296519|NCT00883116|974650|P1|Overall Study|Adverse event unrelated to study drug|5
296520|NCT00883090|974672|P1|Overall Study|Withdrawal by Subject|1
296521|NCT00883090|974672|P1|Overall Study|Sponsor's decision|1
296522|NCT00882921|974687|P1|Overall Study|Withdrawal Of Consent|1
296523|NCT00882921|974687|P1|Overall Study|Termination By Investigator|3
296524|NCT00882921|974687|P1|Overall Study|Lost to Follow-up|2
296525|NCT00882921|974687|P1|Overall Study|Not specified|3
296526|NCT00882921|974687|P1|Overall Study|Death|2
296527|NCT00882908|974697|P5|Overall Study|Study terminated in error|0
296528|NCT00882908|974698|P4|Overall Study|Study terminated in error|1
296529|NCT00882908|974699|P3|Overall Study|Study terminated in error|0
296530|NCT00882908|974700|P2|Overall Study|Study terminated in error|0
296531|NCT00882908|974701|P1|Overall Study|Study terminated in error|0
296532|NCT00882908|974697|P5|Overall Study|Subject reached a virologic endpoint|1
296533|NCT00882908|974698|P4|Overall Study|Subject reached a virologic endpoint|0
296534|NCT00882908|974699|P3|Overall Study|Subject reached a virologic endpoint|0
296535|NCT00882908|974700|P2|Overall Study|Subject reached a virologic endpoint|0
296536|NCT00882908|974701|P1|Overall Study|Subject reached a virologic endpoint|0
296537|NCT00882908|974697|P5|Overall Study|Withdrawal by Subject|2
296538|NCT00882908|974698|P4|Overall Study|Withdrawal by Subject|5
296539|NCT00882908|974699|P3|Overall Study|Withdrawal by Subject|3
296540|NCT00882908|974700|P2|Overall Study|Withdrawal by Subject|0
296541|NCT00882908|974701|P1|Overall Study|Withdrawal by Subject|0
296542|NCT00882908|974697|P5|Overall Study|Protocol Violation|0
296543|NCT00882908|974698|P4|Overall Study|Protocol Violation|0
296544|NCT00882908|974699|P3|Overall Study|Protocol Violation|0
296545|NCT00882908|974700|P2|Overall Study|Protocol Violation|1
296546|NCT00882908|974701|P1|Overall Study|Protocol Violation|0
296547|NCT00882908|974697|P5|Overall Study|Lost to Follow-up|2
296548|NCT00882908|974698|P4|Overall Study|Lost to Follow-up|1
296549|NCT00882908|974699|P3|Overall Study|Lost to Follow-up|3
296550|NCT00882908|974700|P2|Overall Study|Lost to Follow-up|5
296551|NCT00882908|974701|P1|Overall Study|Lost to Follow-up|3
296552|NCT00882908|974697|P5|Overall Study|Adverse Event|1
296553|NCT00882908|974698|P4|Overall Study|Adverse Event|0
296554|NCT00882908|974699|P3|Overall Study|Adverse Event|1
296555|NCT00882908|974700|P2|Overall Study|Adverse Event|0
296556|NCT00882908|974701|P1|Overall Study|Adverse Event|0
296557|NCT00882713|974807|P1|Overall Study|Other - Reasons|2
296558|NCT00882713|974807|P1|Overall Study|Failure to return|2
296559|NCT00882713|974807|P1|Overall Study|Insufficient therapeutic response|3
296560|NCT00882713|974807|P1|Overall Study|Blood transfusion|2
296561|NCT00882713|974807|P1|Overall Study|refused treatment/withdrew consent|4
296562|NCT00882713|974807|P1|Overall Study|Administrative reasons|4
296563|NCT00882713|974807|P1|Overall Study|Death|3
296564|NCT00882713|974807|P1|Overall Study|Adverse Event|2
296565|NCT00882583|974900|P2|Overall Study|Adverse Event|1
296566|NCT00882583|974901|P1|Overall Study|Adverse Event|0
296567|NCT00882583|974900|P2|Overall Study|Physician Decision|0
296568|NCT00882583|974901|P1|Overall Study|Physician Decision|1
296569|NCT00882557|974909|P2|Overall Study|Randomized Not Treated|1
296570|NCT00882557|974910|P1|Overall Study|Randomized Not Treated|0
296571|NCT00882557|974909|P2|Overall Study|Trouble with Vein Access|0
296572|NCT00882557|974910|P1|Overall Study|Trouble with Vein Access|1
296573|NCT00882557|974909|P2|Overall Study|Withdrawal by Subject|0
296574|NCT00882557|974910|P1|Overall Study|Withdrawal by Subject|1
296575|NCT00882518|974930|P2|Overall Study|Allocating random number by mistake|1
296663|NCT00881868|975060|P1|Overall Study|Lost to Follow-up|2
296576|NCT00882518|974931|P1|Overall Study|Allocating random number by mistake|0
296577|NCT00882518|974930|P2|Overall Study|Central lab closure for National day|0
296578|NCT00882518|974931|P1|Overall Study|Central lab closure for National day|1
296579|NCT00882518|974930|P2|Overall Study|Incorrect enrolment|2
296580|NCT00882518|974931|P1|Overall Study|Incorrect enrolment|4
296581|NCT00882518|974930|P2|Overall Study|Severe non-compliance to protocol|1
296582|NCT00882518|974931|P1|Overall Study|Severe non-compliance to protocol|3
296583|NCT00882518|974930|P2|Overall Study|Lack of Efficacy|9
296584|NCT00882518|974931|P1|Overall Study|Lack of Efficacy|12
296585|NCT00882518|974930|P2|Overall Study|Withdrawal by Subject|13
296586|NCT00882518|974931|P1|Overall Study|Withdrawal by Subject|9
296587|NCT00882518|974930|P2|Overall Study|Adverse Event|18
296588|NCT00882518|974931|P1|Overall Study|Adverse Event|9
296589|NCT00882440|974960|P7|Overall Study|Patient Uncooperative|0
296590|NCT00882440|974961|P6|Overall Study|Patient Uncooperative|0
296591|NCT00882440|974962|P5|Overall Study|Patient Uncooperative|1
296592|NCT00882440|974963|P4|Overall Study|Patient Uncooperative|0
296593|NCT00882440|974964|P3|Overall Study|Patient Uncooperative|0
296594|NCT00882440|974965|P2|Overall Study|Patient Uncooperative|0
296595|NCT00882440|974966|P1|Overall Study|Patient Uncooperative|2
296596|NCT00882440|974960|P7|Overall Study|Withdrawal by Subject|1
296597|NCT00882440|974961|P6|Overall Study|Withdrawal by Subject|0
296598|NCT00882440|974962|P5|Overall Study|Withdrawal by Subject|6
296599|NCT00882440|974963|P4|Overall Study|Withdrawal by Subject|0
296600|NCT00882440|974964|P3|Overall Study|Withdrawal by Subject|1
296601|NCT00882440|974965|P2|Overall Study|Withdrawal by Subject|1
296602|NCT00882440|974966|P1|Overall Study|Withdrawal by Subject|2
296603|NCT00882440|974960|P7|Overall Study|Protocol Violation|0
296604|NCT00882440|974961|P6|Overall Study|Protocol Violation|0
296605|NCT00882440|974962|P5|Overall Study|Protocol Violation|1
296606|NCT00882440|974963|P4|Overall Study|Protocol Violation|1
296607|NCT00882440|974964|P3|Overall Study|Protocol Violation|1
296608|NCT00882440|974965|P2|Overall Study|Protocol Violation|0
296609|NCT00882440|974966|P1|Overall Study|Protocol Violation|0
296610|NCT00882440|974960|P7|Overall Study|Lost to Follow-up|1
296611|NCT00882440|974961|P6|Overall Study|Lost to Follow-up|0
296612|NCT00882440|974962|P5|Overall Study|Lost to Follow-up|1
296613|NCT00882440|974963|P4|Overall Study|Lost to Follow-up|1
296614|NCT00882440|974964|P3|Overall Study|Lost to Follow-up|1
296615|NCT00882440|974965|P2|Overall Study|Lost to Follow-up|0
296616|NCT00882440|974966|P1|Overall Study|Lost to Follow-up|2
296617|NCT00882440|974960|P7|Overall Study|Lack of Efficacy|0
296618|NCT00882440|974961|P6|Overall Study|Lack of Efficacy|3
296619|NCT00882440|974962|P5|Overall Study|Lack of Efficacy|0
296620|NCT00882440|974963|P4|Overall Study|Lack of Efficacy|0
296621|NCT00882440|974964|P3|Overall Study|Lack of Efficacy|2
296622|NCT00882440|974965|P2|Overall Study|Lack of Efficacy|5
296623|NCT00882440|974966|P1|Overall Study|Lack of Efficacy|3
296624|NCT00882440|974960|P7|Overall Study|Adverse Event|2
296625|NCT00882440|974961|P6|Overall Study|Adverse Event|4
296626|NCT00882440|974962|P5|Overall Study|Adverse Event|1
296627|NCT00882440|974963|P4|Overall Study|Adverse Event|1
296628|NCT00882440|974964|P3|Overall Study|Adverse Event|2
296629|NCT00882440|974965|P2|Overall Study|Adverse Event|2
296630|NCT00882440|974966|P1|Overall Study|Adverse Event|2
296631|NCT00882362|974991|P2|Overall Study|change of residence or other commitments|0
296632|NCT00882362|974992|P1|Overall Study|change of residence or other commitments|5
296633|NCT00882362|974991|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
296634|NCT00882362|974992|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
296635|NCT00882362|974991|P2|Overall Study|Physician Decision|1
296636|NCT00882362|974992|P1|Overall Study|Physician Decision|5
296637|NCT00882362|974991|P2|Overall Study|Pregnancy|0
296638|NCT00882362|974992|P1|Overall Study|Pregnancy|1
296639|NCT00882362|974991|P2|Overall Study|Protocol Violation|2
296640|NCT00882362|974992|P1|Overall Study|Protocol Violation|7
296641|NCT00882362|974991|P2|Overall Study|Lack of Efficacy|0
296642|NCT00882362|974992|P1|Overall Study|Lack of Efficacy|3
296643|NCT00882362|974991|P2|Overall Study|Withdrawal by Subject|10
296644|NCT00882362|974992|P1|Overall Study|Withdrawal by Subject|13
296645|NCT00882362|974991|P2|Overall Study|Adverse Event|10
296646|NCT00882362|974992|P1|Overall Study|Adverse Event|13
296647|NCT00882310|974998|P1|Overall Study|Adverse Event|1
296648|NCT00882310|974998|P1|Overall Study|Progression of disease|4
296649|NCT00882310|974998|P1|Overall Study|Death|6
296650|NCT00882310|974998|P1|Overall Study|Never received treatment|1
296651|NCT00882310|974998|P1|Overall Study|Screen Failure|10
296652|NCT00881959|975017|P2|Overall Study|Lost to Follow-up|4
296653|NCT00881959|975018|P1|Overall Study|Lost to Follow-up|2
296654|NCT00881894|975026|P2|Overall Study|Other reasons for premature termination|2
296655|NCT00881894|975027|P1|Overall Study|Other reasons for premature termination|1
296656|NCT00881894|975026|P2|Overall Study|Consent withdrawn|1
296657|NCT00881894|975027|P1|Overall Study|Consent withdrawn|0
296658|NCT00881868|975059|P2|Overall Study|Protocol Violation|0
296659|NCT00881868|975060|P1|Overall Study|Protocol Violation|2
296660|NCT00881868|975059|P2|Overall Study|Physician Decision|0
296661|NCT00881868|975060|P1|Overall Study|Physician Decision|4
296662|NCT00881868|975059|P2|Overall Study|Lost to Follow-up|1
296664|NCT00881868|975059|P2|Overall Study|Adverse Event|1
296665|NCT00881868|975060|P1|Overall Study|Adverse Event|0
296666|NCT00881712|975075|P3|Overall Study|Withdrawal by Subject|0
296667|NCT00881712|975076|P2|Overall Study|Withdrawal by Subject|0
296668|NCT00881712|975077|P1|Overall Study|Withdrawal by Subject|1
296669|NCT00881712|975075|P3|Overall Study|Death|0
296670|NCT00881712|975076|P2|Overall Study|Death|0
296671|NCT00881712|975077|P1|Overall Study|Death|1
296672|NCT00881621|975110|P1|Overall Study|Physician Decision|34
296673|NCT00881608|975122|P1|Overall Study|Study prematurely terminated|11
296674|NCT00881530|975145|P6|Overall Study|Other reason not defined above|2
296675|NCT00881530|975146|P5|Overall Study|Other reason not defined above|0
296676|NCT00881530|975147|P4|Overall Study|Other reason not defined above|0
296677|NCT00881530|975148|P3|Overall Study|Other reason not defined above|2
296678|NCT00881530|975149|P2|Overall Study|Other reason not defined above|1
296679|NCT00881530|975150|P1|Overall Study|Other reason not defined above|1
296680|NCT00881530|975145|P6|Overall Study|Refused to continue medication|0
296681|NCT00881530|975146|P5|Overall Study|Refused to continue medication|0
296682|NCT00881530|975147|P4|Overall Study|Refused to continue medication|2
296683|NCT00881530|975148|P3|Overall Study|Refused to continue medication|1
296684|NCT00881530|975149|P2|Overall Study|Refused to continue medication|2
296685|NCT00881530|975150|P1|Overall Study|Refused to continue medication|7
296686|NCT00881530|975145|P6|Overall Study|Lost to Follow-up|0
296687|NCT00881530|975146|P5|Overall Study|Lost to Follow-up|1
296688|NCT00881530|975147|P4|Overall Study|Lost to Follow-up|3
296689|NCT00881530|975148|P3|Overall Study|Lost to Follow-up|1
296690|NCT00881530|975149|P2|Overall Study|Lost to Follow-up|1
296691|NCT00881530|975150|P1|Overall Study|Lost to Follow-up|0
296692|NCT00881530|975145|P6|Overall Study|Not compliant with the protocol|0
296693|NCT00881530|975146|P5|Overall Study|Not compliant with the protocol|2
296694|NCT00881530|975147|P4|Overall Study|Not compliant with the protocol|0
296695|NCT00881530|975148|P3|Overall Study|Not compliant with the protocol|0
296696|NCT00881530|975149|P2|Overall Study|Not compliant with the protocol|0
296697|NCT00881530|975150|P1|Overall Study|Not compliant with the protocol|0
296698|NCT00881530|975145|P6|Overall Study|Lack of Efficacy|1
296699|NCT00881530|975146|P5|Overall Study|Lack of Efficacy|1
296700|NCT00881530|975147|P4|Overall Study|Lack of Efficacy|0
296701|NCT00881530|975148|P3|Overall Study|Lack of Efficacy|0
296702|NCT00881530|975149|P2|Overall Study|Lack of Efficacy|0
296703|NCT00881530|975150|P1|Overall Study|Lack of Efficacy|1
296704|NCT00881530|975145|P6|Overall Study|Adverse Event|2
296705|NCT00881530|975146|P5|Overall Study|Adverse Event|10
296706|NCT00881530|975147|P4|Overall Study|Adverse Event|4
296707|NCT00881530|975148|P3|Overall Study|Adverse Event|1
296708|NCT00881530|975149|P2|Overall Study|Adverse Event|1
296709|NCT00881530|975150|P1|Overall Study|Adverse Event|5
296710|NCT00881504|975206|P1|Overall Study|Withdrawal by Subject|1
296711|NCT00881335|975226|P2|Overall Study|Lost to Follow-up|2
296712|NCT00881335|975227|P1|Overall Study|Lost to Follow-up|3
296713|NCT00881205|975247|P2|Overall Study|Condition no longer requires drug|0
296714|NCT00881205|975248|P1|Overall Study|Condition no longer requires drug|1
296715|NCT00881205|975247|P2|Overall Study|Administrative problems|1
296716|NCT00881205|975248|P1|Overall Study|Administrative problems|1
296717|NCT00881205|975247|P2|Overall Study|Lost to Follow-up|1
296718|NCT00881205|975248|P1|Overall Study|Lost to Follow-up|0
296719|NCT00881205|975247|P2|Overall Study|Withdrawal by Subject|2
296720|NCT00881205|975248|P1|Overall Study|Withdrawal by Subject|1
296721|NCT00881205|975247|P2|Overall Study|Adverse Event|3
296722|NCT00881205|975248|P1|Overall Study|Adverse Event|8
296723|NCT00880906|975294|P2|Overall Study|Did not meet criteria following patholog|6
296724|NCT00880906|975295|P1|Overall Study|Did not meet criteria following patholog|12
296725|NCT00880906|975294|P2|Overall Study|Lost to Follow-up|1
296726|NCT00880906|975295|P1|Overall Study|Lost to Follow-up|0
296727|NCT00880763|975305|P4|Extension Period (Part 2)|Lack of Efficacy|1
296728|NCT00880763|975306|P3|Extension Period (Part 2)|Lack of Efficacy|0
296729|NCT00880763|975307|P2|Extension Period (Part 2)|Lack of Efficacy|0
296730|NCT00880763|975308|P1|Extension Period (Part 2)|Lack of Efficacy|0
296731|NCT00880763|975305|P4|Extension Period (Part 2)|Physician Decision|0
296732|NCT00880763|975306|P3|Extension Period (Part 2)|Physician Decision|1
296733|NCT00880763|975307|P2|Extension Period (Part 2)|Physician Decision|1
296734|NCT00880763|975308|P1|Extension Period (Part 2)|Physician Decision|0
296735|NCT00880763|975305|P4|Extension Period (Part 2)|Withdrawal by Subject|1
296736|NCT00880763|975306|P3|Extension Period (Part 2)|Withdrawal by Subject|1
296737|NCT00880763|975307|P2|Extension Period (Part 2)|Withdrawal by Subject|2
296738|NCT00880763|975308|P1|Extension Period (Part 2)|Withdrawal by Subject|0
296739|NCT00880763|975305|P4|Extension Period (Part 2)|Adverse Event|1
296740|NCT00880763|975306|P3|Extension Period (Part 2)|Adverse Event|1
296741|NCT00880763|975307|P2|Extension Period (Part 2)|Adverse Event|0
296742|NCT00880763|975308|P1|Extension Period (Part 2)|Adverse Event|0
296743|NCT00880750|975340|P2|Second Intervention|Unable to collect urine|0
296744|NCT00880750|975341|P1|Second Intervention|Unable to collect urine|1
296745|NCT00880750|975340|P2|Second Intervention|Protocol Violation|0
296746|NCT00880750|975341|P1|Second Intervention|Protocol Violation|1
296747|NCT00880750|975340|P2|Second Intervention|Withdrawal by Subject|2
296748|NCT00880750|975341|P1|Second Intervention|Withdrawal by Subject|2
296749|NCT00880750|975340|P2|First Intervention|Lost to Follow-up|0
296750|NCT00880750|975341|P1|First Intervention|Lost to Follow-up|2
296751|NCT00880750|975340|P2|First Intervention|Withdrawal by Subject|0
296752|NCT00880750|975341|P1|First Intervention|Withdrawal by Subject|2
296753|NCT00880750|975340|P2|First Intervention|Non-compliance with meals|1
296754|NCT00880750|975341|P1|First Intervention|Non-compliance with meals|0
296755|NCT00880750|975340|P2|First Intervention|Unable to collect urine|0
296756|NCT00880750|975341|P1|First Intervention|Unable to collect urine|4
296757|NCT00880750|975340|P2|First Intervention|Adverse Event|0
296758|NCT00880750|975341|P1|First Intervention|Adverse Event|1
296759|NCT00880698|975359|P4|Overall Study|Lost to Follow-up|1
296760|NCT00880698|975360|P3|Overall Study|Lost to Follow-up|0
296761|NCT00880698|975361|P2|Overall Study|Lost to Follow-up|3
296762|NCT00880698|975362|P1|Overall Study|Lost to Follow-up|1
296763|NCT00880698|975359|P4|Overall Study|Death|2
296764|NCT00880698|975360|P3|Overall Study|Death|1
296765|NCT00880698|975361|P2|Overall Study|Death|0
296766|NCT00880698|975362|P1|Overall Study|Death|0
296767|NCT00880685|975388|P1|Memantine 20mg|Withdrawal by Subject|1
296768|NCT00880685|975388|P1|Memantine 10mg|Lost to Follow-up|2
296769|NCT00880620|975400|P4|Overall Study|Not specified|2
296770|NCT00880620|975401|P3|Overall Study|Not specified|2
296771|NCT00880620|975402|P2|Overall Study|Not specified|1
296772|NCT00880620|975403|P1|Overall Study|Not specified|1
296773|NCT00880620|975400|P4|Overall Study|Noncompliance|1
296774|NCT00880620|975401|P3|Overall Study|Noncompliance|1
296775|NCT00880620|975402|P2|Overall Study|Noncompliance|0
296776|NCT00880620|975403|P1|Overall Study|Noncompliance|0
296777|NCT00880620|975400|P4|Overall Study|Withdrawal by Subject|3
296778|NCT00880620|975401|P3|Overall Study|Withdrawal by Subject|1
296779|NCT00880620|975402|P2|Overall Study|Withdrawal by Subject|3
296780|NCT00880620|975403|P1|Overall Study|Withdrawal by Subject|4
296781|NCT00880620|975400|P4|Overall Study|Protocol Violation|2
296782|NCT00880620|975401|P3|Overall Study|Protocol Violation|0
296783|NCT00880620|975402|P2|Overall Study|Protocol Violation|1
296784|NCT00880620|975403|P1|Overall Study|Protocol Violation|0
296785|NCT00880620|975400|P4|Overall Study|Lost to Follow-up|0
296786|NCT00880620|975401|P3|Overall Study|Lost to Follow-up|1
296787|NCT00880620|975402|P2|Overall Study|Lost to Follow-up|1
296788|NCT00880620|975403|P1|Overall Study|Lost to Follow-up|0
296789|NCT00880620|975400|P4|Overall Study|Lack of Efficacy|1
296790|NCT00880620|975401|P3|Overall Study|Lack of Efficacy|0
296791|NCT00880620|975402|P2|Overall Study|Lack of Efficacy|4
296792|NCT00880620|975403|P1|Overall Study|Lack of Efficacy|12
296793|NCT00880620|975400|P4|Overall Study|Death|0
296794|NCT00880620|975401|P3|Overall Study|Death|1
296795|NCT00880620|975402|P2|Overall Study|Death|0
296796|NCT00880620|975403|P1|Overall Study|Death|0
296797|NCT00880620|975400|P4|Overall Study|Adverse Event|15
296798|NCT00880620|975401|P3|Overall Study|Adverse Event|15
296799|NCT00880620|975402|P2|Overall Study|Adverse Event|5
296800|NCT00880620|975403|P1|Overall Study|Adverse Event|4
296801|NCT00880568|975427|P9|Overall Study|Withdrawal by Subject|0
296802|NCT00880568|975428|P8|Overall Study|Withdrawal by Subject|1
296803|NCT00880568|975429|P7|Overall Study|Withdrawal by Subject|0
296804|NCT00880568|975430|P6|Overall Study|Withdrawal by Subject|0
296805|NCT00880568|975431|P5|Overall Study|Withdrawal by Subject|0
296806|NCT00880568|975432|P4|Overall Study|Withdrawal by Subject|0
296807|NCT00880568|975433|P3|Overall Study|Withdrawal by Subject|0
296808|NCT00880568|975434|P2|Overall Study|Withdrawal by Subject|0
296809|NCT00880568|975435|P1|Overall Study|Withdrawal by Subject|0
296810|NCT00880568|975427|P9|Overall Study|Adverse Event|0
296811|NCT00880568|975428|P8|Overall Study|Adverse Event|1
296812|NCT00880568|975429|P7|Overall Study|Adverse Event|1
296813|NCT00880568|975430|P6|Overall Study|Adverse Event|0
296814|NCT00880568|975431|P5|Overall Study|Adverse Event|0
296815|NCT00880568|975432|P4|Overall Study|Adverse Event|0
296816|NCT00880568|975433|P3|Overall Study|Adverse Event|0
296817|NCT00880568|975434|P2|Overall Study|Adverse Event|0
296818|NCT00880568|975435|P1|Overall Study|Adverse Event|0
296819|NCT00880568|975427|P9|Overall Study|Disease progression|3
296820|NCT00880568|975428|P8|Overall Study|Disease progression|0
296821|NCT00880568|975429|P7|Overall Study|Disease progression|5
296822|NCT00880568|975430|P6|Overall Study|Disease progression|3
296823|NCT00880568|975431|P5|Overall Study|Disease progression|3
296824|NCT00880568|975432|P4|Overall Study|Disease progression|1
296825|NCT00880568|975433|P3|Overall Study|Disease progression|3
296826|NCT00880568|975434|P2|Overall Study|Disease progression|3
296827|NCT00880568|975435|P1|Overall Study|Disease progression|3
296828|NCT00880555|975481|P6|Overall Study|Lost to Follow-up|0
296829|NCT00880555|975482|P5|Overall Study|Lost to Follow-up|0
296830|NCT00880555|975483|P4|Overall Study|Lost to Follow-up|0
296831|NCT00880555|975484|P3|Overall Study|Lost to Follow-up|0
296832|NCT00880555|975485|P2|Overall Study|Lost to Follow-up|1
296833|NCT00880555|975486|P1|Overall Study|Lost to Follow-up|0
296834|NCT00880555|975481|P6|Overall Study|Death|1
296835|NCT00880555|975482|P5|Overall Study|Death|0
296836|NCT00880555|975483|P4|Overall Study|Death|0
296837|NCT00880555|975484|P3|Overall Study|Death|0
296838|NCT00880555|975485|P2|Overall Study|Death|0
296839|NCT00880555|975486|P1|Overall Study|Death|0
296840|NCT00880555|975481|P6|Overall Study|Lack of resources (hired rater)|0
296841|NCT00880555|975482|P5|Overall Study|Lack of resources (hired rater)|0
296842|NCT00880555|975483|P4|Overall Study|Lack of resources (hired rater)|0
296843|NCT00880555|975484|P3|Overall Study|Lack of resources (hired rater)|5
296844|NCT00880555|975485|P2|Overall Study|Lack of resources (hired rater)|7
296845|NCT00880555|975486|P1|Overall Study|Lack of resources (hired rater)|9
296846|NCT00880555|975481|P6|Overall Study|Withdrawal by Subject|0
296847|NCT00880555|975482|P5|Overall Study|Withdrawal by Subject|0
296848|NCT00880555|975483|P4|Overall Study|Withdrawal by Subject|0
296849|NCT00880555|975484|P3|Overall Study|Withdrawal by Subject|0
296850|NCT00880555|975485|P2|Overall Study|Withdrawal by Subject|1
296851|NCT00880555|975486|P1|Overall Study|Withdrawal by Subject|1
296852|NCT00880555|975481|P6|Overall Study|Physician Decision|0
296853|NCT00880555|975482|P5|Overall Study|Physician Decision|1
296854|NCT00880555|975483|P4|Overall Study|Physician Decision|2
296855|NCT00880555|975484|P3|Overall Study|Physician Decision|0
296856|NCT00880555|975485|P2|Overall Study|Physician Decision|8
296857|NCT00880555|975486|P1|Overall Study|Physician Decision|0
296858|NCT00880542|975497|P1|REP: Surgical Resection|progressive disease|1
296859|NCT00880542|975497|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
296860|NCT00880542|975497|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
296861|NCT00880334|975517|P2|Overall Study|Brain Metastasis|1
296862|NCT00880334|975518|P1|Overall Study|Brain Metastasis|0
296863|NCT00880334|975517|P2|Overall Study|Inadequate Labs|1
296864|NCT00880334|975518|P1|Overall Study|Inadequate Labs|1
296865|NCT00880334|975517|P2|Overall Study|Withdrawal by Subject|1
296866|NCT00880334|975518|P1|Overall Study|Withdrawal by Subject|2
296867|NCT00880334|975517|P2|Overall Study|Physician Decision|0
296868|NCT00880334|975518|P1|Overall Study|Physician Decision|1
296869|NCT00880269|975534|P2|Overall Study|Adverse Event|9
296870|NCT00880269|975535|P1|Overall Study|Adverse Event|10
296871|NCT00880269|975534|P2|Overall Study|Withdrawal by Subject|4
296872|NCT00880269|975535|P1|Overall Study|Withdrawal by Subject|3
296873|NCT00880269|975534|P2|Overall Study|Lost to Follow-up|1
296874|NCT00880269|975535|P1|Overall Study|Lost to Follow-up|0
296875|NCT00880269|975534|P2|Overall Study|Death|2
296876|NCT00880269|975535|P1|Overall Study|Death|4
296877|NCT00880269|975534|P2|Overall Study|New Cancer Therapy|0
296878|NCT00880269|975535|P1|Overall Study|New Cancer Therapy|1
296879|NCT00880269|975534|P2|Overall Study|Disease Progression|11
296880|NCT00880269|975535|P1|Overall Study|Disease Progression|13
296881|NCT00880269|975534|P2|Overall Study|Protocol Violation|0
296882|NCT00880269|975535|P1|Overall Study|Protocol Violation|1
296883|NCT00880256|975551|P1|Overall Study|Lost to Follow-up|28
296884|NCT00880191|975578|P2|Overall Study|Hospitalization/efficacy|1
296885|NCT00880191|975579|P1|Overall Study|Hospitalization/efficacy|1
296886|NCT00880191|975578|P2|Overall Study|Adverse Event|6
296887|NCT00880191|975579|P1|Overall Study|Adverse Event|8
296888|NCT00880191|975578|P2|Overall Study|Refused further treatment|1
296889|NCT00880191|975579|P1|Overall Study|Refused further treatment|4
296890|NCT00880165|975599|P2|Overall Study|Lost to follow|15
296891|NCT00880165|975600|P1|Overall Study|Lost to follow|9
296892|NCT00880165|975599|P2|Overall Study|Required BIPAP or oxygen treatment|4
296893|NCT00880165|975600|P1|Overall Study|Required BIPAP or oxygen treatment|12
296894|NCT00880165|975599|P2|Overall Study|Not diagnosed with OSA|8
296895|NCT00880165|975600|P1|Overall Study|Not diagnosed with OSA|14
296896|NCT00880165|975599|P2|Overall Study|Withdrawal by Subject|23
296897|NCT00880165|975600|P1|Overall Study|Withdrawal by Subject|27
296898|NCT00880100|975610|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
296899|NCT00880100|975610|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
296900|NCT00880100|975610|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
296901|NCT00880009|975630|P1|Overall Study|Protocol Violation|1
296902|NCT00880009|975630|P1|Overall Study|Withdrawal by Subject|1
296903|NCT00880009|975630|P1|Overall Study|Study terminated by sponsor|14
296904|NCT00879996|975654|P2|Overall Study|put on parole|0
296905|NCT00879996|975655|P1|Overall Study|put on parole|1
296906|NCT00879996|975654|P2|Overall Study|psychiatric problem|1
296907|NCT00879996|975655|P1|Overall Study|psychiatric problem|0
296908|NCT00879996|975654|P2|Overall Study|Physician Decision|2
296909|NCT00879996|975655|P1|Overall Study|Physician Decision|1
296910|NCT00879996|975654|P2|Overall Study|non-compliance|4
296911|NCT00879996|975655|P1|Overall Study|non-compliance|6
296912|NCT00879996|975654|P2|Overall Study|Lost to Follow-up|6
296913|NCT00879996|975655|P1|Overall Study|Lost to Follow-up|7
296914|NCT00879970|975670|P5|Period 2 Vitamin D Randomization|Death|0
296915|NCT00879970|975671|P4|Period 2 Vitamin D Randomization|Death|2
296916|NCT00879970|975672|P3|Period 2 Vitamin D Randomization|Death|0
296917|NCT00879970|975673|P2|Period 2 Vitamin D Randomization|Death|0
296918|NCT00879970|975674|P1|Period 2 Vitamin D Randomization|Death|0
296919|NCT00879970|975670|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
296920|NCT00879970|975671|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
296921|NCT00879970|975672|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
296922|NCT00879970|975673|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
296923|NCT00879970|975674|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
296924|NCT00879970|975670|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
296925|NCT00879970|975671|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
296926|NCT00879970|975672|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
296927|NCT00879970|975673|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
296928|NCT00879970|975674|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
296929|NCT00879970|975670|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
296930|NCT00879970|975671|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
296931|NCT00879970|975672|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
296932|NCT00879970|975673|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
296933|NCT00879970|975674|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
296934|NCT00879970|975670|P5|Period 1 TZD Randomization|Death|0
296935|NCT00879970|975671|P4|Period 1 TZD Randomization|Death|0
296936|NCT00879970|975672|P3|Period 1 TZD Randomization|Death|0
296937|NCT00879970|975673|P2|Period 1 TZD Randomization|Death|1
296938|NCT00879970|975674|P1|Period 1 TZD Randomization|Death|2
296939|NCT00879970|975670|P5|Period 1 TZD Randomization|Lost to Follow-up|0
296940|NCT00879970|975671|P4|Period 1 TZD Randomization|Lost to Follow-up|0
296941|NCT00879970|975672|P3|Period 1 TZD Randomization|Lost to Follow-up|1
296942|NCT00879970|975673|P2|Period 1 TZD Randomization|Lost to Follow-up|0
296943|NCT00879970|975674|P1|Period 1 TZD Randomization|Lost to Follow-up|1
296944|NCT00879970|975670|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
296945|NCT00879970|975671|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
296946|NCT00879970|975672|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
296947|NCT00879970|975673|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
296948|NCT00879970|975674|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
296949|NCT00879879|975756|P1|Overall Study|Physician Decision|1
296950|NCT00879879|975756|P1|Overall Study|Withdrawal by Subject|1
296951|NCT00879879|975756|P1|Overall Study|Death|1
296952|NCT00879814|975764|P4|Overall Study|Unspecified|0
296953|NCT00879814|975765|P3|Overall Study|Unspecified|1
296954|NCT00879814|975766|P2|Overall Study|Unspecified|0
296955|NCT00879814|975767|P1|Overall Study|Unspecified|0
296956|NCT00879814|975764|P4|Overall Study|Physician Decision|0
296957|NCT00879814|975765|P3|Overall Study|Physician Decision|1
296958|NCT00879814|975766|P2|Overall Study|Physician Decision|0
296959|NCT00879814|975767|P1|Overall Study|Physician Decision|0
296960|NCT00879814|975764|P4|Overall Study|Withdrawal by Subject|2
296961|NCT00879814|975765|P3|Overall Study|Withdrawal by Subject|1
296962|NCT00879814|975766|P2|Overall Study|Withdrawal by Subject|1
296963|NCT00879814|975767|P1|Overall Study|Withdrawal by Subject|3
296964|NCT00879814|975764|P4|Overall Study|Participant Failed to Return|1
296965|NCT00879814|975765|P3|Overall Study|Participant Failed to Return|0
296966|NCT00879814|975766|P2|Overall Study|Participant Failed to Return|0
296967|NCT00879814|975767|P1|Overall Study|Participant Failed to Return|0
296968|NCT00879814|975764|P4|Overall Study|Lost to Follow-up|2
296969|NCT00879814|975765|P3|Overall Study|Lost to Follow-up|0
296970|NCT00879814|975766|P2|Overall Study|Lost to Follow-up|0
296971|NCT00879814|975767|P1|Overall Study|Lost to Follow-up|1
296972|NCT00879814|975764|P4|Overall Study|Adverse Event|0
296973|NCT00879814|975765|P3|Overall Study|Adverse Event|0
296974|NCT00879814|975766|P2|Overall Study|Adverse Event|1
296975|NCT00879814|975767|P1|Overall Study|Adverse Event|0
296976|NCT00879775|975875|P2|Overall Study|Lost to Follow-up|1
296977|NCT00879775|975876|P1|Overall Study|Lost to Follow-up|2
296978|NCT00879710|975892|P4|Phase 1 - 6 Weeks|Adverse Event|0
296979|NCT00879710|975893|P3|Phase 1 - 6 Weeks|Adverse Event|1
296980|NCT00879710|975894|P2|Phase 1 - 6 Weeks|Adverse Event|0
296981|NCT00879710|975895|P1|Phase 1 - 6 Weeks|Adverse Event|0
296982|NCT00879710|975892|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
296983|NCT00879710|975893|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
296984|NCT00879710|975894|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
296985|NCT00879710|975895|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
296986|NCT00879697|975905|P2|Overall Study|Physician Decision|2
296987|NCT00879697|975906|P1|Overall Study|Physician Decision|2
296988|NCT00879684|975912|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
296989|NCT00879684|975913|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
296990|NCT00879684|975914|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
296991|NCT00879684|975915|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
296992|NCT00879684|975916|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
296993|NCT00879684|975917|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
296994|NCT00879684|975918|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
296995|NCT00879684|975912|P7|Stage 2: Expanded Cohort|Progressive Disease|11
296996|NCT00879684|975913|P6|Stage 2: Expanded Cohort|Progressive Disease|0
296997|NCT00879684|975914|P5|Stage 2: Expanded Cohort|Progressive Disease|0
296998|NCT00879684|975915|P4|Stage 2: Expanded Cohort|Progressive Disease|0
296999|NCT00879684|975916|P3|Stage 2: Expanded Cohort|Progressive Disease|0
297000|NCT00879684|975917|P2|Stage 2: Expanded Cohort|Progressive Disease|0
297001|NCT00879684|975918|P1|Stage 2: Expanded Cohort|Progressive Disease|0
297002|NCT00879684|975912|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
297003|NCT00879684|975913|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
297004|NCT00879684|975914|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
297005|NCT00879684|975915|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
297006|NCT00879684|975916|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
297007|NCT00879684|975917|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
297008|NCT00879684|975918|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
297009|NCT00879684|975912|P7|Stage 1: Dose Escalation|Death|0
297010|NCT00879684|975913|P6|Stage 1: Dose Escalation|Death|0
297011|NCT00879684|975914|P5|Stage 1: Dose Escalation|Death|0
297012|NCT00879684|975915|P4|Stage 1: Dose Escalation|Death|0
297013|NCT00879684|975916|P3|Stage 1: Dose Escalation|Death|1
297014|NCT00879684|975917|P2|Stage 1: Dose Escalation|Death|0
297015|NCT00879684|975918|P1|Stage 1: Dose Escalation|Death|0
297016|NCT00879684|975912|P7|Stage 1: Dose Escalation|Investigator declined participation|0
297017|NCT00879684|975913|P6|Stage 1: Dose Escalation|Investigator declined participation|0
297018|NCT00879684|975914|P5|Stage 1: Dose Escalation|Investigator declined participation|0
297019|NCT00879684|975915|P4|Stage 1: Dose Escalation|Investigator declined participation|2
297020|NCT00879684|975916|P3|Stage 1: Dose Escalation|Investigator declined participation|2
297021|NCT00879684|975917|P2|Stage 1: Dose Escalation|Investigator declined participation|0
297022|NCT00879684|975918|P1|Stage 1: Dose Escalation|Investigator declined participation|0
297023|NCT00879684|975912|P7|Stage 1: Dose Escalation|Progressive Disease|0
297024|NCT00879684|975913|P6|Stage 1: Dose Escalation|Progressive Disease|3
297025|NCT00879684|975914|P5|Stage 1: Dose Escalation|Progressive Disease|3
297026|NCT00879684|975915|P4|Stage 1: Dose Escalation|Progressive Disease|4
297027|NCT00879684|975916|P3|Stage 1: Dose Escalation|Progressive Disease|0
297028|NCT00879684|975917|P2|Stage 1: Dose Escalation|Progressive Disease|3
297029|NCT00879684|975918|P1|Stage 1: Dose Escalation|Progressive Disease|2
297030|NCT00879684|975912|P7|Stage 1: Dose Escalation|Adverse Event|0
297031|NCT00879684|975913|P6|Stage 1: Dose Escalation|Adverse Event|0
297032|NCT00879684|975914|P5|Stage 1: Dose Escalation|Adverse Event|0
297033|NCT00879684|975915|P4|Stage 1: Dose Escalation|Adverse Event|0
297034|NCT00879684|975916|P3|Stage 1: Dose Escalation|Adverse Event|0
297035|NCT00879684|975917|P2|Stage 1: Dose Escalation|Adverse Event|0
297036|NCT00879684|975918|P1|Stage 1: Dose Escalation|Adverse Event|1
297037|NCT00879645|975984|P4|Overall Study|Adverse Event|0
297038|NCT00879645|975985|P3|Overall Study|Adverse Event|0
297039|NCT00879645|975986|P2|Overall Study|Adverse Event|0
297040|NCT00879645|975987|P1|Overall Study|Adverse Event|1
297041|NCT00879411|976014|P1|Overall Study|lost to follow-up (non-AE)|162
297042|NCT00879398|976020|P1|Overall Study|Other Reasons|171
297043|NCT00879398|976020|P1|Overall Study|Adverse Event|41
297044|NCT00879398|976020|P1|Overall Study|Lack of Efficacy|64
297045|NCT00879398|976020|P1|Overall Study|Visit Stop|399
297046|NCT00879333|976038|P2|Overall Study|Protocol Violation|1
297047|NCT00879333|976039|P1|Overall Study|Protocol Violation|1
297048|NCT00879333|976038|P2|Overall Study|Disease Progression|169
297049|NCT00879333|976039|P1|Overall Study|Disease Progression|292
297050|NCT00879333|976038|P2|Overall Study|Death|5
297051|NCT00879333|976039|P1|Overall Study|Death|16
297052|NCT00879333|976038|P2|Overall Study|Administrative Problems|0
297053|NCT00879333|976039|P1|Overall Study|Administrative Problems|2
297054|NCT00879333|976038|P2|Overall Study|Lost to Follow-up|1
297055|NCT00879333|976039|P1|Overall Study|Lost to Follow-up|2
297056|NCT00879333|976038|P2|Overall Study|Withdrawal by Subject|7
297057|NCT00879333|976039|P1|Overall Study|Withdrawal by Subject|20
297058|NCT00879333|976038|P2|Overall Study|Abnormal Laboratory Value|0
297059|NCT00879333|976039|P1|Overall Study|Abnormal Laboratory Value|1
297060|NCT00879333|976038|P2|Overall Study|Adverse Event|34
297061|NCT00879333|976039|P1|Overall Study|Adverse Event|94
297062|NCT00879229|976072|P2|Overall Study|Other|0
297063|NCT00879229|976073|P1|Overall Study|Other|1
297064|NCT00879229|976072|P2|Overall Study|Clinical status did not improve|0
297065|NCT00879229|976073|P1|Overall Study|Clinical status did not improve|1
297066|NCT00879229|976072|P2|Overall Study|Withdrawal by Subject|0
297067|NCT00879229|976073|P1|Overall Study|Withdrawal by Subject|1
297068|NCT00879229|976072|P2|Overall Study|Adverse Event|0
297069|NCT00879229|976073|P1|Overall Study|Adverse Event|2
297070|NCT00879229|976072|P2|Overall Study|Death|2
297071|NCT00879229|976073|P1|Overall Study|Death|4
297072|NCT00879229|976072|P2|Overall Study|Study terminated by Sponsor|12
297073|NCT00879229|976073|P1|Overall Study|Study terminated by Sponsor|13
297074|NCT00878969|976113|P3|Overall Study|Pregnancy|0
297075|NCT00878969|976114|P2|Overall Study|Pregnancy|1
297076|NCT00878969|976115|P1|Overall Study|Pregnancy|0
297077|NCT00878969|976113|P3|Overall Study|Death|2
297078|NCT00878969|976114|P2|Overall Study|Death|0
297079|NCT00878969|976115|P1|Overall Study|Death|0
297080|NCT00878969|976113|P3|Overall Study|Protocol Violation|0
297081|NCT00878969|976114|P2|Overall Study|Protocol Violation|0
297082|NCT00878969|976115|P1|Overall Study|Protocol Violation|2
297083|NCT00878969|976113|P3|Overall Study|Lost to Follow-up|0
297084|NCT00878969|976114|P2|Overall Study|Lost to Follow-up|1
297085|NCT00878969|976115|P1|Overall Study|Lost to Follow-up|2
297086|NCT00878969|976113|P3|Overall Study|Adverse Event|2
297087|NCT00878969|976114|P2|Overall Study|Adverse Event|1
297088|NCT00878969|976115|P1|Overall Study|Adverse Event|3
297089|NCT00878969|976113|P3|Overall Study|kidney transplant|2
297090|NCT00878969|976114|P2|Overall Study|kidney transplant|3
297091|NCT00878969|976115|P1|Overall Study|kidney transplant|2
297092|NCT00878969|976113|P3|Overall Study|Withdrawal by Subject|3
297093|NCT00878969|976114|P2|Overall Study|Withdrawal by Subject|6
297094|NCT00878969|976115|P1|Overall Study|Withdrawal by Subject|1
297095|NCT00878969|976113|P3|Overall Study|Physician Decision|2
297096|NCT00878969|976114|P2|Overall Study|Physician Decision|3
297097|NCT00878969|976115|P1|Overall Study|Physician Decision|5
297098|NCT00878800|976163|P5|Overall Study|Other|1
297099|NCT00878800|976164|P4|Overall Study|Other|0
297100|NCT00878800|976165|P3|Overall Study|Other|0
297101|NCT00878800|976166|P2|Overall Study|Other|1
297102|NCT00878800|976167|P1|Overall Study|Other|1
297103|NCT00878800|976163|P5|Overall Study|Death|0
297104|NCT00878800|976164|P4|Overall Study|Death|0
297105|NCT00878800|976165|P3|Overall Study|Death|1
297106|NCT00878800|976166|P2|Overall Study|Death|0
297107|NCT00878800|976167|P1|Overall Study|Death|0
297108|NCT00878800|976163|P5|Overall Study|Withdrew consent|1
297109|NCT00878800|976164|P4|Overall Study|Withdrew consent|1
297110|NCT00878800|976165|P3|Overall Study|Withdrew consent|0
297111|NCT00878800|976166|P2|Overall Study|Withdrew consent|1
297112|NCT00878800|976167|P1|Overall Study|Withdrew consent|1
297113|NCT00878800|976163|P5|Overall Study|Progressive disease|13
297114|NCT00878800|976164|P4|Overall Study|Progressive disease|5
297115|NCT00878800|976165|P3|Overall Study|Progressive disease|6
297116|NCT00878800|976166|P2|Overall Study|Progressive disease|5
297117|NCT00878800|976167|P1|Overall Study|Progressive disease|1
297118|NCT00878800|976163|P5|Overall Study|Adverse Event|1
297119|NCT00878800|976164|P4|Overall Study|Adverse Event|0
297120|NCT00878800|976165|P3|Overall Study|Adverse Event|2
297121|NCT00878800|976166|P2|Overall Study|Adverse Event|0
297122|NCT00878800|976167|P1|Overall Study|Adverse Event|0
297123|NCT00878722|976202|P8|Overall Study|Relapse|0
297124|NCT00878722|976203|P7|Overall Study|Relapse|0
297125|NCT00878722|976204|P6|Overall Study|Relapse|0
297126|NCT00878722|976205|P5|Overall Study|Relapse|0
297127|NCT00878722|976206|P4|Overall Study|Relapse|1
297128|NCT00878722|976207|P3|Overall Study|Relapse|0
297129|NCT00878722|976208|P2|Overall Study|Relapse|0
297130|NCT00878722|976209|P1|Overall Study|Relapse|0
297131|NCT00878722|976202|P8|Overall Study|Withdrawal by Subject|2
297132|NCT00878722|976203|P7|Overall Study|Withdrawal by Subject|0
297133|NCT00878722|976204|P6|Overall Study|Withdrawal by Subject|0
297134|NCT00878722|976205|P5|Overall Study|Withdrawal by Subject|0
297135|NCT00878722|976206|P4|Overall Study|Withdrawal by Subject|0
297136|NCT00878722|976207|P3|Overall Study|Withdrawal by Subject|0
297137|NCT00878722|976208|P2|Overall Study|Withdrawal by Subject|0
297138|NCT00878722|976209|P1|Overall Study|Withdrawal by Subject|0
297139|NCT00878722|976202|P8|Overall Study|Adverse Event|0
297140|NCT00878722|976203|P7|Overall Study|Adverse Event|2
297141|NCT00878722|976204|P6|Overall Study|Adverse Event|0
297142|NCT00878722|976205|P5|Overall Study|Adverse Event|0
297143|NCT00878722|976206|P4|Overall Study|Adverse Event|0
297144|NCT00878722|976207|P3|Overall Study|Adverse Event|0
297145|NCT00878722|976208|P2|Overall Study|Adverse Event|0
297146|NCT00878722|976209|P1|Overall Study|Adverse Event|0
297147|NCT00878722|976202|P8|Overall Study|Death|2
297148|NCT00878722|976203|P7|Overall Study|Death|0
297149|NCT00878722|976204|P6|Overall Study|Death|1
297150|NCT00878722|976205|P5|Overall Study|Death|0
297151|NCT00878722|976206|P4|Overall Study|Death|1
297152|NCT00878722|976207|P3|Overall Study|Death|0
297153|NCT00878722|976208|P2|Overall Study|Death|0
297154|NCT00878722|976209|P1|Overall Study|Death|0
297155|NCT00878722|976202|P8|Overall Study|Progressive disease|3
297156|NCT00878722|976203|P7|Overall Study|Progressive disease|4
297157|NCT00878722|976204|P6|Overall Study|Progressive disease|1
297158|NCT00878722|976205|P5|Overall Study|Progressive disease|7
297159|NCT00878722|976206|P4|Overall Study|Progressive disease|7
297160|NCT00878722|976207|P3|Overall Study|Progressive disease|3
297161|NCT00878722|976208|P2|Overall Study|Progressive disease|3
297162|NCT00878722|976209|P1|Overall Study|Progressive disease|3
297163|NCT00878553|976313|P5|PK Study|Withdrawal by Subject|0
297164|NCT00878553|976314|P4|PK Study|Withdrawal by Subject|1
297165|NCT00878553|976315|P3|PK Study|Withdrawal by Subject|0
297166|NCT00878553|976316|P2|PK Study|Withdrawal by Subject|0
297167|NCT00878553|976317|P1|PK Study|Withdrawal by Subject|0
297168|NCT00878553|976313|P5|Sleep Study|family emergency|0
297169|NCT00878553|976314|P4|Sleep Study|family emergency|0
297170|NCT00878553|976315|P3|Sleep Study|family emergency|0
297171|NCT00878553|976316|P2|Sleep Study|family emergency|0
297172|NCT00878553|976317|P1|Sleep Study|family emergency|1
297173|NCT00878553|976313|P5|Sleep Study|car accident|0
297174|NCT00878553|976314|P4|Sleep Study|car accident|0
297175|NCT00878553|976315|P3|Sleep Study|car accident|0
297176|NCT00878553|976316|P2|Sleep Study|car accident|0
297177|NCT00878553|976317|P1|Sleep Study|car accident|1
297178|NCT00878553|976313|P5|Sleep Study|Lost to Follow-up|0
297179|NCT00878553|976314|P4|Sleep Study|Lost to Follow-up|0
297180|NCT00878553|976315|P3|Sleep Study|Lost to Follow-up|0
297181|NCT00878553|976316|P2|Sleep Study|Lost to Follow-up|0
297182|NCT00878553|976317|P1|Sleep Study|Lost to Follow-up|1
297183|NCT00878553|976313|P5|Sleep Study|Withdrawal by Subject|0
297184|NCT00878553|976314|P4|Sleep Study|Withdrawal by Subject|0
297185|NCT00878553|976315|P3|Sleep Study|Withdrawal by Subject|0
297186|NCT00878553|976316|P2|Sleep Study|Withdrawal by Subject|0
297187|NCT00878553|976317|P1|Sleep Study|Withdrawal by Subject|2
297188|NCT00878501|976376|P3|Overall Study|Administrative|1
297189|NCT00878501|976377|P2|Overall Study|Administrative|0
297190|NCT00878501|976378|P1|Overall Study|Administrative|0
297191|NCT00878501|976376|P3|Overall Study|Mis-randomisation of patient|0
297192|NCT00878501|976377|P2|Overall Study|Mis-randomisation of patient|0
297193|NCT00878501|976378|P1|Overall Study|Mis-randomisation of patient|1
297194|NCT00878501|976376|P3|Overall Study|Intake of prohibited concom. medication|1
297195|NCT00878501|976377|P2|Overall Study|Intake of prohibited concom. medication|0
297196|NCT00878501|976378|P1|Overall Study|Intake of prohibited concom. medication|0
297197|NCT00878501|976376|P3|Overall Study|Incorrect enrolment|0
297198|NCT00878501|976377|P2|Overall Study|Incorrect enrolment|2
297199|NCT00878501|976378|P1|Overall Study|Incorrect enrolment|1
297200|NCT00878501|976376|P3|Overall Study|Protocol Violation|1
297201|NCT00878501|976377|P2|Overall Study|Protocol Violation|0
297202|NCT00878501|976378|P1|Overall Study|Protocol Violation|0
297203|NCT00878501|976376|P3|Overall Study|Withdrawal by Subject|2
297204|NCT00878501|976377|P2|Overall Study|Withdrawal by Subject|1
297205|NCT00878501|976378|P1|Overall Study|Withdrawal by Subject|2
297206|NCT00878501|976376|P3|Overall Study|Lack of Efficacy|0
297207|NCT00878501|976377|P2|Overall Study|Lack of Efficacy|1
297208|NCT00878501|976378|P1|Overall Study|Lack of Efficacy|2
297209|NCT00878501|976376|P3|Overall Study|Adverse Event|3
297210|NCT00878501|976377|P2|Overall Study|Adverse Event|3
297211|NCT00878501|976378|P1|Overall Study|Adverse Event|11
297212|NCT00877929|976410|P2|Overall Study|Other reason (not specified)|6
297213|NCT00877929|976411|P1|Overall Study|Other reason (not specified)|2
297214|NCT00877929|976410|P2|Overall Study|Lack of Efficacy|1
297215|NCT00877929|976411|P1|Overall Study|Lack of Efficacy|0
297216|NCT00877929|976410|P2|Overall Study|Withdrawal by Subject|4
297217|NCT00877929|976411|P1|Overall Study|Withdrawal by Subject|4
297218|NCT00877929|976410|P2|Overall Study|Lost to Follow-up|1
297219|NCT00877929|976411|P1|Overall Study|Lost to Follow-up|0
297220|NCT00877929|976410|P2|Overall Study|Protocol Violation|3
297221|NCT00877929|976411|P1|Overall Study|Protocol Violation|3
297222|NCT00877929|976410|P2|Overall Study|Adverse Event|20
297223|NCT00877929|976411|P1|Overall Study|Adverse Event|11
297224|NCT00877890|976499|P2|Overall Study|Loss of Glucose Control|4
297225|NCT00877890|976500|P1|Overall Study|Loss of Glucose Control|3
297226|NCT00877890|976499|P2|Overall Study|Investigator Decision|2
297227|NCT00877890|976500|P1|Overall Study|Investigator Decision|0
297228|NCT00877890|976499|P2|Overall Study|Withdrawal of Consent|12
297229|NCT00877890|976500|P1|Overall Study|Withdrawal of Consent|6
297230|NCT00877890|976499|P2|Overall Study|Protocol Violation|1
297231|NCT00877890|976500|P1|Overall Study|Protocol Violation|0
297232|NCT00877890|976499|P2|Overall Study|Lost to Follow-up|5
297233|NCT00877890|976500|P1|Overall Study|Lost to Follow-up|5
297234|NCT00877890|976499|P2|Overall Study|Adverse Event|6
297235|NCT00877890|976500|P1|Overall Study|Adverse Event|6
297236|NCT00877799|976565|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
297237|NCT00877799|976566|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
297238|NCT00877799|976567|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
297239|NCT00877799|976568|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
297240|NCT00877799|976569|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
297241|NCT00877799|976565|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
297242|NCT00877799|976566|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
297243|NCT00877799|976567|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
297244|NCT00877799|976568|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
297245|NCT00877799|976569|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
297246|NCT00877799|976565|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
297247|NCT00877799|976566|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
297248|NCT00877799|976567|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
297249|NCT00877799|976568|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
297250|NCT00877799|976569|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
297251|NCT00877799|976565|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
297252|NCT00877799|976566|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
297253|NCT00877799|976567|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
297254|NCT00877799|976568|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
297255|NCT00877799|976569|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
297256|NCT00877799|976565|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
297257|NCT00877799|976566|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
297258|NCT00877799|976567|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
297259|NCT00877799|976568|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
297260|NCT00877799|976569|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
297261|NCT00877773|976584|P1|Overall Study|Disease Progression|44
297262|NCT00877487|976597|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
297263|NCT00877487|976598|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
297264|NCT00877487|976597|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
297265|NCT00877487|976598|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
297266|NCT00877487|976597|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
297267|NCT00877487|976598|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
297268|NCT00877487|976597|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
297269|NCT00877487|976598|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
297270|NCT00877487|976597|P2|Open-label Treatment Phase|Out of country for business|0
297271|NCT00877487|976598|P1|Open-label Treatment Phase|Out of country for business|1
297272|NCT00877487|976597|P2|Open-label Treatment Phase|Lost to Follow-up|0
297273|NCT00877487|976598|P1|Open-label Treatment Phase|Lost to Follow-up|1
297274|NCT00877487|976597|P2|Open-label Treatment Phase|Withdrawal by Subject|0
297275|NCT00877487|976598|P1|Open-label Treatment Phase|Withdrawal by Subject|1
297276|NCT00877487|976597|P2|Open-label Treatment Phase|Protocol Violation|0
297277|NCT00877487|976598|P1|Open-label Treatment Phase|Protocol Violation|3
297278|NCT00877487|976597|P2|Open-label Treatment Phase|Adverse Event|0
297279|NCT00877487|976598|P1|Open-label Treatment Phase|Adverse Event|1
297280|NCT00877383|976646|P2|Overall Study|Death|2
297281|NCT00877383|976647|P1|Overall Study|Death|1
297282|NCT00877383|976646|P2|Overall Study|Unsatisfactory therapeutic effect|0
297283|NCT00877383|976647|P1|Overall Study|Unsatisfactory therapeutic effect|1
297284|NCT00877383|976646|P2|Overall Study|Protocol deviation|6
297285|NCT00877383|976647|P1|Overall Study|Protocol deviation|2
297286|NCT00877383|976646|P2|Overall Study|Administrative problems|0
297287|NCT00877383|976647|P1|Overall Study|Administrative problems|2
297288|NCT00877383|976646|P2|Overall Study|Subject no longer requires study drug|0
297289|NCT00877383|976647|P1|Overall Study|Subject no longer requires study drug|2
297290|NCT00877383|976646|P2|Overall Study|Subject withdrew consent|12
297291|NCT00877383|976647|P1|Overall Study|Subject withdrew consent|3
297292|NCT00877383|976646|P2|Overall Study|Lost to Follow-up|3
297293|NCT00877383|976647|P1|Overall Study|Lost to Follow-up|5
297294|NCT00877383|976646|P2|Overall Study|Adverse Event|14
297295|NCT00877383|976647|P1|Overall Study|Adverse Event|13
297296|NCT00877071|976667|P1|Overall Study|disease progression|2
297297|NCT00877032|976700|P7|Overall Study|Did not meet entrance criteria|2
297298|NCT00877032|976701|P6|Overall Study|Did not meet entrance criteria|0
297299|NCT00877032|976702|P5|Overall Study|Did not meet entrance criteria|0
297300|NCT00877032|976703|P4|Overall Study|Did not meet entrance criteria|1
297301|NCT00877032|976704|P3|Overall Study|Did not meet entrance criteria|0
297302|NCT00877032|976705|P2|Overall Study|Did not meet entrance criteria|0
297303|NCT00877032|976706|P1|Overall Study|Did not meet entrance criteria|0
297304|NCT00877006|976807|P2|Treatment Period|Randomized but Not Treated|8
297305|NCT00877006|976808|P1|Treatment Period|Randomized but Not Treated|3
297306|NCT00877006|976807|P2|Treatment Period|Not Specified|4
297307|NCT00877006|976808|P1|Treatment Period|Not Specified|4
297308|NCT00877006|976807|P2|Treatment Period|Started New Treatment Regimen|5
297309|NCT00877006|976808|P1|Treatment Period|Started New Treatment Regimen|1
297310|NCT00877006|976807|P2|Treatment Period|Disease Progression|2
297311|NCT00877006|976808|P1|Treatment Period|Disease Progression|0
297312|NCT00877006|976807|P2|Treatment Period|Lost to Follow-up|1
297313|NCT00877006|976808|P1|Treatment Period|Lost to Follow-up|0
297314|NCT00877006|976807|P2|Treatment Period|Protocol Violation|0
297315|NCT00877006|976808|P1|Treatment Period|Protocol Violation|1
297316|NCT00877006|976807|P2|Treatment Period|Withdrawal by Subject|3
297317|NCT00877006|976808|P1|Treatment Period|Withdrawal by Subject|2
297318|NCT00877006|976807|P2|Treatment Period|Adverse Event|3
297319|NCT00877006|976808|P1|Treatment Period|Adverse Event|9
297320|NCT00877006|976807|P2|Treatment Period|Death|1
297321|NCT00877006|976808|P1|Treatment Period|Death|1
297322|NCT00876928|976836|P2|Overall Study|Hypokalemia-affects insulin secretion|0
297323|NCT00876928|976837|P1|Overall Study|Hypokalemia-affects insulin secretion|1
297324|NCT00876928|976836|P2|Overall Study|Lost to Follow-up|5
297325|NCT00876928|976837|P1|Overall Study|Lost to Follow-up|2
297326|NCT00876733|976874|P4|Overall Study|Data not available|1
297327|NCT00876733|976875|P3|Overall Study|Data not available|7
297328|NCT00876733|976876|P2|Overall Study|Data not available|3
297329|NCT00876733|976877|P1|Overall Study|Data not available|14
297330|NCT00876733|976874|P4|Overall Study|Lost to Follow-up|2
297331|NCT00876733|976875|P3|Overall Study|Lost to Follow-up|3
297332|NCT00876733|976876|P2|Overall Study|Lost to Follow-up|10
297333|NCT00876733|976877|P1|Overall Study|Lost to Follow-up|26
297334|NCT00876733|976874|P4|Overall Study|Lack of Efficacy|1
297335|NCT00876733|976875|P3|Overall Study|Lack of Efficacy|10
297336|NCT00876733|976876|P2|Overall Study|Lack of Efficacy|9
297337|NCT00876733|976877|P1|Overall Study|Lack of Efficacy|17
297338|NCT00876733|976874|P4|Overall Study|Adverse Event|3
297339|NCT00876733|976875|P3|Overall Study|Adverse Event|10
297340|NCT00876733|976876|P2|Overall Study|Adverse Event|20
297341|NCT00876733|976877|P1|Overall Study|Adverse Event|34
297342|NCT00876694|976985|P2|Overall Study|Death|0
297343|NCT00876694|976986|P1|Overall Study|Death|1
297344|NCT00876694|976985|P2|Overall Study|Administrative problems|1
297345|NCT00876694|976986|P1|Overall Study|Administrative problems|1
297346|NCT00876694|976985|P2|Overall Study|Abnormal test procedure result(s)|0
297347|NCT00876694|976986|P1|Overall Study|Abnormal test procedure result(s)|1
297348|NCT00876694|976985|P2|Overall Study|Unsatisfactory therapeutic effect|0
297349|NCT00876694|976986|P1|Overall Study|Unsatisfactory therapeutic effect|2
297350|NCT00876694|976985|P2|Overall Study|Subject withdrew consent|4
297351|NCT00876694|976986|P1|Overall Study|Subject withdrew consent|6
297352|NCT00876694|976985|P2|Overall Study|Adverse Event|7
297353|NCT00876694|976986|P1|Overall Study|Adverse Event|10
297354|NCT00876460|977012|P8|Mono Therapy Phase|Adverse Event|0
297355|NCT00876460|977013|P7|Mono Therapy Phase|Adverse Event|0
297356|NCT00876460|977014|P6|Mono Therapy Phase|Adverse Event|0
297357|NCT00876460|977015|P5|Mono Therapy Phase|Adverse Event|0
297358|NCT00876460|977016|P4|Mono Therapy Phase|Adverse Event|1
297359|NCT00876460|977017|P3|Mono Therapy Phase|Adverse Event|0
297360|NCT00876460|977018|P2|Mono Therapy Phase|Adverse Event|0
297361|NCT00876460|977019|P1|Mono Therapy Phase|Adverse Event|0
297362|NCT00876460|977012|P8|Mono Therapy Phase|Withdrawal by Subject|0
297363|NCT00876460|977013|P7|Mono Therapy Phase|Withdrawal by Subject|0
297364|NCT00876460|977014|P6|Mono Therapy Phase|Withdrawal by Subject|0
297365|NCT00876460|977015|P5|Mono Therapy Phase|Withdrawal by Subject|0
297366|NCT00876460|977016|P4|Mono Therapy Phase|Withdrawal by Subject|0
297367|NCT00876460|977017|P3|Mono Therapy Phase|Withdrawal by Subject|0
297368|NCT00876460|977018|P2|Mono Therapy Phase|Withdrawal by Subject|1
297369|NCT00876460|977019|P1|Mono Therapy Phase|Withdrawal by Subject|0
297370|NCT00876460|977012|P8|Mono Therapy Phase|Progressive disease|3
297371|NCT00876460|977013|P7|Mono Therapy Phase|Progressive disease|1
297372|NCT00876460|977014|P6|Mono Therapy Phase|Progressive disease|0
297373|NCT00876460|977015|P5|Mono Therapy Phase|Progressive disease|2
297374|NCT00876460|977016|P4|Mono Therapy Phase|Progressive disease|0
297375|NCT00876460|977017|P3|Mono Therapy Phase|Progressive disease|0
297376|NCT00876460|977018|P2|Mono Therapy Phase|Progressive disease|0
297377|NCT00876460|977019|P1|Mono Therapy Phase|Progressive disease|0
297378|NCT00876460|977012|P8|Combination Therapy Phase|Not treated|0
297379|NCT00876460|977013|P7|Combination Therapy Phase|Not treated|1
297380|NCT00876460|977014|P6|Combination Therapy Phase|Not treated|0
297381|NCT00876460|977015|P5|Combination Therapy Phase|Not treated|0
297382|NCT00876460|977016|P4|Combination Therapy Phase|Not treated|0
297383|NCT00876460|977017|P3|Combination Therapy Phase|Not treated|0
297384|NCT00876460|977018|P2|Combination Therapy Phase|Not treated|0
297385|NCT00876460|977019|P1|Combination Therapy Phase|Not treated|0
297386|NCT00876460|977012|P8|Combination Therapy Phase|Other reason not defined above|2
297387|NCT00876460|977013|P7|Combination Therapy Phase|Other reason not defined above|1
297388|NCT00876460|977014|P6|Combination Therapy Phase|Other reason not defined above|0
297389|NCT00876460|977015|P5|Combination Therapy Phase|Other reason not defined above|0
297390|NCT00876460|977016|P4|Combination Therapy Phase|Other reason not defined above|0
297391|NCT00876460|977017|P3|Combination Therapy Phase|Other reason not defined above|0
297392|NCT00876460|977018|P2|Combination Therapy Phase|Other reason not defined above|0
297393|NCT00876460|977019|P1|Combination Therapy Phase|Other reason not defined above|0
297394|NCT00876460|977012|P8|Combination Therapy Phase|Withdrawal by Subject|0
297395|NCT00876460|977013|P7|Combination Therapy Phase|Withdrawal by Subject|0
297396|NCT00876460|977014|P6|Combination Therapy Phase|Withdrawal by Subject|0
297397|NCT00876460|977015|P5|Combination Therapy Phase|Withdrawal by Subject|1
297398|NCT00876460|977016|P4|Combination Therapy Phase|Withdrawal by Subject|0
297399|NCT00876460|977017|P3|Combination Therapy Phase|Withdrawal by Subject|0
297400|NCT00876460|977018|P2|Combination Therapy Phase|Withdrawal by Subject|1
297401|NCT00876460|977019|P1|Combination Therapy Phase|Withdrawal by Subject|1
297402|NCT00876460|977012|P8|Combination Therapy Phase|Adverse Event|2
297403|NCT00876460|977013|P7|Combination Therapy Phase|Adverse Event|3
297404|NCT00876460|977014|P6|Combination Therapy Phase|Adverse Event|0
297405|NCT00876460|977015|P5|Combination Therapy Phase|Adverse Event|2
297406|NCT00876460|977016|P4|Combination Therapy Phase|Adverse Event|2
297407|NCT00876460|977017|P3|Combination Therapy Phase|Adverse Event|0
297408|NCT00876460|977018|P2|Combination Therapy Phase|Adverse Event|2
297409|NCT00876460|977019|P1|Combination Therapy Phase|Adverse Event|0
297410|NCT00876460|977012|P8|Combination Therapy Phase|Dose limiting toxicity|1
297411|NCT00876460|977013|P7|Combination Therapy Phase|Dose limiting toxicity|2
297412|NCT00876460|977014|P6|Combination Therapy Phase|Dose limiting toxicity|2
297413|NCT00876460|977015|P5|Combination Therapy Phase|Dose limiting toxicity|1
297414|NCT00876460|977016|P4|Combination Therapy Phase|Dose limiting toxicity|1
297415|NCT00876460|977017|P3|Combination Therapy Phase|Dose limiting toxicity|0
297416|NCT00876460|977018|P2|Combination Therapy Phase|Dose limiting toxicity|1
297417|NCT00876460|977019|P1|Combination Therapy Phase|Dose limiting toxicity|0
297418|NCT00876460|977012|P8|Combination Therapy Phase|Progressive disease|1
297419|NCT00876460|977013|P7|Combination Therapy Phase|Progressive disease|1
297420|NCT00876460|977014|P6|Combination Therapy Phase|Progressive disease|1
297421|NCT00876460|977015|P5|Combination Therapy Phase|Progressive disease|3
297422|NCT00876460|977016|P4|Combination Therapy Phase|Progressive disease|3
297423|NCT00876460|977017|P3|Combination Therapy Phase|Progressive disease|3
297424|NCT00876460|977018|P2|Combination Therapy Phase|Progressive disease|3
297425|NCT00876460|977019|P1|Combination Therapy Phase|Progressive disease|2
297426|NCT00876447|977091|P2|Overall Study|Adverse Event|8
297427|NCT00876447|977092|P1|Overall Study|Adverse Event|4
297428|NCT00876447|977091|P2|Overall Study|Lack of Efficacy|3
297429|NCT00876447|977092|P1|Overall Study|Lack of Efficacy|5
297430|NCT00876447|977091|P2|Overall Study|Pregnancy|2
297431|NCT00876447|977092|P1|Overall Study|Pregnancy|4
297432|NCT00876447|977091|P2|Overall Study|Lost to Follow-up|15
297433|NCT00876447|977092|P1|Overall Study|Lost to Follow-up|6
297434|NCT00876447|977091|P2|Overall Study|Personal reasons|28
297435|NCT00876447|977092|P1|Overall Study|Personal reasons|30
297436|NCT00876447|977091|P2|Overall Study|Protocol Violation|3
297437|NCT00876447|977092|P1|Overall Study|Protocol Violation|9
297438|NCT00876447|977091|P2|Overall Study|Site closure|14
297439|NCT00876447|977092|P1|Overall Study|Site closure|19
297440|NCT00876447|977091|P2|Overall Study|Other miscellaneous reasons|8
297441|NCT00876447|977092|P1|Overall Study|Other miscellaneous reasons|3
297442|NCT00876343|977153|P3|Overall Study|Change of residence or other commitments|3
297443|NCT00876343|977154|P2|Overall Study|Change of residence or other commitments|2
297444|NCT00876343|977155|P1|Overall Study|Change of residence or other commitments|2
297445|NCT00876343|977153|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
297446|NCT00876343|977154|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
297447|NCT00876343|977155|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
297448|NCT00876343|977153|P3|Overall Study|Physician Decision|1
297449|NCT00876343|977154|P2|Overall Study|Physician Decision|1
297450|NCT00876343|977155|P1|Overall Study|Physician Decision|0
297451|NCT00876343|977153|P3|Overall Study|Protocol Violation|1
297452|NCT00876343|977154|P2|Overall Study|Protocol Violation|1
297453|NCT00876343|977155|P1|Overall Study|Protocol Violation|4
297454|NCT00876343|977153|P3|Overall Study|Lack of Efficacy|1
297455|NCT00876343|977154|P2|Overall Study|Lack of Efficacy|0
297456|NCT00876343|977155|P1|Overall Study|Lack of Efficacy|0
297457|NCT00876343|977153|P3|Overall Study|Withdrawal by Subject|3
297458|NCT00876343|977154|P2|Overall Study|Withdrawal by Subject|4
297459|NCT00876343|977155|P1|Overall Study|Withdrawal by Subject|4
297460|NCT00876343|977153|P3|Overall Study|Adverse Event|2
297461|NCT00876343|977154|P2|Overall Study|Adverse Event|8
297462|NCT00876343|977155|P1|Overall Study|Adverse Event|7
297463|NCT00876265|977169|P1|Overall Study|Withdrawal by Subject|2
297464|NCT00876265|977169|P1|Overall Study|Lost to Follow-up|6
297465|NCT00876265|977169|P1|Overall Study|Miscellaneous reasons|4
297466|NCT00875979|977177|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
297467|NCT00875979|977178|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
297468|NCT00875979|977177|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
297469|NCT00875979|977178|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
297470|NCT00875979|977177|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
297471|NCT00875979|977178|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
297472|NCT00875979|977177|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
297473|NCT00875979|977178|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
297474|NCT00875979|977177|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
297475|NCT00875979|977178|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
297476|NCT00875979|977177|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
297477|NCT00875979|977178|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
297478|NCT00875979|977177|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
297479|NCT00875979|977178|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
297480|NCT00875979|977177|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
297481|NCT00875979|977178|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
297482|NCT00875979|977177|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
297483|NCT00875979|977178|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
297484|NCT00875810|977201|P1|Overall Study|Device explanted|1
297485|NCT00875810|977201|P1|Overall Study|Patient enroled but not implanted|2
297486|NCT00875810|977201|P1|Overall Study|Lost to Follow-up|39
297487|NCT00875810|977201|P1|Overall Study|Physician Decision|3
297488|NCT00875810|977201|P1|Overall Study|Withdrawal by Subject|1
297489|NCT00875797|977210|P2|Overall Study|Protocol Violation|3
297490|NCT00875797|977211|P1|Overall Study|Protocol Violation|6
297491|NCT00875706|977224|P3|Overall Study|Withdrawal by Subject|0
297492|NCT00875706|977225|P2|Overall Study|Withdrawal by Subject|0
297493|NCT00875706|977226|P1|Overall Study|Withdrawal by Subject|1
297494|NCT00875615|977243|P1|Overall Study|Withdrawal by Subject|1
297495|NCT00875563|977257|P1|Overall Study|Still be eligible for follow-up|7
297496|NCT00875563|977257|P1|Overall Study|No long-term (3-5 year) consent|6
297497|NCT00875563|977257|P1|Overall Study|Withdrawal by Subject|7
297498|NCT00875563|977257|P1|Overall Study|Death|4
297499|NCT00875485|977282|P2|Challenge Dose Epoch|Pregnancy|0
297500|NCT00875485|977283|P1|Challenge Dose Epoch|Pregnancy|1
297501|NCT00875433|977323|P1|Overall Study|Not specified|3
297502|NCT00875433|977323|P1|Overall Study|Withdrawal by Subject|2
297503|NCT00875433|977323|P1|Overall Study|Other Adverse Event|14
297504|NCT00875433|977323|P1|Overall Study|Progressive disease|41
297505|NCT00875420|977353|P5|Overall Study|Withdrawal by Subject|0
297506|NCT00875420|977354|P4|Overall Study|Withdrawal by Subject|0
297507|NCT00875420|977355|P3|Overall Study|Withdrawal by Subject|1
297508|NCT00875420|977356|P2|Overall Study|Withdrawal by Subject|0
297509|NCT00875420|977357|P1|Overall Study|Withdrawal by Subject|0
297510|NCT00875420|977353|P5|Overall Study|Sponsor decision|0
297511|NCT00875420|977354|P4|Overall Study|Sponsor decision|0
297512|NCT00875420|977355|P3|Overall Study|Sponsor decision|0
297513|NCT00875420|977356|P2|Overall Study|Sponsor decision|1
297514|NCT00875420|977357|P1|Overall Study|Sponsor decision|0
297515|NCT00875420|977353|P5|Overall Study|Prohibited medication|0
297516|NCT00875420|977354|P4|Overall Study|Prohibited medication|1
297517|NCT00875420|977355|P3|Overall Study|Prohibited medication|0
297518|NCT00875420|977356|P2|Overall Study|Prohibited medication|0
297519|NCT00875420|977357|P1|Overall Study|Prohibited medication|0
297520|NCT00875420|977353|P5|Overall Study|Personal reason|1
297521|NCT00875420|977354|P4|Overall Study|Personal reason|0
297522|NCT00875420|977355|P3|Overall Study|Personal reason|0
297523|NCT00875420|977356|P2|Overall Study|Personal reason|0
297524|NCT00875420|977357|P1|Overall Study|Personal reason|0
297525|NCT00875420|977353|P5|Overall Study|Lost to Follow-up|0
297526|NCT00875420|977354|P4|Overall Study|Lost to Follow-up|0
297527|NCT00875420|977355|P3|Overall Study|Lost to Follow-up|0
297528|NCT00875420|977356|P2|Overall Study|Lost to Follow-up|0
297529|NCT00875420|977357|P1|Overall Study|Lost to Follow-up|1
297530|NCT00875420|977353|P5|Overall Study|Inability to complete study procedures|1
297531|NCT00875420|977354|P4|Overall Study|Inability to complete study procedures|1
297532|NCT00875420|977355|P3|Overall Study|Inability to complete study procedures|1
297533|NCT00875420|977356|P2|Overall Study|Inability to complete study procedures|0
297534|NCT00875420|977357|P1|Overall Study|Inability to complete study procedures|1
297535|NCT00875420|977353|P5|Overall Study|Adverse Event|0
297536|NCT00875420|977354|P4|Overall Study|Adverse Event|0
297537|NCT00875420|977355|P3|Overall Study|Adverse Event|1
297538|NCT00875420|977356|P2|Overall Study|Adverse Event|1
297539|NCT00875420|977357|P1|Overall Study|Adverse Event|0
297540|NCT00875017|977418|P6|Fourth Intervention|Inability to comply with fasting|1
297541|NCT00875017|977419|P5|Fourth Intervention|Inability to comply with fasting|0
297542|NCT00875017|977420|P4|Fourth Intervention|Inability to comply with fasting|0
297543|NCT00875017|977421|P3|Fourth Intervention|Inability to comply with fasting|0
297544|NCT00875017|977422|P2|Fourth Intervention|Inability to comply with fasting|0
297545|NCT00875017|977423|P1|Fourth Intervention|Inability to comply with fasting|0
297546|NCT00875017|977418|P6|Washout|Withdrawal by Subject|0
297547|NCT00875017|977419|P5|Washout|Withdrawal by Subject|1
297548|NCT00875017|977420|P4|Washout|Withdrawal by Subject|0
297549|NCT00875017|977421|P3|Washout|Withdrawal by Subject|0
297550|NCT00875017|977422|P2|Washout|Withdrawal by Subject|0
297551|NCT00875017|977423|P1|Washout|Withdrawal by Subject|0
297552|NCT00875017|977418|P6|Third Intervention|Adverse Event|0
297553|NCT00875017|977419|P5|Third Intervention|Adverse Event|0
297554|NCT00875017|977420|P4|Third Intervention|Adverse Event|0
297555|NCT00875017|977421|P3|Third Intervention|Adverse Event|1
297556|NCT00875017|977422|P2|Third Intervention|Adverse Event|1
297557|NCT00875017|977423|P1|Third Intervention|Adverse Event|0
297558|NCT00875017|977418|P6|Washout|Problems collecting rectal effluent|0
297559|NCT00875017|977419|P5|Washout|Problems collecting rectal effluent|0
297560|NCT00875017|977420|P4|Washout|Problems collecting rectal effluent|0
297561|NCT00875017|977421|P3|Washout|Problems collecting rectal effluent|0
297562|NCT00875017|977422|P2|Washout|Problems collecting rectal effluent|1
297563|NCT00875017|977423|P1|Washout|Problems collecting rectal effluent|0
297564|NCT00875017|977418|P6|Second Intervention|Adverse Event|0
297565|NCT00875017|977419|P5|Second Intervention|Adverse Event|0
297566|NCT00875017|977420|P4|Second Intervention|Adverse Event|1
297567|NCT00875017|977421|P3|Second Intervention|Adverse Event|0
297568|NCT00875017|977422|P2|Second Intervention|Adverse Event|0
297569|NCT00875017|977423|P1|Second Intervention|Adverse Event|0
297570|NCT00875017|977418|P6|Washout|Problem collecting rectal effluent|0
297571|NCT00875017|977419|P5|Washout|Problem collecting rectal effluent|0
297572|NCT00875017|977420|P4|Washout|Problem collecting rectal effluent|0
297573|NCT00875017|977421|P3|Washout|Problem collecting rectal effluent|1
297574|NCT00875017|977422|P2|Washout|Problem collecting rectal effluent|0
297575|NCT00875017|977423|P1|Washout|Problem collecting rectal effluent|0
297576|NCT00875017|977418|P6|First Intervention|Intolerance to nasogastric tube|0
297577|NCT00875017|977419|P5|First Intervention|Intolerance to nasogastric tube|1
297578|NCT00875017|977420|P4|First Intervention|Intolerance to nasogastric tube|0
297579|NCT00875017|977421|P3|First Intervention|Intolerance to nasogastric tube|0
297580|NCT00875017|977422|P2|First Intervention|Intolerance to nasogastric tube|0
297581|NCT00875017|977423|P1|First Intervention|Intolerance to nasogastric tube|0
297582|NCT00875017|977418|P6|First Intervention|Problems collecting rectal effluent|0
297583|NCT00875017|977419|P5|First Intervention|Problems collecting rectal effluent|0
297584|NCT00875017|977420|P4|First Intervention|Problems collecting rectal effluent|0
297585|NCT00875017|977421|P3|First Intervention|Problems collecting rectal effluent|0
297586|NCT00875017|977422|P2|First Intervention|Problems collecting rectal effluent|0
297587|NCT00875017|977423|P1|First Intervention|Problems collecting rectal effluent|1
297588|NCT00875017|977418|P6|First Intervention|Adverse Event|0
297589|NCT00875017|977419|P5|First Intervention|Adverse Event|0
297590|NCT00875017|977420|P4|First Intervention|Adverse Event|1
297591|NCT00875017|977421|P3|First Intervention|Adverse Event|0
297592|NCT00875017|977422|P2|First Intervention|Adverse Event|0
297593|NCT00875017|977423|P1|First Intervention|Adverse Event|0
297594|NCT00875017|977418|P6|First Intervention|Withdrawal by Subject|0
297595|NCT00875017|977419|P5|First Intervention|Withdrawal by Subject|0
297596|NCT00875017|977420|P4|First Intervention|Withdrawal by Subject|0
297597|NCT00875017|977421|P3|First Intervention|Withdrawal by Subject|1
297598|NCT00875017|977422|P2|First Intervention|Withdrawal by Subject|0
297599|NCT00875017|977423|P1|First Intervention|Withdrawal by Subject|1
297600|NCT00874939|977437|P1|Overall Study|Study terminated|4
297601|NCT00874848|977470|P2|Overall Study|Physician Decision|2
297602|NCT00874848|977471|P1|Overall Study|Physician Decision|0
297603|NCT00874848|977470|P2|Overall Study|Failure to comply with protocol|1
297604|NCT00874848|977471|P1|Overall Study|Failure to comply with protocol|0
297605|NCT00874848|977470|P2|Overall Study|Noncompliance|1
297606|NCT00874848|977471|P1|Overall Study|Noncompliance|1
297607|NCT00874848|977470|P2|Overall Study|Withdrawal by Subject|4
297608|NCT00874848|977471|P1|Overall Study|Withdrawal by Subject|7
297609|NCT00874848|977470|P2|Overall Study|Progressive neoplastic disease|18
297610|NCT00874848|977471|P1|Overall Study|Progressive neoplastic disease|38
297611|NCT00874848|977470|P2|Overall Study|Adverse Event|2
297612|NCT00874848|977471|P1|Overall Study|Adverse Event|13
297613|NCT00874822|977487|P1|Overall Study|excluded by criteria|8
297614|NCT00874770|977495|P4|Overall Study|Subject no Longer Meets Study Criteria|0
297615|NCT00874770|977496|P3|Overall Study|Subject no Longer Meets Study Criteria|0
297616|NCT00874770|977497|P2|Overall Study|Subject no Longer Meets Study Criteria|0
297617|NCT00874770|977498|P1|Overall Study|Subject no Longer Meets Study Criteria|1
297618|NCT00874770|977495|P4|Overall Study|Lost to Follow-up|1
297619|NCT00874770|977496|P3|Overall Study|Lost to Follow-up|0
297620|NCT00874770|977497|P2|Overall Study|Lost to Follow-up|0
297621|NCT00874770|977498|P1|Overall Study|Lost to Follow-up|1
297622|NCT00874770|977495|P4|Overall Study|Adverse Event|2
297623|NCT00874770|977496|P3|Overall Study|Adverse Event|4
297624|NCT00874770|977497|P2|Overall Study|Adverse Event|1
297625|NCT00874770|977498|P1|Overall Study|Adverse Event|1
297626|NCT00874770|977495|P4|Overall Study|Lack of Efficacy|2
297627|NCT00874770|977496|P3|Overall Study|Lack of Efficacy|0
297628|NCT00874770|977497|P2|Overall Study|Lack of Efficacy|0
297629|NCT00874770|977498|P1|Overall Study|Lack of Efficacy|2
297630|NCT00874549|977536|P4|Overall Study|Withdrawal by Subject|1
297631|NCT00874549|977537|P3|Overall Study|Withdrawal by Subject|0
297632|NCT00874549|977538|P2|Overall Study|Withdrawal by Subject|1
297633|NCT00874549|977539|P1|Overall Study|Withdrawal by Subject|0
297634|NCT00874549|977536|P4|Overall Study|Lost to Follow-up|0
297635|NCT00874549|977537|P3|Overall Study|Lost to Follow-up|1
297636|NCT00874549|977538|P2|Overall Study|Lost to Follow-up|0
297637|NCT00874549|977539|P1|Overall Study|Lost to Follow-up|0
297638|NCT00874549|977536|P4|Overall Study|Protocol Violation|1
297639|NCT00874549|977537|P3|Overall Study|Protocol Violation|2
297640|NCT00874549|977538|P2|Overall Study|Protocol Violation|0
297641|NCT00874549|977539|P1|Overall Study|Protocol Violation|1
297642|NCT00874549|977536|P4|Overall Study|Adverse Event|0
297643|NCT00874549|977537|P3|Overall Study|Adverse Event|1
297644|NCT00874549|977538|P2|Overall Study|Adverse Event|0
297645|NCT00874549|977539|P1|Overall Study|Adverse Event|0
297646|NCT00874497|977616|P2|Overall Study|Withdrawal by Subject|4
297647|NCT00874497|977617|P1|Overall Study|Withdrawal by Subject|5
297648|NCT00874497|977616|P2|Overall Study|Physician Decision|1
297649|NCT00874497|977617|P1|Overall Study|Physician Decision|1
297650|NCT00874497|977616|P2|Overall Study|Met Withdrawal Criteria|2
297651|NCT00874497|977617|P1|Overall Study|Met Withdrawal Criteria|4
297652|NCT00874497|977616|P2|Overall Study|Sponsor Discontinued Trial|3
297653|NCT00874497|977617|P1|Overall Study|Sponsor Discontinued Trial|7
297654|NCT00874497|977616|P2|Overall Study|Adverse Event|4
297655|NCT00874497|977617|P1|Overall Study|Adverse Event|9
297656|NCT00874497|977616|P2|Overall Study|Lost to Follow-up|4
297657|NCT00874497|977617|P1|Overall Study|Lost to Follow-up|2
297658|NCT00874276|977657|P2|Overall Study|Withdrawal by Subject|1
297659|NCT00874276|977658|P1|Overall Study|Withdrawal by Subject|1
297660|NCT00874120|977678|P2|Second Intervention|Protocol Violation|0
297661|NCT00874120|977679|P1|Second Intervention|Protocol Violation|1
297662|NCT00874120|977678|P2|Second Intervention|Withdrawal by Subject|0
297663|NCT00874120|977679|P1|Second Intervention|Withdrawal by Subject|1
297664|NCT00874120|977678|P2|First Intervention|positive drug test|0
297665|NCT00874120|977679|P1|First Intervention|positive drug test|1
297666|NCT00874120|977678|P2|First Intervention|Protocol Violation|0
297667|NCT00874120|977679|P1|First Intervention|Protocol Violation|3
297668|NCT00874120|977678|P2|First Intervention|Lost to Follow-up|1
297669|NCT00874120|977679|P1|First Intervention|Lost to Follow-up|0
297670|NCT00874120|977678|P2|First Intervention|Withdrawal by Subject|0
297671|NCT00874120|977679|P1|First Intervention|Withdrawal by Subject|2
297672|NCT00874120|977678|P2|First Intervention|Adverse Event|1
297673|NCT00874120|977679|P1|First Intervention|Adverse Event|0
297674|NCT00874029|977692|P1|Overall Study|Lost to Follow-up|5
297675|NCT00874029|977692|P1|Overall Study|Adverse Event|1
297676|NCT00874029|977692|P1|Overall Study|Physician Decision|1
297677|NCT00874029|977692|P1|Overall Study|Pregnancy|4
297678|NCT00874029|977692|P1|Overall Study|Withdrawal by Subject|10
297679|NCT00873912|977708|P2|Overall Study|Lost to Follow-up|0
297680|NCT00873912|977709|P1|Overall Study|Lost to Follow-up|2
297681|NCT00873912|977708|P2|Overall Study|Withdrawal by Subject|0
297682|NCT00873912|977709|P1|Overall Study|Withdrawal by Subject|1
297683|NCT00873860|977748|P4|Overall Study|Unspecified|0
297684|NCT00873860|977749|P3|Overall Study|Unspecified|1
297685|NCT00873860|977750|P2|Overall Study|Unspecified|0
297686|NCT00873860|977751|P1|Overall Study|Unspecified|1
297687|NCT00873860|977748|P4|Overall Study|Death|0
297688|NCT00873860|977749|P3|Overall Study|Death|0
297689|NCT00873860|977750|P2|Overall Study|Death|0
297690|NCT00873860|977751|P1|Overall Study|Death|1
297691|NCT00873860|977748|P4|Overall Study|Withdrawal by Subject|0
297692|NCT00873860|977749|P3|Overall Study|Withdrawal by Subject|2
297693|NCT00873860|977750|P2|Overall Study|Withdrawal by Subject|0
297694|NCT00873860|977751|P1|Overall Study|Withdrawal by Subject|1
297695|NCT00873860|977748|P4|Overall Study|Lost to Follow-up|1
297696|NCT00873860|977749|P3|Overall Study|Lost to Follow-up|0
297697|NCT00873860|977750|P2|Overall Study|Lost to Follow-up|0
297698|NCT00873860|977751|P1|Overall Study|Lost to Follow-up|1
297699|NCT00873730|977839|P2|Overall Study|Sponsor decision|0
297700|NCT00873730|977840|P1|Overall Study|Sponsor decision|1
297701|NCT00873730|977839|P2|Overall Study|Withdrawal by Subject|1
297702|NCT00873730|977840|P1|Overall Study|Withdrawal by Subject|0
297703|NCT00873730|977839|P2|Overall Study|Adverse Event|2
297704|NCT00873730|977840|P1|Overall Study|Adverse Event|0
297705|NCT00873730|977839|P2|Overall Study|Protocol Deviation|2
297706|NCT00873730|977840|P1|Overall Study|Protocol Deviation|5
297707|NCT00873119|977889|P2|Overall Study|Not treated|0
297708|NCT00873119|977890|P1|Overall Study|Not treated|2
297709|NCT00873119|977889|P2|Overall Study|Other|5
297710|NCT00873119|977890|P1|Overall Study|Other|2
297711|NCT00873119|977889|P2|Overall Study|Death|1
297712|NCT00873119|977890|P1|Overall Study|Death|2
297713|NCT00873119|977889|P2|Overall Study|Progressive disease|18
297714|NCT00873119|977890|P1|Overall Study|Progressive disease|26
297715|NCT00873119|977889|P2|Overall Study|Adverse Event|0
297716|NCT00873119|977890|P1|Overall Study|Adverse Event|8
297717|NCT00873119|977889|P2|Overall Study|Patient request|2
297718|NCT00873119|977890|P1|Overall Study|Patient request|4
297719|NCT00873093|977911|P5|Overall Study|Ineligible|0
297720|NCT00873093|977912|P4|Overall Study|Ineligible|1
297721|NCT00873093|977913|P3|Overall Study|Ineligible|0
297722|NCT00873093|977914|P2|Overall Study|Ineligible|1
297723|NCT00873093|977915|P1|Overall Study|Ineligible|0
297724|NCT00873093|977911|P5|Overall Study|Withdrawal by Subject|0
297725|NCT00873093|977912|P4|Overall Study|Withdrawal by Subject|0
297726|NCT00873093|977913|P3|Overall Study|Withdrawal by Subject|4
297727|NCT00873093|977914|P2|Overall Study|Withdrawal by Subject|4
297728|NCT00873093|977915|P1|Overall Study|Withdrawal by Subject|1
297729|NCT00873093|977911|P5|Overall Study|Physician Decision|2
297730|NCT00873093|977912|P4|Overall Study|Physician Decision|10
297731|NCT00873093|977913|P3|Overall Study|Physician Decision|10
297732|NCT00873093|977914|P2|Overall Study|Physician Decision|17
297733|NCT00873093|977915|P1|Overall Study|Physician Decision|0
297734|NCT00873093|977911|P5|Overall Study|Death|0
297735|NCT00873093|977912|P4|Overall Study|Death|0
297736|NCT00873093|977913|P3|Overall Study|Death|2
297737|NCT00873093|977914|P2|Overall Study|Death|3
297738|NCT00873093|977915|P1|Overall Study|Death|0
297739|NCT00873093|977911|P5|Overall Study|Adverse Event|0
297740|NCT00873093|977912|P4|Overall Study|Adverse Event|0
297741|NCT00873093|977913|P3|Overall Study|Adverse Event|0
297742|NCT00873093|977914|P2|Overall Study|Adverse Event|2
297743|NCT00873093|977915|P1|Overall Study|Adverse Event|0
297744|NCT00873041|977972|P3|Extension Study|Administrative reasons|1
297745|NCT00873041|977973|P2|Extension Study|Administrative reasons|0
297746|NCT00873041|977974|P1|Extension Study|Administrative reasons|0
297747|NCT00873041|977972|P3|Extension Study|Adverse Event|1
297748|NCT00873041|977973|P2|Extension Study|Adverse Event|0
297749|NCT00873041|977974|P1|Extension Study|Adverse Event|1
297750|NCT00873041|977972|P3|Core Study|Protocol deviation|1
297751|NCT00873041|977973|P2|Core Study|Protocol deviation|0
297752|NCT00873041|977974|P1|Core Study|Protocol deviation|1
297753|NCT00873041|977972|P3|Core Study|Abnormal laboratory value|1
297754|NCT00873041|977973|P2|Core Study|Abnormal laboratory value|0
297755|NCT00873041|977974|P1|Core Study|Abnormal laboratory value|0
297756|NCT00873041|977972|P3|Core Study|Lost to Follow-up|0
297757|NCT00873041|977973|P2|Core Study|Lost to Follow-up|1
297758|NCT00873041|977974|P1|Core Study|Lost to Follow-up|3
297759|NCT00873041|977972|P3|Core Study|Withdrawal by Subject|2
297760|NCT00873041|977973|P2|Core Study|Withdrawal by Subject|2
297761|NCT00873041|977974|P1|Core Study|Withdrawal by Subject|1
297762|NCT00873041|977972|P3|Core Study|Adverse Event|1
297763|NCT00873041|977973|P2|Core Study|Adverse Event|3
297764|NCT00873041|977974|P1|Core Study|Adverse Event|2
297765|NCT00873015|978032|P4|Overall Study|Withdrawal by Subject|0
297766|NCT00873015|978033|P3|Overall Study|Withdrawal by Subject|0
297767|NCT00873015|978034|P2|Overall Study|Withdrawal by Subject|1
297768|NCT00873015|978035|P1|Overall Study|Withdrawal by Subject|0
297769|NCT00872989|978044|P2|Overall Study|Not protocol specified|8
297770|NCT00872989|978045|P1|Overall Study|Not protocol specified|3
297771|NCT00872989|978044|P2|Overall Study|Progression/relapse|35
297772|NCT00872989|978045|P1|Overall Study|Progression/relapse|47
297773|NCT00872989|978044|P2|Overall Study|Withdrawal by Subject|5
297774|NCT00872989|978045|P1|Overall Study|Withdrawal by Subject|8
297775|NCT00872989|978044|P2|Overall Study|Adverse Event|15
297776|NCT00872989|978045|P1|Overall Study|Adverse Event|7
297777|NCT00872898|978064|P2|Part Two - Double Blind|Other reasons|0
297778|NCT00872898|978065|P1|Part Two - Double Blind|Other reasons|2
297779|NCT00872898|978064|P2|Part Two - Double Blind|Lost to Follow-up|2
297780|NCT00872898|978065|P1|Part Two - Double Blind|Lost to Follow-up|0
297781|NCT00872898|978064|P2|Part Two - Double Blind|Withdrawal by Subject|1
297782|NCT00872898|978065|P1|Part Two - Double Blind|Withdrawal by Subject|3
297783|NCT00872898|978064|P2|Part Two - Double Blind|Protocol Violation|0
297784|NCT00872898|978065|P1|Part Two - Double Blind|Protocol Violation|1
297785|NCT00872898|978064|P2|Part Two - Double Blind|Lack of Efficacy|0
297786|NCT00872898|978065|P1|Part Two - Double Blind|Lack of Efficacy|1
297787|NCT00872898|978064|P2|Part Two - Double Blind|Adverse Event|3
297788|NCT00872898|978065|P1|Part Two - Double Blind|Adverse Event|4
297789|NCT00872599|978139|P2|Second Washout Period|Adverse Event|1
297790|NCT00872599|978140|P1|Second Washout Period|Adverse Event|1
297791|NCT00872521|978160|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
297792|NCT00872521|978161|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
297793|NCT00872521|978162|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
297794|NCT00872521|978160|P3|Completed 3-month Follow up|Physician Decision|0
297795|NCT00872521|978161|P2|Completed 3-month Follow up|Physician Decision|1
297796|NCT00872521|978162|P1|Completed 3-month Follow up|Physician Decision|0
297797|NCT00872521|978160|P3|Completed 3-month Follow up|Not specified|0
297798|NCT00872521|978161|P2|Completed 3-month Follow up|Not specified|2
297799|NCT00872521|978162|P1|Completed 3-month Follow up|Not specified|0
297800|NCT00872521|978160|P3|Primary Endpoint Analysis|Patient response missing|1
297801|NCT00872521|978161|P2|Primary Endpoint Analysis|Patient response missing|0
297802|NCT00872521|978162|P1|Primary Endpoint Analysis|Patient response missing|0
297803|NCT00872521|978160|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
297804|NCT00872521|978161|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
297805|NCT00872521|978162|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
297806|NCT00872521|978160|P3|Primary Endpoint Analysis|Patient choice|0
297807|NCT00872521|978161|P2|Primary Endpoint Analysis|Patient choice|1
297808|NCT00872521|978162|P1|Primary Endpoint Analysis|Patient choice|0
297809|NCT00872521|978160|P3|Primary Endpoint Analysis|Not specified|0
297810|NCT00872521|978161|P2|Primary Endpoint Analysis|Not specified|2
297811|NCT00872521|978162|P1|Primary Endpoint Analysis|Not specified|1
297812|NCT00872521|978160|P3|Completed PAD Induction|Death|0
297813|NCT00872521|978161|P2|Completed PAD Induction|Death|1
297814|NCT00872521|978162|P1|Completed PAD Induction|Death|1
297815|NCT00872521|978160|P3|Completed PAD Induction|Adverse Event|0
297816|NCT00872521|978161|P2|Completed PAD Induction|Adverse Event|0
297817|NCT00872521|978162|P1|Completed PAD Induction|Adverse Event|4
297818|NCT00872521|978160|P3|Completed PAD Induction|Disease progression|0
297819|NCT00872521|978161|P2|Completed PAD Induction|Disease progression|2
297820|NCT00872521|978162|P1|Completed PAD Induction|Disease progression|0
297821|NCT00872521|978160|P3|Completed PAD Induction|Patient choice|0
297822|NCT00872521|978161|P2|Completed PAD Induction|Patient choice|1
297823|NCT00872521|978162|P1|Completed PAD Induction|Patient choice|0
297824|NCT00872170|978233|P2|Overall Study|Adverse Event|0
297825|NCT00872170|978234|P1|Overall Study|Adverse Event|1
297826|NCT00872001|978264|P2|Overall Study|Administrative|15
297827|NCT00872001|978265|P1|Overall Study|Administrative|23
297828|NCT00872001|978264|P2|Overall Study|Did Not Meet Protocol Eligibility|36
297829|NCT00872001|978265|P1|Overall Study|Did Not Meet Protocol Eligibility|38
297830|NCT00872001|978264|P2|Overall Study|Protocol Violation|8
297831|NCT00872001|978265|P1|Overall Study|Protocol Violation|5
297832|NCT00872001|978264|P2|Overall Study|Withdrawal by Subject|30
297833|NCT00872001|978265|P1|Overall Study|Withdrawal by Subject|18
297834|NCT00872001|978264|P2|Overall Study|Lost to Follow-up|12
297835|NCT00872001|978265|P1|Overall Study|Lost to Follow-up|13
297836|NCT00872001|978264|P2|Overall Study|Protocol Defined Clinical Event|7
297837|NCT00872001|978265|P1|Overall Study|Protocol Defined Clinical Event|5
297838|NCT00872001|978264|P2|Overall Study|Adverse Event|23
297839|NCT00872001|978265|P1|Overall Study|Adverse Event|34
297840|NCT00871975|978273|P1|Overall Study|Motion artifact, tracing uninterpretable|5
297841|NCT00871975|978273|P1|Overall Study|Patient unable to void/insufficient vol|13
297842|NCT00871975|978273|P1|Overall Study|Catheters could not be inserted|1
297843|NCT00871975|978273|P1|Overall Study|Technical difficulty w155-1ith equipment|3
297844|NCT00871871|978279|P4|Part II|Protocol Violation|1
297845|NCT00871871|978280|P3|Part II|Protocol Violation|0
297846|NCT00871871|978281|P2|Part II|Protocol Violation|0
297847|NCT00871871|978282|P1|Part II|Protocol Violation|0
297848|NCT00871871|978279|P4|Part II|Adverse Event|2
297849|NCT00871871|978280|P3|Part II|Adverse Event|1
297850|NCT00871871|978281|P2|Part II|Adverse Event|0
297851|NCT00871871|978282|P1|Part II|Adverse Event|0
297852|NCT00871871|978279|P4|Part II|Withdrawal by Subject|1
297853|NCT00871871|978280|P3|Part II|Withdrawal by Subject|2
297854|NCT00871871|978281|P2|Part II|Withdrawal by Subject|0
297855|NCT00871871|978282|P1|Part II|Withdrawal by Subject|0
297856|NCT00871871|978279|P4|Part II|Lack of Efficacy|0
297857|NCT00871871|978280|P3|Part II|Lack of Efficacy|1
297858|NCT00871871|978281|P2|Part II|Lack of Efficacy|0
297859|NCT00871871|978282|P1|Part II|Lack of Efficacy|0
297860|NCT00871871|978279|P4|Part I|Laboratory abnormality|0
297861|NCT00871871|978280|P3|Part I|Laboratory abnormality|0
297862|NCT00871871|978281|P2|Part I|Laboratory abnormality|1
297863|NCT00871871|978282|P1|Part I|Laboratory abnormality|0
297864|NCT00871871|978279|P4|Part I|Withdrawal by Subject|0
297865|NCT00871871|978280|P3|Part I|Withdrawal by Subject|0
297866|NCT00871871|978281|P2|Part I|Withdrawal by Subject|0
297867|NCT00871871|978282|P1|Part I|Withdrawal by Subject|3
297868|NCT00871871|978279|P4|Part I|Adverse Event|0
297869|NCT00871871|978280|P3|Part I|Adverse Event|0
297870|NCT00871871|978281|P2|Part I|Adverse Event|2
297871|NCT00871871|978282|P1|Part I|Adverse Event|0
297872|NCT00871780|978306|P1|Overall Study|Physician Decision|1
297873|NCT00871780|978306|P1|Overall Study|Death|1
297874|NCT00871780|978306|P1|Overall Study|Voluntary Discontinuation|4
297875|NCT00871780|978306|P1|Overall Study|Adverse Event|6
297876|NCT00871780|978306|P1|Overall Study|Withdrawal by Subject|9
297877|NCT00871780|978306|P1|Overall Study|Enrolled But Not Treated|6
297878|NCT00871741|978326|P2|Overall Study|Premature study termination|7
297879|NCT00871741|978327|P1|Overall Study|Premature study termination|9
297880|NCT00871728|978341|P1|Overall Study|Withdrawal of Informed Consent|5
297881|NCT00871728|978341|P1|Overall Study|Participant Non-compliance|1
297882|NCT00871728|978341|P1|Overall Study|Failed to Visit Hospital|4
297883|NCT00871728|978341|P1|Overall Study|Lost to Follow-up|2
297884|NCT00871728|978341|P1|Overall Study|Protocol Violation|7
297885|NCT00871728|978341|P1|Overall Study|Adverse Event|1
297886|NCT00871715|978354|P3|Overall Study|Lost to Follow-up|9
297887|NCT00871715|978355|P2|Overall Study|Lost to Follow-up|6
297888|NCT00871715|978356|P1|Overall Study|Lost to Follow-up|3
297889|NCT00871715|978354|P3|Overall Study|Physician Decision|2
297890|NCT00871715|978355|P2|Overall Study|Physician Decision|0
297891|NCT00871715|978356|P1|Overall Study|Physician Decision|6
297892|NCT00871715|978354|P3|Overall Study|Withdrawal by Subject|15
297893|NCT00871715|978355|P2|Overall Study|Withdrawal by Subject|10
297894|NCT00871715|978356|P1|Overall Study|Withdrawal by Subject|6
297895|NCT00871494|978394|P1|Overall Study|Lost to Follow-up|1
297896|NCT00871494|978394|P1|Overall Study|Adverse Event|4
297897|NCT00871494|978394|P1|Overall Study|Lack of Efficacy|4
297898|NCT00871494|978394|P1|Overall Study|Protocol Violation|5
297899|NCT00871429|978401|P1|Overall Study|Questionnaire not completed|1
297900|NCT00871429|978401|P1|Overall Study|Withdrawal by Subject|17
297901|NCT00871429|978401|P1|Overall Study|Lost to Follow-up|6
297902|NCT00871403|978412|P3|Monotherapy Treatment Phase|Adverse Event|0
297903|NCT00871403|978413|P2|Monotherapy Treatment Phase|Adverse Event|4
297904|NCT00871403|978414|P1|Monotherapy Treatment Phase|Adverse Event|0
297905|NCT00871403|978412|P3|Monotherapy Treatment Phase|Disease Progression|1
297906|NCT00871403|978413|P2|Monotherapy Treatment Phase|Disease Progression|9
297907|NCT00871403|978414|P1|Monotherapy Treatment Phase|Disease Progression|0
297908|NCT00871403|978412|P3|Combination Treatment Phase|Physician Decision|3
297909|NCT00871403|978413|P2|Combination Treatment Phase|Physician Decision|1
297910|NCT00871403|978414|P1|Combination Treatment Phase|Physician Decision|0
297911|NCT00871403|978412|P3|Combination Treatment Phase|Withdrawal by Subject|1
297912|NCT00871403|978413|P2|Combination Treatment Phase|Withdrawal by Subject|3
297913|NCT00871403|978414|P1|Combination Treatment Phase|Withdrawal by Subject|0
297914|NCT00871403|978412|P3|Combination Treatment Phase|Disease Progression|5
297915|NCT00871403|978413|P2|Combination Treatment Phase|Disease Progression|8
297916|NCT00871403|978414|P1|Combination Treatment Phase|Disease Progression|0
297917|NCT00871403|978412|P3|Combination Treatment Phase|Adverse Event|2
297918|NCT00871403|978413|P2|Combination Treatment Phase|Adverse Event|17
297919|NCT00871403|978414|P1|Combination Treatment Phase|Adverse Event|0
297920|NCT00871403|978412|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
297921|NCT00871403|978413|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
297922|NCT00871403|978414|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
297923|NCT00871403|978412|P3|Combination Treatment Phase|Randomized but Not Treated|1
297924|NCT00871403|978413|P2|Combination Treatment Phase|Randomized but Not Treated|1
297925|NCT00871403|978414|P1|Combination Treatment Phase|Randomized but Not Treated|1
297926|NCT00871377|978427|P6|Third Intervention (10 Weeks)|Death|0
297927|NCT00871377|978428|P5|Third Intervention (10 Weeks)|Death|0
297928|NCT00871377|978429|P4|Third Intervention (10 Weeks)|Death|1
297929|NCT00871377|978430|P3|Third Intervention (10 Weeks)|Death|0
297930|NCT00871377|978431|P2|Third Intervention (10 Weeks)|Death|0
297931|NCT00871377|978432|P1|Third Intervention (10 Weeks)|Death|0
297932|NCT00871377|978427|P6|Washout (6 Weeks)|Withdrawal by Subject|1
297933|NCT00871377|978428|P5|Washout (6 Weeks)|Withdrawal by Subject|0
297934|NCT00871377|978429|P4|Washout (6 Weeks)|Withdrawal by Subject|0
297935|NCT00871377|978430|P3|Washout (6 Weeks)|Withdrawal by Subject|0
297936|NCT00871377|978431|P2|Washout (6 Weeks)|Withdrawal by Subject|0
297937|NCT00871377|978432|P1|Washout (6 Weeks)|Withdrawal by Subject|0
297938|NCT00871377|978427|P6|Washout (6 Weeks)|Withdrawal by Subject|0
297939|NCT00871377|978428|P5|Washout (6 Weeks)|Withdrawal by Subject|0
297940|NCT00871377|978429|P4|Washout (6 Weeks)|Withdrawal by Subject|0
297941|NCT00871377|978430|P3|Washout (6 Weeks)|Withdrawal by Subject|0
297942|NCT00871377|978431|P2|Washout (6 Weeks)|Withdrawal by Subject|0
297943|NCT00871377|978432|P1|Washout (6 Weeks)|Withdrawal by Subject|1
297944|NCT00871377|978427|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
297945|NCT00871377|978428|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
297946|NCT00871377|978429|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
297947|NCT00871377|978430|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
297948|NCT00871377|978431|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
297949|NCT00871377|978432|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
297950|NCT00871377|978427|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
297951|NCT00871377|978428|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
297952|NCT00871377|978429|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
297953|NCT00871377|978430|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
297954|NCT00871377|978431|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
297955|NCT00871377|978432|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
297956|NCT00871351|978443|P3|Overall Study|Adverse Event|0
297957|NCT00871351|978444|P2|Overall Study|Adverse Event|1
297958|NCT00871351|978445|P1|Overall Study|Adverse Event|3
297959|NCT00871351|978443|P3|Overall Study|Withdrawal by Subject|0
297960|NCT00871351|978444|P2|Overall Study|Withdrawal by Subject|0
297961|NCT00871351|978445|P1|Overall Study|Withdrawal by Subject|1
297962|NCT00871338|978467|P2|Prior to Booster|Lost to Follow-up|0
297963|NCT00871338|978468|P1|Prior to Booster|Lost to Follow-up|1
297964|NCT00871338|978467|P2|Prior to Booster|Withdrawal by Subject|3
297965|NCT00871338|978468|P1|Prior to Booster|Withdrawal by Subject|1
297966|NCT00871234|978557|P1|Overall Study|Lost to Follow-up|3
297967|NCT00871234|978557|P1|Overall Study|Adverse Event|2
297968|NCT00871169|978561|P1|Overall Study|Patient did not receive study treatment|2
297969|NCT00871169|978561|P1|Overall Study|Protocol Violation|1
297970|NCT00871117|978589|P2|Overall Study|Lost to Follow-up|10
297971|NCT00871117|978590|P1|Overall Study|Lost to Follow-up|5
297972|NCT00871000|978622|P2|Overall Study|Withdrawal by Subject|0
297973|NCT00871000|978623|P1|Overall Study|Withdrawal by Subject|1
297974|NCT00870740|978677|P6|Overall Study|Not Specified|5
297975|NCT00870740|978678|P5|Overall Study|Not Specified|3
297976|NCT00870740|978679|P4|Overall Study|Not Specified|4
297977|NCT00870740|978680|P3|Overall Study|Not Specified|2
297978|NCT00870740|978681|P2|Overall Study|Not Specified|5
297979|NCT00870740|978682|P1|Overall Study|Not Specified|2
297980|NCT00870740|978677|P6|Overall Study|Death|0
297981|NCT00870740|978678|P5|Overall Study|Death|1
297982|NCT00870740|978679|P4|Overall Study|Death|0
297983|NCT00870740|978680|P3|Overall Study|Death|0
297984|NCT00870740|978681|P2|Overall Study|Death|0
297985|NCT00870740|978682|P1|Overall Study|Death|0
297986|NCT00870740|978677|P6|Overall Study|Subject Non-compliance|1
297987|NCT00870740|978678|P5|Overall Study|Subject Non-compliance|0
297988|NCT00870740|978679|P4|Overall Study|Subject Non-compliance|0
297989|NCT00870740|978680|P3|Overall Study|Subject Non-compliance|0
297990|NCT00870740|978681|P2|Overall Study|Subject Non-compliance|0
297991|NCT00870740|978682|P1|Overall Study|Subject Non-compliance|0
297992|NCT00870740|978677|P6|Overall Study|Investigator Decision|0
297993|NCT00870740|978678|P5|Overall Study|Investigator Decision|0
297994|NCT00870740|978679|P4|Overall Study|Investigator Decision|0
297995|NCT00870740|978680|P3|Overall Study|Investigator Decision|1
297996|NCT00870740|978681|P2|Overall Study|Investigator Decision|0
297997|NCT00870740|978682|P1|Overall Study|Investigator Decision|2
297998|NCT00870740|978677|P6|Overall Study|Consent Withdrawn|5
297999|NCT00870740|978678|P5|Overall Study|Consent Withdrawn|6
298000|NCT00870740|978679|P4|Overall Study|Consent Withdrawn|6
298001|NCT00870740|978680|P3|Overall Study|Consent Withdrawn|4
298002|NCT00870740|978681|P2|Overall Study|Consent Withdrawn|3
298003|NCT00870740|978682|P1|Overall Study|Consent Withdrawn|6
298004|NCT00870740|978677|P6|Overall Study|Adverse Event|6
298005|NCT00870740|978678|P5|Overall Study|Adverse Event|1
298006|NCT00870740|978679|P4|Overall Study|Adverse Event|2
298007|NCT00870740|978680|P3|Overall Study|Adverse Event|3
298008|NCT00870740|978681|P2|Overall Study|Adverse Event|1
298009|NCT00870740|978682|P1|Overall Study|Adverse Event|2
298010|NCT00870688|978756|P1|Overall Study|Granules in the Stools|1
298011|NCT00870688|978756|P1|Overall Study|Death, Unrelated|1
298012|NCT00870688|978756|P1|Overall Study|Lost to Follow-up|2
298013|NCT00870584|978761|P2|Overall Study|Protocol Deviation|2
298014|NCT00870584|978762|P1|Overall Study|Protocol Deviation|2
298015|NCT00870584|978761|P2|Overall Study|Lost to Follow-up|1
298016|NCT00870584|978762|P1|Overall Study|Lost to Follow-up|5
298017|NCT00870584|978761|P2|Overall Study|Withdrawal by Subject|7
298018|NCT00870584|978762|P1|Overall Study|Withdrawal by Subject|6
298019|NCT00870584|978761|P2|Overall Study|Adverse Event|3
298020|NCT00870584|978762|P1|Overall Study|Adverse Event|3
298021|NCT00870194|978873|P2|Overall Study|Subject Decision|2
298022|NCT00870194|978874|P1|Overall Study|Subject Decision|7
298023|NCT00870194|978873|P2|Overall Study|Entry Criteria Not Met|2
298024|NCT00870194|978874|P1|Overall Study|Entry Criteria Not Met|1
298025|NCT00870194|978873|P2|Overall Study|Protocol Violation|3
298026|NCT00870194|978874|P1|Overall Study|Protocol Violation|3
298027|NCT00870194|978873|P2|Overall Study|Physician Decision|1
298028|NCT00870194|978874|P1|Overall Study|Physician Decision|3
298029|NCT00870194|978873|P2|Overall Study|Lost to Follow-up|0
298030|NCT00870194|978874|P1|Overall Study|Lost to Follow-up|2
298031|NCT00870194|978873|P2|Overall Study|Lack of Efficacy|1
298032|NCT00870194|978874|P1|Overall Study|Lack of Efficacy|0
298033|NCT00870194|978873|P2|Overall Study|Adverse Event|5
298034|NCT00870194|978874|P1|Overall Study|Adverse Event|10
298035|NCT00870103|978912|P1|Overall Study|Lost to Follow-up|2
298036|NCT00870103|978912|P1|Overall Study|Physician Decision|2
298037|NCT00869999|978917|P1|Overall Study|removed prior to starting therapy|1
298038|NCT00869999|978917|P1|Overall Study|Withdrawal by Subject|1
298039|NCT00869960|978923|P1|Overall Study|Lost to Follow-up|2
298040|NCT00869778|978972|P3|Overall Study|Unblinding|0
298041|NCT00869778|978973|P2|Overall Study|Unblinding|0
298042|NCT00869778|978974|P1|Overall Study|Unblinding|1
298043|NCT00869778|978972|P3|Overall Study|Protocol Violation|5
298044|NCT00869778|978973|P2|Overall Study|Protocol Violation|3
298045|NCT00869778|978974|P1|Overall Study|Protocol Violation|5
298046|NCT00869778|978972|P3|Overall Study|Pregnancy|0
298047|NCT00869778|978973|P2|Overall Study|Pregnancy|0
298048|NCT00869778|978974|P1|Overall Study|Pregnancy|1
298049|NCT00869778|978972|P3|Overall Study|Withdrawal by Subject|5
298050|NCT00869778|978973|P2|Overall Study|Withdrawal by Subject|4
298051|NCT00869778|978974|P1|Overall Study|Withdrawal by Subject|3
298052|NCT00869778|978972|P3|Overall Study|Adverse Event|0
298053|NCT00869778|978973|P2|Overall Study|Adverse Event|0
298054|NCT00869778|978974|P1|Overall Study|Adverse Event|2
298055|NCT00869557|979049|P2|Extension Phase|Withdrew Consent|0
298056|NCT00869557|979050|P1|Extension Phase|Withdrew Consent|2
298057|NCT00869557|979049|P2|Extension Phase|Investigator's Discretion|0
298058|NCT00869557|979050|P1|Extension Phase|Investigator's Discretion|2
298059|NCT00869557|979049|P2|Extension Phase|Lost to Follow-up|1
298060|NCT00869557|979050|P1|Extension Phase|Lost to Follow-up|3
298061|NCT00869557|979049|P2|Extension Phase|Lack of Efficacy|0
298062|NCT00869557|979050|P1|Extension Phase|Lack of Efficacy|1
298063|NCT00869557|979049|P2|Extension Phase|Adverse Event|2
298064|NCT00869557|979050|P1|Extension Phase|Adverse Event|2
298065|NCT00869557|979049|P2|Randomized Phase|Withdrew Consent|1
298066|NCT00869557|979050|P1|Randomized Phase|Withdrew Consent|0
298067|NCT00869557|979049|P2|Randomized Phase|Investigator's Discretion|0
298068|NCT00869557|979050|P1|Randomized Phase|Investigator's Discretion|1
298069|NCT00869557|979049|P2|Randomized Phase|Lost to Follow-up|1
298070|NCT00869557|979050|P1|Randomized Phase|Lost to Follow-up|2
298071|NCT00869518|979069|P2|Overall Study|Lost to Follow-up|1
298072|NCT00869518|979070|P1|Overall Study|Lost to Follow-up|1
298073|NCT00869401|979085|P5|Overall Study|Withdrawal by Subject|3
298074|NCT00869401|979086|P4|Overall Study|Withdrawal by Subject|5
298075|NCT00869401|979087|P3|Overall Study|Withdrawal by Subject|0
298076|NCT00869401|979088|P2|Overall Study|Withdrawal by Subject|0
298077|NCT00869401|979089|P1|Overall Study|Withdrawal by Subject|0
298078|NCT00869362|979118|P2|Overall Study|Lost to Follow-up|3
298079|NCT00869362|979119|P1|Overall Study|Lost to Follow-up|1
298080|NCT00869362|979118|P2|Overall Study|Death|2
298081|NCT00869362|979119|P1|Overall Study|Death|0
298082|NCT00869323|979140|P1|Maintenance Therapy|concurrent illness|1
298083|NCT00869258|979148|P1|Overall Study|Physician Decision|1
298084|NCT00869128|979182|P2|Overall Study|lack of Compliance|6
298085|NCT00869128|979183|P1|Overall Study|lack of Compliance|6
298086|NCT00869089|979187|P1|Overall Study|Screen Fail|1
298087|NCT00869089|979187|P1|Overall Study|Withdrawal by Subject|1
298088|NCT00869089|979187|P1|Overall Study|Lost to Follow-up|1
298089|NCT00869050|979191|P1|Overall Study|Screen Failure|3
298090|NCT00868998|979196|P1|Overall Study|Death|1
298091|NCT00868998|979196|P1|Overall Study|Progression of disease|2
298092|NCT00868998|979196|P1|Overall Study|Withdrawal by Subject|1
298093|NCT00868998|979196|P1|Overall Study|Screen Failure|1
298094|NCT00868790|979207|P14|Post-study|Excluded Medication|0
298095|NCT00868790|979208|P13|Post-study|Excluded Medication|0
298096|NCT00868790|979209|P12|Post-study|Excluded Medication|0
298097|NCT00868790|979210|P11|Post-study|Excluded Medication|0
298098|NCT00868790|979211|P10|Post-study|Excluded Medication|1
298099|NCT00868790|979212|P9|Post-study|Excluded Medication|0
298100|NCT00868790|979213|P8|Post-study|Excluded Medication|2
298101|NCT00868790|979214|P7|Post-study|Excluded Medication|0
298102|NCT00868790|979215|P6|Post-study|Excluded Medication|0
298103|NCT00868790|979216|P5|Post-study|Excluded Medication|0
298104|NCT00868790|979217|P4|Post-study|Excluded Medication|0
298105|NCT00868790|979218|P3|Post-study|Excluded Medication|0
298106|NCT00868790|979219|P2|Post-study|Excluded Medication|0
298107|NCT00868790|979220|P1|Post-study|Excluded Medication|0
298108|NCT00868790|979207|P14|Post-study|Withdrawal by Subject|0
298109|NCT00868790|979208|P13|Post-study|Withdrawal by Subject|0
298110|NCT00868790|979209|P12|Post-study|Withdrawal by Subject|0
298111|NCT00868790|979210|P11|Post-study|Withdrawal by Subject|0
298112|NCT00868790|979211|P10|Post-study|Withdrawal by Subject|0
298113|NCT00868790|979212|P9|Post-study|Withdrawal by Subject|0
298114|NCT00868790|979213|P8|Post-study|Withdrawal by Subject|0
298115|NCT00868790|979214|P7|Post-study|Withdrawal by Subject|0
298116|NCT00868790|979215|P6|Post-study|Withdrawal by Subject|0
298117|NCT00868790|979216|P5|Post-study|Withdrawal by Subject|1
298118|NCT00868790|979217|P4|Post-study|Withdrawal by Subject|0
298119|NCT00868790|979218|P3|Post-study|Withdrawal by Subject|0
298120|NCT00868790|979219|P2|Post-study|Withdrawal by Subject|0
298121|NCT00868790|979220|P1|Post-study|Withdrawal by Subject|0
298122|NCT00868790|979207|P14|Period 4|Abnormal ALT/AST|0
298123|NCT00868790|979208|P13|Period 4|Abnormal ALT/AST|0
298124|NCT00868790|979209|P12|Period 4|Abnormal ALT/AST|0
298125|NCT00868790|979210|P11|Period 4|Abnormal ALT/AST|0
298126|NCT00868790|979211|P10|Period 4|Abnormal ALT/AST|0
298127|NCT00868790|979212|P9|Period 4|Abnormal ALT/AST|0
298128|NCT00868790|979213|P8|Period 4|Abnormal ALT/AST|0
298129|NCT00868790|979214|P7|Period 4|Abnormal ALT/AST|0
298130|NCT00868790|979215|P6|Period 4|Abnormal ALT/AST|0
298131|NCT00868790|979216|P5|Period 4|Abnormal ALT/AST|0
298132|NCT00868790|979217|P4|Period 4|Abnormal ALT/AST|0
298133|NCT00868790|979218|P3|Period 4|Abnormal ALT/AST|1
298134|NCT00868790|979219|P2|Period 4|Abnormal ALT/AST|0
298135|NCT00868790|979220|P1|Period 4|Abnormal ALT/AST|0
298136|NCT00868790|979207|P14|Period 4|Study Terminated by Sponsor|1
298137|NCT00868790|979208|P13|Period 4|Study Terminated by Sponsor|0
298138|NCT00868790|979209|P12|Period 4|Study Terminated by Sponsor|1
298139|NCT00868790|979210|P11|Period 4|Study Terminated by Sponsor|2
298140|NCT00868790|979211|P10|Period 4|Study Terminated by Sponsor|0
298141|NCT00868790|979212|P9|Period 4|Study Terminated by Sponsor|2
298142|NCT00868790|979213|P8|Period 4|Study Terminated by Sponsor|1
298143|NCT00868790|979214|P7|Period 4|Study Terminated by Sponsor|0
298144|NCT00868790|979215|P6|Period 4|Study Terminated by Sponsor|0
298145|NCT00868790|979216|P5|Period 4|Study Terminated by Sponsor|0
298146|NCT00868790|979217|P4|Period 4|Study Terminated by Sponsor|0
298147|NCT00868790|979218|P3|Period 4|Study Terminated by Sponsor|0
298148|NCT00868790|979219|P2|Period 4|Study Terminated by Sponsor|0
298149|NCT00868790|979220|P1|Period 4|Study Terminated by Sponsor|2
298150|NCT00868790|979207|P14|Period 4|Lost to Follow-up|0
298151|NCT00868790|979208|P13|Period 4|Lost to Follow-up|0
298152|NCT00868790|979209|P12|Period 4|Lost to Follow-up|0
298153|NCT00868790|979210|P11|Period 4|Lost to Follow-up|0
298154|NCT00868790|979211|P10|Period 4|Lost to Follow-up|0
298155|NCT00868790|979212|P9|Period 4|Lost to Follow-up|0
298156|NCT00868790|979213|P8|Period 4|Lost to Follow-up|1
298157|NCT00868790|979214|P7|Period 4|Lost to Follow-up|0
298158|NCT00868790|979215|P6|Period 4|Lost to Follow-up|0
298159|NCT00868790|979216|P5|Period 4|Lost to Follow-up|0
298160|NCT00868790|979217|P4|Period 4|Lost to Follow-up|0
298161|NCT00868790|979218|P3|Period 4|Lost to Follow-up|0
298162|NCT00868790|979219|P2|Period 4|Lost to Follow-up|0
298163|NCT00868790|979220|P1|Period 4|Lost to Follow-up|0
298164|NCT00868790|979207|P14|Period 4|Adverse Event|0
298165|NCT00868790|979208|P13|Period 4|Adverse Event|1
298166|NCT00868790|979209|P12|Period 4|Adverse Event|0
298167|NCT00868790|979210|P11|Period 4|Adverse Event|1
298168|NCT00868790|979211|P10|Period 4|Adverse Event|0
298169|NCT00868790|979212|P9|Period 4|Adverse Event|0
298170|NCT00868790|979213|P8|Period 4|Adverse Event|1
298171|NCT00868790|979214|P7|Period 4|Adverse Event|0
298172|NCT00868790|979215|P6|Period 4|Adverse Event|0
298173|NCT00868790|979216|P5|Period 4|Adverse Event|0
298174|NCT00868790|979217|P4|Period 4|Adverse Event|0
298175|NCT00868790|979218|P3|Period 4|Adverse Event|0
298176|NCT00868790|979219|P2|Period 4|Adverse Event|0
298177|NCT00868790|979220|P1|Period 4|Adverse Event|0
298178|NCT00868790|979207|P14|Period 3|Study Terminated by Sponsor|0
298179|NCT00868790|979208|P13|Period 3|Study Terminated by Sponsor|0
298180|NCT00868790|979209|P12|Period 3|Study Terminated by Sponsor|0
298181|NCT00868790|979210|P11|Period 3|Study Terminated by Sponsor|0
298182|NCT00868790|979211|P10|Period 3|Study Terminated by Sponsor|0
298183|NCT00868790|979212|P9|Period 3|Study Terminated by Sponsor|0
298184|NCT00868790|979213|P8|Period 3|Study Terminated by Sponsor|0
298185|NCT00868790|979214|P7|Period 3|Study Terminated by Sponsor|0
298186|NCT00868790|979215|P6|Period 3|Study Terminated by Sponsor|0
298187|NCT00868790|979216|P5|Period 3|Study Terminated by Sponsor|0
298188|NCT00868790|979217|P4|Period 3|Study Terminated by Sponsor|1
298189|NCT00868790|979218|P3|Period 3|Study Terminated by Sponsor|0
298190|NCT00868790|979219|P2|Period 3|Study Terminated by Sponsor|0
298191|NCT00868790|979220|P1|Period 3|Study Terminated by Sponsor|0
298192|NCT00868790|979207|P14|Period 3|Protocol Violation|0
298193|NCT00868790|979208|P13|Period 3|Protocol Violation|0
298194|NCT00868790|979209|P12|Period 3|Protocol Violation|0
298195|NCT00868790|979210|P11|Period 3|Protocol Violation|1
298196|NCT00868790|979211|P10|Period 3|Protocol Violation|0
298197|NCT00868790|979212|P9|Period 3|Protocol Violation|0
298198|NCT00868790|979213|P8|Period 3|Protocol Violation|0
298199|NCT00868790|979214|P7|Period 3|Protocol Violation|0
298200|NCT00868790|979215|P6|Period 3|Protocol Violation|0
298201|NCT00868790|979216|P5|Period 3|Protocol Violation|0
298202|NCT00868790|979217|P4|Period 3|Protocol Violation|0
298203|NCT00868790|979218|P3|Period 3|Protocol Violation|0
298204|NCT00868790|979219|P2|Period 3|Protocol Violation|0
298205|NCT00868790|979220|P1|Period 3|Protocol Violation|0
298206|NCT00868790|979207|P14|Period 3|Adverse Event|0
298207|NCT00868790|979208|P13|Period 3|Adverse Event|0
298208|NCT00868790|979209|P12|Period 3|Adverse Event|0
298209|NCT00868790|979210|P11|Period 3|Adverse Event|0
298210|NCT00868790|979211|P10|Period 3|Adverse Event|1
298211|NCT00868790|979212|P9|Period 3|Adverse Event|0
298212|NCT00868790|979213|P8|Period 3|Adverse Event|0
298213|NCT00868790|979214|P7|Period 3|Adverse Event|0
298214|NCT00868790|979215|P6|Period 3|Adverse Event|0
298215|NCT00868790|979216|P5|Period 3|Adverse Event|0
298216|NCT00868790|979217|P4|Period 3|Adverse Event|0
298217|NCT00868790|979218|P3|Period 3|Adverse Event|0
298218|NCT00868790|979219|P2|Period 3|Adverse Event|0
298219|NCT00868790|979220|P1|Period 3|Adverse Event|0
298220|NCT00868790|979207|P14|Period 2|Withdrawal by Subject|1
298221|NCT00868790|979208|P13|Period 2|Withdrawal by Subject|0
298222|NCT00868790|979209|P12|Period 2|Withdrawal by Subject|0
298223|NCT00868790|979210|P11|Period 2|Withdrawal by Subject|0
298224|NCT00868790|979211|P10|Period 2|Withdrawal by Subject|0
298225|NCT00868790|979212|P9|Period 2|Withdrawal by Subject|1
298226|NCT00868790|979213|P8|Period 2|Withdrawal by Subject|0
298227|NCT00868790|979214|P7|Period 2|Withdrawal by Subject|0
298228|NCT00868790|979215|P6|Period 2|Withdrawal by Subject|0
298229|NCT00868790|979216|P5|Period 2|Withdrawal by Subject|0
298230|NCT00868790|979217|P4|Period 2|Withdrawal by Subject|0
298231|NCT00868790|979218|P3|Period 2|Withdrawal by Subject|0
298232|NCT00868790|979219|P2|Period 2|Withdrawal by Subject|0
298233|NCT00868790|979220|P1|Period 2|Withdrawal by Subject|0
298234|NCT00868790|979207|P14|Period 2|Lost to Follow-up|0
298235|NCT00868790|979208|P13|Period 2|Lost to Follow-up|0
298236|NCT00868790|979209|P12|Period 2|Lost to Follow-up|0
298237|NCT00868790|979210|P11|Period 2|Lost to Follow-up|0
298238|NCT00868790|979211|P10|Period 2|Lost to Follow-up|0
298239|NCT00868790|979212|P9|Period 2|Lost to Follow-up|0
298240|NCT00868790|979213|P8|Period 2|Lost to Follow-up|0
298241|NCT00868790|979214|P7|Period 2|Lost to Follow-up|0
298242|NCT00868790|979215|P6|Period 2|Lost to Follow-up|1
298243|NCT00868790|979216|P5|Period 2|Lost to Follow-up|0
298244|NCT00868790|979217|P4|Period 2|Lost to Follow-up|0
298245|NCT00868790|979218|P3|Period 2|Lost to Follow-up|0
298246|NCT00868790|979219|P2|Period 2|Lost to Follow-up|1
298247|NCT00868790|979220|P1|Period 2|Lost to Follow-up|0
298248|NCT00868790|979207|P14|Period 2|Adverse Event|0
298249|NCT00868790|979208|P13|Period 2|Adverse Event|0
298250|NCT00868790|979209|P12|Period 2|Adverse Event|0
298251|NCT00868790|979210|P11|Period 2|Adverse Event|0
298252|NCT00868790|979211|P10|Period 2|Adverse Event|0
298253|NCT00868790|979212|P9|Period 2|Adverse Event|1
298254|NCT00868790|979213|P8|Period 2|Adverse Event|0
298255|NCT00868790|979214|P7|Period 2|Adverse Event|0
298256|NCT00868790|979215|P6|Period 2|Adverse Event|0
298257|NCT00868790|979216|P5|Period 2|Adverse Event|0
298258|NCT00868790|979217|P4|Period 2|Adverse Event|0
298259|NCT00868790|979218|P3|Period 2|Adverse Event|0
298260|NCT00868790|979219|P2|Period 2|Adverse Event|0
298261|NCT00868790|979220|P1|Period 2|Adverse Event|0
298262|NCT00868790|979207|P14|Period 1|Lost to Follow-up|0
298263|NCT00868790|979208|P13|Period 1|Lost to Follow-up|0
298264|NCT00868790|979209|P12|Period 1|Lost to Follow-up|0
298265|NCT00868790|979210|P11|Period 1|Lost to Follow-up|0
298266|NCT00868790|979211|P10|Period 1|Lost to Follow-up|0
298267|NCT00868790|979212|P9|Period 1|Lost to Follow-up|0
298268|NCT00868790|979213|P8|Period 1|Lost to Follow-up|0
298269|NCT00868790|979214|P7|Period 1|Lost to Follow-up|0
298270|NCT00868790|979215|P6|Period 1|Lost to Follow-up|1
298271|NCT00868790|979216|P5|Period 1|Lost to Follow-up|0
298272|NCT00868790|979217|P4|Period 1|Lost to Follow-up|0
298273|NCT00868790|979218|P3|Period 1|Lost to Follow-up|0
298274|NCT00868790|979219|P2|Period 1|Lost to Follow-up|0
298275|NCT00868790|979220|P1|Period 1|Lost to Follow-up|0
298276|NCT00868790|979207|P14|Period 1|Abnormal Triglycerides|0
298277|NCT00868790|979208|P13|Period 1|Abnormal Triglycerides|0
298278|NCT00868790|979209|P12|Period 1|Abnormal Triglycerides|0
298279|NCT00868790|979210|P11|Period 1|Abnormal Triglycerides|0
298280|NCT00868790|979211|P10|Period 1|Abnormal Triglycerides|0
298281|NCT00868790|979212|P9|Period 1|Abnormal Triglycerides|0
298282|NCT00868790|979213|P8|Period 1|Abnormal Triglycerides|0
298283|NCT00868790|979214|P7|Period 1|Abnormal Triglycerides|0
298284|NCT00868790|979215|P6|Period 1|Abnormal Triglycerides|0
298285|NCT00868790|979216|P5|Period 1|Abnormal Triglycerides|1
298286|NCT00868790|979217|P4|Period 1|Abnormal Triglycerides|0
298287|NCT00868790|979218|P3|Period 1|Abnormal Triglycerides|0
298288|NCT00868790|979219|P2|Period 1|Abnormal Triglycerides|0
298289|NCT00868790|979220|P1|Period 1|Abnormal Triglycerides|0
298290|NCT00868790|979207|P14|Period 1|Withdrawal by Subject|1
298291|NCT00868790|979208|P13|Period 1|Withdrawal by Subject|0
298292|NCT00868790|979209|P12|Period 1|Withdrawal by Subject|0
298293|NCT00868790|979210|P11|Period 1|Withdrawal by Subject|0
298294|NCT00868790|979211|P10|Period 1|Withdrawal by Subject|0
298295|NCT00868790|979212|P9|Period 1|Withdrawal by Subject|0
298296|NCT00868790|979213|P8|Period 1|Withdrawal by Subject|0
298297|NCT00868790|979214|P7|Period 1|Withdrawal by Subject|0
298298|NCT00868790|979215|P6|Period 1|Withdrawal by Subject|0
298299|NCT00868790|979216|P5|Period 1|Withdrawal by Subject|0
298300|NCT00868790|979217|P4|Period 1|Withdrawal by Subject|0
298301|NCT00868790|979218|P3|Period 1|Withdrawal by Subject|0
298302|NCT00868790|979219|P2|Period 1|Withdrawal by Subject|1
298303|NCT00868790|979220|P1|Period 1|Withdrawal by Subject|0
298304|NCT00868790|979207|P14|Period 1|Protocol Violation|0
298305|NCT00868790|979208|P13|Period 1|Protocol Violation|0
298306|NCT00868790|979209|P12|Period 1|Protocol Violation|0
298307|NCT00868790|979210|P11|Period 1|Protocol Violation|0
298308|NCT00868790|979211|P10|Period 1|Protocol Violation|0
298309|NCT00868790|979212|P9|Period 1|Protocol Violation|0
298310|NCT00868790|979213|P8|Period 1|Protocol Violation|0
298311|NCT00868790|979214|P7|Period 1|Protocol Violation|0
298312|NCT00868790|979215|P6|Period 1|Protocol Violation|0
298313|NCT00868790|979216|P5|Period 1|Protocol Violation|0
298314|NCT00868790|979217|P4|Period 1|Protocol Violation|0
298315|NCT00868790|979218|P3|Period 1|Protocol Violation|0
298316|NCT00868790|979219|P2|Period 1|Protocol Violation|0
298317|NCT00868790|979220|P1|Period 1|Protocol Violation|1
298318|NCT00868790|979207|P14|Period 1|Adverse Event|1
298319|NCT00868790|979208|P13|Period 1|Adverse Event|0
298320|NCT00868790|979209|P12|Period 1|Adverse Event|0
298321|NCT00868790|979210|P11|Period 1|Adverse Event|0
298322|NCT00868790|979211|P10|Period 1|Adverse Event|0
298323|NCT00868790|979212|P9|Period 1|Adverse Event|1
298324|NCT00868790|979213|P8|Period 1|Adverse Event|3
298325|NCT00868790|979214|P7|Period 1|Adverse Event|0
298326|NCT00868790|979215|P6|Period 1|Adverse Event|0
298327|NCT00868790|979216|P5|Period 1|Adverse Event|0
298328|NCT00868790|979217|P4|Period 1|Adverse Event|0
298329|NCT00868790|979218|P3|Period 1|Adverse Event|0
298330|NCT00868790|979219|P2|Period 1|Adverse Event|0
298331|NCT00868790|979220|P1|Period 1|Adverse Event|1
298332|NCT00868530|979300|P1|Overall Study|Lost to Follow-up|1
298333|NCT00868530|979300|P1|Overall Study|Adverse Event|3
298334|NCT00868517|979315|P3|Overall Study|Protocol Violation|0
298335|NCT00868517|979316|P2|Overall Study|Protocol Violation|1
298336|NCT00868517|979317|P1|Overall Study|Protocol Violation|1
298337|NCT00868517|979315|P3|Overall Study|Withdrawal by Subject|2
298338|NCT00868517|979316|P2|Overall Study|Withdrawal by Subject|3
298339|NCT00868517|979317|P1|Overall Study|Withdrawal by Subject|3
298340|NCT00868439|979355|P2|Overall Study|Withdrawal by Subject|1
298341|NCT00868439|979356|P1|Overall Study|Withdrawal by Subject|0
298342|NCT00868439|979355|P2|Overall Study|Physician Decision|0
298343|NCT00868439|979356|P1|Overall Study|Physician Decision|1
298344|NCT00868439|979355|P2|Overall Study|Protocol Violation|1
298345|NCT00868439|979356|P1|Overall Study|Protocol Violation|1
298346|NCT00868439|979355|P2|Overall Study|Death|1
298347|NCT00868439|979356|P1|Overall Study|Death|0
298348|NCT00868439|979355|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
298349|NCT00868439|979356|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
298350|NCT00868439|979355|P2|Overall Study|Adverse Event|3
298351|NCT00868439|979356|P1|Overall Study|Adverse Event|4
298352|NCT00868296|979413|P2|Overall Study|Withdrawal by Subject|1
298353|NCT00868296|979414|P1|Overall Study|Withdrawal by Subject|0
298354|NCT00868296|979413|P2|Overall Study|Adverse Event|2
298355|NCT00868296|979414|P1|Overall Study|Adverse Event|0
298356|NCT00868231|979422|P6|Treatment Period 3|Adverse Event|0
298357|NCT00868231|979423|P5|Treatment Period 3|Adverse Event|0
298358|NCT00868231|979424|P4|Treatment Period 3|Adverse Event|0
298359|NCT00868231|979425|P3|Treatment Period 3|Adverse Event|1
298360|NCT00868231|979426|P2|Treatment Period 3|Adverse Event|0
298361|NCT00868231|979427|P1|Treatment Period 3|Adverse Event|0
298362|NCT00868231|979422|P6|Treatment Period 2|Adverse Event|0
298363|NCT00868231|979423|P5|Treatment Period 2|Adverse Event|0
298364|NCT00868231|979424|P4|Treatment Period 2|Adverse Event|0
298365|NCT00868231|979425|P3|Treatment Period 2|Adverse Event|0
298366|NCT00868231|979426|P2|Treatment Period 2|Adverse Event|0
298367|NCT00868231|979427|P1|Treatment Period 2|Adverse Event|1
298368|NCT00868231|979422|P6|Treatment Period 1|Adverse Event|0
298369|NCT00868231|979423|P5|Treatment Period 1|Adverse Event|1
298370|NCT00868231|979424|P4|Treatment Period 1|Adverse Event|0
298371|NCT00868231|979425|P3|Treatment Period 1|Adverse Event|0
298372|NCT00868231|979426|P2|Treatment Period 1|Adverse Event|0
298373|NCT00868231|979427|P1|Treatment Period 1|Adverse Event|0
298374|NCT00868192|979493|P1|Overall Study|Ineligible|4
298375|NCT00867568|979547|P1|Overall Study|Withdrawal by Subject|1
298376|NCT00867568|979547|P1|Overall Study|Adverse Event|4
298377|NCT00867568|979547|P1|Overall Study|Lack of Efficacy|10
298378|NCT00867503|979561|P1|Overall Study|Withdrawal by Subject|1
298379|NCT00867490|979567|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
298380|NCT00867490|979567|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
298381|NCT00867490|979567|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
298382|NCT00867490|979567|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
298383|NCT00867490|979567|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
298384|NCT00867360|979609|P2|Overall Study|Physician Decision|1
298385|NCT00867360|979610|P1|Overall Study|Physician Decision|0
298386|NCT00867360|979609|P2|Overall Study|Withdrawal by Subject|0
298387|NCT00867360|979610|P1|Overall Study|Withdrawal by Subject|1
298388|NCT00866177|979620|P1|Overall Study|Not Treated|151
298389|NCT00866177|979620|P1|Overall Study|Withdrawal by Subject|1
298390|NCT00867165|979626|P2|Overall Study|Withdrawal by Subject|0
298391|NCT00867165|979627|P1|Overall Study|Withdrawal by Subject|1
298392|NCT00867165|979626|P2|Overall Study|Adverse Event|0
298393|NCT00867165|979627|P1|Overall Study|Adverse Event|3
298394|NCT00867035|979777|P2|Baseline to 1 Week|Withdrawal by Subject|0
298395|NCT00867035|979778|P1|Baseline to 1 Week|Withdrawal by Subject|1
298396|NCT00867035|979777|P2|Baseline to 1 Hour|Withdrawal by Subject|1
298397|NCT00867035|979778|P1|Baseline to 1 Hour|Withdrawal by Subject|1
298398|NCT00867009|979804|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
298399|NCT00867009|979804|P1|Induction Period|Progressive Disease (PD)|25
298400|NCT00867009|979804|P1|Induction Period|Physician Decision|3
298401|NCT00867009|979804|P1|Induction Period|Withdrawal by Subject|8
298402|NCT00867009|979804|P1|Induction Period|Protocol Violation|1
298403|NCT00867009|979804|P1|Induction Period|Death due to Study Disease|4
298404|NCT00867009|979804|P1|Induction Period|Death due to serious adverse event|6
298405|NCT00867009|979804|P1|Induction Period|Serious Adverse Event|10
298406|NCT00867009|979804|P1|Induction Period|Nonserious Adverse Event|5
298407|NCT00866918|979813|P2|Overall Study|Secondary malignancy|0
298408|NCT00866918|979814|P1|Overall Study|Secondary malignancy|1
298409|NCT00866918|979813|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
298410|NCT00866918|979814|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
298411|NCT00866918|979813|P2|Overall Study|Ineligible|4
298412|NCT00866918|979814|P1|Overall Study|Ineligible|2
298413|NCT00866918|979813|P2|Overall Study|Physician Decision|2
298414|NCT00866918|979814|P1|Overall Study|Physician Decision|10
298415|NCT00866918|979813|P2|Overall Study|Lack of Efficacy|1
298416|NCT00866918|979814|P1|Overall Study|Lack of Efficacy|1
298417|NCT00866918|979813|P2|Overall Study|Death|5
298418|NCT00866918|979814|P1|Overall Study|Death|1
298419|NCT00866814|979831|P1|Overall Study|Moved to area without study site|1
298420|NCT00866814|979831|P1|Overall Study|Unable to meet follow-up requirements|2
298421|NCT00866814|979831|P1|Overall Study|No longer wished to participate|1
298422|NCT00866814|979831|P1|Overall Study|Death|1
298423|NCT00866814|979831|P1|Overall Study|Physician Decision|1
298424|NCT00866814|979831|P1|Overall Study|Adverse Event|2
298425|NCT00866814|979831|P1|Overall Study|Lost to Follow-up|12
298426|NCT00866788|979844|P4|Overall Study|Physician Decision|1
298427|NCT00866788|979845|P3|Overall Study|Physician Decision|1
298428|NCT00866788|979846|P2|Overall Study|Physician Decision|0
298429|NCT00866788|979847|P1|Overall Study|Physician Decision|0
298430|NCT00866788|979844|P4|Overall Study|Disease progression|0
298431|NCT00866788|979845|P3|Overall Study|Disease progression|1
298432|NCT00866788|979846|P2|Overall Study|Disease progression|1
298433|NCT00866788|979847|P1|Overall Study|Disease progression|3
298434|NCT00866788|979844|P4|Overall Study|Pregnancy|0
298435|NCT00866788|979845|P3|Overall Study|Pregnancy|0
298436|NCT00866788|979846|P2|Overall Study|Pregnancy|1
298437|NCT00866788|979847|P1|Overall Study|Pregnancy|0
298438|NCT00866788|979844|P4|Overall Study|Withdrawal by Subject|1
298439|NCT00866788|979845|P3|Overall Study|Withdrawal by Subject|0
298440|NCT00866788|979846|P2|Overall Study|Withdrawal by Subject|1
298441|NCT00866788|979847|P1|Overall Study|Withdrawal by Subject|2
298442|NCT00866788|979844|P4|Overall Study|Lost to Follow-up|2
298443|NCT00866788|979845|P3|Overall Study|Lost to Follow-up|0
298444|NCT00866788|979846|P2|Overall Study|Lost to Follow-up|1
298445|NCT00866788|979847|P1|Overall Study|Lost to Follow-up|1
298446|NCT00866788|979844|P4|Overall Study|Adverse Event|1
298447|NCT00866788|979845|P3|Overall Study|Adverse Event|0
298448|NCT00866788|979846|P2|Overall Study|Adverse Event|2
298449|NCT00866788|979847|P1|Overall Study|Adverse Event|0
298450|NCT00866775|979895|P2|Overall Study|discontinued due to communication error|1
298451|NCT00866775|979896|P1|Overall Study|discontinued due to communication error|0
298452|NCT00866775|979895|P2|Overall Study|met exit criteria|17
298453|NCT00866775|979896|P1|Overall Study|met exit criteria|23
298454|NCT00866775|979895|P2|Overall Study|Withdrawal by Subject|4
298455|NCT00866775|979896|P1|Overall Study|Withdrawal by Subject|4
298456|NCT00866775|979895|P2|Overall Study|Protocol Violation|4
298457|NCT00866775|979896|P1|Overall Study|Protocol Violation|3
298458|NCT00866775|979895|P2|Overall Study|Physician Decision|3
298459|NCT00866775|979896|P1|Overall Study|Physician Decision|0
298460|NCT00866775|979895|P2|Overall Study|Lost to Follow-up|4
298461|NCT00866775|979896|P1|Overall Study|Lost to Follow-up|0
298462|NCT00866775|979895|P2|Overall Study|Death|0
298463|NCT00866775|979896|P1|Overall Study|Death|1
298464|NCT00866775|979895|P2|Overall Study|Adverse Event|19
298465|NCT00866775|979896|P1|Overall Study|Adverse Event|5
298466|NCT00866723|979932|P1|Overall Study|Disease Progression|4
298467|NCT00866723|979932|P1|Overall Study|Withdrawal by Subject|1
298468|NCT00866697|979939|P2|Overall Study|Ongoing|312
298469|NCT00866697|979940|P1|Overall Study|Ongoing|335
298470|NCT00866697|979939|P2|Overall Study|Withdrawal by Subject|53
298471|NCT00866697|979940|P1|Overall Study|Withdrawal by Subject|28
298472|NCT00866697|979939|P2|Overall Study|Physician Decision|4
298473|NCT00866697|979940|P1|Overall Study|Physician Decision|3
298474|NCT00866697|979939|P2|Overall Study|Lost to Follow-up|8
298475|NCT00866697|979940|P1|Overall Study|Lost to Follow-up|7
298476|NCT00866658|979984|P2|Overall Study|Familial and Personal Reasons|5
298477|NCT00866658|979985|P1|Overall Study|Familial and Personal Reasons|4
298478|NCT00866658|979984|P2|Overall Study|Protocol Violation|1
298479|NCT00866658|979985|P1|Overall Study|Protocol Violation|1
298480|NCT00866658|979984|P2|Overall Study|Withdrawal by Subject|0
298481|NCT00866658|979985|P1|Overall Study|Withdrawal by Subject|1
298482|NCT00866658|979984|P2|Overall Study|Lack of Efficacy|1
298483|NCT00866658|979985|P1|Overall Study|Lack of Efficacy|2
298484|NCT00866658|979984|P2|Overall Study|Adverse Event|14
298485|NCT00866658|979985|P1|Overall Study|Adverse Event|5
298486|NCT00866606|980013|P1|Overall Study|Adverse Event|1
298487|NCT00866606|980013|P1|Overall Study|Lost to Follow-up|3
298488|NCT00866359|980027|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
298489|NCT00866359|980028|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
298490|NCT00866359|980029|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
298491|NCT00866359|980030|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
298492|NCT00866359|980027|P4|Treatment Phase (Days 1 to 85)|Unspecified|0
298493|NCT00866359|980028|P3|Treatment Phase (Days 1 to 85)|Unspecified|0
298494|NCT00866359|980029|P2|Treatment Phase (Days 1 to 85)|Unspecified|0
298495|NCT00866359|980030|P1|Treatment Phase (Days 1 to 85)|Unspecified|1
298496|NCT00866359|980027|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
298497|NCT00866359|980028|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
298498|NCT00866359|980029|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
298499|NCT00866359|980030|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
298500|NCT00866359|980027|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
298501|NCT00866359|980028|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
298502|NCT00866359|980029|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
298503|NCT00866359|980030|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
298504|NCT00866359|980027|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
298505|NCT00866359|980028|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
298506|NCT00866359|980029|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
298507|NCT00866359|980030|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
298508|NCT00866359|980027|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
298509|NCT00866359|980028|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
298510|NCT00866359|980029|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
298511|NCT00866359|980030|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
298512|NCT00866320|980083|P1|Overall Study|Death|2
298513|NCT00866320|980083|P1|Overall Study|Withdrawal by Subject|4
298514|NCT00866307|980090|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
298515|NCT00866307|980091|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
298516|NCT00866307|980092|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
298517|NCT00866307|980090|P3|Consolidation/Maintenance|Non-compliance|1
298518|NCT00866307|980091|P2|Consolidation/Maintenance|Non-compliance|0
298519|NCT00866307|980092|P1|Consolidation/Maintenance|Non-compliance|0
298520|NCT00866307|980090|P3|Consolidation/Maintenance|Therapy error|0
298521|NCT00866307|980091|P2|Consolidation/Maintenance|Therapy error|1
298522|NCT00866307|980092|P1|Consolidation/Maintenance|Therapy error|0
298523|NCT00866307|980090|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
298524|NCT00866307|980091|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
298525|NCT00866307|980092|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
298526|NCT00866307|980090|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
298527|NCT00866307|980091|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
298528|NCT00866307|980092|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
298529|NCT00866307|980090|P3|Consolidation/Maintenance|Withdrawal by Subject|1
298530|NCT00866307|980091|P2|Consolidation/Maintenance|Withdrawal by Subject|1
298531|NCT00866307|980092|P1|Consolidation/Maintenance|Withdrawal by Subject|0
298532|NCT00866307|980090|P3|Consolidation/Maintenance|Physician Decision|2
298533|NCT00866307|980091|P2|Consolidation/Maintenance|Physician Decision|3
298534|NCT00866307|980092|P1|Consolidation/Maintenance|Physician Decision|0
298535|NCT00866307|980090|P3|Consolidation/Maintenance|Death|1
298536|NCT00866307|980091|P2|Consolidation/Maintenance|Death|0
298537|NCT00866307|980092|P1|Consolidation/Maintenance|Death|0
298538|NCT00866307|980090|P3|Consolidation/Maintenance|Adverse Event|8
298539|NCT00866307|980091|P2|Consolidation/Maintenance|Adverse Event|0
298540|NCT00866307|980092|P1|Consolidation/Maintenance|Adverse Event|0
298541|NCT00866307|980090|P3|Induction|Study was closed at the time|0
298542|NCT00866307|980091|P2|Induction|Study was closed at the time|0
298543|NCT00866307|980092|P1|Induction|Study was closed at the time|1
298544|NCT00866307|980090|P3|Induction|Improper post-induction consent|0
298545|NCT00866307|980091|P2|Induction|Improper post-induction consent|0
298546|NCT00866307|980092|P1|Induction|Improper post-induction consent|2
298547|NCT00866307|980090|P3|Induction|Inadequate cytognetic samples th|0
298548|NCT00866307|980091|P2|Induction|Inadequate cytognetic samples th|0
298549|NCT00866307|980092|P1|Induction|Inadequate cytognetic samples th|1
298550|NCT00866307|980090|P3|Induction|Identification of Patients with Day 29 M|0
298551|NCT00866307|980091|P2|Induction|Identification of Patients with Day 29 M|0
298552|NCT00866307|980092|P1|Induction|Identification of Patients with Day 29 M|3
298553|NCT00866307|980090|P3|Induction|Progressive Disease|0
298554|NCT00866307|980091|P2|Induction|Progressive Disease|0
298555|NCT00866307|980092|P1|Induction|Progressive Disease|1
298556|NCT00866307|980090|P3|Induction|Physician Decision|0
298557|NCT00866307|980091|P2|Induction|Physician Decision|0
298558|NCT00866307|980092|P1|Induction|Physician Decision|5
298559|NCT00866307|980090|P3|Induction|Death|0
298560|NCT00866307|980091|P2|Induction|Death|0
298561|NCT00866307|980092|P1|Induction|Death|2
298562|NCT00866307|980090|P3|Induction|Adverse Event|0
298563|NCT00866307|980091|P2|Induction|Adverse Event|0
298564|NCT00866307|980092|P1|Induction|Adverse Event|5
298565|NCT00866294|980102|P3|Overall Study|Physician Decision|1
298566|NCT00866294|980103|P2|Overall Study|Physician Decision|2
298567|NCT00866294|980104|P1|Overall Study|Physician Decision|6
298568|NCT00866294|980102|P3|Overall Study|Lost to Follow-up|0
298569|NCT00866294|980103|P2|Overall Study|Lost to Follow-up|3
298570|NCT00866294|980104|P1|Overall Study|Lost to Follow-up|1
298571|NCT00866294|980102|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
298572|NCT00866294|980103|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
298573|NCT00866294|980104|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
298574|NCT00866294|980102|P3|Overall Study|Protocol Violation|0
298575|NCT00866294|980103|P2|Overall Study|Protocol Violation|0
298576|NCT00866294|980104|P1|Overall Study|Protocol Violation|2
298577|NCT00866294|980102|P3|Overall Study|Lack of Efficacy|0
298578|NCT00866294|980103|P2|Overall Study|Lack of Efficacy|1
298579|NCT00866294|980104|P1|Overall Study|Lack of Efficacy|7
298580|NCT00866294|980102|P3|Overall Study|Adverse Event|9
298581|NCT00866294|980103|P2|Overall Study|Adverse Event|13
298582|NCT00866294|980104|P1|Overall Study|Adverse Event|12
298583|NCT00866281|980133|P2|Overall Study|New cancer therapy|4
298584|NCT00866281|980134|P1|Overall Study|New cancer therapy|0
298585|NCT00866281|980133|P2|Overall Study|Disease progression|11
298586|NCT00866281|980134|P1|Overall Study|Disease progression|3
298587|NCT00866281|980133|P2|Overall Study|Withdrawal by participants|0
298588|NCT00866281|980134|P1|Overall Study|Withdrawal by participants|3
298589|NCT00866281|980133|P2|Overall Study|Adverse Event|0
298590|NCT00866281|980134|P1|Overall Study|Adverse Event|1
298591|NCT00866047|980150|P1|Follow-up Period|Lost to Follow-up|5
298592|NCT00866047|980150|P1|Treatment Period|Withdrawal by Subject|5
298593|NCT00866047|980150|P1|Treatment Period|Physician Decision|14
298594|NCT00866047|980150|P1|Treatment Period|Adverse Event|16
298595|NCT00866047|980150|P1|Treatment Period|Progressive disease|13
298596|NCT00865904|980182|P5|Overall Study|Randomized but not Treated|1
298597|NCT00865904|980183|P4|Overall Study|Randomized but not Treated|1
298598|NCT00865904|980184|P3|Overall Study|Randomized but not Treated|0
298599|NCT00865904|980185|P2|Overall Study|Randomized but not Treated|0
298600|NCT00865904|980186|P1|Overall Study|Randomized but not Treated|2
298601|NCT00865709|980243|P2|Treatment|Surgery|3
298602|NCT00865709|980244|P1|Treatment|Surgery|8
298603|NCT00865709|980243|P2|Treatment|Physician Decision|2
298604|NCT00865709|980244|P1|Treatment|Physician Decision|3
298605|NCT00865709|980243|P2|Treatment|Withdrawal by Subject|7
298606|NCT00865709|980244|P1|Treatment|Withdrawal by Subject|10
298607|NCT00865709|980243|P2|Treatment|Adverse Event|6
298608|NCT00865709|980244|P1|Treatment|Adverse Event|9
298609|NCT00865514|980260|P1|Overall Study|Infusion cost exceeded funding|2
298610|NCT00865345|980265|P1|Overall Study|Withdrawal by Subject|2
298611|NCT00865306|980272|P2|Controlled Trial|Withdrawal by Subject|1
298612|NCT00865306|980273|P1|Controlled Trial|Withdrawal by Subject|0
298613|NCT00865306|980272|P2|Controlled Trial|Sought treatment for conduct disorder|0
298614|NCT00865306|980273|P1|Controlled Trial|Sought treatment for conduct disorder|1
298615|NCT00865306|980272|P2|Controlled Trial|Improved btw baseline and first session|0
298616|NCT00865306|980273|P1|Controlled Trial|Improved btw baseline and first session|1
298617|NCT00865306|980272|P2|Controlled Trial|Difficulty commuting|0
298618|NCT00865306|980273|P1|Controlled Trial|Difficulty commuting|2
298619|NCT00865306|980272|P2|Controlled Trial|Lost to Follow-up|1
298620|NCT00865306|980273|P1|Controlled Trial|Lost to Follow-up|1
298621|NCT00865124|980303|P3|Overall Study|Withdrawn consent|0
298622|NCT00865124|980304|P2|Overall Study|Withdrawn consent|0
298623|NCT00865124|980305|P1|Overall Study|Withdrawn consent|2
298624|NCT00865124|980303|P3|Overall Study|Physician Decision|0
298625|NCT00865124|980304|P2|Overall Study|Physician Decision|1
298626|NCT00865124|980305|P1|Overall Study|Physician Decision|2
298627|NCT00865098|980322|P1|Overall Study|Progressive disease|1
298628|NCT00865046|980334|P3|Overall Study|Withdrawal by Subject|0
298629|NCT00865046|980335|P2|Overall Study|Withdrawal by Subject|0
298630|NCT00865046|980336|P1|Overall Study|Withdrawal by Subject|5
298631|NCT00865046|980334|P3|Overall Study|Death|1
298632|NCT00865046|980335|P2|Overall Study|Death|1
298633|NCT00865046|980336|P1|Overall Study|Death|0
298634|NCT00865046|980334|P3|Overall Study|Lost to Follow-up|0
298635|NCT00865046|980335|P2|Overall Study|Lost to Follow-up|4
298636|NCT00865046|980336|P1|Overall Study|Lost to Follow-up|1
298637|NCT00865020|980346|P2|Overall Study|Randomized but discontinued|4
298638|NCT00865020|980347|P1|Overall Study|Randomized but discontinued|2
298639|NCT00865020|980346|P2|Overall Study|Death|1
298640|NCT00865020|980347|P1|Overall Study|Death|0
298641|NCT00865020|980346|P2|Overall Study|Abnormal laboratory value(s)|1
298642|NCT00865020|980347|P1|Overall Study|Abnormal laboratory value(s)|0
298643|NCT00865020|980346|P2|Overall Study|Administrative problems|2
298644|NCT00865020|980347|P1|Overall Study|Administrative problems|0
298645|NCT00865020|980346|P2|Overall Study|Protocol deviation|1
298646|NCT00865020|980347|P1|Overall Study|Protocol deviation|4
298647|NCT00865020|980346|P2|Overall Study|Lost to Follow-up|4
298648|NCT00865020|980347|P1|Overall Study|Lost to Follow-up|6
298649|NCT00865020|980346|P2|Overall Study|Abnormal test procedure result(s)|8
298650|NCT00865020|980347|P1|Overall Study|Abnormal test procedure result(s)|6
298651|NCT00865020|980346|P2|Overall Study|Adverse Event|14
298652|NCT00865020|980347|P1|Overall Study|Adverse Event|9
298653|NCT00865020|980346|P2|Overall Study|Withdrawal by Subject|16
298654|NCT00865020|980347|P1|Overall Study|Withdrawal by Subject|22
298655|NCT00864916|980363|P2|Overall Study|Withdrawal by Subject|0
298656|NCT00864916|980364|P1|Overall Study|Withdrawal by Subject|1
298657|NCT00864916|980363|P2|Overall Study|Protocol Violation|0
298658|NCT00864916|980364|P1|Overall Study|Protocol Violation|1
298659|NCT00864916|980363|P2|Overall Study|Lost to Follow-up|4
298660|NCT00864916|980364|P1|Overall Study|Lost to Follow-up|4
298661|NCT00864851|980373|P3|Overall Study|Patient uncooperative|0
298662|NCT00864851|980374|P2|Overall Study|Patient uncooperative|0
298663|NCT00864851|980375|P1|Overall Study|Patient uncooperative|1
298664|NCT00864851|980373|P3|Overall Study|Death|0
298665|NCT00864851|980374|P2|Overall Study|Death|0
298666|NCT00864851|980375|P1|Overall Study|Death|1
298667|NCT00864851|980373|P3|Overall Study|Physician Decision|0
298668|NCT00864851|980374|P2|Overall Study|Physician Decision|0
298669|NCT00864851|980375|P1|Overall Study|Physician Decision|1
298670|NCT00864851|980373|P3|Overall Study|Withdrawal by Subject|0
298671|NCT00864851|980374|P2|Overall Study|Withdrawal by Subject|1
298672|NCT00864851|980375|P1|Overall Study|Withdrawal by Subject|0
298673|NCT00864682|980421|P3|Overall Study|Protocol Violation|2
298674|NCT00864682|980422|P2|Overall Study|Protocol Violation|1
298675|NCT00864682|980423|P1|Overall Study|Protocol Violation|2
298676|NCT00864513|980462|P1|Overall Study|Withdrawal by Subject|3
298677|NCT00864253|980508|P2|Overall Study|Untreated|7
298678|NCT00864253|980509|P1|Overall Study|Untreated|7
298679|NCT00864253|980508|P2|Overall Study|Ongoing|3
298680|NCT00864253|980509|P1|Overall Study|Ongoing|2
298681|NCT00864253|980508|P2|Overall Study|Death|0
298682|NCT00864253|980509|P1|Overall Study|Death|1
298683|NCT00864253|980508|P2|Overall Study|Withdrawal by Subject|18
298684|NCT00864253|980509|P1|Overall Study|Withdrawal by Subject|18
298685|NCT00864253|980508|P2|Overall Study|Lost to Follow-up|1
298686|NCT00864253|980509|P1|Overall Study|Lost to Follow-up|1
298687|NCT00864253|980508|P2|Overall Study|Protocol Violation|2
298688|NCT00864253|980509|P1|Overall Study|Protocol Violation|0
298689|NCT00864253|980508|P2|Overall Study|Physician Decision|15
298690|NCT00864253|980509|P1|Overall Study|Physician Decision|11
298691|NCT00864253|980508|P2|Overall Study|Unrelated Adverse Event|1
298692|NCT00864253|980509|P1|Overall Study|Unrelated Adverse Event|3
298693|NCT00864253|980508|P2|Overall Study|Adverse Event|11
298694|NCT00864253|980509|P1|Overall Study|Adverse Event|56
298695|NCT00864227|980539|P1|Overall Study|Disease Relapse/Progression|3
298696|NCT00864227|980539|P1|Overall Study|Withdrawal by Subject|1
298697|NCT00863798|980601|P3|Overall Study|Randomized not treated|3
298698|NCT00863798|980602|P2|Overall Study|Randomized not treated|2
298699|NCT00863798|980603|P1|Overall Study|Randomized not treated|4
298700|NCT00863798|980601|P3|Overall Study|Withdrawal by Subject|4
298701|NCT00863798|980602|P2|Overall Study|Withdrawal by Subject|7
298702|NCT00863798|980603|P1|Overall Study|Withdrawal by Subject|8
298703|NCT00863798|980601|P3|Overall Study|Protocol Violation|1
298704|NCT00863798|980602|P2|Overall Study|Protocol Violation|1
298705|NCT00863798|980603|P1|Overall Study|Protocol Violation|0
298706|NCT00863798|980601|P3|Overall Study|Unspecified|1
298707|NCT00863798|980602|P2|Overall Study|Unspecified|3
298708|NCT00863798|980603|P1|Overall Study|Unspecified|2
298709|NCT00863798|980601|P3|Overall Study|Lost to Follow-up|5
298710|NCT00863798|980602|P2|Overall Study|Lost to Follow-up|9
298711|NCT00863798|980603|P1|Overall Study|Lost to Follow-up|6
298712|NCT00863798|980601|P3|Overall Study|Lack of Efficacy|6
298713|NCT00863798|980602|P2|Overall Study|Lack of Efficacy|3
298714|NCT00863798|980603|P1|Overall Study|Lack of Efficacy|4
298715|NCT00863798|980601|P3|Overall Study|Investigator request|1
298716|NCT00863798|980602|P2|Overall Study|Investigator request|2
298717|NCT00863798|980603|P1|Overall Study|Investigator request|1
298718|NCT00863798|980601|P3|Overall Study|Participant failed to return|0
298719|NCT00863798|980602|P2|Overall Study|Participant failed to return|1
298720|NCT00863798|980603|P1|Overall Study|Participant failed to return|2
298721|NCT00863798|980601|P3|Overall Study|Adverse Event|4
298722|NCT00863798|980602|P2|Overall Study|Adverse Event|2
298723|NCT00863798|980603|P1|Overall Study|Adverse Event|5
298724|NCT00863746|980655|P2|Survival Follow up|Consent Withdrawn|8
298725|NCT00863746|980656|P1|Survival Follow up|Consent Withdrawn|7
298726|NCT00863746|980655|P2|Survival Follow up|Lost to Follow-up|1
298727|NCT00863746|980656|P1|Survival Follow up|Lost to Follow-up|2
298728|NCT00863746|980655|P2|Survival Follow up|Death|271
298729|NCT00863746|980656|P1|Survival Follow up|Death|244
298730|NCT00863746|980655|P2|Treatment|not available|0
298731|NCT00863746|980656|P1|Treatment|not available|1
298732|NCT00863746|980655|P2|Treatment|Protocol Violation|3
298733|NCT00863746|980656|P1|Treatment|Protocol Violation|5
298734|NCT00863746|980655|P2|Treatment|Lost to Follow-up|0
298735|NCT00863746|980656|P1|Treatment|Lost to Follow-up|1
298736|NCT00863746|980655|P2|Treatment|Consent withdrawn|14
298737|NCT00863746|980656|P1|Treatment|Consent withdrawn|15
298738|NCT00863746|980655|P2|Treatment|non-compliant with study medication|0
298739|NCT00863746|980656|P1|Treatment|non-compliant with study medication|4
298740|NCT00863746|980655|P2|Treatment|Adverse Event|16
298741|NCT00863746|980656|P1|Treatment|Adverse Event|41
298742|NCT00863746|980655|P2|Treatment|Not treated|2
298743|NCT00863746|980656|P1|Treatment|Not treated|4
298744|NCT00863707|980682|P2|Overall Study|Randomized, but drug not received|3
298745|NCT00863707|980683|P1|Overall Study|Randomized, but drug not received|4
298746|NCT00863655|980691|P2|Overall Study|Treatment completed as per protocol|1
298747|NCT00863655|980692|P1|Overall Study|Treatment completed as per protocol|5
298748|NCT00863655|980691|P2|Overall Study|Disease progression|221
298749|NCT00863655|980692|P1|Overall Study|Disease progression|364
298750|NCT00863655|980691|P2|Overall Study|New cancer therapy|1
298751|NCT00863655|980692|P1|Overall Study|New cancer therapy|5
298752|NCT00863655|980691|P2|Overall Study|Death|1
298753|NCT00863655|980692|P1|Overall Study|Death|7
298754|NCT00863655|980691|P2|Overall Study|Administrative problems|0
298755|NCT00863655|980692|P1|Overall Study|Administrative problems|1
298756|NCT00863655|980691|P2|Overall Study|Withdrawal by Subject|7
298757|NCT00863655|980692|P1|Overall Study|Withdrawal by Subject|47
298758|NCT00863655|980691|P2|Overall Study|Adverse Event|8
298759|NCT00863655|980692|P1|Overall Study|Adverse Event|52
298760|NCT00863655|980691|P2|Overall Study|Protocol Violation|0
298761|NCT00863655|980692|P1|Overall Study|Protocol Violation|4
298762|NCT00863512|980729|P2|Overall Study|Physician Decision|0
298763|NCT00863512|980730|P1|Overall Study|Physician Decision|1
298764|NCT00863512|980729|P2|Overall Study|Withdrawal by Subject|0
298765|NCT00863512|980730|P1|Overall Study|Withdrawal by Subject|11
298766|NCT00863512|980729|P2|Overall Study|Adverse Event|0
298767|NCT00863512|980730|P1|Overall Study|Adverse Event|2
298768|NCT00863330|980761|P1|Overall Study|study terminated early due to administra|6
298769|NCT00863317|980767|P2|Overall Study|Lost to Follow-up|9
298770|NCT00863317|980768|P1|Overall Study|Lost to Follow-up|8
298771|NCT00863057|980791|P4|Period 2 (Weeks 6-10)|Physician Decision|1
298772|NCT00863057|980792|P3|Period 2 (Weeks 6-10)|Physician Decision|0
298773|NCT00863057|980793|P2|Period 2 (Weeks 6-10)|Physician Decision|0
298774|NCT00863057|980794|P1|Period 2 (Weeks 6-10)|Physician Decision|0
298775|NCT00863057|980791|P4|Period 2 (Weeks 6-10)|Adverse Event|0
298776|NCT00863057|980792|P3|Period 2 (Weeks 6-10)|Adverse Event|1
298777|NCT00863057|980793|P2|Period 2 (Weeks 6-10)|Adverse Event|1
298778|NCT00863057|980794|P1|Period 2 (Weeks 6-10)|Adverse Event|0
298779|NCT00863057|980791|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
298780|NCT00863057|980792|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
298781|NCT00863057|980793|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
298782|NCT00863057|980794|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
298783|NCT00863057|980791|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
298784|NCT00863057|980792|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
298785|NCT00863057|980793|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
298786|NCT00863057|980794|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
298787|NCT00862940|980836|P2|Overall Study|Administrative or other reason(s)|3
298788|NCT00862940|980837|P1|Overall Study|Administrative or other reason(s)|4
298789|NCT00862940|980836|P2|Overall Study|Lost to Follow-up|1
298790|NCT00862940|980837|P1|Overall Study|Lost to Follow-up|0
298791|NCT00862940|980836|P2|Overall Study|Non-compliance|0
298792|NCT00862940|980837|P1|Overall Study|Non-compliance|4
298793|NCT00862940|980836|P2|Overall Study|Withdrawal by Subject|6
298794|NCT00862940|980837|P1|Overall Study|Withdrawal by Subject|4
298795|NCT00862940|980836|P2|Overall Study|Protocol Violation|5
298796|NCT00862940|980837|P1|Overall Study|Protocol Violation|2
298797|NCT00862940|980836|P2|Overall Study|Lack of Efficacy|3
298798|NCT00862940|980837|P1|Overall Study|Lack of Efficacy|1
298799|NCT00862940|980836|P2|Overall Study|Adverse Event|12
298800|NCT00862940|980837|P1|Overall Study|Adverse Event|15
298801|NCT00862849|980849|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
298802|NCT00862849|980850|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
298803|NCT00862849|980851|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
298804|NCT00862849|980852|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
298805|NCT00862849|980853|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
298806|NCT00862849|980854|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
298807|NCT00862849|980849|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
298808|NCT00862849|980850|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
298809|NCT00862849|980851|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
298810|NCT00862849|980852|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
298811|NCT00862849|980853|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
298812|NCT00862849|980854|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
298813|NCT00862836|980877|P1|Overall Study|Withdrawal by Subject|1
298814|NCT00862823|980888|P2|First Intervention|Withdrawal by Subject|1
298815|NCT00862823|980889|P1|First Intervention|Withdrawal by Subject|1
298816|NCT00862719|980938|P4|Overall Study|Veno-Occlusive Disease|0
298817|NCT00862719|980939|P3|Overall Study|Veno-Occlusive Disease|1
298818|NCT00862719|980940|P2|Overall Study|Veno-Occlusive Disease|0
298819|NCT00862719|980941|P1|Overall Study|Veno-Occlusive Disease|0
298820|NCT00862719|980938|P4|Overall Study|Engraftment failure|0
298821|NCT00862719|980939|P3|Overall Study|Engraftment failure|1
298822|NCT00862719|980940|P2|Overall Study|Engraftment failure|0
298823|NCT00862719|980941|P1|Overall Study|Engraftment failure|0
298824|NCT00862719|980938|P4|Overall Study|Death|1
298825|NCT00862719|980939|P3|Overall Study|Death|1
298826|NCT00862719|980940|P2|Overall Study|Death|6
298827|NCT00862719|980941|P1|Overall Study|Death|5
298828|NCT00862719|980938|P4|Overall Study|Disease Progression|0
298829|NCT00862719|980939|P3|Overall Study|Disease Progression|1
298830|NCT00862719|980940|P2|Overall Study|Disease Progression|0
298831|NCT00862719|980941|P1|Overall Study|Disease Progression|5
298832|NCT00862654|980964|P4|Overall Study|Included after end of inclusions|0
298833|NCT00862654|980965|P3|Overall Study|Included after end of inclusions|1
298834|NCT00862654|980966|P2|Overall Study|Included after end of inclusions|0
298835|NCT00862654|980967|P1|Overall Study|Included after end of inclusions|0
298836|NCT00862654|980964|P4|Overall Study|Never used study drugs|0
298837|NCT00862654|980965|P3|Overall Study|Never used study drugs|0
298838|NCT00862654|980966|P2|Overall Study|Never used study drugs|0
298839|NCT00862654|980967|P1|Overall Study|Never used study drugs|1
298840|NCT00862654|980964|P4|Overall Study|Familly constraint|0
298841|NCT00862654|980965|P3|Overall Study|Familly constraint|0
298842|NCT00862654|980966|P2|Overall Study|Familly constraint|1
298843|NCT00862654|980967|P1|Overall Study|Familly constraint|0
298844|NCT00862654|980964|P4|Overall Study|Subject mistake|0
298845|NCT00862654|980965|P3|Overall Study|Subject mistake|0
298846|NCT00862654|980966|P2|Overall Study|Subject mistake|1
298847|NCT00862654|980967|P1|Overall Study|Subject mistake|0
298848|NCT00862654|980964|P4|Overall Study|Withdrawal by Subject|3
298849|NCT00862654|980965|P3|Overall Study|Withdrawal by Subject|2
298850|NCT00862654|980966|P2|Overall Study|Withdrawal by Subject|2
298851|NCT00862654|980967|P1|Overall Study|Withdrawal by Subject|2
298852|NCT00862654|980964|P4|Overall Study|Pregnancy|0
298853|NCT00862654|980965|P3|Overall Study|Pregnancy|0
298854|NCT00862654|980966|P2|Overall Study|Pregnancy|1
298855|NCT00862654|980967|P1|Overall Study|Pregnancy|1
298856|NCT00862654|980964|P4|Overall Study|Adverse Event|0
298857|NCT00862654|980965|P3|Overall Study|Adverse Event|1
298858|NCT00862654|980966|P2|Overall Study|Adverse Event|1
298859|NCT00862654|980967|P1|Overall Study|Adverse Event|0
298860|NCT00862654|980964|P4|Overall Study|Lost to Follow-up|3
298861|NCT00862654|980965|P3|Overall Study|Lost to Follow-up|1
298862|NCT00862654|980966|P2|Overall Study|Lost to Follow-up|2
298863|NCT00862654|980967|P1|Overall Study|Lost to Follow-up|1
298864|NCT00862654|980964|P4|Overall Study|Lack of Efficacy|0
298865|NCT00862654|980965|P3|Overall Study|Lack of Efficacy|1
298866|NCT00862654|980966|P2|Overall Study|Lack of Efficacy|0
298867|NCT00862654|980967|P1|Overall Study|Lack of Efficacy|1
298868|NCT00862641|980981|P4|Overall Study|Randomized, but drug not received|4
298869|NCT00862641|980982|P3|Overall Study|Randomized, but drug not received|1
298870|NCT00862641|980983|P2|Overall Study|Randomized, but drug not received|4
298871|NCT00862641|980984|P1|Overall Study|Randomized, but drug not received|1
298872|NCT00862459|981078|P3|Overall Study|Administrative problems|0
298873|NCT00862459|981079|P2|Overall Study|Administrative problems|1
298874|NCT00862459|981080|P1|Overall Study|Administrative problems|0
298875|NCT00862459|981078|P3|Overall Study|Inclusion/exclusion criteria not met|0
298876|NCT00862459|981079|P2|Overall Study|Inclusion/exclusion criteria not met|1
298877|NCT00862459|981080|P1|Overall Study|Inclusion/exclusion criteria not met|0
298878|NCT00862459|981078|P3|Overall Study|Unable to hold still for imaging|0
298879|NCT00862459|981079|P2|Overall Study|Unable to hold still for imaging|1
298880|NCT00862459|981080|P1|Overall Study|Unable to hold still for imaging|0
298881|NCT00862459|981078|P3|Overall Study|Intravenous (IV) site problems|1
298882|NCT00862459|981079|P2|Overall Study|Intravenous (IV) site problems|0
298883|NCT00862459|981080|P1|Overall Study|Intravenous (IV) site problems|1
298884|NCT00862459|981078|P3|Overall Study|Operation|0
298885|NCT00862459|981079|P2|Overall Study|Operation|1
298886|NCT00862459|981080|P1|Overall Study|Operation|1
298887|NCT00862459|981078|P3|Overall Study|Personal reasons|0
298888|NCT00862459|981079|P2|Overall Study|Personal reasons|0
298889|NCT00862459|981080|P1|Overall Study|Personal reasons|1
298890|NCT00862459|981078|P3|Overall Study|Adverse Event|0
298891|NCT00862459|981079|P2|Overall Study|Adverse Event|1
298892|NCT00862459|981080|P1|Overall Study|Adverse Event|0
298893|NCT00862459|981078|P3|Overall Study|Withdrawal by Subject|3
298894|NCT00862459|981079|P2|Overall Study|Withdrawal by Subject|1
298895|NCT00862459|981080|P1|Overall Study|Withdrawal by Subject|1
298896|NCT00862459|981078|P3|Overall Study|Protocol Violation|0
298897|NCT00862459|981079|P2|Overall Study|Protocol Violation|0
298898|NCT00862459|981080|P1|Overall Study|Protocol Violation|1
298899|NCT00862459|981078|P3|Overall Study|Lost to Follow-up|2
298900|NCT00862459|981079|P2|Overall Study|Lost to Follow-up|2
298901|NCT00862459|981080|P1|Overall Study|Lost to Follow-up|1
298902|NCT00862277|981227|P3|Overall Study|Protocol Violation|5
298903|NCT00862277|981228|P2|Overall Study|Protocol Violation|2
298904|NCT00862277|981229|P1|Overall Study|Protocol Violation|1
298905|NCT00862251|981243|P3|Overall Study|Withdrawal by Subject|6
298906|NCT00862251|981244|P2|Overall Study|Withdrawal by Subject|2
298907|NCT00862251|981245|P1|Overall Study|Withdrawal by Subject|9
298908|NCT00862251|981243|P3|Overall Study|Protocol Violation|1
298909|NCT00862251|981244|P2|Overall Study|Protocol Violation|0
298910|NCT00862251|981245|P1|Overall Study|Protocol Violation|2
298911|NCT00862251|981243|P3|Overall Study|Lost to Follow-up|1
298912|NCT00862251|981244|P2|Overall Study|Lost to Follow-up|0
298913|NCT00862251|981245|P1|Overall Study|Lost to Follow-up|0
298914|NCT00862251|981243|P3|Overall Study|Adverse Event|1
298915|NCT00862251|981244|P2|Overall Study|Adverse Event|3
298916|NCT00862251|981245|P1|Overall Study|Adverse Event|8
298917|NCT00862134|981305|P2|Overall Study|Withdrew prior to dosing|0
298918|NCT00862134|981306|P1|Overall Study|Withdrew prior to dosing|2
298919|NCT00862134|981305|P2|Overall Study|Adverse Event|2
298920|NCT00862134|981306|P1|Overall Study|Adverse Event|2
298921|NCT00862134|981305|P2|Overall Study|Sponsor terminated study|7
298922|NCT00862134|981306|P1|Overall Study|Sponsor terminated study|5
298923|NCT00862134|981305|P2|Overall Study|Withdrawal by Subject|2
298924|NCT00862134|981306|P1|Overall Study|Withdrawal by Subject|1
298925|NCT00862134|981305|P2|Overall Study|Physician Decision|1
298926|NCT00862134|981306|P1|Overall Study|Physician Decision|0
298927|NCT00862134|981305|P2|Overall Study|Death|0
298928|NCT00862134|981306|P1|Overall Study|Death|1
298929|NCT00862121|981318|P2|Overall Study|Incorrect randomisation|1
298930|NCT00862121|981319|P1|Overall Study|Incorrect randomisation|0
298931|NCT00862121|981318|P2|Overall Study|Exclusion criterion violation|1
298932|NCT00862121|981319|P1|Overall Study|Exclusion criterion violation|0
298933|NCT00862121|981318|P2|Overall Study|Protocol Violation|1
298934|NCT00862121|981319|P1|Overall Study|Protocol Violation|0
298935|NCT00862121|981318|P2|Overall Study|Lack of Efficacy|3
298936|NCT00862121|981319|P1|Overall Study|Lack of Efficacy|0
298937|NCT00862121|981318|P2|Overall Study|Adverse Event|2
298938|NCT00862121|981319|P1|Overall Study|Adverse Event|1
298939|NCT00862082|981337|P2|Overall Study|Withdrawal by Subject|1
298940|NCT00862082|981338|P1|Overall Study|Withdrawal by Subject|0
298941|NCT00862082|981337|P2|Overall Study|Sponsor decision to terminate the study|0
298942|NCT00862082|981338|P1|Overall Study|Sponsor decision to terminate the study|5
298943|NCT00861757|981393|P4|Overall Study|Withdrawal by Subject|2
298944|NCT00861757|981394|P3|Overall Study|Withdrawal by Subject|5
298945|NCT00861757|981395|P2|Overall Study|Withdrawal by Subject|5
298946|NCT00861757|981396|P1|Overall Study|Withdrawal by Subject|1
298947|NCT00861757|981393|P4|Overall Study|Protocol Violation|1
298948|NCT00861757|981394|P3|Overall Study|Protocol Violation|4
298949|NCT00861757|981395|P2|Overall Study|Protocol Violation|2
298950|NCT00861757|981396|P1|Overall Study|Protocol Violation|2
298951|NCT00861757|981393|P4|Overall Study|Physician Decision|1
298952|NCT00861757|981394|P3|Overall Study|Physician Decision|0
298953|NCT00861757|981395|P2|Overall Study|Physician Decision|0
298954|NCT00861757|981396|P1|Overall Study|Physician Decision|0
298955|NCT00861757|981393|P4|Overall Study|Lost to Follow-up|1
298956|NCT00861757|981394|P3|Overall Study|Lost to Follow-up|1
298957|NCT00861757|981395|P2|Overall Study|Lost to Follow-up|0
298958|NCT00861757|981396|P1|Overall Study|Lost to Follow-up|1
298959|NCT00861757|981393|P4|Overall Study|Lack of Efficacy|1
298960|NCT00861757|981394|P3|Overall Study|Lack of Efficacy|0
298961|NCT00861757|981395|P2|Overall Study|Lack of Efficacy|1
298962|NCT00861757|981396|P1|Overall Study|Lack of Efficacy|3
298963|NCT00861757|981393|P4|Overall Study|Entry Criteria Not Met|1
298964|NCT00861757|981394|P3|Overall Study|Entry Criteria Not Met|1
298965|NCT00861757|981395|P2|Overall Study|Entry Criteria Not Met|2
298966|NCT00861757|981396|P1|Overall Study|Entry Criteria Not Met|1
298967|NCT00861757|981393|P4|Overall Study|Adverse Event|2
298968|NCT00861757|981394|P3|Overall Study|Adverse Event|7
298969|NCT00861757|981395|P2|Overall Study|Adverse Event|5
298970|NCT00861757|981396|P1|Overall Study|Adverse Event|1
298971|NCT00861744|981454|P4|Overall Study|Blood draws|1
298972|NCT00861744|981455|P3|Overall Study|Blood draws|0
298973|NCT00861744|981456|P2|Overall Study|Blood draws|0
298974|NCT00861744|981457|P1|Overall Study|Blood draws|0
298975|NCT00861744|981454|P4|Overall Study|Migration from study area|0
298976|NCT00861744|981455|P3|Overall Study|Migration from study area|1
298977|NCT00861744|981456|P2|Overall Study|Migration from study area|3
298978|NCT00861744|981457|P1|Overall Study|Migration from study area|0
298979|NCT00861744|981454|P4|Overall Study|Protocol Violation|0
298980|NCT00861744|981455|P3|Overall Study|Protocol Violation|0
298981|NCT00861744|981456|P2|Overall Study|Protocol Violation|1
298982|NCT00861744|981457|P1|Overall Study|Protocol Violation|0
298983|NCT00861744|981454|P4|Overall Study|Withdrawal by Subject|19
298984|NCT00861744|981455|P3|Overall Study|Withdrawal by Subject|6
298985|NCT00861744|981456|P2|Overall Study|Withdrawal by Subject|6
298986|NCT00861744|981457|P1|Overall Study|Withdrawal by Subject|10
298987|NCT00861744|981454|P4|Overall Study|Lost to Follow-up|12
298988|NCT00861744|981455|P3|Overall Study|Lost to Follow-up|17
298989|NCT00861744|981456|P2|Overall Study|Lost to Follow-up|19
298990|NCT00861744|981457|P1|Overall Study|Lost to Follow-up|7
298991|NCT00861744|981454|P4|Overall Study|Adverse Event|1
298992|NCT00861744|981455|P3|Overall Study|Adverse Event|0
298993|NCT00861744|981456|P2|Overall Study|Adverse Event|0
298994|NCT00861744|981457|P1|Overall Study|Adverse Event|0
298995|NCT00861705|981639|P4|Overall Study|Never Began Treatment|1
298996|NCT00861705|981640|P3|Overall Study|Never Began Treatment|0
298997|NCT00861705|981641|P2|Overall Study|Never Began Treatment|3
298998|NCT00861705|981642|P1|Overall Study|Never Began Treatment|7
298999|NCT00861692|981658|P1|Overall Study|Death|6
299000|NCT00861614|981670|P2|Overall Study|Unspecified|22
299001|NCT00861614|981671|P1|Overall Study|Unspecified|17
299002|NCT00861614|981670|P2|Overall Study|Withdrawal by Subject|35
299003|NCT00861614|981671|P1|Overall Study|Withdrawal by Subject|34
299004|NCT00861614|981670|P2|Overall Study|Adverse Event|23
299005|NCT00861614|981671|P1|Overall Study|Adverse Event|27
299006|NCT00861614|981670|P2|Overall Study|Death|19
299007|NCT00861614|981671|P1|Overall Study|Death|32
299008|NCT00861614|981670|P2|Overall Study|Study Drug Toxicity|6
299009|NCT00861614|981671|P1|Overall Study|Study Drug Toxicity|79
299010|NCT00861614|981670|P2|Overall Study|Disease Progression|263
299011|NCT00861614|981671|P1|Overall Study|Disease Progression|182
299012|NCT00861471|981756|P1|Overall Study|Physician Decision|2
299013|NCT00861471|981756|P1|Overall Study|treatment for lumbar laminectomy|1
299014|NCT00861471|981756|P1|Overall Study|Lack of Efficacy|3
299015|NCT00861471|981756|P1|Overall Study|Adverse Event|2
299016|NCT00861471|981756|P1|Overall Study|Withdrawal by Subject|1
299017|NCT00861341|981764|P1|Overall Study|Withdrawal by Subject|2
299018|NCT00861198|981773|P1|Overall Study|SpyGlass Failed|5
299019|NCT00860951|981790|P1|Overall Study|Lost to Follow-up|5
299020|NCT00860951|981790|P1|Overall Study|Withdrawal by Subject|2
299021|NCT00860743|981832|P2|Overall Study|Withdrawal by Subject|0
299022|NCT00860743|981833|P1|Overall Study|Withdrawal by Subject|3
299023|NCT00860470|981846|P2|Overall Study|Lost to Follow-up|39
299024|NCT00860470|981847|P1|Overall Study|Lost to Follow-up|34
299025|NCT00860470|981846|P2|Overall Study|Moved away|10
299026|NCT00860470|981847|P1|Overall Study|Moved away|8
299027|NCT00860470|981846|P2|Overall Study|Death|10
299028|NCT00860470|981847|P1|Overall Study|Death|6
299029|NCT00860405|981877|P2|Overall Study|Main reason: Follow-up data not complete|4
299030|NCT00860405|981878|P1|Overall Study|Main reason: Follow-up data not complete|5
299031|NCT00860262|981918|P3|Overall Study|Not Specified|1
299032|NCT00860262|981919|P2|Overall Study|Not Specified|3
299033|NCT00860262|981920|P1|Overall Study|Not Specified|5
299034|NCT00860262|981918|P3|Overall Study|Lack of Efficacy|3
299035|NCT00860262|981919|P2|Overall Study|Lack of Efficacy|4
299036|NCT00860262|981920|P1|Overall Study|Lack of Efficacy|0
299037|NCT00860262|981918|P3|Overall Study|Withdrawal by Subject|6
299038|NCT00860262|981919|P2|Overall Study|Withdrawal by Subject|8
299039|NCT00860262|981920|P1|Overall Study|Withdrawal by Subject|4
299040|NCT00860262|981918|P3|Overall Study|Lost to Follow-up|1
299041|NCT00860262|981919|P2|Overall Study|Lost to Follow-up|0
299042|NCT00860262|981920|P1|Overall Study|Lost to Follow-up|2
299043|NCT00860262|981918|P3|Overall Study|Protocol Violation|0
299044|NCT00860262|981919|P2|Overall Study|Protocol Violation|1
299045|NCT00860262|981920|P1|Overall Study|Protocol Violation|0
299046|NCT00860262|981918|P3|Overall Study|Adverse Event|7
299047|NCT00860262|981919|P2|Overall Study|Adverse Event|6
299048|NCT00860262|981920|P1|Overall Study|Adverse Event|9
299049|NCT00860249|982033|P3|Overall Study|trial was terminated prior to completion|21
299050|NCT00860249|982034|P2|Overall Study|trial was terminated prior to completion|18
299051|NCT00860249|982035|P1|Overall Study|trial was terminated prior to completion|21
299052|NCT00860158|982046|P1|Overall Study|Study Terminated|1
299053|NCT00860067|982057|P3|Overall Study|Pregnancy|0
299054|NCT00860067|982058|P2|Overall Study|Pregnancy|0
299055|NCT00860067|982059|P1|Overall Study|Pregnancy|1
299056|NCT00860067|982057|P3|Overall Study|Withdrawal by Subject|0
299057|NCT00860067|982058|P2|Overall Study|Withdrawal by Subject|0
299058|NCT00860067|982059|P1|Overall Study|Withdrawal by Subject|4
299059|NCT00860067|982057|P3|Overall Study|Lost to Follow-up|9
299060|NCT00860067|982058|P2|Overall Study|Lost to Follow-up|9
299061|NCT00860067|982059|P1|Overall Study|Lost to Follow-up|46
299062|NCT00860028|982119|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
299063|NCT00860028|982120|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
299064|NCT00859937|982141|P2|Overall Study|Protocol Violation|0
299065|NCT00859937|982142|P1|Overall Study|Protocol Violation|1
299066|NCT00859898|982157|P3|Overall Study|non-specified|1
299067|NCT00859898|982158|P2|Overall Study|non-specified|1
299068|NCT00859898|982159|P1|Overall Study|non-specified|1
299069|NCT00859898|982157|P3|Overall Study|No longer meets criteria|0
299070|NCT00859898|982158|P2|Overall Study|No longer meets criteria|1
299071|NCT00859898|982159|P1|Overall Study|No longer meets criteria|0
299072|NCT00859898|982157|P3|Overall Study|poor/non-compliance|0
299073|NCT00859898|982158|P2|Overall Study|poor/non-compliance|0
299074|NCT00859898|982159|P1|Overall Study|poor/non-compliance|2
299075|NCT00859898|982157|P3|Overall Study|Lost to Follow-up|5
299076|NCT00859898|982158|P2|Overall Study|Lost to Follow-up|11
299077|NCT00859898|982159|P1|Overall Study|Lost to Follow-up|10
299078|NCT00859898|982157|P3|Overall Study|Death|1
299079|NCT00859898|982158|P2|Overall Study|Death|0
299080|NCT00859898|982159|P1|Overall Study|Death|0
299081|NCT00859898|982157|P3|Overall Study|Withdrawal by Subject|11
299082|NCT00859898|982158|P2|Overall Study|Withdrawal by Subject|8
299083|NCT00859898|982159|P1|Overall Study|Withdrawal by Subject|11
299084|NCT00859898|982157|P3|Overall Study|Adverse Event|8
299085|NCT00859898|982158|P2|Overall Study|Adverse Event|9
299086|NCT00859898|982159|P1|Overall Study|Adverse Event|4
299087|NCT00859898|982157|P3|Overall Study|Lack of Efficacy|1
299088|NCT00859898|982158|P2|Overall Study|Lack of Efficacy|1
299089|NCT00859898|982159|P1|Overall Study|Lack of Efficacy|0
299090|NCT00859638|982207|P2|Overall Study|Ill health|1
299091|NCT00859638|982208|P1|Overall Study|Ill health|1
299092|NCT00859638|982207|P2|Overall Study|Withdrawal by Subject|2
299093|NCT00859638|982208|P1|Overall Study|Withdrawal by Subject|3
299094|NCT00859638|982207|P2|Overall Study|Lost to Follow-up|1
299095|NCT00859638|982208|P1|Overall Study|Lost to Follow-up|6
299096|NCT00859586|982214|P1|Overall Study|Donors|4
299097|NCT00859573|982220|P2|Overall Study|Physician Decision|1
299098|NCT00859573|982221|P1|Overall Study|Physician Decision|1
299099|NCT00859573|982220|P2|Overall Study|Withdrawal by Subject|1
299100|NCT00859573|982221|P1|Overall Study|Withdrawal by Subject|4
299101|NCT00859547|982227|P1|Overall Study|Parent withdrew consent|1
299102|NCT00859547|982227|P1|Overall Study|Lost to Follow-up|1
299103|NCT00859521|982240|P2|Washout|Withdrawal by Subject|1
299104|NCT00859521|982241|P1|Washout|Withdrawal by Subject|0
299105|NCT00859469|982258|P1|Overall Study|Death|16
299106|NCT00859469|982258|P1|Overall Study|Withdrawal by Subject|1
299107|NCT00859469|982258|P1|Overall Study|Lack of Efficacy|9
299108|NCT00859469|982258|P1|Overall Study|Adverse Event|2
299109|NCT00859430|982266|P2|First Intervention|Withdrawal by Subject|1
299110|NCT00859430|982267|P1|First Intervention|Withdrawal by Subject|0
299111|NCT00859313|982283|P1|Overall Study|staff error|1
299112|NCT00859313|982283|P1|Overall Study|Adverse Event|1
299113|NCT00859313|982283|P1|Overall Study|Lack of Efficacy|2
299114|NCT00859222|982290|P5|Overall Study|DLT|0
299115|NCT00859222|982291|P4|Overall Study|DLT|0
299116|NCT00859222|982292|P3|Overall Study|DLT|0
299117|NCT00859222|982293|P2|Overall Study|DLT|0
299118|NCT00859222|982294|P1|Overall Study|DLT|1
299119|NCT00859222|982290|P5|Overall Study|Adverse Event|15
299120|NCT00859222|982291|P4|Overall Study|Adverse Event|24
299121|NCT00859222|982292|P3|Overall Study|Adverse Event|6
299122|NCT00859222|982293|P2|Overall Study|Adverse Event|3
299123|NCT00859222|982294|P1|Overall Study|Adverse Event|2
299124|NCT00859014|982413|P1|Overall Study|Lost to Follow-up|1
299125|NCT00859014|982413|P1|Overall Study|Death|4
299126|NCT00858845|982426|P1|Overall Study|Patient underwent heart transplant.|1
299127|NCT00858832|982432|P2|Overall Study|Adverse Event|1
299128|NCT00858832|982433|P1|Overall Study|Adverse Event|0
299129|NCT00858832|982432|P2|Overall Study|became ineligible: delivered vaginally|0
299130|NCT00858832|982433|P1|Overall Study|became ineligible: delivered vaginally|1
299131|NCT00858780|982439|P5|OL Re-Treatment (Failure to Week 48)|Unspecified|1
299132|NCT00858780|982440|P4|OL Re-Treatment (Failure to Week 48)|Unspecified|0
299133|NCT00858780|982441|P3|OL Re-Treatment (Failure to Week 48)|Unspecified|0
299134|NCT00858780|982442|P2|OL Re-Treatment (Failure to Week 48)|Unspecified|0
299135|NCT00858780|982443|P1|OL Re-Treatment (Failure to Week 48)|Unspecified|0
299136|NCT00858780|982439|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
299137|NCT00858780|982440|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
299138|NCT00858780|982441|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
299139|NCT00858780|982442|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
299140|NCT00858780|982443|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
299141|NCT00858780|982439|P5|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
299142|NCT00858780|982440|P4|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
299143|NCT00858780|982441|P3|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
299144|NCT00858780|982442|P2|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|1
299145|NCT00858780|982443|P1|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
299146|NCT00858780|982439|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
299147|NCT00858780|982440|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
299148|NCT00858780|982441|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
299149|NCT00858780|982442|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
299150|NCT00858780|982443|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
299151|NCT00858780|982439|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
299152|NCT00858780|982440|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
299153|NCT00858780|982441|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
299154|NCT00858780|982442|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
299155|NCT00858780|982443|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
299156|NCT00858780|982439|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
299157|NCT00858780|982440|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
299158|NCT00858780|982441|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
299159|NCT00858780|982442|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
299160|NCT00858780|982443|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
299161|NCT00858702|982518|P2|Overall Study|Withdrawal by Subject|0
299162|NCT00858702|982519|P1|Overall Study|Withdrawal by Subject|1
299163|NCT00858702|982518|P2|Overall Study|Other|1
299164|NCT00858702|982519|P1|Overall Study|Other|2
299165|NCT00858702|982518|P2|Overall Study|Protocol Violation|1
299166|NCT00858702|982519|P1|Overall Study|Protocol Violation|1
299167|NCT00858702|982518|P2|Overall Study|Lack of Efficacy|0
299168|NCT00858702|982519|P1|Overall Study|Lack of Efficacy|1
299169|NCT00858637|982536|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
299170|NCT00858637|982537|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
299171|NCT00858637|982538|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
299172|NCT00858637|982539|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
299173|NCT00858637|982540|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
299174|NCT00858637|982541|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
299175|NCT00858637|982536|P6|Placebo-controlled Withdrawal Phase|Death|0
299176|NCT00858637|982537|P5|Placebo-controlled Withdrawal Phase|Death|1
299177|NCT00858637|982538|P4|Placebo-controlled Withdrawal Phase|Death|0
299178|NCT00858637|982539|P3|Placebo-controlled Withdrawal Phase|Death|1
299179|NCT00858637|982540|P2|Placebo-controlled Withdrawal Phase|Death|0
299180|NCT00858637|982541|P1|Placebo-controlled Withdrawal Phase|Death|0
299181|NCT00858637|982536|P6|Active Comparison Phase|Other Reasons|0
299182|NCT00858637|982537|P5|Active Comparison Phase|Other Reasons|0
299183|NCT00858637|982538|P4|Active Comparison Phase|Other Reasons|1
299184|NCT00858637|982539|P3|Active Comparison Phase|Other Reasons|0
299185|NCT00858637|982540|P2|Active Comparison Phase|Other Reasons|0
299186|NCT00858637|982541|P1|Active Comparison Phase|Other Reasons|1
299187|NCT00858637|982536|P6|Active Comparison Phase|Withdrawal by Subject|0
299188|NCT00858637|982537|P5|Active Comparison Phase|Withdrawal by Subject|0
299189|NCT00858637|982538|P4|Active Comparison Phase|Withdrawal by Subject|6
299190|NCT00858637|982539|P3|Active Comparison Phase|Withdrawal by Subject|0
299191|NCT00858637|982540|P2|Active Comparison Phase|Withdrawal by Subject|0
299192|NCT00858637|982541|P1|Active Comparison Phase|Withdrawal by Subject|7
299193|NCT00858637|982536|P6|Active Comparison Phase|Physician Decision|0
299194|NCT00858637|982537|P5|Active Comparison Phase|Physician Decision|0
299195|NCT00858637|982538|P4|Active Comparison Phase|Physician Decision|1
299196|NCT00858637|982539|P3|Active Comparison Phase|Physician Decision|0
299197|NCT00858637|982540|P2|Active Comparison Phase|Physician Decision|0
299198|NCT00858637|982541|P1|Active Comparison Phase|Physician Decision|1
299199|NCT00858637|982536|P6|Active Comparison Phase|Death|0
299200|NCT00858637|982537|P5|Active Comparison Phase|Death|0
299201|NCT00858637|982538|P4|Active Comparison Phase|Death|1
299202|NCT00858637|982539|P3|Active Comparison Phase|Death|0
299203|NCT00858637|982540|P2|Active Comparison Phase|Death|0
299204|NCT00858637|982541|P1|Active Comparison Phase|Death|1
299205|NCT00858637|982536|P6|Active Comparison Phase|Adverse Event|0
299206|NCT00858637|982537|P5|Active Comparison Phase|Adverse Event|0
299207|NCT00858637|982538|P4|Active Comparison Phase|Adverse Event|9
299208|NCT00858637|982539|P3|Active Comparison Phase|Adverse Event|0
299209|NCT00858637|982540|P2|Active Comparison Phase|Adverse Event|0
299210|NCT00858637|982541|P1|Active Comparison Phase|Adverse Event|14
299211|NCT00858442|982582|P2|Compression:Start to Finish|Lost to Follow-up|3
299212|NCT00858442|982583|P1|Compression:Start to Finish|Lost to Follow-up|1
299213|NCT00858403|982593|P1|Overall Study|Disease Progression|1
299214|NCT00858403|982593|P1|Overall Study|Death|3
299215|NCT00858403|982593|P1|Overall Study|Withdrawal by Subject|1
299216|NCT00858247|982614|P2|Week 12 Follow-up|Withdrawal by Subject|1
299217|NCT00858247|982615|P1|Week 12 Follow-up|Withdrawal by Subject|0
299218|NCT00858247|982614|P2|Baseline Assessment|Protocol Violation|1
299219|NCT00858247|982615|P1|Baseline Assessment|Protocol Violation|0
299220|NCT00858247|982614|P2|Baseline Assessment|Poor IV access|0
299221|NCT00858247|982615|P1|Baseline Assessment|Poor IV access|1
299222|NCT00858247|982614|P2|Baseline Assessment|Withdrawal by Subject|1
299223|NCT00858247|982615|P1|Baseline Assessment|Withdrawal by Subject|1
299224|NCT00858208|982631|P1|Overall Study|Unspecified|10
299225|NCT00858208|982631|P1|Overall Study|Participant refused|40
299226|NCT00858208|982631|P1|Overall Study|Lost to Follow-up|26
299227|NCT00858208|982631|P1|Overall Study|Adverse Event|3
299228|NCT00858143|982648|P1|Overall Study|Other|23
299229|NCT00858143|982648|P1|Overall Study|Death|7
299230|NCT00858143|982648|P1|Overall Study|Lack of Efficacy|4
299231|NCT00858143|982648|P1|Overall Study|Adverse Event|16
299232|NCT00857948|982752|P4|Overall Study|Protocol Violation|0
299233|NCT00857948|982753|P3|Overall Study|Protocol Violation|1
299234|NCT00857948|982754|P2|Overall Study|Protocol Violation|0
299235|NCT00857948|982755|P1|Overall Study|Protocol Violation|1
299236|NCT00857948|982752|P4|Overall Study|Withdrawal by Subject|0
299237|NCT00857948|982753|P3|Overall Study|Withdrawal by Subject|0
299238|NCT00857948|982754|P2|Overall Study|Withdrawal by Subject|0
299239|NCT00857948|982755|P1|Overall Study|Withdrawal by Subject|2
299240|NCT00857896|982777|P1|Baseline to Week 4|Withdrawal by Subject|1
299241|NCT00857818|982791|P2|Overall Study|Investigator decision|0
299242|NCT00857818|982792|P1|Overall Study|Investigator decision|1
299243|NCT00857818|982791|P2|Overall Study|Sponsor terminated study|4
299244|NCT00857818|982792|P1|Overall Study|Sponsor terminated study|6
299245|NCT00857818|982791|P2|Overall Study|Withdrawal by Subject|4
299246|NCT00857818|982792|P1|Overall Study|Withdrawal by Subject|0
299247|NCT00857818|982791|P2|Overall Study|Adverse Event|0
299248|NCT00857818|982792|P1|Overall Study|Adverse Event|3
299249|NCT00857818|982791|P2|Overall Study|Lack of Efficacy|0
299250|NCT00857818|982792|P1|Overall Study|Lack of Efficacy|1
299251|NCT00857792|982820|P1|Overall Study|inadequate image quality for analysis|12
299252|NCT00857766|982826|P2|Overall Study|Participant Withdrew Consent|4
299253|NCT00857766|982827|P1|Overall Study|Participant Withdrew Consent|4
299254|NCT00857766|982826|P2|Overall Study|Investigator Discretion|3
299255|NCT00857766|982827|P1|Overall Study|Investigator Discretion|2
299256|NCT00857766|982826|P2|Overall Study|Lost to Follow-up|0
299257|NCT00857766|982827|P1|Overall Study|Lost to Follow-up|1
299258|NCT00857766|982826|P2|Overall Study|Protocol Violation|11
299259|NCT00857766|982827|P1|Overall Study|Protocol Violation|11
299260|NCT00857766|982826|P2|Overall Study|Adverse Event|12
299261|NCT00857766|982827|P1|Overall Study|Adverse Event|13
299262|NCT00857649|982844|P2|Overall Study|Other Reasons|3
299263|NCT00857649|982845|P1|Overall Study|Other Reasons|1
299264|NCT00857649|982844|P2|Overall Study|Nursing Home Placement|9
299265|NCT00857649|982845|P1|Overall Study|Nursing Home Placement|2
299266|NCT00857649|982844|P2|Overall Study|Withdrawal of Consent|7
299267|NCT00857649|982845|P1|Overall Study|Withdrawal of Consent|10
299268|NCT00857649|982844|P2|Overall Study|Protocol Violation|2
299269|NCT00857649|982845|P1|Overall Study|Protocol Violation|2
299270|NCT00857649|982844|P2|Overall Study|Non-compliance|1
299271|NCT00857649|982845|P1|Overall Study|Non-compliance|1
299272|NCT00857649|982844|P2|Overall Study|Adverse Event|10
299273|NCT00857649|982845|P1|Overall Study|Adverse Event|15
299274|NCT00857623|982861|P2|Overall Study|Positive for HEP C|1
299275|NCT00857623|982862|P1|Overall Study|Positive for HEP C|0
299276|NCT00857623|982861|P2|Overall Study|Intake of prohibited medication|1
299277|NCT00857623|982862|P1|Overall Study|Intake of prohibited medication|0
299278|NCT00857623|982861|P2|Overall Study|Severe non-compliance to protocol|1
299279|NCT00857623|982862|P1|Overall Study|Severe non-compliance to protocol|1
299280|NCT00857623|982861|P2|Overall Study|Lack of Efficacy|1
299281|NCT00857623|982862|P1|Overall Study|Lack of Efficacy|1
299282|NCT00857623|982861|P2|Overall Study|Withdrawal by Subject|1
299283|NCT00857623|982862|P1|Overall Study|Withdrawal by Subject|2
299284|NCT00857623|982861|P2|Overall Study|Study-specific discontinuation criteria|3
299285|NCT00857623|982862|P1|Overall Study|Study-specific discontinuation criteria|5
299286|NCT00857623|982861|P2|Overall Study|Adverse Event|2
299287|NCT00857623|982862|P1|Overall Study|Adverse Event|5
299288|NCT00857584|982886|P2|Overall Study|Physician Decision|1
299289|NCT00857584|982887|P1|Overall Study|Physician Decision|1
299290|NCT00857584|982886|P2|Overall Study|Adverse Event|2
299291|NCT00857584|982887|P1|Overall Study|Adverse Event|2
299292|NCT00857584|982886|P2|Overall Study|Lack of Efficacy|2
299293|NCT00857584|982887|P1|Overall Study|Lack of Efficacy|1
299294|NCT00857454|982966|P1|Overall Study|MTE09 enrollment criteria not met|6
299295|NCT00857454|982966|P1|Overall Study|Total Testosterone <300 ng/dL|8
299296|NCT00857454|982966|P1|Overall Study|Total Testosterone >1050 ng/dL|1
299297|NCT00857454|982966|P1|Overall Study|Adverse Event|2
299298|NCT00857454|982966|P1|Overall Study|Lost to Follow-up|1
299299|NCT00857454|982966|P1|Overall Study|Withdrawal by Subject|2
299300|NCT00857415|982979|P2|Overall Study|Deceased with no autopsy|0
299301|NCT00857415|982980|P1|Overall Study|Deceased with no autopsy|2
299302|NCT00857415|982979|P2|Overall Study|Subject still living at end of study|0
299303|NCT00857415|982980|P1|Overall Study|Subject still living at end of study|110
299304|NCT00857415|982979|P2|Overall Study|Invalid image or not imaged|0
299305|NCT00857415|982980|P1|Overall Study|Invalid image or not imaged|3
299306|NCT00857415|982979|P2|Overall Study|Image acquisition failure|0
299307|NCT00857415|982980|P1|Overall Study|Image acquisition failure|2
299308|NCT00857311|982991|P4|Overall Study|Lost to Follow-up|0
299309|NCT00857311|982992|P3|Overall Study|Lost to Follow-up|0
299310|NCT00857311|982993|P2|Overall Study|Lost to Follow-up|0
299311|NCT00857311|982994|P1|Overall Study|Lost to Follow-up|1
299312|NCT00857285|983006|P2|Overall Study|Randomization criteria not met|1
299313|NCT00857285|983007|P1|Overall Study|Randomization criteria not met|1
299314|NCT00857285|983006|P2|Overall Study|Withdrawal by Subject|0
299315|NCT00857285|983007|P1|Overall Study|Withdrawal by Subject|4
299316|NCT00857285|983006|P2|Overall Study|Protocol Violation|1
299317|NCT00857285|983007|P1|Overall Study|Protocol Violation|3
299318|NCT00857285|983006|P2|Overall Study|Lack of Efficacy|2
299319|NCT00857285|983007|P1|Overall Study|Lack of Efficacy|0
299320|NCT00857285|983006|P2|Overall Study|Adverse Event|2
299321|NCT00857285|983007|P1|Overall Study|Adverse Event|4
299322|NCT00857259|983023|P3|Overall Study|Protocol Violation|1
299323|NCT00857259|983024|P2|Overall Study|Protocol Violation|0
299324|NCT00857259|983025|P1|Overall Study|Protocol Violation|1
299325|NCT00857246|983035|P1|ChemoRT|Adverse Event|2
299326|NCT00857246|983035|P1|ChemoRT|Withdrawal by Subject|1
299327|NCT00857246|983035|P1|Surgery (Curative)|disease progression|6
299328|NCT00857246|983035|P1|Induction Regimen|Withdrawal by Subject|1
299329|NCT00857246|983035|P1|Induction Regimen|disease-related complications|1
299330|NCT00857246|983035|P1|Induction Regimen|Adverse Event|1
299331|NCT00857233|983045|P1|Overall Study|Other Reasons|2
299332|NCT00857233|983045|P1|Overall Study|Nursing Home Placement|14
299333|NCT00857233|983045|P1|Overall Study|Lost to Follow-up|4
299334|NCT00857233|983045|P1|Overall Study|Withdrawal of Consent|9
299335|NCT00857233|983045|P1|Overall Study|Non-compliance|1
299336|NCT00857233|983045|P1|Overall Study|Lack of Efficacy|1
299337|NCT00857233|983045|P1|Overall Study|Adverse Event|24
299338|NCT00857220|983054|P1|Overall Study|Miscellaneous|8
299339|NCT00857220|983054|P1|Overall Study|Site Closed|5
299340|NCT00857220|983054|P1|Overall Study|Clinical Hold|6
299341|NCT00857220|983054|P1|Overall Study|Withdrawal by Subject|67
299342|NCT00857220|983054|P1|Overall Study|Protocol Violation|16
299343|NCT00857220|983054|P1|Overall Study|Physician Decision|4
299344|NCT00857220|983054|P1|Overall Study|Lost to Follow-up|30
299345|NCT00857220|983054|P1|Overall Study|Lack of Efficacy|11
299346|NCT00857220|983054|P1|Overall Study|Death|1
299347|NCT00857220|983054|P1|Overall Study|Adverse Event|35
299348|NCT00856986|983076|P5|Extension Period, Weeks 26-52|Unclassified|0
299349|NCT00856986|983077|P4|Extension Period, Weeks 26-52|Unclassified|0
299350|NCT00856986|983078|P3|Extension Period, Weeks 26-52|Unclassified|11
299351|NCT00856986|983079|P2|Extension Period, Weeks 26-52|Unclassified|2
299352|NCT00856986|983080|P1|Extension Period, Weeks 26-52|Unclassified|4
299353|NCT00856986|983076|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
299354|NCT00856986|983077|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
299355|NCT00856986|983078|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
299356|NCT00856986|983079|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
299357|NCT00856986|983080|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
299358|NCT00856986|983076|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
299359|NCT00856986|983077|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
299360|NCT00856986|983078|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
299361|NCT00856986|983079|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
299362|NCT00856986|983080|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
299363|NCT00856986|983076|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
299364|NCT00856986|983077|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
299365|NCT00856986|983078|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
299366|NCT00856986|983079|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
299367|NCT00856986|983080|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
299368|NCT00856986|983076|P5|Extension Period, Weeks 26-52|Protocol Violation|0
299369|NCT00856986|983077|P4|Extension Period, Weeks 26-52|Protocol Violation|0
299370|NCT00856986|983078|P3|Extension Period, Weeks 26-52|Protocol Violation|5
299371|NCT00856986|983079|P2|Extension Period, Weeks 26-52|Protocol Violation|2
299372|NCT00856986|983080|P1|Extension Period, Weeks 26-52|Protocol Violation|6
299373|NCT00856986|983076|P5|Extension Period, Weeks 26-52|Adverse Event|0
299374|NCT00856986|983077|P4|Extension Period, Weeks 26-52|Adverse Event|0
299375|NCT00856986|983078|P3|Extension Period, Weeks 26-52|Adverse Event|10
299376|NCT00856986|983079|P2|Extension Period, Weeks 26-52|Adverse Event|3
299377|NCT00856986|983080|P1|Extension Period, Weeks 26-52|Adverse Event|3
299378|NCT00856986|983076|P5|Main Period, Weeks 0-26|Unclassified|0
299379|NCT00856986|983077|P4|Main Period, Weeks 0-26|Unclassified|0
299380|NCT00856986|983078|P3|Main Period, Weeks 0-26|Unclassified|7
299381|NCT00856986|983079|P2|Main Period, Weeks 0-26|Unclassified|6
299382|NCT00856986|983080|P1|Main Period, Weeks 0-26|Unclassified|7
299383|NCT00856986|983076|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
299384|NCT00856986|983077|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
299385|NCT00856986|983078|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
299386|NCT00856986|983079|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
299387|NCT00856986|983080|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
299388|NCT00856986|983076|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
299389|NCT00856986|983077|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
299390|NCT00856986|983078|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
299391|NCT00856986|983079|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
299392|NCT00856986|983080|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
299393|NCT00856986|983076|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
299394|NCT00856986|983077|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
299395|NCT00856986|983078|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
299396|NCT00856986|983079|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
299397|NCT00856986|983080|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
299398|NCT00856986|983076|P5|Main Period, Weeks 0-26|Protocol Violation|0
299399|NCT00856986|983077|P4|Main Period, Weeks 0-26|Protocol Violation|0
299400|NCT00856986|983078|P3|Main Period, Weeks 0-26|Protocol Violation|7
299401|NCT00856986|983079|P2|Main Period, Weeks 0-26|Protocol Violation|5
299402|NCT00856986|983080|P1|Main Period, Weeks 0-26|Protocol Violation|4
299403|NCT00856986|983076|P5|Main Period, Weeks 0-26|Adverse Event|0
299404|NCT00856986|983077|P4|Main Period, Weeks 0-26|Adverse Event|0
299405|NCT00856986|983078|P3|Main Period, Weeks 0-26|Adverse Event|9
299406|NCT00856986|983079|P2|Main Period, Weeks 0-26|Adverse Event|4
299407|NCT00856986|983080|P1|Main Period, Weeks 0-26|Adverse Event|6
299408|NCT00856986|983076|P5|Run-in Period, Weeks -12-0|Unclassified|0
299409|NCT00856986|983077|P4|Run-in Period, Weeks -12-0|Unclassified|24
299410|NCT00856986|983078|P3|Run-in Period, Weeks -12-0|Unclassified|0
299411|NCT00856986|983079|P2|Run-in Period, Weeks -12-0|Unclassified|0
299412|NCT00856986|983080|P1|Run-in Period, Weeks -12-0|Unclassified|0
299413|NCT00856986|983076|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
299414|NCT00856986|983077|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
299415|NCT00856986|983078|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
299416|NCT00856986|983079|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
299417|NCT00856986|983080|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
299418|NCT00856986|983076|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
299419|NCT00856986|983077|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
299420|NCT00856986|983078|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
299421|NCT00856986|983079|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
299422|NCT00856986|983080|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
299423|NCT00856986|983076|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
299424|NCT00856986|983077|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
299425|NCT00856986|983078|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
299426|NCT00856986|983079|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
299427|NCT00856986|983080|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
299428|NCT00856986|983076|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
299429|NCT00856986|983077|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
299430|NCT00856986|983078|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
299431|NCT00856986|983079|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
299432|NCT00856986|983080|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
299433|NCT00856986|983076|P5|Run-in Period, Weeks -12-0|Adverse Event|0
299434|NCT00856986|983077|P4|Run-in Period, Weeks -12-0|Adverse Event|92
299435|NCT00856986|983078|P3|Run-in Period, Weeks -12-0|Adverse Event|0
299436|NCT00856986|983079|P2|Run-in Period, Weeks -12-0|Adverse Event|0
299437|NCT00856986|983080|P1|Run-in Period, Weeks -12-0|Adverse Event|0
299438|NCT00856973|983250|P3|Overall Study|Other|13
299439|NCT00856973|983251|P2|Overall Study|Other|12
299440|NCT00856973|983252|P1|Overall Study|Other|11
299441|NCT00856973|983250|P3|Overall Study|Withdrawal by Subject|15
299442|NCT00856973|983251|P2|Overall Study|Withdrawal by Subject|16
299443|NCT00856973|983252|P1|Overall Study|Withdrawal by Subject|13
299444|NCT00856973|983250|P3|Overall Study|Protocol Violation|1
299445|NCT00856973|983251|P2|Overall Study|Protocol Violation|2
299446|NCT00856973|983252|P1|Overall Study|Protocol Violation|1
299447|NCT00856973|983250|P3|Overall Study|Physician Decision|1
299448|NCT00856973|983251|P2|Overall Study|Physician Decision|3
299449|NCT00856973|983252|P1|Overall Study|Physician Decision|0
299450|NCT00856973|983250|P3|Overall Study|Lost to Follow-up|5
299451|NCT00856973|983251|P2|Overall Study|Lost to Follow-up|3
299452|NCT00856973|983252|P1|Overall Study|Lost to Follow-up|6
299453|NCT00856973|983250|P3|Overall Study|Adverse Event|3
299454|NCT00856973|983251|P2|Overall Study|Adverse Event|5
299455|NCT00856973|983252|P1|Overall Study|Adverse Event|5
299456|NCT00856908|983332|P2|Overall Study|Lost to Follow-up|0
299457|NCT00856908|983333|P1|Overall Study|Lost to Follow-up|1
299458|NCT00856843|983360|P2|Overall Study|Lack of Efficacy|0
299459|NCT00856843|983361|P1|Overall Study|Lack of Efficacy|1
299460|NCT00856843|983360|P2|Overall Study|Withdrawal by Subject|5
299461|NCT00856843|983361|P1|Overall Study|Withdrawal by Subject|1
299462|NCT00856778|983398|P1|Overall Study|Lost to Follow-up|5
299463|NCT00856778|983398|P1|Overall Study|Study deviation|2
299464|NCT00856778|983398|P1|Overall Study|Withdrawal by Subject|10
299465|NCT00856778|983398|P1|Overall Study|Adverse Event|7
299466|NCT00856661|983432|P2|Overall Study|Physician Judgement|5
299467|NCT00856661|983433|P1|Overall Study|Physician Judgement|8
299468|NCT00856661|983432|P2|Overall Study|Lost to Follow-up|3
299469|NCT00856661|983433|P1|Overall Study|Lost to Follow-up|1
299470|NCT00856661|983432|P2|Overall Study|Withdrawal by Subject|2
299471|NCT00856661|983433|P1|Overall Study|Withdrawal by Subject|1
299472|NCT00856661|983432|P2|Overall Study|Protocol Violation|1
299473|NCT00856661|983433|P1|Overall Study|Protocol Violation|2
299474|NCT00856661|983432|P2|Overall Study|Death|18
299475|NCT00856661|983433|P1|Overall Study|Death|15
299476|NCT00856635|983447|P2|Overall Study|Discontinued at Randomization|2
299477|NCT00856635|983448|P1|Overall Study|Discontinued at Randomization|2
299478|NCT00856635|983447|P2|Overall Study|Other|0
299479|NCT00856635|983448|P1|Overall Study|Other|1
299480|NCT00856635|983447|P2|Overall Study|Serious Adverse Event|0
299481|NCT00856635|983448|P1|Overall Study|Serious Adverse Event|1
299482|NCT00856635|983447|P2|Overall Study|Withdrawal by Subject|1
299483|NCT00856635|983448|P1|Overall Study|Withdrawal by Subject|3
299484|NCT00856635|983447|P2|Overall Study|Pregnancy|0
299485|NCT00856635|983448|P1|Overall Study|Pregnancy|1
299486|NCT00856635|983447|P2|Overall Study|Lost to Follow-up|5
299487|NCT00856635|983448|P1|Overall Study|Lost to Follow-up|2
299488|NCT00856583|983456|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
299489|NCT00856583|983457|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
299490|NCT00856583|983456|P2|Overall Study|Other|104
299491|NCT00856583|983457|P1|Overall Study|Other|92
299492|NCT00856583|983456|P2|Overall Study|Pregnancy|5
299493|NCT00856583|983457|P1|Overall Study|Pregnancy|14
299494|NCT00856583|983456|P2|Overall Study|Physician Decision|82
299495|NCT00856583|983457|P1|Overall Study|Physician Decision|59
299496|NCT00856583|983456|P2|Overall Study|Withdrawal by Subject|919
299497|NCT00856583|983457|P1|Overall Study|Withdrawal by Subject|1092
299498|NCT00856583|983456|P2|Overall Study|Non-compliance|262
299499|NCT00856583|983457|P1|Overall Study|Non-compliance|305
299500|NCT00856583|983456|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
299501|NCT00856583|983457|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
299502|NCT00856583|983456|P2|Overall Study|Serious Adverse Event (SAE)|65
299503|NCT00856583|983457|P1|Overall Study|Serious Adverse Event (SAE)|99
299504|NCT00856583|983456|P2|Overall Study|Lack of Efficacy|377
299505|NCT00856583|983457|P1|Overall Study|Lack of Efficacy|389
299506|NCT00856557|983487|P2|Overall Study|No patients with contextual flags|16
299507|NCT00856557|983488|P1|Overall Study|No patients with contextual flags|12
299508|NCT00856544|983502|P4|Overall Study|Withdrawal by Subject|1
299509|NCT00856544|983503|P3|Overall Study|Withdrawal by Subject|0
299510|NCT00856544|983504|P2|Overall Study|Withdrawal by Subject|5
299511|NCT00856544|983505|P1|Overall Study|Withdrawal by Subject|8
299512|NCT00856544|983502|P4|Overall Study|Lost to Follow-up|0
299513|NCT00856544|983503|P3|Overall Study|Lost to Follow-up|2
299514|NCT00856544|983504|P2|Overall Study|Lost to Follow-up|2
299515|NCT00856544|983505|P1|Overall Study|Lost to Follow-up|1
299516|NCT00856544|983502|P4|Overall Study|Unspecified|6
299517|NCT00856544|983503|P3|Overall Study|Unspecified|1
299518|NCT00856544|983504|P2|Overall Study|Unspecified|16
299519|NCT00856544|983505|P1|Overall Study|Unspecified|9
299520|NCT00856544|983502|P4|Overall Study|Lack of Efficacy|3
299521|NCT00856544|983503|P3|Overall Study|Lack of Efficacy|3
299522|NCT00856544|983504|P2|Overall Study|Lack of Efficacy|12
299523|NCT00856544|983505|P1|Overall Study|Lack of Efficacy|16
299524|NCT00856544|983502|P4|Overall Study|Adverse Event|3
299525|NCT00856544|983503|P3|Overall Study|Adverse Event|2
299526|NCT00856544|983504|P2|Overall Study|Adverse Event|29
299527|NCT00856544|983505|P1|Overall Study|Adverse Event|20
299528|NCT00856544|983502|P4|Overall Study|Death|0
299529|NCT00856544|983503|P3|Overall Study|Death|0
299530|NCT00856544|983504|P2|Overall Study|Death|2
299531|NCT00856544|983505|P1|Overall Study|Death|0
299532|NCT00856544|983502|P4|Overall Study|Randomized but not treated|0
299533|NCT00856544|983503|P3|Overall Study|Randomized but not treated|0
299534|NCT00856544|983504|P2|Overall Study|Randomized but not treated|0
299535|NCT00856544|983505|P1|Overall Study|Randomized but not treated|3
299536|NCT00856518|983684|P2|Overall Study|Lost to Follow-up|2
299537|NCT00856518|983685|P1|Overall Study|Lost to Follow-up|4
299538|NCT00856388|983703|P1|Overall Study|Not Specified|1
299539|NCT00856349|983714|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
299540|NCT00856349|983714|P1|Overall Study|Site closure|78
299541|NCT00856349|983714|P1|Overall Study|Device explant|33
299542|NCT00856349|983714|P1|Overall Study|Subject relocation|104
299543|NCT00856349|983714|P1|Overall Study|Physician Decision|13
299544|NCT00856349|983714|P1|Overall Study|Protocol Violation|38
299545|NCT00856349|983714|P1|Overall Study|Lost to Follow-up|91
299546|NCT00856349|983714|P1|Overall Study|Withdrawal by Subject|116
299547|NCT00856349|983714|P1|Overall Study|Death|418
299548|NCT00856323|983723|P1|Overall Study|Withdrawal by Subject|2
299549|NCT00856297|983735|P5|Overall Study|Unable to classify|0
299550|NCT00856297|983736|P4|Overall Study|Unable to classify|0
299551|NCT00856297|983737|P3|Overall Study|Unable to classify|0
299552|NCT00856297|983738|P2|Overall Study|Unable to classify|0
299553|NCT00856297|983739|P1|Overall Study|Unable to classify|2
299554|NCT00856284|983772|P3|Overall Study|Randomized in error|1
299555|NCT00856284|983773|P2|Overall Study|Randomized in error|0
299556|NCT00856284|983774|P1|Overall Study|Randomized in error|0
299557|NCT00856284|983772|P3|Overall Study|Other|14
299558|NCT00856284|983773|P2|Overall Study|Other|17
299559|NCT00856284|983774|P1|Overall Study|Other|15
299560|NCT00856284|983772|P3|Overall Study|Investigator discretion|10
299561|NCT00856284|983773|P2|Overall Study|Investigator discretion|8
299562|NCT00856284|983774|P1|Overall Study|Investigator discretion|9
299563|NCT00856284|983772|P3|Overall Study|Pregnancy|0
299564|NCT00856284|983773|P2|Overall Study|Pregnancy|2
299565|NCT00856284|983774|P1|Overall Study|Pregnancy|1
299566|NCT00856284|983772|P3|Overall Study|Voluntary withdrawal|62
299567|NCT00856284|983773|P2|Overall Study|Voluntary withdrawal|52
299568|NCT00856284|983774|P1|Overall Study|Voluntary withdrawal|48
299569|NCT00856284|983772|P3|Overall Study|Lost to Follow-up|28
299570|NCT00856284|983773|P2|Overall Study|Lost to Follow-up|22
299571|NCT00856284|983774|P1|Overall Study|Lost to Follow-up|20
299572|NCT00856284|983772|P3|Overall Study|Major protocol deviation|15
299573|NCT00856284|983773|P2|Overall Study|Major protocol deviation|16
299574|NCT00856284|983774|P1|Overall Study|Major protocol deviation|24
299575|NCT00856284|983772|P3|Overall Study|Adverse Event|82
299576|NCT00856284|983773|P2|Overall Study|Adverse Event|74
299577|NCT00856284|983774|P1|Overall Study|Adverse Event|60
299578|NCT00856284|983772|P3|Overall Study|Hyperglycemic rescue|235
299579|NCT00856284|983773|P2|Overall Study|Hyperglycemic rescue|201
299580|NCT00856284|983774|P1|Overall Study|Hyperglycemic rescue|231
299581|NCT00856245|983800|P1|Overall Study|Was not transplanted|5
299582|NCT00856206|983823|P2|Overall Study|Other than specified above|10
299583|NCT00856206|983824|P1|Overall Study|Other than specified above|3
299584|NCT00856206|983823|P2|Overall Study|Decision by the Sponsor|8
299585|NCT00856206|983824|P1|Overall Study|Decision by the Sponsor|4
299586|NCT00856206|983823|P2|Overall Study|Death|2
299587|NCT00856206|983824|P1|Overall Study|Death|2
299588|NCT00856206|983823|P2|Overall Study|Lost to Follow-up|39
299589|NCT00856206|983824|P1|Overall Study|Lost to Follow-up|13
299590|NCT00856206|983823|P2|Overall Study|Withdrawal by Subject|36
299591|NCT00856206|983824|P1|Overall Study|Withdrawal by Subject|15
299592|NCT00856206|983823|P2|Overall Study|Lack of Efficacy|2
299593|NCT00856206|983824|P1|Overall Study|Lack of Efficacy|1
299594|NCT00856206|983823|P2|Overall Study|Adverse Event|46
299595|NCT00856206|983824|P1|Overall Study|Adverse Event|10
299596|NCT00856206|983823|P2|Overall Study|Protocol Violation|18
299597|NCT00856206|983824|P1|Overall Study|Protocol Violation|6
299598|NCT00856193|983838|P2|Period 2|Lost to Follow-up|1
299599|NCT00856193|983839|P1|Period 2|Lost to Follow-up|0
299600|NCT00856193|983838|P2|Period 2|Abnormal test procedure results|1
299601|NCT00856193|983839|P1|Period 2|Abnormal test procedure results|0
299602|NCT00856180|983851|P1|Overall Study|Progressive Disease|16
299603|NCT00856180|983851|P1|Overall Study|Adverse Event|4
299604|NCT00855959|983876|P1|Overall Study|Incorrect enrolment|1
299605|NCT00855959|983876|P1|Overall Study|Pregnancy|1
299606|NCT00855959|983876|P1|Overall Study|Withdrawal by Subject|3
299607|NCT00855959|983876|P1|Overall Study|Lost to Follow-up|2
299608|NCT00855959|983876|P1|Overall Study|Adverse Event|2
299609|NCT00855933|983893|P2|Overall Study|Withdrawal by Subject|1
299610|NCT00855933|983894|P1|Overall Study|Withdrawal by Subject|0
299611|NCT00855920|983903|P3|Overall Study|Other than specified above|1
299612|NCT00855920|983904|P2|Overall Study|Other than specified above|1
299613|NCT00855920|983905|P1|Overall Study|Other than specified above|1
299614|NCT00855920|983903|P3|Overall Study|Decision by the sponsor|1
299615|NCT00855920|983904|P2|Overall Study|Decision by the sponsor|1
299616|NCT00855920|983905|P1|Overall Study|Decision by the sponsor|0
299617|NCT00855920|983903|P3|Overall Study|Death|0
299618|NCT00855920|983904|P2|Overall Study|Death|1
299619|NCT00855920|983905|P1|Overall Study|Death|0
299620|NCT00855920|983903|P3|Overall Study|Lost to Follow-up|2
299621|NCT00855920|983904|P2|Overall Study|Lost to Follow-up|0
299622|NCT00855920|983905|P1|Overall Study|Lost to Follow-up|1
299623|NCT00855920|983903|P3|Overall Study|Withdrawal by Subject|2
299624|NCT00855920|983904|P2|Overall Study|Withdrawal by Subject|3
299625|NCT00855920|983905|P1|Overall Study|Withdrawal by Subject|2
299626|NCT00855920|983903|P3|Overall Study|Lack of Efficacy|2
299627|NCT00855920|983904|P2|Overall Study|Lack of Efficacy|2
299628|NCT00855920|983905|P1|Overall Study|Lack of Efficacy|2
299629|NCT00855920|983903|P3|Overall Study|Adverse Event|1
299630|NCT00855920|983904|P2|Overall Study|Adverse Event|1
299631|NCT00855920|983905|P1|Overall Study|Adverse Event|2
299632|NCT00855920|983903|P3|Overall Study|Protocol Violation|2
299633|NCT00855920|983904|P2|Overall Study|Protocol Violation|0
299634|NCT00855920|983905|P1|Overall Study|Protocol Violation|0
299635|NCT00855894|983922|P1|Overall Study|Disease progression|1
299636|NCT00855894|983922|P1|Overall Study|Patient's decision|1
299637|NCT00855894|983922|P1|Overall Study|Death|31
299638|NCT00855816|983945|P2|Overall Study|Became ineligible|1
299639|NCT00855816|983946|P1|Overall Study|Became ineligible|0
299640|NCT00855816|983945|P2|Overall Study|Death|0
299641|NCT00855816|983946|P1|Overall Study|Death|1
299642|NCT00855816|983945|P2|Overall Study|Lost to Follow-up|5
299643|NCT00855816|983946|P1|Overall Study|Lost to Follow-up|3
299644|NCT00855816|983945|P2|Overall Study|Withdrawal by Subject|15
299645|NCT00855816|983946|P1|Overall Study|Withdrawal by Subject|22
299646|NCT00855738|983952|P1|Overall Study|Death|1
299647|NCT00855738|983952|P1|Overall Study|Subject Defaulted|1
299648|NCT00855738|983952|P1|Overall Study|Adverse Event|1
299649|NCT00855738|983952|P1|Overall Study|Lost to Follow-up|2
299650|NCT00855595|983980|P2|Overall Study|patient left country|1
299651|NCT00855595|983981|P1|Overall Study|patient left country|0
299652|NCT00855595|983980|P2|Overall Study|patient moved out of state|0
299653|NCT00855595|983981|P1|Overall Study|patient moved out of state|1
299654|NCT00855595|983980|P2|Overall Study|Adverse Event|1
299655|NCT00855595|983981|P1|Overall Study|Adverse Event|1
299656|NCT00855595|983980|P2|Overall Study|Lost to Follow-up|3
299657|NCT00855595|983981|P1|Overall Study|Lost to Follow-up|3
299658|NCT00855595|983980|P2|Overall Study|Withdrawal by Subject|2
299659|NCT00855595|983981|P1|Overall Study|Withdrawal by Subject|1
299660|NCT00855582|984020|P3|Overall Study|Withdrawal by Subject|8
299661|NCT00855582|984021|P2|Overall Study|Withdrawal by Subject|4
299662|NCT00855582|984022|P1|Overall Study|Withdrawal by Subject|7
299663|NCT00855582|984020|P3|Overall Study|Entry Criteria Not Met|3
299664|NCT00855582|984021|P2|Overall Study|Entry Criteria Not Met|6
299665|NCT00855582|984022|P1|Overall Study|Entry Criteria Not Met|8
299666|NCT00855582|984020|P3|Overall Study|Protocol Violation|6
299667|NCT00855582|984021|P2|Overall Study|Protocol Violation|2
299668|NCT00855582|984022|P1|Overall Study|Protocol Violation|6
299669|NCT00855582|984020|P3|Overall Study|Physician Decision|1
299670|NCT00855582|984021|P2|Overall Study|Physician Decision|0
299671|NCT00855582|984022|P1|Overall Study|Physician Decision|0
299672|NCT00855582|984020|P3|Overall Study|Lost to Follow-up|1
299673|NCT00855582|984021|P2|Overall Study|Lost to Follow-up|3
299674|NCT00855582|984022|P1|Overall Study|Lost to Follow-up|1
299675|NCT00855582|984020|P3|Overall Study|Lack of Efficacy|8
299676|NCT00855582|984021|P2|Overall Study|Lack of Efficacy|3
299677|NCT00855582|984022|P1|Overall Study|Lack of Efficacy|1
299678|NCT00855582|984020|P3|Overall Study|Death|0
299679|NCT00855582|984021|P2|Overall Study|Death|0
299680|NCT00855582|984022|P1|Overall Study|Death|1
299681|NCT00855582|984020|P3|Overall Study|Adverse Event|3
299682|NCT00855582|984021|P2|Overall Study|Adverse Event|6
299683|NCT00855582|984022|P1|Overall Study|Adverse Event|2
299684|NCT00855465|984111|P2|Follow-up Period (FUP)|Missing|0
299685|NCT00855465|984112|P1|Follow-up Period (FUP)|Missing|1
299686|NCT00855465|984111|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
299687|NCT00855465|984112|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
299688|NCT00855465|984111|P2|Follow-up Period (FUP)|Lost to Follow-up|0
299689|NCT00855465|984112|P1|Follow-up Period (FUP)|Lost to Follow-up|3
299690|NCT00855465|984111|P2|Follow-up Period (FUP)|Death|1
299691|NCT00855465|984112|P1|Follow-up Period (FUP)|Death|0
299692|NCT00855465|984111|P2|Follow-up Period (FUP)|Adverse Event|1
299693|NCT00855465|984112|P1|Follow-up Period (FUP)|Adverse Event|0
299694|NCT00855465|984111|P2|Treatment Period|Not treated|0
299695|NCT00855465|984112|P1|Treatment Period|Not treated|1
299696|NCT00855465|984111|P2|Treatment Period|Withdrawal by Subject|0
299697|NCT00855465|984112|P1|Treatment Period|Withdrawal by Subject|2
299698|NCT00855465|984111|P2|Treatment Period|Protocol Violation|0
299699|NCT00855465|984112|P1|Treatment Period|Protocol Violation|2
299700|NCT00855465|984111|P2|Treatment Period|Non-compliance|0
299701|NCT00855465|984112|P1|Treatment Period|Non-compliance|1
299702|NCT00855465|984111|P2|Treatment Period|Lack of Efficacy|1
299703|NCT00855465|984112|P1|Treatment Period|Lack of Efficacy|2
299704|NCT00855465|984111|P2|Treatment Period|Death|2
299705|NCT00855465|984112|P1|Treatment Period|Death|2
299706|NCT00855465|984111|P2|Treatment Period|Adverse Event|2
299707|NCT00855465|984112|P1|Treatment Period|Adverse Event|4
299708|NCT00855439|984202|P2|Overall Study|Pregnancy|0
299709|NCT00855439|984203|P1|Overall Study|Pregnancy|1
299710|NCT00855439|984202|P2|Overall Study|Withdrawal by Subject|0
299711|NCT00855439|984203|P1|Overall Study|Withdrawal by Subject|2
299712|NCT00855309|984217|P2|Overall Study|patient never recieved drug|0
299713|NCT00855309|984218|P1|Overall Study|patient never recieved drug|1
299714|NCT00855218|984226|P2|Overall Study|Clinical endpoint reached|13
299715|NCT00855218|984227|P1|Overall Study|Clinical endpoint reached|10
299716|NCT00855218|984226|P2|Overall Study|Progression measurement proven|15
299717|NCT00855218|984227|P1|Overall Study|Progression measurement proven|7
299718|NCT00855218|984226|P2|Overall Study|Second malignancy|1
299719|NCT00855218|984227|P1|Overall Study|Second malignancy|0
299720|NCT00855218|984226|P2|Overall Study|Untreatable disease progression|67
299721|NCT00855218|984227|P1|Overall Study|Untreatable disease progression|54
299722|NCT00855218|984226|P2|Overall Study|Still treated with study medication|1
299723|NCT00855218|984227|P1|Overall Study|Still treated with study medication|0
299724|NCT00855218|984226|P2|Overall Study|technical problems|1
299725|NCT00855218|984227|P1|Overall Study|technical problems|2
299726|NCT00855218|984226|P2|Overall Study|patient convenience|0
299727|NCT00855218|984227|P1|Overall Study|patient convenience|2
299728|NCT00855218|984226|P2|Overall Study|non-compliant with study drug|1
299729|NCT00855218|984227|P1|Overall Study|non-compliant with study drug|3
299730|NCT00855218|984226|P2|Overall Study|Protocol Violation|9
299731|NCT00855218|984227|P1|Overall Study|Protocol Violation|5
299732|NCT00855218|984226|P2|Overall Study|Lost to Follow-up|1
299733|NCT00855218|984227|P1|Overall Study|Lost to Follow-up|0
299734|NCT00855218|984226|P2|Overall Study|Physician Decision|11
299735|NCT00855218|984227|P1|Overall Study|Physician Decision|18
299736|NCT00855218|984226|P2|Overall Study|Withdrawal by Subject|6
299737|NCT00855218|984227|P1|Overall Study|Withdrawal by Subject|10
299738|NCT00855218|984226|P2|Overall Study|Adverse Event|27
299739|NCT00855218|984227|P1|Overall Study|Adverse Event|43
299740|NCT00855166|984245|P2|Overall Study|Subject no longer meets study criteria|1
299741|NCT00855166|984246|P1|Overall Study|Subject no longer meets study criteria|1
299742|NCT00855166|984245|P2|Overall Study|Administrative reasons by sponsor|0
299743|NCT00855166|984246|P1|Overall Study|Administrative reasons by sponsor|1
299744|NCT00855166|984245|P2|Overall Study|Poor/non-compliance|0
299745|NCT00855166|984246|P1|Overall Study|Poor/non-compliance|2
299746|NCT00855166|984245|P2|Overall Study|Withdrawal by Subject|4
299747|NCT00855166|984246|P1|Overall Study|Withdrawal by Subject|1
299748|NCT00855166|984245|P2|Overall Study|Death|1
299749|NCT00855166|984246|P1|Overall Study|Death|0
299750|NCT00855166|984245|P2|Overall Study|Adverse Event|2
299751|NCT00855166|984246|P1|Overall Study|Adverse Event|0
299752|NCT00855062|984266|P2|Step2|Initiation of antiretroviral therapy/ART|1
299753|NCT00855062|984267|P1|Step2|Initiation of antiretroviral therapy/ART|0
299754|NCT00855062|984266|P2|Step2|Adverse Event|3
299755|NCT00855062|984267|P1|Step2|Adverse Event|0
299756|NCT00855062|984266|P2|Step2|Early Study Closure|2
299757|NCT00855062|984267|P1|Step2|Early Study Closure|6
299758|NCT00855062|984266|P2|Step1|Withdrawal by Subject|3
299759|NCT00855062|984267|P1|Step1|Withdrawal by Subject|2
299760|NCT00855062|984266|P2|Step1|Pregnancy|0
299761|NCT00855062|984267|P1|Step1|Pregnancy|1
299762|NCT00855062|984266|P2|Step1|Protocol Violation|0
299763|NCT00855062|984267|P1|Step1|Protocol Violation|1
299764|NCT00855062|984266|P2|Step1|Adverse Event|1
299765|NCT00855062|984267|P1|Step1|Adverse Event|1
299766|NCT00855062|984266|P2|Step1|Early Study Closure|7
299767|NCT00855062|984267|P1|Step1|Early Study Closure|5
299768|NCT00854906|984291|P1|Overall Study|One person had no ocular history|1
299769|NCT00854724|984300|P2|Second Intervention|Physician Decision|1
299770|NCT00854724|984301|P1|Second Intervention|Physician Decision|0
299771|NCT00854724|984300|P2|Second Intervention|Protocol Violation|0
299772|NCT00854724|984301|P1|Second Intervention|Protocol Violation|1
299773|NCT00854724|984300|P2|Washout|Withdrawal by Subject|1
299774|NCT00854724|984301|P1|Washout|Withdrawal by Subject|0
299775|NCT00854724|984300|P2|Washout|Protocol Violation|0
299776|NCT00854724|984301|P1|Washout|Protocol Violation|1
299777|NCT00854724|984300|P2|First Intervention|Withdrawal by Subject|1
299778|NCT00854724|984301|P1|First Intervention|Withdrawal by Subject|1
299779|NCT00854620|984307|P1|Overall Study|Adverse Event|1
299780|NCT00854607|984311|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
299781|NCT00854373|984366|P2|Overall Study|Forgot to take study drug|1
299782|NCT00854373|984367|P1|Overall Study|Forgot to take study drug|1
299783|NCT00854373|984366|P2|Overall Study|Withdrawal by Subject|3
299784|NCT00854373|984367|P1|Overall Study|Withdrawal by Subject|1
299785|NCT00854360|984381|P4|Overall Study|Other|3
299786|NCT00854360|984382|P3|Overall Study|Other|0
299787|NCT00854360|984383|P2|Overall Study|Other|0
299788|NCT00854360|984384|P1|Overall Study|Other|0
299789|NCT00854360|984381|P4|Overall Study|Lack of Efficacy|0
299790|NCT00854360|984382|P3|Overall Study|Lack of Efficacy|0
299791|NCT00854360|984383|P2|Overall Study|Lack of Efficacy|1
299792|NCT00854360|984384|P1|Overall Study|Lack of Efficacy|2
299793|NCT00854360|984381|P4|Overall Study|Pregnancy|0
299794|NCT00854360|984382|P3|Overall Study|Pregnancy|0
299795|NCT00854360|984383|P2|Overall Study|Pregnancy|1
299796|NCT00854360|984384|P1|Overall Study|Pregnancy|0
299797|NCT00854360|984381|P4|Overall Study|Withdrawal by Subject|1
299798|NCT00854360|984382|P3|Overall Study|Withdrawal by Subject|0
299799|NCT00854360|984383|P2|Overall Study|Withdrawal by Subject|0
299800|NCT00854360|984384|P1|Overall Study|Withdrawal by Subject|0
299801|NCT00854360|984381|P4|Overall Study|Adverse Event|6
299802|NCT00854360|984382|P3|Overall Study|Adverse Event|2
299803|NCT00854360|984383|P2|Overall Study|Adverse Event|1
299804|NCT00854360|984384|P1|Overall Study|Adverse Event|0
299805|NCT00854308|984416|P2|Overall Study|Sponsor's decision to terminate study|1
299806|NCT00854308|984417|P1|Overall Study|Sponsor's decision to terminate study|0
299807|NCT00854308|984416|P2|Overall Study|Withdrawal by Subject|2
299808|NCT00854308|984417|P1|Overall Study|Withdrawal by Subject|4
299809|NCT00854308|984416|P2|Overall Study|Physician Decision|6
299810|NCT00854308|984417|P1|Overall Study|Physician Decision|6
299811|NCT00854308|984416|P2|Overall Study|Death|5
299812|NCT00854308|984417|P1|Overall Study|Death|2
299813|NCT00854308|984416|P2|Overall Study|Adverse Event|3
299814|NCT00854308|984417|P1|Overall Study|Adverse Event|8
299815|NCT00854308|984416|P2|Overall Study|Disease progression|50
299816|NCT00854308|984417|P1|Overall Study|Disease progression|42
299817|NCT00854113|984442|P11|Overall Study|Withdrawal by Subject|0
299818|NCT00854113|984443|P10|Overall Study|Withdrawal by Subject|0
299819|NCT00854113|984444|P9|Overall Study|Withdrawal by Subject|1
299820|NCT00854113|984445|P8|Overall Study|Withdrawal by Subject|1
299821|NCT00854113|984446|P7|Overall Study|Withdrawal by Subject|0
299822|NCT00854113|984447|P6|Overall Study|Withdrawal by Subject|0
299823|NCT00854113|984448|P5|Overall Study|Withdrawal by Subject|0
299824|NCT00854113|984449|P4|Overall Study|Withdrawal by Subject|0
299825|NCT00854113|984450|P3|Overall Study|Withdrawal by Subject|0
299826|NCT00854113|984451|P2|Overall Study|Withdrawal by Subject|0
299827|NCT00854113|984452|P1|Overall Study|Withdrawal by Subject|0
299828|NCT00854113|984442|P11|Overall Study|Adverse Event|0
299829|NCT00854113|984443|P10|Overall Study|Adverse Event|0
299830|NCT00854113|984444|P9|Overall Study|Adverse Event|0
299831|NCT00854113|984445|P8|Overall Study|Adverse Event|2
299832|NCT00854113|984446|P7|Overall Study|Adverse Event|0
299833|NCT00854113|984447|P6|Overall Study|Adverse Event|0
299834|NCT00854113|984448|P5|Overall Study|Adverse Event|0
299835|NCT00854113|984449|P4|Overall Study|Adverse Event|0
299836|NCT00854113|984450|P3|Overall Study|Adverse Event|0
299837|NCT00854113|984451|P2|Overall Study|Adverse Event|0
299838|NCT00854113|984452|P1|Overall Study|Adverse Event|0
299839|NCT00853970|984569|P2|Overall Study|Cancelled surgery|2
299840|NCT00853970|984570|P1|Overall Study|Cancelled surgery|4
299841|NCT00853970|984569|P2|Overall Study|Withdrawal by Subject|1
299842|NCT00853970|984570|P1|Overall Study|Withdrawal by Subject|2
299843|NCT00853957|984580|P2|Overall Study|Protocol deviation|3
299844|NCT00853957|984581|P1|Overall Study|Protocol deviation|0
299845|NCT00853957|984580|P2|Overall Study|Lost to Follow-up|6
299846|NCT00853957|984581|P1|Overall Study|Lost to Follow-up|1
299847|NCT00853957|984580|P2|Overall Study|Subject withdrew consent|5
299848|NCT00853957|984581|P1|Overall Study|Subject withdrew consent|4
299849|NCT00853957|984580|P2|Overall Study|Unsatisfactory therapeutic effect|2
299850|NCT00853957|984581|P1|Overall Study|Unsatisfactory therapeutic effect|0
299851|NCT00853957|984580|P2|Overall Study|Adverse Event|3
299852|NCT00853957|984581|P1|Overall Study|Adverse Event|9
299853|NCT00853905|984599|P2|Overall Study|never had surgery|0
299854|NCT00853905|984600|P1|Overall Study|never had surgery|1
299855|NCT00853905|984599|P2|Overall Study|Withdrawal by Subject|1
299856|NCT00853905|984600|P1|Overall Study|Withdrawal by Subject|0
299857|NCT00853905|984599|P2|Overall Study|Lost to Follow-up|3
299858|NCT00853905|984600|P1|Overall Study|Lost to Follow-up|1
299859|NCT00853827|984624|P2|Double Blind Period (103 Weeks)|Death|6
299860|NCT00853827|984625|P1|Double Blind Period (103 Weeks)|Death|1
299861|NCT00853827|984624|P2|Double Blind Period (103 Weeks)|Administrative problems|56
299862|NCT00853827|984625|P1|Double Blind Period (103 Weeks)|Administrative problems|45
299863|NCT00853827|984624|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
299864|NCT00853827|984625|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
299865|NCT00853827|984624|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
299866|NCT00853827|984625|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
299867|NCT00853827|984624|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
299868|NCT00853827|984625|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
299869|NCT00853827|984624|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
299870|NCT00853827|984625|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
299871|NCT00853827|984624|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
299872|NCT00853827|984625|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
299873|NCT00853827|984624|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
299874|NCT00853827|984625|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
299875|NCT00853827|984624|P2|Double Blind Period (103 Weeks)|Adverse Event|14
299876|NCT00853827|984625|P1|Double Blind Period (103 Weeks)|Adverse Event|25
299877|NCT00853827|984624|P2|Single Blind Period (1 Week)|Protocol Violation|0
299878|NCT00853827|984625|P1|Single Blind Period (1 Week)|Protocol Violation|12
299879|NCT00853827|984624|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
299880|NCT00853827|984625|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
299881|NCT00853827|984624|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
299882|NCT00853827|984625|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
299883|NCT00853827|984624|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
299884|NCT00853827|984625|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
299885|NCT00853827|984624|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
299886|NCT00853827|984625|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
299887|NCT00853827|984624|P2|Single Blind Period (1 Week)|Adverse Event|0
299888|NCT00853827|984625|P1|Single Blind Period (1 Week)|Adverse Event|9
299889|NCT00853827|984624|P2|Single Blind Period (1 Week)|Other|0
299890|NCT00853827|984625|P1|Single Blind Period (1 Week)|Other|4
299891|NCT00853762|984641|P4|Overall Study|Randomised but not Treated|0
299892|NCT00853762|984642|P3|Overall Study|Randomised but not Treated|2
299893|NCT00853762|984643|P2|Overall Study|Randomised but not Treated|2
299894|NCT00853762|984644|P1|Overall Study|Randomised but not Treated|0
299895|NCT00853762|984641|P4|Overall Study|Unspecified|0
299896|NCT00853762|984642|P3|Overall Study|Unspecified|0
299897|NCT00853762|984643|P2|Overall Study|Unspecified|2
299898|NCT00853762|984644|P1|Overall Study|Unspecified|0
299899|NCT00853762|984641|P4|Overall Study|Withdrawal by Subject|0
299900|NCT00853762|984642|P3|Overall Study|Withdrawal by Subject|1
299901|NCT00853762|984643|P2|Overall Study|Withdrawal by Subject|0
299902|NCT00853762|984644|P1|Overall Study|Withdrawal by Subject|0
299903|NCT00853762|984641|P4|Overall Study|Protocol Violation|1
299904|NCT00853762|984642|P3|Overall Study|Protocol Violation|0
299905|NCT00853762|984643|P2|Overall Study|Protocol Violation|0
299906|NCT00853762|984644|P1|Overall Study|Protocol Violation|0
299907|NCT00853762|984641|P4|Overall Study|Premature Termination|21
299908|NCT00853762|984642|P3|Overall Study|Premature Termination|14
299909|NCT00853762|984643|P2|Overall Study|Premature Termination|15
299910|NCT00853762|984644|P1|Overall Study|Premature Termination|16
299911|NCT00853749|984712|P2|Overall Study|Lost to Follow-up|1
299912|NCT00853749|984713|P1|Overall Study|Lost to Follow-up|0
299913|NCT00853723|984734|P3|Overall Study|Protocol Violation|1
299914|NCT00853723|984735|P2|Overall Study|Protocol Violation|2
299915|NCT00853723|984736|P1|Overall Study|Protocol Violation|1
299916|NCT00853723|984734|P3|Overall Study|Withdrawal by Subject|0
299917|NCT00853723|984735|P2|Overall Study|Withdrawal by Subject|1
299918|NCT00853723|984736|P1|Overall Study|Withdrawal by Subject|2
299919|NCT00853723|984734|P3|Overall Study|Adverse Event|1
299920|NCT00853723|984735|P2|Overall Study|Adverse Event|4
299921|NCT00853723|984736|P1|Overall Study|Adverse Event|3
299922|NCT00853658|984783|P3|Overall Study|Missing study completion information|6
299923|NCT00853658|984784|P2|Overall Study|Missing study completion information|4
299924|NCT00853658|984785|P1|Overall Study|Missing study completion information|5
299925|NCT00853658|984783|P3|Overall Study|Patient's request|11
299926|NCT00853658|984784|P2|Overall Study|Patient's request|17
299927|NCT00853658|984785|P1|Overall Study|Patient's request|21
299928|NCT00853658|984783|P3|Overall Study|Vital Status at study end N/A|10
299929|NCT00853658|984784|P2|Overall Study|Vital Status at study end N/A|10
299930|NCT00853658|984785|P1|Overall Study|Vital Status at study end N/A|8
299931|NCT00853658|984783|P3|Overall Study|Vital Status unknown at study end|0
299932|NCT00853658|984784|P2|Overall Study|Vital Status unknown at study end|1
299933|NCT00853658|984785|P1|Overall Study|Vital Status unknown at study end|1
299934|NCT00853658|984783|P3|Overall Study|Vital Status known (alive) at study end|3
299935|NCT00853658|984784|P2|Overall Study|Vital Status known (alive) at study end|3
299936|NCT00853658|984785|P1|Overall Study|Vital Status known (alive) at study end|2
299937|NCT00853658|984783|P3|Overall Study|IRB request|2
299938|NCT00853658|984784|P2|Overall Study|IRB request|0
299939|NCT00853658|984785|P1|Overall Study|IRB request|0
299940|NCT00853658|984783|P3|Overall Study|H.A. Request|19
299941|NCT00853658|984784|P2|Overall Study|H.A. Request|23
299942|NCT00853658|984785|P1|Overall Study|H.A. Request|26
299943|NCT00853658|984783|P3|Overall Study|Lost to Follow-up|11
299944|NCT00853658|984784|P2|Overall Study|Lost to Follow-up|6
299945|NCT00853658|984785|P1|Overall Study|Lost to Follow-up|11
299946|NCT00853658|984783|P3|Overall Study|Death|753
299947|NCT00853658|984784|P2|Overall Study|Death|768
299948|NCT00853658|984785|P1|Overall Study|Death|713
299949|NCT00853593|984805|P1|Overall Study|Implant not attempted|4
299950|NCT00853593|984805|P1|Overall Study|Model 4396 lead not attempted|29
299951|NCT00853593|984805|P1|Overall Study|Subjects did not receive a 4396 lead|12
299952|NCT00853567|984833|P1|Overall Study|Study prematurely terminated|71
299953|NCT00853385|984846|P5|Overall Study|Unspecified|12
299954|NCT00853385|984847|P4|Overall Study|Unspecified|4
299955|NCT00853385|984848|P3|Overall Study|Unspecified|4
299956|NCT00853385|984849|P2|Overall Study|Unspecified|9
299957|NCT00853385|984850|P1|Overall Study|Unspecified|18
299958|NCT00853385|984846|P5|Overall Study|Withdrawal by Subject|1
299959|NCT00853385|984847|P4|Overall Study|Withdrawal by Subject|1
299960|NCT00853385|984848|P3|Overall Study|Withdrawal by Subject|0
299961|NCT00853385|984849|P2|Overall Study|Withdrawal by Subject|2
299962|NCT00853385|984850|P1|Overall Study|Withdrawal by Subject|4
299963|NCT00853385|984846|P5|Overall Study|Lost to Follow-up|0
299964|NCT00853385|984847|P4|Overall Study|Lost to Follow-up|0
299965|NCT00853385|984848|P3|Overall Study|Lost to Follow-up|0
299966|NCT00853385|984849|P2|Overall Study|Lost to Follow-up|1
299967|NCT00853385|984850|P1|Overall Study|Lost to Follow-up|2
299968|NCT00853385|984846|P5|Overall Study|Lack of Efficacy|6
299969|NCT00853385|984847|P4|Overall Study|Lack of Efficacy|3
299970|NCT00853385|984848|P3|Overall Study|Lack of Efficacy|3
299971|NCT00853385|984849|P2|Overall Study|Lack of Efficacy|7
299972|NCT00853385|984850|P1|Overall Study|Lack of Efficacy|6
299973|NCT00853385|984846|P5|Overall Study|Adverse Event|22
299974|NCT00853385|984847|P4|Overall Study|Adverse Event|5
299975|NCT00853385|984848|P3|Overall Study|Adverse Event|2
299976|NCT00853385|984849|P2|Overall Study|Adverse Event|24
299977|NCT00853385|984850|P1|Overall Study|Adverse Event|24
299978|NCT00853385|984846|P5|Overall Study|Death|1
299979|NCT00853385|984847|P4|Overall Study|Death|0
299980|NCT00853385|984848|P3|Overall Study|Death|0
299981|NCT00853385|984849|P2|Overall Study|Death|0
299982|NCT00853385|984850|P1|Overall Study|Death|0
299983|NCT00853242|985083|P7|Overall Study|Unspecified|2
299984|NCT00853242|985084|P6|Overall Study|Unspecified|1
299985|NCT00853242|985085|P5|Overall Study|Unspecified|0
299986|NCT00853242|985086|P4|Overall Study|Unspecified|0
299987|NCT00853242|985087|P3|Overall Study|Unspecified|2
299988|NCT00853242|985088|P2|Overall Study|Unspecified|0
299989|NCT00853242|985089|P1|Overall Study|Unspecified|2
299990|NCT00853242|985083|P7|Overall Study|Withdrawal by Subject|2
299991|NCT00853242|985084|P6|Overall Study|Withdrawal by Subject|0
299992|NCT00853242|985085|P5|Overall Study|Withdrawal by Subject|0
299993|NCT00853242|985086|P4|Overall Study|Withdrawal by Subject|4
299994|NCT00853242|985087|P3|Overall Study|Withdrawal by Subject|0
299995|NCT00853242|985088|P2|Overall Study|Withdrawal by Subject|2
299996|NCT00853242|985089|P1|Overall Study|Withdrawal by Subject|1
299997|NCT00853242|985083|P7|Overall Study|Noncompliant|0
299998|NCT00853242|985084|P6|Overall Study|Noncompliant|0
299999|NCT00853242|985085|P5|Overall Study|Noncompliant|1
300000|NCT00853242|985086|P4|Overall Study|Noncompliant|0
300001|NCT00853242|985087|P3|Overall Study|Noncompliant|0
300002|NCT00853242|985088|P2|Overall Study|Noncompliant|0
300003|NCT00853242|985089|P1|Overall Study|Noncompliant|0
300004|NCT00853242|985083|P7|Overall Study|Adverse Event|1
300005|NCT00853242|985084|P6|Overall Study|Adverse Event|1
300006|NCT00853242|985085|P5|Overall Study|Adverse Event|3
300007|NCT00853242|985086|P4|Overall Study|Adverse Event|0
300008|NCT00853242|985087|P3|Overall Study|Adverse Event|1
300009|NCT00853242|985088|P2|Overall Study|Adverse Event|1
300010|NCT00853242|985089|P1|Overall Study|Adverse Event|0
300011|NCT00853229|985131|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
300012|NCT00853229|985132|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
300013|NCT00853151|985142|P4|Overall Study|Sponsor Decision|0
300014|NCT00853151|985143|P3|Overall Study|Sponsor Decision|0
300015|NCT00853151|985144|P2|Overall Study|Sponsor Decision|3
300016|NCT00853151|985145|P1|Overall Study|Sponsor Decision|0
300017|NCT00853151|985142|P4|Overall Study|Physician Decision|0
300018|NCT00853151|985143|P3|Overall Study|Physician Decision|1
300019|NCT00853151|985144|P2|Overall Study|Physician Decision|2
300020|NCT00853151|985145|P1|Overall Study|Physician Decision|0
300021|NCT00853151|985142|P4|Overall Study|Withdrawal by Subject|1
300022|NCT00853151|985143|P3|Overall Study|Withdrawal by Subject|2
300023|NCT00853151|985144|P2|Overall Study|Withdrawal by Subject|4
300024|NCT00853151|985145|P1|Overall Study|Withdrawal by Subject|5
300025|NCT00853151|985142|P4|Overall Study|Protocol Violation|1
300026|NCT00853151|985143|P3|Overall Study|Protocol Violation|0
300027|NCT00853151|985144|P2|Overall Study|Protocol Violation|0
300028|NCT00853151|985145|P1|Overall Study|Protocol Violation|0
300029|NCT00853151|985142|P4|Overall Study|Death|1
300030|NCT00853151|985143|P3|Overall Study|Death|0
300031|NCT00853151|985144|P2|Overall Study|Death|0
300032|NCT00853151|985145|P1|Overall Study|Death|1
300033|NCT00853151|985142|P4|Overall Study|Lost to Follow-up|0
300034|NCT00853151|985143|P3|Overall Study|Lost to Follow-up|3
300035|NCT00853151|985144|P2|Overall Study|Lost to Follow-up|0
300036|NCT00853151|985145|P1|Overall Study|Lost to Follow-up|2
300037|NCT00853151|985142|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
300038|NCT00853151|985143|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
300039|NCT00853151|985144|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
300040|NCT00853151|985145|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
300041|NCT00853151|985142|P4|Overall Study|Adverse Event|0
300042|NCT00853151|985143|P3|Overall Study|Adverse Event|2
300043|NCT00853151|985144|P2|Overall Study|Adverse Event|4
300044|NCT00853151|985145|P1|Overall Study|Adverse Event|1
300045|NCT00853099|985290|P4|Double-blind + Open-label Periods|Not Specified|6
300046|NCT00853099|985291|P3|Double-blind + Open-label Periods|Not Specified|0
300047|NCT00853099|985292|P2|Double-blind + Open-label Periods|Not Specified|0
300048|NCT00853099|985293|P1|Double-blind + Open-label Periods|Not Specified|0
300049|NCT00853099|985290|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
300050|NCT00853099|985291|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
300051|NCT00853099|985292|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
300052|NCT00853099|985293|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
300053|NCT00853099|985290|P4|Double-blind + Open-label Periods|Adverse Event|47
300054|NCT00853099|985291|P3|Double-blind + Open-label Periods|Adverse Event|0
300055|NCT00853099|985292|P2|Double-blind + Open-label Periods|Adverse Event|0
300056|NCT00853099|985293|P1|Double-blind + Open-label Periods|Adverse Event|0
300057|NCT00853099|985290|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
300058|NCT00853099|985291|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
300059|NCT00853099|985292|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
300060|NCT00853099|985293|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
300061|NCT00853099|985290|P4|Double-blind Period|Mistreated with rescue study drug|0
300062|NCT00853099|985291|P3|Double-blind Period|Mistreated with rescue study drug|1
300063|NCT00853099|985292|P2|Double-blind Period|Mistreated with rescue study drug|0
300064|NCT00853099|985293|P1|Double-blind Period|Mistreated with rescue study drug|0
300065|NCT00853099|985290|P4|Double-blind Period|Not Specified|0
300066|NCT00853099|985291|P3|Double-blind Period|Not Specified|1
300067|NCT00853099|985292|P2|Double-blind Period|Not Specified|0
300068|NCT00853099|985293|P1|Double-blind Period|Not Specified|0
300069|NCT00853099|985290|P4|Double-blind Period|Lack of Efficacy|0
300070|NCT00853099|985291|P3|Double-blind Period|Lack of Efficacy|16
300071|NCT00853099|985292|P2|Double-blind Period|Lack of Efficacy|17
300072|NCT00853099|985293|P1|Double-blind Period|Lack of Efficacy|14
300073|NCT00853099|985290|P4|Double-blind Period|Withdrawal by Subject|0
300074|NCT00853099|985291|P3|Double-blind Period|Withdrawal by Subject|0
300075|NCT00853099|985292|P2|Double-blind Period|Withdrawal by Subject|3
300076|NCT00853099|985293|P1|Double-blind Period|Withdrawal by Subject|2
300077|NCT00853099|985290|P4|Double-blind Period|Adverse Event|0
300078|NCT00853099|985291|P3|Double-blind Period|Adverse Event|13
300079|NCT00853099|985292|P2|Double-blind Period|Adverse Event|9
300080|NCT00853099|985293|P1|Double-blind Period|Adverse Event|7
300081|NCT00853073|985335|P2|Overall Study|Withdrawal by Subject|2
300082|NCT00853073|985336|P1|Overall Study|Withdrawal by Subject|3
300083|NCT00853021|985342|P1|Overall Study|Death|1
300084|NCT00853021|985342|P1|Overall Study|Withdrawal by Subject|2
300085|NCT00853021|985342|P1|Overall Study|Adverse Event|2
300086|NCT00852995|985354|P5|Overall Study|Moved Out of Area|0
300087|NCT00852995|985355|P4|Overall Study|Moved Out of Area|0
300088|NCT00852995|985356|P3|Overall Study|Moved Out of Area|0
300089|NCT00852995|985357|P2|Overall Study|Moved Out of Area|0
300090|NCT00852995|985358|P1|Overall Study|Moved Out of Area|1
300091|NCT00852995|985354|P5|Overall Study|Protocol Violation|1
300092|NCT00852995|985355|P4|Overall Study|Protocol Violation|0
300093|NCT00852995|985356|P3|Overall Study|Protocol Violation|0
300094|NCT00852995|985357|P2|Overall Study|Protocol Violation|0
300095|NCT00852995|985358|P1|Overall Study|Protocol Violation|0
300096|NCT00852995|985354|P5|Overall Study|Physician Decision|0
300097|NCT00852995|985355|P4|Overall Study|Physician Decision|0
300098|NCT00852995|985356|P3|Overall Study|Physician Decision|0
300099|NCT00852995|985357|P2|Overall Study|Physician Decision|0
300100|NCT00852995|985358|P1|Overall Study|Physician Decision|1
300101|NCT00852995|985354|P5|Overall Study|Progressive Disease|1
300102|NCT00852995|985355|P4|Overall Study|Progressive Disease|2
300103|NCT00852995|985356|P3|Overall Study|Progressive Disease|0
300104|NCT00852995|985357|P2|Overall Study|Progressive Disease|0
300105|NCT00852995|985358|P1|Overall Study|Progressive Disease|1
300106|NCT00852995|985354|P5|Overall Study|Non-Compliance|0
300107|NCT00852995|985355|P4|Overall Study|Non-Compliance|2
300108|NCT00852995|985356|P3|Overall Study|Non-Compliance|0
300109|NCT00852995|985357|P2|Overall Study|Non-Compliance|0
300110|NCT00852995|985358|P1|Overall Study|Non-Compliance|0
300111|NCT00852995|985354|P5|Overall Study|Withdrawal by Subject|2
300112|NCT00852995|985355|P4|Overall Study|Withdrawal by Subject|1
300113|NCT00852995|985356|P3|Overall Study|Withdrawal by Subject|0
300114|NCT00852995|985357|P2|Overall Study|Withdrawal by Subject|0
300115|NCT00852995|985358|P1|Overall Study|Withdrawal by Subject|4
300116|NCT00852995|985354|P5|Overall Study|Lost to Follow-up|0
300117|NCT00852995|985355|P4|Overall Study|Lost to Follow-up|0
300118|NCT00852995|985356|P3|Overall Study|Lost to Follow-up|1
300119|NCT00852995|985357|P2|Overall Study|Lost to Follow-up|1
300120|NCT00852995|985358|P1|Overall Study|Lost to Follow-up|0
300121|NCT00852995|985354|P5|Overall Study|Adverse Event|0
300122|NCT00852995|985355|P4|Overall Study|Adverse Event|0
300123|NCT00852995|985356|P3|Overall Study|Adverse Event|4
300124|NCT00852995|985357|P2|Overall Study|Adverse Event|0
300125|NCT00852995|985358|P1|Overall Study|Adverse Event|1
300126|NCT00852969|985402|P2|Overall Study|Lost to Follow-up|1
300127|NCT00852969|985403|P1|Overall Study|Lost to Follow-up|0
300128|NCT00852969|985402|P2|Overall Study|Adverse Event|1
300129|NCT00852969|985403|P1|Overall Study|Adverse Event|0
300130|NCT00852930|985414|P3|Overall Study|Physician Decision|1
300131|NCT00852930|985415|P2|Overall Study|Physician Decision|0
300132|NCT00852930|985416|P1|Overall Study|Physician Decision|0
300133|NCT00852930|985414|P3|Overall Study|Withdrawal by Subject|1
300134|NCT00852930|985415|P2|Overall Study|Withdrawal by Subject|1
300135|NCT00852930|985416|P1|Overall Study|Withdrawal by Subject|1
300136|NCT00852917|985437|P4|Overall Study|Death|1
300137|NCT00852917|985438|P3|Overall Study|Death|0
300138|NCT00852917|985439|P2|Overall Study|Death|0
300139|NCT00852917|985440|P1|Overall Study|Death|0
300140|NCT00852917|985437|P4|Overall Study|Physician Decision|19
300141|NCT00852917|985438|P3|Overall Study|Physician Decision|2
300142|NCT00852917|985439|P2|Overall Study|Physician Decision|7
300143|NCT00852917|985440|P1|Overall Study|Physician Decision|6
300144|NCT00852917|985437|P4|Overall Study|Withdrawal by Subject|9
300145|NCT00852917|985438|P3|Overall Study|Withdrawal by Subject|10
300146|NCT00852917|985439|P2|Overall Study|Withdrawal by Subject|8
300147|NCT00852917|985440|P1|Overall Study|Withdrawal by Subject|4
300148|NCT00852917|985437|P4|Overall Study|Lack of Efficacy|47
300149|NCT00852917|985438|P3|Overall Study|Lack of Efficacy|11
300150|NCT00852917|985439|P2|Overall Study|Lack of Efficacy|11
300151|NCT00852917|985440|P1|Overall Study|Lack of Efficacy|21
300152|NCT00852917|985437|P4|Overall Study|Adverse Event|17
300153|NCT00852917|985438|P3|Overall Study|Adverse Event|35
300154|NCT00852917|985439|P2|Overall Study|Adverse Event|20
300155|NCT00852917|985440|P1|Overall Study|Adverse Event|13
300156|NCT00852540|985542|P2|Overall Study|Did Not Receive Study Drug|3
300157|NCT00852540|985543|P1|Overall Study|Did Not Receive Study Drug|3
300158|NCT00852540|985542|P2|Overall Study|Withdrawal by Subject|1
300159|NCT00852540|985543|P1|Overall Study|Withdrawal by Subject|3
300160|NCT00852540|985542|P2|Overall Study|Investigator Discretion|3
300161|NCT00852540|985543|P1|Overall Study|Investigator Discretion|2
300162|NCT00852540|985542|P2|Overall Study|Lost to Follow-up|3
300163|NCT00852540|985543|P1|Overall Study|Lost to Follow-up|2
300164|NCT00852540|985542|P2|Overall Study|Protocol Violation|2
300165|NCT00852540|985543|P1|Overall Study|Protocol Violation|1
300166|NCT00852540|985542|P2|Overall Study|Lack of Efficacy|3
300167|NCT00852540|985543|P1|Overall Study|Lack of Efficacy|15
300168|NCT00852540|985542|P2|Overall Study|Adverse Event|3
300169|NCT00852540|985543|P1|Overall Study|Adverse Event|10
300170|NCT00852475|985577|P2|Overall Study|Lost to Follow-up|4
300171|NCT00852475|985578|P1|Overall Study|Lost to Follow-up|3
300172|NCT00852397|985589|P3|Overall Study|Protocol Violation|1
300173|NCT00852397|985590|P2|Overall Study|Protocol Violation|0
300174|NCT00852397|985591|P1|Overall Study|Protocol Violation|0
300175|NCT00852397|985589|P3|Overall Study|Difficulty in study site visit|0
300176|NCT00852397|985590|P2|Overall Study|Difficulty in study site visit|0
300177|NCT00852397|985591|P1|Overall Study|Difficulty in study site visit|1
300178|NCT00852397|985589|P3|Overall Study|Study terminated by sponsor|6
300179|NCT00852397|985590|P2|Overall Study|Study terminated by sponsor|1
300180|NCT00852397|985591|P1|Overall Study|Study terminated by sponsor|2
300181|NCT00852397|985589|P3|Overall Study|Withdrawal by Subject|2
300182|NCT00852397|985590|P2|Overall Study|Withdrawal by Subject|1
300183|NCT00852397|985591|P1|Overall Study|Withdrawal by Subject|4
300184|NCT00852397|985589|P3|Overall Study|Death|1
300185|NCT00852397|985590|P2|Overall Study|Death|0
300186|NCT00852397|985591|P1|Overall Study|Death|0
300187|NCT00852397|985589|P3|Overall Study|Adverse Event|4
300188|NCT00852397|985590|P2|Overall Study|Adverse Event|6
300189|NCT00852397|985591|P1|Overall Study|Adverse Event|4
300190|NCT00851903|985651|P1|Overall Study|Withdrawal by Subject|2
300191|NCT00851890|985665|P4|Overall Study|Lost to Follow-up|1
300192|NCT00851890|985666|P3|Overall Study|Lost to Follow-up|0
300193|NCT00851890|985667|P2|Overall Study|Lost to Follow-up|1
300194|NCT00851890|985668|P1|Overall Study|Lost to Follow-up|0
300195|NCT00851799|985728|P3|Overall Study|Completed protocol due to pregnancy|1
300196|NCT00851799|985729|P2|Overall Study|Completed protocol due to pregnancy|0
300197|NCT00851799|985730|P1|Overall Study|Completed protocol due to pregnancy|0
300198|NCT00851799|985728|P3|Overall Study|Severe Debilitation|0
300199|NCT00851799|985729|P2|Overall Study|Severe Debilitation|1
300200|NCT00851799|985730|P1|Overall Study|Severe Debilitation|0
300201|NCT00851799|985728|P3|Overall Study|Withdrew consent prior study completion|1
300202|NCT00851799|985729|P2|Overall Study|Withdrew consent prior study completion|2
300203|NCT00851799|985730|P1|Overall Study|Withdrew consent prior study completion|1
300204|NCT00851799|985728|P3|Overall Study|Not willing to adhere to requirements|2
300205|NCT00851799|985729|P2|Overall Study|Not willing to adhere to requirements|2
300206|NCT00851799|985730|P1|Overall Study|Not willing to adhere to requirements|1
300207|NCT00851799|985728|P3|Overall Study|Not able to get to clinic|9
300208|NCT00851799|985729|P2|Overall Study|Not able to get to clinic|5
300209|NCT00851799|985730|P1|Overall Study|Not able to get to clinic|8
300210|NCT00851799|985728|P3|Overall Study|Lost to Follow-up|10
300211|NCT00851799|985729|P2|Overall Study|Lost to Follow-up|3
300212|NCT00851799|985730|P1|Overall Study|Lost to Follow-up|5
300213|NCT00851799|985728|P3|Overall Study|Death|1
300214|NCT00851799|985729|P2|Overall Study|Death|0
300215|NCT00851799|985730|P1|Overall Study|Death|1
300216|NCT00851786|985818|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
300217|NCT00851786|985819|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
300218|NCT00851786|985818|P2|Overall Study|Site Closure|0
300219|NCT00851786|985819|P1|Overall Study|Site Closure|1
300220|NCT00851786|985818|P2|Overall Study|Incarceration|0
300221|NCT00851786|985819|P1|Overall Study|Incarceration|1
300222|NCT00851786|985818|P2|Overall Study|Lost to Follow-up|0
300223|NCT00851786|985819|P1|Overall Study|Lost to Follow-up|1
300224|NCT00851786|985818|P2|Overall Study|Protocol Violation|1
300225|NCT00851786|985819|P1|Overall Study|Protocol Violation|0
300226|NCT00851786|985818|P2|Overall Study|Withdrawal by Subject|1
300227|NCT00851786|985819|P1|Overall Study|Withdrawal by Subject|0
300228|NCT00851721|985829|P2|Overall Study|Adverse Event|1
300229|NCT00851721|985830|P1|Overall Study|Adverse Event|0
300230|NCT00851721|985829|P2|Overall Study|Death|0
300231|NCT00851721|985830|P1|Overall Study|Death|1
300232|NCT00851721|985829|P2|Overall Study|planned surgery|0
300233|NCT00851721|985830|P1|Overall Study|planned surgery|1
300234|NCT00851682|985920|P2|Overall Study|screen failure|0
300235|NCT00851682|985921|P1|Overall Study|screen failure|5
300236|NCT00851643|985935|P6|Extension Study (Up to 36 Months)|Moved|1
300237|NCT00851643|985936|P5|Extension Study (Up to 36 Months)|Moved|0
300238|NCT00851643|985937|P4|Extension Study (Up to 36 Months)|Moved|1
300239|NCT00851643|985938|P3|Extension Study (Up to 36 Months)|Moved|1
300240|NCT00851643|985939|P2|Extension Study (Up to 36 Months)|Moved|2
300241|NCT00851643|985940|P1|Extension Study (Up to 36 Months)|Moved|0
300242|NCT00851643|985935|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
300243|NCT00851643|985936|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
300244|NCT00851643|985937|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
300245|NCT00851643|985938|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
300246|NCT00851643|985939|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
300247|NCT00851643|985940|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
300248|NCT00851643|985935|P6|Base Study (Up to 12 Months)|Unspecified|1
300249|NCT00851643|985936|P5|Base Study (Up to 12 Months)|Unspecified|0
300250|NCT00851643|985937|P4|Base Study (Up to 12 Months)|Unspecified|0
300251|NCT00851643|985938|P3|Base Study (Up to 12 Months)|Unspecified|0
300252|NCT00851643|985939|P2|Base Study (Up to 12 Months)|Unspecified|0
300253|NCT00851643|985940|P1|Base Study (Up to 12 Months)|Unspecified|0
300254|NCT00851643|985935|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
300255|NCT00851643|985936|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
300256|NCT00851643|985937|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
300257|NCT00851643|985938|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
300258|NCT00851643|985939|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
300259|NCT00851643|985940|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
300260|NCT00851630|985961|P2|Overall Study|Clinical failure|1
300261|NCT00851630|985962|P1|Overall Study|Clinical failure|0
300262|NCT00851630|985961|P2|Overall Study|Death|1
300263|NCT00851630|985962|P1|Overall Study|Death|2
300264|NCT00851591|985976|P2|Overall Study|Withdrawal by Subject|0
300265|NCT00851591|985977|P1|Overall Study|Withdrawal by Subject|2
300266|NCT00851552|985983|P1|Overall Study|Disease Progression|4
300267|NCT00851552|985983|P1|Overall Study|Adverse Event|1
300268|NCT00851552|985983|P1|Overall Study|Death|2
300269|NCT00851318|985997|P4|Overall Study|Physician Decision|1
300270|NCT00851318|985998|P3|Overall Study|Physician Decision|1
300271|NCT00851318|985999|P2|Overall Study|Physician Decision|0
300272|NCT00851318|986000|P1|Overall Study|Physician Decision|0
300273|NCT00851318|985997|P4|Overall Study|Non-compliance with Study Procedures|0
300274|NCT00851318|985998|P3|Overall Study|Non-compliance with Study Procedures|1
300275|NCT00851318|985999|P2|Overall Study|Non-compliance with Study Procedures|0
300276|NCT00851318|986000|P1|Overall Study|Non-compliance with Study Procedures|2
300277|NCT00851318|985997|P4|Overall Study|Lack of Efficacy|2
300278|NCT00851318|985998|P3|Overall Study|Lack of Efficacy|4
300279|NCT00851318|985999|P2|Overall Study|Lack of Efficacy|2
300280|NCT00851318|986000|P1|Overall Study|Lack of Efficacy|8
300281|NCT00851318|985997|P4|Overall Study|Pregnancy|1
300282|NCT00851318|985998|P3|Overall Study|Pregnancy|1
300283|NCT00851318|985999|P2|Overall Study|Pregnancy|0
300284|NCT00851318|986000|P1|Overall Study|Pregnancy|0
300285|NCT00851318|985997|P4|Overall Study|Adverse Event|12
300286|NCT00851318|985998|P3|Overall Study|Adverse Event|9
300287|NCT00851318|985999|P2|Overall Study|Adverse Event|2
300288|NCT00851318|986000|P1|Overall Study|Adverse Event|13
300289|NCT00851318|985997|P4|Overall Study|Withdrawal by Subject|3
300290|NCT00851318|985998|P3|Overall Study|Withdrawal by Subject|5
300291|NCT00851318|985999|P2|Overall Study|Withdrawal by Subject|1
300292|NCT00851318|986000|P1|Overall Study|Withdrawal by Subject|7
300293|NCT00851084|986036|P2|Overall Study|Not specified|1
300294|NCT00851084|986037|P1|Overall Study|Not specified|7
300295|NCT00851084|986036|P2|Overall Study|Metastatic surgery|6
300296|NCT00851084|986037|P1|Overall Study|Metastatic surgery|6
300297|NCT00851084|986036|P2|Overall Study|Withdrawal by Subject|12
300298|NCT00851084|986037|P1|Overall Study|Withdrawal by Subject|11
300299|NCT00851084|986036|P2|Overall Study|Consent withdrawn|2
300300|NCT00851084|986037|P1|Overall Study|Consent withdrawn|0
300301|NCT00851084|986036|P2|Overall Study|Physician Decision|14
300302|NCT00851084|986037|P1|Overall Study|Physician Decision|13
300303|NCT00851084|986036|P2|Overall Study|Poor compliance to protocol|1
300304|NCT00851084|986037|P1|Overall Study|Poor compliance to protocol|1
300305|NCT00851084|986036|P2|Overall Study|Disease progression|47
300306|NCT00851084|986037|P1|Overall Study|Disease progression|52
300307|NCT00851084|986036|P2|Overall Study|Adverse Event|36
300308|NCT00851084|986037|P1|Overall Study|Adverse Event|26
300309|NCT00851084|986036|P2|Overall Study|Randomized but not treated|0
300310|NCT00851084|986037|P1|Overall Study|Randomized but not treated|1
300311|NCT00850759|986097|P4|Overall Study|Lost to Follow-up|3
300312|NCT00850759|986098|P3|Overall Study|Lost to Follow-up|5
300313|NCT00850759|986099|P2|Overall Study|Lost to Follow-up|5
300314|NCT00850759|986100|P1|Overall Study|Lost to Follow-up|7
300315|NCT00850564|986145|P1|Overall Study|Withdrawal by Subject|2
300316|NCT00850538|986150|P1|Overall Study|Protocol Violation|2
300317|NCT00850538|986150|P1|Overall Study|radiology error|2
300318|NCT00850538|986150|P1|Overall Study|Withdrawal by Subject|3
300319|NCT00850538|986150|P1|Overall Study|specimen unusable|7
300320|NCT00850538|986150|P1|Overall Study|specimen missed due to scheduling error|14
300321|NCT00850538|986150|P1|Overall Study|unable/unwilling to complete MRI|13
300322|NCT00850499|986156|P2|Overall Study|Lack of Efficacy|1
300323|NCT00850499|986157|P1|Overall Study|Lack of Efficacy|0
300324|NCT00850499|986156|P2|Overall Study|Adverse Event|1
300325|NCT00850499|986157|P1|Overall Study|Adverse Event|3
300326|NCT00850460|986167|P2|Overall Study|Lost to Follow-up|4
300327|NCT00850460|986168|P1|Overall Study|Lost to Follow-up|4
300328|NCT00850395|986180|P1|Overall Study|Unspecified|5
300329|NCT00850395|986180|P1|Overall Study|Insufficient clinical response|3
300330|NCT00850395|986180|P1|Overall Study|Adverse Event|1
300331|NCT00850395|986180|P1|Overall Study|Death|1
300332|NCT00850343|986200|P4|Overall Study|Physician Decision|1
300333|NCT00850343|986201|P3|Overall Study|Physician Decision|1
300334|NCT00850343|986202|P2|Overall Study|Physician Decision|1
300335|NCT00850343|986203|P1|Overall Study|Physician Decision|2
300336|NCT00850343|986200|P4|Overall Study|Non-compliance with Study Procedures|1
300337|NCT00850343|986201|P3|Overall Study|Non-compliance with Study Procedures|1
300338|NCT00850343|986202|P2|Overall Study|Non-compliance with Study Procedures|0
300339|NCT00850343|986203|P1|Overall Study|Non-compliance with Study Procedures|1
300340|NCT00850343|986200|P4|Overall Study|Lack of Efficacy|2
300341|NCT00850343|986201|P3|Overall Study|Lack of Efficacy|3
300342|NCT00850343|986202|P2|Overall Study|Lack of Efficacy|0
300343|NCT00850343|986203|P1|Overall Study|Lack of Efficacy|17
300344|NCT00850343|986200|P4|Overall Study|Pregnancy|1
300345|NCT00850343|986201|P3|Overall Study|Pregnancy|0
300346|NCT00850343|986202|P2|Overall Study|Pregnancy|0
300347|NCT00850343|986203|P1|Overall Study|Pregnancy|0
300348|NCT00850343|986200|P4|Overall Study|Adverse Event|6
300349|NCT00850343|986201|P3|Overall Study|Adverse Event|6
300350|NCT00850343|986202|P2|Overall Study|Adverse Event|2
300351|NCT00850343|986203|P1|Overall Study|Adverse Event|15
300352|NCT00850343|986200|P4|Overall Study|Withdrawal by Subject|2
300353|NCT00850343|986201|P3|Overall Study|Withdrawal by Subject|3
300354|NCT00850343|986202|P2|Overall Study|Withdrawal by Subject|0
300355|NCT00850343|986203|P1|Overall Study|Withdrawal by Subject|11
300356|NCT00850200|986233|P1|Overall Study|Withdrawal by Subject|1
300357|NCT00850174|986241|P2|Second Intervention|Withdrawal by Subject|0
300358|NCT00850174|986242|P1|Second Intervention|Withdrawal by Subject|1
300359|NCT00850174|986241|P2|Washout: One Week|Withdrawal by Subject|2
300360|NCT00850174|986242|P1|Washout: One Week|Withdrawal by Subject|0
300361|NCT00850135|986256|P1|Overall Study|Physician Decision|1
300362|NCT00850070|986275|P2|Overall Study|Adverse Event|0
300363|NCT00850070|986276|P1|Overall Study|Adverse Event|2
300364|NCT00850070|986275|P2|Overall Study|Lack of Efficacy|1
300365|NCT00850070|986276|P1|Overall Study|Lack of Efficacy|1
300366|NCT00849940|986297|P1|Overall Study|Physician Decision|4
300367|NCT00849901|986308|P3|Extension Phase|Lack of Efficacy|1
300368|NCT00849901|986309|P2|Extension Phase|Lack of Efficacy|4
300369|NCT00849901|986310|P1|Extension Phase|Lack of Efficacy|2
300370|NCT00849901|986308|P3|Extension Phase|Physician Decision|0
300371|NCT00849901|986309|P2|Extension Phase|Physician Decision|2
300372|NCT00849901|986310|P1|Extension Phase|Physician Decision|1
300373|NCT00849901|986308|P3|Extension Phase|Parent or Caregiver Decision|4
300374|NCT00849901|986309|P2|Extension Phase|Parent or Caregiver Decision|4
300375|NCT00849901|986310|P1|Extension Phase|Parent or Caregiver Decision|10
300376|NCT00849901|986308|P3|Extension Phase|Withdrawal by Subject|3
300377|NCT00849901|986309|P2|Extension Phase|Withdrawal by Subject|6
300378|NCT00849901|986310|P1|Extension Phase|Withdrawal by Subject|7
300379|NCT00849901|986308|P3|Extension Phase|Protocol Violation|4
300380|NCT00849901|986309|P2|Extension Phase|Protocol Violation|2
300381|NCT00849901|986310|P1|Extension Phase|Protocol Violation|2
300382|NCT00849901|986308|P3|Extension Phase|Lost to Follow-up|1
300383|NCT00849901|986309|P2|Extension Phase|Lost to Follow-up|0
300384|NCT00849901|986310|P1|Extension Phase|Lost to Follow-up|3
300385|NCT00849901|986308|P3|Extension Phase|Adverse Event|4
300386|NCT00849901|986309|P2|Extension Phase|Adverse Event|8
300387|NCT00849901|986310|P1|Extension Phase|Adverse Event|2
300388|NCT00849901|986308|P3|Acute Treatment Phase|Lack of Efficacy|2
300389|NCT00849901|986309|P2|Acute Treatment Phase|Lack of Efficacy|3
300390|NCT00849901|986310|P1|Acute Treatment Phase|Lack of Efficacy|2
300391|NCT00849901|986308|P3|Acute Treatment Phase|Sponsor Decision|0
300392|NCT00849901|986309|P2|Acute Treatment Phase|Sponsor Decision|0
300393|NCT00849901|986310|P1|Acute Treatment Phase|Sponsor Decision|1
300394|NCT00849901|986308|P3|Acute Treatment Phase|Physician Decision|1
300395|NCT00849901|986309|P2|Acute Treatment Phase|Physician Decision|1
300396|NCT00849901|986310|P1|Acute Treatment Phase|Physician Decision|1
300397|NCT00849901|986308|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
300398|NCT00849901|986309|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
300399|NCT00849901|986310|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
300400|NCT00849901|986308|P3|Acute Treatment Phase|Withdrawal by Subject|4
300401|NCT00849901|986309|P2|Acute Treatment Phase|Withdrawal by Subject|10
300402|NCT00849901|986310|P1|Acute Treatment Phase|Withdrawal by Subject|4
300403|NCT00849901|986308|P3|Acute Treatment Phase|Protocol Violation|1
300404|NCT00849901|986309|P2|Acute Treatment Phase|Protocol Violation|2
300405|NCT00849901|986310|P1|Acute Treatment Phase|Protocol Violation|0
300406|NCT00849901|986308|P3|Acute Treatment Phase|Lost to Follow-up|1
300407|NCT00849901|986309|P2|Acute Treatment Phase|Lost to Follow-up|4
300408|NCT00849901|986310|P1|Acute Treatment Phase|Lost to Follow-up|2
300409|NCT00849901|986308|P3|Acute Treatment Phase|Adverse Event|3
300410|NCT00849901|986309|P2|Acute Treatment Phase|Adverse Event|1
300411|NCT00849901|986310|P1|Acute Treatment Phase|Adverse Event|9
300412|NCT00849875|986357|P1|Overall Study|Lost to Follow-up|2
300413|NCT00849875|986357|P1|Overall Study|Others|6
300414|NCT00849875|986357|P1|Overall Study|Ongoing (unknown completion status)|11
300415|NCT00849875|986357|P1|Overall Study|Death|28
300416|NCT00849797|986454|P2|Washout: One Week|Withdrawal by Subject|2
300417|NCT00849797|986455|P1|Washout: One Week|Withdrawal by Subject|0
300418|NCT00849797|986454|P2|First Intervention|Adverse Event|1
300419|NCT00849797|986455|P1|First Intervention|Adverse Event|0
300420|NCT00849797|986454|P2|First Intervention|bad veins|0
300421|NCT00849797|986455|P1|First Intervention|bad veins|1
300422|NCT00849693|986473|P4|Extension Phase|Lack of Efficacy|1
300423|NCT00849693|986474|P3|Extension Phase|Lack of Efficacy|2
300424|NCT00849693|986475|P2|Extension Phase|Lack of Efficacy|2
300425|NCT00849693|986476|P1|Extension Phase|Lack of Efficacy|2
300426|NCT00849693|986473|P4|Extension Phase|Sponsor decision|1
300427|NCT00849693|986474|P3|Extension Phase|Sponsor decision|0
300428|NCT00849693|986475|P2|Extension Phase|Sponsor decision|0
300429|NCT00849693|986476|P1|Extension Phase|Sponsor decision|1
300430|NCT00849693|986473|P4|Extension Phase|Physician Decision|0
300431|NCT00849693|986474|P3|Extension Phase|Physician Decision|2
300432|NCT00849693|986475|P2|Extension Phase|Physician Decision|1
300433|NCT00849693|986476|P1|Extension Phase|Physician Decision|1
300434|NCT00849693|986473|P4|Extension Phase|Parent or caregiver decision|5
300435|NCT00849693|986474|P3|Extension Phase|Parent or caregiver decision|10
300436|NCT00849693|986475|P2|Extension Phase|Parent or caregiver decision|4
300437|NCT00849693|986476|P1|Extension Phase|Parent or caregiver decision|9
300438|NCT00849693|986473|P4|Extension Phase|Withdrawal by Subject|15
300439|NCT00849693|986474|P3|Extension Phase|Withdrawal by Subject|10
300440|NCT00849693|986475|P2|Extension Phase|Withdrawal by Subject|9
300441|NCT00849693|986476|P1|Extension Phase|Withdrawal by Subject|6
300442|NCT00849693|986473|P4|Extension Phase|Protocol Violation|3
300443|NCT00849693|986474|P3|Extension Phase|Protocol Violation|2
300444|NCT00849693|986475|P2|Extension Phase|Protocol Violation|3
300445|NCT00849693|986476|P1|Extension Phase|Protocol Violation|0
300446|NCT00849693|986473|P4|Extension Phase|Lost to Follow-up|6
300447|NCT00849693|986474|P3|Extension Phase|Lost to Follow-up|6
300448|NCT00849693|986475|P2|Extension Phase|Lost to Follow-up|5
300449|NCT00849693|986476|P1|Extension Phase|Lost to Follow-up|7
300450|NCT00849693|986473|P4|Extension Phase|Adverse Event|7
300451|NCT00849693|986474|P3|Extension Phase|Adverse Event|3
300452|NCT00849693|986475|P2|Extension Phase|Adverse Event|6
300453|NCT00849693|986476|P1|Extension Phase|Adverse Event|4
300454|NCT00849693|986473|P4|Acute Treatment Phase|Lack of Efficacy|2
300455|NCT00849693|986474|P3|Acute Treatment Phase|Lack of Efficacy|1
300456|NCT00849693|986475|P2|Acute Treatment Phase|Lack of Efficacy|3
300457|NCT00849693|986476|P1|Acute Treatment Phase|Lack of Efficacy|1
300458|NCT00849693|986473|P4|Acute Treatment Phase|Sponsor decision|0
300459|NCT00849693|986474|P3|Acute Treatment Phase|Sponsor decision|1
300460|NCT00849693|986475|P2|Acute Treatment Phase|Sponsor decision|0
300461|NCT00849693|986476|P1|Acute Treatment Phase|Sponsor decision|0
300462|NCT00849693|986473|P4|Acute Treatment Phase|Physician Decision|1
300463|NCT00849693|986474|P3|Acute Treatment Phase|Physician Decision|2
300464|NCT00849693|986475|P2|Acute Treatment Phase|Physician Decision|1
300465|NCT00849693|986476|P1|Acute Treatment Phase|Physician Decision|2
300466|NCT00849693|986473|P4|Acute Treatment Phase|Parent or caregiver decision|7
300467|NCT00849693|986474|P3|Acute Treatment Phase|Parent or caregiver decision|7
300468|NCT00849693|986475|P2|Acute Treatment Phase|Parent or caregiver decision|6
300469|NCT00849693|986476|P1|Acute Treatment Phase|Parent or caregiver decision|7
300470|NCT00849693|986473|P4|Acute Treatment Phase|Withdrawal by Subject|8
300471|NCT00849693|986474|P3|Acute Treatment Phase|Withdrawal by Subject|3
300472|NCT00849693|986475|P2|Acute Treatment Phase|Withdrawal by Subject|5
300473|NCT00849693|986476|P1|Acute Treatment Phase|Withdrawal by Subject|5
300474|NCT00849693|986473|P4|Acute Treatment Phase|Protocol Violation|6
300475|NCT00849693|986474|P3|Acute Treatment Phase|Protocol Violation|2
300476|NCT00849693|986475|P2|Acute Treatment Phase|Protocol Violation|5
300477|NCT00849693|986476|P1|Acute Treatment Phase|Protocol Violation|1
300478|NCT00849693|986473|P4|Acute Treatment Phase|Lost to Follow-up|9
300479|NCT00849693|986474|P3|Acute Treatment Phase|Lost to Follow-up|11
300480|NCT00849693|986475|P2|Acute Treatment Phase|Lost to Follow-up|8
300481|NCT00849693|986476|P1|Acute Treatment Phase|Lost to Follow-up|5
300482|NCT00849693|986473|P4|Acute Treatment Phase|Adverse Event|4
300483|NCT00849693|986474|P3|Acute Treatment Phase|Adverse Event|6
300484|NCT00849693|986475|P2|Acute Treatment Phase|Adverse Event|7
300485|NCT00849693|986476|P1|Acute Treatment Phase|Adverse Event|12
300486|NCT00849680|986543|P8|Overall Study|Subject unable to comply with protocol|0
300487|NCT00849680|986544|P7|Overall Study|Subject unable to comply with protocol|0
300488|NCT00849680|986545|P6|Overall Study|Subject unable to comply with protocol|0
300489|NCT00849680|986546|P5|Overall Study|Subject unable to comply with protocol|0
300490|NCT00849680|986547|P4|Overall Study|Subject unable to comply with protocol|0
300491|NCT00849680|986548|P3|Overall Study|Subject unable to comply with protocol|0
300492|NCT00849680|986549|P2|Overall Study|Subject unable to comply with protocol|0
300493|NCT00849680|986550|P1|Overall Study|Subject unable to comply with protocol|1
300494|NCT00849680|986543|P8|Overall Study|Withdrawal by Subject|1
300495|NCT00849680|986544|P7|Overall Study|Withdrawal by Subject|1
300496|NCT00849680|986545|P6|Overall Study|Withdrawal by Subject|2
300497|NCT00849680|986546|P5|Overall Study|Withdrawal by Subject|2
300498|NCT00849680|986547|P4|Overall Study|Withdrawal by Subject|2
300499|NCT00849680|986548|P3|Overall Study|Withdrawal by Subject|0
300500|NCT00849680|986549|P2|Overall Study|Withdrawal by Subject|0
300501|NCT00849680|986550|P1|Overall Study|Withdrawal by Subject|2
300502|NCT00849680|986543|P8|Overall Study|Subject moved|2
300503|NCT00849680|986544|P7|Overall Study|Subject moved|2
300504|NCT00849680|986545|P6|Overall Study|Subject moved|2
300505|NCT00849680|986546|P5|Overall Study|Subject moved|0
300506|NCT00849680|986547|P4|Overall Study|Subject moved|1
300507|NCT00849680|986548|P3|Overall Study|Subject moved|3
300508|NCT00849680|986549|P2|Overall Study|Subject moved|0
300509|NCT00849680|986550|P1|Overall Study|Subject moved|1
300510|NCT00849680|986543|P8|Overall Study|Lost to Follow-up|5
300511|NCT00849680|986544|P7|Overall Study|Lost to Follow-up|12
300512|NCT00849680|986545|P6|Overall Study|Lost to Follow-up|11
300513|NCT00849680|986546|P5|Overall Study|Lost to Follow-up|8
300514|NCT00849680|986547|P4|Overall Study|Lost to Follow-up|11
300515|NCT00849680|986548|P3|Overall Study|Lost to Follow-up|12
300516|NCT00849680|986549|P2|Overall Study|Lost to Follow-up|3
300517|NCT00849680|986550|P1|Overall Study|Lost to Follow-up|7
300518|NCT00849680|986543|P8|Overall Study|Adverse Event|0
300519|NCT00849680|986544|P7|Overall Study|Adverse Event|2
300520|NCT00849680|986545|P6|Overall Study|Adverse Event|0
300521|NCT00849680|986546|P5|Overall Study|Adverse Event|0
300522|NCT00849680|986547|P4|Overall Study|Adverse Event|0
300523|NCT00849680|986548|P3|Overall Study|Adverse Event|0
300524|NCT00849680|986549|P2|Overall Study|Adverse Event|0
300525|NCT00849680|986550|P1|Overall Study|Adverse Event|0
300526|NCT00849524|986592|P1|Overall Study|Lack of Efficacy|3
300527|NCT00849472|986609|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
300528|NCT00849472|986609|P1|Pazopanib Postsurgery Treatment|Moved|1
300529|NCT00849472|986609|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
300530|NCT00849472|986609|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
300531|NCT00849472|986609|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
300532|NCT00849472|986609|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
300533|NCT00849472|986609|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
300534|NCT00849472|986609|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
300535|NCT00849472|986609|P1|Weekly Paclitaxel|Physician Decision|3
300536|NCT00849472|986609|P1|Weekly Paclitaxel|Withdrawal by Subject|1
300537|NCT00849472|986609|P1|Weekly Paclitaxel|Adverse Event|11
300538|NCT00849472|986609|P1|Weekly Paclitaxel|Disease Progression|1
300539|NCT00849472|986609|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
300540|NCT00849472|986609|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
300541|NCT00849472|986609|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
300542|NCT00849472|986609|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
300543|NCT00849472|986609|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
300544|NCT00849381|986623|P1|Overall Study|Unspecified|4
300545|NCT00849381|986623|P1|Overall Study|Withdrawal by Subject|6
300546|NCT00849381|986623|P1|Overall Study|Protocol Violation|5
300547|NCT00849381|986623|P1|Overall Study|Lost to Follow-up|129
300548|NCT00849381|986623|P1|Overall Study|Adverse Event|1
300549|NCT00849290|986629|P1|Overall Study|Disease Progression|20
300550|NCT00849290|986629|P1|Overall Study|Protocol Violation|5
300551|NCT00849290|986629|P1|Overall Study|Lost to Follow-up|2
300552|NCT00849290|986629|P1|Overall Study|Withdrawal by Subject|11
300553|NCT00849290|986629|P1|Overall Study|Death|14
300554|NCT00849290|986629|P1|Overall Study|Adverse Event|3
300555|NCT00849212|986633|P1|Overall Study|Miscellaneous|1
300556|NCT00849212|986633|P1|Overall Study|Adverse Event|2
300557|NCT00849212|986633|P1|Overall Study|Withdrawal by Subject|3
300558|NCT00849212|986633|P1|Overall Study|Lack of Efficacy|1
300559|NCT00849186|986638|P1|Overall Study|Other|1
300560|NCT00849186|986638|P1|Overall Study|not treated|6
300561|NCT00849186|986638|P1|Overall Study|Withdrawal by Subject|1
300562|NCT00849186|986638|P1|Overall Study|Adverse Event|2
300563|NCT00849147|986644|P1|Overall Study|Disease Relapse/Progression|2
300564|NCT00849147|986644|P1|Overall Study|Protocol Violation|2
300565|NCT00849147|986644|P1|Overall Study|Withdrawal by Subject|1
300566|NCT00849108|986677|P2|Cohort 2 Efficacy|Not specified|9
300567|NCT00849108|986678|P1|Cohort 2 Efficacy|Not specified|0
300568|NCT00849108|986677|P2|Cohort 2 Efficacy|Adverse Event|1
300569|NCT00849108|986678|P1|Cohort 2 Efficacy|Adverse Event|0
300570|NCT00849108|986677|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
300571|NCT00849108|986678|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
300572|NCT00849056|986688|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
300573|NCT00849056|986689|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
300574|NCT00849056|986688|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
300575|NCT00849056|986689|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
300576|NCT00849056|986688|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
300577|NCT00849056|986689|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
300578|NCT00849056|986688|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
300579|NCT00849056|986689|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
300580|NCT00849056|986688|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
300581|NCT00849056|986689|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
300582|NCT00849056|986688|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
300583|NCT00849056|986689|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
300584|NCT00849056|986688|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
300585|NCT00849056|986689|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
300586|NCT00849056|986688|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
300587|NCT00849056|986689|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
300588|NCT00849056|986688|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
300589|NCT00849056|986689|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
300590|NCT00849056|986688|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
300591|NCT00849056|986689|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
300592|NCT00849056|986688|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
300593|NCT00849056|986689|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
300594|NCT00849056|986688|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
300595|NCT00849056|986689|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
300596|NCT00849056|986688|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
300597|NCT00849056|986689|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
300598|NCT00849056|986688|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
300599|NCT00849056|986689|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
300600|NCT00849056|986688|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
300601|NCT00849056|986689|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
300602|NCT00849056|986688|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
300603|NCT00849056|986689|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
300604|NCT00849017|986714|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
300605|NCT00849017|986715|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
300606|NCT00849017|986716|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
300607|NCT00849017|986714|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
300608|NCT00849017|986715|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
300609|NCT00849017|986716|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
300610|NCT00849017|986714|P3|Follow-up Period (8 Weeks)|Physician Decision|1
300611|NCT00849017|986715|P2|Follow-up Period (8 Weeks)|Physician Decision|1
300612|NCT00849017|986716|P1|Follow-up Period (8 Weeks)|Physician Decision|0
300613|NCT00849017|986714|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
300614|NCT00849017|986715|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
300615|NCT00849017|986716|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
300616|NCT00849017|986714|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
300617|NCT00849017|986715|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
300618|NCT00849017|986716|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
300619|NCT00849017|986714|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
300620|NCT00849017|986715|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
300621|NCT00849017|986716|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
300622|NCT00849017|986714|P3|Follow-up Period (8 Weeks)|Noncompliance|0
300623|NCT00849017|986715|P2|Follow-up Period (8 Weeks)|Noncompliance|1
300624|NCT00849017|986716|P1|Follow-up Period (8 Weeks)|Noncompliance|2
300625|NCT00849017|986714|P3|Follow-up Period (8 Weeks)|Adverse Event|0
300626|NCT00849017|986715|P2|Follow-up Period (8 Weeks)|Adverse Event|0
300627|NCT00849017|986716|P1|Follow-up Period (8 Weeks)|Adverse Event|1
300628|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
300629|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
300630|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
300631|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Pregnancy|1
300632|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Pregnancy|0
300633|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Pregnancy|1
300634|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
300635|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
300636|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
300637|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
300638|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
300639|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
300640|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
300641|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
300642|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
300643|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
300644|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
300645|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
300646|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Physician Decision|1
300647|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Physician Decision|2
300648|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Physician Decision|0
300649|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
300650|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
300651|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
300652|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
300653|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
300654|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
300655|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Noncompliance|4
300656|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Noncompliance|3
300657|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Noncompliance|3
300658|NCT00849017|986714|P3|Treatment Period (156 Weeks)|Adverse Event|15
300659|NCT00849017|986715|P2|Treatment Period (156 Weeks)|Adverse Event|6
300660|NCT00849017|986716|P1|Treatment Period (156 Weeks)|Adverse Event|5
300661|NCT00848965|986759|P1|Overall Study|Withdrawal by Subject|1
300662|NCT00848965|986759|P1|Overall Study|Adverse Event|1
300663|NCT00848926|986801|P1|Follow-up Period|Not specified|2
300664|NCT00848926|986801|P1|Follow-up Period|Withdrawal by Subject|3
300665|NCT00848926|986801|P1|Follow-up Period|Lost to Follow-up|7
300666|NCT00848926|986801|P1|Treatment Period|Withdrawal by Subject|7
300667|NCT00848926|986801|P1|Treatment Period|Physician Decision|12
300668|NCT00848926|986801|P1|Treatment Period|Adverse Event|20
300669|NCT00848926|986801|P1|Treatment Period|Progressive disease|45
300670|NCT00848549|986835|P2|E2090-E044-314 (Extension Study)|Not Specified|6
300671|NCT00848549|986836|P1|E2090-E044-314 (Extension Study)|Not Specified|5
300672|NCT00848549|986835|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
300673|NCT00848549|986836|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
300674|NCT00848549|986835|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
300675|NCT00848549|986836|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
300676|NCT00848549|986835|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
300677|NCT00848549|986836|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
300678|NCT00848549|986835|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
300679|NCT00848549|986836|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
300680|NCT00848549|986835|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
300681|NCT00848549|986836|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
300682|NCT00848549|986835|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
300683|NCT00848549|986836|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
300684|NCT00848549|986835|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
300685|NCT00848549|986836|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
300686|NCT00848549|986835|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
300687|NCT00848549|986836|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
300688|NCT00848549|986835|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
300689|NCT00848549|986836|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
300690|NCT00848549|986835|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
300691|NCT00848549|986836|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
300692|NCT00848549|986835|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
300693|NCT00848549|986836|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
300694|NCT00848549|986835|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
300695|NCT00848549|986836|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
300696|NCT00848549|986835|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
300697|NCT00848549|986836|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
300698|NCT00848536|986854|P2|Overall Study|Patient Moved|2
300699|NCT00848536|986855|P1|Overall Study|Patient Moved|0
300700|NCT00848536|986854|P2|Overall Study|Inadequate Control of IOP|1
300701|NCT00848536|986855|P1|Overall Study|Inadequate Control of IOP|1
300702|NCT00848536|986854|P2|Overall Study|Noncompliance|0
300703|NCT00848536|986855|P1|Overall Study|Noncompliance|1
300704|NCT00848536|986854|P2|Overall Study|Protocol Violation|1
300705|NCT00848536|986855|P1|Overall Study|Protocol Violation|0
300706|NCT00848536|986854|P2|Overall Study|Withdrawal by Subject|1
300707|NCT00848536|986855|P1|Overall Study|Withdrawal by Subject|0
300708|NCT00848536|986854|P2|Overall Study|Adverse Event|2
300709|NCT00848536|986855|P1|Overall Study|Adverse Event|2
300710|NCT00848497|986920|P2|Overall Study|Withdrawal by Subject|1
300711|NCT00848497|986921|P1|Overall Study|Withdrawal by Subject|0
300712|NCT00848497|986920|P2|Overall Study|Screen failure|0
300713|NCT00848497|986921|P1|Overall Study|Screen failure|2
300714|NCT00848484|986935|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
300715|NCT00848484|986936|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
300716|NCT00848484|986935|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
300717|NCT00848484|986936|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
300718|NCT00848484|986935|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
300719|NCT00848484|986936|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
300720|NCT00848484|986935|P2|First Intervention (Treatment Period 1)|Physician Decision|1
300721|NCT00848484|986936|P1|First Intervention (Treatment Period 1)|Physician Decision|0
300722|NCT00848484|986935|P2|First Intervention (Treatment Period 1)|Adverse Event|1
300723|NCT00848484|986936|P1|First Intervention (Treatment Period 1)|Adverse Event|2
300724|NCT00848354|986965|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
300725|NCT00848354|986966|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
300726|NCT00848354|986965|P2|Phase 2 Year 2|Subject Request|1
300727|NCT00848354|986966|P1|Phase 2 Year 2|Subject Request|1
300728|NCT00848354|986965|P2|Phase 2 Year 2|Protocol Violation|1
300729|NCT00848354|986966|P1|Phase 2 Year 2|Protocol Violation|1
300730|NCT00848354|986965|P2|Phase 2 Year 2|Unspecified Reason|0
300731|NCT00848354|986966|P1|Phase 2 Year 2|Unspecified Reason|1
300732|NCT00848354|986965|P2|Phase 2 Year 2|Lost to Follow-up|3
300733|NCT00848354|986966|P1|Phase 2 Year 2|Lost to Follow-up|1
300734|NCT00848354|986965|P2|Phase 2 Year 2|Failed to return|0
300735|NCT00848354|986966|P1|Phase 2 Year 2|Failed to return|3
300736|NCT00848354|986965|P2|Phase 2 Year 2|Death|0
300737|NCT00848354|986966|P1|Phase 2 Year 2|Death|2
300738|NCT00848354|986965|P2|Phase 2 Year 2|Adverse Event|2
300739|NCT00848354|986966|P1|Phase 2 Year 2|Adverse Event|12
300740|NCT00848354|986965|P2|Phase 2 Year 1|Subject Request|2
300741|NCT00848354|986966|P1|Phase 2 Year 1|Subject Request|1
300742|NCT00848354|986965|P2|Phase 2 Year 1|Protocol Violation|1
300743|NCT00848354|986966|P1|Phase 2 Year 1|Protocol Violation|4
300744|NCT00848354|986965|P2|Phase 2 Year 1|Unspecified Reason|0
300745|NCT00848354|986966|P1|Phase 2 Year 1|Unspecified Reason|3
300746|NCT00848354|986965|P2|Phase 2 Year 1|Lost to Follow-up|0
300747|NCT00848354|986966|P1|Phase 2 Year 1|Lost to Follow-up|1
300748|NCT00848354|986965|P2|Phase 2 Year 1|Failed to Return|1
300749|NCT00848354|986966|P1|Phase 2 Year 1|Failed to Return|1
300750|NCT00848354|986965|P2|Phase 2 Year 1|Death|0
300751|NCT00848354|986966|P1|Phase 2 Year 1|Death|1
300752|NCT00848354|986965|P2|Phase 2 Year 1|Adverse Event|2
300753|NCT00848354|986966|P1|Phase 2 Year 1|Adverse Event|7
300754|NCT00848354|986965|P2|Phase 1|Lack of Efficacy|1
300755|NCT00848354|986966|P1|Phase 1|Lack of Efficacy|0
300756|NCT00848354|986965|P2|Phase 1|Withdrawal by Subject|4
300757|NCT00848354|986966|P1|Phase 1|Withdrawal by Subject|2
300758|NCT00848354|986965|P2|Phase 1|Protocol Violation|1
300759|NCT00848354|986966|P1|Phase 1|Protocol Violation|1
300760|NCT00848354|986965|P2|Phase 1|Unspecified Reason|1
300761|NCT00848354|986966|P1|Phase 1|Unspecified Reason|1
300762|NCT00848354|986965|P2|Phase 1|Lost to Follow-up|1
300763|NCT00848354|986966|P1|Phase 1|Lost to Follow-up|1
300764|NCT00848354|986965|P2|Phase 1|Failed to return|1
300765|NCT00848354|986966|P1|Phase 1|Failed to return|0
300766|NCT00848354|986965|P2|Phase 1|Discontinuation of study by sponsor|1
300767|NCT00848354|986966|P1|Phase 1|Discontinuation of study by sponsor|2
300768|NCT00848354|986965|P2|Phase 1|Adverse Event|4
300769|NCT00848354|986966|P1|Phase 1|Adverse Event|5
300770|NCT00848211|987129|P4|Overall Study|Adverse Event|0
300771|NCT00848211|987130|P3|Overall Study|Adverse Event|0
300772|NCT00848211|987131|P2|Overall Study|Adverse Event|0
300773|NCT00848211|987132|P1|Overall Study|Adverse Event|0
300774|NCT00848211|987129|P4|Overall Study|Protocol Violation|0
300775|NCT00848211|987130|P3|Overall Study|Protocol Violation|1
300776|NCT00848211|987131|P2|Overall Study|Protocol Violation|1
300777|NCT00848211|987132|P1|Overall Study|Protocol Violation|0
300778|NCT00848198|987150|P1|Overall Study|Incomplete Case Report Forms|15
300779|NCT00848120|987215|P1|Overall Study|Adverse Event|1
300780|NCT00848107|987227|P1|Overall Study|Pregnancy|1
300781|NCT00848107|987227|P1|Overall Study|Death|1
300782|NCT00848107|987227|P1|Overall Study|Adverse Event|9
300783|NCT00848107|987227|P1|Overall Study|Withdrawal by Subject|8
300784|NCT00848107|987227|P1|Overall Study|Lost to Follow-up|2
300785|NCT00848081|987237|P2|Overall Study|Withdrawal by Subject|3
300786|NCT00848081|987238|P1|Overall Study|Withdrawal by Subject|5
300787|NCT00848081|987237|P2|Overall Study|Physician Decision|3
300788|NCT00848081|987238|P1|Overall Study|Physician Decision|0
300789|NCT00848081|987237|P2|Overall Study|Lost to Follow-up|0
300790|NCT00848081|987238|P1|Overall Study|Lost to Follow-up|1
300791|NCT00848081|987237|P2|Overall Study|Protocol Violation|5
300792|NCT00848081|987238|P1|Overall Study|Protocol Violation|8
300793|NCT00848081|987237|P2|Overall Study|Adverse Event|7
300794|NCT00848081|987238|P1|Overall Study|Adverse Event|6
300795|NCT00848042|987255|P3|Overall Study|Other Therapy|0
300796|NCT00848042|987256|P2|Overall Study|Other Therapy|0
300797|NCT00848042|987257|P1|Overall Study|Other Therapy|3
300798|NCT00848042|987255|P3|Overall Study|Death|0
300799|NCT00848042|987256|P2|Overall Study|Death|2
300800|NCT00848042|987257|P1|Overall Study|Death|1
300801|NCT00847912|987276|P2|Overall Study|Withdrawal by Subject|6
300802|NCT00847912|987277|P1|Overall Study|Withdrawal by Subject|3
300803|NCT00847912|987276|P2|Overall Study|Protocol Violation|7
300804|NCT00847912|987277|P1|Overall Study|Protocol Violation|6
300805|NCT00847886|987287|P2|Overall Study|Adverse Event|1
300806|NCT00847886|987288|P1|Overall Study|Adverse Event|0
300807|NCT00847808|987314|P1|Overall Study|Participant Took Excluded Medication|1
300808|NCT00847808|987314|P1|Overall Study|Participant Reported Lack of Efficacy|1
300809|NCT00847808|987314|P1|Overall Study|Withdrawal by Subject|4
300810|NCT00847808|987314|P1|Overall Study|Lost to Follow-up|1
300811|NCT00847808|987314|P1|Overall Study|Protocol Violation|1
300812|NCT00847808|987314|P1|Overall Study|Adverse Event|7
300813|NCT00847704|987331|P1|Overall Study|Withdrawal by Subject|1
300814|NCT00847665|987342|P2|Overall Study|Withdrawal by Subject|0
300815|NCT00847665|987343|P1|Overall Study|Withdrawal by Subject|1
300816|NCT00847626|987366|P11|Overall Study|Other|3
300817|NCT00847626|987367|P10|Overall Study|Other|1
300818|NCT00847626|987368|P9|Overall Study|Other|1
300819|NCT00847626|987369|P8|Overall Study|Other|3
300820|NCT00847626|987370|P7|Overall Study|Other|2
300821|NCT00847626|987371|P6|Overall Study|Other|2
300822|NCT00847626|987372|P5|Overall Study|Other|2
300823|NCT00847626|987373|P4|Overall Study|Other|1
300824|NCT00847626|987374|P3|Overall Study|Other|4
300825|NCT00847626|987375|P2|Overall Study|Other|5
300826|NCT00847626|987376|P1|Overall Study|Other|1
300827|NCT00847626|987366|P11|Overall Study|Lack of Efficacy|7
300828|NCT00847626|987367|P10|Overall Study|Lack of Efficacy|1
300829|NCT00847626|987368|P9|Overall Study|Lack of Efficacy|5
300830|NCT00847626|987369|P8|Overall Study|Lack of Efficacy|2
300831|NCT00847626|987370|P7|Overall Study|Lack of Efficacy|6
300832|NCT00847626|987371|P6|Overall Study|Lack of Efficacy|0
300833|NCT00847626|987372|P5|Overall Study|Lack of Efficacy|2
300834|NCT00847626|987373|P4|Overall Study|Lack of Efficacy|1
300835|NCT00847626|987374|P3|Overall Study|Lack of Efficacy|0
300836|NCT00847626|987375|P2|Overall Study|Lack of Efficacy|1
300837|NCT00847626|987376|P1|Overall Study|Lack of Efficacy|3
300838|NCT00847626|987366|P11|Overall Study|Withdrawal by Subject|2
300839|NCT00847626|987367|P10|Overall Study|Withdrawal by Subject|5
300840|NCT00847626|987368|P9|Overall Study|Withdrawal by Subject|4
300841|NCT00847626|987369|P8|Overall Study|Withdrawal by Subject|4
300842|NCT00847626|987370|P7|Overall Study|Withdrawal by Subject|8
300843|NCT00847626|987371|P6|Overall Study|Withdrawal by Subject|9
300844|NCT00847626|987372|P5|Overall Study|Withdrawal by Subject|12
300845|NCT00847626|987373|P4|Overall Study|Withdrawal by Subject|8
300846|NCT00847626|987374|P3|Overall Study|Withdrawal by Subject|3
300847|NCT00847626|987375|P2|Overall Study|Withdrawal by Subject|5
300848|NCT00847626|987376|P1|Overall Study|Withdrawal by Subject|5
300849|NCT00847626|987366|P11|Overall Study|Lost to Follow-up|1
300850|NCT00847626|987367|P10|Overall Study|Lost to Follow-up|0
300851|NCT00847626|987368|P9|Overall Study|Lost to Follow-up|1
300852|NCT00847626|987369|P8|Overall Study|Lost to Follow-up|3
300853|NCT00847626|987370|P7|Overall Study|Lost to Follow-up|1
300854|NCT00847626|987371|P6|Overall Study|Lost to Follow-up|3
300855|NCT00847626|987372|P5|Overall Study|Lost to Follow-up|0
300856|NCT00847626|987373|P4|Overall Study|Lost to Follow-up|1
300857|NCT00847626|987374|P3|Overall Study|Lost to Follow-up|1
300858|NCT00847626|987375|P2|Overall Study|Lost to Follow-up|1
300859|NCT00847626|987376|P1|Overall Study|Lost to Follow-up|0
300860|NCT00847626|987366|P11|Overall Study|Protocol Violation|1
300861|NCT00847626|987367|P10|Overall Study|Protocol Violation|1
300862|NCT00847626|987368|P9|Overall Study|Protocol Violation|0
300863|NCT00847626|987369|P8|Overall Study|Protocol Violation|1
300864|NCT00847626|987370|P7|Overall Study|Protocol Violation|1
300865|NCT00847626|987371|P6|Overall Study|Protocol Violation|1
300866|NCT00847626|987372|P5|Overall Study|Protocol Violation|1
300867|NCT00847626|987373|P4|Overall Study|Protocol Violation|1
300868|NCT00847626|987374|P3|Overall Study|Protocol Violation|2
300869|NCT00847626|987375|P2|Overall Study|Protocol Violation|1
300870|NCT00847626|987376|P1|Overall Study|Protocol Violation|2
300871|NCT00847626|987366|P11|Overall Study|Adverse Event|6
300872|NCT00847626|987367|P10|Overall Study|Adverse Event|6
300873|NCT00847626|987368|P9|Overall Study|Adverse Event|3
300874|NCT00847626|987369|P8|Overall Study|Adverse Event|6
300875|NCT00847626|987370|P7|Overall Study|Adverse Event|4
300876|NCT00847626|987371|P6|Overall Study|Adverse Event|22
300877|NCT00847626|987372|P5|Overall Study|Adverse Event|11
300878|NCT00847626|987373|P4|Overall Study|Adverse Event|19
300879|NCT00847626|987374|P3|Overall Study|Adverse Event|6
300880|NCT00847626|987375|P2|Overall Study|Adverse Event|10
300881|NCT00847626|987376|P1|Overall Study|Adverse Event|10
300882|NCT00847613|987575|P4|Overall Study|Unspecified|0
300883|NCT00847613|987576|P3|Overall Study|Unspecified|2
300884|NCT00847613|987577|P2|Overall Study|Unspecified|1
300885|NCT00847613|987578|P1|Overall Study|Unspecified|1
300886|NCT00847613|987575|P4|Overall Study|Randomized, but not treated|0
300887|NCT00847613|987576|P3|Overall Study|Randomized, but not treated|0
300888|NCT00847613|987577|P2|Overall Study|Randomized, but not treated|3
300889|NCT00847613|987578|P1|Overall Study|Randomized, but not treated|0
300890|NCT00847613|987575|P4|Overall Study|Sponsor request|0
300891|NCT00847613|987576|P3|Overall Study|Sponsor request|0
300892|NCT00847613|987577|P2|Overall Study|Sponsor request|1
300893|NCT00847613|987578|P1|Overall Study|Sponsor request|0
300894|NCT00847613|987575|P4|Overall Study|Participant moved|0
300895|NCT00847613|987576|P3|Overall Study|Participant moved|0
300896|NCT00847613|987577|P2|Overall Study|Participant moved|1
300897|NCT00847613|987578|P1|Overall Study|Participant moved|4
300898|NCT00847613|987575|P4|Overall Study|Withdrawal by Subject|2
300899|NCT00847613|987576|P3|Overall Study|Withdrawal by Subject|2
300900|NCT00847613|987577|P2|Overall Study|Withdrawal by Subject|11
300901|NCT00847613|987578|P1|Overall Study|Withdrawal by Subject|8
300902|NCT00847613|987575|P4|Overall Study|Site closure|1
300903|NCT00847613|987576|P3|Overall Study|Site closure|0
300904|NCT00847613|987577|P2|Overall Study|Site closure|0
300905|NCT00847613|987578|P1|Overall Study|Site closure|1
300906|NCT00847613|987575|P4|Overall Study|Pregnancy|0
300907|NCT00847613|987576|P3|Overall Study|Pregnancy|0
300908|NCT00847613|987577|P2|Overall Study|Pregnancy|1
300909|NCT00847613|987578|P1|Overall Study|Pregnancy|1
300910|NCT00847613|987575|P4|Overall Study|Protocol Violation|1
300911|NCT00847613|987576|P3|Overall Study|Protocol Violation|3
300912|NCT00847613|987577|P2|Overall Study|Protocol Violation|6
300913|NCT00847613|987578|P1|Overall Study|Protocol Violation|6
300914|NCT00847613|987575|P4|Overall Study|Lost to Follow-up|3
300915|NCT00847613|987576|P3|Overall Study|Lost to Follow-up|0
300916|NCT00847613|987577|P2|Overall Study|Lost to Follow-up|0
300917|NCT00847613|987578|P1|Overall Study|Lost to Follow-up|5
300918|NCT00847613|987575|P4|Overall Study|Study terminated by Sponsor|1
300919|NCT00847613|987576|P3|Overall Study|Study terminated by Sponsor|2
300920|NCT00847613|987577|P2|Overall Study|Study terminated by Sponsor|0
300921|NCT00847613|987578|P1|Overall Study|Study terminated by Sponsor|1
300922|NCT00847613|987575|P4|Overall Study|Lack of Efficacy|1
300923|NCT00847613|987576|P3|Overall Study|Lack of Efficacy|3
300924|NCT00847613|987577|P2|Overall Study|Lack of Efficacy|3
300925|NCT00847613|987578|P1|Overall Study|Lack of Efficacy|7
300926|NCT00847613|987575|P4|Overall Study|Adverse Event|6
300927|NCT00847613|987576|P3|Overall Study|Adverse Event|5
300928|NCT00847613|987577|P2|Overall Study|Adverse Event|26
300929|NCT00847613|987578|P1|Overall Study|Adverse Event|36
300930|NCT00847613|987575|P4|Overall Study|Death|0
300931|NCT00847613|987576|P3|Overall Study|Death|0
300932|NCT00847613|987577|P2|Overall Study|Death|1
300933|NCT00847613|987578|P1|Overall Study|Death|1
300934|NCT00847613|987575|P4|Overall Study|Ongoing at cut-off date|64
300935|NCT00847613|987576|P3|Overall Study|Ongoing at cut-off date|64
300936|NCT00847613|987577|P2|Overall Study|Ongoing at cut-off date|265
300937|NCT00847613|987578|P1|Overall Study|Ongoing at cut-off date|250
300938|NCT00847561|987829|P2|Overall Study|Unable to schedule|1
300939|NCT00847561|987830|P1|Overall Study|Unable to schedule|9
300940|NCT00847561|987829|P2|Overall Study|Withdrawal by Subject|3
300941|NCT00847561|987830|P1|Overall Study|Withdrawal by Subject|4
300942|NCT00847535|987836|P3|Overall Study|Lost to Follow-up|0
300943|NCT00847535|987837|P2|Overall Study|Lost to Follow-up|1
300944|NCT00847535|987838|P1|Overall Study|Lost to Follow-up|0
300945|NCT00847535|987836|P3|Overall Study|Withdrawal by Subject|1
300946|NCT00847535|987837|P2|Overall Study|Withdrawal by Subject|1
300947|NCT00847535|987838|P1|Overall Study|Withdrawal by Subject|2
300948|NCT00847405|987852|P2|Washout of 7 Days|Withdrawal by Subject|0
300949|NCT00847405|987853|P1|Washout of 7 Days|Withdrawal by Subject|1
300950|NCT00847405|987852|P2|First Intervention|Adverse Event|1
300951|NCT00847405|987853|P1|First Intervention|Adverse Event|0
300952|NCT00847301|987861|P1|Overall Study|Other reason not defined above|1
300953|NCT00847301|987861|P1|Overall Study|No prescription after hospital discharge|1
300954|NCT00847301|987861|P1|Overall Study|Lost to Follow-up|1
300955|NCT00847301|987861|P1|Overall Study|Switch to other anticoagulants|16
300956|NCT00847301|987861|P1|Overall Study|Adverse Event|35
300957|NCT00847197|987909|P2|Overall Study|Withdrawal by Subject|1
300958|NCT00847197|987910|P1|Overall Study|Withdrawal by Subject|3
300959|NCT00847197|987909|P2|Overall Study|Protocol Violation|1
300960|NCT00847197|987910|P1|Overall Study|Protocol Violation|0
300961|NCT00847197|987909|P2|Overall Study|Adverse Event|3
300962|NCT00847197|987910|P1|Overall Study|Adverse Event|21
300963|NCT00847145|987928|P8|Overall Study|Protocol Violation|1
300964|NCT00847145|987929|P7|Overall Study|Protocol Violation|0
300965|NCT00847145|987930|P6|Overall Study|Protocol Violation|0
300966|NCT00847145|987931|P5|Overall Study|Protocol Violation|1
300967|NCT00847145|987932|P4|Overall Study|Protocol Violation|0
300968|NCT00847145|987933|P3|Overall Study|Protocol Violation|3
300969|NCT00847145|987934|P2|Overall Study|Protocol Violation|0
300970|NCT00847145|987935|P1|Overall Study|Protocol Violation|0
300971|NCT00847145|987928|P8|Overall Study|Inappropriate enrollment|0
300972|NCT00847145|987929|P7|Overall Study|Inappropriate enrollment|0
300973|NCT00847145|987930|P6|Overall Study|Inappropriate enrollment|0
300974|NCT00847145|987931|P5|Overall Study|Inappropriate enrollment|1
300975|NCT00847145|987932|P4|Overall Study|Inappropriate enrollment|0
300976|NCT00847145|987933|P3|Overall Study|Inappropriate enrollment|0
300977|NCT00847145|987934|P2|Overall Study|Inappropriate enrollment|0
300978|NCT00847145|987935|P1|Overall Study|Inappropriate enrollment|0
300979|NCT00847145|987928|P8|Overall Study|Lost to Follow-up|2
300980|NCT00847145|987929|P7|Overall Study|Lost to Follow-up|8
300981|NCT00847145|987930|P6|Overall Study|Lost to Follow-up|4
300982|NCT00847145|987931|P5|Overall Study|Lost to Follow-up|4
300983|NCT00847145|987932|P4|Overall Study|Lost to Follow-up|0
300984|NCT00847145|987933|P3|Overall Study|Lost to Follow-up|1
300985|NCT00847145|987934|P2|Overall Study|Lost to Follow-up|1
300986|NCT00847145|987935|P1|Overall Study|Lost to Follow-up|3
300987|NCT00847145|987928|P8|Overall Study|Withdrawal by Subject|1
300988|NCT00847145|987929|P7|Overall Study|Withdrawal by Subject|1
300989|NCT00847145|987930|P6|Overall Study|Withdrawal by Subject|0
300990|NCT00847145|987931|P5|Overall Study|Withdrawal by Subject|0
300991|NCT00847145|987932|P4|Overall Study|Withdrawal by Subject|1
300992|NCT00847145|987933|P3|Overall Study|Withdrawal by Subject|6
300993|NCT00847145|987934|P2|Overall Study|Withdrawal by Subject|4
300994|NCT00847145|987935|P1|Overall Study|Withdrawal by Subject|3
300995|NCT00847145|987928|P8|Overall Study|AE or Death|0
300996|NCT00847145|987929|P7|Overall Study|AE or Death|0
300997|NCT00847145|987930|P6|Overall Study|AE or Death|0
300998|NCT00847145|987931|P5|Overall Study|AE or Death|0
300999|NCT00847145|987932|P4|Overall Study|AE or Death|0
301000|NCT00847145|987933|P3|Overall Study|AE or Death|1
301001|NCT00847145|987934|P2|Overall Study|AE or Death|1
301002|NCT00847145|987935|P1|Overall Study|AE or Death|0
301003|NCT00847132|987985|P2|Overall Study|Death|1
301004|NCT00847132|987986|P1|Overall Study|Death|1
301005|NCT00847015|987994|P1|Overall Study|partial cystectomy vs radical cystectomy|1
301006|NCT00847015|987994|P1|Overall Study|declined any surgery|1
301007|NCT00847015|987994|P1|Overall Study|Withdrawal by Subject|1
301008|NCT00846846|988022|P1|Overall Study|Withdrawal by Subject|19
301009|NCT00846846|988022|P1|Overall Study|Death|56
301010|NCT00846027|988042|P1|Overall Study|Subject Not Treated|7
301011|NCT00846027|988042|P1|Overall Study|Protocol Violation|2
301012|NCT00846027|988042|P1|Overall Study|Investigator Discretion|29
301013|NCT00846027|988042|P1|Overall Study|Patient Decision|7
301014|NCT00846027|988042|P1|Overall Study|Toxicity|12
301015|NCT00846027|988042|P1|Overall Study|Disease Progression|30
301016|NCT00846027|988042|P1|Overall Study|Death|3
301017|NCT00846807|988062|P1|Overall Study|Other|60
301018|NCT00846807|988062|P1|Overall Study|No prescription after hospital discharge|56
301019|NCT00846807|988062|P1|Overall Study|Switch to other anticoagulants|89
301020|NCT00846807|988062|P1|Overall Study|Non compliant with European label|7
301021|NCT00846807|988062|P1|Overall Study|Withdrawal by Subject|56
301022|NCT00846807|988062|P1|Overall Study|Lost to Follow-up|94
301023|NCT00846807|988062|P1|Overall Study|Adverse Event|270
301024|NCT00846768|988070|P4|Overall Study|Adverse Event|0
301025|NCT00846768|988071|P3|Overall Study|Adverse Event|0
301026|NCT00846768|988072|P2|Overall Study|Adverse Event|1
301027|NCT00846768|988073|P1|Overall Study|Adverse Event|0
301028|NCT00846586|988162|P2|Overall Study|Unsatisfactory therapeutic effect|1
301029|NCT00846586|988163|P1|Overall Study|Unsatisfactory therapeutic effect|0
301030|NCT00846586|988162|P2|Overall Study|Lost to Follow-up|4
301031|NCT00846586|988163|P1|Overall Study|Lost to Follow-up|1
301032|NCT00846586|988162|P2|Overall Study|Abnormal test procedure result(s)|0
301033|NCT00846586|988163|P1|Overall Study|Abnormal test procedure result(s)|1
301034|NCT00846586|988162|P2|Overall Study|Protocol deviation|6
301035|NCT00846586|988163|P1|Overall Study|Protocol deviation|2
301036|NCT00846586|988162|P2|Overall Study|Death|0
301037|NCT00846586|988163|P1|Overall Study|Death|2
301038|NCT00846586|988162|P2|Overall Study|Administrative problems|4
301039|NCT00846586|988163|P1|Overall Study|Administrative problems|5
301040|NCT00846586|988162|P2|Overall Study|Subject withdrew consent|10
301041|NCT00846586|988163|P1|Overall Study|Subject withdrew consent|8
301042|NCT00846586|988162|P2|Overall Study|Adverse Event|10
301043|NCT00846586|988163|P1|Overall Study|Adverse Event|20
301044|NCT00846521|988197|P1|Overall Study|Protocol Violation|1
301045|NCT00846521|988197|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
301046|NCT00846521|988197|P1|Overall Study|Withdrawal by Subject|5
301047|NCT00846495|988204|P2|Overall Study|Physician Decision|0
301048|NCT00846495|988205|P1|Overall Study|Physician Decision|1
301049|NCT00846495|988204|P2|Overall Study|Lack of Efficacy|2
301050|NCT00846495|988205|P1|Overall Study|Lack of Efficacy|1
301051|NCT00846495|988204|P2|Overall Study|Adverse Event|1
301052|NCT00846495|988205|P1|Overall Study|Adverse Event|5
301053|NCT00846495|988204|P2|Overall Study|Lost to Follow-up|0
301054|NCT00846495|988205|P1|Overall Study|Lost to Follow-up|1
301055|NCT00846391|988228|P3|Overall Study|Study Terminated by Sponsor|2
301056|NCT00846391|988229|P2|Overall Study|Study Terminated by Sponsor|2
301057|NCT00846391|988230|P1|Overall Study|Study Terminated by Sponsor|1
301058|NCT00846391|988228|P3|Overall Study|Physician Decision|1
301059|NCT00846391|988229|P2|Overall Study|Physician Decision|0
301060|NCT00846391|988230|P1|Overall Study|Physician Decision|0
301061|NCT00846365|988241|P3|Overall Study|Other|6
301062|NCT00846365|988242|P2|Overall Study|Other|1
301063|NCT00846365|988243|P1|Overall Study|Other|9
301064|NCT00846365|988241|P3|Overall Study|Lack of Efficacy|2
301065|NCT00846365|988242|P2|Overall Study|Lack of Efficacy|1
301066|NCT00846365|988243|P1|Overall Study|Lack of Efficacy|1
301067|NCT00846365|988241|P3|Overall Study|Pregnancy|0
301068|NCT00846365|988242|P2|Overall Study|Pregnancy|0
301069|NCT00846365|988243|P1|Overall Study|Pregnancy|1
301070|NCT00846365|988241|P3|Overall Study|Withdrawal by Subject|9
301071|NCT00846365|988242|P2|Overall Study|Withdrawal by Subject|11
301072|NCT00846365|988243|P1|Overall Study|Withdrawal by Subject|11
301073|NCT00846365|988241|P3|Overall Study|Lost to Follow-up|5
301074|NCT00846365|988242|P2|Overall Study|Lost to Follow-up|2
301075|NCT00846365|988243|P1|Overall Study|Lost to Follow-up|8
301076|NCT00846365|988241|P3|Overall Study|Protocol Violation|0
301077|NCT00846365|988242|P2|Overall Study|Protocol Violation|4
301078|NCT00846365|988243|P1|Overall Study|Protocol Violation|5
301079|NCT00846365|988241|P3|Overall Study|Adverse Event|11
301080|NCT00846365|988242|P2|Overall Study|Adverse Event|30
301081|NCT00846365|988243|P1|Overall Study|Adverse Event|20
301082|NCT00845897|988310|P3|Overall Study|Too ill to participate|0
301083|NCT00845897|988311|P2|Overall Study|Too ill to participate|1
301084|NCT00845897|988312|P1|Overall Study|Too ill to participate|0
301085|NCT00845897|988310|P3|Overall Study|Ulcer did not heal|1
301086|NCT00845897|988311|P2|Overall Study|Ulcer did not heal|0
301087|NCT00845897|988312|P1|Overall Study|Ulcer did not heal|1
301088|NCT00845897|988310|P3|Overall Study|Withdrawal by Subject|2
301089|NCT00845897|988311|P2|Overall Study|Withdrawal by Subject|3
301090|NCT00845897|988312|P1|Overall Study|Withdrawal by Subject|0
301091|NCT00845897|988310|P3|Overall Study|Lost to Follow-up|0
301092|NCT00845897|988311|P2|Overall Study|Lost to Follow-up|1
301093|NCT00845897|988312|P1|Overall Study|Lost to Follow-up|1
301094|NCT00845858|988326|P3|Overall Study|not eligible|2
301095|NCT00845858|988327|P2|Overall Study|not eligible|3
301096|NCT00845858|988328|P1|Overall Study|not eligible|0
301097|NCT00845858|988326|P3|Overall Study|Protocol Violation|1
301098|NCT00845858|988327|P2|Overall Study|Protocol Violation|0
301099|NCT00845858|988328|P1|Overall Study|Protocol Violation|0
301100|NCT00845858|988326|P3|Overall Study|Adverse Event|4
301101|NCT00845858|988327|P2|Overall Study|Adverse Event|8
301102|NCT00845858|988328|P1|Overall Study|Adverse Event|3
301103|NCT00845858|988326|P3|Overall Study|Withdrawal by Subject|1
301104|NCT00845858|988327|P2|Overall Study|Withdrawal by Subject|1
301105|NCT00845858|988328|P1|Overall Study|Withdrawal by Subject|5
301106|NCT00845845|988341|P2|Overall Study|Lost to Follow-up|4
301107|NCT00845845|988342|P1|Overall Study|Lost to Follow-up|0
301108|NCT00845832|988353|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
301109|NCT00845832|988354|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
301110|NCT00845832|988355|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
301111|NCT00845832|988353|P3|Safety Follow-Up|Withdrawal by Subject|0
301112|NCT00845832|988354|P2|Safety Follow-Up|Withdrawal by Subject|0
301113|NCT00845832|988355|P1|Safety Follow-Up|Withdrawal by Subject|1
301114|NCT00845832|988353|P3|Treatment Period|Protocol Violation|0
301115|NCT00845832|988354|P2|Treatment Period|Protocol Violation|1
301116|NCT00845832|988355|P1|Treatment Period|Protocol Violation|1
301117|NCT00845832|988353|P3|Treatment Period|Adverse Event|0
301118|NCT00845832|988354|P2|Treatment Period|Adverse Event|2
301119|NCT00845832|988355|P1|Treatment Period|Adverse Event|0
301120|NCT00845728|988401|P2|Overall Study|Withdrawal by Subject|108
301121|NCT00845728|988402|P1|Overall Study|Withdrawal by Subject|105
301122|NCT00845728|988401|P2|Overall Study|Adverse Event|96
301123|NCT00845728|988402|P1|Overall Study|Adverse Event|101
301124|NCT00845728|988401|P2|Overall Study|Lack of Efficacy|39
301125|NCT00845728|988402|P1|Overall Study|Lack of Efficacy|51
301126|NCT00845728|988401|P2|Overall Study|Protocol Violation|24
301127|NCT00845728|988402|P1|Overall Study|Protocol Violation|36
301128|NCT00845728|988401|P2|Overall Study|Administrative Problems|26
301129|NCT00845728|988402|P1|Overall Study|Administrative Problems|34
301130|NCT00845728|988401|P2|Overall Study|Death|26
301131|NCT00845728|988402|P1|Overall Study|Death|24
301132|NCT00845728|988401|P2|Overall Study|Lost to Follow-up|13
301133|NCT00845728|988402|P1|Overall Study|Lost to Follow-up|22
301134|NCT00845728|988401|P2|Overall Study|Abnormal test procedure result (s)|2
301135|NCT00845728|988402|P1|Overall Study|Abnormal test procedure result (s)|7
301136|NCT00845728|988401|P2|Overall Study|Patient's inability to use the device|6
301137|NCT00845728|988402|P1|Overall Study|Patient's inability to use the device|4
301138|NCT00845728|988401|P2|Overall Study|Abnormal laboratory value (s)|2
301139|NCT00845728|988402|P1|Overall Study|Abnormal laboratory value (s)|2
301140|NCT00845676|988416|P1|Overall Study|Adverse Event|1
301141|NCT00845676|988416|P1|Overall Study|Virologic breakthrough at week 20|1
301142|NCT00845429|988483|P3|Overall Study|Serious adverse event|1
301143|NCT00845429|988484|P2|Overall Study|Serious adverse event|0
301144|NCT00845429|988485|P1|Overall Study|Serious adverse event|0
301145|NCT00845429|988483|P3|Overall Study|Withdrawal by Subject|2
301146|NCT00845429|988484|P2|Overall Study|Withdrawal by Subject|2
301147|NCT00845429|988485|P1|Overall Study|Withdrawal by Subject|2
301148|NCT00845429|988483|P3|Overall Study|Lost to Follow-up|10
301149|NCT00845429|988484|P2|Overall Study|Lost to Follow-up|9
301150|NCT00845429|988485|P1|Overall Study|Lost to Follow-up|7
301151|NCT00845429|988483|P3|Overall Study|Protocol Violation|7
301152|NCT00845429|988484|P2|Overall Study|Protocol Violation|4
301153|NCT00845429|988485|P1|Overall Study|Protocol Violation|5
301154|NCT00845182|988520|P3|Overall Study|Physician Decision|1
301155|NCT00845182|988521|P2|Overall Study|Physician Decision|0
301156|NCT00845182|988522|P1|Overall Study|Physician Decision|0
301157|NCT00845182|988520|P3|Overall Study|Adverse Event|1
301158|NCT00845182|988521|P2|Overall Study|Adverse Event|1
301159|NCT00845182|988522|P1|Overall Study|Adverse Event|0
301160|NCT00845182|988520|P3|Overall Study|Lost to Follow-up|4
301161|NCT00845182|988521|P2|Overall Study|Lost to Follow-up|3
301162|NCT00845182|988522|P1|Overall Study|Lost to Follow-up|3
301163|NCT00845065|988546|P2|Overall Study|Non-Medical Reasons|11
301164|NCT00845065|988547|P1|Overall Study|Non-Medical Reasons|1
301165|NCT00845065|988546|P2|Overall Study|Lack of Efficacy|21
301166|NCT00845065|988547|P1|Overall Study|Lack of Efficacy|43
301167|NCT00845065|988546|P2|Overall Study|Adverse Event|23
301168|NCT00845065|988547|P1|Overall Study|Adverse Event|3
301169|NCT00844896|988591|P2|Overall Study|Parents did not have time to complete|1
301170|NCT00844896|988592|P1|Overall Study|Parents did not have time to complete|0
301171|NCT00844896|988591|P2|Overall Study|Lost to Follow-up|16
301172|NCT00844896|988592|P1|Overall Study|Lost to Follow-up|12
301173|NCT00844857|988616|P2|Overall Study|Good Clinical Practice Violations|11
301174|NCT00844857|988617|P1|Overall Study|Good Clinical Practice Violations|21
301175|NCT00844857|988616|P2|Overall Study|Did Not Take Study Drug|1
301176|NCT00844857|988617|P1|Overall Study|Did Not Take Study Drug|3
301177|NCT00844857|988616|P2|Overall Study|Lost to Follow-up|3
301178|NCT00844857|988617|P1|Overall Study|Lost to Follow-up|2
301179|NCT00844857|988616|P2|Overall Study|Entry Criteria Not Met|1
301180|NCT00844857|988617|P1|Overall Study|Entry Criteria Not Met|0
301181|NCT00844857|988616|P2|Overall Study|Clinical Relapse|1
301182|NCT00844857|988617|P1|Overall Study|Clinical Relapse|0
301183|NCT00844857|988616|P2|Overall Study|Lack of Efficacy|5
301184|NCT00844857|988617|P1|Overall Study|Lack of Efficacy|5
301185|NCT00844857|988616|P2|Overall Study|Protocol Violation|0
301186|NCT00844857|988617|P1|Overall Study|Protocol Violation|6
301187|NCT00844857|988616|P2|Overall Study|Withdrawal by Subject|7
301188|NCT00844857|988617|P1|Overall Study|Withdrawal by Subject|8
301189|NCT00844857|988616|P2|Overall Study|Parent/Caregiver Decision|2
301190|NCT00844857|988617|P1|Overall Study|Parent/Caregiver Decision|6
301191|NCT00844857|988616|P2|Overall Study|Physician Decision|0
301192|NCT00844857|988617|P1|Overall Study|Physician Decision|2
301193|NCT00844857|988616|P2|Overall Study|Sponsor Decision|1
301194|NCT00844857|988617|P1|Overall Study|Sponsor Decision|1
301195|NCT00844857|988616|P2|Overall Study|Adverse Event|5
301196|NCT00844857|988617|P1|Overall Study|Adverse Event|24
301197|NCT00844844|988661|P1|Post Treatment Period|Withdrawal by Subject|1
301198|NCT00844844|988661|P1|Extension Treatment Period|Adverse Event|2
301199|NCT00844844|988661|P1|Treatment Period (26 Weeks)|Protocol Violation|1
301200|NCT00844844|988661|P1|Treatment Period (26 Weeks)|Adverse Event|1
301201|NCT00844805|988677|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
301202|NCT00844805|988678|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
301203|NCT00844805|988679|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
301204|NCT00844805|988680|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
301205|NCT00844805|988677|P4|Follow-Up Phase|Relapse/Recurrence|4
301206|NCT00844805|988678|P3|Follow-Up Phase|Relapse/Recurrence|2
301207|NCT00844805|988679|P2|Follow-Up Phase|Relapse/Recurrence|0
301208|NCT00844805|988680|P1|Follow-Up Phase|Relapse/Recurrence|0
301209|NCT00844805|988677|P4|Follow-Up Phase|Noncompliance With Protocol|1
301210|NCT00844805|988678|P3|Follow-Up Phase|Noncompliance With Protocol|0
301211|NCT00844805|988679|P2|Follow-Up Phase|Noncompliance With Protocol|0
301212|NCT00844805|988680|P1|Follow-Up Phase|Noncompliance With Protocol|0
301213|NCT00844805|988677|P4|Follow-Up Phase|Withdrawal by Subject|3
301214|NCT00844805|988678|P3|Follow-Up Phase|Withdrawal by Subject|6
301215|NCT00844805|988679|P2|Follow-Up Phase|Withdrawal by Subject|0
301216|NCT00844805|988680|P1|Follow-Up Phase|Withdrawal by Subject|0
301217|NCT00844805|988677|P4|Follow-Up Phase|Adverse Event|0
301218|NCT00844805|988678|P3|Follow-Up Phase|Adverse Event|1
301219|NCT00844805|988679|P2|Follow-Up Phase|Adverse Event|0
301220|NCT00844805|988680|P1|Follow-Up Phase|Adverse Event|0
301221|NCT00844805|988677|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
301222|NCT00844805|988678|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
301223|NCT00844805|988679|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
301224|NCT00844805|988680|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
301225|NCT00844805|988677|P4|Treatment Phase|Noncompliance With Protocol|0
301226|NCT00844805|988678|P3|Treatment Phase|Noncompliance With Protocol|0
301227|NCT00844805|988679|P2|Treatment Phase|Noncompliance With Protocol|0
301228|NCT00844805|988680|P1|Treatment Phase|Noncompliance With Protocol|1
301229|NCT00844805|988677|P4|Treatment Phase|Withdrawal by Subject|0
301230|NCT00844805|988678|P3|Treatment Phase|Withdrawal by Subject|0
301231|NCT00844805|988679|P2|Treatment Phase|Withdrawal by Subject|4
301232|NCT00844805|988680|P1|Treatment Phase|Withdrawal by Subject|3
301233|NCT00844805|988677|P4|Treatment Phase|Adverse Event|0
301234|NCT00844805|988678|P3|Treatment Phase|Adverse Event|0
301235|NCT00844805|988679|P2|Treatment Phase|Adverse Event|1
301236|NCT00844805|988680|P1|Treatment Phase|Adverse Event|5
301237|NCT00844753|988724|P4|Overall Study|Withdrawal by Subject|3
301238|NCT00844753|988725|P3|Overall Study|Withdrawal by Subject|0
301239|NCT00844753|988726|P2|Overall Study|Withdrawal by Subject|0
301240|NCT00844753|988727|P1|Overall Study|Withdrawal by Subject|1
301241|NCT00844753|988724|P4|Overall Study|could not swallow medication|0
301242|NCT00844753|988725|P3|Overall Study|could not swallow medication|0
301243|NCT00844753|988726|P2|Overall Study|could not swallow medication|0
301244|NCT00844753|988727|P1|Overall Study|could not swallow medication|2
301245|NCT00844753|988724|P4|Overall Study|Lost to Follow-up|1
301246|NCT00844753|988725|P3|Overall Study|Lost to Follow-up|0
301247|NCT00844753|988726|P2|Overall Study|Lost to Follow-up|1
301248|NCT00844753|988727|P1|Overall Study|Lost to Follow-up|1
301249|NCT00844753|988724|P4|Overall Study|Adverse Event|5
301250|NCT00844753|988725|P3|Overall Study|Adverse Event|5
301251|NCT00844753|988726|P2|Overall Study|Adverse Event|2
301252|NCT00844753|988727|P1|Overall Study|Adverse Event|3
301253|NCT00844753|988724|P4|Overall Study|Lack of Efficacy|2
301254|NCT00844753|988725|P3|Overall Study|Lack of Efficacy|2
301255|NCT00844753|988726|P2|Overall Study|Lack of Efficacy|0
301256|NCT00844753|988727|P1|Overall Study|Lack of Efficacy|1
301257|NCT00844649|988745|P2|Overall Study|Withdrew prior to starting treatment|27
301258|NCT00844649|988746|P1|Overall Study|Withdrew prior to starting treatment|11
301259|NCT00844649|988745|P2|Overall Study|Unspecified|10
301260|NCT00844649|988746|P1|Overall Study|Unspecified|7
301261|NCT00844649|988745|P2|Overall Study|Withdrawal by Subject|39
301262|NCT00844649|988746|P1|Overall Study|Withdrawal by Subject|28
301263|NCT00844649|988745|P2|Overall Study|Protocol Violation|6
301264|NCT00844649|988746|P1|Overall Study|Protocol Violation|10
301265|NCT00844649|988745|P2|Overall Study|Physician Decision|18
301266|NCT00844649|988746|P1|Overall Study|Physician Decision|25
301267|NCT00844649|988745|P2|Overall Study|Adverse Event|73
301268|NCT00844649|988746|P1|Overall Study|Adverse Event|128
301269|NCT00844649|988745|P2|Overall Study|Progressive Disease|245
301270|NCT00844649|988746|P1|Overall Study|Progressive Disease|196
301271|NCT00844597|988770|P6|Overall Study|Adverse Event|0
301272|NCT00844597|988771|P5|Overall Study|Adverse Event|0
301273|NCT00844597|988772|P4|Overall Study|Adverse Event|1
301274|NCT00844597|988773|P3|Overall Study|Adverse Event|0
301275|NCT00844597|988774|P2|Overall Study|Adverse Event|0
301276|NCT00844597|988775|P1|Overall Study|Adverse Event|0
301277|NCT00844558|988795|P2|Overall Study|Physician Decision|0
301278|NCT00844558|988796|P1|Overall Study|Physician Decision|1
301279|NCT00844558|988795|P2|Overall Study|Lost to Follow-up|1
301280|NCT00844558|988796|P1|Overall Study|Lost to Follow-up|0
301281|NCT00844558|988795|P2|Overall Study|Protocol Violation|1
301282|NCT00844558|988796|P1|Overall Study|Protocol Violation|1
301283|NCT00844558|988795|P2|Overall Study|Death|0
301284|NCT00844558|988796|P1|Overall Study|Death|1
301285|NCT00844558|988795|P2|Overall Study|Withdrawal by Subject|2
301286|NCT00844558|988796|P1|Overall Study|Withdrawal by Subject|9
301287|NCT00844545|988812|P1|Post Treatment Period|Withdrawal by Subject|1
301288|NCT00844545|988812|P1|Extension Treatment Period|Adverse Event|2
301289|NCT00844545|988812|P1|Treatment Period (26 Weeks)|Protocol Violation|1
301290|NCT00844545|988812|P1|Treatment Period (26 Weeks)|Adverse Event|1
301291|NCT00844532|988826|P1|Overall Study|Lost to Follow-up|7
301292|NCT00844532|988826|P1|Overall Study|Withdrawal by Subject|16
301293|NCT00844532|988826|P1|Overall Study|Death|16
301294|NCT00844519|988912|P2|Overall Study|Adverse Event|0
301295|NCT00844519|988913|P1|Overall Study|Adverse Event|1
301296|NCT00844519|988912|P2|Overall Study|Withdrawal by Subject|1
301297|NCT00844519|988913|P1|Overall Study|Withdrawal by Subject|1
301298|NCT00844480|988921|P2|Overall Study|Withdrawal by Subject|3
301299|NCT00844480|988922|P1|Overall Study|Withdrawal by Subject|2
301300|NCT00844428|988930|P1|Post Treatment Period (Patients Who Disc|Death|1
301301|NCT00844428|988930|P1|Extension Treatment Period|Death|1
301302|NCT00844428|988930|P1|Screening Period|Screen Failure|3
301303|NCT00844415|988946|P1|Overall Study|Withdrawal by Subject|1
301304|NCT00844376|988960|P2|Period 1: First Intervention|Withdrawal by Subject|0
301305|NCT00844376|988961|P1|Period 1: First Intervention|Withdrawal by Subject|1
301306|NCT00844194|988985|P2|Overall Study|Other reason (not specified)|0
301307|NCT00844194|988986|P1|Overall Study|Other reason (not specified)|1
301308|NCT00844194|988985|P2|Overall Study|Lack of Efficacy|0
301309|NCT00844194|988986|P1|Overall Study|Lack of Efficacy|3
301310|NCT00844194|988985|P2|Overall Study|Withdrawal by Subject|1
301311|NCT00844194|988986|P1|Overall Study|Withdrawal by Subject|2
301312|NCT00844194|988985|P2|Overall Study|Lost to Follow-up|1
301313|NCT00844194|988986|P1|Overall Study|Lost to Follow-up|1
301314|NCT00844194|988985|P2|Overall Study|Protocol Violation|1
301315|NCT00844194|988986|P1|Overall Study|Protocol Violation|1
301316|NCT00844194|988985|P2|Overall Study|Adverse Event|5
301317|NCT00844194|988986|P1|Overall Study|Adverse Event|17
301318|NCT00843843|989241|P2|Overall Study|Protocol Violation|1
301319|NCT00843843|989242|P1|Overall Study|Protocol Violation|1
301320|NCT00843843|989241|P2|Overall Study|Physician Decision|1
301321|NCT00843843|989242|P1|Overall Study|Physician Decision|1
301322|NCT00843778|989255|P1|Overall Study|Withdrawal by Subject|4
301323|NCT00843778|989255|P1|Overall Study|Loss of efficacy|2
301324|NCT00843778|989255|P1|Overall Study|Lack of Efficacy|14
301325|NCT00843778|989255|P1|Overall Study|Adverse Event|15
301326|NCT00843635|989325|P3|Overall Study|Adverse Event|0
301327|NCT00843635|989326|P2|Overall Study|Adverse Event|2
301328|NCT00843635|989327|P1|Overall Study|Adverse Event|2
301329|NCT00843492|989356|P2|Overall Study|Deep-vein Thrombosis|0
301330|NCT00843492|989357|P1|Overall Study|Deep-vein Thrombosis|1
301331|NCT00843492|989356|P2|Overall Study|Visit Not Performed|0
301332|NCT00843492|989357|P1|Overall Study|Visit Not Performed|1
301333|NCT00843492|989356|P2|Overall Study|Orthopedic Surgery|2
301334|NCT00843492|989357|P1|Overall Study|Orthopedic Surgery|0
301335|NCT00843492|989356|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
301336|NCT00843492|989357|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
301337|NCT00843492|989356|P2|Overall Study|Immobilization Stopped|0
301338|NCT00843492|989357|P1|Overall Study|Immobilization Stopped|1
301339|NCT00843492|989356|P2|Overall Study|Withdrawal by Subject|4
301340|NCT00843492|989357|P1|Overall Study|Withdrawal by Subject|0
301341|NCT00843492|989356|P2|Overall Study|Lost to Follow-up|4
301342|NCT00843492|989357|P1|Overall Study|Lost to Follow-up|4
301343|NCT00843492|989356|P2|Overall Study|Adverse Event|3
301344|NCT00843492|989357|P1|Overall Study|Adverse Event|0
301345|NCT00843284|989431|P1|Overall Study|Death|3
301346|NCT00843284|989431|P1|Overall Study|Withdrawal by Subject|4
301347|NCT00843284|989431|P1|Overall Study|Other|10
301348|NCT00843284|989431|P1|Overall Study|Lost to Follow-up|11
301349|NCT00843284|989431|P1|Overall Study|Lack of Efficacy|5
301350|NCT00843284|989431|P1|Overall Study|Adverse Event|39
301351|NCT00843167|989456|P2|Treatment Period|Withdrawal by Subject|3
301352|NCT00843167|989457|P1|Treatment Period|Withdrawal by Subject|2
301353|NCT00843167|989456|P2|Treatment Period|Adverse Event|5
301354|NCT00843167|989457|P1|Treatment Period|Adverse Event|1
301355|NCT00843115|989470|P1|Overall Study|Syndrome De Glissement|1
301356|NCT00843115|989470|P1|Overall Study|week 12 not done|1
301357|NCT00843115|989470|P1|Overall Study|hospitalized due to deterioration|1
301358|NCT00843115|989470|P1|Overall Study|patient never took the medication|1
301359|NCT00843115|989470|P1|Overall Study|patient took for 2 days then stopped|1
301360|NCT00843115|989470|P1|Overall Study|Family discontinued meds|1
301361|NCT00843115|989470|P1|Overall Study|Physician Decision|1
301362|NCT00843115|989470|P1|Overall Study|Does not meet entrance criteria|1
301363|NCT00843115|989470|P1|Overall Study|Patient forgot to take meds|1
301364|NCT00843115|989470|P1|Overall Study|Family does not want continuation|1
301365|NCT00843115|989470|P1|Overall Study|Family wanted meds stopped|1
301366|NCT00843115|989470|P1|Overall Study|Withdrawal by Subject|17
301367|NCT00843115|989470|P1|Overall Study|Lost to Follow-up|4
301368|NCT00843115|989470|P1|Overall Study|Adverse Event|30
301369|NCT00843115|989470|P1|Overall Study|Death|4
301370|NCT00843024|989526|P6|Double-blind Treatment Phase|Lack of Efficacy|0
301371|NCT00843024|989527|P5|Double-blind Treatment Phase|Lack of Efficacy|1
301372|NCT00843024|989528|P4|Double-blind Treatment Phase|Lack of Efficacy|0
301373|NCT00843024|989529|P3|Double-blind Treatment Phase|Lack of Efficacy|0
301374|NCT00843024|989530|P2|Double-blind Treatment Phase|Lack of Efficacy|0
301375|NCT00843024|989531|P1|Double-blind Treatment Phase|Lack of Efficacy|0
301376|NCT00843024|989526|P6|Double-blind Treatment Phase|Adverse Event|1
301377|NCT00843024|989527|P5|Double-blind Treatment Phase|Adverse Event|1
301378|NCT00843024|989528|P4|Double-blind Treatment Phase|Adverse Event|0
301379|NCT00843024|989529|P3|Double-blind Treatment Phase|Adverse Event|0
301380|NCT00843024|989530|P2|Double-blind Treatment Phase|Adverse Event|0
301381|NCT00843024|989531|P1|Double-blind Treatment Phase|Adverse Event|0
301382|NCT00843024|989526|P6|Double-blind Treatment Phase|Physician Decision|1
301383|NCT00843024|989527|P5|Double-blind Treatment Phase|Physician Decision|1
301384|NCT00843024|989528|P4|Double-blind Treatment Phase|Physician Decision|3
301385|NCT00843024|989529|P3|Double-blind Treatment Phase|Physician Decision|0
301386|NCT00843024|989530|P2|Double-blind Treatment Phase|Physician Decision|0
301387|NCT00843024|989531|P1|Double-blind Treatment Phase|Physician Decision|0
301388|NCT00843024|989526|P6|Double-blind Treatment Phase|Protocol Violation|3
301389|NCT00843024|989527|P5|Double-blind Treatment Phase|Protocol Violation|0
301390|NCT00843024|989528|P4|Double-blind Treatment Phase|Protocol Violation|0
301391|NCT00843024|989529|P3|Double-blind Treatment Phase|Protocol Violation|3
301392|NCT00843024|989530|P2|Double-blind Treatment Phase|Protocol Violation|0
301393|NCT00843024|989531|P1|Double-blind Treatment Phase|Protocol Violation|0
301394|NCT00843024|989526|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
301395|NCT00843024|989527|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
301396|NCT00843024|989528|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
301397|NCT00843024|989529|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
301398|NCT00843024|989530|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
301399|NCT00843024|989531|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
301400|NCT00843024|989526|P6|Double-blind Treatment Phase|Lost to Follow-up|4
301401|NCT00843024|989527|P5|Double-blind Treatment Phase|Lost to Follow-up|4
301402|NCT00843024|989528|P4|Double-blind Treatment Phase|Lost to Follow-up|4
301403|NCT00843024|989529|P3|Double-blind Treatment Phase|Lost to Follow-up|8
301404|NCT00843024|989530|P2|Double-blind Treatment Phase|Lost to Follow-up|0
301405|NCT00843024|989531|P1|Double-blind Treatment Phase|Lost to Follow-up|0
301406|NCT00843024|989526|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
301407|NCT00843024|989527|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
301408|NCT00843024|989528|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
301409|NCT00843024|989529|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
301410|NCT00843024|989530|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
301411|NCT00843024|989531|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
301412|NCT00843024|989526|P6|Single-blind Placebo Run-In Phase|Other|0
301413|NCT00843024|989527|P5|Single-blind Placebo Run-In Phase|Other|0
301414|NCT00843024|989528|P4|Single-blind Placebo Run-In Phase|Other|0
301415|NCT00843024|989529|P3|Single-blind Placebo Run-In Phase|Other|0
301416|NCT00843024|989530|P2|Single-blind Placebo Run-In Phase|Other|1
301417|NCT00843024|989531|P1|Single-blind Placebo Run-In Phase|Other|0
301418|NCT00843024|989526|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
301419|NCT00843024|989527|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
301420|NCT00843024|989528|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
301421|NCT00843024|989529|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
301422|NCT00843024|989530|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
301423|NCT00843024|989531|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
301424|NCT00843024|989526|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
301425|NCT00843024|989527|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
301426|NCT00843024|989528|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
301427|NCT00843024|989529|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
301428|NCT00843024|989530|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
301429|NCT00843024|989531|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
301430|NCT00843024|989526|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
301431|NCT00843024|989527|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
301432|NCT00843024|989528|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
301433|NCT00843024|989529|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
301434|NCT00843024|989530|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
301435|NCT00843024|989531|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
301436|NCT00843024|989526|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
301437|NCT00843024|989527|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
301438|NCT00843024|989528|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
301439|NCT00843024|989529|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
301440|NCT00843024|989530|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
301441|NCT00843024|989531|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
301442|NCT00843024|989526|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
301443|NCT00843024|989527|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
301444|NCT00843024|989528|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
301445|NCT00843024|989529|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
301446|NCT00843024|989530|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
301447|NCT00843024|989531|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
301448|NCT00843024|989526|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
301449|NCT00843024|989527|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
301450|NCT00843024|989528|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
301451|NCT00843024|989529|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
301452|NCT00843024|989530|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
301453|NCT00843024|989531|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
301454|NCT00842985|989596|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
301455|NCT00842985|989596|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
301456|NCT00842985|989596|P1|First Intervention|Protocol Violation|3
301457|NCT00842985|989596|P1|First Intervention|Withdrawal by Subject|3
301458|NCT00842985|989596|P1|Screening|Did not meet entrance requirements|27
301459|NCT00842829|989614|P3|Continuation Period|Non-compliance to study drug|1
301460|NCT00842829|989615|P2|Continuation Period|Non-compliance to study drug|0
301461|NCT00842829|989616|P1|Continuation Period|Non-compliance to study drug|0
301462|NCT00842829|989614|P3|Continuation Period|Non-compliance to study procedures|2
301463|NCT00842829|989615|P2|Continuation Period|Non-compliance to study procedures|0
301464|NCT00842829|989616|P1|Continuation Period|Non-compliance to study procedures|0
301465|NCT00842829|989614|P3|Continuation Period|Not specified|7
301466|NCT00842829|989615|P2|Continuation Period|Not specified|0
301467|NCT00842829|989616|P1|Continuation Period|Not specified|0
301468|NCT00842829|989614|P3|Continuation Period|Withdrawal by Subject|10
301469|NCT00842829|989615|P2|Continuation Period|Withdrawal by Subject|0
301470|NCT00842829|989616|P1|Continuation Period|Withdrawal by Subject|0
301471|NCT00842829|989614|P3|Continuation Period|Unstable persistent cancer pain|3
301472|NCT00842829|989615|P2|Continuation Period|Unstable persistent cancer pain|0
301473|NCT00842829|989616|P1|Continuation Period|Unstable persistent cancer pain|0
301474|NCT00842829|989614|P3|Continuation Period|Lack of Efficacy|6
301475|NCT00842829|989615|P2|Continuation Period|Lack of Efficacy|0
301476|NCT00842829|989616|P1|Continuation Period|Lack of Efficacy|0
301477|NCT00842829|989614|P3|Continuation Period|Adverse Event|32
301478|NCT00842829|989615|P2|Continuation Period|Adverse Event|0
301479|NCT00842829|989616|P1|Continuation Period|Adverse Event|0
301480|NCT00842829|989614|P3|Treatment Period|Unclear completion status|1
301481|NCT00842829|989615|P2|Treatment Period|Unclear completion status|0
301482|NCT00842829|989616|P1|Treatment Period|Unclear completion status|0
301483|NCT00842829|989614|P3|Treatment Period|Non-compliance to study procedures|4
301484|NCT00842829|989615|P2|Treatment Period|Non-compliance to study procedures|0
301485|NCT00842829|989616|P1|Treatment Period|Non-compliance to study procedures|0
301486|NCT00842829|989614|P3|Treatment Period|Not specified|18
301487|NCT00842829|989615|P2|Treatment Period|Not specified|0
301488|NCT00842829|989616|P1|Treatment Period|Not specified|0
301489|NCT00842829|989614|P3|Treatment Period|Protocol Violation|2
301490|NCT00842829|989615|P2|Treatment Period|Protocol Violation|0
301491|NCT00842829|989616|P1|Treatment Period|Protocol Violation|0
301492|NCT00842829|989614|P3|Treatment Period|Consistently >4 BTP episodes daily|1
301493|NCT00842829|989615|P2|Treatment Period|Consistently >4 BTP episodes daily|0
301494|NCT00842829|989616|P1|Treatment Period|Consistently >4 BTP episodes daily|0
301495|NCT00842829|989614|P3|Treatment Period|Withdrawal by Subject|11
301496|NCT00842829|989615|P2|Treatment Period|Withdrawal by Subject|0
301497|NCT00842829|989616|P1|Treatment Period|Withdrawal by Subject|0
301498|NCT00842829|989614|P3|Treatment Period|Unstable persistent cancer pain|5
301499|NCT00842829|989615|P2|Treatment Period|Unstable persistent cancer pain|0
301500|NCT00842829|989616|P1|Treatment Period|Unstable persistent cancer pain|0
301501|NCT00842829|989614|P3|Treatment Period|Lack of Efficacy|6
301502|NCT00842829|989615|P2|Treatment Period|Lack of Efficacy|0
301503|NCT00842829|989616|P1|Treatment Period|Lack of Efficacy|0
301504|NCT00842829|989614|P3|Treatment Period|Adverse Event|15
301505|NCT00842829|989615|P2|Treatment Period|Adverse Event|0
301506|NCT00842829|989616|P1|Treatment Period|Adverse Event|0
301507|NCT00842829|989614|P3|Dose Titration Period|Non-compliance to study drug|0
301508|NCT00842829|989615|P2|Dose Titration Period|Non-compliance to study drug|1
301509|NCT00842829|989616|P1|Dose Titration Period|Non-compliance to study drug|2
301510|NCT00842829|989614|P3|Dose Titration Period|Non-compliance to study procedures|0
301511|NCT00842829|989615|P2|Dose Titration Period|Non-compliance to study procedures|1
301512|NCT00842829|989616|P1|Dose Titration Period|Non-compliance to study procedures|1
301513|NCT00842829|989614|P3|Dose Titration Period|Not specified|0
301514|NCT00842829|989615|P2|Dose Titration Period|Not specified|4
301515|NCT00842829|989616|P1|Dose Titration Period|Not specified|5
301516|NCT00842829|989614|P3|Dose Titration Period|Withdrawal by Subject|0
301517|NCT00842829|989615|P2|Dose Titration Period|Withdrawal by Subject|6
301518|NCT00842829|989616|P1|Dose Titration Period|Withdrawal by Subject|2
301519|NCT00842829|989614|P3|Dose Titration Period|Unstable persistent cancer pain|0
301520|NCT00842829|989615|P2|Dose Titration Period|Unstable persistent cancer pain|0
301521|NCT00842829|989616|P1|Dose Titration Period|Unstable persistent cancer pain|1
301522|NCT00842829|989614|P3|Dose Titration Period|Lack of Efficacy|0
301523|NCT00842829|989615|P2|Dose Titration Period|Lack of Efficacy|1
301524|NCT00842829|989616|P1|Dose Titration Period|Lack of Efficacy|4
301525|NCT00842829|989614|P3|Dose Titration Period|Adverse Event|0
301526|NCT00842829|989615|P2|Dose Titration Period|Adverse Event|10
301527|NCT00842829|989616|P1|Dose Titration Period|Adverse Event|11
301528|NCT00842712|989671|P7|Randomized Part|Ongoing at cut-off date|2
301529|NCT00842712|989672|P6|Randomized Part|Ongoing at cut-off date|0
301530|NCT00842712|989673|P5|Randomized Part|Ongoing at cut-off date|0
301531|NCT00842712|989674|P4|Randomized Part|Ongoing at cut-off date|0
301532|NCT00842712|989675|P3|Randomized Part|Ongoing at cut-off date|0
301533|NCT00842712|989676|P2|Randomized Part|Ongoing at cut-off date|0
301534|NCT00842712|989677|P1|Randomized Part|Ongoing at cut-off date|0
301535|NCT00842712|989671|P7|Randomized Part|Randomized but not treated|4
301536|NCT00842712|989672|P6|Randomized Part|Randomized but not treated|1
301537|NCT00842712|989673|P5|Randomized Part|Randomized but not treated|0
301538|NCT00842712|989674|P4|Randomized Part|Randomized but not treated|0
301539|NCT00842712|989675|P3|Randomized Part|Randomized but not treated|0
301540|NCT00842712|989676|P2|Randomized Part|Randomized but not treated|0
301541|NCT00842712|989677|P1|Randomized Part|Randomized but not treated|0
301542|NCT00842712|989671|P7|Safety Run-in Part|Progressive disease|0
301543|NCT00842712|989672|P6|Safety Run-in Part|Progressive disease|0
301544|NCT00842712|989673|P5|Safety Run-in Part|Progressive disease|0
301545|NCT00842712|989674|P4|Safety Run-in Part|Progressive disease|1
301546|NCT00842712|989675|P3|Safety Run-in Part|Progressive disease|0
301547|NCT00842712|989676|P2|Safety Run-in Part|Progressive disease|1
301548|NCT00842712|989677|P1|Safety Run-in Part|Progressive disease|3
301549|NCT00842712|989671|P7|Safety Run-in Part|Adverse Event|0
301550|NCT00842712|989672|P6|Safety Run-in Part|Adverse Event|0
301551|NCT00842712|989673|P5|Safety Run-in Part|Adverse Event|0
301552|NCT00842712|989674|P4|Safety Run-in Part|Adverse Event|0
301553|NCT00842712|989675|P3|Safety Run-in Part|Adverse Event|0
301554|NCT00842712|989676|P2|Safety Run-in Part|Adverse Event|1
301555|NCT00842712|989677|P1|Safety Run-in Part|Adverse Event|0
301556|NCT00842543|989709|P4|Overall Study|Withdrawal by Subject|4
301557|NCT00842543|989710|P3|Overall Study|Withdrawal by Subject|3
301558|NCT00842543|989711|P2|Overall Study|Withdrawal by Subject|0
301559|NCT00842543|989712|P1|Overall Study|Withdrawal by Subject|2
301560|NCT00842361|989726|P2|Overall Study|Unclassified|2
301561|NCT00842361|989727|P1|Overall Study|Unclassified|0
301562|NCT00842361|989726|P2|Overall Study|Protocol Violation|0
301563|NCT00842361|989727|P1|Overall Study|Protocol Violation|1
301564|NCT00842348|989747|P2|Study 729|Surgical resection|0
301565|NCT00842348|989748|P1|Study 729|Surgical resection|1
301566|NCT00842348|989747|P2|Study 729|Sponsor's decision|0
301567|NCT00842348|989748|P1|Study 729|Sponsor's decision|1
301568|NCT00842348|989747|P2|Study 729|Due to non-availability of IP|1
301569|NCT00842348|989748|P1|Study 729|Due to non-availability of IP|0
301570|NCT00842348|989747|P2|Study 729|Due to Sponsor stopping the study|1
301571|NCT00842348|989748|P1|Study 729|Due to Sponsor stopping the study|1
301572|NCT00842348|989747|P2|Study 729|Withdrawal by Subject|4
301573|NCT00842348|989748|P1|Study 729|Withdrawal by Subject|2
301574|NCT00842348|989747|P2|Study 729|Protocol Violation|1
301575|NCT00842348|989748|P1|Study 729|Protocol Violation|1
301576|NCT00842348|989747|P2|Study 729|Adverse Event|1
301577|NCT00842348|989748|P1|Study 729|Adverse Event|1
301578|NCT00842348|989747|P2|Study 729|Disease progression/death|30
301579|NCT00842348|989748|P1|Study 729|Disease progression/death|19
301580|NCT00842348|989747|P2|Patients Randomised in Study 726|Did not enter Study 729|56
301581|NCT00842348|989748|P1|Patients Randomised in Study 726|Did not enter Study 729|59
301582|NCT00842257|989765|P1|Overall Study|Adverse Event|1
301583|NCT00842244|989772|P1|Overall Study|Unspecified|17
301584|NCT00842244|989772|P1|Overall Study|Withdrawal by Subject|1
301585|NCT00842244|989772|P1|Overall Study|Death|3
301586|NCT00842153|989799|P2|Overall Study|Lost to Follow-up|2
301587|NCT00842153|989800|P1|Overall Study|Lost to Follow-up|1
301588|NCT00842153|989799|P2|Overall Study|Adverse Event|1
301589|NCT00842153|989800|P1|Overall Study|Adverse Event|0
301590|NCT00841906|989875|P2|Overall Study|Withdrawal by Subject|0
301591|NCT00841906|989876|P1|Overall Study|Withdrawal by Subject|2
301592|NCT00841815|989890|P2|Washout|Withdrawal by Subject|1
301593|NCT00841815|989891|P1|Washout|Withdrawal by Subject|0
301594|NCT00841776|989901|P2|Overall Study|Withdrawal by Subject|1
301595|NCT00841776|989902|P1|Overall Study|Withdrawal by Subject|0
301596|NCT00841776|989901|P2|Overall Study|Lost to Follow-up|1
301597|NCT00841776|989902|P1|Overall Study|Lost to Follow-up|2
301598|NCT00841776|989901|P2|Overall Study|Lack of Efficacy|1
301599|NCT00841776|989902|P1|Overall Study|Lack of Efficacy|0
301600|NCT00841763|989920|P4|Overall Study|Unable to Classify|0
301601|NCT00841763|989921|P3|Overall Study|Unable to Classify|0
301602|NCT00841763|989922|P2|Overall Study|Unable to Classify|1
301603|NCT00841763|989923|P1|Overall Study|Unable to Classify|7
301604|NCT00841763|989920|P4|Overall Study|Administrative Reasons|0
301605|NCT00841763|989921|P3|Overall Study|Administrative Reasons|0
301606|NCT00841763|989922|P2|Overall Study|Administrative Reasons|1
301607|NCT00841763|989923|P1|Overall Study|Administrative Reasons|3
301608|NCT00841763|989920|P4|Overall Study|Protocol Violation|0
301609|NCT00841763|989921|P3|Overall Study|Protocol Violation|1
301610|NCT00841763|989922|P2|Overall Study|Protocol Violation|3
301611|NCT00841763|989923|P1|Overall Study|Protocol Violation|20
301612|NCT00841763|989920|P4|Overall Study|Lost to Follow-up|0
301613|NCT00841763|989921|P3|Overall Study|Lost to Follow-up|0
301614|NCT00841763|989922|P2|Overall Study|Lost to Follow-up|25
301615|NCT00841763|989923|P1|Overall Study|Lost to Follow-up|63
301616|NCT00841763|989920|P4|Overall Study|Adverse Event|2
301617|NCT00841763|989921|P3|Overall Study|Adverse Event|3
301618|NCT00841763|989922|P2|Overall Study|Adverse Event|10
301619|NCT00841763|989923|P1|Overall Study|Adverse Event|9
301620|NCT00841763|989920|P4|Overall Study|Withdrawal by Subject|1
301621|NCT00841763|989921|P3|Overall Study|Withdrawal by Subject|4
301622|NCT00841763|989922|P2|Overall Study|Withdrawal by Subject|17
301623|NCT00841763|989923|P1|Overall Study|Withdrawal by Subject|60
301624|NCT00841698|989985|P2|First Intervention|Withdrawal by Subject|0
301625|NCT00841698|989986|P1|First Intervention|Withdrawal by Subject|1
301626|NCT00841672|989996|P2|Overall Study|Protocol Deviation|1
301627|NCT00841672|989997|P1|Overall Study|Protocol Deviation|0
301628|NCT00841672|989996|P2|Overall Study|Misrandomized|0
301629|NCT00841672|989997|P1|Overall Study|Misrandomized|1
301630|NCT00841672|989996|P2|Overall Study|Administrative problems|9
301631|NCT00841672|989997|P1|Overall Study|Administrative problems|9
301632|NCT00841672|989996|P2|Overall Study|Lost to Follow-up|1
301633|NCT00841672|989997|P1|Overall Study|Lost to Follow-up|1
301634|NCT00841672|989996|P2|Overall Study|Subject withdrew consent|4
301635|NCT00841672|989997|P1|Overall Study|Subject withdrew consent|2
301636|NCT00841672|989996|P2|Overall Study|Abnormal test procedure result(s)|1
301637|NCT00841672|989997|P1|Overall Study|Abnormal test procedure result(s)|0
301638|NCT00841672|989996|P2|Overall Study|Adverse Event|16
301639|NCT00841672|989997|P1|Overall Study|Adverse Event|7
301640|NCT00841659|990013|P2|Washout: 2 Weeks|Protocol Violation|0
301641|NCT00841659|990014|P1|Washout: 2 Weeks|Protocol Violation|1
301642|NCT00841542|990037|P2|Period 1|Adverse Event|0
301643|NCT00841542|990038|P1|Period 1|Adverse Event|1
301644|NCT00841321|990053|P2|Overall Study|Adverse Event|2
301645|NCT00841321|990054|P1|Overall Study|Adverse Event|0
301646|NCT00841321|990053|P2|Overall Study|Lost to Follow-up|1
301647|NCT00841321|990054|P1|Overall Study|Lost to Follow-up|1
301648|NCT00841035|990104|P1|Phase 1 Overall Study|Physician Decision|13
301649|NCT00840996|990111|P2|Overall Study|Withdrawal by Subject|0
301650|NCT00840996|990112|P1|Overall Study|Withdrawal by Subject|1
301651|NCT00840879|990132|P2|Second Intervention|Withdrawal by Subject|0
301652|NCT00840879|990133|P1|Second Intervention|Withdrawal by Subject|1
301653|NCT00840658|990173|P4|Overall Study|Lost to Follow-up|1
301654|NCT00840658|990174|P3|Overall Study|Lost to Follow-up|2
301655|NCT00840658|990175|P2|Overall Study|Lost to Follow-up|1
301656|NCT00840658|990176|P1|Overall Study|Lost to Follow-up|3
301657|NCT00840658|990173|P4|Overall Study|Death|3
301658|NCT00840658|990174|P3|Overall Study|Death|3
301659|NCT00840658|990175|P2|Overall Study|Death|2
301660|NCT00840658|990176|P1|Overall Study|Death|2
301661|NCT00840632|990188|P2|Washout|Withdrawal by Subject|1
301662|NCT00840632|990189|P1|Washout|Withdrawal by Subject|1
301663|NCT00840632|990188|P2|First Intervention|Withdrawal by Subject|1
301664|NCT00840632|990189|P1|First Intervention|Withdrawal by Subject|0
301665|NCT00840450|990214|P1|Overall Study|Lack of Efficacy|2
301666|NCT00840450|990214|P1|Overall Study|Adverse Event|1
301667|NCT00840411|990222|P2|Washout|Withdrawal by Subject|0
301668|NCT00840411|990223|P1|Washout|Withdrawal by Subject|1
301669|NCT00840411|990222|P2|First Intervention|Adverse Event|0
301670|NCT00840411|990223|P1|First Intervention|Adverse Event|1
301671|NCT00840294|990233|P2|Overall Study|Illness|1
301672|NCT00840294|990234|P1|Overall Study|Illness|0
301673|NCT00840294|990233|P2|Overall Study|Protocol Violation|3
301674|NCT00840294|990234|P1|Overall Study|Protocol Violation|1
301675|NCT00840294|990233|P2|Overall Study|Withdrawal by Subject|1
301676|NCT00840294|990234|P1|Overall Study|Withdrawal by Subject|2
301677|NCT00840216|990255|P2|Washout: 7 Days|Withdrawal by Subject|0
301678|NCT00840216|990256|P1|Washout: 7 Days|Withdrawal by Subject|1
301679|NCT00840203|990266|P2|Washout|Protocol Violation|0
301680|NCT00840203|990267|P1|Washout|Protocol Violation|1
301681|NCT00840203|990266|P2|First Intervention|Protocol Violation|1
301682|NCT00840203|990267|P1|First Intervention|Protocol Violation|1
301683|NCT00840086|990298|P1|Overall Study|Lost to Follow-up|1
301684|NCT00840086|990298|P1|Overall Study|Protocol Violation|2
301685|NCT00840086|990298|P1|Overall Study|Adverse Event|1
301686|NCT00840073|990307|P2|Second Intervention|Missed 72 hour blood draw|1
301687|NCT00840073|990308|P1|Second Intervention|Missed 72 hour blood draw|1
301688|NCT00840060|990322|P2|Overall Study|Change in emotional/behavioral status|1
301689|NCT00840060|990323|P1|Overall Study|Change in emotional/behavioral status|0
301690|NCT00840060|990322|P2|Overall Study|Withdrawal by Subject|0
301691|NCT00840060|990323|P1|Overall Study|Withdrawal by Subject|1
301692|NCT00839956|990331|P1|Overall Study|Withdrawal by Subject|3
301693|NCT00839956|990331|P1|Overall Study|Physician Decision|1
301694|NCT00839956|990331|P1|Overall Study|Lack of Efficacy|6
301695|NCT00839956|990331|P1|Overall Study|Adverse Event|2
301696|NCT00839917|990351|P2|Overall Study|Did not receive vaccine|1
301697|NCT00839917|990352|P1|Overall Study|Did not receive vaccine|0
301698|NCT00839917|990351|P2|Overall Study|Lost to Follow-up|0
301699|NCT00839917|990352|P1|Overall Study|Lost to Follow-up|1
301700|NCT00839800|990390|P2|Overall Study|Severe Non-Compliance to Protocol|7
301701|NCT00839800|990391|P1|Overall Study|Severe Non-Compliance to Protocol|7
301702|NCT00839800|990390|P2|Overall Study|Not Specified|14
301703|NCT00839800|990391|P1|Overall Study|Not Specified|8
301704|NCT00839800|990390|P2|Overall Study|Safety Reasons|1
301705|NCT00839800|990391|P1|Overall Study|Safety Reasons|2
301706|NCT00839800|990390|P2|Overall Study|Study-Specific Discontinuation Criteria|13
301707|NCT00839800|990391|P1|Overall Study|Study-Specific Discontinuation Criteria|6
301708|NCT00839800|990390|P2|Overall Study|Incorrect Enrolment|3
301709|NCT00839800|990391|P1|Overall Study|Incorrect Enrolment|3
301710|NCT00839800|990390|P2|Overall Study|Withdrawal by Subject|34
301711|NCT00839800|990391|P1|Overall Study|Withdrawal by Subject|28
301712|NCT00839800|990390|P2|Overall Study|Lost to Follow-up|26
301713|NCT00839800|990391|P1|Overall Study|Lost to Follow-up|31
301714|NCT00839800|990390|P2|Overall Study|Adverse Event|12
301715|NCT00839800|990391|P1|Overall Study|Adverse Event|8
301716|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
301717|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
301718|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
301719|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
301720|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
301721|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
301722|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
301723|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
301724|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
301725|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
301726|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
301727|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
301728|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
301729|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
301730|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
301731|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
301732|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
301733|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
301734|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
301735|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
301736|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
301737|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
301738|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
301739|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
301740|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
301741|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
301742|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
301743|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
301744|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
301745|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
301746|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
301747|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
301748|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
301749|NCT00839527|990437|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
301750|NCT00839527|990438|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
301751|NCT00839527|990439|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
301752|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
301753|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
301754|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
301755|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
301756|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
301757|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
301758|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
301759|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
301760|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
301761|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
301762|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
301763|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
301764|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Missing|0
301765|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Missing|1
301766|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Missing|0
301767|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
301768|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
301769|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
301770|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
301771|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
301772|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
301773|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
301774|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
301775|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
301776|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
301777|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
301778|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
301779|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
301780|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
301781|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
301782|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
301783|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
301784|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
301785|NCT00839527|990437|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
301786|NCT00839527|990438|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
301787|NCT00839527|990439|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
301788|NCT00839436|990474|P3|Overall Study|Study drug no longer available|1
301789|NCT00839436|990475|P2|Overall Study|Study drug no longer available|0
301790|NCT00839436|990476|P1|Overall Study|Study drug no longer available|0
301791|NCT00839436|990474|P3|Overall Study|Withdrawal by Subject|0
301792|NCT00839436|990475|P2|Overall Study|Withdrawal by Subject|1
301793|NCT00839436|990476|P1|Overall Study|Withdrawal by Subject|0
301794|NCT00839436|990474|P3|Overall Study|Developed exclusionary condition|0
301795|NCT00839436|990475|P2|Overall Study|Developed exclusionary condition|0
301796|NCT00839436|990476|P1|Overall Study|Developed exclusionary condition|1
301797|NCT00839423|990488|P4|Overall Study|Administrative or other reasons|0
301798|NCT00839423|990489|P3|Overall Study|Administrative or other reasons|1
301799|NCT00839423|990490|P2|Overall Study|Administrative or other reasons|0
301800|NCT00839423|990491|P1|Overall Study|Administrative or other reasons|3
301801|NCT00839423|990488|P4|Overall Study|Lost to Follow-up|0
301802|NCT00839423|990489|P3|Overall Study|Lost to Follow-up|1
301803|NCT00839423|990490|P2|Overall Study|Lost to Follow-up|0
301804|NCT00839423|990491|P1|Overall Study|Lost to Follow-up|1
301805|NCT00839423|990488|P4|Overall Study|Withdrawal of consent|1
301806|NCT00839423|990489|P3|Overall Study|Withdrawal of consent|4
301807|NCT00839423|990490|P2|Overall Study|Withdrawal of consent|0
301808|NCT00839423|990491|P1|Overall Study|Withdrawal of consent|4
301809|NCT00839423|990488|P4|Overall Study|Protocol Violation|0
301810|NCT00839423|990489|P3|Overall Study|Protocol Violation|2
301811|NCT00839423|990490|P2|Overall Study|Protocol Violation|1
301812|NCT00839423|990491|P1|Overall Study|Protocol Violation|0
301813|NCT00839423|990488|P4|Overall Study|Non-compliance|1
301814|NCT00839423|990489|P3|Overall Study|Non-compliance|0
301815|NCT00839423|990490|P2|Overall Study|Non-compliance|0
301816|NCT00839423|990491|P1|Overall Study|Non-compliance|0
301817|NCT00839423|990488|P4|Overall Study|Lack of Efficacy|2
301818|NCT00839423|990489|P3|Overall Study|Lack of Efficacy|3
301819|NCT00839423|990490|P2|Overall Study|Lack of Efficacy|6
301820|NCT00839423|990491|P1|Overall Study|Lack of Efficacy|6
301821|NCT00839423|990488|P4|Overall Study|Adverse Event|16
301822|NCT00839423|990489|P3|Overall Study|Adverse Event|7
301823|NCT00839423|990490|P2|Overall Study|Adverse Event|3
301824|NCT00839423|990491|P1|Overall Study|Adverse Event|4
301825|NCT00839306|990567|P2|Overall Study|Not specified|18
301826|NCT00839306|990568|P1|Overall Study|Not specified|6
301827|NCT00839306|990567|P2|Overall Study|Lack of Efficacy|4
301828|NCT00839306|990568|P1|Overall Study|Lack of Efficacy|5
301829|NCT00839306|990567|P2|Overall Study|Withdrawal by Subject|7
301830|NCT00839306|990568|P1|Overall Study|Withdrawal by Subject|5
301831|NCT00839306|990567|P2|Overall Study|Lost to Follow-up|9
301832|NCT00839306|990568|P1|Overall Study|Lost to Follow-up|6
301833|NCT00839306|990567|P2|Overall Study|Adverse Event|5
301834|NCT00839306|990568|P1|Overall Study|Adverse Event|3
301835|NCT00839098|990666|P3|Overall Study|Withdrawal by Subject|7
301836|NCT00839098|990667|P2|Overall Study|Withdrawal by Subject|1
301837|NCT00839098|990668|P1|Overall Study|Withdrawal by Subject|2
301838|NCT00839072|990694|P2|Second Intervention Period|Withdrawal by Subject|0
301839|NCT00839072|990695|P1|Second Intervention Period|Withdrawal by Subject|1
301840|NCT00839072|990694|P2|First Intervention Period|Adverse Event|1
301841|NCT00839072|990695|P1|First Intervention Period|Adverse Event|1
301842|NCT00839072|990694|P2|First Intervention Period|Withdrawal by Subject|0
301843|NCT00839072|990695|P1|First Intervention Period|Withdrawal by Subject|1
301844|NCT00838929|990714|P3|Overall Study|Disease progression|1
301845|NCT00838929|990715|P2|Overall Study|Disease progression|2
301846|NCT00838929|990716|P1|Overall Study|Disease progression|0
301847|NCT00838929|990714|P3|Overall Study|Protocol Violation|0
301848|NCT00838929|990715|P2|Overall Study|Protocol Violation|1
301849|NCT00838929|990716|P1|Overall Study|Protocol Violation|0
301850|NCT00838916|990724|P2|Follow-up Period (8 Weeks)|Missing|0
301851|NCT00838916|990725|P1|Follow-up Period (8 Weeks)|Missing|3
301852|NCT00838916|990724|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
301853|NCT00838916|990725|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
301854|NCT00838916|990724|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
301855|NCT00838916|990725|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
301856|NCT00838916|990724|P2|Follow-up Period (8 Weeks)|Physician Decision|0
301857|NCT00838916|990725|P1|Follow-up Period (8 Weeks)|Physician Decision|2
301858|NCT00838916|990724|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
301859|NCT00838916|990725|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
301860|NCT00838916|990724|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
301861|NCT00838916|990725|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
301862|NCT00838916|990724|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
301863|NCT00838916|990725|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
301864|NCT00838916|990724|P2|Follow-up Period (8 Weeks)|Noncompliance|5
301865|NCT00838916|990725|P1|Follow-up Period (8 Weeks)|Noncompliance|6
301866|NCT00838916|990724|P2|Follow-up Period (8 Weeks)|Adverse Event|5
301867|NCT00838916|990725|P1|Follow-up Period (8 Weeks)|Adverse Event|10
301868|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Pregnancy|0
301869|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Pregnancy|2
301870|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Missing|1
301871|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Missing|3
301872|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
301873|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
301874|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Physician Decision|1
301875|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Physician Decision|6
301876|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
301877|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
301878|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
301879|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
301880|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
301881|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
301882|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Noncompliance|14
301883|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Noncompliance|21
301884|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Protocol Violation|3
301885|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Protocol Violation|12
301886|NCT00838916|990724|P2|Treatment Period (156 Weeks)|Adverse Event|11
301887|NCT00838916|990725|P1|Treatment Period (156 Weeks)|Adverse Event|50
301888|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Missing|1
301889|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Missing|1
301890|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Missing|2
301891|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Missing|1
301892|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
301893|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
301894|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
301895|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
301896|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
301897|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
301898|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
301899|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
301900|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
301901|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
301902|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
301903|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
301904|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
301905|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
301906|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
301907|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
301908|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Physician Decision|1
301909|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Physician Decision|1
301910|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Physician Decision|1
301911|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Physician Decision|1
301912|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
301913|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
301914|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
301915|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
301916|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
301917|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
301918|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
301919|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
301920|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
301921|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
301922|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
301923|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
301924|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Noncompliance|5
301925|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Noncompliance|5
301926|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Noncompliance|8
301927|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Noncompliance|2
301928|NCT00838903|990754|P4|Follow-up Period (8 Weeks)|Adverse Event|1
301929|NCT00838903|990755|P3|Follow-up Period (8 Weeks)|Adverse Event|3
301930|NCT00838903|990756|P2|Follow-up Period (8 Weeks)|Adverse Event|0
301931|NCT00838903|990757|P1|Follow-up Period (8 Weeks)|Adverse Event|0
301932|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
301933|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
301934|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
301935|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
301936|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
301937|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
301938|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
301939|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
301940|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
301941|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
301942|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
301943|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
301944|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Site closed|0
301945|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Site closed|1
301946|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Site closed|0
301947|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Site closed|0
301948|NCT00838903|990754|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
301949|NCT00838903|990755|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
301950|NCT00838903|990756|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
301951|NCT00838903|990757|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
301952|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Pregnancy|0
301953|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Pregnancy|1
301954|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Pregnancy|0
301955|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Pregnancy|0
301956|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
301957|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
301958|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
301959|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
301960|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
301961|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
301962|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
301963|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
301964|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
301965|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
301966|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
302048|NCT00838110|990951|P3|Overall Study|Randomized but not treated|0
301967|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
301968|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
301969|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
301970|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
301971|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
301972|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Physician Decision|2
301973|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Physician Decision|1
301974|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Physician Decision|2
301975|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Physician Decision|1
301976|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
301977|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
301978|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
301979|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
301980|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
301981|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
301982|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
301983|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
301984|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
301985|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
301986|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
301987|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
301988|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Noncompliance|6
301989|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Noncompliance|12
301990|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Noncompliance|13
301991|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Noncompliance|9
301992|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Protocol Violation|5
301993|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Protocol Violation|6
301994|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Protocol Violation|6
301995|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Protocol Violation|1
301996|NCT00838903|990754|P4|Treatment Period (156 Weeks)|Adverse Event|25
301997|NCT00838903|990755|P3|Treatment Period (156 Weeks)|Adverse Event|17
301998|NCT00838903|990756|P2|Treatment Period (156 Weeks)|Adverse Event|13
301999|NCT00838903|990757|P1|Treatment Period (156 Weeks)|Adverse Event|5
302000|NCT00838682|990801|P2|Overall Study|Withdrawal by Subject|1
302001|NCT00838682|990802|P1|Overall Study|Withdrawal by Subject|0
302002|NCT00838682|990801|P2|Overall Study|Protocol Violation|1
302003|NCT00838682|990802|P1|Overall Study|Protocol Violation|0
302004|NCT00838682|990801|P2|Overall Study|detection of exclusion criteria|3
302005|NCT00838682|990802|P1|Overall Study|detection of exclusion criteria|4
302006|NCT00838682|990801|P2|Overall Study|Lost to Follow-up|14
302007|NCT00838682|990802|P1|Overall Study|Lost to Follow-up|21
302008|NCT00838630|990820|P2|Washout: 7 Days|Protocol Violation|0
302009|NCT00838630|990821|P1|Washout: 7 Days|Protocol Violation|1
302010|NCT00838630|990820|P2|First Intervention|Adverse Event|0
302011|NCT00838630|990821|P1|First Intervention|Adverse Event|1
302012|NCT00838578|990829|P1|Overall Study|Protocol Violation|2
302013|NCT00838526|990839|P2|Overall Study|Not specified|7
302014|NCT00838526|990840|P1|Overall Study|Not specified|11
302015|NCT00838526|990839|P2|Overall Study|Lack of Efficacy|3
302016|NCT00838526|990840|P1|Overall Study|Lack of Efficacy|2
302017|NCT00838526|990839|P2|Overall Study|Withdrawal by Subject|5
302018|NCT00838526|990840|P1|Overall Study|Withdrawal by Subject|4
302019|NCT00838526|990839|P2|Overall Study|Lost to Follow-up|12
302020|NCT00838526|990840|P1|Overall Study|Lost to Follow-up|4
302021|NCT00838526|990839|P2|Overall Study|Adverse Event|12
302022|NCT00838526|990840|P1|Overall Study|Adverse Event|3
302023|NCT00838513|990848|P1|Post Treatment Period (Patients Who Disc|Death|1
302024|NCT00838513|990848|P1|Extension Treatment Period|Death|1
302025|NCT00838513|990848|P1|Screening Period|Screen Failure|3
302026|NCT00838331|990864|P1|Aged Blood Transfusion|Withdrawal by Subject|9
302027|NCT00838279|990870|P2|Washout|Withdrawal by Subject|1
302028|NCT00838279|990871|P1|Washout|Withdrawal by Subject|0
302029|NCT00838279|990870|P2|Washout|Protocol Violation|0
302030|NCT00838279|990871|P1|Washout|Protocol Violation|1
302031|NCT00838201|990881|P2|Overall Study|Death|13
302032|NCT00838201|990882|P1|Overall Study|Death|11
302033|NCT00838201|990881|P2|Overall Study|Adverse Event|9
302034|NCT00838201|990882|P1|Overall Study|Adverse Event|5
302035|NCT00838201|990881|P2|Overall Study|Lost to Follow-up|3
302036|NCT00838201|990882|P1|Overall Study|Lost to Follow-up|4
302037|NCT00838201|990881|P2|Overall Study|Consetn withdrawn|19
302038|NCT00838201|990882|P1|Overall Study|Consetn withdrawn|16
302039|NCT00838201|990881|P2|Overall Study|Disease progression|3
302040|NCT00838201|990882|P1|Overall Study|Disease progression|3
302041|NCT00838201|990881|P2|Overall Study|Administrative decision|2
302042|NCT00838201|990882|P1|Overall Study|Administrative decision|1
302043|NCT00838201|990881|P2|Overall Study|Noncompliance|1
302044|NCT00838201|990882|P1|Overall Study|Noncompliance|0
302045|NCT00838201|990881|P2|Overall Study|Investigator decision, or other reasons|3
302046|NCT00838201|990882|P1|Overall Study|Investigator decision, or other reasons|2
302047|NCT00838110|990950|P4|Overall Study|Randomized but not treated|0
302049|NCT00838110|990952|P2|Overall Study|Randomized but not treated|1
302050|NCT00838110|990953|P1|Overall Study|Randomized but not treated|0
302051|NCT00838110|990950|P4|Overall Study|Did not meet eligibility criteria|2
302052|NCT00838110|990951|P3|Overall Study|Did not meet eligibility criteria|1
302053|NCT00838110|990952|P2|Overall Study|Did not meet eligibility criteria|0
302054|NCT00838110|990953|P1|Overall Study|Did not meet eligibility criteria|0
302055|NCT00838110|990950|P4|Overall Study|Lost to Follow-up|0
302056|NCT00838110|990951|P3|Overall Study|Lost to Follow-up|0
302057|NCT00838110|990952|P2|Overall Study|Lost to Follow-up|0
302058|NCT00838110|990953|P1|Overall Study|Lost to Follow-up|3
302059|NCT00838110|990950|P4|Overall Study|Protocol Violation|1
302060|NCT00838110|990951|P3|Overall Study|Protocol Violation|1
302061|NCT00838110|990952|P2|Overall Study|Protocol Violation|2
302062|NCT00838110|990953|P1|Overall Study|Protocol Violation|0
302063|NCT00838110|990950|P4|Overall Study|Unspecified|2
302064|NCT00838110|990951|P3|Overall Study|Unspecified|3
302065|NCT00838110|990952|P2|Overall Study|Unspecified|3
302066|NCT00838110|990953|P1|Overall Study|Unspecified|3
302067|NCT00838110|990950|P4|Overall Study|Withdrawal by Subject|4
302068|NCT00838110|990951|P3|Overall Study|Withdrawal by Subject|3
302069|NCT00838110|990952|P2|Overall Study|Withdrawal by Subject|6
302070|NCT00838110|990953|P1|Overall Study|Withdrawal by Subject|5
302071|NCT00838110|990950|P4|Overall Study|Adverse Event|7
302072|NCT00838110|990951|P3|Overall Study|Adverse Event|8
302073|NCT00838110|990952|P2|Overall Study|Adverse Event|10
302074|NCT00838110|990953|P1|Overall Study|Adverse Event|11
302075|NCT00838110|990950|P4|Overall Study|Death|2
302076|NCT00838110|990951|P3|Overall Study|Death|1
302077|NCT00838110|990952|P2|Overall Study|Death|0
302078|NCT00838110|990953|P1|Overall Study|Death|0
302079|NCT00838097|990973|P1|Overall Study|Protocol-specified criteria|142
302080|NCT00838097|990973|P1|Overall Study|Death|6
302081|NCT00838097|990973|P1|Overall Study|Lost to Follow-up|11
302082|NCT00838097|990973|P1|Overall Study|Physician Decision|4
302083|NCT00838097|990973|P1|Overall Study|Requirement for alternative therapy|2
302084|NCT00838097|990973|P1|Overall Study|Withdrawal by Subject|3
302085|NCT00838097|990973|P1|Overall Study|Adverse Event|2
302086|NCT00838097|990973|P1|Overall Study|Ineligibility determined|6
302087|NCT00837967|990981|P2|Washout Period of 7 - 14 Days|Adverse Event|0
302088|NCT00837967|990982|P1|Washout Period of 7 - 14 Days|Adverse Event|2
302089|NCT00837876|990998|P1|Overall Study|disease progression|24
302090|NCT00837876|990998|P1|Overall Study|Withdrawal by Subject|3
302091|NCT00837876|990998|P1|Overall Study|Physician Decision|1
302092|NCT00837876|990998|P1|Overall Study|Adverse Event|7
302093|NCT00837876|990998|P1|Overall Study|Death|2
302094|NCT00837759|991017|P1|Overall Study|Lost to Follow-up|1
302095|NCT00837759|991017|P1|Overall Study|Protocol Violation|3
302096|NCT00837616|991028|P2|Overall Study|Withdrawal by Subject|1
302097|NCT00837616|991029|P1|Overall Study|Withdrawal by Subject|0
302098|NCT00837577|991055|P2|Open-label Period|Other Reason|1
302099|NCT00837577|991056|P1|Open-label Period|Other Reason|1
302100|NCT00837577|991055|P2|Open-label Period|Withdrawal by Subject|2
302101|NCT00837577|991056|P1|Open-label Period|Withdrawal by Subject|1
302102|NCT00837577|991055|P2|Open-label Period|Lack of Efficacy|3
302103|NCT00837577|991056|P1|Open-label Period|Lack of Efficacy|4
302104|NCT00837577|991055|P2|Open-label Period|Laboratory Adverse Event|1
302105|NCT00837577|991056|P1|Open-label Period|Laboratory Adverse Event|0
302106|NCT00837577|991055|P2|Open-label Period|Clinical Adverse Event|2
302107|NCT00837577|991056|P1|Open-label Period|Clinical Adverse Event|2
302108|NCT00837577|991055|P2|Double-blind Period|Withdrawal by Subject|0
302109|NCT00837577|991056|P1|Double-blind Period|Withdrawal by Subject|1
302110|NCT00837577|991055|P2|Double-blind Period|Clinical Adverse Event|0
302111|NCT00837577|991056|P1|Double-blind Period|Clinical Adverse Event|1
302112|NCT00837486|991076|P2|Long-term Follow-up Phase - Open Label|Death|0
302113|NCT00837486|991077|P1|Long-term Follow-up Phase - Open Label|Death|1
302114|NCT00837486|991076|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
302115|NCT00837486|991077|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
302116|NCT00837486|991076|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
302117|NCT00837486|991077|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
302118|NCT00837486|991076|P2|Blinded-treatment Phase|Physician Decision|0
302119|NCT00837486|991077|P1|Blinded-treatment Phase|Physician Decision|1
302120|NCT00837434|991096|P2|Overall Study|Unable to obtain study drug|0
302121|NCT00837434|991097|P1|Overall Study|Unable to obtain study drug|1
302122|NCT00837434|991096|P2|Overall Study|Baseline assessments not done in time|0
302123|NCT00837434|991097|P1|Overall Study|Baseline assessments not done in time|1
302124|NCT00837434|991096|P2|Overall Study|Noncompliant|0
302125|NCT00837434|991097|P1|Overall Study|Noncompliant|2
302126|NCT00837434|991096|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
302127|NCT00837434|991097|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
302128|NCT00837434|991096|P2|Overall Study|Lost to Follow-up|1
302129|NCT00837434|991097|P1|Overall Study|Lost to Follow-up|1
302130|NCT00837434|991096|P2|Overall Study|Physician Decision|0
302131|NCT00837434|991097|P1|Overall Study|Physician Decision|3
302132|NCT00837330|991117|P2|Overall Study|Lost to Follow-up|3
302133|NCT00837330|991118|P1|Overall Study|Lost to Follow-up|1
302134|NCT00837213|991141|P2|Overall Study|not stated|1
302135|NCT00837213|991142|P1|Overall Study|not stated|1
302136|NCT00837213|991141|P2|Overall Study|Withdrawal by Subject|2
302137|NCT00837213|991142|P1|Overall Study|Withdrawal by Subject|2
302138|NCT00837213|991141|P2|Overall Study|Lost to Follow-up|2
302139|NCT00837213|991142|P1|Overall Study|Lost to Follow-up|3
302140|NCT00837161|991168|P1|Overall Study|refused hysterectomy|2
302141|NCT00837148|991176|P1|Overall Study|Death|1
302142|NCT00837148|991176|P1|Overall Study|Adverse Event|1
302143|NCT00836953|991186|P1|Overall Study|Lost to Follow-up|1
302144|NCT00836953|991186|P1|Overall Study|Withdrawal by Subject|1
302145|NCT00836901|991194|P2|First Intervention|Withdrawal by Subject|0
302146|NCT00836901|991195|P1|First Intervention|Withdrawal by Subject|1
302147|NCT00836875|991211|P2|Overall Study|Withdrawal by Subject|1
302148|NCT00836875|991212|P1|Overall Study|Withdrawal by Subject|0
302149|NCT00836875|991211|P2|Overall Study|Death|2
302150|NCT00836875|991212|P1|Overall Study|Death|3
302151|NCT00836745|991226|P1|Overall Study|Unspecified|2
302152|NCT00836745|991226|P1|Overall Study|Objective progression or relapse|4
302153|NCT00836745|991226|P1|Overall Study|Adverse Event|3
302154|NCT00836745|991226|P1|Overall Study|Lost to Follow-up|10
302155|NCT00836745|991226|P1|Overall Study|Death|2
302156|NCT00836706|991240|P2|Washout: 7 Days|Withdrawal by Subject|1
302157|NCT00836706|991241|P1|Washout: 7 Days|Withdrawal by Subject|0
302158|NCT00836693|991251|P2|Overall Study|Lost to Follow-up|0
302159|NCT00836693|991252|P1|Overall Study|Lost to Follow-up|1
302160|NCT00836693|991251|P2|Overall Study|Protocol Violation|0
302161|NCT00836693|991252|P1|Overall Study|Protocol Violation|1
302162|NCT00836693|991251|P2|Overall Study|Withdrawal by Subject|4
302163|NCT00836693|991252|P1|Overall Study|Withdrawal by Subject|9
302164|NCT00836693|991251|P2|Overall Study|Physician Decision|0
302165|NCT00836693|991252|P1|Overall Study|Physician Decision|2
302166|NCT00836693|991251|P2|Overall Study|Sponsor Decision|1
302167|NCT00836693|991252|P1|Overall Study|Sponsor Decision|0
302168|NCT00836693|991251|P2|Overall Study|Adverse Event|1
302169|NCT00836693|991252|P1|Overall Study|Adverse Event|4
302170|NCT00836498|991304|P2|Overall Study|Withdrawal by Subject|1
302171|NCT00836498|991305|P1|Overall Study|Withdrawal by Subject|2
302172|NCT00836498|991304|P2|Overall Study|Lost to Follow-up|0
302173|NCT00836498|991305|P1|Overall Study|Lost to Follow-up|1
302174|NCT00836498|991304|P2|Overall Study|Adverse Event|0
302175|NCT00836498|991305|P1|Overall Study|Adverse Event|1
302176|NCT00836472|991337|P2|Washout|Withdrawal by Subject|1
302177|NCT00836472|991338|P1|Washout|Withdrawal by Subject|1
302178|NCT00836472|991337|P2|Washout|Adverse Event|2
302179|NCT00836472|991338|P1|Washout|Adverse Event|1
302180|NCT00836277|991415|P1|Overall Study|Not evaluable for response|6
302181|NCT00836095|991425|P2|Overall Study|Physician Decision|3
302182|NCT00836095|991426|P1|Overall Study|Physician Decision|0
302183|NCT00836056|991436|P2|First Intervention|Adverse Event|0
302184|NCT00836056|991437|P1|First Intervention|Adverse Event|1
302185|NCT00835991|991466|P2|Washout|Withdrawal by Subject|1
302186|NCT00835991|991467|P1|Washout|Withdrawal by Subject|3
302187|NCT00835991|991466|P2|Washout|Protocol Violation|2
302188|NCT00835991|991467|P1|Washout|Protocol Violation|0
302189|NCT00835991|991466|P2|First Intervention|Adverse Event|1
302190|NCT00835991|991467|P1|First Intervention|Adverse Event|0
302191|NCT00835978|991485|P4|Overall Study|Study terminated by sponsor|0
302192|NCT00835978|991486|P3|Overall Study|Study terminated by sponsor|30
302193|NCT00835978|991487|P2|Overall Study|Study terminated by sponsor|8
302194|NCT00835978|991488|P1|Overall Study|Study terminated by sponsor|12
302195|NCT00835978|991485|P4|Overall Study|Withdrawal by Subject|5
302196|NCT00835978|991486|P3|Overall Study|Withdrawal by Subject|0
302197|NCT00835978|991487|P2|Overall Study|Withdrawal by Subject|3
302198|NCT00835978|991488|P1|Overall Study|Withdrawal by Subject|0
302199|NCT00835978|991485|P4|Overall Study|Adverse Event|0
302200|NCT00835978|991486|P3|Overall Study|Adverse Event|1
302201|NCT00835978|991487|P2|Overall Study|Adverse Event|0
302202|NCT00835978|991488|P1|Overall Study|Adverse Event|1
302203|NCT00835978|991485|P4|Overall Study|Objective progression or relapse|0
302204|NCT00835978|991486|P3|Overall Study|Objective progression or relapse|1
302205|NCT00835978|991487|P2|Overall Study|Objective progression or relapse|0
302206|NCT00835978|991488|P1|Overall Study|Objective progression or relapse|2
302207|NCT00835978|991485|P4|Overall Study|Not Specified|0
302208|NCT00835978|991486|P3|Overall Study|Not Specified|8
302209|NCT00835978|991487|P2|Overall Study|Not Specified|1
302210|NCT00835978|991488|P1|Overall Study|Not Specified|5
302211|NCT00835978|991485|P4|Overall Study|Lost to Follow-up|1
302212|NCT00835978|991486|P3|Overall Study|Lost to Follow-up|2
302213|NCT00835978|991487|P2|Overall Study|Lost to Follow-up|4
302214|NCT00835978|991488|P1|Overall Study|Lost to Follow-up|3
302215|NCT00835978|991485|P4|Overall Study|Death|4
302216|NCT00835978|991486|P3|Overall Study|Death|49
302217|NCT00835978|991487|P2|Overall Study|Death|40
302218|NCT00835978|991488|P1|Overall Study|Death|33
302219|NCT00835796|991599|P2|First Intervention|Withdrawal by Subject|1
302220|NCT00835796|991600|P1|First Intervention|Withdrawal by Subject|0
302221|NCT00835731|991610|P2|Overall Study|Physician Decision|1
302222|NCT00835731|991611|P1|Overall Study|Physician Decision|1
302223|NCT00835731|991610|P2|Overall Study|Withdrawal by Subject|0
302224|NCT00835731|991611|P1|Overall Study|Withdrawal by Subject|1
302225|NCT00835705|991627|P2|Second Intervention|Difficulty with vein|0
302226|NCT00835705|991628|P1|Second Intervention|Difficulty with vein|1
302227|NCT00835705|991627|P2|First Intervention|Difficulty with vein|0
302228|NCT00835705|991628|P1|First Intervention|Difficulty with vein|1
302229|NCT00835692|991644|P2|First Intervention|Withdrawal by Subject|0
302230|NCT00835692|991645|P1|First Intervention|Withdrawal by Subject|1
302231|NCT00835679|991657|P4|Overall Study|Withdrawal by Subject|0
302232|NCT00835679|991658|P3|Overall Study|Withdrawal by Subject|0
302233|NCT00835679|991659|P2|Overall Study|Withdrawal by Subject|0
302234|NCT00835679|991660|P1|Overall Study|Withdrawal by Subject|1
302235|NCT00835666|991684|P2|Washout|Withdrawal by Subject|0
302236|NCT00835666|991685|P1|Washout|Withdrawal by Subject|1
302237|NCT00835666|991684|P2|Washout|Protocol Violation|0
302238|NCT00835666|991685|P1|Washout|Protocol Violation|1
302239|NCT00835640|991695|P2|Second Intervention|Protocol Violation|0
302240|NCT00835640|991696|P1|Second Intervention|Protocol Violation|1
302241|NCT00835575|991728|P2|Washout of 14 Days|Withdrawal by Subject|0
302242|NCT00835575|991729|P1|Washout of 14 Days|Withdrawal by Subject|1
302243|NCT00835549|991739|P2|Washout of 7 Days|Withdrawal by Subject|0
302244|NCT00835549|991740|P1|Washout of 7 Days|Withdrawal by Subject|2
302245|NCT00835536|991750|P2|Washout of 5 Weeks|Withdrawal by Subject|0
302246|NCT00835536|991751|P1|Washout of 5 Weeks|Withdrawal by Subject|1
302247|NCT00835406|991812|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
302248|NCT00835406|991813|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
302249|NCT00835406|991812|P2|Period: First Intervention|Withdrawal by Subject|0
302250|NCT00835406|991813|P1|Period: First Intervention|Withdrawal by Subject|2
302251|NCT00835406|991812|P2|Period: First Intervention|Adverse Event|1
302252|NCT00835406|991813|P1|Period: First Intervention|Adverse Event|0
302253|NCT00835380|991819|P1|Overall Study|Withdrawal by Subject|2
302254|NCT00835367|991826|P2|Second Intervention|Adverse Event|1
302255|NCT00835367|991827|P1|Second Intervention|Adverse Event|1
302256|NCT00835367|991826|P2|Washout|Withdrawal by Subject|0
302257|NCT00835367|991827|P1|Washout|Withdrawal by Subject|1
302258|NCT00835367|991826|P2|Washout|Adverse Event|0
302259|NCT00835367|991827|P1|Washout|Adverse Event|2
302260|NCT00835354|991849|P2|First Intervention|Adverse Event|1
302261|NCT00835354|991850|P1|First Intervention|Adverse Event|0
302262|NCT00835341|991860|P2|Overall Study|Lost to Follow-up|12
302263|NCT00835341|991861|P1|Overall Study|Lost to Follow-up|3
302264|NCT00835263|991880|P2|Second Intervention|Adverse Event|0
302265|NCT00835263|991881|P1|Second Intervention|Adverse Event|1
302266|NCT00835237|991891|P2|Overall Study|Withdrawal by Subject|0
302267|NCT00835237|991892|P1|Overall Study|Withdrawal by Subject|2
302268|NCT00835237|991891|P2|Overall Study|Lost to Follow-up|0
302269|NCT00835237|991892|P1|Overall Study|Lost to Follow-up|4
302270|NCT00835211|991932|P2|Washout: 7 Days|Withdrawal by Subject|0
302271|NCT00835211|991933|P1|Washout: 7 Days|Withdrawal by Subject|1
302272|NCT00835211|991932|P2|Washout: 7 Days|Adverse Event|1
302273|NCT00835211|991933|P1|Washout: 7 Days|Adverse Event|2
302274|NCT00835211|991932|P2|First Intervention|Withdrawal by Subject|1
302275|NCT00835211|991933|P1|First Intervention|Withdrawal by Subject|0
302276|NCT00835172|991979|P2|Washout|Protocol Violation|1
302277|NCT00835172|991980|P1|Washout|Protocol Violation|0
302278|NCT00835120|992006|P1|Overall Study|Withdrawal by Subject|2
302279|NCT00835120|992006|P1|Overall Study|Adverse Event|2
302280|NCT00835120|992006|P1|Overall Study|Lost to Follow-up|3
302281|NCT00835120|992006|P1|Overall Study|Lack of Efficacy|1
302282|NCT00835081|992016|P2|Washout of 7 Days|Withdrawal by Subject|0
302283|NCT00835081|992017|P1|Washout of 7 Days|Withdrawal by Subject|1
302284|NCT00835068|992027|P2|Overall Study|Withdrawal by Subject|0
302285|NCT00835068|992028|P1|Overall Study|Withdrawal by Subject|1
302286|NCT00835068|992027|P2|Overall Study|Unspecified|0
302287|NCT00835068|992028|P1|Overall Study|Unspecified|8
302288|NCT00835068|992027|P2|Overall Study|Adverse Event|1
302289|NCT00835068|992028|P1|Overall Study|Adverse Event|0
302290|NCT00835068|992027|P2|Overall Study|Death|0
302291|NCT00835068|992028|P1|Overall Study|Death|1
302292|NCT00835042|992048|P2|Washout of 21 Days|Withdrawal by Subject|2
302293|NCT00835042|992049|P1|Washout of 21 Days|Withdrawal by Subject|0
302294|NCT00835042|992048|P2|First Intervention|Adverse Event|2
302295|NCT00835042|992049|P1|First Intervention|Adverse Event|1
302296|NCT00835042|992048|P2|First Intervention|Withdrawal by Subject|0
302297|NCT00835042|992049|P1|First Intervention|Withdrawal by Subject|3
302298|NCT00834912|992135|P6|Treatment Period 2|Withdrawal by Subject|0
302299|NCT00834912|992136|P5|Treatment Period 2|Withdrawal by Subject|1
302300|NCT00834912|992137|P4|Treatment Period 2|Withdrawal by Subject|0
302301|NCT00834912|992138|P3|Treatment Period 2|Withdrawal by Subject|1
302302|NCT00834912|992139|P2|Treatment Period 2|Withdrawal by Subject|0
302303|NCT00834912|992140|P1|Treatment Period 2|Withdrawal by Subject|0
302304|NCT00834912|992135|P6|Treatment Period 1|Adverse Event|0
302305|NCT00834912|992136|P5|Treatment Period 1|Adverse Event|0
302306|NCT00834912|992137|P4|Treatment Period 1|Adverse Event|1
302307|NCT00834912|992138|P3|Treatment Period 1|Adverse Event|0
302308|NCT00834912|992139|P2|Treatment Period 1|Adverse Event|1
302309|NCT00834912|992140|P1|Treatment Period 1|Adverse Event|0
302310|NCT00834899|992162|P2|Overall Study|Withdrawal by Subject|1
302311|NCT00834899|992163|P1|Overall Study|Withdrawal by Subject|1
302312|NCT00834873|992202|P2|First Intervention|Adverse Event|1
302313|NCT00834873|992203|P1|First Intervention|Adverse Event|0
302314|NCT00834795|992238|P2|Second Intervention|Adverse Event|0
302315|NCT00834795|992239|P1|Second Intervention|Adverse Event|1
302316|NCT00834795|992238|P2|Washout: 7 Days|Withdrawal by Subject|1
302317|NCT00834795|992239|P1|Washout: 7 Days|Withdrawal by Subject|0
302318|NCT00833794|992249|P2|Double-blind Phase|Administrative reason|3
302319|NCT00833794|992250|P1|Double-blind Phase|Administrative reason|1
302320|NCT00833794|992249|P2|Double-blind Phase|Physician Decision|7
302321|NCT00833794|992250|P1|Double-blind Phase|Physician Decision|4
302322|NCT00833794|992249|P2|Double-blind Phase|Withdrawal by Subject|6
302323|NCT00833794|992250|P1|Double-blind Phase|Withdrawal by Subject|23
302324|NCT00833794|992249|P2|Double-blind Phase|Lack of Efficacy|22
302325|NCT00833794|992250|P1|Double-blind Phase|Lack of Efficacy|34
302326|NCT00833794|992249|P2|Double-blind Phase|Adverse Event|11
302327|NCT00833794|992250|P1|Double-blind Phase|Adverse Event|44
302328|NCT00833794|992249|P2|Open-label Phase|enrolled in error (immediately D/C)|0
302329|NCT00833794|992250|P1|Open-label Phase|enrolled in error (immediately D/C)|1
302330|NCT00833794|992249|P2|Open-label Phase|Did not complete wash-out period|0
302331|NCT00833794|992250|P1|Open-label Phase|Did not complete wash-out period|12
302332|NCT00833794|992249|P2|Open-label Phase|Protocol Violation|0
302333|NCT00833794|992250|P1|Open-label Phase|Protocol Violation|47
302334|NCT00833794|992249|P2|Open-label Phase|Administrative reason|0
302335|NCT00833794|992250|P1|Open-label Phase|Administrative reason|1
302336|NCT00833794|992249|P2|Open-label Phase|Physician Decision|0
302337|NCT00833794|992250|P1|Open-label Phase|Physician Decision|20
302338|NCT00833794|992249|P2|Open-label Phase|Withdrawal by Subject|0
302339|NCT00833794|992250|P1|Open-label Phase|Withdrawal by Subject|48
302340|NCT00833794|992249|P2|Open-label Phase|Lack of Efficacy|0
302341|NCT00833794|992250|P1|Open-label Phase|Lack of Efficacy|28
302342|NCT00833794|992249|P2|Open-label Phase|Adverse Event|0
302343|NCT00833794|992250|P1|Open-label Phase|Adverse Event|225
302344|NCT00833755|992294|P4|Overall Study|Subject had scheduling issues|0
302345|NCT00833755|992295|P3|Overall Study|Subject had scheduling issues|0
302346|NCT00833755|992296|P2|Overall Study|Subject had scheduling issues|1
302347|NCT00833755|992297|P1|Overall Study|Subject had scheduling issues|0
302348|NCT00833755|992294|P4|Overall Study|Physician Decision|6
302349|NCT00833755|992295|P3|Overall Study|Physician Decision|2
302350|NCT00833755|992296|P2|Overall Study|Physician Decision|4
302351|NCT00833755|992297|P1|Overall Study|Physician Decision|4
302352|NCT00833703|992317|P2|Overall Study|Parent(s)/guardian(s)'s request|1
302353|NCT00833703|992318|P1|Overall Study|Parent(s)/guardian(s)'s request|0
302354|NCT00833690|992331|P3|Overall Study|Discontinued study drug|0
302355|NCT00833690|992332|P2|Overall Study|Discontinued study drug|2
302356|NCT00833690|992333|P1|Overall Study|Discontinued study drug|3
302357|NCT00833690|992331|P3|Overall Study|Withdrawal by Subject|0
302358|NCT00833690|992332|P2|Overall Study|Withdrawal by Subject|0
302359|NCT00833690|992333|P1|Overall Study|Withdrawal by Subject|1
302360|NCT00834756|992457|P2|Washout: 21 Days|Withdrawal by Subject|0
302361|NCT00834756|992458|P1|Washout: 21 Days|Withdrawal by Subject|1
302362|NCT00834756|992457|P2|First Intervention|Adverse Event|0
302363|NCT00834756|992458|P1|First Intervention|Adverse Event|1
302364|NCT00834743|992468|P2|Second Intervention|Withdrawal by Subject|0
302365|NCT00834743|992469|P1|Second Intervention|Withdrawal by Subject|1
302366|NCT00834717|992479|P2|First Intervention|Withdrawal by Subject|1
302367|NCT00834717|992480|P1|First Intervention|Withdrawal by Subject|0
302368|NCT00834717|992479|P2|First Intervention|Adverse Event|0
302369|NCT00834717|992480|P1|First Intervention|Adverse Event|1
302370|NCT00834639|992501|P2|Second Intervention|Physician Decision|2
302371|NCT00834639|992502|P1|Second Intervention|Physician Decision|0
302372|NCT00834613|992519|P2|First Intervention|Protocol Violation|0
302373|NCT00834613|992520|P1|First Intervention|Protocol Violation|1
302374|NCT00834587|992530|P2|Washout: 7 Days|Withdrawal by Subject|0
302375|NCT00834587|992531|P1|Washout: 7 Days|Withdrawal by Subject|1
302376|NCT00834522|992580|P2|Washout|Withdrawal by Subject|1
302377|NCT00834522|992581|P1|Washout|Withdrawal by Subject|2
302378|NCT00834522|992580|P2|Washout|Adverse Event|0
302379|NCT00834522|992581|P1|Washout|Adverse Event|1
302380|NCT00834444|992604|P2|Second Intervention|Adverse Event|0
302381|NCT00834444|992605|P1|Second Intervention|Adverse Event|1
302382|NCT00834444|992604|P2|Washout of 7 Days|Withdrawal by Subject|1
302383|NCT00834444|992605|P1|Washout of 7 Days|Withdrawal by Subject|0
302384|NCT00834444|992604|P2|First Intervention|Intolerance to Venopuncture|1
302385|NCT00834444|992605|P1|First Intervention|Intolerance to Venopuncture|0
302386|NCT00834444|992604|P2|First Intervention|Adverse Event|0
302387|NCT00834444|992605|P1|First Intervention|Adverse Event|1
302388|NCT00834431|992615|P2|Washout of 7 Days|Withdrawal by Subject|1
302389|NCT00834431|992616|P1|Washout of 7 Days|Withdrawal by Subject|0
302390|NCT00834431|992615|P2|First Intervention|Adverse Event|1
302391|NCT00834431|992616|P1|First Intervention|Adverse Event|0
302392|NCT00834418|992626|P2|Overall Study|Adverse Event|2
302393|NCT00834418|992627|P1|Overall Study|Adverse Event|0
302394|NCT00834366|992644|P2|Treatment Period 1|Adverse Event|1
302395|NCT00834366|992645|P1|Treatment Period 1|Adverse Event|1
302396|NCT00834340|992661|P2|Washout|Withdrawal by Subject|0
302397|NCT00834340|992662|P1|Washout|Withdrawal by Subject|1
302398|NCT00834340|992661|P2|Washout|Adverse Event|0
302399|NCT00834340|992662|P1|Washout|Adverse Event|1
302400|NCT00834249|992706|P2|Second Intervention|Adverse Event|0
302401|NCT00834249|992707|P1|Second Intervention|Adverse Event|1
302402|NCT00834249|992706|P2|Washout: 7 Days|Withdrawal by Subject|1
302403|NCT00834249|992707|P1|Washout: 7 Days|Withdrawal by Subject|1
302404|NCT00834080|992776|P1|Overall Study|Subject Relocated|1
302405|NCT00834080|992776|P1|Overall Study|Physician Decision|1
302406|NCT00834080|992776|P1|Overall Study|Other - False positive tests of the UDS|1
302407|NCT00834080|992776|P1|Overall Study|Other - Pregnancy|1
302408|NCT00834080|992776|P1|Overall Study|Withdrawal by Subject|5
302409|NCT00834080|992776|P1|Overall Study|Lost to Follow-up|7
302410|NCT00834080|992776|P1|Overall Study|Adverse Event|7
302411|NCT00834067|992782|P2|Washout of 21 Days|Protocol Violation|1
302412|NCT00834067|992783|P1|Washout of 21 Days|Protocol Violation|0
302413|NCT00834041|992805|P2|Overall Study|Lost to Follow-up|1
302414|NCT00834041|992806|P1|Overall Study|Lost to Follow-up|0
302415|NCT00834041|992805|P2|Overall Study|Withdrawal by Subject|0
302416|NCT00834041|992806|P1|Overall Study|Withdrawal by Subject|1
302417|NCT00833976|992820|P1|Overall Study|Physician Decision|1
302418|NCT00833976|992820|P1|Overall Study|Did not meet eligibility criteria|41
302419|NCT00833976|992820|P1|Overall Study|Lost to Follow-up|4
302420|NCT00833976|992820|P1|Overall Study|Withdrawal by Subject|5
302421|NCT00833937|992828|P2|Washout|Withdrawal by Subject|0
302422|NCT00833937|992829|P1|Washout|Withdrawal by Subject|1
302423|NCT00833924|992837|P1|Overall Study|In study follow-up|71
302424|NCT00833924|992837|P1|Overall Study|Withdrawal by Subject|13
302425|NCT00833924|992837|P1|Overall Study|Lost to Follow-up|2
302426|NCT00833924|992837|P1|Overall Study|Conversion|2
302427|NCT00833924|992837|P1|Overall Study|Death|21
302428|NCT00833911|992842|P1|Maintenance Phase II|Lack of Efficacy|1
302429|NCT00833911|992842|P1|Maintenance Phase II|Withdrawal by Subject|1
302430|NCT00833911|992842|P1|Maintenance Phase II|Physician Decision|2
302431|NCT00833911|992842|P1|Maintenance Phase II|Adverse Event|6
302432|NCT00833911|992842|P1|Maintenance Phase I|Lack of Efficacy|4
302433|NCT00833911|992842|P1|Maintenance Phase I|Physician Decision|10
302434|NCT00833911|992842|P1|Maintenance Phase I|Withdrawal by Subject|11
302435|NCT00833911|992842|P1|Maintenance Phase I|Adverse Event|73
302436|NCT00833911|992842|P1|Titration|Withdrawal by Subject|3
302437|NCT00833911|992842|P1|Titration|Adverse Event|18
302438|NCT00833898|992852|P2|Overall Study|Patient did not receive transplant|2
302439|NCT00833898|992853|P1|Overall Study|Patient did not receive transplant|0
302440|NCT00833898|992852|P2|Overall Study|Lost to Follow-up|7
302441|NCT00833898|992853|P1|Overall Study|Lost to Follow-up|7
302442|NCT00833898|992852|P2|Overall Study|Withdrawal by Subject|27
302443|NCT00833898|992853|P1|Overall Study|Withdrawal by Subject|33
302444|NCT00833833|992909|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
302445|NCT00833833|992910|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
302446|NCT00833833|992911|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
302447|NCT00833833|992912|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
302448|NCT00833833|992913|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
302449|NCT00833833|992914|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
302450|NCT00833833|992909|P6|Phase 2 (as of 01 April 2011)|Unspecified|3
302451|NCT00833833|992910|P5|Phase 2 (as of 01 April 2011)|Unspecified|4
302452|NCT00833833|992911|P4|Phase 2 (as of 01 April 2011)|Unspecified|0
302453|NCT00833833|992912|P3|Phase 2 (as of 01 April 2011)|Unspecified|0
302454|NCT00833833|992913|P2|Phase 2 (as of 01 April 2011)|Unspecified|0
302455|NCT00833833|992914|P1|Phase 2 (as of 01 April 2011)|Unspecified|0
302456|NCT00833833|992909|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
302457|NCT00833833|992910|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
302458|NCT00833833|992911|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
302459|NCT00833833|992912|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
302460|NCT00833833|992913|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
302461|NCT00833833|992914|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
302462|NCT00833833|992909|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
302463|NCT00833833|992910|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
302464|NCT00833833|992911|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
302465|NCT00833833|992912|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
302466|NCT00833833|992913|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
302467|NCT00833833|992914|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
302468|NCT00833833|992909|P6|Phase 2 (as of 01 April 2011)|Death|9
302469|NCT00833833|992910|P5|Phase 2 (as of 01 April 2011)|Death|8
302470|NCT00833833|992911|P4|Phase 2 (as of 01 April 2011)|Death|0
302471|NCT00833833|992912|P3|Phase 2 (as of 01 April 2011)|Death|0
302472|NCT00833833|992913|P2|Phase 2 (as of 01 April 2011)|Death|0
302473|NCT00833833|992914|P1|Phase 2 (as of 01 April 2011)|Death|0
302474|NCT00833833|992909|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
302475|NCT00833833|992910|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
302476|NCT00833833|992911|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
302477|NCT00833833|992912|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
302478|NCT00833833|992913|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
302479|NCT00833833|992914|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
302480|NCT00833833|992909|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
302481|NCT00833833|992910|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
302482|NCT00833833|992911|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
302483|NCT00833833|992912|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
302484|NCT00833833|992913|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
302485|NCT00833833|992914|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
302486|NCT00833833|992909|P6|Phase 1 (as of 01 April 2011)|Unspecified|0
302487|NCT00833833|992910|P5|Phase 1 (as of 01 April 2011)|Unspecified|0
302488|NCT00833833|992911|P4|Phase 1 (as of 01 April 2011)|Unspecified|1
302489|NCT00833833|992912|P3|Phase 1 (as of 01 April 2011)|Unspecified|0
302490|NCT00833833|992913|P2|Phase 1 (as of 01 April 2011)|Unspecified|3
302491|NCT00833833|992914|P1|Phase 1 (as of 01 April 2011)|Unspecified|1
302492|NCT00833833|992909|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
302493|NCT00833833|992910|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
302494|NCT00833833|992911|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
302495|NCT00833833|992912|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
302496|NCT00833833|992913|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
302497|NCT00833833|992914|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
302498|NCT00833833|992909|P6|Phase 1 (as of 01 April 2011)|Death|0
302499|NCT00833833|992910|P5|Phase 1 (as of 01 April 2011)|Death|0
302500|NCT00833833|992911|P4|Phase 1 (as of 01 April 2011)|Death|0
302501|NCT00833833|992912|P3|Phase 1 (as of 01 April 2011)|Death|2
302502|NCT00833833|992913|P2|Phase 1 (as of 01 April 2011)|Death|1
302503|NCT00833833|992914|P1|Phase 1 (as of 01 April 2011)|Death|0
302504|NCT00833833|992909|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
302505|NCT00833833|992910|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
302506|NCT00833833|992911|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
302507|NCT00833833|992912|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
302508|NCT00833833|992913|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
302509|NCT00833833|992914|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
302510|NCT00833833|992909|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
302511|NCT00833833|992910|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
302512|NCT00833833|992911|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
302513|NCT00833833|992912|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
302514|NCT00833833|992913|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
302515|NCT00833833|992914|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
302516|NCT00833833|992909|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
302517|NCT00833833|992910|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
302518|NCT00833833|992911|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
302519|NCT00833833|992912|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
302520|NCT00833833|992913|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
302521|NCT00833833|992914|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
302522|NCT00833638|992966|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
302523|NCT00833638|992967|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
302524|NCT00833638|992968|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
302525|NCT00833638|992966|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
302526|NCT00833638|992967|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
302527|NCT00833638|992968|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
302528|NCT00833638|992966|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
302529|NCT00833638|992967|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
302530|NCT00833638|992968|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
302531|NCT00833638|992966|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
302532|NCT00833638|992967|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
302533|NCT00833638|992968|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
302534|NCT00833638|992966|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
302535|NCT00833638|992967|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
302536|NCT00833638|992968|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
302537|NCT00833638|992966|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
302538|NCT00833638|992967|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
302539|NCT00833638|992968|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
302540|NCT00833638|992966|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
302541|NCT00833638|992967|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
302542|NCT00833638|992968|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
302543|NCT00833638|992966|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
302544|NCT00833638|992967|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
302545|NCT00833638|992968|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
302546|NCT00833638|992966|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
302547|NCT00833638|992967|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
302548|NCT00833638|992968|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
302549|NCT00833560|993019|P1|Overall Study|Not specified|5
302550|NCT00833560|993019|P1|Overall Study|Pregression of other disease|1
302551|NCT00833560|993019|P1|Overall Study|Death|2
302552|NCT00833560|993019|P1|Overall Study|Lack of Efficacy|4
302553|NCT00833560|993019|P1|Overall Study|Protocol Violation|6
302554|NCT00833560|993019|P1|Overall Study|Adverse Event|11
302555|NCT00833560|993019|P1|Overall Study|Toxicity|13
302556|NCT00833547|993028|P2|Overall Study|Withdrawal by Subject|2
302557|NCT00833547|993029|P1|Overall Study|Withdrawal by Subject|2
302558|NCT00833482|993050|P6|Days 21-30|Withdrawal by Subject|0
302559|NCT00833482|993051|P5|Days 21-30|Withdrawal by Subject|1
302560|NCT00833482|993052|P4|Days 21-30|Withdrawal by Subject|0
302561|NCT00833482|993053|P3|Days 21-30|Withdrawal by Subject|0
302562|NCT00833482|993054|P2|Days 21-30|Withdrawal by Subject|0
302563|NCT00833482|993055|P1|Days 21-30|Withdrawal by Subject|0
302564|NCT00833482|993050|P6|Days 21-30|Adverse Event|0
302565|NCT00833482|993051|P5|Days 21-30|Adverse Event|0
302566|NCT00833482|993052|P4|Days 21-30|Adverse Event|0
302567|NCT00833482|993053|P3|Days 21-30|Adverse Event|1
302568|NCT00833482|993054|P2|Days 21-30|Adverse Event|0
302569|NCT00833482|993055|P1|Days 21-30|Adverse Event|0
302570|NCT00833482|993050|P6|Days 11-20|Withdrawal by Subject|0
302571|NCT00833482|993051|P5|Days 11-20|Withdrawal by Subject|0
302572|NCT00833482|993052|P4|Days 11-20|Withdrawal by Subject|0
302573|NCT00833482|993053|P3|Days 11-20|Withdrawal by Subject|0
302574|NCT00833482|993054|P2|Days 11-20|Withdrawal by Subject|1
302575|NCT00833482|993055|P1|Days 11-20|Withdrawal by Subject|0
302576|NCT00833482|993050|P6|Days 11-20|Adverse Event|0
302577|NCT00833482|993051|P5|Days 11-20|Adverse Event|0
302578|NCT00833482|993052|P4|Days 11-20|Adverse Event|0
302579|NCT00833482|993053|P3|Days 11-20|Adverse Event|0
302580|NCT00833482|993054|P2|Days 11-20|Adverse Event|2
302581|NCT00833482|993055|P1|Days 11-20|Adverse Event|0
302582|NCT00833469|993111|P1|Overall Study|Lost to Follow-up|1
302583|NCT00833469|993111|P1|Overall Study|Withdrawal by Subject|1
302584|NCT00833417|993134|P2|Overall Study|Reason Not Specified|1
302585|NCT00833417|993135|P1|Overall Study|Reason Not Specified|0
302586|NCT00833417|993134|P2|Overall Study|Disease Progression|17
302587|NCT00833417|993135|P1|Overall Study|Disease Progression|18
302588|NCT00833417|993134|P2|Overall Study|Sponsor Decision to Terminate Study|2
302589|NCT00833417|993135|P1|Overall Study|Sponsor Decision to Terminate Study|1
302590|NCT00833417|993134|P2|Overall Study|Patient Decision to Withdraw|23
302591|NCT00833417|993135|P1|Overall Study|Patient Decision to Withdraw|4
302592|NCT00833417|993134|P2|Overall Study|Physician Decision to Withdraw Patient|7
302593|NCT00833417|993135|P1|Overall Study|Physician Decision to Withdraw Patient|3
302594|NCT00833417|993134|P2|Overall Study|Lost to Follow-up|2
302595|NCT00833417|993135|P1|Overall Study|Lost to Follow-up|1
302596|NCT00833417|993134|P2|Overall Study|Death|3
302597|NCT00833417|993135|P1|Overall Study|Death|1
302598|NCT00833417|993134|P2|Overall Study|Adverse Event|16
302599|NCT00833417|993135|P1|Overall Study|Adverse Event|5
302600|NCT00833248|993161|P2|Overall Study|Withdrawal by Subject|1
302601|NCT00833248|993162|P1|Overall Study|Withdrawal by Subject|0
302602|NCT00833248|993161|P2|Overall Study|Protocol Violation|2
302603|NCT00833248|993162|P1|Overall Study|Protocol Violation|1
302604|NCT00833248|993161|P2|Overall Study|Adverse Event|0
302605|NCT00833248|993162|P1|Overall Study|Adverse Event|3
302606|NCT00833092|993186|P2|Overall Study|constipation|1
302607|NCT00833092|993187|P1|Overall Study|constipation|0
302608|NCT00833092|993186|P2|Overall Study|Diarrhea|2
302609|NCT00833092|993187|P1|Overall Study|Diarrhea|0
302610|NCT00833092|993186|P2|Overall Study|Protocol Violation|1
302611|NCT00833092|993187|P1|Overall Study|Protocol Violation|2
302612|NCT00833092|993186|P2|Overall Study|Withdrawal by Subject|3
302613|NCT00833092|993187|P1|Overall Study|Withdrawal by Subject|2
302614|NCT00833053|993195|P2|Overall Study|Protocol Violation|1
302615|NCT00833053|993196|P1|Overall Study|Protocol Violation|2
302616|NCT00833053|993195|P2|Overall Study|Withdrawal by Subject|1
302617|NCT00833053|993196|P1|Overall Study|Withdrawal by Subject|0
302618|NCT00833053|993195|P2|Overall Study|Treatment Failure|1
302619|NCT00833053|993196|P1|Overall Study|Treatment Failure|3
302620|NCT00833053|993195|P2|Overall Study|Adverse Event|0
302621|NCT00833053|993196|P1|Overall Study|Adverse Event|4
302622|NCT00833040|993214|P6|Overall Study|Adverse Event|1
302623|NCT00833040|993215|P5|Overall Study|Adverse Event|0
302624|NCT00833040|993216|P4|Overall Study|Adverse Event|0
302625|NCT00833040|993217|P3|Overall Study|Adverse Event|0
302626|NCT00833040|993218|P2|Overall Study|Adverse Event|0
302627|NCT00833040|993219|P1|Overall Study|Adverse Event|0
302628|NCT00833027|993224|P1|Overall Study|Missing|10
302629|NCT00833027|993224|P1|Overall Study|Withdrawal by Subject|16
302630|NCT00833027|993224|P1|Overall Study|Protocol Violation|115
302631|NCT00833027|993224|P1|Overall Study|Lost to Follow-up|24
302632|NCT00833027|993224|P1|Overall Study|Lack of Efficacy|12
302633|NCT00833027|993224|P1|Overall Study|Death|1
302634|NCT00833027|993224|P1|Overall Study|Adverse Event|33
302635|NCT00832975|993229|P1|Overall Study|Other reasons|14
302636|NCT00832975|993229|P1|Overall Study|Withdrawal by Subject|3
302637|NCT00832975|993229|P1|Overall Study|Physician Decision|4
302638|NCT00832975|993229|P1|Overall Study|Death|5
302639|NCT00832975|993229|P1|Overall Study|Protocol Violation|6
302640|NCT00832975|993229|P1|Overall Study|Lost to Follow-up|7
302641|NCT00832819|993243|P3|Overall Study|Protocol Violation|1
302642|NCT00832819|993244|P2|Overall Study|Protocol Violation|0
302643|NCT00832819|993245|P1|Overall Study|Protocol Violation|0
302644|NCT00832819|993243|P3|Overall Study|Adverse Event|0
302645|NCT00832819|993244|P2|Overall Study|Adverse Event|1
302646|NCT00832819|993245|P1|Overall Study|Adverse Event|0
302647|NCT00832650|993254|P3|Overall Study|Randomized but not treated|1
302648|NCT00832650|993255|P2|Overall Study|Randomized but not treated|0
302649|NCT00832650|993256|P1|Overall Study|Randomized but not treated|0
302650|NCT00832624|993296|P1|Overall Study|Study Terminated|10
302651|NCT00832585|993300|P1|Overall Study|Lost to Follow-up|1
302652|NCT00832585|993300|P1|Overall Study|Withdrawal by Subject|1
302653|NCT00832455|993324|P1|Overall Study|Patient moved|1
302654|NCT00832455|993324|P1|Overall Study|No improvement|3
302655|NCT00832455|993324|P1|Overall Study|Parent dissatisfied|1
302656|NCT00832455|993324|P1|Overall Study|Parent misunderstood study|1
302657|NCT00832455|993324|P1|Overall Study|Stopped Medication|4
302658|NCT00832455|993324|P1|Overall Study|Screening Failure|2
302659|NCT00832455|993324|P1|Overall Study|Withdrawal by Subject|17
302660|NCT00832455|993324|P1|Overall Study|Protocol Violation|4
302661|NCT00832455|993324|P1|Overall Study|Lost to Follow-up|26
302662|NCT00832455|993324|P1|Overall Study|Adverse Event|13
302663|NCT00832416|993348|P4|Overall Study|Death|0
302664|NCT00832416|993349|P3|Overall Study|Death|0
302665|NCT00832416|993350|P2|Overall Study|Death|0
302666|NCT00832416|993351|P1|Overall Study|Death|1
302667|NCT00832416|993348|P4|Overall Study|Adverse Event|10
302668|NCT00832416|993349|P3|Overall Study|Adverse Event|41
302669|NCT00832416|993350|P2|Overall Study|Adverse Event|19
302670|NCT00832416|993351|P1|Overall Study|Adverse Event|21
302671|NCT00832416|993348|P4|Overall Study|Administrative|1
302672|NCT00832416|993349|P3|Overall Study|Administrative|0
302673|NCT00832416|993350|P2|Overall Study|Administrative|0
302674|NCT00832416|993351|P1|Overall Study|Administrative|0
302675|NCT00832416|993348|P4|Overall Study|Physician Decision|10
302676|NCT00832416|993349|P3|Overall Study|Physician Decision|5
302677|NCT00832416|993350|P2|Overall Study|Physician Decision|12
302678|NCT00832416|993351|P1|Overall Study|Physician Decision|2
302679|NCT00832416|993348|P4|Overall Study|Withdrawal by Subject|10
302680|NCT00832416|993349|P3|Overall Study|Withdrawal by Subject|2
302681|NCT00832416|993350|P2|Overall Study|Withdrawal by Subject|7
302682|NCT00832416|993351|P1|Overall Study|Withdrawal by Subject|5
302683|NCT00832416|993348|P4|Overall Study|Lack of Efficacy|52
302684|NCT00832416|993349|P3|Overall Study|Lack of Efficacy|13
302685|NCT00832416|993350|P2|Overall Study|Lack of Efficacy|15
302686|NCT00832416|993351|P1|Overall Study|Lack of Efficacy|17
302687|NCT00832377|993402|P1|Overall Study|Protocol Violation|1
302688|NCT00832117|993447|P1|Overall Study|Disease Progression|11
302689|NCT00832117|993447|P1|Overall Study|Death|1
302690|NCT00832091|993466|P2|Overall Study|Prohibited Medication|0
302691|NCT00832091|993467|P1|Overall Study|Prohibited Medication|1
302692|NCT00832091|993466|P2|Overall Study|Withdrawal by Subject|1
302693|NCT00832091|993467|P1|Overall Study|Withdrawal by Subject|2
302694|NCT00832091|993466|P2|Overall Study|Protocol Violation|0
302695|NCT00832091|993467|P1|Overall Study|Protocol Violation|1
302696|NCT00832091|993466|P2|Overall Study|Adverse Event|1
302697|NCT00832091|993467|P1|Overall Study|Adverse Event|1
302698|NCT00832078|993475|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
302699|NCT00832078|993476|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
302700|NCT00832078|993475|P2|Test Day 1-2 Period|Lack of Efficacy|2
302701|NCT00832078|993476|P1|Test Day 1-2 Period|Lack of Efficacy|0
302702|NCT00832000|993482|P2|Overall Study|No calls to IVR in period 2|0
302703|NCT00832000|993483|P1|Overall Study|No calls to IVR in period 2|2
302704|NCT00832000|993482|P2|Overall Study|No calls to IVR in either period|1
302705|NCT00832000|993483|P1|Overall Study|No calls to IVR in either period|1
302706|NCT00832000|993482|P2|Overall Study|Withdrawal by Subject|0
302707|NCT00832000|993483|P1|Overall Study|Withdrawal by Subject|1
302708|NCT00832000|993482|P2|Overall Study|Adverse Event|0
302709|NCT00832000|993483|P1|Overall Study|Adverse Event|2
302710|NCT00831844|993544|P10|Overall Study|Ineligible|0
302711|NCT00831844|993545|P9|Overall Study|Ineligible|0
302712|NCT00831844|993546|P8|Overall Study|Ineligible|0
302713|NCT00831844|993547|P7|Overall Study|Ineligible|0
302714|NCT00831844|993548|P6|Overall Study|Ineligible|0
302715|NCT00831844|993549|P5|Overall Study|Ineligible|1
302716|NCT00831844|993550|P4|Overall Study|Ineligible|0
302717|NCT00831844|993551|P3|Overall Study|Ineligible|1
302718|NCT00831844|993552|P2|Overall Study|Ineligible|1
302719|NCT00831844|993553|P1|Overall Study|Ineligible|0
302720|NCT00831844|993544|P10|Overall Study|Withdrawal by Subject|0
302721|NCT00831844|993545|P9|Overall Study|Withdrawal by Subject|1
302722|NCT00831844|993546|P8|Overall Study|Withdrawal by Subject|1
302723|NCT00831844|993547|P7|Overall Study|Withdrawal by Subject|0
302724|NCT00831844|993548|P6|Overall Study|Withdrawal by Subject|0
302725|NCT00831844|993549|P5|Overall Study|Withdrawal by Subject|0
302726|NCT00831844|993550|P4|Overall Study|Withdrawal by Subject|0
302727|NCT00831844|993551|P3|Overall Study|Withdrawal by Subject|1
302728|NCT00831844|993552|P2|Overall Study|Withdrawal by Subject|0
302729|NCT00831844|993553|P1|Overall Study|Withdrawal by Subject|0
302730|NCT00831844|993544|P10|Overall Study|Physician Decision|0
302731|NCT00831844|993545|P9|Overall Study|Physician Decision|1
302732|NCT00831844|993546|P8|Overall Study|Physician Decision|0
302733|NCT00831844|993547|P7|Overall Study|Physician Decision|0
302734|NCT00831844|993548|P6|Overall Study|Physician Decision|1
302735|NCT00831844|993549|P5|Overall Study|Physician Decision|1
302736|NCT00831844|993550|P4|Overall Study|Physician Decision|1
302737|NCT00831844|993551|P3|Overall Study|Physician Decision|3
302738|NCT00831844|993552|P2|Overall Study|Physician Decision|1
302739|NCT00831844|993553|P1|Overall Study|Physician Decision|0
302740|NCT00831844|993544|P10|Overall Study|Lack of Efficacy|0
302741|NCT00831844|993545|P9|Overall Study|Lack of Efficacy|7
302742|NCT00831844|993546|P8|Overall Study|Lack of Efficacy|9
302743|NCT00831844|993547|P7|Overall Study|Lack of Efficacy|8
302744|NCT00831844|993548|P6|Overall Study|Lack of Efficacy|17
302745|NCT00831844|993549|P5|Overall Study|Lack of Efficacy|11
302746|NCT00831844|993550|P4|Overall Study|Lack of Efficacy|8
302747|NCT00831844|993551|P3|Overall Study|Lack of Efficacy|15
302748|NCT00831844|993552|P2|Overall Study|Lack of Efficacy|10
302749|NCT00831844|993553|P1|Overall Study|Lack of Efficacy|8
302750|NCT00831844|993544|P10|Overall Study|Death|0
302751|NCT00831844|993545|P9|Overall Study|Death|0
302752|NCT00831844|993546|P8|Overall Study|Death|0
302753|NCT00831844|993547|P7|Overall Study|Death|0
302754|NCT00831844|993548|P6|Overall Study|Death|0
302755|NCT00831844|993549|P5|Overall Study|Death|0
302756|NCT00831844|993550|P4|Overall Study|Death|1
302757|NCT00831844|993551|P3|Overall Study|Death|0
302758|NCT00831844|993552|P2|Overall Study|Death|0
302759|NCT00831844|993553|P1|Overall Study|Death|0
302760|NCT00831844|993544|P10|Overall Study|Adverse Event|0
302761|NCT00831844|993545|P9|Overall Study|Adverse Event|0
302762|NCT00831844|993546|P8|Overall Study|Adverse Event|0
302763|NCT00831844|993547|P7|Overall Study|Adverse Event|2
302764|NCT00831844|993548|P6|Overall Study|Adverse Event|1
302765|NCT00831844|993549|P5|Overall Study|Adverse Event|1
302766|NCT00831844|993550|P4|Overall Study|Adverse Event|0
302767|NCT00831844|993551|P3|Overall Study|Adverse Event|0
302768|NCT00831844|993552|P2|Overall Study|Adverse Event|0
302769|NCT00831844|993553|P1|Overall Study|Adverse Event|2
302770|NCT00831779|993577|P2|Overall Study|No longer met criteria|1
302771|NCT00831779|993578|P1|Overall Study|No longer met criteria|0
302772|NCT00831779|993577|P2|Overall Study|Lost to Follow-up|0
302773|NCT00831779|993578|P1|Overall Study|Lost to Follow-up|1
302774|NCT00831701|993612|P2|Overall Study|Lost to Follow-up|3
302775|NCT00831701|993613|P1|Overall Study|Lost to Follow-up|1
302776|NCT00831701|993612|P2|Overall Study|Stone expulsion before first medication|2
302777|NCT00831701|993613|P1|Overall Study|Stone expulsion before first medication|2
302778|NCT00831701|993612|P2|Overall Study|Withdrawal by Subject|0
302779|NCT00831701|993613|P1|Overall Study|Withdrawal by Subject|2
302780|NCT00831493|993642|P1|Overall Study|Intractable nausea and vomiting|1
302781|NCT00831441|993652|P2|Follow Up (30 Days)|missing end of study status|1
302782|NCT00831441|993653|P1|Follow Up (30 Days)|missing end of study status|0
302783|NCT00831441|993652|P2|Follow Up (30 Days)|non-specified|26
302784|NCT00831441|993653|P1|Follow Up (30 Days)|non-specified|16
302785|NCT00831441|993652|P2|Follow Up (30 Days)|Death|86
302786|NCT00831441|993653|P1|Follow Up (30 Days)|Death|63
302787|NCT00831441|993652|P2|Follow Up (30 Days)|Lost to Follow-up|27
302788|NCT00831441|993653|P1|Follow Up (30 Days)|Lost to Follow-up|13
302789|NCT00831441|993652|P2|Follow Up (30 Days)|Withdrawal by Subject|34
302790|NCT00831441|993653|P1|Follow Up (30 Days)|Withdrawal by Subject|41
302791|NCT00831441|993652|P2|Randomized|non-specified|266
302792|NCT00831441|993653|P1|Randomized|non-specified|276
302793|NCT00831441|993652|P2|Randomized|poor/non-compliance|38
302794|NCT00831441|993653|P1|Randomized|poor/non-compliance|30
302795|NCT00831441|993652|P2|Randomized|Administrative reason by sponsor|2671
302796|NCT00831441|993653|P1|Randomized|Administrative reason by sponsor|2780
302797|NCT00831441|993652|P2|Randomized|Lost to Follow-up|35
302798|NCT00831441|993653|P1|Randomized|Lost to Follow-up|26
302799|NCT00831441|993652|P2|Randomized|Withdrawal by Subject|212
302800|NCT00831441|993653|P1|Randomized|Withdrawal by Subject|178
302801|NCT00831441|993652|P2|Randomized|No longer met criteria|19
302802|NCT00831441|993653|P1|Randomized|No longer met criteria|13
302803|NCT00831441|993652|P2|Randomized|Physician Decision|35
302804|NCT00831441|993653|P1|Randomized|Physician Decision|26
302805|NCT00831441|993652|P2|Randomized|Elective procedure|25
302806|NCT00831441|993653|P1|Randomized|Elective procedure|26
302807|NCT00831441|993652|P2|Randomized|Emergency procedure|2
302808|NCT00831441|993653|P1|Randomized|Emergency procedure|2
302809|NCT00831441|993652|P2|Randomized|Adverse Event|321
302810|NCT00831441|993653|P1|Randomized|Adverse Event|248
302811|NCT00831441|993652|P2|Randomized|Death|81
302812|NCT00831441|993653|P1|Randomized|Death|82
302813|NCT00831415|993685|P1|Overall Study|Death|1
302814|NCT00831415|993685|P1|Overall Study|Unsatisfactory response - Efficacy|4
302815|NCT00831415|993685|P1|Overall Study|Withdrawal by Subject|35
302816|NCT00831415|993685|P1|Overall Study|Protocol Violation|3
302817|NCT00831415|993685|P1|Overall Study|Lost to Follow-up|9
302818|NCT00831415|993685|P1|Overall Study|Physician Decision|6
302819|NCT00831415|993685|P1|Overall Study|Failed to return|3
302820|NCT00831415|993685|P1|Overall Study|Adverse Event|14
302821|NCT00831389|993692|P1|Overall Study|Withdrawal by Subject|1
302822|NCT00831311|993718|P2|Overall Study|Withdrawal by Subject|4
302823|NCT00831311|993719|P1|Overall Study|Withdrawal by Subject|6
302824|NCT00831311|993718|P2|Overall Study|Physician Decision|1
302825|NCT00831311|993719|P1|Overall Study|Physician Decision|0
302826|NCT00831311|993718|P2|Overall Study|Lost to Follow-up|0
302827|NCT00831311|993719|P1|Overall Study|Lost to Follow-up|3
302828|NCT00831311|993718|P2|Overall Study|Definitive Contraindication|3
302829|NCT00831311|993719|P1|Overall Study|Definitive Contraindication|3
302830|NCT00831233|993756|P2|Overall Study|Selection Criteria Not Met|0
302831|NCT00831233|993757|P1|Overall Study|Selection Criteria Not Met|2
302832|NCT00831233|993756|P2|Overall Study|Protocol Violation|0
302833|NCT00831233|993757|P1|Overall Study|Protocol Violation|1
302834|NCT00831233|993756|P2|Overall Study|Adverse Event|1
302835|NCT00831233|993757|P1|Overall Study|Adverse Event|0
302836|NCT00831129|993783|P2|Overall Study|9 lost to follow-up reasons uknown|9
302837|NCT00831129|993784|P1|Overall Study|9 lost to follow-up reasons uknown|0
302838|NCT00831129|993783|P2|Overall Study|Adverse Event|1
302839|NCT00831129|993784|P1|Overall Study|Adverse Event|0
302840|NCT00830960|993826|P6|Overall Study|No study drug received|7
302841|NCT00830960|993827|P5|Overall Study|No study drug received|5
302842|NCT00830960|993828|P4|Overall Study|No study drug received|3
302843|NCT00830960|993829|P3|Overall Study|No study drug received|4
302844|NCT00830960|993830|P2|Overall Study|No study drug received|2
302845|NCT00830960|993831|P1|Overall Study|No study drug received|7
302846|NCT00830960|993826|P6|Overall Study|Sponsor Decision|7
302847|NCT00830960|993827|P5|Overall Study|Sponsor Decision|5
302848|NCT00830960|993828|P4|Overall Study|Sponsor Decision|4
302849|NCT00830960|993829|P3|Overall Study|Sponsor Decision|3
302850|NCT00830960|993830|P2|Overall Study|Sponsor Decision|2
302851|NCT00830960|993831|P1|Overall Study|Sponsor Decision|1
302852|NCT00830960|993826|P6|Overall Study|Withdrawal by Subject|21
302853|NCT00830960|993827|P5|Overall Study|Withdrawal by Subject|16
302854|NCT00830960|993828|P4|Overall Study|Withdrawal by Subject|23
302855|NCT00830960|993829|P3|Overall Study|Withdrawal by Subject|18
302856|NCT00830960|993830|P2|Overall Study|Withdrawal by Subject|19
302857|NCT00830960|993831|P1|Overall Study|Withdrawal by Subject|19
302858|NCT00830960|993826|P6|Overall Study|Lost to Follow-up|1
302859|NCT00830960|993827|P5|Overall Study|Lost to Follow-up|0
302860|NCT00830960|993828|P4|Overall Study|Lost to Follow-up|0
302861|NCT00830960|993829|P3|Overall Study|Lost to Follow-up|1
302862|NCT00830960|993830|P2|Overall Study|Lost to Follow-up|1
302863|NCT00830960|993831|P1|Overall Study|Lost to Follow-up|1
302864|NCT00830960|993826|P6|Overall Study|Death|1
302865|NCT00830960|993827|P5|Overall Study|Death|6
302866|NCT00830960|993828|P4|Overall Study|Death|2
302867|NCT00830960|993829|P3|Overall Study|Death|3
302868|NCT00830960|993830|P2|Overall Study|Death|4
302869|NCT00830960|993831|P1|Overall Study|Death|5
302870|NCT00830947|993947|P2|Overall Study|Lost to Follow-up|4
302871|NCT00830947|993948|P1|Overall Study|Lost to Follow-up|4
302872|NCT00830804|993954|P1|Overall Study|Unwilling to adhere to study requirement|1
302873|NCT00830804|993954|P1|Overall Study|Consent withdrawn|2
302874|NCT00830804|993954|P1|Overall Study|Unable to get to clinic|7
302875|NCT00830804|993954|P1|Overall Study|Death|1
302876|NCT00830804|993954|P1|Overall Study|Lost to Follow-up|4
302877|NCT00830765|994034|P2|Overall Study|Protocol Violation|2
302878|NCT00830765|994035|P1|Overall Study|Protocol Violation|3
302879|NCT00830440|994043|P2|Overall Study|Adverse Event|0
302880|NCT00830440|994044|P1|Overall Study|Adverse Event|2
302881|NCT00830440|994043|P2|Overall Study|unsuccessful procedure|0
302882|NCT00830440|994044|P1|Overall Study|unsuccessful procedure|4
302883|NCT00830440|994043|P2|Overall Study|Withdrawal by Subject|0
302884|NCT00830440|994044|P1|Overall Study|Withdrawal by Subject|1
302885|NCT00830440|994043|P2|Overall Study|Protocol Violation|0
302886|NCT00830440|994044|P1|Overall Study|Protocol Violation|1
302887|NCT00830375|994059|P1|Overall Study|Lost to Follow-up|1
302888|NCT00830336|994074|P2|Washout: 21 Days|Withdrawal by Subject|0
302889|NCT00830336|994075|P1|Washout: 21 Days|Withdrawal by Subject|1
302890|NCT00830258|994102|P2|Washout: 7 Days|Protocol Violation|0
302891|NCT00830258|994103|P1|Washout: 7 Days|Protocol Violation|1
302892|NCT00830258|994102|P2|First Intervention|Adverse Event|0
302893|NCT00830258|994103|P1|First Intervention|Adverse Event|1
302894|NCT00830219|994122|P2|Washout of 7 Days|Withdrawal by Subject|1
302895|NCT00830219|994123|P1|Washout of 7 Days|Withdrawal by Subject|1
302896|NCT00830206|994133|P2|Washout: 21 Days|Withdrawal by Subject|1
302897|NCT00830206|994134|P1|Washout: 21 Days|Withdrawal by Subject|1
302898|NCT00830167|994144|P2|Overall Study|Other|2
302899|NCT00830167|994145|P1|Overall Study|Other|2
302900|NCT00830167|994144|P2|Overall Study|Protocol Violation|1
302901|NCT00830167|994145|P1|Overall Study|Protocol Violation|0
302902|NCT00830167|994144|P2|Overall Study|Lost to Follow-up|1
302903|NCT00830167|994145|P1|Overall Study|Lost to Follow-up|0
302904|NCT00830167|994144|P2|Overall Study|Withdrawal by Subject|0
302905|NCT00830167|994145|P1|Overall Study|Withdrawal by Subject|2
302906|NCT00830167|994144|P2|Overall Study|Not meeting entrance criteria|5
302907|NCT00830167|994145|P1|Overall Study|Not meeting entrance criteria|2
302908|NCT00830167|994144|P2|Overall Study|Adverse Event|24
302909|NCT00830167|994145|P1|Overall Study|Adverse Event|8
302910|NCT00830167|994144|P2|Overall Study|Lack of Efficacy|10
302911|NCT00830167|994145|P1|Overall Study|Lack of Efficacy|26
302912|NCT00830128|994215|P1|Overall Study|Operating a vehicle|1
302913|NCT00830128|994215|P1|Overall Study|Work obligation|1
302914|NCT00830128|994215|P1|Overall Study|Relocation|1
302915|NCT00830128|994215|P1|Overall Study|Family obligation|1
302916|NCT00830128|994215|P1|Overall Study|Withdrawal by Subject|2
302917|NCT00830128|994215|P1|Overall Study|Protocol Violation|1
302918|NCT00830128|994215|P1|Overall Study|Lack of Efficacy|7
302919|NCT00830128|994215|P1|Overall Study|Adverse Event|5
302920|NCT00830115|994230|P1|Overall Study|Improvement/recovery|1
302921|NCT00830115|994230|P1|Overall Study|Adverse Event|2
302922|NCT00830037|994257|P2|Overall Study|Active when terminated by DSMB|14
302923|NCT00830037|994258|P1|Overall Study|Active when terminated by DSMB|15
302924|NCT00830037|994257|P2|Overall Study|Lost to Follow-up|2
302925|NCT00830037|994258|P1|Overall Study|Lost to Follow-up|1
302926|NCT00830037|994257|P2|Overall Study|Withdrawal by Subject|3
302927|NCT00830037|994258|P1|Overall Study|Withdrawal by Subject|2
302928|NCT00830024|994268|P2|Washout: 7 Days|Withdrawal by Subject|0
302929|NCT00830024|994269|P1|Washout: 7 Days|Withdrawal by Subject|1
302930|NCT00829998|994279|P2|Washout|Adverse Event|1
302931|NCT00829998|994280|P1|Washout|Adverse Event|0
302932|NCT00829933|994309|P4|Overall Study|withdrew before treatment started|9
302933|NCT00829933|994310|P3|Overall Study|withdrew before treatment started|2
302934|NCT00829933|994311|P2|Overall Study|withdrew before treatment started|1
302935|NCT00829933|994312|P1|Overall Study|withdrew before treatment started|5
302936|NCT00829933|994309|P4|Overall Study|Protocol Violation|0
302937|NCT00829933|994310|P3|Overall Study|Protocol Violation|0
302938|NCT00829933|994311|P2|Overall Study|Protocol Violation|1
302939|NCT00829933|994312|P1|Overall Study|Protocol Violation|2
302940|NCT00829933|994309|P4|Overall Study|Pregnancy|2
302941|NCT00829933|994310|P3|Overall Study|Pregnancy|0
302942|NCT00829933|994311|P2|Overall Study|Pregnancy|0
302943|NCT00829933|994312|P1|Overall Study|Pregnancy|0
302944|NCT00829933|994309|P4|Overall Study|Physician Decision|1
302945|NCT00829933|994310|P3|Overall Study|Physician Decision|8
302946|NCT00829933|994311|P2|Overall Study|Physician Decision|7
302947|NCT00829933|994312|P1|Overall Study|Physician Decision|5
302948|NCT00829933|994309|P4|Overall Study|Lack of Efficacy|0
302949|NCT00829933|994310|P3|Overall Study|Lack of Efficacy|0
302950|NCT00829933|994311|P2|Overall Study|Lack of Efficacy|1
302951|NCT00829933|994312|P1|Overall Study|Lack of Efficacy|0
302952|NCT00829933|994309|P4|Overall Study|Death|1
302953|NCT00829933|994310|P3|Overall Study|Death|1
302954|NCT00829933|994311|P2|Overall Study|Death|0
302955|NCT00829933|994312|P1|Overall Study|Death|0
302956|NCT00829933|994309|P4|Overall Study|Adverse Event|1
302957|NCT00829933|994310|P3|Overall Study|Adverse Event|2
302958|NCT00829933|994311|P2|Overall Study|Adverse Event|3
302959|NCT00829933|994312|P1|Overall Study|Adverse Event|2
302960|NCT00829868|994324|P2|Washout|Physician Decision|0
302961|NCT00829868|994325|P1|Washout|Physician Decision|1
302962|NCT00829829|994336|P3|Overall Study|Other than specified above|1
302963|NCT00829829|994337|P2|Overall Study|Other than specified above|2
302964|NCT00829829|994338|P1|Overall Study|Other than specified above|2
302965|NCT00829829|994336|P3|Overall Study|Lost to Follow-up|3
302966|NCT00829829|994337|P2|Overall Study|Lost to Follow-up|3
302967|NCT00829829|994338|P1|Overall Study|Lost to Follow-up|7
302968|NCT00829829|994336|P3|Overall Study|Decision by the Sponsor|2
302969|NCT00829829|994337|P2|Overall Study|Decision by the Sponsor|0
302970|NCT00829829|994338|P1|Overall Study|Decision by the Sponsor|1
302971|NCT00829829|994336|P3|Overall Study|Withdrawal by Subject|2
302972|NCT00829829|994337|P2|Overall Study|Withdrawal by Subject|4
302973|NCT00829829|994338|P1|Overall Study|Withdrawal by Subject|8
302974|NCT00829829|994336|P3|Overall Study|Adverse Event|3
302975|NCT00829829|994337|P2|Overall Study|Adverse Event|4
302976|NCT00829829|994338|P1|Overall Study|Adverse Event|4
302977|NCT00829829|994336|P3|Overall Study|Protocol Violation|0
302978|NCT00829829|994337|P2|Overall Study|Protocol Violation|3
302979|NCT00829829|994338|P1|Overall Study|Protocol Violation|0
302980|NCT00829790|994363|P2|Washout of 14 Days|Withdrawal by Subject|1
302981|NCT00829790|994364|P1|Washout of 14 Days|Withdrawal by Subject|0
302982|NCT00829764|994374|P2|First Intervention|Withdrawal by Subject|1
302983|NCT00829764|994375|P1|First Intervention|Withdrawal by Subject|1
302984|NCT00829764|994374|P2|First Intervention|Adverse Event|0
302985|NCT00829764|994375|P1|First Intervention|Adverse Event|1
302986|NCT00829712|994401|P2|Washout of 7 Days|Withdrawal by Subject|1
302987|NCT00829712|994402|P1|Washout of 7 Days|Withdrawal by Subject|0
302988|NCT00829673|994421|P2|Washout of 7 Days|Withdrawal by Subject|0
302989|NCT00829673|994422|P1|Washout of 7 Days|Withdrawal by Subject|1
302990|NCT00829621|994432|P2|Overall Study|Lost to Follow-up|4
302991|NCT00829621|994433|P1|Overall Study|Lost to Follow-up|3
302992|NCT00829621|994432|P2|Overall Study|Death|0
302993|NCT00829621|994433|P1|Overall Study|Death|1
302994|NCT00829530|994441|P2|Second Intervention|Intolerance to Venopuncture|0
302995|NCT00829530|994442|P1|Second Intervention|Intolerance to Venopuncture|1
302996|NCT00829530|994441|P2|First Intervention|Intolerance to Venopuncture|1
302997|NCT00829530|994442|P1|First Intervention|Intolerance to Venopuncture|0
302998|NCT00829530|994441|P2|First Intervention|Adverse Event|1
302999|NCT00829530|994442|P1|First Intervention|Adverse Event|0
303000|NCT00829504|994456|P2|Second Intervention|Physician Decision|0
303001|NCT00829504|994457|P1|Second Intervention|Physician Decision|1
303002|NCT00829504|994456|P2|Washout of 7 Days|Withdrawal by Subject|0
303003|NCT00829504|994457|P1|Washout of 7 Days|Withdrawal by Subject|1
303004|NCT00829504|994456|P2|First Intervention|Adverse Event|0
303005|NCT00829504|994457|P1|First Intervention|Adverse Event|1
303006|NCT00829452|994467|P2|Second Intervention|Physician Decision|1
303007|NCT00829452|994468|P1|Second Intervention|Physician Decision|0
303008|NCT00829452|994467|P2|Washout of 42 Days|Withdrawal by Subject|1
303009|NCT00829452|994468|P1|Washout of 42 Days|Withdrawal by Subject|0
303010|NCT00829452|994467|P2|First Intervention|Withdrawal by Subject|1
303011|NCT00829452|994468|P1|First Intervention|Withdrawal by Subject|0
303012|NCT00829439|994480|P4|Overall Study|Adverse Event|0
303013|NCT00829439|994481|P3|Overall Study|Adverse Event|1
303014|NCT00829439|994482|P2|Overall Study|Adverse Event|0
303015|NCT00829439|994483|P1|Overall Study|Adverse Event|0
303016|NCT00829426|994489|P2|Washout: 7 Days|Withdrawal by Subject|0
303017|NCT00829426|994490|P1|Washout: 7 Days|Withdrawal by Subject|1
303018|NCT00829387|994500|P2|Overall Study|Disqualified by PI|0
303019|NCT00829387|994501|P1|Overall Study|Disqualified by PI|1
303020|NCT00829387|994500|P2|Overall Study|Withdrawal by Subject|3
303021|NCT00829387|994501|P1|Overall Study|Withdrawal by Subject|2
303022|NCT00829309|994519|P2|Washout: 7 Days|Protocol Violation|0
303023|NCT00829309|994520|P1|Washout: 7 Days|Protocol Violation|1
303024|NCT00829296|994530|P2|Overall Study|Adverse Event|4
303025|NCT00829296|994531|P1|Overall Study|Adverse Event|5
303026|NCT00829283|994545|P2|Overall Study|Lost to Follow-up|25
303027|NCT00829283|994546|P1|Overall Study|Lost to Follow-up|7
303028|NCT00829244|994556|P2|Overall Study|No embryo cleavage|2
303029|NCT00829244|994557|P1|Overall Study|No embryo cleavage|0
303030|NCT00829244|994556|P2|Overall Study|All embryos discarded|3
303031|NCT00829244|994557|P1|Overall Study|All embryos discarded|0
303032|NCT00829244|994556|P2|Overall Study|No fertilization|2
303033|NCT00829244|994557|P1|Overall Study|No fertilization|2
303034|NCT00829244|994556|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
303035|NCT00829244|994557|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
303036|NCT00829244|994556|P2|Overall Study|Lack of ovarian response to stimulation|5
303037|NCT00829244|994557|P1|Overall Study|Lack of ovarian response to stimulation|9
303038|NCT00829244|994556|P2|Overall Study|Protocol Violation|0
303039|NCT00829244|994557|P1|Overall Study|Protocol Violation|1
303040|NCT00829244|994556|P2|Overall Study|Adverse Event|3
303041|NCT00829244|994557|P1|Overall Study|Adverse Event|1
303042|NCT00829179|994587|P1|Overall Study|Withdrawal by Subject|1
303043|NCT00829166|994593|P2|Overall Study|Reason Not Specified|3
303044|NCT00829166|994594|P1|Overall Study|Reason Not Specified|3
303045|NCT00829166|994593|P2|Overall Study|Sponsor’s Decision|98
303046|NCT00829166|994594|P1|Overall Study|Sponsor’s Decision|137
303047|NCT00829166|994593|P2|Overall Study|Subject's Decision|55
303048|NCT00829166|994594|P1|Overall Study|Subject's Decision|41
303049|NCT00829166|994593|P2|Overall Study|Physician's Decision|3
303050|NCT00829166|994594|P1|Overall Study|Physician's Decision|4
303051|NCT00829166|994593|P2|Overall Study|Lost to Follow-up|4
303052|NCT00829166|994594|P1|Overall Study|Lost to Follow-up|5
303053|NCT00829166|994593|P2|Overall Study|Death|333
303054|NCT00829166|994594|P1|Overall Study|Death|305
303055|NCT00829010|994657|P5|Overall Study|Migrated/Moved from study area|0
303056|NCT00829010|994658|P4|Overall Study|Migrated/Moved from study area|5
303057|NCT00829010|994659|P3|Overall Study|Migrated/Moved from study area|0
303058|NCT00829010|994660|P2|Overall Study|Migrated/Moved from study area|4
303059|NCT00829010|994661|P1|Overall Study|Migrated/Moved from study area|3
303060|NCT00829010|994657|P5|Overall Study|Fatality|0
303061|NCT00829010|994658|P4|Overall Study|Fatality|3
303062|NCT00829010|994659|P3|Overall Study|Fatality|0
303063|NCT00829010|994660|P2|Overall Study|Fatality|4
303064|NCT00829010|994661|P1|Overall Study|Fatality|5
303065|NCT00829010|994657|P5|Overall Study|Lost to Follow-up|0
303066|NCT00829010|994658|P4|Overall Study|Lost to Follow-up|0
303067|NCT00829010|994659|P3|Overall Study|Lost to Follow-up|2
303068|NCT00829010|994660|P2|Overall Study|Lost to Follow-up|0
303069|NCT00829010|994661|P1|Overall Study|Lost to Follow-up|1
303070|NCT00829010|994657|P5|Overall Study|Withdrawal by Subject|2
303071|NCT00829010|994658|P4|Overall Study|Withdrawal by Subject|0
303072|NCT00829010|994659|P3|Overall Study|Withdrawal by Subject|1
303073|NCT00829010|994660|P2|Overall Study|Withdrawal by Subject|1
303074|NCT00829010|994661|P1|Overall Study|Withdrawal by Subject|0
303075|NCT00829010|994657|P5|Overall Study|Adverse Event|0
303076|NCT00829010|994658|P4|Overall Study|Adverse Event|0
303077|NCT00829010|994659|P3|Overall Study|Adverse Event|0
303078|NCT00829010|994660|P2|Overall Study|Adverse Event|0
303079|NCT00829010|994661|P1|Overall Study|Adverse Event|1
303080|NCT00828984|994826|P3|Overall Study|ConMed|1
303081|NCT00828984|994827|P2|Overall Study|ConMed|1
303082|NCT00828984|994828|P1|Overall Study|ConMed|1
303083|NCT00828984|994826|P3|Overall Study|Noncompliant|3
303084|NCT00828984|994827|P2|Overall Study|Noncompliant|2
303085|NCT00828984|994828|P1|Overall Study|Noncompliant|1
303086|NCT00828984|994826|P3|Overall Study|Medical Contraindication|0
303087|NCT00828984|994827|P2|Overall Study|Medical Contraindication|1
303088|NCT00828984|994828|P1|Overall Study|Medical Contraindication|0
303089|NCT00828984|994826|P3|Overall Study|Ineligable|0
303090|NCT00828984|994827|P2|Overall Study|Ineligable|2
303091|NCT00828984|994828|P1|Overall Study|Ineligable|1
303092|NCT00828984|994826|P3|Overall Study|Withdrawal by Subject|4
303093|NCT00828984|994827|P2|Overall Study|Withdrawal by Subject|4
303094|NCT00828984|994828|P1|Overall Study|Withdrawal by Subject|4
303095|NCT00828984|994826|P3|Overall Study|Lost to Follow-up|1
303096|NCT00828984|994827|P2|Overall Study|Lost to Follow-up|3
303097|NCT00828984|994828|P1|Overall Study|Lost to Follow-up|5
303098|NCT00828984|994826|P3|Overall Study|Adverse Event|0
303099|NCT00828984|994827|P2|Overall Study|Adverse Event|3
303100|NCT00828984|994828|P1|Overall Study|Adverse Event|2
303101|NCT00828945|994851|P1|Overall Study|Unspecified|36
303102|NCT00828945|994851|P1|Overall Study|Participant was missing|1
303103|NCT00828945|994851|P1|Overall Study|Death|4
303104|NCT00828750|994883|P1|Overall Study|Normal PC Remained While No Treatment|1
303105|NCT00828750|994883|P1|Overall Study|Lack of Efficacy|3
303106|NCT00828711|994897|P3|Overall Study|Lost to Follow-up|0
303107|NCT00828711|994898|P2|Overall Study|Lost to Follow-up|0
303108|NCT00828711|994899|P1|Overall Study|Lost to Follow-up|1
303109|NCT00828568|994931|P3|Treated - Received at Least One Dose|Protocol Violation|3
303110|NCT00828568|994932|P2|Treated - Received at Least One Dose|Protocol Violation|5
303111|NCT00828568|994933|P1|Treated - Received at Least One Dose|Protocol Violation|9
303112|NCT00828568|994931|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
303113|NCT00828568|994932|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
303114|NCT00828568|994933|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
303115|NCT00828568|994931|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
303116|NCT00828568|994932|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
303117|NCT00828568|994933|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
303118|NCT00828568|994931|P3|Treated - Received at Least One Dose|Adverse Event|1
303119|NCT00828568|994932|P2|Treated - Received at Least One Dose|Adverse Event|8
303120|NCT00828568|994933|P1|Treated - Received at Least One Dose|Adverse Event|11
303121|NCT00828568|994931|P3|Randomized|Withdrawal by Subject|2
303122|NCT00828568|994932|P2|Randomized|Withdrawal by Subject|0
303123|NCT00828568|994933|P1|Randomized|Withdrawal by Subject|1
303124|NCT00828516|994955|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
303125|NCT00828464|994960|P1|Overall Study|Withdrawal by Subject|1
303126|NCT00828321|994997|P2|Second Intervention|Protocol Violation|1
303127|NCT00828321|994998|P1|Second Intervention|Protocol Violation|0
303128|NCT00828321|994997|P2|Washout of 42 Days|Withdrawal by Subject|0
303129|NCT00828321|994998|P1|Washout of 42 Days|Withdrawal by Subject|2
303130|NCT00828204|995027|P2|Extension Study|Physician Decision|2
303131|NCT00828204|995028|P1|Extension Study|Physician Decision|0
303132|NCT00828204|995027|P2|Extension Study|Lost to Follow-up|1
303133|NCT00828204|995028|P1|Extension Study|Lost to Follow-up|0
303134|NCT00828204|995027|P2|Main Study: After Study Restart|Noncompliance|1
303135|NCT00828204|995028|P1|Main Study: After Study Restart|Noncompliance|0
303136|NCT00828204|995027|P2|Main Study: After Study Restart|Adverse Event|2
303137|NCT00828204|995028|P1|Main Study: After Study Restart|Adverse Event|0
303138|NCT00828204|995027|P2|Main Study: Prior to Study Suspension|Study Suspension|0
303139|NCT00828204|995028|P1|Main Study: Prior to Study Suspension|Study Suspension|11
303140|NCT00828204|995027|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
303141|NCT00828204|995028|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
303142|NCT00828204|995027|P2|Main Study: Prior to Study Suspension|Adverse Event|0
303143|NCT00828204|995028|P1|Main Study: Prior to Study Suspension|Adverse Event|1
303144|NCT00828139|995075|P4|Overall Study|Not specified|2
303145|NCT00828139|995076|P3|Overall Study|Not specified|5
303146|NCT00828139|995077|P2|Overall Study|Not specified|2
303147|NCT00828139|995078|P1|Overall Study|Not specified|4
303148|NCT00828139|995075|P4|Overall Study|Disease Progression|39
303149|NCT00828139|995076|P3|Overall Study|Disease Progression|35
303150|NCT00828139|995077|P2|Overall Study|Disease Progression|33
303151|NCT00828139|995078|P1|Overall Study|Disease Progression|24
303152|NCT00828139|995075|P4|Overall Study|Refusal unrelated to toxicity|3
303153|NCT00828139|995076|P3|Overall Study|Refusal unrelated to toxicity|5
303154|NCT00828139|995077|P2|Overall Study|Refusal unrelated to toxicity|4
303155|NCT00828139|995078|P1|Overall Study|Refusal unrelated to toxicity|3
303156|NCT00828139|995075|P4|Overall Study|Death|2
303157|NCT00828139|995076|P3|Overall Study|Death|0
303158|NCT00828139|995077|P2|Overall Study|Death|1
303159|NCT00828139|995078|P1|Overall Study|Death|2
303160|NCT00828139|995075|P4|Overall Study|Adverse Event|5
303161|NCT00828139|995076|P3|Overall Study|Adverse Event|10
303162|NCT00828139|995077|P2|Overall Study|Adverse Event|1
303163|NCT00828139|995078|P1|Overall Study|Adverse Event|8
303164|NCT00828113|995098|P2|Overall Study|Lost to Follow-up|5
303165|NCT00828113|995099|P1|Overall Study|Lost to Follow-up|3
303166|NCT00828113|995098|P2|Overall Study|Withdrawal by Subject|26
303167|NCT00828113|995099|P1|Overall Study|Withdrawal by Subject|27
303168|NCT00827931|995173|P2|Overall Study|Unspecified|0
303169|NCT00827931|995174|P1|Overall Study|Unspecified|1
303170|NCT00827931|995173|P2|Overall Study|Withdrawal by Subject|1
303171|NCT00827931|995174|P1|Overall Study|Withdrawal by Subject|0
303172|NCT00827931|995173|P2|Overall Study|Lost to Follow-up|0
303173|NCT00827931|995174|P1|Overall Study|Lost to Follow-up|1
303174|NCT00827931|995173|P2|Overall Study|Adverse Event|0
303175|NCT00827931|995174|P1|Overall Study|Adverse Event|1
303176|NCT00827931|995173|P2|Overall Study|Death|5
303177|NCT00827931|995174|P1|Overall Study|Death|3
303178|NCT00827918|995195|P3|Overall Study|Withdrawal by Subject|6
303179|NCT00827918|995196|P2|Overall Study|Withdrawal by Subject|2
303180|NCT00827918|995197|P1|Overall Study|Withdrawal by Subject|6
303181|NCT00827918|995195|P3|Overall Study|Protocol Violation|0
303182|NCT00827918|995196|P2|Overall Study|Protocol Violation|1
303183|NCT00827918|995197|P1|Overall Study|Protocol Violation|0
303184|NCT00827918|995195|P3|Overall Study|Progressive Disease|0
303185|NCT00827918|995196|P2|Overall Study|Progressive Disease|1
303186|NCT00827918|995197|P1|Overall Study|Progressive Disease|1
303187|NCT00827918|995195|P3|Overall Study|Pregnancy|0
303188|NCT00827918|995196|P2|Overall Study|Pregnancy|1
303189|NCT00827918|995197|P1|Overall Study|Pregnancy|0
303190|NCT00827918|995195|P3|Overall Study|Physician Decision|0
303191|NCT00827918|995196|P2|Overall Study|Physician Decision|0
303192|NCT00827918|995197|P1|Overall Study|Physician Decision|1
303193|NCT00827918|995195|P3|Overall Study|Lack of Efficacy|15
303194|NCT00827918|995196|P2|Overall Study|Lack of Efficacy|4
303195|NCT00827918|995197|P1|Overall Study|Lack of Efficacy|16
303196|NCT00827918|995195|P3|Overall Study|Adverse Event|0
303197|NCT00827918|995196|P2|Overall Study|Adverse Event|0
303198|NCT00827918|995197|P1|Overall Study|Adverse Event|4
303199|NCT00827827|995225|P2|Overall Study|Burned with water at home|0
303200|NCT00827827|995226|P1|Overall Study|Burned with water at home|1
303201|NCT00827827|995225|P2|Overall Study|Transportation issues|0
303202|NCT00827827|995226|P1|Overall Study|Transportation issues|1
303203|NCT00827827|995225|P2|Overall Study|Gout|0
303204|NCT00827827|995226|P1|Overall Study|Gout|1
303205|NCT00827827|995225|P2|Overall Study|Another cerebrovascular accident (CVA)|0
303206|NCT00827827|995226|P1|Overall Study|Another cerebrovascular accident (CVA)|1
303207|NCT00827827|995225|P2|Overall Study|Fall at home- hospitalization|0
303208|NCT00827827|995226|P1|Overall Study|Fall at home- hospitalization|1
303209|NCT00827827|995225|P2|Overall Study|Lost to Follow-up|0
303210|NCT00827827|995226|P1|Overall Study|Lost to Follow-up|3
303211|NCT00827632|995270|P2|Overall Study|Early withdrawal|11
303212|NCT00827632|995271|P1|Overall Study|Early withdrawal|14
303213|NCT00827632|995270|P2|Overall Study|Lost to Follow-up|12
303214|NCT00827632|995271|P1|Overall Study|Lost to Follow-up|8
303215|NCT00827606|995279|P2|Overall Study|Adverse Event|2
303216|NCT00827606|995280|P1|Overall Study|Adverse Event|4
303217|NCT00827606|995279|P2|Overall Study|LDL below 2.59 mmol/L|12
303218|NCT00827606|995280|P1|Overall Study|LDL below 2.59 mmol/L|4
303219|NCT00827606|995279|P2|Overall Study|Not specified|13
303220|NCT00827606|995280|P1|Overall Study|Not specified|5
303221|NCT00827606|995279|P2|Overall Study|Pregnancy|1
303222|NCT00827606|995280|P1|Overall Study|Pregnancy|0
303223|NCT00827606|995279|P2|Overall Study|Withdrawal by Subject|6
303224|NCT00827606|995280|P1|Overall Study|Withdrawal by Subject|7
303225|NCT00827606|995279|P2|Overall Study|Lost to Follow-up|1
303226|NCT00827606|995280|P1|Overall Study|Lost to Follow-up|3
303227|NCT00827606|995279|P2|Overall Study|Protocol Violation|3
303228|NCT00827606|995280|P1|Overall Study|Protocol Violation|4
303229|NCT00827567|995341|P1|Overall Study|Progression of Disease/Screen Failure|4
303230|NCT00827541|995347|P2|Overall Study|Lack of effectiveness|0
303231|NCT00827541|995348|P1|Overall Study|Lack of effectiveness|1
303232|NCT00827541|995347|P2|Overall Study|Pathogen not susceptible|0
303233|NCT00827541|995348|P1|Overall Study|Pathogen not susceptible|1
303234|NCT00827541|995347|P2|Overall Study|Unspecified|3
303235|NCT00827541|995348|P1|Overall Study|Unspecified|1
303236|NCT00827541|995347|P2|Overall Study|Exitus|8
303237|NCT00827541|995348|P1|Overall Study|Exitus|1
303238|NCT00827502|995360|P1|Overall Study|Withdrawal by Subject|5
303239|NCT00827502|995360|P1|Overall Study|Lost to Follow-up|4
303240|NCT00827502|995360|P1|Overall Study|Adverse Event|1
303241|NCT00827502|995360|P1|Overall Study|randomized but not treated|11
303242|NCT00827372|995366|P1|Overall Study|Lack of Efficacy|3
303243|NCT00827372|995366|P1|Overall Study|Adverse Event|5
303244|NCT00827242|995381|P2|Overall Study|Lack of Efficacy|0
303245|NCT00827242|995382|P1|Overall Study|Lack of Efficacy|1
303246|NCT00827242|995381|P2|Overall Study|Death|0
303247|NCT00827242|995382|P1|Overall Study|Death|1
303248|NCT00827242|995381|P2|Overall Study|Physician Decision|0
303249|NCT00827242|995382|P1|Overall Study|Physician Decision|2
303250|NCT00827242|995381|P2|Overall Study|Entry Criteria Not Met|1
303251|NCT00827242|995382|P1|Overall Study|Entry Criteria Not Met|4
303252|NCT00827242|995381|P2|Overall Study|Adverse Event Excluding Death|1
303253|NCT00827242|995382|P1|Overall Study|Adverse Event Excluding Death|2
303254|NCT00827242|995381|P2|Overall Study|Lost to Follow-up|3
303255|NCT00827242|995382|P1|Overall Study|Lost to Follow-up|0
303256|NCT00827242|995381|P2|Overall Study|Protocol Violation|3
303257|NCT00827242|995382|P1|Overall Study|Protocol Violation|1
303258|NCT00827242|995381|P2|Overall Study|Withdrawal by Subject|4
303259|NCT00827242|995382|P1|Overall Study|Withdrawal by Subject|2
303260|NCT00827112|995420|P2|Overall Study|Unspecified|3
303261|NCT00827112|995421|P1|Overall Study|Unspecified|1
303262|NCT00827112|995420|P2|Overall Study|Randomized but not treated|3
303263|NCT00827112|995421|P1|Overall Study|Randomized but not treated|5
303264|NCT00827112|995420|P2|Overall Study|Withdrawal by Subject|1
303265|NCT00827112|995421|P1|Overall Study|Withdrawal by Subject|2
303266|NCT00827112|995420|P2|Overall Study|Protocol Violation|2
303267|NCT00827112|995421|P1|Overall Study|Protocol Violation|0
303268|NCT00827112|995420|P2|Overall Study|Pregnancy|1
303269|NCT00827112|995421|P1|Overall Study|Pregnancy|0
303270|NCT00827112|995420|P2|Overall Study|Lost to Follow-up|2
303271|NCT00827112|995421|P1|Overall Study|Lost to Follow-up|3
303272|NCT00827112|995420|P2|Overall Study|Lack of Efficacy|0
303273|NCT00827112|995421|P1|Overall Study|Lack of Efficacy|2
303274|NCT00827112|995420|P2|Overall Study|Adverse Event|0
303275|NCT00827112|995421|P1|Overall Study|Adverse Event|2
303276|NCT00826943|995474|P6|Overall Study|Withdrawal by Subject|0
303277|NCT00826943|995475|P5|Overall Study|Withdrawal by Subject|1
303278|NCT00826943|995476|P4|Overall Study|Withdrawal by Subject|0
303279|NCT00826943|995477|P3|Overall Study|Withdrawal by Subject|0
303280|NCT00826943|995478|P2|Overall Study|Withdrawal by Subject|0
303281|NCT00826943|995479|P1|Overall Study|Withdrawal by Subject|0
303282|NCT00826618|995497|P1|Overall Study|Withdrawal by Subject|1
303283|NCT00826540|995501|P1|Overall Study|Withdrawal by Subject|1
303284|NCT00826540|995501|P1|Overall Study|ineligible|3
303285|NCT00826449|995507|P1|Overall Study|Withdrawal by Subject|1
303286|NCT00826449|995507|P1|Overall Study|Disease Progression|4
303287|NCT00826280|995516|P3|Overall Study|One or more non-interpretable scan|1
303288|NCT00826280|995517|P2|Overall Study|One or more non-interpretable scan|1
303289|NCT00826280|995518|P1|Overall Study|One or more non-interpretable scan|0
303290|NCT00826280|995516|P3|Overall Study|Machine Failure|0
303291|NCT00826280|995517|P2|Overall Study|Machine Failure|1
303292|NCT00826280|995518|P1|Overall Study|Machine Failure|1
303293|NCT00826280|995516|P3|Overall Study|Interpretation Failure|0
303294|NCT00826280|995517|P2|Overall Study|Interpretation Failure|0
303295|NCT00826280|995518|P1|Overall Study|Interpretation Failure|1
303296|NCT00826280|995516|P3|Overall Study|Reversible ischemic defect not present|44
303297|NCT00826280|995517|P2|Overall Study|Reversible ischemic defect not present|40
303298|NCT00826280|995518|P1|Overall Study|Reversible ischemic defect not present|43
303299|NCT00826280|995516|P3|Overall Study|Sponsor discontinued subject or study|0
303300|NCT00826280|995517|P2|Overall Study|Sponsor discontinued subject or study|0
303301|NCT00826280|995518|P1|Overall Study|Sponsor discontinued subject or study|1
303302|NCT00826280|995516|P3|Overall Study|Lost to Follow-up|0
303303|NCT00826280|995517|P2|Overall Study|Lost to Follow-up|1
303304|NCT00826280|995518|P1|Overall Study|Lost to Follow-up|0
303305|NCT00826280|995516|P3|Overall Study|Adverse Event|0
303306|NCT00826280|995517|P2|Overall Study|Adverse Event|3
303307|NCT00826280|995518|P1|Overall Study|Adverse Event|1
303308|NCT00826280|995516|P3|Overall Study|Randomized but drug not received|1
303309|NCT00826280|995517|P2|Overall Study|Randomized but drug not received|0
303310|NCT00826280|995518|P1|Overall Study|Randomized but drug not received|1
303311|NCT00826267|995547|P3|Overall Study|Other Adverse Event|0
303312|NCT00826267|995548|P2|Overall Study|Other Adverse Event|0
303313|NCT00826267|995549|P1|Overall Study|Other Adverse Event|1
303314|NCT00826228|995567|P1|Overall Study|Withdrawal by Subject|1
303315|NCT00826176|995589|P2|Overall Study|Administrative|0
303316|NCT00826176|995590|P1|Overall Study|Administrative|9
303317|NCT00826176|995589|P2|Overall Study|Subject Withdrew Consent|0
303318|NCT00826176|995590|P1|Overall Study|Subject Withdrew Consent|3
303319|NCT00826176|995589|P2|Overall Study|Lost to Follow-up|0
303320|NCT00826176|995590|P1|Overall Study|Lost to Follow-up|1
303321|NCT00826111|995602|P2|Overall Study|Physician Decision|1
303322|NCT00826111|995603|P1|Overall Study|Physician Decision|1
303323|NCT00826111|995602|P2|Overall Study|Withdrawal by Subject|0
303324|NCT00826111|995603|P1|Overall Study|Withdrawal by Subject|5
303325|NCT00826111|995602|P2|Overall Study|Protocol Violation|0
303326|NCT00826111|995603|P1|Overall Study|Protocol Violation|1
303327|NCT00826111|995602|P2|Overall Study|Lost to Follow-up|1
303328|NCT00826111|995603|P1|Overall Study|Lost to Follow-up|0
303329|NCT00825994|995633|P1|Overall Study|Placebo Responder at V2|1
303330|NCT00825994|995633|P1|Overall Study|Protocol Violation|1
303331|NCT00825994|995633|P1|Overall Study|Lost to Follow-up|1
303332|NCT00825994|995633|P1|Overall Study|Withdrawal by Subject|2
303333|NCT00825916|995641|P3|Overall Study|Lost to Follow-up|1
303334|NCT00825916|995642|P2|Overall Study|Lost to Follow-up|2
303335|NCT00825916|995643|P1|Overall Study|Lost to Follow-up|4
303336|NCT00825825|995684|P6|Third Medication Period (14 Days)|poor data quality|0
303337|NCT00825825|995685|P5|Third Medication Period (14 Days)|poor data quality|0
303338|NCT00825825|995686|P4|Third Medication Period (14 Days)|poor data quality|0
303339|NCT00825825|995687|P3|Third Medication Period (14 Days)|poor data quality|0
303340|NCT00825825|995688|P2|Third Medication Period (14 Days)|poor data quality|1
303341|NCT00825825|995689|P1|Third Medication Period (14 Days)|poor data quality|0
303342|NCT00825825|995684|P6|Third Medication Period (14 Days)|Protocol Violation|2
303343|NCT00825825|995685|P5|Third Medication Period (14 Days)|Protocol Violation|0
303344|NCT00825825|995686|P4|Third Medication Period (14 Days)|Protocol Violation|0
303345|NCT00825825|995687|P3|Third Medication Period (14 Days)|Protocol Violation|0
303346|NCT00825825|995688|P2|Third Medication Period (14 Days)|Protocol Violation|0
303347|NCT00825825|995689|P1|Third Medication Period (14 Days)|Protocol Violation|0
303348|NCT00825825|995684|P6|Third Medication Period (14 Days)|Adverse Event|0
303349|NCT00825825|995685|P5|Third Medication Period (14 Days)|Adverse Event|0
303350|NCT00825825|995686|P4|Third Medication Period (14 Days)|Adverse Event|0
303351|NCT00825825|995687|P3|Third Medication Period (14 Days)|Adverse Event|0
303352|NCT00825825|995688|P2|Third Medication Period (14 Days)|Adverse Event|1
303353|NCT00825825|995689|P1|Third Medication Period (14 Days)|Adverse Event|0
303354|NCT00825825|995684|P6|Second Medication Period (14 Days)|Protocol Violation|0
303355|NCT00825825|995685|P5|Second Medication Period (14 Days)|Protocol Violation|1
303356|NCT00825825|995686|P4|Second Medication Period (14 Days)|Protocol Violation|0
303357|NCT00825825|995687|P3|Second Medication Period (14 Days)|Protocol Violation|0
303358|NCT00825825|995688|P2|Second Medication Period (14 Days)|Protocol Violation|0
303359|NCT00825825|995689|P1|Second Medication Period (14 Days)|Protocol Violation|1
303360|NCT00825825|995684|P6|Second Medication Period (14 Days)|Physician Decision|0
303361|NCT00825825|995685|P5|Second Medication Period (14 Days)|Physician Decision|0
303362|NCT00825825|995686|P4|Second Medication Period (14 Days)|Physician Decision|2
303363|NCT00825825|995687|P3|Second Medication Period (14 Days)|Physician Decision|0
303364|NCT00825825|995688|P2|Second Medication Period (14 Days)|Physician Decision|0
303365|NCT00825825|995689|P1|Second Medication Period (14 Days)|Physician Decision|1
303366|NCT00825825|995684|P6|First Medication Period (14 Days)|Physician Decision|1
303367|NCT00825825|995685|P5|First Medication Period (14 Days)|Physician Decision|0
303368|NCT00825825|995686|P4|First Medication Period (14 Days)|Physician Decision|0
303369|NCT00825825|995687|P3|First Medication Period (14 Days)|Physician Decision|1
303370|NCT00825825|995688|P2|First Medication Period (14 Days)|Physician Decision|0
303371|NCT00825825|995689|P1|First Medication Period (14 Days)|Physician Decision|2
303372|NCT00825825|995684|P6|First Medication Period (14 Days)|Adverse Event|1
303373|NCT00825825|995685|P5|First Medication Period (14 Days)|Adverse Event|0
303374|NCT00825825|995686|P4|First Medication Period (14 Days)|Adverse Event|0
303375|NCT00825825|995687|P3|First Medication Period (14 Days)|Adverse Event|0
303376|NCT00825825|995688|P2|First Medication Period (14 Days)|Adverse Event|0
303377|NCT00825825|995689|P1|First Medication Period (14 Days)|Adverse Event|1
303378|NCT00825812|995705|P4|Overall Study|Administrative|5
303379|NCT00825812|995706|P3|Overall Study|Administrative|3
303380|NCT00825812|995707|P2|Overall Study|Administrative|1
303381|NCT00825812|995708|P1|Overall Study|Administrative|0
303382|NCT00825812|995705|P4|Overall Study|Non-compliance with protocol|1
303383|NCT00825812|995706|P3|Overall Study|Non-compliance with protocol|0
303384|NCT00825812|995707|P2|Overall Study|Non-compliance with protocol|0
303385|NCT00825812|995708|P1|Overall Study|Non-compliance with protocol|0
303386|NCT00825812|995705|P4|Overall Study|Subject withdrew consent|2
303387|NCT00825812|995706|P3|Overall Study|Subject withdrew consent|3
303388|NCT00825812|995707|P2|Overall Study|Subject withdrew consent|0
303389|NCT00825812|995708|P1|Overall Study|Subject withdrew consent|0
303390|NCT00825812|995705|P4|Overall Study|Adverse Event|1
303391|NCT00825812|995706|P3|Overall Study|Adverse Event|0
303392|NCT00825812|995707|P2|Overall Study|Adverse Event|0
303393|NCT00825812|995708|P1|Overall Study|Adverse Event|0
303394|NCT00825812|995705|P4|Overall Study|Never entered follow up|1
303395|NCT00825812|995706|P3|Overall Study|Never entered follow up|0
303396|NCT00825812|995707|P2|Overall Study|Never entered follow up|0
303397|NCT00825812|995708|P1|Overall Study|Never entered follow up|0
303398|NCT00825682|995755|P2|Overall Study|personal reasons/ inconvenience|5
303399|NCT00825682|995756|P1|Overall Study|personal reasons/ inconvenience|13
303400|NCT00825305|995827|P2|Overall Study|Can not be classified|1
303401|NCT00825305|995828|P1|Overall Study|Can not be classified|0
303402|NCT00825305|995827|P2|Overall Study|Protocol Violation|9
303403|NCT00825305|995828|P1|Overall Study|Protocol Violation|9
303404|NCT00825305|995827|P2|Overall Study|Inappropriate inclusion|0
303405|NCT00825305|995828|P1|Overall Study|Inappropriate inclusion|1
303406|NCT00825305|995827|P2|Overall Study|Withdrawal by Subject|12
303407|NCT00825305|995828|P1|Overall Study|Withdrawal by Subject|6
303408|NCT00825305|995827|P2|Overall Study|Adverse Event|1
303409|NCT00825305|995828|P1|Overall Study|Adverse Event|1
303410|NCT00825175|995864|P2|Overall Study|Withdrawal by Subject|5
303411|NCT00825175|995865|P1|Overall Study|Withdrawal by Subject|0
303412|NCT00825162|995874|P3|Overall Study|Unable to attend the study visit|0
303413|NCT00825162|995875|P2|Overall Study|Unable to attend the study visit|2
303414|NCT00825162|995876|P1|Overall Study|Unable to attend the study visit|5
303415|NCT00825162|995874|P3|Overall Study|Move away from the study area|0
303416|NCT00825162|995875|P2|Overall Study|Move away from the study area|0
303417|NCT00825162|995876|P1|Overall Study|Move away from the study area|1
303418|NCT00825162|995874|P3|Overall Study|Physician Decision|0
303419|NCT00825162|995875|P2|Overall Study|Physician Decision|0
303420|NCT00825162|995876|P1|Overall Study|Physician Decision|2
303421|NCT00825162|995874|P3|Overall Study|Lost to Follow-up|3
303422|NCT00825162|995875|P2|Overall Study|Lost to Follow-up|6
303423|NCT00825162|995876|P1|Overall Study|Lost to Follow-up|9
303424|NCT00825162|995874|P3|Overall Study|Withdrawal by Subject|3
303425|NCT00825162|995875|P2|Overall Study|Withdrawal by Subject|13
303426|NCT00825162|995876|P1|Overall Study|Withdrawal by Subject|11
303427|NCT00824850|995902|P2|Overall Study|Withdrawal by Subject|1
303428|NCT00824850|995903|P1|Overall Study|Withdrawal by Subject|0
303429|NCT00824772|995956|P1|Overall Study|Withdrawal by Subject|8
303430|NCT00824720|995976|P3|Overall Study|Protocol Violation|1
303431|NCT00824720|995977|P2|Overall Study|Protocol Violation|0
303432|NCT00824720|995978|P1|Overall Study|Protocol Violation|0
303433|NCT00824720|995976|P3|Overall Study|failed plug insertion|0
303434|NCT00824720|995977|P2|Overall Study|failed plug insertion|1
303435|NCT00824720|995978|P1|Overall Study|failed plug insertion|3
303436|NCT00824655|995994|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
303437|NCT00824655|995995|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
303438|NCT00824655|995994|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
303439|NCT00824655|995995|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
303440|NCT00824616|996015|P2|Overall Study|Withdrawal by Subject|1
303441|NCT00824616|996016|P1|Overall Study|Withdrawal by Subject|1
303442|NCT00824616|996015|P2|Overall Study|Lost to Follow-up|1
303443|NCT00824616|996016|P1|Overall Study|Lost to Follow-up|0
303444|NCT00824616|996015|P2|Overall Study|Lack of Efficacy|1
303445|NCT00824616|996016|P1|Overall Study|Lack of Efficacy|2
303446|NCT00824616|996015|P2|Overall Study|Hyperglycemia|1
303447|NCT00824616|996016|P1|Overall Study|Hyperglycemia|1
303448|NCT00824616|996015|P2|Overall Study|Creatinine/Creatinine Clearance|2
303449|NCT00824616|996016|P1|Overall Study|Creatinine/Creatinine Clearance|0
303450|NCT00824616|996015|P2|Overall Study|Adverse Event|1
303451|NCT00824616|996016|P1|Overall Study|Adverse Event|2
303452|NCT00824564|996026|P2|Overall Study|Randomized, but not treated|0
303453|NCT00824564|996027|P1|Overall Study|Randomized, but not treated|1
303454|NCT00824564|996026|P2|Overall Study|Unspecified|2
303455|NCT00824564|996027|P1|Overall Study|Unspecified|1
303456|NCT00824564|996026|P2|Overall Study|Withdrawal by Subject|1
303457|NCT00824564|996027|P1|Overall Study|Withdrawal by Subject|1
303458|NCT00824564|996026|P2|Overall Study|Lost to Follow-up|7
303459|NCT00824564|996027|P1|Overall Study|Lost to Follow-up|5
303460|NCT00824473|996104|P2|Overall Study|Other|1
303461|NCT00824473|996105|P1|Overall Study|Other|1
303462|NCT00824473|996104|P2|Overall Study|Withdrawal by Subject|3
303463|NCT00824473|996105|P1|Overall Study|Withdrawal by Subject|2
303464|NCT00824473|996104|P2|Overall Study|Non-Compliance|2
303465|NCT00824473|996105|P1|Overall Study|Non-Compliance|4
303466|NCT00824473|996104|P2|Overall Study|Protocol Violation|0
303467|NCT00824473|996105|P1|Overall Study|Protocol Violation|2
303468|NCT00824473|996104|P2|Overall Study|Lack of Efficacy|2
303469|NCT00824473|996105|P1|Overall Study|Lack of Efficacy|2
303470|NCT00824473|996104|P2|Overall Study|Adverse Event|5
303471|NCT00824473|996105|P1|Overall Study|Adverse Event|4
303472|NCT00824421|996186|P3|Overall Study|Unspecified|0
303473|NCT00824421|996187|P2|Overall Study|Unspecified|1
303474|NCT00824421|996188|P1|Overall Study|Unspecified|0
303475|NCT00824421|996186|P3|Overall Study|Randomized but not Treated|0
303476|NCT00824421|996187|P2|Overall Study|Randomized but not Treated|1
303477|NCT00824421|996188|P1|Overall Study|Randomized but not Treated|1
303478|NCT00824421|996186|P3|Overall Study|Withdrawal by Subject|3
303479|NCT00824421|996187|P2|Overall Study|Withdrawal by Subject|3
303480|NCT00824421|996188|P1|Overall Study|Withdrawal by Subject|2
303481|NCT00824421|996186|P3|Overall Study|Pregnancy|1
303482|NCT00824421|996187|P2|Overall Study|Pregnancy|0
303483|NCT00824421|996188|P1|Overall Study|Pregnancy|1
303484|NCT00824421|996186|P3|Overall Study|Lost to Follow-up|0
303485|NCT00824421|996187|P2|Overall Study|Lost to Follow-up|3
303486|NCT00824421|996188|P1|Overall Study|Lost to Follow-up|2
303487|NCT00824421|996186|P3|Overall Study|Lack of Efficacy|4
303488|NCT00824421|996187|P2|Overall Study|Lack of Efficacy|7
303489|NCT00824421|996188|P1|Overall Study|Lack of Efficacy|5
303490|NCT00824421|996186|P3|Overall Study|Death|0
303491|NCT00824421|996187|P2|Overall Study|Death|1
303492|NCT00824421|996188|P1|Overall Study|Death|0
303493|NCT00824421|996186|P3|Overall Study|Adverse Event|6
303494|NCT00824421|996187|P2|Overall Study|Adverse Event|6
303495|NCT00824421|996188|P1|Overall Study|Adverse Event|6
303496|NCT00824408|996239|P5|Randomized Phase|Other reason not defined above|4
303497|NCT00824408|996240|P4|Randomized Phase|Other reason not defined above|2
303498|NCT00824408|996241|P3|Randomized Phase|Other reason not defined above|4
303499|NCT00824408|996242|P2|Randomized Phase|Other reason not defined above|0
303500|NCT00824408|996243|P1|Randomized Phase|Other reason not defined above|0
303501|NCT00824408|996239|P5|Randomized Phase|Refused to continue medication|2
303502|NCT00824408|996240|P4|Randomized Phase|Refused to continue medication|2
303503|NCT00824408|996241|P3|Randomized Phase|Refused to continue medication|2
303504|NCT00824408|996242|P2|Randomized Phase|Refused to continue medication|0
303505|NCT00824408|996243|P1|Randomized Phase|Refused to continue medication|0
303506|NCT00824408|996239|P5|Randomized Phase|Adverse Event|5
303507|NCT00824408|996240|P4|Randomized Phase|Adverse Event|5
303508|NCT00824408|996241|P3|Randomized Phase|Adverse Event|4
303509|NCT00824408|996242|P2|Randomized Phase|Adverse Event|0
303510|NCT00824408|996243|P1|Randomized Phase|Adverse Event|0
303511|NCT00824408|996239|P5|Randomized Phase|Progressive disease|34
303512|NCT00824408|996240|P4|Randomized Phase|Progressive disease|36
303513|NCT00824408|996241|P3|Randomized Phase|Progressive disease|25
303514|NCT00824408|996242|P2|Randomized Phase|Progressive disease|0
303515|NCT00824408|996243|P1|Randomized Phase|Progressive disease|0
303516|NCT00824408|996239|P5|Randomized Phase|Not treated|1
303517|NCT00824408|996240|P4|Randomized Phase|Not treated|1
303518|NCT00824408|996241|P3|Randomized Phase|Not treated|1
303519|NCT00824408|996242|P2|Randomized Phase|Not treated|0
303520|NCT00824408|996243|P1|Randomized Phase|Not treated|0
303521|NCT00824408|996239|P5|Run-in Phase|Other reason not defined above|0
303522|NCT00824408|996240|P4|Run-in Phase|Other reason not defined above|0
303523|NCT00824408|996241|P3|Run-in Phase|Other reason not defined above|0
303524|NCT00824408|996242|P2|Run-in Phase|Other reason not defined above|1
303525|NCT00824408|996243|P1|Run-in Phase|Other reason not defined above|0
303526|NCT00824408|996239|P5|Run-in Phase|Refused to continue medication|0
303527|NCT00824408|996240|P4|Run-in Phase|Refused to continue medication|0
303528|NCT00824408|996241|P3|Run-in Phase|Refused to continue medication|0
303529|NCT00824408|996242|P2|Run-in Phase|Refused to continue medication|0
303530|NCT00824408|996243|P1|Run-in Phase|Refused to continue medication|1
303531|NCT00824408|996239|P5|Run-in Phase|Adverse Event|0
303532|NCT00824408|996240|P4|Run-in Phase|Adverse Event|0
303533|NCT00824408|996241|P3|Run-in Phase|Adverse Event|0
303534|NCT00824408|996242|P2|Run-in Phase|Adverse Event|1
303535|NCT00824408|996243|P1|Run-in Phase|Adverse Event|1
303536|NCT00824408|996239|P5|Run-in Phase|Progressive disease|0
303537|NCT00824408|996240|P4|Run-in Phase|Progressive disease|0
303538|NCT00824408|996241|P3|Run-in Phase|Progressive disease|0
303539|NCT00824408|996242|P2|Run-in Phase|Progressive disease|4
303540|NCT00824408|996243|P1|Run-in Phase|Progressive disease|4
303541|NCT00824382|996295|P4|Overall Study|Investigator's decision|0
303542|NCT00824382|996296|P3|Overall Study|Investigator's decision|2
303543|NCT00824382|996297|P2|Overall Study|Investigator's decision|1
303544|NCT00824382|996298|P1|Overall Study|Investigator's decision|0
303545|NCT00824382|996295|P4|Overall Study|Protocol Violation|1
303546|NCT00824382|996296|P3|Overall Study|Protocol Violation|0
303547|NCT00824382|996297|P2|Overall Study|Protocol Violation|0
303548|NCT00824382|996298|P1|Overall Study|Protocol Violation|1
303549|NCT00824382|996295|P4|Overall Study|Adverse Event|4
303550|NCT00824382|996296|P3|Overall Study|Adverse Event|1
303551|NCT00824382|996297|P2|Overall Study|Adverse Event|1
303552|NCT00824382|996298|P1|Overall Study|Adverse Event|4
303553|NCT00824369|996374|P6|Overall Study|Lost to Follow-up|0
303554|NCT00824369|996375|P5|Overall Study|Lost to Follow-up|1
303555|NCT00824369|996376|P4|Overall Study|Lost to Follow-up|0
303556|NCT00824369|996377|P3|Overall Study|Lost to Follow-up|0
303557|NCT00824369|996378|P2|Overall Study|Lost to Follow-up|0
303558|NCT00824369|996379|P1|Overall Study|Lost to Follow-up|0
303559|NCT00824369|996374|P6|Overall Study|Nolonger willing to participate in study|1
303560|NCT00824369|996375|P5|Overall Study|Nolonger willing to participate in study|0
303561|NCT00824369|996376|P4|Overall Study|Nolonger willing to participate in study|2
303562|NCT00824369|996377|P3|Overall Study|Nolonger willing to participate in study|1
303563|NCT00824369|996378|P2|Overall Study|Nolonger willing to participate in study|0
303564|NCT00824369|996379|P1|Overall Study|Nolonger willing to participate in study|1
303565|NCT00824291|996419|P2|Overall Study|Participant on prohibited medication|0
303566|NCT00824291|996420|P1|Overall Study|Participant on prohibited medication|1
303567|NCT00824291|996419|P2|Overall Study|Lack of Efficacy|8
303568|NCT00824291|996420|P1|Overall Study|Lack of Efficacy|7
303569|NCT00824291|996419|P2|Overall Study|Withdrawal by Subject|8
303570|NCT00824291|996420|P1|Overall Study|Withdrawal by Subject|14
303571|NCT00824291|996419|P2|Overall Study|Protocol Violation|1
303572|NCT00824291|996420|P1|Overall Study|Protocol Violation|4
303573|NCT00824291|996419|P2|Overall Study|Non-compliance|1
303574|NCT00824291|996420|P1|Overall Study|Non-compliance|1
303575|NCT00824291|996419|P2|Overall Study|Lost to Follow-up|9
303576|NCT00824291|996420|P1|Overall Study|Lost to Follow-up|11
303577|NCT00824291|996419|P2|Overall Study|Discontinuation of Study by Sponsor|2
303578|NCT00824291|996420|P1|Overall Study|Discontinuation of Study by Sponsor|1
303579|NCT00824291|996419|P2|Overall Study|Adverse Event|6
303580|NCT00824291|996420|P1|Overall Study|Adverse Event|15
303581|NCT00824265|996442|P2|Overall Study|Withdrawal by Subject|15
303582|NCT00824265|996443|P1|Overall Study|Withdrawal by Subject|6
303583|NCT00824265|996442|P2|Overall Study|Physician Decision|12
303584|NCT00824265|996443|P1|Overall Study|Physician Decision|6
303585|NCT00824265|996442|P2|Overall Study|Lost to Follow-up|1
303586|NCT00824265|996443|P1|Overall Study|Lost to Follow-up|1
303587|NCT00824265|996442|P2|Overall Study|Protocol Violation|0
303588|NCT00824265|996443|P1|Overall Study|Protocol Violation|1
303589|NCT00824265|996442|P2|Overall Study|Adverse Event,non-fatal|52
303590|NCT00824265|996443|P1|Overall Study|Adverse Event,non-fatal|50
303591|NCT00824161|996502|P1|Overall Study|Screen Failure|1
303592|NCT00824161|996502|P1|Overall Study|Withdrawal by Subject|1
303593|NCT00823264|996532|P2|Overall Study|Protocol Violation|0
303594|NCT00823264|996533|P1|Overall Study|Protocol Violation|2
303595|NCT00823212|996541|P2|Overall Study|Missed 12-month visit|21
303596|NCT00823212|996542|P1|Overall Study|Missed 12-month visit|21
303597|NCT00823212|996541|P2|Overall Study|Incarcerated|1
303598|NCT00823212|996542|P1|Overall Study|Incarcerated|0
303599|NCT00823212|996541|P2|Overall Study|Withdrawal by Subject|1
303600|NCT00823212|996542|P1|Overall Study|Withdrawal by Subject|6
303601|NCT00823212|996541|P2|Overall Study|Death|10
303602|NCT00823212|996542|P1|Overall Study|Death|8
303603|NCT00823199|996624|P1|Overall Study|Withdrawal by Subject|2
303604|NCT00824005|996632|P2|Overall Study|Lost to Follow-up|1
303605|NCT00824005|996633|P1|Overall Study|Lost to Follow-up|0
303606|NCT00824005|996632|P2|Overall Study|Death|1
303607|NCT00824005|996633|P1|Overall Study|Death|0
303608|NCT00823979|996668|P3|Overall Study|Study Terminated by Sponsor|7
303609|NCT00823979|996669|P2|Overall Study|Study Terminated by Sponsor|5
303610|NCT00823979|996670|P1|Overall Study|Study Terminated by Sponsor|5
303611|NCT00823979|996668|P3|Overall Study|Randomized but not Treated|1
303612|NCT00823979|996669|P2|Overall Study|Randomized but not Treated|3
303613|NCT00823979|996670|P1|Overall Study|Randomized but not Treated|4
303614|NCT00823979|996668|P3|Overall Study|Unspecified|1
303615|NCT00823979|996669|P2|Overall Study|Unspecified|0
303616|NCT00823979|996670|P1|Overall Study|Unspecified|2
303617|NCT00823979|996668|P3|Overall Study|Adverse Event|4
303618|NCT00823979|996669|P2|Overall Study|Adverse Event|2
303619|NCT00823979|996670|P1|Overall Study|Adverse Event|0
303620|NCT00823979|996668|P3|Overall Study|Pregnancy|0
303621|NCT00823979|996669|P2|Overall Study|Pregnancy|1
303622|NCT00823979|996670|P1|Overall Study|Pregnancy|0
303623|NCT00823979|996668|P3|Overall Study|Protocol Violation|0
303624|NCT00823979|996669|P2|Overall Study|Protocol Violation|1
303625|NCT00823979|996670|P1|Overall Study|Protocol Violation|1
303626|NCT00823979|996668|P3|Overall Study|Withdrawal by Subject|2
303627|NCT00823979|996669|P2|Overall Study|Withdrawal by Subject|3
303628|NCT00823979|996670|P1|Overall Study|Withdrawal by Subject|2
303629|NCT00823979|996668|P3|Overall Study|Lost to Follow-up|0
303630|NCT00823979|996669|P2|Overall Study|Lost to Follow-up|1
303631|NCT00823979|996670|P1|Overall Study|Lost to Follow-up|2
303632|NCT00823979|996668|P3|Overall Study|Lack of Efficacy|9
303633|NCT00823979|996669|P2|Overall Study|Lack of Efficacy|16
303634|NCT00823979|996670|P1|Overall Study|Lack of Efficacy|13
303635|NCT00823901|996715|P2|Overall Study|Lost to Follow-up|1
303636|NCT00823901|996716|P1|Overall Study|Lost to Follow-up|2
303637|NCT00823901|996715|P2|Overall Study|Lack of Efficacy|0
303638|NCT00823901|996716|P1|Overall Study|Lack of Efficacy|1
303639|NCT00823901|996715|P2|Overall Study|Adverse Event|1
303640|NCT00823901|996716|P1|Overall Study|Adverse Event|1
303641|NCT00823836|996724|P2|Long-term Phase|Withdrawal by Subject|1
303642|NCT00823836|996725|P1|Long-term Phase|Withdrawal by Subject|1
303643|NCT00823836|996724|P2|Long-term Phase|Physician Decision|2
303644|NCT00823836|996725|P1|Long-term Phase|Physician Decision|1
303645|NCT00823836|996724|P2|Long-term Phase|Adverse Event|2
303646|NCT00823836|996725|P1|Long-term Phase|Adverse Event|3
303647|NCT00823836|996724|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
303648|NCT00823836|996725|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
303649|NCT00823836|996724|P2|NV and PR/XR Switching Phases|Physician Decision|2
303650|NCT00823836|996725|P1|NV and PR/XR Switching Phases|Physician Decision|5
303651|NCT00823836|996724|P2|NV and PR/XR Switching Phases|Protocol Violation|1
303652|NCT00823836|996725|P1|NV and PR/XR Switching Phases|Protocol Violation|1
303653|NCT00823836|996724|P2|NV and PR/XR Switching Phases|Adverse Event|21
303654|NCT00823836|996725|P1|NV and PR/XR Switching Phases|Adverse Event|22
303655|NCT00823823|996831|P2|Overall Study|Protocol Violation|5
303656|NCT00823823|996832|P1|Overall Study|Protocol Violation|5
303657|NCT00823823|996831|P2|Overall Study|Lost to Follow-up|1
303658|NCT00823823|996832|P1|Overall Study|Lost to Follow-up|3
303659|NCT00823719|996856|P2|Overall Study|Disease Progression|4
303660|NCT00823719|996857|P1|Overall Study|Disease Progression|4
303661|NCT00823719|996856|P2|Overall Study|Withdrawal by Subject|1
303662|NCT00823719|996857|P1|Overall Study|Withdrawal by Subject|0
303663|NCT00823719|996856|P2|Overall Study|Physician Decision|4
303664|NCT00823719|996857|P1|Overall Study|Physician Decision|1
303665|NCT00823719|996856|P2|Overall Study|Adverse Event|2
303666|NCT00823719|996857|P1|Overall Study|Adverse Event|1
303667|NCT00823615|996910|P2|Period 2|Time/Job Conflict|2
303668|NCT00823615|996911|P1|Period 2|Time/Job Conflict|1
303669|NCT00823615|996910|P2|Period 2|Lost to Follow-up|0
303670|NCT00823615|996911|P1|Period 2|Lost to Follow-up|2
303671|NCT00823472|996921|P2|Overall Study|Physician Decision|28
303672|NCT00823472|996922|P1|Overall Study|Physician Decision|24
303673|NCT00822900|997002|P2|Overall Study|Became a ward of the state|1
303674|NCT00822900|997003|P1|Overall Study|Became a ward of the state|2
303675|NCT00822900|997002|P2|Overall Study|Death|69
303676|NCT00822900|997003|P1|Overall Study|Death|83
303677|NCT00822900|997002|P2|Overall Study|Lost to Follow-up|9
303678|NCT00822900|997003|P1|Overall Study|Lost to Follow-up|9
303679|NCT00822900|997002|P2|Overall Study|Withdrawal by Subject|14
303680|NCT00822900|997003|P1|Overall Study|Withdrawal by Subject|14
303681|NCT00822692|997050|P2|Overall Study|Lost to Follow-up|25
303682|NCT00822692|997051|P1|Overall Study|Lost to Follow-up|17
303683|NCT00822237|997189|P2|Dose 2 Vaccination|Lost to Follow-up|9
303684|NCT00822237|997190|P1|Dose 2 Vaccination|Lost to Follow-up|2
303685|NCT00822237|997189|P2|Dose 2 Vaccination|Withdrawal by Subject|2
303686|NCT00822237|997190|P1|Dose 2 Vaccination|Withdrawal by Subject|2
303687|NCT00822237|997189|P2|Dose 1 Vaccination|Lost to Follow-up|12
303688|NCT00822237|997190|P1|Dose 1 Vaccination|Lost to Follow-up|9
303689|NCT00822237|997189|P2|Dose 1 Vaccination|Withdrawal by Subject|14
303690|NCT00822237|997190|P1|Dose 1 Vaccination|Withdrawal by Subject|13
303691|NCT00822237|997189|P2|Dose 1 Vaccination|Not vaccinated|0
303692|NCT00822237|997190|P1|Dose 1 Vaccination|Not vaccinated|3
303693|NCT00822172|997271|P2|Overall Study|Other|1
303694|NCT00822172|997272|P1|Overall Study|Other|0
303695|NCT00822172|997271|P2|Overall Study|site closed|1
303696|NCT00822172|997272|P1|Overall Study|site closed|0
303697|NCT00822172|997271|P2|Overall Study|Withdrawal by Subject|4
303698|NCT00822172|997272|P1|Overall Study|Withdrawal by Subject|1
303699|NCT00822172|997271|P2|Overall Study|Lost to Follow-up|1
303700|NCT00822172|997272|P1|Overall Study|Lost to Follow-up|3
303701|NCT00822172|997271|P2|Overall Study|Death|0
303702|NCT00822172|997272|P1|Overall Study|Death|1
303703|NCT00822172|997271|P2|Overall Study|Adverse Event|12
303704|NCT00822172|997272|P1|Overall Study|Adverse Event|10
303705|NCT00821873|997289|P1|Overall Study|Lost to Follow-up|4
303706|NCT00821678|997310|P2|Overall Study|Death|2
303707|NCT00821678|997311|P1|Overall Study|Death|0
303708|NCT00821678|997310|P2|Overall Study|Lost to Follow-up|12
303709|NCT00821678|997311|P1|Overall Study|Lost to Follow-up|13
303710|NCT00821678|997310|P2|Overall Study|Withdrawal by Subject|0
303711|NCT00821678|997311|P1|Overall Study|Withdrawal by Subject|8
303712|NCT00821587|997329|P2|Overall Study|Physician Decision|1
303713|NCT00821587|997330|P1|Overall Study|Physician Decision|0
303714|NCT00821509|997339|P3|Overall Study|Withdrawal by Subject|34
303715|NCT00821509|997340|P2|Overall Study|Withdrawal by Subject|11
303716|NCT00821509|997341|P1|Overall Study|Withdrawal by Subject|12
303717|NCT00821431|997354|P2|Overall Study|Physician Decision|1
303718|NCT00821431|997355|P1|Overall Study|Physician Decision|0
303719|NCT00821431|997354|P2|Overall Study|Protocol Violation|1
303720|NCT00821431|997355|P1|Overall Study|Protocol Violation|3
303721|NCT00821431|997354|P2|Overall Study|Lost to Follow-up|0
303722|NCT00821431|997355|P1|Overall Study|Lost to Follow-up|1
303723|NCT00821431|997354|P2|Overall Study|Withdrawal by Subject|0
303724|NCT00821431|997355|P1|Overall Study|Withdrawal by Subject|5
303725|NCT00821431|997354|P2|Overall Study|Adverse Event|3
303726|NCT00821431|997355|P1|Overall Study|Adverse Event|6
303727|NCT00821327|997363|P1|Overall Study|Other/Unknown|5
303728|NCT00821327|997363|P1|Overall Study|Disease Progression|13
303729|NCT00821327|997363|P1|Overall Study|Sponsor Request|1
303730|NCT00821327|997363|P1|Overall Study|Investigator Request|2
303731|NCT00821327|997363|P1|Overall Study|Patient Request|1
303732|NCT00821327|997363|P1|Overall Study|Adverse Event|13
303733|NCT00821236|997372|P1|Overall Study|Lost to Follow-up|3
303734|NCT00821093|997410|P2|Overall Study|Administrative problems|2
303735|NCT00821093|997411|P1|Overall Study|Administrative problems|1
303736|NCT00821093|997410|P2|Overall Study|Abnormal test procedure result(s)|1
303737|NCT00821093|997411|P1|Overall Study|Abnormal test procedure result(s)|1
303738|NCT00821093|997410|P2|Overall Study|Death|1
303739|NCT00821093|997411|P1|Overall Study|Death|2
303740|NCT00821093|997410|P2|Overall Study|Lack of Efficacy|2
303741|NCT00821093|997411|P1|Overall Study|Lack of Efficacy|2
303742|NCT00821093|997410|P2|Overall Study|Abnormal laboratory value(s)|0
303743|NCT00821093|997411|P1|Overall Study|Abnormal laboratory value(s)|2
303744|NCT00821093|997410|P2|Overall Study|Protocol deviation|6
303745|NCT00821093|997411|P1|Overall Study|Protocol deviation|3
303746|NCT00821093|997410|P2|Overall Study|Lost to Follow-up|3
303747|NCT00821093|997411|P1|Overall Study|Lost to Follow-up|9
303748|NCT00821093|997410|P2|Overall Study|Withdrawal by Subject|13
303749|NCT00821093|997411|P1|Overall Study|Withdrawal by Subject|9
303750|NCT00821093|997410|P2|Overall Study|Adverse Event|12
303751|NCT00821093|997411|P1|Overall Study|Adverse Event|20
303752|NCT00820755|997434|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
303753|NCT00820755|997435|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
303754|NCT00820755|997436|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
303755|NCT00820755|997434|P3|Period 1: Combination Therapy Phase|Unspecified|0
303756|NCT00820755|997435|P2|Period 1: Combination Therapy Phase|Unspecified|0
303757|NCT00820755|997436|P1|Period 1: Combination Therapy Phase|Unspecified|11
303758|NCT00820755|997434|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
303759|NCT00820755|997435|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
303760|NCT00820755|997436|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
303761|NCT00820755|997434|P3|Period 1: Combination Therapy Phase|Progressive disease|0
303762|NCT00820755|997435|P2|Period 1: Combination Therapy Phase|Progressive disease|0
303763|NCT00820755|997436|P1|Period 1: Combination Therapy Phase|Progressive disease|114
303764|NCT00820755|997434|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
303765|NCT00820755|997435|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
303766|NCT00820755|997436|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
303767|NCT00820755|997434|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
303768|NCT00820755|997435|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
303769|NCT00820755|997436|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
303770|NCT00820755|997434|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
303771|NCT00820755|997435|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
303772|NCT00820755|997436|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
303773|NCT00820755|997434|P3|Period 1: Combination Therapy Phase|Death|0
303774|NCT00820755|997435|P2|Period 1: Combination Therapy Phase|Death|0
303775|NCT00820755|997436|P1|Period 1: Combination Therapy Phase|Death|28
303776|NCT00820755|997434|P3|Period 1: Combination Therapy Phase|Adverse Event|0
303777|NCT00820755|997435|P2|Period 1: Combination Therapy Phase|Adverse Event|0
303778|NCT00820755|997436|P1|Period 1: Combination Therapy Phase|Adverse Event|77
303779|NCT00820222|997529|P2|Overall Study|Ongoing|191
303780|NCT00820222|997530|P1|Overall Study|Ongoing|185
303781|NCT00820222|997529|P2|Overall Study|Sponsor Terminated Study|1
303782|NCT00820222|997530|P1|Overall Study|Sponsor Terminated Study|0
303783|NCT00820222|997529|P2|Overall Study|Physician Decision|6
303784|NCT00820222|997530|P1|Overall Study|Physician Decision|4
303785|NCT00820222|997529|P2|Overall Study|Withdrawal by Subject|9
303786|NCT00820222|997530|P1|Overall Study|Withdrawal by Subject|8
303787|NCT00820222|997529|P2|Overall Study|Lost to Follow-up|4
303788|NCT00820222|997530|P1|Overall Study|Lost to Follow-up|4
303789|NCT00819156|997597|P6|Overall Study|Prostate-specific antigen progression|0
303790|NCT00819156|997598|P5|Overall Study|Prostate-specific antigen progression|1
303791|NCT00819156|997599|P4|Overall Study|Prostate-specific antigen progression|0
303792|NCT00819156|997600|P3|Overall Study|Prostate-specific antigen progression|0
303793|NCT00819156|997601|P2|Overall Study|Prostate-specific antigen progression|0
303794|NCT00819156|997602|P1|Overall Study|Prostate-specific antigen progression|0
303795|NCT00819156|997597|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
303796|NCT00819156|997598|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
303797|NCT00819156|997599|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
303798|NCT00819156|997600|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
303799|NCT00819156|997601|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
303800|NCT00819156|997602|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
303801|NCT00819156|997597|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
303802|NCT00819156|997598|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
303803|NCT00819156|997599|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
303804|NCT00819156|997600|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
303805|NCT00819156|997601|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
303806|NCT00819156|997602|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
303807|NCT00819156|997597|P6|Overall Study|Lost to Follow-up|2
303808|NCT00819156|997598|P5|Overall Study|Lost to Follow-up|0
303809|NCT00819156|997599|P4|Overall Study|Lost to Follow-up|0
303810|NCT00819156|997600|P3|Overall Study|Lost to Follow-up|0
303811|NCT00819156|997601|P2|Overall Study|Lost to Follow-up|1
303812|NCT00819156|997602|P1|Overall Study|Lost to Follow-up|0
303813|NCT00819156|997597|P6|Overall Study|Protocol Violation|1
303814|NCT00819156|997598|P5|Overall Study|Protocol Violation|0
303815|NCT00819156|997599|P4|Overall Study|Protocol Violation|0
303816|NCT00819156|997600|P3|Overall Study|Protocol Violation|1
303817|NCT00819156|997601|P2|Overall Study|Protocol Violation|0
303818|NCT00819156|997602|P1|Overall Study|Protocol Violation|1
303819|NCT00819156|997597|P6|Overall Study|Withdrawal by Subject|0
303820|NCT00819156|997598|P5|Overall Study|Withdrawal by Subject|1
303821|NCT00819156|997599|P4|Overall Study|Withdrawal by Subject|0
303822|NCT00819156|997600|P3|Overall Study|Withdrawal by Subject|2
303823|NCT00819156|997601|P2|Overall Study|Withdrawal by Subject|3
303824|NCT00819156|997602|P1|Overall Study|Withdrawal by Subject|0
303825|NCT00819156|997597|P6|Overall Study|Adverse Event|3
303826|NCT00819156|997598|P5|Overall Study|Adverse Event|2
303827|NCT00819156|997599|P4|Overall Study|Adverse Event|1
303828|NCT00819156|997600|P3|Overall Study|Adverse Event|2
303829|NCT00819156|997601|P2|Overall Study|Adverse Event|4
303830|NCT00819156|997602|P1|Overall Study|Adverse Event|1
303831|NCT00819910|997698|P4|Overall Study|Lost to Follow-up|0
303832|NCT00819910|997699|P3|Overall Study|Lost to Follow-up|0
303833|NCT00819910|997700|P2|Overall Study|Lost to Follow-up|0
303834|NCT00819910|997701|P1|Overall Study|Lost to Follow-up|1
303835|NCT00819910|997698|P4|Overall Study|Withdrawal by Subject|0
303836|NCT00819910|997699|P3|Overall Study|Withdrawal by Subject|1
303837|NCT00819910|997700|P2|Overall Study|Withdrawal by Subject|1
303838|NCT00819910|997701|P1|Overall Study|Withdrawal by Subject|1
303839|NCT00819910|997698|P4|Overall Study|Adverse Event|1
303840|NCT00819910|997699|P3|Overall Study|Adverse Event|2
303841|NCT00819910|997700|P2|Overall Study|Adverse Event|0
303842|NCT00819910|997701|P1|Overall Study|Adverse Event|0
303843|NCT00819832|997733|P6|Overall Study|Sponsor Termination of Study|0
303844|NCT00819832|997734|P5|Overall Study|Sponsor Termination of Study|0
303845|NCT00819832|997735|P4|Overall Study|Sponsor Termination of Study|0
303846|NCT00819832|997736|P3|Overall Study|Sponsor Termination of Study|0
303847|NCT00819832|997737|P2|Overall Study|Sponsor Termination of Study|0
303848|NCT00819832|997738|P1|Overall Study|Sponsor Termination of Study|3
303849|NCT00819780|997754|P2|Overall Study|Still in treatment|17
303850|NCT00819780|997755|P1|Overall Study|Still in treatment|25
303851|NCT00819780|997754|P2|Overall Study|Did not receive study drug|4
303852|NCT00819780|997755|P1|Overall Study|Did not receive study drug|3
303853|NCT00819767|997789|P2|Overall Study|Unsatisfactory therapeutic effect|2
303854|NCT00819767|997790|P1|Overall Study|Unsatisfactory therapeutic effect|1
303855|NCT00819741|997802|P2|Overall Study|Reasons unknown|3
303856|NCT00819741|997803|P1|Overall Study|Reasons unknown|3
303857|NCT00819741|997802|P2|Overall Study|Unclassified|0
303858|NCT00819741|997803|P1|Overall Study|Unclassified|6
303859|NCT00819741|997802|P2|Overall Study|Withdrawal by Subject|2
303860|NCT00819741|997803|P1|Overall Study|Withdrawal by Subject|2
303861|NCT00819741|997802|P2|Overall Study|Protocol Violation|4
303862|NCT00819741|997803|P1|Overall Study|Protocol Violation|3
303863|NCT00819741|997802|P2|Overall Study|Lost to Follow-up|1
303864|NCT00819741|997803|P1|Overall Study|Lost to Follow-up|3
303865|NCT00819741|997802|P2|Overall Study|Lack of Efficacy|2
303866|NCT00819741|997803|P1|Overall Study|Lack of Efficacy|0
303867|NCT00819741|997802|P2|Overall Study|Adverse Event|2
303868|NCT00819741|997803|P1|Overall Study|Adverse Event|5
303869|NCT00819585|997857|P7|Overall Study|Protocol Violation|3
303870|NCT00819585|997858|P6|Overall Study|Protocol Violation|1
303871|NCT00819585|997859|P5|Overall Study|Protocol Violation|0
303872|NCT00819585|997860|P4|Overall Study|Protocol Violation|0
303873|NCT00819585|997861|P3|Overall Study|Protocol Violation|1
303874|NCT00819585|997862|P2|Overall Study|Protocol Violation|0
303875|NCT00819585|997863|P1|Overall Study|Protocol Violation|0
303876|NCT00819585|997857|P7|Overall Study|Death|1
303877|NCT00819585|997858|P6|Overall Study|Death|0
303878|NCT00819585|997859|P5|Overall Study|Death|0
303879|NCT00819585|997860|P4|Overall Study|Death|0
303880|NCT00819585|997861|P3|Overall Study|Death|0
303881|NCT00819585|997862|P2|Overall Study|Death|0
303882|NCT00819585|997863|P1|Overall Study|Death|0
303883|NCT00819585|997857|P7|Overall Study|Administrative problems|2
303884|NCT00819585|997858|P6|Overall Study|Administrative problems|0
303885|NCT00819585|997859|P5|Overall Study|Administrative problems|0
303886|NCT00819585|997860|P4|Overall Study|Administrative problems|0
303887|NCT00819585|997861|P3|Overall Study|Administrative problems|0
303888|NCT00819585|997862|P2|Overall Study|Administrative problems|0
303889|NCT00819585|997863|P1|Overall Study|Administrative problems|0
303890|NCT00819585|997857|P7|Overall Study|Lost to Follow-up|1
303891|NCT00819585|997858|P6|Overall Study|Lost to Follow-up|1
303892|NCT00819585|997859|P5|Overall Study|Lost to Follow-up|1
303893|NCT00819585|997860|P4|Overall Study|Lost to Follow-up|0
303894|NCT00819585|997861|P3|Overall Study|Lost to Follow-up|2
303895|NCT00819585|997862|P2|Overall Study|Lost to Follow-up|1
303896|NCT00819585|997863|P1|Overall Study|Lost to Follow-up|2
303897|NCT00819585|997857|P7|Overall Study|Subject withdrew consent|3
303898|NCT00819585|997858|P6|Overall Study|Subject withdrew consent|0
303899|NCT00819585|997859|P5|Overall Study|Subject withdrew consent|0
303900|NCT00819585|997860|P4|Overall Study|Subject withdrew consent|1
303901|NCT00819585|997861|P3|Overall Study|Subject withdrew consent|2
303902|NCT00819585|997862|P2|Overall Study|Subject withdrew consent|3
303903|NCT00819585|997863|P1|Overall Study|Subject withdrew consent|0
303904|NCT00819585|997857|P7|Overall Study|Subject no longer requires study drug|0
303905|NCT00819585|997858|P6|Overall Study|Subject no longer requires study drug|0
303906|NCT00819585|997859|P5|Overall Study|Subject no longer requires study drug|1
303907|NCT00819585|997860|P4|Overall Study|Subject no longer requires study drug|0
303908|NCT00819585|997861|P3|Overall Study|Subject no longer requires study drug|0
303909|NCT00819585|997862|P2|Overall Study|Subject no longer requires study drug|0
303910|NCT00819585|997863|P1|Overall Study|Subject no longer requires study drug|0
303911|NCT00819585|997857|P7|Overall Study|Unsatisfactory therapeutic effect|1
303912|NCT00819585|997858|P6|Overall Study|Unsatisfactory therapeutic effect|0
303913|NCT00819585|997859|P5|Overall Study|Unsatisfactory therapeutic effect|0
303914|NCT00819585|997860|P4|Overall Study|Unsatisfactory therapeutic effect|0
303915|NCT00819585|997861|P3|Overall Study|Unsatisfactory therapeutic effect|0
303916|NCT00819585|997862|P2|Overall Study|Unsatisfactory therapeutic effect|1
303917|NCT00819585|997863|P1|Overall Study|Unsatisfactory therapeutic effect|0
303918|NCT00819585|997857|P7|Overall Study|Abnormal laboratory value(s)|0
303919|NCT00819585|997858|P6|Overall Study|Abnormal laboratory value(s)|0
303920|NCT00819585|997859|P5|Overall Study|Abnormal laboratory value(s)|0
303921|NCT00819585|997860|P4|Overall Study|Abnormal laboratory value(s)|0
303922|NCT00819585|997861|P3|Overall Study|Abnormal laboratory value(s)|0
303923|NCT00819585|997862|P2|Overall Study|Abnormal laboratory value(s)|0
303924|NCT00819585|997863|P1|Overall Study|Abnormal laboratory value(s)|2
303925|NCT00819585|997857|P7|Overall Study|Adverse Event|2
303926|NCT00819585|997858|P6|Overall Study|Adverse Event|0
303927|NCT00819585|997859|P5|Overall Study|Adverse Event|1
303928|NCT00819585|997860|P4|Overall Study|Adverse Event|4
303929|NCT00819585|997861|P3|Overall Study|Adverse Event|1
303930|NCT00819585|997862|P2|Overall Study|Adverse Event|1
303931|NCT00819585|997863|P1|Overall Study|Adverse Event|2
303932|NCT00819390|997935|P4|Overall Study|Adverse Event|0
303933|NCT00819390|997936|P3|Overall Study|Adverse Event|1
303934|NCT00819390|997937|P2|Overall Study|Adverse Event|0
303935|NCT00819390|997938|P1|Overall Study|Adverse Event|0
303936|NCT00819390|997935|P4|Overall Study|Withdrawal by Subject|0
303937|NCT00819390|997936|P3|Overall Study|Withdrawal by Subject|0
303938|NCT00819390|997937|P2|Overall Study|Withdrawal by Subject|0
303939|NCT00819390|997938|P1|Overall Study|Withdrawal by Subject|2
303940|NCT00819390|997935|P4|Overall Study|Lost to Follow-up|0
303941|NCT00819390|997936|P3|Overall Study|Lost to Follow-up|0
303942|NCT00819390|997937|P2|Overall Study|Lost to Follow-up|1
303943|NCT00819390|997938|P1|Overall Study|Lost to Follow-up|1
303944|NCT00819247|998074|P3|Overall Study|not specified|0
303945|NCT00819247|998075|P2|Overall Study|not specified|0
303946|NCT00819247|998076|P1|Overall Study|not specified|1
303947|NCT00819247|998074|P3|Overall Study|Bad prostate-specific antigen response|0
303948|NCT00819247|998075|P2|Overall Study|Bad prostate-specific antigen response|2
303949|NCT00819247|998076|P1|Overall Study|Bad prostate-specific antigen response|3
303950|NCT00819247|998074|P3|Overall Study|Mistakenly withdrawn|0
303951|NCT00819247|998075|P2|Overall Study|Mistakenly withdrawn|1
303952|NCT00819247|998076|P1|Overall Study|Mistakenly withdrawn|0
303953|NCT00819247|998074|P3|Overall Study|Protocol Violation|1
303954|NCT00819247|998075|P2|Overall Study|Protocol Violation|0
303955|NCT00819247|998076|P1|Overall Study|Protocol Violation|1
303956|NCT00819247|998074|P3|Overall Study|Withdrawal by Subject|0
303957|NCT00819247|998075|P2|Overall Study|Withdrawal by Subject|0
303958|NCT00819247|998076|P1|Overall Study|Withdrawal by Subject|1
303959|NCT00819247|998074|P3|Overall Study|Insufficient testosterone response|10
303960|NCT00819247|998075|P2|Overall Study|Insufficient testosterone response|8
303961|NCT00819247|998076|P1|Overall Study|Insufficient testosterone response|5
303962|NCT00819247|998074|P3|Overall Study|Adverse Event|3
303963|NCT00819247|998075|P2|Overall Study|Adverse Event|5
303964|NCT00819247|998076|P1|Overall Study|Adverse Event|0
303965|NCT00819234|998102|P10|Overall Study|Lost to Follow-up|2
303966|NCT00819234|998103|P9|Overall Study|Lost to Follow-up|1
303967|NCT00819234|998104|P8|Overall Study|Lost to Follow-up|1
303968|NCT00819234|998105|P7|Overall Study|Lost to Follow-up|1
303969|NCT00819234|998106|P6|Overall Study|Lost to Follow-up|1
303970|NCT00819234|998107|P5|Overall Study|Lost to Follow-up|1
303971|NCT00819234|998108|P4|Overall Study|Lost to Follow-up|2
303972|NCT00819234|998109|P3|Overall Study|Lost to Follow-up|0
303973|NCT00819234|998110|P2|Overall Study|Lost to Follow-up|2
303974|NCT00819234|998111|P1|Overall Study|Lost to Follow-up|2
303975|NCT00819234|998102|P10|Overall Study|Protocol Violation|0
303976|NCT00819234|998103|P9|Overall Study|Protocol Violation|0
303977|NCT00819234|998104|P8|Overall Study|Protocol Violation|0
303978|NCT00819234|998105|P7|Overall Study|Protocol Violation|0
303979|NCT00819234|998106|P6|Overall Study|Protocol Violation|0
303980|NCT00819234|998107|P5|Overall Study|Protocol Violation|0
303981|NCT00819234|998108|P4|Overall Study|Protocol Violation|0
303982|NCT00819234|998109|P3|Overall Study|Protocol Violation|1
303983|NCT00819234|998110|P2|Overall Study|Protocol Violation|0
303984|NCT00819234|998111|P1|Overall Study|Protocol Violation|0
303985|NCT00819234|998102|P10|Overall Study|Physician Decision|2
303986|NCT00819234|998103|P9|Overall Study|Physician Decision|0
303987|NCT00819234|998104|P8|Overall Study|Physician Decision|0
303988|NCT00819234|998105|P7|Overall Study|Physician Decision|0
303989|NCT00819234|998106|P6|Overall Study|Physician Decision|0
303990|NCT00819234|998107|P5|Overall Study|Physician Decision|0
303991|NCT00819234|998108|P4|Overall Study|Physician Decision|1
303992|NCT00819234|998109|P3|Overall Study|Physician Decision|0
303993|NCT00819234|998110|P2|Overall Study|Physician Decision|0
303994|NCT00819234|998111|P1|Overall Study|Physician Decision|0
303995|NCT00819234|998102|P10|Overall Study|Adverse Event|0
303996|NCT00819234|998103|P9|Overall Study|Adverse Event|0
303997|NCT00819234|998104|P8|Overall Study|Adverse Event|0
303998|NCT00819234|998105|P7|Overall Study|Adverse Event|0
303999|NCT00819234|998106|P6|Overall Study|Adverse Event|2
304000|NCT00819234|998107|P5|Overall Study|Adverse Event|0
304001|NCT00819234|998108|P4|Overall Study|Adverse Event|0
304002|NCT00819234|998109|P3|Overall Study|Adverse Event|1
304003|NCT00819234|998110|P2|Overall Study|Adverse Event|0
304004|NCT00819234|998111|P1|Overall Study|Adverse Event|0
304005|NCT00819234|998102|P10|Overall Study|Withdrawal by Subject|3
304006|NCT00819234|998103|P9|Overall Study|Withdrawal by Subject|5
304007|NCT00819234|998104|P8|Overall Study|Withdrawal by Subject|8
304008|NCT00819234|998105|P7|Overall Study|Withdrawal by Subject|4
304009|NCT00819234|998106|P6|Overall Study|Withdrawal by Subject|4
304010|NCT00819234|998107|P5|Overall Study|Withdrawal by Subject|0
304011|NCT00819234|998108|P4|Overall Study|Withdrawal by Subject|3
304012|NCT00819234|998109|P3|Overall Study|Withdrawal by Subject|6
304013|NCT00819234|998110|P2|Overall Study|Withdrawal by Subject|13
304014|NCT00819234|998111|P1|Overall Study|Withdrawal by Subject|8
304015|NCT00819091|998271|P2|Overall Study|Not Specified|2
304016|NCT00819091|998272|P1|Overall Study|Not Specified|1
304017|NCT00819091|998271|P2|Overall Study|Withdrawal by Subject|2
304018|NCT00819091|998272|P1|Overall Study|Withdrawal by Subject|1
304019|NCT00819091|998271|P2|Overall Study|Lost to Follow-up|0
304020|NCT00819091|998272|P1|Overall Study|Lost to Follow-up|2
304021|NCT00819091|998271|P2|Overall Study|Protocol Violation|1
304022|NCT00819091|998272|P1|Overall Study|Protocol Violation|0
304023|NCT00819091|998271|P2|Overall Study|Adverse Event|5
304024|NCT00819091|998272|P1|Overall Study|Adverse Event|3
304025|NCT00819052|998298|P2|Overall Study|Death or events leading to death|0
304026|NCT00819052|998299|P1|Overall Study|Death or events leading to death|1
304027|NCT00819052|998298|P2|Overall Study|Pregnancy|2
304028|NCT00819052|998299|P1|Overall Study|Pregnancy|1
304029|NCT00819052|998298|P2|Overall Study|Lack of Efficacy|1
304030|NCT00819052|998299|P1|Overall Study|Lack of Efficacy|1
304031|NCT00819052|998298|P2|Overall Study|Withdrawal by Subject|2
304032|NCT00819052|998299|P1|Overall Study|Withdrawal by Subject|1
304033|NCT00819052|998298|P2|Overall Study|Lost to Follow-up|2
304034|NCT00819052|998299|P1|Overall Study|Lost to Follow-up|1
304035|NCT00819052|998298|P2|Overall Study|Protocol Violation|2
304036|NCT00819052|998299|P1|Overall Study|Protocol Violation|1
304037|NCT00819052|998298|P2|Overall Study|Adverse Event|5
304038|NCT00819052|998299|P1|Overall Study|Adverse Event|0
304039|NCT00819039|998414|P3|Overall Study|Protocol Violation|0
304040|NCT00819039|998415|P2|Overall Study|Protocol Violation|0
304041|NCT00819039|998416|P1|Overall Study|Protocol Violation|1
304042|NCT00819039|998414|P3|Overall Study|Physician Decision|1
304043|NCT00819039|998415|P2|Overall Study|Physician Decision|0
304044|NCT00819039|998416|P1|Overall Study|Physician Decision|1
304045|NCT00819013|998446|P4|Overall Study|Death|1
304046|NCT00819013|998447|P3|Overall Study|Death|0
304047|NCT00819013|998448|P2|Overall Study|Death|0
304048|NCT00819013|998449|P1|Overall Study|Death|0
304049|NCT00819013|998446|P4|Overall Study|Lost to Follow-up|2
304050|NCT00819013|998447|P3|Overall Study|Lost to Follow-up|1
304051|NCT00819013|998448|P2|Overall Study|Lost to Follow-up|0
304052|NCT00819013|998449|P1|Overall Study|Lost to Follow-up|0
304053|NCT00819013|998446|P4|Overall Study|Withdrawal by Subject|0
304054|NCT00819013|998447|P3|Overall Study|Withdrawal by Subject|1
304055|NCT00819013|998448|P2|Overall Study|Withdrawal by Subject|0
304056|NCT00819013|998449|P1|Overall Study|Withdrawal by Subject|1
304057|NCT00819013|998446|P4|Overall Study|Adverse Event|0
304058|NCT00819013|998447|P3|Overall Study|Adverse Event|1
304059|NCT00819013|998448|P2|Overall Study|Adverse Event|0
304060|NCT00819013|998449|P1|Overall Study|Adverse Event|0
304061|NCT00819013|998446|P4|Overall Study|Not meeting continuing study eligibility|1
304062|NCT00819013|998447|P3|Overall Study|Not meeting continuing study eligibility|2
304063|NCT00819013|998448|P2|Overall Study|Not meeting continuing study eligibility|1
304064|NCT00819013|998449|P1|Overall Study|Not meeting continuing study eligibility|2
304065|NCT00818883|998515|P2|Overall Study|Other|7
304066|NCT00818883|998516|P1|Overall Study|Other|2
304067|NCT00818883|998515|P2|Overall Study|Lack of Efficacy|2
304068|NCT00818883|998516|P1|Overall Study|Lack of Efficacy|0
304069|NCT00818883|998515|P2|Overall Study|Withdrawal by Subject|14
304070|NCT00818883|998516|P1|Overall Study|Withdrawal by Subject|16
304071|NCT00818883|998515|P2|Overall Study|Lost to Follow-up|2
304072|NCT00818883|998516|P1|Overall Study|Lost to Follow-up|3
304073|NCT00818883|998515|P2|Overall Study|Protocol Violation|2
304074|NCT00818883|998516|P1|Overall Study|Protocol Violation|2
304075|NCT00818883|998515|P2|Overall Study|Adverse Event|19
304076|NCT00818883|998516|P1|Overall Study|Adverse Event|28
304077|NCT00818779|998563|P2|Overall Study|Adverse Event|1
304078|NCT00818779|998564|P1|Overall Study|Adverse Event|4
304079|NCT00818779|998563|P2|Overall Study|Lost to Follow-up|0
304080|NCT00818779|998564|P1|Overall Study|Lost to Follow-up|1
304081|NCT00818779|998563|P2|Overall Study|Protocol Violation|0
304082|NCT00818779|998564|P1|Overall Study|Protocol Violation|1
304083|NCT00818766|998572|P2|Overall Study|Did not Receive Allocated Intervention|0
304084|NCT00818766|998573|P1|Overall Study|Did not Receive Allocated Intervention|3
304085|NCT00818766|998572|P2|Overall Study|Death|0
304086|NCT00818766|998573|P1|Overall Study|Death|1
304087|NCT00818766|998572|P2|Overall Study|Could not be Contacted on Day 28|10
304088|NCT00818766|998573|P1|Overall Study|Could not be Contacted on Day 28|11
304089|NCT00818753|998602|P3|Overall Study|Randomised and not treated|0
304090|NCT00818753|998603|P2|Overall Study|Randomised and not treated|0
304091|NCT00818753|998604|P1|Overall Study|Randomised and not treated|2
304092|NCT00818753|998602|P3|Overall Study|Other reason (not specified)|1
304093|NCT00818753|998603|P2|Overall Study|Other reason (not specified)|0
304094|NCT00818753|998604|P1|Overall Study|Other reason (not specified)|0
304095|NCT00818753|998602|P3|Overall Study|Protocol Violation|0
304096|NCT00818753|998603|P2|Overall Study|Protocol Violation|0
304097|NCT00818753|998604|P1|Overall Study|Protocol Violation|1
304098|NCT00818662|998628|P4|Overall Study|Admitted to long term nursing care|0
304099|NCT00818662|998629|P3|Overall Study|Admitted to long term nursing care|0
304100|NCT00818662|998630|P2|Overall Study|Admitted to long term nursing care|1
304101|NCT00818662|998631|P1|Overall Study|Admitted to long term nursing care|0
304102|NCT00818662|998628|P4|Overall Study|Study partner decision|1
304103|NCT00818662|998629|P3|Overall Study|Study partner decision|0
304104|NCT00818662|998630|P2|Overall Study|Study partner decision|0
304105|NCT00818662|998631|P1|Overall Study|Study partner decision|0
304106|NCT00818662|998628|P4|Overall Study|Change in living situation|1
304107|NCT00818662|998629|P3|Overall Study|Change in living situation|0
304108|NCT00818662|998630|P2|Overall Study|Change in living situation|0
304109|NCT00818662|998631|P1|Overall Study|Change in living situation|0
304110|NCT00818662|998628|P4|Overall Study|Declined move to another study site|0
304111|NCT00818662|998629|P3|Overall Study|Declined move to another study site|0
304112|NCT00818662|998630|P2|Overall Study|Declined move to another study site|0
304113|NCT00818662|998631|P1|Overall Study|Declined move to another study site|1
304114|NCT00818662|998628|P4|Overall Study|Moving out of state|1
304115|NCT00818662|998629|P3|Overall Study|Moving out of state|0
304116|NCT00818662|998630|P2|Overall Study|Moving out of state|0
304117|NCT00818662|998631|P1|Overall Study|Moving out of state|0
304118|NCT00818662|998628|P4|Overall Study|Caregiver to pursue other treatment|0
304119|NCT00818662|998629|P3|Overall Study|Caregiver to pursue other treatment|0
304120|NCT00818662|998630|P2|Overall Study|Caregiver to pursue other treatment|1
304121|NCT00818662|998631|P1|Overall Study|Caregiver to pursue other treatment|0
304122|NCT00818662|998628|P4|Overall Study|Participant's health declined|1
304123|NCT00818662|998629|P3|Overall Study|Participant's health declined|0
304124|NCT00818662|998630|P2|Overall Study|Participant's health declined|0
304125|NCT00818662|998631|P1|Overall Study|Participant's health declined|0
304126|NCT00818662|998628|P4|Overall Study|Study Partner Unwilling or Unable|1
304127|NCT00818662|998629|P3|Overall Study|Study Partner Unwilling or Unable|1
304128|NCT00818662|998630|P2|Overall Study|Study Partner Unwilling or Unable|2
304129|NCT00818662|998631|P1|Overall Study|Study Partner Unwilling or Unable|3
304130|NCT00818662|998628|P4|Overall Study|Safety Risk|1
304131|NCT00818662|998629|P3|Overall Study|Safety Risk|0
304132|NCT00818662|998630|P2|Overall Study|Safety Risk|1
304133|NCT00818662|998631|P1|Overall Study|Safety Risk|1
304134|NCT00818662|998628|P4|Overall Study|Requires a Prohibited Medication|0
304135|NCT00818662|998629|P3|Overall Study|Requires a Prohibited Medication|0
304136|NCT00818662|998630|P2|Overall Study|Requires a Prohibited Medication|0
304137|NCT00818662|998631|P1|Overall Study|Requires a Prohibited Medication|1
304138|NCT00818662|998628|P4|Overall Study|Protocol Violation|0
304139|NCT00818662|998629|P3|Overall Study|Protocol Violation|0
304140|NCT00818662|998630|P2|Overall Study|Protocol Violation|1
304141|NCT00818662|998631|P1|Overall Study|Protocol Violation|1
304142|NCT00818662|998628|P4|Overall Study|Unwilling or Unable to Participate|4
304143|NCT00818662|998629|P3|Overall Study|Unwilling or Unable to Participate|2
304144|NCT00818662|998630|P2|Overall Study|Unwilling or Unable to Participate|6
304145|NCT00818662|998631|P1|Overall Study|Unwilling or Unable to Participate|4
304146|NCT00818662|998628|P4|Overall Study|Lost to Follow-up|1
304147|NCT00818662|998629|P3|Overall Study|Lost to Follow-up|0
304148|NCT00818662|998630|P2|Overall Study|Lost to Follow-up|0
304149|NCT00818662|998631|P1|Overall Study|Lost to Follow-up|0
304150|NCT00818662|998628|P4|Overall Study|Physician Decision|0
304151|NCT00818662|998629|P3|Overall Study|Physician Decision|0
304152|NCT00818662|998630|P2|Overall Study|Physician Decision|0
304153|NCT00818662|998631|P1|Overall Study|Physician Decision|1
304154|NCT00818662|998628|P4|Overall Study|Death|0
304155|NCT00818662|998629|P3|Overall Study|Death|0
304156|NCT00818662|998630|P2|Overall Study|Death|3
304157|NCT00818662|998631|P1|Overall Study|Death|1
304158|NCT00818662|998628|P4|Overall Study|Withdrawal by Subject|2
304159|NCT00818662|998629|P3|Overall Study|Withdrawal by Subject|2
304160|NCT00818662|998630|P2|Overall Study|Withdrawal by Subject|4
304161|NCT00818662|998631|P1|Overall Study|Withdrawal by Subject|5
304162|NCT00818662|998628|P4|Overall Study|Adverse Event|3
304163|NCT00818662|998629|P3|Overall Study|Adverse Event|4
304164|NCT00818662|998630|P2|Overall Study|Adverse Event|14
304165|NCT00818662|998631|P1|Overall Study|Adverse Event|5
304166|NCT00818649|998717|P1|Overall Study|Adverse Event|1
304167|NCT00818649|998717|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
304168|NCT00818649|998717|P1|Overall Study|Declining performance status|2
304169|NCT00818623|998731|P8|Overall Study|Disease progression|0
304170|NCT00818623|998732|P7|Overall Study|Disease progression|1
304171|NCT00818623|998733|P6|Overall Study|Disease progression|0
304172|NCT00818623|998734|P5|Overall Study|Disease progression|0
304173|NCT00818623|998735|P4|Overall Study|Disease progression|0
304174|NCT00818623|998736|P3|Overall Study|Disease progression|0
304175|NCT00818623|998737|P2|Overall Study|Disease progression|0
304176|NCT00818623|998738|P1|Overall Study|Disease progression|0
304177|NCT00818623|998731|P8|Overall Study|Lack of trial drug at site|0
304178|NCT00818623|998732|P7|Overall Study|Lack of trial drug at site|1
304179|NCT00818623|998733|P6|Overall Study|Lack of trial drug at site|0
304180|NCT00818623|998734|P5|Overall Study|Lack of trial drug at site|2
304181|NCT00818623|998735|P4|Overall Study|Lack of trial drug at site|0
304182|NCT00818623|998736|P3|Overall Study|Lack of trial drug at site|0
304183|NCT00818623|998737|P2|Overall Study|Lack of trial drug at site|0
304184|NCT00818623|998738|P1|Overall Study|Lack of trial drug at site|0
304185|NCT00818623|998731|P8|Overall Study|Need of additional treatment|0
304186|NCT00818623|998732|P7|Overall Study|Need of additional treatment|0
304187|NCT00818623|998733|P6|Overall Study|Need of additional treatment|0
304188|NCT00818623|998734|P5|Overall Study|Need of additional treatment|1
304189|NCT00818623|998735|P4|Overall Study|Need of additional treatment|0
304190|NCT00818623|998736|P3|Overall Study|Need of additional treatment|0
304191|NCT00818623|998737|P2|Overall Study|Need of additional treatment|0
304192|NCT00818623|998738|P1|Overall Study|Need of additional treatment|0
304193|NCT00818623|998731|P8|Overall Study|Protocol Violation|0
304194|NCT00818623|998732|P7|Overall Study|Protocol Violation|1
304195|NCT00818623|998733|P6|Overall Study|Protocol Violation|0
304196|NCT00818623|998734|P5|Overall Study|Protocol Violation|1
304197|NCT00818623|998735|P4|Overall Study|Protocol Violation|0
304198|NCT00818623|998736|P3|Overall Study|Protocol Violation|0
304199|NCT00818623|998737|P2|Overall Study|Protocol Violation|0
304200|NCT00818623|998738|P1|Overall Study|Protocol Violation|1
304201|NCT00818623|998731|P8|Overall Study|Withdrawal by Subject|1
304202|NCT00818623|998732|P7|Overall Study|Withdrawal by Subject|1
304203|NCT00818623|998733|P6|Overall Study|Withdrawal by Subject|1
304204|NCT00818623|998734|P5|Overall Study|Withdrawal by Subject|0
304205|NCT00818623|998735|P4|Overall Study|Withdrawal by Subject|0
304206|NCT00818623|998736|P3|Overall Study|Withdrawal by Subject|1
304207|NCT00818623|998737|P2|Overall Study|Withdrawal by Subject|1
304208|NCT00818623|998738|P1|Overall Study|Withdrawal by Subject|0
304209|NCT00818623|998731|P8|Overall Study|Bad prostate specific antigen response|0
304210|NCT00818623|998732|P7|Overall Study|Bad prostate specific antigen response|0
304211|NCT00818623|998733|P6|Overall Study|Bad prostate specific antigen response|1
304212|NCT00818623|998734|P5|Overall Study|Bad prostate specific antigen response|0
304213|NCT00818623|998735|P4|Overall Study|Bad prostate specific antigen response|5
304214|NCT00818623|998736|P3|Overall Study|Bad prostate specific antigen response|2
304215|NCT00818623|998737|P2|Overall Study|Bad prostate specific antigen response|3
304216|NCT00818623|998738|P1|Overall Study|Bad prostate specific antigen response|0
304217|NCT00818623|998731|P8|Overall Study|Adverse Event|0
304218|NCT00818623|998732|P7|Overall Study|Adverse Event|0
304219|NCT00818623|998733|P6|Overall Study|Adverse Event|1
304220|NCT00818623|998734|P5|Overall Study|Adverse Event|0
304221|NCT00818623|998735|P4|Overall Study|Adverse Event|0
304222|NCT00818623|998736|P3|Overall Study|Adverse Event|1
304223|NCT00818623|998737|P2|Overall Study|Adverse Event|0
304224|NCT00818623|998738|P1|Overall Study|Adverse Event|1
304225|NCT00818519|998814|P2|Overall Study|participant will leave for long tme|0
304226|NCT00818519|998815|P1|Overall Study|participant will leave for long tme|1
304227|NCT00818519|998814|P2|Overall Study|participant recovered completely|0
304228|NCT00818519|998815|P1|Overall Study|participant recovered completely|1
304229|NCT00818519|998814|P2|Overall Study|Withdrawal by Subject|9
304230|NCT00818519|998815|P1|Overall Study|Withdrawal by Subject|4
304231|NCT00818519|998814|P2|Overall Study|Pregnancy|1
304232|NCT00818519|998815|P1|Overall Study|Pregnancy|0
304233|NCT00818519|998814|P2|Overall Study|Protocol Violation|1
304234|NCT00818519|998815|P1|Overall Study|Protocol Violation|2
304235|NCT00818519|998814|P2|Overall Study|Lost to Follow-up|6
304236|NCT00818519|998815|P1|Overall Study|Lost to Follow-up|4
304237|NCT00818519|998814|P2|Overall Study|Adverse Event|2
304238|NCT00818519|998815|P1|Overall Study|Adverse Event|2
304239|NCT00818454|998845|P4|Treatment Period 3|Adverse Event|1
304240|NCT00818454|998846|P3|Treatment Period 3|Adverse Event|0
304241|NCT00818454|998847|P2|Treatment Period 3|Adverse Event|0
304242|NCT00818454|998848|P1|Treatment Period 3|Adverse Event|0
304243|NCT00818454|998845|P4|Treatment Period 2|not specified|0
304244|NCT00818454|998846|P3|Treatment Period 2|not specified|0
304245|NCT00818454|998847|P2|Treatment Period 2|not specified|1
304246|NCT00818454|998848|P1|Treatment Period 2|not specified|2
304247|NCT00818454|998845|P4|Washout Period of 1 Week|not specified|0
304248|NCT00818454|998846|P3|Washout Period of 1 Week|not specified|0
304249|NCT00818454|998847|P2|Washout Period of 1 Week|not specified|2
304250|NCT00818454|998848|P1|Washout Period of 1 Week|not specified|1
304251|NCT00818454|998845|P4|Washout Period of 1 Week|Protocol Violation|0
304252|NCT00818454|998846|P3|Washout Period of 1 Week|Protocol Violation|0
304253|NCT00818454|998847|P2|Washout Period of 1 Week|Protocol Violation|0
304254|NCT00818454|998848|P1|Washout Period of 1 Week|Protocol Violation|2
304255|NCT00818454|998845|P4|Washout Period of 1 Week|Adverse Event|0
304256|NCT00818454|998846|P3|Washout Period of 1 Week|Adverse Event|0
304257|NCT00818454|998847|P2|Washout Period of 1 Week|Adverse Event|1
304258|NCT00818454|998848|P1|Washout Period of 1 Week|Adverse Event|1
304259|NCT00818454|998845|P4|Treatment Period 1|not specified|0
304260|NCT00818454|998846|P3|Treatment Period 1|not specified|0
304261|NCT00818454|998847|P2|Treatment Period 1|not specified|0
304262|NCT00818454|998848|P1|Treatment Period 1|not specified|3
304263|NCT00818454|998845|P4|Treatment Period 1|Adverse Event|0
304264|NCT00818454|998846|P3|Treatment Period 1|Adverse Event|0
304265|NCT00818454|998847|P2|Treatment Period 1|Adverse Event|1
304266|NCT00818454|998848|P1|Treatment Period 1|Adverse Event|0
304267|NCT00818441|998876|P2|Overall Study|Study terminated by sponsor|2
304268|NCT00818441|998877|P1|Overall Study|Study terminated by sponsor|11
304269|NCT00818441|998876|P2|Overall Study|Adverse Event|1
304270|NCT00818441|998877|P1|Overall Study|Adverse Event|0
304271|NCT00818441|998876|P2|Overall Study|Withdrawal by Subject|0
304272|NCT00818441|998877|P1|Overall Study|Withdrawal by Subject|2
304273|NCT00818441|998876|P2|Overall Study|Lost to Follow-up|1
304274|NCT00818441|998877|P1|Overall Study|Lost to Follow-up|2
304275|NCT00818441|998876|P2|Overall Study|Unspecified|0
304276|NCT00818441|998877|P1|Overall Study|Unspecified|5
304277|NCT00818441|998876|P2|Overall Study|Death|26
304278|NCT00818441|998877|P1|Overall Study|Death|69
304279|NCT00818389|998899|P2|Overall Study|Adverse Event|1
304280|NCT00818389|998900|P1|Overall Study|Adverse Event|0
304281|NCT00818389|998899|P2|Overall Study|Withdrawal by Subject|2
304282|NCT00818389|998900|P1|Overall Study|Withdrawal by Subject|2
304283|NCT00818389|998899|P2|Overall Study|ALS Disease Progression|0
304284|NCT00818389|998900|P1|Overall Study|ALS Disease Progression|1
304285|NCT00818389|998899|P2|Overall Study|Death|3
304286|NCT00818389|998900|P1|Overall Study|Death|1
304287|NCT00818259|998935|P9|Part V|Adverse Event|0
304288|NCT00818259|998936|P8|Part V|Adverse Event|1
304289|NCT00818259|998937|P7|Part V|Adverse Event|0
304290|NCT00818259|998938|P6|Part V|Adverse Event|0
304291|NCT00818259|998939|P5|Part V|Adverse Event|0
304292|NCT00818259|998940|P4|Part V|Adverse Event|0
304293|NCT00818259|998941|P3|Part V|Adverse Event|0
304294|NCT00818259|998942|P2|Part V|Adverse Event|0
304295|NCT00818259|998943|P1|Part V|Adverse Event|0
304296|NCT00818259|998935|P9|Part IV|Physician Decision|0
304297|NCT00818259|998936|P8|Part IV|Physician Decision|0
304298|NCT00818259|998937|P7|Part IV|Physician Decision|0
304299|NCT00818259|998938|P6|Part IV|Physician Decision|1
304300|NCT00818259|998939|P5|Part IV|Physician Decision|0
304301|NCT00818259|998940|P4|Part IV|Physician Decision|0
304302|NCT00818259|998941|P3|Part IV|Physician Decision|0
304303|NCT00818259|998942|P2|Part IV|Physician Decision|0
304304|NCT00818259|998943|P1|Part IV|Physician Decision|0
304305|NCT00818259|998935|P9|Part II|Not Treated|0
304306|NCT00818259|998936|P8|Part II|Not Treated|0
304307|NCT00818259|998937|P7|Part II|Not Treated|0
304308|NCT00818259|998938|P6|Part II|Not Treated|0
304309|NCT00818259|998939|P5|Part II|Not Treated|0
304310|NCT00818259|998940|P4|Part II|Not Treated|1
304311|NCT00818259|998941|P3|Part II|Not Treated|0
304312|NCT00818259|998942|P2|Part II|Not Treated|0
304313|NCT00818259|998943|P1|Part II|Not Treated|0
304314|NCT00818259|998935|P9|Part II|Lack of Efficacy|0
304315|NCT00818259|998936|P8|Part II|Lack of Efficacy|0
304316|NCT00818259|998937|P7|Part II|Lack of Efficacy|0
304317|NCT00818259|998938|P6|Part II|Lack of Efficacy|0
304318|NCT00818259|998939|P5|Part II|Lack of Efficacy|0
304319|NCT00818259|998940|P4|Part II|Lack of Efficacy|1
304320|NCT00818259|998941|P3|Part II|Lack of Efficacy|0
304321|NCT00818259|998942|P2|Part II|Lack of Efficacy|0
304322|NCT00818259|998943|P1|Part II|Lack of Efficacy|0
304323|NCT00818259|998935|P9|Part II|Physician Decision|0
304324|NCT00818259|998936|P8|Part II|Physician Decision|0
304325|NCT00818259|998937|P7|Part II|Physician Decision|0
304326|NCT00818259|998938|P6|Part II|Physician Decision|0
304327|NCT00818259|998939|P5|Part II|Physician Decision|0
304328|NCT00818259|998940|P4|Part II|Physician Decision|0
304329|NCT00818259|998941|P3|Part II|Physician Decision|1
304330|NCT00818259|998942|P2|Part II|Physician Decision|0
304331|NCT00818259|998943|P1|Part II|Physician Decision|0
304332|NCT00818259|998935|P9|Part I|Withdrawal by Subject|0
304333|NCT00818259|998936|P8|Part I|Withdrawal by Subject|0
304334|NCT00818259|998937|P7|Part I|Withdrawal by Subject|0
304335|NCT00818259|998938|P6|Part I|Withdrawal by Subject|0
304336|NCT00818259|998939|P5|Part I|Withdrawal by Subject|0
304337|NCT00818259|998940|P4|Part I|Withdrawal by Subject|0
304338|NCT00818259|998941|P3|Part I|Withdrawal by Subject|0
304339|NCT00818259|998942|P2|Part I|Withdrawal by Subject|0
304340|NCT00818259|998943|P1|Part I|Withdrawal by Subject|1
304341|NCT00818246|999015|P1|Overall Study|Impossible to match pictures|5
304342|NCT00818207|999024|P2|Overall Study|Death|5
304343|NCT00818207|999025|P1|Overall Study|Death|3
304344|NCT00818207|999024|P2|Overall Study|Withdrawal by Subject|104
304345|NCT00818207|999025|P1|Overall Study|Withdrawal by Subject|42
304346|NCT00818207|999024|P2|Overall Study|Multiple reasons|12
304347|NCT00818207|999025|P1|Overall Study|Multiple reasons|11
304348|NCT00818207|999024|P2|Overall Study|Lost to Follow-up|146
304349|NCT00818207|999025|P1|Overall Study|Lost to Follow-up|160
304350|NCT00818207|999024|P2|Overall Study|Adverse Event|0
304351|NCT00818207|999025|P1|Overall Study|Adverse Event|6
304352|NCT00818168|999039|P1|Overall Study|Participant Moved|2
304353|NCT00818168|999039|P1|Overall Study|Reason for Non-completion Not reported|6
304354|NCT00818168|999039|P1|Overall Study|Adverse Event|19
304355|NCT00818168|999039|P1|Overall Study|Lost to Follow-up|7
304356|NCT00818168|999039|P1|Overall Study|Withdrawal by Subject|16
304357|NCT00818168|999039|P1|Overall Study|Pregnancy|2
304358|NCT00818168|999039|P1|Overall Study|Lack of Efficacy|18
304359|NCT00817778|999079|P2|Overall Study|Poor venous access|0
304360|NCT00817778|999080|P1|Overall Study|Poor venous access|1
304361|NCT00817778|999079|P2|Overall Study|Study-specific discontinuation criteria|1
304362|NCT00817778|999080|P1|Overall Study|Study-specific discontinuation criteria|0
304363|NCT00817778|999079|P2|Overall Study|Protocol Violation|1
304364|NCT00817778|999080|P1|Overall Study|Protocol Violation|0
304365|NCT00817778|999079|P2|Overall Study|Withdrawal by Subject|1
304366|NCT00817778|999080|P1|Overall Study|Withdrawal by Subject|1
304367|NCT00817778|999079|P2|Overall Study|Adverse Event|0
304368|NCT00817778|999080|P1|Overall Study|Adverse Event|1
304369|NCT00817531|999105|P1|Overall Study|Lack of Efficacy|1
304370|NCT00817531|999105|P1|Overall Study|Adverse Event|1
304371|NCT00817479|999111|P2|Overall Study|Physician Decision|1
304372|NCT00817479|999112|P1|Overall Study|Physician Decision|1
304373|NCT00817206|999135|P2|Overall Study|Physician Decision|0
304374|NCT00817206|999136|P1|Overall Study|Physician Decision|2
304375|NCT00817206|999135|P2|Overall Study|Withdrawal by Subject|3
304376|NCT00817206|999136|P1|Overall Study|Withdrawal by Subject|7
304377|NCT00817206|999135|P2|Overall Study|Death|0
304378|NCT00817206|999136|P1|Overall Study|Death|2
304379|NCT00817206|999135|P2|Overall Study|Lost to Follow-up|1
304380|NCT00817206|999136|P1|Overall Study|Lost to Follow-up|0
304381|NCT00817206|999135|P2|Overall Study|Protocol Violation|2
304382|NCT00817206|999136|P1|Overall Study|Protocol Violation|0
304383|NCT00817206|999135|P2|Overall Study|Adverse Event|3
304384|NCT00817206|999136|P1|Overall Study|Adverse Event|10
304385|NCT00816595|999203|P2|Overall Study|Withdrawal by Subject|0
304386|NCT00816595|999204|P1|Overall Study|Withdrawal by Subject|2
304387|NCT00816556|999217|P3|Overall Study|Lost to Follow-up|1
304388|NCT00816556|999218|P2|Overall Study|Lost to Follow-up|0
304389|NCT00816556|999219|P1|Overall Study|Lost to Follow-up|0
304390|NCT00816556|999217|P3|Overall Study|Withdrawal by Subject|1
304391|NCT00816556|999218|P2|Overall Study|Withdrawal by Subject|1
304392|NCT00816556|999219|P1|Overall Study|Withdrawal by Subject|1
304393|NCT00816556|999217|P3|Overall Study|Adverse Event|1
304394|NCT00816556|999218|P2|Overall Study|Adverse Event|1
304395|NCT00816556|999219|P1|Overall Study|Adverse Event|1
304396|NCT00816400|999242|P9|Overall Study|In hospice care at the end of the study|0
304397|NCT00816400|999243|P8|Overall Study|In hospice care at the end of the study|0
304398|NCT00816400|999244|P7|Overall Study|In hospice care at the end of the study|0
304399|NCT00816400|999245|P6|Overall Study|In hospice care at the end of the study|0
304400|NCT00816400|999246|P5|Overall Study|In hospice care at the end of the study|0
304401|NCT00816400|999247|P4|Overall Study|In hospice care at the end of the study|0
304402|NCT00816400|999248|P3|Overall Study|In hospice care at the end of the study|2
304403|NCT00816400|999249|P2|Overall Study|In hospice care at the end of the study|0
304404|NCT00816400|999250|P1|Overall Study|In hospice care at the end of the study|0
304405|NCT00816400|999242|P9|Overall Study|Death|6
304406|NCT00816400|999243|P8|Overall Study|Death|5
304407|NCT00816400|999244|P7|Overall Study|Death|2
304408|NCT00816400|999245|P6|Overall Study|Death|3
304409|NCT00816400|999246|P5|Overall Study|Death|2
304410|NCT00816400|999247|P4|Overall Study|Death|3
304411|NCT00816400|999248|P3|Overall Study|Death|3
304412|NCT00816400|999249|P2|Overall Study|Death|3
304413|NCT00816400|999250|P1|Overall Study|Death|2
304414|NCT00816166|999440|P2|Overall Study|Death|2
304415|NCT00816166|999441|P1|Overall Study|Death|4
304416|NCT00816166|999440|P2|Overall Study|Lost to Follow-up|10
304417|NCT00816166|999441|P1|Overall Study|Lost to Follow-up|6
304418|NCT00816036|999468|P2|Overall Study|Withdrawal by Subject|23
304419|NCT00816036|999469|P1|Overall Study|Withdrawal by Subject|54
304420|NCT00816036|999468|P2|Overall Study|Lost to Follow-up|57
304421|NCT00816036|999469|P1|Overall Study|Lost to Follow-up|75
304422|NCT00816036|999468|P2|Overall Study|Death|28
304423|NCT00816036|999469|P1|Overall Study|Death|47
304424|NCT00816023|999483|P4|Overall Study|Randomized Not Treated|11
304425|NCT00816023|999484|P3|Overall Study|Randomized Not Treated|6
304426|NCT00816023|999485|P2|Overall Study|Randomized Not Treated|4
304427|NCT00816023|999486|P1|Overall Study|Randomized Not Treated|6
304428|NCT00816023|999483|P4|Overall Study|assessments complete prior to window|1
304429|NCT00816023|999484|P3|Overall Study|assessments complete prior to window|2
304430|NCT00816023|999485|P2|Overall Study|assessments complete prior to window|1
304431|NCT00816023|999486|P1|Overall Study|assessments complete prior to window|1
304432|NCT00816023|999483|P4|Overall Study|Physician Decision|0
304433|NCT00816023|999484|P3|Overall Study|Physician Decision|1
304434|NCT00816023|999485|P2|Overall Study|Physician Decision|0
304435|NCT00816023|999486|P1|Overall Study|Physician Decision|0
304436|NCT00816023|999483|P4|Overall Study|Withdrawal by Subject|0
304437|NCT00816023|999484|P3|Overall Study|Withdrawal by Subject|0
304438|NCT00816023|999485|P2|Overall Study|Withdrawal by Subject|0
304439|NCT00816023|999486|P1|Overall Study|Withdrawal by Subject|1
304440|NCT00816023|999483|P4|Overall Study|Lost to Follow-up|0
304441|NCT00816023|999484|P3|Overall Study|Lost to Follow-up|0
304442|NCT00816023|999485|P2|Overall Study|Lost to Follow-up|1
304443|NCT00816023|999486|P1|Overall Study|Lost to Follow-up|1
304444|NCT00815919|999500|P1|Overall Study|Lack of Efficacy|2
304445|NCT00815919|999500|P1|Overall Study|AML Relapse|1
304446|NCT00815919|999500|P1|Overall Study|Unrelated Fungal Infection|1
304447|NCT00815659|999543|P1|Overall Study|Protocol Violation|1
304448|NCT00815659|999543|P1|Overall Study|Lost to Follow-up|4
304449|NCT00815659|999543|P1|Overall Study|Withdrawal by Subject|9
304450|NCT00815659|999543|P1|Overall Study|Adverse Event|9
304451|NCT00815516|999588|P2|Overall Study|Physician Decision|0
304452|NCT00815516|999589|P1|Overall Study|Physician Decision|1
304453|NCT00815516|999588|P2|Overall Study|Death|1
304454|NCT00815516|999589|P1|Overall Study|Death|3
304455|NCT00815308|999654|P1|Overall Study|Protocol Violation|6
304456|NCT00815308|999654|P1|Overall Study|Withdrawal by Subject|0
304457|NCT00815308|999654|P1|Overall Study|Adverse Event|4
304458|NCT00815295|999663|P3|Overall Study|Cetuximab hypersensitivity reaction|3
304459|NCT00815295|999664|P2|Overall Study|Cetuximab hypersensitivity reaction|1
304460|NCT00815295|999665|P1|Overall Study|Cetuximab hypersensitivity reaction|0
304461|NCT00815191|999677|P2|Overall Study|Protocol Violation|1
304462|NCT00815191|999678|P1|Overall Study|Protocol Violation|1
304463|NCT00814983|999715|P2|Overall Study|Graft failure|0
304464|NCT00814983|999716|P1|Overall Study|Graft failure|1
304465|NCT00814983|999715|P2|Overall Study|Withdrawal by Subject|0
304466|NCT00814983|999716|P1|Overall Study|Withdrawal by Subject|1
304467|NCT00814983|999715|P2|Overall Study|Screen failure|0
304468|NCT00814983|999716|P1|Overall Study|Screen failure|1
304469|NCT00814892|999747|P1|Overall Study|Study Termination|1
304470|NCT00814892|999747|P1|Overall Study|Disease Progression|1
304471|NCT00814879|999759|P2|By Week 48|Death|1
304472|NCT00814879|999760|P1|By Week 48|Death|0
304473|NCT00814879|999759|P2|By Week 48|Lost to Follow-up|2
304474|NCT00814879|999760|P1|By Week 48|Lost to Follow-up|2
304475|NCT00814879|999759|P2|By Week 24|Incarceration|1
304476|NCT00814879|999760|P1|By Week 24|Incarceration|0
304477|NCT00814879|999759|P2|By Week 24|Cancer Diagnosis|0
304478|NCT00814879|999760|P1|By Week 24|Cancer Diagnosis|1
304479|NCT00814801|999779|P3|Overall Study|Not specified|4
304480|NCT00814801|999780|P2|Overall Study|Not specified|6
304481|NCT00814801|999781|P1|Overall Study|Not specified|2
304482|NCT00814801|999779|P3|Overall Study|Non-compliance|1
304483|NCT00814801|999780|P2|Overall Study|Non-compliance|1
304484|NCT00814801|999781|P1|Overall Study|Non-compliance|0
304485|NCT00814801|999779|P3|Overall Study|Missing or change of caregiver|4
304486|NCT00814801|999780|P2|Overall Study|Missing or change of caregiver|2
304487|NCT00814801|999781|P1|Overall Study|Missing or change of caregiver|6
304488|NCT00814801|999779|P3|Overall Study|Change of patients for CIBIC plus-J|0
304489|NCT00814801|999780|P2|Overall Study|Change of patients for CIBIC plus-J|1
304490|NCT00814801|999781|P1|Overall Study|Change of patients for CIBIC plus-J|1
304491|NCT00814801|999779|P3|Overall Study|Inappropriate as a subject|1
304492|NCT00814801|999780|P2|Overall Study|Inappropriate as a subject|1
304493|NCT00814801|999781|P1|Overall Study|Inappropriate as a subject|1
304494|NCT00814801|999779|P3|Overall Study|Withdrawal by Subject|14
304495|NCT00814801|999780|P2|Overall Study|Withdrawal by Subject|11
304496|NCT00814801|999781|P1|Overall Study|Withdrawal by Subject|9
304497|NCT00814801|999779|P3|Overall Study|Adverse Event|19
304498|NCT00814801|999780|P2|Overall Study|Adverse Event|16
304499|NCT00814801|999781|P1|Overall Study|Adverse Event|15
304500|NCT00814710|999820|P2|Overall Study|Lost to Follow-up|3
304501|NCT00814710|999821|P1|Overall Study|Lost to Follow-up|7
304502|NCT00814710|999820|P2|Overall Study|Adverse Event|0
304503|NCT00814710|999821|P1|Overall Study|Adverse Event|1
304504|NCT00814658|999881|P2|Overall Study|Adverse Event|3
304505|NCT00814658|999882|P1|Overall Study|Adverse Event|3
304506|NCT00814658|999881|P2|Overall Study|Physician Decision|0
304507|NCT00814658|999882|P1|Overall Study|Physician Decision|1
304508|NCT00814658|999881|P2|Overall Study|Lost to Follow-up|1
304509|NCT00814658|999882|P1|Overall Study|Lost to Follow-up|0
304510|NCT00814632|999948|P1|Overall Study|Lack of Efficacy|2
304511|NCT00814580|999954|P2|Overall Study|Did Not Take Drug|2
304512|NCT00814580|999955|P1|Overall Study|Did Not Take Drug|2
304513|NCT00814580|999954|P2|Overall Study|Other|3
304514|NCT00814580|999955|P1|Overall Study|Other|1
304515|NCT00814580|999954|P2|Overall Study|Withdrawal by Subject|2
304516|NCT00814580|999955|P1|Overall Study|Withdrawal by Subject|2
304517|NCT00814580|999954|P2|Overall Study|Protocol Violation|0
304518|NCT00814580|999955|P1|Overall Study|Protocol Violation|2
304519|NCT00814580|999954|P2|Overall Study|Lack of Efficacy|25
304520|NCT00814580|999955|P1|Overall Study|Lack of Efficacy|18
304521|NCT00814580|999954|P2|Overall Study|Adverse Event|15
304522|NCT00814580|999955|P1|Overall Study|Adverse Event|6
304523|NCT00814502|1000085|P2|Overall Study|Withdrawal by Subject|2
304524|NCT00814502|1000086|P1|Overall Study|Withdrawal by Subject|0
304525|NCT00814502|1000085|P2|Overall Study|Adverse Event|0
304526|NCT00814502|1000086|P1|Overall Study|Adverse Event|1
304527|NCT00814489|1000099|P3|Overall Study|Unspecified|1
304528|NCT00814489|1000100|P2|Overall Study|Unspecified|0
304529|NCT00814489|1000101|P1|Overall Study|Unspecified|2
304530|NCT00814463|1000133|P1|Overall Study|Lost to Follow-up|1
304531|NCT00814346|1000139|P2|Open Phase (17 Months)|Not otherwise specified|0
304532|NCT00814346|1000140|P1|Open Phase (17 Months)|Not otherwise specified|1
304533|NCT00814346|1000139|P2|Open Phase (17 Months)|Lost to Follow-up|0
304534|NCT00814346|1000140|P1|Open Phase (17 Months)|Lost to Follow-up|2
304535|NCT00814346|1000139|P2|Open Phase (17 Months)|Consent|0
304536|NCT00814346|1000140|P1|Open Phase (17 Months)|Consent|2
304537|NCT00814346|1000139|P2|Open Phase (17 Months)|Adverse Event|0
304538|NCT00814346|1000140|P1|Open Phase (17 Months)|Adverse Event|5
304539|NCT00814346|1000139|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
304540|NCT00814346|1000140|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
304541|NCT00814346|1000139|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
304542|NCT00814346|1000140|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
304543|NCT00814333|1000206|P2|Enrollment|Lost to Follow-up|0
304544|NCT00814333|1000207|P1|Enrollment|Lost to Follow-up|1
304545|NCT00814320|1000215|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
304546|NCT00814320|1000216|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
304547|NCT00814320|1000215|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
304548|NCT00814320|1000216|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
304549|NCT00814320|1000215|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
304550|NCT00814320|1000216|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
304551|NCT00814320|1000215|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
304552|NCT00814320|1000216|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
304553|NCT00814320|1000215|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
304554|NCT00814320|1000216|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
304555|NCT00814320|1000215|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
304556|NCT00814320|1000216|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
304557|NCT00814320|1000215|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
304558|NCT00814320|1000216|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
304559|NCT00814320|1000215|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
304560|NCT00814320|1000216|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
304561|NCT00814320|1000215|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
304562|NCT00814320|1000216|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
304563|NCT00814320|1000215|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
304564|NCT00814320|1000216|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
304565|NCT00814307|1000348|P4|Overall Study|Death|0
304566|NCT00814307|1000349|P3|Overall Study|Death|0
304567|NCT00814307|1000350|P2|Overall Study|Death|1
304568|NCT00814307|1000351|P1|Overall Study|Death|0
304569|NCT00814307|1000348|P4|Overall Study|Withdrawal by Subject|2
304570|NCT00814307|1000349|P3|Overall Study|Withdrawal by Subject|0
304571|NCT00814307|1000350|P2|Overall Study|Withdrawal by Subject|6
304572|NCT00814307|1000351|P1|Overall Study|Withdrawal by Subject|4
304573|NCT00814307|1000348|P4|Overall Study|Protocol Violation|1
304574|NCT00814307|1000349|P3|Overall Study|Protocol Violation|1
304575|NCT00814307|1000350|P2|Overall Study|Protocol Violation|8
304576|NCT00814307|1000351|P1|Overall Study|Protocol Violation|2
304577|NCT00814307|1000348|P4|Overall Study|Unspecified|1
304578|NCT00814307|1000349|P3|Overall Study|Unspecified|0
304579|NCT00814307|1000350|P2|Overall Study|Unspecified|2
304580|NCT00814307|1000351|P1|Overall Study|Unspecified|1
304581|NCT00814307|1000348|P4|Overall Study|Lack of Efficacy|4
304582|NCT00814307|1000349|P3|Overall Study|Lack of Efficacy|3
304583|NCT00814307|1000350|P2|Overall Study|Lack of Efficacy|1
304584|NCT00814307|1000351|P1|Overall Study|Lack of Efficacy|1
304585|NCT00814307|1000348|P4|Overall Study|Adverse Event|2
304586|NCT00814307|1000349|P3|Overall Study|Adverse Event|3
304587|NCT00814307|1000350|P2|Overall Study|Adverse Event|9
304588|NCT00814307|1000351|P1|Overall Study|Adverse Event|3
304589|NCT00814307|1000348|P4|Overall Study|Randomized but not treated|0
304590|NCT00814307|1000349|P3|Overall Study|Randomized but not treated|0
304591|NCT00814307|1000350|P2|Overall Study|Randomized but not treated|0
304592|NCT00814307|1000351|P1|Overall Study|Randomized but not treated|1
304593|NCT00814164|1000547|P1|Overall Study|Death|5
304594|NCT00814164|1000547|P1|Overall Study|not stated|7
304595|NCT00814164|1000547|P1|Overall Study|Progression|7
304596|NCT00813995|1000581|P2|Overall Study|Withdrawal by Subject|5
304597|NCT00813995|1000582|P1|Overall Study|Withdrawal by Subject|0
304598|NCT00813995|1000581|P2|Overall Study|Subject moved|0
304599|NCT00813995|1000582|P1|Overall Study|Subject moved|4
304600|NCT00813995|1000581|P2|Overall Study|Protocol Violation|2
304601|NCT00813995|1000582|P1|Overall Study|Protocol Violation|3
304602|NCT00813995|1000581|P2|Overall Study|Other reason|2
304603|NCT00813995|1000582|P1|Overall Study|Other reason|2
304604|NCT00813995|1000581|P2|Overall Study|Lost to Follow-up|2
304605|NCT00813995|1000582|P1|Overall Study|Lost to Follow-up|4
304606|NCT00813995|1000581|P2|Overall Study|Lack of Efficacy|0
304607|NCT00813995|1000582|P1|Overall Study|Lack of Efficacy|1
304608|NCT00813995|1000581|P2|Overall Study|Laboratory adverse event|2
304609|NCT00813995|1000582|P1|Overall Study|Laboratory adverse event|0
304610|NCT00813995|1000581|P2|Overall Study|Clinical adverse event|3
304611|NCT00813995|1000582|P1|Overall Study|Clinical adverse event|9
304612|NCT00813943|1000605|P3|Overall Study|Ongoing at cut-off date|3
304613|NCT00813943|1000606|P2|Overall Study|Ongoing at cut-off date|5
304614|NCT00813943|1000607|P1|Overall Study|Ongoing at cut-off date|5
304615|NCT00813917|1000637|P2|Overall Study|Lost to Follow-up|1
304616|NCT00813917|1000638|P1|Overall Study|Lost to Follow-up|3
304617|NCT00813917|1000637|P2|Overall Study|Withdrawal by Subject|4
304618|NCT00813917|1000638|P1|Overall Study|Withdrawal by Subject|3
304619|NCT00813917|1000637|P2|Overall Study|Adverse Event|1
304620|NCT00813917|1000638|P1|Overall Study|Adverse Event|0
304621|NCT00813904|1000644|P1|Overall Study|Death|1
304622|NCT00813813|1000652|P2|Overall Study|Other|1
304623|NCT00813813|1000653|P1|Overall Study|Other|0
304624|NCT00813813|1000652|P2|Overall Study|Lost to Follow-up|7
304625|NCT00813813|1000653|P1|Overall Study|Lost to Follow-up|2
304626|NCT00813813|1000652|P2|Overall Study|Withdrawal by Subject|1
304627|NCT00813813|1000653|P1|Overall Study|Withdrawal by Subject|1
304628|NCT00813800|1000669|P1|Overall Study|Physician Decision|1
304629|NCT00813800|1000669|P1|Overall Study|Worsening of depression|2
304630|NCT00813800|1000669|P1|Overall Study|Adverse Event|1
304631|NCT00813800|1000669|P1|Overall Study|Screen Failure after Consent|2
304632|NCT00813761|1000677|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
304633|NCT00813761|1000678|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
304634|NCT00813761|1000679|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
304635|NCT00813761|1000680|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
304636|NCT00813761|1000677|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
304637|NCT00813761|1000678|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
304638|NCT00813761|1000679|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
304639|NCT00813761|1000680|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
304640|NCT00813761|1000677|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
304641|NCT00813761|1000678|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
304642|NCT00813761|1000679|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
304643|NCT00813761|1000680|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
304644|NCT00813761|1000677|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
304645|NCT00813761|1000678|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
304646|NCT00813761|1000679|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
304647|NCT00813761|1000680|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
304648|NCT00813761|1000677|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
304649|NCT00813761|1000678|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
304650|NCT00813761|1000679|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
304651|NCT00813761|1000680|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
304652|NCT00813761|1000677|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
304653|NCT00813761|1000678|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
304654|NCT00813761|1000679|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
304655|NCT00813761|1000680|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
304656|NCT00813761|1000677|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
304657|NCT00813761|1000678|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
304658|NCT00813761|1000679|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
304659|NCT00813761|1000680|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
304660|NCT00813761|1000677|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
304661|NCT00813761|1000678|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
304662|NCT00813761|1000679|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
304663|NCT00813761|1000680|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
304664|NCT00813761|1000677|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
304665|NCT00813761|1000678|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
304666|NCT00813761|1000679|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
304667|NCT00813761|1000680|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
304668|NCT00813761|1000677|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
304669|NCT00813761|1000678|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
304670|NCT00813761|1000679|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
304671|NCT00813761|1000680|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
304672|NCT00813761|1000677|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
304673|NCT00813761|1000678|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
304674|NCT00813761|1000679|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
304675|NCT00813761|1000680|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
304676|NCT00813761|1000677|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
304677|NCT00813761|1000678|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
304678|NCT00813761|1000679|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
304679|NCT00813761|1000680|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
304680|NCT00813748|1000730|P2|Skin Test Substudy|Physician Decision|1
304681|NCT00813748|1000731|P1|Skin Test Substudy|Physician Decision|0
304682|NCT00813709|1000760|P6|Open Label Period|Unspecified|6
304683|NCT00813709|1000761|P5|Open Label Period|Unspecified|5
304684|NCT00813709|1000762|P4|Open Label Period|Unspecified|11
304685|NCT00813709|1000763|P3|Open Label Period|Unspecified|0
304686|NCT00813709|1000764|P2|Open Label Period|Unspecified|0
304687|NCT00813709|1000765|P1|Open Label Period|Unspecified|0
304688|NCT00813709|1000760|P6|Open Label Period|Randomized but not treated|1
304689|NCT00813709|1000761|P5|Open Label Period|Randomized but not treated|0
304690|NCT00813709|1000762|P4|Open Label Period|Randomized but not treated|1
304691|NCT00813709|1000763|P3|Open Label Period|Randomized but not treated|0
304692|NCT00813709|1000764|P2|Open Label Period|Randomized but not treated|0
304693|NCT00813709|1000765|P1|Open Label Period|Randomized but not treated|0
304694|NCT00813709|1000760|P6|Open Label Period|Lack of Efficacy|1
304695|NCT00813709|1000761|P5|Open Label Period|Lack of Efficacy|1
304696|NCT00813709|1000762|P4|Open Label Period|Lack of Efficacy|3
304697|NCT00813709|1000763|P3|Open Label Period|Lack of Efficacy|0
304698|NCT00813709|1000764|P2|Open Label Period|Lack of Efficacy|0
304699|NCT00813709|1000765|P1|Open Label Period|Lack of Efficacy|0
304700|NCT00813709|1000760|P6|Open Label Period|Adverse Event|3
304701|NCT00813709|1000761|P5|Open Label Period|Adverse Event|4
304702|NCT00813709|1000762|P4|Open Label Period|Adverse Event|5
304703|NCT00813709|1000763|P3|Open Label Period|Adverse Event|0
304704|NCT00813709|1000764|P2|Open Label Period|Adverse Event|0
304705|NCT00813709|1000765|P1|Open Label Period|Adverse Event|0
304706|NCT00813709|1000760|P6|Double Blind Period|Unspecified|0
304707|NCT00813709|1000761|P5|Double Blind Period|Unspecified|0
304708|NCT00813709|1000762|P4|Double Blind Period|Unspecified|0
304709|NCT00813709|1000763|P3|Double Blind Period|Unspecified|6
304710|NCT00813709|1000764|P2|Double Blind Period|Unspecified|9
304711|NCT00813709|1000765|P1|Double Blind Period|Unspecified|14
304712|NCT00813709|1000760|P6|Double Blind Period|Randomized but not treated|0
304713|NCT00813709|1000761|P5|Double Blind Period|Randomized but not treated|0
304714|NCT00813709|1000762|P4|Double Blind Period|Randomized but not treated|0
304715|NCT00813709|1000763|P3|Double Blind Period|Randomized but not treated|1
304716|NCT00813709|1000764|P2|Double Blind Period|Randomized but not treated|3
304717|NCT00813709|1000765|P1|Double Blind Period|Randomized but not treated|1
304718|NCT00813709|1000760|P6|Double Blind Period|Switched to open label phase|0
304719|NCT00813709|1000761|P5|Double Blind Period|Switched to open label phase|0
304720|NCT00813709|1000762|P4|Double Blind Period|Switched to open label phase|0
304721|NCT00813709|1000763|P3|Double Blind Period|Switched to open label phase|18
304722|NCT00813709|1000764|P2|Double Blind Period|Switched to open label phase|26
304723|NCT00813709|1000765|P1|Double Blind Period|Switched to open label phase|9
304724|NCT00813709|1000760|P6|Double Blind Period|Lost to Follow-up|0
304725|NCT00813709|1000761|P5|Double Blind Period|Lost to Follow-up|0
304726|NCT00813709|1000762|P4|Double Blind Period|Lost to Follow-up|0
304727|NCT00813709|1000763|P3|Double Blind Period|Lost to Follow-up|2
304728|NCT00813709|1000764|P2|Double Blind Period|Lost to Follow-up|2
304729|NCT00813709|1000765|P1|Double Blind Period|Lost to Follow-up|3
304730|NCT00813709|1000760|P6|Double Blind Period|Adverse Event|0
304731|NCT00813709|1000761|P5|Double Blind Period|Adverse Event|0
304732|NCT00813709|1000762|P4|Double Blind Period|Adverse Event|0
304733|NCT00813709|1000763|P3|Double Blind Period|Adverse Event|4
304734|NCT00813709|1000764|P2|Double Blind Period|Adverse Event|1
304735|NCT00813709|1000765|P1|Double Blind Period|Adverse Event|4
304736|NCT00813592|1000845|P1|Overall Study|Disease assessment was not completed per|2
304737|NCT00813488|1000854|P2|Open-label Extension|Not specified|0
304738|NCT00813488|1000855|P1|Open-label Extension|Not specified|1
304739|NCT00813488|1000854|P2|Open-label Extension|Non-compliance study procedures|1
304740|NCT00813488|1000855|P1|Open-label Extension|Non-compliance study procedures|2
304741|NCT00813488|1000854|P2|Open-label Extension|Non-compliance study medication|0
304742|NCT00813488|1000855|P1|Open-label Extension|Non-compliance study medication|4
304743|NCT00813488|1000854|P2|Open-label Extension|Protocol Violation|2
304744|NCT00813488|1000855|P1|Open-label Extension|Protocol Violation|1
304745|NCT00813488|1000854|P2|Open-label Extension|Withdrawal by Subject|2
304746|NCT00813488|1000855|P1|Open-label Extension|Withdrawal by Subject|0
304747|NCT00813488|1000854|P2|Open-label Extension|Lack of Efficacy|0
304748|NCT00813488|1000855|P1|Open-label Extension|Lack of Efficacy|3
304749|NCT00813488|1000854|P2|Open-label Extension|Adverse Event|2
304750|NCT00813488|1000855|P1|Open-label Extension|Adverse Event|1
304751|NCT00813488|1000854|P2|Double-blind Treatment Period 2|Not Specified|0
304752|NCT00813488|1000855|P1|Double-blind Treatment Period 2|Not Specified|1
304753|NCT00813488|1000854|P2|Double-blind Treatment Period 2|Protocol Violation|0
304754|NCT00813488|1000855|P1|Double-blind Treatment Period 2|Protocol Violation|2
304755|NCT00813488|1000854|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
304756|NCT00813488|1000855|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
304757|NCT00813488|1000854|P2|Double-blind Treatment Period 2|Adverse Event|0
304758|NCT00813488|1000855|P1|Double-blind Treatment Period 2|Adverse Event|1
304759|NCT00813488|1000854|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
304760|NCT00813488|1000855|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
304761|NCT00813488|1000854|P2|Double-blind Treatment Period 1|Protocol Violation|2
304762|NCT00813488|1000855|P1|Double-blind Treatment Period 1|Protocol Violation|0
304763|NCT00813488|1000854|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
304764|NCT00813488|1000855|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
304765|NCT00813488|1000854|P2|Double-blind Treatment Period 1|Adverse Event|1
304766|NCT00813488|1000855|P1|Double-blind Treatment Period 1|Adverse Event|1
304767|NCT00813488|1000854|P2|Titration Period 2|Non-compliance with study procedures|1
304768|NCT00813488|1000855|P1|Titration Period 2|Non-compliance with study procedures|2
304769|NCT00813488|1000854|P2|Titration Period 2|Lost to Follow-up|0
304770|NCT00813488|1000855|P1|Titration Period 2|Lost to Follow-up|1
304771|NCT00813488|1000854|P2|Titration Period 2|Protocol Violation|2
304772|NCT00813488|1000855|P1|Titration Period 2|Protocol Violation|3
304773|NCT00813488|1000854|P2|Titration Period 2|Lack of Efficacy|4
304774|NCT00813488|1000855|P1|Titration Period 2|Lack of Efficacy|8
304775|NCT00813488|1000854|P2|Titration Period 2|Adverse Event|3
304776|NCT00813488|1000855|P1|Titration Period 2|Adverse Event|2
304777|NCT00813488|1000854|P2|Titration Period 1|Technical Difficulties|1
304778|NCT00813488|1000855|P1|Titration Period 1|Technical Difficulties|0
304779|NCT00813488|1000854|P2|Titration Period 1|Non-compliance to study procedures|2
304780|NCT00813488|1000855|P1|Titration Period 1|Non-compliance to study procedures|2
304781|NCT00813488|1000854|P2|Titration Period 1|Non-compliance to study medication|1
304782|NCT00813488|1000855|P1|Titration Period 1|Non-compliance to study medication|4
304783|NCT00813488|1000854|P2|Titration Period 1|Protocol Violation|3
304784|NCT00813488|1000855|P1|Titration Period 1|Protocol Violation|4
304785|NCT00813488|1000854|P2|Titration Period 1|Withdrawal by Subject|2
304786|NCT00813488|1000855|P1|Titration Period 1|Withdrawal by Subject|2
304787|NCT00813488|1000854|P2|Titration Period 1|Lack of Efficacy|7
304788|NCT00813488|1000855|P1|Titration Period 1|Lack of Efficacy|9
304789|NCT00813488|1000854|P2|Titration Period 1|Adverse Event|1
304790|NCT00813488|1000855|P1|Titration Period 1|Adverse Event|6
304791|NCT00813150|1000966|P2|Long Term Follow-up|Progression/Relapse|24
304792|NCT00813150|1000967|P1|Long Term Follow-up|Progression/Relapse|22
304793|NCT00813150|1000966|P2|Long Term Follow-up|Lost to Follow-up|0
304794|NCT00813150|1000967|P1|Long Term Follow-up|Lost to Follow-up|2
304795|NCT00813150|1000966|P2|Long Term Follow-up|Not specified|3
304796|NCT00813150|1000967|P1|Long Term Follow-up|Not specified|0
304797|NCT00813150|1000966|P2|Long Term Follow-up|Death|4
304798|NCT00813150|1000967|P1|Long Term Follow-up|Death|0
304799|NCT00813150|1000966|P2|Treatment Period|Data not available|2
304800|NCT00813150|1000967|P1|Treatment Period|Data not available|1
304801|NCT00813150|1000966|P2|Treatment Period|Reason not specified|4
304802|NCT00813150|1000967|P1|Treatment Period|Reason not specified|3
304803|NCT00813150|1000966|P2|Treatment Period|Non compliance|1
304804|NCT00813150|1000967|P1|Treatment Period|Non compliance|0
304805|NCT00813150|1000966|P2|Treatment Period|Withdrawal by Subject|3
304806|NCT00813150|1000967|P1|Treatment Period|Withdrawal by Subject|5
304807|NCT00813150|1000966|P2|Treatment Period|Protocol Violation|4
304808|NCT00813150|1000967|P1|Treatment Period|Protocol Violation|3
304809|NCT00813150|1000966|P2|Treatment Period|Stable disease|2
304810|NCT00813150|1000967|P1|Treatment Period|Stable disease|1
304811|NCT00813150|1000966|P2|Treatment Period|Complete response|1
304812|NCT00813150|1000967|P1|Treatment Period|Complete response|0
304813|NCT00813150|1000966|P2|Treatment Period|Progressive disease|0
304814|NCT00813150|1000967|P1|Treatment Period|Progressive disease|1
304815|NCT00813150|1000966|P2|Treatment Period|Death|0
304816|NCT00813150|1000967|P1|Treatment Period|Death|2
304817|NCT00813150|1000966|P2|Treatment Period|Adverse Event|15
304818|NCT00813150|1000967|P1|Treatment Period|Adverse Event|16
304819|NCT00813098|1000991|P3|Overall Study|Withdrew Consent|0
304820|NCT00813098|1000992|P2|Overall Study|Withdrew Consent|1
304821|NCT00813098|1000993|P1|Overall Study|Withdrew Consent|0
304822|NCT00813098|1000991|P3|Overall Study|Principal Investigator decision|0
304823|NCT00813098|1000992|P2|Overall Study|Principal Investigator decision|1
304824|NCT00813098|1000993|P1|Overall Study|Principal Investigator decision|0
304825|NCT00813098|1000991|P3|Overall Study|Protocol Violation|1
304826|NCT00813098|1000992|P2|Overall Study|Protocol Violation|0
304827|NCT00813098|1000993|P1|Overall Study|Protocol Violation|0
304828|NCT00813098|1000991|P3|Overall Study|Lost to Follow-up|0
304829|NCT00813098|1000992|P2|Overall Study|Lost to Follow-up|1
304830|NCT00813098|1000993|P1|Overall Study|Lost to Follow-up|0
304831|NCT00813098|1000991|P3|Overall Study|Inability to complete study procedures|0
304832|NCT00813098|1000992|P2|Overall Study|Inability to complete study procedures|0
304833|NCT00813098|1000993|P1|Overall Study|Inability to complete study procedures|1
304834|NCT00813098|1000991|P3|Overall Study|Withdrawal by Subject|0
304835|NCT00813098|1000992|P2|Overall Study|Withdrawal by Subject|1
304836|NCT00813098|1000993|P1|Overall Study|Withdrawal by Subject|0
304837|NCT00813098|1000991|P3|Overall Study|Adverse Event|1
304838|NCT00813098|1000992|P2|Overall Study|Adverse Event|4
304839|NCT00813098|1000993|P1|Overall Study|Adverse Event|2
304840|NCT00812981|1001018|P2|Overall Study|Unspecified|1
304841|NCT00812981|1001019|P1|Overall Study|Unspecified|0
304842|NCT00812968|1001057|P1|Overall Study|Study closed due to marketing approval|3
304843|NCT00812968|1001057|P1|Overall Study|No further treatment required|1
304844|NCT00812968|1001057|P1|Overall Study|Disease progression|1
304845|NCT00812968|1001057|P1|Overall Study|Relapse after erythroid response|6
304846|NCT00812955|1001092|P4|Overall Study|randomized in error|0
304847|NCT00812955|1001093|P3|Overall Study|randomized in error|1
304848|NCT00812955|1001094|P2|Overall Study|randomized in error|0
304849|NCT00812955|1001095|P1|Overall Study|randomized in error|0
304850|NCT00812955|1001092|P4|Overall Study|Withdrawal by Subject|2
304851|NCT00812955|1001093|P3|Overall Study|Withdrawal by Subject|1
304852|NCT00812955|1001094|P2|Overall Study|Withdrawal by Subject|0
304853|NCT00812955|1001095|P1|Overall Study|Withdrawal by Subject|1
304854|NCT00812955|1001092|P4|Overall Study|Lost to Follow-up|2
304855|NCT00812955|1001093|P3|Overall Study|Lost to Follow-up|1
304856|NCT00812955|1001094|P2|Overall Study|Lost to Follow-up|1
304857|NCT00812955|1001095|P1|Overall Study|Lost to Follow-up|2
304858|NCT00812955|1001092|P4|Overall Study|Adverse Event|4
304859|NCT00812955|1001093|P3|Overall Study|Adverse Event|3
304860|NCT00812955|1001094|P2|Overall Study|Adverse Event|6
304861|NCT00812955|1001095|P1|Overall Study|Adverse Event|7
304862|NCT00812812|1001137|P2|Overall Study|Withdrawal by Subject|2
304863|NCT00812812|1001138|P1|Overall Study|Withdrawal by Subject|0
304864|NCT00812812|1001137|P2|Overall Study|Lost to Follow-up|1
304865|NCT00812812|1001138|P1|Overall Study|Lost to Follow-up|0
304866|NCT00812812|1001137|P2|Overall Study|Lack of Efficacy|0
304867|NCT00812812|1001138|P1|Overall Study|Lack of Efficacy|1
304868|NCT00812812|1001137|P2|Overall Study|Adverse Event|1
304869|NCT00812812|1001138|P1|Overall Study|Adverse Event|2
304870|NCT00812565|1001170|P8|Overall Study|Reason Not Specified|0
304871|NCT00812565|1001171|P7|Overall Study|Reason Not Specified|0
304872|NCT00812565|1001172|P6|Overall Study|Reason Not Specified|1
304873|NCT00812565|1001173|P5|Overall Study|Reason Not Specified|0
304874|NCT00812565|1001174|P4|Overall Study|Reason Not Specified|0
304875|NCT00812565|1001175|P3|Overall Study|Reason Not Specified|0
304876|NCT00812565|1001176|P2|Overall Study|Reason Not Specified|0
304877|NCT00812565|1001177|P1|Overall Study|Reason Not Specified|0
304878|NCT00812565|1001170|P8|Overall Study|Withdrawal of Consent|0
304879|NCT00812565|1001171|P7|Overall Study|Withdrawal of Consent|0
304880|NCT00812565|1001172|P6|Overall Study|Withdrawal of Consent|0
304881|NCT00812565|1001173|P5|Overall Study|Withdrawal of Consent|1
304882|NCT00812565|1001174|P4|Overall Study|Withdrawal of Consent|0
304883|NCT00812565|1001175|P3|Overall Study|Withdrawal of Consent|0
304884|NCT00812565|1001176|P2|Overall Study|Withdrawal of Consent|0
304885|NCT00812565|1001177|P1|Overall Study|Withdrawal of Consent|1
304886|NCT00812565|1001170|P8|Overall Study|Did Not Come to Study Visit|0
304887|NCT00812565|1001171|P7|Overall Study|Did Not Come to Study Visit|0
304888|NCT00812565|1001172|P6|Overall Study|Did Not Come to Study Visit|0
304889|NCT00812565|1001173|P5|Overall Study|Did Not Come to Study Visit|0
304890|NCT00812565|1001174|P4|Overall Study|Did Not Come to Study Visit|0
304891|NCT00812565|1001175|P3|Overall Study|Did Not Come to Study Visit|0
304892|NCT00812565|1001176|P2|Overall Study|Did Not Come to Study Visit|0
304893|NCT00812565|1001177|P1|Overall Study|Did Not Come to Study Visit|1
304894|NCT00812565|1001170|P8|Overall Study|Adverse Event|1
304895|NCT00812565|1001171|P7|Overall Study|Adverse Event|0
304896|NCT00812565|1001172|P6|Overall Study|Adverse Event|0
304897|NCT00812565|1001173|P5|Overall Study|Adverse Event|0
304898|NCT00812565|1001174|P4|Overall Study|Adverse Event|2
304899|NCT00812565|1001175|P3|Overall Study|Adverse Event|0
304900|NCT00812565|1001176|P2|Overall Study|Adverse Event|0
304901|NCT00812565|1001177|P1|Overall Study|Adverse Event|0
304902|NCT00812565|1001170|P8|Overall Study|Did Not Receive Study Medication|0
304903|NCT00812565|1001171|P7|Overall Study|Did Not Receive Study Medication|0
304904|NCT00812565|1001172|P6|Overall Study|Did Not Receive Study Medication|0
304905|NCT00812565|1001173|P5|Overall Study|Did Not Receive Study Medication|0
304906|NCT00812565|1001174|P4|Overall Study|Did Not Receive Study Medication|0
304907|NCT00812565|1001175|P3|Overall Study|Did Not Receive Study Medication|0
304908|NCT00812565|1001176|P2|Overall Study|Did Not Receive Study Medication|1
304909|NCT00812565|1001177|P1|Overall Study|Did Not Receive Study Medication|1
304910|NCT00812487|1001301|P2|Overall Study|Protocol Violation|1
304911|NCT00812487|1001302|P1|Overall Study|Protocol Violation|0
304912|NCT00812487|1001301|P2|Overall Study|Transfer to ICU prior to intervention|0
304913|NCT00812487|1001302|P1|Overall Study|Transfer to ICU prior to intervention|1
304914|NCT00812487|1001301|P2|Overall Study|Withdrawal by Subject|2
304915|NCT00812487|1001302|P1|Overall Study|Withdrawal by Subject|3
304916|NCT00812487|1001301|P2|Overall Study|Lost to Follow-up|0
304917|NCT00812487|1001302|P1|Overall Study|Lost to Follow-up|2
304918|NCT00812461|1001328|P2|All Treated Patients|Other Reason|21
304919|NCT00812461|1001329|P1|All Treated Patients|Other Reason|13
304920|NCT00812461|1001328|P2|All Treated Patients|Lost to Follow-up|14
304921|NCT00812461|1001329|P1|All Treated Patients|Lost to Follow-up|11
304922|NCT00812461|1001328|P2|All Treated Patients|Withdrawal by Subject|54
304923|NCT00812461|1001329|P1|All Treated Patients|Withdrawal by Subject|45
304924|NCT00812461|1001328|P2|All Treated Patients|Protocol Violation|27
304925|NCT00812461|1001329|P1|All Treated Patients|Protocol Violation|36
304926|NCT00812461|1001328|P2|All Treated Patients|Non-compliance|9
304927|NCT00812461|1001329|P1|All Treated Patients|Non-compliance|6
304928|NCT00812461|1001328|P2|All Treated Patients|Lack of Efficacy|7
304929|NCT00812461|1001329|P1|All Treated Patients|Lack of Efficacy|13
304930|NCT00812461|1001328|P2|All Treated Patients|Adverse Event|15
304931|NCT00812461|1001329|P1|All Treated Patients|Adverse Event|8
304932|NCT00812461|1001328|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
304933|NCT00812461|1001329|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
304934|NCT00812331|1001352|P5|Overall Study|Adverse Event|0
304935|NCT00812331|1001353|P4|Overall Study|Adverse Event|0
304936|NCT00812331|1001354|P3|Overall Study|Adverse Event|0
304937|NCT00812331|1001355|P2|Overall Study|Adverse Event|0
304938|NCT00812331|1001356|P1|Overall Study|Adverse Event|1
304939|NCT00812253|1001431|P2|Overall Study|Lost to Follow-up|0
304940|NCT00812253|1001432|P1|Overall Study|Lost to Follow-up|2
304941|NCT00812253|1001431|P2|Overall Study|Protocol Violation|1
304942|NCT00812253|1001432|P1|Overall Study|Protocol Violation|1
304943|NCT00812253|1001431|P2|Overall Study|Withdrawal by Subject|2
304944|NCT00812253|1001432|P1|Overall Study|Withdrawal by Subject|3
304945|NCT00812097|1001451|P4|Overall Study|Unknown reasons and patient/doctor moves|5
304946|NCT00812097|1001452|P3|Overall Study|Unknown reasons and patient/doctor moves|15
304947|NCT00812097|1001453|P2|Overall Study|Unknown reasons and patient/doctor moves|24
304948|NCT00812097|1001454|P1|Overall Study|Unknown reasons and patient/doctor moves|111
304949|NCT00812097|1001451|P4|Overall Study|Explantation of study device(s)|20
304950|NCT00812097|1001452|P3|Overall Study|Explantation of study device(s)|14
304951|NCT00812097|1001453|P2|Overall Study|Explantation of study device(s)|29
304952|NCT00812097|1001454|P1|Overall Study|Explantation of study device(s)|27
304953|NCT00812097|1001451|P4|Overall Study|Lost to Follow-up|5
304954|NCT00812097|1001452|P3|Overall Study|Lost to Follow-up|17
304955|NCT00812097|1001453|P2|Overall Study|Lost to Follow-up|14
304956|NCT00812097|1001454|P1|Overall Study|Lost to Follow-up|90
304957|NCT00812097|1001451|P4|Overall Study|Withdrawal by Subject|2
304958|NCT00812097|1001452|P3|Overall Study|Withdrawal by Subject|8
304959|NCT00812097|1001453|P2|Overall Study|Withdrawal by Subject|12
304960|NCT00812097|1001454|P1|Overall Study|Withdrawal by Subject|14
304961|NCT00812097|1001451|P4|Overall Study|Death|3
304962|NCT00812097|1001452|P3|Overall Study|Death|3
304963|NCT00812097|1001453|P2|Overall Study|Death|10
304964|NCT00812097|1001454|P1|Overall Study|Death|3
304965|NCT00812006|1001483|P3|Overall Study|Lack of Qualifying Event|2
304966|NCT00812006|1001484|P2|Overall Study|Lack of Qualifying Event|2
304967|NCT00812006|1001485|P1|Overall Study|Lack of Qualifying Event|4
304968|NCT00812006|1001483|P3|Overall Study|Withdrawal by Subject|1
304969|NCT00812006|1001484|P2|Overall Study|Withdrawal by Subject|1
304970|NCT00812006|1001485|P1|Overall Study|Withdrawal by Subject|2
304971|NCT00812006|1001483|P3|Overall Study|Physician Decision|1
304972|NCT00812006|1001484|P2|Overall Study|Physician Decision|0
304973|NCT00812006|1001485|P1|Overall Study|Physician Decision|0
304974|NCT00812006|1001483|P3|Overall Study|Lost to Follow-up|2
304975|NCT00812006|1001484|P2|Overall Study|Lost to Follow-up|0
304976|NCT00812006|1001485|P1|Overall Study|Lost to Follow-up|0
304977|NCT00811954|1001502|P3|Overall Study|Complete Protocol: No follow-up|1
304978|NCT00811954|1001503|P2|Overall Study|Complete Protocol: No follow-up|0
304979|NCT00811954|1001504|P1|Overall Study|Complete Protocol: No follow-up|0
304980|NCT00811954|1001502|P3|Overall Study|Severe Debilitation|1
304981|NCT00811954|1001503|P2|Overall Study|Severe Debilitation|0
304982|NCT00811954|1001504|P1|Overall Study|Severe Debilitation|2
304983|NCT00811954|1001502|P3|Overall Study|Site Closure|1
304984|NCT00811954|1001503|P2|Overall Study|Site Closure|0
304985|NCT00811954|1001504|P1|Overall Study|Site Closure|4
304986|NCT00811954|1001502|P3|Overall Study|Withdraw consent prior study completion|5
304987|NCT00811954|1001503|P2|Overall Study|Withdraw consent prior study completion|6
304988|NCT00811954|1001504|P1|Overall Study|Withdraw consent prior study completion|4
304989|NCT00811954|1001502|P3|Overall Study|Not willing to adhere to requirements|16
304990|NCT00811954|1001503|P2|Overall Study|Not willing to adhere to requirements|2
304991|NCT00811954|1001504|P1|Overall Study|Not willing to adhere to requirements|12
304992|NCT00811954|1001502|P3|Overall Study|Not able to get to clinic|30
304993|NCT00811954|1001503|P2|Overall Study|Not able to get to clinic|35
304994|NCT00811954|1001504|P1|Overall Study|Not able to get to clinic|28
304995|NCT00811954|1001502|P3|Overall Study|Lost to Follow-up|34
304996|NCT00811954|1001503|P2|Overall Study|Lost to Follow-up|23
304997|NCT00811954|1001504|P1|Overall Study|Lost to Follow-up|29
304998|NCT00811954|1001502|P3|Overall Study|Death|13
304999|NCT00811954|1001503|P2|Overall Study|Death|6
305000|NCT00811954|1001504|P1|Overall Study|Death|10
305001|NCT00811941|1001568|P2|All Treated Patients|Other Reason|14
305002|NCT00811941|1001569|P1|All Treated Patients|Other Reason|4
305003|NCT00811941|1001568|P2|All Treated Patients|Lost to Follow-up|12
305004|NCT00811941|1001569|P1|All Treated Patients|Lost to Follow-up|3
305005|NCT00811941|1001568|P2|All Treated Patients|Withdrawal by Subject|94
305006|NCT00811941|1001569|P1|All Treated Patients|Withdrawal by Subject|35
305007|NCT00811941|1001568|P2|All Treated Patients|Protocol Violation|17
305008|NCT00811941|1001569|P1|All Treated Patients|Protocol Violation|5
305009|NCT00811941|1001568|P2|All Treated Patients|Non-compliance|8
305010|NCT00811941|1001569|P1|All Treated Patients|Non-compliance|1
305011|NCT00811941|1001568|P2|All Treated Patients|Lack of Efficacy|3
305012|NCT00811941|1001569|P1|All Treated Patients|Lack of Efficacy|2
305013|NCT00811941|1001568|P2|All Treated Patients|Adverse Event|43
305014|NCT00811941|1001569|P1|All Treated Patients|Adverse Event|2
305015|NCT00811941|1001568|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
305016|NCT00811941|1001569|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
305017|NCT00811928|1001607|P2|Overall Study|Poor Compliance|5
305018|NCT00811928|1001608|P1|Overall Study|Poor Compliance|2
305019|NCT00811928|1001607|P2|Overall Study|Investigator Decision|1
305020|NCT00811928|1001608|P1|Overall Study|Investigator Decision|2
305021|NCT00811928|1001607|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
305022|NCT00811928|1001608|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
305023|NCT00811928|1001607|P2|Overall Study|Did Not Take Study Drug|0
305024|NCT00811928|1001608|P1|Overall Study|Did Not Take Study Drug|3
305025|NCT00811928|1001607|P2|Overall Study|Withdrawal by Subject|12
305026|NCT00811928|1001608|P1|Overall Study|Withdrawal by Subject|18
305027|NCT00811928|1001607|P2|Overall Study|AEs and SAEs Including Death|11
305028|NCT00811928|1001608|P1|Overall Study|AEs and SAEs Including Death|7
305029|NCT00811733|1001652|P2|Overall Study|Withdrawal by Subject|2
305030|NCT00811733|1001653|P1|Overall Study|Withdrawal by Subject|1
305031|NCT00811733|1001652|P2|Overall Study|Investigator Discretion|8
305032|NCT00811733|1001653|P1|Overall Study|Investigator Discretion|10
305033|NCT00811720|1001701|P2|All Treated Patients|Other Reason|4
305034|NCT00811720|1001702|P1|All Treated Patients|Other Reason|7
305035|NCT00811720|1001701|P2|All Treated Patients|Lost to Follow-up|16
305036|NCT00811720|1001702|P1|All Treated Patients|Lost to Follow-up|10
305037|NCT00811720|1001701|P2|All Treated Patients|Withdrawal by Subject|34
305038|NCT00811720|1001702|P1|All Treated Patients|Withdrawal by Subject|28
305039|NCT00811720|1001701|P2|All Treated Patients|Protocol Violation|16
305040|NCT00811720|1001702|P1|All Treated Patients|Protocol Violation|9
305041|NCT00811720|1001701|P2|All Treated Patients|Non-compliance|14
305042|NCT00811720|1001702|P1|All Treated Patients|Non-compliance|0
305043|NCT00811720|1001701|P2|All Treated Patients|Lack of Efficacy|18
305044|NCT00811720|1001702|P1|All Treated Patients|Lack of Efficacy|22
305045|NCT00811720|1001701|P2|All Treated Patients|Adverse Event|62
305046|NCT00811720|1001702|P1|All Treated Patients|Adverse Event|20
305047|NCT00811720|1001701|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
305048|NCT00811720|1001702|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
305049|NCT00811655|1001720|P1|Overall Study|Physician Decision|1
305050|NCT00811642|1001732|P1|Overall Study|Cumulative use of antifungal agent|2
305051|NCT00811642|1001732|P1|Overall Study|Withdrawal by Subject|7
305052|NCT00811642|1001732|P1|Overall Study|Death|2
305053|NCT00811642|1001732|P1|Overall Study|Protocol Violation|1
305054|NCT00811642|1001732|P1|Overall Study|Adverse Event|3
305055|NCT00811577|1001748|P2|Overall Study|Withdrawal by Subject|0
305056|NCT00811577|1001749|P1|Overall Study|Withdrawal by Subject|3
305057|NCT00811577|1001748|P2|Overall Study|Lost to Follow-up|1
305058|NCT00811577|1001749|P1|Overall Study|Lost to Follow-up|7
305059|NCT00811473|1001809|P2|Overall Study|Safety Reasons|0
305060|NCT00811473|1001810|P1|Overall Study|Safety Reasons|1
305061|NCT00811473|1001809|P2|Overall Study|Incorrect Enrollment|0
305062|NCT00811473|1001810|P1|Overall Study|Incorrect Enrollment|1
305063|NCT00811473|1001809|P2|Overall Study|Other 2|1
305064|NCT00811473|1001810|P1|Overall Study|Other 2|4
305065|NCT00811473|1001809|P2|Overall Study|Condition under investigation worsened|3
305066|NCT00811473|1001810|P1|Overall Study|Condition under investigation worsened|1
305067|NCT00811473|1001809|P2|Overall Study|Lack of therapeutic response|1
305068|NCT00811473|1001810|P1|Overall Study|Lack of therapeutic response|4
305069|NCT00811473|1001809|P2|Overall Study|Severe non-compliance to protocol|4
305070|NCT00811473|1001810|P1|Overall Study|Severe non-compliance to protocol|2
305071|NCT00811473|1001809|P2|Overall Study|Withdrawal by Subject|4
305072|NCT00811473|1001810|P1|Overall Study|Withdrawal by Subject|2
305073|NCT00811473|1001809|P2|Overall Study|Lost to Follow-up|1
305074|NCT00811473|1001810|P1|Overall Study|Lost to Follow-up|5
305075|NCT00811473|1001809|P2|Overall Study|Adverse Event|12
305076|NCT00811473|1001810|P1|Overall Study|Adverse Event|3
305077|NCT00811395|1001841|P6|Extension Treatment|Other than above|0
305078|NCT00811395|1001842|P5|Extension Treatment|Other than above|0
305079|NCT00811395|1001843|P4|Extension Treatment|Other than above|0
305080|NCT00811395|1001844|P3|Extension Treatment|Other than above|1
305081|NCT00811395|1001845|P2|Extension Treatment|Other than above|0
305082|NCT00811395|1001846|P1|Extension Treatment|Other than above|0
305083|NCT00811395|1001841|P6|Extension Treatment|Participant did not wish to continue|1
305084|NCT00811395|1001842|P5|Extension Treatment|Participant did not wish to continue|0
305085|NCT00811395|1001843|P4|Extension Treatment|Participant did not wish to continue|1
305086|NCT00811395|1001844|P3|Extension Treatment|Participant did not wish to continue|0
305087|NCT00811395|1001845|P2|Extension Treatment|Participant did not wish to continue|3
305088|NCT00811395|1001846|P1|Extension Treatment|Participant did not wish to continue|0
305089|NCT00811395|1001841|P6|Extension Treatment|Progressive disease|0
305090|NCT00811395|1001842|P5|Extension Treatment|Progressive disease|0
305091|NCT00811395|1001843|P4|Extension Treatment|Progressive disease|0
305092|NCT00811395|1001844|P3|Extension Treatment|Progressive disease|0
305093|NCT00811395|1001845|P2|Extension Treatment|Progressive disease|1
305094|NCT00811395|1001846|P1|Extension Treatment|Progressive disease|1
305095|NCT00811395|1001841|P6|Extension Treatment|Adverse Event|1
305096|NCT00811395|1001842|P5|Extension Treatment|Adverse Event|0
305097|NCT00811395|1001843|P4|Extension Treatment|Adverse Event|2
305098|NCT00811395|1001844|P3|Extension Treatment|Adverse Event|2
305099|NCT00811395|1001845|P2|Extension Treatment|Adverse Event|2
305100|NCT00811395|1001846|P1|Extension Treatment|Adverse Event|1
305101|NCT00811252|1001926|P3|Overall Study|Administrative or Other Reasons|2
305102|NCT00811252|1001927|P2|Overall Study|Administrative or Other Reasons|3
305103|NCT00811252|1001928|P1|Overall Study|Administrative or Other Reasons|0
305104|NCT00811252|1001926|P3|Overall Study|Lost to Follow-up|2
305105|NCT00811252|1001927|P2|Overall Study|Lost to Follow-up|0
305106|NCT00811252|1001928|P1|Overall Study|Lost to Follow-up|0
305107|NCT00811252|1001926|P3|Overall Study|Withdrawal of Consent|2
305108|NCT00811252|1001927|P2|Overall Study|Withdrawal of Consent|2
305109|NCT00811252|1001928|P1|Overall Study|Withdrawal of Consent|1
305110|NCT00811252|1001926|P3|Overall Study|Protocol Violation|2
305111|NCT00811252|1001927|P2|Overall Study|Protocol Violation|3
305112|NCT00811252|1001928|P1|Overall Study|Protocol Violation|3
305113|NCT00811252|1001926|P3|Overall Study|Lack of Efficacy|0
305114|NCT00811252|1001927|P2|Overall Study|Lack of Efficacy|2
305115|NCT00811252|1001928|P1|Overall Study|Lack of Efficacy|7
305116|NCT00811252|1001926|P3|Overall Study|Adverse Event|15
305117|NCT00811252|1001927|P2|Overall Study|Adverse Event|10
305118|NCT00811252|1001928|P1|Overall Study|Adverse Event|6
305119|NCT00811135|1001972|P1|Overall Study|Ongoing|59
305120|NCT00811135|1001972|P1|Overall Study|Administrative/Other Unspecified|11
305121|NCT00811135|1001972|P1|Overall Study|Withdrawal by Subject|3
305122|NCT00811135|1001972|P1|Overall Study|Refused Treatment|1
305123|NCT00811135|1001972|P1|Overall Study|Violation of Selection Criteria|1
305124|NCT00811135|1001972|P1|Overall Study|Protocol Violation|2
305125|NCT00811135|1001972|P1|Overall Study|Death|3
305126|NCT00811135|1001972|P1|Overall Study|Adverse Event/Intercurrent Illness|8
305127|NCT00811070|1001990|P6|Overall Study|Physician Decision|1
305128|NCT00811070|1001991|P5|Overall Study|Physician Decision|0
305129|NCT00811070|1001992|P4|Overall Study|Physician Decision|0
305130|NCT00811070|1001993|P3|Overall Study|Physician Decision|0
305131|NCT00811070|1001994|P2|Overall Study|Physician Decision|0
305132|NCT00811070|1001995|P1|Overall Study|Physician Decision|0
305133|NCT00811070|1001990|P6|Overall Study|Withdrawal by Subject|0
305134|NCT00811070|1001991|P5|Overall Study|Withdrawal by Subject|0
305135|NCT00811070|1001992|P4|Overall Study|Withdrawal by Subject|0
305136|NCT00811070|1001993|P3|Overall Study|Withdrawal by Subject|0
305137|NCT00811070|1001994|P2|Overall Study|Withdrawal by Subject|1
305138|NCT00811070|1001995|P1|Overall Study|Withdrawal by Subject|0
305139|NCT00811070|1001990|P6|Overall Study|Unspecified|0
305140|NCT00811070|1001991|P5|Overall Study|Unspecified|0
305141|NCT00811070|1001992|P4|Overall Study|Unspecified|0
305142|NCT00811070|1001993|P3|Overall Study|Unspecified|0
305143|NCT00811070|1001994|P2|Overall Study|Unspecified|0
305144|NCT00811070|1001995|P1|Overall Study|Unspecified|1
305145|NCT00811070|1001990|P6|Overall Study|Death|0
305146|NCT00811070|1001991|P5|Overall Study|Death|5
305147|NCT00811070|1001992|P4|Overall Study|Death|2
305148|NCT00811070|1001993|P3|Overall Study|Death|0
305149|NCT00811070|1001994|P2|Overall Study|Death|0
305150|NCT00811070|1001995|P1|Overall Study|Death|0
305151|NCT00811057|1002055|P3|Overall Study|Protocol Violation|10
305152|NCT00811057|1002056|P2|Overall Study|Protocol Violation|10
305153|NCT00811057|1002057|P1|Overall Study|Protocol Violation|5
305154|NCT00811018|1002068|P1|Overall Study|Unspecified|26
305155|NCT00811018|1002068|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
305156|NCT00811018|1002068|P1|Overall Study|Withdrawal by Subject|70
305157|NCT00811018|1002068|P1|Overall Study|Sponsor Decision|450
305158|NCT00811018|1002068|P1|Overall Study|Pregnancy|6
305159|NCT00811018|1002068|P1|Overall Study|Lost to Follow-up|19
305160|NCT00811018|1002068|P1|Overall Study|Investigator Decision|57
305161|NCT00811018|1002068|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
305162|NCT00811018|1002068|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
305163|NCT00811018|1002068|P1|Overall Study|Death|147
305164|NCT00811018|1002068|P1|Overall Study|Adverse Event|79
305165|NCT00811018|1002068|P1|Overall Study|Additional Chronic Treatment|31
305166|NCT00810901|1002086|P2|Overall Study|Lost to Follow-up|58
305167|NCT00810901|1002087|P1|Overall Study|Lost to Follow-up|88
305168|NCT00810693|1002129|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
305169|NCT00810693|1002130|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
305170|NCT00810693|1002131|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
305171|NCT00810693|1002129|P3|Follow-up Period (FUP)|Protocol Violation|0
305172|NCT00810693|1002130|P2|Follow-up Period (FUP)|Protocol Violation|1
305173|NCT00810693|1002131|P1|Follow-up Period (FUP)|Protocol Violation|0
305174|NCT00810693|1002129|P3|Follow-up Period (FUP)|Lost to Follow-up|2
305175|NCT00810693|1002130|P2|Follow-up Period (FUP)|Lost to Follow-up|0
305176|NCT00810693|1002131|P1|Follow-up Period (FUP)|Lost to Follow-up|1
305177|NCT00810693|1002129|P3|Follow-up Period (FUP)|Death|1
305178|NCT00810693|1002130|P2|Follow-up Period (FUP)|Death|0
305179|NCT00810693|1002131|P1|Follow-up Period (FUP)|Death|2
305180|NCT00810693|1002129|P3|Follow-up Period (FUP)|Adverse Event|1
305181|NCT00810693|1002130|P2|Follow-up Period (FUP)|Adverse Event|1
305182|NCT00810693|1002131|P1|Follow-up Period (FUP)|Adverse Event|3
305183|NCT00810693|1002129|P3|Treatment Period|Not treated|1
305184|NCT00810693|1002130|P2|Treatment Period|Not treated|1
305185|NCT00810693|1002131|P1|Treatment Period|Not treated|0
305186|NCT00810693|1002129|P3|Treatment Period|Withdrawal by Subject|3
305187|NCT00810693|1002130|P2|Treatment Period|Withdrawal by Subject|2
305188|NCT00810693|1002131|P1|Treatment Period|Withdrawal by Subject|6
305189|NCT00810693|1002129|P3|Treatment Period|Protocol Violation|2
305190|NCT00810693|1002130|P2|Treatment Period|Protocol Violation|2
305191|NCT00810693|1002131|P1|Treatment Period|Protocol Violation|1
305192|NCT00810693|1002129|P3|Treatment Period|Non-compliance|0
305193|NCT00810693|1002130|P2|Treatment Period|Non-compliance|0
305194|NCT00810693|1002131|P1|Treatment Period|Non-compliance|1
305195|NCT00810693|1002129|P3|Treatment Period|Lost to Follow-up|0
305196|NCT00810693|1002130|P2|Treatment Period|Lost to Follow-up|0
305197|NCT00810693|1002131|P1|Treatment Period|Lost to Follow-up|1
305198|NCT00810693|1002129|P3|Treatment Period|Lack of Efficacy|1
305199|NCT00810693|1002130|P2|Treatment Period|Lack of Efficacy|0
305200|NCT00810693|1002131|P1|Treatment Period|Lack of Efficacy|0
305201|NCT00810693|1002129|P3|Treatment Period|Death|2
305202|NCT00810693|1002130|P2|Treatment Period|Death|1
305203|NCT00810693|1002131|P1|Treatment Period|Death|0
305204|NCT00810693|1002129|P3|Treatment Period|Adverse Event|7
305205|NCT00810693|1002130|P2|Treatment Period|Adverse Event|1
305206|NCT00810693|1002131|P1|Treatment Period|Adverse Event|8
305207|NCT00810641|1002163|P3|Overall Study|Withdrawal by Subject|2
305208|NCT00810641|1002164|P2|Overall Study|Withdrawal by Subject|1
305209|NCT00810641|1002165|P1|Overall Study|Withdrawal by Subject|0
305210|NCT00810602|1002173|P2|Overall Study|Withdrawal by Subject|3
305211|NCT00810602|1002174|P1|Overall Study|Withdrawal by Subject|8
305212|NCT00810511|1002187|P2|Overall Study|deposits on contact lens|1
305213|NCT00810511|1002188|P1|Overall Study|deposits on contact lens|0
305214|NCT00810511|1002187|P2|Overall Study|Lost to Follow-up|0
305215|NCT00810511|1002188|P1|Overall Study|Lost to Follow-up|1
305216|NCT00810511|1002187|P2|Overall Study|death in the family|1
305217|NCT00810511|1002188|P1|Overall Study|death in the family|0
305218|NCT00810511|1002187|P2|Overall Study|Lack of Efficacy|1
305219|NCT00810511|1002188|P1|Overall Study|Lack of Efficacy|9
305220|NCT00810511|1002187|P2|Overall Study|Protocol Violation|1
305221|NCT00810511|1002188|P1|Overall Study|Protocol Violation|0
305222|NCT00810394|1002194|P1|Overall Study|Withdrawal by Subject|3
305223|NCT00810368|1002202|P2|Overall Study|Lack of Efficacy|0
305224|NCT00810368|1002203|P1|Overall Study|Lack of Efficacy|2
305225|NCT00810368|1002202|P2|Overall Study|Lost to Follow-up|2
305226|NCT00810368|1002203|P1|Overall Study|Lost to Follow-up|4
305227|NCT00810355|1002224|P3|Overall Study|Withdrawal by Subject|0
305228|NCT00810355|1002225|P2|Overall Study|Withdrawal by Subject|0
305229|NCT00810355|1002226|P1|Overall Study|Withdrawal by Subject|1
305230|NCT00810355|1002224|P3|Overall Study|Lost to Follow-up|11
305231|NCT00810355|1002225|P2|Overall Study|Lost to Follow-up|17
305232|NCT00810355|1002226|P1|Overall Study|Lost to Follow-up|13
305233|NCT00810342|1002242|P2|12-month Followup|Lost to Follow-up|1
305234|NCT00810342|1002243|P1|12-month Followup|Lost to Follow-up|3
305235|NCT00810342|1002242|P2|12-month Followup|Pregnancy|10
305236|NCT00810342|1002243|P1|12-month Followup|Pregnancy|9
305237|NCT00810342|1002242|P2|6-month Follow-up|Pregnancy|2
305238|NCT00810342|1002243|P1|6-month Follow-up|Pregnancy|6
305239|NCT00810342|1002242|P2|6-month Follow-up|Lost to Follow-up|6
305240|NCT00810342|1002243|P1|6-month Follow-up|Lost to Follow-up|18
305241|NCT00810342|1002242|P2|Month 1 Follow-up|Pregnancy|0
305242|NCT00810342|1002243|P1|Month 1 Follow-up|Pregnancy|1
305243|NCT00810342|1002242|P2|Month 1 Follow-up|Lost to Follow-up|2
305244|NCT00810342|1002243|P1|Month 1 Follow-up|Lost to Follow-up|4
305245|NCT00810277|1002276|P1|Overall Study|Adverse Event|1
305246|NCT00810199|1002291|P2|Overall Study|Did not receive study drug|1
305247|NCT00810199|1002292|P1|Overall Study|Did not receive study drug|2
305248|NCT00810199|1002291|P2|Overall Study|Failure to return|4
305249|NCT00810199|1002292|P1|Overall Study|Failure to return|1
305250|NCT00810199|1002291|P2|Overall Study|Protocol Violation|6
305251|NCT00810199|1002292|P1|Overall Study|Protocol Violation|2
305252|NCT00810199|1002291|P2|Overall Study|Administrative/Other|6
305253|NCT00810199|1002292|P1|Overall Study|Administrative/Other|5
305254|NCT00810199|1002291|P2|Overall Study|Refused treatment/Did not cooperate|7
305255|NCT00810199|1002292|P1|Overall Study|Refused treatment/Did not cooperate|7
305256|NCT00810199|1002291|P2|Overall Study|Insufficient therapeutic response|14
305257|NCT00810199|1002292|P1|Overall Study|Insufficient therapeutic response|5
305258|NCT00810199|1002291|P2|Overall Study|Withdrew consent|12
305259|NCT00810199|1002292|P1|Overall Study|Withdrew consent|9
305260|NCT00810199|1002291|P2|Overall Study|Death|6
305261|NCT00810199|1002292|P1|Overall Study|Death|4
305262|NCT00810199|1002291|P2|Overall Study|Adverse Event|26
305263|NCT00810199|1002292|P1|Overall Study|Adverse Event|24
305264|NCT00810108|1002370|P2|Overall Study|Withdrawal by Subject|0
305265|NCT00810108|1002371|P1|Overall Study|Withdrawal by Subject|1
305266|NCT00810082|1002385|P2|Overall Study|Lost to Follow-up|4
305267|NCT00810082|1002386|P1|Overall Study|Lost to Follow-up|0
305268|NCT00810069|1002394|P3|Double-Blind Period II|Protocol Violation|6
305269|NCT00810069|1002395|P2|Double-Blind Period II|Protocol Violation|7
305270|NCT00810069|1002396|P1|Double-Blind Period II|Protocol Violation|0
305271|NCT00810069|1002394|P3|Double-Blind Period II|Clinical relapse|0
305272|NCT00810069|1002395|P2|Double-Blind Period II|Clinical relapse|3
305273|NCT00810069|1002396|P1|Double-Blind Period II|Clinical relapse|0
305274|NCT00810069|1002394|P3|Double-Blind Period II|Protocol entry criterion not met|1
305275|NCT00810069|1002395|P2|Double-Blind Period II|Protocol entry criterion not met|0
305276|NCT00810069|1002396|P1|Double-Blind Period II|Protocol entry criterion not met|0
305277|NCT00810069|1002394|P3|Double-Blind Period II|Withdrawal by Subject|35
305278|NCT00810069|1002395|P2|Double-Blind Period II|Withdrawal by Subject|21
305279|NCT00810069|1002396|P1|Double-Blind Period II|Withdrawal by Subject|0
305280|NCT00810069|1002394|P3|Double-Blind Period II|Physician Decision|1
305281|NCT00810069|1002395|P2|Double-Blind Period II|Physician Decision|0
305282|NCT00810069|1002396|P1|Double-Blind Period II|Physician Decision|0
305283|NCT00810069|1002394|P3|Double-Blind Period II|Lost to Follow-up|9
305284|NCT00810069|1002395|P2|Double-Blind Period II|Lost to Follow-up|9
305285|NCT00810069|1002396|P1|Double-Blind Period II|Lost to Follow-up|0
305286|NCT00810069|1002394|P3|Double-Blind Period II|Lack of Efficacy|12
305287|NCT00810069|1002395|P2|Double-Blind Period II|Lack of Efficacy|7
305288|NCT00810069|1002396|P1|Double-Blind Period II|Lack of Efficacy|0
305289|NCT00810069|1002394|P3|Double-Blind Period II|Adverse Event|8
305290|NCT00810069|1002395|P2|Double-Blind Period II|Adverse Event|9
305291|NCT00810069|1002396|P1|Double-Blind Period II|Adverse Event|0
305292|NCT00810069|1002394|P3|Lead-in Period I|Randomization criteria not met|0
305293|NCT00810069|1002395|P2|Lead-in Period I|Randomization criteria not met|0
305294|NCT00810069|1002396|P1|Lead-in Period I|Randomization criteria not met|158
305295|NCT00810069|1002394|P3|Lead-in Period I|Protocol entry criterion not met|0
305296|NCT00810069|1002395|P2|Lead-in Period I|Protocol entry criterion not met|0
305297|NCT00810069|1002396|P1|Lead-in Period I|Protocol entry criterion not met|5
305298|NCT00810069|1002394|P3|Lead-in Period I|Withdrawal by Subject|0
305299|NCT00810069|1002395|P2|Lead-in Period I|Withdrawal by Subject|0
305300|NCT00810069|1002396|P1|Lead-in Period I|Withdrawal by Subject|46
305301|NCT00810069|1002394|P3|Lead-in Period I|Protocol Violation|0
305302|NCT00810069|1002395|P2|Lead-in Period I|Protocol Violation|0
305303|NCT00810069|1002396|P1|Lead-in Period I|Protocol Violation|1
305304|NCT00810069|1002394|P3|Lead-in Period I|Physician Decision|0
305305|NCT00810069|1002395|P2|Lead-in Period I|Physician Decision|0
305306|NCT00810069|1002396|P1|Lead-in Period I|Physician Decision|1
305307|NCT00810069|1002394|P3|Lead-in Period I|Lost to Follow-up|0
305308|NCT00810069|1002395|P2|Lead-in Period I|Lost to Follow-up|0
305309|NCT00810069|1002396|P1|Lead-in Period I|Lost to Follow-up|19
305310|NCT00810069|1002394|P3|Lead-in Period I|Lack of Efficacy|0
305311|NCT00810069|1002395|P2|Lead-in Period I|Lack of Efficacy|0
305312|NCT00810069|1002396|P1|Lead-in Period I|Lack of Efficacy|1
305313|NCT00810069|1002394|P3|Lead-in Period I|Adverse Event|0
305314|NCT00810069|1002395|P2|Lead-in Period I|Adverse Event|0
305315|NCT00810069|1002396|P1|Lead-in Period I|Adverse Event|43
305316|NCT00810043|1002441|P3|Overall Study|No longer met enrollment criteria|3
305317|NCT00810043|1002442|P2|Overall Study|No longer met enrollment criteria|0
305318|NCT00810043|1002443|P1|Overall Study|No longer met enrollment criteria|0
305319|NCT00810043|1002441|P3|Overall Study|Non-medical problem|1
305320|NCT00810043|1002442|P2|Overall Study|Non-medical problem|0
305321|NCT00810043|1002443|P1|Overall Study|Non-medical problem|0
305322|NCT00810043|1002441|P3|Overall Study|Unrelated medical problem|0
305323|NCT00810043|1002442|P2|Overall Study|Unrelated medical problem|1
305324|NCT00810043|1002443|P1|Overall Study|Unrelated medical problem|0
305325|NCT00810043|1002441|P3|Overall Study|Death|0
305326|NCT00810043|1002442|P2|Overall Study|Death|0
305327|NCT00810043|1002443|P1|Overall Study|Death|2
305328|NCT00810043|1002441|P3|Overall Study|Physician Decision|2
305329|NCT00810043|1002442|P2|Overall Study|Physician Decision|0
305330|NCT00810043|1002443|P1|Overall Study|Physician Decision|0
305331|NCT00810043|1002441|P3|Overall Study|Lost to Follow-up|0
305332|NCT00810043|1002442|P2|Overall Study|Lost to Follow-up|0
305333|NCT00810043|1002443|P1|Overall Study|Lost to Follow-up|1
305334|NCT00810043|1002441|P3|Overall Study|Withdrawal by Subject|2
305335|NCT00810043|1002442|P2|Overall Study|Withdrawal by Subject|0
305336|NCT00810043|1002443|P1|Overall Study|Withdrawal by Subject|1
305337|NCT00809965|1002465|P3|Overall Study|Other Reason|189
305338|NCT00809965|1002466|P2|Overall Study|Other Reason|170
305339|NCT00809965|1002467|P1|Overall Study|Other Reason|167
305340|NCT00809965|1002465|P3|Overall Study|Withdrawal by Subject|441
305341|NCT00809965|1002466|P2|Overall Study|Withdrawal by Subject|448
305342|NCT00809965|1002467|P1|Overall Study|Withdrawal by Subject|405
305343|NCT00809965|1002465|P3|Overall Study|Lost to Follow-up|18
305344|NCT00809965|1002466|P2|Overall Study|Lost to Follow-up|10
305345|NCT00809965|1002467|P1|Overall Study|Lost to Follow-up|17
305346|NCT00809965|1002465|P3|Overall Study|Death|196
305347|NCT00809965|1002466|P2|Overall Study|Death|147
305348|NCT00809965|1002467|P1|Overall Study|Death|194
305349|NCT00809926|1002489|P2|Overall Study|Protocol deviation|2
305350|NCT00809926|1002490|P1|Overall Study|Protocol deviation|0
305351|NCT00809926|1002489|P2|Overall Study|Administrative Problems|1
305352|NCT00809926|1002490|P1|Overall Study|Administrative Problems|0
305353|NCT00809926|1002489|P2|Overall Study|Lost to Follow-up|1
305354|NCT00809926|1002490|P1|Overall Study|Lost to Follow-up|2
305355|NCT00809926|1002489|P2|Overall Study|Patient withdrew consent|6
305356|NCT00809926|1002490|P1|Overall Study|Patient withdrew consent|8
305357|NCT00809926|1002489|P2|Overall Study|Unsatisfactory therapeutic effect|3
305358|NCT00809926|1002490|P1|Overall Study|Unsatisfactory therapeutic effect|3
305359|NCT00809926|1002489|P2|Overall Study|Adverse Event|10
305360|NCT00809926|1002490|P1|Overall Study|Adverse Event|18
305361|NCT00809835|1002544|P4|Overall Study|Withdrawal by Subject|0
305362|NCT00809835|1002545|P3|Overall Study|Withdrawal by Subject|1
305363|NCT00809835|1002546|P2|Overall Study|Withdrawal by Subject|1
305364|NCT00809835|1002547|P1|Overall Study|Withdrawal by Subject|1
305365|NCT00809835|1002544|P4|Overall Study|Lost to Follow-up|2
305366|NCT00809835|1002545|P3|Overall Study|Lost to Follow-up|10
305367|NCT00809835|1002546|P2|Overall Study|Lost to Follow-up|6
305368|NCT00809835|1002547|P1|Overall Study|Lost to Follow-up|7
305369|NCT00809757|1002577|P3|Overall Study|Noncompliance with Medication|1
305370|NCT00809757|1002578|P2|Overall Study|Noncompliance with Medication|0
305371|NCT00809757|1002579|P1|Overall Study|Noncompliance with Medication|0
305372|NCT00809757|1002577|P3|Overall Study|Subject Uncooperative|2
305373|NCT00809757|1002578|P2|Overall Study|Subject Uncooperative|0
305374|NCT00809757|1002579|P1|Overall Study|Subject Uncooperative|1
305375|NCT00809757|1002577|P3|Overall Study|Withdrawal by Subject|3
305376|NCT00809757|1002578|P2|Overall Study|Withdrawal by Subject|1
305377|NCT00809757|1002579|P1|Overall Study|Withdrawal by Subject|2
305378|NCT00809757|1002577|P3|Overall Study|Protocol Violation|1
305379|NCT00809757|1002578|P2|Overall Study|Protocol Violation|1
305380|NCT00809757|1002579|P1|Overall Study|Protocol Violation|1
305381|NCT00809757|1002577|P3|Overall Study|Lost to Follow-up|1
305382|NCT00809757|1002578|P2|Overall Study|Lost to Follow-up|0
305383|NCT00809757|1002579|P1|Overall Study|Lost to Follow-up|0
305384|NCT00809757|1002577|P3|Overall Study|Adverse Event|3
305385|NCT00809757|1002578|P2|Overall Study|Adverse Event|3
305386|NCT00809757|1002579|P1|Overall Study|Adverse Event|2
305387|NCT00809614|1002664|P2|Overall Study|Withdrawal by Subject|1
305388|NCT00809614|1002665|P1|Overall Study|Withdrawal by Subject|1
305389|NCT00809614|1002664|P2|Overall Study|Lack of Efficacy|3
305390|NCT00809614|1002665|P1|Overall Study|Lack of Efficacy|2
305391|NCT00809471|1002709|P3|Overall Study|Requirement for restricted medication|0
305392|NCT00809471|1002710|P2|Overall Study|Requirement for restricted medication|1
305393|NCT00809471|1002711|P1|Overall Study|Requirement for restricted medication|1
305394|NCT00809471|1002709|P3|Overall Study|Adverse Event|2
305395|NCT00809471|1002710|P2|Overall Study|Adverse Event|2
305396|NCT00809471|1002711|P1|Overall Study|Adverse Event|0
305397|NCT00809471|1002709|P3|Overall Study|Lost to Follow-up|9
305398|NCT00809471|1002710|P2|Overall Study|Lost to Follow-up|2
305399|NCT00809471|1002711|P1|Overall Study|Lost to Follow-up|4
305400|NCT00809471|1002709|P3|Overall Study|Protocol non-compliance|6
305401|NCT00809471|1002710|P2|Overall Study|Protocol non-compliance|15
305402|NCT00809471|1002711|P1|Overall Study|Protocol non-compliance|15
305403|NCT00809445|1002741|P3|6 Month Follow-up|Withdrew consent|1
305404|NCT00809445|1002742|P2|6 Month Follow-up|Withdrew consent|0
305405|NCT00809445|1002743|P1|6 Month Follow-up|Withdrew consent|0
305406|NCT00809445|1002741|P3|6 Month Follow-up|Incarcerated|8
305407|NCT00809445|1002742|P2|6 Month Follow-up|Incarcerated|8
305408|NCT00809445|1002743|P1|6 Month Follow-up|Incarcerated|6
305409|NCT00809445|1002741|P3|6 Month Follow-up|Death|1
305410|NCT00809445|1002742|P2|6 Month Follow-up|Death|1
305411|NCT00809445|1002743|P1|6 Month Follow-up|Death|2
305412|NCT00809445|1002741|P3|6 Month Follow-up|Lost contact|14
305413|NCT00809445|1002742|P2|6 Month Follow-up|Lost contact|14
305414|NCT00809445|1002743|P1|6 Month Follow-up|Lost contact|16
305415|NCT00809445|1002741|P3|1 Month Follow-up|Incarcerated|1
305416|NCT00809445|1002742|P2|1 Month Follow-up|Incarcerated|0
305417|NCT00809445|1002743|P1|1 Month Follow-up|Incarcerated|0
305418|NCT00809445|1002741|P3|1 Month Follow-up|Death|1
305419|NCT00809445|1002742|P2|1 Month Follow-up|Death|1
305420|NCT00809445|1002743|P1|1 Month Follow-up|Death|0
305421|NCT00809445|1002741|P3|1 Month Follow-up|Withdrew consent|1
305422|NCT00809445|1002742|P2|1 Month Follow-up|Withdrew consent|1
305423|NCT00809445|1002743|P1|1 Month Follow-up|Withdrew consent|1
305424|NCT00809445|1002741|P3|1 Month Follow-up|Lost contact|1
305425|NCT00809445|1002742|P2|1 Month Follow-up|Lost contact|2
305426|NCT00809445|1002743|P1|1 Month Follow-up|Lost contact|1
305427|NCT00809328|1002760|P1|Overall Study|Withdrawal by Subject|2
305428|NCT00809328|1002760|P1|Overall Study|Protocol Violation|3
305429|NCT00809328|1002760|P1|Overall Study|Adverse Event|6
305430|NCT00809328|1002760|P1|Overall Study|Lack of Efficacy|18
305431|NCT00809159|1002780|P6|Part 1 and 2|Withdrawal by Subject|1
305432|NCT00809159|1002781|P5|Part 1 and 2|Withdrawal by Subject|0
305433|NCT00809159|1002782|P4|Part 1 and 2|Withdrawal by Subject|0
305434|NCT00809159|1002783|P3|Part 1 and 2|Withdrawal by Subject|4
305435|NCT00809159|1002784|P2|Part 1 and 2|Withdrawal by Subject|0
305436|NCT00809159|1002785|P1|Part 1 and 2|Withdrawal by Subject|0
305437|NCT00809159|1002780|P6|Part 1 and 2|Lost to Follow-up|0
305438|NCT00809159|1002781|P5|Part 1 and 2|Lost to Follow-up|0
305439|NCT00809159|1002782|P4|Part 1 and 2|Lost to Follow-up|1
305440|NCT00809159|1002783|P3|Part 1 and 2|Lost to Follow-up|1
305441|NCT00809159|1002784|P2|Part 1 and 2|Lost to Follow-up|0
305442|NCT00809159|1002785|P1|Part 1 and 2|Lost to Follow-up|0
305443|NCT00809159|1002780|P6|Part 1 and 2|Adverse Event|1
305444|NCT00809159|1002781|P5|Part 1 and 2|Adverse Event|1
305445|NCT00809159|1002782|P4|Part 1 and 2|Adverse Event|0
305446|NCT00809159|1002783|P3|Part 1 and 2|Adverse Event|1
305447|NCT00809159|1002784|P2|Part 1 and 2|Adverse Event|0
305448|NCT00809159|1002785|P1|Part 1 and 2|Adverse Event|0
305449|NCT00809159|1002780|P6|Part 1 and 2|Administrative problems|0
305450|NCT00809159|1002781|P5|Part 1 and 2|Administrative problems|0
305451|NCT00809159|1002782|P4|Part 1 and 2|Administrative problems|1
305452|NCT00809159|1002783|P3|Part 1 and 2|Administrative problems|0
305453|NCT00809159|1002784|P2|Part 1 and 2|Administrative problems|0
305454|NCT00809159|1002785|P1|Part 1 and 2|Administrative problems|0
305455|NCT00809159|1002780|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
305456|NCT00809159|1002781|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
305457|NCT00809159|1002782|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
305458|NCT00809159|1002783|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
305459|NCT00809159|1002784|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
305460|NCT00809159|1002785|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
305461|NCT00809159|1002780|P6|Part 1|Unsatisfactory therapeutic effect|0
305462|NCT00809159|1002781|P5|Part 1|Unsatisfactory therapeutic effect|0
305463|NCT00809159|1002782|P4|Part 1|Unsatisfactory therapeutic effect|0
305464|NCT00809159|1002783|P3|Part 1|Unsatisfactory therapeutic effect|0
305465|NCT00809159|1002784|P2|Part 1|Unsatisfactory therapeutic effect|1
305466|NCT00809159|1002785|P1|Part 1|Unsatisfactory therapeutic effect|3
305467|NCT00809159|1002780|P6|Part 1|Withdrawal by Subject|0
305468|NCT00809159|1002781|P5|Part 1|Withdrawal by Subject|0
305469|NCT00809159|1002782|P4|Part 1|Withdrawal by Subject|0
305470|NCT00809159|1002783|P3|Part 1|Withdrawal by Subject|0
305471|NCT00809159|1002784|P2|Part 1|Withdrawal by Subject|1
305472|NCT00809159|1002785|P1|Part 1|Withdrawal by Subject|3
305473|NCT00809159|1002780|P6|Part 1|Lost to Follow-up|0
305474|NCT00809159|1002781|P5|Part 1|Lost to Follow-up|0
305475|NCT00809159|1002782|P4|Part 1|Lost to Follow-up|0
305476|NCT00809159|1002783|P3|Part 1|Lost to Follow-up|0
305477|NCT00809159|1002784|P2|Part 1|Lost to Follow-up|0
305478|NCT00809159|1002785|P1|Part 1|Lost to Follow-up|1
305479|NCT00809159|1002780|P6|Part 1|Adverse Event|0
305480|NCT00809159|1002781|P5|Part 1|Adverse Event|0
305481|NCT00809159|1002782|P4|Part 1|Adverse Event|0
305482|NCT00809159|1002783|P3|Part 1|Adverse Event|0
305483|NCT00809159|1002784|P2|Part 1|Adverse Event|1
305484|NCT00809159|1002785|P1|Part 1|Adverse Event|1
305485|NCT00809133|1002890|P14|Overall Study|Other not mentioned above|0
305486|NCT00809133|1002891|P13|Overall Study|Other not mentioned above|0
305487|NCT00809133|1002892|P12|Overall Study|Other not mentioned above|0
305488|NCT00809133|1002893|P11|Overall Study|Other not mentioned above|0
305489|NCT00809133|1002894|P10|Overall Study|Other not mentioned above|0
305490|NCT00809133|1002895|P9|Overall Study|Other not mentioned above|0
305491|NCT00809133|1002896|P8|Overall Study|Other not mentioned above|0
305492|NCT00809133|1002897|P7|Overall Study|Other not mentioned above|0
305493|NCT00809133|1002898|P6|Overall Study|Other not mentioned above|1
305494|NCT00809133|1002899|P5|Overall Study|Other not mentioned above|0
305495|NCT00809133|1002900|P4|Overall Study|Other not mentioned above|0
305496|NCT00809133|1002901|P3|Overall Study|Other not mentioned above|0
305497|NCT00809133|1002902|P2|Overall Study|Other not mentioned above|1
305498|NCT00809133|1002903|P1|Overall Study|Other not mentioned above|0
305499|NCT00809133|1002890|P14|Overall Study|Consent withdrawn|0
305500|NCT00809133|1002891|P13|Overall Study|Consent withdrawn|0
305501|NCT00809133|1002892|P12|Overall Study|Consent withdrawn|0
305502|NCT00809133|1002893|P11|Overall Study|Consent withdrawn|0
305503|NCT00809133|1002894|P10|Overall Study|Consent withdrawn|0
305504|NCT00809133|1002895|P9|Overall Study|Consent withdrawn|0
305505|NCT00809133|1002896|P8|Overall Study|Consent withdrawn|0
305506|NCT00809133|1002897|P7|Overall Study|Consent withdrawn|0
305507|NCT00809133|1002898|P6|Overall Study|Consent withdrawn|0
305508|NCT00809133|1002899|P5|Overall Study|Consent withdrawn|1
305509|NCT00809133|1002900|P4|Overall Study|Consent withdrawn|0
305510|NCT00809133|1002901|P3|Overall Study|Consent withdrawn|0
305511|NCT00809133|1002902|P2|Overall Study|Consent withdrawn|0
305512|NCT00809133|1002903|P1|Overall Study|Consent withdrawn|0
305513|NCT00809133|1002890|P14|Overall Study|Lost to Follow-up|0
305514|NCT00809133|1002891|P13|Overall Study|Lost to Follow-up|0
305515|NCT00809133|1002892|P12|Overall Study|Lost to Follow-up|0
305516|NCT00809133|1002893|P11|Overall Study|Lost to Follow-up|0
305517|NCT00809133|1002894|P10|Overall Study|Lost to Follow-up|0
305518|NCT00809133|1002895|P9|Overall Study|Lost to Follow-up|0
305519|NCT00809133|1002896|P8|Overall Study|Lost to Follow-up|0
305520|NCT00809133|1002897|P7|Overall Study|Lost to Follow-up|0
305521|NCT00809133|1002898|P6|Overall Study|Lost to Follow-up|1
305522|NCT00809133|1002899|P5|Overall Study|Lost to Follow-up|0
305523|NCT00809133|1002900|P4|Overall Study|Lost to Follow-up|0
305524|NCT00809133|1002901|P3|Overall Study|Lost to Follow-up|0
305525|NCT00809133|1002902|P2|Overall Study|Lost to Follow-up|0
305526|NCT00809133|1002903|P1|Overall Study|Lost to Follow-up|0
305527|NCT00809133|1002890|P14|Overall Study|Other adverse event|1
305528|NCT00809133|1002891|P13|Overall Study|Other adverse event|0
305529|NCT00809133|1002892|P12|Overall Study|Other adverse event|1
305530|NCT00809133|1002893|P11|Overall Study|Other adverse event|1
305531|NCT00809133|1002894|P10|Overall Study|Other adverse event|0
305532|NCT00809133|1002895|P9|Overall Study|Other adverse event|0
305533|NCT00809133|1002896|P8|Overall Study|Other adverse event|4
305534|NCT00809133|1002897|P7|Overall Study|Other adverse event|2
305535|NCT00809133|1002898|P6|Overall Study|Other adverse event|3
305536|NCT00809133|1002899|P5|Overall Study|Other adverse event|0
305537|NCT00809133|1002900|P4|Overall Study|Other adverse event|0
305538|NCT00809133|1002901|P3|Overall Study|Other adverse event|1
305539|NCT00809133|1002902|P2|Overall Study|Other adverse event|1
305540|NCT00809133|1002903|P1|Overall Study|Other adverse event|1
305541|NCT00809133|1002890|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
305542|NCT00809133|1002891|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
305543|NCT00809133|1002892|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
305544|NCT00809133|1002893|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
305545|NCT00809133|1002894|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
305546|NCT00809133|1002895|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
305547|NCT00809133|1002896|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
305548|NCT00809133|1002897|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
305549|NCT00809133|1002898|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
305550|NCT00809133|1002899|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
305551|NCT00809133|1002900|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
305552|NCT00809133|1002901|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
305553|NCT00809133|1002902|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
305554|NCT00809133|1002903|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
305555|NCT00809133|1002890|P14|Overall Study|Progressive disease|4
305556|NCT00809133|1002891|P13|Overall Study|Progressive disease|5
305557|NCT00809133|1002892|P12|Overall Study|Progressive disease|7
305558|NCT00809133|1002893|P11|Overall Study|Progressive disease|5
305559|NCT00809133|1002894|P10|Overall Study|Progressive disease|9
305560|NCT00809133|1002895|P9|Overall Study|Progressive disease|3
305561|NCT00809133|1002896|P8|Overall Study|Progressive disease|3
305562|NCT00809133|1002897|P7|Overall Study|Progressive disease|3
305563|NCT00809133|1002898|P6|Overall Study|Progressive disease|1
305564|NCT00809133|1002899|P5|Overall Study|Progressive disease|4
305565|NCT00809133|1002900|P4|Overall Study|Progressive disease|3
305566|NCT00809133|1002901|P3|Overall Study|Progressive disease|5
305567|NCT00809133|1002902|P2|Overall Study|Progressive disease|5
305568|NCT00809133|1002903|P1|Overall Study|Progressive disease|2
305569|NCT00809094|1003057|P2|Overall Study|Lost to Follow-up|1
305570|NCT00809094|1003058|P1|Overall Study|Lost to Follow-up|0
305571|NCT00808899|1003103|P1|Overall Study|Physician Decision|3
305572|NCT00808899|1003103|P1|Overall Study|Death|1
305573|NCT00808808|1003117|P3|Overall Study|Employee was not vaccinated.|2255
305574|NCT00808808|1003118|P2|Overall Study|Employee was not vaccinated.|2268
305575|NCT00808808|1003119|P1|Overall Study|Employee was not vaccinated.|2686
305576|NCT00808808|1003117|P3|Overall Study|Vaccinated; survey not completed|302
305577|NCT00808808|1003118|P2|Overall Study|Vaccinated; survey not completed|169
305578|NCT00808808|1003119|P1|Overall Study|Vaccinated; survey not completed|131
305579|NCT00808639|1003152|P1|Overall Study|Disease progression before surgery.|1
305580|NCT00808509|1003160|P2|Randomized Phase|Patient refused rescue therapy|3
305581|NCT00808509|1003161|P1|Randomized Phase|Patient refused rescue therapy|0
305582|NCT00808509|1003160|P2|Randomized Phase|Reduced methotrexate dose|2
305583|NCT00808509|1003161|P1|Randomized Phase|Reduced methotrexate dose|1
305584|NCT00808509|1003160|P2|Randomized Phase|Did not meet eligibility criteria|0
305585|NCT00808509|1003161|P1|Randomized Phase|Did not meet eligibility criteria|1
305586|NCT00808483|1003259|P2|From 5 Months to 12 Months|Lack of Efficacy|0
305587|NCT00808483|1003260|P1|From 5 Months to 12 Months|Lack of Efficacy|1
305588|NCT00808483|1003259|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
305589|NCT00808483|1003260|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
305590|NCT00808483|1003259|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
305591|NCT00808483|1003260|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
305592|NCT00808444|1003297|P2|Overall Study|Lost to Follow-up|1
305593|NCT00808444|1003298|P1|Overall Study|Lost to Follow-up|0
305594|NCT00808444|1003297|P2|Overall Study|Withdrawal by Subject|0
305595|NCT00808444|1003298|P1|Overall Study|Withdrawal by Subject|1
305596|NCT00808249|1003373|P4|Overall Study|All other reasons|1
305597|NCT00808249|1003374|P3|Overall Study|All other reasons|3
305598|NCT00808249|1003375|P2|Overall Study|All other reasons|1
305599|NCT00808249|1003376|P1|Overall Study|All other reasons|2
305600|NCT00808249|1003373|P4|Overall Study|study specific discontinuation criteria|0
305601|NCT00808249|1003374|P3|Overall Study|study specific discontinuation criteria|1
305602|NCT00808249|1003375|P2|Overall Study|study specific discontinuation criteria|0
305603|NCT00808249|1003376|P1|Overall Study|study specific discontinuation criteria|1
305604|NCT00808249|1003373|P4|Overall Study|Lack of Efficacy|0
305605|NCT00808249|1003374|P3|Overall Study|Lack of Efficacy|0
305606|NCT00808249|1003375|P2|Overall Study|Lack of Efficacy|1
305607|NCT00808249|1003376|P1|Overall Study|Lack of Efficacy|1
305608|NCT00808249|1003373|P4|Overall Study|Protocol Violation|0
305609|NCT00808249|1003374|P3|Overall Study|Protocol Violation|3
305610|NCT00808249|1003375|P2|Overall Study|Protocol Violation|3
305611|NCT00808249|1003376|P1|Overall Study|Protocol Violation|3
305612|NCT00808249|1003373|P4|Overall Study|Withdrawal by Subject|4
305613|NCT00808249|1003374|P3|Overall Study|Withdrawal by Subject|2
305614|NCT00808249|1003375|P2|Overall Study|Withdrawal by Subject|0
305615|NCT00808249|1003376|P1|Overall Study|Withdrawal by Subject|4
305616|NCT00808249|1003373|P4|Overall Study|Lost to Follow-up|5
305617|NCT00808249|1003374|P3|Overall Study|Lost to Follow-up|3
305618|NCT00808249|1003375|P2|Overall Study|Lost to Follow-up|3
305619|NCT00808249|1003376|P1|Overall Study|Lost to Follow-up|2
305620|NCT00808249|1003373|P4|Overall Study|Adverse Event|6
305621|NCT00808249|1003374|P3|Overall Study|Adverse Event|10
305622|NCT00808249|1003375|P2|Overall Study|Adverse Event|7
305623|NCT00808249|1003376|P1|Overall Study|Adverse Event|4
305624|NCT00808236|1003404|P2|Overall Study|Death|30
305625|NCT00808236|1003405|P1|Overall Study|Death|18
305626|NCT00808236|1003404|P2|Overall Study|Physician Decision|1
305627|NCT00808236|1003405|P1|Overall Study|Physician Decision|0
305628|NCT00808236|1003404|P2|Overall Study|Lost to Follow-up|1
305629|NCT00808236|1003405|P1|Overall Study|Lost to Follow-up|1
305630|NCT00808236|1003404|P2|Overall Study|Pre-defined exclusion|3
305631|NCT00808236|1003405|P1|Overall Study|Pre-defined exclusion|13
305632|NCT00808236|1003404|P2|Overall Study|Was not resuscitated|56
305633|NCT00808236|1003405|P1|Overall Study|Was not resuscitated|50
305634|NCT00808132|1003438|P5|Overall Study|Unsatisfactory response|12
305635|NCT00808132|1003439|P4|Overall Study|Unsatisfactory response|4
305636|NCT00808132|1003440|P3|Overall Study|Unsatisfactory response|6
305637|NCT00808132|1003441|P2|Overall Study|Unsatisfactory response|6
305638|NCT00808132|1003442|P1|Overall Study|Unsatisfactory response|5
305639|NCT00808132|1003438|P5|Overall Study|Randomized, but not treated|9
305640|NCT00808132|1003439|P4|Overall Study|Randomized, but not treated|8
305641|NCT00808132|1003440|P3|Overall Study|Randomized, but not treated|9
305642|NCT00808132|1003441|P2|Overall Study|Randomized, but not treated|7
305643|NCT00808132|1003442|P1|Overall Study|Randomized, but not treated|10
305644|NCT00808132|1003438|P5|Overall Study|Unspecified|15
305645|NCT00808132|1003439|P4|Overall Study|Unspecified|2
305646|NCT00808132|1003440|P3|Overall Study|Unspecified|6
305647|NCT00808132|1003441|P2|Overall Study|Unspecified|4
305648|NCT00808132|1003442|P1|Overall Study|Unspecified|6
305649|NCT00808132|1003438|P5|Overall Study|Withdrawal by Subject|16
305650|NCT00808132|1003439|P4|Overall Study|Withdrawal by Subject|7
305651|NCT00808132|1003440|P3|Overall Study|Withdrawal by Subject|2
305652|NCT00808132|1003441|P2|Overall Study|Withdrawal by Subject|18
305653|NCT00808132|1003442|P1|Overall Study|Withdrawal by Subject|27
305654|NCT00808132|1003438|P5|Overall Study|Protocol Violation|5
305655|NCT00808132|1003439|P4|Overall Study|Protocol Violation|9
305656|NCT00808132|1003440|P3|Overall Study|Protocol Violation|4
305657|NCT00808132|1003441|P2|Overall Study|Protocol Violation|9
305658|NCT00808132|1003442|P1|Overall Study|Protocol Violation|8
305659|NCT00808132|1003438|P5|Overall Study|Lost to Follow-up|9
305660|NCT00808132|1003439|P4|Overall Study|Lost to Follow-up|8
305661|NCT00808132|1003440|P3|Overall Study|Lost to Follow-up|11
305662|NCT00808132|1003441|P2|Overall Study|Lost to Follow-up|10
305663|NCT00808132|1003442|P1|Overall Study|Lost to Follow-up|8
305664|NCT00808132|1003438|P5|Overall Study|Physician Decision|0
305665|NCT00808132|1003439|P4|Overall Study|Physician Decision|0
305666|NCT00808132|1003440|P3|Overall Study|Physician Decision|0
305667|NCT00808132|1003441|P2|Overall Study|Physician Decision|1
305668|NCT00808132|1003442|P1|Overall Study|Physician Decision|0
305669|NCT00808132|1003438|P5|Overall Study|Death|1
305670|NCT00808132|1003439|P4|Overall Study|Death|0
305671|NCT00808132|1003440|P3|Overall Study|Death|0
305672|NCT00808132|1003441|P2|Overall Study|Death|0
305673|NCT00808132|1003442|P1|Overall Study|Death|0
305674|NCT00808132|1003438|P5|Overall Study|Adverse Event|33
305675|NCT00808132|1003439|P4|Overall Study|Adverse Event|31
305676|NCT00808132|1003440|P3|Overall Study|Adverse Event|16
305677|NCT00808132|1003441|P2|Overall Study|Adverse Event|33
305678|NCT00808132|1003442|P1|Overall Study|Adverse Event|34
305679|NCT00808080|1003514|P1|Overall Study|Patients Became Ineligible for infusion|6
305680|NCT00808067|1003520|P2|Overall Study|Excluded from analysis|19
305681|NCT00808067|1003521|P1|Overall Study|Excluded from analysis|13
305682|NCT00808067|1003520|P2|Overall Study|Other reason not defined above|5
305683|NCT00808067|1003521|P1|Overall Study|Other reason not defined above|5
305684|NCT00808067|1003520|P2|Overall Study|Site closed for cause|19
305685|NCT00808067|1003521|P1|Overall Study|Site closed for cause|19
305686|NCT00808067|1003520|P2|Overall Study|Patient elected|9
305687|NCT00808067|1003521|P1|Overall Study|Patient elected|7
305688|NCT00808067|1003520|P2|Overall Study|Protocol Violation|11
305689|NCT00808067|1003521|P1|Overall Study|Protocol Violation|3
305690|NCT00808067|1003520|P2|Overall Study|Physician Decision|38
305691|NCT00808067|1003521|P1|Overall Study|Physician Decision|47
305692|NCT00808067|1003520|P2|Overall Study|Site closed|3
305693|NCT00808067|1003521|P1|Overall Study|Site closed|4
305694|NCT00808067|1003520|P2|Overall Study|Withdrawal by Subject|25
305695|NCT00808067|1003521|P1|Overall Study|Withdrawal by Subject|21
305696|NCT00808067|1003520|P2|Overall Study|Procedure|7
305697|NCT00808067|1003521|P1|Overall Study|Procedure|6
305698|NCT00808067|1003520|P2|Overall Study|Death|1
305699|NCT00808067|1003521|P1|Overall Study|Death|1
305700|NCT00808067|1003520|P2|Overall Study|Missing|0
305701|NCT00808067|1003521|P1|Overall Study|Missing|1
305702|NCT00808067|1003520|P2|Overall Study|Patient refused to take study medication|76
305703|NCT00808067|1003521|P1|Overall Study|Patient refused to take study medication|65
305704|NCT00808067|1003520|P2|Overall Study|Elevated LFT results|3
305705|NCT00808067|1003521|P1|Overall Study|Elevated LFT results|7
305706|NCT00808067|1003520|P2|Overall Study|Reduced creatinine clearance|55
305707|NCT00808067|1003521|P1|Overall Study|Reduced creatinine clearance|53
305708|NCT00808067|1003520|P2|Overall Study|Hospitalization due to surgery|40
305709|NCT00808067|1003521|P1|Overall Study|Hospitalization due to surgery|37
305710|NCT00808067|1003520|P2|Overall Study|Hospitalization (not including surgery)|17
305711|NCT00808067|1003521|P1|Overall Study|Hospitalization (not including surgery)|18
305712|NCT00808067|1003520|P2|Overall Study|Adverse Event|121
305713|NCT00808067|1003521|P1|Overall Study|Adverse Event|111
305714|NCT00808067|1003520|P2|Overall Study|Outcome event - other|25
305715|NCT00808067|1003521|P1|Overall Study|Outcome event - other|33
305716|NCT00808067|1003520|P2|Overall Study|Major/minor bleed|44
305717|NCT00808067|1003521|P1|Overall Study|Major/minor bleed|30
305718|NCT00808028|1003557|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
305719|NCT00808028|1003558|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
305720|NCT00808028|1003559|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
305721|NCT00808028|1003560|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
305722|NCT00808028|1003557|P4|Stage 2 (Followed up to 48 Months )|Death|0
305723|NCT00808028|1003558|P3|Stage 2 (Followed up to 48 Months )|Death|1
305724|NCT00808028|1003559|P2|Stage 2 (Followed up to 48 Months )|Death|0
305725|NCT00808028|1003560|P1|Stage 2 (Followed up to 48 Months )|Death|0
305726|NCT00808028|1003557|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
305727|NCT00808028|1003558|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
305728|NCT00808028|1003559|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
305729|NCT00808028|1003560|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
305730|NCT00808028|1003557|P4|Stage 2 (Followed up to 48 Months )|Unspecified|1
305731|NCT00808028|1003558|P3|Stage 2 (Followed up to 48 Months )|Unspecified|1
305732|NCT00808028|1003559|P2|Stage 2 (Followed up to 48 Months )|Unspecified|0
305733|NCT00808028|1003560|P1|Stage 2 (Followed up to 48 Months )|Unspecified|0
305734|NCT00808028|1003557|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
305735|NCT00808028|1003558|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
305736|NCT00808028|1003559|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
305737|NCT00808028|1003560|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
305738|NCT00808028|1003557|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
305739|NCT00808028|1003558|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
305740|NCT00808028|1003559|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
305741|NCT00808028|1003560|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
305742|NCT00808028|1003557|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
305743|NCT00808028|1003558|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
305744|NCT00808028|1003559|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
305745|NCT00808028|1003560|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
305746|NCT00808028|1003557|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
305747|NCT00808028|1003558|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
305748|NCT00808028|1003559|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
305749|NCT00808028|1003560|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
305750|NCT00808028|1003557|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
305751|NCT00808028|1003558|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
305752|NCT00808028|1003559|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
305753|NCT00808028|1003560|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
305754|NCT00808028|1003557|P4|Stage 1 (6 Months)|Protocol Violation|1
305755|NCT00808028|1003558|P3|Stage 1 (6 Months)|Protocol Violation|0
305756|NCT00808028|1003559|P2|Stage 1 (6 Months)|Protocol Violation|0
305757|NCT00808028|1003560|P1|Stage 1 (6 Months)|Protocol Violation|0
305758|NCT00808028|1003557|P4|Stage 1 (6 Months)|Lost to Follow-up|0
305759|NCT00808028|1003558|P3|Stage 1 (6 Months)|Lost to Follow-up|1
305760|NCT00808028|1003559|P2|Stage 1 (6 Months)|Lost to Follow-up|0
305761|NCT00808028|1003560|P1|Stage 1 (6 Months)|Lost to Follow-up|1
305762|NCT00808028|1003557|P4|Stage 1 (6 Months)|Adverse Event|2
305763|NCT00808028|1003558|P3|Stage 1 (6 Months)|Adverse Event|1
305764|NCT00808028|1003559|P2|Stage 1 (6 Months)|Adverse Event|0
305765|NCT00808028|1003560|P1|Stage 1 (6 Months)|Adverse Event|0
305766|NCT00808028|1003557|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
305767|NCT00808028|1003558|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
305768|NCT00808028|1003559|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
305769|NCT00808028|1003560|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
305770|NCT00808028|1003557|P4|Stage 1 (6 Months)|Unspecified|4
305771|NCT00808028|1003558|P3|Stage 1 (6 Months)|Unspecified|2
305772|NCT00808028|1003559|P2|Stage 1 (6 Months)|Unspecified|0
305773|NCT00808028|1003560|P1|Stage 1 (6 Months)|Unspecified|1
305774|NCT00808028|1003557|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
305775|NCT00808028|1003558|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
305776|NCT00808028|1003559|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
305777|NCT00808028|1003560|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
305778|NCT00808015|1003596|P1|Overall Study|Enrolled but not treated|4
305779|NCT00808015|1003596|P1|Overall Study|Unspecified|25
305780|NCT00808015|1003596|P1|Overall Study|Adverse Event|22
305781|NCT00808015|1003596|P1|Overall Study|Participants not willing to participate|158
305782|NCT00808015|1003596|P1|Overall Study|Lost to Follow-up|76
305783|NCT00808015|1003596|P1|Overall Study|Lack of Efficacy|58
305784|NCT00808015|1003596|P1|Overall Study|Death|1
305785|NCT00807937|1003625|P4|Overall Study|All other reasons (not provided)|1
305786|NCT00807937|1003626|P3|Overall Study|All other reasons (not provided)|0
305787|NCT00807937|1003627|P2|Overall Study|All other reasons (not provided)|4
305788|NCT00807937|1003628|P1|Overall Study|All other reasons (not provided)|2
305789|NCT00807937|1003625|P4|Overall Study|Intake of prohibited medicine|0
305790|NCT00807937|1003626|P3|Overall Study|Intake of prohibited medicine|2
305791|NCT00807937|1003627|P2|Overall Study|Intake of prohibited medicine|0
305792|NCT00807937|1003628|P1|Overall Study|Intake of prohibited medicine|0
305793|NCT00807937|1003625|P4|Overall Study|Lack of Efficacy|2
305794|NCT00807937|1003626|P3|Overall Study|Lack of Efficacy|1
305795|NCT00807937|1003627|P2|Overall Study|Lack of Efficacy|0
305796|NCT00807937|1003628|P1|Overall Study|Lack of Efficacy|0
305797|NCT00807937|1003625|P4|Overall Study|Lost to Follow-up|1
305798|NCT00807937|1003626|P3|Overall Study|Lost to Follow-up|2
305799|NCT00807937|1003627|P2|Overall Study|Lost to Follow-up|0
305800|NCT00807937|1003628|P1|Overall Study|Lost to Follow-up|4
305801|NCT00807937|1003625|P4|Overall Study|Withdrawal by Subject|4
305802|NCT00807937|1003626|P3|Overall Study|Withdrawal by Subject|1
305803|NCT00807937|1003627|P2|Overall Study|Withdrawal by Subject|4
305804|NCT00807937|1003628|P1|Overall Study|Withdrawal by Subject|5
305805|NCT00807937|1003625|P4|Overall Study|Protocol Violation|3
305806|NCT00807937|1003626|P3|Overall Study|Protocol Violation|3
305807|NCT00807937|1003627|P2|Overall Study|Protocol Violation|5
305808|NCT00807937|1003628|P1|Overall Study|Protocol Violation|4
305809|NCT00807937|1003625|P4|Overall Study|Adverse Event|4
305810|NCT00807937|1003626|P3|Overall Study|Adverse Event|5
305811|NCT00807937|1003627|P2|Overall Study|Adverse Event|12
305812|NCT00807937|1003628|P1|Overall Study|Adverse Event|12
305813|NCT00807885|1003663|P9|Overall Study|Lost to Follow-up|0
305814|NCT00807885|1003664|P8|Overall Study|Lost to Follow-up|0
305815|NCT00807885|1003665|P7|Overall Study|Lost to Follow-up|0
305816|NCT00807885|1003666|P6|Overall Study|Lost to Follow-up|1
305817|NCT00807885|1003667|P5|Overall Study|Lost to Follow-up|0
305818|NCT00807885|1003668|P4|Overall Study|Lost to Follow-up|0
305819|NCT00807885|1003669|P3|Overall Study|Lost to Follow-up|0
305820|NCT00807885|1003670|P2|Overall Study|Lost to Follow-up|0
305821|NCT00807885|1003671|P1|Overall Study|Lost to Follow-up|0
305822|NCT00807846|1003720|P2|Overall Study|Not Specified|2
305823|NCT00807846|1003721|P1|Overall Study|Not Specified|1
305824|NCT00807846|1003720|P2|Overall Study|Withdrawal by Subject|1
305825|NCT00807846|1003721|P1|Overall Study|Withdrawal by Subject|2
305826|NCT00807846|1003720|P2|Overall Study|Protocol Violation|1
305827|NCT00807846|1003721|P1|Overall Study|Protocol Violation|2
305828|NCT00807846|1003720|P2|Overall Study|Lack of Efficacy|0
305829|NCT00807846|1003721|P1|Overall Study|Lack of Efficacy|2
305830|NCT00807846|1003720|P2|Overall Study|Adverse Event|0
305831|NCT00807846|1003721|P1|Overall Study|Adverse Event|5
305832|NCT00807573|1003753|P1|Overall Study|Adverse Event|1
305833|NCT00807573|1003753|P1|Overall Study|Withdrawal by Subject|1
305834|NCT00807365|1003798|P1|Overall Study|Study Terminated|5
305835|NCT00807248|1003806|P4|Overall Study|Other Reason|0
305836|NCT00807248|1003807|P3|Overall Study|Other Reason|2
305837|NCT00807248|1003808|P2|Overall Study|Other Reason|0
305838|NCT00807248|1003809|P1|Overall Study|Other Reason|0
305839|NCT00807248|1003806|P4|Overall Study|Lost to Follow-up|0
305840|NCT00807248|1003807|P3|Overall Study|Lost to Follow-up|0
305841|NCT00807248|1003808|P2|Overall Study|Lost to Follow-up|0
305842|NCT00807248|1003809|P1|Overall Study|Lost to Follow-up|1
305843|NCT00807248|1003806|P4|Overall Study|Withdrawal of Consent|5
305844|NCT00807248|1003807|P3|Overall Study|Withdrawal of Consent|5
305845|NCT00807248|1003808|P2|Overall Study|Withdrawal of Consent|5
305846|NCT00807248|1003809|P1|Overall Study|Withdrawal of Consent|5
305847|NCT00807248|1003806|P4|Overall Study|Protocol Violation|0
305848|NCT00807248|1003807|P3|Overall Study|Protocol Violation|1
305849|NCT00807248|1003808|P2|Overall Study|Protocol Violation|1
305850|NCT00807248|1003809|P1|Overall Study|Protocol Violation|0
305851|NCT00807248|1003806|P4|Overall Study|Lack of Efficacy|3
305852|NCT00807248|1003807|P3|Overall Study|Lack of Efficacy|8
305853|NCT00807248|1003808|P2|Overall Study|Lack of Efficacy|4
305854|NCT00807248|1003809|P1|Overall Study|Lack of Efficacy|14
305855|NCT00807248|1003806|P4|Overall Study|Adverse Event|6
305856|NCT00807248|1003807|P3|Overall Study|Adverse Event|2
305857|NCT00807248|1003808|P2|Overall Study|Adverse Event|2
305858|NCT00807248|1003809|P1|Overall Study|Adverse Event|1
305859|NCT00807235|1003853|P2|Overall Study|Adverse Event|0
305860|NCT00807235|1003854|P1|Overall Study|Adverse Event|1
305861|NCT00807092|1003899|P2|Overall Study|CGMS data collection failed|1
305862|NCT00807092|1003900|P1|Overall Study|CGMS data collection failed|0
305863|NCT00807092|1003899|P2|Overall Study|Withdrawal by Subject|0
305864|NCT00807092|1003900|P1|Overall Study|Withdrawal by Subject|1
305865|NCT00807092|1003899|P2|Overall Study|Protocol Violation|2
305866|NCT00807092|1003900|P1|Overall Study|Protocol Violation|0
305867|NCT00807092|1003899|P2|Overall Study|Adverse Event|1
305868|NCT00807092|1003900|P1|Overall Study|Adverse Event|0
305869|NCT00807014|1003930|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
305870|NCT00807014|1003931|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
305871|NCT00807014|1003930|P2|Overall Study|Recovery|0
305872|NCT00807014|1003931|P1|Overall Study|Recovery|1
305873|NCT00807014|1003930|P2|Overall Study|Lost to Follow-up|7
305874|NCT00807014|1003931|P1|Overall Study|Lost to Follow-up|9
305875|NCT00807014|1003930|P2|Overall Study|Adverse Event|2
305876|NCT00807014|1003931|P1|Overall Study|Adverse Event|0
305877|NCT00807014|1003930|P2|Overall Study|Protocol Violation|8
305878|NCT00807014|1003931|P1|Overall Study|Protocol Violation|2
305879|NCT00807014|1003930|P2|Overall Study|Participant Considered Disease Not Cured|7
305880|NCT00807014|1003931|P1|Overall Study|Participant Considered Disease Not Cured|2
305881|NCT00807014|1003930|P2|Overall Study|Participant Considered Disease Cured|2
305882|NCT00807014|1003931|P1|Overall Study|Participant Considered Disease Cured|13
305883|NCT00807001|1003962|P5|Overall Study|Non-compliance|0
305884|NCT00807001|1003963|P4|Overall Study|Non-compliance|0
305885|NCT00807001|1003964|P3|Overall Study|Non-compliance|0
305886|NCT00807001|1003965|P2|Overall Study|Non-compliance|1
305887|NCT00807001|1003966|P1|Overall Study|Non-compliance|0
305888|NCT00806819|1003985|P2|Overall Study|Reasons other than stated above|41
305889|NCT00806819|1003986|P1|Overall Study|Reasons other than stated above|25
305890|NCT00806819|1003985|P2|Overall Study|Not treated|3
305891|NCT00806819|1003986|P1|Overall Study|Not treated|6
305892|NCT00806819|1003985|P2|Overall Study|Withdrawal by Subject|29
305893|NCT00806819|1003986|P1|Overall Study|Withdrawal by Subject|32
305894|NCT00806819|1003985|P2|Overall Study|Lost to Follow-up|0
305895|NCT00806819|1003986|P1|Overall Study|Lost to Follow-up|1
305896|NCT00806819|1003985|P2|Overall Study|Protocol Violation|4
305897|NCT00806819|1003986|P1|Overall Study|Protocol Violation|9
305898|NCT00806819|1003985|P2|Overall Study|Other AE|40
305899|NCT00806819|1003986|P1|Overall Study|Other AE|38
305900|NCT00806819|1003985|P2|Overall Study|Worsening or AE of underlying disease|25
305901|NCT00806819|1003986|P1|Overall Study|Worsening or AE of underlying disease|18
305902|NCT00806819|1003985|P2|Overall Study|progressive disease (modified RECIST )|216
305903|NCT00806819|1003986|P1|Overall Study|progressive disease (modified RECIST )|217
305904|NCT00806624|1004021|P3|Overall Study|discontinued before start of treatment|1
305905|NCT00806624|1004022|P2|Overall Study|discontinued before start of treatment|0
305906|NCT00806624|1004023|P1|Overall Study|discontinued before start of treatment|0
305907|NCT00806624|1004021|P3|Overall Study|Withdrawal by Subject|3
305908|NCT00806624|1004022|P2|Overall Study|Withdrawal by Subject|3
305909|NCT00806624|1004023|P1|Overall Study|Withdrawal by Subject|6
305910|NCT00806624|1004021|P3|Overall Study|Lost to Follow-up|1
305911|NCT00806624|1004022|P2|Overall Study|Lost to Follow-up|0
305912|NCT00806624|1004023|P1|Overall Study|Lost to Follow-up|1
305913|NCT00806624|1004021|P3|Overall Study|Death|1
305914|NCT00806624|1004022|P2|Overall Study|Death|1
305915|NCT00806624|1004023|P1|Overall Study|Death|0
305916|NCT00806624|1004021|P3|Overall Study|Adverse Event|0
305917|NCT00806624|1004022|P2|Overall Study|Adverse Event|8
305918|NCT00806624|1004023|P1|Overall Study|Adverse Event|2
305919|NCT00806585|1004040|P5|Overall Study|Completion status unknown|12
305920|NCT00806585|1004041|P4|Overall Study|Completion status unknown|4
305921|NCT00806585|1004042|P3|Overall Study|Completion status unknown|12
305922|NCT00806585|1004043|P2|Overall Study|Completion status unknown|14
305923|NCT00806585|1004044|P1|Overall Study|Completion status unknown|15
305924|NCT00806585|1004040|P5|Overall Study|Withdrawal by Subject|11
305925|NCT00806585|1004041|P4|Overall Study|Withdrawal by Subject|3
305926|NCT00806585|1004042|P3|Overall Study|Withdrawal by Subject|9
305927|NCT00806585|1004043|P2|Overall Study|Withdrawal by Subject|8
305928|NCT00806585|1004044|P1|Overall Study|Withdrawal by Subject|10
305929|NCT00806585|1004040|P5|Overall Study|Adverse Event|2
305930|NCT00806585|1004041|P4|Overall Study|Adverse Event|4
305931|NCT00806585|1004042|P3|Overall Study|Adverse Event|3
305932|NCT00806585|1004043|P2|Overall Study|Adverse Event|5
305933|NCT00806585|1004044|P1|Overall Study|Adverse Event|1
305934|NCT00806585|1004040|P5|Overall Study|Lack of Efficacy|0
305935|NCT00806585|1004041|P4|Overall Study|Lack of Efficacy|0
305936|NCT00806585|1004042|P3|Overall Study|Lack of Efficacy|0
305937|NCT00806585|1004043|P2|Overall Study|Lack of Efficacy|0
305938|NCT00806585|1004044|P1|Overall Study|Lack of Efficacy|1
305939|NCT00806585|1004040|P5|Overall Study|Lost to Follow-up|5
305940|NCT00806585|1004041|P4|Overall Study|Lost to Follow-up|2
305941|NCT00806585|1004042|P3|Overall Study|Lost to Follow-up|2
305942|NCT00806585|1004043|P2|Overall Study|Lost to Follow-up|1
305943|NCT00806585|1004044|P1|Overall Study|Lost to Follow-up|2
305944|NCT00806585|1004040|P5|Overall Study|Physician Decision|1
305945|NCT00806585|1004041|P4|Overall Study|Physician Decision|0
305946|NCT00806585|1004042|P3|Overall Study|Physician Decision|3
305947|NCT00806585|1004043|P2|Overall Study|Physician Decision|2
305948|NCT00806585|1004044|P1|Overall Study|Physician Decision|0
305949|NCT00806585|1004040|P5|Overall Study|Protocol Violation|0
305950|NCT00806585|1004041|P4|Overall Study|Protocol Violation|0
305951|NCT00806585|1004042|P3|Overall Study|Protocol Violation|2
305952|NCT00806585|1004043|P2|Overall Study|Protocol Violation|1
305953|NCT00806585|1004044|P1|Overall Study|Protocol Violation|3
305954|NCT00806585|1004040|P5|Overall Study|Study terminated by Sponsor|0
305955|NCT00806585|1004041|P4|Overall Study|Study terminated by Sponsor|2
305956|NCT00806585|1004042|P3|Overall Study|Study terminated by Sponsor|1
305957|NCT00806585|1004043|P2|Overall Study|Study terminated by Sponsor|0
305958|NCT00806585|1004044|P1|Overall Study|Study terminated by Sponsor|0
305959|NCT00806546|1004076|P1|Overall Study|Various|42
305960|NCT00806546|1004076|P1|Overall Study|Protocol Violation|49
305961|NCT00806546|1004076|P1|Overall Study|Withdrawal by Subject|75
305962|NCT00806546|1004076|P1|Overall Study|Adverse Event|74
305963|NCT00806546|1004076|P1|Overall Study|Lost to Follow-up|32
305964|NCT00806546|1004076|P1|Overall Study|Enrolled, not treated|35
305965|NCT00806494|1004080|P1|Overall Study|Withdrawal by Subject|5
305966|NCT00806494|1004080|P1|Overall Study|Unspecified|30
305967|NCT00806494|1004080|P1|Overall Study|Lost to Follow-up|10
305968|NCT00806494|1004080|P1|Overall Study|Lack of Efficacy|6
305969|NCT00806494|1004080|P1|Overall Study|Adverse Event|29
305970|NCT00806416|1004106|P4|Period 1 - Part II|Withdrawal by Subject|2
305971|NCT00806416|1004107|P3|Period 1 - Part II|Withdrawal by Subject|0
305972|NCT00806416|1004108|P2|Period 1 - Part II|Withdrawal by Subject|0
305973|NCT00806416|1004109|P1|Period 1 - Part II|Withdrawal by Subject|0
305974|NCT00806416|1004106|P4|Period 1 - Part I|Withdrawal by Subject|0
305975|NCT00806416|1004107|P3|Period 1 - Part I|Withdrawal by Subject|0
305976|NCT00806416|1004108|P2|Period 1 - Part I|Withdrawal by Subject|1
305977|NCT00806416|1004109|P1|Period 1 - Part I|Withdrawal by Subject|3
305978|NCT00806416|1004106|P4|Period 1 - Part I|Lost to Follow-up|0
305979|NCT00806416|1004107|P3|Period 1 - Part I|Lost to Follow-up|0
305980|NCT00806416|1004108|P2|Period 1 - Part I|Lost to Follow-up|2
305981|NCT00806416|1004109|P1|Period 1 - Part I|Lost to Follow-up|0
305982|NCT00806416|1004106|P4|Period 1 - Part I|Adverse Event|0
305983|NCT00806416|1004107|P3|Period 1 - Part I|Adverse Event|0
305984|NCT00806416|1004108|P2|Period 1 - Part I|Adverse Event|1
305985|NCT00806416|1004109|P1|Period 1 - Part I|Adverse Event|0
305986|NCT00806403|1004122|P2|Overall Study|Death|3
305987|NCT00806403|1004123|P1|Overall Study|Death|4
305988|NCT00806351|1004146|P2|Overall Study|Death|4
305989|NCT00806351|1004147|P1|Overall Study|Death|5
305990|NCT00806260|1004184|P6|Period 3|Pregnancy|0
305991|NCT00806260|1004185|P5|Period 3|Pregnancy|0
305992|NCT00806260|1004186|P4|Period 3|Pregnancy|0
305993|NCT00806260|1004187|P3|Period 3|Pregnancy|0
305994|NCT00806260|1004188|P2|Period 3|Pregnancy|0
305995|NCT00806260|1004189|P1|Period 3|Pregnancy|1
305996|NCT00806260|1004184|P6|Period 3|Protocol Violation|0
305997|NCT00806260|1004185|P5|Period 3|Protocol Violation|0
305998|NCT00806260|1004186|P4|Period 3|Protocol Violation|0
305999|NCT00806260|1004187|P3|Period 3|Protocol Violation|1
306000|NCT00806260|1004188|P2|Period 3|Protocol Violation|1
306001|NCT00806260|1004189|P1|Period 3|Protocol Violation|0
306002|NCT00806260|1004184|P6|Period 2|sponsor request|0
306003|NCT00806260|1004185|P5|Period 2|sponsor request|0
306004|NCT00806260|1004186|P4|Period 2|sponsor request|1
306005|NCT00806260|1004187|P3|Period 2|sponsor request|1
306006|NCT00806260|1004188|P2|Period 2|sponsor request|0
306007|NCT00806260|1004189|P1|Period 2|sponsor request|0
306008|NCT00806260|1004184|P6|Period 2|Need to take concomitant medication|0
306009|NCT00806260|1004185|P5|Period 2|Need to take concomitant medication|0
306010|NCT00806260|1004186|P4|Period 2|Need to take concomitant medication|0
306011|NCT00806260|1004187|P3|Period 2|Need to take concomitant medication|0
306012|NCT00806260|1004188|P2|Period 2|Need to take concomitant medication|0
306013|NCT00806260|1004189|P1|Period 2|Need to take concomitant medication|1
306014|NCT00806260|1004184|P6|Period 2|Protocol Violation|0
306015|NCT00806260|1004185|P5|Period 2|Protocol Violation|0
306016|NCT00806260|1004186|P4|Period 2|Protocol Violation|0
306017|NCT00806260|1004187|P3|Period 2|Protocol Violation|1
306018|NCT00806260|1004188|P2|Period 2|Protocol Violation|0
306019|NCT00806260|1004189|P1|Period 2|Protocol Violation|1
306020|NCT00806260|1004184|P6|Period 2|Adverse Event|0
306021|NCT00806260|1004185|P5|Period 2|Adverse Event|0
306022|NCT00806260|1004186|P4|Period 2|Adverse Event|1
306023|NCT00806260|1004187|P3|Period 2|Adverse Event|0
306024|NCT00806260|1004188|P2|Period 2|Adverse Event|0
306025|NCT00806260|1004189|P1|Period 2|Adverse Event|0
306026|NCT00806260|1004184|P6|Period 1 (1 Day)|Adverse Event|0
306027|NCT00806260|1004185|P5|Period 1 (1 Day)|Adverse Event|3
306028|NCT00806260|1004186|P4|Period 1 (1 Day)|Adverse Event|0
306029|NCT00806260|1004187|P3|Period 1 (1 Day)|Adverse Event|0
306030|NCT00806260|1004188|P2|Period 1 (1 Day)|Adverse Event|0
306031|NCT00806260|1004189|P1|Period 1 (1 Day)|Adverse Event|0
306032|NCT00806195|1004227|P4|Overall Study|Protocol Violation|9
306033|NCT00806195|1004228|P3|Overall Study|Protocol Violation|26
306034|NCT00806195|1004229|P2|Overall Study|Protocol Violation|24
306035|NCT00806195|1004230|P1|Overall Study|Protocol Violation|34
306036|NCT00806195|1004227|P4|Overall Study|Administrative Reason|26
306037|NCT00806195|1004228|P3|Overall Study|Administrative Reason|66
306038|NCT00806195|1004229|P2|Overall Study|Administrative Reason|35
306039|NCT00806195|1004230|P1|Overall Study|Administrative Reason|113
306040|NCT00806195|1004227|P4|Overall Study|Inappropriate Enrollment|0
306041|NCT00806195|1004228|P3|Overall Study|Inappropriate Enrollment|0
306042|NCT00806195|1004229|P2|Overall Study|Inappropriate Enrollment|1
306043|NCT00806195|1004230|P1|Overall Study|Inappropriate Enrollment|0
306044|NCT00806195|1004227|P4|Overall Study|Lost to Follow-up|34
306045|NCT00806195|1004228|P3|Overall Study|Lost to Follow-up|90
306046|NCT00806195|1004229|P2|Overall Study|Lost to Follow-up|66
306047|NCT00806195|1004230|P1|Overall Study|Lost to Follow-up|217
306048|NCT00806195|1004227|P4|Overall Study|Withdrawal by Subject|35
306049|NCT00806195|1004228|P3|Overall Study|Withdrawal by Subject|76
306050|NCT00806195|1004229|P2|Overall Study|Withdrawal by Subject|31
306051|NCT00806195|1004230|P1|Overall Study|Withdrawal by Subject|119
306052|NCT00806195|1004227|P4|Overall Study|Adverse Event|2
306053|NCT00806195|1004228|P3|Overall Study|Adverse Event|11
306054|NCT00806195|1004229|P2|Overall Study|Adverse Event|5
306055|NCT00806195|1004230|P1|Overall Study|Adverse Event|25
306056|NCT00806195|1004227|P4|Overall Study|Death|0
306057|NCT00806195|1004228|P3|Overall Study|Death|1
306058|NCT00806195|1004229|P2|Overall Study|Death|0
306059|NCT00806195|1004230|P1|Overall Study|Death|6
306060|NCT00804908|1004258|P3|Overall Study|Not specified|114
306061|NCT00804908|1004259|P2|Overall Study|Not specified|116
306062|NCT00804908|1004260|P1|Overall Study|Not specified|115
306063|NCT00804843|1004291|P2|Overall Study|Withdrawal by Subject|2
306064|NCT00804843|1004292|P1|Overall Study|Withdrawal by Subject|1
306065|NCT00804843|1004291|P2|Overall Study|Adverse Event|5
306066|NCT00804843|1004292|P1|Overall Study|Adverse Event|8
306067|NCT00804843|1004291|P2|Overall Study|Protocol Violation|0
306068|NCT00804843|1004292|P1|Overall Study|Protocol Violation|1
306069|NCT00806026|1004308|P6|Overall Study|Adverse Event|9
306070|NCT00806026|1004309|P5|Overall Study|Adverse Event|9
306071|NCT00806026|1004310|P4|Overall Study|Adverse Event|17
306072|NCT00806026|1004311|P3|Overall Study|Adverse Event|44
306073|NCT00806026|1004312|P2|Overall Study|Adverse Event|35
306074|NCT00806026|1004313|P1|Overall Study|Adverse Event|52
306075|NCT00806026|1004308|P6|Overall Study|Protocol Violation|3
306076|NCT00806026|1004309|P5|Overall Study|Protocol Violation|2
306077|NCT00806026|1004310|P4|Overall Study|Protocol Violation|0
306078|NCT00806026|1004311|P3|Overall Study|Protocol Violation|9
306079|NCT00806026|1004312|P2|Overall Study|Protocol Violation|9
306080|NCT00806026|1004313|P1|Overall Study|Protocol Violation|6
306081|NCT00806026|1004308|P6|Overall Study|Unspecified|4
306082|NCT00806026|1004309|P5|Overall Study|Unspecified|0
306083|NCT00806026|1004310|P4|Overall Study|Unspecified|2
306084|NCT00806026|1004311|P3|Overall Study|Unspecified|8
306085|NCT00806026|1004312|P2|Overall Study|Unspecified|6
306086|NCT00806026|1004313|P1|Overall Study|Unspecified|3
306087|NCT00806026|1004308|P6|Overall Study|Withdrawal by Subject|3
306088|NCT00806026|1004309|P5|Overall Study|Withdrawal by Subject|5
306089|NCT00806026|1004310|P4|Overall Study|Withdrawal by Subject|2
306090|NCT00806026|1004311|P3|Overall Study|Withdrawal by Subject|9
306091|NCT00806026|1004312|P2|Overall Study|Withdrawal by Subject|17
306092|NCT00806026|1004313|P1|Overall Study|Withdrawal by Subject|14
306093|NCT00806026|1004308|P6|Overall Study|Lost to Follow-up|6
306094|NCT00806026|1004309|P5|Overall Study|Lost to Follow-up|6
306095|NCT00806026|1004310|P4|Overall Study|Lost to Follow-up|2
306096|NCT00806026|1004311|P3|Overall Study|Lost to Follow-up|8
306097|NCT00806026|1004312|P2|Overall Study|Lost to Follow-up|15
306098|NCT00806026|1004313|P1|Overall Study|Lost to Follow-up|8
306099|NCT00806026|1004308|P6|Overall Study|Lack of Efficacy|7
306100|NCT00806026|1004309|P5|Overall Study|Lack of Efficacy|8
306101|NCT00806026|1004310|P4|Overall Study|Lack of Efficacy|4
306102|NCT00806026|1004311|P3|Overall Study|Lack of Efficacy|13
306103|NCT00806026|1004312|P2|Overall Study|Lack of Efficacy|18
306104|NCT00806026|1004313|P1|Overall Study|Lack of Efficacy|5
306105|NCT00806026|1004308|P6|Overall Study|Did not meet entrance criteria|0
306106|NCT00806026|1004309|P5|Overall Study|Did not meet entrance criteria|0
306107|NCT00806026|1004310|P4|Overall Study|Did not meet entrance criteria|1
306108|NCT00806026|1004311|P3|Overall Study|Did not meet entrance criteria|2
306109|NCT00806026|1004312|P2|Overall Study|Did not meet entrance criteria|1
306110|NCT00806026|1004313|P1|Overall Study|Did not meet entrance criteria|4
306111|NCT00806026|1004308|P6|Overall Study|Death|0
306112|NCT00806026|1004309|P5|Overall Study|Death|0
306113|NCT00806026|1004310|P4|Overall Study|Death|1
306114|NCT00806026|1004311|P3|Overall Study|Death|0
306115|NCT00806026|1004312|P2|Overall Study|Death|0
306116|NCT00806026|1004313|P1|Overall Study|Death|0
306117|NCT00805961|1004408|P1|Maintenance Treatment|Withdrawn Consent|1
306118|NCT00805961|1004408|P1|Maintenance Treatment|Symptomatic Deterioration|2
306119|NCT00805961|1004408|P1|Maintenance Treatment|Withdrawal by Subject|5
306120|NCT00805961|1004408|P1|Maintenance Treatment|Adverse Event|6
306121|NCT00805961|1004408|P1|Maintenance Treatment|Intercurrent Illness|7
306122|NCT00805961|1004408|P1|Maintenance Treatment|Lack of Efficacy|13
306123|NCT00805961|1004408|P1|Treatment-Free Interval|Lack of Efficacy|1
306124|NCT00805961|1004408|P1|Treatment-Free Interval|Physician Decision|1
306125|NCT00805961|1004408|P1|Treatment-Free Interval|Intercurrent Illness|2
306126|NCT00805961|1004408|P1|Treatment-Free Interval|Adverse Event|3
306127|NCT00805961|1004408|P1|Modality Therapy|Disease Progression|2
306128|NCT00805961|1004408|P1|Modality Therapy|Adverse Event|1
306129|NCT00805961|1004408|P1|Modality Therapy|Withdrawal by Subject|1
306130|NCT00805935|1004418|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
306131|NCT00805935|1004419|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
306132|NCT00805935|1004420|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
306133|NCT00805935|1004421|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
306134|NCT00805935|1004418|P4|Overall Study|Ectopic pregnancy|0
306135|NCT00805935|1004419|P3|Overall Study|Ectopic pregnancy|1
306136|NCT00805935|1004420|P2|Overall Study|Ectopic pregnancy|0
306137|NCT00805935|1004421|P1|Overall Study|Ectopic pregnancy|0
306138|NCT00805935|1004418|P4|Overall Study|Chemical pregnancy|2
306139|NCT00805935|1004419|P3|Overall Study|Chemical pregnancy|3
306140|NCT00805935|1004420|P2|Overall Study|Chemical pregnancy|5
306141|NCT00805935|1004421|P1|Overall Study|Chemical pregnancy|0
306142|NCT00805935|1004418|P4|Overall Study|Biochemical pregnancy|0
306143|NCT00805935|1004419|P3|Overall Study|Biochemical pregnancy|0
306144|NCT00805935|1004420|P2|Overall Study|Biochemical pregnancy|1
306145|NCT00805935|1004421|P1|Overall Study|Biochemical pregnancy|0
306146|NCT00805935|1004418|P4|Overall Study|Pregnancy loss/miscarriage|0
306147|NCT00805935|1004419|P3|Overall Study|Pregnancy loss/miscarriage|0
306148|NCT00805935|1004420|P2|Overall Study|Pregnancy loss/miscarriage|0
306149|NCT00805935|1004421|P1|Overall Study|Pregnancy loss/miscarriage|2
306150|NCT00805935|1004418|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
306151|NCT00805935|1004419|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
306152|NCT00805935|1004420|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
306153|NCT00805935|1004421|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
306154|NCT00805935|1004418|P4|Overall Study|No positive serum pregnancy|5
306155|NCT00805935|1004419|P3|Overall Study|No positive serum pregnancy|6
306156|NCT00805935|1004420|P2|Overall Study|No positive serum pregnancy|7
306157|NCT00805935|1004421|P1|Overall Study|No positive serum pregnancy|8
306158|NCT00805935|1004418|P4|Overall Study|Lost to Follow-up|0
306159|NCT00805935|1004419|P3|Overall Study|Lost to Follow-up|0
306160|NCT00805935|1004420|P2|Overall Study|Lost to Follow-up|0
306161|NCT00805935|1004421|P1|Overall Study|Lost to Follow-up|1
306162|NCT00805935|1004418|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
306163|NCT00805935|1004419|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
306164|NCT00805935|1004420|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
306165|NCT00805935|1004421|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
306166|NCT00805935|1004418|P4|Overall Study|Cycle cancellation for risk of OHSS|0
306167|NCT00805935|1004419|P3|Overall Study|Cycle cancellation for risk of OHSS|1
306168|NCT00805935|1004420|P2|Overall Study|Cycle cancellation for risk of OHSS|0
306169|NCT00805935|1004421|P1|Overall Study|Cycle cancellation for risk of OHSS|1
306170|NCT00805935|1004418|P4|Overall Study|Cycle cancelled|0
306171|NCT00805935|1004419|P3|Overall Study|Cycle cancelled|2
306172|NCT00805935|1004420|P2|Overall Study|Cycle cancelled|0
306173|NCT00805935|1004421|P1|Overall Study|Cycle cancelled|0
306174|NCT00805935|1004418|P4|Overall Study|Stimulation Failure|2
306175|NCT00805935|1004419|P3|Overall Study|Stimulation Failure|2
306176|NCT00805935|1004420|P2|Overall Study|Stimulation Failure|5
306177|NCT00805935|1004421|P1|Overall Study|Stimulation Failure|1
306178|NCT00805792|1004488|P1|Overall Study|Lost to Follow-up|2
306179|NCT00805792|1004488|P1|Overall Study|Death|3
306180|NCT00805766|1004496|P1|Increased Dose Period|Withdrawal by Subject|1
306181|NCT00805766|1004496|P1|Increased Dose Period|Pregnancy|1
306182|NCT00805766|1004496|P1|Increased Dose Period|Lack of Efficacy|7
306183|NCT00805766|1004496|P1|Increased Dose Period|Adverse Event|4
306184|NCT00805766|1004496|P1|Screening Period|Responder|2
306185|NCT00805766|1004496|P1|Screening Period|Pregnancy|1
306186|NCT00805766|1004496|P1|Screening Period|Lack of Efficacy|2
306187|NCT00805766|1004496|P1|Screening Period|Adverse Event|1
306188|NCT00805740|1004505|P2|Overall Study|Randomized, but not treated|0
306189|NCT00805740|1004506|P1|Overall Study|Randomized, but not treated|2
306190|NCT00805740|1004505|P2|Overall Study|Lost to Follow-up|0
306191|NCT00805740|1004506|P1|Overall Study|Lost to Follow-up|1
306192|NCT00805740|1004505|P2|Overall Study|Withdrawal by Subject|0
306193|NCT00805740|1004506|P1|Overall Study|Withdrawal by Subject|1
306194|NCT00805740|1004505|P2|Overall Study|Death|4
306195|NCT00805740|1004506|P1|Overall Study|Death|7
306196|NCT00805675|1004531|P3|Overall Study|Adverse Event|1
306197|NCT00805675|1004532|P2|Overall Study|Adverse Event|0
306198|NCT00805675|1004533|P1|Overall Study|Adverse Event|0
306199|NCT00805545|1004567|P2|Overall Study|Protocol Violation|1
306200|NCT00805545|1004568|P1|Overall Study|Protocol Violation|3
306201|NCT00805545|1004567|P2|Overall Study|Protocol Violation|2
306202|NCT00805545|1004568|P1|Overall Study|Protocol Violation|3
306203|NCT00805480|1004594|P4|Overall Study|Adverse Event|0
306204|NCT00805480|1004595|P3|Overall Study|Adverse Event|1
306205|NCT00805480|1004596|P2|Overall Study|Adverse Event|0
306206|NCT00805480|1004597|P1|Overall Study|Adverse Event|0
306207|NCT00805480|1004594|P4|Overall Study|Lost to Follow-up|0
306208|NCT00805480|1004595|P3|Overall Study|Lost to Follow-up|0
306209|NCT00805480|1004596|P2|Overall Study|Lost to Follow-up|2
306210|NCT00805480|1004597|P1|Overall Study|Lost to Follow-up|1
306211|NCT00805480|1004594|P4|Overall Study|Withdrawal by Subject|5
306212|NCT00805480|1004595|P3|Overall Study|Withdrawal by Subject|11
306213|NCT00805480|1004596|P2|Overall Study|Withdrawal by Subject|5
306214|NCT00805480|1004597|P1|Overall Study|Withdrawal by Subject|13
306215|NCT00805467|1004626|P4|Overall Study|Not reported|7
306216|NCT00805467|1004627|P3|Overall Study|Not reported|3
306217|NCT00805467|1004628|P2|Overall Study|Not reported|0
306218|NCT00805467|1004629|P1|Overall Study|Not reported|0
306219|NCT00805467|1004626|P4|Overall Study|Physician Decision|6
306220|NCT00805467|1004627|P3|Overall Study|Physician Decision|2
306221|NCT00805467|1004628|P2|Overall Study|Physician Decision|1
306222|NCT00805467|1004629|P1|Overall Study|Physician Decision|0
306223|NCT00805467|1004626|P4|Overall Study|Death|5
306224|NCT00805467|1004627|P3|Overall Study|Death|7
306225|NCT00805467|1004628|P2|Overall Study|Death|2
306226|NCT00805467|1004629|P1|Overall Study|Death|0
306227|NCT00805467|1004626|P4|Overall Study|Adverse Event|57
306228|NCT00805467|1004627|P3|Overall Study|Adverse Event|26
306229|NCT00805467|1004628|P2|Overall Study|Adverse Event|13
306230|NCT00805467|1004629|P1|Overall Study|Adverse Event|0
306231|NCT00805467|1004626|P4|Overall Study|Protocol Violation|5
306232|NCT00805467|1004627|P3|Overall Study|Protocol Violation|0
306233|NCT00805467|1004628|P2|Overall Study|Protocol Violation|3
306234|NCT00805467|1004629|P1|Overall Study|Protocol Violation|0
306235|NCT00805467|1004626|P4|Overall Study|Withdrawal by Subject|50
306236|NCT00805467|1004627|P3|Overall Study|Withdrawal by Subject|45
306237|NCT00805467|1004628|P2|Overall Study|Withdrawal by Subject|6
306238|NCT00805467|1004629|P1|Overall Study|Withdrawal by Subject|0
306239|NCT00805467|1004626|P4|Overall Study|Lost to Follow-up|21
306240|NCT00805467|1004627|P3|Overall Study|Lost to Follow-up|7
306241|NCT00805467|1004628|P2|Overall Study|Lost to Follow-up|1
306242|NCT00805467|1004629|P1|Overall Study|Lost to Follow-up|0
306243|NCT00805467|1004626|P4|Overall Study|Lack of Efficacy|86
306244|NCT00805467|1004627|P3|Overall Study|Lack of Efficacy|13
306245|NCT00805467|1004628|P2|Overall Study|Lack of Efficacy|8
306246|NCT00805467|1004629|P1|Overall Study|Lack of Efficacy|0
306247|NCT00805389|1004652|P5|Overall Study|Withdrawal by Subject|4
306248|NCT00805389|1004653|P4|Overall Study|Withdrawal by Subject|5
306249|NCT00805389|1004654|P3|Overall Study|Withdrawal by Subject|4
306250|NCT00805389|1004655|P2|Overall Study|Withdrawal by Subject|2
306251|NCT00805389|1004656|P1|Overall Study|Withdrawal by Subject|3
306252|NCT00805389|1004652|P5|Overall Study|Protocol Violation|0
306253|NCT00805389|1004653|P4|Overall Study|Protocol Violation|0
306254|NCT00805389|1004654|P3|Overall Study|Protocol Violation|1
306255|NCT00805389|1004655|P2|Overall Study|Protocol Violation|0
306256|NCT00805389|1004656|P1|Overall Study|Protocol Violation|0
306257|NCT00805389|1004652|P5|Overall Study|Lost to Follow-up|9
306258|NCT00805389|1004653|P4|Overall Study|Lost to Follow-up|10
306259|NCT00805389|1004654|P3|Overall Study|Lost to Follow-up|6
306260|NCT00805389|1004655|P2|Overall Study|Lost to Follow-up|3
306261|NCT00805389|1004656|P1|Overall Study|Lost to Follow-up|4
306262|NCT00805389|1004652|P5|Overall Study|Adverse Event|0
306263|NCT00805389|1004653|P4|Overall Study|Adverse Event|2
306264|NCT00805389|1004654|P3|Overall Study|Adverse Event|1
306265|NCT00805389|1004655|P2|Overall Study|Adverse Event|0
306266|NCT00805389|1004656|P1|Overall Study|Adverse Event|0
306267|NCT00805285|1004898|P1|Overall Study|Lack of Efficacy|1
306268|NCT00805194|1004908|P2|Overall Study|Reasons other than stated above|16
306269|NCT00805194|1004909|P1|Overall Study|Reasons other than stated above|20
306270|NCT00805194|1004908|P2|Overall Study|Not treated|4
306271|NCT00805194|1004909|P1|Overall Study|Not treated|3
306272|NCT00805194|1004908|P2|Overall Study|Withdrawal by Subject|42
306273|NCT00805194|1004909|P1|Overall Study|Withdrawal by Subject|60
306274|NCT00805194|1004908|P2|Overall Study|Lost to Follow-up|5
306275|NCT00805194|1004909|P1|Overall Study|Lost to Follow-up|5
306276|NCT00805194|1004908|P2|Overall Study|Protocol Violation|9
306277|NCT00805194|1004909|P1|Overall Study|Protocol Violation|9
306278|NCT00805194|1004908|P2|Overall Study|Other AE|73
306279|NCT00805194|1004909|P1|Overall Study|Other AE|84
306280|NCT00805194|1004908|P2|Overall Study|Worsening or AE of underlying disease|70
306281|NCT00805194|1004909|P1|Overall Study|Worsening or AE of underlying disease|64
306282|NCT00805194|1004908|P2|Overall Study|Progressive disease (modified RECIST)|435
306283|NCT00805194|1004909|P1|Overall Study|Progressive disease (modified RECIST)|404
306284|NCT00805142|1004943|P2|Maintenance Period|Unspecified|1
306285|NCT00805142|1004944|P1|Maintenance Period|Unspecified|0
306286|NCT00805142|1004943|P2|Maintenance Period|Adverse Event|1
306287|NCT00805142|1004944|P1|Maintenance Period|Adverse Event|0
306288|NCT00805142|1004943|P2|Titration Period|Unspecified|3
306289|NCT00805142|1004944|P1|Titration Period|Unspecified|0
306290|NCT00805142|1004943|P2|Titration Period|Withdrawal of consent|1
306291|NCT00805142|1004944|P1|Titration Period|Withdrawal of consent|0
306292|NCT00805142|1004943|P2|Titration Period|Disease Progression|1
306293|NCT00805142|1004944|P1|Titration Period|Disease Progression|2
306294|NCT00805142|1004943|P2|Titration Period|Lost to Follow-up|1
306295|NCT00805142|1004944|P1|Titration Period|Lost to Follow-up|0
306296|NCT00805142|1004943|P2|Titration Period|Lack of Efficacy|1
306297|NCT00805142|1004944|P1|Titration Period|Lack of Efficacy|1
306298|NCT00805142|1004943|P2|Titration Period|Adverse Event|3
306299|NCT00805142|1004944|P1|Titration Period|Adverse Event|3
306300|NCT00805025|1004977|P1|Overall Study|Physician Decision|1
306301|NCT00805025|1004977|P1|Overall Study|Withdrawal by Subject|2
306302|NCT00805025|1004977|P1|Overall Study|Adverse Event|4
306303|NCT00805025|1004977|P1|Overall Study|Screened but not enrolled/treated|42
306304|NCT00804986|1004989|P6|Overall Study|Physician Decision|0
306305|NCT00804986|1004990|P5|Overall Study|Physician Decision|0
306306|NCT00804986|1004991|P4|Overall Study|Physician Decision|0
306307|NCT00804986|1004992|P3|Overall Study|Physician Decision|0
306308|NCT00804986|1004993|P2|Overall Study|Physician Decision|0
306309|NCT00804986|1004994|P1|Overall Study|Physician Decision|1
306310|NCT00804986|1004989|P6|Overall Study|Sponsor Decision|0
306311|NCT00804986|1004990|P5|Overall Study|Sponsor Decision|0
306312|NCT00804986|1004991|P4|Overall Study|Sponsor Decision|0
306313|NCT00804986|1004992|P3|Overall Study|Sponsor Decision|0
306314|NCT00804986|1004993|P2|Overall Study|Sponsor Decision|1
306315|NCT00804986|1004994|P1|Overall Study|Sponsor Decision|0
306316|NCT00804986|1004989|P6|Overall Study|Inclusion/Exclusion criteria not met|1
306317|NCT00804986|1004990|P5|Overall Study|Inclusion/Exclusion criteria not met|0
306318|NCT00804986|1004991|P4|Overall Study|Inclusion/Exclusion criteria not met|1
306319|NCT00804986|1004992|P3|Overall Study|Inclusion/Exclusion criteria not met|0
306320|NCT00804986|1004993|P2|Overall Study|Inclusion/Exclusion criteria not met|2
306321|NCT00804986|1004994|P1|Overall Study|Inclusion/Exclusion criteria not met|0
306322|NCT00804986|1004989|P6|Overall Study|Withdrawal by Subject|3
306323|NCT00804986|1004990|P5|Overall Study|Withdrawal by Subject|5
306324|NCT00804986|1004991|P4|Overall Study|Withdrawal by Subject|3
306325|NCT00804986|1004992|P3|Overall Study|Withdrawal by Subject|0
306326|NCT00804986|1004993|P2|Overall Study|Withdrawal by Subject|3
306327|NCT00804986|1004994|P1|Overall Study|Withdrawal by Subject|0
306328|NCT00804986|1004989|P6|Overall Study|Protocol Violation|0
306329|NCT00804986|1004990|P5|Overall Study|Protocol Violation|0
306330|NCT00804986|1004991|P4|Overall Study|Protocol Violation|1
306331|NCT00804986|1004992|P3|Overall Study|Protocol Violation|0
306332|NCT00804986|1004993|P2|Overall Study|Protocol Violation|1
306333|NCT00804986|1004994|P1|Overall Study|Protocol Violation|0
306334|NCT00804986|1004989|P6|Overall Study|Lost to Follow-up|3
306335|NCT00804986|1004990|P5|Overall Study|Lost to Follow-up|1
306336|NCT00804986|1004991|P4|Overall Study|Lost to Follow-up|1
306337|NCT00804986|1004992|P3|Overall Study|Lost to Follow-up|0
306338|NCT00804986|1004993|P2|Overall Study|Lost to Follow-up|0
306339|NCT00804986|1004994|P1|Overall Study|Lost to Follow-up|0
306340|NCT00804986|1004989|P6|Overall Study|Lack of Efficacy|3
306341|NCT00804986|1004990|P5|Overall Study|Lack of Efficacy|0
306342|NCT00804986|1004991|P4|Overall Study|Lack of Efficacy|1
306343|NCT00804986|1004992|P3|Overall Study|Lack of Efficacy|0
306344|NCT00804986|1004993|P2|Overall Study|Lack of Efficacy|0
306345|NCT00804986|1004994|P1|Overall Study|Lack of Efficacy|0
306346|NCT00804986|1004989|P6|Overall Study|Adverse Event|0
306347|NCT00804986|1004990|P5|Overall Study|Adverse Event|3
306348|NCT00804986|1004991|P4|Overall Study|Adverse Event|1
306349|NCT00804986|1004992|P3|Overall Study|Adverse Event|2
306350|NCT00804986|1004993|P2|Overall Study|Adverse Event|1
306351|NCT00804986|1004994|P1|Overall Study|Adverse Event|0
306352|NCT00804687|1005094|P6|Period 5: Treatment Period|Positive drug test|0
306353|NCT00804687|1005095|P5|Period 5: Treatment Period|Positive drug test|0
306354|NCT00804687|1005096|P4|Period 5: Treatment Period|Positive drug test|0
306355|NCT00804687|1005097|P3|Period 5: Treatment Period|Positive drug test|0
306356|NCT00804687|1005098|P2|Period 5: Treatment Period|Positive drug test|0
306357|NCT00804687|1005099|P1|Period 5: Treatment Period|Positive drug test|1
306358|NCT00804687|1005094|P6|Period 5: Treatment Period|Positive drugs of abuse|0
306359|NCT00804687|1005095|P5|Period 5: Treatment Period|Positive drugs of abuse|0
306360|NCT00804687|1005096|P4|Period 5: Treatment Period|Positive drugs of abuse|0
306361|NCT00804687|1005097|P3|Period 5: Treatment Period|Positive drugs of abuse|1
306362|NCT00804687|1005098|P2|Period 5: Treatment Period|Positive drugs of abuse|0
306363|NCT00804687|1005099|P1|Period 5: Treatment Period|Positive drugs of abuse|0
306364|NCT00804687|1005094|P6|Period 5: Treatment Period|Withdrawal by Subject|0
306365|NCT00804687|1005095|P5|Period 5: Treatment Period|Withdrawal by Subject|1
306366|NCT00804687|1005096|P4|Period 5: Treatment Period|Withdrawal by Subject|0
306367|NCT00804687|1005097|P3|Period 5: Treatment Period|Withdrawal by Subject|0
306368|NCT00804687|1005098|P2|Period 5: Treatment Period|Withdrawal by Subject|0
306369|NCT00804687|1005099|P1|Period 5: Treatment Period|Withdrawal by Subject|0
306370|NCT00804687|1005094|P6|Period 3: Treatment Period|Positive Drug screen|0
306371|NCT00804687|1005095|P5|Period 3: Treatment Period|Positive Drug screen|0
306372|NCT00804687|1005096|P4|Period 3: Treatment Period|Positive Drug screen|1
306373|NCT00804687|1005097|P3|Period 3: Treatment Period|Positive Drug screen|0
306374|NCT00804687|1005098|P2|Period 3: Treatment Period|Positive Drug screen|0
306375|NCT00804687|1005099|P1|Period 3: Treatment Period|Positive Drug screen|0
306376|NCT00804570|1005178|P2|Overall Study|Withdrawal by Subject|38
306377|NCT00804570|1005179|P1|Overall Study|Withdrawal by Subject|21
306378|NCT00804570|1005178|P2|Overall Study|Sponsor decision|4
306379|NCT00804570|1005179|P1|Overall Study|Sponsor decision|1
306380|NCT00804570|1005178|P2|Overall Study|Physician Decision|2
306381|NCT00804570|1005179|P1|Overall Study|Physician Decision|1
306382|NCT00804570|1005178|P2|Overall Study|Protocol Violation|16
306383|NCT00804570|1005179|P1|Overall Study|Protocol Violation|12
306384|NCT00804570|1005178|P2|Overall Study|Entry criteria not met|5
306385|NCT00804570|1005179|P1|Overall Study|Entry criteria not met|5
306386|NCT00804570|1005178|P2|Overall Study|Lost to Follow-up|21
306387|NCT00804570|1005179|P1|Overall Study|Lost to Follow-up|18
306388|NCT00804570|1005178|P2|Overall Study|Lack of Efficacy|1
306389|NCT00804570|1005179|P1|Overall Study|Lack of Efficacy|0
306390|NCT00804570|1005178|P2|Overall Study|Adverse Event|7
306391|NCT00804570|1005179|P1|Overall Study|Adverse Event|14
306392|NCT00804193|1005238|P3|Overall Study|Withdrawal by Subject|2
306393|NCT00804193|1005239|P2|Overall Study|Withdrawal by Subject|1
306394|NCT00804193|1005240|P1|Overall Study|Withdrawal by Subject|3
306395|NCT00804193|1005238|P3|Overall Study|Lost to Follow-up|4
306396|NCT00804193|1005239|P2|Overall Study|Lost to Follow-up|3
306397|NCT00804193|1005240|P1|Overall Study|Lost to Follow-up|3
306398|NCT00804193|1005238|P3|Overall Study|Protocol Violation|2
306399|NCT00804193|1005239|P2|Overall Study|Protocol Violation|8
306400|NCT00804193|1005240|P1|Overall Study|Protocol Violation|0
306401|NCT00804193|1005238|P3|Overall Study|Lack of Efficacy|3
306402|NCT00804193|1005239|P2|Overall Study|Lack of Efficacy|1
306403|NCT00804193|1005240|P1|Overall Study|Lack of Efficacy|1
306404|NCT00804193|1005238|P3|Overall Study|Adverse Event|2
306405|NCT00804193|1005239|P2|Overall Study|Adverse Event|0
306406|NCT00804193|1005240|P1|Overall Study|Adverse Event|0
306407|NCT00804193|1005238|P3|Overall Study|Lack of baseline fungus|19
306408|NCT00804193|1005239|P2|Overall Study|Lack of baseline fungus|31
306409|NCT00804193|1005240|P1|Overall Study|Lack of baseline fungus|32
306410|NCT00803790|1005289|P4|Period 2|Positive Drug Screen or Personal Reasons|0
306411|NCT00803790|1005290|P3|Period 2|Positive Drug Screen or Personal Reasons|0
306412|NCT00803790|1005291|P2|Period 2|Positive Drug Screen or Personal Reasons|0
306413|NCT00803790|1005292|P1|Period 2|Positive Drug Screen or Personal Reasons|1
306414|NCT00803790|1005289|P4|Period 2|Withdrawal by Subject|0
306415|NCT00803790|1005290|P3|Period 2|Withdrawal by Subject|0
306416|NCT00803790|1005291|P2|Period 2|Withdrawal by Subject|0
306417|NCT00803790|1005292|P1|Period 2|Withdrawal by Subject|1
306418|NCT00803790|1005289|P4|Period 2|Adverse Event|1
306419|NCT00803790|1005290|P3|Period 2|Adverse Event|1
306420|NCT00803790|1005291|P2|Period 2|Adverse Event|0
306421|NCT00803790|1005292|P1|Period 2|Adverse Event|0
306422|NCT00803790|1005289|P4|Period 1|Protocol Violation|0
306423|NCT00803790|1005290|P3|Period 1|Protocol Violation|1
306424|NCT00803790|1005291|P2|Period 1|Protocol Violation|0
306425|NCT00803790|1005292|P1|Period 1|Protocol Violation|0
306426|NCT00803790|1005289|P4|Period 1|positive drug screen or personal reasons|4
306427|NCT00803790|1005290|P3|Period 1|positive drug screen or personal reasons|0
306428|NCT00803790|1005291|P2|Period 1|positive drug screen or personal reasons|3
306429|NCT00803790|1005292|P1|Period 1|positive drug screen or personal reasons|0
306430|NCT00803790|1005289|P4|Period 1|Withdrawal by Subject|0
306431|NCT00803790|1005290|P3|Period 1|Withdrawal by Subject|0
306432|NCT00803790|1005291|P2|Period 1|Withdrawal by Subject|6
306433|NCT00803790|1005292|P1|Period 1|Withdrawal by Subject|8
306434|NCT00803790|1005289|P4|Period 1|Lost to Follow-up|0
306435|NCT00803790|1005290|P3|Period 1|Lost to Follow-up|0
306436|NCT00803790|1005291|P2|Period 1|Lost to Follow-up|2
306437|NCT00803790|1005292|P1|Period 1|Lost to Follow-up|1
306438|NCT00803790|1005289|P4|Period 1|Adverse Event|0
306439|NCT00803790|1005290|P3|Period 1|Adverse Event|0
306440|NCT00803790|1005291|P2|Period 1|Adverse Event|1
306441|NCT00803790|1005292|P1|Period 1|Adverse Event|0
306442|NCT00803738|1005332|P2|Overall Study|Positive Results for STD or abnormal PAP|8
306443|NCT00803738|1005333|P1|Overall Study|Positive Results for STD or abnormal PAP|2
306444|NCT00803738|1005332|P2|Overall Study|Negative Baseline Culture of Candida|63
306445|NCT00803738|1005333|P1|Overall Study|Negative Baseline Culture of Candida|56
306446|NCT00803738|1005332|P2|Overall Study|Lack of Efficacy|16
306447|NCT00803738|1005333|P1|Overall Study|Lack of Efficacy|10
306448|NCT00803738|1005332|P2|Overall Study|Withdrawal by Subject|4
306449|NCT00803738|1005333|P1|Overall Study|Withdrawal by Subject|1
306450|NCT00803738|1005332|P2|Overall Study|Protocol Violation|10
306451|NCT00803738|1005333|P1|Overall Study|Protocol Violation|18
306452|NCT00803738|1005332|P2|Overall Study|Lost to Follow-up|4
306453|NCT00803738|1005333|P1|Overall Study|Lost to Follow-up|4
306454|NCT00803738|1005332|P2|Overall Study|Adverse Event|5
306455|NCT00803738|1005333|P1|Overall Study|Adverse Event|3
306456|NCT00803712|1005345|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
306457|NCT00803712|1005346|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
306458|NCT00803712|1005345|P2|Overall Study|Administrative decision|3
306459|NCT00803712|1005346|P1|Overall Study|Administrative decision|2
306460|NCT00803712|1005345|P2|Overall Study|Protocol criteria (renal transplant)|8
306461|NCT00803712|1005346|P1|Overall Study|Protocol criteria (renal transplant)|12
306462|NCT00803712|1005345|P2|Overall Study|Protocol criteria (other)|2
306463|NCT00803712|1005346|P1|Overall Study|Protocol criteria (other)|0
306464|NCT00803712|1005345|P2|Overall Study|"Other in electronic Case Report Form"|1
306465|NCT00803712|1005346|P1|Overall Study|"Other in electronic Case Report Form"|0
306466|NCT00803712|1005345|P2|Overall Study|Withdrawal by Subject|4
306467|NCT00803712|1005346|P1|Overall Study|Withdrawal by Subject|2
306468|NCT00803712|1005345|P2|Overall Study|Lost to Follow-up|1
306469|NCT00803712|1005346|P1|Overall Study|Lost to Follow-up|3
306470|NCT00803712|1005345|P2|Overall Study|Death|7
306471|NCT00803712|1005346|P1|Overall Study|Death|8
306472|NCT00803712|1005345|P2|Overall Study|Adverse Event|0
306473|NCT00803712|1005346|P1|Overall Study|Adverse Event|5
306474|NCT00803712|1005345|P2|Overall Study|Noncompliance|0
306475|NCT00803712|1005346|P1|Overall Study|Noncompliance|3
306476|NCT00803634|1005444|P2|Overall Study|Death|2
306477|NCT00803634|1005445|P1|Overall Study|Death|3
306478|NCT00803634|1005444|P2|Overall Study|Lost to Follow-up|3
306479|NCT00803634|1005445|P1|Overall Study|Lost to Follow-up|2
306480|NCT00803634|1005444|P2|Overall Study|Withdrew Consent|0
306481|NCT00803634|1005445|P1|Overall Study|Withdrew Consent|1
306482|NCT00803595|1005474|P3|Overall Study|Withdrawal by Subject|3
306483|NCT00803595|1005475|P2|Overall Study|Withdrawal by Subject|2
306484|NCT00803595|1005476|P1|Overall Study|Withdrawal by Subject|5
306485|NCT00803595|1005474|P3|Overall Study|Protocol Violation|12
306486|NCT00803595|1005475|P2|Overall Study|Protocol Violation|2
306487|NCT00803595|1005476|P1|Overall Study|Protocol Violation|7
306488|NCT00803595|1005474|P3|Overall Study|Adverse Event|1
306489|NCT00803595|1005475|P2|Overall Study|Adverse Event|4
306490|NCT00803595|1005476|P1|Overall Study|Adverse Event|3
306491|NCT00803361|1005528|P2|Overall Study|Withdrawal by Subject|6
306492|NCT00803361|1005529|P1|Overall Study|Withdrawal by Subject|5
306493|NCT00803361|1005528|P2|Overall Study|Protocol Violation|4
306494|NCT00803361|1005529|P1|Overall Study|Protocol Violation|2
306495|NCT00803361|1005528|P2|Overall Study|Physician Decision|0
306496|NCT00803361|1005529|P1|Overall Study|Physician Decision|1
306497|NCT00803361|1005528|P2|Overall Study|Lost to Follow-up|2
306498|NCT00803361|1005529|P1|Overall Study|Lost to Follow-up|1
306499|NCT00803361|1005528|P2|Overall Study|Lack of Efficacy|13
306500|NCT00803361|1005529|P1|Overall Study|Lack of Efficacy|4
306501|NCT00803361|1005528|P2|Overall Study|Adverse Event|3
306502|NCT00803361|1005529|P1|Overall Study|Adverse Event|13
306503|NCT00803270|1005576|P2|Overall Study|Lost to Follow-up|2
306504|NCT00803270|1005577|P1|Overall Study|Lost to Follow-up|1
306505|NCT00803244|1005587|P2|Overall Study|Any other reason not above-mentioned|10
306506|NCT00803244|1005588|P1|Overall Study|Any other reason not above-mentioned|4
306507|NCT00803244|1005587|P2|Overall Study|Withdrawal by Subject|3
306508|NCT00803244|1005588|P1|Overall Study|Withdrawal by Subject|2
306509|NCT00803244|1005587|P2|Overall Study|Adverse Event|2
306510|NCT00803244|1005588|P1|Overall Study|Adverse Event|1
306511|NCT00803179|1005596|P1|Overall Study|Lost to Follow-up|3
306512|NCT00803101|1005615|P2|Overall Study|Patient did not have surgery|1
306513|NCT00803101|1005616|P1|Overall Study|Patient did not have surgery|1
306514|NCT00803101|1005615|P2|Overall Study|Patient did not attend scheduled visit|1
306515|NCT00803101|1005616|P1|Overall Study|Patient did not attend scheduled visit|2
306516|NCT00803101|1005615|P2|Overall Study|Patient died outside SAE report period|0
306517|NCT00803101|1005616|P1|Overall Study|Patient died outside SAE report period|1
306518|NCT00803101|1005615|P2|Overall Study|Surgery finished outside protocol window|1
306519|NCT00803101|1005616|P1|Overall Study|Surgery finished outside protocol window|1
306520|NCT00803101|1005615|P2|Overall Study|Protocol Violation|7
306521|NCT00803101|1005616|P1|Overall Study|Protocol Violation|1
306522|NCT00803101|1005615|P2|Overall Study|Lost to Follow-up|2
306523|NCT00803101|1005616|P1|Overall Study|Lost to Follow-up|2
306524|NCT00803101|1005615|P2|Overall Study|Withdrawal by Subject|4
306525|NCT00803101|1005616|P1|Overall Study|Withdrawal by Subject|6
306526|NCT00803101|1005615|P2|Overall Study|Death / Serious Adverse Event|6
306527|NCT00803101|1005616|P1|Overall Study|Death / Serious Adverse Event|4
306528|NCT00803049|1005663|P4|Overall Study|Other than Specified Above|5
306529|NCT00803049|1005664|P3|Overall Study|Other than Specified Above|2
306530|NCT00803049|1005665|P2|Overall Study|Other than Specified Above|9
306531|NCT00803049|1005666|P1|Overall Study|Other than Specified Above|3
306532|NCT00803049|1005663|P4|Overall Study|Randomized and Not Treated|2
306533|NCT00803049|1005664|P3|Overall Study|Randomized and Not Treated|0
306534|NCT00803049|1005665|P2|Overall Study|Randomized and Not Treated|0
306535|NCT00803049|1005666|P1|Overall Study|Randomized and Not Treated|0
306536|NCT00803049|1005663|P4|Overall Study|Protocol Violation|0
306537|NCT00803049|1005664|P3|Overall Study|Protocol Violation|1
306538|NCT00803049|1005665|P2|Overall Study|Protocol Violation|1
306539|NCT00803049|1005666|P1|Overall Study|Protocol Violation|0
306540|NCT00803049|1005663|P4|Overall Study|Withdrawal by Subject|44
306541|NCT00803049|1005664|P3|Overall Study|Withdrawal by Subject|16
306542|NCT00803049|1005665|P2|Overall Study|Withdrawal by Subject|43
306543|NCT00803049|1005666|P1|Overall Study|Withdrawal by Subject|19
306544|NCT00803049|1005663|P4|Overall Study|Progressive Disease|6
306545|NCT00803049|1005664|P3|Overall Study|Progressive Disease|6
306546|NCT00803049|1005665|P2|Overall Study|Progressive Disease|10
306547|NCT00803049|1005666|P1|Overall Study|Progressive Disease|6
306548|NCT00803049|1005663|P4|Overall Study|Death|2
306549|NCT00803049|1005664|P3|Overall Study|Death|0
306550|NCT00803049|1005665|P2|Overall Study|Death|1
306551|NCT00803049|1005666|P1|Overall Study|Death|2
306552|NCT00803049|1005663|P4|Overall Study|Lost to Follow-up|3
306553|NCT00803049|1005664|P3|Overall Study|Lost to Follow-up|0
306554|NCT00803049|1005665|P2|Overall Study|Lost to Follow-up|2
306555|NCT00803049|1005666|P1|Overall Study|Lost to Follow-up|0
306556|NCT00803049|1005663|P4|Overall Study|Lack of Efficacy|13
306557|NCT00803049|1005664|P3|Overall Study|Lack of Efficacy|6
306558|NCT00803049|1005665|P2|Overall Study|Lack of Efficacy|19
306559|NCT00803049|1005666|P1|Overall Study|Lack of Efficacy|10
306560|NCT00803049|1005663|P4|Overall Study|Adverse Event|27
306561|NCT00803049|1005664|P3|Overall Study|Adverse Event|13
306562|NCT00803049|1005665|P2|Overall Study|Adverse Event|33
306563|NCT00803049|1005666|P1|Overall Study|Adverse Event|21
306564|NCT00803023|1005700|P4|Overall Study|Lack of Efficacy|1
306565|NCT00803023|1005701|P3|Overall Study|Lack of Efficacy|1
306566|NCT00803023|1005702|P2|Overall Study|Lack of Efficacy|1
306567|NCT00803023|1005703|P1|Overall Study|Lack of Efficacy|0
306568|NCT00803023|1005700|P4|Overall Study|Lost to Follow-up|1
306569|NCT00803023|1005701|P3|Overall Study|Lost to Follow-up|2
306570|NCT00803023|1005702|P2|Overall Study|Lost to Follow-up|1
306571|NCT00803023|1005703|P1|Overall Study|Lost to Follow-up|0
306572|NCT00803023|1005700|P4|Overall Study|Withdrawal by Subject|0
306573|NCT00803023|1005701|P3|Overall Study|Withdrawal by Subject|0
306574|NCT00803023|1005702|P2|Overall Study|Withdrawal by Subject|2
306575|NCT00803023|1005703|P1|Overall Study|Withdrawal by Subject|0
306576|NCT00803023|1005700|P4|Overall Study|Adverse Event|6
306577|NCT00803023|1005701|P3|Overall Study|Adverse Event|8
306578|NCT00803023|1005702|P2|Overall Study|Adverse Event|4
306579|NCT00803023|1005703|P1|Overall Study|Adverse Event|5
306580|NCT00802867|1005758|P1|Overall Study|Withdrawal by Subject|1
306581|NCT00802867|1005758|P1|Overall Study|Protocol Violation|6
306582|NCT00802867|1005758|P1|Overall Study|Lost to Follow-up|6
306583|NCT00802841|1005768|P2|Overall Study|Treatment duration completed|76
306584|NCT00802841|1005769|P1|Overall Study|Treatment duration completed|66
306585|NCT00802841|1005768|P2|Overall Study|Protocol deviation|6
306586|NCT00802841|1005769|P1|Overall Study|Protocol deviation|2
306587|NCT00802841|1005768|P2|Overall Study|Withdrawal by Subject|5
306588|NCT00802841|1005769|P1|Overall Study|Withdrawal by Subject|9
306589|NCT00802841|1005768|P2|Overall Study|Disease progression|3
306590|NCT00802841|1005769|P1|Overall Study|Disease progression|7
306591|NCT00802841|1005768|P2|Overall Study|Adverse Event|2
306592|NCT00802841|1005769|P1|Overall Study|Adverse Event|8
306593|NCT00802841|1005768|P2|Overall Study|Death|2
306594|NCT00802841|1005769|P1|Overall Study|Death|1
306595|NCT00802841|1005768|P2|Overall Study|Lost to Follow-up|1
306596|NCT00802841|1005769|P1|Overall Study|Lost to Follow-up|2
306597|NCT00802841|1005768|P2|Overall Study|Administrative problems|0
306598|NCT00802841|1005769|P1|Overall Study|Administrative problems|1
306599|NCT00802737|1005794|P3|Overall Study|Participant too Unwell|0
306600|NCT00802737|1005795|P2|Overall Study|Participant too Unwell|2
306601|NCT00802737|1005796|P1|Overall Study|Participant too Unwell|0
306602|NCT00802737|1005794|P3|Overall Study|Ongoing CLL-Treatment|0
306603|NCT00802737|1005795|P2|Overall Study|Ongoing CLL-Treatment|1
306604|NCT00802737|1005796|P1|Overall Study|Ongoing CLL-Treatment|0
306605|NCT00802737|1005794|P3|Overall Study|Received Prohibited Therapy|0
306606|NCT00802737|1005795|P2|Overall Study|Received Prohibited Therapy|0
306607|NCT00802737|1005796|P1|Overall Study|Received Prohibited Therapy|1
306608|NCT00802737|1005794|P3|Overall Study|Adverse Event|0
306609|NCT00802737|1005795|P2|Overall Study|Adverse Event|0
306610|NCT00802737|1005796|P1|Overall Study|Adverse Event|1
306611|NCT00802737|1005794|P3|Overall Study|Death|1
306612|NCT00802737|1005795|P2|Overall Study|Death|5
306613|NCT00802737|1005796|P1|Overall Study|Death|6
306614|NCT00802737|1005794|P3|Overall Study|Withdrawn due to Disease Progression|0
306615|NCT00802737|1005795|P2|Overall Study|Withdrawn due to Disease Progression|3
306616|NCT00802737|1005796|P1|Overall Study|Withdrawn due to Disease Progression|9
306617|NCT00802672|1005856|P3|Overall Study|other|2
306618|NCT00802672|1005857|P2|Overall Study|other|1
306619|NCT00802672|1005858|P1|Overall Study|other|3
306620|NCT00802672|1005856|P3|Overall Study|Withdrawal by Subject|2
306621|NCT00802672|1005857|P2|Overall Study|Withdrawal by Subject|1
306622|NCT00802672|1005858|P1|Overall Study|Withdrawal by Subject|1
306623|NCT00802672|1005856|P3|Overall Study|Lost to Follow-up|3
306624|NCT00802672|1005857|P2|Overall Study|Lost to Follow-up|5
306625|NCT00802672|1005858|P1|Overall Study|Lost to Follow-up|5
306626|NCT00802672|1005856|P3|Overall Study|Protocol Violation|1
306627|NCT00802672|1005857|P2|Overall Study|Protocol Violation|1
306628|NCT00802672|1005858|P1|Overall Study|Protocol Violation|2
306629|NCT00802672|1005856|P3|Overall Study|Adverse Event|1
306630|NCT00802672|1005857|P2|Overall Study|Adverse Event|1
306631|NCT00802672|1005858|P1|Overall Study|Adverse Event|1
306632|NCT00802672|1005856|P3|Overall Study|Lack of fungal pathogen at baseline|25
306633|NCT00802672|1005857|P2|Overall Study|Lack of fungal pathogen at baseline|43
306634|NCT00802672|1005858|P1|Overall Study|Lack of fungal pathogen at baseline|56
306635|NCT00802659|1005876|P4|Overall Study|Physician Decision|0
306636|NCT00802659|1005877|P3|Overall Study|Physician Decision|0
306637|NCT00802659|1005878|P2|Overall Study|Physician Decision|1
306638|NCT00802659|1005879|P1|Overall Study|Physician Decision|0
306639|NCT00802529|1005918|P2|Overall Study|Lost to Follow-up|1
306640|NCT00802529|1005919|P1|Overall Study|Lost to Follow-up|0
306641|NCT00802360|1005969|P4|Overall Study|Unspecified|3
306642|NCT00802360|1005970|P3|Overall Study|Unspecified|6
306643|NCT00802360|1005971|P2|Overall Study|Unspecified|3
306644|NCT00802360|1005972|P1|Overall Study|Unspecified|2
306645|NCT00802360|1005969|P4|Overall Study|Pregnancy loss/miscarriage|3
306646|NCT00802360|1005970|P3|Overall Study|Pregnancy loss/miscarriage|0
306647|NCT00802360|1005971|P2|Overall Study|Pregnancy loss/miscarriage|2
306648|NCT00802360|1005972|P1|Overall Study|Pregnancy loss/miscarriage|0
306649|NCT00802360|1005969|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
306650|NCT00802360|1005970|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
306651|NCT00802360|1005971|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
306652|NCT00802360|1005972|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
306653|NCT00802360|1005969|P4|Overall Study|No positive serum pregnancy|10
306654|NCT00802360|1005970|P3|Overall Study|No positive serum pregnancy|14
306655|NCT00802360|1005971|P2|Overall Study|No positive serum pregnancy|20
306656|NCT00802360|1005972|P1|Overall Study|No positive serum pregnancy|17
306657|NCT00802360|1005969|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
306658|NCT00802360|1005970|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
306659|NCT00802360|1005971|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
306660|NCT00802360|1005972|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
306661|NCT00802360|1005969|P4|Overall Study|Cycle cancelled|1
306662|NCT00802360|1005970|P3|Overall Study|Cycle cancelled|1
306663|NCT00802360|1005971|P2|Overall Study|Cycle cancelled|1
306664|NCT00802360|1005972|P1|Overall Study|Cycle cancelled|0
306665|NCT00802360|1005969|P4|Overall Study|Inadequate number of oocytes retrieved|1
306666|NCT00802360|1005970|P3|Overall Study|Inadequate number of oocytes retrieved|0
306667|NCT00802360|1005971|P2|Overall Study|Inadequate number of oocytes retrieved|0
306668|NCT00802360|1005972|P1|Overall Study|Inadequate number of oocytes retrieved|0
306669|NCT00802360|1005969|P4|Overall Study|Stimulation failure|3
306670|NCT00802360|1005970|P3|Overall Study|Stimulation failure|3
306671|NCT00802360|1005971|P2|Overall Study|Stimulation failure|0
306672|NCT00802360|1005972|P1|Overall Study|Stimulation failure|4
306673|NCT00802178|1006039|P1|Overall Study|Patients wish and other reason|1
306674|NCT00802178|1006039|P1|Overall Study|IT and patient wish|8
306675|NCT00802178|1006039|P1|Overall Study|Lack of efficacy and patient wish|1
306676|NCT00802178|1006039|P1|Overall Study|Other|32
306677|NCT00802178|1006039|P1|Overall Study|Withdrawal by Subject|18
306678|NCT00802178|1006039|P1|Overall Study|Insufficient tolerability (IT)|17
306679|NCT00802178|1006039|P1|Overall Study|Lack of Efficacy|36
306680|NCT00802074|1006066|P6|Overall Study|Withdrawal by Subject|0
306681|NCT00802074|1006067|P5|Overall Study|Withdrawal by Subject|0
306682|NCT00802074|1006068|P4|Overall Study|Withdrawal by Subject|0
306683|NCT00802074|1006069|P3|Overall Study|Withdrawal by Subject|0
306684|NCT00802074|1006070|P2|Overall Study|Withdrawal by Subject|0
306685|NCT00802074|1006071|P1|Overall Study|Withdrawal by Subject|1
306686|NCT00802074|1006066|P6|Overall Study|Adverse Event|0
306687|NCT00802074|1006067|P5|Overall Study|Adverse Event|0
306688|NCT00802074|1006068|P4|Overall Study|Adverse Event|0
306689|NCT00802074|1006069|P3|Overall Study|Adverse Event|1
306690|NCT00802074|1006070|P2|Overall Study|Adverse Event|1
306691|NCT00802074|1006071|P1|Overall Study|Adverse Event|1
306692|NCT00801983|1006105|P2|Period 2|Withdrawal by Subject|1
306693|NCT00801983|1006106|P1|Period 2|Withdrawal by Subject|2
306694|NCT00801983|1006105|P2|Period 1|Withdrawal by Subject|8
306695|NCT00801983|1006106|P1|Period 1|Withdrawal by Subject|2
306696|NCT00801983|1006105|P2|Period 1|Lost to Follow-up|0
306697|NCT00801983|1006106|P1|Period 1|Lost to Follow-up|2
306698|NCT00801632|1006152|P1|Overall Study|Re-transplant|1
306699|NCT00801242|1006163|P1|Overall Study|Miscellaneous reasons|20
306700|NCT00801242|1006163|P1|Overall Study|Lost to Follow-up|1
306701|NCT00801242|1006163|P1|Overall Study|Physician Decision|3
306702|NCT00801242|1006163|P1|Overall Study|Protocol Violation|5
306703|NCT00801242|1006163|P1|Overall Study|Withdrawal by Subject|13
306704|NCT00801242|1006163|P1|Overall Study|Adverse Event|10
306705|NCT00801229|1006176|P2|Received Study Drug/Placebo|Adverse Event|1
306706|NCT00801229|1006177|P1|Received Study Drug/Placebo|Adverse Event|1
306707|NCT00801229|1006176|P2|Received Study Drug/Placebo|Lost to Follow-up|1
306708|NCT00801229|1006177|P1|Received Study Drug/Placebo|Lost to Follow-up|0
306709|NCT00801229|1006176|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
306710|NCT00801229|1006177|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
306711|NCT00801229|1006176|P2|Received Study Drug/Placebo|Simulator sickness|1
306712|NCT00801229|1006177|P1|Received Study Drug/Placebo|Simulator sickness|1
306713|NCT00801229|1006176|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
306714|NCT00801229|1006177|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
306715|NCT00801229|1006176|P2|Received Study Drug/Placebo|Elevated SGOT level|0
306716|NCT00801229|1006177|P1|Received Study Drug/Placebo|Elevated SGOT level|1
306717|NCT00801229|1006176|P2|Signed Consent|Found Ineligible|1
306718|NCT00801229|1006177|P1|Signed Consent|Found Ineligible|1
306719|NCT00801229|1006176|P2|Signed Consent|Withdrawal by Subject|2
306720|NCT00801229|1006177|P1|Signed Consent|Withdrawal by Subject|2
306721|NCT00801099|1006212|P1|Overall Study|Lost to Follow-up|101
306722|NCT00800982|1006218|P2|Overall Study|Patient moved out of state|0
306723|NCT00800982|1006219|P1|Overall Study|Patient moved out of state|1
306724|NCT00800982|1006218|P2|Overall Study|Withdrawal by Subject|1
306725|NCT00800982|1006219|P1|Overall Study|Withdrawal by Subject|0
306726|NCT00800982|1006218|P2|Overall Study|Lost to Follow-up|2
306727|NCT00800982|1006219|P1|Overall Study|Lost to Follow-up|1
306728|NCT00800735|1006245|P1|Overall Study|Withdrew Consent|3
306729|NCT00800735|1006245|P1|Overall Study|Violation of Selection Criteria at Entry|7
306730|NCT00800735|1006245|P1|Overall Study|Insufficient Therapeutic Response|2
306731|NCT00800735|1006245|P1|Overall Study|Administrative/Other|2
306732|NCT00800683|1006251|P2|Overall Study|Not specified|2
306733|NCT00800683|1006252|P1|Overall Study|Not specified|1
306734|NCT00800683|1006251|P2|Overall Study|Lack of Efficacy|1
306735|NCT00800683|1006252|P1|Overall Study|Lack of Efficacy|1
306736|NCT00800683|1006251|P2|Overall Study|Withdrawal by Subject|7
306737|NCT00800683|1006252|P1|Overall Study|Withdrawal by Subject|1
306738|NCT00800683|1006251|P2|Overall Study|Lost to Follow-up|1
306739|NCT00800683|1006252|P1|Overall Study|Lost to Follow-up|3
306740|NCT00800683|1006251|P2|Overall Study|Adverse Event|8
306741|NCT00800683|1006252|P1|Overall Study|Adverse Event|11
306742|NCT00800540|1006298|P2|Period 2: 6 Weeks|Adverse Event|1
306743|NCT00800540|1006299|P1|Period 2: 6 Weeks|Adverse Event|0
306744|NCT00800540|1006298|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
306745|NCT00800540|1006299|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
306746|NCT00800540|1006298|P2|Period One: 6 Weeks|Noncompliance|0
306747|NCT00800540|1006299|P1|Period One: 6 Weeks|Noncompliance|1
306748|NCT00800436|1006334|P7|Overall Study|Withdrawal by Subject|0
306749|NCT00800436|1006335|P6|Overall Study|Withdrawal by Subject|0
306750|NCT00800436|1006336|P5|Overall Study|Withdrawal by Subject|0
306751|NCT00800436|1006337|P4|Overall Study|Withdrawal by Subject|1
306752|NCT00800436|1006338|P3|Overall Study|Withdrawal by Subject|1
306753|NCT00800436|1006339|P2|Overall Study|Withdrawal by Subject|0
306754|NCT00800436|1006340|P1|Overall Study|Withdrawal by Subject|0
306755|NCT00800384|1006386|P2|Overall Study|Lost to Follow-up|26
306756|NCT00800384|1006387|P1|Overall Study|Lost to Follow-up|17
306757|NCT00800384|1006386|P2|Overall Study|Withdrawal by Subject|17
306758|NCT00800384|1006387|P1|Overall Study|Withdrawal by Subject|24
306759|NCT00800202|1006425|P2|Overall Study|Disease Progression|18
306760|NCT00800202|1006426|P1|Overall Study|Disease Progression|54
306761|NCT00800202|1006425|P2|Overall Study|Unspecified|0
306762|NCT00800202|1006426|P1|Overall Study|Unspecified|5
306763|NCT00800202|1006425|P2|Overall Study|Death|0
306764|NCT00800202|1006426|P1|Overall Study|Death|1
306765|NCT00800202|1006425|P2|Overall Study|Adverse Event|6
306766|NCT00800202|1006426|P1|Overall Study|Adverse Event|7
306767|NCT00799825|1006444|P1|Overall Study|Pregnancy|3
306768|NCT00799825|1006444|P1|Overall Study|Lost to Follow-up|38
306769|NCT00799825|1006444|P1|Overall Study|Withdrawal by Subject|6
306770|NCT00799825|1006444|P1|Overall Study|Adverse Event|1
306771|NCT00799708|1006484|P3|Overall Study|non-compliance|0
306772|NCT00799708|1006485|P2|Overall Study|non-compliance|0
306773|NCT00799708|1006486|P1|Overall Study|non-compliance|1
306774|NCT00799591|1006536|P1|Overall Study|Infectious origin not probable|1
306775|NCT00799591|1006536|P1|Overall Study|Antibiotic changed, no apparent reason|1
306776|NCT00799591|1006536|P1|Overall Study|Persistance of fever undetermined origin|1
306777|NCT00799591|1006536|P1|Overall Study|Resistance germ and technical failure|2
306778|NCT00799591|1006536|P1|Overall Study|New infection|4
306779|NCT00799591|1006536|P1|Overall Study|Resistant germ|11
306780|NCT00799591|1006536|P1|Overall Study|Technical failure|12
306781|NCT00799591|1006536|P1|Overall Study|Death|14
306782|NCT00799591|1006536|P1|Overall Study|De-escalation of doses|20
306783|NCT00799487|1006554|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
306784|NCT00799487|1006555|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
306785|NCT00799487|1006556|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
306786|NCT00799487|1006554|P3|Double-Blind Assessment Period|Subject was out of the state|1
306787|NCT00799487|1006555|P2|Double-Blind Assessment Period|Subject was out of the state|0
306788|NCT00799487|1006556|P1|Double-Blind Assessment Period|Subject was out of the state|0
306789|NCT00799487|1006554|P3|Double-Blind Assessment Period|Lost to Follow-up|1
306790|NCT00799487|1006555|P2|Double-Blind Assessment Period|Lost to Follow-up|0
306791|NCT00799487|1006556|P1|Double-Blind Assessment Period|Lost to Follow-up|0
306792|NCT00799487|1006554|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
306793|NCT00799487|1006555|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
306794|NCT00799487|1006556|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
306795|NCT00799487|1006554|P3|Dose Adjustment Period|Missed laboratory day 1|0
306796|NCT00799487|1006555|P2|Dose Adjustment Period|Missed laboratory day 1|0
306797|NCT00799487|1006556|P1|Dose Adjustment Period|Missed laboratory day 1|1
306798|NCT00799487|1006554|P3|Dose Adjustment Period|Child too young (exclusion)|0
306799|NCT00799487|1006555|P2|Dose Adjustment Period|Child too young (exclusion)|0
306800|NCT00799487|1006556|P1|Dose Adjustment Period|Child too young (exclusion)|1
306801|NCT00799487|1006554|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
306802|NCT00799487|1006555|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
306803|NCT00799487|1006556|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
306804|NCT00799487|1006554|P3|Dose Adjustment Period|Withdrawal by Subject|0
306805|NCT00799487|1006555|P2|Dose Adjustment Period|Withdrawal by Subject|0
306806|NCT00799487|1006556|P1|Dose Adjustment Period|Withdrawal by Subject|3
306807|NCT00799487|1006554|P3|Dose Adjustment Period|Investigator Discretion|0
306808|NCT00799487|1006555|P2|Dose Adjustment Period|Investigator Discretion|0
306809|NCT00799487|1006556|P1|Dose Adjustment Period|Investigator Discretion|2
306810|NCT00799487|1006554|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
306811|NCT00799487|1006555|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
306812|NCT00799487|1006556|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
306813|NCT00799487|1006554|P3|Dose Adjustment Period|Adverse Event|0
306814|NCT00799487|1006555|P2|Dose Adjustment Period|Adverse Event|0
306815|NCT00799487|1006556|P1|Dose Adjustment Period|Adverse Event|2
306816|NCT00799487|1006554|P3|Dose Adjustment Period|Lost to Follow-up|0
306817|NCT00799487|1006555|P2|Dose Adjustment Period|Lost to Follow-up|0
306818|NCT00799487|1006556|P1|Dose Adjustment Period|Lost to Follow-up|1
306819|NCT00799422|1006642|P6|First Week of Wear|Adverse Event|0
306820|NCT00799422|1006643|P5|First Week of Wear|Adverse Event|0
306821|NCT00799422|1006644|P4|First Week of Wear|Adverse Event|1
306822|NCT00799422|1006645|P3|First Week of Wear|Adverse Event|0
306823|NCT00799422|1006646|P2|First Week of Wear|Adverse Event|0
306824|NCT00799422|1006647|P1|First Week of Wear|Adverse Event|0
306825|NCT00799422|1006642|P6|First Week of Wear|Lost to Follow-up|0
306826|NCT00799422|1006643|P5|First Week of Wear|Lost to Follow-up|0
306827|NCT00799422|1006644|P4|First Week of Wear|Lost to Follow-up|0
306828|NCT00799422|1006645|P3|First Week of Wear|Lost to Follow-up|1
306829|NCT00799422|1006646|P2|First Week of Wear|Lost to Follow-up|0
306830|NCT00799422|1006647|P1|First Week of Wear|Lost to Follow-up|0
306831|NCT00799409|1006664|P3|Overall Study|medication compliance|0
306832|NCT00799409|1006665|P2|Overall Study|medication compliance|0
306833|NCT00799409|1006666|P1|Overall Study|medication compliance|1
306834|NCT00799409|1006664|P3|Overall Study|Did not attend lab school day 1|0
306835|NCT00799409|1006665|P2|Overall Study|Did not attend lab school day 1|0
306836|NCT00799409|1006666|P1|Overall Study|Did not attend lab school day 1|1
306837|NCT00799409|1006664|P3|Overall Study|Failure to follow study protocol)|0
306838|NCT00799409|1006665|P2|Overall Study|Failure to follow study protocol)|0
306839|NCT00799409|1006666|P1|Overall Study|Failure to follow study protocol)|1
306840|NCT00799409|1006664|P3|Overall Study|Optimal Dose Not Achieved|0
306841|NCT00799409|1006665|P2|Overall Study|Optimal Dose Not Achieved|0
306842|NCT00799409|1006666|P1|Overall Study|Optimal Dose Not Achieved|2
306843|NCT00799409|1006664|P3|Overall Study|Lost to Follow-up|0
306844|NCT00799409|1006665|P2|Overall Study|Lost to Follow-up|0
306845|NCT00799409|1006666|P1|Overall Study|Lost to Follow-up|1
306846|NCT00799409|1006664|P3|Overall Study|Withdrawal by Subject|0
306847|NCT00799409|1006665|P2|Overall Study|Withdrawal by Subject|0
306848|NCT00799409|1006666|P1|Overall Study|Withdrawal by Subject|1
306849|NCT00799396|1006746|P1|Clopidogrel Plus Aspirin|Physician Decision|4
306850|NCT00799396|1006746|P1|Clopidogrel Plus Aspirin|Adverse Event|2
306851|NCT00799396|1006746|P1|Clopidogrel Treatment|Withdrawal by Subject|2
306852|NCT00799396|1006746|P1|Clopidogrel Treatment|Physician Decision|5
306853|NCT00799396|1006746|P1|Clopidogrel Treatment|Adverse Event|6
306854|NCT00798967|1006767|P2|Overall Study|Randomized in error by site|0
306855|NCT00798967|1006768|P1|Overall Study|Randomized in error by site|1
306856|NCT00798967|1006767|P2|Overall Study|Physician Decision|0
306857|NCT00798967|1006768|P1|Overall Study|Physician Decision|1
306858|NCT00798967|1006767|P2|Overall Study|Withdrawal by Subject|1
306859|NCT00798967|1006768|P1|Overall Study|Withdrawal by Subject|0
306860|NCT00798967|1006767|P2|Overall Study|Adverse Event|3
306861|NCT00798967|1006768|P1|Overall Study|Adverse Event|2
306862|NCT00798889|1006776|P1|Overall Study|Enrolled, Not treated|3
306863|NCT00798889|1006776|P1|Overall Study|Decision of Sponsor|11
306864|NCT00798889|1006776|P1|Overall Study|Lack of Efficacy|213
306865|NCT00798889|1006776|P1|Overall Study|Lost to Follow-up|1
306866|NCT00798889|1006776|P1|Overall Study|Withdrawal by Subject|31
306867|NCT00798889|1006776|P1|Overall Study|Protocol Violation|2
306868|NCT00798889|1006776|P1|Overall Study|Adverse Event|53
306869|NCT00798759|1006782|P2|Overall Study|Not specified|1
306870|NCT00798759|1006783|P1|Overall Study|Not specified|0
306871|NCT00798759|1006782|P2|Overall Study|Protocol Violation|8
306872|NCT00798759|1006783|P1|Overall Study|Protocol Violation|4
306873|NCT00798759|1006782|P2|Overall Study|Lost to Follow-up|1
306874|NCT00798759|1006783|P1|Overall Study|Lost to Follow-up|1
306875|NCT00798759|1006782|P2|Overall Study|Adverse Event|3
306876|NCT00798759|1006783|P1|Overall Study|Adverse Event|3
306877|NCT00798707|1006801|P3|Overall Study|Randomized not treated|1
306878|NCT00798707|1006802|P2|Overall Study|Randomized not treated|5
306879|NCT00798707|1006803|P1|Overall Study|Randomized not treated|4
306880|NCT00798707|1006801|P3|Overall Study|Withdrawal by Subject|2
306881|NCT00798707|1006802|P2|Overall Study|Withdrawal by Subject|8
306882|NCT00798707|1006803|P1|Overall Study|Withdrawal by Subject|3
306883|NCT00798707|1006801|P3|Overall Study|Protocol Violation|2
306884|NCT00798707|1006802|P2|Overall Study|Protocol Violation|0
306885|NCT00798707|1006803|P1|Overall Study|Protocol Violation|4
306886|NCT00798707|1006801|P3|Overall Study|Unspecified|0
306887|NCT00798707|1006802|P2|Overall Study|Unspecified|1
306888|NCT00798707|1006803|P1|Overall Study|Unspecified|0
306889|NCT00798707|1006801|P3|Overall Study|Lost to Follow-up|6
306890|NCT00798707|1006802|P2|Overall Study|Lost to Follow-up|6
306891|NCT00798707|1006803|P1|Overall Study|Lost to Follow-up|5
306892|NCT00798707|1006801|P3|Overall Study|Lack of Efficacy|1
306893|NCT00798707|1006802|P2|Overall Study|Lack of Efficacy|2
306894|NCT00798707|1006803|P1|Overall Study|Lack of Efficacy|2
306895|NCT00798707|1006801|P3|Overall Study|Investigator|2
306896|NCT00798707|1006802|P2|Overall Study|Investigator|1
306897|NCT00798707|1006803|P1|Overall Study|Investigator|0
306898|NCT00798707|1006801|P3|Overall Study|Failed to return|0
306899|NCT00798707|1006802|P2|Overall Study|Failed to return|2
306900|NCT00798707|1006803|P1|Overall Study|Failed to return|2
306901|NCT00798707|1006801|P3|Overall Study|Adverse Event|8
306902|NCT00798707|1006802|P2|Overall Study|Adverse Event|8
306903|NCT00798707|1006803|P1|Overall Study|Adverse Event|6
306904|NCT00798655|1006853|P1|Overall Study|Did not receive at least one dose of pan|2
306905|NCT00798603|1006858|P1|Overall Study|Lack of insurance coverage|1
306906|NCT00798603|1006858|P1|Overall Study|Physician Decision|1
306907|NCT00798603|1006858|P1|Overall Study|Adverse Event|22
306908|NCT00798603|1006858|P1|Overall Study|Withdrawal by Subject|10
306909|NCT00798603|1006858|P1|Overall Study|Still on treatment as of 11/6/2012|1
306910|NCT00798434|1006904|P2|Open-Label|Not Treated|1
306911|NCT00798434|1006905|P1|Open-Label|Not Treated|0
306912|NCT00798434|1006904|P2|Open-Label|Not Specified|2
306913|NCT00798434|1006905|P1|Open-Label|Not Specified|1
306914|NCT00798434|1006904|P2|Open-Label|Protocol Violation|0
306915|NCT00798434|1006905|P1|Open-Label|Protocol Violation|1
306916|NCT00798434|1006904|P2|Open-Label|Withdrawal by Subject|7
306917|NCT00798434|1006905|P1|Open-Label|Withdrawal by Subject|2
306918|NCT00798434|1006904|P2|Open-Label|Lack of Efficacy|11
306919|NCT00798434|1006905|P1|Open-Label|Lack of Efficacy|5
306920|NCT00798434|1006904|P2|Open-Label|Adverse Event|11
306921|NCT00798434|1006905|P1|Open-Label|Adverse Event|33
306922|NCT00798434|1006904|P2|Double-Blind|Not Treated|6
306923|NCT00798434|1006905|P1|Double-Blind|Not Treated|3
306924|NCT00798434|1006904|P2|Double-Blind|Not Specified|0
306925|NCT00798434|1006905|P1|Double-Blind|Not Specified|1
306926|NCT00798434|1006904|P2|Double-Blind|Did Not Meet Entrance Criteria|1
306927|NCT00798434|1006905|P1|Double-Blind|Did Not Meet Entrance Criteria|2
306928|NCT00798434|1006904|P2|Double-Blind|Protocol Violation|4
306929|NCT00798434|1006905|P1|Double-Blind|Protocol Violation|1
306930|NCT00798434|1006904|P2|Double-Blind|Withdrawal by Subject|14
306931|NCT00798434|1006905|P1|Double-Blind|Withdrawal by Subject|17
306932|NCT00798434|1006904|P2|Double-Blind|Lack of Efficacy|12
306933|NCT00798434|1006905|P1|Double-Blind|Lack of Efficacy|8
306934|NCT00798434|1006904|P2|Double-Blind|Lost to Follow-up|0
306935|NCT00798434|1006905|P1|Double-Blind|Lost to Follow-up|1
306936|NCT00798434|1006904|P2|Double-Blind|Death|1
306937|NCT00798434|1006905|P1|Double-Blind|Death|0
306938|NCT00798434|1006904|P2|Double-Blind|Adverse Event|46
306939|NCT00798434|1006905|P1|Double-Blind|Adverse Event|22
306940|NCT00798369|1006991|P6|Overall Study|Adminstrative problems|1
306941|NCT00798369|1006992|P5|Overall Study|Adminstrative problems|0
306942|NCT00798369|1006993|P4|Overall Study|Adminstrative problems|0
306943|NCT00798369|1006994|P3|Overall Study|Adminstrative problems|0
306944|NCT00798369|1006995|P2|Overall Study|Adminstrative problems|0
306945|NCT00798369|1006996|P1|Overall Study|Adminstrative problems|0
306946|NCT00798369|1006991|P6|Overall Study|Lost to Follow-up|0
306947|NCT00798369|1006992|P5|Overall Study|Lost to Follow-up|1
306948|NCT00798369|1006993|P4|Overall Study|Lost to Follow-up|0
306949|NCT00798369|1006994|P3|Overall Study|Lost to Follow-up|1
306950|NCT00798369|1006995|P2|Overall Study|Lost to Follow-up|1
306951|NCT00798369|1006996|P1|Overall Study|Lost to Follow-up|1
306952|NCT00798369|1006991|P6|Overall Study|Subject withdrew consent|2
306953|NCT00798369|1006992|P5|Overall Study|Subject withdrew consent|0
306954|NCT00798369|1006993|P4|Overall Study|Subject withdrew consent|1
306955|NCT00798369|1006994|P3|Overall Study|Subject withdrew consent|1
306956|NCT00798369|1006995|P2|Overall Study|Subject withdrew consent|0
306957|NCT00798369|1006996|P1|Overall Study|Subject withdrew consent|0
306958|NCT00798317|1007043|P2|Overall Study|Death|0
306959|NCT00798317|1007044|P1|Overall Study|Death|1
306960|NCT00798317|1007043|P2|Overall Study|Adverse Event|0
306961|NCT00798317|1007044|P1|Overall Study|Adverse Event|2
306962|NCT00798317|1007043|P2|Overall Study|Lost to Follow-up|2
306963|NCT00798317|1007044|P1|Overall Study|Lost to Follow-up|2
306964|NCT00798317|1007043|P2|Overall Study|Withdrawal by Subject|4
306965|NCT00798317|1007044|P1|Overall Study|Withdrawal by Subject|5
306966|NCT00798317|1007043|P2|Overall Study|Physician Decision|1
306967|NCT00798317|1007044|P1|Overall Study|Physician Decision|0
306968|NCT00798304|1007055|P3|Overall Study|Discontinuation by Sponsor|9
306969|NCT00798304|1007056|P2|Overall Study|Discontinuation by Sponsor|21
306970|NCT00798304|1007057|P1|Overall Study|Discontinuation by Sponsor|14
306971|NCT00798304|1007055|P3|Overall Study|Adverse Event|1
306972|NCT00798304|1007056|P2|Overall Study|Adverse Event|1
306973|NCT00798304|1007057|P1|Overall Study|Adverse Event|0
306974|NCT00798161|1007090|P7|Overall Study|Other reason (incl. lack of efficacy)|5
306975|NCT00798161|1007091|P6|Overall Study|Other reason (incl. lack of efficacy)|4
307067|NCT00797966|1007237|P6|Phase B|Met Withdrawal Criteria|0
306976|NCT00798161|1007092|P5|Overall Study|Other reason (incl. lack of efficacy)|2
306977|NCT00798161|1007093|P4|Overall Study|Other reason (incl. lack of efficacy)|5
306978|NCT00798161|1007094|P3|Overall Study|Other reason (incl. lack of efficacy)|3
306979|NCT00798161|1007095|P2|Overall Study|Other reason (incl. lack of efficacy)|5
306980|NCT00798161|1007096|P1|Overall Study|Other reason (incl. lack of efficacy)|7
306981|NCT00798161|1007090|P7|Overall Study|Withdrawal by Subject|1
306982|NCT00798161|1007091|P6|Overall Study|Withdrawal by Subject|3
306983|NCT00798161|1007092|P5|Overall Study|Withdrawal by Subject|2
306984|NCT00798161|1007093|P4|Overall Study|Withdrawal by Subject|4
306985|NCT00798161|1007094|P3|Overall Study|Withdrawal by Subject|5
306986|NCT00798161|1007095|P2|Overall Study|Withdrawal by Subject|4
306987|NCT00798161|1007096|P1|Overall Study|Withdrawal by Subject|5
306988|NCT00798161|1007090|P7|Overall Study|Lost to Follow-up|0
306989|NCT00798161|1007091|P6|Overall Study|Lost to Follow-up|0
306990|NCT00798161|1007092|P5|Overall Study|Lost to Follow-up|4
306991|NCT00798161|1007093|P4|Overall Study|Lost to Follow-up|3
306992|NCT00798161|1007094|P3|Overall Study|Lost to Follow-up|4
306993|NCT00798161|1007095|P2|Overall Study|Lost to Follow-up|3
306994|NCT00798161|1007096|P1|Overall Study|Lost to Follow-up|1
306995|NCT00798161|1007090|P7|Overall Study|Protocol Violation|0
306996|NCT00798161|1007091|P6|Overall Study|Protocol Violation|2
306997|NCT00798161|1007092|P5|Overall Study|Protocol Violation|3
306998|NCT00798161|1007093|P4|Overall Study|Protocol Violation|3
306999|NCT00798161|1007094|P3|Overall Study|Protocol Violation|3
307000|NCT00798161|1007095|P2|Overall Study|Protocol Violation|1
307001|NCT00798161|1007096|P1|Overall Study|Protocol Violation|2
307002|NCT00798161|1007090|P7|Overall Study|Adverse Event|4
307003|NCT00798161|1007091|P6|Overall Study|Adverse Event|2
307004|NCT00798161|1007092|P5|Overall Study|Adverse Event|5
307005|NCT00798161|1007093|P4|Overall Study|Adverse Event|6
307006|NCT00798161|1007094|P3|Overall Study|Adverse Event|6
307007|NCT00798161|1007095|P2|Overall Study|Adverse Event|4
307008|NCT00798161|1007096|P1|Overall Study|Adverse Event|3
307009|NCT00798135|1007203|P1|Overall Study|Physician Decision|1
307010|NCT00798135|1007203|P1|Overall Study|Disease progression, refractory|1
307011|NCT00798135|1007203|P1|Overall Study|Disease progression, relapse|11
307012|NCT00798096|1007209|P1|Overall Study|Ongoing|2
307013|NCT00797966|1007237|P6|Phase A+|Protocol deviation|4
307014|NCT00797966|1007238|P5|Phase A+|Protocol deviation|0
307015|NCT00797966|1007239|P4|Phase A+|Protocol deviation|0
307016|NCT00797966|1007240|P3|Phase A+|Protocol deviation|0
307017|NCT00797966|1007241|P2|Phase A+|Protocol deviation|0
307018|NCT00797966|1007242|P1|Phase A+|Protocol deviation|0
307019|NCT00797966|1007237|P6|Phase A+|Adverse Event|4
307020|NCT00797966|1007238|P5|Phase A+|Adverse Event|0
307021|NCT00797966|1007239|P4|Phase A+|Adverse Event|0
307022|NCT00797966|1007240|P3|Phase A+|Adverse Event|0
307023|NCT00797966|1007241|P2|Phase A+|Adverse Event|0
307024|NCT00797966|1007242|P1|Phase A+|Adverse Event|0
307025|NCT00797966|1007237|P6|Phase A+|Withdrawal by Subject|6
307026|NCT00797966|1007238|P5|Phase A+|Withdrawal by Subject|0
307027|NCT00797966|1007239|P4|Phase A+|Withdrawal by Subject|0
307028|NCT00797966|1007240|P3|Phase A+|Withdrawal by Subject|0
307029|NCT00797966|1007241|P2|Phase A+|Withdrawal by Subject|0
307030|NCT00797966|1007242|P1|Phase A+|Withdrawal by Subject|0
307031|NCT00797966|1007237|P6|Phase A+|Met withdrawal criteria|5
307032|NCT00797966|1007238|P5|Phase A+|Met withdrawal criteria|0
307033|NCT00797966|1007239|P4|Phase A+|Met withdrawal criteria|0
307034|NCT00797966|1007240|P3|Phase A+|Met withdrawal criteria|0
307035|NCT00797966|1007241|P2|Phase A+|Met withdrawal criteria|0
307036|NCT00797966|1007242|P1|Phase A+|Met withdrawal criteria|0
307037|NCT00797966|1007237|P6|Phase A+|Lost to Follow-up|9
307038|NCT00797966|1007238|P5|Phase A+|Lost to Follow-up|0
307039|NCT00797966|1007239|P4|Phase A+|Lost to Follow-up|0
307040|NCT00797966|1007240|P3|Phase A+|Lost to Follow-up|0
307041|NCT00797966|1007241|P2|Phase A+|Lost to Follow-up|0
307042|NCT00797966|1007242|P1|Phase A+|Lost to Follow-up|0
307043|NCT00797966|1007237|P6|Phase B|Lack of Efficacy|0
307044|NCT00797966|1007238|P5|Phase B|Lack of Efficacy|0
307045|NCT00797966|1007239|P4|Phase B|Lack of Efficacy|4
307046|NCT00797966|1007240|P3|Phase B|Lack of Efficacy|1
307047|NCT00797966|1007241|P2|Phase B|Lack of Efficacy|1
307048|NCT00797966|1007242|P1|Phase B|Lack of Efficacy|0
307049|NCT00797966|1007237|P6|Phase B|Protocol Deviation|0
307050|NCT00797966|1007238|P5|Phase B|Protocol Deviation|0
307051|NCT00797966|1007239|P4|Phase B|Protocol Deviation|6
307052|NCT00797966|1007240|P3|Phase B|Protocol Deviation|2
307053|NCT00797966|1007241|P2|Phase B|Protocol Deviation|8
307054|NCT00797966|1007242|P1|Phase B|Protocol Deviation|4
307055|NCT00797966|1007237|P6|Phase B|Withdrawal by Subject|0
307056|NCT00797966|1007238|P5|Phase B|Withdrawal by Subject|0
307057|NCT00797966|1007239|P4|Phase B|Withdrawal by Subject|3
307058|NCT00797966|1007240|P3|Phase B|Withdrawal by Subject|3
307059|NCT00797966|1007241|P2|Phase B|Withdrawal by Subject|4
307060|NCT00797966|1007242|P1|Phase B|Withdrawal by Subject|1
307061|NCT00797966|1007237|P6|Phase B|Physician Decision|0
307062|NCT00797966|1007238|P5|Phase B|Physician Decision|0
307063|NCT00797966|1007239|P4|Phase B|Physician Decision|1
307064|NCT00797966|1007240|P3|Phase B|Physician Decision|3
307065|NCT00797966|1007241|P2|Phase B|Physician Decision|0
307066|NCT00797966|1007242|P1|Phase B|Physician Decision|1
307068|NCT00797966|1007238|P5|Phase B|Met Withdrawal Criteria|0
307069|NCT00797966|1007239|P4|Phase B|Met Withdrawal Criteria|1
307070|NCT00797966|1007240|P3|Phase B|Met Withdrawal Criteria|6
307071|NCT00797966|1007241|P2|Phase B|Met Withdrawal Criteria|3
307072|NCT00797966|1007242|P1|Phase B|Met Withdrawal Criteria|3
307073|NCT00797966|1007237|P6|Phase B|Adverse Event|0
307074|NCT00797966|1007238|P5|Phase B|Adverse Event|0
307075|NCT00797966|1007239|P4|Phase B|Adverse Event|1
307076|NCT00797966|1007240|P3|Phase B|Adverse Event|3
307077|NCT00797966|1007241|P2|Phase B|Adverse Event|1
307078|NCT00797966|1007242|P1|Phase B|Adverse Event|2
307079|NCT00797966|1007237|P6|Phase B|Lost to Follow-up|0
307080|NCT00797966|1007238|P5|Phase B|Lost to Follow-up|0
307081|NCT00797966|1007239|P4|Phase B|Lost to Follow-up|0
307082|NCT00797966|1007240|P3|Phase B|Lost to Follow-up|3
307083|NCT00797966|1007241|P2|Phase B|Lost to Follow-up|1
307084|NCT00797966|1007242|P1|Phase B|Lost to Follow-up|0
307085|NCT00797966|1007237|P6|Phase A|Protocol deviation|0
307086|NCT00797966|1007238|P5|Phase A|Protocol deviation|56
307087|NCT00797966|1007239|P4|Phase A|Protocol deviation|0
307088|NCT00797966|1007240|P3|Phase A|Protocol deviation|0
307089|NCT00797966|1007241|P2|Phase A|Protocol deviation|0
307090|NCT00797966|1007242|P1|Phase A|Protocol deviation|0
307091|NCT00797966|1007237|P6|Phase A|Withdrawal by Subject|0
307092|NCT00797966|1007238|P5|Phase A|Withdrawal by Subject|33
307093|NCT00797966|1007239|P4|Phase A|Withdrawal by Subject|0
307094|NCT00797966|1007240|P3|Phase A|Withdrawal by Subject|0
307095|NCT00797966|1007241|P2|Phase A|Withdrawal by Subject|0
307096|NCT00797966|1007242|P1|Phase A|Withdrawal by Subject|0
307097|NCT00797966|1007237|P6|Phase A|Physician Decision|0
307098|NCT00797966|1007238|P5|Phase A|Physician Decision|13
307099|NCT00797966|1007239|P4|Phase A|Physician Decision|0
307100|NCT00797966|1007240|P3|Phase A|Physician Decision|0
307101|NCT00797966|1007241|P2|Phase A|Physician Decision|0
307102|NCT00797966|1007242|P1|Phase A|Physician Decision|0
307103|NCT00797966|1007237|P6|Phase A|Met withdrawal criteria|0
307104|NCT00797966|1007238|P5|Phase A|Met withdrawal criteria|4
307105|NCT00797966|1007239|P4|Phase A|Met withdrawal criteria|0
307106|NCT00797966|1007240|P3|Phase A|Met withdrawal criteria|0
307107|NCT00797966|1007241|P2|Phase A|Met withdrawal criteria|0
307108|NCT00797966|1007242|P1|Phase A|Met withdrawal criteria|0
307109|NCT00797966|1007237|P6|Phase A|Adverse Event|0
307110|NCT00797966|1007238|P5|Phase A|Adverse Event|46
307111|NCT00797966|1007239|P4|Phase A|Adverse Event|0
307112|NCT00797966|1007240|P3|Phase A|Adverse Event|0
307113|NCT00797966|1007241|P2|Phase A|Adverse Event|0
307114|NCT00797966|1007242|P1|Phase A|Adverse Event|0
307115|NCT00797966|1007237|P6|Phase A|Lost to Follow-up|0
307116|NCT00797966|1007238|P5|Phase A|Lost to Follow-up|33
307117|NCT00797966|1007239|P4|Phase A|Lost to Follow-up|0
307118|NCT00797966|1007240|P3|Phase A|Lost to Follow-up|0
307119|NCT00797966|1007241|P2|Phase A|Lost to Follow-up|0
307120|NCT00797966|1007242|P1|Phase A|Lost to Follow-up|0
307121|NCT00797862|1007307|P3|Overall Study|Mis-randomized|1
307122|NCT00797862|1007308|P2|Overall Study|Mis-randomized|3
307123|NCT00797862|1007309|P1|Overall Study|Mis-randomized|3
307124|NCT00797862|1007307|P3|Overall Study|Protocol Violation|8
307125|NCT00797862|1007308|P2|Overall Study|Protocol Violation|6
307126|NCT00797862|1007309|P1|Overall Study|Protocol Violation|4
307127|NCT00797862|1007307|P3|Overall Study|Administrative Problem|0
307128|NCT00797862|1007308|P2|Overall Study|Administrative Problem|0
307129|NCT00797862|1007309|P1|Overall Study|Administrative Problem|4
307130|NCT00797862|1007307|P3|Overall Study|Lost to Follow-up|5
307131|NCT00797862|1007308|P2|Overall Study|Lost to Follow-up|0
307132|NCT00797862|1007309|P1|Overall Study|Lost to Follow-up|11
307133|NCT00797862|1007307|P3|Overall Study|Withdrawal by Subject|7
307134|NCT00797862|1007308|P2|Overall Study|Withdrawal by Subject|7
307135|NCT00797862|1007309|P1|Overall Study|Withdrawal by Subject|14
307136|NCT00797862|1007307|P3|Overall Study|No longer required study medication|0
307137|NCT00797862|1007308|P2|Overall Study|No longer required study medication|0
307138|NCT00797862|1007309|P1|Overall Study|No longer required study medication|1
307139|NCT00797862|1007307|P3|Overall Study|Lack of Efficacy|6
307140|NCT00797862|1007308|P2|Overall Study|Lack of Efficacy|7
307141|NCT00797862|1007309|P1|Overall Study|Lack of Efficacy|1
307142|NCT00797862|1007307|P3|Overall Study|Abnormal Test Procedure Result|1
307143|NCT00797862|1007308|P2|Overall Study|Abnormal Test Procedure Result|1
307144|NCT00797862|1007309|P1|Overall Study|Abnormal Test Procedure Result|0
307145|NCT00797862|1007307|P3|Overall Study|Adverse Event|58
307146|NCT00797862|1007308|P2|Overall Study|Adverse Event|44
307147|NCT00797862|1007309|P1|Overall Study|Adverse Event|86
307148|NCT00797823|1007338|P3|First Period (Initial Randomization)|Physician Decision|0
307149|NCT00797823|1007339|P2|First Period (Initial Randomization)|Physician Decision|0
307150|NCT00797823|1007340|P1|First Period (Initial Randomization)|Physician Decision|1
307151|NCT00797667|1007363|P3|Overall Study|Adverse Event|8
307152|NCT00797667|1007364|P2|Overall Study|Adverse Event|8
307153|NCT00797667|1007365|P1|Overall Study|Adverse Event|19
307154|NCT00797667|1007363|P3|Overall Study|Withdrawal by Subject|2
307155|NCT00797667|1007364|P2|Overall Study|Withdrawal by Subject|14
307156|NCT00797667|1007365|P1|Overall Study|Withdrawal by Subject|9
307157|NCT00797667|1007363|P3|Overall Study|Study Terminated by Sponsor|115
307158|NCT00797667|1007364|P2|Overall Study|Study Terminated by Sponsor|216
307159|NCT00797667|1007365|P1|Overall Study|Study Terminated by Sponsor|217
307160|NCT00797667|1007363|P3|Overall Study|Protocol Violation|0
307161|NCT00797667|1007364|P2|Overall Study|Protocol Violation|7
307162|NCT00797667|1007365|P1|Overall Study|Protocol Violation|2
307163|NCT00797667|1007363|P3|Overall Study|Pregnancy|0
307164|NCT00797667|1007364|P2|Overall Study|Pregnancy|0
307165|NCT00797667|1007365|P1|Overall Study|Pregnancy|2
307166|NCT00797667|1007363|P3|Overall Study|Physician Decision|0
307167|NCT00797667|1007364|P2|Overall Study|Physician Decision|1
307168|NCT00797667|1007365|P1|Overall Study|Physician Decision|3
307169|NCT00797667|1007363|P3|Overall Study|Lost to Follow-up|2
307170|NCT00797667|1007364|P2|Overall Study|Lost to Follow-up|12
307171|NCT00797667|1007365|P1|Overall Study|Lost to Follow-up|8
307172|NCT00797667|1007363|P3|Overall Study|Lack of Efficacy|0
307173|NCT00797667|1007364|P2|Overall Study|Lack of Efficacy|1
307174|NCT00797667|1007365|P1|Overall Study|Lack of Efficacy|0
307175|NCT00797563|1007391|P1|Overall Study|Adverse Event|1
307176|NCT00797511|1007397|P1|Overall Study|Withdrawal by Subject|1
307177|NCT00797316|1007415|P2|Overall Study|Unsatisfactory therapeutic effect|13
307178|NCT00797316|1007416|P1|Overall Study|Unsatisfactory therapeutic effect|0
307179|NCT00797316|1007415|P2|Overall Study|Patient withdrew consent|6
307180|NCT00797316|1007416|P1|Overall Study|Patient withdrew consent|12
307181|NCT00797316|1007415|P2|Overall Study|Protocol Deviation|2
307182|NCT00797316|1007416|P1|Overall Study|Protocol Deviation|1
307183|NCT00797316|1007415|P2|Overall Study|Lost to Follow-up|8
307184|NCT00797316|1007416|P1|Overall Study|Lost to Follow-up|4
307185|NCT00797316|1007415|P2|Overall Study|Adverse Event|3
307186|NCT00797316|1007416|P1|Overall Study|Adverse Event|5
307187|NCT00797316|1007415|P2|Overall Study|Administrative problems|0
307188|NCT00797316|1007416|P1|Overall Study|Administrative problems|1
307189|NCT00797108|1007450|P3|Overall Study|Randomized but not Treated|0
307190|NCT00797108|1007451|P2|Overall Study|Randomized but not Treated|0
307191|NCT00797108|1007452|P1|Overall Study|Randomized but not Treated|2
307192|NCT00797108|1007450|P3|Overall Study|Unspecified|2
307193|NCT00797108|1007451|P2|Overall Study|Unspecified|0
307194|NCT00797108|1007452|P1|Overall Study|Unspecified|0
307195|NCT00797108|1007450|P3|Overall Study|Lack of Efficacy|1
307196|NCT00797108|1007451|P2|Overall Study|Lack of Efficacy|0
307197|NCT00797108|1007452|P1|Overall Study|Lack of Efficacy|1
307198|NCT00797108|1007450|P3|Overall Study|Global Deterioration of Health Status|0
307199|NCT00797108|1007451|P2|Overall Study|Global Deterioration of Health Status|1
307200|NCT00797108|1007452|P1|Overall Study|Global Deterioration of Health Status|0
307201|NCT00797108|1007450|P3|Overall Study|Did Not Meet Entrance Criteria|0
307202|NCT00797108|1007451|P2|Overall Study|Did Not Meet Entrance Criteria|1
307203|NCT00797108|1007452|P1|Overall Study|Did Not Meet Entrance Criteria|0
307204|NCT00797108|1007450|P3|Overall Study|Adverse Event|3
307205|NCT00797108|1007451|P2|Overall Study|Adverse Event|0
307206|NCT00797108|1007452|P1|Overall Study|Adverse Event|1
307207|NCT00796991|1007487|P3|Overall Study|Withdrawal by Subject|1
307208|NCT00796991|1007488|P2|Overall Study|Withdrawal by Subject|0
307209|NCT00796991|1007489|P1|Overall Study|Withdrawal by Subject|0
307210|NCT00796991|1007487|P3|Overall Study|Study Drug Toxicity|5
307211|NCT00796991|1007488|P2|Overall Study|Study Drug Toxicity|3
307212|NCT00796991|1007489|P1|Overall Study|Study Drug Toxicity|3
307213|NCT00796991|1007487|P3|Overall Study|Disease Progression|7
307214|NCT00796991|1007488|P2|Overall Study|Disease Progression|9
307215|NCT00796991|1007489|P1|Overall Study|Disease Progression|10
307216|NCT00796991|1007487|P3|Overall Study|Death|0
307217|NCT00796991|1007488|P2|Overall Study|Death|0
307218|NCT00796991|1007489|P1|Overall Study|Death|2
307219|NCT00796991|1007487|P3|Overall Study|Adverse Event|1
307220|NCT00796991|1007488|P2|Overall Study|Adverse Event|0
307221|NCT00796991|1007489|P1|Overall Study|Adverse Event|0
307222|NCT00796822|1007598|P2|Overall Study|Adverse Event|0
307223|NCT00796822|1007599|P1|Overall Study|Adverse Event|1
307224|NCT00796822|1007598|P2|Overall Study|Lost to Follow-up|0
307225|NCT00796822|1007599|P1|Overall Study|Lost to Follow-up|2
307226|NCT00796757|1007605|P1|Overall Study|Not specified|7
307227|NCT00796757|1007605|P1|Overall Study|Investigator's decision|2
307228|NCT00796757|1007605|P1|Overall Study|Participant noncompliance|1
307229|NCT00796757|1007605|P1|Overall Study|Protocol Violation|1
307230|NCT00796757|1007605|P1|Overall Study|Death|61
307231|NCT00796757|1007605|P1|Overall Study|Withdrawal by Subject|14
307232|NCT00796718|1007639|P1|Overall Study|Withdrawal by Informed Consent|1
307233|NCT00796718|1007639|P1|Overall Study|Lost to Follow-up|5
307234|NCT00796718|1007639|P1|Overall Study|Exclusion Criteria|1
307235|NCT00796718|1007639|P1|Overall Study|Adverse Event|2
307236|NCT00796666|1007691|P2|Overall Study|Randomized and not treated|0
307237|NCT00796666|1007692|P1|Overall Study|Randomized and not treated|1
307238|NCT00796666|1007691|P2|Overall Study|Terminated by sponsor|55
307239|NCT00796666|1007692|P1|Overall Study|Terminated by sponsor|53
307240|NCT00796666|1007691|P2|Overall Study|Unspecified|0
307241|NCT00796666|1007692|P1|Overall Study|Unspecified|1
307242|NCT00796666|1007691|P2|Overall Study|Protocol Violation|0
307243|NCT00796666|1007692|P1|Overall Study|Protocol Violation|1
307244|NCT00796666|1007691|P2|Overall Study|Adverse Event|5
307245|NCT00796666|1007692|P1|Overall Study|Adverse Event|7
307246|NCT00796666|1007691|P2|Overall Study|Withdrawal by Subject|0
307247|NCT00796666|1007692|P1|Overall Study|Withdrawal by Subject|2
307248|NCT00796666|1007691|P2|Overall Study|Death|4
307249|NCT00796666|1007692|P1|Overall Study|Death|2
307250|NCT00796653|1007726|P4|Overall Study|Other reason not described above|4
307251|NCT00796653|1007727|P3|Overall Study|Other reason not described above|7
307252|NCT00796653|1007728|P2|Overall Study|Other reason not described above|9
307253|NCT00796653|1007729|P1|Overall Study|Other reason not described above|4
307254|NCT00796653|1007726|P4|Overall Study|Non compliance with protocol|2
307255|NCT00796653|1007727|P3|Overall Study|Non compliance with protocol|0
307256|NCT00796653|1007728|P2|Overall Study|Non compliance with protocol|2
307257|NCT00796653|1007729|P1|Overall Study|Non compliance with protocol|2
307258|NCT00796653|1007726|P4|Overall Study|Lack of Efficacy|2
307259|NCT00796653|1007727|P3|Overall Study|Lack of Efficacy|3
307260|NCT00796653|1007728|P2|Overall Study|Lack of Efficacy|1
307261|NCT00796653|1007729|P1|Overall Study|Lack of Efficacy|8
307262|NCT00796653|1007726|P4|Overall Study|Withdrawal by Subject|13
307263|NCT00796653|1007727|P3|Overall Study|Withdrawal by Subject|8
307264|NCT00796653|1007728|P2|Overall Study|Withdrawal by Subject|8
307265|NCT00796653|1007729|P1|Overall Study|Withdrawal by Subject|16
307266|NCT00796653|1007726|P4|Overall Study|Lost to Follow-up|3
307267|NCT00796653|1007727|P3|Overall Study|Lost to Follow-up|2
307268|NCT00796653|1007728|P2|Overall Study|Lost to Follow-up|1
307269|NCT00796653|1007729|P1|Overall Study|Lost to Follow-up|2
307270|NCT00796653|1007726|P4|Overall Study|Adverse Event|16
307271|NCT00796653|1007727|P3|Overall Study|Adverse Event|16
307272|NCT00796653|1007728|P2|Overall Study|Adverse Event|16
307273|NCT00796653|1007729|P1|Overall Study|Adverse Event|19
307274|NCT00796614|1007999|P4|Overall Study|Other than stated|0
307275|NCT00796614|1008000|P3|Overall Study|Other than stated|0
307276|NCT00796614|1008001|P2|Overall Study|Other than stated|0
307277|NCT00796614|1008002|P1|Overall Study|Other than stated|1
307278|NCT00796614|1007999|P4|Overall Study|Withdrawal by Subject|1
307279|NCT00796614|1008000|P3|Overall Study|Withdrawal by Subject|0
307280|NCT00796614|1008001|P2|Overall Study|Withdrawal by Subject|0
307281|NCT00796614|1008002|P1|Overall Study|Withdrawal by Subject|1
307282|NCT00796614|1007999|P4|Overall Study|Lost to Follow-up|0
307283|NCT00796614|1008000|P3|Overall Study|Lost to Follow-up|1
307284|NCT00796614|1008001|P2|Overall Study|Lost to Follow-up|2
307285|NCT00796614|1008002|P1|Overall Study|Lost to Follow-up|2
307286|NCT00796614|1007999|P4|Overall Study|Protocol Violation|0
307287|NCT00796614|1008000|P3|Overall Study|Protocol Violation|2
307288|NCT00796614|1008001|P2|Overall Study|Protocol Violation|0
307289|NCT00796614|1008002|P1|Overall Study|Protocol Violation|0
307290|NCT00796614|1007999|P4|Overall Study|Adverse Event|0
307291|NCT00796614|1008000|P3|Overall Study|Adverse Event|0
307292|NCT00796614|1008001|P2|Overall Study|Adverse Event|2
307293|NCT00796614|1008002|P1|Overall Study|Adverse Event|1
307294|NCT00796549|1008044|P1|Overall Study|Progressive disease|56
307295|NCT00796549|1008044|P1|Overall Study|Other|2
307296|NCT00796549|1008044|P1|Overall Study|not entered|149
307297|NCT00796549|1008044|P1|Overall Study|Adverse Event|11
307298|NCT00796523|1008061|P2|Overall Study|Lost to Follow-up|7
307299|NCT00796523|1008062|P1|Overall Study|Lost to Follow-up|9
307300|NCT00796510|1008072|P2|Overall Study|Study Terminated|0
307301|NCT00796510|1008073|P1|Overall Study|Study Terminated|2
307302|NCT00796510|1008072|P2|Overall Study|Death|0
307303|NCT00796510|1008073|P1|Overall Study|Death|1
307304|NCT00796419|1008085|P2|Overall Study|Death|1
307305|NCT00796419|1008086|P1|Overall Study|Death|0
307306|NCT00796367|1008099|P3|Overall Study|other|3
307307|NCT00796367|1008100|P2|Overall Study|other|4
307308|NCT00796367|1008101|P1|Overall Study|other|2
307309|NCT00796367|1008099|P3|Overall Study|Requirement for restricted medication|2
307310|NCT00796367|1008100|P2|Overall Study|Requirement for restricted medication|0
307311|NCT00796367|1008101|P1|Overall Study|Requirement for restricted medication|2
307312|NCT00796367|1008099|P3|Overall Study|Pregnancy|1
307313|NCT00796367|1008100|P2|Overall Study|Pregnancy|0
307314|NCT00796367|1008101|P1|Overall Study|Pregnancy|1
307315|NCT00796367|1008099|P3|Overall Study|non compliance|1
307316|NCT00796367|1008100|P2|Overall Study|non compliance|1
307317|NCT00796367|1008101|P1|Overall Study|non compliance|3
307318|NCT00796367|1008099|P3|Overall Study|Lack of Efficacy|0
307319|NCT00796367|1008100|P2|Overall Study|Lack of Efficacy|1
307320|NCT00796367|1008101|P1|Overall Study|Lack of Efficacy|2
307321|NCT00796367|1008099|P3|Overall Study|Withdrawal by Subject|12
307322|NCT00796367|1008100|P2|Overall Study|Withdrawal by Subject|11
307323|NCT00796367|1008101|P1|Overall Study|Withdrawal by Subject|9
307324|NCT00796367|1008099|P3|Overall Study|Lost to Follow-up|21
307325|NCT00796367|1008100|P2|Overall Study|Lost to Follow-up|4
307326|NCT00796367|1008101|P1|Overall Study|Lost to Follow-up|5
307327|NCT00796367|1008099|P3|Overall Study|Adverse Event|7
307328|NCT00796367|1008100|P2|Overall Study|Adverse Event|4
307329|NCT00796367|1008101|P1|Overall Study|Adverse Event|6
307330|NCT00796328|1008112|P1|Overall Study|experienced hypotension requiring tx|6
307331|NCT00796315|1008116|P3|Overall Study|Protocol Violation|0
307332|NCT00796315|1008117|P2|Overall Study|Protocol Violation|1
307333|NCT00796315|1008118|P1|Overall Study|Protocol Violation|0
307334|NCT00796224|1008146|P2|Overall Study|Protocol Violation|1
307335|NCT00796224|1008147|P1|Overall Study|Protocol Violation|0
307336|NCT00796224|1008146|P2|Overall Study|Adverse Event|0
307337|NCT00796224|1008147|P1|Overall Study|Adverse Event|1
307338|NCT00796120|1008167|P2|Overall Study|Randomized but not treated|3
307339|NCT00796120|1008168|P1|Overall Study|Randomized but not treated|0
307340|NCT00796120|1008167|P2|Overall Study|Physician Decision|17
307341|NCT00796120|1008168|P1|Overall Study|Physician Decision|16
307342|NCT00796120|1008167|P2|Overall Study|unspecified|17
307343|NCT00796120|1008168|P1|Overall Study|unspecified|6
307344|NCT00796120|1008167|P2|Overall Study|Participant refusal|4
307345|NCT00796120|1008168|P1|Overall Study|Participant refusal|3
307346|NCT00796120|1008167|P2|Overall Study|Progressive disease|13
307347|NCT00796120|1008168|P1|Overall Study|Progressive disease|22
307348|NCT00796120|1008167|P2|Overall Study|Adverse Event|6
307349|NCT00796120|1008168|P1|Overall Study|Adverse Event|11
307350|NCT00796120|1008167|P2|Overall Study|Death|0
307351|NCT00796120|1008168|P1|Overall Study|Death|3
307352|NCT00796003|1008184|P2|Overall Study|Participants Not treated|2
307353|NCT00796003|1008185|P1|Overall Study|Participants Not treated|0
307354|NCT00796003|1008184|P2|Overall Study|Unspecified|1
307355|NCT00796003|1008185|P1|Overall Study|Unspecified|0
307356|NCT00796003|1008184|P2|Overall Study|Withdrawal by Subject|1
307357|NCT00796003|1008185|P1|Overall Study|Withdrawal by Subject|0
307358|NCT00796003|1008184|P2|Overall Study|Physician Decision|4
307359|NCT00796003|1008185|P1|Overall Study|Physician Decision|0
307360|NCT00796003|1008184|P2|Overall Study|Specified organ function not met|1
307361|NCT00796003|1008185|P1|Overall Study|Specified organ function not met|0
307362|NCT00796003|1008184|P2|Overall Study|Adverse Event|7
307363|NCT00796003|1008185|P1|Overall Study|Adverse Event|1
307364|NCT00796003|1008184|P2|Overall Study|Disease Progression|13
307365|NCT00796003|1008185|P1|Overall Study|Disease Progression|2
307366|NCT00795951|1008206|P1|Overall Study|Withdrawal by Subject|1
307367|NCT00795951|1008206|P1|Overall Study|Lost to Follow-up|1
307368|NCT00795886|1008243|P1|Overall Study|Death|10
307369|NCT00795717|1008255|P2|Phase II|too busy|1
307370|NCT00795717|1008256|P1|Phase II|too busy|0
307371|NCT00795717|1008255|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
307372|NCT00795717|1008256|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
307373|NCT00795717|1008255|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
307374|NCT00795717|1008256|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
307375|NCT00795717|1008255|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
307376|NCT00795717|1008256|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
307377|NCT00795704|1008268|P2|Overall Study|Adverse Event|1
307378|NCT00795704|1008269|P1|Overall Study|Adverse Event|1
307379|NCT00795704|1008268|P2|Overall Study|Withdrawal by Subject|2
307380|NCT00795704|1008269|P1|Overall Study|Withdrawal by Subject|3
307381|NCT00795639|1008281|P2|Overall Study|Randomized and not treated|1
307382|NCT00795639|1008282|P1|Overall Study|Randomized and not treated|0
307383|NCT00795639|1008281|P2|Overall Study|Terminated by sponsor|12
307384|NCT00795639|1008282|P1|Overall Study|Terminated by sponsor|13
307385|NCT00795639|1008281|P2|Overall Study|Unspecified|2
307386|NCT00795639|1008282|P1|Overall Study|Unspecified|0
307387|NCT00795639|1008281|P2|Overall Study|Adverse Event|2
307388|NCT00795639|1008282|P1|Overall Study|Adverse Event|5
307389|NCT00795639|1008281|P2|Overall Study|Pregnancy|0
307390|NCT00795639|1008282|P1|Overall Study|Pregnancy|1
307391|NCT00795639|1008281|P2|Overall Study|Withdrawal by Subject|3
307392|NCT00795639|1008282|P1|Overall Study|Withdrawal by Subject|1
307393|NCT00795639|1008281|P2|Overall Study|Death|6
307394|NCT00795639|1008282|P1|Overall Study|Death|1
307395|NCT00795600|1008294|P2|Overall Study|Unclassified|1
307396|NCT00795600|1008295|P1|Overall Study|Unclassified|1
307397|NCT00795600|1008294|P2|Overall Study|Withdrawal by Subject|0
307398|NCT00795600|1008295|P1|Overall Study|Withdrawal by Subject|1
307399|NCT00795600|1008294|P2|Overall Study|Protocol Violation|2
307400|NCT00795600|1008295|P1|Overall Study|Protocol Violation|1
307401|NCT00795600|1008294|P2|Overall Study|Adverse Event|1
307402|NCT00795600|1008295|P1|Overall Study|Adverse Event|1
307403|NCT00795535|1008415|P1|Overall Study|incomplete data and technical problems|20
307404|NCT00795509|1008422|P1|Overall Study|Protocol Violation|31
307405|NCT00795184|1008478|P2|Overall Study|Tissue sampling incomplete/conclusive|13
307406|NCT00795184|1008479|P1|Overall Study|Tissue sampling incomplete/conclusive|8
307407|NCT00795132|1008540|P1|Overall Study|Relapse|2
307408|NCT00795132|1008540|P1|Overall Study|Death|1
307409|NCT00794963|1008563|P2|Overall Study|Withdrawal by Subject|4
307410|NCT00794963|1008564|P1|Overall Study|Withdrawal by Subject|1
307411|NCT00794924|1008572|P2|Overall Study|Adverse Event|2
307412|NCT00794924|1008573|P1|Overall Study|Adverse Event|6
307413|NCT00794924|1008572|P2|Overall Study|Withdrawal by Subject|60
307414|NCT00794924|1008573|P1|Overall Study|Withdrawal by Subject|48
307415|NCT00794924|1008572|P2|Overall Study|Lost to Follow-up|8
307416|NCT00794924|1008573|P1|Overall Study|Lost to Follow-up|6
307417|NCT00794820|1008577|P1|Overall Study|Ineligible/Screen Failure|1
307418|NCT00794820|1008577|P1|Overall Study|Resistant Disease|2
307419|NCT00794820|1008577|P1|Overall Study|Secondary Malignancies|2
307420|NCT00794820|1008577|P1|Overall Study|Adverse Event|11
307421|NCT00794677|1008585|P2|First Intervention|Withdrawal by Subject|0
307422|NCT00794677|1008586|P1|First Intervention|Withdrawal by Subject|2
307423|NCT00794664|1008608|P2|Follow-up Period|Protocol non-compliance|1
307424|NCT00794664|1008609|P1|Follow-up Period|Protocol non-compliance|0
307425|NCT00794664|1008608|P2|Follow-up Period|Withdrawal by Subject|2
307426|NCT00794664|1008609|P1|Follow-up Period|Withdrawal by Subject|0
307427|NCT00794664|1008608|P2|Follow-up Period|Not specified|2
307428|NCT00794664|1008609|P1|Follow-up Period|Not specified|1
307429|NCT00794664|1008608|P2|Treatment Period|Adverse Event|8
307430|NCT00794664|1008609|P1|Treatment Period|Adverse Event|1
307431|NCT00794664|1008608|P2|Treatment Period|Not specified|1
307432|NCT00794664|1008609|P1|Treatment Period|Not specified|0
307433|NCT00794664|1008608|P2|Treatment Period|Protocol non-compliance|1
307434|NCT00794664|1008609|P1|Treatment Period|Protocol non-compliance|0
307435|NCT00794664|1008608|P2|Treatment Period|Withdrawal by Subject|2
307436|NCT00794664|1008609|P1|Treatment Period|Withdrawal by Subject|0
307437|NCT00794365|1008693|P1|Overall Study|Lack of Efficacy|3
307438|NCT00794365|1008693|P1|Overall Study|Adverse Event|10
307439|NCT00794365|1008693|P1|Overall Study|Poor Compliance|11
307440|NCT00794365|1008693|P1|Overall Study|Unspecified|17
307441|NCT00794365|1008693|P1|Overall Study|Lost to Follow-up|38
307442|NCT00794196|1008714|P2|Overall Study|Lost to Follow-up|23
307443|NCT00794196|1008715|P1|Overall Study|Lost to Follow-up|5
307444|NCT00794157|1008735|P3|Overall Study|Protocol deviation|1
307445|NCT00794157|1008736|P2|Overall Study|Protocol deviation|1
307446|NCT00794157|1008737|P1|Overall Study|Protocol deviation|0
307447|NCT00794157|1008735|P3|Overall Study|Abnormal test procedure result(s)|0
307448|NCT00794157|1008736|P2|Overall Study|Abnormal test procedure result(s)|1
307449|NCT00794157|1008737|P1|Overall Study|Abnormal test procedure result(s)|0
307450|NCT00794157|1008735|P3|Overall Study|Administrative problems|4
307451|NCT00794157|1008736|P2|Overall Study|Administrative problems|7
307452|NCT00794157|1008737|P1|Overall Study|Administrative problems|1
307453|NCT00794157|1008735|P3|Overall Study|Unsatisfactory therapeutic effect|2
307454|NCT00794157|1008736|P2|Overall Study|Unsatisfactory therapeutic effect|0
307455|NCT00794157|1008737|P1|Overall Study|Unsatisfactory therapeutic effect|1
307456|NCT00794157|1008735|P3|Overall Study|Lost to Follow-up|1
307457|NCT00794157|1008736|P2|Overall Study|Lost to Follow-up|0
307458|NCT00794157|1008737|P1|Overall Study|Lost to Follow-up|2
307459|NCT00794157|1008735|P3|Overall Study|Subject withdrew consent|3
307460|NCT00794157|1008736|P2|Overall Study|Subject withdrew consent|0
307461|NCT00794157|1008737|P1|Overall Study|Subject withdrew consent|2
307462|NCT00794157|1008735|P3|Overall Study|Adverse Event|8
307463|NCT00794157|1008736|P2|Overall Study|Adverse Event|1
307464|NCT00794157|1008737|P1|Overall Study|Adverse Event|4
307465|NCT00794118|1008766|P1|Overall Study|Changed hospital center|2
307466|NCT00794118|1008766|P1|Overall Study|Withdrawal by Subject|9
307467|NCT00794118|1008766|P1|Overall Study|Lost to Follow-up|16
307468|NCT00793910|1008824|P2|Overall Study|Withdrawal by Subject|1
307469|NCT00793910|1008825|P1|Overall Study|Withdrawal by Subject|0
307470|NCT00793910|1008824|P2|Overall Study|decided to undergo LASIK instead of PRK|1
307471|NCT00793910|1008825|P1|Overall Study|decided to undergo LASIK instead of PRK|2
307472|NCT00793910|1008824|P2|Overall Study|ineligible based on entry criteria|3
307473|NCT00793910|1008825|P1|Overall Study|ineligible based on entry criteria|2
307474|NCT00793910|1008824|P2|Overall Study|did not pick up medications|1
307475|NCT00793910|1008825|P1|Overall Study|did not pick up medications|1
307476|NCT00793910|1008824|P2|Overall Study|discarded study pills|1
307477|NCT00793910|1008825|P1|Overall Study|discarded study pills|0
307478|NCT00793871|1008839|P1|Overall Study|Study terminated by the Sponsor|7
307479|NCT00793871|1008839|P1|Overall Study|Lost to Follow-up|3
307480|NCT00793871|1008839|P1|Overall Study|Death|50
307481|NCT00793819|1008853|P2|Overall Study|Lost to Follow-up|1
307482|NCT00793819|1008854|P1|Overall Study|Lost to Follow-up|1
307483|NCT00793819|1008853|P2|Overall Study|Withdrawal by Subject|3
307484|NCT00793819|1008854|P1|Overall Study|Withdrawal by Subject|4
307485|NCT00793819|1008853|P2|Overall Study|Lack of Efficacy|1
307486|NCT00793819|1008854|P1|Overall Study|Lack of Efficacy|1
307487|NCT00793819|1008853|P2|Overall Study|Adverse Event|4
307488|NCT00793819|1008854|P1|Overall Study|Adverse Event|8
307489|NCT00793793|1008872|P12|Overall Study|reason not specified|4
307490|NCT00793793|1008873|P11|Overall Study|reason not specified|2
307491|NCT00793793|1008874|P10|Overall Study|reason not specified|6
307492|NCT00793793|1008875|P9|Overall Study|reason not specified|7
307493|NCT00793793|1008876|P8|Overall Study|reason not specified|0
307494|NCT00793793|1008877|P7|Overall Study|reason not specified|2
307495|NCT00793793|1008878|P6|Overall Study|reason not specified|1
307496|NCT00793793|1008879|P5|Overall Study|reason not specified|1
307497|NCT00793793|1008880|P4|Overall Study|reason not specified|1
307498|NCT00793793|1008881|P3|Overall Study|reason not specified|0
307499|NCT00793793|1008882|P2|Overall Study|reason not specified|1
307500|NCT00793793|1008883|P1|Overall Study|reason not specified|0
307501|NCT00793793|1008872|P12|Overall Study|Withdrawal by Subject|0
307502|NCT00793793|1008873|P11|Overall Study|Withdrawal by Subject|0
307503|NCT00793793|1008874|P10|Overall Study|Withdrawal by Subject|0
307504|NCT00793793|1008875|P9|Overall Study|Withdrawal by Subject|1
307505|NCT00793793|1008876|P8|Overall Study|Withdrawal by Subject|0
307506|NCT00793793|1008877|P7|Overall Study|Withdrawal by Subject|0
307507|NCT00793793|1008878|P6|Overall Study|Withdrawal by Subject|0
307508|NCT00793793|1008879|P5|Overall Study|Withdrawal by Subject|1
307509|NCT00793793|1008880|P4|Overall Study|Withdrawal by Subject|0
307510|NCT00793793|1008881|P3|Overall Study|Withdrawal by Subject|0
307511|NCT00793793|1008882|P2|Overall Study|Withdrawal by Subject|0
307512|NCT00793793|1008883|P1|Overall Study|Withdrawal by Subject|0
307513|NCT00793793|1008872|P12|Overall Study|Lost to Follow-up|0
307514|NCT00793793|1008873|P11|Overall Study|Lost to Follow-up|1
307515|NCT00793793|1008874|P10|Overall Study|Lost to Follow-up|3
307516|NCT00793793|1008875|P9|Overall Study|Lost to Follow-up|1
307517|NCT00793793|1008876|P8|Overall Study|Lost to Follow-up|0
307518|NCT00793793|1008877|P7|Overall Study|Lost to Follow-up|0
307519|NCT00793793|1008878|P6|Overall Study|Lost to Follow-up|0
307520|NCT00793793|1008879|P5|Overall Study|Lost to Follow-up|0
307521|NCT00793793|1008880|P4|Overall Study|Lost to Follow-up|0
307522|NCT00793793|1008881|P3|Overall Study|Lost to Follow-up|1
307523|NCT00793793|1008882|P2|Overall Study|Lost to Follow-up|0
307524|NCT00793793|1008883|P1|Overall Study|Lost to Follow-up|0
307525|NCT00793793|1008872|P12|Overall Study|Protocol Violation|0
307526|NCT00793793|1008873|P11|Overall Study|Protocol Violation|0
307527|NCT00793793|1008874|P10|Overall Study|Protocol Violation|0
307528|NCT00793793|1008875|P9|Overall Study|Protocol Violation|0
307529|NCT00793793|1008876|P8|Overall Study|Protocol Violation|0
307530|NCT00793793|1008877|P7|Overall Study|Protocol Violation|0
307531|NCT00793793|1008878|P6|Overall Study|Protocol Violation|0
307532|NCT00793793|1008879|P5|Overall Study|Protocol Violation|0
307533|NCT00793793|1008880|P4|Overall Study|Protocol Violation|1
307534|NCT00793793|1008881|P3|Overall Study|Protocol Violation|0
307535|NCT00793793|1008882|P2|Overall Study|Protocol Violation|0
307536|NCT00793793|1008883|P1|Overall Study|Protocol Violation|0
307537|NCT00793793|1008872|P12|Overall Study|Adverse Event|2
307538|NCT00793793|1008873|P11|Overall Study|Adverse Event|0
307539|NCT00793793|1008874|P10|Overall Study|Adverse Event|0
307540|NCT00793793|1008875|P9|Overall Study|Adverse Event|0
307541|NCT00793793|1008876|P8|Overall Study|Adverse Event|0
307542|NCT00793793|1008877|P7|Overall Study|Adverse Event|2
307543|NCT00793793|1008878|P6|Overall Study|Adverse Event|1
307544|NCT00793793|1008879|P5|Overall Study|Adverse Event|0
307545|NCT00793793|1008880|P4|Overall Study|Adverse Event|1
307546|NCT00793793|1008881|P3|Overall Study|Adverse Event|1
307547|NCT00793793|1008882|P2|Overall Study|Adverse Event|0
307548|NCT00793793|1008883|P1|Overall Study|Adverse Event|0
307549|NCT00793780|1009258|P2|Overall Study|Withdrawal by Subject|1
307550|NCT00793780|1009259|P1|Overall Study|Withdrawal by Subject|2
307551|NCT00793624|1009290|P4|Overall Study|Other reason not described above|3
307552|NCT00793624|1009291|P3|Overall Study|Other reason not described above|6
307553|NCT00793624|1009292|P2|Overall Study|Other reason not described above|4
307554|NCT00793624|1009293|P1|Overall Study|Other reason not described above|6
307555|NCT00793624|1009290|P4|Overall Study|Non compliance with protocol|3
307556|NCT00793624|1009291|P3|Overall Study|Non compliance with protocol|2
307557|NCT00793624|1009292|P2|Overall Study|Non compliance with protocol|3
307558|NCT00793624|1009293|P1|Overall Study|Non compliance with protocol|2
307559|NCT00793624|1009290|P4|Overall Study|Lack of Efficacy|3
307560|NCT00793624|1009291|P3|Overall Study|Lack of Efficacy|1
307561|NCT00793624|1009292|P2|Overall Study|Lack of Efficacy|2
307562|NCT00793624|1009293|P1|Overall Study|Lack of Efficacy|9
307563|NCT00793624|1009290|P4|Overall Study|Withdrawal by Subject|14
307564|NCT00793624|1009291|P3|Overall Study|Withdrawal by Subject|11
307565|NCT00793624|1009292|P2|Overall Study|Withdrawal by Subject|9
307566|NCT00793624|1009293|P1|Overall Study|Withdrawal by Subject|20
307567|NCT00793624|1009290|P4|Overall Study|Lost to Follow-up|0
307568|NCT00793624|1009291|P3|Overall Study|Lost to Follow-up|4
307569|NCT00793624|1009292|P2|Overall Study|Lost to Follow-up|2
307570|NCT00793624|1009293|P1|Overall Study|Lost to Follow-up|2
307571|NCT00793624|1009290|P4|Overall Study|Adverse Event|20
307572|NCT00793624|1009291|P3|Overall Study|Adverse Event|15
307573|NCT00793624|1009292|P2|Overall Study|Adverse Event|16
307574|NCT00793624|1009293|P1|Overall Study|Adverse Event|18
307575|NCT00793585|1009574|P2|Overall Study|Protocol Violation|2
307576|NCT00793585|1009575|P1|Overall Study|Protocol Violation|1
307577|NCT00793585|1009574|P2|Overall Study|Adverse Event|1
307578|NCT00793585|1009575|P1|Overall Study|Adverse Event|1
307579|NCT00793546|1009594|P2|Overall Study|Unspecified|0
307580|NCT00793546|1009595|P1|Overall Study|Unspecified|1
307581|NCT00793546|1009594|P2|Overall Study|Study Terminated by Sponsor|27
307582|NCT00793546|1009595|P1|Overall Study|Study Terminated by Sponsor|8
307583|NCT00793546|1009594|P2|Overall Study|Withdrawal by Subject|1
307584|NCT00793546|1009595|P1|Overall Study|Withdrawal by Subject|1
307585|NCT00793546|1009594|P2|Overall Study|Lost to Follow-up|0
307586|NCT00793546|1009595|P1|Overall Study|Lost to Follow-up|1
307587|NCT00793546|1009594|P2|Overall Study|Death|0
307588|NCT00793546|1009595|P1|Overall Study|Death|3
307589|NCT00793403|1009645|P1|Overall Study|Unspecified|73
307590|NCT00793325|1009692|P1|Overall Study|Lost to Follow-up|1
307591|NCT00793325|1009692|P1|Overall Study|Protocol Violation|18
307592|NCT00793104|1009720|P1|Overall Study|Lost to Follow-up|1
307593|NCT00792948|1009728|P1|Overall Study|Protocol Violation|1
307594|NCT00792948|1009728|P1|Overall Study|Physician Decision|11
307595|NCT00792948|1009728|P1|Overall Study|Insurance denial - not treated|1
307596|NCT00792948|1009728|P1|Overall Study|Ineligible|2
307597|NCT00792948|1009728|P1|Overall Study|Withdrawal by Subject|3
307598|NCT00792948|1009728|P1|Overall Study|Death|4
307599|NCT00792948|1009728|P1|Overall Study|Adverse Event|6
307600|NCT00792935|1009739|P2|Overall Study|Withdrawal by Subject|1
307601|NCT00792935|1009740|P1|Overall Study|Withdrawal by Subject|0
307602|NCT00792935|1009739|P2|Overall Study|Protocol Violation|0
307603|NCT00792935|1009740|P1|Overall Study|Protocol Violation|2
307604|NCT00792935|1009739|P2|Overall Study|Lost to Follow-up|1
307605|NCT00792935|1009740|P1|Overall Study|Lost to Follow-up|0
307606|NCT00792935|1009739|P2|Overall Study|Adverse Event|1
307607|NCT00792935|1009740|P1|Overall Study|Adverse Event|2
307608|NCT00792805|1009751|P3|Overall Study|Protocol deviation|1
307609|NCT00792805|1009752|P2|Overall Study|Protocol deviation|1
307610|NCT00792805|1009753|P1|Overall Study|Protocol deviation|0
307611|NCT00792805|1009751|P3|Overall Study|Abnormal laboratory value(s)|1
307612|NCT00792805|1009752|P2|Overall Study|Abnormal laboratory value(s)|0
307613|NCT00792805|1009753|P1|Overall Study|Abnormal laboratory value(s)|0
307614|NCT00792805|1009751|P3|Overall Study|Lost to Follow-up|6
307615|NCT00792805|1009752|P2|Overall Study|Lost to Follow-up|1
307616|NCT00792805|1009753|P1|Overall Study|Lost to Follow-up|1
307617|NCT00792805|1009751|P3|Overall Study|Unsatisfactory therapeutic effect|6
307618|NCT00792805|1009752|P2|Overall Study|Unsatisfactory therapeutic effect|6
307619|NCT00792805|1009753|P1|Overall Study|Unsatisfactory therapeutic effect|1
307620|NCT00792805|1009751|P3|Overall Study|Abnormal test procedure result(s)|0
307621|NCT00792805|1009752|P2|Overall Study|Abnormal test procedure result(s)|2
307622|NCT00792805|1009753|P1|Overall Study|Abnormal test procedure result(s)|1
307623|NCT00792805|1009751|P3|Overall Study|Administrative problems|4
307624|NCT00792805|1009752|P2|Overall Study|Administrative problems|0
307625|NCT00792805|1009753|P1|Overall Study|Administrative problems|2
307626|NCT00792805|1009751|P3|Overall Study|Subject withdrew consent|5
307627|NCT00792805|1009752|P2|Overall Study|Subject withdrew consent|6
307628|NCT00792805|1009753|P1|Overall Study|Subject withdrew consent|5
307629|NCT00792805|1009751|P3|Overall Study|Adverse Event|10
307630|NCT00792805|1009752|P2|Overall Study|Adverse Event|10
307631|NCT00792805|1009753|P1|Overall Study|Adverse Event|12
307632|NCT00792636|1009780|P3|Overall Study|Investigator Discretion|2
307633|NCT00792636|1009781|P2|Overall Study|Investigator Discretion|0
307634|NCT00792636|1009782|P1|Overall Study|Investigator Discretion|2
307635|NCT00792636|1009780|P3|Overall Study|Adverse Event|3
307636|NCT00792636|1009781|P2|Overall Study|Adverse Event|2
307637|NCT00792636|1009782|P1|Overall Study|Adverse Event|4
307638|NCT00792636|1009780|P3|Overall Study|Lack of Efficacy|13
307639|NCT00792636|1009781|P2|Overall Study|Lack of Efficacy|4
307640|NCT00792636|1009782|P1|Overall Study|Lack of Efficacy|3
307641|NCT00792636|1009780|P3|Overall Study|Withdrew Consent|9
307642|NCT00792636|1009781|P2|Overall Study|Withdrew Consent|13
307643|NCT00792636|1009782|P1|Overall Study|Withdrew Consent|10
307644|NCT00792636|1009780|P3|Overall Study|Lost to Follow-up|14
307645|NCT00792636|1009781|P2|Overall Study|Lost to Follow-up|19
307646|NCT00792636|1009782|P1|Overall Study|Lost to Follow-up|13
307647|NCT00792636|1009780|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
307648|NCT00792636|1009781|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
307649|NCT00792636|1009782|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
307650|NCT00792636|1009780|P3|Overall Study|Protocol Violation|20
307651|NCT00792636|1009781|P2|Overall Study|Protocol Violation|23
307652|NCT00792636|1009782|P1|Overall Study|Protocol Violation|17
307653|NCT00792298|1009823|P8|Treatment Period 2|Withdrawal by Subject|2
307654|NCT00792298|1009824|P7|Treatment Period 2|Withdrawal by Subject|0
307655|NCT00792298|1009825|P6|Treatment Period 2|Withdrawal by Subject|0
307656|NCT00792298|1009826|P5|Treatment Period 2|Withdrawal by Subject|1
307657|NCT00792298|1009827|P4|Treatment Period 2|Withdrawal by Subject|2
307658|NCT00792298|1009828|P3|Treatment Period 2|Withdrawal by Subject|0
307659|NCT00792298|1009829|P2|Treatment Period 2|Withdrawal by Subject|1
307660|NCT00792298|1009830|P1|Treatment Period 2|Withdrawal by Subject|1
307661|NCT00792298|1009823|P8|Treatment Period 2|Pregnancy|0
307662|NCT00792298|1009824|P7|Treatment Period 2|Pregnancy|0
307663|NCT00792298|1009825|P6|Treatment Period 2|Pregnancy|0
307664|NCT00792298|1009826|P5|Treatment Period 2|Pregnancy|0
307665|NCT00792298|1009827|P4|Treatment Period 2|Pregnancy|0
307666|NCT00792298|1009828|P3|Treatment Period 2|Pregnancy|1
307667|NCT00792298|1009829|P2|Treatment Period 2|Pregnancy|0
307668|NCT00792298|1009830|P1|Treatment Period 2|Pregnancy|0
307669|NCT00792298|1009823|P8|Treatment Period 2|Physician Decision|0
307670|NCT00792298|1009824|P7|Treatment Period 2|Physician Decision|1
307671|NCT00792298|1009825|P6|Treatment Period 2|Physician Decision|0
307672|NCT00792298|1009826|P5|Treatment Period 2|Physician Decision|0
307673|NCT00792298|1009827|P4|Treatment Period 2|Physician Decision|0
307674|NCT00792298|1009828|P3|Treatment Period 2|Physician Decision|0
307675|NCT00792298|1009829|P2|Treatment Period 2|Physician Decision|0
307676|NCT00792298|1009830|P1|Treatment Period 2|Physician Decision|0
307677|NCT00792298|1009823|P8|Treatment Period 2|Lack of Efficacy|0
307678|NCT00792298|1009824|P7|Treatment Period 2|Lack of Efficacy|0
307679|NCT00792298|1009825|P6|Treatment Period 2|Lack of Efficacy|0
307680|NCT00792298|1009826|P5|Treatment Period 2|Lack of Efficacy|1
307681|NCT00792298|1009827|P4|Treatment Period 2|Lack of Efficacy|0
307682|NCT00792298|1009828|P3|Treatment Period 2|Lack of Efficacy|0
307683|NCT00792298|1009829|P2|Treatment Period 2|Lack of Efficacy|0
307684|NCT00792298|1009830|P1|Treatment Period 2|Lack of Efficacy|0
307685|NCT00792298|1009823|P8|Washout|Withdrawal by Subject|0
307686|NCT00792298|1009824|P7|Washout|Withdrawal by Subject|0
307687|NCT00792298|1009825|P6|Washout|Withdrawal by Subject|1
307688|NCT00792298|1009826|P5|Washout|Withdrawal by Subject|0
307689|NCT00792298|1009827|P4|Washout|Withdrawal by Subject|0
307690|NCT00792298|1009828|P3|Washout|Withdrawal by Subject|1
307691|NCT00792298|1009829|P2|Washout|Withdrawal by Subject|0
307692|NCT00792298|1009830|P1|Washout|Withdrawal by Subject|0
307693|NCT00792298|1009823|P8|Washout|Adverse Event|0
307694|NCT00792298|1009824|P7|Washout|Adverse Event|0
307695|NCT00792298|1009825|P6|Washout|Adverse Event|1
307696|NCT00792298|1009826|P5|Washout|Adverse Event|0
307697|NCT00792298|1009827|P4|Washout|Adverse Event|0
307698|NCT00792298|1009828|P3|Washout|Adverse Event|0
307699|NCT00792298|1009829|P2|Washout|Adverse Event|0
307700|NCT00792298|1009830|P1|Washout|Adverse Event|0
307701|NCT00792298|1009823|P8|Treatment Period 1|Protocol Violation|1
307702|NCT00792298|1009824|P7|Treatment Period 1|Protocol Violation|0
307703|NCT00792298|1009825|P6|Treatment Period 1|Protocol Violation|0
307704|NCT00792298|1009826|P5|Treatment Period 1|Protocol Violation|0
307705|NCT00792298|1009827|P4|Treatment Period 1|Protocol Violation|0
307706|NCT00792298|1009828|P3|Treatment Period 1|Protocol Violation|0
307707|NCT00792298|1009829|P2|Treatment Period 1|Protocol Violation|0
307708|NCT00792298|1009830|P1|Treatment Period 1|Protocol Violation|0
307709|NCT00792298|1009823|P8|Treatment Period 1|Physician Decision|0
307710|NCT00792298|1009824|P7|Treatment Period 1|Physician Decision|1
307711|NCT00792298|1009825|P6|Treatment Period 1|Physician Decision|0
307712|NCT00792298|1009826|P5|Treatment Period 1|Physician Decision|0
307713|NCT00792298|1009827|P4|Treatment Period 1|Physician Decision|1
307714|NCT00792298|1009828|P3|Treatment Period 1|Physician Decision|0
307715|NCT00792298|1009829|P2|Treatment Period 1|Physician Decision|0
307716|NCT00792298|1009830|P1|Treatment Period 1|Physician Decision|0
307717|NCT00792298|1009823|P8|Treatment Period 1|Lost to Follow-up|0
307718|NCT00792298|1009824|P7|Treatment Period 1|Lost to Follow-up|1
307719|NCT00792298|1009825|P6|Treatment Period 1|Lost to Follow-up|0
307720|NCT00792298|1009826|P5|Treatment Period 1|Lost to Follow-up|0
307721|NCT00792298|1009827|P4|Treatment Period 1|Lost to Follow-up|0
307722|NCT00792298|1009828|P3|Treatment Period 1|Lost to Follow-up|0
307723|NCT00792298|1009829|P2|Treatment Period 1|Lost to Follow-up|0
307724|NCT00792298|1009830|P1|Treatment Period 1|Lost to Follow-up|0
307725|NCT00792298|1009823|P8|Treatment Period 1|Withdrawal by Subject|0
307726|NCT00792298|1009824|P7|Treatment Period 1|Withdrawal by Subject|1
307727|NCT00792298|1009825|P6|Treatment Period 1|Withdrawal by Subject|2
307728|NCT00792298|1009826|P5|Treatment Period 1|Withdrawal by Subject|0
307729|NCT00792298|1009827|P4|Treatment Period 1|Withdrawal by Subject|2
307730|NCT00792298|1009828|P3|Treatment Period 1|Withdrawal by Subject|1
307731|NCT00792298|1009829|P2|Treatment Period 1|Withdrawal by Subject|0
307732|NCT00792298|1009830|P1|Treatment Period 1|Withdrawal by Subject|1
307733|NCT00792298|1009823|P8|Treatment Period 1|Lack of Efficacy|0
307734|NCT00792298|1009824|P7|Treatment Period 1|Lack of Efficacy|0
307735|NCT00792298|1009825|P6|Treatment Period 1|Lack of Efficacy|0
307736|NCT00792298|1009826|P5|Treatment Period 1|Lack of Efficacy|0
307737|NCT00792298|1009827|P4|Treatment Period 1|Lack of Efficacy|0
307738|NCT00792298|1009828|P3|Treatment Period 1|Lack of Efficacy|1
307739|NCT00792298|1009829|P2|Treatment Period 1|Lack of Efficacy|0
307740|NCT00792298|1009830|P1|Treatment Period 1|Lack of Efficacy|0
307741|NCT00792298|1009823|P8|Treatment Period 1|Adverse Event|0
307742|NCT00792298|1009824|P7|Treatment Period 1|Adverse Event|1
307743|NCT00792298|1009825|P6|Treatment Period 1|Adverse Event|1
307744|NCT00792298|1009826|P5|Treatment Period 1|Adverse Event|0
307745|NCT00792298|1009827|P4|Treatment Period 1|Adverse Event|1
307746|NCT00792298|1009828|P3|Treatment Period 1|Adverse Event|0
307747|NCT00792298|1009829|P2|Treatment Period 1|Adverse Event|1
307748|NCT00792298|1009830|P1|Treatment Period 1|Adverse Event|0
307749|NCT00792259|1009860|P3|Overall Study|Poor Quality Scans|0
307750|NCT00792259|1009861|P2|Overall Study|Poor Quality Scans|0
307751|NCT00792259|1009862|P1|Overall Study|Poor Quality Scans|1
307752|NCT00792116|1009872|P2|Overall Study|Discontnued intervention|0
307753|NCT00792116|1009873|P1|Overall Study|Discontnued intervention|1
307754|NCT00792116|1009872|P2|Overall Study|Lost to Follow-up|1
307755|NCT00792116|1009873|P1|Overall Study|Lost to Follow-up|0
307756|NCT00792103|1009883|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
307757|NCT00792103|1009883|P1|Overall Study|Protocol Violation|10
307758|NCT00792103|1009883|P1|Overall Study|Withdrawal by Subject|52
307759|NCT00792103|1009883|P1|Overall Study|Adverse Event|25
307760|NCT00792103|1009883|P1|Overall Study|Lost to Follow-up|17
307761|NCT00792103|1009883|P1|Overall Study|Enrolled, not treated|15
307762|NCT00791999|1009895|P4|Overall Study|Reason other than those above|0
307763|NCT00791999|1009896|P3|Overall Study|Reason other than those above|1
307764|NCT00791999|1009897|P2|Overall Study|Reason other than those above|0
307765|NCT00791999|1009898|P1|Overall Study|Reason other than those above|1
307766|NCT00791999|1009895|P4|Overall Study|Lack of Efficacy|2
307767|NCT00791999|1009896|P3|Overall Study|Lack of Efficacy|0
307768|NCT00791999|1009897|P2|Overall Study|Lack of Efficacy|1
307769|NCT00791999|1009898|P1|Overall Study|Lack of Efficacy|0
307770|NCT00791999|1009895|P4|Overall Study|Adverse Event|3
307771|NCT00791999|1009896|P3|Overall Study|Adverse Event|7
307772|NCT00791999|1009897|P2|Overall Study|Adverse Event|3
307773|NCT00791999|1009898|P1|Overall Study|Adverse Event|3
307774|NCT00791999|1009895|P4|Overall Study|Protocol Violation|0
307775|NCT00791999|1009896|P3|Overall Study|Protocol Violation|1
307776|NCT00791999|1009897|P2|Overall Study|Protocol Violation|0
307777|NCT00791999|1009898|P1|Overall Study|Protocol Violation|3
307778|NCT00791999|1009895|P4|Overall Study|Withdrawal by Subject|2
307779|NCT00791999|1009896|P3|Overall Study|Withdrawal by Subject|0
307780|NCT00791999|1009897|P2|Overall Study|Withdrawal by Subject|1
307781|NCT00791999|1009898|P1|Overall Study|Withdrawal by Subject|0
307782|NCT00791999|1009895|P4|Overall Study|Protocol planed withdrawal|45
307783|NCT00791999|1009896|P3|Overall Study|Protocol planed withdrawal|11
307784|NCT00791999|1009897|P2|Overall Study|Protocol planed withdrawal|11
307785|NCT00791999|1009898|P1|Overall Study|Protocol planed withdrawal|14
307786|NCT00791934|1009923|P1|Overall Study|Did not consent for extended follow-up|13
307787|NCT00791934|1009923|P1|Overall Study|Withdrawal by Subject|2
307788|NCT00791921|1009933|P2|Overall Study|Reason other than those above|1
307789|NCT00791921|1009934|P1|Overall Study|Reason other than those above|0
307790|NCT00791921|1009933|P2|Overall Study|Lack of study drug administration|1
307791|NCT00791921|1009934|P1|Overall Study|Lack of study drug administration|1
307792|NCT00791921|1009933|P2|Overall Study|Lack of Efficacy|2
307793|NCT00791921|1009934|P1|Overall Study|Lack of Efficacy|0
307794|NCT00791921|1009933|P2|Overall Study|Adverse Event|2
307795|NCT00791921|1009934|P1|Overall Study|Adverse Event|8
307796|NCT00791921|1009933|P2|Overall Study|Withdrawal by Subject|2
307797|NCT00791921|1009934|P1|Overall Study|Withdrawal by Subject|1
307798|NCT00791921|1009933|P2|Overall Study|Protocol planed|88
307799|NCT00791921|1009934|P1|Overall Study|Protocol planed|24
307800|NCT00791778|1009961|P2|Follow-up|Lost to Follow-up|1
307801|NCT00791778|1009962|P1|Follow-up|Lost to Follow-up|2
307802|NCT00791778|1009961|P2|Follow-up|Withdrawal by Subject|0
307803|NCT00791778|1009962|P1|Follow-up|Withdrawal by Subject|3
307804|NCT00791778|1009961|P2|Double-blind Treatment|Non-compliant with study medication|0
307805|NCT00791778|1009962|P1|Double-blind Treatment|Non-compliant with study medication|2
307806|NCT00791778|1009961|P2|Double-blind Treatment|Withdrawal by Subject|9
307807|NCT00791778|1009962|P1|Double-blind Treatment|Withdrawal by Subject|20
307808|NCT00791778|1009961|P2|Double-blind Treatment|Protocol Violation|4
307809|NCT00791778|1009962|P1|Double-blind Treatment|Protocol Violation|0
307810|NCT00791778|1009961|P2|Double-blind Treatment|Physician Decision|26
307811|NCT00791778|1009962|P1|Double-blind Treatment|Physician Decision|6
307812|NCT00791778|1009961|P2|Double-blind Treatment|Adverse Event|9
307813|NCT00791778|1009962|P1|Double-blind Treatment|Adverse Event|49
307814|NCT00791765|1010016|P2|Weeks 13 to 24|Other|1
307815|NCT00791765|1010017|P1|Weeks 13 to 24|Other|0
307816|NCT00791765|1010016|P2|Weeks 13 to 24|Lost to Follow-up|2
307817|NCT00791765|1010017|P1|Weeks 13 to 24|Lost to Follow-up|1
307818|NCT00791765|1010016|P2|Weeks 13 to 24|Disease progression|1
307819|NCT00791765|1010017|P1|Weeks 13 to 24|Disease progression|0
307820|NCT00791765|1010016|P2|Weeks 13 to 24|Withdrawal by Subject|1
307821|NCT00791765|1010017|P1|Weeks 13 to 24|Withdrawal by Subject|2
307822|NCT00791765|1010016|P2|Weeks 13 to 24|Adverse Event|3
307823|NCT00791765|1010017|P1|Weeks 13 to 24|Adverse Event|0
307824|NCT00791765|1010016|P2|Weeks 13 to 24|Protocol deviation|0
307825|NCT00791765|1010017|P1|Weeks 13 to 24|Protocol deviation|2
307826|NCT00791765|1010016|P2|Weeks 1 to 12|Ineligibility determined|3
307827|NCT00791765|1010017|P1|Weeks 1 to 12|Ineligibility determined|0
307828|NCT00791765|1010016|P2|Weeks 1 to 12|Disease progression|0
307829|NCT00791765|1010017|P1|Weeks 1 to 12|Disease progression|3
307830|NCT00791765|1010016|P2|Weeks 1 to 12|Physician Decision|0
307831|NCT00791765|1010017|P1|Weeks 1 to 12|Physician Decision|1
307832|NCT00791765|1010016|P2|Weeks 1 to 12|Withdrawal by Subject|0
307833|NCT00791765|1010017|P1|Weeks 1 to 12|Withdrawal by Subject|3
307834|NCT00791765|1010016|P2|Weeks 1 to 12|Lost to Follow-up|0
307835|NCT00791765|1010017|P1|Weeks 1 to 12|Lost to Follow-up|1
307836|NCT00791765|1010016|P2|Weeks 1 to 12|Adverse Event|1
307837|NCT00791765|1010017|P1|Weeks 1 to 12|Adverse Event|0
307838|NCT00791700|1010032|P4|Overall Study|Blood sampling not done before Stage 1|1
307839|NCT00791700|1010033|P3|Overall Study|Blood sampling not done before Stage 1|0
307840|NCT00791700|1010034|P2|Overall Study|Blood sampling not done before Stage 1|0
307841|NCT00791700|1010035|P1|Overall Study|Blood sampling not done before Stage 1|0
307842|NCT00791700|1010032|P4|Overall Study|Non-compliance with study treatment|2
307843|NCT00791700|1010033|P3|Overall Study|Non-compliance with study treatment|0
307844|NCT00791700|1010034|P2|Overall Study|Non-compliance with study treatment|0
307845|NCT00791700|1010035|P1|Overall Study|Non-compliance with study treatment|1
307846|NCT00791700|1010032|P4|Overall Study|No longer willing to participate|1
307847|NCT00791700|1010033|P3|Overall Study|No longer willing to participate|0
307848|NCT00791700|1010034|P2|Overall Study|No longer willing to participate|1
307849|NCT00791700|1010035|P1|Overall Study|No longer willing to participate|0
307850|NCT00791700|1010032|P4|Overall Study|Adverse Event|1
307851|NCT00791700|1010033|P3|Overall Study|Adverse Event|1
307852|NCT00791700|1010034|P2|Overall Study|Adverse Event|0
307853|NCT00791700|1010035|P1|Overall Study|Adverse Event|0
307854|NCT00791700|1010032|P4|Overall Study|Insufficient clinical response|13
307855|NCT00791700|1010033|P3|Overall Study|Insufficient clinical response|3
307856|NCT00791700|1010034|P2|Overall Study|Insufficient clinical response|4
307857|NCT00791700|1010035|P1|Overall Study|Insufficient clinical response|3
307858|NCT00791661|1010123|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
307859|NCT00791661|1010124|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
307860|NCT00791661|1010125|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
307861|NCT00791661|1010123|P3|7 Day Wash-out|Adverse Event|1
307862|NCT00791661|1010124|P2|7 Day Wash-out|Adverse Event|0
307863|NCT00791661|1010125|P1|7 Day Wash-out|Adverse Event|0
307864|NCT00791648|1010218|P2|Overall Study|Withdrawal by Subject|1
307865|NCT00791648|1010219|P1|Overall Study|Withdrawal by Subject|0
307866|NCT00791648|1010218|P2|Overall Study|Physician Decision|1
307867|NCT00791648|1010219|P1|Overall Study|Physician Decision|0
307868|NCT00791557|1010235|P1|Overall Study|Adverse Event|1
307869|NCT00791518|1010239|P1|Overall Study|Protocol Violation|93
307870|NCT00791492|1010267|P2|Overall Study|Liver transplantation|1
307871|NCT00791492|1010268|P1|Overall Study|Liver transplantation|5
307872|NCT00791492|1010267|P2|Overall Study|Withdrawal by Subject|2
307873|NCT00791492|1010268|P1|Overall Study|Withdrawal by Subject|1
307874|NCT00791479|1010316|P6|Overall Study|Withdrawal by Subject|1
307875|NCT00791479|1010317|P5|Overall Study|Withdrawal by Subject|0
307876|NCT00791479|1010318|P4|Overall Study|Withdrawal by Subject|1
307877|NCT00791479|1010319|P3|Overall Study|Withdrawal by Subject|0
307878|NCT00791479|1010320|P2|Overall Study|Withdrawal by Subject|0
307879|NCT00791479|1010321|P1|Overall Study|Withdrawal by Subject|0
307880|NCT00791479|1010316|P6|Overall Study|Protocol Violation|0
307881|NCT00791479|1010317|P5|Overall Study|Protocol Violation|0
307882|NCT00791479|1010318|P4|Overall Study|Protocol Violation|1
307883|NCT00791479|1010319|P3|Overall Study|Protocol Violation|0
307884|NCT00791479|1010320|P2|Overall Study|Protocol Violation|1
307885|NCT00791479|1010321|P1|Overall Study|Protocol Violation|2
307886|NCT00791479|1010316|P6|Overall Study|Lost to Follow-up|1
307887|NCT00791479|1010317|P5|Overall Study|Lost to Follow-up|0
307888|NCT00791479|1010318|P4|Overall Study|Lost to Follow-up|0
307889|NCT00791479|1010319|P3|Overall Study|Lost to Follow-up|0
307890|NCT00791479|1010320|P2|Overall Study|Lost to Follow-up|1
307891|NCT00791479|1010321|P1|Overall Study|Lost to Follow-up|0
307892|NCT00791479|1010316|P6|Overall Study|Adverse Event|1
307893|NCT00791479|1010317|P5|Overall Study|Adverse Event|0
307894|NCT00791479|1010318|P4|Overall Study|Adverse Event|2
307895|NCT00791479|1010319|P3|Overall Study|Adverse Event|0
307896|NCT00791479|1010320|P2|Overall Study|Adverse Event|1
307897|NCT00791479|1010321|P1|Overall Study|Adverse Event|0
307898|NCT00791479|1010316|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
307899|NCT00791479|1010317|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
307900|NCT00791479|1010318|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
307901|NCT00791479|1010319|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
307902|NCT00791479|1010320|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
307903|NCT00791479|1010321|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
307904|NCT00791388|1010420|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
307905|NCT00791388|1010421|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
307906|NCT00791388|1010422|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
307907|NCT00791388|1010423|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
307908|NCT00791388|1010424|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
307909|NCT00791388|1010420|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
307910|NCT00791388|1010421|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
307911|NCT00791388|1010422|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
307912|NCT00791388|1010423|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
307913|NCT00791388|1010424|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
307914|NCT00791388|1010420|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
307915|NCT00791388|1010421|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
307916|NCT00791388|1010422|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
307917|NCT00791388|1010423|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
307918|NCT00791388|1010424|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
307919|NCT00791258|1010460|P1|Overall Study|Lack of Efficacy|1
307920|NCT00791258|1010460|P1|Overall Study|Subject required restricted medication|1
307921|NCT00791258|1010460|P1|Overall Study|Subject incarcerated|1
307922|NCT00791258|1010460|P1|Overall Study|non-compliance|3
307923|NCT00791258|1010460|P1|Overall Study|subject left area|2
307924|NCT00791258|1010460|P1|Overall Study|Did not take medication for >3 days|1
307925|NCT00791258|1010460|P1|Overall Study|Withdrawal by Subject|40
307926|NCT00791258|1010460|P1|Overall Study|Protocol Violation|109
307927|NCT00791258|1010460|P1|Overall Study|Lost to Follow-up|18
307928|NCT00791258|1010460|P1|Overall Study|Adverse Event|87
307929|NCT00791128|1010522|P1|Overall Study|abdominal tumor, unrelated to device|1
307930|NCT00791128|1010522|P1|Overall Study|non-compliance by subject|2
307931|NCT00791128|1010522|P1|Overall Study|Device migration|2
307932|NCT00791128|1010522|P1|Overall Study|Adverse Event|4
307933|NCT00790907|1010563|P3|Overall Study|Did Not Receive Study Drug|0
307934|NCT00790907|1010564|P2|Overall Study|Did Not Receive Study Drug|0
307935|NCT00790907|1010565|P1|Overall Study|Did Not Receive Study Drug|10
307936|NCT00790907|1010563|P3|Overall Study|Verbatim Reason on the Case Report Form|29
307937|NCT00790907|1010564|P2|Overall Study|Verbatim Reason on the Case Report Form|20
307938|NCT00790907|1010565|P1|Overall Study|Verbatim Reason on the Case Report Form|74
307939|NCT00790907|1010563|P3|Overall Study|Qualifying Condition Not Present|16
307940|NCT00790907|1010564|P2|Overall Study|Qualifying Condition Not Present|14
307941|NCT00790907|1010565|P1|Overall Study|Qualifying Condition Not Present|29
307942|NCT00790907|1010563|P3|Overall Study|Required Protocol-prohibited Therapy|7
307943|NCT00790907|1010564|P2|Overall Study|Required Protocol-prohibited Therapy|5
307944|NCT00790907|1010565|P1|Overall Study|Required Protocol-prohibited Therapy|17
307945|NCT00790907|1010563|P3|Overall Study|Bleeding Event|21
307946|NCT00790907|1010564|P2|Overall Study|Bleeding Event|16
307947|NCT00790907|1010565|P1|Overall Study|Bleeding Event|11
307948|NCT00790907|1010563|P3|Overall Study|Withdrawal by Subject|5
307949|NCT00790907|1010564|P2|Overall Study|Withdrawal by Subject|7
307950|NCT00790907|1010565|P1|Overall Study|Withdrawal by Subject|1
307951|NCT00790907|1010563|P3|Overall Study|Physician Decision|255
307952|NCT00790907|1010564|P2|Overall Study|Physician Decision|271
307953|NCT00790907|1010565|P1|Overall Study|Physician Decision|304
307954|NCT00790907|1010563|P3|Overall Study|Adverse Event|6
307955|NCT00790907|1010564|P2|Overall Study|Adverse Event|7
307956|NCT00790907|1010565|P1|Overall Study|Adverse Event|9
307957|NCT00790790|1010602|P3|Study Period 2: Therapy Phase|Physician Decision|0
307958|NCT00790790|1010603|P2|Study Period 2: Therapy Phase|Physician Decision|1
307959|NCT00790790|1010604|P1|Study Period 2: Therapy Phase|Physician Decision|0
307960|NCT00790790|1010602|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
307961|NCT00790790|1010603|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
307962|NCT00790790|1010604|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
307963|NCT00790790|1010602|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
307964|NCT00790790|1010603|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
307965|NCT00790790|1010604|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
307966|NCT00790790|1010602|P3|Study Period 2: Therapy Phase|Protocol Violation|0
307967|NCT00790790|1010603|P2|Study Period 2: Therapy Phase|Protocol Violation|1
307968|NCT00790790|1010604|P1|Study Period 2: Therapy Phase|Protocol Violation|1
307969|NCT00790790|1010602|P3|Study Period 2: Therapy Phase|Adverse Event|16
307970|NCT00790790|1010603|P2|Study Period 2: Therapy Phase|Adverse Event|16
307971|NCT00790790|1010604|P1|Study Period 2: Therapy Phase|Adverse Event|3
307972|NCT00790751|1010681|P4|Overall Study|Physician Decision|1
307973|NCT00790751|1010682|P3|Overall Study|Physician Decision|0
307974|NCT00790751|1010683|P2|Overall Study|Physician Decision|0
307975|NCT00790751|1010684|P1|Overall Study|Physician Decision|0
307976|NCT00790751|1010681|P4|Overall Study|Death|0
307977|NCT00790751|1010682|P3|Overall Study|Death|1
307978|NCT00790751|1010683|P2|Overall Study|Death|0
307979|NCT00790751|1010684|P1|Overall Study|Death|0
307980|NCT00790751|1010681|P4|Overall Study|Requirement for restricted medication|0
307981|NCT00790751|1010682|P3|Overall Study|Requirement for restricted medication|0
307982|NCT00790751|1010683|P2|Overall Study|Requirement for restricted medication|2
307983|NCT00790751|1010684|P1|Overall Study|Requirement for restricted medication|0
307984|NCT00790751|1010681|P4|Overall Study|Adverse Event|4
307985|NCT00790751|1010682|P3|Overall Study|Adverse Event|5
307986|NCT00790751|1010683|P2|Overall Study|Adverse Event|3
307987|NCT00790751|1010684|P1|Overall Study|Adverse Event|5
307988|NCT00790751|1010681|P4|Overall Study|Lost to Follow-up|5
307989|NCT00790751|1010682|P3|Overall Study|Lost to Follow-up|4
307990|NCT00790751|1010683|P2|Overall Study|Lost to Follow-up|9
307991|NCT00790751|1010684|P1|Overall Study|Lost to Follow-up|4
307992|NCT00790751|1010681|P4|Overall Study|Protocol non-compliance|11
307993|NCT00790751|1010682|P3|Overall Study|Protocol non-compliance|10
307994|NCT00790751|1010683|P2|Overall Study|Protocol non-compliance|16
307995|NCT00790751|1010684|P1|Overall Study|Protocol non-compliance|16
307996|NCT00790647|1010732|P1|Overall Study|Adverse Event|1
307997|NCT00790569|1010742|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
307998|NCT00790569|1010743|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
307999|NCT00790569|1010744|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
308000|NCT00790569|1010742|P3|End of Treatment (6 Month Interview)|Incarcerated|3
308001|NCT00790569|1010743|P2|End of Treatment (6 Month Interview)|Incarcerated|0
308002|NCT00790569|1010744|P1|End of Treatment (6 Month Interview)|Incarcerated|0
308003|NCT00790569|1010742|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
308004|NCT00790569|1010743|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
308005|NCT00790569|1010744|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
308006|NCT00790569|1010742|P3|End of Treatment (6 Month Interview)|Hospitalized|0
308007|NCT00790569|1010743|P2|End of Treatment (6 Month Interview)|Hospitalized|0
308008|NCT00790569|1010744|P1|End of Treatment (6 Month Interview)|Hospitalized|2
308009|NCT00790569|1010742|P3|End of Treatment (6 Month Interview)|Death|1
308010|NCT00790569|1010743|P2|End of Treatment (6 Month Interview)|Death|2
308011|NCT00790569|1010744|P1|End of Treatment (6 Month Interview)|Death|0
308012|NCT00790569|1010742|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
308013|NCT00790569|1010743|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
308014|NCT00790569|1010744|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
308015|NCT00790556|1010767|P2|Treatment Period 1|Withdrawal by Subject|0
308016|NCT00790556|1010768|P1|Treatment Period 1|Withdrawal by Subject|1
308017|NCT00790556|1010767|P2|Treatment Period 1|Physician Decision|0
308018|NCT00790556|1010768|P1|Treatment Period 1|Physician Decision|1
308019|NCT00790452|1010780|P2|Overall Study|Drug supply issue|0
308020|NCT00790452|1010781|P1|Overall Study|Drug supply issue|1
308021|NCT00790400|1010789|P2|Everolimus Period (Core or Extension)|New treatment|0
308022|NCT00790400|1010790|P1|Everolimus Period (Core or Extension)|New treatment|2
308023|NCT00790400|1010789|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
308024|NCT00790400|1010790|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
308025|NCT00790400|1010789|P2|Everolimus Period (Core or Extension)|Disease progression|0
308026|NCT00790400|1010790|P1|Everolimus Period (Core or Extension)|Disease progression|5
308027|NCT00790400|1010789|P2|Everolimus Period (Core or Extension)|Death|0
308028|NCT00790400|1010790|P1|Everolimus Period (Core or Extension)|Death|1
308029|NCT00790400|1010789|P2|Everolimus Period (Core or Extension)|Administrative problems|0
308030|NCT00790400|1010790|P1|Everolimus Period (Core or Extension)|Administrative problems|2
308031|NCT00790400|1010789|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
308032|NCT00790400|1010790|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
308033|NCT00790400|1010789|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
308034|NCT00790400|1010790|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
308035|NCT00790400|1010789|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
308036|NCT00790400|1010790|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
308037|NCT00790400|1010789|P2|Everolimus Period (Core or Extension)|Adverse Event|0
308038|NCT00790400|1010790|P1|Everolimus Period (Core or Extension)|Adverse Event|9
308039|NCT00790400|1010789|P2|Double-blind Period (Core Phase)|Death|0
308040|NCT00790400|1010790|P1|Double-blind Period (Core Phase)|Death|1
308041|NCT00790400|1010789|P2|Double-blind Period (Core Phase)|Administrative problems|0
308042|NCT00790400|1010790|P1|Double-blind Period (Core Phase)|Administrative problems|1
308043|NCT00790400|1010789|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
308044|NCT00790400|1010790|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
308045|NCT00790400|1010789|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
308046|NCT00790400|1010790|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
308047|NCT00790400|1010789|P2|Double-blind Period (Core Phase)|Adverse Event|4
308048|NCT00790400|1010790|P1|Double-blind Period (Core Phase)|Adverse Event|2
308049|NCT00790400|1010789|P2|Double-blind Period (Core Phase)|Progressive disease|9
308050|NCT00790400|1010790|P1|Double-blind Period (Core Phase)|Progressive disease|0
308051|NCT00790400|1010789|P2|Double-blind Period (Core Phase)|Protocol Violation|0
308052|NCT00790400|1010790|P1|Double-blind Period (Core Phase)|Protocol Violation|1
308053|NCT00790296|1010819|P2|Overall Study|Adverse Event|1
308054|NCT00790296|1010820|P1|Overall Study|Adverse Event|0
308055|NCT00790296|1010819|P2|Overall Study|Did not meet study eligibility criteria|1
308056|NCT00790296|1010820|P1|Overall Study|Did not meet study eligibility criteria|1
308057|NCT00790218|1010842|P3|Overall Study|Death|0
308058|NCT00790218|1010843|P2|Overall Study|Death|0
308059|NCT00790218|1010844|P1|Overall Study|Death|1
308060|NCT00790205|1010854|P2|Overall Study|Withdrawal by Subject|363
308061|NCT00790205|1010855|P1|Overall Study|Withdrawal by Subject|299
308062|NCT00790205|1010854|P2|Overall Study|Lost to Follow-up|71
308063|NCT00790205|1010855|P1|Overall Study|Lost to Follow-up|61
308064|NCT00790023|1010953|P3|Overall Study|Not specified|8
308065|NCT00790023|1010954|P2|Overall Study|Not specified|5
308066|NCT00790023|1010955|P1|Overall Study|Not specified|5
308067|NCT00790023|1010953|P3|Overall Study|Lost to Follow-up|1
308068|NCT00790023|1010954|P2|Overall Study|Lost to Follow-up|0
308069|NCT00790023|1010955|P1|Overall Study|Lost to Follow-up|0
308070|NCT00790023|1010953|P3|Overall Study|Withdrawal by Subject|6
308071|NCT00790023|1010954|P2|Overall Study|Withdrawal by Subject|0
308072|NCT00790023|1010955|P1|Overall Study|Withdrawal by Subject|2
308073|NCT00790023|1010953|P3|Overall Study|Protocol Violation|2
308074|NCT00790023|1010954|P2|Overall Study|Protocol Violation|4
308075|NCT00790023|1010955|P1|Overall Study|Protocol Violation|2
308076|NCT00790023|1010953|P3|Overall Study|Adverse Event|4
308077|NCT00790023|1010954|P2|Overall Study|Adverse Event|1
308078|NCT00790023|1010955|P1|Overall Study|Adverse Event|2
308079|NCT00789958|1011054|P1|Overall Study|Not eligible/not analyzable|26
308080|NCT00789958|1011054|P1|Overall Study|not protocol specified|1
308081|NCT00789958|1011054|P1|Overall Study|Progression|3
308082|NCT00789958|1011054|P1|Overall Study|Withdrawal by Subject|4
308083|NCT00789958|1011054|P1|Overall Study|Adverse Event|3
308084|NCT00789880|1011073|P6|Overall Study|Withdrawal by Subject|0
308085|NCT00789880|1011074|P5|Overall Study|Withdrawal by Subject|2
308086|NCT00789880|1011075|P4|Overall Study|Withdrawal by Subject|0
308087|NCT00789880|1011076|P3|Overall Study|Withdrawal by Subject|0
308088|NCT00789880|1011077|P2|Overall Study|Withdrawal by Subject|0
308089|NCT00789880|1011078|P1|Overall Study|Withdrawal by Subject|1
308090|NCT00789880|1011073|P6|Overall Study|Protocol Violation|0
308091|NCT00789880|1011074|P5|Overall Study|Protocol Violation|0
308092|NCT00789880|1011075|P4|Overall Study|Protocol Violation|1
308093|NCT00789880|1011076|P3|Overall Study|Protocol Violation|0
308094|NCT00789880|1011077|P2|Overall Study|Protocol Violation|1
308095|NCT00789880|1011078|P1|Overall Study|Protocol Violation|0
308096|NCT00789880|1011073|P6|Overall Study|Adverse Event|0
308097|NCT00789880|1011074|P5|Overall Study|Adverse Event|1
308098|NCT00789880|1011075|P4|Overall Study|Adverse Event|0
308099|NCT00789880|1011076|P3|Overall Study|Adverse Event|0
308100|NCT00789880|1011077|P2|Overall Study|Adverse Event|0
308101|NCT00789880|1011078|P1|Overall Study|Adverse Event|0
308102|NCT00789854|1011107|P3|Overall Study|Other|5
308103|NCT00789854|1011108|P2|Overall Study|Other|0
308104|NCT00789854|1011109|P1|Overall Study|Other|6
308105|NCT00789854|1011107|P3|Overall Study|Safety reasons|2
308106|NCT00789854|1011108|P2|Overall Study|Safety reasons|0
308107|NCT00789854|1011109|P1|Overall Study|Safety reasons|0
308108|NCT00789854|1011107|P3|Overall Study|Severe non-compliance to the protocol|0
308109|NCT00789854|1011108|P2|Overall Study|Severe non-compliance to the protocol|0
308110|NCT00789854|1011109|P1|Overall Study|Severe non-compliance to the protocol|3
308111|NCT00789854|1011107|P3|Overall Study|Eligibility criteria not fulfilled|1
308112|NCT00789854|1011108|P2|Overall Study|Eligibility criteria not fulfilled|5
308113|NCT00789854|1011109|P1|Overall Study|Eligibility criteria not fulfilled|2
308114|NCT00789854|1011107|P3|Overall Study|Withdrawal by Subject|17
308115|NCT00789854|1011108|P2|Overall Study|Withdrawal by Subject|6
308116|NCT00789854|1011109|P1|Overall Study|Withdrawal by Subject|9
308117|NCT00789854|1011107|P3|Overall Study|Lost to Follow-up|4
308118|NCT00789854|1011108|P2|Overall Study|Lost to Follow-up|1
308119|NCT00789854|1011109|P1|Overall Study|Lost to Follow-up|1
308120|NCT00789854|1011107|P3|Overall Study|Adverse Event|18
308121|NCT00789854|1011108|P2|Overall Study|Adverse Event|23
308122|NCT00789854|1011109|P1|Overall Study|Adverse Event|28
308123|NCT00789828|1011206|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
308124|NCT00789828|1011207|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
308125|NCT00789828|1011206|P2|Open-label Extension Period (4 Years)|Disease progression|0
308126|NCT00789828|1011207|P1|Open-label Extension Period (4 Years)|Disease progression|1
308127|NCT00789828|1011206|P2|Open-label Extension Period (4 Years)|Death|0
308128|NCT00789828|1011207|P1|Open-label Extension Period (4 Years)|Death|1
308129|NCT00789828|1011206|P2|Open-label Extension Period (4 Years)|Administrative problems|0
308130|NCT00789828|1011207|P1|Open-label Extension Period (4 Years)|Administrative problems|7
308131|NCT00789828|1011206|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
308132|NCT00789828|1011207|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
308133|NCT00789828|1011206|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
308134|NCT00789828|1011207|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
308135|NCT00789828|1011206|P2|Open-label Extension Period (4 Years)|Adverse Event|0
308136|NCT00789828|1011207|P1|Open-label Extension Period (4 Years)|Adverse Event|10
308137|NCT00789828|1011206|P2|Core Period (48 Weeks)|Lost to Follow-up|1
308138|NCT00789828|1011207|P1|Core Period (48 Weeks)|Lost to Follow-up|0
308139|NCT00789828|1011206|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
308140|NCT00789828|1011207|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
308141|NCT00789828|1011206|P2|Core Period (48 Weeks)|Administrative problems|1
308142|NCT00789828|1011207|P1|Core Period (48 Weeks)|Administrative problems|0
308143|NCT00789815|1011241|P2|Overall Study|Intubation due to massive bleeding|0
308144|NCT00789815|1011242|P1|Overall Study|Intubation due to massive bleeding|1
308145|NCT00789815|1011241|P2|Overall Study|Protocol Violation|1
308146|NCT00789815|1011242|P1|Overall Study|Protocol Violation|6
308147|NCT00789737|1011277|P2|Overall Study|not specified|7
308148|NCT00789737|1011278|P1|Overall Study|not specified|11
308149|NCT00789737|1011277|P2|Overall Study|hyperglycemia that met protocol-specifie|4
308150|NCT00789737|1011278|P1|Overall Study|hyperglycemia that met protocol-specifie|0
308151|NCT00789737|1011277|P2|Overall Study|Lack of Efficacy|0
308152|NCT00789737|1011278|P1|Overall Study|Lack of Efficacy|3
308153|NCT00789737|1011277|P2|Overall Study|Protocol Violation|0
308154|NCT00789737|1011278|P1|Overall Study|Protocol Violation|3
308155|NCT00789737|1011277|P2|Overall Study|Adverse Event|8
308156|NCT00789737|1011278|P1|Overall Study|Adverse Event|8
308157|NCT00789737|1011277|P2|Overall Study|Lost to Follow-up|14
308158|NCT00789737|1011278|P1|Overall Study|Lost to Follow-up|10
308159|NCT00789737|1011277|P2|Overall Study|Withdrawal by Subject|22
308160|NCT00789737|1011278|P1|Overall Study|Withdrawal by Subject|13
308161|NCT00789698|1011321|P4|Overall Study|Administrative|1
308162|NCT00789698|1011322|P3|Overall Study|Administrative|3
308163|NCT00789698|1011323|P2|Overall Study|Administrative|3
308164|NCT00789698|1011324|P1|Overall Study|Administrative|0
308165|NCT00789698|1011321|P4|Overall Study|Withdrawal by Subject|19
308166|NCT00789698|1011322|P3|Overall Study|Withdrawal by Subject|12
308167|NCT00789698|1011323|P2|Overall Study|Withdrawal by Subject|15
308168|NCT00789698|1011324|P1|Overall Study|Withdrawal by Subject|14
308169|NCT00789698|1011321|P4|Overall Study|Protocol Violation|1
308170|NCT00789698|1011322|P3|Overall Study|Protocol Violation|2
308171|NCT00789698|1011323|P2|Overall Study|Protocol Violation|1
308172|NCT00789698|1011324|P1|Overall Study|Protocol Violation|6
308173|NCT00789698|1011321|P4|Overall Study|Lost to Follow-up|9
308174|NCT00789698|1011322|P3|Overall Study|Lost to Follow-up|2
308175|NCT00789698|1011323|P2|Overall Study|Lost to Follow-up|5
308176|NCT00789698|1011324|P1|Overall Study|Lost to Follow-up|5
308177|NCT00789698|1011321|P4|Overall Study|Adverse Event|4
308178|NCT00789698|1011322|P3|Overall Study|Adverse Event|3
308179|NCT00789698|1011323|P2|Overall Study|Adverse Event|5
308180|NCT00789698|1011324|P1|Overall Study|Adverse Event|5
308181|NCT00789698|1011321|P4|Overall Study|Lack of Efficacy|18
308182|NCT00789698|1011322|P3|Overall Study|Lack of Efficacy|5
308183|NCT00789698|1011323|P2|Overall Study|Lack of Efficacy|4
308184|NCT00789698|1011324|P1|Overall Study|Lack of Efficacy|10
308185|NCT00789581|1011379|P2|Adjuvant Therapy|Not Specified|1
308186|NCT00789581|1011380|P1|Adjuvant Therapy|Not Specified|0
308187|NCT00789581|1011379|P2|Adjuvant Therapy|Protocol Violation|1
308188|NCT00789581|1011380|P1|Adjuvant Therapy|Protocol Violation|1
308189|NCT00789581|1011379|P2|Adjuvant Therapy|Intercurrent Illness|3
308190|NCT00789581|1011380|P1|Adjuvant Therapy|Intercurrent Illness|1
308191|NCT00789581|1011379|P2|Adjuvant Therapy|Disease recurrence|1
308192|NCT00789581|1011380|P1|Adjuvant Therapy|Disease recurrence|2
308193|NCT00789581|1011379|P2|Adjuvant Therapy|Withdrawal by Subject|5
308194|NCT00789581|1011380|P1|Adjuvant Therapy|Withdrawal by Subject|14
308195|NCT00789581|1011379|P2|Adjuvant Therapy|Adverse Event|44
308196|NCT00789581|1011380|P1|Adjuvant Therapy|Adverse Event|20
308197|NCT00789581|1011379|P2|Adjuvant Therapy|Never treated|2
308198|NCT00789581|1011380|P1|Adjuvant Therapy|Never treated|2
308199|NCT00789581|1011379|P2|AC Therapy|Not specified|2
308200|NCT00789581|1011380|P1|AC Therapy|Not specified|0
308201|NCT00789581|1011379|P2|AC Therapy|Never Treated|4
308202|NCT00789581|1011380|P1|AC Therapy|Never Treated|1
308203|NCT00789581|1011379|P2|AC Therapy|Intercurrent Illness|0
308204|NCT00789581|1011380|P1|AC Therapy|Intercurrent Illness|1
308205|NCT00789581|1011379|P2|AC Therapy|Disease recurrence|1
308206|NCT00789581|1011380|P1|AC Therapy|Disease recurrence|3
308207|NCT00789581|1011379|P2|AC Therapy|Withdrawal by Subject|7
308208|NCT00789581|1011380|P1|AC Therapy|Withdrawal by Subject|4
308209|NCT00789581|1011379|P2|AC Therapy|Adverse Event|3
308210|NCT00789581|1011380|P1|AC Therapy|Adverse Event|2
308211|NCT00789555|1011391|P3|Overall Study|Protocol Violation|13
308212|NCT00789555|1011392|P2|Overall Study|Protocol Violation|9
308213|NCT00789555|1011393|P1|Overall Study|Protocol Violation|6
308214|NCT00789555|1011391|P3|Overall Study|Treatment failure|12
308215|NCT00789555|1011392|P2|Overall Study|Treatment failure|8
308216|NCT00789555|1011393|P1|Overall Study|Treatment failure|11
308217|NCT00789555|1011391|P3|Overall Study|Patient decision unnrelated to adv event|26
308218|NCT00789555|1011392|P2|Overall Study|Patient decision unnrelated to adv event|29
308219|NCT00789555|1011393|P1|Overall Study|Patient decision unnrelated to adv event|38
308220|NCT00789555|1011391|P3|Overall Study|Lost to Follow-up|18
308221|NCT00789555|1011392|P2|Overall Study|Lost to Follow-up|10
308222|NCT00789555|1011393|P1|Overall Study|Lost to Follow-up|9
308223|NCT00789555|1011391|P3|Overall Study|Adverse Event|10
308224|NCT00789555|1011392|P2|Overall Study|Adverse Event|7
308225|NCT00789555|1011393|P1|Overall Study|Adverse Event|17
308226|NCT00789555|1011391|P3|Overall Study|Protocol Amendment|80
308227|NCT00789555|1011392|P2|Overall Study|Protocol Amendment|76
308228|NCT00789555|1011393|P1|Overall Study|Protocol Amendment|78
308229|NCT00789529|1011418|P2|Overall Study|Other Reason|0
308230|NCT00789529|1011419|P1|Overall Study|Other Reason|1
308231|NCT00789529|1011418|P2|Overall Study|Withdrawal by Subject|1
308232|NCT00789529|1011419|P1|Overall Study|Withdrawal by Subject|0
308233|NCT00789477|1011432|P5|Overall Study|Other|0
308234|NCT00789477|1011433|P4|Overall Study|Other|3
308235|NCT00789477|1011434|P3|Overall Study|Other|1
308236|NCT00789477|1011435|P2|Overall Study|Other|0
308237|NCT00789477|1011436|P1|Overall Study|Other|2
308238|NCT00789477|1011432|P5|Overall Study|Lack of Efficacy|0
308239|NCT00789477|1011433|P4|Overall Study|Lack of Efficacy|0
308240|NCT00789477|1011434|P3|Overall Study|Lack of Efficacy|0
308241|NCT00789477|1011435|P2|Overall Study|Lack of Efficacy|0
308242|NCT00789477|1011436|P1|Overall Study|Lack of Efficacy|2
308243|NCT00789477|1011432|P5|Overall Study|Lost to Follow-up|4
308244|NCT00789477|1011433|P4|Overall Study|Lost to Follow-up|2
308245|NCT00789477|1011434|P3|Overall Study|Lost to Follow-up|4
308246|NCT00789477|1011435|P2|Overall Study|Lost to Follow-up|1
308247|NCT00789477|1011436|P1|Overall Study|Lost to Follow-up|0
308248|NCT00789477|1011432|P5|Overall Study|Death|0
308249|NCT00789477|1011433|P4|Overall Study|Death|2
308250|NCT00789477|1011434|P3|Overall Study|Death|2
308251|NCT00789477|1011435|P2|Overall Study|Death|1
308252|NCT00789477|1011436|P1|Overall Study|Death|1
308253|NCT00789477|1011432|P5|Overall Study|Adverse Event|0
308254|NCT00789477|1011433|P4|Overall Study|Adverse Event|0
308255|NCT00789477|1011434|P3|Overall Study|Adverse Event|1
308256|NCT00789477|1011435|P2|Overall Study|Adverse Event|3
308257|NCT00789477|1011436|P1|Overall Study|Adverse Event|3
308258|NCT00789477|1011432|P5|Overall Study|Protocol Violation|0
308259|NCT00789477|1011433|P4|Overall Study|Protocol Violation|1
308260|NCT00789477|1011434|P3|Overall Study|Protocol Violation|0
308261|NCT00789477|1011435|P2|Overall Study|Protocol Violation|0
308262|NCT00789477|1011436|P1|Overall Study|Protocol Violation|1
308263|NCT00789477|1011432|P5|Overall Study|Withdrawal by Subject|3
308264|NCT00789477|1011433|P4|Overall Study|Withdrawal by Subject|2
308265|NCT00789477|1011434|P3|Overall Study|Withdrawal by Subject|3
308266|NCT00789477|1011435|P2|Overall Study|Withdrawal by Subject|1
308267|NCT00789477|1011436|P1|Overall Study|Withdrawal by Subject|2
308268|NCT00789373|1011481|P3|Maintenance|Participants On-Going at Data Cut-Off|0
308269|NCT00789373|1011482|P2|Maintenance|Participants On-Going at Data Cut-Off|4
308270|NCT00789373|1011483|P1|Maintenance|Participants On-Going at Data Cut-Off|0
308271|NCT00789373|1011481|P3|Maintenance|Sponsor Decision|2
308272|NCT00789373|1011482|P2|Maintenance|Sponsor Decision|0
308273|NCT00789373|1011483|P1|Maintenance|Sponsor Decision|0
308274|NCT00789373|1011481|P3|Maintenance|Withdrawal by Subject|8
308275|NCT00789373|1011482|P2|Maintenance|Withdrawal by Subject|21
308276|NCT00789373|1011483|P1|Maintenance|Withdrawal by Subject|0
308277|NCT00789373|1011481|P3|Maintenance|Progressive Disease|152
308278|NCT00789373|1011482|P2|Maintenance|Progressive Disease|253
308279|NCT00789373|1011483|P1|Maintenance|Progressive Disease|0
308280|NCT00789373|1011481|P3|Maintenance|Lost to Follow-up|0
308281|NCT00789373|1011482|P2|Maintenance|Lost to Follow-up|2
308282|NCT00789373|1011483|P1|Maintenance|Lost to Follow-up|0
308283|NCT00789373|1011481|P3|Maintenance|Protocol entry criteria not met|0
308284|NCT00789373|1011482|P2|Maintenance|Protocol entry criteria not met|2
308285|NCT00789373|1011483|P1|Maintenance|Protocol entry criteria not met|0
308286|NCT00789373|1011481|P3|Maintenance|Investigator Decision|2
308287|NCT00789373|1011482|P2|Maintenance|Investigator Decision|4
308288|NCT00789373|1011483|P1|Maintenance|Investigator Decision|0
308289|NCT00789373|1011481|P3|Maintenance|Death due to toxicity|2
308290|NCT00789373|1011482|P2|Maintenance|Death due to toxicity|1
308291|NCT00789373|1011483|P1|Maintenance|Death due to toxicity|0
308292|NCT00789373|1011481|P3|Maintenance|Death due to adverse event|1
308293|NCT00789373|1011482|P2|Maintenance|Death due to adverse event|4
308294|NCT00789373|1011483|P1|Maintenance|Death due to adverse event|0
308295|NCT00789373|1011481|P3|Maintenance|Death due to study disease|1
308296|NCT00789373|1011482|P2|Maintenance|Death due to study disease|3
308297|NCT00789373|1011483|P1|Maintenance|Death due to study disease|0
308298|NCT00789373|1011481|P3|Maintenance|Adverse Event|12
308299|NCT00789373|1011482|P2|Maintenance|Adverse Event|65
308300|NCT00789373|1011483|P1|Maintenance|Adverse Event|0
308301|NCT00789373|1011481|P3|Induction|Withdrawal by Subject|0
308302|NCT00789373|1011482|P2|Induction|Withdrawal by Subject|0
308303|NCT00789373|1011483|P1|Induction|Withdrawal by Subject|37
308304|NCT00789373|1011481|P3|Induction|Progressive Disease|0
308305|NCT00789373|1011482|P2|Induction|Progressive Disease|0
308306|NCT00789373|1011483|P1|Induction|Progressive Disease|220
308307|NCT00789373|1011481|P3|Induction|Protocol Violation|0
308308|NCT00789373|1011482|P2|Induction|Protocol Violation|0
308309|NCT00789373|1011483|P1|Induction|Protocol Violation|1
308310|NCT00789373|1011481|P3|Induction|Lost to Follow-up|0
308311|NCT00789373|1011482|P2|Induction|Lost to Follow-up|0
308312|NCT00789373|1011483|P1|Induction|Lost to Follow-up|6
308313|NCT00789373|1011481|P3|Induction|Protocol entry criteria not met|0
308314|NCT00789373|1011482|P2|Induction|Protocol entry criteria not met|0
308315|NCT00789373|1011483|P1|Induction|Protocol entry criteria not met|9
308316|NCT00789373|1011481|P3|Induction|Investigator decision|0
308317|NCT00789373|1011482|P2|Induction|Investigator decision|0
308318|NCT00789373|1011483|P1|Induction|Investigator decision|7
308319|NCT00789373|1011481|P3|Induction|Death due to procedure|0
308320|NCT00789373|1011482|P2|Induction|Death due to procedure|0
308321|NCT00789373|1011483|P1|Induction|Death due to procedure|1
308322|NCT00789373|1011481|P3|Induction|Death due to toxicity|0
308323|NCT00789373|1011482|P2|Induction|Death due to toxicity|0
308324|NCT00789373|1011483|P1|Induction|Death due to toxicity|11
308325|NCT00789373|1011481|P3|Induction|Death due to adverse event|0
308326|NCT00789373|1011482|P2|Induction|Death due to adverse event|0
308327|NCT00789373|1011483|P1|Induction|Death due to adverse event|19
308328|NCT00789373|1011481|P3|Induction|Death Due to study disease|0
308329|NCT00789373|1011482|P2|Induction|Death Due to study disease|0
308330|NCT00789373|1011483|P1|Induction|Death Due to study disease|24
308331|NCT00789373|1011481|P3|Induction|Adverse Event|0
308332|NCT00789373|1011482|P2|Induction|Adverse Event|0
308333|NCT00789373|1011483|P1|Induction|Adverse Event|64
308334|NCT00789321|1011510|P2|Overall Study|Adverse Event|1
308335|NCT00789321|1011511|P1|Overall Study|Adverse Event|0
308336|NCT00789191|1011530|P2|Overall Study|Unclassified|3
308337|NCT00789191|1011531|P1|Overall Study|Unclassified|5
308338|NCT00789191|1011530|P2|Overall Study|Withdrawal Criteria|4
308339|NCT00789191|1011531|P1|Overall Study|Withdrawal Criteria|2
308340|NCT00789191|1011530|P2|Overall Study|Protocol Violation|3
308341|NCT00789191|1011531|P1|Overall Study|Protocol Violation|5
308342|NCT00789191|1011530|P2|Overall Study|Lack of Efficacy|5
308343|NCT00789191|1011531|P1|Overall Study|Lack of Efficacy|0
308344|NCT00789191|1011530|P2|Overall Study|Adverse Event|4
308345|NCT00789191|1011531|P1|Overall Study|Adverse Event|2
308346|NCT00789035|1011588|P5|Overall Study|Other reason not defined above|1
308347|NCT00789035|1011589|P4|Overall Study|Other reason not defined above|0
308348|NCT00789035|1011590|P3|Overall Study|Other reason not defined above|1
308349|NCT00789035|1011591|P2|Overall Study|Other reason not defined above|3
308350|NCT00789035|1011592|P1|Overall Study|Other reason not defined above|2
308351|NCT00789035|1011588|P5|Overall Study|Withdrawal by Subject|0
308352|NCT00789035|1011589|P4|Overall Study|Withdrawal by Subject|0
308353|NCT00789035|1011590|P3|Overall Study|Withdrawal by Subject|0
308354|NCT00789035|1011591|P2|Overall Study|Withdrawal by Subject|2
308355|NCT00789035|1011592|P1|Overall Study|Withdrawal by Subject|0
308356|NCT00789035|1011588|P5|Overall Study|Protocol Violation|0
308357|NCT00789035|1011589|P4|Overall Study|Protocol Violation|0
308358|NCT00789035|1011590|P3|Overall Study|Protocol Violation|0
308359|NCT00789035|1011591|P2|Overall Study|Protocol Violation|0
308360|NCT00789035|1011592|P1|Overall Study|Protocol Violation|1
308361|NCT00789035|1011588|P5|Overall Study|Lack of Efficacy|2
308362|NCT00789035|1011589|P4|Overall Study|Lack of Efficacy|0
308363|NCT00789035|1011590|P3|Overall Study|Lack of Efficacy|0
308364|NCT00789035|1011591|P2|Overall Study|Lack of Efficacy|0
308365|NCT00789035|1011592|P1|Overall Study|Lack of Efficacy|3
308366|NCT00789035|1011588|P5|Overall Study|Adverse Event|3
308367|NCT00789035|1011589|P4|Overall Study|Adverse Event|1
308368|NCT00789035|1011590|P3|Overall Study|Adverse Event|0
308369|NCT00789035|1011591|P2|Overall Study|Adverse Event|2
308370|NCT00789035|1011592|P1|Overall Study|Adverse Event|0
308371|NCT00788957|1011651|P6|Part 3|On-study at time of data cut-off|0
308372|NCT00788957|1011652|P5|Part 3|On-study at time of data cut-off|1
308373|NCT00788957|1011653|P4|Part 3|On-study at time of data cut-off|0
308374|NCT00788957|1011654|P3|Part 3|On-study at time of data cut-off|0
308375|NCT00788957|1011655|P2|Part 3|On-study at time of data cut-off|0
308376|NCT00788957|1011656|P1|Part 3|On-study at time of data cut-off|0
308377|NCT00788957|1011651|P6|Part 3|Death|9
308378|NCT00788957|1011652|P5|Part 3|Death|8
308379|NCT00788957|1011653|P4|Part 3|Death|0
308380|NCT00788957|1011654|P3|Part 3|Death|0
308381|NCT00788957|1011655|P2|Part 3|Death|0
308382|NCT00788957|1011656|P1|Part 3|Death|0
308383|NCT00788957|1011651|P6|Part 3|Withdrawal by Subject|2
308384|NCT00788957|1011652|P5|Part 3|Withdrawal by Subject|0
308385|NCT00788957|1011653|P4|Part 3|Withdrawal by Subject|0
308386|NCT00788957|1011654|P3|Part 3|Withdrawal by Subject|0
308387|NCT00788957|1011655|P2|Part 3|Withdrawal by Subject|0
308388|NCT00788957|1011656|P1|Part 3|Withdrawal by Subject|0
308389|NCT00788957|1011651|P6|Part 2|On-study at time of data cut-off|0
308390|NCT00788957|1011652|P5|Part 2|On-study at time of data cut-off|0
308391|NCT00788957|1011653|P4|Part 2|On-study at time of data cut-off|1
308392|NCT00788957|1011654|P3|Part 2|On-study at time of data cut-off|1
308393|NCT00788957|1011655|P2|Part 2|On-study at time of data cut-off|1
308394|NCT00788957|1011656|P1|Part 2|On-study at time of data cut-off|0
308395|NCT00788957|1011651|P6|Part 2|Lost to Follow-up|0
308396|NCT00788957|1011652|P5|Part 2|Lost to Follow-up|0
308397|NCT00788957|1011653|P4|Part 2|Lost to Follow-up|0
308398|NCT00788957|1011654|P3|Part 2|Lost to Follow-up|3
308399|NCT00788957|1011655|P2|Part 2|Lost to Follow-up|0
308400|NCT00788957|1011656|P1|Part 2|Lost to Follow-up|0
308401|NCT00788957|1011651|P6|Part 2|Death|0
308402|NCT00788957|1011652|P5|Part 2|Death|0
308403|NCT00788957|1011653|P4|Part 2|Death|37
308404|NCT00788957|1011654|P3|Part 2|Death|35
308405|NCT00788957|1011655|P2|Part 2|Death|32
308406|NCT00788957|1011656|P1|Part 2|Death|0
308407|NCT00788957|1011651|P6|Part 2|Withdrawal by Subject|0
308408|NCT00788957|1011652|P5|Part 2|Withdrawal by Subject|0
308409|NCT00788957|1011653|P4|Part 2|Withdrawal by Subject|3
308410|NCT00788957|1011654|P3|Part 2|Withdrawal by Subject|5
308411|NCT00788957|1011655|P2|Part 2|Withdrawal by Subject|9
308412|NCT00788957|1011656|P1|Part 2|Withdrawal by Subject|0
308413|NCT00788957|1011651|P6|Part 1|Lost to Follow-up|0
308414|NCT00788957|1011652|P5|Part 1|Lost to Follow-up|0
308415|NCT00788957|1011653|P4|Part 1|Lost to Follow-up|0
308416|NCT00788957|1011654|P3|Part 1|Lost to Follow-up|0
308417|NCT00788957|1011655|P2|Part 1|Lost to Follow-up|0
308418|NCT00788957|1011656|P1|Part 1|Lost to Follow-up|1
308419|NCT00788957|1011651|P6|Part 1|Death|0
308420|NCT00788957|1011652|P5|Part 1|Death|0
308421|NCT00788957|1011653|P4|Part 1|Death|0
308422|NCT00788957|1011654|P3|Part 1|Death|0
308423|NCT00788957|1011655|P2|Part 1|Death|0
308424|NCT00788957|1011656|P1|Part 1|Death|8
308425|NCT00788775|1011712|P2|Overall Study|Patient's measurable disease resected.|0
308426|NCT00788775|1011713|P1|Overall Study|Patient's measurable disease resected.|1
308427|NCT00788775|1011712|P2|Overall Study|Patient Non-Compliance|0
308428|NCT00788775|1011713|P1|Overall Study|Patient Non-Compliance|1
308429|NCT00788775|1011712|P2|Overall Study|Withdrawal by Subject|2
308430|NCT00788775|1011713|P1|Overall Study|Withdrawal by Subject|0
308431|NCT00788775|1011712|P2|Overall Study|Progressive Disease|6
308432|NCT00788775|1011713|P1|Overall Study|Progressive Disease|8
308433|NCT00788710|1011728|P3|Overall Study|Withdrawal by Subject|0
308434|NCT00788710|1011729|P2|Overall Study|Withdrawal by Subject|2
308435|NCT00788710|1011730|P1|Overall Study|Withdrawal by Subject|2
308436|NCT00788710|1011728|P3|Overall Study|Protocol Violation|1
308437|NCT00788710|1011729|P2|Overall Study|Protocol Violation|1
308438|NCT00788710|1011730|P1|Overall Study|Protocol Violation|0
308439|NCT00788710|1011728|P3|Overall Study|Physician Decision|0
308440|NCT00788710|1011729|P2|Overall Study|Physician Decision|1
308441|NCT00788710|1011730|P1|Overall Study|Physician Decision|2
308442|NCT00788710|1011728|P3|Overall Study|Lost to Follow-up|0
308443|NCT00788710|1011729|P2|Overall Study|Lost to Follow-up|1
308444|NCT00788710|1011730|P1|Overall Study|Lost to Follow-up|0
308445|NCT00788710|1011728|P3|Overall Study|Lack of Efficacy|1
308446|NCT00788710|1011729|P2|Overall Study|Lack of Efficacy|0
308447|NCT00788710|1011730|P1|Overall Study|Lack of Efficacy|0
308448|NCT00788710|1011728|P3|Overall Study|Adverse Event|4
308449|NCT00788710|1011729|P2|Overall Study|Adverse Event|3
308450|NCT00788710|1011730|P1|Overall Study|Adverse Event|1
308451|NCT00788697|1011744|P1|Overall Study|Indeterminate diagnosis from truth stand|17
308452|NCT00788697|1011744|P1|Overall Study|Technically inadequate truth standard|1
308453|NCT00788697|1011744|P1|Overall Study|no truth standard procedure available|5
308454|NCT00788697|1011744|P1|Overall Study|Training Patients|74
308455|NCT00788697|1011744|P1|Overall Study|No study drug administered|12
308456|NCT00788593|1011791|P3|Second Intervention Period|Unspecified|1
308457|NCT00788593|1011792|P2|Second Intervention Period|Unspecified|0
308458|NCT00788593|1011793|P1|Second Intervention Period|Unspecified|0
308459|NCT00788593|1011791|P3|Second Intervention Period|Lost to Follow-up|0
308460|NCT00788593|1011792|P2|Second Intervention Period|Lost to Follow-up|1
308461|NCT00788593|1011793|P1|Second Intervention Period|Lost to Follow-up|0
308462|NCT00788593|1011791|P3|First Intervention Period|Adverse Event|0
308463|NCT00788593|1011792|P2|First Intervention Period|Adverse Event|1
308464|NCT00788593|1011793|P1|First Intervention Period|Adverse Event|0
308465|NCT00788593|1011791|P3|Placebo Run-in Phase|Protocol Violation|0
308466|NCT00788593|1011792|P2|Placebo Run-in Phase|Protocol Violation|0
308467|NCT00788593|1011793|P1|Placebo Run-in Phase|Protocol Violation|2
308468|NCT00788593|1011791|P3|Placebo Run-in Phase|Withdrawal by Subject|0
308469|NCT00788593|1011792|P2|Placebo Run-in Phase|Withdrawal by Subject|0
308470|NCT00788593|1011793|P1|Placebo Run-in Phase|Withdrawal by Subject|2
308471|NCT00788593|1011791|P3|Placebo Run-in Phase|Adverse Event|0
308472|NCT00788593|1011792|P2|Placebo Run-in Phase|Adverse Event|0
308473|NCT00788593|1011793|P1|Placebo Run-in Phase|Adverse Event|2
308474|NCT00788372|1011810|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
308475|NCT00788372|1011810|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
308476|NCT00788372|1011810|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
308477|NCT00788372|1011810|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
308478|NCT00788372|1011810|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
308479|NCT00788372|1011810|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
308480|NCT00788372|1011810|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
308481|NCT00788073|1011839|P2|Placebo Then STX209|Protocol Violation|1
308482|NCT00788073|1011840|P1|Placebo Then STX209|Protocol Violation|0
308483|NCT00788073|1011839|P2|Placebo Then STX209|Adverse Event|0
308484|NCT00788073|1011840|P1|Placebo Then STX209|Adverse Event|2
308485|NCT00788073|1011839|P2|STX209 Then Placebo|unable to return due to travel|1
308486|NCT00788073|1011840|P1|STX209 Then Placebo|unable to return due to travel|0
308487|NCT00788073|1011839|P2|STX209 Then Placebo|Withdrawal by Subject|1
308488|NCT00788073|1011840|P1|STX209 Then Placebo|Withdrawal by Subject|0
308489|NCT00788073|1011839|P2|STX209 Then Placebo|Lost to Follow-up|1
308490|NCT00788073|1011840|P1|STX209 Then Placebo|Lost to Follow-up|0
308491|NCT00788073|1011839|P2|STX209 Then Placebo|Adverse Event|0
308492|NCT00788073|1011840|P1|STX209 Then Placebo|Adverse Event|1
308493|NCT00787930|1011865|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
308494|NCT00787917|1011880|P2|Open Label|Administrative problems|0
308495|NCT00787917|1011881|P1|Open Label|Administrative problems|3
308496|NCT00787917|1011880|P2|Open Label|Unsatisfactory therapeutic effect|0
308497|NCT00787917|1011881|P1|Open Label|Unsatisfactory therapeutic effect|1
308498|NCT00787917|1011880|P2|Blinded Treatment|Administrative problems|2
308499|NCT00787917|1011881|P1|Blinded Treatment|Administrative problems|3
308500|NCT00787917|1011880|P2|Blinded Treatment|Lack of Efficacy|0
308501|NCT00787917|1011881|P1|Blinded Treatment|Lack of Efficacy|1
308502|NCT00787917|1011880|P2|Blinded Treatment|Adverse Event|0
308503|NCT00787917|1011881|P1|Blinded Treatment|Adverse Event|1
308504|NCT00787891|1011911|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
308505|NCT00787891|1011912|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
308506|NCT00787891|1011911|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
308507|NCT00787891|1011912|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
308508|NCT00787891|1011911|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
308509|NCT00787891|1011912|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
308510|NCT00787891|1011911|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
308511|NCT00787891|1011912|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
308512|NCT00787891|1011911|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
308513|NCT00787891|1011912|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
308514|NCT00787891|1011911|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
308515|NCT00787891|1011912|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
308516|NCT00787891|1011911|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
308517|NCT00787891|1011912|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
308518|NCT00787891|1011911|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
308519|NCT00787891|1011912|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
308520|NCT00787891|1011911|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
308521|NCT00787891|1011912|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
308522|NCT00787891|1011911|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
308523|NCT00787891|1011912|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
308524|NCT00787839|1011939|P1|Overall Study|Failure to have the OGTT was most common|404
308525|NCT00787800|1011962|P2|Overall Study|Death|2
308526|NCT00787800|1011963|P1|Overall Study|Death|0
308527|NCT00787800|1011962|P2|Overall Study|Withdrawal by Subject|5
308528|NCT00787800|1011963|P1|Overall Study|Withdrawal by Subject|3
308529|NCT00787787|1011979|P1|Overall Study|Adverse Event|3
308530|NCT00787787|1011979|P1|Overall Study|Lack of Efficacy|4
308531|NCT00787644|1011998|P2|Overall Study|Withdrawal by Subject|1
308532|NCT00787644|1011999|P1|Overall Study|Withdrawal by Subject|1
308533|NCT00787644|1011998|P2|Overall Study|Lost to Follow-up|1
308534|NCT00787644|1011999|P1|Overall Study|Lost to Follow-up|1
308535|NCT00787605|1012020|P2|Overall Study|Lack of Efficacy|9
308536|NCT00787605|1012021|P1|Overall Study|Lack of Efficacy|13
308537|NCT00787605|1012020|P2|Overall Study|Withdrawal by Subject|13
308538|NCT00787605|1012021|P1|Overall Study|Withdrawal by Subject|6
308539|NCT00787605|1012020|P2|Overall Study|Protocol Violation|3
308540|NCT00787605|1012021|P1|Overall Study|Protocol Violation|7
308541|NCT00787605|1012020|P2|Overall Study|Lost to Follow-up|6
308542|NCT00787605|1012021|P1|Overall Study|Lost to Follow-up|3
308543|NCT00787605|1012020|P2|Overall Study|Adverse Event|25
308544|NCT00787605|1012021|P1|Overall Study|Adverse Event|14
308545|NCT00787605|1012020|P2|Overall Study|Administrative Problems|0
308546|NCT00787605|1012021|P1|Overall Study|Administrative Problems|3
308547|NCT00787566|1012040|P3|Overall Study|AE related to chemotherapy|0
308548|NCT00787566|1012041|P2|Overall Study|AE related to chemotherapy|1
308549|NCT00787566|1012042|P1|Overall Study|AE related to chemotherapy|0
308550|NCT00787527|1012050|P1|Overall Study|Toxicity|3
308551|NCT00787319|1012067|P1|Overall Study|Inactive disease|5
308552|NCT00787319|1012067|P1|Overall Study|Stabilized disease findings|3
308553|NCT00787319|1012067|P1|Overall Study|No health insurance reimbursement|2
308554|NCT00787319|1012067|P1|Overall Study|Unresponsiveness to visit invitation|1
308555|NCT00787319|1012067|P1|Overall Study|Budget exhausted/exceeded|1
308556|NCT00787319|1012067|P1|Overall Study|Lack of Efficacy|1
308557|NCT00787319|1012067|P1|Overall Study|Objective progression or relapse|30
308558|NCT00787319|1012067|P1|Overall Study|Adverse Event|3
308559|NCT00787319|1012067|P1|Overall Study|Withdrawal by Subject|15
308560|NCT00787319|1012067|P1|Overall Study|Lost to Follow-up|2
308561|NCT00787267|1012079|P1|Overall Study|Withdrawal by Subject|1
308562|NCT00787267|1012079|P1|Overall Study|No Reason Provided|1
308563|NCT00787267|1012079|P1|Overall Study|Screen failure/Ineligible|10
308564|NCT00787254|1012089|P2|Overall Study|Physician Decision|8
308565|NCT00787254|1012090|P1|Overall Study|Physician Decision|4
308566|NCT00787254|1012089|P2|Overall Study|Institution closed|0
308567|NCT00787254|1012090|P1|Overall Study|Institution closed|1
308568|NCT00787254|1012089|P2|Overall Study|NSAIDs discontinuation|2
308569|NCT00787254|1012090|P1|Overall Study|NSAIDs discontinuation|1
308570|NCT00787254|1012089|P2|Overall Study|Lack of Efficacy|15
308571|NCT00787254|1012090|P1|Overall Study|Lack of Efficacy|4
308572|NCT00787254|1012089|P2|Overall Study|Withdrawal by Subject|11
308573|NCT00787254|1012090|P1|Overall Study|Withdrawal by Subject|16
308574|NCT00787254|1012089|P2|Overall Study|Protocol Violation|23
308575|NCT00787254|1012090|P1|Overall Study|Protocol Violation|26
308576|NCT00787254|1012089|P2|Overall Study|Adverse Event|23
308577|NCT00787254|1012090|P1|Overall Study|Adverse Event|24
308578|NCT00787202|1012214|P5|Overall Study|Randomized, not treated|0
308579|NCT00787202|1012215|P4|Overall Study|Randomized, not treated|0
308580|NCT00787202|1012216|P3|Overall Study|Randomized, not treated|0
308581|NCT00787202|1012217|P2|Overall Study|Randomized, not treated|0
308582|NCT00787202|1012218|P1|Overall Study|Randomized, not treated|1
308583|NCT00787202|1012214|P5|Overall Study|Protocol Violation|1
308584|NCT00787202|1012215|P4|Overall Study|Protocol Violation|0
308585|NCT00787202|1012216|P3|Overall Study|Protocol Violation|0
308586|NCT00787202|1012217|P2|Overall Study|Protocol Violation|1
308587|NCT00787202|1012218|P1|Overall Study|Protocol Violation|2
308588|NCT00787202|1012214|P5|Overall Study|Withdrawal by Subject|0
308589|NCT00787202|1012215|P4|Overall Study|Withdrawal by Subject|0
308590|NCT00787202|1012216|P3|Overall Study|Withdrawal by Subject|2
308591|NCT00787202|1012217|P2|Overall Study|Withdrawal by Subject|2
308592|NCT00787202|1012218|P1|Overall Study|Withdrawal by Subject|2
308593|NCT00787202|1012214|P5|Overall Study|Lost to Follow-up|0
308594|NCT00787202|1012215|P4|Overall Study|Lost to Follow-up|0
308595|NCT00787202|1012216|P3|Overall Study|Lost to Follow-up|0
308596|NCT00787202|1012217|P2|Overall Study|Lost to Follow-up|0
308597|NCT00787202|1012218|P1|Overall Study|Lost to Follow-up|1
308598|NCT00787202|1012214|P5|Overall Study|Lack of Efficacy|1
308599|NCT00787202|1012215|P4|Overall Study|Lack of Efficacy|2
308600|NCT00787202|1012216|P3|Overall Study|Lack of Efficacy|5
308601|NCT00787202|1012217|P2|Overall Study|Lack of Efficacy|6
308602|NCT00787202|1012218|P1|Overall Study|Lack of Efficacy|5
308603|NCT00787202|1012214|P5|Overall Study|Adverse Event|2
308604|NCT00787202|1012215|P4|Overall Study|Adverse Event|0
308605|NCT00787202|1012216|P3|Overall Study|Adverse Event|0
308606|NCT00787202|1012217|P2|Overall Study|Adverse Event|2
308607|NCT00787202|1012218|P1|Overall Study|Adverse Event|3
308608|NCT00787189|1012271|P2|Overall Study|Lost to Follow-up|2
308609|NCT00787189|1012272|P1|Overall Study|Lost to Follow-up|2
308610|NCT00787150|1012281|P3|Overall Study|Dosing incorrect study durg|0
308611|NCT00787150|1012282|P2|Overall Study|Dosing incorrect study durg|0
308612|NCT00787150|1012283|P1|Overall Study|Dosing incorrect study durg|2
308613|NCT00787150|1012281|P3|Overall Study|Withdrawal by Subject|0
308614|NCT00787150|1012282|P2|Overall Study|Withdrawal by Subject|1
308615|NCT00787150|1012283|P1|Overall Study|Withdrawal by Subject|2
308616|NCT00787150|1012281|P3|Overall Study|Physician Decision|1
308617|NCT00787150|1012282|P2|Overall Study|Physician Decision|2
308618|NCT00787150|1012283|P1|Overall Study|Physician Decision|1
308619|NCT00787150|1012281|P3|Overall Study|Adverse Event|4
308620|NCT00787150|1012282|P2|Overall Study|Adverse Event|4
308621|NCT00787150|1012283|P1|Overall Study|Adverse Event|4
308622|NCT00787137|1012328|P3|Overall Study|Study Termination|1
308623|NCT00787137|1012329|P2|Overall Study|Study Termination|0
308624|NCT00787137|1012330|P1|Overall Study|Study Termination|0
308625|NCT00786864|1012405|P2|Overall Study|Sustained serious back injury|0
308626|NCT00786864|1012406|P1|Overall Study|Sustained serious back injury|1
308627|NCT00786864|1012405|P2|Overall Study|Lost to Follow-up|1
308628|NCT00786864|1012406|P1|Overall Study|Lost to Follow-up|0
308629|NCT00786838|1012418|P1|Overall Study|Withdrawal by Subject|4
308630|NCT00786838|1012418|P1|Overall Study|Progressive disease|31
308631|NCT00786838|1012418|P1|Overall Study|Adverse Event|6
308632|NCT00786838|1012418|P1|Overall Study|Death|4
308633|NCT00786838|1012418|P1|Overall Study|Physician Decision|4
308634|NCT00786799|1012445|P2|Overall Study|Lost to Follow-up|1
308635|NCT00786799|1012446|P1|Overall Study|Lost to Follow-up|1
308636|NCT00786565|1012476|P1|Post Surgery|Adapt AO implanted posterior side up|1
308637|NCT00786565|1012476|P1|Post Surgery|Abnormal macular pucker|1
308638|NCT00786565|1012476|P1|Enrollment Prior to Surgery|Protocol Violation|3
308639|NCT00786565|1012476|P1|Enrollment Prior to Surgery|Site Closed|3
308640|NCT00786474|1012533|P2|Overall Study|Not Specified|4
308641|NCT00786474|1012534|P1|Overall Study|Not Specified|4
308642|NCT00786474|1012533|P2|Overall Study|Physician Decision|1
308643|NCT00786474|1012534|P1|Overall Study|Physician Decision|2
308644|NCT00786474|1012533|P2|Overall Study|Lost to Follow-up|3
308645|NCT00786474|1012534|P1|Overall Study|Lost to Follow-up|3
308646|NCT00786474|1012533|P2|Overall Study|Withdrawal by Subject|31
308647|NCT00786474|1012534|P1|Overall Study|Withdrawal by Subject|23
308648|NCT00786474|1012533|P2|Overall Study|Death|4
308649|NCT00786474|1012534|P1|Overall Study|Death|5
308650|NCT00786422|1012546|P1|Follow-up Period|End-of-study done up to 4 days early|2
308651|NCT00786422|1012546|P1|Follow-up Period|Death|1
308652|NCT00786422|1012546|P1|Rivaroxaban Treatment|Adverse Event|2
308653|NCT00786422|1012546|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
308654|NCT00786422|1012546|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
308655|NCT00786422|1012546|P1|Rivaroxaban Treatment|Physician Decision|1
308656|NCT00786422|1012546|P1|Rivaroxaban Treatment|Lack of Efficacy|1
308657|NCT00786422|1012546|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
308658|NCT00786422|1012546|P1|Rivaroxaban Treatment|Death|2
308659|NCT00786188|1012564|P2|Overall Study|Withdrawal by Subject|0
308660|NCT00786188|1012565|P1|Overall Study|Withdrawal by Subject|2
308661|NCT00786188|1012564|P2|Overall Study|Adverse Event|1
308662|NCT00786188|1012565|P1|Overall Study|Adverse Event|3
308663|NCT00786032|1012591|P1|Overall Study|Did not complete in the timeframe|6
308664|NCT00786032|1012591|P1|Overall Study|Withdrawal by Subject|14
308665|NCT00786032|1012591|P1|Overall Study|Death|4
308666|NCT00785980|1012601|P1|7 Day Washout Period|Protocol Violation|3
308667|NCT00785785|1012619|P2|Optional Extension Phase|Study terminated by sponsor|37
308668|NCT00785785|1012620|P1|Optional Extension Phase|Study terminated by sponsor|3
308669|NCT00785785|1012619|P2|Optional Extension Phase|Protocol deviation|2
308670|NCT00785785|1012620|P1|Optional Extension Phase|Protocol deviation|0
308671|NCT00785785|1012619|P2|Optional Extension Phase|Disease progression|70
308672|NCT00785785|1012620|P1|Optional Extension Phase|Disease progression|22
308673|NCT00785785|1012619|P2|Optional Extension Phase|Death|5
308674|NCT00785785|1012620|P1|Optional Extension Phase|Death|1
308675|NCT00785785|1012619|P2|Optional Extension Phase|Administrative problems|0
308676|NCT00785785|1012620|P1|Optional Extension Phase|Administrative problems|2
308677|NCT00785785|1012619|P2|Optional Extension Phase|Lost to Follow-up|0
308678|NCT00785785|1012620|P1|Optional Extension Phase|Lost to Follow-up|1
308679|NCT00785785|1012619|P2|Optional Extension Phase|Withdrawal by Subject|6
308680|NCT00785785|1012620|P1|Optional Extension Phase|Withdrawal by Subject|6
308681|NCT00785785|1012619|P2|Optional Extension Phase|Adverse Event|5
308682|NCT00785785|1012620|P1|Optional Extension Phase|Adverse Event|4
308683|NCT00785785|1012619|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
308684|NCT00785785|1012620|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
308685|NCT00785785|1012619|P2|Core Phase up to 36 Months|Protocol deviation|6
308686|NCT00785785|1012620|P1|Core Phase up to 36 Months|Protocol deviation|5
308687|NCT00785785|1012619|P2|Core Phase up to 36 Months|Disease progression|119
308688|NCT00785785|1012620|P1|Core Phase up to 36 Months|Disease progression|139
308689|NCT00785785|1012619|P2|Core Phase up to 36 Months|Death|8
308690|NCT00785785|1012620|P1|Core Phase up to 36 Months|Death|5
308691|NCT00785785|1012619|P2|Core Phase up to 36 Months|Administrative problems|3
308692|NCT00785785|1012620|P1|Core Phase up to 36 Months|Administrative problems|3
308693|NCT00785785|1012619|P2|Core Phase up to 36 Months|Lost to Follow-up|7
308694|NCT00785785|1012620|P1|Core Phase up to 36 Months|Lost to Follow-up|3
308695|NCT00785785|1012619|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
308696|NCT00785785|1012620|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
308697|NCT00785785|1012619|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
308698|NCT00785785|1012620|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
308699|NCT00785785|1012619|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
308700|NCT00785785|1012620|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
308701|NCT00785785|1012619|P2|Core Phase up to 36 Months|Adverse Event|21
308702|NCT00785785|1012620|P1|Core Phase up to 36 Months|Adverse Event|31
308703|NCT00785785|1012619|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
308704|NCT00785785|1012620|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
308705|NCT00785629|1012638|P4|Overall Study|Withdrawal by Subject|2
308706|NCT00785629|1012639|P3|Overall Study|Withdrawal by Subject|2
308707|NCT00785629|1012640|P2|Overall Study|Withdrawal by Subject|1
308708|NCT00785629|1012641|P1|Overall Study|Withdrawal by Subject|0
308709|NCT00785629|1012638|P4|Overall Study|administrative decision|4
308710|NCT00785629|1012639|P3|Overall Study|administrative decision|3
308711|NCT00785629|1012640|P2|Overall Study|administrative decision|1
308712|NCT00785629|1012641|P1|Overall Study|administrative decision|5
308713|NCT00785629|1012638|P4|Overall Study|Protocol Violation|5
308714|NCT00785629|1012639|P3|Overall Study|Protocol Violation|4
308715|NCT00785629|1012640|P2|Overall Study|Protocol Violation|2
308716|NCT00785629|1012641|P1|Overall Study|Protocol Violation|1
308717|NCT00785629|1012638|P4|Overall Study|Adverse Event|5
308718|NCT00785629|1012639|P3|Overall Study|Adverse Event|1
308719|NCT00785629|1012640|P2|Overall Study|Adverse Event|1
308720|NCT00785629|1012641|P1|Overall Study|Adverse Event|2
308721|NCT00785577|1012654|P5|Study Period 3: 1-Week Washout Phase|Death|1
308722|NCT00785577|1012655|P4|Study Period 3: 1-Week Washout Phase|Death|0
308723|NCT00785577|1012656|P3|Study Period 3: 1-Week Washout Phase|Death|0
308724|NCT00785577|1012657|P2|Study Period 3: 1-Week Washout Phase|Death|0
308725|NCT00785577|1012658|P1|Study Period 3: 1-Week Washout Phase|Death|0
308726|NCT00785577|1012654|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
308727|NCT00785577|1012655|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
308728|NCT00785577|1012656|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
308729|NCT00785577|1012657|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
308730|NCT00785577|1012658|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
308731|NCT00785577|1012654|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
308732|NCT00785577|1012655|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
308733|NCT00785577|1012656|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
308734|NCT00785577|1012657|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
308735|NCT00785577|1012658|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
308736|NCT00785577|1012654|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
308737|NCT00785577|1012655|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
308738|NCT00785577|1012656|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
308739|NCT00785577|1012657|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
308740|NCT00785577|1012658|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
308741|NCT00785577|1012654|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
308742|NCT00785577|1012655|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
308743|NCT00785577|1012656|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
308744|NCT00785577|1012657|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
308745|NCT00785577|1012658|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
308746|NCT00785577|1012654|P5|Study Period 2: Therapy Phase|Protocol Violation|1
308747|NCT00785577|1012655|P4|Study Period 2: Therapy Phase|Protocol Violation|0
308748|NCT00785577|1012656|P3|Study Period 2: Therapy Phase|Protocol Violation|1
308749|NCT00785577|1012657|P2|Study Period 2: Therapy Phase|Protocol Violation|1
308750|NCT00785577|1012658|P1|Study Period 2: Therapy Phase|Protocol Violation|1
308751|NCT00785577|1012654|P5|Study Period 2: Therapy Phase|Physician Decision|0
308752|NCT00785577|1012655|P4|Study Period 2: Therapy Phase|Physician Decision|0
308753|NCT00785577|1012656|P3|Study Period 2: Therapy Phase|Physician Decision|0
308754|NCT00785577|1012657|P2|Study Period 2: Therapy Phase|Physician Decision|0
308755|NCT00785577|1012658|P1|Study Period 2: Therapy Phase|Physician Decision|1
308756|NCT00785577|1012654|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
308757|NCT00785577|1012655|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
308758|NCT00785577|1012656|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
308759|NCT00785577|1012657|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
308760|NCT00785577|1012658|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
308761|NCT00785577|1012654|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
308762|NCT00785577|1012655|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
308763|NCT00785577|1012656|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
308764|NCT00785577|1012657|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
308765|NCT00785577|1012658|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
308766|NCT00785577|1012654|P5|Study Period 2: Therapy Phase|Adverse Event|17
308767|NCT00785577|1012655|P4|Study Period 2: Therapy Phase|Adverse Event|10
308768|NCT00785577|1012656|P3|Study Period 2: Therapy Phase|Adverse Event|14
308769|NCT00785577|1012657|P2|Study Period 2: Therapy Phase|Adverse Event|7
308770|NCT00785577|1012658|P1|Study Period 2: Therapy Phase|Adverse Event|5
308771|NCT00785512|1012796|P2|Overall Study|Lack of compliance|1
308772|NCT00785512|1012797|P1|Overall Study|Lack of compliance|0
308773|NCT00785512|1012796|P2|Overall Study|Physician Decision|0
308774|NCT00785512|1012797|P1|Overall Study|Physician Decision|0
308775|NCT00785512|1012796|P2|Overall Study|IVRS Programing Error|0
308776|NCT00785512|1012797|P1|Overall Study|IVRS Programing Error|0
308777|NCT00785512|1012796|P2|Overall Study|Precedure Refused|0
308778|NCT00785512|1012797|P1|Overall Study|Precedure Refused|0
308779|NCT00785512|1012796|P2|Overall Study|Lost to Follow-up|0
308780|NCT00785512|1012797|P1|Overall Study|Lost to Follow-up|3
308781|NCT00785512|1012796|P2|Overall Study|Withdrawal by Subject|1
308782|NCT00785512|1012797|P1|Overall Study|Withdrawal by Subject|0
308783|NCT00785512|1012796|P2|Overall Study|Lack of Efficacy|2
308784|NCT00785512|1012797|P1|Overall Study|Lack of Efficacy|0
308785|NCT00785512|1012796|P2|Overall Study|Adverse Event|0
308786|NCT00785512|1012797|P1|Overall Study|Adverse Event|0
308787|NCT00785512|1012796|P2|Overall Study|Inclusion/Exclusion not meet|0
308788|NCT00785512|1012797|P1|Overall Study|Inclusion/Exclusion not meet|0
308789|NCT00785486|1012806|P1|Midazolam Alone|Withdrawal by Subject|1
308790|NCT00785356|1012830|P1|Overall Study|Study prematurely terminated|8
308791|NCT00785291|1012841|P3|Overall Study|Other Medical Reasons|15
308792|NCT00785291|1012842|P2|Overall Study|Other Medical Reasons|25
308793|NCT00785291|1012843|P1|Overall Study|Other Medical Reasons|29
308794|NCT00785291|1012841|P3|Overall Study|Complicating illness|4
308795|NCT00785291|1012842|P2|Overall Study|Complicating illness|4
308796|NCT00785291|1012843|P1|Overall Study|Complicating illness|6
308797|NCT00785291|1012841|P3|Overall Study|Alternative Therapy|7
308798|NCT00785291|1012842|P2|Overall Study|Alternative Therapy|6
308799|NCT00785291|1012843|P1|Overall Study|Alternative Therapy|12
308800|NCT00785291|1012841|P3|Overall Study|Withdrawal by Subject|17
308801|NCT00785291|1012842|P2|Overall Study|Withdrawal by Subject|36
308802|NCT00785291|1012843|P1|Overall Study|Withdrawal by Subject|35
308803|NCT00785291|1012841|P3|Overall Study|Death|3
308804|NCT00785291|1012842|P2|Overall Study|Death|4
308805|NCT00785291|1012843|P1|Overall Study|Death|7
308806|NCT00785291|1012841|P3|Overall Study|Adverse Event|56
308807|NCT00785291|1012842|P2|Overall Study|Adverse Event|70
308808|NCT00785291|1012843|P1|Overall Study|Adverse Event|39
308809|NCT00785291|1012841|P3|Overall Study|Never began treatment|4
308810|NCT00785291|1012842|P2|Overall Study|Never began treatment|4
308811|NCT00785291|1012843|P1|Overall Study|Never began treatment|8
308812|NCT00785213|1012863|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
308813|NCT00785213|1012863|P1|Quinine Sulfate Alone|Adverse Event|4
308814|NCT00785044|1012874|P1|Overall Study|Withdrawal by Subject|1
308815|NCT00785044|1012874|P1|Overall Study|Lost to Follow-up|266
308816|NCT00785044|1012874|P1|Overall Study|Death|77
308817|NCT00785044|1012874|P1|Overall Study|Dosed at non-participating sites|152
308818|NCT00784979|1012879|P1|Overall Study|incomplete data|6
308819|NCT00784927|1012883|P1|Overall Study|Ineligible|1
308820|NCT00784927|1012883|P1|Overall Study|Protocol Violation|1
308821|NCT00784927|1012883|P1|Overall Study|Cancel Prior to Initiating Treatment|1
308822|NCT00784875|1012895|P4|Period D|Lost to Follow-up|1
308823|NCT00784875|1012896|P3|Period D|Lost to Follow-up|1
308824|NCT00784875|1012897|P2|Period D|Lost to Follow-up|0
308825|NCT00784875|1012898|P1|Period D|Lost to Follow-up|1
308826|NCT00784875|1012895|P4|Period D|Sponsor Decision|0
308827|NCT00784875|1012896|P3|Period D|Sponsor Decision|1
308828|NCT00784875|1012897|P2|Period D|Sponsor Decision|1
308829|NCT00784875|1012898|P1|Period D|Sponsor Decision|1
308830|NCT00784875|1012895|P4|Period D|Physician Decision|0
308831|NCT00784875|1012896|P3|Period D|Physician Decision|0
308832|NCT00784875|1012897|P2|Period D|Physician Decision|1
308833|NCT00784875|1012898|P1|Period D|Physician Decision|0
308834|NCT00784875|1012895|P4|Period D|Withdrawal by Subject|0
308835|NCT00784875|1012896|P3|Period D|Withdrawal by Subject|2
308836|NCT00784875|1012897|P2|Period D|Withdrawal by Subject|0
308837|NCT00784875|1012898|P1|Period D|Withdrawal by Subject|2
308838|NCT00784875|1012895|P4|Period D|Protocol Violation|0
308839|NCT00784875|1012896|P3|Period D|Protocol Violation|0
308840|NCT00784875|1012897|P2|Period D|Protocol Violation|0
308841|NCT00784875|1012898|P1|Period D|Protocol Violation|1
308842|NCT00784875|1012895|P4|Period D|Adverse Event|0
308843|NCT00784875|1012896|P3|Period D|Adverse Event|2
308844|NCT00784875|1012897|P2|Period D|Adverse Event|2
308845|NCT00784875|1012898|P1|Period D|Adverse Event|0
308846|NCT00784875|1012895|P4|Period C|Sponsor Decision|2
308847|NCT00784875|1012896|P3|Period C|Sponsor Decision|4
308848|NCT00784875|1012897|P2|Period C|Sponsor Decision|5
308849|NCT00784875|1012898|P1|Period C|Sponsor Decision|5
308850|NCT00784875|1012895|P4|Period C|Physician Decision|1
308851|NCT00784875|1012896|P3|Period C|Physician Decision|1
308852|NCT00784875|1012897|P2|Period C|Physician Decision|0
308853|NCT00784875|1012898|P1|Period C|Physician Decision|0
308854|NCT00784875|1012895|P4|Period C|Withdrawal by Subject|0
308855|NCT00784875|1012896|P3|Period C|Withdrawal by Subject|2
308856|NCT00784875|1012897|P2|Period C|Withdrawal by Subject|1
308857|NCT00784875|1012898|P1|Period C|Withdrawal by Subject|1
308858|NCT00784875|1012895|P4|Period C|Lack of Efficacy|0
308859|NCT00784875|1012896|P3|Period C|Lack of Efficacy|1
308860|NCT00784875|1012897|P2|Period C|Lack of Efficacy|0
308861|NCT00784875|1012898|P1|Period C|Lack of Efficacy|0
308862|NCT00784875|1012895|P4|Period C|Protocol Violation|2
308863|NCT00784875|1012896|P3|Period C|Protocol Violation|1
308864|NCT00784875|1012897|P2|Period C|Protocol Violation|0
308865|NCT00784875|1012898|P1|Period C|Protocol Violation|0
308866|NCT00784875|1012895|P4|Period C|Adverse Event|2
308867|NCT00784875|1012896|P3|Period C|Adverse Event|4
308868|NCT00784875|1012897|P2|Period C|Adverse Event|0
308869|NCT00784875|1012898|P1|Period C|Adverse Event|1
308870|NCT00784875|1012895|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
308871|NCT00784875|1012896|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
308872|NCT00784875|1012897|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
308873|NCT00784875|1012898|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
308874|NCT00784875|1012895|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
308875|NCT00784875|1012896|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
308876|NCT00784875|1012897|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
308877|NCT00784875|1012898|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
308878|NCT00784875|1012895|P4|Period B - Efficacy Endpoint|Physician Decision|0
308879|NCT00784875|1012896|P3|Period B - Efficacy Endpoint|Physician Decision|1
308880|NCT00784875|1012897|P2|Period B - Efficacy Endpoint|Physician Decision|0
308881|NCT00784875|1012898|P1|Period B - Efficacy Endpoint|Physician Decision|0
308882|NCT00784875|1012895|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
308883|NCT00784875|1012896|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
308884|NCT00784875|1012897|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
308885|NCT00784875|1012898|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
308886|NCT00784875|1012895|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
308887|NCT00784875|1012896|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
308888|NCT00784875|1012897|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
308889|NCT00784875|1012898|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
308890|NCT00784875|1012895|P4|Period B - Efficacy Endpoint|Protocol Violation|3
308891|NCT00784875|1012896|P3|Period B - Efficacy Endpoint|Protocol Violation|2
308892|NCT00784875|1012897|P2|Period B - Efficacy Endpoint|Protocol Violation|1
308893|NCT00784875|1012898|P1|Period B - Efficacy Endpoint|Protocol Violation|1
308894|NCT00784875|1012895|P4|Period B - Efficacy Endpoint|Adverse Event|1
308895|NCT00784875|1012896|P3|Period B - Efficacy Endpoint|Adverse Event|2
308896|NCT00784875|1012897|P2|Period B - Efficacy Endpoint|Adverse Event|3
308897|NCT00784875|1012898|P1|Period B - Efficacy Endpoint|Adverse Event|0
308898|NCT00784875|1012895|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
308899|NCT00784875|1012896|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
308900|NCT00784875|1012897|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
308901|NCT00784875|1012898|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
308902|NCT00784875|1012895|P4|Period A - Baseline|Lost to Follow-up|2
308903|NCT00784875|1012896|P3|Period A - Baseline|Lost to Follow-up|0
308904|NCT00784875|1012897|P2|Period A - Baseline|Lost to Follow-up|0
308905|NCT00784875|1012898|P1|Period A - Baseline|Lost to Follow-up|0
308906|NCT00784875|1012895|P4|Period A - Baseline|Sponsor Decision|113
308907|NCT00784875|1012896|P3|Period A - Baseline|Sponsor Decision|0
308908|NCT00784875|1012897|P2|Period A - Baseline|Sponsor Decision|0
308909|NCT00784875|1012898|P1|Period A - Baseline|Sponsor Decision|0
308910|NCT00784875|1012895|P4|Period A - Baseline|Physician Decision|2
308911|NCT00784875|1012896|P3|Period A - Baseline|Physician Decision|0
308912|NCT00784875|1012897|P2|Period A - Baseline|Physician Decision|0
308913|NCT00784875|1012898|P1|Period A - Baseline|Physician Decision|0
308914|NCT00784875|1012895|P4|Period A - Baseline|Withdrawal by Subject|27
308915|NCT00784875|1012896|P3|Period A - Baseline|Withdrawal by Subject|0
308916|NCT00784875|1012897|P2|Period A - Baseline|Withdrawal by Subject|0
308917|NCT00784875|1012898|P1|Period A - Baseline|Withdrawal by Subject|0
308918|NCT00784875|1012895|P4|Period A - Baseline|Protocol Violation|25
308919|NCT00784875|1012896|P3|Period A - Baseline|Protocol Violation|0
308920|NCT00784875|1012897|P2|Period A - Baseline|Protocol Violation|0
308921|NCT00784875|1012898|P1|Period A - Baseline|Protocol Violation|0
308922|NCT00784875|1012895|P4|Period A - Baseline|Adverse Event|8
308923|NCT00784875|1012896|P3|Period A - Baseline|Adverse Event|0
308924|NCT00784875|1012897|P2|Period A - Baseline|Adverse Event|0
308925|NCT00784875|1012898|P1|Period A - Baseline|Adverse Event|0
308926|NCT00784875|1012895|P4|Period A - Baseline|Entry Criteria Not Met|5
308927|NCT00784875|1012896|P3|Period A - Baseline|Entry Criteria Not Met|0
308928|NCT00784875|1012897|P2|Period A - Baseline|Entry Criteria Not Met|0
308929|NCT00784875|1012898|P1|Period A - Baseline|Entry Criteria Not Met|0
308930|NCT00784836|1013018|P1|Overall Study|Early Study Termination|3
308931|NCT00784810|1013025|P2|Overall Study|Lost to Follow-up|1
308932|NCT00784810|1013026|P1|Overall Study|Lost to Follow-up|1
308933|NCT00784810|1013025|P2|Overall Study|Administrative|8
308934|NCT00784810|1013026|P1|Overall Study|Administrative|5
308935|NCT00784810|1013025|P2|Overall Study|Withdrawal by Subject|9
308936|NCT00784810|1013026|P1|Overall Study|Withdrawal by Subject|11
308937|NCT00784810|1013025|P2|Overall Study|Lack of Efficacy|11
308938|NCT00784810|1013026|P1|Overall Study|Lack of Efficacy|14
308939|NCT00784810|1013025|P2|Overall Study|Adverse Event|20
308940|NCT00784810|1013026|P1|Overall Study|Adverse Event|32
308941|NCT00784784|1013036|P2|Overall Study|Withdrawal by Subject|2
308942|NCT00784784|1013037|P1|Overall Study|Withdrawal by Subject|2
308943|NCT00784719|1013052|P7|Overall Study|Withdrawal by Subject|1
308944|NCT00784719|1013053|P6|Overall Study|Withdrawal by Subject|0
308945|NCT00784719|1013054|P5|Overall Study|Withdrawal by Subject|2
308946|NCT00784719|1013055|P4|Overall Study|Withdrawal by Subject|0
308947|NCT00784719|1013056|P3|Overall Study|Withdrawal by Subject|0
308948|NCT00784719|1013057|P2|Overall Study|Withdrawal by Subject|0
308949|NCT00784719|1013058|P1|Overall Study|Withdrawal by Subject|1
308950|NCT00784719|1013052|P7|Overall Study|Unspecified|3
308951|NCT00784719|1013053|P6|Overall Study|Unspecified|1
308952|NCT00784719|1013054|P5|Overall Study|Unspecified|2
308953|NCT00784719|1013055|P4|Overall Study|Unspecified|0
308954|NCT00784719|1013056|P3|Overall Study|Unspecified|1
308955|NCT00784719|1013057|P2|Overall Study|Unspecified|1
308956|NCT00784719|1013058|P1|Overall Study|Unspecified|2
308957|NCT00784719|1013052|P7|Overall Study|Lost to Follow-up|0
308958|NCT00784719|1013053|P6|Overall Study|Lost to Follow-up|1
308959|NCT00784719|1013054|P5|Overall Study|Lost to Follow-up|1
308960|NCT00784719|1013055|P4|Overall Study|Lost to Follow-up|0
308961|NCT00784719|1013056|P3|Overall Study|Lost to Follow-up|0
308962|NCT00784719|1013057|P2|Overall Study|Lost to Follow-up|0
308963|NCT00784719|1013058|P1|Overall Study|Lost to Follow-up|0
308964|NCT00784719|1013052|P7|Overall Study|Adverse Event|1
308965|NCT00784719|1013053|P6|Overall Study|Adverse Event|1
308966|NCT00784719|1013054|P5|Overall Study|Adverse Event|1
308967|NCT00784719|1013055|P4|Overall Study|Adverse Event|0
308968|NCT00784719|1013056|P3|Overall Study|Adverse Event|0
308969|NCT00784719|1013057|P2|Overall Study|Adverse Event|2
308970|NCT00784719|1013058|P1|Overall Study|Adverse Event|0
308971|NCT00784654|1013228|P3|Randomized Withdrawal Period|Family reasons|1
308972|NCT00784654|1013229|P2|Randomized Withdrawal Period|Family reasons|0
308973|NCT00784654|1013230|P1|Randomized Withdrawal Period|Family reasons|0
308974|NCT00784654|1013228|P3|Randomized Withdrawal Period|Did not complete a visit|0
308975|NCT00784654|1013229|P2|Randomized Withdrawal Period|Did not complete a visit|1
308976|NCT00784654|1013230|P1|Randomized Withdrawal Period|Did not complete a visit|0
308977|NCT00784654|1013228|P3|Randomized Withdrawal Period|Adverse Event|1
308978|NCT00784654|1013229|P2|Randomized Withdrawal Period|Adverse Event|1
308979|NCT00784654|1013230|P1|Randomized Withdrawal Period|Adverse Event|0
308980|NCT00784654|1013228|P3|Randomized Withdrawal Period|Protocol Violation|1
308981|NCT00784654|1013229|P2|Randomized Withdrawal Period|Protocol Violation|2
308982|NCT00784654|1013230|P1|Randomized Withdrawal Period|Protocol Violation|0
308983|NCT00784654|1013228|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
308984|NCT00784654|1013229|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
308985|NCT00784654|1013230|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
308986|NCT00784654|1013228|P3|Randomized Withdrawal Period|Lack of Efficacy|18
308987|NCT00784654|1013229|P2|Randomized Withdrawal Period|Lack of Efficacy|5
308988|NCT00784654|1013230|P1|Randomized Withdrawal Period|Lack of Efficacy|0
308989|NCT00784654|1013228|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
308990|NCT00784654|1013229|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
308991|NCT00784654|1013230|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
308992|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
308993|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
308994|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
308995|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
308996|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
308997|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
308998|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
308999|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
309000|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
309001|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
309002|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
309003|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
309004|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
309005|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
309006|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
309007|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
309008|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
309009|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
309010|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
309011|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
309012|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
309013|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
309014|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
309015|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
309016|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
309017|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
309018|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
309019|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
309020|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
309021|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
309022|NCT00784654|1013228|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
309023|NCT00784654|1013229|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
309024|NCT00784654|1013230|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
309025|NCT00784563|1013265|P3|Year 3|Adverse Event|1
309026|NCT00784563|1013266|P2|Year 3|Adverse Event|0
309027|NCT00784563|1013267|P1|Year 3|Adverse Event|0
309028|NCT00784563|1013265|P3|Year 3|Withdrawal by Subject|2
309029|NCT00784563|1013266|P2|Year 3|Withdrawal by Subject|0
309030|NCT00784563|1013267|P1|Year 3|Withdrawal by Subject|0
309031|NCT00784563|1013265|P3|Years 1 & 2|Adverse Event|0
309032|NCT00784563|1013266|P2|Years 1 & 2|Adverse Event|3
309033|NCT00784563|1013267|P1|Years 1 & 2|Adverse Event|0
309034|NCT00784563|1013265|P3|Years 1 & 2|Withdrawal by Subject|0
309035|NCT00784563|1013266|P2|Years 1 & 2|Withdrawal by Subject|2
309036|NCT00784563|1013267|P1|Years 1 & 2|Withdrawal by Subject|3
309037|NCT00784550|1013285|P2|Overall Study|Withdrawal by Subject|13
309038|NCT00784550|1013286|P1|Overall Study|Withdrawal by Subject|4
309039|NCT00784550|1013285|P2|Overall Study|Physician Decision|3
309040|NCT00784550|1013286|P1|Overall Study|Physician Decision|2
309041|NCT00784550|1013285|P2|Overall Study|Lost to Follow-up|5
309042|NCT00784550|1013286|P1|Overall Study|Lost to Follow-up|8
309043|NCT00784550|1013285|P2|Overall Study|Protocol Violation|10
309044|NCT00784550|1013286|P1|Overall Study|Protocol Violation|10
309045|NCT00784550|1013285|P2|Overall Study|Lack of Efficacy|1
309046|NCT00784550|1013286|P1|Overall Study|Lack of Efficacy|0
309047|NCT00784550|1013285|P2|Overall Study|Adverse Event|10
309048|NCT00784550|1013286|P1|Overall Study|Adverse Event|12
309049|NCT00784459|1013304|P2|Overall Study|Adverse Event|2
309050|NCT00784459|1013305|P1|Overall Study|Adverse Event|0
309051|NCT00784368|1013316|P3|Overall Study|Withdrawal of informed consent|0
309052|NCT00784368|1013317|P2|Overall Study|Withdrawal of informed consent|1
309053|NCT00784368|1013318|P1|Overall Study|Withdrawal of informed consent|0
309054|NCT00784368|1013316|P3|Overall Study|Worsening of symptoms|0
309055|NCT00784368|1013317|P2|Overall Study|Worsening of symptoms|1
309056|NCT00784368|1013318|P1|Overall Study|Worsening of symptoms|0
309057|NCT00784368|1013316|P3|Overall Study|Worsening of complications|1
309058|NCT00784368|1013317|P2|Overall Study|Worsening of complications|0
309059|NCT00784368|1013318|P1|Overall Study|Worsening of complications|0
309060|NCT00784368|1013316|P3|Overall Study|Diagnosis of fever|1
309061|NCT00784368|1013317|P2|Overall Study|Diagnosis of fever|0
309062|NCT00784368|1013318|P1|Overall Study|Diagnosis of fever|0
309063|NCT00784368|1013316|P3|Overall Study|Adverse Event|2
309064|NCT00784368|1013317|P2|Overall Study|Adverse Event|9
309065|NCT00784368|1013318|P1|Overall Study|Adverse Event|6
309066|NCT00784368|1013316|P3|Overall Study|Lack of Efficacy|1
309067|NCT00784368|1013317|P2|Overall Study|Lack of Efficacy|0
309068|NCT00784368|1013318|P1|Overall Study|Lack of Efficacy|2
309069|NCT00784368|1013316|P3|Overall Study|Physician Decision|6
309070|NCT00784368|1013317|P2|Overall Study|Physician Decision|0
309071|NCT00784368|1013318|P1|Overall Study|Physician Decision|0
309072|NCT00784277|1013356|P7|ER Treatment|Other|2
309073|NCT00784277|1013357|P6|ER Treatment|Other|3
309074|NCT00784277|1013358|P5|ER Treatment|Other|1
309075|NCT00784277|1013359|P4|ER Treatment|Other|0
309076|NCT00784277|1013360|P3|ER Treatment|Other|0
309077|NCT00784277|1013361|P2|ER Treatment|Other|0
309078|NCT00784277|1013362|P1|ER Treatment|Other|0
309079|NCT00784277|1013356|P7|ER Treatment|Study Medication Non-Compliant|3
309080|NCT00784277|1013357|P6|ER Treatment|Study Medication Non-Compliant|3
309081|NCT00784277|1013358|P5|ER Treatment|Study Medication Non-Compliant|2
309082|NCT00784277|1013359|P4|ER Treatment|Study Medication Non-Compliant|0
309083|NCT00784277|1013360|P3|ER Treatment|Study Medication Non-Compliant|0
309084|NCT00784277|1013361|P2|ER Treatment|Study Medication Non-Compliant|0
309085|NCT00784277|1013362|P1|ER Treatment|Study Medication Non-Compliant|0
309086|NCT00784277|1013356|P7|ER Treatment|Withdrawal by Subject|3
309087|NCT00784277|1013357|P6|ER Treatment|Withdrawal by Subject|5
309088|NCT00784277|1013358|P5|ER Treatment|Withdrawal by Subject|2
309089|NCT00784277|1013359|P4|ER Treatment|Withdrawal by Subject|0
309090|NCT00784277|1013360|P3|ER Treatment|Withdrawal by Subject|0
309091|NCT00784277|1013361|P2|ER Treatment|Withdrawal by Subject|0
309092|NCT00784277|1013362|P1|ER Treatment|Withdrawal by Subject|0
309093|NCT00784277|1013356|P7|ER Treatment|Lost to Follow-up|0
309094|NCT00784277|1013357|P6|ER Treatment|Lost to Follow-up|2
309095|NCT00784277|1013358|P5|ER Treatment|Lost to Follow-up|0
309096|NCT00784277|1013359|P4|ER Treatment|Lost to Follow-up|0
309097|NCT00784277|1013360|P3|ER Treatment|Lost to Follow-up|0
309098|NCT00784277|1013361|P2|ER Treatment|Lost to Follow-up|0
309099|NCT00784277|1013362|P1|ER Treatment|Lost to Follow-up|0
309100|NCT00784277|1013356|P7|ER Treatment|Lack of Efficacy|0
309101|NCT00784277|1013357|P6|ER Treatment|Lack of Efficacy|4
309102|NCT00784277|1013358|P5|ER Treatment|Lack of Efficacy|3
309103|NCT00784277|1013359|P4|ER Treatment|Lack of Efficacy|0
309104|NCT00784277|1013360|P3|ER Treatment|Lack of Efficacy|0
309105|NCT00784277|1013361|P2|ER Treatment|Lack of Efficacy|0
309106|NCT00784277|1013362|P1|ER Treatment|Lack of Efficacy|0
309107|NCT00784277|1013356|P7|ER Treatment|Adverse Event|7
309108|NCT00784277|1013357|P6|ER Treatment|Adverse Event|7
309109|NCT00784277|1013358|P5|ER Treatment|Adverse Event|1
309110|NCT00784277|1013359|P4|ER Treatment|Adverse Event|0
309111|NCT00784277|1013360|P3|ER Treatment|Adverse Event|0
309112|NCT00784277|1013361|P2|ER Treatment|Adverse Event|0
309113|NCT00784277|1013362|P1|ER Treatment|Adverse Event|0
309114|NCT00784277|1013356|P7|IR Treatment|Other|0
309115|NCT00784277|1013357|P6|IR Treatment|Other|0
309116|NCT00784277|1013358|P5|IR Treatment|Other|0
309117|NCT00784277|1013359|P4|IR Treatment|Other|2
309118|NCT00784277|1013360|P3|IR Treatment|Other|3
309119|NCT00784277|1013361|P2|IR Treatment|Other|3
309120|NCT00784277|1013362|P1|IR Treatment|Other|2
309121|NCT00784277|1013356|P7|IR Treatment|Resolution Of Pain|0
309122|NCT00784277|1013357|P6|IR Treatment|Resolution Of Pain|0
309123|NCT00784277|1013358|P5|IR Treatment|Resolution Of Pain|0
309124|NCT00784277|1013359|P4|IR Treatment|Resolution Of Pain|0
309125|NCT00784277|1013360|P3|IR Treatment|Resolution Of Pain|0
309126|NCT00784277|1013361|P2|IR Treatment|Resolution Of Pain|1
309127|NCT00784277|1013362|P1|IR Treatment|Resolution Of Pain|0
309128|NCT00784277|1013356|P7|IR Treatment|Withdrawal by Subject|0
309129|NCT00784277|1013357|P6|IR Treatment|Withdrawal by Subject|0
309130|NCT00784277|1013358|P5|IR Treatment|Withdrawal by Subject|0
309131|NCT00784277|1013359|P4|IR Treatment|Withdrawal by Subject|6
309132|NCT00784277|1013360|P3|IR Treatment|Withdrawal by Subject|4
309133|NCT00784277|1013361|P2|IR Treatment|Withdrawal by Subject|1
309134|NCT00784277|1013362|P1|IR Treatment|Withdrawal by Subject|5
309135|NCT00784277|1013356|P7|IR Treatment|Lost to Follow-up|0
309136|NCT00784277|1013357|P6|IR Treatment|Lost to Follow-up|0
309137|NCT00784277|1013358|P5|IR Treatment|Lost to Follow-up|0
309138|NCT00784277|1013359|P4|IR Treatment|Lost to Follow-up|0
309139|NCT00784277|1013360|P3|IR Treatment|Lost to Follow-up|1
309140|NCT00784277|1013361|P2|IR Treatment|Lost to Follow-up|0
309141|NCT00784277|1013362|P1|IR Treatment|Lost to Follow-up|1
309142|NCT00784277|1013356|P7|IR Treatment|Lack of Efficacy|0
309143|NCT00784277|1013357|P6|IR Treatment|Lack of Efficacy|0
309144|NCT00784277|1013358|P5|IR Treatment|Lack of Efficacy|0
309145|NCT00784277|1013359|P4|IR Treatment|Lack of Efficacy|0
309146|NCT00784277|1013360|P3|IR Treatment|Lack of Efficacy|1
309147|NCT00784277|1013361|P2|IR Treatment|Lack of Efficacy|4
309148|NCT00784277|1013362|P1|IR Treatment|Lack of Efficacy|4
309149|NCT00784277|1013356|P7|IR Treatment|Adverse Event|0
309150|NCT00784277|1013357|P6|IR Treatment|Adverse Event|0
309151|NCT00784277|1013358|P5|IR Treatment|Adverse Event|0
309152|NCT00784277|1013359|P4|IR Treatment|Adverse Event|35
309153|NCT00784277|1013360|P3|IR Treatment|Adverse Event|19
309154|NCT00784277|1013361|P2|IR Treatment|Adverse Event|8
309155|NCT00784277|1013362|P1|IR Treatment|Adverse Event|4
309156|NCT00784238|1013379|P1|Overall Study|Unspecified|14
309157|NCT00784238|1013379|P1|Overall Study|Withdrawal by Subject|26
309158|NCT00784238|1013379|P1|Overall Study|Pregnancy|1
309159|NCT00784238|1013379|P1|Overall Study|Lost to Follow-up|29
309160|NCT00784238|1013379|P1|Overall Study|Lack of Efficacy|33
309161|NCT00784238|1013379|P1|Overall Study|Death|2
309162|NCT00784238|1013379|P1|Overall Study|Adverse Event|14
309163|NCT00784147|1013422|P2|Overall Study|Death|0
309164|NCT00784147|1013423|P1|Overall Study|Death|2
309165|NCT00784147|1013422|P2|Overall Study|Protocol Violation|1
309166|NCT00784147|1013423|P1|Overall Study|Protocol Violation|1
309167|NCT00784147|1013422|P2|Overall Study|Physician Decision|1
309168|NCT00784147|1013423|P1|Overall Study|Physician Decision|2
309169|NCT00784147|1013422|P2|Overall Study|Withdrawal by Subject|3
309170|NCT00784147|1013423|P1|Overall Study|Withdrawal by Subject|1
309171|NCT00784147|1013422|P2|Overall Study|Lost to Follow-up|4
309172|NCT00784147|1013423|P1|Overall Study|Lost to Follow-up|2
309173|NCT00783835|1013491|P1|Overall Study|Participant not Adherent|3
309174|NCT00783835|1013491|P1|Overall Study|Lost to Follow-up|1
309175|NCT00783835|1013491|P1|Overall Study|Withdrawal by Subject|2
309176|NCT00783835|1013491|P1|Overall Study|Medical Criteria|1
309177|NCT00783835|1013491|P1|Overall Study|Adverse Event|3
309178|NCT00783796|1013503|P1|Overall Study|Received commercial XIENCE V stent|1
309179|NCT00783796|1013503|P1|Overall Study|Received non-XIENCE V stent|1
309180|NCT00783796|1013503|P1|Overall Study|Did not receive any stent|4
309181|NCT00783718|1013608|P7|Maintenance Phase|Lost to Follow-up|2
309182|NCT00783718|1013609|P6|Maintenance Phase|Lost to Follow-up|0
309183|NCT00783718|1013610|P5|Maintenance Phase|Lost to Follow-up|2
309184|NCT00783718|1013611|P4|Maintenance Phase|Lost to Follow-up|0
309185|NCT00783718|1013612|P3|Maintenance Phase|Lost to Follow-up|0
309186|NCT00783718|1013613|P2|Maintenance Phase|Lost to Follow-up|0
309187|NCT00783718|1013614|P1|Maintenance Phase|Lost to Follow-up|3
309188|NCT00783718|1013608|P7|Maintenance Phase|Withdrawal by Subject|20
309189|NCT00783718|1013609|P6|Maintenance Phase|Withdrawal by Subject|2
309190|NCT00783718|1013610|P5|Maintenance Phase|Withdrawal by Subject|5
309191|NCT00783718|1013611|P4|Maintenance Phase|Withdrawal by Subject|2
309192|NCT00783718|1013612|P3|Maintenance Phase|Withdrawal by Subject|0
309193|NCT00783718|1013613|P2|Maintenance Phase|Withdrawal by Subject|0
309194|NCT00783718|1013614|P1|Maintenance Phase|Withdrawal by Subject|6
309195|NCT00783718|1013608|P7|Maintenance Phase|Lack of Efficacy|155
309196|NCT00783718|1013609|P6|Maintenance Phase|Lack of Efficacy|33
309197|NCT00783718|1013610|P5|Maintenance Phase|Lack of Efficacy|31
309198|NCT00783718|1013611|P4|Maintenance Phase|Lack of Efficacy|61
309199|NCT00783718|1013612|P3|Maintenance Phase|Lack of Efficacy|0
309200|NCT00783718|1013613|P2|Maintenance Phase|Lack of Efficacy|0
309201|NCT00783718|1013614|P1|Maintenance Phase|Lack of Efficacy|83
309202|NCT00783718|1013608|P7|Maintenance Phase|Protocol Violation|2
309203|NCT00783718|1013609|P6|Maintenance Phase|Protocol Violation|0
309204|NCT00783718|1013610|P5|Maintenance Phase|Protocol Violation|0
309205|NCT00783718|1013611|P4|Maintenance Phase|Protocol Violation|0
309206|NCT00783718|1013612|P3|Maintenance Phase|Protocol Violation|0
309207|NCT00783718|1013613|P2|Maintenance Phase|Protocol Violation|0
309208|NCT00783718|1013614|P1|Maintenance Phase|Protocol Violation|1
309209|NCT00783718|1013608|P7|Maintenance Phase|Adverse Event|16
309210|NCT00783718|1013609|P6|Maintenance Phase|Adverse Event|6
309211|NCT00783718|1013610|P5|Maintenance Phase|Adverse Event|7
309212|NCT00783718|1013611|P4|Maintenance Phase|Adverse Event|15
309213|NCT00783718|1013612|P3|Maintenance Phase|Adverse Event|0
309214|NCT00783718|1013613|P2|Maintenance Phase|Adverse Event|0
309215|NCT00783718|1013614|P1|Maintenance Phase|Adverse Event|12
309216|NCT00783718|1013608|P7|Induction Phase|Lost to Follow-up|0
309217|NCT00783718|1013609|P6|Induction Phase|Lost to Follow-up|0
309218|NCT00783718|1013610|P5|Induction Phase|Lost to Follow-up|0
309219|NCT00783718|1013611|P4|Induction Phase|Lost to Follow-up|0
309220|NCT00783718|1013612|P3|Induction Phase|Lost to Follow-up|1
309221|NCT00783718|1013613|P2|Induction Phase|Lost to Follow-up|0
309222|NCT00783718|1013614|P1|Induction Phase|Lost to Follow-up|1
309223|NCT00783718|1013608|P7|Induction Phase|Withdrawal by Subject|0
309224|NCT00783718|1013609|P6|Induction Phase|Withdrawal by Subject|0
309225|NCT00783718|1013610|P5|Induction Phase|Withdrawal by Subject|0
309226|NCT00783718|1013611|P4|Induction Phase|Withdrawal by Subject|0
309227|NCT00783718|1013612|P3|Induction Phase|Withdrawal by Subject|8
309228|NCT00783718|1013613|P2|Induction Phase|Withdrawal by Subject|4
309229|NCT00783718|1013614|P1|Induction Phase|Withdrawal by Subject|3
309230|NCT00783718|1013608|P7|Induction Phase|Lack of Efficacy|0
309231|NCT00783718|1013609|P6|Induction Phase|Lack of Efficacy|0
309232|NCT00783718|1013610|P5|Induction Phase|Lack of Efficacy|0
309233|NCT00783718|1013611|P4|Induction Phase|Lack of Efficacy|0
309234|NCT00783718|1013612|P3|Induction Phase|Lack of Efficacy|14
309235|NCT00783718|1013613|P2|Induction Phase|Lack of Efficacy|2
309236|NCT00783718|1013614|P1|Induction Phase|Lack of Efficacy|5
309237|NCT00783718|1013608|P7|Induction Phase|Protocol Violation|0
309238|NCT00783718|1013609|P6|Induction Phase|Protocol Violation|0
309239|NCT00783718|1013610|P5|Induction Phase|Protocol Violation|0
309240|NCT00783718|1013611|P4|Induction Phase|Protocol Violation|0
309241|NCT00783718|1013612|P3|Induction Phase|Protocol Violation|6
309242|NCT00783718|1013613|P2|Induction Phase|Protocol Violation|1
309243|NCT00783718|1013614|P1|Induction Phase|Protocol Violation|1
309244|NCT00783718|1013608|P7|Induction Phase|Adverse Event|0
309245|NCT00783718|1013609|P6|Induction Phase|Adverse Event|0
309246|NCT00783718|1013610|P5|Induction Phase|Adverse Event|0
309247|NCT00783718|1013611|P4|Induction Phase|Adverse Event|0
309248|NCT00783718|1013612|P3|Induction Phase|Adverse Event|7
309249|NCT00783718|1013613|P2|Induction Phase|Adverse Event|0
309250|NCT00783718|1013614|P1|Induction Phase|Adverse Event|4
309251|NCT00783705|1013642|P2|Overall Study|Lost to Follow-up|3
309252|NCT00783705|1013643|P1|Overall Study|Lost to Follow-up|1
309253|NCT00783705|1013642|P2|Overall Study|Withdrawal by Subject|2
309254|NCT00783705|1013643|P1|Overall Study|Withdrawal by Subject|3
309255|NCT00783705|1013642|P2|Overall Study|Adverse Event|0
309256|NCT00783705|1013643|P1|Overall Study|Adverse Event|2
309257|NCT00783692|1013688|P7|Maintenance Phase|Other|1
309258|NCT00783692|1013689|P6|Maintenance Phase|Other|1
309259|NCT00783692|1013690|P5|Maintenance Phase|Other|0
309260|NCT00783692|1013691|P4|Maintenance Phase|Other|1
309261|NCT00783692|1013692|P3|Maintenance Phase|Other|0
309262|NCT00783692|1013693|P2|Maintenance Phase|Other|0
309263|NCT00783692|1013694|P1|Maintenance Phase|Other|0
309264|NCT00783692|1013688|P7|Maintenance Phase|Lost to Follow-up|5
309265|NCT00783692|1013689|P6|Maintenance Phase|Lost to Follow-up|2
309266|NCT00783692|1013690|P5|Maintenance Phase|Lost to Follow-up|3
309267|NCT00783692|1013691|P4|Maintenance Phase|Lost to Follow-up|1
309268|NCT00783692|1013692|P3|Maintenance Phase|Lost to Follow-up|0
309269|NCT00783692|1013693|P2|Maintenance Phase|Lost to Follow-up|0
309270|NCT00783692|1013694|P1|Maintenance Phase|Lost to Follow-up|2
309271|NCT00783692|1013688|P7|Maintenance Phase|Withdrawal by Subject|24
309272|NCT00783692|1013689|P6|Maintenance Phase|Withdrawal by Subject|9
309273|NCT00783692|1013690|P5|Maintenance Phase|Withdrawal by Subject|6
309274|NCT00783692|1013691|P4|Maintenance Phase|Withdrawal by Subject|7
309275|NCT00783692|1013692|P3|Maintenance Phase|Withdrawal by Subject|0
309276|NCT00783692|1013693|P2|Maintenance Phase|Withdrawal by Subject|0
309277|NCT00783692|1013694|P1|Maintenance Phase|Withdrawal by Subject|7
309278|NCT00783692|1013688|P7|Maintenance Phase|Lack of Efficacy|177
309279|NCT00783692|1013689|P6|Maintenance Phase|Lack of Efficacy|48
309280|NCT00783692|1013690|P5|Maintenance Phase|Lack of Efficacy|58
309281|NCT00783692|1013691|P4|Maintenance Phase|Lack of Efficacy|64
309282|NCT00783692|1013692|P3|Maintenance Phase|Lack of Efficacy|0
309283|NCT00783692|1013693|P2|Maintenance Phase|Lack of Efficacy|0
309284|NCT00783692|1013694|P1|Maintenance Phase|Lack of Efficacy|79
309285|NCT00783692|1013688|P7|Maintenance Phase|Protocol Violation|4
309286|NCT00783692|1013689|P6|Maintenance Phase|Protocol Violation|3
309287|NCT00783692|1013690|P5|Maintenance Phase|Protocol Violation|2
309288|NCT00783692|1013691|P4|Maintenance Phase|Protocol Violation|1
309289|NCT00783692|1013692|P3|Maintenance Phase|Protocol Violation|0
309290|NCT00783692|1013693|P2|Maintenance Phase|Protocol Violation|0
309291|NCT00783692|1013694|P1|Maintenance Phase|Protocol Violation|0
309292|NCT00783692|1013688|P7|Maintenance Phase|Adverse Event|38
309293|NCT00783692|1013689|P6|Maintenance Phase|Adverse Event|9
309294|NCT00783692|1013690|P5|Maintenance Phase|Adverse Event|12
309295|NCT00783692|1013691|P4|Maintenance Phase|Adverse Event|15
309296|NCT00783692|1013692|P3|Maintenance Phase|Adverse Event|0
309297|NCT00783692|1013693|P2|Maintenance Phase|Adverse Event|0
309298|NCT00783692|1013694|P1|Maintenance Phase|Adverse Event|7
309299|NCT00783692|1013688|P7|Induction Phase|Other|0
309300|NCT00783692|1013689|P6|Induction Phase|Other|0
309301|NCT00783692|1013690|P5|Induction Phase|Other|0
309302|NCT00783692|1013691|P4|Induction Phase|Other|0
309303|NCT00783692|1013692|P3|Induction Phase|Other|2
309304|NCT00783692|1013693|P2|Induction Phase|Other|0
309305|NCT00783692|1013694|P1|Induction Phase|Other|0
309306|NCT00783692|1013688|P7|Induction Phase|Lost to Follow-up|0
309307|NCT00783692|1013689|P6|Induction Phase|Lost to Follow-up|0
309308|NCT00783692|1013690|P5|Induction Phase|Lost to Follow-up|0
309309|NCT00783692|1013691|P4|Induction Phase|Lost to Follow-up|0
309310|NCT00783692|1013692|P3|Induction Phase|Lost to Follow-up|3
309311|NCT00783692|1013693|P2|Induction Phase|Lost to Follow-up|0
309312|NCT00783692|1013694|P1|Induction Phase|Lost to Follow-up|0
309313|NCT00783692|1013688|P7|Induction Phase|Withdrawal by Subject|0
309314|NCT00783692|1013689|P6|Induction Phase|Withdrawal by Subject|0
309315|NCT00783692|1013690|P5|Induction Phase|Withdrawal by Subject|0
309316|NCT00783692|1013691|P4|Induction Phase|Withdrawal by Subject|0
309317|NCT00783692|1013692|P3|Induction Phase|Withdrawal by Subject|16
309318|NCT00783692|1013693|P2|Induction Phase|Withdrawal by Subject|9
309319|NCT00783692|1013694|P1|Induction Phase|Withdrawal by Subject|3
309320|NCT00783692|1013688|P7|Induction Phase|Lack of Efficacy|0
309321|NCT00783692|1013689|P6|Induction Phase|Lack of Efficacy|0
309322|NCT00783692|1013690|P5|Induction Phase|Lack of Efficacy|0
309323|NCT00783692|1013691|P4|Induction Phase|Lack of Efficacy|0
309324|NCT00783692|1013692|P3|Induction Phase|Lack of Efficacy|28
309325|NCT00783692|1013693|P2|Induction Phase|Lack of Efficacy|3
309326|NCT00783692|1013694|P1|Induction Phase|Lack of Efficacy|1
309327|NCT00783692|1013688|P7|Induction Phase|Protocol Violation|0
309328|NCT00783692|1013689|P6|Induction Phase|Protocol Violation|0
309329|NCT00783692|1013690|P5|Induction Phase|Protocol Violation|0
309330|NCT00783692|1013691|P4|Induction Phase|Protocol Violation|0
309331|NCT00783692|1013692|P3|Induction Phase|Protocol Violation|1
309332|NCT00783692|1013693|P2|Induction Phase|Protocol Violation|0
309333|NCT00783692|1013694|P1|Induction Phase|Protocol Violation|0
309334|NCT00783692|1013688|P7|Induction Phase|Adverse Event|0
309335|NCT00783692|1013689|P6|Induction Phase|Adverse Event|0
309336|NCT00783692|1013690|P5|Induction Phase|Adverse Event|0
309337|NCT00783692|1013691|P4|Induction Phase|Adverse Event|0
309338|NCT00783692|1013692|P3|Induction Phase|Adverse Event|24
309339|NCT00783692|1013693|P2|Induction Phase|Adverse Event|9
309340|NCT00783692|1013694|P1|Induction Phase|Adverse Event|7
309341|NCT00783432|1013736|P2|Overall Study|Protocol Violation|9
309342|NCT00783432|1013737|P1|Overall Study|Protocol Violation|6
309343|NCT00783432|1013736|P2|Overall Study|subject moved|5
309344|NCT00783432|1013737|P1|Overall Study|subject moved|3
309345|NCT00783432|1013736|P2|Overall Study|Withdrawal by Subject|20
309346|NCT00783432|1013737|P1|Overall Study|Withdrawal by Subject|23
309347|NCT00783432|1013736|P2|Overall Study|Lost to Follow-up|6
309348|NCT00783432|1013737|P1|Overall Study|Lost to Follow-up|11
309349|NCT00783432|1013736|P2|Overall Study|Lack of Efficacy|21
309350|NCT00783432|1013737|P1|Overall Study|Lack of Efficacy|20
309351|NCT00783432|1013736|P2|Overall Study|Adverse Event|17
309352|NCT00783432|1013737|P1|Overall Study|Adverse Event|22
309353|NCT00783302|1013747|P1|Overall Study|Withdrawal by Subject|3
309354|NCT00783302|1013747|P1|Overall Study|Physician Decision|1
309355|NCT00783302|1013747|P1|Overall Study|Protocol Violation|3
309356|NCT00783302|1013747|P1|Overall Study|Technical Problems|11
309357|NCT00783302|1013747|P1|Overall Study|Lost to Follow-up|17
309358|NCT00783263|1013769|P4|Overall Study|Withdrawal by Subject|2
309359|NCT00783263|1013770|P3|Overall Study|Withdrawal by Subject|1
309360|NCT00783263|1013771|P2|Overall Study|Withdrawal by Subject|1
309361|NCT00783263|1013772|P1|Overall Study|Withdrawal by Subject|0
309362|NCT00783263|1013769|P4|Overall Study|Lost to Follow-up|0
309363|NCT00783263|1013770|P3|Overall Study|Lost to Follow-up|0
309364|NCT00783263|1013771|P2|Overall Study|Lost to Follow-up|1
309365|NCT00783263|1013772|P1|Overall Study|Lost to Follow-up|1
309366|NCT00783263|1013769|P4|Overall Study|Adverse Event|1
309367|NCT00783263|1013770|P3|Overall Study|Adverse Event|2
309368|NCT00783263|1013771|P2|Overall Study|Adverse Event|0
309369|NCT00783263|1013772|P1|Overall Study|Adverse Event|3
309370|NCT00783224|1013802|P4|Overall Study|Inappropriate as a study subject|1
309371|NCT00783224|1013803|P3|Overall Study|Inappropriate as a study subject|0
309372|NCT00783224|1013804|P2|Overall Study|Inappropriate as a study subject|0
309373|NCT00783224|1013805|P1|Overall Study|Inappropriate as a study subject|0
309374|NCT00783224|1013802|P4|Overall Study|Discarded the Investigational Drug Used|1
309375|NCT00783224|1013803|P3|Overall Study|Discarded the Investigational Drug Used|0
309376|NCT00783224|1013804|P2|Overall Study|Discarded the Investigational Drug Used|0
309377|NCT00783224|1013805|P1|Overall Study|Discarded the Investigational Drug Used|0
309378|NCT00783224|1013802|P4|Overall Study|Adverse Event|0
309379|NCT00783224|1013803|P3|Overall Study|Adverse Event|1
309380|NCT00783224|1013804|P2|Overall Study|Adverse Event|0
309381|NCT00783224|1013805|P1|Overall Study|Adverse Event|0
309382|NCT00783198|1013817|P3|Overall Study|Administrative|2
309383|NCT00783198|1013818|P2|Overall Study|Administrative|1
309384|NCT00783198|1013819|P1|Overall Study|Administrative|2
309385|NCT00783198|1013817|P3|Overall Study|Did not meet protocol eligibility|0
309386|NCT00783198|1013818|P2|Overall Study|Did not meet protocol eligibility|1
309387|NCT00783198|1013819|P1|Overall Study|Did not meet protocol eligibility|0
309388|NCT00783198|1013817|P3|Overall Study|Noncompliance with protocol|10
309389|NCT00783198|1013818|P2|Overall Study|Noncompliance with protocol|7
309390|NCT00783198|1013819|P1|Overall Study|Noncompliance with protocol|7
309391|NCT00783198|1013817|P3|Overall Study|Withdrawal by Subject|20
309392|NCT00783198|1013818|P2|Overall Study|Withdrawal by Subject|14
309393|NCT00783198|1013819|P1|Overall Study|Withdrawal by Subject|22
309394|NCT00783198|1013817|P3|Overall Study|Lost to Follow-up|7
309395|NCT00783198|1013818|P2|Overall Study|Lost to Follow-up|1
309396|NCT00783198|1013819|P1|Overall Study|Lost to Follow-up|11
309397|NCT00783198|1013817|P3|Overall Study|Adverse Event|3
309398|NCT00783198|1013818|P2|Overall Study|Adverse Event|19
309399|NCT00783198|1013819|P1|Overall Study|Adverse Event|15
309400|NCT00783094|1013842|P3|Open-Label Extension Period|Lack of Efficacy|0
309401|NCT00783094|1013843|P2|Open-Label Extension Period|Lack of Efficacy|4
309402|NCT00783094|1013844|P1|Open-Label Extension Period|Lack of Efficacy|1
309403|NCT00783094|1013842|P3|Open-Label Extension Period|Physician Decision|3
309404|NCT00783094|1013843|P2|Open-Label Extension Period|Physician Decision|2
309405|NCT00783094|1013844|P1|Open-Label Extension Period|Physician Decision|4
309406|NCT00783094|1013842|P3|Open-Label Extension Period|Withdrawal by Subject|3
309407|NCT00783094|1013843|P2|Open-Label Extension Period|Withdrawal by Subject|1
309408|NCT00783094|1013844|P1|Open-Label Extension Period|Withdrawal by Subject|1
309409|NCT00783094|1013842|P3|Open-Label Extension Period|Protocol Violation|7
309410|NCT00783094|1013843|P2|Open-Label Extension Period|Protocol Violation|5
309411|NCT00783094|1013844|P1|Open-Label Extension Period|Protocol Violation|4
309412|NCT00783094|1013842|P3|Open-Label Extension Period|Death|1
309413|NCT00783094|1013843|P2|Open-Label Extension Period|Death|0
309414|NCT00783094|1013844|P1|Open-Label Extension Period|Death|0
309415|NCT00783094|1013842|P3|Open-Label Extension Period|Adverse Event|16
309416|NCT00783094|1013843|P2|Open-Label Extension Period|Adverse Event|7
309417|NCT00783094|1013844|P1|Open-Label Extension Period|Adverse Event|12
309418|NCT00783094|1013842|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
309419|NCT00783094|1013843|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
309420|NCT00783094|1013844|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
309421|NCT00783094|1013842|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
309422|NCT00783094|1013843|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
309423|NCT00783094|1013844|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
309424|NCT00783094|1013842|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
309425|NCT00783094|1013843|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
309426|NCT00783094|1013844|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
309427|NCT00783094|1013842|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
309428|NCT00783094|1013843|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
309429|NCT00783094|1013844|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
309430|NCT00783094|1013842|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
309431|NCT00783094|1013843|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
309432|NCT00783094|1013844|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
309433|NCT00782834|1013920|P1|Treatment Phase|fibrous tumor not GIST|1
309434|NCT00782717|1013960|P2|Overall Study|Exited in error|2
309435|NCT00782717|1013961|P1|Overall Study|Exited in error|0
309436|NCT00782717|1013960|P2|Overall Study|Did not meet entrance criteria|3
309437|NCT00782717|1013961|P1|Overall Study|Did not meet entrance criteria|1
309438|NCT00782717|1013960|P2|Overall Study|Enrollment close prior to surgery|0
309439|NCT00782717|1013961|P1|Overall Study|Enrollment close prior to surgery|1
309440|NCT00782717|1013960|P2|Overall Study|Treatment failure|14
309441|NCT00782717|1013961|P1|Overall Study|Treatment failure|3
309442|NCT00782717|1013960|P2|Overall Study|Noncompliance|1
309443|NCT00782717|1013961|P1|Overall Study|Noncompliance|2
309444|NCT00782717|1013960|P2|Overall Study|Patient decision unrelated to AE|3
309445|NCT00782717|1013961|P1|Overall Study|Patient decision unrelated to AE|6
309446|NCT00782717|1013960|P2|Overall Study|Adverse Event|5
309447|NCT00782717|1013961|P1|Overall Study|Adverse Event|2
309448|NCT00782626|1013988|P1|Overall Study|Other Complicating Disease|1
309449|NCT00782626|1013988|P1|Overall Study|Progressive Disease|5
309450|NCT00782626|1013988|P1|Overall Study|Adverse Event|1
309451|NCT00782509|1013995|P3|Overall Study|Lack of Efficacy|2
309452|NCT00782509|1013996|P2|Overall Study|Lack of Efficacy|5
309453|NCT00782509|1013997|P1|Overall Study|Lack of Efficacy|10
309454|NCT00782509|1013995|P3|Overall Study|Other reasons not stated above|3
309455|NCT00782509|1013996|P2|Overall Study|Other reasons not stated above|2
309456|NCT00782509|1013997|P1|Overall Study|Other reasons not stated above|5
309457|NCT00782509|1013995|P3|Overall Study|Non compliance with protocol|0
309458|NCT00782509|1013996|P2|Overall Study|Non compliance with protocol|0
309459|NCT00782509|1013997|P1|Overall Study|Non compliance with protocol|2
309460|NCT00782509|1013995|P3|Overall Study|Withdrawal by Subject|8
309461|NCT00782509|1013996|P2|Overall Study|Withdrawal by Subject|5
309462|NCT00782509|1013997|P1|Overall Study|Withdrawal by Subject|3
309463|NCT00782509|1013995|P3|Overall Study|Lost to Follow-up|3
309464|NCT00782509|1013996|P2|Overall Study|Lost to Follow-up|2
309465|NCT00782509|1013997|P1|Overall Study|Lost to Follow-up|1
309466|NCT00782509|1013995|P3|Overall Study|Adverse Event|20
309467|NCT00782509|1013996|P2|Overall Study|Adverse Event|10
309468|NCT00782509|1013997|P1|Overall Study|Adverse Event|20
309469|NCT00782496|1014190|P2|Overall Study|Lost to Follow-up|15
309470|NCT00782496|1014191|P1|Overall Study|Lost to Follow-up|14
309471|NCT00782483|1014198|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
309472|NCT00782418|1014202|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
309473|NCT00782418|1014203|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
309474|NCT00782418|1014204|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
309475|NCT00782418|1014205|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
309476|NCT00782418|1014206|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
309477|NCT00782418|1014207|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
309478|NCT00782418|1014208|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
309479|NCT00782418|1014202|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
309480|NCT00782418|1014203|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
309481|NCT00782418|1014204|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
309482|NCT00782418|1014205|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
309483|NCT00782418|1014206|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
309484|NCT00782418|1014207|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
309485|NCT00782418|1014208|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
309486|NCT00782340|1014245|P3|Open Label Titration|Randomized in error|0
309487|NCT00782340|1014246|P2|Open Label Titration|Randomized in error|0
309488|NCT00782340|1014247|P1|Open Label Titration|Randomized in error|6
309489|NCT00782340|1014245|P3|Open Label Titration|Lost to Follow-up|0
309490|NCT00782340|1014246|P2|Open Label Titration|Lost to Follow-up|0
309491|NCT00782340|1014247|P1|Open Label Titration|Lost to Follow-up|5
309492|NCT00782340|1014245|P3|Open Label Titration|Did not meet responder criteria|0
309493|NCT00782340|1014246|P2|Open Label Titration|Did not meet responder criteria|0
309494|NCT00782340|1014247|P1|Open Label Titration|Did not meet responder criteria|2
309495|NCT00782340|1014245|P3|Open Label Titration|Enrollment capped|0
309496|NCT00782340|1014246|P2|Open Label Titration|Enrollment capped|0
309497|NCT00782340|1014247|P1|Open Label Titration|Enrollment capped|16
309498|NCT00782340|1014245|P3|Open Label Titration|Withdrawal by Subject|0
309499|NCT00782340|1014246|P2|Open Label Titration|Withdrawal by Subject|0
309500|NCT00782340|1014247|P1|Open Label Titration|Withdrawal by Subject|5
309501|NCT00782340|1014245|P3|Open Label Titration|Protocol Violation|0
309502|NCT00782340|1014246|P2|Open Label Titration|Protocol Violation|0
309503|NCT00782340|1014247|P1|Open Label Titration|Protocol Violation|5
309504|NCT00782340|1014245|P3|Open Label Titration|Treatment failure|0
309505|NCT00782340|1014246|P2|Open Label Titration|Treatment failure|0
309506|NCT00782340|1014247|P1|Open Label Titration|Treatment failure|50
309507|NCT00782340|1014245|P3|Open Label Titration|Adverse Event|0
309508|NCT00782340|1014246|P2|Open Label Titration|Adverse Event|0
309509|NCT00782340|1014247|P1|Open Label Titration|Adverse Event|12
309510|NCT00782210|1014320|P3|Overall Study|Other reason not described above|3
309511|NCT00782210|1014321|P2|Overall Study|Other reason not described above|2
309512|NCT00782210|1014322|P1|Overall Study|Other reason not described above|3
309513|NCT00782210|1014320|P3|Overall Study|Lack of Efficacy|1
309514|NCT00782210|1014321|P2|Overall Study|Lack of Efficacy|4
309515|NCT00782210|1014322|P1|Overall Study|Lack of Efficacy|13
309516|NCT00782210|1014320|P3|Overall Study|Non compliance with protocol|2
309517|NCT00782210|1014321|P2|Overall Study|Non compliance with protocol|3
309518|NCT00782210|1014322|P1|Overall Study|Non compliance with protocol|0
309519|NCT00782210|1014320|P3|Overall Study|Withdrawal by Subject|11
309520|NCT00782210|1014321|P2|Overall Study|Withdrawal by Subject|8
309521|NCT00782210|1014322|P1|Overall Study|Withdrawal by Subject|11
309522|NCT00782210|1014320|P3|Overall Study|Lost to Follow-up|2
309523|NCT00782210|1014321|P2|Overall Study|Lost to Follow-up|1
309524|NCT00782210|1014322|P1|Overall Study|Lost to Follow-up|2
309525|NCT00782210|1014320|P3|Overall Study|Adverse Event|16
309526|NCT00782210|1014321|P2|Overall Study|Adverse Event|17
309527|NCT00782210|1014322|P1|Overall Study|Adverse Event|21
309528|NCT00782184|1014515|P2|Overall Study|Withdrawal by Subject|2
309529|NCT00782184|1014516|P1|Overall Study|Withdrawal by Subject|3
309530|NCT00782184|1014515|P2|Overall Study|Protocol Violation|1
309531|NCT00782184|1014516|P1|Overall Study|Protocol Violation|0
309532|NCT00782184|1014515|P2|Overall Study|Adverse Event|2
309533|NCT00782184|1014516|P1|Overall Study|Adverse Event|1
309534|NCT00782067|1014551|P1|Overall Study|Disease progression|44
309535|NCT00782067|1014551|P1|Overall Study|Withdrawal by Subject|10
309536|NCT00782067|1014551|P1|Overall Study|Adverse Event|28
309537|NCT00782067|1014551|P1|Overall Study|Death|8
309538|NCT00782067|1014551|P1|Overall Study|Protocol deviation|2
309539|NCT00782067|1014551|P1|Overall Study|Lost to Follow-up|1
309540|NCT00782067|1014551|P1|Overall Study|Administrative problems|1
309541|NCT00782067|1014551|P1|Overall Study|Abnormal procedure results|1
309542|NCT00781963|1014561|P3|Overall Study|Refused follow-up|0
309543|NCT00781963|1014562|P2|Overall Study|Refused follow-up|5
309544|NCT00781963|1014563|P1|Overall Study|Refused follow-up|4
309545|NCT00781963|1014561|P3|Overall Study|Withdrawal by Subject|1
309546|NCT00781963|1014562|P2|Overall Study|Withdrawal by Subject|3
309547|NCT00781963|1014563|P1|Overall Study|Withdrawal by Subject|0
309548|NCT00781963|1014561|P3|Overall Study|Lost to Follow-up|1
309549|NCT00781963|1014562|P2|Overall Study|Lost to Follow-up|1
309550|NCT00781963|1014563|P1|Overall Study|Lost to Follow-up|1
309551|NCT00781963|1014561|P3|Overall Study|Death|0
309552|NCT00781963|1014562|P2|Overall Study|Death|0
309553|NCT00781963|1014563|P1|Overall Study|Death|3
309554|NCT00781937|1014584|P2|Follow up Period (Week 56-68)|Unclassified|4
309555|NCT00781937|1014585|P1|Follow up Period (Week 56-68)|Unclassified|5
309556|NCT00781937|1014584|P2|Follow up Period (Week 56-68)|Protocol Violation|1
309557|NCT00781937|1014585|P1|Follow up Period (Week 56-68)|Protocol Violation|1
309558|NCT00781937|1014584|P2|Main Trial Period Through Week 56|Unclassified|15
309559|NCT00781937|1014585|P1|Main Trial Period Through Week 56|Unclassified|10
309560|NCT00781937|1014584|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
309561|NCT00781937|1014585|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
309562|NCT00781937|1014584|P2|Main Trial Period Through Week 56|Protocol Violation|5
309563|NCT00781937|1014585|P1|Main Trial Period Through Week 56|Protocol Violation|8
309564|NCT00781937|1014584|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
309565|NCT00781937|1014585|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
309566|NCT00781937|1014584|P2|Main Trial Period Through Week 56|Adverse Event|18
309567|NCT00781937|1014585|P1|Main Trial Period Through Week 56|Adverse Event|18
309568|NCT00781859|1014643|P2|Overall Study|Death|0
309569|NCT00781859|1014644|P1|Overall Study|Death|3
309570|NCT00781859|1014643|P2|Overall Study|Lost to Follow-up|3
309571|NCT00781859|1014644|P1|Overall Study|Lost to Follow-up|6
309572|NCT00781859|1014643|P2|Overall Study|Withdrawal by Subject|4
309573|NCT00781859|1014644|P1|Overall Study|Withdrawal by Subject|8
309574|NCT00781859|1014643|P2|Overall Study|Adverse Event|2
309575|NCT00781859|1014644|P1|Overall Study|Adverse Event|2
309576|NCT00781599|1014654|P2|Overall Study|Lost to Follow-up|4
309577|NCT00781599|1014655|P1|Overall Study|Lost to Follow-up|7
309578|NCT00781456|1014680|P2|Overall Study|Other Reason, Unknown|1
309579|NCT00781456|1014681|P1|Overall Study|Other Reason, Unknown|0
309580|NCT00781456|1014680|P2|Overall Study|Lost to Follow-up|5
309581|NCT00781456|1014681|P1|Overall Study|Lost to Follow-up|10
309582|NCT00781456|1014680|P2|Overall Study|Noncompliance With Protocol|1
309583|NCT00781456|1014681|P1|Overall Study|Noncompliance With Protocol|1
309584|NCT00781456|1014680|P2|Overall Study|Protocol Violation|1
309585|NCT00781456|1014681|P1|Overall Study|Protocol Violation|4
309586|NCT00781456|1014680|P2|Overall Study|Withdrawal by Subject|5
309587|NCT00781456|1014681|P1|Overall Study|Withdrawal by Subject|3
309588|NCT00781456|1014680|P2|Overall Study|Adverse Event|3
309589|NCT00781456|1014681|P1|Overall Study|Adverse Event|3
309590|NCT00781391|1014704|P3|Overall Study|Lost to Follow-up|1
309591|NCT00781391|1014705|P2|Overall Study|Lost to Follow-up|0
309592|NCT00781391|1014706|P1|Overall Study|Lost to Follow-up|0
309593|NCT00781391|1014704|P3|Overall Study|Withdrawal by Subject|25
309594|NCT00781391|1014705|P2|Overall Study|Withdrawal by Subject|37
309595|NCT00781391|1014706|P1|Overall Study|Withdrawal by Subject|47
309596|NCT00781391|1014704|P3|Overall Study|Death|706
309597|NCT00781391|1014705|P2|Overall Study|Death|730
309598|NCT00781391|1014706|P1|Overall Study|Death|789
309599|NCT00781391|1014704|P3|Overall Study|Protocol Violation|20
309600|NCT00781391|1014705|P2|Overall Study|Protocol Violation|17
309601|NCT00781391|1014706|P1|Overall Study|Protocol Violation|19
309602|NCT00781391|1014704|P3|Overall Study|never received study drug|32
309603|NCT00781391|1014705|P2|Overall Study|never received study drug|23
309604|NCT00781391|1014706|P1|Overall Study|never received study drug|24
309605|NCT00781365|1014740|P2|Overall Study|Language barrier|0
309606|NCT00781365|1014741|P1|Overall Study|Language barrier|1
309607|NCT00781365|1014740|P2|Overall Study|Did Not Attend Visit|28
309608|NCT00781365|1014741|P1|Overall Study|Did Not Attend Visit|20
309609|NCT00781365|1014740|P2|Overall Study|Withdrawal by Subject|8
309610|NCT00781365|1014741|P1|Overall Study|Withdrawal by Subject|13
309611|NCT00781326|1014751|P1|Phase I|Physician Decision|2
309612|NCT00781326|1014751|P1|Phase I|Withdrawal by Subject|1
309613|NCT00781326|1014751|P1|Phase I|Adverse Event|1
309614|NCT00781274|1014755|P1|Overall Study|Withdrawal by Subject|2
309615|NCT00780416|1014761|P2|Overall Study|Withdrawal by Subject|6
309616|NCT00780416|1014762|P1|Overall Study|Withdrawal by Subject|8
309617|NCT00780416|1014761|P2|Overall Study|Protocol Violation|0
309618|NCT00780416|1014762|P1|Overall Study|Protocol Violation|1
309619|NCT00780416|1014761|P2|Overall Study|Physician Decision|3
309620|NCT00780416|1014762|P1|Overall Study|Physician Decision|3
309621|NCT00778375|1014807|P1|Overall Study|Ineligible|3
309622|NCT00780910|1014828|P1|Overall Study|Adverse Event|2
309623|NCT00780273|1014898|P1|Overall Study|Lost to Follow-up|1
309624|NCT00780273|1014898|P1|Overall Study|Death|1
309625|NCT00779857|1014907|P1|Overall Study|Missed Visit|2
309626|NCT00779857|1014907|P1|Overall Study|Withdrawal by Subject|3
309627|NCT00779857|1014907|P1|Overall Study|Death|1
309628|NCT00779779|1014912|P1|Overall Study|Lost to Follow-up|5
309629|NCT00779779|1014912|P1|Overall Study|Withdrawal by Subject|4
309630|NCT00779779|1014912|P1|Overall Study|Protocol Violation|14
309631|NCT00779779|1014912|P1|Overall Study|Adverse Event|1
309632|NCT00779766|1014921|P2|Overall Study|Withdrawal by Subject|67
309633|NCT00779766|1014922|P1|Overall Study|Withdrawal by Subject|84
309634|NCT00779766|1014921|P2|Overall Study|Protocol Violation|1
309635|NCT00779766|1014922|P1|Overall Study|Protocol Violation|1
309636|NCT00779675|1015004|P1|Extended Treatment Period|Lost to Follow-up|6
309637|NCT00779675|1015004|P1|Extended Treatment Period|Protocol defined clinical event|1
309638|NCT00779675|1015004|P1|Extended Treatment Period|Treatment Failure|11
309639|NCT00779675|1015004|P1|Extended Treatment Period|Adverse Event|6
309640|NCT00779675|1015004|P1|Extended Treatment Period|Protocol Violation|13
309641|NCT00779675|1015004|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
309642|NCT00779675|1015004|P1|Treatment Period|Administrative|3
309643|NCT00779675|1015004|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
309644|NCT00779675|1015004|P1|Treatment Period|Protocol Violation|54
309645|NCT00779675|1015004|P1|Treatment Period|Withdrawal by Subject|46
309646|NCT00779675|1015004|P1|Treatment Period|Lost to Follow-up|23
309647|NCT00779675|1015004|P1|Treatment Period|Transferred to Another Study|38
309648|NCT00779675|1015004|P1|Treatment Period|Treatment Failure|80
309649|NCT00779675|1015004|P1|Treatment Period|Adverse Event|87
309650|NCT00779506|1015040|P1|Overall Study|Lost to Follow-up|1
309651|NCT00779506|1015040|P1|Overall Study|Withdrawal by Subject|6
309652|NCT00779506|1015040|P1|Overall Study|Protocol Violation|5
309653|NCT00779506|1015040|P1|Overall Study|Lack of Efficacy|11
309654|NCT00779506|1015040|P1|Overall Study|Adverse Event|4
309655|NCT00779506|1015040|P1|Overall Study|Screening Failed|2
309656|NCT00779467|1015054|P4|Overall Study|unavailable research staff|1
309657|NCT00779467|1015055|P3|Overall Study|unavailable research staff|0
309658|NCT00779467|1015056|P2|Overall Study|unavailable research staff|0
309659|NCT00779467|1015057|P1|Overall Study|unavailable research staff|0
309660|NCT00779467|1015054|P4|Overall Study|technical issue|1
309661|NCT00779467|1015055|P3|Overall Study|technical issue|2
309662|NCT00779467|1015056|P2|Overall Study|technical issue|0
309663|NCT00779467|1015057|P1|Overall Study|technical issue|0
309664|NCT00779467|1015054|P4|Overall Study|missing data|4
309665|NCT00779467|1015055|P3|Overall Study|missing data|1
309666|NCT00779467|1015056|P2|Overall Study|missing data|0
309667|NCT00779467|1015057|P1|Overall Study|missing data|1
309668|NCT00779467|1015054|P4|Overall Study|failed inclusion criteria|2
309669|NCT00779467|1015055|P3|Overall Study|failed inclusion criteria|1
309670|NCT00779467|1015056|P2|Overall Study|failed inclusion criteria|3
309671|NCT00779467|1015057|P1|Overall Study|failed inclusion criteria|3
309672|NCT00779467|1015054|P4|Overall Study|Lack of Efficacy|11
309673|NCT00779467|1015055|P3|Overall Study|Lack of Efficacy|6
309674|NCT00779467|1015056|P2|Overall Study|Lack of Efficacy|2
309675|NCT00779467|1015057|P1|Overall Study|Lack of Efficacy|11
309676|NCT00779259|1015130|P1|Quinine Alone|Adverse Event|2
309677|NCT00779246|1015151|P2|Overall Study|Missing sufficient data for analysis|53
309678|NCT00779246|1015152|P1|Overall Study|Missing sufficient data for analysis|33
309679|NCT00779142|1015167|P1|Overall Study|Screen Failures|3
309680|NCT00779038|1015179|P1|Overall Study|Study Prematurely Terminated|13
309681|NCT00779025|1015188|P1|Overall Study|Withdrawal by Subject|1
309682|NCT00778999|1015199|P2|Overall Study|Did not receive recFSH|20
309683|NCT00778999|1015200|P1|Overall Study|Did not receive recFSH|14
309684|NCT00778999|1015199|P2|Overall Study|Discontinuation: no embryo transfer|14
309685|NCT00778999|1015200|P1|Overall Study|Discontinuation: no embryo transfer|14
309686|NCT00778921|1015209|P3|Overall Study|Not treated|2
309687|NCT00778921|1015210|P2|Overall Study|Not treated|2
309688|NCT00778921|1015211|P1|Overall Study|Not treated|0
309689|NCT00778921|1015209|P3|Overall Study|Protocol Violation|2
309690|NCT00778921|1015210|P2|Overall Study|Protocol Violation|0
309691|NCT00778921|1015211|P1|Overall Study|Protocol Violation|3
309692|NCT00778921|1015209|P3|Overall Study|Administrative Problems|0
309693|NCT00778921|1015210|P2|Overall Study|Administrative Problems|2
309694|NCT00778921|1015211|P1|Overall Study|Administrative Problems|1
309695|NCT00778921|1015209|P3|Overall Study|Lost to Follow-up|1
309696|NCT00778921|1015210|P2|Overall Study|Lost to Follow-up|2
309697|NCT00778921|1015211|P1|Overall Study|Lost to Follow-up|0
309698|NCT00778921|1015209|P3|Overall Study|Patient withdrew request|6
309699|NCT00778921|1015210|P2|Overall Study|Patient withdrew request|1
309700|NCT00778921|1015211|P1|Overall Study|Patient withdrew request|3
309701|NCT00778921|1015209|P3|Overall Study|Patient No Longer Requires Study Drug|0
309702|NCT00778921|1015210|P2|Overall Study|Patient No Longer Requires Study Drug|1
309703|NCT00778921|1015211|P1|Overall Study|Patient No Longer Requires Study Drug|0
309704|NCT00778921|1015209|P3|Overall Study|Unsatisfactory therapeutic response|1
309705|NCT00778921|1015210|P2|Overall Study|Unsatisfactory therapeutic response|1
309706|NCT00778921|1015211|P1|Overall Study|Unsatisfactory therapeutic response|1
309707|NCT00778921|1015209|P3|Overall Study|Abnormal Test Procedure Result(s)|2
309708|NCT00778921|1015210|P2|Overall Study|Abnormal Test Procedure Result(s)|0
309709|NCT00778921|1015211|P1|Overall Study|Abnormal Test Procedure Result(s)|0
309710|NCT00778921|1015209|P3|Overall Study|Abnormal Laboratory Value(s)|0
309711|NCT00778921|1015210|P2|Overall Study|Abnormal Laboratory Value(s)|0
309712|NCT00778921|1015211|P1|Overall Study|Abnormal Laboratory Value(s)|1
309713|NCT00778921|1015209|P3|Overall Study|Adverse Event|14
309714|NCT00778921|1015210|P2|Overall Study|Adverse Event|10
309715|NCT00778921|1015211|P1|Overall Study|Adverse Event|9
309716|NCT00778895|1015228|P3|ESFU Phase|Unspecified|0
309717|NCT00778895|1015229|P2|ESFU Phase|Unspecified|0
309718|NCT00778895|1015230|P1|ESFU Phase|Unspecified|2
309719|NCT00778895|1015228|P3|ESFU Phase|Lost to Follow-up|2
309720|NCT00778895|1015229|P2|ESFU Phase|Lost to Follow-up|7
309721|NCT00778895|1015230|P1|ESFU Phase|Lost to Follow-up|6
309722|NCT00778895|1015228|P3|ESFU Phase|Withdrawal by Subject|0
309723|NCT00778895|1015229|P2|ESFU Phase|Withdrawal by Subject|4
309724|NCT00778895|1015230|P1|ESFU Phase|Withdrawal by Subject|1
309725|NCT00778895|1015228|P3|ESFU Phase|Adverse Event|0
309726|NCT00778895|1015229|P2|ESFU Phase|Adverse Event|1
309727|NCT00778895|1015230|P1|ESFU Phase|Adverse Event|2
309728|NCT00778895|1015228|P3|Active Phase|Unspecified|0
309729|NCT00778895|1015229|P2|Active Phase|Unspecified|0
309730|NCT00778895|1015230|P1|Active Phase|Unspecified|2
309731|NCT00778895|1015228|P3|Active Phase|Lost to Follow-up|0
309732|NCT00778895|1015229|P2|Active Phase|Lost to Follow-up|1
309733|NCT00778895|1015230|P1|Active Phase|Lost to Follow-up|1
309734|NCT00778895|1015228|P3|Active Phase|Withdrawal by Subject|0
309735|NCT00778895|1015229|P2|Active Phase|Withdrawal by Subject|4
309736|NCT00778895|1015230|P1|Active Phase|Withdrawal by Subject|1
309737|NCT00778895|1015228|P3|Active Phase|Adverse Event|0
309738|NCT00778895|1015229|P2|Active Phase|Adverse Event|1
309739|NCT00778895|1015230|P1|Active Phase|Adverse Event|3
309740|NCT00778830|1015274|P2|Overall Study|Ongoing at data cut-off|1
309741|NCT00778830|1015275|P1|Overall Study|Ongoing at data cut-off|0
309742|NCT00778817|1015287|P1|Overall Study|Withdrawal by Subject|2
309743|NCT00778817|1015287|P1|Overall Study|Adverse Event|2
309744|NCT00778622|1015314|P3|Overall Study|unspecified|1
309745|NCT00778622|1015315|P2|Overall Study|unspecified|0
309746|NCT00778622|1015316|P1|Overall Study|unspecified|1
309747|NCT00778622|1015314|P3|Overall Study|immigration|0
309748|NCT00778622|1015315|P2|Overall Study|immigration|0
309749|NCT00778622|1015316|P1|Overall Study|immigration|1
309750|NCT00778622|1015314|P3|Overall Study|Lack of Efficacy|0
309751|NCT00778622|1015315|P2|Overall Study|Lack of Efficacy|0
309752|NCT00778622|1015316|P1|Overall Study|Lack of Efficacy|2
309753|NCT00778622|1015314|P3|Overall Study|Protocol Violation|0
309754|NCT00778622|1015315|P2|Overall Study|Protocol Violation|3
309755|NCT00778622|1015316|P1|Overall Study|Protocol Violation|0
309756|NCT00778622|1015314|P3|Overall Study|Lost to Follow-up|2
309757|NCT00778622|1015315|P2|Overall Study|Lost to Follow-up|3
309758|NCT00778622|1015316|P1|Overall Study|Lost to Follow-up|3
309759|NCT00778622|1015314|P3|Overall Study|Withdrawal by Subject|5
309760|NCT00778622|1015315|P2|Overall Study|Withdrawal by Subject|5
309761|NCT00778622|1015316|P1|Overall Study|Withdrawal by Subject|4
309762|NCT00778622|1015314|P3|Overall Study|Adverse Event|7
309763|NCT00778622|1015315|P2|Overall Study|Adverse Event|4
309764|NCT00778622|1015316|P1|Overall Study|Adverse Event|5
309765|NCT00778336|1015373|P4|3 Month Follow Up|Death|0
309766|NCT00778336|1015374|P3|3 Month Follow Up|Death|2
309767|NCT00778336|1015375|P2|3 Month Follow Up|Death|3
309768|NCT00778336|1015376|P1|3 Month Follow Up|Death|8
309769|NCT00778336|1015373|P4|3 Month Follow Up|Lost to Follow-up|0
309770|NCT00778336|1015374|P3|3 Month Follow Up|Lost to Follow-up|3
309771|NCT00778336|1015375|P2|3 Month Follow Up|Lost to Follow-up|20
309772|NCT00778336|1015376|P1|3 Month Follow Up|Lost to Follow-up|15
309773|NCT00778336|1015373|P4|Index Procedure-Discharge|Death|0
309774|NCT00778336|1015374|P3|Index Procedure-Discharge|Death|2
309775|NCT00778336|1015375|P2|Index Procedure-Discharge|Death|3
309776|NCT00778336|1015376|P1|Index Procedure-Discharge|Death|6
309777|NCT00778258|1015414|P9|Overall Study|Unspecified|0
309778|NCT00778258|1015415|P8|Overall Study|Unspecified|0
309779|NCT00778258|1015416|P7|Overall Study|Unspecified|1
309780|NCT00778258|1015417|P6|Overall Study|Unspecified|0
309781|NCT00778258|1015418|P5|Overall Study|Unspecified|0
309782|NCT00778258|1015419|P4|Overall Study|Unspecified|0
309783|NCT00778258|1015420|P3|Overall Study|Unspecified|0
309784|NCT00778258|1015421|P2|Overall Study|Unspecified|0
309785|NCT00778258|1015422|P1|Overall Study|Unspecified|0
309786|NCT00778258|1015414|P9|Overall Study|Non-compliance|0
309787|NCT00778258|1015415|P8|Overall Study|Non-compliance|0
309788|NCT00778258|1015416|P7|Overall Study|Non-compliance|0
309789|NCT00778258|1015417|P6|Overall Study|Non-compliance|0
309790|NCT00778258|1015418|P5|Overall Study|Non-compliance|0
309791|NCT00778258|1015419|P4|Overall Study|Non-compliance|1
309792|NCT00778258|1015420|P3|Overall Study|Non-compliance|0
309793|NCT00778258|1015421|P2|Overall Study|Non-compliance|0
309794|NCT00778258|1015422|P1|Overall Study|Non-compliance|0
309795|NCT00778258|1015414|P9|Overall Study|New Contraindication|0
309796|NCT00778258|1015415|P8|Overall Study|New Contraindication|1
309797|NCT00778258|1015416|P7|Overall Study|New Contraindication|0
309798|NCT00778258|1015417|P6|Overall Study|New Contraindication|0
309799|NCT00778258|1015418|P5|Overall Study|New Contraindication|0
309800|NCT00778258|1015419|P4|Overall Study|New Contraindication|0
309801|NCT00778258|1015420|P3|Overall Study|New Contraindication|0
309802|NCT00778258|1015421|P2|Overall Study|New Contraindication|0
309803|NCT00778258|1015422|P1|Overall Study|New Contraindication|0
309804|NCT00778258|1015414|P9|Overall Study|Withdrawal by Subject|4
309805|NCT00778258|1015415|P8|Overall Study|Withdrawal by Subject|12
309806|NCT00778258|1015416|P7|Overall Study|Withdrawal by Subject|12
309807|NCT00778258|1015417|P6|Overall Study|Withdrawal by Subject|6
309808|NCT00778258|1015418|P5|Overall Study|Withdrawal by Subject|0
309809|NCT00778258|1015419|P4|Overall Study|Withdrawal by Subject|2
309810|NCT00778258|1015420|P3|Overall Study|Withdrawal by Subject|8
309811|NCT00778258|1015421|P2|Overall Study|Withdrawal by Subject|2
309812|NCT00778258|1015422|P1|Overall Study|Withdrawal by Subject|6
309813|NCT00778258|1015414|P9|Overall Study|Lost to Follow-up|0
309814|NCT00778258|1015415|P8|Overall Study|Lost to Follow-up|2
309815|NCT00778258|1015416|P7|Overall Study|Lost to Follow-up|2
309816|NCT00778258|1015417|P6|Overall Study|Lost to Follow-up|3
309817|NCT00778258|1015418|P5|Overall Study|Lost to Follow-up|0
309818|NCT00778258|1015419|P4|Overall Study|Lost to Follow-up|0
309819|NCT00778258|1015420|P3|Overall Study|Lost to Follow-up|2
309820|NCT00778258|1015421|P2|Overall Study|Lost to Follow-up|0
309821|NCT00778258|1015422|P1|Overall Study|Lost to Follow-up|0
309822|NCT00778258|1015414|P9|Overall Study|Adverse Event|0
309823|NCT00778258|1015415|P8|Overall Study|Adverse Event|0
309824|NCT00778258|1015416|P7|Overall Study|Adverse Event|0
309825|NCT00778258|1015417|P6|Overall Study|Adverse Event|1
309826|NCT00778258|1015418|P5|Overall Study|Adverse Event|0
309827|NCT00778258|1015419|P4|Overall Study|Adverse Event|0
309828|NCT00778258|1015420|P3|Overall Study|Adverse Event|0
309829|NCT00778258|1015421|P2|Overall Study|Adverse Event|0
309830|NCT00778258|1015422|P1|Overall Study|Adverse Event|1
309831|NCT00778102|1015489|P2|Overall Study|Administrative Reason|10
309832|NCT00778102|1015490|P1|Overall Study|Administrative Reason|7
309833|NCT00778102|1015489|P2|Overall Study|Withdrawal by Subject|1
309834|NCT00778102|1015490|P1|Overall Study|Withdrawal by Subject|1
309835|NCT00778102|1015489|P2|Overall Study|Refused Treatment|3
309836|NCT00778102|1015490|P1|Overall Study|Refused Treatment|2
309837|NCT00778102|1015489|P2|Overall Study|Protocol Violation|1
309838|NCT00778102|1015490|P1|Overall Study|Protocol Violation|0
309839|NCT00778102|1015489|P2|Overall Study|Violation of Selection Criteria|1
309840|NCT00778102|1015490|P1|Overall Study|Violation of Selection Criteria|1
309841|NCT00778102|1015489|P2|Overall Study|Lost to Follow-up|0
309842|NCT00778102|1015490|P1|Overall Study|Lost to Follow-up|1
309843|NCT00778102|1015489|P2|Overall Study|Death|1
309844|NCT00778102|1015490|P1|Overall Study|Death|1
309845|NCT00778102|1015489|P2|Overall Study|Adverse Event|5
309846|NCT00778102|1015490|P1|Overall Study|Adverse Event|8
309847|NCT00777946|1015525|P3|Overall Study|Randomized in error|0
309848|NCT00777946|1015526|P2|Overall Study|Randomized in error|1
309849|NCT00777946|1015527|P1|Overall Study|Randomized in error|1
309850|NCT00777946|1015525|P3|Overall Study|Protocol deviation|1
309851|NCT00777946|1015526|P2|Overall Study|Protocol deviation|1
309852|NCT00777946|1015527|P1|Overall Study|Protocol deviation|2
309853|NCT00777946|1015525|P3|Overall Study|Lost to Follow-up|0
309854|NCT00777946|1015526|P2|Overall Study|Lost to Follow-up|1
309855|NCT00777946|1015527|P1|Overall Study|Lost to Follow-up|3
309856|NCT00777946|1015525|P3|Overall Study|Patient withdrew consent|3
309857|NCT00777946|1015526|P2|Overall Study|Patient withdrew consent|2
309858|NCT00777946|1015527|P1|Overall Study|Patient withdrew consent|3
309859|NCT00777946|1015525|P3|Overall Study|Condition no longer required study drug|0
309860|NCT00777946|1015526|P2|Overall Study|Condition no longer required study drug|0
309861|NCT00777946|1015527|P1|Overall Study|Condition no longer required study drug|1
309862|NCT00777946|1015525|P3|Overall Study|Lack of Efficacy|9
309863|NCT00777946|1015526|P2|Overall Study|Lack of Efficacy|0
309864|NCT00777946|1015527|P1|Overall Study|Lack of Efficacy|0
309865|NCT00777946|1015525|P3|Overall Study|Adverse Event|3
309866|NCT00777946|1015526|P2|Overall Study|Adverse Event|1
309867|NCT00777946|1015527|P1|Overall Study|Adverse Event|11
309868|NCT00777803|1015562|P2|Overall Study|Non-compliance|2
309869|NCT00777803|1015563|P1|Overall Study|Non-compliance|2
309870|NCT00777803|1015562|P2|Overall Study|Adverse Event|0
309871|NCT00777803|1015563|P1|Overall Study|Adverse Event|1
309872|NCT00777803|1015562|P2|Overall Study|Lost to Follow-up|5
309873|NCT00777803|1015563|P1|Overall Study|Lost to Follow-up|12
309874|NCT00777608|1015642|P2|Overall Study|Investigator Decision|2
309875|NCT00777608|1015643|P1|Overall Study|Investigator Decision|1
309876|NCT00777608|1015642|P2|Overall Study|Protocol Violation|0
309877|NCT00777608|1015643|P1|Overall Study|Protocol Violation|1
309878|NCT00777608|1015642|P2|Overall Study|Withdrawal by Subject|3
309879|NCT00777608|1015643|P1|Overall Study|Withdrawal by Subject|1
309880|NCT00777608|1015642|P2|Overall Study|Lost to Follow-up|1
309881|NCT00777608|1015643|P1|Overall Study|Lost to Follow-up|1
309882|NCT00777556|1015653|P1|Overall Study|Did not complete all 3 follow-up visits|20
309883|NCT00777556|1015653|P1|Overall Study|Dispensed but did not use product|12
309884|NCT00777556|1015653|P1|Overall Study|Inappropriate self-selection|34
309885|NCT00776659|1015671|P1|Overall Study|Study Terminated by Sponsor|1
309886|NCT00776659|1015671|P1|Overall Study|Withdrawal by Subject|10
309887|NCT00776659|1015671|P1|Overall Study|Lost to Follow-up|15
309888|NCT00776555|1015698|P2|Overall Study|Study terminated|0
309889|NCT00776555|1015699|P1|Overall Study|Study terminated|3
309890|NCT00777257|1015712|P3|Overall Study|Withdrawal by Subject|5
309891|NCT00777257|1015713|P2|Overall Study|Withdrawal by Subject|6
309892|NCT00777257|1015714|P1|Overall Study|Withdrawal by Subject|3
309893|NCT00777257|1015712|P3|Overall Study|Protocol Violation|2
309894|NCT00777257|1015713|P2|Overall Study|Protocol Violation|2
309895|NCT00777257|1015714|P1|Overall Study|Protocol Violation|2
309896|NCT00777257|1015712|P3|Overall Study|Lost to Follow-up|2
309897|NCT00777257|1015713|P2|Overall Study|Lost to Follow-up|3
309898|NCT00777257|1015714|P1|Overall Study|Lost to Follow-up|3
309899|NCT00777257|1015712|P3|Overall Study|Adverse Event|0
309900|NCT00777257|1015713|P2|Overall Study|Adverse Event|1
309901|NCT00777257|1015714|P1|Overall Study|Adverse Event|3
309902|NCT00777205|1015733|P2|Overall Study|Protocol Violation|56
309903|NCT00777205|1015734|P1|Overall Study|Protocol Violation|0
309904|NCT00777205|1015733|P2|Overall Study|Death|2
309905|NCT00777205|1015734|P1|Overall Study|Death|0
309906|NCT00777205|1015733|P2|Overall Study|Withdrawal by Subject|4
309907|NCT00777205|1015734|P1|Overall Study|Withdrawal by Subject|6
309908|NCT00777205|1015733|P2|Overall Study|Lost to Follow-up|9
309909|NCT00777205|1015734|P1|Overall Study|Lost to Follow-up|25
309910|NCT00777153|1015768|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
309911|NCT00777153|1015769|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
309912|NCT00777153|1015770|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
309913|NCT00777153|1015768|P3|Overall Study|Withdrawal by Subject|3
309914|NCT00777153|1015769|P2|Overall Study|Withdrawal by Subject|4
309915|NCT00777153|1015770|P1|Overall Study|Withdrawal by Subject|3
309916|NCT00777153|1015768|P3|Overall Study|Death|33
309917|NCT00777153|1015769|P2|Overall Study|Death|73
309918|NCT00777153|1015770|P1|Overall Study|Death|85
309919|NCT00777153|1015768|P3|Overall Study|Lost to Follow-up|0
309920|NCT00777153|1015769|P2|Overall Study|Lost to Follow-up|1
309921|NCT00777153|1015770|P1|Overall Study|Lost to Follow-up|1
309922|NCT00777049|1015806|P2|Overall Study|No treatment (elevated liver enzymes)|1
309923|NCT00777049|1015807|P1|Overall Study|No treatment (elevated liver enzymes)|0
309924|NCT00777049|1015806|P2|Overall Study|Withdrawal by Subject|0
309925|NCT00777049|1015807|P1|Overall Study|Withdrawal by Subject|1
309926|NCT00777023|1015816|P3|Overall Study|Last dose date unknown|1
309927|NCT00777023|1015817|P2|Overall Study|Last dose date unknown|3
309928|NCT00777023|1015818|P1|Overall Study|Last dose date unknown|3
309929|NCT00777023|1015816|P3|Overall Study|Reasons not specified|2
309930|NCT00777023|1015817|P2|Overall Study|Reasons not specified|4
309931|NCT00777023|1015818|P1|Overall Study|Reasons not specified|4
309932|NCT00777023|1015816|P3|Overall Study|Missing data|0
309933|NCT00777023|1015817|P2|Overall Study|Missing data|1
309934|NCT00777023|1015818|P1|Overall Study|Missing data|1
309935|NCT00777023|1015816|P3|Overall Study|Withdrawal by Subject|8
309936|NCT00777023|1015817|P2|Overall Study|Withdrawal by Subject|7
309937|NCT00777023|1015818|P1|Overall Study|Withdrawal by Subject|7
309938|NCT00777023|1015816|P3|Overall Study|Death|0
309939|NCT00777023|1015817|P2|Overall Study|Death|1
309940|NCT00777023|1015818|P1|Overall Study|Death|0
309941|NCT00777023|1015816|P3|Overall Study|Lost to Follow-up|3
309942|NCT00777023|1015817|P2|Overall Study|Lost to Follow-up|3
309943|NCT00777023|1015818|P1|Overall Study|Lost to Follow-up|2
309944|NCT00777023|1015816|P3|Overall Study|Protocol Violation|1
309945|NCT00777023|1015817|P2|Overall Study|Protocol Violation|1
309946|NCT00777023|1015818|P1|Overall Study|Protocol Violation|2
309947|NCT00777023|1015816|P3|Overall Study|Lack of Efficacy|14
309948|NCT00777023|1015817|P2|Overall Study|Lack of Efficacy|0
309949|NCT00777023|1015818|P1|Overall Study|Lack of Efficacy|1
309950|NCT00777023|1015816|P3|Overall Study|Adverse Event|8
309951|NCT00777023|1015817|P2|Overall Study|Adverse Event|21
309952|NCT00777023|1015818|P1|Overall Study|Adverse Event|15
309953|NCT00776997|1015835|P1|Overall Study|Adverse Event|2
309954|NCT00776984|1015844|P2|Overall Study|Other|9
309955|NCT00776984|1015845|P1|Overall Study|Other|5
309956|NCT00776984|1015844|P2|Overall Study|Lack of Efficacy|1
309957|NCT00776984|1015845|P1|Overall Study|Lack of Efficacy|0
309958|NCT00776984|1015844|P2|Overall Study|Withdrawal by Subject|7
309959|NCT00776984|1015845|P1|Overall Study|Withdrawal by Subject|12
309960|NCT00776984|1015844|P2|Overall Study|Lost to Follow-up|0
309961|NCT00776984|1015845|P1|Overall Study|Lost to Follow-up|2
309962|NCT00776984|1015844|P2|Overall Study|Protocol Violation|2
309963|NCT00776984|1015845|P1|Overall Study|Protocol Violation|4
309964|NCT00776984|1015844|P2|Overall Study|Adverse Event|2
309965|NCT00776984|1015845|P1|Overall Study|Adverse Event|8
309966|NCT00776919|1015919|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
309967|NCT00776919|1015920|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
309968|NCT00776919|1015921|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
309969|NCT00776919|1015922|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
309970|NCT00776919|1015919|P4|Overall Study|Protocol Violation|1
309971|NCT00776919|1015920|P3|Overall Study|Protocol Violation|0
309972|NCT00776919|1015921|P2|Overall Study|Protocol Violation|2
309973|NCT00776919|1015922|P1|Overall Study|Protocol Violation|1
309974|NCT00776919|1015919|P4|Overall Study|Adverse Event|2
309975|NCT00776919|1015920|P3|Overall Study|Adverse Event|2
309976|NCT00776919|1015921|P2|Overall Study|Adverse Event|0
309977|NCT00776919|1015922|P1|Overall Study|Adverse Event|1
309978|NCT00776919|1015919|P4|Overall Study|Lost to Follow-up|8
309979|NCT00776919|1015920|P3|Overall Study|Lost to Follow-up|11
309980|NCT00776919|1015921|P2|Overall Study|Lost to Follow-up|12
309981|NCT00776919|1015922|P1|Overall Study|Lost to Follow-up|8
309982|NCT00776919|1015919|P4|Overall Study|Withdrawal by Subject|26
309983|NCT00776919|1015920|P3|Overall Study|Withdrawal by Subject|15
309984|NCT00776919|1015921|P2|Overall Study|Withdrawal by Subject|14
309985|NCT00776919|1015922|P1|Overall Study|Withdrawal by Subject|16
309986|NCT00776789|1015986|P2|Overall Study|Poor quality video|1
309987|NCT00776789|1015987|P1|Overall Study|Poor quality video|1
309988|NCT00776789|1015986|P2|Overall Study|Consent refusal|2
309989|NCT00776789|1015987|P1|Overall Study|Consent refusal|2
309990|NCT00776230|1016007|P3|Overall Study|Subject missed Visit 4|0
309991|NCT00776230|1016008|P2|Overall Study|Subject missed Visit 4|1
309992|NCT00776230|1016009|P1|Overall Study|Subject missed Visit 4|0
309993|NCT00776230|1016007|P3|Overall Study|Withdrawal by Subject|0
309994|NCT00776230|1016008|P2|Overall Study|Withdrawal by Subject|1
309995|NCT00776230|1016009|P1|Overall Study|Withdrawal by Subject|0
309996|NCT00776230|1016007|P3|Overall Study|Not vaccinated at Day 0|0
309997|NCT00776230|1016008|P2|Overall Study|Not vaccinated at Day 0|0
309998|NCT00776230|1016009|P1|Overall Study|Not vaccinated at Day 0|1
309999|NCT00776230|1016007|P3|Overall Study|Lost to Follow-up|5
310000|NCT00776230|1016008|P2|Overall Study|Lost to Follow-up|1
310001|NCT00776230|1016009|P1|Overall Study|Lost to Follow-up|2
310002|NCT00776100|1016019|P2|Overall Study|Disease Progression|0
310003|NCT00776100|1016020|P1|Overall Study|Disease Progression|1
310004|NCT00776009|1016042|P6|Period 3: Third Intervention|Withdrawal by Subject|0
310005|NCT00776009|1016043|P5|Period 3: Third Intervention|Withdrawal by Subject|0
310006|NCT00776009|1016044|P4|Period 3: Third Intervention|Withdrawal by Subject|0
310007|NCT00776009|1016045|P3|Period 3: Third Intervention|Withdrawal by Subject|0
310008|NCT00776009|1016046|P2|Period 3: Third Intervention|Withdrawal by Subject|0
310009|NCT00776009|1016047|P1|Period 3: Third Intervention|Withdrawal by Subject|1
310010|NCT00776009|1016042|P6|Period 2: Second Intervention|Protocol Violation|0
310011|NCT00776009|1016043|P5|Period 2: Second Intervention|Protocol Violation|0
310012|NCT00776009|1016044|P4|Period 2: Second Intervention|Protocol Violation|0
310013|NCT00776009|1016045|P3|Period 2: Second Intervention|Protocol Violation|1
310014|NCT00776009|1016046|P2|Period 2: Second Intervention|Protocol Violation|0
310015|NCT00776009|1016047|P1|Period 2: Second Intervention|Protocol Violation|1
310016|NCT00776009|1016042|P6|Period 2: Second Intervention|Withdrawal by Subject|1
310017|NCT00776009|1016043|P5|Period 2: Second Intervention|Withdrawal by Subject|0
310018|NCT00776009|1016044|P4|Period 2: Second Intervention|Withdrawal by Subject|0
310019|NCT00776009|1016045|P3|Period 2: Second Intervention|Withdrawal by Subject|0
310020|NCT00776009|1016046|P2|Period 2: Second Intervention|Withdrawal by Subject|0
310021|NCT00776009|1016047|P1|Period 2: Second Intervention|Withdrawal by Subject|0
310022|NCT00776009|1016042|P6|Period 1: First Intervention|Protocol Violation|0
310023|NCT00776009|1016043|P5|Period 1: First Intervention|Protocol Violation|1
310024|NCT00776009|1016044|P4|Period 1: First Intervention|Protocol Violation|0
310025|NCT00776009|1016045|P3|Period 1: First Intervention|Protocol Violation|0
310026|NCT00776009|1016046|P2|Period 1: First Intervention|Protocol Violation|1
310027|NCT00776009|1016047|P1|Period 1: First Intervention|Protocol Violation|0
310028|NCT00776009|1016042|P6|Period 1: First Intervention|Withdrawal by Subject|0
310029|NCT00776009|1016043|P5|Period 1: First Intervention|Withdrawal by Subject|1
310030|NCT00776009|1016044|P4|Period 1: First Intervention|Withdrawal by Subject|0
310031|NCT00776009|1016045|P3|Period 1: First Intervention|Withdrawal by Subject|1
310032|NCT00776009|1016046|P2|Period 1: First Intervention|Withdrawal by Subject|0
310033|NCT00776009|1016047|P1|Period 1: First Intervention|Withdrawal by Subject|0
310034|NCT00775983|1016069|P2|Overall Study|Protocol Violation|2
310035|NCT00775983|1016070|P1|Overall Study|Protocol Violation|1
310036|NCT00775606|1016137|P2|Overall Study|Study sponsor terminated funding|0
310037|NCT00775606|1016138|P1|Overall Study|Study sponsor terminated funding|3
310038|NCT00775593|1016148|P1|Overall Study|Death|1
310039|NCT00775593|1016148|P1|Overall Study|Unmet eligibility criteria|6
310040|NCT00775528|1016155|P1|Overall Study|Protocol Violation|1
310041|NCT00775463|1016164|P2|Overall Study|Lack of Efficacy|1
310042|NCT00775463|1016165|P1|Overall Study|Lack of Efficacy|1
310043|NCT00775463|1016164|P2|Overall Study|Lost to Follow-up|0
310044|NCT00775463|1016165|P1|Overall Study|Lost to Follow-up|1
310045|NCT00775463|1016164|P2|Overall Study|Protocol Violation|2
310046|NCT00775463|1016165|P1|Overall Study|Protocol Violation|2
310047|NCT00775463|1016164|P2|Overall Study|Adverse Event|9
310048|NCT00775463|1016165|P1|Overall Study|Adverse Event|7
310049|NCT00775463|1016164|P2|Overall Study|Withdrawal by Subject|1
310050|NCT00775463|1016165|P1|Overall Study|Withdrawal by Subject|0
310051|NCT00775450|1016202|P5|Overall Study|Withdrawal by Subject|1
310052|NCT00775450|1016203|P4|Overall Study|Withdrawal by Subject|0
310053|NCT00775450|1016204|P3|Overall Study|Withdrawal by Subject|0
310054|NCT00775450|1016205|P2|Overall Study|Withdrawal by Subject|0
310055|NCT00775450|1016206|P1|Overall Study|Withdrawal by Subject|1
310056|NCT00775450|1016202|P5|Overall Study|Protocol Violation|1
310057|NCT00775450|1016203|P4|Overall Study|Protocol Violation|0
310058|NCT00775450|1016204|P3|Overall Study|Protocol Violation|0
310059|NCT00775450|1016205|P2|Overall Study|Protocol Violation|0
310060|NCT00775450|1016206|P1|Overall Study|Protocol Violation|0
310061|NCT00775450|1016202|P5|Overall Study|Serious Adverse Event|0
310062|NCT00775450|1016203|P4|Overall Study|Serious Adverse Event|0
310063|NCT00775450|1016204|P3|Overall Study|Serious Adverse Event|0
310064|NCT00775450|1016205|P2|Overall Study|Serious Adverse Event|0
310065|NCT00775450|1016206|P1|Overall Study|Serious Adverse Event|2
310066|NCT00775437|1016233|P1|Overall Study|Lost to Follow-up|1
310067|NCT00775437|1016233|P1|Overall Study|Withdrawal by Subject|3
310068|NCT00775437|1016233|P1|Overall Study|Loss of efficacy|2
310069|NCT00775203|1016308|P2|Overall Study|Physician Decision|1
310070|NCT00775203|1016309|P1|Overall Study|Physician Decision|0
310071|NCT00775203|1016308|P2|Overall Study|Entered other study|0
310072|NCT00775203|1016309|P1|Overall Study|Entered other study|1
310073|NCT00775203|1016308|P2|Overall Study|Protocol Violation|1
310074|NCT00775203|1016309|P1|Overall Study|Protocol Violation|0
310075|NCT00775203|1016308|P2|Overall Study|Noncompliance|2
310076|NCT00775203|1016309|P1|Overall Study|Noncompliance|4
310077|NCT00775203|1016308|P2|Overall Study|Administrative reason|0
310078|NCT00775203|1016309|P1|Overall Study|Administrative reason|2
310079|NCT00775203|1016308|P2|Overall Study|Lost to Follow-up|15
310080|NCT00775203|1016309|P1|Overall Study|Lost to Follow-up|11
310081|NCT00775203|1016308|P2|Overall Study|Withdrawal by Subject|9
310082|NCT00775203|1016309|P1|Overall Study|Withdrawal by Subject|11
310083|NCT00775203|1016308|P2|Overall Study|Lack of Efficacy|9
310084|NCT00775203|1016309|P1|Overall Study|Lack of Efficacy|8
310085|NCT00775203|1016308|P2|Overall Study|Adverse Event|6
310086|NCT00775203|1016309|P1|Overall Study|Adverse Event|25
310087|NCT00775190|1016343|P2|Overall Study|Protocol Violation|0
310088|NCT00775190|1016344|P1|Overall Study|Protocol Violation|1
310089|NCT00775190|1016343|P2|Overall Study|Withdrawal by Subject|2
310090|NCT00775190|1016344|P1|Overall Study|Withdrawal by Subject|1
310091|NCT00775190|1016343|P2|Overall Study|Lost to Follow-up|3
310092|NCT00775190|1016344|P1|Overall Study|Lost to Follow-up|2
310093|NCT00775021|1016366|P2|Second Intervention|Adverse Event|1
310094|NCT00775021|1016367|P1|Second Intervention|Adverse Event|0
310095|NCT00775021|1016366|P2|First Intervention|Lost to Follow-up|0
310096|NCT00775021|1016367|P1|First Intervention|Lost to Follow-up|1
310097|NCT00774995|1016385|P4|Overall Study|Protocol Violation|0
310098|NCT00774995|1016386|P3|Overall Study|Protocol Violation|1
310099|NCT00774995|1016387|P2|Overall Study|Protocol Violation|0
310100|NCT00774995|1016388|P1|Overall Study|Protocol Violation|0
310101|NCT00774930|1016428|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
310102|NCT00774930|1016429|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
310103|NCT00774930|1016428|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
310104|NCT00774930|1016429|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
310105|NCT00774930|1016428|P2|LTOLE Phase|Disease Progression|5
310106|NCT00774930|1016429|P1|LTOLE Phase|Disease Progression|2
310107|NCT00774930|1016428|P2|LTOLE Phase|Sponsor decision|1
310108|NCT00774930|1016429|P1|LTOLE Phase|Sponsor decision|2
310109|NCT00774930|1016428|P2|LTOLE Phase|Physician Decision|1
310110|NCT00774930|1016429|P1|LTOLE Phase|Physician Decision|4
310111|NCT00774930|1016428|P2|LTOLE Phase|Subject decision|5
310112|NCT00774930|1016429|P1|LTOLE Phase|Subject decision|0
310113|NCT00774930|1016428|P2|LTOLE Phase|Adverse Event|3
310114|NCT00774930|1016429|P1|LTOLE Phase|Adverse Event|7
310115|NCT00774930|1016428|P2|IOL Phase|Brain radiation|1
310116|NCT00774930|1016429|P1|IOL Phase|Brain radiation|0
310117|NCT00774930|1016428|P2|IOL Phase|Unspecified|0
310118|NCT00774930|1016429|P1|IOL Phase|Unspecified|1
310119|NCT00774930|1016428|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
310120|NCT00774930|1016429|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
310121|NCT00774930|1016428|P2|IOL Phase|Subject Consumed Prohibited Medication|0
310122|NCT00774930|1016429|P1|IOL Phase|Subject Consumed Prohibited Medication|1
310123|NCT00774930|1016428|P2|IOL Phase|Disease Progression|1
310124|NCT00774930|1016429|P1|IOL Phase|Disease Progression|2
310125|NCT00774930|1016428|P2|IOL Phase|Sponsor Decision|0
310126|NCT00774930|1016429|P1|IOL Phase|Sponsor Decision|1
310127|NCT00774930|1016428|P2|IOL Phase|Physician Decision|2
310128|NCT00774930|1016429|P1|IOL Phase|Physician Decision|3
310129|NCT00774930|1016428|P2|IOL Phase|Subject Decision|3
310130|NCT00774930|1016429|P1|IOL Phase|Subject Decision|4
310131|NCT00774930|1016428|P2|IOL Phase|Adverse Event|1
310132|NCT00774930|1016429|P1|IOL Phase|Adverse Event|1
310133|NCT00774930|1016428|P2|DB Phase|Started Nonprotocol Radiation therapy|1
310134|NCT00774930|1016429|P1|DB Phase|Started Nonprotocol Radiation therapy|0
310135|NCT00774930|1016428|P2|DB Phase|Disease Progression|1
310136|NCT00774930|1016429|P1|DB Phase|Disease Progression|1
310137|NCT00774930|1016428|P2|DB Phase|Sponsor Decision|1
310138|NCT00774930|1016429|P1|DB Phase|Sponsor Decision|0
310139|NCT00774930|1016428|P2|DB Phase|Subject Decision|5
310140|NCT00774930|1016429|P1|DB Phase|Subject Decision|1
310141|NCT00774930|1016428|P2|DB Phase|Adverse Event|2
310142|NCT00774930|1016429|P1|DB Phase|Adverse Event|1
310143|NCT00774930|1016428|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
310144|NCT00774930|1016429|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
310145|NCT00774852|1016457|P2|Overall Study|Subject received prohibited medication|0
310146|NCT00774852|1016458|P1|Overall Study|Subject received prohibited medication|1
310147|NCT00774852|1016457|P2|Overall Study|Protocol Violation|0
310148|NCT00774852|1016458|P1|Overall Study|Protocol Violation|1
310149|NCT00774852|1016457|P2|Overall Study|Subject non-compliance|1
310150|NCT00774852|1016458|P1|Overall Study|Subject non-compliance|0
310151|NCT00774852|1016457|P2|Overall Study|Non-responder|11
310152|NCT00774852|1016458|P1|Overall Study|Non-responder|15
310153|NCT00774852|1016457|P2|Overall Study|Withdrawal by Subject|2
310154|NCT00774852|1016458|P1|Overall Study|Withdrawal by Subject|2
310155|NCT00774852|1016457|P2|Overall Study|Pregnancy|2
310156|NCT00774852|1016458|P1|Overall Study|Pregnancy|1
310157|NCT00774852|1016457|P2|Overall Study|Physician Decision|6
310158|NCT00774852|1016458|P1|Overall Study|Physician Decision|2
310159|NCT00774852|1016457|P2|Overall Study|Lost to Follow-up|5
310160|NCT00774852|1016458|P1|Overall Study|Lost to Follow-up|9
310161|NCT00774852|1016457|P2|Overall Study|Lack of Efficacy|7
310162|NCT00774852|1016458|P1|Overall Study|Lack of Efficacy|3
310163|NCT00774852|1016457|P2|Overall Study|Death|1
310164|NCT00774852|1016458|P1|Overall Study|Death|2
310165|NCT00774852|1016457|P2|Overall Study|Adverse Event|6
310166|NCT00774852|1016458|P1|Overall Study|Adverse Event|9
310167|NCT00774800|1016506|P1|Intervention 4|Withdrawal by Subject|1
310168|NCT00774787|1016528|P1|Overall Study|Lost to Follow-up|1
310169|NCT00774748|1016535|P1|Overall Study|Lost to Follow-up|3
310170|NCT00774397|1016550|P7|Overall Study|Other than those stated above|1
310171|NCT00774397|1016551|P6|Overall Study|Other than those stated above|0
310172|NCT00774397|1016552|P5|Overall Study|Other than those stated above|2
310173|NCT00774397|1016553|P4|Overall Study|Other than those stated above|2
310174|NCT00774397|1016554|P3|Overall Study|Other than those stated above|3
310175|NCT00774397|1016555|P2|Overall Study|Other than those stated above|1
310176|NCT00774397|1016556|P1|Overall Study|Other than those stated above|1
310177|NCT00774397|1016550|P7|Overall Study|Not treated|1
310178|NCT00774397|1016551|P6|Overall Study|Not treated|0
310179|NCT00774397|1016552|P5|Overall Study|Not treated|1
310180|NCT00774397|1016553|P4|Overall Study|Not treated|0
310181|NCT00774397|1016554|P3|Overall Study|Not treated|0
310182|NCT00774397|1016555|P2|Overall Study|Not treated|0
310183|NCT00774397|1016556|P1|Overall Study|Not treated|0
310184|NCT00774397|1016550|P7|Overall Study|Refused to continue trial medication|3
310185|NCT00774397|1016551|P6|Overall Study|Refused to continue trial medication|2
310186|NCT00774397|1016552|P5|Overall Study|Refused to continue trial medication|6
310187|NCT00774397|1016553|P4|Overall Study|Refused to continue trial medication|2
310188|NCT00774397|1016554|P3|Overall Study|Refused to continue trial medication|2
310189|NCT00774397|1016555|P2|Overall Study|Refused to continue trial medication|3
310190|NCT00774397|1016556|P1|Overall Study|Refused to continue trial medication|1
310191|NCT00774397|1016550|P7|Overall Study|Lost to Follow-up|0
310192|NCT00774397|1016551|P6|Overall Study|Lost to Follow-up|1
310193|NCT00774397|1016552|P5|Overall Study|Lost to Follow-up|0
310194|NCT00774397|1016553|P4|Overall Study|Lost to Follow-up|1
310195|NCT00774397|1016554|P3|Overall Study|Lost to Follow-up|1
310196|NCT00774397|1016555|P2|Overall Study|Lost to Follow-up|1
310197|NCT00774397|1016556|P1|Overall Study|Lost to Follow-up|0
310198|NCT00774397|1016550|P7|Overall Study|Protocol Violation|0
310199|NCT00774397|1016551|P6|Overall Study|Protocol Violation|1
310200|NCT00774397|1016552|P5|Overall Study|Protocol Violation|2
310201|NCT00774397|1016553|P4|Overall Study|Protocol Violation|1
310202|NCT00774397|1016554|P3|Overall Study|Protocol Violation|3
310203|NCT00774397|1016555|P2|Overall Study|Protocol Violation|1
310204|NCT00774397|1016556|P1|Overall Study|Protocol Violation|0
310205|NCT00774397|1016550|P7|Overall Study|Lack of Efficacy|9
310206|NCT00774397|1016551|P6|Overall Study|Lack of Efficacy|15
310207|NCT00774397|1016552|P5|Overall Study|Lack of Efficacy|27
310208|NCT00774397|1016553|P4|Overall Study|Lack of Efficacy|3
310209|NCT00774397|1016554|P3|Overall Study|Lack of Efficacy|5
310210|NCT00774397|1016555|P2|Overall Study|Lack of Efficacy|4
310211|NCT00774397|1016556|P1|Overall Study|Lack of Efficacy|11
310212|NCT00774397|1016550|P7|Overall Study|Adverse Event|16
310213|NCT00774397|1016551|P6|Overall Study|Adverse Event|3
310214|NCT00774397|1016552|P5|Overall Study|Adverse Event|8
310215|NCT00774397|1016553|P4|Overall Study|Adverse Event|8
310216|NCT00774397|1016554|P3|Overall Study|Adverse Event|16
310217|NCT00774397|1016555|P2|Overall Study|Adverse Event|3
310218|NCT00774397|1016556|P1|Overall Study|Adverse Event|1
310219|NCT00774306|1016792|P4|Overall Study|Death|0
310220|NCT00774306|1016793|P3|Overall Study|Death|0
310221|NCT00774306|1016794|P2|Overall Study|Death|1
310222|NCT00774306|1016795|P1|Overall Study|Death|1
310223|NCT00774306|1016792|P4|Overall Study|Lost to Follow-up|5
310224|NCT00774306|1016793|P3|Overall Study|Lost to Follow-up|4
310225|NCT00774306|1016794|P2|Overall Study|Lost to Follow-up|0
310226|NCT00774306|1016795|P1|Overall Study|Lost to Follow-up|6
310227|NCT00774306|1016792|P4|Overall Study|Withdrawal by Subject|0
310228|NCT00774306|1016793|P3|Overall Study|Withdrawal by Subject|1
310229|NCT00774306|1016794|P2|Overall Study|Withdrawal by Subject|1
310230|NCT00774306|1016795|P1|Overall Study|Withdrawal by Subject|6
310231|NCT00774306|1016792|P4|Overall Study|Protocol Violation|0
310232|NCT00774306|1016793|P3|Overall Study|Protocol Violation|3
310233|NCT00774306|1016794|P2|Overall Study|Protocol Violation|0
310234|NCT00774306|1016795|P1|Overall Study|Protocol Violation|2
310235|NCT00774306|1016792|P4|Overall Study|Adverse Event|0
310236|NCT00774306|1016793|P3|Overall Study|Adverse Event|0
310237|NCT00774306|1016794|P2|Overall Study|Adverse Event|0
310238|NCT00774306|1016795|P1|Overall Study|Adverse Event|3
310239|NCT00774046|1016863|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
310240|NCT00774046|1016863|P1|Enrollment|Desired other therapy/refused|28
310241|NCT00774046|1016863|P1|Screening|Not eligible|56
310242|NCT00773968|1016873|P1|Overall Study|Unspecified|8
310243|NCT00773968|1016873|P1|Overall Study|Screen Failure|17
310244|NCT00773968|1016873|P1|Overall Study|Withdrawal by Subject|11
310245|NCT00773968|1016873|P1|Overall Study|Protocol Violation|1
310246|NCT00773968|1016873|P1|Overall Study|Lack of Efficacy|3
310247|NCT00773968|1016873|P1|Overall Study|Failure to Return|2
310248|NCT00773968|1016873|P1|Overall Study|Death|1
310249|NCT00773968|1016873|P1|Overall Study|Adverse Event|2
310250|NCT00773734|1016904|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
310251|NCT00773734|1016905|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
310252|NCT00773734|1016906|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
310253|NCT00773734|1016907|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
310254|NCT00773734|1016908|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
310255|NCT00773734|1016909|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
310256|NCT00773734|1016904|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
310257|NCT00773734|1016905|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
310258|NCT00773734|1016906|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
310259|NCT00773734|1016907|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
310260|NCT00773734|1016908|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
310261|NCT00773734|1016909|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
310262|NCT00773734|1016904|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
310263|NCT00773734|1016905|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
310264|NCT00773734|1016906|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
310265|NCT00773734|1016907|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
310266|NCT00773734|1016908|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
310267|NCT00773734|1016909|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
310268|NCT00773734|1016904|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
310269|NCT00773734|1016905|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
310270|NCT00773734|1016906|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
310271|NCT00773734|1016907|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
310272|NCT00773734|1016908|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
310273|NCT00773734|1016909|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
310274|NCT00773734|1016904|P6|Extension: Active Treatment Week 24-52|Unspecified|1
310275|NCT00773734|1016905|P5|Extension: Active Treatment Week 24-52|Unspecified|0
310276|NCT00773734|1016906|P4|Extension: Active Treatment Week 24-52|Unspecified|2
310277|NCT00773734|1016907|P3|Extension: Active Treatment Week 24-52|Unspecified|1
310278|NCT00773734|1016908|P2|Extension: Active Treatment Week 24-52|Unspecified|0
310279|NCT00773734|1016909|P1|Extension: Active Treatment Week 24-52|Unspecified|0
310280|NCT00773734|1016904|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
310281|NCT00773734|1016905|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
310282|NCT00773734|1016906|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
310283|NCT00773734|1016907|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
310284|NCT00773734|1016908|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
310285|NCT00773734|1016909|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
310286|NCT00773734|1016904|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
310287|NCT00773734|1016905|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
310288|NCT00773734|1016906|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
310289|NCT00773734|1016907|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
310290|NCT00773734|1016908|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
310291|NCT00773734|1016909|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
310292|NCT00773734|1016904|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
310293|NCT00773734|1016905|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
310294|NCT00773734|1016906|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
310295|NCT00773734|1016907|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
310296|NCT00773734|1016908|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
310297|NCT00773734|1016909|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
310298|NCT00773734|1016904|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
310299|NCT00773734|1016905|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
310300|NCT00773734|1016906|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
310301|NCT00773734|1016907|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
310302|NCT00773734|1016908|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
310303|NCT00773734|1016909|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
310304|NCT00773734|1016904|P6|Core: Active Treatment Phase Week 16-24|Unspecified|0
310305|NCT00773734|1016905|P5|Core: Active Treatment Phase Week 16-24|Unspecified|0
310306|NCT00773734|1016906|P4|Core: Active Treatment Phase Week 16-24|Unspecified|0
310307|NCT00773734|1016907|P3|Core: Active Treatment Phase Week 16-24|Unspecified|0
310308|NCT00773734|1016908|P2|Core: Active Treatment Phase Week 16-24|Unspecified|1
310309|NCT00773734|1016909|P1|Core: Active Treatment Phase Week 16-24|Unspecified|0
310310|NCT00773734|1016904|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
310311|NCT00773734|1016905|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
310312|NCT00773734|1016906|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
310313|NCT00773734|1016907|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
310314|NCT00773734|1016908|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
310315|NCT00773734|1016909|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
310316|NCT00773734|1016904|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
310317|NCT00773734|1016905|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
310318|NCT00773734|1016906|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
310319|NCT00773734|1016907|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
310320|NCT00773734|1016908|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
310321|NCT00773734|1016909|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
310322|NCT00773734|1016904|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
310323|NCT00773734|1016905|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
310324|NCT00773734|1016906|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
310325|NCT00773734|1016907|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
310326|NCT00773734|1016908|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
310327|NCT00773734|1016909|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
310328|NCT00773734|1016904|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
310329|NCT00773734|1016905|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
310330|NCT00773734|1016906|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
310331|NCT00773734|1016907|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
310332|NCT00773734|1016908|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
310333|NCT00773734|1016909|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
310334|NCT00773734|1016904|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
310335|NCT00773734|1016905|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
310336|NCT00773734|1016906|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
310337|NCT00773734|1016907|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
310338|NCT00773734|1016908|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
310339|NCT00773734|1016909|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
310340|NCT00773734|1016904|P6|Core: Placebo Controlled Phase Week 0-16|Unspecified|0
310341|NCT00773734|1016905|P5|Core: Placebo Controlled Phase Week 0-16|Unspecified|0
310342|NCT00773734|1016906|P4|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
310343|NCT00773734|1016907|P3|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
310344|NCT00773734|1016908|P2|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
310345|NCT00773734|1016909|P1|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
310346|NCT00773734|1016904|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
310347|NCT00773734|1016905|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
310348|NCT00773734|1016906|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
310349|NCT00773734|1016907|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
310350|NCT00773734|1016908|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
310351|NCT00773734|1016909|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
310352|NCT00773734|1016904|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
310353|NCT00773734|1016905|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
310354|NCT00773734|1016906|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
310355|NCT00773734|1016907|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
310356|NCT00773734|1016908|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
310357|NCT00773734|1016909|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
310358|NCT00773734|1016904|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
310359|NCT00773734|1016905|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
310360|NCT00773734|1016906|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
310361|NCT00773734|1016907|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
310362|NCT00773734|1016908|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
310363|NCT00773734|1016909|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
310364|NCT00773734|1016904|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
310365|NCT00773734|1016905|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
310366|NCT00773734|1016906|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
310367|NCT00773734|1016907|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
310368|NCT00773734|1016908|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
310369|NCT00773734|1016909|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
310370|NCT00773734|1016904|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
310371|NCT00773734|1016905|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
310372|NCT00773734|1016906|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
310373|NCT00773734|1016907|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
310374|NCT00773734|1016908|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
310375|NCT00773734|1016909|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
310376|NCT00773734|1016904|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
310377|NCT00773734|1016905|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
310378|NCT00773734|1016906|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
310379|NCT00773734|1016907|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
310380|NCT00773734|1016908|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
310381|NCT00773734|1016909|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
310382|NCT00773461|1017480|P2|Overall Study|Withdrawal by Subject|1
310383|NCT00773461|1017481|P1|Overall Study|Withdrawal by Subject|4
310384|NCT00773461|1017480|P2|Overall Study|Adverse Event|3
310385|NCT00773461|1017481|P1|Overall Study|Adverse Event|1
310386|NCT00773383|1017519|P1|Overall Study|No study dose received|1
310387|NCT00773383|1017519|P1|Overall Study|not specified|2
310388|NCT00773383|1017519|P1|Overall Study|Progression of Disease|23
310389|NCT00773383|1017519|P1|Overall Study|Death|1
310390|NCT00773383|1017519|P1|Overall Study|Adverse Event|4
310391|NCT00773279|1017554|P2|Period 2|Unclassified|2
310392|NCT00773279|1017555|P1|Period 2|Unclassified|2
310393|NCT00773279|1017554|P2|Period 2|Protocol Violation|3
310394|NCT00773279|1017555|P1|Period 2|Protocol Violation|0
310395|NCT00773279|1017554|P2|Period 2|Lack of Efficacy|0
310396|NCT00773279|1017555|P1|Period 2|Lack of Efficacy|1
310397|NCT00773279|1017554|P2|Period 2|Adverse Event|1
310398|NCT00773279|1017555|P1|Period 2|Adverse Event|0
310399|NCT00773279|1017554|P2|Period 1|Unclassified|1
310400|NCT00773279|1017555|P1|Period 1|Unclassified|5
310401|NCT00773279|1017554|P2|Period 1|Lack of Efficacy|2
310402|NCT00773279|1017555|P1|Period 1|Lack of Efficacy|0
310403|NCT00773279|1017554|P2|Period 1|Adverse Event|1
310404|NCT00773279|1017555|P1|Period 1|Adverse Event|2
310405|NCT00773253|1017576|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
310406|NCT00773253|1017577|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
310407|NCT00773136|1017583|P1|Overall Study|Physician Decision|2
310408|NCT00773097|1017588|P1|Overall Study|Physician Decision|6
310409|NCT00773097|1017588|P1|Overall Study|Withdrawal by Subject|1
310410|NCT00772967|1017594|P6|Crossover Treatment 3|Adverse Event|0
310411|NCT00772967|1017595|P5|Crossover Treatment 3|Adverse Event|1
310412|NCT00772967|1017596|P4|Crossover Treatment 3|Adverse Event|0
310413|NCT00772967|1017597|P3|Crossover Treatment 3|Adverse Event|0
310414|NCT00772967|1017598|P2|Crossover Treatment 3|Adverse Event|0
310415|NCT00772967|1017599|P1|Crossover Treatment 3|Adverse Event|0
310416|NCT00772967|1017594|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
310417|NCT00772967|1017595|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
310418|NCT00772967|1017596|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
310419|NCT00772967|1017597|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
310420|NCT00772967|1017598|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
310421|NCT00772967|1017599|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
310422|NCT00772967|1017594|P6|Crossover Treatment 1|Adverse Event (Pain)|0
310423|NCT00772967|1017595|P5|Crossover Treatment 1|Adverse Event (Pain)|0
310424|NCT00772967|1017596|P4|Crossover Treatment 1|Adverse Event (Pain)|1
310425|NCT00772967|1017597|P3|Crossover Treatment 1|Adverse Event (Pain)|0
310426|NCT00772967|1017598|P2|Crossover Treatment 1|Adverse Event (Pain)|0
310427|NCT00772967|1017599|P1|Crossover Treatment 1|Adverse Event (Pain)|0
310428|NCT00772954|1017619|P3|Overall Study|Adverse Event|1
310429|NCT00772954|1017620|P2|Overall Study|Adverse Event|0
310430|NCT00772954|1017621|P1|Overall Study|Adverse Event|0
310431|NCT00772941|1017629|P1|Overall Study|GPSP Violation|90
310432|NCT00772941|1017629|P1|Overall Study|Poor Compliance|7
310433|NCT00772941|1017629|P1|Overall Study|Missed Visits|374
310434|NCT00772941|1017629|P1|Overall Study|Study not completed|16
310435|NCT00772941|1017629|P1|Overall Study|CRFs not available|195
310436|NCT00772928|1017660|P2|Overall Study|Did not receive vaccine|1
310437|NCT00772928|1017661|P1|Overall Study|Did not receive vaccine|0
310438|NCT00772928|1017660|P2|Overall Study|Withdrawal by Subject|22
310439|NCT00772928|1017661|P1|Overall Study|Withdrawal by Subject|25
310440|NCT00772928|1017660|P2|Overall Study|Protocol Violation|12
310441|NCT00772928|1017661|P1|Overall Study|Protocol Violation|10
310442|NCT00772928|1017660|P2|Overall Study|Lost to Follow-up|6
310443|NCT00772928|1017661|P1|Overall Study|Lost to Follow-up|9
310444|NCT00772889|1017678|P3|Overall Study|Lost to Follow-up|7
310445|NCT00772889|1017679|P2|Overall Study|Lost to Follow-up|6
310446|NCT00772889|1017680|P1|Overall Study|Lost to Follow-up|6
310447|NCT00772889|1017678|P3|Overall Study|Withdrawal by Subject|9
310448|NCT00772889|1017679|P2|Overall Study|Withdrawal by Subject|8
310449|NCT00772889|1017680|P1|Overall Study|Withdrawal by Subject|9
310450|NCT00772889|1017678|P3|Overall Study|Adverse Event|0
310451|NCT00772889|1017679|P2|Overall Study|Adverse Event|4
310452|NCT00772889|1017680|P1|Overall Study|Adverse Event|7
310453|NCT00772707|1017738|P1|Overall Study|Withdrawn|3
310454|NCT00772668|1017743|P1|Overall Study|Physician Decision|3
310455|NCT00772629|1017749|P2|Overall Study|Subject was not vaccinated|0
310456|NCT00772629|1017750|P1|Overall Study|Subject was not vaccinated|1
310457|NCT00772603|1017759|P3|Overall Study|Other|2
310458|NCT00772603|1017760|P2|Overall Study|Other|0
310459|NCT00772603|1017761|P1|Overall Study|Other|2
310460|NCT00772603|1017759|P3|Overall Study|Physician Decision|1
310461|NCT00772603|1017760|P2|Overall Study|Physician Decision|0
310462|NCT00772603|1017761|P1|Overall Study|Physician Decision|0
310463|NCT00772603|1017759|P3|Overall Study|Lost to Follow-up|2
310464|NCT00772603|1017760|P2|Overall Study|Lost to Follow-up|5
310465|NCT00772603|1017761|P1|Overall Study|Lost to Follow-up|1
310466|NCT00772603|1017759|P3|Overall Study|Protocol Violation|1
310467|NCT00772603|1017760|P2|Overall Study|Protocol Violation|1
310468|NCT00772603|1017761|P1|Overall Study|Protocol Violation|0
310469|NCT00772603|1017759|P3|Overall Study|Subject Non-compliance|4
310470|NCT00772603|1017760|P2|Overall Study|Subject Non-compliance|6
310471|NCT00772603|1017761|P1|Overall Study|Subject Non-compliance|1
310472|NCT00772603|1017759|P3|Overall Study|Adverse Event|10
310473|NCT00772603|1017760|P2|Overall Study|Adverse Event|18
310474|NCT00772603|1017761|P1|Overall Study|Adverse Event|37
310475|NCT00772603|1017759|P3|Overall Study|Withdrawal by Subject|6
310476|NCT00772603|1017760|P2|Overall Study|Withdrawal by Subject|10
310477|NCT00772603|1017761|P1|Overall Study|Withdrawal by Subject|11
310478|NCT00772577|1017800|P2|Overall Study|Protocol Deviation|2
310479|NCT00772577|1017801|P1|Overall Study|Protocol Deviation|3
310480|NCT00772577|1017800|P2|Overall Study|Administrative problems|1
310481|NCT00772577|1017801|P1|Overall Study|Administrative problems|2
310482|NCT00772577|1017800|P2|Overall Study|Lost to Follow-up|3
310483|NCT00772577|1017801|P1|Overall Study|Lost to Follow-up|4
310484|NCT00772577|1017800|P2|Overall Study|Patient withdrew consent|5
310485|NCT00772577|1017801|P1|Overall Study|Patient withdrew consent|8
310486|NCT00772577|1017800|P2|Overall Study|Unsatisfactory therapeutic effect|8
310487|NCT00772577|1017801|P1|Overall Study|Unsatisfactory therapeutic effect|0
310488|NCT00772577|1017800|P2|Overall Study|Abnormal laboratory values|1
310489|NCT00772577|1017801|P1|Overall Study|Abnormal laboratory values|0
310490|NCT00772577|1017800|P2|Overall Study|Adverse Event|3
310491|NCT00772577|1017801|P1|Overall Study|Adverse Event|6
310492|NCT00772538|1017817|P2|Overall Study|Other|7
310493|NCT00772538|1017818|P1|Overall Study|Other|7
310494|NCT00772538|1017817|P2|Overall Study|Lack of Efficacy|1
310495|NCT00772538|1017818|P1|Overall Study|Lack of Efficacy|0
310496|NCT00772538|1017817|P2|Overall Study|Withdrawal by Subject|8
310497|NCT00772538|1017818|P1|Overall Study|Withdrawal by Subject|3
310498|NCT00772538|1017817|P2|Overall Study|Lost to Follow-up|1
310499|NCT00772538|1017818|P1|Overall Study|Lost to Follow-up|1
310500|NCT00772538|1017817|P2|Overall Study|Protocol Violation|3
310501|NCT00772538|1017818|P1|Overall Study|Protocol Violation|3
310502|NCT00772538|1017817|P2|Overall Study|Adverse Event|6
310503|NCT00772538|1017818|P1|Overall Study|Adverse Event|6
310504|NCT00772447|1017890|P2|Overall Study|all others|2
310505|NCT00772447|1017891|P1|Overall Study|all others|2
310506|NCT00772447|1017890|P2|Overall Study|Protocol Violation|1
310507|NCT00772447|1017891|P1|Overall Study|Protocol Violation|0
310508|NCT00772447|1017890|P2|Overall Study|incorrect enrolment|4
310509|NCT00772447|1017891|P1|Overall Study|incorrect enrolment|3
310510|NCT00772447|1017890|P2|Overall Study|Lost to Follow-up|4
310511|NCT00772447|1017891|P1|Overall Study|Lost to Follow-up|2
310512|NCT00772447|1017890|P2|Overall Study|Physician Decision|8
310513|NCT00772447|1017891|P1|Overall Study|Physician Decision|4
310514|NCT00772447|1017890|P2|Overall Study|Withdrawal by Subject|5
310515|NCT00772447|1017891|P1|Overall Study|Withdrawal by Subject|9
310516|NCT00772382|1017919|P1|Overall Study|Other Reasons|10
310517|NCT00772382|1017919|P1|Overall Study|Withdrawal by Subject|10
310518|NCT00772382|1017919|P1|Overall Study|Protocol Violation|1
310519|NCT00772382|1017919|P1|Overall Study|Physician Decision|5
310520|NCT00772382|1017919|P1|Overall Study|Lack of Efficacy|4
310521|NCT00772382|1017919|P1|Overall Study|Death|6
310522|NCT00772382|1017919|P1|Overall Study|Adverse Event|19
310523|NCT00772369|1017924|P1|Overall Study|Did not return record release form|1
310524|NCT00772148|1017935|P2|Maintenance Phase (Week 52)|Administrative/other|2
310525|NCT00772148|1017936|P1|Maintenance Phase (Week 52)|Administrative/other|1
310526|NCT00772148|1017935|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
310527|NCT00772148|1017936|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
310528|NCT00772148|1017935|P2|Maintenance Phase (Week 52)|Adverse Event|0
310529|NCT00772148|1017936|P1|Maintenance Phase (Week 52)|Adverse Event|1
310530|NCT00772148|1017935|P2|Maintenance Phase (Week 52)|Death|2
310531|NCT00772148|1017936|P1|Maintenance Phase (Week 52)|Death|2
310532|NCT00772148|1017935|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
310533|NCT00772148|1017936|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
310534|NCT00772148|1017935|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
310535|NCT00772148|1017936|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
310536|NCT00772148|1017935|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
310537|NCT00772148|1017936|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
310538|NCT00772109|1017956|P4|Overall Study|Withdrawal by Subject|16
310539|NCT00772109|1017957|P3|Overall Study|Withdrawal by Subject|6
310540|NCT00772109|1017958|P2|Overall Study|Withdrawal by Subject|8
310541|NCT00772109|1017959|P1|Overall Study|Withdrawal by Subject|8
310542|NCT00772109|1017956|P4|Overall Study|Lost to Follow-up|9
310543|NCT00772109|1017957|P3|Overall Study|Lost to Follow-up|5
310544|NCT00772109|1017958|P2|Overall Study|Lost to Follow-up|3
310545|NCT00772109|1017959|P1|Overall Study|Lost to Follow-up|7
310546|NCT00772109|1017956|P4|Overall Study|Protocol Violation|6
310547|NCT00772109|1017957|P3|Overall Study|Protocol Violation|7
310548|NCT00772109|1017958|P2|Overall Study|Protocol Violation|8
310549|NCT00772109|1017959|P1|Overall Study|Protocol Violation|5
310550|NCT00772109|1017956|P4|Overall Study|Serious adverse event|0
310551|NCT00772109|1017957|P3|Overall Study|Serious adverse event|1
310552|NCT00772109|1017958|P2|Overall Study|Serious adverse event|0
310553|NCT00772109|1017959|P1|Overall Study|Serious adverse event|1
310554|NCT00772070|1017983|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
310555|NCT00772070|1017984|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
310556|NCT00772070|1017983|P2|Overall Study|Withdrawal by Subject|2
310557|NCT00772070|1017984|P1|Overall Study|Withdrawal by Subject|0
310558|NCT00772070|1017983|P2|Overall Study|Lost to Follow-up|8
310559|NCT00772070|1017984|P1|Overall Study|Lost to Follow-up|0
310560|NCT00772031|1017996|P2|Overall Study|Lost to Follow-up|33
310561|NCT00772031|1017997|P1|Overall Study|Lost to Follow-up|20
310562|NCT00772031|1017996|P2|Overall Study|Early termination of trial|10
310563|NCT00772031|1017997|P1|Overall Study|Early termination of trial|12
310564|NCT00772005|1018023|P4|Overall Study|Non-compliance with drug administration|1
310565|NCT00772005|1018024|P3|Overall Study|Non-compliance with drug administration|1
310566|NCT00772005|1018025|P2|Overall Study|Non-compliance with drug administration|0
310567|NCT00772005|1018026|P1|Overall Study|Non-compliance with drug administration|3
310568|NCT00772005|1018023|P4|Overall Study|Non-compliance with study procedures|1
310569|NCT00772005|1018024|P3|Overall Study|Non-compliance with study procedures|0
310570|NCT00772005|1018025|P2|Overall Study|Non-compliance with study procedures|1
310571|NCT00772005|1018026|P1|Overall Study|Non-compliance with study procedures|1
310572|NCT00772005|1018023|P4|Overall Study|Lost to Follow-up|3
310573|NCT00772005|1018024|P3|Overall Study|Lost to Follow-up|6
310574|NCT00772005|1018025|P2|Overall Study|Lost to Follow-up|3
310575|NCT00772005|1018026|P1|Overall Study|Lost to Follow-up|7
310576|NCT00772005|1018023|P4|Overall Study|Protocol Violation|6
310577|NCT00772005|1018024|P3|Overall Study|Protocol Violation|1
310578|NCT00772005|1018025|P2|Overall Study|Protocol Violation|4
310579|NCT00772005|1018026|P1|Overall Study|Protocol Violation|2
310580|NCT00772005|1018023|P4|Overall Study|Withdrawal by Subject|2
310581|NCT00772005|1018024|P3|Overall Study|Withdrawal by Subject|10
310582|NCT00772005|1018025|P2|Overall Study|Withdrawal by Subject|7
310583|NCT00772005|1018026|P1|Overall Study|Withdrawal by Subject|3
310584|NCT00772005|1018023|P4|Overall Study|Lack of Efficacy|0
310585|NCT00772005|1018024|P3|Overall Study|Lack of Efficacy|0
310586|NCT00772005|1018025|P2|Overall Study|Lack of Efficacy|1
310587|NCT00772005|1018026|P1|Overall Study|Lack of Efficacy|0
310588|NCT00772005|1018023|P4|Overall Study|Adverse Event|13
310589|NCT00772005|1018024|P3|Overall Study|Adverse Event|10
310590|NCT00772005|1018025|P2|Overall Study|Adverse Event|14
310591|NCT00772005|1018026|P1|Overall Study|Adverse Event|9
310592|NCT00771953|1018714|P2|Overall Study|Withdrawal by Subject|3
310593|NCT00771953|1018715|P1|Overall Study|Withdrawal by Subject|0
310594|NCT00771953|1018714|P2|Overall Study|Other complicating disease|0
310595|NCT00771953|1018715|P1|Overall Study|Other complicating disease|1
310596|NCT00771953|1018714|P2|Overall Study|Sponsor decision|0
310597|NCT00771953|1018715|P1|Overall Study|Sponsor decision|1
310598|NCT00771953|1018714|P2|Overall Study|Progression before active Tx|2
310599|NCT00771953|1018715|P1|Overall Study|Progression before active Tx|1
310600|NCT00771953|1018714|P2|Overall Study|Death|2
310601|NCT00771953|1018715|P1|Overall Study|Death|2
310602|NCT00771953|1018714|P2|Overall Study|Adverse Event|3
310603|NCT00771953|1018715|P1|Overall Study|Adverse Event|5
310604|NCT00771927|1018725|P2|Overall Study|Other reason|27
310605|NCT00771927|1018726|P1|Overall Study|Other reason|23
310606|NCT00771927|1018725|P2|Overall Study|Withdrawal by Subject|17
310607|NCT00771927|1018726|P1|Overall Study|Withdrawal by Subject|16
310608|NCT00771927|1018725|P2|Overall Study|Lost to Follow-up|46
310609|NCT00771927|1018726|P1|Overall Study|Lost to Follow-up|46
310610|NCT00771927|1018725|P2|Overall Study|Lack of Efficacy|42
310611|NCT00771927|1018726|P1|Overall Study|Lack of Efficacy|70
310612|NCT00771927|1018725|P2|Overall Study|Adverse Event|105
310613|NCT00771927|1018726|P1|Overall Study|Adverse Event|100
310614|NCT00771914|1018738|P4|Overall Study|Lost to Follow-up|1
310615|NCT00771914|1018739|P3|Overall Study|Lost to Follow-up|0
310616|NCT00771914|1018740|P2|Overall Study|Lost to Follow-up|0
310617|NCT00771914|1018741|P1|Overall Study|Lost to Follow-up|0
310618|NCT00771914|1018738|P4|Overall Study|Physician Decision|1
310619|NCT00771914|1018739|P3|Overall Study|Physician Decision|0
310620|NCT00771914|1018740|P2|Overall Study|Physician Decision|0
310621|NCT00771914|1018741|P1|Overall Study|Physician Decision|0
310622|NCT00771849|1018784|P2|Overall Study|Not vaccinated|1
310623|NCT00771849|1018785|P1|Overall Study|Not vaccinated|0
310624|NCT00771849|1018784|P2|Overall Study|Withdrawal by Subject|1
310625|NCT00771849|1018785|P1|Overall Study|Withdrawal by Subject|1
310626|NCT00771849|1018784|P2|Overall Study|Lost to Follow-up|2
310627|NCT00771849|1018785|P1|Overall Study|Lost to Follow-up|1
310628|NCT00771810|1018796|P3|Overall Study|Other|1
310629|NCT00771810|1018797|P2|Overall Study|Other|0
310630|NCT00771810|1018798|P1|Overall Study|Other|0
310631|NCT00771810|1018796|P3|Overall Study|Withdrawal by Subject|0
310632|NCT00771810|1018797|P2|Overall Study|Withdrawal by Subject|2
310633|NCT00771810|1018798|P1|Overall Study|Withdrawal by Subject|1
310634|NCT00771810|1018796|P3|Overall Study|Protocol Violation|1
310635|NCT00771810|1018797|P2|Overall Study|Protocol Violation|1
310636|NCT00771810|1018798|P1|Overall Study|Protocol Violation|0
310637|NCT00771810|1018796|P3|Overall Study|Physician Decision|2
310638|NCT00771810|1018797|P2|Overall Study|Physician Decision|2
310639|NCT00771810|1018798|P1|Overall Study|Physician Decision|1
310640|NCT00771810|1018796|P3|Overall Study|Lost to Follow-up|1
310641|NCT00771810|1018797|P2|Overall Study|Lost to Follow-up|0
310642|NCT00771810|1018798|P1|Overall Study|Lost to Follow-up|0
310643|NCT00771810|1018796|P3|Overall Study|Adverse Event|2
310644|NCT00771810|1018797|P2|Overall Study|Adverse Event|0
310645|NCT00771810|1018798|P1|Overall Study|Adverse Event|3
310646|NCT00771758|1018836|P3|Overall Study|Other|0
310647|NCT00771758|1018837|P2|Overall Study|Other|2
310648|NCT00771758|1018838|P1|Overall Study|Other|3
310649|NCT00771758|1018836|P3|Overall Study|Withdrawal by Subject|0
310650|NCT00771758|1018837|P2|Overall Study|Withdrawal by Subject|0
310651|NCT00771758|1018838|P1|Overall Study|Withdrawal by Subject|1
310652|NCT00771758|1018836|P3|Overall Study|Protocol Violation|0
310653|NCT00771758|1018837|P2|Overall Study|Protocol Violation|0
310654|NCT00771758|1018838|P1|Overall Study|Protocol Violation|1
310655|NCT00771758|1018836|P3|Overall Study|Lost to Follow-up|0
310656|NCT00771758|1018837|P2|Overall Study|Lost to Follow-up|0
310657|NCT00771758|1018838|P1|Overall Study|Lost to Follow-up|1
310658|NCT00771758|1018836|P3|Overall Study|Lack of Efficacy|1
310659|NCT00771758|1018837|P2|Overall Study|Lack of Efficacy|2
310660|NCT00771758|1018838|P1|Overall Study|Lack of Efficacy|0
310661|NCT00771758|1018836|P3|Overall Study|Adverse Event|1
310662|NCT00771758|1018837|P2|Overall Study|Adverse Event|8
310663|NCT00771758|1018838|P1|Overall Study|Adverse Event|2
310664|NCT00771667|1018999|P10|Maintenance Phase|Other|3
310665|NCT00771667|1019000|P9|Maintenance Phase|Other|3
310666|NCT00771667|1019001|P8|Maintenance Phase|Other|2
310667|NCT00771667|1019002|P7|Maintenance Phase|Other|2
310668|NCT00771667|1019003|P6|Maintenance Phase|Other|1
310669|NCT00771667|1019004|P5|Maintenance Phase|Other|0
310670|NCT00771667|1019005|P4|Maintenance Phase|Other|0
310671|NCT00771667|1019006|P3|Maintenance Phase|Other|0
310672|NCT00771667|1019007|P2|Maintenance Phase|Other|0
310673|NCT00771667|1019008|P1|Maintenance Phase|Other|0
310674|NCT00771667|1018999|P10|Maintenance Phase|Lack of Efficacy|7
310675|NCT00771667|1019000|P9|Maintenance Phase|Lack of Efficacy|11
310676|NCT00771667|1019001|P8|Maintenance Phase|Lack of Efficacy|2
310677|NCT00771667|1019002|P7|Maintenance Phase|Lack of Efficacy|3
310678|NCT00771667|1019003|P6|Maintenance Phase|Lack of Efficacy|3
310679|NCT00771667|1019004|P5|Maintenance Phase|Lack of Efficacy|1
310680|NCT00771667|1019005|P4|Maintenance Phase|Lack of Efficacy|0
310681|NCT00771667|1019006|P3|Maintenance Phase|Lack of Efficacy|0
310682|NCT00771667|1019007|P2|Maintenance Phase|Lack of Efficacy|0
310683|NCT00771667|1019008|P1|Maintenance Phase|Lack of Efficacy|0
310684|NCT00771667|1018999|P10|Maintenance Phase|Adverse Event|7
310685|NCT00771667|1019000|P9|Maintenance Phase|Adverse Event|8
310686|NCT00771667|1019001|P8|Maintenance Phase|Adverse Event|1
310687|NCT00771667|1019002|P7|Maintenance Phase|Adverse Event|5
310688|NCT00771667|1019003|P6|Maintenance Phase|Adverse Event|3
310689|NCT00771667|1019004|P5|Maintenance Phase|Adverse Event|1
310690|NCT00771667|1019005|P4|Maintenance Phase|Adverse Event|0
310691|NCT00771667|1019006|P3|Maintenance Phase|Adverse Event|0
310692|NCT00771667|1019007|P2|Maintenance Phase|Adverse Event|0
310693|NCT00771667|1019008|P1|Maintenance Phase|Adverse Event|0
310694|NCT00771667|1018999|P10|Induction Phase|Other|0
310695|NCT00771667|1019000|P9|Induction Phase|Other|0
310696|NCT00771667|1019001|P8|Induction Phase|Other|0
310697|NCT00771667|1019002|P7|Induction Phase|Other|0
310698|NCT00771667|1019003|P6|Induction Phase|Other|0
310699|NCT00771667|1019004|P5|Induction Phase|Other|0
310700|NCT00771667|1019005|P4|Induction Phase|Other|4
310701|NCT00771667|1019006|P3|Induction Phase|Other|3
310702|NCT00771667|1019007|P2|Induction Phase|Other|6
310703|NCT00771667|1019008|P1|Induction Phase|Other|4
310704|NCT00771667|1018999|P10|Induction Phase|Lost to Follow-up|0
310705|NCT00771667|1019000|P9|Induction Phase|Lost to Follow-up|0
310706|NCT00771667|1019001|P8|Induction Phase|Lost to Follow-up|0
310707|NCT00771667|1019002|P7|Induction Phase|Lost to Follow-up|0
310708|NCT00771667|1019003|P6|Induction Phase|Lost to Follow-up|0
310709|NCT00771667|1019004|P5|Induction Phase|Lost to Follow-up|0
310710|NCT00771667|1019005|P4|Induction Phase|Lost to Follow-up|0
310711|NCT00771667|1019006|P3|Induction Phase|Lost to Follow-up|1
310712|NCT00771667|1019007|P2|Induction Phase|Lost to Follow-up|0
310713|NCT00771667|1019008|P1|Induction Phase|Lost to Follow-up|1
310714|NCT00771667|1018999|P10|Induction Phase|Lack of Efficacy|0
310715|NCT00771667|1019000|P9|Induction Phase|Lack of Efficacy|0
310716|NCT00771667|1019001|P8|Induction Phase|Lack of Efficacy|0
310717|NCT00771667|1019002|P7|Induction Phase|Lack of Efficacy|0
310718|NCT00771667|1019003|P6|Induction Phase|Lack of Efficacy|0
310719|NCT00771667|1019004|P5|Induction Phase|Lack of Efficacy|0
310720|NCT00771667|1019005|P4|Induction Phase|Lack of Efficacy|3
310721|NCT00771667|1019006|P3|Induction Phase|Lack of Efficacy|4
310722|NCT00771667|1019007|P2|Induction Phase|Lack of Efficacy|2
310723|NCT00771667|1019008|P1|Induction Phase|Lack of Efficacy|9
310724|NCT00771667|1018999|P10|Induction Phase|Adverse Event|0
310725|NCT00771667|1019000|P9|Induction Phase|Adverse Event|0
310726|NCT00771667|1019001|P8|Induction Phase|Adverse Event|0
310727|NCT00771667|1019002|P7|Induction Phase|Adverse Event|0
310728|NCT00771667|1019003|P6|Induction Phase|Adverse Event|0
310729|NCT00771667|1019004|P5|Induction Phase|Adverse Event|0
310730|NCT00771667|1019005|P4|Induction Phase|Adverse Event|1
310731|NCT00771667|1019006|P3|Induction Phase|Adverse Event|4
310732|NCT00771667|1019007|P2|Induction Phase|Adverse Event|2
310733|NCT00771667|1019008|P1|Induction Phase|Adverse Event|5
310734|NCT00771615|1019053|P9|Overall Study|Lost to Follow-up|0
310735|NCT00771615|1019054|P8|Overall Study|Lost to Follow-up|0
310736|NCT00771615|1019055|P7|Overall Study|Lost to Follow-up|1
310737|NCT00771615|1019056|P6|Overall Study|Lost to Follow-up|1
310738|NCT00771615|1019057|P5|Overall Study|Lost to Follow-up|0
310739|NCT00771615|1019058|P4|Overall Study|Lost to Follow-up|1
310740|NCT00771615|1019059|P3|Overall Study|Lost to Follow-up|1
310741|NCT00771615|1019060|P2|Overall Study|Lost to Follow-up|1
310742|NCT00771615|1019061|P1|Overall Study|Lost to Follow-up|1
310743|NCT00771615|1019053|P9|Overall Study|Withdrawal by Subject|0
310744|NCT00771615|1019054|P8|Overall Study|Withdrawal by Subject|1
310745|NCT00771615|1019055|P7|Overall Study|Withdrawal by Subject|0
310746|NCT00771615|1019056|P6|Overall Study|Withdrawal by Subject|0
310747|NCT00771615|1019057|P5|Overall Study|Withdrawal by Subject|0
310748|NCT00771615|1019058|P4|Overall Study|Withdrawal by Subject|0
310749|NCT00771615|1019059|P3|Overall Study|Withdrawal by Subject|0
310750|NCT00771615|1019060|P2|Overall Study|Withdrawal by Subject|1
310751|NCT00771615|1019061|P1|Overall Study|Withdrawal by Subject|0
310752|NCT00771472|1019322|P2|Overall Study|Protocol Violation|0
310753|NCT00771472|1019323|P1|Overall Study|Protocol Violation|1
310754|NCT00771472|1019322|P2|Overall Study|Progressive Disease|1
310755|NCT00771472|1019323|P1|Overall Study|Progressive Disease|3
310756|NCT00771472|1019322|P2|Overall Study|Physician Decision|3
310757|NCT00771472|1019323|P1|Overall Study|Physician Decision|2
310758|NCT00771316|1019343|P2|Overall Study|Discontinued due to early termination|0
310759|NCT00771316|1019344|P1|Overall Study|Discontinued due to early termination|1
310760|NCT00771316|1019343|P2|Overall Study|Patient withdrew consent|0
310761|NCT00771316|1019344|P1|Overall Study|Patient withdrew consent|1
310762|NCT00771316|1019343|P2|Overall Study|Adverse Event|1
310763|NCT00771316|1019344|P1|Overall Study|Adverse Event|0
310764|NCT00770991|1019396|P2|Overall Study|Pregnancy|0
310765|NCT00770991|1019397|P1|Overall Study|Pregnancy|1
310766|NCT00770991|1019396|P2|Overall Study|Adverse Event|5
310767|NCT00770991|1019397|P1|Overall Study|Adverse Event|1
310768|NCT00770991|1019396|P2|Overall Study|Withdrawal by Subject|0
310769|NCT00770991|1019397|P1|Overall Study|Withdrawal by Subject|1
310770|NCT00770991|1019396|P2|Overall Study|Physician Decision|0
310771|NCT00770991|1019397|P1|Overall Study|Physician Decision|2
310772|NCT00770965|1019413|P4|Excluded Set|Withdrawal by Subject|3
310773|NCT00770965|1019414|P3|Excluded Set|Withdrawal by Subject|2
310774|NCT00770965|1019415|P2|Excluded Set|Withdrawal by Subject|1
310775|NCT00770965|1019416|P1|Excluded Set|Withdrawal by Subject|1
310776|NCT00770965|1019413|P4|Excluded Set|Administrative problems|10
310777|NCT00770965|1019414|P3|Excluded Set|Administrative problems|12
310778|NCT00770965|1019415|P2|Excluded Set|Administrative problems|12
310779|NCT00770965|1019416|P1|Excluded Set|Administrative problems|14
310780|NCT00770965|1019413|P4|Safety Set|Protocol deviation|0
310781|NCT00770965|1019414|P3|Safety Set|Protocol deviation|1
310782|NCT00770965|1019415|P2|Safety Set|Protocol deviation|0
310783|NCT00770965|1019416|P1|Safety Set|Protocol deviation|0
310784|NCT00770965|1019413|P4|Safety Set|Withdrawal by Subject|1
310785|NCT00770965|1019414|P3|Safety Set|Withdrawal by Subject|0
310786|NCT00770965|1019415|P2|Safety Set|Withdrawal by Subject|0
310787|NCT00770965|1019416|P1|Safety Set|Withdrawal by Subject|0
310788|NCT00770913|1019437|P3|Overall Study|Incorrect drug was allocated|0
310789|NCT00770913|1019438|P2|Overall Study|Incorrect drug was allocated|0
310790|NCT00770913|1019439|P1|Overall Study|Incorrect drug was allocated|1
310791|NCT00770913|1019437|P3|Overall Study|Protocol Violation|1
310792|NCT00770913|1019438|P2|Overall Study|Protocol Violation|0
310793|NCT00770913|1019439|P1|Overall Study|Protocol Violation|3
310794|NCT00770913|1019437|P3|Overall Study|Physician Decision|1
310795|NCT00770913|1019438|P2|Overall Study|Physician Decision|1
310796|NCT00770913|1019439|P1|Overall Study|Physician Decision|0
310797|NCT00770913|1019437|P3|Overall Study|Refusal to continue participation|5
310798|NCT00770913|1019438|P2|Overall Study|Refusal to continue participation|4
310799|NCT00770913|1019439|P1|Overall Study|Refusal to continue participation|6
310800|NCT00770913|1019437|P3|Overall Study|Adverse Event|6
310801|NCT00770913|1019438|P2|Overall Study|Adverse Event|3
310802|NCT00770913|1019439|P1|Overall Study|Adverse Event|1
310803|NCT00770809|1019461|P3|Overall Study|Other Medical Reasons|3
310804|NCT00770809|1019462|P2|Overall Study|Other Medical Reasons|4
310805|NCT00770809|1019463|P1|Overall Study|Other Medical Reasons|2
310806|NCT00770809|1019461|P3|Overall Study|Complicating illness|1
310807|NCT00770809|1019462|P2|Overall Study|Complicating illness|0
310808|NCT00770809|1019463|P1|Overall Study|Complicating illness|0
310809|NCT00770809|1019461|P3|Overall Study|Progression|0
310810|NCT00770809|1019462|P2|Overall Study|Progression|2
310811|NCT00770809|1019463|P1|Overall Study|Progression|2
310812|NCT00770809|1019461|P3|Overall Study|Withdrawal by Subject|7
310813|NCT00770809|1019462|P2|Overall Study|Withdrawal by Subject|3
310814|NCT00770809|1019463|P1|Overall Study|Withdrawal by Subject|3
310815|NCT00770809|1019461|P3|Overall Study|Death|0
310816|NCT00770809|1019462|P2|Overall Study|Death|0
310817|NCT00770809|1019463|P1|Overall Study|Death|1
310818|NCT00770809|1019461|P3|Overall Study|Adverse Event|12
310819|NCT00770809|1019462|P2|Overall Study|Adverse Event|1
310820|NCT00770809|1019463|P1|Overall Study|Adverse Event|9
310821|NCT00770770|1019473|P2|Overall Study|Study Terminated|0
310822|NCT00770770|1019474|P1|Overall Study|Study Terminated|8
310823|NCT00770770|1019473|P2|Overall Study|Death|1
310824|NCT00770770|1019474|P1|Overall Study|Death|0
310825|NCT00770770|1019473|P2|Overall Study|Withdrawal by Subject|0
310826|NCT00770770|1019474|P1|Overall Study|Withdrawal by Subject|1
310827|NCT00770770|1019473|P2|Overall Study|Lost to Follow-up|0
310828|NCT00770770|1019474|P1|Overall Study|Lost to Follow-up|1
310829|NCT00770692|1019492|P4|Overall Study|Investigator judgment|1
310830|NCT00770692|1019493|P3|Overall Study|Investigator judgment|1
310831|NCT00770692|1019494|P2|Overall Study|Investigator judgment|0
310832|NCT00770692|1019495|P1|Overall Study|Investigator judgment|2
310833|NCT00770692|1019492|P4|Overall Study|Adverse Event|4
310834|NCT00770692|1019493|P3|Overall Study|Adverse Event|4
310835|NCT00770692|1019494|P2|Overall Study|Adverse Event|0
310836|NCT00770692|1019495|P1|Overall Study|Adverse Event|3
310837|NCT00770692|1019492|P4|Overall Study|Withdrawal by Subject|6
310838|NCT00770692|1019493|P3|Overall Study|Withdrawal by Subject|9
310839|NCT00770692|1019494|P2|Overall Study|Withdrawal by Subject|9
310840|NCT00770692|1019495|P1|Overall Study|Withdrawal by Subject|7
310841|NCT00770653|1019523|P2|Overall Study|Physician Decision|0
310842|NCT00770653|1019524|P1|Overall Study|Physician Decision|1
310843|NCT00770653|1019523|P2|Overall Study|Lost to Follow-up|2
310844|NCT00770653|1019524|P1|Overall Study|Lost to Follow-up|1
310845|NCT00770653|1019523|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
310846|NCT00770653|1019524|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
310847|NCT00770653|1019523|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
310848|NCT00770653|1019524|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
310849|NCT00770653|1019523|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
310850|NCT00770653|1019524|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
310851|NCT00770653|1019523|P2|Overall Study|Lack of Compliance|4
310852|NCT00770653|1019524|P1|Overall Study|Lack of Compliance|1
310853|NCT00770653|1019523|P2|Overall Study|Withdrawal by Subject|7
310854|NCT00770653|1019524|P1|Overall Study|Withdrawal by Subject|4
310855|NCT00770653|1019523|P2|Overall Study|Protocol Violation|6
310856|NCT00770653|1019524|P1|Overall Study|Protocol Violation|8
310857|NCT00770653|1019523|P2|Overall Study|Adverse Event|5
310858|NCT00770653|1019524|P1|Overall Study|Adverse Event|13
310859|NCT00770588|1019594|P2|Overall Study|Withdrawal by Subject|1
310860|NCT00770588|1019595|P1|Overall Study|Withdrawal by Subject|1
310861|NCT00770588|1019594|P2|Overall Study|Lost to Follow-up|1
310862|NCT00770588|1019595|P1|Overall Study|Lost to Follow-up|1
310863|NCT00770588|1019594|P2|Overall Study|Death caused by progression of disease|91
310864|NCT00770588|1019595|P1|Overall Study|Death caused by progression of disease|70
310865|NCT00770588|1019594|P2|Overall Study|Adverse Event|2
310866|NCT00770588|1019595|P1|Overall Study|Adverse Event|9
310867|NCT00770562|1019611|P2|Overall Study|Did not take treatment|1
310868|NCT00770562|1019612|P1|Overall Study|Did not take treatment|1
310869|NCT00770510|1019623|P1|Overall Study|Withdrawal by Subject|2
310870|NCT00770510|1019623|P1|Overall Study|Pregnancy|1
310871|NCT00770510|1019623|P1|Overall Study|Lost to Follow-up|2
310872|NCT00770484|1019662|P2|Overall Study|Withdrawal by Subject|0
310873|NCT00770484|1019663|P1|Overall Study|Withdrawal by Subject|1
310874|NCT00770432|1019671|P2|Overall Study|Non-compliance|1
310875|NCT00770432|1019672|P1|Overall Study|Non-compliance|0
310876|NCT00770432|1019671|P2|Overall Study|Not specified|6
310877|NCT00770432|1019672|P1|Overall Study|Not specified|4
310878|NCT00770367|1019680|P2|Second Intervention|Lost to Follow-up|0
310879|NCT00770367|1019681|P1|Second Intervention|Lost to Follow-up|2
310880|NCT00770367|1019680|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
310881|NCT00770367|1019681|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
310882|NCT00770367|1019680|P2|First Intervention|Withdrawal by Subject|2
310883|NCT00770367|1019681|P1|First Intervention|Withdrawal by Subject|0
310884|NCT00770341|1019690|P3|Overall Study|Not treated|0
310885|NCT00770341|1019691|P2|Overall Study|Not treated|0
310886|NCT00770341|1019692|P1|Overall Study|Not treated|1
310887|NCT00770341|1019690|P3|Overall Study|Not specified|0
310888|NCT00770341|1019691|P2|Overall Study|Not specified|0
310889|NCT00770341|1019692|P1|Overall Study|Not specified|1
310890|NCT00770341|1019690|P3|Overall Study|Lack of Efficacy|1
310891|NCT00770341|1019691|P2|Overall Study|Lack of Efficacy|0
310892|NCT00770341|1019692|P1|Overall Study|Lack of Efficacy|3
310893|NCT00770341|1019690|P3|Overall Study|Laboratory adverse event|0
310894|NCT00770341|1019691|P2|Overall Study|Laboratory adverse event|3
310895|NCT00770341|1019692|P1|Overall Study|Laboratory adverse event|3
310896|NCT00770341|1019690|P3|Overall Study|Clinical Adverse Event|2
310897|NCT00770341|1019691|P2|Overall Study|Clinical Adverse Event|1
310898|NCT00770341|1019692|P1|Overall Study|Clinical Adverse Event|3
310899|NCT00770341|1019690|P3|Overall Study|Withdrawal by Subject|0
310900|NCT00770341|1019691|P2|Overall Study|Withdrawal by Subject|1
310901|NCT00770341|1019692|P1|Overall Study|Withdrawal by Subject|0
310902|NCT00770341|1019690|P3|Overall Study|Did not meet eligibility criteria|0
310903|NCT00770341|1019691|P2|Overall Study|Did not meet eligibility criteria|0
310904|NCT00770341|1019692|P1|Overall Study|Did not meet eligibility criteria|1
310905|NCT00770315|1019720|P4|Overall Study|Noncompliance with Protocol|9
310906|NCT00770315|1019721|P3|Overall Study|Noncompliance with Protocol|7
310907|NCT00770315|1019722|P2|Overall Study|Noncompliance with Protocol|4
310908|NCT00770315|1019723|P1|Overall Study|Noncompliance with Protocol|7
310909|NCT00770315|1019720|P4|Overall Study|Withdrawal by Subject|20
310910|NCT00770315|1019721|P3|Overall Study|Withdrawal by Subject|24
310911|NCT00770315|1019722|P2|Overall Study|Withdrawal by Subject|17
310912|NCT00770315|1019723|P1|Overall Study|Withdrawal by Subject|13
310913|NCT00770315|1019720|P4|Overall Study|Lost to Follow-up|3
310914|NCT00770315|1019721|P3|Overall Study|Lost to Follow-up|10
310915|NCT00770315|1019722|P2|Overall Study|Lost to Follow-up|5
310916|NCT00770315|1019723|P1|Overall Study|Lost to Follow-up|9
310917|NCT00770315|1019720|P4|Overall Study|Adverse Event|6
310918|NCT00770315|1019721|P3|Overall Study|Adverse Event|16
310919|NCT00770315|1019722|P2|Overall Study|Adverse Event|17
310920|NCT00770315|1019723|P1|Overall Study|Adverse Event|11
310921|NCT00770289|1019749|P1|Overall Study|Unspecified|6
310922|NCT00770211|1019760|P2|Overall Study|Withdrawal by Subject|2
310923|NCT00770211|1019761|P1|Overall Study|Withdrawal by Subject|0
310924|NCT00770211|1019760|P2|Overall Study|Lost to Follow-up|0
310925|NCT00770211|1019761|P1|Overall Study|Lost to Follow-up|1
310926|NCT00770146|1019777|P2|Follow-up Period|Other|5
310927|NCT00770146|1019778|P1|Follow-up Period|Other|4
310928|NCT00770146|1019777|P2|Follow-up Period|Adverse Event|2
310929|NCT00770146|1019778|P1|Follow-up Period|Adverse Event|0
310930|NCT00770146|1019777|P2|Follow-up Period|Withdrawal by Subject|13
310931|NCT00770146|1019778|P1|Follow-up Period|Withdrawal by Subject|7
310932|NCT00770146|1019777|P2|Treatment Period|Protocol non-compliance|1
310933|NCT00770146|1019778|P1|Treatment Period|Protocol non-compliance|0
310934|NCT00770146|1019777|P2|Treatment Period|Other|5
310935|NCT00770146|1019778|P1|Treatment Period|Other|1
310936|NCT00770146|1019777|P2|Treatment Period|Adverse Event|26
310937|NCT00770146|1019778|P1|Treatment Period|Adverse Event|2
310938|NCT00770146|1019777|P2|Treatment Period|Withdrawal by Subject|13
310939|NCT00770146|1019778|P1|Treatment Period|Withdrawal by Subject|6
310940|NCT00770120|1019822|P1|Overall Study|Reason under Review|1
310941|NCT00770120|1019822|P1|Overall Study|Never Received Treatment/Not Analyzable|1
310942|NCT00770120|1019822|P1|Overall Study|Ineligible|1
310943|NCT00770120|1019822|P1|Overall Study|Withdrawal by Subject|2
310944|NCT00770120|1019822|P1|Overall Study|Death|3
310945|NCT00770120|1019822|P1|Overall Study|Not Protocol Specified|11
310946|NCT00770120|1019822|P1|Overall Study|Adverse Event|11
310947|NCT00770120|1019822|P1|Overall Study|Progression|31
310948|NCT00770029|1019831|P2|Overall Study|Adverse Event|0
310949|NCT00770029|1019832|P1|Overall Study|Adverse Event|1
310950|NCT00770029|1019831|P2|Overall Study|Withdrawal by Subject|3
310951|NCT00770029|1019832|P1|Overall Study|Withdrawal by Subject|3
310952|NCT00770029|1019831|P2|Overall Study|Lost to Follow-up|0
310953|NCT00770029|1019832|P1|Overall Study|Lost to Follow-up|2
310954|NCT00769860|1019848|P2|Overall Study|Withdrawal by Subject|0
310955|NCT00769860|1019849|P1|Overall Study|Withdrawal by Subject|2
310956|NCT00769704|1019877|P2|Overall Study|Other|2
310957|NCT00769704|1019878|P1|Overall Study|Other|1
310958|NCT00769704|1019877|P2|Overall Study|Withdrawal by Subject|5
310959|NCT00769704|1019878|P1|Overall Study|Withdrawal by Subject|12
310960|NCT00769704|1019877|P2|Overall Study|Death|190
310961|NCT00769704|1019878|P1|Overall Study|Death|95
310962|NCT00769704|1019877|P2|Overall Study|Lost to Follow-up|2
310963|NCT00769704|1019878|P1|Overall Study|Lost to Follow-up|3
310964|NCT00769561|1019911|P2|Overall Study|Lost to Follow-up|3
310965|NCT00769561|1019912|P1|Overall Study|Lost to Follow-up|1
310966|NCT00769561|1019911|P2|Overall Study|Withdrawal by Subject|2
310967|NCT00769561|1019912|P1|Overall Study|Withdrawal by Subject|2
310968|NCT00769184|1019961|P2|No Treatment (6 Weeks)|Adverse Event|1
310969|NCT00769184|1019962|P1|No Treatment (6 Weeks)|Adverse Event|1
310970|NCT00769184|1019961|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
310971|NCT00769184|1019962|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
310972|NCT00769184|1019961|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
310973|NCT00769184|1019962|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
310974|NCT00769132|1019970|P4|Period 4|Withdrawal by Subject|0
310975|NCT00769132|1019971|P3|Period 4|Withdrawal by Subject|0
310976|NCT00769132|1019972|P2|Period 4|Withdrawal by Subject|1
310977|NCT00769132|1019973|P1|Period 4|Withdrawal by Subject|0
310978|NCT00769132|1019970|P4|Period 3|Withdrawal by Subject|0
310979|NCT00769132|1019971|P3|Period 3|Withdrawal by Subject|0
310980|NCT00769132|1019972|P2|Period 3|Withdrawal by Subject|0
310981|NCT00769132|1019973|P1|Period 3|Withdrawal by Subject|1
310982|NCT00769132|1019970|P4|Period 2|Withdrawal by Subject|1
310983|NCT00769132|1019971|P3|Period 2|Withdrawal by Subject|0
310984|NCT00769132|1019972|P2|Period 2|Withdrawal by Subject|0
310985|NCT00769132|1019973|P1|Period 2|Withdrawal by Subject|0
310986|NCT00769132|1019970|P4|Period 1|Adverse Event|1
310987|NCT00769132|1019971|P3|Period 1|Adverse Event|0
310988|NCT00769132|1019972|P2|Period 1|Adverse Event|0
310989|NCT00769132|1019973|P1|Period 1|Adverse Event|1
310990|NCT00769119|1019989|P2|Overall Study|Disallowed medication|0
310991|NCT00769119|1019990|P1|Overall Study|Disallowed medication|1
310992|NCT00769119|1019989|P2|Overall Study|Adverse Event|1
310993|NCT00769119|1019990|P1|Overall Study|Adverse Event|1
310994|NCT00769119|1019989|P2|Overall Study|Voluntary discontinuation|2
310995|NCT00769119|1019990|P1|Overall Study|Voluntary discontinuation|0
310996|NCT00769067|1020036|P2|Overall Study|Withdrawal by Subject|1
310997|NCT00769067|1020037|P1|Overall Study|Withdrawal by Subject|0
310998|NCT00769067|1020036|P2|Overall Study|Unspecified|3
310999|NCT00769067|1020037|P1|Overall Study|Unspecified|1
311000|NCT00769067|1020036|P2|Overall Study|Study terminated by sponsor|3
311001|NCT00769067|1020037|P1|Overall Study|Study terminated by sponsor|1
311002|NCT00769067|1020036|P2|Overall Study|Lost to Follow-up|1
311003|NCT00769067|1020037|P1|Overall Study|Lost to Follow-up|3
311004|NCT00769067|1020036|P2|Overall Study|Death|86
311005|NCT00769067|1020037|P1|Overall Study|Death|89
311006|NCT00768989|1020085|P2|On or After Week 36|Sponsor Termination|26
311007|NCT00768989|1020086|P1|On or After Week 36|Sponsor Termination|45
311008|NCT00768989|1020085|P2|On or After Week 36|Did not attend termination visit|0
311009|NCT00768989|1020086|P1|On or After Week 36|Did not attend termination visit|2
311010|NCT00768989|1020085|P2|On or After Week 36|Protocol Violation|0
311011|NCT00768989|1020086|P1|On or After Week 36|Protocol Violation|1
311012|NCT00768989|1020085|P2|On or After Week 36|Poor Compliance|0
311013|NCT00768989|1020086|P1|On or After Week 36|Poor Compliance|1
311014|NCT00768989|1020085|P2|On or After Week 36|Lost to Follow-up|0
311015|NCT00768989|1020086|P1|On or After Week 36|Lost to Follow-up|1
311016|NCT00768989|1020085|P2|On or After Week 36|Adverse Event|1
311017|NCT00768989|1020086|P1|On or After Week 36|Adverse Event|0
311018|NCT00768989|1020085|P2|On or After Week 36|Lack of Efficacy|0
311019|NCT00768989|1020086|P1|On or After Week 36|Lack of Efficacy|1
311020|NCT00768989|1020085|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
311021|NCT00768989|1020086|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
311022|NCT00768989|1020085|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
311023|NCT00768989|1020086|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
311024|NCT00768989|1020085|P2|Week 24 to Prior to Week 36|Adverse Event|0
311025|NCT00768989|1020086|P1|Week 24 to Prior to Week 36|Adverse Event|1
311026|NCT00768989|1020085|P2|Prior to Week 24|Protocol Violation|2
311027|NCT00768989|1020086|P1|Prior to Week 24|Protocol Violation|0
311028|NCT00768989|1020085|P2|Prior to Week 24|Lost to Follow-up|1
311029|NCT00768989|1020086|P1|Prior to Week 24|Lost to Follow-up|0
311030|NCT00768989|1020085|P2|Prior to Week 24|Adverse Event|0
311031|NCT00768989|1020086|P1|Prior to Week 24|Adverse Event|3
311032|NCT00768989|1020085|P2|Prior to Week 24|Withdrawal by Subject|0
311033|NCT00768989|1020086|P1|Prior to Week 24|Withdrawal by Subject|1
311034|NCT00768898|1020134|P1|Overall Study|Headache|1
311035|NCT00768898|1020134|P1|Overall Study|Unrelated injury|1
311036|NCT00768755|1020158|P4|Phase 2|Randomized but not treated|2
311037|NCT00768755|1020159|P3|Phase 2|Randomized but not treated|0
311038|NCT00768755|1020160|P2|Phase 2|Randomized but not treated|0
311039|NCT00768755|1020161|P1|Phase 2|Randomized but not treated|0
311040|NCT00768755|1020158|P4|Phase 2|Study Terminated by Sponsor|14
311041|NCT00768755|1020159|P3|Phase 2|Study Terminated by Sponsor|7
311042|NCT00768755|1020160|P2|Phase 2|Study Terminated by Sponsor|13
311043|NCT00768755|1020161|P1|Phase 2|Study Terminated by Sponsor|0
311044|NCT00768755|1020158|P4|Phase 2|Unspecified|4
311045|NCT00768755|1020159|P3|Phase 2|Unspecified|2
311046|NCT00768755|1020160|P2|Phase 2|Unspecified|1
311047|NCT00768755|1020161|P1|Phase 2|Unspecified|0
311048|NCT00768755|1020158|P4|Phase 2|Withdrawal by Subject|1
311049|NCT00768755|1020159|P3|Phase 2|Withdrawal by Subject|0
311050|NCT00768755|1020160|P2|Phase 2|Withdrawal by Subject|1
311051|NCT00768755|1020161|P1|Phase 2|Withdrawal by Subject|0
311052|NCT00768755|1020158|P4|Phase 2|Lost to Follow-up|4
311053|NCT00768755|1020159|P3|Phase 2|Lost to Follow-up|1
311054|NCT00768755|1020160|P2|Phase 2|Lost to Follow-up|1
311055|NCT00768755|1020161|P1|Phase 2|Lost to Follow-up|0
311056|NCT00768755|1020158|P4|Phase 2|Protocol Violation|1
311057|NCT00768755|1020159|P3|Phase 2|Protocol Violation|0
311058|NCT00768755|1020160|P2|Phase 2|Protocol Violation|2
311059|NCT00768755|1020161|P1|Phase 2|Protocol Violation|0
311060|NCT00768755|1020158|P4|Phase 2|Death|31
311061|NCT00768755|1020159|P3|Phase 2|Death|48
311062|NCT00768755|1020160|P2|Phase 2|Death|37
311063|NCT00768755|1020161|P1|Phase 2|Death|0
311064|NCT00768755|1020158|P4|Phase 1|Unspecified|0
311065|NCT00768755|1020159|P3|Phase 1|Unspecified|0
311066|NCT00768755|1020160|P2|Phase 1|Unspecified|0
311067|NCT00768755|1020161|P1|Phase 1|Unspecified|4
311068|NCT00768755|1020158|P4|Phase 1|Death|0
311069|NCT00768755|1020159|P3|Phase 1|Death|0
311070|NCT00768755|1020160|P2|Phase 1|Death|0
311071|NCT00768755|1020161|P1|Phase 1|Death|6
311072|NCT00768651|1020185|P1|Overall Study|Withdrawal by Subject|1
311073|NCT00768560|1020224|P6|Intervention Set 1|Adverse Event|0
311074|NCT00768560|1020225|P5|Intervention Set 1|Adverse Event|0
311075|NCT00768560|1020226|P4|Intervention Set 1|Adverse Event|0
311076|NCT00768560|1020227|P3|Intervention Set 1|Adverse Event|0
311077|NCT00768560|1020228|P2|Intervention Set 1|Adverse Event|1
311078|NCT00768560|1020229|P1|Intervention Set 1|Adverse Event|0
311079|NCT00768430|1020266|P2|7 Day Endpoint|Withdrawal by Subject|3
311080|NCT00768430|1020267|P1|7 Day Endpoint|Withdrawal by Subject|2
311081|NCT00768300|1020275|P2|Overall Study|Missing data|0
311082|NCT00768300|1020276|P1|Overall Study|Missing data|1
311083|NCT00768300|1020275|P2|Overall Study|Treated but never dosed with Study drug|0
311084|NCT00768300|1020276|P1|Overall Study|Treated but never dosed with Study drug|1
311085|NCT00768300|1020275|P2|Overall Study|Began prohibited concomitant medication|1
311086|NCT00768300|1020276|P1|Overall Study|Began prohibited concomitant medication|0
311087|NCT00768300|1020275|P2|Overall Study|Lost to Follow-up|1
311088|NCT00768300|1020276|P1|Overall Study|Lost to Follow-up|0
311089|NCT00768300|1020275|P2|Overall Study|Received lung transplant|1
311090|NCT00768300|1020276|P1|Overall Study|Received lung transplant|1
311091|NCT00768300|1020275|P2|Overall Study|Screen failure following randomization|0
311092|NCT00768300|1020276|P1|Overall Study|Screen failure following randomization|1
311093|NCT00768300|1020275|P2|Overall Study|Subject moved to pursue lung transplant|1
311094|NCT00768300|1020276|P1|Overall Study|Subject moved to pursue lung transplant|1
311095|NCT00768300|1020275|P2|Overall Study|Death|5
311096|NCT00768300|1020276|P1|Overall Study|Death|21
311097|NCT00768300|1020275|P2|Overall Study|Study discontinued by Sponsor|140
311098|NCT00768300|1020276|P1|Overall Study|Study discontinued by Sponsor|271
311099|NCT00768300|1020275|P2|Overall Study|Physician Decision|3
311100|NCT00768300|1020276|P1|Overall Study|Physician Decision|2
311101|NCT00768300|1020275|P2|Overall Study|Withdrawal by Subject|7
311102|NCT00768300|1020276|P1|Overall Study|Withdrawal by Subject|13
311103|NCT00768300|1020275|P2|Overall Study|Protocol Violation|1
311104|NCT00768300|1020276|P1|Overall Study|Protocol Violation|6
311105|NCT00768300|1020275|P2|Overall Study|Adverse Event|2
311106|NCT00768300|1020276|P1|Overall Study|Adverse Event|10
311107|NCT00768300|1020275|P2|Overall Study|Randomized but not treated|1
311108|NCT00768300|1020276|P1|Overall Study|Randomized but not treated|1
311109|NCT00768222|1020300|P2|Overall Study|Protocol Violation|2
311110|NCT00768222|1020301|P1|Overall Study|Protocol Violation|0
311111|NCT00768222|1020300|P2|Overall Study|Withdrawal by Subject|1
311112|NCT00768222|1020301|P1|Overall Study|Withdrawal by Subject|3
311113|NCT00768222|1020300|P2|Overall Study|Lost to Follow-up|1
311114|NCT00768222|1020301|P1|Overall Study|Lost to Follow-up|1
311115|NCT00768144|1020323|P1|Overall Study|Pt Withdrew Consent|1
311116|NCT00768144|1020323|P1|Overall Study|Patient or MD Decision to End Treatment|1
311117|NCT00768144|1020323|P1|Overall Study|Progressive Disease|21
311118|NCT00768144|1020323|P1|Overall Study|Adverse Event|13
311119|NCT00768066|1020336|P3|Overall Study|Did not receive study product injection.|0
311120|NCT00768066|1020337|P2|Overall Study|Did not receive study product injection.|3
311121|NCT00768066|1020338|P1|Overall Study|Did not receive study product injection.|3
311122|NCT00768053|1020370|P1|Overall Study|Lost to Follow-up|1
311123|NCT00768053|1020370|P1|Overall Study|Adverse Event|10
311124|NCT00768040|1020401|P2|Overall Study|Abnormal laboratory value|1
311125|NCT00768040|1020402|P1|Overall Study|Abnormal laboratory value|1
311126|NCT00768040|1020401|P2|Overall Study|Adverse Event|2
311127|NCT00768040|1020402|P1|Overall Study|Adverse Event|3
311128|NCT00767806|1020410|P2|Overall Study|Sponsor Decision|1
311129|NCT00767806|1020411|P1|Overall Study|Sponsor Decision|0
311130|NCT00767806|1020410|P2|Overall Study|Entry Criteria Not Met|1
311131|NCT00767806|1020411|P1|Overall Study|Entry Criteria Not Met|1
311132|NCT00767806|1020410|P2|Overall Study|Lost to Follow-up|4
311133|NCT00767806|1020411|P1|Overall Study|Lost to Follow-up|1
311134|NCT00767806|1020410|P2|Overall Study|Physician Decision|3
311135|NCT00767806|1020411|P1|Overall Study|Physician Decision|4
311136|NCT00767806|1020410|P2|Overall Study|Lack of Efficacy|9
311137|NCT00767806|1020411|P1|Overall Study|Lack of Efficacy|1
311138|NCT00767806|1020410|P2|Overall Study|Protocol Violation|5
311139|NCT00767806|1020411|P1|Overall Study|Protocol Violation|6
311140|NCT00767806|1020410|P2|Overall Study|Withdrawal by Subject|13
311141|NCT00767806|1020411|P1|Overall Study|Withdrawal by Subject|8
311142|NCT00767806|1020410|P2|Overall Study|Adverse Event|11
311143|NCT00767806|1020411|P1|Overall Study|Adverse Event|30
311144|NCT00767676|1020488|P1|Overall Study|Investigator error|54
311145|NCT00767520|1020511|P2|Overall Study|Randomized in error and Never treated|2
311146|NCT00767520|1020512|P1|Overall Study|Randomized in error and Never treated|0
311147|NCT00767520|1020511|P2|Overall Study|Participants still on treatment|15
311148|NCT00767520|1020512|P1|Overall Study|Participants still on treatment|11
311149|NCT00767455|1020565|P1|Overall Study|Investigator error|19
311150|NCT00767325|1020599|P1|Overall Study|Missed visit due to family reasons|1
311151|NCT00767325|1020599|P1|Overall Study|No longer met study criteria|2
311152|NCT00767325|1020599|P1|Overall Study|Lost to Follow-up|3
311153|NCT00767325|1020599|P1|Overall Study|Adverse Event|7
311154|NCT00767325|1020599|P1|Overall Study|Lack of Efficacy|2
311155|NCT00767104|1020610|P2|Overall Study|Lost to Follow-up|2
311156|NCT00767104|1020611|P1|Overall Study|Lost to Follow-up|1
311157|NCT00767039|1020621|P2|Overall Study|Death|2
311158|NCT00767039|1020622|P1|Overall Study|Death|5
311159|NCT00767000|1020653|P5|Optional 104-week Extension|Study terminated by sponsor|4
311160|NCT00767000|1020654|P4|Optional 104-week Extension|Study terminated by sponsor|2
311161|NCT00767000|1020655|P3|Optional 104-week Extension|Study terminated by sponsor|7
311162|NCT00767000|1020656|P2|Optional 104-week Extension|Study terminated by sponsor|3
311163|NCT00767000|1020657|P1|Optional 104-week Extension|Study terminated by sponsor|7
311164|NCT00767000|1020653|P5|54-week Study|Reason not reported|0
311165|NCT00767000|1020654|P4|54-week Study|Reason not reported|1
311166|NCT00767000|1020655|P3|54-week Study|Reason not reported|0
311167|NCT00767000|1020656|P2|54-week Study|Reason not reported|0
311168|NCT00767000|1020657|P1|54-week Study|Reason not reported|0
311169|NCT00767000|1020653|P5|54-week Study|Study terminated by sponsor|194
311170|NCT00767000|1020654|P4|54-week Study|Study terminated by sponsor|196
311171|NCT00767000|1020655|P3|54-week Study|Study terminated by sponsor|89
311172|NCT00767000|1020656|P2|54-week Study|Study terminated by sponsor|102
311173|NCT00767000|1020657|P1|54-week Study|Study terminated by sponsor|90
311174|NCT00767000|1020653|P5|54-week Study|Withdrawal by Subject|13
311175|NCT00767000|1020654|P4|54-week Study|Withdrawal by Subject|11
311176|NCT00767000|1020655|P3|54-week Study|Withdrawal by Subject|5
311177|NCT00767000|1020656|P2|54-week Study|Withdrawal by Subject|3
311178|NCT00767000|1020657|P1|54-week Study|Withdrawal by Subject|2
311179|NCT00767000|1020653|P5|54-week Study|Protocol Violation|0
311180|NCT00767000|1020654|P4|54-week Study|Protocol Violation|2
311181|NCT00767000|1020655|P3|54-week Study|Protocol Violation|1
311182|NCT00767000|1020656|P2|54-week Study|Protocol Violation|0
311183|NCT00767000|1020657|P1|54-week Study|Protocol Violation|0
311184|NCT00767000|1020653|P5|54-week Study|Progressive disease|0
311185|NCT00767000|1020654|P4|54-week Study|Progressive disease|0
311186|NCT00767000|1020655|P3|54-week Study|Progressive disease|1
311187|NCT00767000|1020656|P2|54-week Study|Progressive disease|0
311188|NCT00767000|1020657|P1|54-week Study|Progressive disease|0
311189|NCT00767000|1020653|P5|54-week Study|Physician Decision|1
311190|NCT00767000|1020654|P4|54-week Study|Physician Decision|1
311191|NCT00767000|1020655|P3|54-week Study|Physician Decision|1
311192|NCT00767000|1020656|P2|54-week Study|Physician Decision|0
311193|NCT00767000|1020657|P1|54-week Study|Physician Decision|4
311194|NCT00767000|1020653|P5|54-week Study|Lost to Follow-up|2
311195|NCT00767000|1020654|P4|54-week Study|Lost to Follow-up|4
311196|NCT00767000|1020655|P3|54-week Study|Lost to Follow-up|1
311197|NCT00767000|1020656|P2|54-week Study|Lost to Follow-up|0
311198|NCT00767000|1020657|P1|54-week Study|Lost to Follow-up|4
311199|NCT00767000|1020653|P5|54-week Study|Lack of Efficacy|5
311200|NCT00767000|1020654|P4|54-week Study|Lack of Efficacy|0
311201|NCT00767000|1020655|P3|54-week Study|Lack of Efficacy|1
311202|NCT00767000|1020656|P2|54-week Study|Lack of Efficacy|0
311203|NCT00767000|1020657|P1|54-week Study|Lack of Efficacy|2
311204|NCT00767000|1020653|P5|54-week Study|Interruption of study medication|0
311205|NCT00767000|1020654|P4|54-week Study|Interruption of study medication|0
311206|NCT00767000|1020655|P3|54-week Study|Interruption of study medication|1
311207|NCT00767000|1020656|P2|54-week Study|Interruption of study medication|0
311208|NCT00767000|1020657|P1|54-week Study|Interruption of study medication|0
311209|NCT00767000|1020653|P5|54-week Study|Hypoglycemia|0
311210|NCT00767000|1020654|P4|54-week Study|Hypoglycemia|0
311211|NCT00767000|1020655|P3|54-week Study|Hypoglycemia|0
311212|NCT00767000|1020656|P2|54-week Study|Hypoglycemia|1
311213|NCT00767000|1020657|P1|54-week Study|Hypoglycemia|0
311214|NCT00767000|1020653|P5|54-week Study|Hyperglycemia|1
311215|NCT00767000|1020654|P4|54-week Study|Hyperglycemia|0
311216|NCT00767000|1020655|P3|54-week Study|Hyperglycemia|1
311217|NCT00767000|1020656|P2|54-week Study|Hyperglycemia|0
311218|NCT00767000|1020657|P1|54-week Study|Hyperglycemia|0
311219|NCT00767000|1020653|P5|54-week Study|Creaninine/creatinine clearance|4
311220|NCT00767000|1020654|P4|54-week Study|Creaninine/creatinine clearance|2
311221|NCT00767000|1020655|P3|54-week Study|Creaninine/creatinine clearance|2
311222|NCT00767000|1020656|P2|54-week Study|Creaninine/creatinine clearance|1
311223|NCT00767000|1020657|P1|54-week Study|Creaninine/creatinine clearance|2
311224|NCT00767000|1020653|P5|54-week Study|Adverse Event|4
311225|NCT00767000|1020654|P4|54-week Study|Adverse Event|8
311226|NCT00767000|1020655|P3|54-week Study|Adverse Event|6
311227|NCT00767000|1020656|P2|54-week Study|Adverse Event|6
311228|NCT00767000|1020657|P1|54-week Study|Adverse Event|4
311229|NCT00766831|1020699|P1|Overall Study|Not specified|28
311230|NCT00766831|1020699|P1|Overall Study|Non cooperation by participants|14
311231|NCT00766831|1020699|P1|Overall Study|Withdrawal of consent|26
311232|NCT00766831|1020699|P1|Overall Study|Physician Decision|5
311233|NCT00766831|1020699|P1|Overall Study|Protocol Violation|15
311234|NCT00766831|1020699|P1|Overall Study|Adverse Event|20
311235|NCT00766831|1020699|P1|Overall Study|Lost to Follow-up|3
311236|NCT00766831|1020699|P1|Overall Study|Withdrawal by Subject|4
311237|NCT00766675|1020729|P1|Overall Study|Insufficient therapy|1
311238|NCT00766675|1020729|P1|Overall Study|Receive other anti-neoplastic treatment|1
311239|NCT00766675|1020729|P1|Overall Study|Participant took prohibited medication|1
311240|NCT00766675|1020729|P1|Overall Study|Protocol Violation|8
311241|NCT00766675|1020729|P1|Overall Study|Withdrawal by Subject|11
311242|NCT00766675|1020729|P1|Overall Study|Lost to Follow-up|2
311243|NCT00766675|1020729|P1|Overall Study|Adverse Event|16
311244|NCT00766636|1020756|P2|Overall Study|Disease Progression|0
311245|NCT00766636|1020757|P1|Overall Study|Disease Progression|1
311246|NCT00766636|1020756|P2|Overall Study|Adverse Event|0
311247|NCT00766636|1020757|P1|Overall Study|Adverse Event|1
311248|NCT00766636|1020756|P2|Overall Study|Incomplete Treatment|1
311249|NCT00766636|1020757|P1|Overall Study|Incomplete Treatment|0
311250|NCT00766636|1020756|P2|Overall Study|Withdrawal by Subject|1
311251|NCT00766636|1020757|P1|Overall Study|Withdrawal by Subject|1
311252|NCT00766597|1020763|P1|Overall Study|Without CCR5-tropic virus|5
311253|NCT00766597|1020763|P1|Overall Study|Unexpected closure of study|4
311254|NCT00766532|1020775|P1|Overall Study|Protocol Violation|2
311255|NCT00766506|1020781|P2|Overall Study|Unspecified|2
311256|NCT00766506|1020782|P1|Overall Study|Unspecified|2
311257|NCT00766506|1020781|P2|Overall Study|Use rescue medication after 3 hours|0
311258|NCT00766506|1020782|P1|Overall Study|Use rescue medication after 3 hours|3
311259|NCT00766493|1020806|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
311260|NCT00766493|1020806|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
311261|NCT00766493|1020806|P1|30 Days Post-Procedure|Discontinued|7
311262|NCT00766467|1020816|P2|Overall Study|Physician Decision|0
311263|NCT00766467|1020817|P1|Overall Study|Physician Decision|1
311264|NCT00766467|1020816|P2|Overall Study|Tumor Progression on Study|1
311265|NCT00766467|1020817|P1|Overall Study|Tumor Progression on Study|0
311266|NCT00766467|1020816|P2|Overall Study|Protocol Violation|4
311267|NCT00766467|1020817|P1|Overall Study|Protocol Violation|2
311268|NCT00766467|1020816|P2|Overall Study|Adverse Event|1
311269|NCT00766467|1020817|P1|Overall Study|Adverse Event|1
311270|NCT00766467|1020816|P2|Overall Study|Withdrawal by Subject|2
311271|NCT00766467|1020817|P1|Overall Study|Withdrawal by Subject|7
311272|NCT00766415|1020829|P2|Overall Study|Withdrawal by Subject|1
311273|NCT00766415|1020830|P1|Overall Study|Withdrawal by Subject|0
311274|NCT00766376|1020878|P1|Overall Study|Withdrawal by Subject|27
311275|NCT00766363|1020887|P4|Overall Study|Adverse Event Prior to Randomization|0
311276|NCT00766363|1020888|P3|Overall Study|Adverse Event Prior to Randomization|0
311277|NCT00766363|1020889|P2|Overall Study|Adverse Event Prior to Randomization|1
311278|NCT00766363|1020890|P1|Overall Study|Adverse Event Prior to Randomization|0
311279|NCT00766363|1020887|P4|Overall Study|Withdrawal by Subject|0
311280|NCT00766363|1020888|P3|Overall Study|Withdrawal by Subject|0
311281|NCT00766363|1020889|P2|Overall Study|Withdrawal by Subject|0
311282|NCT00766363|1020890|P1|Overall Study|Withdrawal by Subject|1
311283|NCT00766090|1020929|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311284|NCT00766090|1020930|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311285|NCT00766090|1020931|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311286|NCT00766090|1020932|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311287|NCT00766090|1020933|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311288|NCT00766090|1020934|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311289|NCT00766090|1020935|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311290|NCT00766090|1020936|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
311291|NCT00766090|1020937|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311292|NCT00766090|1020938|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311293|NCT00766090|1020939|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311294|NCT00766090|1020940|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
311295|NCT00766090|1020929|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
311296|NCT00766090|1020930|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
311297|NCT00766090|1020931|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
311298|NCT00766090|1020932|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
311299|NCT00766090|1020933|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
311300|NCT00766090|1020934|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
311301|NCT00766090|1020935|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
311302|NCT00766090|1020936|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
311303|NCT00766090|1020937|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
311304|NCT00766090|1020938|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
311305|NCT00766090|1020939|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
311306|NCT00766090|1020940|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
311307|NCT00766090|1020929|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
311308|NCT00766090|1020930|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
311309|NCT00766090|1020931|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
311310|NCT00766090|1020932|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
311311|NCT00766090|1020933|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
311312|NCT00766090|1020934|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
311313|NCT00766090|1020935|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
311314|NCT00766090|1020936|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
311315|NCT00766090|1020937|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
311316|NCT00766090|1020938|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
311317|NCT00766090|1020939|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
311318|NCT00766090|1020940|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
311319|NCT00766090|1020929|P12|Washout Period 2 (14 Days)|Physician Decision|0
311320|NCT00766090|1020930|P11|Washout Period 2 (14 Days)|Physician Decision|0
311321|NCT00766090|1020931|P10|Washout Period 2 (14 Days)|Physician Decision|0
311322|NCT00766090|1020932|P9|Washout Period 2 (14 Days)|Physician Decision|0
311323|NCT00766090|1020933|P8|Washout Period 2 (14 Days)|Physician Decision|0
311324|NCT00766090|1020934|P7|Washout Period 2 (14 Days)|Physician Decision|0
311325|NCT00766090|1020935|P6|Washout Period 2 (14 Days)|Physician Decision|0
311326|NCT00766090|1020936|P5|Washout Period 2 (14 Days)|Physician Decision|0
311327|NCT00766090|1020937|P4|Washout Period 2 (14 Days)|Physician Decision|0
311328|NCT00766090|1020938|P3|Washout Period 2 (14 Days)|Physician Decision|1
311329|NCT00766090|1020939|P2|Washout Period 2 (14 Days)|Physician Decision|0
311330|NCT00766090|1020940|P1|Washout Period 2 (14 Days)|Physician Decision|0
311331|NCT00766090|1020929|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311332|NCT00766090|1020930|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311333|NCT00766090|1020931|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311334|NCT00766090|1020932|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311335|NCT00766090|1020933|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311336|NCT00766090|1020934|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311337|NCT00766090|1020935|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311338|NCT00766090|1020936|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311339|NCT00766090|1020937|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311340|NCT00766090|1020938|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
311341|NCT00766090|1020939|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311342|NCT00766090|1020940|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
311343|NCT00766090|1020929|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311344|NCT00766090|1020930|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311345|NCT00766090|1020931|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311346|NCT00766090|1020932|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311347|NCT00766090|1020933|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311348|NCT00766090|1020934|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311349|NCT00766090|1020935|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311350|NCT00766090|1020936|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
311351|NCT00766090|1020937|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311352|NCT00766090|1020938|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311353|NCT00766090|1020939|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311354|NCT00766090|1020940|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
311355|NCT00766090|1020929|P12|Washout Period 1 (14 Days)|Protocol Violation|0
311356|NCT00766090|1020930|P11|Washout Period 1 (14 Days)|Protocol Violation|0
311357|NCT00766090|1020931|P10|Washout Period 1 (14 Days)|Protocol Violation|0
311358|NCT00766090|1020932|P9|Washout Period 1 (14 Days)|Protocol Violation|0
311359|NCT00766090|1020933|P8|Washout Period 1 (14 Days)|Protocol Violation|0
311360|NCT00766090|1020934|P7|Washout Period 1 (14 Days)|Protocol Violation|0
311361|NCT00766090|1020935|P6|Washout Period 1 (14 Days)|Protocol Violation|0
311362|NCT00766090|1020936|P5|Washout Period 1 (14 Days)|Protocol Violation|0
311363|NCT00766090|1020937|P4|Washout Period 1 (14 Days)|Protocol Violation|0
311364|NCT00766090|1020938|P3|Washout Period 1 (14 Days)|Protocol Violation|1
311365|NCT00766090|1020939|P2|Washout Period 1 (14 Days)|Protocol Violation|0
311366|NCT00766090|1020940|P1|Washout Period 1 (14 Days)|Protocol Violation|0
311367|NCT00766090|1020929|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311368|NCT00766090|1020930|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311369|NCT00766090|1020931|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311370|NCT00766090|1020932|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311371|NCT00766090|1020933|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311372|NCT00766090|1020934|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311373|NCT00766090|1020935|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311374|NCT00766090|1020936|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311375|NCT00766090|1020937|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
311376|NCT00766090|1020938|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311377|NCT00766090|1020939|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
311378|NCT00766090|1020940|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
311379|NCT00766090|1020929|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311380|NCT00766090|1020930|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311381|NCT00766090|1020931|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311382|NCT00766090|1020932|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311383|NCT00766090|1020933|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311384|NCT00766090|1020934|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311385|NCT00766090|1020935|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311386|NCT00766090|1020936|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311387|NCT00766090|1020937|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311388|NCT00766090|1020938|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311389|NCT00766090|1020939|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
311390|NCT00766090|1020940|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
311391|NCT00766090|1020929|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311392|NCT00766090|1020930|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311393|NCT00766090|1020931|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311394|NCT00766090|1020932|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
311395|NCT00766090|1020933|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311396|NCT00766090|1020934|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311397|NCT00766090|1020935|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311398|NCT00766090|1020936|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311399|NCT00766090|1020937|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311400|NCT00766090|1020938|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311401|NCT00766090|1020939|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311402|NCT00766090|1020940|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
311403|NCT00766051|1020981|P2|Overall Study|Withdrawal by Subject|0
311404|NCT00766051|1020982|P1|Overall Study|Withdrawal by Subject|2
311405|NCT00765882|1021013|P3|Overall Study|Other Reason|2
311406|NCT00765882|1021014|P2|Overall Study|Other Reason|1
311407|NCT00765882|1021015|P1|Overall Study|Other Reason|3
311408|NCT00765882|1021013|P3|Overall Study|Lost to Follow-up|6
311409|NCT00765882|1021014|P2|Overall Study|Lost to Follow-up|9
311410|NCT00765882|1021015|P1|Overall Study|Lost to Follow-up|1
311411|NCT00765882|1021013|P3|Overall Study|Withdrawal by Subject|6
311412|NCT00765882|1021014|P2|Overall Study|Withdrawal by Subject|6
311413|NCT00765882|1021015|P1|Overall Study|Withdrawal by Subject|2
311414|NCT00765882|1021013|P3|Overall Study|Protocol Violation|1
311415|NCT00765882|1021014|P2|Overall Study|Protocol Violation|3
311416|NCT00765882|1021015|P1|Overall Study|Protocol Violation|4
311417|NCT00765882|1021013|P3|Overall Study|Lack of Efficacy|1
311418|NCT00765882|1021014|P2|Overall Study|Lack of Efficacy|0
311419|NCT00765882|1021015|P1|Overall Study|Lack of Efficacy|4
311420|NCT00765882|1021013|P3|Overall Study|Adverse Event|20
311421|NCT00765882|1021014|P2|Overall Study|Adverse Event|21
311422|NCT00765882|1021015|P1|Overall Study|Adverse Event|10
311423|NCT00765843|1021047|P3|Overall Study|Adverse Event|1
311424|NCT00765843|1021048|P2|Overall Study|Adverse Event|0
311425|NCT00765843|1021049|P1|Overall Study|Adverse Event|0
311426|NCT00765843|1021047|P3|Overall Study|did not return to receive intervention|0
311427|NCT00765843|1021048|P2|Overall Study|did not return to receive intervention|1
311428|NCT00765843|1021049|P1|Overall Study|did not return to receive intervention|0
311429|NCT00765843|1021047|P3|Overall Study|Lost to Follow-up|2
311430|NCT00765843|1021048|P2|Overall Study|Lost to Follow-up|3
311431|NCT00765843|1021049|P1|Overall Study|Lost to Follow-up|1
311432|NCT00765817|1021059|P2|Overall Study|Subject decision|11
311433|NCT00765817|1021060|P1|Overall Study|Subject decision|7
311434|NCT00765817|1021059|P2|Overall Study|Protocol Violation|1
311435|NCT00765817|1021060|P1|Overall Study|Protocol Violation|1
311436|NCT00765817|1021059|P2|Overall Study|Physician Decision|1
311437|NCT00765817|1021060|P1|Overall Study|Physician Decision|2
311438|NCT00765817|1021059|P2|Overall Study|Lost to Follow-up|3
311439|NCT00765817|1021060|P1|Overall Study|Lost to Follow-up|1
311440|NCT00765817|1021059|P2|Overall Study|Loss of glucose control|2
311441|NCT00765817|1021060|P1|Overall Study|Loss of glucose control|0
311442|NCT00765817|1021059|P2|Overall Study|Entry criteria not met|2
311443|NCT00765817|1021060|P1|Overall Study|Entry criteria not met|2
311444|NCT00765817|1021059|P2|Overall Study|Death|1
311445|NCT00765817|1021060|P1|Overall Study|Death|0
311446|NCT00765817|1021059|P2|Overall Study|Adverse Event|1
311447|NCT00765817|1021060|P1|Overall Study|Adverse Event|13
311448|NCT00765726|1021108|P1|Overall Study|Discontinuation of study by sponsor|8
311449|NCT00765726|1021108|P1|Overall Study|Withdrawal by Subject|1
311540|NCT00764946|1021388|P3|Overall Study|Physician Decision|0
311450|NCT00765674|1021116|P4|Overall Study|Randomized in Error - No Study Drug|1
311451|NCT00765674|1021117|P3|Overall Study|Randomized in Error - No Study Drug|0
311452|NCT00765674|1021118|P2|Overall Study|Randomized in Error - No Study Drug|1
311453|NCT00765674|1021119|P1|Overall Study|Randomized in Error - No Study Drug|0
311454|NCT00765674|1021116|P4|Overall Study|Lost to Follow-up|1
311455|NCT00765674|1021117|P3|Overall Study|Lost to Follow-up|2
311456|NCT00765674|1021118|P2|Overall Study|Lost to Follow-up|6
311457|NCT00765674|1021119|P1|Overall Study|Lost to Follow-up|4
311458|NCT00765674|1021116|P4|Overall Study|Withdrawal by Subject|8
311459|NCT00765674|1021117|P3|Overall Study|Withdrawal by Subject|3
311460|NCT00765674|1021118|P2|Overall Study|Withdrawal by Subject|7
311461|NCT00765674|1021119|P1|Overall Study|Withdrawal by Subject|5
311462|NCT00765674|1021116|P4|Overall Study|Protocol Violation|0
311463|NCT00765674|1021117|P3|Overall Study|Protocol Violation|1
311464|NCT00765674|1021118|P2|Overall Study|Protocol Violation|0
311465|NCT00765674|1021119|P1|Overall Study|Protocol Violation|2
311466|NCT00765674|1021116|P4|Overall Study|Lack of Efficacy|2
311467|NCT00765674|1021117|P3|Overall Study|Lack of Efficacy|1
311468|NCT00765674|1021118|P2|Overall Study|Lack of Efficacy|3
311469|NCT00765674|1021119|P1|Overall Study|Lack of Efficacy|2
311470|NCT00765674|1021116|P4|Overall Study|Abnormal Test Procedure Result(s)|2
311471|NCT00765674|1021117|P3|Overall Study|Abnormal Test Procedure Result(s)|1
311472|NCT00765674|1021118|P2|Overall Study|Abnormal Test Procedure Result(s)|3
311473|NCT00765674|1021119|P1|Overall Study|Abnormal Test Procedure Result(s)|1
311474|NCT00765674|1021116|P4|Overall Study|Abnormal Laboratory Value(s)|0
311475|NCT00765674|1021117|P3|Overall Study|Abnormal Laboratory Value(s)|1
311476|NCT00765674|1021118|P2|Overall Study|Abnormal Laboratory Value(s)|0
311477|NCT00765674|1021119|P1|Overall Study|Abnormal Laboratory Value(s)|0
311478|NCT00765674|1021116|P4|Overall Study|Adverse Event|11
311479|NCT00765674|1021117|P3|Overall Study|Adverse Event|8
311480|NCT00765674|1021118|P2|Overall Study|Adverse Event|2
311481|NCT00765674|1021119|P1|Overall Study|Adverse Event|7
311482|NCT00765388|1021186|P2|Period 1|Hip operation|1
311483|NCT00765388|1021187|P1|Period 1|Hip operation|0
311484|NCT00765388|1021186|P2|Period 1|Herpes Zoster|1
311485|NCT00765388|1021187|P1|Period 1|Herpes Zoster|0
311486|NCT00765388|1021186|P2|Period 1|Lost to Follow-up|1
311487|NCT00765388|1021187|P1|Period 1|Lost to Follow-up|0
311488|NCT00765388|1021186|P2|Period 1|Lack of Efficacy|2
311489|NCT00765388|1021187|P1|Period 1|Lack of Efficacy|1
311490|NCT00765362|1021221|P1|Overall Study|Lost to Follow-up|95
311491|NCT00765362|1021221|P1|Overall Study|Withdrawal by Subject|13
311492|NCT00765362|1021221|P1|Overall Study|Protocol Violation|18
311493|NCT00765362|1021221|P1|Overall Study|Adverse Event|2
311494|NCT00765362|1021221|P1|Overall Study|Death|9
311495|NCT00765336|1021229|P2|Overall Study|Adverse Event|1
311496|NCT00765336|1021230|P1|Overall Study|Adverse Event|2
311497|NCT00765336|1021229|P2|Overall Study|Lost to Follow-up|9
311498|NCT00765336|1021230|P1|Overall Study|Lost to Follow-up|7
311499|NCT00765336|1021229|P2|Overall Study|Withdrawal by Subject|4
311500|NCT00765336|1021230|P1|Overall Study|Withdrawal by Subject|6
311501|NCT00765336|1021229|P2|Overall Study|Protocol Violation|2
311502|NCT00765336|1021230|P1|Overall Study|Protocol Violation|4
311503|NCT00765245|1021238|P2|Overall Study|Death|0
311504|NCT00765245|1021239|P1|Overall Study|Death|1
311505|NCT00765245|1021238|P2|Overall Study|Physician Decision|0
311506|NCT00765245|1021239|P1|Overall Study|Physician Decision|1
311507|NCT00765245|1021238|P2|Overall Study|Adverse Event|0
311508|NCT00765245|1021239|P1|Overall Study|Adverse Event|5
311509|NCT00765245|1021238|P2|Overall Study|Withdrawal by Subject|0
311510|NCT00765245|1021239|P1|Overall Study|Withdrawal by Subject|3
311511|NCT00765245|1021238|P2|Overall Study|disease progression|2
311512|NCT00765245|1021239|P1|Overall Study|disease progression|3
311513|NCT00765102|1021285|P1|Overall Study|Protocol Violation|1
311514|NCT00765102|1021285|P1|Overall Study|Withdrawal by Subject|2
311515|NCT00765102|1021285|P1|Overall Study|Physician Decision|4
311516|NCT00765102|1021285|P1|Overall Study|Adverse Event|6
311517|NCT00765102|1021285|P1|Overall Study|Progressive disease|18
311518|NCT00765076|1021310|P3|Overall Study|Withdrawal by Subject|1
311519|NCT00765076|1021311|P2|Overall Study|Withdrawal by Subject|0
311520|NCT00765076|1021312|P1|Overall Study|Withdrawal by Subject|0
311521|NCT00765076|1021310|P3|Overall Study|Adverse Event|0
311522|NCT00765076|1021311|P2|Overall Study|Adverse Event|0
311523|NCT00765076|1021312|P1|Overall Study|Adverse Event|1
311524|NCT00765063|1021365|P1|Overall Study|Adverse Event|4
311525|NCT00765063|1021365|P1|Overall Study|Protocol Violation|6
311526|NCT00765063|1021365|P1|Overall Study|Unspecified|16
311527|NCT00765063|1021365|P1|Overall Study|Withdrawal by Subject|1
311528|NCT00765063|1021365|P1|Overall Study|Lack of Efficacy|5
311529|NCT00765037|1021381|P1|Overall Study|Adverse Event|1
311530|NCT00765037|1021381|P1|Overall Study|Lost to Follow-up|5
311531|NCT00764946|1021388|P3|Overall Study|Never Treated|1
311532|NCT00764946|1021389|P2|Overall Study|Never Treated|1
311533|NCT00764946|1021390|P1|Overall Study|Never Treated|1
311534|NCT00764946|1021388|P3|Overall Study|Withdrawal by Subject|2
311535|NCT00764946|1021389|P2|Overall Study|Withdrawal by Subject|6
311536|NCT00764946|1021390|P1|Overall Study|Withdrawal by Subject|3
311537|NCT00764946|1021388|P3|Overall Study|Adverse Event|1
311538|NCT00764946|1021389|P2|Overall Study|Adverse Event|2
311539|NCT00764946|1021390|P1|Overall Study|Adverse Event|3
311541|NCT00764946|1021389|P2|Overall Study|Physician Decision|4
311542|NCT00764946|1021390|P1|Overall Study|Physician Decision|2
311543|NCT00764946|1021388|P3|Overall Study|Lost to Follow-up|0
311544|NCT00764946|1021389|P2|Overall Study|Lost to Follow-up|4
311545|NCT00764946|1021390|P1|Overall Study|Lost to Follow-up|3
311546|NCT00764946|1021388|P3|Overall Study|Lack of Efficacy|0
311547|NCT00764946|1021389|P2|Overall Study|Lack of Efficacy|0
311548|NCT00764946|1021390|P1|Overall Study|Lack of Efficacy|1
311549|NCT00764881|1021418|P2|Overall Study|no treatment or no observation|2
311550|NCT00764881|1021419|P1|Overall Study|no treatment or no observation|2
311551|NCT00764881|1021418|P2|Overall Study|Possibly noncompliant (study drug)|2
311552|NCT00764881|1021419|P1|Overall Study|Possibly noncompliant (study drug)|0
311553|NCT00764881|1021418|P2|Overall Study|Carcinoma detected|0
311554|NCT00764881|1021419|P1|Overall Study|Carcinoma detected|1
311555|NCT00764881|1021418|P2|Overall Study|Wished to become pregnant|0
311556|NCT00764881|1021419|P1|Overall Study|Wished to become pregnant|1
311557|NCT00764881|1021418|P2|Overall Study|Accidentally discontinued study drug|0
311558|NCT00764881|1021419|P1|Overall Study|Accidentally discontinued study drug|1
311559|NCT00764881|1021418|P2|Overall Study|Noncompliant|0
311560|NCT00764881|1021419|P1|Overall Study|Noncompliant|1
311561|NCT00764881|1021418|P2|Overall Study|Lost to Follow-up|0
311562|NCT00764881|1021419|P1|Overall Study|Lost to Follow-up|2
311563|NCT00764881|1021418|P2|Overall Study|Protocol Violation|2
311564|NCT00764881|1021419|P1|Overall Study|Protocol Violation|2
311565|NCT00764881|1021418|P2|Overall Study|Withdrawal by Subject|3
311566|NCT00764881|1021419|P1|Overall Study|Withdrawal by Subject|1
311567|NCT00764881|1021418|P2|Overall Study|Adverse Event|1
311568|NCT00764881|1021419|P1|Overall Study|Adverse Event|5
311569|NCT00764868|1021643|P1|Overall Study|Sponsor requested withdrawal|1
311570|NCT00764868|1021643|P1|Overall Study|Positive drug screen|2
311571|NCT00764868|1021643|P1|Overall Study|Met an exclusion criteria|1
311572|NCT00764868|1021643|P1|Overall Study|Subject sent to boarding school|1
311573|NCT00764868|1021643|P1|Overall Study|Misuse and compliance of study drug|1
311574|NCT00764868|1021643|P1|Overall Study|Out of town|1
311575|NCT00764868|1021643|P1|Overall Study|Prohibited medication|1
311576|NCT00764868|1021643|P1|Overall Study|Pregnancy|3
311577|NCT00764868|1021643|P1|Overall Study|Subject moved|7
311578|NCT00764868|1021643|P1|Overall Study|Lack of Efficacy|5
311579|NCT00764868|1021643|P1|Overall Study|Lost to Follow-up|25
311580|NCT00764868|1021643|P1|Overall Study|Non-compliance|16
311581|NCT00764868|1021643|P1|Overall Study|Withdrawal by Subject|31
311582|NCT00764868|1021643|P1|Overall Study|Adverse Event|18
311583|NCT00764790|1021652|P3|Overall Study|Lost to Follow-up|23
311584|NCT00764790|1021653|P2|Overall Study|Lost to Follow-up|29
311585|NCT00764790|1021654|P1|Overall Study|Lost to Follow-up|28
311586|NCT00764790|1021652|P3|Overall Study|Withdrawal by Subject|6
311587|NCT00764790|1021653|P2|Overall Study|Withdrawal by Subject|12
311588|NCT00764790|1021654|P1|Overall Study|Withdrawal by Subject|10
311589|NCT00764790|1021652|P3|Overall Study|Protocol Violation|1
311590|NCT00764790|1021653|P2|Overall Study|Protocol Violation|0
311591|NCT00764790|1021654|P1|Overall Study|Protocol Violation|0
311592|NCT00764673|1021686|P1|Overall Study|Revision of Device|2
311593|NCT00764673|1021686|P1|Overall Study|Withdrawal by Subject|6
311594|NCT00764673|1021686|P1|Overall Study|Lost to Follow-up|3
311595|NCT00764673|1021686|P1|Overall Study|Death|1
311596|NCT00764660|1021696|P2|Overall Study|Did Not Meet Protocol Eligibility|0
311597|NCT00764660|1021697|P1|Overall Study|Did Not Meet Protocol Eligibility|1
311598|NCT00764660|1021696|P2|Overall Study|Noncompliance With Protocol|1
311599|NCT00764660|1021697|P1|Overall Study|Noncompliance With Protocol|5
311600|NCT00764660|1021696|P2|Overall Study|Withdrawal by Subject|3
311601|NCT00764660|1021697|P1|Overall Study|Withdrawal by Subject|7
311602|NCT00764660|1021696|P2|Overall Study|Lost to Follow-up|4
311603|NCT00764660|1021697|P1|Overall Study|Lost to Follow-up|3
311604|NCT00764660|1021696|P2|Overall Study|Adverse Event|3
311605|NCT00764660|1021697|P1|Overall Study|Adverse Event|6
311606|NCT00764504|1021732|P3|Overall Study|Lost to Follow-up|72
311607|NCT00764504|1021733|P2|Overall Study|Lost to Follow-up|34
311608|NCT00764504|1021734|P1|Overall Study|Lost to Follow-up|40
311609|NCT00764504|1021732|P3|Overall Study|Withdrawal by Subject|4
311610|NCT00764504|1021733|P2|Overall Study|Withdrawal by Subject|7
311611|NCT00764504|1021734|P1|Overall Study|Withdrawal by Subject|1
311612|NCT00764504|1021732|P3|Overall Study|Physician Decision|0
311613|NCT00764504|1021733|P2|Overall Study|Physician Decision|0
311614|NCT00764504|1021734|P1|Overall Study|Physician Decision|1
311615|NCT00764504|1021732|P3|Overall Study|Revision of Device|14
311616|NCT00764504|1021733|P2|Overall Study|Revision of Device|23
311617|NCT00764504|1021734|P1|Overall Study|Revision of Device|12
311618|NCT00764504|1021732|P3|Overall Study|Death|13
311619|NCT00764504|1021733|P2|Overall Study|Death|6
311620|NCT00764504|1021734|P1|Overall Study|Death|12
311621|NCT00764478|1021770|P3|Overall Study|Protocol Violation|1
311622|NCT00764478|1021771|P2|Overall Study|Protocol Violation|1
311623|NCT00764478|1021772|P1|Overall Study|Protocol Violation|0
311624|NCT00764478|1021770|P3|Overall Study|Lost to Follow-up|5
311625|NCT00764478|1021771|P2|Overall Study|Lost to Follow-up|8
311626|NCT00764478|1021772|P1|Overall Study|Lost to Follow-up|7
311627|NCT00764478|1021770|P3|Overall Study|Withdrawal by Subject|1
311628|NCT00764478|1021771|P2|Overall Study|Withdrawal by Subject|12
311629|NCT00764478|1021772|P1|Overall Study|Withdrawal by Subject|7
311630|NCT00764478|1021770|P3|Overall Study|Adverse Event|1
311631|NCT00764478|1021771|P2|Overall Study|Adverse Event|1
311632|NCT00764478|1021772|P1|Overall Study|Adverse Event|1
311633|NCT00764465|1021852|P6|Overall Study|Withdrawal by Subject|0
311634|NCT00764465|1021853|P5|Overall Study|Withdrawal by Subject|0
311635|NCT00764465|1021854|P4|Overall Study|Withdrawal by Subject|0
311636|NCT00764465|1021855|P3|Overall Study|Withdrawal by Subject|1
311637|NCT00764465|1021856|P2|Overall Study|Withdrawal by Subject|1
311638|NCT00764465|1021857|P1|Overall Study|Withdrawal by Subject|0
311639|NCT00764465|1021852|P6|Overall Study|Adverse Event|1
311640|NCT00764465|1021853|P5|Overall Study|Adverse Event|1
311641|NCT00764465|1021854|P4|Overall Study|Adverse Event|1
311642|NCT00764465|1021855|P3|Overall Study|Adverse Event|0
311643|NCT00764465|1021856|P2|Overall Study|Adverse Event|0
311644|NCT00764465|1021857|P1|Overall Study|Adverse Event|2
311645|NCT00764361|1021885|P2|Overall Study|Adverse Event|1
311646|NCT00764361|1021886|P1|Overall Study|Adverse Event|0
311647|NCT00764361|1021885|P2|Overall Study|Withdrawal by Subject|3
311648|NCT00764361|1021886|P1|Overall Study|Withdrawal by Subject|2
311649|NCT00763971|1021902|P3|Overall Study|Participation in 489-326 required|0
311650|NCT00763971|1021903|P2|Overall Study|Participation in 489-326 required|0
311651|NCT00763971|1021904|P1|Overall Study|Participation in 489-326 required|1
311652|NCT00763971|1021902|P3|Overall Study|Performed final visit on phone|0
311653|NCT00763971|1021903|P2|Overall Study|Performed final visit on phone|1
311654|NCT00763971|1021904|P1|Overall Study|Performed final visit on phone|0
311655|NCT00763971|1021902|P3|Overall Study|Lack of availability|0
311656|NCT00763971|1021903|P2|Overall Study|Lack of availability|1
311657|NCT00763971|1021904|P1|Overall Study|Lack of availability|0
311658|NCT00763971|1021902|P3|Overall Study|Subject wanted dose reduction|0
311659|NCT00763971|1021903|P2|Overall Study|Subject wanted dose reduction|1
311660|NCT00763971|1021904|P1|Overall Study|Subject wanted dose reduction|0
311661|NCT00763971|1021902|P3|Overall Study|Moved to another country|0
311662|NCT00763971|1021903|P2|Overall Study|Moved to another country|1
311663|NCT00763971|1021904|P1|Overall Study|Moved to another country|0
311664|NCT00763971|1021902|P3|Overall Study|Medical monitor decision|1
311665|NCT00763971|1021903|P2|Overall Study|Medical monitor decision|0
311666|NCT00763971|1021904|P1|Overall Study|Medical monitor decision|0
311667|NCT00763971|1021902|P3|Overall Study|Randomization error|1
311668|NCT00763971|1021903|P2|Overall Study|Randomization error|0
311669|NCT00763971|1021904|P1|Overall Study|Randomization error|0
311670|NCT00763971|1021902|P3|Overall Study|Due to holiday season|1
311671|NCT00763971|1021903|P2|Overall Study|Due to holiday season|0
311672|NCT00763971|1021904|P1|Overall Study|Due to holiday season|2
311673|NCT00763971|1021902|P3|Overall Study|Sponsor decision|0
311674|NCT00763971|1021903|P2|Overall Study|Sponsor decision|0
311675|NCT00763971|1021904|P1|Overall Study|Sponsor decision|1
311676|NCT00763971|1021902|P3|Overall Study|Exclusion criteria met|0
311677|NCT00763971|1021903|P2|Overall Study|Exclusion criteria met|0
311678|NCT00763971|1021904|P1|Overall Study|Exclusion criteria met|1
311679|NCT00763971|1021902|P3|Overall Study|Personal reason|0
311680|NCT00763971|1021903|P2|Overall Study|Personal reason|0
311681|NCT00763971|1021904|P1|Overall Study|Personal reason|3
311682|NCT00763971|1021902|P3|Overall Study|Unable to swallow capsule|1
311683|NCT00763971|1021903|P2|Overall Study|Unable to swallow capsule|1
311684|NCT00763971|1021904|P1|Overall Study|Unable to swallow capsule|2
311685|NCT00763971|1021902|P3|Overall Study|Lack of Efficacy|54
311686|NCT00763971|1021903|P2|Overall Study|Lack of Efficacy|22
311687|NCT00763971|1021904|P1|Overall Study|Lack of Efficacy|11
311688|NCT00763971|1021902|P3|Overall Study|Lost to Follow-up|0
311689|NCT00763971|1021903|P2|Overall Study|Lost to Follow-up|1
311690|NCT00763971|1021904|P1|Overall Study|Lost to Follow-up|0
311691|NCT00763971|1021902|P3|Overall Study|Withdrawal by Subject|5
311692|NCT00763971|1021903|P2|Overall Study|Withdrawal by Subject|5
311693|NCT00763971|1021904|P1|Overall Study|Withdrawal by Subject|4
311694|NCT00763971|1021902|P3|Overall Study|Protocol Violation|2
311695|NCT00763971|1021903|P2|Overall Study|Protocol Violation|3
311696|NCT00763971|1021904|P1|Overall Study|Protocol Violation|3
311697|NCT00763971|1021902|P3|Overall Study|Adverse Event|4
311698|NCT00763971|1021903|P2|Overall Study|Adverse Event|2
311699|NCT00763971|1021904|P1|Overall Study|Adverse Event|5
311700|NCT00763958|1021935|P2|Overall Study|Believed they were receiving placebo|5
311701|NCT00763958|1021936|P1|Overall Study|Believed they were receiving placebo|0
311702|NCT00763958|1021935|P2|Overall Study|Lost to Follow-up|2
311703|NCT00763958|1021936|P1|Overall Study|Lost to Follow-up|10
311704|NCT00763958|1021935|P2|Overall Study|did not meet final criteria|4
311705|NCT00763958|1021936|P1|Overall Study|did not meet final criteria|4
311706|NCT00763815|1022071|P2|Overall Study|Sponsor's Decision|1
311707|NCT00763815|1022072|P1|Overall Study|Sponsor's Decision|0
311708|NCT00763815|1022071|P2|Overall Study|Protocol Violation|5
311709|NCT00763815|1022072|P1|Overall Study|Protocol Violation|2
311710|NCT00763815|1022071|P2|Overall Study|Withdrawal by Subject|12
311711|NCT00763815|1022072|P1|Overall Study|Withdrawal by Subject|7
311712|NCT00763815|1022071|P2|Overall Study|Physician Decision|0
311713|NCT00763815|1022072|P1|Overall Study|Physician Decision|1
311714|NCT00763815|1022071|P2|Overall Study|Familial and Personal Reasons|16
311715|NCT00763815|1022072|P1|Overall Study|Familial and Personal Reasons|9
311716|NCT00763815|1022071|P2|Overall Study|Early Termination|0
311717|NCT00763815|1022072|P1|Overall Study|Early Termination|1
311718|NCT00763815|1022071|P2|Overall Study|Lost to Follow-up|4
311719|NCT00763815|1022072|P1|Overall Study|Lost to Follow-up|2
311720|NCT00763815|1022071|P2|Overall Study|Poor Compliance to Protocol|6
311721|NCT00763815|1022072|P1|Overall Study|Poor Compliance to Protocol|6
311722|NCT00763815|1022071|P2|Overall Study|Lack of Efficacy|11
311723|NCT00763815|1022072|P1|Overall Study|Lack of Efficacy|10
311724|NCT00763815|1022071|P2|Overall Study|Adverse Event|29
311725|NCT00763815|1022072|P1|Overall Study|Adverse Event|14
311726|NCT00763698|1022100|P1|Overall Study|Withdrawal by Subject|1
311727|NCT00763698|1022100|P1|Overall Study|Death|4
311728|NCT00763698|1022100|P1|Overall Study|Unsuccessful Implant|5
311729|NCT00763451|1022110|P4|Overall Study|Study Site Reason|1
311730|NCT00763451|1022111|P3|Overall Study|Study Site Reason|1
311731|NCT00763451|1022112|P2|Overall Study|Study Site Reason|1
311732|NCT00763451|1022113|P1|Overall Study|Study Site Reason|0
311733|NCT00763451|1022110|P4|Overall Study|Randomized but not Treated|0
311734|NCT00763451|1022111|P3|Overall Study|Randomized but not Treated|0
311735|NCT00763451|1022112|P2|Overall Study|Randomized but not Treated|1
311736|NCT00763451|1022113|P1|Overall Study|Randomized but not Treated|1
311737|NCT00763451|1022110|P4|Overall Study|Familial and Personal Reasons|4
311738|NCT00763451|1022111|P3|Overall Study|Familial and Personal Reasons|5
311739|NCT00763451|1022112|P2|Overall Study|Familial and Personal Reasons|3
311740|NCT00763451|1022113|P1|Overall Study|Familial and Personal Reasons|5
311741|NCT00763451|1022110|P4|Overall Study|Poor Compliance to Protocol|2
311742|NCT00763451|1022111|P3|Overall Study|Poor Compliance to Protocol|2
311743|NCT00763451|1022112|P2|Overall Study|Poor Compliance to Protocol|1
311744|NCT00763451|1022113|P1|Overall Study|Poor Compliance to Protocol|1
311745|NCT00763451|1022110|P4|Overall Study|Protocol Violation|0
311746|NCT00763451|1022111|P3|Overall Study|Protocol Violation|1
311747|NCT00763451|1022112|P2|Overall Study|Protocol Violation|0
311748|NCT00763451|1022113|P1|Overall Study|Protocol Violation|0
311749|NCT00763451|1022110|P4|Overall Study|Withdrawal by Subject|7
311750|NCT00763451|1022111|P3|Overall Study|Withdrawal by Subject|9
311751|NCT00763451|1022112|P2|Overall Study|Withdrawal by Subject|6
311752|NCT00763451|1022113|P1|Overall Study|Withdrawal by Subject|1
311753|NCT00763451|1022110|P4|Overall Study|Lack of Efficacy|2
311754|NCT00763451|1022111|P3|Overall Study|Lack of Efficacy|3
311755|NCT00763451|1022112|P2|Overall Study|Lack of Efficacy|4
311756|NCT00763451|1022113|P1|Overall Study|Lack of Efficacy|1
311757|NCT00763451|1022110|P4|Overall Study|Adverse Event|14
311758|NCT00763451|1022111|P3|Overall Study|Adverse Event|19
311759|NCT00763451|1022112|P2|Overall Study|Adverse Event|6
311760|NCT00763451|1022113|P1|Overall Study|Adverse Event|4
311761|NCT00763386|1022172|P2|Overall Study|Study Prosthesis Removed|0
311762|NCT00763386|1022173|P1|Overall Study|Study Prosthesis Removed|1
311763|NCT00763386|1022172|P2|Overall Study|CRF missing|1
311764|NCT00763386|1022173|P1|Overall Study|CRF missing|0
311765|NCT00763386|1022172|P2|Overall Study|Withdrawal by Subject|1
311766|NCT00763386|1022173|P1|Overall Study|Withdrawal by Subject|0
311767|NCT00763386|1022172|P2|Overall Study|Lost to Follow-up|3
311768|NCT00763386|1022173|P1|Overall Study|Lost to Follow-up|3
311769|NCT00763386|1022172|P2|Overall Study|Death|2
311770|NCT00763386|1022173|P1|Overall Study|Death|1
311771|NCT00763386|1022172|P2|Overall Study|Adverse Event|33
311772|NCT00763386|1022173|P1|Overall Study|Adverse Event|43
311773|NCT00763321|1022206|P3|Double-blind Period|Not specified|3
311774|NCT00763321|1022207|P2|Double-blind Period|Not specified|2
311775|NCT00763321|1022208|P1|Double-blind Period|Not specified|0
311776|NCT00763321|1022206|P3|Double-blind Period|Withdrawal by Subject|3
311777|NCT00763321|1022207|P2|Double-blind Period|Withdrawal by Subject|2
311778|NCT00763321|1022208|P1|Double-blind Period|Withdrawal by Subject|0
311779|NCT00763321|1022206|P3|Double-blind Period|Lost to Follow-up|2
311780|NCT00763321|1022207|P2|Double-blind Period|Lost to Follow-up|4
311781|NCT00763321|1022208|P1|Double-blind Period|Lost to Follow-up|0
311782|NCT00763321|1022206|P3|Double-blind Period|Adverse Event|4
311783|NCT00763321|1022207|P2|Double-blind Period|Adverse Event|4
311784|NCT00763321|1022208|P1|Double-blind Period|Adverse Event|0
311785|NCT00763321|1022206|P3|Double-blind Period|Lack of Efficacy|17
311786|NCT00763321|1022207|P2|Double-blind Period|Lack of Efficacy|9
311787|NCT00763321|1022208|P1|Double-blind Period|Lack of Efficacy|0
311788|NCT00763321|1022206|P3|Open-label Period|Not specified|0
311789|NCT00763321|1022207|P2|Open-label Period|Not specified|0
311790|NCT00763321|1022208|P1|Open-label Period|Not specified|4
311791|NCT00763321|1022206|P3|Open-label Period|Lack of Efficacy|0
311792|NCT00763321|1022207|P2|Open-label Period|Lack of Efficacy|0
311793|NCT00763321|1022208|P1|Open-label Period|Lack of Efficacy|2
311794|NCT00763321|1022206|P3|Open-label Period|Did not meet DB randomization criteria|0
311795|NCT00763321|1022207|P2|Open-label Period|Did not meet DB randomization criteria|0
311796|NCT00763321|1022208|P1|Open-label Period|Did not meet DB randomization criteria|5
311797|NCT00763321|1022206|P3|Open-label Period|Subject noncompliant|0
311798|NCT00763321|1022207|P2|Open-label Period|Subject noncompliant|0
311799|NCT00763321|1022208|P1|Open-label Period|Subject noncompliant|7
311800|NCT00763321|1022206|P3|Open-label Period|Withdrawal by Subject|0
311801|NCT00763321|1022207|P2|Open-label Period|Withdrawal by Subject|0
316247|NCT00725985|1037037|P3|OLMP|Death|0
311802|NCT00763321|1022208|P1|Open-label Period|Withdrawal by Subject|7
311803|NCT00763321|1022206|P3|Open-label Period|Lost to Follow-up|0
311804|NCT00763321|1022207|P2|Open-label Period|Lost to Follow-up|0
311805|NCT00763321|1022208|P1|Open-label Period|Lost to Follow-up|14
311806|NCT00763321|1022206|P3|Open-label Period|Adverse Event|0
311807|NCT00763321|1022207|P2|Open-label Period|Adverse Event|0
311808|NCT00763321|1022208|P1|Open-label Period|Adverse Event|24
311809|NCT00763282|1022219|P2|Overall Study|Lost to Follow-up|26
311810|NCT00763282|1022220|P1|Overall Study|Lost to Follow-up|22
311811|NCT00763282|1022219|P2|Overall Study|Death|3
311812|NCT00763282|1022220|P1|Overall Study|Death|4
311813|NCT00763282|1022219|P2|Overall Study|Withdrawal by Subject|5
311814|NCT00763282|1022220|P1|Overall Study|Withdrawal by Subject|6
311815|NCT00763269|1022236|P2|Overall Study|Lost to Follow-up|13
311816|NCT00763269|1022237|P1|Overall Study|Lost to Follow-up|12
311817|NCT00763256|1022251|P2|Overall Study|Didn't return for appointments|10
311818|NCT00763256|1022252|P1|Overall Study|Didn't return for appointments|7
311819|NCT00763139|1022266|P2|Overall Study|med change not allowed by protocol|0
311820|NCT00763139|1022267|P1|Overall Study|med change not allowed by protocol|1
311821|NCT00763139|1022266|P2|Overall Study|Withdrawal by Subject|1
311822|NCT00763139|1022267|P1|Overall Study|Withdrawal by Subject|0
311823|NCT00763139|1022266|P2|Overall Study|Adverse Event|2
311824|NCT00763139|1022267|P1|Overall Study|Adverse Event|4
311825|NCT00763009|1022329|P1|Overall Study|Coronary Anatomy unsuitable|1
311826|NCT00762996|1022333|P4|Period One|Withdrawal by Subject|0
311827|NCT00762996|1022334|P3|Period One|Withdrawal by Subject|1
311828|NCT00762996|1022335|P2|Period One|Withdrawal by Subject|0
311829|NCT00762996|1022336|P1|Period One|Withdrawal by Subject|0
311830|NCT00762996|1022333|P4|Period One|Adverse Event|0
311831|NCT00762996|1022334|P3|Period One|Adverse Event|1
311832|NCT00762996|1022335|P2|Period One|Adverse Event|0
311833|NCT00762996|1022336|P1|Period One|Adverse Event|0
311834|NCT00762996|1022333|P4|Period One|ineligible|1
311835|NCT00762996|1022334|P3|Period One|ineligible|1
311836|NCT00762996|1022335|P2|Period One|ineligible|0
311837|NCT00762996|1022336|P1|Period One|ineligible|0
311838|NCT00762996|1022333|P4|Period One|Protocol Violation|0
311839|NCT00762996|1022334|P3|Period One|Protocol Violation|1
311840|NCT00762996|1022335|P2|Period One|Protocol Violation|0
311841|NCT00762996|1022336|P1|Period One|Protocol Violation|0
311842|NCT00762970|1022349|P3|Overall Study|Difficulty of handling lens|0
311843|NCT00762970|1022350|P2|Overall Study|Difficulty of handling lens|2
311844|NCT00762970|1022351|P1|Overall Study|Difficulty of handling lens|1
311845|NCT00762970|1022349|P3|Overall Study|Lost to Follow-up|0
311846|NCT00762970|1022350|P2|Overall Study|Lost to Follow-up|2
311847|NCT00762970|1022351|P1|Overall Study|Lost to Follow-up|1
311848|NCT00762970|1022349|P3|Overall Study|Protocol Violation|1
311849|NCT00762970|1022350|P2|Overall Study|Protocol Violation|1
311850|NCT00762970|1022351|P1|Overall Study|Protocol Violation|3
311851|NCT00762970|1022349|P3|Overall Study|Withdrawal by Subject|0
311852|NCT00762970|1022350|P2|Overall Study|Withdrawal by Subject|4
311853|NCT00762970|1022351|P1|Overall Study|Withdrawal by Subject|7
311854|NCT00762892|1022364|P2|Overall Study|Incarceration|0
311855|NCT00762892|1022365|P1|Overall Study|Incarceration|1
311856|NCT00762892|1022364|P2|Overall Study|Pregnancy|0
311857|NCT00762892|1022365|P1|Overall Study|Pregnancy|1
311858|NCT00762892|1022364|P2|Overall Study|Death|0
311859|NCT00762892|1022365|P1|Overall Study|Death|1
311860|NCT00762892|1022364|P2|Overall Study|Withdrawal by Subject|1
311861|NCT00762892|1022365|P1|Overall Study|Withdrawal by Subject|0
311862|NCT00762892|1022364|P2|Overall Study|Lost to Follow-up|5
311863|NCT00762892|1022365|P1|Overall Study|Lost to Follow-up|2
311864|NCT00762788|1022394|P6|Overall Study|Lost to Follow-up|21
311865|NCT00762788|1022395|P5|Overall Study|Lost to Follow-up|13
311866|NCT00762788|1022396|P4|Overall Study|Lost to Follow-up|26
311867|NCT00762788|1022397|P3|Overall Study|Lost to Follow-up|21
311868|NCT00762788|1022398|P2|Overall Study|Lost to Follow-up|37
311869|NCT00762788|1022399|P1|Overall Study|Lost to Follow-up|26
311870|NCT00762762|1022421|P2|Overall Study|Did not report for appointments|10
311871|NCT00762762|1022422|P1|Overall Study|Did not report for appointments|8
311872|NCT00762723|1022439|P3|Overall Study|Study Terminated slow enrollement|3
311873|NCT00762723|1022440|P2|Overall Study|Study Terminated slow enrollement|5
311874|NCT00762723|1022441|P1|Overall Study|Study Terminated slow enrollement|5
311875|NCT00762606|1022605|P2|Overall Study|Lost to Follow-up|13
311876|NCT00762606|1022606|P1|Overall Study|Lost to Follow-up|18
311877|NCT00762502|1022651|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
311878|NCT00762502|1022652|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
311879|NCT00762502|1022653|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
311880|NCT00762502|1022651|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
311881|NCT00762502|1022652|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
311882|NCT00762502|1022653|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
311883|NCT00762502|1022651|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
311884|NCT00762502|1022652|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
311885|NCT00762502|1022653|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
311886|NCT00762476|1022667|P2|Overall Study|Seasonal allergies|0
311887|NCT00762476|1022668|P1|Overall Study|Seasonal allergies|1
311888|NCT00762476|1022667|P2|Overall Study|non-compliance with study visits|2
311889|NCT00762476|1022668|P1|Overall Study|non-compliance with study visits|0
311890|NCT00762476|1022667|P2|Overall Study|antibiotic use|1
311891|NCT00762476|1022668|P1|Overall Study|antibiotic use|0
311892|NCT00762476|1022667|P2|Overall Study|Withdrawal by Subject|12
311893|NCT00762476|1022668|P1|Overall Study|Withdrawal by Subject|6
311894|NCT00762476|1022667|P2|Overall Study|Physician Decision|14
311895|NCT00762476|1022668|P1|Overall Study|Physician Decision|2
311896|NCT00762476|1022667|P2|Overall Study|Protocol Violation|6
311897|NCT00762476|1022668|P1|Overall Study|Protocol Violation|5
311898|NCT00762476|1022667|P2|Overall Study|Lost to Follow-up|0
311899|NCT00762476|1022668|P1|Overall Study|Lost to Follow-up|2
311900|NCT00762476|1022667|P2|Overall Study|Adverse Event|1
311901|NCT00762476|1022668|P1|Overall Study|Adverse Event|7
311902|NCT00762463|1022680|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
311903|NCT00762463|1022681|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
311904|NCT00762463|1022682|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
311905|NCT00762463|1022683|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
311906|NCT00762463|1022680|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
311907|NCT00762463|1022681|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
311908|NCT00762463|1022682|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
311909|NCT00762463|1022683|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
311910|NCT00762463|1022680|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
311911|NCT00762463|1022681|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
311912|NCT00762463|1022682|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
311913|NCT00762463|1022683|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
311914|NCT00762463|1022680|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
311915|NCT00762463|1022681|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
311916|NCT00762463|1022682|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
311917|NCT00762463|1022683|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
311918|NCT00762463|1022680|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
311919|NCT00762463|1022681|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
311920|NCT00762463|1022682|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
311921|NCT00762463|1022683|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
311922|NCT00762463|1022680|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
311923|NCT00762463|1022681|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
311924|NCT00762463|1022682|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
311925|NCT00762463|1022683|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
311926|NCT00762463|1022680|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
311927|NCT00762463|1022681|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
311928|NCT00762463|1022682|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
311929|NCT00762463|1022683|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
311930|NCT00762463|1022680|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
311931|NCT00762463|1022681|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
311932|NCT00762463|1022682|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
311933|NCT00762463|1022683|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
311934|NCT00762411|1022789|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
311935|NCT00762411|1022790|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
311936|NCT00762411|1022789|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
311937|NCT00762411|1022790|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
311938|NCT00762411|1022789|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
311939|NCT00762411|1022790|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
311940|NCT00762411|1022789|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
311941|NCT00762411|1022790|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
311942|NCT00762411|1022789|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
311943|NCT00762411|1022790|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
311944|NCT00762411|1022789|P2|Safety Follow Up (SFU)-Optional|Death|8
311945|NCT00762411|1022790|P1|Safety Follow Up (SFU)-Optional|Death|1
311946|NCT00762411|1022789|P2|Delayed Start|Caregiver Decision|1
311947|NCT00762411|1022790|P1|Delayed Start|Caregiver Decision|1
311948|NCT00762411|1022789|P2|Delayed Start|Sponsor Decision|20
311949|NCT00762411|1022790|P1|Delayed Start|Sponsor Decision|16
311950|NCT00762411|1022789|P2|Delayed Start|Protocol Violation|1
311951|NCT00762411|1022790|P1|Delayed Start|Protocol Violation|0
311952|NCT00762411|1022789|P2|Delayed Start|Adverse Event|4
311953|NCT00762411|1022790|P1|Delayed Start|Adverse Event|0
311954|NCT00762411|1022789|P2|Initial Treatment|Entry Criteria Exclusion|1
311955|NCT00762411|1022790|P1|Initial Treatment|Entry Criteria Exclusion|0
311956|NCT00762411|1022789|P2|Initial Treatment|Abnormal Lab/ECG Result|4
311957|NCT00762411|1022790|P1|Initial Treatment|Abnormal Lab/ECG Result|6
311958|NCT00762411|1022789|P2|Initial Treatment|Caregiver Decision|16
311959|NCT00762411|1022790|P1|Initial Treatment|Caregiver Decision|21
311960|NCT00762411|1022789|P2|Initial Treatment|Lost to Follow-up|0
311961|NCT00762411|1022790|P1|Initial Treatment|Lost to Follow-up|5
311962|NCT00762411|1022789|P2|Initial Treatment|Sponsor Decision|401
311963|NCT00762411|1022790|P1|Initial Treatment|Sponsor Decision|293
311964|NCT00762411|1022789|P2|Initial Treatment|Physician Decision|0
311965|NCT00762411|1022790|P1|Initial Treatment|Physician Decision|1
311966|NCT00762411|1022789|P2|Initial Treatment|Withdrawal by Subject|52
311967|NCT00762411|1022790|P1|Initial Treatment|Withdrawal by Subject|65
311968|NCT00762411|1022789|P2|Initial Treatment|Protocol Violation|1
311969|NCT00762411|1022790|P1|Initial Treatment|Protocol Violation|4
311970|NCT00762411|1022789|P2|Initial Treatment|Adverse Event|40
311971|NCT00762411|1022790|P1|Initial Treatment|Adverse Event|132
311972|NCT00762411|1022789|P2|Initial Treatment|Death|6
311973|NCT00762411|1022790|P1|Initial Treatment|Death|7
311974|NCT00762385|1022854|P2|Second Intervention|Protocol Violation|3
311975|NCT00762385|1022855|P1|Second Intervention|Protocol Violation|3
311976|NCT00762385|1022854|P2|First Intervention|Protocol Violation|1
311977|NCT00762385|1022855|P1|First Intervention|Protocol Violation|0
311978|NCT00762385|1022854|P2|First Intervention|Ineligible|0
311979|NCT00762385|1022855|P1|First Intervention|Ineligible|1
311980|NCT00762385|1022854|P2|First Intervention|Lost to Follow-up|2
311981|NCT00762385|1022855|P1|First Intervention|Lost to Follow-up|0
311982|NCT00762385|1022854|P2|First Intervention|Lens Issue|1
311983|NCT00762385|1022855|P1|First Intervention|Lens Issue|1
311984|NCT00762359|1022867|P2|Overall Study|Withdrew consent|0
311985|NCT00762359|1022868|P1|Overall Study|Withdrew consent|1
311986|NCT00762359|1022867|P2|Overall Study|Removal|1
311987|NCT00762359|1022868|P1|Overall Study|Removal|0
311988|NCT00762359|1022867|P2|Overall Study|Physician Decision|3
311989|NCT00762359|1022868|P1|Overall Study|Physician Decision|2
311990|NCT00762359|1022867|P2|Overall Study|Institution closed|3
311991|NCT00762359|1022868|P1|Overall Study|Institution closed|2
311992|NCT00762359|1022867|P2|Overall Study|Lack of Efficacy|4
311993|NCT00762359|1022868|P1|Overall Study|Lack of Efficacy|0
311994|NCT00762359|1022867|P2|Overall Study|Withdrawal by Subject|10
311995|NCT00762359|1022868|P1|Overall Study|Withdrawal by Subject|13
311996|NCT00762359|1022867|P2|Overall Study|Protocol Violation|13
311997|NCT00762359|1022868|P1|Overall Study|Protocol Violation|21
311998|NCT00762359|1022867|P2|Overall Study|Adverse Event|23
311999|NCT00762359|1022868|P1|Overall Study|Adverse Event|20
312000|NCT00762268|1022985|P2|Overall Study|Protocol Violation|2
312001|NCT00762268|1022986|P1|Overall Study|Protocol Violation|1
312002|NCT00762229|1022994|P2|Overall Study|did not recveive intervention|1
312003|NCT00762229|1022995|P1|Overall Study|did not recveive intervention|0
312004|NCT00762229|1022994|P2|Overall Study|Lost to Follow-up|1
312005|NCT00762229|1022995|P1|Overall Study|Lost to Follow-up|1
312006|NCT00762164|1023092|P2|Overall Study|Withdrawal by Subject|1
312007|NCT00762164|1023093|P1|Overall Study|Withdrawal by Subject|0
312008|NCT00762164|1023092|P2|Overall Study|Discontinued medication|0
312009|NCT00762164|1023093|P1|Overall Study|Discontinued medication|2
312010|NCT00762164|1023092|P2|Overall Study|Lost to Follow-up|1
312011|NCT00762164|1023093|P1|Overall Study|Lost to Follow-up|1
312012|NCT00762086|1023103|P2|Overall Study|Ineligible to participate in the study|0
312013|NCT00762086|1023104|P1|Overall Study|Ineligible to participate in the study|1
312014|NCT00762086|1023103|P2|Overall Study|Withdrawal by Subject|2
312015|NCT00762086|1023104|P1|Overall Study|Withdrawal by Subject|2
312016|NCT00762086|1023103|P2|Overall Study|Non compliance|0
312017|NCT00762086|1023104|P1|Overall Study|Non compliance|1
312018|NCT00762086|1023103|P2|Overall Study|Lost to Follow-up|2
312019|NCT00762086|1023104|P1|Overall Study|Lost to Follow-up|0
312020|NCT00762086|1023103|P2|Overall Study|Adverse Event|0
312021|NCT00762086|1023104|P1|Overall Study|Adverse Event|2
312022|NCT00762073|1023114|P4|Overall Study|Not on treatment for >/= 77 days|0
312023|NCT00762073|1023115|P3|Overall Study|Not on treatment for >/= 77 days|0
312024|NCT00762073|1023116|P2|Overall Study|Not on treatment for >/= 77 days|0
312025|NCT00762073|1023117|P1|Overall Study|Not on treatment for >/= 77 days|1
312026|NCT00762073|1023114|P4|Overall Study|Withdrawal by Subject|1
312027|NCT00762073|1023115|P3|Overall Study|Withdrawal by Subject|1
312028|NCT00762073|1023116|P2|Overall Study|Withdrawal by Subject|2
312029|NCT00762073|1023117|P1|Overall Study|Withdrawal by Subject|1
312030|NCT00762073|1023114|P4|Overall Study|Significant Subject Noncompliance|1
312031|NCT00762073|1023115|P3|Overall Study|Significant Subject Noncompliance|0
312032|NCT00762073|1023116|P2|Overall Study|Significant Subject Noncompliance|1
312033|NCT00762073|1023117|P1|Overall Study|Significant Subject Noncompliance|0
312034|NCT00762073|1023114|P4|Overall Study|Adverse Event|1
312035|NCT00762073|1023115|P3|Overall Study|Adverse Event|1
312036|NCT00762073|1023116|P2|Overall Study|Adverse Event|0
312037|NCT00762073|1023117|P1|Overall Study|Adverse Event|1
312038|NCT00762073|1023114|P4|Overall Study|Lack of Efficacy|0
312039|NCT00762073|1023115|P3|Overall Study|Lack of Efficacy|0
312040|NCT00762073|1023116|P2|Overall Study|Lack of Efficacy|1
312041|NCT00762073|1023117|P1|Overall Study|Lack of Efficacy|1
312042|NCT00762034|1023181|P2|Maintenance Period|Other|1
312043|NCT00762034|1023182|P1|Maintenance Period|Other|1
312044|NCT00762034|1023181|P2|Maintenance Period|Death due to study disease|3
312045|NCT00762034|1023182|P1|Maintenance Period|Death due to study disease|3
312046|NCT00762034|1023181|P2|Maintenance Period|Death not due to study disease|5
312047|NCT00762034|1023182|P1|Maintenance Period|Death not due to study disease|2
312048|NCT00762034|1023181|P2|Maintenance Period|Withdrawal by Subject|14
312049|NCT00762034|1023182|P1|Maintenance Period|Withdrawal by Subject|34
312050|NCT00762034|1023181|P2|Maintenance Period|Physician Decision|20
312051|NCT00762034|1023182|P1|Maintenance Period|Physician Decision|25
312052|NCT00762034|1023181|P2|Maintenance Period|Progressive Disease|224
312053|NCT00762034|1023182|P1|Maintenance Period|Progressive Disease|186
312054|NCT00762034|1023181|P2|Maintenance Period|Adverse Event|26
312055|NCT00762034|1023182|P1|Maintenance Period|Adverse Event|42
312056|NCT00762034|1023181|P2|Maintenance Period|Entry Criterion Not Met|2
312057|NCT00762034|1023182|P1|Maintenance Period|Entry Criterion Not Met|0
312058|NCT00762034|1023181|P2|Maintenance Period|Protocol Violation|3
312059|NCT00762034|1023182|P1|Maintenance Period|Protocol Violation|1
312060|NCT00762034|1023181|P2|Induction Period|Deaths Due to Study Disease|9
312061|NCT00762034|1023182|P1|Induction Period|Deaths Due to Study Disease|9
312062|NCT00762034|1023181|P2|Induction Period|Deaths Not Due to Study Disease|14
312063|NCT00762034|1023182|P1|Induction Period|Deaths Not Due to Study Disease|19
312064|NCT00762034|1023181|P2|Induction Period|Withdrawal by Subject|19
312065|NCT00762034|1023182|P1|Induction Period|Withdrawal by Subject|15
312066|NCT00762034|1023181|P2|Induction Period|Physician Decision|20
312067|NCT00762034|1023182|P1|Induction Period|Physician Decision|21
312068|NCT00762034|1023181|P2|Induction Period|Progressive Disease|55
312069|NCT00762034|1023182|P1|Induction Period|Progressive Disease|73
312070|NCT00762034|1023181|P2|Induction Period|Lost to Follow-up|1
312071|NCT00762034|1023182|P1|Induction Period|Lost to Follow-up|1
312072|NCT00762034|1023181|P2|Induction Period|Adverse Event|38
312073|NCT00762034|1023182|P1|Induction Period|Adverse Event|27
312074|NCT00762034|1023181|P2|Induction Period|Entry Criterion Not Met|11
312075|NCT00762034|1023182|P1|Induction Period|Entry Criterion Not Met|12
312076|NCT00762034|1023181|P2|Induction Period|Protocol Violation|2
312077|NCT00762034|1023182|P1|Induction Period|Protocol Violation|1
312078|NCT00761969|1023254|P2|Overall Study|Lost to Follow-up|93
312079|NCT00761969|1023255|P1|Overall Study|Lost to Follow-up|88
312080|NCT00761969|1023254|P2|Overall Study|Death|47
312081|NCT00761969|1023255|P1|Overall Study|Death|112
312082|NCT00761956|1023265|P2|Overall Study|Adverse Event|34
312083|NCT00761956|1023266|P1|Overall Study|Adverse Event|26
312084|NCT00761956|1023265|P2|Overall Study|Death|1
312085|NCT00761956|1023266|P1|Overall Study|Death|0
312086|NCT00761956|1023265|P2|Overall Study|Withdrawal by Subject|8
312087|NCT00761956|1023266|P1|Overall Study|Withdrawal by Subject|3
312088|NCT00761956|1023265|P2|Overall Study|Lost to Follow-up|11
312089|NCT00761956|1023266|P1|Overall Study|Lost to Follow-up|6
312090|NCT00761865|1023295|P2|Overall Study|Lost to Follow-up|7
312091|NCT00761865|1023296|P1|Overall Study|Lost to Follow-up|8
312092|NCT00761761|1023306|P2|Overall Study|Withdrawal by Subject|0
312093|NCT00761761|1023307|P1|Overall Study|Withdrawal by Subject|3
312094|NCT00761761|1023306|P2|Overall Study|Lost to Follow-up|1
312095|NCT00761761|1023307|P1|Overall Study|Lost to Follow-up|3
312096|NCT00761748|1023319|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
312097|NCT00761748|1023320|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
312098|NCT00761748|1023319|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
312099|NCT00761748|1023320|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
312100|NCT00761735|1023326|P1|Overall Study|Administrative|1
312101|NCT00761735|1023326|P1|Overall Study|Non-compliance with protocol|1
312102|NCT00761735|1023326|P1|Overall Study|Withdrawal by Subject|6
312103|NCT00761735|1023326|P1|Overall Study|Lost to Follow-up|6
312104|NCT00761631|1023342|P6|Overall Study|Unspecified|1
312105|NCT00761631|1023343|P5|Overall Study|Unspecified|1
312106|NCT00761631|1023344|P4|Overall Study|Unspecified|0
312107|NCT00761631|1023345|P3|Overall Study|Unspecified|0
312108|NCT00761631|1023346|P2|Overall Study|Unspecified|0
312109|NCT00761631|1023347|P1|Overall Study|Unspecified|0
312110|NCT00761631|1023342|P6|Overall Study|Physician Decision|0
312111|NCT00761631|1023343|P5|Overall Study|Physician Decision|0
312112|NCT00761631|1023344|P4|Overall Study|Physician Decision|0
312113|NCT00761631|1023345|P3|Overall Study|Physician Decision|0
312114|NCT00761631|1023346|P2|Overall Study|Physician Decision|0
312115|NCT00761631|1023347|P1|Overall Study|Physician Decision|1
312116|NCT00761631|1023342|P6|Overall Study|Failed to return|2
312117|NCT00761631|1023343|P5|Overall Study|Failed to return|5
312118|NCT00761631|1023344|P4|Overall Study|Failed to return|1
312119|NCT00761631|1023345|P3|Overall Study|Failed to return|1
312120|NCT00761631|1023346|P2|Overall Study|Failed to return|0
312121|NCT00761631|1023347|P1|Overall Study|Failed to return|1
312122|NCT00761631|1023342|P6|Overall Study|Randomized, not treated|0
312123|NCT00761631|1023343|P5|Overall Study|Randomized, not treated|0
312124|NCT00761631|1023344|P4|Overall Study|Randomized, not treated|0
312125|NCT00761631|1023345|P3|Overall Study|Randomized, not treated|0
312126|NCT00761631|1023346|P2|Overall Study|Randomized, not treated|0
312127|NCT00761631|1023347|P1|Overall Study|Randomized, not treated|1
312128|NCT00761631|1023342|P6|Overall Study|Protocol Violation|1
312129|NCT00761631|1023343|P5|Overall Study|Protocol Violation|5
312130|NCT00761631|1023344|P4|Overall Study|Protocol Violation|1
312131|NCT00761631|1023345|P3|Overall Study|Protocol Violation|0
312132|NCT00761631|1023346|P2|Overall Study|Protocol Violation|0
312133|NCT00761631|1023347|P1|Overall Study|Protocol Violation|2
312134|NCT00761631|1023342|P6|Overall Study|Lost to Follow-up|1
312135|NCT00761631|1023343|P5|Overall Study|Lost to Follow-up|6
312136|NCT00761631|1023344|P4|Overall Study|Lost to Follow-up|1
312137|NCT00761631|1023345|P3|Overall Study|Lost to Follow-up|7
312138|NCT00761631|1023346|P2|Overall Study|Lost to Follow-up|4
312139|NCT00761631|1023347|P1|Overall Study|Lost to Follow-up|2
312140|NCT00761631|1023342|P6|Overall Study|Parent/legal guardian request|0
312141|NCT00761631|1023343|P5|Overall Study|Parent/legal guardian request|5
312142|NCT00761631|1023344|P4|Overall Study|Parent/legal guardian request|0
312143|NCT00761631|1023345|P3|Overall Study|Parent/legal guardian request|8
312144|NCT00761631|1023346|P2|Overall Study|Parent/legal guardian request|3
312145|NCT00761631|1023347|P1|Overall Study|Parent/legal guardian request|8
312146|NCT00761605|1023382|P1|Overall Study|Unspecified|21
312147|NCT00761605|1023382|P1|Overall Study|Withdrawal by Subject|37
312148|NCT00761605|1023382|P1|Overall Study|Lost to Follow-up|29
312149|NCT00761605|1023382|P1|Overall Study|Lack of Efficacy|26
312150|NCT00761605|1023382|P1|Overall Study|Death|2
312151|NCT00761605|1023382|P1|Overall Study|Adverse Event|26
312152|NCT00761579|1023426|P1|Overall Study|Intake of prohibited concomitant drug|1
312153|NCT00761579|1023426|P1|Overall Study|Lost survey form|1
312154|NCT00761579|1023426|P1|Overall Study|Aggravation of symptoms by changing drug|1
312155|NCT00761579|1023426|P1|Overall Study|Aggravation of depression|1
312156|NCT00761579|1023426|P1|Overall Study|Drug overdose|1
312157|NCT00761579|1023426|P1|Overall Study|Protocol deviation|1
312158|NCT00761579|1023426|P1|Overall Study|Lack of compliance|2
312159|NCT00761579|1023426|P1|Overall Study|Withdrawal by Subject|34
312160|NCT00761579|1023426|P1|Overall Study|Pregnancy|1
312161|NCT00761579|1023426|P1|Overall Study|Lost to Follow-up|16
312162|NCT00761579|1023426|P1|Overall Study|Lack of Efficacy|21
312163|NCT00761579|1023426|P1|Overall Study|Death|2
312164|NCT00761579|1023426|P1|Overall Study|Adverse Event|10
312165|NCT00761527|1023459|P1|Overall Study|Unknown reason|2
312166|NCT00761527|1023459|P1|Overall Study|Lost to Follow-up|9
312167|NCT00761527|1023459|P1|Overall Study|Poor Compliance|8
312168|NCT00761527|1023459|P1|Overall Study|Adverse Event|3
312169|NCT00761514|1023466|P1|Overall Study|Unable to pay for medications|1
312170|NCT00761514|1023466|P1|Overall Study|Problem complying with study visit|1
312171|NCT00761514|1023466|P1|Overall Study|Health insurance didn't cover study drug|1
312172|NCT00761514|1023466|P1|Overall Study|Lost to Follow-up|1
312173|NCT00761514|1023466|P1|Overall Study|Withdrawal by Subject|2
312174|NCT00761514|1023466|P1|Overall Study|Adverse Event|1
312175|NCT00761462|1023473|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
312176|NCT00761462|1023474|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
312177|NCT00761462|1023473|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
312178|NCT00761462|1023474|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
312179|NCT00761462|1023473|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
312180|NCT00761462|1023474|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
312181|NCT00761462|1023473|P2|Treatment|Subjects never received study medication|12
312182|NCT00761462|1023474|P1|Treatment|Subjects never received study medication|23
312183|NCT00761319|1023488|P2|Overall Study|Missing|0
312184|NCT00761319|1023489|P1|Overall Study|Missing|1
312185|NCT00761319|1023488|P2|Overall Study|Nonspecified|2
312186|NCT00761319|1023489|P1|Overall Study|Nonspecified|2
312187|NCT00761319|1023488|P2|Overall Study|Lost to Follow-up|1
312188|NCT00761319|1023489|P1|Overall Study|Lost to Follow-up|1
312189|NCT00761319|1023488|P2|Overall Study|Noncompliance|3
312190|NCT00761319|1023489|P1|Overall Study|Noncompliance|4
312191|NCT00761319|1023488|P2|Overall Study|Withdrawal by Subject|7
312192|NCT00761319|1023489|P1|Overall Study|Withdrawal by Subject|8
312193|NCT00761319|1023488|P2|Overall Study|Adverse Event|7
312194|NCT00761319|1023489|P1|Overall Study|Adverse Event|11
312195|NCT00761319|1023488|P2|Overall Study|Protocol Violation|14
312196|NCT00761319|1023489|P1|Overall Study|Protocol Violation|21
312197|NCT00761306|1023497|P1|Overall Study|Administrative or Other Reasons|5
312198|NCT00761306|1023497|P1|Overall Study|Lost to Follow-up|1
312199|NCT00761306|1023497|P1|Overall Study|Withdrawal of Consent|3
312200|NCT00761306|1023497|P1|Overall Study|Protocol Violation|2
312201|NCT00761306|1023497|P1|Overall Study|Lack of Efficacy|4
312202|NCT00761306|1023497|P1|Overall Study|Adverse Event|5
312203|NCT00761280|1023508|P2|First Dose to End of Study|Lost to Follow-up|1
312204|NCT00761280|1023509|P1|First Dose to End of Study|Lost to Follow-up|0
312205|NCT00761280|1023508|P2|First Dose to End of Study|Death|0
312206|NCT00761280|1023509|P1|First Dose to End of Study|Death|1
312207|NCT00761280|1023508|P2|First Dose to End of Study|Sponsor decision|2
312208|NCT00761280|1023509|P1|First Dose to End of Study|Sponsor decision|1
312209|NCT00761280|1023508|P2|First Dose to End of Study|Progressive disease|3
312210|NCT00761280|1023509|P1|First Dose to End of Study|Progressive disease|5
312211|NCT00761280|1023508|P2|First Dose to End of Study|End of trial|5
312212|NCT00761280|1023509|P1|First Dose to End of Study|End of trial|5
312213|NCT00761280|1023508|P2|Randomization to First Dose|Other|0
312214|NCT00761280|1023509|P1|Randomization to First Dose|Other|1
312215|NCT00761280|1023508|P2|Randomization to First Dose|Sponsor decision|0
312216|NCT00761280|1023509|P1|Randomization to First Dose|Sponsor decision|1
312217|NCT00761280|1023508|P2|Randomization to First Dose|Withdrawal by Subject|2
312218|NCT00761280|1023509|P1|Randomization to First Dose|Withdrawal by Subject|0
312219|NCT00761215|1023540|P3|Overall Study|Bacteremia|0
312220|NCT00761215|1023541|P2|Overall Study|Bacteremia|0
312221|NCT00761215|1023542|P1|Overall Study|Bacteremia|1
316248|NCT00725985|1037038|P2|OLMP|Death|0
312222|NCT00761215|1023540|P3|Overall Study|Withdrawal by Subject|0
312223|NCT00761215|1023541|P2|Overall Study|Withdrawal by Subject|0
312224|NCT00761215|1023542|P1|Overall Study|Withdrawal by Subject|1
312225|NCT00761215|1023540|P3|Overall Study|Lost to Follow-up|6
312226|NCT00761215|1023541|P2|Overall Study|Lost to Follow-up|3
312227|NCT00761215|1023542|P1|Overall Study|Lost to Follow-up|6
312228|NCT00761215|1023540|P3|Overall Study|Randomized but didn't receive drug|2
312229|NCT00761215|1023541|P2|Overall Study|Randomized but didn't receive drug|1
312230|NCT00761215|1023542|P1|Overall Study|Randomized but didn't receive drug|1
312231|NCT00761189|1023584|P1|Overall Study|Unspecified|13
312232|NCT00761189|1023584|P1|Overall Study|Withdrawal by Subject|49
312233|NCT00761189|1023584|P1|Overall Study|Lost to Follow-up|36
312234|NCT00761189|1023584|P1|Overall Study|Lack of Efficacy|45
312235|NCT00761189|1023584|P1|Overall Study|Adverse Event|42
312236|NCT00761176|1023601|P2|Overall Study|Withdrawal by Subject|1
312237|NCT00761176|1023602|P1|Overall Study|Withdrawal by Subject|1
312238|NCT00761176|1023601|P2|Overall Study|Death|0
312239|NCT00761176|1023602|P1|Overall Study|Death|1
312240|NCT00761150|1023611|P3|Double-blind Period|Not specified|3
312241|NCT00761150|1023612|P2|Double-blind Period|Not specified|3
312242|NCT00761150|1023613|P1|Double-blind Period|Not specified|0
312243|NCT00761150|1023611|P3|Double-blind Period|Noncompliance|0
312244|NCT00761150|1023612|P2|Double-blind Period|Noncompliance|1
312245|NCT00761150|1023613|P1|Double-blind Period|Noncompliance|0
312246|NCT00761150|1023611|P3|Double-blind Period|Did not meet DB randomization criteria|1
312247|NCT00761150|1023612|P2|Double-blind Period|Did not meet DB randomization criteria|0
312248|NCT00761150|1023613|P1|Double-blind Period|Did not meet DB randomization criteria|0
312249|NCT00761150|1023611|P3|Double-blind Period|Lost to Follow-up|1
312250|NCT00761150|1023612|P2|Double-blind Period|Lost to Follow-up|2
312251|NCT00761150|1023613|P1|Double-blind Period|Lost to Follow-up|0
312252|NCT00761150|1023611|P3|Double-blind Period|Withdrawal by Subject|2
312253|NCT00761150|1023612|P2|Double-blind Period|Withdrawal by Subject|3
312254|NCT00761150|1023613|P1|Double-blind Period|Withdrawal by Subject|0
312255|NCT00761150|1023611|P3|Double-blind Period|Adverse Event|3
312256|NCT00761150|1023612|P2|Double-blind Period|Adverse Event|3
312257|NCT00761150|1023613|P1|Double-blind Period|Adverse Event|0
312258|NCT00761150|1023611|P3|Double-blind Period|Lack of Efficacy|19
312259|NCT00761150|1023612|P2|Double-blind Period|Lack of Efficacy|2
312260|NCT00761150|1023613|P1|Double-blind Period|Lack of Efficacy|0
312261|NCT00761150|1023611|P3|Open-label Period|Not specified|0
312262|NCT00761150|1023612|P2|Open-label Period|Not specified|0
312263|NCT00761150|1023613|P1|Open-label Period|Not specified|5
312264|NCT00761150|1023611|P3|Open-label Period|Noncompliance|0
312265|NCT00761150|1023612|P2|Open-label Period|Noncompliance|0
312266|NCT00761150|1023613|P1|Open-label Period|Noncompliance|2
312267|NCT00761150|1023611|P3|Open-label Period|Withdrawal by Subject|0
312268|NCT00761150|1023612|P2|Open-label Period|Withdrawal by Subject|0
312269|NCT00761150|1023613|P1|Open-label Period|Withdrawal by Subject|5
312270|NCT00761150|1023611|P3|Open-label Period|Lack of Efficacy|0
312271|NCT00761150|1023612|P2|Open-label Period|Lack of Efficacy|0
312272|NCT00761150|1023613|P1|Open-label Period|Lack of Efficacy|4
312273|NCT00761150|1023611|P3|Open-label Period|Lost to Follow-up|0
312274|NCT00761150|1023612|P2|Open-label Period|Lost to Follow-up|0
312275|NCT00761150|1023613|P1|Open-label Period|Lost to Follow-up|7
312276|NCT00761150|1023611|P3|Open-label Period|Did not meet DB randomization criteria|0
312277|NCT00761150|1023612|P2|Open-label Period|Did not meet DB randomization criteria|0
312278|NCT00761150|1023613|P1|Open-label Period|Did not meet DB randomization criteria|11
312279|NCT00761150|1023611|P3|Open-label Period|Adverse Event|0
312280|NCT00761150|1023612|P2|Open-label Period|Adverse Event|0
312281|NCT00761150|1023613|P1|Open-label Period|Adverse Event|36
312282|NCT00760266|1023635|P2|Overall Study|Administrative Problems|1
312283|NCT00760266|1023636|P1|Overall Study|Administrative Problems|0
312284|NCT00760266|1023635|P2|Overall Study|Lost to Follow-up|1
312285|NCT00760266|1023636|P1|Overall Study|Lost to Follow-up|2
312286|NCT00760266|1023635|P2|Overall Study|Patient withdrew consent|3
312287|NCT00760266|1023636|P1|Overall Study|Patient withdrew consent|3
312288|NCT00760266|1023635|P2|Overall Study|Protocol deviation|4
312289|NCT00760266|1023636|P1|Overall Study|Protocol deviation|2
312290|NCT00760266|1023635|P2|Overall Study|Lack of Efficacy|2
312291|NCT00760266|1023636|P1|Overall Study|Lack of Efficacy|2
312292|NCT00760266|1023635|P2|Overall Study|Abnormal test procedure result(s)|0
312293|NCT00760266|1023636|P1|Overall Study|Abnormal test procedure result(s)|1
312294|NCT00760266|1023635|P2|Overall Study|Abnormal laboratory value(s)|0
312295|NCT00760266|1023636|P1|Overall Study|Abnormal laboratory value(s)|1
312296|NCT00760266|1023635|P2|Overall Study|Adverse Event|7
312297|NCT00760266|1023636|P1|Overall Study|Adverse Event|13
312298|NCT00760214|1023653|P3|Overall Study|Other|6
312299|NCT00760214|1023654|P2|Overall Study|Other|4
312300|NCT00760214|1023655|P1|Overall Study|Other|3
312301|NCT00760214|1023653|P3|Overall Study|Physician Decision|1
312302|NCT00760214|1023654|P2|Overall Study|Physician Decision|1
312303|NCT00760214|1023655|P1|Overall Study|Physician Decision|1
312304|NCT00760214|1023653|P3|Overall Study|Pregnancy|1
312305|NCT00760214|1023654|P2|Overall Study|Pregnancy|0
312306|NCT00760214|1023655|P1|Overall Study|Pregnancy|0
312307|NCT00760214|1023653|P3|Overall Study|Lack of Efficacy|4
312308|NCT00760214|1023654|P2|Overall Study|Lack of Efficacy|2
312309|NCT00760214|1023655|P1|Overall Study|Lack of Efficacy|3
312310|NCT00760214|1023653|P3|Overall Study|Withdrawal by Subject|13
312311|NCT00760214|1023654|P2|Overall Study|Withdrawal by Subject|14
312312|NCT00760214|1023655|P1|Overall Study|Withdrawal by Subject|12
312313|NCT00760214|1023653|P3|Overall Study|Lost to Follow-up|1
312314|NCT00760214|1023654|P2|Overall Study|Lost to Follow-up|0
312315|NCT00760214|1023655|P1|Overall Study|Lost to Follow-up|0
312316|NCT00760214|1023653|P3|Overall Study|Protocol Violation|3
312317|NCT00760214|1023654|P2|Overall Study|Protocol Violation|0
312318|NCT00760214|1023655|P1|Overall Study|Protocol Violation|3
312319|NCT00760214|1023653|P3|Overall Study|Adverse Event|12
312320|NCT00760214|1023654|P2|Overall Study|Adverse Event|9
312321|NCT00760214|1023655|P1|Overall Study|Adverse Event|8
312322|NCT00760877|1023727|P2|Overall Study|Treatment failure|0
312323|NCT00760877|1023728|P1|Overall Study|Treatment failure|1
312324|NCT00760877|1023727|P2|Overall Study|Participants transferred to AMN107A2408|1
312325|NCT00760877|1023728|P1|Overall Study|Participants transferred to AMN107A2408|11
312326|NCT00760877|1023727|P2|Overall Study|Physician Decision|2
312327|NCT00760877|1023728|P1|Overall Study|Physician Decision|1
312328|NCT00760877|1023727|P2|Overall Study|Participant not eligible to cross-over|1
312329|NCT00760877|1023728|P1|Overall Study|Participant not eligible to cross-over|0
312330|NCT00760877|1023727|P2|Overall Study|Participant diagnosed with AML|1
312331|NCT00760877|1023728|P1|Overall Study|Participant diagnosed with AML|0
312332|NCT00760877|1023727|P2|Overall Study|Adverse Event|12
312333|NCT00760877|1023728|P1|Overall Study|Adverse Event|19
312334|NCT00760877|1023727|P2|Overall Study|Withdrawal by Subject|3
312335|NCT00760877|1023728|P1|Overall Study|Withdrawal by Subject|7
312336|NCT00760877|1023727|P2|Overall Study|Death|1
312337|NCT00760877|1023728|P1|Overall Study|Death|2
312338|NCT00760877|1023727|P2|Overall Study|Pregnancy|4
312339|NCT00760877|1023728|P1|Overall Study|Pregnancy|1
312340|NCT00760877|1023727|P2|Overall Study|Non-compliance with protocol treatment|1
312341|NCT00760877|1023728|P1|Overall Study|Non-compliance with protocol treatment|2
312342|NCT00760877|1023727|P2|Overall Study|Protocol Violation|0
312343|NCT00760877|1023728|P1|Overall Study|Protocol Violation|1
312344|NCT00760838|1023746|P2|Overall Study|Withdrawal by Subject|1
312345|NCT00760838|1023747|P1|Overall Study|Withdrawal by Subject|1
312346|NCT00760838|1023746|P2|Overall Study|Lost to Follow-up|0
312347|NCT00760838|1023747|P1|Overall Study|Lost to Follow-up|2
312348|NCT00760838|1023746|P2|Overall Study|Lack of Efficacy|0
312349|NCT00760838|1023747|P1|Overall Study|Lack of Efficacy|1
312350|NCT00760838|1023746|P2|Overall Study|Adverse Event|1
312351|NCT00760838|1023747|P1|Overall Study|Adverse Event|1
312352|NCT00760747|1023765|P2|Study Period III|Physician Decision|1
312353|NCT00760747|1023766|P1|Study Period III|Physician Decision|0
312354|NCT00760747|1023765|P2|Study Period III|Protocol Violation|1
312355|NCT00760747|1023766|P1|Study Period III|Protocol Violation|1
312356|NCT00760747|1023765|P2|Study Period III|Parent/Caregiver Decision|1
312357|NCT00760747|1023766|P1|Study Period III|Parent/Caregiver Decision|0
312358|NCT00760747|1023765|P2|Study Period III|Lack of Efficacy|0
312359|NCT00760747|1023766|P1|Study Period III|Lack of Efficacy|1
312360|NCT00760747|1023765|P2|Study Period III|Adverse Event|0
312361|NCT00760747|1023766|P1|Study Period III|Adverse Event|1
312362|NCT00760747|1023765|P2|Study Period II|No drug administered|1
312363|NCT00760747|1023766|P1|Study Period II|No drug administered|0
312364|NCT00760747|1023765|P2|Study Period II|Withdrawal by Subject|0
312365|NCT00760747|1023766|P1|Study Period II|Withdrawal by Subject|1
312366|NCT00760747|1023765|P2|Study Period II|Protocol Violation|3
312367|NCT00760747|1023766|P1|Study Period II|Protocol Violation|6
312368|NCT00760747|1023765|P2|Study Period II|Parent/Caregiver Decision|0
312369|NCT00760747|1023766|P1|Study Period II|Parent/Caregiver Decision|3
312370|NCT00760747|1023765|P2|Study Period II|Lack of Efficacy|6
312371|NCT00760747|1023766|P1|Study Period II|Lack of Efficacy|0
312372|NCT00760747|1023765|P2|Study Period II|Adverse Event|4
312373|NCT00760747|1023766|P1|Study Period II|Adverse Event|3
312374|NCT00760669|1023794|P1|Overall Study|Took drug before entering in contract|5
312375|NCT00760669|1023794|P1|Overall Study|Participants with overlapping cases|1
312376|NCT00760669|1023794|P1|Overall Study|Participants missing efficacy assessment|6
312377|NCT00760669|1023794|P1|Overall Study|Not assessed for overall improvement|18
312378|NCT00760617|1023811|P3|Overall Study|Lost to Follow-up|5
312379|NCT00760617|1023812|P2|Overall Study|Lost to Follow-up|0
312380|NCT00760617|1023813|P1|Overall Study|Lost to Follow-up|0
312381|NCT00760617|1023811|P3|Overall Study|Adverse Event|0
312382|NCT00760617|1023812|P2|Overall Study|Adverse Event|2
312383|NCT00760617|1023813|P1|Overall Study|Adverse Event|5
312384|NCT00760552|1023927|P2|Overall Study|Lost to Follow-up|10
312385|NCT00760552|1023928|P1|Overall Study|Lost to Follow-up|11
312386|NCT00760552|1023927|P2|Overall Study|Death|0
312387|NCT00760552|1023928|P1|Overall Study|Death|2
312388|NCT00760487|1023962|P1|Overall Study|Unilateral implantation|3
312389|NCT00760474|1023968|P2|Period 2 (P2)|Adverse Event|1
312390|NCT00760474|1023969|P1|Period 2 (P2)|Adverse Event|0
312391|NCT00760474|1023968|P2|Period 2 (P2)|Lost to Follow-up|0
312392|NCT00760474|1023969|P1|Period 2 (P2)|Lost to Follow-up|1
312393|NCT00760474|1023968|P2|Placebo Washout Period|Unspecified|1
312394|NCT00760474|1023969|P1|Placebo Washout Period|Unspecified|0
316249|NCT00725985|1037039|P1|OLMP|Death|0
312395|NCT00760474|1023968|P2|Period 1 (P1)|Discontinued then re-entered|1
312396|NCT00760474|1023969|P1|Period 1 (P1)|Discontinued then re-entered|1
312397|NCT00760383|1024022|P2|Overall Study|moved away; withdrew; medical reasons|7
312398|NCT00760383|1024023|P1|Overall Study|moved away; withdrew; medical reasons|5
312399|NCT00760084|1024033|P1|Overall Study|Progressive Disease|3
312400|NCT00760084|1024033|P1|Overall Study|Withdrawal by Subject|2
312401|NCT00760084|1024033|P1|Overall Study|Physician Decision|5
312402|NCT00759954|1024050|P2|Overall Study|Adverse Event|2
312403|NCT00759954|1024051|P1|Overall Study|Adverse Event|1
312404|NCT00759954|1024050|P2|Overall Study|Personal reason|0
312405|NCT00759954|1024051|P1|Overall Study|Personal reason|1
312406|NCT00759941|1024065|P2|Overall Study|Exited in error by site|1
312407|NCT00759941|1024066|P1|Overall Study|Exited in error by site|1
312408|NCT00759941|1024065|P2|Overall Study|Adverse Event|0
312409|NCT00759941|1024066|P1|Overall Study|Adverse Event|1
312410|NCT00759941|1024065|P2|Overall Study|Use of medication|0
312411|NCT00759941|1024066|P1|Overall Study|Use of medication|1
312412|NCT00759915|1024080|P2|Overall Study|Adverse Event|1
312413|NCT00759915|1024081|P1|Overall Study|Adverse Event|0
312414|NCT00759915|1024080|P2|Overall Study|Withdrawal by Subject|0
312415|NCT00759915|1024081|P1|Overall Study|Withdrawal by Subject|1
312416|NCT00759902|1024095|P2|Overall Study|Adverse Event|1
312417|NCT00759902|1024096|P1|Overall Study|Adverse Event|0
312418|NCT00759863|1024110|P2|Overall Study|Death, moved, or lost contact|18
312419|NCT00759863|1024111|P1|Overall Study|Death, moved, or lost contact|20
312420|NCT00759785|1024132|P2|Overall Study|Withdrawal by Subject|1
312421|NCT00759785|1024133|P1|Overall Study|Withdrawal by Subject|0
312422|NCT00759785|1024132|P2|Overall Study|Physician Decision|1
312423|NCT00759785|1024133|P1|Overall Study|Physician Decision|0
312424|NCT00759785|1024132|P2|Overall Study|Protocol Violation|0
312425|NCT00759785|1024133|P1|Overall Study|Protocol Violation|1
312426|NCT00759785|1024132|P2|Overall Study|Participant sample lost|1
312427|NCT00759785|1024133|P1|Overall Study|Participant sample lost|0
312428|NCT00759785|1024132|P2|Overall Study|Participant sample not evaluable|2
312429|NCT00759785|1024133|P1|Overall Study|Participant sample not evaluable|11
312430|NCT00759759|1024156|P2|Overall Study|Withdrawal by Subject|1
312431|NCT00759759|1024157|P1|Overall Study|Withdrawal by Subject|2
312432|NCT00759759|1024156|P2|Overall Study|Didn't receive drug in period 2|0
312433|NCT00759759|1024157|P1|Overall Study|Didn't receive drug in period 2|1
312434|NCT00759759|1024156|P2|Overall Study|didn't return for period 2|0
312435|NCT00759759|1024157|P1|Overall Study|didn't return for period 2|1
312436|NCT00759681|1024175|P2|Overall Study|Lost to Follow-up|5
312437|NCT00759681|1024176|P1|Overall Study|Lost to Follow-up|8
312438|NCT00759681|1024175|P2|Overall Study|Death|5
312439|NCT00759681|1024176|P1|Overall Study|Death|2
312440|NCT00759655|1024203|P1|Overall Study|Termination of the study by sponsor|1
312441|NCT00759564|1024231|P5|Washout Period (at Least 14 Days)|Adverse Event|1
312442|NCT00759564|1024232|P4|Washout Period (at Least 14 Days)|Adverse Event|0
312443|NCT00759564|1024233|P3|Washout Period (at Least 14 Days)|Adverse Event|0
312444|NCT00759564|1024234|P2|Washout Period (at Least 14 Days)|Adverse Event|0
312445|NCT00759564|1024235|P1|Washout Period (at Least 14 Days)|Adverse Event|0
312446|NCT00759395|1024405|P2|Overall Study|Lack of Efficacy|2
312447|NCT00759395|1024406|P1|Overall Study|Lack of Efficacy|0
312448|NCT00759395|1024405|P2|Overall Study|Withdrawal by Subject|0
312449|NCT00759395|1024406|P1|Overall Study|Withdrawal by Subject|1
312450|NCT00759395|1024405|P2|Overall Study|Adverse Event|0
312451|NCT00759395|1024406|P1|Overall Study|Adverse Event|1
312452|NCT00759356|1024422|P2|Overall Study|Subject was unable to return|0
312453|NCT00759356|1024423|P1|Overall Study|Subject was unable to return|1
312454|NCT00759356|1024422|P2|Overall Study|Withdrawal by Subject|2
312455|NCT00759356|1024423|P1|Overall Study|Withdrawal by Subject|0
312456|NCT00759356|1024422|P2|Overall Study|Adverse Event|1
312457|NCT00759356|1024423|P1|Overall Study|Adverse Event|0
312458|NCT00759174|1024503|P2|Overall Study|Unspecified|2
312459|NCT00759174|1024504|P1|Overall Study|Unspecified|0
312460|NCT00759109|1024539|P2|Overall Study|Lost during study|0
312461|NCT00759109|1024540|P1|Overall Study|Lost during study|1
312462|NCT00759109|1024539|P2|Overall Study|Participant had a liver transplant|1
312463|NCT00759109|1024540|P1|Overall Study|Participant had a liver transplant|0
312464|NCT00759109|1024539|P2|Overall Study|Participant moved to a different city|1
312465|NCT00759109|1024540|P1|Overall Study|Participant moved to a different city|0
312466|NCT00759109|1024539|P2|Overall Study|HCV RNA negative|0
312467|NCT00759109|1024540|P1|Overall Study|HCV RNA negative|1
312468|NCT00759109|1024539|P2|Overall Study|Started new therapy|6
312469|NCT00759109|1024540|P1|Overall Study|Started new therapy|2
312470|NCT00759109|1024539|P2|Overall Study|Lost to Follow-up|6
312471|NCT00759109|1024540|P1|Overall Study|Lost to Follow-up|4
312472|NCT00759109|1024539|P2|Overall Study|Death|3
312473|NCT00759109|1024540|P1|Overall Study|Death|4
312474|NCT00759109|1024539|P2|Overall Study|Withdrawal by Subject|5
312475|NCT00759109|1024540|P1|Overall Study|Withdrawal by Subject|9
312476|NCT00759109|1024539|P2|Overall Study|Inability to comply|1
312477|NCT00759109|1024540|P1|Overall Study|Inability to comply|1
312478|NCT00759109|1024539|P2|Overall Study|Adverse Event|12
312479|NCT00759109|1024540|P1|Overall Study|Adverse Event|17
312480|NCT00759031|1024562|P2|First Intervention (1 Day)|Screening failure|0
312481|NCT00759031|1024563|P1|First Intervention (1 Day)|Screening failure|1
312482|NCT00759031|1024562|P2|First Intervention (1 Day)|Withdrawal by Subject|1
312483|NCT00759031|1024563|P1|First Intervention (1 Day)|Withdrawal by Subject|0
312484|NCT00759031|1024562|P2|First Intervention (1 Day)|Physician Decision|0
312485|NCT00759031|1024563|P1|First Intervention (1 Day)|Physician Decision|1
312486|NCT00758771|1024600|P2|Overall Study|Did not meet eligibility criteria|4
312487|NCT00758771|1024601|P1|Overall Study|Did not meet eligibility criteria|2
312488|NCT00758771|1024600|P2|Overall Study|Withdrawal by Subject|1
312489|NCT00758771|1024601|P1|Overall Study|Withdrawal by Subject|1
312490|NCT00758706|1024659|P2|Overall Study|Adverse Event|4
312491|NCT00758706|1024660|P1|Overall Study|Adverse Event|4
312492|NCT00758680|1024696|P10|Overall Study|Withdrawal by Subject|0
312493|NCT00758680|1024697|P9|Overall Study|Withdrawal by Subject|1
312494|NCT00758680|1024698|P8|Overall Study|Withdrawal by Subject|0
312495|NCT00758680|1024699|P7|Overall Study|Withdrawal by Subject|1
312496|NCT00758680|1024700|P6|Overall Study|Withdrawal by Subject|0
312497|NCT00758680|1024701|P5|Overall Study|Withdrawal by Subject|0
312498|NCT00758680|1024702|P4|Overall Study|Withdrawal by Subject|0
312499|NCT00758680|1024703|P3|Overall Study|Withdrawal by Subject|0
312500|NCT00758680|1024704|P2|Overall Study|Withdrawal by Subject|0
312501|NCT00758680|1024705|P1|Overall Study|Withdrawal by Subject|0
312502|NCT00758680|1024696|P10|Overall Study|Laboratory Adverse Event|0
312503|NCT00758680|1024697|P9|Overall Study|Laboratory Adverse Event|1
312504|NCT00758680|1024698|P8|Overall Study|Laboratory Adverse Event|0
312505|NCT00758680|1024699|P7|Overall Study|Laboratory Adverse Event|0
312506|NCT00758680|1024700|P6|Overall Study|Laboratory Adverse Event|0
312507|NCT00758680|1024701|P5|Overall Study|Laboratory Adverse Event|0
312508|NCT00758680|1024702|P4|Overall Study|Laboratory Adverse Event|0
312509|NCT00758680|1024703|P3|Overall Study|Laboratory Adverse Event|0
312510|NCT00758680|1024704|P2|Overall Study|Laboratory Adverse Event|0
312511|NCT00758680|1024705|P1|Overall Study|Laboratory Adverse Event|0
312512|NCT00758680|1024696|P10|Overall Study|Adverse Event|1
312513|NCT00758680|1024697|P9|Overall Study|Adverse Event|0
312514|NCT00758680|1024698|P8|Overall Study|Adverse Event|1
312515|NCT00758680|1024699|P7|Overall Study|Adverse Event|0
312516|NCT00758680|1024700|P6|Overall Study|Adverse Event|0
312517|NCT00758680|1024701|P5|Overall Study|Adverse Event|0
312518|NCT00758680|1024702|P4|Overall Study|Adverse Event|0
312519|NCT00758680|1024703|P3|Overall Study|Adverse Event|0
312520|NCT00758680|1024704|P2|Overall Study|Adverse Event|0
312521|NCT00758680|1024705|P1|Overall Study|Adverse Event|0
312522|NCT00758602|1024758|P2|Overall Study|Reason not specified|3
312523|NCT00758602|1024759|P1|Overall Study|Reason not specified|3
312524|NCT00758602|1024758|P2|Overall Study|Death|1
312525|NCT00758602|1024759|P1|Overall Study|Death|0
312526|NCT00758602|1024758|P2|Overall Study|Protocol Violation|2
312527|NCT00758602|1024759|P1|Overall Study|Protocol Violation|0
312528|NCT00758602|1024758|P2|Overall Study|Withdrawal by Subject|3
312529|NCT00758602|1024759|P1|Overall Study|Withdrawal by Subject|1
312530|NCT00758602|1024758|P2|Overall Study|Lost to Follow-up|3
312531|NCT00758602|1024759|P1|Overall Study|Lost to Follow-up|4
312532|NCT00758602|1024758|P2|Overall Study|Adverse Event|10
312533|NCT00758602|1024759|P1|Overall Study|Adverse Event|11
312534|NCT00758589|1024785|P4|Overall Study|Palm stopped to work|1
312535|NCT00758589|1024786|P3|Overall Study|Palm stopped to work|0
312536|NCT00758589|1024787|P2|Overall Study|Palm stopped to work|0
312537|NCT00758589|1024788|P1|Overall Study|Palm stopped to work|0
312538|NCT00758589|1024785|P4|Overall Study|Withdrawal by Subject|1
312539|NCT00758589|1024786|P3|Overall Study|Withdrawal by Subject|1
312540|NCT00758589|1024787|P2|Overall Study|Withdrawal by Subject|1
312541|NCT00758589|1024788|P1|Overall Study|Withdrawal by Subject|0
312542|NCT00758589|1024785|P4|Overall Study|Adverse Event|4
312543|NCT00758589|1024786|P3|Overall Study|Adverse Event|5
312544|NCT00758589|1024787|P2|Overall Study|Adverse Event|2
312545|NCT00758589|1024788|P1|Overall Study|Adverse Event|3
312546|NCT00758498|1024881|P3|Overall Study|Noncompliance to study procedures|1
312547|NCT00758498|1024882|P2|Overall Study|Noncompliance to study procedures|0
312548|NCT00758498|1024883|P1|Overall Study|Noncompliance to study procedures|0
312549|NCT00758498|1024881|P3|Overall Study|Withdrawal by Subject|1
312550|NCT00758498|1024882|P2|Overall Study|Withdrawal by Subject|0
312551|NCT00758498|1024883|P1|Overall Study|Withdrawal by Subject|0
312552|NCT00758498|1024881|P3|Overall Study|Subject legally detained out of state|0
312553|NCT00758498|1024882|P2|Overall Study|Subject legally detained out of state|0
312554|NCT00758498|1024883|P1|Overall Study|Subject legally detained out of state|1
312555|NCT00758498|1024881|P3|Overall Study|Adverse Event|3
312556|NCT00758498|1024882|P2|Overall Study|Adverse Event|2
312557|NCT00758498|1024883|P1|Overall Study|Adverse Event|2
312558|NCT00758485|1024968|P2|Overall Study|Not Treated|2
312559|NCT00758485|1024969|P1|Overall Study|Not Treated|1
312560|NCT00758485|1024968|P2|Overall Study|Lost to Follow-up|1
312561|NCT00758485|1024969|P1|Overall Study|Lost to Follow-up|0
312562|NCT00758459|1024981|P2|Overall Study|Withdrawal by Subject|1
312563|NCT00758459|1024982|P1|Overall Study|Withdrawal by Subject|0
312564|NCT00758459|1024981|P2|Overall Study|Protocol Violation|1
312565|NCT00758459|1024982|P1|Overall Study|Protocol Violation|0
312566|NCT00758459|1024981|P2|Overall Study|Adverse Event|2
312567|NCT00758459|1024982|P1|Overall Study|Adverse Event|3
312568|NCT00758394|1025027|P4|3rd Intervention|Lost to Follow-up|1
312569|NCT00758394|1025028|P3|3rd Intervention|Lost to Follow-up|0
312570|NCT00758394|1025029|P2|3rd Intervention|Lost to Follow-up|0
312571|NCT00758394|1025030|P1|3rd Intervention|Lost to Follow-up|1
312572|NCT00758394|1025027|P4|2nd Intervention Order|Lost to Follow-up|0
312573|NCT00758394|1025028|P3|2nd Intervention Order|Lost to Follow-up|0
312574|NCT00758394|1025029|P2|2nd Intervention Order|Lost to Follow-up|1
312575|NCT00758394|1025030|P1|2nd Intervention Order|Lost to Follow-up|0
312576|NCT00758160|1025056|P1|Overall Study|Withdrawal by Subject|8
312577|NCT00758160|1025056|P1|Overall Study|Protocol Violation|12
312578|NCT00758160|1025056|P1|Overall Study|Lost to Follow-up|14
312579|NCT00758160|1025056|P1|Overall Study|Lack of Efficacy|10
312580|NCT00758160|1025056|P1|Overall Study|Adverse Event|15
312581|NCT00758160|1025056|P1|Overall Study|Administration Problems|3
312582|NCT00758160|1025056|P1|Overall Study|No Longer Requires Study Medication|4
312583|NCT00758069|1025077|P3|Overall Study|Incorrect Study Drug|0
312584|NCT00758069|1025078|P2|Overall Study|Incorrect Study Drug|0
312585|NCT00758069|1025079|P1|Overall Study|Incorrect Study Drug|1
312586|NCT00758069|1025077|P3|Overall Study|Lack of Efficacy|1
312587|NCT00758069|1025078|P2|Overall Study|Lack of Efficacy|0
312588|NCT00758069|1025079|P1|Overall Study|Lack of Efficacy|0
312589|NCT00758043|1025094|P4|Overall Study|Other Reasons|5
312590|NCT00758043|1025095|P3|Overall Study|Other Reasons|0
312591|NCT00758043|1025096|P2|Overall Study|Other Reasons|1
312592|NCT00758043|1025097|P1|Overall Study|Other Reasons|0
312593|NCT00758043|1025094|P4|Overall Study|Non-Compliant With study Drug|1
312594|NCT00758043|1025095|P3|Overall Study|Non-Compliant With study Drug|0
312595|NCT00758043|1025096|P2|Overall Study|Non-Compliant With study Drug|0
312596|NCT00758043|1025097|P1|Overall Study|Non-Compliant With study Drug|0
312597|NCT00758043|1025094|P4|Overall Study|Required Prohibited Medication|3
312598|NCT00758043|1025095|P3|Overall Study|Required Prohibited Medication|1
312599|NCT00758043|1025096|P2|Overall Study|Required Prohibited Medication|0
312600|NCT00758043|1025097|P1|Overall Study|Required Prohibited Medication|0
312601|NCT00758043|1025094|P4|Overall Study|Withdrawal by Subject|4
312602|NCT00758043|1025095|P3|Overall Study|Withdrawal by Subject|1
312603|NCT00758043|1025096|P2|Overall Study|Withdrawal by Subject|1
312604|NCT00758043|1025097|P1|Overall Study|Withdrawal by Subject|0
312605|NCT00758043|1025094|P4|Overall Study|Lost to Follow-up|5
312606|NCT00758043|1025095|P3|Overall Study|Lost to Follow-up|2
312607|NCT00758043|1025096|P2|Overall Study|Lost to Follow-up|2
312608|NCT00758043|1025097|P1|Overall Study|Lost to Follow-up|0
312609|NCT00758043|1025094|P4|Overall Study|Refused Further Treatment|8
312610|NCT00758043|1025095|P3|Overall Study|Refused Further Treatment|5
312611|NCT00758043|1025096|P2|Overall Study|Refused Further Treatment|11
312612|NCT00758043|1025097|P1|Overall Study|Refused Further Treatment|0
312613|NCT00758043|1025094|P4|Overall Study|Lack of Efficacy|12
312614|NCT00758043|1025095|P3|Overall Study|Lack of Efficacy|18
312615|NCT00758043|1025096|P2|Overall Study|Lack of Efficacy|6
312616|NCT00758043|1025097|P1|Overall Study|Lack of Efficacy|0
312617|NCT00758043|1025094|P4|Overall Study|Adverse Event|62
312618|NCT00758043|1025095|P3|Overall Study|Adverse Event|12
312619|NCT00758043|1025096|P2|Overall Study|Adverse Event|20
312620|NCT00758043|1025097|P1|Overall Study|Adverse Event|1
312621|NCT00757848|1025125|P2|Overall Study|Incorrect enrolment|0
312622|NCT00757848|1025126|P1|Overall Study|Incorrect enrolment|1
312623|NCT00757848|1025125|P2|Overall Study|Adverse Event|2
312624|NCT00757848|1025126|P1|Overall Study|Adverse Event|1
312625|NCT00757848|1025125|P2|Overall Study|Voluntary discontinuation|0
312626|NCT00757848|1025126|P1|Overall Study|Voluntary discontinuation|1
312627|NCT00757783|1025195|P2|Overall Study|Unspecified|2
312628|NCT00757783|1025196|P1|Overall Study|Unspecified|1
312629|NCT00757783|1025195|P2|Overall Study|Withdrawal by Subject|1
312630|NCT00757783|1025196|P1|Overall Study|Withdrawal by Subject|2
312631|NCT00757783|1025195|P2|Overall Study|Protocol Violation|0
312632|NCT00757783|1025196|P1|Overall Study|Protocol Violation|1
312633|NCT00757783|1025195|P2|Overall Study|Lost to Follow-up|1
312634|NCT00757783|1025196|P1|Overall Study|Lost to Follow-up|1
312635|NCT00757783|1025195|P2|Overall Study|Adverse Event|2
312636|NCT00757783|1025196|P1|Overall Study|Adverse Event|0
312637|NCT00757705|1025232|P1|Overall Study|Unspecified|18
312638|NCT00757705|1025232|P1|Overall Study|Non-compliant|9
312639|NCT00757705|1025232|P1|Overall Study|Ineligible to continue|8
312640|NCT00757705|1025232|P1|Overall Study|Insufficient Response|26
312641|NCT00757705|1025232|P1|Overall Study|Withdrawal by Subject|25
312642|NCT00757705|1025232|P1|Overall Study|Lost to Follow-up|16
312643|NCT00757705|1025232|P1|Overall Study|Adverse Event|19
312644|NCT00757627|1025261|P1|Overall Study|Unspecified|1
312645|NCT00757627|1025261|P1|Overall Study|Withdrawal by Subject|27
312646|NCT00757627|1025261|P1|Overall Study|Lost to Follow-up|28
312647|NCT00757627|1025261|P1|Overall Study|Lack of Efficacy|10
312648|NCT00757627|1025261|P1|Overall Study|Adverse Event|15
312649|NCT00757588|1025396|P2|Period 2: Long-term (52-week) Phase|Not specified|0
312650|NCT00757588|1025397|P1|Period 2: Long-term (52-week) Phase|Not specified|1
312651|NCT00757588|1025396|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
312652|NCT00757588|1025397|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
312653|NCT00757588|1025396|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
312654|NCT00757588|1025397|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
312655|NCT00757588|1025396|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
312656|NCT00757588|1025397|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
312657|NCT00757588|1025396|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
312658|NCT00757588|1025397|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
312659|NCT00757588|1025396|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
312660|NCT00757588|1025397|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
312661|NCT00757588|1025396|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
312662|NCT00757588|1025397|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
312663|NCT00757588|1025396|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
312664|NCT00757588|1025397|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
312665|NCT00757588|1025396|P2|Period 1: Short-term (24-week) Phase|Not specified|1
312666|NCT00757588|1025397|P1|Period 1: Short-term (24-week) Phase|Not specified|0
312667|NCT00757588|1025396|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
312668|NCT00757588|1025397|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
312669|NCT00757588|1025396|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
312670|NCT00757588|1025397|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
312671|NCT00757588|1025396|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
312672|NCT00757588|1025397|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
312673|NCT00757588|1025396|P2|Period 1: Short-term (24-week) Phase|Death|0
312674|NCT00757588|1025397|P1|Period 1: Short-term (24-week) Phase|Death|1
312675|NCT00757588|1025396|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
312676|NCT00757588|1025397|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
312677|NCT00757588|1025396|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
312678|NCT00757588|1025397|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
312679|NCT00757588|1025396|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
312680|NCT00757588|1025397|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
312681|NCT00757237|1025438|P2|Overall Study|Other|2
312682|NCT00757237|1025439|P1|Overall Study|Other|0
312683|NCT00757237|1025438|P2|Overall Study|Safety or Tolerability|5
312684|NCT00757237|1025439|P1|Overall Study|Safety or Tolerability|3
312685|NCT00757237|1025438|P2|Overall Study|Withdrawal by Subject|12
312686|NCT00757237|1025439|P1|Overall Study|Withdrawal by Subject|8
312687|NCT00757237|1025438|P2|Overall Study|Physician Decision|3
312688|NCT00757237|1025439|P1|Overall Study|Physician Decision|2
312689|NCT00757237|1025438|P2|Overall Study|Protocol Violation|2
312690|NCT00757237|1025439|P1|Overall Study|Protocol Violation|0
312691|NCT00757237|1025438|P2|Overall Study|Lost to Follow-up|1
312692|NCT00757237|1025439|P1|Overall Study|Lost to Follow-up|0
312693|NCT00757172|1025467|P1|Overall Study|Progression|4
312694|NCT00757172|1025467|P1|Overall Study|Physician Decision|3
312695|NCT00757172|1025467|P1|Overall Study|Withdrawal by Subject|4
312696|NCT00757003|1025475|P1|Overall Study|Not implanted|1
312697|NCT00757003|1025475|P1|Overall Study|Surgically explanted|2
312698|NCT00757003|1025475|P1|Overall Study|Withdrawal by Subject|4
312699|NCT00757003|1025475|P1|Overall Study|Lost to Follow-up|9
312700|NCT00757003|1025475|P1|Overall Study|Death|33
312701|NCT00756938|1025522|P4|Optional Extension|Adverse Event|1
312702|NCT00756938|1025523|P3|Optional Extension|Adverse Event|0
312703|NCT00756938|1025524|P2|Optional Extension|Adverse Event|0
312704|NCT00756938|1025525|P1|Optional Extension|Adverse Event|0
312705|NCT00756938|1025522|P4|Optional Extension|Withdrawal by Subject|10
312706|NCT00756938|1025523|P3|Optional Extension|Withdrawal by Subject|0
312707|NCT00756938|1025524|P2|Optional Extension|Withdrawal by Subject|0
312708|NCT00756938|1025525|P1|Optional Extension|Withdrawal by Subject|0
312709|NCT00756938|1025522|P4|Optional Extension|Protocol Violation|1
312710|NCT00756938|1025523|P3|Optional Extension|Protocol Violation|0
312711|NCT00756938|1025524|P2|Optional Extension|Protocol Violation|0
312712|NCT00756938|1025525|P1|Optional Extension|Protocol Violation|0
312713|NCT00756938|1025522|P4|Optional Extension|Lost to Follow-up|1
312714|NCT00756938|1025523|P3|Optional Extension|Lost to Follow-up|0
312715|NCT00756938|1025524|P2|Optional Extension|Lost to Follow-up|0
312716|NCT00756938|1025525|P1|Optional Extension|Lost to Follow-up|0
312717|NCT00756938|1025522|P4|Optional Extension|Physician Decision|3
312718|NCT00756938|1025523|P3|Optional Extension|Physician Decision|0
312719|NCT00756938|1025524|P2|Optional Extension|Physician Decision|0
312720|NCT00756938|1025525|P1|Optional Extension|Physician Decision|0
312721|NCT00756938|1025522|P4|Optional Extension|Protocol-specific criteria met|9
312722|NCT00756938|1025523|P3|Optional Extension|Protocol-specific criteria met|0
312723|NCT00756938|1025524|P2|Optional Extension|Protocol-specific criteria met|0
312724|NCT00756938|1025525|P1|Optional Extension|Protocol-specific criteria met|0
312725|NCT00756938|1025522|P4|Optional Extension|End of Study|11
312726|NCT00756938|1025523|P3|Optional Extension|End of Study|0
312727|NCT00756938|1025524|P2|Optional Extension|End of Study|0
312728|NCT00756938|1025525|P1|Optional Extension|End of Study|0
312729|NCT00756938|1025522|P4|Optional Extension|Lack of Efficacy|1
312730|NCT00756938|1025523|P3|Optional Extension|Lack of Efficacy|0
312731|NCT00756938|1025524|P2|Optional Extension|Lack of Efficacy|0
312732|NCT00756938|1025525|P1|Optional Extension|Lack of Efficacy|0
312733|NCT00756938|1025522|P4|12-week Base Study|Lost to Follow-up|0
312734|NCT00756938|1025523|P3|12-week Base Study|Lost to Follow-up|0
312735|NCT00756938|1025524|P2|12-week Base Study|Lost to Follow-up|0
312736|NCT00756938|1025525|P1|12-week Base Study|Lost to Follow-up|1
312737|NCT00756938|1025522|P4|12-week Base Study|Protocol Violation|0
312738|NCT00756938|1025523|P3|12-week Base Study|Protocol Violation|1
312739|NCT00756938|1025524|P2|12-week Base Study|Protocol Violation|0
312740|NCT00756938|1025525|P1|12-week Base Study|Protocol Violation|0
312741|NCT00756938|1025522|P4|12-week Base Study|Protocol-specific Criteria Met|0
312742|NCT00756938|1025523|P3|12-week Base Study|Protocol-specific Criteria Met|1
312743|NCT00756938|1025524|P2|12-week Base Study|Protocol-specific Criteria Met|0
312744|NCT00756938|1025525|P1|12-week Base Study|Protocol-specific Criteria Met|1
312745|NCT00756886|1025553|P2|Overall Study|Ineligible|4
312746|NCT00756886|1025554|P1|Overall Study|Ineligible|9
312747|NCT00756886|1025553|P2|Overall Study|Lack of Efficacy|0
312748|NCT00756886|1025554|P1|Overall Study|Lack of Efficacy|1
312749|NCT00756886|1025553|P2|Overall Study|Adverse Event|3
312750|NCT00756886|1025554|P1|Overall Study|Adverse Event|0
312751|NCT00756886|1025553|P2|Overall Study|Lost to Follow-up|0
312752|NCT00756886|1025554|P1|Overall Study|Lost to Follow-up|1
312753|NCT00756730|1025562|P2|Overall Study|persistent low-level viremmia|1
312754|NCT00756730|1025563|P1|Overall Study|persistent low-level viremmia|0
312755|NCT00756730|1025562|P2|Overall Study|discontinued due to rash prior to week 4|1
312756|NCT00756730|1025563|P1|Overall Study|discontinued due to rash prior to week 4|0
312757|NCT00756574|1025596|P2|Overall Study|Lost to Follow-up|4
312758|NCT00756574|1025597|P1|Overall Study|Lost to Follow-up|4
312759|NCT00756574|1025596|P2|Overall Study|Withdrawal by Subject|7
312760|NCT00756574|1025597|P1|Overall Study|Withdrawal by Subject|9
312761|NCT00756470|1025641|P1|Overall Study|Adverse Event|4
312762|NCT00756470|1025641|P1|Overall Study|Withdrawal by Subject|1
312763|NCT00756457|1025648|P2|Overall Study|Lost to Follow-up|2
312764|NCT00756457|1025649|P1|Overall Study|Lost to Follow-up|1
312765|NCT00756444|1025679|P2|Overall Study|Ineligibility Determined|0
312766|NCT00756444|1025680|P1|Overall Study|Ineligibility Determined|1
312767|NCT00756444|1025679|P2|Overall Study|Disease Progression|7
312768|NCT00756444|1025680|P1|Overall Study|Disease Progression|2
312769|NCT00756444|1025679|P2|Overall Study|Death|4
312770|NCT00756444|1025680|P1|Overall Study|Death|5
312771|NCT00756444|1025679|P2|Overall Study|Lost to Follow-up|1
312772|NCT00756444|1025680|P1|Overall Study|Lost to Follow-up|0
312773|NCT00756444|1025679|P2|Overall Study|Withdrawal by Subject|8
312774|NCT00756444|1025680|P1|Overall Study|Withdrawal by Subject|6
312775|NCT00756444|1025679|P2|Overall Study|Adverse Event|1
312776|NCT00756444|1025680|P1|Overall Study|Adverse Event|1
312777|NCT00756314|1025691|P2|Overall Study|Lost to Follow-up|59
312778|NCT00756314|1025692|P1|Overall Study|Lost to Follow-up|2
312779|NCT00756002|1025721|P2|Double-Blind Treatment Period|Not Specified|2
312780|NCT00756002|1025722|P1|Double-Blind Treatment Period|Not Specified|2
312781|NCT00756002|1025721|P2|Double-Blind Treatment Period|Protocol Violation|5
312782|NCT00756002|1025722|P1|Double-Blind Treatment Period|Protocol Violation|6
312783|NCT00756002|1025721|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
312784|NCT00756002|1025722|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
312785|NCT00756002|1025721|P2|Double-Blind Treatment Period|Lost to Follow-up|1
312786|NCT00756002|1025722|P1|Double-Blind Treatment Period|Lost to Follow-up|0
312787|NCT00756002|1025721|P2|Double-Blind Treatment Period|Lack of Efficacy|1
312788|NCT00756002|1025722|P1|Double-Blind Treatment Period|Lack of Efficacy|1
312789|NCT00755937|1025816|P1|Observational Follow-up|Lost to Follow-up|148
312790|NCT00755937|1025816|P1|Recruitment|Unknown if infliximab received|164
312791|NCT00755846|1025843|P6|Overall Study|Participant Non-compliance|0
312792|NCT00755846|1025844|P5|Overall Study|Participant Non-compliance|1
312793|NCT00755846|1025845|P4|Overall Study|Participant Non-compliance|0
312794|NCT00755846|1025846|P3|Overall Study|Participant Non-compliance|0
312795|NCT00755846|1025847|P2|Overall Study|Participant Non-compliance|0
312796|NCT00755846|1025848|P1|Overall Study|Participant Non-compliance|0
312797|NCT00755846|1025843|P6|Overall Study|Administrative Error|0
312798|NCT00755846|1025844|P5|Overall Study|Administrative Error|0
312799|NCT00755846|1025845|P4|Overall Study|Administrative Error|0
312800|NCT00755846|1025846|P3|Overall Study|Administrative Error|0
312801|NCT00755846|1025847|P2|Overall Study|Administrative Error|1
312802|NCT00755846|1025848|P1|Overall Study|Administrative Error|0
312803|NCT00755846|1025843|P6|Overall Study|Physician Decision|1
312804|NCT00755846|1025844|P5|Overall Study|Physician Decision|0
312805|NCT00755846|1025845|P4|Overall Study|Physician Decision|1
312806|NCT00755846|1025846|P3|Overall Study|Physician Decision|0
312807|NCT00755846|1025847|P2|Overall Study|Physician Decision|3
312808|NCT00755846|1025848|P1|Overall Study|Physician Decision|1
312809|NCT00755846|1025843|P6|Overall Study|Hyperglycemic Rescue|7
312810|NCT00755846|1025844|P5|Overall Study|Hyperglycemic Rescue|8
312811|NCT00755846|1025845|P4|Overall Study|Hyperglycemic Rescue|8
312812|NCT00755846|1025846|P3|Overall Study|Hyperglycemic Rescue|5
312813|NCT00755846|1025847|P2|Overall Study|Hyperglycemic Rescue|7
312814|NCT00755846|1025848|P1|Overall Study|Hyperglycemic Rescue|21
312815|NCT00755846|1025843|P6|Overall Study|Withdrawal by Subject|1
312816|NCT00755846|1025844|P5|Overall Study|Withdrawal by Subject|0
312817|NCT00755846|1025845|P4|Overall Study|Withdrawal by Subject|2
312818|NCT00755846|1025846|P3|Overall Study|Withdrawal by Subject|5
312819|NCT00755846|1025847|P2|Overall Study|Withdrawal by Subject|3
312820|NCT00755846|1025848|P1|Overall Study|Withdrawal by Subject|2
312821|NCT00755846|1025843|P6|Overall Study|Lost to Follow-up|2
312822|NCT00755846|1025844|P5|Overall Study|Lost to Follow-up|4
312823|NCT00755846|1025845|P4|Overall Study|Lost to Follow-up|0
312824|NCT00755846|1025846|P3|Overall Study|Lost to Follow-up|1
312825|NCT00755846|1025847|P2|Overall Study|Lost to Follow-up|2
312826|NCT00755846|1025848|P1|Overall Study|Lost to Follow-up|0
312827|NCT00755846|1025843|P6|Overall Study|Protocol Violation|1
312828|NCT00755846|1025844|P5|Overall Study|Protocol Violation|1
312829|NCT00755846|1025845|P4|Overall Study|Protocol Violation|1
312830|NCT00755846|1025846|P3|Overall Study|Protocol Violation|1
312831|NCT00755846|1025847|P2|Overall Study|Protocol Violation|1
312832|NCT00755846|1025848|P1|Overall Study|Protocol Violation|1
312833|NCT00755846|1025843|P6|Overall Study|Adverse Event|2
312834|NCT00755846|1025844|P5|Overall Study|Adverse Event|3
312835|NCT00755846|1025845|P4|Overall Study|Adverse Event|1
312836|NCT00755846|1025846|P3|Overall Study|Adverse Event|0
312837|NCT00755846|1025847|P2|Overall Study|Adverse Event|0
312838|NCT00755846|1025848|P1|Overall Study|Adverse Event|0
312839|NCT00755807|1025948|P2|Open-label Extension Phase|Sponsor Decision|1
312840|NCT00755807|1025949|P1|Open-label Extension Phase|Sponsor Decision|0
312841|NCT00755807|1025948|P2|Open-label Extension Phase|Lost to Follow-up|0
312842|NCT00755807|1025949|P1|Open-label Extension Phase|Lost to Follow-up|2
312843|NCT00755807|1025948|P2|Open-label Extension Phase|Withdrawal by Subject|3
312844|NCT00755807|1025949|P1|Open-label Extension Phase|Withdrawal by Subject|1
312845|NCT00755807|1025948|P2|Open-label Extension Phase|Lack of Efficacy|3
312846|NCT00755807|1025949|P1|Open-label Extension Phase|Lack of Efficacy|3
312847|NCT00755807|1025948|P2|Open-label Extension Phase|Protocol Violation|2
312848|NCT00755807|1025949|P1|Open-label Extension Phase|Protocol Violation|5
312849|NCT00755807|1025948|P2|Open-label Extension Phase|Adverse Event|7
312850|NCT00755807|1025949|P1|Open-label Extension Phase|Adverse Event|7
312851|NCT00755807|1025948|P2|Acute Phase|Physician Decision|1
312852|NCT00755807|1025949|P1|Acute Phase|Physician Decision|0
312853|NCT00755807|1025948|P2|Acute Phase|Lack of Efficacy|1
312854|NCT00755807|1025949|P1|Acute Phase|Lack of Efficacy|0
312855|NCT00755807|1025948|P2|Acute Phase|Withdrawal by Subject|2
312856|NCT00755807|1025949|P1|Acute Phase|Withdrawal by Subject|1
312857|NCT00755807|1025948|P2|Acute Phase|Protocol Violation|3
312858|NCT00755807|1025949|P1|Acute Phase|Protocol Violation|1
312859|NCT00755807|1025948|P2|Acute Phase|Adverse Event|5
312860|NCT00755807|1025949|P1|Acute Phase|Adverse Event|16
312861|NCT00755417|1026029|P3|Overall Study|Not specified or missing data|12
312862|NCT00755417|1026030|P2|Overall Study|Not specified or missing data|18
312863|NCT00755417|1026031|P1|Overall Study|Not specified or missing data|9
312864|NCT00755417|1026029|P3|Overall Study|Withdrawal by Subject|12
312865|NCT00755417|1026030|P2|Overall Study|Withdrawal by Subject|12
312866|NCT00755417|1026031|P1|Overall Study|Withdrawal by Subject|12
312867|NCT00755417|1026029|P3|Overall Study|Lost to Follow-up|1
312868|NCT00755417|1026030|P2|Overall Study|Lost to Follow-up|0
312869|NCT00755417|1026031|P1|Overall Study|Lost to Follow-up|3
312870|NCT00755417|1026029|P3|Overall Study|Protocol Violation|1
312871|NCT00755417|1026030|P2|Overall Study|Protocol Violation|1
312872|NCT00755417|1026031|P1|Overall Study|Protocol Violation|2
312873|NCT00755417|1026029|P3|Overall Study|Lack of Efficacy|9
312874|NCT00755417|1026030|P2|Overall Study|Lack of Efficacy|4
312875|NCT00755417|1026031|P1|Overall Study|Lack of Efficacy|8
312876|NCT00755417|1026029|P3|Overall Study|Adverse Event|7
312877|NCT00755417|1026030|P2|Overall Study|Adverse Event|20
312878|NCT00755417|1026031|P1|Overall Study|Adverse Event|28
312879|NCT00755222|1026088|P2|Overall Study|Protocol Violation|0
312880|NCT00755222|1026089|P1|Overall Study|Protocol Violation|2
312881|NCT00755222|1026088|P2|Overall Study|Adverse Event|0
312882|NCT00755222|1026089|P1|Overall Study|Adverse Event|2
312883|NCT00755222|1026088|P2|Overall Study|Withdrawal by Subject|2
312884|NCT00755222|1026089|P1|Overall Study|Withdrawal by Subject|4
312885|NCT00755196|1026103|P1|Overall Study|Lack of Efficiency|1
312886|NCT00755196|1026103|P1|Overall Study|Lost to Follow-up|1
312887|NCT00755105|1026124|P3|Overall Study|Withdrawal by Subject|4
312888|NCT00755105|1026125|P2|Overall Study|Withdrawal by Subject|11
312889|NCT00755105|1026126|P1|Overall Study|Withdrawal by Subject|9
312890|NCT00755079|1026136|P2|Overall Study|Withdrawal by Subject|2
312891|NCT00755079|1026137|P1|Overall Study|Withdrawal by Subject|0
312892|NCT00755079|1026136|P2|Overall Study|Adverse Event|1
312893|NCT00755079|1026137|P1|Overall Study|Adverse Event|0
312894|NCT00755079|1026136|P2|Overall Study|Lost to Follow-up|3
312895|NCT00755079|1026137|P1|Overall Study|Lost to Follow-up|1
312896|NCT00754793|1026174|P2|Overall Study|voluntary withdrawn from study|1
312897|NCT00754793|1026175|P1|Overall Study|voluntary withdrawn from study|0
312898|NCT00754741|1026193|P3|Overall Study|Died or disenrolled|54
312899|NCT00754741|1026194|P2|Overall Study|Died or disenrolled|69
312900|NCT00754741|1026195|P1|Overall Study|Died or disenrolled|57
312901|NCT00754650|1026242|P1|Overall Study|Disease Progression|2
312902|NCT00754624|1026247|P1|Overall Study|Lost to Follow-up|3
312903|NCT00754624|1026247|P1|Overall Study|Various|12
312904|NCT00754624|1026247|P1|Overall Study|Withdrawal by Subject|28
312905|NCT00754624|1026247|P1|Overall Study|Protocol Violation|1
312906|NCT00754624|1026247|P1|Overall Study|Physician Decision|8
312907|NCT00754624|1026247|P1|Overall Study|Death|1
312908|NCT00754624|1026247|P1|Overall Study|Adverse Event|16
312909|NCT00754572|1026257|P1|Overall Study|Lost to Follow-up|1
312910|NCT00754572|1026257|P1|Overall Study|Administrative Reason|3
312911|NCT00754572|1026257|P1|Overall Study|Death|1
312912|NCT00754572|1026257|P1|Overall Study|Lack of Efficacy|2
312913|NCT00754572|1026257|P1|Overall Study|Withdrawal by Subject|3
312914|NCT00754572|1026257|P1|Overall Study|Protocol Violation|3
312915|NCT00754572|1026257|P1|Overall Study|Unspecified|39
312916|NCT00754572|1026257|P1|Overall Study|Adverse Event|19
312917|NCT00754559|1026284|P1|Overall Study|Withdrawal by Subject|3
312918|NCT00754559|1026284|P1|Overall Study|Other|5
312919|NCT00754559|1026284|P1|Overall Study|Administrative reason|1
312920|NCT00754559|1026284|P1|Overall Study|Lost to Follow-up|2
312921|NCT00754559|1026284|P1|Overall Study|Lack of Efficacy|10
312922|NCT00754559|1026284|P1|Overall Study|Protocol Violation|11
312923|NCT00754559|1026284|P1|Overall Study|Adverse Event|15
312924|NCT00754442|1026384|P2|Overall Study|Withdrawal by Subject|3
312925|NCT00754442|1026385|P1|Overall Study|Withdrawal by Subject|5
312926|NCT00754390|1026392|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
312927|NCT00754390|1026392|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
312928|NCT00754390|1026392|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
312929|NCT00754390|1026392|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
312930|NCT00754338|1026414|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
312931|NCT00754338|1026415|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
312932|NCT00754338|1026416|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
312933|NCT00754338|1026417|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
312934|NCT00754338|1026414|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
312935|NCT00754338|1026415|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
312936|NCT00754338|1026416|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
312937|NCT00754338|1026417|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
312938|NCT00754325|1026449|P2|Initial Treatment|Disease Progression|35
312939|NCT00754325|1026450|P1|Initial Treatment|Disease Progression|35
312940|NCT00754325|1026449|P2|Initial Treatment|Sponsor Request|1
312941|NCT00754325|1026450|P1|Initial Treatment|Sponsor Request|0
312942|NCT00754325|1026449|P2|Initial Treatment|Physician Decision|0
312943|NCT00754325|1026450|P1|Initial Treatment|Physician Decision|2
312944|NCT00754325|1026449|P2|Initial Treatment|Withdrawal by Subject|2
312945|NCT00754325|1026450|P1|Initial Treatment|Withdrawal by Subject|2
312946|NCT00754325|1026449|P2|Initial Treatment|Adverse Event|6
312947|NCT00754325|1026450|P1|Initial Treatment|Adverse Event|7
312948|NCT00754325|1026449|P2|Initial Treatment|Continuing Active Treatment|5
312949|NCT00754325|1026450|P1|Initial Treatment|Continuing Active Treatment|4
312950|NCT00754234|1026469|P1|Overall Study|Withdrawal by Subject|3
312951|NCT00754065|1026548|P2|Overall Study|Reason not specified or unknown, etc.|27
312952|NCT00754065|1026549|P1|Overall Study|Reason not specified or unknown, etc.|21
312953|NCT00754065|1026548|P2|Overall Study|Pregnancy|0
312954|NCT00754065|1026549|P1|Overall Study|Pregnancy|6
312955|NCT00754065|1026548|P2|Overall Study|Withdrawal by Subject|5
312956|NCT00754065|1026549|P1|Overall Study|Withdrawal by Subject|4
312957|NCT00754065|1026548|P2|Overall Study|Protocol Violation|10
312958|NCT00754065|1026549|P1|Overall Study|Protocol Violation|12
312959|NCT00754065|1026548|P2|Overall Study|Lost to Follow-up|11
312960|NCT00754065|1026549|P1|Overall Study|Lost to Follow-up|7
312961|NCT00754065|1026548|P2|Overall Study|Adverse Event|25
312962|NCT00754065|1026549|P1|Overall Study|Adverse Event|19
312963|NCT00754065|1026548|P2|Overall Study|Never received treatment|2
312964|NCT00754065|1026549|P1|Overall Study|Never received treatment|12
312965|NCT00754013|1026789|P2|Overall Study|didn't return after study termed|4
312966|NCT00754013|1026790|P1|Overall Study|didn't return after study termed|3
312967|NCT00754013|1026789|P2|Overall Study|Lost to Follow-up|1
312968|NCT00754013|1026790|P1|Overall Study|Lost to Follow-up|1
312969|NCT00753922|1026815|P4|Overall Study|Discontinuation Due to Explantation|4
312970|NCT00753922|1026816|P3|Overall Study|Discontinuation Due to Explantation|14
312971|NCT00753922|1026817|P2|Overall Study|Discontinuation Due to Explantation|14
312972|NCT00753922|1026818|P1|Overall Study|Discontinuation Due to Explantation|14
312973|NCT00753922|1026815|P4|Overall Study|Death|1
312974|NCT00753922|1026816|P3|Overall Study|Death|2
312975|NCT00753922|1026817|P2|Overall Study|Death|23
312976|NCT00753922|1026818|P1|Overall Study|Death|2
312977|NCT00753922|1026815|P4|Overall Study|Patients Not Completing Visit|0
312978|NCT00753922|1026816|P3|Overall Study|Patients Not Completing Visit|1
312979|NCT00753922|1026817|P2|Overall Study|Patients Not Completing Visit|0
312980|NCT00753922|1026818|P1|Overall Study|Patients Not Completing Visit|11
312981|NCT00753922|1026815|P4|Overall Study|Patient Non-compliance|11
312982|NCT00753922|1026816|P3|Overall Study|Patient Non-compliance|14
312983|NCT00753922|1026817|P2|Overall Study|Patient Non-compliance|22
312984|NCT00753922|1026818|P1|Overall Study|Patient Non-compliance|55
312985|NCT00753922|1026815|P4|Overall Study|Withdrawal by Subject|2
312986|NCT00753922|1026816|P3|Overall Study|Withdrawal by Subject|4
312987|NCT00753922|1026817|P2|Overall Study|Withdrawal by Subject|11
312988|NCT00753922|1026818|P1|Overall Study|Withdrawal by Subject|9
312989|NCT00753922|1026815|P4|Overall Study|Lost to Follow-up|5
312990|NCT00753922|1026816|P3|Overall Study|Lost to Follow-up|28
312991|NCT00753922|1026817|P2|Overall Study|Lost to Follow-up|24
312992|NCT00753922|1026818|P1|Overall Study|Lost to Follow-up|155
312993|NCT00753896|1026848|P1|Overall Study|Entry Criteria Not Met|4
312994|NCT00753896|1026848|P1|Overall Study|Withdrawal by Subject|4
312995|NCT00753896|1026848|P1|Overall Study|Protocol Violation|1
312996|NCT00753896|1026848|P1|Overall Study|Lost to Follow-up|2
312997|NCT00753896|1026848|P1|Overall Study|Death|1
312998|NCT00753896|1026848|P1|Overall Study|Adverse Event|4
312999|NCT00753766|1026864|P2|Overall Study|Physician Decision|0
313000|NCT00753766|1026865|P1|Overall Study|Physician Decision|1
313001|NCT00753714|1026875|P2|Overall Study|not specified|5
313002|NCT00753714|1026876|P1|Overall Study|not specified|7
313003|NCT00753714|1026875|P2|Overall Study|Death|3
313004|NCT00753714|1026876|P1|Overall Study|Death|3
313005|NCT00753714|1026875|P2|Overall Study|Withdrawal by Subject|1
313006|NCT00753714|1026876|P1|Overall Study|Withdrawal by Subject|2
313007|NCT00753714|1026875|P2|Overall Study|Lost to Follow-up|1
313008|NCT00753714|1026876|P1|Overall Study|Lost to Follow-up|0
313009|NCT00753714|1026875|P2|Overall Study|Protocol Violation|0
313010|NCT00753714|1026876|P1|Overall Study|Protocol Violation|1
313011|NCT00753714|1026875|P2|Overall Study|Adverse Event|18
313012|NCT00753714|1026876|P1|Overall Study|Adverse Event|26
313013|NCT00753714|1026875|P2|Overall Study|Lack of Efficacy|34
313014|NCT00753714|1026876|P1|Overall Study|Lack of Efficacy|21
313015|NCT00753688|1026892|P2|Overall Study|Adverse Event|1
313016|NCT00753688|1026893|P1|Overall Study|Adverse Event|0
313017|NCT00753688|1026892|P2|Overall Study|Ongoing - in Follow-up|31
313018|NCT00753688|1026893|P1|Overall Study|Ongoing - in Follow-up|15
313019|NCT00753688|1026892|P2|Overall Study|Participant Withdrew Consent|2
313020|NCT00753688|1026893|P1|Overall Study|Participant Withdrew Consent|2
313021|NCT00753688|1026892|P2|Overall Study|Missing|9
313022|NCT00753688|1026893|P1|Overall Study|Missing|4
313023|NCT00753688|1026892|P2|Overall Study|Death|203
313024|NCT00753688|1026893|P1|Overall Study|Death|102
313025|NCT00753675|1026922|P3|Overall Study|Lost to Follow-up|0
313026|NCT00753675|1026923|P2|Overall Study|Lost to Follow-up|0
313027|NCT00753675|1026924|P1|Overall Study|Lost to Follow-up|1
313028|NCT00753675|1026922|P3|Overall Study|Withdrawal by Subject|0
313029|NCT00753675|1026923|P2|Overall Study|Withdrawal by Subject|1
313030|NCT00753675|1026924|P1|Overall Study|Withdrawal by Subject|0
313031|NCT00753675|1026922|P3|Overall Study|Objective progression of disease|35
313032|NCT00753675|1026923|P2|Overall Study|Objective progression of disease|35
313033|NCT00753675|1026924|P1|Overall Study|Objective progression of disease|35
313034|NCT00753675|1026922|P3|Overall Study|Adverse Event|4
313035|NCT00753675|1026923|P2|Overall Study|Adverse Event|9
313036|NCT00753675|1026924|P1|Overall Study|Adverse Event|11
313037|NCT00753675|1026922|P3|Overall Study|Death|4
313038|NCT00753675|1026923|P2|Overall Study|Death|2
313039|NCT00753675|1026924|P1|Overall Study|Death|1
313040|NCT00753675|1026922|P3|Overall Study|other reason|13
313041|NCT00753675|1026923|P2|Overall Study|other reason|12
313042|NCT00753675|1026924|P1|Overall Study|other reason|11
313043|NCT00753649|1026946|P2|Overall Study|Protocol Violation|0
313044|NCT00753649|1026947|P1|Overall Study|Protocol Violation|2
313045|NCT00753649|1026946|P2|Overall Study|Lost to follow-up-complete vaccination|0
313046|NCT00753649|1026947|P1|Overall Study|Lost to follow-up-complete vaccination|1
313047|NCT00753649|1026946|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
313048|NCT00753649|1026947|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
313049|NCT00753649|1026946|P2|Overall Study|Migrated/moved from study area|0
313050|NCT00753649|1026947|P1|Overall Study|Migrated/moved from study area|1
313051|NCT00753623|1026979|P2|Phase II (14 Days)|Physician Decision|1
313052|NCT00753623|1026980|P1|Phase II (14 Days)|Physician Decision|0
313053|NCT00753623|1026979|P2|Washout (7 Days)|Physician Decision|0
313054|NCT00753623|1026980|P1|Washout (7 Days)|Physician Decision|1
313055|NCT00753623|1026979|P2|Phase I (14 Days)|Adverse Event|1
313056|NCT00753623|1026980|P1|Phase I (14 Days)|Adverse Event|0
313057|NCT00753623|1026979|P2|Phase I (14 Days)|Physician Decision|2
313058|NCT00753623|1026980|P1|Phase I (14 Days)|Physician Decision|1
313059|NCT00753623|1026979|P2|Phase I (14 Days)|Withdrawal by Subject|1
313060|NCT00753623|1026980|P1|Phase I (14 Days)|Withdrawal by Subject|1
313061|NCT00753545|1026988|P2|Overall Study|Consent withrawn prior to treatment|1
313062|NCT00753545|1026989|P1|Overall Study|Consent withrawn prior to treatment|0
313063|NCT00753545|1026988|P2|Overall Study|Not specified|3
313064|NCT00753545|1026989|P1|Overall Study|Not specified|1
313065|NCT00753545|1026988|P2|Overall Study|Protocol Violation|1
313066|NCT00753545|1026989|P1|Overall Study|Protocol Violation|0
313067|NCT00753545|1026988|P2|Overall Study|Lost to Follow-up|0
313068|NCT00753545|1026989|P1|Overall Study|Lost to Follow-up|1
313069|NCT00753545|1026988|P2|Overall Study|Withdrawal by Subject|8
313070|NCT00753545|1026989|P1|Overall Study|Withdrawal by Subject|9
313071|NCT00753545|1026988|P2|Overall Study|Lack of Efficacy|93
313072|NCT00753545|1026989|P1|Overall Study|Lack of Efficacy|54
313073|NCT00753545|1026988|P2|Overall Study|Adverse Event|2
313074|NCT00753545|1026989|P1|Overall Study|Adverse Event|3
313075|NCT00753519|1027027|P2|Overall Study|Withdrawal by Subject|2
313076|NCT00753519|1027028|P1|Overall Study|Withdrawal by Subject|0
313077|NCT00753506|1027050|P2|Overall Study|Other reason|1
313078|NCT00753506|1027051|P1|Overall Study|Other reason|1
313079|NCT00753506|1027050|P2|Overall Study|Lost to Follow-up|0
313080|NCT00753506|1027051|P1|Overall Study|Lost to Follow-up|2
313081|NCT00753506|1027050|P2|Overall Study|Withdrawal by Subject|1
313082|NCT00753506|1027051|P1|Overall Study|Withdrawal by Subject|4
313083|NCT00753454|1027057|P1|Overall Study|Investigator Decision|1
313084|NCT00753454|1027057|P1|Overall Study|Withdrawal by Subject|5
313085|NCT00753454|1027057|P1|Overall Study|Lost to Follow-up|3
313086|NCT00753454|1027057|P1|Overall Study|Lack of Efficacy|1
313087|NCT00753454|1027057|P1|Overall Study|Adverse Event|4
313088|NCT00753415|1027091|P10|Part B|Disease progression|1
313089|NCT00753415|1027092|P9|Part B|Disease progression|2
313090|NCT00753415|1027093|P8|Part B|Disease progression|0
313091|NCT00753415|1027094|P7|Part B|Disease progression|0
313092|NCT00753415|1027095|P6|Part B|Disease progression|0
313093|NCT00753415|1027096|P5|Part B|Disease progression|0
313094|NCT00753415|1027097|P4|Part B|Disease progression|0
313095|NCT00753415|1027098|P3|Part B|Disease progression|0
313096|NCT00753415|1027099|P2|Part B|Disease progression|0
313097|NCT00753415|1027100|P1|Part B|Disease progression|0
313098|NCT00753415|1027091|P10|Part B|Lost to Follow-up|0
313099|NCT00753415|1027092|P9|Part B|Lost to Follow-up|1
313100|NCT00753415|1027093|P8|Part B|Lost to Follow-up|1
313101|NCT00753415|1027094|P7|Part B|Lost to Follow-up|0
313102|NCT00753415|1027095|P6|Part B|Lost to Follow-up|0
313103|NCT00753415|1027096|P5|Part B|Lost to Follow-up|0
313104|NCT00753415|1027097|P4|Part B|Lost to Follow-up|0
313105|NCT00753415|1027098|P3|Part B|Lost to Follow-up|0
313106|NCT00753415|1027099|P2|Part B|Lost to Follow-up|0
313107|NCT00753415|1027100|P1|Part B|Lost to Follow-up|0
313108|NCT00753415|1027091|P10|Part A|Withdrawal by Subject|0
313109|NCT00753415|1027092|P9|Part A|Withdrawal by Subject|0
313110|NCT00753415|1027093|P8|Part A|Withdrawal by Subject|0
313111|NCT00753415|1027094|P7|Part A|Withdrawal by Subject|0
313112|NCT00753415|1027095|P6|Part A|Withdrawal by Subject|0
313113|NCT00753415|1027096|P5|Part A|Withdrawal by Subject|0
313114|NCT00753415|1027097|P4|Part A|Withdrawal by Subject|0
313115|NCT00753415|1027098|P3|Part A|Withdrawal by Subject|1
313116|NCT00753415|1027099|P2|Part A|Withdrawal by Subject|0
313117|NCT00753415|1027100|P1|Part A|Withdrawal by Subject|0
313118|NCT00753415|1027091|P10|Part A|Disease progression|0
313119|NCT00753415|1027092|P9|Part A|Disease progression|0
313120|NCT00753415|1027093|P8|Part A|Disease progression|0
313121|NCT00753415|1027094|P7|Part A|Disease progression|0
313122|NCT00753415|1027095|P6|Part A|Disease progression|0
313123|NCT00753415|1027096|P5|Part A|Disease progression|0
313124|NCT00753415|1027097|P4|Part A|Disease progression|2
313125|NCT00753415|1027098|P3|Part A|Disease progression|1
313126|NCT00753415|1027099|P2|Part A|Disease progression|0
313127|NCT00753415|1027100|P1|Part A|Disease progression|1
313128|NCT00753272|1027190|P2|Overall Study|Unspecified|1088
313129|NCT00753272|1027191|P1|Overall Study|Unspecified|1104
313130|NCT00753272|1027190|P2|Overall Study|Lost to Follow-up|497
313131|NCT00753272|1027191|P1|Overall Study|Lost to Follow-up|491
313132|NCT00753272|1027190|P2|Overall Study|Withdrawal by Subject|2407
313133|NCT00753272|1027191|P1|Overall Study|Withdrawal by Subject|2481
313134|NCT00753272|1027190|P2|Overall Study|Protocol Violation|46
313135|NCT00753272|1027191|P1|Overall Study|Protocol Violation|28
313136|NCT00753272|1027190|P2|Overall Study|Adverse Event|869
313137|NCT00753272|1027191|P1|Overall Study|Adverse Event|878
313138|NCT00753012|1027276|P2|Overall Study|Confounded endpoint data|0
313139|NCT00753012|1027277|P1|Overall Study|Confounded endpoint data|1
313140|NCT00753012|1027276|P2|Overall Study|Lost to Follow-up|0
313141|NCT00753012|1027277|P1|Overall Study|Lost to Follow-up|4
313142|NCT00753012|1027276|P2|Overall Study|Withdrawal by Subject|1
313143|NCT00753012|1027277|P1|Overall Study|Withdrawal by Subject|0
313144|NCT00753012|1027276|P2|Overall Study|Adverse Event|0
313145|NCT00753012|1027277|P1|Overall Study|Adverse Event|2
313146|NCT00753012|1027276|P2|Overall Study|Ineligible, abnormal cardiac histo|0
313147|NCT00753012|1027277|P1|Overall Study|Ineligible, abnormal cardiac histo|1
313148|NCT00752986|1027290|P3|Overall Study|Protocol Violation|0
313149|NCT00752986|1027291|P2|Overall Study|Protocol Violation|0
313150|NCT00752986|1027292|P1|Overall Study|Protocol Violation|3
313151|NCT00752986|1027290|P3|Overall Study|Withdrawal by Subject|2
313152|NCT00752986|1027291|P2|Overall Study|Withdrawal by Subject|1
313153|NCT00752986|1027292|P1|Overall Study|Withdrawal by Subject|2
313154|NCT00752895|1027321|P2|Overall Study|Withdrawal by Subject|3
313155|NCT00752895|1027322|P1|Overall Study|Withdrawal by Subject|8
313156|NCT00752791|1027330|P1|Overall Study|Protocol deviation|1
313157|NCT00752791|1027330|P1|Overall Study|Switched to hemodialysis|2
313158|NCT00752791|1027330|P1|Overall Study|Renal transplant|3
313159|NCT00752791|1027330|P1|Overall Study|Death|1
313160|NCT00752791|1027330|P1|Overall Study|Physician Decision|1
313161|NCT00752791|1027330|P1|Overall Study|Withdrawal by Subject|1
313162|NCT00752791|1027330|P1|Overall Study|Adverse Event|7
313163|NCT00752726|1027342|P2|Overall Study|Other Reason|2
313164|NCT00752726|1027343|P1|Overall Study|Other Reason|1
313165|NCT00752726|1027342|P2|Overall Study|Withdrawal by Subject|10
313166|NCT00752726|1027343|P1|Overall Study|Withdrawal by Subject|5
313167|NCT00752726|1027342|P2|Overall Study|Adverse Event|0
313168|NCT00752726|1027343|P1|Overall Study|Adverse Event|3
313169|NCT00752726|1027342|P2|Overall Study|Lost to Follow-up|1
313170|NCT00752726|1027343|P1|Overall Study|Lost to Follow-up|2
313171|NCT00752622|1027368|P1|Interventional Phase|Premature Study Termination|5
313172|NCT00752622|1027368|P1|Interventional Phase|Physician Decision|1
313173|NCT00752622|1027368|P1|Interventional Phase|Non-responder|2
313174|NCT00752622|1027368|P1|Observational Phase|Unspecified|2
313175|NCT00752622|1027368|P1|Observational Phase|Adverse Event|1
313176|NCT00752622|1027368|P1|Observational Phase|Withdrawal by Subject|2
313177|NCT00752622|1027368|P1|Observational Phase|Non-responder|2
313178|NCT00752622|1027368|P1|Observational Phase|Premature Study Termination|36
313179|NCT00752622|1027368|P1|Induction Phase|Premature study termination|14
313180|NCT00752622|1027368|P1|Induction Phase|Withdrawal by Subject|1
313181|NCT00752622|1027368|P1|Induction Phase|Non-responder|14
313182|NCT00752622|1027368|P1|Induction Phase|Unspecified|3
313183|NCT00752622|1027368|P1|Induction Phase|Adverse Event|3
313184|NCT00752609|1027381|P2|Overall Study|Received Aranesp in error|0
313185|NCT00752609|1027382|P1|Overall Study|Received Aranesp in error|1
313186|NCT00752609|1027381|P2|Overall Study|Met exclusion criteria|0
313187|NCT00752609|1027382|P1|Overall Study|Met exclusion criteria|1
313188|NCT00752609|1027381|P2|Overall Study|Death|0
313189|NCT00752609|1027382|P1|Overall Study|Death|1
313190|NCT00752609|1027381|P2|Overall Study|Physician Decision|0
313191|NCT00752609|1027382|P1|Overall Study|Physician Decision|1
313192|NCT00752609|1027381|P2|Overall Study|Withdrawal by Subject|0
313193|NCT00752609|1027382|P1|Overall Study|Withdrawal by Subject|3
313194|NCT00752609|1027381|P2|Overall Study|Adverse Event|2
313195|NCT00752609|1027382|P1|Overall Study|Adverse Event|2
313196|NCT00752232|1027408|P7|Overall Study|Caregiver could not attend the subject|0
313197|NCT00752232|1027409|P6|Overall Study|Caregiver could not attend the subject|0
313198|NCT00752232|1027410|P5|Overall Study|Caregiver could not attend the subject|1
313199|NCT00752232|1027411|P4|Overall Study|Caregiver could not attend the subject|0
313200|NCT00752232|1027412|P3|Overall Study|Caregiver could not attend the subject|0
313201|NCT00752232|1027413|P2|Overall Study|Caregiver could not attend the subject|0
313202|NCT00752232|1027414|P1|Overall Study|Caregiver could not attend the subject|0
313203|NCT00752232|1027408|P7|Overall Study|Group home admission|0
313204|NCT00752232|1027409|P6|Overall Study|Group home admission|0
313205|NCT00752232|1027410|P5|Overall Study|Group home admission|0
313206|NCT00752232|1027411|P4|Overall Study|Group home admission|1
313207|NCT00752232|1027412|P3|Overall Study|Group home admission|0
313208|NCT00752232|1027413|P2|Overall Study|Group home admission|0
313209|NCT00752232|1027414|P1|Overall Study|Group home admission|0
313210|NCT00752232|1027408|P7|Overall Study|Subject request|0
313211|NCT00752232|1027409|P6|Overall Study|Subject request|0
313212|NCT00752232|1027410|P5|Overall Study|Subject request|0
313213|NCT00752232|1027411|P4|Overall Study|Subject request|0
313214|NCT00752232|1027412|P3|Overall Study|Subject request|1
313215|NCT00752232|1027413|P2|Overall Study|Subject request|0
313216|NCT00752232|1027414|P1|Overall Study|Subject request|0
313217|NCT00752232|1027408|P7|Overall Study|Investigator request|0
313218|NCT00752232|1027409|P6|Overall Study|Investigator request|0
313219|NCT00752232|1027410|P5|Overall Study|Investigator request|1
313220|NCT00752232|1027411|P4|Overall Study|Investigator request|0
313221|NCT00752232|1027412|P3|Overall Study|Investigator request|0
313222|NCT00752232|1027413|P2|Overall Study|Investigator request|0
313223|NCT00752232|1027414|P1|Overall Study|Investigator request|0
313224|NCT00752232|1027408|P7|Overall Study|Caregiver request|0
313225|NCT00752232|1027409|P6|Overall Study|Caregiver request|0
313226|NCT00752232|1027410|P5|Overall Study|Caregiver request|1
313227|NCT00752232|1027411|P4|Overall Study|Caregiver request|0
313228|NCT00752232|1027412|P3|Overall Study|Caregiver request|0
313229|NCT00752232|1027413|P2|Overall Study|Caregiver request|0
313230|NCT00752232|1027414|P1|Overall Study|Caregiver request|2
313231|NCT00752232|1027408|P7|Overall Study|Protocol Violation|0
313232|NCT00752232|1027409|P6|Overall Study|Protocol Violation|1
313233|NCT00752232|1027410|P5|Overall Study|Protocol Violation|0
313234|NCT00752232|1027411|P4|Overall Study|Protocol Violation|0
313235|NCT00752232|1027412|P3|Overall Study|Protocol Violation|0
313236|NCT00752232|1027413|P2|Overall Study|Protocol Violation|0
313237|NCT00752232|1027414|P1|Overall Study|Protocol Violation|0
313238|NCT00752128|1027486|P1|Overall Study|Withdrawal by Subject|4
313239|NCT00752089|1027491|P1|Overall Study|Cannot continue the study|1
313240|NCT00752089|1027491|P1|Overall Study|Not capable of wearing partial denture|1
313241|NCT00752089|1027491|P1|Overall Study|Could not attend visit 9|1
313242|NCT00752089|1027491|P1|Overall Study|Protocol Deviation|2
313243|NCT00752089|1027491|P1|Overall Study|Adverse Event|1
313244|NCT00751998|1027505|P1|Overall Study|Withdrawal by Subject|2
313245|NCT00751998|1027505|P1|Overall Study|Death|11
313246|NCT00751998|1027505|P1|Overall Study|Lost to Follow-up|7
313247|NCT00751933|1027524|P4|Overall Study|Physician Decision|1
313248|NCT00751933|1027525|P3|Overall Study|Physician Decision|1
313249|NCT00751933|1027526|P2|Overall Study|Physician Decision|0
313250|NCT00751933|1027527|P1|Overall Study|Physician Decision|0
313251|NCT00751933|1027524|P4|Overall Study|Withdrawal by Subject|0
313252|NCT00751933|1027525|P3|Overall Study|Withdrawal by Subject|0
313253|NCT00751933|1027526|P2|Overall Study|Withdrawal by Subject|1
313254|NCT00751933|1027527|P1|Overall Study|Withdrawal by Subject|0
313255|NCT00751881|1027535|P3|Extension Study Period|Other than specified above|18
313256|NCT00751881|1027536|P2|Extension Study Period|Other than specified above|30
313257|NCT00751881|1027537|P1|Extension Study Period|Other than specified above|26
313258|NCT00751881|1027535|P3|Extension Study Period|Poor Compliance to Protocol|1
313259|NCT00751881|1027536|P2|Extension Study Period|Poor Compliance to Protocol|2
313260|NCT00751881|1027537|P1|Extension Study Period|Poor Compliance to Protocol|3
313261|NCT00751881|1027535|P3|Extension Study Period|Lost to Follow-up|6
313262|NCT00751881|1027536|P2|Extension Study Period|Lost to Follow-up|9
313263|NCT00751881|1027537|P1|Extension Study Period|Lost to Follow-up|4
313264|NCT00751881|1027535|P3|Extension Study Period|Lack of Efficacy|20
313265|NCT00751881|1027536|P2|Extension Study Period|Lack of Efficacy|10
313266|NCT00751881|1027537|P1|Extension Study Period|Lack of Efficacy|14
313267|NCT00751881|1027535|P3|Extension Study Period|Adverse Event|21
313268|NCT00751881|1027536|P2|Extension Study Period|Adverse Event|20
313269|NCT00751881|1027537|P1|Extension Study Period|Adverse Event|18
313270|NCT00751881|1027535|P3|Core Treatment Period|Other:participant's decision/unspecified|16
313271|NCT00751881|1027536|P2|Core Treatment Period|Other:participant's decision/unspecified|22
313272|NCT00751881|1027537|P1|Core Treatment Period|Other:participant's decision/unspecified|19
313273|NCT00751881|1027535|P3|Core Treatment Period|Other: tolerability complaints|0
313274|NCT00751881|1027536|P2|Core Treatment Period|Other: tolerability complaints|0
313275|NCT00751881|1027537|P1|Core Treatment Period|Other: tolerability complaints|2
313276|NCT00751881|1027535|P3|Core Treatment Period|Other: MS treatment change|4
313277|NCT00751881|1027536|P2|Core Treatment Period|Other: MS treatment change|4
313278|NCT00751881|1027537|P1|Core Treatment Period|Other: MS treatment change|6
313279|NCT00751881|1027535|P3|Core Treatment Period|Other: personal/family constraints|10
313280|NCT00751881|1027536|P2|Core Treatment Period|Other: personal/family constraints|7
313281|NCT00751881|1027537|P1|Core Treatment Period|Other: personal/family constraints|6
313282|NCT00751881|1027535|P3|Core Treatment Period|Other: wish to parent|4
313283|NCT00751881|1027536|P2|Core Treatment Period|Other: wish to parent|7
313284|NCT00751881|1027537|P1|Core Treatment Period|Other: wish to parent|5
313285|NCT00751881|1027535|P3|Core Treatment Period|Other: protocol deviation|7
313286|NCT00751881|1027536|P2|Core Treatment Period|Other: protocol deviation|3
313287|NCT00751881|1027537|P1|Core Treatment Period|Other: protocol deviation|3
313288|NCT00751881|1027535|P3|Core Treatment Period|Lost to Follow-up|3
313289|NCT00751881|1027536|P2|Core Treatment Period|Lost to Follow-up|4
313290|NCT00751881|1027537|P1|Core Treatment Period|Lost to Follow-up|6
313291|NCT00751881|1027535|P3|Core Treatment Period|Poor compliance to protocol|4
313292|NCT00751881|1027536|P2|Core Treatment Period|Poor compliance to protocol|3
313293|NCT00751881|1027537|P1|Core Treatment Period|Poor compliance to protocol|15
313294|NCT00751881|1027535|P3|Core Treatment Period|Lack of Efficacy|20
313295|NCT00751881|1027536|P2|Core Treatment Period|Lack of Efficacy|30
313296|NCT00751881|1027537|P1|Core Treatment Period|Lack of Efficacy|37
313297|NCT00751881|1027535|P3|Core Treatment Period|Adverse Event|58
313298|NCT00751881|1027536|P2|Core Treatment Period|Adverse Event|54
313299|NCT00751881|1027537|P1|Core Treatment Period|Adverse Event|26
313300|NCT00751881|1027535|P3|Core Treatment Period|Not treated|2
313301|NCT00751881|1027536|P2|Core Treatment Period|Not treated|1
313302|NCT00751881|1027537|P1|Core Treatment Period|Not treated|1
313303|NCT00751790|1027584|P1|Overall Study|Withdrawal by Subject|1
313304|NCT00751790|1027584|P1|Overall Study|Death|3
313305|NCT00751790|1027584|P1|Overall Study|Lost to Follow-up|1
313306|NCT00751621|1027609|P1|Overall Study|Poor adherence to asthma treatment|1
313307|NCT00751621|1027609|P1|Overall Study|Subject moved to another country|1
313308|NCT00751621|1027609|P1|Overall Study|Withdrawal by Subject|1
313309|NCT00751621|1027609|P1|Overall Study|Adverse Event|1
313310|NCT00751400|1027643|P1|Overall Study|Lost to Follow-up|10
313311|NCT00751348|1027658|P2|Overall Study|Migration from study area|0
313312|NCT00751348|1027659|P1|Overall Study|Migration from study area|1
313313|NCT00751348|1027658|P2|Overall Study|Withdrawal by Subject|2
313314|NCT00751348|1027659|P1|Overall Study|Withdrawal by Subject|5
313315|NCT00751296|1027681|P1|Overall Study|Adverse Event|2
313316|NCT00751140|1027709|P1|Overall Study|benign angioma excluded from analysis|1
313317|NCT00751114|1027719|P2|Overall Study|Move to another city|0
313318|NCT00751114|1027720|P1|Overall Study|Move to another city|1
313319|NCT00751114|1027719|P2|Overall Study|Out of country for 2 months|0
313320|NCT00751114|1027720|P1|Overall Study|Out of country for 2 months|1
313321|NCT00751114|1027719|P2|Overall Study|Not Treated|1
313322|NCT00751114|1027720|P1|Overall Study|Not Treated|13
313323|NCT00751114|1027719|P2|Overall Study|Lack of Efficacy|7
313324|NCT00751114|1027720|P1|Overall Study|Lack of Efficacy|0
313325|NCT00751114|1027719|P2|Overall Study|Lost to Follow-up|7
313326|NCT00751114|1027720|P1|Overall Study|Lost to Follow-up|4
313327|NCT00751114|1027719|P2|Overall Study|Withdrawal by Subject|4
313328|NCT00751114|1027720|P1|Overall Study|Withdrawal by Subject|9
313329|NCT00751114|1027719|P2|Overall Study|Protocol Violation|9
313330|NCT00751114|1027720|P1|Overall Study|Protocol Violation|8
313331|NCT00751114|1027719|P2|Overall Study|Adverse Event|4
313332|NCT00751114|1027720|P1|Overall Study|Adverse Event|2
313333|NCT00751036|1027745|P2|Overall Study|Missing end of Treatment Page|3
313334|NCT00751036|1027746|P1|Overall Study|Missing end of Treatment Page|2
313335|NCT00751036|1027745|P2|Overall Study|Protocol Violation|0
313336|NCT00751036|1027746|P1|Overall Study|Protocol Violation|1
313337|NCT00751036|1027745|P2|Overall Study|Lost to Follow-up|1
313338|NCT00751036|1027746|P1|Overall Study|Lost to Follow-up|0
313339|NCT00751036|1027745|P2|Overall Study|Death|3
313340|NCT00751036|1027746|P1|Overall Study|Death|3
313341|NCT00751036|1027745|P2|Overall Study|Withdrawal by Subject|2
313342|NCT00751036|1027746|P1|Overall Study|Withdrawal by Subject|5
313343|NCT00751036|1027745|P2|Overall Study|Administrative Problems|4
313344|NCT00751036|1027746|P1|Overall Study|Administrative Problems|3
313345|NCT00751036|1027745|P2|Overall Study|Adverse Event|4
313346|NCT00751036|1027746|P1|Overall Study|Adverse Event|6
313347|NCT00751036|1027745|P2|Overall Study|Disease Progression|29
313348|NCT00751036|1027746|P1|Overall Study|Disease Progression|28
313349|NCT00750919|1027758|P1|Overall Study|Unspecified|36
313350|NCT00750919|1027758|P1|Overall Study|Could not cooperate, unrelated to trial|4
313351|NCT00750919|1027758|P1|Overall Study|Lack of Efficacy|8
313352|NCT00750919|1027758|P1|Overall Study|Withdrawal by Subject|1
313353|NCT00750919|1027758|P1|Overall Study|Adverse Event|9
313354|NCT00750893|1027766|P1|Overall Study|Unspecified|17
313355|NCT00750893|1027766|P1|Overall Study|Lost to Follow-up|510
313356|NCT00750893|1027766|P1|Overall Study|Withdrawal by Subject|10
313357|NCT00750893|1027766|P1|Overall Study|Adverse Event|5
313358|NCT00750880|1027781|P1|Overall Study|Administrative|11
313359|NCT00750880|1027781|P1|Overall Study|Physician Decision|20
313360|NCT00750880|1027781|P1|Overall Study|Withdrawal by Subject|33
313361|NCT00750880|1027781|P1|Overall Study|Protocol Violation|15
313362|NCT00750880|1027781|P1|Overall Study|Lost to Follow-up|10
313363|NCT00750880|1027781|P1|Overall Study|Lack of Efficacy|46
313364|NCT00750880|1027781|P1|Overall Study|Death|4
313365|NCT00750880|1027781|P1|Overall Study|Adverse Event|76
313366|NCT00750867|1027804|P1|Overall Study|Adverse Event|2
313367|NCT00750737|1027825|P2|Overall Study|Withdrawal by Subject|3
313368|NCT00750737|1027826|P1|Overall Study|Withdrawal by Subject|3
313369|NCT00750308|1027886|P12|Third Treatment|Withdrawal by Subject|0
313370|NCT00750308|1027887|P11|Third Treatment|Withdrawal by Subject|0
313371|NCT00750308|1027888|P10|Third Treatment|Withdrawal by Subject|0
313372|NCT00750308|1027889|P9|Third Treatment|Withdrawal by Subject|0
313373|NCT00750308|1027890|P8|Third Treatment|Withdrawal by Subject|0
313374|NCT00750308|1027891|P7|Third Treatment|Withdrawal by Subject|0
313375|NCT00750308|1027892|P6|Third Treatment|Withdrawal by Subject|0
313376|NCT00750308|1027893|P5|Third Treatment|Withdrawal by Subject|0
313377|NCT00750308|1027894|P4|Third Treatment|Withdrawal by Subject|0
313378|NCT00750308|1027895|P3|Third Treatment|Withdrawal by Subject|0
313379|NCT00750308|1027896|P2|Third Treatment|Withdrawal by Subject|1
313380|NCT00750308|1027897|P1|Third Treatment|Withdrawal by Subject|0
313381|NCT00750308|1027886|P12|Second Treatment|Withdrawal by Subject|0
313382|NCT00750308|1027887|P11|Second Treatment|Withdrawal by Subject|0
313383|NCT00750308|1027888|P10|Second Treatment|Withdrawal by Subject|0
313384|NCT00750308|1027889|P9|Second Treatment|Withdrawal by Subject|0
313385|NCT00750308|1027890|P8|Second Treatment|Withdrawal by Subject|0
313386|NCT00750308|1027891|P7|Second Treatment|Withdrawal by Subject|0
313387|NCT00750308|1027892|P6|Second Treatment|Withdrawal by Subject|0
313388|NCT00750308|1027893|P5|Second Treatment|Withdrawal by Subject|1
313389|NCT00750308|1027894|P4|Second Treatment|Withdrawal by Subject|0
313390|NCT00750308|1027895|P3|Second Treatment|Withdrawal by Subject|0
313391|NCT00750308|1027896|P2|Second Treatment|Withdrawal by Subject|0
313392|NCT00750308|1027897|P1|Second Treatment|Withdrawal by Subject|0
313393|NCT00750308|1027886|P12|Second Treatment|Adverse Event|0
313394|NCT00750308|1027887|P11|Second Treatment|Adverse Event|0
313395|NCT00750308|1027888|P10|Second Treatment|Adverse Event|0
313396|NCT00750308|1027889|P9|Second Treatment|Adverse Event|1
313397|NCT00750308|1027890|P8|Second Treatment|Adverse Event|0
313398|NCT00750308|1027891|P7|Second Treatment|Adverse Event|0
313399|NCT00750308|1027892|P6|Second Treatment|Adverse Event|1
313400|NCT00750308|1027893|P5|Second Treatment|Adverse Event|0
313401|NCT00750308|1027894|P4|Second Treatment|Adverse Event|0
313402|NCT00750308|1027895|P3|Second Treatment|Adverse Event|0
313403|NCT00750308|1027896|P2|Second Treatment|Adverse Event|0
313404|NCT00750308|1027897|P1|Second Treatment|Adverse Event|0
313405|NCT00750308|1027886|P12|First Treatment|Withdrawal by Subject|0
313406|NCT00750308|1027887|P11|First Treatment|Withdrawal by Subject|0
313407|NCT00750308|1027888|P10|First Treatment|Withdrawal by Subject|0
313408|NCT00750308|1027889|P9|First Treatment|Withdrawal by Subject|0
313409|NCT00750308|1027890|P8|First Treatment|Withdrawal by Subject|1
313410|NCT00750308|1027891|P7|First Treatment|Withdrawal by Subject|0
313411|NCT00750308|1027892|P6|First Treatment|Withdrawal by Subject|0
313412|NCT00750308|1027893|P5|First Treatment|Withdrawal by Subject|0
313413|NCT00750308|1027894|P4|First Treatment|Withdrawal by Subject|1
313414|NCT00750308|1027895|P3|First Treatment|Withdrawal by Subject|0
313415|NCT00750308|1027896|P2|First Treatment|Withdrawal by Subject|0
313416|NCT00750308|1027897|P1|First Treatment|Withdrawal by Subject|0
313417|NCT00750308|1027886|P12|First Treatment|Adverse Event|1
313418|NCT00750308|1027887|P11|First Treatment|Adverse Event|1
313419|NCT00750308|1027888|P10|First Treatment|Adverse Event|0
313420|NCT00750308|1027889|P9|First Treatment|Adverse Event|0
313421|NCT00750308|1027890|P8|First Treatment|Adverse Event|0
313422|NCT00750308|1027891|P7|First Treatment|Adverse Event|0
313423|NCT00750308|1027892|P6|First Treatment|Adverse Event|0
313424|NCT00750308|1027893|P5|First Treatment|Adverse Event|0
313425|NCT00750308|1027894|P4|First Treatment|Adverse Event|0
313426|NCT00750308|1027895|P3|First Treatment|Adverse Event|0
313427|NCT00750308|1027896|P2|First Treatment|Adverse Event|1
313428|NCT00750308|1027897|P1|First Treatment|Adverse Event|0
313429|NCT00750269|1027947|P5|Overall Study|Fiducials could not be placed|1
313430|NCT00750269|1027948|P4|Overall Study|Fiducials could not be placed|0
313431|NCT00750269|1027949|P3|Overall Study|Fiducials could not be placed|0
313432|NCT00750269|1027950|P2|Overall Study|Fiducials could not be placed|0
313433|NCT00750269|1027951|P1|Overall Study|Fiducials could not be placed|0
313434|NCT00750269|1027947|P5|Overall Study|SBRT plan could not be drawn|1
313435|NCT00750269|1027948|P4|Overall Study|SBRT plan could not be drawn|0
313436|NCT00750269|1027949|P3|Overall Study|SBRT plan could not be drawn|0
313437|NCT00750269|1027950|P2|Overall Study|SBRT plan could not be drawn|0
313438|NCT00750269|1027951|P1|Overall Study|SBRT plan could not be drawn|0
313439|NCT00750269|1027947|P5|Overall Study|Site error|0
313440|NCT00750269|1027948|P4|Overall Study|Site error|1
313441|NCT00750269|1027949|P3|Overall Study|Site error|0
313442|NCT00750269|1027950|P2|Overall Study|Site error|0
313443|NCT00750269|1027951|P1|Overall Study|Site error|0
313444|NCT00750269|1027947|P5|Overall Study|Patient too large for positioning|0
313445|NCT00750269|1027948|P4|Overall Study|Patient too large for positioning|0
313446|NCT00750269|1027949|P3|Overall Study|Patient too large for positioning|1
313447|NCT00750269|1027950|P2|Overall Study|Patient too large for positioning|0
313448|NCT00750269|1027951|P1|Overall Study|Patient too large for positioning|0
313449|NCT00750269|1027947|P5|Overall Study|Physician Decision|2
313450|NCT00750269|1027948|P4|Overall Study|Physician Decision|0
313451|NCT00750269|1027949|P3|Overall Study|Physician Decision|0
313452|NCT00750269|1027950|P2|Overall Study|Physician Decision|0
313453|NCT00750269|1027951|P1|Overall Study|Physician Decision|0
313454|NCT00750269|1027947|P5|Overall Study|Withdrawal by Subject|2
313455|NCT00750269|1027948|P4|Overall Study|Withdrawal by Subject|2
313456|NCT00750269|1027949|P3|Overall Study|Withdrawal by Subject|2
313457|NCT00750269|1027950|P2|Overall Study|Withdrawal by Subject|0
313458|NCT00750269|1027951|P1|Overall Study|Withdrawal by Subject|0
313459|NCT00750269|1027947|P5|Overall Study|Protocol Violation|4
313460|NCT00750269|1027948|P4|Overall Study|Protocol Violation|2
313461|NCT00750269|1027949|P3|Overall Study|Protocol Violation|1
313462|NCT00750269|1027950|P2|Overall Study|Protocol Violation|1
313463|NCT00750269|1027951|P1|Overall Study|Protocol Violation|0
313464|NCT00750204|1027998|P2|Overall Study|study halted prematurely|1
313465|NCT00750204|1027999|P1|Overall Study|study halted prematurely|1
313466|NCT00750152|1028022|P2|Overall Study|Not specified|8
313467|NCT00750152|1028023|P1|Overall Study|Not specified|7
313468|NCT00750152|1028022|P2|Overall Study|Termination by sponsor|0
313469|NCT00750152|1028023|P1|Overall Study|Termination by sponsor|1
313470|NCT00750152|1028022|P2|Overall Study|Non-compliance|1
313471|NCT00750152|1028023|P1|Overall Study|Non-compliance|0
313472|NCT00750152|1028022|P2|Overall Study|Physician Decision|1
313473|NCT00750152|1028023|P1|Overall Study|Physician Decision|1
313474|NCT00750152|1028022|P2|Overall Study|Withdrawal by Subject|3
313475|NCT00750152|1028023|P1|Overall Study|Withdrawal by Subject|3
313476|NCT00750152|1028022|P2|Overall Study|Lost to Follow-up|13
313477|NCT00750152|1028023|P1|Overall Study|Lost to Follow-up|8
313478|NCT00750152|1028022|P2|Overall Study|Adverse Event|1
313479|NCT00750152|1028023|P1|Overall Study|Adverse Event|2
313480|NCT00750139|1028035|P4|Overall Study|Non-specific|33
313481|NCT00750139|1028036|P3|Overall Study|Non-specific|79
313482|NCT00750139|1028037|P2|Overall Study|Non-specific|42
313483|NCT00750139|1028038|P1|Overall Study|Non-specific|62
313484|NCT00750139|1028035|P4|Overall Study|Termination by sponsor|1
313485|NCT00750139|1028036|P3|Overall Study|Termination by sponsor|0
313486|NCT00750139|1028037|P2|Overall Study|Termination by sponsor|0
313487|NCT00750139|1028038|P1|Overall Study|Termination by sponsor|4
313488|NCT00750139|1028035|P4|Overall Study|Non-compliance|3
313489|NCT00750139|1028036|P3|Overall Study|Non-compliance|1
313490|NCT00750139|1028037|P2|Overall Study|Non-compliance|0
313491|NCT00750139|1028038|P1|Overall Study|Non-compliance|1
313492|NCT00750139|1028035|P4|Overall Study|Physician Decision|0
313493|NCT00750139|1028036|P3|Overall Study|Physician Decision|0
313494|NCT00750139|1028037|P2|Overall Study|Physician Decision|1
313495|NCT00750139|1028038|P1|Overall Study|Physician Decision|1
313496|NCT00750139|1028035|P4|Overall Study|Withdrawal by Subject|2
313497|NCT00750139|1028036|P3|Overall Study|Withdrawal by Subject|6
313498|NCT00750139|1028037|P2|Overall Study|Withdrawal by Subject|2
313499|NCT00750139|1028038|P1|Overall Study|Withdrawal by Subject|3
313500|NCT00750139|1028035|P4|Overall Study|Lost to Follow-up|6
313501|NCT00750139|1028036|P3|Overall Study|Lost to Follow-up|15
313502|NCT00750139|1028037|P2|Overall Study|Lost to Follow-up|12
313503|NCT00750139|1028038|P1|Overall Study|Lost to Follow-up|17
313504|NCT00750139|1028035|P4|Overall Study|Adverse Event|1
313505|NCT00750139|1028036|P3|Overall Study|Adverse Event|0
313506|NCT00750139|1028037|P2|Overall Study|Adverse Event|2
313507|NCT00750139|1028038|P1|Overall Study|Adverse Event|1
313508|NCT00750061|1028054|P2|Overall Study|Physician Decision|1
313509|NCT00750061|1028055|P1|Overall Study|Physician Decision|0
313510|NCT00750061|1028054|P2|Overall Study|Withdrawal by Subject|1
313511|NCT00750061|1028055|P1|Overall Study|Withdrawal by Subject|0
313512|NCT00750061|1028054|P2|Overall Study|Adverse Event|0
313513|NCT00750061|1028055|P1|Overall Study|Adverse Event|2
313514|NCT00749996|1028065|P2|Overall Study|Death|0
313515|NCT00749996|1028066|P1|Overall Study|Death|1
313516|NCT00749996|1028065|P2|Overall Study|Adverse Event|0
313517|NCT00749996|1028066|P1|Overall Study|Adverse Event|1
313518|NCT00749996|1028065|P2|Overall Study|Pregnancy|2
313519|NCT00749996|1028066|P1|Overall Study|Pregnancy|0
313520|NCT00749996|1028065|P2|Overall Study|Physician Decision|0
313521|NCT00749996|1028066|P1|Overall Study|Physician Decision|2
313522|NCT00749996|1028065|P2|Overall Study|Protocol Violation|3
313523|NCT00749996|1028066|P1|Overall Study|Protocol Violation|2
313524|NCT00749996|1028065|P2|Overall Study|Withdrawal by Subject|4
313525|NCT00749996|1028066|P1|Overall Study|Withdrawal by Subject|5
313526|NCT00749996|1028065|P2|Overall Study|Lost to Follow-up|4
313527|NCT00749996|1028066|P1|Overall Study|Lost to Follow-up|7
313528|NCT00749944|1028089|P2|Overall Study|Withdrawal by Subject|0
313529|NCT00749944|1028090|P1|Overall Study|Withdrawal by Subject|2
313530|NCT00749944|1028089|P2|Overall Study|Not specified|0
313531|NCT00749944|1028090|P1|Overall Study|Not specified|1
313532|NCT00749944|1028089|P2|Overall Study|Lost to Follow-up|1
313533|NCT00749944|1028090|P1|Overall Study|Lost to Follow-up|2
313534|NCT00749775|1028169|P1|Overall Study|No drug administration|3
313535|NCT00749775|1028169|P1|Overall Study|No visit after first day of treatment|44
313536|NCT00749775|1028169|P1|Overall Study|Lost to Follow-up|36
313537|NCT00749775|1028169|P1|Overall Study|Protocol Violation|24
313538|NCT00749684|1028185|P1|Overall Study|Missing|9
313539|NCT00749684|1028185|P1|Overall Study|AE+discontinuation on participants wish|1
313540|NCT00749684|1028185|P1|Overall Study|Therapy according to protocol + AE|2
313541|NCT00749684|1028185|P1|Overall Study|Progressive Desease|31
313542|NCT00749684|1028185|P1|Overall Study|Not Documented|1
313543|NCT00749684|1028185|P1|Overall Study|Participant's Wish|10
313544|NCT00749684|1028185|P1|Overall Study|Adverse Event|27
313545|NCT00749684|1028185|P1|Overall Study|Death|1
313546|NCT00749580|1028203|P2|Overall Study|Adverse Event|1
313547|NCT00749580|1028204|P1|Overall Study|Adverse Event|0
313548|NCT00749580|1028203|P2|Overall Study|Lost to Follow-up|8
313549|NCT00749580|1028204|P1|Overall Study|Lost to Follow-up|4
313550|NCT00749463|1028219|P3|Overall Study|Withdrawal by Subject|0
313551|NCT00749463|1028220|P2|Overall Study|Withdrawal by Subject|0
313552|NCT00749463|1028221|P1|Overall Study|Withdrawal by Subject|1
313553|NCT00749463|1028219|P3|Overall Study|Adverse Event|1
313554|NCT00749463|1028220|P2|Overall Study|Adverse Event|4
313555|NCT00749463|1028221|P1|Overall Study|Adverse Event|0
313556|NCT00749398|1028247|P1|Overall Study|Unknown reason|1
313557|NCT00749398|1028247|P1|Overall Study|Reason not specified|2
313558|NCT00749398|1028247|P1|Overall Study|Lost to Follow-up|11
313559|NCT00749398|1028247|P1|Overall Study|Withdrawal by Subject|17
313560|NCT00749398|1028247|P1|Overall Study|Serious adverse event|11
313561|NCT00749398|1028247|P1|Overall Study|Adverse Event|4
313562|NCT00749398|1028247|P1|Overall Study|Lack of Efficacy|7
313563|NCT00749190|1028295|P7|Overall Study|Other reason not defined above|0
313564|NCT00749190|1028296|P6|Overall Study|Other reason not defined above|0
313565|NCT00749190|1028297|P5|Overall Study|Other reason not defined above|0
313566|NCT00749190|1028298|P4|Overall Study|Other reason not defined above|1
313567|NCT00749190|1028299|P3|Overall Study|Other reason not defined above|0
313568|NCT00749190|1028300|P2|Overall Study|Other reason not defined above|0
313569|NCT00749190|1028301|P1|Overall Study|Other reason not defined above|0
313570|NCT00749190|1028295|P7|Overall Study|Protocol Violation|1
313571|NCT00749190|1028296|P6|Overall Study|Protocol Violation|0
313572|NCT00749190|1028297|P5|Overall Study|Protocol Violation|0
313573|NCT00749190|1028298|P4|Overall Study|Protocol Violation|0
313574|NCT00749190|1028299|P3|Overall Study|Protocol Violation|0
313575|NCT00749190|1028300|P2|Overall Study|Protocol Violation|1
313576|NCT00749190|1028301|P1|Overall Study|Protocol Violation|0
313577|NCT00749190|1028295|P7|Overall Study|Withdrawal by Subject|0
313578|NCT00749190|1028296|P6|Overall Study|Withdrawal by Subject|1
313579|NCT00749190|1028297|P5|Overall Study|Withdrawal by Subject|0
313580|NCT00749190|1028298|P4|Overall Study|Withdrawal by Subject|0
313581|NCT00749190|1028299|P3|Overall Study|Withdrawal by Subject|0
313582|NCT00749190|1028300|P2|Overall Study|Withdrawal by Subject|1
313583|NCT00749190|1028301|P1|Overall Study|Withdrawal by Subject|2
313584|NCT00749190|1028295|P7|Overall Study|Lack of Efficacy|0
313585|NCT00749190|1028296|P6|Overall Study|Lack of Efficacy|1
313586|NCT00749190|1028297|P5|Overall Study|Lack of Efficacy|0
313587|NCT00749190|1028298|P4|Overall Study|Lack of Efficacy|0
313588|NCT00749190|1028299|P3|Overall Study|Lack of Efficacy|1
313589|NCT00749190|1028300|P2|Overall Study|Lack of Efficacy|1
313590|NCT00749190|1028301|P1|Overall Study|Lack of Efficacy|3
313591|NCT00749190|1028295|P7|Overall Study|Adverse Event|0
313592|NCT00749190|1028296|P6|Overall Study|Adverse Event|3
313593|NCT00749190|1028297|P5|Overall Study|Adverse Event|0
313594|NCT00749190|1028298|P4|Overall Study|Adverse Event|4
313595|NCT00749190|1028299|P3|Overall Study|Adverse Event|0
313596|NCT00749190|1028300|P2|Overall Study|Adverse Event|2
313597|NCT00749190|1028301|P1|Overall Study|Adverse Event|0
313598|NCT00748709|1028450|P1|Overall Study|Other Reasons|1
313599|NCT00748709|1028450|P1|Overall Study|Withdrawal by Subject|1
313600|NCT00748709|1028450|P1|Overall Study|Other Adverse Event|1
313601|NCT00748709|1028450|P1|Overall Study|Drug reducing Toxity|2
313602|NCT00748709|1028450|P1|Overall Study|Progressive disease|15
313603|NCT00748566|1028477|P1|Overall Study|Unspecified|9
313604|NCT00748566|1028477|P1|Overall Study|Study terminated by sponsor|5
313605|NCT00748566|1028477|P1|Overall Study|Withdrawal by Subject|22
313606|NCT00748566|1028477|P1|Overall Study|Protocol Violation|13
313607|NCT00748566|1028477|P1|Overall Study|Lost to Follow-up|1
313608|NCT00748566|1028477|P1|Overall Study|Lack of Efficacy|12
313609|NCT00748566|1028477|P1|Overall Study|Death|1
313610|NCT00748566|1028477|P1|Overall Study|Adverse Event|49
313611|NCT00748241|1028505|P1|Overall Study|Death|2
313612|NCT00748241|1028505|P1|Overall Study|Lost to Follow-up|5
313613|NCT00748241|1028505|P1|Overall Study|Implant failure|1
313614|NCT00748189|1028515|P2|Overall Study|Ongoing|162
313615|NCT00748189|1028516|P1|Overall Study|Ongoing|155
313616|NCT00748189|1028515|P2|Overall Study|Study terminated by Sponsor|1
313617|NCT00748189|1028516|P1|Overall Study|Study terminated by Sponsor|0
313618|NCT00748189|1028515|P2|Overall Study|Lost to Follow-up|4
313619|NCT00748189|1028516|P1|Overall Study|Lost to Follow-up|2
313620|NCT00748189|1028515|P2|Overall Study|Physician Decision|4
313621|NCT00748189|1028516|P1|Overall Study|Physician Decision|13
313622|NCT00748189|1028515|P2|Overall Study|Withdrawal by Subject|16
313623|NCT00748189|1028516|P1|Overall Study|Withdrawal by Subject|15
313624|NCT00748189|1028515|P2|Overall Study|Death|34
313625|NCT00748189|1028516|P1|Overall Study|Death|40
313626|NCT00748098|1028570|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
313627|NCT00748098|1028571|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
313628|NCT00748098|1028570|P2|Second Treatment Intervention Period|Lost to Follow-up|1
313629|NCT00748098|1028571|P1|Second Treatment Intervention Period|Lost to Follow-up|1
313630|NCT00748098|1028570|P2|Second Treatment Intervention Period|Adverse Event|1
313631|NCT00748098|1028571|P1|Second Treatment Intervention Period|Adverse Event|4
313632|NCT00748098|1028570|P2|1-Week Washout Period|Withdrawal by Subject|0
313633|NCT00748098|1028571|P1|1-Week Washout Period|Withdrawal by Subject|2
313634|NCT00748098|1028570|P2|1-Week Washout Period|Adverse Event|1
313635|NCT00748098|1028571|P1|1-Week Washout Period|Adverse Event|0
313636|NCT00748098|1028570|P2|First Taper Period|Protocol Stopping Criteria Met|1
313637|NCT00748098|1028571|P1|First Taper Period|Protocol Stopping Criteria Met|0
313638|NCT00748098|1028570|P2|First Taper Period|Withdrawal by Subject|0
313639|NCT00748098|1028571|P1|First Taper Period|Withdrawal by Subject|2
313640|NCT00748098|1028570|P2|First Taper Period|Protocol Violation|0
313641|NCT00748098|1028571|P1|First Taper Period|Protocol Violation|1
313642|NCT00748098|1028570|P2|First Treatment Intervention Period|Withdrawal by Subject|0
313643|NCT00748098|1028571|P1|First Treatment Intervention Period|Withdrawal by Subject|2
313644|NCT00748098|1028570|P2|First Treatment Intervention Period|Lost to Follow-up|0
313645|NCT00748098|1028571|P1|First Treatment Intervention Period|Lost to Follow-up|1
313646|NCT00748098|1028570|P2|First Treatment Intervention Period|Protocol Violation|0
313647|NCT00748098|1028571|P1|First Treatment Intervention Period|Protocol Violation|1
313648|NCT00748098|1028570|P2|First Treatment Intervention Period|Adverse Event|1
313649|NCT00748098|1028571|P1|First Treatment Intervention Period|Adverse Event|1
313650|NCT00747812|1028652|P2|Overall Study|Research Site Staff Relocation|3
313651|NCT00747812|1028653|P1|Overall Study|Research Site Staff Relocation|5
313652|NCT00747643|1028691|P2|Overall Study|Withdrawal by Subject|27
313653|NCT00747643|1028692|P1|Overall Study|Withdrawal by Subject|36
313654|NCT00747617|1028706|P2|Overall Study|Lost to Follow-up|1
313655|NCT00747617|1028707|P1|Overall Study|Lost to Follow-up|3
313656|NCT00747565|1028715|P2|Overall Study|Lost to Follow-up|1
313657|NCT00747565|1028716|P1|Overall Study|Lost to Follow-up|4
313658|NCT00747565|1028715|P2|Overall Study|Withdrawal by Subject|6
313659|NCT00747565|1028716|P1|Overall Study|Withdrawal by Subject|10
313660|NCT00747474|1028729|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313661|NCT00747474|1028730|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313662|NCT00747474|1028731|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313663|NCT00747474|1028732|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313664|NCT00747474|1028733|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
313665|NCT00747474|1028734|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313666|NCT00747474|1028735|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313667|NCT00747474|1028736|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313668|NCT00747474|1028737|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313669|NCT00747474|1028738|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313670|NCT00747474|1028739|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313671|NCT00747474|1028740|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
313672|NCT00747461|1028766|P1|Overall Study|study terminated by sponsor|5
313673|NCT00747435|1028771|P1|Overall Study|Still undergoing follow up|1
313674|NCT00747435|1028771|P1|Overall Study|Withdrawal by Subject|3
313675|NCT00747435|1028771|P1|Overall Study|Lost to Follow-up|2
313676|NCT00747344|1028781|P4|After Controlled Period|Adverse Event|1
313677|NCT00747344|1028782|P3|After Controlled Period|Adverse Event|0
313678|NCT00747344|1028783|P2|After Controlled Period|Adverse Event|0
313679|NCT00747344|1028784|P1|After Controlled Period|Adverse Event|0
313680|NCT00747344|1028781|P4|Controlled Period|Other|0
313681|NCT00747344|1028782|P3|Controlled Period|Other|0
313682|NCT00747344|1028783|P2|Controlled Period|Other|3
313683|NCT00747344|1028784|P1|Controlled Period|Other|0
313684|NCT00747344|1028781|P4|Controlled Period|Lack of Efficacy|0
313685|NCT00747344|1028782|P3|Controlled Period|Lack of Efficacy|0
313686|NCT00747344|1028783|P2|Controlled Period|Lack of Efficacy|1
313687|NCT00747344|1028784|P1|Controlled Period|Lack of Efficacy|2
313688|NCT00747344|1028781|P4|Controlled Period|Adverse Event|0
313689|NCT00747344|1028782|P3|Controlled Period|Adverse Event|0
313690|NCT00747344|1028783|P2|Controlled Period|Adverse Event|0
313691|NCT00747344|1028784|P1|Controlled Period|Adverse Event|3
313692|NCT00747227|1028798|P2|Overall Study|Illness|1
313693|NCT00747227|1028799|P1|Overall Study|Illness|1
313694|NCT00747227|1028798|P2|Overall Study|Lost to Follow-up|2
313695|NCT00747227|1028799|P1|Overall Study|Lost to Follow-up|1
313696|NCT00747227|1028798|P2|Overall Study|Withdrawal by Subject|0
313697|NCT00747227|1028799|P1|Overall Study|Withdrawal by Subject|1
313698|NCT00747227|1028798|P2|Overall Study|Death|1
313699|NCT00747227|1028799|P1|Overall Study|Death|3
313700|NCT00747149|1028828|P2|Overall Study|Not reported|4
313701|NCT00747149|1028829|P1|Overall Study|Not reported|1
313702|NCT00747149|1028828|P2|Overall Study|Severe non-compliance to protocol|1
313703|NCT00747149|1028829|P1|Overall Study|Severe non-compliance to protocol|0
313704|NCT00747149|1028828|P2|Overall Study|Incorrect enrollment|6
313705|NCT00747149|1028829|P1|Overall Study|Incorrect enrollment|0
313706|NCT00747149|1028828|P2|Overall Study|Did not receive treatment|1
313707|NCT00747149|1028829|P1|Overall Study|Did not receive treatment|0
313708|NCT00747149|1028828|P2|Overall Study|Withdrawal by Subject|6
313709|NCT00747149|1028829|P1|Overall Study|Withdrawal by Subject|0
313710|NCT00747149|1028828|P2|Overall Study|Lost to Follow-up|10
313711|NCT00747149|1028829|P1|Overall Study|Lost to Follow-up|0
313712|NCT00747149|1028828|P2|Overall Study|Adverse Event|15
313713|NCT00747149|1028829|P1|Overall Study|Adverse Event|0
313714|NCT00747006|1028844|P3|Overall Study|Physician Decision|1
313715|NCT00747006|1028845|P2|Overall Study|Physician Decision|0
313716|NCT00747006|1028846|P1|Overall Study|Physician Decision|2
313717|NCT00747006|1028844|P3|Overall Study|Lost to Follow-up|0
313718|NCT00747006|1028845|P2|Overall Study|Lost to Follow-up|1
313719|NCT00747006|1028846|P1|Overall Study|Lost to Follow-up|0
313720|NCT00747006|1028844|P3|Overall Study|Adverse Event|0
313721|NCT00747006|1028845|P2|Overall Study|Adverse Event|0
313722|NCT00747006|1028846|P1|Overall Study|Adverse Event|1
313723|NCT00746941|1028924|P4|Overall Study|Adverse Event|1
313724|NCT00746941|1028925|P3|Overall Study|Adverse Event|0
313725|NCT00746941|1028926|P2|Overall Study|Adverse Event|0
313726|NCT00746941|1028927|P1|Overall Study|Adverse Event|0
313727|NCT00746941|1028924|P4|Overall Study|Other, reason not provided|4
313728|NCT00746941|1028925|P3|Overall Study|Other, reason not provided|0
313729|NCT00746941|1028926|P2|Overall Study|Other, reason not provided|4
313730|NCT00746941|1028927|P1|Overall Study|Other, reason not provided|2
313731|NCT00746941|1028924|P4|Overall Study|Withdrawal by Subject|2
313732|NCT00746941|1028925|P3|Overall Study|Withdrawal by Subject|0
313733|NCT00746941|1028926|P2|Overall Study|Withdrawal by Subject|0
313734|NCT00746941|1028927|P1|Overall Study|Withdrawal by Subject|3
313735|NCT00746941|1028924|P4|Overall Study|Physician Decision|0
313736|NCT00746941|1028925|P3|Overall Study|Physician Decision|2
313737|NCT00746941|1028926|P2|Overall Study|Physician Decision|0
313738|NCT00746941|1028927|P1|Overall Study|Physician Decision|0
313739|NCT00746941|1028924|P4|Overall Study|Death|6
313740|NCT00746941|1028925|P3|Overall Study|Death|0
313741|NCT00746941|1028926|P2|Overall Study|Death|0
313742|NCT00746941|1028927|P1|Overall Study|Death|2
313743|NCT00746798|1028985|P4|Overall Study|Participant unable to return for visit|0
313744|NCT00746798|1028986|P3|Overall Study|Participant unable to return for visit|0
313745|NCT00746798|1028987|P2|Overall Study|Participant unable to return for visit|0
313746|NCT00746798|1028988|P1|Overall Study|Participant unable to return for visit|1
313747|NCT00746798|1028985|P4|Overall Study|Death|0
313748|NCT00746798|1028986|P3|Overall Study|Death|2
313749|NCT00746798|1028987|P2|Overall Study|Death|0
313750|NCT00746798|1028988|P1|Overall Study|Death|0
313751|NCT00746798|1028985|P4|Overall Study|Withdrawal by Subject|0
313752|NCT00746798|1028986|P3|Overall Study|Withdrawal by Subject|1
313753|NCT00746798|1028987|P2|Overall Study|Withdrawal by Subject|1
313754|NCT00746798|1028988|P1|Overall Study|Withdrawal by Subject|0
313755|NCT00746798|1028985|P4|Overall Study|Protocol Violation|0
313756|NCT00746798|1028986|P3|Overall Study|Protocol Violation|0
313757|NCT00746798|1028987|P2|Overall Study|Protocol Violation|1
313758|NCT00746798|1028988|P1|Overall Study|Protocol Violation|0
313759|NCT00746785|1029013|P3|Overall Study|Lost to Follow-up|27
313760|NCT00746785|1029014|P2|Overall Study|Lost to Follow-up|25
313761|NCT00746785|1029015|P1|Overall Study|Lost to Follow-up|29
313762|NCT00746733|1029023|P2|Third Intervention|Withdrawal by Subject|1
313763|NCT00746733|1029024|P1|Third Intervention|Withdrawal by Subject|1
313764|NCT00746733|1029023|P2|Second Intervention|Adverse Event|0
313765|NCT00746733|1029024|P1|Second Intervention|Adverse Event|1
313766|NCT00746590|1029108|P1|Overall Study|Death|1
313767|NCT00746564|1029112|P1|Overall Study|Required Pacemaker/ICD Implant|2
313768|NCT00746551|1029127|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
313769|NCT00746551|1029128|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
313770|NCT00746551|1029127|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
313771|NCT00746551|1029128|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
313772|NCT00746551|1029127|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
313773|NCT00746551|1029128|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
313774|NCT00746356|1029179|P2|Overall Study|Patient relocated|0
313775|NCT00746356|1029180|P1|Overall Study|Patient relocated|1
313776|NCT00746356|1029179|P2|Overall Study|Removal of Device|1
313777|NCT00746356|1029180|P1|Overall Study|Removal of Device|0
313778|NCT00746356|1029179|P2|Overall Study|Lost to Follow-up|0
313779|NCT00746356|1029180|P1|Overall Study|Lost to Follow-up|1
313780|NCT00746356|1029179|P2|Overall Study|Death|3
313781|NCT00746356|1029180|P1|Overall Study|Death|7
313782|NCT00746356|1029179|P2|Overall Study|Withdrawal by Subject|3
313783|NCT00746356|1029180|P1|Overall Study|Withdrawal by Subject|2
313784|NCT00746330|1029192|P4|Period 1|Abnormal test procedure result|0
313785|NCT00746330|1029193|P3|Period 1|Abnormal test procedure result|1
313786|NCT00746330|1029194|P2|Period 1|Abnormal test procedure result|0
313787|NCT00746330|1029195|P1|Period 1|Abnormal test procedure result|0
313788|NCT00746096|1029238|P2|Overall Study|No study drug treatment|1
313789|NCT00746096|1029239|P1|Overall Study|No study drug treatment|1
313790|NCT00746096|1029238|P2|Overall Study|Protocol Violation|0
313791|NCT00746096|1029239|P1|Overall Study|Protocol Violation|1
313792|NCT00746096|1029238|P2|Overall Study|Lost to Follow-up|1
313793|NCT00746096|1029239|P1|Overall Study|Lost to Follow-up|2
313794|NCT00746096|1029238|P2|Overall Study|Withdrawal by Subject|1
313795|NCT00746096|1029239|P1|Overall Study|Withdrawal by Subject|5
313796|NCT00746096|1029238|P2|Overall Study|Adverse Event|0
313797|NCT00746096|1029239|P1|Overall Study|Adverse Event|1
313798|NCT00745901|1029266|P2|Overall Study|Patient didn't take any study medication|3
313799|NCT00745901|1029267|P1|Overall Study|Patient didn't take any study medication|7
313800|NCT00745901|1029266|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
313801|NCT00745901|1029267|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
313802|NCT00745901|1029266|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
313803|NCT00745901|1029267|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
313804|NCT00745901|1029266|P2|Overall Study|Patient's next menses did not start with|0
313805|NCT00745901|1029267|P1|Overall Study|Patient's next menses did not start with|1
313806|NCT00745901|1029266|P2|Overall Study|Lack of compliance|2
313807|NCT00745901|1029267|P1|Overall Study|Lack of compliance|2
313808|NCT00745901|1029266|P2|Overall Study|Pregnancy|4
313809|NCT00745901|1029267|P1|Overall Study|Pregnancy|2
313810|NCT00745901|1029266|P2|Overall Study|Lost to Follow-up|4
313811|NCT00745901|1029267|P1|Overall Study|Lost to Follow-up|7
313812|NCT00745901|1029266|P2|Overall Study|Withdrawal by Subject|0
313813|NCT00745901|1029267|P1|Overall Study|Withdrawal by Subject|1
313814|NCT00745901|1029266|P2|Overall Study|Protocol Violation|1
313815|NCT00745901|1029267|P1|Overall Study|Protocol Violation|0
313816|NCT00745901|1029266|P2|Overall Study|Adverse Event|4
313817|NCT00745901|1029267|P1|Overall Study|Adverse Event|3
313818|NCT00745875|1029313|P2|Overall Study|Continuing study treatment|4
313819|NCT00745875|1029314|P1|Overall Study|Continuing study treatment|4
313820|NCT00745095|1029328|P6|Overall Study|Ineligible due to GFR criteria|28
313821|NCT00745095|1029329|P5|Overall Study|Ineligible due to GFR criteria|30
313822|NCT00745095|1029330|P4|Overall Study|Ineligible due to GFR criteria|3
313823|NCT00745095|1029331|P3|Overall Study|Ineligible due to GFR criteria|3
313824|NCT00745095|1029332|P2|Overall Study|Ineligible due to GFR criteria|2
313825|NCT00745095|1029333|P1|Overall Study|Ineligible due to GFR criteria|0
313826|NCT00745095|1029328|P6|Overall Study|Declined to participate|95
313827|NCT00745095|1029329|P5|Overall Study|Declined to participate|92
313828|NCT00745095|1029330|P4|Overall Study|Declined to participate|0
313829|NCT00745095|1029331|P3|Overall Study|Declined to participate|0
313830|NCT00745095|1029332|P2|Overall Study|Declined to participate|0
313831|NCT00745095|1029333|P1|Overall Study|Declined to participate|1
313832|NCT00744978|1029364|P2|Period 2|Adverse Event|1
313833|NCT00744978|1029365|P1|Period 2|Adverse Event|0
313834|NCT00744978|1029364|P2|Period 1|Randomized but not Treated|1
313835|NCT00744978|1029365|P1|Period 1|Randomized but not Treated|1
313836|NCT00744978|1029364|P2|Period 1|Adverse Event|0
313837|NCT00744978|1029365|P1|Period 1|Adverse Event|4
313838|NCT00744978|1029364|P2|Period 1|Unspecified|2
313839|NCT00744978|1029365|P1|Period 1|Unspecified|0
313840|NCT00744978|1029364|P2|Period 1|Withdrawal by Subject|2
313841|NCT00744978|1029365|P1|Period 1|Withdrawal by Subject|0
313842|NCT00744978|1029364|P2|Period 1|Lost to Follow-up|0
313843|NCT00744978|1029365|P1|Period 1|Lost to Follow-up|1
313844|NCT00744939|1029417|P1|Overall Study|incorrect race|1
313845|NCT00744939|1029417|P1|Overall Study|coma|1
313846|NCT00744939|1029417|P1|Overall Study|Failed inclusion/exclusion criteria|19
313847|NCT00744939|1029417|P1|Overall Study|Did not receive Magnevist|7
313848|NCT00744939|1029417|P1|Overall Study|Medical history exclusionary|1
313849|NCT00744939|1029417|P1|Overall Study|Lost to Follow-up|12
313850|NCT00744939|1029417|P1|Overall Study|distance|4
313851|NCT00744939|1029417|P1|Overall Study|Death|24
313852|NCT00744939|1029417|P1|Overall Study|Protocol Violation|13
313853|NCT00744939|1029417|P1|Overall Study|Withdrawal by Subject|9
313854|NCT00745823|1029455|P2|Overall Study|Study Terminated by Sponsor|349
313855|NCT00745823|1029456|P1|Overall Study|Study Terminated by Sponsor|326
313856|NCT00745823|1029455|P2|Overall Study|Withdrawal by Subject|8
313857|NCT00745823|1029456|P1|Overall Study|Withdrawal by Subject|14
313858|NCT00745823|1029455|P2|Overall Study|Pregnancy|4
313859|NCT00745823|1029456|P1|Overall Study|Pregnancy|0
313860|NCT00745823|1029455|P2|Overall Study|Physician Decision|5
313861|NCT00745823|1029456|P1|Overall Study|Physician Decision|10
313862|NCT00745823|1029455|P2|Overall Study|Lost to Follow-up|11
313863|NCT00745823|1029456|P1|Overall Study|Lost to Follow-up|10
313864|NCT00745823|1029455|P2|Overall Study|Lack of Efficacy|6
313865|NCT00745823|1029456|P1|Overall Study|Lack of Efficacy|20
313866|NCT00745823|1029455|P2|Overall Study|Adverse Event|3
313867|NCT00745823|1029456|P1|Overall Study|Adverse Event|5
313868|NCT00745498|1029483|P3|Overall Study|Edophthalmitis after preoperative IVB|0
313869|NCT00745498|1029484|P2|Overall Study|Edophthalmitis after preoperative IVB|0
313870|NCT00745498|1029485|P1|Overall Study|Edophthalmitis after preoperative IVB|1
313871|NCT00745498|1029483|P3|Overall Study|Non-PDR related VH|1
313872|NCT00745498|1029484|P2|Overall Study|Non-PDR related VH|1
313873|NCT00745498|1029485|P1|Overall Study|Non-PDR related VH|0
313874|NCT00745498|1029483|P3|Overall Study|Injection of intravitreal silicone oil o|4
313875|NCT00745498|1029484|P2|Overall Study|Injection of intravitreal silicone oil o|4
313876|NCT00745498|1029485|P1|Overall Study|Injection of intravitreal silicone oil o|3
313877|NCT00745498|1029483|P3|Overall Study|Lost to Follow-up|3
313878|NCT00745498|1029484|P2|Overall Study|Lost to Follow-up|1
313879|NCT00745498|1029485|P1|Overall Study|Lost to Follow-up|1
313880|NCT00745368|1029499|P1|Overall Study|Unable to provide sample|3
313881|NCT00745251|1029521|P2|Overall Study|Withdrawal by Subject|1
313882|NCT00745251|1029522|P1|Overall Study|Withdrawal by Subject|1
313883|NCT00745251|1029521|P2|Overall Study|Adverse Event|2
313884|NCT00745251|1029522|P1|Overall Study|Adverse Event|1
313885|NCT00744874|1029530|P1|Overall Study|Unable to accomodate schedule|1
313886|NCT00744874|1029530|P1|Overall Study|Study Device not available at procedure|1
313887|NCT00744874|1029530|P1|Overall Study|Withdrawal by Subject|1
313888|NCT00744874|1029530|P1|Overall Study|Lost to Follow-up|1
313889|NCT00744757|1029555|P1|Overall Study|Adverse Event|2
313890|NCT00744757|1029555|P1|Overall Study|Death|6
313891|NCT00744757|1029555|P1|Overall Study|Withdrawal by Subject|1
313892|NCT00744757|1029555|P1|Overall Study|Physician Decision|5
313893|NCT00744757|1029555|P1|Overall Study|Objective disease progression|7
313894|NCT00744653|1029580|P1|Overall Study|Physician Decision|3
313895|NCT00744653|1029580|P1|Overall Study|Lost to Follow-up|1
313896|NCT00744653|1029580|P1|Overall Study|Death|1
313897|NCT00744653|1029580|P1|Overall Study|antineoplastic treatment|11
313898|NCT00744627|1029588|P2|Overall Study|Other|0
313899|NCT00744627|1029589|P1|Overall Study|Other|1
313900|NCT00744627|1029588|P2|Overall Study|Lost to Follow-up|1
313901|NCT00744627|1029589|P1|Overall Study|Lost to Follow-up|2
313902|NCT00744627|1029588|P2|Overall Study|Voluntary Withdrawal|6
313903|NCT00744627|1029589|P1|Overall Study|Voluntary Withdrawal|9
313904|NCT00744627|1029588|P2|Overall Study|Protocol Deviations|2
313905|NCT00744627|1029589|P1|Overall Study|Protocol Deviations|0
313906|NCT00744627|1029588|P2|Overall Study|Noncompliance|1
313907|NCT00744627|1029589|P1|Overall Study|Noncompliance|0
313908|NCT00744627|1029588|P2|Overall Study|Lack of Efficacy|3
313909|NCT00744627|1029589|P1|Overall Study|Lack of Efficacy|7
313910|NCT00744627|1029588|P2|Overall Study|Adverse Event|9
313911|NCT00744627|1029589|P1|Overall Study|Adverse Event|6
313912|NCT00744523|1029645|P2|30 Days After the Procedure|Insufficient follow-up|5
313913|NCT00744523|1029646|P1|30 Days After the Procedure|Insufficient follow-up|0
313914|NCT00744497|1029666|P2|Overall Study|Not defined|13
313915|NCT00744497|1029667|P1|Overall Study|Not defined|19
313916|NCT00744497|1029666|P2|Overall Study|Maximum clinical benefit|142
313917|NCT00744497|1029667|P1|Overall Study|Maximum clinical benefit|141
313918|NCT00744497|1029666|P2|Overall Study|Patient requested to stop study drug|80
313919|NCT00744497|1029667|P1|Overall Study|Patient requested to stop study drug|65
313920|NCT00744497|1029666|P2|Overall Study|Adverse event unrelated to study drug|122
313921|NCT00744497|1029667|P1|Overall Study|Adverse event unrelated to study drug|78
313922|NCT00744497|1029666|P2|Overall Study|Study drug toxicity|141
313923|NCT00744497|1029667|P1|Overall Study|Study drug toxicity|68
313924|NCT00744497|1029666|P2|Overall Study|Disease progression|219
313925|NCT00744497|1029667|P1|Overall Study|Disease progression|312
313926|NCT00744497|1029666|P2|Overall Study|Administrative Reason By Sponsor|8
313927|NCT00744497|1029667|P1|Overall Study|Administrative Reason By Sponsor|25
313928|NCT00744497|1029666|P2|Overall Study|No longer meets study criteria|3
313929|NCT00744497|1029667|P1|Overall Study|No longer meets study criteria|7
313930|NCT00744497|1029666|P2|Overall Study|Poor compliance/noncompliance|5
313931|NCT00744497|1029667|P1|Overall Study|Poor compliance/noncompliance|9
313932|NCT00744497|1029666|P2|Overall Study|Lost to Follow-up|2
313933|NCT00744497|1029667|P1|Overall Study|Lost to Follow-up|4
313934|NCT00744497|1029666|P2|Overall Study|Death|9
313935|NCT00744497|1029667|P1|Overall Study|Death|11
313936|NCT00744497|1029666|P2|Overall Study|Withdrawal by Subject|18
313937|NCT00744497|1029667|P1|Overall Study|Withdrawal by Subject|21
313938|NCT00744328|1029727|P3|Overall Study|Found ineligible after randomization|1
313939|NCT00744328|1029728|P2|Overall Study|Found ineligible after randomization|0
313940|NCT00744328|1029729|P1|Overall Study|Found ineligible after randomization|0
313941|NCT00744328|1029727|P3|Overall Study|Withdrawal by Subject|4
313942|NCT00744328|1029728|P2|Overall Study|Withdrawal by Subject|3
313943|NCT00744328|1029729|P1|Overall Study|Withdrawal by Subject|5
313944|NCT00744328|1029727|P3|Overall Study|Lost to Follow-up|3
313945|NCT00744328|1029728|P2|Overall Study|Lost to Follow-up|5
313946|NCT00744328|1029729|P1|Overall Study|Lost to Follow-up|2
313947|NCT00744263|1029739|P2|Overall Study|Unspecified|2
313948|NCT00744263|1029740|P1|Overall Study|Unspecified|2
313949|NCT00744263|1029739|P2|Overall Study|Adverse Event|0
313950|NCT00744263|1029740|P1|Overall Study|Adverse Event|1
313951|NCT00744263|1029739|P2|Overall Study|Protocol Violation|5
313952|NCT00744263|1029740|P1|Overall Study|Protocol Violation|3
313953|NCT00744263|1029739|P2|Overall Study|Physician Decision|23
313954|NCT00744263|1029740|P1|Overall Study|Physician Decision|20
313955|NCT00744263|1029739|P2|Overall Study|Withdrawal by Subject|150
313956|NCT00744263|1029740|P1|Overall Study|Withdrawal by Subject|166
313957|NCT00744263|1029739|P2|Overall Study|Lost to Follow-up|2135
313958|NCT00744263|1029740|P1|Overall Study|Lost to Follow-up|2038
313959|NCT00744263|1029739|P2|Overall Study|Death|3005
313960|NCT00744263|1029740|P1|Overall Study|Death|3006
313961|NCT00744237|1029763|P3|Overall Study|Adverse Event|5
313962|NCT00744237|1029764|P2|Overall Study|Adverse Event|13
313963|NCT00744237|1029765|P1|Overall Study|Adverse Event|9
313964|NCT00744237|1029763|P3|Overall Study|Administrative. Site Closed|1
313965|NCT00744237|1029764|P2|Overall Study|Administrative. Site Closed|1
313966|NCT00744237|1029765|P1|Overall Study|Administrative. Site Closed|1
313967|NCT00744237|1029763|P3|Overall Study|Poor Compliance|0
313968|NCT00744237|1029764|P2|Overall Study|Poor Compliance|2
313969|NCT00744237|1029765|P1|Overall Study|Poor Compliance|0
313970|NCT00744237|1029763|P3|Overall Study|Prohibited Concomitant Medication|1
313971|NCT00744237|1029764|P2|Overall Study|Prohibited Concomitant Medication|0
313972|NCT00744237|1029765|P1|Overall Study|Prohibited Concomitant Medication|0
313973|NCT00744237|1029763|P3|Overall Study|Study Drug Error|0
313974|NCT00744237|1029764|P2|Overall Study|Study Drug Error|0
313975|NCT00744237|1029765|P1|Overall Study|Study Drug Error|1
313976|NCT00744237|1029763|P3|Overall Study|Dosing Error|1
313977|NCT00744237|1029764|P2|Overall Study|Dosing Error|0
313978|NCT00744237|1029765|P1|Overall Study|Dosing Error|1
313979|NCT00744237|1029763|P3|Overall Study|Inclusion/Exclusion criteria not met|0
313980|NCT00744237|1029764|P2|Overall Study|Inclusion/Exclusion criteria not met|0
313981|NCT00744237|1029765|P1|Overall Study|Inclusion/Exclusion criteria not met|1
313982|NCT00744237|1029763|P3|Overall Study|Protocol Violation|3
313983|NCT00744237|1029764|P2|Overall Study|Protocol Violation|4
313984|NCT00744237|1029765|P1|Overall Study|Protocol Violation|3
313985|NCT00744237|1029763|P3|Overall Study|Lost to Follow-up|1
313986|NCT00744237|1029764|P2|Overall Study|Lost to Follow-up|1
313987|NCT00744237|1029765|P1|Overall Study|Lost to Follow-up|1
313988|NCT00744237|1029763|P3|Overall Study|Withdrawal by Subject|3
313989|NCT00744237|1029764|P2|Overall Study|Withdrawal by Subject|5
313990|NCT00744237|1029765|P1|Overall Study|Withdrawal by Subject|9
313991|NCT00744237|1029763|P3|Overall Study|Lack of Efficacy|0
313992|NCT00744237|1029764|P2|Overall Study|Lack of Efficacy|1
313993|NCT00744237|1029765|P1|Overall Study|Lack of Efficacy|1
313994|NCT00744055|1029778|P2|Overall Study|Lost to Follow-up|1
313995|NCT00744055|1029779|P1|Overall Study|Lost to Follow-up|0
313996|NCT00744055|1029778|P2|Overall Study|Protocol Violation|1
313997|NCT00744055|1029779|P1|Overall Study|Protocol Violation|1
313998|NCT00744055|1029778|P2|Overall Study|Physician Decision|2
313999|NCT00744055|1029779|P1|Overall Study|Physician Decision|0
314000|NCT00744055|1029778|P2|Overall Study|Lack of Efficacy|1
314001|NCT00744055|1029779|P1|Overall Study|Lack of Efficacy|0
314002|NCT00744055|1029778|P2|Overall Study|Withdrawal by Subject|9
314003|NCT00744055|1029779|P1|Overall Study|Withdrawal by Subject|6
314004|NCT00744042|1029787|P1|Overall Study|Withdrawal by Subject|1
314005|NCT00743652|1029830|P5|Overall Study|Lost to Follow-up|0
314006|NCT00743652|1029831|P4|Overall Study|Lost to Follow-up|0
314007|NCT00743652|1029832|P3|Overall Study|Lost to Follow-up|0
314008|NCT00743652|1029833|P2|Overall Study|Lost to Follow-up|0
314009|NCT00743652|1029834|P1|Overall Study|Lost to Follow-up|1
314010|NCT00743652|1029830|P5|Overall Study|Unspecified|0
314011|NCT00743652|1029831|P4|Overall Study|Unspecified|0
314012|NCT00743652|1029832|P3|Overall Study|Unspecified|0
314013|NCT00743652|1029833|P2|Overall Study|Unspecified|1
314014|NCT00743652|1029834|P1|Overall Study|Unspecified|1
314015|NCT00743652|1029830|P5|Overall Study|Investigator Request|0
314016|NCT00743652|1029831|P4|Overall Study|Investigator Request|2
314017|NCT00743652|1029832|P3|Overall Study|Investigator Request|0
314018|NCT00743652|1029833|P2|Overall Study|Investigator Request|0
314019|NCT00743652|1029834|P1|Overall Study|Investigator Request|0
314020|NCT00743652|1029830|P5|Overall Study|Death|0
314021|NCT00743652|1029831|P4|Overall Study|Death|0
314022|NCT00743652|1029832|P3|Overall Study|Death|0
314023|NCT00743652|1029833|P2|Overall Study|Death|0
314024|NCT00743652|1029834|P1|Overall Study|Death|2
314025|NCT00743652|1029830|P5|Overall Study|Adverse Event|0
314026|NCT00743652|1029831|P4|Overall Study|Adverse Event|0
314027|NCT00743652|1029832|P3|Overall Study|Adverse Event|0
314028|NCT00743652|1029833|P2|Overall Study|Adverse Event|0
314029|NCT00743652|1029834|P1|Overall Study|Adverse Event|3
314030|NCT00743652|1029830|P5|Overall Study|Parent/Legal Guardian Request|0
314031|NCT00743652|1029831|P4|Overall Study|Parent/Legal Guardian Request|2
314032|NCT00743652|1029832|P3|Overall Study|Parent/Legal Guardian Request|2
314033|NCT00743652|1029833|P2|Overall Study|Parent/Legal Guardian Request|2
314034|NCT00743652|1029834|P1|Overall Study|Parent/Legal Guardian Request|3
314035|NCT00743509|1029918|P1|Overall Study|Withdrawal by Subject|2
314036|NCT00743483|1029923|P1|Treatment Period|Adverse Event|1
314037|NCT00743483|1029923|P1|Baseline Period|Physician Decision|1
314038|NCT00743444|1029927|P2|Washout Period|Adverse Event|1
314039|NCT00743444|1029928|P1|Washout Period|Adverse Event|0
314040|NCT00743444|1029927|P2|First Intervention|Catheter placement problems|1
314041|NCT00743444|1029928|P1|First Intervention|Catheter placement problems|0
314042|NCT00743431|1029937|P1|Overall Study|No documentation available|13
314043|NCT00743431|1029937|P1|Overall Study|Reason for discontinuation not specified|29
314044|NCT00743431|1029937|P1|Overall Study|Death|9
314045|NCT00743431|1029937|P1|Overall Study|Withdrawal by Subject|13
314046|NCT00743431|1029937|P1|Overall Study|Tumor progression|56
314047|NCT00743431|1029937|P1|Overall Study|Toxicity|6
314048|NCT00743288|1029941|P7|Overall Study|Worsening of condition (Not PD)|0
314049|NCT00743288|1029942|P6|Overall Study|Worsening of condition (Not PD)|0
314050|NCT00743288|1029943|P5|Overall Study|Worsening of condition (Not PD)|0
314051|NCT00743288|1029944|P4|Overall Study|Worsening of condition (Not PD)|1
314052|NCT00743288|1029945|P3|Overall Study|Worsening of condition (Not PD)|1
314053|NCT00743288|1029946|P2|Overall Study|Worsening of condition (Not PD)|2
314054|NCT00743288|1029947|P1|Overall Study|Worsening of condition (Not PD)|0
314055|NCT00743288|1029941|P7|Overall Study|Progressive disease (PD)|6
314056|NCT00743288|1029942|P6|Overall Study|Progressive disease (PD)|3
314057|NCT00743288|1029943|P5|Overall Study|Progressive disease (PD)|5
314058|NCT00743288|1029944|P4|Overall Study|Progressive disease (PD)|4
314059|NCT00743288|1029945|P3|Overall Study|Progressive disease (PD)|1
314060|NCT00743288|1029946|P2|Overall Study|Progressive disease (PD)|0
314061|NCT00743288|1029947|P1|Overall Study|Progressive disease (PD)|2
314062|NCT00743288|1029941|P7|Overall Study|Withdrawal by Subject|1
314063|NCT00743288|1029942|P6|Overall Study|Withdrawal by Subject|1
314064|NCT00743288|1029943|P5|Overall Study|Withdrawal by Subject|0
314065|NCT00743288|1029944|P4|Overall Study|Withdrawal by Subject|0
314066|NCT00743288|1029945|P3|Overall Study|Withdrawal by Subject|1
314067|NCT00743288|1029946|P2|Overall Study|Withdrawal by Subject|0
314068|NCT00743288|1029947|P1|Overall Study|Withdrawal by Subject|0
314069|NCT00743288|1029941|P7|Overall Study|Adverse Event|2
314070|NCT00743288|1029942|P6|Overall Study|Adverse Event|1
314071|NCT00743288|1029943|P5|Overall Study|Adverse Event|1
314072|NCT00743288|1029944|P4|Overall Study|Adverse Event|2
314073|NCT00743288|1029945|P3|Overall Study|Adverse Event|2
314074|NCT00743288|1029946|P2|Overall Study|Adverse Event|1
314075|NCT00743288|1029947|P1|Overall Study|Adverse Event|1
314076|NCT00743275|1029961|P2|Overall Study|Protocol Violation|1
314077|NCT00743275|1029962|P1|Overall Study|Protocol Violation|0
314078|NCT00743249|1029982|P2|Overall Study|Unsuccessful insertion of stent|1
314079|NCT00743249|1029983|P1|Overall Study|Unsuccessful insertion of stent|2
314080|NCT00743249|1029982|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
314081|NCT00743249|1029983|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
314082|NCT00743249|1029982|P2|Overall Study|Adverse Event|4
314083|NCT00743249|1029983|P1|Overall Study|Adverse Event|0
314084|NCT00743197|1029993|P2|Overall Study|Study terminated due to departure of PI.|2
314085|NCT00743197|1029994|P1|Overall Study|Study terminated due to departure of PI.|1
314086|NCT00743106|1030002|P2|Overall Study|Met intraoperative exclusion criterion|5
314087|NCT00743106|1030003|P1|Overall Study|Met intraoperative exclusion criterion|8
314088|NCT00742924|1030024|P4|Overall Study|Withdrawal by Subject|0
314089|NCT00742924|1030025|P3|Overall Study|Withdrawal by Subject|1
314090|NCT00742924|1030026|P2|Overall Study|Withdrawal by Subject|1
314091|NCT00742924|1030027|P1|Overall Study|Withdrawal by Subject|0
314092|NCT00742924|1030024|P4|Overall Study|Physician Decision|1
314093|NCT00742924|1030025|P3|Overall Study|Physician Decision|0
314094|NCT00742924|1030026|P2|Overall Study|Physician Decision|0
314095|NCT00742924|1030027|P1|Overall Study|Physician Decision|0
314096|NCT00742924|1030024|P4|Overall Study|Lack of Efficacy|4
314097|NCT00742924|1030025|P3|Overall Study|Lack of Efficacy|2
314098|NCT00742924|1030026|P2|Overall Study|Lack of Efficacy|1
314099|NCT00742924|1030027|P1|Overall Study|Lack of Efficacy|5
314100|NCT00742924|1030024|P4|Overall Study|Adverse Event|1
314101|NCT00742924|1030025|P3|Overall Study|Adverse Event|1
314102|NCT00742924|1030026|P2|Overall Study|Adverse Event|0
314103|NCT00742924|1030027|P1|Overall Study|Adverse Event|0
314104|NCT00742885|1030039|P2|Overall Study|Lost to Follow-up|0
314105|NCT00742885|1030040|P1|Overall Study|Lost to Follow-up|1
314106|NCT00742781|1030095|P1|Overall Study|Withdrawal by Subject|3
314107|NCT00742625|1030104|P1|Consolidation|Non protocol therapy|13
314108|NCT00742625|1030104|P1|Consolidation|Refused|1
314109|NCT00742625|1030104|P1|Consolidation|Death|1
314110|NCT00742625|1030104|P1|Consolidation|Adverse Event|1
314111|NCT00742625|1030104|P1|Consolidation|Progression|5
314112|NCT00742625|1030104|P1|Remission Induction|Other, not specified|5
314113|NCT00742625|1030104|P1|Remission Induction|Non protocol treatment|17
314114|NCT00742625|1030104|P1|Remission Induction|Refusal|5
314115|NCT00742625|1030104|P1|Remission Induction|Death|10
314116|NCT00742625|1030104|P1|Remission Induction|Adverse Event|3
314117|NCT00742625|1030104|P1|Remission Induction|Failed induction|8
314118|NCT00742625|1030104|P1|Remission Induction|Progression|6
314119|NCT00742508|1030115|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
314120|NCT00742508|1030116|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
314121|NCT00742508|1030115|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
314122|NCT00742508|1030116|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
314123|NCT00742508|1030115|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
314124|NCT00742508|1030116|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
314125|NCT00742508|1030115|P2|8-Week Primary Evaluation Period|Protocol Violation|0
314126|NCT00742508|1030116|P1|8-Week Primary Evaluation Period|Protocol Violation|1
314127|NCT00742508|1030115|P2|8-Week Primary Evaluation Period|Adverse Event|4
314128|NCT00742508|1030116|P1|8-Week Primary Evaluation Period|Adverse Event|2
314129|NCT00742417|1030180|P2|Intensive Period|Adverse Event|0
314130|NCT00742417|1030181|P1|Intensive Period|Adverse Event|2
314131|NCT00742417|1030180|P2|Intensive Period|Withdrawal by Subject|1
314132|NCT00742417|1030181|P1|Intensive Period|Withdrawal by Subject|1
314133|NCT00742417|1030180|P2|Randomized|Physician Decision|0
314134|NCT00742417|1030181|P1|Randomized|Physician Decision|1
314135|NCT00742417|1030180|P2|Randomized|Withdrawal by Subject|0
314136|NCT00742417|1030181|P1|Randomized|Withdrawal by Subject|1
314137|NCT00742417|1030180|P2|Randomized|Withdrawal by legal representative|1
314138|NCT00742417|1030181|P1|Randomized|Withdrawal by legal representative|0
314139|NCT00742391|1030205|P2|Overall Study|Protocol Violation|0
314140|NCT00742391|1030206|P1|Overall Study|Protocol Violation|1
314141|NCT00742391|1030205|P2|Overall Study|Lost to Follow-up|0
314142|NCT00742391|1030206|P1|Overall Study|Lost to Follow-up|1
314143|NCT00742391|1030205|P2|Overall Study|Adverse Event|1
314144|NCT00742391|1030206|P1|Overall Study|Adverse Event|2
314145|NCT00742326|1030216|P2|Overall Study|Physician Decision|1
314146|NCT00742326|1030217|P1|Overall Study|Physician Decision|0
314147|NCT00742274|1030236|P2|Overall Study|Removed for medical reasons|1
314148|NCT00742274|1030237|P1|Overall Study|Removed for medical reasons|1
314149|NCT00742274|1030236|P2|Overall Study|Withdrawal by Subject|2
314150|NCT00742274|1030237|P1|Overall Study|Withdrawal by Subject|1
314151|NCT00742274|1030236|P2|Overall Study|Death|0
314152|NCT00742274|1030237|P1|Overall Study|Death|1
314153|NCT00742235|1030245|P2|Overall Study|Lost to Follow-up|31
314154|NCT00742235|1030246|P1|Overall Study|Lost to Follow-up|0
314155|NCT00742209|1030259|P5|Overall Study|Investigator Discretion|1
314156|NCT00742209|1030260|P4|Overall Study|Investigator Discretion|1
314157|NCT00742209|1030261|P3|Overall Study|Investigator Discretion|5
314158|NCT00742209|1030262|P2|Overall Study|Investigator Discretion|0
314159|NCT00742209|1030263|P1|Overall Study|Investigator Discretion|0
314160|NCT00742209|1030259|P5|Overall Study|Lack of Efficacy|1
314161|NCT00742209|1030260|P4|Overall Study|Lack of Efficacy|3
314162|NCT00742209|1030261|P3|Overall Study|Lack of Efficacy|1
314163|NCT00742209|1030262|P2|Overall Study|Lack of Efficacy|1
314164|NCT00742209|1030263|P1|Overall Study|Lack of Efficacy|6
314165|NCT00742209|1030259|P5|Overall Study|Lost to Follow-up|3
314166|NCT00742209|1030260|P4|Overall Study|Lost to Follow-up|5
314167|NCT00742209|1030261|P3|Overall Study|Lost to Follow-up|5
314168|NCT00742209|1030262|P2|Overall Study|Lost to Follow-up|4
314169|NCT00742209|1030263|P1|Overall Study|Lost to Follow-up|3
314170|NCT00742209|1030259|P5|Overall Study|Protocol Violation|3
314171|NCT00742209|1030260|P4|Overall Study|Protocol Violation|5
314172|NCT00742209|1030261|P3|Overall Study|Protocol Violation|4
314173|NCT00742209|1030262|P2|Overall Study|Protocol Violation|5
314174|NCT00742209|1030263|P1|Overall Study|Protocol Violation|6
314175|NCT00742209|1030259|P5|Overall Study|Participant Withdrew Consent|4
314176|NCT00742209|1030260|P4|Overall Study|Participant Withdrew Consent|7
314177|NCT00742209|1030261|P3|Overall Study|Participant Withdrew Consent|14
314178|NCT00742209|1030262|P2|Overall Study|Participant Withdrew Consent|4
314179|NCT00742209|1030263|P1|Overall Study|Participant Withdrew Consent|8
314180|NCT00742209|1030259|P5|Overall Study|Adverse Event|13
314181|NCT00742209|1030260|P4|Overall Study|Adverse Event|16
314182|NCT00742209|1030261|P3|Overall Study|Adverse Event|17
314183|NCT00742209|1030262|P2|Overall Study|Adverse Event|4
314184|NCT00742209|1030263|P1|Overall Study|Adverse Event|11
314185|NCT00742183|1030366|P2|Overall Study|Lack of Efficacy|3
314186|NCT00742183|1030367|P1|Overall Study|Lack of Efficacy|0
314187|NCT00742183|1030366|P2|Overall Study|Withdrawal by Subject|0
314188|NCT00742183|1030367|P1|Overall Study|Withdrawal by Subject|1
314189|NCT00742183|1030366|P2|Overall Study|Required skin-graft|1
314190|NCT00742183|1030367|P1|Overall Study|Required skin-graft|1
314191|NCT00742183|1030366|P2|Overall Study|Lost to Follow-up|4
314192|NCT00742183|1030367|P1|Overall Study|Lost to Follow-up|4
314193|NCT00742183|1030366|P2|Overall Study|Physician Decision|2
314194|NCT00742183|1030367|P1|Overall Study|Physician Decision|0
314195|NCT00742183|1030366|P2|Overall Study|Death|0
314196|NCT00742183|1030367|P1|Overall Study|Death|1
314197|NCT00742183|1030366|P2|Overall Study|Adverse Event|2
314198|NCT00742183|1030367|P1|Overall Study|Adverse Event|2
314199|NCT00742079|1030386|P2|Overall Study|Lost to Follow-up|1
314200|NCT00742079|1030387|P1|Overall Study|Lost to Follow-up|0
314201|NCT00741988|1030399|P2|Overall Study|Lack of Efficacy|0
314202|NCT00741988|1030400|P1|Overall Study|Lack of Efficacy|2
314203|NCT00741988|1030399|P2|Overall Study|Adverse Event|4
314204|NCT00741988|1030400|P1|Overall Study|Adverse Event|2
314205|NCT00741936|1030412|P2|Overall Study|Low compliance|0
314206|NCT00741936|1030413|P1|Overall Study|Low compliance|3
314207|NCT00741936|1030412|P2|Overall Study|Lack of Efficacy|2
314208|NCT00741936|1030413|P1|Overall Study|Lack of Efficacy|0
314209|NCT00741936|1030412|P2|Overall Study|Protocol Violation|0
314210|NCT00741936|1030413|P1|Overall Study|Protocol Violation|2
314211|NCT00741936|1030412|P2|Overall Study|Pregnancy|1
314212|NCT00741936|1030413|P1|Overall Study|Pregnancy|0
314213|NCT00741936|1030412|P2|Overall Study|Adverse Event|4
314214|NCT00741936|1030413|P1|Overall Study|Adverse Event|3
314215|NCT00741936|1030412|P2|Overall Study|Lost to Follow-up|1
314216|NCT00741936|1030413|P1|Overall Study|Lost to Follow-up|1
314217|NCT00741819|1030448|P1|Overall Study|Disease progression|1
314218|NCT00741819|1030448|P1|Overall Study|Death|1
314219|NCT00741819|1030448|P1|Overall Study|Withdrawal by Subject|3
314220|NCT00741819|1030448|P1|Overall Study|Adverse Event|3
314221|NCT00741611|1030462|P3|Overall Study|Withdrawal by Subject|2
314222|NCT00741611|1030463|P2|Overall Study|Withdrawal by Subject|2
314223|NCT00741611|1030464|P1|Overall Study|Withdrawal by Subject|0
314224|NCT00741611|1030462|P3|Overall Study|Death|1
314225|NCT00741611|1030463|P2|Overall Study|Death|0
314226|NCT00741611|1030464|P1|Overall Study|Death|0
314227|NCT00741598|1030483|P2|Overall Study|Withdrawal by Subject|2
314228|NCT00741598|1030484|P1|Overall Study|Withdrawal by Subject|3
314229|NCT00741598|1030483|P2|Overall Study|Pregnancy|0
314230|NCT00741598|1030484|P1|Overall Study|Pregnancy|1
314231|NCT00741598|1030483|P2|Overall Study|Physician Decision|1
314232|NCT00741598|1030484|P1|Overall Study|Physician Decision|1
314233|NCT00741598|1030483|P2|Overall Study|Lack of Efficacy|2
314234|NCT00741598|1030484|P1|Overall Study|Lack of Efficacy|1
314235|NCT00741598|1030483|P2|Overall Study|Lost to Follow-up|4
314236|NCT00741598|1030484|P1|Overall Study|Lost to Follow-up|3
314237|NCT00741338|1030530|P2|Overall Study|Adverse Event|1
314238|NCT00741338|1030531|P1|Overall Study|Adverse Event|0
314239|NCT00741286|1030541|P2|Overall Study|Primary Outcome|1
314240|NCT00741286|1030542|P1|Overall Study|Primary Outcome|1
314241|NCT00741286|1030541|P2|Overall Study|Protocol Violation|2
314242|NCT00741286|1030542|P1|Overall Study|Protocol Violation|3
314243|NCT00741286|1030541|P2|Overall Study|Adverse Event|6
314244|NCT00741286|1030542|P1|Overall Study|Adverse Event|1
314245|NCT00741286|1030541|P2|Overall Study|Lost to Follow-up|10
314246|NCT00741286|1030542|P1|Overall Study|Lost to Follow-up|15
314247|NCT00741091|1030591|P1|Overall Study|Missed Visit|22
314248|NCT00741091|1030591|P1|Overall Study|Withdrawal by Subject|6
314249|NCT00741091|1030591|P1|Overall Study|Lost to Follow-up|16
314250|NCT00741091|1030591|P1|Overall Study|Death|13
314251|NCT00741039|1030601|P2|Overall Study|Patient non-compliance|0
314252|NCT00741039|1030602|P1|Overall Study|Patient non-compliance|2
314253|NCT00741013|1030639|P3|Overall Study|Discovered failed screen after enrolled|0
314254|NCT00741013|1030640|P2|Overall Study|Discovered failed screen after enrolled|2
314255|NCT00741013|1030641|P1|Overall Study|Discovered failed screen after enrolled|0
314256|NCT00741013|1030639|P3|Overall Study|Withdrawal by Subject|1
314257|NCT00741013|1030640|P2|Overall Study|Withdrawal by Subject|0
314258|NCT00741013|1030641|P1|Overall Study|Withdrawal by Subject|0
314259|NCT00741013|1030639|P3|Overall Study|Adverse Event|0
314260|NCT00741013|1030640|P2|Overall Study|Adverse Event|0
314261|NCT00741013|1030641|P1|Overall Study|Adverse Event|1
314262|NCT00740857|1030655|P3|Overall Study|Withdrawal by Subject|0
314263|NCT00740857|1030656|P2|Overall Study|Withdrawal by Subject|0
314264|NCT00740857|1030657|P1|Overall Study|Withdrawal by Subject|1
314265|NCT00740792|1030712|P4|Overall Study|administrative|2
314266|NCT00740792|1030713|P3|Overall Study|administrative|8
314267|NCT00740792|1030714|P2|Overall Study|administrative|3
314268|NCT00740792|1030715|P1|Overall Study|administrative|3
314269|NCT00740792|1030712|P4|Overall Study|Withdrawal by Subject|0
314270|NCT00740792|1030713|P3|Overall Study|Withdrawal by Subject|0
314271|NCT00740792|1030714|P2|Overall Study|Withdrawal by Subject|1
314272|NCT00740792|1030715|P1|Overall Study|Withdrawal by Subject|1
314273|NCT00740792|1030712|P4|Overall Study|Protocol Violation|2
314274|NCT00740792|1030713|P3|Overall Study|Protocol Violation|0
314275|NCT00740792|1030714|P2|Overall Study|Protocol Violation|1
314276|NCT00740792|1030715|P1|Overall Study|Protocol Violation|0
314277|NCT00740792|1030712|P4|Overall Study|Lost to Follow-up|0
314278|NCT00740792|1030713|P3|Overall Study|Lost to Follow-up|0
314279|NCT00740792|1030714|P2|Overall Study|Lost to Follow-up|1
314280|NCT00740792|1030715|P1|Overall Study|Lost to Follow-up|2
314281|NCT00740792|1030712|P4|Overall Study|Lack of Efficacy|3
314282|NCT00740792|1030713|P3|Overall Study|Lack of Efficacy|0
314283|NCT00740792|1030714|P2|Overall Study|Lack of Efficacy|1
314284|NCT00740792|1030715|P1|Overall Study|Lack of Efficacy|1
314285|NCT00740792|1030712|P4|Overall Study|Adverse Event|3
314286|NCT00740792|1030713|P3|Overall Study|Adverse Event|1
314287|NCT00740792|1030714|P2|Overall Study|Adverse Event|1
314288|NCT00740792|1030715|P1|Overall Study|Adverse Event|3
314289|NCT00740779|1030736|P3|Overall Study|Lost to Follow-up|5
314290|NCT00740779|1030737|P2|Overall Study|Lost to Follow-up|3
314291|NCT00740779|1030738|P1|Overall Study|Lost to Follow-up|2
314292|NCT00740779|1030736|P3|Overall Study|Withdrawal by Subject|2
314293|NCT00740779|1030737|P2|Overall Study|Withdrawal by Subject|4
314294|NCT00740779|1030738|P1|Overall Study|Withdrawal by Subject|2
314295|NCT00740779|1030736|P3|Overall Study|Lack of Efficacy|2
314296|NCT00740779|1030737|P2|Overall Study|Lack of Efficacy|0
314297|NCT00740779|1030738|P1|Overall Study|Lack of Efficacy|0
314298|NCT00740779|1030736|P3|Overall Study|Protocol Violation|1
314299|NCT00740779|1030737|P2|Overall Study|Protocol Violation|1
314300|NCT00740779|1030738|P1|Overall Study|Protocol Violation|1
314301|NCT00740779|1030736|P3|Overall Study|Adverse Event|3
314302|NCT00740779|1030737|P2|Overall Study|Adverse Event|6
314303|NCT00740779|1030738|P1|Overall Study|Adverse Event|4
314304|NCT00740714|1030755|P3|Overall Study|Withdrawal by Subject|29
314305|NCT00740714|1030756|P2|Overall Study|Withdrawal by Subject|19
314306|NCT00740714|1030757|P1|Overall Study|Withdrawal by Subject|17
314307|NCT00740636|1030833|P2|Overall Study|Death|0
314308|NCT00740636|1030834|P1|Overall Study|Death|1
314309|NCT00740636|1030833|P2|Overall Study|Progressive Disease|0
314310|NCT00740636|1030834|P1|Overall Study|Progressive Disease|1
314311|NCT00740636|1030833|P2|Overall Study|Patient Not Treated|1
314312|NCT00740636|1030834|P1|Overall Study|Patient Not Treated|0
314313|NCT00740636|1030833|P2|Overall Study|Patient Ineligible|1
314314|NCT00740636|1030834|P1|Overall Study|Patient Ineligible|0
314315|NCT00740636|1030833|P2|Overall Study|Adverse Event|2
314316|NCT00740636|1030834|P1|Overall Study|Adverse Event|0
314317|NCT00740597|1030840|P1|Overall Study|insurance would not cover treatment|1
314318|NCT00740584|1030844|P1|Overall Study|Withdrawal by Subject|1
314319|NCT00740480|1030848|P1|Overall Study|Physician Decision|1
314320|NCT00740480|1030848|P1|Overall Study|Adverse Event|1
314321|NCT00740220|1030852|P1|Overall Study|screen failures (non-COPD patients)|9
314322|NCT00740051|1030877|P2|Overall Study|Other reason (not specified)|1
314323|NCT00740051|1030878|P1|Overall Study|Other reason (not specified)|4
314324|NCT00740051|1030877|P2|Overall Study|Withdrawal by Subject|8
314325|NCT00740051|1030878|P1|Overall Study|Withdrawal by Subject|6
314326|NCT00740051|1030877|P2|Overall Study|Lost to Follow-up|8
314327|NCT00740051|1030878|P1|Overall Study|Lost to Follow-up|3
314328|NCT00740051|1030877|P2|Overall Study|Protocol Violation|6
314329|NCT00740051|1030878|P1|Overall Study|Protocol Violation|2
314330|NCT00740051|1030877|P2|Overall Study|Adverse Event|4
314331|NCT00740051|1030878|P1|Overall Study|Adverse Event|1
314332|NCT00740051|1030877|P2|Overall Study|Lack of Efficacy|5
314333|NCT00740051|1030878|P1|Overall Study|Lack of Efficacy|2
314334|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
314335|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
314336|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
314337|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
314338|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
314339|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
314340|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
314341|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
314342|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
314343|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
314344|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
314345|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
314346|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
314347|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
314348|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
314349|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
314350|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
314351|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
314352|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
314353|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
314354|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
314355|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
314356|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
314357|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
314358|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
314359|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
314360|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
314361|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
314362|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
314363|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
314364|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
314365|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
314366|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
314367|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
314368|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
314369|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
314370|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
314371|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
314372|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
314373|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
314374|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
314375|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
314376|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
314377|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
314378|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
314379|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
314380|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
314381|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
314382|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
314383|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
314384|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
314385|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
314386|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
314387|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
314388|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
314389|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
314390|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
314391|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
314392|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
314393|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
314394|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
314395|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
314396|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
314397|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
314398|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
314399|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
314400|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
314401|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
314402|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
314403|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
314404|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
314405|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
314406|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
314407|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
314408|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
314409|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
314410|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
314411|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
314412|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
314413|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
314414|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
314415|NCT00739973|1030981|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
314416|NCT00739973|1030982|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
314417|NCT00739973|1030983|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
314418|NCT00739973|1030984|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
314419|NCT00739973|1030985|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
314420|NCT00739973|1030986|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
314421|NCT00739973|1030987|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
314422|NCT00739973|1030988|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
314423|NCT00739973|1030989|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
314424|NCT00739973|1030981|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
314425|NCT00739973|1030982|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
314426|NCT00739973|1030983|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
314427|NCT00739973|1030984|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
314428|NCT00739973|1030985|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
314429|NCT00739973|1030986|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
314430|NCT00739973|1030987|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
314431|NCT00739973|1030988|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
314432|NCT00739973|1030989|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
314433|NCT00739973|1030981|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
314434|NCT00739973|1030982|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
314435|NCT00739973|1030983|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
314436|NCT00739973|1030984|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
314437|NCT00739973|1030985|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
314438|NCT00739973|1030986|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
314439|NCT00739973|1030987|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
314440|NCT00739973|1030988|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
314441|NCT00739973|1030989|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
314442|NCT00739973|1030981|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
314443|NCT00739973|1030982|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
314444|NCT00739973|1030983|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
314445|NCT00739973|1030984|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
314446|NCT00739973|1030985|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
314447|NCT00739973|1030986|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
314448|NCT00739973|1030987|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
314449|NCT00739973|1030988|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
314450|NCT00739973|1030989|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
314451|NCT00739973|1030981|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
314452|NCT00739973|1030982|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
314453|NCT00739973|1030983|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
314454|NCT00739973|1030984|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
314455|NCT00739973|1030985|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
314456|NCT00739973|1030986|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
314457|NCT00739973|1030987|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
314458|NCT00739973|1030988|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
314459|NCT00739973|1030989|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
314460|NCT00739973|1030981|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
314461|NCT00739973|1030982|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
314462|NCT00739973|1030983|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
314463|NCT00739973|1030984|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
314464|NCT00739973|1030985|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
314465|NCT00739973|1030986|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
314466|NCT00739973|1030987|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
314467|NCT00739973|1030988|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
314468|NCT00739973|1030989|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
314469|NCT00739973|1030981|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
314470|NCT00739973|1030982|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
314471|NCT00739973|1030983|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
314472|NCT00739973|1030984|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
314473|NCT00739973|1030985|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
314474|NCT00739973|1030986|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
314475|NCT00739973|1030987|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
314476|NCT00739973|1030988|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
314477|NCT00739973|1030989|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
314478|NCT00739973|1030981|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
314479|NCT00739973|1030982|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
314480|NCT00739973|1030983|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
314481|NCT00739973|1030984|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
314482|NCT00739973|1030985|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
314483|NCT00739973|1030986|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
314484|NCT00739973|1030987|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
314485|NCT00739973|1030988|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
314486|NCT00739973|1030989|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
314487|NCT00739934|1031075|P1|Voriconazole Oral|unspecified|3
314488|NCT00739934|1031075|P1|Voriconazole IV|Adverse Event|6
314489|NCT00739908|1031097|P2|Overall Study|Relocation|1
314490|NCT00739908|1031098|P1|Overall Study|Relocation|0
314491|NCT00739908|1031097|P2|Overall Study|Lack of Efficacy|1
314492|NCT00739908|1031098|P1|Overall Study|Lack of Efficacy|0
314493|NCT00739908|1031097|P2|Overall Study|Non-Compliance With Study Medication|3
314494|NCT00739908|1031098|P1|Overall Study|Non-Compliance With Study Medication|0
314495|NCT00739908|1031097|P2|Overall Study|Non-Compliance With Study Procedures|3
314496|NCT00739908|1031098|P1|Overall Study|Non-Compliance With Study Procedures|2
314497|NCT00739908|1031097|P2|Overall Study|Lost to Follow-up|9
314498|NCT00739908|1031098|P1|Overall Study|Lost to Follow-up|14
314499|NCT00739908|1031097|P2|Overall Study|Withdrawal by Subject|2
314500|NCT00739908|1031098|P1|Overall Study|Withdrawal by Subject|4
314501|NCT00739908|1031097|P2|Overall Study|Adverse Event|6
314502|NCT00739908|1031098|P1|Overall Study|Adverse Event|5
314503|NCT00739882|1031118|P2|Open-label Period|Other|5
314504|NCT00739882|1031119|P1|Open-label Period|Other|9
314505|NCT00739882|1031118|P2|Open-label Period|Adverse Event|0
314506|NCT00739882|1031119|P1|Open-label Period|Adverse Event|1
314507|NCT00739882|1031118|P2|Double-blind Period|Not specified|8
314508|NCT00739882|1031119|P1|Double-blind Period|Not specified|16
314509|NCT00739882|1031118|P2|Double-blind Period|Lack of Efficacy|1
314510|NCT00739882|1031119|P1|Double-blind Period|Lack of Efficacy|1
314511|NCT00739882|1031118|P2|Double-blind Period|Protocol Violation|0
314512|NCT00739882|1031119|P1|Double-blind Period|Protocol Violation|1
314513|NCT00739882|1031118|P2|Double-blind Period|Adverse Event|2
314514|NCT00739882|1031119|P1|Double-blind Period|Adverse Event|1
314515|NCT00739674|1031155|P2|Overall Study|Erectile dysfunction|1
314516|NCT00739674|1031156|P1|Overall Study|Erectile dysfunction|0
314517|NCT00739674|1031155|P2|Overall Study|Home monitoring off meds|0
314518|NCT00739674|1031156|P1|Overall Study|Home monitoring off meds|1
314519|NCT00739674|1031155|P2|Overall Study|Unable to attend visit|1
314520|NCT00739674|1031156|P1|Overall Study|Unable to attend visit|3
314521|NCT00739674|1031155|P2|Overall Study|Non compliant|0
314522|NCT00739674|1031156|P1|Overall Study|Non compliant|4
314523|NCT00739674|1031155|P2|Overall Study|Patient moved|2
314524|NCT00739674|1031156|P1|Overall Study|Patient moved|3
314525|NCT00739674|1031155|P2|Overall Study|Clinic closed|4
314526|NCT00739674|1031156|P1|Overall Study|Clinic closed|6
314527|NCT00739674|1031155|P2|Overall Study|Reason missing|0
314528|NCT00739674|1031156|P1|Overall Study|Reason missing|2
314529|NCT00739674|1031155|P2|Overall Study|Withdrawal by Subject|9
314530|NCT00739674|1031156|P1|Overall Study|Withdrawal by Subject|9
314531|NCT00739674|1031155|P2|Overall Study|Protocol Violation|5
314532|NCT00739674|1031156|P1|Overall Study|Protocol Violation|5
314533|NCT00739674|1031155|P2|Overall Study|Lost to Follow-up|30
314534|NCT00739674|1031156|P1|Overall Study|Lost to Follow-up|52
314535|NCT00739674|1031155|P2|Overall Study|Lack of Efficacy|0
314536|NCT00739674|1031156|P1|Overall Study|Lack of Efficacy|1
314537|NCT00739674|1031155|P2|Overall Study|Death|0
314538|NCT00739674|1031156|P1|Overall Study|Death|1
314539|NCT00739674|1031155|P2|Overall Study|Adverse Event|13
314540|NCT00739674|1031156|P1|Overall Study|Adverse Event|22
314541|NCT00739674|1031155|P2|Overall Study|Dietician consultation >30 days|9
314542|NCT00739674|1031156|P1|Overall Study|Dietician consultation >30 days|1
314543|NCT00739674|1031155|P2|Overall Study|No follow-up data|18
314544|NCT00739674|1031156|P1|Overall Study|No follow-up data|33
314545|NCT00739674|1031155|P2|Overall Study|Site 212 removal|13
314546|NCT00739674|1031156|P1|Overall Study|Site 212 removal|19
314547|NCT00739674|1031155|P2|Overall Study|Screening failures|17
314548|NCT00739674|1031156|P1|Overall Study|Screening failures|19
314549|NCT00739661|1031184|P2|Overall Study|Reason for discontinuation not available|1
314550|NCT00739661|1031185|P1|Overall Study|Reason for discontinuation not available|1
314551|NCT00739661|1031184|P2|Overall Study|Disease progression, radiographic|37
314552|NCT00739661|1031185|P1|Overall Study|Disease progression, radiographic|33
314553|NCT00739661|1031184|P2|Overall Study|Patient decision to withdraw|4
314554|NCT00739661|1031185|P1|Overall Study|Patient decision to withdraw|9
314555|NCT00739661|1031184|P2|Overall Study|Physician decision to withdraw patient|0
314556|NCT00739661|1031185|P1|Overall Study|Physician decision to withdraw patient|1
314557|NCT00739661|1031184|P2|Overall Study|Adverse Event|0
314558|NCT00739661|1031185|P1|Overall Study|Adverse Event|2
314559|NCT00739648|1031197|P2|Overall Study|Do not know|6
314560|NCT00739648|1031198|P1|Overall Study|Do not know|4
314561|NCT00739648|1031197|P2|Overall Study|Death|0
314562|NCT00739648|1031198|P1|Overall Study|Death|2
314563|NCT00739648|1031197|P2|Overall Study|Lost to Follow-up|7
314564|NCT00739648|1031198|P1|Overall Study|Lost to Follow-up|4
314565|NCT00739648|1031197|P2|Overall Study|Withdrawal by Subject|25
314566|NCT00739648|1031198|P1|Overall Study|Withdrawal by Subject|13
314567|NCT00739648|1031197|P2|Overall Study|Adverse Event|15
314568|NCT00739648|1031198|P1|Overall Study|Adverse Event|3
314569|NCT00739596|1031212|P2|Overall Study|Protocol Deviation|1
314570|NCT00739596|1031213|P1|Overall Study|Protocol Deviation|1
314571|NCT00739596|1031212|P2|Overall Study|Lost to Follow-up|2
314572|NCT00739596|1031213|P1|Overall Study|Lost to Follow-up|0
314573|NCT00739596|1031212|P2|Overall Study|Patient Withdrew Consent|8
314574|NCT00739596|1031213|P1|Overall Study|Patient Withdrew Consent|8
314575|NCT00739596|1031212|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
314576|NCT00739596|1031213|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
314577|NCT00739596|1031212|P2|Overall Study|Adverse Event|6
314578|NCT00739596|1031213|P1|Overall Study|Adverse Event|12
314579|NCT00739310|1031255|P1|Overall Study|Lost to Follow-up|2
314580|NCT00739310|1031255|P1|Overall Study|Withdrawal by Subject|1
314581|NCT00739310|1031255|P1|Overall Study|Poor adherance to prescribed therapy|4
314582|NCT00739297|1031260|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
314583|NCT00739297|1031261|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
314584|NCT00739297|1031262|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
314585|NCT00739297|1031263|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
314586|NCT00739297|1031264|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
314587|NCT00739297|1031265|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
314588|NCT00739297|1031266|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
314589|NCT00739297|1031260|P7|First Washout Period of 4-7 Days|Adverse Event|2
314590|NCT00739297|1031261|P6|First Washout Period of 4-7 Days|Adverse Event|0
314591|NCT00739297|1031262|P5|First Washout Period of 4-7 Days|Adverse Event|0
314592|NCT00739297|1031263|P4|First Washout Period of 4-7 Days|Adverse Event|2
314593|NCT00739297|1031264|P3|First Washout Period of 4-7 Days|Adverse Event|0
314594|NCT00739297|1031265|P2|First Washout Period of 4-7 Days|Adverse Event|0
314595|NCT00739297|1031266|P1|First Washout Period of 4-7 Days|Adverse Event|0
314596|NCT00738062|1031297|P3|Open-Label Extension|Study Terminated|0
314597|NCT00738062|1031298|P2|Open-Label Extension|Study Terminated|0
314598|NCT00738062|1031299|P1|Open-Label Extension|Study Terminated|2
314599|NCT00738062|1031297|P3|Open-Label Extension|Protocol Violation|0
314600|NCT00738062|1031298|P2|Open-Label Extension|Protocol Violation|0
314601|NCT00738062|1031299|P1|Open-Label Extension|Protocol Violation|1
314602|NCT00738062|1031297|P3|Open-Label Extension|Withdrawal by Subject|0
314603|NCT00738062|1031298|P2|Open-Label Extension|Withdrawal by Subject|0
314604|NCT00738062|1031299|P1|Open-Label Extension|Withdrawal by Subject|6
314605|NCT00738062|1031297|P3|Open-Label Extension|Lack of Efficacy|0
314606|NCT00738062|1031298|P2|Open-Label Extension|Lack of Efficacy|0
314607|NCT00738062|1031299|P1|Open-Label Extension|Lack of Efficacy|2
314608|NCT00738062|1031297|P3|Open-Label Extension|Physician Decision|0
314609|NCT00738062|1031298|P2|Open-Label Extension|Physician Decision|0
314610|NCT00738062|1031299|P1|Open-Label Extension|Physician Decision|1
314611|NCT00738062|1031297|P3|Open-Label Extension|Adverse Event|0
314612|NCT00738062|1031298|P2|Open-Label Extension|Adverse Event|0
314613|NCT00738062|1031299|P1|Open-Label Extension|Adverse Event|5
314614|NCT00738062|1031297|P3|Open Label Treatment|Investigator Decision|0
314615|NCT00738062|1031298|P2|Open Label Treatment|Investigator Decision|0
314616|NCT00738062|1031299|P1|Open Label Treatment|Investigator Decision|1
314617|NCT00738062|1031297|P3|Open Label Treatment|Withdrawal by Subject|0
314618|NCT00738062|1031298|P2|Open Label Treatment|Withdrawal by Subject|0
314619|NCT00738062|1031299|P1|Open Label Treatment|Withdrawal by Subject|9
314620|NCT00738062|1031297|P3|Open Label Treatment|Protocol Violation|0
314621|NCT00738062|1031298|P2|Open Label Treatment|Protocol Violation|0
314622|NCT00738062|1031299|P1|Open Label Treatment|Protocol Violation|2
314623|NCT00738062|1031297|P3|Open Label Treatment|Adverse Event|0
314624|NCT00738062|1031298|P2|Open Label Treatment|Adverse Event|0
314625|NCT00738062|1031299|P1|Open Label Treatment|Adverse Event|11
314626|NCT00738062|1031297|P3|Open Label Treatment|Lack of Efficacy|0
314627|NCT00738062|1031298|P2|Open Label Treatment|Lack of Efficacy|0
314628|NCT00738062|1031299|P1|Open Label Treatment|Lack of Efficacy|5
314629|NCT00739102|1031350|P1|Overall Study|Withdrawal by Subject|10
314630|NCT00739102|1031350|P1|Overall Study|Death|5
314631|NCT00739063|1031366|P1|Overall Study|Screen failures|8
314632|NCT00738881|1031411|P2|Overall Study|Withdrawal by Subject|2
314633|NCT00738881|1031412|P1|Overall Study|Withdrawal by Subject|0
314634|NCT00738699|1031426|P2|Overall Study|Not specified|0
314635|NCT00738699|1031427|P1|Overall Study|Not specified|2
314636|NCT00738699|1031426|P2|Overall Study|Discontinuation of study by Sponsor|72
314637|NCT00738699|1031427|P1|Overall Study|Discontinuation of study by Sponsor|123
314638|NCT00738699|1031426|P2|Overall Study|Death|68
314639|NCT00738699|1031427|P1|Overall Study|Death|144
314640|NCT00738699|1031426|P2|Overall Study|Lost to Follow-up|0
314641|NCT00738699|1031427|P1|Overall Study|Lost to Follow-up|1
314642|NCT00738699|1031426|P2|Overall Study|Withdrawal by Subject|0
314643|NCT00738699|1031427|P1|Overall Study|Withdrawal by Subject|5
314644|NCT00738673|1031445|P2|Overall Study|Withdrawal by Subject|1
314645|NCT00738673|1031446|P1|Overall Study|Withdrawal by Subject|3
314646|NCT00738673|1031445|P2|Overall Study|Protocol Violation|2
314647|NCT00738673|1031446|P1|Overall Study|Protocol Violation|1
314648|NCT00738673|1031445|P2|Overall Study|Lack of Efficacy|8
314649|NCT00738673|1031446|P1|Overall Study|Lack of Efficacy|19
314650|NCT00738673|1031445|P2|Overall Study|Adverse Event|0
314651|NCT00738673|1031446|P1|Overall Study|Adverse Event|1
314652|NCT00738530|1031484|P2|Overall Study|Withdrawal by Subject|8
314653|NCT00738530|1031485|P1|Overall Study|Withdrawal by Subject|6
314654|NCT00738530|1031484|P2|Overall Study|Lost to Follow-up|6
314655|NCT00738530|1031485|P1|Overall Study|Lost to Follow-up|8
314656|NCT00738530|1031484|P2|Overall Study|Death|224
314657|NCT00738530|1031485|P1|Overall Study|Death|220
314658|NCT00738400|1031520|P2|Overall Study|Non-compliant with study medication|1
314659|NCT00738400|1031521|P1|Overall Study|Non-compliant with study medication|0
314660|NCT00738400|1031520|P2|Overall Study|Protocol Violation|0
314661|NCT00738400|1031521|P1|Overall Study|Protocol Violation|1
314662|NCT00738400|1031520|P2|Overall Study|Lost to Follow-up|3
314663|NCT00738400|1031521|P1|Overall Study|Lost to Follow-up|0
314664|NCT00738400|1031520|P2|Overall Study|Lack of Efficacy|1
314665|NCT00738400|1031521|P1|Overall Study|Lack of Efficacy|0
314666|NCT00738400|1031520|P2|Overall Study|Withdrawal by Subject|1
314667|NCT00738400|1031521|P1|Overall Study|Withdrawal by Subject|0
314668|NCT00738400|1031520|P2|Overall Study|Adverse Event|1
314669|NCT00738400|1031521|P1|Overall Study|Adverse Event|3
314670|NCT00738374|1031542|P4|Maintenance Treatment/Observation Phase|Not Specified|0
314671|NCT00738374|1031543|P3|Maintenance Treatment/Observation Phase|Not Specified|0
314672|NCT00738374|1031544|P2|Maintenance Treatment/Observation Phase|Not Specified|1
314673|NCT00738374|1031545|P1|Maintenance Treatment/Observation Phase|Not Specified|0
314674|NCT00738374|1031542|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
314675|NCT00738374|1031543|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
314676|NCT00738374|1031544|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
314677|NCT00738374|1031545|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
314678|NCT00738374|1031542|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
314679|NCT00738374|1031543|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
314680|NCT00738374|1031544|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
314681|NCT00738374|1031545|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
314682|NCT00738374|1031542|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
314683|NCT00738374|1031543|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
314684|NCT00738374|1031544|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
314685|NCT00738374|1031545|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
314686|NCT00738374|1031542|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
314687|NCT00738374|1031543|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
314688|NCT00738374|1031544|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
314689|NCT00738374|1031545|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
314690|NCT00738374|1031542|P4|Induction Treatment Phase|Withdrawal by Subject|0
314691|NCT00738374|1031543|P3|Induction Treatment Phase|Withdrawal by Subject|0
314692|NCT00738374|1031544|P2|Induction Treatment Phase|Withdrawal by Subject|0
314693|NCT00738374|1031545|P1|Induction Treatment Phase|Withdrawal by Subject|1
314694|NCT00738374|1031542|P4|Induction Treatment Phase|Non-compliance|0
314695|NCT00738374|1031543|P3|Induction Treatment Phase|Non-compliance|0
314696|NCT00738374|1031544|P2|Induction Treatment Phase|Non-compliance|0
314697|NCT00738374|1031545|P1|Induction Treatment Phase|Non-compliance|1
314698|NCT00738374|1031542|P4|Induction Treatment Phase|Protocol Violation|0
314699|NCT00738374|1031543|P3|Induction Treatment Phase|Protocol Violation|0
314700|NCT00738374|1031544|P2|Induction Treatment Phase|Protocol Violation|0
314701|NCT00738374|1031545|P1|Induction Treatment Phase|Protocol Violation|2
314702|NCT00738374|1031542|P4|Induction Treatment Phase|Physician Decision|0
314703|NCT00738374|1031543|P3|Induction Treatment Phase|Physician Decision|0
314704|NCT00738374|1031544|P2|Induction Treatment Phase|Physician Decision|0
314705|NCT00738374|1031545|P1|Induction Treatment Phase|Physician Decision|2
314706|NCT00738374|1031542|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
314707|NCT00738374|1031543|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
314708|NCT00738374|1031544|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
314709|NCT00738374|1031545|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
314710|NCT00738374|1031542|P4|Induction Treatment Phase|Adverse Event|0
314711|NCT00738374|1031543|P3|Induction Treatment Phase|Adverse Event|0
314712|NCT00738374|1031544|P2|Induction Treatment Phase|Adverse Event|0
314713|NCT00738374|1031545|P1|Induction Treatment Phase|Adverse Event|14
314714|NCT00738283|1031583|P1|Overall Study|Discharge home prior to end of study|1
314715|NCT00738283|1031583|P1|Overall Study|Transfer to another facility|2
314716|NCT00738283|1031583|P1|Overall Study|Death|1
314717|NCT00737711|1031598|P1|Overall Study|Other|5
314718|NCT00737711|1031598|P1|Overall Study|Blood transfusion|6
314719|NCT00737711|1031598|P1|Overall Study|Withdrawal by Subject|5
314720|NCT00737711|1031598|P1|Overall Study|Protocol Violation|1
314721|NCT00737711|1031598|P1|Overall Study|Failure to return|4
314722|NCT00737711|1031598|P1|Overall Study|Death|8
314723|NCT00737711|1031598|P1|Overall Study|Adverse Event|2
314724|NCT00737672|1031631|P2|Overall Study|Physician Decision|2
314725|NCT00737672|1031632|P1|Overall Study|Physician Decision|0
314726|NCT00737672|1031631|P2|Overall Study|Miscellaneous|1
314727|NCT00737672|1031632|P1|Overall Study|Miscellaneous|7
314728|NCT00737672|1031631|P2|Overall Study|Lost to Follow-up|0
314729|NCT00737672|1031632|P1|Overall Study|Lost to Follow-up|1
314730|NCT00737672|1031631|P2|Overall Study|Withdrawal by Subject|2
314731|NCT00737672|1031632|P1|Overall Study|Withdrawal by Subject|1
314732|NCT00737672|1031631|P2|Overall Study|Death|22
314733|NCT00737672|1031632|P1|Overall Study|Death|23
314734|NCT00737672|1031631|P2|Overall Study|Graft Abandonment|56
314735|NCT00737672|1031632|P1|Overall Study|Graft Abandonment|48
314736|NCT00737633|1031670|P2|Overall Study|protocol non-compliance|1
314737|NCT00737633|1031671|P1|Overall Study|protocol non-compliance|0
314738|NCT00737633|1031670|P2|Overall Study|Lost to Follow-up|1
314739|NCT00737633|1031671|P1|Overall Study|Lost to Follow-up|0
314740|NCT00737633|1031670|P2|Overall Study|Study terminated by sponsor|55
314741|NCT00737633|1031671|P1|Overall Study|Study terminated by sponsor|44
314742|NCT00737568|1031694|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
314743|NCT00737568|1031695|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
314744|NCT00737568|1031694|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
314745|NCT00737568|1031695|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
314746|NCT00737568|1031694|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
314747|NCT00737568|1031695|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
314748|NCT00737568|1031694|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
314749|NCT00737568|1031695|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
314750|NCT00737568|1031694|P2|Treatment Period Through Week 240|Protocol Violation|3
314751|NCT00737568|1031695|P1|Treatment Period Through Week 240|Protocol Violation|2
314752|NCT00737568|1031694|P2|Treatment Period Through Week 240|Lost to Follow-up|3
314753|NCT00737568|1031695|P1|Treatment Period Through Week 240|Lost to Follow-up|3
314754|NCT00737568|1031694|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
314755|NCT00737568|1031695|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
314756|NCT00737568|1031694|P2|Treatment Period Through Week 240|Withdrew Consent|6
314757|NCT00737568|1031695|P1|Treatment Period Through Week 240|Withdrew Consent|5
314758|NCT00737568|1031694|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
314759|NCT00737568|1031695|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
314760|NCT00737529|1031725|P1|Overall Study|Unspecified|2
314761|NCT00737529|1031725|P1|Overall Study|Protocol Violation|1
314762|NCT00737529|1031725|P1|Overall Study|Death|3
314763|NCT00737529|1031725|P1|Overall Study|Withdrawal by Subject|3
314764|NCT00737529|1031725|P1|Overall Study|Adverse Event|23
314765|NCT00737529|1031725|P1|Overall Study|Disease Progression|80
314766|NCT00737477|1031739|P1|Overall Study|Not Specified|4
314767|NCT00737477|1031739|P1|Overall Study|Renal Transplantation|10
314768|NCT00737477|1031739|P1|Overall Study|Withdrawal by Subject|1
314769|NCT00737477|1031739|P1|Overall Study|Treatment Refusal|1
314770|NCT00737477|1031739|P1|Overall Study|Death|9
314771|NCT00737477|1031739|P1|Overall Study|Adverse Event|9
314772|NCT00737464|1031755|P1|Overall Study|Other reasons|4
314773|NCT00737464|1031755|P1|Overall Study|Refused Treatment / Withdrew Consent|6
314774|NCT00737464|1031755|P1|Overall Study|Other - Failure to Return|1
314775|NCT00737464|1031755|P1|Overall Study|Death|6
314776|NCT00737464|1031755|P1|Overall Study|Adverse Event|1
314777|NCT00737438|1031776|P1|Overall Study|Patient ineligible|1
314778|NCT00737438|1031776|P1|Overall Study|Withdrawal by Subject|2
314779|NCT00737282|1031789|P1|Overall Study|Study prematurely terminated|175
314780|NCT00737100|1031832|P3|Overall Study|Reason discontinued not explained above|1
314781|NCT00737100|1031833|P2|Overall Study|Reason discontinued not explained above|1
314782|NCT00737100|1031834|P1|Overall Study|Reason discontinued not explained above|1
314783|NCT00737100|1031832|P3|Overall Study|Withdrawal by Subject|3
314784|NCT00737100|1031833|P2|Overall Study|Withdrawal by Subject|0
314785|NCT00737100|1031834|P1|Overall Study|Withdrawal by Subject|0
314786|NCT00737100|1031832|P3|Overall Study|Lost to Follow-up|0
314787|NCT00737100|1031833|P2|Overall Study|Lost to Follow-up|1
314788|NCT00737100|1031834|P1|Overall Study|Lost to Follow-up|0
314789|NCT00737100|1031832|P3|Overall Study|Adverse Event|3
314790|NCT00737100|1031833|P2|Overall Study|Adverse Event|5
314791|NCT00737100|1031834|P1|Overall Study|Adverse Event|6
314792|NCT00737061|1031878|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
314793|NCT00737061|1031878|P1|1 Year Wearing Period|Discontinued reilance|3
314794|NCT00737061|1031878|P1|1 Year Wearing Period|Withdrawal by Subject|2
314795|NCT00737061|1031878|P1|1 Year Wearing Period|Lost to Follow-up|11
314796|NCT00737061|1031878|P1|Waiting Period|Elected surgical tubal ligation|5
314797|NCT00737061|1031878|P1|Waiting Period|Alternative contraception failure|3
314798|NCT00737061|1031878|P1|Waiting Period|Deemed patent following HSG|26
314799|NCT00737061|1031878|P1|Waiting Period|Bilateral placement failure|34
314800|NCT00737061|1031878|P1|Waiting Period|Withdrawal by Subject|1
314801|NCT00737061|1031878|P1|Waiting Period|Lost to Follow-up|6
314802|NCT00737048|1031895|P3|Overall Study|Worsening of the symptoms|3
314803|NCT00737048|1031896|P2|Overall Study|Worsening of the symptoms|5
314804|NCT00737048|1031897|P1|Overall Study|Worsening of the symptoms|3
314805|NCT00737048|1031895|P3|Overall Study|Adverse Event|0
314806|NCT00737048|1031896|P2|Overall Study|Adverse Event|1
314807|NCT00737048|1031897|P1|Overall Study|Adverse Event|0
314808|NCT00737048|1031895|P3|Overall Study|Physician Decision|1
314809|NCT00737048|1031896|P2|Overall Study|Physician Decision|0
314810|NCT00737048|1031897|P1|Overall Study|Physician Decision|0
314811|NCT00736996|1031941|P3|Overall Study|Lost to Follow-up|2
314812|NCT00736996|1031942|P2|Overall Study|Lost to Follow-up|9
314813|NCT00736996|1031943|P1|Overall Study|Lost to Follow-up|1
314814|NCT00736957|1031957|P1|Overall Study|Physician Decision|5
314815|NCT00736957|1031957|P1|Overall Study|not eligible for Treatment Period I|22
314816|NCT00736957|1031957|P1|Overall Study|did not attend hospital appointments|1
314817|NCT00736957|1031957|P1|Overall Study|violation of eligibility criteria|2
314818|NCT00736957|1031957|P1|Overall Study|Withdrawal by Subject|49
314819|NCT00736957|1031957|P1|Overall Study|Adverse Event|43
314820|NCT00736944|1031967|P1|Definitive Treatment|Physician Decision|1
314821|NCT00736944|1031967|P1|Induction|Death|1
314822|NCT00736879|1031998|P4|Follow up Period - No Drug Treatment|non-specified|0
314823|NCT00736879|1031999|P3|Follow up Period - No Drug Treatment|non-specified|0
314824|NCT00736879|1032000|P2|Follow up Period - No Drug Treatment|non-specified|2
314825|NCT00736879|1032001|P1|Follow up Period - No Drug Treatment|non-specified|1
314826|NCT00736879|1031998|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
314827|NCT00736879|1031999|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
314828|NCT00736879|1032000|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
314829|NCT00736879|1032001|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
314830|NCT00736879|1031998|P4|Double Blind Treatment Period|non-specified|0
314831|NCT00736879|1031999|P3|Double Blind Treatment Period|non-specified|0
314832|NCT00736879|1032000|P2|Double Blind Treatment Period|non-specified|1
314833|NCT00736879|1032001|P1|Double Blind Treatment Period|non-specified|0
314834|NCT00736879|1031998|P4|Double Blind Treatment Period|No longer met criteria|0
314835|NCT00736879|1031999|P3|Double Blind Treatment Period|No longer met criteria|0
314836|NCT00736879|1032000|P2|Double Blind Treatment Period|No longer met criteria|1
314837|NCT00736879|1032001|P1|Double Blind Treatment Period|No longer met criteria|0
314838|NCT00736879|1031998|P4|Double Blind Treatment Period|Poor non-compliance|1
314839|NCT00736879|1031999|P3|Double Blind Treatment Period|Poor non-compliance|1
314840|NCT00736879|1032000|P2|Double Blind Treatment Period|Poor non-compliance|0
314841|NCT00736879|1032001|P1|Double Blind Treatment Period|Poor non-compliance|0
314842|NCT00736879|1031998|P4|Double Blind Treatment Period|Lost to Follow-up|1
314843|NCT00736879|1031999|P3|Double Blind Treatment Period|Lost to Follow-up|2
314844|NCT00736879|1032000|P2|Double Blind Treatment Period|Lost to Follow-up|0
314845|NCT00736879|1032001|P1|Double Blind Treatment Period|Lost to Follow-up|0
314846|NCT00736879|1031998|P4|Double Blind Treatment Period|Withdrawal by Subject|3
314847|NCT00736879|1031999|P3|Double Blind Treatment Period|Withdrawal by Subject|3
314848|NCT00736879|1032000|P2|Double Blind Treatment Period|Withdrawal by Subject|1
314849|NCT00736879|1032001|P1|Double Blind Treatment Period|Withdrawal by Subject|2
314850|NCT00736879|1031998|P4|Double Blind Treatment Period|Adverse Event|0
314851|NCT00736879|1031999|P3|Double Blind Treatment Period|Adverse Event|1
314852|NCT00736879|1032000|P2|Double Blind Treatment Period|Adverse Event|1
314853|NCT00736879|1032001|P1|Double Blind Treatment Period|Adverse Event|0
314854|NCT00736879|1031998|P4|Double Blind Treatment Period|Lack of Efficacy|0
314855|NCT00736879|1031999|P3|Double Blind Treatment Period|Lack of Efficacy|0
314856|NCT00736879|1032000|P2|Double Blind Treatment Period|Lack of Efficacy|0
314857|NCT00736879|1032001|P1|Double Blind Treatment Period|Lack of Efficacy|1
314858|NCT00736853|1032055|P3|Double-Blind Period|Ineligible to participate the study|0
314859|NCT00736853|1032056|P2|Double-Blind Period|Ineligible to participate the study|1
314860|NCT00736853|1032057|P1|Double-Blind Period|Ineligible to participate the study|0
314861|NCT00736853|1032055|P3|Double-Blind Period|Withdrawal by Subject|4
314862|NCT00736853|1032056|P2|Double-Blind Period|Withdrawal by Subject|1
314863|NCT00736853|1032057|P1|Double-Blind Period|Withdrawal by Subject|0
314864|NCT00736853|1032055|P3|Double-Blind Period|Adverse Event|2
314865|NCT00736853|1032056|P2|Double-Blind Period|Adverse Event|3
314866|NCT00736853|1032057|P1|Double-Blind Period|Adverse Event|0
314867|NCT00736853|1032055|P3|Double-Blind Period|Lack of Efficacy|42
314868|NCT00736853|1032056|P2|Double-Blind Period|Lack of Efficacy|19
314869|NCT00736853|1032057|P1|Double-Blind Period|Lack of Efficacy|0
314870|NCT00736853|1032055|P3|Open-Label Period|Unable to attend hospital appointments|0
314871|NCT00736853|1032056|P2|Open-Label Period|Unable to attend hospital appointments|0
314872|NCT00736853|1032057|P1|Open-Label Period|Unable to attend hospital appointments|1
314873|NCT00736853|1032055|P3|Open-Label Period|Failed to meet the transfer criteria|0
314874|NCT00736853|1032056|P2|Open-Label Period|Failed to meet the transfer criteria|0
314875|NCT00736853|1032057|P1|Open-Label Period|Failed to meet the transfer criteria|40
314876|NCT00736853|1032055|P3|Open-Label Period|Started but not treated|0
314877|NCT00736853|1032056|P2|Open-Label Period|Started but not treated|0
314878|NCT00736853|1032057|P1|Open-Label Period|Started but not treated|42
314879|NCT00736853|1032055|P3|Open-Label Period|Withdrawal by Subject|0
314880|NCT00736853|1032056|P2|Open-Label Period|Withdrawal by Subject|0
314881|NCT00736853|1032057|P1|Open-Label Period|Withdrawal by Subject|16
314882|NCT00736853|1032055|P3|Open-Label Period|Adverse Event|0
314883|NCT00736853|1032056|P2|Open-Label Period|Adverse Event|0
314884|NCT00736853|1032057|P1|Open-Label Period|Adverse Event|31
314885|NCT00736853|1032055|P3|Open-Label Period|Physician Decision|0
314886|NCT00736853|1032056|P2|Open-Label Period|Physician Decision|0
314887|NCT00736853|1032057|P1|Open-Label Period|Physician Decision|2
314888|NCT00736840|1032097|P1|Overall Study|Lost to Follow-up|13
314889|NCT00736723|1032104|P2|Overall Study|Withdrawal by Subject|3
314890|NCT00736723|1032105|P1|Overall Study|Withdrawal by Subject|4
314891|NCT00736502|1032120|P1|Overall Study|Lost to Follow-up|27
314892|NCT00736502|1032120|P1|Overall Study|Lack of Efficacy|16
314893|NCT00736502|1032120|P1|Overall Study|Adverse Event|22
314894|NCT00736489|1032126|P6|Period 1|Withdrawal by Subject|1
314895|NCT00736489|1032127|P5|Period 1|Withdrawal by Subject|0
314896|NCT00736489|1032128|P4|Period 1|Withdrawal by Subject|0
314897|NCT00736489|1032129|P3|Period 1|Withdrawal by Subject|0
314898|NCT00736489|1032130|P2|Period 1|Withdrawal by Subject|0
314899|NCT00736489|1032131|P1|Period 1|Withdrawal by Subject|0
314900|NCT00736489|1032126|P6|Period 1|Lost to Follow-up|0
314901|NCT00736489|1032127|P5|Period 1|Lost to Follow-up|0
314902|NCT00736489|1032128|P4|Period 1|Lost to Follow-up|0
314903|NCT00736489|1032129|P3|Period 1|Lost to Follow-up|0
314904|NCT00736489|1032130|P2|Period 1|Lost to Follow-up|0
314905|NCT00736489|1032131|P1|Period 1|Lost to Follow-up|1
314906|NCT00736476|1032285|P2|Overall Study|Adverse Event|0
314907|NCT00736476|1032286|P1|Overall Study|Adverse Event|1
314908|NCT00736385|1032308|P2|Overall Study|Adverse Event|1
314909|NCT00736385|1032309|P1|Overall Study|Adverse Event|0
314910|NCT00736385|1032308|P2|Overall Study|Withdrawal by Subject|2
314911|NCT00736385|1032309|P1|Overall Study|Withdrawal by Subject|2
314912|NCT00736333|1032321|P1|Overall Study|Not Specified|4
314913|NCT00736333|1032321|P1|Overall Study|Death|7
314914|NCT00736333|1032321|P1|Overall Study|Withdrawal by Subject|10
314915|NCT00736333|1032321|P1|Overall Study|Toxicity|6
314916|NCT00736333|1032321|P1|Overall Study|Tumor Progression|75
314917|NCT00736333|1032321|P1|Overall Study|Data Missing|2
314918|NCT00736333|1032321|P1|Overall Study|Did Not Receive Drug or Not Documented|7
314919|NCT00736255|1032332|P2|Overall Study|Non-compliance|1
314920|NCT00736255|1032333|P1|Overall Study|Non-compliance|1
314921|NCT00736255|1032332|P2|Overall Study|Physician Decision|0
314922|NCT00736255|1032333|P1|Overall Study|Physician Decision|1
314923|NCT00736255|1032332|P2|Overall Study|Adverse Event|0
314924|NCT00736255|1032333|P1|Overall Study|Adverse Event|1
314925|NCT00736190|1032372|P1|Overall Study|Adverse Event|1
314926|NCT00736190|1032372|P1|Overall Study|Withdrawal by Subject|1
314927|NCT00736190|1032372|P1|Overall Study|Pregnancy|1
314928|NCT00736099|1032398|P2|Overall Study|Other reason|10
314929|NCT00736099|1032399|P1|Overall Study|Other reason|43
314930|NCT00736099|1032398|P2|Overall Study|Lack of Efficacy|8
314931|NCT00736099|1032399|P1|Overall Study|Lack of Efficacy|15
314932|NCT00736099|1032398|P2|Overall Study|Withdrawal by Subject|13
314933|NCT00736099|1032399|P1|Overall Study|Withdrawal by Subject|42
314934|NCT00736099|1032398|P2|Overall Study|Lost to Follow-up|5
314935|NCT00736099|1032399|P1|Overall Study|Lost to Follow-up|12
314936|NCT00736099|1032398|P2|Overall Study|Protocol Violation|4
314937|NCT00736099|1032399|P1|Overall Study|Protocol Violation|10
314938|NCT00736099|1032398|P2|Overall Study|Adverse Event|18
314939|NCT00736099|1032399|P1|Overall Study|Adverse Event|61
314940|NCT00736034|1032508|P1|Overall Study|Adverse Event|2
314941|NCT00735943|1032516|P1|Overall Study|Adverse Event|1
314942|NCT00735943|1032516|P1|Overall Study|Lost to Follow-up|1
314943|NCT00735904|1032541|P1|Overall Study|Unspecified|8
314944|NCT00735904|1032541|P1|Overall Study|Study Terminated by Sponsor|5
314945|NCT00735904|1032541|P1|Overall Study|Withdrawal by Subject|1
314946|NCT00735904|1032541|P1|Overall Study|Protocol Violation|1
314947|NCT00735904|1032541|P1|Overall Study|Death|20
314948|NCT00735904|1032541|P1|Overall Study|Adverse Event|3
314949|NCT00735709|1032610|P4|Overall Study|Excluded medication|1
314950|NCT00735709|1032611|P3|Overall Study|Excluded medication|0
314951|NCT00735709|1032612|P2|Overall Study|Excluded medication|0
314952|NCT00735709|1032613|P1|Overall Study|Excluded medication|1
314953|NCT00735709|1032610|P4|Overall Study|Lost to Follow-up|1
314954|NCT00735709|1032611|P3|Overall Study|Lost to Follow-up|1
314955|NCT00735709|1032612|P2|Overall Study|Lost to Follow-up|1
314956|NCT00735709|1032613|P1|Overall Study|Lost to Follow-up|0
314957|NCT00735709|1032610|P4|Overall Study|Voluntary Withdrawal|7
314958|NCT00735709|1032611|P3|Overall Study|Voluntary Withdrawal|5
314959|NCT00735709|1032612|P2|Overall Study|Voluntary Withdrawal|3
314960|NCT00735709|1032613|P1|Overall Study|Voluntary Withdrawal|1
314961|NCT00735709|1032610|P4|Overall Study|Protocol deviations|1
314962|NCT00735709|1032611|P3|Overall Study|Protocol deviations|1
314963|NCT00735709|1032612|P2|Overall Study|Protocol deviations|2
314964|NCT00735709|1032613|P1|Overall Study|Protocol deviations|1
314965|NCT00735709|1032610|P4|Overall Study|Noncompliance|0
314966|NCT00735709|1032611|P3|Overall Study|Noncompliance|1
314967|NCT00735709|1032612|P2|Overall Study|Noncompliance|0
314968|NCT00735709|1032613|P1|Overall Study|Noncompliance|0
314969|NCT00735709|1032610|P4|Overall Study|Lack of Efficacy|3
314970|NCT00735709|1032611|P3|Overall Study|Lack of Efficacy|2
314971|NCT00735709|1032612|P2|Overall Study|Lack of Efficacy|4
314972|NCT00735709|1032613|P1|Overall Study|Lack of Efficacy|8
314973|NCT00735709|1032610|P4|Overall Study|Adverse Event|5
314974|NCT00735709|1032611|P3|Overall Study|Adverse Event|1
314975|NCT00735709|1032612|P2|Overall Study|Adverse Event|3
314976|NCT00735709|1032613|P1|Overall Study|Adverse Event|2
314977|NCT00735696|1032723|P1|Overall Study|Enrolled but never Treated|1
314978|NCT00735696|1032723|P1|Overall Study|Withdrawal by Subject|1
314979|NCT00735644|1032751|P5|Overall Study|Withdrawal by Subject|0
314980|NCT00735644|1032752|P4|Overall Study|Withdrawal by Subject|1
314981|NCT00735644|1032753|P3|Overall Study|Withdrawal by Subject|1
314982|NCT00735644|1032754|P2|Overall Study|Withdrawal by Subject|1
314983|NCT00735644|1032755|P1|Overall Study|Withdrawal by Subject|0
314984|NCT00735644|1032751|P5|Overall Study|Did not receive study vaccine|0
314985|NCT00735644|1032752|P4|Overall Study|Did not receive study vaccine|0
314986|NCT00735644|1032753|P3|Overall Study|Did not receive study vaccine|0
314987|NCT00735644|1032754|P2|Overall Study|Did not receive study vaccine|1
314988|NCT00735644|1032755|P1|Overall Study|Did not receive study vaccine|0
314989|NCT00735553|1032799|P1|Overall Study|Study prematurely terminated|77
314990|NCT00735475|1032809|P2|Overall Study|Withdrawal by Subject|5
314991|NCT00735475|1032810|P1|Overall Study|Withdrawal by Subject|4
314992|NCT00735475|1032809|P2|Overall Study|Physician Decision|1
314993|NCT00735475|1032810|P1|Overall Study|Physician Decision|0
314994|NCT00735475|1032809|P2|Overall Study|Lost to Follow-up|3
314995|NCT00735475|1032810|P1|Overall Study|Lost to Follow-up|3
314996|NCT00735475|1032809|P2|Overall Study|Death|1
314997|NCT00735475|1032810|P1|Overall Study|Death|1
314998|NCT00735475|1032809|P2|Overall Study|Adverse Event|1
314999|NCT00735475|1032810|P1|Overall Study|Adverse Event|0
315000|NCT00735397|1032870|P1|Overall Study|Administrative/Other|502
315001|NCT00735397|1032870|P1|Overall Study|Inadequate therapeutic effect|202
315002|NCT00735397|1032870|P1|Overall Study|Participant choice|252
315003|NCT00735397|1032870|P1|Overall Study|Lost to Follow-up|33
315004|NCT00735397|1032870|P1|Overall Study|Adverse Event|194
315005|NCT00735371|1032884|P4|Overall Study|Exclusion criteria|0
315006|NCT00735371|1032885|P3|Overall Study|Exclusion criteria|0
315007|NCT00735371|1032886|P2|Overall Study|Exclusion criteria|0
315008|NCT00735371|1032887|P1|Overall Study|Exclusion criteria|1
315009|NCT00735371|1032884|P4|Overall Study|Prior Vyvanse Exposure|0
315010|NCT00735371|1032885|P3|Overall Study|Prior Vyvanse Exposure|0
315011|NCT00735371|1032886|P2|Overall Study|Prior Vyvanse Exposure|1
315012|NCT00735371|1032887|P1|Overall Study|Prior Vyvanse Exposure|1
315013|NCT00735371|1032884|P4|Overall Study|Protocol Violation|0
315014|NCT00735371|1032885|P3|Overall Study|Protocol Violation|2
315015|NCT00735371|1032886|P2|Overall Study|Protocol Violation|1
315016|NCT00735371|1032887|P1|Overall Study|Protocol Violation|0
315017|NCT00735371|1032884|P4|Overall Study|Sponsor Decision|1
315018|NCT00735371|1032885|P3|Overall Study|Sponsor Decision|0
315019|NCT00735371|1032886|P2|Overall Study|Sponsor Decision|1
315020|NCT00735371|1032887|P1|Overall Study|Sponsor Decision|3
315021|NCT00735371|1032884|P4|Overall Study|Lack of Efficacy|4
315022|NCT00735371|1032885|P3|Overall Study|Lack of Efficacy|0
315023|NCT00735371|1032886|P2|Overall Study|Lack of Efficacy|2
315024|NCT00735371|1032887|P1|Overall Study|Lack of Efficacy|4
315025|NCT00735371|1032884|P4|Overall Study|Lost to Follow-up|1
315026|NCT00735371|1032885|P3|Overall Study|Lost to Follow-up|3
315027|NCT00735371|1032886|P2|Overall Study|Lost to Follow-up|1
315028|NCT00735371|1032887|P1|Overall Study|Lost to Follow-up|1
315029|NCT00735371|1032884|P4|Overall Study|Withdrawal by Subject|0
315030|NCT00735371|1032885|P3|Overall Study|Withdrawal by Subject|2
315031|NCT00735371|1032886|P2|Overall Study|Withdrawal by Subject|2
315032|NCT00735371|1032887|P1|Overall Study|Withdrawal by Subject|0
315033|NCT00735371|1032884|P4|Overall Study|Protocol Violation|3
315034|NCT00735371|1032885|P3|Overall Study|Protocol Violation|0
315035|NCT00735371|1032886|P2|Overall Study|Protocol Violation|2
315036|NCT00735371|1032887|P1|Overall Study|Protocol Violation|2
315037|NCT00735371|1032884|P4|Overall Study|Adverse Event|1
315038|NCT00735371|1032885|P3|Overall Study|Adverse Event|4
315039|NCT00735371|1032886|P2|Overall Study|Adverse Event|3
315040|NCT00735371|1032887|P1|Overall Study|Adverse Event|3
315041|NCT00735072|1032913|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
315042|NCT00735072|1032914|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
315043|NCT00735072|1032913|P2|Overall Study|interrupted study med during ARV change|0
315044|NCT00735072|1032914|P1|Overall Study|interrupted study med during ARV change|1
315045|NCT00735007|1032920|P1|Overall Study|Protocol Violation|1
315046|NCT00735007|1032920|P1|Overall Study|Adverse Event|4
315047|NCT00734994|1032945|P1|Overall Study|Withdrawal by Subject|1
315048|NCT00734929|1032965|P2|Overall Study|No intervention/ screen fail|3
315049|NCT00734929|1032966|P1|Overall Study|No intervention/ screen fail|5
315050|NCT00734929|1032965|P2|Overall Study|Lost to Follow-up|2
315051|NCT00734929|1032966|P1|Overall Study|Lost to Follow-up|1
315052|NCT00734851|1032994|P1|Overall Study|Physician Decision|18
315053|NCT00734851|1032994|P1|Overall Study|Lost to Follow-up|1
315054|NCT00734851|1032994|P1|Overall Study|Withdrawal by Subject|2
315055|NCT00734747|1033015|P1|6 Month Follow-up|Did not meet inclusion criteria|3
315056|NCT00734747|1033015|P1|SRS Procedure|No staples placed|3
315057|NCT00734656|1033029|P4|Lab Session 4|Withdrawal by Subject|1
315058|NCT00734656|1033030|P3|Lab Session 4|Withdrawal by Subject|0
315059|NCT00734656|1033031|P2|Lab Session 4|Withdrawal by Subject|0
315060|NCT00734656|1033032|P1|Lab Session 4|Withdrawal by Subject|0
315061|NCT00734656|1033029|P4|Washout 3|Withdrawal by Subject|1
315062|NCT00734656|1033030|P3|Washout 3|Withdrawal by Subject|0
315063|NCT00734656|1033031|P2|Washout 3|Withdrawal by Subject|0
315064|NCT00734656|1033032|P1|Washout 3|Withdrawal by Subject|1
315065|NCT00734656|1033029|P4|Washout 2|Withdrawal by Subject|0
315066|NCT00734656|1033030|P3|Washout 2|Withdrawal by Subject|1
315067|NCT00734656|1033031|P2|Washout 2|Withdrawal by Subject|1
315068|NCT00734656|1033032|P1|Washout 2|Withdrawal by Subject|1
315069|NCT00734656|1033029|P4|Lab Session 2|Withdrawal by Subject|1
315070|NCT00734656|1033030|P3|Lab Session 2|Withdrawal by Subject|0
315071|NCT00734656|1033031|P2|Lab Session 2|Withdrawal by Subject|0
315072|NCT00734656|1033032|P1|Lab Session 2|Withdrawal by Subject|1
315073|NCT00734656|1033029|P4|Washout 1|Withdrawal by Subject|3
315074|NCT00734656|1033030|P3|Washout 1|Withdrawal by Subject|2
315075|NCT00734656|1033031|P2|Washout 1|Withdrawal by Subject|5
315076|NCT00734656|1033032|P1|Washout 1|Withdrawal by Subject|1
315077|NCT00734656|1033029|P4|Lab Session 1|Withdrawal by Subject|0
315078|NCT00734656|1033030|P3|Lab Session 1|Withdrawal by Subject|0
315079|NCT00734656|1033031|P2|Lab Session 1|Withdrawal by Subject|0
315080|NCT00734656|1033032|P1|Lab Session 1|Withdrawal by Subject|2
315081|NCT00734630|1033056|P2|Overall Study|Poor Compliance|1
315082|NCT00734630|1033057|P1|Overall Study|Poor Compliance|1
315083|NCT00734630|1033056|P2|Overall Study|Tested Positive for Illegal Drug Use|1
315084|NCT00734630|1033057|P1|Overall Study|Tested Positive for Illegal Drug Use|1
315085|NCT00734630|1033056|P2|Overall Study|Randomized in Error|1
315086|NCT00734630|1033057|P1|Overall Study|Randomized in Error|0
315087|NCT00734630|1033056|P2|Overall Study|Adverse Event|6
315088|NCT00734630|1033057|P1|Overall Study|Adverse Event|3
315089|NCT00734630|1033056|P2|Overall Study|Inclusion/Exclusion criteria not met|1
315090|NCT00734630|1033057|P1|Overall Study|Inclusion/Exclusion criteria not met|0
315091|NCT00734630|1033056|P2|Overall Study|Protocol Violation|3
315092|NCT00734630|1033057|P1|Overall Study|Protocol Violation|0
315093|NCT00734630|1033056|P2|Overall Study|Lost to Follow-up|7
315094|NCT00734630|1033057|P1|Overall Study|Lost to Follow-up|13
315095|NCT00734630|1033056|P2|Overall Study|Withdrawal by Subject|9
315096|NCT00734630|1033057|P1|Overall Study|Withdrawal by Subject|7
315097|NCT00734630|1033056|P2|Overall Study|Lack of Efficacy|4
315098|NCT00734630|1033057|P1|Overall Study|Lack of Efficacy|4
315099|NCT00734617|1033067|P2|Overall Study|Withdrawal by Subject|95
315100|NCT00734617|1033068|P1|Overall Study|Withdrawal by Subject|103
315101|NCT00734617|1033067|P2|Overall Study|Adverse Event|7
315102|NCT00734617|1033068|P1|Overall Study|Adverse Event|4
315103|NCT00734604|1033080|P6|Overall Study|Lack of Efficacy|0
315104|NCT00734604|1033081|P5|Overall Study|Lack of Efficacy|0
315105|NCT00734604|1033082|P4|Overall Study|Lack of Efficacy|0
315106|NCT00734604|1033083|P3|Overall Study|Lack of Efficacy|1
315107|NCT00734604|1033084|P2|Overall Study|Lack of Efficacy|1
315108|NCT00734604|1033085|P1|Overall Study|Lack of Efficacy|0
315109|NCT00734604|1033080|P6|Overall Study|Withdrawal by Subject|1
315110|NCT00734604|1033081|P5|Overall Study|Withdrawal by Subject|2
315111|NCT00734604|1033082|P4|Overall Study|Withdrawal by Subject|1
315112|NCT00734604|1033083|P3|Overall Study|Withdrawal by Subject|0
315113|NCT00734604|1033084|P2|Overall Study|Withdrawal by Subject|2
315114|NCT00734604|1033085|P1|Overall Study|Withdrawal by Subject|0
315115|NCT00734604|1033080|P6|Overall Study|Sponsor Decision|0
315116|NCT00734604|1033081|P5|Overall Study|Sponsor Decision|2
315117|NCT00734604|1033082|P4|Overall Study|Sponsor Decision|0
315118|NCT00734604|1033083|P3|Overall Study|Sponsor Decision|1
315119|NCT00734604|1033084|P2|Overall Study|Sponsor Decision|2
315120|NCT00734604|1033085|P1|Overall Study|Sponsor Decision|1
315121|NCT00734604|1033080|P6|Overall Study|Protocol Violation|0
315122|NCT00734604|1033081|P5|Overall Study|Protocol Violation|1
315123|NCT00734604|1033082|P4|Overall Study|Protocol Violation|0
315124|NCT00734604|1033083|P3|Overall Study|Protocol Violation|0
315125|NCT00734604|1033084|P2|Overall Study|Protocol Violation|2
315126|NCT00734604|1033085|P1|Overall Study|Protocol Violation|0
315127|NCT00734604|1033080|P6|Overall Study|Physician Decision|0
315128|NCT00734604|1033081|P5|Overall Study|Physician Decision|0
315129|NCT00734604|1033082|P4|Overall Study|Physician Decision|0
315130|NCT00734604|1033083|P3|Overall Study|Physician Decision|1
315131|NCT00734604|1033084|P2|Overall Study|Physician Decision|1
315132|NCT00734604|1033085|P1|Overall Study|Physician Decision|0
315133|NCT00734604|1033080|P6|Overall Study|Lost to Follow-up|3
315134|NCT00734604|1033081|P5|Overall Study|Lost to Follow-up|2
315135|NCT00734604|1033082|P4|Overall Study|Lost to Follow-up|4
315136|NCT00734604|1033083|P3|Overall Study|Lost to Follow-up|2
315137|NCT00734604|1033084|P2|Overall Study|Lost to Follow-up|2
315138|NCT00734604|1033085|P1|Overall Study|Lost to Follow-up|1
315139|NCT00734604|1033080|P6|Overall Study|Serious Adverse Event|1
315140|NCT00734604|1033081|P5|Overall Study|Serious Adverse Event|0
315141|NCT00734604|1033082|P4|Overall Study|Serious Adverse Event|2
315142|NCT00734604|1033083|P3|Overall Study|Serious Adverse Event|1
315143|NCT00734604|1033084|P2|Overall Study|Serious Adverse Event|0
315144|NCT00734604|1033085|P1|Overall Study|Serious Adverse Event|1
315145|NCT00734604|1033080|P6|Overall Study|Adverse Event|1
315146|NCT00734604|1033081|P5|Overall Study|Adverse Event|1
315147|NCT00734604|1033082|P4|Overall Study|Adverse Event|2
315148|NCT00734604|1033083|P3|Overall Study|Adverse Event|0
315149|NCT00734604|1033084|P2|Overall Study|Adverse Event|2
315150|NCT00734604|1033085|P1|Overall Study|Adverse Event|0
315151|NCT00734591|1033135|P2|Prospective Period|Unspecified|2
315152|NCT00734591|1033136|P1|Prospective Period|Unspecified|2
315153|NCT00734591|1033135|P2|Prospective Period|Study Terminated|0
315154|NCT00734591|1033136|P1|Prospective Period|Study Terminated|1
315155|NCT00734591|1033135|P2|Prospective Period|Lost to Follow-up|33
315156|NCT00734591|1033136|P1|Prospective Period|Lost to Follow-up|37
315157|NCT00734591|1033135|P2|Prospective Period|Withdrawal by Subject|9
315158|NCT00734591|1033136|P1|Prospective Period|Withdrawal by Subject|11
315159|NCT00734591|1033135|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
315160|NCT00734591|1033136|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
315161|NCT00734591|1033135|P2|Screening for Prospective Period|Site did not participate|1488
315162|NCT00734591|1033136|P1|Screening for Prospective Period|Site did not participate|1604
315163|NCT00734578|1033151|P3|Overall Study|Exclusion criteria|0
315164|NCT00734578|1033152|P2|Overall Study|Exclusion criteria|0
315165|NCT00734578|1033153|P1|Overall Study|Exclusion criteria|1
315166|NCT00734578|1033151|P3|Overall Study|Randomized in error|0
315167|NCT00734578|1033152|P2|Overall Study|Randomized in error|0
315168|NCT00734578|1033153|P1|Overall Study|Randomized in error|1
315169|NCT00734578|1033151|P3|Overall Study|Lack of Efficacy|5
315170|NCT00734578|1033152|P2|Overall Study|Lack of Efficacy|2
315171|NCT00734578|1033153|P1|Overall Study|Lack of Efficacy|3
315172|NCT00734578|1033151|P3|Overall Study|Lost to Follow-up|5
315173|NCT00734578|1033152|P2|Overall Study|Lost to Follow-up|3
315174|NCT00734578|1033153|P1|Overall Study|Lost to Follow-up|9
315175|NCT00734578|1033151|P3|Overall Study|Withdrawal by Subject|11
315176|NCT00734578|1033152|P2|Overall Study|Withdrawal by Subject|8
315177|NCT00734578|1033153|P1|Overall Study|Withdrawal by Subject|7
315178|NCT00734578|1033151|P3|Overall Study|Protocol Violation|3
315179|NCT00734578|1033152|P2|Overall Study|Protocol Violation|6
315180|NCT00734578|1033153|P1|Overall Study|Protocol Violation|8
315181|NCT00734578|1033151|P3|Overall Study|Adverse Event|1
315182|NCT00734578|1033152|P2|Overall Study|Adverse Event|6
315183|NCT00734578|1033153|P1|Overall Study|Adverse Event|4
315184|NCT00734539|1033187|P2|Main Study|Enrolled in error; ineligible|0
315185|NCT00734539|1033188|P1|Main Study|Enrolled in error; ineligible|1
315186|NCT00734539|1033187|P2|Main Study|Withdrawal by Subject|3
315187|NCT00734539|1033188|P1|Main Study|Withdrawal by Subject|1
315188|NCT00734539|1033187|P2|Main Study|Physician Decision|0
315189|NCT00734539|1033188|P1|Main Study|Physician Decision|2
315190|NCT00734539|1033187|P2|Main Study|Death|32
315191|NCT00734539|1033188|P1|Main Study|Death|33
315192|NCT00734474|1033230|P9|Overall Study|Lack of Efficacy|6
315193|NCT00734474|1033231|P8|Overall Study|Lack of Efficacy|4
315194|NCT00734474|1033232|P7|Overall Study|Lack of Efficacy|0
315195|NCT00734474|1033233|P6|Overall Study|Lack of Efficacy|0
315196|NCT00734474|1033234|P5|Overall Study|Lack of Efficacy|0
315197|NCT00734474|1033235|P4|Overall Study|Lack of Efficacy|0
315198|NCT00734474|1033236|P3|Overall Study|Lack of Efficacy|4
315199|NCT00734474|1033237|P2|Overall Study|Lack of Efficacy|0
315200|NCT00734474|1033238|P1|Overall Study|Lack of Efficacy|0
315201|NCT00734474|1033230|P9|Overall Study|Death|1
315202|NCT00734474|1033231|P8|Overall Study|Death|2
315203|NCT00734474|1033232|P7|Overall Study|Death|0
315204|NCT00734474|1033233|P6|Overall Study|Death|0
315205|NCT00734474|1033234|P5|Overall Study|Death|0
315206|NCT00734474|1033235|P4|Overall Study|Death|0
315207|NCT00734474|1033236|P3|Overall Study|Death|1
315208|NCT00734474|1033237|P2|Overall Study|Death|0
315209|NCT00734474|1033238|P1|Overall Study|Death|0
315210|NCT00734474|1033230|P9|Overall Study|Sponsor Decision|0
315211|NCT00734474|1033231|P8|Overall Study|Sponsor Decision|0
315212|NCT00734474|1033232|P7|Overall Study|Sponsor Decision|0
315213|NCT00734474|1033233|P6|Overall Study|Sponsor Decision|0
315214|NCT00734474|1033234|P5|Overall Study|Sponsor Decision|2
315215|NCT00734474|1033235|P4|Overall Study|Sponsor Decision|0
315216|NCT00734474|1033236|P3|Overall Study|Sponsor Decision|0
315217|NCT00734474|1033237|P2|Overall Study|Sponsor Decision|0
315218|NCT00734474|1033238|P1|Overall Study|Sponsor Decision|0
315219|NCT00734474|1033230|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
315220|NCT00734474|1033231|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
315221|NCT00734474|1033232|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
315222|NCT00734474|1033233|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
315223|NCT00734474|1033234|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
315224|NCT00734474|1033235|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
315225|NCT00734474|1033236|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
315226|NCT00734474|1033237|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
315227|NCT00734474|1033238|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
315228|NCT00734474|1033230|P9|Overall Study|Protocol Violation|1
315229|NCT00734474|1033231|P8|Overall Study|Protocol Violation|3
315230|NCT00734474|1033232|P7|Overall Study|Protocol Violation|0
315231|NCT00734474|1033233|P6|Overall Study|Protocol Violation|0
315232|NCT00734474|1033234|P5|Overall Study|Protocol Violation|3
315233|NCT00734474|1033235|P4|Overall Study|Protocol Violation|0
315234|NCT00734474|1033236|P3|Overall Study|Protocol Violation|4
315235|NCT00734474|1033237|P2|Overall Study|Protocol Violation|0
315236|NCT00734474|1033238|P1|Overall Study|Protocol Violation|0
315237|NCT00734474|1033230|P9|Overall Study|Adverse Event|39
315238|NCT00734474|1033231|P8|Overall Study|Adverse Event|65
315239|NCT00734474|1033232|P7|Overall Study|Adverse Event|1
315240|NCT00734474|1033233|P6|Overall Study|Adverse Event|0
315241|NCT00734474|1033234|P5|Overall Study|Adverse Event|64
315242|NCT00734474|1033235|P4|Overall Study|Adverse Event|1
315243|NCT00734474|1033236|P3|Overall Study|Adverse Event|63
315244|NCT00734474|1033237|P2|Overall Study|Adverse Event|4
315245|NCT00734474|1033238|P1|Overall Study|Adverse Event|4
315246|NCT00734474|1033230|P9|Overall Study|Physician Decision|9
315247|NCT00734474|1033231|P8|Overall Study|Physician Decision|9
315248|NCT00734474|1033232|P7|Overall Study|Physician Decision|0
315249|NCT00734474|1033233|P6|Overall Study|Physician Decision|0
315250|NCT00734474|1033234|P5|Overall Study|Physician Decision|11
315251|NCT00734474|1033235|P4|Overall Study|Physician Decision|1
315252|NCT00734474|1033236|P3|Overall Study|Physician Decision|4
315253|NCT00734474|1033237|P2|Overall Study|Physician Decision|0
315254|NCT00734474|1033238|P1|Overall Study|Physician Decision|0
315255|NCT00734474|1033230|P9|Overall Study|Withdrawal by Subject|21
315256|NCT00734474|1033231|P8|Overall Study|Withdrawal by Subject|36
315257|NCT00734474|1033232|P7|Overall Study|Withdrawal by Subject|0
315258|NCT00734474|1033233|P6|Overall Study|Withdrawal by Subject|2
315259|NCT00734474|1033234|P5|Overall Study|Withdrawal by Subject|24
315260|NCT00734474|1033235|P4|Overall Study|Withdrawal by Subject|0
315261|NCT00734474|1033236|P3|Overall Study|Withdrawal by Subject|18
315262|NCT00734474|1033237|P2|Overall Study|Withdrawal by Subject|1
315263|NCT00734474|1033238|P1|Overall Study|Withdrawal by Subject|2
315264|NCT00734474|1033230|P9|Overall Study|Lost to Follow-up|4
315265|NCT00734474|1033231|P8|Overall Study|Lost to Follow-up|9
315266|NCT00734474|1033232|P7|Overall Study|Lost to Follow-up|0
315267|NCT00734474|1033233|P6|Overall Study|Lost to Follow-up|1
315268|NCT00734474|1033234|P5|Overall Study|Lost to Follow-up|11
315269|NCT00734474|1033235|P4|Overall Study|Lost to Follow-up|0
315270|NCT00734474|1033236|P3|Overall Study|Lost to Follow-up|13
315271|NCT00734474|1033237|P2|Overall Study|Lost to Follow-up|0
315272|NCT00734474|1033238|P1|Overall Study|Lost to Follow-up|1
315273|NCT00734474|1033230|P9|Overall Study|Entry Criteria Not Met|1
315274|NCT00734474|1033231|P8|Overall Study|Entry Criteria Not Met|1
315275|NCT00734474|1033232|P7|Overall Study|Entry Criteria Not Met|0
315276|NCT00734474|1033233|P6|Overall Study|Entry Criteria Not Met|1
315277|NCT00734474|1033234|P5|Overall Study|Entry Criteria Not Met|3
315278|NCT00734474|1033235|P4|Overall Study|Entry Criteria Not Met|0
315279|NCT00734474|1033236|P3|Overall Study|Entry Criteria Not Met|5
315280|NCT00734474|1033237|P2|Overall Study|Entry Criteria Not Met|0
315281|NCT00734474|1033238|P1|Overall Study|Entry Criteria Not Met|0
315282|NCT00734214|1033528|P2|Overall Study|MD withdrawal|0
315283|NCT00734214|1033529|P1|Overall Study|MD withdrawal|1
315284|NCT00734214|1033528|P2|Overall Study|Withdrawal by Subject|4
315285|NCT00734214|1033529|P1|Overall Study|Withdrawal by Subject|3
315286|NCT00734162|1033539|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
315287|NCT00734162|1033540|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
315288|NCT00734162|1033541|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
315289|NCT00734162|1033542|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
315290|NCT00734162|1033539|P4|Open-Label Phase|Lost to Follow-up|1
315291|NCT00734162|1033540|P3|Open-Label Phase|Lost to Follow-up|0
315292|NCT00734162|1033541|P2|Open-Label Phase|Lost to Follow-up|2
315293|NCT00734162|1033542|P1|Open-Label Phase|Lost to Follow-up|1
315294|NCT00734162|1033539|P4|Open-Label Phase|Withdrew Consent|1
315295|NCT00734162|1033540|P3|Open-Label Phase|Withdrew Consent|1
315296|NCT00734162|1033541|P2|Open-Label Phase|Withdrew Consent|0
315297|NCT00734162|1033542|P1|Open-Label Phase|Withdrew Consent|1
315298|NCT00734162|1033539|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
315299|NCT00734162|1033540|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
315300|NCT00734162|1033541|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
315301|NCT00734162|1033542|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
315302|NCT00734162|1033539|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
315303|NCT00734162|1033540|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
315304|NCT00734162|1033541|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
315305|NCT00734162|1033542|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
315306|NCT00734162|1033539|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
315307|NCT00734162|1033540|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
315308|NCT00734162|1033541|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
315309|NCT00734162|1033542|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
315310|NCT00734149|1033766|P1|Overall Study|Withdrawal by Subject|1
315311|NCT00734097|1033773|P1|Open Label|Protocol Violation|4
315312|NCT00734097|1033773|P1|Open Label|Withdrawal by Subject|5
315313|NCT00734097|1033773|P1|Open Label|Lost to Follow-up|7
315314|NCT00734097|1033773|P1|Screening|Unconfirmed pregnancy|1
315315|NCT00734097|1033773|P1|Screening|Lost to Follow-up|2
315316|NCT00734097|1033773|P1|Screening|Withdrawal by Subject|5
315317|NCT00734097|1033773|P1|Screening|Protocol Violation|12
315318|NCT00734071|1033790|P2|Overall Study|Other|2
315319|NCT00734071|1033791|P1|Overall Study|Other|1
315320|NCT00734071|1033790|P2|Overall Study|Lost to Follow-up|8
315321|NCT00734071|1033791|P1|Overall Study|Lost to Follow-up|16
315322|NCT00734071|1033790|P2|Overall Study|Voluntary Withdrawal|7
315323|NCT00734071|1033791|P1|Overall Study|Voluntary Withdrawal|9
315324|NCT00734071|1033790|P2|Overall Study|Protocol Deviations|4
315325|NCT00734071|1033791|P1|Overall Study|Protocol Deviations|3
315326|NCT00734071|1033790|P2|Overall Study|Noncompliance|2
315327|NCT00734071|1033791|P1|Overall Study|Noncompliance|2
315328|NCT00734071|1033790|P2|Overall Study|Lack of Efficacy|1
315329|NCT00734071|1033791|P1|Overall Study|Lack of Efficacy|3
315330|NCT00734071|1033790|P2|Overall Study|Adverse Event|3
315331|NCT00734071|1033791|P1|Overall Study|Adverse Event|4
315332|NCT00733954|1033883|P2|Overall Study|Withdrawal by Subject|0
315333|NCT00733954|1033884|P1|Overall Study|Withdrawal by Subject|2
315334|NCT00733954|1033883|P2|Overall Study|Protocol Violation|0
315335|NCT00733954|1033884|P1|Overall Study|Protocol Violation|1
315336|NCT00733954|1033883|P2|Overall Study|Lost to Follow-up|2
315337|NCT00733954|1033884|P1|Overall Study|Lost to Follow-up|5
315338|NCT00733824|1033931|P5|Phase I|Withdrawal by Subject|0
315339|NCT00733824|1033932|P4|Phase I|Withdrawal by Subject|0
315340|NCT00733824|1033933|P3|Phase I|Withdrawal by Subject|0
315341|NCT00733824|1033934|P2|Phase I|Withdrawal by Subject|0
315342|NCT00733824|1033935|P1|Phase I|Withdrawal by Subject|1
315343|NCT00733746|1033954|P1|Overall Study|Ineligible|5
315344|NCT00733499|1033969|P2|24 Months Follow-up|Death|1
315345|NCT00733499|1033970|P1|24 Months Follow-up|Death|0
315346|NCT00733499|1033969|P2|12 Months Follow-up|Death|1
315347|NCT00733499|1033970|P1|12 Months Follow-up|Death|2
315348|NCT00733499|1033969|P2|6 Months Follow-up|Adverse Event|1
315349|NCT00733499|1033970|P1|6 Months Follow-up|Adverse Event|0
315350|NCT00733499|1033969|P2|6 Months Follow-up|Death|2
315351|NCT00733499|1033970|P1|6 Months Follow-up|Death|0
315352|NCT00733499|1033969|P2|3 Months Follow-up|Death|2
315353|NCT00733499|1033970|P1|3 Months Follow-up|Death|1
315354|NCT00733499|1033969|P2|Pre-operative|Protocol Violation|1
315355|NCT00733499|1033970|P1|Pre-operative|Protocol Violation|0
315356|NCT00733421|1033978|P2|Overall Study|Withdrawal by Subject|1
315357|NCT00733421|1033979|P1|Overall Study|Withdrawal by Subject|1
315358|NCT00733369|1034003|P2|Overall Study|Protocol Violation|4
315359|NCT00733369|1034004|P1|Overall Study|Protocol Violation|4
315360|NCT00733369|1034003|P2|Overall Study|Adverse Event|4
315361|NCT00733369|1034004|P1|Overall Study|Adverse Event|4
315362|NCT00733369|1034003|P2|Overall Study|Lost to Follow-up|1
315363|NCT00733369|1034004|P1|Overall Study|Lost to Follow-up|2
315364|NCT00733291|1034207|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
315365|NCT00733291|1034208|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
315366|NCT00733291|1034209|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
315367|NCT00733291|1034210|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
315368|NCT00733226|1034239|P2|Overall Study|moved to another place|0
315369|NCT00733226|1034240|P1|Overall Study|moved to another place|2
315370|NCT00733226|1034239|P2|Overall Study|Lost to Follow-up|0
315371|NCT00733226|1034240|P1|Overall Study|Lost to Follow-up|2
315372|NCT00733226|1034239|P2|Overall Study|Withdrawal by Subject|0
315373|NCT00733226|1034240|P1|Overall Study|Withdrawal by Subject|1
315374|NCT00733005|1034289|P2|Overall Study|Protocol Violation|0
315375|NCT00733005|1034290|P1|Overall Study|Protocol Violation|2
315376|NCT00733005|1034289|P2|Overall Study|Withdrawal by Subject|1
315377|NCT00733005|1034290|P1|Overall Study|Withdrawal by Subject|0
315378|NCT00733005|1034289|P2|Overall Study|Treatment Failure|1
315379|NCT00733005|1034290|P1|Overall Study|Treatment Failure|0
315380|NCT00733005|1034289|P2|Overall Study|Adverse Event|1
315381|NCT00733005|1034290|P1|Overall Study|Adverse Event|0
315382|NCT00732992|1034300|P2|Overall Study|Withdrawal by Subject|0
315383|NCT00732992|1034301|P1|Overall Study|Withdrawal by Subject|1
315384|NCT00732992|1034300|P2|Overall Study|Global Deterioration of Health Status|0
315385|NCT00732992|1034301|P1|Overall Study|Global Deterioration of Health Status|1
315386|NCT00732992|1034300|P2|Overall Study|Objective Progression or Relapse|5
315387|NCT00732992|1034301|P1|Overall Study|Objective Progression or Relapse|3
315388|NCT00732992|1034300|P2|Overall Study|Adverse Event|1
315389|NCT00732992|1034301|P1|Overall Study|Adverse Event|1
315390|NCT00732940|1034320|P2|Overall Study|Lost to Follow-up|0
315391|NCT00732940|1034321|P1|Overall Study|Lost to Follow-up|1
315392|NCT00732940|1034320|P2|Overall Study|Adverse Event|1
315393|NCT00732940|1034321|P1|Overall Study|Adverse Event|0
315394|NCT00732940|1034320|P2|Overall Study|Withdrawal by Subject|2
315395|NCT00732940|1034321|P1|Overall Study|Withdrawal by Subject|1
315396|NCT00732875|1034402|P1|Overall Study|Lack of Efficacy|13
315397|NCT00732875|1034402|P1|Overall Study|Withdrawal by Subject|6
315398|NCT00732875|1034402|P1|Overall Study|Adverse Event|16
315399|NCT00732758|1034410|P2|Overall Study|Lost to Follow-up|16
315400|NCT00732758|1034411|P1|Overall Study|Lost to Follow-up|8
315401|NCT00732641|1034451|P2|Overall Study|Not Specified|5
315402|NCT00732641|1034452|P1|Overall Study|Not Specified|18
315403|NCT00732641|1034451|P2|Overall Study|Unable to Complete|1
315404|NCT00732641|1034452|P1|Overall Study|Unable to Complete|1
315405|NCT00732641|1034451|P2|Overall Study|Withdrawal by Subject|2
315406|NCT00732641|1034452|P1|Overall Study|Withdrawal by Subject|4
315407|NCT00732641|1034451|P2|Overall Study|Physician Decision|0
315408|NCT00732641|1034452|P1|Overall Study|Physician Decision|6
315409|NCT00732641|1034451|P2|Overall Study|Serious Adverse Events|3
315410|NCT00732641|1034452|P1|Overall Study|Serious Adverse Events|12
315411|NCT00732641|1034451|P2|Overall Study|Relapse or Progressive Disease|101
315412|NCT00732641|1034452|P1|Overall Study|Relapse or Progressive Disease|65
315413|NCT00732615|1034472|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
315414|NCT00732615|1034473|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
315415|NCT00732615|1034472|P2|Overall Study|Physician Decision|0
315416|NCT00732615|1034473|P1|Overall Study|Physician Decision|3
315417|NCT00732615|1034472|P2|Overall Study|Adverse Event|2
315418|NCT00732615|1034473|P1|Overall Study|Adverse Event|0
315419|NCT00732615|1034472|P2|Overall Study|Lost to Follow-up|1
315420|NCT00732615|1034473|P1|Overall Study|Lost to Follow-up|0
315421|NCT00732615|1034472|P2|Overall Study|Withdrawal by Subject|1
315422|NCT00732615|1034473|P1|Overall Study|Withdrawal by Subject|3
315423|NCT00732472|1034489|P4|Overall Study|Withdrawal by Subject|1
315424|NCT00732472|1034490|P3|Overall Study|Withdrawal by Subject|0
315425|NCT00732472|1034491|P2|Overall Study|Withdrawal by Subject|2
315426|NCT00732472|1034492|P1|Overall Study|Withdrawal by Subject|0
315427|NCT00732472|1034489|P4|Overall Study|Protocol Violation|1
315428|NCT00732472|1034490|P3|Overall Study|Protocol Violation|0
315429|NCT00732472|1034491|P2|Overall Study|Protocol Violation|0
315430|NCT00732472|1034492|P1|Overall Study|Protocol Violation|0
315431|NCT00732472|1034489|P4|Overall Study|Adverse Event|1
315432|NCT00732472|1034490|P3|Overall Study|Adverse Event|1
315433|NCT00732472|1034491|P2|Overall Study|Adverse Event|1
315434|NCT00732472|1034492|P1|Overall Study|Adverse Event|0
315435|NCT00732381|1034592|P2|Overall Study|Treatment Failure|1
315436|NCT00732381|1034593|P1|Overall Study|Treatment Failure|1
315437|NCT00732381|1034592|P2|Overall Study|Adverse Event|0
315438|NCT00732381|1034593|P1|Overall Study|Adverse Event|1
315439|NCT00732303|1034601|P1|Overall Study|Study Terminated|2
315440|NCT00732238|1034609|P2|Overall Study|Asymptomatic bacteriuria|0
315441|NCT00732238|1034610|P1|Overall Study|Asymptomatic bacteriuria|1
315442|NCT00732238|1034609|P2|Overall Study|Bacteremia|1
315443|NCT00732238|1034610|P1|Overall Study|Bacteremia|4
315444|NCT00732160|1034713|P4|Overall Study|scheduling|1
315445|NCT00732160|1034714|P3|Overall Study|scheduling|2
315446|NCT00732160|1034715|P2|Overall Study|scheduling|4
315447|NCT00732160|1034716|P1|Overall Study|scheduling|4
315448|NCT00732160|1034713|P4|Overall Study|Adverse Event|1
315449|NCT00732160|1034714|P3|Overall Study|Adverse Event|1
315450|NCT00732160|1034715|P2|Overall Study|Adverse Event|0
315451|NCT00732160|1034716|P1|Overall Study|Adverse Event|1
315452|NCT00732069|1034730|P6|Washout After First Study Drug|Adverse Event|0
315453|NCT00732069|1034731|P5|Washout After First Study Drug|Adverse Event|0
315454|NCT00732069|1034732|P4|Washout After First Study Drug|Adverse Event|0
315455|NCT00732069|1034733|P3|Washout After First Study Drug|Adverse Event|0
315456|NCT00732069|1034734|P2|Washout After First Study Drug|Adverse Event|0
315457|NCT00732069|1034735|P1|Washout After First Study Drug|Adverse Event|1
315458|NCT00731939|1034753|P1|Overall Study|Did not meet enrollment criteria|2
315459|NCT00731939|1034753|P1|Overall Study|Withdrawal by Subject|2
315460|NCT00731939|1034753|P1|Overall Study|Not implanted with study device|9
315461|NCT00731939|1034753|P1|Overall Study|Lost to Follow-up|15
315462|NCT00731939|1034753|P1|Overall Study|Adverse Event|6
315463|NCT00731822|1034814|P2|Overall Study|Lost to Follow-up|0
315464|NCT00731822|1034815|P1|Overall Study|Lost to Follow-up|1
315465|NCT00731822|1034814|P2|Overall Study|Protocol Violation|0
315466|NCT00731822|1034815|P1|Overall Study|Protocol Violation|1
315467|NCT00731822|1034814|P2|Overall Study|Adverse Event|1
315468|NCT00731822|1034815|P1|Overall Study|Adverse Event|2
315469|NCT00731783|1034829|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
315470|NCT00731783|1034830|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
315471|NCT00731783|1034829|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
315472|NCT00731783|1034830|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
315473|NCT00731783|1034829|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
315474|NCT00731783|1034830|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
315475|NCT00731783|1034829|P2|One Month Follow-Up Visit|Lost to Follow-up|22
315476|NCT00731783|1034830|P1|One Month Follow-Up Visit|Lost to Follow-up|14
315477|NCT00731731|1034853|P3|Overall Study|Cancel prior to treatment|2
315478|NCT00731731|1034854|P2|Overall Study|Cancel prior to treatment|0
315479|NCT00731731|1034855|P1|Overall Study|Cancel prior to treatment|0
315480|NCT00731731|1034853|P3|Overall Study|Protocol Violation|1
315481|NCT00731731|1034854|P2|Overall Study|Protocol Violation|0
315482|NCT00731731|1034855|P1|Overall Study|Protocol Violation|0
315483|NCT00731692|1034873|P3|Extension Phase|Adverse Event|15
315484|NCT00731692|1034874|P2|Extension Phase|Adverse Event|1
315485|NCT00731692|1034875|P1|Extension Phase|Adverse Event|1
315486|NCT00731692|1034873|P3|Extension Phase|Withdrawal by Subject|3
315487|NCT00731692|1034874|P2|Extension Phase|Withdrawal by Subject|5
315488|NCT00731692|1034875|P1|Extension Phase|Withdrawal by Subject|4
315489|NCT00731692|1034873|P3|Extension Phase|Lost to Follow-up|4
315490|NCT00731692|1034874|P2|Extension Phase|Lost to Follow-up|1
315491|NCT00731692|1034875|P1|Extension Phase|Lost to Follow-up|0
315492|NCT00731692|1034873|P3|Extension Phase|Abnormal lab values|1
315493|NCT00731692|1034874|P2|Extension Phase|Abnormal lab values|0
315494|NCT00731692|1034875|P1|Extension Phase|Abnormal lab values|0
315495|NCT00731692|1034873|P3|Extension Phase|Abnormal test procedure|1
315496|NCT00731692|1034874|P2|Extension Phase|Abnormal test procedure|0
315497|NCT00731692|1034875|P1|Extension Phase|Abnormal test procedure|0
315498|NCT00731692|1034873|P3|Extension Phase|Admin Problems: Terminated # patients|277
315499|NCT00731692|1034874|P2|Extension Phase|Admin Problems: Terminated # patients|189
315500|NCT00731692|1034875|P1|Extension Phase|Admin Problems: Terminated # patients|69
315501|NCT00731692|1034873|P3|Core Study (36 Months)|Withdrawal by Subject|46
315502|NCT00731692|1034874|P2|Core Study (36 Months)|Withdrawal by Subject|32
315503|NCT00731692|1034875|P1|Core Study (36 Months)|Withdrawal by Subject|12
315504|NCT00731692|1034873|P3|Core Study (36 Months)|Adverse Event|29
315505|NCT00731692|1034874|P2|Core Study (36 Months)|Adverse Event|28
315506|NCT00731692|1034875|P1|Core Study (36 Months)|Adverse Event|25
315507|NCT00731692|1034873|P3|Core Study (36 Months)|Abnormal Lab values|5
315508|NCT00731692|1034874|P2|Core Study (36 Months)|Abnormal Lab values|19
315509|NCT00731692|1034875|P1|Core Study (36 Months)|Abnormal Lab values|6
315510|NCT00731692|1034873|P3|Core Study (36 Months)|Protocol Violation|8
315511|NCT00731692|1034874|P2|Core Study (36 Months)|Protocol Violation|5
315512|NCT00731692|1034875|P1|Core Study (36 Months)|Protocol Violation|4
315513|NCT00731692|1034873|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
315514|NCT00731692|1034874|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
315515|NCT00731692|1034875|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
315516|NCT00731692|1034873|P3|Core Study (36 Months)|Administrative|6
315517|NCT00731692|1034874|P2|Core Study (36 Months)|Administrative|2
315518|NCT00731692|1034875|P1|Core Study (36 Months)|Administrative|2
315519|NCT00731692|1034873|P3|Core Study (36 Months)|Lost to Follow-up|3
315520|NCT00731692|1034874|P2|Core Study (36 Months)|Lost to Follow-up|3
315521|NCT00731692|1034875|P1|Core Study (36 Months)|Lost to Follow-up|1
315522|NCT00731692|1034873|P3|Core Study (36 Months)|Death|2
315523|NCT00731692|1034874|P2|Core Study (36 Months)|Death|1
315524|NCT00731692|1034875|P1|Core Study (36 Months)|Death|2
315525|NCT00731692|1034873|P3|Core Study (36 Months)|Physician Decision|2
315526|NCT00731692|1034874|P2|Core Study (36 Months)|Physician Decision|0
315527|NCT00731692|1034875|P1|Core Study (36 Months)|Physician Decision|1
315528|NCT00731692|1034873|P3|Core Study (36 Months)|Lack of Efficacy|64
315529|NCT00731692|1034874|P2|Core Study (36 Months)|Lack of Efficacy|23
315530|NCT00731692|1034875|P1|Core Study (36 Months)|Lack of Efficacy|11
315531|NCT00731679|1034921|P2|Overall Study|Pregnancy|1
315532|NCT00731679|1034922|P1|Overall Study|Pregnancy|0
315533|NCT00731679|1034921|P2|Overall Study|Noncompliance|1
315534|NCT00731679|1034922|P1|Overall Study|Noncompliance|0
315535|NCT00731679|1034921|P2|Overall Study|Lost to Follow-up|8
315536|NCT00731679|1034922|P1|Overall Study|Lost to Follow-up|7
315537|NCT00731679|1034921|P2|Overall Study|Withdrawal by Subject|8
315538|NCT00731679|1034922|P1|Overall Study|Withdrawal by Subject|8
315539|NCT00731679|1034921|P2|Overall Study|Adverse Event|8
315540|NCT00731679|1034922|P1|Overall Study|Adverse Event|7
315541|NCT00731666|1034930|P1|Overall Study|Withdrawal by Subject|2
315542|NCT00731666|1034930|P1|Overall Study|Lost to Follow-up|8
315543|NCT00731666|1034930|P1|Overall Study|Adverse Event|2
315544|NCT00731549|1034964|P1|Overall Study|Lack of efficacy without AE|6
315545|NCT00731549|1034964|P1|Overall Study|Lack of efficacy with AE|37
315546|NCT00731549|1034964|P1|Overall Study|Adverse Event|31
315547|NCT00731549|1034964|P1|Overall Study|Protocol deviation|1
315548|NCT00731549|1034964|P1|Overall Study|Withdrawal by Subject|89
315549|NCT00731549|1034964|P1|Overall Study|Physician Decision|16
315550|NCT00731549|1034964|P1|Overall Study|Met withdrawal criteria|24
315551|NCT00731549|1034964|P1|Overall Study|Lost to Follow-up|19
315552|NCT00731133|1035004|P1|Overall Study|Withdrawal by Subject|10
315553|NCT00731120|1035012|P3|Overall Study|Other|1
315554|NCT00731120|1035013|P2|Overall Study|Other|0
315555|NCT00731120|1035014|P1|Overall Study|Other|4
315556|NCT00731120|1035012|P3|Overall Study|Lost to Follow-up|17
315557|NCT00731120|1035013|P2|Overall Study|Lost to Follow-up|15
315558|NCT00731120|1035014|P1|Overall Study|Lost to Follow-up|10
315559|NCT00731120|1035012|P3|Overall Study|Withdrawal of Consent|4
315560|NCT00731120|1035013|P2|Overall Study|Withdrawal of Consent|8
315561|NCT00731120|1035014|P1|Overall Study|Withdrawal of Consent|13
315562|NCT00731120|1035012|P3|Overall Study|Protocol Deviations|1
315563|NCT00731120|1035013|P2|Overall Study|Protocol Deviations|6
315564|NCT00731120|1035014|P1|Overall Study|Protocol Deviations|1
315565|NCT00731120|1035012|P3|Overall Study|Noncompliance with Study Drug|1
315566|NCT00731120|1035013|P2|Overall Study|Noncompliance with Study Drug|3
315567|NCT00731120|1035014|P1|Overall Study|Noncompliance with Study Drug|3
315568|NCT00731120|1035012|P3|Overall Study|Lack of Efficacy|4
315569|NCT00731120|1035013|P2|Overall Study|Lack of Efficacy|5
315570|NCT00731120|1035014|P1|Overall Study|Lack of Efficacy|4
315571|NCT00731120|1035012|P3|Overall Study|Adverse Event|8
315572|NCT00731120|1035013|P2|Overall Study|Adverse Event|6
315573|NCT00731120|1035014|P1|Overall Study|Adverse Event|7
315574|NCT00731042|1035131|P2|Second Intervention|Did not meet inclusion criteria|2
315575|NCT00731042|1035132|P1|Second Intervention|Did not meet inclusion criteria|0
315576|NCT00730925|1035143|P1|Overall Study|Other|1
315577|NCT00730925|1035143|P1|Overall Study|Switch to combination therapy|8
315578|NCT00730925|1035143|P1|Overall Study|Withdrawal by Subject|1
315579|NCT00730925|1035143|P1|Overall Study|Protocol Violation|1
315580|NCT00730925|1035143|P1|Overall Study|Other Averse Event|7
315581|NCT00730925|1035143|P1|Overall Study|Dose reducing Event|2
315582|NCT00730925|1035143|P1|Overall Study|Progressive Disease|21
315583|NCT00730912|1035153|P3|Overall Study|Discontinued|1
315584|NCT00730912|1035154|P2|Overall Study|Discontinued|0
315585|NCT00730912|1035155|P1|Overall Study|Discontinued|0
315586|NCT00730847|1035166|P1|Overall Study|Unspecified|24
315587|NCT00730847|1035166|P1|Overall Study|Unknown completion status|21
315588|NCT00730847|1035166|P1|Overall Study|Lost to Follow-up|67
315589|NCT00730847|1035166|P1|Overall Study|Withdrawal by Subject|16
315590|NCT00730847|1035166|P1|Overall Study|Protocol Violation|2
315591|NCT00730847|1035166|P1|Overall Study|Adverse Event|1
315592|NCT00730756|1035175|P2|Overall Study|Withdrew Consent|1
315593|NCT00730756|1035176|P1|Overall Study|Withdrew Consent|0
315594|NCT00730756|1035175|P2|Overall Study|Lost to Follow-up|1
315595|NCT00730756|1035176|P1|Overall Study|Lost to Follow-up|0
315596|NCT00730756|1035175|P2|Overall Study|Protocol Deviation|2
315597|NCT00730756|1035176|P1|Overall Study|Protocol Deviation|1
315598|NCT00730756|1035175|P2|Overall Study|Lack of Efficacy|1
315599|NCT00730756|1035176|P1|Overall Study|Lack of Efficacy|1
315600|NCT00730756|1035175|P2|Overall Study|Adverse Event|0
315601|NCT00730756|1035176|P1|Overall Study|Adverse Event|2
315602|NCT00730691|1035210|P5|Overall Study|Other|2
315603|NCT00730691|1035211|P4|Overall Study|Other|2
315604|NCT00730691|1035212|P3|Overall Study|Other|1
315605|NCT00730691|1035213|P2|Overall Study|Other|1
315606|NCT00730691|1035214|P1|Overall Study|Other|1
315607|NCT00730691|1035210|P5|Overall Study|Lost to Follow-up|13
315608|NCT00730691|1035211|P4|Overall Study|Lost to Follow-up|15
315609|NCT00730691|1035212|P3|Overall Study|Lost to Follow-up|13
315610|NCT00730691|1035213|P2|Overall Study|Lost to Follow-up|8
315611|NCT00730691|1035214|P1|Overall Study|Lost to Follow-up|11
315612|NCT00730691|1035210|P5|Overall Study|Withdrawal of Consent|3
315613|NCT00730691|1035211|P4|Overall Study|Withdrawal of Consent|6
315614|NCT00730691|1035212|P3|Overall Study|Withdrawal of Consent|3
315615|NCT00730691|1035213|P2|Overall Study|Withdrawal of Consent|9
315616|NCT00730691|1035214|P1|Overall Study|Withdrawal of Consent|7
315617|NCT00730691|1035210|P5|Overall Study|Protocol Deviations|5
315618|NCT00730691|1035211|P4|Overall Study|Protocol Deviations|7
315619|NCT00730691|1035212|P3|Overall Study|Protocol Deviations|3
315620|NCT00730691|1035213|P2|Overall Study|Protocol Deviations|5
315621|NCT00730691|1035214|P1|Overall Study|Protocol Deviations|3
315622|NCT00730691|1035210|P5|Overall Study|Non-compliance with Study Drug|3
315623|NCT00730691|1035211|P4|Overall Study|Non-compliance with Study Drug|3
315624|NCT00730691|1035212|P3|Overall Study|Non-compliance with Study Drug|6
315625|NCT00730691|1035213|P2|Overall Study|Non-compliance with Study Drug|1
315626|NCT00730691|1035214|P1|Overall Study|Non-compliance with Study Drug|6
315627|NCT00730691|1035210|P5|Overall Study|Lack of Efficacy|1
315628|NCT00730691|1035211|P4|Overall Study|Lack of Efficacy|1
315629|NCT00730691|1035212|P3|Overall Study|Lack of Efficacy|2
315630|NCT00730691|1035213|P2|Overall Study|Lack of Efficacy|4
315631|NCT00730691|1035214|P1|Overall Study|Lack of Efficacy|4
315632|NCT00730691|1035210|P5|Overall Study|Adverse Event|23
315633|NCT00730691|1035211|P4|Overall Study|Adverse Event|11
315634|NCT00730691|1035212|P3|Overall Study|Adverse Event|11
315635|NCT00730691|1035213|P2|Overall Study|Adverse Event|8
315636|NCT00730691|1035214|P1|Overall Study|Adverse Event|4
315637|NCT00730639|1035306|P5|Overall Study|Treatment on-going|4
315638|NCT00730639|1035307|P4|Overall Study|Treatment on-going|4
315639|NCT00730639|1035308|P3|Overall Study|Treatment on-going|5
315640|NCT00730639|1035309|P2|Overall Study|Treatment on-going|5
315641|NCT00730639|1035310|P1|Overall Study|Treatment on-going|2
315642|NCT00730639|1035306|P5|Overall Study|Withdrawal by Subject|4
315643|NCT00730639|1035307|P4|Overall Study|Withdrawal by Subject|3
315644|NCT00730639|1035308|P3|Overall Study|Withdrawal by Subject|6
315645|NCT00730639|1035309|P2|Overall Study|Withdrawal by Subject|0
315646|NCT00730639|1035310|P1|Overall Study|Withdrawal by Subject|0
315647|NCT00730639|1035306|P5|Overall Study|Protocol Violation|0
315648|NCT00730639|1035307|P4|Overall Study|Protocol Violation|0
315649|NCT00730639|1035308|P3|Overall Study|Protocol Violation|1
315650|NCT00730639|1035309|P2|Overall Study|Protocol Violation|0
315651|NCT00730639|1035310|P1|Overall Study|Protocol Violation|0
315652|NCT00730639|1035306|P5|Overall Study|non-specified|3
315653|NCT00730639|1035307|P4|Overall Study|non-specified|2
315654|NCT00730639|1035308|P3|Overall Study|non-specified|4
315655|NCT00730639|1035309|P2|Overall Study|non-specified|0
315656|NCT00730639|1035310|P1|Overall Study|non-specified|0
315657|NCT00730639|1035306|P5|Overall Study|Disease Progression|88
315658|NCT00730639|1035307|P4|Overall Study|Disease Progression|32
315659|NCT00730639|1035308|P3|Overall Study|Disease Progression|48
315660|NCT00730639|1035309|P2|Overall Study|Disease Progression|13
315661|NCT00730639|1035310|P1|Overall Study|Disease Progression|12
315662|NCT00730639|1035306|P5|Overall Study|Death|2
315663|NCT00730639|1035307|P4|Overall Study|Death|0
315664|NCT00730639|1035308|P3|Overall Study|Death|0
315665|NCT00730639|1035309|P2|Overall Study|Death|0
315666|NCT00730639|1035310|P1|Overall Study|Death|0
315667|NCT00730639|1035306|P5|Overall Study|Completed Maximum Cycles|6
315668|NCT00730639|1035307|P4|Overall Study|Completed Maximum Cycles|3
315669|NCT00730639|1035308|P3|Overall Study|Completed Maximum Cycles|11
315670|NCT00730639|1035309|P2|Overall Study|Completed Maximum Cycles|0
315671|NCT00730639|1035310|P1|Overall Study|Completed Maximum Cycles|0
315672|NCT00730639|1035306|P5|Overall Study|Complete Response|1
315673|NCT00730639|1035307|P4|Overall Study|Complete Response|2
315674|NCT00730639|1035308|P3|Overall Study|Complete Response|2
315675|NCT00730639|1035309|P2|Overall Study|Complete Response|0
315676|NCT00730639|1035310|P1|Overall Study|Complete Response|0
315677|NCT00730639|1035306|P5|Overall Study|Adverse Event|23
315678|NCT00730639|1035307|P4|Overall Study|Adverse Event|8
315679|NCT00730639|1035308|P3|Overall Study|Adverse Event|9
315680|NCT00730639|1035309|P2|Overall Study|Adverse Event|0
315681|NCT00730639|1035310|P1|Overall Study|Adverse Event|3
315682|NCT00730327|1035384|P2|Overall Study|Subject withdrew (reason not specified)|7
315683|NCT00730327|1035385|P1|Overall Study|Subject withdrew (reason not specified)|2
315684|NCT00730327|1035384|P2|Overall Study|Withdrawal by Subject|13
315685|NCT00730327|1035385|P1|Overall Study|Withdrawal by Subject|3
315686|NCT00730327|1035384|P2|Overall Study|Adverse Event|1
315687|NCT00730327|1035385|P1|Overall Study|Adverse Event|8
315688|NCT00730327|1035384|P2|Overall Study|Lost to Follow-up|16
315689|NCT00730327|1035385|P1|Overall Study|Lost to Follow-up|14
315690|NCT00730275|1035410|P4|Overall Study|Withdrawal by Subject|1
315691|NCT00730275|1035411|P3|Overall Study|Withdrawal by Subject|0
315692|NCT00730275|1035412|P2|Overall Study|Withdrawal by Subject|0
315693|NCT00730275|1035413|P1|Overall Study|Withdrawal by Subject|0
315694|NCT00730236|1035439|P1|Overall Study|Non-compliance|1
315695|NCT00730236|1035439|P1|Overall Study|Withdrawal by Subject|1
315696|NCT00730236|1035439|P1|Overall Study|Adverse Event|4
315697|NCT00730132|1035454|P1|Overall Study|Death|1
315698|NCT00730132|1035454|P1|Overall Study|Protocol Violation|154
315699|NCT00730041|1035472|P2|Overall Study|Lost to Follow-up|2
315700|NCT00730041|1035473|P1|Overall Study|Lost to Follow-up|0
315701|NCT00730028|1035496|P5|Overall Study|Randomization Error|2
315702|NCT00730028|1035497|P4|Overall Study|Randomization Error|0
315703|NCT00730028|1035498|P3|Overall Study|Randomization Error|0
315704|NCT00730028|1035499|P2|Overall Study|Randomization Error|0
315705|NCT00730028|1035500|P1|Overall Study|Randomization Error|1
315706|NCT00730028|1035496|P5|Overall Study|Treatment Failure|1
315707|NCT00730028|1035497|P4|Overall Study|Treatment Failure|0
315708|NCT00730028|1035498|P3|Overall Study|Treatment Failure|0
315709|NCT00730028|1035499|P2|Overall Study|Treatment Failure|5
315710|NCT00730028|1035500|P1|Overall Study|Treatment Failure|5
315711|NCT00730028|1035496|P5|Overall Study|Physician Decision|2
315712|NCT00730028|1035497|P4|Overall Study|Physician Decision|3
315713|NCT00730028|1035498|P3|Overall Study|Physician Decision|2
315714|NCT00730028|1035499|P2|Overall Study|Physician Decision|3
315715|NCT00730028|1035500|P1|Overall Study|Physician Decision|3
315716|NCT00730028|1035496|P5|Overall Study|Withdrawal by Subject|9
315717|NCT00730028|1035497|P4|Overall Study|Withdrawal by Subject|5
315718|NCT00730028|1035498|P3|Overall Study|Withdrawal by Subject|4
315719|NCT00730028|1035499|P2|Overall Study|Withdrawal by Subject|5
315720|NCT00730028|1035500|P1|Overall Study|Withdrawal by Subject|9
315721|NCT00730028|1035496|P5|Overall Study|Protocol Violation|0
315722|NCT00730028|1035497|P4|Overall Study|Protocol Violation|2
315723|NCT00730028|1035498|P3|Overall Study|Protocol Violation|1
315724|NCT00730028|1035499|P2|Overall Study|Protocol Violation|1
315725|NCT00730028|1035500|P1|Overall Study|Protocol Violation|6
315726|NCT00730028|1035496|P5|Overall Study|Lost to Follow-up|25
315727|NCT00730028|1035497|P4|Overall Study|Lost to Follow-up|26
315728|NCT00730028|1035498|P3|Overall Study|Lost to Follow-up|22
315729|NCT00730028|1035499|P2|Overall Study|Lost to Follow-up|26
315730|NCT00730028|1035500|P1|Overall Study|Lost to Follow-up|13
315731|NCT00730028|1035496|P5|Overall Study|Adverse Event|43
315732|NCT00730028|1035497|P4|Overall Study|Adverse Event|20
315733|NCT00730028|1035498|P3|Overall Study|Adverse Event|16
315734|NCT00730028|1035499|P2|Overall Study|Adverse Event|26
315735|NCT00730028|1035500|P1|Overall Study|Adverse Event|23
315736|NCT00730015|1035550|P3|Overall Study|Other Reason|1
315737|NCT00730015|1035551|P2|Overall Study|Other Reason|0
315738|NCT00730015|1035552|P1|Overall Study|Other Reason|1
315739|NCT00730015|1035550|P3|Overall Study|Lack of Efficacy|8
315740|NCT00730015|1035551|P2|Overall Study|Lack of Efficacy|2
315741|NCT00730015|1035552|P1|Overall Study|Lack of Efficacy|1
315742|NCT00730015|1035550|P3|Overall Study|Lost to Follow-up|3
315743|NCT00730015|1035551|P2|Overall Study|Lost to Follow-up|10
315744|NCT00730015|1035552|P1|Overall Study|Lost to Follow-up|4
315745|NCT00730015|1035550|P3|Overall Study|Withdrawal by Subject|8
315746|NCT00730015|1035551|P2|Overall Study|Withdrawal by Subject|12
315747|NCT00730015|1035552|P1|Overall Study|Withdrawal by Subject|12
315748|NCT00730015|1035550|P3|Overall Study|Protocol Violation|4
315749|NCT00730015|1035551|P2|Overall Study|Protocol Violation|6
315750|NCT00730015|1035552|P1|Overall Study|Protocol Violation|2
315751|NCT00730015|1035550|P3|Overall Study|Adverse Event|8
315752|NCT00730015|1035551|P2|Overall Study|Adverse Event|10
315753|NCT00730015|1035552|P1|Overall Study|Adverse Event|11
315754|NCT00729937|1035592|P6|Overall Study|Incarcerated|0
315755|NCT00729937|1035593|P5|Overall Study|Incarcerated|0
315756|NCT00729937|1035594|P4|Overall Study|Incarcerated|1
315757|NCT00729937|1035595|P3|Overall Study|Incarcerated|1
315758|NCT00729937|1035596|P2|Overall Study|Incarcerated|2
315759|NCT00729937|1035597|P1|Overall Study|Incarcerated|0
315760|NCT00729937|1035592|P6|Overall Study|Did not meet eligibility criteria|0
315761|NCT00729937|1035593|P5|Overall Study|Did not meet eligibility criteria|0
315762|NCT00729937|1035594|P4|Overall Study|Did not meet eligibility criteria|0
315763|NCT00729937|1035595|P3|Overall Study|Did not meet eligibility criteria|0
315764|NCT00729937|1035596|P2|Overall Study|Did not meet eligibility criteria|1
315765|NCT00729937|1035597|P1|Overall Study|Did not meet eligibility criteria|2
315766|NCT00729937|1035592|P6|Overall Study|Randomized but not treated|3
315767|NCT00729937|1035593|P5|Overall Study|Randomized but not treated|1
315768|NCT00729937|1035594|P4|Overall Study|Randomized but not treated|0
315769|NCT00729937|1035595|P3|Overall Study|Randomized but not treated|1
315770|NCT00729937|1035596|P2|Overall Study|Randomized but not treated|6
315771|NCT00729937|1035597|P1|Overall Study|Randomized but not treated|12
315772|NCT00729937|1035592|P6|Overall Study|Withdrawal by Subject|2
315773|NCT00729937|1035593|P5|Overall Study|Withdrawal by Subject|4
315774|NCT00729937|1035594|P4|Overall Study|Withdrawal by Subject|0
315775|NCT00729937|1035595|P3|Overall Study|Withdrawal by Subject|6
315776|NCT00729937|1035596|P2|Overall Study|Withdrawal by Subject|5
315777|NCT00729937|1035597|P1|Overall Study|Withdrawal by Subject|3
315778|NCT00729937|1035592|P6|Overall Study|Death|1
315779|NCT00729937|1035593|P5|Overall Study|Death|0
315780|NCT00729937|1035594|P4|Overall Study|Death|0
315781|NCT00729937|1035595|P3|Overall Study|Death|1
315782|NCT00729937|1035596|P2|Overall Study|Death|0
315783|NCT00729937|1035597|P1|Overall Study|Death|1
315784|NCT00729937|1035592|P6|Overall Study|Physician Decision|8
315785|NCT00729937|1035593|P5|Overall Study|Physician Decision|5
315786|NCT00729937|1035594|P4|Overall Study|Physician Decision|0
315787|NCT00729937|1035595|P3|Overall Study|Physician Decision|2
315788|NCT00729937|1035596|P2|Overall Study|Physician Decision|16
315789|NCT00729937|1035597|P1|Overall Study|Physician Decision|7
315790|NCT00729937|1035592|P6|Overall Study|Lost to Follow-up|23
315791|NCT00729937|1035593|P5|Overall Study|Lost to Follow-up|18
315792|NCT00729937|1035594|P4|Overall Study|Lost to Follow-up|33
315793|NCT00729937|1035595|P3|Overall Study|Lost to Follow-up|18
315794|NCT00729937|1035596|P2|Overall Study|Lost to Follow-up|58
315795|NCT00729937|1035597|P1|Overall Study|Lost to Follow-up|49
315796|NCT00729859|1035801|P3|Overall Study|Withdrawal by Subject|0
315797|NCT00729859|1035802|P2|Overall Study|Withdrawal by Subject|1
315798|NCT00729859|1035803|P1|Overall Study|Withdrawal by Subject|0
315799|NCT00729859|1035801|P3|Overall Study|Adverse Event|0
315800|NCT00729859|1035802|P2|Overall Study|Adverse Event|1
315801|NCT00729859|1035803|P1|Overall Study|Adverse Event|0
315802|NCT00729833|1035847|P4|Overall Study|Unspecified Reasons|1
315803|NCT00729833|1035848|P3|Overall Study|Unspecified Reasons|5
315804|NCT00729833|1035849|P2|Overall Study|Unspecified Reasons|5
315805|NCT00729833|1035850|P1|Overall Study|Unspecified Reasons|11
315806|NCT00729833|1035847|P4|Overall Study|Withdrawal by Subject|0
315807|NCT00729833|1035848|P3|Overall Study|Withdrawal by Subject|3
315808|NCT00729833|1035849|P2|Overall Study|Withdrawal by Subject|1
315809|NCT00729833|1035850|P1|Overall Study|Withdrawal by Subject|3
315810|NCT00729833|1035847|P4|Overall Study|Lost to Follow-up|0
315811|NCT00729833|1035848|P3|Overall Study|Lost to Follow-up|0
315812|NCT00729833|1035849|P2|Overall Study|Lost to Follow-up|0
315813|NCT00729833|1035850|P1|Overall Study|Lost to Follow-up|1
315814|NCT00729833|1035847|P4|Overall Study|Study Terminated by Sponsor|0
315815|NCT00729833|1035848|P3|Overall Study|Study Terminated by Sponsor|1
315816|NCT00729833|1035849|P2|Overall Study|Study Terminated by Sponsor|0
315817|NCT00729833|1035850|P1|Overall Study|Study Terminated by Sponsor|0
315818|NCT00729833|1035847|P4|Overall Study|Death|5
315819|NCT00729833|1035848|P3|Overall Study|Death|3
315820|NCT00729833|1035849|P2|Overall Study|Death|1
315821|NCT00729833|1035850|P1|Overall Study|Death|5
315822|NCT00729690|1035902|P3|Overall Study|IT Catheter Malfunction|2
315823|NCT00729690|1035903|P2|Overall Study|IT Catheter Malfunction|2
315824|NCT00729690|1035904|P1|Overall Study|IT Catheter Malfunction|0
315825|NCT00729651|1035934|P2|Overall Study|Subject’s private reason|0
315826|NCT00729651|1035935|P1|Overall Study|Subject’s private reason|2
315827|NCT00729651|1035934|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
315828|NCT00729651|1035935|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
315829|NCT00729651|1035934|P2|Overall Study|Adverse Event|3
315830|NCT00729651|1035935|P1|Overall Study|Adverse Event|7
315831|NCT00729651|1035934|P2|Overall Study|Protocol Violation|1
315832|NCT00729651|1035935|P1|Overall Study|Protocol Violation|0
315833|NCT00729651|1035934|P2|Overall Study|Lost to Follow-up|4
315834|NCT00729651|1035935|P1|Overall Study|Lost to Follow-up|5
315835|NCT00729651|1035934|P2|Overall Study|Withdrawal by Subject|6
315836|NCT00729651|1035935|P1|Overall Study|Withdrawal by Subject|5
315837|NCT00729612|1035947|P1|Overall Study|Non evaluable for response|10
315838|NCT00729560|1035954|P1|Overall Study|Withdrawal by Subject|3
315839|NCT00729469|1035980|P2|Overall Study|Other-Not mentioned|4
315840|NCT00729469|1035981|P1|Overall Study|Other-Not mentioned|9
315841|NCT00729469|1035980|P2|Overall Study|Withdrawal by Subject|8
315842|NCT00729469|1035981|P1|Overall Study|Withdrawal by Subject|19
315843|NCT00729469|1035980|P2|Overall Study|Protocol Violation|1
315844|NCT00729469|1035981|P1|Overall Study|Protocol Violation|2
315845|NCT00729469|1035980|P2|Overall Study|Lost to Follow-up|9
315846|NCT00729469|1035981|P1|Overall Study|Lost to Follow-up|9
315847|NCT00729469|1035980|P2|Overall Study|Adverse Event|25
315848|NCT00729469|1035981|P1|Overall Study|Adverse Event|14
315849|NCT00729365|1036035|P3|Overall Study|Physician Decision|7
315850|NCT00729365|1036036|P2|Overall Study|Physician Decision|6
315851|NCT00729365|1036037|P1|Overall Study|Physician Decision|33
315852|NCT00729326|1036050|P2|Overall Study|Sponsor Decision|2
315853|NCT00729326|1036051|P1|Overall Study|Sponsor Decision|1
315854|NCT00729326|1036050|P2|Overall Study|Subject Decision|4
315855|NCT00729326|1036051|P1|Overall Study|Subject Decision|4
315856|NCT00729326|1036050|P2|Overall Study|Protocol Violation|2
315857|NCT00729326|1036051|P1|Overall Study|Protocol Violation|3
315858|NCT00729326|1036050|P2|Overall Study|Physician Decision|1
315859|NCT00729326|1036051|P1|Overall Study|Physician Decision|0
315860|NCT00729326|1036050|P2|Overall Study|Lost to Follow-up|0
315861|NCT00729326|1036051|P1|Overall Study|Lost to Follow-up|2
315862|NCT00729248|1036093|P1|Overall Study|Physician Decision|2
315863|NCT00729183|1036100|P2|Overall Study|Withdrawal by Subject|7
315864|NCT00729183|1036101|P1|Overall Study|Withdrawal by Subject|9
315865|NCT00729183|1036100|P2|Overall Study|Protocol Violation|0
315866|NCT00729183|1036101|P1|Overall Study|Protocol Violation|1
315867|NCT00729183|1036100|P2|Overall Study|Physician Decision|1
315868|NCT00729183|1036101|P1|Overall Study|Physician Decision|1
315869|NCT00729183|1036100|P2|Overall Study|Lost to Follow-up|1
315870|NCT00729183|1036101|P1|Overall Study|Lost to Follow-up|3
315871|NCT00729183|1036100|P2|Overall Study|Lack of Efficacy|1
315872|NCT00729183|1036101|P1|Overall Study|Lack of Efficacy|0
315873|NCT00729183|1036100|P2|Overall Study|Adverse Event|5
315874|NCT00729183|1036101|P1|Overall Study|Adverse Event|11
315875|NCT00729157|1036133|P1|Overall Study|Withdrawal by Subject|1
315876|NCT00728988|1036143|P2|Overall Study|Withdrawal by Subject|6
315877|NCT00728988|1036144|P1|Overall Study|Withdrawal by Subject|2
315878|NCT00728988|1036143|P2|Overall Study|Unspecified|77
315879|NCT00728988|1036144|P1|Overall Study|Unspecified|85
315880|NCT00728988|1036143|P2|Overall Study|Adverse Event|2
315881|NCT00728988|1036144|P1|Overall Study|Adverse Event|3
315882|NCT00728988|1036143|P2|Overall Study|Death|1
315883|NCT00728988|1036144|P1|Overall Study|Death|1
315884|NCT00728988|1036143|P2|Overall Study|Not Treated|2
315885|NCT00728988|1036144|P1|Overall Study|Not Treated|2
315886|NCT00728962|1036162|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
315887|NCT00728962|1036162|P1|Permanent Prosthesis Placement|Adverse Event|3
315888|NCT00728962|1036162|P1|Implant Placement Surgery|Protocol Violation|1
315889|NCT00728962|1036162|P1|Implant Placement Surgery|Lost to Follow-up|1
315890|NCT00728962|1036162|P1|Implant Placement Surgery|Adverse Event|8
315891|NCT00728884|1036183|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
315892|NCT00728884|1036183|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
315893|NCT00728754|1036206|P2|One Year Post Placement Follow-up|Adverse Event|0
315894|NCT00728754|1036207|P1|One Year Post Placement Follow-up|Adverse Event|1
315895|NCT00728754|1036206|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
315896|NCT00728754|1036207|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
315897|NCT00728754|1036206|P2|Permanent Prosthesis Placement|Adverse Event|1
315898|NCT00728754|1036207|P1|Permanent Prosthesis Placement|Adverse Event|1
315899|NCT00726986|1036234|P1|Maintenance Phase|Lack of Efficacy|2
315900|NCT00726986|1036234|P1|Maintenance Phase|Adverse Event|1
315901|NCT00726986|1036234|P1|Induction Phase|Secondary Disease|2
315902|NCT00726986|1036234|P1|Induction Phase|Lack of Efficacy|5
315903|NCT00726986|1036234|P1|Induction Phase|Death|2
315904|NCT00726986|1036234|P1|Induction Phase|Withdrawal by Subject|2
315905|NCT00726986|1036234|P1|Induction Phase|Adverse Event|4
315906|NCT00726895|1036241|P2|Washout Period of 7 Days|Withdrawal by Subject|1
315907|NCT00726895|1036242|P1|Washout Period of 7 Days|Withdrawal by Subject|0
315908|NCT00726882|1036255|P1|Overall Study|Not Specified|10
315909|NCT00726882|1036255|P1|Overall Study|Lost to Follow-up|7
315910|NCT00726882|1036255|P1|Overall Study|Withdrawal by Subject|5
315911|NCT00728689|1036272|P2|Washout Period (Days 4 - 10)|Death in family|0
315912|NCT00728689|1036273|P1|Washout Period (Days 4 - 10)|Death in family|1
315913|NCT00728494|1036302|P2|Overall Study|No data available|1
315914|NCT00728494|1036303|P1|Overall Study|No data available|0
315915|NCT00728494|1036302|P2|Overall Study|Lack of Efficacy|4
315916|NCT00728494|1036303|P1|Overall Study|Lack of Efficacy|2
315917|NCT00728494|1036302|P2|Overall Study|Withdrawal by Subject|2
315918|NCT00728494|1036303|P1|Overall Study|Withdrawal by Subject|0
315919|NCT00728494|1036302|P2|Overall Study|Adverse Event|0
315920|NCT00728494|1036303|P1|Overall Study|Adverse Event|7
315921|NCT00728481|1036321|P2|Overall Study|Incorrectly assigned to opposite arm|0
315922|NCT00728481|1036322|P1|Overall Study|Incorrectly assigned to opposite arm|1
315923|NCT00728481|1036321|P2|Overall Study|Study medication non-compliance|2
315924|NCT00728481|1036322|P1|Overall Study|Study medication non-compliance|0
315925|NCT00728481|1036321|P2|Overall Study|Adverse Event|1
315926|NCT00728481|1036322|P1|Overall Study|Adverse Event|0
315927|NCT00728481|1036321|P2|Overall Study|Withdrawal by Subject|1
315928|NCT00728481|1036322|P1|Overall Study|Withdrawal by Subject|0
315929|NCT00728416|1036340|P2|Overall Study|Withdrawal by Subject|0
315930|NCT00728416|1036341|P1|Overall Study|Withdrawal by Subject|1
315931|NCT00728416|1036340|P2|Overall Study|Treatment Failure|1
315932|NCT00728416|1036341|P1|Overall Study|Treatment Failure|0
315933|NCT00728416|1036340|P2|Overall Study|Adverse Event|1
315934|NCT00728416|1036341|P1|Overall Study|Adverse Event|1
315935|NCT00728182|1036357|P2|Overall Study|Protocol Noncompliance|1
315936|NCT00728182|1036358|P1|Overall Study|Protocol Noncompliance|0
315937|NCT00728182|1036357|P2|Overall Study|Death|2
315938|NCT00728182|1036358|P1|Overall Study|Death|0
315939|NCT00728182|1036357|P2|Overall Study|Lost to Follow-up|0
315940|NCT00728182|1036358|P1|Overall Study|Lost to Follow-up|2
315941|NCT00728182|1036357|P2|Overall Study|Adverse Event|0
315942|NCT00728182|1036358|P1|Overall Study|Adverse Event|1
315943|NCT00728130|1036386|P1|Overall Study|Physician Decision|1
315944|NCT00728130|1036386|P1|Overall Study|Paperwork not completed in time|1
315945|NCT00728130|1036386|P1|Overall Study|Withdrawal by Subject|1
315946|NCT00727961|1036391|P1|Overall Study|Progression|30
315947|NCT00727961|1036391|P1|Overall Study|Patient's refusal|2
315948|NCT00727961|1036391|P1|Overall Study|Adverse Event|4
315949|NCT00727961|1036391|P1|Overall Study|Lost to Follow-up|1
315950|NCT00727909|1036401|P4|Overall Study|Death|0
315951|NCT00727909|1036402|P3|Overall Study|Death|1
315952|NCT00727909|1036403|P2|Overall Study|Death|0
315953|NCT00727909|1036404|P1|Overall Study|Death|0
315954|NCT00727909|1036401|P4|Overall Study|Withdrawal by Subject|5
315955|NCT00727909|1036402|P3|Overall Study|Withdrawal by Subject|8
315956|NCT00727909|1036403|P2|Overall Study|Withdrawal by Subject|11
315957|NCT00727909|1036404|P1|Overall Study|Withdrawal by Subject|5
315958|NCT00727844|1036501|P4|Initial Randomization|Physician Decision|0
315959|NCT00727844|1036502|P3|Initial Randomization|Physician Decision|0
315960|NCT00727844|1036503|P2|Initial Randomization|Physician Decision|0
315961|NCT00727844|1036504|P1|Initial Randomization|Physician Decision|2
315962|NCT00726752|1036509|P1|Overall Study|Lack of Efficacy|6
315963|NCT00727714|1036578|P1|Overall Study|Lost to Follow-up|2
315964|NCT00727649|1036588|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
315965|NCT00727649|1036589|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
315966|NCT00727649|1036588|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
315967|NCT00727649|1036589|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
315968|NCT00727649|1036588|P2|Second Intervention (4-weeks)|Death|0
315969|NCT00727649|1036589|P1|Second Intervention (4-weeks)|Death|1
315970|NCT00727649|1036588|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
315971|NCT00727649|1036589|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
315972|NCT00727649|1036588|P2|Wash-out (2-weeks)|Lost to Follow-up|1
315973|NCT00727649|1036589|P1|Wash-out (2-weeks)|Lost to Follow-up|3
315974|NCT00727649|1036588|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
315975|NCT00727649|1036589|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
315976|NCT00727649|1036588|P2|First Intervention (4-weeks)|Lost to Follow-up|2
315977|NCT00727649|1036589|P1|First Intervention (4-weeks)|Lost to Follow-up|1
315978|NCT00727571|1036631|P4|Overall Study|Other|0
315979|NCT00727571|1036632|P3|Overall Study|Other|6
315980|NCT00727571|1036633|P2|Overall Study|Other|4
315981|NCT00727571|1036634|P1|Overall Study|Other|0
315982|NCT00727571|1036631|P4|Overall Study|AE not leading to hospitalization|0
315983|NCT00727571|1036632|P3|Overall Study|AE not leading to hospitalization|2
315984|NCT00727571|1036633|P2|Overall Study|AE not leading to hospitalization|0
315985|NCT00727571|1036634|P1|Overall Study|AE not leading to hospitalization|0
315986|NCT00727571|1036631|P4|Overall Study|Hospitalization|1
315987|NCT00727571|1036632|P3|Overall Study|Hospitalization|0
315988|NCT00727571|1036633|P2|Overall Study|Hospitalization|1
315989|NCT00727571|1036634|P1|Overall Study|Hospitalization|0
315990|NCT00727571|1036631|P4|Overall Study|Dismissed from nursing home|0
315991|NCT00727571|1036632|P3|Overall Study|Dismissed from nursing home|5
315992|NCT00727571|1036633|P2|Overall Study|Dismissed from nursing home|9
315993|NCT00727571|1036634|P1|Overall Study|Dismissed from nursing home|0
315994|NCT00727571|1036631|P4|Overall Study|Subject Non Compliance|4
315995|NCT00727571|1036632|P3|Overall Study|Subject Non Compliance|0
315996|NCT00727571|1036633|P2|Overall Study|Subject Non Compliance|6
315997|NCT00727571|1036634|P1|Overall Study|Subject Non Compliance|0
315998|NCT00727571|1036631|P4|Overall Study|Withdrawal by Subject|0
315999|NCT00727571|1036632|P3|Overall Study|Withdrawal by Subject|11
316000|NCT00727571|1036633|P2|Overall Study|Withdrawal by Subject|10
316001|NCT00727571|1036634|P1|Overall Study|Withdrawal by Subject|0
316002|NCT00727571|1036631|P4|Overall Study|Physician Decision|0
316003|NCT00727571|1036632|P3|Overall Study|Physician Decision|0
316004|NCT00727571|1036633|P2|Overall Study|Physician Decision|5
316005|NCT00727571|1036634|P1|Overall Study|Physician Decision|0
316006|NCT00727571|1036631|P4|Overall Study|Death|1
316007|NCT00727571|1036632|P3|Overall Study|Death|5
316008|NCT00727571|1036633|P2|Overall Study|Death|19
316009|NCT00727571|1036634|P1|Overall Study|Death|0
316010|NCT00727571|1036631|P4|Overall Study|Ineligibility determined|0
316011|NCT00727571|1036632|P3|Overall Study|Ineligibility determined|1
316012|NCT00727571|1036633|P2|Overall Study|Ineligibility determined|1
316013|NCT00727571|1036634|P1|Overall Study|Ineligibility determined|1
316014|NCT00727558|1036661|P2|Overall Study|Lost to Follow-up|0
316015|NCT00727558|1036662|P1|Overall Study|Lost to Follow-up|1
316016|NCT00727558|1036661|P2|Overall Study|Subject unable to return for follow-up|1
316017|NCT00727558|1036662|P1|Overall Study|Subject unable to return for follow-up|1
316018|NCT00727558|1036661|P2|Overall Study|Adverse Event|1
316019|NCT00727558|1036662|P1|Overall Study|Adverse Event|0
316020|NCT00727558|1036661|P2|Overall Study|Lens issue|1
316021|NCT00727558|1036662|P1|Overall Study|Lens issue|0
316022|NCT00727506|1036686|P6|Overall Study|Other reason not described above|1
316023|NCT00727506|1036687|P5|Overall Study|Other reason not described above|1
316024|NCT00727506|1036688|P4|Overall Study|Other reason not described above|4
316025|NCT00727506|1036689|P3|Overall Study|Other reason not described above|1
316026|NCT00727506|1036690|P2|Overall Study|Other reason not described above|0
316027|NCT00727506|1036691|P1|Overall Study|Other reason not described above|0
316028|NCT00727506|1036686|P6|Overall Study|Refused to continue medication|2
316029|NCT00727506|1036687|P5|Overall Study|Refused to continue medication|1
316030|NCT00727506|1036688|P4|Overall Study|Refused to continue medication|2
316031|NCT00727506|1036689|P3|Overall Study|Refused to continue medication|2
316032|NCT00727506|1036690|P2|Overall Study|Refused to continue medication|1
316033|NCT00727506|1036691|P1|Overall Study|Refused to continue medication|0
316034|NCT00727506|1036686|P6|Overall Study|Progressive disease|26
316035|NCT00727506|1036687|P5|Overall Study|Progressive disease|37
316036|NCT00727506|1036688|P4|Overall Study|Progressive disease|28
316037|NCT00727506|1036689|P3|Overall Study|Progressive disease|9
316038|NCT00727506|1036690|P2|Overall Study|Progressive disease|7
316039|NCT00727506|1036691|P1|Overall Study|Progressive disease|4
316040|NCT00727506|1036686|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
316041|NCT00727506|1036687|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
316042|NCT00727506|1036688|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
316043|NCT00727506|1036689|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
316044|NCT00727506|1036690|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
316045|NCT00727506|1036691|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
316046|NCT00727506|1036686|P6|Overall Study|Adverse Event|8
316047|NCT00727506|1036687|P5|Overall Study|Adverse Event|1
316048|NCT00727506|1036688|P4|Overall Study|Adverse Event|4
316049|NCT00727506|1036689|P3|Overall Study|Adverse Event|4
316050|NCT00727506|1036690|P2|Overall Study|Adverse Event|0
316051|NCT00727506|1036691|P1|Overall Study|Adverse Event|0
316052|NCT00727402|1036711|P1|Overall Study|Physician Decision|116
316053|NCT00727311|1036732|P1|Overall Study|Multiple reasons|39
316054|NCT00727311|1036732|P1|Overall Study|not specified|97
316055|NCT00727311|1036732|P1|Overall Study|Withdrawal by Subject|77
316056|NCT00727311|1036732|P1|Overall Study|Lost to Follow-up|73
316057|NCT00727311|1036732|P1|Overall Study|Lack of Efficacy|242
316058|NCT00727311|1036732|P1|Overall Study|Adverse Event|58
316059|NCT00727311|1036732|P1|Overall Study|Missing end of therapy data|205
316060|NCT00727311|1036732|P1|Overall Study|Did not receive drug|316
316061|NCT00727272|1036745|P3|Washout Period B|Withdrawal by Subject|1
316062|NCT00727272|1036746|P2|Washout Period B|Withdrawal by Subject|0
316063|NCT00727272|1036747|P1|Washout Period B|Withdrawal by Subject|0
316064|NCT00727272|1036745|P3|Washout Period A|Adverse Event|1
316065|NCT00727272|1036746|P2|Washout Period A|Adverse Event|0
316066|NCT00727272|1036747|P1|Washout Period A|Adverse Event|0
316067|NCT00727259|1036764|P1|Overall Study|Not all questionnaires completed|1055
316068|NCT00727194|1036778|P3|Treatment Period 2|Lack of Efficacy|0
316069|NCT00727194|1036779|P2|Treatment Period 2|Lack of Efficacy|1
316070|NCT00727194|1036780|P1|Treatment Period 2|Lack of Efficacy|0
316071|NCT00727194|1036778|P3|Screening Period|History of thymoma|1
316072|NCT00727194|1036779|P2|Screening Period|History of thymoma|0
316073|NCT00727194|1036780|P1|Screening Period|History of thymoma|0
316074|NCT00727194|1036778|P3|Screening Period|Severe infections|2
316075|NCT00727194|1036779|P2|Screening Period|Severe infections|0
316076|NCT00727194|1036780|P1|Screening Period|Severe infections|0
316077|NCT00727194|1036778|P3|Screening Period|Not stable on concomitant MG therapy|2
316078|NCT00727194|1036779|P2|Screening Period|Not stable on concomitant MG therapy|0
316079|NCT00727194|1036780|P1|Screening Period|Not stable on concomitant MG therapy|0
316080|NCT00727194|1036778|P3|Screening Period|Lacked AChR antibodies|5
316081|NCT00727194|1036779|P2|Screening Period|Lacked AChR antibodies|0
316082|NCT00727194|1036780|P1|Screening Period|Lacked AChR antibodies|0
316083|NCT00727194|1036778|P3|Screening Period|Low QMG scores|6
316084|NCT00727194|1036779|P2|Screening Period|Low QMG scores|0
316085|NCT00727194|1036780|P1|Screening Period|Low QMG scores|0
316086|NCT00727025|1036852|P1|Overall Study|Physician Decision|23
316087|NCT00726999|1036864|P2|Overall Study|Protocol Violation|0
316088|NCT00726999|1036865|P1|Overall Study|Protocol Violation|1
316089|NCT00726999|1036864|P2|Overall Study|Withdrawal by Subject|0
316090|NCT00726999|1036865|P1|Overall Study|Withdrawal by Subject|2
316091|NCT00726999|1036864|P2|Overall Study|Physician Decision|1
316092|NCT00726999|1036865|P1|Overall Study|Physician Decision|0
316093|NCT00726661|1036877|P2|Overall Study|Not specified|35
316094|NCT00726661|1036878|P1|Overall Study|Not specified|47
316095|NCT00726661|1036877|P2|Overall Study|Physician Decision|13
316096|NCT00726661|1036878|P1|Overall Study|Physician Decision|25
316097|NCT00726661|1036877|P2|Overall Study|Death|159
316098|NCT00726661|1036878|P1|Overall Study|Death|475
316099|NCT00726661|1036877|P2|Overall Study|Trial terminated by sponsor|187
316100|NCT00726661|1036878|P1|Overall Study|Trial terminated by sponsor|214
316101|NCT00726661|1036877|P2|Overall Study|Withdrawal by Subject|13
316102|NCT00726661|1036878|P1|Overall Study|Withdrawal by Subject|17
316103|NCT00726661|1036877|P2|Overall Study|Lost to Follow-up|11
316104|NCT00726661|1036878|P1|Overall Study|Lost to Follow-up|36
316105|NCT00726622|1036895|P2|Overall Study|Metastasis|0
316106|NCT00726622|1036896|P1|Overall Study|Metastasis|2
316107|NCT00726622|1036895|P2|Overall Study|Physician Decision|1
316108|NCT00726622|1036896|P1|Overall Study|Physician Decision|0
316109|NCT00726622|1036895|P2|Overall Study|Withdrawal by Subject|2
316110|NCT00726622|1036896|P1|Overall Study|Withdrawal by Subject|16
316111|NCT00726609|1036914|P1|Overall Study|Other|3
316112|NCT00726609|1036914|P1|Overall Study|Missing|42
316113|NCT00726609|1036914|P1|Overall Study|Not specified|16
316114|NCT00726609|1036914|P1|Overall Study|Lack of Efficacy|25
316115|NCT00726609|1036914|P1|Overall Study|Withdrawal by Subject|2
316116|NCT00726609|1036914|P1|Overall Study|Adverse Event|10
316117|NCT00726557|1036918|P1|Overall Study|Inclusion criteria not met|15
316118|NCT00726557|1036918|P1|Overall Study|Treatment less than 3 months|17
316119|NCT00726557|1036918|P1|Overall Study|No follow-up documentation available|55
316120|NCT00726557|1036918|P1|Overall Study|No end of treatment documentation|37
316121|NCT00726557|1036918|P1|Overall Study|Screening failure|4
316122|NCT00726453|1036925|P2|38 mm Length Group|Death|3
316123|NCT00726453|1036926|P1|38 mm Length Group|Death|0
316124|NCT00726453|1036925|P2|Primary Enrollment Group|Withdrawal by Subject|0
316125|NCT00726453|1036926|P1|Primary Enrollment Group|Withdrawal by Subject|13
316126|NCT00726453|1036925|P2|Primary Enrollment Group|Death|0
316127|NCT00726453|1036926|P1|Primary Enrollment Group|Death|18
316128|NCT00726232|1036958|P6|Overall Study|No response|1
316129|NCT00726232|1036959|P5|Overall Study|No response|3
316130|NCT00726232|1036960|P4|Overall Study|No response|0
316131|NCT00726232|1036961|P3|Overall Study|No response|0
316132|NCT00726232|1036962|P2|Overall Study|No response|0
316133|NCT00726232|1036963|P1|Overall Study|No response|1
316134|NCT00726232|1036958|P6|Overall Study|Disease progression|0
316135|NCT00726232|1036959|P5|Overall Study|Disease progression|0
316136|NCT00726232|1036960|P4|Overall Study|Disease progression|0
316137|NCT00726232|1036961|P3|Overall Study|Disease progression|0
316138|NCT00726232|1036962|P2|Overall Study|Disease progression|0
316139|NCT00726232|1036963|P1|Overall Study|Disease progression|1
316140|NCT00726232|1036958|P6|Overall Study|Adverse Event|1
316141|NCT00726232|1036959|P5|Overall Study|Adverse Event|2
316142|NCT00726232|1036960|P4|Overall Study|Adverse Event|1
316143|NCT00726232|1036961|P3|Overall Study|Adverse Event|0
316144|NCT00726232|1036962|P2|Overall Study|Adverse Event|1
316145|NCT00726232|1036963|P1|Overall Study|Adverse Event|1
316146|NCT00726232|1036958|P6|Overall Study|Withdrawal by Subject|2
316147|NCT00726232|1036959|P5|Overall Study|Withdrawal by Subject|0
316148|NCT00726232|1036960|P4|Overall Study|Withdrawal by Subject|0
316149|NCT00726232|1036961|P3|Overall Study|Withdrawal by Subject|0
316150|NCT00726232|1036962|P2|Overall Study|Withdrawal by Subject|0
316151|NCT00726232|1036963|P1|Overall Study|Withdrawal by Subject|2
316152|NCT00726063|1037013|P2|Overall Study|Adverse Event|7
316153|NCT00726063|1037014|P1|Overall Study|Adverse Event|9
316154|NCT00725985|1037028|P12|LTFU (No Cladribine Treatment)|Unspecified|14
316155|NCT00725985|1037029|P11|LTFU (No Cladribine Treatment)|Unspecified|36
316156|NCT00725985|1037030|P10|LTFU (No Cladribine Treatment)|Unspecified|34
316157|NCT00725985|1037031|P9|LTFU (No Cladribine Treatment)|Unspecified|0
316158|NCT00725985|1037032|P8|LTFU (No Cladribine Treatment)|Unspecified|0
316159|NCT00725985|1037033|P7|LTFU (No Cladribine Treatment)|Unspecified|0
316160|NCT00725985|1037034|P6|LTFU (No Cladribine Treatment)|Unspecified|0
316161|NCT00725985|1037035|P5|LTFU (No Cladribine Treatment)|Unspecified|0
316162|NCT00725985|1037036|P4|LTFU (No Cladribine Treatment)|Unspecified|0
316163|NCT00725985|1037037|P3|LTFU (No Cladribine Treatment)|Unspecified|0
316164|NCT00725985|1037038|P2|LTFU (No Cladribine Treatment)|Unspecified|0
316165|NCT00725985|1037039|P1|LTFU (No Cladribine Treatment)|Unspecified|0
316166|NCT00725985|1037028|P12|LTFU (With Cladribine Treatment)|Unspecified|0
316167|NCT00725985|1037029|P11|LTFU (With Cladribine Treatment)|Unspecified|0
316168|NCT00725985|1037030|P10|LTFU (With Cladribine Treatment)|Unspecified|0
316169|NCT00725985|1037031|P9|LTFU (With Cladribine Treatment)|Unspecified|16
316170|NCT00725985|1037032|P8|LTFU (With Cladribine Treatment)|Unspecified|8
316171|NCT00725985|1037033|P7|LTFU (With Cladribine Treatment)|Unspecified|9
316172|NCT00725985|1037034|P6|LTFU (With Cladribine Treatment)|Unspecified|0
316173|NCT00725985|1037035|P5|LTFU (With Cladribine Treatment)|Unspecified|0
316174|NCT00725985|1037036|P4|LTFU (With Cladribine Treatment)|Unspecified|0
316175|NCT00725985|1037037|P3|LTFU (With Cladribine Treatment)|Unspecified|0
316176|NCT00725985|1037038|P2|LTFU (With Cladribine Treatment)|Unspecified|0
316177|NCT00725985|1037039|P1|LTFU (With Cladribine Treatment)|Unspecified|0
316178|NCT00725985|1037028|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316179|NCT00725985|1037029|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316180|NCT00725985|1037030|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316181|NCT00725985|1037031|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
316182|NCT00725985|1037032|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316183|NCT00725985|1037033|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316184|NCT00725985|1037034|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316185|NCT00725985|1037035|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316186|NCT00725985|1037036|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316187|NCT00725985|1037037|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316188|NCT00725985|1037038|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316189|NCT00725985|1037039|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
316190|NCT00725985|1037028|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
316191|NCT00725985|1037029|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
316192|NCT00725985|1037030|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
316193|NCT00725985|1037031|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
316194|NCT00725985|1037032|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
316195|NCT00725985|1037033|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
316196|NCT00725985|1037034|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
316197|NCT00725985|1037035|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
316198|NCT00725985|1037036|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
316199|NCT00725985|1037037|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
316200|NCT00725985|1037038|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
316201|NCT00725985|1037039|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
316202|NCT00725985|1037028|P12|OLMP|Unspecified|0
316203|NCT00725985|1037029|P11|OLMP|Unspecified|0
316204|NCT00725985|1037030|P10|OLMP|Unspecified|0
316205|NCT00725985|1037031|P9|OLMP|Unspecified|0
316206|NCT00725985|1037032|P8|OLMP|Unspecified|0
316207|NCT00725985|1037033|P7|OLMP|Unspecified|0
316208|NCT00725985|1037034|P6|OLMP|Unspecified|44
316209|NCT00725985|1037035|P5|OLMP|Unspecified|20
316210|NCT00725985|1037036|P4|OLMP|Unspecified|15
316211|NCT00725985|1037037|P3|OLMP|Unspecified|0
316212|NCT00725985|1037038|P2|OLMP|Unspecified|0
316213|NCT00725985|1037039|P1|OLMP|Unspecified|0
316214|NCT00725985|1037028|P12|OLMP|Disease progression|0
316215|NCT00725985|1037029|P11|OLMP|Disease progression|0
316216|NCT00725985|1037030|P10|OLMP|Disease progression|0
316217|NCT00725985|1037031|P9|OLMP|Disease progression|0
316218|NCT00725985|1037032|P8|OLMP|Disease progression|0
316219|NCT00725985|1037033|P7|OLMP|Disease progression|0
316220|NCT00725985|1037034|P6|OLMP|Disease progression|4
316221|NCT00725985|1037035|P5|OLMP|Disease progression|0
316222|NCT00725985|1037036|P4|OLMP|Disease progression|0
316223|NCT00725985|1037037|P3|OLMP|Disease progression|0
316224|NCT00725985|1037038|P2|OLMP|Disease progression|0
316225|NCT00725985|1037039|P1|OLMP|Disease progression|0
316226|NCT00725985|1037028|P12|OLMP|Lost to Follow-up|0
316227|NCT00725985|1037029|P11|OLMP|Lost to Follow-up|0
316228|NCT00725985|1037030|P10|OLMP|Lost to Follow-up|0
316229|NCT00725985|1037031|P9|OLMP|Lost to Follow-up|0
316230|NCT00725985|1037032|P8|OLMP|Lost to Follow-up|0
316231|NCT00725985|1037033|P7|OLMP|Lost to Follow-up|0
316232|NCT00725985|1037034|P6|OLMP|Lost to Follow-up|0
316233|NCT00725985|1037035|P5|OLMP|Lost to Follow-up|0
316234|NCT00725985|1037036|P4|OLMP|Lost to Follow-up|1
316235|NCT00725985|1037037|P3|OLMP|Lost to Follow-up|0
316236|NCT00725985|1037038|P2|OLMP|Lost to Follow-up|0
316237|NCT00725985|1037039|P1|OLMP|Lost to Follow-up|0
316238|NCT00725985|1037028|P12|OLMP|Death|0
316239|NCT00725985|1037029|P11|OLMP|Death|0
316240|NCT00725985|1037030|P10|OLMP|Death|0
316241|NCT00725985|1037031|P9|OLMP|Death|0
316242|NCT00725985|1037032|P8|OLMP|Death|0
316243|NCT00725985|1037033|P7|OLMP|Death|0
316244|NCT00725985|1037034|P6|OLMP|Death|0
316245|NCT00725985|1037035|P5|OLMP|Death|1
316246|NCT00725985|1037036|P4|OLMP|Death|0
316250|NCT00725985|1037028|P12|OLMP|Adverse Event|0
316251|NCT00725985|1037029|P11|OLMP|Adverse Event|0
316252|NCT00725985|1037030|P10|OLMP|Adverse Event|0
316253|NCT00725985|1037031|P9|OLMP|Adverse Event|0
316254|NCT00725985|1037032|P8|OLMP|Adverse Event|0
316255|NCT00725985|1037033|P7|OLMP|Adverse Event|0
316256|NCT00725985|1037034|P6|OLMP|Adverse Event|5
316257|NCT00725985|1037035|P5|OLMP|Adverse Event|2
316258|NCT00725985|1037036|P4|OLMP|Adverse Event|2
316259|NCT00725985|1037037|P3|OLMP|Adverse Event|0
316260|NCT00725985|1037038|P2|OLMP|Adverse Event|0
316261|NCT00725985|1037039|P1|OLMP|Adverse Event|0
316262|NCT00725985|1037028|P12|ITP (Up to 96 Weeks)|Unspecified|0
316263|NCT00725985|1037029|P11|ITP (Up to 96 Weeks)|Unspecified|0
316264|NCT00725985|1037030|P10|ITP (Up to 96 Weeks)|Unspecified|0
316265|NCT00725985|1037031|P9|ITP (Up to 96 Weeks)|Unspecified|0
316266|NCT00725985|1037032|P8|ITP (Up to 96 Weeks)|Unspecified|0
316267|NCT00725985|1037033|P7|ITP (Up to 96 Weeks)|Unspecified|0
316268|NCT00725985|1037034|P6|ITP (Up to 96 Weeks)|Unspecified|0
316269|NCT00725985|1037035|P5|ITP (Up to 96 Weeks)|Unspecified|0
316270|NCT00725985|1037036|P4|ITP (Up to 96 Weeks)|Unspecified|0
316271|NCT00725985|1037037|P3|ITP (Up to 96 Weeks)|Unspecified|24
316272|NCT00725985|1037038|P2|ITP (Up to 96 Weeks)|Unspecified|38
316273|NCT00725985|1037039|P1|ITP (Up to 96 Weeks)|Unspecified|50
316274|NCT00725985|1037028|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
316275|NCT00725985|1037029|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
316276|NCT00725985|1037030|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
316277|NCT00725985|1037031|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
316278|NCT00725985|1037032|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
316279|NCT00725985|1037033|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
316280|NCT00725985|1037034|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
316281|NCT00725985|1037035|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
316282|NCT00725985|1037036|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
316283|NCT00725985|1037037|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
316284|NCT00725985|1037038|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
316285|NCT00725985|1037039|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
316286|NCT00725985|1037028|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
316287|NCT00725985|1037029|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
316288|NCT00725985|1037030|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
316289|NCT00725985|1037031|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
316290|NCT00725985|1037032|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
316291|NCT00725985|1037033|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
316292|NCT00725985|1037034|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
316293|NCT00725985|1037035|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
316294|NCT00725985|1037036|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
316295|NCT00725985|1037037|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
316296|NCT00725985|1037038|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
316297|NCT00725985|1037039|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
316298|NCT00725985|1037028|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316299|NCT00725985|1037029|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316300|NCT00725985|1037030|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316301|NCT00725985|1037031|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316302|NCT00725985|1037032|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316303|NCT00725985|1037033|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316304|NCT00725985|1037034|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316305|NCT00725985|1037035|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316306|NCT00725985|1037036|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316307|NCT00725985|1037037|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
316308|NCT00725985|1037038|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316309|NCT00725985|1037039|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
316310|NCT00725985|1037028|P12|ITP (Up to 96 Weeks)|Adverse Event|0
316311|NCT00725985|1037029|P11|ITP (Up to 96 Weeks)|Adverse Event|0
316312|NCT00725985|1037030|P10|ITP (Up to 96 Weeks)|Adverse Event|0
316313|NCT00725985|1037031|P9|ITP (Up to 96 Weeks)|Adverse Event|0
316314|NCT00725985|1037032|P8|ITP (Up to 96 Weeks)|Adverse Event|0
316315|NCT00725985|1037033|P7|ITP (Up to 96 Weeks)|Adverse Event|0
316316|NCT00725985|1037034|P6|ITP (Up to 96 Weeks)|Adverse Event|0
316317|NCT00725985|1037035|P5|ITP (Up to 96 Weeks)|Adverse Event|0
316318|NCT00725985|1037036|P4|ITP (Up to 96 Weeks)|Adverse Event|0
316319|NCT00725985|1037037|P3|ITP (Up to 96 Weeks)|Adverse Event|5
316320|NCT00725985|1037038|P2|ITP (Up to 96 Weeks)|Adverse Event|10
316321|NCT00725985|1037039|P1|ITP (Up to 96 Weeks)|Adverse Event|20
316322|NCT00725920|1037067|P2|Overall Study|Lack of Efficacy|6
316323|NCT00725920|1037068|P1|Overall Study|Lack of Efficacy|3
316324|NCT00725842|1037074|P1|Overall Study|No Visit 1 data|1
316325|NCT00725842|1037074|P1|Overall Study|Inclusion criterion not met|1
316326|NCT00725842|1037074|P1|Overall Study|Consent date prior to study start date|5
316327|NCT00725842|1037074|P1|Overall Study|Positive HCV-RNA at Visit 2|13
316328|NCT00725842|1037074|P1|Overall Study|Death|1
316329|NCT00725842|1037074|P1|Overall Study|Lost to Follow-up|19
316330|NCT00725725|1037096|P3|Overall Study|Protocol Violation|0
316331|NCT00725725|1037097|P2|Overall Study|Protocol Violation|1
316332|NCT00725725|1037098|P1|Overall Study|Protocol Violation|0
316333|NCT00725725|1037096|P3|Overall Study|Withdrawal by Subject|1
316334|NCT00725725|1037097|P2|Overall Study|Withdrawal by Subject|0
316335|NCT00725725|1037098|P1|Overall Study|Withdrawal by Subject|1
316336|NCT00725725|1037096|P3|Overall Study|Lost to Follow-up|2
316337|NCT00725725|1037097|P2|Overall Study|Lost to Follow-up|0
316338|NCT00725725|1037098|P1|Overall Study|Lost to Follow-up|2
316339|NCT00725725|1037096|P3|Overall Study|Adverse Event|2
316340|NCT00725725|1037097|P2|Overall Study|Adverse Event|3
316341|NCT00725725|1037098|P1|Overall Study|Adverse Event|1
316342|NCT00725621|1037139|P1|Overall Study|Reason not specified|55
316343|NCT00725621|1037139|P1|Overall Study|Prepared for elective surgery|1
316344|NCT00725621|1037139|P1|Overall Study|Switched to other drug|1
316345|NCT00725621|1037139|P1|Overall Study|Switched to other study|1
316346|NCT00725621|1037139|P1|Overall Study|Continued treatment by other physician|6
316347|NCT00725621|1037139|P1|Overall Study|Non-compliance|8
316348|NCT00725621|1037139|P1|Overall Study|Lost to Follow-up|52
316349|NCT00725621|1037139|P1|Overall Study|Physician Decision|19
316350|NCT00725621|1037139|P1|Overall Study|Withdrawal by Subject|57
316351|NCT00725621|1037139|P1|Overall Study|Lack of Efficacy|46
316352|NCT00725621|1037139|P1|Overall Study|Adverse Event|25
316353|NCT00725608|1037162|P1|Overall Study|Other|7
316354|NCT00725608|1037162|P1|Overall Study|Individual reasons|86
316355|NCT00725608|1037162|P1|Overall Study|Adverse Event|14
316356|NCT00725608|1037162|P1|Overall Study|Lost to Follow-up|60
316357|NCT00725543|1037168|P1|Overall Study|Not specified|119
316358|NCT00725543|1037168|P1|Overall Study|Non-compliance|2
316359|NCT00725543|1037168|P1|Overall Study|Lost to Follow-up|4
316360|NCT00725543|1037168|P1|Overall Study|Physician Decision|5
316361|NCT00725543|1037168|P1|Overall Study|Withdrawal by Subject|10
316362|NCT00725543|1037168|P1|Overall Study|Lack of Efficacy|3
316363|NCT00725543|1037168|P1|Overall Study|Adverse Event|10
316364|NCT00725491|1037193|P2|Overall Study|No/too few embryos/ bad quality embryos|2
316365|NCT00725491|1037194|P1|Overall Study|No/too few embryos/ bad quality embryos|3
316366|NCT00725491|1037193|P2|Overall Study|Fertilization failure|1
316367|NCT00725491|1037194|P1|Overall Study|Fertilization failure|0
316368|NCT00725491|1037193|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
316369|NCT00725491|1037194|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
316370|NCT00725491|1037193|P2|Overall Study|Risk for hyperstimulation|9
316371|NCT00725491|1037194|P1|Overall Study|Risk for hyperstimulation|2
316372|NCT00725491|1037193|P2|Overall Study|Pregnancy|3
316373|NCT00725491|1037194|P1|Overall Study|Pregnancy|0
316374|NCT00725491|1037193|P2|Overall Study|Adverse Event|2
316375|NCT00725491|1037194|P1|Overall Study|Adverse Event|3
316376|NCT00725452|1037200|P1|Overall Study|Lost to Follow-up|1
316377|NCT00725452|1037200|P1|Overall Study|Withdrawal by Subject|3
316378|NCT00725452|1037200|P1|Overall Study|Physician Decision|1
316379|NCT00725452|1037200|P1|Overall Study|Reason not specified|1
316380|NCT00725452|1037200|P1|Overall Study|Lack of Efficacy|2
316381|NCT00725452|1037200|P1|Overall Study|Adverse Event|3
316382|NCT00725296|1037217|P1|Overall Study|Not Specified|38
316383|NCT00725296|1037217|P1|Overall Study|Lost to Follow-up|1
316384|NCT00725296|1037217|P1|Overall Study|Non-Compliance|2
316385|NCT00725296|1037217|P1|Overall Study|Withdrawal by Subject|3
316386|NCT00725296|1037217|P1|Overall Study|Lack of Efficacy|7
316387|NCT00725296|1037217|P1|Overall Study|Adverse Event|11
316388|NCT00725205|1037237|P1|Overall Study|Treatment Failure|41
316389|NCT00725205|1037237|P1|Overall Study|Protocol Defined Clinical Event|1
316390|NCT00725205|1037237|P1|Overall Study|Other|8
316391|NCT00725205|1037237|P1|Overall Study|Non-compliance With Protocol|14
316392|NCT00725205|1037237|P1|Overall Study|Investigator Discontinued|1
316393|NCT00725205|1037237|P1|Overall Study|Adverse Event|22
316394|NCT00725101|1037250|P1|Overall Study|not specified/no reason given|11
316395|NCT00725101|1037250|P1|Overall Study|Withdrawal by Subject|127
316396|NCT00725101|1037250|P1|Overall Study|Protocol Violation|1
316397|NCT00725101|1037250|P1|Overall Study|Lost to Follow-up|353
316398|NCT00725101|1037250|P1|Overall Study|Death|3
316399|NCT00725075|1037273|P3|Overall Study|Other|0
316400|NCT00725075|1037274|P2|Overall Study|Other|0
316401|NCT00725075|1037275|P1|Overall Study|Other|1
316402|NCT00725075|1037273|P3|Overall Study|Inclusion/Exclusion Criteria|1
316403|NCT00725075|1037274|P2|Overall Study|Inclusion/Exclusion Criteria|0
316404|NCT00725075|1037275|P1|Overall Study|Inclusion/Exclusion Criteria|1
316405|NCT00725075|1037273|P3|Overall Study|Worsening of Disease|2
316406|NCT00725075|1037274|P2|Overall Study|Worsening of Disease|1
316407|NCT00725075|1037275|P1|Overall Study|Worsening of Disease|2
316408|NCT00725075|1037273|P3|Overall Study|Adverse Event|1
316409|NCT00725075|1037274|P2|Overall Study|Adverse Event|1
316410|NCT00725075|1037275|P1|Overall Study|Adverse Event|2
316411|NCT00725075|1037273|P3|Overall Study|Withdrawal by Subject|4
316412|NCT00725075|1037274|P2|Overall Study|Withdrawal by Subject|5
316413|NCT00725075|1037275|P1|Overall Study|Withdrawal by Subject|4
316414|NCT00725075|1037273|P3|Overall Study|Lost to Follow-up|0
316415|NCT00725075|1037274|P2|Overall Study|Lost to Follow-up|0
316416|NCT00725075|1037275|P1|Overall Study|Lost to Follow-up|1
316417|NCT00725075|1037273|P3|Overall Study|Protocol Violation|1
316418|NCT00725075|1037274|P2|Overall Study|Protocol Violation|0
316419|NCT00725075|1037275|P1|Overall Study|Protocol Violation|0
316420|NCT00725075|1037273|P3|Overall Study|Use of Excluded Medication|0
316421|NCT00725075|1037274|P2|Overall Study|Use of Excluded Medication|1
316422|NCT00725075|1037275|P1|Overall Study|Use of Excluded Medication|0
316423|NCT00725010|1037328|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
316424|NCT00725010|1037328|P1|Overall Study|No further documentation|1
316425|NCT00725010|1037328|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
316426|NCT00725010|1037328|P1|Overall Study|Hepatopathy probably not Temodal-related|1
316427|NCT00725010|1037328|P1|Overall Study|Lost to Follow-up|1
316428|NCT00725010|1037328|P1|Overall Study|Death|1
316429|NCT00725010|1037328|P1|Overall Study|Withdrawal by Subject|2
316430|NCT00725010|1037328|P1|Overall Study|Tumor Progression|7
316431|NCT00725010|1037328|P1|Overall Study|Toxicity|9
316432|NCT00724958|1037361|P1|Overall Study|No documentation for end of therapy|13
316433|NCT00724958|1037361|P1|Overall Study|Other Reason|76
316434|NCT00724958|1037361|P1|Overall Study|Remission|7
316435|NCT00724958|1037361|P1|Overall Study|No Response|18
316436|NCT00724958|1037361|P1|Overall Study|Loss of Response|40
316437|NCT00724958|1037361|P1|Overall Study|Adverse Event|28
316438|NCT00724945|1037370|P2|Period 2|lens physiology issue|0
316439|NCT00724945|1037371|P1|Period 2|lens physiology issue|1
316440|NCT00724945|1037370|P2|Period 2|lens comfort issue|0
316441|NCT00724945|1037371|P1|Period 2|lens comfort issue|3
316442|NCT00724945|1037370|P2|Period 1|Lost to Follow-up|0
316443|NCT00724945|1037371|P1|Period 1|Lost to Follow-up|1
316444|NCT00724945|1037370|P2|Period 1|Adverse Event|1
316445|NCT00724945|1037371|P1|Period 1|Adverse Event|1
316446|NCT00724945|1037370|P2|Period 1|non-compliance|0
316447|NCT00724945|1037371|P1|Period 1|non-compliance|1
316448|NCT00724932|1037383|P2|Overall Study|Not treated|3
316449|NCT00724932|1037384|P1|Overall Study|Not treated|4
316450|NCT00724932|1037383|P2|Overall Study|Lost to Follow-up|0
316451|NCT00724932|1037384|P1|Overall Study|Lost to Follow-up|1
316452|NCT00724893|1037455|P2|Overall Study|Unknown, missing data|1
316453|NCT00724893|1037456|P1|Overall Study|Unknown, missing data|1
316454|NCT00724893|1037455|P2|Overall Study|Lost to Follow-up|52
316455|NCT00724893|1037456|P1|Overall Study|Lost to Follow-up|0
316456|NCT00724893|1037455|P2|Overall Study|Assigned shorter treatment|2
316457|NCT00724893|1037456|P1|Overall Study|Assigned shorter treatment|0
316458|NCT00724893|1037455|P2|Overall Study|Financial reasons|2
316459|NCT00724893|1037456|P1|Overall Study|Financial reasons|0
316460|NCT00724893|1037455|P2|Overall Study|Substance abuse|3
316461|NCT00724893|1037456|P1|Overall Study|Substance abuse|0
316462|NCT00724893|1037455|P2|Overall Study|Incarceration|9
316463|NCT00724893|1037456|P1|Overall Study|Incarceration|0
316464|NCT00724893|1037455|P2|Overall Study|Geographic reasons|11
316465|NCT00724893|1037456|P1|Overall Study|Geographic reasons|0
316466|NCT00724893|1037455|P2|Overall Study|Patient choice|26
316467|NCT00724893|1037456|P1|Overall Study|Patient choice|0
316468|NCT00724893|1037455|P2|Overall Study|Reason not specified|7
316469|NCT00724893|1037456|P1|Overall Study|Reason not specified|193
316470|NCT00724893|1037455|P2|Overall Study|Lack of virologic response|202
316471|NCT00724893|1037456|P1|Overall Study|Lack of virologic response|94
316472|NCT00724893|1037455|P2|Overall Study|Withdrawal by Subject|1
316473|NCT00724893|1037456|P1|Overall Study|Withdrawal by Subject|0
316474|NCT00724893|1037455|P2|Overall Study|Adverse Event|142
316475|NCT00724893|1037456|P1|Overall Study|Adverse Event|76
316476|NCT00724867|1037524|P1|Overall Study|Elected to exit due to site closure|2
316477|NCT00724867|1037524|P1|Overall Study|Subject moved out of state|1
316478|NCT00724867|1037524|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
316479|NCT00724867|1037524|P1|Overall Study|Subject incarcerated|1
316480|NCT00724867|1037524|P1|Overall Study|Sponsor decision to end study|14
316481|NCT00724867|1037524|P1|Overall Study|Withdrawal by Subject|31
316482|NCT00724867|1037524|P1|Overall Study|Protocol Violation|1
316483|NCT00724867|1037524|P1|Overall Study|Physician Decision|17
316484|NCT00724867|1037524|P1|Overall Study|Non-compliance with study drug|6
316485|NCT00724867|1037524|P1|Overall Study|Lost to Follow-up|12
316486|NCT00724867|1037524|P1|Overall Study|Lack of Efficacy|14
316487|NCT00724867|1037524|P1|Overall Study|Adverse Event|25
316488|NCT00724854|1037564|P2|Overall Study|Adverse event + lack of efficacy|1
316489|NCT00724854|1037565|P1|Overall Study|Adverse event + lack of efficacy|2
316490|NCT00724854|1037564|P2|Overall Study|Withdrawal by Subject|0
316491|NCT00724854|1037565|P1|Overall Study|Withdrawal by Subject|5
316492|NCT00724854|1037564|P2|Overall Study|Change of treatment|0
316493|NCT00724854|1037565|P1|Overall Study|Change of treatment|7
316494|NCT00724854|1037564|P2|Overall Study|Death|0
316495|NCT00724854|1037565|P1|Overall Study|Death|11
316496|NCT00724854|1037564|P2|Overall Study|Not specified|3
316497|NCT00724854|1037565|P1|Overall Study|Not specified|42
316498|NCT00724854|1037564|P2|Overall Study|Adverse Event|4
316499|NCT00724854|1037565|P1|Overall Study|Adverse Event|62
316500|NCT00724854|1037564|P2|Overall Study|Lost to Follow-up|10
316501|NCT00724854|1037565|P1|Overall Study|Lost to Follow-up|87
316502|NCT00724854|1037564|P2|Overall Study|Lack of Efficacy|13
316503|NCT00724854|1037565|P1|Overall Study|Lack of Efficacy|187
316504|NCT00724815|1037582|P2|Overall Study|Other Various|5
316505|NCT00724815|1037583|P1|Overall Study|Other Various|3
316506|NCT00724815|1037582|P2|Overall Study|Lost to Follow-up|1
316507|NCT00724815|1037583|P1|Overall Study|Lost to Follow-up|4
316508|NCT00724815|1037582|P2|Overall Study|Adverse Event|3
316509|NCT00724815|1037583|P1|Overall Study|Adverse Event|5
316510|NCT00724815|1037582|P2|Overall Study|Randomized, not treated|30
316511|NCT00724815|1037583|P1|Overall Study|Randomized, not treated|31
316512|NCT00724711|1037616|P2|Overall Study|Protocol Violation|0
316513|NCT00724711|1037617|P1|Overall Study|Protocol Violation|1
316514|NCT00724711|1037616|P2|Overall Study|Lost to Follow-up|5
316515|NCT00724711|1037617|P1|Overall Study|Lost to Follow-up|4
316516|NCT00724711|1037616|P2|Overall Study|Withdrawal by Subject|4
316517|NCT00724711|1037617|P1|Overall Study|Withdrawal by Subject|5
316518|NCT00724711|1037616|P2|Overall Study|Physician Decision|3
316519|NCT00724711|1037617|P1|Overall Study|Physician Decision|0
316520|NCT00724711|1037616|P2|Overall Study|Lack of Efficacy|1
316521|NCT00724711|1037617|P1|Overall Study|Lack of Efficacy|0
316522|NCT00724711|1037616|P2|Overall Study|Pregnancy|1
316523|NCT00724711|1037617|P1|Overall Study|Pregnancy|0
316524|NCT00724711|1037616|P2|Overall Study|Adverse Event|3
316525|NCT00724711|1037617|P1|Overall Study|Adverse Event|7
316526|NCT00724698|1037649|P1|Overall Study|No Info|25
316527|NCT00724698|1037649|P1|Overall Study|Lost to Follow-up|36
316528|NCT00724698|1037649|P1|Overall Study|Poor Compliance|16
316529|NCT00724698|1037649|P1|Overall Study|Failure of Therapy|4
316530|NCT00724698|1037649|P1|Overall Study|Adverse Event|9
316531|NCT00724451|1037704|P1|Overall Study|Investigator + Participant Decision|13
316532|NCT00724451|1037704|P1|Overall Study|Withdrawal by Subject|45
316533|NCT00724451|1037704|P1|Overall Study|Physician Decision|116
316534|NCT00724451|1037704|P1|Overall Study|Unknown; No Data Sources Available|9
316535|NCT00724451|1037704|P1|Overall Study|Never Started Treatment|89
316536|NCT00724451|1037704|P1|Overall Study|Participant Refused Treatment|89
316537|NCT00724451|1037704|P1|Overall Study|Not Eligible for Treatment|431
316538|NCT00724451|1037704|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
316539|NCT00724451|1037704|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
316540|NCT00724373|1037710|P1|Overall Study|Tolerability|23
316541|NCT00724373|1037710|P1|Overall Study|Drug Relapse|1
316542|NCT00724373|1037710|P1|Overall Study|Acute HCV infection|1
316543|NCT00724373|1037710|P1|Overall Study|Viral Relapse|1
316544|NCT00724373|1037710|P1|Overall Study|Only to have 24 week regimen|1
316545|NCT00724373|1037710|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
316546|NCT00724373|1037710|P1|Overall Study|Participant moved away|1
316547|NCT00724373|1037710|P1|Overall Study|HCV RNA negative after 4 weeks|9
316548|NCT00724373|1037710|P1|Overall Study|Non-compliance|2
316549|NCT00724373|1037710|P1|Overall Study|Lost to Follow-up|7
316550|NCT00724373|1037710|P1|Overall Study|Lack of Efficacy|82
316551|NCT00724373|1037710|P1|Overall Study|Adverse Event|41
316552|NCT00724282|1037727|P1|Overall Study|Physician Decision|1
316553|NCT00724282|1037727|P1|Overall Study|Withdrawal by Subject|3
316554|NCT00724243|1037731|P1|Overall Study|Adverse Event|5
316555|NCT00724243|1037731|P1|Overall Study|Lack of Efficacy|10
316556|NCT00724152|1037741|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
316557|NCT00724152|1037742|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
316558|NCT00724152|1037743|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
316559|NCT00724152|1037741|P3|Two-arm Study Period|Withdrawal by Subject|0
316560|NCT00724152|1037742|P2|Two-arm Study Period|Withdrawal by Subject|2
316561|NCT00724152|1037743|P1|Two-arm Study Period|Withdrawal by Subject|3
316562|NCT00724126|1037760|P2|Overall Study|Subject had to leave vicinity of site|1
316563|NCT00724126|1037761|P1|Overall Study|Subject had to leave vicinity of site|0
316564|NCT00724126|1037760|P2|Overall Study|Subject randomized although ineligible|1
316565|NCT00724126|1037761|P1|Overall Study|Subject randomized although ineligible|1
316566|NCT00724126|1037760|P2|Overall Study|Noncompliance|1
316567|NCT00724126|1037761|P1|Overall Study|Noncompliance|2
316568|NCT00724126|1037760|P2|Overall Study|Lost to Follow-up|6
316569|NCT00724126|1037761|P1|Overall Study|Lost to Follow-up|6
316570|NCT00724126|1037760|P2|Overall Study|Withdrawal by Subject|6
316571|NCT00724126|1037761|P1|Overall Study|Withdrawal by Subject|8
316572|NCT00724126|1037760|P2|Overall Study|Adverse Event|0
316573|NCT00724126|1037761|P1|Overall Study|Adverse Event|2
316574|NCT00724061|1037769|P1|Dose Escalation Phase|Disease Progression|3
316575|NCT00724061|1037769|P1|Dose Escalation Phase|Adverse Event|2
316576|NCT00723957|1037786|P2|Overall Study|Never received treatment|3
316577|NCT00723957|1037787|P1|Overall Study|Never received treatment|3
316578|NCT00723957|1037786|P2|Overall Study|Reason not analyzed|0
316579|NCT00723957|1037787|P1|Overall Study|Reason not analyzed|1
316580|NCT00723957|1037786|P2|Overall Study|Withdrawal by Subject|5
316581|NCT00723957|1037787|P1|Overall Study|Withdrawal by Subject|7
316582|NCT00723957|1037786|P2|Overall Study|Study drug toxicity|6
316583|NCT00723957|1037787|P1|Overall Study|Study drug toxicity|4
316584|NCT00723957|1037786|P2|Overall Study|Investigator decision|1
316585|NCT00723957|1037787|P1|Overall Study|Investigator decision|1
316586|NCT00723957|1037786|P2|Overall Study|Maximum clinical benefit|5
316587|NCT00723957|1037787|P1|Overall Study|Maximum clinical benefit|4
316588|NCT00723957|1037786|P2|Overall Study|Disease progression|25
316589|NCT00723957|1037787|P1|Overall Study|Disease progression|27
316590|NCT00723957|1037786|P2|Overall Study|Death|4
316591|NCT00723957|1037787|P1|Overall Study|Death|3
316592|NCT00723957|1037786|P2|Overall Study|Adverse event unrelated to study drug|4
316593|NCT00723957|1037787|P1|Overall Study|Adverse event unrelated to study drug|1
316594|NCT00723944|1037811|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
316595|NCT00723944|1037812|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
316596|NCT00723944|1037811|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
316597|NCT00723944|1037812|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
316598|NCT00723944|1037811|P2|Permanent Prosthesis Placement|Adverse Event|7
316599|NCT00723944|1037812|P1|Permanent Prosthesis Placement|Adverse Event|1
316600|NCT00723892|1037825|P2|Overall Study|Drug addiction|0
316601|NCT00723892|1037826|P1|Overall Study|Drug addiction|1
316602|NCT00723892|1037825|P2|Overall Study|Intercurrent infection|0
316603|NCT00723892|1037826|P1|Overall Study|Intercurrent infection|2
316604|NCT00723892|1037825|P2|Overall Study|Alcohol abuse|1
316605|NCT00723892|1037826|P1|Overall Study|Alcohol abuse|0
316606|NCT00723892|1037825|P2|Overall Study|Weight loss|3
316607|NCT00723892|1037826|P1|Overall Study|Weight loss|1
316608|NCT00723892|1037825|P2|Overall Study|Study end|3
316609|NCT00723892|1037826|P1|Overall Study|Study end|1
316610|NCT00723892|1037825|P2|Overall Study|Not specified|3
316611|NCT00723892|1037826|P1|Overall Study|Not specified|6
316612|NCT00723892|1037825|P2|Overall Study|Multiple reasons|12
316613|NCT00723892|1037826|P1|Overall Study|Multiple reasons|17
316614|NCT00723892|1037825|P2|Overall Study|Bad tolerance|5
316615|NCT00723892|1037826|P1|Overall Study|Bad tolerance|5
316616|NCT00723892|1037825|P2|Overall Study|End planned|7
316617|NCT00723892|1037826|P1|Overall Study|End planned|11
316618|NCT00723892|1037825|P2|Overall Study|Withdrawal by Subject|9
316619|NCT00723892|1037826|P1|Overall Study|Withdrawal by Subject|6
316620|NCT00723892|1037825|P2|Overall Study|Virological criterion|9
316621|NCT00723892|1037826|P1|Overall Study|Virological criterion|24
316622|NCT00723892|1037825|P2|Overall Study|Participant not tracked|35
316623|NCT00723892|1037826|P1|Overall Study|Participant not tracked|33
316624|NCT00723840|1037833|P1|Overall Study|Unspecified reason|2
316625|NCT00723840|1037833|P1|Overall Study|Other Medical Event|2
316626|NCT00723840|1037833|P1|Overall Study|Serious Adverse Events|3
316627|NCT00723840|1037833|P1|Overall Study|Withdrawal by Subject|55
316628|NCT00723840|1037833|P1|Overall Study|Failure to return|18
316629|NCT00723840|1037833|P1|Overall Study|Lost to Follow-up|2
316630|NCT00722800|1037854|P2|Overall Study|Physician Decision|0
316631|NCT00722800|1037855|P1|Overall Study|Physician Decision|1
316632|NCT00722800|1037854|P2|Overall Study|Withdrawal by Subject|0
316633|NCT00722800|1037855|P1|Overall Study|Withdrawal by Subject|1
316634|NCT00722761|1037867|P2|Overall Study|Withdrawal by Subject|2
316635|NCT00722761|1037868|P1|Overall Study|Withdrawal by Subject|5
316636|NCT00722761|1037867|P2|Overall Study|Lost to Follow-up|4
316637|NCT00722761|1037868|P1|Overall Study|Lost to Follow-up|1
316638|NCT00723801|1037878|P2|Overall Study|Protocol Violation|1
316639|NCT00723801|1037879|P1|Overall Study|Protocol Violation|2
316640|NCT00723801|1037878|P2|Overall Study|Lost to Follow-up|2
316641|NCT00723801|1037879|P1|Overall Study|Lost to Follow-up|1
316642|NCT00723710|1037904|P1|Overall Study|Physician Decision|2
316643|NCT00723710|1037904|P1|Overall Study|Withdrawal by Subject|36
316644|NCT00723710|1037904|P1|Overall Study|Adverse Event|88
316645|NCT00723710|1037904|P1|Overall Study|Disease progression|48
316646|NCT00723697|1037908|P1|Overall Study|Other exclusion criteria applied|6
316647|NCT00723697|1037908|P1|Overall Study|Missing Informed Consent Form|10
316648|NCT00723697|1037908|P1|Overall Study|Physician questionnaires not received|2
316649|NCT00723606|1037929|P2|Overall Study|Withdrawal by Subject|2
316650|NCT00723606|1037930|P1|Overall Study|Withdrawal by Subject|0
316651|NCT00723606|1037929|P2|Overall Study|Unspecified|0
316652|NCT00723606|1037930|P1|Overall Study|Unspecified|2
316653|NCT00723606|1037929|P2|Overall Study|Adverse Event|5
316654|NCT00723606|1037930|P1|Overall Study|Adverse Event|2
316655|NCT00723554|1037950|P1|Overall Study|Non-compliance|1
316656|NCT00723554|1037950|P1|Overall Study|Lost to Follow-up|1
316657|NCT00723554|1037950|P1|Overall Study|Not specified|3
316658|NCT00723554|1037950|P1|Overall Study|Withdrawal of consent|3
316659|NCT00723554|1037950|P1|Overall Study|Inhaled medication other than iloprost|4
316660|NCT00723554|1037950|P1|Overall Study|Investigator's judgement|5
316661|NCT00723554|1037950|P1|Overall Study|Adverse Event|12
316662|NCT00723528|1038000|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
316663|NCT00723528|1038001|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
316664|NCT00723528|1038002|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
316665|NCT00723528|1038003|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
316666|NCT00723528|1038004|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
316667|NCT00723528|1038005|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
316668|NCT00723528|1038006|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
316669|NCT00723528|1038000|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
316670|NCT00723528|1038001|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
316671|NCT00723528|1038002|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
316672|NCT00723528|1038003|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
316673|NCT00723528|1038004|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
316674|NCT00723528|1038005|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
316675|NCT00723528|1038006|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
316676|NCT00723528|1038000|P7|Period 2: After Controlled Period|Adverse Event|1
316677|NCT00723528|1038001|P6|Period 2: After Controlled Period|Adverse Event|0
316678|NCT00723528|1038002|P5|Period 2: After Controlled Period|Adverse Event|1
316679|NCT00723528|1038003|P4|Period 2: After Controlled Period|Adverse Event|0
316680|NCT00723528|1038004|P3|Period 2: After Controlled Period|Adverse Event|0
316681|NCT00723528|1038005|P2|Period 2: After Controlled Period|Adverse Event|0
316682|NCT00723528|1038006|P1|Period 2: After Controlled Period|Adverse Event|0
316683|NCT00723528|1038000|P7|Period 2: After Controlled Period|Unspecified|0
316684|NCT00723528|1038001|P6|Period 2: After Controlled Period|Unspecified|4
316685|NCT00723528|1038002|P5|Period 2: After Controlled Period|Unspecified|1
316686|NCT00723528|1038003|P4|Period 2: After Controlled Period|Unspecified|0
316687|NCT00723528|1038004|P3|Period 2: After Controlled Period|Unspecified|0
316688|NCT00723528|1038005|P2|Period 2: After Controlled Period|Unspecified|0
316689|NCT00723528|1038006|P1|Period 2: After Controlled Period|Unspecified|0
316690|NCT00723528|1038000|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
316691|NCT00723528|1038001|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
316692|NCT00723528|1038002|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
316693|NCT00723528|1038003|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
316694|NCT00723528|1038004|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
316695|NCT00723528|1038005|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
316696|NCT00723528|1038006|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
316697|NCT00723528|1038000|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
316698|NCT00723528|1038001|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
316699|NCT00723528|1038002|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
316700|NCT00723528|1038003|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
316701|NCT00723528|1038004|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
316702|NCT00723528|1038005|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
316703|NCT00723528|1038006|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
316704|NCT00723528|1038000|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
316705|NCT00723528|1038001|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
316706|NCT00723528|1038002|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
316707|NCT00723528|1038003|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
316708|NCT00723528|1038004|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
316709|NCT00723528|1038005|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
316710|NCT00723528|1038006|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
316711|NCT00723528|1038000|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
316712|NCT00723528|1038001|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
316713|NCT00723528|1038002|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
316714|NCT00723528|1038003|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
316715|NCT00723528|1038004|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
316716|NCT00723528|1038005|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
316717|NCT00723528|1038006|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
316718|NCT00723528|1038000|P7|Period 1: Controlled Period (CP)|Physician Decision|0
316719|NCT00723528|1038001|P6|Period 1: Controlled Period (CP)|Physician Decision|0
316720|NCT00723528|1038002|P5|Period 1: Controlled Period (CP)|Physician Decision|0
316721|NCT00723528|1038003|P4|Period 1: Controlled Period (CP)|Physician Decision|0
316722|NCT00723528|1038004|P3|Period 1: Controlled Period (CP)|Physician Decision|1
316723|NCT00723528|1038005|P2|Period 1: Controlled Period (CP)|Physician Decision|0
316724|NCT00723528|1038006|P1|Period 1: Controlled Period (CP)|Physician Decision|0
316725|NCT00723528|1038000|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
316726|NCT00723528|1038001|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
316727|NCT00723528|1038002|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
316728|NCT00723528|1038003|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
316729|NCT00723528|1038004|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
316730|NCT00723528|1038005|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
316731|NCT00723528|1038006|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
316732|NCT00723528|1038000|P7|Period 1: Controlled Period (CP)|Adverse Event|0
316733|NCT00723528|1038001|P6|Period 1: Controlled Period (CP)|Adverse Event|0
316734|NCT00723528|1038002|P5|Period 1: Controlled Period (CP)|Adverse Event|0
316735|NCT00723528|1038003|P4|Period 1: Controlled Period (CP)|Adverse Event|0
316736|NCT00723528|1038004|P3|Period 1: Controlled Period (CP)|Adverse Event|1
316737|NCT00723528|1038005|P2|Period 1: Controlled Period (CP)|Adverse Event|0
316738|NCT00723528|1038006|P1|Period 1: Controlled Period (CP)|Adverse Event|0
316739|NCT00723489|1038068|P4|Overall Study|Samples Collected Out of Window|0
316740|NCT00723489|1038069|P3|Overall Study|Samples Collected Out of Window|0
316741|NCT00723489|1038070|P2|Overall Study|Samples Collected Out of Window|3
316742|NCT00723489|1038071|P1|Overall Study|Samples Collected Out of Window|0
316743|NCT00723489|1038068|P4|Overall Study|Prohibited Medication|1
316744|NCT00723489|1038069|P3|Overall Study|Prohibited Medication|0
316745|NCT00723489|1038070|P2|Overall Study|Prohibited Medication|0
316746|NCT00723489|1038071|P1|Overall Study|Prohibited Medication|0
316747|NCT00723489|1038068|P4|Overall Study|Seropositive at baseline|0
316748|NCT00723489|1038069|P3|Overall Study|Seropositive at baseline|0
316749|NCT00723489|1038070|P2|Overall Study|Seropositive at baseline|0
316750|NCT00723489|1038071|P1|Overall Study|Seropositive at baseline|1
316751|NCT00723489|1038068|P4|Overall Study|Withdrawal by Subject|1
316752|NCT00723489|1038069|P3|Overall Study|Withdrawal by Subject|0
316753|NCT00723489|1038070|P2|Overall Study|Withdrawal by Subject|0
316754|NCT00723489|1038071|P1|Overall Study|Withdrawal by Subject|0
316755|NCT00723489|1038068|P4|Overall Study|Pregnancy|1
316756|NCT00723489|1038069|P3|Overall Study|Pregnancy|0
316757|NCT00723489|1038070|P2|Overall Study|Pregnancy|0
316758|NCT00723489|1038071|P1|Overall Study|Pregnancy|0
316759|NCT00723489|1038068|P4|Overall Study|Physician Decision|0
316760|NCT00723489|1038069|P3|Overall Study|Physician Decision|0
316761|NCT00723489|1038070|P2|Overall Study|Physician Decision|1
316762|NCT00723489|1038071|P1|Overall Study|Physician Decision|0
316763|NCT00723450|1038099|P3|Randomized Phase|Withdrawal by Subject|22
316764|NCT00723450|1038100|P2|Randomized Phase|Withdrawal by Subject|14
316765|NCT00723450|1038101|P1|Randomized Phase|Withdrawal by Subject|0
316766|NCT00723450|1038099|P3|Randomized Phase|Physician Decision|1
316767|NCT00723450|1038100|P2|Randomized Phase|Physician Decision|3
316768|NCT00723450|1038101|P1|Randomized Phase|Physician Decision|0
316769|NCT00723450|1038099|P3|Randomized Phase|Lost to Follow-up|3
316770|NCT00723450|1038100|P2|Randomized Phase|Lost to Follow-up|2
316771|NCT00723450|1038101|P1|Randomized Phase|Lost to Follow-up|0
316772|NCT00723450|1038099|P3|Randomized Phase|Protocol Violation|13
316773|NCT00723450|1038100|P2|Randomized Phase|Protocol Violation|9
316774|NCT00723450|1038101|P1|Randomized Phase|Protocol Violation|0
316775|NCT00723450|1038099|P3|Randomized Phase|Lack of Efficacy|11
316776|NCT00723450|1038100|P2|Randomized Phase|Lack of Efficacy|11
316777|NCT00723450|1038101|P1|Randomized Phase|Lack of Efficacy|0
316778|NCT00723450|1038099|P3|Randomized Phase|Adverse Event|17
316779|NCT00723450|1038100|P2|Randomized Phase|Adverse Event|26
316780|NCT00723450|1038101|P1|Randomized Phase|Adverse Event|0
316781|NCT00723450|1038099|P3|Open-Label Phase|Withdrawal by Subject|0
316782|NCT00723450|1038100|P2|Open-Label Phase|Withdrawal by Subject|0
316783|NCT00723450|1038101|P1|Open-Label Phase|Withdrawal by Subject|37
316784|NCT00723450|1038099|P3|Open-Label Phase|Physician Decision|0
316785|NCT00723450|1038100|P2|Open-Label Phase|Physician Decision|0
316786|NCT00723450|1038101|P1|Open-Label Phase|Physician Decision|2
316787|NCT00723450|1038099|P3|Open-Label Phase|Lost to Follow-up|0
316788|NCT00723450|1038100|P2|Open-Label Phase|Lost to Follow-up|0
316789|NCT00723450|1038101|P1|Open-Label Phase|Lost to Follow-up|7
316790|NCT00723450|1038099|P3|Open-Label Phase|Protocol Violation|0
316791|NCT00723450|1038100|P2|Open-Label Phase|Protocol Violation|0
316792|NCT00723450|1038101|P1|Open-Label Phase|Protocol Violation|35
316793|NCT00723450|1038099|P3|Open-Label Phase|Lack of Efficacy|0
316794|NCT00723450|1038100|P2|Open-Label Phase|Lack of Efficacy|0
316795|NCT00723450|1038101|P1|Open-Label Phase|Lack of Efficacy|18
316796|NCT00723450|1038099|P3|Open-Label Phase|Adverse Event|0
316797|NCT00723450|1038100|P2|Open-Label Phase|Adverse Event|0
316798|NCT00723450|1038101|P1|Open-Label Phase|Adverse Event|26
316799|NCT00723294|1038142|P1|Overall Study|No treatment due to probe failure|1
316800|NCT00723294|1038142|P1|Overall Study|Withdrawal by Subject|1
316801|NCT00723294|1038142|P1|Overall Study|Benign lesion|1
316802|NCT00723294|1038142|P1|Overall Study|Treated by non-credentialed surgeon|1
316803|NCT00723294|1038142|P1|Overall Study|Treated prior to registration|1
316804|NCT00723294|1038142|P1|Overall Study|Did not undergo surgery|1
316805|NCT00723294|1038142|P1|Overall Study|No cryoabalation|2
316806|NCT00723294|1038142|P1|Overall Study|1.0-Tesla MRI|1
316807|NCT00723294|1038142|P1|Overall Study|No MRI tumor enhancement|1
316808|NCT00723294|1038142|P1|Overall Study|>25% intraductal component|1
316809|NCT00723294|1038142|P1|Overall Study|Lobular histology|2
316810|NCT00723255|1038147|P1|Overall Study|Ineligible: Wrong Primary|2
316811|NCT00723255|1038147|P1|Overall Study|Ineligible: Second primary|1
316812|NCT00723255|1038147|P1|Overall Study|Ineligible: Inadequate pathology|1
316813|NCT00723229|1038168|P2|First Intervention|Lost to Follow-up|3
316814|NCT00723229|1038169|P1|First Intervention|Lost to Follow-up|7
316815|NCT00723203|1038181|P1|Overall Study|Withdrawal by Subject|3
316816|NCT00723190|1038185|P1|Overall Study|Other-Not included in safety population|2
316817|NCT00723190|1038185|P1|Overall Study|Other-Premature Discontinuation|9
316818|NCT00723190|1038185|P1|Overall Study|Protocol Violation|15
316819|NCT00723190|1038185|P1|Overall Study|Lack of Efficacy|16
316820|NCT00723190|1038185|P1|Overall Study|Adverse Event|18
316821|NCT00723190|1038185|P1|Overall Study|Lost to Follow-up|37
316822|NCT00723190|1038185|P1|Overall Study|Withdrawal by Subject|45
316823|NCT00723125|1038218|P2|Overall Study|Adverse Event|0
316824|NCT00723125|1038219|P1|Overall Study|Adverse Event|2
316825|NCT00723125|1038218|P2|Overall Study|Withdrawal by Subject|6
316826|NCT00723125|1038219|P1|Overall Study|Withdrawal by Subject|15
316827|NCT00723125|1038218|P2|Overall Study|Met Dx|0
316828|NCT00723125|1038219|P1|Overall Study|Met Dx|1
316829|NCT00723021|1038256|P5|Intervention Period 4|Adverse Event|1
316830|NCT00723021|1038257|P4|Intervention Period 4|Adverse Event|0
316831|NCT00723021|1038258|P3|Intervention Period 4|Adverse Event|0
316832|NCT00723021|1038259|P2|Intervention Period 4|Adverse Event|0
316833|NCT00723021|1038260|P1|Intervention Period 4|Adverse Event|0
316834|NCT00723008|1038314|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
316835|NCT00723008|1038315|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
316836|NCT00723008|1038314|P2|4-Week Unblinded Treatment|Adverse Event|0
316837|NCT00723008|1038315|P1|4-Week Unblinded Treatment|Adverse Event|1
316838|NCT00723008|1038314|P2|4-Week Double Blinded|Lost to Follow-up|3
316839|NCT00723008|1038315|P1|4-Week Double Blinded|Lost to Follow-up|4
316840|NCT00723008|1038314|P2|4-Week Double Blinded|Withdrawal by Subject|1
316841|NCT00723008|1038315|P1|4-Week Double Blinded|Withdrawal by Subject|1
316842|NCT00723008|1038314|P2|4-Week Double Blinded|Lack of Efficacy|1
316843|NCT00723008|1038315|P1|4-Week Double Blinded|Lack of Efficacy|0
316844|NCT00723008|1038314|P2|Enrollment|Lost to Follow-up|0
316845|NCT00723008|1038315|P1|Enrollment|Lost to Follow-up|1
316846|NCT00722423|1038394|P2|Overall Study|Protocol Violation|1
316847|NCT00722423|1038395|P1|Overall Study|Protocol Violation|0
316848|NCT00722371|1038410|P7|Overall Study|Withdrawal by Subject|26
316849|NCT00722371|1038411|P6|Overall Study|Withdrawal by Subject|18
316850|NCT00722371|1038412|P5|Overall Study|Withdrawal by Subject|19
316851|NCT00722371|1038413|P4|Overall Study|Withdrawal by Subject|23
316852|NCT00722371|1038414|P3|Overall Study|Withdrawal by Subject|19
316853|NCT00722371|1038415|P2|Overall Study|Withdrawal by Subject|27
316854|NCT00722371|1038416|P1|Overall Study|Withdrawal by Subject|18
316855|NCT00722371|1038410|P7|Overall Study|Protocol Violation|1
316856|NCT00722371|1038411|P6|Overall Study|Protocol Violation|2
316857|NCT00722371|1038412|P5|Overall Study|Protocol Violation|4
316858|NCT00722371|1038413|P4|Overall Study|Protocol Violation|1
316859|NCT00722371|1038414|P3|Overall Study|Protocol Violation|0
316860|NCT00722371|1038415|P2|Overall Study|Protocol Violation|1
316861|NCT00722371|1038416|P1|Overall Study|Protocol Violation|6
316862|NCT00722371|1038410|P7|Overall Study|Pregnancy|0
316863|NCT00722371|1038411|P6|Overall Study|Pregnancy|1
316864|NCT00722371|1038412|P5|Overall Study|Pregnancy|0
316865|NCT00722371|1038413|P4|Overall Study|Pregnancy|0
316866|NCT00722371|1038414|P3|Overall Study|Pregnancy|0
316867|NCT00722371|1038415|P2|Overall Study|Pregnancy|1
316868|NCT00722371|1038416|P1|Overall Study|Pregnancy|1
316869|NCT00722371|1038410|P7|Overall Study|Physician Decision|4
316870|NCT00722371|1038411|P6|Overall Study|Physician Decision|3
316871|NCT00722371|1038412|P5|Overall Study|Physician Decision|2
316872|NCT00722371|1038413|P4|Overall Study|Physician Decision|5
316873|NCT00722371|1038414|P3|Overall Study|Physician Decision|2
316874|NCT00722371|1038415|P2|Overall Study|Physician Decision|2
316875|NCT00722371|1038416|P1|Overall Study|Physician Decision|5
316876|NCT00722371|1038410|P7|Overall Study|Lost to Follow-up|13
316877|NCT00722371|1038411|P6|Overall Study|Lost to Follow-up|16
316878|NCT00722371|1038412|P5|Overall Study|Lost to Follow-up|8
316879|NCT00722371|1038413|P4|Overall Study|Lost to Follow-up|13
316880|NCT00722371|1038414|P3|Overall Study|Lost to Follow-up|21
316881|NCT00722371|1038415|P2|Overall Study|Lost to Follow-up|14
316882|NCT00722371|1038416|P1|Overall Study|Lost to Follow-up|11
316883|NCT00722371|1038410|P7|Overall Study|Lack of Efficacy|0
316884|NCT00722371|1038411|P6|Overall Study|Lack of Efficacy|3
316885|NCT00722371|1038412|P5|Overall Study|Lack of Efficacy|2
316886|NCT00722371|1038413|P4|Overall Study|Lack of Efficacy|6
316887|NCT00722371|1038414|P3|Overall Study|Lack of Efficacy|6
316888|NCT00722371|1038415|P2|Overall Study|Lack of Efficacy|6
316889|NCT00722371|1038416|P1|Overall Study|Lack of Efficacy|4
316890|NCT00722371|1038410|P7|Overall Study|Hypoglycemia|0
316891|NCT00722371|1038411|P6|Overall Study|Hypoglycemia|0
316892|NCT00722371|1038412|P5|Overall Study|Hypoglycemia|0
316893|NCT00722371|1038413|P4|Overall Study|Hypoglycemia|0
316894|NCT00722371|1038414|P3|Overall Study|Hypoglycemia|0
316895|NCT00722371|1038415|P2|Overall Study|Hypoglycemia|0
316896|NCT00722371|1038416|P1|Overall Study|Hypoglycemia|1
316897|NCT00722371|1038410|P7|Overall Study|Hyperglycemia|1
316898|NCT00722371|1038411|P6|Overall Study|Hyperglycemia|1
316899|NCT00722371|1038412|P5|Overall Study|Hyperglycemia|5
316900|NCT00722371|1038413|P4|Overall Study|Hyperglycemia|2
316901|NCT00722371|1038414|P3|Overall Study|Hyperglycemia|4
316902|NCT00722371|1038415|P2|Overall Study|Hyperglycemia|6
316903|NCT00722371|1038416|P1|Overall Study|Hyperglycemia|2
316904|NCT00722371|1038410|P7|Overall Study|Excluded medication|1
316905|NCT00722371|1038411|P6|Overall Study|Excluded medication|0
316906|NCT00722371|1038412|P5|Overall Study|Excluded medication|0
316907|NCT00722371|1038413|P4|Overall Study|Excluded medication|0
316908|NCT00722371|1038414|P3|Overall Study|Excluded medication|1
316909|NCT00722371|1038415|P2|Overall Study|Excluded medication|1
316910|NCT00722371|1038416|P1|Overall Study|Excluded medication|0
316911|NCT00722371|1038410|P7|Overall Study|Creatinine / Creatinine clearance|1
316912|NCT00722371|1038411|P6|Overall Study|Creatinine / Creatinine clearance|1
316913|NCT00722371|1038412|P5|Overall Study|Creatinine / Creatinine clearance|2
316914|NCT00722371|1038413|P4|Overall Study|Creatinine / Creatinine clearance|3
316915|NCT00722371|1038414|P3|Overall Study|Creatinine / Creatinine clearance|2
316916|NCT00722371|1038415|P2|Overall Study|Creatinine / Creatinine clearance|1
316917|NCT00722371|1038416|P1|Overall Study|Creatinine / Creatinine clearance|2
316918|NCT00722371|1038410|P7|Overall Study|Contraindication|0
316919|NCT00722371|1038411|P6|Overall Study|Contraindication|0
316920|NCT00722371|1038412|P5|Overall Study|Contraindication|0
316921|NCT00722371|1038413|P4|Overall Study|Contraindication|0
316922|NCT00722371|1038414|P3|Overall Study|Contraindication|1
316923|NCT00722371|1038415|P2|Overall Study|Contraindication|0
316924|NCT00722371|1038416|P1|Overall Study|Contraindication|0
316925|NCT00722371|1038410|P7|Overall Study|Adverse Event|4
316926|NCT00722371|1038411|P6|Overall Study|Adverse Event|8
316927|NCT00722371|1038412|P5|Overall Study|Adverse Event|6
316928|NCT00722371|1038413|P4|Overall Study|Adverse Event|10
316929|NCT00722371|1038414|P3|Overall Study|Adverse Event|9
316930|NCT00722371|1038415|P2|Overall Study|Adverse Event|13
316931|NCT00722371|1038416|P1|Overall Study|Adverse Event|6
316932|NCT00722137|1038469|P2|Overall Study|Randomized But Not Treated|2
316933|NCT00722137|1038470|P1|Overall Study|Randomized But Not Treated|3
316934|NCT00722137|1038469|P2|Overall Study|Other Reason Uknown|3
316935|NCT00722137|1038470|P1|Overall Study|Other Reason Uknown|4
316936|NCT00722137|1038469|P2|Overall Study|Withdrawal by Subject|6
316937|NCT00722137|1038470|P1|Overall Study|Withdrawal by Subject|9
316938|NCT00722137|1038469|P2|Overall Study|Death|12
316939|NCT00722137|1038470|P1|Overall Study|Death|7
316940|NCT00722137|1038469|P2|Overall Study|Adverse Event|17
316941|NCT00722137|1038470|P1|Overall Study|Adverse Event|21
316942|NCT00722137|1038469|P2|Overall Study|Overt Disease Progression|5
316943|NCT00722137|1038470|P1|Overall Study|Overt Disease Progression|4
316944|NCT00721968|1038524|P2|Overall Study|Lost to Follow-up|0
316945|NCT00721968|1038525|P1|Overall Study|Lost to Follow-up|2
316946|NCT00721734|1038538|P5|Overall Study|Other|0
316947|NCT00721734|1038539|P4|Overall Study|Other|1
316948|NCT00721734|1038540|P3|Overall Study|Other|0
316949|NCT00721734|1038541|P2|Overall Study|Other|0
316950|NCT00721734|1038542|P1|Overall Study|Other|0
316951|NCT00721734|1038538|P5|Overall Study|Withdrawal by Subject|1
316952|NCT00721734|1038539|P4|Overall Study|Withdrawal by Subject|0
316953|NCT00721734|1038540|P3|Overall Study|Withdrawal by Subject|0
316954|NCT00721734|1038541|P2|Overall Study|Withdrawal by Subject|1
316955|NCT00721734|1038542|P1|Overall Study|Withdrawal by Subject|2
316956|NCT00721734|1038538|P5|Overall Study|Adverse Event|3
316957|NCT00721734|1038539|P4|Overall Study|Adverse Event|0
316958|NCT00721734|1038540|P3|Overall Study|Adverse Event|4
316959|NCT00721734|1038541|P2|Overall Study|Adverse Event|1
316960|NCT00721734|1038542|P1|Overall Study|Adverse Event|3
316961|NCT00721734|1038538|P5|Overall Study|Progressive Disease|2
316962|NCT00721734|1038539|P4|Overall Study|Progressive Disease|5
316963|NCT00721734|1038540|P3|Overall Study|Progressive Disease|4
316964|NCT00721734|1038541|P2|Overall Study|Progressive Disease|10
316965|NCT00721734|1038542|P1|Overall Study|Progressive Disease|3
316966|NCT00721578|1038678|P2|Overall Study|Withdrawal by Subject|1
316967|NCT00721578|1038679|P1|Overall Study|Withdrawal by Subject|1
316968|NCT00721578|1038678|P2|Overall Study|Death|1
316969|NCT00721578|1038679|P1|Overall Study|Death|1
316970|NCT00721409|1038722|P3|Overall Study|Death|0
316971|NCT00721409|1038723|P2|Overall Study|Death|1
316972|NCT00721409|1038724|P1|Overall Study|Death|0
316973|NCT00721409|1038722|P3|Overall Study|Adverse Event|2
316974|NCT00721409|1038723|P2|Overall Study|Adverse Event|11
316975|NCT00721409|1038724|P1|Overall Study|Adverse Event|0
316976|NCT00721409|1038722|P3|Overall Study|Reason not specified|5
316977|NCT00721409|1038723|P2|Overall Study|Reason not specified|1
316978|NCT00721409|1038724|P1|Overall Study|Reason not specified|0
316979|NCT00721409|1038722|P3|Overall Study|Withdrawal by Subject|6
316980|NCT00721409|1038723|P2|Overall Study|Withdrawal by Subject|5
316981|NCT00721409|1038724|P1|Overall Study|Withdrawal by Subject|1
316982|NCT00721409|1038722|P3|Overall Study|Objective progression or relapse|57
316983|NCT00721409|1038723|P2|Overall Study|Objective progression or relapse|42
316984|NCT00721409|1038724|P1|Overall Study|Objective progression or relapse|7
316985|NCT00721409|1038722|P3|Overall Study|Global deterioration of health status|3
316986|NCT00721409|1038723|P2|Overall Study|Global deterioration of health status|5
316987|NCT00721409|1038724|P1|Overall Study|Global deterioration of health status|2
316988|NCT00721409|1038722|P3|Overall Study|Ongoing at date of cutoff|8
316989|NCT00721409|1038723|P2|Overall Study|Ongoing at date of cutoff|19
316990|NCT00721409|1038724|P1|Overall Study|Ongoing at date of cutoff|2
316991|NCT00721396|1038851|P4|Overall Study|Administrative reason|0
316992|NCT00721396|1038852|P3|Overall Study|Administrative reason|1
316993|NCT00721396|1038853|P2|Overall Study|Administrative reason|0
316994|NCT00721396|1038854|P1|Overall Study|Administrative reason|3
316995|NCT00721396|1038851|P4|Overall Study|Inappropriate enrollment|0
316996|NCT00721396|1038852|P3|Overall Study|Inappropriate enrollment|0
316997|NCT00721396|1038853|P2|Overall Study|Inappropriate enrollment|2
316998|NCT00721396|1038854|P1|Overall Study|Inappropriate enrollment|0
316999|NCT00721396|1038851|P4|Overall Study|Protocol Violation|0
317000|NCT00721396|1038852|P3|Overall Study|Protocol Violation|1
317001|NCT00721396|1038853|P2|Overall Study|Protocol Violation|3
317002|NCT00721396|1038854|P1|Overall Study|Protocol Violation|4
317003|NCT00721396|1038851|P4|Overall Study|Lost to Follow-up|3
317004|NCT00721396|1038852|P3|Overall Study|Lost to Follow-up|3
317005|NCT00721396|1038853|P2|Overall Study|Lost to Follow-up|9
317006|NCT00721396|1038854|P1|Overall Study|Lost to Follow-up|7
317007|NCT00721396|1038851|P4|Overall Study|Withdrawal by Subject|7
317008|NCT00721396|1038852|P3|Overall Study|Withdrawal by Subject|3
317009|NCT00721396|1038853|P2|Overall Study|Withdrawal by Subject|15
317010|NCT00721396|1038854|P1|Overall Study|Withdrawal by Subject|12
317011|NCT00721396|1038851|P4|Overall Study|Adverse Event|0
317012|NCT00721396|1038852|P3|Overall Study|Adverse Event|2
317013|NCT00721396|1038853|P2|Overall Study|Adverse Event|7
317014|NCT00721396|1038854|P1|Overall Study|Adverse Event|4
317015|NCT00721279|1038901|P2|Overall Study|Other|16
317016|NCT00721279|1038902|P1|Overall Study|Other|12
317017|NCT00721279|1038901|P2|Overall Study|Withdrawal by Subject|3
317018|NCT00721279|1038902|P1|Overall Study|Withdrawal by Subject|13
317019|NCT00721279|1038901|P2|Overall Study|Tolerability insufficient|2
317020|NCT00721279|1038902|P1|Overall Study|Tolerability insufficient|5
317021|NCT00721279|1038901|P2|Overall Study|Lack of Efficacy|3
317022|NCT00721279|1038902|P1|Overall Study|Lack of Efficacy|6
317023|NCT00721227|1038930|P2|Overall Study|Noncompliance with scheduled visits.|0
317024|NCT00721227|1038931|P1|Overall Study|Noncompliance with scheduled visits.|1
317025|NCT00721227|1038930|P2|Overall Study|Lost to Follow-up|0
317026|NCT00721227|1038931|P1|Overall Study|Lost to Follow-up|3
317027|NCT00721214|1038941|P1|Overall Study|Death|3
317028|NCT00721214|1038941|P1|Overall Study|Chose another center for transplant|1
317029|NCT00721149|1038991|P1|Overall Study|Physician Decision|1
317030|NCT00721123|1039000|P1|Overall Study|Withdrawal by Subject|5
317031|NCT00721123|1039000|P1|Overall Study|Failure to Return|9
317032|NCT00721123|1039000|P1|Overall Study|Refused Treatment|41
317033|NCT00721123|1039000|P1|Overall Study|Protocol Violation|1
317034|NCT00721123|1039000|P1|Overall Study|Insufficient Therapeutic Response|21
317035|NCT00721123|1039000|P1|Overall Study|Death|10
317036|NCT00721123|1039000|P1|Overall Study|Adverse Event|96
317037|NCT00720941|1039076|P2|Overall Study|Ongoing|23
317038|NCT00720941|1039077|P1|Overall Study|Ongoing|34
317039|NCT00720941|1039076|P2|Overall Study|Withdrawal by Subject|35
317040|NCT00720941|1039077|P1|Overall Study|Withdrawal by Subject|27
317041|NCT00720941|1039076|P2|Overall Study|Physician Decision|5
317042|NCT00720941|1039077|P1|Overall Study|Physician Decision|1
317043|NCT00720941|1039076|P2|Overall Study|Lost to Follow-up|15
317044|NCT00720941|1039077|P1|Overall Study|Lost to Follow-up|17
317045|NCT00720941|1039076|P2|Overall Study|Protocol Violation|2
317046|NCT00720941|1039077|P1|Overall Study|Protocol Violation|0
317047|NCT00720941|1039076|P2|Overall Study|Death|335
317048|NCT00720941|1039077|P1|Overall Study|Death|334
317049|NCT00720798|1039117|P1|Overall Study|Reason not Specified|83
317050|NCT00720798|1039117|P1|Overall Study|Failure to Return|46
317051|NCT00720798|1039117|P1|Overall Study|Refused Treatment|151
317052|NCT00720798|1039117|P1|Overall Study|Protocol Violation|4
317053|NCT00720798|1039117|P1|Overall Study|Insufficient Therapeutic Response|129
317054|NCT00720798|1039117|P1|Overall Study|Death|39
317055|NCT00720798|1039117|P1|Overall Study|Adverse Event|304
317056|NCT00720759|1039140|P4|Overall Study|Lost to Follow-up|0
317057|NCT00720759|1039141|P3|Overall Study|Lost to Follow-up|1
317058|NCT00720759|1039142|P2|Overall Study|Lost to Follow-up|1
317059|NCT00720759|1039143|P1|Overall Study|Lost to Follow-up|0
317060|NCT00720499|1039163|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
317061|NCT00720499|1039164|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
317062|NCT00720499|1039163|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
317063|NCT00720499|1039164|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
317064|NCT00720499|1039163|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
317065|NCT00720499|1039164|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
317066|NCT00720434|1039257|P4|Open-Label Period (Week 5-72)|Unspecified|2
317067|NCT00720434|1039258|P3|Open-Label Period (Week 5-72)|Unspecified|3
317068|NCT00720434|1039259|P2|Open-Label Period (Week 5-72)|Unspecified|3
317069|NCT00720434|1039260|P1|Open-Label Period (Week 5-72)|Unspecified|4
317070|NCT00720434|1039257|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
317071|NCT00720434|1039258|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
317072|NCT00720434|1039259|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
317073|NCT00720434|1039260|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
317074|NCT00720434|1039257|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
317075|NCT00720434|1039258|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
317076|NCT00720434|1039259|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
317077|NCT00720434|1039260|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
317078|NCT00720434|1039257|P4|Open-Label Period (Week 5-72)|Adverse Event|2
317079|NCT00720434|1039258|P3|Open-Label Period (Week 5-72)|Adverse Event|0
317080|NCT00720434|1039259|P2|Open-Label Period (Week 5-72)|Adverse Event|0
317081|NCT00720434|1039260|P1|Open-Label Period (Week 5-72)|Adverse Event|0
317082|NCT00720434|1039257|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
317083|NCT00720434|1039258|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
317084|NCT00720434|1039259|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
317085|NCT00720434|1039260|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
317086|NCT00720382|1039284|P2|Overall Study|administrative|5
317087|NCT00720382|1039285|P1|Overall Study|administrative|14
317088|NCT00720382|1039284|P2|Overall Study|Lost to Follow-up|14
317089|NCT00720382|1039285|P1|Overall Study|Lost to Follow-up|28
317090|NCT00720382|1039284|P2|Overall Study|Withdrawal by Subject|11
317091|NCT00720382|1039285|P1|Overall Study|Withdrawal by Subject|47
317092|NCT00720382|1039284|P2|Overall Study|Non-Compliance|5
317093|NCT00720382|1039285|P1|Overall Study|Non-Compliance|15
317094|NCT00720382|1039284|P2|Overall Study|Lack of Efficacy|7
317095|NCT00720382|1039285|P1|Overall Study|Lack of Efficacy|18
317096|NCT00720382|1039284|P2|Overall Study|Adverse Event|17
317097|NCT00720382|1039285|P1|Overall Study|Adverse Event|54
317098|NCT00720343|1039304|P1|Overall Study|No data|3
317099|NCT00720343|1039304|P1|Overall Study|Physician Decision|3
317100|NCT00720278|1039338|P3|Overall Study|eligibility criteria violation|1
317101|NCT00720278|1039339|P2|Overall Study|eligibility criteria violation|0
317102|NCT00720278|1039340|P1|Overall Study|eligibility criteria violation|1
317103|NCT00720278|1039338|P3|Overall Study|Non-compliance|0
317104|NCT00720278|1039339|P2|Overall Study|Non-compliance|0
317105|NCT00720278|1039340|P1|Overall Study|Non-compliance|1
317106|NCT00720278|1039338|P3|Overall Study|Lost to Follow-up|1
317107|NCT00720278|1039339|P2|Overall Study|Lost to Follow-up|0
317108|NCT00720278|1039340|P1|Overall Study|Lost to Follow-up|0
317109|NCT00720278|1039338|P3|Overall Study|Withdrawal by Subject|0
317110|NCT00720278|1039339|P2|Overall Study|Withdrawal by Subject|1
317111|NCT00720278|1039340|P1|Overall Study|Withdrawal by Subject|0
317112|NCT00720278|1039338|P3|Overall Study|Adverse Event|4
317113|NCT00720278|1039339|P2|Overall Study|Adverse Event|3
317114|NCT00720278|1039340|P1|Overall Study|Adverse Event|5
317115|NCT00720226|1039362|P2|Overall Study|Withdrawal by Subject|4
317116|NCT00720226|1039363|P1|Overall Study|Withdrawal by Subject|7
317117|NCT00720122|1039371|P1|Overall Study|Withdrawal by Subject|7
317118|NCT00720122|1039371|P1|Overall Study|Physician Decision|1
317119|NCT00720122|1039371|P1|Overall Study|Lost to Follow-up|1
317120|NCT00720109|1039375|P3|Risk Stratification Period|Development of second malignant neoplasm|0
317121|NCT00720109|1039376|P2|Risk Stratification Period|Development of second malignant neoplasm|1
317122|NCT00720109|1039377|P1|Risk Stratification Period|Development of second malignant neoplasm|0
317123|NCT00720109|1039375|P3|Risk Stratification Period|Disease progression or relapse|0
317124|NCT00720109|1039376|P2|Risk Stratification Period|Disease progression or relapse|2
317125|NCT00720109|1039377|P1|Risk Stratification Period|Disease progression or relapse|0
317126|NCT00720109|1039375|P3|Risk Stratification Period|Bone marrow transplant|7
317127|NCT00720109|1039376|P2|Risk Stratification Period|Bone marrow transplant|9
317128|NCT00720109|1039377|P1|Risk Stratification Period|Bone marrow transplant|0
317129|NCT00720109|1039375|P3|Risk Stratification Period|Physician Decision|1
317130|NCT00720109|1039376|P2|Risk Stratification Period|Physician Decision|2
317131|NCT00720109|1039377|P1|Risk Stratification Period|Physician Decision|0
317132|NCT00720109|1039375|P3|Risk Stratification Period|Adverse Event|0
317133|NCT00720109|1039376|P2|Risk Stratification Period|Adverse Event|1
317134|NCT00720109|1039377|P1|Risk Stratification Period|Adverse Event|0
317135|NCT00720109|1039375|P3|Induction Period|Physician Decision|0
317136|NCT00720109|1039376|P2|Induction Period|Physician Decision|0
317137|NCT00720109|1039377|P1|Induction Period|Physician Decision|1
317138|NCT00720109|1039375|P3|Induction Period|Bone Marrow Transplant|0
317139|NCT00720109|1039376|P2|Induction Period|Bone Marrow Transplant|0
317140|NCT00720109|1039377|P1|Induction Period|Bone Marrow Transplant|2
317141|NCT00720109|1039375|P3|Induction Period|Did not meet eligibility criteria|0
317142|NCT00720109|1039376|P2|Induction Period|Did not meet eligibility criteria|0
317143|NCT00720109|1039377|P1|Induction Period|Did not meet eligibility criteria|3
317144|NCT00720096|1039397|P2|Overall Study|Withdrawal by Subject|2
317145|NCT00720096|1039398|P1|Overall Study|Withdrawal by Subject|0
317146|NCT00720083|1039408|P2|Overall Study|Ineligible|2
317147|NCT00720083|1039409|P1|Overall Study|Ineligible|1
317148|NCT00720057|1039417|P2|Overall Study|Withdrawal by Subject|1
317149|NCT00720057|1039418|P1|Overall Study|Withdrawal by Subject|0
317150|NCT00720057|1039417|P2|Overall Study|Protocol Violation|0
317151|NCT00720057|1039418|P1|Overall Study|Protocol Violation|1
317152|NCT00720057|1039417|P2|Overall Study|Lost to Follow-up|2
317153|NCT00720057|1039418|P1|Overall Study|Lost to Follow-up|0
317154|NCT00719953|1039434|P1|Overall Study|Adverse Event|4
317155|NCT00719901|1039447|P1|Overall Study|Availability of Study Drug|1
317156|NCT00719901|1039447|P1|Overall Study|Disease Progression|3
317157|NCT00719901|1039447|P1|Overall Study|Alternate Treatment|1
317158|NCT00719901|1039447|P1|Overall Study|Withdrawal by Subject|1
317159|NCT00719901|1039447|P1|Overall Study|Adverse Event|5
317160|NCT00719862|1039459|P2|Overall Study|Other|3
317161|NCT00719862|1039460|P1|Overall Study|Other|2
317162|NCT00719862|1039459|P2|Overall Study|Lost to Follow-up|1
317163|NCT00719862|1039460|P1|Overall Study|Lost to Follow-up|0
317164|NCT00719862|1039459|P2|Overall Study|Withdrawal by Subject|0
317165|NCT00719862|1039460|P1|Overall Study|Withdrawal by Subject|1
317166|NCT00719862|1039459|P2|Overall Study|Non-Compliance|0
317167|NCT00719862|1039460|P1|Overall Study|Non-Compliance|1
317168|NCT00719862|1039459|P2|Overall Study|Lack of Efficacy|0
317169|NCT00719862|1039460|P1|Overall Study|Lack of Efficacy|3
317170|NCT00719862|1039459|P2|Overall Study|Adverse Event|2
317171|NCT00719862|1039460|P1|Overall Study|Adverse Event|1
317172|NCT00719849|1039478|P2|Overall Study|Death|1
317173|NCT00719849|1039479|P1|Overall Study|Death|0
317174|NCT00719810|1039518|P3|Overall Study|Withdrawal by Subject|2
317175|NCT00719810|1039519|P2|Overall Study|Withdrawal by Subject|1
317176|NCT00719810|1039520|P1|Overall Study|Withdrawal by Subject|1
317177|NCT00719810|1039518|P3|Overall Study|Physician Decision|0
317178|NCT00719810|1039519|P2|Overall Study|Physician Decision|1
317179|NCT00719810|1039520|P1|Overall Study|Physician Decision|0
317180|NCT00719810|1039518|P3|Overall Study|Lost to Follow-up|3
317181|NCT00719810|1039519|P2|Overall Study|Lost to Follow-up|0
317182|NCT00719810|1039520|P1|Overall Study|Lost to Follow-up|2
317183|NCT00719810|1039518|P3|Overall Study|Adverse Event|3
317184|NCT00719810|1039519|P2|Overall Study|Adverse Event|2
317185|NCT00719810|1039520|P1|Overall Study|Adverse Event|0
317186|NCT00719732|1039531|P1|Overall Study|Illness not associated with device|1
317187|NCT00719732|1039531|P1|Overall Study|Unilateral (not bilateral) implantation|1
317188|NCT00719732|1039531|P1|Overall Study|Lost to Follow-up|20
317189|NCT00719706|1039537|P2|Overall Study|Protocol Violation|0
317190|NCT00719706|1039538|P1|Overall Study|Protocol Violation|3
317191|NCT00719706|1039537|P2|Overall Study|Withdrawal by Subject|2
317192|NCT00719706|1039538|P1|Overall Study|Withdrawal by Subject|1
317193|NCT00719706|1039537|P2|Overall Study|Adverse Event|4
317194|NCT00719706|1039538|P1|Overall Study|Adverse Event|5
317195|NCT00719680|1039552|P1|Overall Study|Withdrawal by Subject|3
317196|NCT00719680|1039552|P1|Overall Study|Lost to Follow-up|1
317197|NCT00719680|1039552|P1|Overall Study|Adverse Event|1
317198|NCT00719563|1039587|P2|Overall Study|Lost to Follow-up|3
317199|NCT00719563|1039588|P1|Overall Study|Lost to Follow-up|5
317200|NCT00719563|1039587|P2|Overall Study|Noncompliant|1
317201|NCT00719563|1039588|P1|Overall Study|Noncompliant|1
317202|NCT00719563|1039587|P2|Overall Study|Unknown reasons|6
317203|NCT00719563|1039588|P1|Overall Study|Unknown reasons|4
317204|NCT00719563|1039587|P2|Overall Study|Personal reasons|7
317205|NCT00719563|1039588|P1|Overall Study|Personal reasons|6
317206|NCT00719563|1039587|P2|Overall Study|Lack of Efficacy|7
317207|NCT00719563|1039588|P1|Overall Study|Lack of Efficacy|3
317208|NCT00719563|1039587|P2|Overall Study|Medical condition changed|5
317209|NCT00719563|1039588|P1|Overall Study|Medical condition changed|3
317210|NCT00719563|1039587|P2|Overall Study|Adverse Event|13
317211|NCT00719563|1039588|P1|Overall Study|Adverse Event|16
317212|NCT00719537|1039620|P2|Overall Study|Lost to Follow-up|1
317213|NCT00719537|1039621|P1|Overall Study|Lost to Follow-up|0
317214|NCT00719537|1039620|P2|Overall Study|Withdrawal by Subject|0
317215|NCT00719537|1039621|P1|Overall Study|Withdrawal by Subject|1
317216|NCT00719472|1039627|P1|Received Cycle 2 Treatment|Various Reasons|25
317217|NCT00719472|1039627|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
317218|NCT00719472|1039627|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
317219|NCT00719472|1039627|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
317220|NCT00719472|1039627|P1|Received Cycle 2 Treatment|Disease progression|3
317221|NCT00719472|1039627|P1|Received Cycle 2 Treatment|Death|6
317222|NCT00719472|1039627|P1|Received Cycle 2 Treatment|Adverse Event|12
317223|NCT00719472|1039627|P1|Received Cycle 1 Treatment|Various Reasons|13
317224|NCT00719472|1039627|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
317225|NCT00719472|1039627|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
317226|NCT00719472|1039627|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
317227|NCT00719472|1039627|P1|Received Cycle 1 Treatment|Death|5
317228|NCT00719472|1039627|P1|Received Cycle 1 Treatment|Adverse Event|8
317229|NCT00719472|1039627|P1|Enrolled in Study|Various Reasons|17
317230|NCT00719472|1039627|P1|Enrolled in Study|Subject decision to withdraw|8
317231|NCT00719472|1039627|P1|Enrolled in Study|Physician decision to withdraw patient|1
317232|NCT00719355|1039638|P2|Overall Study|Moved|1
317233|NCT00719355|1039639|P1|Overall Study|Moved|0
317234|NCT00719355|1039638|P2|Overall Study|Compliance|6
317235|NCT00719355|1039639|P1|Overall Study|Compliance|4
317236|NCT00719355|1039638|P2|Overall Study|Medical|5
317237|NCT00719355|1039639|P1|Overall Study|Medical|14
317238|NCT00719355|1039638|P2|Overall Study|Death|1
317239|NCT00719355|1039639|P1|Overall Study|Death|0
317240|NCT00719264|1039668|P2|Overall Study|Disease Progression|107
317241|NCT00719264|1039669|P1|Overall Study|Disease Progression|104
317242|NCT00719264|1039668|P2|Overall Study|New Cancer Therapy|2
317243|NCT00719264|1039669|P1|Overall Study|New Cancer Therapy|4
317244|NCT00719264|1039668|P2|Overall Study|Protocol Deviation|3
317245|NCT00719264|1039669|P1|Overall Study|Protocol Deviation|1
317246|NCT00719264|1039668|P2|Overall Study|Withdrawal by Subject|7
317247|NCT00719264|1039669|P1|Overall Study|Withdrawal by Subject|12
317248|NCT00719264|1039668|P2|Overall Study|Lost to Follow-up|1
317249|NCT00719264|1039669|P1|Overall Study|Lost to Follow-up|1
317250|NCT00719264|1039668|P2|Overall Study|Administrative Problems|4
317251|NCT00719264|1039669|P1|Overall Study|Administrative Problems|6
317252|NCT00719264|1039668|P2|Overall Study|Death|10
317253|NCT00719264|1039669|P1|Overall Study|Death|13
317254|NCT00719264|1039668|P2|Overall Study|Adverse Event|49
317255|NCT00719264|1039669|P1|Overall Study|Adverse Event|41
317256|NCT00719212|1039688|P1|Overall Study|Withdrawal by Subject|1
317257|NCT00719212|1039688|P1|Overall Study|Lost to Follow-up|2
317258|NCT00719212|1039688|P1|Overall Study|Death|41
317259|NCT00719043|1039734|P7|Overall Study|Withdrawal by Subject|14
317260|NCT00719043|1039735|P6|Overall Study|Withdrawal by Subject|18
317261|NCT00719043|1039736|P5|Overall Study|Withdrawal by Subject|16
317262|NCT00719043|1039737|P4|Overall Study|Withdrawal by Subject|10
317263|NCT00719043|1039738|P3|Overall Study|Withdrawal by Subject|9
317264|NCT00719043|1039739|P2|Overall Study|Withdrawal by Subject|14
317265|NCT00719043|1039740|P1|Overall Study|Withdrawal by Subject|12
317266|NCT00719043|1039734|P7|Overall Study|Unspecified|1
317267|NCT00719043|1039735|P6|Overall Study|Unspecified|2
317268|NCT00719043|1039736|P5|Overall Study|Unspecified|0
317269|NCT00719043|1039737|P4|Overall Study|Unspecified|2
317270|NCT00719043|1039738|P3|Overall Study|Unspecified|1
317271|NCT00719043|1039739|P2|Overall Study|Unspecified|0
317272|NCT00719043|1039740|P1|Overall Study|Unspecified|1
317273|NCT00719043|1039734|P7|Overall Study|Protocol Violation|0
317274|NCT00719043|1039735|P6|Overall Study|Protocol Violation|1
317275|NCT00719043|1039736|P5|Overall Study|Protocol Violation|0
317276|NCT00719043|1039737|P4|Overall Study|Protocol Violation|0
317277|NCT00719043|1039738|P3|Overall Study|Protocol Violation|0
317278|NCT00719043|1039739|P2|Overall Study|Protocol Violation|0
317279|NCT00719043|1039740|P1|Overall Study|Protocol Violation|0
317280|NCT00719043|1039734|P7|Overall Study|Lost to Follow-up|9
317281|NCT00719043|1039735|P6|Overall Study|Lost to Follow-up|9
317282|NCT00719043|1039736|P5|Overall Study|Lost to Follow-up|10
317283|NCT00719043|1039737|P4|Overall Study|Lost to Follow-up|9
317284|NCT00719043|1039738|P3|Overall Study|Lost to Follow-up|8
317285|NCT00719043|1039739|P2|Overall Study|Lost to Follow-up|10
317286|NCT00719043|1039740|P1|Overall Study|Lost to Follow-up|14
317287|NCT00719043|1039734|P7|Overall Study|Adverse Event|4
317288|NCT00719043|1039735|P6|Overall Study|Adverse Event|4
317289|NCT00719043|1039736|P5|Overall Study|Adverse Event|1
317290|NCT00719043|1039737|P4|Overall Study|Adverse Event|2
317291|NCT00719043|1039738|P3|Overall Study|Adverse Event|2
317292|NCT00719043|1039739|P2|Overall Study|Adverse Event|1
317293|NCT00719043|1039740|P1|Overall Study|Adverse Event|5
317294|NCT00718887|1039864|P2|Overall Study|Not identified|7
317295|NCT00718887|1039865|P1|Overall Study|Not identified|2
317296|NCT00718887|1039864|P2|Overall Study|Withdrawal by Subject|2
317297|NCT00718887|1039865|P1|Overall Study|Withdrawal by Subject|3
317298|NCT00718861|1039889|P2|Overall Study|Death|5
317299|NCT00718861|1039890|P1|Overall Study|Death|1
317300|NCT00718861|1039889|P2|Overall Study|Administrative Problems|1
317301|NCT00718861|1039890|P1|Overall Study|Administrative Problems|1
317302|NCT00718861|1039889|P2|Overall Study|Lost to Follow-up|1
317303|NCT00718861|1039890|P1|Overall Study|Lost to Follow-up|2
317304|NCT00718861|1039889|P2|Overall Study|Adverse Event|1
317305|NCT00718861|1039890|P1|Overall Study|Adverse Event|2
317306|NCT00718861|1039889|P2|Overall Study|Withdrawal by Subject|10
317307|NCT00718861|1039890|P1|Overall Study|Withdrawal by Subject|15
317308|NCT00718809|1039918|P2|Overall Study|Noncompliance|0
317309|NCT00718809|1039919|P1|Overall Study|Noncompliance|1
317310|NCT00718809|1039918|P2|Overall Study|Lost to Follow-up|0
317311|NCT00718809|1039919|P1|Overall Study|Lost to Follow-up|1
317312|NCT00718809|1039918|P2|Overall Study|Withdrawal by Subject|1
317313|NCT00718809|1039919|P1|Overall Study|Withdrawal by Subject|0
317314|NCT00718809|1039918|P2|Overall Study|Adverse Event|1
317315|NCT00718809|1039919|P1|Overall Study|Adverse Event|1
317316|NCT00718809|1039918|P2|Overall Study|Disease progression|7
317317|NCT00718809|1039919|P1|Overall Study|Disease progression|9
317318|NCT00718770|1039933|P1|Overall Study|Adverse Event|1
317319|NCT00718770|1039933|P1|Overall Study|Lack of Efficacy|1
317320|NCT00718770|1039933|P1|Overall Study|Adverse Event|1
317321|NCT00718770|1039933|P1|Overall Study|Lack of Efficacy|1
317322|NCT00718770|1039933|P1|Overall Study|Adverse Event|1
317323|NCT00718770|1039933|P1|Overall Study|Lack of Efficacy|1
317324|NCT00718770|1039933|P1|Overall Study|Lack of Efficacy|1
317325|NCT00718770|1039933|P1|Overall Study|Adverse Event|1
317326|NCT00718640|1039937|P1|Overall Study|Unresolved toxicity after 2 weeks|2
317327|NCT00718640|1039937|P1|Overall Study|Death|1
317328|NCT00718640|1039937|P1|Overall Study|Adverse Event|4
317329|NCT00718523|1039951|P2|Overall Study|Death|17
317330|NCT00718523|1039952|P1|Overall Study|Death|13
317331|NCT00718523|1039951|P2|Overall Study|Withdrawal by Subject|7
317332|NCT00718523|1039952|P1|Overall Study|Withdrawal by Subject|5
317333|NCT00718328|1039964|P2|Overall Study|Lost to Follow-up|0
317334|NCT00718328|1039965|P1|Overall Study|Lost to Follow-up|1
317335|NCT00718315|1039974|P3|Overall Study|Use of ATB and Corticoids|2
317336|NCT00718315|1039975|P2|Overall Study|Use of ATB and Corticoids|1
317337|NCT00718315|1039976|P1|Overall Study|Use of ATB and Corticoids|0
317338|NCT00718315|1039974|P3|Overall Study|Other|1
317339|NCT00718315|1039975|P2|Overall Study|Other|0
317340|NCT00718315|1039976|P1|Overall Study|Other|0
317341|NCT00718315|1039974|P3|Overall Study|Disease progression|1
317342|NCT00718315|1039975|P2|Overall Study|Disease progression|1
317343|NCT00718315|1039976|P1|Overall Study|Disease progression|0
317344|NCT00718315|1039974|P3|Overall Study|Use of Minocyclin|1
317345|NCT00718315|1039975|P2|Overall Study|Use of Minocyclin|1
317346|NCT00718315|1039976|P1|Overall Study|Use of Minocyclin|1
317347|NCT00718315|1039974|P3|Overall Study|Erlotinib dose decreased|1
317348|NCT00718315|1039975|P2|Overall Study|Erlotinib dose decreased|3
317349|NCT00718315|1039976|P1|Overall Study|Erlotinib dose decreased|4
317350|NCT00718315|1039974|P3|Overall Study|Protocol Violation|3
317351|NCT00718315|1039975|P2|Overall Study|Protocol Violation|5
317352|NCT00718315|1039976|P1|Overall Study|Protocol Violation|5
317353|NCT00718315|1039974|P3|Overall Study|Lost to Follow-up|4
317354|NCT00718315|1039975|P2|Overall Study|Lost to Follow-up|3
317355|NCT00718315|1039976|P1|Overall Study|Lost to Follow-up|2
317356|NCT00718315|1039974|P3|Overall Study|Death|5
317357|NCT00718315|1039975|P2|Overall Study|Death|6
317358|NCT00718315|1039976|P1|Overall Study|Death|6
317359|NCT00718315|1039974|P3|Overall Study|Adverse Event|3
317360|NCT00718315|1039975|P2|Overall Study|Adverse Event|2
317361|NCT00718315|1039976|P1|Overall Study|Adverse Event|1
317362|NCT00718237|1040027|P2|Overall Study|Withdrawal by Subject|10
317363|NCT00718237|1040028|P1|Overall Study|Withdrawal by Subject|9
317364|NCT00718237|1040027|P2|Overall Study|Physician Decision|0
317365|NCT00718237|1040028|P1|Overall Study|Physician Decision|1
317366|NCT00718237|1040027|P2|Overall Study|Lost to Follow-up|2
317367|NCT00718237|1040028|P1|Overall Study|Lost to Follow-up|2
317368|NCT00718237|1040027|P2|Overall Study|Adverse Event|3
317369|NCT00718237|1040028|P1|Overall Study|Adverse Event|1
317370|NCT00718081|1040062|P3|Overall Study|Lack of Efficacy|21
317371|NCT00718081|1040063|P2|Overall Study|Lack of Efficacy|3
317372|NCT00718081|1040064|P1|Overall Study|Lack of Efficacy|7
317373|NCT00718081|1040062|P3|Overall Study|Adverse Event|0
317374|NCT00718081|1040063|P2|Overall Study|Adverse Event|1
317375|NCT00718081|1040064|P1|Overall Study|Adverse Event|0
317376|NCT00718042|1040081|P6|Donor Follow-up|Lost to Follow-up|0
317377|NCT00718042|1040082|P5|Donor Follow-up|Lost to Follow-up|19
317378|NCT00718042|1040083|P4|Donor Follow-up|Lost to Follow-up|0
317379|NCT00718042|1040084|P3|Donor Follow-up|Lost to Follow-up|0
317380|NCT00718042|1040085|P2|Donor Follow-up|Lost to Follow-up|0
317381|NCT00718042|1040086|P1|Donor Follow-up|Lost to Follow-up|13
317382|NCT00718042|1040081|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
317383|NCT00718042|1040082|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
317384|NCT00718042|1040083|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
317385|NCT00718042|1040084|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
317386|NCT00718042|1040085|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
317387|NCT00718042|1040086|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
317388|NCT00718042|1040081|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
317389|NCT00718042|1040082|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
317390|NCT00718042|1040083|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
317391|NCT00718042|1040084|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
317392|NCT00718042|1040085|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
317393|NCT00718042|1040086|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
317394|NCT00718042|1040081|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
317395|NCT00718042|1040082|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
317396|NCT00718042|1040083|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
317397|NCT00718042|1040084|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
317398|NCT00718042|1040085|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
317399|NCT00718042|1040086|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
317400|NCT00718042|1040081|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
317401|NCT00718042|1040082|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
317402|NCT00718042|1040083|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
317403|NCT00718042|1040084|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
317404|NCT00718042|1040085|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
317405|NCT00718042|1040086|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
317406|NCT00717886|1040126|P1|Overall Study|Treatment Failure|1
317407|NCT00717886|1040126|P1|Overall Study|Withdrawal by Subject|3
317408|NCT00717860|1040141|P2|Overall Study|Withdrew consent|3
317409|NCT00717860|1040142|P1|Overall Study|Withdrew consent|7
317410|NCT00717860|1040141|P2|Overall Study|Discontinued for other reason|1
317411|NCT00717860|1040142|P1|Overall Study|Discontinued for other reason|6
317412|NCT00717860|1040141|P2|Overall Study|Lack of Efficacy|13
317413|NCT00717860|1040142|P1|Overall Study|Lack of Efficacy|7
317414|NCT00717860|1040141|P2|Overall Study|Laboratory adverse experience|2
317415|NCT00717860|1040142|P1|Overall Study|Laboratory adverse experience|2
317416|NCT00717860|1040141|P2|Overall Study|Clinical adverse experience|9
317417|NCT00717860|1040142|P1|Overall Study|Clinical adverse experience|5
317418|NCT00717756|1040152|P1|Overall Study|Withdrawal by Subject|1
317419|NCT00717522|1040156|P1|Overall Study|Death|1
317420|NCT00717522|1040156|P1|Overall Study|Adverse Event|1
317421|NCT00717522|1040156|P1|Overall Study|Disease Progression|5
317422|NCT00717314|1040192|P2|Overall Study|Withdrawal by Subject|3
317423|NCT00717314|1040193|P1|Overall Study|Withdrawal by Subject|1
317424|NCT00717314|1040192|P2|Overall Study|Lost to Follow-up|5
317425|NCT00717314|1040193|P1|Overall Study|Lost to Follow-up|1
317426|NCT00717314|1040192|P2|Overall Study|Protocol Violation|0
317427|NCT00717314|1040193|P1|Overall Study|Protocol Violation|1
317428|NCT00717314|1040192|P2|Overall Study|Adverse Event|2
317429|NCT00717314|1040193|P1|Overall Study|Adverse Event|3
317430|NCT00717275|1040230|P1|Overall Study|Premature study termination.|3
317431|NCT00717249|1040236|P2|Overall Study|Headaches|0
317432|NCT00717249|1040237|P1|Overall Study|Headaches|1
317433|NCT00717249|1040236|P2|Overall Study|Subject relocated|0
317434|NCT00717249|1040237|P1|Overall Study|Subject relocated|1
317435|NCT00717249|1040236|P2|Overall Study|Diagnosed with Multiple Scletosis|0
317436|NCT00717249|1040237|P1|Overall Study|Diagnosed with Multiple Scletosis|1
317437|NCT00717249|1040236|P2|Overall Study|Diagnosed with Diabetes|0
317438|NCT00717249|1040237|P1|Overall Study|Diagnosed with Diabetes|1
317439|NCT00717249|1040236|P2|Overall Study|Gastric Surgery|1
317440|NCT00717249|1040237|P1|Overall Study|Gastric Surgery|0
317441|NCT00717249|1040236|P2|Overall Study|Unsatisfactory Physiological Response|1
317442|NCT00717249|1040237|P1|Overall Study|Unsatisfactory Physiological Response|0
317443|NCT00717249|1040236|P2|Overall Study|Subject became Ineligible|1
317444|NCT00717249|1040237|P1|Overall Study|Subject became Ineligible|1
317445|NCT00717249|1040236|P2|Overall Study|Protocol Violation|2
317446|NCT00717249|1040237|P1|Overall Study|Protocol Violation|0
317447|NCT00717249|1040236|P2|Overall Study|Pregnancy|3
317448|NCT00717249|1040237|P1|Overall Study|Pregnancy|6
317449|NCT00717249|1040236|P2|Overall Study|Withdrawal by Subject|2
317450|NCT00717249|1040237|P1|Overall Study|Withdrawal by Subject|1
317451|NCT00717249|1040236|P2|Overall Study|Lost to Follow-up|0
317452|NCT00717249|1040237|P1|Overall Study|Lost to Follow-up|2
317453|NCT00717249|1040236|P2|Overall Study|Adverse Event|2
317454|NCT00717249|1040237|P1|Overall Study|Adverse Event|4
317455|NCT00717249|1040236|P2|Overall Study|Unsatisfactory visual Response|2
317456|NCT00717249|1040237|P1|Overall Study|Unsatisfactory visual Response|0
317457|NCT00717249|1040236|P2|Overall Study|Lens Discomfort|1
317458|NCT00717249|1040237|P1|Overall Study|Lens Discomfort|4
317459|NCT00717236|1040251|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
317460|NCT00717236|1040252|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
317461|NCT00717236|1040251|P2|Open-Label Period|Other: Completion Accidently Performed|0
317462|NCT00717236|1040252|P1|Open-Label Period|Other: Completion Accidently Performed|1
317463|NCT00717236|1040251|P2|Open-Label Period|Other: Administration of Golimumab|0
317464|NCT00717236|1040252|P1|Open-Label Period|Other: Administration of Golimumab|1
317465|NCT00717236|1040251|P2|Open-Label Period|Other: Cataract Surgery|0
317466|NCT00717236|1040252|P1|Open-Label Period|Other: Cataract Surgery|1
317467|NCT00717236|1040251|P2|Open-Label Period|Other: Sponsor Request|0
317468|NCT00717236|1040252|P1|Open-Label Period|Other: Sponsor Request|3
317469|NCT00717236|1040251|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
317470|NCT00717236|1040252|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
317471|NCT00717236|1040251|P2|Open-Label Period|Other: Investigator Decision|0
317472|NCT00717236|1040252|P1|Open-Label Period|Other: Investigator Decision|1
317473|NCT00717236|1040251|P2|Open-Label Period|Other: Moved|0
317474|NCT00717236|1040252|P1|Open-Label Period|Other: Moved|1
317475|NCT00717236|1040251|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
317476|NCT00717236|1040252|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
317477|NCT00717236|1040251|P2|Open-Label Period|Other: Lack of Compliance|1
317478|NCT00717236|1040252|P1|Open-Label Period|Other: Lack of Compliance|1
317479|NCT00717236|1040251|P2|Open-Label Period|Other: Peripheral Neuropathy|1
317480|NCT00717236|1040252|P1|Open-Label Period|Other: Peripheral Neuropathy|0
317481|NCT00717236|1040251|P2|Open-Label Period|Loss of Efficacy|1
317482|NCT00717236|1040252|P1|Open-Label Period|Loss of Efficacy|6
317483|NCT00717236|1040251|P2|Open-Label Period|Withdrawal by Subject|2
317484|NCT00717236|1040252|P1|Open-Label Period|Withdrawal by Subject|20
317485|NCT00717236|1040251|P2|Open-Label Period|Lost to Follow-up|4
317486|NCT00717236|1040252|P1|Open-Label Period|Lost to Follow-up|28
317487|NCT00717236|1040251|P2|Open-Label Period|Lack of Efficacy|8
317488|NCT00717236|1040252|P1|Open-Label Period|Lack of Efficacy|30
317489|NCT00717236|1040251|P2|Open-Label Period|Adverse Event|4
317490|NCT00717236|1040252|P1|Open-Label Period|Adverse Event|29
317491|NCT00717236|1040251|P2|Double-Blind Period|Other: Investigator Decision|1
317492|NCT00717236|1040252|P1|Double-Blind Period|Other: Investigator Decision|0
317493|NCT00717236|1040251|P2|Double-Blind Period|Other: Transportation problems|1
317494|NCT00717236|1040252|P1|Double-Blind Period|Other: Transportation problems|0
317495|NCT00717236|1040251|P2|Double-Blind Period|Other: Prohibited medication taken|2
317496|NCT00717236|1040252|P1|Double-Blind Period|Other: Prohibited medication taken|2
317497|NCT00717236|1040251|P2|Double-Blind Period|Other: Stopped taking DMARD|0
317498|NCT00717236|1040252|P1|Double-Blind Period|Other: Stopped taking DMARD|1
317499|NCT00717236|1040251|P2|Double-Blind Period|Other: Subject moved|1
317500|NCT00717236|1040252|P1|Double-Blind Period|Other: Subject moved|1
317501|NCT00717236|1040251|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
317502|NCT00717236|1040252|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
317503|NCT00717236|1040251|P2|Double-Blind Period|Other: Inappropriate randomization|0
317504|NCT00717236|1040252|P1|Double-Blind Period|Other: Inappropriate randomization|1
317505|NCT00717236|1040251|P2|Double-Blind Period|Other: Sponsor request|0
317506|NCT00717236|1040252|P1|Double-Blind Period|Other: Sponsor request|1
317507|NCT00717236|1040251|P2|Double-Blind Period|Other: History of cancer|0
317508|NCT00717236|1040252|P1|Double-Blind Period|Other: History of cancer|1
317509|NCT00717236|1040251|P2|Double-Blind Period|Other: History of adenoid grown|0
317510|NCT00717236|1040252|P1|Double-Blind Period|Other: History of adenoid grown|1
317511|NCT00717236|1040251|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
317512|NCT00717236|1040252|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
317513|NCT00717236|1040251|P2|Double-Blind Period|Other: subject withdrew consent|1
317514|NCT00717236|1040252|P1|Double-Blind Period|Other: subject withdrew consent|1
317515|NCT00717236|1040251|P2|Double-Blind Period|Other: Screening failure|0
317516|NCT00717236|1040252|P1|Double-Blind Period|Other: Screening failure|1
317517|NCT00717236|1040251|P2|Double-Blind Period|Other: Site withdrew|0
317518|NCT00717236|1040252|P1|Double-Blind Period|Other: Site withdrew|2
317519|NCT00717236|1040251|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
317520|NCT00717236|1040252|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
317521|NCT00717236|1040251|P2|Double-Blind Period|Other: Protocol Violation|0
317522|NCT00717236|1040252|P1|Double-Blind Period|Other: Protocol Violation|2
317523|NCT00717236|1040251|P2|Double-Blind Period|Other: Pregnancy|0
317524|NCT00717236|1040252|P1|Double-Blind Period|Other: Pregnancy|1
317525|NCT00717236|1040251|P2|Double-Blind Period|Other: Death|0
317526|NCT00717236|1040252|P1|Double-Blind Period|Other: Death|1
317527|NCT00717236|1040251|P2|Double-Blind Period|Loss of efficacy|0
317528|NCT00717236|1040252|P1|Double-Blind Period|Loss of efficacy|3
317529|NCT00717236|1040251|P2|Double-Blind Period|Withdrawal by Subject|2
317530|NCT00717236|1040252|P1|Double-Blind Period|Withdrawal by Subject|10
317531|NCT00717236|1040251|P2|Double-Blind Period|Lost to Follow-up|5
317532|NCT00717236|1040252|P1|Double-Blind Period|Lost to Follow-up|3
317533|NCT00717236|1040251|P2|Double-Blind Period|Lack of Efficacy|6
317534|NCT00717236|1040252|P1|Double-Blind Period|Lack of Efficacy|6
317535|NCT00717236|1040251|P2|Double-Blind Period|Adverse Event|6
317536|NCT00717236|1040252|P1|Double-Blind Period|Adverse Event|33
317537|NCT00717197|1040321|P1|Overall Study|Physician Decision|1
317538|NCT00717197|1040321|P1|Overall Study|Tumor Progression|1
317539|NCT00717197|1040321|P1|Overall Study|Unable to purchase study drug|5
317540|NCT00717093|1040327|P2|Overall Study|Randomized but not treated|0
317541|NCT00717093|1040328|P1|Overall Study|Randomized but not treated|1
317542|NCT00717093|1040327|P2|Overall Study|Unspecified|1
317543|NCT00717093|1040328|P1|Overall Study|Unspecified|0
317544|NCT00717093|1040327|P2|Overall Study|Withdrawal by Subject|19
317545|NCT00717093|1040328|P1|Overall Study|Withdrawal by Subject|12
317546|NCT00717093|1040327|P2|Overall Study|Lost to Follow-up|6
317547|NCT00717093|1040328|P1|Overall Study|Lost to Follow-up|9
317548|NCT00717093|1040327|P2|Overall Study|Lack of Efficacy|13
317549|NCT00717093|1040328|P1|Overall Study|Lack of Efficacy|3
317550|NCT00717093|1040327|P2|Overall Study|Adverse Event|9
317551|NCT00717093|1040328|P1|Overall Study|Adverse Event|19
317552|NCT00717067|1040345|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
317553|NCT00717067|1040346|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
317554|NCT00717067|1040347|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
317555|NCT00717067|1040348|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
317556|NCT00717067|1040349|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
317557|NCT00716976|1040456|P2|Overall Study|Ineligibles|2
317558|NCT00716976|1040457|P1|Overall Study|Ineligibles|4
317559|NCT00716976|1040456|P2|Overall Study|Radiation during protocol|0
317560|NCT00716976|1040457|P1|Overall Study|Radiation during protocol|1
317561|NCT00716976|1040456|P2|Overall Study|Premature discontinuation cisplatin|4
317562|NCT00716976|1040457|P1|Overall Study|Premature discontinuation cisplatin|5
317563|NCT00716976|1040456|P2|Overall Study|Withdrawal by Subject|1
317564|NCT00716976|1040457|P1|Overall Study|Withdrawal by Subject|5
317565|NCT00716976|1040456|P2|Overall Study|Physician Decision|2
317566|NCT00716976|1040457|P1|Overall Study|Physician Decision|2
317567|NCT00716976|1040456|P2|Overall Study|Death|0
317568|NCT00716976|1040457|P1|Overall Study|Death|1
317569|NCT00716976|1040456|P2|Overall Study|Adverse Event|0
317570|NCT00716976|1040457|P1|Overall Study|Adverse Event|2
317571|NCT00716859|1040495|P2|Overall Study|Not treated|1
317572|NCT00716859|1040496|P1|Overall Study|Not treated|1
317573|NCT00716859|1040495|P2|Overall Study|Withdrawal by Subject|3
317574|NCT00716859|1040496|P1|Overall Study|Withdrawal by Subject|1
317575|NCT00716859|1040495|P2|Overall Study|Lack of Efficacy|0
317576|NCT00716859|1040496|P1|Overall Study|Lack of Efficacy|3
317577|NCT00716859|1040495|P2|Overall Study|Adverse Event|1
317578|NCT00716859|1040496|P1|Overall Study|Adverse Event|4
317579|NCT00716625|1040581|P1|Overall Study|Safety was not Assessable|1
317580|NCT00716482|1040606|P1|Overall Study|inclusion/exclusion criteria not met|25
317581|NCT00716482|1040606|P1|Overall Study|technical/machine error|28
317582|NCT00716482|1040606|P1|Overall Study|no pathology obtained|10
317583|NCT00716482|1040606|P1|Overall Study|Inadequate acquisition or analysis|50
317584|NCT00716482|1040606|P1|Overall Study|Lost to Follow-up|6
317585|NCT00716456|1040619|P3|Overall Study|Adverse Event|0
317586|NCT00716456|1040620|P2|Overall Study|Adverse Event|2
317587|NCT00716456|1040621|P1|Overall Study|Adverse Event|0
317588|NCT00716417|1040672|P10|Overall Study|On patient request due to toxicities|0
317589|NCT00716417|1040673|P9|Overall Study|On patient request due to toxicities|0
317590|NCT00716417|1040674|P8|Overall Study|On patient request due to toxicities|1
317591|NCT00716417|1040675|P7|Overall Study|On patient request due to toxicities|0
317592|NCT00716417|1040676|P6|Overall Study|On patient request due to toxicities|0
317593|NCT00716417|1040677|P5|Overall Study|On patient request due to toxicities|0
317594|NCT00716417|1040678|P4|Overall Study|On patient request due to toxicities|0
317595|NCT00716417|1040679|P3|Overall Study|On patient request due to toxicities|0
317596|NCT00716417|1040680|P2|Overall Study|On patient request due to toxicities|0
317597|NCT00716417|1040681|P1|Overall Study|On patient request due to toxicities|0
317598|NCT00716417|1040672|P10|Overall Study|Dose limiting toxicity (DLT)|0
317599|NCT00716417|1040673|P9|Overall Study|Dose limiting toxicity (DLT)|0
317600|NCT00716417|1040674|P8|Overall Study|Dose limiting toxicity (DLT)|0
317601|NCT00716417|1040675|P7|Overall Study|Dose limiting toxicity (DLT)|0
317602|NCT00716417|1040676|P6|Overall Study|Dose limiting toxicity (DLT)|0
317603|NCT00716417|1040677|P5|Overall Study|Dose limiting toxicity (DLT)|1
317604|NCT00716417|1040678|P4|Overall Study|Dose limiting toxicity (DLT)|0
317605|NCT00716417|1040679|P3|Overall Study|Dose limiting toxicity (DLT)|0
317606|NCT00716417|1040680|P2|Overall Study|Dose limiting toxicity (DLT)|0
317607|NCT00716417|1040681|P1|Overall Study|Dose limiting toxicity (DLT)|0
317608|NCT00716417|1040672|P10|Overall Study|Progressive disease|0
317609|NCT00716417|1040673|P9|Overall Study|Progressive disease|5
317610|NCT00716417|1040674|P8|Overall Study|Progressive disease|1
317611|NCT00716417|1040675|P7|Overall Study|Progressive disease|3
317612|NCT00716417|1040676|P6|Overall Study|Progressive disease|3
317613|NCT00716417|1040677|P5|Overall Study|Progressive disease|0
317614|NCT00716417|1040678|P4|Overall Study|Progressive disease|8
317615|NCT00716417|1040679|P3|Overall Study|Progressive disease|3
317616|NCT00716417|1040680|P2|Overall Study|Progressive disease|5
317617|NCT00716417|1040681|P1|Overall Study|Progressive disease|3
317618|NCT00716417|1040672|P10|Overall Study|Withdrawal by Subject|0
317619|NCT00716417|1040673|P9|Overall Study|Withdrawal by Subject|0
317620|NCT00716417|1040674|P8|Overall Study|Withdrawal by Subject|0
317621|NCT00716417|1040675|P7|Overall Study|Withdrawal by Subject|1
317622|NCT00716417|1040676|P6|Overall Study|Withdrawal by Subject|0
317623|NCT00716417|1040677|P5|Overall Study|Withdrawal by Subject|0
317624|NCT00716417|1040678|P4|Overall Study|Withdrawal by Subject|2
317625|NCT00716417|1040679|P3|Overall Study|Withdrawal by Subject|0
317626|NCT00716417|1040680|P2|Overall Study|Withdrawal by Subject|1
317627|NCT00716417|1040681|P1|Overall Study|Withdrawal by Subject|0
317628|NCT00716417|1040672|P10|Overall Study|Adverse Event|3
317629|NCT00716417|1040673|P9|Overall Study|Adverse Event|0
317630|NCT00716417|1040674|P8|Overall Study|Adverse Event|1
317631|NCT00716417|1040675|P7|Overall Study|Adverse Event|3
317632|NCT00716417|1040676|P6|Overall Study|Adverse Event|0
317633|NCT00716417|1040677|P5|Overall Study|Adverse Event|0
317634|NCT00716417|1040678|P4|Overall Study|Adverse Event|1
317635|NCT00716417|1040679|P3|Overall Study|Adverse Event|2
317636|NCT00716417|1040680|P2|Overall Study|Adverse Event|0
317637|NCT00716417|1040681|P1|Overall Study|Adverse Event|0
317638|NCT00716092|1040728|P3|Overall Study|Other incl. Lack of Efficacy|0
317639|NCT00716092|1040729|P2|Overall Study|Other incl. Lack of Efficacy|1
317640|NCT00716092|1040730|P1|Overall Study|Other incl. Lack of Efficacy|2
317641|NCT00715949|1040783|P1|Overall Study|could not finish first test|4
317642|NCT00715910|1040791|P6|Booster and ESFU Phase|Unspecified|0
317643|NCT00715910|1040792|P5|Booster and ESFU Phase|Unspecified|1
317644|NCT00715910|1040793|P4|Booster and ESFU Phase|Unspecified|5
317645|NCT00715910|1040794|P3|Booster and ESFU Phase|Unspecified|0
317646|NCT00715910|1040795|P2|Booster and ESFU Phase|Unspecified|0
317647|NCT00715910|1040796|P1|Booster and ESFU Phase|Unspecified|0
317648|NCT00715910|1040791|P6|Booster and ESFU Phase|Lost to Follow-up|13
317649|NCT00715910|1040792|P5|Booster and ESFU Phase|Lost to Follow-up|1
317650|NCT00715910|1040793|P4|Booster and ESFU Phase|Lost to Follow-up|6
317651|NCT00715910|1040794|P3|Booster and ESFU Phase|Lost to Follow-up|0
317652|NCT00715910|1040795|P2|Booster and ESFU Phase|Lost to Follow-up|0
317653|NCT00715910|1040796|P1|Booster and ESFU Phase|Lost to Follow-up|0
317654|NCT00715676|1040953|P3|Overall Study|Elevated Blood Glucose|0
317655|NCT00715676|1040954|P2|Overall Study|Elevated Blood Glucose|1
317656|NCT00715676|1040955|P1|Overall Study|Elevated Blood Glucose|0
317657|NCT00715676|1040953|P3|Overall Study|Use of Exclusionary Medication|1
317658|NCT00715676|1040954|P2|Overall Study|Use of Exclusionary Medication|0
317659|NCT00715676|1040955|P1|Overall Study|Use of Exclusionary Medication|0
317660|NCT00715676|1040953|P3|Overall Study|Did Not Meet Entry Criteria|1
317661|NCT00715676|1040954|P2|Overall Study|Did Not Meet Entry Criteria|0
317662|NCT00715676|1040955|P1|Overall Study|Did Not Meet Entry Criteria|0
317663|NCT00715676|1040953|P3|Overall Study|Terminated by Sponsor|0
317664|NCT00715676|1040954|P2|Overall Study|Terminated by Sponsor|0
317665|NCT00715676|1040955|P1|Overall Study|Terminated by Sponsor|1
317666|NCT00715676|1040953|P3|Overall Study|Lost to Follow-up|1
317667|NCT00715676|1040954|P2|Overall Study|Lost to Follow-up|2
317668|NCT00715676|1040955|P1|Overall Study|Lost to Follow-up|1
317669|NCT00715676|1040953|P3|Overall Study|Withdrawal by Subject|8
317670|NCT00715676|1040954|P2|Overall Study|Withdrawal by Subject|3
317671|NCT00715676|1040955|P1|Overall Study|Withdrawal by Subject|1
317672|NCT00715676|1040953|P3|Overall Study|Adverse Event|21
317673|NCT00715676|1040954|P2|Overall Study|Adverse Event|5
317674|NCT00715676|1040955|P1|Overall Study|Adverse Event|3
317675|NCT00715624|1040998|P2|Overall Study|Other|1
317676|NCT00715624|1040999|P1|Overall Study|Other|0
317677|NCT00715624|1040998|P2|Overall Study|Incorrect randomization (not treated)|1
317678|NCT00715624|1040999|P1|Overall Study|Incorrect randomization (not treated)|0
317679|NCT00715624|1040998|P2|Overall Study|Sponsor decision|4
317680|NCT00715624|1040999|P1|Overall Study|Sponsor decision|0
317681|NCT00715624|1040998|P2|Overall Study|Poor compliance|13
317682|NCT00715624|1040999|P1|Overall Study|Poor compliance|6
317683|NCT00715624|1040998|P2|Overall Study|Familial and personal reasons|22
317684|NCT00715624|1040999|P1|Overall Study|Familial and personal reasons|10
317685|NCT00715624|1040998|P2|Overall Study|Withdrawal by Subject|25
317686|NCT00715624|1040999|P1|Overall Study|Withdrawal by Subject|11
317687|NCT00715624|1040998|P2|Overall Study|Protocol Violation|0
317688|NCT00715624|1040999|P1|Overall Study|Protocol Violation|1
317689|NCT00715624|1040998|P2|Overall Study|Lost to Follow-up|2
317690|NCT00715624|1040999|P1|Overall Study|Lost to Follow-up|1
317691|NCT00715624|1040998|P2|Overall Study|Lack of Efficacy|11
317692|NCT00715624|1040999|P1|Overall Study|Lack of Efficacy|11
317693|NCT00715624|1040998|P2|Overall Study|Adverse Event|37
317694|NCT00715624|1040999|P1|Overall Study|Adverse Event|12
317695|NCT00715559|1041027|P1|Overall Study|medication not tolerated - nausea|1
317696|NCT00715403|1041041|P7|Overall Study|Other reason not defined above|0
317697|NCT00715403|1041042|P6|Overall Study|Other reason not defined above|1
317698|NCT00715403|1041043|P5|Overall Study|Other reason not defined above|1
317699|NCT00715403|1041044|P4|Overall Study|Other reason not defined above|0
317700|NCT00715403|1041045|P3|Overall Study|Other reason not defined above|1
317701|NCT00715403|1041046|P2|Overall Study|Other reason not defined above|0
317702|NCT00715403|1041047|P1|Overall Study|Other reason not defined above|0
317703|NCT00715403|1041041|P7|Overall Study|Protocol Violation|0
317704|NCT00715403|1041042|P6|Overall Study|Protocol Violation|1
317705|NCT00715403|1041043|P5|Overall Study|Protocol Violation|0
317706|NCT00715403|1041044|P4|Overall Study|Protocol Violation|0
317707|NCT00715403|1041045|P3|Overall Study|Protocol Violation|0
317708|NCT00715403|1041046|P2|Overall Study|Protocol Violation|0
317709|NCT00715403|1041047|P1|Overall Study|Protocol Violation|0
317710|NCT00715403|1041041|P7|Overall Study|Other Adverse Event than DLT|0
317711|NCT00715403|1041042|P6|Overall Study|Other Adverse Event than DLT|2
317712|NCT00715403|1041043|P5|Overall Study|Other Adverse Event than DLT|0
317713|NCT00715403|1041044|P4|Overall Study|Other Adverse Event than DLT|0
317714|NCT00715403|1041045|P3|Overall Study|Other Adverse Event than DLT|0
317715|NCT00715403|1041046|P2|Overall Study|Other Adverse Event than DLT|0
317716|NCT00715403|1041047|P1|Overall Study|Other Adverse Event than DLT|1
317717|NCT00715403|1041041|P7|Overall Study|Dose limiting Toxicity (DLT)|0
317718|NCT00715403|1041042|P6|Overall Study|Dose limiting Toxicity (DLT)|1
317719|NCT00715403|1041043|P5|Overall Study|Dose limiting Toxicity (DLT)|0
317720|NCT00715403|1041044|P4|Overall Study|Dose limiting Toxicity (DLT)|0
317721|NCT00715403|1041045|P3|Overall Study|Dose limiting Toxicity (DLT)|0
317722|NCT00715403|1041046|P2|Overall Study|Dose limiting Toxicity (DLT)|0
317723|NCT00715403|1041047|P1|Overall Study|Dose limiting Toxicity (DLT)|0
317724|NCT00715403|1041041|P7|Overall Study|Progressive disease|1
317725|NCT00715403|1041042|P6|Overall Study|Progressive disease|14
317726|NCT00715403|1041043|P5|Overall Study|Progressive disease|5
317727|NCT00715403|1041044|P4|Overall Study|Progressive disease|9
317728|NCT00715403|1041045|P3|Overall Study|Progressive disease|3
317729|NCT00715403|1041046|P2|Overall Study|Progressive disease|1
317730|NCT00715403|1041047|P1|Overall Study|Progressive disease|0
317731|NCT00715299|1041186|P1|Overall Study|failed the pre-screen exercise test|2
317732|NCT00715299|1041186|P1|Overall Study|Adverse Event|3
317733|NCT00715299|1041186|P1|Overall Study|Withdrawal by Subject|1
317734|NCT00715208|1041192|P2|Overall Study|Lack of Efficacy|2
317735|NCT00715208|1041193|P1|Overall Study|Lack of Efficacy|0
317736|NCT00715208|1041192|P2|Overall Study|Adverse Event|6
317737|NCT00715208|1041193|P1|Overall Study|Adverse Event|0
317738|NCT00715208|1041192|P2|Overall Study|Withdrawal by Subject|1
317739|NCT00715208|1041193|P1|Overall Study|Withdrawal by Subject|1
317740|NCT00715117|1041209|P2|Overall Study|Crohn's flare and rescue with steroids|1
317741|NCT00715117|1041210|P1|Overall Study|Crohn's flare and rescue with steroids|0
317742|NCT00715078|1041278|P3|Overall Study|Unable to start due to disease prog.|1
317743|NCT00715078|1041279|P2|Overall Study|Unable to start due to disease prog.|0
317744|NCT00715078|1041280|P1|Overall Study|Unable to start due to disease prog.|0
317745|NCT00715078|1041278|P3|Overall Study|Withdrawal by Subject|1
317746|NCT00715078|1041279|P2|Overall Study|Withdrawal by Subject|0
317747|NCT00715078|1041280|P1|Overall Study|Withdrawal by Subject|1
317748|NCT00715078|1041278|P3|Overall Study|Death|36
317749|NCT00715078|1041279|P2|Overall Study|Death|36
317750|NCT00715078|1041280|P1|Overall Study|Death|29
317751|NCT00715026|1041288|P1|Overall Study|Surgery done on non-study consented hip|1
317752|NCT00715026|1041288|P1|Overall Study|Protocol Violation|1
317753|NCT00715026|1041288|P1|Overall Study|Lost to Follow-up|3
317754|NCT00715026|1041288|P1|Overall Study|Withdrawal by Subject|5
317755|NCT00714948|1041293|P1|Overall Study|Adverse Event|2
317756|NCT00714870|1041299|P2|Overall Study|did not attend minimum of 4 sessions|0
317757|NCT00714870|1041300|P1|Overall Study|did not attend minimum of 4 sessions|4
317758|NCT00714870|1041299|P2|Overall Study|patient unable to come b/c back pain|0
317759|NCT00714870|1041300|P1|Overall Study|patient unable to come b/c back pain|1
317760|NCT00714870|1041299|P2|Overall Study|Lost to Follow-up|5
317761|NCT00714870|1041300|P1|Overall Study|Lost to Follow-up|22
317762|NCT00714714|1041315|P1|Overall Study|Adverse Event|1
317763|NCT00714688|1041324|P3|Overall Study|Other|5
317764|NCT00714688|1041325|P2|Overall Study|Other|6
317765|NCT00714688|1041326|P1|Overall Study|Other|1
317766|NCT00714688|1041324|P3|Overall Study|Sponsor's Decision|0
317767|NCT00714688|1041325|P2|Overall Study|Sponsor's Decision|2
317768|NCT00714688|1041326|P1|Overall Study|Sponsor's Decision|0
317769|NCT00714688|1041324|P3|Overall Study|Ineligible to Continue the Study|1
317770|NCT00714688|1041325|P2|Overall Study|Ineligible to Continue the Study|1
317771|NCT00714688|1041326|P1|Overall Study|Ineligible to Continue the Study|0
317772|NCT00714688|1041324|P3|Overall Study|Subject Non-compliant|5
317773|NCT00714688|1041325|P2|Overall Study|Subject Non-compliant|5
317774|NCT00714688|1041326|P1|Overall Study|Subject Non-compliant|3
317775|NCT00714688|1041324|P3|Overall Study|Adverse Event|19
317776|NCT00714688|1041325|P2|Overall Study|Adverse Event|15
317777|NCT00714688|1041326|P1|Overall Study|Adverse Event|2
317778|NCT00714688|1041324|P3|Overall Study|Lost to Follow-up|0
317779|NCT00714688|1041325|P2|Overall Study|Lost to Follow-up|2
317780|NCT00714688|1041326|P1|Overall Study|Lost to Follow-up|5
317781|NCT00714688|1041324|P3|Overall Study|Withdrawal by Subject|3
317782|NCT00714688|1041325|P2|Overall Study|Withdrawal by Subject|3
317783|NCT00714688|1041326|P1|Overall Study|Withdrawal by Subject|4
317784|NCT00714688|1041324|P3|Overall Study|Lack of Efficacy|4
317785|NCT00714688|1041325|P2|Overall Study|Lack of Efficacy|1
317786|NCT00714688|1041326|P1|Overall Study|Lack of Efficacy|14
317787|NCT00714493|1041368|P1|Overall Study|OTHER|2
317788|NCT00714493|1041368|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
317789|NCT00714493|1041368|P1|Overall Study|Protocol Violation|12
317790|NCT00714493|1041368|P1|Overall Study|Lost to Follow-up|3
317791|NCT00714493|1041368|P1|Overall Study|Lack of Efficacy|10
317792|NCT00714493|1041368|P1|Overall Study|Death|3
317793|NCT00714493|1041368|P1|Overall Study|Adverse Event|11
317794|NCT00714285|1041396|P4|Overall Study|Migrated/moved from study area|0
317795|NCT00714285|1041397|P3|Overall Study|Migrated/moved from study area|0
317796|NCT00714285|1041398|P2|Overall Study|Migrated/moved from study area|1
317797|NCT00714285|1041399|P1|Overall Study|Migrated/moved from study area|0
317798|NCT00714285|1041396|P4|Overall Study|Lost to Follow-up|1
317799|NCT00714285|1041397|P3|Overall Study|Lost to Follow-up|0
317800|NCT00714285|1041398|P2|Overall Study|Lost to Follow-up|2
317801|NCT00714285|1041399|P1|Overall Study|Lost to Follow-up|0
317802|NCT00714259|1041449|P1|Overall Study|Death|2
317803|NCT00714168|1041495|P2|Overall Study|Non-study medical condition|2
317804|NCT00714168|1041496|P1|Overall Study|Non-study medical condition|3
317805|NCT00714168|1041495|P2|Overall Study|Relocation|3
317806|NCT00714168|1041496|P1|Overall Study|Relocation|4
317807|NCT00714168|1041495|P2|Overall Study|Lost to Follow-up|50
317808|NCT00714168|1041496|P1|Overall Study|Lost to Follow-up|32
317809|NCT00714168|1041495|P2|Overall Study|Pregnancy|4
317810|NCT00714168|1041496|P1|Overall Study|Pregnancy|5
317811|NCT00714051|1041512|P2|Overall Study|Death|1
317812|NCT00714051|1041513|P1|Overall Study|Death|0
317813|NCT00714051|1041512|P2|Overall Study|Withdrawal by Subject|0
317814|NCT00714051|1041513|P1|Overall Study|Withdrawal by Subject|1
317815|NCT00713830|1041521|P2|Overall Study|Sponsor Decision|10
317816|NCT00713830|1041522|P1|Overall Study|Sponsor Decision|4
317817|NCT00713830|1041521|P2|Overall Study|Familial and Personal Reasons|34
317818|NCT00713830|1041522|P1|Overall Study|Familial and Personal Reasons|9
317819|NCT00713830|1041521|P2|Overall Study|Poor Compliance to Protocol|14
317820|NCT00713830|1041522|P1|Overall Study|Poor Compliance to Protocol|7
317821|NCT00713830|1041521|P2|Overall Study|Withdrawal by Subject|23
317822|NCT00713830|1041522|P1|Overall Study|Withdrawal by Subject|13
317823|NCT00713830|1041521|P2|Overall Study|Lost to Follow-up|9
317824|NCT00713830|1041522|P1|Overall Study|Lost to Follow-up|2
317825|NCT00713830|1041521|P2|Overall Study|Lack of Efficacy|16
317826|NCT00713830|1041522|P1|Overall Study|Lack of Efficacy|24
317827|NCT00713830|1041521|P2|Overall Study|Adverse Event|71
317828|NCT00713830|1041522|P1|Overall Study|Adverse Event|23
317829|NCT00713700|1041579|P1|Overall Study|Withdrawal by Subject|1
317830|NCT00713700|1041579|P1|Overall Study|Lost to Follow-up|3
317831|NCT00713648|1041605|P1|Overall Study|Development of antibodies|3
317832|NCT00713648|1041605|P1|Overall Study|According to Protocol|2
317833|NCT00713648|1041605|P1|Overall Study|Unclassified|2
317834|NCT00713648|1041605|P1|Overall Study|Adverse Event|1
317835|NCT00713609|1041618|P6|Overall Study|Protocol Violation|0
317836|NCT00713609|1041619|P5|Overall Study|Protocol Violation|2
317837|NCT00713609|1041620|P4|Overall Study|Protocol Violation|1
317838|NCT00713609|1041621|P3|Overall Study|Protocol Violation|1
317839|NCT00713609|1041622|P2|Overall Study|Protocol Violation|3
317840|NCT00713609|1041623|P1|Overall Study|Protocol Violation|6
317841|NCT00713609|1041618|P6|Overall Study|Withdrawal by Subject|7
317842|NCT00713609|1041619|P5|Overall Study|Withdrawal by Subject|5
317843|NCT00713609|1041620|P4|Overall Study|Withdrawal by Subject|1
317844|NCT00713609|1041621|P3|Overall Study|Withdrawal by Subject|5
317845|NCT00713609|1041622|P2|Overall Study|Withdrawal by Subject|1
317846|NCT00713609|1041623|P1|Overall Study|Withdrawal by Subject|6
317847|NCT00713609|1041618|P6|Overall Study|Non-Compliance with Study Treatment|0
317848|NCT00713609|1041619|P5|Overall Study|Non-Compliance with Study Treatment|1
317849|NCT00713609|1041620|P4|Overall Study|Non-Compliance with Study Treatment|0
317850|NCT00713609|1041621|P3|Overall Study|Non-Compliance with Study Treatment|2
317851|NCT00713609|1041622|P2|Overall Study|Non-Compliance with Study Treatment|1
317852|NCT00713609|1041623|P1|Overall Study|Non-Compliance with Study Treatment|1
317853|NCT00713609|1041618|P6|Overall Study|Lack of Efficacy|0
317854|NCT00713609|1041619|P5|Overall Study|Lack of Efficacy|1
317855|NCT00713609|1041620|P4|Overall Study|Lack of Efficacy|0
317856|NCT00713609|1041621|P3|Overall Study|Lack of Efficacy|0
317857|NCT00713609|1041622|P2|Overall Study|Lack of Efficacy|3
317858|NCT00713609|1041623|P1|Overall Study|Lack of Efficacy|1
317859|NCT00713609|1041618|P6|Overall Study|Lost to Follow-up|0
317860|NCT00713609|1041619|P5|Overall Study|Lost to Follow-up|7
317861|NCT00713609|1041620|P4|Overall Study|Lost to Follow-up|5
317862|NCT00713609|1041621|P3|Overall Study|Lost to Follow-up|5
317863|NCT00713609|1041622|P2|Overall Study|Lost to Follow-up|7
317864|NCT00713609|1041623|P1|Overall Study|Lost to Follow-up|5
317865|NCT00713609|1041618|P6|Overall Study|Adverse Event|1
317866|NCT00713609|1041619|P5|Overall Study|Adverse Event|3
317867|NCT00713609|1041620|P4|Overall Study|Adverse Event|2
317868|NCT00713609|1041621|P3|Overall Study|Adverse Event|2
317869|NCT00713609|1041622|P2|Overall Study|Adverse Event|0
317870|NCT00713609|1041623|P1|Overall Study|Adverse Event|2
317871|NCT00713596|1041658|P3|Overall Study|Study was terminated|2
317872|NCT00713596|1041659|P2|Overall Study|Study was terminated|3
317873|NCT00713596|1041660|P1|Overall Study|Study was terminated|2
317874|NCT00713544|1041677|P6|Overall Study|Hepatotoxicity - not an AE|0
317875|NCT00713544|1041678|P5|Overall Study|Hepatotoxicity - not an AE|1
317876|NCT00713544|1041679|P4|Overall Study|Hepatotoxicity - not an AE|0
317877|NCT00713544|1041680|P3|Overall Study|Hepatotoxicity - not an AE|0
317878|NCT00713544|1041681|P2|Overall Study|Hepatotoxicity - not an AE|0
317879|NCT00713544|1041682|P1|Overall Study|Hepatotoxicity - not an AE|0
317880|NCT00713544|1041677|P6|Overall Study|Incorrect enrollment|0
317881|NCT00713544|1041678|P5|Overall Study|Incorrect enrollment|0
317882|NCT00713544|1041679|P4|Overall Study|Incorrect enrollment|0
317883|NCT00713544|1041680|P3|Overall Study|Incorrect enrollment|0
317884|NCT00713544|1041681|P2|Overall Study|Incorrect enrollment|1
317885|NCT00713544|1041682|P1|Overall Study|Incorrect enrollment|0
317886|NCT00713544|1041677|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
317887|NCT00713544|1041678|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
317888|NCT00713544|1041679|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
317889|NCT00713544|1041680|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
317890|NCT00713544|1041681|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
317891|NCT00713544|1041682|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
317892|NCT00713544|1041677|P6|Overall Study|Lost to Follow-up|0
317893|NCT00713544|1041678|P5|Overall Study|Lost to Follow-up|0
317894|NCT00713544|1041679|P4|Overall Study|Lost to Follow-up|0
317895|NCT00713544|1041680|P3|Overall Study|Lost to Follow-up|1
317896|NCT00713544|1041681|P2|Overall Study|Lost to Follow-up|0
317897|NCT00713544|1041682|P1|Overall Study|Lost to Follow-up|0
317898|NCT00713544|1041677|P6|Overall Study|Lack of Efficacy|0
317899|NCT00713544|1041678|P5|Overall Study|Lack of Efficacy|1
317900|NCT00713544|1041679|P4|Overall Study|Lack of Efficacy|1
317901|NCT00713544|1041680|P3|Overall Study|Lack of Efficacy|0
317902|NCT00713544|1041681|P2|Overall Study|Lack of Efficacy|1
317903|NCT00713544|1041682|P1|Overall Study|Lack of Efficacy|0
317904|NCT00713544|1041677|P6|Overall Study|Physician Decision|2
317905|NCT00713544|1041678|P5|Overall Study|Physician Decision|0
317906|NCT00713544|1041679|P4|Overall Study|Physician Decision|0
317907|NCT00713544|1041680|P3|Overall Study|Physician Decision|0
317908|NCT00713544|1041681|P2|Overall Study|Physician Decision|0
317909|NCT00713544|1041682|P1|Overall Study|Physician Decision|0
317910|NCT00713544|1041677|P6|Overall Study|Protocol Violation|1
317911|NCT00713544|1041678|P5|Overall Study|Protocol Violation|0
317912|NCT00713544|1041679|P4|Overall Study|Protocol Violation|0
317913|NCT00713544|1041680|P3|Overall Study|Protocol Violation|0
317914|NCT00713544|1041681|P2|Overall Study|Protocol Violation|0
317915|NCT00713544|1041682|P1|Overall Study|Protocol Violation|0
317916|NCT00713544|1041677|P6|Overall Study|Withdrawal by Subject|1
317917|NCT00713544|1041678|P5|Overall Study|Withdrawal by Subject|3
317918|NCT00713544|1041679|P4|Overall Study|Withdrawal by Subject|2
317919|NCT00713544|1041680|P3|Overall Study|Withdrawal by Subject|3
317920|NCT00713544|1041681|P2|Overall Study|Withdrawal by Subject|0
317921|NCT00713544|1041682|P1|Overall Study|Withdrawal by Subject|2
317922|NCT00713544|1041677|P6|Overall Study|Adverse Event|5
317923|NCT00713544|1041678|P5|Overall Study|Adverse Event|3
317924|NCT00713544|1041679|P4|Overall Study|Adverse Event|7
317925|NCT00713544|1041680|P3|Overall Study|Adverse Event|7
317926|NCT00713544|1041681|P2|Overall Study|Adverse Event|3
317927|NCT00713544|1041682|P1|Overall Study|Adverse Event|5
317928|NCT00713349|1041733|P1|Overall Study|Protocol Violation|1
317929|NCT00713323|1041739|P1|Overall Study|Treatment that may interact with Sativex|1
317930|NCT00713323|1041739|P1|Overall Study|Subject travelling to Dominica Republic|1
317931|NCT00713323|1041739|P1|Overall Study|Subject travelling to USA|1
317932|NCT00713323|1041739|P1|Overall Study|Pain resolved|1
317933|NCT00713323|1041739|P1|Overall Study|Non-compliance|1
317934|NCT00713323|1041739|P1|Overall Study|Pain free|1
317935|NCT00713323|1041739|P1|Overall Study|Surgery cured allodynic pain|1
317936|NCT00713323|1041739|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
317937|NCT00713323|1041739|P1|Overall Study|Low creatine clearance at screening|1
317938|NCT00713323|1041739|P1|Overall Study|Lack of Efficacy|36
317939|NCT00713323|1041739|P1|Overall Study|Lost to Follow-up|11
317940|NCT00713323|1041739|P1|Overall Study|Withdrawal by Subject|15
317941|NCT00713323|1041739|P1|Overall Study|Adverse Event|75
317942|NCT00713310|1041752|P2|Overall Study|Withdrawal by Subject|2
317943|NCT00713310|1041753|P1|Overall Study|Withdrawal by Subject|0
317944|NCT00713310|1041752|P2|Overall Study|Lack of Efficacy|2
317945|NCT00713310|1041753|P1|Overall Study|Lack of Efficacy|0
317946|NCT00713310|1041752|P2|Overall Study|Adverse Event|2
317947|NCT00713310|1041753|P1|Overall Study|Adverse Event|5
317948|NCT00713258|1041763|P2|Overall Study|Other|1
317949|NCT00713258|1041764|P1|Overall Study|Other|1
317950|NCT00713258|1041763|P2|Overall Study|Non-Compliance|1
317951|NCT00713258|1041764|P1|Overall Study|Non-Compliance|2
317952|NCT00713258|1041763|P2|Overall Study|Adverse Event|4
317953|NCT00713258|1041764|P1|Overall Study|Adverse Event|2
317954|NCT00713219|1041772|P1|Overall Study|Protocol Violation|1
317955|NCT00713219|1041772|P1|Overall Study|Death|1
317956|NCT00713206|1041778|P2|Overall Study|Adverse Event|1
317957|NCT00713206|1041779|P1|Overall Study|Adverse Event|2
317958|NCT00713206|1041778|P2|Overall Study|Lost to Follow-up|2
317959|NCT00713206|1041779|P1|Overall Study|Lost to Follow-up|5
317960|NCT00712985|1041785|P1|Overall Study|Lack of Efficacy|3
317961|NCT00712985|1041785|P1|Overall Study|1 patient moved out of state|1
317962|NCT00712985|1041785|P1|Overall Study|1 withdrew prior to start of drug|1
317963|NCT00712959|1041791|P2|Overall Study|Withdrawal by Subject|0
317964|NCT00712959|1041792|P1|Overall Study|Withdrawal by Subject|3
317965|NCT00712959|1041791|P2|Overall Study|Lost to Follow-up|2
317966|NCT00712959|1041792|P1|Overall Study|Lost to Follow-up|13
317967|NCT00712959|1041791|P2|Overall Study|Protocol Violation|1
317968|NCT00712959|1041792|P1|Overall Study|Protocol Violation|3
317969|NCT00712920|1041813|P3|Overall Study|Non-compliance|0
317970|NCT00712920|1041814|P2|Overall Study|Non-compliance|0
317971|NCT00712920|1041815|P1|Overall Study|Non-compliance|3
317972|NCT00712920|1041813|P3|Overall Study|Other|3
317973|NCT00712920|1041814|P2|Overall Study|Other|7
317974|NCT00712920|1041815|P1|Overall Study|Other|5
317975|NCT00712920|1041813|P3|Overall Study|Lack of Efficacy|1
317976|NCT00712920|1041814|P2|Overall Study|Lack of Efficacy|0
317977|NCT00712920|1041815|P1|Overall Study|Lack of Efficacy|1
317978|NCT00712920|1041813|P3|Overall Study|Lost to Follow-up|0
317979|NCT00712920|1041814|P2|Overall Study|Lost to Follow-up|4
317980|NCT00712920|1041815|P1|Overall Study|Lost to Follow-up|1
317981|NCT00712920|1041813|P3|Overall Study|Withdrawal by Subject|1
317982|NCT00712920|1041814|P2|Overall Study|Withdrawal by Subject|2
317983|NCT00712920|1041815|P1|Overall Study|Withdrawal by Subject|4
317984|NCT00712920|1041813|P3|Overall Study|Adverse Event|7
317985|NCT00712920|1041814|P2|Overall Study|Adverse Event|4
317986|NCT00712920|1041815|P1|Overall Study|Adverse Event|3
317987|NCT00712725|1041843|P8|Overall Study|Protocol Specified Criteria|1
317988|NCT00712725|1041844|P7|Overall Study|Protocol Specified Criteria|2
317989|NCT00712725|1041845|P6|Overall Study|Protocol Specified Criteria|0
317990|NCT00712725|1041846|P5|Overall Study|Protocol Specified Criteria|1
317991|NCT00712725|1041847|P4|Overall Study|Protocol Specified Criteria|2
317992|NCT00712725|1041848|P3|Overall Study|Protocol Specified Criteria|1
317993|NCT00712725|1041849|P2|Overall Study|Protocol Specified Criteria|0
317994|NCT00712725|1041850|P1|Overall Study|Protocol Specified Criteria|3
317995|NCT00712725|1041843|P8|Overall Study|Lack of Qualifying Event|6
317996|NCT00712725|1041844|P7|Overall Study|Lack of Qualifying Event|11
317997|NCT00712725|1041845|P6|Overall Study|Lack of Qualifying Event|13
317998|NCT00712725|1041846|P5|Overall Study|Lack of Qualifying Event|11
317999|NCT00712725|1041847|P4|Overall Study|Lack of Qualifying Event|8
318000|NCT00712725|1041848|P3|Overall Study|Lack of Qualifying Event|6
318001|NCT00712725|1041849|P2|Overall Study|Lack of Qualifying Event|2
318002|NCT00712725|1041850|P1|Overall Study|Lack of Qualifying Event|16
318003|NCT00712725|1041843|P8|Overall Study|Withdrawal by Subject|2
318004|NCT00712725|1041844|P7|Overall Study|Withdrawal by Subject|1
318005|NCT00712725|1041845|P6|Overall Study|Withdrawal by Subject|1
318006|NCT00712725|1041846|P5|Overall Study|Withdrawal by Subject|1
318007|NCT00712725|1041847|P4|Overall Study|Withdrawal by Subject|2
318008|NCT00712725|1041848|P3|Overall Study|Withdrawal by Subject|1
318009|NCT00712725|1041849|P2|Overall Study|Withdrawal by Subject|1
318010|NCT00712725|1041850|P1|Overall Study|Withdrawal by Subject|2
318011|NCT00712725|1041843|P8|Overall Study|Protocol Violation|1
318012|NCT00712725|1041844|P7|Overall Study|Protocol Violation|1
318013|NCT00712725|1041845|P6|Overall Study|Protocol Violation|0
318014|NCT00712725|1041846|P5|Overall Study|Protocol Violation|2
318015|NCT00712725|1041847|P4|Overall Study|Protocol Violation|3
318016|NCT00712725|1041848|P3|Overall Study|Protocol Violation|1
318017|NCT00712725|1041849|P2|Overall Study|Protocol Violation|0
318018|NCT00712725|1041850|P1|Overall Study|Protocol Violation|2
318019|NCT00712725|1041843|P8|Overall Study|Pregnancy|0
318020|NCT00712725|1041844|P7|Overall Study|Pregnancy|2
318021|NCT00712725|1041845|P6|Overall Study|Pregnancy|0
318022|NCT00712725|1041846|P5|Overall Study|Pregnancy|1
318023|NCT00712725|1041847|P4|Overall Study|Pregnancy|0
318024|NCT00712725|1041848|P3|Overall Study|Pregnancy|0
318025|NCT00712725|1041849|P2|Overall Study|Pregnancy|1
318026|NCT00712725|1041850|P1|Overall Study|Pregnancy|0
318027|NCT00712725|1041843|P8|Overall Study|Physician Decision|0
318028|NCT00712725|1041844|P7|Overall Study|Physician Decision|2
318029|NCT00712725|1041845|P6|Overall Study|Physician Decision|0
318030|NCT00712725|1041846|P5|Overall Study|Physician Decision|1
318031|NCT00712725|1041847|P4|Overall Study|Physician Decision|0
318032|NCT00712725|1041848|P3|Overall Study|Physician Decision|0
318033|NCT00712725|1041849|P2|Overall Study|Physician Decision|0
318034|NCT00712725|1041850|P1|Overall Study|Physician Decision|2
318035|NCT00712725|1041843|P8|Overall Study|Lost to Follow-up|1
318036|NCT00712725|1041844|P7|Overall Study|Lost to Follow-up|3
318037|NCT00712725|1041845|P6|Overall Study|Lost to Follow-up|2
318038|NCT00712725|1041846|P5|Overall Study|Lost to Follow-up|2
318039|NCT00712725|1041847|P4|Overall Study|Lost to Follow-up|1
318040|NCT00712725|1041848|P3|Overall Study|Lost to Follow-up|1
318041|NCT00712725|1041849|P2|Overall Study|Lost to Follow-up|2
318042|NCT00712725|1041850|P1|Overall Study|Lost to Follow-up|3
318043|NCT00712725|1041843|P8|Overall Study|Adverse Event|0
318044|NCT00712725|1041844|P7|Overall Study|Adverse Event|0
318045|NCT00712725|1041845|P6|Overall Study|Adverse Event|0
318046|NCT00712725|1041846|P5|Overall Study|Adverse Event|0
318047|NCT00712725|1041847|P4|Overall Study|Adverse Event|1
318048|NCT00712725|1041848|P3|Overall Study|Adverse Event|0
318049|NCT00712725|1041849|P2|Overall Study|Adverse Event|0
318050|NCT00712725|1041850|P1|Overall Study|Adverse Event|1
318051|NCT00712673|1041911|P4|Overall Study|Protocol Violation|0
318052|NCT00712673|1041912|P3|Overall Study|Protocol Violation|2
318053|NCT00712673|1041913|P2|Overall Study|Protocol Violation|0
318054|NCT00712673|1041914|P1|Overall Study|Protocol Violation|0
318055|NCT00712673|1041911|P4|Overall Study|Investigator's Decision|0
318056|NCT00712673|1041912|P3|Overall Study|Investigator's Decision|0
318057|NCT00712673|1041913|P2|Overall Study|Investigator's Decision|0
318058|NCT00712673|1041914|P1|Overall Study|Investigator's Decision|1
318059|NCT00712673|1041911|P4|Overall Study|Familial and Personal Reasons|2
318060|NCT00712673|1041912|P3|Overall Study|Familial and Personal Reasons|5
318061|NCT00712673|1041913|P2|Overall Study|Familial and Personal Reasons|0
318062|NCT00712673|1041914|P1|Overall Study|Familial and Personal Reasons|5
318063|NCT00712673|1041911|P4|Overall Study|Withdrawal by Subject|20
318064|NCT00712673|1041912|P3|Overall Study|Withdrawal by Subject|15
318065|NCT00712673|1041913|P2|Overall Study|Withdrawal by Subject|7
318066|NCT00712673|1041914|P1|Overall Study|Withdrawal by Subject|6
318067|NCT00712673|1041911|P4|Overall Study|Lost to Follow-up|0
318068|NCT00712673|1041912|P3|Overall Study|Lost to Follow-up|2
318069|NCT00712673|1041913|P2|Overall Study|Lost to Follow-up|0
318070|NCT00712673|1041914|P1|Overall Study|Lost to Follow-up|1
318071|NCT00712673|1041911|P4|Overall Study|Poor Compliance to Protocol|16
318072|NCT00712673|1041912|P3|Overall Study|Poor Compliance to Protocol|4
318073|NCT00712673|1041913|P2|Overall Study|Poor Compliance to Protocol|3
318074|NCT00712673|1041914|P1|Overall Study|Poor Compliance to Protocol|3
318075|NCT00712673|1041911|P4|Overall Study|Lack of Efficacy|6
318076|NCT00712673|1041912|P3|Overall Study|Lack of Efficacy|8
318077|NCT00712673|1041913|P2|Overall Study|Lack of Efficacy|8
318078|NCT00712673|1041914|P1|Overall Study|Lack of Efficacy|2
318079|NCT00712673|1041911|P4|Overall Study|Adverse Event|26
318080|NCT00712673|1041912|P3|Overall Study|Adverse Event|21
318081|NCT00712673|1041913|P2|Overall Study|Adverse Event|3
318082|NCT00712673|1041914|P1|Overall Study|Adverse Event|3
318083|NCT00712543|1041978|P2|Day 8-14|Lost to Follow-up|2
318084|NCT00712543|1041979|P1|Day 8-14|Lost to Follow-up|0
318085|NCT00712348|1042013|P1|Overall Study|Withdrawal by Subject|1
318086|NCT00712335|1042025|P5|Overall Study|Other Reason|0
318087|NCT00712335|1042026|P4|Overall Study|Other Reason|0
318088|NCT00712335|1042027|P3|Overall Study|Other Reason|1
318089|NCT00712335|1042028|P2|Overall Study|Other Reason|3
318090|NCT00712335|1042029|P1|Overall Study|Other Reason|0
318091|NCT00712335|1042025|P5|Overall Study|Lack of Efficacy|0
318092|NCT00712335|1042026|P4|Overall Study|Lack of Efficacy|1
318093|NCT00712335|1042027|P3|Overall Study|Lack of Efficacy|1
318094|NCT00712335|1042028|P2|Overall Study|Lack of Efficacy|0
318095|NCT00712335|1042029|P1|Overall Study|Lack of Efficacy|0
318096|NCT00712335|1042025|P5|Overall Study|Protocol Violation|0
318097|NCT00712335|1042026|P4|Overall Study|Protocol Violation|0
318098|NCT00712335|1042027|P3|Overall Study|Protocol Violation|1
318099|NCT00712335|1042028|P2|Overall Study|Protocol Violation|2
318100|NCT00712335|1042029|P1|Overall Study|Protocol Violation|1
318101|NCT00712335|1042025|P5|Overall Study|Lost to Follow-up|0
318102|NCT00712335|1042026|P4|Overall Study|Lost to Follow-up|1
318103|NCT00712335|1042027|P3|Overall Study|Lost to Follow-up|0
318104|NCT00712335|1042028|P2|Overall Study|Lost to Follow-up|5
318105|NCT00712335|1042029|P1|Overall Study|Lost to Follow-up|2
318106|NCT00712335|1042025|P5|Overall Study|Withdrawal by Subject|0
318107|NCT00712335|1042026|P4|Overall Study|Withdrawal by Subject|3
318108|NCT00712335|1042027|P3|Overall Study|Withdrawal by Subject|2
318109|NCT00712335|1042028|P2|Overall Study|Withdrawal by Subject|7
318110|NCT00712335|1042029|P1|Overall Study|Withdrawal by Subject|0
318111|NCT00712166|1042126|P2|Overall Study|Noncompliance|1
318112|NCT00712166|1042127|P1|Overall Study|Noncompliance|0
318113|NCT00712010|1042170|P1|Washout (7 Days)|Withdrawal by Subject|1
318114|NCT00711971|1042209|P3|Overall Study|Lost to Follow-up|1
318115|NCT00711971|1042210|P2|Overall Study|Lost to Follow-up|4
318116|NCT00711971|1042211|P1|Overall Study|Lost to Follow-up|3
318117|NCT00711880|1042245|P2|Overall Study|Lack of Efficacy|5
318118|NCT00711880|1042246|P1|Overall Study|Lack of Efficacy|1
318119|NCT00711880|1042245|P2|Overall Study|Patient non-compliance|0
318120|NCT00711880|1042246|P1|Overall Study|Patient non-compliance|1
318121|NCT00711880|1042245|P2|Overall Study|Adverse Event|2
318122|NCT00711880|1042246|P1|Overall Study|Adverse Event|11
318123|NCT00711802|1042308|P8|Overall Study|Reason not reported|0
318124|NCT00711802|1042309|P7|Overall Study|Reason not reported|1
318125|NCT00711802|1042310|P6|Overall Study|Reason not reported|0
318126|NCT00711802|1042311|P5|Overall Study|Reason not reported|1
318127|NCT00711802|1042312|P4|Overall Study|Reason not reported|0
318128|NCT00711802|1042313|P3|Overall Study|Reason not reported|1
318129|NCT00711802|1042314|P2|Overall Study|Reason not reported|1
318130|NCT00711802|1042315|P1|Overall Study|Reason not reported|0
318131|NCT00711802|1042308|P8|Overall Study|Lost to Follow-up|2
318132|NCT00711802|1042309|P7|Overall Study|Lost to Follow-up|4
318133|NCT00711802|1042310|P6|Overall Study|Lost to Follow-up|6
318134|NCT00711802|1042311|P5|Overall Study|Lost to Follow-up|10
318135|NCT00711802|1042312|P4|Overall Study|Lost to Follow-up|1
318136|NCT00711802|1042313|P3|Overall Study|Lost to Follow-up|3
318137|NCT00711802|1042314|P2|Overall Study|Lost to Follow-up|0
318138|NCT00711802|1042315|P1|Overall Study|Lost to Follow-up|0
318139|NCT00711802|1042308|P8|Overall Study|Withdrawal by Subject|0
318140|NCT00711802|1042309|P7|Overall Study|Withdrawal by Subject|0
318141|NCT00711802|1042310|P6|Overall Study|Withdrawal by Subject|0
318142|NCT00711802|1042311|P5|Overall Study|Withdrawal by Subject|0
318143|NCT00711802|1042312|P4|Overall Study|Withdrawal by Subject|1
318144|NCT00711802|1042313|P3|Overall Study|Withdrawal by Subject|0
318145|NCT00711802|1042314|P2|Overall Study|Withdrawal by Subject|1
318146|NCT00711802|1042315|P1|Overall Study|Withdrawal by Subject|0
318147|NCT00711802|1042308|P8|Overall Study|Physician Decision|0
318148|NCT00711802|1042309|P7|Overall Study|Physician Decision|0
318149|NCT00711802|1042310|P6|Overall Study|Physician Decision|0
318150|NCT00711802|1042311|P5|Overall Study|Physician Decision|0
318151|NCT00711802|1042312|P4|Overall Study|Physician Decision|0
318152|NCT00711802|1042313|P3|Overall Study|Physician Decision|0
318153|NCT00711802|1042314|P2|Overall Study|Physician Decision|2
318154|NCT00711802|1042315|P1|Overall Study|Physician Decision|0
318155|NCT00711802|1042308|P8|Overall Study|Protocol Violation|0
318156|NCT00711802|1042309|P7|Overall Study|Protocol Violation|0
318157|NCT00711802|1042310|P6|Overall Study|Protocol Violation|0
318158|NCT00711802|1042311|P5|Overall Study|Protocol Violation|0
318159|NCT00711802|1042312|P4|Overall Study|Protocol Violation|1
318160|NCT00711802|1042313|P3|Overall Study|Protocol Violation|0
318161|NCT00711802|1042314|P2|Overall Study|Protocol Violation|0
318162|NCT00711802|1042315|P1|Overall Study|Protocol Violation|0
318163|NCT00711802|1042308|P8|Overall Study|Microbiological failure|0
318164|NCT00711802|1042309|P7|Overall Study|Microbiological failure|0
318165|NCT00711802|1042310|P6|Overall Study|Microbiological failure|1
318166|NCT00711802|1042311|P5|Overall Study|Microbiological failure|0
318167|NCT00711802|1042312|P4|Overall Study|Microbiological failure|0
318168|NCT00711802|1042313|P3|Overall Study|Microbiological failure|0
318169|NCT00711802|1042314|P2|Overall Study|Microbiological failure|1
318170|NCT00711802|1042315|P1|Overall Study|Microbiological failure|0
318171|NCT00711802|1042308|P8|Overall Study|Adverse Event|0
318172|NCT00711802|1042309|P7|Overall Study|Adverse Event|0
318173|NCT00711802|1042310|P6|Overall Study|Adverse Event|1
318174|NCT00711802|1042311|P5|Overall Study|Adverse Event|1
318175|NCT00711802|1042312|P4|Overall Study|Adverse Event|0
318176|NCT00711802|1042313|P3|Overall Study|Adverse Event|0
318177|NCT00711802|1042314|P2|Overall Study|Adverse Event|0
318178|NCT00711802|1042315|P1|Overall Study|Adverse Event|0
318179|NCT00711802|1042308|P8|Overall Study|Not treated (no further detail)|0
318180|NCT00711802|1042309|P7|Overall Study|Not treated (no further detail)|0
318181|NCT00711802|1042310|P6|Overall Study|Not treated (no further detail)|0
318182|NCT00711802|1042311|P5|Overall Study|Not treated (no further detail)|2
318183|NCT00711802|1042312|P4|Overall Study|Not treated (no further detail)|0
318184|NCT00711802|1042313|P3|Overall Study|Not treated (no further detail)|2
318185|NCT00711802|1042314|P2|Overall Study|Not treated (no further detail)|1
318186|NCT00711802|1042315|P1|Overall Study|Not treated (no further detail)|2
318187|NCT00711646|1042347|P2|Overall Study|patient non-compliance|0
318188|NCT00711646|1042348|P1|Overall Study|patient non-compliance|1
318189|NCT00711646|1042347|P2|Overall Study|administrative decision|1
318190|NCT00711646|1042348|P1|Overall Study|administrative decision|0
318191|NCT00711646|1042347|P2|Overall Study|Lost to Follow-up|0
318192|NCT00711646|1042348|P1|Overall Study|Lost to Follow-up|1
318193|NCT00711646|1042347|P2|Overall Study|Protocol Violation|1
318194|NCT00711646|1042348|P1|Overall Study|Protocol Violation|0
318195|NCT00711646|1042347|P2|Overall Study|Withdrawal by Subject|0
318196|NCT00711646|1042348|P1|Overall Study|Withdrawal by Subject|4
318197|NCT00711646|1042347|P2|Overall Study|Adverse Event|1
318198|NCT00711646|1042348|P1|Overall Study|Adverse Event|6
318199|NCT00711594|1042370|P4|Overall Study|Withdrawal by Subject|2
318200|NCT00711594|1042371|P3|Overall Study|Withdrawal by Subject|0
318201|NCT00711594|1042372|P2|Overall Study|Withdrawal by Subject|1
318202|NCT00711594|1042373|P1|Overall Study|Withdrawal by Subject|0
318203|NCT00711594|1042370|P4|Overall Study|Other Adverse Event|16
318204|NCT00711594|1042371|P3|Overall Study|Other Adverse Event|0
318205|NCT00711594|1042372|P2|Overall Study|Other Adverse Event|0
318206|NCT00711594|1042373|P1|Overall Study|Other Adverse Event|1
318207|NCT00711594|1042370|P4|Overall Study|Progressive disease|44
318208|NCT00711594|1042371|P3|Overall Study|Progressive disease|6
318209|NCT00711594|1042372|P2|Overall Study|Progressive disease|2
318210|NCT00711594|1042373|P1|Overall Study|Progressive disease|2
318211|NCT00711555|1042410|P1|Overall Study|Adverse Event|3
318212|NCT00711529|1042419|P2|Overall Study|Withdrawal by Subject|6
318213|NCT00711529|1042420|P1|Overall Study|Withdrawal by Subject|2
318214|NCT00711529|1042419|P2|Overall Study|Protocol Violation|0
318215|NCT00711529|1042420|P1|Overall Study|Protocol Violation|2
318216|NCT00711516|1042444|P2|Overall Study|Protocol Violation|1
318217|NCT00711516|1042445|P1|Overall Study|Protocol Violation|0
318218|NCT00711516|1042444|P2|Overall Study|Withdrawal by Subject|1
318219|NCT00711516|1042445|P1|Overall Study|Withdrawal by Subject|0
318220|NCT00711516|1042444|P2|Overall Study|Adverse Event|1
318221|NCT00711516|1042445|P1|Overall Study|Adverse Event|1
318222|NCT00711477|1042552|P2|Overall Study|Noncompliance|1
318223|NCT00711477|1042553|P1|Overall Study|Noncompliance|0
318224|NCT00711477|1042552|P2|Overall Study|Lost to Follow-up|1
318225|NCT00711477|1042553|P1|Overall Study|Lost to Follow-up|0
318226|NCT00711477|1042552|P2|Overall Study|Adverse Event|1
318227|NCT00711477|1042553|P1|Overall Study|Adverse Event|3
318228|NCT00711425|1042581|P1|Overall Study|Lost to Follow-up|1
318229|NCT00711425|1042581|P1|Overall Study|Death|2
318230|NCT00711425|1042581|P1|Overall Study|Protocol Violation|1
318231|NCT00711191|1042609|P3|Overall Study|Withdrawal by Subject|3
318232|NCT00711191|1042610|P2|Overall Study|Withdrawal by Subject|1
318233|NCT00711191|1042611|P1|Overall Study|Withdrawal by Subject|0
318234|NCT00711191|1042609|P3|Overall Study|Objective progression or relapse|7
318235|NCT00711191|1042610|P2|Overall Study|Objective progression or relapse|3
318236|NCT00711191|1042611|P1|Overall Study|Objective progression or relapse|2
318237|NCT00711191|1042609|P3|Overall Study|Adverse Event|2
318238|NCT00711191|1042610|P2|Overall Study|Adverse Event|1
318239|NCT00711191|1042611|P1|Overall Study|Adverse Event|1
318240|NCT00711113|1042648|P1|Overall Study|Implant lost|2
318241|NCT00711113|1042648|P1|Overall Study|Lost to Follow-up|9
318242|NCT00711100|1042654|P1|Overall Study|Withdrawal by Subject|8
318243|NCT00711100|1042654|P1|Overall Study|Lack of Efficacy|5
318244|NCT00711087|1042672|P2|Overall Study|Lost to Follow-up|0
318245|NCT00711087|1042673|P1|Overall Study|Lost to Follow-up|1
318246|NCT00711009|1042685|P2|Overall Study|Dose adjustment|0
318247|NCT00711009|1042686|P1|Overall Study|Dose adjustment|1
318248|NCT00711009|1042685|P2|Overall Study|Site closing|1
318249|NCT00711009|1042686|P1|Overall Study|Site closing|0
318250|NCT00711009|1042685|P2|Overall Study|Pregnancy|0
318251|NCT00711009|1042686|P1|Overall Study|Pregnancy|1
318252|NCT00711009|1042685|P2|Overall Study|Virologic Failure|1
318253|NCT00711009|1042686|P1|Overall Study|Virologic Failure|2
318254|NCT00711009|1042685|P2|Overall Study|Participant Noncompliant|1
318255|NCT00711009|1042686|P1|Overall Study|Participant Noncompliant|0
318256|NCT00711009|1042685|P2|Overall Study|Lost to Follow-up|9
318257|NCT00711009|1042686|P1|Overall Study|Lost to Follow-up|3
318258|NCT00711009|1042685|P2|Overall Study|Withdrawal by Subject|2
318259|NCT00711009|1042686|P1|Overall Study|Withdrawal by Subject|4
318260|NCT00711009|1042685|P2|Overall Study|Adverse Event/HIV-Related Event|5
318261|NCT00711009|1042686|P1|Overall Study|Adverse Event/HIV-Related Event|4
318262|NCT00710970|1042867|P1|Overall Study|Never took drug|2
318263|NCT00710970|1042867|P1|Overall Study|Lost to Follow-up|8
318264|NCT00710879|1042894|P2|Overall Study|Protocol Violation|3
318265|NCT00710879|1042895|P1|Overall Study|Protocol Violation|0
318266|NCT00710879|1042894|P2|Overall Study|Lost to Follow-up|1
318267|NCT00710879|1042895|P1|Overall Study|Lost to Follow-up|2
318268|NCT00710866|1042907|P2|Overall Study|Failed to meet eligibility|1
318269|NCT00710866|1042908|P1|Overall Study|Failed to meet eligibility|1
318270|NCT00710866|1042907|P2|Overall Study|Lost to Follow-up|0
318271|NCT00710866|1042908|P1|Overall Study|Lost to Follow-up|1
318272|NCT00710866|1042907|P2|Overall Study|Withdrawal by Subject|1
318273|NCT00710866|1042908|P1|Overall Study|Withdrawal by Subject|2
318274|NCT00710866|1042907|P2|Overall Study|Protocol Violation|4
318275|NCT00710866|1042908|P1|Overall Study|Protocol Violation|5
318276|NCT00710762|1042954|P2|Overall Study|Reason other than listed above|2
318277|NCT00710762|1042955|P1|Overall Study|Reason other than listed above|2
318278|NCT00710762|1042954|P2|Overall Study|Lost to Follow-up|0
318279|NCT00710762|1042955|P1|Overall Study|Lost to Follow-up|1
318280|NCT00710762|1042954|P2|Overall Study|Other Adverse Event|7
318281|NCT00710762|1042955|P1|Overall Study|Other Adverse Event|7
318282|NCT00710762|1042954|P2|Overall Study|Adverse Event other disease worsening|1
318283|NCT00710762|1042955|P1|Overall Study|Adverse Event other disease worsening|2
318284|NCT00710762|1042954|P2|Overall Study|Progressive disease|30
318285|NCT00710762|1042955|P1|Overall Study|Progressive disease|27
318286|NCT00710749|1042971|P2|First Intervention|Withdrawal by Subject|0
318287|NCT00710749|1042972|P1|First Intervention|Withdrawal by Subject|1
318288|NCT00710606|1042982|P2|Overall Study|Adverse Event|2
318289|NCT00710606|1042983|P1|Overall Study|Adverse Event|0
318290|NCT00710593|1042995|P2|Overall Study|Prem disc vaccine, completed all visits|2
318291|NCT00710593|1042996|P1|Overall Study|Prem disc vaccine, completed all visits|6
318292|NCT00710593|1042995|P2|Overall Study|Protocol Violation|1
318293|NCT00710593|1042996|P1|Overall Study|Protocol Violation|1
318294|NCT00710593|1042995|P2|Overall Study|Failure to adhere or complete study eval|1
318295|NCT00710593|1042996|P1|Overall Study|Failure to adhere or complete study eval|1
318296|NCT00710593|1042995|P2|Overall Study|Moved out of area|0
318297|NCT00710593|1042996|P1|Overall Study|Moved out of area|1
318298|NCT00710593|1042995|P2|Overall Study|Lost to Follow-up|1
318299|NCT00710593|1042996|P1|Overall Study|Lost to Follow-up|3
318300|NCT00710593|1042995|P2|Overall Study|Unable to complete Wk 48 within window|0
318301|NCT00710593|1042996|P1|Overall Study|Unable to complete Wk 48 within window|2
318302|NCT00710593|1042995|P2|Overall Study|Incarceration|0
318303|NCT00710593|1042996|P1|Overall Study|Incarceration|1
318304|NCT00710554|1043039|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
318305|NCT00710554|1043040|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
318306|NCT00710554|1043039|P2|Overall Study|Lack of Efficacy|12
318307|NCT00710554|1043040|P1|Overall Study|Lack of Efficacy|11
318308|NCT00710554|1043039|P2|Overall Study|Lost to Follow-up|1
318309|NCT00710554|1043040|P1|Overall Study|Lost to Follow-up|7
318310|NCT00710554|1043039|P2|Overall Study|Withdrawal by Subject|3
318311|NCT00710554|1043040|P1|Overall Study|Withdrawal by Subject|7
318312|NCT00710554|1043039|P2|Overall Study|Adverse Event|7
318313|NCT00710554|1043040|P1|Overall Study|Adverse Event|24
318314|NCT00710424|1043068|P2|Overall Study|Felt good so stopped treatment|1
318315|NCT00710424|1043069|P1|Overall Study|Felt good so stopped treatment|0
318316|NCT00710424|1043068|P2|Overall Study|Subject preferred paracetamol|1
318317|NCT00710424|1043069|P1|Overall Study|Subject preferred paracetamol|0
318318|NCT00710424|1043068|P2|Overall Study|Ceased treatment due to travel|0
318319|NCT00710424|1043069|P1|Overall Study|Ceased treatment due to travel|1
318320|NCT00710424|1043068|P2|Overall Study|Subject thought medication changed|0
318321|NCT00710424|1043069|P1|Overall Study|Subject thought medication changed|1
318322|NCT00710424|1043068|P2|Overall Study|Did not meet entry criteria at visit 1|0
318323|NCT00710424|1043069|P1|Overall Study|Did not meet entry criteria at visit 1|1
318324|NCT00710424|1043068|P2|Overall Study|Non-compliance with stable analgesia|0
318325|NCT00710424|1043069|P1|Overall Study|Non-compliance with stable analgesia|1
318326|NCT00710424|1043068|P2|Overall Study|Refused medication, no side effects|0
318327|NCT00710424|1043069|P1|Overall Study|Refused medication, no side effects|1
318328|NCT00710424|1043068|P2|Overall Study|Lost to Follow-up|1
318329|NCT00710424|1043069|P1|Overall Study|Lost to Follow-up|0
318330|NCT00710424|1043068|P2|Overall Study|Withdrawal by Subject|3
318331|NCT00710424|1043069|P1|Overall Study|Withdrawal by Subject|5
318332|NCT00710424|1043068|P2|Overall Study|Lack of Efficacy|5
318333|NCT00710424|1043069|P1|Overall Study|Lack of Efficacy|4
318334|NCT00710424|1043068|P2|Overall Study|Adverse Event|12
318335|NCT00710424|1043069|P1|Overall Study|Adverse Event|30
318336|NCT00710385|1043093|P1|Overall Study|Undisclosed excessive methadone use|1
318337|NCT00710385|1043093|P1|Overall Study|Physician Decision|1
318338|NCT00710385|1043093|P1|Overall Study|Undisclosed back pain|1
318339|NCT00710385|1043093|P1|Overall Study|Withdrawal by Subject|1
318340|NCT00710385|1043093|P1|Overall Study|Did not qualify|1
318341|NCT00710021|1043139|P3|Overall Study|Physician Decision|0
318342|NCT00710021|1043140|P2|Overall Study|Physician Decision|1
318343|NCT00710021|1043141|P1|Overall Study|Physician Decision|0
318344|NCT00710021|1043139|P3|Overall Study|Subject misrandomized|1
318345|NCT00710021|1043140|P2|Overall Study|Subject misrandomized|1
318346|NCT00710021|1043141|P1|Overall Study|Subject misrandomized|0
318347|NCT00710021|1043139|P3|Overall Study|Subject's Decision|0
318348|NCT00710021|1043140|P2|Overall Study|Subject's Decision|1
318349|NCT00710021|1043141|P1|Overall Study|Subject's Decision|0
318350|NCT00710021|1043139|P3|Overall Study|Lost to Follow-up|0
318351|NCT00710021|1043140|P2|Overall Study|Lost to Follow-up|0
318352|NCT00710021|1043141|P1|Overall Study|Lost to Follow-up|1
318353|NCT00709956|1043256|P2|Overall Study|Inclusion/exclusion criteria violation|3
318354|NCT00709956|1043257|P1|Overall Study|Inclusion/exclusion criteria violation|2
318355|NCT00709956|1043256|P2|Overall Study|Withdrawal by Subject|1
318356|NCT00709956|1043257|P1|Overall Study|Withdrawal by Subject|1
318357|NCT00709852|1043287|P2|Period 2|No 72-hour follow-up|0
318358|NCT00709852|1043288|P1|Period 2|No 72-hour follow-up|3
318359|NCT00709852|1043287|P2|Period 2|Lost to Follow-up|0
318360|NCT00709852|1043288|P1|Period 2|Lost to Follow-up|1
318361|NCT00709852|1043287|P2|Period 2|Adverse Event|1
318362|NCT00709852|1043288|P1|Period 2|Adverse Event|1
318363|NCT00709852|1043287|P2|Period 2|Protocol Violation|1
318364|NCT00709852|1043288|P1|Period 2|Protocol Violation|4
318365|NCT00709852|1043287|P2|Period 1|Lost to Follow-up|0
318366|NCT00709852|1043288|P1|Period 1|Lost to Follow-up|1
318367|NCT00709852|1043287|P2|Period 1|Defective scanner|1
318368|NCT00709852|1043288|P1|Period 1|Defective scanner|0
318369|NCT00709852|1043287|P2|Period 1|Protocol Violation|0
318370|NCT00709852|1043288|P1|Period 1|Protocol Violation|1
318371|NCT00709852|1043287|P2|Period 1|Withdrawal by Subject|2
318372|NCT00709852|1043288|P1|Period 1|Withdrawal by Subject|4
318373|NCT00709852|1043287|P2|Period 1|Adverse Event|0
318374|NCT00709852|1043288|P1|Period 1|Adverse Event|2
318375|NCT00708734|1043452|P1|Overall Study|leg fracture|1
318376|NCT00708734|1043452|P1|Overall Study|vertigo|1
318377|NCT00708734|1043452|P1|Overall Study|knee replacement|1
318378|NCT00708734|1043452|P1|Overall Study|leg injury|1
318379|NCT00708734|1043452|P1|Overall Study|moved|1
318380|NCT00708734|1043452|P1|Overall Study|scheduling conflict|2
318381|NCT00708708|1043472|P1|Overall Study|Missing values|392
318382|NCT00708708|1043472|P1|Overall Study|Adverse Event|3
318383|NCT00708708|1043472|P1|Overall Study|Pregnancy|3
318384|NCT00708708|1043472|P1|Overall Study|Lack of compliance|3
318385|NCT00708708|1043472|P1|Overall Study|Lack of effectiveness|4
318386|NCT00708708|1043472|P1|Overall Study|Administrative reasons|7
318387|NCT00708708|1043472|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
318388|NCT00708708|1043472|P1|Overall Study|Good effectiveness|9
318389|NCT00708708|1043472|P1|Overall Study|Other unspecified|11
318390|NCT00708708|1043472|P1|Overall Study|Another therapy along with Enbrel|15
318391|NCT00708708|1043472|P1|Overall Study|Intolerance|42
318392|NCT00708708|1043472|P1|Overall Study|Withdrawal by Subject|51
318393|NCT00708708|1043472|P1|Overall Study|Lost to Follow-up|52
318394|NCT00708708|1043472|P1|Overall Study|Another therapy instead of Enbrel|141
318395|NCT00708682|1043520|P1|Toddler Dose|Failed to Return|4
318396|NCT00708682|1043520|P1|Toddler Dose|Lost to Follow-up|3
318397|NCT00708682|1043520|P1|Toddler Dose|Parent/Legal Guardian Request|1
318398|NCT00708682|1043520|P1|After Infant Series|Parent/Legal Guardian Request|1
318399|NCT00708682|1043520|P1|Infant Series|Not Specified|19
318400|NCT00708682|1043520|P1|Infant Series|Failed to return|2
318401|NCT00708682|1043520|P1|Infant Series|Parent/legal guardian request|6
318402|NCT00708682|1043520|P1|Infant Series|Protocol Violation|1
318403|NCT00708682|1043520|P1|Infant Series|Lost to Follow-up|4
318404|NCT00708682|1043520|P1|Infant Series|Adverse Event|1
318405|NCT00708643|1043541|P2|Overall Study|Adverse Event|1
318406|NCT00708643|1043542|P1|Overall Study|Adverse Event|0
318407|NCT00709761|1043558|P1|Overall Study|Ongoing|40
318408|NCT00709761|1043558|P1|Overall Study|Withdrawal by Subject|7
318409|NCT00709735|1043569|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
318410|NCT00709735|1043570|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
318411|NCT00709735|1043569|P2|Overall Study|Relapse into Opioid Abuse|1
318412|NCT00709735|1043570|P1|Overall Study|Relapse into Opioid Abuse|0
318413|NCT00709735|1043569|P2|Overall Study|Lost to Follow-up|1
318414|NCT00709735|1043570|P1|Overall Study|Lost to Follow-up|1
318415|NCT00709722|1043578|P1|Overall Study|Adverse Event|1
318416|NCT00709618|1043584|P1|Overall Study|Study Closed/Terminated|25
318417|NCT00709618|1043584|P1|Overall Study|Lost to Follow-up|1
318418|NCT00709618|1043584|P1|Overall Study|Withdrawal by Subject|4
318419|NCT00709592|1043596|P2|Overall Study|Unable to proceed to transplant|1
318420|NCT00709592|1043597|P1|Overall Study|Unable to proceed to transplant|0
318421|NCT00709319|1043617|P1|Overall Study|Withdrawal by Subject|2
318422|NCT00709319|1043617|P1|Overall Study|Death|4
318423|NCT00709228|1043625|P1|Overall Study|Non-compliance|5
318424|NCT00709228|1043625|P1|Overall Study|Lost to Follow-up|6
318425|NCT00709228|1043625|P1|Overall Study|Disease progression|1
318426|NCT00709228|1043625|P1|Overall Study|Discontinued follow-up|5
318427|NCT00709228|1043625|P1|Overall Study|Did not enter follow-up|4
318428|NCT00709228|1043625|P1|Overall Study|Discontinued treatment|14
318429|NCT00709228|1043625|P1|Overall Study|Adverse events|2
318430|NCT00709228|1043625|P1|Overall Study|Eligibility criteria not met|281
318431|NCT00709228|1043625|P1|Overall Study|Not treated|14
318432|NCT00709124|1043631|P2|Overall Study|encephalopathy; can't do assessment|0
318433|NCT00709124|1043632|P1|Overall Study|encephalopathy; can't do assessment|1
318434|NCT00709124|1043631|P2|Overall Study|Death|1
318435|NCT00709124|1043632|P1|Overall Study|Death|3
318436|NCT00709111|1043638|P1|Overall Study|Unable to attend clinic visits|1
318437|NCT00709111|1043638|P1|Overall Study|Withdrawal by Subject|1
318438|NCT00709098|1043679|P3|Open-label Period|Lost to Follow-up|1
318439|NCT00709098|1043680|P2|Open-label Period|Lost to Follow-up|0
318440|NCT00709098|1043681|P1|Open-label Period|Lost to Follow-up|0
318441|NCT00709098|1043679|P3|Open-label Period|Death|1
318442|NCT00709098|1043680|P2|Open-label Period|Death|0
318443|NCT00709098|1043681|P1|Open-label Period|Death|0
318444|NCT00709098|1043679|P3|Open-label Period|Administrative reason|5
318445|NCT00709098|1043680|P2|Open-label Period|Administrative reason|0
318446|NCT00709098|1043681|P1|Open-label Period|Administrative reason|0
318447|NCT00709098|1043679|P3|Open-label Period|Withdrawal of consent|7
318448|NCT00709098|1043680|P2|Open-label Period|Withdrawal of consent|0
318449|NCT00709098|1043681|P1|Open-label Period|Withdrawal of consent|0
318450|NCT00709098|1043679|P3|Double-blind Period|Lost to Follow-up|0
318451|NCT00709098|1043680|P2|Double-blind Period|Lost to Follow-up|1
318452|NCT00709098|1043681|P1|Double-blind Period|Lost to Follow-up|1
318453|NCT00709098|1043679|P3|Double-blind Period|Death|0
318454|NCT00709098|1043680|P2|Double-blind Period|Death|1
318455|NCT00709098|1043681|P1|Double-blind Period|Death|1
318456|NCT00709098|1043679|P3|Double-blind Period|Administrative reason|0
318457|NCT00709098|1043680|P2|Double-blind Period|Administrative reason|3
318458|NCT00709098|1043681|P1|Double-blind Period|Administrative reason|1
318459|NCT00709098|1043679|P3|Double-blind Period|Withdrawal of consent|0
318460|NCT00709098|1043680|P2|Double-blind Period|Withdrawal of consent|3
318461|NCT00709098|1043681|P1|Double-blind Period|Withdrawal of consent|3
318462|NCT00709059|1043700|P1|Overall Study|Serious side effects|11
318463|NCT00709059|1043700|P1|Overall Study|Side effects|20
318464|NCT00709059|1043700|P1|Overall Study|Disease complication|3
318465|NCT00709059|1043700|P1|Overall Study|Physician Decision|7
318466|NCT00709059|1043700|P1|Overall Study|Withdrawal by Subject|19
318467|NCT00709059|1043700|P1|Overall Study|Lost to Follow-up|34
318468|NCT00708500|1043761|P3|FOLLOWUP|Non-compliance with protocol|1
318469|NCT00708500|1043762|P2|FOLLOWUP|Non-compliance with protocol|0
318470|NCT00708500|1043763|P1|FOLLOWUP|Non-compliance with protocol|5
318471|NCT00708500|1043761|P3|FOLLOWUP|Subject withdrew consent|5
318472|NCT00708500|1043762|P2|FOLLOWUP|Subject withdrew consent|4
318473|NCT00708500|1043763|P1|FOLLOWUP|Subject withdrew consent|31
318474|NCT00708500|1043761|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
318475|NCT00708500|1043762|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
318476|NCT00708500|1043763|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
318477|NCT00708500|1043761|P3|FOLLOWUP|Lost to Follow-up|4
318478|NCT00708500|1043762|P2|FOLLOWUP|Lost to Follow-up|6
318479|NCT00708500|1043763|P1|FOLLOWUP|Lost to Follow-up|1
318480|NCT00708500|1043761|P3|FOLLOWUP|Adverse Event|0
318481|NCT00708500|1043762|P2|FOLLOWUP|Adverse Event|1
318482|NCT00708500|1043763|P1|FOLLOWUP|Adverse Event|0
318483|NCT00708500|1043761|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
318484|NCT00708500|1043762|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
318485|NCT00708500|1043763|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
318486|NCT00708500|1043761|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
318487|NCT00708500|1043762|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
318488|NCT00708500|1043763|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
318489|NCT00708500|1043761|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
318490|NCT00708500|1043762|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
318491|NCT00708500|1043763|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
318492|NCT00708500|1043761|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
318493|NCT00708500|1043762|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
318494|NCT00708500|1043763|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
318495|NCT00708500|1043761|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
318496|NCT00708500|1043762|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
318497|NCT00708500|1043763|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
318498|NCT00708500|1043761|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
318499|NCT00708500|1043762|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
318500|NCT00708500|1043763|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
318501|NCT00708500|1043761|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
318502|NCT00708500|1043762|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
318503|NCT00708500|1043763|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
318504|NCT00708500|1043761|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
318505|NCT00708500|1043762|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
318506|NCT00708500|1043763|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
318507|NCT00708500|1043761|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
318508|NCT00708500|1043762|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
318509|NCT00708500|1043763|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
318510|NCT00708500|1043761|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
318511|NCT00708500|1043762|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
318512|NCT00708500|1043763|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
318513|NCT00708500|1043761|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
318514|NCT00708500|1043762|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
318515|NCT00708500|1043763|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
318516|NCT00708500|1043761|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
318517|NCT00708500|1043762|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
318518|NCT00708500|1043763|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
318519|NCT00708500|1043761|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
318520|NCT00708500|1043762|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
318521|NCT00708500|1043763|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
318522|NCT00708461|1043782|P2|Overall Study|left workforce|180
318523|NCT00708461|1043783|P1|Overall Study|left workforce|115
318524|NCT00708461|1043782|P2|Overall Study|Withdrawal by Subject|9
318525|NCT00708461|1043783|P1|Overall Study|Withdrawal by Subject|8
318526|NCT00708461|1043782|P2|Overall Study|Lost to Follow-up|11
318527|NCT00708461|1043783|P1|Overall Study|Lost to Follow-up|18
318528|NCT00708435|1043791|P2|Overall Study|Refused hospitalization|0
318529|NCT00708435|1043792|P1|Overall Study|Refused hospitalization|1
318530|NCT00708435|1043791|P2|Overall Study|Intervention by primary care physician|0
318531|NCT00708435|1043792|P1|Overall Study|Intervention by primary care physician|1
318532|NCT00708435|1043791|P2|Overall Study|Protocol Violation|1
318533|NCT00708435|1043792|P1|Overall Study|Protocol Violation|0
318534|NCT00708435|1043791|P2|Overall Study|Adverse Event|0
318535|NCT00708435|1043792|P1|Overall Study|Adverse Event|1
318536|NCT00708435|1043791|P2|Overall Study|Withdrawal by Subject|7
318537|NCT00708435|1043792|P1|Overall Study|Withdrawal by Subject|3
318538|NCT00708435|1043791|P2|Overall Study|Lost to Follow-up|4
318539|NCT00708435|1043792|P1|Overall Study|Lost to Follow-up|9
318540|NCT00708435|1043791|P2|Overall Study|Death / Serious Adverse Event|5
318541|NCT00708435|1043792|P1|Overall Study|Death / Serious Adverse Event|10
318542|NCT00708422|1043819|P2|Overall Study|Withdrawal by Subject|0
318543|NCT00708422|1043820|P1|Overall Study|Withdrawal by Subject|1
318544|NCT00708422|1043819|P2|Overall Study|Adverse Event|1
318545|NCT00708422|1043820|P1|Overall Study|Adverse Event|3
318546|NCT00708305|1043828|P4|Period 3|Other Reason|0
318547|NCT00708305|1043829|P3|Period 3|Other Reason|0
318548|NCT00708305|1043830|P2|Period 3|Other Reason|0
318549|NCT00708305|1043831|P1|Period 3|Other Reason|1
318550|NCT00708305|1043828|P4|Period 3|Protocol Violation|0
318551|NCT00708305|1043829|P3|Period 3|Protocol Violation|0
318552|NCT00708305|1043830|P2|Period 3|Protocol Violation|2
318553|NCT00708305|1043831|P1|Period 3|Protocol Violation|0
318554|NCT00708305|1043828|P4|Period 2|Other Reason|1
318555|NCT00708305|1043829|P3|Period 2|Other Reason|0
318556|NCT00708305|1043830|P2|Period 2|Other Reason|0
318557|NCT00708305|1043831|P1|Period 2|Other Reason|1
318558|NCT00708305|1043828|P4|Period 2|Protocol Violation|0
318559|NCT00708305|1043829|P3|Period 2|Protocol Violation|0
318560|NCT00708305|1043830|P2|Period 2|Protocol Violation|1
318561|NCT00708305|1043831|P1|Period 2|Protocol Violation|0
318562|NCT00708305|1043828|P4|Period 2|Lost to Follow-up|0
318563|NCT00708305|1043829|P3|Period 2|Lost to Follow-up|0
318564|NCT00708305|1043830|P2|Period 2|Lost to Follow-up|1
318565|NCT00708305|1043831|P1|Period 2|Lost to Follow-up|0
318566|NCT00708305|1043828|P4|Period 1|Other Reason|2
318567|NCT00708305|1043829|P3|Period 1|Other Reason|0
318568|NCT00708305|1043830|P2|Period 1|Other Reason|0
318569|NCT00708305|1043831|P1|Period 1|Other Reason|0
318570|NCT00708305|1043828|P4|Period 1|Protocol Violation|0
318571|NCT00708305|1043829|P3|Period 1|Protocol Violation|1
318572|NCT00708305|1043830|P2|Period 1|Protocol Violation|0
318573|NCT00708305|1043831|P1|Period 1|Protocol Violation|1
318574|NCT00708214|1043866|P3|Overall Study|Progressive Disease|5
318575|NCT00708214|1043867|P2|Overall Study|Progressive Disease|6
318576|NCT00708214|1043868|P1|Overall Study|Progressive Disease|4
318577|NCT00708214|1043866|P3|Overall Study|Other|1
318578|NCT00708214|1043867|P2|Overall Study|Other|1
318579|NCT00708214|1043868|P1|Overall Study|Other|0
318580|NCT00708214|1043866|P3|Overall Study|Other Adverse Event|2
318581|NCT00708214|1043867|P2|Overall Study|Other Adverse Event|6
318582|NCT00708214|1043868|P1|Overall Study|Other Adverse Event|3
318583|NCT00708201|1043911|P2|Overall Study|Protocol Violation|1
318584|NCT00708201|1043912|P1|Overall Study|Protocol Violation|0
318585|NCT00708201|1043911|P2|Overall Study|Lost to Follow-up|0
318586|NCT00708201|1043912|P1|Overall Study|Lost to Follow-up|2
318587|NCT00708201|1043911|P2|Overall Study|Withdrawal by Subject|1
318588|NCT00708201|1043912|P1|Overall Study|Withdrawal by Subject|1
318589|NCT00708201|1043911|P2|Overall Study|Adverse Event|4
318590|NCT00708201|1043912|P1|Overall Study|Adverse Event|4
318591|NCT00708175|1043936|P2|Overall Study|BMD loss >7%|3
318592|NCT00708175|1043937|P1|Overall Study|BMD loss >7%|2
318593|NCT00708175|1043936|P2|Overall Study|Withdrawal by Subject|7
318594|NCT00708175|1043937|P1|Overall Study|Withdrawal by Subject|5
318595|NCT00708175|1043936|P2|Overall Study|Lost to Follow-up|3
318596|NCT00708175|1043937|P1|Overall Study|Lost to Follow-up|5
318597|NCT00708175|1043936|P2|Overall Study|Protocol Violation|3
318598|NCT00708175|1043937|P1|Overall Study|Protocol Violation|2
318599|NCT00708175|1043936|P2|Overall Study|Adverse Event|5
318600|NCT00708175|1043937|P1|Overall Study|Adverse Event|4
318601|NCT00708162|1043953|P2|Open-Label Phase|Other|0
318602|NCT00708162|1043954|P1|Open-Label Phase|Other|1
318603|NCT00708162|1043953|P2|Open-Label Phase|Adverse Event|2
318604|NCT00708162|1043954|P1|Open-Label Phase|Adverse Event|1
318605|NCT00708162|1043953|P2|Open-Label Phase|Death|1
318606|NCT00708162|1043954|P1|Open-Label Phase|Death|3
318607|NCT00708162|1043953|P2|Open-Label Phase|Investigator's Discretion|2
318608|NCT00708162|1043954|P1|Open-Label Phase|Investigator's Discretion|3
318609|NCT00708162|1043953|P2|Open-Label Phase|Lack of Efficacy|4
318610|NCT00708162|1043954|P1|Open-Label Phase|Lack of Efficacy|7
318611|NCT00708162|1043953|P2|Open-Label Phase|Participant Noncompliance|7
318612|NCT00708162|1043954|P1|Open-Label Phase|Participant Noncompliance|7
318613|NCT00708162|1043953|P2|Open-Label Phase|Withdrew Consent|6
318614|NCT00708162|1043954|P1|Open-Label Phase|Withdrew Consent|12
318615|NCT00708162|1043953|P2|Open-Label Phase|Lost to Follow-up|8
318616|NCT00708162|1043954|P1|Open-Label Phase|Lost to Follow-up|10
318617|NCT00708162|1043953|P2|Randomized Phase|Pregnancy|0
318618|NCT00708162|1043954|P1|Randomized Phase|Pregnancy|3
318619|NCT00708162|1043953|P2|Randomized Phase|Death|9
318620|NCT00708162|1043954|P1|Randomized Phase|Death|2
318621|NCT00708162|1043953|P2|Randomized Phase|Investigator’s Discretion|10
318622|NCT00708162|1043954|P1|Randomized Phase|Investigator’s Discretion|7
318623|NCT00708162|1043953|P2|Randomized Phase|Adverse Event|12
318624|NCT00708162|1043954|P1|Randomized Phase|Adverse Event|8
318625|NCT00708162|1043953|P2|Randomized Phase|Protocol Violation|11
318626|NCT00708162|1043954|P1|Randomized Phase|Protocol Violation|10
318627|NCT00708162|1043953|P2|Randomized Phase|Lack of Efficacy|19
318628|NCT00708162|1043954|P1|Randomized Phase|Lack of Efficacy|14
318629|NCT00708162|1043953|P2|Randomized Phase|Withdrew Consent|22
318630|NCT00708162|1043954|P1|Randomized Phase|Withdrew Consent|31
318631|NCT00708162|1043953|P2|Randomized Phase|Lost to Follow-up|34
318632|NCT00708162|1043954|P1|Randomized Phase|Lost to Follow-up|34
318633|NCT00708162|1043953|P2|Randomized Phase|Participant Noncompliance|32
318634|NCT00708162|1043954|P1|Randomized Phase|Participant Noncompliance|40
318635|NCT00708162|1043953|P2|Randomized Phase|Randomized but Not Treated|5
318636|NCT00708162|1043954|P1|Randomized Phase|Randomized but Not Treated|7
318637|NCT00708123|1043995|P5|Period 4|Protocol Violation|0
318638|NCT00708123|1043996|P4|Period 4|Protocol Violation|0
318639|NCT00708123|1043997|P3|Period 4|Protocol Violation|0
318640|NCT00708123|1043998|P2|Period 4|Protocol Violation|1
318641|NCT00708123|1043999|P1|Period 4|Protocol Violation|0
318642|NCT00708123|1043995|P5|Period 3|Lost to Follow-up|0
318643|NCT00708123|1043996|P4|Period 3|Lost to Follow-up|1
318644|NCT00708123|1043997|P3|Period 3|Lost to Follow-up|1
318645|NCT00708123|1043998|P2|Period 3|Lost to Follow-up|0
318646|NCT00708123|1043999|P1|Period 3|Lost to Follow-up|0
318647|NCT00708123|1043995|P5|Period 2|Other Reason|0
318648|NCT00708123|1043996|P4|Period 2|Other Reason|0
318649|NCT00708123|1043997|P3|Period 2|Other Reason|0
318650|NCT00708123|1043998|P2|Period 2|Other Reason|0
318651|NCT00708123|1043999|P1|Period 2|Other Reason|1
318652|NCT00708123|1043995|P5|Period 2|Protocol Violation|0
318653|NCT00708123|1043996|P4|Period 2|Protocol Violation|1
318654|NCT00708123|1043997|P3|Period 2|Protocol Violation|0
318655|NCT00708123|1043998|P2|Period 2|Protocol Violation|0
318656|NCT00708123|1043999|P1|Period 2|Protocol Violation|0
318657|NCT00708123|1043995|P5|Period 1|Adverse Event|0
318658|NCT00708123|1043996|P4|Period 1|Adverse Event|0
318659|NCT00708123|1043997|P3|Period 1|Adverse Event|1
318660|NCT00708123|1043998|P2|Period 1|Adverse Event|0
318661|NCT00708123|1043999|P1|Period 1|Adverse Event|0
318662|NCT00708123|1043995|P5|Period 1|Protocol Violation|0
318663|NCT00708123|1043996|P4|Period 1|Protocol Violation|1
318664|NCT00708123|1043997|P3|Period 1|Protocol Violation|0
318665|NCT00708123|1043998|P2|Period 1|Protocol Violation|1
318666|NCT00708123|1043999|P1|Period 1|Protocol Violation|0
318667|NCT00708097|1044132|P5|Period 2|Protocol Violation|0
318668|NCT00708097|1044133|P4|Period 2|Protocol Violation|1
318669|NCT00708097|1044134|P3|Period 2|Protocol Violation|1
318670|NCT00708097|1044135|P2|Period 2|Protocol Violation|1
318671|NCT00708097|1044136|P1|Period 2|Protocol Violation|0
318672|NCT00708097|1044132|P5|Period 1|Other Reason|1
318673|NCT00708097|1044133|P4|Period 1|Other Reason|0
318674|NCT00708097|1044134|P3|Period 1|Other Reason|0
318675|NCT00708097|1044135|P2|Period 1|Other Reason|0
318676|NCT00708097|1044136|P1|Period 1|Other Reason|0
318677|NCT00708097|1044132|P5|Period 1|Protocol Violation|0
318678|NCT00708097|1044133|P4|Period 1|Protocol Violation|2
318679|NCT00708097|1044134|P3|Period 1|Protocol Violation|0
318680|NCT00708097|1044135|P2|Period 1|Protocol Violation|1
318681|NCT00708097|1044136|P1|Period 1|Protocol Violation|0
318682|NCT00708032|1044246|P2|Overall Study|Withdrawal by Subject|1
318683|NCT00708032|1044247|P1|Overall Study|Withdrawal by Subject|0
318684|NCT00708032|1044246|P2|Overall Study|Protocol Violation|1
318685|NCT00708032|1044247|P1|Overall Study|Protocol Violation|4
318686|NCT00708032|1044246|P2|Overall Study|Did not meet protocol criteria|2
318687|NCT00708032|1044247|P1|Overall Study|Did not meet protocol criteria|1
318688|NCT00708032|1044246|P2|Overall Study|Visit out of range at month 12|1
318689|NCT00708032|1044247|P1|Overall Study|Visit out of range at month 12|4
318690|NCT00708032|1044246|P2|Overall Study|Poor vision|6
318691|NCT00708032|1044247|P1|Overall Study|Poor vision|0
318692|NCT00708032|1044246|P2|Overall Study|Pregnancy|1
318693|NCT00708032|1044247|P1|Overall Study|Pregnancy|0
318694|NCT00708032|1044246|P2|Overall Study|Lost to Follow-up|2
318695|NCT00708032|1044247|P1|Overall Study|Lost to Follow-up|1
318696|NCT00708032|1044246|P2|Overall Study|Adverse Event|2
318697|NCT00708032|1044247|P1|Overall Study|Adverse Event|0
318698|NCT00707993|1044274|P2|Overall Study|Other|0
318699|NCT00707993|1044275|P1|Overall Study|Other|2
318700|NCT00707993|1044274|P2|Overall Study|Hyperglycemic Rescue|47
318701|NCT00707993|1044275|P1|Overall Study|Hyperglycemic Rescue|55
318702|NCT00707993|1044274|P2|Overall Study|Withdrawal by Subject|16
318703|NCT00707993|1044275|P1|Overall Study|Withdrawal by Subject|12
318704|NCT00707993|1044274|P2|Overall Study|Lost to Follow-up|4
318705|NCT00707993|1044275|P1|Overall Study|Lost to Follow-up|0
318706|NCT00707993|1044274|P2|Overall Study|Protocol Violation|7
318707|NCT00707993|1044275|P1|Overall Study|Protocol Violation|4
318708|NCT00707993|1044274|P2|Overall Study|Adverse Event|20
318709|NCT00707993|1044275|P1|Overall Study|Adverse Event|16
318710|NCT00707980|1044317|P1|Overall Study|Other|39
318711|NCT00707980|1044317|P1|Overall Study|Lost to Follow-up|59
318712|NCT00707980|1044317|P1|Overall Study|Withdrawal of Consent|81
318713|NCT00707980|1044317|P1|Overall Study|Protocol Deviations|19
318714|NCT00707980|1044317|P1|Overall Study|Non-Compliance with Study Drug|28
318715|NCT00707980|1044317|P1|Overall Study|Lack of Efficacy|35
318716|NCT00707980|1044317|P1|Overall Study|Adverse Event|49
318717|NCT00707954|1044401|P5|Overall Study|Physician Decision|1
318718|NCT00707954|1044402|P4|Overall Study|Physician Decision|0
318719|NCT00707954|1044403|P3|Overall Study|Physician Decision|0
318720|NCT00707954|1044404|P2|Overall Study|Physician Decision|0
318721|NCT00707954|1044405|P1|Overall Study|Physician Decision|0
318722|NCT00707746|1044446|P2|Treatment Period|Ineligibility|1
318723|NCT00707746|1044447|P1|Treatment Period|Ineligibility|0
318724|NCT00707746|1044446|P2|Treatment Period|Adverse Event|4
318725|NCT00707746|1044447|P1|Treatment Period|Adverse Event|2
318726|NCT00707577|1044508|P2|Overall Study|Pregnancy|1
318727|NCT00707577|1044509|P1|Overall Study|Pregnancy|4
318728|NCT00707577|1044508|P2|Overall Study|Left employment|10
318729|NCT00707577|1044509|P1|Overall Study|Left employment|13
318730|NCT00707577|1044508|P2|Overall Study|Lost to Follow-up|25
318731|NCT00707577|1044509|P1|Overall Study|Lost to Follow-up|34
318732|NCT00707577|1044508|P2|Overall Study|Withdrawal by Subject|2
318733|NCT00707577|1044509|P1|Overall Study|Withdrawal by Subject|3
318734|NCT00707486|1044515|P1|Overall Study|Withdrawal by Subject|1
318735|NCT00707239|1044558|P3|Overall Study|Unspecified|5
318736|NCT00707239|1044559|P2|Overall Study|Unspecified|3
318737|NCT00707239|1044560|P1|Overall Study|Unspecified|8
318738|NCT00707239|1044558|P3|Overall Study|Randomized, but not treated|1
318739|NCT00707239|1044559|P2|Overall Study|Randomized, but not treated|1
318740|NCT00707239|1044560|P1|Overall Study|Randomized, but not treated|1
318741|NCT00707239|1044558|P3|Overall Study|Lack of Efficacy|0
318742|NCT00707239|1044559|P2|Overall Study|Lack of Efficacy|2
318743|NCT00707239|1044560|P1|Overall Study|Lack of Efficacy|1
318744|NCT00707239|1044558|P3|Overall Study|Protocol Violation|1
318745|NCT00707239|1044559|P2|Overall Study|Protocol Violation|0
318746|NCT00707239|1044560|P1|Overall Study|Protocol Violation|0
318747|NCT00707239|1044558|P3|Overall Study|Physician Decision|2
318748|NCT00707239|1044559|P2|Overall Study|Physician Decision|1
318749|NCT00707239|1044560|P1|Overall Study|Physician Decision|1
318750|NCT00707239|1044558|P3|Overall Study|Death|3
318751|NCT00707239|1044559|P2|Overall Study|Death|1
318752|NCT00707239|1044560|P1|Overall Study|Death|3
318753|NCT00707239|1044558|P3|Overall Study|Adverse Event|2
318754|NCT00707239|1044559|P2|Overall Study|Adverse Event|3
318755|NCT00707239|1044560|P1|Overall Study|Adverse Event|5
318756|NCT00707174|1044608|P2|Overall Study|Withdrawal by Subject|1
318757|NCT00707174|1044609|P1|Overall Study|Withdrawal by Subject|4
318758|NCT00707174|1044608|P2|Overall Study|Adverse Event|6
318759|NCT00707174|1044609|P1|Overall Study|Adverse Event|1
318760|NCT00707161|1044615|P1|Overall Study|Physician Decision|6
318761|NCT00707057|1044621|P2|Overall Study|Dosed incorrectly|1
318762|NCT00707057|1044622|P1|Overall Study|Dosed incorrectly|0
318763|NCT00707057|1044621|P2|Overall Study|Withdrawal by Subject|3
318764|NCT00707057|1044622|P1|Overall Study|Withdrawal by Subject|8
318765|NCT00707031|1044656|P2|Overall Study|Sponsor Decision|8
318766|NCT00707031|1044657|P1|Overall Study|Sponsor Decision|9
318767|NCT00707031|1044656|P2|Overall Study|Serious Noncompliance|3
318768|NCT00707031|1044657|P1|Overall Study|Serious Noncompliance|2
318769|NCT00707031|1044656|P2|Overall Study|Familial or Personal Reasons|15
318770|NCT00707031|1044657|P1|Overall Study|Familial or Personal Reasons|12
318771|NCT00707031|1044656|P2|Overall Study|Poor Compliance to Protocol|13
318772|NCT00707031|1044657|P1|Overall Study|Poor Compliance to Protocol|7
318773|NCT00707031|1044656|P2|Overall Study|Withdrawal by Subject|8
318774|NCT00707031|1044657|P1|Overall Study|Withdrawal by Subject|7
318775|NCT00707031|1044656|P2|Overall Study|Protocol Violation|0
318776|NCT00707031|1044657|P1|Overall Study|Protocol Violation|1
318777|NCT00707031|1044656|P2|Overall Study|Lost to Follow-up|1
318778|NCT00707031|1044657|P1|Overall Study|Lost to Follow-up|2
318779|NCT00707031|1044656|P2|Overall Study|Lack of Efficacy|6
318780|NCT00707031|1044657|P1|Overall Study|Lack of Efficacy|19
318781|NCT00707031|1044656|P2|Overall Study|Adverse Event|45
318782|NCT00707031|1044657|P1|Overall Study|Adverse Event|45
318783|NCT00706992|1044686|P7|Overall Study|Disease progression before treatment|0
318784|NCT00706992|1044687|P6|Overall Study|Disease progression before treatment|0
318785|NCT00706992|1044688|P5|Overall Study|Disease progression before treatment|1
318786|NCT00706992|1044689|P4|Overall Study|Disease progression before treatment|0
318787|NCT00706992|1044690|P3|Overall Study|Disease progression before treatment|0
318788|NCT00706992|1044691|P2|Overall Study|Disease progression before treatment|0
318789|NCT00706992|1044692|P1|Overall Study|Disease progression before treatment|0
318790|NCT00706992|1044686|P7|Overall Study|Study termination|3
318791|NCT00706992|1044687|P6|Overall Study|Study termination|2
318792|NCT00706992|1044688|P5|Overall Study|Study termination|3
318793|NCT00706992|1044689|P4|Overall Study|Study termination|2
318794|NCT00706992|1044690|P3|Overall Study|Study termination|6
318795|NCT00706992|1044691|P2|Overall Study|Study termination|5
318796|NCT00706992|1044692|P1|Overall Study|Study termination|5
318797|NCT00706966|1044724|P1|Overall Study|Adverse Event|1
318798|NCT00706914|1044760|P3|Overall Study|Protocol Violation|1
318799|NCT00706914|1044761|P2|Overall Study|Protocol Violation|1
318800|NCT00706914|1044762|P1|Overall Study|Protocol Violation|3
318801|NCT00706914|1044760|P3|Overall Study|Adverse Event|0
318802|NCT00706914|1044761|P2|Overall Study|Adverse Event|2
318803|NCT00706914|1044762|P1|Overall Study|Adverse Event|2
318804|NCT00706914|1044760|P3|Overall Study|Lost to Follow-up|0
318805|NCT00706914|1044761|P2|Overall Study|Lost to Follow-up|0
318806|NCT00706914|1044762|P1|Overall Study|Lost to Follow-up|1
318807|NCT00706914|1044760|P3|Overall Study|Lack of Efficacy|0
318808|NCT00706914|1044761|P2|Overall Study|Lack of Efficacy|1
318809|NCT00706914|1044762|P1|Overall Study|Lack of Efficacy|0
318810|NCT00706901|1044785|P3|Overall Study|Death|0
318811|NCT00706901|1044786|P2|Overall Study|Death|0
318812|NCT00706901|1044787|P1|Overall Study|Death|1
318813|NCT00706901|1044785|P3|Overall Study|In Jail|1
318814|NCT00706901|1044786|P2|Overall Study|In Jail|0
318815|NCT00706901|1044787|P1|Overall Study|In Jail|1
318816|NCT00706901|1044785|P3|Overall Study|Withdrawal by Subject|5
318817|NCT00706901|1044786|P2|Overall Study|Withdrawal by Subject|2
318818|NCT00706901|1044787|P1|Overall Study|Withdrawal by Subject|4
318819|NCT00706901|1044785|P3|Overall Study|Lost to Follow-up|2
318820|NCT00706901|1044786|P2|Overall Study|Lost to Follow-up|3
318821|NCT00706901|1044787|P1|Overall Study|Lost to Follow-up|2
318822|NCT00706849|1044812|P2|Follow-up Period|Protocol non-compliance|1
318823|NCT00706849|1044813|P1|Follow-up Period|Protocol non-compliance|0
318824|NCT00706849|1044812|P2|Follow-up Period|Withdrawal by Subject|2
318825|NCT00706849|1044813|P1|Follow-up Period|Withdrawal by Subject|0
318826|NCT00706849|1044812|P2|Treatment Period|Other|1
318827|NCT00706849|1044813|P1|Treatment Period|Other|0
318828|NCT00706849|1044812|P2|Treatment Period|Adverse Event|9
318829|NCT00706849|1044813|P1|Treatment Period|Adverse Event|0
318830|NCT00706797|1044891|P2|Overall Study|Unspecified|0
318831|NCT00706797|1044892|P1|Overall Study|Unspecified|1
318832|NCT00706797|1044891|P2|Overall Study|Lost to Follow-up|2
318833|NCT00706797|1044892|P1|Overall Study|Lost to Follow-up|1
318834|NCT00706797|1044891|P2|Overall Study|Protocol Violation|2
318835|NCT00706797|1044892|P1|Overall Study|Protocol Violation|3
318836|NCT00706797|1044891|P2|Overall Study|Discontinuation of study by sponsor|63
318837|NCT00706797|1044892|P1|Overall Study|Discontinuation of study by sponsor|52
318838|NCT00706797|1044891|P2|Overall Study|Death|0
318839|NCT00706797|1044892|P1|Overall Study|Death|1
318840|NCT00706797|1044891|P2|Overall Study|Withdrawal by Subject|1
318841|NCT00706797|1044892|P1|Overall Study|Withdrawal by Subject|8
318842|NCT00706797|1044891|P2|Overall Study|Adverse Event|3
318843|NCT00706797|1044892|P1|Overall Study|Adverse Event|0
318844|NCT00706797|1044891|P2|Overall Study|Lack of Efficacy|0
318845|NCT00706797|1044892|P1|Overall Study|Lack of Efficacy|3
318846|NCT00706706|1044961|P1|Overall Study|Study endpoint had reached|45
318847|NCT00706706|1044961|P1|Overall Study|Lost to Follow-up|7
318848|NCT00706706|1044961|P1|Overall Study|Death|53
318849|NCT00706654|1044971|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
318850|NCT00706654|1044972|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
318851|NCT00706654|1044973|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
318852|NCT00706654|1044974|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
318853|NCT00706654|1044971|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
318854|NCT00706654|1044972|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
318855|NCT00706654|1044973|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
318856|NCT00706654|1044974|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
318857|NCT00706654|1044971|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
318858|NCT00706654|1044972|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
318859|NCT00706654|1044973|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
318860|NCT00706654|1044974|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
318861|NCT00706654|1044971|P4|Depot Maintenance Phase|Protocol Deviation|1
318862|NCT00706654|1044972|P3|Depot Maintenance Phase|Protocol Deviation|3
318863|NCT00706654|1044973|P2|Depot Maintenance Phase|Protocol Deviation|2
318864|NCT00706654|1044974|P1|Depot Maintenance Phase|Protocol Deviation|0
318865|NCT00706654|1044971|P4|Depot Maintenance Phase|Withdrew Consent|14
318866|NCT00706654|1044972|P3|Depot Maintenance Phase|Withdrew Consent|29
318867|NCT00706654|1044973|P2|Depot Maintenance Phase|Withdrew Consent|21
318868|NCT00706654|1044974|P1|Depot Maintenance Phase|Withdrew Consent|0
318869|NCT00706654|1044971|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
318870|NCT00706654|1044972|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
318871|NCT00706654|1044973|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
318872|NCT00706654|1044974|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
318873|NCT00706654|1044971|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
318874|NCT00706654|1044972|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
318875|NCT00706654|1044973|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
318876|NCT00706654|1044974|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
318877|NCT00706654|1044971|P4|Depot Maintenance Phase|Lost to Follow-up|6
318878|NCT00706654|1044972|P3|Depot Maintenance Phase|Lost to Follow-up|10
318879|NCT00706654|1044973|P2|Depot Maintenance Phase|Lost to Follow-up|4
318880|NCT00706654|1044974|P1|Depot Maintenance Phase|Lost to Follow-up|0
318881|NCT00706654|1044971|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
318882|NCT00706654|1044972|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
318883|NCT00706654|1044973|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
318884|NCT00706654|1044974|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
318885|NCT00706654|1044971|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
318886|NCT00706654|1044972|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
318887|NCT00706654|1044973|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
318888|NCT00706654|1044974|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
318889|NCT00706654|1044971|P4|Oral Stabilization Phase|Adverse Event|0
318890|NCT00706654|1044972|P3|Oral Stabilization Phase|Adverse Event|0
318891|NCT00706654|1044973|P2|Oral Stabilization Phase|Adverse Event|0
318892|NCT00706654|1044974|P1|Oral Stabilization Phase|Adverse Event|21
318893|NCT00706654|1044971|P4|Oral Stabilization Phase|Protocol Deviation|0
318894|NCT00706654|1044972|P3|Oral Stabilization Phase|Protocol Deviation|0
318895|NCT00706654|1044973|P2|Oral Stabilization Phase|Protocol Deviation|0
318896|NCT00706654|1044974|P1|Oral Stabilization Phase|Protocol Deviation|2
318897|NCT00706654|1044971|P4|Oral Stabilization Phase|Withdrew consent|0
318898|NCT00706654|1044972|P3|Oral Stabilization Phase|Withdrew consent|0
318899|NCT00706654|1044973|P2|Oral Stabilization Phase|Withdrew consent|0
318900|NCT00706654|1044974|P1|Oral Stabilization Phase|Withdrew consent|55
318901|NCT00706654|1044971|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
318902|NCT00706654|1044972|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
318903|NCT00706654|1044973|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
318904|NCT00706654|1044974|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
318905|NCT00706654|1044971|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
318906|NCT00706654|1044972|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
318907|NCT00706654|1044973|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
318908|NCT00706654|1044974|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
318909|NCT00706654|1044971|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
318910|NCT00706654|1044972|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
318911|NCT00706654|1044973|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
318912|NCT00706654|1044974|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
318913|NCT00706654|1044971|P4|Oral Stabilization Phase|Lost to Follow-up|0
318914|NCT00706654|1044972|P3|Oral Stabilization Phase|Lost to Follow-up|0
318915|NCT00706654|1044973|P2|Oral Stabilization Phase|Lost to Follow-up|0
318916|NCT00706654|1044974|P1|Oral Stabilization Phase|Lost to Follow-up|17
318917|NCT00706654|1044971|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
318918|NCT00706654|1044972|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
318919|NCT00706654|1044973|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
318920|NCT00706654|1044974|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
318921|NCT00706654|1044971|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
318922|NCT00706654|1044972|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
318923|NCT00706654|1044973|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
318924|NCT00706654|1044974|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
318925|NCT00706654|1044971|P4|Conversion Phase|Adverse Event|0
318926|NCT00706654|1044972|P3|Conversion Phase|Adverse Event|0
318927|NCT00706654|1044973|P2|Conversion Phase|Adverse Event|0
318928|NCT00706654|1044974|P1|Conversion Phase|Adverse Event|18
318929|NCT00706654|1044971|P4|Conversion Phase|Withdrew Consent|0
318930|NCT00706654|1044972|P3|Conversion Phase|Withdrew Consent|0
318931|NCT00706654|1044973|P2|Conversion Phase|Withdrew Consent|0
318932|NCT00706654|1044974|P1|Conversion Phase|Withdrew Consent|38
318933|NCT00706654|1044971|P4|Conversion Phase|Withdrawn by Investigator|0
318934|NCT00706654|1044972|P3|Conversion Phase|Withdrawn by Investigator|0
318935|NCT00706654|1044973|P2|Conversion Phase|Withdrawn by Investigator|0
318936|NCT00706654|1044974|P1|Conversion Phase|Withdrawn by Investigator|14
318937|NCT00706654|1044971|P4|Conversion Phase|Met Withdrawal Criteria|0
318938|NCT00706654|1044972|P3|Conversion Phase|Met Withdrawal Criteria|0
318939|NCT00706654|1044973|P2|Conversion Phase|Met Withdrawal Criteria|0
318940|NCT00706654|1044974|P1|Conversion Phase|Met Withdrawal Criteria|2
318941|NCT00706654|1044971|P4|Conversion Phase|Sponsor Discontinued Trial|0
318942|NCT00706654|1044972|P3|Conversion Phase|Sponsor Discontinued Trial|0
318943|NCT00706654|1044973|P2|Conversion Phase|Sponsor Discontinued Trial|0
318944|NCT00706654|1044974|P1|Conversion Phase|Sponsor Discontinued Trial|8
318945|NCT00706654|1044971|P4|Conversion Phase|Lost to Follow-up|0
318946|NCT00706654|1044972|P3|Conversion Phase|Lost to Follow-up|0
318947|NCT00706654|1044973|P2|Conversion Phase|Lost to Follow-up|0
318948|NCT00706654|1044974|P1|Conversion Phase|Lost to Follow-up|4
318949|NCT00706641|1044993|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
318950|NCT00706641|1044993|P1|Dasatinib Administration|Ineligible after start of therapy|1
318951|NCT00706641|1044993|P1|Dasatinib Administration|Withdrawal by Subject|1
318952|NCT00706628|1045007|P4|Overall Study|Not treated|0
318953|NCT00706628|1045008|P3|Overall Study|Not treated|0
318954|NCT00706628|1045009|P2|Overall Study|Not treated|1
318955|NCT00706628|1045010|P1|Overall Study|Not treated|1
318956|NCT00706628|1045007|P4|Overall Study|Other than those stated above|0
318957|NCT00706628|1045008|P3|Overall Study|Other than those stated above|0
318958|NCT00706628|1045009|P2|Overall Study|Other than those stated above|0
318959|NCT00706628|1045010|P1|Overall Study|Other than those stated above|4
318960|NCT00706628|1045007|P4|Overall Study|Progressive disease|1
318961|NCT00706628|1045008|P3|Overall Study|Progressive disease|8
318962|NCT00706628|1045009|P2|Overall Study|Progressive disease|13
318963|NCT00706628|1045010|P1|Overall Study|Progressive disease|20
318964|NCT00706628|1045007|P4|Overall Study|Consent withdrawn|0
318965|NCT00706628|1045008|P3|Overall Study|Consent withdrawn|3
318966|NCT00706628|1045009|P2|Overall Study|Consent withdrawn|1
318967|NCT00706628|1045010|P1|Overall Study|Consent withdrawn|6
318968|NCT00706628|1045007|P4|Overall Study|Non compliant with protocol|0
318969|NCT00706628|1045008|P3|Overall Study|Non compliant with protocol|0
318970|NCT00706628|1045009|P2|Overall Study|Non compliant with protocol|1
318971|NCT00706628|1045010|P1|Overall Study|Non compliant with protocol|0
318972|NCT00706628|1045007|P4|Overall Study|Other Adverse Event|2
318973|NCT00706628|1045008|P3|Overall Study|Other Adverse Event|5
318974|NCT00706628|1045009|P2|Overall Study|Other Adverse Event|5
318975|NCT00706628|1045010|P1|Overall Study|Other Adverse Event|16
318976|NCT00706433|1045170|P4|Overall Study|new job|1
318977|NCT00706433|1045171|P3|Overall Study|new job|0
318978|NCT00706433|1045172|P2|Overall Study|new job|0
318979|NCT00706433|1045173|P1|Overall Study|new job|0
318980|NCT00706433|1045170|P4|Overall Study|Protocol Violation|0
318981|NCT00706433|1045171|P3|Overall Study|Protocol Violation|0
318982|NCT00706433|1045172|P2|Overall Study|Protocol Violation|0
318983|NCT00706433|1045173|P1|Overall Study|Protocol Violation|1
318984|NCT00706433|1045170|P4|Overall Study|Adverse Event|0
318985|NCT00706433|1045171|P3|Overall Study|Adverse Event|1
318986|NCT00706433|1045172|P2|Overall Study|Adverse Event|0
318987|NCT00706433|1045173|P1|Overall Study|Adverse Event|0
318988|NCT00706433|1045170|P4|Overall Study|Withdrawal by Subject|1
318989|NCT00706433|1045171|P3|Overall Study|Withdrawal by Subject|3
318990|NCT00706433|1045172|P2|Overall Study|Withdrawal by Subject|2
318991|NCT00706433|1045173|P1|Overall Study|Withdrawal by Subject|1
318992|NCT00706433|1045170|P4|Overall Study|Lost to Follow-up|0
318993|NCT00706433|1045171|P3|Overall Study|Lost to Follow-up|6
318994|NCT00706433|1045172|P2|Overall Study|Lost to Follow-up|1
318995|NCT00706433|1045173|P1|Overall Study|Lost to Follow-up|3
318996|NCT00706355|1045491|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
318997|NCT00706355|1045492|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
318998|NCT00706355|1045493|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
318999|NCT00706355|1045494|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
319000|NCT00706355|1045491|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
319001|NCT00706355|1045492|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
319002|NCT00706355|1045493|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
319003|NCT00706355|1045494|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
319004|NCT00706355|1045491|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
319005|NCT00706355|1045492|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
319006|NCT00706355|1045493|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
319007|NCT00706355|1045494|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
319008|NCT00706355|1045491|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
319009|NCT00706355|1045492|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
319010|NCT00706355|1045493|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
319011|NCT00706355|1045494|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
319012|NCT00706355|1045491|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
319013|NCT00706355|1045492|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
319014|NCT00706355|1045493|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
319015|NCT00706355|1045494|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
319016|NCT00706355|1045491|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
319017|NCT00706355|1045492|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
319018|NCT00706355|1045493|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
319019|NCT00706355|1045494|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
319020|NCT00706355|1045491|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
319021|NCT00706355|1045492|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
319022|NCT00706355|1045493|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
319023|NCT00706355|1045494|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
319024|NCT00706355|1045491|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
319025|NCT00706355|1045492|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
319026|NCT00706355|1045493|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
319027|NCT00706355|1045494|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
319028|NCT00706355|1045491|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
319029|NCT00706355|1045492|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
319030|NCT00706355|1045493|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
319031|NCT00706355|1045494|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
319032|NCT00706342|1045546|P1|Overall Study|WIthdrawal of consent|1
319033|NCT00706342|1045546|P1|Overall Study|Ongoing|6
319034|NCT00706342|1045546|P1|Overall Study|Non-responder Week 12|1
319035|NCT00706342|1045546|P1|Overall Study|Investigator discretion|2
319036|NCT00706342|1045546|P1|Overall Study|Withdrew from the study on his own.|1
319037|NCT00706342|1045546|P1|Overall Study|Death|1
319038|NCT00706342|1045546|P1|Overall Study|Withdrawn due to failure to respond|1
319039|NCT00706342|1045546|P1|Overall Study|Not responding to treatment|2
319040|NCT00706342|1045546|P1|Overall Study|Adverse Event|3
319041|NCT00706134|1045563|P4|Overall Study|Did not meet study criteria|0
319042|NCT00706134|1045564|P3|Overall Study|Did not meet study criteria|0
319043|NCT00706134|1045565|P2|Overall Study|Did not meet study criteria|0
319044|NCT00706134|1045566|P1|Overall Study|Did not meet study criteria|2
319045|NCT00706134|1045563|P4|Overall Study|Unsatisfactory therapeutic effect|5
319046|NCT00706134|1045564|P3|Overall Study|Unsatisfactory therapeutic effect|3
319047|NCT00706134|1045565|P2|Overall Study|Unsatisfactory therapeutic effect|3
319048|NCT00706134|1045566|P1|Overall Study|Unsatisfactory therapeutic effect|9
319049|NCT00706134|1045563|P4|Overall Study|Withdrawal by Subject|0
319050|NCT00706134|1045564|P3|Overall Study|Withdrawal by Subject|1
319051|NCT00706134|1045565|P2|Overall Study|Withdrawal by Subject|2
319052|NCT00706134|1045566|P1|Overall Study|Withdrawal by Subject|1
319053|NCT00706134|1045563|P4|Overall Study|Protocol Violation|3
319054|NCT00706134|1045564|P3|Overall Study|Protocol Violation|0
319055|NCT00706134|1045565|P2|Overall Study|Protocol Violation|6
319056|NCT00706134|1045566|P1|Overall Study|Protocol Violation|0
319057|NCT00706134|1045563|P4|Overall Study|Lost to Follow-up|0
319058|NCT00706134|1045564|P3|Overall Study|Lost to Follow-up|0
319059|NCT00706134|1045565|P2|Overall Study|Lost to Follow-up|1
319060|NCT00706134|1045566|P1|Overall Study|Lost to Follow-up|0
319061|NCT00706134|1045563|P4|Overall Study|Adverse Event|3
319062|NCT00706134|1045564|P3|Overall Study|Adverse Event|2
319063|NCT00706134|1045565|P2|Overall Study|Adverse Event|7
319064|NCT00706134|1045566|P1|Overall Study|Adverse Event|8
319065|NCT00706095|1045632|P3|Overall Study|Withdrawal by Subject|0
319066|NCT00706095|1045633|P2|Overall Study|Withdrawal by Subject|0
319067|NCT00706095|1045634|P1|Overall Study|Withdrawal by Subject|1
319068|NCT00706095|1045632|P3|Overall Study|Clinical Progression|2
319069|NCT00706095|1045633|P2|Overall Study|Clinical Progression|2
319070|NCT00706095|1045634|P1|Overall Study|Clinical Progression|1
319071|NCT00706095|1045632|P3|Overall Study|Progressive Disease|3
319072|NCT00706095|1045633|P2|Overall Study|Progressive Disease|5
319073|NCT00706095|1045634|P1|Overall Study|Progressive Disease|4
319074|NCT00706004|1045648|P1|Overall Study|Did not meet eligibility criteria|2
319075|NCT00705939|1045676|P3|Overall Study|Physician Decision|0
319076|NCT00705939|1045677|P2|Overall Study|Physician Decision|1
319077|NCT00705939|1045678|P1|Overall Study|Physician Decision|0
319078|NCT00705939|1045676|P3|Overall Study|Withdrawal by Subject|3
319079|NCT00705939|1045677|P2|Overall Study|Withdrawal by Subject|1
319080|NCT00705939|1045678|P1|Overall Study|Withdrawal by Subject|0
319081|NCT00705939|1045676|P3|Overall Study|Protocol Violation|1
319082|NCT00705939|1045677|P2|Overall Study|Protocol Violation|0
319083|NCT00705939|1045678|P1|Overall Study|Protocol Violation|0
319084|NCT00705783|1045732|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
319085|NCT00705783|1045733|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
319086|NCT00705783|1045734|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
319087|NCT00705783|1045732|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
319088|NCT00705783|1045733|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
319089|NCT00705783|1045734|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
319090|NCT00705783|1045732|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
319091|NCT00705783|1045733|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
319092|NCT00705783|1045734|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
319093|NCT00705783|1045732|P3|Depot Maintenance Phase|Protocol Deviation|0
319094|NCT00705783|1045733|P2|Depot Maintenance Phase|Protocol Deviation|2
319095|NCT00705783|1045734|P1|Depot Maintenance Phase|Protocol Deviation|0
319096|NCT00705783|1045732|P3|Depot Maintenance Phase|Withdrew Consent|4
319097|NCT00705783|1045733|P2|Depot Maintenance Phase|Withdrew Consent|14
319098|NCT00705783|1045734|P1|Depot Maintenance Phase|Withdrew Consent|0
319099|NCT00705783|1045732|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
319100|NCT00705783|1045733|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
319101|NCT00705783|1045734|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
319102|NCT00705783|1045732|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
319103|NCT00705783|1045733|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
319104|NCT00705783|1045734|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
319105|NCT00705783|1045732|P3|Depot Maintenance Phase|Lost to Follow-up|3
319106|NCT00705783|1045733|P2|Depot Maintenance Phase|Lost to Follow-up|5
319107|NCT00705783|1045734|P1|Depot Maintenance Phase|Lost to Follow-up|0
319108|NCT00705783|1045732|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
319109|NCT00705783|1045733|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
319110|NCT00705783|1045734|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
319111|NCT00705783|1045732|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
319112|NCT00705783|1045733|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
319113|NCT00705783|1045734|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
319114|NCT00705783|1045732|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
319115|NCT00705783|1045733|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
319116|NCT00705783|1045734|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
319117|NCT00705783|1045732|P3|Depot Stabilization Phase|Adverse Event|0
319118|NCT00705783|1045733|P2|Depot Stabilization Phase|Adverse Event|0
319119|NCT00705783|1045734|P1|Depot Stabilization Phase|Adverse Event|17
319120|NCT00705783|1045732|P3|Depot Stabilization Phase|Withdrew Consent|0
319121|NCT00705783|1045733|P2|Depot Stabilization Phase|Withdrew Consent|0
319122|NCT00705783|1045734|P1|Depot Stabilization Phase|Withdrew Consent|29
319123|NCT00705783|1045732|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
319124|NCT00705783|1045733|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
319125|NCT00705783|1045734|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
319126|NCT00705783|1045732|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
319127|NCT00705783|1045733|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
319128|NCT00705783|1045734|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
319129|NCT00705783|1045732|P3|Depot Stabilization Phase|Lost to Follow-up|0
319130|NCT00705783|1045733|P2|Depot Stabilization Phase|Lost to Follow-up|0
319131|NCT00705783|1045734|P1|Depot Stabilization Phase|Lost to Follow-up|11
319132|NCT00705783|1045732|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
319133|NCT00705783|1045733|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
319134|NCT00705783|1045734|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
319135|NCT00705783|1045732|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
319136|NCT00705783|1045733|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
319137|NCT00705783|1045734|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
319138|NCT00705783|1045732|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
319139|NCT00705783|1045733|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
319140|NCT00705783|1045734|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
319141|NCT00705783|1045732|P3|Oral Stabilization Phase|Adverse Event|0
319142|NCT00705783|1045733|P2|Oral Stabilization Phase|Adverse Event|0
319143|NCT00705783|1045734|P1|Oral Stabilization Phase|Adverse Event|14
319144|NCT00705783|1045732|P3|Oral Stabilization Phase|Withdrew Consent|0
319145|NCT00705783|1045733|P2|Oral Stabilization Phase|Withdrew Consent|0
319146|NCT00705783|1045734|P1|Oral Stabilization Phase|Withdrew Consent|29
319147|NCT00705783|1045732|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
319148|NCT00705783|1045733|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
319149|NCT00705783|1045734|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
319150|NCT00705783|1045732|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
319151|NCT00705783|1045733|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
319152|NCT00705783|1045734|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
319153|NCT00705783|1045732|P3|Oral Stabilization Phase|Lost to Follow-up|0
319154|NCT00705783|1045733|P2|Oral Stabilization Phase|Lost to Follow-up|0
319155|NCT00705783|1045734|P1|Oral Stabilization Phase|Lost to Follow-up|7
319156|NCT00705783|1045732|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
319157|NCT00705783|1045733|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
319158|NCT00705783|1045734|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
319159|NCT00705783|1045732|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
319160|NCT00705783|1045733|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
319161|NCT00705783|1045734|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
319162|NCT00705783|1045732|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
319163|NCT00705783|1045733|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
319164|NCT00705783|1045734|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
319165|NCT00705783|1045732|P3|Conversion Phase|Adverse Event|0
319166|NCT00705783|1045733|P2|Conversion Phase|Adverse Event|0
319167|NCT00705783|1045734|P1|Conversion Phase|Adverse Event|11
319168|NCT00705783|1045732|P3|Conversion Phase|Protocol Deviation|0
319169|NCT00705783|1045733|P2|Conversion Phase|Protocol Deviation|0
319170|NCT00705783|1045734|P1|Conversion Phase|Protocol Deviation|2
319171|NCT00705783|1045732|P3|Conversion Phase|Withdrew Consent|0
319172|NCT00705783|1045733|P2|Conversion Phase|Withdrew Consent|0
319173|NCT00705783|1045734|P1|Conversion Phase|Withdrew Consent|24
319174|NCT00705783|1045732|P3|Conversion Phase|Withdrawn by Investigator|0
319175|NCT00705783|1045733|P2|Conversion Phase|Withdrawn by Investigator|0
319176|NCT00705783|1045734|P1|Conversion Phase|Withdrawn by Investigator|4
319177|NCT00705783|1045732|P3|Conversion Phase|Met Withdrawal Criteria|0
319178|NCT00705783|1045733|P2|Conversion Phase|Met Withdrawal Criteria|0
319179|NCT00705783|1045734|P1|Conversion Phase|Met Withdrawal Criteria|4
319180|NCT00705783|1045732|P3|Conversion Phase|Lost to Follow-up|0
319181|NCT00705783|1045733|P2|Conversion Phase|Lost to Follow-up|0
319182|NCT00705783|1045734|P1|Conversion Phase|Lost to Follow-up|13
319183|NCT00705783|1045732|P3|Conversion Phase|Sponsor Discontinued Study|0
319184|NCT00705783|1045733|P2|Conversion Phase|Sponsor Discontinued Study|0
319185|NCT00705783|1045734|P1|Conversion Phase|Sponsor Discontinued Study|54
319186|NCT00705757|1045764|P3|Overall Study|Withdrawal by Subject|2
319187|NCT00705757|1045765|P2|Overall Study|Withdrawal by Subject|1
319188|NCT00705757|1045766|P1|Overall Study|Withdrawal by Subject|1
319189|NCT00705757|1045764|P3|Overall Study|Lost to Follow-up|6
319190|NCT00705757|1045765|P2|Overall Study|Lost to Follow-up|6
319191|NCT00705757|1045766|P1|Overall Study|Lost to Follow-up|7
319192|NCT00705757|1045764|P3|Overall Study|Lack of Efficacy|3
319193|NCT00705757|1045765|P2|Overall Study|Lack of Efficacy|1
319194|NCT00705757|1045766|P1|Overall Study|Lack of Efficacy|5
319195|NCT00705718|1045776|P2|Overall Study|Follow up not done|4
319196|NCT00705718|1045777|P1|Overall Study|Follow up not done|1
319197|NCT00705718|1045776|P2|Overall Study|Not due for Visit|12
319198|NCT00705718|1045777|P1|Overall Study|Not due for Visit|0
319199|NCT00705718|1045776|P2|Overall Study|Death|6
319200|NCT00705718|1045777|P1|Overall Study|Death|6
319201|NCT00705679|1045798|P5|Overall Study|Withdrawal by Subject|33
319202|NCT00705679|1045799|P4|Overall Study|Withdrawal by Subject|47
319203|NCT00705679|1045800|P3|Overall Study|Withdrawal by Subject|68
319204|NCT00705679|1045801|P2|Overall Study|Withdrawal by Subject|77
319205|NCT00705679|1045802|P1|Overall Study|Withdrawal by Subject|32
319206|NCT00705679|1045798|P5|Overall Study|Physician Decision|0
319207|NCT00705679|1045799|P4|Overall Study|Physician Decision|1
319208|NCT00705679|1045800|P3|Overall Study|Physician Decision|0
319209|NCT00705679|1045801|P2|Overall Study|Physician Decision|1
319210|NCT00705679|1045802|P1|Overall Study|Physician Decision|0
319211|NCT00705679|1045798|P5|Overall Study|Lost to Follow-up|35
319212|NCT00705679|1045799|P4|Overall Study|Lost to Follow-up|30
319213|NCT00705679|1045800|P3|Overall Study|Lost to Follow-up|44
319214|NCT00705679|1045801|P2|Overall Study|Lost to Follow-up|60
319215|NCT00705679|1045802|P1|Overall Study|Lost to Follow-up|32
319216|NCT00705679|1045798|P5|Overall Study|Death|1
319217|NCT00705679|1045799|P4|Overall Study|Death|2
319218|NCT00705679|1045800|P3|Overall Study|Death|3
319219|NCT00705679|1045801|P2|Overall Study|Death|0
319220|NCT00705679|1045802|P1|Overall Study|Death|0
319221|NCT00705679|1045798|P5|Overall Study|Adverse Event|0
319222|NCT00705679|1045799|P4|Overall Study|Adverse Event|0
319223|NCT00705679|1045800|P3|Overall Study|Adverse Event|0
319224|NCT00705679|1045801|P2|Overall Study|Adverse Event|1
319225|NCT00705679|1045802|P1|Overall Study|Adverse Event|1
319226|NCT00705666|1045837|P1|Overall Study|Untreated|5
319227|NCT00705666|1045837|P1|Overall Study|Lack of data|3
319228|NCT00705666|1045837|P1|Overall Study|Other|2
319229|NCT00705666|1045837|P1|Overall Study|Not specified|12
319230|NCT00705666|1045837|P1|Overall Study|Adverse Event|4
319231|NCT00705666|1045837|P1|Overall Study|Death|1
319232|NCT00705666|1045837|P1|Overall Study|Lost to Follow-up|5
319233|NCT00705666|1045837|P1|Overall Study|Physician Decision|7
319234|NCT00705666|1045837|P1|Overall Study|Withdrawal by Subject|21
319235|NCT00705666|1045837|P1|Overall Study|No post-treatment questionnaire|279
319236|NCT00705614|1045848|P2|Switch to Remicade|Administrative Reason|9
319237|NCT00705614|1045849|P1|Switch to Remicade|Administrative Reason|0
319238|NCT00705614|1045848|P2|Switch to Remicade|Withdrawal by Subject|12
319239|NCT00705614|1045849|P1|Switch to Remicade|Withdrawal by Subject|0
319240|NCT00705614|1045848|P2|Switch to Remicade|Lost to Follow-up|23
319241|NCT00705614|1045849|P1|Switch to Remicade|Lost to Follow-up|0
319242|NCT00705614|1045848|P2|Switch to Remicade|Adverse Event|5
319243|NCT00705614|1045849|P1|Switch to Remicade|Adverse Event|0
319244|NCT00705614|1045848|P2|Initial Intervention|Status completion unknown|0
319245|NCT00705614|1045849|P1|Initial Intervention|Status completion unknown|3
319246|NCT00705614|1045848|P2|Initial Intervention|Administrative Reason|38
319247|NCT00705614|1045849|P1|Initial Intervention|Administrative Reason|51
319248|NCT00705614|1045848|P2|Initial Intervention|Withdrawal by Subject|71
319249|NCT00705614|1045849|P1|Initial Intervention|Withdrawal by Subject|114
319250|NCT00705614|1045848|P2|Initial Intervention|Lost to Follow-up|191
319251|NCT00705614|1045849|P1|Initial Intervention|Lost to Follow-up|310
319252|NCT00705614|1045848|P2|Initial Intervention|Adverse Event|21
319253|NCT00705614|1045849|P1|Initial Intervention|Adverse Event|40
319254|NCT00705575|1045898|P2|Overall Study|Withdrawal by Subject|10
319255|NCT00705575|1045899|P1|Overall Study|Withdrawal by Subject|5
319256|NCT00705575|1045898|P2|Overall Study|Protocol Violation|2
319257|NCT00705575|1045899|P1|Overall Study|Protocol Violation|2
319258|NCT00705575|1045898|P2|Overall Study|Lost to Follow-up|4
319259|NCT00705575|1045899|P1|Overall Study|Lost to Follow-up|3
319260|NCT00705575|1045898|P2|Overall Study|Adverse Event|15
319261|NCT00705575|1045899|P1|Overall Study|Adverse Event|11
319262|NCT00705575|1045898|P2|Overall Study|Abnormal test procedure result(s)|12
319263|NCT00705575|1045899|P1|Overall Study|Abnormal test procedure result(s)|2
319264|NCT00705575|1045898|P2|Overall Study|Abnormal laboratory value(s)|3
319265|NCT00705575|1045899|P1|Overall Study|Abnormal laboratory value(s)|0
319266|NCT00705536|1045913|P4|Start Period 1|Withdrawal by Subject|1
319267|NCT00705536|1045914|P3|Start Period 1|Withdrawal by Subject|0
319268|NCT00705536|1045915|P2|Start Period 1|Withdrawal by Subject|0
319269|NCT00705536|1045916|P1|Start Period 1|Withdrawal by Subject|0
319270|NCT00705523|1045977|P2|Overall Study|Lost to Follow-up|3
319271|NCT00705523|1045978|P1|Overall Study|Lost to Follow-up|2
319272|NCT00705432|1045992|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
319273|NCT00705432|1045993|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
319274|NCT00705432|1045994|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
319275|NCT00705432|1045995|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
319276|NCT00705432|1045996|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
319277|NCT00705432|1045997|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
319278|NCT00705432|1045992|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
319279|NCT00705432|1045993|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
319280|NCT00705432|1045994|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
319281|NCT00705432|1045995|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
319282|NCT00705432|1045996|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
319283|NCT00705432|1045997|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
319284|NCT00705432|1045992|P6|Treatment Period|Non medical reason|7
319285|NCT00705432|1045993|P5|Treatment Period|Non medical reason|7
319286|NCT00705432|1045994|P4|Treatment Period|Non medical reason|4
319287|NCT00705432|1045995|P3|Treatment Period|Non medical reason|37
319288|NCT00705432|1045996|P2|Treatment Period|Non medical reason|32
319289|NCT00705432|1045997|P1|Treatment Period|Non medical reason|26
319290|NCT00705432|1045992|P6|Treatment Period|Treatment failure|14
319291|NCT00705432|1045993|P5|Treatment Period|Treatment failure|13
319292|NCT00705432|1045994|P4|Treatment Period|Treatment failure|25
319293|NCT00705432|1045995|P3|Treatment Period|Treatment failure|33
319294|NCT00705432|1045996|P2|Treatment Period|Treatment failure|42
319295|NCT00705432|1045997|P1|Treatment Period|Treatment failure|92
319296|NCT00705432|1045992|P6|Treatment Period|Adverse Event|9
319297|NCT00705432|1045993|P5|Treatment Period|Adverse Event|8
319298|NCT00705432|1045994|P4|Treatment Period|Adverse Event|12
319299|NCT00705432|1045995|P3|Treatment Period|Adverse Event|51
319300|NCT00705432|1045996|P2|Treatment Period|Adverse Event|37
319301|NCT00705432|1045997|P1|Treatment Period|Adverse Event|45
319302|NCT00705406|1046034|P2|Overall Study|Did not receive study drug|2
319303|NCT00705406|1046035|P1|Overall Study|Did not receive study drug|1
319304|NCT00705406|1046034|P2|Overall Study|Lost to Follow-up|3
319305|NCT00705406|1046035|P1|Overall Study|Lost to Follow-up|3
319306|NCT00705367|1046059|P2|Long-term Extension Period|Administrative reason by sponsor|0
319307|NCT00705367|1046060|P1|Long-term Extension Period|Administrative reason by sponsor|3
319308|NCT00705367|1046059|P2|Long-term Extension Period|No longer met study criteria|0
319309|NCT00705367|1046060|P1|Long-term Extension Period|No longer met study criteria|1
319310|NCT00705367|1046059|P2|Long-term Extension Period|Lack of Efficacy|0
319311|NCT00705367|1046060|P1|Long-term Extension Period|Lack of Efficacy|1
319312|NCT00705367|1046059|P2|Long-term Extension Period|Withdrawal by Subject|0
319313|NCT00705367|1046060|P1|Long-term Extension Period|Withdrawal by Subject|2
319314|NCT00705367|1046059|P2|Long-term Extension Period|Adverse Event|0
319315|NCT00705367|1046060|P1|Long-term Extension Period|Adverse Event|2
319316|NCT00705341|1046087|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
319317|NCT00705341|1046088|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
319318|NCT00705341|1046089|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
319319|NCT00705341|1046090|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
319320|NCT00705341|1046087|P4|Phase 2: Trial|Withdrawal by Subject|4
319321|NCT00705341|1046088|P3|Phase 2: Trial|Withdrawal by Subject|6
319322|NCT00705341|1046089|P2|Phase 2: Trial|Withdrawal by Subject|0
319323|NCT00705341|1046090|P1|Phase 2: Trial|Withdrawal by Subject|0
319324|NCT00705289|1046098|P1|Overall Study|Subject or treating physician's choice|131
319325|NCT00705263|1046122|P1|Overall Study|Withdrawal by Subject|2
319326|NCT00705250|1046126|P1|Overall Study|Patient died in car accident|1
319327|NCT00705250|1046126|P1|Overall Study|Withdrawal by Subject|1
319328|NCT00705224|1046130|P1|Overall Study|Lost to Follow-up|5
319329|NCT00705224|1046130|P1|Overall Study|Withdrawal by Subject|3
319330|NCT00705224|1046130|P1|Overall Study|Lack of Efficacy|2
319331|NCT00705224|1046130|P1|Overall Study|Adverse Event|1
319332|NCT00705159|1046146|P4|Overall Study|Screen Failure|1
319333|NCT00705159|1046147|P3|Overall Study|Screen Failure|0
319334|NCT00705159|1046148|P2|Overall Study|Screen Failure|0
319335|NCT00705159|1046149|P1|Overall Study|Screen Failure|0
319336|NCT00705159|1046146|P4|Overall Study|Lost to Follow-up|2
319337|NCT00705159|1046147|P3|Overall Study|Lost to Follow-up|3
319338|NCT00705159|1046148|P2|Overall Study|Lost to Follow-up|0
319339|NCT00705159|1046149|P1|Overall Study|Lost to Follow-up|0
319340|NCT00705159|1046146|P4|Overall Study|Adverse Event|0
319341|NCT00705159|1046147|P3|Overall Study|Adverse Event|1
319342|NCT00705159|1046148|P2|Overall Study|Adverse Event|0
319343|NCT00705159|1046149|P1|Overall Study|Adverse Event|0
319344|NCT00705159|1046146|P4|Overall Study|Protocol Violation|0
319345|NCT00705159|1046147|P3|Overall Study|Protocol Violation|0
319346|NCT00705159|1046148|P2|Overall Study|Protocol Violation|1
319347|NCT00705159|1046149|P1|Overall Study|Protocol Violation|0
319348|NCT00705159|1046146|P4|Overall Study|Withdrawal by Subject|1
319349|NCT00705159|1046147|P3|Overall Study|Withdrawal by Subject|1
319350|NCT00705159|1046148|P2|Overall Study|Withdrawal by Subject|1
319351|NCT00705159|1046149|P1|Overall Study|Withdrawal by Subject|0
319352|NCT00705146|1046169|P2|Overall Study|Lost to Follow-up|1
319353|NCT00705146|1046170|P1|Overall Study|Lost to Follow-up|1
319354|NCT00705016|1046199|P3|Overall Study|Unspecified|6
319355|NCT00705016|1046200|P2|Overall Study|Unspecified|6
319356|NCT00705016|1046201|P1|Overall Study|Unspecified|9
319357|NCT00705016|1046199|P3|Overall Study|Symptomatic Deterioration|1
319358|NCT00705016|1046200|P2|Overall Study|Symptomatic Deterioration|1
319359|NCT00705016|1046201|P1|Overall Study|Symptomatic Deterioration|3
319360|NCT00705016|1046199|P3|Overall Study|Progressive Disease|33
319361|NCT00705016|1046200|P2|Overall Study|Progressive Disease|29
319362|NCT00705016|1046201|P1|Overall Study|Progressive Disease|33
319363|NCT00705016|1046199|P3|Overall Study|Withdrawal by Subject|2
319364|NCT00705016|1046200|P2|Overall Study|Withdrawal by Subject|3
319365|NCT00705016|1046201|P1|Overall Study|Withdrawal by Subject|4
319366|NCT00705016|1046199|P3|Overall Study|Protocol Violation|1
319367|NCT00705016|1046200|P2|Overall Study|Protocol Violation|1
319368|NCT00705016|1046201|P1|Overall Study|Protocol Violation|0
319369|NCT00705016|1046199|P3|Overall Study|Death|5
319370|NCT00705016|1046200|P2|Overall Study|Death|7
319371|NCT00705016|1046201|P1|Overall Study|Death|5
319372|NCT00705016|1046199|P3|Overall Study|Adverse Event|10
319373|NCT00705016|1046200|P2|Overall Study|Adverse Event|11
319374|NCT00705016|1046201|P1|Overall Study|Adverse Event|6
319375|NCT00704964|1046252|P1|Overall Study|Not completed on time|328
319376|NCT00704808|1046301|P1|Overall Study|Treatment change|1
319377|NCT00704808|1046301|P1|Overall Study|Lost to Follow-up|1
319378|NCT00704808|1046301|P1|Overall Study|Adverse Event|1
319379|NCT00704808|1046301|P1|Overall Study|Early therapy discontinuation|16
319380|NCT00704808|1046301|P1|Overall Study|Patient's decision|11
319381|NCT00704808|1046301|P1|Overall Study|Tumor progression|80
319382|NCT00704808|1046301|P1|Overall Study|Death|7
319383|NCT00704808|1046301|P1|Overall Study|Discontinued prior to starting treatment|14
319384|NCT00704730|1046312|P2|Overall Study|Withdrawal by Subject|13
319385|NCT00704730|1046313|P1|Overall Study|Withdrawal by Subject|9
319386|NCT00704730|1046312|P2|Overall Study|data unavailable|0
319387|NCT00704730|1046313|P1|Overall Study|data unavailable|1
319388|NCT00704730|1046312|P2|Overall Study|Disease progression per PI|67
319389|NCT00704730|1046313|P1|Overall Study|Disease progression per PI|58
319390|NCT00704730|1046312|P2|Overall Study|Did not receive drug|2
319391|NCT00704730|1046313|P1|Overall Study|Did not receive drug|5
319392|NCT00704730|1046312|P2|Overall Study|Physician Decision|0
319393|NCT00704730|1046313|P1|Overall Study|Physician Decision|2
319394|NCT00704730|1046312|P2|Overall Study|Death|5
319395|NCT00704730|1046313|P1|Overall Study|Death|11
319396|NCT00704730|1046312|P2|Overall Study|Adverse Event|9
319397|NCT00704730|1046313|P1|Overall Study|Adverse Event|35
319398|NCT00704535|1046333|P1|Overall Study|Completed status not on Case Report Form|124
319399|NCT00704535|1046333|P1|Overall Study|Protocol Violation|10
319400|NCT00704535|1046333|P1|Overall Study|Lost to Follow-up|8
319401|NCT00704535|1046333|P1|Overall Study|Death|2
319402|NCT00704535|1046333|P1|Overall Study|Adverse Event|2
319403|NCT00704522|1046346|P2|Overall Study|No information on therapy end|2
319404|NCT00704522|1046347|P1|Overall Study|No information on therapy end|27
319405|NCT00704522|1046346|P2|Overall Study|Undefined causes|7
319406|NCT00704522|1046347|P1|Overall Study|Undefined causes|9
319407|NCT00704522|1046346|P2|Overall Study|Adverse Event|1
319408|NCT00704522|1046347|P1|Overall Study|Adverse Event|9
319409|NCT00704522|1046346|P2|Overall Study|Withdrawal by Subject|8
319410|NCT00704522|1046347|P1|Overall Study|Withdrawal by Subject|17
319411|NCT00704522|1046346|P2|Overall Study|Failure to appear again at hospital|10
319412|NCT00704522|1046347|P1|Overall Study|Failure to appear again at hospital|56
319413|NCT00704522|1046346|P2|Overall Study|Lack of Efficacy|17
319414|NCT00704522|1046347|P1|Overall Study|Lack of Efficacy|65
319415|NCT00704418|1046356|P2|Overall Study|Over-enrolled/surgery postponed|6
319499|NCT00703846|1046611|P1|Overall Study|Withdrawal by Subject|40
319416|NCT00704418|1046357|P1|Overall Study|Over-enrolled/surgery postponed|3
319417|NCT00704418|1046356|P2|Overall Study|Withdrawal by Subject|0
319418|NCT00704418|1046357|P1|Overall Study|Withdrawal by Subject|2
319419|NCT00704405|1046370|P5|Overall Study (C Population)|Lost to Follow-up|0
319420|NCT00704405|1046371|P4|Overall Study (C Population)|Lost to Follow-up|0
319421|NCT00704405|1046372|P3|Overall Study (C Population)|Lost to Follow-up|0
319422|NCT00704405|1046373|P2|Overall Study (C Population)|Lost to Follow-up|2
319423|NCT00704405|1046374|P1|Overall Study (C Population)|Lost to Follow-up|0
319424|NCT00704405|1046370|P5|Overall Study (C Population)|Withdrawal by Subject|0
319425|NCT00704405|1046371|P4|Overall Study (C Population)|Withdrawal by Subject|1
319426|NCT00704405|1046372|P3|Overall Study (C Population)|Withdrawal by Subject|1
319427|NCT00704405|1046373|P2|Overall Study (C Population)|Withdrawal by Subject|1
319428|NCT00704405|1046374|P1|Overall Study (C Population)|Withdrawal by Subject|1
319429|NCT00704405|1046370|P5|Overall Study (NC Population)|Other|1
319430|NCT00704405|1046371|P4|Overall Study (NC Population)|Other|0
319431|NCT00704405|1046372|P3|Overall Study (NC Population)|Other|0
319432|NCT00704405|1046373|P2|Overall Study (NC Population)|Other|0
319433|NCT00704405|1046374|P1|Overall Study (NC Population)|Other|0
319434|NCT00704405|1046370|P5|Overall Study (NC Population)|Withdrawal by Subject|2
319435|NCT00704405|1046371|P4|Overall Study (NC Population)|Withdrawal by Subject|2
319436|NCT00704405|1046372|P3|Overall Study (NC Population)|Withdrawal by Subject|2
319437|NCT00704405|1046373|P2|Overall Study (NC Population)|Withdrawal by Subject|3
319438|NCT00704405|1046374|P1|Overall Study (NC Population)|Withdrawal by Subject|2
319439|NCT00704405|1046370|P5|Overall Study (NC Population)|Lost to Follow-up|2
319440|NCT00704405|1046371|P4|Overall Study (NC Population)|Lost to Follow-up|2
319441|NCT00704405|1046372|P3|Overall Study (NC Population)|Lost to Follow-up|1
319442|NCT00704405|1046373|P2|Overall Study (NC Population)|Lost to Follow-up|1
319443|NCT00704405|1046374|P1|Overall Study (NC Population)|Lost to Follow-up|2
319444|NCT00704405|1046370|P5|Overall Study (NC Population)|Adverse Event|0
319445|NCT00704405|1046371|P4|Overall Study (NC Population)|Adverse Event|0
319446|NCT00704405|1046372|P3|Overall Study (NC Population)|Adverse Event|0
319447|NCT00704405|1046373|P2|Overall Study (NC Population)|Adverse Event|0
319448|NCT00704405|1046374|P1|Overall Study (NC Population)|Adverse Event|1
319449|NCT00704340|1046432|P2|Overall Study|Death|1
319450|NCT00704340|1046433|P1|Overall Study|Death|0
319451|NCT00704340|1046432|P2|Overall Study|Lost to Follow-up|1
319452|NCT00704340|1046433|P1|Overall Study|Lost to Follow-up|2
319453|NCT00704184|1046448|P5|Open-Label Treatment|Withdrawal by Subject|0
319454|NCT00704184|1046449|P4|Open-Label Treatment|Withdrawal by Subject|3
319455|NCT00704184|1046450|P3|Open-Label Treatment|Withdrawal by Subject|0
319456|NCT00704184|1046451|P2|Open-Label Treatment|Withdrawal by Subject|0
319457|NCT00704184|1046452|P1|Open-Label Treatment|Withdrawal by Subject|1
319458|NCT00704184|1046448|P5|Open-Label Treatment|Physician Decision|1
319459|NCT00704184|1046449|P4|Open-Label Treatment|Physician Decision|0
319460|NCT00704184|1046450|P3|Open-Label Treatment|Physician Decision|0
319461|NCT00704184|1046451|P2|Open-Label Treatment|Physician Decision|0
319462|NCT00704184|1046452|P1|Open-Label Treatment|Physician Decision|0
319463|NCT00704184|1046448|P5|Open-Label Treatment|Lack of Efficacy|1
319464|NCT00704184|1046449|P4|Open-Label Treatment|Lack of Efficacy|2
319465|NCT00704184|1046450|P3|Open-Label Treatment|Lack of Efficacy|2
319466|NCT00704184|1046451|P2|Open-Label Treatment|Lack of Efficacy|2
319467|NCT00704184|1046452|P1|Open-Label Treatment|Lack of Efficacy|0
319468|NCT00704184|1046448|P5|Open-Label Treatment|Adverse Event|1
319469|NCT00704184|1046449|P4|Open-Label Treatment|Adverse Event|0
319470|NCT00704184|1046450|P3|Open-Label Treatment|Adverse Event|2
319471|NCT00704184|1046451|P2|Open-Label Treatment|Adverse Event|0
319472|NCT00704184|1046452|P1|Open-Label Treatment|Adverse Event|0
319473|NCT00704184|1046448|P5|Double-Blind Treatment|Withdrawal by Subject|0
319474|NCT00704184|1046449|P4|Double-Blind Treatment|Withdrawal by Subject|0
319475|NCT00704184|1046450|P3|Double-Blind Treatment|Withdrawal by Subject|0
319476|NCT00704184|1046451|P2|Double-Blind Treatment|Withdrawal by Subject|0
319477|NCT00704184|1046452|P1|Double-Blind Treatment|Withdrawal by Subject|1
319478|NCT00704171|1046491|P2|Overall Study|Withdrawal by Subject|0
319479|NCT00704171|1046492|P1|Overall Study|Withdrawal by Subject|1
319480|NCT00704132|1046510|P2|Overall Study|Withdrawal by Subject|1
319481|NCT00704132|1046511|P1|Overall Study|Withdrawal by Subject|0
319482|NCT00704132|1046510|P2|Overall Study|Lack of Efficacy|1
319483|NCT00704132|1046511|P1|Overall Study|Lack of Efficacy|0
319484|NCT00704132|1046510|P2|Overall Study|Clinical Adverse Experience|0
319485|NCT00704132|1046511|P1|Overall Study|Clinical Adverse Experience|1
319486|NCT00703963|1046539|P2|Overall Study|Physician Decision|1
319487|NCT00703963|1046540|P1|Overall Study|Physician Decision|0
319488|NCT00703963|1046539|P2|Overall Study|Withdrawal by Subject|13
319489|NCT00703963|1046540|P1|Overall Study|Withdrawal by Subject|7
319490|NCT00703924|1046561|P2|Overall Study|Withdrawal by Subject|1
319491|NCT00703924|1046562|P1|Overall Study|Withdrawal by Subject|1
319492|NCT00703911|1046578|P1|Overall Study|Withdrawal by Subject|2
319493|NCT00703911|1046578|P1|Overall Study|Lost to Follow-up|1
319494|NCT00703911|1046578|P1|Overall Study|Physician Decision|6
319495|NCT00703911|1046578|P1|Overall Study|Death|1
319496|NCT00703846|1046611|P1|Overall Study|Did Not Receive Study Drug|2
319497|NCT00703846|1046611|P1|Overall Study|Other|14
319498|NCT00703846|1046611|P1|Overall Study|Death|1
319500|NCT00703846|1046611|P1|Overall Study|Noncompliance with Study Treatment|2
319501|NCT00703846|1046611|P1|Overall Study|Lack of Efficacy|15
319502|NCT00703846|1046611|P1|Overall Study|Lost to Follow-up|55
319503|NCT00703846|1046611|P1|Overall Study|Adverse Event|8
319504|NCT00703781|1046627|P2|Overall Study|Cancelled surgery|0
319505|NCT00703781|1046628|P1|Overall Study|Cancelled surgery|1
319506|NCT00703781|1046627|P2|Overall Study|Withdrawal by Subject|2
319507|NCT00703781|1046628|P1|Overall Study|Withdrawal by Subject|1
319508|NCT00703677|1046673|P1|Overall Study|Dropout-withdrawal not related to drug|3
319509|NCT00703534|1046688|P2|Overall Study|Severe Non Compliance|5
319510|NCT00703534|1046689|P1|Overall Study|Severe Non Compliance|1
319511|NCT00703534|1046688|P2|Overall Study|Lost to Follow-up|4
319512|NCT00703534|1046689|P1|Overall Study|Lost to Follow-up|1
319513|NCT00703534|1046688|P2|Overall Study|Incorrect Enrollment|6
319514|NCT00703534|1046689|P1|Overall Study|Incorrect Enrollment|6
319515|NCT00703534|1046688|P2|Overall Study|Withdrawal by Subject|7
319516|NCT00703534|1046689|P1|Overall Study|Withdrawal by Subject|8
319517|NCT00703534|1046688|P2|Overall Study|Adverse Event|3
319518|NCT00703534|1046689|P1|Overall Study|Adverse Event|14
319519|NCT00703326|1046760|P2|Overall Study|Withdrawal by Subject|20
319520|NCT00703326|1046761|P1|Overall Study|Withdrawal by Subject|42
319521|NCT00703326|1046760|P2|Overall Study|Lost to Follow-up|8
319522|NCT00703326|1046761|P1|Overall Study|Lost to Follow-up|25
319523|NCT00703326|1046760|P2|Overall Study|Still on study|197
319524|NCT00703326|1046761|P1|Overall Study|Still on study|380
319525|NCT00703157|1046793|P2|Overall Study|source data permanently lost/ other|1
319526|NCT00703157|1046794|P1|Overall Study|source data permanently lost/ other|4
319527|NCT00703157|1046793|P2|Overall Study|Lost to Follow-up|1
319528|NCT00703157|1046794|P1|Overall Study|Lost to Follow-up|0
319529|NCT00703118|1046828|P3|Overall Study|Not specified|1
319530|NCT00703118|1046829|P2|Overall Study|Not specified|0
319531|NCT00703118|1046830|P1|Overall Study|Not specified|0
319532|NCT00703118|1046828|P3|Overall Study|Withdrawal by Subject|13
319533|NCT00703118|1046829|P2|Overall Study|Withdrawal by Subject|7
319534|NCT00703118|1046830|P1|Overall Study|Withdrawal by Subject|8
319535|NCT00703118|1046828|P3|Overall Study|Lost to Follow-up|4
319536|NCT00703118|1046829|P2|Overall Study|Lost to Follow-up|4
319537|NCT00703118|1046830|P1|Overall Study|Lost to Follow-up|6
319538|NCT00703118|1046828|P3|Overall Study|Subject Ineligible To Continue The Trial|2
319539|NCT00703118|1046829|P2|Overall Study|Subject Ineligible To Continue The Trial|3
319540|NCT00703118|1046830|P1|Overall Study|Subject Ineligible To Continue The Trial|6
319541|NCT00703118|1046828|P3|Overall Study|Adverse Event|2
319542|NCT00703118|1046829|P2|Overall Study|Adverse Event|2
319543|NCT00703118|1046830|P1|Overall Study|Adverse Event|1
319544|NCT00703092|1046861|P1|Overall Study|Withdrawal by Subject|2
319545|NCT00703014|1047068|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
319546|NCT00703014|1047069|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
319547|NCT00703014|1047070|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
319548|NCT00703014|1047071|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
319549|NCT00703014|1047068|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
319550|NCT00703014|1047069|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
319551|NCT00703014|1047070|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
319552|NCT00703014|1047071|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
319553|NCT00702949|1047092|P3|Overall Study|Other Medical Reason/unknown|3
319554|NCT00702949|1047093|P2|Overall Study|Other Medical Reason/unknown|1
319555|NCT00702949|1047094|P1|Overall Study|Other Medical Reason/unknown|1
319556|NCT00702949|1047092|P3|Overall Study|Adverse Event|3
319557|NCT00702949|1047093|P2|Overall Study|Adverse Event|6
319558|NCT00702949|1047094|P1|Overall Study|Adverse Event|1
319559|NCT00702949|1047092|P3|Overall Study|Refusal|2
319560|NCT00702949|1047093|P2|Overall Study|Refusal|2
319561|NCT00702949|1047094|P1|Overall Study|Refusal|3
319562|NCT00702923|1047119|P1|Overall Study|Adverse Event|1
319563|NCT00702845|1047142|P2|Overall Study|Not randomized|1
319564|NCT00702845|1047143|P1|Overall Study|Not randomized|0
319565|NCT00702845|1047142|P2|Overall Study|Patient's decision|1
319566|NCT00702845|1047143|P1|Overall Study|Patient's decision|2
319567|NCT00702845|1047142|P2|Overall Study|No or abnormal fertilization|2
319568|NCT00702845|1047143|P1|Overall Study|No or abnormal fertilization|4
319569|NCT00702845|1047142|P2|Overall Study|No/too few/bad quality embryos retrieved|1
319570|NCT00702845|1047143|P1|Overall Study|No/too few/bad quality embryos retrieved|7
319571|NCT00702845|1047142|P2|Overall Study|Insufficient ovarian response|0
319572|NCT00702845|1047143|P1|Overall Study|Insufficient ovarian response|1
319573|NCT00702845|1047142|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
319574|NCT00702845|1047143|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
319575|NCT00702845|1047142|P2|Overall Study|Too high ovarian response|1
319576|NCT00702845|1047143|P1|Overall Study|Too high ovarian response|5
319577|NCT00702845|1047142|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
319578|NCT00702845|1047143|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
319579|NCT00702715|1047205|P2|Overall Study|Lost to Follow-up|0
319580|NCT00702715|1047206|P1|Overall Study|Lost to Follow-up|1
319581|NCT00702702|1047219|P1|Overall Study|Study prematurely terminated|56
319582|NCT00702689|1047227|P1|Overall Study|Adverse Event|1
319583|NCT00702689|1047227|P1|Overall Study|Recurrent malignancy|1
319584|NCT00702689|1047227|P1|Overall Study|Withdrawal by Subject|4
319585|NCT00702650|1047238|P1|Overall Study|Adverse Event|3
319586|NCT00702650|1047238|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
319587|NCT00702650|1047238|P1|Overall Study|Sponsor Request|1
319588|NCT00702650|1047238|P1|Overall Study|Non-Compliance with Site Directives|1
319589|NCT00702650|1047238|P1|Overall Study|Lost to Follow-up|2
319590|NCT00702650|1047238|P1|Overall Study|Non-Compliance of Study Drug|3
319591|NCT00702650|1047238|P1|Overall Study|Withdrawal by Subject|9
319592|NCT00702520|1047300|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
319593|NCT00702520|1047301|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
319594|NCT00702520|1047302|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
319595|NCT00702520|1047303|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
319596|NCT00702520|1047300|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
319597|NCT00702520|1047301|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
319598|NCT00702520|1047302|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
319599|NCT00702520|1047303|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
319600|NCT00702520|1047300|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
319601|NCT00702520|1047301|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
319602|NCT00702520|1047302|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
319603|NCT00702520|1047303|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
319604|NCT00702507|1047319|P1|Follow-up Phase|Late Enrollment|1
319605|NCT00702507|1047319|P1|Follow-up Phase|Lost to Follow-up|23
319606|NCT00702507|1047319|P1|Follow-up Phase|Protocol Violation|2
319607|NCT00702507|1047319|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
319608|NCT00702507|1047319|P1|Initial Treatment Phase|Negative Candida Culture|34
319609|NCT00702507|1047319|P1|Initial Treatment Phase|Lost to Follow-up|2
319610|NCT00702507|1047319|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
319611|NCT00702507|1047319|P1|Initial Treatment Phase|Adverse Event|2
319612|NCT00702403|1047356|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
319613|NCT00702403|1047356|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
319614|NCT00702403|1047356|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
319615|NCT00702403|1047356|P1|From Engraftment to Study Completion|Suicide|1
319616|NCT00702403|1047356|P1|From Engraftment to Study Completion|Liver GVHD|1
319617|NCT00702403|1047356|P1|From Engraftment to Study Completion|Adenocarcinoma|1
319618|NCT00702403|1047356|P1|From Engraftment to Study Completion|Non-compliance|2
319619|NCT00702403|1047356|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
319620|NCT00702403|1047356|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
319621|NCT00702403|1047356|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
319622|NCT00702403|1047356|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
319623|NCT00702403|1047356|P1|From Consent to Engraftment|Myocardial infarction|1
319624|NCT00702403|1047356|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
319625|NCT00702403|1047356|P1|From Consent to Engraftment|Critically ill|2
319626|NCT00702403|1047356|P1|From Consent to Engraftment|Progressive leukemia|6
319627|NCT00702325|1047410|P2|Overall Study|Incorrectly Discontinued|1
319628|NCT00702325|1047411|P1|Overall Study|Incorrectly Discontinued|0
319629|NCT00702325|1047410|P2|Overall Study|Withdrew consent|1
319630|NCT00702325|1047411|P1|Overall Study|Withdrew consent|0
319631|NCT00702325|1047410|P2|Overall Study|Didn't follow study medication dosage|2
319632|NCT00702325|1047411|P1|Overall Study|Didn't follow study medication dosage|0
319633|NCT00702325|1047410|P2|Overall Study|Termination due to lab results|0
319634|NCT00702325|1047411|P1|Overall Study|Termination due to lab results|1
319635|NCT00702325|1047410|P2|Overall Study|Severe noncompliance to protocol|3
319636|NCT00702325|1047411|P1|Overall Study|Severe noncompliance to protocol|3
319637|NCT00702325|1047410|P2|Overall Study|Developed study discontinuation criteria|28
319638|NCT00702325|1047411|P1|Overall Study|Developed study discontinuation criteria|18
319639|NCT00702325|1047410|P2|Overall Study|Incorrect enrollment|7
319640|NCT00702325|1047411|P1|Overall Study|Incorrect enrollment|5
319641|NCT00702325|1047410|P2|Overall Study|Lost to Follow-up|4
319642|NCT00702325|1047411|P1|Overall Study|Lost to Follow-up|3
319643|NCT00702325|1047410|P2|Overall Study|Withdrawal by Subject|7
319644|NCT00702325|1047411|P1|Overall Study|Withdrawal by Subject|7
319645|NCT00702325|1047410|P2|Overall Study|Adverse Event|0
319646|NCT00702325|1047411|P1|Overall Study|Adverse Event|1
319647|NCT00702221|1047507|P2|Overall Study|Adverse Event|3
319648|NCT00702221|1047508|P1|Overall Study|Adverse Event|4
319649|NCT00702208|1047514|P1|Overall Study|Unsatisfactory colposcopy|2
319650|NCT00702208|1047514|P1|Overall Study|Did not self-lavage|1
319651|NCT00702208|1047514|P1|Overall Study|Lost to Follow-up|28
319652|NCT00702143|1047523|P3|Overall Study|Lost to Follow-up|1
319653|NCT00702143|1047524|P2|Overall Study|Lost to Follow-up|0
319654|NCT00702143|1047525|P1|Overall Study|Lost to Follow-up|0
319655|NCT00701805|1047574|P4|Overall Study|Resumption criteria were not met|0
319656|NCT00701805|1047575|P3|Overall Study|Resumption criteria were not met|0
319657|NCT00701805|1047576|P2|Overall Study|Resumption criteria were not met|1
319658|NCT00701805|1047577|P1|Overall Study|Resumption criteria were not met|0
319659|NCT00701805|1047574|P4|Overall Study|Difficult to travel to dialysis site|0
319660|NCT00701805|1047575|P3|Overall Study|Difficult to travel to dialysis site|1
319661|NCT00701805|1047576|P2|Overall Study|Difficult to travel to dialysis site|0
319662|NCT00701805|1047577|P1|Overall Study|Difficult to travel to dialysis site|0
319663|NCT00701805|1047574|P4|Overall Study|Physician decision, change of therapy|1
319664|NCT00701805|1047575|P3|Overall Study|Physician decision, change of therapy|0
319665|NCT00701805|1047576|P2|Overall Study|Physician decision, change of therapy|0
319666|NCT00701805|1047577|P1|Overall Study|Physician decision, change of therapy|0
319667|NCT00701805|1047574|P4|Overall Study|Admitted to hospital for 2 weeks|0
319668|NCT00701805|1047575|P3|Overall Study|Admitted to hospital for 2 weeks|1
319669|NCT00701805|1047576|P2|Overall Study|Admitted to hospital for 2 weeks|0
319670|NCT00701805|1047577|P1|Overall Study|Admitted to hospital for 2 weeks|0
319671|NCT00701805|1047574|P4|Overall Study|Missed 7 consecutive doses|0
319672|NCT00701805|1047575|P3|Overall Study|Missed 7 consecutive doses|0
319673|NCT00701805|1047576|P2|Overall Study|Missed 7 consecutive doses|1
319674|NCT00701805|1047577|P1|Overall Study|Missed 7 consecutive doses|0
319675|NCT00701805|1047574|P4|Overall Study|Adverse Event|0
319676|NCT00701805|1047575|P3|Overall Study|Adverse Event|1
319677|NCT00701805|1047576|P2|Overall Study|Adverse Event|1
319678|NCT00701805|1047577|P1|Overall Study|Adverse Event|0
319679|NCT00701805|1047574|P4|Overall Study|Withdrawal by Subject|3
319680|NCT00701805|1047575|P3|Overall Study|Withdrawal by Subject|4
319681|NCT00701805|1047576|P2|Overall Study|Withdrawal by Subject|1
319682|NCT00701805|1047577|P1|Overall Study|Withdrawal by Subject|3
319683|NCT00701779|1047627|P1|Overall Study|Withdrawal by Subject|2
319684|NCT00701779|1047627|P1|Overall Study|Lost to Follow-up|1
319685|NCT00701779|1047627|P1|Overall Study|Adverse Event|6
319686|NCT00701727|1047636|P2|Second Treatment Period|Withdrawal by Subject|0
319687|NCT00701727|1047637|P1|Second Treatment Period|Withdrawal by Subject|2
319688|NCT00701727|1047636|P2|First Treatment Period|Lost to Follow-up|1
319689|NCT00701727|1047637|P1|First Treatment Period|Lost to Follow-up|0
319690|NCT00701727|1047636|P2|First Treatment Period|sponsor decision|1
319691|NCT00701727|1047637|P1|First Treatment Period|sponsor decision|0
319692|NCT00701727|1047636|P2|First Treatment Period|Withdrawal by Subject|0
319693|NCT00701727|1047637|P1|First Treatment Period|Withdrawal by Subject|1
319694|NCT00701727|1047636|P2|First Treatment Period|Adverse Event|0
319695|NCT00701727|1047637|P1|First Treatment Period|Adverse Event|0
319696|NCT00701662|1047668|P1|Overall Study|Lack of Efficacy|1
319697|NCT00701558|1047693|P1|Overall Study|Lost to Follow-up|8
319698|NCT00701558|1047693|P1|Overall Study|Death|7
319699|NCT00701441|1047701|P2|Overall Study|failure in cpap compliance|4
319700|NCT00701441|1047702|P1|Overall Study|failure in cpap compliance|0
319701|NCT00701415|1047714|P2|Overall Study|Social/family issues and needle phobia|0
319702|NCT00701415|1047715|P1|Overall Study|Social/family issues and needle phobia|1
319703|NCT00701415|1047714|P2|Overall Study|Adverse Event|1
319704|NCT00701415|1047715|P1|Overall Study|Adverse Event|0
319705|NCT00701363|1047750|P4|Treatment Phase 2|Withdrawal by Subject|0
319706|NCT00701363|1047751|P3|Treatment Phase 2|Withdrawal by Subject|1
319707|NCT00701363|1047752|P2|Treatment Phase 2|Withdrawal by Subject|0
319708|NCT00701363|1047753|P1|Treatment Phase 2|Withdrawal by Subject|0
319709|NCT00701363|1047750|P4|Treatment Phase 2|Adverse Event|0
319710|NCT00701363|1047751|P3|Treatment Phase 2|Adverse Event|1
319711|NCT00701363|1047752|P2|Treatment Phase 2|Adverse Event|0
319712|NCT00701363|1047753|P1|Treatment Phase 2|Adverse Event|0
319713|NCT00701363|1047750|P4|Treatment Phase 1|Lack of Efficacy|0
319714|NCT00701363|1047751|P3|Treatment Phase 1|Lack of Efficacy|0
319715|NCT00701363|1047752|P2|Treatment Phase 1|Lack of Efficacy|0
319716|NCT00701363|1047753|P1|Treatment Phase 1|Lack of Efficacy|1
319717|NCT00701363|1047750|P4|Treatment Phase 1|Withdrawal by Subject|0
319718|NCT00701363|1047751|P3|Treatment Phase 1|Withdrawal by Subject|0
319719|NCT00701363|1047752|P2|Treatment Phase 1|Withdrawal by Subject|0
319720|NCT00701363|1047753|P1|Treatment Phase 1|Withdrawal by Subject|5
319721|NCT00701363|1047750|P4|Treatment Phase 1|Protocol Violation|0
319722|NCT00701363|1047751|P3|Treatment Phase 1|Protocol Violation|0
319723|NCT00701363|1047752|P2|Treatment Phase 1|Protocol Violation|0
319724|NCT00701363|1047753|P1|Treatment Phase 1|Protocol Violation|1
319725|NCT00701363|1047750|P4|Treatment Phase 1|Adverse Event|0
319726|NCT00701363|1047751|P3|Treatment Phase 1|Adverse Event|0
319727|NCT00701363|1047752|P2|Treatment Phase 1|Adverse Event|0
319728|NCT00701363|1047753|P1|Treatment Phase 1|Adverse Event|7
319729|NCT00701363|1047750|P4|Treatment Phase 1|Does not meet entry Criteria|0
319730|NCT00701363|1047751|P3|Treatment Phase 1|Does not meet entry Criteria|0
319731|NCT00701363|1047752|P2|Treatment Phase 1|Does not meet entry Criteria|0
319732|NCT00701363|1047753|P1|Treatment Phase 1|Does not meet entry Criteria|1
319733|NCT00701363|1047750|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
319734|NCT00701363|1047751|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
319735|NCT00701363|1047752|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
319736|NCT00701363|1047753|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
319737|NCT00701311|1047793|P1|Overall Study|Withdrawal by Subject|2
319738|NCT00701311|1047793|P1|Overall Study|Adverse Event|3
319739|NCT00701311|1047793|P1|Overall Study|Lack of Efficacy|3
319740|NCT00701129|1047797|P1|Overall Study|Death|2
319741|NCT00701103|1047819|P11|Overall Study|Unspecified|0
319742|NCT00701103|1047820|P10|Overall Study|Unspecified|1
319743|NCT00701103|1047821|P9|Overall Study|Unspecified|1
319744|NCT00701103|1047822|P8|Overall Study|Unspecified|0
319745|NCT00701103|1047823|P7|Overall Study|Unspecified|0
319746|NCT00701103|1047824|P6|Overall Study|Unspecified|0
319747|NCT00701103|1047825|P5|Overall Study|Unspecified|0
319748|NCT00701103|1047826|P4|Overall Study|Unspecified|0
319749|NCT00701103|1047827|P3|Overall Study|Unspecified|0
319750|NCT00701103|1047828|P2|Overall Study|Unspecified|0
319751|NCT00701103|1047829|P1|Overall Study|Unspecified|0
319752|NCT00701103|1047819|P11|Overall Study|Withdrawal by Subject|0
319753|NCT00701103|1047820|P10|Overall Study|Withdrawal by Subject|0
319754|NCT00701103|1047821|P9|Overall Study|Withdrawal by Subject|0
319755|NCT00701103|1047822|P8|Overall Study|Withdrawal by Subject|0
319756|NCT00701103|1047823|P7|Overall Study|Withdrawal by Subject|0
319757|NCT00701103|1047824|P6|Overall Study|Withdrawal by Subject|0
319758|NCT00701103|1047825|P5|Overall Study|Withdrawal by Subject|0
319759|NCT00701103|1047826|P4|Overall Study|Withdrawal by Subject|0
319760|NCT00701103|1047827|P3|Overall Study|Withdrawal by Subject|1
319761|NCT00701103|1047828|P2|Overall Study|Withdrawal by Subject|1
319762|NCT00701103|1047829|P1|Overall Study|Withdrawal by Subject|0
319763|NCT00701103|1047819|P11|Overall Study|Progressive Disease|11
319764|NCT00701103|1047820|P10|Overall Study|Progressive Disease|8
319765|NCT00701103|1047821|P9|Overall Study|Progressive Disease|8
319766|NCT00701103|1047822|P8|Overall Study|Progressive Disease|7
319767|NCT00701103|1047823|P7|Overall Study|Progressive Disease|7
319768|NCT00701103|1047824|P6|Overall Study|Progressive Disease|5
319769|NCT00701103|1047825|P5|Overall Study|Progressive Disease|6
319770|NCT00701103|1047826|P4|Overall Study|Progressive Disease|5
319771|NCT00701103|1047827|P3|Overall Study|Progressive Disease|6
319772|NCT00701103|1047828|P2|Overall Study|Progressive Disease|2
319773|NCT00701103|1047829|P1|Overall Study|Progressive Disease|5
319774|NCT00701103|1047819|P11|Overall Study|Adverse Event|0
319775|NCT00701103|1047820|P10|Overall Study|Adverse Event|2
319776|NCT00701103|1047821|P9|Overall Study|Adverse Event|0
319777|NCT00701103|1047822|P8|Overall Study|Adverse Event|0
319778|NCT00701103|1047823|P7|Overall Study|Adverse Event|1
319779|NCT00701103|1047824|P6|Overall Study|Adverse Event|1
319780|NCT00701103|1047825|P5|Overall Study|Adverse Event|0
319781|NCT00701103|1047826|P4|Overall Study|Adverse Event|1
319782|NCT00701103|1047827|P3|Overall Study|Adverse Event|1
319783|NCT00701103|1047828|P2|Overall Study|Adverse Event|0
319784|NCT00701103|1047829|P1|Overall Study|Adverse Event|0
319785|NCT00701090|1047935|P2|Overall Study|Other|12
319786|NCT00701090|1047936|P1|Overall Study|Other|7
319787|NCT00701090|1047935|P2|Overall Study|Withdrawal by Subject|16
319788|NCT00701090|1047936|P1|Overall Study|Withdrawal by Subject|11
319789|NCT00701090|1047935|P2|Overall Study|Protocol Violation|3
319790|NCT00701090|1047936|P1|Overall Study|Protocol Violation|2
319791|NCT00701090|1047935|P2|Overall Study|Physician Decision|4
319792|NCT00701090|1047936|P1|Overall Study|Physician Decision|3
319793|NCT00701090|1047935|P2|Overall Study|Lost to Follow-up|9
319794|NCT00701090|1047936|P1|Overall Study|Lost to Follow-up|9
319795|NCT00701090|1047935|P2|Overall Study|Lack of Efficacy|4
319796|NCT00701090|1047936|P1|Overall Study|Lack of Efficacy|5
319797|NCT00701090|1047935|P2|Overall Study|Death|1
319798|NCT00701090|1047936|P1|Overall Study|Death|0
319799|NCT00701090|1047935|P2|Overall Study|Adverse Event|2
319800|NCT00701090|1047936|P1|Overall Study|Adverse Event|11
319801|NCT00701064|1047954|P2|Overall Study|initiated other PTSD treatment|2
319802|NCT00701064|1047955|P1|Overall Study|initiated other PTSD treatment|2
319803|NCT00701064|1047954|P2|Overall Study|Withdrawal by Subject|1
319804|NCT00701064|1047955|P1|Overall Study|Withdrawal by Subject|1
319805|NCT00701064|1047954|P2|Overall Study|Protocol Violation|1
319806|NCT00701064|1047955|P1|Overall Study|Protocol Violation|1
319807|NCT00701051|1047963|P3|Exercise Intervention|time conflict; non-study related illness|3
319808|NCT00701051|1047964|P2|Exercise Intervention|time conflict; non-study related illness|5
319809|NCT00701051|1047965|P1|Exercise Intervention|time conflict; non-study related illness|0
319810|NCT00701051|1047963|P3|Screening|Time conflicts|0
319811|NCT00701051|1047964|P2|Screening|Time conflicts|0
319812|NCT00701051|1047965|P1|Screening|Time conflicts|19
319813|NCT00701051|1047963|P3|Screening|Failed Screening|0
319814|NCT00701051|1047964|P2|Screening|Failed Screening|0
319815|NCT00701051|1047965|P1|Screening|Failed Screening|40
319816|NCT00701038|1047983|P2|Overall Study|study amended pilot group of patients|4
319817|NCT00701038|1047984|P1|Overall Study|study amended pilot group of patients|4
319818|NCT00700999|1047992|P2|Overall Study|Withdrawal by Subject|1
319819|NCT00700999|1047993|P1|Overall Study|Withdrawal by Subject|8
319820|NCT00700999|1047992|P2|Overall Study|Excluded - did not meet study criteria|1
319821|NCT00700999|1047993|P1|Overall Study|Excluded - did not meet study criteria|0
319822|NCT00700999|1047992|P2|Overall Study|Lost to Follow-up|7
319823|NCT00700999|1047993|P1|Overall Study|Lost to Follow-up|7
319824|NCT00700817|1048013|P5|Week 52-78 (Extension Period 2)|Unclassified|1
319825|NCT00700817|1048014|P4|Week 52-78 (Extension Period 2)|Unclassified|0
319826|NCT00700817|1048015|P3|Week 52-78 (Extension Period 2)|Unclassified|0
319827|NCT00700817|1048016|P2|Week 52-78 (Extension Period 2)|Unclassified|4
319828|NCT00700817|1048017|P1|Week 52-78 (Extension Period 2)|Unclassified|2
319829|NCT00700817|1048013|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
319830|NCT00700817|1048014|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
319831|NCT00700817|1048015|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
319832|NCT00700817|1048016|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
319833|NCT00700817|1048017|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
319834|NCT00700817|1048013|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
319835|NCT00700817|1048014|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
319836|NCT00700817|1048015|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
319837|NCT00700817|1048016|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
319838|NCT00700817|1048017|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
319839|NCT00700817|1048013|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
319840|NCT00700817|1048014|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
319841|NCT00700817|1048015|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
319842|NCT00700817|1048016|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
319843|NCT00700817|1048017|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
319844|NCT00700817|1048013|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
319845|NCT00700817|1048014|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
319846|NCT00700817|1048015|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
319847|NCT00700817|1048016|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
319848|NCT00700817|1048017|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
319849|NCT00700817|1048013|P5|Week 26-52 (Extension Period 1)|Unclassified|0
319850|NCT00700817|1048014|P4|Week 26-52 (Extension Period 1)|Unclassified|0
319851|NCT00700817|1048015|P3|Week 26-52 (Extension Period 1)|Unclassified|1
319852|NCT00700817|1048016|P2|Week 26-52 (Extension Period 1)|Unclassified|3
319853|NCT00700817|1048017|P1|Week 26-52 (Extension Period 1)|Unclassified|4
319854|NCT00700817|1048013|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
319855|NCT00700817|1048014|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
319856|NCT00700817|1048015|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
319857|NCT00700817|1048016|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
319858|NCT00700817|1048017|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
319859|NCT00700817|1048013|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
319860|NCT00700817|1048014|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
319861|NCT00700817|1048015|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
319862|NCT00700817|1048016|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
319863|NCT00700817|1048017|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
319864|NCT00700817|1048013|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
319865|NCT00700817|1048014|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
319866|NCT00700817|1048015|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
319867|NCT00700817|1048016|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
319868|NCT00700817|1048017|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
319869|NCT00700817|1048013|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
319870|NCT00700817|1048014|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
319871|NCT00700817|1048015|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
319872|NCT00700817|1048016|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
319873|NCT00700817|1048017|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
319874|NCT00700817|1048013|P5|Week 0-26 (Main Period)|Unclassified|0
319875|NCT00700817|1048014|P4|Week 0-26 (Main Period)|Unclassified|0
319876|NCT00700817|1048015|P3|Week 0-26 (Main Period)|Unclassified|8
319877|NCT00700817|1048016|P2|Week 0-26 (Main Period)|Unclassified|4
319878|NCT00700817|1048017|P1|Week 0-26 (Main Period)|Unclassified|14
319879|NCT00700817|1048013|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
319880|NCT00700817|1048014|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
319881|NCT00700817|1048015|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
319882|NCT00700817|1048016|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
319883|NCT00700817|1048017|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
319884|NCT00700817|1048013|P5|Week 0-26 (Main Period)|Protocol Violation|0
319885|NCT00700817|1048014|P4|Week 0-26 (Main Period)|Protocol Violation|0
319886|NCT00700817|1048015|P3|Week 0-26 (Main Period)|Protocol Violation|4
319887|NCT00700817|1048016|P2|Week 0-26 (Main Period)|Protocol Violation|4
319888|NCT00700817|1048017|P1|Week 0-26 (Main Period)|Protocol Violation|14
319889|NCT00700817|1048013|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
319890|NCT00700817|1048014|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
319891|NCT00700817|1048015|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
319892|NCT00700817|1048016|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
319893|NCT00700817|1048017|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
319894|NCT00700817|1048013|P5|Week 0-26 (Main Period)|Adverse Event|0
319895|NCT00700817|1048014|P4|Week 0-26 (Main Period)|Adverse Event|0
319896|NCT00700817|1048015|P3|Week 0-26 (Main Period)|Adverse Event|4
319897|NCT00700817|1048016|P2|Week 0-26 (Main Period)|Adverse Event|15
319898|NCT00700817|1048017|P1|Week 0-26 (Main Period)|Adverse Event|14
319899|NCT00700804|1048399|P2|Overall Study|Loose Stools|1
319900|NCT00700804|1048400|P1|Overall Study|Loose Stools|1
319901|NCT00700804|1048399|P2|Overall Study|Protocol Violation|1
319902|NCT00700804|1048400|P1|Overall Study|Protocol Violation|1
319903|NCT00700804|1048399|P2|Overall Study|Withdrawal by Subject|2
319904|NCT00700804|1048400|P1|Overall Study|Withdrawal by Subject|1
319905|NCT00700752|1048408|P2|First Intervention|Withdrawal by Subject|2
319906|NCT00700752|1048409|P1|First Intervention|Withdrawal by Subject|0
319907|NCT00700739|1048417|P2|Overall Study|Lost to Follow-up|4
319908|NCT00700739|1048418|P1|Overall Study|Lost to Follow-up|4
319909|NCT00700713|1048457|P3|Overall Study|Withdrawal by Subject|1
319910|NCT00700713|1048458|P2|Overall Study|Withdrawal by Subject|0
319911|NCT00700713|1048459|P1|Overall Study|Withdrawal by Subject|0
319912|NCT00700713|1048457|P3|Overall Study|Protocol Violation|1
319913|NCT00700713|1048458|P2|Overall Study|Protocol Violation|0
319914|NCT00700713|1048459|P1|Overall Study|Protocol Violation|1
319915|NCT00700635|1048476|P3|Overall Study|Withdrawal by Subject|1
319916|NCT00700635|1048477|P2|Overall Study|Withdrawal by Subject|3
319917|NCT00700635|1048478|P1|Overall Study|Withdrawal by Subject|7
319918|NCT00700635|1048476|P3|Overall Study|Protocol Violation|0
319919|NCT00700635|1048477|P2|Overall Study|Protocol Violation|2
319920|NCT00700635|1048478|P1|Overall Study|Protocol Violation|2
319921|NCT00700635|1048476|P3|Overall Study|Lost to Follow-up|0
319922|NCT00700635|1048477|P2|Overall Study|Lost to Follow-up|3
319923|NCT00700635|1048478|P1|Overall Study|Lost to Follow-up|1
319924|NCT00700635|1048476|P3|Overall Study|Adverse Event|0
319925|NCT00700635|1048477|P2|Overall Study|Adverse Event|0
319926|NCT00700635|1048478|P1|Overall Study|Adverse Event|1
319927|NCT00700622|1048500|P2|Overall Study|Other|1
319928|NCT00700622|1048501|P1|Overall Study|Other|3
319929|NCT00700622|1048500|P2|Overall Study|Withdrawal by Subject|1
319930|NCT00700622|1048501|P1|Overall Study|Withdrawal by Subject|4
319931|NCT00700622|1048500|P2|Overall Study|Protocol Violation|1
319932|NCT00700622|1048501|P1|Overall Study|Protocol Violation|0
319933|NCT00700622|1048500|P2|Overall Study|Physician Decision|1
319934|NCT00700622|1048501|P1|Overall Study|Physician Decision|2
319935|NCT00700622|1048500|P2|Overall Study|Lost to Follow-up|1
319936|NCT00700622|1048501|P1|Overall Study|Lost to Follow-up|0
319937|NCT00700622|1048500|P2|Overall Study|Adverse Event|0
319938|NCT00700622|1048501|P1|Overall Study|Adverse Event|4
319939|NCT00700570|1048509|P2|Overall Study|Withdrawal by Subject|6
319940|NCT00700570|1048510|P1|Overall Study|Withdrawal by Subject|1
319941|NCT00700570|1048509|P2|Overall Study|Disease Progression|11
319942|NCT00700570|1048510|P1|Overall Study|Disease Progression|8
319943|NCT00700570|1048509|P2|Overall Study|Discretion of Investigator or Sponsor|3
319944|NCT00700570|1048510|P1|Overall Study|Discretion of Investigator or Sponsor|0
319945|NCT00700570|1048509|P2|Overall Study|Adverse Event|6
319946|NCT00700570|1048510|P1|Overall Study|Adverse Event|2
319947|NCT00700427|1048526|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
319948|NCT00700427|1048527|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
319949|NCT00700427|1048528|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
319950|NCT00700427|1048529|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
319951|NCT00700427|1048530|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
319952|NCT00700427|1048526|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
319953|NCT00700427|1048527|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
319954|NCT00700427|1048528|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
319955|NCT00700427|1048529|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
319956|NCT00700427|1048530|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
319957|NCT00700427|1048526|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
319958|NCT00700427|1048527|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
319959|NCT00700427|1048528|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
319960|NCT00700427|1048529|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
319961|NCT00700427|1048530|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
319962|NCT00700427|1048526|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
319963|NCT00700427|1048527|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
319964|NCT00700427|1048528|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
319965|NCT00700427|1048529|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
319966|NCT00700427|1048530|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
319967|NCT00700427|1048526|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
319968|NCT00700427|1048527|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
319969|NCT00700427|1048528|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
319970|NCT00700427|1048529|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
319971|NCT00700427|1048530|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
319972|NCT00700427|1048526|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
319973|NCT00700427|1048527|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
319974|NCT00700427|1048528|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
319975|NCT00700427|1048529|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
319976|NCT00700427|1048530|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
319977|NCT00700427|1048526|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
319978|NCT00700427|1048527|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
319979|NCT00700427|1048528|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
319980|NCT00700427|1048529|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
319981|NCT00700427|1048530|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
319982|NCT00700427|1048526|P5|Study Period 4 (Open-Label Extension)|Death|1
319983|NCT00700427|1048527|P4|Study Period 4 (Open-Label Extension)|Death|0
319984|NCT00700427|1048528|P3|Study Period 4 (Open-Label Extension)|Death|0
319985|NCT00700427|1048529|P2|Study Period 4 (Open-Label Extension)|Death|0
319986|NCT00700427|1048530|P1|Study Period 4 (Open-Label Extension)|Death|0
319987|NCT00700427|1048526|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
319988|NCT00700427|1048527|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
319989|NCT00700427|1048528|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
319990|NCT00700427|1048529|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
319991|NCT00700427|1048530|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
319992|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Death|0
319993|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Death|0
319994|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Death|1
319995|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Death|0
319996|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Death|0
319997|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
319998|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
319999|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
320000|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
320001|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
320002|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
320003|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
320004|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
320005|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
320006|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
320007|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
320008|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
320009|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
320010|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
320011|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
320012|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
320013|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
320014|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
320015|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
320016|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
320017|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
320018|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
320019|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
320020|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
320021|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
320022|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
320023|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
320024|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
320025|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
320026|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
320027|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
320028|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
320029|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
320030|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
320031|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
320032|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
320033|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
320034|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
320035|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
320036|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
320037|NCT00700427|1048526|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
320038|NCT00700427|1048527|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
320039|NCT00700427|1048528|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
320040|NCT00700427|1048529|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
320041|NCT00700427|1048530|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
320042|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
320043|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
320044|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
320045|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
320046|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
320047|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
320048|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
320049|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
320050|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
320051|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
320052|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
320053|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
320054|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
320055|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
320056|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
320057|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
320058|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
320059|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
320060|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
320061|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
320062|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
320063|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
320064|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
320065|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
320066|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
320067|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
320068|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
320069|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
320070|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
320071|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
320072|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
320073|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
320074|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
320075|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
320076|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
320077|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
320078|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
320079|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
320080|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
320081|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
320082|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
320083|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
320084|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
320085|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
320086|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
320087|NCT00700427|1048526|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
320088|NCT00700427|1048527|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
320089|NCT00700427|1048528|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
320090|NCT00700427|1048529|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
320091|NCT00700427|1048530|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
320092|NCT00700427|1048526|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
320093|NCT00700427|1048527|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
320094|NCT00700427|1048528|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
320095|NCT00700427|1048529|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
320096|NCT00700427|1048530|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
320097|NCT00700427|1048526|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
320098|NCT00700427|1048527|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
320099|NCT00700427|1048528|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
320100|NCT00700427|1048529|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
320101|NCT00700427|1048530|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
320102|NCT00700427|1048526|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
320103|NCT00700427|1048527|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
320104|NCT00700427|1048528|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
320105|NCT00700427|1048529|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
320106|NCT00700427|1048530|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
320107|NCT00700427|1048526|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
320108|NCT00700427|1048527|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
320109|NCT00700427|1048528|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
320110|NCT00700427|1048529|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
320111|NCT00700427|1048530|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
320112|NCT00700427|1048526|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
320113|NCT00700427|1048527|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
320114|NCT00700427|1048528|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
320115|NCT00700427|1048529|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
320116|NCT00700427|1048530|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
320117|NCT00700427|1048526|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
320118|NCT00700427|1048527|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
320119|NCT00700427|1048528|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
320120|NCT00700427|1048529|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
320121|NCT00700427|1048530|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
320122|NCT00700427|1048526|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
320123|NCT00700427|1048527|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
320124|NCT00700427|1048528|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
320125|NCT00700427|1048529|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
320126|NCT00700427|1048530|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
320127|NCT00700427|1048526|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
320128|NCT00700427|1048527|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
320129|NCT00700427|1048528|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
320130|NCT00700427|1048529|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
320131|NCT00700427|1048530|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
320132|NCT00700427|1048526|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
320133|NCT00700427|1048527|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
320134|NCT00700427|1048528|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
320135|NCT00700427|1048529|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
320136|NCT00700427|1048530|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
320137|NCT00700401|1048552|P1|Overall Study|Withdrawal by Subject|2
320138|NCT00700401|1048552|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
320139|NCT00700401|1048552|P1|Overall Study|Treatment never started|1
320140|NCT00700401|1048552|P1|Overall Study|Lost to Follow-up|1
320141|NCT00700401|1048552|P1|Overall Study|Refused Treatment|2
320142|NCT00700401|1048552|P1|Overall Study|Adverse Event|5
320143|NCT00700401|1048552|P1|Overall Study|Detectable HCV RNA after Week 4|82
320144|NCT00700310|1048576|P4|Overall Study|Randomized, Not Treated|2
320145|NCT00700310|1048577|P3|Overall Study|Randomized, Not Treated|2
320146|NCT00700310|1048578|P2|Overall Study|Randomized, Not Treated|0
320147|NCT00700310|1048579|P1|Overall Study|Randomized, Not Treated|2
320148|NCT00700310|1048576|P4|Overall Study|Administrative/Other|3
320149|NCT00700310|1048577|P3|Overall Study|Administrative/Other|1
320150|NCT00700310|1048578|P2|Overall Study|Administrative/Other|3
320151|NCT00700310|1048579|P1|Overall Study|Administrative/Other|1
320152|NCT00700310|1048576|P4|Overall Study|Lack of Efficacy|1
320153|NCT00700310|1048577|P3|Overall Study|Lack of Efficacy|0
320154|NCT00700310|1048578|P2|Overall Study|Lack of Efficacy|3
320155|NCT00700310|1048579|P1|Overall Study|Lack of Efficacy|0
320156|NCT00700310|1048576|P4|Overall Study|Withdrawal by Subject|8
320157|NCT00700310|1048577|P3|Overall Study|Withdrawal by Subject|8
320158|NCT00700310|1048578|P2|Overall Study|Withdrawal by Subject|9
320159|NCT00700310|1048579|P1|Overall Study|Withdrawal by Subject|8
320160|NCT00700310|1048576|P4|Overall Study|Lost to Follow-up|1
320161|NCT00700310|1048577|P3|Overall Study|Lost to Follow-up|0
320162|NCT00700310|1048578|P2|Overall Study|Lost to Follow-up|1
320163|NCT00700310|1048579|P1|Overall Study|Lost to Follow-up|4
320164|NCT00700310|1048576|P4|Overall Study|Adverse Event|11
320165|NCT00700310|1048577|P3|Overall Study|Adverse Event|5
320166|NCT00700310|1048578|P2|Overall Study|Adverse Event|10
320167|NCT00700310|1048579|P1|Overall Study|Adverse Event|6
320168|NCT00700271|1048599|P2|Overall Study|Lost to Follow-up|2
320169|NCT00700271|1048600|P1|Overall Study|Lost to Follow-up|2
320170|NCT00700271|1048599|P2|Overall Study|Withdrawal by Subject|4
320171|NCT00700271|1048600|P1|Overall Study|Withdrawal by Subject|6
320172|NCT00700271|1048599|P2|Overall Study|Administrative Reasons|0
320173|NCT00700271|1048600|P1|Overall Study|Administrative Reasons|1
320174|NCT00700271|1048599|P2|Overall Study|Protocol Violation|0
320175|NCT00700271|1048600|P1|Overall Study|Protocol Violation|1
320176|NCT00700271|1048599|P2|Overall Study|Adverse Event|6
320177|NCT00700271|1048600|P1|Overall Study|Adverse Event|4
320178|NCT00700180|1048628|P2|Overall Study|Lost to Follow-up|5
320179|NCT00700180|1048629|P1|Overall Study|Lost to Follow-up|4
320180|NCT00700180|1048628|P2|Overall Study|Alive in follow-up|27
320181|NCT00700180|1048629|P1|Overall Study|Alive in follow-up|46
320182|NCT00700180|1048628|P2|Overall Study|Alive on treatment|3
320183|NCT00700180|1048629|P1|Overall Study|Alive on treatment|5
320184|NCT00700180|1048628|P2|Overall Study|Death|114
320185|NCT00700180|1048629|P1|Overall Study|Death|99
320186|NCT00700115|1048658|P2|Overall Study|Lost to Follow-up|1
320187|NCT00700115|1048659|P1|Overall Study|Lost to Follow-up|0
320188|NCT00700115|1048658|P2|Overall Study|Withdrawal by Subject|0
320189|NCT00700115|1048659|P1|Overall Study|Withdrawal by Subject|1
320190|NCT00700102|1048669|P2|Overall Study|Lost to Follow-up|10
320191|NCT00700102|1048670|P1|Overall Study|Lost to Follow-up|8
320192|NCT00700102|1048669|P2|Overall Study|Died|385
320193|NCT00700102|1048670|P1|Overall Study|Died|394
320194|NCT00700011|1048809|P2|Overall Study|Death|1
320195|NCT00700011|1048810|P1|Overall Study|Death|0
320196|NCT00699998|1048826|P4|Overall Study|Lost to Follow-up|1
320197|NCT00699998|1048827|P3|Overall Study|Lost to Follow-up|3
320198|NCT00699998|1048828|P2|Overall Study|Lost to Follow-up|1
320199|NCT00699998|1048829|P1|Overall Study|Lost to Follow-up|2
320200|NCT00699998|1048826|P4|Overall Study|Physician Decision|1
320201|NCT00699998|1048827|P3|Overall Study|Physician Decision|1
320202|NCT00699998|1048828|P2|Overall Study|Physician Decision|2
320203|NCT00699998|1048829|P1|Overall Study|Physician Decision|3
320204|NCT00699998|1048826|P4|Overall Study|Withdrawal by Subject|80
320205|NCT00699998|1048827|P3|Overall Study|Withdrawal by Subject|202
320206|NCT00699998|1048828|P2|Overall Study|Withdrawal by Subject|83
320207|NCT00699998|1048829|P1|Overall Study|Withdrawal by Subject|194
320208|NCT00699972|1048874|P3|Overall Study|Randomized, Not Treated|1
320209|NCT00699972|1048875|P2|Overall Study|Randomized, Not Treated|0
320210|NCT00699972|1048876|P1|Overall Study|Randomized, Not Treated|1
320211|NCT00699972|1048874|P3|Overall Study|Administrative/Other|4
320212|NCT00699972|1048875|P2|Overall Study|Administrative/Other|1
320213|NCT00699972|1048876|P1|Overall Study|Administrative/Other|3
320214|NCT00699972|1048874|P3|Overall Study|Lack of Efficacy|2
320215|NCT00699972|1048875|P2|Overall Study|Lack of Efficacy|0
320216|NCT00699972|1048876|P1|Overall Study|Lack of Efficacy|2
320217|NCT00699972|1048874|P3|Overall Study|Withdrawal by Subject|4
320218|NCT00699972|1048875|P2|Overall Study|Withdrawal by Subject|7
320219|NCT00699972|1048876|P1|Overall Study|Withdrawal by Subject|3
320220|NCT00699972|1048874|P3|Overall Study|Lost to Follow-up|0
320221|NCT00699972|1048875|P2|Overall Study|Lost to Follow-up|2
320222|NCT00699972|1048876|P1|Overall Study|Lost to Follow-up|0
320223|NCT00699972|1048874|P3|Overall Study|Adverse Event|24
320224|NCT00699972|1048875|P2|Overall Study|Adverse Event|9
320225|NCT00699972|1048876|P1|Overall Study|Adverse Event|7
320226|NCT00699842|1048893|P3|Overall Study|Death|0
320227|NCT00699842|1048894|P2|Overall Study|Death|1
320228|NCT00699842|1048895|P1|Overall Study|Death|0
320229|NCT00699816|1048908|P2|Overall Study|Protocol Violation|3
320230|NCT00699816|1048909|P1|Overall Study|Protocol Violation|1
320231|NCT00699751|1048927|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
320232|NCT00699751|1048928|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
320233|NCT00699751|1048927|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
320234|NCT00699751|1048928|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
320235|NCT00699751|1048927|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
320236|NCT00699751|1048928|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
320237|NCT00699751|1048927|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
320238|NCT00699751|1048928|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
320239|NCT00699751|1048927|P2|Period 1: Without/Before Drug Switch|Unspecified|20
320240|NCT00699751|1048928|P1|Period 1: Without/Before Drug Switch|Unspecified|30
320241|NCT00699751|1048927|P2|Period 1: Without/Before Drug Switch|Subject Request|23
320242|NCT00699751|1048928|P1|Period 1: Without/Before Drug Switch|Subject Request|43
320243|NCT00699751|1048927|P2|Period 1: Without/Before Drug Switch|Death|29
320244|NCT00699751|1048928|P1|Period 1: Without/Before Drug Switch|Death|28
320245|NCT00699751|1048927|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
320246|NCT00699751|1048928|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
320247|NCT00699699|1049013|P1|Overall Study|Individual different reasons|21
320248|NCT00699699|1049013|P1|Overall Study|Adverse Event|36
320249|NCT00699660|1049022|P2|Overall Study|missing reports and recording failures|6
320250|NCT00699660|1049023|P1|Overall Study|missing reports and recording failures|10
320251|NCT00699660|1049022|P2|Overall Study|Lost to Follow-up|2
320252|NCT00699660|1049023|P1|Overall Study|Lost to Follow-up|4
320253|NCT00699608|1049035|P6|Second Intervention|Withdrawal by Subject|0
320254|NCT00699608|1049036|P5|Second Intervention|Withdrawal by Subject|0
320255|NCT00699608|1049037|P4|Second Intervention|Withdrawal by Subject|1
320256|NCT00699608|1049038|P3|Second Intervention|Withdrawal by Subject|0
320257|NCT00699608|1049039|P2|Second Intervention|Withdrawal by Subject|0
320258|NCT00699608|1049040|P1|Second Intervention|Withdrawal by Subject|0
320259|NCT00699608|1049035|P6|Second Intervention|Adverse Event|0
320260|NCT00699608|1049036|P5|Second Intervention|Adverse Event|0
320261|NCT00699608|1049037|P4|Second Intervention|Adverse Event|0
320262|NCT00699608|1049038|P3|Second Intervention|Adverse Event|1
320263|NCT00699608|1049039|P2|Second Intervention|Adverse Event|0
320264|NCT00699608|1049040|P1|Second Intervention|Adverse Event|0
320265|NCT00699608|1049035|P6|First Intervention|Protocol Violation|0
320266|NCT00699608|1049036|P5|First Intervention|Protocol Violation|1
320267|NCT00699608|1049037|P4|First Intervention|Protocol Violation|0
320268|NCT00699608|1049038|P3|First Intervention|Protocol Violation|0
320269|NCT00699608|1049039|P2|First Intervention|Protocol Violation|0
320270|NCT00699608|1049040|P1|First Intervention|Protocol Violation|0
320271|NCT00699608|1049035|P6|First Intervention|Withdrawal by Subject|0
320272|NCT00699608|1049036|P5|First Intervention|Withdrawal by Subject|0
320273|NCT00699608|1049037|P4|First Intervention|Withdrawal by Subject|0
320274|NCT00699608|1049038|P3|First Intervention|Withdrawal by Subject|1
320275|NCT00699608|1049039|P2|First Intervention|Withdrawal by Subject|0
320276|NCT00699608|1049040|P1|First Intervention|Withdrawal by Subject|0
320277|NCT00699582|1049093|P3|Overall Study|Randomized, Not Treated|0
320278|NCT00699582|1049094|P2|Overall Study|Randomized, Not Treated|1
320279|NCT00699582|1049095|P1|Overall Study|Randomized, Not Treated|2
320280|NCT00699582|1049093|P3|Overall Study|Administrative/Other|0
320281|NCT00699582|1049094|P2|Overall Study|Administrative/Other|3
320282|NCT00699582|1049095|P1|Overall Study|Administrative/Other|4
320283|NCT00699582|1049093|P3|Overall Study|Progressive Disease|0
320284|NCT00699582|1049094|P2|Overall Study|Progressive Disease|0
320285|NCT00699582|1049095|P1|Overall Study|Progressive Disease|1
320286|NCT00699582|1049093|P3|Overall Study|Lack of Efficacy|1
320287|NCT00699582|1049094|P2|Overall Study|Lack of Efficacy|0
320288|NCT00699582|1049095|P1|Overall Study|Lack of Efficacy|1
320289|NCT00699582|1049093|P3|Overall Study|Withdrawal by Subject|4
320290|NCT00699582|1049094|P2|Overall Study|Withdrawal by Subject|7
320291|NCT00699582|1049095|P1|Overall Study|Withdrawal by Subject|6
320292|NCT00699582|1049093|P3|Overall Study|Adverse Event|23
320293|NCT00699582|1049094|P2|Overall Study|Adverse Event|11
320294|NCT00699582|1049095|P1|Overall Study|Adverse Event|4
320295|NCT00699374|1049190|P2|Overall Study|Died 28 days after last dose|9
320296|NCT00699374|1049191|P1|Overall Study|Died 28 days after last dose|5
320297|NCT00699374|1049190|P2|Overall Study|Randomized but not treated|2
320298|NCT00699374|1049191|P1|Overall Study|Randomized but not treated|4
320299|NCT00699374|1049190|P2|Overall Study|Study terminated by sponsor|28
320300|NCT00699374|1049191|P1|Overall Study|Study terminated by sponsor|13
320301|NCT00699374|1049190|P2|Overall Study|Protocol Violation|6
320302|NCT00699374|1049191|P1|Overall Study|Protocol Violation|2
320303|NCT00699374|1049190|P2|Overall Study|Unspecified|15
320304|NCT00699374|1049191|P1|Overall Study|Unspecified|18
320305|NCT00699374|1049190|P2|Overall Study|Objective progression or relapse|277
320306|NCT00699374|1049191|P1|Overall Study|Objective progression or relapse|281
320307|NCT00699374|1049190|P2|Overall Study|Withdrawal by Subject|44
320308|NCT00699374|1049191|P1|Overall Study|Withdrawal by Subject|34
320309|NCT00699374|1049190|P2|Overall Study|Lost to Follow-up|5
320310|NCT00699374|1049191|P1|Overall Study|Lost to Follow-up|3
320311|NCT00699374|1049190|P2|Overall Study|Global deterioration of health status|8
320312|NCT00699374|1049191|P1|Overall Study|Global deterioration of health status|7
320313|NCT00699374|1049190|P2|Overall Study|Adverse Event|67
320314|NCT00699374|1049191|P1|Overall Study|Adverse Event|70
320315|NCT00699374|1049190|P2|Overall Study|Death|83
320316|NCT00699374|1049191|P1|Overall Study|Death|93
320317|NCT00699348|1049203|P1|Overall Study|Unspecified|5
320318|NCT00699348|1049203|P1|Overall Study|Renal transplantation|10
320319|NCT00699348|1049203|P1|Overall Study|Blood transfusion|24
320320|NCT00699348|1049203|P1|Overall Study|Failure to return|1
320321|NCT00699348|1049203|P1|Overall Study|Lack of Efficacy|8
320322|NCT00699348|1049203|P1|Overall Study|Protocol Violation|10
320323|NCT00699348|1049203|P1|Overall Study|Withdrawal by Subject|11
320324|NCT00699348|1049203|P1|Overall Study|Adverse Event|15
320325|NCT00699348|1049203|P1|Overall Study|Death|6
320326|NCT00699335|1049212|P1|Overall Study|Missing data|52
320327|NCT00699335|1049212|P1|Overall Study|Combination of multiple reasons|176
320328|NCT00699283|1049245|P2|Overall Study|AE of unknown type|0
320329|NCT00699283|1049246|P1|Overall Study|AE of unknown type|1
320330|NCT00699283|1049245|P2|Overall Study|AE, non-serious non-fatal|1
320331|NCT00699283|1049246|P1|Overall Study|AE, non-serious non-fatal|8
320332|NCT00699283|1049245|P2|Overall Study|SAE, non-fatal|1
320333|NCT00699283|1049246|P1|Overall Study|SAE, non-fatal|1
320334|NCT00699283|1049245|P2|Overall Study|Other Reason|1
320335|NCT00699283|1049246|P1|Overall Study|Other Reason|5
320336|NCT00699283|1049245|P2|Overall Study|Withdrawal by Subject|0
320337|NCT00699283|1049246|P1|Overall Study|Withdrawal by Subject|1
320338|NCT00699283|1049245|P2|Overall Study|Lost to Follow-up|0
320339|NCT00699283|1049246|P1|Overall Study|Lost to Follow-up|2
320340|NCT00699283|1049245|P2|Overall Study|Lack of Efficacy|5
320341|NCT00699283|1049246|P1|Overall Study|Lack of Efficacy|15
320342|NCT00699192|1049254|P3|Overall Study|Protocol Violation|0
320343|NCT00699192|1049255|P2|Overall Study|Protocol Violation|2
320344|NCT00699192|1049256|P1|Overall Study|Protocol Violation|2
320345|NCT00699192|1049254|P3|Overall Study|Administrative problems|1
320346|NCT00699192|1049255|P2|Overall Study|Administrative problems|3
320347|NCT00699192|1049256|P1|Overall Study|Administrative problems|1
320348|NCT00699192|1049254|P3|Overall Study|Withdrawal by Subject|4
320349|NCT00699192|1049255|P2|Overall Study|Withdrawal by Subject|2
320350|NCT00699192|1049256|P1|Overall Study|Withdrawal by Subject|3
320351|NCT00699192|1049254|P3|Overall Study|Lack of Efficacy|1
320352|NCT00699192|1049255|P2|Overall Study|Lack of Efficacy|0
320353|NCT00699192|1049256|P1|Overall Study|Lack of Efficacy|0
320354|NCT00699192|1049254|P3|Overall Study|Abnormal test procedure result(s)|1
320355|NCT00699192|1049255|P2|Overall Study|Abnormal test procedure result(s)|0
320356|NCT00699192|1049256|P1|Overall Study|Abnormal test procedure result(s)|0
320357|NCT00699192|1049254|P3|Overall Study|Adverse Event|3
320358|NCT00699192|1049255|P2|Overall Study|Adverse Event|4
320359|NCT00699192|1049256|P1|Overall Study|Adverse Event|9
320360|NCT00699192|1049254|P3|Overall Study|Missing|1
320361|NCT00699192|1049255|P2|Overall Study|Missing|1
320362|NCT00699192|1049256|P1|Overall Study|Missing|1
320363|NCT00699153|1049278|P2|Overall Study|Travel Problem|0
320364|NCT00699153|1049279|P1|Overall Study|Travel Problem|1
320365|NCT00699153|1049278|P2|Overall Study|Protocol Violation|0
320366|NCT00699153|1049279|P1|Overall Study|Protocol Violation|1
320367|NCT00699153|1049278|P2|Overall Study|Adverse Event|2
320368|NCT00699153|1049279|P1|Overall Study|Adverse Event|0
320369|NCT00699153|1049278|P2|Overall Study|Lost to Follow-up|0
320370|NCT00699153|1049279|P1|Overall Study|Lost to Follow-up|1
320371|NCT00698932|1049305|P2|Overall Study|Death|0
320372|NCT00698932|1049306|P1|Overall Study|Death|1
320373|NCT00698932|1049305|P2|Overall Study|Safety reasons|2
320374|NCT00698932|1049306|P1|Overall Study|Safety reasons|0
320375|NCT00698932|1049305|P2|Overall Study|Severe non-compliance to protocol|2
320376|NCT00698932|1049306|P1|Overall Study|Severe non-compliance to protocol|1
320377|NCT00698932|1049305|P2|Overall Study|Lost to Follow-up|1
320378|NCT00698932|1049306|P1|Overall Study|Lost to Follow-up|6
320379|NCT00698932|1049305|P2|Overall Study|Withdrawal by Subject|23
320380|NCT00698932|1049306|P1|Overall Study|Withdrawal by Subject|11
320381|NCT00698932|1049305|P2|Overall Study|Study specific discontinuation criteria|4
320382|NCT00698932|1049306|P1|Overall Study|Study specific discontinuation criteria|3
320383|NCT00698932|1049305|P2|Overall Study|Incorrect enrollment|2
320384|NCT00698932|1049306|P1|Overall Study|Incorrect enrollment|0
320385|NCT00698932|1049305|P2|Overall Study|Adverse Event|2
320386|NCT00698932|1049306|P1|Overall Study|Adverse Event|0
320387|NCT00698841|1049322|P1|Overall Study|Other|2
320388|NCT00698841|1049322|P1|Overall Study|Study drug toxicity|2
320389|NCT00698841|1049322|P1|Overall Study|Failure to meet eligibility criteria|2
320390|NCT00698841|1049322|P1|Overall Study|Disease progression|7
320391|NCT00698841|1049322|P1|Overall Study|Adverse Event|3
320392|NCT00698841|1049322|P1|Overall Study|Withdrawal by Subject|2
320393|NCT00698815|1049336|P3|Overall Study|Did not receive protocol treatment|2
320394|NCT00698815|1049337|P2|Overall Study|Did not receive protocol treatment|2
320395|NCT00698815|1049338|P1|Overall Study|Did not receive protocol treatment|1
320396|NCT00698815|1049336|P3|Overall Study|MD discretion|2
320397|NCT00698815|1049337|P2|Overall Study|MD discretion|7
320398|NCT00698815|1049338|P1|Overall Study|MD discretion|2
320399|NCT00698815|1049336|P3|Overall Study|Withdrawal by Subject|2
320400|NCT00698815|1049337|P2|Overall Study|Withdrawal by Subject|3
320401|NCT00698815|1049338|P1|Overall Study|Withdrawal by Subject|6
320402|NCT00698815|1049336|P3|Overall Study|Death|4
320403|NCT00698815|1049337|P2|Overall Study|Death|2
320404|NCT00698815|1049338|P1|Overall Study|Death|1
320405|NCT00698685|1049355|P1|Overall Study|Off study pre transplant by clinic MD|1
320406|NCT00698685|1049355|P1|Overall Study|Sister withdrew as donor|1
320407|NCT00698646|1049363|P3|Overall Study|Administrative problems|1
320408|NCT00698646|1049364|P2|Overall Study|Administrative problems|0
320409|NCT00698646|1049365|P1|Overall Study|Administrative problems|1
320410|NCT00698646|1049363|P3|Overall Study|Lost to Follow-up|2
320411|NCT00698646|1049364|P2|Overall Study|Lost to Follow-up|0
320412|NCT00698646|1049365|P1|Overall Study|Lost to Follow-up|0
320413|NCT00698646|1049363|P3|Overall Study|Withdrawal by Subject|8
320414|NCT00698646|1049364|P2|Overall Study|Withdrawal by Subject|11
320415|NCT00698646|1049365|P1|Overall Study|Withdrawal by Subject|10
320416|NCT00698646|1049363|P3|Overall Study|Protocol Deviation|3
320417|NCT00698646|1049364|P2|Overall Study|Protocol Deviation|2
320418|NCT00698646|1049365|P1|Overall Study|Protocol Deviation|6
320419|NCT00698646|1049363|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
320420|NCT00698646|1049364|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
320421|NCT00698646|1049365|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
320422|NCT00698646|1049363|P3|Overall Study|Adverse Event|8
320423|NCT00698646|1049364|P2|Overall Study|Adverse Event|7
320424|NCT00698646|1049365|P1|Overall Study|Adverse Event|8
320425|NCT00698581|1049390|P2|Overall Study|AE of unknown type|0
320426|NCT00698581|1049391|P1|Overall Study|AE of unknown type|1
320427|NCT00698581|1049390|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
320428|NCT00698581|1049391|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
320429|NCT00698581|1049390|P2|Overall Study|AE, non-serious non-fatal|0
320430|NCT00698581|1049391|P1|Overall Study|AE, non-serious non-fatal|4
320431|NCT00698581|1049390|P2|Overall Study|SAE, non-fatal|0
320432|NCT00698581|1049391|P1|Overall Study|SAE, non-fatal|1
320433|NCT00698581|1049390|P2|Overall Study|Other reason|1
320434|NCT00698581|1049391|P1|Overall Study|Other reason|9
320435|NCT00698581|1049390|P2|Overall Study|Withdrawal by Subject|0
320436|NCT00698581|1049391|P1|Overall Study|Withdrawal by Subject|6
320437|NCT00698581|1049390|P2|Overall Study|Lack of Efficacy|11
320438|NCT00698581|1049391|P1|Overall Study|Lack of Efficacy|23
320439|NCT00698516|1049402|P1|Overall Study|Withdrawal by Subject|3
320440|NCT00698516|1049402|P1|Overall Study|Study Termination|2
320441|NCT00698451|1049420|P1|Overall Study|Disease progression|3
320442|NCT00698451|1049420|P1|Overall Study|Withdrawal by Subject|6
320443|NCT00698451|1049420|P1|Overall Study|Protocol Violation|6
320444|NCT00698451|1049420|P1|Overall Study|Physician Decision|2
320445|NCT00698451|1049420|P1|Overall Study|Adverse Event|22
320446|NCT00698204|1049427|P2|Overall Study|Withdrawal by Subject|0
320447|NCT00698204|1049428|P1|Overall Study|Withdrawal by Subject|1
320448|NCT00698009|1049488|P1|Overall Study|Withdrawal by Subject|1
320449|NCT00697827|1049494|P2|Overall Study|enrolled but not treated|1
320450|NCT00697827|1049495|P1|Overall Study|enrolled but not treated|2
320451|NCT00697619|1049535|P2|Overall Study|Adverse Event|6
320452|NCT00697619|1049536|P1|Overall Study|Adverse Event|4
320453|NCT00697619|1049535|P2|Overall Study|Lack of Efficacy|2
320454|NCT00697619|1049536|P1|Overall Study|Lack of Efficacy|2
320455|NCT00697593|1049542|P1|Overall Study|Suspension of the study by sponsor|12
320456|NCT00697593|1049542|P1|Overall Study|Lack of Efficacy|3
320457|NCT00697593|1049542|P1|Overall Study|Protocol Violation|1
320458|NCT00697593|1049542|P1|Overall Study|Adverse Event|3
320459|NCT00697515|1049586|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
320460|NCT00697515|1049587|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
320461|NCT00697515|1049586|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
320462|NCT00697515|1049587|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
320463|NCT00697515|1049586|P2|First Intervention (Crossover Period)|Adverse Event|2
320464|NCT00697515|1049587|P1|First Intervention (Crossover Period)|Adverse Event|0
320465|NCT00697515|1049586|P2|First Intervention (Crossover Period)|Natural disaster|9
320466|NCT00697515|1049587|P1|First Intervention (Crossover Period)|Natural disaster|8
320467|NCT00697515|1049586|P2|Dose Optimization Period|elevated QTc|0
320468|NCT00697515|1049587|P1|Dose Optimization Period|elevated QTc|1
320469|NCT00697515|1049586|P2|Dose Optimization Period|called to active duty|0
320470|NCT00697515|1049587|P1|Dose Optimization Period|called to active duty|1
320471|NCT00697515|1049586|P2|Dose Optimization Period|sponsor request|0
320472|NCT00697515|1049587|P1|Dose Optimization Period|sponsor request|2
320473|NCT00697515|1049586|P2|Dose Optimization Period|Lost to Follow-up|0
320474|NCT00697515|1049587|P1|Dose Optimization Period|Lost to Follow-up|2
320475|NCT00697515|1049586|P2|Dose Optimization Period|Withdrawal by Subject|0
320476|NCT00697515|1049587|P1|Dose Optimization Period|Withdrawal by Subject|5
320477|NCT00697515|1049586|P2|Dose Optimization Period|Adverse Event|0
320478|NCT00697515|1049587|P1|Dose Optimization Period|Adverse Event|4
320479|NCT00697255|1049617|P2|Stage 1b|Insufficient ovarian response|1
320480|NCT00697255|1049618|P1|Stage 1b|Insufficient ovarian response|0
320481|NCT00697255|1049617|P2|Stage 1b|Not growing of dominant follicle|1
320482|NCT00697255|1049618|P1|Stage 1b|Not growing of dominant follicle|0
320483|NCT00697255|1049617|P2|Stage 1a|Not growing of dominant follicle|0
320484|NCT00697255|1049618|P1|Stage 1a|Not growing of dominant follicle|1
320485|NCT00697255|1049617|P2|Stage 1a|Multifollicular growth|0
320486|NCT00697255|1049618|P1|Stage 1a|Multifollicular growth|1
320487|NCT00697255|1049617|P2|Stage 1a|Insufficient ovarian response|0
320488|NCT00697255|1049618|P1|Stage 1a|Insufficient ovarian response|1
320489|NCT00697112|1049669|P1|Overall Study|Did not meet inclusion criteria|1
320490|NCT00697112|1049669|P1|Overall Study|Lost to Follow-up|1
320491|NCT00697112|1049669|P1|Overall Study|Adverse Event|8
320492|NCT00697073|1049693|P1|Overall Study|non compliance and other|6
320493|NCT00697073|1049693|P1|Overall Study|Pregnancy|1
320494|NCT00697073|1049693|P1|Overall Study|Withdrawal by Subject|2
320495|NCT00696878|1049697|P1|Overall Study|Other reason (not specified)|55
320496|NCT00696878|1049697|P1|Overall Study|Trial stopped|32
320497|NCT00696878|1049697|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
320498|NCT00696878|1049697|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
320499|NCT00696878|1049697|P1|Overall Study|Withdrawal by Subject|87
320500|NCT00696878|1049697|P1|Overall Study|Adverse Event|8
320501|NCT00696800|1049771|P2|Overall Study|Not treated|2
320502|NCT00696800|1049772|P1|Overall Study|Not treated|1
320503|NCT00696800|1049771|P2|Overall Study|Other Reasons|3
320504|NCT00696800|1049772|P1|Overall Study|Other Reasons|5
320505|NCT00696800|1049771|P2|Overall Study|No/too few/bad quality embryos|18
320506|NCT00696800|1049772|P1|Overall Study|No/too few/bad quality embryos|24
320507|NCT00696800|1049771|P2|Overall Study|No/abnormal fertilization|13
320508|NCT00696800|1049772|P1|Overall Study|No/abnormal fertilization|11
320509|NCT00696800|1049771|P2|Overall Study|No/too few/bad quality oocytes|3
320510|NCT00696800|1049772|P1|Overall Study|No/too few/bad quality oocytes|4
320511|NCT00696800|1049771|P2|Overall Study|Too high ovarian response|1
320512|NCT00696800|1049772|P1|Overall Study|Too high ovarian response|6
320513|NCT00696800|1049771|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
320514|NCT00696800|1049772|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
320515|NCT00696800|1049771|P2|Overall Study|Insufficient ovarian response|1
320516|NCT00696800|1049772|P1|Overall Study|Insufficient ovarian response|4
320517|NCT00696800|1049771|P2|Overall Study|Insufficient ovarian response on Day 8|1
320518|NCT00696800|1049772|P1|Overall Study|Insufficient ovarian response on Day 8|4
320519|NCT00696800|1049771|P2|Overall Study|Insufficient compliance with medication|1
320520|NCT00696800|1049772|P1|Overall Study|Insufficient compliance with medication|2
320521|NCT00696800|1049771|P2|Overall Study|Adverse Event|3
320522|NCT00696800|1049772|P1|Overall Study|Adverse Event|16
320523|NCT00696787|1049825|P3|Overall Study|Failed to return|1
320524|NCT00696787|1049826|P2|Overall Study|Failed to return|3
320525|NCT00696787|1049827|P1|Overall Study|Failed to return|1
320526|NCT00696787|1049825|P3|Overall Study|Withdrawal by Subject|2
320527|NCT00696787|1049826|P2|Overall Study|Withdrawal by Subject|3
320528|NCT00696787|1049827|P1|Overall Study|Withdrawal by Subject|0
320529|NCT00696787|1049825|P3|Overall Study|Lost to Follow-up|3
320530|NCT00696787|1049826|P2|Overall Study|Lost to Follow-up|0
320531|NCT00696787|1049827|P1|Overall Study|Lost to Follow-up|4
320532|NCT00696787|1049825|P3|Overall Study|Lack of Efficacy|0
320533|NCT00696787|1049826|P2|Overall Study|Lack of Efficacy|1
320534|NCT00696787|1049827|P1|Overall Study|Lack of Efficacy|0
320535|NCT00696787|1049825|P3|Overall Study|Discontinuation by Sponsor|14
320536|NCT00696787|1049826|P2|Overall Study|Discontinuation by Sponsor|13
320537|NCT00696787|1049827|P1|Overall Study|Discontinuation by Sponsor|9
320538|NCT00696787|1049825|P3|Overall Study|Adverse Event|6
320539|NCT00696787|1049826|P2|Overall Study|Adverse Event|0
320540|NCT00696787|1049827|P1|Overall Study|Adverse Event|1
320541|NCT00696774|1049841|P3|Period III|Lack of Efficacy|0
320542|NCT00696774|1049842|P2|Period III|Lack of Efficacy|2
320543|NCT00696774|1049843|P1|Period III|Lack of Efficacy|0
320544|NCT00696774|1049841|P3|Period III|Sponsor Decision|0
320545|NCT00696774|1049842|P2|Period III|Sponsor Decision|0
320546|NCT00696774|1049843|P1|Period III|Sponsor Decision|2
320547|NCT00696774|1049841|P3|Period III|Withdrawal by Subject|0
320548|NCT00696774|1049842|P2|Period III|Withdrawal by Subject|2
320549|NCT00696774|1049843|P1|Period III|Withdrawal by Subject|1
320550|NCT00696774|1049841|P3|Period III|Protocol Violation|0
320551|NCT00696774|1049842|P2|Period III|Protocol Violation|1
320552|NCT00696774|1049843|P1|Period III|Protocol Violation|1
320553|NCT00696774|1049841|P3|Period III|Lost to Follow-up|0
320554|NCT00696774|1049842|P2|Period III|Lost to Follow-up|1
320555|NCT00696774|1049843|P1|Period III|Lost to Follow-up|2
320556|NCT00696774|1049841|P3|Period III|Adverse Event|0
320557|NCT00696774|1049842|P2|Period III|Adverse Event|1
320558|NCT00696774|1049843|P1|Period III|Adverse Event|1
320559|NCT00696774|1049841|P3|Period II|Lack of Efficacy|2
320560|NCT00696774|1049842|P2|Period II|Lack of Efficacy|0
320561|NCT00696774|1049843|P1|Period II|Lack of Efficacy|0
320562|NCT00696774|1049841|P3|Period II|Sponsor Decision|0
320563|NCT00696774|1049842|P2|Period II|Sponsor Decision|0
320564|NCT00696774|1049843|P1|Period II|Sponsor Decision|0
320565|NCT00696774|1049841|P3|Period II|Withdrawal by Subject|4
320566|NCT00696774|1049842|P2|Period II|Withdrawal by Subject|0
320567|NCT00696774|1049843|P1|Period II|Withdrawal by Subject|0
320568|NCT00696774|1049841|P3|Period II|Protocol Violation|11
320569|NCT00696774|1049842|P2|Period II|Protocol Violation|0
320570|NCT00696774|1049843|P1|Period II|Protocol Violation|0
320571|NCT00696774|1049841|P3|Period II|Lost to Follow-up|4
320572|NCT00696774|1049842|P2|Period II|Lost to Follow-up|0
320573|NCT00696774|1049843|P1|Period II|Lost to Follow-up|0
320574|NCT00696774|1049841|P3|Period II|Adverse Event|15
320575|NCT00696774|1049842|P2|Period II|Adverse Event|0
320576|NCT00696774|1049843|P1|Period II|Adverse Event|0
320577|NCT00696696|1049898|P1|Overall Study|Death|3
320578|NCT00696696|1049898|P1|Overall Study|Physician Decision|2
320579|NCT00696696|1049898|P1|Overall Study|Withdrawal by Subject|8
320580|NCT00696696|1049898|P1|Overall Study|Adverse Event|5
320581|NCT00696436|1049949|P5|Overall Study|Missing|0
320582|NCT00696436|1049950|P4|Overall Study|Missing|0
320583|NCT00696436|1049951|P3|Overall Study|Missing|1
320584|NCT00696436|1049952|P2|Overall Study|Missing|1
320585|NCT00696436|1049953|P1|Overall Study|Missing|0
320586|NCT00696436|1049949|P5|Overall Study|Administrative Decision|0
320587|NCT00696436|1049950|P4|Overall Study|Administrative Decision|0
320588|NCT00696436|1049951|P3|Overall Study|Administrative Decision|0
320589|NCT00696436|1049952|P2|Overall Study|Administrative Decision|0
320590|NCT00696436|1049953|P1|Overall Study|Administrative Decision|1
320591|NCT00696436|1049949|P5|Overall Study|Participant Non-compliance|0
320592|NCT00696436|1049950|P4|Overall Study|Participant Non-compliance|2
320593|NCT00696436|1049951|P3|Overall Study|Participant Non-compliance|1
320594|NCT00696436|1049952|P2|Overall Study|Participant Non-compliance|0
320595|NCT00696436|1049953|P1|Overall Study|Participant Non-compliance|0
320596|NCT00696436|1049949|P5|Overall Study|Administrative Error|0
320597|NCT00696436|1049950|P4|Overall Study|Administrative Error|0
320598|NCT00696436|1049951|P3|Overall Study|Administrative Error|2
320599|NCT00696436|1049952|P2|Overall Study|Administrative Error|0
320600|NCT00696436|1049953|P1|Overall Study|Administrative Error|2
320601|NCT00696436|1049949|P5|Overall Study|Participant Unavailability|0
320602|NCT00696436|1049950|P4|Overall Study|Participant Unavailability|1
320603|NCT00696436|1049951|P3|Overall Study|Participant Unavailability|2
320604|NCT00696436|1049952|P2|Overall Study|Participant Unavailability|0
320605|NCT00696436|1049953|P1|Overall Study|Participant Unavailability|2
320606|NCT00696436|1049949|P5|Overall Study|Lack of Efficacy|4
320607|NCT00696436|1049950|P4|Overall Study|Lack of Efficacy|2
320608|NCT00696436|1049951|P3|Overall Study|Lack of Efficacy|5
320609|NCT00696436|1049952|P2|Overall Study|Lack of Efficacy|1
320610|NCT00696436|1049953|P1|Overall Study|Lack of Efficacy|3
320611|NCT00696436|1049949|P5|Overall Study|Withdrawal by Subject|1
320612|NCT00696436|1049950|P4|Overall Study|Withdrawal by Subject|7
320613|NCT00696436|1049951|P3|Overall Study|Withdrawal by Subject|5
320614|NCT00696436|1049952|P2|Overall Study|Withdrawal by Subject|11
320615|NCT00696436|1049953|P1|Overall Study|Withdrawal by Subject|4
320616|NCT00696436|1049949|P5|Overall Study|Lost to Follow-up|3
320617|NCT00696436|1049950|P4|Overall Study|Lost to Follow-up|4
320618|NCT00696436|1049951|P3|Overall Study|Lost to Follow-up|2
320619|NCT00696436|1049952|P2|Overall Study|Lost to Follow-up|6
320620|NCT00696436|1049953|P1|Overall Study|Lost to Follow-up|1
320621|NCT00696436|1049949|P5|Overall Study|Protocol Violation|1
320622|NCT00696436|1049950|P4|Overall Study|Protocol Violation|0
320623|NCT00696436|1049951|P3|Overall Study|Protocol Violation|2
320624|NCT00696436|1049952|P2|Overall Study|Protocol Violation|2
320625|NCT00696436|1049953|P1|Overall Study|Protocol Violation|3
320626|NCT00696436|1049949|P5|Overall Study|Adverse Event|4
320627|NCT00696436|1049950|P4|Overall Study|Adverse Event|6
320628|NCT00696436|1049951|P3|Overall Study|Adverse Event|8
320629|NCT00696436|1049952|P2|Overall Study|Adverse Event|9
320630|NCT00696436|1049953|P1|Overall Study|Adverse Event|7
320631|NCT00696423|1050037|P2|Overall Study|Lost to Follow-up|5
320632|NCT00696423|1050038|P1|Overall Study|Lost to Follow-up|0
320633|NCT00696384|1050068|P3|Double Blind Phase|Physician Decision|0
320634|NCT00696384|1050069|P2|Double Blind Phase|Physician Decision|2
320635|NCT00696384|1050070|P1|Double Blind Phase|Physician Decision|0
320636|NCT00696384|1050068|P3|Double Blind Phase|Lack of Efficacy|0
320637|NCT00696384|1050069|P2|Double Blind Phase|Lack of Efficacy|1
320638|NCT00696384|1050070|P1|Double Blind Phase|Lack of Efficacy|0
320639|NCT00696384|1050068|P3|Double Blind Phase|Withdrawal by Subject|3
320640|NCT00696384|1050069|P2|Double Blind Phase|Withdrawal by Subject|4
320641|NCT00696384|1050070|P1|Double Blind Phase|Withdrawal by Subject|0
320642|NCT00696384|1050068|P3|Double Blind Phase|Lost to Follow-up|1
320643|NCT00696384|1050069|P2|Double Blind Phase|Lost to Follow-up|2
320644|NCT00696384|1050070|P1|Double Blind Phase|Lost to Follow-up|0
320645|NCT00696384|1050068|P3|Double Blind Phase|Adverse Event|2
320646|NCT00696384|1050069|P2|Double Blind Phase|Adverse Event|2
320647|NCT00696384|1050070|P1|Double Blind Phase|Adverse Event|0
320648|NCT00696384|1050068|P3|Open Label Phase|Physician Decision|0
320649|NCT00696384|1050069|P2|Open Label Phase|Physician Decision|0
320650|NCT00696384|1050070|P1|Open Label Phase|Physician Decision|4
320651|NCT00696384|1050068|P3|Open Label Phase|Lack of Efficacy|0
320652|NCT00696384|1050069|P2|Open Label Phase|Lack of Efficacy|0
320653|NCT00696384|1050070|P1|Open Label Phase|Lack of Efficacy|3
320654|NCT00696384|1050068|P3|Open Label Phase|Other|0
320655|NCT00696384|1050069|P2|Open Label Phase|Other|0
320656|NCT00696384|1050070|P1|Open Label Phase|Other|6
320657|NCT00696384|1050068|P3|Open Label Phase|Withdrawal by Subject|0
320658|NCT00696384|1050069|P2|Open Label Phase|Withdrawal by Subject|0
320659|NCT00696384|1050070|P1|Open Label Phase|Withdrawal by Subject|37
320660|NCT00696384|1050068|P3|Open Label Phase|Lost to Follow-up|0
320661|NCT00696384|1050069|P2|Open Label Phase|Lost to Follow-up|0
320662|NCT00696384|1050070|P1|Open Label Phase|Lost to Follow-up|24
320663|NCT00696384|1050068|P3|Open Label Phase|Protocol Violation|0
320664|NCT00696384|1050069|P2|Open Label Phase|Protocol Violation|0
320665|NCT00696384|1050070|P1|Open Label Phase|Protocol Violation|18
320666|NCT00696384|1050068|P3|Open Label Phase|Adverse Event|0
320667|NCT00696384|1050069|P2|Open Label Phase|Adverse Event|0
320668|NCT00696384|1050070|P1|Open Label Phase|Adverse Event|27
320669|NCT00696241|1050094|P5|Overall Study|Other|1
320670|NCT00696241|1050095|P4|Overall Study|Other|2
320671|NCT00696241|1050096|P3|Overall Study|Other|5
320672|NCT00696241|1050097|P2|Overall Study|Other|1
320673|NCT00696241|1050098|P1|Overall Study|Other|6
320674|NCT00696241|1050094|P5|Overall Study|Lack of Efficacy|3
320675|NCT00696241|1050095|P4|Overall Study|Lack of Efficacy|5
320676|NCT00696241|1050096|P3|Overall Study|Lack of Efficacy|4
320677|NCT00696241|1050097|P2|Overall Study|Lack of Efficacy|5
320678|NCT00696241|1050098|P1|Overall Study|Lack of Efficacy|1
320679|NCT00696241|1050094|P5|Overall Study|Withdrawal by Subject|0
320680|NCT00696241|1050095|P4|Overall Study|Withdrawal by Subject|1
320681|NCT00696241|1050096|P3|Overall Study|Withdrawal by Subject|6
320682|NCT00696241|1050097|P2|Overall Study|Withdrawal by Subject|8
320683|NCT00696241|1050098|P1|Overall Study|Withdrawal by Subject|4
320684|NCT00696241|1050094|P5|Overall Study|Lost to Follow-up|0
320685|NCT00696241|1050095|P4|Overall Study|Lost to Follow-up|2
320686|NCT00696241|1050096|P3|Overall Study|Lost to Follow-up|1
320687|NCT00696241|1050097|P2|Overall Study|Lost to Follow-up|4
320688|NCT00696241|1050098|P1|Overall Study|Lost to Follow-up|1
320689|NCT00696241|1050094|P5|Overall Study|Protocol Violation|3
320690|NCT00696241|1050095|P4|Overall Study|Protocol Violation|0
320691|NCT00696241|1050096|P3|Overall Study|Protocol Violation|2
320692|NCT00696241|1050097|P2|Overall Study|Protocol Violation|1
320693|NCT00696241|1050098|P1|Overall Study|Protocol Violation|1
320694|NCT00696241|1050094|P5|Overall Study|Adverse Event|5
320695|NCT00696241|1050095|P4|Overall Study|Adverse Event|4
320696|NCT00696241|1050096|P3|Overall Study|Adverse Event|6
320697|NCT00696241|1050097|P2|Overall Study|Adverse Event|3
320698|NCT00696241|1050098|P1|Overall Study|Adverse Event|11
320699|NCT00696072|1050182|P2|Overall Study|Non-specified|2
320700|NCT00696072|1050183|P1|Overall Study|Non-specified|1
320701|NCT00696072|1050182|P2|Overall Study|Disease Progression|30
320702|NCT00696072|1050183|P1|Overall Study|Disease Progression|32
320703|NCT00696072|1050182|P2|Overall Study|Sponsor Request|1
320704|NCT00696072|1050183|P1|Overall Study|Sponsor Request|0
320705|NCT00696072|1050182|P2|Overall Study|Investigator Request|4
320706|NCT00696072|1050183|P1|Overall Study|Investigator Request|1
320707|NCT00696072|1050182|P2|Overall Study|Patient Request|7
320708|NCT00696072|1050183|P1|Overall Study|Patient Request|3
320709|NCT00696072|1050182|P2|Overall Study|Adverse Event|6
320710|NCT00696072|1050183|P1|Overall Study|Adverse Event|10
320711|NCT00696072|1050182|P2|Overall Study|continuing active treatment|13
320712|NCT00696072|1050183|P1|Overall Study|continuing active treatment|10
320713|NCT00696020|1050204|P4|Overall Study|Other not stated above|1
320714|NCT00696020|1050205|P3|Overall Study|Other not stated above|1
320715|NCT00696020|1050206|P2|Overall Study|Other not stated above|0
320716|NCT00696020|1050207|P1|Overall Study|Other not stated above|0
320717|NCT00696020|1050204|P4|Overall Study|Withdrawal by Subject|1
320718|NCT00696020|1050205|P3|Overall Study|Withdrawal by Subject|0
320719|NCT00696020|1050206|P2|Overall Study|Withdrawal by Subject|1
320720|NCT00696020|1050207|P1|Overall Study|Withdrawal by Subject|0
320721|NCT00696020|1050204|P4|Overall Study|Protocol Violation|1
320722|NCT00696020|1050205|P3|Overall Study|Protocol Violation|0
320723|NCT00696020|1050206|P2|Overall Study|Protocol Violation|0
320724|NCT00696020|1050207|P1|Overall Study|Protocol Violation|0
320725|NCT00696020|1050204|P4|Overall Study|Lack of Efficacy|0
320726|NCT00696020|1050205|P3|Overall Study|Lack of Efficacy|0
320727|NCT00696020|1050206|P2|Overall Study|Lack of Efficacy|0
320728|NCT00696020|1050207|P1|Overall Study|Lack of Efficacy|1
320729|NCT00696020|1050204|P4|Overall Study|Adverse Event|1
320730|NCT00696020|1050205|P3|Overall Study|Adverse Event|2
320731|NCT00696020|1050206|P2|Overall Study|Adverse Event|1
320732|NCT00696020|1050207|P1|Overall Study|Adverse Event|3
320733|NCT00695955|1050315|P1|Cohort 2|Other|5
320734|NCT00695955|1050315|P1|Cohort 2|Lack of Efficacy|4
320735|NCT00695955|1050315|P1|Cohort 2|Withdrawal by Subject|28
320736|NCT00695955|1050315|P1|Cohort 2|Lost to Follow-up|38
320737|NCT00695955|1050315|P1|Cohort 2|Protocol Violation|5
320738|NCT00695955|1050315|P1|Cohort 2|Adverse Event|24
320739|NCT00695955|1050315|P1|Cohort 1|Other|16
320740|NCT00695955|1050315|P1|Cohort 1|Lack of Efficacy|3
320741|NCT00695955|1050315|P1|Cohort 1|Withdrawal by Subject|25
320742|NCT00695955|1050315|P1|Cohort 1|Lost to Follow-up|30
320743|NCT00695955|1050315|P1|Cohort 1|Protocol Violation|2
320744|NCT00695955|1050315|P1|Cohort 1|Adverse Event|26
320745|NCT00695903|1050327|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
320746|NCT00695903|1050328|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
320747|NCT00695903|1050327|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
320748|NCT00695903|1050328|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
320749|NCT00695903|1050327|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
320750|NCT00695903|1050328|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
320751|NCT00695903|1050327|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
320752|NCT00695903|1050328|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
320753|NCT00695903|1050327|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
320754|NCT00695903|1050328|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
320755|NCT00695903|1050327|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
320756|NCT00695903|1050328|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
320757|NCT00695903|1050327|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
320758|NCT00695903|1050328|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
320759|NCT00695903|1050327|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
320760|NCT00695903|1050328|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
320761|NCT00695903|1050327|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
320762|NCT00695903|1050328|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
320763|NCT00695864|1050340|P1|Placebo|Physician Decision|4
320764|NCT00695864|1050340|P1|Placebo|Withdrawal by Subject|1
320765|NCT00695669|1050350|P4|Overall Study|Lost to Follow-up|4
320766|NCT00695669|1050351|P3|Overall Study|Lost to Follow-up|1
320767|NCT00695669|1050352|P2|Overall Study|Lost to Follow-up|4
320768|NCT00695669|1050353|P1|Overall Study|Lost to Follow-up|4
320769|NCT00695669|1050350|P4|Overall Study|Adverse Event|0
320770|NCT00695669|1050351|P3|Overall Study|Adverse Event|2
320771|NCT00695669|1050352|P2|Overall Study|Adverse Event|0
320772|NCT00695669|1050353|P1|Overall Study|Adverse Event|0
320773|NCT00695565|1050429|P2|Overall Study|Subject did not follow instructions|1
320774|NCT00695565|1050430|P1|Overall Study|Subject did not follow instructions|1
320775|NCT00695565|1050429|P2|Overall Study|Lack of Efficacy|1
320776|NCT00695565|1050430|P1|Overall Study|Lack of Efficacy|1
320777|NCT00695565|1050429|P2|Overall Study|Withdrawal by Subject|1
320778|NCT00695565|1050430|P1|Overall Study|Withdrawal by Subject|1
320779|NCT00695565|1050429|P2|Overall Study|Protocol Violation|1
320780|NCT00695565|1050430|P1|Overall Study|Protocol Violation|3
320781|NCT00695565|1050429|P2|Overall Study|Adverse Event|1
320782|NCT00695565|1050430|P1|Overall Study|Adverse Event|3
320783|NCT00695565|1050429|P2|Overall Study|Lost to Follow-up|4
320784|NCT00695565|1050430|P1|Overall Study|Lost to Follow-up|4
320785|NCT00695396|1050491|P3|Overall Study|Withdrawal by Subject|0
320786|NCT00695396|1050492|P2|Overall Study|Withdrawal by Subject|2
320787|NCT00695396|1050493|P1|Overall Study|Withdrawal by Subject|2
320788|NCT00695396|1050491|P3|Overall Study|Study Closed Prematurely|8
320789|NCT00695396|1050492|P2|Overall Study|Study Closed Prematurely|6
320790|NCT00695396|1050493|P1|Overall Study|Study Closed Prematurely|5
320791|NCT00695318|1050509|P2|Overall Study|Study Terminated|0
320792|NCT00695318|1050510|P1|Overall Study|Study Terminated|1
320793|NCT00695318|1050509|P2|Overall Study|Death|1
320794|NCT00695318|1050510|P1|Overall Study|Death|1
320795|NCT00695318|1050509|P2|Overall Study|Withdrawal by Subject|0
320796|NCT00695318|1050510|P1|Overall Study|Withdrawal by Subject|2
320797|NCT00695318|1050509|P2|Overall Study|Lost to Follow-up|0
320798|NCT00695318|1050510|P1|Overall Study|Lost to Follow-up|1
320799|NCT00695136|1050535|P1|Overall Study|unrelated adverse event|1
320800|NCT00695136|1050535|P1|Overall Study|Withdrawal by Subject|1
320801|NCT00695019|1050551|P3|Overall Study|Various|4
320802|NCT00695019|1050552|P2|Overall Study|Various|5
320803|NCT00695019|1050553|P1|Overall Study|Various|4
320804|NCT00695019|1050551|P3|Overall Study|Lack of Efficacy|1
320805|NCT00695019|1050552|P2|Overall Study|Lack of Efficacy|0
320806|NCT00695019|1050553|P1|Overall Study|Lack of Efficacy|0
320807|NCT00695019|1050551|P3|Overall Study|Protocol Violation|1
320808|NCT00695019|1050552|P2|Overall Study|Protocol Violation|3
320809|NCT00695019|1050553|P1|Overall Study|Protocol Violation|1
320810|NCT00695019|1050551|P3|Overall Study|Withdrawal by Subject|4
320811|NCT00695019|1050552|P2|Overall Study|Withdrawal by Subject|6
320812|NCT00695019|1050553|P1|Overall Study|Withdrawal by Subject|8
320813|NCT00694551|1050594|P3|Overall Study|Disease Progression|1
320814|NCT00694551|1050595|P2|Overall Study|Disease Progression|0
320815|NCT00694551|1050596|P1|Overall Study|Disease Progression|1
320816|NCT00694369|1050615|P5|Overall Study|Withdrawal by Subject|2
320817|NCT00694369|1050616|P4|Overall Study|Withdrawal by Subject|1
320818|NCT00694369|1050617|P3|Overall Study|Withdrawal by Subject|1
320819|NCT00694369|1050618|P2|Overall Study|Withdrawal by Subject|1
320820|NCT00694369|1050619|P1|Overall Study|Withdrawal by Subject|1
320821|NCT00694369|1050615|P5|Overall Study|Protocol Violation|0
320822|NCT00694369|1050616|P4|Overall Study|Protocol Violation|0
320823|NCT00694369|1050617|P3|Overall Study|Protocol Violation|0
320824|NCT00694369|1050618|P2|Overall Study|Protocol Violation|1
320825|NCT00694369|1050619|P1|Overall Study|Protocol Violation|0
320826|NCT00694369|1050615|P5|Overall Study|Physician Decision|1
320827|NCT00694369|1050616|P4|Overall Study|Physician Decision|0
320828|NCT00694369|1050617|P3|Overall Study|Physician Decision|0
320829|NCT00694369|1050618|P2|Overall Study|Physician Decision|0
320830|NCT00694369|1050619|P1|Overall Study|Physician Decision|0
320831|NCT00694369|1050615|P5|Overall Study|Lost to Follow-up|0
320832|NCT00694369|1050616|P4|Overall Study|Lost to Follow-up|1
320833|NCT00694369|1050617|P3|Overall Study|Lost to Follow-up|1
320834|NCT00694369|1050618|P2|Overall Study|Lost to Follow-up|0
320835|NCT00694369|1050619|P1|Overall Study|Lost to Follow-up|0
320836|NCT00694369|1050615|P5|Overall Study|Adverse Event|3
320837|NCT00694369|1050616|P4|Overall Study|Adverse Event|1
320838|NCT00694369|1050617|P3|Overall Study|Adverse Event|0
320839|NCT00694369|1050618|P2|Overall Study|Adverse Event|1
320840|NCT00694369|1050619|P1|Overall Study|Adverse Event|0
320841|NCT00694356|1050639|P3|Overall Study|Progressive Disease|6
320842|NCT00694356|1050640|P2|Overall Study|Progressive Disease|6
320843|NCT00694356|1050641|P1|Overall Study|Progressive Disease|2
320844|NCT00694356|1050639|P3|Overall Study|Adverse Event|0
320845|NCT00694356|1050640|P2|Overall Study|Adverse Event|0
320846|NCT00694356|1050641|P1|Overall Study|Adverse Event|1
320847|NCT00694304|1050676|P1|Overall Study|Administrative or Other Reasons|32
320848|NCT00694304|1050676|P1|Overall Study|Lost to Follow-up|15
320849|NCT00694304|1050676|P1|Overall Study|Withdrawal of Consent|61
320850|NCT00694304|1050676|P1|Overall Study|Protocol Violation|6
320851|NCT00694304|1050676|P1|Overall Study|Non-compliance With Study Product|16
320852|NCT00694304|1050676|P1|Overall Study|Lack of Efficacy|35
320853|NCT00694304|1050676|P1|Overall Study|Adverse Event|42
320854|NCT00694161|1050689|P1|Part 2 (After Week 6 up to Month 12)|Death|1
320855|NCT00694161|1050689|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
320856|NCT00694161|1050689|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
320857|NCT00694122|1050728|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
320858|NCT00694122|1050729|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
320859|NCT00694122|1050728|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
320860|NCT00694122|1050729|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
320861|NCT00694122|1050728|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
320862|NCT00694122|1050729|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
320863|NCT00694109|1050745|P1|Overall Study|Consented but no additional treatment|3
320864|NCT00694109|1050745|P1|Overall Study|Unspecified|2
320865|NCT00694109|1050745|P1|Overall Study|Enrolled but not treated|1
320866|NCT00694109|1050745|P1|Overall Study|Pregnancy|1
320867|NCT00694109|1050745|P1|Overall Study|Withdrawal by Subject|13
320868|NCT00694109|1050745|P1|Overall Study|Lack of Efficacy|2
320869|NCT00694109|1050745|P1|Overall Study|Not consent of more 2 years of treatment|18
320870|NCT00694109|1050745|P1|Overall Study|Adverse Event|74
320871|NCT00694109|1050745|P1|Overall Study|Physician Decision|3
320872|NCT00694096|1050769|P1|Overall Study|Withdrawal by Subject|5
320873|NCT00693784|1050805|P1|Overall Study|Withdrawal by Subject|2
320874|NCT00693784|1050805|P1|Overall Study|Lost to Follow-up|2
320875|NCT00693706|1050818|P2|Overall Study|Protocol Violation|1
320876|NCT00693706|1050819|P1|Overall Study|Protocol Violation|0
320877|NCT00693693|1050846|P3|Overall Study|Lost to Follow-up|2
320878|NCT00693693|1050847|P2|Overall Study|Lost to Follow-up|1
320879|NCT00693693|1050848|P1|Overall Study|Lost to Follow-up|1
320880|NCT00693472|1050905|P4|Part 2|Withdrew - reason unrelated to treatment|2
320881|NCT00693472|1050906|P3|Part 2|Withdrew - reason unrelated to treatment|1
320882|NCT00693472|1050907|P2|Part 2|Withdrew - reason unrelated to treatment|0
320883|NCT00693472|1050908|P1|Part 2|Withdrew - reason unrelated to treatment|0
320884|NCT00693472|1050905|P4|Part 2|Adverse Event|0
320885|NCT00693472|1050906|P3|Part 2|Adverse Event|1
320886|NCT00693472|1050907|P2|Part 2|Adverse Event|0
320887|NCT00693472|1050908|P1|Part 2|Adverse Event|0
320888|NCT00693472|1050905|P4|Part 1|Withdrew - reason unrelated to treatment|0
320889|NCT00693472|1050906|P3|Part 1|Withdrew - reason unrelated to treatment|0
320890|NCT00693472|1050907|P2|Part 1|Withdrew - reason unrelated to treatment|2
320891|NCT00693472|1050908|P1|Part 1|Withdrew - reason unrelated to treatment|5
320892|NCT00693472|1050905|P4|Part 1|Lost to Follow-up|0
320893|NCT00693472|1050906|P3|Part 1|Lost to Follow-up|0
320894|NCT00693472|1050907|P2|Part 1|Lost to Follow-up|1
320895|NCT00693472|1050908|P1|Part 1|Lost to Follow-up|0
320896|NCT00693472|1050905|P4|Part 1|Adverse Event|0
320897|NCT00693472|1050906|P3|Part 1|Adverse Event|0
320898|NCT00693472|1050907|P2|Part 1|Adverse Event|1
320899|NCT00693472|1050908|P1|Part 1|Adverse Event|1
320900|NCT00693420|1050928|P2|Overall Study|Personal Reasons|4
320901|NCT00693420|1050929|P1|Overall Study|Personal Reasons|1
320902|NCT00693420|1050928|P2|Overall Study|Sponsor Request - Conflict of Interest|2
320903|NCT00693420|1050929|P1|Overall Study|Sponsor Request - Conflict of Interest|0
320904|NCT00693420|1050928|P2|Overall Study|Protocol Violation|2
320905|NCT00693420|1050929|P1|Overall Study|Protocol Violation|0
320906|NCT00693420|1050928|P2|Overall Study|Withdrawal by Subject|0
320907|NCT00693420|1050929|P1|Overall Study|Withdrawal by Subject|1
320908|NCT00693420|1050928|P2|Overall Study|Lost to Follow-up|3
320909|NCT00693420|1050929|P1|Overall Study|Lost to Follow-up|0
320910|NCT00693420|1050928|P2|Overall Study|Adverse Event|4
320911|NCT00693420|1050929|P1|Overall Study|Adverse Event|4
320912|NCT00693225|1050968|P2|Overall Study|Adverse Event|3
320913|NCT00693225|1050969|P1|Overall Study|Adverse Event|1
320914|NCT00693225|1050968|P2|Overall Study|Lost to Follow-up|2
320915|NCT00693225|1050969|P1|Overall Study|Lost to Follow-up|1
320916|NCT00693017|1050992|P2|Overall Study|Death|1
320917|NCT00693017|1050993|P1|Overall Study|Death|0
320918|NCT00693017|1050992|P2|Overall Study|Sponsor Decision|1
320919|NCT00693017|1050993|P1|Overall Study|Sponsor Decision|2
320920|NCT00692913|1051003|P2|Overall Study|Withdrawal by Subject|20
320921|NCT00692913|1051004|P1|Overall Study|Withdrawal by Subject|15
320922|NCT00692913|1051003|P2|Overall Study|Protocol Violation|1
320923|NCT00692913|1051004|P1|Overall Study|Protocol Violation|1
320924|NCT00692913|1051003|P2|Overall Study|Physician Decision|0
320925|NCT00692913|1051004|P1|Overall Study|Physician Decision|2
320926|NCT00692913|1051003|P2|Overall Study|Lost to Follow-up|5
320927|NCT00692913|1051004|P1|Overall Study|Lost to Follow-up|3
320928|NCT00692913|1051003|P2|Overall Study|Adverse Event|4
320929|NCT00692913|1051004|P1|Overall Study|Adverse Event|8
320930|NCT00692770|1051026|P2|Overall Study|Randomized but not treated|4
320931|NCT00692770|1051027|P1|Overall Study|Randomized but not treated|3
320932|NCT00692770|1051026|P2|Overall Study|Study terminated by sponsor|2
320933|NCT00692770|1051027|P1|Overall Study|Study terminated by sponsor|2
320934|NCT00692770|1051026|P2|Overall Study|Clinical endpoint reached|43
320935|NCT00692770|1051027|P1|Overall Study|Clinical endpoint reached|16
320936|NCT00692770|1051026|P2|Overall Study|Radiological and clinical progression|8
320937|NCT00692770|1051027|P1|Overall Study|Radiological and clinical progression|8
320938|NCT00692770|1051026|P2|Overall Study|Completed all planned assessments|101
320939|NCT00692770|1051027|P1|Overall Study|Completed all planned assessments|79
320940|NCT00692770|1051026|P2|Overall Study|Protocol driven decision point|7
320941|NCT00692770|1051027|P1|Overall Study|Protocol driven decision point|3
320942|NCT00692770|1051026|P2|Overall Study|Disease progression, recurrence/relapse|279
320943|NCT00692770|1051027|P1|Overall Study|Disease progression, recurrence/relapse|170
320944|NCT00692770|1051026|P2|Overall Study|Physician decision not protocol driven|14
320945|NCT00692770|1051027|P1|Overall Study|Physician decision not protocol driven|10
320946|NCT00692770|1051026|P2|Overall Study|Progression by clinical judgment|3
320947|NCT00692770|1051027|P1|Overall Study|Progression by clinical judgment|2
320948|NCT00692770|1051026|P2|Overall Study|Non-compliant with study medication|5
320949|NCT00692770|1051027|P1|Overall Study|Non-compliant with study medication|11
320950|NCT00692770|1051026|P2|Overall Study|Lost to Follow-up|3
320951|NCT00692770|1051027|P1|Overall Study|Lost to Follow-up|7
320952|NCT00692770|1051026|P2|Overall Study|Death|5
320953|NCT00692770|1051027|P1|Overall Study|Death|10
320954|NCT00692770|1051026|P2|Overall Study|Adverse Event|41
320955|NCT00692770|1051027|P1|Overall Study|Adverse Event|136
320956|NCT00692770|1051026|P2|Overall Study|Withdrawal by Subject|36
320957|NCT00692770|1051027|P1|Overall Study|Withdrawal by Subject|97
320958|NCT00692770|1051026|P2|Overall Study|Protocol Violation|7
320959|NCT00692770|1051027|P1|Overall Study|Protocol Violation|2
320960|NCT00691704|1051045|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
320961|NCT00691704|1051045|P1|Two Years of Maintenance Therapy|Physician Decision|4
320962|NCT00691704|1051045|P1|Two Years of Maintenance Therapy|Disease Progression|8
320963|NCT00691704|1051045|P1|Induction Therapy|Active Hepatitis|1
320964|NCT00691704|1051045|P1|Induction Therapy|Disease Progression|1
320965|NCT00691483|1051074|P2|Overall Study|Randomized by not treated|1
320966|NCT00691483|1051075|P1|Overall Study|Randomized by not treated|7
320967|NCT00691483|1051074|P2|Overall Study|Other known cause|1
320968|NCT00691483|1051075|P1|Overall Study|Other known cause|6
320969|NCT00691483|1051074|P2|Overall Study|Withdrawal by Subject|7
320970|NCT00691483|1051075|P1|Overall Study|Withdrawal by Subject|24
320971|NCT00691483|1051074|P2|Overall Study|Lost to Follow-up|10
320972|NCT00691483|1051075|P1|Overall Study|Lost to Follow-up|17
320973|NCT00691483|1051074|P2|Overall Study|Adverse Event|6
320974|NCT00691483|1051075|P1|Overall Study|Adverse Event|14
320975|NCT00692406|1051111|P1|Overall Study|PI dropped, bad data|57
320976|NCT00692237|1051173|P2|Overall Study|Adverse Event|1
320977|NCT00692237|1051174|P1|Overall Study|Adverse Event|0
320978|NCT00692237|1051173|P2|Overall Study|Withdrawal by Subject|3
320979|NCT00692237|1051174|P1|Overall Study|Withdrawal by Subject|1
320980|NCT00692003|1051238|P2|Overall Study|Sponsor Decision|1
320981|NCT00692003|1051239|P1|Overall Study|Sponsor Decision|5
320982|NCT00691938|1051254|P7|Overall Study|QTc prolongation|0
320983|NCT00691938|1051255|P6|Overall Study|QTc prolongation|0
320984|NCT00691938|1051256|P5|Overall Study|QTc prolongation|0
320985|NCT00691938|1051257|P4|Overall Study|QTc prolongation|0
320986|NCT00691938|1051258|P3|Overall Study|QTc prolongation|0
320987|NCT00691938|1051259|P2|Overall Study|QTc prolongation|0
320988|NCT00691938|1051260|P1|Overall Study|QTc prolongation|1
320989|NCT00691210|1051346|P8|Overall Study|Lack of Efficacy|0
320990|NCT00691210|1051347|P7|Overall Study|Lack of Efficacy|0
320991|NCT00691210|1051348|P6|Overall Study|Lack of Efficacy|1
320992|NCT00691210|1051349|P5|Overall Study|Lack of Efficacy|0
320993|NCT00691210|1051350|P4|Overall Study|Lack of Efficacy|1
320994|NCT00691210|1051351|P3|Overall Study|Lack of Efficacy|0
320995|NCT00691210|1051352|P2|Overall Study|Lack of Efficacy|0
320996|NCT00691210|1051353|P1|Overall Study|Lack of Efficacy|0
320997|NCT00691210|1051346|P8|Overall Study|Progression of Disease|0
320998|NCT00691210|1051347|P7|Overall Study|Progression of Disease|0
320999|NCT00691210|1051348|P6|Overall Study|Progression of Disease|0
321000|NCT00691210|1051349|P5|Overall Study|Progression of Disease|0
321001|NCT00691210|1051350|P4|Overall Study|Progression of Disease|2
321002|NCT00691210|1051351|P3|Overall Study|Progression of Disease|0
321003|NCT00691210|1051352|P2|Overall Study|Progression of Disease|0
321004|NCT00691210|1051353|P1|Overall Study|Progression of Disease|0
321005|NCT00691132|1051388|P2|Overall Study|Withdrawal by Subject|10
321006|NCT00691132|1051389|P1|Overall Study|Withdrawal by Subject|10
321007|NCT00691132|1051388|P2|Overall Study|Adverse Event|3
321008|NCT00691132|1051389|P1|Overall Study|Adverse Event|2
321009|NCT00691093|1051408|P1|Overall Study|Ongoing at Date of Cut-Off|4
321010|NCT00691093|1051408|P1|Overall Study|Lack of Efficacy|1
321011|NCT00691093|1051408|P1|Overall Study|Lost to Follow-up|1
321012|NCT00691093|1051408|P1|Overall Study|Adverse Event|1
321013|NCT00691054|1051442|P1|Overall Study|Withdrawal by Subject|1
321014|NCT00691028|1051454|P4|Double-blind Period|not come to a hospital.|0
321015|NCT00691028|1051455|P3|Double-blind Period|not come to a hospital.|0
321016|NCT00691028|1051456|P2|Double-blind Period|not come to a hospital.|1
321017|NCT00691028|1051457|P1|Double-blind Period|not come to a hospital.|0
321018|NCT00691028|1051454|P4|Double-blind Period|Withdrawal by Subject|0
321019|NCT00691028|1051455|P3|Double-blind Period|Withdrawal by Subject|1
321020|NCT00691028|1051456|P2|Double-blind Period|Withdrawal by Subject|0
321021|NCT00691028|1051457|P1|Double-blind Period|Withdrawal by Subject|1
321022|NCT00691028|1051454|P4|Double-blind Period|Lack of Efficacy|0
321023|NCT00691028|1051455|P3|Double-blind Period|Lack of Efficacy|2
321024|NCT00691028|1051456|P2|Double-blind Period|Lack of Efficacy|3
321025|NCT00691028|1051457|P1|Double-blind Period|Lack of Efficacy|4
321026|NCT00691028|1051454|P4|Double-blind Period|Adverse Event|0
321027|NCT00691028|1051455|P3|Double-blind Period|Adverse Event|6
321028|NCT00691028|1051456|P2|Double-blind Period|Adverse Event|9
321029|NCT00691028|1051457|P1|Double-blind Period|Adverse Event|8
321030|NCT00691028|1051454|P4|Open-label Period|not come to a hospital|1
321031|NCT00691028|1051455|P3|Open-label Period|not come to a hospital|0
321032|NCT00691028|1051456|P2|Open-label Period|not come to a hospital|0
321033|NCT00691028|1051457|P1|Open-label Period|not come to a hospital|0
321034|NCT00691028|1051454|P4|Open-label Period|Withdrawal by Subject|3
321035|NCT00691028|1051455|P3|Open-label Period|Withdrawal by Subject|0
321036|NCT00691028|1051456|P2|Open-label Period|Withdrawal by Subject|0
321037|NCT00691028|1051457|P1|Open-label Period|Withdrawal by Subject|0
321038|NCT00691028|1051454|P4|Open-label Period|Adverse Event|16
321039|NCT00691028|1051455|P3|Open-label Period|Adverse Event|0
321040|NCT00691028|1051456|P2|Open-label Period|Adverse Event|0
321041|NCT00691028|1051457|P1|Open-label Period|Adverse Event|0
321042|NCT00690898|1051490|P1|TREATMENT|Other (not otherwise specified)|1
321043|NCT00690898|1051490|P1|TREATMENT|Withdrawal by Subject|4
321044|NCT00690898|1051490|P1|TREATMENT|Lack of Efficacy|18
321045|NCT00690898|1051490|P1|TREATMENT|Adverse Event|3
321046|NCT00690898|1051490|P1|SCREENING|Screen failure|18
321047|NCT00690820|1051510|P2|Period 1|Withdrawal by Subject|1
321048|NCT00690820|1051511|P1|Period 1|Withdrawal by Subject|0
321049|NCT00690794|1051533|P2|Overall Study|Other not specified|3
321050|NCT00690794|1051534|P1|Overall Study|Other not specified|1
321051|NCT00690794|1051533|P2|Overall Study|Noncompliance|2
321052|NCT00690794|1051534|P1|Overall Study|Noncompliance|1
321053|NCT00690794|1051533|P2|Overall Study|Protocol Violation|7
321054|NCT00690794|1051534|P1|Overall Study|Protocol Violation|6
321055|NCT00690794|1051533|P2|Overall Study|Withdrawal by Subject|9
321056|NCT00690794|1051534|P1|Overall Study|Withdrawal by Subject|0
321057|NCT00690794|1051533|P2|Overall Study|Lost to Follow-up|4
321058|NCT00690794|1051534|P1|Overall Study|Lost to Follow-up|1
321059|NCT00690794|1051533|P2|Overall Study|Adverse Event|10
321060|NCT00690794|1051534|P1|Overall Study|Adverse Event|12
321061|NCT00690755|1051549|P7|Overall Study|Physician Decision|0
321062|NCT00690755|1051550|P6|Overall Study|Physician Decision|4
321063|NCT00690755|1051551|P5|Overall Study|Physician Decision|0
321064|NCT00690755|1051552|P4|Overall Study|Physician Decision|5
321065|NCT00690755|1051553|P3|Overall Study|Physician Decision|46
321066|NCT00690755|1051554|P2|Overall Study|Physician Decision|0
321067|NCT00690755|1051555|P1|Overall Study|Physician Decision|2
321068|NCT00690612|1051571|P1|Overall Study|Withdrawal by Subject|2
321069|NCT00690612|1051571|P1|Overall Study|Adverse Event|1
321070|NCT00690573|1051576|P1|Overall Study|Withdrawal by Subject|1
321071|NCT00690573|1051576|P1|Overall Study|Lack of Efficacy|8
321072|NCT00690482|1051595|P2|Overall Study|withdrew consent at rand.day|1
321073|NCT00690482|1051596|P1|Overall Study|withdrew consent at rand.day|0
321074|NCT00690482|1051595|P2|Overall Study|Intake of prohibited medicine|0
321075|NCT00690482|1051596|P1|Overall Study|Intake of prohibited medicine|1
321076|NCT00690482|1051595|P2|Overall Study|Study-specific discontinuation criteria|0
321077|NCT00690482|1051596|P1|Overall Study|Study-specific discontinuation criteria|1
321078|NCT00690482|1051595|P2|Overall Study|Incorrect enrolment|1
321079|NCT00690482|1051596|P1|Overall Study|Incorrect enrolment|0
321080|NCT00690482|1051595|P2|Overall Study|Adverse Event|1
321081|NCT00690482|1051596|P1|Overall Study|Adverse Event|2
321082|NCT00690443|1051630|P2|Overall Study|Adverse Event|2
321083|NCT00690443|1051631|P1|Overall Study|Adverse Event|1
321084|NCT00690430|1051641|P3|Extension Phase|Early Termination|3
321085|NCT00690430|1051642|P2|Extension Phase|Early Termination|1
321086|NCT00690430|1051643|P1|Extension Phase|Early Termination|10
321087|NCT00690430|1051641|P3|Extension Phase|Withdrawal by Subject|2
321088|NCT00690430|1051642|P2|Extension Phase|Withdrawal by Subject|0
321089|NCT00690430|1051643|P1|Extension Phase|Withdrawal by Subject|0
321090|NCT00690430|1051641|P3|Extension Phase|Death|1
321091|NCT00690430|1051642|P2|Extension Phase|Death|1
321092|NCT00690430|1051643|P1|Extension Phase|Death|1
321093|NCT00690430|1051641|P3|Extension Phase|Adverse Event|2
321094|NCT00690430|1051642|P2|Extension Phase|Adverse Event|1
321095|NCT00690430|1051643|P1|Extension Phase|Adverse Event|2
321096|NCT00690430|1051641|P3|Extension Phase|Administrative Problems|1
321097|NCT00690430|1051642|P2|Extension Phase|Administrative Problems|1
321098|NCT00690430|1051643|P1|Extension Phase|Administrative Problems|0
321099|NCT00690430|1051641|P3|Extension Phase|Abnormal test procedure results|0
321100|NCT00690430|1051642|P2|Extension Phase|Abnormal test procedure results|0
321101|NCT00690430|1051643|P1|Extension Phase|Abnormal test procedure results|1
321102|NCT00690430|1051641|P3|Extension Phase|Abnormal Lab Values|0
321103|NCT00690430|1051642|P2|Extension Phase|Abnormal Lab Values|0
321104|NCT00690430|1051643|P1|Extension Phase|Abnormal Lab Values|1
321105|NCT00690430|1051641|P3|Extension Phase|Lack of Efficacy|4
321106|NCT00690430|1051642|P2|Extension Phase|Lack of Efficacy|1
321107|NCT00690430|1051643|P1|Extension Phase|Lack of Efficacy|3
321108|NCT00690430|1051641|P3|Core Phase|Early Termination|0
321109|NCT00690430|1051642|P2|Core Phase|Early Termination|5
321110|NCT00690430|1051643|P1|Core Phase|Early Termination|0
321111|NCT00690430|1051641|P3|Core Phase|Administrative Problems|0
321112|NCT00690430|1051642|P2|Core Phase|Administrative Problems|1
321113|NCT00690430|1051643|P1|Core Phase|Administrative Problems|0
321114|NCT00690430|1051641|P3|Core Phase|Lack of Efficacy|0
321115|NCT00690430|1051642|P2|Core Phase|Lack of Efficacy|10
321116|NCT00690430|1051643|P1|Core Phase|Lack of Efficacy|8
321117|NCT00690430|1051641|P3|Core Phase|Subject no longer requires study drug|0
321118|NCT00690430|1051642|P2|Core Phase|Subject no longer requires study drug|0
321119|NCT00690430|1051643|P1|Core Phase|Subject no longer requires study drug|1
321120|NCT00690430|1051641|P3|Core Phase|Withdrawal by Subject|0
321121|NCT00690430|1051642|P2|Core Phase|Withdrawal by Subject|3
321122|NCT00690430|1051643|P1|Core Phase|Withdrawal by Subject|3
321123|NCT00690430|1051641|P3|Core Phase|Protocol Violation|0
321124|NCT00690430|1051642|P2|Core Phase|Protocol Violation|0
321125|NCT00690430|1051643|P1|Core Phase|Protocol Violation|1
321126|NCT00690430|1051641|P3|Core Phase|Death|0
321127|NCT00690430|1051642|P2|Core Phase|Death|2
321128|NCT00690430|1051643|P1|Core Phase|Death|0
321129|NCT00690430|1051641|P3|Core Phase|Adverse Event|0
321130|NCT00690430|1051642|P2|Core Phase|Adverse Event|1
321131|NCT00690430|1051643|P1|Core Phase|Adverse Event|5
321132|NCT00690430|1051641|P3|Core Phase|Abnormal Laboratory value|0
321133|NCT00690430|1051642|P2|Core Phase|Abnormal Laboratory value|1
321134|NCT00690430|1051643|P1|Core Phase|Abnormal Laboratory value|0
321135|NCT00689871|1051709|P4|Overall Study|Physician Decision|0
321136|NCT00689871|1051710|P3|Overall Study|Physician Decision|1
321137|NCT00689871|1051711|P2|Overall Study|Physician Decision|1
321138|NCT00689871|1051712|P1|Overall Study|Physician Decision|2
321139|NCT00689871|1051709|P4|Overall Study|Death|2
321140|NCT00689871|1051710|P3|Overall Study|Death|2
321141|NCT00689871|1051711|P2|Overall Study|Death|10
321142|NCT00689871|1051712|P1|Overall Study|Death|1
321143|NCT00689871|1051709|P4|Overall Study|Withdrawal by Subject|1
321144|NCT00689871|1051710|P3|Overall Study|Withdrawal by Subject|4
321145|NCT00689871|1051711|P2|Overall Study|Withdrawal by Subject|3
321146|NCT00689871|1051712|P1|Overall Study|Withdrawal by Subject|13
321147|NCT00689871|1051709|P4|Overall Study|Explanted of All Study Devices|3
321148|NCT00689871|1051710|P3|Overall Study|Explanted of All Study Devices|29
321149|NCT00689871|1051711|P2|Overall Study|Explanted of All Study Devices|25
321150|NCT00689871|1051712|P1|Overall Study|Explanted of All Study Devices|36
321151|NCT00689871|1051709|P4|Overall Study|Lost to Follow-up|1
321152|NCT00689871|1051710|P3|Overall Study|Lost to Follow-up|37
321153|NCT00689871|1051711|P2|Overall Study|Lost to Follow-up|13
321154|NCT00689871|1051712|P1|Overall Study|Lost to Follow-up|123
321155|NCT00689793|1051739|P2|Overall Study|Lost to Follow-up|5
321156|NCT00689793|1051740|P1|Overall Study|Lost to Follow-up|4
321157|NCT00689611|1051758|P2|Overall Study|Lost to Follow-up|28
321158|NCT00689611|1051759|P1|Overall Study|Lost to Follow-up|27
321159|NCT00689611|1051758|P2|Overall Study|Withdrawal by Subject|9
321160|NCT00689611|1051759|P1|Overall Study|Withdrawal by Subject|8
321161|NCT00689611|1051758|P2|Overall Study|Death|9
321162|NCT00689611|1051759|P1|Overall Study|Death|6
321163|NCT00689481|1051769|P2|Overall Study|Subject early term, left on vacation|1
321164|NCT00689481|1051770|P1|Overall Study|Subject early term, left on vacation|0
321165|NCT00689481|1051769|P2|Overall Study|Excluded medication started during study|1
321166|NCT00689481|1051770|P1|Overall Study|Excluded medication started during study|0
321167|NCT00689481|1051769|P2|Overall Study|Withdrawal by Subject|4
321168|NCT00689481|1051770|P1|Overall Study|Withdrawal by Subject|8
321169|NCT00689481|1051769|P2|Overall Study|Non-compliance with study treatment|1
321170|NCT00689481|1051770|P1|Overall Study|Non-compliance with study treatment|1
321171|NCT00689481|1051769|P2|Overall Study|Lack of Efficacy|3
321172|NCT00689481|1051770|P1|Overall Study|Lack of Efficacy|4
321173|NCT00689481|1051769|P2|Overall Study|Lost to Follow-up|3
321174|NCT00689481|1051770|P1|Overall Study|Lost to Follow-up|4
321175|NCT00689481|1051769|P2|Overall Study|Adverse Event|1
321176|NCT00689481|1051770|P1|Overall Study|Adverse Event|7
321177|NCT00689390|1051788|P2|Overall Study|Administrative|0
321178|NCT00689390|1051789|P1|Overall Study|Administrative|37
321179|NCT00689390|1051788|P2|Overall Study|Did Not Meet Protocol Eligibility|0
321180|NCT00689390|1051789|P1|Overall Study|Did Not Meet Protocol Eligibility|1
321181|NCT00689390|1051788|P2|Overall Study|Non-Compliance With Protocol|0
321182|NCT00689390|1051789|P1|Overall Study|Non-Compliance With Protocol|21
321183|NCT00689390|1051788|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
321184|NCT00689390|1051789|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
321185|NCT00689390|1051788|P2|Overall Study|Withdrawal by Subject|3
321186|NCT00689390|1051789|P1|Overall Study|Withdrawal by Subject|117
321187|NCT00689390|1051788|P2|Overall Study|Lost to Follow-up|7
321188|NCT00689390|1051789|P1|Overall Study|Lost to Follow-up|179
321189|NCT00689390|1051788|P2|Overall Study|Adverse Event|0
321190|NCT00689390|1051789|P1|Overall Study|Adverse Event|19
321191|NCT00689351|1051807|P2|After Infant Series|Parent/legal guardian request|0
321192|NCT00689351|1051808|P1|After Infant Series|Parent/legal guardian request|1
321193|NCT00689351|1051807|P2|Infant Series of Dosing|Lost to Follow-up|1
321194|NCT00689351|1051808|P1|Infant Series of Dosing|Lost to Follow-up|0
321195|NCT00689351|1051807|P2|Infant Series of Dosing|Adverse Event|0
321196|NCT00689351|1051808|P1|Infant Series of Dosing|Adverse Event|1
321197|NCT00689351|1051807|P2|Infant Series of Dosing|Parent/legal guardian request|0
321198|NCT00689351|1051808|P1|Infant Series of Dosing|Parent/legal guardian request|5
321199|NCT00689338|1051840|P1|Overall Study|Protocol Violation|15
321200|NCT00689338|1051840|P1|Overall Study|Withdrawal by Subject|3
321201|NCT00689338|1051840|P1|Overall Study|Lost to Follow-up|5
321202|NCT00689338|1051840|P1|Overall Study|Did not Meet Entrance Criteria|27
321203|NCT00689338|1051840|P1|Overall Study|Unspecified|8
321204|NCT00689338|1051840|P1|Overall Study|Lack of Efficacy|6
321205|NCT00689338|1051840|P1|Overall Study|Insufficient Clinical Response|1
321206|NCT00689338|1051840|P1|Overall Study|Adverse Event|13
321207|NCT00689338|1051840|P1|Overall Study|Death|65
321208|NCT00689299|1051853|P3|Overall Study|Protocol Violation|0
321209|NCT00689299|1051854|P2|Overall Study|Protocol Violation|0
321210|NCT00689299|1051855|P1|Overall Study|Protocol Violation|1
321211|NCT00689299|1051853|P3|Overall Study|Withdrawal by Subject|3
321212|NCT00689299|1051854|P2|Overall Study|Withdrawal by Subject|1
321213|NCT00689299|1051855|P1|Overall Study|Withdrawal by Subject|4
321214|NCT00689299|1051853|P3|Overall Study|Lost to Follow-up|1
321215|NCT00689299|1051854|P2|Overall Study|Lost to Follow-up|1
321216|NCT00689299|1051855|P1|Overall Study|Lost to Follow-up|0
321217|NCT00689299|1051853|P3|Overall Study|Adverse Event|1
321218|NCT00689299|1051854|P2|Overall Study|Adverse Event|1
321219|NCT00689299|1051855|P1|Overall Study|Adverse Event|2
321220|NCT00689221|1051884|P2|Overall Study|Ongoing at cut-off date|36
321221|NCT00689221|1051885|P1|Overall Study|Ongoing at cut-off date|39
321222|NCT00689117|1051914|P4|Overall Study|Dispensing Error|0
321223|NCT00689117|1051915|P3|Overall Study|Dispensing Error|0
321224|NCT00689117|1051916|P2|Overall Study|Dispensing Error|1
321225|NCT00689117|1051917|P1|Overall Study|Dispensing Error|0
321226|NCT00689117|1051914|P4|Overall Study|Personal Reason|0
321227|NCT00689117|1051915|P3|Overall Study|Personal Reason|0
321228|NCT00689117|1051916|P2|Overall Study|Personal Reason|1
321229|NCT00689117|1051917|P1|Overall Study|Personal Reason|0
321230|NCT00689117|1051914|P4|Overall Study|Patient Withdrew from Study|1
321231|NCT00689117|1051915|P3|Overall Study|Patient Withdrew from Study|0
321232|NCT00689117|1051916|P2|Overall Study|Patient Withdrew from Study|0
321233|NCT00689117|1051917|P1|Overall Study|Patient Withdrew from Study|0
321234|NCT00689117|1051914|P4|Overall Study|Transportation|0
321235|NCT00689117|1051915|P3|Overall Study|Transportation|0
321236|NCT00689117|1051916|P2|Overall Study|Transportation|0
321237|NCT00689117|1051917|P1|Overall Study|Transportation|1
321238|NCT00689117|1051914|P4|Overall Study|Fear of Birth Defects|0
321239|NCT00689117|1051915|P3|Overall Study|Fear of Birth Defects|1
321240|NCT00689117|1051916|P2|Overall Study|Fear of Birth Defects|0
321241|NCT00689117|1051917|P1|Overall Study|Fear of Birth Defects|0
321242|NCT00689117|1051914|P4|Overall Study|Incarceration|0
321243|NCT00689117|1051915|P3|Overall Study|Incarceration|0
321244|NCT00689117|1051916|P2|Overall Study|Incarceration|0
321245|NCT00689117|1051917|P1|Overall Study|Incarceration|2
321246|NCT00689117|1051914|P4|Overall Study|Pregnancy|2
321247|NCT00689117|1051915|P3|Overall Study|Pregnancy|0
321248|NCT00689117|1051916|P2|Overall Study|Pregnancy|2
321249|NCT00689117|1051917|P1|Overall Study|Pregnancy|0
321250|NCT00689117|1051914|P4|Overall Study|Use of Prohibitive Medication|0
321251|NCT00689117|1051915|P3|Overall Study|Use of Prohibitive Medication|3
321252|NCT00689117|1051916|P2|Overall Study|Use of Prohibitive Medication|1
321253|NCT00689117|1051917|P1|Overall Study|Use of Prohibitive Medication|2
321254|NCT00689117|1051914|P4|Overall Study|Change/Discontinuation of Birth Control|0
321255|NCT00689117|1051915|P3|Overall Study|Change/Discontinuation of Birth Control|1
321256|NCT00689117|1051916|P2|Overall Study|Change/Discontinuation of Birth Control|1
321257|NCT00689117|1051917|P1|Overall Study|Change/Discontinuation of Birth Control|1
321258|NCT00689117|1051914|P4|Overall Study|Non-compliance with Treatment Regimen|0
321259|NCT00689117|1051915|P3|Overall Study|Non-compliance with Treatment Regimen|0
321260|NCT00689117|1051916|P2|Overall Study|Non-compliance with Treatment Regimen|1
321261|NCT00689117|1051917|P1|Overall Study|Non-compliance with Treatment Regimen|0
321262|NCT00689117|1051914|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
321263|NCT00689117|1051915|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
321264|NCT00689117|1051916|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
321265|NCT00689117|1051917|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
321266|NCT00689117|1051914|P4|Overall Study|Unable to Comply with Visit Schedule|1
321267|NCT00689117|1051915|P3|Overall Study|Unable to Comply with Visit Schedule|1
321268|NCT00689117|1051916|P2|Overall Study|Unable to Comply with Visit Schedule|0
321269|NCT00689117|1051917|P1|Overall Study|Unable to Comply with Visit Schedule|0
321270|NCT00689117|1051914|P4|Overall Study|Withdrawal by Subject|13
321271|NCT00689117|1051915|P3|Overall Study|Withdrawal by Subject|26
321272|NCT00689117|1051916|P2|Overall Study|Withdrawal by Subject|18
321273|NCT00689117|1051917|P1|Overall Study|Withdrawal by Subject|19
321274|NCT00689117|1051914|P4|Overall Study|Non-Compliance with Study Treatment|1
321275|NCT00689117|1051915|P3|Overall Study|Non-Compliance with Study Treatment|3
321276|NCT00689117|1051916|P2|Overall Study|Non-Compliance with Study Treatment|3
321277|NCT00689117|1051917|P1|Overall Study|Non-Compliance with Study Treatment|3
321278|NCT00689117|1051914|P4|Overall Study|Lack of Efficacy|2
321279|NCT00689117|1051915|P3|Overall Study|Lack of Efficacy|2
321280|NCT00689117|1051916|P2|Overall Study|Lack of Efficacy|2
321281|NCT00689117|1051917|P1|Overall Study|Lack of Efficacy|1
321282|NCT00689117|1051914|P4|Overall Study|Lost to Follow-up|11
321283|NCT00689117|1051915|P3|Overall Study|Lost to Follow-up|17
321284|NCT00689117|1051916|P2|Overall Study|Lost to Follow-up|19
321285|NCT00689117|1051917|P1|Overall Study|Lost to Follow-up|26
321286|NCT00689117|1051914|P4|Overall Study|Adverse Event|0
321287|NCT00689117|1051915|P3|Overall Study|Adverse Event|5
321288|NCT00689117|1051916|P2|Overall Study|Adverse Event|0
321289|NCT00689117|1051917|P1|Overall Study|Adverse Event|6
321290|NCT00689104|1051947|P4|Overall Study|Non-compliance with study procedures|0
321291|NCT00689104|1051948|P3|Overall Study|Non-compliance with study procedures|1
321292|NCT00689104|1051949|P2|Overall Study|Non-compliance with study procedures|0
321293|NCT00689104|1051950|P1|Overall Study|Non-compliance with study procedures|0
321294|NCT00689104|1051947|P4|Overall Study|Physician Decision|0
321295|NCT00689104|1051948|P3|Overall Study|Physician Decision|0
321296|NCT00689104|1051949|P2|Overall Study|Physician Decision|0
321297|NCT00689104|1051950|P1|Overall Study|Physician Decision|1
321298|NCT00689104|1051947|P4|Overall Study|Randomized but never received study drug|0
321299|NCT00689104|1051948|P3|Overall Study|Randomized but never received study drug|1
321300|NCT00689104|1051949|P2|Overall Study|Randomized but never received study drug|1
321301|NCT00689104|1051950|P1|Overall Study|Randomized but never received study drug|2
321302|NCT00689104|1051947|P4|Overall Study|Protocol Violation|3
321303|NCT00689104|1051948|P3|Overall Study|Protocol Violation|5
321304|NCT00689104|1051949|P2|Overall Study|Protocol Violation|3
321305|NCT00689104|1051950|P1|Overall Study|Protocol Violation|2
321306|NCT00689104|1051947|P4|Overall Study|Lost to Follow-up|5
321307|NCT00689104|1051948|P3|Overall Study|Lost to Follow-up|2
321308|NCT00689104|1051949|P2|Overall Study|Lost to Follow-up|3
321309|NCT00689104|1051950|P1|Overall Study|Lost to Follow-up|4
321310|NCT00689104|1051947|P4|Overall Study|Withdrawal by Subject|11
321311|NCT00689104|1051948|P3|Overall Study|Withdrawal by Subject|18
321312|NCT00689104|1051949|P2|Overall Study|Withdrawal by Subject|11
321313|NCT00689104|1051950|P1|Overall Study|Withdrawal by Subject|12
321314|NCT00689104|1051947|P4|Overall Study|Lack of Efficacy|3
321315|NCT00689104|1051948|P3|Overall Study|Lack of Efficacy|2
321316|NCT00689104|1051949|P2|Overall Study|Lack of Efficacy|6
321317|NCT00689104|1051950|P1|Overall Study|Lack of Efficacy|5
321318|NCT00689104|1051947|P4|Overall Study|Adverse Event|24
321319|NCT00689104|1051948|P3|Overall Study|Adverse Event|16
321320|NCT00689104|1051949|P2|Overall Study|Adverse Event|25
321321|NCT00689104|1051950|P1|Overall Study|Adverse Event|13
321322|NCT00689104|1051947|P4|Overall Study|Eligibility criterion not met|4
321323|NCT00689104|1051948|P3|Overall Study|Eligibility criterion not met|0
321324|NCT00689104|1051949|P2|Overall Study|Eligibility criterion not met|8
321325|NCT00689104|1051950|P1|Overall Study|Eligibility criterion not met|5
321326|NCT00689052|1052091|P2|Overall Study|Early termination of the trial|24
321327|NCT00689052|1052092|P1|Overall Study|Early termination of the trial|22
321328|NCT00689052|1052091|P2|Overall Study|Withdrawal by Subject|0
321329|NCT00689052|1052092|P1|Overall Study|Withdrawal by Subject|2
321330|NCT00689052|1052091|P2|Overall Study|Lost to Follow-up|0
321331|NCT00689052|1052092|P1|Overall Study|Lost to Follow-up|2
321332|NCT00689052|1052091|P2|Overall Study|Protocol Violation|0
321333|NCT00689052|1052092|P1|Overall Study|Protocol Violation|1
321334|NCT00689052|1052091|P2|Overall Study|Adverse Event|6
321335|NCT00689052|1052092|P1|Overall Study|Adverse Event|4
321336|NCT00689026|1052124|P2|Overall Study|Withdrawal by Subject|6
321337|NCT00689026|1052125|P1|Overall Study|Withdrawal by Subject|13
321338|NCT00688870|1052133|P2|Infant Series|Parent or legal guardian request|0
321339|NCT00688870|1052134|P1|Infant Series|Parent or legal guardian request|4
321340|NCT00688844|1052166|P1|Overall Study|Lost to Follow-up|10
321341|NCT00688753|1052176|P1|Overall Study|Lost to Follow-up|3
321342|NCT00688753|1052176|P1|Overall Study|Protocol Violation|1
321343|NCT00688753|1052176|P1|Overall Study|Adverse Event|20
321344|NCT00688753|1052176|P1|Overall Study|Withdrawal by Subject|3
321345|NCT00688753|1052176|P1|Overall Study|Death|9
321346|NCT00688753|1052176|P1|Overall Study|Missing|1
321347|NCT00688753|1052176|P1|Overall Study|Disease progression|55
321348|NCT00688740|1052187|P2|Overall Study|Violation of Inclusion Criteria|3
321349|NCT00688740|1052188|P1|Overall Study|Violation of Inclusion Criteria|1
321350|NCT00688740|1052187|P2|Overall Study|Breast Cancer Relapse|4
321351|NCT00688740|1052188|P1|Overall Study|Breast Cancer Relapse|1
321352|NCT00688740|1052187|P2|Overall Study|Consent Withdrawn|17
321353|NCT00688740|1052188|P1|Overall Study|Consent Withdrawn|17
321354|NCT00688740|1052187|P2|Overall Study|Lost to Follow-up|1
321355|NCT00688740|1052188|P1|Overall Study|Lost to Follow-up|0
321356|NCT00688740|1052187|P2|Overall Study|Death|2
321357|NCT00688740|1052188|P1|Overall Study|Death|2
321358|NCT00688740|1052187|P2|Overall Study|Adverse Event|8
321359|NCT00688740|1052188|P1|Overall Study|Adverse Event|45
321360|NCT00688701|1052201|P4|Overall Study|Poor compliance to protocol|0
321361|NCT00688701|1052202|P3|Overall Study|Poor compliance to protocol|1
321362|NCT00688701|1052203|P2|Overall Study|Poor compliance to protocol|1
321363|NCT00688701|1052204|P1|Overall Study|Poor compliance to protocol|0
321364|NCT00688701|1052201|P4|Overall Study|Withdrawal by Subject|8
321365|NCT00688701|1052202|P3|Overall Study|Withdrawal by Subject|4
321366|NCT00688701|1052203|P2|Overall Study|Withdrawal by Subject|3
321367|NCT00688701|1052204|P1|Overall Study|Withdrawal by Subject|3
321368|NCT00688701|1052201|P4|Overall Study|Lack of Efficacy|0
321369|NCT00688701|1052202|P3|Overall Study|Lack of Efficacy|0
321370|NCT00688701|1052203|P2|Overall Study|Lack of Efficacy|1
321371|NCT00688701|1052204|P1|Overall Study|Lack of Efficacy|0
321372|NCT00688701|1052201|P4|Overall Study|Adverse Event|3
321373|NCT00688701|1052202|P3|Overall Study|Adverse Event|5
321374|NCT00688701|1052203|P2|Overall Study|Adverse Event|0
321375|NCT00688701|1052204|P1|Overall Study|Adverse Event|1
321376|NCT00688688|1052245|P3|Overall Study|Violation of exclusion criterion|0
321377|NCT00688688|1052246|P2|Overall Study|Violation of exclusion criterion|1
321378|NCT00688688|1052247|P1|Overall Study|Violation of exclusion criterion|0
321379|NCT00688688|1052245|P3|Overall Study|Site closure|0
321380|NCT00688688|1052246|P2|Overall Study|Site closure|1
321381|NCT00688688|1052247|P1|Overall Study|Site closure|0
321382|NCT00688688|1052245|P3|Overall Study|Taking exclusionary medications|0
321383|NCT00688688|1052246|P2|Overall Study|Taking exclusionary medications|0
321384|NCT00688688|1052247|P1|Overall Study|Taking exclusionary medications|1
321385|NCT00688688|1052245|P3|Overall Study|Non-compliance with study procedures|4
321386|NCT00688688|1052246|P2|Overall Study|Non-compliance with study procedures|3
321387|NCT00688688|1052247|P1|Overall Study|Non-compliance with study procedures|5
321388|NCT00688688|1052245|P3|Overall Study|Randomized but never received study drug|0
321389|NCT00688688|1052246|P2|Overall Study|Randomized but never received study drug|0
321390|NCT00688688|1052247|P1|Overall Study|Randomized but never received study drug|1
321391|NCT00688688|1052245|P3|Overall Study|Protocol Violation|11
321392|NCT00688688|1052246|P2|Overall Study|Protocol Violation|9
321393|NCT00688688|1052247|P1|Overall Study|Protocol Violation|6
321394|NCT00688688|1052245|P3|Overall Study|Lost to Follow-up|7
321395|NCT00688688|1052246|P2|Overall Study|Lost to Follow-up|7
321396|NCT00688688|1052247|P1|Overall Study|Lost to Follow-up|14
321397|NCT00688688|1052245|P3|Overall Study|Withdrawal by Subject|65
321398|NCT00688688|1052246|P2|Overall Study|Withdrawal by Subject|75
321399|NCT00688688|1052247|P1|Overall Study|Withdrawal by Subject|66
321400|NCT00688688|1052245|P3|Overall Study|Lack of Efficacy|45
321401|NCT00688688|1052246|P2|Overall Study|Lack of Efficacy|25
321402|NCT00688688|1052247|P1|Overall Study|Lack of Efficacy|34
321403|NCT00688688|1052245|P3|Overall Study|Adverse Event|50
321404|NCT00688688|1052246|P2|Overall Study|Adverse Event|51
321405|NCT00688688|1052247|P1|Overall Study|Adverse Event|52
321406|NCT00688688|1052245|P3|Overall Study|Eligibility criterion not met|10
321407|NCT00688688|1052246|P2|Overall Study|Eligibility criterion not met|7
321408|NCT00688688|1052247|P1|Overall Study|Eligibility criterion not met|7
321409|NCT00688636|1052349|P2|Overall Study|Adverse Event|1
321410|NCT00688636|1052350|P1|Overall Study|Adverse Event|2
321411|NCT00688545|1052366|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
321412|NCT00688545|1052367|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
321413|NCT00688545|1052366|P2|Overall Study|Withdrawal by Subject|3
321414|NCT00688545|1052367|P1|Overall Study|Withdrawal by Subject|2
321415|NCT00688545|1052366|P2|Overall Study|Insurance/cost of drug|1
321416|NCT00688545|1052367|P1|Overall Study|Insurance/cost of drug|0
321417|NCT00688545|1052366|P2|Overall Study|Lost to Follow-up|4
321418|NCT00688545|1052367|P1|Overall Study|Lost to Follow-up|1
321419|NCT00688519|1052377|P2|Overall Study|Pregnancy|1
321420|NCT00688519|1052378|P1|Overall Study|Pregnancy|0
321421|NCT00688519|1052377|P2|Overall Study|Subject moved out of area|0
321422|NCT00688519|1052378|P1|Overall Study|Subject moved out of area|1
321423|NCT00688519|1052377|P2|Overall Study|Investigator decision|0
321424|NCT00688519|1052378|P1|Overall Study|Investigator decision|1
321425|NCT00688519|1052377|P2|Overall Study|Subject moved out of state|0
321426|NCT00688519|1052378|P1|Overall Study|Subject moved out of state|1
321427|NCT00688519|1052377|P2|Overall Study|Non-compliance|1
321428|NCT00688519|1052378|P1|Overall Study|Non-compliance|0
321429|NCT00688519|1052377|P2|Overall Study|Prohibited medication|0
321430|NCT00688519|1052378|P1|Overall Study|Prohibited medication|1
321431|NCT00688519|1052377|P2|Overall Study|Withdrawal by Subject|6
321432|NCT00688519|1052378|P1|Overall Study|Withdrawal by Subject|7
321433|NCT00688519|1052377|P2|Overall Study|Lack of Efficacy|1
321434|NCT00688519|1052378|P1|Overall Study|Lack of Efficacy|3
321435|NCT00688519|1052377|P2|Overall Study|Lost to Follow-up|3
321436|NCT00688519|1052378|P1|Overall Study|Lost to Follow-up|3
321437|NCT00688519|1052377|P2|Overall Study|Adverse Event|3
321438|NCT00688519|1052378|P1|Overall Study|Adverse Event|2
321439|NCT00688467|1052396|P2|Treatment Period 2|Adverse Event|1
321440|NCT00688467|1052397|P1|Treatment Period 2|Adverse Event|0
321441|NCT00688467|1052396|P2|Treatment Period 2|Protocol Violation|1
321442|NCT00688467|1052397|P1|Treatment Period 2|Protocol Violation|0
321443|NCT00688467|1052396|P2|Treatment Period 1|Did not meet protocol eligibility|1
321444|NCT00688467|1052397|P1|Treatment Period 1|Did not meet protocol eligibility|0
321445|NCT00688467|1052396|P2|Treatment Period 1|Adverse Event|1
321446|NCT00688467|1052397|P1|Treatment Period 1|Adverse Event|2
321447|NCT00688103|1052429|P2|Overall Study|complex reasons|9
321448|NCT00688103|1052430|P1|Overall Study|complex reasons|11
321449|NCT00688103|1052429|P2|Overall Study|Withdrawal by Subject|2
321450|NCT00688103|1052430|P1|Overall Study|Withdrawal by Subject|4
321451|NCT00688103|1052429|P2|Overall Study|Lack of Efficacy|1
321452|NCT00688103|1052430|P1|Overall Study|Lack of Efficacy|11
321453|NCT00688103|1052429|P2|Overall Study|Adverse Event|1
321454|NCT00688103|1052430|P1|Overall Study|Adverse Event|4
321455|NCT00688064|1052442|P2|Overall Study|Any other reasons|3
321456|NCT00688064|1052443|P1|Overall Study|Any other reasons|1
321457|NCT00688064|1052442|P2|Overall Study|Pregnancy|0
321458|NCT00688064|1052443|P1|Overall Study|Pregnancy|1
321459|NCT00688064|1052442|P2|Overall Study|Lack of Efficacy|1
321460|NCT00688064|1052443|P1|Overall Study|Lack of Efficacy|0
321461|NCT00688064|1052442|P2|Overall Study|Lost to Follow-up|10
321462|NCT00688064|1052443|P1|Overall Study|Lost to Follow-up|10
321463|NCT00688064|1052442|P2|Overall Study|Withdrawal by Subject|7
321464|NCT00688064|1052443|P1|Overall Study|Withdrawal by Subject|7
321465|NCT00688064|1052442|P2|Overall Study|Adverse Event|4
321466|NCT00688064|1052443|P1|Overall Study|Adverse Event|2
321467|NCT00688064|1052442|P2|Overall Study|Protocol Violation|1
321468|NCT00688064|1052443|P1|Overall Study|Protocol Violation|0
321469|NCT00687973|1052459|P2|Overall Study|Withdrawal by Subject|3
321470|NCT00687973|1052460|P1|Overall Study|Withdrawal by Subject|3
321471|NCT00687973|1052459|P2|Overall Study|Administrative Reasons|2
321472|NCT00687973|1052460|P1|Overall Study|Administrative Reasons|0
321473|NCT00687973|1052459|P2|Overall Study|Protocol Violation|2
321474|NCT00687973|1052460|P1|Overall Study|Protocol Violation|1
321475|NCT00687973|1052459|P2|Overall Study|Lack of Efficacy|3
321476|NCT00687973|1052460|P1|Overall Study|Lack of Efficacy|2
321477|NCT00687973|1052459|P2|Overall Study|Adverse Event|28
321478|NCT00687973|1052460|P1|Overall Study|Adverse Event|18
321479|NCT00687804|1052522|P3|Open-Label Extension Study|Death|3
321480|NCT00687804|1052523|P2|Open-Label Extension Study|Death|3
321481|NCT00687804|1052524|P1|Open-Label Extension Study|Death|2
321482|NCT00687804|1052522|P3|Open-Label Extension Study|Administrative problems|0
321483|NCT00687804|1052523|P2|Open-Label Extension Study|Administrative problems|1
321484|NCT00687804|1052524|P1|Open-Label Extension Study|Administrative problems|1
321485|NCT00687804|1052522|P3|Open-Label Extension Study|Lost to Follow-up|2
321486|NCT00687804|1052523|P2|Open-Label Extension Study|Lost to Follow-up|1
321487|NCT00687804|1052524|P1|Open-Label Extension Study|Lost to Follow-up|2
321488|NCT00687804|1052522|P3|Open-Label Extension Study|Subject withdrew consent|4
321489|NCT00687804|1052523|P2|Open-Label Extension Study|Subject withdrew consent|4
321490|NCT00687804|1052524|P1|Open-Label Extension Study|Subject withdrew consent|3
321491|NCT00687804|1052522|P3|Open-Label Extension Study|Adverse Event|2
321492|NCT00687804|1052523|P2|Open-Label Extension Study|Adverse Event|2
321493|NCT00687804|1052524|P1|Open-Label Extension Study|Adverse Event|2
321494|NCT00687804|1052522|P3|Core Study|Protocol Violation|0
321495|NCT00687804|1052523|P2|Core Study|Protocol Violation|1
321496|NCT00687804|1052524|P1|Core Study|Protocol Violation|1
321497|NCT00687804|1052522|P3|Core Study|Death|2
321498|NCT00687804|1052523|P2|Core Study|Death|2
321499|NCT00687804|1052524|P1|Core Study|Death|2
321500|NCT00687804|1052522|P3|Core Study|Lost to Follow-up|0
321501|NCT00687804|1052523|P2|Core Study|Lost to Follow-up|1
321502|NCT00687804|1052524|P1|Core Study|Lost to Follow-up|0
321503|NCT00687804|1052522|P3|Core Study|Withdrawal by Subject|7
321504|NCT00687804|1052523|P2|Core Study|Withdrawal by Subject|7
321505|NCT00687804|1052524|P1|Core Study|Withdrawal by Subject|4
321506|NCT00687804|1052522|P3|Core Study|Lack of Efficacy|1
321507|NCT00687804|1052523|P2|Core Study|Lack of Efficacy|1
321508|NCT00687804|1052524|P1|Core Study|Lack of Efficacy|1
321509|NCT00687804|1052522|P3|Core Study|Abnormal laboratory value(s)|0
321510|NCT00687804|1052523|P2|Core Study|Abnormal laboratory value(s)|0
321511|NCT00687804|1052524|P1|Core Study|Abnormal laboratory value(s)|1
321512|NCT00687804|1052522|P3|Core Study|Adverse Event|3
321513|NCT00687804|1052523|P2|Core Study|Adverse Event|3
321514|NCT00687804|1052524|P1|Core Study|Adverse Event|5
321515|NCT00687609|1052585|P1|Overall Study|Withdrawal by Subject|2
321516|NCT00687609|1052585|P1|Overall Study|Physician Decision|1
321517|NCT00687531|1052608|P1|Overall Study|Lost to Follow-up|26
321518|NCT00687531|1052608|P1|Overall Study|Adverse Event|5
321519|NCT00687531|1052608|P1|Overall Study|Did not meet protocol eligibility|104
321520|NCT00687440|1052631|P1|Overall Study|Missing|1
321521|NCT00687440|1052631|P1|Overall Study|Not specified|1
321522|NCT00687440|1052631|P1|Overall Study|Death|2
321523|NCT00687440|1052631|P1|Overall Study|Lack of Efficacy|2
321524|NCT00687440|1052631|P1|Overall Study|Lost to Follow-up|3
321525|NCT00687440|1052631|P1|Overall Study|Adverse Event|3
321526|NCT00687401|1052635|P1|Overall Study|For reasons different from those above|4
321527|NCT00687401|1052635|P1|Overall Study|Did not return for visit|3
321528|NCT00687401|1052635|P1|Overall Study|Withdrawal by Subject|4
321529|NCT00687401|1052635|P1|Overall Study|Lack of Efficacy|6
321530|NCT00687401|1052635|P1|Overall Study|Adverse Event|6
321531|NCT00687401|1052635|P1|Overall Study|Protocol Violation|7
321532|NCT00687362|1052640|P1|Overall Study|Withdrawal by Subject|1
321533|NCT00687362|1052640|P1|Overall Study|Protocol Violation|2
321534|NCT00687323|1052644|P1|Overall Study|Screen failure|148
321535|NCT00687323|1052644|P1|Overall Study|Excluded from efficacy evaluations|6
321536|NCT00687323|1052644|P1|Overall Study|Withdrawal by Subject|1
321537|NCT00687323|1052644|P1|Overall Study|Death|25
321538|NCT00687297|1052660|P2|Induction|Other|1
321539|NCT00687297|1052661|P1|Induction|Other|0
321540|NCT00687297|1052660|P2|Induction|Physician Decision|2
321541|NCT00687297|1052661|P1|Induction|Physician Decision|0
321542|NCT00687297|1052660|P2|Induction|Patient Noncompliance|0
321543|NCT00687297|1052661|P1|Induction|Patient Noncompliance|1
321544|NCT00687297|1052660|P2|Induction|Ineligible|1
321545|NCT00687297|1052661|P1|Induction|Ineligible|0
321546|NCT00687297|1052660|P2|Induction|Lack of Efficacy|21
321547|NCT00687297|1052661|P1|Induction|Lack of Efficacy|17
321548|NCT00687297|1052660|P2|Induction|Death|11
321549|NCT00687297|1052661|P1|Induction|Death|7
321550|NCT00687297|1052660|P2|Induction|Adverse Event|15
321551|NCT00687297|1052661|P1|Induction|Adverse Event|16
321552|NCT00687297|1052660|P2|Induction|Withdrawal by Subject|4
321553|NCT00687297|1052661|P1|Induction|Withdrawal by Subject|4
321554|NCT00687297|1052660|P2|Randomization|Withdrew before treatment, ineligible|1
321555|NCT00687297|1052661|P1|Randomization|Withdrew before treatment, ineligible|1
321556|NCT00687297|1052660|P2|Randomization|Withdrawal by Subject|0
321557|NCT00687297|1052661|P1|Randomization|Withdrawal by Subject|2
321558|NCT00687219|1052671|P1|Overall Study|Lack of Efficacy|1
321559|NCT00687219|1052671|P1|Overall Study|Withdrawal by Subject|1
321560|NCT00687219|1052671|P1|Overall Study|HCV-RNA positive conversion|34
321561|NCT00687219|1052671|P1|Overall Study|Discontinuance criteria met|7
321562|NCT00687219|1052671|P1|Overall Study|Adverse Event|8
321563|NCT00687193|1052683|P6|Overall Study|Protocol Violation|0
321564|NCT00687193|1052684|P5|Overall Study|Protocol Violation|2
321565|NCT00687193|1052685|P4|Overall Study|Protocol Violation|1
321566|NCT00687193|1052686|P3|Overall Study|Protocol Violation|0
321567|NCT00687193|1052687|P2|Overall Study|Protocol Violation|2
321568|NCT00687193|1052688|P1|Overall Study|Protocol Violation|1
321569|NCT00687193|1052683|P6|Overall Study|Lack of Efficacy|2
321570|NCT00687193|1052684|P5|Overall Study|Lack of Efficacy|0
321571|NCT00687193|1052685|P4|Overall Study|Lack of Efficacy|0
321572|NCT00687193|1052686|P3|Overall Study|Lack of Efficacy|0
321573|NCT00687193|1052687|P2|Overall Study|Lack of Efficacy|1
321574|NCT00687193|1052688|P1|Overall Study|Lack of Efficacy|1
321575|NCT00687193|1052683|P6|Overall Study|Adverse Event|2
321576|NCT00687193|1052684|P5|Overall Study|Adverse Event|0
321577|NCT00687193|1052685|P4|Overall Study|Adverse Event|3
321578|NCT00687193|1052686|P3|Overall Study|Adverse Event|2
321579|NCT00687193|1052687|P2|Overall Study|Adverse Event|1
321580|NCT00687193|1052688|P1|Overall Study|Adverse Event|0
321581|NCT00686166|1052852|P1|Overall Study|Did not begin protocol therapy|4
321582|NCT00686166|1052852|P1|Overall Study|Ineligible|5
321583|NCT00686166|1052852|P1|Overall Study|Not Protocol Specified|1
321584|NCT00686166|1052852|P1|Overall Study|Death|1
321585|NCT00686166|1052852|P1|Overall Study|Progression/Relapse|1
321586|NCT00686166|1052852|P1|Overall Study|Withdrawal by Subject|1
321587|NCT00686166|1052852|P1|Overall Study|Adverse Event|7
321588|NCT00686127|1052864|P2|Overall Study|Withdrawal by Subject|6
321589|NCT00686127|1052865|P1|Overall Study|Withdrawal by Subject|14
321590|NCT00686075|1052881|P10|Overall Study|unspecified|1
321591|NCT00686075|1052882|P9|Overall Study|unspecified|0
321592|NCT00686075|1052883|P8|Overall Study|unspecified|0
321593|NCT00686075|1052884|P7|Overall Study|unspecified|0
321594|NCT00686075|1052885|P6|Overall Study|unspecified|0
321595|NCT00686075|1052886|P5|Overall Study|unspecified|0
321596|NCT00686075|1052887|P4|Overall Study|unspecified|0
321597|NCT00686075|1052888|P3|Overall Study|unspecified|0
321598|NCT00686075|1052889|P2|Overall Study|unspecified|1
321599|NCT00686075|1052890|P1|Overall Study|unspecified|1
321600|NCT00686075|1052881|P10|Overall Study|Lost to Follow-up|3
321601|NCT00686075|1052882|P9|Overall Study|Lost to Follow-up|2
321602|NCT00686075|1052883|P8|Overall Study|Lost to Follow-up|0
321603|NCT00686075|1052884|P7|Overall Study|Lost to Follow-up|0
321604|NCT00686075|1052885|P6|Overall Study|Lost to Follow-up|3
321605|NCT00686075|1052886|P5|Overall Study|Lost to Follow-up|3
321606|NCT00686075|1052887|P4|Overall Study|Lost to Follow-up|2
321607|NCT00686075|1052888|P3|Overall Study|Lost to Follow-up|3
321608|NCT00686075|1052889|P2|Overall Study|Lost to Follow-up|6
321609|NCT00686075|1052890|P1|Overall Study|Lost to Follow-up|3
321610|NCT00686075|1052881|P10|Overall Study|Withdrawal by Subject|6
321611|NCT00686075|1052882|P9|Overall Study|Withdrawal by Subject|4
321612|NCT00686075|1052883|P8|Overall Study|Withdrawal by Subject|2
321613|NCT00686075|1052884|P7|Overall Study|Withdrawal by Subject|0
321614|NCT00686075|1052885|P6|Overall Study|Withdrawal by Subject|0
321615|NCT00686075|1052886|P5|Overall Study|Withdrawal by Subject|1
321616|NCT00686075|1052887|P4|Overall Study|Withdrawal by Subject|7
321617|NCT00686075|1052888|P3|Overall Study|Withdrawal by Subject|3
321618|NCT00686075|1052889|P2|Overall Study|Withdrawal by Subject|3
321619|NCT00686075|1052890|P1|Overall Study|Withdrawal by Subject|4
321620|NCT00686036|1053084|P2|Overall Study|Other reasons not identified|4
321621|NCT00686036|1053085|P1|Overall Study|Other reasons not identified|0
321622|NCT00686036|1053084|P2|Overall Study|PSA ≥ 10ng/mL|0
321623|NCT00686036|1053085|P1|Overall Study|PSA ≥ 10ng/mL|1
321624|NCT00686036|1053084|P2|Overall Study|Study terminated by AstraZeneca|1
321625|NCT00686036|1053085|P1|Overall Study|Study terminated by AstraZeneca|2
321626|NCT00686036|1053084|P2|Overall Study|Withdrawal by Subject|1
321627|NCT00686036|1053085|P1|Overall Study|Withdrawal by Subject|3
321628|NCT00686036|1053084|P2|Overall Study|Adverse Event|0
321629|NCT00686036|1053085|P1|Overall Study|Adverse Event|3
321630|NCT00685945|1053097|P1|L-NMMA + Bradykinin|Physician Decision|1
321631|NCT00686998|1053135|P3|Overall Study|Safety Reasons|0
321632|NCT00686998|1053136|P2|Overall Study|Safety Reasons|0
321633|NCT00686998|1053137|P1|Overall Study|Safety Reasons|1
321634|NCT00686998|1053135|P3|Overall Study|Not specified|1
321635|NCT00686998|1053136|P2|Overall Study|Not specified|0
321636|NCT00686998|1053137|P1|Overall Study|Not specified|0
321637|NCT00686998|1053135|P3|Overall Study|Lack of Efficacy|0
321638|NCT00686998|1053136|P2|Overall Study|Lack of Efficacy|5
321639|NCT00686998|1053137|P1|Overall Study|Lack of Efficacy|7
321640|NCT00686998|1053135|P3|Overall Study|Withdrawal by Subject|2
321641|NCT00686998|1053136|P2|Overall Study|Withdrawal by Subject|1
321642|NCT00686998|1053137|P1|Overall Study|Withdrawal by Subject|2
321643|NCT00686998|1053135|P3|Overall Study|Adverse Event|1
321644|NCT00686998|1053136|P2|Overall Study|Adverse Event|2
321645|NCT00686998|1053137|P1|Overall Study|Adverse Event|3
321646|NCT00686959|1053147|P2|Overall Study|Participants censored (no death events)|117
321647|NCT00686959|1053148|P1|Overall Study|Participants censored (no death events)|124
321648|NCT00686894|1053166|P1|Overall Study|Protocol Violation|4
321649|NCT00686894|1053166|P1|Overall Study|Relapse|2
321650|NCT00686881|1053172|P2|Overall Study|Never received study drug|6
321651|NCT00686881|1053173|P1|Overall Study|Never received study drug|2
321652|NCT00686881|1053172|P2|Overall Study|Study discontinuation|32
321653|NCT00686881|1053173|P1|Overall Study|Study discontinuation|35
321654|NCT00686881|1053172|P2|Overall Study|Irregular visits|0
321655|NCT00686881|1053173|P1|Overall Study|Irregular visits|1
321656|NCT00686881|1053172|P2|Overall Study|Did not meet protocol eligibility|0
321657|NCT00686881|1053173|P1|Overall Study|Did not meet protocol eligibility|1
321658|NCT00686881|1053172|P2|Overall Study|Circumstances of site|1
321659|NCT00686881|1053173|P1|Overall Study|Circumstances of site|1
321660|NCT00686881|1053172|P2|Overall Study|Physician Decision|0
321661|NCT00686881|1053173|P1|Overall Study|Physician Decision|1
321662|NCT00686881|1053172|P2|Overall Study|Lack of Efficacy|3
321663|NCT00686881|1053173|P1|Overall Study|Lack of Efficacy|4
321664|NCT00686881|1053172|P2|Overall Study|Onset of malignant tumor|11
321665|NCT00686881|1053173|P1|Overall Study|Onset of malignant tumor|11
321666|NCT00686881|1053172|P2|Overall Study|Met discontinuation criteria|0
321667|NCT00686881|1053173|P1|Overall Study|Met discontinuation criteria|5
321668|NCT00686881|1053172|P2|Overall Study|Treatment-related adverse event|9
321669|NCT00686881|1053173|P1|Overall Study|Treatment-related adverse event|10
321670|NCT00686881|1053172|P2|Overall Study|Lost to Follow-up|1
321671|NCT00686881|1053173|P1|Overall Study|Lost to Follow-up|0
321672|NCT00686881|1053172|P2|Overall Study|Withdrawal by Subject|18
321673|NCT00686881|1053173|P1|Overall Study|Withdrawal by Subject|11
321674|NCT00686855|1053185|P2|Overall Study|Progressive GVHD|1
321675|NCT00686855|1053186|P1|Overall Study|Progressive GVHD|0
321676|NCT00686855|1053185|P2|Overall Study|Lost to Follow-up|0
321677|NCT00686855|1053186|P1|Overall Study|Lost to Follow-up|1
321678|NCT00686790|1053212|P1|Overall Study|Lost to Follow-up|12
321679|NCT00686790|1053212|P1|Overall Study|Death|1
321680|NCT00686790|1053212|P1|Overall Study|Withdrawal by Subject|1
321681|NCT00686790|1053212|P1|Overall Study|Adverse Event|2
321682|NCT00686777|1053220|P1|Overall Study|No Visit|1
321683|NCT00686777|1053220|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
321684|NCT00686777|1053220|P1|Overall Study|Withdrawal by Subject|2
321685|NCT00686777|1053220|P1|Overall Study|Pregnancy|1
321686|NCT00686777|1053220|P1|Overall Study|Adverse Event|2
321687|NCT00686725|1053228|P2|Overall Study|Not Specified|3
321688|NCT00686725|1053229|P1|Overall Study|Not Specified|1
321689|NCT00686725|1053228|P2|Overall Study|Protocol Violation|3
321690|NCT00686725|1053229|P1|Overall Study|Protocol Violation|1
321691|NCT00686725|1053228|P2|Overall Study|Withdrawal by Subject|4
321692|NCT00686725|1053229|P1|Overall Study|Withdrawal by Subject|13
321693|NCT00686725|1053228|P2|Overall Study|Death|3
321694|NCT00686725|1053229|P1|Overall Study|Death|6
321695|NCT00686725|1053228|P2|Overall Study|Lost to Follow-up|5
321696|NCT00686725|1053229|P1|Overall Study|Lost to Follow-up|7
321697|NCT00686725|1053228|P2|Overall Study|Progressive Disease|23
321698|NCT00686725|1053229|P1|Overall Study|Progressive Disease|17
321699|NCT00686725|1053228|P2|Overall Study|Adverse Event|1
321700|NCT00686725|1053229|P1|Overall Study|Adverse Event|1
321701|NCT00686712|1053254|P3|Overall Study|Adverse Event|0
321702|NCT00686712|1053255|P2|Overall Study|Adverse Event|1
321703|NCT00686712|1053256|P1|Overall Study|Adverse Event|1
321704|NCT00686712|1053254|P3|Overall Study|Lost to Follow-up|3
321705|NCT00686712|1053255|P2|Overall Study|Lost to Follow-up|2
321706|NCT00686712|1053256|P1|Overall Study|Lost to Follow-up|1
321707|NCT00686712|1053254|P3|Overall Study|Protocol Violation|10
321708|NCT00686712|1053255|P2|Overall Study|Protocol Violation|8
321709|NCT00686712|1053256|P1|Overall Study|Protocol Violation|8
321710|NCT00686699|1053284|P2|Treatment Period 1|Adverse Event|2
321711|NCT00686699|1053285|P1|Treatment Period 1|Adverse Event|0
321712|NCT00686686|1053309|P1|Overall Study|Lost to Follow-up|3
321713|NCT00686686|1053309|P1|Overall Study|Adverse Event|2
321714|NCT00686686|1053309|P1|Overall Study|Non-compliance|1
321715|NCT00686647|1053317|P1|Overall Study|Death|1
321716|NCT00686647|1053317|P1|Overall Study|Lost to Follow-up|1
321717|NCT00686634|1053323|P1|Overall Study|Protocol Violation|6
321718|NCT00686595|1053330|P1|Overall Study|Poor Compliance|1
321719|NCT00686595|1053330|P1|Overall Study|Lack of Efficacy|1
321720|NCT00686595|1053330|P1|Overall Study|Lost to Follow-up|1
321721|NCT00686595|1053330|P1|Overall Study|Protocol Violation|1
321722|NCT00686595|1053330|P1|Overall Study|Adverse Event|3
321723|NCT00686543|1053359|P4|Overall Study|Protocol Violation|1
321724|NCT00686543|1053360|P3|Overall Study|Protocol Violation|2
321725|NCT00686543|1053361|P2|Overall Study|Protocol Violation|0
321726|NCT00686543|1053362|P1|Overall Study|Protocol Violation|3
321727|NCT00686543|1053359|P4|Overall Study|Withdrawal by Subject|0
321728|NCT00686543|1053360|P3|Overall Study|Withdrawal by Subject|0
321729|NCT00686543|1053361|P2|Overall Study|Withdrawal by Subject|0
321730|NCT00686543|1053362|P1|Overall Study|Withdrawal by Subject|2
321731|NCT00686543|1053359|P4|Overall Study|Adverse Event|2
321732|NCT00686543|1053360|P3|Overall Study|Adverse Event|3
321733|NCT00686543|1053361|P2|Overall Study|Adverse Event|1
321734|NCT00686543|1053362|P1|Overall Study|Adverse Event|9
321735|NCT00686517|1053383|P3|Treatment|Protocol Violation|0
321736|NCT00686517|1053384|P2|Treatment|Protocol Violation|1
321737|NCT00686517|1053385|P1|Treatment|Protocol Violation|2
321738|NCT00686517|1053383|P3|Treatment|Poor Protocol Compliance|0
321739|NCT00686517|1053384|P2|Treatment|Poor Protocol Compliance|0
321740|NCT00686517|1053385|P1|Treatment|Poor Protocol Compliance|1
321741|NCT00686517|1053383|P3|Treatment|Adverse Event|0
321742|NCT00686517|1053384|P2|Treatment|Adverse Event|0
321743|NCT00686517|1053385|P1|Treatment|Adverse Event|2
321744|NCT00686517|1053383|P3|Treatment|Serious Adverse Event|1
321745|NCT00686517|1053384|P2|Treatment|Serious Adverse Event|2
321746|NCT00686517|1053385|P1|Treatment|Serious Adverse Event|1
321747|NCT00686335|1053408|P1|Run-in Period|violation of inclusion/exclusion criteri|3
321748|NCT00686335|1053408|P1|Run-in Period|asthma exacerbation|1
321749|NCT00686335|1053408|P1|Run-in Period|Adverse Event|1
321750|NCT00686205|1053438|P2|Overall Study|Specimens not confirmed HIV positive|981
321751|NCT00686205|1053439|P1|Overall Study|Specimens not confirmed HIV positive|0
321752|NCT00686205|1053438|P2|Overall Study|Specimen handling procedure altered|0
321753|NCT00686205|1053439|P1|Overall Study|Specimen handling procedure altered|5878
321754|NCT00686205|1053438|P2|Overall Study|Withdrawal by Subject|0
321755|NCT00686205|1053439|P1|Overall Study|Withdrawal by Subject|2
321756|NCT00686205|1053438|P2|Overall Study|Protocol Violation|0
321757|NCT00686205|1053439|P1|Overall Study|Protocol Violation|127
321758|NCT00685802|1053454|P2|Washout Period of 7 Days|Withdrawal by Subject|1
321759|NCT00685802|1053455|P1|Washout Period of 7 Days|Withdrawal by Subject|0
321760|NCT00685802|1053454|P2|Washout Period of 7 Days|Protocol Violation|0
321761|NCT00685802|1053455|P1|Washout Period of 7 Days|Protocol Violation|2
321762|NCT00685763|1053465|P1|Overall Study|Protocol Violation|1
321763|NCT00685763|1053465|P1|Overall Study|Intercurrent death-incomplete treatment|1
321764|NCT00685698|1053469|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
321765|NCT00685698|1053469|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
321766|NCT00685698|1053469|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
321767|NCT00685698|1053469|P1|Overall Study|Adverse Event|3
321768|NCT00685698|1053469|P1|Overall Study|Protocol Violation|6
321769|NCT00685698|1053469|P1|Overall Study|Withdrawal by Subject|1
321770|NCT00685685|1053504|P2|Washout Period of 7 Days|Withdrawal by Subject|1
321771|NCT00685685|1053505|P1|Washout Period of 7 Days|Withdrawal by Subject|0
321772|NCT00685685|1053504|P2|Washout Period of 7 Days|Adverse Event|0
321773|NCT00685685|1053505|P1|Washout Period of 7 Days|Adverse Event|2
321774|NCT00685373|1053579|P1|Overall Study|Protocol Violation|1
321775|NCT00685373|1053579|P1|Overall Study|Lost to Follow-up|2
321776|NCT00685373|1053579|P1|Overall Study|Condition no longer requires study drug|1
321777|NCT00685373|1053579|P1|Overall Study|Lack of Efficacy|3
321778|NCT00685373|1053579|P1|Overall Study|Withdrawal by Subject|5
321779|NCT00685373|1053579|P1|Overall Study|Adverse Event|3
321780|NCT00685334|1053588|P2|Overall Study|Chose to enter hospital|1
321781|NCT00685334|1053589|P1|Overall Study|Chose to enter hospital|1
321782|NCT00685334|1053588|P2|Overall Study|Lost to Follow-up|0
321783|NCT00685334|1053589|P1|Overall Study|Lost to Follow-up|4
321784|NCT00685334|1053588|P2|Overall Study|Withdrawal by Subject|6
321785|NCT00685334|1053589|P1|Overall Study|Withdrawal by Subject|5
321786|NCT00685165|1053610|P2|Washout Period of 14 Days|Adverse Event|0
321787|NCT00685165|1053611|P1|Washout Period of 14 Days|Adverse Event|1
321788|NCT00685035|1053630|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
321789|NCT00685035|1053631|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
321790|NCT00684996|1053655|P1|Overall Study|Other reasons not protocol specified|1
321791|NCT00684996|1053655|P1|Overall Study|Progression/relapse|2
321792|NCT00684996|1053655|P1|Overall Study|Refusal unrelated to adverse event|1
321793|NCT00684996|1053655|P1|Overall Study|Adverse Event|1
321794|NCT00684814|1053677|P2|Second Intervention|Adverse Event|0
321795|NCT00684814|1053678|P1|Second Intervention|Adverse Event|1
321796|NCT00684814|1053677|P2|Washout Period of 7 Days|Withdrawal by Subject|2
321797|NCT00684814|1053678|P1|Washout Period of 7 Days|Withdrawal by Subject|1
321798|NCT00684814|1053677|P2|Washout Period of 7 Days|Adverse Event|2
321799|NCT00684814|1053678|P1|Washout Period of 7 Days|Adverse Event|1
321800|NCT00684762|1053688|P2|Washout Period of 7 Days|Withdrawal by Subject|2
321801|NCT00684762|1053689|P1|Washout Period of 7 Days|Withdrawal by Subject|2
321802|NCT00684671|1053717|P3|Overall Study|Alcoholic dependance|0
321803|NCT00684671|1053718|P2|Overall Study|Alcoholic dependance|0
321804|NCT00684671|1053719|P1|Overall Study|Alcoholic dependance|1
321805|NCT00684671|1053717|P3|Overall Study|Lost to Follow-up|0
321806|NCT00684671|1053718|P2|Overall Study|Lost to Follow-up|0
321807|NCT00684671|1053719|P1|Overall Study|Lost to Follow-up|1
321808|NCT00684671|1053717|P3|Overall Study|Adverse Event|0
321809|NCT00684671|1053718|P2|Overall Study|Adverse Event|0
321810|NCT00684671|1053719|P1|Overall Study|Adverse Event|1
321811|NCT00684645|1053748|P1|Overall Study|Not specified|15
321812|NCT00684645|1053748|P1|Overall Study|Lost to Follow-up|3
321813|NCT00684645|1053748|P1|Overall Study|Adverse Event|27
321814|NCT00684645|1053748|P1|Overall Study|Progressive disease|67
321815|NCT00684645|1053748|P1|Overall Study|Death|2
321816|NCT00684593|1053768|P2|Overall Study|Adverse Event|2
321817|NCT00684593|1053769|P1|Overall Study|Adverse Event|0
321818|NCT00684567|1053781|P1|Monotherapy Period|Progression of primary disease|11
321819|NCT00684567|1053781|P1|Monotherapy Period|Death|1
321820|NCT00684567|1053781|P1|Monotherapy Period|Adverse Event|2
321821|NCT00684567|1053781|P1|Concomitant Radiotherapy Period|Adverse Event|2
321822|NCT00684515|1053814|P3|Overall Study|Protocol-Defined Clinical Event|0
321823|NCT00684515|1053815|P2|Overall Study|Protocol-Defined Clinical Event|0
321824|NCT00684515|1053816|P1|Overall Study|Protocol-Defined Clinical Event|1
321825|NCT00684515|1053814|P3|Overall Study|Adverse Event|1
321826|NCT00684515|1053815|P2|Overall Study|Adverse Event|3
321827|NCT00684515|1053816|P1|Overall Study|Adverse Event|3
321828|NCT00684424|1053839|P1|Overall Study|Not Specified|2
321829|NCT00684424|1053839|P1|Overall Study|Lost to Follow-up|2
321830|NCT00684424|1053839|P1|Overall Study|Adverse Event|1
321831|NCT00684411|1053854|P1|Overall Study|Adverse Event|1
321832|NCT00684411|1053854|P1|Overall Study|Disease Progression|10
321833|NCT00684411|1053854|P1|Overall Study|New Primary Cancer|1
321834|NCT00684307|1053876|P5|Overall Study|Criteria from the CSR|3
321835|NCT00684307|1053877|P4|Overall Study|Criteria from the CSR|3
321836|NCT00684307|1053878|P3|Overall Study|Criteria from the CSR|1
321837|NCT00684307|1053879|P2|Overall Study|Criteria from the CSR|0
321838|NCT00684307|1053880|P1|Overall Study|Criteria from the CSR|0
321839|NCT00684307|1053876|P5|Overall Study|Participant not willing to continue|8
321840|NCT00684307|1053877|P4|Overall Study|Participant not willing to continue|5
321841|NCT00684307|1053878|P3|Overall Study|Participant not willing to continue|11
321842|NCT00684307|1053879|P2|Overall Study|Participant not willing to continue|10
321843|NCT00684307|1053880|P1|Overall Study|Participant not willing to continue|7
321844|NCT00684307|1053876|P5|Overall Study|Severe non compliance to protocol|2
321845|NCT00684307|1053877|P4|Overall Study|Severe non compliance to protocol|1
321846|NCT00684307|1053878|P3|Overall Study|Severe non compliance to protocol|0
321847|NCT00684307|1053879|P2|Overall Study|Severe non compliance to protocol|0
321848|NCT00684307|1053880|P1|Overall Study|Severe non compliance to protocol|1
321849|NCT00684307|1053876|P5|Overall Study|Interupted IP for more than 7 days|3
321850|NCT00684307|1053877|P4|Overall Study|Interupted IP for more than 7 days|3
321851|NCT00684307|1053878|P3|Overall Study|Interupted IP for more than 7 days|1
321852|NCT00684307|1053879|P2|Overall Study|Interupted IP for more than 7 days|4
321853|NCT00684307|1053880|P1|Overall Study|Interupted IP for more than 7 days|0
321854|NCT00684307|1053876|P5|Overall Study|Incorrect enrolment or randomization|0
321855|NCT00684307|1053877|P4|Overall Study|Incorrect enrolment or randomization|0
321856|NCT00684307|1053878|P3|Overall Study|Incorrect enrolment or randomization|0
321857|NCT00684307|1053879|P2|Overall Study|Incorrect enrolment or randomization|0
321858|NCT00684307|1053880|P1|Overall Study|Incorrect enrolment or randomization|4
321859|NCT00684307|1053876|P5|Overall Study|Fullfillment of exclusion criteria|1
321860|NCT00684307|1053877|P4|Overall Study|Fullfillment of exclusion criteria|3
321861|NCT00684307|1053878|P3|Overall Study|Fullfillment of exclusion criteria|0
321862|NCT00684307|1053879|P2|Overall Study|Fullfillment of exclusion criteria|0
321863|NCT00684307|1053880|P1|Overall Study|Fullfillment of exclusion criteria|1
321864|NCT00684307|1053876|P5|Overall Study|Development of increasing Liver Function|0
321865|NCT00684307|1053877|P4|Overall Study|Development of increasing Liver Function|1
321866|NCT00684307|1053878|P3|Overall Study|Development of increasing Liver Function|0
321867|NCT00684307|1053879|P2|Overall Study|Development of increasing Liver Function|2
321868|NCT00684307|1053880|P1|Overall Study|Development of increasing Liver Function|0
321869|NCT00684307|1053876|P5|Overall Study|Adverse Event|8
321870|NCT00684307|1053877|P4|Overall Study|Adverse Event|16
321871|NCT00684307|1053878|P3|Overall Study|Adverse Event|15
321872|NCT00684307|1053879|P2|Overall Study|Adverse Event|6
321873|NCT00684307|1053880|P1|Overall Study|Adverse Event|11
321874|NCT00684203|1053962|P6|Overall Study|Did not meet protocol eligibility|0
321875|NCT00684203|1053963|P5|Overall Study|Did not meet protocol eligibility|0
321876|NCT00684203|1053964|P4|Overall Study|Did not meet protocol eligibility|0
321877|NCT00684203|1053965|P3|Overall Study|Did not meet protocol eligibility|0
321878|NCT00684203|1053966|P2|Overall Study|Did not meet protocol eligibility|1
321879|NCT00684203|1053967|P1|Overall Study|Did not meet protocol eligibility|0
321880|NCT00684203|1053962|P6|Overall Study|Withdrawal by Subject|0
321881|NCT00684203|1053963|P5|Overall Study|Withdrawal by Subject|0
321882|NCT00684203|1053964|P4|Overall Study|Withdrawal by Subject|0
321883|NCT00684203|1053965|P3|Overall Study|Withdrawal by Subject|1
321884|NCT00684203|1053966|P2|Overall Study|Withdrawal by Subject|2
321885|NCT00684203|1053967|P1|Overall Study|Withdrawal by Subject|0
321886|NCT00684203|1053962|P6|Overall Study|Protocol-defined clinical event|0
321887|NCT00684203|1053963|P5|Overall Study|Protocol-defined clinical event|0
321888|NCT00684203|1053964|P4|Overall Study|Protocol-defined clinical event|0
321889|NCT00684203|1053965|P3|Overall Study|Protocol-defined clinical event|0
321890|NCT00684203|1053966|P2|Overall Study|Protocol-defined clinical event|1
321891|NCT00684203|1053967|P1|Overall Study|Protocol-defined clinical event|3
321892|NCT00684203|1053962|P6|Overall Study|Adverse Event|0
321893|NCT00684203|1053963|P5|Overall Study|Adverse Event|0
321894|NCT00684203|1053964|P4|Overall Study|Adverse Event|0
321895|NCT00684203|1053965|P3|Overall Study|Adverse Event|8
321896|NCT00684203|1053966|P2|Overall Study|Adverse Event|4
321897|NCT00684203|1053967|P1|Overall Study|Adverse Event|6
321898|NCT00684177|1054028|P2|Overall Study|Other|2
321899|NCT00684177|1054029|P1|Overall Study|Other|1
321900|NCT00684177|1054028|P2|Overall Study|Withdrawal by Subject|2
321901|NCT00684177|1054029|P1|Overall Study|Withdrawal by Subject|1
321902|NCT00684177|1054028|P2|Overall Study|Physician Decision|0
321903|NCT00684177|1054029|P1|Overall Study|Physician Decision|2
321904|NCT00684177|1054028|P2|Overall Study|Lost to Follow-up|1
321905|NCT00684177|1054029|P1|Overall Study|Lost to Follow-up|2
321906|NCT00684177|1054028|P2|Overall Study|Protocol Violation|0
321907|NCT00684177|1054029|P1|Overall Study|Protocol Violation|1
321908|NCT00684177|1054028|P2|Overall Study|Lack of Efficacy|15
321909|NCT00684177|1054029|P1|Overall Study|Lack of Efficacy|10
321910|NCT00684177|1054028|P2|Overall Study|Adverse Event|3
321911|NCT00684177|1054029|P1|Overall Study|Adverse Event|4
321912|NCT00684073|1054064|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
321913|NCT00684073|1054064|P1|Selection|request of the sponsor|1
321914|NCT00684073|1054064|P1|Selection|Lost to Follow-up|1
321915|NCT00684073|1054064|P1|Selection|noncompliance|1
321916|NCT00684073|1054064|P1|Selection|Death|1
321917|NCT00684073|1054064|P1|Selection|Selection/non-selection criteria|3
321918|NCT00684060|1054074|P2|Overall Study|Death|1
321919|NCT00684060|1054075|P1|Overall Study|Death|0
321920|NCT00684060|1054074|P2|Overall Study|Unable to collect MRI|2
321921|NCT00684060|1054075|P1|Overall Study|Unable to collect MRI|1
321922|NCT00684060|1054074|P2|Overall Study|New stenosis identified|0
321923|NCT00684060|1054075|P1|Overall Study|New stenosis identified|1
321924|NCT00684060|1054074|P2|Overall Study|Lost to Follow-up|0
321925|NCT00684060|1054075|P1|Overall Study|Lost to Follow-up|1
321926|NCT00684021|1054114|P4|Overall Study|Death|0
321927|NCT00684021|1054115|P3|Overall Study|Death|0
321928|NCT00684021|1054116|P2|Overall Study|Death|0
321929|NCT00684021|1054117|P1|Overall Study|Death|1
321930|NCT00684021|1054114|P4|Overall Study|MRI not performed|2
321931|NCT00684021|1054115|P3|Overall Study|MRI not performed|1
321932|NCT00684021|1054116|P2|Overall Study|MRI not performed|1
321933|NCT00684021|1054117|P1|Overall Study|MRI not performed|0
321934|NCT00684021|1054114|P4|Overall Study|MRI Contraindicated|0
321935|NCT00684021|1054115|P3|Overall Study|MRI Contraindicated|1
321936|NCT00684021|1054116|P2|Overall Study|MRI Contraindicated|1
321937|NCT00684021|1054117|P1|Overall Study|MRI Contraindicated|1
321938|NCT00683917|1054178|P1|Overall Study|Study prematurely terminated|10
321939|NCT00683904|1054188|P2|Dose Level 2|Adverse Event|2
321940|NCT00683904|1054189|P1|Dose Level 2|Adverse Event|0
321941|NCT00683904|1054188|P2|Dose Level 1|Adverse Event|0
321942|NCT00683904|1054189|P1|Dose Level 1|Adverse Event|1
321943|NCT00683904|1054188|P2|Dose Level 1|Disease progression|0
321944|NCT00683904|1054189|P1|Dose Level 1|Disease progression|2
321945|NCT00683878|1054225|P3|Overall Study|Non-compliance, not met criteria etc.|0
321946|NCT00683878|1054226|P2|Overall Study|Non-compliance, not met criteria etc.|2
321947|NCT00683878|1054227|P1|Overall Study|Non-compliance, not met criteria etc.|3
321948|NCT00683878|1054225|P3|Overall Study|Lost to Follow-up|4
321949|NCT00683878|1054226|P2|Overall Study|Lost to Follow-up|2
321950|NCT00683878|1054227|P1|Overall Study|Lost to Follow-up|4
321951|NCT00683878|1054225|P3|Overall Study|Death|0
321952|NCT00683878|1054226|P2|Overall Study|Death|1
321953|NCT00683878|1054227|P1|Overall Study|Death|0
321954|NCT00683878|1054225|P3|Overall Study|Withdrawal by Subject|6
321955|NCT00683878|1054226|P2|Overall Study|Withdrawal by Subject|8
321956|NCT00683878|1054227|P1|Overall Study|Withdrawal by Subject|9
321957|NCT00683878|1054225|P3|Overall Study|Adverse Event|3
321958|NCT00683878|1054226|P2|Overall Study|Adverse Event|3
321959|NCT00683878|1054227|P1|Overall Study|Adverse Event|4
321960|NCT00683878|1054225|P3|Overall Study|Lack of Efficacy|1
321961|NCT00683878|1054226|P2|Overall Study|Lack of Efficacy|0
321962|NCT00683878|1054227|P1|Overall Study|Lack of Efficacy|3
321963|NCT00683800|1054266|P2|Overall Study|Randomized, not treated|33
321964|NCT00683800|1054267|P1|Overall Study|Randomized, not treated|35
321965|NCT00683800|1054266|P2|Overall Study|Lack of Efficacy|104
321966|NCT00683800|1054267|P1|Overall Study|Lack of Efficacy|61
321967|NCT00683800|1054266|P2|Overall Study|Withdrawal by Subject|64
321968|NCT00683800|1054267|P1|Overall Study|Withdrawal by Subject|66
321969|NCT00683800|1054266|P2|Overall Study|Protocol Violation|16
321970|NCT00683800|1054267|P1|Overall Study|Protocol Violation|13
321971|NCT00683800|1054266|P2|Overall Study|Unspecified|2
321972|NCT00683800|1054267|P1|Overall Study|Unspecified|5
321973|NCT00683800|1054266|P2|Overall Study|Lost to Follow-up|44
321974|NCT00683800|1054267|P1|Overall Study|Lost to Follow-up|57
321975|NCT00683800|1054266|P2|Overall Study|Death|1
321976|NCT00683800|1054267|P1|Overall Study|Death|0
321977|NCT00683800|1054266|P2|Overall Study|Adverse Event|102
321978|NCT00683800|1054267|P1|Overall Study|Adverse Event|195
321979|NCT00683787|1054334|P3|Overall Study|Adverse Event|2
321980|NCT00683787|1054335|P2|Overall Study|Adverse Event|0
321981|NCT00683787|1054336|P1|Overall Study|Adverse Event|0
321982|NCT00683787|1054334|P3|Overall Study|Progression|0
321983|NCT00683787|1054335|P2|Overall Study|Progression|3
321984|NCT00683787|1054336|P1|Overall Study|Progression|3
321985|NCT00683774|1054355|P2|Overall Study|Physician Decision|0
321986|NCT00683774|1054356|P1|Overall Study|Physician Decision|3
321987|NCT00683774|1054355|P2|Overall Study|Withdrawal by Subject|1
321988|NCT00683774|1054356|P1|Overall Study|Withdrawal by Subject|0
321989|NCT00683696|1054366|P2|Overall Study|Death|30
321990|NCT00683696|1054367|P1|Overall Study|Death|46
321991|NCT00683696|1054366|P2|Overall Study|Vital status follow-up only|3
321992|NCT00683696|1054367|P1|Overall Study|Vital status follow-up only|3
321993|NCT00683696|1054366|P2|Overall Study|Lost to Follow-up|6
321994|NCT00683696|1054367|P1|Overall Study|Lost to Follow-up|5
321995|NCT00683696|1054366|P2|Overall Study|Withdrawn prior to study closure|28
321996|NCT00683696|1054367|P1|Overall Study|Withdrawn prior to study closure|13
321997|NCT00683696|1054366|P2|Overall Study|Withdrawn due to study closure|338
321998|NCT00683696|1054367|P1|Overall Study|Withdrawn due to study closure|337
321999|NCT00683657|1054376|P2|Overall Study|Subject Withdrew Consent|0
322000|NCT00683657|1054377|P1|Overall Study|Subject Withdrew Consent|1
322001|NCT00683657|1054376|P2|Overall Study|Adverse Event|1
322002|NCT00683657|1054377|P1|Overall Study|Adverse Event|0
322003|NCT00683618|1054394|P3|Extension Treatment Period|Protocol Violation|0
322004|NCT00683618|1054395|P2|Extension Treatment Period|Protocol Violation|0
322005|NCT00683618|1054396|P1|Extension Treatment Period|Protocol Violation|1
322006|NCT00683618|1054394|P3|Extension Treatment Period|Adverse Event|0
322007|NCT00683618|1054395|P2|Extension Treatment Period|Adverse Event|0
322008|NCT00683618|1054396|P1|Extension Treatment Period|Adverse Event|1
322009|NCT00683618|1054394|P3|Extension Treatment Period|Withdrawal by Subject|0
322010|NCT00683618|1054395|P2|Extension Treatment Period|Withdrawal by Subject|0
322011|NCT00683618|1054396|P1|Extension Treatment Period|Withdrawal by Subject|1
322012|NCT00683618|1054394|P3|Randomised Treatment Period|Reason not provided|2
322013|NCT00683618|1054395|P2|Randomised Treatment Period|Reason not provided|0
322014|NCT00683618|1054396|P1|Randomised Treatment Period|Reason not provided|0
322015|NCT00683618|1054394|P3|Randomised Treatment Period|Adverse Event|2
322016|NCT00683618|1054395|P2|Randomised Treatment Period|Adverse Event|0
322017|NCT00683618|1054396|P1|Randomised Treatment Period|Adverse Event|2
322018|NCT00683618|1054394|P3|Randomised Treatment Period|Protocol Violation|0
322019|NCT00683618|1054395|P2|Randomised Treatment Period|Protocol Violation|1
322020|NCT00683618|1054396|P1|Randomised Treatment Period|Protocol Violation|0
322021|NCT00683618|1054394|P3|Randomised Treatment Period|Withdrawal by Subject|2
322022|NCT00683618|1054395|P2|Randomised Treatment Period|Withdrawal by Subject|1
322023|NCT00683618|1054396|P1|Randomised Treatment Period|Withdrawal by Subject|4
322024|NCT00683592|1054446|P2|Overall Study|Other|1
322025|NCT00683592|1054447|P1|Overall Study|Other|1
322026|NCT00683592|1054446|P2|Overall Study|Non-compliance|5
322027|NCT00683592|1054447|P1|Overall Study|Non-compliance|3
322028|NCT00683592|1054446|P2|Overall Study|Physician Decision|1
322029|NCT00683592|1054447|P1|Overall Study|Physician Decision|0
322030|NCT00683592|1054446|P2|Overall Study|Lack of Efficacy|7
322031|NCT00683592|1054447|P1|Overall Study|Lack of Efficacy|3
322032|NCT00683592|1054446|P2|Overall Study|Lost to Follow-up|17
322033|NCT00683592|1054447|P1|Overall Study|Lost to Follow-up|17
322034|NCT00683592|1054446|P2|Overall Study|Withdrawal by Subject|11
322035|NCT00683592|1054447|P1|Overall Study|Withdrawal by Subject|11
322036|NCT00683592|1054446|P2|Overall Study|Adverse Event|4
322037|NCT00683592|1054447|P1|Overall Study|Adverse Event|12
322038|NCT00683475|1054465|P2|Overall Study|Never Treated: Progressive Disease|0
322039|NCT00683475|1054466|P1|Overall Study|Never Treated: Progressive Disease|1
322040|NCT00683475|1054465|P2|Overall Study|Never Treated: Adverse Event|3
322041|NCT00683475|1054466|P1|Overall Study|Never Treated: Adverse Event|2
322042|NCT00683475|1054465|P2|Overall Study|Withdrawal by Subject|0
322043|NCT00683475|1054466|P1|Overall Study|Withdrawal by Subject|1
322044|NCT00683449|1054501|P5|Overall Study|Lost to Follow-up|0
322045|NCT00683449|1054502|P4|Overall Study|Lost to Follow-up|0
322046|NCT00683449|1054503|P3|Overall Study|Lost to Follow-up|0
322047|NCT00683449|1054504|P2|Overall Study|Lost to Follow-up|1
322048|NCT00683449|1054505|P1|Overall Study|Lost to Follow-up|0
322049|NCT00683384|1054531|P1|Overall Study|Adverse Event|1
322050|NCT00683384|1054531|P1|Overall Study|Death|1
322051|NCT00683293|1054541|P2|Overall Study|Withdrawal by Subject|3
322052|NCT00683293|1054542|P1|Overall Study|Withdrawal by Subject|2
322053|NCT00682890|1054604|P2|Overall Study|heavy menstrual bleeding|0
322054|NCT00682890|1054605|P1|Overall Study|heavy menstrual bleeding|1
322055|NCT00682890|1054604|P2|Overall Study|subject moved away|1
322056|NCT00682890|1054605|P1|Overall Study|subject moved away|0
322057|NCT00682890|1054604|P2|Overall Study|Lost to Follow-up|1
322058|NCT00682890|1054605|P1|Overall Study|Lost to Follow-up|1
322059|NCT00682786|1054647|P2|Overall Study|Did not receive irinotecan|1
322060|NCT00682786|1054648|P1|Overall Study|Did not receive irinotecan|0
322061|NCT00682786|1054647|P2|Overall Study|Withdrawal by Subject|2
322062|NCT00682786|1054648|P1|Overall Study|Withdrawal by Subject|2
322063|NCT00682643|1054693|P2|Overall Study|Did Not Receive Study Drug|1
322064|NCT00682643|1054694|P1|Overall Study|Did Not Receive Study Drug|1
322065|NCT00682643|1054693|P2|Overall Study|Withdrawal by Subject|53
322066|NCT00682643|1054694|P1|Overall Study|Withdrawal by Subject|19
322067|NCT00682643|1054693|P2|Overall Study|Physician Decision|6
322068|NCT00682643|1054694|P1|Overall Study|Physician Decision|2
322069|NCT00682643|1054693|P2|Overall Study|Lost to Follow-up|6
322070|NCT00682643|1054694|P1|Overall Study|Lost to Follow-up|1
322071|NCT00682643|1054693|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
322072|NCT00682643|1054694|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
322073|NCT00682643|1054693|P2|Overall Study|Protocol Violation|76
322074|NCT00682643|1054694|P1|Overall Study|Protocol Violation|38
322075|NCT00682643|1054693|P2|Overall Study|Lack of Efficacy|0
322076|NCT00682643|1054694|P1|Overall Study|Lack of Efficacy|2
322077|NCT00682643|1054693|P2|Overall Study|Adverse Event|23
322078|NCT00682643|1054694|P1|Overall Study|Adverse Event|12
322079|NCT00682539|1054755|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
322080|NCT00682539|1054756|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
322081|NCT00682539|1054757|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
322082|NCT00682539|1054755|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
322083|NCT00682539|1054756|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
322084|NCT00682539|1054757|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
322085|NCT00682461|1054770|P2|Overall Study|Withdrawal by Subject|19
322086|NCT00682461|1054771|P1|Overall Study|Withdrawal by Subject|12
322087|NCT00682461|1054770|P2|Overall Study|Lost to Follow-up|5
322088|NCT00682461|1054771|P1|Overall Study|Lost to Follow-up|8
322089|NCT00682461|1054770|P2|Overall Study|Adverse Event|7
322090|NCT00682461|1054771|P1|Overall Study|Adverse Event|5
322091|NCT00681863|1054811|P1|Overall Study|not specified|18
322092|NCT00681863|1054811|P1|Overall Study|Lack of Efficacy|2
322093|NCT00681863|1054811|P1|Overall Study|Lost to Follow-up|2
322094|NCT00681863|1054811|P1|Overall Study|Adverse Event|1
322095|NCT00681824|1054859|P3|Overall Study|Death|0
322096|NCT00681824|1054860|P2|Overall Study|Death|1
322097|NCT00681824|1054861|P1|Overall Study|Death|0
322098|NCT00681824|1054859|P3|Overall Study|scheduling conflict|0
322099|NCT00681824|1054860|P2|Overall Study|scheduling conflict|0
322100|NCT00681824|1054861|P1|Overall Study|scheduling conflict|1
322101|NCT00681824|1054859|P3|Overall Study|withdrawn by investigator|1
322102|NCT00681824|1054860|P2|Overall Study|withdrawn by investigator|0
322103|NCT00681824|1054861|P1|Overall Study|withdrawn by investigator|0
322104|NCT00681811|1054879|P2|Overall Study|Non-compliance|1
322105|NCT00681811|1054880|P1|Overall Study|Non-compliance|0
322106|NCT00681811|1054879|P2|Overall Study|Withdrawal by Subject|2
322107|NCT00681811|1054880|P1|Overall Study|Withdrawal by Subject|2
322108|NCT00681811|1054879|P2|Overall Study|Adverse Event|1
322109|NCT00681811|1054880|P1|Overall Study|Adverse Event|1
322110|NCT00681668|1054908|P1|Overall Study|Withdrawal by Subject|1
322111|NCT00681668|1054908|P1|Overall Study|Protocol Violation|1
322112|NCT00681629|1054917|P2|Overall Study|Adverse Event|0
322113|NCT00681629|1054918|P1|Overall Study|Adverse Event|1
322114|NCT00681629|1054917|P2|Overall Study|Study termination|2
322115|NCT00681629|1054918|P1|Overall Study|Study termination|4
322116|NCT00681590|1054964|P2|Overall Study|Withdrawal by Subject|12
322117|NCT00681590|1054965|P1|Overall Study|Withdrawal by Subject|2
322118|NCT00681564|1054975|P2|Overall Study|Death|1
322119|NCT00681564|1054976|P1|Overall Study|Death|0
322120|NCT00681564|1054975|P2|Overall Study|Withdrawal by Subject|1
322121|NCT00681564|1054976|P1|Overall Study|Withdrawal by Subject|0
322122|NCT00681564|1054975|P2|Overall Study|Lost to Follow-up|6
322123|NCT00681564|1054976|P1|Overall Study|Lost to Follow-up|6
322124|NCT00681187|1055068|P2|Overall Study|Adverse Event|1
322125|NCT00681187|1055069|P1|Overall Study|Adverse Event|0
322126|NCT00681187|1055068|P2|Overall Study|Death|1
322127|NCT00681187|1055069|P1|Overall Study|Death|0
322128|NCT00681187|1055068|P2|Overall Study|Withdrawal by Subject|0
322129|NCT00681187|1055069|P1|Overall Study|Withdrawal by Subject|1
322130|NCT00681109|1055104|P3|Overall Study|Lost to Follow-up|0
322131|NCT00681109|1055105|P2|Overall Study|Lost to Follow-up|6
322132|NCT00681109|1055106|P1|Overall Study|Lost to Follow-up|2
322133|NCT00679211|1055129|P1|Overall Study|Other|1
322134|NCT00679211|1055129|P1|Overall Study|Transferred to extension study TDM4529g|12
322135|NCT00679211|1055129|P1|Overall Study|Refused to undergo protocol procedures|1
322136|NCT00679211|1055129|P1|Overall Study|Physician Decision|5
322137|NCT00679211|1055129|P1|Overall Study|Withdrawal by Subject|2
322138|NCT00679211|1055129|P1|Overall Study|Adverse Event|7
322139|NCT00679211|1055129|P1|Overall Study|Progressive disease|82
322140|NCT00679172|1055146|P5|Overall Study|Other not specified|0
322141|NCT00679172|1055147|P4|Overall Study|Other not specified|0
322142|NCT00679172|1055148|P3|Overall Study|Other not specified|1
322143|NCT00679172|1055149|P2|Overall Study|Other not specified|0
322144|NCT00679172|1055150|P1|Overall Study|Other not specified|0
322145|NCT00679172|1055146|P5|Overall Study|Non-compliance|0
322146|NCT00679172|1055147|P4|Overall Study|Non-compliance|1
322147|NCT00679172|1055148|P3|Overall Study|Non-compliance|0
322148|NCT00679172|1055149|P2|Overall Study|Non-compliance|1
322149|NCT00679172|1055150|P1|Overall Study|Non-compliance|1
322150|NCT00679081|1055213|P1|Overall Study|Lost to Follow-up|1
322151|NCT00679055|1055223|P2|Overall Study|Study Terminated|1
322152|NCT00679055|1055224|P1|Overall Study|Study Terminated|2
322153|NCT00679055|1055223|P2|Overall Study|Other|3
322154|NCT00679055|1055224|P1|Overall Study|Other|0
322155|NCT00679055|1055223|P2|Overall Study|Adverse Event|1
322156|NCT00679055|1055224|P1|Overall Study|Adverse Event|0
322157|NCT00680914|1055263|P2|Overall Study|serious adverse event (SAE)|1
322158|NCT00680914|1055264|P1|Overall Study|serious adverse event (SAE)|0
322159|NCT00680914|1055263|P2|Overall Study|Lost to Follow-up|0
322160|NCT00680914|1055264|P1|Overall Study|Lost to Follow-up|4
322161|NCT00680914|1055263|P2|Overall Study|Consent withdrawal|3
322162|NCT00680914|1055264|P1|Overall Study|Consent withdrawal|6
322163|NCT00680901|1055298|P2|Overall Study|Ongoing: In Follow Up|41
322164|NCT00680901|1055299|P1|Overall Study|Ongoing: In Follow Up|45
322165|NCT00680901|1055298|P2|Overall Study|Ongoing: On Study Treatment|13
322166|NCT00680901|1055299|P1|Overall Study|Ongoing: On Study Treatment|16
322167|NCT00680901|1055298|P2|Overall Study|Physician Decision|1
322168|NCT00680901|1055299|P1|Overall Study|Physician Decision|0
322169|NCT00680901|1055298|P2|Overall Study|Withdrawal by Subject|13
322170|NCT00680901|1055299|P1|Overall Study|Withdrawal by Subject|4
322171|NCT00680901|1055298|P2|Overall Study|Lost to Follow-up|8
322172|NCT00680901|1055299|P1|Overall Study|Lost to Follow-up|8
322173|NCT00680836|1055337|P2|Overall Study|Physician Decision|1
322174|NCT00680836|1055338|P1|Overall Study|Physician Decision|2
322175|NCT00680836|1055337|P2|Overall Study|Lost to Follow-up|1
322176|NCT00680836|1055338|P1|Overall Study|Lost to Follow-up|3
322177|NCT00680836|1055337|P2|Overall Study|Withdrawal by Subject|0
322178|NCT00680836|1055338|P1|Overall Study|Withdrawal by Subject|3
322179|NCT00680771|1055373|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
322180|NCT00680771|1055374|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
322181|NCT00680771|1055373|P2|Overall Study|Sleep Apnea suspected after PSG|0
322182|NCT00680771|1055374|P1|Overall Study|Sleep Apnea suspected after PSG|1
322183|NCT00680771|1055373|P2|Overall Study|Withdrawal by Subject|0
322184|NCT00680771|1055374|P1|Overall Study|Withdrawal by Subject|1
322185|NCT00680745|1055384|P4|Overall Study|False Treatment|0
322186|NCT00680745|1055385|P3|Overall Study|False Treatment|3
322187|NCT00680745|1055386|P2|Overall Study|False Treatment|1
322188|NCT00680745|1055387|P1|Overall Study|False Treatment|0
322189|NCT00680745|1055384|P4|Overall Study|Subject No Longer Meets Study Criteria|2
322190|NCT00680745|1055385|P3|Overall Study|Subject No Longer Meets Study Criteria|0
322191|NCT00680745|1055386|P2|Overall Study|Subject No Longer Meets Study Criteria|2
322192|NCT00680745|1055387|P1|Overall Study|Subject No Longer Meets Study Criteria|0
322193|NCT00680745|1055384|P4|Overall Study|Poor/Non-compliance|0
322194|NCT00680745|1055385|P3|Overall Study|Poor/Non-compliance|0
322195|NCT00680745|1055386|P2|Overall Study|Poor/Non-compliance|3
322196|NCT00680745|1055387|P1|Overall Study|Poor/Non-compliance|0
322197|NCT00680745|1055384|P4|Overall Study|Adverse Event|3
322198|NCT00680745|1055385|P3|Overall Study|Adverse Event|3
322199|NCT00680745|1055386|P2|Overall Study|Adverse Event|3
322200|NCT00680745|1055387|P1|Overall Study|Adverse Event|5
322201|NCT00680745|1055384|P4|Overall Study|Death|0
322202|NCT00680745|1055385|P3|Overall Study|Death|1
322203|NCT00680745|1055386|P2|Overall Study|Death|0
322204|NCT00680745|1055387|P1|Overall Study|Death|1
322205|NCT00680745|1055384|P4|Overall Study|Lost to Follow-up|0
322206|NCT00680745|1055385|P3|Overall Study|Lost to Follow-up|1
322207|NCT00680745|1055386|P2|Overall Study|Lost to Follow-up|1
322208|NCT00680745|1055387|P1|Overall Study|Lost to Follow-up|0
322209|NCT00680745|1055384|P4|Overall Study|Withdrawal by Subject|8
322210|NCT00680745|1055385|P3|Overall Study|Withdrawal by Subject|2
322211|NCT00680745|1055386|P2|Overall Study|Withdrawal by Subject|3
322212|NCT00680745|1055387|P1|Overall Study|Withdrawal by Subject|8
322213|NCT00680407|1055461|P3|Overall Study|Withdrawal by Subject|2
322214|NCT00680407|1055462|P2|Overall Study|Withdrawal by Subject|2
322215|NCT00680407|1055463|P1|Overall Study|Withdrawal by Subject|5
322216|NCT00680407|1055461|P3|Overall Study|Lost to Follow-up|1
322217|NCT00680407|1055462|P2|Overall Study|Lost to Follow-up|3
322218|NCT00680407|1055463|P1|Overall Study|Lost to Follow-up|3
322219|NCT00680368|1055477|P1|Overall Study|not supervised, not eligible|15
322220|NCT00680186|1055490|P2|Overall Study|Other|1
322221|NCT00680186|1055491|P1|Overall Study|Other|4
322222|NCT00680186|1055490|P2|Overall Study|Withdrawal by Subject|39
322223|NCT00680186|1055491|P1|Overall Study|Withdrawal by Subject|32
322224|NCT00680186|1055490|P2|Overall Study|Lost to Follow-up|6
322225|NCT00680186|1055491|P1|Overall Study|Lost to Follow-up|11
322226|NCT00680186|1055490|P2|Overall Study|Protocol Violation|26
322227|NCT00680186|1055491|P1|Overall Study|Protocol Violation|31
322228|NCT00680186|1055490|P2|Overall Study|Adverse Event|44
322229|NCT00680186|1055491|P1|Overall Study|Adverse Event|47
322230|NCT00680121|1055517|P2|Overall Study|Lost to Follow-up|23
322231|NCT00680121|1055518|P1|Overall Study|Lost to Follow-up|27
322232|NCT00680056|1055532|P2|Second Intervention|Protocol Violation|1
322233|NCT00680056|1055533|P1|Second Intervention|Protocol Violation|3
322234|NCT00680056|1055532|P2|First Intervention|Mainly Exacerbation of COPD|2
322235|NCT00680056|1055533|P1|First Intervention|Mainly Exacerbation of COPD|1
322236|NCT00680043|1055544|P3|Overall Study|Renal Transplant|4
322237|NCT00680043|1055545|P2|Overall Study|Renal Transplant|0
322238|NCT00680043|1055546|P1|Overall Study|Renal Transplant|1
322239|NCT00680043|1055544|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
322240|NCT00680043|1055545|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
322241|NCT00680043|1055546|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
322242|NCT00680043|1055544|P3|Overall Study|Withdrawal by Subject|0
322243|NCT00680043|1055545|P2|Overall Study|Withdrawal by Subject|0
322244|NCT00680043|1055546|P1|Overall Study|Withdrawal by Subject|1
322245|NCT00680017|1055562|P2|Overall Study|Lost to Follow-up|0
322246|NCT00680017|1055563|P1|Overall Study|Lost to Follow-up|2
322247|NCT00680017|1055562|P2|Overall Study|Withdrawal by Subject|5
322248|NCT00680017|1055563|P1|Overall Study|Withdrawal by Subject|2
322249|NCT00680017|1055562|P2|Overall Study|Adverse Event|7
322250|NCT00680017|1055563|P1|Overall Study|Adverse Event|13
322251|NCT00679939|1055582|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
322252|NCT00679939|1055583|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
322253|NCT00679939|1055582|P2|24-Week Open-Label (OL) Period|Physician Decision|0
322254|NCT00679939|1055583|P1|24-Week Open-Label (OL) Period|Physician Decision|1
322255|NCT00679939|1055582|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
322256|NCT00679939|1055583|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
322257|NCT00679939|1055582|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
322258|NCT00679939|1055583|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
322259|NCT00679939|1055582|P2|24-Week Open-Label (OL) Period|Adverse Event|1
322260|NCT00679939|1055583|P1|24-Week Open-Label (OL) Period|Adverse Event|0
322261|NCT00679939|1055582|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
322262|NCT00679939|1055583|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
322263|NCT00679939|1055582|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
322264|NCT00679939|1055583|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
322265|NCT00679939|1055582|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
322266|NCT00679939|1055583|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
322267|NCT00679939|1055582|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
322268|NCT00679939|1055583|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
322269|NCT00679939|1055582|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
322270|NCT00679939|1055583|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
322271|NCT00679913|1055734|P2|Overall Study|Protocol Violation|13
322272|NCT00679913|1055735|P1|Overall Study|Protocol Violation|18
322273|NCT00679783|1055750|P7|Overall Study|Ongoing at data cut-off|0
322274|NCT00679783|1055751|P6|Overall Study|Ongoing at data cut-off|0
322275|NCT00679783|1055752|P5|Overall Study|Ongoing at data cut-off|1
322276|NCT00679783|1055753|P4|Overall Study|Ongoing at data cut-off|9
322277|NCT00679783|1055754|P3|Overall Study|Ongoing at data cut-off|0
322278|NCT00679783|1055755|P2|Overall Study|Ongoing at data cut-off|2
322279|NCT00679783|1055756|P1|Overall Study|Ongoing at data cut-off|2
322280|NCT00679783|1055750|P7|Overall Study|Not Captured|0
322281|NCT00679783|1055751|P6|Overall Study|Not Captured|0
322282|NCT00679783|1055752|P5|Overall Study|Not Captured|0
322283|NCT00679783|1055753|P4|Overall Study|Not Captured|5
322284|NCT00679783|1055754|P3|Overall Study|Not Captured|0
322285|NCT00679783|1055755|P2|Overall Study|Not Captured|0
322286|NCT00679783|1055756|P1|Overall Study|Not Captured|0
322287|NCT00679783|1055750|P7|Overall Study|Withdrawal by Subject|0
322288|NCT00679783|1055751|P6|Overall Study|Withdrawal by Subject|0
322289|NCT00679783|1055752|P5|Overall Study|Withdrawal by Subject|0
322290|NCT00679783|1055753|P4|Overall Study|Withdrawal by Subject|1
322291|NCT00679783|1055754|P3|Overall Study|Withdrawal by Subject|1
322292|NCT00679783|1055755|P2|Overall Study|Withdrawal by Subject|0
322293|NCT00679783|1055756|P1|Overall Study|Withdrawal by Subject|0
322294|NCT00679783|1055750|P7|Overall Study|Lack of Efficacy|0
322295|NCT00679783|1055751|P6|Overall Study|Lack of Efficacy|0
322296|NCT00679783|1055752|P5|Overall Study|Lack of Efficacy|0
322297|NCT00679783|1055753|P4|Overall Study|Lack of Efficacy|2
322298|NCT00679783|1055754|P3|Overall Study|Lack of Efficacy|0
322299|NCT00679783|1055755|P2|Overall Study|Lack of Efficacy|1
322300|NCT00679783|1055756|P1|Overall Study|Lack of Efficacy|0
322301|NCT00679783|1055750|P7|Overall Study|Adverse Event|1
322302|NCT00679783|1055751|P6|Overall Study|Adverse Event|0
322303|NCT00679783|1055752|P5|Overall Study|Adverse Event|0
322304|NCT00679783|1055753|P4|Overall Study|Adverse Event|3
322305|NCT00679783|1055754|P3|Overall Study|Adverse Event|0
322306|NCT00679783|1055755|P2|Overall Study|Adverse Event|0
322307|NCT00679783|1055756|P1|Overall Study|Adverse Event|0
322308|NCT00679627|1055809|P2|Overall Study|Early Study Closure|405
322309|NCT00679627|1055810|P1|Overall Study|Early Study Closure|425
322310|NCT00679627|1055809|P2|Overall Study|Lost to Follow-up|26
322311|NCT00679627|1055810|P1|Overall Study|Lost to Follow-up|22
322312|NCT00679627|1055809|P2|Overall Study|Withdrawal by Subject|172
322313|NCT00679627|1055810|P1|Overall Study|Withdrawal by Subject|168
322314|NCT00679627|1055809|P2|Overall Study|Adverse Event|53
322315|NCT00679627|1055810|P1|Overall Study|Adverse Event|43
322316|NCT00679627|1055809|P2|Overall Study|Death|29
322317|NCT00679627|1055810|P1|Overall Study|Death|41
322318|NCT00679432|1055836|P4|Overall Study|Randomization error, return to prior Rx|0
322319|NCT00679432|1055837|P3|Overall Study|Randomization error, return to prior Rx|3
322320|NCT00679432|1055838|P2|Overall Study|Randomization error, return to prior Rx|0
322321|NCT00679432|1055839|P1|Overall Study|Randomization error, return to prior Rx|0
322322|NCT00679432|1055836|P4|Overall Study|Infectious colitis, normal histology|3
322323|NCT00679432|1055837|P3|Overall Study|Infectious colitis, normal histology|8
322324|NCT00679432|1055838|P2|Overall Study|Infectious colitis, normal histology|4
322325|NCT00679432|1055839|P1|Overall Study|Infectious colitis, normal histology|5
322326|NCT00679432|1055836|P4|Overall Study|Lack of Efficacy|8
322327|NCT00679432|1055837|P3|Overall Study|Lack of Efficacy|14
322328|NCT00679432|1055838|P2|Overall Study|Lack of Efficacy|9
322329|NCT00679432|1055839|P1|Overall Study|Lack of Efficacy|13
322330|NCT00679432|1055836|P4|Overall Study|Sponsor decision|0
322331|NCT00679432|1055837|P3|Overall Study|Sponsor decision|0
322332|NCT00679432|1055838|P2|Overall Study|Sponsor decision|0
322333|NCT00679432|1055839|P1|Overall Study|Sponsor decision|1
322334|NCT00679432|1055836|P4|Overall Study|Physician Decision|2
322335|NCT00679432|1055837|P3|Overall Study|Physician Decision|2
322336|NCT00679432|1055838|P2|Overall Study|Physician Decision|2
322337|NCT00679432|1055839|P1|Overall Study|Physician Decision|3
322338|NCT00679432|1055836|P4|Overall Study|Lost to Follow-up|2
322339|NCT00679432|1055837|P3|Overall Study|Lost to Follow-up|4
322340|NCT00679432|1055838|P2|Overall Study|Lost to Follow-up|5
322341|NCT00679432|1055839|P1|Overall Study|Lost to Follow-up|1
322342|NCT00679432|1055836|P4|Overall Study|Withdrawal by Subject|9
322343|NCT00679432|1055837|P3|Overall Study|Withdrawal by Subject|10
322344|NCT00679432|1055838|P2|Overall Study|Withdrawal by Subject|11
322345|NCT00679432|1055839|P1|Overall Study|Withdrawal by Subject|8
322346|NCT00679432|1055836|P4|Overall Study|Protocol Violation|1
322347|NCT00679432|1055837|P3|Overall Study|Protocol Violation|2
322348|NCT00679432|1055838|P2|Overall Study|Protocol Violation|1
322349|NCT00679432|1055839|P1|Overall Study|Protocol Violation|1
322350|NCT00679432|1055836|P4|Overall Study|Adverse Event|7
322351|NCT00679432|1055837|P3|Overall Study|Adverse Event|10
322352|NCT00679432|1055838|P2|Overall Study|Adverse Event|6
322353|NCT00679432|1055839|P1|Overall Study|Adverse Event|5
322354|NCT00679367|1055882|P1|Overall Study|Withdrawal by Subject|1
322355|NCT00679367|1055882|P1|Overall Study|Lack of Efficacy|3
322356|NCT00679367|1055882|P1|Overall Study|inability to swallow oral drugs|1
322357|NCT00679367|1055882|P1|Overall Study|Adverse Event|7
322358|NCT00679354|1055888|P1|Overall Study|Ineligible|1
322359|NCT00679354|1055888|P1|Overall Study|Physician Decision|4
322360|NCT00679354|1055888|P1|Overall Study|Lack of Efficacy|22
322361|NCT00679354|1055888|P1|Overall Study|Death|3
322362|NCT00679341|1055894|P2|Overall Study|Physician/patient decision to withdraw|6
322363|NCT00679341|1055895|P1|Overall Study|Physician/patient decision to withdraw|0
322364|NCT00679341|1055894|P2|Overall Study|Not treated|2
322365|NCT00679341|1055895|P1|Overall Study|Not treated|0
322366|NCT00679341|1055894|P2|Overall Study|Physician Decision|0
322367|NCT00679341|1055895|P1|Overall Study|Physician Decision|1
322368|NCT00679341|1055894|P2|Overall Study|Not specified|0
322369|NCT00679341|1055895|P1|Overall Study|Not specified|1
322370|NCT00679341|1055894|P2|Overall Study|Death|1
322371|NCT00679341|1055895|P1|Overall Study|Death|1
322372|NCT00679341|1055894|P2|Overall Study|Subject/guardian decision to discontinue|0
322373|NCT00679341|1055895|P1|Overall Study|Subject/guardian decision to discontinue|3
322374|NCT00679341|1055894|P2|Overall Study|Adverse Event|6
322375|NCT00679341|1055895|P1|Overall Study|Adverse Event|5
322376|NCT00679341|1055894|P2|Overall Study|Disease progression|36
322377|NCT00679341|1055895|P1|Overall Study|Disease progression|42
322378|NCT00679302|1055915|P2|Overall Study|Lost to Follow-up|4
322379|NCT00679302|1055916|P1|Overall Study|Lost to Follow-up|8
322380|NCT00679263|1055927|P3|Visit 2/Dose 1|subject not compliance|0
322381|NCT00679263|1055928|P2|Visit 2/Dose 1|subject not compliance|1
322382|NCT00679263|1055929|P1|Visit 2/Dose 1|subject not compliance|1
322383|NCT00679263|1055927|P3|Visit 2/Dose 1|Adverse Event|0
322384|NCT00679263|1055928|P2|Visit 2/Dose 1|Adverse Event|0
322385|NCT00679263|1055929|P1|Visit 2/Dose 1|Adverse Event|1
322386|NCT00678899|1055940|P1|Overall Study|Adverse Event|1
322387|NCT00678795|1055972|P2|Overall Study|Lack of Efficacy|1
322388|NCT00678795|1055973|P1|Overall Study|Lack of Efficacy|1
322389|NCT00678795|1055972|P2|Overall Study|Lost to Follow-up|1
322390|NCT00678795|1055973|P1|Overall Study|Lost to Follow-up|0
322391|NCT00678795|1055972|P2|Overall Study|Protocol Violation|1
322392|NCT00678795|1055973|P1|Overall Study|Protocol Violation|0
322393|NCT00678795|1055972|P2|Overall Study|Withdrawal by Subject|0
322394|NCT00678795|1055973|P1|Overall Study|Withdrawal by Subject|3
322395|NCT00678795|1055972|P2|Overall Study|Adverse Event|3
322396|NCT00678795|1055973|P1|Overall Study|Adverse Event|7
322397|NCT00678691|1055995|P2|Overall Study|Adverse Event|4
322398|NCT00678691|1055996|P1|Overall Study|Adverse Event|6
322399|NCT00678639|1056004|P2|Overall Study|Lost to Follow-up at 30 days|0
322400|NCT00678639|1056005|P1|Overall Study|Lost to Follow-up at 30 days|2
322401|NCT00678587|1056020|P2|Overall Study|Withdrew Consent|3
322402|NCT00678587|1056021|P1|Overall Study|Withdrew Consent|8
322403|NCT00678587|1056020|P2|Overall Study|Investigator Discretion|6
322404|NCT00678587|1056021|P1|Overall Study|Investigator Discretion|2
322405|NCT00678587|1056020|P2|Overall Study|Lost to Follow-up|5
322406|NCT00678587|1056021|P1|Overall Study|Lost to Follow-up|3
322407|NCT00678587|1056020|P2|Overall Study|Study Closed/Terminated|0
322408|NCT00678587|1056021|P1|Overall Study|Study Closed/Terminated|1
322409|NCT00678587|1056020|P2|Overall Study|Protocol Violation|1
322410|NCT00678587|1056021|P1|Overall Study|Protocol Violation|2
322411|NCT00678587|1056020|P2|Overall Study|Lack of Efficacy|0
322412|NCT00678587|1056021|P1|Overall Study|Lack of Efficacy|1
322413|NCT00678587|1056020|P2|Overall Study|Adverse Event|3
322414|NCT00678587|1056021|P1|Overall Study|Adverse Event|3
322415|NCT00678392|1056095|P2|Overall Study|Unspecified|53
322416|NCT00678392|1056096|P1|Overall Study|Unspecified|56
322417|NCT00678392|1056095|P2|Overall Study|Randomized But Not Treated|7
322418|NCT00678392|1056096|P1|Overall Study|Randomized But Not Treated|2
322419|NCT00678392|1056095|P2|Overall Study|Withdrawal by Subject|4
322420|NCT00678392|1056096|P1|Overall Study|Withdrawal by Subject|4
322421|NCT00678392|1056095|P2|Overall Study|Sponsor's Decision|2
322422|NCT00678392|1056096|P1|Overall Study|Sponsor's Decision|1
322423|NCT00678392|1056095|P2|Overall Study|Objective Progression or Relapse|8
322424|NCT00678392|1056096|P1|Overall Study|Objective Progression or Relapse|3
322425|NCT00678392|1056095|P2|Overall Study|Lost to Follow-up|13
322426|NCT00678392|1056096|P1|Overall Study|Lost to Follow-up|15
322427|NCT00678392|1056095|P2|Overall Study|Death|269
322428|NCT00678392|1056096|P1|Overall Study|Death|280
322429|NCT00678392|1056095|P2|Overall Study|Adverse Event|6
322430|NCT00678392|1056096|P1|Overall Study|Adverse Event|0
322431|NCT00678288|1056130|P2|Overall Study|Disease progression/recurrence/relapse|1
322432|NCT00678288|1056131|P1|Overall Study|Disease progression/recurrence/relapse|6
322433|NCT00678288|1056130|P2|Overall Study|Reason not reported|0
322434|NCT00678288|1056131|P1|Overall Study|Reason not reported|1
322435|NCT00678288|1056130|P2|Overall Study|Switch to commercial drug|1
322436|NCT00678288|1056131|P1|Overall Study|Switch to commercial drug|0
322437|NCT00678288|1056130|P2|Overall Study|Not compliant with study medication|1
322438|NCT00678288|1056131|P1|Overall Study|Not compliant with study medication|0
322439|NCT00678288|1056130|P2|Overall Study|Study terminated by the sponsor|0
322440|NCT00678288|1056131|P1|Overall Study|Study terminated by the sponsor|2
322441|NCT00678288|1056130|P2|Overall Study|Withdrawal by Subject|1
322442|NCT00678288|1056131|P1|Overall Study|Withdrawal by Subject|1
322443|NCT00678288|1056130|P2|Overall Study|Adverse Event|2
322444|NCT00678288|1056131|P1|Overall Study|Adverse Event|0
322445|NCT00678210|1056186|P4|Overall Study|Unspecified|0
322446|NCT00678210|1056187|P3|Overall Study|Unspecified|1
322447|NCT00678210|1056188|P2|Overall Study|Unspecified|0
322448|NCT00678210|1056189|P1|Overall Study|Unspecified|1
322449|NCT00678210|1056186|P4|Overall Study|Withdrawal by Subject|7
322450|NCT00678210|1056187|P3|Overall Study|Withdrawal by Subject|1
322451|NCT00678210|1056188|P2|Overall Study|Withdrawal by Subject|4
322452|NCT00678210|1056189|P1|Overall Study|Withdrawal by Subject|3
322453|NCT00678210|1056186|P4|Overall Study|Lost to Follow-up|1
322454|NCT00678210|1056187|P3|Overall Study|Lost to Follow-up|0
322455|NCT00678210|1056188|P2|Overall Study|Lost to Follow-up|2
322456|NCT00678210|1056189|P1|Overall Study|Lost to Follow-up|4
322457|NCT00678210|1056186|P4|Overall Study|Lack of Efficacy|9
322458|NCT00678210|1056187|P3|Overall Study|Lack of Efficacy|1
322459|NCT00678210|1056188|P2|Overall Study|Lack of Efficacy|3
322460|NCT00678210|1056189|P1|Overall Study|Lack of Efficacy|2
322461|NCT00678210|1056186|P4|Overall Study|Adverse Event|3
322462|NCT00678210|1056187|P3|Overall Study|Adverse Event|3
322463|NCT00678210|1056188|P2|Overall Study|Adverse Event|2
322464|NCT00678210|1056189|P1|Overall Study|Adverse Event|1
322465|NCT00678041|1056225|P2|Overall Study|Physician Decision|5
322466|NCT00678041|1056226|P1|Overall Study|Physician Decision|5
322467|NCT00677833|1056279|P4|Overall Study|Lost to Follow-up|0
322468|NCT00677833|1056280|P3|Overall Study|Lost to Follow-up|1
322469|NCT00677833|1056281|P2|Overall Study|Lost to Follow-up|0
322470|NCT00677833|1056282|P1|Overall Study|Lost to Follow-up|0
322471|NCT00677833|1056279|P4|Overall Study|Withdrawal by Subject|3
322472|NCT00677833|1056280|P3|Overall Study|Withdrawal by Subject|1
322473|NCT00677833|1056281|P2|Overall Study|Withdrawal by Subject|0
322474|NCT00677833|1056282|P1|Overall Study|Withdrawal by Subject|4
322475|NCT00677820|1056332|P2|Overall Study|Lost to Follow-up|0
322476|NCT00677820|1056333|P1|Overall Study|Lost to Follow-up|1
322477|NCT00677807|1056354|P3|Overall Study|Protocol Deviation|0
322478|NCT00677807|1056355|P2|Overall Study|Protocol Deviation|3
322479|NCT00677807|1056356|P1|Overall Study|Protocol Deviation|1
322480|NCT00677807|1056354|P3|Overall Study|Death|1
322481|NCT00677807|1056355|P2|Overall Study|Death|1
322482|NCT00677807|1056356|P1|Overall Study|Death|0
322483|NCT00677807|1056354|P3|Overall Study|Administrative problems|2
322484|NCT00677807|1056355|P2|Overall Study|Administrative problems|1
322485|NCT00677807|1056356|P1|Overall Study|Administrative problems|1
322486|NCT00677807|1056354|P3|Overall Study|Lost to Follow-up|2
322487|NCT00677807|1056355|P2|Overall Study|Lost to Follow-up|2
322488|NCT00677807|1056356|P1|Overall Study|Lost to Follow-up|2
322489|NCT00677807|1056354|P3|Overall Study|Withdrawal by Subject|6
322490|NCT00677807|1056355|P2|Overall Study|Withdrawal by Subject|3
322491|NCT00677807|1056356|P1|Overall Study|Withdrawal by Subject|10
322492|NCT00677807|1056354|P3|Overall Study|Participant no longer needs study drug|1
322493|NCT00677807|1056355|P2|Overall Study|Participant no longer needs study drug|0
322494|NCT00677807|1056356|P1|Overall Study|Participant no longer needs study drug|0
322495|NCT00677807|1056354|P3|Overall Study|Lack of Efficacy|2
322496|NCT00677807|1056355|P2|Overall Study|Lack of Efficacy|0
322497|NCT00677807|1056356|P1|Overall Study|Lack of Efficacy|0
322498|NCT00677807|1056354|P3|Overall Study|Adverse Event|6
322499|NCT00677807|1056355|P2|Overall Study|Adverse Event|1
322500|NCT00677807|1056356|P1|Overall Study|Adverse Event|4
322501|NCT00677534|1056402|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
322502|NCT00677534|1056402|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
322503|NCT00677534|1056402|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
322504|NCT00677365|1056410|P4|Overall Study|Other reason|1
322505|NCT00677365|1056411|P3|Overall Study|Other reason|0
322506|NCT00677365|1056412|P2|Overall Study|Other reason|0
322507|NCT00677365|1056413|P1|Overall Study|Other reason|0
322508|NCT00677365|1056410|P4|Overall Study|Withdrawal by Subject|0
322509|NCT00677365|1056411|P3|Overall Study|Withdrawal by Subject|1
322510|NCT00677365|1056412|P2|Overall Study|Withdrawal by Subject|0
322511|NCT00677365|1056413|P1|Overall Study|Withdrawal by Subject|0
322512|NCT00677365|1056410|P4|Overall Study|Adverse Event|2
322513|NCT00677365|1056411|P3|Overall Study|Adverse Event|1
322514|NCT00677365|1056412|P2|Overall Study|Adverse Event|1
322515|NCT00677365|1056413|P1|Overall Study|Adverse Event|2
322516|NCT00677352|1056445|P2|Tapering Phase|Job transfer|1
322517|NCT00677352|1056446|P1|Tapering Phase|Job transfer|0
322518|NCT00677352|1056445|P2|Tapering Phase|Pregnancy|1
322519|NCT00677352|1056446|P1|Tapering Phase|Pregnancy|0
322520|NCT00677352|1056445|P2|Tapering Phase|Withdrawal by Subject|3
322521|NCT00677352|1056446|P1|Tapering Phase|Withdrawal by Subject|5
322522|NCT00677352|1056445|P2|Tapering Phase|Adverse Event|5
322523|NCT00677352|1056446|P1|Tapering Phase|Adverse Event|1
322524|NCT00677352|1056445|P2|Treatment Phase|Not treated|2
322525|NCT00677352|1056446|P1|Treatment Phase|Not treated|0
322526|NCT00677352|1056445|P2|Treatment Phase|Transference or work related matter|5
322527|NCT00677352|1056446|P1|Treatment Phase|Transference or work related matter|0
322528|NCT00677352|1056445|P2|Treatment Phase|Protocol Violation|1
322529|NCT00677352|1056446|P1|Treatment Phase|Protocol Violation|1
322530|NCT00677352|1056445|P2|Treatment Phase|Pregnancy|1
322531|NCT00677352|1056446|P1|Treatment Phase|Pregnancy|0
322532|NCT00677352|1056445|P2|Treatment Phase|Physician Decision|0
322533|NCT00677352|1056446|P1|Treatment Phase|Physician Decision|1
322534|NCT00677352|1056445|P2|Treatment Phase|Withdrawal by Subject|7
322535|NCT00677352|1056446|P1|Treatment Phase|Withdrawal by Subject|7
322536|NCT00677352|1056445|P2|Treatment Phase|Lost to Follow-up|1
322537|NCT00677352|1056446|P1|Treatment Phase|Lost to Follow-up|0
322538|NCT00677352|1056445|P2|Treatment Phase|Lack of Efficacy|3
322539|NCT00677352|1056446|P1|Treatment Phase|Lack of Efficacy|2
322540|NCT00677352|1056445|P2|Treatment Phase|Adverse Event|22
322541|NCT00677352|1056446|P1|Treatment Phase|Adverse Event|14
322542|NCT00677235|1056466|P2|Overall Study|Adverse Experience|0
322543|NCT00677235|1056467|P1|Overall Study|Adverse Experience|1
322544|NCT00677235|1056466|P2|Overall Study|Death|36
322545|NCT00677235|1056467|P1|Overall Study|Death|37
322546|NCT00677235|1056466|P2|Overall Study|Lost to Follow-up|1
322547|NCT00677235|1056467|P1|Overall Study|Lost to Follow-up|2
322548|NCT00677235|1056466|P2|Overall Study|Withdrawal by Subject|1
322549|NCT00677235|1056467|P1|Overall Study|Withdrawal by Subject|1
322550|NCT00677092|1056507|P1|Overall Study|Death Prior to Receiving Treatment|1
322551|NCT00677092|1056507|P1|Overall Study|Withdrawal by Subject|3
322552|NCT00677092|1056507|P1|Overall Study|Lost to Follow-up|1
322553|NCT00677092|1056507|P1|Overall Study|Adverse Event|1
322554|NCT00677014|1056519|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
322555|NCT00677014|1056520|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
322556|NCT00677014|1056521|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
322557|NCT00677014|1056519|P3|Overall Study|Death|7
322558|NCT00677014|1056520|P2|Overall Study|Death|15
322559|NCT00677014|1056521|P1|Overall Study|Death|6
322560|NCT00677014|1056519|P3|Overall Study|Lost to Follow-up|24
322561|NCT00677014|1056520|P2|Overall Study|Lost to Follow-up|12
322562|NCT00677014|1056521|P1|Overall Study|Lost to Follow-up|20
322563|NCT00676715|1056574|P4|Overall Study|Participants Ongoing|24
322564|NCT00676715|1056575|P3|Overall Study|Participants Ongoing|17
322565|NCT00676715|1056576|P2|Overall Study|Participants Ongoing|29
322566|NCT00676715|1056577|P1|Overall Study|Participants Ongoing|29
322567|NCT00676715|1056574|P4|Overall Study|Adverse Event|0
322568|NCT00676715|1056575|P3|Overall Study|Adverse Event|2
322569|NCT00676715|1056576|P2|Overall Study|Adverse Event|1
322570|NCT00676715|1056577|P1|Overall Study|Adverse Event|0
322571|NCT00676715|1056574|P4|Overall Study|Death|0
322572|NCT00676715|1056575|P3|Overall Study|Death|1
322573|NCT00676715|1056576|P2|Overall Study|Death|1
322574|NCT00676715|1056577|P1|Overall Study|Death|1
322575|NCT00676715|1056574|P4|Overall Study|Lost to Follow-up|3
322576|NCT00676715|1056575|P3|Overall Study|Lost to Follow-up|7
322577|NCT00676715|1056576|P2|Overall Study|Lost to Follow-up|1
322578|NCT00676715|1056577|P1|Overall Study|Lost to Follow-up|1
322579|NCT00676715|1056574|P4|Overall Study|Unspecified|3
322580|NCT00676715|1056575|P3|Overall Study|Unspecified|4
322581|NCT00676715|1056576|P2|Overall Study|Unspecified|6
322582|NCT00676715|1056577|P1|Overall Study|Unspecified|2
322583|NCT00676715|1056574|P4|Overall Study|Withdrawal by Subject|10
322584|NCT00676715|1056575|P3|Overall Study|Withdrawal by Subject|10
322585|NCT00676715|1056576|P2|Overall Study|Withdrawal by Subject|9
322586|NCT00676715|1056577|P1|Overall Study|Withdrawal by Subject|7
322587|NCT00676689|1056607|P1|Overall Study|Continuing FU|49
322588|NCT00676689|1056607|P1|Overall Study|Withdrawal by Subject|3
322589|NCT00676689|1056607|P1|Overall Study|Physician Decision|1
322590|NCT00676689|1056607|P1|Overall Study|Lost to Follow-up|4
322591|NCT00676689|1056607|P1|Overall Study|Death|2
322592|NCT00676689|1056607|P1|Overall Study|Screen Failure|2
322593|NCT00676650|1056619|P2|Overall Study|Randomized but not treated|4
322594|NCT00676650|1056620|P1|Overall Study|Randomized but not treated|3
322595|NCT00676650|1056619|P2|Overall Study|Withdrawal by Subject|24
322596|NCT00676650|1056620|P1|Overall Study|Withdrawal by Subject|48
322597|NCT00676650|1056619|P2|Overall Study|Study terminated by sponsor|43
322598|NCT00676650|1056620|P1|Overall Study|Study terminated by sponsor|57
322599|NCT00676650|1056619|P2|Overall Study|Protocol Violation|1
322600|NCT00676650|1056620|P1|Overall Study|Protocol Violation|3
322601|NCT00676650|1056619|P2|Overall Study|Unspecified|10
322602|NCT00676650|1056620|P1|Overall Study|Unspecified|14
322603|NCT00676650|1056619|P2|Overall Study|Objective progression or relapse|140
322604|NCT00676650|1056620|P1|Overall Study|Objective progression or relapse|189
322605|NCT00676650|1056619|P2|Overall Study|Lost to Follow-up|1
322606|NCT00676650|1056620|P1|Overall Study|Lost to Follow-up|0
322607|NCT00676650|1056619|P2|Overall Study|Global deterioration of health status|31
322608|NCT00676650|1056620|P1|Overall Study|Global deterioration of health status|66
322609|NCT00676650|1056619|P2|Overall Study|Adverse Event|21
322610|NCT00676650|1056620|P1|Overall Study|Adverse Event|159
322611|NCT00676650|1056619|P2|Overall Study|Death|14
322612|NCT00676650|1056620|P1|Overall Study|Death|45
322613|NCT00676520|1056651|P1|Overall Study|Other Reason|18
322614|NCT00676520|1056651|P1|Overall Study|Ineligible for Randomization to DAPT|209
322615|NCT00676520|1056651|P1|Overall Study|Physician Decision|20
322616|NCT00676520|1056651|P1|Overall Study|Death|159
322617|NCT00676520|1056651|P1|Overall Study|Lost to Follow-up|162
322618|NCT00676520|1056651|P1|Overall Study|Withdrawal by Subject|163
322619|NCT00676494|1056708|P1|Overall Study|Withdrawal by Subject|6
322620|NCT00676494|1056708|P1|Overall Study|Missed Visit|8
322621|NCT00676403|1056725|P6|Overall Study|Withdrawal by Subject|1
322622|NCT00676403|1056726|P5|Overall Study|Withdrawal by Subject|0
322623|NCT00676403|1056727|P4|Overall Study|Withdrawal by Subject|0
322624|NCT00676403|1056728|P3|Overall Study|Withdrawal by Subject|0
322625|NCT00676403|1056729|P2|Overall Study|Withdrawal by Subject|0
322626|NCT00676403|1056730|P1|Overall Study|Withdrawal by Subject|0
322627|NCT00676403|1056725|P6|Overall Study|Reason Unspecified|1
322628|NCT00676403|1056726|P5|Overall Study|Reason Unspecified|0
322629|NCT00676403|1056727|P4|Overall Study|Reason Unspecified|0
322630|NCT00676403|1056728|P3|Overall Study|Reason Unspecified|1
322631|NCT00676403|1056729|P2|Overall Study|Reason Unspecified|0
322632|NCT00676403|1056730|P1|Overall Study|Reason Unspecified|1
322633|NCT00676403|1056725|P6|Overall Study|Lost to Follow-up|1
322634|NCT00676403|1056726|P5|Overall Study|Lost to Follow-up|0
322635|NCT00676403|1056727|P4|Overall Study|Lost to Follow-up|0
322636|NCT00676403|1056728|P3|Overall Study|Lost to Follow-up|0
322637|NCT00676403|1056729|P2|Overall Study|Lost to Follow-up|0
322638|NCT00676403|1056730|P1|Overall Study|Lost to Follow-up|0
322639|NCT00676403|1056725|P6|Overall Study|Adverse Event|2
322640|NCT00676403|1056726|P5|Overall Study|Adverse Event|1
322641|NCT00676403|1056727|P4|Overall Study|Adverse Event|5
322642|NCT00676403|1056728|P3|Overall Study|Adverse Event|0
322643|NCT00676403|1056729|P2|Overall Study|Adverse Event|2
322644|NCT00676403|1056730|P1|Overall Study|Adverse Event|1
322645|NCT00676338|1056873|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
322646|NCT00676338|1056874|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
322647|NCT00676338|1056875|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
322648|NCT00676338|1056876|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
322649|NCT00676338|1056873|P4|Overall Study|Entry Criteria Not Met|1
322650|NCT00676338|1056874|P3|Overall Study|Entry Criteria Not Met|1
322651|NCT00676338|1056875|P2|Overall Study|Entry Criteria Not Met|2
322652|NCT00676338|1056876|P1|Overall Study|Entry Criteria Not Met|0
322653|NCT00676338|1056873|P4|Overall Study|Withdrawal by Subject|6
322654|NCT00676338|1056874|P3|Overall Study|Withdrawal by Subject|12
322655|NCT00676338|1056875|P2|Overall Study|Withdrawal by Subject|9
322656|NCT00676338|1056876|P1|Overall Study|Withdrawal by Subject|17
322657|NCT00676338|1056873|P4|Overall Study|Protocol Violation|5
322658|NCT00676338|1056874|P3|Overall Study|Protocol Violation|2
322659|NCT00676338|1056875|P2|Overall Study|Protocol Violation|9
322660|NCT00676338|1056876|P1|Overall Study|Protocol Violation|5
322661|NCT00676338|1056873|P4|Overall Study|Physician Decision|3
322662|NCT00676338|1056874|P3|Overall Study|Physician Decision|2
322663|NCT00676338|1056875|P2|Overall Study|Physician Decision|3
322664|NCT00676338|1056876|P1|Overall Study|Physician Decision|3
322665|NCT00676338|1056873|P4|Overall Study|Lost to Follow-up|4
322666|NCT00676338|1056874|P3|Overall Study|Lost to Follow-up|3
322667|NCT00676338|1056875|P2|Overall Study|Lost to Follow-up|1
322668|NCT00676338|1056876|P1|Overall Study|Lost to Follow-up|4
322669|NCT00676338|1056873|P4|Overall Study|Adverse Event|1
322670|NCT00676338|1056874|P3|Overall Study|Adverse Event|5
322671|NCT00676338|1056875|P2|Overall Study|Adverse Event|6
322672|NCT00676338|1056876|P1|Overall Study|Adverse Event|6
322673|NCT00676208|1056928|P2|Overall Study|Incomplete data|4
322674|NCT00676208|1056929|P1|Overall Study|Incomplete data|2
322675|NCT00676208|1056928|P2|Overall Study|Lost to Follow-up|2
322676|NCT00676208|1056929|P1|Overall Study|Lost to Follow-up|0
322677|NCT00676195|1056937|P1|Overall Study|Physician Decision|1
322678|NCT00676195|1056937|P1|Overall Study|Adverse Event|1
322679|NCT00676195|1056937|P1|Overall Study|Lost to Follow-up|1
322680|NCT00676143|1056962|P2|Overall Study|Vasogenic edema recurrence|3
322681|NCT00676143|1056963|P1|Overall Study|Vasogenic edema recurrence|1
322682|NCT00676143|1056962|P2|Overall Study|Participant participation unknown|4
322683|NCT00676143|1056963|P1|Overall Study|Participant participation unknown|1
322684|NCT00676143|1056962|P2|Overall Study|Not specified|20
322685|NCT00676143|1056963|P1|Overall Study|Not specified|11
322686|NCT00676143|1056962|P2|Overall Study|Loss of caregiver|3
322687|NCT00676143|1056963|P1|Overall Study|Loss of caregiver|5
322688|NCT00676143|1056962|P2|Overall Study|Failed to return|1
322689|NCT00676143|1056963|P1|Overall Study|Failed to return|2
322690|NCT00676143|1056962|P2|Overall Study|Discontinuation of study by sponsor|88
322691|NCT00676143|1056963|P1|Overall Study|Discontinuation of study by sponsor|65
322692|NCT00676143|1056962|P2|Overall Study|Withdrawal by Subject|42
322693|NCT00676143|1056963|P1|Overall Study|Withdrawal by Subject|24
322694|NCT00676143|1056962|P2|Overall Study|Protocol Violation|8
322695|NCT00676143|1056963|P1|Overall Study|Protocol Violation|4
322696|NCT00676143|1056962|P2|Overall Study|Physician Decision|8
322697|NCT00676143|1056963|P1|Overall Study|Physician Decision|5
322698|NCT00676143|1056962|P2|Overall Study|Lost to Follow-up|13
322699|NCT00676143|1056963|P1|Overall Study|Lost to Follow-up|0
322700|NCT00676143|1056962|P2|Overall Study|Lack of Efficacy|6
322701|NCT00676143|1056963|P1|Overall Study|Lack of Efficacy|0
322702|NCT00676143|1056962|P2|Overall Study|Death|4
322703|NCT00676143|1056963|P1|Overall Study|Death|4
322704|NCT00676143|1056962|P2|Overall Study|Adverse Event|60
322705|NCT00676143|1056963|P1|Overall Study|Adverse Event|34
322706|NCT00676130|1057003|P2|Overall Study|Withdrawal by Subject|1
322707|NCT00676130|1057004|P1|Overall Study|Withdrawal by Subject|0
322708|NCT00676130|1057003|P2|Overall Study|Found ineligible|2
322709|NCT00676130|1057004|P1|Overall Study|Found ineligible|3
322710|NCT00676130|1057003|P2|Overall Study|Lost to Follow-up|1
322711|NCT00676130|1057004|P1|Overall Study|Lost to Follow-up|0
322712|NCT00676091|1057014|P2|Toddler Dose|Parent or legal guardian request|0
322713|NCT00676091|1057015|P1|Toddler Dose|Parent or legal guardian request|1
322714|NCT00676091|1057014|P2|Toddler Dose|Failed to return|0
322715|NCT00676091|1057015|P1|Toddler Dose|Failed to return|2
322716|NCT00676091|1057014|P2|After Infant Series|Failed to return|1
322717|NCT00676091|1057015|P1|After Infant Series|Failed to return|1
322718|NCT00676091|1057014|P2|After Infant Series|Protocol Violation|1
322719|NCT00676091|1057015|P1|After Infant Series|Protocol Violation|0
322720|NCT00676091|1057014|P2|After Infant Series|Adverse Event|1
322721|NCT00676091|1057015|P1|After Infant Series|Adverse Event|0
322722|NCT00676091|1057014|P2|Infant Series|Died prior to receiving 7vPnC|1
322723|NCT00676091|1057015|P1|Infant Series|Died prior to receiving 7vPnC|0
322724|NCT00676091|1057014|P2|Infant Series|Lost to Follow-up|0
322725|NCT00676091|1057015|P1|Infant Series|Lost to Follow-up|1
322726|NCT00676091|1057014|P2|Infant Series|Failed to return|3
322727|NCT00676091|1057015|P1|Infant Series|Failed to return|1
322728|NCT00676091|1057014|P2|Infant Series|Adverse Event|3
322729|NCT00676091|1057015|P1|Infant Series|Adverse Event|2
322730|NCT00676091|1057014|P2|Infant Series|Protocol Violation|3
322731|NCT00676091|1057015|P1|Infant Series|Protocol Violation|6
322732|NCT00676091|1057014|P2|Infant Series|Parent or legal guardian request|8
322733|NCT00676091|1057015|P1|Infant Series|Parent or legal guardian request|10
322734|NCT00675948|1057083|P2|Overall Study|Patient feels unable to take medication|1
322735|NCT00675948|1057084|P1|Overall Study|Patient feels unable to take medication|0
322736|NCT00675948|1057083|P2|Overall Study|Patient unable to comply with diaries|0
322737|NCT00675948|1057084|P1|Overall Study|Patient unable to comply with diaries|1
322738|NCT00675948|1057083|P2|Overall Study|Patient died|0
322739|NCT00675948|1057084|P1|Overall Study|Patient died|1
322740|NCT00675948|1057083|P2|Overall Study|Sponsor decision|1
322741|NCT00675948|1057084|P1|Overall Study|Sponsor decision|0
322742|NCT00675948|1057083|P2|Overall Study|Pain under control|0
322743|NCT00675948|1057084|P1|Overall Study|Pain under control|1
322744|NCT00675948|1057083|P2|Overall Study|Protocol Violation|0
322745|NCT00675948|1057084|P1|Overall Study|Protocol Violation|1
322746|NCT00675948|1057083|P2|Overall Study|Lost to Follow-up|0
322747|NCT00675948|1057084|P1|Overall Study|Lost to Follow-up|2
322748|NCT00675948|1057083|P2|Overall Study|Withdrawal by Subject|0
322749|NCT00675948|1057084|P1|Overall Study|Withdrawal by Subject|7
322750|NCT00675948|1057083|P2|Overall Study|Lack of Efficacy|0
322751|NCT00675948|1057084|P1|Overall Study|Lack of Efficacy|3
322752|NCT00675948|1057083|P2|Overall Study|Adverse Event|1
322753|NCT00675948|1057084|P1|Overall Study|Adverse Event|23
322754|NCT00675766|1057135|P4|Overall Study|Lost to Follow-up|26
322755|NCT00675766|1057136|P3|Overall Study|Lost to Follow-up|21
322756|NCT00675766|1057137|P2|Overall Study|Lost to Follow-up|5
322757|NCT00675766|1057138|P1|Overall Study|Lost to Follow-up|6
322758|NCT00675597|1057148|P1|Overall Study|Withdrawal by Subject|3
322759|NCT00675506|1057182|P2|Overall Study|Schedule conflict|1
322760|NCT00675506|1057183|P1|Overall Study|Schedule conflict|0
322761|NCT00675506|1057182|P2|Overall Study|Declined participation|0
322762|NCT00675506|1057183|P1|Overall Study|Declined participation|1
322763|NCT00675506|1057182|P2|Overall Study|Disclosed history of cancer|0
322764|NCT00675506|1057183|P1|Overall Study|Disclosed history of cancer|1
322765|NCT00675506|1057182|P2|Overall Study|Hypersensitivity Reaction|0
322766|NCT00675506|1057183|P1|Overall Study|Hypersensitivity Reaction|1
322767|NCT00675506|1057182|P2|Overall Study|Elevated IGF-1|0
322768|NCT00675506|1057183|P1|Overall Study|Elevated IGF-1|2
322769|NCT00675506|1057182|P2|Overall Study|Elevated IGF-1 prior to treatment|0
322770|NCT00675506|1057183|P1|Overall Study|Elevated IGF-1 prior to treatment|1
322771|NCT00675506|1057182|P2|Overall Study|Elevated fasting glucose|1
322772|NCT00675506|1057183|P1|Overall Study|Elevated fasting glucose|2
322773|NCT00675506|1057182|P2|Overall Study|Lost interest|5
322774|NCT00675506|1057183|P1|Overall Study|Lost interest|3
322775|NCT00675506|1057182|P2|Overall Study|Lost to Follow-up|5
322776|NCT00675506|1057183|P1|Overall Study|Lost to Follow-up|1
322777|NCT00675441|1057195|P1|Overall Study|Death|1
322778|NCT00675441|1057195|P1|Overall Study|Withdrawal by Subject|2
322779|NCT00675428|1057201|P2|Overall Study|Physician Decision|0
322780|NCT00675428|1057202|P1|Overall Study|Physician Decision|1
322781|NCT00675428|1057201|P2|Overall Study|No Disease Response After Cycle 6|1
322782|NCT00675428|1057202|P1|Overall Study|No Disease Response After Cycle 6|0
322783|NCT00675428|1057201|P2|Overall Study|Disease Progression|2
322784|NCT00675428|1057202|P1|Overall Study|Disease Progression|2
322785|NCT00675103|1057238|P1|Overall Study|Adverse Event|1
322786|NCT00675103|1057238|P1|Overall Study|Lack of Efficacy|2
322787|NCT00674986|1057245|P2|Overall Study|Other reasons|8
322788|NCT00674986|1057246|P1|Overall Study|Other reasons|4
322789|NCT00674986|1057245|P2|Overall Study|Lost to Follow-up|53
322790|NCT00674986|1057246|P1|Overall Study|Lost to Follow-up|25
322791|NCT00674986|1057245|P2|Overall Study|Subject withdrew consent|19
322792|NCT00674986|1057246|P1|Overall Study|Subject withdrew consent|12
322793|NCT00674986|1057245|P2|Overall Study|Adverse Event|1
322794|NCT00674986|1057246|P1|Overall Study|Adverse Event|2
322795|NCT00674973|1057267|P2|Overall Study|Protocol Violation|1
322796|NCT00674973|1057268|P1|Overall Study|Protocol Violation|0
322797|NCT00674973|1057267|P2|Overall Study|Death|15
322798|NCT00674973|1057268|P1|Overall Study|Death|19
322799|NCT00674973|1057267|P2|Overall Study|Adverse Event|9
322800|NCT00674973|1057268|P1|Overall Study|Adverse Event|2
322801|NCT00674973|1057267|P2|Overall Study|Failure to Return|0
322802|NCT00674973|1057268|P1|Overall Study|Failure to Return|1
322803|NCT00674973|1057267|P2|Overall Study|Refused Treatment|5
322804|NCT00674973|1057268|P1|Overall Study|Refused Treatment|1
322805|NCT00674973|1057267|P2|Overall Study|Insufficient Therapeutic Response|72
322806|NCT00674973|1057268|P1|Overall Study|Insufficient Therapeutic Response|77
322807|NCT00674817|1057282|P1|Period 4|Adverse Event|1
322808|NCT00674817|1057282|P1|Period 3|Protocol Violation|1
322809|NCT00674817|1057282|P1|Period 3|Adverse Event|1
322810|NCT00674817|1057282|P1|Period 1|Protocol Violation|1
322811|NCT00674817|1057282|P1|Period 1|Withdrawal by Subject|2
322812|NCT00674700|1057459|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
322813|NCT00674700|1057460|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
322814|NCT00674700|1057461|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
322815|NCT00674700|1057459|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
322816|NCT00674700|1057460|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
322817|NCT00674700|1057461|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
322818|NCT00674700|1057459|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
322819|NCT00674700|1057460|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
322820|NCT00674700|1057461|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
322821|NCT00674700|1057459|P3|Year 1|Any other reason not above-mentioned|6
322822|NCT00674700|1057460|P2|Year 1|Any other reason not above-mentioned|7
322823|NCT00674700|1057461|P1|Year 1|Any other reason not above-mentioned|7
322824|NCT00674700|1057459|P3|Year 1|Withdrawal by Subject|6
322825|NCT00674700|1057460|P2|Year 1|Withdrawal by Subject|7
322826|NCT00674700|1057461|P1|Year 1|Withdrawal by Subject|7
322827|NCT00674700|1057459|P3|Year 1|Adverse Event|5
322828|NCT00674700|1057460|P2|Year 1|Adverse Event|20
322829|NCT00674700|1057461|P1|Year 1|Adverse Event|17
322830|NCT00674661|1057474|P2|Overall Study|Withdrawal by Subject|5
322831|NCT00674661|1057475|P1|Overall Study|Withdrawal by Subject|0
322832|NCT00674661|1057474|P2|Overall Study|Lost to Follow-up|3
322833|NCT00674661|1057475|P1|Overall Study|Lost to Follow-up|6
322834|NCT00674661|1057474|P2|Overall Study|not specified|7
322835|NCT00674661|1057475|P1|Overall Study|not specified|5
322836|NCT00674362|1057568|P2|Open Label|Other: Subject moved to extension study|0
322837|NCT00674362|1057569|P1|Open Label|Other: Subject moved to extension study|1
322838|NCT00674362|1057568|P2|Open Label|Adverse Event|0
322839|NCT00674362|1057569|P1|Open Label|Adverse Event|1
322840|NCT00674362|1057568|P2|Double Blind|Other: Surgery|1
322841|NCT00674362|1057569|P1|Double Blind|Other: Surgery|0
322842|NCT00674362|1057568|P2|Double Blind|Other: Loss of Patient Compliance|1
322843|NCT00674362|1057569|P1|Double Blind|Other: Loss of Patient Compliance|0
322844|NCT00674362|1057568|P2|Double Blind|Withdrawal by Subject|3
322845|NCT00674362|1057569|P1|Double Blind|Withdrawal by Subject|4
322846|NCT00674362|1057568|P2|Double Blind|Loss of efficacy|1
322847|NCT00674362|1057569|P1|Double Blind|Loss of efficacy|0
322848|NCT00674362|1057568|P2|Double Blind|Lack of Efficacy|6
322849|NCT00674362|1057569|P1|Double Blind|Lack of Efficacy|2
322850|NCT00674362|1057568|P2|Double Blind|Adverse Event|6
322851|NCT00674362|1057569|P1|Double Blind|Adverse Event|6
322852|NCT00674323|1057637|P3|Overall Study|Protocol Violation|0
322853|NCT00674323|1057638|P2|Overall Study|Protocol Violation|0
322854|NCT00674323|1057639|P1|Overall Study|Protocol Violation|1
322855|NCT00674323|1057637|P3|Overall Study|Adverse Event|0
322856|NCT00674323|1057638|P2|Overall Study|Adverse Event|1
322857|NCT00674323|1057639|P1|Overall Study|Adverse Event|0
322858|NCT00674154|1057663|P2|Overall Study|Did not want parathyroidectomy|2
322859|NCT00674154|1057664|P1|Overall Study|Did not want parathyroidectomy|0
322860|NCT00674154|1057663|P2|Overall Study|Withdrawal by Subject|1
322861|NCT00674154|1057664|P1|Overall Study|Withdrawal by Subject|3
322862|NCT00674128|1057672|P2|Overall Study|Withdrawal by Subject|23
322863|NCT00674128|1057673|P1|Overall Study|Withdrawal by Subject|25
322864|NCT00673933|1057698|P1|Overall Study|Lost to Follow-up|1
322865|NCT00673933|1057698|P1|Overall Study|Withdrawal by Subject|2
322866|NCT00673881|1057714|P1|Overall Study|Withdrawal by Subject|1
322867|NCT00673816|1057728|P1|Overall Study|Withdrawal by Subject|1
322868|NCT00673816|1057728|P1|Overall Study|Adverse Event|1
322869|NCT00673673|1057763|P1|Overall Study|Investigators' discretion|2
322870|NCT00673673|1057763|P1|Overall Study|Withdrawal by Subject|3
322871|NCT00673673|1057763|P1|Overall Study|Adverse Event|4
322872|NCT00673673|1057763|P1|Overall Study|Progressive disease|27
322873|NCT00673660|1057769|P1|Overall Study|Lost to Follow-up|107
322874|NCT00673465|1057791|P12|Part 1/Period 2 (United States)|Protocol Violation|0
322875|NCT00673465|1057792|P11|Part 1/Period 2 (United States)|Protocol Violation|0
322876|NCT00673465|1057793|P10|Part 1/Period 2 (United States)|Protocol Violation|0
322877|NCT00673465|1057794|P9|Part 1/Period 2 (United States)|Protocol Violation|0
322878|NCT00673465|1057795|P8|Part 1/Period 2 (United States)|Protocol Violation|0
322879|NCT00673465|1057796|P7|Part 1/Period 2 (United States)|Protocol Violation|0
322880|NCT00673465|1057797|P6|Part 1/Period 2 (United States)|Protocol Violation|0
322881|NCT00673465|1057798|P5|Part 1/Period 2 (United States)|Protocol Violation|1
322882|NCT00673465|1057799|P4|Part 1/Period 2 (United States)|Protocol Violation|0
322883|NCT00673465|1057800|P3|Part 1/Period 2 (United States)|Protocol Violation|0
322884|NCT00673465|1057801|P2|Part 1/Period 2 (United States)|Protocol Violation|0
322885|NCT00673465|1057802|P1|Part 1/Period 2 (United States)|Protocol Violation|0
322886|NCT00673465|1057791|P12|Part 1/Period 1 (United States)|Protocol Violation|0
322887|NCT00673465|1057792|P11|Part 1/Period 1 (United States)|Protocol Violation|0
322888|NCT00673465|1057793|P10|Part 1/Period 1 (United States)|Protocol Violation|0
322889|NCT00673465|1057794|P9|Part 1/Period 1 (United States)|Protocol Violation|0
322890|NCT00673465|1057795|P8|Part 1/Period 1 (United States)|Protocol Violation|0
322891|NCT00673465|1057796|P7|Part 1/Period 1 (United States)|Protocol Violation|0
322892|NCT00673465|1057797|P6|Part 1/Period 1 (United States)|Protocol Violation|1
322893|NCT00673465|1057798|P5|Part 1/Period 1 (United States)|Protocol Violation|1
322894|NCT00673465|1057799|P4|Part 1/Period 1 (United States)|Protocol Violation|0
322895|NCT00673465|1057800|P3|Part 1/Period 1 (United States)|Protocol Violation|0
322896|NCT00673465|1057801|P2|Part 1/Period 1 (United States)|Protocol Violation|0
322897|NCT00673465|1057802|P1|Part 1/Period 1 (United States)|Protocol Violation|0
322898|NCT00673452|1057851|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
322899|NCT00673452|1057852|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
322900|NCT00673452|1057851|P2|Continuation Double-Blind Phase|Physician Decision|0
322901|NCT00673452|1057852|P1|Continuation Double-Blind Phase|Physician Decision|2
322902|NCT00673452|1057851|P2|Continuation Double-Blind Phase|Sponsor Decision|3
322903|NCT00673452|1057852|P1|Continuation Double-Blind Phase|Sponsor Decision|0
322904|NCT00673452|1057851|P2|Continuation Double-Blind Phase|Protocol Violation|3
322905|NCT00673452|1057852|P1|Continuation Double-Blind Phase|Protocol Violation|2
322906|NCT00673452|1057851|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
322907|NCT00673452|1057852|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
322908|NCT00673452|1057851|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
322909|NCT00673452|1057852|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
322910|NCT00673452|1057851|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
322911|NCT00673452|1057852|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
322912|NCT00673452|1057851|P2|Continuation Double-Blind Phase|Adverse Event|13
322913|NCT00673452|1057852|P1|Continuation Double-Blind Phase|Adverse Event|5
322914|NCT00673452|1057851|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
322915|NCT00673452|1057852|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
322916|NCT00673452|1057851|P2|Acute Double-Blind Phase|Sponsor Decision|1
322917|NCT00673452|1057852|P1|Acute Double-Blind Phase|Sponsor Decision|0
322918|NCT00673452|1057851|P2|Acute Double-Blind Phase|Protocol Violation|3
322919|NCT00673452|1057852|P1|Acute Double-Blind Phase|Protocol Violation|5
322920|NCT00673452|1057851|P2|Acute Double-Blind Phase|Physician Decision|6
322921|NCT00673452|1057852|P1|Acute Double-Blind Phase|Physician Decision|0
322922|NCT00673452|1057851|P2|Acute Double-Blind Phase|Lost to Follow-up|19
322923|NCT00673452|1057852|P1|Acute Double-Blind Phase|Lost to Follow-up|16
322924|NCT00673452|1057851|P2|Acute Double-Blind Phase|Lack of Efficacy|14
322925|NCT00673452|1057852|P1|Acute Double-Blind Phase|Lack of Efficacy|9
322926|NCT00673452|1057851|P2|Acute Double-Blind Phase|Adverse Event|24
322927|NCT00673452|1057852|P1|Acute Double-Blind Phase|Adverse Event|41
322928|NCT00673387|1057915|P8|Overall Study|Lost to Follow-up|5
322929|NCT00673387|1057916|P7|Overall Study|Lost to Follow-up|8
322930|NCT00673387|1057917|P6|Overall Study|Lost to Follow-up|5
322931|NCT00673387|1057918|P5|Overall Study|Lost to Follow-up|6
322932|NCT00673387|1057919|P4|Overall Study|Lost to Follow-up|6
322933|NCT00673387|1057920|P3|Overall Study|Lost to Follow-up|5
322934|NCT00673387|1057921|P2|Overall Study|Lost to Follow-up|6
322935|NCT00673387|1057922|P1|Overall Study|Lost to Follow-up|8
322936|NCT00673387|1057915|P8|Overall Study|Protocol Violation|3
322937|NCT00673387|1057916|P7|Overall Study|Protocol Violation|1
322938|NCT00673387|1057917|P6|Overall Study|Protocol Violation|1
322939|NCT00673387|1057918|P5|Overall Study|Protocol Violation|0
322940|NCT00673387|1057919|P4|Overall Study|Protocol Violation|2
322941|NCT00673387|1057920|P3|Overall Study|Protocol Violation|1
322942|NCT00673387|1057921|P2|Overall Study|Protocol Violation|0
322943|NCT00673387|1057922|P1|Overall Study|Protocol Violation|3
322944|NCT00673387|1057915|P8|Overall Study|Physician Decision|1
322945|NCT00673387|1057916|P7|Overall Study|Physician Decision|1
322946|NCT00673387|1057917|P6|Overall Study|Physician Decision|5
322947|NCT00673387|1057918|P5|Overall Study|Physician Decision|0
322948|NCT00673387|1057919|P4|Overall Study|Physician Decision|0
322949|NCT00673387|1057920|P3|Overall Study|Physician Decision|0
322950|NCT00673387|1057921|P2|Overall Study|Physician Decision|0
322951|NCT00673387|1057922|P1|Overall Study|Physician Decision|0
322952|NCT00673387|1057915|P8|Overall Study|Adverse Event|5
322953|NCT00673387|1057916|P7|Overall Study|Adverse Event|5
322954|NCT00673387|1057917|P6|Overall Study|Adverse Event|2
322955|NCT00673387|1057918|P5|Overall Study|Adverse Event|6
322956|NCT00673387|1057919|P4|Overall Study|Adverse Event|2
322957|NCT00673387|1057920|P3|Overall Study|Adverse Event|5
322958|NCT00673387|1057921|P2|Overall Study|Adverse Event|1
322959|NCT00673387|1057922|P1|Overall Study|Adverse Event|3
322960|NCT00673387|1057915|P8|Overall Study|Withdrawal by Subject|21
322961|NCT00673387|1057916|P7|Overall Study|Withdrawal by Subject|15
322962|NCT00673387|1057917|P6|Overall Study|Withdrawal by Subject|21
322963|NCT00673387|1057918|P5|Overall Study|Withdrawal by Subject|18
322964|NCT00673387|1057919|P4|Overall Study|Withdrawal by Subject|16
322965|NCT00673387|1057920|P3|Overall Study|Withdrawal by Subject|20
322966|NCT00673387|1057921|P2|Overall Study|Withdrawal by Subject|16
322967|NCT00673387|1057922|P1|Overall Study|Withdrawal by Subject|15
322968|NCT00673361|1058138|P1|Overall Study|Screen Failure|2
322969|NCT00673257|1058142|P1|Overall Study|Unable to obtain specimen|1
322970|NCT00673257|1058142|P1|Overall Study|Withdrawal by Subject|4
322971|NCT00673231|1058151|P4|Overall Study|Study criteria,compliance,safety, other|4
322972|NCT00673231|1058152|P3|Overall Study|Study criteria,compliance,safety, other|7
322973|NCT00673231|1058153|P2|Overall Study|Study criteria,compliance,safety, other|5
322974|NCT00673231|1058154|P1|Overall Study|Study criteria,compliance,safety, other|8
322975|NCT00673231|1058151|P4|Overall Study|Death|0
322976|NCT00673231|1058152|P3|Overall Study|Death|1
322977|NCT00673231|1058153|P2|Overall Study|Death|0
322978|NCT00673231|1058154|P1|Overall Study|Death|0
322979|NCT00673231|1058151|P4|Overall Study|Lost to Follow-up|2
322980|NCT00673231|1058152|P3|Overall Study|Lost to Follow-up|1
322981|NCT00673231|1058153|P2|Overall Study|Lost to Follow-up|2
322982|NCT00673231|1058154|P1|Overall Study|Lost to Follow-up|1
322983|NCT00673231|1058151|P4|Overall Study|Adverse Event|6
322984|NCT00673231|1058152|P3|Overall Study|Adverse Event|9
322985|NCT00673231|1058153|P2|Overall Study|Adverse Event|5
322986|NCT00673231|1058154|P1|Overall Study|Adverse Event|6
322987|NCT00673231|1058151|P4|Overall Study|Withdrawal by Subject|6
322988|NCT00673231|1058152|P3|Overall Study|Withdrawal by Subject|8
322989|NCT00673231|1058153|P2|Overall Study|Withdrawal by Subject|10
322990|NCT00673231|1058154|P1|Overall Study|Withdrawal by Subject|14
322991|NCT00673179|1058186|P2|Overall Study|Toxicity/Complications|0
322992|NCT00673179|1058187|P1|Overall Study|Toxicity/Complications|3
322993|NCT00673049|1058236|P4|After Progression on Erlotinib|study terminated by sponsor|4
322994|NCT00673049|1058237|P3|After Progression on Erlotinib|study terminated by sponsor|0
322995|NCT00673049|1058238|P2|After Progression on Erlotinib|study terminated by sponsor|0
322996|NCT00673049|1058239|P1|After Progression on Erlotinib|study terminated by sponsor|0
322997|NCT00673049|1058236|P4|After Progression on Erlotinib|Withdrawal by Subject|5
322998|NCT00673049|1058237|P3|After Progression on Erlotinib|Withdrawal by Subject|0
322999|NCT00673049|1058238|P2|After Progression on Erlotinib|Withdrawal by Subject|0
323000|NCT00673049|1058239|P1|After Progression on Erlotinib|Withdrawal by Subject|0
323001|NCT00673049|1058236|P4|After Progression on Erlotinib|Lost to Follow-up|3
323002|NCT00673049|1058237|P3|After Progression on Erlotinib|Lost to Follow-up|0
323003|NCT00673049|1058238|P2|After Progression on Erlotinib|Lost to Follow-up|0
323004|NCT00673049|1058239|P1|After Progression on Erlotinib|Lost to Follow-up|0
323005|NCT00673049|1058236|P4|After Progression on Erlotinib|Death|71
323006|NCT00673049|1058237|P3|After Progression on Erlotinib|Death|0
323007|NCT00673049|1058238|P2|After Progression on Erlotinib|Death|0
323008|NCT00673049|1058239|P1|After Progression on Erlotinib|Death|0
323009|NCT00673049|1058236|P4|Before Progression on Erlotinib|Switched to figitumumab|0
323010|NCT00673049|1058237|P3|Before Progression on Erlotinib|Switched to figitumumab|0
323011|NCT00673049|1058238|P2|Before Progression on Erlotinib|Switched to figitumumab|83
323012|NCT00673049|1058239|P1|Before Progression on Erlotinib|Switched to figitumumab|0
323013|NCT00673049|1058236|P4|Before Progression on Erlotinib|study terminated by sponsor|0
323014|NCT00673049|1058237|P3|Before Progression on Erlotinib|study terminated by sponsor|0
323015|NCT00673049|1058238|P2|Before Progression on Erlotinib|study terminated by sponsor|14
323016|NCT00673049|1058239|P1|Before Progression on Erlotinib|study terminated by sponsor|18
323017|NCT00673049|1058236|P4|Before Progression on Erlotinib|Unspecified|0
323018|NCT00673049|1058237|P3|Before Progression on Erlotinib|Unspecified|0
323019|NCT00673049|1058238|P2|Before Progression on Erlotinib|Unspecified|2
323020|NCT00673049|1058239|P1|Before Progression on Erlotinib|Unspecified|1
323021|NCT00673049|1058236|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
323022|NCT00673049|1058237|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
323023|NCT00673049|1058238|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
323024|NCT00673049|1058239|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
323025|NCT00673049|1058236|P4|Before Progression on Erlotinib|Lost to Follow-up|0
323026|NCT00673049|1058237|P3|Before Progression on Erlotinib|Lost to Follow-up|0
323027|NCT00673049|1058238|P2|Before Progression on Erlotinib|Lost to Follow-up|5
323028|NCT00673049|1058239|P1|Before Progression on Erlotinib|Lost to Follow-up|9
323029|NCT00673049|1058236|P4|Before Progression on Erlotinib|Death|0
323030|NCT00673049|1058237|P3|Before Progression on Erlotinib|Death|1
323031|NCT00673049|1058238|P2|Before Progression on Erlotinib|Death|167
323032|NCT00673049|1058239|P1|Before Progression on Erlotinib|Death|235
323033|NCT00673049|1058236|P4|Before Progression on Erlotinib|Randomized but not treated|0
323034|NCT00673049|1058237|P3|Before Progression on Erlotinib|Randomized but not treated|0
323035|NCT00673049|1058238|P2|Before Progression on Erlotinib|Randomized but not treated|1
323036|NCT00673049|1058239|P1|Before Progression on Erlotinib|Randomized but not treated|3
323037|NCT00672984|1058263|P3|Third Intervention|Adverse Event|1
323038|NCT00672984|1058264|P2|Third Intervention|Adverse Event|0
323039|NCT00672984|1058265|P1|Third Intervention|Adverse Event|1
323040|NCT00672984|1058263|P3|Second Intervention|Protocol Violation|1
323041|NCT00672984|1058264|P2|Second Intervention|Protocol Violation|1
323042|NCT00672984|1058265|P1|Second Intervention|Protocol Violation|0
323043|NCT00672984|1058263|P3|Second Intervention|Withdrawal by Subject|0
323044|NCT00672984|1058264|P2|Second Intervention|Withdrawal by Subject|3
323045|NCT00672984|1058265|P1|Second Intervention|Withdrawal by Subject|0
323046|NCT00672984|1058263|P3|Second Intervention|Non-compliance with facility policies|0
323047|NCT00672984|1058264|P2|Second Intervention|Non-compliance with facility policies|2
323048|NCT00672984|1058265|P1|Second Intervention|Non-compliance with facility policies|0
323049|NCT00672984|1058263|P3|First Intervention|Sponsor decision|0
323050|NCT00672984|1058264|P2|First Intervention|Sponsor decision|0
323051|NCT00672984|1058265|P1|First Intervention|Sponsor decision|3
323052|NCT00672984|1058263|P3|First Intervention|Withdrawal by Subject|2
323053|NCT00672984|1058264|P2|First Intervention|Withdrawal by Subject|2
323054|NCT00672984|1058265|P1|First Intervention|Withdrawal by Subject|1
323055|NCT00672984|1058263|P3|First Intervention|Adverse Event|0
323056|NCT00672984|1058264|P2|First Intervention|Adverse Event|0
323057|NCT00672984|1058265|P1|First Intervention|Adverse Event|5
323058|NCT00672958|1058316|P2|Overall Study|Reason not specified|3
323059|NCT00672958|1058317|P1|Overall Study|Reason not specified|0
323060|NCT00672958|1058316|P2|Overall Study|Lost to Follow-up|17
323061|NCT00672958|1058317|P1|Overall Study|Lost to Follow-up|22
323062|NCT00672958|1058316|P2|Overall Study|Voluntary withdrawal|8
323063|NCT00672958|1058317|P1|Overall Study|Voluntary withdrawal|12
323064|NCT00672958|1058316|P2|Overall Study|Protocol deviations|5
323065|NCT00672958|1058317|P1|Overall Study|Protocol deviations|11
323066|NCT00672958|1058316|P2|Overall Study|Non-compliance with study drug|3
323067|NCT00672958|1058317|P1|Overall Study|Non-compliance with study drug|2
323068|NCT00672958|1058316|P2|Overall Study|Lack of Efficacy|11
323069|NCT00672958|1058317|P1|Overall Study|Lack of Efficacy|6
323070|NCT00672958|1058316|P2|Overall Study|Adverse Event|9
323071|NCT00672958|1058317|P1|Overall Study|Adverse Event|11
323072|NCT00672841|1058369|P2|Overall Study|Pregnancy|1
323073|NCT00672841|1058370|P1|Overall Study|Pregnancy|0
323074|NCT00672841|1058369|P2|Overall Study|Adverse Event|3
323075|NCT00672841|1058370|P1|Overall Study|Adverse Event|0
323076|NCT00672841|1058369|P2|Overall Study|Antifungal therapy, negative glucan|4
323077|NCT00672841|1058370|P1|Overall Study|Antifungal therapy, negative glucan|0
323078|NCT00672841|1058369|P2|Overall Study|icteric specimens|3
323079|NCT00672841|1058370|P1|Overall Study|icteric specimens|0
323080|NCT00672841|1058369|P2|Overall Study|Comfort care|4
323081|NCT00672841|1058370|P1|Overall Study|Comfort care|1
323082|NCT00672646|1058385|P3|Overall Study|Withdrawal by Subject|1
323083|NCT00672646|1058386|P2|Overall Study|Withdrawal by Subject|0
323084|NCT00672646|1058387|P1|Overall Study|Withdrawal by Subject|0
323085|NCT00672646|1058385|P3|Overall Study|Lost to Follow-up|2
323086|NCT00672646|1058386|P2|Overall Study|Lost to Follow-up|1
323087|NCT00672646|1058387|P1|Overall Study|Lost to Follow-up|0
323088|NCT00672633|1058412|P2|Overall Study|Withdrawal by Subject|1
323089|NCT00672633|1058413|P1|Overall Study|Withdrawal by Subject|0
323090|NCT00672620|1058427|P4|Overall Study|Reason not Specified|1
323091|NCT00672620|1058428|P3|Overall Study|Reason not Specified|2
323092|NCT00672620|1058429|P2|Overall Study|Reason not Specified|3
323093|NCT00672620|1058430|P1|Overall Study|Reason not Specified|3
323094|NCT00672620|1058427|P4|Overall Study|Lost to Follow-up|11
323095|NCT00672620|1058428|P3|Overall Study|Lost to Follow-up|8
323096|NCT00672620|1058429|P2|Overall Study|Lost to Follow-up|19
323097|NCT00672620|1058430|P1|Overall Study|Lost to Follow-up|8
323098|NCT00672620|1058427|P4|Overall Study|Withdrawal of Consent|6
323099|NCT00672620|1058428|P3|Overall Study|Withdrawal of Consent|5
323100|NCT00672620|1058429|P2|Overall Study|Withdrawal of Consent|12
323101|NCT00672620|1058430|P1|Overall Study|Withdrawal of Consent|6
323102|NCT00672620|1058427|P4|Overall Study|Protocol Deviations|5
323103|NCT00672620|1058428|P3|Overall Study|Protocol Deviations|2
323104|NCT00672620|1058429|P2|Overall Study|Protocol Deviations|7
323105|NCT00672620|1058430|P1|Overall Study|Protocol Deviations|5
323106|NCT00672620|1058427|P4|Overall Study|Noncompliance with Study Drug|2
323107|NCT00672620|1058428|P3|Overall Study|Noncompliance with Study Drug|0
323108|NCT00672620|1058429|P2|Overall Study|Noncompliance with Study Drug|4
323109|NCT00672620|1058430|P1|Overall Study|Noncompliance with Study Drug|3
323110|NCT00672620|1058427|P4|Overall Study|Lack of Efficacy|0
323111|NCT00672620|1058428|P3|Overall Study|Lack of Efficacy|2
323112|NCT00672620|1058429|P2|Overall Study|Lack of Efficacy|2
323113|NCT00672620|1058430|P1|Overall Study|Lack of Efficacy|1
323114|NCT00672620|1058427|P4|Overall Study|Adverse Event|17
323115|NCT00672620|1058428|P3|Overall Study|Adverse Event|12
323116|NCT00672620|1058429|P2|Overall Study|Adverse Event|7
323117|NCT00672620|1058430|P1|Overall Study|Adverse Event|7
323118|NCT00672555|1058495|P1|Overall Study|Did not want to answer questionnaire|2
323119|NCT00672555|1058495|P1|Overall Study|Lost to Follow-up|4
323120|NCT00672490|1058506|P2|Overall Study|No reason was provided|2
323121|NCT00672490|1058507|P1|Overall Study|No reason was provided|6
323122|NCT00672490|1058506|P2|Overall Study|Lost to Follow-up|5
323123|NCT00672490|1058507|P1|Overall Study|Lost to Follow-up|1
323124|NCT00672490|1058506|P2|Overall Study|Intolerance|2
323125|NCT00672490|1058507|P1|Overall Study|Intolerance|0
323126|NCT00672490|1058506|P2|Overall Study|Violation of Concomitant Medicine|0
323127|NCT00672490|1058507|P1|Overall Study|Violation of Concomitant Medicine|1
323128|NCT00672490|1058506|P2|Overall Study|Adverse Event|8
323129|NCT00672490|1058507|P1|Overall Study|Adverse Event|5
323130|NCT00672490|1058506|P2|Overall Study|Mismatch Include/Exclude Criteria|0
323131|NCT00672490|1058507|P1|Overall Study|Mismatch Include/Exclude Criteria|1
323132|NCT00672490|1058506|P2|Overall Study|Lack of Compliance|7
323133|NCT00672490|1058507|P1|Overall Study|Lack of Compliance|2
323134|NCT00672490|1058506|P2|Overall Study|Withdrawal by Subject|8
323135|NCT00672490|1058507|P1|Overall Study|Withdrawal by Subject|8
323136|NCT00672256|1058563|P1|Overall Study|PI dropped, bad data|44
323137|NCT00671931|1058637|P5|Overall Study|Physician Decision|1
323138|NCT00671931|1058638|P4|Overall Study|Physician Decision|2
323139|NCT00671931|1058639|P3|Overall Study|Physician Decision|0
323140|NCT00671931|1058640|P2|Overall Study|Physician Decision|0
323141|NCT00671931|1058641|P1|Overall Study|Physician Decision|1
323142|NCT00671879|1058661|P3|Overall Study|Withdrawal by Subject|6
323143|NCT00671879|1058662|P2|Overall Study|Withdrawal by Subject|4
323144|NCT00671879|1058663|P1|Overall Study|Withdrawal by Subject|0
323145|NCT00671853|1058676|P2|Overall Study|Non-adherence with study procedures|4
323146|NCT00671853|1058677|P1|Overall Study|Non-adherence with study procedures|1
323147|NCT00671853|1058676|P2|Overall Study|Physician Decision|2
323148|NCT00671853|1058677|P1|Overall Study|Physician Decision|0
323149|NCT00671853|1058676|P2|Overall Study|Lost to Follow-up|8
323150|NCT00671853|1058677|P1|Overall Study|Lost to Follow-up|8
323151|NCT00671853|1058676|P2|Overall Study|Withdrawal by Subject|5
323152|NCT00671853|1058677|P1|Overall Study|Withdrawal by Subject|1
323153|NCT00671853|1058676|P2|Overall Study|Adverse Event|1
323154|NCT00671853|1058677|P1|Overall Study|Adverse Event|7
323155|NCT00671853|1058676|P2|Overall Study|Lack of Efficacy|7
323156|NCT00671853|1058677|P1|Overall Study|Lack of Efficacy|3
323157|NCT00671788|1058693|P1|Overall Study|Other|1
323158|NCT00671788|1058693|P1|Overall Study|MD Decision|1
323159|NCT00671788|1058693|P1|Overall Study|Ineligible|1
323160|NCT00671788|1058693|P1|Overall Study|Refused further treatment|3
323161|NCT00671788|1058693|P1|Overall Study|Adverse Event|8
323162|NCT00671749|1058700|P1|Overall Study|Lost to Follow-up|1
323163|NCT00671749|1058700|P1|Overall Study|Protocol Violation|1
323164|NCT00671749|1058700|P1|Overall Study|Withdrawal by Subject|4
323165|NCT00671749|1058700|P1|Overall Study|Adverse Event|2
323166|NCT00671554|1058743|P1|Overall Study|Disease progression|3
323167|NCT00671437|1058782|P1|Overall Study|Ineligible post-hoc|1
323168|NCT00671437|1058782|P1|Overall Study|Adverse Event|3
323169|NCT00671437|1058782|P1|Overall Study|Cutaneous SCC of head and neck|3
323170|NCT00671437|1058782|P1|Overall Study|Progressive disease before C1 week 8|8
323171|NCT00671060|1058816|P2|Overall Study|Physician Decision|1
323172|NCT00671060|1058817|P1|Overall Study|Physician Decision|0
323173|NCT00671060|1058816|P2|Overall Study|Protocol Violation|0
323174|NCT00671060|1058817|P1|Overall Study|Protocol Violation|1
323175|NCT00670930|1058843|P2|Overall Study|Lost to Follow-up|0
323176|NCT00670930|1058844|P1|Overall Study|Lost to Follow-up|1
323177|NCT00670930|1058843|P2|Overall Study|Adminstrative Problem|1
323178|NCT00670930|1058844|P1|Overall Study|Adminstrative Problem|0
323179|NCT00670800|1058860|P2|Overall Study|2 controls were insulin resistant|2
323180|NCT00670800|1058861|P1|Overall Study|2 controls were insulin resistant|0
323181|NCT00670748|1058881|P4|Overall Study|Not off study|1
323182|NCT00670748|1058882|P3|Overall Study|Not off study|1
323183|NCT00670748|1058883|P2|Overall Study|Not off study|1
323184|NCT00670748|1058884|P1|Overall Study|Not off study|2
323185|NCT00670748|1058881|P4|Overall Study|Death during treatment|0
323186|NCT00670748|1058882|P3|Overall Study|Death during treatment|1
323187|NCT00670748|1058883|P2|Overall Study|Death during treatment|1
323188|NCT00670748|1058884|P1|Overall Study|Death during treatment|1
323189|NCT00670540|1058913|P1|Overall Study|missing information inclusion criteria|1
323190|NCT00670540|1058913|P1|Overall Study|controls randomised for no follow up|2770
323191|NCT00670540|1058913|P1|Overall Study|refused to participate|189
323192|NCT00670540|1058913|P1|Overall Study|not living in France|348
323193|NCT00670540|1058913|P1|Overall Study|ineligible|17
323194|NCT00670449|1058958|P4|Overall Study|Abnormal Laboratory Value(s)|0
323195|NCT00670449|1058959|P3|Overall Study|Abnormal Laboratory Value(s)|0
323196|NCT00670449|1058960|P2|Overall Study|Abnormal Laboratory Value(s)|2
323197|NCT00670449|1058961|P1|Overall Study|Abnormal Laboratory Value(s)|0
323198|NCT00670449|1058958|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
323199|NCT00670449|1058959|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
323200|NCT00670449|1058960|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
323201|NCT00670449|1058961|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
323202|NCT00670449|1058958|P4|Overall Study|Subject Withdrew Consent|1
323203|NCT00670449|1058959|P3|Overall Study|Subject Withdrew Consent|0
323204|NCT00670449|1058960|P2|Overall Study|Subject Withdrew Consent|2
323205|NCT00670449|1058961|P1|Overall Study|Subject Withdrew Consent|0
323206|NCT00670449|1058958|P4|Overall Study|Administrative Problems|1
323207|NCT00670449|1058959|P3|Overall Study|Administrative Problems|0
323208|NCT00670449|1058960|P2|Overall Study|Administrative Problems|2
323209|NCT00670449|1058961|P1|Overall Study|Administrative Problems|0
323210|NCT00670449|1058958|P4|Overall Study|Protocol Deviation|1
323211|NCT00670449|1058959|P3|Overall Study|Protocol Deviation|0
323212|NCT00670449|1058960|P2|Overall Study|Protocol Deviation|2
323213|NCT00670449|1058961|P1|Overall Study|Protocol Deviation|1
323214|NCT00670449|1058958|P4|Overall Study|Adverse Event|5
323215|NCT00670449|1058959|P3|Overall Study|Adverse Event|8
323216|NCT00670449|1058960|P2|Overall Study|Adverse Event|2
323217|NCT00670449|1058961|P1|Overall Study|Adverse Event|6
323218|NCT00670306|1058985|P1|Overall Study|incl/excl criterias did not meet|19
323219|NCT00670306|1058985|P1|Overall Study|Lost to Follow-up|8
323220|NCT00670306|1058985|P1|Overall Study|Physician Decision|1
323221|NCT00670306|1058985|P1|Overall Study|Withdrawal by Subject|9
323222|NCT00670306|1058985|P1|Overall Study|Lack of Efficacy|10
323223|NCT00670306|1058985|P1|Overall Study|Adverse Event|8
323224|NCT00670228|1059024|P2|Overall Study|Not meeting the selection criteria|0
323225|NCT00670228|1059025|P1|Overall Study|Not meeting the selection criteria|2
323226|NCT00670228|1059024|P2|Overall Study|Not treated|2
323227|NCT00670228|1059025|P1|Overall Study|Not treated|2
323228|NCT00670228|1059024|P2|Overall Study|Death or MACE|1
323229|NCT00670228|1059025|P1|Overall Study|Death or MACE|0
323230|NCT00670228|1059024|P2|Overall Study|Adverse Event|0
323231|NCT00670228|1059025|P1|Overall Study|Adverse Event|1
323232|NCT00670111|1059049|P3|Enrollment to One Month|Physician Decision|0
323233|NCT00670111|1059050|P2|Enrollment to One Month|Physician Decision|0
323234|NCT00670111|1059051|P1|Enrollment to One Month|Physician Decision|1
323235|NCT00670111|1059049|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
323236|NCT00670111|1059050|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
323237|NCT00670111|1059051|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
323238|NCT00670111|1059049|P3|Enrollment to One Month|Testing Failure|13
323239|NCT00670111|1059050|P2|Enrollment to One Month|Testing Failure|0
323240|NCT00670111|1059051|P1|Enrollment to One Month|Testing Failure|0
323241|NCT00670007|1059059|P1|Overall Study|Withdrawal by Subject|4
323242|NCT00670007|1059059|P1|Overall Study|Adverse Event|1
323243|NCT00670007|1059059|P1|Overall Study|Adverse event, serious fatal|1
323244|NCT00670007|1059059|P1|Overall Study|Travel/Vacation|1
323245|NCT00670007|1059059|P1|Overall Study|Lung transplant|1
323246|NCT00670007|1059059|P1|Overall Study|Drug abuse|1
323247|NCT00669955|1059086|P2|Overall Study|not compliant with study drug/visit|3
323248|NCT00669955|1059087|P1|Overall Study|not compliant with study drug/visit|2
323249|NCT00669955|1059086|P2|Overall Study|Investigator Sponsor Judgement|1
323250|NCT00669955|1059087|P1|Overall Study|Investigator Sponsor Judgement|0
323251|NCT00669955|1059086|P2|Overall Study|Protocol Violation|7
323252|NCT00669955|1059087|P1|Overall Study|Protocol Violation|2
323253|NCT00669955|1059086|P2|Overall Study|Lost to Follow-up|7
323254|NCT00669955|1059087|P1|Overall Study|Lost to Follow-up|5
323255|NCT00669955|1059086|P2|Overall Study|Withdrawal by Subject|3
323256|NCT00669955|1059087|P1|Overall Study|Withdrawal by Subject|2
323257|NCT00669955|1059086|P2|Overall Study|Death|1
323258|NCT00669955|1059087|P1|Overall Study|Death|0
323259|NCT00669955|1059086|P2|Overall Study|Adverse Event|5
323260|NCT00669955|1059087|P1|Overall Study|Adverse Event|3
323261|NCT00669942|1059117|P12|Parts 2 and 3|Protocol Violation|0
323262|NCT00669942|1059118|P11|Parts 2 and 3|Protocol Violation|0
323263|NCT00669942|1059119|P10|Parts 2 and 3|Protocol Violation|0
323264|NCT00669942|1059120|P9|Parts 2 and 3|Protocol Violation|0
323265|NCT00669942|1059121|P8|Parts 2 and 3|Protocol Violation|0
323266|NCT00669942|1059122|P7|Parts 2 and 3|Protocol Violation|0
323267|NCT00669942|1059123|P6|Parts 2 and 3|Protocol Violation|1
323268|NCT00669942|1059124|P5|Parts 2 and 3|Protocol Violation|0
323269|NCT00669942|1059125|P4|Parts 2 and 3|Protocol Violation|0
323270|NCT00669942|1059126|P3|Parts 2 and 3|Protocol Violation|0
323271|NCT00669942|1059127|P2|Parts 2 and 3|Protocol Violation|0
323272|NCT00669942|1059128|P1|Parts 2 and 3|Protocol Violation|0
323273|NCT00669942|1059117|P12|Parts 2 and 3|Withdrawal by Subject|0
323274|NCT00669942|1059118|P11|Parts 2 and 3|Withdrawal by Subject|0
323275|NCT00669942|1059119|P10|Parts 2 and 3|Withdrawal by Subject|0
323276|NCT00669942|1059120|P9|Parts 2 and 3|Withdrawal by Subject|2
323277|NCT00669942|1059121|P8|Parts 2 and 3|Withdrawal by Subject|0
323278|NCT00669942|1059122|P7|Parts 2 and 3|Withdrawal by Subject|0
323279|NCT00669942|1059123|P6|Parts 2 and 3|Withdrawal by Subject|1
323280|NCT00669942|1059124|P5|Parts 2 and 3|Withdrawal by Subject|0
323281|NCT00669942|1059125|P4|Parts 2 and 3|Withdrawal by Subject|0
323282|NCT00669942|1059126|P3|Parts 2 and 3|Withdrawal by Subject|0
323283|NCT00669942|1059127|P2|Parts 2 and 3|Withdrawal by Subject|0
323284|NCT00669942|1059128|P1|Parts 2 and 3|Withdrawal by Subject|0
323285|NCT00669942|1059117|P12|Parts 2 and 3|Adverse Event|0
323286|NCT00669942|1059118|P11|Parts 2 and 3|Adverse Event|0
323287|NCT00669942|1059119|P10|Parts 2 and 3|Adverse Event|0
323288|NCT00669942|1059120|P9|Parts 2 and 3|Adverse Event|1
323289|NCT00669942|1059121|P8|Parts 2 and 3|Adverse Event|2
323290|NCT00669942|1059122|P7|Parts 2 and 3|Adverse Event|0
323291|NCT00669942|1059123|P6|Parts 2 and 3|Adverse Event|0
323292|NCT00669942|1059124|P5|Parts 2 and 3|Adverse Event|0
323293|NCT00669942|1059125|P4|Parts 2 and 3|Adverse Event|0
323294|NCT00669942|1059126|P3|Parts 2 and 3|Adverse Event|0
323295|NCT00669942|1059127|P2|Parts 2 and 3|Adverse Event|0
323296|NCT00669942|1059128|P1|Parts 2 and 3|Adverse Event|0
323297|NCT00669903|1059211|P4|Overall Study|Protocol Violation|0
323298|NCT00669903|1059212|P3|Overall Study|Protocol Violation|0
323299|NCT00669903|1059213|P2|Overall Study|Protocol Violation|1
323300|NCT00669903|1059214|P1|Overall Study|Protocol Violation|0
323301|NCT00669903|1059211|P4|Overall Study|Lost to Follow-up|1
323302|NCT00669903|1059212|P3|Overall Study|Lost to Follow-up|0
323303|NCT00669903|1059213|P2|Overall Study|Lost to Follow-up|1
323304|NCT00669903|1059214|P1|Overall Study|Lost to Follow-up|1
323305|NCT00669903|1059211|P4|Overall Study|Withdrawal by Subject|2
323306|NCT00669903|1059212|P3|Overall Study|Withdrawal by Subject|2
323307|NCT00669903|1059213|P2|Overall Study|Withdrawal by Subject|2
323308|NCT00669903|1059214|P1|Overall Study|Withdrawal by Subject|0
323309|NCT00669903|1059211|P4|Overall Study|Adverse Event|1
323310|NCT00669903|1059212|P3|Overall Study|Adverse Event|3
323311|NCT00669903|1059213|P2|Overall Study|Adverse Event|1
323312|NCT00669903|1059214|P1|Overall Study|Adverse Event|0
323313|NCT00669864|1059244|P1|Overall Study|Other|2
323314|NCT00669864|1059244|P1|Overall Study|Withdrawal by Subject|3
323315|NCT00669864|1059244|P1|Overall Study|Protocol Violation|2
323316|NCT00669864|1059244|P1|Overall Study|Lost to Follow-up|2
323317|NCT00669617|1059258|P5|Period 3|Lost to Follow-up|0
323318|NCT00669617|1059259|P4|Period 3|Lost to Follow-up|0
323319|NCT00669617|1059260|P3|Period 3|Lost to Follow-up|0
323320|NCT00669617|1059261|P2|Period 3|Lost to Follow-up|0
323321|NCT00669617|1059262|P1|Period 3|Lost to Follow-up|1
323322|NCT00669617|1059258|P5|Period 1|Protocol Deviation|1
323323|NCT00669617|1059259|P4|Period 1|Protocol Deviation|0
323324|NCT00669617|1059260|P3|Period 1|Protocol Deviation|0
323325|NCT00669617|1059261|P2|Period 1|Protocol Deviation|0
323326|NCT00669617|1059262|P1|Period 1|Protocol Deviation|0
323327|NCT00669617|1059258|P5|Period 1|Withdrawal by Subject|0
323328|NCT00669617|1059259|P4|Period 1|Withdrawal by Subject|0
323329|NCT00669617|1059260|P3|Period 1|Withdrawal by Subject|1
323330|NCT00669617|1059261|P2|Period 1|Withdrawal by Subject|0
323331|NCT00669617|1059262|P1|Period 1|Withdrawal by Subject|0
323332|NCT00669396|1059310|P2|Overall Study|Lost to Follow-up|12
323333|NCT00669396|1059311|P1|Overall Study|Lost to Follow-up|10
323334|NCT00669331|1059325|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
323335|NCT00669331|1059326|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
323336|NCT00669331|1059325|P2|Blinded Treatment Period|Physician Decision|3
323337|NCT00669331|1059326|P1|Blinded Treatment Period|Physician Decision|3
323338|NCT00669331|1059325|P2|Blinded Treatment Period|Death|2
323339|NCT00669331|1059326|P1|Blinded Treatment Period|Death|0
323340|NCT00669331|1059325|P2|Blinded Treatment Period|Lost to Follow-up|2
323341|NCT00669331|1059326|P1|Blinded Treatment Period|Lost to Follow-up|3
323342|NCT00669331|1059325|P2|Blinded Treatment Period|Withdrawal by Subject|19
323343|NCT00669331|1059326|P1|Blinded Treatment Period|Withdrawal by Subject|17
323344|NCT00669331|1059325|P2|Blinded Treatment Period|Protocol Violation|1
323345|NCT00669331|1059326|P1|Blinded Treatment Period|Protocol Violation|1
323346|NCT00669331|1059325|P2|Blinded Treatment Period|Adverse Event|10
323347|NCT00669331|1059326|P1|Blinded Treatment Period|Adverse Event|16
323348|NCT00669331|1059325|P2|Randomisation to First Dose|Randomised in error|10
323349|NCT00669331|1059326|P1|Randomisation to First Dose|Randomised in error|3
323350|NCT00669331|1059325|P2|Randomisation to First Dose|Sponsor decision|1
323351|NCT00669331|1059326|P1|Randomisation to First Dose|Sponsor decision|0
323352|NCT00669331|1059325|P2|Randomisation to First Dose|Death|0
323353|NCT00669331|1059326|P1|Randomisation to First Dose|Death|1
323354|NCT00669331|1059325|P2|Randomisation to First Dose|Lost to Follow-up|0
323355|NCT00669331|1059326|P1|Randomisation to First Dose|Lost to Follow-up|2
323356|NCT00669331|1059325|P2|Randomisation to First Dose|Withdrawal by Subject|2
323357|NCT00669331|1059326|P1|Randomisation to First Dose|Withdrawal by Subject|3
323358|NCT00669331|1059325|P2|Randomisation to First Dose|Protocol Violation|0
323359|NCT00669331|1059326|P1|Randomisation to First Dose|Protocol Violation|1
323360|NCT00669331|1059325|P2|Randomisation to First Dose|Adverse Event|0
323361|NCT00669331|1059326|P1|Randomisation to First Dose|Adverse Event|1
323362|NCT00669318|1059368|P1|Overall Study|Withdrawal by Subject|2
323363|NCT00669240|1059385|P1|Overall Study|Enrolled but no dosing record|1
323364|NCT00669240|1059385|P1|Overall Study|Enrolled but not treated|15
323365|NCT00669240|1059385|P1|Overall Study|Unspecified|19
323366|NCT00669240|1059385|P1|Overall Study|Adverse Event|21
323367|NCT00669240|1059385|P1|Overall Study|Lost to Follow-up|34
323368|NCT00669240|1059385|P1|Overall Study|Withdrawal by Subject|42
323369|NCT00669240|1059385|P1|Overall Study|Lack of Efficacy|33
323370|NCT00669110|1059436|P2|Overall Study|Withdrawal by Subject|2
323371|NCT00669110|1059437|P1|Overall Study|Withdrawal by Subject|0
323372|NCT00669110|1059436|P2|Overall Study|Protocol Violation|5
323373|NCT00669110|1059437|P1|Overall Study|Protocol Violation|0
323374|NCT00669110|1059436|P2|Overall Study|Lost to Follow-up|0
323375|NCT00669110|1059437|P1|Overall Study|Lost to Follow-up|1
323376|NCT00669110|1059436|P2|Overall Study|Physician Decision|1
323377|NCT00669110|1059437|P1|Overall Study|Physician Decision|0
323378|NCT00669110|1059436|P2|Overall Study|Caregiver request|2
323379|NCT00669110|1059437|P1|Overall Study|Caregiver request|3
323380|NCT00669110|1059436|P2|Overall Study|Adverse Event|3
323381|NCT00669110|1059437|P1|Overall Study|Adverse Event|4
323382|NCT00669071|1059473|P1|Overall Study|Final visit 40 days out of window|1
323383|NCT00669071|1059473|P1|Overall Study|Lost to Follow-up|3
323384|NCT00669032|1059494|P2|Overall Study|No fulfilment of the selection criteria|5
323385|NCT00669032|1059495|P1|Overall Study|No fulfilment of the selection criteria|5
323386|NCT00669032|1059494|P2|Overall Study|Physician Decision|1
323387|NCT00669032|1059495|P1|Overall Study|Physician Decision|1
323388|NCT00669032|1059494|P2|Overall Study|Adverse Event|16
323389|NCT00669032|1059495|P1|Overall Study|Adverse Event|12
323390|NCT00669032|1059494|P2|Overall Study|Withdrawal by Subject|13
323391|NCT00669032|1059495|P1|Overall Study|Withdrawal by Subject|12
323392|NCT00669032|1059494|P2|Overall Study|Lack of Efficacy|19
323393|NCT00669032|1059495|P1|Overall Study|Lack of Efficacy|8
323394|NCT00669032|1059494|P2|Overall Study|Lost to Follow-up|5
323395|NCT00669032|1059495|P1|Overall Study|Lost to Follow-up|6
323396|NCT00668863|1059541|P1|Overall Study|Physician Decision|1
323397|NCT00668863|1059541|P1|Overall Study|Subject’s work scheduling problem|1
323398|NCT00668863|1059541|P1|Overall Study|Surgery|1
323399|NCT00668863|1059541|P1|Overall Study|Withdrawal by Subject|1
323400|NCT00668863|1059541|P1|Overall Study|Global Deterioration of Health Status|4
323401|NCT00668863|1059541|P1|Overall Study|Study Terminated by Sponsor|8
323402|NCT00668863|1059541|P1|Overall Study|Adverse Event|13
323403|NCT00668863|1059541|P1|Overall Study|Objective Progression or Relapse|42
323404|NCT00668746|1059566|P2|Overall Study|Lost to Follow-up|1
323405|NCT00668746|1059567|P1|Overall Study|Lost to Follow-up|2
323406|NCT00668733|1059587|P2|Overall Study|Withdrawal by Subject|4
323407|NCT00668733|1059588|P1|Overall Study|Withdrawal by Subject|0
323408|NCT00668733|1059587|P2|Overall Study|Lost to Follow-up|3
323409|NCT00668733|1059588|P1|Overall Study|Lost to Follow-up|2
323410|NCT00668395|1059633|P3|Overall Study|Physician Decision|0
323411|NCT00668395|1059634|P2|Overall Study|Physician Decision|1
323412|NCT00668395|1059635|P1|Overall Study|Physician Decision|1
323413|NCT00668395|1059633|P3|Overall Study|Adverse Event|0
323414|NCT00668395|1059634|P2|Overall Study|Adverse Event|1
323415|NCT00668395|1059635|P1|Overall Study|Adverse Event|1
323416|NCT00668395|1059633|P3|Overall Study|Withdrawal by Subject|1
323417|NCT00668395|1059634|P2|Overall Study|Withdrawal by Subject|4
323418|NCT00668395|1059635|P1|Overall Study|Withdrawal by Subject|4
323419|NCT00668317|1059647|P1|Overall Study|Adverse Event|2
323420|NCT00668200|1059662|P1|Overall Study|Lost to Follow-up|1
323421|NCT00668200|1059662|P1|Overall Study|Withdrawal by Subject|2
323422|NCT00667992|1059670|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
323423|NCT00667992|1059671|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
323424|NCT00667992|1059670|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
323425|NCT00667992|1059671|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
323426|NCT00667992|1059670|P2|Wash-out|Withdrawal by Subject|0
323427|NCT00667992|1059671|P1|Wash-out|Withdrawal by Subject|1
323428|NCT00667992|1059670|P2|Wash-out|Failure to wash-out|2
323429|NCT00667992|1059671|P1|Wash-out|Failure to wash-out|2
323430|NCT00667992|1059670|P2|Wash-out|Not within one doubling dilution|3
323431|NCT00667992|1059671|P1|Wash-out|Not within one doubling dilution|4
323432|NCT00667992|1059670|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
323433|NCT00667992|1059671|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
323434|NCT00667992|1059670|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
323435|NCT00667992|1059671|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
323436|NCT00667992|1059670|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
323437|NCT00667992|1059671|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
323438|NCT00667992|1059670|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
323439|NCT00667992|1059671|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
323440|NCT00667992|1059670|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
323441|NCT00667992|1059671|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
323442|NCT00667992|1059670|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
323443|NCT00667992|1059671|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
323444|NCT00667992|1059670|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
323445|NCT00667992|1059671|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
323446|NCT00667992|1059670|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
323447|NCT00667992|1059671|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
323448|NCT00667875|1059728|P3|Overall Study|Withdrawal by Subject|7
323449|NCT00667875|1059729|P2|Overall Study|Withdrawal by Subject|9
323450|NCT00667875|1059730|P1|Overall Study|Withdrawal by Subject|10
323451|NCT00667875|1059728|P3|Overall Study|Adverse Event|6
323452|NCT00667875|1059729|P2|Overall Study|Adverse Event|2
323453|NCT00667875|1059730|P1|Overall Study|Adverse Event|0
323454|NCT00667810|1059755|P4|Overall Study|Not specified|0
323455|NCT00667810|1059756|P3|Overall Study|Not specified|5
323456|NCT00667810|1059757|P2|Overall Study|Not specified|6
323457|NCT00667810|1059758|P1|Overall Study|Not specified|6
323458|NCT00667810|1059755|P4|Overall Study|Vasogenic Edema Recurrence|0
323459|NCT00667810|1059756|P3|Overall Study|Vasogenic Edema Recurrence|0
323460|NCT00667810|1059757|P2|Overall Study|Vasogenic Edema Recurrence|3
323461|NCT00667810|1059758|P1|Overall Study|Vasogenic Edema Recurrence|0
323462|NCT00667810|1059755|P4|Overall Study|Loss of Caregiver|0
323463|NCT00667810|1059756|P3|Overall Study|Loss of Caregiver|3
323464|NCT00667810|1059757|P2|Overall Study|Loss of Caregiver|1
323465|NCT00667810|1059758|P1|Overall Study|Loss of Caregiver|0
323466|NCT00667810|1059755|P4|Overall Study|Failed to Return|0
323467|NCT00667810|1059756|P3|Overall Study|Failed to Return|2
323468|NCT00667810|1059757|P2|Overall Study|Failed to Return|0
323469|NCT00667810|1059758|P1|Overall Study|Failed to Return|0
323470|NCT00667810|1059755|P4|Overall Study|Discontinuation of Study by Sponsor|0
323471|NCT00667810|1059756|P3|Overall Study|Discontinuation of Study by Sponsor|155
323472|NCT00667810|1059757|P2|Overall Study|Discontinuation of Study by Sponsor|118
323473|NCT00667810|1059758|P1|Overall Study|Discontinuation of Study by Sponsor|130
323474|NCT00667810|1059755|P4|Overall Study|Withdrawal by Subject|1
323475|NCT00667810|1059756|P3|Overall Study|Withdrawal by Subject|29
323476|NCT00667810|1059757|P2|Overall Study|Withdrawal by Subject|20
323477|NCT00667810|1059758|P1|Overall Study|Withdrawal by Subject|14
323478|NCT00667810|1059755|P4|Overall Study|Protocol Violation|0
323479|NCT00667810|1059756|P3|Overall Study|Protocol Violation|0
323480|NCT00667810|1059757|P2|Overall Study|Protocol Violation|2
323481|NCT00667810|1059758|P1|Overall Study|Protocol Violation|0
323482|NCT00667810|1059755|P4|Overall Study|Physician Decision|0
323483|NCT00667810|1059756|P3|Overall Study|Physician Decision|2
323484|NCT00667810|1059757|P2|Overall Study|Physician Decision|1
323485|NCT00667810|1059758|P1|Overall Study|Physician Decision|1
323486|NCT00667810|1059755|P4|Overall Study|Lost to Follow-up|0
323487|NCT00667810|1059756|P3|Overall Study|Lost to Follow-up|2
323488|NCT00667810|1059757|P2|Overall Study|Lost to Follow-up|4
323489|NCT00667810|1059758|P1|Overall Study|Lost to Follow-up|1
323490|NCT00667810|1059755|P4|Overall Study|Lack of Efficacy|0
323491|NCT00667810|1059756|P3|Overall Study|Lack of Efficacy|2
323492|NCT00667810|1059757|P2|Overall Study|Lack of Efficacy|0
323493|NCT00667810|1059758|P1|Overall Study|Lack of Efficacy|1
323494|NCT00667810|1059755|P4|Overall Study|Death|0
323495|NCT00667810|1059756|P3|Overall Study|Death|3
323496|NCT00667810|1059757|P2|Overall Study|Death|1
323497|NCT00667810|1059758|P1|Overall Study|Death|1
323498|NCT00667810|1059755|P4|Overall Study|Adverse Event|1
323499|NCT00667810|1059756|P3|Overall Study|Adverse Event|19
323500|NCT00667810|1059757|P2|Overall Study|Adverse Event|14
323501|NCT00667810|1059758|P1|Overall Study|Adverse Event|13
323502|NCT00667732|1059828|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
323503|NCT00667732|1059829|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
323504|NCT00667732|1059830|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
323505|NCT00667732|1059828|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
323506|NCT00667732|1059829|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
323507|NCT00667732|1059830|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
323508|NCT00667732|1059828|P3|Run -In (8 Weeks)|Adverse Event|0
323509|NCT00667732|1059829|P2|Run -In (8 Weeks)|Adverse Event|0
323510|NCT00667732|1059830|P1|Run -In (8 Weeks)|Adverse Event|4
323511|NCT00667602|1059853|P3|Overall Study|Protocol Violation|0
323512|NCT00667602|1059854|P2|Overall Study|Protocol Violation|1
323513|NCT00667602|1059855|P1|Overall Study|Protocol Violation|0
323514|NCT00667602|1059853|P3|Overall Study|Administrative reason|2
323515|NCT00667602|1059854|P2|Overall Study|Administrative reason|0
323516|NCT00667602|1059855|P1|Overall Study|Administrative reason|0
323517|NCT00667602|1059853|P3|Overall Study|Lost to Follow-up|6
323518|NCT00667602|1059854|P2|Overall Study|Lost to Follow-up|5
323519|NCT00667602|1059855|P1|Overall Study|Lost to Follow-up|4
323520|NCT00667602|1059853|P3|Overall Study|Withdrawal by Subject|10
323521|NCT00667602|1059854|P2|Overall Study|Withdrawal by Subject|9
323522|NCT00667602|1059855|P1|Overall Study|Withdrawal by Subject|4
323523|NCT00667576|1059923|P5|Overall Study|Missed Visit|0
323524|NCT00667576|1059924|P4|Overall Study|Missed Visit|1
323525|NCT00667576|1059925|P3|Overall Study|Missed Visit|0
323526|NCT00667576|1059926|P2|Overall Study|Missed Visit|0
323527|NCT00667576|1059927|P1|Overall Study|Missed Visit|0
323528|NCT00667576|1059923|P5|Overall Study|Physician Decision|0
323529|NCT00667576|1059924|P4|Overall Study|Physician Decision|1
323530|NCT00667576|1059925|P3|Overall Study|Physician Decision|0
323531|NCT00667576|1059926|P2|Overall Study|Physician Decision|0
323532|NCT00667576|1059927|P1|Overall Study|Physician Decision|0
323533|NCT00667576|1059923|P5|Overall Study|Protocol Violation|0
323534|NCT00667576|1059924|P4|Overall Study|Protocol Violation|1
323535|NCT00667576|1059925|P3|Overall Study|Protocol Violation|0
323536|NCT00667576|1059926|P2|Overall Study|Protocol Violation|0
323537|NCT00667576|1059927|P1|Overall Study|Protocol Violation|0
323538|NCT00667576|1059923|P5|Overall Study|Lost to Follow-up|0
323539|NCT00667576|1059924|P4|Overall Study|Lost to Follow-up|0
323540|NCT00667576|1059925|P3|Overall Study|Lost to Follow-up|1
323541|NCT00667576|1059926|P2|Overall Study|Lost to Follow-up|0
323542|NCT00667576|1059927|P1|Overall Study|Lost to Follow-up|0
323543|NCT00667576|1059923|P5|Overall Study|Adverse Event|0
323544|NCT00667576|1059924|P4|Overall Study|Adverse Event|0
323545|NCT00667576|1059925|P3|Overall Study|Adverse Event|0
323546|NCT00667576|1059926|P2|Overall Study|Adverse Event|1
323547|NCT00667576|1059927|P1|Overall Study|Adverse Event|1
323548|NCT00667576|1059923|P5|Overall Study|Withdrawal by Subject|1
323549|NCT00667576|1059924|P4|Overall Study|Withdrawal by Subject|1
323550|NCT00667576|1059925|P3|Overall Study|Withdrawal by Subject|1
323551|NCT00667576|1059926|P2|Overall Study|Withdrawal by Subject|0
323552|NCT00667576|1059927|P1|Overall Study|Withdrawal by Subject|1
323553|NCT00667563|1059974|P1|Overall Study|Protocol Violation|24
323554|NCT00667459|1059994|P2|Overall Study|Lost to Follow-up|43
323555|NCT00667459|1059995|P1|Overall Study|Lost to Follow-up|8
323556|NCT00667459|1059994|P2|Overall Study|Death|2
323557|NCT00667459|1059995|P1|Overall Study|Death|0
323558|NCT00667446|1060037|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
323559|NCT00667446|1060038|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
323560|NCT00667446|1060037|P2|Treatment Period (36 Months)|Therapeutic Failure|1
323561|NCT00667446|1060038|P1|Treatment Period (36 Months)|Therapeutic Failure|1
323562|NCT00667446|1060037|P2|Treatment Period (36 Months)|Protocol Violation|1
323563|NCT00667446|1060038|P1|Treatment Period (36 Months)|Protocol Violation|1
323564|NCT00667446|1060037|P2|Treatment Period (36 Months)|Lost to Follow-up|0
323565|NCT00667446|1060038|P1|Treatment Period (36 Months)|Lost to Follow-up|1
323566|NCT00667446|1060037|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
323567|NCT00667446|1060038|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
323568|NCT00667446|1060037|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
323569|NCT00667446|1060038|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
323570|NCT00667446|1060037|P2|Treatment Period (36 Months)|Personal reasons|2
323571|NCT00667446|1060038|P1|Treatment Period (36 Months)|Personal reasons|2
323572|NCT00667446|1060037|P2|Treatment Period (36 Months)|Other|2
323573|NCT00667446|1060038|P1|Treatment Period (36 Months)|Other|2
323574|NCT00667446|1060037|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
323575|NCT00667446|1060038|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
323576|NCT00667420|1060060|P1|Overall Study|Withdrawal by Subject|2
323577|NCT00667420|1060060|P1|Overall Study|Physician Decision|1
323578|NCT00667420|1060060|P1|Overall Study|Lack of Efficacy|5
323579|NCT00667420|1060060|P1|Overall Study|Adverse Event|2
323580|NCT00667394|1060070|P2|Overall Study|Progressive disease|0
323581|NCT00667394|1060071|P1|Overall Study|Progressive disease|1
323582|NCT00667394|1060070|P2|Overall Study|Adverse Event|0
323583|NCT00667394|1060071|P1|Overall Study|Adverse Event|3
323584|NCT00667368|1060098|P2|Overall Study|Discontinued early|17
323585|NCT00667368|1060099|P1|Overall Study|Discontinued early|24
323586|NCT00667368|1060098|P2|Overall Study|Lost to Follow-up|155
323587|NCT00667368|1060099|P1|Overall Study|Lost to Follow-up|176
323588|NCT00667355|1060107|P1|Overall Study|Other reason was not specified|5
323589|NCT00667355|1060107|P1|Overall Study|Lost to Follow-up|1
323590|NCT00667355|1060107|P1|Overall Study|Adverse Event|5
323591|NCT00667342|1060132|P3|Overall Study|Ineligible|1
323592|NCT00667342|1060133|P2|Overall Study|Ineligible|0
323593|NCT00667342|1060134|P1|Overall Study|Ineligible|0
323594|NCT00667342|1060132|P3|Overall Study|Adverse Event|1
323595|NCT00667342|1060133|P2|Overall Study|Adverse Event|0
323596|NCT00667342|1060134|P1|Overall Study|Adverse Event|0
323597|NCT00667342|1060132|P3|Overall Study|Relapse or tumor progression|7
323598|NCT00667342|1060133|P2|Overall Study|Relapse or tumor progression|0
323599|NCT00667342|1060134|P1|Overall Study|Relapse or tumor progression|9
323600|NCT00667342|1060132|P3|Overall Study|Physician Decision|0
323601|NCT00667342|1060133|P2|Overall Study|Physician Decision|0
323602|NCT00667342|1060134|P1|Overall Study|Physician Decision|3
323603|NCT00667342|1060132|P3|Overall Study|Withdrawal by Subject|0
323604|NCT00667342|1060133|P2|Overall Study|Withdrawal by Subject|0
323605|NCT00667342|1060134|P1|Overall Study|Withdrawal by Subject|1
323606|NCT00667342|1060132|P3|Overall Study|Protocol Violation|0
323607|NCT00667342|1060133|P2|Overall Study|Protocol Violation|0
323608|NCT00667342|1060134|P1|Overall Study|Protocol Violation|1
323609|NCT00667277|1060172|P1|Overall Study|Withdrawal by Subject|2
323610|NCT00667251|1060179|P2|Overall Study|Symptomatic progression|2
323611|NCT00667251|1060180|P1|Overall Study|Symptomatic progression|1
323612|NCT00667251|1060179|P2|Overall Study|Intercurrent Illness|3
323613|NCT00667251|1060180|P1|Overall Study|Intercurrent Illness|4
323614|NCT00667251|1060179|P2|Overall Study|Other/missing|84
323615|NCT00667251|1060180|P1|Overall Study|Other/missing|46
323616|NCT00667251|1060179|P2|Overall Study|Withdrawal by Subject|2
323617|NCT00667251|1060180|P1|Overall Study|Withdrawal by Subject|6
323618|NCT00667251|1060179|P2|Overall Study|Adverse Event|4
323619|NCT00667251|1060180|P1|Overall Study|Adverse Event|13
323620|NCT00667225|1060206|P2|Overall Study|Lost to Follow-up|1
323621|NCT00667225|1060207|P1|Overall Study|Lost to Follow-up|0
323622|NCT00667225|1060206|P2|Overall Study|Subject had no more lesions to treat.|0
323623|NCT00667225|1060207|P1|Overall Study|Subject had no more lesions to treat.|1
323624|NCT00667095|1060228|P2|Overall Study|Withdrawal by Subject|1
323625|NCT00667095|1060229|P1|Overall Study|Withdrawal by Subject|0
323626|NCT00666965|1060249|P4|Overall Study|Withdrawal by Subject|2
323627|NCT00666965|1060250|P3|Overall Study|Withdrawal by Subject|0
323628|NCT00666965|1060251|P2|Overall Study|Withdrawal by Subject|0
323629|NCT00666965|1060252|P1|Overall Study|Withdrawal by Subject|0
323630|NCT00666965|1060249|P4|Overall Study|Discontinuation criteria|2
323631|NCT00666965|1060250|P3|Overall Study|Discontinuation criteria|1
323632|NCT00666965|1060251|P2|Overall Study|Discontinuation criteria|1
323633|NCT00666965|1060252|P1|Overall Study|Discontinuation criteria|2
323634|NCT00666965|1060249|P4|Overall Study|Protocol Violation|2
323635|NCT00666965|1060250|P3|Overall Study|Protocol Violation|0
323636|NCT00666965|1060251|P2|Overall Study|Protocol Violation|0
323637|NCT00666965|1060252|P1|Overall Study|Protocol Violation|0
323638|NCT00666965|1060249|P4|Overall Study|Lack of Efficacy|0
323639|NCT00666965|1060250|P3|Overall Study|Lack of Efficacy|0
323640|NCT00666965|1060251|P2|Overall Study|Lack of Efficacy|1
323641|NCT00666965|1060252|P1|Overall Study|Lack of Efficacy|1
323642|NCT00666965|1060249|P4|Overall Study|Adverse Event|9
323643|NCT00666965|1060250|P3|Overall Study|Adverse Event|1
323644|NCT00666965|1060251|P2|Overall Study|Adverse Event|2
323645|NCT00666965|1060252|P1|Overall Study|Adverse Event|0
323646|NCT00666926|1060282|P16|Overall Study|Death|0
323647|NCT00666926|1060283|P15|Overall Study|Death|0
323648|NCT00666926|1060284|P14|Overall Study|Death|0
323649|NCT00666926|1060285|P13|Overall Study|Death|0
323650|NCT00666926|1060286|P12|Overall Study|Death|1
323651|NCT00666926|1060287|P11|Overall Study|Death|0
323652|NCT00666926|1060288|P10|Overall Study|Death|0
323653|NCT00666926|1060289|P9|Overall Study|Death|0
323654|NCT00666926|1060290|P8|Overall Study|Death|0
323655|NCT00666926|1060291|P7|Overall Study|Death|0
323656|NCT00666926|1060292|P6|Overall Study|Death|0
323657|NCT00666926|1060293|P5|Overall Study|Death|0
323658|NCT00666926|1060294|P4|Overall Study|Death|0
323659|NCT00666926|1060295|P3|Overall Study|Death|0
323660|NCT00666926|1060296|P2|Overall Study|Death|0
323661|NCT00666926|1060297|P1|Overall Study|Death|0
323662|NCT00666926|1060282|P16|Overall Study|Withdrawal by Subject|3
323663|NCT00666926|1060283|P15|Overall Study|Withdrawal by Subject|3
323664|NCT00666926|1060284|P14|Overall Study|Withdrawal by Subject|1
323665|NCT00666926|1060285|P13|Overall Study|Withdrawal by Subject|0
323666|NCT00666926|1060286|P12|Overall Study|Withdrawal by Subject|3
323667|NCT00666926|1060287|P11|Overall Study|Withdrawal by Subject|0
323668|NCT00666926|1060288|P10|Overall Study|Withdrawal by Subject|3
323669|NCT00666926|1060289|P9|Overall Study|Withdrawal by Subject|0
323670|NCT00666926|1060290|P8|Overall Study|Withdrawal by Subject|1
323671|NCT00666926|1060291|P7|Overall Study|Withdrawal by Subject|0
323672|NCT00666926|1060292|P6|Overall Study|Withdrawal by Subject|0
323673|NCT00666926|1060293|P5|Overall Study|Withdrawal by Subject|0
323674|NCT00666926|1060294|P4|Overall Study|Withdrawal by Subject|0
323675|NCT00666926|1060295|P3|Overall Study|Withdrawal by Subject|0
323676|NCT00666926|1060296|P2|Overall Study|Withdrawal by Subject|0
323677|NCT00666926|1060297|P1|Overall Study|Withdrawal by Subject|0
323678|NCT00666926|1060282|P16|Overall Study|Unspecified|4
323679|NCT00666926|1060283|P15|Overall Study|Unspecified|4
323680|NCT00666926|1060284|P14|Overall Study|Unspecified|2
323681|NCT00666926|1060285|P13|Overall Study|Unspecified|3
323682|NCT00666926|1060286|P12|Overall Study|Unspecified|26
323683|NCT00666926|1060287|P11|Overall Study|Unspecified|3
323684|NCT00666926|1060288|P10|Overall Study|Unspecified|5
323685|NCT00666926|1060289|P9|Overall Study|Unspecified|3
323686|NCT00666926|1060290|P8|Overall Study|Unspecified|0
323687|NCT00666926|1060291|P7|Overall Study|Unspecified|4
323688|NCT00666926|1060292|P6|Overall Study|Unspecified|3
323689|NCT00666926|1060293|P5|Overall Study|Unspecified|3
323690|NCT00666926|1060294|P4|Overall Study|Unspecified|3
323691|NCT00666926|1060295|P3|Overall Study|Unspecified|3
323692|NCT00666926|1060296|P2|Overall Study|Unspecified|4
323693|NCT00666926|1060297|P1|Overall Study|Unspecified|2
323694|NCT00666926|1060282|P16|Overall Study|Lost to Follow-up|0
323695|NCT00666926|1060283|P15|Overall Study|Lost to Follow-up|0
323696|NCT00666926|1060284|P14|Overall Study|Lost to Follow-up|0
323697|NCT00666926|1060285|P13|Overall Study|Lost to Follow-up|0
323698|NCT00666926|1060286|P12|Overall Study|Lost to Follow-up|0
323699|NCT00666926|1060287|P11|Overall Study|Lost to Follow-up|0
323700|NCT00666926|1060288|P10|Overall Study|Lost to Follow-up|0
323701|NCT00666926|1060289|P9|Overall Study|Lost to Follow-up|0
323702|NCT00666926|1060290|P8|Overall Study|Lost to Follow-up|0
323703|NCT00666926|1060291|P7|Overall Study|Lost to Follow-up|0
323704|NCT00666926|1060292|P6|Overall Study|Lost to Follow-up|0
323705|NCT00666926|1060293|P5|Overall Study|Lost to Follow-up|0
323706|NCT00666926|1060294|P4|Overall Study|Lost to Follow-up|1
323707|NCT00666926|1060295|P3|Overall Study|Lost to Follow-up|0
323708|NCT00666926|1060296|P2|Overall Study|Lost to Follow-up|0
323709|NCT00666926|1060297|P1|Overall Study|Lost to Follow-up|0
323710|NCT00666926|1060282|P16|Overall Study|Lack of Efficacy|0
323711|NCT00666926|1060283|P15|Overall Study|Lack of Efficacy|0
323712|NCT00666926|1060284|P14|Overall Study|Lack of Efficacy|0
323713|NCT00666926|1060285|P13|Overall Study|Lack of Efficacy|0
323714|NCT00666926|1060286|P12|Overall Study|Lack of Efficacy|1
323715|NCT00666926|1060287|P11|Overall Study|Lack of Efficacy|0
323716|NCT00666926|1060288|P10|Overall Study|Lack of Efficacy|0
323717|NCT00666926|1060289|P9|Overall Study|Lack of Efficacy|0
323718|NCT00666926|1060290|P8|Overall Study|Lack of Efficacy|0
323719|NCT00666926|1060291|P7|Overall Study|Lack of Efficacy|0
323720|NCT00666926|1060292|P6|Overall Study|Lack of Efficacy|1
323721|NCT00666926|1060293|P5|Overall Study|Lack of Efficacy|0
323722|NCT00666926|1060294|P4|Overall Study|Lack of Efficacy|0
323723|NCT00666926|1060295|P3|Overall Study|Lack of Efficacy|0
323724|NCT00666926|1060296|P2|Overall Study|Lack of Efficacy|0
323725|NCT00666926|1060297|P1|Overall Study|Lack of Efficacy|0
323726|NCT00666926|1060282|P16|Overall Study|Laboratory abnormality|1
323727|NCT00666926|1060283|P15|Overall Study|Laboratory abnormality|0
323728|NCT00666926|1060284|P14|Overall Study|Laboratory abnormality|0
323729|NCT00666926|1060285|P13|Overall Study|Laboratory abnormality|0
323730|NCT00666926|1060286|P12|Overall Study|Laboratory abnormality|0
323731|NCT00666926|1060287|P11|Overall Study|Laboratory abnormality|1
323732|NCT00666926|1060288|P10|Overall Study|Laboratory abnormality|0
323733|NCT00666926|1060289|P9|Overall Study|Laboratory abnormality|0
323734|NCT00666926|1060290|P8|Overall Study|Laboratory abnormality|0
323735|NCT00666926|1060291|P7|Overall Study|Laboratory abnormality|0
323736|NCT00666926|1060292|P6|Overall Study|Laboratory abnormality|0
323737|NCT00666926|1060293|P5|Overall Study|Laboratory abnormality|0
323738|NCT00666926|1060294|P4|Overall Study|Laboratory abnormality|0
323739|NCT00666926|1060295|P3|Overall Study|Laboratory abnormality|0
323740|NCT00666926|1060296|P2|Overall Study|Laboratory abnormality|0
323741|NCT00666926|1060297|P1|Overall Study|Laboratory abnormality|0
323742|NCT00666926|1060282|P16|Overall Study|Adverse Event|0
323743|NCT00666926|1060283|P15|Overall Study|Adverse Event|0
323744|NCT00666926|1060284|P14|Overall Study|Adverse Event|1
323745|NCT00666926|1060285|P13|Overall Study|Adverse Event|0
323746|NCT00666926|1060286|P12|Overall Study|Adverse Event|2
323747|NCT00666926|1060287|P11|Overall Study|Adverse Event|2
323748|NCT00666926|1060288|P10|Overall Study|Adverse Event|2
323749|NCT00666926|1060289|P9|Overall Study|Adverse Event|0
323750|NCT00666926|1060290|P8|Overall Study|Adverse Event|0
323751|NCT00666926|1060291|P7|Overall Study|Adverse Event|0
323752|NCT00666926|1060292|P6|Overall Study|Adverse Event|0
323753|NCT00666926|1060293|P5|Overall Study|Adverse Event|0
323754|NCT00666926|1060294|P4|Overall Study|Adverse Event|0
323755|NCT00666926|1060295|P3|Overall Study|Adverse Event|0
323756|NCT00666926|1060296|P2|Overall Study|Adverse Event|0
323757|NCT00666926|1060297|P1|Overall Study|Adverse Event|0
323758|NCT00666757|1060606|P2|Overall Study|Sponsor decision|1
323759|NCT00666757|1060607|P1|Overall Study|Sponsor decision|0
323760|NCT00666757|1060606|P2|Overall Study|Physician Decision|2
323761|NCT00666757|1060607|P1|Overall Study|Physician Decision|0
323762|NCT00666757|1060606|P2|Overall Study|Lack of Efficacy|6
323763|NCT00666757|1060607|P1|Overall Study|Lack of Efficacy|3
323764|NCT00666757|1060606|P2|Overall Study|Withdrawal by Subject|17
323765|NCT00666757|1060607|P1|Overall Study|Withdrawal by Subject|13
323766|NCT00666757|1060606|P2|Overall Study|Adverse Event|12
323767|NCT00666757|1060607|P1|Overall Study|Adverse Event|22
323768|NCT00666757|1060606|P2|Overall Study|Protocol Violation|24
323769|NCT00666757|1060607|P1|Overall Study|Protocol Violation|23
323770|NCT00666757|1060606|P2|Overall Study|Lost to Follow-up|35
323771|NCT00666757|1060607|P1|Overall Study|Lost to Follow-up|39
323772|NCT00666718|1060666|P2|Overall Study|Physician Decision|2
323773|NCT00666718|1060667|P1|Overall Study|Physician Decision|0
323774|NCT00666718|1060666|P2|Overall Study|Withdrawal by Subject|12
323775|NCT00666718|1060667|P1|Overall Study|Withdrawal by Subject|7
323776|NCT00666718|1060666|P2|Overall Study|Protocol Violation|3
323777|NCT00666718|1060667|P1|Overall Study|Protocol Violation|1
323778|NCT00666718|1060666|P2|Overall Study|Entry Criteria Not Met|0
323779|NCT00666718|1060667|P1|Overall Study|Entry Criteria Not Met|2
323780|NCT00666718|1060666|P2|Overall Study|Lost to Follow-up|0
323781|NCT00666718|1060667|P1|Overall Study|Lost to Follow-up|1
323782|NCT00666718|1060666|P2|Overall Study|Death|0
323783|NCT00666718|1060667|P1|Overall Study|Death|1
323784|NCT00666718|1060666|P2|Overall Study|Adverse Event|1
323785|NCT00666718|1060667|P1|Overall Study|Adverse Event|0
323786|NCT00666705|1060693|P1|Overall Study|Withdrawal by Subject|1
323787|NCT00666679|1060712|P2|Second Intervention|Death|1
323788|NCT00666679|1060713|P1|Second Intervention|Death|0
323789|NCT00666679|1060712|P2|Second Intervention|Adverse Event|0
323790|NCT00666679|1060713|P1|Second Intervention|Adverse Event|1
323791|NCT00666679|1060712|P2|Washout Period of 1 Week|Protocol Violation|1
323792|NCT00666679|1060713|P1|Washout Period of 1 Week|Protocol Violation|0
323793|NCT00666679|1060712|P2|Washout Period of 1 Week|Lost to Follow-up|1
323794|NCT00666679|1060713|P1|Washout Period of 1 Week|Lost to Follow-up|0
323795|NCT00666679|1060712|P2|First Intervention|Randomized did not start treatment|1
323796|NCT00666679|1060713|P1|First Intervention|Randomized did not start treatment|1
323797|NCT00666679|1060712|P2|First Intervention|Withdrawal by Subject|0
323798|NCT00666679|1060713|P1|First Intervention|Withdrawal by Subject|1
323799|NCT00666679|1060712|P2|First Intervention|Protocol Violation|0
323800|NCT00666679|1060713|P1|First Intervention|Protocol Violation|1
323801|NCT00666679|1060712|P2|First Intervention|Lost to Follow-up|0
323802|NCT00666679|1060713|P1|First Intervention|Lost to Follow-up|1
323803|NCT00666588|1060743|P4|Overall Study|inevaluable|0
323804|NCT00666588|1060744|P3|Overall Study|inevaluable|0
323805|NCT00666588|1060745|P2|Overall Study|inevaluable|0
323806|NCT00666588|1060746|P1|Overall Study|inevaluable|2
323807|NCT00666588|1060743|P4|Overall Study|ineligible|2
323808|NCT00666588|1060744|P3|Overall Study|ineligible|0
323809|NCT00666588|1060745|P2|Overall Study|ineligible|0
323810|NCT00666588|1060746|P1|Overall Study|ineligible|2
323811|NCT00666562|1060763|P3|Overall Study|Concomitant Medication|0
323812|NCT00666562|1060764|P2|Overall Study|Concomitant Medication|1
323813|NCT00666562|1060765|P1|Overall Study|Concomitant Medication|0
323814|NCT00666562|1060763|P3|Overall Study|Withdrawal by Subject|0
323815|NCT00666562|1060764|P2|Overall Study|Withdrawal by Subject|1
323816|NCT00666562|1060765|P1|Overall Study|Withdrawal by Subject|0
323817|NCT00666536|1060812|P2|Overall Study|Lost to Follow-up|3
323818|NCT00666536|1060813|P1|Overall Study|Lost to Follow-up|4
323819|NCT00666536|1060812|P2|Overall Study|Withdrawal by Subject|9
323820|NCT00666536|1060813|P1|Overall Study|Withdrawal by Subject|10
323821|NCT00666536|1060812|P2|Overall Study|Protocol deviation(s)|6
323822|NCT00666536|1060813|P1|Overall Study|Protocol deviation(s)|8
323823|NCT00666536|1060812|P2|Overall Study|Unsatisfactory therapeutic effect|0
323824|NCT00666536|1060813|P1|Overall Study|Unsatisfactory therapeutic effect|2
323825|NCT00666536|1060812|P2|Overall Study|Adverse Event|19
323826|NCT00666536|1060813|P1|Overall Study|Adverse Event|9
323827|NCT00666458|1060831|P2|Overall Study|Medical history of anemia|0
323828|NCT00666458|1060832|P1|Overall Study|Medical history of anemia|1
323829|NCT00666458|1060831|P2|Overall Study|Safety reasons|0
323830|NCT00666458|1060832|P1|Overall Study|Safety reasons|1
323831|NCT00666458|1060831|P2|Overall Study|Severe non-compliance to the protocol|1
323832|NCT00666458|1060832|P1|Overall Study|Severe non-compliance to the protocol|1
323833|NCT00666458|1060831|P2|Overall Study|Study specific discontinuation criteria|7
323834|NCT00666458|1060832|P1|Overall Study|Study specific discontinuation criteria|14
323835|NCT00666458|1060831|P2|Overall Study|Incorrect enrollment|1
323836|NCT00666458|1060832|P1|Overall Study|Incorrect enrollment|7
323837|NCT00666458|1060831|P2|Overall Study|Administrative reason by sponsor|1
323838|NCT00666458|1060832|P1|Overall Study|Administrative reason by sponsor|1
323839|NCT00666458|1060831|P2|Overall Study|Lost to Follow-up|3
323840|NCT00666458|1060832|P1|Overall Study|Lost to Follow-up|0
323841|NCT00666458|1060831|P2|Overall Study|Withdrawal by Subject|4
323842|NCT00666458|1060832|P1|Overall Study|Withdrawal by Subject|5
323843|NCT00666458|1060831|P2|Overall Study|Adverse Event|7
323844|NCT00666458|1060832|P1|Overall Study|Adverse Event|8
323845|NCT00666328|1060920|P1|Overall Study|No longer met eligibility criteria|1
323846|NCT00666328|1060920|P1|Overall Study|Lost to Follow-up|2
323847|NCT00666328|1060920|P1|Overall Study|Death|2
323848|NCT00666276|1060933|P1|Overall Study|Protocol Violation|34
323849|NCT00666263|1060957|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
323850|NCT00666263|1060958|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
323851|NCT00666263|1060957|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
323852|NCT00666263|1060958|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
323853|NCT00666263|1060957|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
323854|NCT00666263|1060958|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
323855|NCT00666224|1061102|P2|Open-Label|Undefined/Unknown|1
323856|NCT00666224|1061103|P1|Open-Label|Undefined/Unknown|1
323857|NCT00666224|1061102|P2|Open-Label|Noncompliance|1
323858|NCT00666224|1061103|P1|Open-Label|Noncompliance|2
323859|NCT00666224|1061102|P2|Open-Label|Pregnancy|5
323860|NCT00666224|1061103|P1|Open-Label|Pregnancy|1
323861|NCT00666224|1061102|P2|Open-Label|Physician Decision|5
323862|NCT00666224|1061103|P1|Open-Label|Physician Decision|7
323863|NCT00666224|1061102|P2|Open-Label|Withdrawal by Subject|25
323864|NCT00666224|1061103|P1|Open-Label|Withdrawal by Subject|12
323865|NCT00666224|1061102|P2|Open-Label|Lost to Follow-up|5
323866|NCT00666224|1061103|P1|Open-Label|Lost to Follow-up|4
323867|NCT00666224|1061102|P2|Open-Label|Adverse Event|43
323868|NCT00666224|1061103|P1|Open-Label|Adverse Event|8
323869|NCT00666224|1061102|P2|Double-Blind|Undefined/Unknown|1
323870|NCT00666224|1061103|P1|Double-Blind|Undefined/Unknown|4
323871|NCT00666224|1061102|P2|Double-Blind|Death|0
323872|NCT00666224|1061103|P1|Double-Blind|Death|1
323873|NCT00666224|1061102|P2|Double-Blind|Noncompliance|0
323874|NCT00666224|1061103|P1|Double-Blind|Noncompliance|1
323875|NCT00666224|1061102|P2|Double-Blind|Pregnancy|2
323876|NCT00666224|1061103|P1|Double-Blind|Pregnancy|3
323877|NCT00666224|1061102|P2|Double-Blind|Sponsor decision|0
323878|NCT00666224|1061103|P1|Double-Blind|Sponsor decision|1
323879|NCT00666224|1061102|P2|Double-Blind|Physician Decision|3
323880|NCT00666224|1061103|P1|Double-Blind|Physician Decision|0
323881|NCT00666224|1061102|P2|Double-Blind|Withdrawal by Subject|14
323882|NCT00666224|1061103|P1|Double-Blind|Withdrawal by Subject|18
323883|NCT00666224|1061102|P2|Double-Blind|Lost to Follow-up|2
323884|NCT00666224|1061103|P1|Double-Blind|Lost to Follow-up|2
323885|NCT00666224|1061102|P2|Double-Blind|Adverse Event|5
323886|NCT00666224|1061103|P1|Double-Blind|Adverse Event|15
323887|NCT00666211|1061122|P2|Overall Study|Physician Decision|1
323888|NCT00666211|1061123|P1|Overall Study|Physician Decision|0
323889|NCT00666211|1061122|P2|Overall Study|off tx for other complicating disease|1
323890|NCT00666211|1061123|P1|Overall Study|off tx for other complicating disease|0
323891|NCT00666211|1061122|P2|Overall Study|Death|2
323892|NCT00666211|1061123|P1|Overall Study|Death|0
323893|NCT00666211|1061122|P2|Overall Study|hospital admission|5
323894|NCT00666211|1061123|P1|Overall Study|hospital admission|0
323895|NCT00666211|1061122|P2|Overall Study|toxicity|2
323896|NCT00666211|1061123|P1|Overall Study|toxicity|0
323897|NCT00666211|1061122|P2|Overall Study|Lost to Follow-up|0
323898|NCT00666211|1061123|P1|Overall Study|Lost to Follow-up|2
323899|NCT00666211|1061122|P2|Overall Study|disease progression|8
323900|NCT00666211|1061123|P1|Overall Study|disease progression|1
323901|NCT00666211|1061122|P2|Overall Study|patient non-compliant|6
323902|NCT00666211|1061123|P1|Overall Study|patient non-compliant|6
323903|NCT00666211|1061122|P2|Overall Study|went off medication, no more pain|0
323904|NCT00666211|1061123|P1|Overall Study|went off medication, no more pain|1
323905|NCT00666211|1061122|P2|Overall Study|Withdrawal by Subject|13
323906|NCT00666211|1061123|P1|Overall Study|Withdrawal by Subject|10
323907|NCT00666198|1061141|P1|Overall Study|No Drug Administration|4
323908|NCT00666198|1061141|P1|Overall Study|Safety Not Assessable|6
323909|NCT00666198|1061141|P1|Overall Study|No Visit After First Day of Treatment|13
323910|NCT00666198|1061141|P1|Overall Study|Protocol Violation|10
323911|NCT00665925|1061169|P4|Overall Study|Due to exclusion criteria|0
323912|NCT00665925|1061170|P3|Overall Study|Due to exclusion criteria|0
323913|NCT00665925|1061171|P2|Overall Study|Due to exclusion criteria|0
323914|NCT00665925|1061172|P1|Overall Study|Due to exclusion criteria|1
323915|NCT00665925|1061169|P4|Overall Study|Enrolled by mistake|1
323916|NCT00665925|1061170|P3|Overall Study|Enrolled by mistake|0
323917|NCT00665925|1061171|P2|Overall Study|Enrolled by mistake|0
323918|NCT00665925|1061172|P1|Overall Study|Enrolled by mistake|0
323919|NCT00665925|1061169|P4|Overall Study|Adverse Event|5
323920|NCT00665925|1061170|P3|Overall Study|Adverse Event|10
323921|NCT00665925|1061171|P2|Overall Study|Adverse Event|5
323922|NCT00665925|1061172|P1|Overall Study|Adverse Event|1
323923|NCT00665925|1061169|P4|Overall Study|Severe Non-Compliance to Protocol|1
323924|NCT00665925|1061170|P3|Overall Study|Severe Non-Compliance to Protocol|1
323925|NCT00665925|1061171|P2|Overall Study|Severe Non-Compliance to Protocol|0
323926|NCT00665925|1061172|P1|Overall Study|Severe Non-Compliance to Protocol|0
323927|NCT00665925|1061169|P4|Overall Study|Physician Decision|2
323928|NCT00665925|1061170|P3|Overall Study|Physician Decision|1
323929|NCT00665925|1061171|P2|Overall Study|Physician Decision|0
323930|NCT00665925|1061172|P1|Overall Study|Physician Decision|0
323931|NCT00665925|1061169|P4|Overall Study|Withdrawal by Subject|2
323932|NCT00665925|1061170|P3|Overall Study|Withdrawal by Subject|3
323933|NCT00665925|1061171|P2|Overall Study|Withdrawal by Subject|2
323934|NCT00665925|1061172|P1|Overall Study|Withdrawal by Subject|2
323935|NCT00665925|1061169|P4|Overall Study|Lost to Follow-up|2
323936|NCT00665925|1061170|P3|Overall Study|Lost to Follow-up|2
323937|NCT00665925|1061171|P2|Overall Study|Lost to Follow-up|2
323938|NCT00665925|1061172|P1|Overall Study|Lost to Follow-up|1
323939|NCT00665925|1061169|P4|Overall Study|Lack of Efficacy|8
323940|NCT00665925|1061170|P3|Overall Study|Lack of Efficacy|9
323941|NCT00665925|1061171|P2|Overall Study|Lack of Efficacy|8
323942|NCT00665925|1061172|P1|Overall Study|Lack of Efficacy|10
323943|NCT00665847|1061583|P1|Overall Study|Switch to Commercial Medication|1
323944|NCT00665847|1061583|P1|Overall Study|Subject ineligible to continue the trial|1
323945|NCT00665847|1061583|P1|Overall Study|Resistance to TMC125|1
323946|NCT00665847|1061583|P1|Overall Study|Subject reached a virologic endpoint|4
323947|NCT00665847|1061583|P1|Overall Study|Subject non-compliant|8
323948|NCT00665847|1061583|P1|Overall Study|Withdrawal by Subject|2
323949|NCT00665847|1061583|P1|Overall Study|Adverse Event|8
323950|NCT00665626|1061602|P2|Overall Study|Death|0
323951|NCT00665626|1061603|P1|Overall Study|Death|1
323952|NCT00665626|1061602|P2|Overall Study|Unably to comply with dosing regimen|1
323953|NCT00665626|1061603|P1|Overall Study|Unably to comply with dosing regimen|0
323954|NCT00665626|1061602|P2|Overall Study|Did not fulfil inclusion criteria|1
323955|NCT00665626|1061603|P1|Overall Study|Did not fulfil inclusion criteria|0
323956|NCT00665626|1061602|P2|Overall Study|Due to exclusion criteria|1
323957|NCT00665626|1061603|P1|Overall Study|Due to exclusion criteria|0
323958|NCT00665626|1061602|P2|Overall Study|Adverse Event|9
323959|NCT00665626|1061603|P1|Overall Study|Adverse Event|1
323960|NCT00665626|1061602|P2|Overall Study|Protocol Violation|2
323961|NCT00665626|1061603|P1|Overall Study|Protocol Violation|0
323962|NCT00665626|1061602|P2|Overall Study|Withdrawal by Subject|1
323963|NCT00665626|1061603|P1|Overall Study|Withdrawal by Subject|0
323964|NCT00665626|1061602|P2|Overall Study|Lost to Follow-up|2
323965|NCT00665626|1061603|P1|Overall Study|Lost to Follow-up|0
323966|NCT00665626|1061602|P2|Overall Study|Lack of Efficacy|5
323967|NCT00665626|1061603|P1|Overall Study|Lack of Efficacy|8
323968|NCT00665444|1061680|P1|Overall Study|Study Terminated by Study Sponsor|1
323969|NCT00665444|1061680|P1|Overall Study|Physician Decision|1
323970|NCT00665431|1061688|P3|Overall Study|Other|2
323971|NCT00665431|1061689|P2|Overall Study|Other|7
323972|NCT00665431|1061690|P1|Overall Study|Other|4
323973|NCT00665431|1061688|P3|Overall Study|Lost to Follow-up|1
323974|NCT00665431|1061689|P2|Overall Study|Lost to Follow-up|3
323975|NCT00665431|1061690|P1|Overall Study|Lost to Follow-up|3
323976|NCT00665431|1061688|P3|Overall Study|Withdrawal by Subject|15
323977|NCT00665431|1061689|P2|Overall Study|Withdrawal by Subject|25
323978|NCT00665431|1061690|P1|Overall Study|Withdrawal by Subject|17
323979|NCT00665431|1061688|P3|Overall Study|Adverse Event|6
323980|NCT00665431|1061689|P2|Overall Study|Adverse Event|22
323981|NCT00665431|1061690|P1|Overall Study|Adverse Event|16
323982|NCT00665366|1061733|P2|Overall Study|Other reasons|1
323983|NCT00665366|1061734|P1|Overall Study|Other reasons|4
323984|NCT00665366|1061733|P2|Overall Study|No longer meets study criteria|1
323985|NCT00665366|1061734|P1|Overall Study|No longer meets study criteria|0
323986|NCT00665366|1061733|P2|Overall Study|Pregnancy|0
323987|NCT00665366|1061734|P1|Overall Study|Pregnancy|1
323988|NCT00665366|1061733|P2|Overall Study|Poor compliance/noncompliance|5
323989|NCT00665366|1061734|P1|Overall Study|Poor compliance/noncompliance|3
323990|NCT00665366|1061733|P2|Overall Study|Lost to Follow-up|5
323991|NCT00665366|1061734|P1|Overall Study|Lost to Follow-up|3
323992|NCT00665366|1061733|P2|Overall Study|Withdrawal by Subject|14
323993|NCT00665366|1061734|P1|Overall Study|Withdrawal by Subject|11
323994|NCT00665366|1061733|P2|Overall Study|Adverse Event|23
323995|NCT00665366|1061734|P1|Overall Study|Adverse Event|25
323996|NCT00665366|1061733|P2|Overall Study|Lack of Efficacy|10
323997|NCT00665366|1061734|P1|Overall Study|Lack of Efficacy|11
323998|NCT00665353|1061762|P1|Study Step 2|Lack of Efficacy|12
323999|NCT00665353|1061762|P1|Study Step 2|Lost to Follow-up|2
324000|NCT00665353|1061762|P1|Study Step 1|Withdrawal by Subject|2
324001|NCT00665353|1061762|P1|Study Step 1|Adverse Event|1
324002|NCT00665002|1061779|P1|Overall Study|Cytogenetic resistance|1
324003|NCT00665002|1061779|P1|Overall Study|Progression/relapse during treatment|11
324004|NCT00664742|1061784|P1|Overall Study|Lost to Follow-up|92
324005|NCT00664742|1061784|P1|Overall Study|Withdrawal by Subject|31
324006|NCT00664742|1061784|P1|Overall Study|Withdrawn due to adverse events|3
324007|NCT00664560|1061792|P3|Overall Study|Other|5
324008|NCT00664560|1061793|P2|Overall Study|Other|4
324009|NCT00664560|1061794|P1|Overall Study|Other|11
324010|NCT00664560|1061792|P3|Overall Study|Lost to Follow-up|0
324011|NCT00664560|1061793|P2|Overall Study|Lost to Follow-up|2
324012|NCT00664560|1061794|P1|Overall Study|Lost to Follow-up|0
324013|NCT00664560|1061792|P3|Overall Study|Withdrawal by Subject|7
324014|NCT00664560|1061793|P2|Overall Study|Withdrawal by Subject|13
324015|NCT00664560|1061794|P1|Overall Study|Withdrawal by Subject|9
324016|NCT00664560|1061792|P3|Overall Study|Adverse Event|7
324017|NCT00664560|1061793|P2|Overall Study|Adverse Event|16
324018|NCT00664560|1061794|P1|Overall Study|Adverse Event|19
324019|NCT00664534|1061837|P2|Overall Study|Sponsor decision|6
324020|NCT00664534|1061838|P1|Overall Study|Sponsor decision|8
324021|NCT00664534|1061837|P2|Overall Study|Physician Decision|0
324022|NCT00664534|1061838|P1|Overall Study|Physician Decision|8
324023|NCT00664534|1061837|P2|Overall Study|Withdrawal by Subject|6
324024|NCT00664534|1061838|P1|Overall Study|Withdrawal by Subject|7
324025|NCT00664534|1061837|P2|Overall Study|Protocol Violation|8
324026|NCT00664534|1061838|P1|Overall Study|Protocol Violation|10
324027|NCT00664534|1061837|P2|Overall Study|Lost to Follow-up|10
324028|NCT00664534|1061838|P1|Overall Study|Lost to Follow-up|6
324029|NCT00664534|1061837|P2|Overall Study|Adverse Event|3
324030|NCT00664534|1061838|P1|Overall Study|Adverse Event|2
324031|NCT00664521|1061866|P2|Overall Study|Unspecified|0
324032|NCT00664521|1061867|P1|Overall Study|Unspecified|1
324033|NCT00664521|1061866|P2|Overall Study|Lost to Follow-up|0
324034|NCT00664521|1061867|P1|Overall Study|Lost to Follow-up|1
324035|NCT00664521|1061866|P2|Overall Study|Adverse Event|1
324036|NCT00664521|1061867|P1|Overall Study|Adverse Event|4
324037|NCT00664326|1061893|P1|Overall Study|ongoing with treatment|6
324038|NCT00664326|1061893|P1|Overall Study|Physician Decision|1
324039|NCT00664326|1061893|P1|Overall Study|Withdrawal by Subject|1
324040|NCT00664326|1061893|P1|Overall Study|Noncompliance with study medication|3
324041|NCT00664326|1061893|P1|Overall Study|Adverse Event|13
324042|NCT00664105|1061912|P1|Overall Study|Disease progression|7
324043|NCT00664105|1061912|P1|Overall Study|Adverse Event|9
324044|NCT00664105|1061912|P1|Overall Study|Withdrawal by Subject|5
324045|NCT00664105|1061912|P1|Overall Study|Death|3
324046|NCT00664066|1061919|P1|Overall Study|Study terminated|3
324047|NCT00663962|1061925|P2|Overall Study|somnolence|0
324048|NCT00663962|1061926|P1|Overall Study|somnolence|1
324049|NCT00663923|1061932|P1|Overall Study|Lost to Follow-up|2
324050|NCT00663858|1061949|P3|Overall Study|Other|4
324051|NCT00663858|1061950|P2|Overall Study|Other|2
324052|NCT00663858|1061951|P1|Overall Study|Other|8
324053|NCT00663858|1061949|P3|Overall Study|Protocol Violation|4
324054|NCT00663858|1061950|P2|Overall Study|Protocol Violation|3
324055|NCT00663858|1061951|P1|Overall Study|Protocol Violation|5
324056|NCT00663858|1061949|P3|Overall Study|Withdrawal by Subject|3
324057|NCT00663858|1061950|P2|Overall Study|Withdrawal by Subject|3
324058|NCT00663858|1061951|P1|Overall Study|Withdrawal by Subject|7
324059|NCT00663858|1061949|P3|Overall Study|Lack of Efficacy|3
324060|NCT00663858|1061950|P2|Overall Study|Lack of Efficacy|1
324061|NCT00663858|1061951|P1|Overall Study|Lack of Efficacy|5
324062|NCT00663858|1061949|P3|Overall Study|Adverse Event|6
324063|NCT00663858|1061950|P2|Overall Study|Adverse Event|1
324064|NCT00663858|1061951|P1|Overall Study|Adverse Event|9
324065|NCT00663702|1061983|P2|Overall Study|Lack of Efficacy|3
324066|NCT00663702|1061984|P1|Overall Study|Lack of Efficacy|3
324067|NCT00663702|1061983|P2|Overall Study|Death|1
324068|NCT00663702|1061984|P1|Overall Study|Death|1
324069|NCT00663702|1061983|P2|Overall Study|Lost to Follow-up|0
324070|NCT00663702|1061984|P1|Overall Study|Lost to Follow-up|3
324071|NCT00663702|1061983|P2|Overall Study|Pregnancy|1
324072|NCT00663702|1061984|P1|Overall Study|Pregnancy|0
324073|NCT00663702|1061983|P2|Overall Study|Withdrawal by Subject|1
324074|NCT00663702|1061984|P1|Overall Study|Withdrawal by Subject|3
324075|NCT00663702|1061983|P2|Overall Study|Adverse Event|4
324076|NCT00663702|1061984|P1|Overall Study|Adverse Event|8
324077|NCT00663260|1062020|P3|Overall Study|non-compliance, not met criteria, etc.|3
324078|NCT00663260|1062021|P2|Overall Study|non-compliance, not met criteria, etc.|2
324079|NCT00663260|1062022|P1|Overall Study|non-compliance, not met criteria, etc.|3
324080|NCT00663260|1062020|P3|Overall Study|Lost to Follow-up|0
324081|NCT00663260|1062021|P2|Overall Study|Lost to Follow-up|1
324082|NCT00663260|1062022|P1|Overall Study|Lost to Follow-up|0
324083|NCT00663260|1062020|P3|Overall Study|Death|1
324084|NCT00663260|1062021|P2|Overall Study|Death|0
324085|NCT00663260|1062022|P1|Overall Study|Death|1
324086|NCT00663260|1062020|P3|Overall Study|Withdrawal by Subject|6
324087|NCT00663260|1062021|P2|Overall Study|Withdrawal by Subject|1
324088|NCT00663260|1062022|P1|Overall Study|Withdrawal by Subject|3
324089|NCT00663260|1062020|P3|Overall Study|Adverse Event|6
324090|NCT00663260|1062021|P2|Overall Study|Adverse Event|7
324091|NCT00663260|1062022|P1|Overall Study|Adverse Event|12
324092|NCT00663260|1062020|P3|Overall Study|Lack of Efficacy|0
324093|NCT00663260|1062021|P2|Overall Study|Lack of Efficacy|0
324094|NCT00663260|1062022|P1|Overall Study|Lack of Efficacy|2
324095|NCT00663234|1062036|P1|Overall Study|Not willing to adhere to requirements|1
324096|NCT00663208|1062069|P7|Follow-up Period|Other reason|1
324097|NCT00663208|1062070|P6|Follow-up Period|Other reason|0
324098|NCT00663208|1062071|P5|Follow-up Period|Other reason|0
324099|NCT00663208|1062072|P4|Follow-up Period|Other reason|0
324100|NCT00663208|1062073|P3|Follow-up Period|Other reason|0
324101|NCT00663208|1062074|P2|Follow-up Period|Other reason|0
324102|NCT00663208|1062075|P1|Follow-up Period|Other reason|1
324103|NCT00663208|1062069|P7|Follow-up Period|Lost to Follow-up|0
324104|NCT00663208|1062070|P6|Follow-up Period|Lost to Follow-up|0
324105|NCT00663208|1062071|P5|Follow-up Period|Lost to Follow-up|0
324106|NCT00663208|1062072|P4|Follow-up Period|Lost to Follow-up|2
324107|NCT00663208|1062073|P3|Follow-up Period|Lost to Follow-up|3
324108|NCT00663208|1062074|P2|Follow-up Period|Lost to Follow-up|0
324109|NCT00663208|1062075|P1|Follow-up Period|Lost to Follow-up|2
324110|NCT00663208|1062069|P7|Treatment Period|Lost to Follow-up|0
324111|NCT00663208|1062070|P6|Treatment Period|Lost to Follow-up|0
324112|NCT00663208|1062071|P5|Treatment Period|Lost to Follow-up|0
324113|NCT00663208|1062072|P4|Treatment Period|Lost to Follow-up|0
324114|NCT00663208|1062073|P3|Treatment Period|Lost to Follow-up|0
324115|NCT00663208|1062074|P2|Treatment Period|Lost to Follow-up|1
324116|NCT00663208|1062075|P1|Treatment Period|Lost to Follow-up|0
324117|NCT00663117|1062253|P2|Overall Study|Lack of Efficacy|0
324118|NCT00663117|1062254|P1|Overall Study|Lack of Efficacy|1
324119|NCT00663052|1062268|P2|Overall Study|Unspecified|1
324120|NCT00663052|1062269|P1|Overall Study|Unspecified|0
324121|NCT00663052|1062268|P2|Overall Study|Unsatisfactory Response - Efficacy|1
324122|NCT00663052|1062269|P1|Overall Study|Unsatisfactory Response - Efficacy|1
324123|NCT00663052|1062268|P2|Overall Study|Withdrawal by Subject|5
324124|NCT00663052|1062269|P1|Overall Study|Withdrawal by Subject|2
324125|NCT00663052|1062268|P2|Overall Study|Protocol Violation|0
324126|NCT00663052|1062269|P1|Overall Study|Protocol Violation|1
324127|NCT00663052|1062268|P2|Overall Study|Discontinuation of Study by Sponsor|0
324128|NCT00663052|1062269|P1|Overall Study|Discontinuation of Study by Sponsor|2
324129|NCT00663052|1062268|P2|Overall Study|Adverse Event|3
324130|NCT00663052|1062269|P1|Overall Study|Adverse Event|6
324131|NCT00663026|1062352|P3|Overall Study|Withdrawal by Subject|1
324132|NCT00663026|1062353|P2|Overall Study|Withdrawal by Subject|0
324133|NCT00663026|1062354|P1|Overall Study|Withdrawal by Subject|0
324134|NCT00663026|1062352|P3|Overall Study|Caregiver Request|0
324135|NCT00663026|1062353|P2|Overall Study|Caregiver Request|2
324136|NCT00663026|1062354|P1|Overall Study|Caregiver Request|0
324137|NCT00663026|1062352|P3|Overall Study|Adverse Event|3
324138|NCT00663026|1062353|P2|Overall Study|Adverse Event|2
324139|NCT00663026|1062354|P1|Overall Study|Adverse Event|0
324140|NCT00663026|1062352|P3|Overall Study|Unspecified|0
324141|NCT00663026|1062353|P2|Overall Study|Unspecified|2
324142|NCT00663026|1062354|P1|Overall Study|Unspecified|1
324143|NCT00663026|1062352|P3|Overall Study|Lost to Follow-up|0
324144|NCT00663026|1062353|P2|Overall Study|Lost to Follow-up|0
324145|NCT00663026|1062354|P1|Overall Study|Lost to Follow-up|1
324146|NCT00662909|1062377|P3|Overall Study|Eligibility criterion not met|1
324147|NCT00662909|1062378|P2|Overall Study|Eligibility criterion not met|1
324148|NCT00662909|1062379|P1|Overall Study|Eligibility criterion not met|0
324149|NCT00662909|1062377|P3|Overall Study|Physician Decision|2
324150|NCT00662909|1062378|P2|Overall Study|Physician Decision|1
324151|NCT00662909|1062379|P1|Overall Study|Physician Decision|1
324152|NCT00662909|1062377|P3|Overall Study|Non-compliance with study procedures|2
324153|NCT00662909|1062378|P2|Overall Study|Non-compliance with study procedures|3
324154|NCT00662909|1062379|P1|Overall Study|Non-compliance with study procedures|3
324155|NCT00662909|1062377|P3|Overall Study|Randomized- never received study drug|0
324156|NCT00662909|1062378|P2|Overall Study|Randomized- never received study drug|0
324157|NCT00662909|1062379|P1|Overall Study|Randomized- never received study drug|1
324158|NCT00662909|1062377|P3|Overall Study|Protocol Violation|5
324159|NCT00662909|1062378|P2|Overall Study|Protocol Violation|4
324160|NCT00662909|1062379|P1|Overall Study|Protocol Violation|7
324161|NCT00662909|1062377|P3|Overall Study|Lost to Follow-up|3
324162|NCT00662909|1062378|P2|Overall Study|Lost to Follow-up|9
324163|NCT00662909|1062379|P1|Overall Study|Lost to Follow-up|2
324164|NCT00662909|1062377|P3|Overall Study|Withdrawal by Subject|16
324165|NCT00662909|1062378|P2|Overall Study|Withdrawal by Subject|22
324166|NCT00662909|1062379|P1|Overall Study|Withdrawal by Subject|29
324167|NCT00662909|1062377|P3|Overall Study|Lack of Efficacy|5
324168|NCT00662909|1062378|P2|Overall Study|Lack of Efficacy|1
324169|NCT00662909|1062379|P1|Overall Study|Lack of Efficacy|9
324170|NCT00662909|1062377|P3|Overall Study|Adverse Event|19
324171|NCT00662909|1062378|P2|Overall Study|Adverse Event|18
324172|NCT00662909|1062379|P1|Overall Study|Adverse Event|17
324173|NCT00662857|1062477|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
324174|NCT00662857|1062478|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
324175|NCT00662857|1062477|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
324176|NCT00662857|1062478|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
324177|NCT00662857|1062477|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
324178|NCT00662857|1062478|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
324179|NCT00662831|1062493|P2|Overall Study|Adverse Event|16
324180|NCT00662831|1062494|P1|Overall Study|Adverse Event|23
324181|NCT00662831|1062493|P2|Overall Study|Protocol Violation|4
324182|NCT00662831|1062494|P1|Overall Study|Protocol Violation|8
324183|NCT00662831|1062493|P2|Overall Study|Unspecified|31
324184|NCT00662831|1062494|P1|Overall Study|Unspecified|62
324185|NCT00662831|1062493|P2|Overall Study|Withdrawal by Subject|1
324186|NCT00662831|1062494|P1|Overall Study|Withdrawal by Subject|2
324187|NCT00662831|1062493|P2|Overall Study|Lost to Follow-up|0
324188|NCT00662831|1062494|P1|Overall Study|Lost to Follow-up|1
324189|NCT00662831|1062493|P2|Overall Study|Lack of Efficacy|6
324190|NCT00662831|1062494|P1|Overall Study|Lack of Efficacy|6
324191|NCT00662831|1062493|P2|Overall Study|Death|1
324192|NCT00662831|1062494|P1|Overall Study|Death|4
324193|NCT00662649|1062574|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
324194|NCT00662649|1062575|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
324195|NCT00662649|1062576|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
324196|NCT00662649|1062577|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
324197|NCT00662649|1062578|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
324198|NCT00662649|1062574|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
324199|NCT00662649|1062575|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
324200|NCT00662649|1062576|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
324201|NCT00662649|1062577|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
324202|NCT00662649|1062578|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
324203|NCT00662649|1062574|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
324204|NCT00662649|1062575|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
324205|NCT00662649|1062576|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
324206|NCT00662649|1062577|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
324207|NCT00662649|1062578|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
324208|NCT00662649|1062574|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
324209|NCT00662649|1062575|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
324210|NCT00662649|1062576|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
324211|NCT00662649|1062577|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
324212|NCT00662649|1062578|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
324213|NCT00662649|1062574|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
324214|NCT00662649|1062575|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
324215|NCT00662649|1062576|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
324216|NCT00662649|1062577|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
324217|NCT00662649|1062578|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
324218|NCT00662649|1062574|P5|Extension Study (Month 24 to 60)|Adverse Event|10
324219|NCT00662649|1062575|P4|Extension Study (Month 24 to 60)|Adverse Event|6
324220|NCT00662649|1062576|P3|Extension Study (Month 24 to 60)|Adverse Event|0
324221|NCT00662649|1062577|P2|Extension Study (Month 24 to 60)|Adverse Event|9
324222|NCT00662649|1062578|P1|Extension Study (Month 24 to 60)|Adverse Event|6
324223|NCT00662649|1062574|P5|Extension Study (Month 24 to 60)|Administrative problems|0
324224|NCT00662649|1062575|P4|Extension Study (Month 24 to 60)|Administrative problems|1
324225|NCT00662649|1062576|P3|Extension Study (Month 24 to 60)|Administrative problems|0
324226|NCT00662649|1062577|P2|Extension Study (Month 24 to 60)|Administrative problems|0
324227|NCT00662649|1062578|P1|Extension Study (Month 24 to 60)|Administrative problems|0
324228|NCT00662649|1062574|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
324229|NCT00662649|1062575|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
324230|NCT00662649|1062576|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
324231|NCT00662649|1062577|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
324232|NCT00662649|1062578|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
324233|NCT00662649|1062574|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
324234|NCT00662649|1062575|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
324235|NCT00662649|1062576|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
324236|NCT00662649|1062577|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
324237|NCT00662649|1062578|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
324238|NCT00662649|1062574|P5|Core Study (24 Months)|Death|0
324239|NCT00662649|1062575|P4|Core Study (24 Months)|Death|0
324240|NCT00662649|1062576|P3|Core Study (24 Months)|Death|2
324241|NCT00662649|1062577|P2|Core Study (24 Months)|Death|0
324242|NCT00662649|1062578|P1|Core Study (24 Months)|Death|1
324243|NCT00662649|1062574|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
324244|NCT00662649|1062575|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
324245|NCT00662649|1062576|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
324246|NCT00662649|1062577|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
324247|NCT00662649|1062578|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
324248|NCT00662649|1062574|P5|Core Study (24 Months)|Protocol Violation|0
324249|NCT00662649|1062575|P4|Core Study (24 Months)|Protocol Violation|0
324250|NCT00662649|1062576|P3|Core Study (24 Months)|Protocol Violation|4
324251|NCT00662649|1062577|P2|Core Study (24 Months)|Protocol Violation|5
324252|NCT00662649|1062578|P1|Core Study (24 Months)|Protocol Violation|5
324253|NCT00662649|1062574|P5|Core Study (24 Months)|Lost to Follow-up|0
324254|NCT00662649|1062575|P4|Core Study (24 Months)|Lost to Follow-up|0
324255|NCT00662649|1062576|P3|Core Study (24 Months)|Lost to Follow-up|7
324256|NCT00662649|1062577|P2|Core Study (24 Months)|Lost to Follow-up|5
324257|NCT00662649|1062578|P1|Core Study (24 Months)|Lost to Follow-up|3
324258|NCT00662649|1062574|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
324259|NCT00662649|1062575|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
324260|NCT00662649|1062576|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
324261|NCT00662649|1062577|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
324262|NCT00662649|1062578|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
324263|NCT00662649|1062574|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
324264|NCT00662649|1062575|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
324265|NCT00662649|1062576|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
324266|NCT00662649|1062577|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
324267|NCT00662649|1062578|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
324268|NCT00662649|1062574|P5|Core Study (24 Months)|Adverse Event|0
324269|NCT00662649|1062575|P4|Core Study (24 Months)|Adverse Event|0
324270|NCT00662649|1062576|P3|Core Study (24 Months)|Adverse Event|18
324271|NCT00662649|1062577|P2|Core Study (24 Months)|Adverse Event|13
324272|NCT00662649|1062578|P1|Core Study (24 Months)|Adverse Event|22
324273|NCT00662649|1062574|P5|Core Study (24 Months)|Withdrawal by Subject|0
324274|NCT00662649|1062575|P4|Core Study (24 Months)|Withdrawal by Subject|0
324275|NCT00662649|1062576|P3|Core Study (24 Months)|Withdrawal by Subject|28
324276|NCT00662649|1062577|P2|Core Study (24 Months)|Withdrawal by Subject|17
324277|NCT00662649|1062578|P1|Core Study (24 Months)|Withdrawal by Subject|31
324278|NCT00662558|1062618|P2|Overall Study|Randomized But Did Not Receive Treatment|8
324279|NCT00662558|1062619|P1|Overall Study|Randomized But Did Not Receive Treatment|2
324280|NCT00662558|1062618|P2|Overall Study|Withdrawal by Subject|12
324281|NCT00662558|1062619|P1|Overall Study|Withdrawal by Subject|7
324282|NCT00662558|1062618|P2|Overall Study|Other|14
324283|NCT00662558|1062619|P1|Overall Study|Other|9
324284|NCT00662558|1062618|P2|Overall Study|Lost to Follow-up|10
324285|NCT00662558|1062619|P1|Overall Study|Lost to Follow-up|13
324286|NCT00662558|1062618|P2|Overall Study|Lack of Efficacy|7
324287|NCT00662558|1062619|P1|Overall Study|Lack of Efficacy|4
324288|NCT00662558|1062618|P2|Overall Study|Adverse Event|59
324289|NCT00662558|1062619|P1|Overall Study|Adverse Event|21
324290|NCT00662532|1062670|P2|Overall Study|Lost to Follow-up|1
324291|NCT00662532|1062671|P1|Overall Study|Lost to Follow-up|0
324292|NCT00662532|1062670|P2|Overall Study|Adverse Event|1
324293|NCT00662532|1062671|P1|Overall Study|Adverse Event|0
324294|NCT00662363|1062686|P2|Overall Study|Protocol Violation|1
324295|NCT00662363|1062687|P1|Overall Study|Protocol Violation|1
324296|NCT00662363|1062686|P2|Overall Study|Discharged early from rehab|1
324297|NCT00662363|1062687|P1|Overall Study|Discharged early from rehab|4
324298|NCT00662363|1062686|P2|Overall Study|Adverse Event|3
324299|NCT00662363|1062687|P1|Overall Study|Adverse Event|0
324300|NCT00662363|1062686|P2|Overall Study|Withdrawal by Subject|5
324301|NCT00662363|1062687|P1|Overall Study|Withdrawal by Subject|6
324302|NCT00662311|1062698|P3|Overall Study|Respiratory Infection|0
324303|NCT00662311|1062699|P2|Overall Study|Respiratory Infection|0
324304|NCT00662311|1062700|P1|Overall Study|Respiratory Infection|1
324305|NCT00662129|1062730|P1|Overall Study|Ineligible|1
324306|NCT00662129|1062730|P1|Overall Study|Cancel prior to beginning treatment|1
324307|NCT00662129|1062730|P1|Overall Study|Protocol Violation|1
324308|NCT00662038|1062740|P1|Overall Study|Continued treatment|5
324309|NCT00662038|1062740|P1|Overall Study|Adverse Event|358
324310|NCT00662038|1062740|P1|Overall Study|Death|95
324311|NCT00662038|1062740|P1|Overall Study|Lost to Follow-up|1
324312|NCT00662038|1062740|P1|Overall Study|Lung transplantation|44
324313|NCT00662038|1062740|P1|Overall Study|Physician Decision|19
324314|NCT00662038|1062740|P1|Overall Study|Sponsor decision|1
324315|NCT00662038|1062740|P1|Overall Study|Withdrawal by Subject|83
324316|NCT00662038|1062740|P1|Overall Study|Withdrawn consent|22
324317|NCT00662038|1062740|P1|Overall Study|Reason not specified|3
324318|NCT00662025|1062744|P1|Overall Study|Domestic circumstances|1
324319|NCT00662025|1062744|P1|Overall Study|Target lesion cannot be evaluated|1
324320|NCT00662025|1062744|P1|Overall Study|Results of other clinical study|2
324321|NCT00662025|1062744|P1|Overall Study|Withdrawal by Subject|1
324322|NCT00662025|1062744|P1|Overall Study|Adverse Event|7
324323|NCT00662025|1062744|P1|Overall Study|Objective progression or relapse|51
324324|NCT00662012|1062764|P1|Overall Study|Withdrawal by Subject|1
324325|NCT00662012|1062764|P1|Overall Study|Death|1
324326|NCT00662012|1062764|P1|Overall Study|Lost to Follow-up|85
324327|NCT00661999|1062772|P3|Overall Study|Other Medical Problems|9
324328|NCT00661999|1062773|P2|Overall Study|Other Medical Problems|4
324329|NCT00661999|1062774|P1|Overall Study|Other Medical Problems|4
324330|NCT00661999|1062772|P3|Overall Study|Alternative Treatment|0
324331|NCT00661999|1062773|P2|Overall Study|Alternative Treatment|0
324332|NCT00661999|1062774|P1|Overall Study|Alternative Treatment|1
324333|NCT00661999|1062772|P3|Overall Study|Withdrawal by Subject|14
324334|NCT00661999|1062773|P2|Overall Study|Withdrawal by Subject|23
324335|NCT00661999|1062774|P1|Overall Study|Withdrawal by Subject|30
324336|NCT00661999|1062772|P3|Overall Study|Other Reasons|23
324337|NCT00661999|1062773|P2|Overall Study|Other Reasons|12
324338|NCT00661999|1062774|P1|Overall Study|Other Reasons|5
324339|NCT00661999|1062772|P3|Overall Study|Death|3
324340|NCT00661999|1062773|P2|Overall Study|Death|6
324341|NCT00661999|1062774|P1|Overall Study|Death|8
324342|NCT00661999|1062772|P3|Overall Study|Adverse Event|8
324343|NCT00661999|1062773|P2|Overall Study|Adverse Event|5
324344|NCT00661999|1062774|P1|Overall Study|Adverse Event|11
324345|NCT00661830|1062851|P2|Overall Study|Other reason|5
324346|NCT00661830|1062852|P1|Overall Study|Other reason|1
324347|NCT00661830|1062851|P2|Overall Study|Withdrawal by Subject|1
324348|NCT00661830|1062852|P1|Overall Study|Withdrawal by Subject|1
324349|NCT00661830|1062851|P2|Overall Study|Lost to Follow-up|3
324350|NCT00661830|1062852|P1|Overall Study|Lost to Follow-up|1
324351|NCT00661830|1062851|P2|Overall Study|Death|33
324352|NCT00661830|1062852|P1|Overall Study|Death|37
324353|NCT00661778|1062864|P1|Overall Study|Withdrawal of Consent|1
324354|NCT00661778|1062864|P1|Overall Study|Protocol Violation|2
324355|NCT00661778|1062864|P1|Overall Study|Reason not Specified|6
324356|NCT00661778|1062864|P1|Overall Study|Adverse Event|18
324357|NCT00661778|1062864|P1|Overall Study|Disease Progression|23
324358|NCT00661726|1062871|P1|Overall Study|Adverse Event|1
324359|NCT00661713|1062894|P8|Overall Study|Inappropriate Enrollment|0
324360|NCT00661713|1062895|P7|Overall Study|Inappropriate Enrollment|1
324361|NCT00661713|1062896|P6|Overall Study|Inappropriate Enrollment|0
324362|NCT00661713|1062897|P5|Overall Study|Inappropriate Enrollment|0
324363|NCT00661713|1062898|P4|Overall Study|Inappropriate Enrollment|0
324364|NCT00661713|1062899|P3|Overall Study|Inappropriate Enrollment|0
324365|NCT00661713|1062900|P2|Overall Study|Inappropriate Enrollment|0
324366|NCT00661713|1062901|P1|Overall Study|Inappropriate Enrollment|0
324367|NCT00661713|1062894|P8|Overall Study|Adverse Event|0
324368|NCT00661713|1062895|P7|Overall Study|Adverse Event|1
324369|NCT00661713|1062896|P6|Overall Study|Adverse Event|0
324370|NCT00661713|1062897|P5|Overall Study|Adverse Event|0
324371|NCT00661713|1062898|P4|Overall Study|Adverse Event|0
324372|NCT00661713|1062899|P3|Overall Study|Adverse Event|0
324373|NCT00661713|1062900|P2|Overall Study|Adverse Event|0
324374|NCT00661713|1062901|P1|Overall Study|Adverse Event|0
324375|NCT00661713|1062894|P8|Overall Study|Administrative Reason|0
324376|NCT00661713|1062895|P7|Overall Study|Administrative Reason|1
324377|NCT00661713|1062896|P6|Overall Study|Administrative Reason|2
324378|NCT00661713|1062897|P5|Overall Study|Administrative Reason|2
324379|NCT00661713|1062898|P4|Overall Study|Administrative Reason|2
324380|NCT00661713|1062899|P3|Overall Study|Administrative Reason|0
324381|NCT00661713|1062900|P2|Overall Study|Administrative Reason|1
324382|NCT00661713|1062901|P1|Overall Study|Administrative Reason|0
324383|NCT00661713|1062894|P8|Overall Study|Lost to Follow-up|1
324384|NCT00661713|1062895|P7|Overall Study|Lost to Follow-up|14
324385|NCT00661713|1062896|P6|Overall Study|Lost to Follow-up|7
324386|NCT00661713|1062897|P5|Overall Study|Lost to Follow-up|5
324387|NCT00661713|1062898|P4|Overall Study|Lost to Follow-up|2
324388|NCT00661713|1062899|P3|Overall Study|Lost to Follow-up|2
324389|NCT00661713|1062900|P2|Overall Study|Lost to Follow-up|7
324390|NCT00661713|1062901|P1|Overall Study|Lost to Follow-up|2
324391|NCT00661713|1062894|P8|Overall Study|Withdrawal by Subject|9
324392|NCT00661713|1062895|P7|Overall Study|Withdrawal by Subject|45
324393|NCT00661713|1062896|P6|Overall Study|Withdrawal by Subject|26
324394|NCT00661713|1062897|P5|Overall Study|Withdrawal by Subject|12
324395|NCT00661713|1062898|P4|Overall Study|Withdrawal by Subject|21
324396|NCT00661713|1062899|P3|Overall Study|Withdrawal by Subject|12
324397|NCT00661713|1062900|P2|Overall Study|Withdrawal by Subject|25
324398|NCT00661713|1062901|P1|Overall Study|Withdrawal by Subject|11
324399|NCT00661713|1062894|P8|Overall Study|Protocol Violation|1
324400|NCT00661713|1062895|P7|Overall Study|Protocol Violation|2
324401|NCT00661713|1062896|P6|Overall Study|Protocol Violation|2
324402|NCT00661713|1062897|P5|Overall Study|Protocol Violation|0
324403|NCT00661713|1062898|P4|Overall Study|Protocol Violation|3
324404|NCT00661713|1062899|P3|Overall Study|Protocol Violation|3
324405|NCT00661713|1062900|P2|Overall Study|Protocol Violation|6
324406|NCT00661713|1062901|P1|Overall Study|Protocol Violation|1
324407|NCT00661713|1062894|P8|Overall Study|Unable to Classify|0
324408|NCT00661713|1062895|P7|Overall Study|Unable to Classify|0
324409|NCT00661713|1062896|P6|Overall Study|Unable to Classify|0
324410|NCT00661713|1062897|P5|Overall Study|Unable to Classify|0
324411|NCT00661713|1062898|P4|Overall Study|Unable to Classify|0
324412|NCT00661713|1062899|P3|Overall Study|Unable to Classify|0
324413|NCT00661713|1062900|P2|Overall Study|Unable to Classify|0
324414|NCT00661713|1062901|P1|Overall Study|Unable to Classify|1
324415|NCT00661713|1062894|P8|Overall Study|Death|0
324416|NCT00661713|1062895|P7|Overall Study|Death|0
324417|NCT00661713|1062896|P6|Overall Study|Death|0
324418|NCT00661713|1062897|P5|Overall Study|Death|1
324419|NCT00661713|1062898|P4|Overall Study|Death|0
324420|NCT00661713|1062899|P3|Overall Study|Death|0
324421|NCT00661713|1062900|P2|Overall Study|Death|0
324422|NCT00661713|1062901|P1|Overall Study|Death|1
324423|NCT00661687|1062991|P1|Overall Study|Adverse Event|2
324424|NCT00661687|1062991|P1|Overall Study|Physician Decision|1
324425|NCT00661687|1062991|P1|Overall Study|Inability to maintain wearing schedule|3
324426|NCT00661687|1062991|P1|Overall Study|Positive slit lamp findings|4
324427|NCT00661687|1062991|P1|Overall Study|Study related symptoms and complaints|5
324428|NCT00661661|1063019|P2|Overall Study|Not assigned treatment|0
324429|NCT00661661|1063020|P1|Overall Study|Not assigned treatment|1
324430|NCT00661661|1063019|P2|Overall Study|Unspecified|7
324431|NCT00661661|1063020|P1|Overall Study|Unspecified|22
324432|NCT00661661|1063019|P2|Overall Study|Withdrawal by Subject|5
324433|NCT00661661|1063020|P1|Overall Study|Withdrawal by Subject|15
324434|NCT00661661|1063019|P2|Overall Study|Lost to Follow-up|1
324435|NCT00661661|1063020|P1|Overall Study|Lost to Follow-up|0
324436|NCT00661661|1063019|P2|Overall Study|Lack of Efficacy|2
324437|NCT00661661|1063020|P1|Overall Study|Lack of Efficacy|3
324438|NCT00661661|1063019|P2|Overall Study|Adverse Event|24
324439|NCT00661661|1063020|P1|Overall Study|Adverse Event|99
324440|NCT00661622|1063096|P2|Overall Study|Protocol Violation|0
324441|NCT00661622|1063097|P1|Overall Study|Protocol Violation|1
324442|NCT00661609|1063111|P1|Overall Study|Disease progression|3
324443|NCT00661609|1063111|P1|Overall Study|Survival follow up stage discontinued|11
324444|NCT00661609|1063111|P1|Overall Study|PI Decision|1
324445|NCT00661609|1063111|P1|Overall Study|Withdrawal by Subject|2
324446|NCT00661609|1063111|P1|Overall Study|Death|20
324447|NCT00661609|1063111|P1|Overall Study|Adverse Event|4
324448|NCT00661531|1063151|P1|Overall Study|Withdrawal by Subject|3
324449|NCT00661505|1063156|P1|Overall Study|Not Specified|2
324450|NCT00661505|1063156|P1|Overall Study|Lost to Follow-up|3
324451|NCT00661505|1063156|P1|Overall Study|Withdrawal by Subject|8
324452|NCT00661505|1063156|P1|Overall Study|Protocol Violation|14
324453|NCT00661505|1063156|P1|Overall Study|Adverse Event|3
324454|NCT00661492|1063184|P2|Overall Study|Other|0
324455|NCT00661492|1063185|P1|Overall Study|Other|1
324456|NCT00661492|1063184|P2|Overall Study|Lost to Follow-up|1
324457|NCT00661492|1063185|P1|Overall Study|Lost to Follow-up|0
324458|NCT00661492|1063184|P2|Overall Study|Investigator Request|0
324459|NCT00661492|1063185|P1|Overall Study|Investigator Request|1
324460|NCT00661492|1063184|P2|Overall Study|Patient Request|1
324461|NCT00661492|1063185|P1|Overall Study|Patient Request|6
324462|NCT00661492|1063184|P2|Overall Study|Disease Progression|14
324463|NCT00661492|1063185|P1|Overall Study|Disease Progression|44
324464|NCT00661492|1063184|P2|Overall Study|Adverse Event|13
324465|NCT00661492|1063185|P1|Overall Study|Adverse Event|16
324466|NCT00661427|1063231|P2|Overall Study|Patient not treated|2
324467|NCT00661427|1063232|P1|Overall Study|Patient not treated|0
324468|NCT00661427|1063231|P2|Overall Study|Adverse Event|5
324469|NCT00661427|1063232|P1|Overall Study|Adverse Event|5
324470|NCT00661388|1063238|P1|Overall Study|Administrative reasons|1
324471|NCT00661388|1063238|P1|Overall Study|Dialysis initiation|1
324472|NCT00661388|1063238|P1|Overall Study|Renal transplantation|1
324473|NCT00661388|1063238|P1|Overall Study|Protocol Violation|7
324474|NCT00661388|1063238|P1|Overall Study|Adverse Event|14
324475|NCT00661362|1063261|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
324476|NCT00661362|1063262|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
324477|NCT00661362|1063261|P2|Overall Study|Safety reasons|0
324478|NCT00661362|1063262|P1|Overall Study|Safety reasons|1
324479|NCT00661362|1063261|P2|Overall Study|Severe non-compliance to protocol|1
324480|NCT00661362|1063262|P1|Overall Study|Severe non-compliance to protocol|0
324481|NCT00661362|1063261|P2|Overall Study|Lost to Follow-up|1
324482|NCT00661362|1063262|P1|Overall Study|Lost to Follow-up|3
324483|NCT00661362|1063261|P2|Overall Study|Withdrawal by Subject|23
324484|NCT00661362|1063262|P1|Overall Study|Withdrawal by Subject|13
324485|NCT00661362|1063261|P2|Overall Study|Study specific discontinuation criteria|11
324486|NCT00661362|1063262|P1|Overall Study|Study specific discontinuation criteria|4
324487|NCT00661362|1063261|P2|Overall Study|Incorrect enrollment|0
324488|NCT00661362|1063262|P1|Overall Study|Incorrect enrollment|2
324489|NCT00661362|1063261|P2|Overall Study|Adverse Event|4
324490|NCT00661362|1063262|P1|Overall Study|Adverse Event|5
324491|NCT00661258|1063280|P2|Overall Study|caught by police and in detox center|1
324492|NCT00661258|1063281|P1|Overall Study|caught by police and in detox center|2
324493|NCT00661258|1063280|P2|Overall Study|Death|0
324494|NCT00661258|1063281|P1|Overall Study|Death|1
324495|NCT00661193|1063291|P2|Overall Study|Not protocol specified|0
324496|NCT00661193|1063292|P1|Overall Study|Not protocol specified|1
324497|NCT00661193|1063291|P2|Overall Study|Progression|24
324498|NCT00661193|1063292|P1|Overall Study|Progression|27
324499|NCT00661193|1063291|P2|Overall Study|Withdrawal by Subject|1
324500|NCT00661193|1063292|P1|Overall Study|Withdrawal by Subject|3
324501|NCT00661193|1063291|P2|Overall Study|Adverse Event|1
324502|NCT00661193|1063292|P1|Overall Study|Adverse Event|2
324503|NCT00661089|1063302|P2|Overall Study|death at 8 weeks due to new stroke|1
324504|NCT00661089|1063303|P1|Overall Study|death at 8 weeks due to new stroke|0
324505|NCT00661089|1063302|P2|Overall Study|1 subject withdrawal|1
324506|NCT00661089|1063303|P1|Overall Study|1 subject withdrawal|0
324507|NCT00660907|1063338|P2|Overall Study|Various|8
324508|NCT00660907|1063339|P1|Overall Study|Various|11
324509|NCT00660907|1063338|P2|Overall Study|Death|3
324510|NCT00660907|1063339|P1|Overall Study|Death|1
324511|NCT00660907|1063338|P2|Overall Study|Safety|0
324512|NCT00660907|1063339|P1|Overall Study|Safety|1
324513|NCT00660907|1063338|P2|Overall Study|Poor/Non-Compliance|1
324514|NCT00660907|1063339|P1|Overall Study|Poor/Non-Compliance|5
324515|NCT00660907|1063338|P2|Overall Study|Lost to Follow-up|3
324516|NCT00660907|1063339|P1|Overall Study|Lost to Follow-up|3
324517|NCT00660907|1063338|P2|Overall Study|Withdrawal by Subject|32
324518|NCT00660907|1063339|P1|Overall Study|Withdrawal by Subject|23
324519|NCT00660907|1063338|P2|Overall Study|Subject No Longer Meets Study Criteria|27
324520|NCT00660907|1063339|P1|Overall Study|Subject No Longer Meets Study Criteria|6
324521|NCT00660907|1063338|P2|Overall Study|Adverse Event|19
324522|NCT00660907|1063339|P1|Overall Study|Adverse Event|33
324523|NCT00660907|1063338|P2|Overall Study|Incorrect Enrollment|1
324524|NCT00660907|1063339|P1|Overall Study|Incorrect Enrollment|1
324525|NCT00660829|1063353|P2|Overall Study|Other|4
324526|NCT00660829|1063354|P1|Overall Study|Other|9
324527|NCT00660829|1063353|P2|Overall Study|Lost to Follow-up|2
324528|NCT00660829|1063354|P1|Overall Study|Lost to Follow-up|3
324529|NCT00660829|1063353|P2|Overall Study|Withdrawal by Subject|2
324530|NCT00660829|1063354|P1|Overall Study|Withdrawal by Subject|1
324531|NCT00660829|1063353|P2|Overall Study|Non-Compliance|4
324532|NCT00660829|1063354|P1|Overall Study|Non-Compliance|0
324533|NCT00660829|1063353|P2|Overall Study|Lack of Efficacy|3
324534|NCT00660829|1063354|P1|Overall Study|Lack of Efficacy|2
324535|NCT00660829|1063353|P2|Overall Study|Adverse Event|4
324536|NCT00660829|1063354|P1|Overall Study|Adverse Event|3
324537|NCT00660816|1063372|P2|Overall Study|Complicating Disease|1
324538|NCT00660816|1063373|P1|Overall Study|Complicating Disease|0
324539|NCT00660816|1063372|P2|Overall Study|Disease Progression|12
324540|NCT00660816|1063373|P1|Overall Study|Disease Progression|16
324541|NCT00660816|1063372|P2|Overall Study|Protocol Violation|0
324542|NCT00660816|1063373|P1|Overall Study|Protocol Violation|1
324543|NCT00660816|1063372|P2|Overall Study|Physician Decision|2
324544|NCT00660816|1063373|P1|Overall Study|Physician Decision|0
324545|NCT00660816|1063372|P2|Overall Study|Lack of Efficacy|0
324546|NCT00660816|1063373|P1|Overall Study|Lack of Efficacy|1
324547|NCT00660816|1063372|P2|Overall Study|Death|2
324548|NCT00660816|1063373|P1|Overall Study|Death|0
324549|NCT00660816|1063372|P2|Overall Study|Withdrawal by Subject|0
324550|NCT00660816|1063373|P1|Overall Study|Withdrawal by Subject|1
324551|NCT00660816|1063372|P2|Overall Study|Adverse Event|2
324552|NCT00660816|1063373|P1|Overall Study|Adverse Event|1
324553|NCT00660699|1063385|P1|Overall Study|Withdrawal by Subject|2
324554|NCT00660660|1063401|P2|Overall Study|New medication after randomization|0
324555|NCT00660660|1063402|P1|Overall Study|New medication after randomization|1
324556|NCT00660660|1063401|P2|Overall Study|Incorrect enrollment and other|1
324557|NCT00660660|1063402|P1|Overall Study|Incorrect enrollment and other|0
324558|NCT00660660|1063401|P2|Overall Study|Withdrawal by Subject|0
324559|NCT00660660|1063402|P1|Overall Study|Withdrawal by Subject|3
324560|NCT00660660|1063401|P2|Overall Study|Lack of Efficacy|2
324561|NCT00660660|1063402|P1|Overall Study|Lack of Efficacy|0
324562|NCT00660660|1063401|P2|Overall Study|Lost to Follow-up|6
324563|NCT00660660|1063402|P1|Overall Study|Lost to Follow-up|0
324564|NCT00660660|1063401|P2|Overall Study|Adverse Event|0
324565|NCT00660660|1063402|P1|Overall Study|Adverse Event|1
324566|NCT00660595|1063502|P2|Overall Study|Non Specified reasons|0
324567|NCT00660595|1063503|P1|Overall Study|Non Specified reasons|5
324568|NCT00660595|1063502|P2|Overall Study|Participant left hospital|0
324569|NCT00660595|1063503|P1|Overall Study|Participant left hospital|1
324570|NCT00660595|1063502|P2|Overall Study|Did not consent to participate in study|8
324571|NCT00660595|1063503|P1|Overall Study|Did not consent to participate in study|12
324572|NCT00660595|1063502|P2|Overall Study|Lost to Follow-up|1
324573|NCT00660595|1063503|P1|Overall Study|Lost to Follow-up|0
324574|NCT00660400|1063564|P1|Overall Study|Withdrawal by Subject|1
324575|NCT00660400|1063564|P1|Overall Study|Intracranial hemorrhage|1
324576|NCT00660400|1063564|P1|Overall Study|Suboptimal organ function|1
324577|NCT00660400|1063564|P1|Overall Study|Lack of insurance approval|1
324578|NCT00660387|1063573|P2|Overall Study|Protocol Violation|0
324579|NCT00660387|1063574|P1|Overall Study|Protocol Violation|1
324580|NCT00660387|1063573|P2|Overall Study|Lack of Efficacy|1
324581|NCT00660387|1063574|P1|Overall Study|Lack of Efficacy|0
324582|NCT00660387|1063573|P2|Overall Study|Adverse Event|2
324583|NCT00660387|1063574|P1|Overall Study|Adverse Event|1
324584|NCT00660348|1063628|P2|Overall Study|Withdrawal by Subject|0
324585|NCT00660348|1063629|P1|Overall Study|Withdrawal by Subject|1
324586|NCT00660309|1063637|P2|Overall Study|Withdrawal by Subject|3
324587|NCT00660309|1063638|P1|Overall Study|Withdrawal by Subject|0
324588|NCT00660309|1063637|P2|Overall Study|Adverse Event|0
324589|NCT00660309|1063638|P1|Overall Study|Adverse Event|2
324590|NCT00660192|1063679|P2|Overall Study|Lost to Follow-up|3
324591|NCT00660192|1063680|P1|Overall Study|Lost to Follow-up|2
324592|NCT00660179|1063691|P3|Overall Study|Incorrect randomization|0
324593|NCT00660179|1063692|P2|Overall Study|Incorrect randomization|0
324594|NCT00660179|1063693|P1|Overall Study|Incorrect randomization|1
324595|NCT00660179|1063691|P3|Overall Study|Administrative reason|1
324596|NCT00660179|1063692|P2|Overall Study|Administrative reason|0
324597|NCT00660179|1063693|P1|Overall Study|Administrative reason|0
324598|NCT00660179|1063691|P3|Overall Study|Lost to Follow-up|2
324599|NCT00660179|1063692|P2|Overall Study|Lost to Follow-up|5
324600|NCT00660179|1063693|P1|Overall Study|Lost to Follow-up|7
324601|NCT00660179|1063691|P3|Overall Study|Withdrawal of consent|4
324602|NCT00660179|1063692|P2|Overall Study|Withdrawal of consent|6
324603|NCT00660179|1063693|P1|Overall Study|Withdrawal of consent|4
324604|NCT00660179|1063691|P3|Overall Study|Death|34
324605|NCT00660179|1063692|P2|Overall Study|Death|47
324606|NCT00660179|1063693|P1|Overall Study|Death|44
324607|NCT00660023|1063738|P1|Overall Study|Other Screening Failure|9
324608|NCT00660023|1063738|P1|Overall Study|Missed Pregnancy Test|1
324609|NCT00660023|1063738|P1|Overall Study|Withdrawal by Subject|1
324610|NCT00660023|1063738|P1|Overall Study|Renal Transplantation|3
324611|NCT00660023|1063738|P1|Overall Study|Blood Transfusion|5
324612|NCT00660023|1063738|P1|Overall Study|Death|8
324613|NCT00660023|1063738|P1|Overall Study|Adverse Event|2
324614|NCT00660010|1063749|P1|Overall Study|Noncompliance with visit schedule|3
324615|NCT00660010|1063749|P1|Overall Study|Adverse Event|1
324616|NCT00660010|1063749|P1|Overall Study|Lost to Follow-up|3
324617|NCT00660010|1063749|P1|Overall Study|Withdrawal by Subject|2
324618|NCT00659984|1063763|P1|Overall Study|Adverse Event|1
324619|NCT00659815|1063785|P2|Overall Study|Withdrawal by Subject|1
324620|NCT00659815|1063786|P1|Overall Study|Withdrawal by Subject|1
324621|NCT00659815|1063785|P2|Overall Study|Inability to maintain wearing schedule|2
324622|NCT00659815|1063786|P1|Overall Study|Inability to maintain wearing schedule|1
324623|NCT00659815|1063785|P2|Overall Study|Study related symptoms and complaints|1
324624|NCT00659815|1063786|P1|Overall Study|Study related symptoms and complaints|2
324625|NCT00659607|1063846|P1|Overall Study|Inconsistent BP measuring date|2
324626|NCT00659607|1063846|P1|Overall Study|No recorded efficacy data|15
324627|NCT00659607|1063846|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
324628|NCT00659607|1063846|P1|Overall Study|Unknown measuring date of blood pressure|85
324629|NCT00659607|1063846|P1|Overall Study|No blood pressure recorded|147
324630|NCT00659581|1063864|P1|Overall Study|Other|6393
324631|NCT00659581|1063864|P1|Overall Study|Lack of Efficacy|1183
324632|NCT00659581|1063864|P1|Overall Study|Adverse Event|1006
324633|NCT00659529|1063876|P1|Overall Study|Screen failure|9
324634|NCT00659529|1063876|P1|Overall Study|Protocol Violation|3
324635|NCT00659529|1063876|P1|Overall Study|Withdrawal by Subject|4
324636|NCT00659490|1063883|P3|Overall Study|Lost to Follow-up|1
324637|NCT00659490|1063884|P2|Overall Study|Lost to Follow-up|0
324638|NCT00659490|1063885|P1|Overall Study|Lost to Follow-up|2
324639|NCT00659438|1063958|P2|Overall Study|Lost to Follow-up|0
324640|NCT00659438|1063959|P1|Overall Study|Lost to Follow-up|1
324641|NCT00659438|1063958|P2|Overall Study|Death|6
324642|NCT00659438|1063959|P1|Overall Study|Death|11
324643|NCT00659438|1063958|P2|Overall Study|Withdrawal by Subject|2
324644|NCT00659438|1063959|P1|Overall Study|Withdrawal by Subject|2
324645|NCT00659373|1063983|P2|Overall Study|Assessment Missed|2
324646|NCT00659373|1063984|P1|Overall Study|Assessment Missed|2
324647|NCT00659373|1063983|P2|Overall Study|Withdrawal by Subject|5
324648|NCT00659373|1063984|P1|Overall Study|Withdrawal by Subject|3
324649|NCT00659334|1064005|P7|Overall Study|Screen Failure|1
324650|NCT00659334|1064006|P6|Overall Study|Screen Failure|0
324651|NCT00659334|1064007|P5|Overall Study|Screen Failure|0
324652|NCT00659334|1064008|P4|Overall Study|Screen Failure|0
324653|NCT00659334|1064009|P3|Overall Study|Screen Failure|0
324654|NCT00659334|1064010|P2|Overall Study|Screen Failure|5
324655|NCT00659334|1064011|P1|Overall Study|Screen Failure|8
324656|NCT00659269|1064038|P2|Overall Study|Physician Decision|1
324657|NCT00659269|1064039|P1|Overall Study|Physician Decision|1
324658|NCT00659230|1064069|P2|Overall Study|Did not return post-randomization|3
324659|NCT00659230|1064070|P1|Overall Study|Did not return post-randomization|2
324660|NCT00659230|1064069|P2|Overall Study|Lost source documentation|4
324661|NCT00659230|1064070|P1|Overall Study|Lost source documentation|5
324662|NCT00659230|1064069|P2|Overall Study|Lost to Follow-up|5
324663|NCT00659230|1064070|P1|Overall Study|Lost to Follow-up|2
324664|NCT00659061|1064093|P2|Overall Study|Migration due to political unrest|15
324665|NCT00659061|1064094|P1|Overall Study|Migration due to political unrest|21
324666|NCT00658996|1064112|P2|Second Intervention|Positive slit lamp finding|1
324667|NCT00658996|1064113|P1|Second Intervention|Positive slit lamp finding|0
324668|NCT00658996|1064112|P2|Second Intervention|Developed a stye on upper lid|0
324669|NCT00658996|1064113|P1|Second Intervention|Developed a stye on upper lid|1
324670|NCT00658996|1064112|P2|Crossover Period|Ineligible|1
324671|NCT00658996|1064113|P1|Crossover Period|Ineligible|1
324672|NCT00658996|1064112|P2|Crossover Period|Physician Decision|0
324673|NCT00658996|1064113|P1|Crossover Period|Physician Decision|1
324674|NCT00658996|1064112|P2|First Intervention|Lack of lenses|1
324675|NCT00658996|1064113|P1|First Intervention|Lack of lenses|0
324676|NCT00658996|1064112|P2|First Intervention|Positive slit lamp finding|0
324677|NCT00658996|1064113|P1|First Intervention|Positive slit lamp finding|1
324678|NCT00658814|1064125|P2|Maintenance Therapy|Not eligible|0
324679|NCT00658814|1064126|P1|Maintenance Therapy|Not eligible|1
324680|NCT00658814|1064125|P2|Maintenance Therapy|Not protocol specified|0
324681|NCT00658814|1064126|P1|Maintenance Therapy|Not protocol specified|1
324682|NCT00658814|1064125|P2|Maintenance Therapy|Adverse Event|1
324683|NCT00658814|1064126|P1|Maintenance Therapy|Adverse Event|1
324684|NCT00658814|1064125|P2|Consolidation Therapy|Not eligible|2
324685|NCT00658814|1064126|P1|Consolidation Therapy|Not eligible|2
324686|NCT00658814|1064125|P2|Consolidation Therapy|Not protocol specified|1
324687|NCT00658814|1064126|P1|Consolidation Therapy|Not protocol specified|0
324688|NCT00658814|1064125|P2|Remission Induction Chemotherapy|Not eligible|2
324689|NCT00658814|1064126|P1|Remission Induction Chemotherapy|Not eligible|1
324690|NCT00658814|1064125|P2|Remission Induction Chemotherapy|Not protocol specified|4
324691|NCT00658814|1064126|P1|Remission Induction Chemotherapy|Not protocol specified|2
324692|NCT00658814|1064125|P2|Remission Induction Chemotherapy|Death|4
324693|NCT00658814|1064126|P1|Remission Induction Chemotherapy|Death|1
324694|NCT00658814|1064125|P2|Remission Induction Chemotherapy|Progression/Relapse|1
324695|NCT00658814|1064126|P1|Remission Induction Chemotherapy|Progression/Relapse|0
324696|NCT00658814|1064125|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
324697|NCT00658814|1064126|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
324698|NCT00658814|1064125|P2|Remission Induction Chemotherapy|Adverse Event|3
324699|NCT00658814|1064126|P1|Remission Induction Chemotherapy|Adverse Event|1
324700|NCT00658788|1064140|P1|Overall Study|Treatment Discontinuation|32
324701|NCT00658788|1064140|P1|Overall Study|Lost to Follow-up|18
324702|NCT00658788|1064140|P1|Overall Study|Withdrawal by Subject|13
324703|NCT00658788|1064140|P1|Overall Study|Adverse Event|11
324704|NCT00658775|1064195|P2|Overall Study|Not specified|8
324705|NCT00658775|1064196|P1|Overall Study|Not specified|7
324706|NCT00658775|1064195|P2|Overall Study|Withdrawal of consent|7
324707|NCT00658775|1064196|P1|Overall Study|Withdrawal of consent|8
324708|NCT00658775|1064195|P2|Overall Study|Withdrawal by Subject|4
324709|NCT00658775|1064196|P1|Overall Study|Withdrawal by Subject|6
324710|NCT00658775|1064195|P2|Overall Study|Lost to Follow-up|18
324711|NCT00658775|1064196|P1|Overall Study|Lost to Follow-up|17
324712|NCT00658775|1064195|P2|Overall Study|Adverse Event|6
324713|NCT00658775|1064196|P1|Overall Study|Adverse Event|4
324714|NCT00658723|1064219|P3|Overall Study|Withdrawal by Subject|1
324715|NCT00658723|1064220|P2|Overall Study|Withdrawal by Subject|0
324716|NCT00658723|1064221|P1|Overall Study|Withdrawal by Subject|1
324717|NCT00658723|1064219|P3|Overall Study|Scheduling Issue|0
324718|NCT00658723|1064220|P2|Overall Study|Scheduling Issue|1
324719|NCT00658723|1064221|P1|Overall Study|Scheduling Issue|1
324720|NCT00658723|1064219|P3|Overall Study|Death|4
324721|NCT00658723|1064220|P2|Overall Study|Death|1
324722|NCT00658723|1064221|P1|Overall Study|Death|2
324723|NCT00658723|1064219|P3|Overall Study|Lost to Follow-up|2
324724|NCT00658723|1064220|P2|Overall Study|Lost to Follow-up|2
324725|NCT00658723|1064221|P1|Overall Study|Lost to Follow-up|0
324726|NCT00658684|1064259|P4|Overall Study|Pregnancy|0
324727|NCT00658684|1064260|P3|Overall Study|Pregnancy|0
324728|NCT00658684|1064261|P2|Overall Study|Pregnancy|1
324729|NCT00658684|1064262|P1|Overall Study|Pregnancy|1
324730|NCT00658684|1064259|P4|Overall Study|Protocol Violation|0
324731|NCT00658684|1064260|P3|Overall Study|Protocol Violation|0
324732|NCT00658684|1064261|P2|Overall Study|Protocol Violation|1
324733|NCT00658684|1064262|P1|Overall Study|Protocol Violation|1
324734|NCT00658684|1064259|P4|Overall Study|Lack of Efficacy|0
324735|NCT00658684|1064260|P3|Overall Study|Lack of Efficacy|0
324736|NCT00658684|1064261|P2|Overall Study|Lack of Efficacy|1
324737|NCT00658684|1064262|P1|Overall Study|Lack of Efficacy|1
324738|NCT00658684|1064259|P4|Overall Study|Withdrawal by Subject|1
324739|NCT00658684|1064260|P3|Overall Study|Withdrawal by Subject|1
324740|NCT00658684|1064261|P2|Overall Study|Withdrawal by Subject|4
324741|NCT00658684|1064262|P1|Overall Study|Withdrawal by Subject|6
324742|NCT00658684|1064259|P4|Overall Study|Adverse Event|0
324743|NCT00658684|1064260|P3|Overall Study|Adverse Event|2
324744|NCT00658684|1064261|P2|Overall Study|Adverse Event|8
324745|NCT00658684|1064262|P1|Overall Study|Adverse Event|10
324746|NCT00658658|1064317|P5|Overall Study|Other|1
324747|NCT00658658|1064318|P4|Overall Study|Other|0
324748|NCT00658658|1064319|P3|Overall Study|Other|0
324749|NCT00658658|1064320|P2|Overall Study|Other|0
324750|NCT00658658|1064321|P1|Overall Study|Other|0
324751|NCT00658658|1064317|P5|Overall Study|Protocol-specified Criteria|0
324752|NCT00658658|1064318|P4|Overall Study|Protocol-specified Criteria|0
324753|NCT00658658|1064319|P3|Overall Study|Protocol-specified Criteria|0
324754|NCT00658658|1064320|P2|Overall Study|Protocol-specified Criteria|0
324755|NCT00658658|1064321|P1|Overall Study|Protocol-specified Criteria|1
324756|NCT00658658|1064317|P5|Overall Study|Disease Progression|3
324757|NCT00658658|1064318|P4|Overall Study|Disease Progression|1
324758|NCT00658658|1064319|P3|Overall Study|Disease Progression|0
324759|NCT00658658|1064320|P2|Overall Study|Disease Progression|1
324760|NCT00658658|1064321|P1|Overall Study|Disease Progression|0
324761|NCT00658658|1064317|P5|Overall Study|Death|1
324762|NCT00658658|1064318|P4|Overall Study|Death|1
324763|NCT00658658|1064319|P3|Overall Study|Death|0
324764|NCT00658658|1064320|P2|Overall Study|Death|0
324765|NCT00658658|1064321|P1|Overall Study|Death|4
324766|NCT00658658|1064317|P5|Overall Study|Withdrawal by Subject|0
324767|NCT00658658|1064318|P4|Overall Study|Withdrawal by Subject|0
324768|NCT00658658|1064319|P3|Overall Study|Withdrawal by Subject|0
324769|NCT00658658|1064320|P2|Overall Study|Withdrawal by Subject|1
324770|NCT00658658|1064321|P1|Overall Study|Withdrawal by Subject|0
324771|NCT00658632|1064380|P2|Overall Study|Not specified|8
324772|NCT00658632|1064381|P1|Overall Study|Not specified|7
324773|NCT00658632|1064380|P2|Overall Study|Pregnancy|1
324774|NCT00658632|1064381|P1|Overall Study|Pregnancy|1
324775|NCT00658632|1064380|P2|Overall Study|Withdrawal of consent|14
324776|NCT00658632|1064381|P1|Overall Study|Withdrawal of consent|8
324777|NCT00658632|1064380|P2|Overall Study|Lack of Efficacy|1
324778|NCT00658632|1064381|P1|Overall Study|Lack of Efficacy|0
324779|NCT00658632|1064380|P2|Overall Study|Withdrawal by Subject|7
324780|NCT00658632|1064381|P1|Overall Study|Withdrawal by Subject|10
324781|NCT00658632|1064380|P2|Overall Study|Lost to Follow-up|23
324782|NCT00658632|1064381|P1|Overall Study|Lost to Follow-up|25
324783|NCT00658632|1064380|P2|Overall Study|Adverse Event|11
324784|NCT00658632|1064381|P1|Overall Study|Adverse Event|13
324785|NCT00658606|1064422|P2|Overall Study|Lack of Compliance|3
324786|NCT00658606|1064423|P1|Overall Study|Lack of Compliance|0
324787|NCT00658606|1064422|P2|Overall Study|Withdrawal by Subject|16
324788|NCT00658606|1064423|P1|Overall Study|Withdrawal by Subject|7
324789|NCT00658606|1064422|P2|Overall Study|Lost to Follow-up|0
324790|NCT00658606|1064423|P1|Overall Study|Lost to Follow-up|1
324791|NCT00658606|1064422|P2|Overall Study|Lack of Efficacy|3
324792|NCT00658606|1064423|P1|Overall Study|Lack of Efficacy|6
324793|NCT00658606|1064422|P2|Overall Study|Adverse Event|1
324794|NCT00658606|1064423|P1|Overall Study|Adverse Event|2
324795|NCT00658567|1064452|P3|Overall Study|At Discretion of Sponsor|1
324796|NCT00658567|1064453|P2|Overall Study|At Discretion of Sponsor|1
324797|NCT00658567|1064454|P1|Overall Study|At Discretion of Sponsor|1
324798|NCT00658567|1064452|P3|Overall Study|Physician Decision|0
324799|NCT00658567|1064453|P2|Overall Study|Physician Decision|1
324800|NCT00658567|1064454|P1|Overall Study|Physician Decision|0
324801|NCT00658567|1064452|P3|Overall Study|Voluntary Withdrawal of Consent|2
324802|NCT00658567|1064453|P2|Overall Study|Voluntary Withdrawal of Consent|0
324803|NCT00658567|1064454|P1|Overall Study|Voluntary Withdrawal of Consent|2
324804|NCT00658567|1064452|P3|Overall Study|Adverse Event|3
324805|NCT00658567|1064453|P2|Overall Study|Adverse Event|2
324806|NCT00658567|1064454|P1|Overall Study|Adverse Event|5
324807|NCT00658541|1064465|P2|Washout Period of 7 Days|Withdrawal by Subject|1
324808|NCT00658541|1064466|P1|Washout Period of 7 Days|Withdrawal by Subject|0
324809|NCT00658541|1064465|P2|Washout Period of 7 Days|Withdrawal by Subject|1
324810|NCT00658541|1064466|P1|Washout Period of 7 Days|Withdrawal by Subject|1
324811|NCT00658528|1064478|P2|Overall Study|Not specified|4
324812|NCT00658528|1064479|P1|Overall Study|Not specified|8
324813|NCT00658528|1064478|P2|Overall Study|Withdrawal of consent|6
324814|NCT00658528|1064479|P1|Overall Study|Withdrawal of consent|5
324815|NCT00658528|1064478|P2|Overall Study|Withdrawal by Subject|6
324816|NCT00658528|1064479|P1|Overall Study|Withdrawal by Subject|8
324817|NCT00658528|1064478|P2|Overall Study|Lost to Follow-up|22
324818|NCT00658528|1064479|P1|Overall Study|Lost to Follow-up|14
324819|NCT00658528|1064478|P2|Overall Study|Adverse Event|7
324820|NCT00658528|1064479|P1|Overall Study|Adverse Event|5
324821|NCT00658333|1064503|P2|Overall Study|Adverse Event|1
324822|NCT00658333|1064504|P1|Overall Study|Adverse Event|2
324823|NCT00658320|1064514|P2|Extension Study: After Month 24|Subject withdrew consent|0
324824|NCT00658320|1064515|P1|Extension Study: After Month 24|Subject withdrew consent|2
324825|NCT00658320|1064514|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
324826|NCT00658320|1064515|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
324827|NCT00658320|1064514|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
324828|NCT00658320|1064515|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
324829|NCT00658320|1064514|P2|Core Study: 12 Months|Subject withdrew consent|3
324830|NCT00658320|1064515|P1|Core Study: 12 Months|Subject withdrew consent|5
324831|NCT00657709|1064552|P5|Overall Study|Protocol Violation|2
324832|NCT00657709|1064553|P4|Overall Study|Protocol Violation|1
324833|NCT00657709|1064554|P3|Overall Study|Protocol Violation|0
324834|NCT00657709|1064555|P2|Overall Study|Protocol Violation|2
324835|NCT00657709|1064556|P1|Overall Study|Protocol Violation|0
324836|NCT00657709|1064552|P5|Overall Study|Lost to Follow-up|21
324837|NCT00657709|1064553|P4|Overall Study|Lost to Follow-up|1
324838|NCT00657709|1064554|P3|Overall Study|Lost to Follow-up|7
324839|NCT00657709|1064555|P2|Overall Study|Lost to Follow-up|9
324840|NCT00657709|1064556|P1|Overall Study|Lost to Follow-up|9
324841|NCT00657709|1064552|P5|Overall Study|Withdrawal by Subject|9
324842|NCT00657709|1064553|P4|Overall Study|Withdrawal by Subject|5
324843|NCT00657709|1064554|P3|Overall Study|Withdrawal by Subject|15
324844|NCT00657709|1064555|P2|Overall Study|Withdrawal by Subject|15
324845|NCT00657709|1064556|P1|Overall Study|Withdrawal by Subject|7
324846|NCT00657709|1064552|P5|Overall Study|AE or Death|1
324847|NCT00657709|1064553|P4|Overall Study|AE or Death|7
324848|NCT00657709|1064554|P3|Overall Study|AE or Death|6
324849|NCT00657709|1064555|P2|Overall Study|AE or Death|7
324850|NCT00657709|1064556|P1|Overall Study|AE or Death|7
324851|NCT00657553|1064607|P2|Overall Study|low accrual, no analysis run|5
324852|NCT00657553|1064608|P1|Overall Study|low accrual, no analysis run|5
324853|NCT00657371|1064614|P1|Overall Study|Pre-existing medical condition|4
324854|NCT00657371|1064614|P1|Overall Study|Device- related reasons|13
324855|NCT00657371|1064614|P1|Overall Study|Protocol Violation|2
324856|NCT00657371|1064614|P1|Overall Study|Unable to intubate the cecum|5
324857|NCT00657371|1064614|P1|Overall Study|Poor bowel preparation|15
324858|NCT00657358|1064619|P1|Overall Study|Lack of Efficacy|6
324859|NCT00657267|1064631|P1|Overall Study|Adverse Event|9
324860|NCT00657267|1064631|P1|Overall Study|Progressive disease|45
324861|NCT00657150|1064641|P2|Treatment|Not Specified|15
324862|NCT00657150|1064642|P1|Treatment|Not Specified|13
324863|NCT00657150|1064641|P2|Treatment|Withdrawal by Subject|20
324864|NCT00657150|1064642|P1|Treatment|Withdrawal by Subject|23
324865|NCT00657150|1064641|P2|Treatment|Lost to Follow-up|0
324866|NCT00657150|1064642|P1|Treatment|Lost to Follow-up|1
324867|NCT00657150|1064641|P2|Treatment|Non-compliant with protocol|9
324868|NCT00657150|1064642|P1|Treatment|Non-compliant with protocol|10
324869|NCT00657150|1064641|P2|Treatment|Adverse Event|53
324870|NCT00657150|1064642|P1|Treatment|Adverse Event|60
324871|NCT00657150|1064641|P2|Overall Study|Not Specified|38
324872|NCT00657150|1064642|P1|Overall Study|Not Specified|38
324873|NCT00657150|1064641|P2|Overall Study|Withdrawal by Subject|36
324874|NCT00657150|1064642|P1|Overall Study|Withdrawal by Subject|51
324875|NCT00657150|1064641|P2|Overall Study|Lost to Follow-up|0
324876|NCT00657150|1064642|P1|Overall Study|Lost to Follow-up|2
324877|NCT00657150|1064641|P2|Overall Study|Non-compliant with protocol|9
324878|NCT00657150|1064642|P1|Overall Study|Non-compliant with protocol|5
324879|NCT00657150|1064641|P2|Overall Study|Adverse Event|10
324880|NCT00657150|1064642|P1|Overall Study|Adverse Event|19
324881|NCT00657046|1064673|P3|Overall Study|Surgery|1
324882|NCT00657046|1064674|P2|Overall Study|Surgery|0
324883|NCT00657046|1064675|P1|Overall Study|Surgery|0
324884|NCT00657046|1064673|P3|Overall Study|Death|1
324885|NCT00657046|1064674|P2|Overall Study|Death|0
324886|NCT00657046|1064675|P1|Overall Study|Death|0
324887|NCT00657046|1064673|P3|Overall Study|Withdrawal by Subject|0
324888|NCT00657046|1064674|P2|Overall Study|Withdrawal by Subject|0
324889|NCT00657046|1064675|P1|Overall Study|Withdrawal by Subject|1
324890|NCT00657046|1064673|P3|Overall Study|Protocol Violation|0
324891|NCT00657046|1064674|P2|Overall Study|Protocol Violation|2
324892|NCT00657046|1064675|P1|Overall Study|Protocol Violation|2
324893|NCT00657046|1064673|P3|Overall Study|Adverse Event|0
324894|NCT00657046|1064674|P2|Overall Study|Adverse Event|1
324895|NCT00657046|1064675|P1|Overall Study|Adverse Event|1
324896|NCT00657020|1064707|P2|PERIOD 1|Adverse Event|1
324897|NCT00657020|1064708|P1|PERIOD 1|Adverse Event|0
324898|NCT00656851|1064758|P2|Overall Study|Withdrawal by Subject|4
324899|NCT00656851|1064759|P1|Overall Study|Withdrawal by Subject|0
324900|NCT00656799|1064781|P1|Overall Study|Death|2
324901|NCT00656669|1064803|P1|AC (Cycles 6-9)|Did not start segment 3|1
324902|NCT00656669|1064803|P1|AC (Cycles 6-9)|Adverse Event|1
324903|NCT00656669|1064803|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
324904|NCT00656669|1064803|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
324905|NCT00656617|1064842|P1|Overall Study|Move to different clinical trial|2
324906|NCT00656617|1064842|P1|Overall Study|Insurance Issues|2
324907|NCT00656617|1064842|P1|Overall Study|Death|2
324908|NCT00656617|1064842|P1|Overall Study|Adverse Event|1
324909|NCT00656474|1064876|P1|Overall Study|Other Reason|1
324910|NCT00656370|1064894|P1|Overall Study|Alternates|3
324911|NCT00656370|1064894|P1|Overall Study|Screen Failures|7
324912|NCT00656292|1064902|P2|Overall Study|Screen failure|2
324913|NCT00656292|1064903|P1|Overall Study|Screen failure|1
324914|NCT00656292|1064902|P2|Overall Study|Withdrawal by Subject|3
324915|NCT00656292|1064903|P1|Overall Study|Withdrawal by Subject|2
324916|NCT00656175|1064930|P2|Overall Study|Transportation issues|1
324917|NCT00656175|1064931|P1|Overall Study|Transportation issues|0
324918|NCT00656175|1064930|P2|Overall Study|Adverse Event|0
324919|NCT00656175|1064931|P1|Overall Study|Adverse Event|1
324920|NCT00656136|1064939|P2|Overall Study|Unknown and others|4
324921|NCT00656136|1064940|P1|Overall Study|Unknown and others|4
324922|NCT00656136|1064939|P2|Overall Study|Patient refused to take study medication|10
324923|NCT00656136|1064940|P1|Overall Study|Patient refused to take study medication|7
324924|NCT00656136|1064939|P2|Overall Study|Protocol Violation|3
324925|NCT00656136|1064940|P1|Overall Study|Protocol Violation|2
324926|NCT00656136|1064939|P2|Overall Study|Other Adverse Event|51
324927|NCT00656136|1064940|P1|Overall Study|Other Adverse Event|5
324928|NCT00656136|1064939|P2|Overall Study|Progressive disease|322
324929|NCT00656136|1064940|P1|Overall Study|Progressive disease|177
324930|NCT00656084|1064950|P1|Overall Study|Investigator Request|1
324931|NCT00656084|1064950|P1|Overall Study|Patient Request|1
324932|NCT00656084|1064950|P1|Overall Study|Withdrawal by Subject|1
324933|NCT00656084|1064950|P1|Overall Study|Adverse Event|4
324934|NCT00656058|1064957|P1|Overall Study|Withdrawal by Subject|4
324935|NCT00656058|1064957|P1|Overall Study|Withdrawal by Subject|2
324936|NCT00655889|1064966|P1|Overall Study|Protocol Violation|1
324937|NCT00655889|1064966|P1|Overall Study|Inadequate cell growth|1
324938|NCT00655863|1064974|P3|Overall Study|Lost to Follow-up|1
324939|NCT00655863|1064975|P2|Overall Study|Lost to Follow-up|0
324940|NCT00655863|1064976|P1|Overall Study|Lost to Follow-up|0
324941|NCT00655850|1065035|P1|Overall Study|Withdrawal by Subject|1
324942|NCT00655850|1065035|P1|Overall Study|Death|2
324943|NCT00655824|1065042|P1|Follow-up (FU) Period|Did Not Show for Scheduled FU Visit|1
324944|NCT00655824|1065042|P1|Follow-up (FU) Period|Physician Decision; Low B-cells|1
324945|NCT00655824|1065042|P1|Follow-up (FU) Period|Started Adalimumab Therapy|1
324946|NCT00655824|1065042|P1|Follow-up (FU) Period|Withdrawal by Subject|4
324947|NCT00655824|1065042|P1|Follow-up (FU) Period|Protocol Violation|59
324948|NCT00655824|1065042|P1|Treatment Period|Deterioration of Trial Disease|2
324949|NCT00655824|1065042|P1|Treatment Period|Withdrawal by Subject|4
324950|NCT00655824|1065042|P1|Treatment Period|Protocol Violation|1
324951|NCT00655824|1065042|P1|Treatment Period|Early Termination of Study by Sponsor|74
324952|NCT00655824|1065042|P1|Treatment Period|Adverse Event|3
324953|NCT00655746|1065086|P1|Overall Study|Withdrawal by Subject|1
324954|NCT00655733|1065105|P2|Overall Study|Physician Decision|1
324955|NCT00655733|1065106|P1|Overall Study|Physician Decision|0
324956|NCT00655733|1065105|P2|Overall Study|Withdrawal by Subject|3
324957|NCT00655733|1065106|P1|Overall Study|Withdrawal by Subject|3
324958|NCT00655733|1065105|P2|Overall Study|Adverse Event|2
324959|NCT00655733|1065106|P1|Overall Study|Adverse Event|2
324960|NCT00655733|1065105|P2|Overall Study|Lost to Follow-up|2
324961|NCT00655733|1065106|P1|Overall Study|Lost to Follow-up|2
324962|NCT00655668|1065112|P1|Overall Study|Withdrawal by Subject|2
324963|NCT00655668|1065112|P1|Overall Study|New Lymphoma Treatment Started|4
324964|NCT00655668|1065112|P1|Overall Study|Unspecified|1
324965|NCT00655668|1065112|P1|Overall Study|Study Terminated|9
324966|NCT00655668|1065112|P1|Overall Study|Disease Progression|27
324967|NCT00655668|1065112|P1|Overall Study|Death|5
324968|NCT00655668|1065112|P1|Overall Study|Adverse Event|6
324969|NCT00655629|1065139|P2|Overall Study|consent withdrawn|4
324970|NCT00655629|1065140|P1|Overall Study|consent withdrawn|6
324971|NCT00655629|1065139|P2|Overall Study|Protocol Violation|3
324972|NCT00655629|1065140|P1|Overall Study|Protocol Violation|5
324973|NCT00655629|1065139|P2|Overall Study|Lost to Follow-up|3
324974|NCT00655629|1065140|P1|Overall Study|Lost to Follow-up|4
324975|NCT00655629|1065139|P2|Overall Study|Lack of Efficacy|12
324976|NCT00655629|1065140|P1|Overall Study|Lack of Efficacy|2
324977|NCT00655629|1065139|P2|Overall Study|Adverse Event|1
324978|NCT00655629|1065140|P1|Overall Study|Adverse Event|4
324979|NCT00655564|1065176|P1|Overall Study|Desired Alternate Therapy|1
324980|NCT00655564|1065176|P1|Overall Study|Lost to Follow-up|1
324981|NCT00655564|1065176|P1|Overall Study|Adverse Event|1
324982|NCT00655551|1065184|P3|Period 4 (up to 7 Days)|Adverse Event|0
324983|NCT00655551|1065185|P2|Period 4 (up to 7 Days)|Adverse Event|2
324984|NCT00655551|1065186|P1|Period 4 (up to 7 Days)|Adverse Event|0
324985|NCT00655551|1065184|P3|Period 3 (up to 7 Days)|Adverse Event|4
324986|NCT00655551|1065185|P2|Period 3 (up to 7 Days)|Adverse Event|0
324987|NCT00655551|1065186|P1|Period 3 (up to 7 Days)|Adverse Event|0
324988|NCT00655551|1065184|P3|Period 2 (up to 7 Days)|Adverse Event|0
324989|NCT00655551|1065185|P2|Period 2 (up to 7 Days)|Adverse Event|1
324990|NCT00655551|1065186|P1|Period 2 (up to 7 Days)|Adverse Event|0
324991|NCT00655551|1065184|P3|All Periods Combined|Adverse Event|4
324992|NCT00655551|1065185|P2|All Periods Combined|Adverse Event|3
324993|NCT00655551|1065186|P1|All Periods Combined|Adverse Event|0
324994|NCT00655486|1065200|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
324995|NCT00655486|1065200|P1|Overall Study|Other: Could not tolerate BID dosing|1
324996|NCT00655486|1065200|P1|Overall Study|Other: Pregnancy|1
324997|NCT00655486|1065200|P1|Overall Study|Unsatisfactory compliance|2
324998|NCT00655486|1065200|P1|Overall Study|Protocol Violation|1
324999|NCT00655486|1065200|P1|Overall Study|Withdrawal by Subject|4
325000|NCT00655486|1065200|P1|Overall Study|Lack of Efficacy|8
325001|NCT00655486|1065200|P1|Overall Study|Adverse Event|10
325002|NCT00655356|1065207|P2|Overall Study|Other Reason|0
325003|NCT00655356|1065208|P1|Overall Study|Other Reason|1
325004|NCT00655356|1065207|P2|Overall Study|Protocol Violation|1
325005|NCT00655356|1065208|P1|Overall Study|Protocol Violation|2
325006|NCT00655356|1065207|P2|Overall Study|Adverse Event|1
325007|NCT00655356|1065208|P1|Overall Study|Adverse Event|1
325008|NCT00655356|1065207|P2|Overall Study|Sponsor Request|4
325009|NCT00655356|1065208|P1|Overall Study|Sponsor Request|10
325010|NCT00655356|1065207|P2|Overall Study|Withdrawal by Subject|4
325011|NCT00655356|1065208|P1|Overall Study|Withdrawal by Subject|3
325012|NCT00654940|1065259|P2|Period 1|Intolerable Pain Level|0
325013|NCT00654940|1065260|P1|Period 1|Intolerable Pain Level|1
325014|NCT00654940|1065259|P2|Period 1|Adverse Event|1
325015|NCT00654940|1065260|P1|Period 1|Adverse Event|0
325016|NCT00654901|1065284|P4|Overall Study|Withdrawal by Subject|0
325017|NCT00654901|1065285|P3|Overall Study|Withdrawal by Subject|1
325018|NCT00654901|1065286|P2|Overall Study|Withdrawal by Subject|0
325019|NCT00654901|1065287|P1|Overall Study|Withdrawal by Subject|3
325020|NCT00654901|1065284|P4|Overall Study|Lost to Follow-up|0
325021|NCT00654901|1065285|P3|Overall Study|Lost to Follow-up|1
325022|NCT00654901|1065286|P2|Overall Study|Lost to Follow-up|0
325023|NCT00654901|1065287|P1|Overall Study|Lost to Follow-up|1
325024|NCT00654875|1065307|P2|Overall Study|Administrative Problems|0
325025|NCT00654875|1065308|P1|Overall Study|Administrative Problems|1
325026|NCT00654875|1065307|P2|Overall Study|Abnormal Test Procedure Result(s)|0
325027|NCT00654875|1065308|P1|Overall Study|Abnormal Test Procedure Result(s)|1
325028|NCT00654875|1065307|P2|Overall Study|Lost to Follow-up|3
325029|NCT00654875|1065308|P1|Overall Study|Lost to Follow-up|1
325030|NCT00654875|1065307|P2|Overall Study|Lack of Efficacy|2
325031|NCT00654875|1065308|P1|Overall Study|Lack of Efficacy|2
325032|NCT00654875|1065307|P2|Overall Study|Protocol Violation|3
325033|NCT00654875|1065308|P1|Overall Study|Protocol Violation|3
325034|NCT00654875|1065307|P2|Overall Study|Withdrawal by Subject|4
325035|NCT00654875|1065308|P1|Overall Study|Withdrawal by Subject|4
325036|NCT00654875|1065307|P2|Overall Study|Adverse Event|5
325037|NCT00654875|1065308|P1|Overall Study|Adverse Event|5
325038|NCT00654745|1065335|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
325039|NCT00654745|1065335|P1|Overall Study|Withdrawal by Subject|10
325040|NCT00654745|1065335|P1|Overall Study|Protocol Violation|11
325041|NCT00654745|1065335|P1|Overall Study|Lost to Follow-up|7
325042|NCT00654745|1065335|P1|Overall Study|Adverse Event|12
325043|NCT00654641|1065380|P2|Overall Study|Lost to Follow-up|3
325044|NCT00654641|1065381|P1|Overall Study|Lost to Follow-up|2
325045|NCT00654628|1065387|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
325046|NCT00654628|1065387|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
325047|NCT00654628|1065387|P1|6-week Active Treatment Period|Out of window period|1
325048|NCT00654628|1065387|P1|6-week Active Treatment Period|Transferred to branch hospital|1
325049|NCT00654628|1065387|P1|6-week Active Treatment Period|Lost to Follow-up|10
325050|NCT00654628|1065387|P1|6-week Active Treatment Period|Adverse Event|9
325051|NCT00654498|1065425|P2|Overall Study|Other reason not defined above|5
325052|NCT00654498|1065426|P1|Overall Study|Other reason not defined above|4
325053|NCT00654498|1065425|P2|Overall Study|Withdrawal by Subject|0
325054|NCT00654498|1065426|P1|Overall Study|Withdrawal by Subject|1
325055|NCT00654498|1065425|P2|Overall Study|Lost to Follow-up|5
325056|NCT00654498|1065426|P1|Overall Study|Lost to Follow-up|1
325057|NCT00654498|1065425|P2|Overall Study|Protocol Violation|1
325058|NCT00654498|1065426|P1|Overall Study|Protocol Violation|1
325059|NCT00654498|1065425|P2|Overall Study|Adverse Event|1
325060|NCT00654498|1065426|P1|Overall Study|Adverse Event|6
325061|NCT00654498|1065425|P2|Overall Study|Not Treated|0
325062|NCT00654498|1065426|P1|Overall Study|Not Treated|1
325063|NCT00654420|1065458|P4|Phase II|Missing Disposition Record|0
325064|NCT00654420|1065459|P3|Phase II|Missing Disposition Record|1
325065|NCT00654420|1065460|P2|Phase II|Missing Disposition Record|0
325066|NCT00654420|1065461|P1|Phase II|Missing Disposition Record|0
325067|NCT00654420|1065458|P4|Phase II|Withdrawal by Subject|1
325068|NCT00654420|1065459|P3|Phase II|Withdrawal by Subject|4
325069|NCT00654420|1065460|P2|Phase II|Withdrawal by Subject|0
325070|NCT00654420|1065461|P1|Phase II|Withdrawal by Subject|0
325071|NCT00654420|1065458|P4|Phase II|Progressive Disease|29
325072|NCT00654420|1065459|P3|Phase II|Progressive Disease|29
325073|NCT00654420|1065460|P2|Phase II|Progressive Disease|0
325074|NCT00654420|1065461|P1|Phase II|Progressive Disease|0
325075|NCT00654420|1065458|P4|Phase II|Physician Decision|4
325076|NCT00654420|1065459|P3|Phase II|Physician Decision|0
325077|NCT00654420|1065460|P2|Phase II|Physician Decision|0
325078|NCT00654420|1065461|P1|Phase II|Physician Decision|0
325079|NCT00654420|1065458|P4|Phase II|Lost to Follow-up|1
325080|NCT00654420|1065459|P3|Phase II|Lost to Follow-up|0
325081|NCT00654420|1065460|P2|Phase II|Lost to Follow-up|0
325082|NCT00654420|1065461|P1|Phase II|Lost to Follow-up|0
325083|NCT00654420|1065458|P4|Phase II|Adverse Event|3
325084|NCT00654420|1065459|P3|Phase II|Adverse Event|3
325085|NCT00654420|1065460|P2|Phase II|Adverse Event|0
325086|NCT00654420|1065461|P1|Phase II|Adverse Event|0
325087|NCT00654420|1065458|P4|Phase I (Dose Escalation)|Progressive Disease|0
325088|NCT00654420|1065459|P3|Phase I (Dose Escalation)|Progressive Disease|0
325089|NCT00654420|1065460|P2|Phase I (Dose Escalation)|Progressive Disease|15
325090|NCT00654420|1065461|P1|Phase I (Dose Escalation)|Progressive Disease|4
325091|NCT00654420|1065458|P4|Phase I (Dose Escalation)|Adverse Event|0
325092|NCT00654420|1065459|P3|Phase I (Dose Escalation)|Adverse Event|0
325093|NCT00654420|1065460|P2|Phase I (Dose Escalation)|Adverse Event|1
325094|NCT00654420|1065461|P1|Phase I (Dose Escalation)|Adverse Event|0
325095|NCT00654381|1065487|P6|Extension Stage|Closure of the trial site|1
325096|NCT00654381|1065488|P5|Extension Stage|Closure of the trial site|1
325097|NCT00654381|1065489|P4|Extension Stage|Closure of the trial site|0
325098|NCT00654381|1065490|P3|Extension Stage|Closure of the trial site|0
325099|NCT00654381|1065491|P2|Extension Stage|Closure of the trial site|0
325100|NCT00654381|1065492|P1|Extension Stage|Closure of the trial site|0
325101|NCT00654381|1065487|P6|Extension Stage|Withdrawal by Subject|1
325102|NCT00654381|1065488|P5|Extension Stage|Withdrawal by Subject|1
325103|NCT00654381|1065489|P4|Extension Stage|Withdrawal by Subject|1
325104|NCT00654381|1065490|P3|Extension Stage|Withdrawal by Subject|1
325105|NCT00654381|1065491|P2|Extension Stage|Withdrawal by Subject|0
325106|NCT00654381|1065492|P1|Extension Stage|Withdrawal by Subject|0
325107|NCT00654381|1065487|P6|Extension Stage|Lack of Efficacy|0
325108|NCT00654381|1065488|P5|Extension Stage|Lack of Efficacy|0
325109|NCT00654381|1065489|P4|Extension Stage|Lack of Efficacy|0
325110|NCT00654381|1065490|P3|Extension Stage|Lack of Efficacy|1
325111|NCT00654381|1065491|P2|Extension Stage|Lack of Efficacy|0
325112|NCT00654381|1065492|P1|Extension Stage|Lack of Efficacy|0
325113|NCT00654381|1065487|P6|Extension Stage|Protocol Violation|0
325114|NCT00654381|1065488|P5|Extension Stage|Protocol Violation|0
325115|NCT00654381|1065489|P4|Extension Stage|Protocol Violation|1
325116|NCT00654381|1065490|P3|Extension Stage|Protocol Violation|0
325117|NCT00654381|1065491|P2|Extension Stage|Protocol Violation|0
325118|NCT00654381|1065492|P1|Extension Stage|Protocol Violation|0
325119|NCT00654381|1065487|P6|Extension Stage|Adverse Event|1
325120|NCT00654381|1065488|P5|Extension Stage|Adverse Event|1
325121|NCT00654381|1065489|P4|Extension Stage|Adverse Event|7
325122|NCT00654381|1065490|P3|Extension Stage|Adverse Event|9
325123|NCT00654381|1065491|P2|Extension Stage|Adverse Event|2
325124|NCT00654381|1065492|P1|Extension Stage|Adverse Event|1
325125|NCT00654381|1065487|P6|2nd Stage|Investigator's decision|0
325126|NCT00654381|1065488|P5|2nd Stage|Investigator's decision|0
325127|NCT00654381|1065489|P4|2nd Stage|Investigator's decision|1
325128|NCT00654381|1065490|P3|2nd Stage|Investigator's decision|1
325129|NCT00654381|1065491|P2|2nd Stage|Investigator's decision|0
325130|NCT00654381|1065492|P1|2nd Stage|Investigator's decision|0
325131|NCT00654381|1065487|P6|2nd Stage|Withdrawal by Subject|1
325132|NCT00654381|1065488|P5|2nd Stage|Withdrawal by Subject|1
325133|NCT00654381|1065489|P4|2nd Stage|Withdrawal by Subject|0
325134|NCT00654381|1065490|P3|2nd Stage|Withdrawal by Subject|0
325135|NCT00654381|1065491|P2|2nd Stage|Withdrawal by Subject|0
325136|NCT00654381|1065492|P1|2nd Stage|Withdrawal by Subject|0
325137|NCT00654381|1065487|P6|2nd Stage|Adverse Event|2
325138|NCT00654381|1065488|P5|2nd Stage|Adverse Event|7
325139|NCT00654381|1065489|P4|2nd Stage|Adverse Event|3
325140|NCT00654381|1065490|P3|2nd Stage|Adverse Event|2
325141|NCT00654381|1065491|P2|2nd Stage|Adverse Event|0
325142|NCT00654381|1065492|P1|2nd Stage|Adverse Event|2
325143|NCT00654381|1065487|P6|1st Stage|Investigator's decision|0
325144|NCT00654381|1065488|P5|1st Stage|Investigator's decision|0
325145|NCT00654381|1065489|P4|1st Stage|Investigator's decision|1
325146|NCT00654381|1065490|P3|1st Stage|Investigator's decision|0
325147|NCT00654381|1065491|P2|1st Stage|Investigator's decision|0
325148|NCT00654381|1065492|P1|1st Stage|Investigator's decision|0
325149|NCT00654381|1065487|P6|1st Stage|Withdrawal by Subject|1
325150|NCT00654381|1065488|P5|1st Stage|Withdrawal by Subject|0
325151|NCT00654381|1065489|P4|1st Stage|Withdrawal by Subject|1
325152|NCT00654381|1065490|P3|1st Stage|Withdrawal by Subject|0
325153|NCT00654381|1065491|P2|1st Stage|Withdrawal by Subject|0
325154|NCT00654381|1065492|P1|1st Stage|Withdrawal by Subject|0
325155|NCT00654381|1065487|P6|1st Stage|Adverse Event|1
325156|NCT00654381|1065488|P5|1st Stage|Adverse Event|2
325157|NCT00654381|1065489|P4|1st Stage|Adverse Event|3
325158|NCT00654381|1065490|P3|1st Stage|Adverse Event|3
325159|NCT00654381|1065491|P2|1st Stage|Adverse Event|3
325160|NCT00654381|1065492|P1|1st Stage|Adverse Event|3
325161|NCT00654368|1065529|P3|Overall Study|Adverse Event|6
325162|NCT00654368|1065530|P2|Overall Study|Adverse Event|9
325163|NCT00654368|1065531|P1|Overall Study|Adverse Event|14
325164|NCT00654368|1065529|P3|Overall Study|Other|3
325165|NCT00654368|1065530|P2|Overall Study|Other|2
325166|NCT00654368|1065531|P1|Overall Study|Other|0
325167|NCT00654368|1065529|P3|Overall Study|Pregnancy|2
325168|NCT00654368|1065530|P2|Overall Study|Pregnancy|0
325169|NCT00654368|1065531|P1|Overall Study|Pregnancy|0
325170|NCT00654368|1065529|P3|Overall Study|Death|0
325171|NCT00654368|1065530|P2|Overall Study|Death|0
325172|NCT00654368|1065531|P1|Overall Study|Death|1
325173|NCT00654368|1065529|P3|Overall Study|Physician Decision|2
325174|NCT00654368|1065530|P2|Overall Study|Physician Decision|0
325175|NCT00654368|1065531|P1|Overall Study|Physician Decision|0
325176|NCT00654368|1065529|P3|Overall Study|Requirement for alternative therapy|1
325177|NCT00654368|1065530|P2|Overall Study|Requirement for alternative therapy|1
325178|NCT00654368|1065531|P1|Overall Study|Requirement for alternative therapy|1
325179|NCT00654368|1065529|P3|Overall Study|Disease progression|13
325180|NCT00654368|1065530|P2|Overall Study|Disease progression|31
325181|NCT00654368|1065531|P1|Overall Study|Disease progression|21
325182|NCT00654368|1065529|P3|Overall Study|Withdrawal by Subject|2
325183|NCT00654368|1065530|P2|Overall Study|Withdrawal by Subject|2
325184|NCT00654368|1065531|P1|Overall Study|Withdrawal by Subject|5
325185|NCT00654368|1065529|P3|Overall Study|Non-compliance|2
325186|NCT00654368|1065530|P2|Overall Study|Non-compliance|1
325187|NCT00654368|1065531|P1|Overall Study|Non-compliance|2
325188|NCT00654368|1065529|P3|Overall Study|Protocol deviation|1
325189|NCT00654368|1065530|P2|Overall Study|Protocol deviation|2
325190|NCT00654368|1065531|P1|Overall Study|Protocol deviation|3
325191|NCT00654368|1065529|P3|Overall Study|Ineligibility determined|0
325192|NCT00654368|1065530|P2|Overall Study|Ineligibility determined|0
325193|NCT00654368|1065531|P1|Overall Study|Ineligibility determined|6
325194|NCT00654355|1065564|P2|Overall Study|Lost to Follow-up|2
325195|NCT00654355|1065565|P1|Overall Study|Lost to Follow-up|2
325196|NCT00654186|1065596|P1|Overall Study|Withdrawal by Subject|5
325197|NCT00654095|1065621|P1|Overall Study|Did not meet inclusion criteria|1
325198|NCT00654095|1065621|P1|Overall Study|Adverse reaction did not improve (5)|4
325199|NCT00654095|1065621|P1|Overall Study|Elevated alanine aminotransferase (4)|7
325200|NCT00654095|1065621|P1|Overall Study|Withdrawal by Subject|5
325201|NCT00654095|1065621|P1|Overall Study|Adverse Event|11
325202|NCT00654095|1065621|P1|Overall Study|Elevated alanine aminotransferase (3)|1
325203|NCT00654095|1065621|P1|Overall Study|Elevated triglyceride level (2)|1
325204|NCT00654095|1065621|P1|Overall Study|Drop in low density lipoprotein (1)|2
325205|NCT00654004|1065631|P2|Overall Study|Lost to Follow-up|0
325206|NCT00654004|1065632|P1|Overall Study|Lost to Follow-up|1
325207|NCT00653939|1065648|P2|Overall Study|Not Specified|6
325208|NCT00653939|1065649|P1|Overall Study|Not Specified|2
325209|NCT00653939|1065648|P2|Overall Study|Disease Progression|3
325210|NCT00653939|1065649|P1|Overall Study|Disease Progression|2
325211|NCT00653939|1065648|P2|Overall Study|Physician Decision|0
325212|NCT00653939|1065649|P1|Overall Study|Physician Decision|4
325213|NCT00653939|1065648|P2|Overall Study|Withdrawal by Subject|3
325214|NCT00653939|1065649|P1|Overall Study|Withdrawal by Subject|3
325215|NCT00653939|1065648|P2|Overall Study|Adverse Event|3
325216|NCT00653939|1065649|P1|Overall Study|Adverse Event|1
325217|NCT00653523|1065674|P1|Overall Study|Adverse reaction did not improve (4)|1
325218|NCT00653523|1065674|P1|Overall Study|Elevated alanine aminotransferase (3)|2
325219|NCT00653523|1065674|P1|Overall Study|Withdrawal by Subject|6
325220|NCT00653523|1065674|P1|Overall Study|Adverse Event|7
325221|NCT00653523|1065674|P1|Overall Study|Elevated creatine phosphokinase (2)|1
325222|NCT00653523|1065674|P1|Overall Study|Drop in low density lipoprotein (1)|2
325223|NCT00653328|1065678|P1|Overall Study|Drug manufacturer no longing making drug|2
325224|NCT00653328|1065678|P1|Overall Study|Disease progression|10
325225|NCT00653328|1065678|P1|Overall Study|Adverse Event|2
325226|NCT00653328|1065678|P1|Overall Study|Withdrawal by Subject|1
325227|NCT00653263|1065685|P1|Overall Study|Physician Decision|1
325228|NCT00653263|1065685|P1|Overall Study|Withdrawal by Subject|1
325229|NCT00653224|1065693|P2|Overall Study|Other|4
325230|NCT00653224|1065694|P1|Overall Study|Other|2
325231|NCT00653224|1065693|P2|Overall Study|Lost to Follow-up|0
325232|NCT00653224|1065694|P1|Overall Study|Lost to Follow-up|1
325233|NCT00653224|1065693|P2|Overall Study|Loss of efficacy|0
325234|NCT00653224|1065694|P1|Overall Study|Loss of efficacy|1
325235|NCT00653224|1065693|P2|Overall Study|Lack of Efficacy|2
325236|NCT00653224|1065694|P1|Overall Study|Lack of Efficacy|1
325237|NCT00653224|1065693|P2|Overall Study|Adverse Event|1
325238|NCT00653224|1065694|P1|Overall Study|Adverse Event|2
325239|NCT00653159|1065880|P2|Overall Study|Lost to Follow-up|2
325240|NCT00653159|1065881|P1|Overall Study|Lost to Follow-up|1
325241|NCT00653159|1065880|P2|Overall Study|Adverse Event|1
325242|NCT00653159|1065881|P1|Overall Study|Adverse Event|4
325243|NCT00653068|1065908|P1|Overall Study|Ineligible|2
325244|NCT00653068|1065908|P1|Overall Study|Withdrawal by Subject|1
325245|NCT00653068|1065908|P1|Overall Study|Physician Decision|4
325246|NCT00653068|1065908|P1|Overall Study|Lack of Efficacy|34
325247|NCT00653068|1065908|P1|Overall Study|Death|9
325248|NCT00652938|1065922|P3|Overall Study|fear of blood sampling|0
325249|NCT00652938|1065923|P2|Overall Study|fear of blood sampling|1
325250|NCT00652938|1065924|P1|Overall Study|fear of blood sampling|0
325251|NCT00652938|1065922|P3|Overall Study|Lost to Follow-up|2
325252|NCT00652938|1065923|P2|Overall Study|Lost to Follow-up|0
325253|NCT00652938|1065924|P1|Overall Study|Lost to Follow-up|0
325254|NCT00652938|1065922|P3|Overall Study|Withdrawal by Subject|1
325255|NCT00652938|1065923|P2|Overall Study|Withdrawal by Subject|6
325256|NCT00652938|1065924|P1|Overall Study|Withdrawal by Subject|0
325257|NCT00652938|1065922|P3|Overall Study|Adverse Event|2
325258|NCT00652938|1065923|P2|Overall Study|Adverse Event|0
325259|NCT00652938|1065924|P1|Overall Study|Adverse Event|1
325260|NCT00652899|1065989|P1|Overall Study|Treating physician decision|1
325261|NCT00652899|1065989|P1|Overall Study|Death|1
325262|NCT00652834|1065999|P1|Overall Study|Lost to Follow-up|2
325263|NCT00652834|1065999|P1|Overall Study|Withdrawal by Subject|3
325264|NCT00652626|1066010|P7|Extension Phase|Death|1
325265|NCT00652626|1066011|P6|Extension Phase|Death|1
325266|NCT00652626|1066012|P5|Extension Phase|Death|0
325267|NCT00652626|1066013|P4|Extension Phase|Death|0
325268|NCT00652626|1066014|P3|Extension Phase|Death|0
325269|NCT00652626|1066015|P2|Extension Phase|Death|0
325270|NCT00652626|1066016|P1|Extension Phase|Death|0
325271|NCT00652626|1066010|P7|Extension Phase|Physician Decision|1
325272|NCT00652626|1066011|P6|Extension Phase|Physician Decision|1
325273|NCT00652626|1066012|P5|Extension Phase|Physician Decision|0
325274|NCT00652626|1066013|P4|Extension Phase|Physician Decision|0
325275|NCT00652626|1066014|P3|Extension Phase|Physician Decision|0
325276|NCT00652626|1066015|P2|Extension Phase|Physician Decision|0
325277|NCT00652626|1066016|P1|Extension Phase|Physician Decision|0
325278|NCT00652626|1066010|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
325279|NCT00652626|1066011|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
325280|NCT00652626|1066012|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
325281|NCT00652626|1066013|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
325282|NCT00652626|1066014|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
325283|NCT00652626|1066015|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
325284|NCT00652626|1066016|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
325285|NCT00652626|1066010|P7|Extension Phase|Adverse Event|1
325286|NCT00652626|1066011|P6|Extension Phase|Adverse Event|2
325287|NCT00652626|1066012|P5|Extension Phase|Adverse Event|0
325288|NCT00652626|1066013|P4|Extension Phase|Adverse Event|0
325289|NCT00652626|1066014|P3|Extension Phase|Adverse Event|0
325290|NCT00652626|1066015|P2|Extension Phase|Adverse Event|0
325291|NCT00652626|1066016|P1|Extension Phase|Adverse Event|0
325292|NCT00652626|1066010|P7|Extension Phase|Withdrawal by Subject|0
325293|NCT00652626|1066011|P6|Extension Phase|Withdrawal by Subject|2
325294|NCT00652626|1066012|P5|Extension Phase|Withdrawal by Subject|0
325295|NCT00652626|1066013|P4|Extension Phase|Withdrawal by Subject|0
325296|NCT00652626|1066014|P3|Extension Phase|Withdrawal by Subject|0
325297|NCT00652626|1066015|P2|Extension Phase|Withdrawal by Subject|0
325298|NCT00652626|1066016|P1|Extension Phase|Withdrawal by Subject|0
325299|NCT00652626|1066010|P7|Initial Treatment Phase|Lost to Follow-up|0
325300|NCT00652626|1066011|P6|Initial Treatment Phase|Lost to Follow-up|0
325301|NCT00652626|1066012|P5|Initial Treatment Phase|Lost to Follow-up|1
325302|NCT00652626|1066013|P4|Initial Treatment Phase|Lost to Follow-up|0
325303|NCT00652626|1066014|P3|Initial Treatment Phase|Lost to Follow-up|0
325304|NCT00652626|1066015|P2|Initial Treatment Phase|Lost to Follow-up|0
325305|NCT00652626|1066016|P1|Initial Treatment Phase|Lost to Follow-up|0
325306|NCT00652626|1066010|P7|Initial Treatment Phase|Sponsor Request|0
325307|NCT00652626|1066011|P6|Initial Treatment Phase|Sponsor Request|0
325308|NCT00652626|1066012|P5|Initial Treatment Phase|Sponsor Request|0
325309|NCT00652626|1066013|P4|Initial Treatment Phase|Sponsor Request|0
325310|NCT00652626|1066014|P3|Initial Treatment Phase|Sponsor Request|1
325311|NCT00652626|1066015|P2|Initial Treatment Phase|Sponsor Request|0
325312|NCT00652626|1066016|P1|Initial Treatment Phase|Sponsor Request|0
325313|NCT00652626|1066010|P7|Initial Treatment Phase|Physician Decision|0
325314|NCT00652626|1066011|P6|Initial Treatment Phase|Physician Decision|0
325315|NCT00652626|1066012|P5|Initial Treatment Phase|Physician Decision|1
325316|NCT00652626|1066013|P4|Initial Treatment Phase|Physician Decision|0
325317|NCT00652626|1066014|P3|Initial Treatment Phase|Physician Decision|0
325318|NCT00652626|1066015|P2|Initial Treatment Phase|Physician Decision|0
325319|NCT00652626|1066016|P1|Initial Treatment Phase|Physician Decision|0
325320|NCT00652626|1066010|P7|Initial Treatment Phase|Protocol Violation|0
325321|NCT00652626|1066011|P6|Initial Treatment Phase|Protocol Violation|0
325322|NCT00652626|1066012|P5|Initial Treatment Phase|Protocol Violation|0
325323|NCT00652626|1066013|P4|Initial Treatment Phase|Protocol Violation|1
325324|NCT00652626|1066014|P3|Initial Treatment Phase|Protocol Violation|0
325325|NCT00652626|1066015|P2|Initial Treatment Phase|Protocol Violation|0
325326|NCT00652626|1066016|P1|Initial Treatment Phase|Protocol Violation|0
325327|NCT00652626|1066010|P7|Initial Treatment Phase|Adverse Event|0
325328|NCT00652626|1066011|P6|Initial Treatment Phase|Adverse Event|0
325329|NCT00652626|1066012|P5|Initial Treatment Phase|Adverse Event|1
325330|NCT00652626|1066013|P4|Initial Treatment Phase|Adverse Event|0
325331|NCT00652626|1066014|P3|Initial Treatment Phase|Adverse Event|0
325332|NCT00652626|1066015|P2|Initial Treatment Phase|Adverse Event|0
325333|NCT00652626|1066016|P1|Initial Treatment Phase|Adverse Event|0
325334|NCT00652366|1066085|P5|Overall Study|Not specified|0
325335|NCT00652366|1066086|P4|Overall Study|Not specified|4
325336|NCT00652366|1066087|P3|Overall Study|Not specified|3
325337|NCT00652366|1066088|P2|Overall Study|Not specified|2
325338|NCT00652366|1066089|P1|Overall Study|Not specified|5
325339|NCT00652366|1066085|P5|Overall Study|Refused treatment|5
325340|NCT00652366|1066086|P4|Overall Study|Refused treatment|17
325341|NCT00652366|1066087|P3|Overall Study|Refused treatment|6
325342|NCT00652366|1066088|P2|Overall Study|Refused treatment|7
325343|NCT00652366|1066089|P1|Overall Study|Refused treatment|3
325344|NCT00652366|1066085|P5|Overall Study|Protocol Violation|0
325345|NCT00652366|1066086|P4|Overall Study|Protocol Violation|0
325346|NCT00652366|1066087|P3|Overall Study|Protocol Violation|0
325347|NCT00652366|1066088|P2|Overall Study|Protocol Violation|0
325348|NCT00652366|1066089|P1|Overall Study|Protocol Violation|1
325349|NCT00652366|1066085|P5|Overall Study|Violation of Selection Criteria|0
325350|NCT00652366|1066086|P4|Overall Study|Violation of Selection Criteria|0
325351|NCT00652366|1066087|P3|Overall Study|Violation of Selection Criteria|1
325352|NCT00652366|1066088|P2|Overall Study|Violation of Selection Criteria|0
325353|NCT00652366|1066089|P1|Overall Study|Violation of Selection Criteria|0
325354|NCT00652366|1066085|P5|Overall Study|Lack of Efficacy|13
325355|NCT00652366|1066086|P4|Overall Study|Lack of Efficacy|133
325356|NCT00652366|1066087|P3|Overall Study|Lack of Efficacy|53
325357|NCT00652366|1066088|P2|Overall Study|Lack of Efficacy|58
325358|NCT00652366|1066089|P1|Overall Study|Lack of Efficacy|84
325359|NCT00652366|1066085|P5|Overall Study|Death|5
325360|NCT00652366|1066086|P4|Overall Study|Death|8
325361|NCT00652366|1066087|P3|Overall Study|Death|1
325362|NCT00652366|1066088|P2|Overall Study|Death|4
325363|NCT00652366|1066089|P1|Overall Study|Death|5
325364|NCT00652366|1066085|P5|Overall Study|Adverse Event|13
325365|NCT00652366|1066086|P4|Overall Study|Adverse Event|17
325366|NCT00652366|1066087|P3|Overall Study|Adverse Event|7
325367|NCT00652366|1066088|P2|Overall Study|Adverse Event|4
325368|NCT00652366|1066089|P1|Overall Study|Adverse Event|8
325369|NCT00652340|1066124|P2|Overall Study|Had not progressed.|3
325370|NCT00652340|1066125|P1|Overall Study|Had not progressed.|4
325371|NCT00652327|1066135|P2|Overall Study|Lost to Follow-up|3
325372|NCT00652327|1066136|P1|Overall Study|Lost to Follow-up|0
325373|NCT00652327|1066135|P2|Overall Study|Adverse Event|2
325374|NCT00652327|1066136|P1|Overall Study|Adverse Event|0
325375|NCT00652093|1066178|P6|Overall Study|Physician Decision|0
325376|NCT00652093|1066179|P5|Overall Study|Physician Decision|1
325377|NCT00652093|1066180|P4|Overall Study|Physician Decision|0
325378|NCT00652093|1066181|P3|Overall Study|Physician Decision|0
325379|NCT00652093|1066182|P2|Overall Study|Physician Decision|0
325380|NCT00652093|1066183|P1|Overall Study|Physician Decision|0
325381|NCT00652093|1066178|P6|Overall Study|Withdrawal by Subject|0
325382|NCT00652093|1066179|P5|Overall Study|Withdrawal by Subject|1
325383|NCT00652093|1066180|P4|Overall Study|Withdrawal by Subject|0
325384|NCT00652093|1066181|P3|Overall Study|Withdrawal by Subject|1
325385|NCT00652093|1066182|P2|Overall Study|Withdrawal by Subject|0
325386|NCT00652093|1066183|P1|Overall Study|Withdrawal by Subject|0
325387|NCT00652028|1066267|P4|Overall Study|Physician Decision|0
325388|NCT00652028|1066268|P3|Overall Study|Physician Decision|1
325389|NCT00652028|1066269|P2|Overall Study|Physician Decision|0
325390|NCT00652028|1066270|P1|Overall Study|Physician Decision|0
325391|NCT00652028|1066267|P4|Overall Study|No Longer Meets Entry Criteria|0
325392|NCT00652028|1066268|P3|Overall Study|No Longer Meets Entry Criteria|0
325393|NCT00652028|1066269|P2|Overall Study|No Longer Meets Entry Criteria|1
325394|NCT00652028|1066270|P1|Overall Study|No Longer Meets Entry Criteria|0
325395|NCT00652028|1066267|P4|Overall Study|Adverse Event|0
325396|NCT00652028|1066268|P3|Overall Study|Adverse Event|0
325397|NCT00652028|1066269|P2|Overall Study|Adverse Event|0
325398|NCT00652028|1066270|P1|Overall Study|Adverse Event|1
325399|NCT00651924|1066314|P2|Overall Study|Withdrawal by Subject|5
325400|NCT00651924|1066315|P1|Overall Study|Withdrawal by Subject|0
325401|NCT00651924|1066314|P2|Overall Study|Withdrawal by PI|2
325402|NCT00651924|1066315|P1|Overall Study|Withdrawal by PI|0
325403|NCT00651820|1066321|P1|Overall Study|Lost to Follow-up|2
325404|NCT00651755|1066328|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
325405|NCT00651755|1066329|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
325406|NCT00651755|1066328|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
325407|NCT00651755|1066329|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
325408|NCT00651313|1066374|P2|Overall Study|Adminstrative Discontinuation|3
325409|NCT00651313|1066375|P1|Overall Study|Adminstrative Discontinuation|2
325410|NCT00651313|1066374|P2|Overall Study|Lost to Follow-up|1
325411|NCT00651313|1066375|P1|Overall Study|Lost to Follow-up|1
325412|NCT00651313|1066374|P2|Overall Study|Withdrawal by Subject|1
325413|NCT00651313|1066375|P1|Overall Study|Withdrawal by Subject|3
325414|NCT00651313|1066374|P2|Overall Study|Adverse Event|1
325415|NCT00651313|1066375|P1|Overall Study|Adverse Event|0
325416|NCT00651261|1066383|P2|Overall Study|Never treated|3
325417|NCT00651261|1066384|P1|Overall Study|Never treated|5
325418|NCT00651261|1066383|P2|Overall Study|Other disease or participant decisions|23
325419|NCT00651261|1066384|P1|Overall Study|Other disease or participant decisions|23
325420|NCT00651261|1066383|P2|Overall Study|Alternative therapy|107
325421|NCT00651261|1066384|P1|Overall Study|Alternative therapy|109
325422|NCT00651261|1066383|P2|Overall Study|Disease progression|58
325423|NCT00651261|1066384|P1|Overall Study|Disease progression|58
325424|NCT00651261|1066383|P2|Overall Study|Induction failure|35
325425|NCT00651261|1066384|P1|Overall Study|Induction failure|24
325426|NCT00651261|1066383|P2|Overall Study|Withdrawal by Subject|40
325427|NCT00651261|1066384|P1|Overall Study|Withdrawal by Subject|22
325428|NCT00651261|1066383|P2|Overall Study|Death|18
325429|NCT00651261|1066384|P1|Overall Study|Death|18
325430|NCT00651261|1066383|P2|Overall Study|Adverse Event|22
325431|NCT00651261|1066384|P1|Overall Study|Adverse Event|32
325432|NCT00651183|1066400|P2|Overall Study|missing|0
325433|NCT00651183|1066401|P1|Overall Study|missing|1
325434|NCT00651183|1066400|P2|Overall Study|Other reasons|2
325435|NCT00651183|1066401|P1|Overall Study|Other reasons|4
325436|NCT00651183|1066400|P2|Overall Study|Lost to Follow-up|1
325437|NCT00651183|1066401|P1|Overall Study|Lost to Follow-up|3
325438|NCT00651183|1066400|P2|Overall Study|Withdrawal by Subject|3
325439|NCT00651183|1066401|P1|Overall Study|Withdrawal by Subject|6
325440|NCT00651183|1066400|P2|Overall Study|Tolerability insufficient +Patients wish|1
325441|NCT00651183|1066401|P1|Overall Study|Tolerability insufficient +Patients wish|0
325442|NCT00651183|1066400|P2|Overall Study|Tolerability insufficient|2
325443|NCT00651183|1066401|P1|Overall Study|Tolerability insufficient|5
325444|NCT00651183|1066400|P2|Overall Study|Efficacy insufficient + patients wish|1
325445|NCT00651183|1066401|P1|Overall Study|Efficacy insufficient + patients wish|0
325446|NCT00651183|1066400|P2|Overall Study|Lack of Efficacy|0
325447|NCT00651183|1066401|P1|Overall Study|Lack of Efficacy|1
325448|NCT00651157|1066413|P1|Overall Study|Protocol Violation|1
325449|NCT00651157|1066413|P1|Overall Study|Death|1
325450|NCT00651118|1066423|P4|Overall Study|Withdrawal by Subject|1
325451|NCT00651118|1066424|P3|Overall Study|Withdrawal by Subject|1
325452|NCT00651118|1066425|P2|Overall Study|Withdrawal by Subject|1
325453|NCT00651118|1066426|P1|Overall Study|Withdrawal by Subject|0
325454|NCT00651118|1066423|P4|Overall Study|administrative|1
325455|NCT00651118|1066424|P3|Overall Study|administrative|2
325456|NCT00651118|1066425|P2|Overall Study|administrative|4
325457|NCT00651118|1066426|P1|Overall Study|administrative|1
325458|NCT00651118|1066423|P4|Overall Study|Lost to Follow-up|2
325459|NCT00651118|1066424|P3|Overall Study|Lost to Follow-up|1
325460|NCT00651118|1066425|P2|Overall Study|Lost to Follow-up|0
325461|NCT00651118|1066426|P1|Overall Study|Lost to Follow-up|2
325462|NCT00651118|1066423|P4|Overall Study|Protocol Violation|2
325463|NCT00651118|1066424|P3|Overall Study|Protocol Violation|6
325464|NCT00651118|1066425|P2|Overall Study|Protocol Violation|2
325465|NCT00651118|1066426|P1|Overall Study|Protocol Violation|2
325466|NCT00651118|1066423|P4|Overall Study|Adverse Event|1
325467|NCT00651118|1066424|P3|Overall Study|Adverse Event|1
325468|NCT00651118|1066425|P2|Overall Study|Adverse Event|0
325469|NCT00651118|1066426|P1|Overall Study|Adverse Event|4
325470|NCT00650845|1066474|P2|Overall Study|Protocol Violation|13
325471|NCT00650845|1066475|P1|Overall Study|Protocol Violation|0
325472|NCT00650845|1066474|P2|Overall Study|Withdrawal by Subject|0
325473|NCT00650845|1066475|P1|Overall Study|Withdrawal by Subject|5
325474|NCT00650806|1066495|P4|Overall Study|Not specified|0
325475|NCT00650806|1066496|P3|Overall Study|Not specified|2
325476|NCT00650806|1066497|P2|Overall Study|Not specified|1
325477|NCT00650806|1066498|P1|Overall Study|Not specified|1
325478|NCT00650806|1066495|P4|Overall Study|Study terminated by sponsor|4
325479|NCT00650806|1066496|P3|Overall Study|Study terminated by sponsor|5
325480|NCT00650806|1066497|P2|Overall Study|Study terminated by sponsor|3
325481|NCT00650806|1066498|P1|Overall Study|Study terminated by sponsor|2
325482|NCT00650806|1066495|P4|Overall Study|Noncompliance with study drug regimen|0
325483|NCT00650806|1066496|P3|Overall Study|Noncompliance with study drug regimen|0
325484|NCT00650806|1066497|P2|Overall Study|Noncompliance with study drug regimen|1
325485|NCT00650806|1066498|P1|Overall Study|Noncompliance with study drug regimen|1
325486|NCT00650806|1066495|P4|Overall Study|Withdrawal by Subject|6
325487|NCT00650806|1066496|P3|Overall Study|Withdrawal by Subject|8
325488|NCT00650806|1066497|P2|Overall Study|Withdrawal by Subject|5
325489|NCT00650806|1066498|P1|Overall Study|Withdrawal by Subject|7
325490|NCT00650806|1066495|P4|Overall Study|Pregnancy|1
325491|NCT00650806|1066496|P3|Overall Study|Pregnancy|0
325492|NCT00650806|1066497|P2|Overall Study|Pregnancy|0
325493|NCT00650806|1066498|P1|Overall Study|Pregnancy|0
325494|NCT00650806|1066495|P4|Overall Study|Protocol Violation|1
325495|NCT00650806|1066496|P3|Overall Study|Protocol Violation|0
325496|NCT00650806|1066497|P2|Overall Study|Protocol Violation|0
325497|NCT00650806|1066498|P1|Overall Study|Protocol Violation|0
325498|NCT00650806|1066495|P4|Overall Study|Lost to Follow-up|10
325499|NCT00650806|1066496|P3|Overall Study|Lost to Follow-up|11
325500|NCT00650806|1066497|P2|Overall Study|Lost to Follow-up|6
325501|NCT00650806|1066498|P1|Overall Study|Lost to Follow-up|7
325502|NCT00650806|1066495|P4|Overall Study|Adverse Event|4
325503|NCT00650806|1066496|P3|Overall Study|Adverse Event|3
325504|NCT00650806|1066497|P2|Overall Study|Adverse Event|5
325505|NCT00650806|1066498|P1|Overall Study|Adverse Event|0
325506|NCT00650767|1066540|P4|Overall Study|Other|0
325507|NCT00650767|1066541|P3|Overall Study|Other|0
325508|NCT00650767|1066542|P2|Overall Study|Other|1
325509|NCT00650767|1066543|P1|Overall Study|Other|1
325510|NCT00650767|1066540|P4|Overall Study|Lost to Follow-up|0
325511|NCT00650767|1066541|P3|Overall Study|Lost to Follow-up|1
325512|NCT00650767|1066542|P2|Overall Study|Lost to Follow-up|1
325513|NCT00650767|1066543|P1|Overall Study|Lost to Follow-up|1
325514|NCT00650767|1066540|P4|Overall Study|Withdrawal by Subject|3
325515|NCT00650767|1066541|P3|Overall Study|Withdrawal by Subject|3
325516|NCT00650767|1066542|P2|Overall Study|Withdrawal by Subject|4
325517|NCT00650767|1066543|P1|Overall Study|Withdrawal by Subject|2
325518|NCT00650767|1066540|P4|Overall Study|Death|0
325519|NCT00650767|1066541|P3|Overall Study|Death|0
325520|NCT00650767|1066542|P2|Overall Study|Death|0
325521|NCT00650767|1066543|P1|Overall Study|Death|1
325522|NCT00650767|1066540|P4|Overall Study|Adverse Event|8
325523|NCT00650767|1066541|P3|Overall Study|Adverse Event|10
325524|NCT00650767|1066542|P2|Overall Study|Adverse Event|3
325525|NCT00650767|1066543|P1|Overall Study|Adverse Event|0
325526|NCT00650585|1067047|P2|Overall Study|Excluded/ruled ineligible|129
325527|NCT00650585|1067048|P1|Overall Study|Excluded/ruled ineligible|357
325528|NCT00650585|1067047|P2|Overall Study|No parental consent|866
325529|NCT00650585|1067048|P1|Overall Study|No parental consent|935
325530|NCT00650585|1067047|P2|Overall Study|Lost to Follow-up|482
325531|NCT00650585|1067048|P1|Overall Study|Lost to Follow-up|505
325532|NCT00650104|1067092|P1|Overall Study|Sponsor Terminated Dosing|1
325533|NCT00650104|1067092|P1|Overall Study|Non-compliance|2
325534|NCT00650104|1067092|P1|Overall Study|Lost to Follow-up|1
325535|NCT00650104|1067092|P1|Overall Study|Physician Decision|7
325536|NCT00650104|1067092|P1|Overall Study|Withdrawal by Subject|11
325537|NCT00650104|1067092|P1|Overall Study|Death|2
325538|NCT00650104|1067092|P1|Overall Study|Adverse Event|17
325539|NCT00650091|1067107|P3|Amended Study Design|Not specified|0
325540|NCT00650091|1067108|P2|Amended Study Design|Not specified|3
325541|NCT00650091|1067109|P1|Amended Study Design|Not specified|1
325542|NCT00650091|1067107|P3|Amended Study Design|Lung transplantation|0
325543|NCT00650091|1067108|P2|Amended Study Design|Lung transplantation|2
325544|NCT00650091|1067109|P1|Amended Study Design|Lung transplantation|4
325545|NCT00650091|1067107|P3|Amended Study Design|Adverse Event|0
325546|NCT00650091|1067108|P2|Amended Study Design|Adverse Event|4
325547|NCT00650091|1067109|P1|Amended Study Design|Adverse Event|1
325548|NCT00650091|1067107|P3|Amended Study Design|Physician Decision|0
325549|NCT00650091|1067108|P2|Amended Study Design|Physician Decision|0
325550|NCT00650091|1067109|P1|Amended Study Design|Physician Decision|5
325551|NCT00650091|1067107|P3|Amended Study Design|Withdrawal by Subject|0
325552|NCT00650091|1067108|P2|Amended Study Design|Withdrawal by Subject|11
325553|NCT00650091|1067109|P1|Amended Study Design|Withdrawal by Subject|12
325554|NCT00649428|1067152|P2|Overall Study|Physician Decision|1
325555|NCT00649428|1067153|P1|Overall Study|Physician Decision|0
325556|NCT00649428|1067152|P2|Overall Study|Protocol Violation|2
325557|NCT00649428|1067153|P1|Overall Study|Protocol Violation|6
325558|NCT00649428|1067152|P2|Overall Study|Insufficient manufacturing yield|1
325559|NCT00649428|1067153|P1|Overall Study|Insufficient manufacturing yield|5
325560|NCT00649428|1067152|P2|Overall Study|Lost to Follow-up|3
325561|NCT00649428|1067153|P1|Overall Study|Lost to Follow-up|1
325562|NCT00649428|1067152|P2|Overall Study|Withdrawal by Subject|6
325563|NCT00649428|1067153|P1|Overall Study|Withdrawal by Subject|6
325564|NCT00649428|1067152|P2|Overall Study|Adverse Event|2
325565|NCT00649428|1067153|P1|Overall Study|Adverse Event|2
325566|NCT00649389|1067169|P4|Overall Study|Other|6
325567|NCT00649389|1067170|P3|Overall Study|Other|1
325568|NCT00649389|1067171|P2|Overall Study|Other|9
325569|NCT00649389|1067172|P1|Overall Study|Other|3
325570|NCT00649389|1067169|P4|Overall Study|Withdrawal by Subject|23
325571|NCT00649389|1067170|P3|Overall Study|Withdrawal by Subject|19
325572|NCT00649389|1067171|P2|Overall Study|Withdrawal by Subject|21
325573|NCT00649389|1067172|P1|Overall Study|Withdrawal by Subject|20
325574|NCT00649389|1067169|P4|Overall Study|Protocol Violation|8
325575|NCT00649389|1067170|P3|Overall Study|Protocol Violation|9
325576|NCT00649389|1067171|P2|Overall Study|Protocol Violation|13
325577|NCT00649389|1067172|P1|Overall Study|Protocol Violation|11
325578|NCT00649389|1067169|P4|Overall Study|Lost to Follow-up|26
325579|NCT00649389|1067170|P3|Overall Study|Lost to Follow-up|21
325580|NCT00649389|1067171|P2|Overall Study|Lost to Follow-up|17
325581|NCT00649389|1067172|P1|Overall Study|Lost to Follow-up|15
325582|NCT00649389|1067169|P4|Overall Study|Adverse Event|48
325583|NCT00649389|1067170|P3|Overall Study|Adverse Event|38
325584|NCT00649389|1067171|P2|Overall Study|Adverse Event|46
325585|NCT00649389|1067172|P1|Overall Study|Adverse Event|22
325586|NCT00649220|1067194|P1|Overall Study|Withdrawal by Subject|1
325587|NCT00649220|1067194|P1|Overall Study|Adverse Event|2
325588|NCT00648895|1067215|P2|Overall Study|Lack of Efficacy|1
325589|NCT00648895|1067216|P1|Overall Study|Lack of Efficacy|0
325590|NCT00648167|1067222|P1|Overall Study|unable to swallow tablets|1
325591|NCT00648167|1067222|P1|Overall Study|Adverse Event|6
325592|NCT00648037|1067242|P1|Overall Study|Other|1
325593|NCT00648037|1067242|P1|Overall Study|Relapse|2
325594|NCT00648037|1067242|P1|Overall Study|Adverse Event|11
325595|NCT00648037|1067242|P1|Overall Study|Withdrawal by Subject|1
325596|NCT00648037|1067242|P1|Overall Study|Not Treated|1
325597|NCT00647699|1067261|P2|Overall Study|Withdrawal by Subject|8
325598|NCT00647699|1067262|P1|Overall Study|Withdrawal by Subject|3
325599|NCT00647699|1067261|P2|Overall Study|Lost to Follow-up|4
325600|NCT00647699|1067262|P1|Overall Study|Lost to Follow-up|5
325601|NCT00647556|1067270|P2|Overall Study|Surgery for pre-existing neck pain|0
325602|NCT00647556|1067271|P1|Overall Study|Surgery for pre-existing neck pain|1
325603|NCT00647556|1067270|P2|Overall Study|Withdrawal by Subject|0
325604|NCT00647556|1067271|P1|Overall Study|Withdrawal by Subject|1
325605|NCT00647556|1067270|P2|Overall Study|Protocol Violation|1
325606|NCT00647556|1067271|P1|Overall Study|Protocol Violation|0
325607|NCT00647556|1067270|P2|Overall Study|Lost to Follow-up|0
325608|NCT00647556|1067271|P1|Overall Study|Lost to Follow-up|1
325609|NCT00647556|1067270|P2|Overall Study|Adverse Event|1
325610|NCT00647556|1067271|P1|Overall Study|Adverse Event|0
325611|NCT00647270|1067301|P3|Period 2, Placebo Switched to Adalimumab|Other|0
325612|NCT00647270|1067302|P2|Period 2, Placebo Switched to Adalimumab|Other|6
325613|NCT00647270|1067303|P1|Period 2, Placebo Switched to Adalimumab|Other|2
325614|NCT00647270|1067301|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
325615|NCT00647270|1067302|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
325616|NCT00647270|1067303|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
325617|NCT00647270|1067301|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
325618|NCT00647270|1067302|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
325619|NCT00647270|1067303|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
325620|NCT00647270|1067301|P3|Period 1, Placebo-control (12 Weeks)|Other|8
325621|NCT00647270|1067302|P2|Period 1, Placebo-control (12 Weeks)|Other|4
325622|NCT00647270|1067303|P1|Period 1, Placebo-control (12 Weeks)|Other|4
325623|NCT00647270|1067301|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
325624|NCT00647270|1067302|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
325625|NCT00647270|1067303|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
325626|NCT00647270|1067301|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
325627|NCT00647270|1067302|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
325628|NCT00647270|1067303|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
325629|NCT00647270|1067301|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
325630|NCT00647270|1067302|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
325631|NCT00647270|1067303|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
325632|NCT00646958|1067329|P3|Overall Study|Did not receive study drug|2
325633|NCT00646958|1067330|P2|Overall Study|Did not receive study drug|0
325634|NCT00646958|1067331|P1|Overall Study|Did not receive study drug|2
325635|NCT00646958|1067329|P3|Overall Study|Withdrawal by Subject|0
325636|NCT00646958|1067330|P2|Overall Study|Withdrawal by Subject|2
325637|NCT00646958|1067331|P1|Overall Study|Withdrawal by Subject|1
325638|NCT00646958|1067329|P3|Overall Study|Abnormal screening lab tests|0
325639|NCT00646958|1067330|P2|Overall Study|Abnormal screening lab tests|1
325640|NCT00646958|1067331|P1|Overall Study|Abnormal screening lab tests|1
325641|NCT00646958|1067329|P3|Overall Study|Protocol Violation|0
325642|NCT00646958|1067330|P2|Overall Study|Protocol Violation|1
325643|NCT00646958|1067331|P1|Overall Study|Protocol Violation|1
325644|NCT00646958|1067329|P3|Overall Study|Lost to Follow-up|7
325645|NCT00646958|1067330|P2|Overall Study|Lost to Follow-up|5
325646|NCT00646958|1067331|P1|Overall Study|Lost to Follow-up|1
325647|NCT00646958|1067329|P3|Overall Study|Adverse Event|0
325648|NCT00646958|1067330|P2|Overall Study|Adverse Event|0
325649|NCT00646958|1067331|P1|Overall Study|Adverse Event|4
325650|NCT00646958|1067329|P3|Overall Study|Lack of Efficacy|0
325651|NCT00646958|1067330|P2|Overall Study|Lack of Efficacy|0
325652|NCT00646958|1067331|P1|Overall Study|Lack of Efficacy|1
325653|NCT00646776|1067344|P2|Overall Study|Investigator discretion|4
325654|NCT00646776|1067345|P1|Overall Study|Investigator discretion|0
325655|NCT00646776|1067344|P2|Overall Study|Adverse Event|9
325656|NCT00646776|1067345|P1|Overall Study|Adverse Event|1
325657|NCT00646399|1067443|P2|Overall Study|Other Reason|11
325658|NCT00646399|1067444|P1|Overall Study|Other Reason|11
325659|NCT00646399|1067443|P2|Overall Study|Withdrawal by Subject|10
325660|NCT00646399|1067444|P1|Overall Study|Withdrawal by Subject|9
325661|NCT00646399|1067443|P2|Overall Study|Death|53
325662|NCT00646399|1067444|P1|Overall Study|Death|63
325663|NCT00646282|1067452|P2|Overall Study|Protocol terminated|4
325664|NCT00646282|1067453|P1|Overall Study|Protocol terminated|4
325665|NCT00645944|1067476|P2|Received Medication|Protocol Violation|1
325666|NCT00645944|1067477|P1|Received Medication|Protocol Violation|2
325667|NCT00645944|1067476|P2|Received Medication|Lost to Follow-up|0
325668|NCT00645944|1067477|P1|Received Medication|Lost to Follow-up|1
325669|NCT00645944|1067476|P2|Received Medication|Withdrawal by Subject|1
325670|NCT00645944|1067477|P1|Received Medication|Withdrawal by Subject|1
325671|NCT00645944|1067476|P2|Received Medication|Adverse Event|1
325672|NCT00645944|1067477|P1|Received Medication|Adverse Event|2
325673|NCT00645944|1067476|P2|Randomized|Withdrawal by Subject|2
325674|NCT00645944|1067477|P1|Randomized|Withdrawal by Subject|1
325675|NCT00645853|1067485|P2|Overall Study|recall of ICF, planned operation, death|4
325676|NCT00645853|1067486|P1|Overall Study|recall of ICF, planned operation, death|7
325677|NCT00645853|1067485|P2|Overall Study|Discontinuation criteria|2
325678|NCT00645853|1067486|P1|Overall Study|Discontinuation criteria|2
325679|NCT00645853|1067485|P2|Overall Study|Protocol Violation|2
325680|NCT00645853|1067486|P1|Overall Study|Protocol Violation|0
325681|NCT00645853|1067485|P2|Overall Study|Withdrawal by Subject|2
325682|NCT00645853|1067486|P1|Overall Study|Withdrawal by Subject|5
325683|NCT00645853|1067485|P2|Overall Study|AZ study closure in Hungary|40
325684|NCT00645853|1067486|P1|Overall Study|AZ study closure in Hungary|60
325685|NCT00645853|1067485|P2|Overall Study|Adverse Event|7
325686|NCT00645853|1067486|P1|Overall Study|Adverse Event|18
325687|NCT00645788|1067517|P4|Overall Study|Pulmonary exacerbation|9
325688|NCT00645788|1067518|P3|Overall Study|Pulmonary exacerbation|11
325689|NCT00645788|1067519|P2|Overall Study|Pulmonary exacerbation|16
325690|NCT00645788|1067520|P1|Overall Study|Pulmonary exacerbation|13
325691|NCT00645788|1067517|P4|Overall Study|Withdrawal by Subject|2
325692|NCT00645788|1067518|P3|Overall Study|Withdrawal by Subject|0
325693|NCT00645788|1067519|P2|Overall Study|Withdrawal by Subject|1
325694|NCT00645788|1067520|P1|Overall Study|Withdrawal by Subject|0
325695|NCT00645788|1067517|P4|Overall Study|Protocol Violation|0
325696|NCT00645788|1067518|P3|Overall Study|Protocol Violation|2
325697|NCT00645788|1067519|P2|Overall Study|Protocol Violation|0
325698|NCT00645788|1067520|P1|Overall Study|Protocol Violation|1
325699|NCT00645788|1067517|P4|Overall Study|Lost to Follow-up|0
325700|NCT00645788|1067518|P3|Overall Study|Lost to Follow-up|0
325701|NCT00645788|1067519|P2|Overall Study|Lost to Follow-up|0
325702|NCT00645788|1067520|P1|Overall Study|Lost to Follow-up|1
325703|NCT00645788|1067517|P4|Overall Study|Adverse Event|3
325704|NCT00645788|1067518|P3|Overall Study|Adverse Event|5
325705|NCT00645788|1067519|P2|Overall Study|Adverse Event|9
325706|NCT00645788|1067520|P1|Overall Study|Adverse Event|4
325707|NCT00645788|1067517|P4|Overall Study|Did not receive study drug|0
325708|NCT00645788|1067518|P3|Overall Study|Did not receive study drug|0
325709|NCT00645788|1067519|P2|Overall Study|Did not receive study drug|1
325710|NCT00645788|1067520|P1|Overall Study|Did not receive study drug|1
325711|NCT00645671|1067578|P2|Overall Study|Physician Decision|1
325712|NCT00645671|1067579|P1|Overall Study|Physician Decision|0
325713|NCT00645671|1067578|P2|Overall Study|Adverse Event|1
325714|NCT00645671|1067579|P1|Overall Study|Adverse Event|0
325715|NCT00645671|1067578|P2|Overall Study|Withdrawal by Subject|4
325716|NCT00645671|1067579|P1|Overall Study|Withdrawal by Subject|0
325717|NCT00645671|1067578|P2|Overall Study|Protocol Violation|0
325718|NCT00645671|1067579|P1|Overall Study|Protocol Violation|1
325719|NCT00645593|1067593|P2|Overall Study|Later found to be ineligible|0
325720|NCT00645593|1067594|P1|Overall Study|Later found to be ineligible|1
325721|NCT00645567|1067606|P1|Overall Study|Adverse Event|1
325722|NCT00645528|1067614|P1|Overall Study|Did not show up for Visit 2|7
325723|NCT00645411|1067627|P4|Overall Study|Unable to classify|4
325724|NCT00645411|1067628|P3|Overall Study|Unable to classify|3
325725|NCT00645411|1067629|P2|Overall Study|Unable to classify|0
325726|NCT00645411|1067630|P1|Overall Study|Unable to classify|0
325727|NCT00645411|1067627|P4|Overall Study|Inappropriate enrollment|1
325728|NCT00645411|1067628|P3|Overall Study|Inappropriate enrollment|4
325729|NCT00645411|1067629|P2|Overall Study|Inappropriate enrollment|0
325730|NCT00645411|1067630|P1|Overall Study|Inappropriate enrollment|0
325731|NCT00645411|1067627|P4|Overall Study|Protocol Violation|0
325732|NCT00645411|1067628|P3|Overall Study|Protocol Violation|1
325733|NCT00645411|1067629|P2|Overall Study|Protocol Violation|0
325734|NCT00645411|1067630|P1|Overall Study|Protocol Violation|1
325735|NCT00645411|1067627|P4|Overall Study|Lost to Follow-up|75
325736|NCT00645411|1067628|P3|Overall Study|Lost to Follow-up|124
325737|NCT00645411|1067629|P2|Overall Study|Lost to Follow-up|5
325738|NCT00645411|1067630|P1|Overall Study|Lost to Follow-up|10
325739|NCT00645411|1067627|P4|Overall Study|Withdrawal by Subject|21
325740|NCT00645411|1067628|P3|Overall Study|Withdrawal by Subject|19
325741|NCT00645411|1067629|P2|Overall Study|Withdrawal by Subject|1
325742|NCT00645411|1067630|P1|Overall Study|Withdrawal by Subject|2
325743|NCT00645411|1067627|P4|Overall Study|Adverse Event|2
325744|NCT00645411|1067628|P3|Overall Study|Adverse Event|0
325745|NCT00645411|1067629|P2|Overall Study|Adverse Event|0
325746|NCT00645411|1067630|P1|Overall Study|Adverse Event|0
325747|NCT00645164|1067672|P1|Overall Study|Protocol Violation|1
325748|NCT00645164|1067672|P1|Overall Study|Withdrawal by Subject|4
325749|NCT00645164|1067672|P1|Overall Study|Lost to Follow-up|2
325750|NCT00645099|1067678|P2|Overall Study|Other|5
325751|NCT00645099|1067679|P1|Overall Study|Other|9
325752|NCT00645099|1067678|P2|Overall Study|Adverse Event|5
325753|NCT00645099|1067679|P1|Overall Study|Adverse Event|11
325754|NCT00645099|1067678|P2|Overall Study|Lost to Follow-up|4
325755|NCT00645099|1067679|P1|Overall Study|Lost to Follow-up|6
325756|NCT00645099|1067678|P2|Overall Study|Withdrawal by Subject|22
325757|NCT00645099|1067679|P1|Overall Study|Withdrawal by Subject|30
325758|NCT00645099|1067678|P2|Overall Study|Lack of Efficacy|6
325759|NCT00645099|1067679|P1|Overall Study|Lack of Efficacy|15
325760|NCT00644995|1067748|P2|Overall Study|Refused|0
325761|NCT00644995|1067749|P1|Overall Study|Refused|1
325762|NCT00644995|1067748|P2|Overall Study|Lost to Follow-up|4
325763|NCT00644995|1067749|P1|Overall Study|Lost to Follow-up|1
325764|NCT00644969|1067769|P2|Post Treatment Phase|Unspecified|0
325765|NCT00644969|1067770|P1|Post Treatment Phase|Unspecified|1
325766|NCT00644969|1067769|P2|Post Treatment Phase|Lost to Follow-up|1
325767|NCT00644969|1067770|P1|Post Treatment Phase|Lost to Follow-up|4
325768|NCT00644969|1067769|P2|Post Treatment Phase|Withdrawal by Subject|2
325769|NCT00644969|1067770|P1|Post Treatment Phase|Withdrawal by Subject|4
325770|NCT00644969|1067769|P2|Post Treatment Phase|Death|0
325771|NCT00644969|1067770|P1|Post Treatment Phase|Death|1
325772|NCT00644969|1067769|P2|Treatment Phase|Unspecified|1
325773|NCT00644969|1067770|P1|Treatment Phase|Unspecified|4
325774|NCT00644969|1067769|P2|Treatment Phase|Lost to Follow-up|2
325775|NCT00644969|1067770|P1|Treatment Phase|Lost to Follow-up|2
325776|NCT00644969|1067769|P2|Treatment Phase|Withdrawal by Subject|0
325777|NCT00644969|1067770|P1|Treatment Phase|Withdrawal by Subject|4
325778|NCT00644969|1067769|P2|Treatment Phase|Adverse Event|0
325779|NCT00644969|1067770|P1|Treatment Phase|Adverse Event|3
325780|NCT00644969|1067769|P2|Treatment Phase|Randomized, not treated|0
325781|NCT00644969|1067770|P1|Treatment Phase|Randomized, not treated|1
325782|NCT00644917|1067816|P1|Overall Study|Withdrawal by Subject|2
325783|NCT00644787|1067824|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
325784|NCT00644787|1067825|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
325785|NCT00644787|1067826|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
325786|NCT00644787|1067824|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
325787|NCT00644787|1067825|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
325788|NCT00644787|1067826|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
325789|NCT00644787|1067824|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
325790|NCT00644787|1067825|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
325791|NCT00644787|1067826|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
325792|NCT00644787|1067824|P3|Period 2: Double Blind Phase|Adverse Event|4
325793|NCT00644787|1067825|P2|Period 2: Double Blind Phase|Adverse Event|2
325794|NCT00644787|1067826|P1|Period 2: Double Blind Phase|Adverse Event|0
325795|NCT00644787|1067824|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
325796|NCT00644787|1067825|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
325797|NCT00644787|1067826|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
325798|NCT00644787|1067824|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
325799|NCT00644787|1067825|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
325800|NCT00644787|1067826|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
325801|NCT00644787|1067824|P3|Period 1: Titration Phase|Worsening of symptoms|0
325802|NCT00644787|1067825|P2|Period 1: Titration Phase|Worsening of symptoms|0
325803|NCT00644787|1067826|P1|Period 1: Titration Phase|Worsening of symptoms|1
325804|NCT00644787|1067824|P3|Period 1: Titration Phase|Worsening of complications|0
325805|NCT00644787|1067825|P2|Period 1: Titration Phase|Worsening of complications|0
325806|NCT00644787|1067826|P1|Period 1: Titration Phase|Worsening of complications|1
325807|NCT00644787|1067824|P3|Period 1: Titration Phase|Worsening of underlying disease|0
325808|NCT00644787|1067825|P2|Period 1: Titration Phase|Worsening of underlying disease|0
325809|NCT00644787|1067826|P1|Period 1: Titration Phase|Worsening of underlying disease|5
325810|NCT00644787|1067824|P3|Period 1: Titration Phase|Physician Decision|0
325811|NCT00644787|1067825|P2|Period 1: Titration Phase|Physician Decision|0
325812|NCT00644787|1067826|P1|Period 1: Titration Phase|Physician Decision|1
325813|NCT00644787|1067824|P3|Period 1: Titration Phase|Withdrawal by Subject|0
325814|NCT00644787|1067825|P2|Period 1: Titration Phase|Withdrawal by Subject|0
325815|NCT00644787|1067826|P1|Period 1: Titration Phase|Withdrawal by Subject|2
325816|NCT00644787|1067824|P3|Period 1: Titration Phase|Adverse Event|0
325817|NCT00644787|1067825|P2|Period 1: Titration Phase|Adverse Event|0
325818|NCT00644787|1067826|P1|Period 1: Titration Phase|Adverse Event|11
325819|NCT00644332|1067868|P1|Overall Study|Could Not Attend Scheduled Visits|1
325820|NCT00644332|1067868|P1|Overall Study|Did Not Meet Eligibility Requirements|1
325821|NCT00644332|1067868|P1|Overall Study|Completion Status Unknown|2
325822|NCT00644332|1067868|P1|Overall Study|Withdrawal by Subject|6
325823|NCT00644332|1067868|P1|Overall Study|Adverse Event|11
325824|NCT00644059|1067911|P3|Overall Study|Unable to classify|3
325825|NCT00644059|1067912|P2|Overall Study|Unable to classify|2
325826|NCT00644059|1067913|P1|Overall Study|Unable to classify|6
325827|NCT00644059|1067911|P3|Overall Study|Protocol Deviation/violation|15
325828|NCT00644059|1067912|P2|Overall Study|Protocol Deviation/violation|19
325829|NCT00644059|1067913|P1|Overall Study|Protocol Deviation/violation|20
325830|NCT00644059|1067911|P3|Overall Study|Inappropriate Enrollment|0
325831|NCT00644059|1067912|P2|Overall Study|Inappropriate Enrollment|3
325832|NCT00644059|1067913|P1|Overall Study|Inappropriate Enrollment|1
325833|NCT00644059|1067911|P3|Overall Study|Adverse Event|1
325834|NCT00644059|1067912|P2|Overall Study|Adverse Event|5
325835|NCT00644059|1067913|P1|Overall Study|Adverse Event|8
325836|NCT00644059|1067911|P3|Overall Study|Withdrawal by Subject|30
325837|NCT00644059|1067912|P2|Overall Study|Withdrawal by Subject|60
325838|NCT00644059|1067913|P1|Overall Study|Withdrawal by Subject|52
325839|NCT00644059|1067911|P3|Overall Study|Lost to Follow-up|16
325840|NCT00644059|1067912|P2|Overall Study|Lost to Follow-up|34
325841|NCT00644059|1067913|P1|Overall Study|Lost to Follow-up|37
325842|NCT00643201|1067999|P2|Completed Study Follow Up|non-specified|0
325843|NCT00643201|1068000|P1|Completed Study Follow Up|non-specified|1
325844|NCT00643201|1067999|P2|Completed Study Follow Up|Lost to Follow-up|16
325845|NCT00643201|1068000|P1|Completed Study Follow Up|Lost to Follow-up|18
325846|NCT00643201|1067999|P2|Completed Study Follow Up|Withdrawal by Subject|29
325847|NCT00643201|1068000|P1|Completed Study Follow Up|Withdrawal by Subject|23
325848|NCT00643201|1067999|P2|Completed Study Follow Up|Death|34
325849|NCT00643201|1068000|P1|Completed Study Follow Up|Death|28
325850|NCT00643201|1067999|P2|Randomized, Completed 6 Months of Study|not specified|107
325851|NCT00643201|1068000|P1|Randomized, Completed 6 Months of Study|not specified|107
325852|NCT00643201|1067999|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
325853|NCT00643201|1068000|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
325854|NCT00643201|1067999|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
325855|NCT00643201|1068000|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
325856|NCT00643201|1067999|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
325857|NCT00643201|1068000|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
325858|NCT00643201|1067999|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
325859|NCT00643201|1068000|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
325860|NCT00643201|1067999|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
325861|NCT00643201|1068000|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
325862|NCT00643201|1067999|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
325863|NCT00643201|1068000|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
325864|NCT00643201|1067999|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
325865|NCT00643201|1068000|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
325866|NCT00643201|1067999|P2|Randomized, Completed 6 Months of Study|Death|26
325867|NCT00643201|1068000|P1|Randomized, Completed 6 Months of Study|Death|20
325868|NCT00643916|1068052|P6|Overall Study|Not Vaccinated|0
325869|NCT00643916|1068053|P5|Overall Study|Not Vaccinated|2
325870|NCT00643916|1068054|P4|Overall Study|Not Vaccinated|0
325871|NCT00643916|1068055|P3|Overall Study|Not Vaccinated|3
325872|NCT00643916|1068056|P2|Overall Study|Not Vaccinated|2
325873|NCT00643916|1068057|P1|Overall Study|Not Vaccinated|2
325874|NCT00643916|1068052|P6|Overall Study|Withdrawal by Subject|1
325875|NCT00643916|1068053|P5|Overall Study|Withdrawal by Subject|0
325876|NCT00643916|1068054|P4|Overall Study|Withdrawal by Subject|1
325877|NCT00643916|1068055|P3|Overall Study|Withdrawal by Subject|2
325878|NCT00643916|1068056|P2|Overall Study|Withdrawal by Subject|2
325879|NCT00643916|1068057|P1|Overall Study|Withdrawal by Subject|2
325880|NCT00643916|1068052|P6|Overall Study|Lost to Follow-up|0
325881|NCT00643916|1068053|P5|Overall Study|Lost to Follow-up|0
325882|NCT00643916|1068054|P4|Overall Study|Lost to Follow-up|0
325883|NCT00643916|1068055|P3|Overall Study|Lost to Follow-up|0
325884|NCT00643916|1068056|P2|Overall Study|Lost to Follow-up|1
325885|NCT00643916|1068057|P1|Overall Study|Lost to Follow-up|0
325886|NCT00643916|1068052|P6|Overall Study|Protocol Violation|0
325887|NCT00643916|1068053|P5|Overall Study|Protocol Violation|0
325888|NCT00643916|1068054|P4|Overall Study|Protocol Violation|1
325889|NCT00643916|1068055|P3|Overall Study|Protocol Violation|1
325890|NCT00643916|1068056|P2|Overall Study|Protocol Violation|1
325891|NCT00643916|1068057|P1|Overall Study|Protocol Violation|0
325892|NCT00643851|1068080|P3|Overall Study|Non-compl., not met criteria, etc.|6
325893|NCT00643851|1068081|P2|Overall Study|Non-compl., not met criteria, etc.|4
325894|NCT00643851|1068082|P1|Overall Study|Non-compl., not met criteria, etc.|3
325895|NCT00643851|1068080|P3|Overall Study|Withdrawal by Subject|9
325896|NCT00643851|1068081|P2|Overall Study|Withdrawal by Subject|15
325897|NCT00643851|1068082|P1|Overall Study|Withdrawal by Subject|8
325898|NCT00643851|1068080|P3|Overall Study|Lost to Follow-up|9
325899|NCT00643851|1068081|P2|Overall Study|Lost to Follow-up|6
325900|NCT00643851|1068082|P1|Overall Study|Lost to Follow-up|4
325901|NCT00643851|1068080|P3|Overall Study|Adverse Event|6
325902|NCT00643851|1068081|P2|Overall Study|Adverse Event|6
325903|NCT00643851|1068082|P1|Overall Study|Adverse Event|2
325904|NCT00643851|1068080|P3|Overall Study|Lack of Efficacy|0
325905|NCT00643851|1068081|P2|Overall Study|Lack of Efficacy|1
325906|NCT00643851|1068082|P1|Overall Study|Lack of Efficacy|0
325907|NCT00643851|1068080|P3|Overall Study|Death|0
325908|NCT00643851|1068081|P2|Overall Study|Death|1
325909|NCT00643851|1068082|P1|Overall Study|Death|0
325910|NCT00643760|1068110|P5|Overall Study|Withdrawal by Subject|1
325911|NCT00643760|1068111|P4|Overall Study|Withdrawal by Subject|4
325912|NCT00643760|1068112|P3|Overall Study|Withdrawal by Subject|2
325913|NCT00643760|1068113|P2|Overall Study|Withdrawal by Subject|1
325914|NCT00643760|1068114|P1|Overall Study|Withdrawal by Subject|3
325915|NCT00643760|1068110|P5|Overall Study|Investigator Discretion|0
325916|NCT00643760|1068111|P4|Overall Study|Investigator Discretion|2
325917|NCT00643760|1068112|P3|Overall Study|Investigator Discretion|0
325918|NCT00643760|1068113|P2|Overall Study|Investigator Discretion|0
325919|NCT00643760|1068114|P1|Overall Study|Investigator Discretion|0
325920|NCT00643760|1068110|P5|Overall Study|Lost to Follow-up|3
325921|NCT00643760|1068111|P4|Overall Study|Lost to Follow-up|3
325922|NCT00643760|1068112|P3|Overall Study|Lost to Follow-up|1
325923|NCT00643760|1068113|P2|Overall Study|Lost to Follow-up|2
325924|NCT00643760|1068114|P1|Overall Study|Lost to Follow-up|6
325925|NCT00643760|1068110|P5|Overall Study|Protocol Violation|6
325926|NCT00643760|1068111|P4|Overall Study|Protocol Violation|4
325927|NCT00643760|1068112|P3|Overall Study|Protocol Violation|4
325928|NCT00643760|1068113|P2|Overall Study|Protocol Violation|6
325929|NCT00643760|1068114|P1|Overall Study|Protocol Violation|7
325930|NCT00643760|1068110|P5|Overall Study|Lack of Efficacy|3
325931|NCT00643760|1068111|P4|Overall Study|Lack of Efficacy|4
325932|NCT00643760|1068112|P3|Overall Study|Lack of Efficacy|0
325933|NCT00643760|1068113|P2|Overall Study|Lack of Efficacy|1
325934|NCT00643760|1068114|P1|Overall Study|Lack of Efficacy|3
325935|NCT00643760|1068110|P5|Overall Study|Adverse Event|6
325936|NCT00643760|1068111|P4|Overall Study|Adverse Event|21
325937|NCT00643760|1068112|P3|Overall Study|Adverse Event|12
325938|NCT00643760|1068113|P2|Overall Study|Adverse Event|5
325939|NCT00643760|1068114|P1|Overall Study|Adverse Event|11
325940|NCT00643682|1068218|P2|Overall Study|did not keep appointment|509
325941|NCT00643682|1068219|P1|Overall Study|did not keep appointment|522
325942|NCT00643604|1068231|P1|Overall Study|Death|1
325943|NCT00643565|1068259|P2|Overall Study|Lost to Follow-up|0
325944|NCT00643565|1068260|P1|Overall Study|Lost to Follow-up|2
325945|NCT00643565|1068259|P2|Overall Study|Withdrawal by Subject|1
325946|NCT00643565|1068260|P1|Overall Study|Withdrawal by Subject|2
325947|NCT00643565|1068259|P2|Overall Study|Ongoing in Follow-up|39
325948|NCT00643565|1068260|P1|Overall Study|Ongoing in Follow-up|39
325949|NCT00643565|1068259|P2|Overall Study|Death|34
325950|NCT00643565|1068260|P1|Overall Study|Death|37
325951|NCT00643487|1068282|P1|Overall Study|Technical difficulty|3
325952|NCT00643448|1068289|P3|Overall Study|QTcF>550 ms|0
325953|NCT00643448|1068290|P2|Overall Study|QTcF>550 ms|3
325954|NCT00643448|1068291|P1|Overall Study|QTcF>550 ms|0
325955|NCT00643448|1068289|P3|Overall Study|Adverse Event|2
325956|NCT00643448|1068290|P2|Overall Study|Adverse Event|2
325957|NCT00643448|1068291|P1|Overall Study|Adverse Event|2
325958|NCT00643448|1068289|P3|Overall Study|Lack of Efficacy|4
325959|NCT00643448|1068290|P2|Overall Study|Lack of Efficacy|0
325960|NCT00643448|1068291|P1|Overall Study|Lack of Efficacy|2
325961|NCT00643006|1068330|P2|Overall Study|Lost to Follow-up|4
325962|NCT00643006|1068331|P1|Overall Study|Lost to Follow-up|5
325963|NCT00642993|1068341|P2|Overall Study|Administrative|0
325964|NCT00642993|1068342|P1|Overall Study|Administrative|1
325965|NCT00642993|1068341|P2|Overall Study|Did not meet protocol eligibility|1
325966|NCT00642993|1068342|P1|Overall Study|Did not meet protocol eligibility|0
325967|NCT00642993|1068341|P2|Overall Study|Protocol Violation|4
325968|NCT00642993|1068342|P1|Overall Study|Protocol Violation|1
325969|NCT00642993|1068341|P2|Overall Study|Withdrew - reason unrelated to treatment|3
325970|NCT00642993|1068342|P1|Overall Study|Withdrew - reason unrelated to treatment|11
325971|NCT00642993|1068341|P2|Overall Study|Lost to Follow-up|4
325972|NCT00642993|1068342|P1|Overall Study|Lost to Follow-up|8
325973|NCT00642993|1068341|P2|Overall Study|Adverse Event|4
325974|NCT00642993|1068342|P1|Overall Study|Adverse Event|85
325975|NCT00642902|1068360|P4|Overall Study|Unspecified|4
325976|NCT00642902|1068361|P3|Overall Study|Unspecified|1
325977|NCT00642902|1068362|P2|Overall Study|Unspecified|5
325978|NCT00642902|1068363|P1|Overall Study|Unspecified|1
325979|NCT00642902|1068360|P4|Overall Study|Randomized, but not treated|0
325980|NCT00642902|1068361|P3|Overall Study|Randomized, but not treated|1
325981|NCT00642902|1068362|P2|Overall Study|Randomized, but not treated|0
325982|NCT00642902|1068363|P1|Overall Study|Randomized, but not treated|0
325983|NCT00642902|1068360|P4|Overall Study|Premature termination of clinical trial|35
325984|NCT00642902|1068361|P3|Overall Study|Premature termination of clinical trial|35
325985|NCT00642902|1068362|P2|Overall Study|Premature termination of clinical trial|32
325986|NCT00642902|1068363|P1|Overall Study|Premature termination of clinical trial|37
325987|NCT00642902|1068360|P4|Overall Study|Death|0
325988|NCT00642902|1068361|P3|Overall Study|Death|0
325989|NCT00642902|1068362|P2|Overall Study|Death|0
325990|NCT00642902|1068363|P1|Overall Study|Death|1
325991|NCT00642902|1068360|P4|Overall Study|Lack of Efficacy|0
325992|NCT00642902|1068361|P3|Overall Study|Lack of Efficacy|3
325993|NCT00642902|1068362|P2|Overall Study|Lack of Efficacy|3
325994|NCT00642902|1068363|P1|Overall Study|Lack of Efficacy|0
325995|NCT00642902|1068360|P4|Overall Study|Lost to Follow-up|0
325996|NCT00642902|1068361|P3|Overall Study|Lost to Follow-up|0
325997|NCT00642902|1068362|P2|Overall Study|Lost to Follow-up|1
325998|NCT00642902|1068363|P1|Overall Study|Lost to Follow-up|1
325999|NCT00642902|1068360|P4|Overall Study|Adverse Event|1
326000|NCT00642902|1068361|P3|Overall Study|Adverse Event|3
326001|NCT00642902|1068362|P2|Overall Study|Adverse Event|1
326002|NCT00642902|1068363|P1|Overall Study|Adverse Event|0
326003|NCT00642850|1068385|P1|Overall Study|Other reasons|7
326004|NCT00642850|1068385|P1|Overall Study|Blood transfusion|6
326005|NCT00642850|1068385|P1|Overall Study|Kidney transplantation|8
326006|NCT00642850|1068385|P1|Overall Study|Protocol Violation|2
326007|NCT00642850|1068385|P1|Overall Study|Lack of Efficacy|1
326008|NCT00642850|1068385|P1|Overall Study|Adverse Event|2
326009|NCT00642850|1068385|P1|Overall Study|Death|7
326010|NCT00642811|1068401|P6|Overall Study|Other|0
326011|NCT00642811|1068402|P5|Overall Study|Other|0
326012|NCT00642811|1068403|P4|Overall Study|Other|1
326013|NCT00642811|1068404|P3|Overall Study|Other|0
326014|NCT00642811|1068405|P2|Overall Study|Other|1
326015|NCT00642811|1068406|P1|Overall Study|Other|0
326016|NCT00642811|1068401|P6|Overall Study|Severe Non-compliance to protocol|0
326017|NCT00642811|1068402|P5|Overall Study|Severe Non-compliance to protocol|0
326018|NCT00642811|1068403|P4|Overall Study|Severe Non-compliance to protocol|0
326019|NCT00642811|1068404|P3|Overall Study|Severe Non-compliance to protocol|0
326020|NCT00642811|1068405|P2|Overall Study|Severe Non-compliance to protocol|0
326021|NCT00642811|1068406|P1|Overall Study|Severe Non-compliance to protocol|1
326022|NCT00642811|1068401|P6|Overall Study|Developement of discontinuation criteria|0
326023|NCT00642811|1068402|P5|Overall Study|Developement of discontinuation criteria|1
326024|NCT00642811|1068403|P4|Overall Study|Developement of discontinuation criteria|0
326025|NCT00642811|1068404|P3|Overall Study|Developement of discontinuation criteria|0
326026|NCT00642811|1068405|P2|Overall Study|Developement of discontinuation criteria|0
326027|NCT00642811|1068406|P1|Overall Study|Developement of discontinuation criteria|0
326028|NCT00642811|1068401|P6|Overall Study|Adverse Event|1
326029|NCT00642811|1068402|P5|Overall Study|Adverse Event|0
326030|NCT00642811|1068403|P4|Overall Study|Adverse Event|0
326031|NCT00642811|1068404|P3|Overall Study|Adverse Event|0
326032|NCT00642811|1068405|P2|Overall Study|Adverse Event|3
326033|NCT00642811|1068406|P1|Overall Study|Adverse Event|2
326034|NCT00642772|1068428|P1|Overall Study|Withdrawal by Subject|7
326035|NCT00642772|1068428|P1|Overall Study|Lost to Follow-up|3
326036|NCT00642759|1068432|P1|Overall Study|Protocol Violation|1
326037|NCT00642746|1068441|P2|Overall Study|Patient unevaluable|0
326038|NCT00642746|1068442|P1|Overall Study|Patient unevaluable|1
326039|NCT00642707|1068456|P4|Overall Study|Withdrawal by Subject|0
326040|NCT00642707|1068457|P3|Overall Study|Withdrawal by Subject|0
326041|NCT00642707|1068458|P2|Overall Study|Withdrawal by Subject|0
326042|NCT00642707|1068459|P1|Overall Study|Withdrawal by Subject|1
326043|NCT00642707|1068456|P4|Overall Study|Adverse Event|2
326044|NCT00642707|1068457|P3|Overall Study|Adverse Event|0
326045|NCT00642707|1068458|P2|Overall Study|Adverse Event|0
326046|NCT00642707|1068459|P1|Overall Study|Adverse Event|0
326047|NCT00642668|1068480|P1|Overall Study|Blood Transfusion|2
326048|NCT00642668|1068480|P1|Overall Study|Dialysis Initiation|5
326049|NCT00642668|1068480|P1|Overall Study|Failure to Return|1
326050|NCT00642668|1068480|P1|Overall Study|Insufficient Therapeutic Response|1
326051|NCT00642668|1068480|P1|Overall Study|Death|2
326052|NCT00642668|1068480|P1|Overall Study|Adverse Event|2
326053|NCT00642668|1068480|P1|Overall Study|Lost to Follow-up|1
326054|NCT00642642|1068488|P1|Treatment & Follow Up|Lost to Follow-up|10
326055|NCT00642642|1068488|P1|Treatment & Follow Up|Withdrawal by Subject|5
326056|NCT00642642|1068488|P1|Treatment & Follow Up|Adverse Event|2
326057|NCT00642616|1068505|P4|Overall Study|Physician Decision|1
326058|NCT00642616|1068506|P3|Overall Study|Physician Decision|1
326059|NCT00642616|1068507|P2|Overall Study|Physician Decision|0
326060|NCT00642616|1068508|P1|Overall Study|Physician Decision|0
326061|NCT00642616|1068505|P4|Overall Study|Protocol Violation|0
326062|NCT00642616|1068506|P3|Overall Study|Protocol Violation|2
326063|NCT00642616|1068507|P2|Overall Study|Protocol Violation|0
326064|NCT00642616|1068508|P1|Overall Study|Protocol Violation|0
326065|NCT00642616|1068505|P4|Overall Study|Withdrawal by Subject|1
326066|NCT00642616|1068506|P3|Overall Study|Withdrawal by Subject|1
326067|NCT00642616|1068507|P2|Overall Study|Withdrawal by Subject|1
326068|NCT00642616|1068508|P1|Overall Study|Withdrawal by Subject|0
326069|NCT00642616|1068505|P4|Overall Study|Study Terminated by Sponsor|5
326070|NCT00642616|1068506|P3|Overall Study|Study Terminated by Sponsor|4
326071|NCT00642616|1068507|P2|Overall Study|Study Terminated by Sponsor|6
326072|NCT00642616|1068508|P1|Overall Study|Study Terminated by Sponsor|7
326073|NCT00642616|1068505|P4|Overall Study|Adverse Event|0
326074|NCT00642616|1068506|P3|Overall Study|Adverse Event|1
326075|NCT00642616|1068507|P2|Overall Study|Adverse Event|0
326076|NCT00642616|1068508|P1|Overall Study|Adverse Event|2
326077|NCT00642473|1068541|P2|Overall Study|Unspecified|2
326078|NCT00642473|1068542|P1|Overall Study|Unspecified|2
326079|NCT00642473|1068541|P2|Overall Study|Progression or death|4
326080|NCT00642473|1068542|P1|Overall Study|Progression or death|2
326081|NCT00642473|1068541|P2|Overall Study|Withdrawal by Subject|5
326082|NCT00642473|1068542|P1|Overall Study|Withdrawal by Subject|0
326083|NCT00642460|1068556|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
326084|NCT00642460|1068557|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
326085|NCT00642460|1068558|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
326086|NCT00642460|1068559|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
326087|NCT00642460|1068560|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
326088|NCT00642460|1068561|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
326089|NCT00642460|1068556|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
326090|NCT00642460|1068557|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
326091|NCT00642460|1068558|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
326092|NCT00642460|1068559|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
326093|NCT00642460|1068560|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
326094|NCT00642460|1068561|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
326095|NCT00642460|1068556|P6|Part III: Open-Label Up to Week 260|Death|3
326096|NCT00642460|1068557|P5|Part III: Open-Label Up to Week 260|Death|0
326097|NCT00642460|1068558|P4|Part III: Open-Label Up to Week 260|Death|0
326098|NCT00642460|1068559|P3|Part III: Open-Label Up to Week 260|Death|0
326099|NCT00642460|1068560|P2|Part III: Open-Label Up to Week 260|Death|0
326100|NCT00642460|1068561|P1|Part III: Open-Label Up to Week 260|Death|0
326101|NCT00642460|1068556|P6|Part III: Open-Label Up to Week 260|Unspecified|2
326102|NCT00642460|1068557|P5|Part III: Open-Label Up to Week 260|Unspecified|2
326103|NCT00642460|1068558|P4|Part III: Open-Label Up to Week 260|Unspecified|0
326104|NCT00642460|1068559|P3|Part III: Open-Label Up to Week 260|Unspecified|0
326105|NCT00642460|1068560|P2|Part III: Open-Label Up to Week 260|Unspecified|0
326106|NCT00642460|1068561|P1|Part III: Open-Label Up to Week 260|Unspecified|0
326107|NCT00642460|1068556|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
326108|NCT00642460|1068557|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
326109|NCT00642460|1068558|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
326110|NCT00642460|1068559|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
326111|NCT00642460|1068560|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
326112|NCT00642460|1068561|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
326113|NCT00642460|1068556|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
326114|NCT00642460|1068557|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
326115|NCT00642460|1068558|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
326116|NCT00642460|1068559|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
326117|NCT00642460|1068560|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
326118|NCT00642460|1068561|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
326119|NCT00642460|1068556|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
326120|NCT00642460|1068557|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
326121|NCT00642460|1068558|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
326122|NCT00642460|1068559|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
326123|NCT00642460|1068560|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
326124|NCT00642460|1068561|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
326125|NCT00642460|1068556|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
326126|NCT00642460|1068557|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
326127|NCT00642460|1068558|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
326128|NCT00642460|1068559|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
326129|NCT00642460|1068560|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
326130|NCT00642460|1068561|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
326131|NCT00642460|1068556|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
326132|NCT00642460|1068557|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
326133|NCT00642460|1068558|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
326134|NCT00642460|1068559|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
326135|NCT00642460|1068560|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
326136|NCT00642460|1068561|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
326137|NCT00642460|1068556|P6|Part II: Open-Label Up to Week 92|Failure to return|0
326138|NCT00642460|1068557|P5|Part II: Open-Label Up to Week 92|Failure to return|0
326139|NCT00642460|1068558|P4|Part II: Open-Label Up to Week 92|Failure to return|0
326140|NCT00642460|1068559|P3|Part II: Open-Label Up to Week 92|Failure to return|0
326141|NCT00642460|1068560|P2|Part II: Open-Label Up to Week 92|Failure to return|1
326142|NCT00642460|1068561|P1|Part II: Open-Label Up to Week 92|Failure to return|0
326143|NCT00642460|1068556|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
326144|NCT00642460|1068557|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
326145|NCT00642460|1068558|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
326146|NCT00642460|1068559|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
326147|NCT00642460|1068560|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
326148|NCT00642460|1068561|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
326149|NCT00642460|1068556|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
326150|NCT00642460|1068557|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
326151|NCT00642460|1068558|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
326152|NCT00642460|1068559|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
326153|NCT00642460|1068560|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
326154|NCT00642460|1068561|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
326155|NCT00642460|1068556|P6|Part II: Open-Label Up to Week 92|Death|0
326156|NCT00642460|1068557|P5|Part II: Open-Label Up to Week 92|Death|0
326157|NCT00642460|1068558|P4|Part II: Open-Label Up to Week 92|Death|2
326158|NCT00642460|1068559|P3|Part II: Open-Label Up to Week 92|Death|0
326159|NCT00642460|1068560|P2|Part II: Open-Label Up to Week 92|Death|1
326160|NCT00642460|1068561|P1|Part II: Open-Label Up to Week 92|Death|0
326161|NCT00642460|1068556|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
326162|NCT00642460|1068557|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
326163|NCT00642460|1068558|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
326164|NCT00642460|1068559|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
326165|NCT00642460|1068560|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
326166|NCT00642460|1068561|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
326167|NCT00642460|1068556|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
326168|NCT00642460|1068557|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
326169|NCT00642460|1068558|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
326170|NCT00642460|1068559|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
326171|NCT00642460|1068560|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
326172|NCT00642460|1068561|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
326173|NCT00642460|1068556|P6|Part I: 12 Week Double-Blind|Adverse Event|0
326174|NCT00642460|1068557|P5|Part I: 12 Week Double-Blind|Adverse Event|0
326175|NCT00642460|1068558|P4|Part I: 12 Week Double-Blind|Adverse Event|0
326176|NCT00642460|1068559|P3|Part I: 12 Week Double-Blind|Adverse Event|1
326177|NCT00642460|1068560|P2|Part I: 12 Week Double-Blind|Adverse Event|1
326178|NCT00642460|1068561|P1|Part I: 12 Week Double-Blind|Adverse Event|0
326179|NCT00642369|1068627|P2|Overall Study|Lack of Efficacy|2
326180|NCT00642369|1068628|P1|Overall Study|Lack of Efficacy|2
326181|NCT00642369|1068627|P2|Overall Study|misdiagnosis|1
326182|NCT00642369|1068628|P1|Overall Study|misdiagnosis|0
326183|NCT00642369|1068627|P2|Overall Study|Withdrawal by Subject|0
326184|NCT00642369|1068628|P1|Overall Study|Withdrawal by Subject|1
326185|NCT00642369|1068627|P2|Overall Study|Adverse Event|3
326186|NCT00642369|1068628|P1|Overall Study|Adverse Event|2
326187|NCT00642356|1068638|P2|Overall Study|Lack of Efficacy|0
326188|NCT00642356|1068639|P1|Overall Study|Lack of Efficacy|1
326189|NCT00642356|1068638|P2|Overall Study|Protocol Violation|3
326190|NCT00642356|1068639|P1|Overall Study|Protocol Violation|0
326191|NCT00642356|1068638|P2|Overall Study|Adverse Event|0
326192|NCT00642356|1068639|P1|Overall Study|Adverse Event|1
326193|NCT00642304|1068647|P1|Overall Study|Transplantation|1
326194|NCT00642304|1068647|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
326195|NCT00642304|1068647|P1|Overall Study|Blood transfusion|2
326196|NCT00642304|1068647|P1|Overall Study|Death|1
326197|NCT00642304|1068647|P1|Overall Study|Adverse Event|1
326198|NCT00642278|1068663|P7|Overall Study|Not specified|0
326199|NCT00642278|1068664|P6|Overall Study|Not specified|1
326200|NCT00642278|1068665|P5|Overall Study|Not specified|0
326201|NCT00642278|1068666|P4|Overall Study|Not specified|1
326202|NCT00642278|1068667|P3|Overall Study|Not specified|0
326203|NCT00642278|1068668|P2|Overall Study|Not specified|1
326204|NCT00642278|1068669|P1|Overall Study|Not specified|2
326205|NCT00642278|1068663|P7|Overall Study|Noncompliance with study drug regimen|0
326206|NCT00642278|1068664|P6|Overall Study|Noncompliance with study drug regimen|0
326207|NCT00642278|1068665|P5|Overall Study|Noncompliance with study drug regimen|0
326208|NCT00642278|1068666|P4|Overall Study|Noncompliance with study drug regimen|1
326209|NCT00642278|1068667|P3|Overall Study|Noncompliance with study drug regimen|0
326210|NCT00642278|1068668|P2|Overall Study|Noncompliance with study drug regimen|0
326211|NCT00642278|1068669|P1|Overall Study|Noncompliance with study drug regimen|0
326212|NCT00642278|1068663|P7|Overall Study|Withdrawal by Subject|2
326213|NCT00642278|1068664|P6|Overall Study|Withdrawal by Subject|2
326214|NCT00642278|1068665|P5|Overall Study|Withdrawal by Subject|6
326215|NCT00642278|1068666|P4|Overall Study|Withdrawal by Subject|3
326216|NCT00642278|1068667|P3|Overall Study|Withdrawal by Subject|1
326217|NCT00642278|1068668|P2|Overall Study|Withdrawal by Subject|1
326218|NCT00642278|1068669|P1|Overall Study|Withdrawal by Subject|1
326219|NCT00642278|1068663|P7|Overall Study|Protocol Violation|2
326220|NCT00642278|1068664|P6|Overall Study|Protocol Violation|1
326221|NCT00642278|1068665|P5|Overall Study|Protocol Violation|0
326222|NCT00642278|1068666|P4|Overall Study|Protocol Violation|1
326223|NCT00642278|1068667|P3|Overall Study|Protocol Violation|1
326224|NCT00642278|1068668|P2|Overall Study|Protocol Violation|0
326225|NCT00642278|1068669|P1|Overall Study|Protocol Violation|0
326226|NCT00642278|1068663|P7|Overall Study|Physician Decision|0
326227|NCT00642278|1068664|P6|Overall Study|Physician Decision|0
326228|NCT00642278|1068665|P5|Overall Study|Physician Decision|0
326229|NCT00642278|1068666|P4|Overall Study|Physician Decision|1
326230|NCT00642278|1068667|P3|Overall Study|Physician Decision|0
326231|NCT00642278|1068668|P2|Overall Study|Physician Decision|0
326232|NCT00642278|1068669|P1|Overall Study|Physician Decision|0
326233|NCT00642278|1068663|P7|Overall Study|Lost to Follow-up|1
326234|NCT00642278|1068664|P6|Overall Study|Lost to Follow-up|1
326235|NCT00642278|1068665|P5|Overall Study|Lost to Follow-up|0
326236|NCT00642278|1068666|P4|Overall Study|Lost to Follow-up|1
326237|NCT00642278|1068667|P3|Overall Study|Lost to Follow-up|0
326238|NCT00642278|1068668|P2|Overall Study|Lost to Follow-up|1
326239|NCT00642278|1068669|P1|Overall Study|Lost to Follow-up|5
326240|NCT00642278|1068663|P7|Overall Study|Lack of Efficacy|0
326241|NCT00642278|1068664|P6|Overall Study|Lack of Efficacy|0
326242|NCT00642278|1068665|P5|Overall Study|Lack of Efficacy|0
326243|NCT00642278|1068666|P4|Overall Study|Lack of Efficacy|0
326244|NCT00642278|1068667|P3|Overall Study|Lack of Efficacy|0
326245|NCT00642278|1068668|P2|Overall Study|Lack of Efficacy|1
326246|NCT00642278|1068669|P1|Overall Study|Lack of Efficacy|0
326247|NCT00642278|1068663|P7|Overall Study|Adverse Event|0
326248|NCT00642278|1068664|P6|Overall Study|Adverse Event|2
326249|NCT00642278|1068665|P5|Overall Study|Adverse Event|2
326250|NCT00642278|1068666|P4|Overall Study|Adverse Event|1
326251|NCT00642278|1068667|P3|Overall Study|Adverse Event|3
326252|NCT00642278|1068668|P2|Overall Study|Adverse Event|1
326253|NCT00642278|1068669|P1|Overall Study|Adverse Event|2
326254|NCT00642174|1068722|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
326255|NCT00642174|1068723|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
326256|NCT00641719|1068757|P2|Overall Study|Reason Not Specified|2
326257|NCT00641719|1068758|P1|Overall Study|Reason Not Specified|1
326258|NCT00641719|1068757|P2|Overall Study|Withdrawal by Subject|4
326259|NCT00641719|1068758|P1|Overall Study|Withdrawal by Subject|4
326260|NCT00641719|1068757|P2|Overall Study|Adverse Event|29
326261|NCT00641719|1068758|P1|Overall Study|Adverse Event|24
326262|NCT00641719|1068757|P2|Overall Study|Lack of Efficacy|2
326263|NCT00641719|1068758|P1|Overall Study|Lack of Efficacy|1
326264|NCT00641706|1068782|P2|Overall Study|Lead Investigator Decision|1
326265|NCT00641706|1068783|P1|Overall Study|Lead Investigator Decision|0
326266|NCT00641706|1068782|P2|Overall Study|Clinical Decline|0
326267|NCT00641706|1068783|P1|Overall Study|Clinical Decline|1
326268|NCT00641706|1068782|P2|Overall Study|Withdrawal by Subject|1
326269|NCT00641706|1068783|P1|Overall Study|Withdrawal by Subject|6
326270|NCT00641706|1068782|P2|Overall Study|Adverse Event|1
326271|NCT00641706|1068783|P1|Overall Study|Adverse Event|2
326272|NCT00641667|1068795|P1|Overall Study|Worsening of underlying disease|3
326273|NCT00641667|1068795|P1|Overall Study|Physician Decision|1
326274|NCT00641667|1068795|P1|Overall Study|Adverse Event|1
326275|NCT00641667|1068795|P1|Overall Study|Withdrawal by Subject|1
326276|NCT00641537|1068823|P8|24-Week Supplemental Follow-up Period|Unspecified|1
326277|NCT00641537|1068824|P7|24-Week Supplemental Follow-up Period|Unspecified|1
326278|NCT00641537|1068825|P6|24-Week Supplemental Follow-up Period|Unspecified|0
326279|NCT00641537|1068826|P5|24-Week Supplemental Follow-up Period|Unspecified|3
326280|NCT00641537|1068827|P4|24-Week Supplemental Follow-up Period|Unspecified|1
326281|NCT00641537|1068828|P3|24-Week Supplemental Follow-up Period|Unspecified|2
326282|NCT00641537|1068829|P2|24-Week Supplemental Follow-up Period|Unspecified|2
326283|NCT00641537|1068830|P1|24-Week Supplemental Follow-up Period|Unspecified|0
326284|NCT00641537|1068823|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
326285|NCT00641537|1068824|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
326286|NCT00641537|1068825|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
326287|NCT00641537|1068826|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
326288|NCT00641537|1068827|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
326289|NCT00641537|1068828|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
326290|NCT00641537|1068829|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
326291|NCT00641537|1068830|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
326292|NCT00641537|1068823|P8|96-week Period|Unspecified|6
326293|NCT00641537|1068824|P7|96-week Period|Unspecified|4
326294|NCT00641537|1068825|P6|96-week Period|Unspecified|6
326295|NCT00641537|1068826|P5|96-week Period|Unspecified|12
326296|NCT00641537|1068827|P4|96-week Period|Unspecified|9
326297|NCT00641537|1068828|P3|96-week Period|Unspecified|14
326298|NCT00641537|1068829|P2|96-week Period|Unspecified|7
326299|NCT00641537|1068830|P1|96-week Period|Unspecified|4
326300|NCT00641537|1068823|P8|96-week Period|Death|0
326301|NCT00641537|1068824|P7|96-week Period|Death|0
326302|NCT00641537|1068825|P6|96-week Period|Death|0
326303|NCT00641537|1068826|P5|96-week Period|Death|0
326304|NCT00641537|1068827|P4|96-week Period|Death|0
326305|NCT00641537|1068828|P3|96-week Period|Death|1
326306|NCT00641537|1068829|P2|96-week Period|Death|0
326307|NCT00641537|1068830|P1|96-week Period|Death|2
326308|NCT00641537|1068823|P8|96-week Period|Protocol Violation|0
326309|NCT00641537|1068824|P7|96-week Period|Protocol Violation|0
326310|NCT00641537|1068825|P6|96-week Period|Protocol Violation|1
326311|NCT00641537|1068826|P5|96-week Period|Protocol Violation|0
326312|NCT00641537|1068827|P4|96-week Period|Protocol Violation|1
326313|NCT00641537|1068828|P3|96-week Period|Protocol Violation|0
326314|NCT00641537|1068829|P2|96-week Period|Protocol Violation|1
326315|NCT00641537|1068830|P1|96-week Period|Protocol Violation|0
326316|NCT00641537|1068823|P8|96-week Period|Lost to Follow-up|0
326317|NCT00641537|1068824|P7|96-week Period|Lost to Follow-up|1
326318|NCT00641537|1068825|P6|96-week Period|Lost to Follow-up|0
326319|NCT00641537|1068826|P5|96-week Period|Lost to Follow-up|4
326320|NCT00641537|1068827|P4|96-week Period|Lost to Follow-up|2
326321|NCT00641537|1068828|P3|96-week Period|Lost to Follow-up|2
326322|NCT00641537|1068829|P2|96-week Period|Lost to Follow-up|1
326323|NCT00641537|1068830|P1|96-week Period|Lost to Follow-up|3
326324|NCT00641537|1068823|P8|96-week Period|Adverse Event|0
326325|NCT00641537|1068824|P7|96-week Period|Adverse Event|0
326326|NCT00641537|1068825|P6|96-week Period|Adverse Event|0
326327|NCT00641537|1068826|P5|96-week Period|Adverse Event|2
326328|NCT00641537|1068827|P4|96-week Period|Adverse Event|0
326329|NCT00641537|1068828|P3|96-week Period|Adverse Event|3
326330|NCT00641537|1068829|P2|96-week Period|Adverse Event|1
326331|NCT00641537|1068830|P1|96-week Period|Adverse Event|0
326332|NCT00641056|1068885|P2|Overall Study|Sponsor Decision|2
326333|NCT00641056|1068886|P1|Overall Study|Sponsor Decision|1
326334|NCT00641056|1068885|P2|Overall Study|Subject Decision|19
326335|NCT00641056|1068886|P1|Overall Study|Subject Decision|6
326336|NCT00641056|1068885|P2|Overall Study|Entry Criteria Not Met|0
326337|NCT00641056|1068886|P1|Overall Study|Entry Criteria Not Met|3
326338|NCT00641056|1068885|P2|Overall Study|Protocol Violation|0
326339|NCT00641056|1068886|P1|Overall Study|Protocol Violation|2
326340|NCT00641056|1068885|P2|Overall Study|Physician Decision|1
326341|NCT00641056|1068886|P1|Overall Study|Physician Decision|3
326342|NCT00641056|1068885|P2|Overall Study|Lost to Follow-up|1
326343|NCT00641056|1068886|P1|Overall Study|Lost to Follow-up|2
326344|NCT00641056|1068885|P2|Overall Study|Adverse Event|2
326345|NCT00641056|1068886|P1|Overall Study|Adverse Event|12
326346|NCT00641043|1068914|P2|Overall Study|Other incl. lack of efficacy|2
326347|NCT00641043|1068915|P1|Overall Study|Other incl. lack of efficacy|4
326348|NCT00641043|1068914|P2|Overall Study|Withdrawal by Subject|4
326349|NCT00641043|1068915|P1|Overall Study|Withdrawal by Subject|4
326350|NCT00641043|1068914|P2|Overall Study|Lost to Follow-up|2
326351|NCT00641043|1068915|P1|Overall Study|Lost to Follow-up|3
326352|NCT00641043|1068914|P2|Overall Study|Protocol Violation|3
326353|NCT00641043|1068915|P1|Overall Study|Protocol Violation|2
326354|NCT00641043|1068914|P2|Overall Study|Adverse Event|4
326355|NCT00641043|1068915|P1|Overall Study|Adverse Event|6
326356|NCT00640926|1068952|P3|Overall Study|Withdrawal by Subject|1
326357|NCT00640926|1068953|P2|Overall Study|Withdrawal by Subject|0
326358|NCT00640926|1068954|P1|Overall Study|Withdrawal by Subject|1
326359|NCT00640926|1068952|P3|Overall Study|Lost to Follow-up|2
326360|NCT00640926|1068953|P2|Overall Study|Lost to Follow-up|1
326361|NCT00640926|1068954|P1|Overall Study|Lost to Follow-up|3
326362|NCT00640926|1068952|P3|Overall Study|Protocol Violation|2
326363|NCT00640926|1068953|P2|Overall Study|Protocol Violation|0
326364|NCT00640926|1068954|P1|Overall Study|Protocol Violation|2
326365|NCT00640926|1068952|P3|Overall Study|Lack of Efficacy|1
326366|NCT00640926|1068953|P2|Overall Study|Lack of Efficacy|2
326367|NCT00640926|1068954|P1|Overall Study|Lack of Efficacy|0
326368|NCT00640926|1068952|P3|Overall Study|Adverse Event|2
326369|NCT00640926|1068953|P2|Overall Study|Adverse Event|3
326370|NCT00640926|1068954|P1|Overall Study|Adverse Event|2
326371|NCT00640835|1068967|P2|Overall Study|Other Reason|4
326372|NCT00640835|1068968|P1|Overall Study|Other Reason|19
326373|NCT00640835|1068967|P2|Overall Study|Lost to Follow-up|13
326374|NCT00640835|1068968|P1|Overall Study|Lost to Follow-up|17
326375|NCT00640835|1068967|P2|Overall Study|Protocol Violation|2
326376|NCT00640835|1068968|P1|Overall Study|Protocol Violation|2
326377|NCT00640835|1068967|P2|Overall Study|Sponsor's Decision|7
326378|NCT00640835|1068968|P1|Overall Study|Sponsor's Decision|11
326379|NCT00640835|1068967|P2|Overall Study|Physician Decision|14
326380|NCT00640835|1068968|P1|Overall Study|Physician Decision|10
326381|NCT00640835|1068967|P2|Overall Study|Withdrawal by Subject|14
326382|NCT00640835|1068968|P1|Overall Study|Withdrawal by Subject|12
326383|NCT00640835|1068967|P2|Overall Study|Adverse Event|3
326384|NCT00640835|1068968|P1|Overall Study|Adverse Event|5
326385|NCT00640614|1068991|P2|Overall Study|Lost to Follow-up|0
326386|NCT00640614|1068992|P1|Overall Study|Lost to Follow-up|1
326387|NCT00640601|1069034|P1|Overall Study|treatment naive, combination therapy|10
326388|NCT00640601|1069034|P1|Overall Study|Physician Decision|8
326389|NCT00640601|1069034|P1|Overall Study|Lost to Follow-up|9
326390|NCT00640601|1069034|P1|Overall Study|Lack of Efficacy|16
326391|NCT00640601|1069034|P1|Overall Study|Protocol Violation|6
326392|NCT00640601|1069034|P1|Overall Study|Withdrawal by Subject|20
326393|NCT00640601|1069034|P1|Overall Study|Adverse Event|43
326394|NCT00640562|1069050|P2|Overall Study|Glycosylated Hemoglobin >8|0
326395|NCT00640562|1069051|P1|Overall Study|Glycosylated Hemoglobin >8|1
326396|NCT00640562|1069050|P2|Overall Study|Low study drug dose|1
326397|NCT00640562|1069051|P1|Overall Study|Low study drug dose|0
326398|NCT00640562|1069050|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
326399|NCT00640562|1069051|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
326400|NCT00640562|1069050|P2|Overall Study|Known risperidone intolerance|1
326401|NCT00640562|1069051|P1|Overall Study|Known risperidone intolerance|0
326402|NCT00640562|1069050|P2|Overall Study|Withdrawal by Subject|10
326403|NCT00640562|1069051|P1|Overall Study|Withdrawal by Subject|6
326404|NCT00640562|1069050|P2|Overall Study|Protocol Violation|4
326405|NCT00640562|1069051|P1|Overall Study|Protocol Violation|2
326406|NCT00640562|1069050|P2|Overall Study|Lack of Efficacy|4
326407|NCT00640562|1069051|P1|Overall Study|Lack of Efficacy|1
326408|NCT00640562|1069050|P2|Overall Study|Adverse Event|5
326409|NCT00640562|1069051|P1|Overall Study|Adverse Event|8
326410|NCT00640510|1069079|P2|Overall Study|Physician Decision|1
326411|NCT00640510|1069080|P1|Overall Study|Physician Decision|0
326412|NCT00640510|1069079|P2|Overall Study|Protocol Violation|0
326413|NCT00640510|1069080|P1|Overall Study|Protocol Violation|1
326414|NCT00640510|1069079|P2|Overall Study|Lack of Efficacy|1
326415|NCT00640510|1069080|P1|Overall Study|Lack of Efficacy|0
326416|NCT00640393|1069092|P3|Part 2|Adverse Event|0
326417|NCT00640393|1069093|P2|Part 2|Adverse Event|1
326418|NCT00640393|1069094|P1|Part 2|Adverse Event|0
326419|NCT00640393|1069092|P3|Part 2|Non-adherence|0
326420|NCT00640393|1069093|P2|Part 2|Non-adherence|1
326421|NCT00640393|1069094|P1|Part 2|Non-adherence|0
326422|NCT00640393|1069092|P3|Part 2|Withdrawal by Subject|1
326423|NCT00640393|1069093|P2|Part 2|Withdrawal by Subject|6
326424|NCT00640393|1069094|P1|Part 2|Withdrawal by Subject|0
326425|NCT00640393|1069092|P3|Part 2|Lost to Follow-up|2
326426|NCT00640393|1069093|P2|Part 2|Lost to Follow-up|2
326427|NCT00640393|1069094|P1|Part 2|Lost to Follow-up|0
326428|NCT00640393|1069092|P3|Randomization|Never randomized by site|0
326429|NCT00640393|1069093|P2|Randomization|Never randomized by site|0
326430|NCT00640393|1069094|P1|Randomization|Never randomized by site|2
326431|NCT00640393|1069092|P3|Randomization|Withdrawn per protocol|0
326432|NCT00640393|1069093|P2|Randomization|Withdrawn per protocol|0
326433|NCT00640393|1069094|P1|Randomization|Withdrawn per protocol|17
326434|NCT00640393|1069092|P3|Part 1|Withdrawal by Subject|0
326435|NCT00640393|1069093|P2|Part 1|Withdrawal by Subject|0
326436|NCT00640393|1069094|P1|Part 1|Withdrawal by Subject|3
326437|NCT00640393|1069092|P3|Part 1|Lost to Follow-up|0
326438|NCT00640393|1069093|P2|Part 1|Lost to Follow-up|0
326439|NCT00640393|1069094|P1|Part 1|Lost to Follow-up|2
326440|NCT00640341|1069159|P3|Overall Study|Adverse event and positive slit lamp|0
326441|NCT00640341|1069160|P2|Overall Study|Adverse event and positive slit lamp|0
326442|NCT00640341|1069161|P1|Overall Study|Adverse event and positive slit lamp|1
326443|NCT00640341|1069159|P3|Overall Study|Ineligable at Baseline|2
326444|NCT00640341|1069160|P2|Overall Study|Ineligable at Baseline|3
326445|NCT00640341|1069161|P1|Overall Study|Ineligable at Baseline|5
326446|NCT00640341|1069159|P3|Overall Study|Poor fit/Uncomfortable|0
326447|NCT00640341|1069160|P2|Overall Study|Poor fit/Uncomfortable|0
326448|NCT00640341|1069161|P1|Overall Study|Poor fit/Uncomfortable|4
326449|NCT00640341|1069159|P3|Overall Study|Unacceptable Lens Movement|0
326450|NCT00640341|1069160|P2|Overall Study|Unacceptable Lens Movement|0
326451|NCT00640341|1069161|P1|Overall Study|Unacceptable Lens Movement|1
326452|NCT00640341|1069159|P3|Overall Study|Withdrawal by Subject|1
326453|NCT00640341|1069160|P2|Overall Study|Withdrawal by Subject|0
326454|NCT00640341|1069161|P1|Overall Study|Withdrawal by Subject|4
326455|NCT00640341|1069159|P3|Overall Study|Lost to Follow-up|0
326456|NCT00640341|1069160|P2|Overall Study|Lost to Follow-up|0
326457|NCT00640341|1069161|P1|Overall Study|Lost to Follow-up|2
326458|NCT00640341|1069159|P3|Overall Study|Failure to Follow Subject Instructions|0
326459|NCT00640341|1069160|P2|Overall Study|Failure to Follow Subject Instructions|0
326460|NCT00640341|1069161|P1|Overall Study|Failure to Follow Subject Instructions|1
326461|NCT00640341|1069159|P3|Overall Study|Inability to Maintain Wearing Schedule|0
326462|NCT00640341|1069160|P2|Overall Study|Inability to Maintain Wearing Schedule|1
326463|NCT00640341|1069161|P1|Overall Study|Inability to Maintain Wearing Schedule|1
326464|NCT00640341|1069159|P3|Overall Study|Study Related Symptoms/Complaints|2
326465|NCT00640341|1069160|P2|Overall Study|Study Related Symptoms/Complaints|1
326466|NCT00640341|1069161|P1|Overall Study|Study Related Symptoms/Complaints|2
326467|NCT00640341|1069159|P3|Overall Study|Positive Slit Lamp Findings|1
326468|NCT00640341|1069160|P2|Overall Study|Positive Slit Lamp Findings|0
326469|NCT00640341|1069161|P1|Overall Study|Positive Slit Lamp Findings|0
326470|NCT00640341|1069159|P3|Overall Study|Adverse Event|1
326471|NCT00640341|1069160|P2|Overall Study|Adverse Event|0
326472|NCT00640341|1069161|P1|Overall Study|Adverse Event|0
326473|NCT00640328|1069181|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
326474|NCT00640328|1069182|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
326475|NCT00640328|1069183|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
326476|NCT00640328|1069184|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
326477|NCT00640328|1069185|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
326478|NCT00640328|1069186|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
326479|NCT00640328|1069181|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
326480|NCT00640328|1069182|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
326481|NCT00640328|1069183|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
326482|NCT00640328|1069184|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
326483|NCT00640328|1069185|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
326484|NCT00640328|1069186|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
326485|NCT00640328|1069181|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
326486|NCT00640328|1069182|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
326487|NCT00640328|1069183|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
326488|NCT00640328|1069184|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
326489|NCT00640328|1069185|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
326490|NCT00640328|1069186|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
326491|NCT00640328|1069181|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
326492|NCT00640328|1069182|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
326493|NCT00640328|1069183|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
326494|NCT00640328|1069184|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
326495|NCT00640328|1069185|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
326496|NCT00640328|1069186|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
326497|NCT00640315|1069352|P2|Overall Study|Withdrawal by Subject|1
326498|NCT00640315|1069353|P1|Overall Study|Withdrawal by Subject|0
326499|NCT00640042|1069479|P1|Enrollment|Did not receive study drug|83
326500|NCT00640016|1069495|P4|Overall Study|Adverse Event|1
326501|NCT00640016|1069496|P3|Overall Study|Adverse Event|0
326502|NCT00640016|1069497|P2|Overall Study|Adverse Event|0
326503|NCT00640016|1069498|P1|Overall Study|Adverse Event|0
326504|NCT00640016|1069495|P4|Overall Study|Study termination|2
326505|NCT00640016|1069496|P3|Overall Study|Study termination|3
326506|NCT00640016|1069497|P2|Overall Study|Study termination|1
326507|NCT00640016|1069498|P1|Overall Study|Study termination|2
326508|NCT00640016|1069495|P4|Overall Study|Withdrawal by Subject|0
326509|NCT00640016|1069496|P3|Overall Study|Withdrawal by Subject|0
326510|NCT00640016|1069497|P2|Overall Study|Withdrawal by Subject|1
326511|NCT00640016|1069498|P1|Overall Study|Withdrawal by Subject|0
326512|NCT00639769|1069550|P1|Overall Study|Withdrawal by Subject|4
326513|NCT00639769|1069550|P1|Overall Study|Disease progression|26
326514|NCT00639769|1069550|P1|Overall Study|Lack of Efficacy|1
326515|NCT00639769|1069550|P1|Overall Study|Adverse Event|7
326516|NCT00639769|1069550|P1|Overall Study|Death|2
326517|NCT00639678|1069567|P4|Overall Study|Lack of Compliance|0
326518|NCT00639678|1069568|P3|Overall Study|Lack of Compliance|1
326519|NCT00639678|1069569|P2|Overall Study|Lack of Compliance|0
326520|NCT00639678|1069570|P1|Overall Study|Lack of Compliance|0
326521|NCT00639678|1069567|P4|Overall Study|Adverse Event|0
326522|NCT00639678|1069568|P3|Overall Study|Adverse Event|0
326523|NCT00639678|1069569|P2|Overall Study|Adverse Event|1
326524|NCT00639678|1069570|P1|Overall Study|Adverse Event|0
326525|NCT00639678|1069567|P4|Overall Study|Lost to Follow-up|0
326526|NCT00639678|1069568|P3|Overall Study|Lost to Follow-up|6
326527|NCT00639678|1069569|P2|Overall Study|Lost to Follow-up|0
326528|NCT00639678|1069570|P1|Overall Study|Lost to Follow-up|1
326529|NCT00639678|1069567|P4|Overall Study|Withdrawal by Subject|0
326530|NCT00639678|1069568|P3|Overall Study|Withdrawal by Subject|4
326531|NCT00639678|1069569|P2|Overall Study|Withdrawal by Subject|0
326532|NCT00639678|1069570|P1|Overall Study|Withdrawal by Subject|3
326533|NCT00639509|1069630|P1|Overall Study|Death|1
326534|NCT00639457|1069638|P2|Overall Study|Withdrawal by Subject|3
326535|NCT00639457|1069639|P1|Overall Study|Withdrawal by Subject|2
326536|NCT00639379|1069698|P2|Period 1 - 2 Weeks|lens issue|0
326537|NCT00639379|1069699|P1|Period 1 - 2 Weeks|lens issue|3
326538|NCT00639379|1069698|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
326539|NCT00639379|1069699|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
326540|NCT00639223|1069715|P2|Overall Study|Lost to Follow-up|2
326541|NCT00639223|1069716|P1|Overall Study|Lost to Follow-up|0
326542|NCT00639002|1069756|P1|Overall Study|Lack of Efficacy|1
326543|NCT00639002|1069756|P1|Overall Study|Physician Decision|6
326544|NCT00639002|1069756|P1|Overall Study|Disease progression|3
326545|NCT00639002|1069756|P1|Overall Study|Protocol Violation|1
326546|NCT00639002|1069756|P1|Overall Study|Adverse Event|1
326547|NCT00639002|1069756|P1|Overall Study|Death|1
326548|NCT00638989|1069765|P3|Overall Study|Lost to Follow-up|1
326549|NCT00638989|1069766|P2|Overall Study|Lost to Follow-up|0
326550|NCT00638989|1069767|P1|Overall Study|Lost to Follow-up|0
326551|NCT00638963|1069807|P2|Overall Study|Withdrawal by Subject|0
326552|NCT00638963|1069808|P1|Overall Study|Withdrawal by Subject|1
326553|NCT00638846|1069848|P2|Overall Study|lens issue|3
326554|NCT00638846|1069849|P1|Overall Study|lens issue|1
326555|NCT00638846|1069848|P2|Overall Study|Lost to Follow-up|2
326556|NCT00638846|1069849|P1|Overall Study|Lost to Follow-up|3
326557|NCT00638846|1069848|P2|Overall Study|Adverse Event|1
326558|NCT00638846|1069849|P1|Overall Study|Adverse Event|0
326559|NCT00638690|1069893|P2|Overall Study|Lost to Follow-up|2
326560|NCT00638690|1069894|P1|Overall Study|Lost to Follow-up|4
326561|NCT00638690|1069893|P2|Overall Study|Withdrawal by Subject|5
326562|NCT00638690|1069894|P1|Overall Study|Withdrawal by Subject|22
326563|NCT00638690|1069893|P2|Overall Study|Death|335
326564|NCT00638690|1069894|P1|Overall Study|Death|655
326565|NCT00638443|1069912|P2|First Intervention|Adverse Event|1
326566|NCT00638443|1069913|P1|First Intervention|Adverse Event|2
326567|NCT00638378|1069941|P1|Overall Study|Physician Decision|4
326568|NCT00638378|1069941|P1|Overall Study|Disease progression|15
326569|NCT00638378|1069941|P1|Overall Study|Adverse Event|1
326570|NCT00638378|1069941|P1|Overall Study|Death|2
326571|NCT00638235|1069970|P9|Overall Study|Lost to Follow-up|18
326572|NCT00638235|1069971|P8|Overall Study|Lost to Follow-up|1
326573|NCT00638235|1069972|P7|Overall Study|Lost to Follow-up|0
326574|NCT00638235|1069973|P6|Overall Study|Lost to Follow-up|26
326575|NCT00638235|1069974|P5|Overall Study|Lost to Follow-up|13
326576|NCT00638235|1069975|P4|Overall Study|Lost to Follow-up|10
326577|NCT00638235|1069976|P3|Overall Study|Lost to Follow-up|18
326578|NCT00638235|1069977|P2|Overall Study|Lost to Follow-up|3
326579|NCT00638235|1069978|P1|Overall Study|Lost to Follow-up|31
326580|NCT00638183|1070388|P1|Overall Study|Other reason not defined above|27
326581|NCT00638183|1070388|P1|Overall Study|Lost to Follow-up|46
326582|NCT00638183|1070388|P1|Overall Study|Physician Decision|9
326583|NCT00638183|1070388|P1|Overall Study|Lack of Efficacy|14
326584|NCT00638183|1070388|P1|Overall Study|Adverse Event|23
326585|NCT00638157|1070397|P2|Overall Study|Randomized, not treated|0
326586|NCT00638157|1070398|P1|Overall Study|Randomized, not treated|2
326587|NCT00638157|1070397|P2|Overall Study|Not Specified|2
326588|NCT00638157|1070398|P1|Overall Study|Not Specified|1
326589|NCT00638157|1070397|P2|Overall Study|Physician Decision|0
326590|NCT00638157|1070398|P1|Overall Study|Physician Decision|1
326591|NCT00638157|1070397|P2|Overall Study|Lost to Follow-up|0
326592|NCT00638157|1070398|P1|Overall Study|Lost to Follow-up|1
326593|NCT00638157|1070397|P2|Overall Study|Microbiological failure|0
326594|NCT00638157|1070398|P1|Overall Study|Microbiological failure|1
326595|NCT00638157|1070397|P2|Overall Study|Clinical (symptomatic) failure|1
326596|NCT00638157|1070398|P1|Overall Study|Clinical (symptomatic) failure|1
326597|NCT00638157|1070397|P2|Overall Study|Adverse Event|1
326598|NCT00638157|1070398|P1|Overall Study|Adverse Event|0
326599|NCT00638027|1070408|P2|Overall Study|Adverse Event|2
326600|NCT00638027|1070409|P1|Overall Study|Adverse Event|0
326601|NCT00637806|1070456|P4|Extension Phase|Study Discontinued|1
326602|NCT00637806|1070457|P3|Extension Phase|Study Discontinued|0
326603|NCT00637806|1070458|P2|Extension Phase|Study Discontinued|0
326604|NCT00637806|1070459|P1|Extension Phase|Study Discontinued|0
326605|NCT00637806|1070456|P4|Double-blind Phase|Study Discontinued|0
326606|NCT00637806|1070457|P3|Double-blind Phase|Study Discontinued|1
326607|NCT00637806|1070458|P2|Double-blind Phase|Study Discontinued|0
326608|NCT00637806|1070459|P1|Double-blind Phase|Study Discontinued|2
326609|NCT00637728|1070494|P3|Double-blind Phase|Study Discontinued|0
326610|NCT00637728|1070495|P2|Double-blind Phase|Study Discontinued|1
326611|NCT00637728|1070496|P1|Double-blind Phase|Study Discontinued|1
326612|NCT00637728|1070494|P3|Double-blind Phase|Non-compliance|0
326613|NCT00637728|1070495|P2|Double-blind Phase|Non-compliance|0
326614|NCT00637728|1070496|P1|Double-blind Phase|Non-compliance|2
326615|NCT00637728|1070494|P3|Double-blind Phase|Adverse Event|0
326616|NCT00637728|1070495|P2|Double-blind Phase|Adverse Event|0
326617|NCT00637728|1070496|P1|Double-blind Phase|Adverse Event|1
326618|NCT00637572|1070511|P2|Overall Study|Illicit Drug Use|0
326619|NCT00637572|1070512|P1|Overall Study|Illicit Drug Use|1
326620|NCT00637572|1070511|P2|Overall Study|Withdrawal by Subject|2
326621|NCT00637572|1070512|P1|Overall Study|Withdrawal by Subject|0
326622|NCT00637572|1070511|P2|Overall Study|Physician Decision|1
326623|NCT00637572|1070512|P1|Overall Study|Physician Decision|1
326624|NCT00637572|1070511|P2|Overall Study|Lost to Follow-up|1
326625|NCT00637572|1070512|P1|Overall Study|Lost to Follow-up|0
326626|NCT00637572|1070511|P2|Overall Study|Death|1
326627|NCT00637572|1070512|P1|Overall Study|Death|0
326628|NCT00637572|1070511|P2|Overall Study|Adverse Event|2
326629|NCT00637572|1070512|P1|Overall Study|Adverse Event|1
326630|NCT00637416|1070551|P2|Overall Study|Unable to take study drug|1
326631|NCT00637416|1070552|P1|Overall Study|Unable to take study drug|0
326632|NCT00637416|1070551|P2|Overall Study|Lost to Follow-up|1
326633|NCT00637416|1070552|P1|Overall Study|Lost to Follow-up|1
326634|NCT00637377|1070562|P4|Overall Study|Other (no further information available)|5
326635|NCT00637377|1070563|P3|Overall Study|Other (no further information available)|10
326636|NCT00637377|1070564|P2|Overall Study|Other (no further information available)|6
326637|NCT00637377|1070565|P1|Overall Study|Other (no further information available)|7
326638|NCT00637377|1070562|P4|Overall Study|Withdrawal by Subject|11
326639|NCT00637377|1070563|P3|Overall Study|Withdrawal by Subject|13
326640|NCT00637377|1070564|P2|Overall Study|Withdrawal by Subject|15
326641|NCT00637377|1070565|P1|Overall Study|Withdrawal by Subject|11
326642|NCT00637377|1070562|P4|Overall Study|Protocol Violation|0
326643|NCT00637377|1070563|P3|Overall Study|Protocol Violation|1
326644|NCT00637377|1070564|P2|Overall Study|Protocol Violation|1
326645|NCT00637377|1070565|P1|Overall Study|Protocol Violation|2
326646|NCT00637377|1070562|P4|Overall Study|Lost to Follow-up|2
326647|NCT00637377|1070563|P3|Overall Study|Lost to Follow-up|2
326648|NCT00637377|1070564|P2|Overall Study|Lost to Follow-up|1
326649|NCT00637377|1070565|P1|Overall Study|Lost to Follow-up|4
326650|NCT00637377|1070562|P4|Overall Study|Lack of Efficacy|1
326651|NCT00637377|1070563|P3|Overall Study|Lack of Efficacy|1
326652|NCT00637377|1070564|P2|Overall Study|Lack of Efficacy|0
326653|NCT00637377|1070565|P1|Overall Study|Lack of Efficacy|0
326654|NCT00637377|1070562|P4|Overall Study|Death|1
326655|NCT00637377|1070563|P3|Overall Study|Death|2
326656|NCT00637377|1070564|P2|Overall Study|Death|3
326657|NCT00637377|1070565|P1|Overall Study|Death|1
326658|NCT00637377|1070562|P4|Overall Study|Adverse Event|9
326659|NCT00637377|1070563|P3|Overall Study|Adverse Event|8
326660|NCT00637377|1070564|P2|Overall Study|Adverse Event|6
326661|NCT00637377|1070565|P1|Overall Study|Adverse Event|2
326662|NCT00637273|1070614|P3|Overall Study|Loss of Glucose Control|1
326663|NCT00637273|1070615|P2|Overall Study|Loss of Glucose Control|1
326664|NCT00637273|1070616|P1|Overall Study|Loss of Glucose Control|1
326665|NCT00637273|1070614|P3|Overall Study|Administrative|0
326666|NCT00637273|1070615|P2|Overall Study|Administrative|0
326667|NCT00637273|1070616|P1|Overall Study|Administrative|2
326668|NCT00637273|1070614|P3|Overall Study|Investigator Decision|1
326669|NCT00637273|1070615|P2|Overall Study|Investigator Decision|3
326670|NCT00637273|1070616|P1|Overall Study|Investigator Decision|1
326671|NCT00637273|1070614|P3|Overall Study|Withdrawal of Consent|18
326672|NCT00637273|1070615|P2|Overall Study|Withdrawal of Consent|6
326673|NCT00637273|1070616|P1|Overall Study|Withdrawal of Consent|18
326674|NCT00637273|1070614|P3|Overall Study|Protocol Violation|1
326675|NCT00637273|1070615|P2|Overall Study|Protocol Violation|4
326676|NCT00637273|1070616|P1|Overall Study|Protocol Violation|2
326677|NCT00637273|1070614|P3|Overall Study|Lost to Follow-up|13
326678|NCT00637273|1070615|P2|Overall Study|Lost to Follow-up|9
326679|NCT00637273|1070616|P1|Overall Study|Lost to Follow-up|8
326680|NCT00637273|1070614|P3|Overall Study|Adverse Event|7
326681|NCT00637273|1070615|P2|Overall Study|Adverse Event|5
326682|NCT00637273|1070616|P1|Overall Study|Adverse Event|11
326683|NCT00637195|1070672|P2|Overall Study|Withdrawal by Subject|1
326684|NCT00637195|1070673|P1|Overall Study|Withdrawal by Subject|0
326685|NCT00637195|1070672|P2|Overall Study|Other|0
326686|NCT00637195|1070673|P1|Overall Study|Other|2
326687|NCT00637195|1070672|P2|Overall Study|Lost to Follow-up|0
326688|NCT00637195|1070673|P1|Overall Study|Lost to Follow-up|1
326689|NCT00637156|1070709|P2|Overall Study|Lost to Follow-up|16
326690|NCT00637156|1070710|P1|Overall Study|Lost to Follow-up|10
326691|NCT00637156|1070709|P2|Overall Study|Death|1
326692|NCT00637156|1070710|P1|Overall Study|Death|0
326693|NCT00637156|1070709|P2|Overall Study|Withdrawal by Subject|7
326694|NCT00637156|1070710|P1|Overall Study|Withdrawal by Subject|0
326695|NCT00637000|1070752|P2|Overall Study|Withdrawal by Subject|3
326696|NCT00637000|1070753|P1|Overall Study|Withdrawal by Subject|4
326697|NCT00636987|1070793|P1|Overall Study|5 year visit window not complete|69
326698|NCT00636987|1070793|P1|Overall Study|Lost to Follow-up|63
326699|NCT00636987|1070793|P1|Overall Study|Explanted|13
326700|NCT00636987|1070793|P1|Overall Study|Death|44
326701|NCT00636961|1070803|P2|Period 2|Adverse Event|0
326702|NCT00636961|1070804|P1|Period 2|Adverse Event|1
326703|NCT00636961|1070803|P2|Period 1|Administrative problems|1
326704|NCT00636961|1070804|P1|Period 1|Administrative problems|1
326705|NCT00636818|1070818|P1|Overall Study|Withdrawal by Subject|4
326706|NCT00636818|1070818|P1|Overall Study|Protocol Violation|1
326707|NCT00636818|1070818|P1|Overall Study|Entry Criteria Exclusion|3
326708|NCT00636818|1070818|P1|Overall Study|Lost to Follow-up|2
326709|NCT00636818|1070818|P1|Overall Study|Adverse Event|1
326710|NCT00636792|1070843|P1|Overall Study|Other|3
326711|NCT00636792|1070843|P1|Overall Study|Withdrawal by Subject|3
326712|NCT00636792|1070843|P1|Overall Study|Progressive Disease|4
326713|NCT00636792|1070843|P1|Overall Study|Physician Decision|7
326714|NCT00636792|1070843|P1|Overall Study|Adverse Event|16
326715|NCT00636636|1070890|P2|Overall Study|Withdrawal by Subject|9
326716|NCT00636636|1070891|P1|Overall Study|Withdrawal by Subject|4
326717|NCT00636636|1070890|P2|Overall Study|Death|1
326718|NCT00636636|1070891|P1|Overall Study|Death|0
326719|NCT00636636|1070890|P2|Overall Study|Lost to Follow-up|1
326720|NCT00636636|1070891|P1|Overall Study|Lost to Follow-up|0
326721|NCT00636636|1070890|P2|Overall Study|Protocol Violation|2
326722|NCT00636636|1070891|P1|Overall Study|Protocol Violation|2
326723|NCT00636636|1070890|P2|Overall Study|Lack of Efficacy|12
326724|NCT00636636|1070891|P1|Overall Study|Lack of Efficacy|7
326725|NCT00636636|1070890|P2|Overall Study|Adverse Event|8
326726|NCT00636636|1070891|P1|Overall Study|Adverse Event|19
326727|NCT00636636|1070890|P2|Overall Study|Other reason|6
326728|NCT00636636|1070891|P1|Overall Study|Other reason|4
326729|NCT00636610|1070907|P2|Overall Study|Reason for discontinuation not available|2
326730|NCT00636610|1070908|P1|Overall Study|Reason for discontinuation not available|3
326731|NCT00636610|1070907|P2|Overall Study|Disease progression - clinical|3
326732|NCT00636610|1070908|P1|Overall Study|Disease progression - clinical|8
326733|NCT00636610|1070907|P2|Overall Study|Disease progression - radiographic|51
326734|NCT00636610|1070908|P1|Overall Study|Disease progression - radiographic|41
326735|NCT00636610|1070907|P2|Overall Study|Subject decision to withdraw|11
326736|NCT00636610|1070908|P1|Overall Study|Subject decision to withdraw|15
326737|NCT00636610|1070907|P2|Overall Study|Physician decision to withdraw patient|9
326738|NCT00636610|1070908|P1|Overall Study|Physician decision to withdraw patient|15
326739|NCT00636610|1070907|P2|Overall Study|Death|3
326740|NCT00636610|1070908|P1|Overall Study|Death|6
326741|NCT00636610|1070907|P2|Overall Study|Adverse Event|4
326742|NCT00636610|1070908|P1|Overall Study|Adverse Event|4
326743|NCT00636441|1070925|P7|Overall Study|Screen Failure|17
326744|NCT00636441|1070926|P6|Overall Study|Screen Failure|0
326745|NCT00636441|1070927|P5|Overall Study|Screen Failure|0
326746|NCT00636441|1070928|P4|Overall Study|Screen Failure|0
326747|NCT00636441|1070929|P3|Overall Study|Screen Failure|0
326748|NCT00636441|1070930|P2|Overall Study|Screen Failure|0
326749|NCT00636441|1070931|P1|Overall Study|Screen Failure|0
326750|NCT00636441|1070925|P7|Overall Study|Late, ineligible|1
326751|NCT00636441|1070926|P6|Overall Study|Late, ineligible|0
326752|NCT00636441|1070927|P5|Overall Study|Late, ineligible|0
326753|NCT00636441|1070928|P4|Overall Study|Late, ineligible|0
326754|NCT00636441|1070929|P3|Overall Study|Late, ineligible|0
326755|NCT00636441|1070930|P2|Overall Study|Late, ineligible|0
326756|NCT00636441|1070931|P1|Overall Study|Late, ineligible|0
326757|NCT00636441|1070925|P7|Overall Study|Adverse Event|0
326758|NCT00636441|1070926|P6|Overall Study|Adverse Event|1
326759|NCT00636441|1070927|P5|Overall Study|Adverse Event|0
326760|NCT00636441|1070928|P4|Overall Study|Adverse Event|0
326761|NCT00636441|1070929|P3|Overall Study|Adverse Event|1
326762|NCT00636441|1070930|P2|Overall Study|Adverse Event|1
326763|NCT00636441|1070931|P1|Overall Study|Adverse Event|0
326764|NCT00636363|1070974|P3|Overall Study|Withdrawal by Subject|2
326765|NCT00636363|1070975|P2|Overall Study|Withdrawal by Subject|3
326766|NCT00636363|1070976|P1|Overall Study|Withdrawal by Subject|1
326767|NCT00636363|1070974|P3|Overall Study|Lost to Follow-up|2
326768|NCT00636363|1070975|P2|Overall Study|Lost to Follow-up|4
326769|NCT00636363|1070976|P1|Overall Study|Lost to Follow-up|3
326770|NCT00636363|1070974|P3|Overall Study|Protocol Violation|0
326771|NCT00636363|1070975|P2|Overall Study|Protocol Violation|3
326772|NCT00636363|1070976|P1|Overall Study|Protocol Violation|0
326773|NCT00636363|1070974|P3|Overall Study|Lack of motivation|1
326774|NCT00636363|1070975|P2|Overall Study|Lack of motivation|0
326775|NCT00636363|1070976|P1|Overall Study|Lack of motivation|1
326776|NCT00636363|1070974|P3|Overall Study|Missed > 1 visit|3
326777|NCT00636363|1070975|P2|Overall Study|Missed > 1 visit|1
326778|NCT00636363|1070976|P1|Overall Study|Missed > 1 visit|0
326779|NCT00636363|1070974|P3|Overall Study|Met ineligibility criteria|3
326780|NCT00636363|1070975|P2|Overall Study|Met ineligibility criteria|0
326781|NCT00636363|1070976|P1|Overall Study|Met ineligibility criteria|0
326782|NCT00636363|1070974|P3|Overall Study|Study related symptoms/complaints|4
326783|NCT00636363|1070975|P2|Overall Study|Study related symptoms/complaints|7
326784|NCT00636363|1070976|P1|Overall Study|Study related symptoms/complaints|8
326785|NCT00636363|1070974|P3|Overall Study|Positive slit lamp finding|1
326786|NCT00636363|1070975|P2|Overall Study|Positive slit lamp finding|2
326787|NCT00636363|1070976|P1|Overall Study|Positive slit lamp finding|0
326788|NCT00636363|1070974|P3|Overall Study|Adverse Event|1
326789|NCT00636363|1070975|P2|Overall Study|Adverse Event|0
326790|NCT00636363|1070976|P1|Overall Study|Adverse Event|0
326791|NCT00636363|1070974|P3|Overall Study|Conjunctivitis|1
326792|NCT00636363|1070975|P2|Overall Study|Conjunctivitis|0
326793|NCT00636363|1070976|P1|Overall Study|Conjunctivitis|0
326794|NCT00636207|1070997|P7|Overall Study|Withdrawal by Subject|0
326795|NCT00636207|1070998|P6|Overall Study|Withdrawal by Subject|0
326796|NCT00636207|1070999|P5|Overall Study|Withdrawal by Subject|1
326797|NCT00636207|1071000|P4|Overall Study|Withdrawal by Subject|0
326798|NCT00636207|1071001|P3|Overall Study|Withdrawal by Subject|0
326799|NCT00636207|1071002|P2|Overall Study|Withdrawal by Subject|1
326800|NCT00636207|1071003|P1|Overall Study|Withdrawal by Subject|0
326801|NCT00636207|1070997|P7|Overall Study|Adverse Event|0
326802|NCT00636207|1070998|P6|Overall Study|Adverse Event|0
326803|NCT00636207|1070999|P5|Overall Study|Adverse Event|0
326804|NCT00636207|1071000|P4|Overall Study|Adverse Event|0
326805|NCT00636207|1071001|P3|Overall Study|Adverse Event|0
326806|NCT00636207|1071002|P2|Overall Study|Adverse Event|0
326807|NCT00636207|1071003|P1|Overall Study|Adverse Event|1
326808|NCT00636194|1071067|P2|Overall Study|Protocol Violation|0
326809|NCT00636194|1071068|P1|Overall Study|Protocol Violation|2
326810|NCT00636194|1071067|P2|Overall Study|Study related symptoms and complaints|0
326811|NCT00636194|1071068|P1|Overall Study|Study related symptoms and complaints|1
326812|NCT00636168|1071080|P2|Treated With Study Drug|Still remains on treatment|94
326813|NCT00636168|1071081|P1|Treated With Study Drug|Still remains on treatment|48
326814|NCT00636168|1071080|P2|Treated With Study Drug|non-specified|1
326815|NCT00636168|1071081|P1|Treated With Study Drug|non-specified|1
326816|NCT00636168|1071080|P2|Treated With Study Drug|No longer meets criteria|0
326817|NCT00636168|1071081|P1|Treated With Study Drug|No longer meets criteria|1
326818|NCT00636168|1071080|P2|Treated With Study Drug|Pregnancy|0
326819|NCT00636168|1071081|P1|Treated With Study Drug|Pregnancy|1
326820|NCT00636168|1071080|P2|Treated With Study Drug|Death|0
326821|NCT00636168|1071081|P1|Treated With Study Drug|Death|3
326822|NCT00636168|1071080|P2|Treated With Study Drug|Poor or non-compliance|3
326823|NCT00636168|1071081|P1|Treated With Study Drug|Poor or non-compliance|1
326824|NCT00636168|1071080|P2|Treated With Study Drug|Withdrawal by Subject|20
326825|NCT00636168|1071081|P1|Treated With Study Drug|Withdrawal by Subject|16
326826|NCT00636168|1071080|P2|Treated With Study Drug|Adverse Event|20
326827|NCT00636168|1071081|P1|Treated With Study Drug|Adverse Event|244
326828|NCT00636168|1071080|P2|Treated With Study Drug|Recurrence of disease|273
326829|NCT00636168|1071081|P1|Treated With Study Drug|Recurrence of disease|132
326830|NCT00636168|1071080|P2|Randomized to Study Drug|No longer met study criteria|0
326831|NCT00636168|1071081|P1|Randomized to Study Drug|No longer met study criteria|1
326832|NCT00636168|1071080|P2|Randomized to Study Drug|Adverse Event|0
326833|NCT00636168|1071081|P1|Randomized to Study Drug|Adverse Event|1
326834|NCT00636168|1071080|P2|Randomized to Study Drug|Withdrawal by Subject|2
326835|NCT00636168|1071081|P1|Randomized to Study Drug|Withdrawal by Subject|2
326836|NCT00636155|1071101|P1|Overall Study|Physician Decision|5
326837|NCT00636155|1071101|P1|Overall Study|Stem cell transplant|1
326838|NCT00636155|1071101|P1|Overall Study|Withdrawal by Subject|3
326839|NCT00636155|1071101|P1|Overall Study|Lack of Efficacy|1
326840|NCT00636155|1071101|P1|Overall Study|Adverse Event|8
326841|NCT00635882|1071146|P6|Overall Study|Protocol Violation|0
326842|NCT00635882|1071147|P5|Overall Study|Protocol Violation|0
326843|NCT00635882|1071148|P4|Overall Study|Protocol Violation|0
326844|NCT00635882|1071149|P3|Overall Study|Protocol Violation|0
326845|NCT00635882|1071150|P2|Overall Study|Protocol Violation|0
326846|NCT00635882|1071151|P1|Overall Study|Protocol Violation|1
326847|NCT00635804|1071281|P8|Overall Study|Withdrawal by Subject|0
326848|NCT00635804|1071282|P7|Overall Study|Withdrawal by Subject|0
326849|NCT00635804|1071283|P6|Overall Study|Withdrawal by Subject|0
326850|NCT00635804|1071284|P5|Overall Study|Withdrawal by Subject|0
326851|NCT00635804|1071285|P4|Overall Study|Withdrawal by Subject|0
326852|NCT00635804|1071286|P3|Overall Study|Withdrawal by Subject|0
326853|NCT00635804|1071287|P2|Overall Study|Withdrawal by Subject|0
326854|NCT00635804|1071288|P1|Overall Study|Withdrawal by Subject|1
326855|NCT00635804|1071281|P8|Overall Study|Adverse Event|0
326856|NCT00635804|1071282|P7|Overall Study|Adverse Event|0
326857|NCT00635804|1071283|P6|Overall Study|Adverse Event|1
326858|NCT00635804|1071284|P5|Overall Study|Adverse Event|0
326859|NCT00635804|1071285|P4|Overall Study|Adverse Event|0
326860|NCT00635804|1071286|P3|Overall Study|Adverse Event|0
326861|NCT00635804|1071287|P2|Overall Study|Adverse Event|0
326862|NCT00635804|1071288|P1|Overall Study|Adverse Event|0
326863|NCT00635661|1071394|P1|Overall Study|Withdrawal by Subject|4
326864|NCT00635648|1071398|P1|Overall Study|Other reason|2
326865|NCT00635648|1071398|P1|Overall Study|Noncompliance with protocol|1
326866|NCT00635648|1071398|P1|Overall Study|No improvement after 7-10 days treatment|4
326867|NCT00635648|1071398|P1|Overall Study|Use of other antifungal agent needed|1
326868|NCT00635648|1071398|P1|Overall Study|Rapid progression of baseline disease|4
326869|NCT00635648|1071398|P1|Overall Study|Physician Decision|4
326870|NCT00635648|1071398|P1|Overall Study|Withdrawal by Subject|9
326871|NCT00635648|1071398|P1|Overall Study|Adverse Event|12
326872|NCT00635570|1071420|P2|Overall Study|Early termination(No sexual activity)|1
326873|NCT00635570|1071421|P1|Overall Study|Early termination(No sexual activity)|1
326874|NCT00635570|1071420|P2|Overall Study|Did not complete survey|1
326875|NCT00635570|1071421|P1|Overall Study|Did not complete survey|2
326876|NCT00635570|1071420|P2|Overall Study|Physician Decision|0
326877|NCT00635570|1071421|P1|Overall Study|Physician Decision|1
326878|NCT00635570|1071420|P2|Overall Study|Adverse Event|0
326879|NCT00635570|1071421|P1|Overall Study|Adverse Event|2
326880|NCT00635570|1071420|P2|Overall Study|Withdrawal by Subject|1
326881|NCT00635570|1071421|P1|Overall Study|Withdrawal by Subject|1
326882|NCT00635570|1071420|P2|Overall Study|Lost to Follow-up|8
326883|NCT00635570|1071421|P1|Overall Study|Lost to Follow-up|8
326884|NCT00635492|1071435|P2|Overall Study|Withdrawal by Subject|45
326885|NCT00635492|1071436|P1|Overall Study|Withdrawal by Subject|82
326886|NCT00635492|1071435|P2|Overall Study|Sponsor decision|3
326887|NCT00635492|1071436|P1|Overall Study|Sponsor decision|2
326888|NCT00635492|1071435|P2|Overall Study|Physician Decision|22
326889|NCT00635492|1071436|P1|Overall Study|Physician Decision|32
326890|NCT00635492|1071435|P2|Overall Study|Lost to Follow-up|172
326891|NCT00635492|1071436|P1|Overall Study|Lost to Follow-up|151
326892|NCT00635492|1071435|P2|Overall Study|Death|40
326893|NCT00635492|1071436|P1|Overall Study|Death|12
326894|NCT00635427|1071494|P5|Overall Study|Withdrawal Of Consent|2
326895|NCT00635427|1071495|P4|Overall Study|Withdrawal Of Consent|2
326896|NCT00635427|1071496|P3|Overall Study|Withdrawal Of Consent|0
326897|NCT00635427|1071497|P2|Overall Study|Withdrawal Of Consent|0
326898|NCT00635427|1071498|P1|Overall Study|Withdrawal Of Consent|0
326899|NCT00635427|1071494|P5|Overall Study|Termination Of Study By Sponsor|6
326900|NCT00635427|1071495|P4|Overall Study|Termination Of Study By Sponsor|6
326901|NCT00635427|1071496|P3|Overall Study|Termination Of Study By Sponsor|10
326902|NCT00635427|1071497|P2|Overall Study|Termination Of Study By Sponsor|6
326903|NCT00635427|1071498|P1|Overall Study|Termination Of Study By Sponsor|12
326904|NCT00635427|1071494|P5|Overall Study|Death|0
326905|NCT00635427|1071495|P4|Overall Study|Death|1
326906|NCT00635427|1071496|P3|Overall Study|Death|0
326907|NCT00635427|1071497|P2|Overall Study|Death|0
326908|NCT00635427|1071498|P1|Overall Study|Death|0
326909|NCT00635427|1071494|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
326910|NCT00635427|1071495|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
326911|NCT00635427|1071496|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
326912|NCT00635427|1071497|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
326913|NCT00635427|1071498|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
326914|NCT00635349|1071537|P2|Overall Study|Adverse Event|9
326915|NCT00635349|1071538|P1|Overall Study|Adverse Event|11
326916|NCT00635349|1071537|P2|Overall Study|Lost to Follow-up|3
326917|NCT00635349|1071538|P1|Overall Study|Lost to Follow-up|4
326918|NCT00635349|1071537|P2|Overall Study|Withdrawal by Subject|8
326919|NCT00635349|1071538|P1|Overall Study|Withdrawal by Subject|3
326920|NCT00635349|1071537|P2|Overall Study|Protocol Violation|22
326921|NCT00635349|1071538|P1|Overall Study|Protocol Violation|18
326922|NCT00635349|1071537|P2|Overall Study|Unspecified|6
326923|NCT00635349|1071538|P1|Overall Study|Unspecified|8
326924|NCT00635219|1071592|P5|Overall Study|Administrative or Other Reasons|1
326925|NCT00635219|1071593|P4|Overall Study|Administrative or Other Reasons|0
326926|NCT00635219|1071594|P3|Overall Study|Administrative or Other Reasons|1
326927|NCT00635219|1071595|P2|Overall Study|Administrative or Other Reasons|1
326928|NCT00635219|1071596|P1|Overall Study|Administrative or Other Reasons|0
326929|NCT00635219|1071592|P5|Overall Study|Lost to Follow-up|3
326930|NCT00635219|1071593|P4|Overall Study|Lost to Follow-up|0
326931|NCT00635219|1071594|P3|Overall Study|Lost to Follow-up|2
326932|NCT00635219|1071595|P2|Overall Study|Lost to Follow-up|0
326933|NCT00635219|1071596|P1|Overall Study|Lost to Follow-up|0
326934|NCT00635219|1071592|P5|Overall Study|Withdrawal of Consent|8
326935|NCT00635219|1071593|P4|Overall Study|Withdrawal of Consent|11
326936|NCT00635219|1071594|P3|Overall Study|Withdrawal of Consent|8
326937|NCT00635219|1071595|P2|Overall Study|Withdrawal of Consent|6
326938|NCT00635219|1071596|P1|Overall Study|Withdrawal of Consent|8
326939|NCT00635219|1071592|P5|Overall Study|Protocol Violation|4
326940|NCT00635219|1071593|P4|Overall Study|Protocol Violation|2
326941|NCT00635219|1071594|P3|Overall Study|Protocol Violation|3
326942|NCT00635219|1071595|P2|Overall Study|Protocol Violation|2
326943|NCT00635219|1071596|P1|Overall Study|Protocol Violation|0
326944|NCT00635219|1071592|P5|Overall Study|Non-compliance With Study Product|1
326945|NCT00635219|1071593|P4|Overall Study|Non-compliance With Study Product|2
326946|NCT00635219|1071594|P3|Overall Study|Non-compliance With Study Product|0
326947|NCT00635219|1071595|P2|Overall Study|Non-compliance With Study Product|0
326948|NCT00635219|1071596|P1|Overall Study|Non-compliance With Study Product|0
326949|NCT00635219|1071592|P5|Overall Study|Lack of Efficacy|6
326950|NCT00635219|1071593|P4|Overall Study|Lack of Efficacy|4
326951|NCT00635219|1071594|P3|Overall Study|Lack of Efficacy|3
326952|NCT00635219|1071595|P2|Overall Study|Lack of Efficacy|6
326953|NCT00635219|1071596|P1|Overall Study|Lack of Efficacy|5
326954|NCT00635219|1071592|P5|Overall Study|Adverse Event|19
326955|NCT00635219|1071593|P4|Overall Study|Adverse Event|15
326956|NCT00635219|1071594|P3|Overall Study|Adverse Event|18
326957|NCT00635219|1071595|P2|Overall Study|Adverse Event|10
326958|NCT00635219|1071596|P1|Overall Study|Adverse Event|12
326959|NCT00635154|1071653|P1|Overall Study|Still on treatment|21
326960|NCT00635154|1071653|P1|Overall Study|Other|4
326961|NCT00635154|1071653|P1|Overall Study|Alternative Treatment|8
326962|NCT00635102|1071665|P2|Overall Study|Withdrawal by Subject|8
326963|NCT00635102|1071666|P1|Overall Study|Withdrawal by Subject|7
326964|NCT00635089|1071760|P1|Overall Study|Not Specified|31
326965|NCT00635089|1071760|P1|Overall Study|Lost to Follow-up|8
326966|NCT00635089|1071760|P1|Overall Study|Protocol Deviation|4
326967|NCT00635089|1071760|P1|Overall Study|Lack of Efficacy|28
326968|NCT00635089|1071760|P1|Overall Study|Adverse Event|7
326969|NCT00635050|1071787|P1|Overall Study|Withdrawal by Subject|1
326970|NCT00635024|1071794|P1|Overall Study|Adverse Event|1
326971|NCT00634933|1071805|P5|Part B: Week 24 to Week 52|Unspecified|1
326972|NCT00634933|1071806|P4|Part B: Week 24 to Week 52|Unspecified|0
326973|NCT00634933|1071807|P3|Part B: Week 24 to Week 52|Unspecified|5
326974|NCT00634933|1071808|P2|Part B: Week 24 to Week 52|Unspecified|0
326975|NCT00634933|1071809|P1|Part B: Week 24 to Week 52|Unspecified|0
326976|NCT00634933|1071805|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
326977|NCT00634933|1071806|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
326978|NCT00634933|1071807|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
326979|NCT00634933|1071808|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
326980|NCT00634933|1071809|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
326981|NCT00634933|1071805|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
326982|NCT00634933|1071806|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
326983|NCT00634933|1071807|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
326984|NCT00634933|1071808|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
326985|NCT00634933|1071809|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
326986|NCT00634933|1071805|P5|Part B: Week 24 to Week 52|Protocol Violation|1
326987|NCT00634933|1071806|P4|Part B: Week 24 to Week 52|Protocol Violation|0
326988|NCT00634933|1071807|P3|Part B: Week 24 to Week 52|Protocol Violation|0
326989|NCT00634933|1071808|P2|Part B: Week 24 to Week 52|Protocol Violation|0
326990|NCT00634933|1071809|P1|Part B: Week 24 to Week 52|Protocol Violation|0
326991|NCT00634933|1071805|P5|Part B: Week 24 to Week 52|Physician Decision|0
326992|NCT00634933|1071806|P4|Part B: Week 24 to Week 52|Physician Decision|0
326993|NCT00634933|1071807|P3|Part B: Week 24 to Week 52|Physician Decision|1
326994|NCT00634933|1071808|P2|Part B: Week 24 to Week 52|Physician Decision|1
326995|NCT00634933|1071809|P1|Part B: Week 24 to Week 52|Physician Decision|0
326996|NCT00634933|1071805|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
326997|NCT00634933|1071806|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
326998|NCT00634933|1071807|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
326999|NCT00634933|1071808|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
327000|NCT00634933|1071809|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
327001|NCT00634933|1071805|P5|Part B: Week 24 to Week 52|Adverse Event|0
327002|NCT00634933|1071806|P4|Part B: Week 24 to Week 52|Adverse Event|1
327003|NCT00634933|1071807|P3|Part B: Week 24 to Week 52|Adverse Event|1
327004|NCT00634933|1071808|P2|Part B: Week 24 to Week 52|Adverse Event|1
327005|NCT00634933|1071809|P1|Part B: Week 24 to Week 52|Adverse Event|0
327006|NCT00634933|1071805|P5|Between Part A and Part B|Physician Decision|0
327007|NCT00634933|1071806|P4|Between Part A and Part B|Physician Decision|0
327008|NCT00634933|1071807|P3|Between Part A and Part B|Physician Decision|0
327009|NCT00634933|1071808|P2|Between Part A and Part B|Physician Decision|1
327010|NCT00634933|1071809|P1|Between Part A and Part B|Physician Decision|0
327011|NCT00634933|1071805|P5|Part A: Baseline to Week 24|Unspecified|0
327012|NCT00634933|1071806|P4|Part A: Baseline to Week 24|Unspecified|0
327013|NCT00634933|1071807|P3|Part A: Baseline to Week 24|Unspecified|5
327014|NCT00634933|1071808|P2|Part A: Baseline to Week 24|Unspecified|8
327015|NCT00634933|1071809|P1|Part A: Baseline to Week 24|Unspecified|1
327016|NCT00634933|1071805|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
327017|NCT00634933|1071806|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
327018|NCT00634933|1071807|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
327019|NCT00634933|1071808|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
327020|NCT00634933|1071809|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
327021|NCT00634933|1071805|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
327022|NCT00634933|1071806|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
327023|NCT00634933|1071807|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
327024|NCT00634933|1071808|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
327025|NCT00634933|1071809|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
327026|NCT00634933|1071805|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
327027|NCT00634933|1071806|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
327028|NCT00634933|1071807|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
327029|NCT00634933|1071808|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
327030|NCT00634933|1071809|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
327031|NCT00634933|1071805|P5|Part A: Baseline to Week 24|Investigator Request|0
327032|NCT00634933|1071806|P4|Part A: Baseline to Week 24|Investigator Request|0
327033|NCT00634933|1071807|P3|Part A: Baseline to Week 24|Investigator Request|1
327034|NCT00634933|1071808|P2|Part A: Baseline to Week 24|Investigator Request|1
327035|NCT00634933|1071809|P1|Part A: Baseline to Week 24|Investigator Request|1
327036|NCT00634933|1071805|P5|Part A: Baseline to Week 24|Failed to Return|0
327037|NCT00634933|1071806|P4|Part A: Baseline to Week 24|Failed to Return|0
327038|NCT00634933|1071807|P3|Part A: Baseline to Week 24|Failed to Return|0
327039|NCT00634933|1071808|P2|Part A: Baseline to Week 24|Failed to Return|0
327040|NCT00634933|1071809|P1|Part A: Baseline to Week 24|Failed to Return|1
327041|NCT00634933|1071805|P5|Part A: Baseline to Week 24|Death|0
327042|NCT00634933|1071806|P4|Part A: Baseline to Week 24|Death|0
327043|NCT00634933|1071807|P3|Part A: Baseline to Week 24|Death|0
327044|NCT00634933|1071808|P2|Part A: Baseline to Week 24|Death|0
327045|NCT00634933|1071809|P1|Part A: Baseline to Week 24|Death|1
327046|NCT00634933|1071805|P5|Part A: Baseline to Week 24|Adverse Event|0
327047|NCT00634933|1071806|P4|Part A: Baseline to Week 24|Adverse Event|0
327048|NCT00634933|1071807|P3|Part A: Baseline to Week 24|Adverse Event|8
327049|NCT00634933|1071808|P2|Part A: Baseline to Week 24|Adverse Event|4
327050|NCT00634933|1071809|P1|Part A: Baseline to Week 24|Adverse Event|4
327051|NCT00634920|1071878|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
327052|NCT00634920|1071879|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
327053|NCT00634920|1071880|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
327054|NCT00634920|1071878|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
327055|NCT00634920|1071879|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
327056|NCT00634920|1071880|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
327057|NCT00634920|1071878|P3|Period 2 - Post-Randomization|Death|0
327058|NCT00634920|1071879|P2|Period 2 - Post-Randomization|Death|5
327059|NCT00634920|1071880|P1|Period 2 - Post-Randomization|Death|2
327060|NCT00634920|1071878|P3|Period 2 - Post-Randomization|Rejection|0
327061|NCT00634920|1071879|P2|Period 2 - Post-Randomization|Rejection|5
327062|NCT00634920|1071880|P1|Period 2 - Post-Randomization|Rejection|11
327063|NCT00634920|1071878|P3|Period 2 - Post-Randomization|Adverse Event|0
327064|NCT00634920|1071879|P2|Period 2 - Post-Randomization|Adverse Event|9
327065|NCT00634920|1071880|P1|Period 2 - Post-Randomization|Adverse Event|37
327066|NCT00634920|1071878|P3|Period 1 - Pre-Randomization|Other issues|6
327067|NCT00634920|1071879|P2|Period 1 - Pre-Randomization|Other issues|0
327068|NCT00634920|1071880|P1|Period 1 - Pre-Randomization|Other issues|0
327069|NCT00634920|1071878|P3|Period 1 - Pre-Randomization|Non-Compliance|3
327070|NCT00634920|1071879|P2|Period 1 - Pre-Randomization|Non-Compliance|0
327071|NCT00634920|1071880|P1|Period 1 - Pre-Randomization|Non-Compliance|0
327072|NCT00634920|1071878|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
327073|NCT00634920|1071879|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
327074|NCT00634920|1071880|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
327075|NCT00634920|1071878|P3|Period 1 - Pre-Randomization|Rejections|55
327076|NCT00634920|1071879|P2|Period 1 - Pre-Randomization|Rejections|0
327077|NCT00634920|1071880|P1|Period 1 - Pre-Randomization|Rejections|0
327078|NCT00634920|1071878|P3|Period 1 - Pre-Randomization|Wound healing problems|16
327079|NCT00634920|1071879|P2|Period 1 - Pre-Randomization|Wound healing problems|0
327080|NCT00634920|1071880|P1|Period 1 - Pre-Randomization|Wound healing problems|0
327081|NCT00634920|1071878|P3|Period 1 - Pre-Randomization|Adverse Event|36
327082|NCT00634920|1071879|P2|Period 1 - Pre-Randomization|Adverse Event|0
327083|NCT00634920|1071880|P1|Period 1 - Pre-Randomization|Adverse Event|0
327084|NCT00634907|1071924|P2|Overall Study|Withdrawal by Subject|8
327085|NCT00634907|1071925|P1|Overall Study|Withdrawal by Subject|11
327086|NCT00634907|1071924|P2|Overall Study|Physician Decision|9
327087|NCT00634907|1071925|P1|Overall Study|Physician Decision|3
327088|NCT00634907|1071924|P2|Overall Study|Withdrawal by Subject|0
327089|NCT00634907|1071925|P1|Overall Study|Withdrawal by Subject|3
327090|NCT00634842|1071949|P2|Overall Study|Subject off study drug for too long|1
327091|NCT00634842|1071950|P1|Overall Study|Subject off study drug for too long|0
327092|NCT00634842|1071949|P2|Overall Study|No wish to keep taking Avandia|1
327093|NCT00634842|1071950|P1|Overall Study|No wish to keep taking Avandia|0
327094|NCT00634842|1071949|P2|Overall Study|No need of study drug to treat diabetes|1
327095|NCT00634842|1071950|P1|Overall Study|No need of study drug to treat diabetes|0
327096|NCT00634842|1071949|P2|Overall Study|Discontinued due to injection|2
327097|NCT00634842|1071950|P1|Overall Study|Discontinued due to injection|0
327098|NCT00634842|1071949|P2|Overall Study|Lack of time and intolerance to drug|1
327099|NCT00634842|1071950|P1|Overall Study|Lack of time and intolerance to drug|0
327100|NCT00634842|1071949|P2|Overall Study|Withdrawal by Subject|3
327101|NCT00634842|1071950|P1|Overall Study|Withdrawal by Subject|1
327102|NCT00634842|1071949|P2|Overall Study|Physician Decision|0
327103|NCT00634842|1071950|P1|Overall Study|Physician Decision|1
327104|NCT00634842|1071949|P2|Overall Study|Lost to Follow-up|2
327105|NCT00634842|1071950|P1|Overall Study|Lost to Follow-up|1
327106|NCT00634842|1071949|P2|Overall Study|Inclusion criteria were not met|0
327107|NCT00634842|1071950|P1|Overall Study|Inclusion criteria were not met|1
327108|NCT00634842|1071949|P2|Overall Study|Move to another state|0
327109|NCT00634842|1071950|P1|Overall Study|Move to another state|1
327110|NCT00634842|1071949|P2|Overall Study|Protocol Violation|4
327111|NCT00634842|1071950|P1|Overall Study|Protocol Violation|8
327112|NCT00634842|1071949|P2|Overall Study|Adverse Event|3
327113|NCT00634842|1071950|P1|Overall Study|Adverse Event|2
327114|NCT00634647|1071962|P1|Overall Study|declined to participate before treatment|1
327115|NCT00634647|1071962|P1|Overall Study|refused further treatment|3
327116|NCT00634647|1071962|P1|Overall Study|death on study|5
327117|NCT00634569|1071981|P2|Overall Study|Physician Decision|1
327118|NCT00634569|1071982|P1|Overall Study|Physician Decision|0
327119|NCT00634569|1071981|P2|Overall Study|Withdrawal by Subject|4
327120|NCT00634569|1071982|P1|Overall Study|Withdrawal by Subject|0
327121|NCT00634543|1071996|P2|Overall Study|Lost to Follow-up|1
327122|NCT00634543|1071997|P1|Overall Study|Lost to Follow-up|0
327123|NCT00634543|1071996|P2|Overall Study|Withdrawal by Subject|4
327124|NCT00634543|1071997|P1|Overall Study|Withdrawal by Subject|4
327125|NCT00634543|1071996|P2|Overall Study|Adverse Event|11
327126|NCT00634543|1071997|P1|Overall Study|Adverse Event|11
327127|NCT00634543|1071996|P2|Overall Study|Protocol Violation|3
327128|NCT00634543|1071997|P1|Overall Study|Protocol Violation|3
327129|NCT00634543|1071996|P2|Overall Study|Unspecified|2
327130|NCT00634543|1071997|P1|Overall Study|Unspecified|1
327131|NCT00634504|1072015|P2|Overall Study|Protocol Violation|0
327132|NCT00634504|1072016|P1|Overall Study|Protocol Violation|1
327133|NCT00633360|1072024|P2|Overall Study|Protocol Violation|1
327134|NCT00633360|1072025|P1|Overall Study|Protocol Violation|0
327135|NCT00633360|1072024|P2|Overall Study|Adverse Event|1
327136|NCT00633360|1072025|P1|Overall Study|Adverse Event|3
327137|NCT00633360|1072024|P2|Overall Study|Lost to Follow-up|1
327138|NCT00633360|1072025|P1|Overall Study|Lost to Follow-up|1
327139|NCT00633243|1072048|P2|Overall Study|Couldn't tolerate side-effects|1
327140|NCT00633243|1072049|P1|Overall Study|Couldn't tolerate side-effects|1
327141|NCT00633243|1072048|P2|Overall Study|Mental Health--Depression|1
327142|NCT00633243|1072049|P1|Overall Study|Mental Health--Depression|0
327143|NCT00633243|1072048|P2|Overall Study|Not comfortable with self-injecting|1
327144|NCT00633243|1072049|P1|Overall Study|Not comfortable with self-injecting|0
327145|NCT00633243|1072048|P2|Overall Study|Homeless--no refrigeration for meds|1
327146|NCT00633243|1072049|P1|Overall Study|Homeless--no refrigeration for meds|0
327147|NCT00633243|1072048|P2|Overall Study|incarceration|2
327148|NCT00633243|1072049|P1|Overall Study|incarceration|0
327149|NCT00633243|1072048|P2|Overall Study|Withdrawal by Subject|1
327150|NCT00633243|1072049|P1|Overall Study|Withdrawal by Subject|0
327151|NCT00633217|1072057|P2|Overall Study|Withdrew Consent|3
327152|NCT00633217|1072058|P1|Overall Study|Withdrew Consent|3
327153|NCT00633217|1072057|P2|Overall Study|Investigator Discretion|0
327154|NCT00633217|1072058|P1|Overall Study|Investigator Discretion|2
327155|NCT00633217|1072057|P2|Overall Study|Lost to Follow-up|2
327156|NCT00633217|1072058|P1|Overall Study|Lost to Follow-up|2
327157|NCT00633217|1072057|P2|Overall Study|Protocol Violation|7
327158|NCT00633217|1072058|P1|Overall Study|Protocol Violation|3
327159|NCT00633217|1072057|P2|Overall Study|Lack of Efficacy|2
327160|NCT00633217|1072058|P1|Overall Study|Lack of Efficacy|0
327161|NCT00633217|1072057|P2|Overall Study|Adverse Event|9
327162|NCT00633217|1072058|P1|Overall Study|Adverse Event|5
327163|NCT00633152|1072070|P2|Overall Study|Miscellaneous Other|2
327164|NCT00633152|1072071|P1|Overall Study|Miscellaneous Other|3
327165|NCT00633152|1072070|P2|Overall Study|Lost to Follow-up|1
327166|NCT00633152|1072071|P1|Overall Study|Lost to Follow-up|4
327167|NCT00633152|1072070|P2|Overall Study|Withdrawal by Subject|1
327168|NCT00633152|1072071|P1|Overall Study|Withdrawal by Subject|1
327169|NCT00633152|1072070|P2|Overall Study|Randomized, did not receive study drug|2
327170|NCT00633152|1072071|P1|Overall Study|Randomized, did not receive study drug|5
327171|NCT00633152|1072070|P2|Overall Study|Adverse Event|0
327172|NCT00633152|1072071|P1|Overall Study|Adverse Event|1
327173|NCT00634244|1072122|P3|Overall Study|Other complicating disease|0
327174|NCT00634244|1072123|P2|Overall Study|Other complicating disease|1
327175|NCT00634244|1072124|P1|Overall Study|Other complicating disease|0
327176|NCT00634244|1072122|P3|Overall Study|Disease progression/relapse|0
327177|NCT00634244|1072123|P2|Overall Study|Disease progression/relapse|1
327178|NCT00634244|1072124|P1|Overall Study|Disease progression/relapse|0
327179|NCT00634244|1072122|P3|Overall Study|Physician Decision|0
327180|NCT00634244|1072123|P2|Overall Study|Physician Decision|1
327181|NCT00634244|1072124|P1|Overall Study|Physician Decision|0
327182|NCT00634244|1072122|P3|Overall Study|Withdrawal by Subject|0
327183|NCT00634244|1072123|P2|Overall Study|Withdrawal by Subject|1
327184|NCT00634244|1072124|P1|Overall Study|Withdrawal by Subject|0
327185|NCT00634244|1072122|P3|Overall Study|Adverse Event|0
327186|NCT00634244|1072123|P2|Overall Study|Adverse Event|2
327187|NCT00634244|1072124|P1|Overall Study|Adverse Event|0
327188|NCT00634244|1072122|P3|Overall Study|Death|0
327189|NCT00634244|1072123|P2|Overall Study|Death|6
327190|NCT00634244|1072124|P1|Overall Study|Death|1
327191|NCT00634244|1072122|P3|Overall Study|Never started treatment|0
327192|NCT00634244|1072123|P2|Overall Study|Never started treatment|1
327193|NCT00634244|1072124|P1|Overall Study|Never started treatment|0
327194|NCT00634179|1072135|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
327195|NCT00634114|1072154|P3|Overall Study|Other reason|1
327196|NCT00634114|1072155|P2|Overall Study|Other reason|1
327197|NCT00634114|1072156|P1|Overall Study|Other reason|1
327198|NCT00634114|1072154|P3|Overall Study|Difficult to continue|1
327199|NCT00634114|1072155|P2|Overall Study|Difficult to continue|1
327200|NCT00634114|1072156|P1|Overall Study|Difficult to continue|3
327201|NCT00634114|1072154|P3|Overall Study|Recurrence of reflux esophagitis|21
327202|NCT00634114|1072155|P2|Overall Study|Recurrence of reflux esophagitis|15
327203|NCT00634114|1072156|P1|Overall Study|Recurrence of reflux esophagitis|5
327204|NCT00634114|1072154|P3|Overall Study|Incorrect enrolment|0
327205|NCT00634114|1072155|P2|Overall Study|Incorrect enrolment|1
327206|NCT00634114|1072156|P1|Overall Study|Incorrect enrolment|0
327207|NCT00634114|1072154|P3|Overall Study|Pregnancy|0
327208|NCT00634114|1072155|P2|Overall Study|Pregnancy|0
327209|NCT00634114|1072156|P1|Overall Study|Pregnancy|1
327210|NCT00634114|1072154|P3|Overall Study|Protocol Violation|1
327211|NCT00634114|1072155|P2|Overall Study|Protocol Violation|3
327212|NCT00634114|1072156|P1|Overall Study|Protocol Violation|3
327213|NCT00634114|1072154|P3|Overall Study|Lost to Follow-up|1
327214|NCT00634114|1072155|P2|Overall Study|Lost to Follow-up|0
327215|NCT00634114|1072156|P1|Overall Study|Lost to Follow-up|0
327216|NCT00634114|1072154|P3|Overall Study|Withdrawal by Subject|11
327217|NCT00634114|1072155|P2|Overall Study|Withdrawal by Subject|6
327218|NCT00634114|1072156|P1|Overall Study|Withdrawal by Subject|9
327219|NCT00634114|1072154|P3|Overall Study|Adverse Event|3
327220|NCT00634114|1072155|P2|Overall Study|Adverse Event|8
327221|NCT00634114|1072156|P1|Overall Study|Adverse Event|6
327222|NCT00634088|1072174|P4|Time Period 3: Dose Level 3|Progressive disease|0
327223|NCT00634088|1072175|P3|Time Period 3: Dose Level 3|Progressive disease|1
327224|NCT00634088|1072176|P2|Time Period 3: Dose Level 3|Progressive disease|0
327225|NCT00634088|1072177|P1|Time Period 3: Dose Level 3|Progressive disease|0
327226|NCT00634088|1072174|P4|Time Period 2: Dose Level 2|Progressive disease|0
327227|NCT00634088|1072175|P3|Time Period 2: Dose Level 2|Progressive disease|0
327228|NCT00634088|1072176|P2|Time Period 2: Dose Level 2|Progressive disease|1
327229|NCT00634088|1072177|P1|Time Period 2: Dose Level 2|Progressive disease|0
327230|NCT00634088|1072174|P4|Time Period 2: Dose Level 2|Adverse Event|0
327231|NCT00634088|1072175|P3|Time Period 2: Dose Level 2|Adverse Event|0
327232|NCT00634088|1072176|P2|Time Period 2: Dose Level 2|Adverse Event|2
327233|NCT00634088|1072177|P1|Time Period 2: Dose Level 2|Adverse Event|0
327234|NCT00634088|1072174|P4|Time Period 1: Dose Level 1|Adverse Event|0
327235|NCT00634088|1072175|P3|Time Period 1: Dose Level 1|Adverse Event|0
327236|NCT00634088|1072176|P2|Time Period 1: Dose Level 1|Adverse Event|0
327237|NCT00634088|1072177|P1|Time Period 1: Dose Level 1|Adverse Event|3
327238|NCT00634088|1072174|P4|Time Period 1: Dose Level 1|Physician Decision|0
327239|NCT00634088|1072175|P3|Time Period 1: Dose Level 1|Physician Decision|0
327240|NCT00634088|1072176|P2|Time Period 1: Dose Level 1|Physician Decision|0
327241|NCT00634088|1072177|P1|Time Period 1: Dose Level 1|Physician Decision|1
327242|NCT00634088|1072174|P4|Time Period 1: Dose Level 1|Disease progression|0
327243|NCT00634088|1072175|P3|Time Period 1: Dose Level 1|Disease progression|0
327244|NCT00634088|1072176|P2|Time Period 1: Dose Level 1|Disease progression|0
327245|NCT00634088|1072177|P1|Time Period 1: Dose Level 1|Disease progression|2
327246|NCT00634049|1072228|P1|Overall Study|Screening failure|1
327247|NCT00634049|1072228|P1|Overall Study|Died prior to receiving study drug|1
327248|NCT00634049|1072228|P1|Overall Study|Never received study drug|1
327249|NCT00634010|1072307|P2|Overall Study|Non-Compliant|1
327250|NCT00634010|1072308|P1|Overall Study|Non-Compliant|1
327251|NCT00634010|1072307|P2|Overall Study|Disease Progression|1
327252|NCT00634010|1072308|P1|Overall Study|Disease Progression|1
327253|NCT00634010|1072307|P2|Overall Study|Physician Decision|1
327254|NCT00634010|1072308|P1|Overall Study|Physician Decision|1
327255|NCT00634010|1072307|P2|Overall Study|Withdrawal by Subject|6
327256|NCT00634010|1072308|P1|Overall Study|Withdrawal by Subject|5
327257|NCT00634010|1072307|P2|Overall Study|Adverse Event|5
327258|NCT00634010|1072308|P1|Overall Study|Adverse Event|2
327259|NCT00633984|1072316|P2|Overall Study|Hospitalized|0
327260|NCT00633984|1072317|P1|Overall Study|Hospitalized|1
327261|NCT00633984|1072316|P2|Overall Study|Withdrawal by Subject|7
327262|NCT00633984|1072317|P1|Overall Study|Withdrawal by Subject|8
327263|NCT00633984|1072316|P2|Overall Study|Lost to Follow-up|6
327264|NCT00633984|1072317|P1|Overall Study|Lost to Follow-up|0
327265|NCT00633932|1072328|P3|Overall Study|Moved Away|0
327266|NCT00633932|1072329|P2|Overall Study|Moved Away|0
327267|NCT00633932|1072330|P1|Overall Study|Moved Away|1
327268|NCT00633932|1072328|P3|Overall Study|Doctor's judgement|0
327269|NCT00633932|1072329|P2|Overall Study|Doctor's judgement|0
327270|NCT00633932|1072330|P1|Overall Study|Doctor's judgement|1
327271|NCT00633932|1072328|P3|Overall Study|Physician Decision|1
327272|NCT00633932|1072329|P2|Overall Study|Physician Decision|0
327273|NCT00633932|1072330|P1|Overall Study|Physician Decision|0
327274|NCT00633932|1072328|P3|Overall Study|Protocol Violation|3
327275|NCT00633932|1072329|P2|Overall Study|Protocol Violation|2
327276|NCT00633932|1072330|P1|Overall Study|Protocol Violation|5
327277|NCT00633932|1072328|P3|Overall Study|Lost to Follow-up|2
327278|NCT00633932|1072329|P2|Overall Study|Lost to Follow-up|0
327279|NCT00633932|1072330|P1|Overall Study|Lost to Follow-up|1
327280|NCT00633932|1072328|P3|Overall Study|Withdrawal by Subject|1
327281|NCT00633932|1072329|P2|Overall Study|Withdrawal by Subject|9
327282|NCT00633932|1072330|P1|Overall Study|Withdrawal by Subject|3
327283|NCT00633932|1072328|P3|Overall Study|Adverse Event|4
327284|NCT00633932|1072329|P2|Overall Study|Adverse Event|3
327285|NCT00633932|1072330|P1|Overall Study|Adverse Event|1
327286|NCT00633893|1072361|P3|Overall Study|not specified|31
327287|NCT00633893|1072362|P2|Overall Study|not specified|33
327288|NCT00633893|1072363|P1|Overall Study|not specified|28
327289|NCT00633893|1072361|P3|Overall Study|Not meet/no longer meets criteria|4
327290|NCT00633893|1072362|P2|Overall Study|Not meet/no longer meets criteria|6
327291|NCT00633893|1072363|P1|Overall Study|Not meet/no longer meets criteria|4
327292|NCT00633893|1072361|P3|Overall Study|Pregnancy|1
327293|NCT00633893|1072362|P2|Overall Study|Pregnancy|1
327294|NCT00633893|1072363|P1|Overall Study|Pregnancy|2
327295|NCT00633893|1072361|P3|Overall Study|Poor/non-compliance|3
327296|NCT00633893|1072362|P2|Overall Study|Poor/non-compliance|12
327297|NCT00633893|1072363|P1|Overall Study|Poor/non-compliance|5
327298|NCT00633893|1072361|P3|Overall Study|Lost to Follow-up|8
327299|NCT00633893|1072362|P2|Overall Study|Lost to Follow-up|4
327300|NCT00633893|1072363|P1|Overall Study|Lost to Follow-up|2
327301|NCT00633893|1072361|P3|Overall Study|Withdrawal by Subject|6
327302|NCT00633893|1072362|P2|Overall Study|Withdrawal by Subject|12
327303|NCT00633893|1072363|P1|Overall Study|Withdrawal by Subject|7
327304|NCT00633893|1072361|P3|Overall Study|Adverse Event|126
327305|NCT00633893|1072362|P2|Overall Study|Adverse Event|58
327306|NCT00633893|1072363|P1|Overall Study|Adverse Event|65
327307|NCT00633893|1072361|P3|Overall Study|Death|9
327308|NCT00633893|1072362|P2|Overall Study|Death|3
327309|NCT00633893|1072363|P1|Overall Study|Death|1
327310|NCT00633880|1072437|P3|Open Label Titration|Withdrawal by Subject|0
327311|NCT00633880|1072438|P2|Open Label Titration|Withdrawal by Subject|0
327312|NCT00633880|1072439|P1|Open Label Titration|Withdrawal by Subject|4
327313|NCT00633880|1072437|P3|Open Label Titration|Physician Decision|0
327314|NCT00633880|1072438|P2|Open Label Titration|Physician Decision|0
327315|NCT00633880|1072439|P1|Open Label Titration|Physician Decision|1
327316|NCT00633880|1072437|P3|Open Label Titration|Protocol Violation|0
327317|NCT00633880|1072438|P2|Open Label Titration|Protocol Violation|0
327318|NCT00633880|1072439|P1|Open Label Titration|Protocol Violation|6
327319|NCT00633880|1072437|P3|Open Label Titration|Treatment Failure|0
327320|NCT00633880|1072438|P2|Open Label Titration|Treatment Failure|0
327321|NCT00633880|1072439|P1|Open Label Titration|Treatment Failure|55
327322|NCT00633880|1072437|P3|Open Label Titration|Adverse Event|0
327323|NCT00633880|1072438|P2|Open Label Titration|Adverse Event|0
327324|NCT00633880|1072439|P1|Open Label Titration|Adverse Event|13
327325|NCT00633880|1072437|P3|Open Label Titration|Lack of Efficacy|0
327326|NCT00633880|1072438|P2|Open Label Titration|Lack of Efficacy|0
327327|NCT00633880|1072439|P1|Open Label Titration|Lack of Efficacy|1
327328|NCT00633750|1072475|P1|Overall Study|Withdrawal by Subject|3
327329|NCT00633750|1072475|P1|Overall Study|Adverse Event|2
327330|NCT00633594|1072484|P3|Overall Study|Disease Progression|1
327331|NCT00633594|1072485|P2|Overall Study|Disease Progression|0
327332|NCT00633594|1072486|P1|Overall Study|Disease Progression|0
327333|NCT00633594|1072484|P3|Overall Study|Death|2
327334|NCT00633594|1072485|P2|Overall Study|Death|1
327335|NCT00633594|1072486|P1|Overall Study|Death|0
327336|NCT00633594|1072484|P3|Overall Study|Adverse Event|7
327337|NCT00633594|1072485|P2|Overall Study|Adverse Event|4
327338|NCT00633594|1072486|P1|Overall Study|Adverse Event|0
327339|NCT00633477|1072515|P2|Overall Study|Randomized but not treated|0
327340|NCT00633477|1072516|P1|Overall Study|Randomized but not treated|1
327341|NCT00633477|1072515|P2|Overall Study|Death|0
327342|NCT00633477|1072516|P1|Overall Study|Death|1
327343|NCT00633464|1072532|P2|Overall Study|Never Treated (Randomized in error)|1
327344|NCT00633464|1072533|P1|Overall Study|Never Treated (Randomized in error)|0
327345|NCT00633464|1072532|P2|Overall Study|Never Treated (Not met study criteria)|1
327346|NCT00633464|1072533|P1|Overall Study|Never Treated (Not met study criteria)|0
327347|NCT00633139|1072569|P3|Overall Study|Withdrawal by Subject|0
327348|NCT00633139|1072570|P2|Overall Study|Withdrawal by Subject|1
327349|NCT00633139|1072571|P1|Overall Study|Withdrawal by Subject|0
327350|NCT00633139|1072569|P3|Overall Study|Non compliance|1
327351|NCT00633139|1072570|P2|Overall Study|Non compliance|0
327352|NCT00633139|1072571|P1|Overall Study|Non compliance|0
327353|NCT00633126|1072585|P1|Overall Study|Did not receive full dose|1
327354|NCT00633074|1072599|P2|Overall Study|Adverse Event|0
327355|NCT00633074|1072600|P1|Overall Study|Adverse Event|1
327356|NCT00632931|1072644|P3|Part 2|Withdrawal by Subject|3
327357|NCT00632931|1072645|P2|Part 2|Withdrawal by Subject|0
327358|NCT00632931|1072646|P1|Part 2|Withdrawal by Subject|0
327359|NCT00632931|1072644|P3|Part 2|Lack of Efficacy|17
327360|NCT00632931|1072645|P2|Part 2|Lack of Efficacy|0
327361|NCT00632931|1072646|P1|Part 2|Lack of Efficacy|0
327362|NCT00632931|1072644|P3|Part 2|Death|1
327363|NCT00632931|1072645|P2|Part 2|Death|0
327364|NCT00632931|1072646|P1|Part 2|Death|0
327365|NCT00632931|1072644|P3|Part 2|Adverse Event|3
327366|NCT00632931|1072645|P2|Part 2|Adverse Event|0
327367|NCT00632931|1072646|P1|Part 2|Adverse Event|0
327368|NCT00632931|1072644|P3|Part 1, Period 1|Withdrawal by Subject|0
327369|NCT00632931|1072645|P2|Part 1, Period 1|Withdrawal by Subject|0
327370|NCT00632931|1072646|P1|Part 1, Period 1|Withdrawal by Subject|1
327371|NCT00632931|1072644|P3|Part 1, Period 1|Protocol Violation|0
327372|NCT00632931|1072645|P2|Part 1, Period 1|Protocol Violation|0
327373|NCT00632931|1072646|P1|Part 1, Period 1|Protocol Violation|1
327374|NCT00632749|1072716|P14|Overall Study|Reason other than those specified above|2
327375|NCT00632749|1072717|P13|Overall Study|Reason other than those specified above|0
327376|NCT00632749|1072718|P12|Overall Study|Reason other than those specified above|1
327377|NCT00632749|1072719|P11|Overall Study|Reason other than those specified above|2
327378|NCT00632749|1072720|P10|Overall Study|Reason other than those specified above|0
327379|NCT00632749|1072721|P9|Overall Study|Reason other than those specified above|0
327380|NCT00632749|1072722|P8|Overall Study|Reason other than those specified above|0
327381|NCT00632749|1072723|P7|Overall Study|Reason other than those specified above|1
327382|NCT00632749|1072724|P6|Overall Study|Reason other than those specified above|0
327383|NCT00632749|1072725|P5|Overall Study|Reason other than those specified above|1
327384|NCT00632749|1072726|P4|Overall Study|Reason other than those specified above|0
327385|NCT00632749|1072727|P3|Overall Study|Reason other than those specified above|0
327386|NCT00632749|1072728|P2|Overall Study|Reason other than those specified above|2
327387|NCT00632749|1072729|P1|Overall Study|Reason other than those specified above|0
327388|NCT00632749|1072716|P14|Overall Study|Refuse to continue medication|0
327389|NCT00632749|1072717|P13|Overall Study|Refuse to continue medication|0
327390|NCT00632749|1072718|P12|Overall Study|Refuse to continue medication|0
327391|NCT00632749|1072719|P11|Overall Study|Refuse to continue medication|0
327392|NCT00632749|1072720|P10|Overall Study|Refuse to continue medication|1
327393|NCT00632749|1072721|P9|Overall Study|Refuse to continue medication|0
327394|NCT00632749|1072722|P8|Overall Study|Refuse to continue medication|0
327395|NCT00632749|1072723|P7|Overall Study|Refuse to continue medication|0
327396|NCT00632749|1072724|P6|Overall Study|Refuse to continue medication|0
327397|NCT00632749|1072725|P5|Overall Study|Refuse to continue medication|0
327398|NCT00632749|1072726|P4|Overall Study|Refuse to continue medication|1
327399|NCT00632749|1072727|P3|Overall Study|Refuse to continue medication|0
327400|NCT00632749|1072728|P2|Overall Study|Refuse to continue medication|0
327401|NCT00632749|1072729|P1|Overall Study|Refuse to continue medication|0
327402|NCT00632749|1072716|P14|Overall Study|Other Adverse event|0
327403|NCT00632749|1072717|P13|Overall Study|Other Adverse event|1
327404|NCT00632749|1072718|P12|Overall Study|Other Adverse event|0
327405|NCT00632749|1072719|P11|Overall Study|Other Adverse event|1
327406|NCT00632749|1072720|P10|Overall Study|Other Adverse event|0
327407|NCT00632749|1072721|P9|Overall Study|Other Adverse event|2
327408|NCT00632749|1072722|P8|Overall Study|Other Adverse event|2
327409|NCT00632749|1072723|P7|Overall Study|Other Adverse event|1
327410|NCT00632749|1072724|P6|Overall Study|Other Adverse event|4
327411|NCT00632749|1072725|P5|Overall Study|Other Adverse event|2
327412|NCT00632749|1072726|P4|Overall Study|Other Adverse event|1
327413|NCT00632749|1072727|P3|Overall Study|Other Adverse event|1
327414|NCT00632749|1072728|P2|Overall Study|Other Adverse event|1
327415|NCT00632749|1072729|P1|Overall Study|Other Adverse event|1
327416|NCT00632749|1072716|P14|Overall Study|Progressive disease|4
327417|NCT00632749|1072717|P13|Overall Study|Progressive disease|2
327418|NCT00632749|1072718|P12|Overall Study|Progressive disease|3
327419|NCT00632749|1072719|P11|Overall Study|Progressive disease|4
327420|NCT00632749|1072720|P10|Overall Study|Progressive disease|2
327421|NCT00632749|1072721|P9|Overall Study|Progressive disease|3
327422|NCT00632749|1072722|P8|Overall Study|Progressive disease|2
327423|NCT00632749|1072723|P7|Overall Study|Progressive disease|3
327424|NCT00632749|1072724|P6|Overall Study|Progressive disease|4
327425|NCT00632749|1072725|P5|Overall Study|Progressive disease|4
327426|NCT00632749|1072726|P4|Overall Study|Progressive disease|2
327427|NCT00632749|1072727|P3|Overall Study|Progressive disease|2
327428|NCT00632749|1072728|P2|Overall Study|Progressive disease|2
327429|NCT00632749|1072729|P1|Overall Study|Progressive disease|3
327430|NCT00632736|1073023|P1|Overall Study|Other|16
327431|NCT00632736|1073023|P1|Overall Study|Non-compliance|10
327432|NCT00632736|1073023|P1|Overall Study|Sponsor terminated study|5
327433|NCT00632736|1073023|P1|Overall Study|Lack of Efficacy|5
327434|NCT00632736|1073023|P1|Overall Study|Withdrawal by Subject|99
327435|NCT00632736|1073023|P1|Overall Study|Protocol Violation|14
327436|NCT00632736|1073023|P1|Overall Study|Lost to Follow-up|15
327437|NCT00632736|1073023|P1|Overall Study|Adverse Event|104
327438|NCT00632541|1073058|P1|Overall Study|Adverse Event|7
327439|NCT00632502|1073064|P2|Overall Study|Randomized not treated|0
327440|NCT00632502|1073065|P1|Overall Study|Randomized not treated|3
327441|NCT00632502|1073064|P2|Overall Study|Adverse Event|1
327442|NCT00632502|1073065|P1|Overall Study|Adverse Event|0
327443|NCT00632463|1073109|P3|Overall Study|Adverse Event|0
327444|NCT00632463|1073110|P2|Overall Study|Adverse Event|1
327445|NCT00632463|1073111|P1|Overall Study|Adverse Event|0
327446|NCT00632424|1073128|P1|Overall Study|Study Drug Toxicity|1
327447|NCT00632424|1073128|P1|Overall Study|Disease Progression|17
327448|NCT00632229|1073166|P2|Overall Study|Undisclosed reasons within the first wee|1
327449|NCT00632229|1073167|P1|Overall Study|Undisclosed reasons within the first wee|0
327450|NCT00632229|1073166|P2|Overall Study|Lack of Efficacy|2
327451|NCT00632229|1073167|P1|Overall Study|Lack of Efficacy|0
327452|NCT00632229|1073166|P2|Overall Study|Lost to Follow-up|3
327453|NCT00632229|1073167|P1|Overall Study|Lost to Follow-up|0
327454|NCT00632229|1073166|P2|Overall Study|Adverse Event|0
327455|NCT00632229|1073167|P1|Overall Study|Adverse Event|6
327456|NCT00632203|1073177|P2|Overall Study|Did not start study treatment|0
327457|NCT00632203|1073178|P1|Overall Study|Did not start study treatment|1
327458|NCT00632099|1073198|P2|Overall Study|Lost to Follow-up|3
327459|NCT00632099|1073199|P1|Overall Study|Lost to Follow-up|3
327460|NCT00631969|1073207|P2|Overall Study|No Drug Exposure|2
327461|NCT00631969|1073208|P1|Overall Study|No Drug Exposure|2
327462|NCT00631969|1073207|P2|Overall Study|Noncompliant With Study Medication|1
327463|NCT00631969|1073208|P1|Overall Study|Noncompliant With Study Medication|0
327464|NCT00631969|1073207|P2|Overall Study|Consent Withdrawn|7
327465|NCT00631969|1073208|P1|Overall Study|Consent Withdrawn|5
327466|NCT00631969|1073207|P2|Overall Study|Protocol Violation|1
327467|NCT00631969|1073208|P1|Overall Study|Protocol Violation|1
327468|NCT00631969|1073207|P2|Overall Study|Lost to Follow-up|1
327469|NCT00631969|1073208|P1|Overall Study|Lost to Follow-up|2
327470|NCT00631969|1073207|P2|Overall Study|Lack of Efficacy|8
327471|NCT00631969|1073208|P1|Overall Study|Lack of Efficacy|2
327472|NCT00631969|1073207|P2|Overall Study|Adverse Event|1
327473|NCT00631969|1073208|P1|Overall Study|Adverse Event|3
327474|NCT00631917|1073254|P2|Overall Study|Death|0
327475|NCT00631917|1073255|P1|Overall Study|Death|1
327476|NCT00631917|1073254|P2|Overall Study|Administrative problems|0
327477|NCT00631917|1073255|P1|Overall Study|Administrative problems|2
327478|NCT00631917|1073254|P2|Overall Study|Lost to Follow-up|7
327479|NCT00631917|1073255|P1|Overall Study|Lost to Follow-up|7
327480|NCT00631917|1073254|P2|Overall Study|Subject withdrew consent|33
327481|NCT00631917|1073255|P1|Overall Study|Subject withdrew consent|25
327482|NCT00631917|1073254|P2|Overall Study|Protocol deviation|5
327483|NCT00631917|1073255|P1|Overall Study|Protocol deviation|6
327484|NCT00631917|1073254|P2|Overall Study|No longer required study drug|1
327485|NCT00631917|1073255|P1|Overall Study|No longer required study drug|0
327486|NCT00631917|1073254|P2|Overall Study|Unsatisfactory therapeutic effect|14
327487|NCT00631917|1073255|P1|Overall Study|Unsatisfactory therapeutic effect|8
327488|NCT00631917|1073254|P2|Overall Study|Abnormal test procedure result(s)|2
327489|NCT00631917|1073255|P1|Overall Study|Abnormal test procedure result(s)|3
327490|NCT00631917|1073254|P2|Overall Study|Abnormal laboratory value(s)|1
327491|NCT00631917|1073255|P1|Overall Study|Abnormal laboratory value(s)|2
327492|NCT00631917|1073254|P2|Overall Study|Adverse Event|45
327493|NCT00631917|1073255|P1|Overall Study|Adverse Event|34
327494|NCT00631696|1073282|P2|Overall Study|Adverse Event|0
327495|NCT00631696|1073283|P1|Overall Study|Adverse Event|5
327496|NCT00631696|1073282|P2|Overall Study|Study terminated by sponsor|3
327497|NCT00631696|1073283|P1|Overall Study|Study terminated by sponsor|3
327498|NCT00631696|1073282|P2|Overall Study|Protocol Violation|9
327499|NCT00631696|1073283|P1|Overall Study|Protocol Violation|9
327500|NCT00631696|1073282|P2|Overall Study|Unspecified|8
327501|NCT00631696|1073283|P1|Overall Study|Unspecified|8
327502|NCT00631696|1073282|P2|Overall Study|Withdrawal by Subject|9
327503|NCT00631696|1073283|P1|Overall Study|Withdrawal by Subject|2
327504|NCT00631696|1073282|P2|Overall Study|Lost to Follow-up|10
327505|NCT00631696|1073283|P1|Overall Study|Lost to Follow-up|7
327506|NCT00631696|1073282|P2|Overall Study|Follow up after database release date|0
327507|NCT00631696|1073283|P1|Overall Study|Follow up after database release date|1
327508|NCT00631696|1073282|P2|Overall Study|Discontinued after database release date|0
327509|NCT00631696|1073283|P1|Overall Study|Discontinued after database release date|1
327510|NCT00631696|1073282|P2|Overall Study|Entered, not randomized to treatment|1
327511|NCT00631696|1073283|P1|Overall Study|Entered, not randomized to treatment|1
327512|NCT00631657|1073326|P3|7-Day Discontinuation Period|Unspecified|0
327513|NCT00631657|1073327|P2|7-Day Discontinuation Period|Unspecified|0
327514|NCT00631657|1073328|P1|7-Day Discontinuation Period|Unspecified|1
327515|NCT00631657|1073326|P3|7-Day Discontinuation Period|Not Treated|1
327516|NCT00631657|1073327|P2|7-Day Discontinuation Period|Not Treated|1
327517|NCT00631657|1073328|P1|7-Day Discontinuation Period|Not Treated|1
327518|NCT00631657|1073326|P3|6-Month Treatment Period|Not Treated|1
327519|NCT00631657|1073327|P2|6-Month Treatment Period|Not Treated|0
327520|NCT00631657|1073328|P1|6-Month Treatment Period|Not Treated|2
327521|NCT00631657|1073326|P3|6-Month Treatment Period|Unspecified|4
327522|NCT00631657|1073327|P2|6-Month Treatment Period|Unspecified|0
327523|NCT00631657|1073328|P1|6-Month Treatment Period|Unspecified|16
327524|NCT00631657|1073326|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
327525|NCT00631657|1073327|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
327526|NCT00631657|1073328|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
327527|NCT00631657|1073326|P3|6-Month Treatment Period|Lost to Follow-up|2
327528|NCT00631657|1073327|P2|6-Month Treatment Period|Lost to Follow-up|0
327529|NCT00631657|1073328|P1|6-Month Treatment Period|Lost to Follow-up|7
327530|NCT00631657|1073326|P3|6-Month Treatment Period|Lack of Efficacy|25
327531|NCT00631657|1073327|P2|6-Month Treatment Period|Lack of Efficacy|0
327532|NCT00631657|1073328|P1|6-Month Treatment Period|Lack of Efficacy|34
327533|NCT00631657|1073326|P3|6-Month Treatment Period|Withdrawal by Subject|5
327534|NCT00631657|1073327|P2|6-Month Treatment Period|Withdrawal by Subject|0
327535|NCT00631657|1073328|P1|6-Month Treatment Period|Withdrawal by Subject|14
327536|NCT00631657|1073326|P3|6-Month Treatment Period|Adverse Event|7
327537|NCT00631657|1073327|P2|6-Month Treatment Period|Adverse Event|0
327538|NCT00631657|1073328|P1|6-Month Treatment Period|Adverse Event|47
327539|NCT00631540|1073355|P1|Overall Study|Core Lab Data Unavailable|3
327540|NCT00631540|1073355|P1|Overall Study|Lost to Follow-up|2
327541|NCT00631540|1073355|P1|Overall Study|Death|4
327542|NCT00631540|1073355|P1|Overall Study|Withdrawal by Subject|5
327543|NCT00631488|1073367|P3|Overall Study|Protocol Violation|1
327544|NCT00631488|1073368|P2|Overall Study|Protocol Violation|0
327545|NCT00631488|1073369|P1|Overall Study|Protocol Violation|0
327546|NCT00631488|1073367|P3|Overall Study|Physician Decision|1
327547|NCT00631488|1073368|P2|Overall Study|Physician Decision|0
327548|NCT00631488|1073369|P1|Overall Study|Physician Decision|1
327549|NCT00631488|1073367|P3|Overall Study|Lost to Follow-up|0
327550|NCT00631488|1073368|P2|Overall Study|Lost to Follow-up|2
327551|NCT00631488|1073369|P1|Overall Study|Lost to Follow-up|2
327552|NCT00631488|1073367|P3|Overall Study|Adverse Event|0
327553|NCT00631488|1073368|P2|Overall Study|Adverse Event|0
327554|NCT00631488|1073369|P1|Overall Study|Adverse Event|1
327555|NCT00631475|1073389|P1|Overall Study|Preparation for lung transplant|8
327556|NCT00631475|1073389|P1|Overall Study|Withdrew consent|5
327557|NCT00631475|1073389|P1|Overall Study|Adverse Event|14
327558|NCT00631475|1073389|P1|Overall Study|Death|18
327559|NCT00631410|1073408|P2|Overall Study|Surgery|0
327560|NCT00631410|1073409|P1|Overall Study|Surgery|1
327561|NCT00631410|1073408|P2|Overall Study|Objective Progression or Relapse|3
327562|NCT00631410|1073409|P1|Overall Study|Objective Progression or Relapse|4
327563|NCT00631410|1073408|P2|Overall Study|Adverse Event|3
327564|NCT00631410|1073409|P1|Overall Study|Adverse Event|1
327565|NCT00631371|1073428|P2|Overall Study|Death|239
327566|NCT00631371|1073429|P1|Overall Study|Death|263
327567|NCT00631371|1073428|P2|Overall Study|Discontinuation of study by Sponsor|76
327568|NCT00631371|1073429|P1|Overall Study|Discontinuation of study by Sponsor|70
327569|NCT00631371|1073428|P2|Overall Study|subject request|45
327570|NCT00631371|1073429|P1|Overall Study|subject request|38
327571|NCT00631371|1073428|P2|Overall Study|Other reason|12
327572|NCT00631371|1073429|P1|Overall Study|Other reason|5
327573|NCT00631371|1073428|P2|Overall Study|Lost to Follow-up|19
327574|NCT00631371|1073429|P1|Overall Study|Lost to Follow-up|24
327575|NCT00631189|1073462|P4|Treatment Phase|patient did not take pravastatin|0
327576|NCT00631189|1073463|P3|Treatment Phase|patient did not take pravastatin|1
327577|NCT00631189|1073464|P2|Treatment Phase|patient did not take pravastatin|0
327578|NCT00631189|1073465|P1|Treatment Phase|patient did not take pravastatin|0
327579|NCT00631189|1073462|P4|Treatment Phase|Pregnancy|0
327580|NCT00631189|1073463|P3|Treatment Phase|Pregnancy|1
327581|NCT00631189|1073464|P2|Treatment Phase|Pregnancy|0
327582|NCT00631189|1073465|P1|Treatment Phase|Pregnancy|0
327583|NCT00631189|1073462|P4|Treatment Phase|Lost to Follow-up|0
327584|NCT00631189|1073463|P3|Treatment Phase|Lost to Follow-up|0
327585|NCT00631189|1073464|P2|Treatment Phase|Lost to Follow-up|1
327586|NCT00631189|1073465|P1|Treatment Phase|Lost to Follow-up|0
327587|NCT00631189|1073462|P4|Treatment Phase|Adverse Event|4
327588|NCT00631189|1073463|P3|Treatment Phase|Adverse Event|2
327589|NCT00631189|1073464|P2|Treatment Phase|Adverse Event|3
327590|NCT00631189|1073465|P1|Treatment Phase|Adverse Event|0
327591|NCT00631189|1073462|P4|Treatment Phase|Protocol Violation|2
327592|NCT00631189|1073463|P3|Treatment Phase|Protocol Violation|6
327593|NCT00631189|1073464|P2|Treatment Phase|Protocol Violation|1
327594|NCT00631189|1073465|P1|Treatment Phase|Protocol Violation|0
327595|NCT00631189|1073462|P4|Treatment Phase|Withdrawal by Subject|1
327596|NCT00631189|1073463|P3|Treatment Phase|Withdrawal by Subject|1
327597|NCT00631189|1073464|P2|Treatment Phase|Withdrawal by Subject|2
327598|NCT00631189|1073465|P1|Treatment Phase|Withdrawal by Subject|0
327599|NCT00631189|1073462|P4|Initial Phase|Withdrawal by Subject|0
327600|NCT00631189|1073463|P3|Initial Phase|Withdrawal by Subject|0
327601|NCT00631189|1073464|P2|Initial Phase|Withdrawal by Subject|0
327602|NCT00631189|1073465|P1|Initial Phase|Withdrawal by Subject|4
327603|NCT00631189|1073462|P4|Initial Phase|Protocol Violation|0
327604|NCT00631189|1073463|P3|Initial Phase|Protocol Violation|0
327605|NCT00631189|1073464|P2|Initial Phase|Protocol Violation|0
327606|NCT00631189|1073465|P1|Initial Phase|Protocol Violation|347
327607|NCT00631020|1073507|P1|Overall Study|Incarcerated|1
327608|NCT00631020|1073507|P1|Overall Study|Lost to Follow-up|7
327609|NCT00631007|1073522|P6|Overall Study|Other|0
327610|NCT00631007|1073523|P5|Overall Study|Other|1
327611|NCT00631007|1073524|P4|Overall Study|Other|0
327612|NCT00631007|1073525|P3|Overall Study|Other|0
327613|NCT00631007|1073526|P2|Overall Study|Other|1
327614|NCT00631007|1073527|P1|Overall Study|Other|2
327615|NCT00631007|1073522|P6|Overall Study|Withdrawal by Subject|3
327616|NCT00631007|1073523|P5|Overall Study|Withdrawal by Subject|1
327617|NCT00631007|1073524|P4|Overall Study|Withdrawal by Subject|2
327618|NCT00631007|1073525|P3|Overall Study|Withdrawal by Subject|2
327619|NCT00631007|1073526|P2|Overall Study|Withdrawal by Subject|5
327620|NCT00631007|1073527|P1|Overall Study|Withdrawal by Subject|4
327621|NCT00631007|1073522|P6|Overall Study|Persistent Hyperglycemia|5
327622|NCT00631007|1073523|P5|Overall Study|Persistent Hyperglycemia|2
327623|NCT00631007|1073524|P4|Overall Study|Persistent Hyperglycemia|1
327624|NCT00631007|1073525|P3|Overall Study|Persistent Hyperglycemia|5
327625|NCT00631007|1073526|P2|Overall Study|Persistent Hyperglycemia|2
327626|NCT00631007|1073527|P1|Overall Study|Persistent Hyperglycemia|2
327627|NCT00631007|1073522|P6|Overall Study|Physician Decision|2
327628|NCT00631007|1073523|P5|Overall Study|Physician Decision|0
327629|NCT00631007|1073524|P4|Overall Study|Physician Decision|0
327630|NCT00631007|1073525|P3|Overall Study|Physician Decision|1
327631|NCT00631007|1073526|P2|Overall Study|Physician Decision|0
327632|NCT00631007|1073527|P1|Overall Study|Physician Decision|1
327633|NCT00631007|1073522|P6|Overall Study|Lost to Follow-up|3
327634|NCT00631007|1073523|P5|Overall Study|Lost to Follow-up|5
327635|NCT00631007|1073524|P4|Overall Study|Lost to Follow-up|4
327636|NCT00631007|1073525|P3|Overall Study|Lost to Follow-up|2
327637|NCT00631007|1073526|P2|Overall Study|Lost to Follow-up|1
327638|NCT00631007|1073527|P1|Overall Study|Lost to Follow-up|2
327639|NCT00631007|1073522|P6|Overall Study|Adverse Event|2
327640|NCT00631007|1073523|P5|Overall Study|Adverse Event|3
327641|NCT00631007|1073524|P4|Overall Study|Adverse Event|2
327642|NCT00631007|1073525|P3|Overall Study|Adverse Event|0
327643|NCT00631007|1073526|P2|Overall Study|Adverse Event|2
327644|NCT00631007|1073527|P1|Overall Study|Adverse Event|0
327645|NCT00630994|1073547|P1|Overall Study|Other|1
327646|NCT00630994|1073547|P1|Overall Study|Lack of Efficacy|1
327647|NCT00630994|1073547|P1|Overall Study|Disease Progression|1
327648|NCT00630994|1073547|P1|Overall Study|Adverse Event|1
327649|NCT00630916|1073571|P1|Overall Study|Lack of Efficacy|3
327650|NCT00630916|1073571|P1|Overall Study|Physician Decision|47
327651|NCT00630916|1073571|P1|Overall Study|Protocol Violation|7
327652|NCT00630916|1073571|P1|Overall Study|Withdrawal by Subject|30
327653|NCT00630916|1073571|P1|Overall Study|Lost to Follow-up|5
327654|NCT00630916|1073571|P1|Overall Study|Explant|8
327655|NCT00630916|1073571|P1|Overall Study|Death|110
327656|NCT00630877|1073581|P3|Overall Study|Personal reasons|1
327657|NCT00630877|1073582|P2|Overall Study|Personal reasons|0
327658|NCT00630877|1073583|P1|Overall Study|Personal reasons|0
327659|NCT00630877|1073581|P3|Overall Study|Protocol violation|1
327660|NCT00630877|1073582|P2|Overall Study|Protocol violation|0
327661|NCT00630877|1073583|P1|Overall Study|Protocol violation|1
327662|NCT00630877|1073581|P3|Overall Study|Noncompliance|1
327663|NCT00630877|1073582|P2|Overall Study|Noncompliance|3
327664|NCT00630877|1073583|P1|Overall Study|Noncompliance|2
327665|NCT00630877|1073581|P3|Overall Study|Lost to Follow-up|0
327666|NCT00630877|1073582|P2|Overall Study|Lost to Follow-up|0
327667|NCT00630877|1073583|P1|Overall Study|Lost to Follow-up|2
327668|NCT00630877|1073581|P3|Overall Study|Withdrawal by Subject|0
327669|NCT00630877|1073582|P2|Overall Study|Withdrawal by Subject|4
327670|NCT00630877|1073583|P1|Overall Study|Withdrawal by Subject|3
327671|NCT00630877|1073581|P3|Overall Study|Adverse Event|7
327672|NCT00630877|1073582|P2|Overall Study|Adverse Event|8
327673|NCT00630877|1073583|P1|Overall Study|Adverse Event|11
327674|NCT00630864|1073601|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
327675|NCT00630864|1073601|P1|Part 1 (up to Week 6)|Adverse Event|1
327676|NCT00630838|1073640|P2|Overall Study|Lost to Follow-up|1
327677|NCT00630838|1073641|P1|Overall Study|Lost to Follow-up|0
327678|NCT00630838|1073640|P2|Overall Study|Death|1
327679|NCT00630838|1073641|P1|Overall Study|Death|0
327680|NCT00630825|1073653|P4|Overall Study|Withdrawal by Subject|3
327681|NCT00630825|1073654|P3|Overall Study|Withdrawal by Subject|2
327682|NCT00630825|1073655|P2|Overall Study|Withdrawal by Subject|2
327683|NCT00630825|1073656|P1|Overall Study|Withdrawal by Subject|2
327684|NCT00630825|1073653|P4|Overall Study|Physician Decision|0
327685|NCT00630825|1073654|P3|Overall Study|Physician Decision|0
327686|NCT00630825|1073655|P2|Overall Study|Physician Decision|0
327687|NCT00630825|1073656|P1|Overall Study|Physician Decision|1
327688|NCT00630825|1073653|P4|Overall Study|Lost to Follow-up|1
327689|NCT00630825|1073654|P3|Overall Study|Lost to Follow-up|1
327690|NCT00630825|1073655|P2|Overall Study|Lost to Follow-up|1
327691|NCT00630825|1073656|P1|Overall Study|Lost to Follow-up|1
327692|NCT00630825|1073653|P4|Overall Study|Entry Criteria Not Met|1
327693|NCT00630825|1073654|P3|Overall Study|Entry Criteria Not Met|2
327694|NCT00630825|1073655|P2|Overall Study|Entry Criteria Not Met|0
327695|NCT00630825|1073656|P1|Overall Study|Entry Criteria Not Met|1
327696|NCT00630825|1073653|P4|Overall Study|Adverse Event|1
327697|NCT00630825|1073654|P3|Overall Study|Adverse Event|3
327698|NCT00630825|1073655|P2|Overall Study|Adverse Event|4
327699|NCT00630825|1073656|P1|Overall Study|Adverse Event|4
327700|NCT00630786|1073728|P3|Overall Study|Not specified|0
327701|NCT00630786|1073729|P2|Overall Study|Not specified|0
327702|NCT00630786|1073730|P1|Overall Study|Not specified|1
327703|NCT00630786|1073728|P3|Overall Study|Lost to Follow-up|0
327704|NCT00630786|1073729|P2|Overall Study|Lost to Follow-up|1
327705|NCT00630786|1073730|P1|Overall Study|Lost to Follow-up|0
327706|NCT00630786|1073728|P3|Overall Study|Withdrawal by Subject|1
327707|NCT00630786|1073729|P2|Overall Study|Withdrawal by Subject|1
327708|NCT00630786|1073730|P1|Overall Study|Withdrawal by Subject|0
327709|NCT00630786|1073728|P3|Overall Study|Physician Decision|1
327710|NCT00630786|1073729|P2|Overall Study|Physician Decision|0
327711|NCT00630786|1073730|P1|Overall Study|Physician Decision|0
327712|NCT00630747|1073749|P1|Overall Study|Returned to country of origin|1
327713|NCT00630747|1073749|P1|Overall Study|Transferred to Study TKT031NPU|7
327714|NCT00630747|1073749|P1|Overall Study|Death|1
327715|NCT00630539|1073815|P4|Overall Study|Withdrawal by Subject|1
327716|NCT00630539|1073816|P3|Overall Study|Withdrawal by Subject|0
327717|NCT00630539|1073817|P2|Overall Study|Withdrawal by Subject|1
327718|NCT00630539|1073818|P1|Overall Study|Withdrawal by Subject|0
327719|NCT00630539|1073815|P4|Overall Study|Adverse Event|2
327720|NCT00630539|1073816|P3|Overall Study|Adverse Event|1
327721|NCT00630539|1073817|P2|Overall Study|Adverse Event|3
327722|NCT00630539|1073818|P1|Overall Study|Adverse Event|1
327723|NCT00630396|1073914|P1|Overall Study|Lost to Follow-up|3
327724|NCT00630396|1073914|P1|Overall Study|Death|4
327725|NCT00630331|1073927|P3|Overall Study|Protocol Violation|6
327726|NCT00630331|1073928|P2|Overall Study|Protocol Violation|5
327727|NCT00630331|1073929|P1|Overall Study|Protocol Violation|4
327728|NCT00630331|1073927|P3|Overall Study|Unable to classify|3
327729|NCT00630331|1073928|P2|Overall Study|Unable to classify|4
327730|NCT00630331|1073929|P1|Overall Study|Unable to classify|9
327731|NCT00630331|1073927|P3|Overall Study|Inappropriate enrollment|3
327732|NCT00630331|1073928|P2|Overall Study|Inappropriate enrollment|6
327733|NCT00630331|1073929|P1|Overall Study|Inappropriate enrollment|3
327734|NCT00630331|1073927|P3|Overall Study|Lost to Follow-up|170
327735|NCT00630331|1073928|P2|Overall Study|Lost to Follow-up|143
327736|NCT00630331|1073929|P1|Overall Study|Lost to Follow-up|175
327737|NCT00630331|1073927|P3|Overall Study|Withdrawal by Subject|5
327738|NCT00630331|1073928|P2|Overall Study|Withdrawal by Subject|7
327739|NCT00630331|1073929|P1|Overall Study|Withdrawal by Subject|12
327740|NCT00630331|1073927|P3|Overall Study|Adverse Event|0
327741|NCT00630331|1073928|P2|Overall Study|Adverse Event|0
327742|NCT00630331|1073929|P1|Overall Study|Adverse Event|1
327743|NCT00630331|1073927|P3|Overall Study|Death|1
327744|NCT00630331|1073928|P2|Overall Study|Death|1
327745|NCT00630331|1073929|P1|Overall Study|Death|2
327746|NCT00630305|1073970|P1|Overall Study|Inability to insert contact lens|1
327747|NCT00630305|1073970|P1|Overall Study|Withdrawal by Subject|1
327748|NCT00630292|1073992|P1|Overall Study|Withdrawal by Subject|1
327749|NCT00630058|1073998|P2|Overall Study|stopping criteria|2
327750|NCT00630058|1073999|P1|Overall Study|stopping criteria|3
327751|NCT00630058|1073998|P2|Overall Study|Withdrawal by Subject|1
327752|NCT00630058|1073999|P1|Overall Study|Withdrawal by Subject|0
327753|NCT00630058|1073998|P2|Overall Study|Adverse Event|1
327754|NCT00630058|1073999|P1|Overall Study|Adverse Event|1
327755|NCT00629772|1074017|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
327756|NCT00629772|1074018|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
327757|NCT00629772|1074017|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
327758|NCT00629772|1074018|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
327759|NCT00629707|1074038|P2|Overall Study|Physician Decision|1
327760|NCT00629707|1074039|P1|Overall Study|Physician Decision|0
327761|NCT00629707|1074038|P2|Overall Study|Withdrawal by Subject|1
327762|NCT00629707|1074039|P1|Overall Study|Withdrawal by Subject|0
327763|NCT00629265|1074059|P2|Overall Study|Unknown Reason|2
327764|NCT00629265|1074060|P1|Overall Study|Unknown Reason|2
327765|NCT00629265|1074059|P2|Overall Study|Unrelated Medical Complications|1
327766|NCT00629265|1074060|P1|Overall Study|Unrelated Medical Complications|3
327767|NCT00629265|1074059|P2|Overall Study|Needed Esophageal Dilation|1
327768|NCT00629265|1074060|P1|Overall Study|Needed Esophageal Dilation|4
327769|NCT00629265|1074059|P2|Overall Study|Other CA Requiring Treatment|3
327770|NCT00629265|1074060|P1|Overall Study|Other CA Requiring Treatment|1
327771|NCT00629265|1074059|P2|Overall Study|HNC Recurrence|0
327772|NCT00629265|1074060|P1|Overall Study|HNC Recurrence|4
327773|NCT00629265|1074059|P2|Overall Study|Adverse Event|0
327774|NCT00629265|1074060|P1|Overall Study|Adverse Event|2
327775|NCT00629265|1074059|P2|Overall Study|Death|0
327776|NCT00629265|1074060|P1|Overall Study|Death|1
327777|NCT00629265|1074059|P2|Overall Study|Withdrawal by Subject|8
327778|NCT00629265|1074060|P1|Overall Study|Withdrawal by Subject|11
327779|NCT00629265|1074059|P2|Overall Study|Lost to Follow-up|5
327780|NCT00629265|1074060|P1|Overall Study|Lost to Follow-up|4
327781|NCT00629239|1074070|P2|Overall Study|Physician Decision|0
327782|NCT00629239|1074071|P1|Overall Study|Physician Decision|1
327783|NCT00629239|1074070|P2|Overall Study|Adverse Event|4
327784|NCT00629239|1074071|P1|Overall Study|Adverse Event|7
327785|NCT00628927|1074116|P2|Overall Study|Equipment failure|0
327786|NCT00628927|1074117|P1|Overall Study|Equipment failure|1
327787|NCT00628927|1074116|P2|Overall Study|Lost to Follow-up|0
327788|NCT00628927|1074117|P1|Overall Study|Lost to Follow-up|1
327789|NCT00628927|1074116|P2|Overall Study|Problems performing blood draw|0
327790|NCT00628927|1074117|P1|Overall Study|Problems performing blood draw|6
327791|NCT00628862|1074162|P3|Overall Study|COPD Exacerbation|0
327792|NCT00628862|1074163|P2|Overall Study|COPD Exacerbation|1
327793|NCT00628862|1074164|P1|Overall Study|COPD Exacerbation|0
327794|NCT00628862|1074162|P3|Overall Study|Protocol Violation|0
327795|NCT00628862|1074163|P2|Overall Study|Protocol Violation|0
327796|NCT00628862|1074164|P1|Overall Study|Protocol Violation|1
327797|NCT00628862|1074162|P3|Overall Study|Lost to Follow-up|1
327798|NCT00628862|1074163|P2|Overall Study|Lost to Follow-up|2
327799|NCT00628862|1074164|P1|Overall Study|Lost to Follow-up|0
327800|NCT00628862|1074162|P3|Overall Study|Withdrawal by Subject|11
327801|NCT00628862|1074163|P2|Overall Study|Withdrawal by Subject|6
327802|NCT00628862|1074164|P1|Overall Study|Withdrawal by Subject|4
327803|NCT00628862|1074162|P3|Overall Study|Adverse Event|10
327804|NCT00628862|1074163|P2|Overall Study|Adverse Event|8
327805|NCT00628862|1074164|P1|Overall Study|Adverse Event|6
327806|NCT00628758|1074210|P2|Overall Study|Treatment Failure|2
327807|NCT00628758|1074211|P1|Overall Study|Treatment Failure|0
327808|NCT00628758|1074210|P2|Overall Study|Investigator Moved|0
327809|NCT00628758|1074211|P1|Overall Study|Investigator Moved|3
327810|NCT00628758|1074210|P2|Overall Study|Pregnancy|2
327811|NCT00628758|1074211|P1|Overall Study|Pregnancy|2
327812|NCT00628758|1074210|P2|Overall Study|Lost to Follow-up|31
327813|NCT00628758|1074211|P1|Overall Study|Lost to Follow-up|25
327814|NCT00628758|1074210|P2|Overall Study|Protocol Violation|1
327815|NCT00628758|1074211|P1|Overall Study|Protocol Violation|5
327816|NCT00628758|1074210|P2|Overall Study|Death|0
327817|NCT00628758|1074211|P1|Overall Study|Death|1
327818|NCT00628758|1074210|P2|Overall Study|Withdrawal by Subject|3
327819|NCT00628758|1074211|P1|Overall Study|Withdrawal by Subject|6
327820|NCT00628758|1074210|P2|Overall Study|Adverse Event|3
327821|NCT00628758|1074211|P1|Overall Study|Adverse Event|2
327822|NCT00628446|1074232|P1|Overall Study|Protocol Violation|3
327823|NCT00628446|1074232|P1|Overall Study|Withdrawal by Subject|1
327824|NCT00628446|1074232|P1|Overall Study|Lost to Follow-up|3
327825|NCT00628355|1074243|P2|Overall Study|Withdrawal by Subject|1
327826|NCT00628355|1074244|P1|Overall Study|Withdrawal by Subject|1
327827|NCT00628251|1074255|P3|Cross-over/ Continuation of Olaparib|Other|0
327828|NCT00628251|1074256|P2|Cross-over/ Continuation of Olaparib|Other|1
327829|NCT00628251|1074257|P1|Cross-over/ Continuation of Olaparib|Other|1
327830|NCT00628251|1074255|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
327831|NCT00628251|1074256|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
327832|NCT00628251|1074257|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
327833|NCT00628251|1074255|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
327834|NCT00628251|1074256|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
327835|NCT00628251|1074257|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
327836|NCT00628251|1074255|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
327837|NCT00628251|1074256|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
327838|NCT00628251|1074257|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
327839|NCT00628251|1074255|P3|Randomised Part|Did not receive cross over treatment|8
327840|NCT00628251|1074256|P2|Randomised Part|Did not receive cross over treatment|0
327841|NCT00628251|1074257|P1|Randomised Part|Did not receive cross over treatment|0
327842|NCT00628212|1074300|P4|Overall Study|Physician Decision|3
327843|NCT00628212|1074301|P3|Overall Study|Physician Decision|2
327844|NCT00628212|1074302|P2|Overall Study|Physician Decision|1
327845|NCT00628212|1074303|P1|Overall Study|Physician Decision|1
327846|NCT00628212|1074300|P4|Overall Study|Adverse Event|2
327847|NCT00628212|1074301|P3|Overall Study|Adverse Event|1
327848|NCT00628212|1074302|P2|Overall Study|Adverse Event|0
327849|NCT00628212|1074303|P1|Overall Study|Adverse Event|2
327850|NCT00628108|1074351|P2|Overall Study|Withdrawal by Subject|0
327851|NCT00628108|1074352|P1|Overall Study|Withdrawal by Subject|1
327852|NCT00628108|1074351|P2|Overall Study|Adverse Event|3
327853|NCT00628108|1074352|P1|Overall Study|Adverse Event|0
327854|NCT00628030|1074384|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
327855|NCT00628030|1074385|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
327856|NCT00628030|1074384|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
327857|NCT00628030|1074385|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
327858|NCT00628030|1074384|P2|Baseline to Post-Assessment|Lost to Follow-up|29
327859|NCT00628030|1074385|P1|Baseline to Post-Assessment|Lost to Follow-up|28
327860|NCT00627926|1074402|P3|Overall Study|Noncompliance/unspecified|17
327861|NCT00627926|1074403|P2|Overall Study|Noncompliance/unspecified|23
327862|NCT00627926|1074404|P1|Overall Study|Noncompliance/unspecified|8
327863|NCT00627926|1074402|P3|Overall Study|Lack of Efficacy|38
327864|NCT00627926|1074403|P2|Overall Study|Lack of Efficacy|40
327865|NCT00627926|1074404|P1|Overall Study|Lack of Efficacy|118
327866|NCT00627926|1074402|P3|Overall Study|Withdrawal by Subject|0
327867|NCT00627926|1074403|P2|Overall Study|Withdrawal by Subject|1
327868|NCT00627926|1074404|P1|Overall Study|Withdrawal by Subject|2
327869|NCT00627926|1074402|P3|Overall Study|Lost to Follow-up|4
327870|NCT00627926|1074403|P2|Overall Study|Lost to Follow-up|3
327871|NCT00627926|1074404|P1|Overall Study|Lost to Follow-up|4
327872|NCT00627926|1074402|P3|Overall Study|Death|0
327873|NCT00627926|1074403|P2|Overall Study|Death|0
327874|NCT00627926|1074404|P1|Overall Study|Death|1
327875|NCT00627926|1074402|P3|Overall Study|Adverse Event|36
327876|NCT00627926|1074403|P2|Overall Study|Adverse Event|37
327877|NCT00627926|1074404|P1|Overall Study|Adverse Event|26
327878|NCT00627705|1074456|P2|Overall Study|Lost to Follow-up|1
327879|NCT00627705|1074457|P1|Overall Study|Lost to Follow-up|0
327880|NCT00627705|1074456|P2|Overall Study|Withdrawal by Subject|2
327881|NCT00627705|1074457|P1|Overall Study|Withdrawal by Subject|0
327882|NCT00627705|1074456|P2|Overall Study|Adverse Event|0
327883|NCT00627705|1074457|P1|Overall Study|Adverse Event|1
327884|NCT00627705|1074456|P2|Overall Study|Unwilling to take the compound (taste)|3
327885|NCT00627705|1074457|P1|Overall Study|Unwilling to take the compound (taste)|1
327886|NCT00627523|1074508|P2|Overall Study|Not specified|0
327887|NCT00627523|1074509|P1|Overall Study|Not specified|1
327888|NCT00627523|1074508|P2|Overall Study|Withdrawal by Subject|2
327889|NCT00627523|1074509|P1|Overall Study|Withdrawal by Subject|0
327890|NCT00627523|1074508|P2|Overall Study|Lack of Efficacy|0
327891|NCT00627523|1074509|P1|Overall Study|Lack of Efficacy|1
327892|NCT00627497|1074537|P4|Overall Study|Lost to Follow-up|0
327893|NCT00627497|1074538|P3|Overall Study|Lost to Follow-up|0
327894|NCT00627497|1074539|P2|Overall Study|Lost to Follow-up|1
327895|NCT00627497|1074540|P1|Overall Study|Lost to Follow-up|1
327896|NCT00627445|1074600|P2|Overall Study|Other|8
327897|NCT00627445|1074601|P1|Overall Study|Other|6
327898|NCT00627445|1074600|P2|Overall Study|Lack of Efficacy|1
327899|NCT00627445|1074601|P1|Overall Study|Lack of Efficacy|0
327900|NCT00627445|1074600|P2|Overall Study|Adverse Event|3
327901|NCT00627445|1074601|P1|Overall Study|Adverse Event|3
327902|NCT00627393|1074644|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
327903|NCT00627393|1074645|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
327904|NCT00627393|1074644|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
327905|NCT00627393|1074645|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
327906|NCT00627393|1074644|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
327907|NCT00627393|1074645|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
327908|NCT00627393|1074644|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
327909|NCT00627393|1074645|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
327910|NCT00627094|1074666|P2|Overall Study|Other reason|0
327911|NCT00627094|1074667|P1|Overall Study|Other reason|1
327912|NCT00627094|1074666|P2|Overall Study|ulcer healed|7
327913|NCT00627094|1074667|P1|Overall Study|ulcer healed|1
327914|NCT00627094|1074666|P2|Overall Study|Withdrawal by Subject|1
327915|NCT00627094|1074667|P1|Overall Study|Withdrawal by Subject|1
327916|NCT00627094|1074666|P2|Overall Study|Lost to Follow-up|0
327917|NCT00627094|1074667|P1|Overall Study|Lost to Follow-up|1
327918|NCT00627094|1074666|P2|Overall Study|Adverse Event|7
327919|NCT00627094|1074667|P1|Overall Study|Adverse Event|8
327920|NCT00627042|1074679|P1|Overall Study|Withdrawal by Subject|2
327921|NCT00627016|1074691|P2|Overall Study|Pregnancy|0
327922|NCT00627016|1074692|P1|Overall Study|Pregnancy|1
327923|NCT00627016|1074691|P2|Overall Study|Placed on Excluded Drugs|0
327924|NCT00627016|1074692|P1|Overall Study|Placed on Excluded Drugs|1
327925|NCT00627016|1074691|P2|Overall Study|Lack of Efficacy|0
327926|NCT00627016|1074692|P1|Overall Study|Lack of Efficacy|1
327927|NCT00627016|1074691|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
327928|NCT00627016|1074692|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
327929|NCT00627016|1074691|P2|Overall Study|Withdrawal by Subject|1
327930|NCT00627016|1074692|P1|Overall Study|Withdrawal by Subject|2
327931|NCT00627016|1074691|P2|Overall Study|Lost to Follow-up|1
327932|NCT00627016|1074692|P1|Overall Study|Lost to Follow-up|0
327933|NCT00627016|1074691|P2|Overall Study|Protocol Violation|2
327934|NCT00627016|1074692|P1|Overall Study|Protocol Violation|0
327935|NCT00627016|1074691|P2|Overall Study|Adverse Event|1
327936|NCT00627016|1074692|P1|Overall Study|Adverse Event|1
327937|NCT00626925|1074704|P2|Overall Study|Time constraints|1
327938|NCT00626925|1074705|P1|Overall Study|Time constraints|3
327939|NCT00626925|1074704|P2|Overall Study|Lack of Efficacy|4
327940|NCT00626925|1074705|P1|Overall Study|Lack of Efficacy|1
327941|NCT00626925|1074704|P2|Overall Study|Adverse effect|2
327942|NCT00626925|1074705|P1|Overall Study|Adverse effect|6
327943|NCT00626925|1074704|P2|Overall Study|relapse|0
327944|NCT00626925|1074705|P1|Overall Study|relapse|1
327945|NCT00626925|1074704|P2|Overall Study|Lost to Follow-up|2
327946|NCT00626925|1074705|P1|Overall Study|Lost to Follow-up|1
327947|NCT00626821|1074731|P1|Overall Study|other/unknown reason|104
327948|NCT00626821|1074731|P1|Overall Study|Product dysfunction|21
327949|NCT00626821|1074731|P1|Overall Study|Physician Decision|9
327950|NCT00626821|1074731|P1|Overall Study|Withdrawal by Subject|10
327951|NCT00626821|1074731|P1|Overall Study|Protocol Violation|33
327952|NCT00626821|1074731|P1|Overall Study|Adverse Event|44
327953|NCT00626639|1074830|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
327954|NCT00626639|1074831|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
327955|NCT00626561|1074856|P1|Overall Study|Disease Progression|2
327956|NCT00626561|1074856|P1|Overall Study|Withdrawal by Subject|2
327957|NCT00626548|1074862|P2|Overall Study|Other termination reason|613
327958|NCT00626548|1074863|P1|Overall Study|Other termination reason|493
327959|NCT00626548|1074862|P2|Overall Study|Lost to Follow-up|2
327960|NCT00626548|1074863|P1|Overall Study|Lost to Follow-up|2
327961|NCT00626548|1074862|P2|Overall Study|Protocol Violation|11
327962|NCT00626548|1074863|P1|Overall Study|Protocol Violation|4
327963|NCT00626548|1074862|P2|Overall Study|Withdrawal by Subject|46
327964|NCT00626548|1074863|P1|Overall Study|Withdrawal by Subject|42
327965|NCT00626548|1074862|P2|Overall Study|Adverse Event|44
327966|NCT00626548|1074863|P1|Overall Study|Adverse Event|164
327967|NCT00626522|1074877|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
327968|NCT00626522|1074878|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
327969|NCT00626522|1074879|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
327970|NCT00626522|1074880|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
327971|NCT00626522|1074881|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
327972|NCT00626522|1074882|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
327973|NCT00626522|1074877|P6|Overall Study|Inconsistent reason reported|0
327974|NCT00626522|1074878|P5|Overall Study|Inconsistent reason reported|0
327975|NCT00626522|1074879|P4|Overall Study|Inconsistent reason reported|0
327976|NCT00626522|1074880|P3|Overall Study|Inconsistent reason reported|0
327977|NCT00626522|1074881|P2|Overall Study|Inconsistent reason reported|0
327978|NCT00626522|1074882|P1|Overall Study|Inconsistent reason reported|1
327979|NCT00626522|1074877|P6|Overall Study|Lost to Follow-up|0
327980|NCT00626522|1074878|P5|Overall Study|Lost to Follow-up|0
327981|NCT00626522|1074879|P4|Overall Study|Lost to Follow-up|0
327982|NCT00626522|1074880|P3|Overall Study|Lost to Follow-up|0
327983|NCT00626522|1074881|P2|Overall Study|Lost to Follow-up|1
327984|NCT00626522|1074882|P1|Overall Study|Lost to Follow-up|0
327985|NCT00626522|1074877|P6|Overall Study|COPD exacerbation|0
327986|NCT00626522|1074878|P5|Overall Study|COPD exacerbation|1
327987|NCT00626522|1074879|P4|Overall Study|COPD exacerbation|1
327988|NCT00626522|1074880|P3|Overall Study|COPD exacerbation|0
327989|NCT00626522|1074881|P2|Overall Study|COPD exacerbation|0
327990|NCT00626522|1074882|P1|Overall Study|COPD exacerbation|0
327991|NCT00626522|1074877|P6|Overall Study|Withdrawal by Subject|1
327992|NCT00626522|1074878|P5|Overall Study|Withdrawal by Subject|4
327993|NCT00626522|1074879|P4|Overall Study|Withdrawal by Subject|0
327994|NCT00626522|1074880|P3|Overall Study|Withdrawal by Subject|5
327995|NCT00626522|1074881|P2|Overall Study|Withdrawal by Subject|5
327996|NCT00626522|1074882|P1|Overall Study|Withdrawal by Subject|2
327997|NCT00626522|1074877|P6|Overall Study|Adverse Event|1
327998|NCT00626522|1074878|P5|Overall Study|Adverse Event|1
327999|NCT00626522|1074879|P4|Overall Study|Adverse Event|0
328000|NCT00626522|1074880|P3|Overall Study|Adverse Event|2
328001|NCT00626522|1074881|P2|Overall Study|Adverse Event|1
328002|NCT00626522|1074882|P1|Overall Study|Adverse Event|2
328003|NCT00626522|1074877|P6|Overall Study|Protocol Violation|0
328004|NCT00626522|1074878|P5|Overall Study|Protocol Violation|1
328005|NCT00626522|1074879|P4|Overall Study|Protocol Violation|0
328006|NCT00626522|1074880|P3|Overall Study|Protocol Violation|0
328007|NCT00626522|1074881|P2|Overall Study|Protocol Violation|0
328008|NCT00626522|1074882|P1|Overall Study|Protocol Violation|0
328009|NCT00626392|1074949|P6|Coadministration Period|Other|1
328010|NCT00626392|1074950|P5|Coadministration Period|Other|1
328011|NCT00626392|1074951|P4|Coadministration Period|Other|1
328012|NCT00626392|1074952|P3|Coadministration Period|Other|3
328013|NCT00626392|1074953|P2|Coadministration Period|Other|2
328014|NCT00626392|1074954|P1|Coadministration Period|Other|0
328015|NCT00626392|1074949|P6|Coadministration Period|Protocol Violation|0
328016|NCT00626392|1074950|P5|Coadministration Period|Protocol Violation|1
328017|NCT00626392|1074951|P4|Coadministration Period|Protocol Violation|1
328018|NCT00626392|1074952|P3|Coadministration Period|Protocol Violation|0
328019|NCT00626392|1074953|P2|Coadministration Period|Protocol Violation|1
328020|NCT00626392|1074954|P1|Coadministration Period|Protocol Violation|0
328021|NCT00626392|1074949|P6|Coadministration Period|Withdrawal by Subject|1
328022|NCT00626392|1074950|P5|Coadministration Period|Withdrawal by Subject|0
328023|NCT00626392|1074951|P4|Coadministration Period|Withdrawal by Subject|1
328024|NCT00626392|1074952|P3|Coadministration Period|Withdrawal by Subject|0
328025|NCT00626392|1074953|P2|Coadministration Period|Withdrawal by Subject|1
328026|NCT00626392|1074954|P1|Coadministration Period|Withdrawal by Subject|1
328027|NCT00626392|1074949|P6|Coadministration Period|Adverse Event|4
328028|NCT00626392|1074950|P5|Coadministration Period|Adverse Event|3
328029|NCT00626392|1074951|P4|Coadministration Period|Adverse Event|4
328030|NCT00626392|1074952|P3|Coadministration Period|Adverse Event|7
328031|NCT00626392|1074953|P2|Coadministration Period|Adverse Event|1
328032|NCT00626392|1074954|P1|Coadministration Period|Adverse Event|3
328033|NCT00626392|1074949|P6|Run-in Period|Noncompliance|0
328034|NCT00626392|1074950|P5|Run-in Period|Noncompliance|0
328035|NCT00626392|1074951|P4|Run-in Period|Noncompliance|0
328036|NCT00626392|1074952|P3|Run-in Period|Noncompliance|1
328037|NCT00626392|1074953|P2|Run-in Period|Noncompliance|0
328038|NCT00626392|1074954|P1|Run-in Period|Noncompliance|1
328039|NCT00626392|1074949|P6|Run-in Period|Withdrawal by Subject|1
328040|NCT00626392|1074950|P5|Run-in Period|Withdrawal by Subject|3
328041|NCT00626392|1074951|P4|Run-in Period|Withdrawal by Subject|1
328042|NCT00626392|1074952|P3|Run-in Period|Withdrawal by Subject|1
328043|NCT00626392|1074953|P2|Run-in Period|Withdrawal by Subject|1
328044|NCT00626392|1074954|P1|Run-in Period|Withdrawal by Subject|0
328045|NCT00626392|1074949|P6|Run-in Period|Adverse Event|0
328046|NCT00626392|1074950|P5|Run-in Period|Adverse Event|1
328047|NCT00626392|1074951|P4|Run-in Period|Adverse Event|0
328048|NCT00626392|1074952|P3|Run-in Period|Adverse Event|1
328049|NCT00626392|1074953|P2|Run-in Period|Adverse Event|0
328050|NCT00626392|1074954|P1|Run-in Period|Adverse Event|0
328051|NCT00626327|1074973|P3|Overall Study|Protocol Violation|26
328052|NCT00626327|1074974|P2|Overall Study|Protocol Violation|4
328053|NCT00626327|1074975|P1|Overall Study|Protocol Violation|26
328054|NCT00626327|1074973|P3|Overall Study|Administrative Reason|6
328055|NCT00626327|1074974|P2|Overall Study|Administrative Reason|0
328056|NCT00626327|1074975|P1|Overall Study|Administrative Reason|2
328057|NCT00626327|1074973|P3|Overall Study|Inappropriate enrollment|3
328058|NCT00626327|1074974|P2|Overall Study|Inappropriate enrollment|5
328059|NCT00626327|1074975|P1|Overall Study|Inappropriate enrollment|4
328060|NCT00626327|1074973|P3|Overall Study|Lost to Follow-up|23
328061|NCT00626327|1074974|P2|Overall Study|Lost to Follow-up|21
328062|NCT00626327|1074975|P1|Overall Study|Lost to Follow-up|24
328063|NCT00626327|1074973|P3|Overall Study|Adverse Event|0
328064|NCT00626327|1074974|P2|Overall Study|Adverse Event|0
328065|NCT00626327|1074975|P1|Overall Study|Adverse Event|1
328066|NCT00626327|1074973|P3|Overall Study|Withdrawal by Subject|30
328067|NCT00626327|1074974|P2|Overall Study|Withdrawal by Subject|29
328068|NCT00626327|1074975|P1|Overall Study|Withdrawal by Subject|21
328069|NCT00626275|1075001|P8|Part B|Withdrawal by Subject|1
328070|NCT00626275|1075002|P7|Part B|Withdrawal by Subject|0
328071|NCT00626275|1075003|P6|Part B|Withdrawal by Subject|0
328072|NCT00626275|1075004|P5|Part B|Withdrawal by Subject|0
328073|NCT00626275|1075005|P4|Part B|Withdrawal by Subject|0
328074|NCT00626275|1075006|P3|Part B|Withdrawal by Subject|0
328075|NCT00626275|1075007|P2|Part B|Withdrawal by Subject|0
328076|NCT00626275|1075008|P1|Part B|Withdrawal by Subject|0
328077|NCT00626275|1075001|P8|Part B|Lost to Follow-up|0
328078|NCT00626275|1075002|P7|Part B|Lost to Follow-up|1
328079|NCT00626275|1075003|P6|Part B|Lost to Follow-up|0
328080|NCT00626275|1075004|P5|Part B|Lost to Follow-up|0
328081|NCT00626275|1075005|P4|Part B|Lost to Follow-up|0
328082|NCT00626275|1075006|P3|Part B|Lost to Follow-up|0
328083|NCT00626275|1075007|P2|Part B|Lost to Follow-up|0
328084|NCT00626275|1075008|P1|Part B|Lost to Follow-up|0
328085|NCT00626275|1075001|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
328086|NCT00626275|1075002|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
328087|NCT00626275|1075003|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
328088|NCT00626275|1075004|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
328089|NCT00626275|1075005|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
328090|NCT00626275|1075006|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
328091|NCT00626275|1075007|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
328092|NCT00626275|1075008|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
328093|NCT00626275|1075001|P8|Part A - Treatment Period 1|Adverse Event|0
328094|NCT00626275|1075002|P7|Part A - Treatment Period 1|Adverse Event|0
328095|NCT00626275|1075003|P6|Part A - Treatment Period 1|Adverse Event|0
328096|NCT00626275|1075004|P5|Part A - Treatment Period 1|Adverse Event|0
328097|NCT00626275|1075005|P4|Part A - Treatment Period 1|Adverse Event|0
328098|NCT00626275|1075006|P3|Part A - Treatment Period 1|Adverse Event|0
328099|NCT00626275|1075007|P2|Part A - Treatment Period 1|Adverse Event|0
328100|NCT00626275|1075008|P1|Part A - Treatment Period 1|Adverse Event|1
328101|NCT00626093|1075052|P1|Overall Study|One of the required devices not implante|6
328102|NCT00626093|1075052|P1|Overall Study|Protocol Violation|1
328103|NCT00626093|1075052|P1|Overall Study|Withdrawal by Subject|6
328104|NCT00626093|1075052|P1|Overall Study|Physician Decision|4
328105|NCT00626093|1075052|P1|Overall Study|Death|1
328106|NCT00626093|1075052|P1|Overall Study|Lost to Follow-up|5
328107|NCT00626028|1075059|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
328108|NCT00626028|1075060|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
328109|NCT00626028|1075059|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
328110|NCT00626028|1075060|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
328111|NCT00626028|1075059|P2|Treatment 1 NO First, O2 Last|Device Failure|1
328112|NCT00626028|1075060|P1|Treatment 1 NO First, O2 Last|Device Failure|0
328113|NCT00626028|1075059|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
328114|NCT00626028|1075060|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
328115|NCT00625872|1075080|P2|Overall Study|Randomized but not treated|1
328116|NCT00625872|1075081|P1|Overall Study|Randomized but not treated|0
328117|NCT00625872|1075080|P2|Overall Study|Terminated by sponsor|5
328118|NCT00625872|1075081|P1|Overall Study|Terminated by sponsor|2
328119|NCT00625872|1075080|P2|Overall Study|Does not meet inclusion criteria|0
328120|NCT00625872|1075081|P1|Overall Study|Does not meet inclusion criteria|1
328121|NCT00625872|1075080|P2|Overall Study|Withdrawal by Subject|0
328122|NCT00625872|1075081|P1|Overall Study|Withdrawal by Subject|1
328123|NCT00625820|1075191|P1|Overall Study|Withdrawal by Subject|1
328124|NCT00625742|1075197|P1|Overall Study|Ineligible|1
328125|NCT00625742|1075197|P1|Overall Study|Lost to Follow-up|4
328126|NCT00625742|1075197|P1|Overall Study|Adverse Event|4
328127|NCT00625742|1075197|P1|Overall Study|Withdrawal by Subject|1
328128|NCT00625742|1075197|P1|Overall Study|Disease Progression|2
328129|NCT00625586|1075211|P1|Overall Study|Adverse Event|1
328130|NCT00625365|1075271|P1|Overall Study|VSD|1
328131|NCT00625365|1075271|P1|Overall Study|No IV access|5
328132|NCT00625365|1075271|P1|Overall Study|Withdrawal by Subject|1
328133|NCT00625183|1075277|P1|Overall Study|Disease Progression|1
328134|NCT00625131|1075286|P3|Overall Study|Withdrawal by Subject|5
328135|NCT00625131|1075287|P2|Overall Study|Withdrawal by Subject|0
328136|NCT00625131|1075288|P1|Overall Study|Withdrawal by Subject|1
328137|NCT00625131|1075286|P3|Overall Study|Lost to Follow-up|0
328138|NCT00625131|1075287|P2|Overall Study|Lost to Follow-up|2
328139|NCT00625131|1075288|P1|Overall Study|Lost to Follow-up|3
328140|NCT00624832|1075302|P4|Overall Study|Abnormal Laboratory Value|0
328141|NCT00624832|1075303|P3|Overall Study|Abnormal Laboratory Value|0
328142|NCT00624832|1075304|P2|Overall Study|Abnormal Laboratory Value|0
328143|NCT00624832|1075305|P1|Overall Study|Abnormal Laboratory Value|2
328144|NCT00624832|1075302|P4|Overall Study|Adverse Event|1
328145|NCT00624832|1075303|P3|Overall Study|Adverse Event|0
328146|NCT00624832|1075304|P2|Overall Study|Adverse Event|1
328147|NCT00624832|1075305|P1|Overall Study|Adverse Event|0
328148|NCT00624780|1075336|P6|Follow-up (Week 26)|Unspecified|0
328149|NCT00624780|1075337|P5|Follow-up (Week 26)|Unspecified|0
328150|NCT00624780|1075338|P4|Follow-up (Week 26)|Unspecified|0
328151|NCT00624780|1075339|P3|Follow-up (Week 26)|Unspecified|0
328152|NCT00624780|1075340|P2|Follow-up (Week 26)|Unspecified|1
328153|NCT00624780|1075341|P1|Follow-up (Week 26)|Unspecified|1
328154|NCT00624780|1075336|P6|Follow-up (Week 26)|Withdrawal by Subject|0
328155|NCT00624780|1075337|P5|Follow-up (Week 26)|Withdrawal by Subject|0
328156|NCT00624780|1075338|P4|Follow-up (Week 26)|Withdrawal by Subject|0
328157|NCT00624780|1075339|P3|Follow-up (Week 26)|Withdrawal by Subject|0
328158|NCT00624780|1075340|P2|Follow-up (Week 26)|Withdrawal by Subject|0
328159|NCT00624780|1075341|P1|Follow-up (Week 26)|Withdrawal by Subject|1
328160|NCT00624780|1075336|P6|Follow-up (Week 26)|Lost to Follow-up|0
328161|NCT00624780|1075337|P5|Follow-up (Week 26)|Lost to Follow-up|1
328162|NCT00624780|1075338|P4|Follow-up (Week 26)|Lost to Follow-up|0
328163|NCT00624780|1075339|P3|Follow-up (Week 26)|Lost to Follow-up|1
328164|NCT00624780|1075340|P2|Follow-up (Week 26)|Lost to Follow-up|0
328165|NCT00624780|1075341|P1|Follow-up (Week 26)|Lost to Follow-up|0
328166|NCT00624780|1075336|P6|Follow-up (Week 26)|Adverse Event|0
328167|NCT00624780|1075337|P5|Follow-up (Week 26)|Adverse Event|1
328168|NCT00624780|1075338|P4|Follow-up (Week 26)|Adverse Event|0
328169|NCT00624780|1075339|P3|Follow-up (Week 26)|Adverse Event|0
328170|NCT00624780|1075340|P2|Follow-up (Week 26)|Adverse Event|0
328171|NCT00624780|1075341|P1|Follow-up (Week 26)|Adverse Event|0
328172|NCT00624780|1075336|P6|Follow-up (Week 26)|Death|0
328173|NCT00624780|1075337|P5|Follow-up (Week 26)|Death|0
328174|NCT00624780|1075338|P4|Follow-up (Week 26)|Death|0
328175|NCT00624780|1075339|P3|Follow-up (Week 26)|Death|1
328176|NCT00624780|1075340|P2|Follow-up (Week 26)|Death|0
328177|NCT00624780|1075341|P1|Follow-up (Week 26)|Death|0
328178|NCT00624780|1075336|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
328179|NCT00624780|1075337|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
328180|NCT00624780|1075338|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
328181|NCT00624780|1075339|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
328182|NCT00624780|1075340|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
328183|NCT00624780|1075341|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
328184|NCT00624780|1075336|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
328185|NCT00624780|1075337|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
328186|NCT00624780|1075338|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
328187|NCT00624780|1075339|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
328188|NCT00624780|1075340|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
328189|NCT00624780|1075341|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
328190|NCT00624780|1075336|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
328191|NCT00624780|1075337|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
328192|NCT00624780|1075338|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
328193|NCT00624780|1075339|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
328194|NCT00624780|1075340|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
328195|NCT00624780|1075341|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
328196|NCT00624780|1075336|P6|Fixed Dosing (Week 13 to Week 24)|Unspecified|3
328197|NCT00624780|1075337|P5|Fixed Dosing (Week 13 to Week 24)|Unspecified|4
328198|NCT00624780|1075338|P4|Fixed Dosing (Week 13 to Week 24)|Unspecified|1
328199|NCT00624780|1075339|P3|Fixed Dosing (Week 13 to Week 24)|Unspecified|4
328200|NCT00624780|1075340|P2|Fixed Dosing (Week 13 to Week 24)|Unspecified|3
328201|NCT00624780|1075341|P1|Fixed Dosing (Week 13 to Week 24)|Unspecified|5
328202|NCT00624780|1075336|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
328203|NCT00624780|1075337|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
328204|NCT00624780|1075338|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
328205|NCT00624780|1075339|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
328206|NCT00624780|1075340|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
328207|NCT00624780|1075341|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
328208|NCT00624780|1075336|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
328209|NCT00624780|1075337|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
328210|NCT00624780|1075338|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
328211|NCT00624780|1075339|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
328212|NCT00624780|1075340|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
328213|NCT00624780|1075341|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
328214|NCT00624780|1075336|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
328215|NCT00624780|1075337|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
328216|NCT00624780|1075338|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
328217|NCT00624780|1075339|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
328218|NCT00624780|1075340|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
328219|NCT00624780|1075341|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
328220|NCT00624780|1075336|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
328221|NCT00624780|1075337|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
328222|NCT00624780|1075338|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
328223|NCT00624780|1075339|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
328224|NCT00624780|1075340|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
328225|NCT00624780|1075341|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
328226|NCT00624780|1075336|P6|Treatment Optimization (Up to Week 12)|Unspecified|0
328227|NCT00624780|1075337|P5|Treatment Optimization (Up to Week 12)|Unspecified|9
328228|NCT00624780|1075338|P4|Treatment Optimization (Up to Week 12)|Unspecified|2
328229|NCT00624780|1075339|P3|Treatment Optimization (Up to Week 12)|Unspecified|8
328230|NCT00624780|1075340|P2|Treatment Optimization (Up to Week 12)|Unspecified|4
328231|NCT00624780|1075341|P1|Treatment Optimization (Up to Week 12)|Unspecified|10
328232|NCT00624780|1075336|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
328233|NCT00624780|1075337|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
328234|NCT00624780|1075338|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
328235|NCT00624780|1075339|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
328236|NCT00624780|1075340|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
328237|NCT00624780|1075341|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
328238|NCT00624780|1075336|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
328239|NCT00624780|1075337|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
328240|NCT00624780|1075338|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
328241|NCT00624780|1075339|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
328242|NCT00624780|1075340|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
328243|NCT00624780|1075341|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
328244|NCT00624780|1075336|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
328245|NCT00624780|1075337|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
328246|NCT00624780|1075338|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
328247|NCT00624780|1075339|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
328248|NCT00624780|1075340|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
328249|NCT00624780|1075341|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
328250|NCT00624780|1075336|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
328251|NCT00624780|1075337|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
328252|NCT00624780|1075338|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
328253|NCT00624780|1075339|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
328254|NCT00624780|1075340|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
328255|NCT00624780|1075341|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
328256|NCT00624585|1075523|P1|Overall Study|Adverse Event|3
328257|NCT00624585|1075523|P1|Overall Study|Disease Progression|6
328258|NCT00624585|1075523|P1|Overall Study|Death|3
328259|NCT00624520|1075553|P2|Overall Study|Death|1
328260|NCT00624520|1075554|P1|Overall Study|Death|0
328261|NCT00624520|1075553|P2|Overall Study|Withdrawal by Subject|7
328262|NCT00624520|1075554|P1|Overall Study|Withdrawal by Subject|12
328263|NCT00624468|1075581|P4|Safety Follow-up (SFU) Period|Unspecified|1
328264|NCT00624468|1075582|P3|Safety Follow-up (SFU) Period|Unspecified|1
328265|NCT00624468|1075583|P2|Safety Follow-up (SFU) Period|Unspecified|0
328266|NCT00624468|1075584|P1|Safety Follow-up (SFU) Period|Unspecified|0
328267|NCT00624468|1075581|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
328268|NCT00624468|1075582|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
328269|NCT00624468|1075583|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
328270|NCT00624468|1075584|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
328271|NCT00624468|1075581|P4|Double-blind Period|Withdrew Prematurely|0
328272|NCT00624468|1075582|P3|Double-blind Period|Withdrew Prematurely|0
328273|NCT00624468|1075583|P2|Double-blind Period|Withdrew Prematurely|1
328274|NCT00624468|1075584|P1|Double-blind Period|Withdrew Prematurely|1
328275|NCT00624468|1075581|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
328276|NCT00624468|1075582|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
328277|NCT00624468|1075583|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
328278|NCT00624468|1075584|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
328279|NCT00624377|1075651|P1|Overall Study|Non-evaluable population|84
328280|NCT00624377|1075651|P1|Overall Study|Other|91
328281|NCT00624377|1075651|P1|Overall Study|Adverse Event|14
328282|NCT00624377|1075651|P1|Overall Study|Withdrawal by Subject|100
328283|NCT00624377|1075651|P1|Overall Study|Lost to Follow-up|355
328284|NCT00624338|1075665|P3|Overall Study|Randomized but not treated|3
328285|NCT00624338|1075666|P2|Overall Study|Randomized but not treated|1
328286|NCT00624338|1075667|P1|Overall Study|Randomized but not treated|2
328287|NCT00624338|1075665|P3|Overall Study|Unspecified|9
328288|NCT00624338|1075666|P2|Overall Study|Unspecified|5
328289|NCT00624338|1075667|P1|Overall Study|Unspecified|15
328290|NCT00624338|1075665|P3|Overall Study|Termination of 150 mg group by Sponsor|0
328291|NCT00624338|1075666|P2|Overall Study|Termination of 150 mg group by Sponsor|55
328292|NCT00624338|1075667|P1|Overall Study|Termination of 150 mg group by Sponsor|0
328293|NCT00624338|1075665|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
328294|NCT00624338|1075666|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
328295|NCT00624338|1075667|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
328296|NCT00624338|1075665|P3|Overall Study|Death|0
328297|NCT00624338|1075666|P2|Overall Study|Death|2
328298|NCT00624338|1075667|P1|Overall Study|Death|0
328299|NCT00624338|1075665|P3|Overall Study|Protocol Violation|2
328300|NCT00624338|1075666|P2|Overall Study|Protocol Violation|3
328301|NCT00624338|1075667|P1|Overall Study|Protocol Violation|3
328302|NCT00624338|1075665|P3|Overall Study|Lack of Efficacy|14
328303|NCT00624338|1075666|P2|Overall Study|Lack of Efficacy|3
328304|NCT00624338|1075667|P1|Overall Study|Lack of Efficacy|11
328305|NCT00624338|1075665|P3|Overall Study|Lost to Follow-up|0
328306|NCT00624338|1075666|P2|Overall Study|Lost to Follow-up|0
328307|NCT00624338|1075667|P1|Overall Study|Lost to Follow-up|1
328308|NCT00624338|1075665|P3|Overall Study|Adverse Event|18
328309|NCT00624338|1075666|P2|Overall Study|Adverse Event|14
328310|NCT00624338|1075667|P1|Overall Study|Adverse Event|14
328311|NCT00624286|1075689|P2|Overall Study|Death|1
328312|NCT00624286|1075690|P1|Overall Study|Death|0
328313|NCT00624286|1075689|P2|Overall Study|Abnormal test procedure result(s)|1
328314|NCT00624286|1075690|P1|Overall Study|Abnormal test procedure result(s)|0
328315|NCT00624286|1075689|P2|Overall Study|Not stated|1
328316|NCT00624286|1075690|P1|Overall Study|Not stated|0
328317|NCT00624286|1075689|P2|Overall Study|Lack of Efficacy|6
328318|NCT00624286|1075690|P1|Overall Study|Lack of Efficacy|1
328319|NCT00624286|1075689|P2|Overall Study|Administrative problems|0
328320|NCT00624286|1075690|P1|Overall Study|Administrative problems|3
328321|NCT00624286|1075689|P2|Overall Study|Lost to Follow-up|2
328322|NCT00624286|1075690|P1|Overall Study|Lost to Follow-up|3
328323|NCT00624286|1075689|P2|Overall Study|Withdrawal by Subject|4
328324|NCT00624286|1075690|P1|Overall Study|Withdrawal by Subject|5
328325|NCT00624286|1075689|P2|Overall Study|Adverse Event|3
328326|NCT00624286|1075690|P1|Overall Study|Adverse Event|6
328327|NCT00624286|1075689|P2|Overall Study|Protocol Deviation|9
328328|NCT00624286|1075690|P1|Overall Study|Protocol Deviation|7
328329|NCT00624065|1075743|P2|Overall Study|Met protocol-defined stopping criteria|9
328330|NCT00624065|1075744|P1|Overall Study|Met protocol-defined stopping criteria|4
328331|NCT00624065|1075743|P2|Overall Study|Lack of Efficacy|3
328332|NCT00624065|1075744|P1|Overall Study|Lack of Efficacy|0
328333|NCT00624065|1075743|P2|Overall Study|Consent withdrawn|5
328334|NCT00624065|1075744|P1|Overall Study|Consent withdrawn|6
328335|NCT00624065|1075743|P2|Overall Study|Lost to Follow-up|1
328336|NCT00624065|1075744|P1|Overall Study|Lost to Follow-up|4
328337|NCT00624065|1075743|P2|Overall Study|Adverse Event|6
328338|NCT00624065|1075744|P1|Overall Study|Adverse Event|5
328339|NCT00624052|1075756|P4|Overall Study|Changed job/ran out if meds|0
328340|NCT00624052|1075757|P3|Overall Study|Changed job/ran out if meds|0
328341|NCT00624052|1075758|P2|Overall Study|Changed job/ran out if meds|2
328342|NCT00624052|1075759|P1|Overall Study|Changed job/ran out if meds|0
328343|NCT00624052|1075756|P4|Overall Study|Consent withdrawn|0
328344|NCT00624052|1075757|P3|Overall Study|Consent withdrawn|1
328345|NCT00624052|1075758|P2|Overall Study|Consent withdrawn|1
328346|NCT00624052|1075759|P1|Overall Study|Consent withdrawn|3
328347|NCT00624052|1075756|P4|Overall Study|Non compliant with the protocol|1
328348|NCT00624052|1075757|P3|Overall Study|Non compliant with the protocol|1
328349|NCT00624052|1075758|P2|Overall Study|Non compliant with the protocol|1
328350|NCT00624052|1075759|P1|Overall Study|Non compliant with the protocol|2
328351|NCT00624052|1075756|P4|Overall Study|Lost to Follow-up|0
328352|NCT00624052|1075757|P3|Overall Study|Lost to Follow-up|1
328353|NCT00624052|1075758|P2|Overall Study|Lost to Follow-up|3
328354|NCT00624052|1075759|P1|Overall Study|Lost to Follow-up|2
328355|NCT00624052|1075756|P4|Overall Study|Lack of Efficacy|0
328356|NCT00624052|1075757|P3|Overall Study|Lack of Efficacy|0
328357|NCT00624052|1075758|P2|Overall Study|Lack of Efficacy|1
328358|NCT00624052|1075759|P1|Overall Study|Lack of Efficacy|1
328359|NCT00624052|1075756|P4|Overall Study|Adverse Event|3
328360|NCT00624052|1075757|P3|Overall Study|Adverse Event|0
328361|NCT00624052|1075758|P2|Overall Study|Adverse Event|6
328362|NCT00624052|1075759|P1|Overall Study|Adverse Event|7
328363|NCT00623935|1075825|P1|Overall Study|Patient Declined Transplant|1
328364|NCT00623935|1075825|P1|Overall Study|Death|1
328365|NCT00623831|1075832|P2|Overall Study|Progressive Disease|1
328366|NCT00623831|1075833|P1|Overall Study|Progressive Disease|0
328367|NCT00623831|1075832|P2|Overall Study|Withdrawal by Subject|0
328368|NCT00623831|1075833|P1|Overall Study|Withdrawal by Subject|1
328369|NCT00623805|1075845|P2|Overall Study|Reason not Specified|6
328370|NCT00623805|1075846|P1|Overall Study|Reason not Specified|3
328371|NCT00623805|1075845|P2|Overall Study|Protocol Violation|1
328372|NCT00623805|1075846|P1|Overall Study|Protocol Violation|1
328373|NCT00623805|1075845|P2|Overall Study|Lost to Follow-up|2
328374|NCT00623805|1075846|P1|Overall Study|Lost to Follow-up|2
328375|NCT00623805|1075845|P2|Overall Study|Lack of Efficacy|7
328376|NCT00623805|1075846|P1|Overall Study|Lack of Efficacy|3
328377|NCT00623805|1075845|P2|Overall Study|Death|0
328378|NCT00623805|1075846|P1|Overall Study|Death|2
328379|NCT00623805|1075845|P2|Overall Study|Adverse Event|6
328380|NCT00623805|1075846|P1|Overall Study|Adverse Event|9
328381|NCT00623779|1075863|P3|Overall Study|Criteria from CSR|1
328382|NCT00623779|1075864|P2|Overall Study|Criteria from CSR|0
328383|NCT00623779|1075865|P1|Overall Study|Criteria from CSR|2
328384|NCT00623779|1075863|P3|Overall Study|Adverse Event|0
328385|NCT00623779|1075864|P2|Overall Study|Adverse Event|3
328386|NCT00623779|1075865|P1|Overall Study|Adverse Event|1
328387|NCT00623766|1075914|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
328388|NCT00623766|1075915|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
328389|NCT00623766|1075914|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
328390|NCT00623766|1075915|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
328391|NCT00623766|1075914|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
328392|NCT00623766|1075915|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
328393|NCT00623766|1075914|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
328394|NCT00623766|1075915|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
328395|NCT00623766|1075914|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
328396|NCT00623766|1075915|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
328397|NCT00623727|1075939|P2|Open Label Follow-up|Participant convenience|1
328398|NCT00623727|1075940|P1|Open Label Follow-up|Participant convenience|0
328399|NCT00623727|1075939|P2|Open Label Follow-up|Study termination|6
328400|NCT00623727|1075940|P1|Open Label Follow-up|Study termination|0
328401|NCT00623727|1075939|P2|Open Label Follow-up|Withdrawal by Subject|1
328402|NCT00623727|1075940|P1|Open Label Follow-up|Withdrawal by Subject|0
328403|NCT00623727|1075939|P2|Double Blind (DB)|Protocol Violation|2
328404|NCT00623727|1075940|P1|Double Blind (DB)|Protocol Violation|2
328405|NCT00623727|1075939|P2|Double Blind (DB)|Lost to Follow-up|1
328406|NCT00623727|1075940|P1|Double Blind (DB)|Lost to Follow-up|1
328407|NCT00623727|1075939|P2|Double Blind (DB)|Termination of the double-blind period|21
328408|NCT00623727|1075940|P1|Double Blind (DB)|Termination of the double-blind period|22
328409|NCT00623727|1075939|P2|Double Blind (DB)|Lack of Efficacy|2
328410|NCT00623727|1075940|P1|Double Blind (DB)|Lack of Efficacy|2
328411|NCT00623727|1075939|P2|Double Blind (DB)|Withdrawal by Subject|2
328412|NCT00623727|1075940|P1|Double Blind (DB)|Withdrawal by Subject|8
328413|NCT00623727|1075939|P2|Double Blind (DB)|Physician Decision|1
328414|NCT00623727|1075940|P1|Double Blind (DB)|Physician Decision|0
328415|NCT00623727|1075939|P2|Double Blind (DB)|Adverse Event|3
328416|NCT00623727|1075940|P1|Double Blind (DB)|Adverse Event|1
328417|NCT00623597|1075995|P2|Overall Study|Failed to return|0
328418|NCT00623597|1075996|P1|Overall Study|Failed to return|1
328419|NCT00623545|1076059|P1|Overall Study|Withdrawal by Subject|4
328420|NCT00623545|1076059|P1|Overall Study|Adverse Event|6
328421|NCT00623480|1076079|P2|Overall Study|Site closed by sponsor|1
328422|NCT00623480|1076080|P1|Overall Study|Site closed by sponsor|0
328423|NCT00623480|1076079|P2|Overall Study|Protocol Violation|1
328424|NCT00623480|1076080|P1|Overall Study|Protocol Violation|0
328425|NCT00623480|1076079|P2|Overall Study|Non-compliant with study medication|0
328426|NCT00623480|1076080|P1|Overall Study|Non-compliant with study medication|4
328427|NCT00623480|1076079|P2|Overall Study|Lack of Efficacy|0
328428|NCT00623480|1076080|P1|Overall Study|Lack of Efficacy|1
328429|NCT00623480|1076079|P2|Overall Study|Withdrawal by Subject|4
328430|NCT00623480|1076080|P1|Overall Study|Withdrawal by Subject|2
328431|NCT00623480|1076079|P2|Overall Study|Lost to Follow-up|1
328432|NCT00623480|1076080|P1|Overall Study|Lost to Follow-up|0
328433|NCT00623467|1076092|P1|Overall Study|Withdrawal by Subject|2
328434|NCT00623467|1076092|P1|Overall Study|Protocol Violation|4
328435|NCT00623467|1076092|P1|Overall Study|Lost to Follow-up|1
328436|NCT00623428|1076162|P2|Follow-up Period|Death|1
328437|NCT00623428|1076163|P1|Follow-up Period|Death|0
328438|NCT00623428|1076162|P2|Follow-up Period|Reason not specified|1
328439|NCT00623428|1076163|P1|Follow-up Period|Reason not specified|1
328440|NCT00623428|1076162|P2|Follow-up Period|Did not cooperate|3
328441|NCT00623428|1076163|P1|Follow-up Period|Did not cooperate|0
328442|NCT00623428|1076162|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
328443|NCT00623428|1076163|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
328444|NCT00623428|1076162|P2|Follow-up Period|Patient withdrew consent|4
328445|NCT00623428|1076163|P1|Follow-up Period|Patient withdrew consent|5
328446|NCT00623428|1076162|P2|Follow-up Period|Failure to return|2
328447|NCT00623428|1076163|P1|Follow-up Period|Failure to return|10
328448|NCT00623428|1076162|P2|Follow-up Period|Relapse post-treatment|3
328449|NCT00623428|1076163|P1|Follow-up Period|Relapse post-treatment|11
328450|NCT00623428|1076162|P2|Treatment Period|Withdrawal by Subject|1
328451|NCT00623428|1076163|P1|Treatment Period|Withdrawal by Subject|0
328452|NCT00623428|1076162|P2|Treatment Period|Other|1
328453|NCT00623428|1076163|P1|Treatment Period|Other|0
328454|NCT00623428|1076162|P2|Treatment Period|Insufficient therapeutic response|2
328455|NCT00623428|1076163|P1|Treatment Period|Insufficient therapeutic response|0
328456|NCT00623428|1076162|P2|Treatment Period|Did not cooperate / refused treatment|13
328457|NCT00623428|1076163|P1|Treatment Period|Did not cooperate / refused treatment|0
328458|NCT00623428|1076162|P2|Treatment Period|Death|1
328459|NCT00623428|1076163|P1|Treatment Period|Death|0
328460|NCT00623428|1076162|P2|Treatment Period|Adverse event/intercurrent illness|9
328461|NCT00623428|1076163|P1|Treatment Period|Adverse event/intercurrent illness|0
328462|NCT00623233|1076181|P1|Overall Study|Withdrawal by Subject|3
328463|NCT00623233|1076181|P1|Overall Study|Lost to Follow-up|1
328464|NCT00623233|1076181|P1|Overall Study|Physician Decision|10
328465|NCT00623233|1076181|P1|Overall Study|Adverse Event|10
328466|NCT00623194|1076188|P1|Overall Study|Unclassified|1
328467|NCT00623194|1076188|P1|Overall Study|Protocol Violation|3
328468|NCT00623194|1076188|P1|Overall Study|Lack of Efficacy|1
328469|NCT00623103|1076225|P2|Overall Study|Protocol deviation|1
328470|NCT00623103|1076226|P1|Overall Study|Protocol deviation|2
328471|NCT00623103|1076225|P2|Overall Study|Death|11
328472|NCT00623103|1076226|P1|Overall Study|Death|11
328473|NCT00623103|1076225|P2|Overall Study|Administrative problems|4
328474|NCT00623103|1076226|P1|Overall Study|Administrative problems|2
328475|NCT00623103|1076225|P2|Overall Study|Lost to Follow-up|1
328476|NCT00623103|1076226|P1|Overall Study|Lost to Follow-up|4
328477|NCT00623103|1076225|P2|Overall Study|Withdrawal by Subject|24
328478|NCT00623103|1076226|P1|Overall Study|Withdrawal by Subject|18
328479|NCT00623103|1076225|P2|Overall Study|Unsatisfactory therapeutic effect|12
328480|NCT00623103|1076226|P1|Overall Study|Unsatisfactory therapeutic effect|4
328481|NCT00623103|1076225|P2|Overall Study|Adverse Event|60
328482|NCT00623103|1076226|P1|Overall Study|Adverse Event|70
328483|NCT00622908|1076254|P2|Overall Study|Termination by study sponser|1
328484|NCT00622908|1076255|P1|Overall Study|Termination by study sponser|0
328485|NCT00622908|1076254|P2|Overall Study|Refusal|1
328486|NCT00622908|1076255|P1|Overall Study|Refusal|0
328487|NCT00622908|1076254|P2|Overall Study|Lost to Follow-up|0
328488|NCT00622908|1076255|P1|Overall Study|Lost to Follow-up|1
328489|NCT00622908|1076254|P2|Overall Study|Lack of Efficacy|7
328490|NCT00622908|1076255|P1|Overall Study|Lack of Efficacy|1
328491|NCT00622908|1076254|P2|Overall Study|Adverse Event|1
328492|NCT00622908|1076255|P1|Overall Study|Adverse Event|0
328493|NCT00622908|1076254|P2|Overall Study|Protocol Violation|0
328494|NCT00622908|1076255|P1|Overall Study|Protocol Violation|1
328495|NCT00622869|1076270|P3|Overall Study|Missing|1
328496|NCT00622869|1076271|P2|Overall Study|Missing|1
328497|NCT00622869|1076272|P1|Overall Study|Missing|0
328498|NCT00622869|1076270|P3|Overall Study|Graft Loss|2
328499|NCT00622869|1076271|P2|Overall Study|Graft Loss|3
328500|NCT00622869|1076272|P1|Overall Study|Graft Loss|5
328501|NCT00622869|1076270|P3|Overall Study|Lost to Follow-up|2
328502|NCT00622869|1076271|P2|Overall Study|Lost to Follow-up|4
328503|NCT00622869|1076272|P1|Overall Study|Lost to Follow-up|2
328504|NCT00622869|1076270|P3|Overall Study|Death|10
328505|NCT00622869|1076271|P2|Overall Study|Death|15
328506|NCT00622869|1076272|P1|Overall Study|Death|12
328507|NCT00622869|1076270|P3|Overall Study|Administrative Problems|13
328508|NCT00622869|1076271|P2|Overall Study|Administrative Problems|17
328509|NCT00622869|1076272|P1|Overall Study|Administrative Problems|11
328510|NCT00622869|1076270|P3|Overall Study|Subject Withdrew Consent|11
328511|NCT00622869|1076271|P2|Overall Study|Subject Withdrew Consent|17
328512|NCT00622869|1076272|P1|Overall Study|Subject Withdrew Consent|13
328513|NCT00622739|1076291|P2|Overall Study|Lost to Follow-up|1
328514|NCT00622739|1076292|P1|Overall Study|Lost to Follow-up|0
328515|NCT00622739|1076291|P2|Overall Study|Withdrawal by Subject|1
328516|NCT00622739|1076292|P1|Overall Study|Withdrawal by Subject|0
328517|NCT00622739|1076291|P2|Overall Study|Lack of Efficacy|2
328518|NCT00622739|1076292|P1|Overall Study|Lack of Efficacy|0
328519|NCT00622739|1076291|P2|Overall Study|Adverse Event|2
328520|NCT00622739|1076292|P1|Overall Study|Adverse Event|1
328521|NCT00622739|1076291|P2|Overall Study|Physician Decision|0
328522|NCT00622739|1076292|P1|Overall Study|Physician Decision|1
328523|NCT00622726|1076300|P2|August, 2010 to April, 2013|Death|5
328524|NCT00622726|1076301|P1|August, 2010 to April, 2013|Death|1
328525|NCT00622726|1076300|P2|March, 2008 to August, 2010|Death|2
328526|NCT00622726|1076301|P1|March, 2008 to August, 2010|Death|5
328527|NCT00622713|1076311|P1|Overall Study|Did not meet eligibility criteria|1
328528|NCT00622713|1076311|P1|Overall Study|Subject no longer required study drug|1
328529|NCT00622713|1076311|P1|Overall Study|Death|2
328530|NCT00622713|1076311|P1|Overall Study|Lost to Follow-up|5
328531|NCT00622713|1076311|P1|Overall Study|Withdrawal by Subject|11
328532|NCT00622713|1076311|P1|Overall Study|Administrative problems|4
328533|NCT00622713|1076311|P1|Overall Study|Adverse Event|35
328534|NCT00622700|1076322|P7|Extension Treatment Period|Other than specified above|1
328535|NCT00622700|1076323|P6|Extension Treatment Period|Other than specified above|1
328536|NCT00622700|1076324|P5|Extension Treatment Period|Other than specified above|0
328537|NCT00622700|1076325|P4|Extension Treatment Period|Other than specified above|0
328538|NCT00622700|1076326|P3|Extension Treatment Period|Other than specified above|0
328539|NCT00622700|1076327|P2|Extension Treatment Period|Other than specified above|0
328540|NCT00622700|1076328|P1|Extension Treatment Period|Other than specified above|0
328541|NCT00622700|1076322|P7|Extension Treatment Period|Missing|0
328542|NCT00622700|1076323|P6|Extension Treatment Period|Missing|1
328543|NCT00622700|1076324|P5|Extension Treatment Period|Missing|3
328544|NCT00622700|1076325|P4|Extension Treatment Period|Missing|2
328545|NCT00622700|1076326|P3|Extension Treatment Period|Missing|0
328546|NCT00622700|1076327|P2|Extension Treatment Period|Missing|0
328547|NCT00622700|1076328|P1|Extension Treatment Period|Missing|0
328548|NCT00622700|1076322|P7|Extension Treatment Period|Withdrawal by Subject|10
328549|NCT00622700|1076323|P6|Extension Treatment Period|Withdrawal by Subject|6
328550|NCT00622700|1076324|P5|Extension Treatment Period|Withdrawal by Subject|16
328551|NCT00622700|1076325|P4|Extension Treatment Period|Withdrawal by Subject|11
328552|NCT00622700|1076326|P3|Extension Treatment Period|Withdrawal by Subject|0
328553|NCT00622700|1076327|P2|Extension Treatment Period|Withdrawal by Subject|0
328554|NCT00622700|1076328|P1|Extension Treatment Period|Withdrawal by Subject|0
328555|NCT00622700|1076322|P7|Extension Treatment Period|Progressive Disease|2
328556|NCT00622700|1076323|P6|Extension Treatment Period|Progressive Disease|0
328557|NCT00622700|1076324|P5|Extension Treatment Period|Progressive Disease|2
328558|NCT00622700|1076325|P4|Extension Treatment Period|Progressive Disease|1
328559|NCT00622700|1076326|P3|Extension Treatment Period|Progressive Disease|0
328560|NCT00622700|1076327|P2|Extension Treatment Period|Progressive Disease|0
328561|NCT00622700|1076328|P1|Extension Treatment Period|Progressive Disease|0
328562|NCT00622700|1076322|P7|Extension Treatment Period|Lost to Follow-up|0
328563|NCT00622700|1076323|P6|Extension Treatment Period|Lost to Follow-up|0
328564|NCT00622700|1076324|P5|Extension Treatment Period|Lost to Follow-up|1
328565|NCT00622700|1076325|P4|Extension Treatment Period|Lost to Follow-up|0
328566|NCT00622700|1076326|P3|Extension Treatment Period|Lost to Follow-up|0
328567|NCT00622700|1076327|P2|Extension Treatment Period|Lost to Follow-up|0
328568|NCT00622700|1076328|P1|Extension Treatment Period|Lost to Follow-up|0
328569|NCT00622700|1076322|P7|Extension Treatment Period|Protocol Violation|0
328570|NCT00622700|1076323|P6|Extension Treatment Period|Protocol Violation|2
328571|NCT00622700|1076324|P5|Extension Treatment Period|Protocol Violation|0
328572|NCT00622700|1076325|P4|Extension Treatment Period|Protocol Violation|0
328573|NCT00622700|1076326|P3|Extension Treatment Period|Protocol Violation|0
328574|NCT00622700|1076327|P2|Extension Treatment Period|Protocol Violation|0
328575|NCT00622700|1076328|P1|Extension Treatment Period|Protocol Violation|0
328576|NCT00622700|1076322|P7|Extension Treatment Period|Lack of Efficacy|9
328577|NCT00622700|1076323|P6|Extension Treatment Period|Lack of Efficacy|1
328578|NCT00622700|1076324|P5|Extension Treatment Period|Lack of Efficacy|8
328579|NCT00622700|1076325|P4|Extension Treatment Period|Lack of Efficacy|2
328580|NCT00622700|1076326|P3|Extension Treatment Period|Lack of Efficacy|0
328581|NCT00622700|1076327|P2|Extension Treatment Period|Lack of Efficacy|0
328582|NCT00622700|1076328|P1|Extension Treatment Period|Lack of Efficacy|0
328583|NCT00622700|1076322|P7|Extension Treatment Period|Adverse Event|8
328584|NCT00622700|1076323|P6|Extension Treatment Period|Adverse Event|6
328585|NCT00622700|1076324|P5|Extension Treatment Period|Adverse Event|9
328586|NCT00622700|1076325|P4|Extension Treatment Period|Adverse Event|5
328587|NCT00622700|1076326|P3|Extension Treatment Period|Adverse Event|0
328588|NCT00622700|1076327|P2|Extension Treatment Period|Adverse Event|0
328589|NCT00622700|1076328|P1|Extension Treatment Period|Adverse Event|0
328590|NCT00622700|1076322|P7|Core Treatment Period|Other than specified above|0
328673|NCT00622635|1076390|P3|Treatment Period 1|Withdrawal by Subject|0
328591|NCT00622700|1076323|P6|Core Treatment Period|Other than specified above|0
328592|NCT00622700|1076324|P5|Core Treatment Period|Other than specified above|0
328593|NCT00622700|1076325|P4|Core Treatment Period|Other than specified above|0
328594|NCT00622700|1076326|P3|Core Treatment Period|Other than specified above|5
328595|NCT00622700|1076327|P2|Core Treatment Period|Other than specified above|2
328596|NCT00622700|1076328|P1|Core Treatment Period|Other than specified above|2
328597|NCT00622700|1076322|P7|Core Treatment Period|Withdrawal by Subject|0
328598|NCT00622700|1076323|P6|Core Treatment Period|Withdrawal by Subject|0
328599|NCT00622700|1076324|P5|Core Treatment Period|Withdrawal by Subject|0
328600|NCT00622700|1076325|P4|Core Treatment Period|Withdrawal by Subject|0
328601|NCT00622700|1076326|P3|Core Treatment Period|Withdrawal by Subject|15
328602|NCT00622700|1076327|P2|Core Treatment Period|Withdrawal by Subject|18
328603|NCT00622700|1076328|P1|Core Treatment Period|Withdrawal by Subject|12
328604|NCT00622700|1076322|P7|Core Treatment Period|Progressive Disease|0
328605|NCT00622700|1076323|P6|Core Treatment Period|Progressive Disease|0
328606|NCT00622700|1076324|P5|Core Treatment Period|Progressive Disease|0
328607|NCT00622700|1076325|P4|Core Treatment Period|Progressive Disease|0
328608|NCT00622700|1076326|P3|Core Treatment Period|Progressive Disease|0
328609|NCT00622700|1076327|P2|Core Treatment Period|Progressive Disease|1
328610|NCT00622700|1076328|P1|Core Treatment Period|Progressive Disease|3
328611|NCT00622700|1076322|P7|Core Treatment Period|Death|0
328612|NCT00622700|1076323|P6|Core Treatment Period|Death|0
328613|NCT00622700|1076324|P5|Core Treatment Period|Death|0
328614|NCT00622700|1076325|P4|Core Treatment Period|Death|0
328615|NCT00622700|1076326|P3|Core Treatment Period|Death|0
328616|NCT00622700|1076327|P2|Core Treatment Period|Death|0
328617|NCT00622700|1076328|P1|Core Treatment Period|Death|1
328618|NCT00622700|1076322|P7|Core Treatment Period|Lost to Follow-up|0
328619|NCT00622700|1076323|P6|Core Treatment Period|Lost to Follow-up|0
328620|NCT00622700|1076324|P5|Core Treatment Period|Lost to Follow-up|0
328621|NCT00622700|1076325|P4|Core Treatment Period|Lost to Follow-up|0
328622|NCT00622700|1076326|P3|Core Treatment Period|Lost to Follow-up|1
328623|NCT00622700|1076327|P2|Core Treatment Period|Lost to Follow-up|1
328624|NCT00622700|1076328|P1|Core Treatment Period|Lost to Follow-up|1
328625|NCT00622700|1076322|P7|Core Treatment Period|Lack of Efficacy|0
328626|NCT00622700|1076323|P6|Core Treatment Period|Lack of Efficacy|0
328627|NCT00622700|1076324|P5|Core Treatment Period|Lack of Efficacy|0
328628|NCT00622700|1076325|P4|Core Treatment Period|Lack of Efficacy|0
328629|NCT00622700|1076326|P3|Core Treatment Period|Lack of Efficacy|12
328630|NCT00622700|1076327|P2|Core Treatment Period|Lack of Efficacy|6
328631|NCT00622700|1076328|P1|Core Treatment Period|Lack of Efficacy|19
328632|NCT00622700|1076322|P7|Core Treatment Period|Adverse Event|0
328633|NCT00622700|1076323|P6|Core Treatment Period|Adverse Event|0
328634|NCT00622700|1076324|P5|Core Treatment Period|Adverse Event|0
328635|NCT00622700|1076325|P4|Core Treatment Period|Adverse Event|0
328636|NCT00622700|1076326|P3|Core Treatment Period|Adverse Event|18
328637|NCT00622700|1076327|P2|Core Treatment Period|Adverse Event|25
328638|NCT00622700|1076328|P1|Core Treatment Period|Adverse Event|18
328639|NCT00622700|1076322|P7|Core Treatment Period|Randomized but Not Treated|0
328640|NCT00622700|1076323|P6|Core Treatment Period|Randomized but Not Treated|0
328641|NCT00622700|1076324|P5|Core Treatment Period|Randomized but Not Treated|0
328642|NCT00622700|1076325|P4|Core Treatment Period|Randomized but Not Treated|0
328643|NCT00622700|1076326|P3|Core Treatment Period|Randomized but Not Treated|2
328644|NCT00622700|1076327|P2|Core Treatment Period|Randomized but Not Treated|2
328645|NCT00622700|1076328|P1|Core Treatment Period|Randomized but Not Treated|0
328646|NCT00622635|1076387|P6|Treatment Period 3|Withdrawal by Subject|0
328647|NCT00622635|1076388|P5|Treatment Period 3|Withdrawal by Subject|0
328648|NCT00622635|1076389|P4|Treatment Period 3|Withdrawal by Subject|1
328649|NCT00622635|1076390|P3|Treatment Period 3|Withdrawal by Subject|0
328650|NCT00622635|1076391|P2|Treatment Period 3|Withdrawal by Subject|0
328651|NCT00622635|1076392|P1|Treatment Period 3|Withdrawal by Subject|0
328652|NCT00622635|1076387|P6|Treatment Period 3|Adverse Event|0
328653|NCT00622635|1076388|P5|Treatment Period 3|Adverse Event|0
328654|NCT00622635|1076389|P4|Treatment Period 3|Adverse Event|2
328655|NCT00622635|1076390|P3|Treatment Period 3|Adverse Event|0
328656|NCT00622635|1076391|P2|Treatment Period 3|Adverse Event|0
328657|NCT00622635|1076392|P1|Treatment Period 3|Adverse Event|0
328658|NCT00622635|1076387|P6|Treatment Period 2|Adverse Event|0
328659|NCT00622635|1076388|P5|Treatment Period 2|Adverse Event|0
328660|NCT00622635|1076389|P4|Treatment Period 2|Adverse Event|0
328661|NCT00622635|1076390|P3|Treatment Period 2|Adverse Event|0
328662|NCT00622635|1076391|P2|Treatment Period 2|Adverse Event|0
328663|NCT00622635|1076392|P1|Treatment Period 2|Adverse Event|1
328664|NCT00622635|1076387|P6|Treatment Period 1|Abnormal test procedure result(s)|0
328665|NCT00622635|1076388|P5|Treatment Period 1|Abnormal test procedure result(s)|1
328666|NCT00622635|1076389|P4|Treatment Period 1|Abnormal test procedure result(s)|0
328667|NCT00622635|1076390|P3|Treatment Period 1|Abnormal test procedure result(s)|0
328668|NCT00622635|1076391|P2|Treatment Period 1|Abnormal test procedure result(s)|0
328669|NCT00622635|1076392|P1|Treatment Period 1|Abnormal test procedure result(s)|0
328670|NCT00622635|1076387|P6|Treatment Period 1|Withdrawal by Subject|0
328671|NCT00622635|1076388|P5|Treatment Period 1|Withdrawal by Subject|0
328672|NCT00622635|1076389|P4|Treatment Period 1|Withdrawal by Subject|0
328674|NCT00622635|1076391|P2|Treatment Period 1|Withdrawal by Subject|1
328675|NCT00622635|1076392|P1|Treatment Period 1|Withdrawal by Subject|0
328676|NCT00622635|1076387|P6|Treatment Period 1|Adverse Event|0
328677|NCT00622635|1076388|P5|Treatment Period 1|Adverse Event|0
328678|NCT00622635|1076389|P4|Treatment Period 1|Adverse Event|0
328679|NCT00622635|1076390|P3|Treatment Period 1|Adverse Event|1
328680|NCT00622635|1076391|P2|Treatment Period 1|Adverse Event|0
328681|NCT00622635|1076392|P1|Treatment Period 1|Adverse Event|0
328682|NCT00622440|1076470|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
328683|NCT00622440|1076471|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
328684|NCT00622440|1076470|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
328685|NCT00622440|1076471|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
328686|NCT00622440|1076470|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
328687|NCT00622440|1076471|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
328688|NCT00622440|1076470|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
328689|NCT00622440|1076471|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
328690|NCT00622401|1076497|P3|Overall Study|Disease progression prior to treatment|0
328691|NCT00622401|1076498|P2|Overall Study|Disease progression prior to treatment|2
328692|NCT00622401|1076499|P1|Overall Study|Disease progression prior to treatment|3
328693|NCT00622388|1076503|P1|Overall Study|Insurance Expired|1
328694|NCT00622388|1076503|P1|Overall Study|Withdrew Consent|1
328695|NCT00622388|1076503|P1|Overall Study|Took Prohibited Medication|2
328696|NCT00622388|1076503|P1|Overall Study|Received Alternate Anticancer Therapy|8
328697|NCT00622388|1076503|P1|Overall Study|Death|3
328698|NCT00622388|1076503|P1|Overall Study|Participant Refusal|1
328699|NCT00622388|1076503|P1|Overall Study|Protocol Violation|3
328700|NCT00622388|1076503|P1|Overall Study|Adverse Event|6
328701|NCT00622388|1076503|P1|Overall Study|Disease Progression|47
328702|NCT00622336|1076521|P1|Extension Phase|Unspecified|9
328703|NCT00622336|1076521|P1|Extension Phase|Lost to Follow-up|1
328704|NCT00622336|1076521|P1|Extension Phase|Withdrawal by Subject|1
328705|NCT00622336|1076521|P1|Extension Phase|Lack of therapeutic effect|2
328706|NCT00622336|1076521|P1|Extension Phase|Progressive Disease|6
328707|NCT00622336|1076521|P1|Extension Phase|Adverse Event|2
328708|NCT00622336|1076521|P1|Treatment Phase|Lost to Follow-up|2
328709|NCT00622336|1076521|P1|Treatment Phase|Withdrawal by Subject|13
328710|NCT00622336|1076521|P1|Treatment Phase|Lack of therapeutic effect|13
328711|NCT00622336|1076521|P1|Treatment Phase|Death|14
328712|NCT00622336|1076521|P1|Treatment Phase|Unspecified|40
328713|NCT00622336|1076521|P1|Treatment Phase|Adverse Event|46
328714|NCT00622336|1076521|P1|Treatment Phase|Progression of Disease|181
328715|NCT00622284|1076532|P2|Overall Study|Other reason (not specified)|24
328716|NCT00622284|1076533|P1|Overall Study|Other reason (not specified)|33
328717|NCT00622284|1076532|P2|Overall Study|Withdrawal by Subject|24
328718|NCT00622284|1076533|P1|Overall Study|Withdrawal by Subject|27
328719|NCT00622284|1076532|P2|Overall Study|Lost to Follow-up|13
328720|NCT00622284|1076533|P1|Overall Study|Lost to Follow-up|11
328721|NCT00622284|1076532|P2|Overall Study|Protocol Violation|5
328722|NCT00622284|1076533|P1|Overall Study|Protocol Violation|12
328723|NCT00622284|1076532|P2|Overall Study|Adverse Event|90
328724|NCT00622284|1076533|P1|Overall Study|Adverse Event|61
328725|NCT00622284|1076532|P2|Overall Study|Lack of Efficacy|15
328726|NCT00622284|1076533|P1|Overall Study|Lack of Efficacy|45
328727|NCT00622167|1076595|P1|Overall Study|Did not meet angiographic criteria|20
328728|NCT00621985|1076599|P1|Dexamethasone Admission|Adverse Event|1
328729|NCT00621959|1076607|P2|Overall Study|Other|3
328730|NCT00621959|1076608|P1|Overall Study|Other|1
328731|NCT00621959|1076607|P2|Overall Study|Withdrawal by Subject|1
328732|NCT00621959|1076608|P1|Overall Study|Withdrawal by Subject|1
328733|NCT00621959|1076607|P2|Overall Study|Lost to Follow-up|2
328734|NCT00621959|1076608|P1|Overall Study|Lost to Follow-up|0
328735|NCT00621959|1076607|P2|Overall Study|Lack of Efficacy|1
328736|NCT00621959|1076608|P1|Overall Study|Lack of Efficacy|1
328737|NCT00621959|1076607|P2|Overall Study|Adverse Event|2
328738|NCT00621959|1076608|P1|Overall Study|Adverse Event|4
328739|NCT00621855|1076647|P5|Overall Study|Patients did not receive study drug|2
328740|NCT00621855|1076648|P4|Overall Study|Patients did not receive study drug|4
328741|NCT00621855|1076649|P3|Overall Study|Patients did not receive study drug|5
328742|NCT00621855|1076650|P2|Overall Study|Patients did not receive study drug|3
328743|NCT00621855|1076651|P1|Overall Study|Patients did not receive study drug|3
328744|NCT00621855|1076647|P5|Overall Study|Other|4
328745|NCT00621855|1076648|P4|Overall Study|Other|5
328746|NCT00621855|1076649|P3|Overall Study|Other|6
328747|NCT00621855|1076650|P2|Overall Study|Other|7
328748|NCT00621855|1076651|P1|Overall Study|Other|9
328749|NCT00621855|1076647|P5|Overall Study|Withdrawal by Subject|9
328750|NCT00621855|1076648|P4|Overall Study|Withdrawal by Subject|13
328751|NCT00621855|1076649|P3|Overall Study|Withdrawal by Subject|13
328752|NCT00621855|1076650|P2|Overall Study|Withdrawal by Subject|11
328753|NCT00621855|1076651|P1|Overall Study|Withdrawal by Subject|16
328754|NCT00621855|1076647|P5|Overall Study|Protocol Violation|8
328755|NCT00621855|1076648|P4|Overall Study|Protocol Violation|7
328756|NCT00621855|1076649|P3|Overall Study|Protocol Violation|6
328757|NCT00621855|1076650|P2|Overall Study|Protocol Violation|8
328758|NCT00621855|1076651|P1|Overall Study|Protocol Violation|16
328759|NCT00621855|1076647|P5|Overall Study|Lost to Follow-up|1
328760|NCT00621855|1076648|P4|Overall Study|Lost to Follow-up|4
328761|NCT00621855|1076649|P3|Overall Study|Lost to Follow-up|3
328762|NCT00621855|1076650|P2|Overall Study|Lost to Follow-up|1
328763|NCT00621855|1076651|P1|Overall Study|Lost to Follow-up|0
328764|NCT00621855|1076647|P5|Overall Study|Adverse Event|31
328765|NCT00621855|1076648|P4|Overall Study|Adverse Event|34
328766|NCT00621855|1076649|P3|Overall Study|Adverse Event|48
328767|NCT00621855|1076650|P2|Overall Study|Adverse Event|31
328768|NCT00621855|1076651|P1|Overall Study|Adverse Event|32
328769|NCT00621842|1076693|P1|Overall Study|Lack of Efficacy|2
328770|NCT00621842|1076693|P1|Overall Study|Protocol Violation|4
328771|NCT00621842|1076693|P1|Overall Study|Withdrawal by Subject|7
328772|NCT00621842|1076693|P1|Overall Study|Adverse Event|6
328773|NCT00621777|1076710|P2|Randomized Phase|Death|1
328774|NCT00621777|1076711|P1|Randomized Phase|Death|0
328775|NCT00621777|1076710|P2|Randomized Phase|administrative|3
328776|NCT00621777|1076711|P1|Randomized Phase|administrative|0
328777|NCT00621777|1076710|P2|Randomized Phase|Withdrawal by Subject|9
328778|NCT00621777|1076711|P1|Randomized Phase|Withdrawal by Subject|1
328779|NCT00621777|1076710|P2|Randomized Phase|Lost to Follow-up|3
328780|NCT00621777|1076711|P1|Randomized Phase|Lost to Follow-up|3
328781|NCT00621777|1076710|P2|Randomized Phase|Adverse Event|3
328782|NCT00621777|1076711|P1|Randomized Phase|Adverse Event|3
328783|NCT00621777|1076710|P2|Open Phase|Lost to Follow-up|0
328784|NCT00621777|1076711|P1|Open Phase|Lost to Follow-up|10
328785|NCT00621777|1076710|P2|Open Phase|administrative|0
328786|NCT00621777|1076711|P1|Open Phase|administrative|13
328787|NCT00621777|1076710|P2|Open Phase|Withdrawal by Subject|0
328788|NCT00621777|1076711|P1|Open Phase|Withdrawal by Subject|17
328789|NCT00621777|1076710|P2|Open Phase|Did not abstain during open phase|0
328790|NCT00621777|1076711|P1|Open Phase|Did not abstain during open phase|56
328791|NCT00621777|1076710|P2|Open Phase|Adverse Event|0
328792|NCT00621777|1076711|P1|Open Phase|Adverse Event|20
328793|NCT00621764|1076722|P4|Overall Study|Protocol Violation|1
328794|NCT00621764|1076723|P3|Overall Study|Protocol Violation|0
328795|NCT00621764|1076724|P2|Overall Study|Protocol Violation|0
328796|NCT00621764|1076725|P1|Overall Study|Protocol Violation|0
328797|NCT00621621|1076771|P2|Overall Study|Subjects were exited at EP study|0
328798|NCT00621621|1076772|P1|Overall Study|Subjects were exited at EP study|30
328799|NCT00621582|1076780|P1|Overall Study|issues not identified by investigators|18
328800|NCT00621582|1076780|P1|Overall Study|Lost to Follow-up|24
328801|NCT00621582|1076780|P1|Overall Study|Protocol Violation|57
328802|NCT00621582|1076780|P1|Overall Study|Adverse Event|7
328803|NCT00621543|1076787|P1|Overall Study|Lost to Follow-up|23
328804|NCT00621517|1076794|P2|Overall Study|Adverse Event|0
328805|NCT00621517|1076795|P1|Overall Study|Adverse Event|1
328806|NCT00621517|1076794|P2|Overall Study|Withdrawal by Subject|4
328807|NCT00621517|1076795|P1|Overall Study|Withdrawal by Subject|3
328808|NCT00621517|1076794|P2|Overall Study|Lost to Follow-up|3
328809|NCT00621517|1076795|P1|Overall Study|Lost to Follow-up|3
328810|NCT00621504|1076803|P2|Overall Study|Death|6
328811|NCT00621504|1076804|P1|Overall Study|Death|6
328812|NCT00621504|1076803|P2|Overall Study|Other|0
328813|NCT00621504|1076804|P1|Overall Study|Other|1
328814|NCT00621504|1076803|P2|Overall Study|Lost to Follow-up|10
328815|NCT00621504|1076804|P1|Overall Study|Lost to Follow-up|8
328816|NCT00621504|1076803|P2|Overall Study|Withdrew consent|6
328817|NCT00621504|1076804|P1|Overall Study|Withdrew consent|9
328818|NCT00621504|1076803|P2|Overall Study|At the request of sponsor/investigator|0
328819|NCT00621504|1076804|P1|Overall Study|At the request of sponsor/investigator|1
328820|NCT00621504|1076803|P2|Overall Study|Adverse Event|3
328821|NCT00621504|1076804|P1|Overall Study|Adverse Event|1
328822|NCT00621322|1076838|P6|Overall Study|Migrated/moved from study area|2
328823|NCT00621322|1076839|P5|Overall Study|Migrated/moved from study area|0
328824|NCT00621322|1076840|P4|Overall Study|Migrated/moved from study area|1
328825|NCT00621322|1076841|P3|Overall Study|Migrated/moved from study area|1
328826|NCT00621322|1076842|P2|Overall Study|Migrated/moved from study area|0
328827|NCT00621322|1076843|P1|Overall Study|Migrated/moved from study area|1
328828|NCT00621322|1076838|P6|Overall Study|Withdrawal by Subject|2
328829|NCT00621322|1076839|P5|Overall Study|Withdrawal by Subject|0
328830|NCT00621322|1076840|P4|Overall Study|Withdrawal by Subject|1
328831|NCT00621322|1076841|P3|Overall Study|Withdrawal by Subject|0
328832|NCT00621322|1076842|P2|Overall Study|Withdrawal by Subject|0
328833|NCT00621322|1076843|P1|Overall Study|Withdrawal by Subject|0
328834|NCT00621322|1076838|P6|Overall Study|Physician Decision|0
328835|NCT00621322|1076839|P5|Overall Study|Physician Decision|0
328836|NCT00621322|1076840|P4|Overall Study|Physician Decision|1
328837|NCT00621322|1076841|P3|Overall Study|Physician Decision|1
328838|NCT00621322|1076842|P2|Overall Study|Physician Decision|0
328839|NCT00621322|1076843|P1|Overall Study|Physician Decision|0
328840|NCT00621322|1076838|P6|Overall Study|Lost to Follow-up|0
328841|NCT00621322|1076839|P5|Overall Study|Lost to Follow-up|1
328842|NCT00621322|1076840|P4|Overall Study|Lost to Follow-up|0
328843|NCT00621322|1076841|P3|Overall Study|Lost to Follow-up|0
328844|NCT00621322|1076842|P2|Overall Study|Lost to Follow-up|0
328845|NCT00621322|1076843|P1|Overall Study|Lost to Follow-up|0
328846|NCT00621296|1076923|P1|Overall Study|Stopping Criteria|3
328847|NCT00621296|1076923|P1|Overall Study|Unmatch Criteria|1
328848|NCT00621296|1076923|P1|Overall Study|Physician Decision|7
328849|NCT00621296|1076923|P1|Overall Study|Lack of Efficacy|1
328850|NCT00621296|1076923|P1|Overall Study|Adverse Event|2
328851|NCT00621257|1076932|P5|Overall Study|Withdrawal by Subject|1
328852|NCT00621257|1076933|P4|Overall Study|Withdrawal by Subject|1
328853|NCT00621257|1076934|P3|Overall Study|Withdrawal by Subject|0
328854|NCT00621257|1076935|P2|Overall Study|Withdrawal by Subject|0
328855|NCT00621257|1076936|P1|Overall Study|Withdrawal by Subject|0
328856|NCT00621257|1076932|P5|Overall Study|Physician Decision|1
328857|NCT00621257|1076933|P4|Overall Study|Physician Decision|1
328858|NCT00621257|1076934|P3|Overall Study|Physician Decision|0
328859|NCT00621257|1076935|P2|Overall Study|Physician Decision|2
328860|NCT00621257|1076936|P1|Overall Study|Physician Decision|0
328861|NCT00621257|1076932|P5|Overall Study|Adverse Event|0
328862|NCT00621257|1076933|P4|Overall Study|Adverse Event|0
328863|NCT00621257|1076934|P3|Overall Study|Adverse Event|1
328864|NCT00621257|1076935|P2|Overall Study|Adverse Event|1
328865|NCT00621257|1076936|P1|Overall Study|Adverse Event|0
328866|NCT00621257|1076932|P5|Overall Study|Lost to Follow-up|7
328867|NCT00621257|1076933|P4|Overall Study|Lost to Follow-up|4
328868|NCT00621257|1076934|P3|Overall Study|Lost to Follow-up|2
328869|NCT00621257|1076935|P2|Overall Study|Lost to Follow-up|0
328870|NCT00621257|1076936|P1|Overall Study|Lost to Follow-up|4
328871|NCT00620113|1076965|P4|Overall Study|Withdrawal by Subject|5
328872|NCT00620113|1076966|P3|Overall Study|Withdrawal by Subject|3
328873|NCT00620113|1076967|P2|Overall Study|Withdrawal by Subject|1
328874|NCT00620113|1076968|P1|Overall Study|Withdrawal by Subject|5
328875|NCT00620113|1076965|P4|Overall Study|Protocol Violation|0
328876|NCT00620113|1076966|P3|Overall Study|Protocol Violation|0
328877|NCT00620113|1076967|P2|Overall Study|Protocol Violation|1
328878|NCT00620113|1076968|P1|Overall Study|Protocol Violation|2
328879|NCT00620113|1076965|P4|Overall Study|Physician Decision|2
328880|NCT00620113|1076966|P3|Overall Study|Physician Decision|0
328881|NCT00620113|1076967|P2|Overall Study|Physician Decision|0
328882|NCT00620113|1076968|P1|Overall Study|Physician Decision|1
328883|NCT00620113|1076965|P4|Overall Study|Lack of Efficacy|2
328884|NCT00620113|1076966|P3|Overall Study|Lack of Efficacy|0
328885|NCT00620113|1076967|P2|Overall Study|Lack of Efficacy|3
328886|NCT00620113|1076968|P1|Overall Study|Lack of Efficacy|2
328887|NCT00620113|1076965|P4|Overall Study|Adverse Event|1
328888|NCT00620113|1076966|P3|Overall Study|Adverse Event|2
328889|NCT00620113|1076967|P2|Overall Study|Adverse Event|2
328890|NCT00620113|1076968|P1|Overall Study|Adverse Event|3
328891|NCT00621192|1077022|P4|Overall Study|Final Assessments not Completed|1
328892|NCT00621192|1077023|P3|Overall Study|Final Assessments not Completed|3
328893|NCT00621192|1077024|P2|Overall Study|Final Assessments not Completed|0
328894|NCT00621192|1077025|P1|Overall Study|Final Assessments not Completed|0
328895|NCT00621192|1077022|P4|Overall Study|Death|0
328896|NCT00621192|1077023|P3|Overall Study|Death|0
328897|NCT00621192|1077024|P2|Overall Study|Death|5
328898|NCT00621192|1077025|P1|Overall Study|Death|2
328899|NCT00621192|1077022|P4|Overall Study|Adverse Event|1
328900|NCT00621192|1077023|P3|Overall Study|Adverse Event|0
328901|NCT00621192|1077024|P2|Overall Study|Adverse Event|1
328902|NCT00621192|1077025|P1|Overall Study|Adverse Event|0
328903|NCT00621192|1077022|P4|Overall Study|Protocol Violation|1
328904|NCT00621192|1077023|P3|Overall Study|Protocol Violation|0
328905|NCT00621192|1077024|P2|Overall Study|Protocol Violation|0
328906|NCT00621192|1077025|P1|Overall Study|Protocol Violation|1
328907|NCT00621192|1077022|P4|Overall Study|Physician Decision|0
328908|NCT00621192|1077023|P3|Overall Study|Physician Decision|0
328909|NCT00621192|1077024|P2|Overall Study|Physician Decision|3
328910|NCT00621192|1077025|P1|Overall Study|Physician Decision|1
328911|NCT00621192|1077022|P4|Overall Study|Withdrawal by Subject|0
328912|NCT00621192|1077023|P3|Overall Study|Withdrawal by Subject|2
328913|NCT00621192|1077024|P2|Overall Study|Withdrawal by Subject|0
328914|NCT00621192|1077025|P1|Overall Study|Withdrawal by Subject|0
328915|NCT00621153|1077049|P2|Overall Study|Withdrawal by Subject|5
328916|NCT00621153|1077050|P1|Overall Study|Withdrawal by Subject|4
328917|NCT00621153|1077049|P2|Overall Study|Lost to Follow-up|1
328918|NCT00621153|1077050|P1|Overall Study|Lost to Follow-up|5
328919|NCT00621153|1077049|P2|Overall Study|Adverse Event|2
328920|NCT00621153|1077050|P1|Overall Study|Adverse Event|3
328921|NCT00621153|1077049|P2|Overall Study|Safety Reason|7
328922|NCT00621153|1077050|P1|Overall Study|Safety Reason|8
328923|NCT00621140|1077058|P2|Overall Study|Other incl. lack of efficacy|5
328924|NCT00621140|1077059|P1|Overall Study|Other incl. lack of efficacy|6
328925|NCT00621140|1077058|P2|Overall Study|Withdrawal by Subject|6
328926|NCT00621140|1077059|P1|Overall Study|Withdrawal by Subject|4
328927|NCT00621140|1077058|P2|Overall Study|Lost to Follow-up|2
328928|NCT00621140|1077059|P1|Overall Study|Lost to Follow-up|1
328929|NCT00621140|1077058|P2|Overall Study|Adverse Event|5
328930|NCT00621140|1077059|P1|Overall Study|Adverse Event|4
328931|NCT00621023|1077106|P1|Overall Study|Follow up discontinued|1
328932|NCT00621023|1077106|P1|Overall Study|Death|5
328933|NCT00620854|1077118|P6|Washout 1|Withdrawal by Subject|0
328934|NCT00620854|1077119|P5|Washout 1|Withdrawal by Subject|0
328935|NCT00620854|1077120|P4|Washout 1|Withdrawal by Subject|1
328936|NCT00620854|1077121|P3|Washout 1|Withdrawal by Subject|1
328937|NCT00620854|1077122|P2|Washout 1|Withdrawal by Subject|0
328938|NCT00620854|1077123|P1|Washout 1|Withdrawal by Subject|0
328939|NCT00620815|1077154|P3|Overall Study|Protocol Violation|1
328940|NCT00620815|1077155|P2|Overall Study|Protocol Violation|2
328941|NCT00620815|1077156|P1|Overall Study|Protocol Violation|1
328942|NCT00620815|1077154|P3|Overall Study|Inappropriate enrolment|1
328943|NCT00620815|1077155|P2|Overall Study|Inappropriate enrolment|0
328944|NCT00620815|1077156|P1|Overall Study|Inappropriate enrolment|0
328945|NCT00620815|1077154|P3|Overall Study|Lost to Follow-up|3
328946|NCT00620815|1077155|P2|Overall Study|Lost to Follow-up|6
328947|NCT00620815|1077156|P1|Overall Study|Lost to Follow-up|1
328948|NCT00620815|1077154|P3|Overall Study|Withdrawal by Subject|0
328949|NCT00620815|1077155|P2|Overall Study|Withdrawal by Subject|2
328950|NCT00620815|1077156|P1|Overall Study|Withdrawal by Subject|1
328951|NCT00620815|1077154|P3|Overall Study|Adverse Event|2
328952|NCT00620815|1077155|P2|Overall Study|Adverse Event|1
328953|NCT00620815|1077156|P1|Overall Study|Adverse Event|1
328954|NCT00620776|1077196|P2|Overall Study|Withdrawal by Subject|2
328955|NCT00620776|1077197|P1|Overall Study|Withdrawal by Subject|3
328956|NCT00620776|1077196|P2|Overall Study|Lost to Follow-up|5
328957|NCT00620776|1077197|P1|Overall Study|Lost to Follow-up|2
328958|NCT00620776|1077196|P2|Overall Study|Lack of Efficacy|1
328959|NCT00620776|1077197|P1|Overall Study|Lack of Efficacy|2
328960|NCT00620776|1077196|P2|Overall Study|Adverse Event|3
328961|NCT00620776|1077197|P1|Overall Study|Adverse Event|2
328962|NCT00620776|1077196|P2|Overall Study|Did not receive treatment|5
328963|NCT00620776|1077197|P1|Overall Study|Did not receive treatment|3
328964|NCT00620763|1077225|P2|Period: Second Intervention|Withdrawal by Subject|0
328965|NCT00620763|1077226|P1|Period: Second Intervention|Withdrawal by Subject|1
328966|NCT00620763|1077225|P2|Period: First Intervention|Protocol Violation|3
328967|NCT00620763|1077226|P1|Period: First Intervention|Protocol Violation|0
328968|NCT00620763|1077225|P2|Period: First Intervention|Withdrawal by Subject|2
328969|NCT00620763|1077226|P1|Period: First Intervention|Withdrawal by Subject|0
328970|NCT00620750|1077232|P1|Overall Study|Lost to Follow-up|25
328971|NCT00620659|1077247|P6|Treatment Period 3|Withdrawal by Subject|0
328972|NCT00620659|1077248|P5|Treatment Period 3|Withdrawal by Subject|0
328973|NCT00620659|1077249|P4|Treatment Period 3|Withdrawal by Subject|1
328974|NCT00620659|1077250|P3|Treatment Period 3|Withdrawal by Subject|0
328975|NCT00620659|1077251|P2|Treatment Period 3|Withdrawal by Subject|0
328976|NCT00620659|1077252|P1|Treatment Period 3|Withdrawal by Subject|0
328977|NCT00620659|1077247|P6|Treatment Period 3|Adverse Event|0
328978|NCT00620659|1077248|P5|Treatment Period 3|Adverse Event|0
328979|NCT00620659|1077249|P4|Treatment Period 3|Adverse Event|0
328980|NCT00620659|1077250|P3|Treatment Period 3|Adverse Event|0
328981|NCT00620659|1077251|P2|Treatment Period 3|Adverse Event|2
328982|NCT00620659|1077252|P1|Treatment Period 3|Adverse Event|0
328983|NCT00620659|1077247|P6|Placebo Washout Period 2|Adverse Event|0
328984|NCT00620659|1077248|P5|Placebo Washout Period 2|Adverse Event|0
328985|NCT00620659|1077249|P4|Placebo Washout Period 2|Adverse Event|0
328986|NCT00620659|1077250|P3|Placebo Washout Period 2|Adverse Event|0
328987|NCT00620659|1077251|P2|Placebo Washout Period 2|Adverse Event|0
328988|NCT00620659|1077252|P1|Placebo Washout Period 2|Adverse Event|2
328989|NCT00620659|1077247|P6|Treatment Period 2|Withdrawal by Subject|0
328990|NCT00620659|1077248|P5|Treatment Period 2|Withdrawal by Subject|3
328991|NCT00620659|1077249|P4|Treatment Period 2|Withdrawal by Subject|0
328992|NCT00620659|1077250|P3|Treatment Period 2|Withdrawal by Subject|1
328993|NCT00620659|1077251|P2|Treatment Period 2|Withdrawal by Subject|0
328994|NCT00620659|1077252|P1|Treatment Period 2|Withdrawal by Subject|0
328995|NCT00620659|1077247|P6|Treatment Period 2|Adverse Event|0
328996|NCT00620659|1077248|P5|Treatment Period 2|Adverse Event|2
328997|NCT00620659|1077249|P4|Treatment Period 2|Adverse Event|0
328998|NCT00620659|1077250|P3|Treatment Period 2|Adverse Event|0
328999|NCT00620659|1077251|P2|Treatment Period 2|Adverse Event|3
329000|NCT00620659|1077252|P1|Treatment Period 2|Adverse Event|0
329001|NCT00620659|1077247|P6|Placebo Washout Period 1|Withdrawal by Subject|0
329002|NCT00620659|1077248|P5|Placebo Washout Period 1|Withdrawal by Subject|0
329003|NCT00620659|1077249|P4|Placebo Washout Period 1|Withdrawal by Subject|1
329004|NCT00620659|1077250|P3|Placebo Washout Period 1|Withdrawal by Subject|0
329005|NCT00620659|1077251|P2|Placebo Washout Period 1|Withdrawal by Subject|0
329006|NCT00620659|1077252|P1|Placebo Washout Period 1|Withdrawal by Subject|0
329007|NCT00620659|1077247|P6|Treatment Period 1|Withdrawal by Subject|0
329008|NCT00620659|1077248|P5|Treatment Period 1|Withdrawal by Subject|1
329009|NCT00620659|1077249|P4|Treatment Period 1|Withdrawal by Subject|0
329010|NCT00620659|1077250|P3|Treatment Period 1|Withdrawal by Subject|1
329011|NCT00620659|1077251|P2|Treatment Period 1|Withdrawal by Subject|0
329012|NCT00620659|1077252|P1|Treatment Period 1|Withdrawal by Subject|1
329013|NCT00620659|1077247|P6|Treatment Period 1|Protocol Violation|0
329014|NCT00620659|1077248|P5|Treatment Period 1|Protocol Violation|0
329015|NCT00620659|1077249|P4|Treatment Period 1|Protocol Violation|0
329016|NCT00620659|1077250|P3|Treatment Period 1|Protocol Violation|0
329017|NCT00620659|1077251|P2|Treatment Period 1|Protocol Violation|0
329018|NCT00620659|1077252|P1|Treatment Period 1|Protocol Violation|1
329019|NCT00620659|1077247|P6|Treatment Period 1|Adverse Event|0
329020|NCT00620659|1077248|P5|Treatment Period 1|Adverse Event|0
329021|NCT00620659|1077249|P4|Treatment Period 1|Adverse Event|3
329022|NCT00620659|1077250|P3|Treatment Period 1|Adverse Event|0
329023|NCT00620659|1077251|P2|Treatment Period 1|Adverse Event|0
329024|NCT00620659|1077252|P1|Treatment Period 1|Adverse Event|1
329025|NCT00620555|1077270|P1|Overall Study|Visit failure against planned|1
329026|NCT00620555|1077270|P1|Overall Study|Choice of other treatment|1
329027|NCT00620555|1077270|P1|Overall Study|Withdrawal by Subject|1
329028|NCT00620555|1077270|P1|Overall Study|Lack of Efficacy|12
329029|NCT00620555|1077270|P1|Overall Study|Protocol Violation|2
329030|NCT00620555|1077270|P1|Overall Study|Adverse Event|4
329031|NCT00620542|1077279|P4|Part B (2 Year Core Study)|IVUS not available|2
329032|NCT00620542|1077280|P3|Part B (2 Year Core Study)|IVUS not available|3
329033|NCT00620542|1077281|P2|Part B (2 Year Core Study)|IVUS not available|0
329034|NCT00620542|1077282|P1|Part B (2 Year Core Study)|IVUS not available|0
329035|NCT00620542|1077279|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
329036|NCT00620542|1077280|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
329037|NCT00620542|1077281|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
329038|NCT00620542|1077282|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
329039|NCT00620542|1077279|P4|Part B (2 Year Core Study)|Safety reasons|3
329040|NCT00620542|1077280|P3|Part B (2 Year Core Study)|Safety reasons|2
329041|NCT00620542|1077281|P2|Part B (2 Year Core Study)|Safety reasons|0
329042|NCT00620542|1077282|P1|Part B (2 Year Core Study)|Safety reasons|0
329043|NCT00620542|1077279|P4|Part B (2 Year Core Study)|Protocol Violation|16
329044|NCT00620542|1077280|P3|Part B (2 Year Core Study)|Protocol Violation|13
329045|NCT00620542|1077281|P2|Part B (2 Year Core Study)|Protocol Violation|0
329046|NCT00620542|1077282|P1|Part B (2 Year Core Study)|Protocol Violation|0
329047|NCT00620542|1077279|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
329048|NCT00620542|1077280|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
329049|NCT00620542|1077281|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
329050|NCT00620542|1077282|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
329051|NCT00620542|1077279|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
329052|NCT00620542|1077280|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
329053|NCT00620542|1077281|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
329054|NCT00620542|1077282|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
329055|NCT00620542|1077279|P4|Part B (2 Year Core Study)|Protocol Violation|5
329056|NCT00620542|1077280|P3|Part B (2 Year Core Study)|Protocol Violation|3
329057|NCT00620542|1077281|P2|Part B (2 Year Core Study)|Protocol Violation|0
329058|NCT00620542|1077282|P1|Part B (2 Year Core Study)|Protocol Violation|0
329059|NCT00620542|1077279|P4|Part B (2 Year Core Study)|Adverse Event|49
329060|NCT00620542|1077280|P3|Part B (2 Year Core Study)|Adverse Event|46
329061|NCT00620542|1077281|P2|Part B (2 Year Core Study)|Adverse Event|0
329062|NCT00620542|1077282|P1|Part B (2 Year Core Study)|Adverse Event|0
329063|NCT00620542|1077279|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
329064|NCT00620542|1077280|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
329065|NCT00620542|1077281|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
329066|NCT00620542|1077282|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
329067|NCT00620542|1077279|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
329068|NCT00620542|1077280|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
329069|NCT00620542|1077281|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
329070|NCT00620542|1077282|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
329071|NCT00620542|1077279|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
329072|NCT00620542|1077280|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
329073|NCT00620542|1077281|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
329074|NCT00620542|1077282|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
329075|NCT00620542|1077279|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
329076|NCT00620542|1077280|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
329077|NCT00620542|1077281|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
329078|NCT00620542|1077282|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
329079|NCT00620542|1077279|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
329080|NCT00620542|1077280|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
329081|NCT00620542|1077281|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
329082|NCT00620542|1077282|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
329083|NCT00620542|1077279|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
329084|NCT00620542|1077280|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
329085|NCT00620542|1077281|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
329086|NCT00620542|1077282|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
329087|NCT00620542|1077279|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
329088|NCT00620542|1077280|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
329089|NCT00620542|1077281|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
329090|NCT00620542|1077282|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
329091|NCT00620464|1077322|P2|Overall Study|Used prohibited medication|0
329092|NCT00620464|1077323|P1|Overall Study|Used prohibited medication|1
329093|NCT00620464|1077322|P2|Overall Study|Personal|2
329094|NCT00620464|1077323|P1|Overall Study|Personal|2
329095|NCT00620464|1077322|P2|Overall Study|Planning Pregnancy|4
329096|NCT00620464|1077323|P1|Overall Study|Planning Pregnancy|1
329097|NCT00620464|1077322|P2|Overall Study|Lost to Follow-up|1
329098|NCT00620464|1077323|P1|Overall Study|Lost to Follow-up|1
329099|NCT00620464|1077322|P2|Overall Study|Adverse Event|17
329100|NCT00620464|1077323|P1|Overall Study|Adverse Event|15
329101|NCT00620373|1077342|P1|Overall Study|Unverified cancer status|33
329102|NCT00620282|1077361|P3|Overall Study|Withdrawal by Subject|0
329103|NCT00620282|1077362|P2|Overall Study|Withdrawal by Subject|1
329104|NCT00620282|1077363|P1|Overall Study|Withdrawal by Subject|0
329105|NCT00620282|1077361|P3|Overall Study|Arterial line unable to be placed|1
329106|NCT00620282|1077362|P2|Overall Study|Arterial line unable to be placed|0
329107|NCT00620282|1077363|P1|Overall Study|Arterial line unable to be placed|0
329108|NCT00620282|1077361|P3|Overall Study|Adverse Event|0
329109|NCT00620282|1077362|P2|Overall Study|Adverse Event|1
329110|NCT00620282|1077363|P1|Overall Study|Adverse Event|0
329111|NCT00620074|1077410|P1|Overall Study|Adverse Event|1
329112|NCT00620035|1077418|P1|Overall Study|Other Reason|38
329113|NCT00620035|1077418|P1|Overall Study|Withdrawal of Informed Consent|1
329114|NCT00620035|1077418|P1|Overall Study|Adverse Event|106
329115|NCT00620022|1077428|P2|Treatment Period 2|Adverse Event|2
329116|NCT00620022|1077429|P1|Treatment Period 2|Adverse Event|2
329117|NCT00620022|1077428|P2|Treatment Period 1|Subject withdrew consent|0
329118|NCT00620022|1077429|P1|Treatment Period 1|Subject withdrew consent|1
329119|NCT00620022|1077428|P2|Treatment Period 1|Adverse Event|6
329120|NCT00620022|1077429|P1|Treatment Period 1|Adverse Event|4
329121|NCT00619957|1077454|P2|Month 48 Open-Label|Withdrawal by Subject|9
329122|NCT00619957|1077455|P1|Month 48 Open-Label|Withdrawal by Subject|6
329123|NCT00619957|1077454|P2|Month 48 Open-Label|Lost to Follow-up|4
329124|NCT00619957|1077455|P1|Month 48 Open-Label|Lost to Follow-up|2
329125|NCT00619957|1077454|P2|Month 48 Open-Label|Adverse Event|4
329126|NCT00619957|1077455|P1|Month 48 Open-Label|Adverse Event|4
329127|NCT00619957|1077454|P2|Month 24 Double-Blind|Did not take any study medication|1
329128|NCT00619957|1077455|P1|Month 24 Double-Blind|Did not take any study medication|0
329129|NCT00619957|1077454|P2|Month 24 Double-Blind|Lost to Follow-up|0
329130|NCT00619957|1077455|P1|Month 24 Double-Blind|Lost to Follow-up|1
329131|NCT00619957|1077454|P2|Month 24 Double-Blind|Withdrawal by Subject|9
329132|NCT00619957|1077455|P1|Month 24 Double-Blind|Withdrawal by Subject|7
329133|NCT00619957|1077454|P2|Month 24 Double-Blind|Protocol Violation|0
329134|NCT00619957|1077455|P1|Month 24 Double-Blind|Protocol Violation|1
329135|NCT00619957|1077454|P2|Month 24 Double-Blind|Adverse Event|7
329136|NCT00619957|1077455|P1|Month 24 Double-Blind|Adverse Event|9
329137|NCT00619918|1077537|P2|Overall Study|Left before receiving first dose|8
329138|NCT00619918|1077538|P1|Overall Study|Left before receiving first dose|5
329139|NCT00619918|1077537|P2|Overall Study|Transfer to outside facility|3
329140|NCT00619918|1077538|P1|Overall Study|Transfer to outside facility|3
329141|NCT00619918|1077537|P2|Overall Study|Physician Decision|8
329142|NCT00619918|1077538|P1|Overall Study|Physician Decision|8
329143|NCT00619918|1077537|P2|Overall Study|Withdrawal by Subject|3
329144|NCT00619918|1077538|P1|Overall Study|Withdrawal by Subject|4
329145|NCT00619892|1077548|P2|Overall Study|Intercurrent illness|1
329146|NCT00619892|1077549|P1|Overall Study|Intercurrent illness|0
329147|NCT00619892|1077548|P2|Overall Study|Lost to Follow-up|1
329148|NCT00619892|1077549|P1|Overall Study|Lost to Follow-up|0
329149|NCT00619892|1077548|P2|Overall Study|Adverse Event|0
329150|NCT00619892|1077549|P1|Overall Study|Adverse Event|3
329151|NCT00619827|1077559|P2|Overall Study|Withdrawal by Subject|2
329152|NCT00619827|1077560|P1|Overall Study|Withdrawal by Subject|2
329153|NCT00619827|1077559|P2|Overall Study|Adverse Event|2
329154|NCT00619827|1077560|P1|Overall Study|Adverse Event|1
329155|NCT00619801|1077568|P2|Overall Study|Loss of efficacy|1
329156|NCT00619801|1077569|P1|Overall Study|Loss of efficacy|0
329157|NCT00619801|1077568|P2|Overall Study|Withdrawal by Subject|1
329158|NCT00619801|1077569|P1|Overall Study|Withdrawal by Subject|1
329159|NCT00619801|1077568|P2|Overall Study|Lack of Efficacy|1
329160|NCT00619801|1077569|P1|Overall Study|Lack of Efficacy|0
329161|NCT00619645|1077613|P1|Overall Study|Adverse Event|1
329162|NCT00619619|1077627|P8|Overall Study|Adverse Event|2
329163|NCT00619619|1077628|P7|Overall Study|Adverse Event|0
329164|NCT00619619|1077629|P6|Overall Study|Adverse Event|0
329165|NCT00619619|1077630|P5|Overall Study|Adverse Event|2
329166|NCT00619619|1077631|P4|Overall Study|Adverse Event|0
329167|NCT00619619|1077632|P3|Overall Study|Adverse Event|0
329168|NCT00619619|1077633|P2|Overall Study|Adverse Event|0
329169|NCT00619619|1077634|P1|Overall Study|Adverse Event|0
329170|NCT00619619|1077627|P8|Overall Study|Protocol Violation|1
329171|NCT00619619|1077628|P7|Overall Study|Protocol Violation|1
329172|NCT00619619|1077629|P6|Overall Study|Protocol Violation|0
329173|NCT00619619|1077630|P5|Overall Study|Protocol Violation|0
329174|NCT00619619|1077631|P4|Overall Study|Protocol Violation|1
329175|NCT00619619|1077632|P3|Overall Study|Protocol Violation|0
329176|NCT00619619|1077633|P2|Overall Study|Protocol Violation|0
329177|NCT00619619|1077634|P1|Overall Study|Protocol Violation|0
329178|NCT00619619|1077627|P8|Overall Study|Physician Decision|0
329179|NCT00619619|1077628|P7|Overall Study|Physician Decision|0
329180|NCT00619619|1077629|P6|Overall Study|Physician Decision|0
329181|NCT00619619|1077630|P5|Overall Study|Physician Decision|0
329182|NCT00619619|1077631|P4|Overall Study|Physician Decision|0
329183|NCT00619619|1077632|P3|Overall Study|Physician Decision|1
329184|NCT00619619|1077633|P2|Overall Study|Physician Decision|0
329185|NCT00619619|1077634|P1|Overall Study|Physician Decision|0
329186|NCT00619502|1077721|P2|Overall Study|Lost to Follow-up|10
329187|NCT00619502|1077722|P1|Overall Study|Lost to Follow-up|8
329188|NCT00619489|1077734|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
329189|NCT00619489|1077735|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
329190|NCT00619489|1077734|P2|Overall Study|Lack of Efficacy|11
329191|NCT00619489|1077735|P1|Overall Study|Lack of Efficacy|0
329192|NCT00619489|1077734|P2|Overall Study|Withdrawal by Subject|1
329193|NCT00619489|1077735|P1|Overall Study|Withdrawal by Subject|1
329194|NCT00619489|1077734|P2|Overall Study|Adverse Event|7
329195|NCT00619489|1077735|P1|Overall Study|Adverse Event|0
329196|NCT00619476|1077757|P4|Overall Study|Withdrawal by Subject|4
329197|NCT00619476|1077758|P3|Overall Study|Withdrawal by Subject|5
329198|NCT00619476|1077759|P2|Overall Study|Withdrawal by Subject|7
329199|NCT00619476|1077760|P1|Overall Study|Withdrawal by Subject|5
329200|NCT00619476|1077757|P4|Overall Study|Investigator Discretion|0
329201|NCT00619476|1077758|P3|Overall Study|Investigator Discretion|2
329202|NCT00619476|1077759|P2|Overall Study|Investigator Discretion|2
329203|NCT00619476|1077760|P1|Overall Study|Investigator Discretion|2
329204|NCT00619476|1077757|P4|Overall Study|Lost to Follow-up|1
329205|NCT00619476|1077758|P3|Overall Study|Lost to Follow-up|0
329206|NCT00619476|1077759|P2|Overall Study|Lost to Follow-up|2
329207|NCT00619476|1077760|P1|Overall Study|Lost to Follow-up|1
329208|NCT00619476|1077757|P4|Overall Study|Protocol Violation|9
329209|NCT00619476|1077758|P3|Overall Study|Protocol Violation|4
329210|NCT00619476|1077759|P2|Overall Study|Protocol Violation|4
329211|NCT00619476|1077760|P1|Overall Study|Protocol Violation|5
329212|NCT00619476|1077757|P4|Overall Study|Lack of Efficacy|4
329213|NCT00619476|1077758|P3|Overall Study|Lack of Efficacy|1
329214|NCT00619476|1077759|P2|Overall Study|Lack of Efficacy|1
329215|NCT00619476|1077760|P1|Overall Study|Lack of Efficacy|6
329216|NCT00619476|1077757|P4|Overall Study|Adverse Event|16
329217|NCT00619476|1077758|P3|Overall Study|Adverse Event|12
329218|NCT00619476|1077759|P2|Overall Study|Adverse Event|6
329219|NCT00619476|1077760|P1|Overall Study|Adverse Event|12
329220|NCT00619385|1077845|P3|Overall Study|Other|1
329221|NCT00619385|1077846|P2|Overall Study|Other|2
329222|NCT00619385|1077847|P1|Overall Study|Other|1
329223|NCT00619385|1077845|P3|Overall Study|Adverse Event|3
329224|NCT00619385|1077846|P2|Overall Study|Adverse Event|0
329225|NCT00619385|1077847|P1|Overall Study|Adverse Event|0
329226|NCT00619359|1077862|P2|Overall Study|Progressive Disease|1
329227|NCT00619359|1077863|P1|Overall Study|Progressive Disease|3
329228|NCT00619359|1077862|P2|Overall Study|Withdrawal by Subject|20
329229|NCT00619359|1077863|P1|Overall Study|Withdrawal by Subject|19
329230|NCT00619359|1077862|P2|Overall Study|Protocol Violation|1
329231|NCT00619359|1077863|P1|Overall Study|Protocol Violation|1
329232|NCT00619359|1077862|P2|Overall Study|Physician Decision|7
329233|NCT00619359|1077863|P1|Overall Study|Physician Decision|0
329234|NCT00619359|1077862|P2|Overall Study|Lost to Follow-up|16
329235|NCT00619359|1077863|P1|Overall Study|Lost to Follow-up|12
329236|NCT00619359|1077862|P2|Overall Study|Adverse Event|36
329237|NCT00619359|1077863|P1|Overall Study|Adverse Event|32
329238|NCT00619307|1077875|P2|Overall Study|MS attack plus steroids|1
329239|NCT00619307|1077876|P1|Overall Study|MS attack plus steroids|0
329240|NCT00619307|1077875|P2|Overall Study|Severe migraine|1
329241|NCT00619307|1077876|P1|Overall Study|Severe migraine|0
329242|NCT00619307|1077875|P2|Overall Study|Withdrew consent|0
329243|NCT00619307|1077876|P1|Overall Study|Withdrew consent|1
329244|NCT00619307|1077875|P2|Overall Study|Protocol Violation|0
329245|NCT00619307|1077876|P1|Overall Study|Protocol Violation|3
329246|NCT00619307|1077875|P2|Overall Study|Lost to Follow-up|1
329247|NCT00619307|1077876|P1|Overall Study|Lost to Follow-up|0
329248|NCT00619307|1077875|P2|Overall Study|Adverse Event|1
329249|NCT00619307|1077876|P1|Overall Study|Adverse Event|0
329250|NCT00619229|1077896|P2|Overall Study|Investigator planned Cataract Operation|0
329251|NCT00619229|1077897|P1|Overall Study|Investigator planned Cataract Operation|1
329252|NCT00619229|1077896|P2|Overall Study|Termination of the Study by the Sponsor|1
329253|NCT00619229|1077897|P1|Overall Study|Termination of the Study by the Sponsor|1
329254|NCT00619229|1077896|P2|Overall Study|Lost to Follow-up|0
329255|NCT00619229|1077897|P1|Overall Study|Lost to Follow-up|1
329256|NCT00619229|1077896|P2|Overall Study|Withdrawal by Subject|1
329257|NCT00619229|1077897|P1|Overall Study|Withdrawal by Subject|1
329258|NCT00619177|1077936|P1|Overall Study|Not specified reasons|6
329259|NCT00619177|1077936|P1|Overall Study|Missing termination information|481
329260|NCT00619177|1077936|P1|Overall Study|Lack of Efficacy|1
329261|NCT00619177|1077936|P1|Overall Study|Lost to Follow-up|2
329262|NCT00619177|1077936|P1|Overall Study|Adverse Event|18
329263|NCT00619151|1077946|P2|Overall Study|Study terminated prior to followup|0
329264|NCT00619151|1077947|P1|Overall Study|Study terminated prior to followup|1
329265|NCT00619099|1077961|P2|Overall Study|Physician Decision|6
329266|NCT00619099|1077962|P1|Overall Study|Physician Decision|9
329267|NCT00619099|1077961|P2|Overall Study|Withdrawal by Subject|2
329268|NCT00619099|1077962|P1|Overall Study|Withdrawal by Subject|10
329269|NCT00619099|1077961|P2|Overall Study|Emergence of Clinically Significant Lab|2
329270|NCT00619099|1077962|P1|Overall Study|Emergence of Clinically Significant Lab|1
329271|NCT00619099|1077961|P2|Overall Study|Adverse Event|3
329272|NCT00619099|1077962|P1|Overall Study|Adverse Event|4
329273|NCT00619099|1077961|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
329274|NCT00619099|1077962|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
329275|NCT00619099|1077961|P2|Overall Study|Progressive Disease|5
329276|NCT00619099|1077962|P1|Overall Study|Progressive Disease|7
329277|NCT00618995|1077984|P4|Period 4|Adverse Event|0
329278|NCT00618995|1077985|P3|Period 4|Adverse Event|0
329279|NCT00618995|1077986|P2|Period 4|Adverse Event|0
329280|NCT00618995|1077987|P1|Period 4|Adverse Event|1
329281|NCT00618995|1077984|P4|Period 2|Protocol Violation|0
329282|NCT00618995|1077985|P3|Period 2|Protocol Violation|1
329283|NCT00618995|1077986|P2|Period 2|Protocol Violation|0
329284|NCT00618995|1077987|P1|Period 2|Protocol Violation|0
329285|NCT00618995|1077984|P4|Period 1|Protocol Violation|0
329286|NCT00618995|1077985|P3|Period 1|Protocol Violation|1
329287|NCT00618995|1077986|P2|Period 1|Protocol Violation|1
329288|NCT00618995|1077987|P1|Period 1|Protocol Violation|0
329289|NCT00618995|1077984|P4|Period 1|Adverse Event|0
329290|NCT00618995|1077985|P3|Period 1|Adverse Event|1
329291|NCT00618995|1077986|P2|Period 1|Adverse Event|0
329292|NCT00618995|1077987|P1|Period 1|Adverse Event|0
329293|NCT00618982|1078001|P1|Overall Study|ongoing, still treated with study med.|25
329294|NCT00618982|1078001|P1|Overall Study|Protocol Violation|1
329295|NCT00618982|1078001|P1|Overall Study|Withdrawal by Subject|1
329296|NCT00618982|1078001|P1|Overall Study|Adverse Event|23
329297|NCT00618956|1078024|P2|Overall Study|did not meet criteria, non-compliance|1
329298|NCT00618956|1078025|P1|Overall Study|did not meet criteria, non-compliance|2
329299|NCT00618956|1078024|P2|Overall Study|Protocol Violation|2
329300|NCT00618956|1078025|P1|Overall Study|Protocol Violation|2
329301|NCT00618956|1078024|P2|Overall Study|Lost to Follow-up|5
329302|NCT00618956|1078025|P1|Overall Study|Lost to Follow-up|4
329303|NCT00618956|1078024|P2|Overall Study|Withdrawal by Subject|7
329304|NCT00618956|1078025|P1|Overall Study|Withdrawal by Subject|5
329305|NCT00618956|1078024|P2|Overall Study|Lack of Efficacy|1
329306|NCT00618956|1078025|P1|Overall Study|Lack of Efficacy|2
329307|NCT00618956|1078024|P2|Overall Study|Adverse Event|34
329308|NCT00618956|1078025|P1|Overall Study|Adverse Event|10
329309|NCT00618826|1078050|P1|Overall Study|Adverse Event|1
329310|NCT00618813|1078055|P1|Overall Study|Withdrawal by Subject|1
329311|NCT00618813|1078055|P1|Overall Study|Physician Decision|2
329312|NCT00618813|1078055|P1|Overall Study|Lack of Efficacy|1
329313|NCT00618787|1078065|P2|Overall Study|Lost to Follow-up|0
329314|NCT00618787|1078066|P1|Overall Study|Lost to Follow-up|1
329315|NCT00618787|1078065|P2|Overall Study|Withdrawal by Subject|1
329316|NCT00618787|1078066|P1|Overall Study|Withdrawal by Subject|2
329317|NCT00618787|1078065|P2|Overall Study|Adverse Event|1
329318|NCT00618787|1078066|P1|Overall Study|Adverse Event|0
329319|NCT00618774|1078074|P2|Overall Study|Withdrawal by Subject|0
329320|NCT00618774|1078075|P1|Overall Study|Withdrawal by Subject|1
329321|NCT00618774|1078074|P2|Overall Study|Adverse Event|3
329322|NCT00618774|1078075|P1|Overall Study|Adverse Event|5
329323|NCT00618748|1078108|P3|Overall Study|Withdrawal by Subject|5
329324|NCT00618748|1078109|P2|Overall Study|Withdrawal by Subject|1
329325|NCT00618748|1078110|P1|Overall Study|Withdrawal by Subject|4
329326|NCT00618748|1078108|P3|Overall Study|Physician Decision|1
329327|NCT00618748|1078109|P2|Overall Study|Physician Decision|1
329328|NCT00618748|1078110|P1|Overall Study|Physician Decision|3
329329|NCT00618748|1078108|P3|Overall Study|Adverse Event|8
329330|NCT00618748|1078109|P2|Overall Study|Adverse Event|3
329331|NCT00618748|1078110|P1|Overall Study|Adverse Event|4
329332|NCT00618722|1078155|P4|Overall Study|Miscellaneous Reasons|1
329333|NCT00618722|1078156|P3|Overall Study|Miscellaneous Reasons|1
329334|NCT00618722|1078157|P2|Overall Study|Miscellaneous Reasons|0
329335|NCT00618722|1078158|P1|Overall Study|Miscellaneous Reasons|0
329336|NCT00618722|1078155|P4|Overall Study|Lost to Follow-up|2
329337|NCT00618722|1078156|P3|Overall Study|Lost to Follow-up|0
329338|NCT00618722|1078157|P2|Overall Study|Lost to Follow-up|0
329339|NCT00618722|1078158|P1|Overall Study|Lost to Follow-up|2
329340|NCT00618722|1078155|P4|Overall Study|Inability to Complete Study Procedure|0
329341|NCT00618722|1078156|P3|Overall Study|Inability to Complete Study Procedure|0
329342|NCT00618722|1078157|P2|Overall Study|Inability to Complete Study Procedure|1
329343|NCT00618722|1078158|P1|Overall Study|Inability to Complete Study Procedure|0
329344|NCT00618722|1078155|P4|Overall Study|Patient Request|1
329345|NCT00618722|1078156|P3|Overall Study|Patient Request|1
329346|NCT00618722|1078157|P2|Overall Study|Patient Request|1
329347|NCT00618722|1078158|P1|Overall Study|Patient Request|1
329348|NCT00618722|1078155|P4|Overall Study|Refusal of Treatment|0
329349|NCT00618722|1078156|P3|Overall Study|Refusal of Treatment|1
329350|NCT00618722|1078157|P2|Overall Study|Refusal of Treatment|0
329351|NCT00618722|1078158|P1|Overall Study|Refusal of Treatment|0
329352|NCT00618618|1078196|P4|Overall Study|Death|0
329353|NCT00618618|1078197|P3|Overall Study|Death|0
329354|NCT00618618|1078198|P2|Overall Study|Death|1
329355|NCT00618618|1078199|P1|Overall Study|Death|0
329356|NCT00618618|1078196|P4|Overall Study|Did Not Meet Entry Criteria|0
329357|NCT00618618|1078197|P3|Overall Study|Did Not Meet Entry Criteria|1
329358|NCT00618618|1078198|P2|Overall Study|Did Not Meet Entry Criteria|0
329359|NCT00618618|1078199|P1|Overall Study|Did Not Meet Entry Criteria|0
329360|NCT00618618|1078196|P4|Overall Study|Non-compliance|0
329361|NCT00618618|1078197|P3|Overall Study|Non-compliance|0
329362|NCT00618618|1078198|P2|Overall Study|Non-compliance|1
329363|NCT00618618|1078199|P1|Overall Study|Non-compliance|1
329364|NCT00618618|1078196|P4|Overall Study|Lost to Follow-up|1
329365|NCT00618618|1078197|P3|Overall Study|Lost to Follow-up|0
329366|NCT00618618|1078198|P2|Overall Study|Lost to Follow-up|0
329367|NCT00618618|1078199|P1|Overall Study|Lost to Follow-up|3
329368|NCT00618618|1078196|P4|Overall Study|Inability to Complete Study Procedures|0
329369|NCT00618618|1078197|P3|Overall Study|Inability to Complete Study Procedures|0
329370|NCT00618618|1078198|P2|Overall Study|Inability to Complete Study Procedures|1
329371|NCT00618618|1078199|P1|Overall Study|Inability to Complete Study Procedures|0
329372|NCT00618618|1078196|P4|Overall Study|Patient Request|0
329373|NCT00618618|1078197|P3|Overall Study|Patient Request|2
329374|NCT00618618|1078198|P2|Overall Study|Patient Request|0
329375|NCT00618618|1078199|P1|Overall Study|Patient Request|0
329376|NCT00618514|1078258|P3|Overall Study|Lost to Follow-up|4
329377|NCT00618514|1078259|P2|Overall Study|Lost to Follow-up|12
329378|NCT00618514|1078260|P1|Overall Study|Lost to Follow-up|11
329379|NCT00618449|1078280|P2|Overall Study|Lost to Follow-up|110
329380|NCT00618449|1078281|P1|Overall Study|Lost to Follow-up|98
329381|NCT00618410|1078300|P2|Washout Period (2 Weeks)|Physician Decision|1
329382|NCT00618410|1078301|P1|Washout Period (2 Weeks)|Physician Decision|0
329383|NCT00618371|1078317|P1|Overall Study|Withdrawal by Subject|2
329384|NCT00618072|1078350|P3|Overall Study|Physician Decision|1
329385|NCT00618072|1078351|P2|Overall Study|Physician Decision|1
329386|NCT00618072|1078352|P1|Overall Study|Physician Decision|0
329387|NCT00618072|1078350|P3|Overall Study|Lost to Follow-up|3
329388|NCT00618072|1078351|P2|Overall Study|Lost to Follow-up|0
329389|NCT00618072|1078352|P1|Overall Study|Lost to Follow-up|2
329390|NCT00617929|1078393|P1|Overall Study|Physician Decision|1
329391|NCT00617903|1078405|P2|Overall Study|noncompliance|1
329392|NCT00617903|1078406|P1|Overall Study|noncompliance|0
329393|NCT00617903|1078405|P2|Overall Study|Adverse Event|1
329394|NCT00617903|1078406|P1|Overall Study|Adverse Event|0
329395|NCT00617903|1078405|P2|Overall Study|Lack of Efficacy|1
329396|NCT00617903|1078406|P1|Overall Study|Lack of Efficacy|0
329397|NCT00617903|1078405|P2|Overall Study|Lost to Follow-up|1
329398|NCT00617903|1078406|P1|Overall Study|Lost to Follow-up|1
329399|NCT00617903|1078405|P2|Overall Study|Withdrawal by Subject|3
329400|NCT00617903|1078406|P1|Overall Study|Withdrawal by Subject|2
329401|NCT00617890|1078452|P4|Overall Study|Not treated|1
329402|NCT00617890|1078453|P3|Overall Study|Not treated|1
329403|NCT00617890|1078454|P2|Overall Study|Not treated|0
329404|NCT00617890|1078455|P1|Overall Study|Not treated|1
329405|NCT00617890|1078452|P4|Overall Study|Adverse Event|8
329406|NCT00617890|1078453|P3|Overall Study|Adverse Event|3
329407|NCT00617890|1078454|P2|Overall Study|Adverse Event|0
329408|NCT00617890|1078455|P1|Overall Study|Adverse Event|1
329409|NCT00617890|1078452|P4|Overall Study|Protocol Violation|0
329410|NCT00617890|1078453|P3|Overall Study|Protocol Violation|0
329411|NCT00617890|1078454|P2|Overall Study|Protocol Violation|1
329412|NCT00617890|1078455|P1|Overall Study|Protocol Violation|2
329413|NCT00617890|1078452|P4|Overall Study|Withdrawal by Subject|2
329414|NCT00617890|1078453|P3|Overall Study|Withdrawal by Subject|0
329415|NCT00617890|1078454|P2|Overall Study|Withdrawal by Subject|1
329416|NCT00617890|1078455|P1|Overall Study|Withdrawal by Subject|4
329417|NCT00617890|1078452|P4|Overall Study|Lost to Follow-up|2
329418|NCT00617890|1078453|P3|Overall Study|Lost to Follow-up|1
329419|NCT00617890|1078454|P2|Overall Study|Lost to Follow-up|0
329420|NCT00617890|1078455|P1|Overall Study|Lost to Follow-up|0
329421|NCT00617890|1078452|P4|Overall Study|Lack of Efficacy|97
329422|NCT00617890|1078453|P3|Overall Study|Lack of Efficacy|30
329423|NCT00617890|1078454|P2|Overall Study|Lack of Efficacy|26
329424|NCT00617890|1078455|P1|Overall Study|Lack of Efficacy|23
329425|NCT00617890|1078452|P4|Overall Study|Treatment ongoing at data cut-off|5
329426|NCT00617890|1078453|P3|Overall Study|Treatment ongoing at data cut-off|0
329427|NCT00617890|1078454|P2|Overall Study|Treatment ongoing at data cut-off|0
329428|NCT00617890|1078455|P1|Overall Study|Treatment ongoing at data cut-off|0
329429|NCT00617851|1078491|P4|Overall Study|Unable to classify|0
329430|NCT00617851|1078492|P3|Overall Study|Unable to classify|1
329431|NCT00617851|1078493|P2|Overall Study|Unable to classify|0
329432|NCT00617851|1078494|P1|Overall Study|Unable to classify|1
329433|NCT00617851|1078491|P4|Overall Study|Inappropriate Enrollment|1
329434|NCT00617851|1078492|P3|Overall Study|Inappropriate Enrollment|1
329435|NCT00617851|1078493|P2|Overall Study|Inappropriate Enrollment|4
329436|NCT00617851|1078494|P1|Overall Study|Inappropriate Enrollment|5
329437|NCT00617851|1078491|P4|Overall Study|Lost to Follow-up|19
329438|NCT00617851|1078492|P3|Overall Study|Lost to Follow-up|31
329439|NCT00617851|1078493|P2|Overall Study|Lost to Follow-up|29
329440|NCT00617851|1078494|P1|Overall Study|Lost to Follow-up|27
329441|NCT00617851|1078491|P4|Overall Study|Withdrawal by Subject|4
329442|NCT00617851|1078492|P3|Overall Study|Withdrawal by Subject|12
329443|NCT00617851|1078493|P2|Overall Study|Withdrawal by Subject|7
329444|NCT00617851|1078494|P1|Overall Study|Withdrawal by Subject|14
329445|NCT00617851|1078491|P4|Overall Study|Death|1
329446|NCT00617851|1078492|P3|Overall Study|Death|0
329447|NCT00617851|1078493|P2|Overall Study|Death|0
329448|NCT00617851|1078494|P1|Overall Study|Death|0
329449|NCT00617773|1078532|P1|Overall Study|Protocol Violation|1
329450|NCT00617773|1078532|P1|Overall Study|Progressive disease|19
329451|NCT00617773|1078532|P1|Overall Study|Death|1
329452|NCT00617773|1078532|P1|Overall Study|Withdrawal by Subject|1
329453|NCT00617773|1078532|P1|Overall Study|Lack of compliance with the protocol|1
329454|NCT00617773|1078532|P1|Overall Study|Physician Decision|1
329455|NCT00617708|1078550|P3|Overall Study|Not eligible|5
329456|NCT00617708|1078551|P2|Overall Study|Not eligible|3
329457|NCT00617708|1078552|P1|Overall Study|Not eligible|1
329458|NCT00617708|1078550|P3|Overall Study|Not protocol specified|2
329459|NCT00617708|1078551|P2|Overall Study|Not protocol specified|4
329460|NCT00617708|1078552|P1|Overall Study|Not protocol specified|1
329461|NCT00617708|1078550|P3|Overall Study|Progression/Relapse|36
329462|NCT00617708|1078551|P2|Overall Study|Progression/Relapse|40
329463|NCT00617708|1078552|P1|Overall Study|Progression/Relapse|7
329464|NCT00617708|1078550|P3|Overall Study|Death|5
329465|NCT00617708|1078551|P2|Overall Study|Death|6
329466|NCT00617708|1078552|P1|Overall Study|Death|0
329467|NCT00617708|1078550|P3|Overall Study|Withdrawal by Subject|7
329468|NCT00617708|1078551|P2|Overall Study|Withdrawal by Subject|1
329469|NCT00617708|1078552|P1|Overall Study|Withdrawal by Subject|1
329470|NCT00617708|1078550|P3|Overall Study|Adverse Event|9
329471|NCT00617708|1078551|P2|Overall Study|Adverse Event|6
329472|NCT00617708|1078552|P1|Overall Study|Adverse Event|0
329473|NCT00617669|1078569|P2|Overall Study|Patients randomized but not treated|3
329474|NCT00617669|1078570|P1|Overall Study|Patients randomized but not treated|2
329475|NCT00617669|1078569|P2|Overall Study|Reason not otherwise captured, eg; death|290
329476|NCT00617669|1078570|P1|Overall Study|Reason not otherwise captured, eg; death|265
329477|NCT00617669|1078569|P2|Overall Study|Protocol Violation|3
329478|NCT00617669|1078570|P1|Overall Study|Protocol Violation|2
329479|NCT00617669|1078569|P2|Overall Study|Adverse Event|76
329480|NCT00617669|1078570|P1|Overall Study|Adverse Event|87
329481|NCT00617669|1078569|P2|Overall Study|Lost to Follow-up|2
329482|NCT00617669|1078570|P1|Overall Study|Lost to Follow-up|3
329483|NCT00617669|1078569|P2|Overall Study|Withdrawal by Subject|77
329484|NCT00617669|1078570|P1|Overall Study|Withdrawal by Subject|71
329485|NCT00617604|1078592|P2|Overall Study|Randomized but Never Received Study Drug|3
329486|NCT00617604|1078593|P1|Overall Study|Randomized but Never Received Study Drug|3
329487|NCT00617604|1078592|P2|Overall Study|Withdrawal by Subject|6
329488|NCT00617604|1078593|P1|Overall Study|Withdrawal by Subject|4
329489|NCT00617604|1078592|P2|Overall Study|Miscellaneous Reasons|10
329490|NCT00617604|1078593|P1|Overall Study|Miscellaneous Reasons|8
329491|NCT00617604|1078592|P2|Overall Study|Lost to Follow-up|0
329492|NCT00617604|1078593|P1|Overall Study|Lost to Follow-up|1
329493|NCT00617604|1078592|P2|Overall Study|Death|1
329494|NCT00617604|1078593|P1|Overall Study|Death|2
329495|NCT00617591|1078637|P1|Overall Study|Withdrew consent during Maintenance|6
329496|NCT00617591|1078637|P1|Overall Study|Withdrew consent during Induction|4
329497|NCT00617461|1078645|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
329498|NCT00617461|1078646|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
329499|NCT00617461|1078645|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
329500|NCT00617461|1078646|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
329501|NCT00617461|1078645|P2|Second Treatment Intervention Period|Lack of Efficacy|3
329502|NCT00617461|1078646|P1|Second Treatment Intervention Period|Lack of Efficacy|0
329503|NCT00617461|1078645|P2|Second Treatment Intervention Period|Adverse Event|1
329504|NCT00617461|1078646|P1|Second Treatment Intervention Period|Adverse Event|0
329505|NCT00617461|1078645|P2|4-Day Crossover Period|Withdrawal by Subject|0
329506|NCT00617461|1078646|P1|4-Day Crossover Period|Withdrawal by Subject|1
329507|NCT00617461|1078645|P2|First Treatment Intervention Period|Withdrawal by Subject|0
329508|NCT00617461|1078646|P1|First Treatment Intervention Period|Withdrawal by Subject|4
329509|NCT00617461|1078645|P2|First Treatment Intervention Period|Investigator Discretion|1
329510|NCT00617461|1078646|P1|First Treatment Intervention Period|Investigator Discretion|1
329511|NCT00617461|1078645|P2|First Treatment Intervention Period|Lost to Follow-up|1
329512|NCT00617461|1078646|P1|First Treatment Intervention Period|Lost to Follow-up|0
329513|NCT00617461|1078645|P2|First Treatment Intervention Period|Protocol Violation|1
329514|NCT00617461|1078646|P1|First Treatment Intervention Period|Protocol Violation|2
329515|NCT00617461|1078645|P2|First Treatment Intervention Period|Lack of Efficacy|0
329516|NCT00617461|1078646|P1|First Treatment Intervention Period|Lack of Efficacy|1
329517|NCT00617461|1078645|P2|First Treatment Intervention Period|Adverse Event|0
329518|NCT00617461|1078646|P1|First Treatment Intervention Period|Adverse Event|2
329519|NCT00617409|1078702|P3|Overall Study|Alternative Therapy|0
329520|NCT00617409|1078703|P2|Overall Study|Alternative Therapy|2
329521|NCT00617409|1078704|P1|Overall Study|Alternative Therapy|1
329522|NCT00617409|1078702|P3|Overall Study|Death|4
329523|NCT00617409|1078703|P2|Overall Study|Death|5
329524|NCT00617409|1078704|P1|Overall Study|Death|3
329525|NCT00617409|1078702|P3|Overall Study|Disease Progression|18
329526|NCT00617409|1078703|P2|Overall Study|Disease Progression|8
329527|NCT00617409|1078704|P1|Overall Study|Disease Progression|8
329528|NCT00617409|1078702|P3|Overall Study|Adverse Event|3
329529|NCT00617409|1078703|P2|Overall Study|Adverse Event|2
329530|NCT00617409|1078704|P1|Overall Study|Adverse Event|0
329531|NCT00617409|1078702|P3|Overall Study|Withdrawal by Subject|2
329532|NCT00617409|1078703|P2|Overall Study|Withdrawal by Subject|1
329533|NCT00617409|1078704|P1|Overall Study|Withdrawal by Subject|4
329534|NCT00617357|1078719|P1|Overall Study|Physician Decision|1
329535|NCT00617357|1078719|P1|Overall Study|Withdrawal by Subject|1
329536|NCT00617357|1078719|P1|Overall Study|insurance concerns|2
329537|NCT00617357|1078719|P1|Overall Study|Death|5
329538|NCT00617357|1078719|P1|Overall Study|Lost to Follow-up|7
329539|NCT00617305|1078732|P3|Overall Study|Withdrawal by Subject|0
329540|NCT00617305|1078733|P2|Overall Study|Withdrawal by Subject|0
329541|NCT00617305|1078734|P1|Overall Study|Withdrawal by Subject|1
329542|NCT00617305|1078732|P3|Overall Study|Protocol Violation|1
329543|NCT00617305|1078733|P2|Overall Study|Protocol Violation|0
329544|NCT00617305|1078734|P1|Overall Study|Protocol Violation|1
329545|NCT00617305|1078732|P3|Overall Study|Physician Decision|0
329546|NCT00617305|1078733|P2|Overall Study|Physician Decision|0
329547|NCT00617305|1078734|P1|Overall Study|Physician Decision|1
329548|NCT00617305|1078732|P3|Overall Study|Death|0
329549|NCT00617305|1078733|P2|Overall Study|Death|0
329550|NCT00617305|1078734|P1|Overall Study|Death|1
329551|NCT00617305|1078732|P3|Overall Study|Adverse Event|0
329552|NCT00617305|1078733|P2|Overall Study|Adverse Event|0
329553|NCT00617305|1078734|P1|Overall Study|Adverse Event|4
329554|NCT00617279|1078790|P2|Overall Study|Death|2
329555|NCT00617279|1078791|P1|Overall Study|Death|1
329556|NCT00617279|1078790|P2|Overall Study|Lost to Follow-up|0
329557|NCT00617279|1078791|P1|Overall Study|Lost to Follow-up|1
329558|NCT00617279|1078790|P2|Overall Study|Graft abandonment|0
329559|NCT00617279|1078791|P1|Overall Study|Graft abandonment|2
329560|NCT00617279|1078790|P2|Overall Study|Study terminated by Sponsor|15
329561|NCT00617279|1078791|P1|Overall Study|Study terminated by Sponsor|10
329562|NCT00617240|1078847|P2|Overall Study|Lack of Efficacy|0
329563|NCT00617240|1078848|P1|Overall Study|Lack of Efficacy|1
329564|NCT00617201|1078868|P2|Overall Study|Lost to Follow-up|13
329565|NCT00617201|1078869|P1|Overall Study|Lost to Follow-up|9
329566|NCT00617123|1078897|P2|Study Treatment Period|Noncompliance with Protocol|1
329567|NCT00617123|1078898|P1|Study Treatment Period|Noncompliance with Protocol|0
329568|NCT00617123|1078897|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
329569|NCT00617123|1078898|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
329570|NCT00617123|1078897|P2|Study Treatment Period|Adverse Event|3
329571|NCT00617123|1078898|P1|Study Treatment Period|Adverse Event|7
329572|NCT00617123|1078897|P2|Study Treatment Period|Withdrawal by Subject|12
329573|NCT00617123|1078898|P1|Study Treatment Period|Withdrawal by Subject|8
329574|NCT00617123|1078897|P2|Referral Screening Period|Adverse Event|1
329575|NCT00617123|1078898|P1|Referral Screening Period|Adverse Event|0
329576|NCT00617123|1078897|P2|Referral Screening Period|Did Not Wish To Continue|1
329577|NCT00617123|1078898|P1|Referral Screening Period|Did Not Wish To Continue|3
329578|NCT00617123|1078897|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
329579|NCT00617123|1078898|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
329580|NCT00617084|1078929|P2|Overall Study|Missed 12 Months visit|19
329581|NCT00617084|1078930|P1|Overall Study|Missed 12 Months visit|16
329582|NCT00617084|1078929|P2|Overall Study|Withdrawal by Subject|7
329583|NCT00617084|1078930|P1|Overall Study|Withdrawal by Subject|5
329584|NCT00616967|1078983|P3|Overall Study|Withdrawal by Subject|1
329585|NCT00616967|1078984|P2|Overall Study|Withdrawal by Subject|0
329586|NCT00616967|1078985|P1|Overall Study|Withdrawal by Subject|0
329587|NCT00616928|1078998|P4|Overall Study|Lost to Follow-up|0
329588|NCT00616928|1078999|P3|Overall Study|Lost to Follow-up|0
329589|NCT00616928|1079000|P2|Overall Study|Lost to Follow-up|7
329590|NCT00616928|1079001|P1|Overall Study|Lost to Follow-up|5
329591|NCT00616928|1078998|P4|Overall Study|Unspecified|5
329592|NCT00616928|1078999|P3|Overall Study|Unspecified|15
329593|NCT00616928|1079000|P2|Overall Study|Unspecified|8
329594|NCT00616928|1079001|P1|Overall Study|Unspecified|51
329595|NCT00616928|1078998|P4|Overall Study|Adverse Event|2
329596|NCT00616928|1078999|P3|Overall Study|Adverse Event|2
329597|NCT00616928|1079000|P2|Overall Study|Adverse Event|3
329598|NCT00616928|1079001|P1|Overall Study|Adverse Event|6
329599|NCT00616902|1079065|P2|Overall Study|Termination of study|6
329600|NCT00616902|1079066|P1|Overall Study|Termination of study|6
329601|NCT00616759|1079109|P2|Overall Study|Withdrawal by Subject|2
329602|NCT00616759|1079110|P1|Overall Study|Withdrawal by Subject|1
329603|NCT00616759|1079109|P2|Overall Study|Physician Decision|0
329604|NCT00616759|1079110|P1|Overall Study|Physician Decision|2
329605|NCT00616655|1079119|P3|Overall Study|unspecified|5
329606|NCT00616655|1079120|P2|Overall Study|unspecified|6
329607|NCT00616655|1079121|P1|Overall Study|unspecified|6
329608|NCT00616655|1079119|P3|Overall Study|Does not meet in/ex criteria|2
329609|NCT00616655|1079120|P2|Overall Study|Does not meet in/ex criteria|0
329610|NCT00616655|1079121|P1|Overall Study|Does not meet in/ex criteria|0
329611|NCT00616655|1079119|P3|Overall Study|Withdrawal by Subject|11
329612|NCT00616655|1079120|P2|Overall Study|Withdrawal by Subject|7
329613|NCT00616655|1079121|P1|Overall Study|Withdrawal by Subject|9
329614|NCT00616655|1079119|P3|Overall Study|Protocol Violation|3
329615|NCT00616655|1079120|P2|Overall Study|Protocol Violation|4
329616|NCT00616655|1079121|P1|Overall Study|Protocol Violation|2
329617|NCT00616655|1079119|P3|Overall Study|Lost to Follow-up|10
329618|NCT00616655|1079120|P2|Overall Study|Lost to Follow-up|12
329619|NCT00616655|1079121|P1|Overall Study|Lost to Follow-up|3
329620|NCT00616655|1079119|P3|Overall Study|Lack of Efficacy|5
329621|NCT00616655|1079120|P2|Overall Study|Lack of Efficacy|5
329622|NCT00616655|1079121|P1|Overall Study|Lack of Efficacy|5
329623|NCT00616655|1079119|P3|Overall Study|Adverse Event|12
329624|NCT00616655|1079120|P2|Overall Study|Adverse Event|7
329625|NCT00616655|1079121|P1|Overall Study|Adverse Event|10
329626|NCT00616642|1079161|P2|Overall Study|Withdrawal by Subject|1
329627|NCT00616642|1079162|P1|Overall Study|Withdrawal by Subject|0
329628|NCT00616629|1079173|P5|Overall Study|AV-block|0
329629|NCT00616629|1079174|P4|Overall Study|AV-block|0
329630|NCT00616629|1079175|P3|Overall Study|AV-block|0
329631|NCT00616629|1079176|P2|Overall Study|AV-block|0
329632|NCT00616629|1079177|P1|Overall Study|AV-block|1
329633|NCT00616629|1079173|P5|Overall Study|Protocol Violation|0
329634|NCT00616629|1079174|P4|Overall Study|Protocol Violation|0
329635|NCT00616629|1079175|P3|Overall Study|Protocol Violation|1
329636|NCT00616629|1079176|P2|Overall Study|Protocol Violation|2
329637|NCT00616629|1079177|P1|Overall Study|Protocol Violation|1
329638|NCT00616603|1079222|P3|Overall Study|Physician Decision|2
329639|NCT00616603|1079223|P2|Overall Study|Physician Decision|0
329640|NCT00616603|1079224|P1|Overall Study|Physician Decision|2
329641|NCT00616434|1079247|P2|Overall Study|Protocol deviation|1
329642|NCT00616434|1079248|P1|Overall Study|Protocol deviation|0
329643|NCT00616434|1079247|P2|Overall Study|Withdrawal by Subject|1
329644|NCT00616434|1079248|P1|Overall Study|Withdrawal by Subject|1
329645|NCT00616434|1079247|P2|Overall Study|Physician Decision|4
329646|NCT00616434|1079248|P1|Overall Study|Physician Decision|0
329647|NCT00616434|1079247|P2|Overall Study|Adverse Event|2
329648|NCT00616434|1079248|P1|Overall Study|Adverse Event|5
329649|NCT00616421|1079261|P3|Overall Study|Unable to classify|0
329650|NCT00616421|1079262|P2|Overall Study|Unable to classify|0
329651|NCT00616421|1079263|P1|Overall Study|Unable to classify|1
329652|NCT00616421|1079261|P3|Overall Study|Protocol Violation|2
329653|NCT00616421|1079262|P2|Overall Study|Protocol Violation|1
329654|NCT00616421|1079263|P1|Overall Study|Protocol Violation|0
329655|NCT00616421|1079261|P3|Overall Study|Administrative reason|0
329656|NCT00616421|1079262|P2|Overall Study|Administrative reason|0
329657|NCT00616421|1079263|P1|Overall Study|Administrative reason|1
329658|NCT00616421|1079261|P3|Overall Study|Inappropriate enrollment|1
329659|NCT00616421|1079262|P2|Overall Study|Inappropriate enrollment|0
329660|NCT00616421|1079263|P1|Overall Study|Inappropriate enrollment|3
329661|NCT00616421|1079261|P3|Overall Study|Lost to Follow-up|30
329662|NCT00616421|1079262|P2|Overall Study|Lost to Follow-up|26
329663|NCT00616421|1079263|P1|Overall Study|Lost to Follow-up|12
329664|NCT00616421|1079261|P3|Overall Study|Withdrawal by Subject|8
329665|NCT00616421|1079262|P2|Overall Study|Withdrawal by Subject|11
329666|NCT00616421|1079263|P1|Overall Study|Withdrawal by Subject|9
329667|NCT00616239|1079304|P1|Overall Study|Withdrawal by Subject|2
329668|NCT00616018|1079328|P1|Overall Study|Protocol Violation|3
329669|NCT00615992|1079333|P1|Overall Study|Protocol Violation|67
329670|NCT00615914|1079359|P1|Overall Study|Irregularly enrolled patients|10
329671|NCT00615914|1079359|P1|Overall Study|No treatment|2
329672|NCT00615914|1079359|P1|Overall Study|No data was collected.|65
329673|NCT00615914|1079359|P1|Overall Study|Physician Decision|4
329674|NCT00615914|1079359|P1|Overall Study|Withdrawal by Subject|16
329675|NCT00615914|1079359|P1|Overall Study|Lost to Follow-up|187
329676|NCT00615914|1079359|P1|Overall Study|Lack of Efficacy|59
329677|NCT00615914|1079359|P1|Overall Study|Death|20
329678|NCT00615914|1079359|P1|Overall Study|Adverse Event|274
329679|NCT00615901|1079366|P1|Overall Study|Adverse Event|7
329680|NCT00615901|1079366|P1|Overall Study|Withdrawal by Subject|2
329681|NCT00615836|1079374|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
329682|NCT00615836|1079375|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
329683|NCT00615836|1079376|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
329684|NCT00615836|1079377|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
329685|NCT00615836|1079378|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
329686|NCT00615836|1079374|P5|Extension Study (FE992026 CS31)|Not reported|0
329687|NCT00615836|1079375|P4|Extension Study (FE992026 CS31)|Not reported|4
329688|NCT00615836|1079376|P3|Extension Study (FE992026 CS31)|Not reported|1
329689|NCT00615836|1079377|P2|Extension Study (FE992026 CS31)|Not reported|4
329690|NCT00615836|1079378|P1|Extension Study (FE992026 CS31)|Not reported|6
329691|NCT00615836|1079374|P5|Extension Study (FE992026 CS31)|Not specified|0
329692|NCT00615836|1079375|P4|Extension Study (FE992026 CS31)|Not specified|8
329693|NCT00615836|1079376|P3|Extension Study (FE992026 CS31)|Not specified|8
329694|NCT00615836|1079377|P2|Extension Study (FE992026 CS31)|Not specified|7
329695|NCT00615836|1079378|P1|Extension Study (FE992026 CS31)|Not specified|10
329696|NCT00615836|1079374|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
329697|NCT00615836|1079375|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
329698|NCT00615836|1079376|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
329699|NCT00615836|1079377|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
329700|NCT00615836|1079378|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
329701|NCT00615836|1079374|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
329702|NCT00615836|1079375|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
329703|NCT00615836|1079376|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
329704|NCT00615836|1079377|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
329705|NCT00615836|1079378|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
329706|NCT00615836|1079374|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
329707|NCT00615836|1079375|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
329708|NCT00615836|1079376|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
329709|NCT00615836|1079377|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
329710|NCT00615836|1079378|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
329711|NCT00615836|1079374|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
329712|NCT00615836|1079375|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
329713|NCT00615836|1079376|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
329714|NCT00615836|1079377|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
329715|NCT00615836|1079378|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
329716|NCT00615836|1079374|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
329717|NCT00615836|1079375|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
329718|NCT00615836|1079376|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
329719|NCT00615836|1079377|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
329720|NCT00615836|1079378|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
329721|NCT00615836|1079374|P5|Extension Study (FE992026 CS31)|Adverse Event|0
329722|NCT00615836|1079375|P4|Extension Study (FE992026 CS31)|Adverse Event|13
329723|NCT00615836|1079376|P3|Extension Study (FE992026 CS31)|Adverse Event|15
329724|NCT00615836|1079377|P2|Extension Study (FE992026 CS31)|Adverse Event|12
329725|NCT00615836|1079378|P1|Extension Study (FE992026 CS31)|Adverse Event|7
329726|NCT00615719|1079438|P1|Overall Study|Physician Decision|5
329727|NCT00615550|1079452|P2|Overall Study|Lost to Follow-up|1
329728|NCT00615550|1079453|P1|Overall Study|Lost to Follow-up|6
329729|NCT00615459|1079476|P4|Period III|Unsatisfactory therapeutic effect|0
329730|NCT00615459|1079477|P3|Period III|Unsatisfactory therapeutic effect|0
329731|NCT00615459|1079478|P2|Period III|Unsatisfactory therapeutic effect|1
329732|NCT00615459|1079479|P1|Period III|Unsatisfactory therapeutic effect|0
329733|NCT00615459|1079476|P4|Period III|Administrative problems|0
329734|NCT00615459|1079477|P3|Period III|Administrative problems|1
329735|NCT00615459|1079478|P2|Period III|Administrative problems|1
329736|NCT00615459|1079479|P1|Period III|Administrative problems|0
329737|NCT00615459|1079476|P4|Period III|Adverse Event|0
329738|NCT00615459|1079477|P3|Period III|Adverse Event|0
329739|NCT00615459|1079478|P2|Period III|Adverse Event|1
329740|NCT00615459|1079479|P1|Period III|Adverse Event|0
329741|NCT00615459|1079476|P4|Period II|Lost to Follow-up|1
329742|NCT00615459|1079477|P3|Period II|Lost to Follow-up|0
329743|NCT00615459|1079478|P2|Period II|Lost to Follow-up|0
329744|NCT00615459|1079479|P1|Period II|Lost to Follow-up|0
329745|NCT00615459|1079476|P4|Period II|Adverse Event|0
329746|NCT00615459|1079477|P3|Period II|Adverse Event|0
329747|NCT00615459|1079478|P2|Period II|Adverse Event|0
329748|NCT00615459|1079479|P1|Period II|Adverse Event|1
329749|NCT00615459|1079476|P4|Period I|Abnormal test procedure results|0
329750|NCT00615459|1079477|P3|Period I|Abnormal test procedure results|1
329751|NCT00615459|1079478|P2|Period I|Abnormal test procedure results|1
329752|NCT00615459|1079479|P1|Period I|Abnormal test procedure results|1
329753|NCT00615459|1079476|P4|Period I|Subject withdrew consent|1
329754|NCT00615459|1079477|P3|Period I|Subject withdrew consent|0
329755|NCT00615459|1079478|P2|Period I|Subject withdrew consent|0
329756|NCT00615459|1079479|P1|Period I|Subject withdrew consent|1
329757|NCT00615459|1079476|P4|Period I|Adverse Event|0
329758|NCT00615459|1079477|P3|Period I|Adverse Event|1
329759|NCT00615459|1079478|P2|Period I|Adverse Event|0
329760|NCT00615459|1079479|P1|Period I|Adverse Event|2
329761|NCT00615290|1079514|P1|Overall Study|Other|2
329762|NCT00615290|1079514|P1|Overall Study|Withdrawal by Subject|1
329763|NCT00615290|1079514|P1|Overall Study|Lost to Follow-up|3
329764|NCT00615290|1079514|P1|Overall Study|Adverse Event|2
329765|NCT00615264|1079528|P2|Overall Study|Dermal Hypersensitivity|3
329766|NCT00615264|1079529|P1|Overall Study|Dermal Hypersensitivity|0
329767|NCT00615264|1079528|P2|Overall Study|Not defined|4
329768|NCT00615264|1079529|P1|Overall Study|Not defined|7
329769|NCT00615264|1079528|P2|Overall Study|Protocol Violation|7
329770|NCT00615264|1079529|P1|Overall Study|Protocol Violation|11
329771|NCT00615264|1079528|P2|Overall Study|Death|1
329772|NCT00615264|1079529|P1|Overall Study|Death|1
329773|NCT00615264|1079528|P2|Overall Study|Adverse Event|5
329774|NCT00615264|1079529|P1|Overall Study|Adverse Event|8
329775|NCT00615264|1079528|P2|Overall Study|Lost to Follow-up|13
329776|NCT00615264|1079529|P1|Overall Study|Lost to Follow-up|6
329777|NCT00615264|1079528|P2|Overall Study|Withdrawal by Subject|19
329778|NCT00615264|1079529|P1|Overall Study|Withdrawal by Subject|17
329779|NCT00615199|1079541|P4|Overall Study|Withdrawal by Subject|0
329780|NCT00615199|1079542|P3|Overall Study|Withdrawal by Subject|0
329781|NCT00615199|1079543|P2|Overall Study|Withdrawal by Subject|1
329782|NCT00615199|1079544|P1|Overall Study|Withdrawal by Subject|2
329783|NCT00615199|1079541|P4|Overall Study|Unspecified|1
329784|NCT00615199|1079542|P3|Overall Study|Unspecified|0
329785|NCT00615199|1079543|P2|Overall Study|Unspecified|0
329786|NCT00615199|1079544|P1|Overall Study|Unspecified|0
329787|NCT00615199|1079541|P4|Overall Study|Lost to Follow-up|0
329788|NCT00615199|1079542|P3|Overall Study|Lost to Follow-up|0
329789|NCT00615199|1079543|P2|Overall Study|Lost to Follow-up|0
329790|NCT00615199|1079544|P1|Overall Study|Lost to Follow-up|1
329791|NCT00615199|1079541|P4|Overall Study|Lack of Efficacy|1
329792|NCT00615199|1079542|P3|Overall Study|Lack of Efficacy|0
329793|NCT00615199|1079543|P2|Overall Study|Lack of Efficacy|0
329794|NCT00615199|1079544|P1|Overall Study|Lack of Efficacy|2
329795|NCT00615199|1079541|P4|Overall Study|Adverse Event|0
329796|NCT00615199|1079542|P3|Overall Study|Adverse Event|1
329797|NCT00615199|1079543|P2|Overall Study|Adverse Event|1
329798|NCT00615199|1079544|P1|Overall Study|Adverse Event|3
329799|NCT00615108|1079578|P1|Overall Study|Lost to Follow-up|15
329800|NCT00615108|1079578|P1|Overall Study|Other|370
329801|NCT00615108|1079578|P1|Overall Study|Adverse Event|122
329802|NCT00615069|1079593|P1|Overall Study|Withdrawal by Subject|4
329803|NCT00615069|1079593|P1|Overall Study|Physician Decision|2
329804|NCT00615069|1079593|P1|Overall Study|Death|10
329805|NCT00615056|1079602|P4|Overall Study|Randomized but not treated|0
329806|NCT00615056|1079603|P3|Overall Study|Randomized but not treated|0
329807|NCT00615056|1079604|P2|Overall Study|Randomized but not treated|0
329808|NCT00615056|1079605|P1|Overall Study|Randomized but not treated|3
329809|NCT00615056|1079602|P4|Overall Study|Discontinued by Sponsor|0
329810|NCT00615056|1079603|P3|Overall Study|Discontinued by Sponsor|0
329811|NCT00615056|1079604|P2|Overall Study|Discontinued by Sponsor|0
329812|NCT00615056|1079605|P1|Overall Study|Discontinued by Sponsor|1
329813|NCT00615056|1079602|P4|Overall Study|Withdrawal by Subject|0
329814|NCT00615056|1079603|P3|Overall Study|Withdrawal by Subject|1
329815|NCT00615056|1079604|P2|Overall Study|Withdrawal by Subject|1
329816|NCT00615056|1079605|P1|Overall Study|Withdrawal by Subject|0
329817|NCT00615056|1079602|P4|Overall Study|Objective progression or relapse|0
329818|NCT00615056|1079603|P3|Overall Study|Objective progression or relapse|0
329819|NCT00615056|1079604|P2|Overall Study|Objective progression or relapse|2
329820|NCT00615056|1079605|P1|Overall Study|Objective progression or relapse|0
329821|NCT00615056|1079602|P4|Overall Study|Unspecified|7
329822|NCT00615056|1079603|P3|Overall Study|Unspecified|10
329823|NCT00615056|1079604|P2|Overall Study|Unspecified|15
329824|NCT00615056|1079605|P1|Overall Study|Unspecified|13
329825|NCT00615056|1079602|P4|Overall Study|Lost to Follow-up|5
329826|NCT00615056|1079603|P3|Overall Study|Lost to Follow-up|4
329827|NCT00615056|1079604|P2|Overall Study|Lost to Follow-up|2
329828|NCT00615056|1079605|P1|Overall Study|Lost to Follow-up|1
329829|NCT00615056|1079602|P4|Overall Study|Death|23
329830|NCT00615056|1079603|P3|Overall Study|Death|21
329831|NCT00615056|1079604|P2|Overall Study|Death|31
329832|NCT00615056|1079605|P1|Overall Study|Death|31
329833|NCT00615030|1079635|P12|Period III|Administrative problems|0
329834|NCT00615030|1079636|P11|Period III|Administrative problems|0
329835|NCT00615030|1079637|P10|Period III|Administrative problems|0
329836|NCT00615030|1079638|P9|Period III|Administrative problems|0
329837|NCT00615030|1079639|P8|Period III|Administrative problems|0
329838|NCT00615030|1079640|P7|Period III|Administrative problems|0
329839|NCT00615030|1079641|P6|Period III|Administrative problems|0
329840|NCT00615030|1079642|P5|Period III|Administrative problems|0
329841|NCT00615030|1079643|P4|Period III|Administrative problems|1
329842|NCT00615030|1079644|P3|Period III|Administrative problems|0
329843|NCT00615030|1079645|P2|Period III|Administrative problems|0
329844|NCT00615030|1079646|P1|Period III|Administrative problems|1
329845|NCT00615030|1079635|P12|Period II|Subject withdrew consent|0
329846|NCT00615030|1079636|P11|Period II|Subject withdrew consent|0
329847|NCT00615030|1079637|P10|Period II|Subject withdrew consent|0
329848|NCT00615030|1079638|P9|Period II|Subject withdrew consent|0
329849|NCT00615030|1079639|P8|Period II|Subject withdrew consent|0
329850|NCT00615030|1079640|P7|Period II|Subject withdrew consent|1
329851|NCT00615030|1079641|P6|Period II|Subject withdrew consent|0
329852|NCT00615030|1079642|P5|Period II|Subject withdrew consent|0
329853|NCT00615030|1079643|P4|Period II|Subject withdrew consent|1
329854|NCT00615030|1079644|P3|Period II|Subject withdrew consent|0
329855|NCT00615030|1079645|P2|Period II|Subject withdrew consent|0
329856|NCT00615030|1079646|P1|Period II|Subject withdrew consent|0
329857|NCT00615030|1079635|P12|Period II|Adverse Event|0
329858|NCT00615030|1079636|P11|Period II|Adverse Event|0
329859|NCT00615030|1079637|P10|Period II|Adverse Event|0
329860|NCT00615030|1079638|P9|Period II|Adverse Event|1
329861|NCT00615030|1079639|P8|Period II|Adverse Event|0
329862|NCT00615030|1079640|P7|Period II|Adverse Event|0
329863|NCT00615030|1079641|P6|Period II|Adverse Event|0
329864|NCT00615030|1079642|P5|Period II|Adverse Event|0
329865|NCT00615030|1079643|P4|Period II|Adverse Event|0
329866|NCT00615030|1079644|P3|Period II|Adverse Event|1
329867|NCT00615030|1079645|P2|Period II|Adverse Event|0
329868|NCT00615030|1079646|P1|Period II|Adverse Event|0
329869|NCT00615030|1079635|P12|Period I|Abnormal laboratory value(s)|0
329870|NCT00615030|1079636|P11|Period I|Abnormal laboratory value(s)|0
329871|NCT00615030|1079637|P10|Period I|Abnormal laboratory value(s)|0
329872|NCT00615030|1079638|P9|Period I|Abnormal laboratory value(s)|0
329873|NCT00615030|1079639|P8|Period I|Abnormal laboratory value(s)|0
329874|NCT00615030|1079640|P7|Period I|Abnormal laboratory value(s)|0
329875|NCT00615030|1079641|P6|Period I|Abnormal laboratory value(s)|1
329876|NCT00615030|1079642|P5|Period I|Abnormal laboratory value(s)|0
329877|NCT00615030|1079643|P4|Period I|Abnormal laboratory value(s)|0
329878|NCT00615030|1079644|P3|Period I|Abnormal laboratory value(s)|0
329879|NCT00615030|1079645|P2|Period I|Abnormal laboratory value(s)|0
329880|NCT00615030|1079646|P1|Period I|Abnormal laboratory value(s)|0
329881|NCT00615030|1079635|P12|Period I|Subject withdrew consent|1
329882|NCT00615030|1079636|P11|Period I|Subject withdrew consent|1
329883|NCT00615030|1079637|P10|Period I|Subject withdrew consent|0
329884|NCT00615030|1079638|P9|Period I|Subject withdrew consent|1
329885|NCT00615030|1079639|P8|Period I|Subject withdrew consent|0
329886|NCT00615030|1079640|P7|Period I|Subject withdrew consent|0
329887|NCT00615030|1079641|P6|Period I|Subject withdrew consent|0
329888|NCT00615030|1079642|P5|Period I|Subject withdrew consent|0
329889|NCT00615030|1079643|P4|Period I|Subject withdrew consent|0
329890|NCT00615030|1079644|P3|Period I|Subject withdrew consent|0
329891|NCT00615030|1079645|P2|Period I|Subject withdrew consent|0
329892|NCT00615030|1079646|P1|Period I|Subject withdrew consent|0
329893|NCT00615030|1079635|P12|Period I|Protocol deviation|0
329894|NCT00615030|1079636|P11|Period I|Protocol deviation|0
329895|NCT00615030|1079637|P10|Period I|Protocol deviation|0
329896|NCT00615030|1079638|P9|Period I|Protocol deviation|0
329897|NCT00615030|1079639|P8|Period I|Protocol deviation|0
329898|NCT00615030|1079640|P7|Period I|Protocol deviation|0
329899|NCT00615030|1079641|P6|Period I|Protocol deviation|0
329900|NCT00615030|1079642|P5|Period I|Protocol deviation|0
329901|NCT00615030|1079643|P4|Period I|Protocol deviation|0
329902|NCT00615030|1079644|P3|Period I|Protocol deviation|0
329903|NCT00615030|1079645|P2|Period I|Protocol deviation|0
329904|NCT00615030|1079646|P1|Period I|Protocol deviation|1
329905|NCT00615030|1079635|P12|Period I|Administrative problem|0
329906|NCT00615030|1079636|P11|Period I|Administrative problem|0
329907|NCT00615030|1079637|P10|Period I|Administrative problem|0
329908|NCT00615030|1079638|P9|Period I|Administrative problem|0
329909|NCT00615030|1079639|P8|Period I|Administrative problem|0
329910|NCT00615030|1079640|P7|Period I|Administrative problem|0
329911|NCT00615030|1079641|P6|Period I|Administrative problem|0
329912|NCT00615030|1079642|P5|Period I|Administrative problem|1
329913|NCT00615030|1079643|P4|Period I|Administrative problem|0
329914|NCT00615030|1079644|P3|Period I|Administrative problem|0
329915|NCT00615030|1079645|P2|Period I|Administrative problem|0
329916|NCT00615030|1079646|P1|Period I|Administrative problem|0
329917|NCT00615017|1079666|P6|Overall Study|Physician discontinued drug|1
329918|NCT00615017|1079667|P5|Overall Study|Physician discontinued drug|0
329919|NCT00615017|1079668|P4|Overall Study|Physician discontinued drug|0
329920|NCT00615017|1079669|P3|Overall Study|Physician discontinued drug|0
329921|NCT00615017|1079670|P2|Overall Study|Physician discontinued drug|0
329922|NCT00615017|1079671|P1|Overall Study|Physician discontinued drug|0
329923|NCT00615017|1079666|P6|Overall Study|Transferred out of Intensive Care Unit|0
329924|NCT00615017|1079667|P5|Overall Study|Transferred out of Intensive Care Unit|0
329925|NCT00615017|1079668|P4|Overall Study|Transferred out of Intensive Care Unit|1
329926|NCT00615017|1079669|P3|Overall Study|Transferred out of Intensive Care Unit|0
329927|NCT00615017|1079670|P2|Overall Study|Transferred out of Intensive Care Unit|0
329928|NCT00615017|1079671|P1|Overall Study|Transferred out of Intensive Care Unit|0
329929|NCT00615017|1079666|P6|Overall Study|Sepsis resolved|0
329930|NCT00615017|1079667|P5|Overall Study|Sepsis resolved|0
329931|NCT00615017|1079668|P4|Overall Study|Sepsis resolved|0
329932|NCT00615017|1079669|P3|Overall Study|Sepsis resolved|1
329933|NCT00615017|1079670|P2|Overall Study|Sepsis resolved|0
329934|NCT00615017|1079671|P1|Overall Study|Sepsis resolved|0
329935|NCT00615017|1079666|P6|Overall Study|Death|1
329936|NCT00615017|1079667|P5|Overall Study|Death|1
329937|NCT00615017|1079668|P4|Overall Study|Death|0
329938|NCT00615017|1079669|P3|Overall Study|Death|2
329939|NCT00615017|1079670|P2|Overall Study|Death|0
329940|NCT00615017|1079671|P1|Overall Study|Death|0
329941|NCT00615017|1079666|P6|Overall Study|Adverse Event|1
329942|NCT00615017|1079667|P5|Overall Study|Adverse Event|0
329943|NCT00615017|1079668|P4|Overall Study|Adverse Event|0
329944|NCT00615017|1079669|P3|Overall Study|Adverse Event|2
329945|NCT00615017|1079670|P2|Overall Study|Adverse Event|1
329946|NCT00615017|1079671|P1|Overall Study|Adverse Event|0
329947|NCT00614991|1079829|P6|Overall Study|Adverse Event|0
329948|NCT00614991|1079830|P5|Overall Study|Adverse Event|1
329949|NCT00614991|1079831|P4|Overall Study|Adverse Event|0
329950|NCT00614991|1079832|P3|Overall Study|Adverse Event|0
329951|NCT00614991|1079833|P2|Overall Study|Adverse Event|3
329952|NCT00614991|1079834|P1|Overall Study|Adverse Event|3
329953|NCT00614939|1079868|P2|Overall Study|Hospitalized due to kidney transplant|0
329954|NCT00614939|1079869|P1|Overall Study|Hospitalized due to kidney transplant|1
329955|NCT00614939|1079868|P2|Overall Study|Poor/non-compliance|0
329956|NCT00614939|1079869|P1|Overall Study|Poor/non-compliance|4
329957|NCT00614939|1079868|P2|Overall Study|Death|3
329958|NCT00614939|1079869|P1|Overall Study|Death|4
329959|NCT00614939|1079868|P2|Overall Study|Incorrect enrollment|2
329960|NCT00614939|1079869|P1|Overall Study|Incorrect enrollment|1
329961|NCT00614939|1079868|P2|Overall Study|Adverse Event|5
329962|NCT00614939|1079869|P1|Overall Study|Adverse Event|2
329963|NCT00614939|1079868|P2|Overall Study|Study specific discontinuation criteris|16
329964|NCT00614939|1079869|P1|Overall Study|Study specific discontinuation criteris|13
329965|NCT00614939|1079868|P2|Overall Study|Withdrawal by Subject|17
329966|NCT00614939|1079869|P1|Overall Study|Withdrawal by Subject|10
329967|NCT00614926|1079903|P2|Overall Study|Adverse Event|0
329968|NCT00614926|1079904|P1|Overall Study|Adverse Event|3
329969|NCT00614926|1079903|P2|Overall Study|Burden of travel|0
329970|NCT00614926|1079904|P1|Overall Study|Burden of travel|1
329971|NCT00614874|1079917|P1|Overall Study|Withdrawal by Subject|1
329972|NCT00614874|1079917|P1|Overall Study|Protocol Violation|1
329973|NCT00614614|1079926|P5|Booster Vaccination Phase|Unspecified|1
329974|NCT00614614|1079927|P4|Booster Vaccination Phase|Unspecified|2
329975|NCT00614614|1079928|P3|Booster Vaccination Phase|Unspecified|3
329976|NCT00614614|1079929|P2|Booster Vaccination Phase|Unspecified|1
329977|NCT00614614|1079930|P1|Booster Vaccination Phase|Unspecified|0
329978|NCT00614614|1079926|P5|Booster Vaccination Phase|Protocol Violation|0
329979|NCT00614614|1079927|P4|Booster Vaccination Phase|Protocol Violation|3
329980|NCT00614614|1079928|P3|Booster Vaccination Phase|Protocol Violation|2
329981|NCT00614614|1079929|P2|Booster Vaccination Phase|Protocol Violation|0
329982|NCT00614614|1079930|P1|Booster Vaccination Phase|Protocol Violation|0
329983|NCT00614614|1079926|P5|Booster Vaccination Phase|Lost to Follow-up|8
329984|NCT00614614|1079927|P4|Booster Vaccination Phase|Lost to Follow-up|10
329985|NCT00614614|1079928|P3|Booster Vaccination Phase|Lost to Follow-up|17
329986|NCT00614614|1079929|P2|Booster Vaccination Phase|Lost to Follow-up|5
329987|NCT00614614|1079930|P1|Booster Vaccination Phase|Lost to Follow-up|0
329988|NCT00614614|1079926|P5|Booster Vaccination Phase|Withdrawal by Subject|4
329989|NCT00614614|1079927|P4|Booster Vaccination Phase|Withdrawal by Subject|3
329990|NCT00614614|1079928|P3|Booster Vaccination Phase|Withdrawal by Subject|4
329991|NCT00614614|1079929|P2|Booster Vaccination Phase|Withdrawal by Subject|0
329992|NCT00614614|1079930|P1|Booster Vaccination Phase|Withdrawal by Subject|0
329993|NCT00614614|1079926|P5|Booster Vaccination Phase|Adverse Event|0
329994|NCT00614614|1079927|P4|Booster Vaccination Phase|Adverse Event|1
329995|NCT00614614|1079928|P3|Booster Vaccination Phase|Adverse Event|1
329996|NCT00614614|1079929|P2|Booster Vaccination Phase|Adverse Event|0
329997|NCT00614614|1079930|P1|Booster Vaccination Phase|Adverse Event|0
329998|NCT00614614|1079926|P5|Primary Vaccination Phase|Unspecified|0
329999|NCT00614614|1079927|P4|Primary Vaccination Phase|Unspecified|0
330000|NCT00614614|1079928|P3|Primary Vaccination Phase|Unspecified|0
330001|NCT00614614|1079929|P2|Primary Vaccination Phase|Unspecified|0
330002|NCT00614614|1079930|P1|Primary Vaccination Phase|Unspecified|4
330003|NCT00614614|1079926|P5|Primary Vaccination Phase|Protocol Violation|0
330004|NCT00614614|1079927|P4|Primary Vaccination Phase|Protocol Violation|0
330005|NCT00614614|1079928|P3|Primary Vaccination Phase|Protocol Violation|0
330006|NCT00614614|1079929|P2|Primary Vaccination Phase|Protocol Violation|3
330007|NCT00614614|1079930|P1|Primary Vaccination Phase|Protocol Violation|9
330008|NCT00614614|1079926|P5|Primary Vaccination Phase|Lost to Follow-up|0
330009|NCT00614614|1079927|P4|Primary Vaccination Phase|Lost to Follow-up|0
330010|NCT00614614|1079928|P3|Primary Vaccination Phase|Lost to Follow-up|0
330011|NCT00614614|1079929|P2|Primary Vaccination Phase|Lost to Follow-up|8
330012|NCT00614614|1079930|P1|Primary Vaccination Phase|Lost to Follow-up|26
330013|NCT00614614|1079926|P5|Primary Vaccination Phase|Withdrawal by Subject|0
330014|NCT00614614|1079927|P4|Primary Vaccination Phase|Withdrawal by Subject|0
330015|NCT00614614|1079928|P3|Primary Vaccination Phase|Withdrawal by Subject|0
330016|NCT00614614|1079929|P2|Primary Vaccination Phase|Withdrawal by Subject|6
330017|NCT00614614|1079930|P1|Primary Vaccination Phase|Withdrawal by Subject|45
330018|NCT00614614|1079926|P5|Primary Vaccination Phase|Adverse Event|0
330019|NCT00614614|1079927|P4|Primary Vaccination Phase|Adverse Event|0
330020|NCT00614614|1079928|P3|Primary Vaccination Phase|Adverse Event|0
330021|NCT00614614|1079929|P2|Primary Vaccination Phase|Adverse Event|0
330022|NCT00614614|1079930|P1|Primary Vaccination Phase|Adverse Event|6
330023|NCT00614575|1080053|P1|Overall Study|No treatment|1
330024|NCT00614575|1080053|P1|Overall Study|Irregularly enrolled patients|23
330025|NCT00614575|1080053|P1|Overall Study|No data were collected.|18
330026|NCT00614575|1080053|P1|Overall Study|Physician Decision|2
330027|NCT00614575|1080053|P1|Overall Study|Death|3
330028|NCT00614575|1080053|P1|Overall Study|Withdrawal by Subject|6
330029|NCT00614575|1080053|P1|Overall Study|Lack of Efficacy|14
330030|NCT00614575|1080053|P1|Overall Study|Lost to Follow-up|55
330031|NCT00614575|1080053|P1|Overall Study|Adverse Event|106
330032|NCT00614523|1080064|P2|Overall Study|Administrative Decision|46
330033|NCT00614523|1080065|P1|Overall Study|Administrative Decision|23
330034|NCT00614523|1080064|P2|Overall Study|Disease Progression|8
330035|NCT00614523|1080065|P1|Overall Study|Disease Progression|0
330036|NCT00614523|1080064|P2|Overall Study|Ineligibility Determined|2
330037|NCT00614523|1080065|P1|Overall Study|Ineligibility Determined|1
330038|NCT00614523|1080064|P2|Overall Study|Other|11
330039|NCT00614523|1080065|P1|Overall Study|Other|6
330040|NCT00614523|1080064|P2|Overall Study|Withdrawal by Subject|22
330041|NCT00614523|1080065|P1|Overall Study|Withdrawal by Subject|12
330042|NCT00614523|1080064|P2|Overall Study|Protocol Violation|2
330043|NCT00614523|1080065|P1|Overall Study|Protocol Violation|3
330044|NCT00614523|1080064|P2|Overall Study|Lost to Follow-up|1
330045|NCT00614523|1080065|P1|Overall Study|Lost to Follow-up|0
330046|NCT00614523|1080064|P2|Overall Study|Lack of Efficacy|11
330047|NCT00614523|1080065|P1|Overall Study|Lack of Efficacy|9
330048|NCT00614523|1080064|P2|Overall Study|Death|8
330049|NCT00614523|1080065|P1|Overall Study|Death|5
330050|NCT00614523|1080064|P2|Overall Study|Adverse Event|20
330051|NCT00614523|1080065|P1|Overall Study|Adverse Event|4
330052|NCT00614393|1080121|P5|Overall Study|Not Treated|2
330053|NCT00614393|1080122|P4|Overall Study|Not Treated|0
330054|NCT00614393|1080123|P3|Overall Study|Not Treated|0
330055|NCT00614393|1080124|P2|Overall Study|Not Treated|0
330056|NCT00614393|1080125|P1|Overall Study|Not Treated|0
330057|NCT00614393|1080121|P5|Overall Study|Other|2
330058|NCT00614393|1080122|P4|Overall Study|Other|4
330059|NCT00614393|1080123|P3|Overall Study|Other|0
330060|NCT00614393|1080124|P2|Overall Study|Other|0
330061|NCT00614393|1080125|P1|Overall Study|Other|4
330062|NCT00614393|1080121|P5|Overall Study|Withdrawal by Subject|13
330063|NCT00614393|1080122|P4|Overall Study|Withdrawal by Subject|16
330064|NCT00614393|1080123|P3|Overall Study|Withdrawal by Subject|1
330065|NCT00614393|1080124|P2|Overall Study|Withdrawal by Subject|1
330066|NCT00614393|1080125|P1|Overall Study|Withdrawal by Subject|20
330067|NCT00614393|1080121|P5|Overall Study|Terminated by Sponsor|1
330068|NCT00614393|1080122|P4|Overall Study|Terminated by Sponsor|0
330069|NCT00614393|1080123|P3|Overall Study|Terminated by Sponsor|0
330070|NCT00614393|1080124|P2|Overall Study|Terminated by Sponsor|0
330071|NCT00614393|1080125|P1|Overall Study|Terminated by Sponsor|0
330072|NCT00614393|1080121|P5|Overall Study|Protocol Violation|0
330073|NCT00614393|1080122|P4|Overall Study|Protocol Violation|0
330074|NCT00614393|1080123|P3|Overall Study|Protocol Violation|0
330075|NCT00614393|1080124|P2|Overall Study|Protocol Violation|0
330076|NCT00614393|1080125|P1|Overall Study|Protocol Violation|1
330077|NCT00614393|1080121|P5|Overall Study|Progressive Disease|130
330078|NCT00614393|1080122|P4|Overall Study|Progressive Disease|138
330079|NCT00614393|1080123|P3|Overall Study|Progressive Disease|5
330080|NCT00614393|1080124|P2|Overall Study|Progressive Disease|5
330081|NCT00614393|1080125|P1|Overall Study|Progressive Disease|118
330082|NCT00614393|1080121|P5|Overall Study|Physician Decision|9
330083|NCT00614393|1080122|P4|Overall Study|Physician Decision|8
330084|NCT00614393|1080123|P3|Overall Study|Physician Decision|1
330085|NCT00614393|1080124|P2|Overall Study|Physician Decision|0
330086|NCT00614393|1080125|P1|Overall Study|Physician Decision|17
330087|NCT00614393|1080121|P5|Overall Study|Lost to Follow-up|2
330088|NCT00614393|1080122|P4|Overall Study|Lost to Follow-up|1
330089|NCT00614393|1080123|P3|Overall Study|Lost to Follow-up|0
330090|NCT00614393|1080124|P2|Overall Study|Lost to Follow-up|0
330091|NCT00614393|1080125|P1|Overall Study|Lost to Follow-up|0
330092|NCT00614393|1080121|P5|Overall Study|Adverse Event|21
330093|NCT00614393|1080122|P4|Overall Study|Adverse Event|13
330094|NCT00614393|1080123|P3|Overall Study|Adverse Event|3
330095|NCT00614393|1080124|P2|Overall Study|Adverse Event|2
330096|NCT00614393|1080125|P1|Overall Study|Adverse Event|20
330097|NCT00614380|1080171|P4|Overall Study|Consent withdrawn|0
330098|NCT00614380|1080172|P3|Overall Study|Consent withdrawn|0
330099|NCT00614380|1080173|P2|Overall Study|Consent withdrawn|1
330100|NCT00614380|1080174|P1|Overall Study|Consent withdrawn|3
330101|NCT00614380|1080171|P4|Overall Study|Non compliant with the protocol|2
330102|NCT00614380|1080172|P3|Overall Study|Non compliant with the protocol|1
330103|NCT00614380|1080173|P2|Overall Study|Non compliant with the protocol|2
330104|NCT00614380|1080174|P1|Overall Study|Non compliant with the protocol|12
330105|NCT00614380|1080171|P4|Overall Study|Lost to Follow-up|0
330106|NCT00614380|1080172|P3|Overall Study|Lost to Follow-up|0
330107|NCT00614380|1080173|P2|Overall Study|Lost to Follow-up|1
330108|NCT00614380|1080174|P1|Overall Study|Lost to Follow-up|6
330109|NCT00614380|1080171|P4|Overall Study|Adverse Event|0
330110|NCT00614380|1080172|P3|Overall Study|Adverse Event|0
330111|NCT00614380|1080173|P2|Overall Study|Adverse Event|4
330112|NCT00614380|1080174|P1|Overall Study|Adverse Event|14
330113|NCT00614120|1080241|P4|Overall Study|Lost to Follow-up|4
330114|NCT00614120|1080242|P3|Overall Study|Lost to Follow-up|3
330115|NCT00614120|1080243|P2|Overall Study|Lost to Follow-up|2
330116|NCT00614120|1080244|P1|Overall Study|Lost to Follow-up|1
330117|NCT00614120|1080241|P4|Overall Study|Taken inhibition medication eg Prandin|1
330118|NCT00614120|1080242|P3|Overall Study|Taken inhibition medication eg Prandin|1
330119|NCT00614120|1080243|P2|Overall Study|Taken inhibition medication eg Prandin|0
330120|NCT00614120|1080244|P1|Overall Study|Taken inhibition medication eg Prandin|0
330121|NCT00614120|1080241|P4|Overall Study|Late syphilis, latent|0
330122|NCT00614120|1080242|P3|Overall Study|Late syphilis, latent|0
330123|NCT00614120|1080243|P2|Overall Study|Late syphilis, latent|0
330124|NCT00614120|1080244|P1|Overall Study|Late syphilis, latent|1
330125|NCT00614120|1080241|P4|Overall Study|Lack of trial product|0
330126|NCT00614120|1080242|P3|Overall Study|Lack of trial product|2
330127|NCT00614120|1080243|P2|Overall Study|Lack of trial product|3
330128|NCT00614120|1080244|P1|Overall Study|Lack of trial product|3
330129|NCT00614120|1080241|P4|Overall Study|Hypoglycaemia|1
330130|NCT00614120|1080242|P3|Overall Study|Hypoglycaemia|0
330131|NCT00614120|1080243|P2|Overall Study|Hypoglycaemia|0
330132|NCT00614120|1080244|P1|Overall Study|Hypoglycaemia|0
330133|NCT00614120|1080241|P4|Overall Study|hCG positive (not pregnant)|0
330134|NCT00614120|1080242|P3|Overall Study|hCG positive (not pregnant)|1
330135|NCT00614120|1080243|P2|Overall Study|hCG positive (not pregnant)|0
330136|NCT00614120|1080244|P1|Overall Study|hCG positive (not pregnant)|0
330137|NCT00614120|1080241|P4|Overall Study|Did not meet trial criteria|1
330138|NCT00614120|1080242|P3|Overall Study|Did not meet trial criteria|1
330139|NCT00614120|1080243|P2|Overall Study|Did not meet trial criteria|1
330140|NCT00614120|1080244|P1|Overall Study|Did not meet trial criteria|0
330141|NCT00614120|1080241|P4|Overall Study|Withdrawal by Subject|3
330142|NCT00614120|1080242|P3|Overall Study|Withdrawal by Subject|16
330143|NCT00614120|1080243|P2|Overall Study|Withdrawal by Subject|10
330144|NCT00614120|1080244|P1|Overall Study|Withdrawal by Subject|9
330145|NCT00614120|1080241|P4|Overall Study|Withdrawal criteria|0
330146|NCT00614120|1080242|P3|Overall Study|Withdrawal criteria|0
330147|NCT00614120|1080243|P2|Overall Study|Withdrawal criteria|0
330148|NCT00614120|1080244|P1|Overall Study|Withdrawal criteria|1
330149|NCT00614120|1080241|P4|Overall Study|Protocol Violation|1
330150|NCT00614120|1080242|P3|Overall Study|Protocol Violation|3
330151|NCT00614120|1080243|P2|Overall Study|Protocol Violation|5
330152|NCT00614120|1080244|P1|Overall Study|Protocol Violation|2
330153|NCT00614120|1080241|P4|Overall Study|Lack of Efficacy|2
330154|NCT00614120|1080242|P3|Overall Study|Lack of Efficacy|2
330155|NCT00614120|1080243|P2|Overall Study|Lack of Efficacy|3
330156|NCT00614120|1080244|P1|Overall Study|Lack of Efficacy|3
330157|NCT00614120|1080241|P4|Overall Study|Adverse Event|3
330158|NCT00614120|1080242|P3|Overall Study|Adverse Event|30
330159|NCT00614120|1080243|P2|Overall Study|Adverse Event|22
330160|NCT00614120|1080244|P1|Overall Study|Adverse Event|9
330161|NCT00614055|1080285|P3|Overall Study|Unclassified|2
330162|NCT00614055|1080286|P2|Overall Study|Unclassified|4
330163|NCT00614055|1080287|P1|Overall Study|Unclassified|1
330164|NCT00614055|1080285|P3|Overall Study|Lack of Efficacy|2
330165|NCT00614055|1080286|P2|Overall Study|Lack of Efficacy|0
330166|NCT00614055|1080287|P1|Overall Study|Lack of Efficacy|0
330167|NCT00614055|1080285|P3|Overall Study|Protocol Violation|1
330168|NCT00614055|1080286|P2|Overall Study|Protocol Violation|2
330169|NCT00614055|1080287|P1|Overall Study|Protocol Violation|2
330170|NCT00614055|1080285|P3|Overall Study|Adverse Event|0
330171|NCT00614055|1080286|P2|Overall Study|Adverse Event|0
330172|NCT00614055|1080287|P1|Overall Study|Adverse Event|1
330173|NCT00613951|1080334|P3|Overall Study|Unclassified|2
330174|NCT00613951|1080335|P2|Overall Study|Unclassified|3
330175|NCT00613951|1080336|P1|Overall Study|Unclassified|5
330176|NCT00613951|1080334|P3|Overall Study|Protocol Violation|1
330177|NCT00613951|1080335|P2|Overall Study|Protocol Violation|1
330178|NCT00613951|1080336|P1|Overall Study|Protocol Violation|1
330179|NCT00613951|1080334|P3|Overall Study|Lack of Efficacy|1
330180|NCT00613951|1080335|P2|Overall Study|Lack of Efficacy|1
330181|NCT00613951|1080336|P1|Overall Study|Lack of Efficacy|0
330182|NCT00613951|1080334|P3|Overall Study|Adverse Event|1
330183|NCT00613951|1080335|P2|Overall Study|Adverse Event|0
330184|NCT00613951|1080336|P1|Overall Study|Adverse Event|1
330185|NCT00613938|1080381|P4|Overall Study|Other|3
330186|NCT00613938|1080382|P3|Overall Study|Other|1
330187|NCT00613938|1080383|P2|Overall Study|Other|2
330188|NCT00613938|1080384|P1|Overall Study|Other|1
330189|NCT00613938|1080381|P4|Overall Study|Lack of Efficacy|9
330190|NCT00613938|1080382|P3|Overall Study|Lack of Efficacy|5
330191|NCT00613938|1080383|P2|Overall Study|Lack of Efficacy|18
330192|NCT00613938|1080384|P1|Overall Study|Lack of Efficacy|16
330193|NCT00613938|1080381|P4|Overall Study|Adverse Event|5
330194|NCT00613938|1080382|P3|Overall Study|Adverse Event|8
330195|NCT00613938|1080383|P2|Overall Study|Adverse Event|4
330196|NCT00613938|1080384|P1|Overall Study|Adverse Event|1
330197|NCT00613938|1080381|P4|Overall Study|Withdrawal by Subject|9
330198|NCT00613938|1080382|P3|Overall Study|Withdrawal by Subject|9
330199|NCT00613938|1080383|P2|Overall Study|Withdrawal by Subject|4
330200|NCT00613938|1080384|P1|Overall Study|Withdrawal by Subject|2
330201|NCT00613925|1080416|P2|Overall Study|1 did not tolerate outpatient biopsy|1
330202|NCT00613925|1080417|P1|Overall Study|1 did not tolerate outpatient biopsy|0
330203|NCT00613730|1080425|P1|Overall Study|Administrative decision|1
330204|NCT00613730|1080425|P1|Overall Study|Disease progression|2
330205|NCT00613626|1080434|P3|Overall Study|Ineligible|0
330206|NCT00613626|1080435|P2|Overall Study|Ineligible|1
330207|NCT00613626|1080436|P1|Overall Study|Ineligible|0
330208|NCT00613574|1080452|P1|Overall Study|Other|1
330209|NCT00613574|1080452|P1|Overall Study|Lost to Follow-up|2
330210|NCT00613574|1080452|P1|Overall Study|Adverse Event|3
330211|NCT00613509|1080464|P2|Cycle 1|Other administrative reason|1
330212|NCT00613509|1080465|P1|Cycle 1|Other administrative reason|0
330213|NCT00613509|1080464|P2|Cycle 1|Unacceptable Toxicity|0
330214|NCT00613509|1080465|P1|Cycle 1|Unacceptable Toxicity|1
330215|NCT00613509|1080464|P2|Cycle 1|Disease Progression|6
330216|NCT00613509|1080465|P1|Cycle 1|Disease Progression|2
330217|NCT00613509|1080464|P2|Cycle 1|Adverse Event|1
330218|NCT00613509|1080465|P1|Cycle 1|Adverse Event|2
330219|NCT00613366|1080511|P2|Overall Study|Withdrawal by Subject|2
330220|NCT00613366|1080512|P1|Overall Study|Withdrawal by Subject|3
330221|NCT00613327|1080520|P1|Overall Study|Unspecified|47
330222|NCT00613327|1080520|P1|Overall Study|Protocol Violation|2
330223|NCT00613327|1080520|P1|Overall Study|Withdrawal by Subject|6
330224|NCT00613327|1080520|P1|Overall Study|Lost to Follow-up|8
330225|NCT00613327|1080520|P1|Overall Study|Adverse Event|38
330226|NCT00613314|1080539|P1|Overall Study|Other reason not defined above|90
330227|NCT00613314|1080539|P1|Overall Study|Lost to Follow-up|46
330228|NCT00613314|1080539|P1|Overall Study|Protocol Violation|14
330229|NCT00613314|1080539|P1|Overall Study|Adverse Event|5
330230|NCT00613301|1080547|P1|Overall Study|Irregularly enrolled patients|12
330231|NCT00613301|1080547|P1|Overall Study|No data was collected|53
330232|NCT00613301|1080547|P1|Overall Study|Physician Decision|2
330233|NCT00613301|1080547|P1|Overall Study|Lack of Efficacy|13
330234|NCT00613301|1080547|P1|Overall Study|Death|6
330235|NCT00613301|1080547|P1|Overall Study|Withdrawal by Subject|5
330236|NCT00613301|1080547|P1|Overall Study|Lost to Follow-up|88
330237|NCT00613301|1080547|P1|Overall Study|Adverse Event|49
330238|NCT00613106|1080556|P2|Overall Study|misc|3
330239|NCT00613106|1080557|P1|Overall Study|misc|4
330240|NCT00613106|1080556|P2|Overall Study|Lost to Follow-up|2
330241|NCT00613106|1080557|P1|Overall Study|Lost to Follow-up|7
330242|NCT00613106|1080556|P2|Overall Study|Withdrawal by Subject|3
330243|NCT00613106|1080557|P1|Overall Study|Withdrawal by Subject|6
330244|NCT00613106|1080556|P2|Overall Study|Adverse Event|1
330245|NCT00613106|1080557|P1|Overall Study|Adverse Event|3
330246|NCT00613080|1080563|P1|Overall Study|Ineligible / no protocol treatment|11
330247|NCT00613015|1080590|P6|Overall Study|Lost to Follow-up|3
330248|NCT00613015|1080591|P5|Overall Study|Lost to Follow-up|2
330249|NCT00613015|1080592|P4|Overall Study|Lost to Follow-up|3
330250|NCT00613015|1080593|P3|Overall Study|Lost to Follow-up|3
330251|NCT00613015|1080594|P2|Overall Study|Lost to Follow-up|1
330252|NCT00613015|1080595|P1|Overall Study|Lost to Follow-up|0
330253|NCT00612807|1080631|P2|Overall Study|Withdrawal by Subject|0
330254|NCT00612807|1080632|P1|Overall Study|Withdrawal by Subject|2
330255|NCT00612690|1080642|P2|Overall Study|Withdrawal by Site|0
330256|NCT00612690|1080643|P1|Overall Study|Withdrawal by Site|11
330257|NCT00612690|1080642|P2|Overall Study|Withdrawal by Subject|20
330258|NCT00612690|1080643|P1|Overall Study|Withdrawal by Subject|32
330259|NCT00612690|1080642|P2|Overall Study|Lost to Follow-up|98
330260|NCT00612690|1080643|P1|Overall Study|Lost to Follow-up|72
330261|NCT00612677|1080651|P1|Overall Study|study closed before treatment started|1
330262|NCT00612534|1080690|P4|Overall Study|Other Reason|0
330263|NCT00612534|1080691|P3|Overall Study|Other Reason|0
330264|NCT00612534|1080692|P2|Overall Study|Other Reason|1
330265|NCT00612534|1080693|P1|Overall Study|Other Reason|0
330266|NCT00612534|1080690|P4|Overall Study|Lack of Efficacy|16
330267|NCT00612534|1080691|P3|Overall Study|Lack of Efficacy|5
330268|NCT00612534|1080692|P2|Overall Study|Lack of Efficacy|12
330269|NCT00612534|1080693|P1|Overall Study|Lack of Efficacy|13
330270|NCT00612534|1080690|P4|Overall Study|Adverse Event|1
330271|NCT00612534|1080691|P3|Overall Study|Adverse Event|2
330272|NCT00612534|1080692|P2|Overall Study|Adverse Event|4
330273|NCT00612534|1080693|P1|Overall Study|Adverse Event|0
330274|NCT00612508|1080705|P2|Overall Study|Withdrawal by Subject|4
330275|NCT00612508|1080706|P1|Overall Study|Withdrawal by Subject|3
330276|NCT00612352|1080733|P2|Overall Study|didn't return calls/show up on test date|1
330277|NCT00612352|1080734|P1|Overall Study|didn't return calls/show up on test date|4
330278|NCT00612352|1080733|P2|Overall Study|moved out of state|0
330279|NCT00612352|1080734|P1|Overall Study|moved out of state|1
330280|NCT00612352|1080733|P2|Overall Study|Withdrawal by Subject|5
330281|NCT00612352|1080734|P1|Overall Study|Withdrawal by Subject|3
330282|NCT00612352|1080733|P2|Overall Study|Adverse Event|0
330283|NCT00612352|1080734|P1|Overall Study|Adverse Event|1
330284|NCT00612313|1080854|P2|Overall Study|Lost to Follow-up|4
330285|NCT00612313|1080855|P1|Overall Study|Lost to Follow-up|11
330286|NCT00612313|1080854|P2|Overall Study|Withdrawal by Subject|9
330287|NCT00612313|1080855|P1|Overall Study|Withdrawal by Subject|6
330288|NCT00612105|1080879|P2|Period Title 3: 3-Week Taper Phase|Other|0
330289|NCT00612105|1080880|P1|Period Title 3: 3-Week Taper Phase|Other|1
330290|NCT00612105|1080879|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
330291|NCT00612105|1080880|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
330292|NCT00612105|1080879|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
330293|NCT00612105|1080880|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
330294|NCT00612105|1080879|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
330295|NCT00612105|1080880|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
330296|NCT00612105|1080879|P2|Period Title 1: 6-Week Titration Phase|Other|1
330297|NCT00612105|1080880|P1|Period Title 1: 6-Week Titration Phase|Other|0
330298|NCT00612105|1080879|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
330299|NCT00612105|1080880|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
330300|NCT00612105|1080879|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
330301|NCT00612105|1080880|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
330302|NCT00612105|1080879|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
330303|NCT00612105|1080880|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
330304|NCT00612105|1080879|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
330305|NCT00612105|1080880|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
330306|NCT00612105|1080879|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
330307|NCT00612105|1080880|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
330308|NCT00612105|1080879|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
330309|NCT00612105|1080880|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
330310|NCT00612105|1080879|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
330311|NCT00612105|1080880|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
330312|NCT00612066|1080930|P1|Overall Study|Adverse Event|1
330313|NCT00612040|1080937|P3|Overall Study|Unclassified|5
330314|NCT00612040|1080938|P2|Overall Study|Unclassified|2
330315|NCT00612040|1080939|P1|Overall Study|Unclassified|2
330316|NCT00612040|1080937|P3|Overall Study|Lack of Efficacy|0
330317|NCT00612040|1080938|P2|Overall Study|Lack of Efficacy|1
330318|NCT00612040|1080939|P1|Overall Study|Lack of Efficacy|2
330319|NCT00612040|1080937|P3|Overall Study|Protocol Violation|1
330320|NCT00612040|1080938|P2|Overall Study|Protocol Violation|2
330321|NCT00612040|1080939|P1|Overall Study|Protocol Violation|1
330322|NCT00612040|1080937|P3|Overall Study|Adverse Event|1
330323|NCT00612040|1080938|P2|Overall Study|Adverse Event|2
330324|NCT00612040|1080939|P1|Overall Study|Adverse Event|0
330325|NCT00611884|1081012|P4|Overall Study|Unclassified|3
330326|NCT00611884|1081013|P3|Overall Study|Unclassified|2
330327|NCT00611884|1081014|P2|Overall Study|Unclassified|4
330328|NCT00611884|1081015|P1|Overall Study|Unclassified|7
330329|NCT00611884|1081012|P4|Overall Study|Lack of Efficacy|0
330330|NCT00611884|1081013|P3|Overall Study|Lack of Efficacy|0
330331|NCT00611884|1081014|P2|Overall Study|Lack of Efficacy|1
330332|NCT00611884|1081015|P1|Overall Study|Lack of Efficacy|0
330333|NCT00611884|1081012|P4|Overall Study|Non-Compliance|2
330334|NCT00611884|1081013|P3|Overall Study|Non-Compliance|2
330335|NCT00611884|1081014|P2|Overall Study|Non-Compliance|4
330336|NCT00611884|1081015|P1|Overall Study|Non-Compliance|1
330337|NCT00611884|1081012|P4|Overall Study|Adverse Event|1
330338|NCT00611884|1081013|P3|Overall Study|Adverse Event|0
330339|NCT00611884|1081014|P2|Overall Study|Adverse Event|0
330340|NCT00611884|1081015|P1|Overall Study|Adverse Event|1
330341|NCT00611806|1081071|P2|Overall Study|Lost to Follow-up|0
330342|NCT00611806|1081072|P1|Overall Study|Lost to Follow-up|6
330343|NCT00611806|1081071|P2|Overall Study|Adverse Event|1
330344|NCT00611806|1081072|P1|Overall Study|Adverse Event|2
330345|NCT00611806|1081071|P2|Overall Study|Withdrawal by Subject|2
330346|NCT00611806|1081072|P1|Overall Study|Withdrawal by Subject|8
330347|NCT00611767|1081086|P2|Overall Study|Physician Decision|0
330348|NCT00611767|1081087|P1|Overall Study|Physician Decision|1
330349|NCT00611767|1081086|P2|Overall Study|didn't like the medication|1
330350|NCT00611767|1081087|P1|Overall Study|didn't like the medication|1
330351|NCT00611767|1081086|P2|Overall Study|Thiopental not available|0
330352|NCT00611767|1081087|P1|Overall Study|Thiopental not available|3
330353|NCT00611767|1081086|P2|Overall Study|Withdrawal by Subject|1
330354|NCT00611767|1081087|P1|Overall Study|Withdrawal by Subject|4
330355|NCT00611715|1081249|P2|Overall Study|two patients are still on treatment|0
330356|NCT00611715|1081250|P1|Overall Study|two patients are still on treatment|2
330357|NCT00611715|1081249|P2|Overall Study|Death|0
330358|NCT00611715|1081250|P1|Overall Study|Death|1
330359|NCT00611715|1081249|P2|Overall Study|Adverse Event|1
330360|NCT00611715|1081250|P1|Overall Study|Adverse Event|9
330361|NCT00611715|1081249|P2|Overall Study|Withdrawal by Subject|1
330362|NCT00611715|1081250|P1|Overall Study|Withdrawal by Subject|5
330363|NCT00611715|1081249|P2|Overall Study|Disease Progression|4
330364|NCT00611715|1081250|P1|Overall Study|Disease Progression|24
330365|NCT00611559|1081270|P3|Overall Study|Protocol Violation|1
330366|NCT00611559|1081271|P2|Overall Study|Protocol Violation|0
330367|NCT00611559|1081272|P1|Overall Study|Protocol Violation|1
330368|NCT00611559|1081270|P3|Overall Study|Lost to Follow-up|0
330369|NCT00611559|1081271|P2|Overall Study|Lost to Follow-up|1
330370|NCT00611559|1081272|P1|Overall Study|Lost to Follow-up|0
330371|NCT00611533|1081331|P2|Second Intervention (6 Weeks)|Adverse Event|2
330372|NCT00611533|1081332|P1|Second Intervention (6 Weeks)|Adverse Event|0
330373|NCT00611533|1081331|P2|First Intervention (6 Weeks)|Adverse Event|1
330374|NCT00611533|1081332|P1|First Intervention (6 Weeks)|Adverse Event|0
330375|NCT00611533|1081331|P2|First Intervention (6 Weeks)|Never started study|1
330376|NCT00611533|1081332|P1|First Intervention (6 Weeks)|Never started study|0
330377|NCT00611455|1081366|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
330378|NCT00611455|1081367|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
330379|NCT00611455|1081368|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
330380|NCT00611455|1081366|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
330381|NCT00611455|1081367|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
330382|NCT00611455|1081368|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
330383|NCT00611455|1081366|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
330384|NCT00611455|1081367|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
330385|NCT00611455|1081368|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
330386|NCT00611455|1081366|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
330387|NCT00611455|1081367|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
330388|NCT00611455|1081368|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
330389|NCT00611455|1081366|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
330390|NCT00611455|1081367|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
330391|NCT00611455|1081368|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
330392|NCT00611455|1081366|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
330393|NCT00611455|1081367|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
330394|NCT00611455|1081368|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
330395|NCT00611455|1081366|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
330396|NCT00611455|1081367|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
330397|NCT00611455|1081368|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
330398|NCT00611455|1081366|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
330399|NCT00611455|1081367|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
330400|NCT00611455|1081368|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
330401|NCT00611455|1081366|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
330402|NCT00611455|1081367|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
330403|NCT00611455|1081368|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
330404|NCT00611455|1081366|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
330405|NCT00611455|1081367|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
330406|NCT00611455|1081368|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
330407|NCT00611455|1081366|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
330408|NCT00611455|1081367|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
330409|NCT00611455|1081368|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
330410|NCT00611455|1081366|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
330411|NCT00611455|1081367|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
330412|NCT00611455|1081368|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
330413|NCT00611455|1081366|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
330414|NCT00611455|1081367|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
330415|NCT00611455|1081368|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
330416|NCT00611455|1081366|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
330417|NCT00611455|1081367|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
330418|NCT00611455|1081368|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
330419|NCT00611455|1081366|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
330420|NCT00611455|1081367|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
330421|NCT00611455|1081368|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
330422|NCT00611455|1081366|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
330423|NCT00611455|1081367|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
330424|NCT00611455|1081368|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
330425|NCT00611455|1081366|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
330426|NCT00611455|1081367|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
330427|NCT00611455|1081368|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
330428|NCT00611455|1081366|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
330429|NCT00611455|1081367|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
330430|NCT00611455|1081368|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
330431|NCT00611455|1081366|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
330432|NCT00611455|1081367|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
330433|NCT00611455|1081368|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
330434|NCT00611455|1081366|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
330435|NCT00611455|1081367|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
330436|NCT00611455|1081368|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
330437|NCT00611455|1081366|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
330438|NCT00611455|1081367|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
330439|NCT00611455|1081368|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
330440|NCT00611247|1081541|P2|Overall Study|Lack of Efficacy|16
330441|NCT00611247|1081542|P1|Overall Study|Lack of Efficacy|1
330442|NCT00611247|1081541|P2|Overall Study|Death|5
330443|NCT00611247|1081542|P1|Overall Study|Death|1
330444|NCT00611130|1081554|P2|Overall Study|Death|0
330445|NCT00611130|1081555|P1|Overall Study|Death|1
330446|NCT00611130|1081554|P2|Overall Study|Adverse Event|0
330447|NCT00611130|1081555|P1|Overall Study|Adverse Event|1
330448|NCT00611130|1081554|P2|Overall Study|Administrative|1
330449|NCT00611130|1081555|P1|Overall Study|Administrative|1
330450|NCT00611130|1081554|P2|Overall Study|Incarceration|2
330451|NCT00611130|1081555|P1|Overall Study|Incarceration|3
330452|NCT00611130|1081554|P2|Overall Study|Unspecified|4
330453|NCT00611130|1081555|P1|Overall Study|Unspecified|5
330454|NCT00611130|1081554|P2|Overall Study|Withdrawal by Subject|5
330455|NCT00611130|1081555|P1|Overall Study|Withdrawal by Subject|6
330456|NCT00611130|1081554|P2|Overall Study|Protocol noncompliance|6
330457|NCT00611130|1081555|P1|Overall Study|Protocol noncompliance|7
330458|NCT00611130|1081554|P2|Overall Study|Lost to Follow-up|29
330459|NCT00611130|1081555|P1|Overall Study|Lost to Follow-up|25
330460|NCT00611026|1081565|P3|Double-blind Treatment Period|Unspecified|18
330461|NCT00611026|1081566|P2|Double-blind Treatment Period|Unspecified|20
330462|NCT00611026|1081567|P1|Double-blind Treatment Period|Unspecified|13
330463|NCT00611026|1081565|P3|Double-blind Treatment Period|Withdrawal by Subject|16
330464|NCT00611026|1081566|P2|Double-blind Treatment Period|Withdrawal by Subject|19
330465|NCT00611026|1081567|P1|Double-blind Treatment Period|Withdrawal by Subject|7
330466|NCT00611026|1081565|P3|Double-blind Treatment Period|Lost to Follow-up|14
330467|NCT00611026|1081566|P2|Double-blind Treatment Period|Lost to Follow-up|11
330468|NCT00611026|1081567|P1|Double-blind Treatment Period|Lost to Follow-up|6
330469|NCT00611026|1081565|P3|Double-blind Treatment Period|Lack of Efficacy|4
330470|NCT00611026|1081566|P2|Double-blind Treatment Period|Lack of Efficacy|10
330471|NCT00611026|1081567|P1|Double-blind Treatment Period|Lack of Efficacy|11
330472|NCT00611026|1081565|P3|Double-blind Treatment Period|Adverse Event|46
330473|NCT00611026|1081566|P2|Double-blind Treatment Period|Adverse Event|28
330474|NCT00611026|1081567|P1|Double-blind Treatment Period|Adverse Event|9
330475|NCT00611026|1081565|P3|Double-blind Treatment Period|Death|0
330476|NCT00611026|1081566|P2|Double-blind Treatment Period|Death|0
330477|NCT00611026|1081567|P1|Double-blind Treatment Period|Death|1
330478|NCT00611026|1081565|P3|Randomized to Double-blind Treatment|Not treated|3
330479|NCT00611026|1081566|P2|Randomized to Double-blind Treatment|Not treated|1
330480|NCT00611026|1081567|P1|Randomized to Double-blind Treatment|Not treated|2
330482|NCT00610714|1081659|P2|Overall Study|Study completion at 120 PFS events|2
330483|NCT00610714|1081660|P1|Overall Study|Study completion at 120 PFS events|2
330484|NCT00610714|1081659|P2|Overall Study|Withdrawal by Subject|3
330485|NCT00610714|1081660|P1|Overall Study|Withdrawal by Subject|9
330486|NCT00610714|1081659|P2|Overall Study|Death|18
330487|NCT00610714|1081660|P1|Overall Study|Death|12
330488|NCT00610714|1081659|P2|Overall Study|Adverse Event|1
330489|NCT00610714|1081660|P1|Overall Study|Adverse Event|3
330490|NCT00610675|1081698|P1|Overall Study|Other reason (not specified)|25
330491|NCT00610675|1081698|P1|Overall Study|Lost to Follow-up|31
330492|NCT00610675|1081698|P1|Overall Study|Lack of Compliance|7
330493|NCT00610675|1081698|P1|Overall Study|Reasons unrelated to trial|27
330494|NCT00610675|1081698|P1|Overall Study|Withdrawal by Subject|28
330495|NCT00610675|1081698|P1|Overall Study|Insufficient Effect|31
330496|NCT00610675|1081698|P1|Overall Study|Adverse Event|67
330497|NCT00610675|1081698|P1|Overall Study|Untreated|4
330498|NCT00610649|1081720|P11|Overall Study|Withdrawal by Subject|0
330499|NCT00610649|1081721|P10|Overall Study|Withdrawal by Subject|1
330500|NCT00610649|1081722|P9|Overall Study|Withdrawal by Subject|0
330501|NCT00610649|1081723|P8|Overall Study|Withdrawal by Subject|0
330502|NCT00610649|1081724|P7|Overall Study|Withdrawal by Subject|0
330503|NCT00610649|1081725|P6|Overall Study|Withdrawal by Subject|0
330504|NCT00610649|1081726|P5|Overall Study|Withdrawal by Subject|0
330505|NCT00610649|1081727|P4|Overall Study|Withdrawal by Subject|0
330506|NCT00610649|1081728|P3|Overall Study|Withdrawal by Subject|0
330507|NCT00610649|1081729|P2|Overall Study|Withdrawal by Subject|0
330508|NCT00610649|1081730|P1|Overall Study|Withdrawal by Subject|0
330509|NCT00610649|1081720|P11|Overall Study|Family Emergency|0
330510|NCT00610649|1081721|P10|Overall Study|Family Emergency|0
330511|NCT00610649|1081722|P9|Overall Study|Family Emergency|0
330512|NCT00610649|1081723|P8|Overall Study|Family Emergency|0
330513|NCT00610649|1081724|P7|Overall Study|Family Emergency|0
330514|NCT00610649|1081725|P6|Overall Study|Family Emergency|0
330515|NCT00610649|1081726|P5|Overall Study|Family Emergency|0
330516|NCT00610649|1081727|P4|Overall Study|Family Emergency|0
330517|NCT00610649|1081728|P3|Overall Study|Family Emergency|0
330518|NCT00610649|1081729|P2|Overall Study|Family Emergency|1
330519|NCT00610649|1081730|P1|Overall Study|Family Emergency|0
330520|NCT00610649|1081720|P11|Overall Study|Adverse Event|1
330521|NCT00610649|1081721|P10|Overall Study|Adverse Event|0
330522|NCT00610649|1081722|P9|Overall Study|Adverse Event|0
330523|NCT00610649|1081723|P8|Overall Study|Adverse Event|0
330524|NCT00610649|1081724|P7|Overall Study|Adverse Event|0
330525|NCT00610649|1081725|P6|Overall Study|Adverse Event|0
330526|NCT00610649|1081726|P5|Overall Study|Adverse Event|0
330527|NCT00610649|1081727|P4|Overall Study|Adverse Event|0
330528|NCT00610649|1081728|P3|Overall Study|Adverse Event|0
330529|NCT00610649|1081729|P2|Overall Study|Adverse Event|0
330530|NCT00610649|1081730|P1|Overall Study|Adverse Event|1
330531|NCT00610441|1081794|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
330532|NCT00610441|1081795|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
330533|NCT00610441|1081796|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
330534|NCT00610441|1081797|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
330535|NCT00610441|1081794|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
330536|NCT00610441|1081795|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
330537|NCT00610441|1081796|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
330538|NCT00610441|1081797|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
330539|NCT00610441|1081794|P4|Treatment Period 2 - 3 Weeks|Unspecified|1
330540|NCT00610441|1081795|P3|Treatment Period 2 - 3 Weeks|Unspecified|0
330541|NCT00610441|1081796|P2|Treatment Period 2 - 3 Weeks|Unspecified|1
330542|NCT00610441|1081797|P1|Treatment Period 2 - 3 Weeks|Unspecified|1
330543|NCT00610441|1081794|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
330544|NCT00610441|1081795|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
330545|NCT00610441|1081796|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
330546|NCT00610441|1081797|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
330547|NCT00610441|1081794|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
330548|NCT00610441|1081795|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
330549|NCT00610441|1081796|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
330550|NCT00610441|1081797|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
330551|NCT00610441|1081794|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
330552|NCT00610441|1081795|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
330553|NCT00610441|1081796|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
330554|NCT00610441|1081797|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
330555|NCT00610441|1081794|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
330556|NCT00610441|1081795|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
330557|NCT00610441|1081796|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
330558|NCT00610441|1081797|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
330559|NCT00610441|1081794|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
330560|NCT00610441|1081795|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
330561|NCT00610441|1081796|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
330562|NCT00610441|1081797|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
330563|NCT00610441|1081794|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
330564|NCT00610441|1081795|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
330565|NCT00610441|1081796|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
330566|NCT00610441|1081797|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
330567|NCT00610363|1081890|P2|Overall Study|Other than specified above|1
330568|NCT00610363|1081891|P1|Overall Study|Other than specified above|1
330569|NCT00610363|1081890|P2|Overall Study|Withdrawal by Subject|0
330570|NCT00610363|1081891|P1|Overall Study|Withdrawal by Subject|1
330571|NCT00610363|1081890|P2|Overall Study|Lost to Follow-up|0
330572|NCT00610363|1081891|P1|Overall Study|Lost to Follow-up|4
330573|NCT00610363|1081890|P2|Overall Study|Lack of Efficacy|0
330574|NCT00610363|1081891|P1|Overall Study|Lack of Efficacy|2
330575|NCT00610363|1081890|P2|Overall Study|Adverse Event|1
330576|NCT00610363|1081891|P1|Overall Study|Adverse Event|3
330577|NCT00610363|1081890|P2|Overall Study|Non-compliance with protocol|1
330578|NCT00610363|1081891|P1|Overall Study|Non-compliance with protocol|0
330579|NCT00610207|1081916|P1|Overall Study|Lost to Follow-up|3
330580|NCT00610168|1081923|P2|Overall Study|Withdrawal by Subject|0
330581|NCT00610168|1081924|P1|Overall Study|Withdrawal by Subject|2
330582|NCT00610155|1081943|P6|Period 3|Adverse Event|0
330583|NCT00610155|1081944|P5|Period 3|Adverse Event|0
330584|NCT00610155|1081945|P4|Period 3|Adverse Event|0
330585|NCT00610155|1081946|P3|Period 3|Adverse Event|0
330586|NCT00610155|1081947|P2|Period 3|Adverse Event|0
330587|NCT00610155|1081948|P1|Period 3|Adverse Event|1
330588|NCT00610155|1081943|P6|Period 1|Withdrawal by Subject|0
330589|NCT00610155|1081944|P5|Period 1|Withdrawal by Subject|0
330590|NCT00610155|1081945|P4|Period 1|Withdrawal by Subject|0
330591|NCT00610155|1081946|P3|Period 1|Withdrawal by Subject|1
330592|NCT00610155|1081947|P2|Period 1|Withdrawal by Subject|0
330593|NCT00610155|1081948|P1|Period 1|Withdrawal by Subject|0
330594|NCT00610129|1081995|P1|Overall Study|Not treated since patients ineligible|3
330595|NCT00609986|1082001|P2|Overall Study|Did not receive transplant or treatment|3
330596|NCT00609986|1082002|P1|Overall Study|Did not receive transplant or treatment|8
330597|NCT00609973|1082016|P2|Overall Study|Withdrawal by Subject|1
330598|NCT00609973|1082017|P1|Overall Study|Withdrawal by Subject|0
330599|NCT00609973|1082016|P2|Overall Study|Lost to Follow-up|1
330600|NCT00609973|1082017|P1|Overall Study|Lost to Follow-up|2
330601|NCT00609973|1082016|P2|Overall Study|Protocol Violation|3
330602|NCT00609973|1082017|P1|Overall Study|Protocol Violation|4
330603|NCT00609973|1082016|P2|Overall Study|Adverse Event|1
330604|NCT00609973|1082017|P1|Overall Study|Adverse Event|2
330605|NCT00609947|1082025|P1|Overall Study|Death|1
330606|NCT00609869|1082030|P1|Overall Study|Mantle cell: not evaluable|4
330607|NCT00609869|1082030|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
330608|NCT00609869|1082030|P1|Overall Study|Hepatitis B infection|1
330609|NCT00609869|1082030|P1|Overall Study|Severe tumor flare reaction|1
330610|NCT00609869|1082030|P1|Overall Study|Seizures|1
330611|NCT00609869|1082030|P1|Overall Study|Withdrawal by Subject|1
330612|NCT00609869|1082030|P1|Overall Study|Severe hematologic toxicity|1
330613|NCT00609869|1082030|P1|Overall Study|Withdrawn, ischemic stroke|1
330614|NCT00609765|1082049|P1|Overall Study|Study ended prior to 12 months|1
330615|NCT00609674|1082063|P2|Overall Study|Withdrew consent|1
330616|NCT00609674|1082064|P1|Overall Study|Withdrew consent|2
330617|NCT00609674|1082063|P2|Overall Study|Lost to Follow-up|0
330618|NCT00609674|1082064|P1|Overall Study|Lost to Follow-up|1
330619|NCT00609674|1082063|P2|Overall Study|Protocol Violation|5
330620|NCT00609674|1082064|P1|Overall Study|Protocol Violation|3
330621|NCT00609674|1082063|P2|Overall Study|Adverse Event|1
330622|NCT00609674|1082064|P1|Overall Study|Adverse Event|1
330623|NCT00609622|1082100|P2|Overall Study|Global deterioration of health status|2
330624|NCT00609622|1082101|P1|Overall Study|Global deterioration of health status|6
330625|NCT00609622|1082100|P2|Overall Study|Unspecified|14
330626|NCT00609622|1082101|P1|Overall Study|Unspecified|7
330627|NCT00609622|1082100|P2|Overall Study|Study terminated by sponsor|3
330628|NCT00609622|1082101|P1|Overall Study|Study terminated by sponsor|16
330629|NCT00609622|1082100|P2|Overall Study|Objective progression or relapse|41
330630|NCT00609622|1082101|P1|Overall Study|Objective progression or relapse|47
330631|NCT00609622|1082100|P2|Overall Study|Protocol Violation|1
330632|NCT00609622|1082101|P1|Overall Study|Protocol Violation|1
330633|NCT00609622|1082100|P2|Overall Study|Death|4
330634|NCT00609622|1082101|P1|Overall Study|Death|1
330635|NCT00609622|1082100|P2|Overall Study|Withdrawal by Subject|20
330636|NCT00609622|1082101|P1|Overall Study|Withdrawal by Subject|4
330637|NCT00609622|1082100|P2|Overall Study|Adverse Event|10
330638|NCT00609622|1082101|P1|Overall Study|Adverse Event|14
330639|NCT00609518|1082123|P2|Overall Study|Death from Adverse Event|2
330640|NCT00609518|1082124|P1|Overall Study|Death from Adverse Event|2
330641|NCT00609518|1082123|P2|Overall Study|Physician Decision|3
330642|NCT00609518|1082124|P1|Overall Study|Physician Decision|1
330643|NCT00609518|1082123|P2|Overall Study|Lost to Follow-up|0
330644|NCT00609518|1082124|P1|Overall Study|Lost to Follow-up|3
330645|NCT00609518|1082123|P2|Overall Study|Withdrawal by Subject|3
330646|NCT00609518|1082124|P1|Overall Study|Withdrawal by Subject|5
330647|NCT00609518|1082123|P2|Overall Study|Death from Study Disease|32
330648|NCT00609518|1082124|P1|Overall Study|Death from Study Disease|32
330649|NCT00609492|1082139|P3|Overall Study|Lost to Follow-up|4
330650|NCT00609492|1082140|P2|Overall Study|Lost to Follow-up|1
330651|NCT00609492|1082141|P1|Overall Study|Lost to Follow-up|1
330652|NCT00609492|1082139|P3|Overall Study|Withdrawal by Subject|3
330653|NCT00609492|1082140|P2|Overall Study|Withdrawal by Subject|2
330654|NCT00609492|1082141|P1|Overall Study|Withdrawal by Subject|0
330655|NCT00609466|1082226|P3|Overall Study|Lack of Efficacy|2
330656|NCT00609466|1082227|P2|Overall Study|Lack of Efficacy|2
330657|NCT00609466|1082228|P1|Overall Study|Lack of Efficacy|0
330658|NCT00609466|1082226|P3|Overall Study|Adverse Event|1
330659|NCT00609466|1082227|P2|Overall Study|Adverse Event|3
330660|NCT00609466|1082228|P1|Overall Study|Adverse Event|2
330661|NCT00609466|1082226|P3|Overall Study|Withdrawal by Subject|1
330662|NCT00609466|1082227|P2|Overall Study|Withdrawal by Subject|1
330663|NCT00609466|1082228|P1|Overall Study|Withdrawal by Subject|0
330664|NCT00609362|1082256|P2|Overall Study|Adverse Event|0
330665|NCT00609362|1082257|P1|Overall Study|Adverse Event|1
330666|NCT00609362|1082256|P2|Overall Study|Withdrawal by Subject|1
330667|NCT00609362|1082257|P1|Overall Study|Withdrawal by Subject|2
330668|NCT00609245|1082267|P1|Overall Study|Adverse Event|1
330669|NCT00609167|1082275|P2|Overall Study|Stem Cell Transplant|6
330670|NCT00609167|1082276|P1|Overall Study|Stem Cell Transplant|0
330671|NCT00609167|1082275|P2|Overall Study|Disease Progression|0
330672|NCT00609167|1082276|P1|Overall Study|Disease Progression|1
330673|NCT00609167|1082275|P2|Overall Study|Adverse Event|1
330674|NCT00609167|1082276|P1|Overall Study|Adverse Event|5
330675|NCT00609167|1082275|P2|Overall Study|Lack of Efficacy|0
330676|NCT00609167|1082276|P1|Overall Study|Lack of Efficacy|1
330677|NCT00609167|1082275|P2|Overall Study|Withdrawal by Subject|0
330678|NCT00609167|1082276|P1|Overall Study|Withdrawal by Subject|1
330679|NCT00608985|1082302|P4|Overall Study|Lost to Follow-up|0
330680|NCT00608985|1082303|P3|Overall Study|Lost to Follow-up|0
330681|NCT00608985|1082304|P2|Overall Study|Lost to Follow-up|1
330682|NCT00608985|1082305|P1|Overall Study|Lost to Follow-up|2
330683|NCT00608985|1082302|P4|Overall Study|Withdrawal of Consent|1
330684|NCT00608985|1082303|P3|Overall Study|Withdrawal of Consent|1
330685|NCT00608985|1082304|P2|Overall Study|Withdrawal of Consent|1
330686|NCT00608985|1082305|P1|Overall Study|Withdrawal of Consent|5
330687|NCT00608985|1082302|P4|Overall Study|Administrative/Other|2
330688|NCT00608985|1082303|P3|Overall Study|Administrative/Other|1
330689|NCT00608985|1082304|P2|Overall Study|Administrative/Other|4
330690|NCT00608985|1082305|P1|Overall Study|Administrative/Other|7
330691|NCT00608985|1082302|P4|Overall Study|Adverse Event|6
330692|NCT00608985|1082303|P3|Overall Study|Adverse Event|4
330693|NCT00608985|1082304|P2|Overall Study|Adverse Event|7
330694|NCT00608985|1082305|P1|Overall Study|Adverse Event|2
330695|NCT00608959|1082337|P1|Part 1|Did not meet eligibility criteria|1
330696|NCT00608907|1082350|P3|Overall Study|Progressive Disease|0
330697|NCT00608907|1082351|P2|Overall Study|Progressive Disease|0
330698|NCT00608907|1082352|P1|Overall Study|Progressive Disease|1
330699|NCT00608907|1082350|P3|Overall Study|Withdrawal by Subject|0
330700|NCT00608907|1082351|P2|Overall Study|Withdrawal by Subject|0
330701|NCT00608907|1082352|P1|Overall Study|Withdrawal by Subject|4
330702|NCT00608907|1082350|P3|Overall Study|Death|0
330703|NCT00608907|1082351|P2|Overall Study|Death|0
330704|NCT00608907|1082352|P1|Overall Study|Death|1
330705|NCT00608907|1082350|P3|Overall Study|Adverse Event|1
330706|NCT00608907|1082351|P2|Overall Study|Adverse Event|0
330707|NCT00608907|1082352|P1|Overall Study|Adverse Event|6
330708|NCT00608881|1082362|P2|Overall Study|Institutionalized|2
330709|NCT00608881|1082363|P1|Overall Study|Institutionalized|1
330710|NCT00608881|1082362|P2|Overall Study|Physician Decision|5
330711|NCT00608881|1082363|P1|Overall Study|Physician Decision|5
330712|NCT00608881|1082362|P2|Overall Study|Withdrawal by Subject|29
330713|NCT00608881|1082363|P1|Overall Study|Withdrawal by Subject|18
330714|NCT00608881|1082362|P2|Overall Study|Lost to Follow-up|14
330715|NCT00608881|1082363|P1|Overall Study|Lost to Follow-up|28
330716|NCT00608881|1082362|P2|Overall Study|Adverse Event|3
330717|NCT00608881|1082363|P1|Overall Study|Adverse Event|5
330718|NCT00608881|1082362|P2|Overall Study|Death|13
330719|NCT00608881|1082363|P1|Overall Study|Death|22
330720|NCT00608868|1082397|P1|Overall Study|Physician Decision|2
330721|NCT00608868|1082397|P1|Overall Study|Adverse Event|1
330722|NCT00608868|1082397|P1|Overall Study|Lost to Follow-up|2
330723|NCT00608868|1082397|P1|Overall Study|Protocol Violation|3
330724|NCT00608868|1082397|P1|Overall Study|Withdrawal by Subject|7
330725|NCT00608842|1082408|P4|Overall Study|Lost to Follow-up|0
330726|NCT00608842|1082409|P3|Overall Study|Lost to Follow-up|0
330727|NCT00608842|1082410|P2|Overall Study|Lost to Follow-up|0
330728|NCT00608842|1082411|P1|Overall Study|Lost to Follow-up|1
330729|NCT00608842|1082408|P4|Overall Study|Participant's Request|1
330730|NCT00608842|1082409|P3|Overall Study|Participant's Request|2
330731|NCT00608842|1082410|P2|Overall Study|Participant's Request|1
330732|NCT00608842|1082411|P1|Overall Study|Participant's Request|0
330733|NCT00608829|1082445|P1|Overall Study|Subject refuses to follow up or return.|5
330734|NCT00608829|1082445|P1|Overall Study|Withdrawal by Subject|4
330735|NCT00608829|1082445|P1|Overall Study|Death|6
330736|NCT00608582|1082471|P2|Overall Study|Early stage Design Change|3
330737|NCT00608582|1082472|P1|Overall Study|Early stage Design Change|0
330738|NCT00608582|1082471|P2|Overall Study|Illicit Drug Use|0
330739|NCT00608582|1082472|P1|Overall Study|Illicit Drug Use|1
330740|NCT00608582|1082471|P2|Overall Study|No Best Response in Phase 1 located|1
330741|NCT00608582|1082472|P1|Overall Study|No Best Response in Phase 1 located|1
330742|NCT00608582|1082471|P2|Overall Study|Lost to Follow-up|0
330743|NCT00608582|1082472|P1|Overall Study|Lost to Follow-up|2
330744|NCT00608569|1082482|P2|Overall Study|Unable to adhere with study requirements|1
330745|NCT00608569|1082483|P1|Overall Study|Unable to adhere with study requirements|0
330746|NCT00608569|1082482|P2|Overall Study|Adverse Event|0
330747|NCT00608569|1082483|P1|Overall Study|Adverse Event|1
330748|NCT00608569|1082482|P2|Overall Study|Withdrawal by Subject|0
330749|NCT00608569|1082483|P1|Overall Study|Withdrawal by Subject|1
330750|NCT00608569|1082482|P2|Overall Study|Lost to Follow-up|5
330751|NCT00608569|1082483|P1|Overall Study|Lost to Follow-up|4
330752|NCT00608569|1082482|P2|Overall Study|Death|3
330753|NCT00608569|1082483|P1|Overall Study|Death|4
330754|NCT00608543|1082503|P1|Overall Study|Adverse Event|4
330755|NCT00608530|1082514|P2|Overall Study|Withdrawal by Subject|5
330756|NCT00608530|1082515|P1|Overall Study|Withdrawal by Subject|11
330757|NCT00608517|1082528|P3|Overall Study|Death|0
330758|NCT00608517|1082529|P2|Overall Study|Death|0
330759|NCT00608517|1082530|P1|Overall Study|Death|1
330760|NCT00608426|1082710|P2|Overall Study|refused, health issues, wrong address|348
330761|NCT00608426|1082711|P1|Overall Study|refused, health issues, wrong address|319
330762|NCT00608426|1082710|P2|Overall Study|Lost to Follow-up|521
330763|NCT00608426|1082711|P1|Overall Study|Lost to Follow-up|485
330764|NCT00608426|1082710|P2|Overall Study|Death|36
330765|NCT00608426|1082711|P1|Overall Study|Death|32
330766|NCT00608322|1082723|P2|Overall Study|Death|1
330767|NCT00608322|1082724|P1|Overall Study|Death|2
330768|NCT00608244|1082730|P1|Overall Study|Low trough levels|1
330769|NCT00608244|1082730|P1|Overall Study|Adverse Event|1
330770|NCT00608205|1082741|P2|Overall Study|Patient non-compliant|1
330771|NCT00608205|1082742|P1|Overall Study|Patient non-compliant|0
330772|NCT00608205|1082741|P2|Overall Study|Adverse Event|2
330773|NCT00608205|1082742|P1|Overall Study|Adverse Event|3
330774|NCT00608023|1082844|P3|Overall Study|Unknown reason|0
330775|NCT00608023|1082845|P2|Overall Study|Unknown reason|3
330776|NCT00608023|1082846|P1|Overall Study|Unknown reason|0
330777|NCT00608023|1082844|P3|Overall Study|Protocol Violation|1
330778|NCT00608023|1082845|P2|Overall Study|Protocol Violation|3
330779|NCT00608023|1082846|P1|Overall Study|Protocol Violation|1
330780|NCT00608023|1082844|P3|Overall Study|Lost to Follow-up|1
330781|NCT00608023|1082845|P2|Overall Study|Lost to Follow-up|2
330782|NCT00608023|1082846|P1|Overall Study|Lost to Follow-up|2
330783|NCT00608023|1082844|P3|Overall Study|Adverse Event|5
330784|NCT00608023|1082845|P2|Overall Study|Adverse Event|4
330785|NCT00608023|1082846|P1|Overall Study|Adverse Event|1
330786|NCT00608023|1082844|P3|Overall Study|Withdrawal by Subject|7
330787|NCT00608023|1082845|P2|Overall Study|Withdrawal by Subject|10
330788|NCT00608023|1082846|P1|Overall Study|Withdrawal by Subject|8
330789|NCT00607919|1082868|P2|Open-Label Phase|Parent/Caregiver Decision|2
330790|NCT00607919|1082869|P1|Open-Label Phase|Parent/Caregiver Decision|1
330791|NCT00607919|1082868|P2|Open-Label Phase|Withdrawal by Subject|2
330792|NCT00607919|1082869|P1|Open-Label Phase|Withdrawal by Subject|2
330793|NCT00607919|1082868|P2|Open-Label Phase|Protocol Violation|2
330794|NCT00607919|1082869|P1|Open-Label Phase|Protocol Violation|2
330795|NCT00607919|1082868|P2|Open-Label Phase|Lost to Follow-up|1
330796|NCT00607919|1082869|P1|Open-Label Phase|Lost to Follow-up|4
330797|NCT00607919|1082868|P2|Open-Label Phase|Adverse Event|5
330798|NCT00607919|1082869|P1|Open-Label Phase|Adverse Event|1
330799|NCT00607919|1082868|P2|Acute Phase|Withdrawal by Subject|3
330800|NCT00607919|1082869|P1|Acute Phase|Withdrawal by Subject|3
330801|NCT00607919|1082868|P2|Acute Phase|Protocol Violation|1
330802|NCT00607919|1082869|P1|Acute Phase|Protocol Violation|5
330803|NCT00607919|1082868|P2|Acute Phase|Parent/Caregiver Decision|4
330804|NCT00607919|1082869|P1|Acute Phase|Parent/Caregiver Decision|6
330805|NCT00607919|1082868|P2|Acute Phase|Lost to Follow-up|3
330806|NCT00607919|1082869|P1|Acute Phase|Lost to Follow-up|9
330807|NCT00607919|1082868|P2|Acute Phase|Lack of Efficacy|2
330808|NCT00607919|1082869|P1|Acute Phase|Lack of Efficacy|1
330809|NCT00607919|1082868|P2|Acute Phase|Entry Criteria Not Met|1
330810|NCT00607919|1082869|P1|Acute Phase|Entry Criteria Not Met|1
330811|NCT00607919|1082868|P2|Acute Phase|Adverse Event|2
330812|NCT00607919|1082869|P1|Acute Phase|Adverse Event|9
330813|NCT00607880|1082927|P2|Overall Study|Unable to place port due to occlusion|0
330814|NCT00607880|1082928|P1|Overall Study|Unable to place port due to occlusion|1
330815|NCT00607789|1082978|P2|Overall Study|Withdrawal by Subject|0
330816|NCT00607789|1082979|P1|Overall Study|Withdrawal by Subject|1
330817|NCT00607789|1082978|P2|Overall Study|Lost to Follow-up|5
330818|NCT00607789|1082979|P1|Overall Study|Lost to Follow-up|0
330819|NCT00607789|1082978|P2|Overall Study|Inadequate adherence|0
330820|NCT00607789|1082979|P1|Overall Study|Inadequate adherence|3
330821|NCT00607789|1082978|P2|Overall Study|Lack of Efficacy|1
330822|NCT00607789|1082979|P1|Overall Study|Lack of Efficacy|0
330823|NCT00607789|1082978|P2|Overall Study|Adverse Event|0
330824|NCT00607789|1082979|P1|Overall Study|Adverse Event|3
330825|NCT00607724|1082994|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
330826|NCT00607724|1082995|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
330827|NCT00607724|1082996|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
330828|NCT00607724|1082997|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
330829|NCT00607724|1082998|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
330830|NCT00607724|1082999|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
330914|NCT00607087|1083261|P1|Overall Study|Other reason|1
330831|NCT00607724|1083000|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
330832|NCT00607724|1082994|P7|Stage 2: Expanded Cohort|Physician Decision|0
330833|NCT00607724|1082995|P6|Stage 2: Expanded Cohort|Physician Decision|1
330834|NCT00607724|1082996|P5|Stage 2: Expanded Cohort|Physician Decision|1
330835|NCT00607724|1082997|P4|Stage 2: Expanded Cohort|Physician Decision|0
330836|NCT00607724|1082998|P3|Stage 2: Expanded Cohort|Physician Decision|0
330837|NCT00607724|1082999|P2|Stage 2: Expanded Cohort|Physician Decision|0
330838|NCT00607724|1083000|P1|Stage 2: Expanded Cohort|Physician Decision|0
330839|NCT00607724|1082994|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
330840|NCT00607724|1082995|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
330841|NCT00607724|1082996|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
330842|NCT00607724|1082997|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
330843|NCT00607724|1082998|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
330844|NCT00607724|1082999|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
330845|NCT00607724|1083000|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
330846|NCT00607724|1082994|P7|Stage 2: Expanded Cohort|Adverse Event|1
330847|NCT00607724|1082995|P6|Stage 2: Expanded Cohort|Adverse Event|0
330848|NCT00607724|1082996|P5|Stage 2: Expanded Cohort|Adverse Event|0
330849|NCT00607724|1082997|P4|Stage 2: Expanded Cohort|Adverse Event|0
330850|NCT00607724|1082998|P3|Stage 2: Expanded Cohort|Adverse Event|0
330851|NCT00607724|1082999|P2|Stage 2: Expanded Cohort|Adverse Event|0
330852|NCT00607724|1083000|P1|Stage 2: Expanded Cohort|Adverse Event|0
330853|NCT00607724|1082994|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
330854|NCT00607724|1082995|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
330855|NCT00607724|1082996|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
330856|NCT00607724|1082997|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
330857|NCT00607724|1082998|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
330858|NCT00607724|1082999|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
330859|NCT00607724|1083000|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
330860|NCT00607386|1083141|P1|Overall Study|Physician Decision|1
330861|NCT00607373|1083156|P2|Follow-up Period|Withdrawal by Subject|3
330862|NCT00607373|1083157|P1|Follow-up Period|Withdrawal by Subject|1
330863|NCT00607373|1083156|P2|Follow-up Period|Protocol Violation|1
330864|NCT00607373|1083157|P1|Follow-up Period|Protocol Violation|0
330865|NCT00607373|1083156|P2|Follow-up Period|Not specified|1
330866|NCT00607373|1083157|P1|Follow-up Period|Not specified|0
330867|NCT00607373|1083156|P2|Treatment Period|Withdrawal by Subject|1
330868|NCT00607373|1083157|P1|Treatment Period|Withdrawal by Subject|0
330869|NCT00607373|1083156|P2|Treatment Period|Physician Decision|1
330870|NCT00607373|1083157|P1|Treatment Period|Physician Decision|0
330871|NCT00607373|1083156|P2|Treatment Period|Adverse Event|4
330872|NCT00607373|1083157|P1|Treatment Period|Adverse Event|0
330873|NCT00607087|1083259|P3|Period 3|Adverse Event|0
330874|NCT00607087|1083260|P2|Period 3|Adverse Event|1
330875|NCT00607087|1083261|P1|Period 3|Adverse Event|0
330876|NCT00607087|1083259|P3|Period 3|Withdrawal by Subject|0
330877|NCT00607087|1083260|P2|Period 3|Withdrawal by Subject|1
330878|NCT00607087|1083261|P1|Period 3|Withdrawal by Subject|2
330879|NCT00607087|1083259|P3|Period 2|Poor compliance to protocol|1
330880|NCT00607087|1083260|P2|Period 2|Poor compliance to protocol|0
330881|NCT00607087|1083261|P1|Period 2|Poor compliance to protocol|0
330882|NCT00607087|1083259|P3|Period 2|Adverse Event|3
330883|NCT00607087|1083260|P2|Period 2|Adverse Event|1
330884|NCT00607087|1083261|P1|Period 2|Adverse Event|0
330885|NCT00607087|1083259|P3|Period 2|Other reason|0
330886|NCT00607087|1083260|P2|Period 2|Other reason|1
330887|NCT00607087|1083261|P1|Period 2|Other reason|1
330888|NCT00607087|1083259|P3|Period 2|Withdrawal by Subject|1
330889|NCT00607087|1083260|P2|Period 2|Withdrawal by Subject|1
330890|NCT00607087|1083261|P1|Period 2|Withdrawal by Subject|0
330891|NCT00607087|1083259|P3|Period 1|Other reason|2
330892|NCT00607087|1083260|P2|Period 1|Other reason|4
330893|NCT00607087|1083261|P1|Period 1|Other reason|0
330894|NCT00607087|1083259|P3|Period 1|Lost to Follow-up|0
330895|NCT00607087|1083260|P2|Period 1|Lost to Follow-up|0
330896|NCT00607087|1083261|P1|Period 1|Lost to Follow-up|1
330897|NCT00607087|1083259|P3|Period 1|Poor compliance to protocol|0
330898|NCT00607087|1083260|P2|Period 1|Poor compliance to protocol|0
330899|NCT00607087|1083261|P1|Period 1|Poor compliance to protocol|1
330900|NCT00607087|1083259|P3|Period 1|Adverse Event|0
330901|NCT00607087|1083260|P2|Period 1|Adverse Event|0
330902|NCT00607087|1083261|P1|Period 1|Adverse Event|3
330903|NCT00607087|1083259|P3|Period 1|Withdrawal by Subject|3
330904|NCT00607087|1083260|P2|Period 1|Withdrawal by Subject|2
330905|NCT00607087|1083261|P1|Period 1|Withdrawal by Subject|7
330906|NCT00607087|1083259|P3|Overall Study|Lost to Follow-up|0
330907|NCT00607087|1083260|P2|Overall Study|Lost to Follow-up|0
330908|NCT00607087|1083261|P1|Overall Study|Lost to Follow-up|1
330909|NCT00607087|1083259|P3|Overall Study|Poor compliance to protocol|1
330910|NCT00607087|1083260|P2|Overall Study|Poor compliance to protocol|0
330911|NCT00607087|1083261|P1|Overall Study|Poor compliance to protocol|1
330912|NCT00607087|1083259|P3|Overall Study|Other reason|2
330913|NCT00607087|1083260|P2|Overall Study|Other reason|5
330915|NCT00607087|1083259|P3|Overall Study|Adverse Event|3
330916|NCT00607087|1083260|P2|Overall Study|Adverse Event|2
330917|NCT00607087|1083261|P1|Overall Study|Adverse Event|3
330918|NCT00607087|1083259|P3|Overall Study|Withdrawal by Subject|4
330919|NCT00607087|1083260|P2|Overall Study|Withdrawal by Subject|4
330920|NCT00607087|1083261|P1|Overall Study|Withdrawal by Subject|9
330921|NCT00607048|1083319|P6|Overall Study|Unspecified|1
330922|NCT00607048|1083320|P5|Overall Study|Unspecified|0
330923|NCT00607048|1083321|P4|Overall Study|Unspecified|0
330924|NCT00607048|1083322|P3|Overall Study|Unspecified|0
330925|NCT00607048|1083323|P2|Overall Study|Unspecified|1
330926|NCT00607048|1083324|P1|Overall Study|Unspecified|1
330927|NCT00607048|1083319|P6|Overall Study|Withdrawal by Subject|2
330928|NCT00607048|1083320|P5|Overall Study|Withdrawal by Subject|0
330929|NCT00607048|1083321|P4|Overall Study|Withdrawal by Subject|1
330930|NCT00607048|1083322|P3|Overall Study|Withdrawal by Subject|0
330931|NCT00607048|1083323|P2|Overall Study|Withdrawal by Subject|0
330932|NCT00607048|1083324|P1|Overall Study|Withdrawal by Subject|0
330933|NCT00607048|1083319|P6|Overall Study|Objective disease progression - relapse|2
330934|NCT00607048|1083320|P5|Overall Study|Objective disease progression - relapse|2
330935|NCT00607048|1083321|P4|Overall Study|Objective disease progression - relapse|2
330936|NCT00607048|1083322|P3|Overall Study|Objective disease progression - relapse|4
330937|NCT00607048|1083323|P2|Overall Study|Objective disease progression - relapse|2
330938|NCT00607048|1083324|P1|Overall Study|Objective disease progression - relapse|1
330939|NCT00607048|1083319|P6|Overall Study|Global deterioration of health|0
330940|NCT00607048|1083320|P5|Overall Study|Global deterioration of health|0
330941|NCT00607048|1083321|P4|Overall Study|Global deterioration of health|0
330942|NCT00607048|1083322|P3|Overall Study|Global deterioration of health|0
330943|NCT00607048|1083323|P2|Overall Study|Global deterioration of health|0
330944|NCT00607048|1083324|P1|Overall Study|Global deterioration of health|1
330945|NCT00607048|1083319|P6|Overall Study|Adverse Event|0
330946|NCT00607048|1083320|P5|Overall Study|Adverse Event|4
330947|NCT00607048|1083321|P4|Overall Study|Adverse Event|0
330948|NCT00607048|1083322|P3|Overall Study|Adverse Event|0
330949|NCT00607048|1083323|P2|Overall Study|Adverse Event|1
330950|NCT00607048|1083324|P1|Overall Study|Adverse Event|0
330951|NCT00606931|1083415|P1|Overall Study|Withdrawal by Subject|3
330952|NCT00606905|1083423|P2|Overall Study|Withdrew|5
330953|NCT00606905|1083424|P1|Overall Study|Withdrew|5
330954|NCT00606905|1083423|P2|Overall Study|Non-Index Pregnancy|4
330955|NCT00606905|1083424|P1|Overall Study|Non-Index Pregnancy|1
330956|NCT00606905|1083423|P2|Overall Study|No Pregnancy|6
330957|NCT00606905|1083424|P1|Overall Study|No Pregnancy|9
330958|NCT00606892|1083430|P2|First Intervention|Protocol Violation|4
330959|NCT00606892|1083431|P1|First Intervention|Protocol Violation|1
330960|NCT00606801|1083465|P2|Intervention|Protocol Violation|3
330961|NCT00606801|1083466|P1|Intervention|Protocol Violation|3
330962|NCT00606684|1083494|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
330963|NCT00606684|1083495|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
330964|NCT00606684|1083496|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
330965|NCT00606684|1083497|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
330966|NCT00606684|1083498|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
330967|NCT00606684|1083499|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
330968|NCT00606684|1083500|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
330969|NCT00606684|1083494|P7|Double-Blind Treatment Period|Physician Decision|2
330970|NCT00606684|1083495|P6|Double-Blind Treatment Period|Physician Decision|1
330971|NCT00606684|1083496|P5|Double-Blind Treatment Period|Physician Decision|3
330972|NCT00606684|1083497|P4|Double-Blind Treatment Period|Physician Decision|0
330973|NCT00606684|1083498|P3|Double-Blind Treatment Period|Physician Decision|1
330974|NCT00606684|1083499|P2|Double-Blind Treatment Period|Physician Decision|5
330975|NCT00606684|1083500|P1|Double-Blind Treatment Period|Physician Decision|0
330976|NCT00606684|1083494|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
330977|NCT00606684|1083495|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
330978|NCT00606684|1083496|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
330979|NCT00606684|1083497|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
330980|NCT00606684|1083498|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
330981|NCT00606684|1083499|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
330982|NCT00606684|1083500|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
330983|NCT00606684|1083494|P7|Double-Blind Treatment Period|Protocol Violation|4
330984|NCT00606684|1083495|P6|Double-Blind Treatment Period|Protocol Violation|3
330985|NCT00606684|1083496|P5|Double-Blind Treatment Period|Protocol Violation|0
330986|NCT00606684|1083497|P4|Double-Blind Treatment Period|Protocol Violation|3
330987|NCT00606684|1083498|P3|Double-Blind Treatment Period|Protocol Violation|5
330988|NCT00606684|1083499|P2|Double-Blind Treatment Period|Protocol Violation|5
330989|NCT00606684|1083500|P1|Double-Blind Treatment Period|Protocol Violation|0
330990|NCT00606684|1083494|P7|Double-Blind Treatment Period|Lack of Efficacy|0
330991|NCT00606684|1083495|P6|Double-Blind Treatment Period|Lack of Efficacy|0
330992|NCT00606684|1083496|P5|Double-Blind Treatment Period|Lack of Efficacy|1
330993|NCT00606684|1083497|P4|Double-Blind Treatment Period|Lack of Efficacy|0
330994|NCT00606684|1083498|P3|Double-Blind Treatment Period|Lack of Efficacy|0
330995|NCT00606684|1083499|P2|Double-Blind Treatment Period|Lack of Efficacy|1
330996|NCT00606684|1083500|P1|Double-Blind Treatment Period|Lack of Efficacy|0
330997|NCT00606684|1083494|P7|Double-Blind Treatment Period|Adverse Event|1
330998|NCT00606684|1083495|P6|Double-Blind Treatment Period|Adverse Event|0
330999|NCT00606684|1083496|P5|Double-Blind Treatment Period|Adverse Event|2
331000|NCT00606684|1083497|P4|Double-Blind Treatment Period|Adverse Event|4
331001|NCT00606684|1083498|P3|Double-Blind Treatment Period|Adverse Event|2
331002|NCT00606684|1083499|P2|Double-Blind Treatment Period|Adverse Event|3
331003|NCT00606684|1083500|P1|Double-Blind Treatment Period|Adverse Event|0
331004|NCT00606684|1083494|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
331005|NCT00606684|1083495|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
331006|NCT00606684|1083496|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
331007|NCT00606684|1083497|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
331008|NCT00606684|1083498|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
331009|NCT00606684|1083499|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
331010|NCT00606684|1083500|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
331011|NCT00606684|1083494|P7|2-week Single-Blind Run-in Period|Adverse Event|0
331012|NCT00606684|1083495|P6|2-week Single-Blind Run-in Period|Adverse Event|0
331013|NCT00606684|1083496|P5|2-week Single-Blind Run-in Period|Adverse Event|0
331014|NCT00606684|1083497|P4|2-week Single-Blind Run-in Period|Adverse Event|0
331015|NCT00606684|1083498|P3|2-week Single-Blind Run-in Period|Adverse Event|0
331016|NCT00606684|1083499|P2|2-week Single-Blind Run-in Period|Adverse Event|0
331017|NCT00606684|1083500|P1|2-week Single-Blind Run-in Period|Adverse Event|2
331018|NCT00606684|1083494|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
331019|NCT00606684|1083495|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
331020|NCT00606684|1083496|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
331021|NCT00606684|1083497|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
331022|NCT00606684|1083498|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
331023|NCT00606684|1083499|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
331024|NCT00606684|1083500|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
331025|NCT00606684|1083494|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
331026|NCT00606684|1083495|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
331027|NCT00606684|1083496|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
331028|NCT00606684|1083497|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
331029|NCT00606684|1083498|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
331030|NCT00606684|1083499|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
331031|NCT00606684|1083500|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
331032|NCT00606684|1083494|P7|2-week Single-Blind Run-in Period|Physician Decision|0
331033|NCT00606684|1083495|P6|2-week Single-Blind Run-in Period|Physician Decision|0
331034|NCT00606684|1083496|P5|2-week Single-Blind Run-in Period|Physician Decision|0
331035|NCT00606684|1083497|P4|2-week Single-Blind Run-in Period|Physician Decision|0
331036|NCT00606684|1083498|P3|2-week Single-Blind Run-in Period|Physician Decision|0
331037|NCT00606684|1083499|P2|2-week Single-Blind Run-in Period|Physician Decision|0
331038|NCT00606684|1083500|P1|2-week Single-Blind Run-in Period|Physician Decision|18
331039|NCT00606684|1083494|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
331040|NCT00606684|1083495|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
331041|NCT00606684|1083496|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
331042|NCT00606684|1083497|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
331043|NCT00606684|1083498|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
331044|NCT00606684|1083499|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
331045|NCT00606684|1083500|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
331046|NCT00606684|1083494|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
331047|NCT00606684|1083495|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
331048|NCT00606684|1083496|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
331049|NCT00606684|1083497|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
331050|NCT00606684|1083498|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
331051|NCT00606684|1083499|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
331052|NCT00606684|1083500|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
331053|NCT00606632|1083532|P1|Overall Study|Miscellaneous reasons|9
331054|NCT00606632|1083532|P1|Overall Study|Withdrawal by Subject|13
331055|NCT00606593|1083539|P10|Overall Study|Administrative/Other|0
331056|NCT00606593|1083540|P9|Overall Study|Administrative/Other|0
331057|NCT00606593|1083541|P8|Overall Study|Administrative/Other|0
331058|NCT00606593|1083542|P7|Overall Study|Administrative/Other|0
331059|NCT00606593|1083543|P6|Overall Study|Administrative/Other|0
331060|NCT00606593|1083544|P5|Overall Study|Administrative/Other|0
331061|NCT00606593|1083545|P4|Overall Study|Administrative/Other|0
331062|NCT00606593|1083546|P3|Overall Study|Administrative/Other|1
331063|NCT00606593|1083547|P2|Overall Study|Administrative/Other|0
331064|NCT00606593|1083548|P1|Overall Study|Administrative/Other|0
331065|NCT00606593|1083539|P10|Overall Study|Withdrawal of consent|0
331066|NCT00606593|1083540|P9|Overall Study|Withdrawal of consent|0
331067|NCT00606593|1083541|P8|Overall Study|Withdrawal of consent|0
331068|NCT00606593|1083542|P7|Overall Study|Withdrawal of consent|0
331069|NCT00606593|1083543|P6|Overall Study|Withdrawal of consent|0
331070|NCT00606593|1083544|P5|Overall Study|Withdrawal of consent|0
331071|NCT00606593|1083545|P4|Overall Study|Withdrawal of consent|0
331072|NCT00606593|1083546|P3|Overall Study|Withdrawal of consent|1
331073|NCT00606593|1083547|P2|Overall Study|Withdrawal of consent|0
331074|NCT00606593|1083548|P1|Overall Study|Withdrawal of consent|1
331075|NCT00606593|1083539|P10|Overall Study|Adverse Event|0
331076|NCT00606593|1083540|P9|Overall Study|Adverse Event|1
331077|NCT00606593|1083541|P8|Overall Study|Adverse Event|2
331078|NCT00606593|1083542|P7|Overall Study|Adverse Event|1
331079|NCT00606593|1083543|P6|Overall Study|Adverse Event|0
331080|NCT00606593|1083544|P5|Overall Study|Adverse Event|1
331081|NCT00606593|1083545|P4|Overall Study|Adverse Event|1
331082|NCT00606593|1083546|P3|Overall Study|Adverse Event|0
331083|NCT00606593|1083547|P2|Overall Study|Adverse Event|0
331084|NCT00606593|1083548|P1|Overall Study|Adverse Event|0
331085|NCT00606580|1083569|P3|Overall Study|Withdrawal by Subject|0
331086|NCT00606580|1083570|P2|Overall Study|Withdrawal by Subject|1
331087|NCT00606580|1083571|P1|Overall Study|Withdrawal by Subject|0
331088|NCT00606580|1083569|P3|Overall Study|Withdrawal by investigator|6
331089|NCT00606580|1083570|P2|Overall Study|Withdrawal by investigator|1
331090|NCT00606580|1083571|P1|Overall Study|Withdrawal by investigator|0
331091|NCT00606580|1083569|P3|Overall Study|Clinical failures|12
331092|NCT00606580|1083570|P2|Overall Study|Clinical failures|0
331093|NCT00606580|1083571|P1|Overall Study|Clinical failures|1
331094|NCT00606580|1083569|P3|Overall Study|Lost to Follow-up|4
331095|NCT00606580|1083570|P2|Overall Study|Lost to Follow-up|1
331096|NCT00606580|1083571|P1|Overall Study|Lost to Follow-up|1
331097|NCT00606502|1083627|P2|Treatment|Treatment ongoing at time of data cutoff|3
331098|NCT00606502|1083628|P1|Treatment|Treatment ongoing at time of data cutoff|0
331099|NCT00606502|1083627|P2|Randomization|Randomized but not treated|0
331100|NCT00606502|1083628|P1|Randomization|Randomized but not treated|3
331101|NCT00606320|1083649|P1|Overall Study|Progression to depressive phase|4
331102|NCT00606320|1083649|P1|Overall Study|Withdrawal by Subject|10
331103|NCT00606320|1083649|P1|Overall Study|Protocol Violation|8
331104|NCT00606320|1083649|P1|Overall Study|Physician Decision|7
331105|NCT00606320|1083649|P1|Overall Study|Lack of Efficacy|5
331106|NCT00606320|1083649|P1|Overall Study|Adverse Event|3
331107|NCT00606281|1083656|P2|Overall Study|Change of residence or other commitments|1
331108|NCT00606281|1083657|P1|Overall Study|Change of residence or other commitments|1
331109|NCT00606281|1083656|P2|Overall Study|Progression to depressive phase|1
331110|NCT00606281|1083657|P1|Overall Study|Progression to depressive phase|1
331111|NCT00606281|1083656|P2|Overall Study|Withdrawal by Subject|13
331112|NCT00606281|1083657|P1|Overall Study|Withdrawal by Subject|11
331113|NCT00606281|1083656|P2|Overall Study|Protocol Violation|3
331114|NCT00606281|1083657|P1|Overall Study|Protocol Violation|3
331115|NCT00606281|1083656|P2|Overall Study|Physician Decision|1
331116|NCT00606281|1083657|P1|Overall Study|Physician Decision|0
331117|NCT00606281|1083656|P2|Overall Study|Lack of Efficacy|35
331118|NCT00606281|1083657|P1|Overall Study|Lack of Efficacy|28
331119|NCT00606281|1083656|P2|Overall Study|Death|0
331120|NCT00606281|1083657|P1|Overall Study|Death|1
331121|NCT00606281|1083656|P2|Overall Study|Adverse Event|12
331122|NCT00606281|1083657|P1|Overall Study|Adverse Event|11
331123|NCT00606229|1083665|P1|Overall Study|change of residence or other commitments|2
331124|NCT00606229|1083665|P1|Overall Study|does not meet inclusion criterion 1-3|4
331125|NCT00606229|1083665|P1|Overall Study|Withdrawal by Subject|4
331126|NCT00606229|1083665|P1|Overall Study|Lack of Efficacy|1
331127|NCT00606229|1083665|P1|Overall Study|Adverse Event|11
331128|NCT00606177|1083672|P2|Overall Study|Change of residence or other commitments|1
331129|NCT00606177|1083673|P1|Overall Study|Change of residence or other commitments|1
331130|NCT00606177|1083672|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
331131|NCT00606177|1083673|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
331132|NCT00606177|1083672|P2|Overall Study|Progression to depressive phase|1
331133|NCT00606177|1083673|P1|Overall Study|Progression to depressive phase|6
331134|NCT00606177|1083672|P2|Overall Study|Withdrawal by Subject|6
331135|NCT00606177|1083673|P1|Overall Study|Withdrawal by Subject|5
331136|NCT00606177|1083672|P2|Overall Study|Protocol Violation|4
331137|NCT00606177|1083673|P1|Overall Study|Protocol Violation|1
331138|NCT00606177|1083672|P2|Overall Study|Physician Decision|0
331139|NCT00606177|1083673|P1|Overall Study|Physician Decision|1
331140|NCT00606177|1083672|P2|Overall Study|Lack of Efficacy|7
331141|NCT00606177|1083673|P1|Overall Study|Lack of Efficacy|3
331142|NCT00606177|1083672|P2|Overall Study|Adverse Event|5
331143|NCT00606177|1083673|P1|Overall Study|Adverse Event|9
331144|NCT00606086|1083700|P2|Overall Study|Randomized, not treated|2
331145|NCT00606086|1083701|P1|Overall Study|Randomized, not treated|1
331146|NCT00606086|1083700|P2|Overall Study|Non-compliance|1
331147|NCT00606086|1083701|P1|Overall Study|Non-compliance|0
331148|NCT00606086|1083700|P2|Overall Study|Withdrawal by Subject|3
331149|NCT00606086|1083701|P1|Overall Study|Withdrawal by Subject|5
331150|NCT00606086|1083700|P2|Overall Study|Protocol Violation|0
331151|NCT00606086|1083701|P1|Overall Study|Protocol Violation|1
331152|NCT00606086|1083700|P2|Overall Study|Lost to Follow-up|8
331153|NCT00606086|1083701|P1|Overall Study|Lost to Follow-up|4
331154|NCT00606086|1083700|P2|Overall Study|Adverse Event|1
331155|NCT00606086|1083701|P1|Overall Study|Adverse Event|1
331156|NCT00606034|1083707|P1|Overall Study|incarceration|1
331157|NCT00606021|1083715|P3|Maintenance Phase|Lost to Follow-up|2
331158|NCT00606021|1083716|P2|Maintenance Phase|Lost to Follow-up|5
331159|NCT00606021|1083717|P1|Maintenance Phase|Lost to Follow-up|0
331160|NCT00606021|1083715|P3|Maintenance Phase|Physician Decision|0
331161|NCT00606021|1083716|P2|Maintenance Phase|Physician Decision|1
331162|NCT00606021|1083717|P1|Maintenance Phase|Physician Decision|0
331163|NCT00606021|1083715|P3|Maintenance Phase|Death|15
331164|NCT00606021|1083716|P2|Maintenance Phase|Death|17
331165|NCT00606021|1083717|P1|Maintenance Phase|Death|0
331166|NCT00606021|1083715|P3|Induction Phase|Lost to Follow-up|0
331167|NCT00606021|1083716|P2|Induction Phase|Lost to Follow-up|0
331168|NCT00606021|1083717|P1|Induction Phase|Lost to Follow-up|10
331169|NCT00606021|1083715|P3|Induction Phase|Withdrawal by Subject|0
331170|NCT00606021|1083716|P2|Induction Phase|Withdrawal by Subject|0
331171|NCT00606021|1083717|P1|Induction Phase|Withdrawal by Subject|2
331172|NCT00606021|1083715|P3|Induction Phase|Physician Decision|0
331173|NCT00606021|1083716|P2|Induction Phase|Physician Decision|0
331174|NCT00606021|1083717|P1|Induction Phase|Physician Decision|2
331175|NCT00606021|1083715|P3|Induction Phase|Death|0
331176|NCT00606021|1083716|P2|Induction Phase|Death|0
331177|NCT00606021|1083717|P1|Induction Phase|Death|73
331178|NCT00606008|1083735|P1|Overall Study|Withdrawal by Subject|4
331179|NCT00606008|1083735|P1|Overall Study|Adverse Event|1
331180|NCT00605917|1083749|P1|Overall Study|Protocol Violation|79
331181|NCT00605865|1083801|P1|Overall Study|Protocol Violation|115
331182|NCT00605839|1083843|P3|Overall Study|Protocol Violation|0
331183|NCT00605839|1083844|P2|Overall Study|Protocol Violation|0
331184|NCT00605839|1083845|P1|Overall Study|Protocol Violation|1
331185|NCT00605813|1083853|P1|Overall Study|Protocol Violation|25
331186|NCT00605722|1083866|P1|Overall Study|Failure to return|1
331187|NCT00605722|1083866|P1|Overall Study|Insufficient therapeutic response|44
331188|NCT00605722|1083866|P1|Overall Study|Adverse Event|6
331189|NCT00605657|1083887|P1|Overall Study|Protocol Violation|1
331190|NCT00605657|1083887|P1|Overall Study|Adverse Event|1
331191|NCT00605540|1083892|P1|Overall Study|Lost to Follow-up|23
331192|NCT00605540|1083892|P1|Overall Study|Death|15
331193|NCT00605475|1083910|P10|Overall Study|Withdrawal by Subject|1
331194|NCT00605475|1083911|P9|Overall Study|Withdrawal by Subject|0
331195|NCT00605475|1083912|P8|Overall Study|Withdrawal by Subject|0
331196|NCT00605475|1083913|P7|Overall Study|Withdrawal by Subject|0
331197|NCT00605475|1083914|P6|Overall Study|Withdrawal by Subject|2
331198|NCT00605475|1083915|P5|Overall Study|Withdrawal by Subject|0
331199|NCT00605475|1083916|P4|Overall Study|Withdrawal by Subject|0
331200|NCT00605475|1083917|P3|Overall Study|Withdrawal by Subject|0
331201|NCT00605475|1083918|P2|Overall Study|Withdrawal by Subject|0
331202|NCT00605475|1083919|P1|Overall Study|Withdrawal by Subject|0
331203|NCT00605475|1083910|P10|Overall Study|Protocol Violation|0
331204|NCT00605475|1083911|P9|Overall Study|Protocol Violation|0
331205|NCT00605475|1083912|P8|Overall Study|Protocol Violation|0
331206|NCT00605475|1083913|P7|Overall Study|Protocol Violation|0
331207|NCT00605475|1083914|P6|Overall Study|Protocol Violation|0
331208|NCT00605475|1083915|P5|Overall Study|Protocol Violation|1
331209|NCT00605475|1083916|P4|Overall Study|Protocol Violation|0
331210|NCT00605475|1083917|P3|Overall Study|Protocol Violation|0
331211|NCT00605475|1083918|P2|Overall Study|Protocol Violation|0
331212|NCT00605475|1083919|P1|Overall Study|Protocol Violation|0
331213|NCT00605475|1083910|P10|Overall Study|Lost to Follow-up|1
331214|NCT00605475|1083911|P9|Overall Study|Lost to Follow-up|1
331215|NCT00605475|1083912|P8|Overall Study|Lost to Follow-up|0
331216|NCT00605475|1083913|P7|Overall Study|Lost to Follow-up|0
331217|NCT00605475|1083914|P6|Overall Study|Lost to Follow-up|0
331218|NCT00605475|1083915|P5|Overall Study|Lost to Follow-up|0
331219|NCT00605475|1083916|P4|Overall Study|Lost to Follow-up|0
331220|NCT00605475|1083917|P3|Overall Study|Lost to Follow-up|0
331221|NCT00605475|1083918|P2|Overall Study|Lost to Follow-up|0
331222|NCT00605475|1083919|P1|Overall Study|Lost to Follow-up|0
331223|NCT00605475|1083910|P10|Overall Study|Administrative problems|0
331224|NCT00605475|1083911|P9|Overall Study|Administrative problems|0
331225|NCT00605475|1083912|P8|Overall Study|Administrative problems|0
331226|NCT00605475|1083913|P7|Overall Study|Administrative problems|1
331227|NCT00605475|1083914|P6|Overall Study|Administrative problems|0
331228|NCT00605475|1083915|P5|Overall Study|Administrative problems|0
331229|NCT00605475|1083916|P4|Overall Study|Administrative problems|0
331230|NCT00605475|1083917|P3|Overall Study|Administrative problems|0
331231|NCT00605475|1083918|P2|Overall Study|Administrative problems|0
331232|NCT00605475|1083919|P1|Overall Study|Administrative problems|0
331233|NCT00605475|1083910|P10|Overall Study|Abnormal Laboratory Values|0
331234|NCT00605475|1083911|P9|Overall Study|Abnormal Laboratory Values|1
331235|NCT00605475|1083912|P8|Overall Study|Abnormal Laboratory Values|0
331236|NCT00605475|1083913|P7|Overall Study|Abnormal Laboratory Values|0
331237|NCT00605475|1083914|P6|Overall Study|Abnormal Laboratory Values|0
331238|NCT00605475|1083915|P5|Overall Study|Abnormal Laboratory Values|0
331239|NCT00605475|1083916|P4|Overall Study|Abnormal Laboratory Values|0
331240|NCT00605475|1083917|P3|Overall Study|Abnormal Laboratory Values|0
331241|NCT00605475|1083918|P2|Overall Study|Abnormal Laboratory Values|0
331242|NCT00605475|1083919|P1|Overall Study|Abnormal Laboratory Values|0
331243|NCT00605345|1084096|P2|Overall Study|Protocol Violation|2
331244|NCT00605345|1084097|P1|Overall Study|Protocol Violation|0
331245|NCT00605345|1084096|P2|Overall Study|Adverse Event|1
331246|NCT00605345|1084097|P1|Overall Study|Adverse Event|0
331247|NCT00605345|1084096|P2|Overall Study|Withdrawal by Subject|0
331248|NCT00605345|1084097|P1|Overall Study|Withdrawal by Subject|1
331249|NCT00605306|1084115|P2|Overall Study|Adverse Event|1
331250|NCT00605306|1084116|P1|Overall Study|Adverse Event|0
331251|NCT00605293|1084130|P2|Overall Study|Principal Investigator Decision|1
331252|NCT00605293|1084131|P1|Overall Study|Principal Investigator Decision|0
331253|NCT00605293|1084130|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
331254|NCT00605293|1084131|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
331255|NCT00605293|1084130|P2|Overall Study|Incorrect Epoetin Beta Administration|0
331256|NCT00605293|1084131|P1|Overall Study|Incorrect Epoetin Beta Administration|1
331257|NCT00605293|1084130|P2|Overall Study|Renal Transplantation|1
331258|NCT00605293|1084131|P1|Overall Study|Renal Transplantation|3
331259|NCT00605293|1084130|P2|Overall Study|Blood Transfusion|1
331260|NCT00605293|1084131|P1|Overall Study|Blood Transfusion|7
331261|NCT00605293|1084130|P2|Overall Study|Holidays Dialysis Out|0
331262|NCT00605293|1084131|P1|Overall Study|Holidays Dialysis Out|1
331263|NCT00605293|1084130|P2|Overall Study|Adverse Event|0
331264|NCT00605293|1084131|P1|Overall Study|Adverse Event|1
331265|NCT00605293|1084130|P2|Overall Study|Insufficient Therapeutic Response|0
331266|NCT00605293|1084131|P1|Overall Study|Insufficient Therapeutic Response|2
331267|NCT00605293|1084130|P2|Overall Study|Death|1
331268|NCT00605293|1084131|P1|Overall Study|Death|2
331269|NCT00605280|1084151|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
331270|NCT00605280|1084152|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
331271|NCT00605280|1084153|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
331272|NCT00605280|1084154|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
331273|NCT00605280|1084151|P4|Year 3 Extension|Unspecified|0
331274|NCT00605280|1084152|P3|Year 3 Extension|Unspecified|0
331275|NCT00605280|1084153|P2|Year 3 Extension|Unspecified|0
331276|NCT00605280|1084154|P1|Year 3 Extension|Unspecified|2
331277|NCT00605280|1084151|P4|Year 3 Extension|Withdrawal by Subject|5
331278|NCT00605280|1084152|P3|Year 3 Extension|Withdrawal by Subject|0
331279|NCT00605280|1084153|P2|Year 3 Extension|Withdrawal by Subject|0
331280|NCT00605280|1084154|P1|Year 3 Extension|Withdrawal by Subject|2
331281|NCT00605280|1084151|P4|Year 3 Extension|Physician Decision|2
331282|NCT00605280|1084152|P3|Year 3 Extension|Physician Decision|0
331283|NCT00605280|1084153|P2|Year 3 Extension|Physician Decision|0
331284|NCT00605280|1084154|P1|Year 3 Extension|Physician Decision|0
331285|NCT00605280|1084151|P4|Year 3 Extension|Adverse Event|2
331286|NCT00605280|1084152|P3|Year 3 Extension|Adverse Event|0
331287|NCT00605280|1084153|P2|Year 3 Extension|Adverse Event|0
331288|NCT00605280|1084154|P1|Year 3 Extension|Adverse Event|2
331289|NCT00605280|1084151|P4|Year 2|Lost to Follow-up or Patient non-comply|2
331290|NCT00605280|1084152|P3|Year 2|Lost to Follow-up or Patient non-comply|0
331291|NCT00605280|1084153|P2|Year 2|Lost to Follow-up or Patient non-comply|0
331292|NCT00605280|1084154|P1|Year 2|Lost to Follow-up or Patient non-comply|4
331293|NCT00605280|1084151|P4|Year 2|Unspecified|1
331294|NCT00605280|1084152|P3|Year 2|Unspecified|0
331295|NCT00605280|1084153|P2|Year 2|Unspecified|0
331296|NCT00605280|1084154|P1|Year 2|Unspecified|1
331297|NCT00605280|1084151|P4|Year 2|Withdrawal by Subject|4
331298|NCT00605280|1084152|P3|Year 2|Withdrawal by Subject|0
331299|NCT00605280|1084153|P2|Year 2|Withdrawal by Subject|0
331300|NCT00605280|1084154|P1|Year 2|Withdrawal by Subject|4
331301|NCT00605280|1084151|P4|Year 2|Physician Decision|11
331302|NCT00605280|1084152|P3|Year 2|Physician Decision|4
331303|NCT00605280|1084153|P2|Year 2|Physician Decision|6
331304|NCT00605280|1084154|P1|Year 2|Physician Decision|11
331305|NCT00605280|1084151|P4|Year 2|Adverse Event|4
331306|NCT00605280|1084152|P3|Year 2|Adverse Event|2
331307|NCT00605280|1084153|P2|Year 2|Adverse Event|0
331308|NCT00605280|1084154|P1|Year 2|Adverse Event|4
331309|NCT00605280|1084151|P4|Year 1|Lost to Follow-up or Patient non-comply|2
331310|NCT00605280|1084152|P3|Year 1|Lost to Follow-up or Patient non-comply|0
331311|NCT00605280|1084153|P2|Year 1|Lost to Follow-up or Patient non-comply|1
331312|NCT00605280|1084154|P1|Year 1|Lost to Follow-up or Patient non-comply|5
331313|NCT00605280|1084151|P4|Year 1|Unspecified|1
331314|NCT00605280|1084152|P3|Year 1|Unspecified|0
331315|NCT00605280|1084153|P2|Year 1|Unspecified|1
331316|NCT00605280|1084154|P1|Year 1|Unspecified|2
331317|NCT00605280|1084151|P4|Year 1|Withdrawal by Subject|4
331318|NCT00605280|1084152|P3|Year 1|Withdrawal by Subject|0
331319|NCT00605280|1084153|P2|Year 1|Withdrawal by Subject|4
331320|NCT00605280|1084154|P1|Year 1|Withdrawal by Subject|2
331321|NCT00605280|1084151|P4|Year 1|Physician Decision|6
331322|NCT00605280|1084152|P3|Year 1|Physician Decision|0
331323|NCT00605280|1084153|P2|Year 1|Physician Decision|4
331324|NCT00605280|1084154|P1|Year 1|Physician Decision|7
331325|NCT00605280|1084151|P4|Year 1|Adverse Event|5
331326|NCT00605280|1084152|P3|Year 1|Adverse Event|1
331327|NCT00605280|1084153|P2|Year 1|Adverse Event|1
331328|NCT00605280|1084154|P1|Year 1|Adverse Event|3
331329|NCT00605280|1084151|P4|Year 1|Protocol Violation|1
331330|NCT00605280|1084152|P3|Year 1|Protocol Violation|0
331331|NCT00605280|1084153|P2|Year 1|Protocol Violation|0
331332|NCT00605280|1084154|P1|Year 1|Protocol Violation|0
331333|NCT00605267|1084188|P2|Overall Study|Withdrawal by Subject|3
331334|NCT00605267|1084189|P1|Overall Study|Withdrawal by Subject|2
331335|NCT00605267|1084188|P2|Overall Study|Lack of Efficacy|5
331336|NCT00605267|1084189|P1|Overall Study|Lack of Efficacy|1
331337|NCT00605267|1084188|P2|Overall Study|Adverse Event|1
331338|NCT00605267|1084189|P1|Overall Study|Adverse Event|0
331339|NCT00605176|1084237|P3|Overall Study|Other (not due to AE)|0
331340|NCT00605176|1084238|P2|Overall Study|Other (not due to AE)|1
331341|NCT00605176|1084239|P1|Overall Study|Other (not due to AE)|1
331342|NCT00605176|1084237|P3|Overall Study|Use of concomitant therapy|1
331343|NCT00605176|1084238|P2|Overall Study|Use of concomitant therapy|0
331344|NCT00605176|1084239|P1|Overall Study|Use of concomitant therapy|1
331345|NCT00605176|1084237|P3|Overall Study|Non-complicance with study procedures|0
331346|NCT00605176|1084238|P2|Overall Study|Non-complicance with study procedures|0
331347|NCT00605176|1084239|P1|Overall Study|Non-complicance with study procedures|1
331348|NCT00605176|1084237|P3|Overall Study|Lost to Follow-up|1
331349|NCT00605176|1084238|P2|Overall Study|Lost to Follow-up|2
331350|NCT00605176|1084239|P1|Overall Study|Lost to Follow-up|2
331351|NCT00605176|1084237|P3|Overall Study|Withdrawal by Subject|4
331352|NCT00605176|1084238|P2|Overall Study|Withdrawal by Subject|2
331353|NCT00605176|1084239|P1|Overall Study|Withdrawal by Subject|4
331354|NCT00605176|1084237|P3|Overall Study|Adverse Event|3
331355|NCT00605176|1084238|P2|Overall Study|Adverse Event|1
331356|NCT00605176|1084239|P1|Overall Study|Adverse Event|2
331357|NCT00605085|1084262|P2|Overall Study|administrative reasons|8
331358|NCT00605085|1084263|P1|Overall Study|administrative reasons|18
331359|NCT00605085|1084262|P2|Overall Study|Lost to Follow-up|5
331360|NCT00605085|1084263|P1|Overall Study|Lost to Follow-up|10
331361|NCT00605085|1084262|P2|Overall Study|Protocol Violation|2
331362|NCT00605085|1084263|P1|Overall Study|Protocol Violation|3
331363|NCT00605085|1084262|P2|Overall Study|Pregnancy|0
331364|NCT00605085|1084263|P1|Overall Study|Pregnancy|2
331365|NCT00605085|1084262|P2|Overall Study|Adverse Event|5
331366|NCT00605085|1084263|P1|Overall Study|Adverse Event|9
331367|NCT00605085|1084262|P2|Overall Study|Withdrawal by Subject|5
331368|NCT00605085|1084263|P1|Overall Study|Withdrawal by Subject|8
331369|NCT00605033|1084296|P2|Overall Study|Protocol Violation|1
331370|NCT00605033|1084297|P1|Overall Study|Protocol Violation|1
331371|NCT00605033|1084296|P2|Overall Study|Withdrawal by Subject|4
331372|NCT00605033|1084297|P1|Overall Study|Withdrawal by Subject|3
331373|NCT00605033|1084296|P2|Overall Study|Lost to Follow-up|1
331374|NCT00605033|1084297|P1|Overall Study|Lost to Follow-up|1
331375|NCT00605033|1084296|P2|Overall Study|Adverse Event|2
331376|NCT00605033|1084297|P1|Overall Study|Adverse Event|2
331377|NCT00604786|1084355|P2|Overall Study|Lost to Follow-up|0
331378|NCT00604786|1084356|P1|Overall Study|Lost to Follow-up|2
331379|NCT00604721|1084362|P1|Overall Study|Withdrawal by Subject|1
331380|NCT00604721|1084362|P1|Overall Study|Physician Decision|1
331381|NCT00604708|1084370|P2|Overall Study|Adverse Event|6
331382|NCT00604708|1084371|P1|Overall Study|Adverse Event|6
331383|NCT00604708|1084370|P2|Overall Study|administrative reasons|11
331384|NCT00604708|1084371|P1|Overall Study|administrative reasons|9
331385|NCT00604708|1084370|P2|Overall Study|Lost to Follow-up|5
331386|NCT00604708|1084371|P1|Overall Study|Lost to Follow-up|5
331387|NCT00604708|1084370|P2|Overall Study|Protocol Violation|8
331388|NCT00604708|1084371|P1|Overall Study|Protocol Violation|2
331389|NCT00604708|1084370|P2|Overall Study|Withdrawal by Subject|10
331390|NCT00604708|1084371|P1|Overall Study|Withdrawal by Subject|9
331391|NCT00604695|1084381|P2|Overall Study|Did not receive first bolus.|4
331392|NCT00604695|1084382|P1|Overall Study|Did not receive first bolus.|0
331393|NCT00604669|1084404|P1|Overall Study|lack of information in chart|7
331394|NCT00604565|1084410|P2|Overall Study|Study terminated|3
331395|NCT00604565|1084411|P1|Overall Study|Study terminated|0
331396|NCT00604500|1084428|P1|Overall Study|Did not meet protocol eligibility|1
331397|NCT00604500|1084428|P1|Overall Study|Administrative|1
331398|NCT00604500|1084428|P1|Overall Study|Withdrawal by Subject|4
331399|NCT00604500|1084428|P1|Overall Study|Treatment Failure|1
331400|NCT00604500|1084428|P1|Overall Study|Protocol Violation|2
331401|NCT00604500|1084428|P1|Overall Study|Adverse Event|2
331402|NCT00604383|1084442|P2|Overall Study|Physician Decision|3
331403|NCT00604383|1084443|P1|Overall Study|Physician Decision|0
331404|NCT00604383|1084442|P2|Overall Study|Adverse Event|9
331405|NCT00604383|1084443|P1|Overall Study|Adverse Event|16
331406|NCT00604383|1084442|P2|Overall Study|Death|22
331407|NCT00604383|1084443|P1|Overall Study|Death|14
331408|NCT00604383|1084442|P2|Overall Study|Lost to Follow-up|19
331409|NCT00604383|1084443|P1|Overall Study|Lost to Follow-up|24
331410|NCT00604383|1084442|P2|Overall Study|Withdrawal by Subject|31
331411|NCT00604383|1084443|P1|Overall Study|Withdrawal by Subject|33
331412|NCT00604279|1084459|P2|Overall Study|unspecified|4
331413|NCT00604279|1084460|P1|Overall Study|unspecified|8
331414|NCT00604279|1084459|P2|Overall Study|Adverse Event|5
331415|NCT00604279|1084460|P1|Overall Study|Adverse Event|4
331416|NCT00604279|1084459|P2|Overall Study|Withdrawal by Subject|5
331417|NCT00604279|1084460|P1|Overall Study|Withdrawal by Subject|16
331418|NCT00604279|1084459|P2|Overall Study|Protocol Violation|1
331419|NCT00604279|1084460|P1|Overall Study|Protocol Violation|3
331420|NCT00604279|1084459|P2|Overall Study|Pregnancy|0
331421|NCT00604279|1084460|P1|Overall Study|Pregnancy|2
331422|NCT00604279|1084459|P2|Overall Study|Lost to Follow-up|14
331423|NCT00604279|1084460|P1|Overall Study|Lost to Follow-up|9
331424|NCT00604279|1084459|P2|Overall Study|Lack of Efficacy|9
331425|NCT00604279|1084460|P1|Overall Study|Lack of Efficacy|22
331426|NCT00604214|1084476|P2|Day 91 to Day 180|Withdrawal by Subject|1
331427|NCT00604214|1084477|P1|Day 91 to Day 180|Withdrawal by Subject|1
331428|NCT00604214|1084476|P2|Day 91 to Day 180|Lost to Follow-up|8
331429|NCT00604214|1084477|P1|Day 91 to Day 180|Lost to Follow-up|6
331430|NCT00604214|1084476|P2|Day 91 to Day 180|Death|23
331431|NCT00604214|1084477|P1|Day 91 to Day 180|Death|19
331432|NCT00604214|1084476|P2|Day 29 to Day 90|Withdrawal by Subject|6
331433|NCT00604214|1084477|P1|Day 29 to Day 90|Withdrawal by Subject|0
331434|NCT00604214|1084476|P2|Day 29 to Day 90|Lost to Follow-up|6
331435|NCT00604214|1084477|P1|Day 29 to Day 90|Lost to Follow-up|4
331436|NCT00604214|1084476|P2|Day 29 to Day 90|Death|67
331437|NCT00604214|1084477|P1|Day 29 to Day 90|Death|64
331438|NCT00604214|1084476|P2|Baseline to Day 28|Withdrawal by Subject|7
331439|NCT00604214|1084477|P1|Baseline to Day 28|Withdrawal by Subject|3
331440|NCT00604214|1084476|P2|Baseline to Day 28|Lost to Follow-up|4
331441|NCT00604214|1084477|P1|Baseline to Day 28|Lost to Follow-up|2
331442|NCT00604214|1084476|P2|Baseline to Day 28|Death|202
331443|NCT00604214|1084477|P1|Baseline to Day 28|Death|223
331444|NCT00604188|1084509|P2|Overall Study|Did not receive study drug|1
331445|NCT00604188|1084510|P1|Overall Study|Did not receive study drug|0
331446|NCT00604188|1084509|P2|Overall Study|Non-compliance with protocol|4
331447|NCT00604188|1084510|P1|Overall Study|Non-compliance with protocol|4
331448|NCT00604188|1084509|P2|Overall Study|Withdrawal by Subject|1
331449|NCT00604188|1084510|P1|Overall Study|Withdrawal by Subject|5
331450|NCT00604188|1084509|P2|Overall Study|Lost to Follow-up|15
331451|NCT00604188|1084510|P1|Overall Study|Lost to Follow-up|17
331452|NCT00604188|1084509|P2|Overall Study|Adverse Event|4
331453|NCT00604188|1084510|P1|Overall Study|Adverse Event|1
331454|NCT00604175|1084533|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
331455|NCT00604175|1084534|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
331456|NCT00604175|1084535|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
331457|NCT00604175|1084533|P3|Week 29 Through Week 72|Site closure|0
331458|NCT00604175|1084534|P2|Week 29 Through Week 72|Site closure|1
331459|NCT00604175|1084535|P1|Week 29 Through Week 72|Site closure|0
331460|NCT00604175|1084533|P3|Week 29 Through Week 72|Lost to Follow-up|2
331461|NCT00604175|1084534|P2|Week 29 Through Week 72|Lost to Follow-up|6
331462|NCT00604175|1084535|P1|Week 29 Through Week 72|Lost to Follow-up|12
331463|NCT00604175|1084533|P3|Week 29 Through Week 72|Death|1
331464|NCT00604175|1084534|P2|Week 29 Through Week 72|Death|0
331465|NCT00604175|1084535|P1|Week 29 Through Week 72|Death|0
331466|NCT00604175|1084533|P3|Entry Through Week 28|Did not start intervention|1
331467|NCT00604175|1084534|P2|Entry Through Week 28|Did not start intervention|0
331468|NCT00604175|1084535|P1|Entry Through Week 28|Did not start intervention|2
331469|NCT00604175|1084533|P3|Entry Through Week 28|Ineligible|0
331470|NCT00604175|1084534|P2|Entry Through Week 28|Ineligible|0
331471|NCT00604175|1084535|P1|Entry Through Week 28|Ineligible|1
331472|NCT00604175|1084533|P3|Entry Through Week 28|Lost to Follow-up|0
331473|NCT00604175|1084534|P2|Entry Through Week 28|Lost to Follow-up|3
331474|NCT00604175|1084535|P1|Entry Through Week 28|Lost to Follow-up|4
331475|NCT00604175|1084533|P3|Entry Through Week 28|Withdrawal by Subject|0
331476|NCT00604175|1084534|P2|Entry Through Week 28|Withdrawal by Subject|0
331477|NCT00604175|1084535|P1|Entry Through Week 28|Withdrawal by Subject|1
331478|NCT00604175|1084533|P3|Entry Through Week 28|Death|0
331479|NCT00604175|1084534|P2|Entry Through Week 28|Death|0
331480|NCT00604175|1084535|P1|Entry Through Week 28|Death|2
331481|NCT00604162|1084588|P1|Overall Study|Withdrawal by Subject|1
331482|NCT00604162|1084588|P1|Overall Study|Physician Decision|3
331483|NCT00603915|1084630|P1|Overall Study|Physician Decision|1
331484|NCT00603837|1084660|P2|Overall Study|Physician Decision|0
331485|NCT00603837|1084661|P1|Overall Study|Physician Decision|3
331486|NCT00603798|1084670|P3|Overall Study|Not due to AE|4
331487|NCT00603798|1084671|P2|Overall Study|Not due to AE|1
331488|NCT00603798|1084672|P1|Overall Study|Not due to AE|1
331489|NCT00603798|1084670|P3|Overall Study|Non-compliance with study procedures|0
331490|NCT00603798|1084671|P2|Overall Study|Non-compliance with study procedures|1
331491|NCT00603798|1084672|P1|Overall Study|Non-compliance with study procedures|0
331492|NCT00603798|1084670|P3|Overall Study|Lost to Follow-up|1
331493|NCT00603798|1084671|P2|Overall Study|Lost to Follow-up|0
331494|NCT00603798|1084672|P1|Overall Study|Lost to Follow-up|1
331495|NCT00603798|1084670|P3|Overall Study|Withdrawal by Subject|4
331496|NCT00603798|1084671|P2|Overall Study|Withdrawal by Subject|3
331497|NCT00603798|1084672|P1|Overall Study|Withdrawal by Subject|4
331498|NCT00603798|1084670|P3|Overall Study|Adverse Event|1
331499|NCT00603798|1084671|P2|Overall Study|Adverse Event|2
331500|NCT00603798|1084672|P1|Overall Study|Adverse Event|4
331501|NCT00603746|1084695|P6|Overall Study|Withdrawal by Subject|1
331502|NCT00603746|1084696|P5|Overall Study|Withdrawal by Subject|3
331503|NCT00603746|1084697|P4|Overall Study|Withdrawal by Subject|1
331504|NCT00603746|1084698|P3|Overall Study|Withdrawal by Subject|0
331505|NCT00603746|1084699|P2|Overall Study|Withdrawal by Subject|0
331506|NCT00603746|1084700|P1|Overall Study|Withdrawal by Subject|1
331507|NCT00603746|1084695|P6|Overall Study|Physician Decision|0
331508|NCT00603746|1084696|P5|Overall Study|Physician Decision|1
331509|NCT00603746|1084697|P4|Overall Study|Physician Decision|0
331510|NCT00603746|1084698|P3|Overall Study|Physician Decision|0
331511|NCT00603746|1084699|P2|Overall Study|Physician Decision|0
331512|NCT00603746|1084700|P1|Overall Study|Physician Decision|1
331513|NCT00603746|1084695|P6|Overall Study|Lost to Follow-up|0
331514|NCT00603746|1084696|P5|Overall Study|Lost to Follow-up|0
331515|NCT00603746|1084697|P4|Overall Study|Lost to Follow-up|0
331516|NCT00603746|1084698|P3|Overall Study|Lost to Follow-up|1
331517|NCT00603746|1084699|P2|Overall Study|Lost to Follow-up|1
331518|NCT00603746|1084700|P1|Overall Study|Lost to Follow-up|0
331519|NCT00603746|1084695|P6|Overall Study|Protocol Violation|0
331520|NCT00603746|1084696|P5|Overall Study|Protocol Violation|1
331521|NCT00603746|1084697|P4|Overall Study|Protocol Violation|0
331522|NCT00603746|1084698|P3|Overall Study|Protocol Violation|1
331523|NCT00603746|1084699|P2|Overall Study|Protocol Violation|3
331524|NCT00603746|1084700|P1|Overall Study|Protocol Violation|0
331525|NCT00603746|1084695|P6|Overall Study|Lack of Efficacy|8
331526|NCT00603746|1084696|P5|Overall Study|Lack of Efficacy|12
331527|NCT00603746|1084697|P4|Overall Study|Lack of Efficacy|11
331528|NCT00603746|1084698|P3|Overall Study|Lack of Efficacy|6
331529|NCT00603746|1084699|P2|Overall Study|Lack of Efficacy|11
331530|NCT00603746|1084700|P1|Overall Study|Lack of Efficacy|34
331531|NCT00603746|1084695|P6|Overall Study|Adverse Event|4
331532|NCT00603746|1084696|P5|Overall Study|Adverse Event|0
331533|NCT00603746|1084697|P4|Overall Study|Adverse Event|1
331534|NCT00603746|1084698|P3|Overall Study|Adverse Event|0
331535|NCT00603746|1084699|P2|Overall Study|Adverse Event|3
331536|NCT00603746|1084700|P1|Overall Study|Adverse Event|2
331537|NCT00603733|1084848|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
331538|NCT00603733|1084849|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
331539|NCT00603733|1084848|P2|Maintenance Phase ITT|Physician Decision|1
331540|NCT00603733|1084849|P1|Maintenance Phase ITT|Physician Decision|0
331541|NCT00603733|1084848|P2|Maintenance Phase ITT|Lack of Efficacy|2
331542|NCT00603733|1084849|P1|Maintenance Phase ITT|Lack of Efficacy|2
331543|NCT00603733|1084848|P2|Maintenance Phase ITT|Lost to Follow-up|1
331544|NCT00603733|1084849|P1|Maintenance Phase ITT|Lost to Follow-up|0
331545|NCT00603733|1084848|P2|Maintenance Phase ITT|Protocol Violation|1
331546|NCT00603733|1084849|P1|Maintenance Phase ITT|Protocol Violation|1
331547|NCT00603733|1084848|P2|Maintenance Phase ITT|Withdrawal by Subject|0
331548|NCT00603733|1084849|P1|Maintenance Phase ITT|Withdrawal by Subject|1
331549|NCT00603733|1084848|P2|Maintenance Phase ITT|Adverse Event|6
331550|NCT00603733|1084849|P1|Maintenance Phase ITT|Adverse Event|3
331551|NCT00603733|1084848|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
331552|NCT00603733|1084849|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
331553|NCT00603733|1084848|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
331554|NCT00603733|1084849|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
331555|NCT00603733|1084848|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
331556|NCT00603733|1084849|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
331557|NCT00603733|1084848|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
331558|NCT00603733|1084849|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
331559|NCT00603733|1084848|P2|Run-In Phase - 4 Weeks|Adverse Event|1
331560|NCT00603733|1084849|P1|Run-In Phase - 4 Weeks|Adverse Event|2
331561|NCT00603733|1084848|P2|Active Phase ITT|Subject moved, site closed|1
331562|NCT00603733|1084849|P1|Active Phase ITT|Subject moved, site closed|1
331563|NCT00603733|1084848|P2|Active Phase ITT|Lack of Efficacy|2
331564|NCT00603733|1084849|P1|Active Phase ITT|Lack of Efficacy|1
331565|NCT00603733|1084848|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
331566|NCT00603733|1084849|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
331567|NCT00603733|1084848|P2|Active Phase ITT|Lost to Follow-up|1
331568|NCT00603733|1084849|P1|Active Phase ITT|Lost to Follow-up|0
331569|NCT00603733|1084848|P2|Active Phase ITT|Withdrawal by Subject|3
331570|NCT00603733|1084849|P1|Active Phase ITT|Withdrawal by Subject|0
331571|NCT00603733|1084848|P2|Active Phase ITT|Adverse Event|7
331572|NCT00603733|1084849|P1|Active Phase ITT|Adverse Event|8
331573|NCT00603590|1084878|P2|Overall Study|Cardiovascular event|1
331574|NCT00603590|1084879|P1|Overall Study|Cardiovascular event|0
331575|NCT00603590|1084878|P2|Overall Study|Lost to Follow-up|4
331576|NCT00603590|1084879|P1|Overall Study|Lost to Follow-up|8
331577|NCT00603590|1084878|P2|Overall Study|Adverse Event|0
331578|NCT00603590|1084879|P1|Overall Study|Adverse Event|2
331579|NCT00603590|1084878|P2|Overall Study|Patient discontinued study drug|15
331580|NCT00603590|1084879|P1|Overall Study|Patient discontinued study drug|22
331581|NCT00603590|1084878|P2|Overall Study|Refused blood test|1
331582|NCT00603590|1084879|P1|Overall Study|Refused blood test|5
331583|NCT00603590|1084878|P2|Overall Study|Did not attend study clinic|30
331584|NCT00603590|1084879|P1|Overall Study|Did not attend study clinic|39
331585|NCT00603538|1084903|P3|Overall Study|Objective progression or relapse|0
331586|NCT00603538|1084904|P2|Overall Study|Objective progression or relapse|0
331587|NCT00603538|1084905|P1|Overall Study|Objective progression or relapse|3
331588|NCT00603538|1084903|P3|Overall Study|Adverse Event|2
331589|NCT00603538|1084904|P2|Overall Study|Adverse Event|4
331590|NCT00603538|1084905|P1|Overall Study|Adverse Event|0
331591|NCT00603525|1084945|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
331592|NCT00603525|1084946|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
331593|NCT00603525|1084947|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
331594|NCT00603525|1084945|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
331595|NCT00603525|1084946|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
331596|NCT00603525|1084947|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
331597|NCT00603525|1084945|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
331598|NCT00603525|1084946|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
331599|NCT00603525|1084947|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
331600|NCT00603525|1084945|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
331601|NCT00603525|1084946|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
331602|NCT00603525|1084947|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
331603|NCT00603525|1084945|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
331604|NCT00603525|1084946|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
331605|NCT00603525|1084947|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
331606|NCT00603525|1084945|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
331607|NCT00603525|1084946|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
331608|NCT00603525|1084947|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
331609|NCT00603525|1084945|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
331610|NCT00603525|1084946|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
331611|NCT00603525|1084947|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
331612|NCT00603525|1084945|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
331613|NCT00603525|1084946|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
331614|NCT00603525|1084947|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
331615|NCT00603525|1084945|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
331616|NCT00603525|1084946|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
331617|NCT00603525|1084947|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
331618|NCT00603525|1084945|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
331619|NCT00603525|1084946|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
331620|NCT00603525|1084947|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
331621|NCT00603525|1084945|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
331622|NCT00603525|1084946|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
331623|NCT00603525|1084947|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
331624|NCT00603525|1084945|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
331625|NCT00603525|1084946|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
331626|NCT00603525|1084947|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
331627|NCT00603525|1084945|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
331628|NCT00603525|1084946|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
331629|NCT00603525|1084947|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
331630|NCT00603525|1084945|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
331631|NCT00603525|1084946|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
331632|NCT00603525|1084947|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
331633|NCT00603525|1084945|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
331634|NCT00603525|1084946|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
331635|NCT00603525|1084947|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
331636|NCT00603512|1085079|P5|Overall Study|Randomized but not treated|0
331637|NCT00603512|1085080|P4|Overall Study|Randomized but not treated|2
331638|NCT00603512|1085081|P3|Overall Study|Randomized but not treated|1
331639|NCT00603512|1085082|P2|Overall Study|Randomized but not treated|1
331640|NCT00603512|1085083|P1|Overall Study|Randomized but not treated|0
331641|NCT00603512|1085079|P5|Overall Study|Withdrawal by Subject|1
331642|NCT00603512|1085080|P4|Overall Study|Withdrawal by Subject|0
331643|NCT00603512|1085081|P3|Overall Study|Withdrawal by Subject|0
331644|NCT00603512|1085082|P2|Overall Study|Withdrawal by Subject|0
331645|NCT00603512|1085083|P1|Overall Study|Withdrawal by Subject|0
331646|NCT00603512|1085079|P5|Overall Study|Unspecified|1
331647|NCT00603512|1085080|P4|Overall Study|Unspecified|1
331648|NCT00603512|1085081|P3|Overall Study|Unspecified|0
331649|NCT00603512|1085082|P2|Overall Study|Unspecified|1
331650|NCT00603512|1085083|P1|Overall Study|Unspecified|2
331651|NCT00603512|1085079|P5|Overall Study|Lack of Efficacy|1
331652|NCT00603512|1085080|P4|Overall Study|Lack of Efficacy|0
331653|NCT00603512|1085081|P3|Overall Study|Lack of Efficacy|0
331654|NCT00603512|1085082|P2|Overall Study|Lack of Efficacy|1
331655|NCT00603512|1085083|P1|Overall Study|Lack of Efficacy|0
331656|NCT00603512|1085079|P5|Overall Study|Adverse Event|2
331657|NCT00603512|1085080|P4|Overall Study|Adverse Event|4
331658|NCT00603512|1085081|P3|Overall Study|Adverse Event|4
331659|NCT00603512|1085082|P2|Overall Study|Adverse Event|2
331660|NCT00603512|1085083|P1|Overall Study|Adverse Event|0
331661|NCT00603473|1085225|P1|Overall Study|Protocol Violation|1
331662|NCT00603473|1085225|P1|Overall Study|Lack of Efficacy|4
331663|NCT00603473|1085225|P1|Overall Study|Adverse Event|4
331664|NCT00603447|1085238|P7|Overall Study|Withdrew Consent|1
331665|NCT00603447|1085239|P6|Overall Study|Withdrew Consent|0
331666|NCT00603447|1085240|P5|Overall Study|Withdrew Consent|1
331667|NCT00603447|1085241|P4|Overall Study|Withdrew Consent|0
331668|NCT00603447|1085242|P3|Overall Study|Withdrew Consent|0
331669|NCT00603447|1085243|P2|Overall Study|Withdrew Consent|2
331670|NCT00603447|1085244|P1|Overall Study|Withdrew Consent|0
331671|NCT00603447|1085238|P7|Overall Study|Other|13
331672|NCT00603447|1085239|P6|Overall Study|Other|0
331673|NCT00603447|1085240|P5|Overall Study|Other|3
331674|NCT00603447|1085241|P4|Overall Study|Other|0
331675|NCT00603447|1085242|P3|Overall Study|Other|1
331676|NCT00603447|1085243|P2|Overall Study|Other|0
331677|NCT00603447|1085244|P1|Overall Study|Other|0
331678|NCT00603447|1085238|P7|Overall Study|Adverse Event|10
331679|NCT00603447|1085239|P6|Overall Study|Adverse Event|2
331680|NCT00603447|1085240|P5|Overall Study|Adverse Event|1
331681|NCT00603447|1085241|P4|Overall Study|Adverse Event|2
331682|NCT00603447|1085242|P3|Overall Study|Adverse Event|1
331683|NCT00603447|1085243|P2|Overall Study|Adverse Event|1
331684|NCT00603447|1085244|P1|Overall Study|Adverse Event|0
331685|NCT00603382|1085283|P6|Overall Study|Withdrawal by Subject|1
331686|NCT00603382|1085284|P5|Overall Study|Withdrawal by Subject|0
331687|NCT00603382|1085285|P4|Overall Study|Withdrawal by Subject|1
331688|NCT00603382|1085286|P3|Overall Study|Withdrawal by Subject|1
331689|NCT00603382|1085287|P2|Overall Study|Withdrawal by Subject|3
331690|NCT00603382|1085288|P1|Overall Study|Withdrawal by Subject|3
331691|NCT00603382|1085283|P6|Overall Study|Physician Decision|3
331692|NCT00603382|1085284|P5|Overall Study|Physician Decision|1
331693|NCT00603382|1085285|P4|Overall Study|Physician Decision|0
331694|NCT00603382|1085286|P3|Overall Study|Physician Decision|2
331695|NCT00603382|1085287|P2|Overall Study|Physician Decision|0
331696|NCT00603382|1085288|P1|Overall Study|Physician Decision|0
331697|NCT00603382|1085283|P6|Overall Study|Lost to Follow-up|1
331698|NCT00603382|1085284|P5|Overall Study|Lost to Follow-up|0
331699|NCT00603382|1085285|P4|Overall Study|Lost to Follow-up|1
331700|NCT00603382|1085286|P3|Overall Study|Lost to Follow-up|1
331701|NCT00603382|1085287|P2|Overall Study|Lost to Follow-up|1
331702|NCT00603382|1085288|P1|Overall Study|Lost to Follow-up|0
331703|NCT00603382|1085283|P6|Overall Study|Protocol Violation|0
331704|NCT00603382|1085284|P5|Overall Study|Protocol Violation|1
331705|NCT00603382|1085285|P4|Overall Study|Protocol Violation|2
331706|NCT00603382|1085286|P3|Overall Study|Protocol Violation|1
331707|NCT00603382|1085287|P2|Overall Study|Protocol Violation|0
331708|NCT00603382|1085288|P1|Overall Study|Protocol Violation|1
331709|NCT00603382|1085283|P6|Overall Study|Lack of Efficacy|11
331710|NCT00603382|1085284|P5|Overall Study|Lack of Efficacy|6
331711|NCT00603382|1085285|P4|Overall Study|Lack of Efficacy|6
331712|NCT00603382|1085286|P3|Overall Study|Lack of Efficacy|3
331713|NCT00603382|1085287|P2|Overall Study|Lack of Efficacy|9
331714|NCT00603382|1085288|P1|Overall Study|Lack of Efficacy|14
331715|NCT00603382|1085283|P6|Overall Study|Adverse Event|2
331716|NCT00603382|1085284|P5|Overall Study|Adverse Event|1
331717|NCT00603382|1085285|P4|Overall Study|Adverse Event|2
331718|NCT00603382|1085286|P3|Overall Study|Adverse Event|1
331719|NCT00603382|1085287|P2|Overall Study|Adverse Event|1
331720|NCT00603382|1085288|P1|Overall Study|Adverse Event|0
331721|NCT00603304|1085436|P2|Overall Study|Patient Decision|0
331722|NCT00603304|1085437|P1|Overall Study|Patient Decision|2
331723|NCT00603304|1085436|P2|Overall Study|Not Specified|0
331724|NCT00603304|1085437|P1|Overall Study|Not Specified|2
331725|NCT00603304|1085436|P2|Overall Study|Moved Away|2
331726|NCT00603304|1085437|P1|Overall Study|Moved Away|0
331727|NCT00603304|1085436|P2|Overall Study|Non-Compliant|1
331728|NCT00603304|1085437|P1|Overall Study|Non-Compliant|0
331729|NCT00603304|1085436|P2|Overall Study|Exclusionary Medication|3
331730|NCT00603304|1085437|P1|Overall Study|Exclusionary Medication|2
331731|NCT00603304|1085436|P2|Overall Study|Crossed Over to Open Label Therapy|3
331732|NCT00603304|1085437|P1|Overall Study|Crossed Over to Open Label Therapy|3
331733|NCT00603304|1085436|P2|Overall Study|Unacceptable Treatment Toxicity|8
331734|NCT00603304|1085437|P1|Overall Study|Unacceptable Treatment Toxicity|5
331735|NCT00603304|1085436|P2|Overall Study|Adverse Event|2
331736|NCT00603304|1085437|P1|Overall Study|Adverse Event|4
331737|NCT00603304|1085436|P2|Overall Study|Protocol Violation|0
331738|NCT00603304|1085437|P1|Overall Study|Protocol Violation|1
331739|NCT00603304|1085436|P2|Overall Study|Withdrawal by Subject|5
331740|NCT00603304|1085437|P1|Overall Study|Withdrawal by Subject|8
331741|NCT00603304|1085436|P2|Overall Study|Lost to Follow-up|7
331742|NCT00603304|1085437|P1|Overall Study|Lost to Follow-up|5
331743|NCT00603278|1085493|P6|Overall Study|Lost to Follow-up|0
331744|NCT00603278|1085494|P5|Overall Study|Lost to Follow-up|1
331745|NCT00603278|1085495|P4|Overall Study|Lost to Follow-up|0
331746|NCT00603278|1085496|P3|Overall Study|Lost to Follow-up|0
331747|NCT00603278|1085497|P2|Overall Study|Lost to Follow-up|0
331748|NCT00603278|1085498|P1|Overall Study|Lost to Follow-up|1
331749|NCT00603278|1085493|P6|Overall Study|Physician Decision|1
331750|NCT00603278|1085494|P5|Overall Study|Physician Decision|2
331751|NCT00603278|1085495|P4|Overall Study|Physician Decision|0
331752|NCT00603278|1085496|P3|Overall Study|Physician Decision|0
331753|NCT00603278|1085497|P2|Overall Study|Physician Decision|1
331754|NCT00603278|1085498|P1|Overall Study|Physician Decision|0
331755|NCT00603278|1085493|P6|Overall Study|Protocol Violation|1
331756|NCT00603278|1085494|P5|Overall Study|Protocol Violation|0
331757|NCT00603278|1085495|P4|Overall Study|Protocol Violation|1
331758|NCT00603278|1085496|P3|Overall Study|Protocol Violation|1
331759|NCT00603278|1085497|P2|Overall Study|Protocol Violation|0
331760|NCT00603278|1085498|P1|Overall Study|Protocol Violation|3
331761|NCT00603278|1085493|P6|Overall Study|Withdrawal by Subject|2
331762|NCT00603278|1085494|P5|Overall Study|Withdrawal by Subject|1
331763|NCT00603278|1085495|P4|Overall Study|Withdrawal by Subject|2
331764|NCT00603278|1085496|P3|Overall Study|Withdrawal by Subject|1
331765|NCT00603278|1085497|P2|Overall Study|Withdrawal by Subject|3
331766|NCT00603278|1085498|P1|Overall Study|Withdrawal by Subject|2
331767|NCT00603278|1085493|P6|Overall Study|Adverse Event|1
331768|NCT00603278|1085494|P5|Overall Study|Adverse Event|2
331769|NCT00603278|1085495|P4|Overall Study|Adverse Event|0
331770|NCT00603278|1085496|P3|Overall Study|Adverse Event|1
331771|NCT00603278|1085497|P2|Overall Study|Adverse Event|3
331772|NCT00603278|1085498|P1|Overall Study|Adverse Event|0
331773|NCT00603278|1085493|P6|Overall Study|Lack of Efficacy|14
331774|NCT00603278|1085494|P5|Overall Study|Lack of Efficacy|7
331775|NCT00603278|1085495|P4|Overall Study|Lack of Efficacy|8
331776|NCT00603278|1085496|P3|Overall Study|Lack of Efficacy|11
331777|NCT00603278|1085497|P2|Overall Study|Lack of Efficacy|10
331778|NCT00603278|1085498|P1|Overall Study|Lack of Efficacy|35
331779|NCT00603265|1085647|P3|Overall Study|Protocol Violation|0
331780|NCT00603265|1085648|P2|Overall Study|Protocol Violation|0
331781|NCT00603265|1085649|P1|Overall Study|Protocol Violation|1
331782|NCT00603265|1085647|P3|Overall Study|Participant Left Country, No Responses|0
331783|NCT00603265|1085648|P2|Overall Study|Participant Left Country, No Responses|1
331784|NCT00603265|1085649|P1|Overall Study|Participant Left Country, No Responses|0
331785|NCT00603265|1085647|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
331786|NCT00603265|1085648|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
331787|NCT00603265|1085649|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
331788|NCT00603265|1085647|P3|Overall Study|Lost to Follow-up|0
331789|NCT00603265|1085648|P2|Overall Study|Lost to Follow-up|1
331790|NCT00603265|1085649|P1|Overall Study|Lost to Follow-up|0
331791|NCT00603265|1085647|P3|Overall Study|Lack of Efficacy|3
331792|NCT00603265|1085648|P2|Overall Study|Lack of Efficacy|0
331793|NCT00603265|1085649|P1|Overall Study|Lack of Efficacy|3
331794|NCT00603265|1085647|P3|Overall Study|Withdrawal by Subject|1
331795|NCT00603265|1085648|P2|Overall Study|Withdrawal by Subject|2
331796|NCT00603265|1085649|P1|Overall Study|Withdrawal by Subject|1
331797|NCT00603265|1085647|P3|Overall Study|Adverse Event|1
331798|NCT00603265|1085648|P2|Overall Study|Adverse Event|11
331799|NCT00603265|1085649|P1|Overall Study|Adverse Event|2
331800|NCT00603239|1085677|P2|Overall Study|Subject decision|1
331801|NCT00603239|1085678|P1|Overall Study|Subject decision|2
331802|NCT00603239|1085677|P2|Overall Study|Protocol Violation|0
331803|NCT00603239|1085678|P1|Overall Study|Protocol Violation|2
331804|NCT00603239|1085677|P2|Overall Study|Physician Decision|0
331805|NCT00603239|1085678|P1|Overall Study|Physician Decision|2
331806|NCT00603239|1085677|P2|Overall Study|Lost to Follow-up|1
331807|NCT00603239|1085678|P1|Overall Study|Lost to Follow-up|2
331808|NCT00603239|1085677|P2|Overall Study|Loss of glucose control|0
331809|NCT00603239|1085678|P1|Overall Study|Loss of glucose control|3
331810|NCT00603239|1085677|P2|Overall Study|Entry criteria not met|1
331811|NCT00603239|1085678|P1|Overall Study|Entry criteria not met|0
331812|NCT00603239|1085677|P2|Overall Study|Adverse Event|1
331813|NCT00603239|1085678|P1|Overall Study|Adverse Event|4
331814|NCT00602979|1085739|P5|Overall Study|Failed Intubation|0
331815|NCT00602979|1085740|P4|Overall Study|Failed Intubation|1
331816|NCT00602979|1085741|P3|Overall Study|Failed Intubation|0
331817|NCT00602979|1085742|P2|Overall Study|Failed Intubation|1
331818|NCT00602979|1085743|P1|Overall Study|Failed Intubation|0
331819|NCT00602979|1085739|P5|Overall Study|Lost to Follow-up|3
331820|NCT00602979|1085740|P4|Overall Study|Lost to Follow-up|2
331821|NCT00602979|1085741|P3|Overall Study|Lost to Follow-up|3
331822|NCT00602979|1085742|P2|Overall Study|Lost to Follow-up|2
331823|NCT00602979|1085743|P1|Overall Study|Lost to Follow-up|3
331824|NCT00602927|1085757|P2|Period 3: 13 Days|MRI data quality|2
331825|NCT00602927|1085758|P1|Period 3: 13 Days|MRI data quality|2
331826|NCT00602927|1085757|P2|Period 3: 13 Days|Protocol Violation|1
331827|NCT00602927|1085758|P1|Period 3: 13 Days|Protocol Violation|0
331828|NCT00602927|1085757|P2|Period 2: 14 Days|Protocol Violation|2
331829|NCT00602927|1085758|P1|Period 2: 14 Days|Protocol Violation|0
331830|NCT00602927|1085757|P2|Period 1: 13 Days|Claustrophobia|1
331831|NCT00602927|1085758|P1|Period 1: 13 Days|Claustrophobia|0
331832|NCT00602927|1085757|P2|Period 1: 13 Days|Time|0
331833|NCT00602927|1085758|P1|Period 1: 13 Days|Time|1
331834|NCT00602927|1085757|P2|Period 1: 13 Days|MRI scanner technical issue|0
331835|NCT00602927|1085758|P1|Period 1: 13 Days|MRI scanner technical issue|1
331836|NCT00602927|1085757|P2|Period 1: 13 Days|Protocol Violation|4
331837|NCT00602927|1085758|P1|Period 1: 13 Days|Protocol Violation|2
331838|NCT00602641|1085781|P2|Overall Study|Other|1
331839|NCT00602641|1085782|P1|Overall Study|Other|3
331840|NCT00602641|1085781|P2|Overall Study|Administrative Closure|1
331841|NCT00602641|1085782|P1|Overall Study|Administrative Closure|1
331842|NCT00602641|1085781|P2|Overall Study|Physician Decision|4
331843|NCT00602641|1085782|P1|Overall Study|Physician Decision|5
331844|NCT00602641|1085781|P2|Overall Study|Other Complicating Disease|2
331845|NCT00602641|1085782|P1|Overall Study|Other Complicating Disease|5
331846|NCT00602641|1085781|P2|Overall Study|Alternative therapy|2
331847|NCT00602641|1085782|P1|Overall Study|Alternative therapy|5
331848|NCT00602641|1085781|P2|Overall Study|Withdrawal by Subject|12
331849|NCT00602641|1085782|P1|Overall Study|Withdrawal by Subject|15
331850|NCT00602641|1085781|P2|Overall Study|Death|5
331851|NCT00602641|1085782|P1|Overall Study|Death|6
331852|NCT00602641|1085781|P2|Overall Study|Disease progression|55
331853|NCT00602641|1085782|P1|Overall Study|Disease progression|38
331854|NCT00602641|1085781|P2|Overall Study|Adverse Event|53
331855|NCT00602641|1085782|P1|Overall Study|Adverse Event|62
331856|NCT00602641|1085781|P2|Overall Study|Still on treatment at time of analysis|15
331857|NCT00602641|1085782|P1|Overall Study|Still on treatment at time of analysis|8
331858|NCT00602641|1085781|P2|Overall Study|Never started protocol therapy|2
331859|NCT00602641|1085782|P1|Overall Study|Never started protocol therapy|6
331860|NCT00602537|1085796|P2|Follow Up Study Comparison|Withdrawal by Subject|2
331861|NCT00602537|1085797|P1|Follow Up Study Comparison|Withdrawal by Subject|2
331862|NCT00602537|1085796|P2|Follow Up Study Comparison|Lost to Follow-up|1
331863|NCT00602537|1085797|P1|Follow Up Study Comparison|Lost to Follow-up|8
331864|NCT00602537|1085796|P2|Follow Up Study Comparison|Adverse Event|0
331865|NCT00602537|1085797|P1|Follow Up Study Comparison|Adverse Event|1
331866|NCT00602537|1085796|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
331867|NCT00602537|1085797|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
331868|NCT00602537|1085796|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
331869|NCT00602537|1085797|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
331870|NCT00602537|1085796|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
331871|NCT00602537|1085797|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
331872|NCT00602537|1085796|P2|12 Week Double Blind Comparison|Adverse Event|5
331873|NCT00602537|1085797|P1|12 Week Double Blind Comparison|Adverse Event|2
331874|NCT00602472|1085807|P2|Overall Study|Other incl. lack of efficacy|2
331875|NCT00602472|1085808|P1|Overall Study|Other incl. lack of efficacy|4
331876|NCT00602472|1085807|P2|Overall Study|Withdrawal by Subject|14
331877|NCT00602472|1085808|P1|Overall Study|Withdrawal by Subject|8
331878|NCT00602472|1085807|P2|Overall Study|Protocol Violation|19
331879|NCT00602472|1085808|P1|Overall Study|Protocol Violation|4
331880|NCT00602472|1085807|P2|Overall Study|Adverse Event|23
331881|NCT00602472|1085808|P1|Overall Study|Adverse Event|5
331882|NCT00602420|1085868|P2|Overall Study|Adverse Event|0
331883|NCT00602420|1085869|P1|Overall Study|Adverse Event|1
331884|NCT00602420|1085868|P2|Overall Study|Withdrawal by Subject|17
331885|NCT00602420|1085869|P1|Overall Study|Withdrawal by Subject|18
331886|NCT00602420|1085868|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
331887|NCT00602420|1085869|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
331888|NCT00602420|1085868|P2|Overall Study|Death|4
331889|NCT00602420|1085869|P1|Overall Study|Death|1
331890|NCT00601900|1085956|P2|Overall Study|Withdrawal by Subject|3
331891|NCT00601900|1085957|P1|Overall Study|Withdrawal by Subject|0
331892|NCT00601835|1085973|P2|Overall Study|Relocate|2
331893|NCT00601835|1085974|P1|Overall Study|Relocate|12
331894|NCT00601835|1085973|P2|Overall Study|Adverse Event|1
331895|NCT00601835|1085974|P1|Overall Study|Adverse Event|1
331896|NCT00601835|1085973|P2|Overall Study|Lost to Follow-up|5
331897|NCT00601835|1085974|P1|Overall Study|Lost to Follow-up|37
331898|NCT00601835|1085973|P2|Overall Study|Physician Decision|0
331899|NCT00601835|1085974|P1|Overall Study|Physician Decision|1
331900|NCT00601835|1085973|P2|Overall Study|Withdrawal by Subject|6
331901|NCT00601835|1085974|P1|Overall Study|Withdrawal by Subject|9
331902|NCT00601640|1086066|P3|Overall Study|change in eligibility status|1
331903|NCT00601640|1086067|P2|Overall Study|change in eligibility status|1
331904|NCT00601640|1086068|P1|Overall Study|change in eligibility status|0
331905|NCT00601640|1086066|P3|Overall Study|intercurrent illness|0
331906|NCT00601640|1086067|P2|Overall Study|intercurrent illness|0
331907|NCT00601640|1086068|P1|Overall Study|intercurrent illness|1
331908|NCT00601640|1086066|P3|Overall Study|Adverse Event|2
331909|NCT00601640|1086067|P2|Overall Study|Adverse Event|4
331910|NCT00601640|1086068|P1|Overall Study|Adverse Event|0
331911|NCT00601640|1086066|P3|Overall Study|Death|0
331912|NCT00601640|1086067|P2|Overall Study|Death|0
331913|NCT00601640|1086068|P1|Overall Study|Death|1
331914|NCT00601640|1086066|P3|Overall Study|Withdrawal by Subject|7
331915|NCT00601640|1086067|P2|Overall Study|Withdrawal by Subject|0
331916|NCT00601640|1086068|P1|Overall Study|Withdrawal by Subject|3
331917|NCT00601523|1086093|P2|Overall Study|not specified|1
331918|NCT00601523|1086094|P1|Overall Study|not specified|9
331919|NCT00601523|1086093|P2|Overall Study|Withdrawal by Subject|9
331920|NCT00601523|1086094|P1|Overall Study|Withdrawal by Subject|18
331921|NCT00601523|1086093|P2|Overall Study|Lost to Follow-up|1
331922|NCT00601523|1086094|P1|Overall Study|Lost to Follow-up|0
331923|NCT00601523|1086093|P2|Overall Study|Protocol Violation|1
331924|NCT00601523|1086094|P1|Overall Study|Protocol Violation|5
331925|NCT00601523|1086093|P2|Overall Study|Lack of Efficacy|0
331926|NCT00601523|1086094|P1|Overall Study|Lack of Efficacy|3
331927|NCT00601523|1086093|P2|Overall Study|Adverse Event|14
331928|NCT00601523|1086094|P1|Overall Study|Adverse Event|42
331929|NCT00601458|1086129|P3|Overall Study|Early Termination|1
331930|NCT00601458|1086130|P2|Overall Study|Early Termination|1
331931|NCT00601458|1086131|P1|Overall Study|Early Termination|0
331932|NCT00601458|1086129|P3|Overall Study|Protocol Violation|1
331933|NCT00601458|1086130|P2|Overall Study|Protocol Violation|2
331934|NCT00601458|1086131|P1|Overall Study|Protocol Violation|3
331935|NCT00601458|1086129|P3|Overall Study|Incomplete Data|0
331936|NCT00601458|1086130|P2|Overall Study|Incomplete Data|2
331937|NCT00601458|1086131|P1|Overall Study|Incomplete Data|0
331938|NCT00601458|1086129|P3|Overall Study|Dosing Error|0
331939|NCT00601458|1086130|P2|Overall Study|Dosing Error|0
331940|NCT00601458|1086131|P1|Overall Study|Dosing Error|1
331941|NCT00601419|1086142|P1|Overall Study|Missed Visits|1
331942|NCT00601419|1086142|P1|Overall Study|Lost to Follow-up|3
331943|NCT00601354|1086172|P2|Overall Study|Lost to Follow-up|5
331944|NCT00601354|1086173|P1|Overall Study|Lost to Follow-up|4
331945|NCT00601250|1086185|P2|Overall Study|Other incl. lack of efficacy|9
331946|NCT00601250|1086186|P1|Overall Study|Other incl. lack of efficacy|2
331947|NCT00601250|1086185|P2|Overall Study|Withdrawal by Subject|13
331948|NCT00601250|1086186|P1|Overall Study|Withdrawal by Subject|4
331949|NCT00601250|1086185|P2|Overall Study|Lost to Follow-up|6
331950|NCT00601250|1086186|P1|Overall Study|Lost to Follow-up|2
331951|NCT00601250|1086185|P2|Overall Study|Protocol Violation|2
331952|NCT00601250|1086186|P1|Overall Study|Protocol Violation|3
331953|NCT00601250|1086185|P2|Overall Study|Adverse Event|9
331954|NCT00601250|1086186|P1|Overall Study|Adverse Event|3
331955|NCT00601107|1086228|P4|Overall Study|Undefined|0
331956|NCT00601107|1086229|P3|Overall Study|Undefined|1
331957|NCT00601107|1086230|P2|Overall Study|Undefined|0
331958|NCT00601107|1086231|P1|Overall Study|Undefined|1
331959|NCT00601107|1086228|P4|Overall Study|Worsening of Psoriasis|4
331960|NCT00601107|1086229|P3|Overall Study|Worsening of Psoriasis|1
331961|NCT00601107|1086230|P2|Overall Study|Worsening of Psoriasis|1
331962|NCT00601107|1086231|P1|Overall Study|Worsening of Psoriasis|4
331963|NCT00601107|1086228|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
331964|NCT00601107|1086229|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
331965|NCT00601107|1086230|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
331966|NCT00601107|1086231|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
331967|NCT00601107|1086228|P4|Overall Study|Lost to Follow-up|3
331968|NCT00601107|1086229|P3|Overall Study|Lost to Follow-up|0
331969|NCT00601107|1086230|P2|Overall Study|Lost to Follow-up|3
331970|NCT00601107|1086231|P1|Overall Study|Lost to Follow-up|3
331971|NCT00601107|1086228|P4|Overall Study|Withdrawal by Subject|4
331972|NCT00601107|1086229|P3|Overall Study|Withdrawal by Subject|7
331973|NCT00601107|1086230|P2|Overall Study|Withdrawal by Subject|4
331974|NCT00601107|1086231|P1|Overall Study|Withdrawal by Subject|5
331975|NCT00601107|1086228|P4|Overall Study|Adverse Event|0
331976|NCT00601107|1086229|P3|Overall Study|Adverse Event|3
331977|NCT00601107|1086230|P2|Overall Study|Adverse Event|1
331978|NCT00601107|1086231|P1|Overall Study|Adverse Event|0
331979|NCT00600938|1086251|P4|Extension Study|Death|0
331980|NCT00600938|1086252|P3|Extension Study|Death|0
331981|NCT00600938|1086253|P2|Extension Study|Death|0
331982|NCT00600938|1086254|P1|Extension Study|Death|1
331983|NCT00600938|1086251|P4|Extension Study|Lost to Follow-up|0
331984|NCT00600938|1086252|P3|Extension Study|Lost to Follow-up|2
331985|NCT00600938|1086253|P2|Extension Study|Lost to Follow-up|1
331986|NCT00600938|1086254|P1|Extension Study|Lost to Follow-up|1
331987|NCT00600938|1086251|P4|Extension Study|Withdrawal by Subject|0
331988|NCT00600938|1086252|P3|Extension Study|Withdrawal by Subject|3
331989|NCT00600938|1086253|P2|Extension Study|Withdrawal by Subject|2
331990|NCT00600938|1086254|P1|Extension Study|Withdrawal by Subject|2
331991|NCT00600938|1086251|P4|Extension Study|Unsatisfactory therapeutic effect|0
331992|NCT00600938|1086252|P3|Extension Study|Unsatisfactory therapeutic effect|1
331993|NCT00600938|1086253|P2|Extension Study|Unsatisfactory therapeutic effect|1
331994|NCT00600938|1086254|P1|Extension Study|Unsatisfactory therapeutic effect|4
331995|NCT00600938|1086251|P4|Extension Study|Abnormal test procedure results|1
331996|NCT00600938|1086252|P3|Extension Study|Abnormal test procedure results|1
331997|NCT00600938|1086253|P2|Extension Study|Abnormal test procedure results|1
331998|NCT00600938|1086254|P1|Extension Study|Abnormal test procedure results|0
331999|NCT00600938|1086251|P4|Extension Study|Adverse Event|0
332000|NCT00600938|1086252|P3|Extension Study|Adverse Event|2
332001|NCT00600938|1086253|P2|Extension Study|Adverse Event|0
332002|NCT00600938|1086254|P1|Extension Study|Adverse Event|1
332003|NCT00600938|1086251|P4|Core Study|Protocol Violation|0
332004|NCT00600938|1086252|P3|Core Study|Protocol Violation|0
332005|NCT00600938|1086253|P2|Core Study|Protocol Violation|2
332006|NCT00600938|1086254|P1|Core Study|Protocol Violation|1
332007|NCT00600938|1086251|P4|Core Study|Death|0
332008|NCT00600938|1086252|P3|Core Study|Death|0
332009|NCT00600938|1086253|P2|Core Study|Death|1
332010|NCT00600938|1086254|P1|Core Study|Death|1
332011|NCT00600938|1086251|P4|Core Study|Lost to Follow-up|0
332012|NCT00600938|1086252|P3|Core Study|Lost to Follow-up|0
332013|NCT00600938|1086253|P2|Core Study|Lost to Follow-up|2
332014|NCT00600938|1086254|P1|Core Study|Lost to Follow-up|3
332015|NCT00600938|1086251|P4|Core Study|Patient withdrew consent|0
332016|NCT00600938|1086252|P3|Core Study|Patient withdrew consent|0
332017|NCT00600938|1086253|P2|Core Study|Patient withdrew consent|12
332018|NCT00600938|1086254|P1|Core Study|Patient withdrew consent|7
332019|NCT00600938|1086251|P4|Core Study|Unsatisfactory therapeutic effect|0
332020|NCT00600938|1086252|P3|Core Study|Unsatisfactory therapeutic effect|0
332021|NCT00600938|1086253|P2|Core Study|Unsatisfactory therapeutic effect|2
332022|NCT00600938|1086254|P1|Core Study|Unsatisfactory therapeutic effect|1
332023|NCT00600938|1086251|P4|Core Study|Abnormal test procedure result(s)|0
332024|NCT00600938|1086252|P3|Core Study|Abnormal test procedure result(s)|0
332025|NCT00600938|1086253|P2|Core Study|Abnormal test procedure result(s)|2
332026|NCT00600938|1086254|P1|Core Study|Abnormal test procedure result(s)|3
332027|NCT00600886|1086318|P2|Extension - After Crossover (CAS)|Death|0
332028|NCT00600886|1086319|P1|Extension - After Crossover (CAS)|Death|1
332029|NCT00600886|1086318|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
332030|NCT00600886|1086319|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
332031|NCT00600886|1086318|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
332032|NCT00600886|1086319|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
332033|NCT00600886|1086318|P2|Extension - After Crossover (CAS)|Administrative Problems|4
332034|NCT00600886|1086319|P1|Extension - After Crossover (CAS)|Administrative Problems|4
332035|NCT00600886|1086318|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
332036|NCT00600886|1086319|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
332037|NCT00600886|1086318|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
332038|NCT00600886|1086319|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
332039|NCT00600886|1086318|P2|Extension - After Crossover (CAS)|Adverse Event|1
332040|NCT00600886|1086319|P1|Extension - After Crossover (CAS)|Adverse Event|19
332041|NCT00600886|1086318|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
332042|NCT00600886|1086319|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
332043|NCT00600886|1086318|P2|Extension - Same Treatment (FAS)|Death|1
332044|NCT00600886|1086319|P1|Extension - Same Treatment (FAS)|Death|1
332045|NCT00600886|1086318|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
332046|NCT00600886|1086319|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
332047|NCT00600886|1086318|P2|Extension - Same Treatment (FAS)|Adverse Event|1
332048|NCT00600886|1086319|P1|Extension - Same Treatment (FAS)|Adverse Event|4
332049|NCT00600886|1086318|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
332050|NCT00600886|1086319|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
332051|NCT00600886|1086318|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
332052|NCT00600886|1086319|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
332053|NCT00600886|1086318|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
332054|NCT00600886|1086319|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
332055|NCT00600886|1086318|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
332056|NCT00600886|1086319|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
332057|NCT00600886|1086318|P2|Core Phase - Full Analysis Set (FAS)|Death|1
332058|NCT00600886|1086319|P1|Core Phase - Full Analysis Set (FAS)|Death|0
332059|NCT00600886|1086318|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
332060|NCT00600886|1086319|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
332061|NCT00600886|1086318|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
332062|NCT00600886|1086319|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
332063|NCT00600886|1086318|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
332064|NCT00600886|1086319|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
332065|NCT00600886|1086318|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
332066|NCT00600886|1086319|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
332067|NCT00600886|1086318|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
332068|NCT00600886|1086319|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
332069|NCT00600886|1086318|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
332070|NCT00600886|1086319|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
332071|NCT00600886|1086318|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
332072|NCT00600886|1086319|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
332073|NCT00600821|1086383|P2|Overall Study|Unspecified|3
332074|NCT00600821|1086384|P1|Overall Study|Unspecified|2
332075|NCT00600821|1086383|P2|Overall Study|Randomized but not treated|1
332076|NCT00600821|1086384|P1|Overall Study|Randomized but not treated|0
332077|NCT00600821|1086383|P2|Overall Study|Objective progression or relapse|1
332078|NCT00600821|1086384|P1|Overall Study|Objective progression or relapse|0
332079|NCT00600821|1086383|P2|Overall Study|Terminated by sponsor|6
332080|NCT00600821|1086384|P1|Overall Study|Terminated by sponsor|8
332081|NCT00600821|1086383|P2|Overall Study|Withdrawal by Subject|1
332082|NCT00600821|1086384|P1|Overall Study|Withdrawal by Subject|1
332083|NCT00600821|1086383|P2|Overall Study|Lost to Follow-up|2
332084|NCT00600821|1086384|P1|Overall Study|Lost to Follow-up|2
332085|NCT00600821|1086383|P2|Overall Study|Death|46
332086|NCT00600821|1086384|P1|Overall Study|Death|45
332087|NCT00600756|1086412|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
332088|NCT00600756|1086413|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
332089|NCT00600756|1086412|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
332090|NCT00600756|1086413|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
332091|NCT00600756|1086412|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
332092|NCT00600756|1086413|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
332093|NCT00600756|1086412|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
332094|NCT00600756|1086413|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
332095|NCT00600756|1086412|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
332096|NCT00600756|1086413|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
332097|NCT00600756|1086412|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
332098|NCT00600756|1086413|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
332099|NCT00600756|1086412|P2|Overall Study Analysis After 12 Months|Adverse Event|44
332100|NCT00600756|1086413|P1|Overall Study Analysis After 12 Months|Adverse Event|53
332101|NCT00600756|1086412|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
332102|NCT00600756|1086413|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
332103|NCT00600756|1086412|P2|Analysis After 6 Months|Lost to Follow-up|8
332104|NCT00600756|1086413|P1|Analysis After 6 Months|Lost to Follow-up|10
332105|NCT00600756|1086412|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
332106|NCT00600756|1086413|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
332107|NCT00600756|1086412|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
332108|NCT00600756|1086413|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
332109|NCT00600756|1086412|P2|Analysis After 6 Months|Incorrect Enrollment|21
332110|NCT00600756|1086413|P1|Analysis After 6 Months|Incorrect Enrollment|12
332111|NCT00600756|1086412|P2|Analysis After 6 Months|Withdrawal by Subject|30
332112|NCT00600756|1086413|P1|Analysis After 6 Months|Withdrawal by Subject|38
332113|NCT00600756|1086412|P2|Analysis After 6 Months|Adverse Event|33
332114|NCT00600756|1086413|P1|Analysis After 6 Months|Adverse Event|43
332115|NCT00600613|1086522|P1|Overall Study|Protocol Deviation|1
332116|NCT00600353|1086528|P2|Overall Study|History of prepartive regimen|1
332117|NCT00600353|1086529|P1|Overall Study|History of prepartive regimen|0
332118|NCT00600353|1086528|P2|Overall Study|history of malignancy within 5 years|0
332119|NCT00600353|1086529|P1|Overall Study|history of malignancy within 5 years|1
332120|NCT00600171|1086547|P6|Overall Study|Lost to Follow-up|0
332121|NCT00600171|1086548|P5|Overall Study|Lost to Follow-up|0
332122|NCT00600171|1086549|P4|Overall Study|Lost to Follow-up|1
332123|NCT00600171|1086550|P3|Overall Study|Lost to Follow-up|0
332124|NCT00600171|1086551|P2|Overall Study|Lost to Follow-up|0
332125|NCT00600171|1086552|P1|Overall Study|Lost to Follow-up|0
332126|NCT00600171|1086547|P6|Overall Study|Physician Decision|2
332127|NCT00600171|1086548|P5|Overall Study|Physician Decision|0
332128|NCT00600171|1086549|P4|Overall Study|Physician Decision|1
332129|NCT00600171|1086550|P3|Overall Study|Physician Decision|0
332130|NCT00600171|1086551|P2|Overall Study|Physician Decision|1
332131|NCT00600171|1086552|P1|Overall Study|Physician Decision|0
332132|NCT00600171|1086547|P6|Overall Study|Withdrawal by Subject|1
332133|NCT00600171|1086548|P5|Overall Study|Withdrawal by Subject|1
332134|NCT00600171|1086549|P4|Overall Study|Withdrawal by Subject|1
332135|NCT00600171|1086550|P3|Overall Study|Withdrawal by Subject|0
332136|NCT00600171|1086551|P2|Overall Study|Withdrawal by Subject|0
332137|NCT00600171|1086552|P1|Overall Study|Withdrawal by Subject|3
332138|NCT00600171|1086547|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
332139|NCT00600171|1086548|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
332140|NCT00600171|1086549|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
332141|NCT00600171|1086550|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
332142|NCT00600171|1086551|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
332143|NCT00600171|1086552|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
332144|NCT00600171|1086547|P6|Overall Study|Protocol Violation|0
332145|NCT00600171|1086548|P5|Overall Study|Protocol Violation|0
332146|NCT00600171|1086549|P4|Overall Study|Protocol Violation|1
332147|NCT00600171|1086550|P3|Overall Study|Protocol Violation|0
332148|NCT00600171|1086551|P2|Overall Study|Protocol Violation|2
332149|NCT00600171|1086552|P1|Overall Study|Protocol Violation|1
332150|NCT00600171|1086547|P6|Overall Study|Lack of Efficacy|0
332151|NCT00600171|1086548|P5|Overall Study|Lack of Efficacy|4
332152|NCT00600171|1086549|P4|Overall Study|Lack of Efficacy|5
332153|NCT00600171|1086550|P3|Overall Study|Lack of Efficacy|3
332154|NCT00600171|1086551|P2|Overall Study|Lack of Efficacy|12
332155|NCT00600171|1086552|P1|Overall Study|Lack of Efficacy|9
332156|NCT00600171|1086547|P6|Overall Study|Adverse Event|0
332157|NCT00600171|1086548|P5|Overall Study|Adverse Event|1
332158|NCT00600171|1086549|P4|Overall Study|Adverse Event|0
332159|NCT00600171|1086550|P3|Overall Study|Adverse Event|0
332160|NCT00600171|1086551|P2|Overall Study|Adverse Event|1
332161|NCT00600171|1086552|P1|Overall Study|Adverse Event|0
332162|NCT00600119|1086626|P6|Follow-up Period|Other|0
332163|NCT00600119|1086627|P5|Follow-up Period|Other|0
332164|NCT00600119|1086628|P4|Follow-up Period|Other|0
332165|NCT00600119|1086629|P3|Follow-up Period|Other|0
332166|NCT00600119|1086630|P2|Follow-up Period|Other|0
332167|NCT00600119|1086631|P1|Follow-up Period|Other|1
332168|NCT00600119|1086626|P6|Follow-up Period|Adverse Event|1
332169|NCT00600119|1086627|P5|Follow-up Period|Adverse Event|0
332170|NCT00600119|1086628|P4|Follow-up Period|Adverse Event|0
332171|NCT00600119|1086629|P3|Follow-up Period|Adverse Event|0
332172|NCT00600119|1086630|P2|Follow-up Period|Adverse Event|0
332173|NCT00600119|1086631|P1|Follow-up Period|Adverse Event|0
332174|NCT00600119|1086626|P6|Double-blind Treatment Period|Adverse Event|10
332175|NCT00600119|1086627|P5|Double-blind Treatment Period|Adverse Event|2
332176|NCT00600119|1086628|P4|Double-blind Treatment Period|Adverse Event|1
332177|NCT00600119|1086629|P3|Double-blind Treatment Period|Adverse Event|0
332178|NCT00600119|1086630|P2|Double-blind Treatment Period|Adverse Event|1
332179|NCT00600119|1086631|P1|Double-blind Treatment Period|Adverse Event|1
332180|NCT00600119|1086626|P6|Double-blind Treatment Period|Lost to Follow-up|0
332181|NCT00600119|1086627|P5|Double-blind Treatment Period|Lost to Follow-up|0
332182|NCT00600119|1086628|P4|Double-blind Treatment Period|Lost to Follow-up|0
332183|NCT00600119|1086629|P3|Double-blind Treatment Period|Lost to Follow-up|0
332184|NCT00600119|1086630|P2|Double-blind Treatment Period|Lost to Follow-up|1
332185|NCT00600119|1086631|P1|Double-blind Treatment Period|Lost to Follow-up|0
332186|NCT00600119|1086626|P6|Double-blind Treatment Period|Physician Decision|0
332187|NCT00600119|1086627|P5|Double-blind Treatment Period|Physician Decision|0
332188|NCT00600119|1086628|P4|Double-blind Treatment Period|Physician Decision|0
332189|NCT00600119|1086629|P3|Double-blind Treatment Period|Physician Decision|0
332190|NCT00600119|1086630|P2|Double-blind Treatment Period|Physician Decision|0
332191|NCT00600119|1086631|P1|Double-blind Treatment Period|Physician Decision|2
332192|NCT00600119|1086626|P6|Double-blind Treatment Period|Sponsor Decision|0
332193|NCT00600119|1086627|P5|Double-blind Treatment Period|Sponsor Decision|1
332194|NCT00600119|1086628|P4|Double-blind Treatment Period|Sponsor Decision|0
332195|NCT00600119|1086629|P3|Double-blind Treatment Period|Sponsor Decision|0
332196|NCT00600119|1086630|P2|Double-blind Treatment Period|Sponsor Decision|1
332197|NCT00600119|1086631|P1|Double-blind Treatment Period|Sponsor Decision|0
332198|NCT00600119|1086626|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
332199|NCT00600119|1086627|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
332200|NCT00600119|1086628|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
332201|NCT00600119|1086629|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
332202|NCT00600119|1086630|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
332203|NCT00600119|1086631|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
332204|NCT00600119|1086626|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
332205|NCT00600119|1086627|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
332206|NCT00600119|1086628|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
332207|NCT00600119|1086629|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
332208|NCT00600119|1086630|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
332209|NCT00600119|1086631|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
332210|NCT00600119|1086626|P6|Double-blind Treatment Period|Other|1
332211|NCT00600119|1086627|P5|Double-blind Treatment Period|Other|2
332212|NCT00600119|1086628|P4|Double-blind Treatment Period|Other|0
332213|NCT00600119|1086629|P3|Double-blind Treatment Period|Other|0
332214|NCT00600119|1086630|P2|Double-blind Treatment Period|Other|0
332215|NCT00600119|1086631|P1|Double-blind Treatment Period|Other|0
332216|NCT00600119|1086626|P6|Double-blind Treatment Period|Withdrawal by Subject|3
332217|NCT00600119|1086627|P5|Double-blind Treatment Period|Withdrawal by Subject|0
332218|NCT00600119|1086628|P4|Double-blind Treatment Period|Withdrawal by Subject|1
332219|NCT00600119|1086629|P3|Double-blind Treatment Period|Withdrawal by Subject|0
332220|NCT00600119|1086630|P2|Double-blind Treatment Period|Withdrawal by Subject|0
332221|NCT00600119|1086631|P1|Double-blind Treatment Period|Withdrawal by Subject|2
332222|NCT00600119|1086626|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
332223|NCT00600119|1086627|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
332224|NCT00600119|1086628|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
332225|NCT00600119|1086629|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
332226|NCT00600119|1086630|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
332227|NCT00600119|1086631|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
332228|NCT00600119|1086626|P6|Single-blind Placebo run-in Period|Adverse Event|1
332229|NCT00600119|1086627|P5|Single-blind Placebo run-in Period|Adverse Event|0
332230|NCT00600119|1086628|P4|Single-blind Placebo run-in Period|Adverse Event|1
332231|NCT00600119|1086629|P3|Single-blind Placebo run-in Period|Adverse Event|0
332232|NCT00600119|1086630|P2|Single-blind Placebo run-in Period|Adverse Event|0
332233|NCT00600119|1086631|P1|Single-blind Placebo run-in Period|Adverse Event|0
332234|NCT00600119|1086626|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
332235|NCT00600119|1086627|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
332236|NCT00600119|1086628|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
332237|NCT00600119|1086629|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
332238|NCT00600119|1086630|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
332239|NCT00600119|1086631|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
332240|NCT00600119|1086626|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
332241|NCT00600119|1086627|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
332242|NCT00600119|1086628|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
332243|NCT00600119|1086629|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
332244|NCT00600119|1086630|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
332245|NCT00600119|1086631|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
332246|NCT00600119|1086626|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
332247|NCT00600119|1086627|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
332248|NCT00600119|1086628|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
332249|NCT00600119|1086629|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
332250|NCT00600119|1086630|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
332251|NCT00600119|1086631|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
332252|NCT00600119|1086626|P6|Single-blind Placebo run-in Period|Other - Not specified|1
332253|NCT00600119|1086627|P5|Single-blind Placebo run-in Period|Other - Not specified|1
332254|NCT00600119|1086628|P4|Single-blind Placebo run-in Period|Other - Not specified|0
332255|NCT00600119|1086629|P3|Single-blind Placebo run-in Period|Other - Not specified|0
332256|NCT00600119|1086630|P2|Single-blind Placebo run-in Period|Other - Not specified|0
332257|NCT00600119|1086631|P1|Single-blind Placebo run-in Period|Other - Not specified|1
332258|NCT00600067|1086678|P2|Overall Study|Lack of Efficacy|0
332259|NCT00600067|1086679|P1|Overall Study|Lack of Efficacy|1
332260|NCT00600067|1086678|P2|Overall Study|protocol non-compliance|3
332261|NCT00600067|1086679|P1|Overall Study|protocol non-compliance|0
332262|NCT00600067|1086678|P2|Overall Study|Lost to Follow-up|3
332263|NCT00600067|1086679|P1|Overall Study|Lost to Follow-up|2
332264|NCT00600067|1086678|P2|Overall Study|Adverse Event|1
332265|NCT00600067|1086679|P1|Overall Study|Adverse Event|0
332266|NCT00600028|1086689|P2|Second Intervention (12 Weeks)|Adverse Event|2
332267|NCT00600028|1086690|P1|Second Intervention (12 Weeks)|Adverse Event|0
332268|NCT00600028|1086689|P2|First Intervention (12 Weeks)|Adverse Event|1
332269|NCT00600028|1086690|P1|First Intervention (12 Weeks)|Adverse Event|0
332270|NCT00600028|1086689|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
332271|NCT00600028|1086690|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
332272|NCT00599924|1086720|P7|Overall Study|Other|2
332273|NCT00599924|1086721|P6|Overall Study|Other|0
332274|NCT00599924|1086722|P5|Overall Study|Other|2
332275|NCT00599924|1086723|P4|Overall Study|Other|1
332276|NCT00599924|1086724|P3|Overall Study|Other|0
332277|NCT00599924|1086725|P2|Overall Study|Other|0
332278|NCT00599924|1086726|P1|Overall Study|Other|0
332279|NCT00599924|1086720|P7|Overall Study|Withdrawal by Subject|0
332280|NCT00599924|1086721|P6|Overall Study|Withdrawal by Subject|0
332281|NCT00599924|1086722|P5|Overall Study|Withdrawal by Subject|1
332282|NCT00599924|1086723|P4|Overall Study|Withdrawal by Subject|0
332283|NCT00599924|1086724|P3|Overall Study|Withdrawal by Subject|1
332284|NCT00599924|1086725|P2|Overall Study|Withdrawal by Subject|0
332285|NCT00599924|1086726|P1|Overall Study|Withdrawal by Subject|0
332286|NCT00599924|1086720|P7|Overall Study|Protocol Violation|0
332287|NCT00599924|1086721|P6|Overall Study|Protocol Violation|0
332288|NCT00599924|1086722|P5|Overall Study|Protocol Violation|0
332289|NCT00599924|1086723|P4|Overall Study|Protocol Violation|1
332290|NCT00599924|1086724|P3|Overall Study|Protocol Violation|0
332291|NCT00599924|1086725|P2|Overall Study|Protocol Violation|0
332292|NCT00599924|1086726|P1|Overall Study|Protocol Violation|0
332293|NCT00599924|1086720|P7|Overall Study|Death|1
332294|NCT00599924|1086721|P6|Overall Study|Death|2
332295|NCT00599924|1086722|P5|Overall Study|Death|0
332296|NCT00599924|1086723|P4|Overall Study|Death|2
332297|NCT00599924|1086724|P3|Overall Study|Death|0
332298|NCT00599924|1086725|P2|Overall Study|Death|0
332299|NCT00599924|1086726|P1|Overall Study|Death|0
332300|NCT00599924|1086720|P7|Overall Study|Adverse Event|2
332301|NCT00599924|1086721|P6|Overall Study|Adverse Event|0
332302|NCT00599924|1086722|P5|Overall Study|Adverse Event|0
332303|NCT00599924|1086723|P4|Overall Study|Adverse Event|2
332304|NCT00599924|1086724|P3|Overall Study|Adverse Event|0
332305|NCT00599924|1086725|P2|Overall Study|Adverse Event|0
332306|NCT00599924|1086726|P1|Overall Study|Adverse Event|0
332307|NCT00599924|1086720|P7|Overall Study|Lack of Efficacy|0
332308|NCT00599924|1086721|P6|Overall Study|Lack of Efficacy|2
332309|NCT00599924|1086722|P5|Overall Study|Lack of Efficacy|3
332310|NCT00599924|1086723|P4|Overall Study|Lack of Efficacy|2
332311|NCT00599924|1086724|P3|Overall Study|Lack of Efficacy|1
332312|NCT00599924|1086725|P2|Overall Study|Lack of Efficacy|5
332313|NCT00599924|1086726|P1|Overall Study|Lack of Efficacy|3
332314|NCT00599755|1086830|P1|Overall Study|No data available|1
332315|NCT00599755|1086830|P1|Overall Study|Other Reason|2
332316|NCT00599755|1086830|P1|Overall Study|Progression of Disease|3
332317|NCT00599755|1086830|P1|Overall Study|Withdrawal by Subject|2
332318|NCT00599755|1086830|P1|Overall Study|Adverse Event|11
332319|NCT00599521|1086841|P2|Overall Study|Pregnancy|2
332320|NCT00599521|1086842|P1|Overall Study|Pregnancy|0
332321|NCT00599521|1086841|P2|Overall Study|Lost to Follow-up|23
332322|NCT00599521|1086842|P1|Overall Study|Lost to Follow-up|23
332323|NCT00599521|1086841|P2|Overall Study|Protocol Violation|1
332324|NCT00599521|1086842|P1|Overall Study|Protocol Violation|1
332325|NCT00599521|1086841|P2|Overall Study|Withdrawal by Subject|34
332326|NCT00599521|1086842|P1|Overall Study|Withdrawal by Subject|28
332327|NCT00599521|1086841|P2|Overall Study|Adverse Event|1
332328|NCT00599521|1086842|P1|Overall Study|Adverse Event|4
332329|NCT00599521|1086841|P2|Overall Study|Lack of Efficacy|8
332330|NCT00599521|1086842|P1|Overall Study|Lack of Efficacy|4
332331|NCT00599339|1086856|P1|Overall Study|Study Termination Status Unknown|12
332332|NCT00599339|1086856|P1|Overall Study|No valid data consent|36
332333|NCT00599339|1086856|P1|Overall Study|Lost to Follow-up|221
332334|NCT00599339|1086856|P1|Overall Study|Other Reason|179
332335|NCT00599339|1086856|P1|Overall Study|Withdrawal by Subject|137
332336|NCT00599339|1086856|P1|Overall Study|Adverse Event|79
332337|NCT00599326|1086958|P1|Overall Study|Noncompliant|1
332338|NCT00599326|1086958|P1|Overall Study|Lost to Follow-up|1
332339|NCT00599313|1086963|P1|Overall Study|Ineligible|1
332340|NCT00599313|1086963|P1|Overall Study|Patient Request|4
332341|NCT00599313|1086963|P1|Overall Study|Disease Progression|12
332342|NCT00599313|1086963|P1|Overall Study|Adverse Event|19
332343|NCT00599196|1086983|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
332344|NCT00599196|1086983|P1|Overall Study|Other: Patient Stopped Due To Moving|1
332345|NCT00599196|1086983|P1|Overall Study|Other: Pt Moved To Australia|1
332346|NCT00599196|1086983|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
332347|NCT00599196|1086983|P1|Overall Study|Other: Spouse Withdrew Consent|1
332348|NCT00599196|1086983|P1|Overall Study|Other: Patient Leaving For Israel|1
332349|NCT00599196|1086983|P1|Overall Study|Lost to Follow-up|17
332350|NCT00599196|1086983|P1|Overall Study|Study ended per sponsor|197
332351|NCT00599196|1086983|P1|Overall Study|Subject withdrew consent|43
332352|NCT00599196|1086983|P1|Overall Study|Unsatisfactory compliance of subject|3
332353|NCT00599196|1086983|P1|Overall Study|Adverse Event|93
332354|NCT00599196|1086983|P1|Overall Study|Lack of Efficacy|22
332355|NCT00599027|1087014|P2|Overall Study|Treatment Failure|1
332356|NCT00599027|1087015|P1|Overall Study|Treatment Failure|0
332357|NCT00599027|1087014|P2|Overall Study|Adverse Event|1
332358|NCT00599027|1087015|P1|Overall Study|Adverse Event|0
332359|NCT00599027|1087014|P2|Overall Study|Withdrawal by Subject|1
332360|NCT00599027|1087015|P1|Overall Study|Withdrawal by Subject|1
332361|NCT00598871|1087028|P2|Overall Study|Adverse Event|1
332362|NCT00598871|1087029|P1|Overall Study|Adverse Event|0
332363|NCT00598832|1087039|P2|Overall Study|Non compliance|0
332364|NCT00598832|1087040|P1|Overall Study|Non compliance|1
332365|NCT00598832|1087039|P2|Overall Study|Physician Decision|4
332366|NCT00598832|1087040|P1|Overall Study|Physician Decision|1
332367|NCT00598832|1087039|P2|Overall Study|Pregnancy|2
332368|NCT00598832|1087040|P1|Overall Study|Pregnancy|2
332369|NCT00598832|1087039|P2|Overall Study|Lost to Follow-up|29
332370|NCT00598832|1087040|P1|Overall Study|Lost to Follow-up|24
332371|NCT00598832|1087039|P2|Overall Study|Protocol Violation|2
332372|NCT00598832|1087040|P1|Overall Study|Protocol Violation|0
332373|NCT00598832|1087039|P2|Overall Study|Withdrawal by Subject|36
332374|NCT00598832|1087040|P1|Overall Study|Withdrawal by Subject|25
332375|NCT00598832|1087039|P2|Overall Study|Adverse Event|2
332376|NCT00598832|1087040|P1|Overall Study|Adverse Event|6
332377|NCT00598832|1087039|P2|Overall Study|Lack of Efficacy|7
332378|NCT00598832|1087040|P1|Overall Study|Lack of Efficacy|3
332379|NCT00598702|1087070|P8|Overall Study|Dose limiting toxicity|0
332380|NCT00598702|1087071|P7|Overall Study|Dose limiting toxicity|0
332381|NCT00598702|1087072|P6|Overall Study|Dose limiting toxicity|1
332382|NCT00598702|1087073|P5|Overall Study|Dose limiting toxicity|1
332383|NCT00598702|1087074|P4|Overall Study|Dose limiting toxicity|1
332384|NCT00598702|1087075|P3|Overall Study|Dose limiting toxicity|0
332385|NCT00598702|1087076|P2|Overall Study|Dose limiting toxicity|0
332386|NCT00598702|1087077|P1|Overall Study|Dose limiting toxicity|0
332387|NCT00598702|1087070|P8|Overall Study|Physician Decision|0
332388|NCT00598702|1087071|P7|Overall Study|Physician Decision|0
332389|NCT00598702|1087072|P6|Overall Study|Physician Decision|0
332390|NCT00598702|1087073|P5|Overall Study|Physician Decision|1
332391|NCT00598702|1087074|P4|Overall Study|Physician Decision|0
332392|NCT00598702|1087075|P3|Overall Study|Physician Decision|0
332393|NCT00598702|1087076|P2|Overall Study|Physician Decision|0
332394|NCT00598702|1087077|P1|Overall Study|Physician Decision|0
332395|NCT00598702|1087070|P8|Overall Study|Withdrawal by Subject|0
332396|NCT00598702|1087071|P7|Overall Study|Withdrawal by Subject|0
332397|NCT00598702|1087072|P6|Overall Study|Withdrawal by Subject|0
332398|NCT00598702|1087073|P5|Overall Study|Withdrawal by Subject|1
332399|NCT00598702|1087074|P4|Overall Study|Withdrawal by Subject|1
332400|NCT00598702|1087075|P3|Overall Study|Withdrawal by Subject|0
332401|NCT00598702|1087076|P2|Overall Study|Withdrawal by Subject|0
332402|NCT00598702|1087077|P1|Overall Study|Withdrawal by Subject|0
332403|NCT00598702|1087070|P8|Overall Study|Adverse Event|0
332404|NCT00598702|1087071|P7|Overall Study|Adverse Event|0
332405|NCT00598702|1087072|P6|Overall Study|Adverse Event|0
332406|NCT00598702|1087073|P5|Overall Study|Adverse Event|0
332407|NCT00598702|1087074|P4|Overall Study|Adverse Event|1
332408|NCT00598702|1087075|P3|Overall Study|Adverse Event|0
332409|NCT00598702|1087076|P2|Overall Study|Adverse Event|0
332410|NCT00598702|1087077|P1|Overall Study|Adverse Event|0
332411|NCT00598702|1087070|P8|Overall Study|Early discharge from hospital|0
332412|NCT00598702|1087071|P7|Overall Study|Early discharge from hospital|1
332413|NCT00598702|1087072|P6|Overall Study|Early discharge from hospital|10
332414|NCT00598702|1087073|P5|Overall Study|Early discharge from hospital|0
332415|NCT00598702|1087074|P4|Overall Study|Early discharge from hospital|5
332416|NCT00598702|1087075|P3|Overall Study|Early discharge from hospital|2
332417|NCT00598702|1087076|P2|Overall Study|Early discharge from hospital|0
332418|NCT00598702|1087077|P1|Overall Study|Early discharge from hospital|0
332419|NCT00598702|1087070|P8|Overall Study|Not specified|0
332420|NCT00598702|1087071|P7|Overall Study|Not specified|0
332421|NCT00598702|1087072|P6|Overall Study|Not specified|1
332422|NCT00598702|1087073|P5|Overall Study|Not specified|0
332423|NCT00598702|1087074|P4|Overall Study|Not specified|0
332424|NCT00598702|1087075|P3|Overall Study|Not specified|0
332425|NCT00598702|1087076|P2|Overall Study|Not specified|2
332426|NCT00598702|1087077|P1|Overall Study|Not specified|0
332427|NCT00598650|1087132|P1|Overall Study|Physician Decision|2
332428|NCT00598650|1087132|P1|Overall Study|Prohibited Concomitant Medication|2
332429|NCT00598650|1087132|P1|Overall Study|Not eligible|1
332430|NCT00598650|1087132|P1|Overall Study|No treatment for 3 weeks|1
332431|NCT00598650|1087132|P1|Overall Study|Adverse Event|18
332432|NCT00598650|1087132|P1|Overall Study|Withdrawal by Subject|3
332433|NCT00598559|1087142|P3|Overall Study|Subject unable/unwilling to attend visit|0
332525|NCT00597753|1087260|P1|Overall Study|Withdrawal by Subject|35
332434|NCT00598559|1087143|P2|Overall Study|Subject unable/unwilling to attend visit|7
332435|NCT00598559|1087144|P1|Overall Study|Subject unable/unwilling to attend visit|4
332436|NCT00598559|1087142|P3|Overall Study|Early discharge from hospital|3
332437|NCT00598559|1087143|P2|Overall Study|Early discharge from hospital|12
332438|NCT00598559|1087144|P1|Overall Study|Early discharge from hospital|9
332439|NCT00598559|1087142|P3|Overall Study|Protocol Non-compliance|0
332440|NCT00598559|1087143|P2|Overall Study|Protocol Non-compliance|0
332441|NCT00598559|1087144|P1|Overall Study|Protocol Non-compliance|1
332442|NCT00598559|1087142|P3|Overall Study|Withdrawal by Subject|0
332443|NCT00598559|1087143|P2|Overall Study|Withdrawal by Subject|2
332444|NCT00598559|1087144|P1|Overall Study|Withdrawal by Subject|2
332445|NCT00598559|1087142|P3|Overall Study|Adverse Event|0
332446|NCT00598559|1087143|P2|Overall Study|Adverse Event|7
332447|NCT00598559|1087144|P1|Overall Study|Adverse Event|11
332448|NCT00598442|1087171|P3|Overall Study|Started dialysis|0
332449|NCT00598442|1087172|P2|Overall Study|Started dialysis|0
332450|NCT00598442|1087173|P1|Overall Study|Started dialysis|1
332451|NCT00598442|1087171|P3|Overall Study|Site closed by sponsor|1
332452|NCT00598442|1087172|P2|Overall Study|Site closed by sponsor|2
332453|NCT00598442|1087173|P1|Overall Study|Site closed by sponsor|5
332454|NCT00598442|1087171|P3|Overall Study|Renal transplant|1
332455|NCT00598442|1087172|P2|Overall Study|Renal transplant|0
332456|NCT00598442|1087173|P1|Overall Study|Renal transplant|0
332457|NCT00598442|1087171|P3|Overall Study|Relocation|0
332458|NCT00598442|1087172|P2|Overall Study|Relocation|4
332459|NCT00598442|1087173|P1|Overall Study|Relocation|1
332460|NCT00598442|1087171|P3|Overall Study|Noncompliance|1
332461|NCT00598442|1087172|P2|Overall Study|Noncompliance|2
332462|NCT00598442|1087173|P1|Overall Study|Noncompliance|0
332463|NCT00598442|1087171|P3|Overall Study|Withdrawal by Subject|6
332464|NCT00598442|1087172|P2|Overall Study|Withdrawal by Subject|16
332465|NCT00598442|1087173|P1|Overall Study|Withdrawal by Subject|8
332466|NCT00598442|1087171|P3|Overall Study|Physician Decision|1
332467|NCT00598442|1087172|P2|Overall Study|Physician Decision|1
332468|NCT00598442|1087173|P1|Overall Study|Physician Decision|2
332469|NCT00598442|1087171|P3|Overall Study|Lost to Follow-up|3
332470|NCT00598442|1087172|P2|Overall Study|Lost to Follow-up|3
332471|NCT00598442|1087173|P1|Overall Study|Lost to Follow-up|4
332472|NCT00598442|1087171|P3|Overall Study|Death|11
332473|NCT00598442|1087172|P2|Overall Study|Death|11
332474|NCT00598442|1087173|P1|Overall Study|Death|19
332475|NCT00598442|1087171|P3|Overall Study|Adverse Event|0
332476|NCT00598442|1087172|P2|Overall Study|Adverse Event|0
332477|NCT00598442|1087173|P1|Overall Study|Adverse Event|3
332478|NCT00598273|1087190|P3|Overall Study|Started dialysis|5
332479|NCT00598273|1087191|P2|Overall Study|Started dialysis|4
332480|NCT00598273|1087192|P1|Overall Study|Started dialysis|6
332481|NCT00598273|1087190|P3|Overall Study|Site elected to close|0
332482|NCT00598273|1087191|P2|Overall Study|Site elected to close|0
332483|NCT00598273|1087192|P1|Overall Study|Site elected to close|1
332484|NCT00598273|1087190|P3|Overall Study|Renal transplant|1
332485|NCT00598273|1087191|P2|Overall Study|Renal transplant|0
332486|NCT00598273|1087192|P1|Overall Study|Renal transplant|1
332487|NCT00598273|1087190|P3|Overall Study|Relocation|4
332488|NCT00598273|1087191|P2|Overall Study|Relocation|2
332489|NCT00598273|1087192|P1|Overall Study|Relocation|0
332490|NCT00598273|1087190|P3|Overall Study|Noncompliance|3
332491|NCT00598273|1087191|P2|Overall Study|Noncompliance|2
332492|NCT00598273|1087192|P1|Overall Study|Noncompliance|3
332493|NCT00598273|1087190|P3|Overall Study|Withdrawal by Subject|10
332494|NCT00598273|1087191|P2|Overall Study|Withdrawal by Subject|10
332495|NCT00598273|1087192|P1|Overall Study|Withdrawal by Subject|12
332496|NCT00598273|1087190|P3|Overall Study|Physician Decision|1
332497|NCT00598273|1087191|P2|Overall Study|Physician Decision|0
332498|NCT00598273|1087192|P1|Overall Study|Physician Decision|0
332499|NCT00598273|1087190|P3|Overall Study|Lost to Follow-up|5
332500|NCT00598273|1087191|P2|Overall Study|Lost to Follow-up|3
332501|NCT00598273|1087192|P1|Overall Study|Lost to Follow-up|8
332502|NCT00598273|1087190|P3|Overall Study|Death|8
332503|NCT00598273|1087191|P2|Overall Study|Death|12
332504|NCT00598273|1087192|P1|Overall Study|Death|6
332505|NCT00598273|1087190|P3|Overall Study|Adverse Event|2
332506|NCT00598273|1087191|P2|Overall Study|Adverse Event|5
332507|NCT00598273|1087192|P1|Overall Study|Adverse Event|4
332508|NCT00598078|1087206|P2|Period 2 (Day 2)|Adverse Event|0
332509|NCT00598078|1087207|P1|Period 2 (Day 2)|Adverse Event|1
332510|NCT00597753|1087259|P2|Overall Study|Site elected to close|4
332511|NCT00597753|1087260|P1|Overall Study|Site elected to close|2
332512|NCT00597753|1087259|P2|Overall Study|Site closed by sponsor|7
332513|NCT00597753|1087260|P1|Overall Study|Site closed by sponsor|19
332514|NCT00597753|1087259|P2|Overall Study|Renal transplant|3
332515|NCT00597753|1087260|P1|Overall Study|Renal transplant|10
332516|NCT00597753|1087259|P2|Overall Study|Relocation|6
332517|NCT00597753|1087260|P1|Overall Study|Relocation|17
332518|NCT00597753|1087259|P2|Overall Study|Noncompliance|1
332519|NCT00597753|1087260|P1|Overall Study|Noncompliance|2
332520|NCT00597753|1087259|P2|Overall Study|Never dosed|0
332521|NCT00597753|1087260|P1|Overall Study|Never dosed|2
332522|NCT00597753|1087259|P2|Overall Study|Discontinued Dialysis|1
332523|NCT00597753|1087260|P1|Overall Study|Discontinued Dialysis|0
332524|NCT00597753|1087259|P2|Overall Study|Withdrawal by Subject|12
332526|NCT00597753|1087259|P2|Overall Study|Pregnancy|0
332527|NCT00597753|1087260|P1|Overall Study|Pregnancy|1
332528|NCT00597753|1087259|P2|Overall Study|Physician Decision|1
332529|NCT00597753|1087260|P1|Overall Study|Physician Decision|5
332530|NCT00597753|1087259|P2|Overall Study|Lost to Follow-up|3
332531|NCT00597753|1087260|P1|Overall Study|Lost to Follow-up|10
332532|NCT00597753|1087259|P2|Overall Study|Lack of Efficacy|0
332533|NCT00597753|1087260|P1|Overall Study|Lack of Efficacy|2
332534|NCT00597753|1087259|P2|Overall Study|Death|29
332535|NCT00597753|1087260|P1|Overall Study|Death|55
332536|NCT00597753|1087259|P2|Overall Study|Adverse Event|2
332537|NCT00597753|1087260|P1|Overall Study|Adverse Event|6
332538|NCT00597714|1087294|P3|Overall Study|Recipient death|10
332539|NCT00597714|1087295|P2|Overall Study|Recipient death|0
332540|NCT00597714|1087296|P1|Overall Study|Recipient death|0
332541|NCT00597714|1087294|P3|Overall Study|Death|0
332542|NCT00597714|1087295|P2|Overall Study|Death|46
332543|NCT00597714|1087296|P1|Overall Study|Death|56
332544|NCT00597701|1087308|P2|Overall Study|Did not start intervention (pharmacy er)|2
332545|NCT00597701|1087309|P1|Overall Study|Did not start intervention (pharmacy er)|0
332546|NCT00597701|1087308|P2|Overall Study|Physician Decision|0
332547|NCT00597701|1087309|P1|Overall Study|Physician Decision|2
332548|NCT00597701|1087308|P2|Overall Study|Death|1
332549|NCT00597701|1087309|P1|Overall Study|Death|0
332550|NCT00597701|1087308|P2|Overall Study|Withdrawal by Subject|5
332551|NCT00597701|1087309|P1|Overall Study|Withdrawal by Subject|5
332552|NCT00597584|1087331|P2|Overall Study|Renal transplant|7
332553|NCT00597584|1087332|P1|Overall Study|Renal transplant|9
332554|NCT00597584|1087331|P2|Overall Study|Relocation|6
332555|NCT00597584|1087332|P1|Overall Study|Relocation|8
332556|NCT00597584|1087331|P2|Overall Study|Never dosed|0
332557|NCT00597584|1087332|P1|Overall Study|Never dosed|1
332558|NCT00597584|1087331|P2|Overall Study|Lost ability to consent|1
332559|NCT00597584|1087332|P1|Overall Study|Lost ability to consent|1
332560|NCT00597584|1087331|P2|Overall Study|Discontinued Dialysis|1
332561|NCT00597584|1087332|P1|Overall Study|Discontinued Dialysis|0
332562|NCT00597584|1087331|P2|Overall Study|Withdrawal by Subject|12
332563|NCT00597584|1087332|P1|Overall Study|Withdrawal by Subject|44
332564|NCT00597584|1087331|P2|Overall Study|Pregnancy|0
332565|NCT00597584|1087332|P1|Overall Study|Pregnancy|2
332566|NCT00597584|1087331|P2|Overall Study|Physician Decision|0
332567|NCT00597584|1087332|P1|Overall Study|Physician Decision|3
332568|NCT00597584|1087331|P2|Overall Study|Lost to Follow-up|4
332569|NCT00597584|1087332|P1|Overall Study|Lost to Follow-up|2
332570|NCT00597584|1087331|P2|Overall Study|Lack of Efficacy|0
332571|NCT00597584|1087332|P1|Overall Study|Lack of Efficacy|1
332572|NCT00597584|1087331|P2|Overall Study|Death|30
332573|NCT00597584|1087332|P1|Overall Study|Death|53
332574|NCT00597584|1087331|P2|Overall Study|Adverse Event|2
332575|NCT00597584|1087332|P1|Overall Study|Adverse Event|4
332576|NCT00597519|1087357|P1|Overall Study|Death|1
332577|NCT00597506|1087361|P1|Overall Study|Subject is being followed for survival|1
332578|NCT00597376|1087411|P2|Overall Study|Adverse Event|1
332579|NCT00597376|1087412|P1|Overall Study|Adverse Event|4
332580|NCT00597376|1087411|P2|Overall Study|Withdrawal by Subject|3
332581|NCT00597376|1087412|P1|Overall Study|Withdrawal by Subject|4
332582|NCT00597207|1087453|P2|Overall Study|Lost to Follow-up|7
332583|NCT00597207|1087454|P1|Overall Study|Lost to Follow-up|5
332584|NCT00597116|1087462|P2|Overall Study|Progressive disease|6
332585|NCT00597116|1087463|P1|Overall Study|Progressive disease|11
332586|NCT00597116|1087462|P2|Overall Study|Lost to Follow-up|0
332587|NCT00597116|1087463|P1|Overall Study|Lost to Follow-up|1
332588|NCT00597116|1087462|P2|Overall Study|Death|1
332589|NCT00597116|1087463|P1|Overall Study|Death|0
332590|NCT00597116|1087462|P2|Overall Study|Physician Decision|1
332591|NCT00597116|1087463|P1|Overall Study|Physician Decision|0
332592|NCT00597116|1087462|P2|Overall Study|Withdrawal by Subject|2
332593|NCT00597116|1087463|P1|Overall Study|Withdrawal by Subject|0
332594|NCT00597116|1087462|P2|Overall Study|Adverse Event|1
332595|NCT00597116|1087463|P1|Overall Study|Adverse Event|2
332596|NCT00597012|1087489|P2|Overall Study|Lost to Follow-up|2
332597|NCT00597012|1087490|P1|Overall Study|Lost to Follow-up|0
332598|NCT00597012|1087489|P2|Overall Study|Ineligible|0
332599|NCT00597012|1087490|P1|Overall Study|Ineligible|2
332600|NCT00597012|1087489|P2|Overall Study|Withdrawal by Subject|4
332601|NCT00597012|1087490|P1|Overall Study|Withdrawal by Subject|7
332602|NCT00597012|1087489|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
332603|NCT00597012|1087490|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
332604|NCT00597012|1087489|P2|Overall Study|Death|1
332605|NCT00597012|1087490|P1|Overall Study|Death|1
332606|NCT00596960|1087502|P2|Overall Study|No alcohol use data|1
332607|NCT00596960|1087503|P1|Overall Study|No alcohol use data|0
332608|NCT00596960|1087502|P2|Overall Study|Protocol Violation|1
332609|NCT00596960|1087503|P1|Overall Study|Protocol Violation|0
332610|NCT00596960|1087502|P2|Overall Study|Physician Decision|0
332611|NCT00596960|1087503|P1|Overall Study|Physician Decision|1
332612|NCT00596960|1087502|P2|Overall Study|Incarcerated|0
332613|NCT00596960|1087503|P1|Overall Study|Incarcerated|2
332614|NCT00596960|1087502|P2|Overall Study|Withdrawal by Subject|0
332615|NCT00596960|1087503|P1|Overall Study|Withdrawal by Subject|1
332616|NCT00596960|1087502|P2|Overall Study|Lost to Follow-up|5
332617|NCT00596960|1087503|P1|Overall Study|Lost to Follow-up|6
332618|NCT00596960|1087502|P2|Overall Study|Death|2
332619|NCT00596960|1087503|P1|Overall Study|Death|1
332620|NCT00596947|1087515|P2|Overall Study|Lost to Follow-up|0
332621|NCT00596947|1087516|P1|Overall Study|Lost to Follow-up|1
332622|NCT00596947|1087515|P2|Overall Study|study halted due to low enrollment|3
332623|NCT00596947|1087516|P1|Overall Study|study halted due to low enrollment|5
332624|NCT00596934|1087556|P1|Overall Study|Withdrawal by Subject|1
332625|NCT00596934|1087556|P1|Overall Study|Protocol Violation|1
332626|NCT00596830|1087569|P2|Overall Study|Randomized but not treated|7
332627|NCT00596830|1087570|P1|Overall Study|Randomized but not treated|3
332628|NCT00596830|1087569|P2|Overall Study|Follow-up was discontinued|0
332629|NCT00596830|1087570|P1|Overall Study|Follow-up was discontinued|1
332630|NCT00596830|1087569|P2|Overall Study|Study terminated by sponsor|62
332631|NCT00596830|1087570|P1|Overall Study|Study terminated by sponsor|51
332632|NCT00596830|1087569|P2|Overall Study|Withdrawal by Subject|12
332633|NCT00596830|1087570|P1|Overall Study|Withdrawal by Subject|22
332634|NCT00596830|1087569|P2|Overall Study|Lost to Follow-up|11
332635|NCT00596830|1087570|P1|Overall Study|Lost to Follow-up|7
332636|NCT00596830|1087569|P2|Overall Study|Death|247
332637|NCT00596830|1087570|P1|Overall Study|Death|258
332638|NCT00596817|1087596|P2|Double-blind Period|Other Reasons|18
332639|NCT00596817|1087597|P1|Double-blind Period|Other Reasons|10
332640|NCT00596817|1087596|P2|Double-blind Period|Lost to Follow-up|2
332641|NCT00596817|1087597|P1|Double-blind Period|Lost to Follow-up|0
332642|NCT00596817|1087596|P2|Double-blind Period|Withdrawal of Consent|3
332643|NCT00596817|1087597|P1|Double-blind Period|Withdrawal of Consent|7
332644|NCT00596817|1087596|P2|Double-blind Period|Protocol Violation|8
332645|NCT00596817|1087597|P1|Double-blind Period|Protocol Violation|11
332646|NCT00596817|1087596|P2|Double-blind Period|Non-compliance With Study Product|4
332647|NCT00596817|1087597|P1|Double-blind Period|Non-compliance With Study Product|3
332648|NCT00596817|1087596|P2|Double-blind Period|Lack of Efficacy|28
332649|NCT00596817|1087597|P1|Double-blind Period|Lack of Efficacy|52
332650|NCT00596817|1087596|P2|Double-blind Period|Adverse Event|16
332651|NCT00596817|1087597|P1|Double-blind Period|Adverse Event|5
332652|NCT00596817|1087596|P2|Open-label Period to Double-blind Period|Other Reasons|14
332653|NCT00596817|1087597|P1|Open-label Period to Double-blind Period|Other Reasons|0
332654|NCT00596817|1087596|P2|Open-label Period to Double-blind Period|Not Eligible|49
332655|NCT00596817|1087597|P1|Open-label Period to Double-blind Period|Not Eligible|0
332656|NCT00596817|1087596|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
332657|NCT00596817|1087597|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
332658|NCT00596817|1087596|P2|Open-label Period to Double-blind Period|Adverse Event|5
332659|NCT00596817|1087597|P1|Open-label Period to Double-blind Period|Adverse Event|0
332660|NCT00596817|1087596|P2|Open-label Period|Other Reasons|65
332661|NCT00596817|1087597|P1|Open-label Period|Other Reasons|0
332662|NCT00596817|1087596|P2|Open-label Period|Lack of Efficacy|33
332663|NCT00596817|1087597|P1|Open-label Period|Lack of Efficacy|0
332664|NCT00596817|1087596|P2|Open-label Period|Adverse Event|49
332665|NCT00596817|1087597|P1|Open-label Period|Adverse Event|0
332666|NCT00596752|1087622|P2|Overall Study|Protocol Violation|0
332667|NCT00596752|1087623|P1|Overall Study|Protocol Violation|1
332668|NCT00596752|1087622|P2|Overall Study|Lack of Efficacy|7
332669|NCT00596752|1087623|P1|Overall Study|Lack of Efficacy|4
332670|NCT00596752|1087622|P2|Overall Study|Unsatisfactory Compliance|6
332671|NCT00596752|1087623|P1|Overall Study|Unsatisfactory Compliance|9
332672|NCT00596752|1087622|P2|Overall Study|Withdrawal by Subject|9
332673|NCT00596752|1087623|P1|Overall Study|Withdrawal by Subject|12
332674|NCT00596752|1087622|P2|Overall Study|Lost to Follow-up|38
332675|NCT00596752|1087623|P1|Overall Study|Lost to Follow-up|22
332676|NCT00596752|1087622|P2|Overall Study|Adverse Event|34
332677|NCT00596752|1087623|P1|Overall Study|Adverse Event|34
332678|NCT00596752|1087622|P2|Overall Study|Other Reason|49
332679|NCT00596752|1087623|P1|Overall Study|Other Reason|44
332680|NCT00596687|1087653|P2|Overall Study|cancelled surgery|1
332681|NCT00596687|1087654|P1|Overall Study|cancelled surgery|1
332682|NCT00596687|1087653|P2|Overall Study|Withdrawal by Subject|1
332683|NCT00596687|1087654|P1|Overall Study|Withdrawal by Subject|3
332684|NCT00596687|1087653|P2|Overall Study|continuous insulin infusion during TPN|1
332685|NCT00596687|1087654|P1|Overall Study|continuous insulin infusion during TPN|2
332686|NCT00596687|1087653|P2|Overall Study|< 24 hours of insulin treatment|6
332687|NCT00596687|1087654|P1|Overall Study|< 24 hours of insulin treatment|8
332688|NCT00596635|1087665|P3|Overall Study|Could not provide urine specimen|2
332689|NCT00596635|1087666|P2|Overall Study|Could not provide urine specimen|2
332690|NCT00596635|1087667|P1|Overall Study|Could not provide urine specimen|1
332691|NCT00596635|1087665|P3|Overall Study|Hip fracture|3
332692|NCT00596635|1087666|P2|Overall Study|Hip fracture|3
332693|NCT00596635|1087667|P1|Overall Study|Hip fracture|2
332694|NCT00596635|1087665|P3|Overall Study|Treatment for symptomatic UTI|3
332695|NCT00596635|1087666|P2|Overall Study|Treatment for symptomatic UTI|6
332696|NCT00596635|1087667|P1|Overall Study|Treatment for symptomatic UTI|4
332697|NCT00596635|1087665|P3|Overall Study|Lost to Follow-up|0
332698|NCT00596635|1087666|P2|Overall Study|Lost to Follow-up|2
332699|NCT00596635|1087667|P1|Overall Study|Lost to Follow-up|0
332700|NCT00596466|1087693|P1|Overall Study|Enrolled, not treated|2
332701|NCT00596466|1087693|P1|Overall Study|Unpecified|2
332702|NCT00596466|1087693|P1|Overall Study|Protocol Violation|2
332703|NCT00596466|1087693|P1|Overall Study|Withdrawal by Subject|2
332704|NCT00596466|1087693|P1|Overall Study|Adverse Event|4
332705|NCT00596466|1087693|P1|Overall Study|Lack of Efficacy|5
332706|NCT00596427|1087723|P2|Overall Study|Protocol Violation|0
332707|NCT00596427|1087724|P1|Overall Study|Protocol Violation|1
332708|NCT00596427|1087723|P2|Overall Study|Increased Fasting Triacylglycerol level|0
332709|NCT00596427|1087724|P1|Overall Study|Increased Fasting Triacylglycerol level|1
332710|NCT00596427|1087723|P2|Overall Study|Withdrawal by Subject|2
332711|NCT00596427|1087724|P1|Overall Study|Withdrawal by Subject|2
332712|NCT00596362|1087752|P1|Overall Study|Progressive Disease|1
332713|NCT00596011|1087788|P2|Overall Study|Adverse Event|7
332714|NCT00596011|1087789|P1|Overall Study|Adverse Event|11
332715|NCT00596011|1087788|P2|Overall Study|Withdrawal by Subject|3
332716|NCT00596011|1087789|P1|Overall Study|Withdrawal by Subject|2
332717|NCT00595959|1087805|P1|Overall Study|Lost to Follow-up|1
332718|NCT00595959|1087805|P1|Overall Study|Withdrawal by Subject|1
332719|NCT00595920|1087839|P1|Overall Study|The OLTERMS study was discontinued by th|116
332720|NCT00595868|1087850|P2|Overall Study|Lost to Follow-up|50
332721|NCT00595868|1087851|P1|Overall Study|Lost to Follow-up|45
332722|NCT00595764|1087874|P2|Overall Study|Withdrawal by Subject|0
332723|NCT00595764|1087875|P1|Overall Study|Withdrawal by Subject|4
332724|NCT00595764|1087874|P2|Overall Study|Missed 3 PM visits|7
332725|NCT00595764|1087875|P1|Overall Study|Missed 3 PM visits|1
332726|NCT00595764|1087874|P2|Overall Study|Missed Medication >1 week|17
332727|NCT00595764|1087875|P1|Overall Study|Missed Medication >1 week|10
332728|NCT00595764|1087874|P2|Overall Study|Protocol Violation|19
332729|NCT00595764|1087875|P1|Overall Study|Protocol Violation|24
332730|NCT00595582|1087889|P1|Overall Study|Physician Decision|5
332731|NCT00595582|1087889|P1|Overall Study|Adverse Event|2
332732|NCT00595582|1087889|P1|Overall Study|Lost to Follow-up|1
332733|NCT00595582|1087889|P1|Overall Study|Pilot study that PI terminated|2
332734|NCT00595517|1087914|P1|Overall Study|No intention to attend regularly|1
332735|NCT00595517|1087914|P1|Overall Study|usage of prohibited treatment|1
332736|NCT00595517|1087914|P1|Overall Study|Recurrence of ulcer|5
332737|NCT00595517|1087914|P1|Overall Study|Protocol Violation|2
332738|NCT00595517|1087914|P1|Overall Study|Withdrawal by Subject|4
332739|NCT00595517|1087914|P1|Overall Study|Adverse Event|6
332740|NCT00595504|1087923|P2|Overall Study|Physician Decision|0
332741|NCT00595504|1087924|P1|Overall Study|Physician Decision|1
332742|NCT00595504|1087923|P2|Overall Study|Withdrawal by Subject|3
332743|NCT00595504|1087924|P1|Overall Study|Withdrawal by Subject|1
332744|NCT00595465|1087937|P3|Overall Study|administrative reason|1
332745|NCT00595465|1087938|P2|Overall Study|administrative reason|0
332746|NCT00595465|1087939|P1|Overall Study|administrative reason|0
332747|NCT00595465|1087937|P3|Overall Study|Lost to Follow-up|2
332748|NCT00595465|1087938|P2|Overall Study|Lost to Follow-up|0
332749|NCT00595465|1087939|P1|Overall Study|Lost to Follow-up|0
332750|NCT00595465|1087937|P3|Overall Study|Protocol Violation|0
332751|NCT00595465|1087938|P2|Overall Study|Protocol Violation|1
332752|NCT00595465|1087939|P1|Overall Study|Protocol Violation|2
332753|NCT00595465|1087937|P3|Overall Study|Pregnancy|1
332754|NCT00595465|1087938|P2|Overall Study|Pregnancy|0
332755|NCT00595465|1087939|P1|Overall Study|Pregnancy|0
332756|NCT00595465|1087937|P3|Overall Study|Adverse Event|3
332757|NCT00595465|1087938|P2|Overall Study|Adverse Event|3
332758|NCT00595465|1087939|P1|Overall Study|Adverse Event|4
332759|NCT00595413|1087951|P4|Overall Study|Unspecified|0
332760|NCT00595413|1087952|P3|Overall Study|Unspecified|5
332761|NCT00595413|1087953|P2|Overall Study|Unspecified|1
332762|NCT00595413|1087954|P1|Overall Study|Unspecified|5
332763|NCT00595413|1087951|P4|Overall Study|Death|0
332764|NCT00595413|1087952|P3|Overall Study|Death|1
332765|NCT00595413|1087953|P2|Overall Study|Death|0
332766|NCT00595413|1087954|P1|Overall Study|Death|0
332767|NCT00595413|1087951|P4|Overall Study|Lost to Follow-up|3
332768|NCT00595413|1087952|P3|Overall Study|Lost to Follow-up|1
332769|NCT00595413|1087953|P2|Overall Study|Lost to Follow-up|2
332770|NCT00595413|1087954|P1|Overall Study|Lost to Follow-up|2
332771|NCT00595413|1087951|P4|Overall Study|Adverse Event|1
332772|NCT00595413|1087952|P3|Overall Study|Adverse Event|1
332773|NCT00595413|1087953|P2|Overall Study|Adverse Event|2
332774|NCT00595413|1087954|P1|Overall Study|Adverse Event|0
332775|NCT00595335|1087995|P2|Six Months to Twelve Months|Disease Progression|0
332776|NCT00595335|1087996|P1|Six Months to Twelve Months|Disease Progression|1
332777|NCT00595335|1087995|P2|Six Months to Twelve Months|Withdrawal by Subject|1
332778|NCT00595335|1087996|P1|Six Months to Twelve Months|Withdrawal by Subject|0
332779|NCT00595335|1087995|P2|Baseline to Six Months|Adverse Event|0
332780|NCT00595335|1087996|P1|Baseline to Six Months|Adverse Event|1
332781|NCT00595335|1087995|P2|Baseline to Six Months|Disease Progression|1
332782|NCT00595335|1087996|P1|Baseline to Six Months|Disease Progression|1
332783|NCT00595335|1087995|P2|Baseline to Six Months|Withdrawal by Subject|1
332784|NCT00595335|1087996|P1|Baseline to Six Months|Withdrawal by Subject|0
332785|NCT00595309|1088016|P1|Overall Study|personal reason|1
332786|NCT00595309|1088016|P1|Overall Study|acute infection after V0|1
332787|NCT00595309|1088016|P1|Overall Study|planned vaccination against yellow fever|1
332788|NCT00595309|1088016|P1|Overall Study|Lost to Follow-up|1
332789|NCT00595127|1088046|P1|Overall Study|joined another trial|1
332790|NCT00595127|1088046|P1|Overall Study|Relapsed|3
332791|NCT00595127|1088046|P1|Overall Study|Death|6
332792|NCT00595075|1088068|P2|Overall Study|Withdrawal by Subject|0
332793|NCT00595075|1088069|P1|Overall Study|Withdrawal by Subject|1
332794|NCT00594958|1088090|P3|Overall Study|administrative|2
332795|NCT00594958|1088091|P2|Overall Study|administrative|0
332796|NCT00594958|1088092|P1|Overall Study|administrative|3
332797|NCT00594958|1088090|P3|Overall Study|Lost to Follow-up|3
332798|NCT00594958|1088091|P2|Overall Study|Lost to Follow-up|0
332799|NCT00594958|1088092|P1|Overall Study|Lost to Follow-up|5
332800|NCT00594958|1088090|P3|Overall Study|Protocol Violation|2
332801|NCT00594958|1088091|P2|Overall Study|Protocol Violation|0
332802|NCT00594958|1088092|P1|Overall Study|Protocol Violation|1
332803|NCT00594958|1088090|P3|Overall Study|Pregnancy|0
332804|NCT00594958|1088091|P2|Overall Study|Pregnancy|2
332805|NCT00594958|1088092|P1|Overall Study|Pregnancy|0
332806|NCT00594958|1088090|P3|Overall Study|Adverse Event|2
332807|NCT00594958|1088091|P2|Overall Study|Adverse Event|1
332808|NCT00594958|1088092|P1|Overall Study|Adverse Event|4
332809|NCT00594958|1088090|P3|Overall Study|Withdrawal by Subject|1
332810|NCT00594958|1088091|P2|Overall Study|Withdrawal by Subject|0
332811|NCT00594958|1088092|P1|Overall Study|Withdrawal by Subject|1
332812|NCT00594906|1088113|P2|Overall Study|Death|1
332813|NCT00594906|1088114|P1|Overall Study|Death|0
332814|NCT00594906|1088113|P2|Overall Study|Physician Decision|1
332815|NCT00594906|1088114|P1|Overall Study|Physician Decision|0
332816|NCT00594906|1088113|P2|Overall Study|Physician Decision|0
332817|NCT00594906|1088114|P1|Overall Study|Physician Decision|1
332818|NCT00594880|1088122|P2|Overall Study|Lost to Follow-up|0
332819|NCT00594880|1088123|P1|Overall Study|Lost to Follow-up|1
332820|NCT00594880|1088122|P2|Overall Study|Withdrawal by Subject|1
332821|NCT00594880|1088123|P1|Overall Study|Withdrawal by Subject|1
332822|NCT00594854|1088135|P2|Overall Study|Study terminated|10
332823|NCT00594854|1088136|P1|Overall Study|Study terminated|7
332824|NCT00594815|1088146|P1|Overall Study|Toxicity|4
332825|NCT00594815|1088146|P1|Overall Study|Withdrawal by Subject|2
332826|NCT00594815|1088146|P1|Overall Study|Never Treated|3
332827|NCT00594659|1088171|P3|Overall Study|Lost to Follow-up|7
332828|NCT00594659|1088172|P2|Overall Study|Lost to Follow-up|9
332829|NCT00594659|1088173|P1|Overall Study|Lost to Follow-up|13
332830|NCT00594646|1088184|P1|Overall Study|Lost to Follow-up|15
332831|NCT00594646|1088184|P1|Overall Study|Withdrawal by Subject|1
332832|NCT00594568|1088192|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
332833|NCT00594568|1088193|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
332834|NCT00594568|1088194|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
332835|NCT00594568|1088192|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
332836|NCT00594568|1088193|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
332837|NCT00594568|1088194|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
332838|NCT00594568|1088192|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
332839|NCT00594568|1088193|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
332840|NCT00594568|1088194|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
332841|NCT00594568|1088192|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
332842|NCT00594568|1088193|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
332843|NCT00594568|1088194|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
332844|NCT00594568|1088192|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
332845|NCT00594568|1088193|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
332846|NCT00594568|1088194|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
332847|NCT00594568|1088192|P3|Safety Follow Up (SFU)-Optional|Death|0
332848|NCT00594568|1088193|P2|Safety Follow Up (SFU)-Optional|Death|1
332849|NCT00594568|1088194|P1|Safety Follow Up (SFU)-Optional|Death|0
332850|NCT00594568|1088192|P3|Delayed Start|Sponsor Decision|59
332851|NCT00594568|1088193|P2|Delayed Start|Sponsor Decision|66
332852|NCT00594568|1088194|P1|Delayed Start|Sponsor Decision|77
332853|NCT00594568|1088192|P3|Delayed Start|Caregiver Decision|2
332854|NCT00594568|1088193|P2|Delayed Start|Caregiver Decision|6
332855|NCT00594568|1088194|P1|Delayed Start|Caregiver Decision|5
332856|NCT00594568|1088192|P3|Delayed Start|Lost to Follow-up|1
332857|NCT00594568|1088193|P2|Delayed Start|Lost to Follow-up|0
332858|NCT00594568|1088194|P1|Delayed Start|Lost to Follow-up|0
332859|NCT00594568|1088192|P3|Delayed Start|Physician Decision|1
332860|NCT00594568|1088193|P2|Delayed Start|Physician Decision|0
332861|NCT00594568|1088194|P1|Delayed Start|Physician Decision|0
332862|NCT00594568|1088192|P3|Delayed Start|Withdrawal by Subject|0
332863|NCT00594568|1088193|P2|Delayed Start|Withdrawal by Subject|3
332864|NCT00594568|1088194|P1|Delayed Start|Withdrawal by Subject|4
332865|NCT00594568|1088192|P3|Delayed Start|Adverse Event|2
332866|NCT00594568|1088193|P2|Delayed Start|Adverse Event|2
332867|NCT00594568|1088194|P1|Delayed Start|Adverse Event|12
332868|NCT00594568|1088192|P3|Delayed Start|Death|1
332869|NCT00594568|1088193|P2|Delayed Start|Death|0
332870|NCT00594568|1088194|P1|Delayed Start|Death|0
332871|NCT00594568|1088192|P3|Initial Treatment|Entry criteria exclusion|1
332872|NCT00594568|1088193|P2|Initial Treatment|Entry criteria exclusion|1
332873|NCT00594568|1088194|P1|Initial Treatment|Entry criteria exclusion|0
332874|NCT00594568|1088192|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
333120|NCT00592839|1089194|P1|Overall Study|Protocol Violation|1
333121|NCT00592839|1089192|P3|Overall Study|Withdrawal by Subject|3
332875|NCT00594568|1088193|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
332876|NCT00594568|1088194|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
332877|NCT00594568|1088192|P3|Initial Treatment|Caregiver decision|36
332878|NCT00594568|1088193|P2|Initial Treatment|Caregiver decision|36
332879|NCT00594568|1088194|P1|Initial Treatment|Caregiver decision|21
332880|NCT00594568|1088192|P3|Initial Treatment|Sponsor decision|147
332881|NCT00594568|1088193|P2|Initial Treatment|Sponsor decision|142
332882|NCT00594568|1088194|P1|Initial Treatment|Sponsor decision|193
332883|NCT00594568|1088192|P3|Initial Treatment|Withdrawal by Subject|46
332884|NCT00594568|1088193|P2|Initial Treatment|Withdrawal by Subject|31
332885|NCT00594568|1088194|P1|Initial Treatment|Withdrawal by Subject|25
332886|NCT00594568|1088192|P3|Initial Treatment|Protocol Violation|5
332887|NCT00594568|1088193|P2|Initial Treatment|Protocol Violation|2
332888|NCT00594568|1088194|P1|Initial Treatment|Protocol Violation|2
332889|NCT00594568|1088192|P3|Initial Treatment|Physician Decision|4
332890|NCT00594568|1088193|P2|Initial Treatment|Physician Decision|2
332891|NCT00594568|1088194|P1|Initial Treatment|Physician Decision|3
332892|NCT00594568|1088192|P3|Initial Treatment|Lost to Follow-up|4
332893|NCT00594568|1088193|P2|Initial Treatment|Lost to Follow-up|1
332894|NCT00594568|1088194|P1|Initial Treatment|Lost to Follow-up|4
332895|NCT00594568|1088192|P3|Initial Treatment|Death|15
332896|NCT00594568|1088193|P2|Initial Treatment|Death|11
332897|NCT00594568|1088194|P1|Initial Treatment|Death|6
332898|NCT00594568|1088192|P3|Initial Treatment|Adverse Event|144
332899|NCT00594568|1088193|P2|Initial Treatment|Adverse Event|121
332900|NCT00594568|1088194|P1|Initial Treatment|Adverse Event|51
332901|NCT00594516|1088282|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
332902|NCT00594516|1088283|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
332903|NCT00594516|1088284|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
332904|NCT00594516|1088282|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
332905|NCT00594516|1088283|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
332906|NCT00594516|1088284|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
332907|NCT00594516|1088282|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
332908|NCT00594516|1088283|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
332909|NCT00594516|1088284|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
332910|NCT00594516|1088282|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
332911|NCT00594516|1088283|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
332912|NCT00594516|1088284|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
332913|NCT00594516|1088282|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
332914|NCT00594516|1088283|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
332915|NCT00594516|1088284|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
332916|NCT00594516|1088282|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
332917|NCT00594516|1088283|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
332918|NCT00594516|1088284|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
332919|NCT00594516|1088282|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
332920|NCT00594516|1088283|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
332921|NCT00594516|1088284|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
332922|NCT00594516|1088282|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
332923|NCT00594516|1088283|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
332924|NCT00594516|1088284|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
332925|NCT00594516|1088282|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
332926|NCT00594516|1088283|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
332927|NCT00594516|1088284|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
332928|NCT00594464|1088292|P1|Overall Study|Delay in operation|2
332929|NCT00594464|1088292|P1|Overall Study|Withdrawal by Subject|1
332930|NCT00594399|1088421|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
332931|NCT00594399|1088422|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
332932|NCT00594399|1088423|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
332933|NCT00594399|1088421|P3|Rerandomization Arm 1 Only|Death|0
332934|NCT00594399|1088422|P2|Rerandomization Arm 1 Only|Death|1
332935|NCT00594399|1088423|P1|Rerandomization Arm 1 Only|Death|2
332936|NCT00594399|1088421|P3|Initial 3 Month Counseling|Family illness|0
332937|NCT00594399|1088422|P2|Initial 3 Month Counseling|Family illness|0
332938|NCT00594399|1088423|P1|Initial 3 Month Counseling|Family illness|1
332939|NCT00594399|1088421|P3|Initial 3 Month Counseling|Moved|0
332940|NCT00594399|1088422|P2|Initial 3 Month Counseling|Moved|0
332941|NCT00594399|1088423|P1|Initial 3 Month Counseling|Moved|1
332942|NCT00594399|1088421|P3|Initial 3 Month Counseling|Pain|0
332943|NCT00594399|1088422|P2|Initial 3 Month Counseling|Pain|0
332944|NCT00594399|1088423|P1|Initial 3 Month Counseling|Pain|2
332945|NCT00594399|1088421|P3|Initial 3 Month Counseling|Too busy|0
332946|NCT00594399|1088422|P2|Initial 3 Month Counseling|Too busy|1
332947|NCT00594399|1088423|P1|Initial 3 Month Counseling|Too busy|7
332948|NCT00594399|1088421|P3|Initial 3 Month Counseling|Personal issues|0
332949|NCT00594399|1088422|P2|Initial 3 Month Counseling|Personal issues|0
332950|NCT00594399|1088423|P1|Initial 3 Month Counseling|Personal issues|2
332951|NCT00594399|1088421|P3|Initial 3 Month Counseling|Lack of Interest|0
332952|NCT00594399|1088422|P2|Initial 3 Month Counseling|Lack of Interest|3
332953|NCT00594399|1088423|P1|Initial 3 Month Counseling|Lack of Interest|3
332954|NCT00594399|1088421|P3|Initial 3 Month Counseling|Not ready to exercise|0
332955|NCT00594399|1088422|P2|Initial 3 Month Counseling|Not ready to exercise|0
332956|NCT00594399|1088423|P1|Initial 3 Month Counseling|Not ready to exercise|1
332957|NCT00594386|1088445|P1|Overall Study|Other: Loss of drivers license|1
332958|NCT00594386|1088445|P1|Overall Study|Other: Patient wants prescription Neupro|1
332959|NCT00594386|1088445|P1|Overall Study|Other: Site terminated participation|1
332960|NCT00594386|1088445|P1|Overall Study|Other: Sponsor closure of study|1
332961|NCT00594386|1088445|P1|Overall Study|Other: Study terminated per investigator|2
332962|NCT00594386|1088445|P1|Overall Study|Other: Subject admitted to nursing home|1
332963|NCT00594386|1088445|P1|Overall Study|Other: Subject moved to Seattle|1
332964|NCT00594386|1088445|P1|Overall Study|Other: Patient went off patch (hospital)|1
332965|NCT00594386|1088445|P1|Overall Study|Lost to Follow-up|6
332966|NCT00594386|1088445|P1|Overall Study|Study ended per sponsor|115
332967|NCT00594386|1088445|P1|Overall Study|Subject withdrew consent|35
332968|NCT00594386|1088445|P1|Overall Study|Unsatisfactory compliance of subject|11
332969|NCT00594386|1088445|P1|Overall Study|Adverse Event|68
332970|NCT00594386|1088445|P1|Overall Study|Lack of Efficacy|12
332971|NCT00594386|1088445|P1|Overall Study|Major protocol violation|2
332972|NCT00594204|1088478|P2|Overall Study|Randomized but not treated|1
332973|NCT00594204|1088479|P1|Overall Study|Randomized but not treated|4
332974|NCT00594204|1088478|P2|Overall Study|Lack of Efficacy|4
332975|NCT00594204|1088479|P1|Overall Study|Lack of Efficacy|3
332976|NCT00594204|1088478|P2|Overall Study|Unspecified|3
332977|NCT00594204|1088479|P1|Overall Study|Unspecified|4
332978|NCT00594204|1088478|P2|Overall Study|Withdrawal by Subject|29
332979|NCT00594204|1088479|P1|Overall Study|Withdrawal by Subject|23
332980|NCT00594204|1088478|P2|Overall Study|Lost to Follow-up|5
332981|NCT00594204|1088479|P1|Overall Study|Lost to Follow-up|9
332982|NCT00594204|1088478|P2|Overall Study|Adverse Event|3
332983|NCT00594204|1088479|P1|Overall Study|Adverse Event|15
332984|NCT00594178|1088489|P1|Overall Study|Physician Decision|5
332985|NCT00594165|1088494|P1|Overall Study|Other: Site terminated participation|2
332986|NCT00594165|1088494|P1|Overall Study|Other: Subject enrolled in other trial|1
332987|NCT00594165|1088494|P1|Overall Study|Other: House bound; can't get to clinic|1
332988|NCT00594165|1088494|P1|Overall Study|Other: Brain surgery controlled symptoms|1
332989|NCT00594165|1088494|P1|Overall Study|Other: Subject moving|3
332990|NCT00594165|1088494|P1|Overall Study|Other: PI discretion|5
332991|NCT00594165|1088494|P1|Overall Study|Lost to Follow-up|4
332992|NCT00594165|1088494|P1|Overall Study|Study ended per sponsor|102
332993|NCT00594165|1088494|P1|Overall Study|Subject withdrew consent|27
332994|NCT00594165|1088494|P1|Overall Study|Unsatisfactory compliance of subject|6
332995|NCT00594165|1088494|P1|Overall Study|Adverse Event|52
332996|NCT00594165|1088494|P1|Overall Study|Lack of Efficacy|12
332997|NCT00594165|1088494|P1|Overall Study|Major protocol violation|1
332998|NCT00594100|1088500|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
332999|NCT00594100|1088500|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
333000|NCT00594100|1088500|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
333001|NCT00594100|1088500|P1|Procedure|Technical Failure|9
333002|NCT00594035|1088511|P2|Overall Study|Subject couldn't return due to job|1
333003|NCT00594035|1088512|P1|Overall Study|Subject couldn't return due to job|0
333004|NCT00594035|1088511|P2|Overall Study|Subject transferred to nursing home|1
333005|NCT00594035|1088512|P1|Overall Study|Subject transferred to nursing home|0
333006|NCT00594035|1088511|P2|Overall Study|Withdrawal by Subject|0
333007|NCT00594035|1088512|P1|Overall Study|Withdrawal by Subject|1
333008|NCT00594035|1088511|P2|Overall Study|Lost to Follow-up|1
333009|NCT00594035|1088512|P1|Overall Study|Lost to Follow-up|1
333010|NCT00593957|1088538|P3|Overall Study|Physician Decision|2
333011|NCT00593957|1088539|P2|Overall Study|Physician Decision|1
333012|NCT00593957|1088540|P1|Overall Study|Physician Decision|0
333013|NCT00593918|1088564|P2|Overall Study|Withdrawal by Subject|24
333014|NCT00593918|1088565|P1|Overall Study|Withdrawal by Subject|5
333015|NCT00593840|1088578|P1|Overall Study|Withdrawal by Subject|1
333016|NCT00593827|1088590|P2|Overall Study|On Active Treatment/Pending|2
333017|NCT00593827|1088591|P1|Overall Study|On Active Treatment/Pending|0
333018|NCT00593814|1088615|P2|Overall Study|Physician Decision|0
333019|NCT00593814|1088616|P1|Overall Study|Physician Decision|3
333020|NCT00593814|1088615|P2|Overall Study|Lost to Follow-up|0
333021|NCT00593814|1088616|P1|Overall Study|Lost to Follow-up|7
333022|NCT00593814|1088615|P2|Overall Study|Withdrawal by Subject|0
333023|NCT00593814|1088616|P1|Overall Study|Withdrawal by Subject|7
333024|NCT00593814|1088615|P2|Overall Study|Death|0
333025|NCT00593814|1088616|P1|Overall Study|Death|7
333026|NCT00593736|1088626|P4|Treatment Period and Placebo Run-out|Various|0
333027|NCT00593736|1088627|P3|Treatment Period and Placebo Run-out|Various|1
333028|NCT00593736|1088628|P2|Treatment Period and Placebo Run-out|Various|1
333029|NCT00593736|1088629|P1|Treatment Period and Placebo Run-out|Various|1
333030|NCT00593736|1088626|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
333031|NCT00593736|1088627|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
333032|NCT00593736|1088628|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
333033|NCT00593736|1088629|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
333034|NCT00593736|1088626|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
333035|NCT00593736|1088627|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
333036|NCT00593736|1088628|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
333037|NCT00593736|1088629|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
333038|NCT00593736|1088626|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
333039|NCT00593736|1088627|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
333040|NCT00593736|1088628|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
333041|NCT00593736|1088629|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
333042|NCT00593736|1088626|P4|Screening Period and Placebo Run-in|Various|25
333043|NCT00593736|1088627|P3|Screening Period and Placebo Run-in|Various|0
333044|NCT00593736|1088628|P2|Screening Period and Placebo Run-in|Various|0
333045|NCT00593736|1088629|P1|Screening Period and Placebo Run-in|Various|0
333046|NCT00593736|1088626|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
333047|NCT00593736|1088627|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
333048|NCT00593736|1088628|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
333049|NCT00593736|1088629|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
333050|NCT00593736|1088626|P4|Screening Period and Placebo Run-in|Study Termination|15
333051|NCT00593736|1088627|P3|Screening Period and Placebo Run-in|Study Termination|0
333052|NCT00593736|1088628|P2|Screening Period and Placebo Run-in|Study Termination|0
333053|NCT00593736|1088629|P1|Screening Period and Placebo Run-in|Study Termination|0
333054|NCT00593736|1088626|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
333055|NCT00593736|1088627|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
333056|NCT00593736|1088628|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
333057|NCT00593736|1088629|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
333058|NCT00593736|1088626|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
333059|NCT00593736|1088627|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
333060|NCT00593736|1088628|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
333061|NCT00593736|1088629|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
333062|NCT00593736|1088626|P4|Screening Period and Placebo Run-in|Adverse Event|3
333063|NCT00593736|1088627|P3|Screening Period and Placebo Run-in|Adverse Event|0
333064|NCT00593736|1088628|P2|Screening Period and Placebo Run-in|Adverse Event|0
333065|NCT00593736|1088629|P1|Screening Period and Placebo Run-in|Adverse Event|0
333066|NCT00593684|1088877|P2|Overall Study|Death|1
333067|NCT00593684|1088878|P1|Overall Study|Death|2
333068|NCT00593606|1088904|P1|Overall Study|Screen Failure|3
333069|NCT00593606|1088904|P1|Overall Study|Run-In Failure|5
333070|NCT00593606|1088904|P1|Overall Study|Lost to Follow-up|2
333071|NCT00593606|1088904|P1|Overall Study|Protocol Violation|3
333072|NCT00593606|1088904|P1|Overall Study|Withdrawal by Subject|1
333073|NCT00593606|1088904|P1|Overall Study|Adverse Event|13
333074|NCT00593333|1089103|P2|Overall Study|Lost to Follow-up|11
333075|NCT00593333|1089104|P1|Overall Study|Lost to Follow-up|10
333076|NCT00593112|1089127|P2|Overall Study|Withdrawal by Subject|0
333077|NCT00593112|1089128|P1|Overall Study|Withdrawal by Subject|5
333078|NCT00593112|1089127|P2|Overall Study|Unreadable Scan|0
333079|NCT00593112|1089128|P1|Overall Study|Unreadable Scan|1
333080|NCT00593112|1089127|P2|Overall Study|Abnormal Scan|0
333081|NCT00593112|1089128|P1|Overall Study|Abnormal Scan|1
333082|NCT00593112|1089127|P2|Overall Study|Scan Anxiety|0
333083|NCT00593112|1089128|P1|Overall Study|Scan Anxiety|3
333084|NCT00592904|1089155|P4|Overall Study|Not specified|0
333085|NCT00592904|1089156|P3|Overall Study|Not specified|0
333086|NCT00592904|1089157|P2|Overall Study|Not specified|3
333087|NCT00592904|1089158|P1|Overall Study|Not specified|3
333088|NCT00592904|1089155|P4|Overall Study|Physician Decision|0
333089|NCT00592904|1089156|P3|Overall Study|Physician Decision|1
333090|NCT00592904|1089157|P2|Overall Study|Physician Decision|3
333091|NCT00592904|1089158|P1|Overall Study|Physician Decision|0
333092|NCT00592904|1089155|P4|Overall Study|Lack of Efficacy|3
333093|NCT00592904|1089156|P3|Overall Study|Lack of Efficacy|2
333094|NCT00592904|1089157|P2|Overall Study|Lack of Efficacy|7
333095|NCT00592904|1089158|P1|Overall Study|Lack of Efficacy|2
333096|NCT00592904|1089155|P4|Overall Study|Withdrawal by Subject|2
333097|NCT00592904|1089156|P3|Overall Study|Withdrawal by Subject|1
333098|NCT00592904|1089157|P2|Overall Study|Withdrawal by Subject|16
333099|NCT00592904|1089158|P1|Overall Study|Withdrawal by Subject|4
333100|NCT00592904|1089155|P4|Overall Study|Protocol Violation|1
333101|NCT00592904|1089156|P3|Overall Study|Protocol Violation|0
333102|NCT00592904|1089157|P2|Overall Study|Protocol Violation|1
333103|NCT00592904|1089158|P1|Overall Study|Protocol Violation|1
333104|NCT00592904|1089155|P4|Overall Study|Adverse Event|5
333105|NCT00592904|1089156|P3|Overall Study|Adverse Event|13
333106|NCT00592904|1089157|P2|Overall Study|Adverse Event|25
333107|NCT00592904|1089158|P1|Overall Study|Adverse Event|15
333108|NCT00592852|1089184|P1|Overall Study|Withdrawal by Subject|1
333109|NCT00592852|1089184|P1|Overall Study|Found ineligible|1
333110|NCT00592852|1089184|P1|Overall Study|Adverse Event|3
333111|NCT00592852|1089184|P1|Overall Study|Non-compliance|1
333112|NCT00592839|1089192|P3|Overall Study|Lost to Follow-up|1
333113|NCT00592839|1089193|P2|Overall Study|Lost to Follow-up|1
333114|NCT00592839|1089194|P1|Overall Study|Lost to Follow-up|0
333115|NCT00592839|1089192|P3|Overall Study|Adverse Event|0
333116|NCT00592839|1089193|P2|Overall Study|Adverse Event|1
333117|NCT00592839|1089194|P1|Overall Study|Adverse Event|0
333118|NCT00592839|1089192|P3|Overall Study|Protocol Violation|2
333119|NCT00592839|1089193|P2|Overall Study|Protocol Violation|1
333122|NCT00592839|1089193|P2|Overall Study|Withdrawal by Subject|1
333123|NCT00592839|1089194|P1|Overall Study|Withdrawal by Subject|1
333124|NCT00592774|1089222|P5|Overall Study|Not specified|2
333125|NCT00592774|1089223|P4|Overall Study|Not specified|0
333126|NCT00592774|1089224|P3|Overall Study|Not specified|1
333127|NCT00592774|1089225|P2|Overall Study|Not specified|1
333128|NCT00592774|1089226|P1|Overall Study|Not specified|0
333129|NCT00592774|1089222|P5|Overall Study|Physician Decision|1
333130|NCT00592774|1089223|P4|Overall Study|Physician Decision|0
333131|NCT00592774|1089224|P3|Overall Study|Physician Decision|1
333132|NCT00592774|1089225|P2|Overall Study|Physician Decision|1
333133|NCT00592774|1089226|P1|Overall Study|Physician Decision|0
333134|NCT00592774|1089222|P5|Overall Study|Lack of Efficacy|2
333135|NCT00592774|1089223|P4|Overall Study|Lack of Efficacy|0
333136|NCT00592774|1089224|P3|Overall Study|Lack of Efficacy|0
333137|NCT00592774|1089225|P2|Overall Study|Lack of Efficacy|3
333138|NCT00592774|1089226|P1|Overall Study|Lack of Efficacy|3
333139|NCT00592774|1089222|P5|Overall Study|Withdrawal by Subject|0
333140|NCT00592774|1089223|P4|Overall Study|Withdrawal by Subject|0
333141|NCT00592774|1089224|P3|Overall Study|Withdrawal by Subject|0
333142|NCT00592774|1089225|P2|Overall Study|Withdrawal by Subject|7
333143|NCT00592774|1089226|P1|Overall Study|Withdrawal by Subject|3
333144|NCT00592774|1089222|P5|Overall Study|Protocol Violation|1
333145|NCT00592774|1089223|P4|Overall Study|Protocol Violation|0
333146|NCT00592774|1089224|P3|Overall Study|Protocol Violation|0
333147|NCT00592774|1089225|P2|Overall Study|Protocol Violation|1
333148|NCT00592774|1089226|P1|Overall Study|Protocol Violation|0
333149|NCT00592774|1089222|P5|Overall Study|Adverse Event|8
333150|NCT00592774|1089223|P4|Overall Study|Adverse Event|14
333151|NCT00592774|1089224|P3|Overall Study|Adverse Event|2
333152|NCT00592774|1089225|P2|Overall Study|Adverse Event|19
333153|NCT00592774|1089226|P1|Overall Study|Adverse Event|5
333154|NCT00592683|1089298|P2|Overall Study|Lost to Follow-up|1
333155|NCT00592683|1089299|P1|Overall Study|Lost to Follow-up|0
333156|NCT00592683|1089298|P2|Overall Study|Other|0
333157|NCT00592683|1089299|P1|Overall Study|Other|1
333158|NCT00592683|1089298|P2|Overall Study|Study drug expired|0
333159|NCT00592683|1089299|P1|Overall Study|Study drug expired|1
333160|NCT00592683|1089298|P2|Overall Study|Protocol Violation|0
333161|NCT00592683|1089299|P1|Overall Study|Protocol Violation|1
333162|NCT00592683|1089298|P2|Overall Study|Adverse Event|2
333163|NCT00592683|1089299|P1|Overall Study|Adverse Event|0
333164|NCT00592683|1089298|P2|Overall Study|Withdrawal by Subject|0
333165|NCT00592683|1089299|P1|Overall Study|Withdrawal by Subject|1
333166|NCT00592683|1089298|P2|Overall Study|Found ineligible|1
333167|NCT00592683|1089299|P1|Overall Study|Found ineligible|0
333168|NCT00592631|1089309|P2|Overall Study|Lost to Follow-up|2
333169|NCT00592631|1089310|P1|Overall Study|Lost to Follow-up|0
333170|NCT00592384|1089355|P2|Overall Study|Withdrawal by Subject|6
333171|NCT00592384|1089356|P1|Overall Study|Withdrawal by Subject|5
333172|NCT00592358|1089364|P1|Overall Study|Inability to swallow pills|1
333173|NCT00592358|1089364|P1|Overall Study|Lack of Efficacy|2
333174|NCT00592358|1089364|P1|Overall Study|Adverse Event|1
333175|NCT00592358|1089364|P1|Overall Study|Withdrawal by Subject|2
333176|NCT00592319|1089371|P2|Overall Study|Lost to Follow-up|3
333177|NCT00592319|1089372|P1|Overall Study|Lost to Follow-up|0
333178|NCT00592072|1089447|P2|Wash Out Period|Lost to Follow-up|1
333179|NCT00592072|1089448|P1|Wash Out Period|Lost to Follow-up|1
333180|NCT00592007|1089470|P1|Overall Study|patient ineligible (out of lab range)|1
333181|NCT00592007|1089470|P1|Overall Study|Withdrawal by Subject|1
333182|NCT00591864|1089475|P1|Overall Study|Incomplete Imaging|5
333183|NCT00591851|1089481|P1|Overall Study|Progressive Disease|1
333184|NCT00591851|1089481|P1|Overall Study|Adverse Event|2
333185|NCT00591851|1089481|P1|Overall Study|Withdrawal by Subject|3
333186|NCT00591773|1089521|P3|Overall Study|Other|4
333187|NCT00591773|1089522|P2|Overall Study|Other|1
333188|NCT00591773|1089523|P1|Overall Study|Other|1
333189|NCT00591773|1089521|P3|Overall Study|Lack of Efficacy|2
333190|NCT00591773|1089522|P2|Overall Study|Lack of Efficacy|2
333191|NCT00591773|1089523|P1|Overall Study|Lack of Efficacy|1
333192|NCT00591773|1089521|P3|Overall Study|Withdrawal by Subject|3
333193|NCT00591773|1089522|P2|Overall Study|Withdrawal by Subject|5
333194|NCT00591773|1089523|P1|Overall Study|Withdrawal by Subject|2
333195|NCT00591773|1089521|P3|Overall Study|Lost to Follow-up|1
333196|NCT00591773|1089522|P2|Overall Study|Lost to Follow-up|4
333197|NCT00591773|1089523|P1|Overall Study|Lost to Follow-up|1
333198|NCT00591773|1089521|P3|Overall Study|Protocol Violation|0
333199|NCT00591773|1089522|P2|Overall Study|Protocol Violation|3
333200|NCT00591773|1089523|P1|Overall Study|Protocol Violation|2
333201|NCT00591773|1089521|P3|Overall Study|Adverse Event|6
333202|NCT00591773|1089522|P2|Overall Study|Adverse Event|9
333203|NCT00591773|1089523|P1|Overall Study|Adverse Event|9
333204|NCT00591734|1089582|P1|Overall Study|Intercurrent Illness|8
333205|NCT00591734|1089582|P1|Overall Study|Physician Decision|5
333206|NCT00591734|1089582|P1|Overall Study|Adverse Event|5
333207|NCT00591734|1089582|P1|Overall Study|Lack of Efficacy|35
333208|NCT00591721|1089588|P2|Overall Study|Intervention not received|8
333209|NCT00591721|1089589|P1|Overall Study|Intervention not received|10
333210|NCT00591721|1089588|P2|Overall Study|Lost to Follow-up|4
333211|NCT00591721|1089589|P1|Overall Study|Lost to Follow-up|1
333212|NCT00591721|1089588|P2|Overall Study|Withdrawal by Subject|10
333213|NCT00591721|1089589|P1|Overall Study|Withdrawal by Subject|10
333214|NCT00591591|1089597|P2|Overall Study|Lack of Efficacy|2
333215|NCT00591591|1089598|P1|Overall Study|Lack of Efficacy|10
333216|NCT00591591|1089597|P2|Overall Study|Withdrawal by Subject|37
333217|NCT00591591|1089598|P1|Overall Study|Withdrawal by Subject|1
333218|NCT00591578|1089615|P3|Open-Label Extension Phase|Other|0
333219|NCT00591578|1089616|P2|Open-Label Extension Phase|Other|0
333220|NCT00591578|1089617|P1|Open-Label Extension Phase|Other|1
333221|NCT00591578|1089615|P3|Open-Label Extension Phase|Withdrawal by Subject|0
333222|NCT00591578|1089616|P2|Open-Label Extension Phase|Withdrawal by Subject|1
333223|NCT00591578|1089617|P1|Open-Label Extension Phase|Withdrawal by Subject|1
333224|NCT00591578|1089615|P3|Open-Label Extension Phase|Lost to Follow-up|0
333225|NCT00591578|1089616|P2|Open-Label Extension Phase|Lost to Follow-up|4
333226|NCT00591578|1089617|P1|Open-Label Extension Phase|Lost to Follow-up|1
333227|NCT00591578|1089615|P3|Open-Label Extension Phase|Adverse Event|0
333228|NCT00591578|1089616|P2|Open-Label Extension Phase|Adverse Event|5
333229|NCT00591578|1089617|P1|Open-Label Extension Phase|Adverse Event|3
333230|NCT00591578|1089615|P3|Double-Blind Treatment Phase|Other|4
333231|NCT00591578|1089616|P2|Double-Blind Treatment Phase|Other|9
333232|NCT00591578|1089617|P1|Double-Blind Treatment Phase|Other|4
333233|NCT00591578|1089615|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
333234|NCT00591578|1089616|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
333235|NCT00591578|1089617|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
333236|NCT00591578|1089615|P3|Double-Blind Treatment Phase|Pregnancy|0
333237|NCT00591578|1089616|P2|Double-Blind Treatment Phase|Pregnancy|0
333238|NCT00591578|1089617|P1|Double-Blind Treatment Phase|Pregnancy|1
333239|NCT00591578|1089615|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
333240|NCT00591578|1089616|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
333241|NCT00591578|1089617|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
333242|NCT00591578|1089615|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
333243|NCT00591578|1089616|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
333244|NCT00591578|1089617|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
333245|NCT00591578|1089615|P3|Double-Blind Treatment Phase|Protocol Violation|3
333246|NCT00591578|1089616|P2|Double-Blind Treatment Phase|Protocol Violation|2
333247|NCT00591578|1089617|P1|Double-Blind Treatment Phase|Protocol Violation|3
333248|NCT00591578|1089615|P3|Double-Blind Treatment Phase|Adverse Event|19
333249|NCT00591578|1089616|P2|Double-Blind Treatment Phase|Adverse Event|26
333250|NCT00591578|1089617|P1|Double-Blind Treatment Phase|Adverse Event|20
333251|NCT00591565|1089668|P1|Overall Study|lost follow up, withdrawn|5
333252|NCT00591370|1089672|P1|Overall Study|Not Treated|2
333253|NCT00591344|1089680|P2|Overall Study|Did not want to come off medication|1
333254|NCT00591344|1089681|P1|Overall Study|Did not want to come off medication|0
333255|NCT00591344|1089680|P2|Overall Study|Lost to Follow-up|1
333256|NCT00591344|1089681|P1|Overall Study|Lost to Follow-up|0
333257|NCT00591344|1089680|P2|Overall Study|Death|1
333258|NCT00591344|1089681|P1|Overall Study|Death|0
333259|NCT00591344|1089680|P2|Overall Study|Underwent DBS|2
333260|NCT00591344|1089681|P1|Overall Study|Underwent DBS|2
333261|NCT00591344|1089680|P2|Overall Study|Medical complications|3
333262|NCT00591344|1089681|P1|Overall Study|Medical complications|1
333263|NCT00591344|1089680|P2|Overall Study|Moved out of state|0
333264|NCT00591344|1089681|P1|Overall Study|Moved out of state|1
333265|NCT00591344|1089680|P2|Overall Study|Transportation issues|0
333266|NCT00591344|1089681|P1|Overall Study|Transportation issues|1
333267|NCT00591266|1089707|P3|Overall Study|Other|5
333268|NCT00591266|1089708|P2|Overall Study|Other|4
333269|NCT00591266|1089709|P1|Overall Study|Other|1
333270|NCT00591266|1089707|P3|Overall Study|Lack of Efficacy|0
333271|NCT00591266|1089708|P2|Overall Study|Lack of Efficacy|2
333272|NCT00591266|1089709|P1|Overall Study|Lack of Efficacy|0
333273|NCT00591266|1089707|P3|Overall Study|Withdrawal by Subject|5
333274|NCT00591266|1089708|P2|Overall Study|Withdrawal by Subject|2
333275|NCT00591266|1089709|P1|Overall Study|Withdrawal by Subject|6
333276|NCT00591266|1089707|P3|Overall Study|Protocol Violation|1
333277|NCT00591266|1089708|P2|Overall Study|Protocol Violation|0
333278|NCT00591266|1089709|P1|Overall Study|Protocol Violation|0
333279|NCT00591266|1089707|P3|Overall Study|Lost to Follow-up|0
333280|NCT00591266|1089708|P2|Overall Study|Lost to Follow-up|1
333281|NCT00591266|1089709|P1|Overall Study|Lost to Follow-up|0
333282|NCT00591266|1089707|P3|Overall Study|Adverse Event|3
333283|NCT00591266|1089708|P2|Overall Study|Adverse Event|2
333284|NCT00591266|1089709|P1|Overall Study|Adverse Event|2
333285|NCT00591253|1089762|P3|Overall Study|Other|3
333286|NCT00591253|1089763|P2|Overall Study|Other|5
333287|NCT00591253|1089764|P1|Overall Study|Other|5
333288|NCT00591253|1089762|P3|Overall Study|Lack of Efficacy|3
333289|NCT00591253|1089763|P2|Overall Study|Lack of Efficacy|0
333290|NCT00591253|1089764|P1|Overall Study|Lack of Efficacy|1
333291|NCT00591253|1089762|P3|Overall Study|Withdrawal by Subject|6
333292|NCT00591253|1089763|P2|Overall Study|Withdrawal by Subject|7
333293|NCT00591253|1089764|P1|Overall Study|Withdrawal by Subject|1
333294|NCT00591253|1089762|P3|Overall Study|Lost to Follow-up|0
333295|NCT00591253|1089763|P2|Overall Study|Lost to Follow-up|4
333296|NCT00591253|1089764|P1|Overall Study|Lost to Follow-up|2
333297|NCT00591253|1089762|P3|Overall Study|Protocol Violation|2
333298|NCT00591253|1089763|P2|Overall Study|Protocol Violation|2
333299|NCT00591253|1089764|P1|Overall Study|Protocol Violation|2
333300|NCT00591253|1089762|P3|Overall Study|Adverse Event|1
333301|NCT00591253|1089763|P2|Overall Study|Adverse Event|3
333302|NCT00591253|1089764|P1|Overall Study|Adverse Event|3
333303|NCT00591214|1089832|P1|Overall Study|Withdrawal by Subject|1
333304|NCT00591214|1089832|P1|Overall Study|Physician Decision|7
333305|NCT00591149|1089841|P1|Overall Study|Withdrawal by Subject|1
333306|NCT00591149|1089841|P1|Overall Study|Adverse Event|4
333307|NCT00591006|1089857|P24|Overall Study|Adverse Event|0
333308|NCT00591006|1089858|P23|Overall Study|Adverse Event|1
333309|NCT00591006|1089859|P22|Overall Study|Adverse Event|0
333310|NCT00591006|1089860|P21|Overall Study|Adverse Event|0
333311|NCT00591006|1089861|P20|Overall Study|Adverse Event|0
333312|NCT00591006|1089862|P19|Overall Study|Adverse Event|0
333313|NCT00591006|1089863|P18|Overall Study|Adverse Event|0
333314|NCT00591006|1089864|P17|Overall Study|Adverse Event|0
333315|NCT00591006|1089865|P16|Overall Study|Adverse Event|0
333316|NCT00591006|1089866|P15|Overall Study|Adverse Event|0
333317|NCT00591006|1089867|P14|Overall Study|Adverse Event|0
333318|NCT00591006|1089868|P13|Overall Study|Adverse Event|0
333319|NCT00591006|1089869|P12|Overall Study|Adverse Event|0
333320|NCT00591006|1089870|P11|Overall Study|Adverse Event|0
333321|NCT00591006|1089871|P10|Overall Study|Adverse Event|0
333322|NCT00591006|1089872|P9|Overall Study|Adverse Event|0
333323|NCT00591006|1089873|P8|Overall Study|Adverse Event|0
333324|NCT00591006|1089874|P7|Overall Study|Adverse Event|0
333325|NCT00591006|1089875|P6|Overall Study|Adverse Event|0
333326|NCT00591006|1089876|P5|Overall Study|Adverse Event|0
333327|NCT00591006|1089877|P4|Overall Study|Adverse Event|0
333328|NCT00591006|1089878|P3|Overall Study|Adverse Event|0
333329|NCT00591006|1089879|P2|Overall Study|Adverse Event|0
333330|NCT00591006|1089880|P1|Overall Study|Adverse Event|0
333331|NCT00591006|1089857|P24|Overall Study|Withdrawal by Subject|1
333332|NCT00591006|1089858|P23|Overall Study|Withdrawal by Subject|0
333333|NCT00591006|1089859|P22|Overall Study|Withdrawal by Subject|0
333334|NCT00591006|1089860|P21|Overall Study|Withdrawal by Subject|0
333335|NCT00591006|1089861|P20|Overall Study|Withdrawal by Subject|0
333336|NCT00591006|1089862|P19|Overall Study|Withdrawal by Subject|0
333337|NCT00591006|1089863|P18|Overall Study|Withdrawal by Subject|0
333338|NCT00591006|1089864|P17|Overall Study|Withdrawal by Subject|0
333339|NCT00591006|1089865|P16|Overall Study|Withdrawal by Subject|1
333340|NCT00591006|1089866|P15|Overall Study|Withdrawal by Subject|0
333341|NCT00591006|1089867|P14|Overall Study|Withdrawal by Subject|0
333342|NCT00591006|1089868|P13|Overall Study|Withdrawal by Subject|0
333343|NCT00591006|1089869|P12|Overall Study|Withdrawal by Subject|0
333344|NCT00591006|1089870|P11|Overall Study|Withdrawal by Subject|0
333345|NCT00591006|1089871|P10|Overall Study|Withdrawal by Subject|0
333346|NCT00591006|1089872|P9|Overall Study|Withdrawal by Subject|0
333347|NCT00591006|1089873|P8|Overall Study|Withdrawal by Subject|0
333348|NCT00591006|1089874|P7|Overall Study|Withdrawal by Subject|0
333349|NCT00591006|1089875|P6|Overall Study|Withdrawal by Subject|0
333350|NCT00591006|1089876|P5|Overall Study|Withdrawal by Subject|0
333351|NCT00591006|1089877|P4|Overall Study|Withdrawal by Subject|0
333352|NCT00591006|1089878|P3|Overall Study|Withdrawal by Subject|0
333353|NCT00591006|1089879|P2|Overall Study|Withdrawal by Subject|0
333354|NCT00591006|1089880|P1|Overall Study|Withdrawal by Subject|0
333355|NCT00590967|1089900|P2|Overall Study|Did not receive chemo per protocol|0
333356|NCT00590967|1089901|P1|Overall Study|Did not receive chemo per protocol|1
333357|NCT00590967|1089900|P2|Overall Study|Did not sign consent form|1
333358|NCT00590967|1089901|P1|Overall Study|Did not sign consent form|0
333359|NCT00590967|1089900|P2|Overall Study|Non-compliant|2
333360|NCT00590967|1089901|P1|Overall Study|Non-compliant|0
333361|NCT00590967|1089900|P2|Overall Study|Poor performance status|1
333362|NCT00590967|1089901|P1|Overall Study|Poor performance status|0
333363|NCT00590967|1089900|P2|Overall Study|Ineligible|0
333364|NCT00590967|1089901|P1|Overall Study|Ineligible|1
333365|NCT00590967|1089900|P2|Overall Study|Withdrawal by Subject|1
333366|NCT00590967|1089901|P1|Overall Study|Withdrawal by Subject|1
333367|NCT00590902|1089913|P1|Overall Study|Death|1
333368|NCT00590759|1089948|P1|Overall Study|Lost to Follow-up|28
333369|NCT00590759|1089948|P1|Overall Study|Death|52
333370|NCT00590720|1089955|P2|Overall Study|Withdrawal by Subject|1
333371|NCT00590720|1089956|P1|Overall Study|Withdrawal by Subject|0
333372|NCT00590720|1089955|P2|Overall Study|Lost to Follow-up|0
333373|NCT00590720|1089956|P1|Overall Study|Lost to Follow-up|1
333374|NCT00590590|1090001|P3|Overall Study|Did not complete study|0
333375|NCT00590590|1090002|P2|Overall Study|Did not complete study|1
333376|NCT00590590|1090003|P1|Overall Study|Did not complete study|0
333377|NCT00590590|1090001|P3|Overall Study|Did not complete due to study closure|1
333378|NCT00590590|1090002|P2|Overall Study|Did not complete due to study closure|1
333379|NCT00590590|1090003|P1|Overall Study|Did not complete due to study closure|1
333380|NCT00590590|1090001|P3|Overall Study|Withdrawal by Subject|1
333381|NCT00590590|1090002|P2|Overall Study|Withdrawal by Subject|1
333382|NCT00590590|1090003|P1|Overall Study|Withdrawal by Subject|0
333383|NCT00590590|1090001|P3|Overall Study|Lost to Follow-up|2
333384|NCT00590590|1090002|P2|Overall Study|Lost to Follow-up|1
333385|NCT00590590|1090003|P1|Overall Study|Lost to Follow-up|4
333386|NCT00590590|1090001|P3|Overall Study|Protocol Violation|2
333387|NCT00590590|1090002|P2|Overall Study|Protocol Violation|0
333388|NCT00590590|1090003|P1|Overall Study|Protocol Violation|0
333389|NCT00590590|1090001|P3|Overall Study|Adverse Event|0
333390|NCT00590590|1090002|P2|Overall Study|Adverse Event|0
333391|NCT00590590|1090003|P1|Overall Study|Adverse Event|1
333392|NCT00590590|1090001|P3|Overall Study|Lack of Efficacy|0
333393|NCT00590590|1090002|P2|Overall Study|Lack of Efficacy|2
333394|NCT00590590|1090003|P1|Overall Study|Lack of Efficacy|1
333395|NCT00590577|1090030|P4|Overall Study|Various reasons|2
333396|NCT00590577|1090031|P3|Overall Study|Various reasons|1
333397|NCT00590577|1090032|P2|Overall Study|Various reasons|3
333398|NCT00590577|1090033|P1|Overall Study|Various reasons|1
333399|NCT00590577|1090030|P4|Overall Study|Pregnancy|0
333400|NCT00590577|1090031|P3|Overall Study|Pregnancy|0
333401|NCT00590577|1090032|P2|Overall Study|Pregnancy|1
333402|NCT00590577|1090033|P1|Overall Study|Pregnancy|0
333403|NCT00590577|1090030|P4|Overall Study|Lost to Follow-up|9
333404|NCT00590577|1090031|P3|Overall Study|Lost to Follow-up|6
333405|NCT00590577|1090032|P2|Overall Study|Lost to Follow-up|6
333406|NCT00590577|1090033|P1|Overall Study|Lost to Follow-up|12
333407|NCT00590577|1090030|P4|Overall Study|Adverse Event|11
333408|NCT00590577|1090031|P3|Overall Study|Adverse Event|13
333409|NCT00590577|1090032|P2|Overall Study|Adverse Event|10
333410|NCT00590577|1090033|P1|Overall Study|Adverse Event|10
333411|NCT00590577|1090030|P4|Overall Study|Withdrawal by Subject|26
333412|NCT00590577|1090031|P3|Overall Study|Withdrawal by Subject|30
333413|NCT00590577|1090032|P2|Overall Study|Withdrawal by Subject|28
333414|NCT00590577|1090033|P1|Overall Study|Withdrawal by Subject|23
333415|NCT00590577|1090030|P4|Overall Study|Lack of Efficacy|45
333416|NCT00590577|1090031|P3|Overall Study|Lack of Efficacy|23
333417|NCT00590577|1090032|P2|Overall Study|Lack of Efficacy|28
333418|NCT00590577|1090033|P1|Overall Study|Lack of Efficacy|31
333419|NCT00590564|1090051|P1|Overall Study|Patient Non-compliance|6
333420|NCT00590564|1090051|P1|Overall Study|Patient Found to be Ineligible|1
333421|NCT00590564|1090051|P1|Overall Study|Protocol Violation|1
333422|NCT00590564|1090051|P1|Overall Study|Lost to Follow-up|6
333423|NCT00590564|1090051|P1|Overall Study|Withdrawal by Subject|4
333424|NCT00590538|1090055|P1|Overall Study|Study terminated before completed|2
333425|NCT00590317|1090096|P2|Overall Study|Lack of Efficacy|5
333426|NCT00590317|1090097|P1|Overall Study|Lack of Efficacy|1
333427|NCT00590044|1090129|P2|Overall Study|Protocol Violation|0
333428|NCT00590044|1090130|P1|Overall Study|Protocol Violation|1
333429|NCT00590044|1090129|P2|Overall Study|wrong insulin arm assigned|0
333430|NCT00590044|1090130|P1|Overall Study|wrong insulin arm assigned|1
333431|NCT00590044|1090129|P2|Overall Study|Withdrawal by Subject|2
333432|NCT00590044|1090130|P1|Overall Study|Withdrawal by Subject|2
333433|NCT00590031|1090136|P1|Overall Study|Admin Hold|1
333434|NCT00590031|1090136|P1|Overall Study|Metastatic Disease|1
333435|NCT00590031|1090136|P1|Overall Study|Withdrawal by Subject|1
333436|NCT00590031|1090136|P1|Overall Study|Adverse Event|3
333437|NCT00589979|1090163|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
333438|NCT00589979|1090164|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
333439|NCT00589979|1090165|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
333440|NCT00589979|1090163|P3|Double-Blind Treatment Period 3|Protocol Violation|0
333441|NCT00589979|1090164|P2|Double-Blind Treatment Period 3|Protocol Violation|1
333442|NCT00589979|1090165|P1|Double-Blind Treatment Period 3|Protocol Violation|0
333443|NCT00589979|1090163|P3|Double-Blind Treatment Period 2|Other|1
333444|NCT00589979|1090164|P2|Double-Blind Treatment Period 2|Other|0
333445|NCT00589979|1090165|P1|Double-Blind Treatment Period 2|Other|0
333446|NCT00589979|1090163|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
333447|NCT00589979|1090164|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
333448|NCT00589979|1090165|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
333449|NCT00589979|1090163|P3|Double-Blind Treatment Period 2|Adverse Event|0
333450|NCT00589979|1090164|P2|Double-Blind Treatment Period 2|Adverse Event|1
333451|NCT00589979|1090165|P1|Double-Blind Treatment Period 2|Adverse Event|0
333452|NCT00589979|1090163|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
333453|NCT00589979|1090164|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
333454|NCT00589979|1090165|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
333455|NCT00589979|1090163|P3|Double-Blind Treatment Period 1|Protocol Violation|1
333456|NCT00589979|1090164|P2|Double-Blind Treatment Period 1|Protocol Violation|1
333457|NCT00589979|1090165|P1|Double-Blind Treatment Period 1|Protocol Violation|0
333458|NCT00589979|1090163|P3|Double-Blind Treatment Period 1|Adverse Event|0
333459|NCT00589979|1090164|P2|Double-Blind Treatment Period 1|Adverse Event|1
333460|NCT00589979|1090165|P1|Double-Blind Treatment Period 1|Adverse Event|0
333461|NCT00589979|1090163|P3|Run-In Period|Informed Consent Withdrawn|0
333462|NCT00589979|1090164|P2|Run-In Period|Informed Consent Withdrawn|0
333463|NCT00589979|1090165|P1|Run-In Period|Informed Consent Withdrawn|4
333464|NCT00589979|1090163|P3|Run-In Period|Withdrawal by Subject|0
333465|NCT00589979|1090164|P2|Run-In Period|Withdrawal by Subject|0
333466|NCT00589979|1090165|P1|Run-In Period|Withdrawal by Subject|10
333467|NCT00589979|1090163|P3|Run-In Period|Did not qualify for randomization|0
333468|NCT00589979|1090164|P2|Run-In Period|Did not qualify for randomization|0
333469|NCT00589979|1090165|P1|Run-In Period|Did not qualify for randomization|54
333470|NCT00589979|1090163|P3|Run-In Period|Protocol Violation|0
333471|NCT00589979|1090164|P2|Run-In Period|Protocol Violation|0
333472|NCT00589979|1090165|P1|Run-In Period|Protocol Violation|3
333473|NCT00589979|1090163|P3|Run-In Period|Adverse Event|0
333474|NCT00589979|1090164|P2|Run-In Period|Adverse Event|0
333475|NCT00589979|1090165|P1|Run-In Period|Adverse Event|5
333476|NCT00589914|1090204|P2|Overall Study|Other|17
333477|NCT00589914|1090205|P1|Overall Study|Other|22
333478|NCT00589914|1090204|P2|Overall Study|Withdrawal by Subject|49
333479|NCT00589914|1090205|P1|Overall Study|Withdrawal by Subject|55
333480|NCT00589914|1090204|P2|Overall Study|Pregnancy|0
333481|NCT00589914|1090205|P1|Overall Study|Pregnancy|1
333482|NCT00589914|1090204|P2|Overall Study|Lost to Follow-up|18
333483|NCT00589914|1090205|P1|Overall Study|Lost to Follow-up|11
333484|NCT00589914|1090204|P2|Overall Study|Lack of Efficacy|43
333485|NCT00589914|1090205|P1|Overall Study|Lack of Efficacy|40
333486|NCT00589914|1090204|P2|Overall Study|Death|0
333487|NCT00589914|1090205|P1|Overall Study|Death|2
333488|NCT00589914|1090204|P2|Overall Study|Adverse Event|10
333489|NCT00589914|1090205|P1|Overall Study|Adverse Event|19
333490|NCT00589784|1090237|P2|Overall Study|Adverse Event|4
333491|NCT00589784|1090238|P1|Overall Study|Adverse Event|0
333492|NCT00589784|1090237|P2|Overall Study|Patient inevaluable|0
333493|NCT00589784|1090238|P1|Overall Study|Patient inevaluable|1
333494|NCT00589784|1090237|P2|Overall Study|Withdrawal by Subject|6
333495|NCT00589784|1090238|P1|Overall Study|Withdrawal by Subject|0
333496|NCT00589693|1090245|P2|Overall Study|Protocol Violation|1
333497|NCT00589693|1090246|P1|Overall Study|Protocol Violation|1
333498|NCT00589693|1090245|P2|Overall Study|Physician Decision|1
333499|NCT00589693|1090246|P1|Overall Study|Physician Decision|0
333500|NCT00589693|1090245|P2|Overall Study|Lost to Follow-up|0
333501|NCT00589693|1090246|P1|Overall Study|Lost to Follow-up|1
333502|NCT00589693|1090245|P2|Overall Study|Lack of Efficacy|1
333503|NCT00589693|1090246|P1|Overall Study|Lack of Efficacy|0
333504|NCT00589693|1090245|P2|Overall Study|Death|16
333505|NCT00589693|1090246|P1|Overall Study|Death|26
333506|NCT00589693|1090245|P2|Overall Study|Adverse Event|4
333507|NCT00589693|1090246|P1|Overall Study|Adverse Event|4
333508|NCT00589693|1090245|P2|Overall Study|randomized in error|6
333509|NCT00589693|1090246|P1|Overall Study|randomized in error|12
333510|NCT00589667|1090260|P1|Overall Study|Withdrawal by Subject|1
333511|NCT00589667|1090260|P1|Overall Study|Adverse Event|2
333512|NCT00589628|1090267|P2|Overall Study|Lost to Follow-up|1
333513|NCT00589628|1090268|P1|Overall Study|Lost to Follow-up|0
333514|NCT00589602|1090274|P1|Overall Study|Did not collect enough CD34+ cells|1
333515|NCT00589303|1090311|P2|Overall Study|Withdrawal by Subject|1
333516|NCT00589303|1090312|P1|Overall Study|Withdrawal by Subject|2
333517|NCT00589290|1090318|P1|Overall Study|Withdrawal by Subject|1
333518|NCT00589108|1090342|P3|Overall Study|Death|4
333519|NCT00589108|1090343|P2|Overall Study|Death|3
333520|NCT00589108|1090344|P1|Overall Study|Death|3
333521|NCT00589108|1090342|P3|Overall Study|Lost to Follow-up|1
333522|NCT00589108|1090343|P2|Overall Study|Lost to Follow-up|1
333523|NCT00589108|1090344|P1|Overall Study|Lost to Follow-up|1
333524|NCT00588237|1090364|P1|Overall Study|Patien not treated|1
333525|NCT00588237|1090364|P1|Overall Study|Evaluable for toxicity only|3
333526|NCT00588952|1090378|P2|Overall Study|Withdrawal by Subject|5
333527|NCT00588952|1090379|P1|Overall Study|Withdrawal by Subject|3
333528|NCT00588952|1090378|P2|Overall Study|Adverse Event|2
333529|NCT00588952|1090379|P1|Overall Study|Adverse Event|0
333530|NCT00588861|1090407|P2|10 Years|Incomplete due to study termination|114
333531|NCT00588861|1090408|P1|10 Years|Incomplete due to study termination|107
333532|NCT00588861|1090407|P2|8 Years|Patients did not return for follow-up|114
333533|NCT00588861|1090408|P1|8 Years|Patients did not return for follow-up|105
333534|NCT00588861|1090407|P2|6 Years|Patients did not return for follow-up|109
333535|NCT00588861|1090408|P1|6 Years|Patients did not return for follow-up|104
333536|NCT00588861|1090407|P2|4 Years|Patients did not return for follow-up|103
333537|NCT00588861|1090408|P1|4 Years|Patients did not return for follow-up|91
333538|NCT00588861|1090407|P2|2 Years|Patients did not return for follow-up|87
333539|NCT00588861|1090408|P1|2 Years|Patients did not return for follow-up|92
333540|NCT00588861|1090407|P2|1 Year|Patients did not return for follow-up|82
333541|NCT00588861|1090408|P1|1 Year|Patients did not return for follow-up|89
333542|NCT00588861|1090407|P2|6 Months|Patients did not return for follow-up|73
333543|NCT00588861|1090408|P1|6 Months|Patients did not return for follow-up|98
333544|NCT00588861|1090407|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
333545|NCT00588861|1090408|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
333546|NCT00588822|1090427|P1|Overall Study|progression of disease|8
333547|NCT00588731|1090447|P2|Overall Study|Withdrawal by Subject|2
333548|NCT00588731|1090448|P1|Overall Study|Withdrawal by Subject|3
333549|NCT00588692|1090458|P2|Overall Study|Death|0
333550|NCT00588692|1090459|P1|Overall Study|Death|1
333551|NCT00588692|1090458|P2|Overall Study|Cancer|0
333552|NCT00588692|1090459|P1|Overall Study|Cancer|1
333553|NCT00588692|1090458|P2|Overall Study|Severe Peptic Ulcer Disease|0
333554|NCT00588692|1090459|P1|Overall Study|Severe Peptic Ulcer Disease|1
333555|NCT00588692|1090458|P2|Overall Study|Hip Surgery|1
333556|NCT00588692|1090459|P1|Overall Study|Hip Surgery|0
333557|NCT00588692|1090458|P2|Overall Study|Withdrawal by Subject|2
333558|NCT00588692|1090459|P1|Overall Study|Withdrawal by Subject|4
333559|NCT00588666|1090495|P1|Overall Study|Adverse Event|4
333560|NCT00588640|1090500|P1|Overall Study|Ineligible Patient|1
333561|NCT00588640|1090500|P1|Overall Study|Physician Decision|1
333562|NCT00588445|1090519|P1|Overall Study|Not Treated|10
333563|NCT00588445|1090519|P1|Overall Study|Disease Progression|1
333564|NCT00588445|1090519|P1|Overall Study|Withdrawal by Subject|3
333565|NCT00588445|1090519|P1|Overall Study|Protocol Violation|1
333566|NCT00588354|1090543|P2|Baseline to 4 Weeks|Lost to Follow-up|1
333567|NCT00588354|1090544|P1|Baseline to 4 Weeks|Lost to Follow-up|0
333568|NCT00588354|1090543|P2|Baseline to 2 Weeks|Lack of Efficacy|0
333569|NCT00588354|1090544|P1|Baseline to 2 Weeks|Lack of Efficacy|1
333570|NCT00588354|1090543|P2|Baseline to 2 Weeks|Adverse Event|0
333571|NCT00588354|1090544|P1|Baseline to 2 Weeks|Adverse Event|1
333572|NCT00588341|1090564|P1|Overall Study|Patient ineligible|1
333573|NCT00588341|1090564|P1|Overall Study|Not treated due to metastatic disease|1
333574|NCT00588341|1090564|P1|Overall Study|Withdrawal by Subject|3
333575|NCT00588146|1090587|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
333576|NCT00588146|1090588|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
333577|NCT00588094|1090594|P1|Overall Study|Progression of Disease|2
333578|NCT00588094|1090594|P1|Overall Study|Adverse Event|3
333579|NCT00587964|1090611|P1|Overall Study|Progression of Disease|4
333580|NCT00587964|1090611|P1|Overall Study|Patient did not receive intervention|5
333581|NCT00587964|1090611|P1|Overall Study|Patient found to be ineligible|1
333582|NCT00587964|1090611|P1|Overall Study|Lost to Follow-up|1
333583|NCT00587964|1090611|P1|Overall Study|Withdrawal by Subject|1
333584|NCT00587860|1090617|P2|Overall Study|Withdrawal by Subject|3
333585|NCT00587860|1090618|P1|Overall Study|Withdrawal by Subject|3
333586|NCT00587860|1090617|P2|Overall Study|Lost to Follow-up|2
333587|NCT00587860|1090618|P1|Overall Study|Lost to Follow-up|2
333588|NCT00587847|1090638|P1|Overall Study|Adverse Event|2
333589|NCT00587847|1090638|P1|Overall Study|Lack of Efficacy|5
333590|NCT00587639|1090707|P1|Overall Study|Withdrawal by Subject|1
333591|NCT00587587|1090714|P2|Overall Study|Lost to Follow-up|1
333592|NCT00587587|1090715|P1|Overall Study|Lost to Follow-up|6
333593|NCT00587457|1090769|P3|Overall Study|Development of neutralizing Abs|1
333594|NCT00587457|1090770|P2|Overall Study|Development of neutralizing Abs|0
333595|NCT00587457|1090771|P1|Overall Study|Development of neutralizing Abs|0
333596|NCT00587457|1090769|P3|Overall Study|Undefined|1
333597|NCT00587457|1090770|P2|Overall Study|Undefined|0
333598|NCT00587457|1090771|P1|Overall Study|Undefined|0
333599|NCT00587457|1090769|P3|Overall Study|Initiation of alternative therapy|0
333600|NCT00587457|1090770|P2|Overall Study|Initiation of alternative therapy|1
333601|NCT00587457|1090771|P1|Overall Study|Initiation of alternative therapy|0
333602|NCT00587457|1090769|P3|Overall Study|Disease progression|2
333603|NCT00587457|1090770|P2|Overall Study|Disease progression|0
333604|NCT00587457|1090771|P1|Overall Study|Disease progression|2
333605|NCT00587457|1090769|P3|Overall Study|Adverse Event|1
333606|NCT00587457|1090770|P2|Overall Study|Adverse Event|2
333607|NCT00587457|1090771|P1|Overall Study|Adverse Event|1
333608|NCT00587431|1090808|P2|Overall Study|Withdrawal by Subject|1
333609|NCT00587431|1090809|P1|Overall Study|Withdrawal by Subject|0
333610|NCT00587431|1090808|P2|Overall Study|Adverse Event|0
333611|NCT00587431|1090809|P1|Overall Study|Adverse Event|1
333612|NCT00587288|1090820|P2|Overall Study|Protocol Violation|0
333613|NCT00587288|1090821|P1|Overall Study|Protocol Violation|1
333614|NCT00587288|1090820|P2|Overall Study|Lack of Efficacy|8
333615|NCT00587288|1090821|P1|Overall Study|Lack of Efficacy|2
333616|NCT00587288|1090820|P2|Overall Study|Adverse Event|1
333617|NCT00587288|1090821|P1|Overall Study|Adverse Event|0
333618|NCT00587223|1090839|P1|Overall Study|Adverse Event|1
333619|NCT00587171|1090856|P2|Overall Study|Lost to Follow-up|1
333620|NCT00587171|1090857|P1|Overall Study|Lost to Follow-up|1
333621|NCT00587158|1090887|P2|Overall Study|Subject did not want to take study med|1
333622|NCT00587158|1090888|P1|Overall Study|Subject did not want to take study med|0
333623|NCT00587158|1090887|P2|Overall Study|Death|1
333624|NCT00587158|1090888|P1|Overall Study|Death|0
333625|NCT00587158|1090887|P2|Overall Study|Lost to Follow-up|2
333626|NCT00587158|1090888|P1|Overall Study|Lost to Follow-up|1
333627|NCT00587158|1090887|P2|Overall Study|Physician Decision|1
333628|NCT00587158|1090888|P1|Overall Study|Physician Decision|0
333629|NCT00587158|1090887|P2|Overall Study|Did not want to do 24 hr urine collect.|3
333630|NCT00587158|1090888|P1|Overall Study|Did not want to do 24 hr urine collect.|4
333631|NCT00587054|1090935|P1|Overall Study|Patient not treated|9
333632|NCT00586898|1090955|P1|Overall Study|Evaluable for Toxicity Only|5
333633|NCT00586898|1090955|P1|Overall Study|Patiemt Non-compliance|1
333634|NCT00586898|1090955|P1|Overall Study|Adverse Event|1
333635|NCT00586846|1090959|P1|Overall Study|Evaluable for Toxicity Only|4
333636|NCT00586846|1090959|P1|Overall Study|Death|1
333637|NCT00586846|1090959|P1|Overall Study|Physician Decision|1
333638|NCT00586820|1090965|P2|Overall Study|Unsuccessful PCI|0
333639|NCT00586820|1090966|P1|Overall Study|Unsuccessful PCI|1
333640|NCT00586703|1090997|P1|Overall Study|Death|12
333641|NCT00586690|1091004|P2|Overall Study|Lab can't accommodate|0
333642|NCT00586690|1091005|P1|Overall Study|Lab can't accommodate|1
333643|NCT00586690|1091004|P2|Overall Study|Lack of Efficacy|0
333644|NCT00586690|1091005|P1|Overall Study|Lack of Efficacy|2
333645|NCT00586690|1091004|P2|Overall Study|Adverse Event|0
333646|NCT00586690|1091005|P1|Overall Study|Adverse Event|1
333647|NCT00586690|1091004|P2|Overall Study|Disease Progression|0
333648|NCT00586690|1091005|P1|Overall Study|Disease Progression|10
333649|NCT00586690|1091004|P2|Overall Study|Death|0
333650|NCT00586690|1091005|P1|Overall Study|Death|2
333651|NCT00586664|1091015|P3|Overall Study|Exclusion criteria met|0
333652|NCT00586664|1091016|P2|Overall Study|Exclusion criteria met|0
333653|NCT00586664|1091017|P1|Overall Study|Exclusion criteria met|2
333654|NCT00586664|1091015|P3|Overall Study|Withdrawal by Subject|1
333655|NCT00586664|1091016|P2|Overall Study|Withdrawal by Subject|7
333656|NCT00586664|1091017|P1|Overall Study|Withdrawal by Subject|3
333657|NCT00586625|1091063|P2|Overall Study|Subject unable to return for visit|0
333658|NCT00586625|1091064|P1|Overall Study|Subject unable to return for visit|2
333659|NCT00586625|1091063|P2|Overall Study|Subject non-compliance|1
333660|NCT00586625|1091064|P1|Overall Study|Subject non-compliance|0
333661|NCT00586625|1091063|P2|Overall Study|Withdrawal by Subject|10
333662|NCT00586625|1091064|P1|Overall Study|Withdrawal by Subject|32
333663|NCT00586625|1091063|P2|Overall Study|Protocol Violation|0
333664|NCT00586625|1091064|P1|Overall Study|Protocol Violation|3
333665|NCT00586625|1091063|P2|Overall Study|Adverse Event|6
333666|NCT00586625|1091064|P1|Overall Study|Adverse Event|6
333667|NCT00586612|1091072|P2|Booster Phase|Lost to Follow-up|1
333668|NCT00586612|1091073|P1|Booster Phase|Lost to Follow-up|3
333669|NCT00586612|1091072|P2|Primary Phase|Withdrawal by Subject|2
333670|NCT00586612|1091073|P1|Primary Phase|Withdrawal by Subject|0
333671|NCT00586612|1091072|P2|Primary Phase|Lost to Follow-up|1
333672|NCT00586612|1091073|P1|Primary Phase|Lost to Follow-up|0
333673|NCT00586612|1091072|P2|Primary Phase|Protocol Violation|0
333674|NCT00586612|1091073|P1|Primary Phase|Protocol Violation|1
333675|NCT00586521|1091143|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
333676|NCT00586495|1091150|P1|Follow-up|Switch to commercial drug|10
333677|NCT00586495|1091150|P1|Follow-up|Protocol driven decision point|37
333678|NCT00586495|1091150|P1|Follow-up|Withdrawal by Subject|4
333679|NCT00586495|1091150|P1|Follow-up|Lost to Follow-up|1
333680|NCT00586495|1091150|P1|Follow-up|Death|40
333681|NCT00586495|1091150|P1|Treatment Period|Switch to commercial drug|10
333682|NCT00586495|1091150|P1|Treatment Period|Disease progression, recurrence/relapse|71
333683|NCT00586495|1091150|P1|Treatment Period|Withdrawal by Subject|1
333684|NCT00586495|1091150|P1|Treatment Period|Protocol Violation|1
333685|NCT00586495|1091150|P1|Treatment Period|Death|1
333686|NCT00586495|1091150|P1|Treatment Period|Adverse Event|11
333687|NCT00586469|1091179|P2|Overall Study|Adverse Event|1
333688|NCT00586469|1091180|P1|Overall Study|Adverse Event|0
333689|NCT00586339|1091207|P3|Overall Study|Withdrawal by Subject|1
333690|NCT00586339|1091208|P2|Overall Study|Withdrawal by Subject|3
333691|NCT00586339|1091209|P1|Overall Study|Withdrawal by Subject|1
333692|NCT00586339|1091207|P3|Overall Study|Lost to Follow-up|5
333693|NCT00586339|1091208|P2|Overall Study|Lost to Follow-up|4
333694|NCT00586339|1091209|P1|Overall Study|Lost to Follow-up|6
333695|NCT00586326|1091301|P1|Treated Through 5-yr Follow Up-Treated|Other|2
333696|NCT00586326|1091301|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
333697|NCT00586326|1091301|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
333698|NCT00586326|1091301|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
333699|NCT00586326|1091301|P1|Treated Through 5-yr Follow Up-Treated|Death|2
333700|NCT00586326|1091301|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
333701|NCT00586326|1091301|P1|Device Placed toTreatment-ITT|Physician Decision|1
333702|NCT00586326|1091301|P1|Device Placed toTreatment-ITT|Positive Margins|3
333703|NCT00586326|1091301|P1|Device Placed toTreatment-ITT|Microinvasion|1
333704|NCT00586326|1091301|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
333705|NCT00586326|1091301|P1|Device Placed toTreatment-ITT|Skin Distance|7
333706|NCT00586326|1091301|P1|Enrollment to Device Placement-Enrolled|Other|1
333707|NCT00586326|1091301|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
333708|NCT00586326|1091301|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
333709|NCT00586326|1091301|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
333710|NCT00586326|1091301|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
333711|NCT00586326|1091301|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
333712|NCT00586313|1091312|P1|Overall Study|Lack of Efficacy|2
333713|NCT00586157|1091348|P2|Second Intervention|Adverse Event|1
333714|NCT00586157|1091349|P1|Second Intervention|Adverse Event|0
333715|NCT00586157|1091348|P2|Second Intervention|Worsening behavior|0
333716|NCT00586157|1091349|P1|Second Intervention|Worsening behavior|1
333717|NCT00586157|1091348|P2|Second Intervention|Withdrawal by Subject|0
333718|NCT00586157|1091349|P1|Second Intervention|Withdrawal by Subject|1
333719|NCT00586157|1091348|P2|First Intervention|Worsening behavior|0
333720|NCT00586157|1091349|P1|First Intervention|Worsening behavior|1
333721|NCT00586105|1091359|P1|Overall Study|Reason not reported|1
333722|NCT00586105|1091359|P1|Overall Study|Switched to commercial drug|9
333723|NCT00586105|1091359|P1|Overall Study|Disease progression|19
333724|NCT00586105|1091359|P1|Overall Study|Withdrawal by Subject|3
333725|NCT00586105|1091359|P1|Overall Study|Protocol Violation|1
333726|NCT00586105|1091359|P1|Overall Study|Death|2
333727|NCT00586105|1091359|P1|Overall Study|Adverse Event|4
333728|NCT00586066|1091374|P2|Overall Study|Withdrawal of consent|2
333729|NCT00586066|1091375|P1|Overall Study|Withdrawal of consent|4
333730|NCT00586066|1091374|P2|Overall Study|Physician Decision|0
333731|NCT00586066|1091375|P1|Overall Study|Physician Decision|1
333732|NCT00586066|1091374|P2|Overall Study|Adverse Event|2
333733|NCT00586066|1091375|P1|Overall Study|Adverse Event|2
333734|NCT00586066|1091374|P2|Overall Study|Lack of Efficacy|3
333735|NCT00586066|1091375|P1|Overall Study|Lack of Efficacy|5
333736|NCT00586066|1091374|P2|Overall Study|Lost to Follow-up|3
333737|NCT00586066|1091375|P1|Overall Study|Lost to Follow-up|6
333738|NCT00585975|1091387|P2|Overall Study|Enrollment met/over-enrolled|9
333739|NCT00585975|1091388|P1|Overall Study|Enrollment met/over-enrolled|10
333740|NCT00585975|1091387|P2|Overall Study|Lost to Follow-up|1
333741|NCT00585975|1091388|P1|Overall Study|Lost to Follow-up|2
333742|NCT00585975|1091387|P2|Overall Study|Withdrawal by Subject|3
333743|NCT00585975|1091388|P1|Overall Study|Withdrawal by Subject|3
333744|NCT00585923|1091398|P2|Overall Study|Physician decided not to continue|33
333745|NCT00585923|1091399|P1|Overall Study|Physician decided not to continue|31
333746|NCT00585689|1091430|P1|Overall Study|Death|1
333747|NCT00585689|1091430|P1|Overall Study|Patient had unresectable disease|1
333748|NCT00585689|1091430|P1|Overall Study|Patient Declined Surgery|1
333749|NCT00585689|1091430|P1|Overall Study|Adverse Event|1
333750|NCT00585689|1091430|P1|Overall Study|Received different ABI-007 schedule|3
333751|NCT00585533|1091476|P1|Overall Study|objective or symptomatic progression|9
333752|NCT00585468|1091485|P2|First Intervention|Withdrawal by Subject|1
333753|NCT00585468|1091486|P1|First Intervention|Withdrawal by Subject|1
333754|NCT00585351|1091518|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
333755|NCT00585351|1091519|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
333756|NCT00585351|1091520|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
333757|NCT00585351|1091521|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
333758|NCT00585351|1091522|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
333759|NCT00585351|1091523|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
333760|NCT00585351|1091524|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
333761|NCT00585351|1091525|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
333762|NCT00585351|1091518|P8|Enrollment Period (Intervention)|Death|0
333763|NCT00585351|1091519|P7|Enrollment Period (Intervention)|Death|1
333764|NCT00585351|1091520|P6|Enrollment Period (Intervention)|Death|0
333765|NCT00585351|1091521|P5|Enrollment Period (Intervention)|Death|1
333766|NCT00585351|1091522|P4|Enrollment Period (Intervention)|Death|0
333767|NCT00585351|1091523|P3|Enrollment Period (Intervention)|Death|0
333768|NCT00585351|1091524|P2|Enrollment Period (Intervention)|Death|0
333769|NCT00585351|1091525|P1|Enrollment Period (Intervention)|Death|0
333770|NCT00585351|1091518|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
333771|NCT00585351|1091519|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
333772|NCT00585351|1091520|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
333773|NCT00585351|1091521|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
333774|NCT00585351|1091522|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
333775|NCT00585351|1091523|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
333776|NCT00585351|1091524|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
333777|NCT00585351|1091525|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
333778|NCT00585351|1091518|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
333779|NCT00585351|1091519|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
333780|NCT00585351|1091520|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
333781|NCT00585351|1091521|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
333782|NCT00585351|1091522|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
333783|NCT00585351|1091523|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
333784|NCT00585351|1091524|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
333785|NCT00585351|1091525|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
333786|NCT00585351|1091518|P8|Notification Period (Informed Consent)|No study medication on flight|0
333787|NCT00585351|1091519|P7|Notification Period (Informed Consent)|No study medication on flight|0
333788|NCT00585351|1091520|P6|Notification Period (Informed Consent)|No study medication on flight|0
333789|NCT00585351|1091521|P5|Notification Period (Informed Consent)|No study medication on flight|0
333790|NCT00585351|1091522|P4|Notification Period (Informed Consent)|No study medication on flight|0
333791|NCT00585351|1091523|P3|Notification Period (Informed Consent)|No study medication on flight|0
333792|NCT00585351|1091524|P2|Notification Period (Informed Consent)|No study medication on flight|1
333793|NCT00585351|1091525|P1|Notification Period (Informed Consent)|No study medication on flight|0
333794|NCT00585351|1091518|P8|Notification Period (Informed Consent)|Flight aborted|0
333795|NCT00585351|1091519|P7|Notification Period (Informed Consent)|Flight aborted|0
333796|NCT00585351|1091520|P6|Notification Period (Informed Consent)|Flight aborted|0
333797|NCT00585351|1091521|P5|Notification Period (Informed Consent)|Flight aborted|0
333798|NCT00585351|1091522|P4|Notification Period (Informed Consent)|Flight aborted|0
333799|NCT00585351|1091523|P3|Notification Period (Informed Consent)|Flight aborted|0
333800|NCT00585351|1091524|P2|Notification Period (Informed Consent)|Flight aborted|1
333801|NCT00585351|1091525|P1|Notification Period (Informed Consent)|Flight aborted|2
333802|NCT00585351|1091518|P8|Notification Period (Informed Consent)|Physician Decision|0
333803|NCT00585351|1091519|P7|Notification Period (Informed Consent)|Physician Decision|0
333890|NCT00583362|1092013|P1|Overall Study|Protocol Violation|2
333891|NCT00583362|1092013|P1|Overall Study|Physician Decision|19
333804|NCT00585351|1091520|P6|Notification Period (Informed Consent)|Physician Decision|0
333805|NCT00585351|1091521|P5|Notification Period (Informed Consent)|Physician Decision|0
333806|NCT00585351|1091522|P4|Notification Period (Informed Consent)|Physician Decision|0
333807|NCT00585351|1091523|P3|Notification Period (Informed Consent)|Physician Decision|0
333808|NCT00585351|1091524|P2|Notification Period (Informed Consent)|Physician Decision|2
333809|NCT00585351|1091525|P1|Notification Period (Informed Consent)|Physician Decision|0
333810|NCT00585312|1091541|P2|Overall Study|Study terminated by the sponsor|31
333811|NCT00585312|1091542|P1|Overall Study|Study terminated by the sponsor|34
333812|NCT00585312|1091541|P2|Overall Study|Withdrawal by Subject|1
333813|NCT00585312|1091542|P1|Overall Study|Withdrawal by Subject|5
333814|NCT00585312|1091541|P2|Overall Study|Reason not specified|0
333815|NCT00585312|1091542|P1|Overall Study|Reason not specified|2
333816|NCT00585312|1091541|P2|Overall Study|Lost to Follow-up|1
333817|NCT00585312|1091542|P1|Overall Study|Lost to Follow-up|1
333818|NCT00585312|1091541|P2|Overall Study|Lack of Efficacy|11
333819|NCT00585312|1091542|P1|Overall Study|Lack of Efficacy|6
333820|NCT00585312|1091541|P2|Overall Study|Adverse Event|0
333821|NCT00585312|1091542|P1|Overall Study|Adverse Event|3
333822|NCT00585286|1091554|P1|Overall Study|Lost to Follow-up|1
333823|NCT00585221|1091561|P1|Overall Study|Protocol Violation|8
333824|NCT00585169|1091571|P1|Overall Study|Withdrawal by Subject|1
333825|NCT00585078|1091581|P1|Overall Study|Death|1
333826|NCT00585078|1091581|P1|Overall Study|Adverse Event|10
333827|NCT00585078|1091581|P1|Overall Study|Disease Progression|24
333828|NCT00585078|1091581|P1|Overall Study|Poor performance status|1
333829|NCT00585078|1091581|P1|Overall Study|Withdrawal by Subject|4
333830|NCT00585039|1091590|P2|Overall Study|medication spilled|0
333831|NCT00585039|1091591|P1|Overall Study|medication spilled|2
333832|NCT00584987|1091620|P4|Overall Study|Adverse Event|1
333833|NCT00584987|1091621|P3|Overall Study|Adverse Event|0
333834|NCT00584987|1091622|P2|Overall Study|Adverse Event|0
333835|NCT00584987|1091623|P1|Overall Study|Adverse Event|0
333836|NCT00584987|1091620|P4|Overall Study|Protocol Violation|0
333837|NCT00584987|1091621|P3|Overall Study|Protocol Violation|1
333838|NCT00584987|1091622|P2|Overall Study|Protocol Violation|1
333839|NCT00584987|1091623|P1|Overall Study|Protocol Violation|1
333840|NCT00584909|1091668|P1|Overall Study|Adverse Event|4
333841|NCT00584740|1091720|P2|Overall Study|Lost to Follow-up|1
333842|NCT00584740|1091721|P1|Overall Study|Lost to Follow-up|0
333843|NCT00584740|1091720|P2|Overall Study|Withdrawal by Subject|2
333844|NCT00584740|1091721|P1|Overall Study|Withdrawal by Subject|3
333845|NCT00584740|1091720|P2|Overall Study|Lack of Efficacy|2
333846|NCT00584740|1091721|P1|Overall Study|Lack of Efficacy|8
333847|NCT00584740|1091720|P2|Overall Study|Adverse Event|1
333848|NCT00584740|1091721|P1|Overall Study|Adverse Event|1
333849|NCT00584727|1091739|P6|Third Intervention|Protocol Violation|2
333850|NCT00584727|1091740|P5|Third Intervention|Protocol Violation|4
333851|NCT00584727|1091741|P4|Third Intervention|Protocol Violation|0
333852|NCT00584727|1091742|P3|Third Intervention|Protocol Violation|1
333853|NCT00584727|1091743|P2|Third Intervention|Protocol Violation|0
333854|NCT00584727|1091744|P1|Third Intervention|Protocol Violation|0
333855|NCT00584727|1091739|P6|First Intervention|Discontinuation|0
333856|NCT00584727|1091740|P5|First Intervention|Discontinuation|0
333857|NCT00584727|1091741|P4|First Intervention|Discontinuation|0
333858|NCT00584727|1091742|P3|First Intervention|Discontinuation|1
333859|NCT00584727|1091743|P2|First Intervention|Discontinuation|0
333860|NCT00584727|1091744|P1|First Intervention|Discontinuation|0
333861|NCT00584454|1091777|P1|Overall Study|Clinical Hold|2
333862|NCT00584454|1091777|P1|Overall Study|Relocation|1
333863|NCT00584454|1091777|P1|Overall Study|Adverse Event|1
333864|NCT00584415|1091781|P1|Overall Study|Adverse Event|7
333865|NCT00583947|1091801|P2|Cross-over Period|not specified|1
333866|NCT00583947|1091802|P1|Cross-over Period|not specified|1
333867|NCT00583947|1091801|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
333868|NCT00583947|1091802|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
333869|NCT00583947|1091801|P2|Cross-over Period|Withdrawal by Subject|0
333870|NCT00583947|1091802|P1|Cross-over Period|Withdrawal by Subject|2
333871|NCT00583947|1091801|P2|Cross-over Period|Adverse Event|0
333872|NCT00583947|1091802|P1|Cross-over Period|Adverse Event|2
333873|NCT00583596|1091968|P1|Overall Study|Outside f-up window|26
333874|NCT00583596|1091968|P1|Overall Study|Not consented|15
333875|NCT00583596|1091968|P1|Overall Study|Data not complete|1
333876|NCT00583596|1091968|P1|Overall Study|Lost to Follow-up|94
333877|NCT00583596|1091968|P1|Overall Study|Withdrawal by Subject|6
333878|NCT00583596|1091968|P1|Overall Study|Death|2
333879|NCT00583596|1091968|P1|Overall Study|Excluded due to Hurricane Katrina|30
333880|NCT00583596|1091968|P1|Overall Study|Lost to Follow-up|110
333881|NCT00583557|1091973|P1|Overall Study|Did not receive belimumab in LBRA99|2
333882|NCT00583557|1091973|P1|Overall Study|Other|5
333883|NCT00583557|1091973|P1|Overall Study|Lack of Compliance|5
333884|NCT00583557|1091973|P1|Overall Study|Lack of Efficacy|31
333885|NCT00583557|1091973|P1|Overall Study|Adverse Event|9
333886|NCT00583557|1091973|P1|Overall Study|Withdrawal by Subject|18
333887|NCT00583453|1091998|P2|Overall Study|discontinued intervention|2
333888|NCT00583453|1091999|P1|Overall Study|discontinued intervention|0
333889|NCT00583362|1092013|P1|Overall Study|Withdrawal by Subject|57
333892|NCT00583362|1092013|P1|Overall Study|Sponsor request due to missed doses|1
333893|NCT00583362|1092013|P1|Overall Study|Behavioral problems and non-compliance|1
333894|NCT00583362|1092013|P1|Overall Study|Misunderstanding of protocol|1
333895|NCT00583362|1092013|P1|Overall Study|Missed visits due to staff changes|1
333896|NCT00583362|1092013|P1|Overall Study|Subject moved out of the country/state|2
333897|NCT00583362|1092013|P1|Overall Study|Subject not dosed in LBSL99|1
333898|NCT00583362|1092013|P1|Overall Study|Current site closed|7
333899|NCT00583362|1092013|P1|Overall Study|Miscommunication of visit window|5
333900|NCT00583362|1092013|P1|Overall Study|Pregnancy|7
333901|NCT00583362|1092013|P1|Overall Study|Non-compliance with study drug|28
333902|NCT00583362|1092013|P1|Overall Study|Lost to Follow-up|4
333903|NCT00583362|1092013|P1|Overall Study|Lack of Efficacy|22
333904|NCT00583362|1092013|P1|Overall Study|Adverse Event|44
333905|NCT00583219|1092037|P1|Phase 2|Withdrawal by Subject|1
333906|NCT00583115|1092054|P1|Overall Study|Death|1
333907|NCT00582972|1092059|P1|Overall Study|Protocol Violation|2
333908|NCT00582933|1092068|P1|Overall Study|Physician Decision|3
333909|NCT00582907|1092072|P4|2nd Course|Lack of Efficacy|0
333910|NCT00582907|1092073|P3|2nd Course|Lack of Efficacy|0
333911|NCT00582907|1092074|P2|2nd Course|Lack of Efficacy|0
333912|NCT00582907|1092075|P1|2nd Course|Lack of Efficacy|1
333913|NCT00582907|1092072|P4|1st Course|Lost to Follow-up|1
333914|NCT00582907|1092073|P3|1st Course|Lost to Follow-up|0
333915|NCT00582907|1092074|P2|1st Course|Lost to Follow-up|0
333916|NCT00582907|1092075|P1|1st Course|Lost to Follow-up|0
333917|NCT00582907|1092072|P4|1st Course|Withdrawal by Subject|0
333918|NCT00582907|1092073|P3|1st Course|Withdrawal by Subject|0
333919|NCT00582907|1092074|P2|1st Course|Withdrawal by Subject|0
333920|NCT00582907|1092075|P1|1st Course|Withdrawal by Subject|1
333921|NCT00582790|1092114|P1|Overall Study|Rapid progression of disease|1
333922|NCT00582738|1092123|P2|Overall Study|Withdrawal by Subject|3
333923|NCT00582738|1092124|P1|Overall Study|Withdrawal by Subject|0
333924|NCT00582738|1092123|P2|Overall Study|Protocol Violation|1
333925|NCT00582738|1092124|P1|Overall Study|Protocol Violation|1
333926|NCT00582738|1092123|P2|Overall Study|Other|0
333927|NCT00582738|1092124|P1|Overall Study|Other|1
333928|NCT00582738|1092123|P2|Overall Study|Graft Lost|1
333929|NCT00582738|1092124|P1|Overall Study|Graft Lost|0
333930|NCT00582738|1092123|P2|Overall Study|Adverse Event|5
333931|NCT00582738|1092124|P1|Overall Study|Adverse Event|0
333932|NCT00582738|1092123|P2|Overall Study|Administrative Problems|8
333933|NCT00582738|1092124|P1|Overall Study|Administrative Problems|7
333934|NCT00582712|1092148|P1|Overall Study|Complicating disease requiring treatment|1
333935|NCT00582712|1092148|P1|Overall Study|Withdrawal by Subject|1
333936|NCT00582712|1092148|P1|Overall Study|Lack of Efficacy|1
333937|NCT00582712|1092148|P1|Overall Study|Adverse Event|1
333938|NCT00582608|1092163|P1|Overall Study|Lack of accrual|4
333939|NCT00582608|1092163|P1|Overall Study|Patient Ineligible|1
333940|NCT00582608|1092163|P1|Overall Study|Not Treated|7
333941|NCT00582556|1092170|P3|Overall Study|Physician Decision|1
333942|NCT00582556|1092171|P2|Overall Study|Physician Decision|0
333943|NCT00582556|1092172|P1|Overall Study|Physician Decision|0
333944|NCT00582556|1092170|P3|Overall Study|Withdrawal by Subject|1
333945|NCT00582556|1092171|P2|Overall Study|Withdrawal by Subject|1
333946|NCT00582556|1092172|P1|Overall Study|Withdrawal by Subject|0
333947|NCT00582491|1092200|P2|Overall Study|Withdrawal by Subject|0
333948|NCT00582491|1092201|P1|Overall Study|Withdrawal by Subject|1
333949|NCT00582426|1092225|P2|Overall Study|Use of illicit drugs|0
333950|NCT00582426|1092226|P1|Overall Study|Use of illicit drugs|1
333951|NCT00582426|1092225|P2|Overall Study|Disease Progression|2
333952|NCT00582426|1092226|P1|Overall Study|Disease Progression|2
333953|NCT00582426|1092225|P2|Overall Study|Withdrawal by Subject|2
333954|NCT00582426|1092226|P1|Overall Study|Withdrawal by Subject|3
333955|NCT00582426|1092225|P2|Overall Study|Death|3
333956|NCT00582426|1092226|P1|Overall Study|Death|4
333957|NCT00582426|1092225|P2|Overall Study|Protocol Violation|2
333958|NCT00582426|1092226|P1|Overall Study|Protocol Violation|6
333959|NCT00582426|1092225|P2|Overall Study|Adverse Event|2
333960|NCT00582426|1092226|P1|Overall Study|Adverse Event|4
333961|NCT00582426|1092225|P2|Overall Study|Lost to Follow-up|2
333962|NCT00582426|1092226|P1|Overall Study|Lost to Follow-up|0
333963|NCT00582309|1092273|P3|Overall Study|Protocol Violation|2
333964|NCT00582309|1092274|P2|Overall Study|Protocol Violation|0
333965|NCT00582309|1092275|P1|Overall Study|Protocol Violation|0
333966|NCT00582114|1092290|P2|Overall Study|Stopped by data safety monitoring board|20
333967|NCT00582114|1092291|P1|Overall Study|Stopped by data safety monitoring board|19
333968|NCT00582114|1092290|P2|Overall Study|Physician Decision|6
333969|NCT00582114|1092291|P1|Overall Study|Physician Decision|0
333970|NCT00582114|1092290|P2|Overall Study|Adverse Event|1
333971|NCT00582114|1092291|P1|Overall Study|Adverse Event|1
333972|NCT00582114|1092290|P2|Overall Study|Withdrawal by Subject|16
333973|NCT00582114|1092291|P1|Overall Study|Withdrawal by Subject|8
333974|NCT00582114|1092290|P2|Overall Study|Lost to Follow-up|6
333975|NCT00582114|1092291|P1|Overall Study|Lost to Follow-up|7
333976|NCT00582114|1092290|P2|Overall Study|Kidney Transplant|1
333977|NCT00582114|1092291|P1|Overall Study|Kidney Transplant|3
333978|NCT00582114|1092290|P2|Overall Study|Death|4
333979|NCT00582114|1092291|P1|Overall Study|Death|4
333980|NCT00582036|1092306|P2|Overall Study|Withdrawal by Subject|1
333981|NCT00582036|1092307|P1|Overall Study|Withdrawal by Subject|0
333982|NCT00582010|1092315|P2|Overall Study|Death|1
333983|NCT00582010|1092316|P1|Overall Study|Death|0
333984|NCT00581945|1092345|P2|Overall Study|Death|0
333985|NCT00581945|1092346|P1|Overall Study|Death|1
333986|NCT00581945|1092345|P2|Overall Study|Withdrawal by Subject|6
333987|NCT00581945|1092346|P1|Overall Study|Withdrawal by Subject|2
333988|NCT00581945|1092345|P2|Overall Study|Unsatisfactory therapeutic effect|0
333989|NCT00581945|1092346|P1|Overall Study|Unsatisfactory therapeutic effect|2
333990|NCT00581945|1092345|P2|Overall Study|Adverse Event|4
333991|NCT00581945|1092346|P1|Overall Study|Adverse Event|4
333992|NCT00581919|1092362|P1|Overall Study|Withdrawal by Subject|1
333993|NCT00581919|1092362|P1|Overall Study|Started Non-Protocol Therapy|2
333994|NCT00581919|1092362|P1|Overall Study|Other Complicating Disease|1
333995|NCT00581919|1092362|P1|Overall Study|Physician Decision|1
333996|NCT00581919|1092362|P1|Overall Study|Disease Progression|10
333997|NCT00581919|1092362|P1|Overall Study|Death|1
333998|NCT00581919|1092362|P1|Overall Study|Adverse Event|8
333999|NCT00581828|1092381|P1|Overall Study|Protocol Violation|1
334000|NCT00581776|1092385|P1|Overall Study|Disease progression or no response|3
334001|NCT00581555|1092403|P2|Overall Study|Other reasons|4
334002|NCT00581555|1092404|P1|Overall Study|Other reasons|16
334003|NCT00581555|1092403|P2|Overall Study|Lost to Follow-up|2
334004|NCT00581555|1092404|P1|Overall Study|Lost to Follow-up|2
334005|NCT00581555|1092403|P2|Overall Study|Withdrawal by Subject|9
334006|NCT00581555|1092404|P1|Overall Study|Withdrawal by Subject|18
334007|NCT00581555|1092403|P2|Overall Study|Physician Decision|2
334008|NCT00581555|1092404|P1|Overall Study|Physician Decision|3
334009|NCT00581555|1092403|P2|Overall Study|Adverse Event|3
334010|NCT00581555|1092404|P1|Overall Study|Adverse Event|4
334011|NCT00581542|1092428|P2|Overall Study|Lost to Follow-up|21
334012|NCT00581542|1092429|P1|Overall Study|Lost to Follow-up|9
334013|NCT00581542|1092428|P2|Overall Study|they met an exclusion criteria|2
334014|NCT00581542|1092429|P1|Overall Study|they met an exclusion criteria|2
334015|NCT00581360|1092481|P1|Overall Study|Withdrawal by Subject|1
334016|NCT00581308|1092500|P1|Month 12|Other|3
334017|NCT00581308|1092500|P1|Month 12|Device Removed|1
334018|NCT00581308|1092500|P1|Month 12|Withdrawal by Subject|2
334019|NCT00581308|1092500|P1|Month 12|Lost to Follow-up|14
334020|NCT00581308|1092500|P1|Month 12|Death|1
334021|NCT00581308|1092500|P1|Month 6|Withdrawal by Subject|4
334022|NCT00581308|1092500|P1|Month 6|Lost to Follow-up|1
334023|NCT00581308|1092500|P1|Month 1|Device Removed|2
334024|NCT00581308|1092500|P1|Month 1|Withdrawal by Subject|3
334025|NCT00581308|1092500|P1|Month 1|Lost to Follow-up|4
334026|NCT00581308|1092500|P1|Pre Discharge|Device Removed|1
334027|NCT00581308|1092500|P1|Pre Discharge|Lost to Follow-up|2
334028|NCT00581113|1092532|P2|Overall Study|Withdrawal by Subject|1
334029|NCT00581113|1092533|P1|Overall Study|Withdrawal by Subject|0
334030|NCT00581100|1092543|P2|Overall Study|Unspecified|0
334031|NCT00581100|1092544|P1|Overall Study|Unspecified|3
334032|NCT00581100|1092543|P2|Overall Study|Withdrawal by Subject|4
334033|NCT00581100|1092544|P1|Overall Study|Withdrawal by Subject|1
334034|NCT00581100|1092543|P2|Overall Study|Adverse Event|1
334035|NCT00581100|1092544|P1|Overall Study|Adverse Event|2
334036|NCT00581100|1092543|P2|Overall Study|Death|0
334037|NCT00581100|1092544|P1|Overall Study|Death|1
334038|NCT00580983|1092586|P1|Overall Study|Did not complete 12 mon post RT studies|7
334039|NCT00580970|1092593|P1|Treatment (Lovastatin)|Death|1
334040|NCT00580970|1092593|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
334041|NCT00580970|1092593|P1|Treatment (Lovastatin)|Physician Decision|4
334042|NCT00580970|1092593|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
334043|NCT00580970|1092593|P1|Treatment (Lovastatin)|Non-compliance|6
334044|NCT00580970|1092593|P1|Pre-treatment|Non-compliance|1
334045|NCT00580866|1092608|P2|Overall Study|Lost to Follow-up|2
334046|NCT00580866|1092609|P1|Overall Study|Lost to Follow-up|2
334047|NCT00580840|1092633|P4|Double-Blind|Other: Forbidden Medication|0
334048|NCT00580840|1092634|P3|Double-Blind|Other: Forbidden Medication|1
334049|NCT00580840|1092635|P2|Double-Blind|Other: Forbidden Medication|0
334050|NCT00580840|1092636|P1|Double-Blind|Other: Forbidden Medication|0
334051|NCT00580840|1092633|P4|Double-Blind|Other: Discontinued Methotrexate|0
334052|NCT00580840|1092634|P3|Double-Blind|Other: Discontinued Methotrexate|0
334053|NCT00580840|1092635|P2|Double-Blind|Other: Discontinued Methotrexate|1
334054|NCT00580840|1092636|P1|Double-Blind|Other: Discontinued Methotrexate|0
334055|NCT00580840|1092633|P4|Double-Blind|Withdrawal by Subject|2
334056|NCT00580840|1092634|P3|Double-Blind|Withdrawal by Subject|2
334057|NCT00580840|1092635|P2|Double-Blind|Withdrawal by Subject|1
334058|NCT00580840|1092636|P1|Double-Blind|Withdrawal by Subject|0
334059|NCT00580840|1092633|P4|Double-Blind|Lost to Follow-up|2
334060|NCT00580840|1092634|P3|Double-Blind|Lost to Follow-up|0
334061|NCT00580840|1092635|P2|Double-Blind|Lost to Follow-up|1
334062|NCT00580840|1092636|P1|Double-Blind|Lost to Follow-up|0
334063|NCT00580840|1092633|P4|Double-Blind|Loss of Efficacy|10
334064|NCT00580840|1092634|P3|Double-Blind|Loss of Efficacy|2
334065|NCT00580840|1092635|P2|Double-Blind|Loss of Efficacy|1
334066|NCT00580840|1092636|P1|Double-Blind|Loss of Efficacy|0
334067|NCT00580840|1092633|P4|Double-Blind|Adverse Event|1
334068|NCT00580840|1092634|P3|Double-Blind|Adverse Event|4
334069|NCT00580840|1092635|P2|Double-Blind|Adverse Event|3
334070|NCT00580840|1092636|P1|Double-Blind|Adverse Event|0
334071|NCT00580840|1092633|P4|Run-in|Other: Exclusionary Lab Value|0
334072|NCT00580840|1092634|P3|Run-in|Other: Exclusionary Lab Value|0
334073|NCT00580840|1092635|P2|Run-in|Other: Exclusionary Lab Value|0
334074|NCT00580840|1092636|P1|Run-in|Other: Exclusionary Lab Value|1
334075|NCT00580840|1092633|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
334076|NCT00580840|1092634|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
334077|NCT00580840|1092635|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
334078|NCT00580840|1092636|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
334079|NCT00580840|1092633|P4|Run-in|Other: Per Sponsor Request|0
334080|NCT00580840|1092634|P3|Run-in|Other: Per Sponsor Request|0
334081|NCT00580840|1092635|P2|Run-in|Other: Per Sponsor Request|0
334082|NCT00580840|1092636|P1|Run-in|Other: Per Sponsor Request|2
334083|NCT00580840|1092633|P4|Run-in|Withdrawal by Subject|0
334084|NCT00580840|1092634|P3|Run-in|Withdrawal by Subject|0
334085|NCT00580840|1092635|P2|Run-in|Withdrawal by Subject|0
334086|NCT00580840|1092636|P1|Run-in|Withdrawal by Subject|5
334087|NCT00580840|1092633|P4|Run-in|Lost to Follow-up|0
334088|NCT00580840|1092634|P3|Run-in|Lost to Follow-up|0
334089|NCT00580840|1092635|P2|Run-in|Lost to Follow-up|0
334090|NCT00580840|1092636|P1|Run-in|Lost to Follow-up|4
334091|NCT00580840|1092633|P4|Run-in|Loss of Efficacy|0
334092|NCT00580840|1092634|P3|Run-in|Loss of Efficacy|0
334093|NCT00580840|1092635|P2|Run-in|Loss of Efficacy|0
334094|NCT00580840|1092636|P1|Run-in|Loss of Efficacy|1
334095|NCT00580840|1092633|P4|Run-in|Lack of Efficacy|0
334096|NCT00580840|1092634|P3|Run-in|Lack of Efficacy|0
334097|NCT00580840|1092635|P2|Run-in|Lack of Efficacy|0
334098|NCT00580840|1092636|P1|Run-in|Lack of Efficacy|93
334099|NCT00580840|1092633|P4|Run-in|Adverse Event|0
334100|NCT00580840|1092634|P3|Run-in|Adverse Event|0
334101|NCT00580840|1092635|P2|Run-in|Adverse Event|0
334102|NCT00580840|1092636|P1|Run-in|Adverse Event|17
334103|NCT00580801|1092744|P3|Overall Study|Travel|0
334104|NCT00580801|1092745|P2|Overall Study|Travel|0
334105|NCT00580801|1092746|P1|Overall Study|Travel|1
334106|NCT00580801|1092744|P3|Overall Study|Participant non-compliant|1
334107|NCT00580801|1092745|P2|Overall Study|Participant non-compliant|0
334108|NCT00580801|1092746|P1|Overall Study|Participant non-compliant|0
334109|NCT00580801|1092744|P3|Overall Study|Reached a virologic endpoint|2
334110|NCT00580801|1092745|P2|Overall Study|Reached a virologic endpoint|1
334111|NCT00580801|1092746|P1|Overall Study|Reached a virologic endpoint|0
334112|NCT00580801|1092744|P3|Overall Study|Lost to Follow-up|0
334113|NCT00580801|1092745|P2|Overall Study|Lost to Follow-up|0
334114|NCT00580801|1092746|P1|Overall Study|Lost to Follow-up|2
334115|NCT00580801|1092744|P3|Overall Study|Adverse Event|0
334116|NCT00580801|1092745|P2|Overall Study|Adverse Event|0
334117|NCT00580801|1092746|P1|Overall Study|Adverse Event|2
334118|NCT00580801|1092744|P3|Overall Study|Physician Decision|0
334119|NCT00580801|1092745|P2|Overall Study|Physician Decision|0
334120|NCT00580801|1092746|P1|Overall Study|Physician Decision|1
334121|NCT00580788|1092785|P4|Overall Study|Adverse Event|1
334122|NCT00580788|1092786|P3|Overall Study|Adverse Event|0
334123|NCT00580788|1092787|P2|Overall Study|Adverse Event|0
334124|NCT00580788|1092788|P1|Overall Study|Adverse Event|0
334125|NCT00580723|1092846|P1|Overall Study|Lost to Follow-up|5
334126|NCT00580723|1092846|P1|Overall Study|Did not want to participate in extension|3
334127|NCT00580606|1092873|P2|Open Label (OL)|Needed Prohibited Medication|1
334128|NCT00580606|1092874|P1|Open Label (OL)|Needed Prohibited Medication|0
334129|NCT00580606|1092873|P2|Open Label (OL)|Physician Decision|1
334130|NCT00580606|1092874|P1|Open Label (OL)|Physician Decision|1
334131|NCT00580606|1092873|P2|Open Label (OL)|Non-compliance|0
334132|NCT00580606|1092874|P1|Open Label (OL)|Non-compliance|2
334133|NCT00580606|1092873|P2|Open Label (OL)|Pregnancy|1
334134|NCT00580606|1092874|P1|Open Label (OL)|Pregnancy|0
334135|NCT00580606|1092873|P2|Open Label (OL)|Lost to Follow-up|1
334136|NCT00580606|1092874|P1|Open Label (OL)|Lost to Follow-up|0
334137|NCT00580606|1092873|P2|Open Label (OL)|Dosing Symptoms|1
334138|NCT00580606|1092874|P1|Open Label (OL)|Dosing Symptoms|0
334139|NCT00580606|1092873|P2|Open Label (OL)|Withdrawal by Subject|6
334140|NCT00580606|1092874|P1|Open Label (OL)|Withdrawal by Subject|4
334141|NCT00580606|1092873|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
334142|NCT00580606|1092874|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
334143|NCT00580034|1092950|P2|Overall Study|Toxicity|0
334144|NCT00580034|1092951|P1|Overall Study|Toxicity|10
334145|NCT00579982|1092957|P1|Overall Study|Protocol Violation|4
334146|NCT00579982|1092957|P1|Overall Study|Adverse Event|4
334147|NCT00579826|1092978|P2|Overall Study|Withdrawal by Subject|3
334148|NCT00579826|1092979|P1|Overall Study|Withdrawal by Subject|5
334149|NCT00579670|1093013|P5|Overall Study|Withdrawal by Subject|0
334150|NCT00579670|1093014|P4|Overall Study|Withdrawal by Subject|0
334151|NCT00579670|1093015|P3|Overall Study|Withdrawal by Subject|1
334152|NCT00579670|1093016|P2|Overall Study|Withdrawal by Subject|0
334153|NCT00579670|1093017|P1|Overall Study|Withdrawal by Subject|0
334154|NCT00579670|1093013|P5|Overall Study|Other|0
334155|NCT00579670|1093014|P4|Overall Study|Other|2
334156|NCT00579670|1093015|P3|Overall Study|Other|1
334157|NCT00579670|1093016|P2|Overall Study|Other|0
334158|NCT00579670|1093017|P1|Overall Study|Other|0
334159|NCT00579670|1093013|P5|Overall Study|Lost to Follow-up|0
334160|NCT00579670|1093014|P4|Overall Study|Lost to Follow-up|4
334161|NCT00579670|1093015|P3|Overall Study|Lost to Follow-up|0
334162|NCT00579670|1093016|P2|Overall Study|Lost to Follow-up|1
334163|NCT00579670|1093017|P1|Overall Study|Lost to Follow-up|0
334164|NCT00579670|1093013|P5|Overall Study|Lack of Efficacy|0
334165|NCT00579670|1093014|P4|Overall Study|Lack of Efficacy|14
334166|NCT00579670|1093015|P3|Overall Study|Lack of Efficacy|1
334167|NCT00579670|1093016|P2|Overall Study|Lack of Efficacy|0
334168|NCT00579670|1093017|P1|Overall Study|Lack of Efficacy|0
334169|NCT00579670|1093013|P5|Overall Study|Adverse Event|0
334170|NCT00579670|1093014|P4|Overall Study|Adverse Event|2
334171|NCT00579670|1093015|P3|Overall Study|Adverse Event|1
334172|NCT00579670|1093016|P2|Overall Study|Adverse Event|0
334173|NCT00579670|1093017|P1|Overall Study|Adverse Event|1
334174|NCT00579670|1093013|P5|Overall Study|Death|0
334175|NCT00579670|1093014|P4|Overall Study|Death|0
334176|NCT00579670|1093015|P3|Overall Study|Death|0
334177|NCT00579670|1093016|P2|Overall Study|Death|0
334178|NCT00579670|1093017|P1|Overall Study|Death|1
334179|NCT00579501|1093229|P1|Overall Study|Radiation therapy before surgery|1
334180|NCT00579501|1093229|P1|Overall Study|Secondary lesion|1
334181|NCT00579501|1093229|P1|Overall Study|toxicity|1
334182|NCT00579501|1093229|P1|Overall Study|End of neoadjuvant therapy|25
334183|NCT00579501|1093229|P1|Overall Study|Death|1
334184|NCT00579345|1093242|P8|Overall Study|Death|0
334185|NCT00579345|1093243|P7|Overall Study|Death|0
334186|NCT00579345|1093244|P6|Overall Study|Death|0
334187|NCT00579345|1093245|P5|Overall Study|Death|0
334188|NCT00579345|1093246|P4|Overall Study|Death|1
334189|NCT00579345|1093247|P3|Overall Study|Death|1
334190|NCT00579345|1093248|P2|Overall Study|Death|1
334191|NCT00579345|1093249|P1|Overall Study|Death|1
334192|NCT00579345|1093242|P8|Overall Study|Protocol Violation|1
334193|NCT00579345|1093243|P7|Overall Study|Protocol Violation|0
334194|NCT00579345|1093244|P6|Overall Study|Protocol Violation|0
334195|NCT00579345|1093245|P5|Overall Study|Protocol Violation|0
334196|NCT00579345|1093246|P4|Overall Study|Protocol Violation|0
334197|NCT00579345|1093247|P3|Overall Study|Protocol Violation|0
334198|NCT00579345|1093248|P2|Overall Study|Protocol Violation|0
334199|NCT00579345|1093249|P1|Overall Study|Protocol Violation|1
334200|NCT00579345|1093242|P8|Overall Study|Adverse Event|0
334201|NCT00579345|1093243|P7|Overall Study|Adverse Event|0
334202|NCT00579345|1093244|P6|Overall Study|Adverse Event|0
334203|NCT00579345|1093245|P5|Overall Study|Adverse Event|0
334204|NCT00579345|1093246|P4|Overall Study|Adverse Event|0
334205|NCT00579345|1093247|P3|Overall Study|Adverse Event|1
334206|NCT00579345|1093248|P2|Overall Study|Adverse Event|0
334207|NCT00579345|1093249|P1|Overall Study|Adverse Event|0
334208|NCT00579345|1093242|P8|Overall Study|Lost to Follow-up|0
334209|NCT00579345|1093243|P7|Overall Study|Lost to Follow-up|0
334210|NCT00579345|1093244|P6|Overall Study|Lost to Follow-up|0
334211|NCT00579345|1093245|P5|Overall Study|Lost to Follow-up|0
334212|NCT00579345|1093246|P4|Overall Study|Lost to Follow-up|0
334213|NCT00579345|1093247|P3|Overall Study|Lost to Follow-up|0
334214|NCT00579345|1093248|P2|Overall Study|Lost to Follow-up|0
334215|NCT00579345|1093249|P1|Overall Study|Lost to Follow-up|1
334216|NCT00579345|1093242|P8|Overall Study|Withdrawal by Subject|1
334217|NCT00579345|1093243|P7|Overall Study|Withdrawal by Subject|0
334218|NCT00579345|1093244|P6|Overall Study|Withdrawal by Subject|0
334219|NCT00579345|1093245|P5|Overall Study|Withdrawal by Subject|0
334220|NCT00579345|1093246|P4|Overall Study|Withdrawal by Subject|0
334221|NCT00579345|1093247|P3|Overall Study|Withdrawal by Subject|0
334222|NCT00579345|1093248|P2|Overall Study|Withdrawal by Subject|0
334223|NCT00579345|1093249|P1|Overall Study|Withdrawal by Subject|2
334224|NCT00579254|1093281|P1|Overall Study|Discontinued when study terminated|73
334225|NCT00579254|1093281|P1|Overall Study|Lost to Follow-up|39
334226|NCT00579098|1093305|P2|Overall Study|AF returned after ablation|2
334227|NCT00579098|1093306|P1|Overall Study|AF returned after ablation|3
334228|NCT00579098|1093305|P2|Overall Study|Withdrawal by Subject|3
334229|NCT00579098|1093306|P1|Overall Study|Withdrawal by Subject|2
334230|NCT00579098|1093305|P2|Overall Study|Adverse Event|3
334231|NCT00579098|1093306|P1|Overall Study|Adverse Event|2
334232|NCT00579098|1093305|P2|Overall Study|Lost to Follow-up|0
334233|NCT00579098|1093306|P1|Overall Study|Lost to Follow-up|2
334234|NCT00579059|1093322|P2|Overall Study|Study Canceled at 1 Year|10
334235|NCT00579059|1093323|P1|Overall Study|Study Canceled at 1 Year|21
334236|NCT00578942|1093397|P1|Overall Study|Lost to Follow-up|1
334237|NCT00578864|1093436|P2|Overall Study|Death|0
334238|NCT00578864|1093437|P1|Overall Study|Death|1
334239|NCT00578812|1093453|P2|Overall Study|Not treated|7
334240|NCT00578812|1093454|P1|Overall Study|Not treated|6
334241|NCT00578786|1093493|P3|Overall Study|Qualified but Not Enrolled in Extension|0
334242|NCT00578786|1093494|P2|Overall Study|Qualified but Not Enrolled in Extension|3
334243|NCT00578786|1093495|P1|Overall Study|Qualified but Not Enrolled in Extension|0
334244|NCT00578786|1093493|P3|Overall Study|Not Otherwise Specified|1
334245|NCT00578786|1093494|P2|Overall Study|Not Otherwise Specified|4
334246|NCT00578786|1093495|P1|Overall Study|Not Otherwise Specified|0
334247|NCT00578786|1093493|P3|Overall Study|Pregnancy|0
334248|NCT00578786|1093494|P2|Overall Study|Pregnancy|1
334249|NCT00578786|1093495|P1|Overall Study|Pregnancy|0
334250|NCT00578786|1093493|P3|Overall Study|Lost to Follow-up|0
334251|NCT00578786|1093494|P2|Overall Study|Lost to Follow-up|4
334252|NCT00578786|1093495|P1|Overall Study|Lost to Follow-up|0
334253|NCT00578786|1093493|P3|Overall Study|Sponsor Decision|1
334254|NCT00578786|1093494|P2|Overall Study|Sponsor Decision|0
334255|NCT00578786|1093495|P1|Overall Study|Sponsor Decision|0
334256|NCT00578786|1093493|P3|Overall Study|Physician Decision|1
334257|NCT00578786|1093494|P2|Overall Study|Physician Decision|0
334258|NCT00578786|1093495|P1|Overall Study|Physician Decision|1
334259|NCT00578786|1093493|P3|Overall Study|Protocol Violation|1
334260|NCT00578786|1093494|P2|Overall Study|Protocol Violation|3
334261|NCT00578786|1093495|P1|Overall Study|Protocol Violation|0
334262|NCT00578786|1093493|P3|Overall Study|Withdrawal by Subject|5
334263|NCT00578786|1093494|P2|Overall Study|Withdrawal by Subject|8
334264|NCT00578786|1093495|P1|Overall Study|Withdrawal by Subject|7
334265|NCT00578786|1093493|P3|Overall Study|Early Escape from Prior Study|2
334266|NCT00578786|1093494|P2|Overall Study|Early Escape from Prior Study|1
334267|NCT00578786|1093495|P1|Overall Study|Early Escape from Prior Study|2
334268|NCT00578786|1093493|P3|Overall Study|Lack of Efficacy|2
334269|NCT00578786|1093494|P2|Overall Study|Lack of Efficacy|5
334270|NCT00578786|1093495|P1|Overall Study|Lack of Efficacy|2
334271|NCT00578786|1093493|P3|Overall Study|Adverse Event|17
334272|NCT00578786|1093494|P2|Overall Study|Adverse Event|37
334273|NCT00578786|1093495|P1|Overall Study|Adverse Event|27
334274|NCT00578565|1093594|P1|Overall Study|Adverse Event|3
334275|NCT00577655|1093622|P2|Overall Study|Lost to Follow-up|1
334276|NCT00577655|1093623|P1|Overall Study|Lost to Follow-up|1
334277|NCT00577655|1093622|P2|Overall Study|Protocol Violation|1
334278|NCT00577655|1093623|P1|Overall Study|Protocol Violation|0
334279|NCT00577655|1093622|P2|Overall Study|Patient Request|2
334280|NCT00577655|1093623|P1|Overall Study|Patient Request|0
334281|NCT00577642|1093661|P1|Overall Study|Clinical Disease Progression|1
334282|NCT00577629|1093665|P1|Long Term Follow-Up|Physician Decision|1
334283|NCT00577629|1093665|P1|Long Term Follow-Up|Withdrawal by Subject|4
334284|NCT00577629|1093665|P1|Long Term Follow-Up|Lost to Follow-up|5
334285|NCT00577629|1093665|P1|Long Term Follow-Up|Death|15
334286|NCT00577629|1093665|P1|Treatment Period|Death|1
334287|NCT00578448|1093677|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
334288|NCT00578448|1093677|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
334289|NCT00578448|1093677|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
334290|NCT00578448|1093677|P1|Day 1 up to 3 Years of Planned Study|Death|1
334291|NCT00578318|1093741|P2|Overall Study|Physician Decision|0
334292|NCT00578318|1093742|P1|Overall Study|Physician Decision|1
334293|NCT00578318|1093741|P2|Overall Study|Lost to Follow-up|0
334294|NCT00578318|1093742|P1|Overall Study|Lost to Follow-up|2
334295|NCT00578227|1093824|P3|Overall Study|Withdrawal by Subject|3
334296|NCT00578227|1093825|P2|Overall Study|Withdrawal by Subject|1
334297|NCT00578227|1093826|P1|Overall Study|Withdrawal by Subject|5
334298|NCT00578227|1093824|P3|Overall Study|Lost to Follow-up|1
334299|NCT00578227|1093825|P2|Overall Study|Lost to Follow-up|1
334300|NCT00578227|1093826|P1|Overall Study|Lost to Follow-up|0
334301|NCT00578136|1094032|P2|Overall Study|Not given intervention|1
334302|NCT00578136|1094033|P1|Overall Study|Not given intervention|1
334303|NCT00577889|1094051|P3|Overall Study|Withdrawal by Subject|0
334304|NCT00577889|1094052|P2|Overall Study|Withdrawal by Subject|0
334305|NCT00577889|1094053|P1|Overall Study|Withdrawal by Subject|1
334306|NCT00577863|1094072|P2|Overall Study|Did Not Receive at Least One Injection|1
334307|NCT00577863|1094073|P1|Overall Study|Did Not Receive at Least One Injection|0
334308|NCT00577863|1094072|P2|Overall Study|Sponsor Decision|7
334309|NCT00577863|1094073|P1|Overall Study|Sponsor Decision|2
334310|NCT00577863|1094072|P2|Overall Study|Withdrawal by Subject|2
334311|NCT00577863|1094073|P1|Overall Study|Withdrawal by Subject|0
334312|NCT00577863|1094072|P2|Overall Study|Entry Criteria Exclusion|0
334313|NCT00577863|1094073|P1|Overall Study|Entry Criteria Exclusion|1
334314|NCT00577863|1094072|P2|Overall Study|Lost to Follow-up|2
334315|NCT00577863|1094073|P1|Overall Study|Lost to Follow-up|2
334316|NCT00577863|1094072|P2|Overall Study|Death|0
334317|NCT00577863|1094073|P1|Overall Study|Death|1
334318|NCT00577863|1094072|P2|Overall Study|Adverse Event|2
334319|NCT00577863|1094073|P1|Overall Study|Adverse Event|4
334320|NCT00577824|1094115|P3|Overall Study|Protocol Violation|0
334321|NCT00577824|1094116|P2|Overall Study|Protocol Violation|1
334322|NCT00577824|1094117|P1|Overall Study|Protocol Violation|1
334323|NCT00577824|1094115|P3|Overall Study|Patient decision|1
334324|NCT00577824|1094116|P2|Overall Study|Patient decision|1
334325|NCT00577824|1094117|P1|Overall Study|Patient decision|0
334326|NCT00577824|1094115|P3|Overall Study|Adverse Event|1
334327|NCT00577824|1094116|P2|Overall Study|Adverse Event|18
334328|NCT00577824|1094117|P1|Overall Study|Adverse Event|6
334329|NCT00577772|1094175|P2|Overall Study|Lost to Follow-up|1
334330|NCT00577772|1094176|P1|Overall Study|Lost to Follow-up|0
334331|NCT00577720|1094186|P4|Overall Study|Withdrawal by Subject|2
334332|NCT00577720|1094187|P3|Overall Study|Withdrawal by Subject|0
334333|NCT00577720|1094188|P2|Overall Study|Withdrawal by Subject|0
334334|NCT00577720|1094189|P1|Overall Study|Withdrawal by Subject|2
334335|NCT00577720|1094186|P4|Overall Study|Protocol Violation|1
334336|NCT00577720|1094187|P3|Overall Study|Protocol Violation|0
334337|NCT00577720|1094188|P2|Overall Study|Protocol Violation|0
334338|NCT00577720|1094189|P1|Overall Study|Protocol Violation|0
334339|NCT00577720|1094186|P4|Overall Study|Lost to Follow-up|0
334340|NCT00577720|1094187|P3|Overall Study|Lost to Follow-up|1
334341|NCT00577720|1094188|P2|Overall Study|Lost to Follow-up|0
334342|NCT00577720|1094189|P1|Overall Study|Lost to Follow-up|0
334343|NCT00577720|1094186|P4|Overall Study|Adverse Event|4
334344|NCT00577720|1094187|P3|Overall Study|Adverse Event|0
334345|NCT00577720|1094188|P2|Overall Study|Adverse Event|1
334346|NCT00577720|1094189|P1|Overall Study|Adverse Event|2
334347|NCT00577707|1094207|P1|Overall Study|Withdrawal by Subject|3
334348|NCT00577473|1094217|P2|Overall Study|Lack of Efficacy|7
334349|NCT00577473|1094218|P1|Overall Study|Lack of Efficacy|8
334350|NCT00577473|1094217|P2|Overall Study|Physician Decision|2
334351|NCT00577473|1094218|P1|Overall Study|Physician Decision|2
334352|NCT00577473|1094217|P2|Overall Study|Withdrawal by Subject|6
334353|NCT00577473|1094218|P1|Overall Study|Withdrawal by Subject|2
334354|NCT00577473|1094217|P2|Overall Study|Adverse Event|5
334355|NCT00577473|1094218|P1|Overall Study|Adverse Event|8
334356|NCT00577473|1094217|P2|Overall Study|Protocol Violation|4
334357|NCT00577473|1094218|P1|Overall Study|Protocol Violation|1
334358|NCT00577460|1094249|P3|Overall Study|not specified|2
334359|NCT00577460|1094250|P2|Overall Study|not specified|3
334360|NCT00577460|1094251|P1|Overall Study|not specified|0
334361|NCT00577460|1094249|P3|Overall Study|Withdrawal by Subject|6
334362|NCT00577460|1094250|P2|Overall Study|Withdrawal by Subject|5
334363|NCT00577460|1094251|P1|Overall Study|Withdrawal by Subject|5
334364|NCT00577460|1094249|P3|Overall Study|Lost to Follow-up|4
334365|NCT00577460|1094250|P2|Overall Study|Lost to Follow-up|3
334366|NCT00577460|1094251|P1|Overall Study|Lost to Follow-up|0
334367|NCT00577460|1094249|P3|Overall Study|Protocol Violation|1
334368|NCT00577460|1094250|P2|Overall Study|Protocol Violation|1
334369|NCT00577460|1094251|P1|Overall Study|Protocol Violation|0
334370|NCT00577460|1094249|P3|Overall Study|Adverse Event|14
334371|NCT00577460|1094250|P2|Overall Study|Adverse Event|7
334372|NCT00577460|1094251|P1|Overall Study|Adverse Event|11
334373|NCT00577395|1094360|P2|Overall Study|Study was terminated early by Sponsor|6
334374|NCT00577395|1094361|P1|Overall Study|Study was terminated early by Sponsor|7
334375|NCT00577382|1094371|P2|Overall Study|Lost to Follow-up|2
334376|NCT00577382|1094372|P1|Overall Study|Lost to Follow-up|2
334377|NCT00577382|1094371|P2|Overall Study|Death|1
334378|NCT00577382|1094372|P1|Overall Study|Death|1
334379|NCT00577382|1094371|P2|Overall Study|Intercurrent Illness|2
334380|NCT00577382|1094372|P1|Overall Study|Intercurrent Illness|1
334381|NCT00577382|1094371|P2|Overall Study|Progressive Disease|19
334382|NCT00577382|1094372|P1|Overall Study|Progressive Disease|17
334383|NCT00577382|1094371|P2|Overall Study|Withdrawal by Subject|1
334384|NCT00577382|1094372|P1|Overall Study|Withdrawal by Subject|0
334385|NCT00577382|1094371|P2|Overall Study|Adverse Event|6
334386|NCT00577382|1094372|P1|Overall Study|Adverse Event|0
334387|NCT00577122|1094515|P2|Overall Study|Alternative Therapy|1
334388|NCT00577122|1094516|P1|Overall Study|Alternative Therapy|0
334389|NCT00577122|1094515|P2|Overall Study|Prog, refract disease during active trt|5
334390|NCT00577122|1094516|P1|Overall Study|Prog, refract disease during active trt|8
334391|NCT00577122|1094515|P2|Overall Study|Progression, relapse during active trt|8
334392|NCT00577122|1094516|P1|Overall Study|Progression, relapse during active trt|6
334393|NCT00577122|1094515|P2|Overall Study|Adverse Event|2
334394|NCT00577122|1094516|P1|Overall Study|Adverse Event|0
334395|NCT00577096|1094530|P2|Short Term Participation|Death|1
334396|NCT00577096|1094531|P1|Short Term Participation|Death|1
334397|NCT00577096|1094530|P2|Short Term Participation|Withdrawal by Subject|5
334398|NCT00577096|1094531|P1|Short Term Participation|Withdrawal by Subject|3
334399|NCT00577096|1094530|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
334400|NCT00577096|1094531|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
334401|NCT00577031|1094564|P1|Overall Study|Death|6
334402|NCT00577031|1094564|P1|Overall Study|Medical decision|14
334403|NCT00577031|1094564|P1|Overall Study|Need for surgery|17
334404|NCT00577031|1094564|P1|Overall Study|Participant non-compliance|5
334405|NCT00577031|1094564|P1|Overall Study|Participant withdrew consent|13
334406|NCT00577031|1094564|P1|Overall Study|Protocol Violation|5
334407|NCT00577031|1094564|P1|Overall Study|Progression of disease|93
334408|NCT00577031|1094564|P1|Overall Study|Adverse Event|52
334409|NCT00577005|1094585|P2|Overall Study|Withdrawal by Subject|1
334410|NCT00577005|1094586|P1|Overall Study|Withdrawal by Subject|2
334411|NCT00577005|1094585|P2|Overall Study|Lost to Follow-up|2
334412|NCT00577005|1094586|P1|Overall Study|Lost to Follow-up|3
334413|NCT00576927|1094600|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
334414|NCT00576927|1094600|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
334415|NCT00576927|1094600|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
334416|NCT00576927|1094600|P1|Sleep Hygiene Behavioral Intervention|Death|1
334417|NCT00576927|1094600|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
334418|NCT00576927|1094600|P1|Baseline|Withdrawal by Subject|3
334419|NCT00576927|1094600|P1|Baseline|Medication Change by PCP of subject|1
334420|NCT00576927|1094600|P1|Baseline|Physician Decision|9
334421|NCT00576927|1094600|P1|Clinical Assessment|Physician Decision|1
334422|NCT00576927|1094600|P1|Clinical Assessment|Withdrawal by Subject|10
334423|NCT00576927|1094600|P1|Clinical Assessment|Death|1
334424|NCT00576927|1094600|P1|Clinical Assessment|Lack of Efficacy|24
334425|NCT00576901|1094612|P1|Overall Study|Protocol Violation|1
334426|NCT00576901|1094612|P1|Overall Study|Disease course|1
334427|NCT00576901|1094612|P1|Overall Study|Withdrawal by Subject|1
334428|NCT00576823|1094623|P3|40-week Safety Extension Phase|Lack of Efficacy|0
334429|NCT00576823|1094624|P2|40-week Safety Extension Phase|Lack of Efficacy|0
334430|NCT00576823|1094625|P1|40-week Safety Extension Phase|Lack of Efficacy|1
334431|NCT00576823|1094623|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
334432|NCT00576823|1094624|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
334433|NCT00576823|1094625|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
334434|NCT00576758|1094641|P2|Follow-up Period|Withdrew consent|1
334435|NCT00576758|1094642|P1|Follow-up Period|Withdrew consent|2
334436|NCT00576758|1094641|P2|Follow-up Period|Insufficient therapeutic response|5
334437|NCT00576758|1094642|P1|Follow-up Period|Insufficient therapeutic response|16
334438|NCT00576758|1094641|P2|Follow-up Period|Death|3
334439|NCT00576758|1094642|P1|Follow-up Period|Death|3
334440|NCT00576758|1094641|P2|Follow-up Period|Administrative/Other|8
334441|NCT00576758|1094642|P1|Follow-up Period|Administrative/Other|6
334442|NCT00576758|1094641|P2|Extension Treatment Period|Administrative/Other|1
334443|NCT00576758|1094642|P1|Extension Treatment Period|Administrative/Other|3
334444|NCT00576758|1094641|P2|Extension Treatment Period|Insufficient therapeutic response|33
334445|NCT00576758|1094642|P1|Extension Treatment Period|Insufficient therapeutic response|30
334446|NCT00576758|1094641|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
334447|NCT00576758|1094642|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
334448|NCT00576758|1094641|P2|Extension Treatment Period|Death|1
334449|NCT00576758|1094642|P1|Extension Treatment Period|Death|1
334450|NCT00576758|1094641|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
334451|NCT00576758|1094642|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
334452|NCT00576758|1094641|P2|Induction Treatment Period|Withdrew consent|0
334453|NCT00576758|1094642|P1|Induction Treatment Period|Withdrew consent|1
334454|NCT00576758|1094641|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
334455|NCT00576758|1094642|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
334456|NCT00576758|1094641|P2|Induction Treatment Period|Death|0
334457|NCT00576758|1094642|P1|Induction Treatment Period|Death|1
334458|NCT00576758|1094641|P2|Induction Treatment Period|Violation of selection criteria at entry|1
334459|NCT00576758|1094642|P1|Induction Treatment Period|Violation of selection criteria at entry|1
334460|NCT00576758|1094641|P2|Induction Treatment Period|Insufficient therapeutic response|0
334461|NCT00576758|1094642|P1|Induction Treatment Period|Insufficient therapeutic response|2
334462|NCT00576758|1094641|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
334463|NCT00576758|1094642|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
334464|NCT00576732|1094688|P6|OPEN LABEL|Protocol Violation|0
334465|NCT00576732|1094689|P5|OPEN LABEL|Protocol Violation|1
334466|NCT00576732|1094690|P4|OPEN LABEL|Protocol Violation|2
334467|NCT00576732|1094691|P3|OPEN LABEL|Protocol Violation|0
334468|NCT00576732|1094692|P2|OPEN LABEL|Protocol Violation|0
334469|NCT00576732|1094693|P1|OPEN LABEL|Protocol Violation|0
334470|NCT00576732|1094688|P6|OPEN LABEL|Lack of Efficacy|3
334471|NCT00576732|1094689|P5|OPEN LABEL|Lack of Efficacy|2
334472|NCT00576732|1094690|P4|OPEN LABEL|Lack of Efficacy|2
334473|NCT00576732|1094691|P3|OPEN LABEL|Lack of Efficacy|0
334474|NCT00576732|1094692|P2|OPEN LABEL|Lack of Efficacy|0
334475|NCT00576732|1094693|P1|OPEN LABEL|Lack of Efficacy|0
334476|NCT00576732|1094688|P6|OPEN LABEL|OTHER|2
334477|NCT00576732|1094689|P5|OPEN LABEL|OTHER|0
334478|NCT00576732|1094690|P4|OPEN LABEL|OTHER|0
334479|NCT00576732|1094691|P3|OPEN LABEL|OTHER|0
334480|NCT00576732|1094692|P2|OPEN LABEL|OTHER|0
334481|NCT00576732|1094693|P1|OPEN LABEL|OTHER|0
334482|NCT00576732|1094688|P6|OPEN LABEL|Withdrawal by Subject|1
334483|NCT00576732|1094689|P5|OPEN LABEL|Withdrawal by Subject|0
334484|NCT00576732|1094690|P4|OPEN LABEL|Withdrawal by Subject|1
334485|NCT00576732|1094691|P3|OPEN LABEL|Withdrawal by Subject|0
334486|NCT00576732|1094692|P2|OPEN LABEL|Withdrawal by Subject|0
334487|NCT00576732|1094693|P1|OPEN LABEL|Withdrawal by Subject|0
334488|NCT00576732|1094688|P6|OPEN LABEL|Lost to Follow-up|1
334489|NCT00576732|1094689|P5|OPEN LABEL|Lost to Follow-up|1
334490|NCT00576732|1094690|P4|OPEN LABEL|Lost to Follow-up|2
334491|NCT00576732|1094691|P3|OPEN LABEL|Lost to Follow-up|0
334492|NCT00576732|1094692|P2|OPEN LABEL|Lost to Follow-up|0
334493|NCT00576732|1094693|P1|OPEN LABEL|Lost to Follow-up|0
334494|NCT00576732|1094688|P6|OPEN LABEL|Adverse Event|1
334495|NCT00576732|1094689|P5|OPEN LABEL|Adverse Event|0
334496|NCT00576732|1094690|P4|OPEN LABEL|Adverse Event|4
334497|NCT00576732|1094691|P3|OPEN LABEL|Adverse Event|0
334498|NCT00576732|1094692|P2|OPEN LABEL|Adverse Event|0
334499|NCT00576732|1094693|P1|OPEN LABEL|Adverse Event|0
334500|NCT00576732|1094688|P6|DOUBLE BLIND|Protocol Violation|0
334501|NCT00576732|1094689|P5|DOUBLE BLIND|Protocol Violation|0
334502|NCT00576732|1094690|P4|DOUBLE BLIND|Protocol Violation|0
334503|NCT00576732|1094691|P3|DOUBLE BLIND|Protocol Violation|0
334504|NCT00576732|1094692|P2|DOUBLE BLIND|Protocol Violation|0
334505|NCT00576732|1094693|P1|DOUBLE BLIND|Protocol Violation|1
334506|NCT00576732|1094688|P6|DOUBLE BLIND|Lack of Efficacy|0
334507|NCT00576732|1094689|P5|DOUBLE BLIND|Lack of Efficacy|0
334508|NCT00576732|1094690|P4|DOUBLE BLIND|Lack of Efficacy|0
334509|NCT00576732|1094691|P3|DOUBLE BLIND|Lack of Efficacy|0
334510|NCT00576732|1094692|P2|DOUBLE BLIND|Lack of Efficacy|1
334511|NCT00576732|1094693|P1|DOUBLE BLIND|Lack of Efficacy|6
334512|NCT00576732|1094688|P6|DOUBLE BLIND|OTHER|0
334513|NCT00576732|1094689|P5|DOUBLE BLIND|OTHER|0
334514|NCT00576732|1094690|P4|DOUBLE BLIND|OTHER|0
334515|NCT00576732|1094691|P3|DOUBLE BLIND|OTHER|1
334516|NCT00576732|1094692|P2|DOUBLE BLIND|OTHER|2
334517|NCT00576732|1094693|P1|DOUBLE BLIND|OTHER|0
334518|NCT00576732|1094688|P6|DOUBLE BLIND|Withdrawal by Subject|0
334519|NCT00576732|1094689|P5|DOUBLE BLIND|Withdrawal by Subject|0
334520|NCT00576732|1094690|P4|DOUBLE BLIND|Withdrawal by Subject|0
334521|NCT00576732|1094691|P3|DOUBLE BLIND|Withdrawal by Subject|3
334522|NCT00576732|1094692|P2|DOUBLE BLIND|Withdrawal by Subject|1
334523|NCT00576732|1094693|P1|DOUBLE BLIND|Withdrawal by Subject|1
334524|NCT00576732|1094688|P6|DOUBLE BLIND|Lost to Follow-up|0
334525|NCT00576732|1094689|P5|DOUBLE BLIND|Lost to Follow-up|0
334526|NCT00576732|1094690|P4|DOUBLE BLIND|Lost to Follow-up|0
334527|NCT00576732|1094691|P3|DOUBLE BLIND|Lost to Follow-up|1
334528|NCT00576732|1094692|P2|DOUBLE BLIND|Lost to Follow-up|1
334529|NCT00576732|1094693|P1|DOUBLE BLIND|Lost to Follow-up|0
334530|NCT00576732|1094688|P6|DOUBLE BLIND|Adverse Event|0
334531|NCT00576732|1094689|P5|DOUBLE BLIND|Adverse Event|0
334532|NCT00576732|1094690|P4|DOUBLE BLIND|Adverse Event|0
334533|NCT00576732|1094691|P3|DOUBLE BLIND|Adverse Event|1
334534|NCT00576732|1094692|P2|DOUBLE BLIND|Adverse Event|0
334535|NCT00576732|1094693|P1|DOUBLE BLIND|Adverse Event|0
334536|NCT00576693|1094725|P2|Overall Study|Withdrawal by Subject|13
334537|NCT00576693|1094726|P1|Overall Study|Withdrawal by Subject|3
334538|NCT00576693|1094725|P2|Overall Study|Lost to Follow-up|11
334539|NCT00576693|1094726|P1|Overall Study|Lost to Follow-up|7
334540|NCT00576628|1094732|P1|Overall Study|Dialysis|15
334541|NCT00576628|1094732|P1|Overall Study|Transplantation|1
334542|NCT00576628|1094732|P1|Overall Study|The patient move into other town|1
334543|NCT00576628|1094732|P1|Overall Study|Progression of Renal Failure|1
334544|NCT00576628|1094732|P1|Overall Study|Progression of Kidney Disease|1
334545|NCT00576628|1094732|P1|Overall Study|RBC transfusion|1
334546|NCT00576628|1094732|P1|Overall Study|Pregnancy|1
334547|NCT00576628|1094732|P1|Overall Study|Refused Treatment|8
334548|NCT00576628|1094732|P1|Overall Study|Failure to return|1
334549|NCT00576628|1094732|P1|Overall Study|Death|2
334550|NCT00576628|1094732|P1|Overall Study|Adverse Event|11
334551|NCT00576576|1094752|P1|Overall Study|Protocol Violation|1
334552|NCT00576576|1094752|P1|Overall Study|Lost to Follow-up|6
334553|NCT00576472|1094786|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
334554|NCT00576472|1094787|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
334555|NCT00576472|1094788|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
334556|NCT00576472|1094789|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
334557|NCT00576472|1094790|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
334558|NCT00576472|1094791|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
334559|NCT00576472|1094792|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
334560|NCT00576472|1094793|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
334561|NCT00576472|1094794|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
334562|NCT00576472|1094795|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
334563|NCT00576472|1094796|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
334564|NCT00576472|1094797|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
334565|NCT00576472|1094798|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
334566|NCT00576472|1094799|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
334567|NCT00576472|1094800|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
334568|NCT00576472|1094786|P15|MPH Home Maintenance Phase|Medical reasons|6
334569|NCT00576472|1094787|P14|MPH Home Maintenance Phase|Medical reasons|0
334570|NCT00576472|1094788|P13|MPH Home Maintenance Phase|Medical reasons|0
334571|NCT00576472|1094789|P12|MPH Home Maintenance Phase|Medical reasons|0
334572|NCT00576472|1094790|P11|MPH Home Maintenance Phase|Medical reasons|0
334573|NCT00576472|1094791|P10|MPH Home Maintenance Phase|Medical reasons|0
334574|NCT00576472|1094792|P9|MPH Home Maintenance Phase|Medical reasons|0
334575|NCT00576472|1094793|P8|MPH Home Maintenance Phase|Medical reasons|0
334576|NCT00576472|1094794|P7|MPH Home Maintenance Phase|Medical reasons|0
334577|NCT00576472|1094795|P6|MPH Home Maintenance Phase|Medical reasons|0
334578|NCT00576472|1094796|P5|MPH Home Maintenance Phase|Medical reasons|0
334579|NCT00576472|1094797|P4|MPH Home Maintenance Phase|Medical reasons|0
334580|NCT00576472|1094798|P3|MPH Home Maintenance Phase|Medical reasons|0
334581|NCT00576472|1094799|P2|MPH Home Maintenance Phase|Medical reasons|0
334582|NCT00576472|1094800|P1|MPH Home Maintenance Phase|Medical reasons|0
334583|NCT00576472|1094786|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
334584|NCT00576472|1094787|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
334585|NCT00576472|1094788|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
334586|NCT00576472|1094789|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
334587|NCT00576472|1094790|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
334588|NCT00576472|1094791|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
334589|NCT00576472|1094792|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
334590|NCT00576472|1094793|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
334591|NCT00576472|1094794|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
334592|NCT00576472|1094795|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
334593|NCT00576472|1094796|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
334594|NCT00576472|1094797|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
334595|NCT00576472|1094798|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
334596|NCT00576472|1094799|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
334597|NCT00576472|1094800|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
334598|NCT00576472|1094786|P15|MPH Home Maintenance Phase|Side effects|8
334599|NCT00576472|1094787|P14|MPH Home Maintenance Phase|Side effects|0
334600|NCT00576472|1094788|P13|MPH Home Maintenance Phase|Side effects|0
334601|NCT00576472|1094789|P12|MPH Home Maintenance Phase|Side effects|0
334602|NCT00576472|1094790|P11|MPH Home Maintenance Phase|Side effects|0
334603|NCT00576472|1094791|P10|MPH Home Maintenance Phase|Side effects|0
334604|NCT00576472|1094792|P9|MPH Home Maintenance Phase|Side effects|0
334605|NCT00576472|1094793|P8|MPH Home Maintenance Phase|Side effects|0
334606|NCT00576472|1094794|P7|MPH Home Maintenance Phase|Side effects|0
334607|NCT00576472|1094795|P6|MPH Home Maintenance Phase|Side effects|0
334608|NCT00576472|1094796|P5|MPH Home Maintenance Phase|Side effects|0
334609|NCT00576472|1094797|P4|MPH Home Maintenance Phase|Side effects|0
334610|NCT00576472|1094798|P3|MPH Home Maintenance Phase|Side effects|0
334611|NCT00576472|1094799|P2|MPH Home Maintenance Phase|Side effects|0
334612|NCT00576472|1094800|P1|MPH Home Maintenance Phase|Side effects|0
334613|NCT00576472|1094786|P15|MPH Home Maintenance Phase|Insufficient data|0
334614|NCT00576472|1094787|P14|MPH Home Maintenance Phase|Insufficient data|4
334615|NCT00576472|1094788|P13|MPH Home Maintenance Phase|Insufficient data|0
334616|NCT00576472|1094789|P12|MPH Home Maintenance Phase|Insufficient data|0
334617|NCT00576472|1094790|P11|MPH Home Maintenance Phase|Insufficient data|0
334618|NCT00576472|1094791|P10|MPH Home Maintenance Phase|Insufficient data|0
334619|NCT00576472|1094792|P9|MPH Home Maintenance Phase|Insufficient data|0
334620|NCT00576472|1094793|P8|MPH Home Maintenance Phase|Insufficient data|0
334621|NCT00576472|1094794|P7|MPH Home Maintenance Phase|Insufficient data|0
334622|NCT00576472|1094795|P6|MPH Home Maintenance Phase|Insufficient data|0
334623|NCT00576472|1094796|P5|MPH Home Maintenance Phase|Insufficient data|0
334624|NCT00576472|1094797|P4|MPH Home Maintenance Phase|Insufficient data|0
334625|NCT00576472|1094798|P3|MPH Home Maintenance Phase|Insufficient data|0
334626|NCT00576472|1094799|P2|MPH Home Maintenance Phase|Insufficient data|0
334627|NCT00576472|1094800|P1|MPH Home Maintenance Phase|Insufficient data|0
334628|NCT00576472|1094786|P15|MPH Home Maintenance Phase|Declined to participate|0
334629|NCT00576472|1094787|P14|MPH Home Maintenance Phase|Declined to participate|7
334630|NCT00576472|1094788|P13|MPH Home Maintenance Phase|Declined to participate|0
334631|NCT00576472|1094789|P12|MPH Home Maintenance Phase|Declined to participate|0
334632|NCT00576472|1094790|P11|MPH Home Maintenance Phase|Declined to participate|0
334633|NCT00576472|1094791|P10|MPH Home Maintenance Phase|Declined to participate|0
334634|NCT00576472|1094792|P9|MPH Home Maintenance Phase|Declined to participate|0
334635|NCT00576472|1094793|P8|MPH Home Maintenance Phase|Declined to participate|0
334636|NCT00576472|1094794|P7|MPH Home Maintenance Phase|Declined to participate|0
334637|NCT00576472|1094795|P6|MPH Home Maintenance Phase|Declined to participate|0
334638|NCT00576472|1094796|P5|MPH Home Maintenance Phase|Declined to participate|0
334639|NCT00576472|1094797|P4|MPH Home Maintenance Phase|Declined to participate|0
334640|NCT00576472|1094798|P3|MPH Home Maintenance Phase|Declined to participate|0
334641|NCT00576472|1094799|P2|MPH Home Maintenance Phase|Declined to participate|0
334642|NCT00576472|1094800|P1|MPH Home Maintenance Phase|Declined to participate|0
334643|NCT00576472|1094786|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
334644|NCT00576472|1094787|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
334645|NCT00576472|1094788|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
334646|NCT00576472|1094789|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
334647|NCT00576472|1094790|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
334648|NCT00576472|1094791|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
334649|NCT00576472|1094792|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
334650|NCT00576472|1094793|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
334651|NCT00576472|1094794|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
334652|NCT00576472|1094795|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
334653|NCT00576472|1094796|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
334654|NCT00576472|1094797|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
334655|NCT00576472|1094798|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
334656|NCT00576472|1094799|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
334657|NCT00576472|1094800|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
334658|NCT00576472|1094786|P15|MPH Cross Over Phase|Did not complete cross over phase|0
334659|NCT00576472|1094787|P14|MPH Cross Over Phase|Did not complete cross over phase|0
334660|NCT00576472|1094788|P13|MPH Cross Over Phase|Did not complete cross over phase|0
334661|NCT00576472|1094789|P12|MPH Cross Over Phase|Did not complete cross over phase|1
334662|NCT00576472|1094790|P11|MPH Cross Over Phase|Did not complete cross over phase|1
334663|NCT00576472|1094791|P10|MPH Cross Over Phase|Did not complete cross over phase|0
334664|NCT00576472|1094792|P9|MPH Cross Over Phase|Did not complete cross over phase|2
334665|NCT00576472|1094793|P8|MPH Cross Over Phase|Did not complete cross over phase|0
334666|NCT00576472|1094794|P7|MPH Cross Over Phase|Did not complete cross over phase|0
334667|NCT00576472|1094795|P6|MPH Cross Over Phase|Did not complete cross over phase|0
334668|NCT00576472|1094796|P5|MPH Cross Over Phase|Did not complete cross over phase|0
334669|NCT00576472|1094797|P4|MPH Cross Over Phase|Did not complete cross over phase|0
334670|NCT00576472|1094798|P3|MPH Cross Over Phase|Did not complete cross over phase|0
334671|NCT00576472|1094799|P2|MPH Cross Over Phase|Did not complete cross over phase|0
334672|NCT00576472|1094800|P1|MPH Cross Over Phase|Did not complete cross over phase|0
334673|NCT00576472|1094786|P15|MPH Cross Over Phase|Physician Decision|0
334674|NCT00576472|1094787|P14|MPH Cross Over Phase|Physician Decision|0
334675|NCT00576472|1094788|P13|MPH Cross Over Phase|Physician Decision|0
334676|NCT00576472|1094789|P12|MPH Cross Over Phase|Physician Decision|0
334677|NCT00576472|1094790|P11|MPH Cross Over Phase|Physician Decision|0
334678|NCT00576472|1094791|P10|MPH Cross Over Phase|Physician Decision|0
334679|NCT00576472|1094792|P9|MPH Cross Over Phase|Physician Decision|0
334680|NCT00576472|1094793|P8|MPH Cross Over Phase|Physician Decision|0
334681|NCT00576472|1094794|P7|MPH Cross Over Phase|Physician Decision|4
334682|NCT00576472|1094795|P6|MPH Cross Over Phase|Physician Decision|0
334683|NCT00576472|1094796|P5|MPH Cross Over Phase|Physician Decision|0
334684|NCT00576472|1094797|P4|MPH Cross Over Phase|Physician Decision|0
334685|NCT00576472|1094798|P3|MPH Cross Over Phase|Physician Decision|0
334686|NCT00576472|1094799|P2|MPH Cross Over Phase|Physician Decision|0
334687|NCT00576472|1094800|P1|MPH Cross Over Phase|Physician Decision|0
334688|NCT00576472|1094786|P15|MPH Cross Over Phase|Ineligible due to disease|0
334689|NCT00576472|1094787|P14|MPH Cross Over Phase|Ineligible due to disease|0
334690|NCT00576472|1094788|P13|MPH Cross Over Phase|Ineligible due to disease|0
334691|NCT00576472|1094789|P12|MPH Cross Over Phase|Ineligible due to disease|0
334692|NCT00576472|1094790|P11|MPH Cross Over Phase|Ineligible due to disease|0
334693|NCT00576472|1094791|P10|MPH Cross Over Phase|Ineligible due to disease|0
334694|NCT00576472|1094792|P9|MPH Cross Over Phase|Ineligible due to disease|0
334695|NCT00576472|1094793|P8|MPH Cross Over Phase|Ineligible due to disease|0
334696|NCT00576472|1094794|P7|MPH Cross Over Phase|Ineligible due to disease|2
334697|NCT00576472|1094795|P6|MPH Cross Over Phase|Ineligible due to disease|0
334698|NCT00576472|1094796|P5|MPH Cross Over Phase|Ineligible due to disease|0
334699|NCT00576472|1094797|P4|MPH Cross Over Phase|Ineligible due to disease|0
334700|NCT00576472|1094798|P3|MPH Cross Over Phase|Ineligible due to disease|0
334701|NCT00576472|1094799|P2|MPH Cross Over Phase|Ineligible due to disease|0
334702|NCT00576472|1094800|P1|MPH Cross Over Phase|Ineligible due to disease|0
334703|NCT00576472|1094786|P15|MPH Cross Over Phase|Withdrawal by Subject|0
334704|NCT00576472|1094787|P14|MPH Cross Over Phase|Withdrawal by Subject|0
334705|NCT00576472|1094788|P13|MPH Cross Over Phase|Withdrawal by Subject|0
334706|NCT00576472|1094789|P12|MPH Cross Over Phase|Withdrawal by Subject|0
334707|NCT00576472|1094790|P11|MPH Cross Over Phase|Withdrawal by Subject|0
334708|NCT00576472|1094791|P10|MPH Cross Over Phase|Withdrawal by Subject|0
334709|NCT00576472|1094792|P9|MPH Cross Over Phase|Withdrawal by Subject|0
334710|NCT00576472|1094793|P8|MPH Cross Over Phase|Withdrawal by Subject|0
334711|NCT00576472|1094794|P7|MPH Cross Over Phase|Withdrawal by Subject|6
334712|NCT00576472|1094795|P6|MPH Cross Over Phase|Withdrawal by Subject|0
334713|NCT00576472|1094796|P5|MPH Cross Over Phase|Withdrawal by Subject|0
334714|NCT00576472|1094797|P4|MPH Cross Over Phase|Withdrawal by Subject|0
334715|NCT00576472|1094798|P3|MPH Cross Over Phase|Withdrawal by Subject|0
334716|NCT00576472|1094799|P2|MPH Cross Over Phase|Withdrawal by Subject|0
334717|NCT00576472|1094800|P1|MPH Cross Over Phase|Withdrawal by Subject|0
334718|NCT00576472|1094786|P15|MPH In-Lab Phase|Psychiatric exclusion|0
334719|NCT00576472|1094787|P14|MPH In-Lab Phase|Psychiatric exclusion|0
334720|NCT00576472|1094788|P13|MPH In-Lab Phase|Psychiatric exclusion|0
334721|NCT00576472|1094789|P12|MPH In-Lab Phase|Psychiatric exclusion|0
334722|NCT00576472|1094790|P11|MPH In-Lab Phase|Psychiatric exclusion|0
334723|NCT00576472|1094791|P10|MPH In-Lab Phase|Psychiatric exclusion|0
334724|NCT00576472|1094792|P9|MPH In-Lab Phase|Psychiatric exclusion|0
334725|NCT00576472|1094793|P8|MPH In-Lab Phase|Psychiatric exclusion|0
334726|NCT00576472|1094794|P7|MPH In-Lab Phase|Psychiatric exclusion|0
334727|NCT00576472|1094795|P6|MPH In-Lab Phase|Psychiatric exclusion|0
334728|NCT00576472|1094796|P5|MPH In-Lab Phase|Psychiatric exclusion|0
334729|NCT00576472|1094797|P4|MPH In-Lab Phase|Psychiatric exclusion|10
334730|NCT00576472|1094798|P3|MPH In-Lab Phase|Psychiatric exclusion|0
334731|NCT00576472|1094799|P2|MPH In-Lab Phase|Psychiatric exclusion|0
334732|NCT00576472|1094800|P1|MPH In-Lab Phase|Psychiatric exclusion|0
334733|NCT00576472|1094786|P15|MPH In-Lab Phase|No attention/academic problems|0
334734|NCT00576472|1094787|P14|MPH In-Lab Phase|No attention/academic problems|0
334735|NCT00576472|1094788|P13|MPH In-Lab Phase|No attention/academic problems|0
334736|NCT00576472|1094789|P12|MPH In-Lab Phase|No attention/academic problems|0
334737|NCT00576472|1094790|P11|MPH In-Lab Phase|No attention/academic problems|0
334738|NCT00576472|1094791|P10|MPH In-Lab Phase|No attention/academic problems|0
334739|NCT00576472|1094792|P9|MPH In-Lab Phase|No attention/academic problems|0
334740|NCT00576472|1094793|P8|MPH In-Lab Phase|No attention/academic problems|0
334741|NCT00576472|1094794|P7|MPH In-Lab Phase|No attention/academic problems|0
334742|NCT00576472|1094795|P6|MPH In-Lab Phase|No attention/academic problems|0
334743|NCT00576472|1094796|P5|MPH In-Lab Phase|No attention/academic problems|0
334744|NCT00576472|1094797|P4|MPH In-Lab Phase|No attention/academic problems|245
334745|NCT00576472|1094798|P3|MPH In-Lab Phase|No attention/academic problems|0
334746|NCT00576472|1094799|P2|MPH In-Lab Phase|No attention/academic problems|0
334747|NCT00576472|1094800|P1|MPH In-Lab Phase|No attention/academic problems|0
334748|NCT00576472|1094786|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334749|NCT00576472|1094787|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334750|NCT00576472|1094788|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334751|NCT00576472|1094789|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334752|NCT00576472|1094790|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334753|NCT00576472|1094791|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334754|NCT00576472|1094792|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334755|NCT00576472|1094793|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334756|NCT00576472|1094794|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334757|NCT00576472|1094795|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334758|NCT00576472|1094796|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334759|NCT00576472|1094797|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
334760|NCT00576472|1094798|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334761|NCT00576472|1094799|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334762|NCT00576472|1094800|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
334763|NCT00576472|1094786|P15|MPH In-Lab Phase|Lost to Follow-up|0
334764|NCT00576472|1094787|P14|MPH In-Lab Phase|Lost to Follow-up|0
334765|NCT00576472|1094788|P13|MPH In-Lab Phase|Lost to Follow-up|0
334766|NCT00576472|1094789|P12|MPH In-Lab Phase|Lost to Follow-up|0
334767|NCT00576472|1094790|P11|MPH In-Lab Phase|Lost to Follow-up|0
334768|NCT00576472|1094791|P10|MPH In-Lab Phase|Lost to Follow-up|0
334769|NCT00576472|1094792|P9|MPH In-Lab Phase|Lost to Follow-up|0
334770|NCT00576472|1094793|P8|MPH In-Lab Phase|Lost to Follow-up|0
334771|NCT00576472|1094794|P7|MPH In-Lab Phase|Lost to Follow-up|0
334772|NCT00576472|1094795|P6|MPH In-Lab Phase|Lost to Follow-up|0
334773|NCT00576472|1094796|P5|MPH In-Lab Phase|Lost to Follow-up|0
334774|NCT00576472|1094797|P4|MPH In-Lab Phase|Lost to Follow-up|1
334775|NCT00576472|1094798|P3|MPH In-Lab Phase|Lost to Follow-up|0
334776|NCT00576472|1094799|P2|MPH In-Lab Phase|Lost to Follow-up|0
334777|NCT00576472|1094800|P1|MPH In-Lab Phase|Lost to Follow-up|0
334778|NCT00576472|1094786|P15|MPH In-Lab Phase|Declined participation in medication pha|0
334779|NCT00576472|1094787|P14|MPH In-Lab Phase|Declined participation in medication pha|0
334780|NCT00576472|1094788|P13|MPH In-Lab Phase|Declined participation in medication pha|0
334781|NCT00576472|1094789|P12|MPH In-Lab Phase|Declined participation in medication pha|0
334782|NCT00576472|1094790|P11|MPH In-Lab Phase|Declined participation in medication pha|0
334783|NCT00576472|1094791|P10|MPH In-Lab Phase|Declined participation in medication pha|0
334784|NCT00576472|1094792|P9|MPH In-Lab Phase|Declined participation in medication pha|0
334785|NCT00576472|1094793|P8|MPH In-Lab Phase|Declined participation in medication pha|0
334786|NCT00576472|1094794|P7|MPH In-Lab Phase|Declined participation in medication pha|0
334787|NCT00576472|1094795|P6|MPH In-Lab Phase|Declined participation in medication pha|0
334788|NCT00576472|1094796|P5|MPH In-Lab Phase|Declined participation in medication pha|0
334789|NCT00576472|1094797|P4|MPH In-Lab Phase|Declined participation in medication pha|75
334790|NCT00576472|1094798|P3|MPH In-Lab Phase|Declined participation in medication pha|0
334791|NCT00576472|1094799|P2|MPH In-Lab Phase|Declined participation in medication pha|0
334792|NCT00576472|1094800|P1|MPH In-Lab Phase|Declined participation in medication pha|0
334793|NCT00576420|1094893|P3|Overall Study|Death|1
334794|NCT00576420|1094894|P2|Overall Study|Death|0
334795|NCT00576420|1094895|P1|Overall Study|Death|0
334796|NCT00576381|1095060|P1|Overall Study|Adverse Event|4
334797|NCT00576381|1095060|P1|Overall Study|Reoperation|3
334798|NCT00576316|1095064|P1|Overall Study|Protocol Violation|9
334799|NCT00576316|1095064|P1|Overall Study|Withdrawal by Subject|2
334800|NCT00576316|1095064|P1|Overall Study|Adverse Event|9
334801|NCT00576303|1095069|P1|Long Term Safety Period|Early withdrawal|16
334802|NCT00576303|1095069|P1|Efficacy Evaluation Period|Early withdrawal|5
334803|NCT00576303|1095069|P1|Dose Titration Period|Early withdrawal|17
334804|NCT00576199|1095087|P1|Overall Study|Reason Unspecified|2
334805|NCT00576199|1095087|P1|Overall Study|Refused Treatment|2
334806|NCT00576199|1095087|P1|Overall Study|Insufficient Therapeutic Response|14
334807|NCT00576199|1095087|P1|Overall Study|Adverse Event|12
334808|NCT00576056|1095100|P1|Overall Study|Physician Decision|1
334809|NCT00576056|1095100|P1|Overall Study|did not meet eligibility criteria|8
334810|NCT00576056|1095100|P1|Overall Study|Withdrawal by Subject|2
334811|NCT00576056|1095100|P1|Overall Study|Lack of Efficacy|1
334812|NCT00576056|1095100|P1|Overall Study|Death|1
334813|NCT00576056|1095100|P1|Overall Study|Adverse Event|1
334814|NCT00575666|1095116|P2|Overall Study|Physician Decision|1
334815|NCT00575666|1095117|P1|Overall Study|Physician Decision|1
334816|NCT00575666|1095116|P2|Overall Study|Withdrawal by Subject|2
334817|NCT00575666|1095117|P1|Overall Study|Withdrawal by Subject|3
334818|NCT00575588|1095157|P2|Overall Study|Impossible to determine HbA1c|1
334819|NCT00575588|1095158|P1|Overall Study|Impossible to determine HbA1c|0
334820|NCT00575588|1095157|P2|Overall Study|Patient moved|3
334821|NCT00575588|1095158|P1|Overall Study|Patient moved|1
334822|NCT00575588|1095157|P2|Overall Study|Elevated triglyceride|0
334823|NCT00575588|1095158|P1|Overall Study|Elevated triglyceride|1
334824|NCT00575588|1095157|P2|Overall Study|Safety reasons|1
334825|NCT00575588|1095158|P1|Overall Study|Safety reasons|2
334826|NCT00575588|1095157|P2|Overall Study|Severe non-compliance to protocol|7
334827|NCT00575588|1095158|P1|Overall Study|Severe non-compliance to protocol|5
334828|NCT00575588|1095157|P2|Overall Study|Study specific discontinuation criteria|218
334829|NCT00575588|1095158|P1|Overall Study|Study specific discontinuation criteria|203
334830|NCT00575588|1095157|P2|Overall Study|Incorrect enrollment|4
334831|NCT00575588|1095158|P1|Overall Study|Incorrect enrollment|8
334832|NCT00575588|1095157|P2|Overall Study|Death|2
334833|NCT00575588|1095158|P1|Overall Study|Death|4
334834|NCT00575588|1095157|P2|Overall Study|Lost to Follow-up|3
334835|NCT00575588|1095158|P1|Overall Study|Lost to Follow-up|1
334836|NCT00575588|1095157|P2|Overall Study|Withdrawal by Subject|31
334837|NCT00575588|1095158|P1|Overall Study|Withdrawal by Subject|27
334838|NCT00575588|1095157|P2|Overall Study|Adverse Event|13
334839|NCT00575588|1095158|P1|Overall Study|Adverse Event|11
334840|NCT00575510|1095181|P3|Overall Study|Pregnancy|1
334841|NCT00575510|1095182|P2|Overall Study|Pregnancy|0
334842|NCT00575510|1095183|P1|Overall Study|Pregnancy|0
334843|NCT00575510|1095181|P3|Overall Study|Clinic Called Patient|7
334844|NCT00575510|1095182|P2|Overall Study|Clinic Called Patient|7
334845|NCT00575510|1095183|P1|Overall Study|Clinic Called Patient|7
334846|NCT00575510|1095181|P3|Overall Study|Withdrawal by Subject|0
334847|NCT00575510|1095182|P2|Overall Study|Withdrawal by Subject|0
334848|NCT00575510|1095183|P1|Overall Study|Withdrawal by Subject|1
334849|NCT00575510|1095181|P3|Overall Study|Lost to Follow-up|9
334850|NCT00575510|1095182|P2|Overall Study|Lost to Follow-up|6
334851|NCT00575510|1095183|P1|Overall Study|Lost to Follow-up|4
334852|NCT00575380|1095196|P2|Overall Study|Various|2
334853|NCT00575380|1095197|P1|Overall Study|Various|0
334854|NCT00575380|1095196|P2|Overall Study|Adverse Event|1
334855|NCT00575380|1095197|P1|Overall Study|Adverse Event|0
334856|NCT00575380|1095196|P2|Overall Study|Withdrawal by Subject|0
334857|NCT00575380|1095197|P1|Overall Study|Withdrawal by Subject|1
334858|NCT00575094|1095231|P1|Overall Study|Withdrawal by Subject|1
334859|NCT00575094|1095231|P1|Overall Study|Adverse Event|2
334860|NCT00575042|1095235|P1|Overall Study|Lost to Follow-up|1
334861|NCT00575042|1095235|P1|Overall Study|Adverse Event|2
334862|NCT00574912|1095286|P1|Overall Study|Physician Decision|2
334863|NCT00574912|1095286|P1|Overall Study|scheduling conflicts|3
334864|NCT00574912|1095286|P1|Overall Study|Could not place IV lines.|3
334865|NCT00574873|1095300|P2|Overall Study|Extension Study|0
334866|NCT00574873|1095301|P1|Overall Study|Extension Study|126
334867|NCT00574873|1095300|P2|Overall Study|Blank, site closed per local regulations|2
334868|NCT00574873|1095301|P1|Overall Study|Blank, site closed per local regulations|2
334869|NCT00574873|1095300|P2|Overall Study|Discontinuation of study by sponsor|199
334870|NCT00574873|1095301|P1|Overall Study|Discontinuation of study by sponsor|5
334871|NCT00574873|1095300|P2|Overall Study|Unspecified|4
334872|NCT00574873|1095301|P1|Overall Study|Unspecified|40
334873|NCT00574873|1095300|P2|Overall Study|Lost to Follow-up|5
334874|NCT00574873|1095301|P1|Overall Study|Lost to Follow-up|14
334875|NCT00574873|1095300|P2|Overall Study|Death|14
334876|NCT00574873|1095301|P1|Overall Study|Death|15
334877|NCT00574873|1095300|P2|Overall Study|Investigator request|8
334878|NCT00574873|1095301|P1|Overall Study|Investigator request|18
334879|NCT00574873|1095300|P2|Overall Study|Withdrawal by Subject|19
334880|NCT00574873|1095301|P1|Overall Study|Withdrawal by Subject|18
334881|NCT00574847|1095319|P2|Overall Study|Did not receive medication (declined)|5
334882|NCT00574847|1095320|P1|Overall Study|Did not receive medication (declined)|2
334883|NCT00574847|1095319|P2|Overall Study|Physician Decision|0
334884|NCT00574847|1095320|P1|Overall Study|Physician Decision|1
334885|NCT00574847|1095319|P2|Overall Study|Withdrawal by Subject|2
334886|NCT00574847|1095320|P1|Overall Study|Withdrawal by Subject|2
334887|NCT00574847|1095319|P2|Overall Study|Death|0
334888|NCT00574847|1095320|P1|Overall Study|Death|1
334889|NCT00574847|1095319|P2|Overall Study|Adverse Event|0
334890|NCT00574847|1095320|P1|Overall Study|Adverse Event|2
334891|NCT00574795|1095365|P1|Toddler Dose|Withdrawal by Subject|1
334892|NCT00574795|1095365|P1|After Infant Series|Adverse Event|2
334893|NCT00574795|1095365|P1|After Infant Series|Withdrawal by Subject|1
334894|NCT00574795|1095365|P1|Infant Series|Adverse Event|1
334895|NCT00574795|1095365|P1|Infant Series|Protocol Violation|2
334896|NCT00574795|1095365|P1|Infant Series|Withdrawal by Subject|2
334897|NCT00574405|1095448|P2|Overall Study|Withdrawal by Subject|2
334898|NCT00574405|1095449|P1|Overall Study|Withdrawal by Subject|3
334899|NCT00574288|1095469|P7|Overall Study|Ongoing|14
334900|NCT00574288|1095470|P6|Overall Study|Ongoing|0
334901|NCT00574288|1095471|P5|Overall Study|Ongoing|0
334902|NCT00574288|1095472|P4|Overall Study|Ongoing|0
334903|NCT00574288|1095473|P3|Overall Study|Ongoing|0
334904|NCT00574288|1095474|P2|Overall Study|Ongoing|0
334905|NCT00574288|1095475|P1|Overall Study|Ongoing|0
334906|NCT00574288|1095469|P7|Overall Study|Progressive disease|23
334907|NCT00574288|1095470|P6|Overall Study|Progressive disease|30
334908|NCT00574288|1095471|P5|Overall Study|Progressive disease|0
334909|NCT00574288|1095472|P4|Overall Study|Progressive disease|2
334910|NCT00574288|1095473|P3|Overall Study|Progressive disease|0
334911|NCT00574288|1095474|P2|Overall Study|Progressive disease|0
334912|NCT00574288|1095475|P1|Overall Study|Progressive disease|10
334913|NCT00574288|1095469|P7|Overall Study|Physician Decision|4
334914|NCT00574288|1095470|P6|Overall Study|Physician Decision|0
334915|NCT00574288|1095471|P5|Overall Study|Physician Decision|0
334916|NCT00574288|1095472|P4|Overall Study|Physician Decision|0
334917|NCT00574288|1095473|P3|Overall Study|Physician Decision|0
334918|NCT00574288|1095474|P2|Overall Study|Physician Decision|0
334919|NCT00574288|1095475|P1|Overall Study|Physician Decision|0
334920|NCT00574288|1095469|P7|Overall Study|Adverse Event|1
334921|NCT00574288|1095470|P6|Overall Study|Adverse Event|0
334922|NCT00574288|1095471|P5|Overall Study|Adverse Event|1
334923|NCT00574288|1095472|P4|Overall Study|Adverse Event|0
334924|NCT00574288|1095473|P3|Overall Study|Adverse Event|0
334925|NCT00574288|1095474|P2|Overall Study|Adverse Event|1
334926|NCT00574288|1095475|P1|Overall Study|Adverse Event|3
334927|NCT00574275|1095513|P2|Overall Study|Operation for curative intent|1
334928|NCT00574275|1095514|P1|Overall Study|Operation for curative intent|0
334929|NCT00574275|1095513|P2|Overall Study|Insurance change|1
334930|NCT00574275|1095514|P1|Overall Study|Insurance change|0
334931|NCT00574275|1095513|P2|Overall Study|Patient and Investigator decision|1
334932|NCT00574275|1095514|P1|Overall Study|Patient and Investigator decision|0
334933|NCT00574275|1095513|P2|Overall Study|Protocol Violation|1
334934|NCT00574275|1095514|P1|Overall Study|Protocol Violation|0
334935|NCT00574275|1095513|P2|Overall Study|Physician Decision|1
334936|NCT00574275|1095514|P1|Overall Study|Physician Decision|1
334937|NCT00574275|1095513|P2|Overall Study|Error calculating tumor measurement|0
334938|NCT00574275|1095514|P1|Overall Study|Error calculating tumor measurement|1
334939|NCT00574275|1095513|P2|Overall Study|Withdrawal by Subject|17
334940|NCT00574275|1095514|P1|Overall Study|Withdrawal by Subject|15
334941|NCT00574275|1095513|P2|Overall Study|Study stopped based on DMC decision|23
334942|NCT00574275|1095514|P1|Overall Study|Study stopped based on DMC decision|62
334943|NCT00574275|1095513|P2|Overall Study|Lost to Follow-up|1
334944|NCT00574275|1095514|P1|Overall Study|Lost to Follow-up|2
334945|NCT00574275|1095513|P2|Overall Study|Disease progression|146
334946|NCT00574275|1095514|P1|Overall Study|Disease progression|160
334947|NCT00574275|1095513|P2|Overall Study|Adverse Event|76
334948|NCT00574275|1095514|P1|Overall Study|Adverse Event|32
334949|NCT00574275|1095513|P2|Overall Study|Randomized but not treated|3
334950|NCT00574275|1095514|P1|Overall Study|Randomized but not treated|2
334951|NCT00574249|1095532|P2|Overall Study|PPD test taken twice|1
334952|NCT00574249|1095533|P1|Overall Study|PPD test taken twice|0
334953|NCT00574249|1095532|P2|Overall Study|Excluded by company|1
334954|NCT00574249|1095533|P1|Overall Study|Excluded by company|0
334955|NCT00574249|1095532|P2|Overall Study|Pregnancy|0
334956|NCT00574249|1095533|P1|Overall Study|Pregnancy|1
334957|NCT00574249|1095532|P2|Overall Study|Physician Decision|0
334958|NCT00574249|1095533|P1|Overall Study|Physician Decision|1
334959|NCT00574249|1095532|P2|Overall Study|Withdrawal by Subject|0
334960|NCT00574249|1095533|P1|Overall Study|Withdrawal by Subject|3
334961|NCT00574249|1095532|P2|Overall Study|History of carcinoma|0
334962|NCT00574249|1095533|P1|Overall Study|History of carcinoma|1
334963|NCT00574249|1095532|P2|Overall Study|Protocol Violation|2
334964|NCT00574249|1095533|P1|Overall Study|Protocol Violation|5
334965|NCT00574249|1095532|P2|Overall Study|Lost to Follow-up|3
334966|NCT00574249|1095533|P1|Overall Study|Lost to Follow-up|4
334967|NCT00574249|1095532|P2|Overall Study|Lack of Efficacy|3
334968|NCT00574249|1095533|P1|Overall Study|Lack of Efficacy|5
334969|NCT00574249|1095532|P2|Overall Study|Adverse Event|18
334970|NCT00574249|1095533|P1|Overall Study|Adverse Event|6
334971|NCT00574145|1095579|P2|Overall Study|Withdrawal by Subject|1
334972|NCT00574145|1095580|P1|Overall Study|Withdrawal by Subject|2
334973|NCT00574080|1095592|P2|Overall Study|Death|10
334974|NCT00574080|1095593|P1|Overall Study|Death|10
334975|NCT00573937|1095641|P2|Overall Study|Study Terminated|1
334976|NCT00573937|1095642|P1|Overall Study|Study Terminated|0
334977|NCT00573859|1095650|P1|Smoking Versus Abstinence|Scheduling conflicts|12
334978|NCT00573859|1095650|P1|Medication Versus Placebo|Scheduling conflicts|12
334979|NCT00573768|1095659|P3|Overall Study|Lost to Follow-up|1
334980|NCT00573768|1095660|P2|Overall Study|Lost to Follow-up|0
334981|NCT00573768|1095661|P1|Overall Study|Lost to Follow-up|0
334982|NCT00573768|1095659|P3|Overall Study|Withdrawal by Subject|0
334983|NCT00573768|1095660|P2|Overall Study|Withdrawal by Subject|1
334984|NCT00573768|1095661|P1|Overall Study|Withdrawal by Subject|0
334985|NCT00573768|1095659|P3|Overall Study|Protocol Violation|1
334986|NCT00573768|1095660|P2|Overall Study|Protocol Violation|0
334987|NCT00573768|1095661|P1|Overall Study|Protocol Violation|1
334988|NCT00573768|1095659|P3|Overall Study|Adverse Event|2
334989|NCT00573768|1095660|P2|Overall Study|Adverse Event|1
334990|NCT00573768|1095661|P1|Overall Study|Adverse Event|1
334991|NCT00573755|1095671|P2|Overall Study|Still receiving treatment|0
334992|NCT00573755|1095672|P1|Overall Study|Still receiving treatment|1
334993|NCT00573534|1095688|P1|Overall Study|oppositional behavior|3
334994|NCT00573469|1095729|P3|Overall Study|Not Specified|3
334995|NCT00573469|1095730|P2|Overall Study|Not Specified|1
334996|NCT00573469|1095731|P1|Overall Study|Not Specified|5
334997|NCT00573469|1095729|P3|Overall Study|Withdrawal by Subject|0
334998|NCT00573469|1095730|P2|Overall Study|Withdrawal by Subject|2
334999|NCT00573469|1095731|P1|Overall Study|Withdrawal by Subject|0
335000|NCT00573469|1095729|P3|Overall Study|Adverse Event|1
335001|NCT00573469|1095730|P2|Overall Study|Adverse Event|1
335002|NCT00573469|1095731|P1|Overall Study|Adverse Event|1
335003|NCT00573443|1095754|P3|Open-Label Extension Phase|Not Specified|0
335004|NCT00573443|1095755|P2|Open-Label Extension Phase|Not Specified|0
335005|NCT00573443|1095756|P1|Open-Label Extension Phase|Not Specified|2
335006|NCT00573443|1095754|P3|Open-Label Extension Phase|Protocol Violation|0
335007|NCT00573443|1095755|P2|Open-Label Extension Phase|Protocol Violation|0
335008|NCT00573443|1095756|P1|Open-Label Extension Phase|Protocol Violation|2
335009|NCT00573443|1095754|P3|Open-Label Extension Phase|Withdrawal by Subject|0
335010|NCT00573443|1095755|P2|Open-Label Extension Phase|Withdrawal by Subject|0
335011|NCT00573443|1095756|P1|Open-Label Extension Phase|Withdrawal by Subject|3
335012|NCT00573443|1095754|P3|Open-Label Extension Phase|Serious Adverse Event|0
335013|NCT00573443|1095755|P2|Open-Label Extension Phase|Serious Adverse Event|0
335014|NCT00573443|1095756|P1|Open-Label Extension Phase|Serious Adverse Event|5
335015|NCT00573443|1095754|P3|Open-Label Extension Phase|Adverse Event|0
335016|NCT00573443|1095755|P2|Open-Label Extension Phase|Adverse Event|0
335017|NCT00573443|1095756|P1|Open-Label Extension Phase|Adverse Event|3
335018|NCT00573443|1095754|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
335019|NCT00573443|1095755|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
335020|NCT00573443|1095756|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
335021|NCT00573443|1095754|P3|Open-Label Extension Phase|Lost to Follow-up|0
335022|NCT00573443|1095755|P2|Open-Label Extension Phase|Lost to Follow-up|0
335023|NCT00573443|1095756|P1|Open-Label Extension Phase|Lost to Follow-up|1
335024|NCT00573443|1095754|P3|Double-Blind Phase|Not specified|3
335025|NCT00573443|1095755|P2|Double-Blind Phase|Not specified|2
335026|NCT00573443|1095756|P1|Double-Blind Phase|Not specified|0
335027|NCT00573443|1095754|P3|Double-Blind Phase|Protocol Violation|1
335028|NCT00573443|1095755|P2|Double-Blind Phase|Protocol Violation|2
335029|NCT00573443|1095756|P1|Double-Blind Phase|Protocol Violation|0
335030|NCT00573443|1095754|P3|Double-Blind Phase|Withdrawal by Subject|7
335031|NCT00573443|1095755|P2|Double-Blind Phase|Withdrawal by Subject|2
335032|NCT00573443|1095756|P1|Double-Blind Phase|Withdrawal by Subject|2
335033|NCT00573443|1095754|P3|Double-Blind Phase|Medication refusal due to AE|0
335034|NCT00573443|1095755|P2|Double-Blind Phase|Medication refusal due to AE|2
335035|NCT00573443|1095756|P1|Double-Blind Phase|Medication refusal due to AE|2
335036|NCT00573443|1095754|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
335037|NCT00573443|1095755|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
335038|NCT00573443|1095756|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
335039|NCT00573443|1095754|P3|Double-Blind Phase|Adverse Event|0
335040|NCT00573443|1095755|P2|Double-Blind Phase|Adverse Event|5
335041|NCT00573443|1095756|P1|Double-Blind Phase|Adverse Event|1
335042|NCT00573443|1095754|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
335043|NCT00573443|1095755|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
335044|NCT00573443|1095756|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
335045|NCT00573443|1095754|P3|Double-Blind Phase|Lost to Follow-up|2
335046|NCT00573443|1095755|P2|Double-Blind Phase|Lost to Follow-up|3
335047|NCT00573443|1095756|P1|Double-Blind Phase|Lost to Follow-up|1
335048|NCT00573430|1095786|P3|Overall Study|Eligibility criteria not fulfilled|3
335049|NCT00573430|1095787|P2|Overall Study|Eligibility criteria not fulfilled|0
335050|NCT00573430|1095788|P1|Overall Study|Eligibility criteria not fulfilled|0
335051|NCT00573430|1095786|P3|Overall Study|Protocol Violation|1
335052|NCT00573430|1095787|P2|Overall Study|Protocol Violation|1
335053|NCT00573430|1095788|P1|Overall Study|Protocol Violation|0
335054|NCT00573430|1095786|P3|Overall Study|Withdrawal by Subject|1
335055|NCT00573430|1095787|P2|Overall Study|Withdrawal by Subject|0
335056|NCT00573430|1095788|P1|Overall Study|Withdrawal by Subject|1
335057|NCT00573430|1095786|P3|Overall Study|Adverse Event|2
335058|NCT00573430|1095787|P2|Overall Study|Adverse Event|0
335059|NCT00573430|1095788|P1|Overall Study|Adverse Event|0
335060|NCT00573430|1095786|P3|Overall Study|Incorrect enrollment of randomization|3
335061|NCT00573430|1095787|P2|Overall Study|Incorrect enrollment of randomization|4
335062|NCT00573430|1095788|P1|Overall Study|Incorrect enrollment of randomization|0
335063|NCT00573391|1095810|P2|Overall Study|Death|0
335064|NCT00573391|1095811|P1|Overall Study|Death|1
335065|NCT00573391|1095810|P2|Overall Study|study stopped|2
335066|NCT00573391|1095811|P1|Overall Study|study stopped|2
335067|NCT00573313|1095821|P4|Overall Study|Protocol Violation|0
335068|NCT00573313|1095822|P3|Overall Study|Protocol Violation|6
335069|NCT00573313|1095823|P2|Overall Study|Protocol Violation|0
335070|NCT00573313|1095824|P1|Overall Study|Protocol Violation|5
335071|NCT00573248|1095872|P2|Overall Study|scheduling conflicts|11
335072|NCT00573248|1095873|P1|Overall Study|scheduling conflicts|15
335073|NCT00573183|1095887|P2|Overall Study|Unspecified|2
335074|NCT00573183|1095888|P1|Overall Study|Unspecified|5
335075|NCT00573183|1095887|P2|Overall Study|Incarceration|8
335076|NCT00573183|1095888|P1|Overall Study|Incarceration|5
335077|NCT00573183|1095887|P2|Overall Study|Adverse Event|0
335078|NCT00573183|1095888|P1|Overall Study|Adverse Event|2
335079|NCT00573183|1095887|P2|Overall Study|Death|1
335080|NCT00573183|1095888|P1|Overall Study|Death|0
335081|NCT00573183|1095887|P2|Overall Study|Withdrawal by Subject|2
335082|NCT00573183|1095888|P1|Overall Study|Withdrawal by Subject|8
335083|NCT00573183|1095887|P2|Overall Study|Lost to Follow-up|50
335084|NCT00573183|1095888|P1|Overall Study|Lost to Follow-up|52
335085|NCT00573170|1095896|P6|Third Treatment Period|Lost to Follow-up|2
335086|NCT00573170|1095897|P5|Third Treatment Period|Lost to Follow-up|0
335087|NCT00573170|1095898|P4|Third Treatment Period|Lost to Follow-up|0
335088|NCT00573170|1095899|P3|Third Treatment Period|Lost to Follow-up|0
335089|NCT00573170|1095900|P2|Third Treatment Period|Lost to Follow-up|0
335090|NCT00573170|1095901|P1|Third Treatment Period|Lost to Follow-up|0
335091|NCT00573170|1095896|P6|Third Treatment Period|Withdrawal by Subject|0
335092|NCT00573170|1095897|P5|Third Treatment Period|Withdrawal by Subject|0
335093|NCT00573170|1095898|P4|Third Treatment Period|Withdrawal by Subject|0
335094|NCT00573170|1095899|P3|Third Treatment Period|Withdrawal by Subject|0
335095|NCT00573170|1095900|P2|Third Treatment Period|Withdrawal by Subject|0
335096|NCT00573170|1095901|P1|Third Treatment Period|Withdrawal by Subject|1
335097|NCT00573170|1095896|P6|Second Washout Period|Other|2
335098|NCT00573170|1095897|P5|Second Washout Period|Other|6
335099|NCT00573170|1095898|P4|Second Washout Period|Other|4
335100|NCT00573170|1095899|P3|Second Washout Period|Other|1
335101|NCT00573170|1095900|P2|Second Washout Period|Other|2
335102|NCT00573170|1095901|P1|Second Washout Period|Other|1
335103|NCT00573170|1095896|P6|Second Washout Period|Lost to Follow-up|0
335104|NCT00573170|1095897|P5|Second Washout Period|Lost to Follow-up|0
335105|NCT00573170|1095898|P4|Second Washout Period|Lost to Follow-up|1
335106|NCT00573170|1095899|P3|Second Washout Period|Lost to Follow-up|0
335107|NCT00573170|1095900|P2|Second Washout Period|Lost to Follow-up|0
335108|NCT00573170|1095901|P1|Second Washout Period|Lost to Follow-up|0
335109|NCT00573170|1095896|P6|Second Washout Period|Withdrawal by Subject|0
335110|NCT00573170|1095897|P5|Second Washout Period|Withdrawal by Subject|1
335111|NCT00573170|1095898|P4|Second Washout Period|Withdrawal by Subject|0
335112|NCT00573170|1095899|P3|Second Washout Period|Withdrawal by Subject|2
335113|NCT00573170|1095900|P2|Second Washout Period|Withdrawal by Subject|1
335114|NCT00573170|1095901|P1|Second Washout Period|Withdrawal by Subject|1
335115|NCT00573170|1095896|P6|Second Washout Period|Protocol Violation|0
335116|NCT00573170|1095897|P5|Second Washout Period|Protocol Violation|0
335117|NCT00573170|1095898|P4|Second Washout Period|Protocol Violation|0
335118|NCT00573170|1095899|P3|Second Washout Period|Protocol Violation|1
335119|NCT00573170|1095900|P2|Second Washout Period|Protocol Violation|1
335120|NCT00573170|1095901|P1|Second Washout Period|Protocol Violation|2
335121|NCT00573170|1095896|P6|Second Washout Period|Adverse Event|0
335122|NCT00573170|1095897|P5|Second Washout Period|Adverse Event|1
335123|NCT00573170|1095898|P4|Second Washout Period|Adverse Event|0
335124|NCT00573170|1095899|P3|Second Washout Period|Adverse Event|0
335125|NCT00573170|1095900|P2|Second Washout Period|Adverse Event|0
335126|NCT00573170|1095901|P1|Second Washout Period|Adverse Event|1
335127|NCT00573170|1095896|P6|First Washout Period|Other|0
335128|NCT00573170|1095897|P5|First Washout Period|Other|0
335129|NCT00573170|1095898|P4|First Washout Period|Other|1
335130|NCT00573170|1095899|P3|First Washout Period|Other|1
335131|NCT00573170|1095900|P2|First Washout Period|Other|0
335132|NCT00573170|1095901|P1|First Washout Period|Other|4
335133|NCT00573170|1095896|P6|First Washout Period|Withdrawal by Subject|3
335134|NCT00573170|1095897|P5|First Washout Period|Withdrawal by Subject|3
335135|NCT00573170|1095898|P4|First Washout Period|Withdrawal by Subject|2
335136|NCT00573170|1095899|P3|First Washout Period|Withdrawal by Subject|0
335137|NCT00573170|1095900|P2|First Washout Period|Withdrawal by Subject|0
335138|NCT00573170|1095901|P1|First Washout Period|Withdrawal by Subject|2
335139|NCT00573170|1095896|P6|First Washout Period|Lost to Follow-up|2
335140|NCT00573170|1095897|P5|First Washout Period|Lost to Follow-up|0
335141|NCT00573170|1095898|P4|First Washout Period|Lost to Follow-up|2
335142|NCT00573170|1095899|P3|First Washout Period|Lost to Follow-up|0
335143|NCT00573170|1095900|P2|First Washout Period|Lost to Follow-up|1
335144|NCT00573170|1095901|P1|First Washout Period|Lost to Follow-up|1
335145|NCT00573170|1095896|P6|First Washout Period|Lack of Efficacy|1
335146|NCT00573170|1095897|P5|First Washout Period|Lack of Efficacy|0
335147|NCT00573170|1095898|P4|First Washout Period|Lack of Efficacy|0
335148|NCT00573170|1095899|P3|First Washout Period|Lack of Efficacy|0
335149|NCT00573170|1095900|P2|First Washout Period|Lack of Efficacy|0
335150|NCT00573170|1095901|P1|First Washout Period|Lack of Efficacy|0
335151|NCT00573170|1095896|P6|First Washout Period|Adverse Event|1
335152|NCT00573170|1095897|P5|First Washout Period|Adverse Event|0
335153|NCT00573170|1095898|P4|First Washout Period|Adverse Event|0
335154|NCT00573170|1095899|P3|First Washout Period|Adverse Event|0
335155|NCT00573170|1095900|P2|First Washout Period|Adverse Event|1
335156|NCT00573170|1095901|P1|First Washout Period|Adverse Event|1
335157|NCT00573170|1095896|P6|First Treatment Period|Did Not Treat Attack 1|0
335158|NCT00573170|1095897|P5|First Treatment Period|Did Not Treat Attack 1|1
335159|NCT00573170|1095898|P4|First Treatment Period|Did Not Treat Attack 1|0
335160|NCT00573170|1095899|P3|First Treatment Period|Did Not Treat Attack 1|0
335161|NCT00573170|1095900|P2|First Treatment Period|Did Not Treat Attack 1|0
335162|NCT00573170|1095901|P1|First Treatment Period|Did Not Treat Attack 1|0
335163|NCT00573157|1095977|P2|Overall Study|Unspecified|1
335164|NCT00573157|1095978|P1|Overall Study|Unspecified|1
335165|NCT00573157|1095977|P2|Overall Study|Adverse Event|1
335166|NCT00573157|1095978|P1|Overall Study|Adverse Event|3
335167|NCT00573144|1095990|P2|Overall Study|Withdrawal by Subject|3
335168|NCT00573144|1095991|P1|Overall Study|Withdrawal by Subject|2
335169|NCT00573131|1096003|P2|Overall Study|Withdrawal by Subject|8
335170|NCT00573131|1096004|P1|Overall Study|Withdrawal by Subject|10
335171|NCT00573066|1096010|P1|Overall Study|Postoperative bleeding|1
335172|NCT00573066|1096010|P1|Overall Study|IV malfunction|1
335173|NCT00573066|1096010|P1|Overall Study|Exclusion criteria|18
335174|NCT00572910|1096020|P11|Overall Study|Withdrawal by Subject|1
335175|NCT00572910|1096021|P10|Overall Study|Withdrawal by Subject|2
335176|NCT00572910|1096022|P9|Overall Study|Withdrawal by Subject|2
335177|NCT00572910|1096023|P8|Overall Study|Withdrawal by Subject|2
335178|NCT00572910|1096024|P7|Overall Study|Withdrawal by Subject|0
335179|NCT00572910|1096025|P6|Overall Study|Withdrawal by Subject|3
335180|NCT00572910|1096026|P5|Overall Study|Withdrawal by Subject|1
335181|NCT00572910|1096027|P4|Overall Study|Withdrawal by Subject|0
335182|NCT00572910|1096028|P3|Overall Study|Withdrawal by Subject|1
335183|NCT00572910|1096029|P2|Overall Study|Withdrawal by Subject|0
335184|NCT00572910|1096030|P1|Overall Study|Withdrawal by Subject|3
335185|NCT00572910|1096020|P11|Overall Study|Lost to Follow-up|0
335186|NCT00572910|1096021|P10|Overall Study|Lost to Follow-up|1
335187|NCT00572910|1096022|P9|Overall Study|Lost to Follow-up|0
335188|NCT00572910|1096023|P8|Overall Study|Lost to Follow-up|0
335189|NCT00572910|1096024|P7|Overall Study|Lost to Follow-up|0
335190|NCT00572910|1096025|P6|Overall Study|Lost to Follow-up|0
335191|NCT00572910|1096026|P5|Overall Study|Lost to Follow-up|1
335192|NCT00572910|1096027|P4|Overall Study|Lost to Follow-up|2
335193|NCT00572910|1096028|P3|Overall Study|Lost to Follow-up|1
335194|NCT00572910|1096029|P2|Overall Study|Lost to Follow-up|1
335195|NCT00572910|1096030|P1|Overall Study|Lost to Follow-up|0
335196|NCT00572910|1096020|P11|Overall Study|Adverse Event|2
335197|NCT00572910|1096021|P10|Overall Study|Adverse Event|3
335198|NCT00572910|1096022|P9|Overall Study|Adverse Event|1
335199|NCT00572910|1096023|P8|Overall Study|Adverse Event|2
335200|NCT00572910|1096024|P7|Overall Study|Adverse Event|4
335201|NCT00572910|1096025|P6|Overall Study|Adverse Event|0
335202|NCT00572910|1096026|P5|Overall Study|Adverse Event|0
335203|NCT00572910|1096027|P4|Overall Study|Adverse Event|2
335204|NCT00572910|1096028|P3|Overall Study|Adverse Event|0
335205|NCT00572910|1096029|P2|Overall Study|Adverse Event|2
335206|NCT00572910|1096030|P1|Overall Study|Adverse Event|1
335207|NCT00572832|1096097|P2|Overall Study|Pregnancy|1
335208|NCT00572832|1096098|P1|Overall Study|Pregnancy|0
335209|NCT00572832|1096097|P2|Overall Study|Lost to Follow-up|11
335210|NCT00572832|1096098|P1|Overall Study|Lost to Follow-up|0
335211|NCT00572728|1096104|P1|Overall Study|Pathology missing|1
335212|NCT00572728|1096104|P1|Overall Study|FLT2 after second chemotherapy initiated|7
335213|NCT00572728|1096104|P1|Overall Study|Second chemotherapy not initiated|1
335214|NCT00572728|1096104|P1|Overall Study|FLT2 not completed|5
335215|NCT00572728|1096104|P1|Overall Study|First Chemotherapy not initiated|2
335216|NCT00572728|1096104|P1|Overall Study|FLT1 not completed|4
335217|NCT00572728|1096104|P1|Overall Study|Offstudy due to complicating disease|1
335218|NCT00572728|1096104|P1|Overall Study|Enrolled under Amendment 4|5
335219|NCT00572728|1096104|P1|Overall Study|Ineligible|3
335220|NCT00572728|1096104|P1|Overall Study|Withdrawal by Subject|10
335221|NCT00572624|1096118|P2|Overall Study|Health issues unrelated to the study|0
335222|NCT00572624|1096119|P1|Overall Study|Health issues unrelated to the study|1
335223|NCT00572624|1096118|P2|Overall Study|Problem with vascular access|0
335224|NCT00572624|1096119|P1|Overall Study|Problem with vascular access|1
335225|NCT00572624|1096118|P2|Overall Study|Refused to do the stress test|0
335226|NCT00572624|1096119|P1|Overall Study|Refused to do the stress test|1
335227|NCT00572624|1096118|P2|Overall Study|Admitted to being a smoker|0
335228|NCT00572624|1096119|P1|Overall Study|Admitted to being a smoker|1
335229|NCT00572624|1096118|P2|Overall Study|Started a new job-- no time for study|0
335230|NCT00572624|1096119|P1|Overall Study|Started a new job-- no time for study|1
335231|NCT00572624|1096118|P2|Overall Study|Medication change|0
335232|NCT00572624|1096119|P1|Overall Study|Medication change|1
335233|NCT00572624|1096118|P2|Overall Study|Wanted to do a different diet program|0
335234|NCT00572624|1096119|P1|Overall Study|Wanted to do a different diet program|1
335235|NCT00572624|1096118|P2|Overall Study|Lost to Follow-up|4
335236|NCT00572624|1096119|P1|Overall Study|Lost to Follow-up|10
335237|NCT00572572|1096147|P2|Overall Study|Withdrawal by Subject|6
335238|NCT00572572|1096148|P1|Overall Study|Withdrawal by Subject|3
335239|NCT00572533|1096166|P2|Overall Study|Transfer out of Facility|1
335240|NCT00572533|1096167|P1|Overall Study|Transfer out of Facility|0
335241|NCT00572533|1096166|P2|Overall Study|Social Issues|0
335242|NCT00572533|1096167|P1|Overall Study|Social Issues|1
335243|NCT00572533|1096166|P2|Overall Study|Received Kidney Transplant|1
335244|NCT00572533|1096167|P1|Overall Study|Received Kidney Transplant|2
335245|NCT00572533|1096166|P2|Overall Study|Death|1
335246|NCT00572533|1096167|P1|Overall Study|Death|4
335247|NCT00572156|1096195|P4|Overall Study|Sponsor Decision|19
335248|NCT00572156|1096196|P3|Overall Study|Sponsor Decision|17
335249|NCT00572156|1096197|P2|Overall Study|Sponsor Decision|16
335250|NCT00572156|1096198|P1|Overall Study|Sponsor Decision|20
335251|NCT00572156|1096195|P4|Overall Study|Patient/Parent Decision|3
335252|NCT00572156|1096196|P3|Overall Study|Patient/Parent Decision|4
335253|NCT00572156|1096197|P2|Overall Study|Patient/Parent Decision|6
335254|NCT00572156|1096198|P1|Overall Study|Patient/Parent Decision|1
335255|NCT00572156|1096195|P4|Overall Study|Protocol Violation|2
335256|NCT00572156|1096196|P3|Overall Study|Protocol Violation|0
335257|NCT00572156|1096197|P2|Overall Study|Protocol Violation|2
335258|NCT00572156|1096198|P1|Overall Study|Protocol Violation|1
335259|NCT00572156|1096195|P4|Overall Study|Lost to Follow-up|0
335260|NCT00572156|1096196|P3|Overall Study|Lost to Follow-up|1
335261|NCT00572156|1096197|P2|Overall Study|Lost to Follow-up|1
335262|NCT00572156|1096198|P1|Overall Study|Lost to Follow-up|1
335263|NCT00572156|1096195|P4|Overall Study|Adverse Event|1
335264|NCT00572156|1096196|P3|Overall Study|Adverse Event|5
335265|NCT00572156|1096197|P2|Overall Study|Adverse Event|1
335266|NCT00572156|1096198|P1|Overall Study|Adverse Event|3
335267|NCT00572039|1096269|P2|Overall Study|Ill|1
335268|NCT00572039|1096270|P1|Overall Study|Ill|5
335269|NCT00572039|1096269|P2|Overall Study|Death|3
335270|NCT00572039|1096270|P1|Overall Study|Death|2
335271|NCT00572039|1096269|P2|Overall Study|Withdrawal by Subject|6
335272|NCT00572039|1096270|P1|Overall Study|Withdrawal by Subject|9
335273|NCT00571948|1096302|P2|Overall Study|Parent were afraid of blood colection|5
335274|NCT00571948|1096303|P1|Overall Study|Parent were afraid of blood colection|2
335275|NCT00571948|1096302|P2|Overall Study|infant refused study meal|4
335276|NCT00571948|1096303|P1|Overall Study|infant refused study meal|3
335277|NCT00571948|1096302|P2|Overall Study|Protocol Violation|3
335278|NCT00571948|1096303|P1|Overall Study|Protocol Violation|3
335279|NCT00571948|1096302|P2|Overall Study|Withdrawal by Subject|2
335280|NCT00571948|1096303|P1|Overall Study|Withdrawal by Subject|1
335281|NCT00571948|1096302|P2|Overall Study|Lost to Follow-up|0
335282|NCT00571948|1096303|P1|Overall Study|Lost to Follow-up|2
335283|NCT00571922|1096311|P2|Overall Study|Completion unknown|36
335284|NCT00571922|1096312|P1|Overall Study|Completion unknown|36
335285|NCT00571701|1096322|P2|Second Intervention 12 Months|Withdrawal by Subject|0
335286|NCT00571701|1096323|P1|Second Intervention 12 Months|Withdrawal by Subject|3
335287|NCT00571701|1096322|P2|Second Intervention 12 Months|Adverse Event|1
335288|NCT00571701|1096323|P1|Second Intervention 12 Months|Adverse Event|0
335289|NCT00571701|1096322|P2|First Intervention 12 Months|Death|0
335290|NCT00571701|1096323|P1|First Intervention 12 Months|Death|1
335291|NCT00571701|1096322|P2|First Intervention 12 Months|Withdrawal by Subject|1
335292|NCT00571701|1096323|P1|First Intervention 12 Months|Withdrawal by Subject|2
335293|NCT00571662|1096347|P1|Overall Study|Adverse Event|5
335294|NCT00571662|1096347|P1|Overall Study|psychiatric instability|1
335295|NCT00571662|1096347|P1|Overall Study|Withdrawal by Subject|2
335296|NCT00571649|1096355|P2|Follow-up Period|Protocol Violation|12
335297|NCT00571649|1096356|P1|Follow-up Period|Protocol Violation|5
335298|NCT00571649|1096355|P2|Follow-up Period|Patient convenience|121
335299|NCT00571649|1096356|P1|Follow-up Period|Patient convenience|136
335300|NCT00571649|1096355|P2|Follow-up Period|Lost to Follow-up|92
335301|NCT00571649|1096356|P1|Follow-up Period|Lost to Follow-up|95
335302|NCT00571649|1096355|P2|Follow-up Period|Physician Decision|13
335303|NCT00571649|1096356|P1|Follow-up Period|Physician Decision|7
335304|NCT00571649|1096355|P2|Follow-up Period|Death|133
335305|NCT00571649|1096356|P1|Follow-up Period|Death|132
335306|NCT00571649|1096355|P2|Follow-up Period|Withdrawal by Subject|115
335307|NCT00571649|1096356|P1|Follow-up Period|Withdrawal by Subject|119
335308|NCT00571649|1096355|P2|Follow-up Period|Clinical endpoint reached|2
335309|NCT00571649|1096356|P1|Follow-up Period|Clinical endpoint reached|5
335310|NCT00571649|1096355|P2|Follow-up Period|Adverse Event|40
335311|NCT00571649|1096356|P1|Follow-up Period|Adverse Event|46
335312|NCT00571649|1096355|P2|Treatment Period|Technical problems|5
335313|NCT00571649|1096356|P1|Treatment Period|Technical problems|3
335314|NCT00571649|1096355|P2|Treatment Period|Protocol Violation|92
335315|NCT00571649|1096356|P1|Treatment Period|Protocol Violation|90
335316|NCT00571649|1096355|P2|Treatment Period|Patient convenience|13
335317|NCT00571649|1096356|P1|Treatment Period|Patient convenience|11
335318|NCT00571649|1096355|P2|Treatment Period|Non-compliant with study medication|89
335319|NCT00571649|1096356|P1|Treatment Period|Non-compliant with study medication|88
335320|NCT00571649|1096355|P2|Treatment Period|Lost to Follow-up|41
335321|NCT00571649|1096356|P1|Treatment Period|Lost to Follow-up|43
335322|NCT00571649|1096355|P2|Treatment Period|Physician Decision|9
335323|NCT00571649|1096356|P1|Treatment Period|Physician Decision|8
335324|NCT00571649|1096355|P2|Treatment Period|Death|59
335325|NCT00571649|1096356|P1|Treatment Period|Death|76
335326|NCT00571649|1096355|P2|Treatment Period|Withdrawal by Subject|255
335327|NCT00571649|1096356|P1|Treatment Period|Withdrawal by Subject|285
335328|NCT00571649|1096355|P2|Treatment Period|Clinical endpoint reached|56
335329|NCT00571649|1096356|P1|Treatment Period|Clinical endpoint reached|50
335330|NCT00571649|1096355|P2|Treatment Period|Adverse Event|385
335331|NCT00571649|1096356|P1|Treatment Period|Adverse Event|438
335332|NCT00571103|1096440|P1|Overall Study|Lost to Follow-up|1
335333|NCT00571103|1096440|P1|Overall Study|Withdrawal by Subject|1
335334|NCT00571038|1096447|P2|Overall Study|Moved out of state|2
335335|NCT00571038|1096448|P1|Overall Study|Moved out of state|2
335336|NCT00571038|1096447|P2|Overall Study|Withdrawal by Subject|3
335337|NCT00571038|1096448|P1|Overall Study|Withdrawal by Subject|1
335338|NCT00571038|1096447|P2|Overall Study|Death|5
335339|NCT00571038|1096448|P1|Overall Study|Death|7
335340|NCT00571038|1096447|P2|Overall Study|Lost to Follow-up|4
335341|NCT00571038|1096448|P1|Overall Study|Lost to Follow-up|1
335342|NCT00570921|1096503|P1|Overall Study|Physician Decision|1
335343|NCT00570921|1096503|P1|Overall Study|Protocol Violation|1
335344|NCT00570908|1096509|P1|Overall Study|Withdrawal by Subject|2
335345|NCT00570908|1096509|P1|Overall Study|Adverse Event|5
335346|NCT00570778|1096513|P4|Overall Study|Subject no longer requires study drug|0
335347|NCT00570778|1096514|P3|Overall Study|Subject no longer requires study drug|0
335348|NCT00570778|1096515|P2|Overall Study|Subject no longer requires study drug|1
335349|NCT00570778|1096516|P1|Overall Study|Subject no longer requires study drug|0
335350|NCT00570778|1096513|P4|Overall Study|Lost to Follow-up|0
335351|NCT00570778|1096514|P3|Overall Study|Lost to Follow-up|1
335352|NCT00570778|1096515|P2|Overall Study|Lost to Follow-up|0
335353|NCT00570778|1096516|P1|Overall Study|Lost to Follow-up|0
335354|NCT00570778|1096513|P4|Overall Study|Unsatisfactory therapeutic effect|0
335355|NCT00570778|1096514|P3|Overall Study|Unsatisfactory therapeutic effect|0
335356|NCT00570778|1096515|P2|Overall Study|Unsatisfactory therapeutic effect|0
335357|NCT00570778|1096516|P1|Overall Study|Unsatisfactory therapeutic effect|1
335358|NCT00570778|1096513|P4|Overall Study|Abnormal test procedure|0
335359|NCT00570778|1096514|P3|Overall Study|Abnormal test procedure|0
335360|NCT00570778|1096515|P2|Overall Study|Abnormal test procedure|0
335361|NCT00570778|1096516|P1|Overall Study|Abnormal test procedure|1
335362|NCT00570778|1096513|P4|Overall Study|Subject withdrew consent|1
335363|NCT00570778|1096514|P3|Overall Study|Subject withdrew consent|0
335364|NCT00570778|1096515|P2|Overall Study|Subject withdrew consent|1
335365|NCT00570778|1096516|P1|Overall Study|Subject withdrew consent|0
335366|NCT00570778|1096513|P4|Overall Study|Adverse Event|1
335367|NCT00570778|1096514|P3|Overall Study|Adverse Event|4
335368|NCT00570778|1096515|P2|Overall Study|Adverse Event|1
335369|NCT00570778|1096516|P1|Overall Study|Adverse Event|0
335370|NCT00570778|1096513|P4|Overall Study|Protocol deviation|2
335371|NCT00570778|1096514|P3|Overall Study|Protocol deviation|2
335372|NCT00570778|1096515|P2|Overall Study|Protocol deviation|1
335373|NCT00570778|1096516|P1|Overall Study|Protocol deviation|2
335374|NCT00570739|1096557|P4|Overall Study|Not specified|3
335375|NCT00570739|1096558|P3|Overall Study|Not specified|5
335376|NCT00570739|1096559|P2|Overall Study|Not specified|2
335377|NCT00570739|1096560|P1|Overall Study|Not specified|0
335378|NCT00570739|1096557|P4|Overall Study|Met discontinuation criteria|1
335379|NCT00570739|1096558|P3|Overall Study|Met discontinuation criteria|1
335380|NCT00570739|1096559|P2|Overall Study|Met discontinuation criteria|0
335381|NCT00570739|1096560|P1|Overall Study|Met discontinuation criteria|1
335382|NCT00570739|1096557|P4|Overall Study|Required restricted medication|0
335383|NCT00570739|1096558|P3|Overall Study|Required restricted medication|1
335384|NCT00570739|1096559|P2|Overall Study|Required restricted medication|0
335385|NCT00570739|1096560|P1|Overall Study|Required restricted medication|0
335386|NCT00570739|1096557|P4|Overall Study|Withdrawal by Subject|5
335387|NCT00570739|1096558|P3|Overall Study|Withdrawal by Subject|3
335388|NCT00570739|1096559|P2|Overall Study|Withdrawal by Subject|7
335389|NCT00570739|1096560|P1|Overall Study|Withdrawal by Subject|7
335390|NCT00570739|1096557|P4|Overall Study|Physician Decision|0
335391|NCT00570739|1096558|P3|Overall Study|Physician Decision|0
335392|NCT00570739|1096559|P2|Overall Study|Physician Decision|1
335393|NCT00570739|1096560|P1|Overall Study|Physician Decision|1
335394|NCT00570739|1096557|P4|Overall Study|Lost to Follow-up|1
335395|NCT00570739|1096558|P3|Overall Study|Lost to Follow-up|4
335396|NCT00570739|1096559|P2|Overall Study|Lost to Follow-up|5
335397|NCT00570739|1096560|P1|Overall Study|Lost to Follow-up|4
335398|NCT00570739|1096557|P4|Overall Study|Adverse Event|2
335399|NCT00570739|1096558|P3|Overall Study|Adverse Event|2
335400|NCT00570739|1096559|P2|Overall Study|Adverse Event|6
335401|NCT00570739|1096560|P1|Overall Study|Adverse Event|8
335402|NCT00570713|1096712|P2|Overall Study|Discontinuation of Study by the Sponsor|7
335403|NCT00570713|1096713|P1|Overall Study|Discontinuation of Study by the Sponsor|10
335404|NCT00570713|1096712|P2|Overall Study|Withdrawal by Subject|3
335405|NCT00570713|1096713|P1|Overall Study|Withdrawal by Subject|3
335406|NCT00570713|1096712|P2|Overall Study|Physician Decision|2
335407|NCT00570713|1096713|P1|Overall Study|Physician Decision|2
335408|NCT00570713|1096712|P2|Overall Study|Lack of Efficacy|49
335409|NCT00570713|1096713|P1|Overall Study|Lack of Efficacy|40
335410|NCT00570713|1096712|P2|Overall Study|Death|7
335411|NCT00570713|1096713|P1|Overall Study|Death|7
335412|NCT00570713|1096712|P2|Overall Study|Adverse Event|9
335413|NCT00570713|1096713|P1|Overall Study|Adverse Event|16
335414|NCT00570687|1096725|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335415|NCT00570687|1096726|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335416|NCT00570687|1096727|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335417|NCT00570687|1096728|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
335418|NCT00570687|1096729|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335419|NCT00570687|1096730|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335420|NCT00570687|1096731|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335421|NCT00570687|1096732|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335422|NCT00570687|1096733|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335423|NCT00570687|1096734|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335424|NCT00570687|1096725|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335425|NCT00570687|1096726|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
335426|NCT00570687|1096727|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335427|NCT00570687|1096728|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335428|NCT00570687|1096729|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335429|NCT00570687|1096730|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335430|NCT00570687|1096731|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335431|NCT00570687|1096732|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335432|NCT00570687|1096733|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335433|NCT00570687|1096734|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335434|NCT00570687|1096725|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
335435|NCT00570687|1096726|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
335436|NCT00570687|1096727|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
335437|NCT00570687|1096728|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
335438|NCT00570687|1096729|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
335439|NCT00570687|1096730|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
335440|NCT00570687|1096731|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335441|NCT00570687|1096732|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335442|NCT00570687|1096733|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335443|NCT00570687|1096734|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
335444|NCT00570674|1096760|P7|Overall Study|Withdrawal by Subject|0
335445|NCT00570674|1096761|P6|Overall Study|Withdrawal by Subject|0
335446|NCT00570674|1096762|P5|Overall Study|Withdrawal by Subject|0
335447|NCT00570674|1096763|P4|Overall Study|Withdrawal by Subject|0
335448|NCT00570674|1096764|P3|Overall Study|Withdrawal by Subject|1
335449|NCT00570674|1096765|P2|Overall Study|Withdrawal by Subject|0
335450|NCT00570674|1096766|P1|Overall Study|Withdrawal by Subject|0
335451|NCT00570505|1096784|P1|Overall Study|Other loss to follow-up|4
335452|NCT00570505|1096784|P1|Overall Study|Lost to Follow-up|23
335453|NCT00570505|1096784|P1|Overall Study|Withdrawal by Subject|7
335454|NCT00570505|1096784|P1|Overall Study|Adverse Event|7
335455|NCT00570492|1096797|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
335456|NCT00570492|1096798|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
335457|NCT00570492|1096799|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
335458|NCT00570492|1096797|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
335459|NCT00570492|1096798|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
335460|NCT00570492|1096799|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
335461|NCT00570492|1096797|P3|52-week Double-blind Treatment Period|Physician Decision|4
335462|NCT00570492|1096798|P2|52-week Double-blind Treatment Period|Physician Decision|2
335463|NCT00570492|1096799|P1|52-week Double-blind Treatment Period|Physician Decision|0
335464|NCT00570492|1096797|P3|52-week Double-blind Treatment Period|Adverse Event|5
335465|NCT00570492|1096798|P2|52-week Double-blind Treatment Period|Adverse Event|5
335466|NCT00570492|1096799|P1|52-week Double-blind Treatment Period|Adverse Event|0
335467|NCT00570492|1096797|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
335468|NCT00570492|1096798|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
335469|NCT00570492|1096799|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
335470|NCT00570492|1096797|P3|52-week Double-blind Treatment Period|Protocol Violation|15
335471|NCT00570492|1096798|P2|52-week Double-blind Treatment Period|Protocol Violation|12
335472|NCT00570492|1096799|P1|52-week Double-blind Treatment Period|Protocol Violation|0
335473|NCT00570492|1096797|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
335474|NCT00570492|1096798|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
335475|NCT00570492|1096799|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
335476|NCT00570492|1096797|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
335477|NCT00570492|1096798|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
335478|NCT00570492|1096799|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
335479|NCT00570492|1096797|P3|16-week Single-blind Baseline Period|Adverse Event|0
335480|NCT00570492|1096798|P2|16-week Single-blind Baseline Period|Adverse Event|0
335481|NCT00570492|1096799|P1|16-week Single-blind Baseline Period|Adverse Event|1
335482|NCT00570492|1096797|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
335483|NCT00570492|1096798|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
335484|NCT00570492|1096799|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
335485|NCT00570492|1096797|P3|16-week Single-blind Baseline Period|Protocol Violation|0
335486|NCT00570492|1096798|P2|16-week Single-blind Baseline Period|Protocol Violation|0
335487|NCT00570492|1096799|P1|16-week Single-blind Baseline Period|Protocol Violation|15
335488|NCT00570492|1096797|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
335489|NCT00570492|1096798|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
335490|NCT00570492|1096799|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
335491|NCT00570492|1096797|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
335492|NCT00570492|1096798|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
335493|NCT00570492|1096799|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
335494|NCT00570492|1096797|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
335495|NCT00570492|1096798|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
335496|NCT00570492|1096799|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
335497|NCT00570401|1096837|P1|Overall Study|Adverse Event|2
335498|NCT00570310|1096871|P2|Overall Study|Lack of Efficacy|4
335499|NCT00570310|1096872|P1|Overall Study|Lack of Efficacy|1
335500|NCT00570310|1096871|P2|Overall Study|Adverse Event|2
335501|NCT00570310|1096872|P1|Overall Study|Adverse Event|1
335502|NCT00570232|1096880|P1|Overall Study|discontinued due to noncompliance|2
335503|NCT00570232|1096880|P1|Overall Study|discontinued due to recurrence|8
335504|NCT00570232|1096880|P1|Overall Study|discontinued due to medical condition|3
335505|NCT00570232|1096880|P1|Overall Study|Adverse Event|10
335506|NCT00570141|1096886|P1|Overall Study|Lost to Follow-up|1
335507|NCT00570141|1096886|P1|Overall Study|Missed visits|1
335508|NCT00570141|1096886|P1|Overall Study|Adverse Event|1
335509|NCT00570037|1096902|P2|Overall Study|Could not reach for 6-8 week contact|69
335510|NCT00570037|1096903|P1|Overall Study|Could not reach for 6-8 week contact|44
335511|NCT00569946|1096913|P1|Overall Study|Global Deterioration of Health Status|1
335512|NCT00569946|1096913|P1|Overall Study|Objective Progression or Relapse|42
335513|NCT00569946|1096913|P1|Overall Study|Adverse Event|16
335514|NCT00569803|1096945|P8|Overall Study|Withdrawal by Subject|1
335515|NCT00569803|1096946|P7|Overall Study|Withdrawal by Subject|0
335516|NCT00569803|1096947|P6|Overall Study|Withdrawal by Subject|0
335517|NCT00569803|1096948|P5|Overall Study|Withdrawal by Subject|0
335518|NCT00569803|1096949|P4|Overall Study|Withdrawal by Subject|0
335519|NCT00569803|1096950|P3|Overall Study|Withdrawal by Subject|0
335520|NCT00569803|1096951|P2|Overall Study|Withdrawal by Subject|0
335521|NCT00569803|1096952|P1|Overall Study|Withdrawal by Subject|0
335522|NCT00569803|1096945|P8|Overall Study|injection syringe leaked during dosing|0
335523|NCT00569803|1096946|P7|Overall Study|injection syringe leaked during dosing|0
335524|NCT00569803|1096947|P6|Overall Study|injection syringe leaked during dosing|0
335525|NCT00569803|1096948|P5|Overall Study|injection syringe leaked during dosing|0
335526|NCT00569803|1096949|P4|Overall Study|injection syringe leaked during dosing|1
335527|NCT00569803|1096950|P3|Overall Study|injection syringe leaked during dosing|0
335528|NCT00569803|1096951|P2|Overall Study|injection syringe leaked during dosing|0
335529|NCT00569803|1096952|P1|Overall Study|injection syringe leaked during dosing|0
335530|NCT00569803|1096945|P8|Overall Study|Lost to Follow-up|0
335531|NCT00569803|1096946|P7|Overall Study|Lost to Follow-up|0
335532|NCT00569803|1096947|P6|Overall Study|Lost to Follow-up|0
335533|NCT00569803|1096948|P5|Overall Study|Lost to Follow-up|0
335534|NCT00569803|1096949|P4|Overall Study|Lost to Follow-up|0
335535|NCT00569803|1096950|P3|Overall Study|Lost to Follow-up|0
335536|NCT00569803|1096951|P2|Overall Study|Lost to Follow-up|0
335537|NCT00569803|1096952|P1|Overall Study|Lost to Follow-up|1
335538|NCT00569777|1097079|P2|Overall Study|pregnant|0
335539|NCT00569777|1097080|P1|Overall Study|pregnant|1
335540|NCT00569777|1097079|P2|Overall Study|did not meet exclusion criteria|2
335541|NCT00569777|1097080|P1|Overall Study|did not meet exclusion criteria|1
335542|NCT00569777|1097079|P2|Overall Study|scheduled eye surgery|1
335543|NCT00569777|1097080|P1|Overall Study|scheduled eye surgery|0
335544|NCT00569777|1097079|P2|Overall Study|Lost to Follow-up|0
335545|NCT00569777|1097080|P1|Overall Study|Lost to Follow-up|1
335546|NCT00569777|1097079|P2|Overall Study|Adverse Event|0
335547|NCT00569777|1097080|P1|Overall Study|Adverse Event|3
335548|NCT00569777|1097079|P2|Overall Study|Withdrawal by Subject|0
335549|NCT00569777|1097080|P1|Overall Study|Withdrawal by Subject|4
335550|NCT00569582|1097130|P1|Overall Study|Subject was non-compliant.|1
335551|NCT00569582|1097130|P1|Overall Study|Subject was too ill to travel.|1
335552|NCT00569582|1097130|P1|Overall Study|Adverse Event|7
335553|NCT00569582|1097130|P1|Overall Study|Death|2
335554|NCT00569582|1097130|P1|Overall Study|Withdrawal by Subject|5
335555|NCT00569374|1097146|P1|Overall Study|Withdrawal by Subject|4
335556|NCT00569270|1097156|P2|Period: First Intervention|Protocol Violation|1
335557|NCT00569270|1097157|P1|Period: First Intervention|Protocol Violation|0
335558|NCT00569231|1097192|P1|Overall Study|Non-compliance|2
335559|NCT00569231|1097192|P1|Overall Study|Car accident injury|1
335560|NCT00569231|1097192|P1|Overall Study|Withdrawal by Subject|1
335561|NCT00569231|1097192|P1|Overall Study|Airfare expense|2
335562|NCT00569231|1097192|P1|Overall Study|Study unrelated surgery|1
335563|NCT00569166|1097230|P3|Overall Study|Lost to Follow-up|1
335564|NCT00569166|1097231|P2|Overall Study|Lost to Follow-up|1
335565|NCT00569166|1097232|P1|Overall Study|Lost to Follow-up|2
335566|NCT00569166|1097230|P3|Overall Study|Withdrawal by Subject|3
335567|NCT00569166|1097231|P2|Overall Study|Withdrawal by Subject|5
335568|NCT00569166|1097232|P1|Overall Study|Withdrawal by Subject|7
335569|NCT00569127|1097242|P2|Overall Study|Still on Treatment|3
335570|NCT00569127|1097243|P1|Overall Study|Still on Treatment|7
335571|NCT00569127|1097242|P2|Overall Study|Not Eligible|11
335572|NCT00569127|1097243|P1|Overall Study|Not Eligible|14
335573|NCT00569127|1097242|P2|Overall Study|Lost to Follow-up|3
335574|NCT00569127|1097243|P1|Overall Study|Lost to Follow-up|0
335575|NCT00569127|1097242|P2|Overall Study|Not Specified|19
335576|NCT00569127|1097243|P1|Overall Study|Not Specified|20
335577|NCT00569127|1097242|P2|Overall Study|Death|3
335578|NCT00569127|1097243|P1|Overall Study|Death|4
335579|NCT00569127|1097242|P2|Overall Study|Progression|100
335580|NCT00569127|1097243|P1|Overall Study|Progression|99
335581|NCT00569127|1097242|P2|Overall Study|Withdrawal by Subject|27
335582|NCT00569127|1097243|P1|Overall Study|Withdrawal by Subject|13
335583|NCT00569127|1097242|P2|Overall Study|Adverse Event|47
335584|NCT00569127|1097243|P1|Overall Study|Adverse Event|57
335585|NCT00568958|1097278|P2|Follow-Up|Family Emergency|0
335586|NCT00568958|1097279|P1|Follow-Up|Family Emergency|1
335587|NCT00568958|1097278|P2|Follow-Up|Physician Decision|1
335588|NCT00568958|1097279|P1|Follow-Up|Physician Decision|1
335589|NCT00568958|1097278|P2|Follow-Up|Withdrawal by Subject|3
335590|NCT00568958|1097279|P1|Follow-Up|Withdrawal by Subject|6
335591|NCT00568958|1097278|P2|Allocation|Physician Decision|0
335592|NCT00568958|1097279|P1|Allocation|Physician Decision|2
335593|NCT00568958|1097278|P2|Allocation|Withdrawal by Subject|3
335594|NCT00568958|1097279|P1|Allocation|Withdrawal by Subject|7
335595|NCT00568776|1097312|P4|Overall Study|Miscellaeneous|4
335596|NCT00568776|1097313|P3|Overall Study|Miscellaeneous|1
335597|NCT00568776|1097314|P2|Overall Study|Miscellaeneous|3
335598|NCT00568776|1097315|P1|Overall Study|Miscellaeneous|3
335599|NCT00568776|1097312|P4|Overall Study|Sponsor Decision|42
335600|NCT00568776|1097313|P3|Overall Study|Sponsor Decision|41
335601|NCT00568776|1097314|P2|Overall Study|Sponsor Decision|2
335602|NCT00568776|1097315|P1|Overall Study|Sponsor Decision|2
335603|NCT00568776|1097312|P4|Overall Study|Loss of Caregiver|2
335604|NCT00568776|1097313|P3|Overall Study|Loss of Caregiver|1
335605|NCT00568776|1097314|P2|Overall Study|Loss of Caregiver|2
335606|NCT00568776|1097315|P1|Overall Study|Loss of Caregiver|0
335607|NCT00568776|1097312|P4|Overall Study|Withdrawal by Subject|7
335608|NCT00568776|1097313|P3|Overall Study|Withdrawal by Subject|13
335609|NCT00568776|1097314|P2|Overall Study|Withdrawal by Subject|15
335610|NCT00568776|1097315|P1|Overall Study|Withdrawal by Subject|13
335611|NCT00568776|1097312|P4|Overall Study|Protocol Violation|1
335612|NCT00568776|1097313|P3|Overall Study|Protocol Violation|1
335613|NCT00568776|1097314|P2|Overall Study|Protocol Violation|0
335614|NCT00568776|1097315|P1|Overall Study|Protocol Violation|1
335615|NCT00568776|1097312|P4|Overall Study|Lost to Follow-up|1
335616|NCT00568776|1097313|P3|Overall Study|Lost to Follow-up|1
335617|NCT00568776|1097314|P2|Overall Study|Lost to Follow-up|1
335618|NCT00568776|1097315|P1|Overall Study|Lost to Follow-up|1
335619|NCT00568776|1097312|P4|Overall Study|Lack of Efficacy|4
335620|NCT00568776|1097313|P3|Overall Study|Lack of Efficacy|2
335621|NCT00568776|1097314|P2|Overall Study|Lack of Efficacy|2
335622|NCT00568776|1097315|P1|Overall Study|Lack of Efficacy|2
335623|NCT00568776|1097312|P4|Overall Study|Physician Decision|0
335624|NCT00568776|1097313|P3|Overall Study|Physician Decision|0
335625|NCT00568776|1097314|P2|Overall Study|Physician Decision|2
335626|NCT00568776|1097315|P1|Overall Study|Physician Decision|0
335627|NCT00568776|1097312|P4|Overall Study|Death|3
335628|NCT00568776|1097313|P3|Overall Study|Death|4
335629|NCT00568776|1097314|P2|Overall Study|Death|1
335630|NCT00568776|1097315|P1|Overall Study|Death|0
335631|NCT00568776|1097312|P4|Overall Study|Adverse Event|8
335632|NCT00568776|1097313|P3|Overall Study|Adverse Event|10
335633|NCT00568776|1097314|P2|Overall Study|Adverse Event|8
335634|NCT00568776|1097315|P1|Overall Study|Adverse Event|8
335635|NCT00568685|1097352|P3|Overall Study|Protocol Violation|0
335636|NCT00568685|1097353|P2|Overall Study|Protocol Violation|0
335637|NCT00568685|1097354|P1|Overall Study|Protocol Violation|1
335638|NCT00568685|1097352|P3|Overall Study|Withdrawal by Subject|2
335639|NCT00568685|1097353|P2|Overall Study|Withdrawal by Subject|2
335640|NCT00568685|1097354|P1|Overall Study|Withdrawal by Subject|7
335641|NCT00568685|1097352|P3|Overall Study|Adverse Event|3
335642|NCT00568685|1097353|P2|Overall Study|Adverse Event|3
335643|NCT00568685|1097354|P1|Overall Study|Adverse Event|2
335644|NCT00568555|1097388|P2|Overall Study|Withdrawal by Subject|1
335645|NCT00568555|1097389|P1|Overall Study|Withdrawal by Subject|1
335646|NCT00568451|1097407|P4|Overall Study|Disease Progression|7
335647|NCT00568451|1097408|P3|Overall Study|Disease Progression|2
335648|NCT00568451|1097409|P2|Overall Study|Disease Progression|0
335649|NCT00568451|1097410|P1|Overall Study|Disease Progression|0
335650|NCT00568399|1097426|P1|Overall Study|Withdrawal by Subject|8
335651|NCT00568399|1097426|P1|Overall Study|Adverse Event|5
335652|NCT00568399|1097426|P1|Overall Study|Death|2
335653|NCT00568178|1097441|P6|Open Label Extension|Withdrawal by Subject|4
335654|NCT00568178|1097442|P5|Open Label Extension|Withdrawal by Subject|4
335655|NCT00568178|1097443|P4|Open Label Extension|Withdrawal by Subject|0
335656|NCT00568178|1097444|P3|Open Label Extension|Withdrawal by Subject|0
335657|NCT00568178|1097445|P2|Open Label Extension|Withdrawal by Subject|0
335658|NCT00568178|1097446|P1|Open Label Extension|Withdrawal by Subject|0
335659|NCT00568178|1097441|P6|Open Label Extension|Termination of Trial|47
335660|NCT00568178|1097442|P5|Open Label Extension|Termination of Trial|45
335661|NCT00568178|1097443|P4|Open Label Extension|Termination of Trial|0
335662|NCT00568178|1097444|P3|Open Label Extension|Termination of Trial|0
335663|NCT00568178|1097445|P2|Open Label Extension|Termination of Trial|0
335664|NCT00568178|1097446|P1|Open Label Extension|Termination of Trial|0
335665|NCT00568178|1097441|P6|Open Label Extension|Progressive Disease|1
335666|NCT00568178|1097442|P5|Open Label Extension|Progressive Disease|3
335667|NCT00568178|1097443|P4|Open Label Extension|Progressive Disease|0
335668|NCT00568178|1097444|P3|Open Label Extension|Progressive Disease|0
335669|NCT00568178|1097445|P2|Open Label Extension|Progressive Disease|0
335670|NCT00568178|1097446|P1|Open Label Extension|Progressive Disease|0
335671|NCT00568178|1097441|P6|Open Label Extension|Pregnancy|1
335672|NCT00568178|1097442|P5|Open Label Extension|Pregnancy|0
335673|NCT00568178|1097443|P4|Open Label Extension|Pregnancy|0
335674|NCT00568178|1097444|P3|Open Label Extension|Pregnancy|0
335675|NCT00568178|1097445|P2|Open Label Extension|Pregnancy|0
335676|NCT00568178|1097446|P1|Open Label Extension|Pregnancy|0
335677|NCT00568178|1097441|P6|Open Label Extension|Physician Decision|8
335678|NCT00568178|1097442|P5|Open Label Extension|Physician Decision|9
335679|NCT00568178|1097443|P4|Open Label Extension|Physician Decision|0
335680|NCT00568178|1097444|P3|Open Label Extension|Physician Decision|0
335681|NCT00568178|1097445|P2|Open Label Extension|Physician Decision|0
335682|NCT00568178|1097446|P1|Open Label Extension|Physician Decision|0
335683|NCT00568178|1097441|P6|Open Label Extension|Lost to Follow-up|11
335684|NCT00568178|1097442|P5|Open Label Extension|Lost to Follow-up|6
335685|NCT00568178|1097443|P4|Open Label Extension|Lost to Follow-up|0
335686|NCT00568178|1097444|P3|Open Label Extension|Lost to Follow-up|0
335687|NCT00568178|1097445|P2|Open Label Extension|Lost to Follow-up|0
335688|NCT00568178|1097446|P1|Open Label Extension|Lost to Follow-up|0
335689|NCT00568178|1097441|P6|Open Label Extension|Protocol Violation|0
335690|NCT00568178|1097442|P5|Open Label Extension|Protocol Violation|1
335691|NCT00568178|1097443|P4|Open Label Extension|Protocol Violation|0
335692|NCT00568178|1097444|P3|Open Label Extension|Protocol Violation|0
335693|NCT00568178|1097445|P2|Open Label Extension|Protocol Violation|0
335694|NCT00568178|1097446|P1|Open Label Extension|Protocol Violation|0
335695|NCT00568178|1097441|P6|Open Label Extension|Adverse Event|8
335696|NCT00568178|1097442|P5|Open Label Extension|Adverse Event|11
335697|NCT00568178|1097443|P4|Open Label Extension|Adverse Event|0
335698|NCT00568178|1097444|P3|Open Label Extension|Adverse Event|0
335699|NCT00568178|1097445|P2|Open Label Extension|Adverse Event|0
335700|NCT00568178|1097446|P1|Open Label Extension|Adverse Event|0
335701|NCT00568178|1097441|P6|Double Blind Base Study|Progressive Disease|0
335702|NCT00568178|1097442|P5|Double Blind Base Study|Progressive Disease|0
335703|NCT00568178|1097443|P4|Double Blind Base Study|Progressive Disease|1
335704|NCT00568178|1097444|P3|Double Blind Base Study|Progressive Disease|0
335705|NCT00568178|1097445|P2|Double Blind Base Study|Progressive Disease|0
335706|NCT00568178|1097446|P1|Double Blind Base Study|Progressive Disease|0
335707|NCT00568178|1097441|P6|Double Blind Base Study|Withdrawal by Subject|0
335708|NCT00568178|1097442|P5|Double Blind Base Study|Withdrawal by Subject|0
335709|NCT00568178|1097443|P4|Double Blind Base Study|Withdrawal by Subject|0
335710|NCT00568178|1097444|P3|Double Blind Base Study|Withdrawal by Subject|0
335711|NCT00568178|1097445|P2|Double Blind Base Study|Withdrawal by Subject|1
335712|NCT00568178|1097446|P1|Double Blind Base Study|Withdrawal by Subject|1
335713|NCT00568178|1097441|P6|Double Blind Base Study|Protocol Violation|0
335714|NCT00568178|1097442|P5|Double Blind Base Study|Protocol Violation|0
335715|NCT00568178|1097443|P4|Double Blind Base Study|Protocol Violation|0
335716|NCT00568178|1097444|P3|Double Blind Base Study|Protocol Violation|0
335717|NCT00568178|1097445|P2|Double Blind Base Study|Protocol Violation|2
335718|NCT00568178|1097446|P1|Double Blind Base Study|Protocol Violation|3
335719|NCT00568178|1097441|P6|Double Blind Base Study|Physician Decision|0
335720|NCT00568178|1097442|P5|Double Blind Base Study|Physician Decision|0
335721|NCT00568178|1097443|P4|Double Blind Base Study|Physician Decision|1
335722|NCT00568178|1097444|P3|Double Blind Base Study|Physician Decision|0
335723|NCT00568178|1097445|P2|Double Blind Base Study|Physician Decision|1
335724|NCT00568178|1097446|P1|Double Blind Base Study|Physician Decision|1
335725|NCT00568178|1097441|P6|Double Blind Base Study|Lost to Follow-up|0
335726|NCT00568178|1097442|P5|Double Blind Base Study|Lost to Follow-up|0
335727|NCT00568178|1097443|P4|Double Blind Base Study|Lost to Follow-up|1
335728|NCT00568178|1097444|P3|Double Blind Base Study|Lost to Follow-up|0
335729|NCT00568178|1097445|P2|Double Blind Base Study|Lost to Follow-up|0
335730|NCT00568178|1097446|P1|Double Blind Base Study|Lost to Follow-up|1
335731|NCT00568178|1097441|P6|Double Blind Base Study|Adverse Event|0
335732|NCT00568178|1097442|P5|Double Blind Base Study|Adverse Event|0
335733|NCT00568178|1097443|P4|Double Blind Base Study|Adverse Event|2
335734|NCT00568178|1097444|P3|Double Blind Base Study|Adverse Event|1
335735|NCT00568178|1097445|P2|Double Blind Base Study|Adverse Event|2
335736|NCT00568178|1097446|P1|Double Blind Base Study|Adverse Event|0
335737|NCT00568061|1097477|P2|Overall Study|Adverse Event|1
335738|NCT00568061|1097478|P1|Overall Study|Adverse Event|0
335739|NCT00568061|1097477|P2|Overall Study|Inclusion / exclusion criteria|1
335740|NCT00568061|1097478|P1|Overall Study|Inclusion / exclusion criteria|5
335741|NCT00567996|1097522|P3|Overall Study|Patient's inability to use the device|0
335742|NCT00567996|1097523|P2|Overall Study|Patient's inability to use the device|1
335743|NCT00567996|1097524|P1|Overall Study|Patient's inability to use the device|0
335744|NCT00567996|1097522|P3|Overall Study|Death|2
335745|NCT00567996|1097523|P2|Overall Study|Death|0
335746|NCT00567996|1097524|P1|Overall Study|Death|1
335747|NCT00567996|1097522|P3|Overall Study|Administrative problems|0
335748|NCT00567996|1097523|P2|Overall Study|Administrative problems|1
335749|NCT00567996|1097524|P1|Overall Study|Administrative problems|1
335750|NCT00567996|1097522|P3|Overall Study|Unsatisfactory therapeutic effect|15
335751|NCT00567996|1097523|P2|Overall Study|Unsatisfactory therapeutic effect|2
335752|NCT00567996|1097524|P1|Overall Study|Unsatisfactory therapeutic effect|1
335753|NCT00567996|1097522|P3|Overall Study|Lost to Follow-up|2
335754|NCT00567996|1097523|P2|Overall Study|Lost to Follow-up|5
335755|NCT00567996|1097524|P1|Overall Study|Lost to Follow-up|2
335756|NCT00567996|1097522|P3|Overall Study|Abnormal test procedure result(s)|1
335757|NCT00567996|1097523|P2|Overall Study|Abnormal test procedure result(s)|1
335758|NCT00567996|1097524|P1|Overall Study|Abnormal test procedure result(s)|2
335759|NCT00567996|1097522|P3|Overall Study|Abnormal Lab value(s)|2
335760|NCT00567996|1097523|P2|Overall Study|Abnormal Lab value(s)|1
335761|NCT00567996|1097524|P1|Overall Study|Abnormal Lab value(s)|2
335762|NCT00567996|1097522|P3|Overall Study|Withdrawal by Subject|22
335763|NCT00567996|1097523|P2|Overall Study|Withdrawal by Subject|12
335764|NCT00567996|1097524|P1|Overall Study|Withdrawal by Subject|8
335765|NCT00567996|1097522|P3|Overall Study|Protocol Deviation|13
335766|NCT00567996|1097523|P2|Overall Study|Protocol Deviation|11
335767|NCT00567996|1097524|P1|Overall Study|Protocol Deviation|9
335768|NCT00567996|1097522|P3|Overall Study|Adverse Event|13
335769|NCT00567996|1097523|P2|Overall Study|Adverse Event|16
335770|NCT00567996|1097524|P1|Overall Study|Adverse Event|18
335771|NCT00567892|1097540|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
335772|NCT00567892|1097541|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
335773|NCT00567892|1097542|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
335774|NCT00567892|1097543|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
335775|NCT00567892|1097540|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
335776|NCT00567892|1097541|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
335777|NCT00567892|1097542|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
335778|NCT00567892|1097543|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
335779|NCT00567879|1097561|P6|Overall Study|Disease progression|3
335780|NCT00567879|1097562|P5|Overall Study|Disease progression|11
335781|NCT00567879|1097563|P4|Overall Study|Disease progression|5
335782|NCT00567879|1097564|P3|Overall Study|Disease progression|15
335783|NCT00567879|1097565|P2|Overall Study|Disease progression|7
335784|NCT00567879|1097566|P1|Overall Study|Disease progression|5
335785|NCT00567879|1097561|P6|Overall Study|New cancer therapy|0
335786|NCT00567879|1097562|P5|Overall Study|New cancer therapy|0
335787|NCT00567879|1097563|P4|Overall Study|New cancer therapy|0
335788|NCT00567879|1097564|P3|Overall Study|New cancer therapy|1
335789|NCT00567879|1097565|P2|Overall Study|New cancer therapy|0
335790|NCT00567879|1097566|P1|Overall Study|New cancer therapy|0
335791|NCT00567879|1097561|P6|Overall Study|Withdrawal by Subject|0
335792|NCT00567879|1097562|P5|Overall Study|Withdrawal by Subject|0
335793|NCT00567879|1097563|P4|Overall Study|Withdrawal by Subject|1
335794|NCT00567879|1097564|P3|Overall Study|Withdrawal by Subject|3
335795|NCT00567879|1097565|P2|Overall Study|Withdrawal by Subject|0
335796|NCT00567879|1097566|P1|Overall Study|Withdrawal by Subject|0
335797|NCT00567879|1097561|P6|Overall Study|Abnormal test procedure(s)|0
335798|NCT00567879|1097562|P5|Overall Study|Abnormal test procedure(s)|0
335799|NCT00567879|1097563|P4|Overall Study|Abnormal test procedure(s)|0
335800|NCT00567879|1097564|P3|Overall Study|Abnormal test procedure(s)|1
335801|NCT00567879|1097565|P2|Overall Study|Abnormal test procedure(s)|0
335802|NCT00567879|1097566|P1|Overall Study|Abnormal test procedure(s)|0
335803|NCT00567879|1097561|P6|Overall Study|Adverse Event|0
335804|NCT00567879|1097562|P5|Overall Study|Adverse Event|1
335805|NCT00567879|1097563|P4|Overall Study|Adverse Event|0
335806|NCT00567879|1097564|P3|Overall Study|Adverse Event|1
335807|NCT00567879|1097565|P2|Overall Study|Adverse Event|0
335808|NCT00567879|1097566|P1|Overall Study|Adverse Event|2
335809|NCT00567593|1097656|P1|Overall Study|Physician Decision|1
335810|NCT00567593|1097656|P1|Overall Study|Adverse Event|1
335811|NCT00567541|1097662|P2|Overall Study|Adverse Event|1
335812|NCT00567541|1097663|P1|Overall Study|Adverse Event|0
335813|NCT00567502|1097673|P4|Overall Study|Never Initiated Treatment|72
335814|NCT00567502|1097674|P3|Overall Study|Never Initiated Treatment|0
335815|NCT00567502|1097675|P2|Overall Study|Never Initiated Treatment|0
335816|NCT00567502|1097676|P1|Overall Study|Never Initiated Treatment|0
335817|NCT00567502|1097673|P4|Overall Study|Sponsor request|1
335818|NCT00567502|1097674|P3|Overall Study|Sponsor request|30
335819|NCT00567502|1097675|P2|Overall Study|Sponsor request|0
335820|NCT00567502|1097676|P1|Overall Study|Sponsor request|9
335821|NCT00567502|1097673|P4|Overall Study|Participant request|1
335822|NCT00567502|1097674|P3|Overall Study|Participant request|33
335823|NCT00567502|1097675|P2|Overall Study|Participant request|1
335824|NCT00567502|1097676|P1|Overall Study|Participant request|12
335825|NCT00567502|1097673|P4|Overall Study|Unspecified|6
335826|NCT00567502|1097674|P3|Overall Study|Unspecified|134
335827|NCT00567502|1097675|P2|Overall Study|Unspecified|2
335828|NCT00567502|1097676|P1|Overall Study|Unspecified|64
335829|NCT00567502|1097673|P4|Overall Study|Death|5
335830|NCT00567502|1097674|P3|Overall Study|Death|360
335831|NCT00567502|1097675|P2|Overall Study|Death|16
335832|NCT00567502|1097676|P1|Overall Study|Death|65
335833|NCT00567502|1097673|P4|Overall Study|Lost to Follow-up|2
335834|NCT00567502|1097674|P3|Overall Study|Lost to Follow-up|351
335835|NCT00567502|1097675|P2|Overall Study|Lost to Follow-up|14
335836|NCT00567502|1097676|P1|Overall Study|Lost to Follow-up|91
335837|NCT00567476|1097713|P2|Overall Study|Non-adherence to protocol|1
335838|NCT00567476|1097714|P1|Overall Study|Non-adherence to protocol|0
335839|NCT00567476|1097713|P2|Overall Study|Medical Decision|1
335840|NCT00567476|1097714|P1|Overall Study|Medical Decision|0
335841|NCT00567476|1097713|P2|Overall Study|Administrative issues|0
335842|NCT00567476|1097714|P1|Overall Study|Administrative issues|1
335843|NCT00567476|1097713|P2|Overall Study|Lost to Follow-up|1
335844|NCT00567476|1097714|P1|Overall Study|Lost to Follow-up|0
335845|NCT00567476|1097713|P2|Overall Study|Protocol Violation|1
335846|NCT00567476|1097714|P1|Overall Study|Protocol Violation|4
335847|NCT00567476|1097713|P2|Overall Study|Pregnancy|0
335848|NCT00567476|1097714|P1|Overall Study|Pregnancy|1
335849|NCT00567476|1097713|P2|Overall Study|Adverse Event|0
335850|NCT00567476|1097714|P1|Overall Study|Adverse Event|2
335851|NCT00567268|1097756|P1|Overall Study|"Safety Evaluation Not Assessable"|1
335852|NCT00567268|1097756|P1|Overall Study|No Drug Administration|4
335853|NCT00567268|1097756|P1|Overall Study|No Visit After First Day of Treatment|2
335854|NCT00567268|1097756|P1|Overall Study|Lost to Follow-up|36
335855|NCT00567268|1097756|P1|Overall Study|Protocol Violation|7
335856|NCT00567255|1097807|P2|Overall Study|Drug noncompliance,moved,other|15
335857|NCT00567255|1097808|P1|Overall Study|Drug noncompliance,moved,other|25
335858|NCT00567255|1097807|P2|Overall Study|Pregnancy|0
335859|NCT00567255|1097808|P1|Overall Study|Pregnancy|6
335860|NCT00567255|1097807|P2|Overall Study|Protocol Violation|8
335861|NCT00567255|1097808|P1|Overall Study|Protocol Violation|20
335862|NCT00567255|1097807|P2|Overall Study|Lack of Efficacy|33
335863|NCT00567255|1097808|P1|Overall Study|Lack of Efficacy|19
335864|NCT00567255|1097807|P2|Overall Study|Withdrawal by Subject|56
335865|NCT00567255|1097808|P1|Overall Study|Withdrawal by Subject|75
335866|NCT00567255|1097807|P2|Overall Study|Lost to Follow-up|48
335867|NCT00567255|1097808|P1|Overall Study|Lost to Follow-up|77
335868|NCT00567255|1097807|P2|Overall Study|Adverse Event|68
335869|NCT00567255|1097808|P1|Overall Study|Adverse Event|241
335870|NCT00567190|1097871|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
335871|NCT00567190|1097872|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
335872|NCT00567190|1097871|P2|Overall Study|Death|221
335873|NCT00567190|1097872|P1|Overall Study|Death|168
335874|NCT00567164|1097892|P3|Overall Study|Missing|0
335875|NCT00567164|1097893|P2|Overall Study|Missing|0
335876|NCT00567164|1097894|P1|Overall Study|Missing|1
335877|NCT00567164|1097892|P3|Overall Study|Primary Reason coded as 'Other'|16
335878|NCT00567164|1097893|P2|Overall Study|Primary Reason coded as 'Other'|8
335879|NCT00567164|1097894|P1|Overall Study|Primary Reason coded as 'Other'|37
335880|NCT00567164|1097892|P3|Overall Study|Pregnancy|6
335881|NCT00567164|1097893|P2|Overall Study|Pregnancy|4
335882|NCT00567164|1097894|P1|Overall Study|Pregnancy|20
335883|NCT00567164|1097892|P3|Overall Study|Lost to Follow-up|21
335884|NCT00567164|1097893|P2|Overall Study|Lost to Follow-up|23
335885|NCT00567164|1097894|P1|Overall Study|Lost to Follow-up|202
335886|NCT00567164|1097892|P3|Overall Study|Death|1
335887|NCT00567164|1097893|P2|Overall Study|Death|0
335888|NCT00567164|1097894|P1|Overall Study|Death|0
335889|NCT00567164|1097892|P3|Overall Study|Adverse Event|9
335890|NCT00567164|1097893|P2|Overall Study|Adverse Event|13
335891|NCT00567164|1097894|P1|Overall Study|Adverse Event|92
335892|NCT00567164|1097892|P3|Overall Study|Protocol Violation|2
335893|NCT00567164|1097893|P2|Overall Study|Protocol Violation|4
335894|NCT00567164|1097894|P1|Overall Study|Protocol Violation|23
335895|NCT00567164|1097892|P3|Overall Study|Withdrawal by Subject|17
335896|NCT00567164|1097893|P2|Overall Study|Withdrawal by Subject|21
335897|NCT00567164|1097894|P1|Overall Study|Withdrawal by Subject|171
335898|NCT00567112|1097966|P3|Washout Period 3 (3 Days)|Protocol Violation|0
335899|NCT00567112|1097967|P2|Washout Period 3 (3 Days)|Protocol Violation|0
335900|NCT00567112|1097968|P1|Washout Period 3 (3 Days)|Protocol Violation|1
335901|NCT00567112|1097966|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
335902|NCT00567112|1097967|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
335903|NCT00567112|1097968|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
335904|NCT00567112|1097966|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
335905|NCT00567112|1097967|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
335906|NCT00567112|1097968|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
335907|NCT00566995|1097999|P1|Overall Study|Withdrew consent|4
335908|NCT00566995|1097999|P1|Overall Study|Physician Decision|1
335909|NCT00566995|1097999|P1|Overall Study|Toxicity|3
335910|NCT00566982|1098006|P2|Overall Study|Other-family problems & doctor's request|2
335911|NCT00566982|1098007|P1|Overall Study|Other-family problems & doctor's request|0
335912|NCT00566982|1098006|P2|Overall Study|Lost to Follow-up|1
335913|NCT00566982|1098007|P1|Overall Study|Lost to Follow-up|0
335914|NCT00566982|1098006|P2|Overall Study|Protocol Violation|4
335915|NCT00566982|1098007|P1|Overall Study|Protocol Violation|1
335916|NCT00566982|1098006|P2|Overall Study|Withdrawal by Subject|14
335917|NCT00566982|1098007|P1|Overall Study|Withdrawal by Subject|1
335918|NCT00566982|1098006|P2|Overall Study|Adverse Event|48
335919|NCT00566982|1098007|P1|Overall Study|Adverse Event|6
335920|NCT00566735|1098072|P2|Overall Study|Switched into a manic episode|1
335921|NCT00566735|1098073|P1|Overall Study|Switched into a manic episode|0
335922|NCT00566735|1098072|P2|Overall Study|Refused neuropsychological testing|5
335923|NCT00566735|1098073|P1|Overall Study|Refused neuropsychological testing|2
335924|NCT00566735|1098072|P2|Overall Study|Withdrawal by Subject|1
335925|NCT00566735|1098073|P1|Overall Study|Withdrawal by Subject|0
335926|NCT00566722|1098086|P3|Overall Study|Noncompliant with drug administration|1
335927|NCT00566722|1098087|P2|Overall Study|Noncompliant with drug administration|0
335928|NCT00566722|1098088|P1|Overall Study|Noncompliant with drug administration|0
335929|NCT00566722|1098086|P3|Overall Study|Serious adverse event|0
335930|NCT00566722|1098087|P2|Overall Study|Serious adverse event|1
335931|NCT00566722|1098088|P1|Overall Study|Serious adverse event|0
335932|NCT00566722|1098086|P3|Overall Study|Did not meet exclusion criteria|2
335933|NCT00566722|1098087|P2|Overall Study|Did not meet exclusion criteria|0
335934|NCT00566722|1098088|P1|Overall Study|Did not meet exclusion criteria|0
335935|NCT00566722|1098086|P3|Overall Study|Lack of Efficacy|4
335936|NCT00566722|1098087|P2|Overall Study|Lack of Efficacy|2
335937|NCT00566722|1098088|P1|Overall Study|Lack of Efficacy|1
335938|NCT00566722|1098086|P3|Overall Study|Lost to Follow-up|1
335939|NCT00566722|1098087|P2|Overall Study|Lost to Follow-up|1
335940|NCT00566722|1098088|P1|Overall Study|Lost to Follow-up|1
335941|NCT00566722|1098086|P3|Overall Study|Withdrawal by Subject|1
335942|NCT00566722|1098087|P2|Overall Study|Withdrawal by Subject|0
335943|NCT00566722|1098088|P1|Overall Study|Withdrawal by Subject|0
335944|NCT00566722|1098086|P3|Overall Study|Adverse Event|0
335945|NCT00566722|1098087|P2|Overall Study|Adverse Event|1
335946|NCT00566722|1098088|P1|Overall Study|Adverse Event|0
335947|NCT00566709|1098134|P2|Overall Study|Protocol Violation|0
335948|NCT00566709|1098135|P1|Overall Study|Protocol Violation|5
335949|NCT00566696|1098151|P1|Overall Study|Non-Patient Donors|37
335950|NCT00566696|1098151|P1|Overall Study|Physician Decision|1
335951|NCT00566696|1098151|P1|Overall Study|Health Status Change|1
335952|NCT00566696|1098151|P1|Overall Study|Muromonab not available|1
335953|NCT00566696|1098151|P1|Overall Study|Met Exclusion Criteria|2
335954|NCT00566631|1098159|P1|Part 2: Extension Phase|Unspecified|5
335955|NCT00566631|1098159|P1|Part 2: Extension Phase|Death|1
335956|NCT00566631|1098159|P1|Part 2: Extension Phase|Lost to Follow-up|6
335957|NCT00566631|1098159|P1|Part 2: Extension Phase|Adverse Event|11
335958|NCT00566631|1098159|P1|Part 2: Extension Phase|Withdrawal by Subject|34
335959|NCT00566631|1098159|P1|Part 2: Extension Phase|Lack of Efficacy|25
335960|NCT00566631|1098159|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
335961|NCT00566631|1098159|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
335962|NCT00566631|1098159|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
335963|NCT00566631|1098159|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
335964|NCT00566631|1098159|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
335965|NCT00566631|1098159|P1|Part 1: Core Treatment Phase|Adverse Event|9
335966|NCT00566631|1098159|P1|Part 1: Core Treatment Phase|Physician Decision|1
335967|NCT00566631|1098159|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
335968|NCT00566254|1098176|P2|Overall Study|Not Specified|2
335969|NCT00566254|1098177|P1|Overall Study|Not Specified|0
335970|NCT00566254|1098176|P2|Overall Study|Lack of Efficacy|6
335971|NCT00566254|1098177|P1|Overall Study|Lack of Efficacy|5
335972|NCT00566254|1098176|P2|Overall Study|Withdrawal by Subject|2
335973|NCT00566254|1098177|P1|Overall Study|Withdrawal by Subject|1
335974|NCT00566254|1098176|P2|Overall Study|Protocol Violation|3
335975|NCT00566254|1098177|P1|Overall Study|Protocol Violation|1
335976|NCT00566254|1098176|P2|Overall Study|Adverse Event|1
335977|NCT00566254|1098177|P1|Overall Study|Adverse Event|3
335978|NCT00566111|1098206|P2|Overall Study|Adverse Event|2
335979|NCT00566111|1098207|P1|Overall Study|Adverse Event|0
335980|NCT00566020|1098221|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
335981|NCT00566020|1098222|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
335982|NCT00566020|1098221|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
335983|NCT00566020|1098222|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
335984|NCT00566020|1098221|P2|46-week Long-term Administration Phase|Physician Decision|7
335985|NCT00566020|1098222|P1|46-week Long-term Administration Phase|Physician Decision|0
335986|NCT00566020|1098221|P2|46-week Long-term Administration Phase|Adverse Event|7
335987|NCT00566020|1098222|P1|46-week Long-term Administration Phase|Adverse Event|0
335988|NCT00566020|1098221|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
335989|NCT00566020|1098222|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
335990|NCT00566020|1098221|P2|6-week Dosage Adjustment Phase|Adverse Event|0
335991|NCT00566020|1098222|P1|6-week Dosage Adjustment Phase|Adverse Event|5
335992|NCT00565812|1098250|P3|Overall Study|Physician Decision|0
335993|NCT00565812|1098251|P2|Overall Study|Physician Decision|0
335994|NCT00565812|1098252|P1|Overall Study|Physician Decision|2
335995|NCT00565812|1098250|P3|Overall Study|Follow-up Visit Not Completed|1
335996|NCT00565812|1098251|P2|Overall Study|Follow-up Visit Not Completed|0
335997|NCT00565812|1098252|P1|Overall Study|Follow-up Visit Not Completed|2
335998|NCT00565812|1098250|P3|Overall Study|Low Compliance|1
335999|NCT00565812|1098251|P2|Overall Study|Low Compliance|0
336000|NCT00565812|1098252|P1|Overall Study|Low Compliance|1
336001|NCT00565812|1098250|P3|Overall Study|Surgical Intervention|2
336002|NCT00565812|1098251|P2|Overall Study|Surgical Intervention|1
336003|NCT00565812|1098252|P1|Overall Study|Surgical Intervention|0
336004|NCT00565812|1098250|P3|Overall Study|Research Site Closure|8
336005|NCT00565812|1098251|P2|Overall Study|Research Site Closure|1
336006|NCT00565812|1098252|P1|Overall Study|Research Site Closure|6
336007|NCT00565812|1098250|P3|Overall Study|Domestic Reasons|3
336008|NCT00565812|1098251|P2|Overall Study|Domestic Reasons|1
336009|NCT00565812|1098252|P1|Overall Study|Domestic Reasons|7
336010|NCT00565812|1098250|P3|Overall Study|Sponsor Decision|1
336011|NCT00565812|1098251|P2|Overall Study|Sponsor Decision|5
336012|NCT00565812|1098252|P1|Overall Study|Sponsor Decision|1
336013|NCT00565812|1098250|P3|Overall Study|Relocated Out of Area|9
336014|NCT00565812|1098251|P2|Overall Study|Relocated Out of Area|8
336015|NCT00565812|1098252|P1|Overall Study|Relocated Out of Area|5
336016|NCT00565812|1098250|P3|Overall Study|Jury Duty|0
336017|NCT00565812|1098251|P2|Overall Study|Jury Duty|0
336018|NCT00565812|1098252|P1|Overall Study|Jury Duty|1
336019|NCT00565812|1098250|P3|Overall Study|Adverse Event|40
336020|NCT00565812|1098251|P2|Overall Study|Adverse Event|54
336021|NCT00565812|1098252|P1|Overall Study|Adverse Event|41
336022|NCT00565812|1098250|P3|Overall Study|Protocol Violation|4
336023|NCT00565812|1098251|P2|Overall Study|Protocol Violation|6
336024|NCT00565812|1098252|P1|Overall Study|Protocol Violation|2
336025|NCT00565812|1098250|P3|Overall Study|Work Schedule|1
336026|NCT00565812|1098251|P2|Overall Study|Work Schedule|3
336027|NCT00565812|1098252|P1|Overall Study|Work Schedule|5
336028|NCT00565812|1098250|P3|Overall Study|Withdrawal by Subject|48
336029|NCT00565812|1098251|P2|Overall Study|Withdrawal by Subject|47
336030|NCT00565812|1098252|P1|Overall Study|Withdrawal by Subject|58
336031|NCT00565812|1098250|P3|Overall Study|Lost to Follow-up|8
336032|NCT00565812|1098251|P2|Overall Study|Lost to Follow-up|8
336033|NCT00565812|1098252|P1|Overall Study|Lost to Follow-up|10
336034|NCT00565812|1098250|P3|Overall Study|Did not Meet Entrance Criteria|1
336035|NCT00565812|1098251|P2|Overall Study|Did not Meet Entrance Criteria|0
336036|NCT00565812|1098252|P1|Overall Study|Did not Meet Entrance Criteria|1
336037|NCT00565812|1098250|P3|Overall Study|Death|3
336038|NCT00565812|1098251|P2|Overall Study|Death|1
336039|NCT00565812|1098252|P1|Overall Study|Death|2
336040|NCT00565747|1098391|P2|Overall Study|No embryo transfer|73
336041|NCT00565747|1098392|P1|Overall Study|No embryo transfer|67
336042|NCT00565721|1098402|P1|Overall Study|Other reasons|6
336043|NCT00565721|1098402|P1|Overall Study|Physician Decision|2
336044|NCT00565721|1098402|P1|Overall Study|Technical Problems|1
336045|NCT00565721|1098402|P1|Overall Study|Lost to Follow-up|6
336046|NCT00565721|1098402|P1|Overall Study|Screen Failure|2
336047|NCT00565604|1098442|P1|Overall Study|Lost to Follow-up|2
336048|NCT00565604|1098442|P1|Overall Study|Failure to treat|2
336049|NCT00565448|1098470|P2|Overall Study|Withdrawal by Subject|0
336050|NCT00565448|1098471|P1|Overall Study|Withdrawal by Subject|1
336051|NCT00565448|1098470|P2|Overall Study|Disease progression|0
336052|NCT00565448|1098471|P1|Overall Study|Disease progression|1
336053|NCT00565448|1098470|P2|Overall Study|Adverse Event|2
336054|NCT00565448|1098471|P1|Overall Study|Adverse Event|1
336055|NCT00565409|1098482|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
336056|NCT00565409|1098483|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
336057|NCT00565409|1098484|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
336058|NCT00565409|1098485|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
336059|NCT00565409|1098482|P4|Period 2 Double-Blind|unspecified|9
336060|NCT00565409|1098483|P3|Period 2 Double-Blind|unspecified|5
336061|NCT00565409|1098484|P2|Period 2 Double-Blind|unspecified|4
336062|NCT00565409|1098485|P1|Period 2 Double-Blind|unspecified|0
336063|NCT00565409|1098482|P4|Period 2 Double-Blind|Lost to Follow-up|0
336064|NCT00565409|1098483|P3|Period 2 Double-Blind|Lost to Follow-up|1
336065|NCT00565409|1098484|P2|Period 2 Double-Blind|Lost to Follow-up|0
336066|NCT00565409|1098485|P1|Period 2 Double-Blind|Lost to Follow-up|0
336067|NCT00565409|1098482|P4|Period 2 Double-Blind|Protocol Violation|2
336068|NCT00565409|1098483|P3|Period 2 Double-Blind|Protocol Violation|6
336069|NCT00565409|1098484|P2|Period 2 Double-Blind|Protocol Violation|4
336070|NCT00565409|1098485|P1|Period 2 Double-Blind|Protocol Violation|0
336071|NCT00565409|1098482|P4|Period 2 Double-Blind|Death|0
336072|NCT00565409|1098483|P3|Period 2 Double-Blind|Death|0
336073|NCT00565409|1098484|P2|Period 2 Double-Blind|Death|2
336074|NCT00565409|1098485|P1|Period 2 Double-Blind|Death|0
336075|NCT00565409|1098482|P4|Period 2 Double-Blind|Adverse Event|5
336076|NCT00565409|1098483|P3|Period 2 Double-Blind|Adverse Event|4
336077|NCT00565409|1098484|P2|Period 2 Double-Blind|Adverse Event|7
336078|NCT00565409|1098485|P1|Period 2 Double-Blind|Adverse Event|0
336079|NCT00565409|1098482|P4|After Period 1, Prior to Period 2|did not meet criteria|0
336080|NCT00565409|1098483|P3|After Period 1, Prior to Period 2|did not meet criteria|0
336081|NCT00565409|1098484|P2|After Period 1, Prior to Period 2|did not meet criteria|0
336082|NCT00565409|1098485|P1|After Period 1, Prior to Period 2|did not meet criteria|152
336083|NCT00565409|1098482|P4|Period 1 Open Label|no conclusion of participation record|0
336084|NCT00565409|1098483|P3|Period 1 Open Label|no conclusion of participation record|0
336085|NCT00565409|1098484|P2|Period 1 Open Label|no conclusion of participation record|0
336086|NCT00565409|1098485|P1|Period 1 Open Label|no conclusion of participation record|1
336087|NCT00565409|1098482|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
336088|NCT00565409|1098483|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
336089|NCT00565409|1098484|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
336090|NCT00565409|1098485|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
336091|NCT00565409|1098482|P4|Period 1 Open Label|Protocol Violation|0
336092|NCT00565409|1098483|P3|Period 1 Open Label|Protocol Violation|0
336093|NCT00565409|1098484|P2|Period 1 Open Label|Protocol Violation|0
336094|NCT00565409|1098485|P1|Period 1 Open Label|Protocol Violation|14
336095|NCT00565409|1098482|P4|Period 1 Open Label|unspecified|0
336096|NCT00565409|1098483|P3|Period 1 Open Label|unspecified|0
336097|NCT00565409|1098484|P2|Period 1 Open Label|unspecified|0
336098|NCT00565409|1098485|P1|Period 1 Open Label|unspecified|21
336099|NCT00565409|1098482|P4|Period 1 Open Label|Lost to Follow-up|0
336100|NCT00565409|1098483|P3|Period 1 Open Label|Lost to Follow-up|0
336101|NCT00565409|1098484|P2|Period 1 Open Label|Lost to Follow-up|0
336102|NCT00565409|1098485|P1|Period 1 Open Label|Lost to Follow-up|1
336103|NCT00565409|1098482|P4|Period 1 Open Label|Death|0
336104|NCT00565409|1098483|P3|Period 1 Open Label|Death|0
336105|NCT00565409|1098484|P2|Period 1 Open Label|Death|0
336106|NCT00565409|1098485|P1|Period 1 Open Label|Death|2
336107|NCT00565409|1098482|P4|Period 1 Open Label|Adverse Event|0
336108|NCT00565409|1098483|P3|Period 1 Open Label|Adverse Event|0
336109|NCT00565409|1098484|P2|Period 1 Open Label|Adverse Event|0
336110|NCT00565409|1098485|P1|Period 1 Open Label|Adverse Event|17
336111|NCT00565136|1098603|P1|Overall Study|Protocol Violation|1
336112|NCT00565136|1098603|P1|Overall Study|Withdrawal by Subject|1
336113|NCT00565136|1098603|P1|Overall Study|Lost to Follow-up|1
336114|NCT00565058|1098633|P2|Overall Study|Adverse Event|0
336115|NCT00565058|1098634|P1|Overall Study|Adverse Event|1
336116|NCT00564902|1098681|P3|Overall Study|Death|0
336117|NCT00564902|1098682|P2|Overall Study|Death|1
336118|NCT00564902|1098683|P1|Overall Study|Death|1
336119|NCT00564902|1098681|P3|Overall Study|Withdrawal by Subject|4
336120|NCT00564902|1098682|P2|Overall Study|Withdrawal by Subject|3
336121|NCT00564902|1098683|P1|Overall Study|Withdrawal by Subject|0
336122|NCT00564889|1098715|P1|Overall Study|Other, not specified|4
336123|NCT00564889|1098715|P1|Overall Study|Disease progression|3
336124|NCT00564889|1098715|P1|Overall Study|Alternative treatment|3
336125|NCT00564889|1098715|P1|Overall Study|Adverse Event|12
336126|NCT00564889|1098715|P1|Overall Study|Death|7
336127|NCT00564850|1098730|P1|Overall Study|Protocol Violation|2
336128|NCT00564733|1098748|P1|Overall Study|Ineligible|5
336129|NCT00564733|1098748|P1|Overall Study|Withdrawal by Subject|4
336130|NCT00564629|1098782|P2|Overall Study|Vomited within 2 hours of receiving drug|9
336131|NCT00564629|1098783|P1|Overall Study|Vomited within 2 hours of receiving drug|15
336132|NCT00564486|1098808|P4|Overall Study|Lost to Follow-up|2
336133|NCT00564486|1098809|P3|Overall Study|Lost to Follow-up|2
336134|NCT00564486|1098810|P2|Overall Study|Lost to Follow-up|0
336135|NCT00564486|1098811|P1|Overall Study|Lost to Follow-up|3
336136|NCT00564486|1098808|P4|Overall Study|Subject refused to have blood drawn|0
336137|NCT00564486|1098809|P3|Overall Study|Subject refused to have blood drawn|1
336138|NCT00564486|1098810|P2|Overall Study|Subject refused to have blood drawn|0
336139|NCT00564486|1098811|P1|Overall Study|Subject refused to have blood drawn|0
336140|NCT00564486|1098808|P4|Overall Study|Withdrawal by Subject|5
336141|NCT00564486|1098809|P3|Overall Study|Withdrawal by Subject|0
336142|NCT00564486|1098810|P2|Overall Study|Withdrawal by Subject|0
336143|NCT00564486|1098811|P1|Overall Study|Withdrawal by Subject|4
336144|NCT00564486|1098808|P4|Overall Study|Adverse Event|0
336145|NCT00564486|1098809|P3|Overall Study|Adverse Event|0
336146|NCT00564486|1098810|P2|Overall Study|Adverse Event|1
336147|NCT00564486|1098811|P1|Overall Study|Adverse Event|0
336148|NCT00564278|1098862|P2|Overall Study|Withdrawal by Subject|7
336149|NCT00564278|1098863|P1|Overall Study|Withdrawal by Subject|11
336150|NCT00564278|1098862|P2|Overall Study|Physician Decision|2
336151|NCT00564278|1098863|P1|Overall Study|Physician Decision|1
336152|NCT00564278|1098862|P2|Overall Study|Lost to Follow-up|33
336153|NCT00564278|1098863|P1|Overall Study|Lost to Follow-up|35
336154|NCT00563797|1098885|P2|Overall Study|Lost to Follow-up|2
336155|NCT00563797|1098886|P1|Overall Study|Lost to Follow-up|7
336156|NCT00563706|1098907|P9|DB Treatment Period (Day 1 up to Day 28)|Unspecified|2
336157|NCT00563706|1098908|P8|DB Treatment Period (Day 1 up to Day 28)|Unspecified|1
336158|NCT00563706|1098909|P7|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
336159|NCT00563706|1098910|P6|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
336160|NCT00563706|1098911|P5|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
336161|NCT00563706|1098912|P4|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
336162|NCT00563706|1098913|P3|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
336163|NCT00563706|1098914|P2|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
336164|NCT00563706|1098915|P1|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
336165|NCT00563706|1098907|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
336166|NCT00563706|1098908|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
336167|NCT00563706|1098909|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
336168|NCT00563706|1098910|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
336169|NCT00563706|1098911|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
336170|NCT00563706|1098912|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
336171|NCT00563706|1098913|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
336172|NCT00563706|1098914|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
336173|NCT00563706|1098915|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
336174|NCT00563706|1098907|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
336175|NCT00563706|1098908|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
336176|NCT00563706|1098909|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
336177|NCT00563706|1098910|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
336178|NCT00563706|1098911|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
336179|NCT00563706|1098912|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
336180|NCT00563706|1098913|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
336181|NCT00563706|1098914|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
336182|NCT00563706|1098915|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
336183|NCT00563706|1098907|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
336184|NCT00563706|1098908|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
336185|NCT00563706|1098909|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
336186|NCT00563706|1098910|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
336187|NCT00563706|1098911|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
336188|NCT00563706|1098912|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
336189|NCT00563706|1098913|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
336190|NCT00563706|1098914|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
336191|NCT00563706|1098915|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
336192|NCT00563706|1098907|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
336193|NCT00563706|1098908|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
336194|NCT00563706|1098909|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
336195|NCT00563706|1098910|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
336196|NCT00563706|1098911|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
336197|NCT00563706|1098912|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
336198|NCT00563706|1098913|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
336199|NCT00563706|1098914|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
336200|NCT00563706|1098915|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
336201|NCT00563381|1099031|P2|Overall Study|Individual different reasons|34
336202|NCT00563381|1099032|P1|Overall Study|Individual different reasons|24
336203|NCT00563381|1099031|P2|Overall Study|Lack of Efficacy|24
336204|NCT00563381|1099032|P1|Overall Study|Lack of Efficacy|32
336205|NCT00563381|1099031|P2|Overall Study|Withdrawal by Subject|209
336206|NCT00563381|1099032|P1|Overall Study|Withdrawal by Subject|192
336207|NCT00563381|1099031|P2|Overall Study|Lost to Follow-up|15
336208|NCT00563381|1099032|P1|Overall Study|Lost to Follow-up|7
336209|NCT00563381|1099031|P2|Overall Study|Protocol Violation|74
336210|NCT00563381|1099032|P1|Overall Study|Protocol Violation|66
336211|NCT00563381|1099031|P2|Overall Study|Adverse Event|292
336212|NCT00563381|1099032|P1|Overall Study|Adverse Event|264
336213|NCT00563368|1099105|P7|Overall Study|not specified|0
336214|NCT00563368|1099106|P6|Overall Study|not specified|4
336215|NCT00563368|1099107|P5|Overall Study|not specified|4
336216|NCT00563368|1099108|P4|Overall Study|not specified|4
336217|NCT00563368|1099109|P3|Overall Study|not specified|3
336218|NCT00563368|1099110|P2|Overall Study|not specified|5
336219|NCT00563368|1099111|P1|Overall Study|not specified|5
336220|NCT00563368|1099105|P7|Overall Study|requirement for restricted medication|0
336221|NCT00563368|1099106|P6|Overall Study|requirement for restricted medication|0
336222|NCT00563368|1099107|P5|Overall Study|requirement for restricted medication|0
336223|NCT00563368|1099108|P4|Overall Study|requirement for restricted medication|0
336224|NCT00563368|1099109|P3|Overall Study|requirement for restricted medication|2
336225|NCT00563368|1099110|P2|Overall Study|requirement for restricted medication|0
336226|NCT00563368|1099111|P1|Overall Study|requirement for restricted medication|0
336227|NCT00563368|1099105|P7|Overall Study|Pregnancy|0
336228|NCT00563368|1099106|P6|Overall Study|Pregnancy|2
336229|NCT00563368|1099107|P5|Overall Study|Pregnancy|1
336230|NCT00563368|1099108|P4|Overall Study|Pregnancy|2
336231|NCT00563368|1099109|P3|Overall Study|Pregnancy|1
336232|NCT00563368|1099110|P2|Overall Study|Pregnancy|0
336233|NCT00563368|1099111|P1|Overall Study|Pregnancy|1
336234|NCT00563368|1099105|P7|Overall Study|protocol non-compliance|3
336235|NCT00563368|1099106|P6|Overall Study|protocol non-compliance|1
336236|NCT00563368|1099107|P5|Overall Study|protocol non-compliance|0
336237|NCT00563368|1099108|P4|Overall Study|protocol non-compliance|1
336238|NCT00563368|1099109|P3|Overall Study|protocol non-compliance|2
336239|NCT00563368|1099110|P2|Overall Study|protocol non-compliance|1
336240|NCT00563368|1099111|P1|Overall Study|protocol non-compliance|1
336241|NCT00563368|1099105|P7|Overall Study|Withdrawal by Subject|4
336242|NCT00563368|1099106|P6|Overall Study|Withdrawal by Subject|5
336243|NCT00563368|1099107|P5|Overall Study|Withdrawal by Subject|8
336244|NCT00563368|1099108|P4|Overall Study|Withdrawal by Subject|7
336245|NCT00563368|1099109|P3|Overall Study|Withdrawal by Subject|5
336246|NCT00563368|1099110|P2|Overall Study|Withdrawal by Subject|6
336247|NCT00563368|1099111|P1|Overall Study|Withdrawal by Subject|11
336248|NCT00563368|1099105|P7|Overall Study|Adverse Event|17
336249|NCT00563368|1099106|P6|Overall Study|Adverse Event|10
336250|NCT00563368|1099107|P5|Overall Study|Adverse Event|6
336251|NCT00563368|1099108|P4|Overall Study|Adverse Event|9
336252|NCT00563368|1099109|P3|Overall Study|Adverse Event|5
336253|NCT00563368|1099110|P2|Overall Study|Adverse Event|4
336254|NCT00563368|1099111|P1|Overall Study|Adverse Event|3
336255|NCT00563368|1099105|P7|Overall Study|Lost to Follow-up|9
336256|NCT00563368|1099106|P6|Overall Study|Lost to Follow-up|8
336257|NCT00563368|1099107|P5|Overall Study|Lost to Follow-up|9
336258|NCT00563368|1099108|P4|Overall Study|Lost to Follow-up|6
336259|NCT00563368|1099109|P3|Overall Study|Lost to Follow-up|12
336260|NCT00563368|1099110|P2|Overall Study|Lost to Follow-up|14
336261|NCT00563368|1099111|P1|Overall Study|Lost to Follow-up|14
336262|NCT00563316|1099134|P1|Overall Study|Other|1
336263|NCT00563316|1099134|P1|Overall Study|On-going in study as of 16 July 2009.|5
336264|NCT00563316|1099134|P1|Overall Study|Death|1
336265|NCT00563316|1099134|P1|Overall Study|Lost to Follow-up|2
336266|NCT00563316|1099134|P1|Overall Study|Physician Decision|1
336267|NCT00563316|1099134|P1|Overall Study|Adverse Event|2
336268|NCT00562861|1099159|P2|Overall Study|Lost to Follow-up|3
336269|NCT00562861|1099160|P1|Overall Study|Lost to Follow-up|7
336270|NCT00562861|1099159|P2|Overall Study|noncompliance, moved|2
336271|NCT00562861|1099160|P1|Overall Study|noncompliance, moved|7
336272|NCT00562861|1099159|P2|Overall Study|Lack of Efficacy|5
336273|NCT00562861|1099160|P1|Overall Study|Lack of Efficacy|5
336274|NCT00562861|1099159|P2|Overall Study|Adverse Event|1
336275|NCT00562861|1099160|P1|Overall Study|Adverse Event|1
336276|NCT00562627|1099169|P3|Overall Study|Protocol Violation|1
336277|NCT00562627|1099170|P2|Overall Study|Protocol Violation|1
336278|NCT00562627|1099171|P1|Overall Study|Protocol Violation|1
336279|NCT00562588|1099187|P2|Overall Study|Other|2
336280|NCT00562588|1099188|P1|Overall Study|Other|0
336281|NCT00562588|1099187|P2|Overall Study|Withdrawal by Subject|9
336282|NCT00562588|1099188|P1|Overall Study|Withdrawal by Subject|10
336283|NCT00562588|1099187|P2|Overall Study|Lost to Follow-up|4
336284|NCT00562588|1099188|P1|Overall Study|Lost to Follow-up|12
336285|NCT00562588|1099187|P2|Overall Study|Protocol Violation|26
336286|NCT00562588|1099188|P1|Overall Study|Protocol Violation|30
336287|NCT00562588|1099187|P2|Overall Study|Adverse Event|58
336288|NCT00562588|1099188|P1|Overall Study|Adverse Event|40
336289|NCT00562484|1099218|P2|Overall Study|Reason not provided or not specified|12
336290|NCT00562484|1099219|P1|Overall Study|Reason not provided or not specified|25
336291|NCT00562484|1099218|P2|Overall Study|Lost to Follow-up|71
336292|NCT00562484|1099219|P1|Overall Study|Lost to Follow-up|132
336293|NCT00562484|1099218|P2|Overall Study|Moved away from the study area|9
336294|NCT00562484|1099219|P1|Overall Study|Moved away from the study area|20
336295|NCT00562484|1099218|P2|Overall Study|Withdrawal by Subject|9
336296|NCT00562484|1099219|P1|Overall Study|Withdrawal by Subject|12
336297|NCT00562484|1099218|P2|Overall Study|Protocol Violation|2
336298|NCT00562484|1099219|P1|Overall Study|Protocol Violation|11
336299|NCT00562484|1099218|P2|Overall Study|Adverse Event|1
336300|NCT00562484|1099219|P1|Overall Study|Adverse Event|6
336301|NCT00562354|1099251|P2|Overall Study|Lost to Follow-up|1
336302|NCT00562354|1099252|P1|Overall Study|Lost to Follow-up|0
336303|NCT00562354|1099251|P2|Overall Study|Physician Decision|1
336304|NCT00562354|1099252|P1|Overall Study|Physician Decision|0
336305|NCT00562302|1099314|P2|Overall Study|Not stated|4
336306|NCT00562302|1099315|P1|Overall Study|Not stated|1
336307|NCT00562302|1099314|P2|Overall Study|Lung resection prior to study completion|7
336308|NCT00562302|1099315|P1|Overall Study|Lung resection prior to study completion|7
336309|NCT00562302|1099314|P2|Overall Study|Death|2
336310|NCT00562302|1099315|P1|Overall Study|Death|1
336311|NCT00562302|1099314|P2|Overall Study|Withdrawal by Subject|8
336312|NCT00562302|1099315|P1|Overall Study|Withdrawal by Subject|7
336313|NCT00562302|1099314|P2|Overall Study|Non-compliance|2
336314|NCT00562302|1099315|P1|Overall Study|Non-compliance|1
336315|NCT00562302|1099314|P2|Overall Study|Adverse Event|6
336316|NCT00562302|1099315|P1|Overall Study|Adverse Event|0
336317|NCT00562302|1099314|P2|Overall Study|Lost to Follow-up|3
336318|NCT00562302|1099315|P1|Overall Study|Lost to Follow-up|3
336319|NCT00562159|1099337|P2|Overall Study|Did not meet protocol eligibility|1
336320|NCT00562159|1099338|P1|Overall Study|Did not meet protocol eligibility|1
336321|NCT00562159|1099337|P2|Overall Study|Protocol Violation|12
336322|NCT00562159|1099338|P1|Overall Study|Protocol Violation|12
336323|NCT00562159|1099337|P2|Overall Study|Withdrawal by Subject|8
336324|NCT00562159|1099338|P1|Overall Study|Withdrawal by Subject|9
336325|NCT00562159|1099337|P2|Overall Study|Lost to Follow-up|4
336326|NCT00562159|1099338|P1|Overall Study|Lost to Follow-up|5
336327|NCT00562159|1099337|P2|Overall Study|Adverse Event|8
336328|NCT00562159|1099338|P1|Overall Study|Adverse Event|11
336329|NCT00562120|1099350|P4|First Intervention Period|Randomized but not Treated|0
336330|NCT00562120|1099351|P3|First Intervention Period|Randomized but not Treated|0
336331|NCT00562120|1099352|P2|First Intervention Period|Randomized but not Treated|0
336332|NCT00562120|1099353|P1|First Intervention Period|Randomized but not Treated|1
336333|NCT00562120|1099350|P4|First Intervention Period|Adverse Event|0
336334|NCT00562120|1099351|P3|First Intervention Period|Adverse Event|0
336335|NCT00562120|1099352|P2|First Intervention Period|Adverse Event|0
336336|NCT00562120|1099353|P1|First Intervention Period|Adverse Event|1
336337|NCT00562094|1099385|P1|Overall Study|Lost to Follow-up|62
336338|NCT00561977|1099400|P3|Overall Study|Pregnancy|1
336339|NCT00561977|1099401|P2|Overall Study|Pregnancy|1
336340|NCT00561977|1099402|P1|Overall Study|Pregnancy|0
336341|NCT00561977|1099400|P3|Overall Study|Withdrawal by Subject|1
336342|NCT00561977|1099401|P2|Overall Study|Withdrawal by Subject|2
336343|NCT00561977|1099402|P1|Overall Study|Withdrawal by Subject|0
336344|NCT00561951|1099428|P3|Overall Study|Adverse Event Occured Before Treatment|1
336345|NCT00561951|1099429|P2|Overall Study|Adverse Event Occured Before Treatment|2
336346|NCT00561951|1099430|P1|Overall Study|Adverse Event Occured Before Treatment|1
336347|NCT00561951|1099428|P3|Overall Study|Meet Withdrawal Criterion|1
336348|NCT00561951|1099429|P2|Overall Study|Meet Withdrawal Criterion|1
336349|NCT00561951|1099430|P1|Overall Study|Meet Withdrawal Criterion|0
336350|NCT00561951|1099428|P3|Overall Study|Pregnancy|0
336351|NCT00561951|1099429|P2|Overall Study|Pregnancy|1
336352|NCT00561951|1099430|P1|Overall Study|Pregnancy|0
336353|NCT00561951|1099428|P3|Overall Study|Physician Decision|0
336354|NCT00561951|1099429|P2|Overall Study|Physician Decision|0
336355|NCT00561951|1099430|P1|Overall Study|Physician Decision|1
336356|NCT00561951|1099428|P3|Overall Study|Protocol Violation|4
336357|NCT00561951|1099429|P2|Overall Study|Protocol Violation|3
336358|NCT00561951|1099430|P1|Overall Study|Protocol Violation|4
336359|NCT00561951|1099428|P3|Overall Study|Withdrawal by Subject|10
336360|NCT00561951|1099429|P2|Overall Study|Withdrawal by Subject|9
336361|NCT00561951|1099430|P1|Overall Study|Withdrawal by Subject|10
336362|NCT00561951|1099428|P3|Overall Study|Lost to Follow-up|0
336363|NCT00561951|1099429|P2|Overall Study|Lost to Follow-up|1
336364|NCT00561951|1099430|P1|Overall Study|Lost to Follow-up|1
336365|NCT00561951|1099428|P3|Overall Study|Lack of Efficacy|2
336366|NCT00561951|1099429|P2|Overall Study|Lack of Efficacy|3
336367|NCT00561951|1099430|P1|Overall Study|Lack of Efficacy|5
336368|NCT00561951|1099428|P3|Overall Study|Adverse Event|14
336369|NCT00561951|1099429|P2|Overall Study|Adverse Event|14
336370|NCT00561951|1099430|P1|Overall Study|Adverse Event|11
336371|NCT00561925|1099486|P5|Open-Label Extension Period|Declined entry into extension period|50
336372|NCT00561925|1099487|P4|Open-Label Extension Period|Declined entry into extension period|43
336373|NCT00561925|1099488|P3|Open-Label Extension Period|Declined entry into extension period|0
336374|NCT00561925|1099489|P2|Open-Label Extension Period|Declined entry into extension period|0
336375|NCT00561925|1099490|P1|Open-Label Extension Period|Declined entry into extension period|0
336376|NCT00561925|1099486|P5|144-week Double-blind, Double-dummy|Other|0
336377|NCT00561925|1099487|P4|144-week Double-blind, Double-dummy|Other|0
336378|NCT00561925|1099488|P3|144-week Double-blind, Double-dummy|Other|11
336379|NCT00561925|1099489|P2|144-week Double-blind, Double-dummy|Other|8
336380|NCT00561925|1099490|P1|144-week Double-blind, Double-dummy|Other|0
336381|NCT00561925|1099486|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
336382|NCT00561925|1099487|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
336383|NCT00561925|1099488|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
336384|NCT00561925|1099489|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
336385|NCT00561925|1099490|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
336386|NCT00561925|1099486|P5|144-week Double-blind, Double-dummy|Death|0
336387|NCT00561925|1099487|P4|144-week Double-blind, Double-dummy|Death|0
336388|NCT00561925|1099488|P3|144-week Double-blind, Double-dummy|Death|3
336389|NCT00561925|1099489|P2|144-week Double-blind, Double-dummy|Death|6
336390|NCT00561925|1099490|P1|144-week Double-blind, Double-dummy|Death|0
336391|NCT00561925|1099486|P5|144-week Double-blind, Double-dummy|Pregnancy|0
336392|NCT00561925|1099487|P4|144-week Double-blind, Double-dummy|Pregnancy|0
336393|NCT00561925|1099488|P3|144-week Double-blind, Double-dummy|Pregnancy|9
336394|NCT00561925|1099489|P2|144-week Double-blind, Double-dummy|Pregnancy|1
336395|NCT00561925|1099490|P1|144-week Double-blind, Double-dummy|Pregnancy|0
336396|NCT00561925|1099486|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
336397|NCT00561925|1099487|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
336398|NCT00561925|1099488|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
336399|NCT00561925|1099489|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
336400|NCT00561925|1099490|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
336401|NCT00561925|1099486|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
336402|NCT00561925|1099487|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
336403|NCT00561925|1099488|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
336404|NCT00561925|1099489|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
336405|NCT00561925|1099490|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
336406|NCT00561925|1099486|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
336407|NCT00561925|1099487|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
336408|NCT00561925|1099488|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
336409|NCT00561925|1099489|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
336410|NCT00561925|1099490|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
336411|NCT00561925|1099486|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
336412|NCT00561925|1099487|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
336413|NCT00561925|1099488|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
336414|NCT00561925|1099489|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
336415|NCT00561925|1099490|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
336416|NCT00561925|1099486|P5|144-week Double-blind, Double-dummy|Adverse Event|0
336417|NCT00561925|1099487|P4|144-week Double-blind, Double-dummy|Adverse Event|0
336418|NCT00561925|1099488|P3|144-week Double-blind, Double-dummy|Adverse Event|43
336419|NCT00561925|1099489|P2|144-week Double-blind, Double-dummy|Adverse Event|48
336420|NCT00561925|1099490|P1|144-week Double-blind, Double-dummy|Adverse Event|0
336421|NCT00561925|1099486|P5|14 Day Lead-In Period|Other|0
336422|NCT00561925|1099487|P4|14 Day Lead-In Period|Other|0
336423|NCT00561925|1099488|P3|14 Day Lead-In Period|Other|0
336424|NCT00561925|1099489|P2|14 Day Lead-In Period|Other|0
336425|NCT00561925|1099490|P1|14 Day Lead-In Period|Other|5
336426|NCT00561925|1099486|P5|14 Day Lead-In Period|Withdrawal by Subject|0
336427|NCT00561925|1099487|P4|14 Day Lead-In Period|Withdrawal by Subject|0
336428|NCT00561925|1099488|P3|14 Day Lead-In Period|Withdrawal by Subject|0
336429|NCT00561925|1099489|P2|14 Day Lead-In Period|Withdrawal by Subject|0
336430|NCT00561925|1099490|P1|14 Day Lead-In Period|Withdrawal by Subject|4
336431|NCT00561925|1099486|P5|14 Day Lead-In Period|Lost to Follow-up|0
336432|NCT00561925|1099487|P4|14 Day Lead-In Period|Lost to Follow-up|0
336433|NCT00561925|1099488|P3|14 Day Lead-In Period|Lost to Follow-up|0
336434|NCT00561925|1099489|P2|14 Day Lead-In Period|Lost to Follow-up|0
336435|NCT00561925|1099490|P1|14 Day Lead-In Period|Lost to Follow-up|4
336436|NCT00561925|1099486|P5|14 Day Lead-In Period|In/Exclusion criteria|0
336437|NCT00561925|1099487|P4|14 Day Lead-In Period|In/Exclusion criteria|0
336438|NCT00561925|1099488|P3|14 Day Lead-In Period|In/Exclusion criteria|0
336439|NCT00561925|1099489|P2|14 Day Lead-In Period|In/Exclusion criteria|0
336440|NCT00561925|1099490|P1|14 Day Lead-In Period|In/Exclusion criteria|4
336441|NCT00561925|1099486|P5|14 Day Lead-In Period|Adverse Event|0
336442|NCT00561925|1099487|P4|14 Day Lead-In Period|Adverse Event|0
336443|NCT00561925|1099488|P3|14 Day Lead-In Period|Adverse Event|0
336444|NCT00561925|1099489|P2|14 Day Lead-In Period|Adverse Event|0
336445|NCT00561925|1099490|P1|14 Day Lead-In Period|Adverse Event|38
336446|NCT00561912|1099539|P1|Overall Study|ineligible|1
336447|NCT00561821|1099551|P4|Overall Study|Adverse Event|1
336448|NCT00561821|1099552|P3|Overall Study|Adverse Event|1
336449|NCT00561821|1099553|P2|Overall Study|Adverse Event|3
336450|NCT00561821|1099554|P1|Overall Study|Adverse Event|2
336451|NCT00561821|1099551|P4|Overall Study|Other (reason not specified)|0
336452|NCT00561821|1099552|P3|Overall Study|Other (reason not specified)|0
336453|NCT00561821|1099553|P2|Overall Study|Other (reason not specified)|1
336454|NCT00561821|1099554|P1|Overall Study|Other (reason not specified)|1
336455|NCT00561821|1099551|P4|Overall Study|Reasons not related to trial|0
336456|NCT00561821|1099552|P3|Overall Study|Reasons not related to trial|0
336457|NCT00561821|1099553|P2|Overall Study|Reasons not related to trial|1
336458|NCT00561821|1099554|P1|Overall Study|Reasons not related to trial|2
336459|NCT00561821|1099551|P4|Overall Study|Withdrawal by Subject|2
336460|NCT00561821|1099552|P3|Overall Study|Withdrawal by Subject|0
336461|NCT00561821|1099553|P2|Overall Study|Withdrawal by Subject|1
336462|NCT00561821|1099554|P1|Overall Study|Withdrawal by Subject|0
336463|NCT00561821|1099551|P4|Overall Study|Not treated|0
336464|NCT00561821|1099552|P3|Overall Study|Not treated|1
336465|NCT00561821|1099553|P2|Overall Study|Not treated|0
336466|NCT00561821|1099554|P1|Overall Study|Not treated|0
336467|NCT00561795|1099630|P4|Overall Study|Physician Decision|0
336468|NCT00561795|1099631|P3|Overall Study|Physician Decision|0
336469|NCT00561795|1099632|P2|Overall Study|Physician Decision|0
336470|NCT00561795|1099633|P1|Overall Study|Physician Decision|1
336471|NCT00561795|1099630|P4|Overall Study|Study Closed/Terminated|0
336472|NCT00561795|1099631|P3|Overall Study|Study Closed/Terminated|0
336473|NCT00561795|1099632|P2|Overall Study|Study Closed/Terminated|3
336474|NCT00561795|1099633|P1|Overall Study|Study Closed/Terminated|0
336475|NCT00561795|1099630|P4|Overall Study|Adverse Event|0
336476|NCT00561795|1099631|P3|Overall Study|Adverse Event|0
336477|NCT00561795|1099632|P2|Overall Study|Adverse Event|3
336478|NCT00561795|1099633|P1|Overall Study|Adverse Event|3
336479|NCT00561730|1099653|P1|Overall Study|Not specified reasons|1
336480|NCT00561730|1099653|P1|Overall Study|Lost to Follow-up|5
336481|NCT00561730|1099653|P1|Overall Study|Handling of the drug|1
336482|NCT00561730|1099653|P1|Overall Study|Adverse Event|2
336483|NCT00561678|1099669|P2|Overall Study|anesthesia provider refusal|0
336484|NCT00561678|1099670|P1|Overall Study|anesthesia provider refusal|1
336485|NCT00561678|1099669|P2|Overall Study|surgery rescheduled to different site|2
336486|NCT00561678|1099670|P1|Overall Study|surgery rescheduled to different site|2
336487|NCT00561678|1099669|P2|Overall Study|surgery cancelled|1
336488|NCT00561678|1099670|P1|Overall Study|surgery cancelled|1
336489|NCT00561678|1099669|P2|Overall Study|Withdrawal by Subject|3
336490|NCT00561678|1099670|P1|Overall Study|Withdrawal by Subject|4
336491|NCT00561652|1099688|P2|Overall Study|Withdrawal by Subject|1
336492|NCT00561652|1099689|P1|Overall Study|Withdrawal by Subject|0
336493|NCT00561574|1099772|P2|Overall Study|Unspecified|7
336494|NCT00561574|1099773|P1|Overall Study|Unspecified|5
336495|NCT00561574|1099772|P2|Overall Study|Lost to Follow-up|0
336496|NCT00561574|1099773|P1|Overall Study|Lost to Follow-up|1
336497|NCT00561574|1099772|P2|Overall Study|Reason Unrelated to Trial|2
336498|NCT00561574|1099773|P1|Overall Study|Reason Unrelated to Trial|6
336499|NCT00561574|1099772|P2|Overall Study|Withdrawal by Subject|4
336500|NCT00561574|1099773|P1|Overall Study|Withdrawal by Subject|4
336501|NCT00561574|1099772|P2|Overall Study|Lack of Efficacy|21
336502|NCT00561574|1099773|P1|Overall Study|Lack of Efficacy|11
336503|NCT00561574|1099772|P2|Overall Study|Adverse Event|24
336504|NCT00561574|1099773|P1|Overall Study|Adverse Event|21
336505|NCT00561470|1099799|P2|Overall Study|Ongoing Treatment|14
336506|NCT00561470|1099800|P1|Overall Study|Ongoing Treatment|11
336507|NCT00561470|1099799|P2|Overall Study|Planning surgery|1
336508|NCT00561470|1099800|P1|Overall Study|Planning surgery|1
336509|NCT00561470|1099799|P2|Overall Study|Missed visit window|4
336510|NCT00561470|1099800|P1|Overall Study|Missed visit window|1
336511|NCT00561470|1099799|P2|Overall Study|Randomized but not treated|5
336512|NCT00561470|1099800|P1|Overall Study|Randomized but not treated|5
336513|NCT00561470|1099799|P2|Overall Study|Unauthorized procedure|1
336514|NCT00561470|1099800|P1|Overall Study|Unauthorized procedure|3
336515|NCT00561470|1099799|P2|Overall Study|Metastatic surgery|12
336516|NCT00561470|1099800|P1|Overall Study|Metastatic surgery|10
336517|NCT00561470|1099799|P2|Overall Study|Subject request|77
336518|NCT00561470|1099800|P1|Overall Study|Subject request|43
336519|NCT00561470|1099799|P2|Overall Study|Consent Withdrawn|6
336520|NCT00561470|1099800|P1|Overall Study|Consent Withdrawn|2
336521|NCT00561470|1099799|P2|Overall Study|Physician Decision|20
336522|NCT00561470|1099800|P1|Overall Study|Physician Decision|21
336523|NCT00561470|1099799|P2|Overall Study|Lost to Follow-up|0
336524|NCT00561470|1099800|P1|Overall Study|Lost to Follow-up|2
336525|NCT00561470|1099799|P2|Overall Study|poor compliance to protocol|4
336526|NCT00561470|1099800|P1|Overall Study|poor compliance to protocol|4
336527|NCT00561470|1099799|P2|Overall Study|Disease progression|305
336528|NCT00561470|1099800|P1|Overall Study|Disease progression|437
336529|NCT00561470|1099799|P2|Overall Study|Adverse Event|163
336530|NCT00561470|1099800|P1|Overall Study|Adverse Event|74
336531|NCT00561392|1099836|P1|Overall Study|Administrative problems|4
336532|NCT00561392|1099836|P1|Overall Study|Withdrawal by Subject|8
336533|NCT00561392|1099836|P1|Overall Study|Protocol Violation|1
336534|NCT00561392|1099836|P1|Overall Study|Lack of Efficacy|2
336535|NCT00561392|1099836|P1|Overall Study|Adverse Event|38
336536|NCT00561353|1099858|P10|Overall Study|Withdrawal by Subject|0
336537|NCT00561353|1099859|P9|Overall Study|Withdrawal by Subject|0
336538|NCT00561353|1099860|P8|Overall Study|Withdrawal by Subject|0
336539|NCT00561353|1099861|P7|Overall Study|Withdrawal by Subject|0
336540|NCT00561353|1099862|P6|Overall Study|Withdrawal by Subject|0
336541|NCT00561353|1099863|P5|Overall Study|Withdrawal by Subject|0
336542|NCT00561353|1099864|P4|Overall Study|Withdrawal by Subject|0
336543|NCT00561353|1099865|P3|Overall Study|Withdrawal by Subject|0
336544|NCT00561353|1099866|P2|Overall Study|Withdrawal by Subject|2
336545|NCT00561353|1099867|P1|Overall Study|Withdrawal by Subject|0
336546|NCT00561353|1099858|P10|Overall Study|Lost to Follow-up|0
336547|NCT00561353|1099859|P9|Overall Study|Lost to Follow-up|0
336548|NCT00561353|1099860|P8|Overall Study|Lost to Follow-up|0
336549|NCT00561353|1099861|P7|Overall Study|Lost to Follow-up|0
336550|NCT00561353|1099862|P6|Overall Study|Lost to Follow-up|0
336551|NCT00561353|1099863|P5|Overall Study|Lost to Follow-up|0
336552|NCT00561353|1099864|P4|Overall Study|Lost to Follow-up|0
336553|NCT00561353|1099865|P3|Overall Study|Lost to Follow-up|1
336554|NCT00561353|1099866|P2|Overall Study|Lost to Follow-up|0
336555|NCT00561353|1099867|P1|Overall Study|Lost to Follow-up|2
336556|NCT00561353|1099858|P10|Overall Study|Adverse Event|1
336557|NCT00561353|1099859|P9|Overall Study|Adverse Event|0
336558|NCT00561353|1099860|P8|Overall Study|Adverse Event|0
336559|NCT00561353|1099861|P7|Overall Study|Adverse Event|1
336560|NCT00561353|1099862|P6|Overall Study|Adverse Event|0
336561|NCT00561353|1099863|P5|Overall Study|Adverse Event|0
336562|NCT00561353|1099864|P4|Overall Study|Adverse Event|2
336563|NCT00561353|1099865|P3|Overall Study|Adverse Event|0
336564|NCT00561353|1099866|P2|Overall Study|Adverse Event|0
336565|NCT00561353|1099867|P1|Overall Study|Adverse Event|0
336566|NCT00561353|1099858|P10|Overall Study|Not specified|0
336567|NCT00561353|1099859|P9|Overall Study|Not specified|0
336568|NCT00561353|1099860|P8|Overall Study|Not specified|0
336569|NCT00561353|1099861|P7|Overall Study|Not specified|0
336570|NCT00561353|1099862|P6|Overall Study|Not specified|2
336571|NCT00561353|1099863|P5|Overall Study|Not specified|0
336572|NCT00561353|1099864|P4|Overall Study|Not specified|0
336573|NCT00561353|1099865|P3|Overall Study|Not specified|1
336574|NCT00561353|1099866|P2|Overall Study|Not specified|0
336575|NCT00561353|1099867|P1|Overall Study|Not specified|1
336576|NCT00561353|1099858|P10|Overall Study|Subject ineligible to continue the trial|1
336577|NCT00561353|1099859|P9|Overall Study|Subject ineligible to continue the trial|2
336578|NCT00561353|1099860|P8|Overall Study|Subject ineligible to continue the trial|0
336579|NCT00561353|1099861|P7|Overall Study|Subject ineligible to continue the trial|1
336580|NCT00561353|1099862|P6|Overall Study|Subject ineligible to continue the trial|1
336581|NCT00561353|1099863|P5|Overall Study|Subject ineligible to continue the trial|0
336582|NCT00561353|1099864|P4|Overall Study|Subject ineligible to continue the trial|0
336583|NCT00561353|1099865|P3|Overall Study|Subject ineligible to continue the trial|0
336584|NCT00561353|1099866|P2|Overall Study|Subject ineligible to continue the trial|0
336585|NCT00561353|1099867|P1|Overall Study|Subject ineligible to continue the trial|0
336586|NCT00561353|1099858|P10|Overall Study|Subject reached a virologic endpoint|0
336587|NCT00561353|1099859|P9|Overall Study|Subject reached a virologic endpoint|5
336588|NCT00561353|1099860|P8|Overall Study|Subject reached a virologic endpoint|4
336589|NCT00561353|1099861|P7|Overall Study|Subject reached a virologic endpoint|4
336590|NCT00561353|1099862|P6|Overall Study|Subject reached a virologic endpoint|3
336591|NCT00561353|1099863|P5|Overall Study|Subject reached a virologic endpoint|1
336592|NCT00561353|1099864|P4|Overall Study|Subject reached a virologic endpoint|4
336593|NCT00561353|1099865|P3|Overall Study|Subject reached a virologic endpoint|1
336594|NCT00561353|1099866|P2|Overall Study|Subject reached a virologic endpoint|1
336595|NCT00561353|1099867|P1|Overall Study|Subject reached a virologic endpoint|2
336596|NCT00561340|1100022|P2|Overall Study|refused to drink pediasure|0
336597|NCT00561340|1100023|P1|Overall Study|refused to drink pediasure|6
336598|NCT00561015|1100046|P6|Overall Study|Participant non-compliance|0
336599|NCT00561015|1100047|P5|Overall Study|Participant non-compliance|0
336600|NCT00561015|1100048|P4|Overall Study|Participant non-compliance|0
336601|NCT00561015|1100049|P3|Overall Study|Participant non-compliance|0
336602|NCT00561015|1100050|P2|Overall Study|Participant non-compliance|0
336603|NCT00561015|1100051|P1|Overall Study|Participant non-compliance|2
336604|NCT00561015|1100046|P6|Overall Study|Lost to Follow-up|3
336605|NCT00561015|1100047|P5|Overall Study|Lost to Follow-up|0
336606|NCT00561015|1100048|P4|Overall Study|Lost to Follow-up|1
336607|NCT00561015|1100049|P3|Overall Study|Lost to Follow-up|0
336608|NCT00561015|1100050|P2|Overall Study|Lost to Follow-up|0
336609|NCT00561015|1100051|P1|Overall Study|Lost to Follow-up|2
336610|NCT00561015|1100046|P6|Overall Study|Adverse Event|0
336611|NCT00561015|1100047|P5|Overall Study|Adverse Event|1
336612|NCT00561015|1100048|P4|Overall Study|Adverse Event|0
336613|NCT00561015|1100049|P3|Overall Study|Adverse Event|0
336614|NCT00561015|1100050|P2|Overall Study|Adverse Event|0
336615|NCT00561015|1100051|P1|Overall Study|Adverse Event|0
336616|NCT00560950|1100142|P2|Overall Study|Lost to Follow-up|0
336617|NCT00560950|1100143|P1|Overall Study|Lost to Follow-up|1
336618|NCT00560937|1100181|P2|Overall Study|Physician Decision|1
336619|NCT00560937|1100182|P1|Overall Study|Physician Decision|1
336620|NCT00560937|1100181|P2|Overall Study|Withdrawal by Subject|1
336621|NCT00560937|1100182|P1|Overall Study|Withdrawal by Subject|0
336622|NCT00560885|1100198|P1|Overall Study|Withdrawal by Subject|1
336623|NCT00560885|1100198|P1|Overall Study|Death|7
336624|NCT00560833|1100223|P5|Overall Study|Never received drug|1
336625|NCT00560833|1100224|P4|Overall Study|Never received drug|0
336626|NCT00560833|1100225|P3|Overall Study|Never received drug|0
336627|NCT00560833|1100226|P2|Overall Study|Never received drug|1
336628|NCT00560833|1100227|P1|Overall Study|Never received drug|0
336629|NCT00560833|1100223|P5|Overall Study|Unspecified|0
336630|NCT00560833|1100224|P4|Overall Study|Unspecified|0
336631|NCT00560833|1100225|P3|Overall Study|Unspecified|3
336632|NCT00560833|1100226|P2|Overall Study|Unspecified|1
336633|NCT00560833|1100227|P1|Overall Study|Unspecified|1
336634|NCT00560833|1100223|P5|Overall Study|Participant uncooperative|2
336635|NCT00560833|1100224|P4|Overall Study|Participant uncooperative|4
336636|NCT00560833|1100225|P3|Overall Study|Participant uncooperative|4
336637|NCT00560833|1100226|P2|Overall Study|Participant uncooperative|5
336638|NCT00560833|1100227|P1|Overall Study|Participant uncooperative|5
336639|NCT00560833|1100223|P5|Overall Study|Lack of Efficacy|4
336640|NCT00560833|1100224|P4|Overall Study|Lack of Efficacy|4
336641|NCT00560833|1100225|P3|Overall Study|Lack of Efficacy|6
336642|NCT00560833|1100226|P2|Overall Study|Lack of Efficacy|9
336643|NCT00560833|1100227|P1|Overall Study|Lack of Efficacy|22
336644|NCT00560833|1100223|P5|Overall Study|Lost to Follow-up|0
336645|NCT00560833|1100224|P4|Overall Study|Lost to Follow-up|0
336646|NCT00560833|1100225|P3|Overall Study|Lost to Follow-up|1
336647|NCT00560833|1100226|P2|Overall Study|Lost to Follow-up|0
336648|NCT00560833|1100227|P1|Overall Study|Lost to Follow-up|0
336649|NCT00560833|1100223|P5|Overall Study|Adverse Event|35
336650|NCT00560833|1100224|P4|Overall Study|Adverse Event|23
336651|NCT00560833|1100225|P3|Overall Study|Adverse Event|25
336652|NCT00560833|1100226|P2|Overall Study|Adverse Event|10
336653|NCT00560833|1100227|P1|Overall Study|Adverse Event|16
336654|NCT00560794|1100259|P1|Overall Study|Received Bone Marrow Transplant|6
336655|NCT00560794|1100259|P1|Overall Study|Hematological Relapse|1
336656|NCT00560794|1100259|P1|Overall Study|Minimal Residual Disease Relapse|1
336657|NCT00560794|1100259|P1|Overall Study|Patient was not Compliant|1
336658|NCT00560794|1100259|P1|Overall Study|Adverse Event|2
336659|NCT00560703|1100278|P2|Overall Study|non-compliance|1
336660|NCT00560703|1100279|P1|Overall Study|non-compliance|0
336661|NCT00560703|1100278|P2|Overall Study|Withdrawal by Subject|1
336662|NCT00560703|1100279|P1|Overall Study|Withdrawal by Subject|0
336663|NCT00560703|1100278|P2|Overall Study|Protocol Violation|2
336664|NCT00560703|1100279|P1|Overall Study|Protocol Violation|0
336665|NCT00560703|1100278|P2|Overall Study|Adverse Event|2
336666|NCT00560703|1100279|P1|Overall Study|Adverse Event|0
336667|NCT00560573|1100296|P6|Overall Study|Enrolled, not treated|0
336668|NCT00560573|1100297|P5|Overall Study|Enrolled, not treated|1
336669|NCT00560573|1100298|P4|Overall Study|Enrolled, not treated|0
336670|NCT00560573|1100299|P3|Overall Study|Enrolled, not treated|0
336671|NCT00560573|1100300|P2|Overall Study|Enrolled, not treated|0
336672|NCT00560573|1100301|P1|Overall Study|Enrolled, not treated|0
336673|NCT00560573|1100296|P6|Overall Study|Unspecified|3
336674|NCT00560573|1100297|P5|Overall Study|Unspecified|3
336675|NCT00560573|1100298|P4|Overall Study|Unspecified|3
336676|NCT00560573|1100299|P3|Overall Study|Unspecified|2
336677|NCT00560573|1100300|P2|Overall Study|Unspecified|2
336678|NCT00560573|1100301|P1|Overall Study|Unspecified|2
336679|NCT00560573|1100296|P6|Overall Study|Withdrawal by Subject|0
336680|NCT00560573|1100297|P5|Overall Study|Withdrawal by Subject|1
336681|NCT00560573|1100298|P4|Overall Study|Withdrawal by Subject|1
336682|NCT00560573|1100299|P3|Overall Study|Withdrawal by Subject|0
336683|NCT00560573|1100300|P2|Overall Study|Withdrawal by Subject|0
336684|NCT00560573|1100301|P1|Overall Study|Withdrawal by Subject|0
336685|NCT00560573|1100296|P6|Overall Study|Lost to Follow-up|0
336686|NCT00560573|1100297|P5|Overall Study|Lost to Follow-up|1
336687|NCT00560573|1100298|P4|Overall Study|Lost to Follow-up|1
336688|NCT00560573|1100299|P3|Overall Study|Lost to Follow-up|0
336689|NCT00560573|1100300|P2|Overall Study|Lost to Follow-up|0
336690|NCT00560573|1100301|P1|Overall Study|Lost to Follow-up|0
336691|NCT00560573|1100296|P6|Overall Study|Death|10
336692|NCT00560573|1100297|P5|Overall Study|Death|1
336693|NCT00560573|1100298|P4|Overall Study|Death|5
336694|NCT00560573|1100299|P3|Overall Study|Death|4
336695|NCT00560573|1100300|P2|Overall Study|Death|1
336696|NCT00560573|1100301|P1|Overall Study|Death|4
336697|NCT00560508|1100378|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
336698|NCT00560508|1100379|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
336699|NCT00560508|1100378|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
336700|NCT00560508|1100379|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
336701|NCT00560508|1100378|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
336702|NCT00560508|1100379|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
336703|NCT00560508|1100378|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
336704|NCT00560508|1100379|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
336705|NCT00560508|1100378|P2|12 Week Double-blind Period|Withdrawal by Subject|1
336706|NCT00560508|1100379|P1|12 Week Double-blind Period|Withdrawal by Subject|1
336707|NCT00560508|1100378|P2|12 Week Double-blind Period|Protocol Violation|0
336708|NCT00560508|1100379|P1|12 Week Double-blind Period|Protocol Violation|1
336709|NCT00560508|1100378|P2|12 Week Double-blind Period|Adverse Event|2
336710|NCT00560508|1100379|P1|12 Week Double-blind Period|Adverse Event|3
336711|NCT00560417|1100438|P2|Overall Study|Withdrawal by Subject|3
336712|NCT00560417|1100439|P1|Overall Study|Withdrawal by Subject|3
336713|NCT00560417|1100438|P2|Overall Study|Sponsor Decision|0
336714|NCT00560417|1100439|P1|Overall Study|Sponsor Decision|2
336715|NCT00560417|1100438|P2|Overall Study|Protocol Violation|5
336716|NCT00560417|1100439|P1|Overall Study|Protocol Violation|6
336717|NCT00560417|1100438|P2|Overall Study|Physician Decision|6
336718|NCT00560417|1100439|P1|Overall Study|Physician Decision|2
336719|NCT00560417|1100438|P2|Overall Study|Lost to Follow-up|1
336720|NCT00560417|1100439|P1|Overall Study|Lost to Follow-up|0
336721|NCT00560417|1100438|P2|Overall Study|Entry Criteria Not Met|0
336722|NCT00560417|1100439|P1|Overall Study|Entry Criteria Not Met|1
336723|NCT00560417|1100438|P2|Overall Study|Adverse Event|2
336724|NCT00560417|1100439|P1|Overall Study|Adverse Event|3
336725|NCT00560404|1100467|P2|Overall Study|Other withdrawal reason|5
336726|NCT00560404|1100468|P1|Overall Study|Other withdrawal reason|13
336727|NCT00560404|1100467|P2|Overall Study|Failure to return|2
336728|NCT00560404|1100468|P1|Overall Study|Failure to return|1
336729|NCT00560404|1100467|P2|Overall Study|Withdrew Consent|0
336730|NCT00560404|1100468|P1|Overall Study|Withdrew Consent|4
336731|NCT00560404|1100467|P2|Overall Study|Administrative Reasons|1
336732|NCT00560404|1100468|P1|Overall Study|Administrative Reasons|1
336733|NCT00560404|1100467|P2|Overall Study|Protocol Violation|7
336734|NCT00560404|1100468|P1|Overall Study|Protocol Violation|12
336735|NCT00560404|1100467|P2|Overall Study|Death|3
336736|NCT00560404|1100468|P1|Overall Study|Death|3
336737|NCT00560404|1100467|P2|Overall Study|Adverse Event|3
336738|NCT00560404|1100468|P1|Overall Study|Adverse Event|2
336739|NCT00560391|1100515|P5|Overall Study|Still on treatment|2
336740|NCT00560391|1100516|P4|Overall Study|Still on treatment|1
336741|NCT00560391|1100517|P3|Overall Study|Still on treatment|0
336742|NCT00560391|1100518|P2|Overall Study|Still on treatment|0
336743|NCT00560391|1100519|P1|Overall Study|Still on treatment|0
336744|NCT00560352|1100575|P3|Overall Study|Maximum clinical benefit|0
336745|NCT00560352|1100576|P2|Overall Study|Maximum clinical benefit|0
336746|NCT00560352|1100577|P1|Overall Study|Maximum clinical benefit|1
336747|NCT00560352|1100575|P3|Overall Study|Withdrawal by Subject|1
336748|NCT00560352|1100576|P2|Overall Study|Withdrawal by Subject|1
336749|NCT00560352|1100577|P1|Overall Study|Withdrawal by Subject|1
336750|NCT00560352|1100575|P3|Overall Study|Disease progression|1
336751|NCT00560352|1100576|P2|Overall Study|Disease progression|1
336752|NCT00560352|1100577|P1|Overall Study|Disease progression|0
336753|NCT00560352|1100575|P3|Overall Study|Study drug toxicity|1
336754|NCT00560352|1100576|P2|Overall Study|Study drug toxicity|0
336755|NCT00560352|1100577|P1|Overall Study|Study drug toxicity|3
336756|NCT00560352|1100575|P3|Overall Study|Adverse event unrelated to study drug|1
336757|NCT00560352|1100576|P2|Overall Study|Adverse event unrelated to study drug|1
336758|NCT00560352|1100577|P1|Overall Study|Adverse event unrelated to study drug|2
336759|NCT00560313|1100594|P1|Overall Study|Protocol Violation|1
336760|NCT00560313|1100594|P1|Overall Study|Lost to Follow-up|1
336761|NCT00560313|1100594|P1|Overall Study|Withdrawal by Subject|2
336762|NCT00560313|1100594|P1|Overall Study|Adverse Events or Death|2
336763|NCT00560235|1100621|P3|Phase 2|Ongoing at Date of Cut-Off|1
336764|NCT00560235|1100622|P2|Phase 2|Ongoing at Date of Cut-Off|0
336765|NCT00560235|1100623|P1|Phase 2|Ongoing at Date of Cut-Off|0
336766|NCT00560235|1100621|P3|Phase 2|Discontinued|96
336767|NCT00560235|1100622|P2|Phase 2|Discontinued|0
336768|NCT00560235|1100623|P1|Phase 2|Discontinued|0
336769|NCT00560235|1100621|P3|Phase 1B|Discontinued|0
336770|NCT00560235|1100622|P2|Phase 1B|Discontinued|19
336771|NCT00560235|1100623|P1|Phase 1B|Discontinued|0
336772|NCT00560235|1100621|P3|Phase 1|Discontinued|0
336773|NCT00560235|1100622|P2|Phase 1|Discontinued|0
336774|NCT00560235|1100623|P1|Phase 1|Discontinued|8
336775|NCT00560105|1100654|P2|Overall Study|musculoskeletal chest discomfort with us|2
336776|NCT00560105|1100655|P1|Overall Study|musculoskeletal chest discomfort with us|1
336777|NCT00560066|1100669|P2|Overall Study|Missing primary reason|2
336778|NCT00560066|1100670|P1|Overall Study|Missing primary reason|0
336779|NCT00560066|1100669|P2|Overall Study|Administrative reason|5
336780|NCT00560066|1100670|P1|Overall Study|Administrative reason|0
336781|NCT00560066|1100669|P2|Overall Study|Protocol Violation|1
336782|NCT00560066|1100670|P1|Overall Study|Protocol Violation|0
336783|NCT00560066|1100669|P2|Overall Study|Lost to Follow-up|10
336784|NCT00560066|1100670|P1|Overall Study|Lost to Follow-up|4
336785|NCT00560066|1100669|P2|Overall Study|Withdrawal by Subject|3
336786|NCT00560066|1100670|P1|Overall Study|Withdrawal by Subject|0
336787|NCT00560066|1100669|P2|Overall Study|Death|1
336788|NCT00560066|1100670|P1|Overall Study|Death|2
336789|NCT00559988|1100702|P2|Overall Study|ICD device explanted|17
336790|NCT00559988|1100703|P1|Overall Study|ICD device explanted|10
336791|NCT00559988|1100702|P2|Overall Study|Lost to Follow-up|56
336792|NCT00559988|1100703|P1|Overall Study|Lost to Follow-up|42
336793|NCT00559988|1100702|P2|Overall Study|Withdrawal by Subject|139
336794|NCT00559988|1100703|P1|Overall Study|Withdrawal by Subject|152
336795|NCT00559988|1100702|P2|Overall Study|Death|140
336796|NCT00559988|1100703|P1|Overall Study|Death|147
336797|NCT00559962|1100717|P8|Overall Study|Inclusion/exclusion criteria not met|0
336798|NCT00559962|1100718|P7|Overall Study|Inclusion/exclusion criteria not met|1
336799|NCT00559962|1100719|P6|Overall Study|Inclusion/exclusion criteria not met|0
336800|NCT00559962|1100720|P5|Overall Study|Inclusion/exclusion criteria not met|0
336801|NCT00559962|1100721|P4|Overall Study|Inclusion/exclusion criteria not met|0
336802|NCT00559962|1100722|P3|Overall Study|Inclusion/exclusion criteria not met|0
336803|NCT00559962|1100723|P2|Overall Study|Inclusion/exclusion criteria not met|0
336804|NCT00559962|1100724|P1|Overall Study|Inclusion/exclusion criteria not met|0
336805|NCT00559962|1100717|P8|Overall Study|Withdrawal by Subject|2
336806|NCT00559962|1100718|P7|Overall Study|Withdrawal by Subject|0
336807|NCT00559962|1100719|P6|Overall Study|Withdrawal by Subject|1
336808|NCT00559962|1100720|P5|Overall Study|Withdrawal by Subject|3
336809|NCT00559962|1100721|P4|Overall Study|Withdrawal by Subject|0
336810|NCT00559962|1100722|P3|Overall Study|Withdrawal by Subject|2
336811|NCT00559962|1100723|P2|Overall Study|Withdrawal by Subject|1
336812|NCT00559962|1100724|P1|Overall Study|Withdrawal by Subject|1
336813|NCT00559962|1100717|P8|Overall Study|Lost to Follow-up|0
336814|NCT00559962|1100718|P7|Overall Study|Lost to Follow-up|0
336815|NCT00559962|1100719|P6|Overall Study|Lost to Follow-up|0
336816|NCT00559962|1100720|P5|Overall Study|Lost to Follow-up|0
336817|NCT00559962|1100721|P4|Overall Study|Lost to Follow-up|0
336818|NCT00559962|1100722|P3|Overall Study|Lost to Follow-up|0
336819|NCT00559962|1100723|P2|Overall Study|Lost to Follow-up|1
336820|NCT00559962|1100724|P1|Overall Study|Lost to Follow-up|0
336821|NCT00559962|1100717|P8|Overall Study|Adverse Event|2
336822|NCT00559962|1100718|P7|Overall Study|Adverse Event|4
336823|NCT00559962|1100719|P6|Overall Study|Adverse Event|4
336824|NCT00559962|1100720|P5|Overall Study|Adverse Event|11
336825|NCT00559962|1100721|P4|Overall Study|Adverse Event|5
336826|NCT00559962|1100722|P3|Overall Study|Adverse Event|8
336827|NCT00559962|1100723|P2|Overall Study|Adverse Event|7
336828|NCT00559962|1100724|P1|Overall Study|Adverse Event|1
336829|NCT00559949|1100744|P1|Overall Study|No disease evaluation per protocol|1
336830|NCT00559949|1100744|P1|Overall Study|Withdrawal by Subject|4
336831|NCT00559949|1100744|P1|Overall Study|Adverse Event|1
336832|NCT00559949|1100744|P1|Overall Study|Progressive Disease during cycle 1|1
336833|NCT00559754|1100760|P1|Overall Study|Withdrawal by Subject|2
336834|NCT00559754|1100760|P1|Overall Study|Investigator criteria|2
336835|NCT00559754|1100760|P1|Overall Study|Protocol Violation|1
336836|NCT00559754|1100760|P1|Overall Study|Adverse Event|5
336837|NCT00559754|1100760|P1|Overall Study|Disease progression|1
336838|NCT00559637|1100784|P1|Overall Study|Inclusion or exclusion criteria violated|2
336839|NCT00559637|1100784|P1|Overall Study|Change of home|1
336840|NCT00559637|1100784|P1|Overall Study|Change of center|1
336841|NCT00559637|1100784|P1|Overall Study|Delayed administration of C.E.R.A|1
336842|NCT00559637|1100784|P1|Overall Study|Participation in another study|1
336843|NCT00559637|1100784|P1|Overall Study|Suspected lung cancer|1
336844|NCT00559637|1100784|P1|Overall Study|Started requiring dialysis after month 7|2
336845|NCT00559637|1100784|P1|Overall Study|Insufficient response|3
336846|NCT00559637|1100784|P1|Overall Study|Failure to return|6
336847|NCT00559637|1100784|P1|Overall Study|Withdrawal criteria fulfilled|4
336848|NCT00559637|1100784|P1|Overall Study|Protocol Violation|6
336849|NCT00559637|1100784|P1|Overall Study|Withdrawal by Subject|4
336850|NCT00559637|1100784|P1|Overall Study|Adverse Event|22
336851|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
336852|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
336853|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|non-specified|0
336854|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|non-specified|71
336855|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
336856|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
336857|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
336858|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
336859|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
336860|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
336861|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|Death|0
336862|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|Death|20
336863|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
336864|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
336865|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
336866|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
336867|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
336868|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
336869|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
336870|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
336871|NCT00559585|1100797|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
336872|NCT00559585|1100798|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
336873|NCT00559585|1100797|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
336874|NCT00559585|1100798|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
336875|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
336876|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
336877|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Investigator Decision|1
336878|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Investigator Decision|0
336879|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
336880|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
336881|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
336882|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
336883|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Early Discontinuation|1
336884|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Early Discontinuation|0
336885|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
336886|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
336887|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
336888|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
336889|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Missed Doses|1
336890|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Missed Doses|0
336891|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
336892|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
336893|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
336894|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
336895|NCT00559585|1100797|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
336896|NCT00559585|1100798|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
336897|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Death|1
336898|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Death|1
336899|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
336900|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
336901|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
336902|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
336903|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
336904|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
336905|NCT00559585|1100797|P2|Double Blind ST Period Main Study|Adverse Event|25
336906|NCT00559585|1100798|P1|Double Blind ST Period Main Study|Adverse Event|17
336907|NCT00559507|1100858|P1|Overall Study|Not treated, patient ineligible|3
336908|NCT00559377|1100864|P1|Overall Study|Withdrawal by Subject|9
336909|NCT00559364|1100874|P2|Overall Study|Inclusion/exclusion criteria failure|0
336910|NCT00559364|1100875|P1|Overall Study|Inclusion/exclusion criteria failure|1
336911|NCT00559273|1100887|P2|Evaluation Period (8 Weeks)|Physician Decision|1
336912|NCT00559273|1100888|P1|Evaluation Period (8 Weeks)|Physician Decision|0
336913|NCT00559273|1100887|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
336914|NCT00559273|1100888|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
336915|NCT00559273|1100887|P2|Evaluation Period (8 Weeks)|Adverse Event|1
336916|NCT00559273|1100888|P1|Evaluation Period (8 Weeks)|Adverse Event|0
336917|NCT00559273|1100887|P2|Evaluation Period (8 Weeks)|Death|3
336918|NCT00559273|1100888|P1|Evaluation Period (8 Weeks)|Death|1
336919|NCT00559273|1100887|P2|Correction Period (20 Weeks)|Did not received study treatment|0
336920|NCT00559273|1100888|P1|Correction Period (20 Weeks)|Did not received study treatment|2
336921|NCT00559273|1100887|P2|Correction Period (20 Weeks)|Participant treated by another center|1
336922|NCT00559273|1100888|P1|Correction Period (20 Weeks)|Participant treated by another center|0
336923|NCT00559273|1100887|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
336924|NCT00559273|1100888|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
336925|NCT00559273|1100887|P2|Correction Period (20 Weeks)|Adverse Event|1
336926|NCT00559273|1100888|P1|Correction Period (20 Weeks)|Adverse Event|2
336927|NCT00559273|1100887|P2|Correction Period (20 Weeks)|Death|4
336928|NCT00559273|1100888|P1|Correction Period (20 Weeks)|Death|3
336929|NCT00559104|1100910|P2|Overall Study|Lack of Efficacy|0
336930|NCT00559104|1100911|P1|Overall Study|Lack of Efficacy|9
336931|NCT00558896|1100932|P7|Overall Study|Continues on treatment|6
336932|NCT00558896|1100933|P6|Overall Study|Continues on treatment|25
336933|NCT00558896|1100934|P5|Overall Study|Continues on treatment|9
336934|NCT00558896|1100935|P4|Overall Study|Continues on treatment|1
336935|NCT00558896|1100936|P3|Overall Study|Continues on treatment|0
336936|NCT00558896|1100937|P2|Overall Study|Continues on treatment|1
336937|NCT00558896|1100938|P1|Overall Study|Continues on treatment|10
336938|NCT00558896|1100932|P7|Overall Study|Physician discretion|3
336939|NCT00558896|1100933|P6|Overall Study|Physician discretion|3
336940|NCT00558896|1100934|P5|Overall Study|Physician discretion|1
336941|NCT00558896|1100935|P4|Overall Study|Physician discretion|2
336942|NCT00558896|1100936|P3|Overall Study|Physician discretion|1
336943|NCT00558896|1100937|P2|Overall Study|Physician discretion|2
336944|NCT00558896|1100938|P1|Overall Study|Physician discretion|3
336945|NCT00558896|1100932|P7|Overall Study|Alternative Treatment|1
336946|NCT00558896|1100933|P6|Overall Study|Alternative Treatment|7
336947|NCT00558896|1100934|P5|Overall Study|Alternative Treatment|6
336948|NCT00558896|1100935|P4|Overall Study|Alternative Treatment|2
336949|NCT00558896|1100936|P3|Overall Study|Alternative Treatment|0
336950|NCT00558896|1100937|P2|Overall Study|Alternative Treatment|2
336951|NCT00558896|1100938|P1|Overall Study|Alternative Treatment|2
336952|NCT00558896|1100932|P7|Overall Study|Withdrawal by Subject|5
336953|NCT00558896|1100933|P6|Overall Study|Withdrawal by Subject|5
336954|NCT00558896|1100934|P5|Overall Study|Withdrawal by Subject|1
336955|NCT00558896|1100935|P4|Overall Study|Withdrawal by Subject|1
336956|NCT00558896|1100936|P3|Overall Study|Withdrawal by Subject|1
336957|NCT00558896|1100937|P2|Overall Study|Withdrawal by Subject|1
336958|NCT00558896|1100938|P1|Overall Study|Withdrawal by Subject|2
336959|NCT00558896|1100932|P7|Overall Study|Death|6
336960|NCT00558896|1100933|P6|Overall Study|Death|2
336961|NCT00558896|1100934|P5|Overall Study|Death|2
336962|NCT00558896|1100935|P4|Overall Study|Death|3
336963|NCT00558896|1100936|P3|Overall Study|Death|2
336964|NCT00558896|1100937|P2|Overall Study|Death|0
336965|NCT00558896|1100938|P1|Overall Study|Death|3
336966|NCT00558896|1100932|P7|Overall Study|Adverse Event|3
336967|NCT00558896|1100933|P6|Overall Study|Adverse Event|10
336968|NCT00558896|1100934|P5|Overall Study|Adverse Event|4
336969|NCT00558896|1100935|P4|Overall Study|Adverse Event|3
336970|NCT00558896|1100936|P3|Overall Study|Adverse Event|1
336971|NCT00558896|1100937|P2|Overall Study|Adverse Event|1
336972|NCT00558896|1100938|P1|Overall Study|Adverse Event|1
336973|NCT00558831|1100979|P1|Overall Study|Lost to Follow-up|1
336974|NCT00558753|1101036|P2|Overall Study|Lost to Follow-up|7
336975|NCT00558753|1101037|P1|Overall Study|Lost to Follow-up|5
336976|NCT00558701|1101049|P2|Overall Study|Protocol Deviations|4
336977|NCT00558701|1101050|P1|Overall Study|Protocol Deviations|1
336978|NCT00558636|1101058|P2|Follow-up|Premature termination of the study|7
336979|NCT00558636|1101059|P1|Follow-up|Premature termination of the study|12
336980|NCT00558636|1101058|P2|Treatment|Disease progression|5
336981|NCT00558636|1101059|P1|Treatment|Disease progression|1
336982|NCT00558636|1101058|P2|Treatment|Premature termination of the study|37
336983|NCT00558636|1101059|P1|Treatment|Premature termination of the study|35
336984|NCT00558636|1101058|P2|Treatment|Withdrawal by Subject|0
336985|NCT00558636|1101059|P1|Treatment|Withdrawal by Subject|2
336986|NCT00558636|1101058|P2|Treatment|Adverse Event|2
336987|NCT00558636|1101059|P1|Treatment|Adverse Event|9
336988|NCT00558558|1101159|P1|Overall Study|Lack of Efficacy|4
336989|NCT00558558|1101159|P1|Overall Study|Withdrawal by Subject|1
336990|NCT00558558|1101159|P1|Overall Study|Unable to swallow|1
336991|NCT00558467|1101165|P2|Overall Study|Patient moving out of state|1
336992|NCT00558467|1101166|P1|Overall Study|Patient moving out of state|0
336993|NCT00558467|1101165|P2|Overall Study|Lack of Efficacy|1
336994|NCT00558467|1101166|P1|Overall Study|Lack of Efficacy|0
336995|NCT00558467|1101165|P2|Overall Study|Adverse Event|2
336996|NCT00558467|1101166|P1|Overall Study|Adverse Event|1
336997|NCT00558428|1101226|P4|Overall Study|Other|1
336998|NCT00558428|1101227|P3|Overall Study|Other|0
336999|NCT00558428|1101228|P2|Overall Study|Other|0
337000|NCT00558428|1101229|P1|Overall Study|Other|3
337001|NCT00558428|1101226|P4|Overall Study|Consent withdrawn|1
337002|NCT00558428|1101227|P3|Overall Study|Consent withdrawn|0
337003|NCT00558428|1101228|P2|Overall Study|Consent withdrawn|1
337004|NCT00558428|1101229|P1|Overall Study|Consent withdrawn|2
337005|NCT00558428|1101226|P4|Overall Study|Non compliant with protocol|3
337006|NCT00558428|1101227|P3|Overall Study|Non compliant with protocol|0
337007|NCT00558428|1101228|P2|Overall Study|Non compliant with protocol|0
337008|NCT00558428|1101229|P1|Overall Study|Non compliant with protocol|1
337009|NCT00558428|1101226|P4|Overall Study|Lack of Efficacy|2
337010|NCT00558428|1101227|P3|Overall Study|Lack of Efficacy|1
337011|NCT00558428|1101228|P2|Overall Study|Lack of Efficacy|0
337012|NCT00558428|1101229|P1|Overall Study|Lack of Efficacy|0
337013|NCT00558428|1101226|P4|Overall Study|Lost to Follow-up|0
337014|NCT00558428|1101227|P3|Overall Study|Lost to Follow-up|0
337015|NCT00558428|1101228|P2|Overall Study|Lost to Follow-up|1
337016|NCT00558428|1101229|P1|Overall Study|Lost to Follow-up|0
337017|NCT00558428|1101226|P4|Overall Study|Adverse Event|4
337018|NCT00558428|1101227|P3|Overall Study|Adverse Event|3
337019|NCT00558428|1101228|P2|Overall Study|Adverse Event|22
337020|NCT00558428|1101229|P1|Overall Study|Adverse Event|6
337021|NCT00558363|1101269|P2|Overall Study|Hospitalized; Unable to Continue|1
337022|NCT00558363|1101270|P1|Overall Study|Hospitalized; Unable to Continue|0
337023|NCT00558363|1101269|P2|Overall Study|Randomized in Error|2
337024|NCT00558363|1101270|P1|Overall Study|Randomized in Error|1
337025|NCT00558363|1101269|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
337026|NCT00558363|1101270|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
337027|NCT00558363|1101269|P2|Overall Study|Lost to Follow-up|1
337028|NCT00558363|1101270|P1|Overall Study|Lost to Follow-up|0
337029|NCT00558363|1101269|P2|Overall Study|Protocol Violation|1
337030|NCT00558363|1101270|P1|Overall Study|Protocol Violation|2
337031|NCT00558363|1101269|P2|Overall Study|Lack of Efficacy|2
337032|NCT00558363|1101270|P1|Overall Study|Lack of Efficacy|2
337033|NCT00558363|1101269|P2|Overall Study|Adverse Event|5
337034|NCT00558363|1101270|P1|Overall Study|Adverse Event|5
337035|NCT00558363|1101269|P2|Overall Study|Withdrawal by Subject|4
337036|NCT00558363|1101270|P1|Overall Study|Withdrawal by Subject|11
337037|NCT00558363|1101269|P2|Overall Study|Physician Decision|4
337038|NCT00558363|1101270|P1|Overall Study|Physician Decision|18
337039|NCT00558285|1101325|P5|Overall Study|Protocol deviation|0
337040|NCT00558285|1101326|P4|Overall Study|Protocol deviation|1
337041|NCT00558285|1101327|P3|Overall Study|Protocol deviation|0
337042|NCT00558285|1101328|P2|Overall Study|Protocol deviation|1
337043|NCT00558285|1101329|P1|Overall Study|Protocol deviation|1
337044|NCT00558285|1101325|P5|Overall Study|Administrative problems|1
337045|NCT00558285|1101326|P4|Overall Study|Administrative problems|1
337046|NCT00558285|1101327|P3|Overall Study|Administrative problems|0
337047|NCT00558285|1101328|P2|Overall Study|Administrative problems|0
337048|NCT00558285|1101329|P1|Overall Study|Administrative problems|0
337049|NCT00558285|1101325|P5|Overall Study|Lost to Follow-up|0
337050|NCT00558285|1101326|P4|Overall Study|Lost to Follow-up|0
337051|NCT00558285|1101327|P3|Overall Study|Lost to Follow-up|0
337052|NCT00558285|1101328|P2|Overall Study|Lost to Follow-up|1
337053|NCT00558285|1101329|P1|Overall Study|Lost to Follow-up|1
337054|NCT00558285|1101325|P5|Overall Study|Subject withdrew consent|1
337055|NCT00558285|1101326|P4|Overall Study|Subject withdrew consent|1
337056|NCT00558285|1101327|P3|Overall Study|Subject withdrew consent|1
337057|NCT00558285|1101328|P2|Overall Study|Subject withdrew consent|0
337058|NCT00558285|1101329|P1|Overall Study|Subject withdrew consent|2
337059|NCT00558285|1101325|P5|Overall Study|Abnormal test procedure result(s)|0
337060|NCT00558285|1101326|P4|Overall Study|Abnormal test procedure result(s)|0
337061|NCT00558285|1101327|P3|Overall Study|Abnormal test procedure result(s)|0
337062|NCT00558285|1101328|P2|Overall Study|Abnormal test procedure result(s)|0
337063|NCT00558285|1101329|P1|Overall Study|Abnormal test procedure result(s)|1
337064|NCT00558285|1101325|P5|Overall Study|Adverse Event|2
337065|NCT00558285|1101326|P4|Overall Study|Adverse Event|1
337066|NCT00558285|1101327|P3|Overall Study|Adverse Event|4
337067|NCT00558285|1101328|P2|Overall Study|Adverse Event|1
337068|NCT00558285|1101329|P1|Overall Study|Adverse Event|1
337069|NCT00558272|1101373|P2|Overall Study|Withdrawal by Subject|1
337070|NCT00558272|1101374|P1|Overall Study|Withdrawal by Subject|0
337071|NCT00558272|1101373|P2|Overall Study|Incorrectly enrolled|0
337072|NCT00558272|1101374|P1|Overall Study|Incorrectly enrolled|1
337073|NCT00558272|1101373|P2|Overall Study|AZ study team decision|1
337074|NCT00558272|1101374|P1|Overall Study|AZ study team decision|0
337075|NCT00558272|1101373|P2|Overall Study|Dev. of study specific discon. criteria|0
337076|NCT00558272|1101374|P1|Overall Study|Dev. of study specific discon. criteria|1
337077|NCT00558272|1101373|P2|Overall Study|Death|0
337078|NCT00558272|1101374|P1|Overall Study|Death|1
337079|NCT00558272|1101373|P2|Overall Study|Adverse Event|0
337080|NCT00558272|1101374|P1|Overall Study|Adverse Event|10
337081|NCT00558259|1101414|P2|Overall Study|Withdrawal by Subject|13
337082|NCT00558259|1101415|P1|Overall Study|Withdrawal by Subject|12
337083|NCT00558259|1101414|P2|Overall Study|Protocol Violation|5
337084|NCT00558259|1101415|P1|Overall Study|Protocol Violation|9
337085|NCT00558259|1101414|P2|Overall Study|Adverse Event|81
337086|NCT00558259|1101415|P1|Overall Study|Adverse Event|50
337087|NCT00558103|1101455|P6|Monotherapy Extension Phase|Disease Progression|8
337088|NCT00558103|1101456|P5|Monotherapy Extension Phase|Disease Progression|0
337089|NCT00558103|1101457|P4|Monotherapy Extension Phase|Disease Progression|0
337090|NCT00558103|1101458|P3|Monotherapy Extension Phase|Disease Progression|0
337091|NCT00558103|1101459|P2|Monotherapy Extension Phase|Disease Progression|0
337092|NCT00558103|1101460|P1|Monotherapy Extension Phase|Disease Progression|0
337093|NCT00558103|1101455|P6|Monotherapy Extension Phase|Protocol Violation|1
337094|NCT00558103|1101456|P5|Monotherapy Extension Phase|Protocol Violation|0
337095|NCT00558103|1101457|P4|Monotherapy Extension Phase|Protocol Violation|0
337096|NCT00558103|1101458|P3|Monotherapy Extension Phase|Protocol Violation|0
337097|NCT00558103|1101459|P2|Monotherapy Extension Phase|Protocol Violation|0
337098|NCT00558103|1101460|P1|Monotherapy Extension Phase|Protocol Violation|0
337099|NCT00558103|1101455|P6|Randomized Treatment Phase|Adverse Event|0
337100|NCT00558103|1101456|P5|Randomized Treatment Phase|Adverse Event|1
337101|NCT00558103|1101457|P4|Randomized Treatment Phase|Adverse Event|1
337102|NCT00558103|1101458|P3|Randomized Treatment Phase|Adverse Event|0
337103|NCT00558103|1101459|P2|Randomized Treatment Phase|Adverse Event|0
337104|NCT00558103|1101460|P1|Randomized Treatment Phase|Adverse Event|0
337105|NCT00558103|1101455|P6|Randomized Treatment Phase|Disease Progression|0
337106|NCT00558103|1101456|P5|Randomized Treatment Phase|Disease Progression|0
337107|NCT00558103|1101457|P4|Randomized Treatment Phase|Disease Progression|0
337108|NCT00558103|1101458|P3|Randomized Treatment Phase|Disease Progression|1
337109|NCT00558103|1101459|P2|Randomized Treatment Phase|Disease Progression|0
337110|NCT00558103|1101460|P1|Randomized Treatment Phase|Disease Progression|1
337111|NCT00558103|1101455|P6|Randomized Treatment Phase|Withdrawal by Subject|0
337112|NCT00558103|1101456|P5|Randomized Treatment Phase|Withdrawal by Subject|1
337113|NCT00558103|1101457|P4|Randomized Treatment Phase|Withdrawal by Subject|0
337114|NCT00558103|1101458|P3|Randomized Treatment Phase|Withdrawal by Subject|0
337115|NCT00558103|1101459|P2|Randomized Treatment Phase|Withdrawal by Subject|2
337116|NCT00558103|1101460|P1|Randomized Treatment Phase|Withdrawal by Subject|2
337117|NCT00558103|1101455|P6|Randomized Treatment Phase|Lost to Follow-up|0
337118|NCT00558103|1101456|P5|Randomized Treatment Phase|Lost to Follow-up|3
337119|NCT00558103|1101457|P4|Randomized Treatment Phase|Lost to Follow-up|1
337120|NCT00558103|1101458|P3|Randomized Treatment Phase|Lost to Follow-up|2
337121|NCT00558103|1101459|P2|Randomized Treatment Phase|Lost to Follow-up|2
337122|NCT00558103|1101460|P1|Randomized Treatment Phase|Lost to Follow-up|2
337123|NCT00558064|1101490|P2|Overall Study|No visit within allowance period|0
337124|NCT00558064|1101491|P1|Overall Study|No visit within allowance period|1
337125|NCT00558064|1101490|P2|Overall Study|Withdrawal by Subject|1
337126|NCT00558064|1101491|P1|Overall Study|Withdrawal by Subject|0
337127|NCT00558064|1101490|P2|Overall Study|Lost to Follow-up|1
337128|NCT00558064|1101491|P1|Overall Study|Lost to Follow-up|0
337129|NCT00558064|1101490|P2|Overall Study|Protocol Violation|0
337130|NCT00558064|1101491|P1|Overall Study|Protocol Violation|1
337131|NCT00558064|1101490|P2|Overall Study|Lack of Efficacy|1
337132|NCT00558064|1101491|P1|Overall Study|Lack of Efficacy|0
337133|NCT00558064|1101490|P2|Overall Study|Adverse Event|2
337134|NCT00558064|1101491|P1|Overall Study|Adverse Event|3
337135|NCT00558025|1101513|P2|Overall Study|Protocol Violation|0
337136|NCT00558025|1101514|P1|Overall Study|Protocol Violation|1
337137|NCT00558025|1101513|P2|Overall Study|Withdrawal by Subject|2
337138|NCT00558025|1101514|P1|Overall Study|Withdrawal by Subject|2
337139|NCT00558025|1101513|P2|Overall Study|Adverse Event|1
337140|NCT00558025|1101514|P1|Overall Study|Adverse Event|1
337141|NCT00557856|1101561|P9|Part 2: Exploratory Phase|global deterioration of health status|1
337142|NCT00557856|1101562|P8|Part 2: Exploratory Phase|global deterioration of health status|0
337143|NCT00557856|1101563|P7|Part 2: Exploratory Phase|global deterioration of health status|0
337144|NCT00557856|1101564|P6|Part 2: Exploratory Phase|global deterioration of health status|0
337145|NCT00557856|1101565|P5|Part 2: Exploratory Phase|global deterioration of health status|0
337146|NCT00557856|1101566|P4|Part 2: Exploratory Phase|global deterioration of health status|0
337147|NCT00557856|1101567|P3|Part 2: Exploratory Phase|global deterioration of health status|0
337148|NCT00557856|1101568|P2|Part 2: Exploratory Phase|global deterioration of health status|0
337149|NCT00557856|1101569|P1|Part 2: Exploratory Phase|global deterioration of health status|0
337150|NCT00557856|1101561|P9|Part 2: Exploratory Phase|Death|2
337151|NCT00557856|1101562|P8|Part 2: Exploratory Phase|Death|0
337152|NCT00557856|1101563|P7|Part 2: Exploratory Phase|Death|0
337153|NCT00557856|1101564|P6|Part 2: Exploratory Phase|Death|0
337154|NCT00557856|1101565|P5|Part 2: Exploratory Phase|Death|0
337155|NCT00557856|1101566|P4|Part 2: Exploratory Phase|Death|0
337156|NCT00557856|1101567|P3|Part 2: Exploratory Phase|Death|0
337157|NCT00557856|1101568|P2|Part 2: Exploratory Phase|Death|0
337158|NCT00557856|1101569|P1|Part 2: Exploratory Phase|Death|0
337159|NCT00557856|1101561|P9|Part 2: Exploratory Phase|unspecified|1
337160|NCT00557856|1101562|P8|Part 2: Exploratory Phase|unspecified|0
337161|NCT00557856|1101563|P7|Part 2: Exploratory Phase|unspecified|0
337162|NCT00557856|1101564|P6|Part 2: Exploratory Phase|unspecified|0
337163|NCT00557856|1101565|P5|Part 2: Exploratory Phase|unspecified|0
337164|NCT00557856|1101566|P4|Part 2: Exploratory Phase|unspecified|0
337165|NCT00557856|1101567|P3|Part 2: Exploratory Phase|unspecified|0
337166|NCT00557856|1101568|P2|Part 2: Exploratory Phase|unspecified|0
337167|NCT00557856|1101569|P1|Part 2: Exploratory Phase|unspecified|0
337168|NCT00557856|1101561|P9|Part 2: Exploratory Phase|Adverse Event|4
337169|NCT00557856|1101562|P8|Part 2: Exploratory Phase|Adverse Event|0
337170|NCT00557856|1101563|P7|Part 2: Exploratory Phase|Adverse Event|0
337171|NCT00557856|1101564|P6|Part 2: Exploratory Phase|Adverse Event|0
337172|NCT00557856|1101565|P5|Part 2: Exploratory Phase|Adverse Event|0
337173|NCT00557856|1101566|P4|Part 2: Exploratory Phase|Adverse Event|0
337174|NCT00557856|1101567|P3|Part 2: Exploratory Phase|Adverse Event|0
337175|NCT00557856|1101568|P2|Part 2: Exploratory Phase|Adverse Event|0
337176|NCT00557856|1101569|P1|Part 2: Exploratory Phase|Adverse Event|0
337177|NCT00557856|1101561|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
337178|NCT00557856|1101562|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
337179|NCT00557856|1101563|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
337180|NCT00557856|1101564|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
337181|NCT00557856|1101565|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
337182|NCT00557856|1101566|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
337183|NCT00557856|1101567|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
337184|NCT00557856|1101568|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
337185|NCT00557856|1101569|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
337186|NCT00557856|1101561|P9|Part 2: Exploratory Phase|objective progression or relapse|15
337187|NCT00557856|1101562|P8|Part 2: Exploratory Phase|objective progression or relapse|0
337188|NCT00557856|1101563|P7|Part 2: Exploratory Phase|objective progression or relapse|0
337189|NCT00557856|1101564|P6|Part 2: Exploratory Phase|objective progression or relapse|0
337190|NCT00557856|1101565|P5|Part 2: Exploratory Phase|objective progression or relapse|0
337191|NCT00557856|1101566|P4|Part 2: Exploratory Phase|objective progression or relapse|0
337192|NCT00557856|1101567|P3|Part 2: Exploratory Phase|objective progression or relapse|0
337193|NCT00557856|1101568|P2|Part 2: Exploratory Phase|objective progression or relapse|0
337194|NCT00557856|1101569|P1|Part 2: Exploratory Phase|objective progression or relapse|0
337195|NCT00557856|1101561|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
337196|NCT00557856|1101562|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
337197|NCT00557856|1101563|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
337198|NCT00557856|1101564|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
337199|NCT00557856|1101565|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
337200|NCT00557856|1101566|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
337201|NCT00557856|1101567|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
337202|NCT00557856|1101568|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
337203|NCT00557856|1101569|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
337204|NCT00557856|1101561|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
337205|NCT00557856|1101562|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
337206|NCT00557856|1101563|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
337207|NCT00557856|1101564|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
337208|NCT00557856|1101565|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
337209|NCT00557856|1101566|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
337210|NCT00557856|1101567|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
337211|NCT00557856|1101568|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
337212|NCT00557856|1101569|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
337213|NCT00557856|1101561|P9|Part 1: Dose Escalation Phase|Death|0
337214|NCT00557856|1101562|P8|Part 1: Dose Escalation Phase|Death|0
337215|NCT00557856|1101563|P7|Part 1: Dose Escalation Phase|Death|0
337216|NCT00557856|1101564|P6|Part 1: Dose Escalation Phase|Death|1
337217|NCT00557856|1101565|P5|Part 1: Dose Escalation Phase|Death|0
337218|NCT00557856|1101566|P4|Part 1: Dose Escalation Phase|Death|0
337219|NCT00557856|1101567|P3|Part 1: Dose Escalation Phase|Death|0
337220|NCT00557856|1101568|P2|Part 1: Dose Escalation Phase|Death|0
337221|NCT00557856|1101569|P1|Part 1: Dose Escalation Phase|Death|0
337222|NCT00557856|1101561|P9|Part 1: Dose Escalation Phase|unspecified|0
337223|NCT00557856|1101562|P8|Part 1: Dose Escalation Phase|unspecified|1
337224|NCT00557856|1101563|P7|Part 1: Dose Escalation Phase|unspecified|0
337225|NCT00557856|1101564|P6|Part 1: Dose Escalation Phase|unspecified|0
337226|NCT00557856|1101565|P5|Part 1: Dose Escalation Phase|unspecified|0
337227|NCT00557856|1101566|P4|Part 1: Dose Escalation Phase|unspecified|1
337228|NCT00557856|1101567|P3|Part 1: Dose Escalation Phase|unspecified|1
337229|NCT00557856|1101568|P2|Part 1: Dose Escalation Phase|unspecified|0
337230|NCT00557856|1101569|P1|Part 1: Dose Escalation Phase|unspecified|0
337231|NCT00557856|1101561|P9|Part 1: Dose Escalation Phase|Adverse Event|0
337232|NCT00557856|1101562|P8|Part 1: Dose Escalation Phase|Adverse Event|2
337233|NCT00557856|1101563|P7|Part 1: Dose Escalation Phase|Adverse Event|1
337234|NCT00557856|1101564|P6|Part 1: Dose Escalation Phase|Adverse Event|3
337235|NCT00557856|1101565|P5|Part 1: Dose Escalation Phase|Adverse Event|1
337236|NCT00557856|1101566|P4|Part 1: Dose Escalation Phase|Adverse Event|1
337237|NCT00557856|1101567|P3|Part 1: Dose Escalation Phase|Adverse Event|1
337238|NCT00557856|1101568|P2|Part 1: Dose Escalation Phase|Adverse Event|0
337239|NCT00557856|1101569|P1|Part 1: Dose Escalation Phase|Adverse Event|1
337240|NCT00557856|1101561|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
337241|NCT00557856|1101562|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
337242|NCT00557856|1101563|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
337243|NCT00557856|1101564|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
337244|NCT00557856|1101565|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
337245|NCT00557856|1101566|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
337246|NCT00557856|1101567|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
337247|NCT00557856|1101568|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
337248|NCT00557856|1101569|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
337249|NCT00557856|1101561|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
337250|NCT00557856|1101562|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
337251|NCT00557856|1101563|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
337252|NCT00557856|1101564|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
337253|NCT00557856|1101565|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
337254|NCT00557856|1101566|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
337255|NCT00557856|1101567|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
337256|NCT00557856|1101568|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
337257|NCT00557856|1101569|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
337258|NCT00557830|1101768|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
337259|NCT00557830|1101769|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
337260|NCT00557830|1101770|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
337261|NCT00557830|1101768|P3|Screening Treatment Phase|Adverse Event|0
337262|NCT00557830|1101769|P2|Screening Treatment Phase|Adverse Event|0
337263|NCT00557830|1101770|P1|Screening Treatment Phase|Adverse Event|2
337264|NCT00557830|1101768|P3|Screening Treatment Phase|Withdrawal by Subject|0
337265|NCT00557830|1101769|P2|Screening Treatment Phase|Withdrawal by Subject|0
337266|NCT00557830|1101770|P1|Screening Treatment Phase|Withdrawal by Subject|1
337267|NCT00556712|1101792|P2|Overall Study|Ongoing at Data Cutoff|66
337268|NCT00556712|1101793|P1|Overall Study|Ongoing at Data Cutoff|32
337269|NCT00556712|1101792|P2|Overall Study|Not Specified|2
337270|NCT00556712|1101793|P1|Overall Study|Not Specified|2
337271|NCT00556712|1101792|P2|Overall Study|Failure to Return|3
337272|NCT00556712|1101793|P1|Overall Study|Failure to Return|2
337273|NCT00556712|1101792|P2|Overall Study|Refused Treatment|16
337274|NCT00556712|1101793|P1|Overall Study|Refused Treatment|17
337275|NCT00556712|1101792|P2|Overall Study|Protocol Violation|2
337276|NCT00556712|1101793|P1|Overall Study|Protocol Violation|3
337277|NCT00556712|1101792|P2|Overall Study|Progressive Disease|320
337278|NCT00556712|1101793|P1|Overall Study|Progressive Disease|383
337279|NCT00556712|1101792|P2|Overall Study|Death|10
337280|NCT00556712|1101793|P1|Overall Study|Death|5
337281|NCT00556712|1101792|P2|Overall Study|Adverse Event|19
337282|NCT00556712|1101793|P1|Overall Study|Adverse Event|7
337283|NCT00557622|1101871|P2|12-Week Treatment Phase|Lost to Follow-up|1
337284|NCT00557622|1101872|P1|12-Week Treatment Phase|Lost to Follow-up|0
337285|NCT00557622|1101871|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
337286|NCT00557622|1101872|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
337287|NCT00557622|1101871|P2|4-Week Run-in Phase|Withdrawal by Subject|0
337288|NCT00557622|1101872|P1|4-Week Run-in Phase|Withdrawal by Subject|1
337289|NCT00557505|1101901|P9|Overall Study|Withdrawal by Subject|1
337290|NCT00557505|1101902|P8|Overall Study|Withdrawal by Subject|0
337291|NCT00557505|1101903|P7|Overall Study|Withdrawal by Subject|0
337292|NCT00557505|1101904|P6|Overall Study|Withdrawal by Subject|0
337293|NCT00557505|1101905|P5|Overall Study|Withdrawal by Subject|0
337294|NCT00557505|1101906|P4|Overall Study|Withdrawal by Subject|1
337295|NCT00557505|1101907|P3|Overall Study|Withdrawal by Subject|0
337296|NCT00557505|1101908|P2|Overall Study|Withdrawal by Subject|0
337297|NCT00557505|1101909|P1|Overall Study|Withdrawal by Subject|0
337298|NCT00557505|1101901|P9|Overall Study|Objective progression or relapse|15
337299|NCT00557505|1101902|P8|Overall Study|Objective progression or relapse|5
337300|NCT00557505|1101903|P7|Overall Study|Objective progression or relapse|2
337301|NCT00557505|1101904|P6|Overall Study|Objective progression or relapse|3
337302|NCT00557505|1101905|P5|Overall Study|Objective progression or relapse|2
337303|NCT00557505|1101906|P4|Overall Study|Objective progression or relapse|2
337304|NCT00557505|1101907|P3|Overall Study|Objective progression or relapse|3
337305|NCT00557505|1101908|P2|Overall Study|Objective progression or relapse|3
337306|NCT00557505|1101909|P1|Overall Study|Objective progression or relapse|2
337307|NCT00557505|1101901|P9|Overall Study|Global deterioration of health|0
337308|NCT00557505|1101902|P8|Overall Study|Global deterioration of health|0
337309|NCT00557505|1101903|P7|Overall Study|Global deterioration of health|0
337310|NCT00557505|1101904|P6|Overall Study|Global deterioration of health|0
337311|NCT00557505|1101905|P5|Overall Study|Global deterioration of health|0
337312|NCT00557505|1101906|P4|Overall Study|Global deterioration of health|0
337313|NCT00557505|1101907|P3|Overall Study|Global deterioration of health|0
337314|NCT00557505|1101908|P2|Overall Study|Global deterioration of health|0
337315|NCT00557505|1101909|P1|Overall Study|Global deterioration of health|1
337316|NCT00557505|1101901|P9|Overall Study|Adverse Event|0
337317|NCT00557505|1101902|P8|Overall Study|Adverse Event|0
337318|NCT00557505|1101903|P7|Overall Study|Adverse Event|1
337319|NCT00557505|1101904|P6|Overall Study|Adverse Event|0
337320|NCT00557505|1101905|P5|Overall Study|Adverse Event|0
337321|NCT00557505|1101906|P4|Overall Study|Adverse Event|0
337322|NCT00557505|1101907|P3|Overall Study|Adverse Event|1
337323|NCT00557505|1101908|P2|Overall Study|Adverse Event|0
337324|NCT00557505|1101909|P1|Overall Study|Adverse Event|0
337325|NCT00557505|1101901|P9|Overall Study|Death|1
337326|NCT00557505|1101902|P8|Overall Study|Death|0
337327|NCT00557505|1101903|P7|Overall Study|Death|0
337328|NCT00557505|1101904|P6|Overall Study|Death|0
337329|NCT00557505|1101905|P5|Overall Study|Death|0
337330|NCT00557505|1101906|P4|Overall Study|Death|0
337331|NCT00557505|1101907|P3|Overall Study|Death|0
337332|NCT00557505|1101908|P2|Overall Study|Death|0
337333|NCT00557505|1101909|P1|Overall Study|Death|0
337334|NCT00557492|1102073|P1|Overall Study|Change in health insurance|1
337335|NCT00557466|1102091|P6|Overall Study|Lost to Follow-up|0
337336|NCT00557466|1102092|P5|Overall Study|Lost to Follow-up|0
337337|NCT00557466|1102093|P4|Overall Study|Lost to Follow-up|1
337338|NCT00557466|1102094|P3|Overall Study|Lost to Follow-up|0
337339|NCT00557466|1102095|P2|Overall Study|Lost to Follow-up|0
337340|NCT00557466|1102096|P1|Overall Study|Lost to Follow-up|0
337341|NCT00557466|1102091|P6|Overall Study|Abnormal test procedure results|0
337342|NCT00557466|1102092|P5|Overall Study|Abnormal test procedure results|0
337343|NCT00557466|1102093|P4|Overall Study|Abnormal test procedure results|0
337344|NCT00557466|1102094|P3|Overall Study|Abnormal test procedure results|1
337345|NCT00557466|1102095|P2|Overall Study|Abnormal test procedure results|0
337346|NCT00557466|1102096|P1|Overall Study|Abnormal test procedure results|0
337347|NCT00557466|1102091|P6|Overall Study|Administrative problems|0
337348|NCT00557466|1102092|P5|Overall Study|Administrative problems|0
337349|NCT00557466|1102093|P4|Overall Study|Administrative problems|0
337350|NCT00557466|1102094|P3|Overall Study|Administrative problems|1
337351|NCT00557466|1102095|P2|Overall Study|Administrative problems|1
337352|NCT00557466|1102096|P1|Overall Study|Administrative problems|0
337353|NCT00557466|1102091|P6|Overall Study|Subject withdrew consent|2
337354|NCT00557466|1102092|P5|Overall Study|Subject withdrew consent|1
337355|NCT00557466|1102093|P4|Overall Study|Subject withdrew consent|0
337356|NCT00557466|1102094|P3|Overall Study|Subject withdrew consent|0
337357|NCT00557466|1102095|P2|Overall Study|Subject withdrew consent|0
337358|NCT00557466|1102096|P1|Overall Study|Subject withdrew consent|0
337359|NCT00557466|1102091|P6|Overall Study|Protocol deviation|0
337360|NCT00557466|1102092|P5|Overall Study|Protocol deviation|0
337361|NCT00557466|1102093|P4|Overall Study|Protocol deviation|2
337362|NCT00557466|1102094|P3|Overall Study|Protocol deviation|0
337363|NCT00557466|1102095|P2|Overall Study|Protocol deviation|1
337364|NCT00557466|1102096|P1|Overall Study|Protocol deviation|0
337365|NCT00557466|1102091|P6|Overall Study|Abnormal laboratory value(s)|0
337366|NCT00557466|1102092|P5|Overall Study|Abnormal laboratory value(s)|0
337367|NCT00557466|1102093|P4|Overall Study|Abnormal laboratory value(s)|0
337368|NCT00557466|1102094|P3|Overall Study|Abnormal laboratory value(s)|0
337369|NCT00557466|1102095|P2|Overall Study|Abnormal laboratory value(s)|2
337370|NCT00557466|1102096|P1|Overall Study|Abnormal laboratory value(s)|1
337371|NCT00557466|1102091|P6|Overall Study|Adverse Event|4
337372|NCT00557466|1102092|P5|Overall Study|Adverse Event|2
337373|NCT00557466|1102093|P4|Overall Study|Adverse Event|1
337374|NCT00557466|1102094|P3|Overall Study|Adverse Event|4
337375|NCT00557466|1102095|P2|Overall Study|Adverse Event|1
337376|NCT00557466|1102096|P1|Overall Study|Adverse Event|3
337377|NCT00557440|1102149|P3|Treatment Period 1|Adverse Event|1
337378|NCT00557440|1102150|P2|Treatment Period 1|Adverse Event|0
337379|NCT00557440|1102151|P1|Treatment Period 1|Adverse Event|0
337380|NCT00557323|1102205|P1|Overall Study|Administrative change|2
337381|NCT00557323|1102205|P1|Overall Study|Withdrawal by Subject|2
337382|NCT00557323|1102205|P1|Overall Study|Death|3
337383|NCT00557310|1102210|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
337384|NCT00557310|1102210|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
337385|NCT00557310|1102210|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
337386|NCT00557310|1102210|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
337387|NCT00557310|1102210|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
337388|NCT00557310|1102210|P1|Main Study (0 - 18 Months)|Adverse Event|4
337389|NCT00557245|1102256|P3|Overall Study|Ineligible|2
337390|NCT00557245|1102257|P2|Overall Study|Ineligible|4
337391|NCT00557245|1102258|P1|Overall Study|Ineligible|5
337392|NCT00557245|1102256|P3|Overall Study|Lost to Follow-up|10
337393|NCT00557245|1102257|P2|Overall Study|Lost to Follow-up|8
337394|NCT00557245|1102258|P1|Overall Study|Lost to Follow-up|7
337395|NCT00557076|1102298|P2|Overall Study|Unblinding|1
337396|NCT00557076|1102299|P1|Overall Study|Unblinding|0
337397|NCT00556998|1102307|P1|Voriconazole Oral|Intolerant of oral treatment|1
337398|NCT00556998|1102307|P1|Voriconazole Oral|Adverse Event|1
337399|NCT00556998|1102307|P1|Voriconazole Intravenous (IV)|unspecified|4
337400|NCT00556998|1102307|P1|Voriconazole Intravenous (IV)|Adverse Event|1
337401|NCT00556933|1102342|P4|CNI Withdrawal vs. Minimization|Death|1
337402|NCT00556933|1102343|P3|CNI Withdrawal vs. Minimization|Death|0
337403|NCT00556933|1102344|P2|CNI Withdrawal vs. Minimization|Death|0
337404|NCT00556933|1102345|P1|CNI Withdrawal vs. Minimization|Death|0
337405|NCT00556933|1102342|P4|CNI Withdrawal vs. Minimization|Graft loss|0
337406|NCT00556933|1102343|P3|CNI Withdrawal vs. Minimization|Graft loss|2
337407|NCT00556933|1102344|P2|CNI Withdrawal vs. Minimization|Graft loss|1
337408|NCT00556933|1102345|P1|CNI Withdrawal vs. Minimization|Graft loss|0
337409|NCT00556933|1102342|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
337410|NCT00556933|1102343|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
337411|NCT00556933|1102344|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
337412|NCT00556933|1102345|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
337413|NCT00556933|1102342|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
337414|NCT00556933|1102343|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
337415|NCT00556933|1102344|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
337416|NCT00556933|1102345|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
337417|NCT00556933|1102342|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
337418|NCT00556933|1102343|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
337419|NCT00556933|1102344|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
337420|NCT00556933|1102345|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
337421|NCT00556933|1102342|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
337422|NCT00556933|1102343|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
337423|NCT00556933|1102344|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
337424|NCT00556933|1102345|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
337425|NCT00556933|1102342|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
337426|NCT00556933|1102343|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
337427|NCT00556933|1102344|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
337428|NCT00556933|1102345|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
337429|NCT00556933|1102342|P4|Single vs. Divided-dose rATG Induction|Death|0
337430|NCT00556933|1102343|P3|Single vs. Divided-dose rATG Induction|Death|0
337431|NCT00556933|1102344|P2|Single vs. Divided-dose rATG Induction|Death|1
337432|NCT00556933|1102345|P1|Single vs. Divided-dose rATG Induction|Death|0
337433|NCT00556933|1102342|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
337434|NCT00556933|1102343|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
337435|NCT00556933|1102344|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
337524|NCT00555906|1102694|P4|Phase 2|Objective Progression or Relapse|0
337436|NCT00556933|1102345|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
337437|NCT00556933|1102342|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
337438|NCT00556933|1102343|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
337439|NCT00556933|1102344|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
337440|NCT00556933|1102345|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
337441|NCT00556933|1102342|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
337442|NCT00556933|1102343|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
337443|NCT00556933|1102344|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
337444|NCT00556933|1102345|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
337445|NCT00556894|1102402|P3|Overall Study|Withdrawal by Subject|1
337446|NCT00556894|1102403|P2|Overall Study|Withdrawal by Subject|1
337447|NCT00556894|1102404|P1|Overall Study|Withdrawal by Subject|1
337448|NCT00556894|1102402|P3|Overall Study|Change in therapy|2
337449|NCT00556894|1102403|P2|Overall Study|Change in therapy|1
337450|NCT00556894|1102404|P1|Overall Study|Change in therapy|2
337451|NCT00556894|1102402|P3|Overall Study|regulatory decision in Bulgaria|13
337452|NCT00556894|1102403|P2|Overall Study|regulatory decision in Bulgaria|14
337453|NCT00556894|1102404|P1|Overall Study|regulatory decision in Bulgaria|10
337454|NCT00556894|1102402|P3|Overall Study|Death|0
337455|NCT00556894|1102403|P2|Overall Study|Death|0
337456|NCT00556894|1102404|P1|Overall Study|Death|1
337457|NCT00556894|1102402|P3|Overall Study|Adverse Event|3
337458|NCT00556894|1102403|P2|Overall Study|Adverse Event|3
337459|NCT00556894|1102404|P1|Overall Study|Adverse Event|2
337460|NCT00556673|1102414|P2|Overall Study|Protocol deviation|2
337461|NCT00556673|1102415|P1|Overall Study|Protocol deviation|3
337462|NCT00556426|1102536|P1|Overall Study|Death|6
337463|NCT00556426|1102536|P1|Overall Study|Withdrawal by Subject|3
337464|NCT00556374|1102558|P2|Overall Study|Lost to Follow-up|5
337465|NCT00556374|1102559|P1|Overall Study|Lost to Follow-up|7
337466|NCT00556374|1102558|P2|Overall Study|Death|43
337467|NCT00556374|1102559|P1|Overall Study|Death|50
337468|NCT00556374|1102558|P2|Overall Study|Withdrawal by Subject|172
337469|NCT00556374|1102559|P1|Overall Study|Withdrawal by Subject|190
337470|NCT00556322|1102577|P2|Overall Study|Death|14
337471|NCT00556322|1102578|P1|Overall Study|Death|20
337472|NCT00556322|1102577|P2|Overall Study|Ongoing at data cutoff|5
337473|NCT00556322|1102578|P1|Overall Study|Ongoing at data cutoff|3
337474|NCT00556322|1102577|P2|Overall Study|Protocol Violation|1
337475|NCT00556322|1102578|P1|Overall Study|Protocol Violation|5
337476|NCT00556322|1102577|P2|Overall Study|Withdrawal by Subject|7
337477|NCT00556322|1102578|P1|Overall Study|Withdrawal by Subject|19
337478|NCT00556322|1102577|P2|Overall Study|Lost to Follow-up|3
337479|NCT00556322|1102578|P1|Overall Study|Lost to Follow-up|5
337480|NCT00556322|1102577|P2|Overall Study|Unspecified|1
337481|NCT00556322|1102578|P1|Overall Study|Unspecified|4
337482|NCT00556322|1102577|P2|Overall Study|Adverse Event|4
337483|NCT00556322|1102578|P1|Overall Study|Adverse Event|7
337484|NCT00556322|1102577|P2|Overall Study|Insufficient therapeutic response|168
337485|NCT00556322|1102578|P1|Overall Study|Insufficient therapeutic response|158
337486|NCT00556166|1102626|P1|Overall Study|Withdrawal by Subject|1
337487|NCT00556075|1102639|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
337488|NCT00556075|1102640|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
337489|NCT00556075|1102641|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
337490|NCT00556075|1102639|P3|Overall Study|Personal issues|0
337491|NCT00556075|1102640|P2|Overall Study|Personal issues|1
337492|NCT00556075|1102641|P1|Overall Study|Personal issues|4
337493|NCT00556075|1102639|P3|Overall Study|Adverse Event|0
337494|NCT00556075|1102640|P2|Overall Study|Adverse Event|2
337495|NCT00556075|1102641|P1|Overall Study|Adverse Event|1
337496|NCT00556075|1102639|P3|Overall Study|Not eligible|2
337497|NCT00556075|1102640|P2|Overall Study|Not eligible|1
337498|NCT00556075|1102641|P1|Overall Study|Not eligible|1
337499|NCT00556075|1102639|P3|Overall Study|Protocol Violation|3
337500|NCT00556075|1102640|P2|Overall Study|Protocol Violation|1
337501|NCT00556075|1102641|P1|Overall Study|Protocol Violation|1
337502|NCT00556075|1102639|P3|Overall Study|Withdrawal by Subject|0
337503|NCT00556075|1102640|P2|Overall Study|Withdrawal by Subject|3
337504|NCT00556075|1102641|P1|Overall Study|Withdrawal by Subject|3
337505|NCT00556075|1102639|P3|Overall Study|Lost to Follow-up|3
337506|NCT00556075|1102640|P2|Overall Study|Lost to Follow-up|0
337507|NCT00556075|1102641|P1|Overall Study|Lost to Follow-up|3
337508|NCT00555906|1102693|P5|Phase 2|Randomized but not Treated|2
337509|NCT00555906|1102694|P4|Phase 2|Randomized but not Treated|0
337510|NCT00555906|1102695|P3|Phase 2|Randomized but not Treated|0
337511|NCT00555906|1102696|P2|Phase 2|Randomized but not Treated|0
337512|NCT00555906|1102697|P1|Phase 2|Randomized but not Treated|0
337513|NCT00555906|1102693|P5|Phase 2|Unspecified|6
337514|NCT00555906|1102694|P4|Phase 2|Unspecified|0
337515|NCT00555906|1102695|P3|Phase 2|Unspecified|0
337516|NCT00555906|1102696|P2|Phase 2|Unspecified|0
337517|NCT00555906|1102697|P1|Phase 2|Unspecified|0
337518|NCT00555906|1102693|P5|Phase 2|Withdrawal by Subject|2
337519|NCT00555906|1102694|P4|Phase 2|Withdrawal by Subject|0
337520|NCT00555906|1102695|P3|Phase 2|Withdrawal by Subject|0
337521|NCT00555906|1102696|P2|Phase 2|Withdrawal by Subject|0
337522|NCT00555906|1102697|P1|Phase 2|Withdrawal by Subject|0
337523|NCT00555906|1102693|P5|Phase 2|Objective Progression or Relapse|16
337525|NCT00555906|1102695|P3|Phase 2|Objective Progression or Relapse|0
337526|NCT00555906|1102696|P2|Phase 2|Objective Progression or Relapse|0
337527|NCT00555906|1102697|P1|Phase 2|Objective Progression or Relapse|0
337528|NCT00555906|1102693|P5|Phase 2|Global Deterioration of Health Status|2
337529|NCT00555906|1102694|P4|Phase 2|Global Deterioration of Health Status|0
337530|NCT00555906|1102695|P3|Phase 2|Global Deterioration of Health Status|0
337531|NCT00555906|1102696|P2|Phase 2|Global Deterioration of Health Status|0
337532|NCT00555906|1102697|P1|Phase 2|Global Deterioration of Health Status|0
337533|NCT00555906|1102693|P5|Phase 2|Adverse Event|4
337534|NCT00555906|1102694|P4|Phase 2|Adverse Event|0
337535|NCT00555906|1102695|P3|Phase 2|Adverse Event|0
337536|NCT00555906|1102696|P2|Phase 2|Adverse Event|0
337537|NCT00555906|1102697|P1|Phase 2|Adverse Event|0
337538|NCT00555906|1102693|P5|Phase 1|Withdrawal by Subject|0
337539|NCT00555906|1102694|P4|Phase 1|Withdrawal by Subject|1
337540|NCT00555906|1102695|P3|Phase 1|Withdrawal by Subject|0
337541|NCT00555906|1102696|P2|Phase 1|Withdrawal by Subject|0
337542|NCT00555906|1102697|P1|Phase 1|Withdrawal by Subject|0
337543|NCT00555906|1102693|P5|Phase 1|Adverse Event|0
337544|NCT00555906|1102694|P4|Phase 1|Adverse Event|2
337545|NCT00555906|1102695|P3|Phase 1|Adverse Event|3
337546|NCT00555906|1102696|P2|Phase 1|Adverse Event|0
337547|NCT00555906|1102697|P1|Phase 1|Adverse Event|0
337548|NCT00555906|1102693|P5|Phase 1|Global Deterioration of Health Status|0
337549|NCT00555906|1102694|P4|Phase 1|Global Deterioration of Health Status|1
337550|NCT00555906|1102695|P3|Phase 1|Global Deterioration of Health Status|1
337551|NCT00555906|1102696|P2|Phase 1|Global Deterioration of Health Status|1
337552|NCT00555906|1102697|P1|Phase 1|Global Deterioration of Health Status|0
337553|NCT00555906|1102693|P5|Phase 1|Objective Progression or Relapse|0
337554|NCT00555906|1102694|P4|Phase 1|Objective Progression or Relapse|1
337555|NCT00555906|1102695|P3|Phase 1|Objective Progression or Relapse|3
337556|NCT00555906|1102696|P2|Phase 1|Objective Progression or Relapse|5
337557|NCT00555906|1102697|P1|Phase 1|Objective Progression or Relapse|3
337558|NCT00555672|1102813|P2|Overall Study|Participant refused|0
337559|NCT00555672|1102814|P1|Overall Study|Participant refused|2
337560|NCT00555672|1102813|P2|Overall Study|Unspecified|1
337561|NCT00555672|1102814|P1|Overall Study|Unspecified|3
337562|NCT00555672|1102813|P2|Overall Study|Objective progression or relapse|5
337563|NCT00555672|1102814|P1|Overall Study|Objective progression or relapse|11
337564|NCT00555672|1102813|P2|Overall Study|Adverse Event|2
337565|NCT00555672|1102814|P1|Overall Study|Adverse Event|8
337566|NCT00555672|1102813|P2|Overall Study|Death|2
337567|NCT00555672|1102814|P1|Overall Study|Death|0
337568|NCT00555620|1102839|P6|Overall Study|Not specified|3
337569|NCT00555620|1102840|P5|Overall Study|Not specified|0
337570|NCT00555620|1102841|P4|Overall Study|Not specified|1
337571|NCT00555620|1102842|P3|Overall Study|Not specified|0
337572|NCT00555620|1102843|P2|Overall Study|Not specified|0
337573|NCT00555620|1102844|P1|Overall Study|Not specified|0
337574|NCT00555620|1102839|P6|Overall Study|Participant refused treatment|1
337575|NCT00555620|1102840|P5|Overall Study|Participant refused treatment|0
337576|NCT00555620|1102841|P4|Overall Study|Participant refused treatment|0
337577|NCT00555620|1102842|P3|Overall Study|Participant refused treatment|1
337578|NCT00555620|1102843|P2|Overall Study|Participant refused treatment|1
337579|NCT00555620|1102844|P1|Overall Study|Participant refused treatment|0
337580|NCT00555620|1102839|P6|Overall Study|Objective progression or relapse|16
337581|NCT00555620|1102840|P5|Overall Study|Objective progression or relapse|3
337582|NCT00555620|1102841|P4|Overall Study|Objective progression or relapse|17
337583|NCT00555620|1102842|P3|Overall Study|Objective progression or relapse|12
337584|NCT00555620|1102843|P2|Overall Study|Objective progression or relapse|5
337585|NCT00555620|1102844|P1|Overall Study|Objective progression or relapse|6
337586|NCT00555620|1102839|P6|Overall Study|Adverse Event|1
337587|NCT00555620|1102840|P5|Overall Study|Adverse Event|0
337588|NCT00555620|1102841|P4|Overall Study|Adverse Event|5
337589|NCT00555620|1102842|P3|Overall Study|Adverse Event|1
337590|NCT00555620|1102843|P2|Overall Study|Adverse Event|0
337591|NCT00555620|1102844|P1|Overall Study|Adverse Event|0
337592|NCT00555620|1102839|P6|Overall Study|Study terminated by sponsor|0
337593|NCT00555620|1102840|P5|Overall Study|Study terminated by sponsor|0
337594|NCT00555620|1102841|P4|Overall Study|Study terminated by sponsor|0
337595|NCT00555620|1102842|P3|Overall Study|Study terminated by sponsor|1
337596|NCT00555620|1102843|P2|Overall Study|Study terminated by sponsor|0
337597|NCT00555620|1102844|P1|Overall Study|Study terminated by sponsor|0
337598|NCT00555620|1102839|P6|Overall Study|Death|1
337599|NCT00555620|1102840|P5|Overall Study|Death|0
337600|NCT00555620|1102841|P4|Overall Study|Death|0
337601|NCT00555620|1102842|P3|Overall Study|Death|0
337602|NCT00555620|1102843|P2|Overall Study|Death|1
337603|NCT00555620|1102844|P1|Overall Study|Death|0
337604|NCT00555568|1102959|P3|Overall Study|Lost to Follow-up|16
337605|NCT00555568|1102960|P2|Overall Study|Lost to Follow-up|16
337606|NCT00555568|1102961|P1|Overall Study|Lost to Follow-up|26
337607|NCT00555477|1102983|P2|Overall Study|Physician Decision|2
337608|NCT00555477|1102984|P1|Overall Study|Physician Decision|1
337609|NCT00555477|1102983|P2|Overall Study|Withdrawal by Subject|2
337610|NCT00555477|1102984|P1|Overall Study|Withdrawal by Subject|1
337611|NCT00555477|1102983|P2|Overall Study|Adverse Event|9
337612|NCT00555477|1102984|P1|Overall Study|Adverse Event|0
337613|NCT00555438|1103000|P1|Between 10 Days and 30 Days Postoperativ|Death|5
337614|NCT00555438|1103000|P1|10 Days Post-operative|Death|4
337615|NCT00555425|1103010|P2|Overall Study|Became pregnant and transferred care|1
337616|NCT00555425|1103011|P1|Overall Study|Became pregnant and transferred care|0
337617|NCT00555425|1103010|P2|Overall Study|Met criteria for protective transfer|3
337618|NCT00555425|1103011|P1|Overall Study|Met criteria for protective transfer|16
337619|NCT00555425|1103010|P2|Overall Study|Missed 3 physician management visits|0
337620|NCT00555425|1103011|P1|Overall Study|Missed 3 physician management visits|1
337621|NCT00555425|1103010|P2|Overall Study|Missed Medication > 1 wk|15
337622|NCT00555425|1103011|P1|Overall Study|Missed Medication > 1 wk|34
337623|NCT00555321|1103047|P5|Long-term Extension Phase|Other Reason|0
337624|NCT00555321|1103048|P4|Long-term Extension Phase|Other Reason|0
337625|NCT00555321|1103049|P3|Long-term Extension Phase|Other Reason|2
337626|NCT00555321|1103050|P2|Long-term Extension Phase|Other Reason|0
337627|NCT00555321|1103051|P1|Long-term Extension Phase|Other Reason|1
337628|NCT00555321|1103047|P5|Long-term Extension Phase|Participant did not meet study criteria|1
337629|NCT00555321|1103048|P4|Long-term Extension Phase|Participant did not meet study criteria|0
337630|NCT00555321|1103049|P3|Long-term Extension Phase|Participant did not meet study criteria|0
337631|NCT00555321|1103050|P2|Long-term Extension Phase|Participant did not meet study criteria|0
337632|NCT00555321|1103051|P1|Long-term Extension Phase|Participant did not meet study criteria|0
337633|NCT00555321|1103047|P5|Long-term Extension Phase|Death|0
337634|NCT00555321|1103048|P4|Long-term Extension Phase|Death|3
337635|NCT00555321|1103049|P3|Long-term Extension Phase|Death|0
337636|NCT00555321|1103050|P2|Long-term Extension Phase|Death|0
337637|NCT00555321|1103051|P1|Long-term Extension Phase|Death|2
337638|NCT00555321|1103047|P5|Long-term Extension Phase|Administrative reason by sponsor|23
337639|NCT00555321|1103048|P4|Long-term Extension Phase|Administrative reason by sponsor|31
337640|NCT00555321|1103049|P3|Long-term Extension Phase|Administrative reason by sponsor|18
337641|NCT00555321|1103050|P2|Long-term Extension Phase|Administrative reason by sponsor|21
337642|NCT00555321|1103051|P1|Long-term Extension Phase|Administrative reason by sponsor|23
337643|NCT00555321|1103047|P5|Long-term Extension Phase|Withdrawal by Subject|2
337644|NCT00555321|1103048|P4|Long-term Extension Phase|Withdrawal by Subject|3
337645|NCT00555321|1103049|P3|Long-term Extension Phase|Withdrawal by Subject|2
337646|NCT00555321|1103050|P2|Long-term Extension Phase|Withdrawal by Subject|1
337647|NCT00555321|1103051|P1|Long-term Extension Phase|Withdrawal by Subject|2
337648|NCT00555321|1103047|P5|Long-term Extension Phase|Adverse Event|0
337649|NCT00555321|1103048|P4|Long-term Extension Phase|Adverse Event|1
337650|NCT00555321|1103049|P3|Long-term Extension Phase|Adverse Event|2
337651|NCT00555321|1103050|P2|Long-term Extension Phase|Adverse Event|5
337652|NCT00555321|1103051|P1|Long-term Extension Phase|Adverse Event|2
337653|NCT00555321|1103047|P5|Treatment Phase up to 12-months|Never treated|4
337654|NCT00555321|1103048|P4|Treatment Phase up to 12-months|Never treated|0
337655|NCT00555321|1103049|P3|Treatment Phase up to 12-months|Never treated|1
337656|NCT00555321|1103050|P2|Treatment Phase up to 12-months|Never treated|3
337657|NCT00555321|1103051|P1|Treatment Phase up to 12-months|Never treated|2
337658|NCT00555321|1103047|P5|Treatment Phase up to 12-months|Other Reason|0
337659|NCT00555321|1103048|P4|Treatment Phase up to 12-months|Other Reason|0
337660|NCT00555321|1103049|P3|Treatment Phase up to 12-months|Other Reason|2
337661|NCT00555321|1103050|P2|Treatment Phase up to 12-months|Other Reason|3
337662|NCT00555321|1103051|P1|Treatment Phase up to 12-months|Other Reason|1
337663|NCT00555321|1103047|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
337664|NCT00555321|1103048|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
337665|NCT00555321|1103049|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
337666|NCT00555321|1103050|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
337667|NCT00555321|1103051|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
337668|NCT00555321|1103047|P5|Treatment Phase up to 12-months|Death|0
337669|NCT00555321|1103048|P4|Treatment Phase up to 12-months|Death|0
337670|NCT00555321|1103049|P3|Treatment Phase up to 12-months|Death|4
337671|NCT00555321|1103050|P2|Treatment Phase up to 12-months|Death|1
337672|NCT00555321|1103051|P1|Treatment Phase up to 12-months|Death|2
337673|NCT00555321|1103047|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
337674|NCT00555321|1103048|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
337675|NCT00555321|1103049|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
337676|NCT00555321|1103050|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
337677|NCT00555321|1103051|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
337678|NCT00555321|1103047|P5|Treatment Phase up to 12-months|Adverse Event|18
337679|NCT00555321|1103048|P4|Treatment Phase up to 12-months|Adverse Event|7
337680|NCT00555321|1103049|P3|Treatment Phase up to 12-months|Adverse Event|11
337681|NCT00555321|1103050|P2|Treatment Phase up to 12-months|Adverse Event|7
337682|NCT00555321|1103051|P1|Treatment Phase up to 12-months|Adverse Event|6
337683|NCT00555217|1103355|P2|Overall Study|close out sites|17
337684|NCT00555217|1103356|P1|Overall Study|close out sites|21
337685|NCT00555217|1103355|P2|Overall Study|Lost to Follow-up|20
337686|NCT00555217|1103356|P1|Overall Study|Lost to Follow-up|19
337687|NCT00555217|1103355|P2|Overall Study|Withdrawal by Subject|31
337688|NCT00555217|1103356|P1|Overall Study|Withdrawal by Subject|35
337689|NCT00555061|1103393|P1|Overall Study|Participant enrolled, but never treated|1
337690|NCT00555061|1103393|P1|Overall Study|Withdrawal by Subject|2
337691|NCT00555061|1103393|P1|Overall Study|Lost to Follow-up|2
337692|NCT00555061|1103393|P1|Overall Study|Protocol Violation|1
337693|NCT00555061|1103393|P1|Overall Study|Adverse Event|3
337694|NCT00555009|1103412|P2|Overall Study|Terminated by Sponsor|5
337695|NCT00555009|1103413|P1|Overall Study|Terminated by Sponsor|2
337696|NCT00555009|1103412|P2|Overall Study|Withdrawal by Subject|1
337697|NCT00555009|1103413|P1|Overall Study|Withdrawal by Subject|0
337698|NCT00554840|1103493|P2|Overall Study|Physician Decision|1
337699|NCT00554840|1103494|P1|Overall Study|Physician Decision|0
337700|NCT00554801|1103512|P2|Overall Study|Withdrawal by Subject|0
337701|NCT00554801|1103513|P1|Overall Study|Withdrawal by Subject|14
337702|NCT00554801|1103512|P2|Overall Study|left area before completion|0
337703|NCT00554801|1103513|P1|Overall Study|left area before completion|5
337704|NCT00554619|1103535|P1|Overall Study|Liver Function Test Abnormality|1
337705|NCT00554619|1103535|P1|Overall Study|Physician Decision|1
337706|NCT00554619|1103535|P1|Overall Study|Adverse Event|1
337707|NCT00554515|1103547|P1|Overall Study|Misc|15
337708|NCT00554515|1103547|P1|Overall Study|Other|1
337709|NCT00554515|1103547|P1|Overall Study|Achieved Stable Disease|7
337710|NCT00554515|1103547|P1|Overall Study|Death|2
337711|NCT00554515|1103547|P1|Overall Study|Adverse Event|9
337712|NCT00554515|1103547|P1|Overall Study|Withdrawal by Subject|11
337713|NCT00554515|1103547|P1|Overall Study|Physician Decision|18
337714|NCT00554515|1103547|P1|Overall Study|Disease progression|52
337715|NCT00554515|1103547|P1|Overall Study|Withdrawal by Subject|3
337716|NCT00554229|1103604|P2|Overall Study|Randomised but no treatment received|0
337717|NCT00554229|1103605|P1|Overall Study|Randomised but no treatment received|1
337718|NCT00554229|1103604|P2|Overall Study|Reason not otherwise captured, eg; death|140
337719|NCT00554229|1103605|P1|Overall Study|Reason not otherwise captured, eg; death|119
337720|NCT00554229|1103604|P2|Overall Study|Protocol Violation|3
337721|NCT00554229|1103605|P1|Overall Study|Protocol Violation|3
337722|NCT00554229|1103604|P2|Overall Study|Adverse Event|39
337723|NCT00554229|1103605|P1|Overall Study|Adverse Event|71
337724|NCT00554229|1103604|P2|Overall Study|Withdrawal by Subject|37
337725|NCT00554229|1103605|P1|Overall Study|Withdrawal by Subject|29
337726|NCT00554229|1103604|P2|Overall Study|Lost to Follow-up|6
337727|NCT00554229|1103605|P1|Overall Study|Lost to Follow-up|3
337728|NCT00554216|1103630|P3|Overall Study|Lack of Efficacy|0
337729|NCT00554216|1103631|P2|Overall Study|Lack of Efficacy|3
337730|NCT00554216|1103632|P1|Overall Study|Lack of Efficacy|15
337731|NCT00554216|1103630|P3|Overall Study|not specified|10
337732|NCT00554216|1103631|P2|Overall Study|not specified|7
337733|NCT00554216|1103632|P1|Overall Study|not specified|12
337734|NCT00554216|1103630|P3|Overall Study|Restricted med|1
337735|NCT00554216|1103631|P2|Overall Study|Restricted med|1
337736|NCT00554216|1103632|P1|Overall Study|Restricted med|3
337737|NCT00554216|1103630|P3|Overall Study|Pregnancy|14
337738|NCT00554216|1103631|P2|Overall Study|Pregnancy|1
337739|NCT00554216|1103632|P1|Overall Study|Pregnancy|2
337740|NCT00554216|1103630|P3|Overall Study|Non compliance|5
337741|NCT00554216|1103631|P2|Overall Study|Non compliance|4
337742|NCT00554216|1103632|P1|Overall Study|Non compliance|10
337743|NCT00554216|1103630|P3|Overall Study|Withdrawal by Subject|43
337744|NCT00554216|1103631|P2|Overall Study|Withdrawal by Subject|31
337745|NCT00554216|1103632|P1|Overall Study|Withdrawal by Subject|92
337746|NCT00554216|1103630|P3|Overall Study|Adverse Event|36
337747|NCT00554216|1103631|P2|Overall Study|Adverse Event|16
337748|NCT00554216|1103632|P1|Overall Study|Adverse Event|16
337749|NCT00554216|1103630|P3|Overall Study|Lost to Follow-up|63
337750|NCT00554216|1103631|P2|Overall Study|Lost to Follow-up|31
337751|NCT00554216|1103632|P1|Overall Study|Lost to Follow-up|92
337752|NCT00554190|1103643|P1|Overall Study|Termination forms not completed|10
337753|NCT00554099|1103652|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
337754|NCT00554099|1103653|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
337755|NCT00554099|1103654|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
337756|NCT00554099|1103652|P3|Non-Treatment Phase (9 Months)|Relapse|1
337757|NCT00554099|1103653|P2|Non-Treatment Phase (9 Months)|Relapse|1
337758|NCT00554099|1103654|P1|Non-Treatment Phase (9 Months)|Relapse|2
337759|NCT00554099|1103652|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
337760|NCT00554099|1103653|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
337761|NCT00554099|1103654|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
337762|NCT00554099|1103652|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
337763|NCT00554099|1103653|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
337764|NCT00554099|1103654|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
337765|NCT00554099|1103652|P3|Treatment Period (12 Weeks)|Protocol Violation|2
337766|NCT00554099|1103653|P2|Treatment Period (12 Weeks)|Protocol Violation|0
337767|NCT00554099|1103654|P1|Treatment Period (12 Weeks)|Protocol Violation|0
337768|NCT00554099|1103652|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
337769|NCT00554099|1103653|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
337770|NCT00554099|1103654|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
337771|NCT00554099|1103652|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
337772|NCT00554099|1103653|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
337773|NCT00554099|1103654|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
337774|NCT00554099|1103652|P3|Treatment Period (12 Weeks)|Physician Decision|0
337775|NCT00554099|1103653|P2|Treatment Period (12 Weeks)|Physician Decision|0
337776|NCT00554099|1103654|P1|Treatment Period (12 Weeks)|Physician Decision|3
337777|NCT00554099|1103652|P3|Treatment Period (12 Weeks)|Adverse Event|1
337778|NCT00554099|1103653|P2|Treatment Period (12 Weeks)|Adverse Event|5
337779|NCT00554099|1103654|P1|Treatment Period (12 Weeks)|Adverse Event|3
337780|NCT00553787|1103709|P3|Overall Study|not specified|13
337781|NCT00553787|1103710|P2|Overall Study|not specified|10
337782|NCT00553787|1103711|P1|Overall Study|not specified|18
337783|NCT00553787|1103709|P3|Overall Study|Requirement for restricted medication|5
337784|NCT00553787|1103710|P2|Overall Study|Requirement for restricted medication|7
337785|NCT00553787|1103711|P1|Overall Study|Requirement for restricted medication|8
337786|NCT00553787|1103709|P3|Overall Study|non compliance|11
337787|NCT00553787|1103710|P2|Overall Study|non compliance|0
337788|NCT00553787|1103711|P1|Overall Study|non compliance|4
337789|NCT00553787|1103709|P3|Overall Study|Pregnancy|2
337790|NCT00553787|1103710|P2|Overall Study|Pregnancy|1
337791|NCT00553787|1103711|P1|Overall Study|Pregnancy|0
337792|NCT00553787|1103709|P3|Overall Study|Lack of Efficacy|3
337793|NCT00553787|1103710|P2|Overall Study|Lack of Efficacy|1
337794|NCT00553787|1103711|P1|Overall Study|Lack of Efficacy|31
337795|NCT00553787|1103709|P3|Overall Study|Withdrawal by Subject|83
337796|NCT00553787|1103710|P2|Overall Study|Withdrawal by Subject|40
337797|NCT00553787|1103711|P1|Overall Study|Withdrawal by Subject|151
337798|NCT00553787|1103709|P3|Overall Study|Lost to Follow-up|78
337799|NCT00553787|1103710|P2|Overall Study|Lost to Follow-up|44
337800|NCT00553787|1103711|P1|Overall Study|Lost to Follow-up|132
337801|NCT00553787|1103709|P3|Overall Study|Adverse Event|67
337802|NCT00553787|1103710|P2|Overall Study|Adverse Event|21
337803|NCT00553787|1103711|P1|Overall Study|Adverse Event|34
337804|NCT00553696|1103743|P4|Overall Study|Withdrawal by Subject|0
337805|NCT00553696|1103744|P3|Overall Study|Withdrawal by Subject|0
337806|NCT00553696|1103745|P2|Overall Study|Withdrawal by Subject|1
337807|NCT00553696|1103746|P1|Overall Study|Withdrawal by Subject|0
337808|NCT00553696|1103743|P4|Overall Study|Objective progression or relapse|0
337809|NCT00553696|1103744|P3|Overall Study|Objective progression or relapse|6
337810|NCT00553696|1103745|P2|Overall Study|Objective progression or relapse|9
337811|NCT00553696|1103746|P1|Overall Study|Objective progression or relapse|2
337812|NCT00553696|1103743|P4|Overall Study|Global deterioration of health status|0
337813|NCT00553696|1103744|P3|Overall Study|Global deterioration of health status|0
337814|NCT00553696|1103745|P2|Overall Study|Global deterioration of health status|2
337815|NCT00553696|1103746|P1|Overall Study|Global deterioration of health status|0
337816|NCT00553696|1103743|P4|Overall Study|Adverse Event|1
337817|NCT00553696|1103744|P3|Overall Study|Adverse Event|0
337818|NCT00553696|1103745|P2|Overall Study|Adverse Event|4
337819|NCT00553696|1103746|P1|Overall Study|Adverse Event|2
337820|NCT00553644|1103784|P1|Overall Study|Alternative therapy|6
337821|NCT00553644|1103784|P1|Overall Study|Physician Decision|1
337822|NCT00553644|1103784|P1|Overall Study|Withdrawal by Subject|4
337823|NCT00553644|1103784|P1|Overall Study|Adverse Event|17
337824|NCT00553631|1103790|P2|Overall Study|Lost to Follow-up|0
337825|NCT00553631|1103791|P1|Overall Study|Lost to Follow-up|1
337826|NCT00553631|1103790|P2|Overall Study|Withdrawal by Subject|1
337827|NCT00553631|1103791|P1|Overall Study|Withdrawal by Subject|0
337828|NCT00553605|1103813|P2|Overall Study|Randomized but not treated|0
337829|NCT00553605|1103814|P1|Overall Study|Randomized but not treated|2
337830|NCT00553605|1103813|P2|Overall Study|Did not receive full dose|0
337831|NCT00553605|1103814|P1|Overall Study|Did not receive full dose|1
337832|NCT00553605|1103813|P2|Overall Study|Did not meet entrance criteria|3
337833|NCT00553605|1103814|P1|Overall Study|Did not meet entrance criteria|1
337834|NCT00553514|1103843|P5|Overall Study|Unspecified|1
337835|NCT00553514|1103844|P4|Overall Study|Unspecified|0
337836|NCT00553514|1103845|P3|Overall Study|Unspecified|0
337837|NCT00553514|1103846|P2|Overall Study|Unspecified|1
337838|NCT00553514|1103847|P1|Overall Study|Unspecified|1
337839|NCT00553514|1103843|P5|Overall Study|Risk of multiple pregnancy|0
337840|NCT00553514|1103844|P4|Overall Study|Risk of multiple pregnancy|1
337841|NCT00553514|1103845|P3|Overall Study|Risk of multiple pregnancy|0
337842|NCT00553514|1103846|P2|Overall Study|Risk of multiple pregnancy|2
337843|NCT00553514|1103847|P1|Overall Study|Risk of multiple pregnancy|0
337844|NCT00553514|1103843|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
337845|NCT00553514|1103844|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
337846|NCT00553514|1103845|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
337847|NCT00553514|1103846|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
337848|NCT00553514|1103847|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
337849|NCT00553514|1103843|P5|Overall Study|Lack of ovarian response|6
337850|NCT00553514|1103844|P4|Overall Study|Lack of ovarian response|5
337851|NCT00553514|1103845|P3|Overall Study|Lack of ovarian response|5
337852|NCT00553514|1103846|P2|Overall Study|Lack of ovarian response|5
337853|NCT00553514|1103847|P1|Overall Study|Lack of ovarian response|4
337854|NCT00553514|1103843|P5|Overall Study|Protocol deviation|0
337855|NCT00553514|1103844|P4|Overall Study|Protocol deviation|1
337856|NCT00553514|1103845|P3|Overall Study|Protocol deviation|0
337857|NCT00553514|1103846|P2|Overall Study|Protocol deviation|0
337858|NCT00553514|1103847|P1|Overall Study|Protocol deviation|0
337859|NCT00553501|1103884|P1|Overall Study|Progression|1
337860|NCT00553501|1103884|P1|Overall Study|Death|1
337861|NCT00553501|1103884|P1|Overall Study|Adverse Event|2
337862|NCT00553475|1103893|P3|Overall Study|Due to moving|0
337863|NCT00553475|1103894|P2|Overall Study|Due to moving|1
337864|NCT00553475|1103895|P1|Overall Study|Due to moving|0
337865|NCT00553475|1103893|P3|Overall Study|Physician Decision|0
337866|NCT00553475|1103894|P2|Overall Study|Physician Decision|0
337867|NCT00553475|1103895|P1|Overall Study|Physician Decision|1
337868|NCT00553475|1103893|P3|Overall Study|Withdrawal by Subject|0
337869|NCT00553475|1103894|P2|Overall Study|Withdrawal by Subject|1
337870|NCT00553475|1103895|P1|Overall Study|Withdrawal by Subject|1
337871|NCT00553475|1103893|P3|Overall Study|Lack of Efficacy|0
337872|NCT00553475|1103894|P2|Overall Study|Lack of Efficacy|1
337873|NCT00553475|1103895|P1|Overall Study|Lack of Efficacy|7
337874|NCT00553475|1103893|P3|Overall Study|Adverse Event|13
337875|NCT00553475|1103894|P2|Overall Study|Adverse Event|17
337876|NCT00553475|1103895|P1|Overall Study|Adverse Event|7
337877|NCT00553462|1104017|P1|Overall Study|Physician Decision|1
337878|NCT00553462|1104017|P1|Overall Study|Withdrawal by Subject|5
337879|NCT00553462|1104017|P1|Overall Study|Progression|4
337880|NCT00553462|1104017|P1|Overall Study|Adverse Event|4
337881|NCT00553436|1104023|P1|Overall Study|Conversion to another procedure|1
337882|NCT00553358|1104032|P3|Overall Study|Other: Reason Not Specified|20
337883|NCT00553358|1104033|P2|Overall Study|Other: Reason Not Specified|4
337884|NCT00553358|1104034|P1|Overall Study|Other: Reason Not Specified|15
337885|NCT00553358|1104032|P3|Overall Study|Missing|1
337886|NCT00553358|1104033|P2|Overall Study|Missing|1
337887|NCT00553358|1104034|P1|Overall Study|Missing|1
337888|NCT00553358|1104032|P3|Overall Study|Participant Withdrawal from Drug|3
337889|NCT00553358|1104033|P2|Overall Study|Participant Withdrawal from Drug|0
337890|NCT00553358|1104034|P1|Overall Study|Participant Withdrawal from Drug|0
337891|NCT00553358|1104032|P3|Overall Study|Recurrence of Disease|1
337892|NCT00553358|1104033|P2|Overall Study|Recurrence of Disease|4
337893|NCT00553358|1104034|P1|Overall Study|Recurrence of Disease|3
337894|NCT00553358|1104032|P3|Overall Study|Withdrawal by Subject|1
337895|NCT00553358|1104033|P2|Overall Study|Withdrawal by Subject|0
337896|NCT00553358|1104034|P1|Overall Study|Withdrawal by Subject|5
337897|NCT00553358|1104032|P3|Overall Study|Protocol Violation|1
337898|NCT00553358|1104033|P2|Overall Study|Protocol Violation|1
337899|NCT00553358|1104034|P1|Overall Study|Protocol Violation|0
337900|NCT00553358|1104032|P3|Overall Study|Lost to Follow-up|1
337901|NCT00553358|1104033|P2|Overall Study|Lost to Follow-up|0
337902|NCT00553358|1104034|P1|Overall Study|Lost to Follow-up|0
337903|NCT00553358|1104032|P3|Overall Study|Adverse Event|32
337904|NCT00553358|1104033|P2|Overall Study|Adverse Event|2
337905|NCT00553358|1104034|P1|Overall Study|Adverse Event|29
337906|NCT00553332|1104060|P1|Overall Study|ineligible, incorrect diagnosis|1
337907|NCT00553319|1104072|P3|Overall Study|moved|1
337908|NCT00553319|1104073|P2|Overall Study|moved|0
337909|NCT00553319|1104074|P1|Overall Study|moved|1
337910|NCT00553319|1104072|P3|Overall Study|incarceration|0
337911|NCT00553319|1104073|P2|Overall Study|incarceration|0
337912|NCT00553319|1104074|P1|Overall Study|incarceration|1
337913|NCT00553319|1104072|P3|Overall Study|non-compliance|2
337914|NCT00553319|1104073|P2|Overall Study|non-compliance|0
337915|NCT00553319|1104074|P1|Overall Study|non-compliance|0
337916|NCT00553319|1104072|P3|Overall Study|wanted treatment elsewhere|1
337917|NCT00553319|1104073|P2|Overall Study|wanted treatment elsewhere|1
337918|NCT00553319|1104074|P1|Overall Study|wanted treatment elsewhere|2
337919|NCT00553319|1104072|P3|Overall Study|Lost to Follow-up|5
337920|NCT00553319|1104073|P2|Overall Study|Lost to Follow-up|9
337921|NCT00553319|1104074|P1|Overall Study|Lost to Follow-up|10
337922|NCT00553280|1104085|P1|Overall Study|Physician Decision|1
337923|NCT00553280|1104085|P1|Overall Study|Withdrawal by Subject|3
337924|NCT00553280|1104085|P1|Overall Study|Lack of Efficacy|3
337925|NCT00553280|1104085|P1|Overall Study|Adverse Event|19
337926|NCT00553267|1104097|P3|Overall Study|Specified category|1
337927|NCT00553267|1104098|P2|Overall Study|Specified category|2
337928|NCT00553267|1104099|P1|Overall Study|Specified category|1
337929|NCT00553267|1104097|P3|Overall Study|Consent withdrawn|1
337930|NCT00553267|1104098|P2|Overall Study|Consent withdrawn|3
337931|NCT00553267|1104099|P1|Overall Study|Consent withdrawn|2
337932|NCT00553267|1104097|P3|Overall Study|Lost to Follow-up|1
337933|NCT00553267|1104098|P2|Overall Study|Lost to Follow-up|0
337934|NCT00553267|1104099|P1|Overall Study|Lost to Follow-up|0
337935|NCT00553267|1104097|P3|Overall Study|Non compliant with protocol|2
337936|NCT00553267|1104098|P2|Overall Study|Non compliant with protocol|3
337937|NCT00553267|1104099|P1|Overall Study|Non compliant with protocol|3
337938|NCT00553267|1104097|P3|Overall Study|Adverse Event|5
337939|NCT00553267|1104098|P2|Overall Study|Adverse Event|10
337940|NCT00553267|1104099|P1|Overall Study|Adverse Event|8
337941|NCT00553202|1104134|P1|Overall Study|Fails to meet organ function|6
337942|NCT00553202|1104134|P1|Overall Study|No donor identified|16
337943|NCT00553202|1104134|P1|Overall Study|Withdrawal by Subject|1
337944|NCT00553202|1104134|P1|Overall Study|Physician Decision|28
337945|NCT00553202|1104134|P1|Overall Study|Lost to Follow-up|1
337946|NCT00553202|1104134|P1|Overall Study|Death|16
337947|NCT00553150|1104144|P4|Overall Study|Ineligible|1
337948|NCT00553150|1104145|P3|Overall Study|Ineligible|0
337949|NCT00553150|1104146|P2|Overall Study|Ineligible|0
337950|NCT00553150|1104147|P1|Overall Study|Ineligible|0
337951|NCT00553150|1104144|P4|Overall Study|Protocol Violation|1
337952|NCT00553150|1104145|P3|Overall Study|Protocol Violation|0
337953|NCT00553150|1104146|P2|Overall Study|Protocol Violation|0
337954|NCT00553150|1104147|P1|Overall Study|Protocol Violation|0
337955|NCT00553150|1104144|P4|Overall Study|Withdrawal by Subject|2
337956|NCT00553150|1104145|P3|Overall Study|Withdrawal by Subject|0
337957|NCT00553150|1104146|P2|Overall Study|Withdrawal by Subject|0
337958|NCT00553150|1104147|P1|Overall Study|Withdrawal by Subject|0
337959|NCT00552760|1104192|P2|Overall Study|Medication Change|0
337960|NCT00552760|1104193|P1|Overall Study|Medication Change|1
337961|NCT00552760|1104192|P2|Overall Study|Withdrawal by Subject|0
337962|NCT00552760|1104193|P1|Overall Study|Withdrawal by Subject|3
337963|NCT00552760|1104192|P2|Overall Study|Medical Condition|1
337964|NCT00552760|1104193|P1|Overall Study|Medical Condition|1
337965|NCT00552760|1104192|P2|Overall Study|Non-compliance|1
337966|NCT00552760|1104193|P1|Overall Study|Non-compliance|1
337967|NCT00552760|1104192|P2|Overall Study|Lost to Follow-up|1
337968|NCT00552760|1104193|P1|Overall Study|Lost to Follow-up|1
337969|NCT00552760|1104192|P2|Overall Study|Protocol Violation|1
337970|NCT00552760|1104193|P1|Overall Study|Protocol Violation|0
337971|NCT00552760|1104192|P2|Overall Study|Relapsed- Mixed Event|5
337972|NCT00552760|1104193|P1|Overall Study|Relapsed- Mixed Event|3
337973|NCT00552760|1104192|P2|Overall Study|Relapse- Manic Event|3
337974|NCT00552760|1104193|P1|Overall Study|Relapse- Manic Event|3
337975|NCT00552760|1104192|P2|Overall Study|Relapsed- Depressed Event|16
337976|NCT00552760|1104193|P1|Overall Study|Relapsed- Depressed Event|10
337977|NCT00552760|1104192|P2|Overall Study|Adverse Event|5
337978|NCT00552760|1104193|P1|Overall Study|Adverse Event|3
337979|NCT00552669|1104220|P2|Overall Study|Death|7
337980|NCT00552669|1104221|P1|Overall Study|Death|3
337981|NCT00552578|1104233|P2|Overall Study|Lost to Follow-up|1
337982|NCT00552578|1104234|P1|Overall Study|Lost to Follow-up|1
337983|NCT00552513|1104246|P2|Overall Study|Lost to Follow-up|1
337984|NCT00552513|1104247|P1|Overall Study|Lost to Follow-up|5
337985|NCT00552396|1104292|P7|Overall Study|protocol withdrawal criteria|9
337986|NCT00552396|1104293|P6|Overall Study|protocol withdrawal criteria|3
337987|NCT00552396|1104294|P5|Overall Study|protocol withdrawal criteria|3
337988|NCT00552396|1104295|P4|Overall Study|protocol withdrawal criteria|6
337989|NCT00552396|1104296|P3|Overall Study|protocol withdrawal criteria|3
337990|NCT00552396|1104297|P2|Overall Study|protocol withdrawal criteria|3
337991|NCT00552396|1104298|P1|Overall Study|protocol withdrawal criteria|3
337992|NCT00552344|1104335|P1|Overall Study|Other Reason|22
337993|NCT00552344|1104335|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
337994|NCT00552344|1104335|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
337995|NCT00552344|1104335|P1|Overall Study|AE, non-serious non-fatal|38
337996|NCT00552344|1104335|P1|Overall Study|SAE, non-fatal|6
337997|NCT00552344|1104335|P1|Overall Study|Withdrawal by Subject|48
337998|NCT00552344|1104335|P1|Overall Study|Lost to Follow-up|8
337999|NCT00552344|1104335|P1|Overall Study|Loss of efficacy|75
338000|NCT00552344|1104335|P1|Overall Study|Lack of Efficacy|55
338001|NCT00552305|1104344|P1|Overall Study|Other: Subject went to rehab|1
338002|NCT00552305|1104344|P1|Overall Study|Other: Subject incarcerated|1
338003|NCT00552305|1104344|P1|Overall Study|Other: Subject moved from area|2
338004|NCT00552305|1104344|P1|Overall Study|Other: Health problems, not drug related|1
338005|NCT00552305|1104344|P1|Overall Study|Other: Subject became pregnant|1
338006|NCT00552305|1104344|P1|Overall Study|Other: Subject underwent surgery|4
338007|NCT00552305|1104344|P1|Overall Study|Other: Unable to attend visits|1
338008|NCT00552305|1104344|P1|Overall Study|Other: Personal problems|1
338009|NCT00552305|1104344|P1|Overall Study|Other: Site closed|4
338010|NCT00552305|1104344|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
338011|NCT00552305|1104344|P1|Overall Study|AE/Other: prohibited drug required|1
338012|NCT00552305|1104344|P1|Overall Study|Poor compliance/lost to follow-up|1
338013|NCT00552305|1104344|P1|Overall Study|Unsatisfactory compliance|11
338014|NCT00552305|1104344|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
338015|NCT00552305|1104344|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
338016|NCT00552305|1104344|P1|Overall Study|Lack of efficacy/withdrew consent|1
338017|NCT00552305|1104344|P1|Overall Study|Withdrawal by Subject|44
338018|NCT00552305|1104344|P1|Overall Study|Protocol Violation|3
338019|NCT00552305|1104344|P1|Overall Study|Lost to Follow-up|4
338020|NCT00552305|1104344|P1|Overall Study|Lack of Efficacy|120
338021|NCT00552305|1104344|P1|Overall Study|Adverse Event|43
338022|NCT00552279|1104354|P2|Overall Study|Other|1
338023|NCT00552279|1104355|P1|Overall Study|Other|1
338024|NCT00552279|1104354|P2|Overall Study|Lost to Follow-up|0
338025|NCT00552279|1104355|P1|Overall Study|Lost to Follow-up|1
338026|NCT00552279|1104354|P2|Overall Study|Withdrawal by Subject|1
338027|NCT00552279|1104355|P1|Overall Study|Withdrawal by Subject|12
338028|NCT00552279|1104354|P2|Overall Study|Adverse Event|1
338029|NCT00552279|1104355|P1|Overall Study|Adverse Event|0
338030|NCT00552240|1104381|P2|Overall Study|not specified|0
338031|NCT00552240|1104382|P1|Overall Study|not specified|1
338032|NCT00552240|1104381|P2|Overall Study|Lack of Efficacy|0
338033|NCT00552240|1104382|P1|Overall Study|Lack of Efficacy|6
338034|NCT00552240|1104381|P2|Overall Study|Withdrawal by Subject|2
338035|NCT00552240|1104382|P1|Overall Study|Withdrawal by Subject|2
338036|NCT00552240|1104381|P2|Overall Study|Lost to Follow-up|6
338037|NCT00552240|1104382|P1|Overall Study|Lost to Follow-up|5
338038|NCT00552240|1104381|P2|Overall Study|Protocol Violation|1
338039|NCT00552240|1104382|P1|Overall Study|Protocol Violation|1
338040|NCT00552240|1104381|P2|Overall Study|Adverse Event|9
338041|NCT00552240|1104382|P1|Overall Study|Adverse Event|9
338042|NCT00552188|1104484|P2|Overall Study|Subject returned to home country|1
338043|NCT00552188|1104485|P1|Overall Study|Subject returned to home country|0
338044|NCT00552188|1104484|P2|Overall Study|Withdrawal of consent|1
338045|NCT00552188|1104485|P1|Overall Study|Withdrawal of consent|0
338046|NCT00552188|1104484|P2|Overall Study|Lost to Follow-up|1
338047|NCT00552188|1104485|P1|Overall Study|Lost to Follow-up|2
338048|NCT00552188|1104484|P2|Overall Study|Adverse Event|2
338049|NCT00552188|1104485|P1|Overall Study|Adverse Event|0
338050|NCT00552175|1104496|P3|Overall Study|Reason Not Specified|1
338051|NCT00552175|1104497|P2|Overall Study|Reason Not Specified|1
338052|NCT00552175|1104498|P1|Overall Study|Reason Not Specified|3
338053|NCT00552175|1104496|P3|Overall Study|Entry Criteria Not Met|0
338054|NCT00552175|1104497|P2|Overall Study|Entry Criteria Not Met|1
338055|NCT00552175|1104498|P1|Overall Study|Entry Criteria Not Met|1
338056|NCT00552175|1104496|P3|Overall Study|Lost to Follow-up|1
338057|NCT00552175|1104497|P2|Overall Study|Lost to Follow-up|0
338058|NCT00552175|1104498|P1|Overall Study|Lost to Follow-up|0
338059|NCT00552175|1104496|P3|Overall Study|Withdrawal by Subject|1
338060|NCT00552175|1104497|P2|Overall Study|Withdrawal by Subject|2
338061|NCT00552175|1104498|P1|Overall Study|Withdrawal by Subject|2
338062|NCT00552175|1104496|P3|Overall Study|Adverse Event|10
338063|NCT00552175|1104497|P2|Overall Study|Adverse Event|9
338064|NCT00552175|1104498|P1|Overall Study|Adverse Event|9
338065|NCT00552175|1104496|P3|Overall Study|Lack of Efficacy|1
338066|NCT00552175|1104497|P2|Overall Study|Lack of Efficacy|0
338067|NCT00552175|1104498|P1|Overall Study|Lack of Efficacy|2
338068|NCT00552110|1104538|P5|Overall Study|Nonserious Adverse Event (AE)|0
338069|NCT00552110|1104539|P4|Overall Study|Nonserious Adverse Event (AE)|1
338070|NCT00552110|1104540|P3|Overall Study|Nonserious Adverse Event (AE)|0
338071|NCT00552110|1104541|P2|Overall Study|Nonserious Adverse Event (AE)|0
338072|NCT00552110|1104542|P1|Overall Study|Nonserious Adverse Event (AE)|1
338073|NCT00552110|1104538|P5|Overall Study|Increased Blood Pressure at Visit 2|0
338074|NCT00552110|1104539|P4|Overall Study|Increased Blood Pressure at Visit 2|1
338075|NCT00552110|1104540|P3|Overall Study|Increased Blood Pressure at Visit 2|0
338076|NCT00552110|1104541|P2|Overall Study|Increased Blood Pressure at Visit 2|0
338077|NCT00552110|1104542|P1|Overall Study|Increased Blood Pressure at Visit 2|0
338078|NCT00552110|1104538|P5|Overall Study|Delay of Study due to Relabeling|0
338079|NCT00552110|1104539|P4|Overall Study|Delay of Study due to Relabeling|1
338080|NCT00552110|1104540|P3|Overall Study|Delay of Study due to Relabeling|0
338081|NCT00552110|1104541|P2|Overall Study|Delay of Study due to Relabeling|0
338082|NCT00552110|1104542|P1|Overall Study|Delay of Study due to Relabeling|0
338083|NCT00552110|1104538|P5|Overall Study|Use of Prohibited Medication|0
338084|NCT00552110|1104539|P4|Overall Study|Use of Prohibited Medication|0
338085|NCT00552110|1104540|P3|Overall Study|Use of Prohibited Medication|0
338086|NCT00552110|1104541|P2|Overall Study|Use of Prohibited Medication|1
338087|NCT00552110|1104542|P1|Overall Study|Use of Prohibited Medication|1
338088|NCT00552110|1104538|P5|Overall Study|Withdrawn per Sponsor|1
338089|NCT00552110|1104539|P4|Overall Study|Withdrawn per Sponsor|0
338090|NCT00552110|1104540|P3|Overall Study|Withdrawn per Sponsor|0
338091|NCT00552110|1104541|P2|Overall Study|Withdrawn per Sponsor|1
338092|NCT00552110|1104542|P1|Overall Study|Withdrawn per Sponsor|0
338093|NCT00552110|1104538|P5|Overall Study|Failed to Comply With Study Requirements|1
338094|NCT00552110|1104539|P4|Overall Study|Failed to Comply With Study Requirements|0
338095|NCT00552110|1104540|P3|Overall Study|Failed to Comply With Study Requirements|1
338096|NCT00552110|1104541|P2|Overall Study|Failed to Comply With Study Requirements|1
338097|NCT00552110|1104542|P1|Overall Study|Failed to Comply With Study Requirements|1
338098|NCT00552110|1104538|P5|Overall Study|Lost to Follow-up|1
338099|NCT00552110|1104539|P4|Overall Study|Lost to Follow-up|1
338100|NCT00552110|1104540|P3|Overall Study|Lost to Follow-up|0
338101|NCT00552110|1104541|P2|Overall Study|Lost to Follow-up|0
338102|NCT00552110|1104542|P1|Overall Study|Lost to Follow-up|0
338103|NCT00552110|1104538|P5|Overall Study|Withdrawal by Subject|2
338104|NCT00552110|1104539|P4|Overall Study|Withdrawal by Subject|3
338105|NCT00552110|1104540|P3|Overall Study|Withdrawal by Subject|0
338106|NCT00552110|1104541|P2|Overall Study|Withdrawal by Subject|2
338107|NCT00552110|1104542|P1|Overall Study|Withdrawal by Subject|0
338108|NCT00552110|1104538|P5|Overall Study|Lack of Efficacy|4
338109|NCT00552110|1104539|P4|Overall Study|Lack of Efficacy|1
338110|NCT00552110|1104540|P3|Overall Study|Lack of Efficacy|0
338111|NCT00552110|1104541|P2|Overall Study|Lack of Efficacy|0
338112|NCT00552110|1104542|P1|Overall Study|Lack of Efficacy|1
338113|NCT00552110|1104538|P5|Overall Study|Serious or Life-Threatening AE|0
338114|NCT00552110|1104539|P4|Overall Study|Serious or Life-Threatening AE|0
338115|NCT00552110|1104540|P3|Overall Study|Serious or Life-Threatening AE|1
338116|NCT00552110|1104541|P2|Overall Study|Serious or Life-Threatening AE|0
338117|NCT00552110|1104542|P1|Overall Study|Serious or Life-Threatening AE|0
338118|NCT00552084|1104561|P2|Overall Study|change in anti-arrythmic drug|1
338119|NCT00552084|1104562|P1|Overall Study|change in anti-arrythmic drug|1
338120|NCT00552084|1104561|P2|Overall Study|Protocol Violation|0
338121|NCT00552084|1104562|P1|Overall Study|Protocol Violation|1
338122|NCT00552084|1104561|P2|Overall Study|Withdrawal by Subject|5
338123|NCT00552084|1104562|P1|Overall Study|Withdrawal by Subject|4
338124|NCT00552084|1104561|P2|Overall Study|Adverse Event|3
338125|NCT00552084|1104562|P1|Overall Study|Adverse Event|2
338126|NCT00552058|1104570|P2|Overall Study|Other: Early Roll Over|0
338127|NCT00552058|1104571|P1|Overall Study|Other: Early Roll Over|1
338128|NCT00552058|1104570|P2|Overall Study|Other: Sponsors Decision|1
338129|NCT00552058|1104571|P1|Overall Study|Other: Sponsors Decision|0
338130|NCT00552058|1104570|P2|Overall Study|Other: Randomized in error|1
338131|NCT00552058|1104571|P1|Overall Study|Other: Randomized in error|0
338132|NCT00552058|1104570|P2|Overall Study|Other: Positive Stool Result|1
338133|NCT00552058|1104571|P1|Overall Study|Other: Positive Stool Result|0
338134|NCT00552058|1104570|P2|Overall Study|Other: Low CDAI score, entry violation|1
338135|NCT00552058|1104571|P1|Overall Study|Other: Low CDAI score, entry violation|0
338136|NCT00552058|1104570|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
338137|NCT00552058|1104571|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
338138|NCT00552058|1104570|P2|Overall Study|Other: Non Compliance|2
338139|NCT00552058|1104571|P1|Overall Study|Other: Non Compliance|1
338140|NCT00552058|1104570|P2|Overall Study|Other: Protocol Violation|1
338141|NCT00552058|1104571|P1|Overall Study|Other: Protocol Violation|0
338142|NCT00552058|1104570|P2|Overall Study|Withdrawal by Subject|4
338143|NCT00552058|1104571|P1|Overall Study|Withdrawal by Subject|4
338144|NCT00552058|1104570|P2|Overall Study|Lost to Follow-up|0
338145|NCT00552058|1104571|P1|Overall Study|Lost to Follow-up|1
338146|NCT00552058|1104570|P2|Overall Study|Lack of Efficacy|5
338147|NCT00552058|1104571|P1|Overall Study|Lack of Efficacy|1
338148|NCT00552058|1104570|P2|Overall Study|Adverse Event|7
338149|NCT00552058|1104571|P1|Overall Study|Adverse Event|8
338150|NCT00552032|1104611|P2|Overall Study|Lost to Follow-up|5
338151|NCT00552032|1104612|P1|Overall Study|Lost to Follow-up|8
338152|NCT00552032|1104611|P2|Overall Study|Protocol Violation|12
338153|NCT00552032|1104612|P1|Overall Study|Protocol Violation|7
338154|NCT00552032|1104611|P2|Overall Study|Withdrawal by Subject|2
338155|NCT00552032|1104612|P1|Overall Study|Withdrawal by Subject|2
338156|NCT00551759|1104656|P1|Overall Study|Ineligible|1
338157|NCT00551759|1104656|P1|Overall Study|Death|5
338158|NCT00551759|1104656|P1|Overall Study|Adverse Event|7
338159|NCT00551642|1104697|P2|Overall Study|Inclusion/Exclusion criteria|4
338160|NCT00551642|1104698|P1|Overall Study|Inclusion/Exclusion criteria|4
338161|NCT00551642|1104697|P2|Overall Study|Delivery device failure|3
338162|NCT00551642|1104698|P1|Overall Study|Delivery device failure|1
338163|NCT00551642|1104697|P2|Overall Study|Physician Decision|1
338164|NCT00551642|1104698|P1|Overall Study|Physician Decision|0
338165|NCT00551642|1104697|P2|Overall Study|Protocol Violation|11
338166|NCT00551642|1104698|P1|Overall Study|Protocol Violation|6
338167|NCT00551642|1104697|P2|Overall Study|Death|31
338168|NCT00551642|1104698|P1|Overall Study|Death|33
338169|NCT00551642|1104697|P2|Overall Study|Adverse Event|12
338170|NCT00551642|1104698|P1|Overall Study|Adverse Event|15
338171|NCT00551642|1104697|P2|Overall Study|Withdrawal by Subject|1
338172|NCT00551642|1104698|P1|Overall Study|Withdrawal by Subject|2
338173|NCT00551421|1104704|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
338174|NCT00551369|1104711|P1|Overall Study|Not treated per protocol and re|1
338175|NCT00551369|1104711|P1|Overall Study|Withdrawal by Subject|1
338176|NCT00551369|1104711|P1|Overall Study|Protocol Violation|5
338177|NCT00551291|1104718|P1|Overall Study|Physician Decision|1
338178|NCT00551213|1104726|P2|Overall Study|Not Treated|2
338179|NCT00551213|1104727|P1|Overall Study|Not Treated|1
338180|NCT00551213|1104726|P2|Overall Study|Withdrawal by Subject|0
338181|NCT00551213|1104727|P1|Overall Study|Withdrawal by Subject|2
338182|NCT00551213|1104726|P2|Overall Study|Progressive Disease|12
338183|NCT00551213|1104727|P1|Overall Study|Progressive Disease|41
338184|NCT00551213|1104726|P2|Overall Study|Adverse Event|3
338185|NCT00551213|1104727|P1|Overall Study|Adverse Event|6
338186|NCT00551161|1104771|P1|Overall Study|Withdrawal by Subject|1
338187|NCT00551135|1104779|P4|Overall Study|Withdrawal by Subject|1
338188|NCT00551135|1104780|P3|Overall Study|Withdrawal by Subject|3
338189|NCT00551135|1104781|P2|Overall Study|Withdrawal by Subject|0
338190|NCT00551135|1104782|P1|Overall Study|Withdrawal by Subject|1
338191|NCT00551135|1104779|P4|Overall Study|Unspecified|2
338192|NCT00551135|1104780|P3|Overall Study|Unspecified|1
338193|NCT00551135|1104781|P2|Overall Study|Unspecified|2
338194|NCT00551135|1104782|P1|Overall Study|Unspecified|3
338195|NCT00551135|1104779|P4|Overall Study|Lost to Follow-up|1
338196|NCT00551135|1104780|P3|Overall Study|Lost to Follow-up|0
338197|NCT00551135|1104781|P2|Overall Study|Lost to Follow-up|0
338198|NCT00551135|1104782|P1|Overall Study|Lost to Follow-up|0
338199|NCT00551135|1104779|P4|Overall Study|Adverse Event|1
338200|NCT00551135|1104780|P3|Overall Study|Adverse Event|1
338201|NCT00551135|1104781|P2|Overall Study|Adverse Event|0
338202|NCT00551135|1104782|P1|Overall Study|Adverse Event|1
338203|NCT00551031|1104911|P5|Overall Study|Did not receive vaccine|0
338204|NCT00551031|1104912|P4|Overall Study|Did not receive vaccine|0
338205|NCT00551031|1104913|P3|Overall Study|Did not receive vaccine|0
338206|NCT00551031|1104914|P2|Overall Study|Did not receive vaccine|2
338207|NCT00551031|1104915|P1|Overall Study|Did not receive vaccine|1
338208|NCT00551031|1104911|P5|Overall Study|Serious Adverse Event|0
338209|NCT00551031|1104912|P4|Overall Study|Serious Adverse Event|0
338210|NCT00551031|1104913|P3|Overall Study|Serious Adverse Event|1
338211|NCT00551031|1104914|P2|Overall Study|Serious Adverse Event|2
338212|NCT00551031|1104915|P1|Overall Study|Serious Adverse Event|0
338213|NCT00551031|1104911|P5|Overall Study|Withdrawal by Subject|0
338214|NCT00551031|1104912|P4|Overall Study|Withdrawal by Subject|2
338215|NCT00551031|1104913|P3|Overall Study|Withdrawal by Subject|1
338216|NCT00551031|1104914|P2|Overall Study|Withdrawal by Subject|4
338217|NCT00551031|1104915|P1|Overall Study|Withdrawal by Subject|0
338218|NCT00551031|1104911|P5|Overall Study|Lost to Follow-up|1
338219|NCT00551031|1104912|P4|Overall Study|Lost to Follow-up|1
338220|NCT00551031|1104913|P3|Overall Study|Lost to Follow-up|0
338221|NCT00551031|1104914|P2|Overall Study|Lost to Follow-up|1
338222|NCT00551031|1104915|P1|Overall Study|Lost to Follow-up|0
338223|NCT00551031|1104911|P5|Overall Study|Protocol Violation|0
338224|NCT00551031|1104912|P4|Overall Study|Protocol Violation|0
338225|NCT00551031|1104913|P3|Overall Study|Protocol Violation|0
338226|NCT00551031|1104914|P2|Overall Study|Protocol Violation|1
338227|NCT00551031|1104915|P1|Overall Study|Protocol Violation|1
338228|NCT00551031|1104911|P5|Overall Study|Adverse Event|0
338229|NCT00551031|1104912|P4|Overall Study|Adverse Event|0
338230|NCT00551031|1104913|P3|Overall Study|Adverse Event|0
338231|NCT00551031|1104914|P2|Overall Study|Adverse Event|1
338232|NCT00551031|1104915|P1|Overall Study|Adverse Event|0
338233|NCT00550953|1104944|P2|Overall Study|Not able to visit the site|3
338234|NCT00550953|1104945|P1|Overall Study|Not able to visit the site|2
338235|NCT00550953|1104944|P2|Overall Study|Adverse Event|3
338236|NCT00550953|1104945|P1|Overall Study|Adverse Event|4
338237|NCT00550836|1104992|P2|Overall Study|Withdrawal by Subject|9
338238|NCT00550836|1104993|P1|Overall Study|Withdrawal by Subject|3
338239|NCT00550771|1105009|P2|Overall Study|Protocol Violation|5
338240|NCT00550771|1105010|P1|Overall Study|Protocol Violation|4
338241|NCT00550771|1105009|P2|Overall Study|Withdrawal by Subject|1
338242|NCT00550771|1105010|P1|Overall Study|Withdrawal by Subject|0
338243|NCT00550771|1105009|P2|Overall Study|Physician Decision|0
338244|NCT00550771|1105010|P1|Overall Study|Physician Decision|2
338245|NCT00550771|1105009|P2|Overall Study|Discontinued for study-related reasons|1
338246|NCT00550771|1105010|P1|Overall Study|Discontinued for study-related reasons|0
338247|NCT00550771|1105009|P2|Overall Study|Adverse Event|3
338248|NCT00550771|1105010|P1|Overall Study|Adverse Event|11
338249|NCT00550745|1105024|P2|Overall Study|Screen failure|0
338250|NCT00550745|1105025|P1|Overall Study|Screen failure|1
338251|NCT00550745|1105024|P2|Overall Study|Withdrawal by Subject|10
338252|NCT00550745|1105025|P1|Overall Study|Withdrawal by Subject|17
338253|NCT00550745|1105024|P2|Overall Study|Protocol Violation|2
338254|NCT00550745|1105025|P1|Overall Study|Protocol Violation|4
338255|NCT00550745|1105024|P2|Overall Study|Physician Decision|2
338256|NCT00550745|1105025|P1|Overall Study|Physician Decision|0
338257|NCT00550745|1105024|P2|Overall Study|Lost to Follow-up|30
338258|NCT00550745|1105025|P1|Overall Study|Lost to Follow-up|45
338259|NCT00550745|1105024|P2|Overall Study|Death|16
338260|NCT00550745|1105025|P1|Overall Study|Death|20
338261|NCT00550732|1105033|P1|Overall Study|Adverse Event|1
338262|NCT00550732|1105033|P1|Overall Study|Palliative care|1
338263|NCT00550732|1105033|P1|Overall Study|Lost to Follow-up|1
338264|NCT00550732|1105033|P1|Overall Study|Physician Decision|2
338265|NCT00550732|1105033|P1|Overall Study|Withdrawal by Subject|2
338266|NCT00550732|1105033|P1|Overall Study|Death|4
338267|NCT00550680|1105044|P1|Overall Study|Screen Failure|6
338268|NCT00550680|1105044|P1|Overall Study|Refused Treatment|19
338269|NCT00550680|1105044|P1|Overall Study|Protocol Violation|7
338270|NCT00550680|1105044|P1|Overall Study|Not Specified|10
338271|NCT00550680|1105044|P1|Overall Study|Lack of Efficacy|1
338272|NCT00550680|1105044|P1|Overall Study|Lost to Follow-up|3
338273|NCT00550680|1105044|P1|Overall Study|Early Improvement|1
338274|NCT00550680|1105044|P1|Overall Study|Death|3
338275|NCT00550680|1105044|P1|Overall Study|Adverse Event|5
338276|NCT00550680|1105044|P1|Overall Study|Administrative Reasons|1
338277|NCT00550550|1105076|P2|Overall Study|Randomized But Not Treated|0
338278|NCT00550550|1105077|P1|Overall Study|Randomized But Not Treated|1
338279|NCT00550550|1105076|P2|Overall Study|Did Not Meet Protocol Eligibility|1
338280|NCT00550550|1105077|P1|Overall Study|Did Not Meet Protocol Eligibility|1
338281|NCT00550550|1105076|P2|Overall Study|Protocol Violation|14
338282|NCT00550550|1105077|P1|Overall Study|Protocol Violation|5
338283|NCT00550550|1105076|P2|Overall Study|Withdrawal by Subject|8
338284|NCT00550550|1105077|P1|Overall Study|Withdrawal by Subject|10
338285|NCT00550550|1105076|P2|Overall Study|Lost to Follow-up|0
338286|NCT00550550|1105077|P1|Overall Study|Lost to Follow-up|4
338287|NCT00550550|1105076|P2|Overall Study|Treatment Failure|1
338288|NCT00550550|1105077|P1|Overall Study|Treatment Failure|0
338289|NCT00550550|1105076|P2|Overall Study|Adverse Event|5
338290|NCT00550550|1105077|P1|Overall Study|Adverse Event|13
338291|NCT00550537|1105089|P1|Overall Study|Treated closer to home|4
338292|NCT00550537|1105089|P1|Overall Study|Declining performance status|2
338293|NCT00550537|1105089|P1|Overall Study|Other complicating ilness|3
338294|NCT00550537|1105089|P1|Overall Study|Change in treatment plan|4
338295|NCT00550537|1105089|P1|Overall Study|Withdrawal by Subject|7
338296|NCT00550537|1105089|P1|Overall Study|Disease progression before|46
338297|NCT00550537|1105089|P1|Overall Study|Adverse Event|20
338298|NCT00550537|1105089|P1|Overall Study|Death|18
338299|NCT00550459|1105106|P2|Overall Study|Withdrawal by Subject|1
338300|NCT00550459|1105107|P1|Overall Study|Withdrawal by Subject|1
338301|NCT00550459|1105106|P2|Overall Study|Adverse Event|2
338302|NCT00550459|1105107|P1|Overall Study|Adverse Event|0
338303|NCT00550446|1105176|P11|Post Week 12|Unspecified|0
338304|NCT00550446|1105177|P10|Post Week 12|Unspecified|1
338305|NCT00550446|1105178|P9|Post Week 12|Unspecified|1
338306|NCT00550446|1105179|P8|Post Week 12|Unspecified|0
338307|NCT00550446|1105180|P7|Post Week 12|Unspecified|1
338308|NCT00550446|1105181|P6|Post Week 12|Unspecified|0
338309|NCT00550446|1105182|P5|Post Week 12|Unspecified|0
338310|NCT00550446|1105183|P4|Post Week 12|Unspecified|1
338311|NCT00550446|1105184|P3|Post Week 12|Unspecified|0
338312|NCT00550446|1105185|P2|Post Week 12|Unspecified|1
338313|NCT00550446|1105186|P1|Post Week 12|Unspecified|1
338314|NCT00550446|1105176|P11|Post Week 12|Withdrawal by Subject|0
338315|NCT00550446|1105177|P10|Post Week 12|Withdrawal by Subject|0
338316|NCT00550446|1105178|P9|Post Week 12|Withdrawal by Subject|0
338317|NCT00550446|1105179|P8|Post Week 12|Withdrawal by Subject|0
338318|NCT00550446|1105180|P7|Post Week 12|Withdrawal by Subject|0
338319|NCT00550446|1105181|P6|Post Week 12|Withdrawal by Subject|0
338320|NCT00550446|1105182|P5|Post Week 12|Withdrawal by Subject|1
338321|NCT00550446|1105183|P4|Post Week 12|Withdrawal by Subject|0
338322|NCT00550446|1105184|P3|Post Week 12|Withdrawal by Subject|0
338323|NCT00550446|1105185|P2|Post Week 12|Withdrawal by Subject|0
338324|NCT00550446|1105186|P1|Post Week 12|Withdrawal by Subject|0
338325|NCT00550446|1105176|P11|Post Week 12|Lost to Follow-up|0
338326|NCT00550446|1105177|P10|Post Week 12|Lost to Follow-up|0
338327|NCT00550446|1105178|P9|Post Week 12|Lost to Follow-up|0
338328|NCT00550446|1105179|P8|Post Week 12|Lost to Follow-up|0
338329|NCT00550446|1105180|P7|Post Week 12|Lost to Follow-up|1
338330|NCT00550446|1105181|P6|Post Week 12|Lost to Follow-up|0
338331|NCT00550446|1105182|P5|Post Week 12|Lost to Follow-up|0
338332|NCT00550446|1105183|P4|Post Week 12|Lost to Follow-up|1
338333|NCT00550446|1105184|P3|Post Week 12|Lost to Follow-up|1
338334|NCT00550446|1105185|P2|Post Week 12|Lost to Follow-up|0
338335|NCT00550446|1105186|P1|Post Week 12|Lost to Follow-up|0
338336|NCT00550446|1105176|P11|Post Week 12|Lack of Efficacy|1
338337|NCT00550446|1105177|P10|Post Week 12|Lack of Efficacy|2
338338|NCT00550446|1105178|P9|Post Week 12|Lack of Efficacy|1
338339|NCT00550446|1105179|P8|Post Week 12|Lack of Efficacy|1
338340|NCT00550446|1105180|P7|Post Week 12|Lack of Efficacy|0
338341|NCT00550446|1105181|P6|Post Week 12|Lack of Efficacy|0
338342|NCT00550446|1105182|P5|Post Week 12|Lack of Efficacy|0
338343|NCT00550446|1105183|P4|Post Week 12|Lack of Efficacy|0
338344|NCT00550446|1105184|P3|Post Week 12|Lack of Efficacy|1
338345|NCT00550446|1105185|P2|Post Week 12|Lack of Efficacy|0
338346|NCT00550446|1105186|P1|Post Week 12|Lack of Efficacy|0
338347|NCT00550446|1105176|P11|Post Week 12|Adverse Event|0
338348|NCT00550446|1105177|P10|Post Week 12|Adverse Event|4
338349|NCT00550446|1105178|P9|Post Week 12|Adverse Event|0
338350|NCT00550446|1105179|P8|Post Week 12|Adverse Event|0
338351|NCT00550446|1105180|P7|Post Week 12|Adverse Event|0
338352|NCT00550446|1105181|P6|Post Week 12|Adverse Event|1
338353|NCT00550446|1105182|P5|Post Week 12|Adverse Event|1
338354|NCT00550446|1105183|P4|Post Week 12|Adverse Event|1
338355|NCT00550446|1105184|P3|Post Week 12|Adverse Event|1
338356|NCT00550446|1105185|P2|Post Week 12|Adverse Event|1
338357|NCT00550446|1105186|P1|Post Week 12|Adverse Event|2
338358|NCT00550446|1105176|P11|Up To Week 12|Randomized not treated|0
338359|NCT00550446|1105177|P10|Up To Week 12|Randomized not treated|0
338360|NCT00550446|1105178|P9|Up To Week 12|Randomized not treated|0
338361|NCT00550446|1105179|P8|Up To Week 12|Randomized not treated|0
338362|NCT00550446|1105180|P7|Up To Week 12|Randomized not treated|0
338363|NCT00550446|1105181|P6|Up To Week 12|Randomized not treated|0
338364|NCT00550446|1105182|P5|Up To Week 12|Randomized not treated|0
338365|NCT00550446|1105183|P4|Up To Week 12|Randomized not treated|0
338366|NCT00550446|1105184|P3|Up To Week 12|Randomized not treated|1
338367|NCT00550446|1105185|P2|Up To Week 12|Randomized not treated|1
338368|NCT00550446|1105186|P1|Up To Week 12|Randomized not treated|0
338369|NCT00550446|1105176|P11|Up To Week 12|Unspecified|0
338370|NCT00550446|1105177|P10|Up To Week 12|Unspecified|0
338371|NCT00550446|1105178|P9|Up To Week 12|Unspecified|0
338372|NCT00550446|1105179|P8|Up To Week 12|Unspecified|0
338373|NCT00550446|1105180|P7|Up To Week 12|Unspecified|4
338374|NCT00550446|1105181|P6|Up To Week 12|Unspecified|1
338375|NCT00550446|1105182|P5|Up To Week 12|Unspecified|0
338376|NCT00550446|1105183|P4|Up To Week 12|Unspecified|0
338377|NCT00550446|1105184|P3|Up To Week 12|Unspecified|0
338378|NCT00550446|1105185|P2|Up To Week 12|Unspecified|0
338379|NCT00550446|1105186|P1|Up To Week 12|Unspecified|3
338380|NCT00550446|1105176|P11|Up To Week 12|Withdrawal by Subject|0
338381|NCT00550446|1105177|P10|Up To Week 12|Withdrawal by Subject|0
338382|NCT00550446|1105178|P9|Up To Week 12|Withdrawal by Subject|0
338383|NCT00550446|1105179|P8|Up To Week 12|Withdrawal by Subject|0
338384|NCT00550446|1105180|P7|Up To Week 12|Withdrawal by Subject|3
338385|NCT00550446|1105181|P6|Up To Week 12|Withdrawal by Subject|1
338386|NCT00550446|1105182|P5|Up To Week 12|Withdrawal by Subject|0
338387|NCT00550446|1105183|P4|Up To Week 12|Withdrawal by Subject|2
338388|NCT00550446|1105184|P3|Up To Week 12|Withdrawal by Subject|3
338389|NCT00550446|1105185|P2|Up To Week 12|Withdrawal by Subject|0
338390|NCT00550446|1105186|P1|Up To Week 12|Withdrawal by Subject|2
338391|NCT00550446|1105176|P11|Up To Week 12|Lost to Follow-up|0
338392|NCT00550446|1105177|P10|Up To Week 12|Lost to Follow-up|0
338393|NCT00550446|1105178|P9|Up To Week 12|Lost to Follow-up|0
338394|NCT00550446|1105179|P8|Up To Week 12|Lost to Follow-up|0
338395|NCT00550446|1105180|P7|Up To Week 12|Lost to Follow-up|2
338396|NCT00550446|1105181|P6|Up To Week 12|Lost to Follow-up|1
338397|NCT00550446|1105182|P5|Up To Week 12|Lost to Follow-up|1
338398|NCT00550446|1105183|P4|Up To Week 12|Lost to Follow-up|0
338399|NCT00550446|1105184|P3|Up To Week 12|Lost to Follow-up|0
338400|NCT00550446|1105185|P2|Up To Week 12|Lost to Follow-up|1
338401|NCT00550446|1105186|P1|Up To Week 12|Lost to Follow-up|0
338402|NCT00550446|1105176|P11|Up To Week 12|Lack of Efficacy|0
338403|NCT00550446|1105177|P10|Up To Week 12|Lack of Efficacy|0
338404|NCT00550446|1105178|P9|Up To Week 12|Lack of Efficacy|0
338405|NCT00550446|1105179|P8|Up To Week 12|Lack of Efficacy|0
338406|NCT00550446|1105180|P7|Up To Week 12|Lack of Efficacy|3
338407|NCT00550446|1105181|P6|Up To Week 12|Lack of Efficacy|3
338408|NCT00550446|1105182|P5|Up To Week 12|Lack of Efficacy|0
338409|NCT00550446|1105183|P4|Up To Week 12|Lack of Efficacy|1
338410|NCT00550446|1105184|P3|Up To Week 12|Lack of Efficacy|0
338411|NCT00550446|1105185|P2|Up To Week 12|Lack of Efficacy|1
338412|NCT00550446|1105186|P1|Up To Week 12|Lack of Efficacy|3
338413|NCT00550446|1105176|P11|Up To Week 12|Adverse Event|0
338414|NCT00550446|1105177|P10|Up To Week 12|Adverse Event|0
338415|NCT00550446|1105178|P9|Up To Week 12|Adverse Event|0
338416|NCT00550446|1105179|P8|Up To Week 12|Adverse Event|0
338417|NCT00550446|1105180|P7|Up To Week 12|Adverse Event|1
338418|NCT00550446|1105181|P6|Up To Week 12|Adverse Event|2
338419|NCT00550446|1105182|P5|Up To Week 12|Adverse Event|2
338420|NCT00550446|1105183|P4|Up To Week 12|Adverse Event|0
338421|NCT00550446|1105184|P3|Up To Week 12|Adverse Event|0
338422|NCT00550446|1105185|P2|Up To Week 12|Adverse Event|2
338423|NCT00550446|1105186|P1|Up To Week 12|Adverse Event|2
338424|NCT00550407|1105620|P3|26-Week Randomized Phase|Withdrawal by Subject|3
338425|NCT00550407|1105621|P2|26-Week Randomized Phase|Withdrawal by Subject|1
338426|NCT00550407|1105622|P1|26-Week Randomized Phase|Withdrawal by Subject|0
338427|NCT00550407|1105620|P3|26-Week Randomized Phase|Investigator Discretion|0
338428|NCT00550407|1105621|P2|26-Week Randomized Phase|Investigator Discretion|1
338429|NCT00550407|1105622|P1|26-Week Randomized Phase|Investigator Discretion|0
338430|NCT00550407|1105620|P3|26-Week Randomized Phase|Lack of Efficacy|19
338431|NCT00550407|1105621|P2|26-Week Randomized Phase|Lack of Efficacy|36
338432|NCT00550407|1105622|P1|26-Week Randomized Phase|Lack of Efficacy|0
338433|NCT00550407|1105620|P3|26-Week Randomized Phase|Adverse Event|2
338434|NCT00550407|1105621|P2|26-Week Randomized Phase|Adverse Event|5
338435|NCT00550407|1105622|P1|26-Week Randomized Phase|Adverse Event|0
338436|NCT00550407|1105620|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
338437|NCT00550407|1105621|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
338438|NCT00550407|1105622|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
338439|NCT00550407|1105620|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
338440|NCT00550407|1105621|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
338441|NCT00550407|1105622|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
338442|NCT00550407|1105620|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
338443|NCT00550407|1105621|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
338444|NCT00550407|1105622|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
338445|NCT00550407|1105620|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
338446|NCT00550407|1105621|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
338447|NCT00550407|1105622|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
338448|NCT00550407|1105620|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
338449|NCT00550407|1105621|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
338450|NCT00550407|1105622|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
338451|NCT00550407|1105620|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
338452|NCT00550407|1105621|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
338453|NCT00550407|1105622|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
338454|NCT00550407|1105620|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
338455|NCT00550407|1105621|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
338456|NCT00550407|1105622|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
338457|NCT00550407|1105620|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
338458|NCT00550407|1105621|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
338459|NCT00550407|1105622|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
338460|NCT00549601|1105684|P3|Received Study Drug|Withdrawal by Subject|1
338461|NCT00549601|1105685|P2|Received Study Drug|Withdrawal by Subject|0
338462|NCT00549601|1105686|P1|Received Study Drug|Withdrawal by Subject|2
338463|NCT00549601|1105684|P3|Received Study Drug|Protocol Violation|1
338464|NCT00549601|1105685|P2|Received Study Drug|Protocol Violation|4
338465|NCT00549601|1105686|P1|Received Study Drug|Protocol Violation|3
338466|NCT00549601|1105684|P3|Received Study Drug|Lost to Follow-up|1
338467|NCT00549601|1105685|P2|Received Study Drug|Lost to Follow-up|1
338468|NCT00549601|1105686|P1|Received Study Drug|Lost to Follow-up|0
338469|NCT00549601|1105684|P3|Received Study Drug|Death|0
338470|NCT00549601|1105685|P2|Received Study Drug|Death|1
338471|NCT00549601|1105686|P1|Received Study Drug|Death|0
338472|NCT00549601|1105684|P3|Received Study Drug|Adverse Event|1
338473|NCT00549601|1105685|P2|Received Study Drug|Adverse Event|5
338474|NCT00549601|1105686|P1|Received Study Drug|Adverse Event|2
338475|NCT00549601|1105684|P3|Randomized|Withdrawal by Subject|1
338476|NCT00549601|1105685|P2|Randomized|Withdrawal by Subject|1
338477|NCT00549601|1105686|P1|Randomized|Withdrawal by Subject|0
338478|NCT00549601|1105684|P3|Randomized|Protocol Violation|1
338479|NCT00549601|1105685|P2|Randomized|Protocol Violation|0
338480|NCT00549601|1105686|P1|Randomized|Protocol Violation|0
338481|NCT00549562|1105708|P1|Overall Study|Lack of Efficacy|1
338482|NCT00549562|1105708|P1|Overall Study|Adverse Event|1
338483|NCT00550173|1105723|P3|Overall Study|Lost to Follow-up|3
338484|NCT00550173|1105724|P2|Overall Study|Lost to Follow-up|4
338485|NCT00550173|1105725|P1|Overall Study|Lost to Follow-up|4
338486|NCT00550173|1105723|P3|Overall Study|Sponsor Decision|1
338487|NCT00550173|1105724|P2|Overall Study|Sponsor Decision|7
338488|NCT00550173|1105725|P1|Overall Study|Sponsor Decision|13
338489|NCT00550173|1105723|P3|Overall Study|Withdrawal by Subject|17
338490|NCT00550173|1105724|P2|Overall Study|Withdrawal by Subject|12
338491|NCT00550173|1105725|P1|Overall Study|Withdrawal by Subject|9
338492|NCT00550173|1105723|P3|Overall Study|Physician Decision|2
338493|NCT00550173|1105724|P2|Overall Study|Physician Decision|2
338494|NCT00550173|1105725|P1|Overall Study|Physician Decision|1
338495|NCT00550173|1105723|P3|Overall Study|Death|50
338496|NCT00550173|1105724|P2|Overall Study|Death|38
338497|NCT00550173|1105725|P1|Overall Study|Death|45
338498|NCT00550147|1105754|P1|Quetiapine Addition Treatment Period|Moved out of state|1
338499|NCT00550147|1105754|P1|Quetiapine Addition Treatment Period|Noncompliance|2
338500|NCT00550147|1105754|P1|Quetiapine Addition Treatment Period|Adverse Event|3
338501|NCT00550147|1105754|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
338502|NCT00550147|1105754|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
338503|NCT00550043|1105777|P5|Overall Study|Other Reasons- Unspecified|0
338504|NCT00550043|1105778|P4|Overall Study|Other Reasons- Unspecified|1
338505|NCT00550043|1105779|P3|Overall Study|Other Reasons- Unspecified|0
338506|NCT00550043|1105780|P2|Overall Study|Other Reasons- Unspecified|1
338507|NCT00550043|1105781|P1|Overall Study|Other Reasons- Unspecified|0
338508|NCT00550043|1105777|P5|Overall Study|Subject Withdrew Consent|0
338509|NCT00550043|1105778|P4|Overall Study|Subject Withdrew Consent|0
338510|NCT00550043|1105779|P3|Overall Study|Subject Withdrew Consent|1
338511|NCT00550043|1105780|P2|Overall Study|Subject Withdrew Consent|2
338512|NCT00550043|1105781|P1|Overall Study|Subject Withdrew Consent|0
338513|NCT00550043|1105777|P5|Overall Study|Adverse Event|1
338514|NCT00550043|1105778|P4|Overall Study|Adverse Event|1
338515|NCT00550043|1105779|P3|Overall Study|Adverse Event|0
338516|NCT00550043|1105780|P2|Overall Study|Adverse Event|0
338517|NCT00550043|1105781|P1|Overall Study|Adverse Event|0
338518|NCT00549939|1105836|P3|40-week Open Label Treatment Period|Other|4
338519|NCT00549939|1105837|P2|40-week Open Label Treatment Period|Other|1
338520|NCT00549939|1105838|P1|40-week Open Label Treatment Period|Other|0
338521|NCT00549939|1105836|P3|40-week Open Label Treatment Period|Protocol Violation|0
338522|NCT00549939|1105837|P2|40-week Open Label Treatment Period|Protocol Violation|1
338523|NCT00549939|1105838|P1|40-week Open Label Treatment Period|Protocol Violation|0
338524|NCT00549939|1105836|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
338525|NCT00549939|1105837|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
338526|NCT00549939|1105838|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
338527|NCT00549939|1105836|P3|40-week Open Label Treatment Period|Adverse Event|1
338528|NCT00549939|1105837|P2|40-week Open Label Treatment Period|Adverse Event|2
338529|NCT00549939|1105838|P1|40-week Open Label Treatment Period|Adverse Event|0
338530|NCT00549939|1105836|P3|12-week Double Blind Treatment Period|Too many blood draws|0
338531|NCT00549939|1105837|P2|12-week Double Blind Treatment Period|Too many blood draws|1
338532|NCT00549939|1105838|P1|12-week Double Blind Treatment Period|Too many blood draws|0
338533|NCT00549939|1105836|P3|12-week Double Blind Treatment Period|Adverse Event|2
338534|NCT00549939|1105837|P2|12-week Double Blind Treatment Period|Adverse Event|1
338535|NCT00549939|1105838|P1|12-week Double Blind Treatment Period|Adverse Event|1
338536|NCT00549900|1105865|P1|Overall Study|Adverse Event|1
338537|NCT00549770|1105921|P8|Overall Study|Adverse Event|4
338538|NCT00549770|1105922|P7|Overall Study|Adverse Event|5
338539|NCT00549770|1105923|P6|Overall Study|Adverse Event|0
338540|NCT00549770|1105924|P5|Overall Study|Adverse Event|1
338541|NCT00549770|1105925|P4|Overall Study|Adverse Event|2
338542|NCT00549770|1105926|P3|Overall Study|Adverse Event|1
338543|NCT00549770|1105927|P2|Overall Study|Adverse Event|3
338544|NCT00549770|1105928|P1|Overall Study|Adverse Event|1
338545|NCT00549770|1105921|P8|Overall Study|Abnormal laboratory values|0
338546|NCT00549770|1105922|P7|Overall Study|Abnormal laboratory values|0
338547|NCT00549770|1105923|P6|Overall Study|Abnormal laboratory values|1
338548|NCT00549770|1105924|P5|Overall Study|Abnormal laboratory values|0
338549|NCT00549770|1105925|P4|Overall Study|Abnormal laboratory values|0
338550|NCT00549770|1105926|P3|Overall Study|Abnormal laboratory values|0
338551|NCT00549770|1105927|P2|Overall Study|Abnormal laboratory values|0
338552|NCT00549770|1105928|P1|Overall Study|Abnormal laboratory values|0
338553|NCT00549770|1105921|P8|Overall Study|Abnormal test procedure results|1
338554|NCT00549770|1105922|P7|Overall Study|Abnormal test procedure results|1
338555|NCT00549770|1105923|P6|Overall Study|Abnormal test procedure results|1
338556|NCT00549770|1105924|P5|Overall Study|Abnormal test procedure results|0
338557|NCT00549770|1105925|P4|Overall Study|Abnormal test procedure results|2
338558|NCT00549770|1105926|P3|Overall Study|Abnormal test procedure results|0
338559|NCT00549770|1105927|P2|Overall Study|Abnormal test procedure results|0
338560|NCT00549770|1105928|P1|Overall Study|Abnormal test procedure results|0
338561|NCT00549770|1105921|P8|Overall Study|Lack of Efficacy|8
338562|NCT00549770|1105922|P7|Overall Study|Lack of Efficacy|3
338563|NCT00549770|1105923|P6|Overall Study|Lack of Efficacy|1
338564|NCT00549770|1105924|P5|Overall Study|Lack of Efficacy|5
338565|NCT00549770|1105925|P4|Overall Study|Lack of Efficacy|3
338566|NCT00549770|1105926|P3|Overall Study|Lack of Efficacy|2
338567|NCT00549770|1105927|P2|Overall Study|Lack of Efficacy|0
338568|NCT00549770|1105928|P1|Overall Study|Lack of Efficacy|1
338569|NCT00549770|1105921|P8|Overall Study|Withdrawal by Subject|9
338570|NCT00549770|1105922|P7|Overall Study|Withdrawal by Subject|4
338571|NCT00549770|1105923|P6|Overall Study|Withdrawal by Subject|6
338572|NCT00549770|1105924|P5|Overall Study|Withdrawal by Subject|6
338573|NCT00549770|1105925|P4|Overall Study|Withdrawal by Subject|5
338574|NCT00549770|1105926|P3|Overall Study|Withdrawal by Subject|4
338575|NCT00549770|1105927|P2|Overall Study|Withdrawal by Subject|6
338576|NCT00549770|1105928|P1|Overall Study|Withdrawal by Subject|4
338577|NCT00549770|1105921|P8|Overall Study|Lost to Follow-up|0
338578|NCT00549770|1105922|P7|Overall Study|Lost to Follow-up|0
338579|NCT00549770|1105923|P6|Overall Study|Lost to Follow-up|2
338580|NCT00549770|1105924|P5|Overall Study|Lost to Follow-up|3
338581|NCT00549770|1105925|P4|Overall Study|Lost to Follow-up|2
338582|NCT00549770|1105926|P3|Overall Study|Lost to Follow-up|2
338583|NCT00549770|1105927|P2|Overall Study|Lost to Follow-up|0
338584|NCT00549770|1105928|P1|Overall Study|Lost to Follow-up|0
338585|NCT00549770|1105921|P8|Overall Study|Administrative problems|1
338586|NCT00549770|1105922|P7|Overall Study|Administrative problems|0
338587|NCT00549770|1105923|P6|Overall Study|Administrative problems|0
338588|NCT00549770|1105924|P5|Overall Study|Administrative problems|0
338589|NCT00549770|1105925|P4|Overall Study|Administrative problems|0
338590|NCT00549770|1105926|P3|Overall Study|Administrative problems|0
338591|NCT00549770|1105927|P2|Overall Study|Administrative problems|1
338592|NCT00549770|1105928|P1|Overall Study|Administrative problems|0
338593|NCT00549770|1105921|P8|Overall Study|Protocol deviation|2
338594|NCT00549770|1105922|P7|Overall Study|Protocol deviation|1
338595|NCT00549770|1105923|P6|Overall Study|Protocol deviation|2
338596|NCT00549770|1105924|P5|Overall Study|Protocol deviation|2
338597|NCT00549770|1105925|P4|Overall Study|Protocol deviation|2
338598|NCT00549770|1105926|P3|Overall Study|Protocol deviation|1
338599|NCT00549770|1105927|P2|Overall Study|Protocol deviation|1
338600|NCT00549770|1105928|P1|Overall Study|Protocol deviation|1
338601|NCT00549757|1106012|P2|Extension Period (in Average 9 Months)|Patient's request|436
338602|NCT00549757|1106013|P1|Extension Period (in Average 9 Months)|Patient's request|421
338603|NCT00549757|1106012|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
338604|NCT00549757|1106013|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
338605|NCT00549757|1106012|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
338606|NCT00549757|1106013|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
338607|NCT00549757|1106012|P2|Extension Period (in Average 9 Months)|Death|136
338608|NCT00549757|1106013|P1|Extension Period (in Average 9 Months)|Death|143
338609|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
338610|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
338611|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
338612|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
338613|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
338614|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
338615|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Death|200
338616|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Death|188
338617|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
338618|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
338619|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
338620|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
338621|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
338622|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
338623|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
338624|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
338625|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
338626|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
338627|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
338628|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
338629|NCT00549757|1106012|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
338630|NCT00549757|1106013|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
338631|NCT00549718|1106075|P4|Overall Study|Administrative|1
338632|NCT00549718|1106076|P3|Overall Study|Administrative|2
338633|NCT00549718|1106077|P2|Overall Study|Administrative|2
338634|NCT00549718|1106078|P1|Overall Study|Administrative|2
338635|NCT00549718|1106075|P4|Overall Study|Withdrawal by Subject|13
338636|NCT00549718|1106076|P3|Overall Study|Withdrawal by Subject|12
338637|NCT00549718|1106077|P2|Overall Study|Withdrawal by Subject|18
338638|NCT00549718|1106078|P1|Overall Study|Withdrawal by Subject|9
338639|NCT00549718|1106075|P4|Overall Study|Lost to Follow-up|6
338640|NCT00549718|1106076|P3|Overall Study|Lost to Follow-up|0
338641|NCT00549718|1106077|P2|Overall Study|Lost to Follow-up|2
338642|NCT00549718|1106078|P1|Overall Study|Lost to Follow-up|4
338643|NCT00549718|1106075|P4|Overall Study|Adverse Event|3
338644|NCT00549718|1106076|P3|Overall Study|Adverse Event|7
338645|NCT00549718|1106077|P2|Overall Study|Adverse Event|8
338646|NCT00549718|1106078|P1|Overall Study|Adverse Event|6
338647|NCT00549718|1106075|P4|Overall Study|Insufficient clinical response|32
338648|NCT00549718|1106076|P3|Overall Study|Insufficient clinical response|18
338649|NCT00549718|1106077|P2|Overall Study|Insufficient clinical response|7
338650|NCT00549718|1106078|P1|Overall Study|Insufficient clinical response|20
338651|NCT00549640|1106094|P2|Overall Study|Lost to Follow-up|4
338652|NCT00549640|1106095|P1|Overall Study|Lost to Follow-up|7
338653|NCT00549640|1106094|P2|Overall Study|Adverse Event|0
338654|NCT00549640|1106095|P1|Overall Study|Adverse Event|5
338655|NCT00549640|1106094|P2|Overall Study|Withdrawal by Subject|12
338656|NCT00549640|1106095|P1|Overall Study|Withdrawal by Subject|6
338657|NCT00549549|1106109|P4|Overall Study|Randomized but not treated|1
338658|NCT00549549|1106110|P3|Overall Study|Randomized but not treated|1
338659|NCT00549549|1106111|P2|Overall Study|Randomized but not treated|0
338660|NCT00549549|1106112|P1|Overall Study|Randomized but not treated|0
338661|NCT00549549|1106109|P4|Overall Study|Unspecified|11
338662|NCT00549549|1106110|P3|Overall Study|Unspecified|9
338663|NCT00549549|1106111|P2|Overall Study|Unspecified|9
338664|NCT00549549|1106112|P1|Overall Study|Unspecified|9
338665|NCT00549549|1106109|P4|Overall Study|Withdrawal by Subject|0
338666|NCT00549549|1106110|P3|Overall Study|Withdrawal by Subject|1
338667|NCT00549549|1106111|P2|Overall Study|Withdrawal by Subject|4
338668|NCT00549549|1106112|P1|Overall Study|Withdrawal by Subject|0
338669|NCT00549549|1106109|P4|Overall Study|Lost to Follow-up|2
338670|NCT00549549|1106110|P3|Overall Study|Lost to Follow-up|1
338671|NCT00549549|1106111|P2|Overall Study|Lost to Follow-up|0
338672|NCT00549549|1106112|P1|Overall Study|Lost to Follow-up|1
338673|NCT00549549|1106109|P4|Overall Study|Lack of Efficacy|2
338674|NCT00549549|1106110|P3|Overall Study|Lack of Efficacy|4
338675|NCT00549549|1106111|P2|Overall Study|Lack of Efficacy|6
338676|NCT00549549|1106112|P1|Overall Study|Lack of Efficacy|9
338677|NCT00549549|1106109|P4|Overall Study|Adverse Event|9
338678|NCT00549549|1106110|P3|Overall Study|Adverse Event|1
338679|NCT00549549|1106111|P2|Overall Study|Adverse Event|3
338680|NCT00549549|1106112|P1|Overall Study|Adverse Event|5
338681|NCT00549328|1106191|P1|Overall Study|Use of Prohibited Medication|1
338682|NCT00549328|1106191|P1|Overall Study|Death|1
338683|NCT00549328|1106191|P1|Overall Study|Disease Progression|10
338684|NCT00549328|1106191|P1|Overall Study|Adverse Event|2
338685|NCT00549302|1106202|P3|Open-Label|Withdrawal by Subject|6
338686|NCT00549302|1106203|P2|Open-Label|Withdrawal by Subject|0
338687|NCT00549302|1106204|P1|Open-Label|Withdrawal by Subject|0
338688|NCT00549302|1106202|P3|Open-Label|New drug pulmonary atrial hypertension|2
338689|NCT00549302|1106203|P2|Open-Label|New drug pulmonary atrial hypertension|0
338690|NCT00549302|1106204|P1|Open-Label|New drug pulmonary atrial hypertension|0
338691|NCT00549302|1106202|P3|Open-Label|Unspecified|3
338692|NCT00549302|1106203|P2|Open-Label|Unspecified|0
338693|NCT00549302|1106204|P1|Open-Label|Unspecified|0
338694|NCT00549302|1106202|P3|Open-Label|Lost to Follow-up|2
338695|NCT00549302|1106203|P2|Open-Label|Lost to Follow-up|0
338696|NCT00549302|1106204|P1|Open-Label|Lost to Follow-up|0
338697|NCT00549302|1106202|P3|Open-Label|Investigator Decision|5
338698|NCT00549302|1106203|P2|Open-Label|Investigator Decision|0
338699|NCT00549302|1106204|P1|Open-Label|Investigator Decision|0
338700|NCT00549302|1106202|P3|Open-Label|Death|40
338701|NCT00549302|1106203|P2|Open-Label|Death|0
338702|NCT00549302|1106204|P1|Open-Label|Death|0
338703|NCT00549302|1106202|P3|Open-Label|Adverse Event|11
338704|NCT00549302|1106203|P2|Open-Label|Adverse Event|0
338705|NCT00549302|1106204|P1|Open-Label|Adverse Event|0
338706|NCT00549302|1106202|P3|Double-Blind|New condition or starts new therapy|0
338707|NCT00549302|1106203|P2|Double-Blind|New condition or starts new therapy|2
338708|NCT00549302|1106204|P1|Double-Blind|New condition or starts new therapy|0
338709|NCT00549302|1106202|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
338710|NCT00549302|1106203|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
338711|NCT00549302|1106204|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
338712|NCT00549302|1106202|P3|Double-Blind|Lost to Follow-up|0
338713|NCT00549302|1106203|P2|Double-Blind|Lost to Follow-up|2
338714|NCT00549302|1106204|P1|Double-Blind|Lost to Follow-up|1
338715|NCT00549302|1106202|P3|Double-Blind|Sponsor Decision|0
338716|NCT00549302|1106203|P2|Double-Blind|Sponsor Decision|1
338717|NCT00549302|1106204|P1|Double-Blind|Sponsor Decision|0
338718|NCT00549302|1106202|P3|Double-Blind|Investigator Decision|0
338719|NCT00549302|1106203|P2|Double-Blind|Investigator Decision|5
338720|NCT00549302|1106204|P1|Double-Blind|Investigator Decision|1
338721|NCT00549302|1106202|P3|Double-Blind|Withdrawal by Subject|0
338722|NCT00549302|1106203|P2|Double-Blind|Withdrawal by Subject|8
338723|NCT00549302|1106204|P1|Double-Blind|Withdrawal by Subject|3
338724|NCT00549302|1106202|P3|Double-Blind|Adverse Event|0
338725|NCT00549302|1106203|P2|Double-Blind|Adverse Event|16
338726|NCT00549302|1106204|P1|Double-Blind|Adverse Event|3
338727|NCT00549302|1106202|P3|Double-Blind|Death|0
338728|NCT00549302|1106203|P2|Double-Blind|Death|9
338729|NCT00549302|1106204|P1|Double-Blind|Death|2
338730|NCT00549198|1106216|P2|Overall Study|Not Exposed to Study Drug|4
338731|NCT00549198|1106217|P1|Overall Study|Not Exposed to Study Drug|3
338732|NCT00549198|1106216|P2|Overall Study|Pregnancy|3
338733|NCT00549198|1106217|P1|Overall Study|Pregnancy|0
338734|NCT00549198|1106216|P2|Overall Study|No scan facilities|2
338735|NCT00549198|1106217|P1|Overall Study|No scan facilities|0
338736|NCT00549198|1106216|P2|Overall Study|Participant overweight, no scan possible|0
338737|NCT00549198|1106217|P1|Overall Study|Participant overweight, no scan possible|1
338738|NCT00549198|1106216|P2|Overall Study|Participant planning pregnancy|0
338739|NCT00549198|1106217|P1|Overall Study|Participant planning pregnancy|1
338740|NCT00549198|1106216|P2|Overall Study|Prohibited Medication|2
338741|NCT00549198|1106217|P1|Overall Study|Prohibited Medication|1
338742|NCT00549198|1106216|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
338743|NCT00549198|1106217|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
338744|NCT00549198|1106216|P2|Overall Study|Participant not able to perform Week 96|0
338745|NCT00549198|1106217|P1|Overall Study|Participant not able to perform Week 96|1
338746|NCT00549198|1106216|P2|Overall Study|Participant Moved|0
338747|NCT00549198|1106217|P1|Overall Study|Participant Moved|2
338748|NCT00549198|1106216|P2|Overall Study|Disease Progression|0
338749|NCT00549198|1106217|P1|Overall Study|Disease Progression|1
338750|NCT00549198|1106216|P2|Overall Study|Withdrawal by Subject|7
338751|NCT00549198|1106217|P1|Overall Study|Withdrawal by Subject|7
338752|NCT00549198|1106216|P2|Overall Study|Investigator Decision|3
338753|NCT00549198|1106217|P1|Overall Study|Investigator Decision|4
338754|NCT00549198|1106216|P2|Overall Study|Protocol Violation|2
338755|NCT00549198|1106217|P1|Overall Study|Protocol Violation|7
338756|NCT00549198|1106216|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
338757|NCT00549198|1106217|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
338758|NCT00549198|1106216|P2|Overall Study|Lost to Follow-up|8
338759|NCT00549198|1106217|P1|Overall Study|Lost to Follow-up|7
338760|NCT00549198|1106216|P2|Overall Study|Non-compliance|4
338761|NCT00549198|1106217|P1|Overall Study|Non-compliance|2
338762|NCT00549198|1106216|P2|Overall Study|Protocol-defined Virological Failure|0
338763|NCT00549198|1106217|P1|Overall Study|Protocol-defined Virological Failure|7
338764|NCT00549198|1106216|P2|Overall Study|Insufficient Viral Load Response|2
338765|NCT00549198|1106217|P1|Overall Study|Insufficient Viral Load Response|4
338766|NCT00549198|1106216|P2|Overall Study|Adverse Event|26
338767|NCT00549198|1106217|P1|Overall Study|Adverse Event|28
338768|NCT00549055|1106354|P1|Overall Study|Very low visual acuity (VA)|1
338769|NCT00549055|1106354|P1|Overall Study|Choroidal neovascularization|1
338770|NCT00549055|1106354|P1|Overall Study|Growth choroidal neovascularisation|1
338771|NCT00549055|1106354|P1|Overall Study|Vitreous hemorrhage|1
338772|NCT00549055|1106354|P1|Overall Study|Active choroidal neovascula increased|1
338773|NCT00549055|1106354|P1|Overall Study|Decrease of size|1
338774|NCT00549055|1106354|P1|Overall Study|Progression to fibrosis|2
338775|NCT00549055|1106354|P1|Overall Study|Stabilization|5
338776|NCT00549055|1106354|P1|Overall Study|Lack of efficacy|18
338777|NCT00549055|1106354|P1|Overall Study|Adverse Event|4
338778|NCT00548847|1106377|P1|Overall Study|Disease progression|7
338779|NCT00548808|1106384|P2|Overall Study|Sponsor Decision|1
338780|NCT00548808|1106385|P1|Overall Study|Sponsor Decision|1
338781|NCT00548808|1106384|P2|Overall Study|Lack of Efficacy|0
338782|NCT00548808|1106385|P1|Overall Study|Lack of Efficacy|2
338783|NCT00548808|1106384|P2|Overall Study|Entry Criteria Not Met|2
338784|NCT00548808|1106385|P1|Overall Study|Entry Criteria Not Met|2
338785|NCT00548808|1106384|P2|Overall Study|Death|0
338786|NCT00548808|1106385|P1|Overall Study|Death|2
338787|NCT00548808|1106384|P2|Overall Study|Adverse Event|5
338788|NCT00548808|1106385|P1|Overall Study|Adverse Event|4
338789|NCT00548808|1106384|P2|Overall Study|Physician Decision|3
338790|NCT00548808|1106385|P1|Overall Study|Physician Decision|6
338791|NCT00548808|1106384|P2|Overall Study|Withdrawal by Subject|4
338792|NCT00548808|1106385|P1|Overall Study|Withdrawal by Subject|8
338793|NCT00548808|1106384|P2|Overall Study|Protocol Violation|8
338794|NCT00548808|1106385|P1|Overall Study|Protocol Violation|8
338795|NCT00548808|1106384|P2|Overall Study|Lost to Follow-up|3
338796|NCT00548808|1106385|P1|Overall Study|Lost to Follow-up|9
338797|NCT00548717|1106409|P2|Overall Study|Alternative treatment for GVHD|0
338798|NCT00548717|1106410|P1|Overall Study|Alternative treatment for GVHD|1
338799|NCT00548717|1106409|P2|Overall Study|Relapse|0
338800|NCT00548717|1106410|P1|Overall Study|Relapse|3
338801|NCT00548717|1106409|P2|Overall Study|Death|2
338802|NCT00548717|1106410|P1|Overall Study|Death|5
338803|NCT00548548|1106438|P2|Overall Study|Lost to Follow-up|18
338804|NCT00548548|1106439|P1|Overall Study|Lost to Follow-up|17
338805|NCT00548548|1106438|P2|Overall Study|Death|348
338806|NCT00548548|1106439|P1|Overall Study|Death|345
338807|NCT00548405|1106474|P3|Overall Study|Randomized but not treated|0
338808|NCT00548405|1106475|P2|Overall Study|Randomized but not treated|0
338809|NCT00548405|1106476|P1|Overall Study|Randomized but not treated|1
338810|NCT00548405|1106474|P3|Overall Study|Sponsor decision|0
338811|NCT00548405|1106475|P2|Overall Study|Sponsor decision|0
338812|NCT00548405|1106476|P1|Overall Study|Sponsor decision|1
338813|NCT00548405|1106474|P3|Overall Study|Death|1
338814|NCT00548405|1106475|P2|Overall Study|Death|1
338815|NCT00548405|1106476|P1|Overall Study|Death|0
338816|NCT00548405|1106474|P3|Overall Study|Lost to Follow-up|2
338817|NCT00548405|1106475|P2|Overall Study|Lost to Follow-up|1
338818|NCT00548405|1106476|P1|Overall Study|Lost to Follow-up|1
338819|NCT00548405|1106474|P3|Overall Study|Withdrawal by Subject|5
338820|NCT00548405|1106475|P2|Overall Study|Withdrawal by Subject|12
338821|NCT00548405|1106476|P1|Overall Study|Withdrawal by Subject|36
338822|NCT00548405|1106474|P3|Overall Study|Protocol Violation|0
338823|NCT00548405|1106475|P2|Overall Study|Protocol Violation|0
338824|NCT00548405|1106476|P1|Overall Study|Protocol Violation|1
338825|NCT00548405|1106474|P3|Overall Study|Pregnancy|0
338826|NCT00548405|1106475|P2|Overall Study|Pregnancy|0
338827|NCT00548405|1106476|P1|Overall Study|Pregnancy|1
338828|NCT00548405|1106474|P3|Overall Study|Physician Decision|1
338829|NCT00548405|1106475|P2|Overall Study|Physician Decision|4
338830|NCT00548405|1106476|P1|Overall Study|Physician Decision|3
338831|NCT00548405|1106474|P3|Overall Study|Lack of Efficacy|0
338832|NCT00548405|1106475|P2|Overall Study|Lack of Efficacy|0
338833|NCT00548405|1106476|P1|Overall Study|Lack of Efficacy|6
338834|NCT00548405|1106474|P3|Overall Study|Adverse Event|0
338835|NCT00548405|1106475|P2|Overall Study|Adverse Event|2
338836|NCT00548405|1106476|P1|Overall Study|Adverse Event|6
338837|NCT00548340|1106497|P3|Overall Study|Other|1
338838|NCT00548340|1106498|P2|Overall Study|Other|1
338839|NCT00548340|1106499|P1|Overall Study|Other|1
338840|NCT00548340|1106497|P3|Overall Study|Withdrawal by Subject|3
338841|NCT00548340|1106498|P2|Overall Study|Withdrawal by Subject|4
338842|NCT00548340|1106499|P1|Overall Study|Withdrawal by Subject|2
338843|NCT00548340|1106497|P3|Overall Study|Lost to Follow-up|0
338844|NCT00548340|1106498|P2|Overall Study|Lost to Follow-up|1
338845|NCT00548340|1106499|P1|Overall Study|Lost to Follow-up|1
338846|NCT00548340|1106497|P3|Overall Study|Adverse Event|2
338847|NCT00548340|1106498|P2|Overall Study|Adverse Event|2
338848|NCT00548340|1106499|P1|Overall Study|Adverse Event|2
338849|NCT00548340|1106497|P3|Overall Study|Protocol Violation|3
338850|NCT00548340|1106498|P2|Overall Study|Protocol Violation|3
338851|NCT00548340|1106499|P1|Overall Study|Protocol Violation|2
338852|NCT00548327|1106518|P2|Overall Study|Adverse Event|1
338853|NCT00548327|1106519|P1|Overall Study|Adverse Event|0
338854|NCT00548262|1106537|P1|Overall Study|Withdrawal by Subject|1
338855|NCT00548262|1106537|P1|Overall Study|Unspecified|3
338856|NCT00548262|1106537|P1|Overall Study|Lost to Follow-up|1
338857|NCT00548262|1106537|P1|Overall Study|Lack of Efficacy|4
338858|NCT00548262|1106537|P1|Overall Study|Adverse Event|2
338859|NCT00548262|1106537|P1|Overall Study|Death|21
338860|NCT00548249|1106567|P5|Overall Study|Sponsor's request|0
338861|NCT00548249|1106568|P4|Overall Study|Sponsor's request|1
338862|NCT00548249|1106569|P3|Overall Study|Sponsor's request|0
338863|NCT00548249|1106570|P2|Overall Study|Sponsor's request|0
338864|NCT00548249|1106571|P1|Overall Study|Sponsor's request|0
338865|NCT00548249|1106567|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
338866|NCT00548249|1106568|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
338867|NCT00548249|1106569|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
338868|NCT00548249|1106570|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
338869|NCT00548249|1106571|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
338870|NCT00548249|1106567|P5|Overall Study|Withdrawal by Subject|0
338871|NCT00548249|1106568|P4|Overall Study|Withdrawal by Subject|0
338872|NCT00548249|1106569|P3|Overall Study|Withdrawal by Subject|0
338873|NCT00548249|1106570|P2|Overall Study|Withdrawal by Subject|0
338874|NCT00548249|1106571|P1|Overall Study|Withdrawal by Subject|2
338875|NCT00548249|1106567|P5|Overall Study|Prolonged hospitalization|0
338876|NCT00548249|1106568|P4|Overall Study|Prolonged hospitalization|1
338877|NCT00548249|1106569|P3|Overall Study|Prolonged hospitalization|2
338878|NCT00548249|1106570|P2|Overall Study|Prolonged hospitalization|0
338879|NCT00548249|1106571|P1|Overall Study|Prolonged hospitalization|0
338880|NCT00548249|1106567|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
338881|NCT00548249|1106568|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
338882|NCT00548249|1106569|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
338883|NCT00548249|1106570|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
338884|NCT00548249|1106571|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
338885|NCT00548249|1106567|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
338886|NCT00548249|1106568|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
338887|NCT00548249|1106569|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
338888|NCT00548249|1106570|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
338889|NCT00548249|1106571|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
338890|NCT00548249|1106567|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
338891|NCT00548249|1106568|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
338892|NCT00548249|1106569|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
338893|NCT00548249|1106570|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
338894|NCT00548249|1106571|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
338895|NCT00548249|1106567|P5|Overall Study|Adverse Event|1
338896|NCT00548249|1106568|P4|Overall Study|Adverse Event|1
338897|NCT00548249|1106569|P3|Overall Study|Adverse Event|0
338898|NCT00548249|1106570|P2|Overall Study|Adverse Event|2
338899|NCT00548249|1106571|P1|Overall Study|Adverse Event|2
338900|NCT00548249|1106567|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
338901|NCT00548249|1106568|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
338902|NCT00548249|1106569|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
338903|NCT00548249|1106570|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
338904|NCT00548249|1106571|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
338905|NCT00548249|1106567|P5|Overall Study|Miscellaneous|2
338906|NCT00548249|1106568|P4|Overall Study|Miscellaneous|0
338907|NCT00548249|1106569|P3|Overall Study|Miscellaneous|2
338908|NCT00548249|1106570|P2|Overall Study|Miscellaneous|3
338909|NCT00548249|1106571|P1|Overall Study|Miscellaneous|2
338910|NCT00548249|1106567|P5|Overall Study|Protocol Violation|3
338911|NCT00548249|1106568|P4|Overall Study|Protocol Violation|0
338912|NCT00548249|1106569|P3|Overall Study|Protocol Violation|4
338913|NCT00548249|1106570|P2|Overall Study|Protocol Violation|1
338914|NCT00548249|1106571|P1|Overall Study|Protocol Violation|1
338915|NCT00548249|1106567|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
338916|NCT00548249|1106568|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
338917|NCT00548249|1106569|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
338918|NCT00548249|1106570|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
338919|NCT00548249|1106571|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
338920|NCT00548249|1106567|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
338921|NCT00548249|1106568|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
338922|NCT00548249|1106569|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
338923|NCT00548249|1106570|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
338924|NCT00548249|1106571|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
338925|NCT00548184|1106608|P1|Overall Study|Found Her2 negative|1
338926|NCT00548184|1106608|P1|Overall Study|took other drug|1
338927|NCT00548184|1106608|P1|Overall Study|Adverse Event|3
338928|NCT00548145|1106614|P2|Overall Study|Physician Decision|1
338929|NCT00548145|1106615|P1|Overall Study|Physician Decision|1
338930|NCT00548145|1106614|P2|Overall Study|Withdrawal by Subject|2
338931|NCT00548145|1106615|P1|Overall Study|Withdrawal by Subject|0
338932|NCT00548145|1106614|P2|Overall Study|Death|1
338933|NCT00548145|1106615|P1|Overall Study|Death|0
338934|NCT00547911|1106640|P6|Overall Study|Adverse Event|0
338935|NCT00547911|1106641|P5|Overall Study|Adverse Event|0
338936|NCT00547911|1106642|P4|Overall Study|Adverse Event|1
338937|NCT00547911|1106643|P3|Overall Study|Adverse Event|0
338938|NCT00547911|1106644|P2|Overall Study|Adverse Event|0
338939|NCT00547911|1106645|P1|Overall Study|Adverse Event|0
338940|NCT00547703|1106676|P2|Overall Study|Lost to Follow-up|0
338941|NCT00547703|1106677|P1|Overall Study|Lost to Follow-up|1
338942|NCT00547534|1106702|P1|Overall Study|Disease Progression|4
338943|NCT00547534|1106702|P1|Overall Study|Adverse Event|7
338944|NCT00547521|1106710|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
338945|NCT00547521|1106711|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
338946|NCT00547521|1106710|P2|Long Term Extension (LTE) Study|Not Specified|2
338947|NCT00547521|1106711|P1|Long Term Extension (LTE) Study|Not Specified|0
338948|NCT00547521|1106710|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
338949|NCT00547521|1106711|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
338950|NCT00547521|1106710|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
338951|NCT00547521|1106711|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
338952|NCT00547521|1106710|P2|Long Term Extension (LTE) Study|Adverse Event|9
338953|NCT00547521|1106711|P1|Long Term Extension (LTE) Study|Adverse Event|0
338954|NCT00547521|1106710|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
338955|NCT00547521|1106711|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
338956|NCT00547521|1106710|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
338957|NCT00547521|1106711|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
338958|NCT00547521|1106710|P2|Short Term Study (4 Months)|Withdrawal of consent|1
338959|NCT00547521|1106711|P1|Short Term Study (4 Months)|Withdrawal of consent|0
338960|NCT00547521|1106710|P2|Short Term Study (4 Months)|Lack of Efficacy|2
338961|NCT00547521|1106711|P1|Short Term Study (4 Months)|Lack of Efficacy|0
338962|NCT00547521|1106710|P2|Short Term Study (4 Months)|Adverse Event|0
338963|NCT00547521|1106711|P1|Short Term Study (4 Months)|Adverse Event|1
338964|NCT00547365|1106785|P1|Overall Study|death (not related to study)|4
338965|NCT00547365|1106785|P1|Overall Study|Protocol Violation|2
338966|NCT00547365|1106785|P1|Overall Study|Lost to Follow-up|1
338967|NCT00547365|1106785|P1|Overall Study|Physician Decision|1
338968|NCT00547157|1106792|P2|Overall Study|Lost to Follow-up|2
338969|NCT00547157|1106793|P1|Overall Study|Lost to Follow-up|4
338970|NCT00547157|1106792|P2|Overall Study|Administrative decision|2
338971|NCT00547157|1106793|P1|Overall Study|Administrative decision|3
338972|NCT00547157|1106792|P2|Overall Study|Withdrawal by Subject|1
338973|NCT00547157|1106793|P1|Overall Study|Withdrawal by Subject|3
338974|NCT00547157|1106792|P2|Overall Study|Death|18
338975|NCT00547157|1106793|P1|Overall Study|Death|38
338976|NCT00547157|1106792|P2|Overall Study|Other|0
338977|NCT00547157|1106793|P1|Overall Study|Other|1
338978|NCT00547118|1106811|P2|Overall Study|Did not qualify prior to starting drug|2
338979|NCT00547118|1106812|P1|Overall Study|Did not qualify prior to starting drug|0
338980|NCT00547118|1106811|P2|Overall Study|Withdrawal by Subject|0
338981|NCT00547118|1106812|P1|Overall Study|Withdrawal by Subject|1
338982|NCT00546910|1106820|P2|Overall Study|Withdrawal by Subject|0
338983|NCT00546910|1106821|P1|Overall Study|Withdrawal by Subject|2
338984|NCT00546910|1106820|P2|Overall Study|Physician Decision|1
338985|NCT00546910|1106821|P1|Overall Study|Physician Decision|0
338986|NCT00546910|1106820|P2|Overall Study|Lack of Efficacy|7
338987|NCT00546910|1106821|P1|Overall Study|Lack of Efficacy|5
338988|NCT00546910|1106820|P2|Overall Study|Adverse Event|3
338989|NCT00546910|1106821|P1|Overall Study|Adverse Event|2
338990|NCT00546871|1106887|P2|Study Extension Period|Withdrawal by Subject|1
338991|NCT00546871|1106888|P1|Study Extension Period|Withdrawal by Subject|0
338992|NCT00546871|1106887|P2|Study Extension Period|Protocol Violation|0
338993|NCT00546871|1106888|P1|Study Extension Period|Protocol Violation|1
338994|NCT00546871|1106887|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
338995|NCT00546871|1106888|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
338996|NCT00546871|1106887|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
338997|NCT00546871|1106888|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
338998|NCT00546871|1106887|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
338999|NCT00546871|1106888|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
339000|NCT00546819|1106993|P2|Overall Study|Withdrawal by Subject|2
339001|NCT00546819|1106994|P1|Overall Study|Withdrawal by Subject|4
339002|NCT00546819|1106993|P2|Overall Study|Lost to Follow-up|1
339003|NCT00546819|1106994|P1|Overall Study|Lost to Follow-up|2
339004|NCT00546819|1106993|P2|Overall Study|Adverse Event|3
339005|NCT00546819|1106994|P1|Overall Study|Adverse Event|2
339006|NCT00546754|1107006|P2|Overall Study|Missing|7
339007|NCT00546754|1107007|P1|Overall Study|Missing|14
339008|NCT00546754|1107006|P2|Overall Study|Patient's Decision|1
339009|NCT00546754|1107007|P1|Overall Study|Patient's Decision|0
339010|NCT00546754|1107006|P2|Overall Study|Elevated Creatinine and Potassium levels|1
339011|NCT00546754|1107007|P1|Overall Study|Elevated Creatinine and Potassium levels|0
339012|NCT00546754|1107006|P2|Overall Study|Missing Cooperation|0
339013|NCT00546754|1107007|P1|Overall Study|Missing Cooperation|1
339014|NCT00546754|1107006|P2|Overall Study|Suicide|0
339015|NCT00546754|1107007|P1|Overall Study|Suicide|1
339016|NCT00546754|1107006|P2|Overall Study|Hip Replacement|0
339017|NCT00546754|1107007|P1|Overall Study|Hip Replacement|1
339018|NCT00546754|1107006|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
339019|NCT00546754|1107007|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
339020|NCT00546754|1107006|P2|Overall Study|Dyspnea|0
339021|NCT00546754|1107007|P1|Overall Study|Dyspnea|1
339022|NCT00546754|1107006|P2|Overall Study|Withdrawal by Subject|7
339023|NCT00546754|1107007|P1|Overall Study|Withdrawal by Subject|6
339024|NCT00546754|1107006|P2|Overall Study|Protocol Violation|0
339025|NCT00546754|1107007|P1|Overall Study|Protocol Violation|3
339026|NCT00546754|1107006|P2|Overall Study|Lost to Follow-up|15
339027|NCT00546754|1107007|P1|Overall Study|Lost to Follow-up|9
339028|NCT00546754|1107006|P2|Overall Study|Lack of Efficacy|1
339029|NCT00546754|1107007|P1|Overall Study|Lack of Efficacy|1
339030|NCT00546754|1107006|P2|Overall Study|Adverse Event|16
339031|NCT00546754|1107007|P1|Overall Study|Adverse Event|11
339032|NCT00546754|1107006|P2|Overall Study|Serious Adverse Event|1
339033|NCT00546754|1107007|P1|Overall Study|Serious Adverse Event|1
339034|NCT00546715|1107050|P4|Overall Study|Withdrawal by Subject|0
339035|NCT00546715|1107051|P3|Overall Study|Withdrawal by Subject|0
339036|NCT00546715|1107052|P2|Overall Study|Withdrawal by Subject|1
339037|NCT00546715|1107053|P1|Overall Study|Withdrawal by Subject|0
339038|NCT00546637|1107108|P2|Overall Study|Randomized, but not treated|1
339039|NCT00546637|1107109|P1|Overall Study|Randomized, but not treated|3
339040|NCT00546637|1107108|P2|Overall Study|Withdrawal by Subject|9
339041|NCT00546637|1107109|P1|Overall Study|Withdrawal by Subject|7
339042|NCT00546637|1107108|P2|Overall Study|Unspecified|12
339043|NCT00546637|1107109|P1|Overall Study|Unspecified|10
339044|NCT00546637|1107108|P2|Overall Study|Lost to Follow-up|2
339045|NCT00546637|1107109|P1|Overall Study|Lost to Follow-up|2
339046|NCT00546637|1107108|P2|Overall Study|Lack of Efficacy|5
339047|NCT00546637|1107109|P1|Overall Study|Lack of Efficacy|5
339048|NCT00546637|1107108|P2|Overall Study|Adverse Event|20
339049|NCT00546637|1107109|P1|Overall Study|Adverse Event|46
339050|NCT00546572|1107183|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
339051|NCT00546572|1107184|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
339052|NCT00546572|1107183|P2|Vax 2 / Year 1|Adverse Event|0
339053|NCT00546572|1107184|P1|Vax 2 / Year 1|Adverse Event|1
339054|NCT00546572|1107183|P2|Vax 2 / Year 1|Unspecified|1
339055|NCT00546572|1107184|P1|Vax 2 / Year 1|Unspecified|1
339056|NCT00546572|1107183|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
339057|NCT00546572|1107184|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
339058|NCT00546572|1107183|P2|Vax 1 / Year 0|Lost to Follow-up|1
339059|NCT00546572|1107184|P1|Vax 1 / Year 0|Lost to Follow-up|0
339060|NCT00546572|1107183|P2|Vax 1 / Year 0|Adverse Event|1
339061|NCT00546572|1107184|P1|Vax 1 / Year 0|Adverse Event|0
339062|NCT00546572|1107183|P2|Vax 1 / Year 0|Death|2
339063|NCT00546572|1107184|P1|Vax 1 / Year 0|Death|2
339064|NCT00546572|1107183|P2|Vax 1 / Year 0|Protocol Violation|4
339065|NCT00546572|1107184|P1|Vax 1 / Year 0|Protocol Violation|3
339066|NCT00546572|1107183|P2|Vax 1 / Year 0|Withdrawal by Subject|2
339067|NCT00546572|1107184|P1|Vax 1 / Year 0|Withdrawal by Subject|3
339068|NCT00546572|1107183|P2|Vax 1 / Year 0|Randomized, not treated|1
339069|NCT00546572|1107184|P1|Vax 1 / Year 0|Randomized, not treated|1
339070|NCT00546481|1107228|P3|Maintenance Phase (CERA)|Other Reason|1
339071|NCT00546481|1107229|P2|Maintenance Phase (CERA)|Other Reason|0
339072|NCT00546481|1107230|P1|Maintenance Phase (CERA)|Other Reason|0
339073|NCT00546481|1107228|P3|Maintenance Phase (CERA)|Kidney transplantation|1
339074|NCT00546481|1107229|P2|Maintenance Phase (CERA)|Kidney transplantation|0
339075|NCT00546481|1107230|P1|Maintenance Phase (CERA)|Kidney transplantation|0
339076|NCT00546481|1107228|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
339077|NCT00546481|1107229|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
339078|NCT00546481|1107230|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
339079|NCT00546481|1107228|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
339080|NCT00546481|1107229|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
339081|NCT00546481|1107230|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
339082|NCT00546481|1107228|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
339083|NCT00546481|1107229|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
339084|NCT00546481|1107230|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
339085|NCT00546481|1107228|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
339086|NCT00546481|1107229|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
339087|NCT00546481|1107230|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
339088|NCT00546481|1107228|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
339089|NCT00546481|1107229|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
339090|NCT00546481|1107230|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
339091|NCT00546481|1107228|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
339092|NCT00546481|1107229|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
339093|NCT00546481|1107230|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
339094|NCT00546481|1107228|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
339095|NCT00546481|1107229|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
339096|NCT00546481|1107230|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
339097|NCT00546377|1107257|P1|Overall Study|Adverse Event|6
339098|NCT00546377|1107257|P1|Overall Study|Deemed ineligible|1
339099|NCT00546364|1107265|P3|Overall Study|Sponsor decision|1
339100|NCT00546364|1107266|P2|Overall Study|Sponsor decision|0
339101|NCT00546364|1107267|P1|Overall Study|Sponsor decision|0
339102|NCT00546364|1107265|P3|Overall Study|Physician Decision|1
339103|NCT00546364|1107266|P2|Overall Study|Physician Decision|0
339104|NCT00546364|1107267|P1|Overall Study|Physician Decision|0
339105|NCT00546364|1107265|P3|Overall Study|Target lesions resected|0
339106|NCT00546364|1107266|P2|Overall Study|Target lesions resected|0
339107|NCT00546364|1107267|P1|Overall Study|Target lesions resected|1
339108|NCT00546364|1107265|P3|Overall Study|Palliative treatment|1
339109|NCT00546364|1107266|P2|Overall Study|Palliative treatment|0
339110|NCT00546364|1107267|P1|Overall Study|Palliative treatment|1
339111|NCT00546364|1107265|P3|Overall Study|Mixed response|0
339112|NCT00546364|1107266|P2|Overall Study|Mixed response|0
339113|NCT00546364|1107267|P1|Overall Study|Mixed response|1
339114|NCT00546364|1107265|P3|Overall Study|Prior taxotere|0
339115|NCT00546364|1107266|P2|Overall Study|Prior taxotere|0
339116|NCT00546364|1107267|P1|Overall Study|Prior taxotere|1
339117|NCT00546364|1107265|P3|Overall Study|Withdrawal by Subject|3
339118|NCT00546364|1107266|P2|Overall Study|Withdrawal by Subject|6
339119|NCT00546364|1107267|P1|Overall Study|Withdrawal by Subject|5
339120|NCT00546364|1107265|P3|Overall Study|No longer meets study criteria|0
339121|NCT00546364|1107266|P2|Overall Study|No longer meets study criteria|1
339122|NCT00546364|1107267|P1|Overall Study|No longer meets study criteria|1
339123|NCT00546364|1107265|P3|Overall Study|Poor compliance/noncompliance|1
339124|NCT00546364|1107266|P2|Overall Study|Poor compliance/noncompliance|0
339125|NCT00546364|1107267|P1|Overall Study|Poor compliance/noncompliance|0
339126|NCT00546364|1107265|P3|Overall Study|Administrative reason by sponsor|0
339127|NCT00546364|1107266|P2|Overall Study|Administrative reason by sponsor|0
339128|NCT00546364|1107267|P1|Overall Study|Administrative reason by sponsor|1
339129|NCT00546364|1107265|P3|Overall Study|Completed and off treatment|2
339130|NCT00546364|1107266|P2|Overall Study|Completed and off treatment|0
339131|NCT00546364|1107267|P1|Overall Study|Completed and off treatment|1
339132|NCT00546364|1107265|P3|Overall Study|Disease progression|8
339133|NCT00546364|1107266|P2|Overall Study|Disease progression|11
339134|NCT00546364|1107267|P1|Overall Study|Disease progression|5
339135|NCT00546351|1107302|P1|Overall Study|Other reasons for premature termination|17
339136|NCT00546351|1107302|P1|Overall Study|Unsatisfactory compliance|9
339137|NCT00546351|1107302|P1|Overall Study|Protocol Deviation|1
339138|NCT00546351|1107302|P1|Overall Study|Lost to Follow-up|9
339139|NCT00546351|1107302|P1|Overall Study|Withdrawal by Subject|109
339140|NCT00546351|1107302|P1|Overall Study|Lack of Efficacy|15
339141|NCT00546351|1107302|P1|Overall Study|Adverse Event|76
339142|NCT00546260|1107348|P2|Overall Study|Drug not given pre diagnostic angiogr|2
339143|NCT00546260|1107349|P1|Overall Study|Drug not given pre diagnostic angiogr|8
339144|NCT00546117|1107371|P2|Overall Study|Inability to schedule follow-up visit|0
339145|NCT00546117|1107372|P1|Overall Study|Inability to schedule follow-up visit|1
339146|NCT00546117|1107371|P2|Overall Study|Withdrawal by Subject|0
339147|NCT00546117|1107372|P1|Overall Study|Withdrawal by Subject|3
339148|NCT00546078|1107391|P2|Overall Study|Other reason|1
339149|NCT00546078|1107392|P1|Overall Study|Other reason|1
339150|NCT00546078|1107391|P2|Overall Study|Withdrawal by Subject|3
339151|NCT00546078|1107392|P1|Overall Study|Withdrawal by Subject|2
339152|NCT00546078|1107391|P2|Overall Study|Lost to Follow-up|3
339153|NCT00546078|1107392|P1|Overall Study|Lost to Follow-up|1
339154|NCT00546052|1107430|P1|Overall Study|Non Compliance|7
339155|NCT00546052|1107430|P1|Overall Study|Withdrawal by Subject|20
339156|NCT00546052|1107430|P1|Overall Study|Protocol Violation|9
339157|NCT00546052|1107430|P1|Overall Study|Lost to Follow-up|144
339158|NCT00546052|1107430|P1|Overall Study|Adverse Event|47
339159|NCT00546000|1107448|P1|Overall Study|Baseline HPA Axis Supression|2
339160|NCT00546000|1107448|P1|Overall Study|Lost to Follow-up|1
339161|NCT00546000|1107448|P1|Overall Study|Adverse Event|1
339162|NCT00545948|1107467|P3|Overall Study|Not Treated|7
339163|NCT00545948|1107468|P2|Overall Study|Not Treated|1
339164|NCT00545948|1107469|P1|Overall Study|Not Treated|1
339165|NCT00545844|1107479|P1|Overall Study|Withdrawal by Subject|2
339166|NCT00545844|1107479|P1|Overall Study|Protocol Violation|1
339167|NCT00545844|1107479|P1|Overall Study|Lost to Follow-up|9
339168|NCT00545792|1107493|P1|Overall Study|Withdrawal by Subject|1
339169|NCT00545779|1107498|P1|Overall Study|Failure to return|3
339170|NCT00545779|1107498|P1|Overall Study|Adverse Event/intercurrent illness|5
339171|NCT00545779|1107498|P1|Overall Study|Withdrawal by Subject|20
339172|NCT00545779|1107498|P1|Overall Study|Did not cooperate|7
339173|NCT00545779|1107498|P1|Overall Study|Other protocol violation|1
339174|NCT00545779|1107498|P1|Overall Study|Violation of selection criteria at entry|8
339175|NCT00545753|1107518|P3|Overall Study|Protocol Violation|4
339176|NCT00545753|1107519|P2|Overall Study|Protocol Violation|1
339177|NCT00545753|1107520|P1|Overall Study|Protocol Violation|3
339178|NCT00545753|1107518|P3|Overall Study|Lost to Follow-up|12
339179|NCT00545753|1107519|P2|Overall Study|Lost to Follow-up|3
339180|NCT00545753|1107520|P1|Overall Study|Lost to Follow-up|13
339181|NCT00545753|1107518|P3|Overall Study|Withdrawal by Subject|10
339182|NCT00545753|1107519|P2|Overall Study|Withdrawal by Subject|1
339183|NCT00545753|1107520|P1|Overall Study|Withdrawal by Subject|0
339184|NCT00545740|1107533|P4|Overall Study|Husband against study|0
339185|NCT00545740|1107534|P3|Overall Study|Husband against study|1
339186|NCT00545740|1107535|P2|Overall Study|Husband against study|0
339187|NCT00545740|1107536|P1|Overall Study|Husband against study|0
339188|NCT00545740|1107533|P4|Overall Study|Patient difficulties|0
339189|NCT00545740|1107534|P3|Overall Study|Patient difficulties|0
339190|NCT00545740|1107535|P2|Overall Study|Patient difficulties|1
339191|NCT00545740|1107536|P1|Overall Study|Patient difficulties|0
339192|NCT00545740|1107533|P4|Overall Study|Non-adherence to visits|0
339193|NCT00545740|1107534|P3|Overall Study|Non-adherence to visits|0
339194|NCT00545740|1107535|P2|Overall Study|Non-adherence to visits|1
339195|NCT00545740|1107536|P1|Overall Study|Non-adherence to visits|0
339196|NCT00545740|1107533|P4|Overall Study|Lack of time|0
339197|NCT00545740|1107534|P3|Overall Study|Lack of time|0
339198|NCT00545740|1107535|P2|Overall Study|Lack of time|1
339199|NCT00545740|1107536|P1|Overall Study|Lack of time|0
339200|NCT00545740|1107533|P4|Overall Study|Sponsor decision|0
339201|NCT00545740|1107534|P3|Overall Study|Sponsor decision|0
339202|NCT00545740|1107535|P2|Overall Study|Sponsor decision|1
339203|NCT00545740|1107536|P1|Overall Study|Sponsor decision|0
339204|NCT00545740|1107533|P4|Overall Study|Accepted only monthly telephone calls|0
339205|NCT00545740|1107534|P3|Overall Study|Accepted only monthly telephone calls|0
339206|NCT00545740|1107535|P2|Overall Study|Accepted only monthly telephone calls|0
339207|NCT00545740|1107536|P1|Overall Study|Accepted only monthly telephone calls|1
339208|NCT00545740|1107533|P4|Overall Study|Physician Decision|0
339209|NCT00545740|1107534|P3|Overall Study|Physician Decision|3
339210|NCT00545740|1107535|P2|Overall Study|Physician Decision|0
339211|NCT00545740|1107536|P1|Overall Study|Physician Decision|0
339212|NCT00545740|1107533|P4|Overall Study|Missed visit|0
339213|NCT00545740|1107534|P3|Overall Study|Missed visit|0
339214|NCT00545740|1107535|P2|Overall Study|Missed visit|0
339215|NCT00545740|1107536|P1|Overall Study|Missed visit|1
339216|NCT00545740|1107533|P4|Overall Study|Site closure|0
339217|NCT00545740|1107534|P3|Overall Study|Site closure|0
339218|NCT00545740|1107535|P2|Overall Study|Site closure|0
339219|NCT00545740|1107536|P1|Overall Study|Site closure|1
339220|NCT00545740|1107533|P4|Overall Study|Suspected Diverticulitis Recurrence|1
339221|NCT00545740|1107534|P3|Overall Study|Suspected Diverticulitis Recurrence|1
339222|NCT00545740|1107535|P2|Overall Study|Suspected Diverticulitis Recurrence|1
339223|NCT00545740|1107536|P1|Overall Study|Suspected Diverticulitis Recurrence|1
339224|NCT00545740|1107533|P4|Overall Study|Diverticulitis attack|1
339225|NCT00545740|1107534|P3|Overall Study|Diverticulitis attack|1
339226|NCT00545740|1107535|P2|Overall Study|Diverticulitis attack|0
339227|NCT00545740|1107536|P1|Overall Study|Diverticulitis attack|0
339228|NCT00545740|1107533|P4|Overall Study|Moved|0
339229|NCT00545740|1107534|P3|Overall Study|Moved|1
339230|NCT00545740|1107535|P2|Overall Study|Moved|0
339231|NCT00545740|1107536|P1|Overall Study|Moved|2
339232|NCT00545740|1107533|P4|Overall Study|Non-compliance|0
339233|NCT00545740|1107534|P3|Overall Study|Non-compliance|1
339234|NCT00545740|1107535|P2|Overall Study|Non-compliance|2
339235|NCT00545740|1107536|P1|Overall Study|Non-compliance|0
339236|NCT00545740|1107533|P4|Overall Study|Protocol Violation|0
339237|NCT00545740|1107534|P3|Overall Study|Protocol Violation|1
339238|NCT00545740|1107535|P2|Overall Study|Protocol Violation|3
339239|NCT00545740|1107536|P1|Overall Study|Protocol Violation|1
339240|NCT00545740|1107533|P4|Overall Study|Lost to Follow-up|6
339241|NCT00545740|1107534|P3|Overall Study|Lost to Follow-up|5
339242|NCT00545740|1107535|P2|Overall Study|Lost to Follow-up|5
339243|NCT00545740|1107536|P1|Overall Study|Lost to Follow-up|7
339244|NCT00545740|1107533|P4|Overall Study|Adverse Event|9
339245|NCT00545740|1107534|P3|Overall Study|Adverse Event|19
339246|NCT00545740|1107535|P2|Overall Study|Adverse Event|18
339247|NCT00545740|1107536|P1|Overall Study|Adverse Event|10
339248|NCT00545740|1107533|P4|Overall Study|Withdrawal by Subject|18
339249|NCT00545740|1107534|P3|Overall Study|Withdrawal by Subject|16
339250|NCT00545740|1107535|P2|Overall Study|Withdrawal by Subject|15
339251|NCT00545740|1107536|P1|Overall Study|Withdrawal by Subject|17
339252|NCT00545740|1107533|P4|Overall Study|Lack of Efficacy|36
339253|NCT00545740|1107534|P3|Overall Study|Lack of Efficacy|47
339254|NCT00545740|1107535|P2|Overall Study|Lack of Efficacy|35
339255|NCT00545740|1107536|P1|Overall Study|Lack of Efficacy|34
339256|NCT00545688|1107574|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
339257|NCT00545688|1107575|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
339258|NCT00545688|1107576|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
339259|NCT00545688|1107577|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
339260|NCT00545688|1107574|P4|Follow-Up Period|Unspecified Reason|8
339261|NCT00545688|1107575|P3|Follow-Up Period|Unspecified Reason|6
339262|NCT00545688|1107576|P2|Follow-Up Period|Unspecified Reason|5
339263|NCT00545688|1107577|P1|Follow-Up Period|Unspecified Reason|2
339264|NCT00545688|1107574|P4|Follow-Up Period|Lost to Follow-up|1
339265|NCT00545688|1107575|P3|Follow-Up Period|Lost to Follow-up|3
339266|NCT00545688|1107576|P2|Follow-Up Period|Lost to Follow-up|3
339267|NCT00545688|1107577|P1|Follow-Up Period|Lost to Follow-up|3
339268|NCT00545688|1107574|P4|Follow-Up Period|Refused Treatment|2
339269|NCT00545688|1107575|P3|Follow-Up Period|Refused Treatment|0
339270|NCT00545688|1107576|P2|Follow-Up Period|Refused Treatment|2
339271|NCT00545688|1107577|P1|Follow-Up Period|Refused Treatment|6
339272|NCT00545688|1107574|P4|Follow-Up Period|Disease Progression|9
339273|NCT00545688|1107575|P3|Follow-Up Period|Disease Progression|9
339274|NCT00545688|1107576|P2|Follow-Up Period|Disease Progression|5
339275|NCT00545688|1107577|P1|Follow-Up Period|Disease Progression|6
339276|NCT00545688|1107574|P4|Follow-Up Period|Death|6
339277|NCT00545688|1107575|P3|Follow-Up Period|Death|2
339278|NCT00545688|1107576|P2|Follow-Up Period|Death|2
339279|NCT00545688|1107577|P1|Follow-Up Period|Death|4
339280|NCT00545688|1107574|P4|Adjuvant Treatment Period|Unknown Reason|0
339281|NCT00545688|1107575|P3|Adjuvant Treatment Period|Unknown Reason|0
339282|NCT00545688|1107576|P2|Adjuvant Treatment Period|Unknown Reason|1
339283|NCT00545688|1107577|P1|Adjuvant Treatment Period|Unknown Reason|0
339284|NCT00545688|1107574|P4|Adjuvant Treatment Period|Adverse Event|2
339285|NCT00545688|1107575|P3|Adjuvant Treatment Period|Adverse Event|2
339286|NCT00545688|1107576|P2|Adjuvant Treatment Period|Adverse Event|3
339287|NCT00545688|1107577|P1|Adjuvant Treatment Period|Adverse Event|0
339288|NCT00545688|1107574|P4|Adjuvant Treatment Period|Lost to Follow-up|0
339289|NCT00545688|1107575|P3|Adjuvant Treatment Period|Lost to Follow-up|1
339290|NCT00545688|1107576|P2|Adjuvant Treatment Period|Lost to Follow-up|0
339291|NCT00545688|1107577|P1|Adjuvant Treatment Period|Lost to Follow-up|1
339292|NCT00545688|1107574|P4|Adjuvant Treatment Period|Refused Treatment|5
339293|NCT00545688|1107575|P3|Adjuvant Treatment Period|Refused Treatment|1
339294|NCT00545688|1107576|P2|Adjuvant Treatment Period|Refused Treatment|1
339295|NCT00545688|1107577|P1|Adjuvant Treatment Period|Refused Treatment|1
339296|NCT00545688|1107574|P4|Adjuvant Treatment Period|Disease Progression|7
339297|NCT00545688|1107575|P3|Adjuvant Treatment Period|Disease Progression|0
339298|NCT00545688|1107576|P2|Adjuvant Treatment Period|Disease Progression|3
339299|NCT00545688|1107577|P1|Adjuvant Treatment Period|Disease Progression|3
339300|NCT00545688|1107574|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
339301|NCT00545688|1107575|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
339302|NCT00545688|1107576|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
339303|NCT00545688|1107577|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
339304|NCT00545688|1107574|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
339305|NCT00545688|1107575|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
339306|NCT00545688|1107576|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
339307|NCT00545688|1107577|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
339308|NCT00545688|1107574|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
339309|NCT00545688|1107575|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
339310|NCT00545688|1107576|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
339311|NCT00545688|1107577|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
339312|NCT00545688|1107574|P4|Neo-Adjuvant Treatment Period|Death|0
339313|NCT00545688|1107575|P3|Neo-Adjuvant Treatment Period|Death|0
339314|NCT00545688|1107576|P2|Neo-Adjuvant Treatment Period|Death|1
339315|NCT00545688|1107577|P1|Neo-Adjuvant Treatment Period|Death|0
339316|NCT00545688|1107574|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
339317|NCT00545688|1107575|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
339318|NCT00545688|1107576|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
339319|NCT00545688|1107577|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
339320|NCT00545688|1107574|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
339321|NCT00545688|1107575|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
339322|NCT00545688|1107576|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
339323|NCT00545688|1107577|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
339324|NCT00545688|1107574|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
339325|NCT00545688|1107575|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
339326|NCT00545688|1107576|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
339327|NCT00545688|1107577|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
339328|NCT00545584|1107676|P3|Overall Study|Two or more reasons for discontinuation|8
339329|NCT00545584|1107677|P2|Overall Study|Two or more reasons for discontinuation|19
339330|NCT00545584|1107678|P1|Overall Study|Two or more reasons for discontinuation|17
339331|NCT00545584|1107676|P3|Overall Study|Only one reason for discontinuation|48
339332|NCT00545584|1107677|P2|Overall Study|Only one reason for discontinuation|61
339333|NCT00545584|1107678|P1|Overall Study|Only one reason for discontinuation|62
339334|NCT00545571|1107689|P1|Overall Study|Kidney Transplantation|3
339335|NCT00545571|1107689|P1|Overall Study|Early Termination of Study|24
339336|NCT00545571|1107689|P1|Overall Study|Transfusion|12
339337|NCT00545571|1107689|P1|Overall Study|Screen Failure|16
339338|NCT00545571|1107689|P1|Overall Study|Refused Treatment|1
339339|NCT00545571|1107689|P1|Overall Study|Protocol Violation|2
339340|NCT00545571|1107689|P1|Overall Study|Lack of Efficacy|1
339341|NCT00545571|1107689|P1|Overall Study|Death|5
339342|NCT00545571|1107689|P1|Overall Study|Adverse Event|2
339343|NCT00545571|1107689|P1|Overall Study|Administrative Reasons|1
339344|NCT00545441|1107713|P2|Overall Study|Patients were not treated|3
339345|NCT00545441|1107714|P1|Overall Study|Patients were not treated|1
339346|NCT00545441|1107713|P2|Overall Study|Persistence or recurrence of fistula|2
339347|NCT00545441|1107714|P1|Overall Study|Persistence or recurrence of fistula|5
339348|NCT00545441|1107713|P2|Overall Study|Withdrawal by Subject|1
339349|NCT00545441|1107714|P1|Overall Study|Withdrawal by Subject|1
339350|NCT00545441|1107713|P2|Overall Study|Technical failure|1
339351|NCT00545441|1107714|P1|Overall Study|Technical failure|0
339352|NCT00545441|1107713|P2|Overall Study|Lost to Follow-up|5
339353|NCT00545441|1107714|P1|Overall Study|Lost to Follow-up|9
339354|NCT00545441|1107713|P2|Overall Study|Fistula draining at 6 months|4
339355|NCT00545441|1107714|P1|Overall Study|Fistula draining at 6 months|2
339356|NCT00545402|1107722|P2|Overall Study|Reason not specified|1
339357|NCT00545402|1107723|P1|Overall Study|Reason not specified|1
339358|NCT00545402|1107722|P2|Overall Study|Protocol Violation|0
339359|NCT00545402|1107723|P1|Overall Study|Protocol Violation|1
339360|NCT00545402|1107722|P2|Overall Study|Withdrawal by Subject|1
339361|NCT00545402|1107723|P1|Overall Study|Withdrawal by Subject|0
339362|NCT00545402|1107722|P2|Overall Study|Graft loss|4
339363|NCT00545402|1107723|P1|Overall Study|Graft loss|2
339364|NCT00545402|1107722|P2|Overall Study|Death|7
339365|NCT00545402|1107723|P1|Overall Study|Death|5
339366|NCT00545402|1107722|P2|Overall Study|Use of unauthorized immunosuppressant|7
339367|NCT00545402|1107723|P1|Overall Study|Use of unauthorized immunosuppressant|8
339368|NCT00545402|1107722|P2|Overall Study|Discontinuation of treatment|9
339369|NCT00545402|1107723|P1|Overall Study|Discontinuation of treatment|17
339370|NCT00545363|1107741|P2|Overall Study|Unspecified|1
339371|NCT00545363|1107742|P1|Overall Study|Unspecified|1
339372|NCT00545363|1107741|P2|Overall Study|Lost to Follow-up|0
339373|NCT00545363|1107742|P1|Overall Study|Lost to Follow-up|2
339374|NCT00545363|1107741|P2|Overall Study|Did not meet entry criteria|1
339375|NCT00545363|1107742|P1|Overall Study|Did not meet entry criteria|1
339376|NCT00545363|1107741|P2|Overall Study|Non-compliance|1
339377|NCT00545363|1107742|P1|Overall Study|Non-compliance|3
339378|NCT00545363|1107741|P2|Overall Study|Withdrawal by Subject|5
339379|NCT00545363|1107742|P1|Overall Study|Withdrawal by Subject|6
339380|NCT00545363|1107741|P2|Overall Study|Adverse Event|7
339381|NCT00545363|1107742|P1|Overall Study|Adverse Event|6
339382|NCT00545298|1107757|P3|Overall Study|Issues with Standard of Care|1
339383|NCT00545298|1107758|P2|Overall Study|Issues with Standard of Care|0
339384|NCT00545298|1107759|P1|Overall Study|Issues with Standard of Care|2
339385|NCT00545272|1107776|P6|Overall Study|Lost to Follow-up|0
339386|NCT00545272|1107777|P5|Overall Study|Lost to Follow-up|1
339387|NCT00545272|1107778|P4|Overall Study|Lost to Follow-up|0
339388|NCT00545272|1107779|P3|Overall Study|Lost to Follow-up|0
339389|NCT00545272|1107780|P2|Overall Study|Lost to Follow-up|0
339390|NCT00545272|1107781|P1|Overall Study|Lost to Follow-up|0
339391|NCT00545272|1107776|P6|Overall Study|Abnormal test procedure result(s)|0
339392|NCT00545272|1107777|P5|Overall Study|Abnormal test procedure result(s)|1
339393|NCT00545272|1107778|P4|Overall Study|Abnormal test procedure result(s)|0
339394|NCT00545272|1107779|P3|Overall Study|Abnormal test procedure result(s)|0
339395|NCT00545272|1107780|P2|Overall Study|Abnormal test procedure result(s)|0
339396|NCT00545272|1107781|P1|Overall Study|Abnormal test procedure result(s)|0
339397|NCT00545272|1107776|P6|Overall Study|Abnormal laboratory value(s)|1
339398|NCT00545272|1107777|P5|Overall Study|Abnormal laboratory value(s)|0
339399|NCT00545272|1107778|P4|Overall Study|Abnormal laboratory value(s)|0
339400|NCT00545272|1107779|P3|Overall Study|Abnormal laboratory value(s)|0
339401|NCT00545272|1107780|P2|Overall Study|Abnormal laboratory value(s)|0
339402|NCT00545272|1107781|P1|Overall Study|Abnormal laboratory value(s)|0
339403|NCT00545272|1107776|P6|Overall Study|Adverse Event|1
339404|NCT00545272|1107777|P5|Overall Study|Adverse Event|0
339405|NCT00545272|1107778|P4|Overall Study|Adverse Event|0
339406|NCT00545272|1107779|P3|Overall Study|Adverse Event|1
339407|NCT00545272|1107780|P2|Overall Study|Adverse Event|0
339408|NCT00545272|1107781|P1|Overall Study|Adverse Event|0
339409|NCT00545272|1107776|P6|Overall Study|Protocol deviation|1
339410|NCT00545272|1107777|P5|Overall Study|Protocol deviation|0
339411|NCT00545272|1107778|P4|Overall Study|Protocol deviation|1
339412|NCT00545272|1107779|P3|Overall Study|Protocol deviation|0
339413|NCT00545272|1107780|P2|Overall Study|Protocol deviation|1
339414|NCT00545272|1107781|P1|Overall Study|Protocol deviation|0
339415|NCT00545233|1107833|P2|Overall Study|Physician Decision|1
339416|NCT00545233|1107834|P1|Overall Study|Physician Decision|2
339417|NCT00545233|1107833|P2|Overall Study|Insufficient response|15
339418|NCT00545233|1107834|P1|Overall Study|Insufficient response|14
339419|NCT00545233|1107833|P2|Overall Study|Failure to Return|6
339420|NCT00545233|1107834|P1|Overall Study|Failure to Return|4
339421|NCT00545233|1107833|P2|Overall Study|Refused Treatment|7
339422|NCT00545233|1107834|P1|Overall Study|Refused Treatment|9
339423|NCT00545233|1107833|P2|Overall Study|Protocol Violation|0
339424|NCT00545233|1107834|P1|Overall Study|Protocol Violation|2
339425|NCT00545233|1107833|P2|Overall Study|Violation of Selection Criteria at Entry|1
339426|NCT00545233|1107834|P1|Overall Study|Violation of Selection Criteria at Entry|5
339427|NCT00545233|1107833|P2|Overall Study|Adverse Event|5
339428|NCT00545233|1107834|P1|Overall Study|Adverse Event|10
339429|NCT00545168|1107893|P3|Overall Study|Visit for Day 21 was not done in error|2
339430|NCT00545168|1107894|P2|Overall Study|Visit for Day 21 was not done in error|0
339431|NCT00545168|1107895|P1|Overall Study|Visit for Day 21 was not done in error|1
339432|NCT00545168|1107893|P3|Overall Study|Protocol Violation|1
339433|NCT00545168|1107894|P2|Overall Study|Protocol Violation|0
339434|NCT00545168|1107895|P1|Overall Study|Protocol Violation|1
339435|NCT00545168|1107893|P3|Overall Study|Withdrawal by Subject|13
339436|NCT00545168|1107894|P2|Overall Study|Withdrawal by Subject|0
339437|NCT00545168|1107895|P1|Overall Study|Withdrawal by Subject|9
339438|NCT00545168|1107893|P3|Overall Study|Lost to Follow-up|5
339439|NCT00545168|1107894|P2|Overall Study|Lost to Follow-up|5
339440|NCT00545168|1107895|P1|Overall Study|Lost to Follow-up|5
339441|NCT00545103|1107921|P4|Overall Study|Death|0
339442|NCT00545103|1107922|P3|Overall Study|Death|0
339443|NCT00545103|1107923|P2|Overall Study|Death|1
339444|NCT00545103|1107924|P1|Overall Study|Death|0
339445|NCT00545103|1107921|P4|Overall Study|Subject met endpoint under protocol v. 1|0
339446|NCT00545103|1107922|P3|Overall Study|Subject met endpoint under protocol v. 1|1
339447|NCT00545103|1107923|P2|Overall Study|Subject met endpoint under protocol v. 1|0
339448|NCT00545103|1107924|P1|Overall Study|Subject met endpoint under protocol v. 1|0
339449|NCT00545103|1107921|P4|Overall Study|Does not want to take study drug anymore|0
339450|NCT00545103|1107922|P3|Overall Study|Does not want to take study drug anymore|1
339451|NCT00545103|1107923|P2|Overall Study|Does not want to take study drug anymore|0
339452|NCT00545103|1107924|P1|Overall Study|Does not want to take study drug anymore|1
339453|NCT00545103|1107921|P4|Overall Study|Use of prohibited medication|0
339454|NCT00545103|1107922|P3|Overall Study|Use of prohibited medication|1
339455|NCT00545103|1107923|P2|Overall Study|Use of prohibited medication|0
339456|NCT00545103|1107924|P1|Overall Study|Use of prohibited medication|0
339457|NCT00545103|1107921|P4|Overall Study|Subject moved|0
339458|NCT00545103|1107922|P3|Overall Study|Subject moved|0
339459|NCT00545103|1107923|P2|Overall Study|Subject moved|1
339460|NCT00545103|1107924|P1|Overall Study|Subject moved|0
339461|NCT00545103|1107921|P4|Overall Study|Investigator decision|0
339462|NCT00545103|1107922|P3|Overall Study|Investigator decision|1
339463|NCT00545103|1107923|P2|Overall Study|Investigator decision|0
339464|NCT00545103|1107924|P1|Overall Study|Investigator decision|0
339465|NCT00545103|1107921|P4|Overall Study|Noncompliance|0
339466|NCT00545103|1107922|P3|Overall Study|Noncompliance|0
339467|NCT00545103|1107923|P2|Overall Study|Noncompliance|1
339468|NCT00545103|1107924|P1|Overall Study|Noncompliance|0
339469|NCT00545103|1107921|P4|Overall Study|Subject's decision|0
339470|NCT00545103|1107922|P3|Overall Study|Subject's decision|0
339471|NCT00545103|1107923|P2|Overall Study|Subject's decision|0
339472|NCT00545103|1107924|P1|Overall Study|Subject's decision|1
339473|NCT00545103|1107921|P4|Overall Study|Personal reasons|0
339474|NCT00545103|1107922|P3|Overall Study|Personal reasons|0
339475|NCT00545103|1107923|P2|Overall Study|Personal reasons|0
339476|NCT00545103|1107924|P1|Overall Study|Personal reasons|1
339477|NCT00545103|1107921|P4|Overall Study|Diverticulitis crisis|1
339478|NCT00545103|1107922|P3|Overall Study|Diverticulitis crisis|0
339479|NCT00545103|1107923|P2|Overall Study|Diverticulitis crisis|0
339480|NCT00545103|1107924|P1|Overall Study|Diverticulitis crisis|0
339481|NCT00545103|1107921|P4|Overall Study|Wish to start a family|1
339482|NCT00545103|1107922|P3|Overall Study|Wish to start a family|0
339483|NCT00545103|1107923|P2|Overall Study|Wish to start a family|0
339484|NCT00545103|1107924|P1|Overall Study|Wish to start a family|0
339485|NCT00545103|1107921|P4|Overall Study|Investigational product not taken|1
339486|NCT00545103|1107922|P3|Overall Study|Investigational product not taken|0
339487|NCT00545103|1107923|P2|Overall Study|Investigational product not taken|0
339488|NCT00545103|1107924|P1|Overall Study|Investigational product not taken|1
339489|NCT00545103|1107921|P4|Overall Study|Difficult to open package|1
339490|NCT00545103|1107922|P3|Overall Study|Difficult to open package|0
339491|NCT00545103|1107923|P2|Overall Study|Difficult to open package|0
339492|NCT00545103|1107924|P1|Overall Study|Difficult to open package|0
339493|NCT00545103|1107921|P4|Overall Study|Suspected recurrence of diverticulitis|3
339494|NCT00545103|1107922|P3|Overall Study|Suspected recurrence of diverticulitis|0
339495|NCT00545103|1107923|P2|Overall Study|Suspected recurrence of diverticulitis|0
339496|NCT00545103|1107924|P1|Overall Study|Suspected recurrence of diverticulitis|1
339497|NCT00545103|1107921|P4|Overall Study|Protocol Violation|0
339498|NCT00545103|1107922|P3|Overall Study|Protocol Violation|3
339499|NCT00545103|1107923|P2|Overall Study|Protocol Violation|2
339500|NCT00545103|1107924|P1|Overall Study|Protocol Violation|1
339501|NCT00545103|1107921|P4|Overall Study|Lost to Follow-up|4
339502|NCT00545103|1107922|P3|Overall Study|Lost to Follow-up|3
339503|NCT00545103|1107923|P2|Overall Study|Lost to Follow-up|6
339504|NCT00545103|1107924|P1|Overall Study|Lost to Follow-up|4
339505|NCT00545103|1107921|P4|Overall Study|Adverse Event|10
339506|NCT00545103|1107922|P3|Overall Study|Adverse Event|17
339507|NCT00545103|1107923|P2|Overall Study|Adverse Event|12
339508|NCT00545103|1107924|P1|Overall Study|Adverse Event|11
339509|NCT00545103|1107921|P4|Overall Study|Withdrawal by Subject|22
339510|NCT00545103|1107922|P3|Overall Study|Withdrawal by Subject|18
339511|NCT00545103|1107923|P2|Overall Study|Withdrawal by Subject|10
339512|NCT00545103|1107924|P1|Overall Study|Withdrawal by Subject|6
339513|NCT00545103|1107921|P4|Overall Study|Lack of Efficacy|27
339514|NCT00545103|1107922|P3|Overall Study|Lack of Efficacy|31
339515|NCT00545103|1107923|P2|Overall Study|Lack of Efficacy|45
339516|NCT00545103|1107924|P1|Overall Study|Lack of Efficacy|48
339517|NCT00545064|1107958|P1|Overall Study|inclement weather|1
339518|NCT00545064|1107958|P1|Overall Study|cancel all appointments, no rebooking|1
339519|NCT00545064|1107958|P1|Overall Study|did not complete course of treatment|1
339520|NCT00545064|1107958|P1|Overall Study|Withdrawal by Subject|2
339521|NCT00545064|1107958|P1|Overall Study|Lost to Follow-up|3
339522|NCT00545051|1107969|P2|Overall Study|Administrative reasons|1
339523|NCT00545051|1107970|P1|Overall Study|Administrative reasons|0
339524|NCT00545051|1107969|P2|Overall Study|Withdrawal by Subject|1
339525|NCT00545051|1107970|P1|Overall Study|Withdrawal by Subject|0
339526|NCT00545051|1107969|P2|Overall Study|Protocol Violation|0
339527|NCT00545051|1107970|P1|Overall Study|Protocol Violation|1
339528|NCT00545051|1107969|P2|Overall Study|Violation of inclusion/exclusion|2
339529|NCT00545051|1107970|P1|Overall Study|Violation of inclusion/exclusion|0
339530|NCT00545051|1107969|P2|Overall Study|Death|0
339531|NCT00545051|1107970|P1|Overall Study|Death|1
339532|NCT00545051|1107969|P2|Overall Study|Adverse Event|3
339533|NCT00545051|1107970|P1|Overall Study|Adverse Event|7
339534|NCT00544882|1108014|P3|Cycle 3: Follow-up|Pregnancy|0
339535|NCT00544882|1108015|P2|Cycle 3: Follow-up|Pregnancy|1
339536|NCT00544882|1108016|P1|Cycle 3: Follow-up|Pregnancy|0
339537|NCT00544882|1108014|P3|Cycle 3: Follow-up|Noncompliance|0
339538|NCT00544882|1108015|P2|Cycle 3: Follow-up|Noncompliance|1
339539|NCT00544882|1108016|P1|Cycle 3: Follow-up|Noncompliance|0
339540|NCT00544882|1108014|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
339541|NCT00544882|1108015|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
339542|NCT00544882|1108016|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
339543|NCT00544882|1108014|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
339544|NCT00544882|1108015|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
339545|NCT00544882|1108016|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
339546|NCT00544882|1108014|P3|Cycle 1: Run-in Cycle|Adverse Event|0
339547|NCT00544882|1108015|P2|Cycle 1: Run-in Cycle|Adverse Event|0
339548|NCT00544882|1108016|P1|Cycle 1: Run-in Cycle|Adverse Event|1
339549|NCT00544882|1108014|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
339550|NCT00544882|1108015|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
339551|NCT00544882|1108016|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
339552|NCT00544869|1108041|P3|Overall Study|Physician Decision|0
339553|NCT00544869|1108042|P2|Overall Study|Physician Decision|0
339554|NCT00544869|1108043|P1|Overall Study|Physician Decision|2
339555|NCT00544869|1108041|P3|Overall Study|Lack of Efficacy|0
339556|NCT00544869|1108042|P2|Overall Study|Lack of Efficacy|1
339557|NCT00544869|1108043|P1|Overall Study|Lack of Efficacy|1
339558|NCT00544869|1108041|P3|Overall Study|Adverse Event|0
339559|NCT00544869|1108042|P2|Overall Study|Adverse Event|1
339560|NCT00544869|1108043|P1|Overall Study|Adverse Event|6
339561|NCT00544869|1108041|P3|Overall Study|Rsolution of congenitive symptoms|0
339562|NCT00544869|1108042|P2|Overall Study|Rsolution of congenitive symptoms|0
339563|NCT00544869|1108043|P1|Overall Study|Rsolution of congenitive symptoms|3
339564|NCT00544817|1108051|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
339565|NCT00544817|1108051|P1|Follow-up Systemic Therapy|Physician Decision|3
339566|NCT00544817|1108051|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
339567|NCT00544817|1108051|P1|No Treatment Interval|Adverse Event|1
339568|NCT00544817|1108051|P1|No Treatment Interval|Physician Decision|3
339569|NCT00544817|1108051|P1|No Treatment Interval|Lack of Efficacy|8
339570|NCT00544817|1108051|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
339571|NCT00544817|1108051|P1|Combined Modality|Adverse Event|2
339572|NCT00544817|1108051|P1|Combined Modality|Worsening Neurologic Symptoms|2
339573|NCT00544817|1108051|P1|Combined Modality|Lack of Efficacy|2
339574|NCT00544648|1108100|P2|Overall Study|progression of disease|0
339575|NCT00544648|1108101|P1|Overall Study|progression of disease|1
339576|NCT00544648|1108100|P2|Overall Study|Adverse Event|1
339577|NCT00544648|1108101|P1|Overall Study|Adverse Event|1
339578|NCT00544648|1108100|P2|Overall Study|Withdrawal by Subject|0
339579|NCT00544648|1108101|P1|Overall Study|Withdrawal by Subject|1
339580|NCT00544557|1108115|P1|Overall Study|Unspecified|98
339581|NCT00544557|1108115|P1|Overall Study|Lack of Efficacy|196
339582|NCT00544557|1108115|P1|Overall Study|Adverse Event|140
339583|NCT00544544|1108146|P1|Overall Study|Lost to Follow-up|1
339584|NCT00544544|1108146|P1|Overall Study|Adverse Event|1
339585|NCT00544544|1108146|P1|Overall Study|Withdrawal by Subject|1
339586|NCT00544440|1108150|P1|Overall Study|Unspecified|5
339587|NCT00544440|1108150|P1|Overall Study|Progressive Disease|47
339588|NCT00544440|1108150|P1|Overall Study|Subject Non-compliance|1
339589|NCT00544440|1108150|P1|Overall Study|Withdrawal by Subject|2
339590|NCT00544440|1108150|P1|Overall Study|Adverse Event|1
339591|NCT00544440|1108150|P1|Overall Study|Other|1
339592|NCT00544167|1108157|P1|Overall Study|Physician Decision|8
339593|NCT00544167|1108157|P1|Overall Study|Adverse Event|21
339594|NCT00543296|1108161|P1|Overall Study|Physician Decision|7
339595|NCT00543985|1108168|P1|Overall Study|Withdrawal by Subject|4
339596|NCT00543855|1108179|P4|Overall Study|Protocol Violation|0
339597|NCT00543855|1108180|P3|Overall Study|Protocol Violation|0
339598|NCT00543855|1108181|P2|Overall Study|Protocol Violation|0
339599|NCT00543855|1108182|P1|Overall Study|Protocol Violation|1
339600|NCT00543855|1108179|P4|Overall Study|Withdrawal by Subject|0
339601|NCT00543855|1108180|P3|Overall Study|Withdrawal by Subject|2
339602|NCT00543855|1108181|P2|Overall Study|Withdrawal by Subject|1
339603|NCT00543855|1108182|P1|Overall Study|Withdrawal by Subject|0
339604|NCT00543855|1108179|P4|Overall Study|Lost to Follow-up|0
339605|NCT00543855|1108180|P3|Overall Study|Lost to Follow-up|1
339606|NCT00543855|1108181|P2|Overall Study|Lost to Follow-up|0
339607|NCT00543855|1108182|P1|Overall Study|Lost to Follow-up|0
339608|NCT00543855|1108179|P4|Overall Study|Adverse Event|4
339609|NCT00543855|1108180|P3|Overall Study|Adverse Event|3
339610|NCT00543855|1108181|P2|Overall Study|Adverse Event|1
339611|NCT00543855|1108182|P1|Overall Study|Adverse Event|3
339612|NCT00543803|1108204|P1|Overall Study|not specified|86
339613|NCT00543803|1108204|P1|Overall Study|Lost to Follow-up|20
339614|NCT00543803|1108204|P1|Overall Study|Lack of Efficacy|22
339615|NCT00543803|1108204|P1|Overall Study|Adverse Event|14
339616|NCT00543725|1108232|P2|Overall Study|Not specified|3
339617|NCT00543725|1108233|P1|Overall Study|Not specified|3
339618|NCT00543725|1108232|P2|Overall Study|Lost to Follow-up|11
339619|NCT00543725|1108233|P1|Overall Study|Lost to Follow-up|15
339620|NCT00543725|1108232|P2|Overall Study|Withdrawal by Subject|13
339621|NCT00543725|1108233|P1|Overall Study|Withdrawal by Subject|4
339622|NCT00543725|1108232|P2|Overall Study|Protocol Violation|1
339623|NCT00543725|1108233|P1|Overall Study|Protocol Violation|0
339624|NCT00543725|1108232|P2|Overall Study|Subject Reached A Virologic Endpoint|14
339625|NCT00543725|1108233|P1|Overall Study|Subject Reached A Virologic Endpoint|22
339626|NCT00543725|1108232|P2|Overall Study|Subject Ineligible To Continue The Trial|0
339627|NCT00543725|1108233|P1|Overall Study|Subject Ineligible To Continue The Trial|2
339628|NCT00543725|1108232|P2|Overall Study|Subject Non-Compliant|4
339629|NCT00543725|1108233|P1|Overall Study|Subject Non-Compliant|4
339630|NCT00543725|1108232|P2|Overall Study|Sponsor's Decision|1
339631|NCT00543725|1108233|P1|Overall Study|Sponsor's Decision|0
339632|NCT00543725|1108232|P2|Overall Study|Adverse Event|27
339633|NCT00543725|1108233|P1|Overall Study|Adverse Event|18
339634|NCT00543569|1108259|P4|Overall Study|Randomized but never received study drug|3
339635|NCT00543569|1108260|P3|Overall Study|Randomized but never received study drug|5
339636|NCT00543569|1108261|P2|Overall Study|Randomized but never received study drug|3
339637|NCT00543569|1108262|P1|Overall Study|Randomized but never received study drug|3
339638|NCT00543569|1108259|P4|Overall Study|Miscellaneous Reasons|4
339639|NCT00543569|1108260|P3|Overall Study|Miscellaneous Reasons|11
339640|NCT00543569|1108261|P2|Overall Study|Miscellaneous Reasons|3
339641|NCT00543569|1108262|P1|Overall Study|Miscellaneous Reasons|7
339642|NCT00543569|1108259|P4|Overall Study|Lost to Follow-up|1
339643|NCT00543569|1108260|P3|Overall Study|Lost to Follow-up|1
339644|NCT00543569|1108261|P2|Overall Study|Lost to Follow-up|0
339645|NCT00543569|1108262|P1|Overall Study|Lost to Follow-up|0
339646|NCT00543569|1108259|P4|Overall Study|Death|1
339647|NCT00543569|1108260|P3|Overall Study|Death|3
339648|NCT00543569|1108261|P2|Overall Study|Death|2
339649|NCT00543569|1108262|P1|Overall Study|Death|2
339650|NCT00543543|1108368|P4|Overall Study|Withdrawal by Subject|503
339651|NCT00543543|1108369|P3|Overall Study|Withdrawal by Subject|5
339652|NCT00543543|1108370|P2|Overall Study|Withdrawal by Subject|482
339653|NCT00543543|1108371|P1|Overall Study|Withdrawal by Subject|7
339654|NCT00543543|1108368|P4|Overall Study|Protocol Violation|6
339655|NCT00543543|1108369|P3|Overall Study|Protocol Violation|0
339656|NCT00543543|1108370|P2|Overall Study|Protocol Violation|6
339657|NCT00543543|1108371|P1|Overall Study|Protocol Violation|0
339658|NCT00543543|1108368|P4|Overall Study|Physician Decision|7
339659|NCT00543543|1108369|P3|Overall Study|Physician Decision|0
339660|NCT00543543|1108370|P2|Overall Study|Physician Decision|4
339661|NCT00543543|1108371|P1|Overall Study|Physician Decision|0
339662|NCT00543543|1108368|P4|Overall Study|Lost to Follow-up|701
339663|NCT00543543|1108369|P3|Overall Study|Lost to Follow-up|9
339664|NCT00543543|1108370|P2|Overall Study|Lost to Follow-up|749
339665|NCT00543543|1108371|P1|Overall Study|Lost to Follow-up|12
339666|NCT00543543|1108368|P4|Overall Study|Adverse Event|5
339667|NCT00543543|1108369|P3|Overall Study|Adverse Event|0
339668|NCT00543543|1108370|P2|Overall Study|Adverse Event|11
339669|NCT00543543|1108371|P1|Overall Study|Adverse Event|1
339670|NCT00543140|1108407|P1|Overall Study|Conversion to different procedure|1
339671|NCT00543140|1108407|P1|Overall Study|Subject moved|1
339672|NCT00543140|1108407|P1|Overall Study|Death|1
339673|NCT00543140|1108407|P1|Overall Study|SAE leading to explant of SAGB|3
339674|NCT00543140|1108407|P1|Overall Study|Insufficient weight loss|10
339675|NCT00543140|1108407|P1|Overall Study|Protocol Violation|10
339676|NCT00543140|1108407|P1|Overall Study|Withdrawal by Subject|13
339677|NCT00543140|1108407|P1|Overall Study|Lost to Follow-up|33
339678|NCT00542997|1108430|P1|Efficacy Period|Adverse Event|3
339679|NCT00542997|1108430|P1|Wash in / Wash Out Period|Adverse Event|3
339680|NCT00542997|1108430|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
339681|NCT00542880|1108452|P2|Period 3|Adverse Event|2
339682|NCT00542880|1108453|P1|Period 3|Adverse Event|0
339683|NCT00542880|1108452|P2|Period 2|Not specified|1
339684|NCT00542880|1108453|P1|Period 2|Not specified|0
339685|NCT00542880|1108452|P2|Period 2|Severe non-compliance|1
339686|NCT00542880|1108453|P1|Period 2|Severe non-compliance|0
339687|NCT00542880|1108452|P2|Period 2|Discontinuation criteria|0
339688|NCT00542880|1108453|P1|Period 2|Discontinuation criteria|2
339689|NCT00542880|1108452|P2|Period 2|Eligibility not fulfilled|1
339690|NCT00542880|1108453|P1|Period 2|Eligibility not fulfilled|0
339691|NCT00542880|1108452|P2|Period 2|Adverse Event|7
339692|NCT00542880|1108453|P1|Period 2|Adverse Event|5
339693|NCT00542880|1108452|P2|Period 1|Protocol Violation|1
339694|NCT00542880|1108453|P1|Period 1|Protocol Violation|0
339695|NCT00542880|1108452|P2|Period 1|Withdrawal by Subject|1
339696|NCT00542880|1108453|P1|Period 1|Withdrawal by Subject|1
339697|NCT00542880|1108452|P2|Period 1|Development of study-specific criteria|2
339698|NCT00542880|1108453|P1|Period 1|Development of study-specific criteria|1
339699|NCT00542880|1108452|P2|Period 1|Adverse Event|2
339700|NCT00542880|1108453|P1|Period 1|Adverse Event|2
339701|NCT00542880|1108452|P2|Period 1|Eligibility criteria not fulfilled|6
339702|NCT00542880|1108453|P1|Period 1|Eligibility criteria not fulfilled|2
339703|NCT00542828|1108489|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
339704|NCT00542828|1108489|P1|Overall Study|Study Prematurely Discontinued|7
339705|NCT00542828|1108489|P1|Overall Study|Need for Prohibited Treatment|3
339706|NCT00542828|1108489|P1|Overall Study|Physician Decision|1
339707|NCT00542815|1108507|P3|Overall Study|Other reasons|10
339708|NCT00542815|1108508|P2|Overall Study|Other reasons|10
339709|NCT00542815|1108509|P1|Overall Study|Other reasons|24
339710|NCT00542815|1108507|P3|Overall Study|Withdrawal by Subject|8
339711|NCT00542815|1108508|P2|Overall Study|Withdrawal by Subject|5
339712|NCT00542815|1108509|P1|Overall Study|Withdrawal by Subject|41
339713|NCT00542815|1108507|P3|Overall Study|Protocol Violation|2
339714|NCT00542815|1108508|P2|Overall Study|Protocol Violation|1
339715|NCT00542815|1108509|P1|Overall Study|Protocol Violation|1
339716|NCT00542815|1108507|P3|Overall Study|Physician Decision|0
339717|NCT00542815|1108508|P2|Overall Study|Physician Decision|1
339718|NCT00542815|1108509|P1|Overall Study|Physician Decision|2
339719|NCT00542815|1108507|P3|Overall Study|Lack of Efficacy|0
339720|NCT00542815|1108508|P2|Overall Study|Lack of Efficacy|2
339721|NCT00542815|1108509|P1|Overall Study|Lack of Efficacy|9
339722|NCT00542815|1108507|P3|Overall Study|Death|3
339723|NCT00542815|1108508|P2|Overall Study|Death|7
339724|NCT00542815|1108509|P1|Overall Study|Death|10
339725|NCT00542815|1108507|P3|Overall Study|Adverse Event|9
339726|NCT00542815|1108508|P2|Overall Study|Adverse Event|6
339727|NCT00542815|1108509|P1|Overall Study|Adverse Event|19
339728|NCT00542789|1108522|P2|Overall Study|Recurrence of Gastric Ulcer|57
339729|NCT00542789|1108523|P1|Overall Study|Recurrence of Gastric Ulcer|8
339730|NCT00542789|1108522|P2|Overall Study|Protocol Violation|1
339731|NCT00542789|1108523|P1|Overall Study|Protocol Violation|8
339732|NCT00542789|1108522|P2|Overall Study|Withdrawal by Subject|3
339733|NCT00542789|1108523|P1|Overall Study|Withdrawal by Subject|7
339734|NCT00542789|1108522|P2|Overall Study|Adverse Event|17
339735|NCT00542789|1108523|P1|Overall Study|Adverse Event|18
339736|NCT00542425|1108614|P5|Extended 24 Weeks of Treatment|Other|1
339737|NCT00542425|1108615|P4|Extended 24 Weeks of Treatment|Other|0
339738|NCT00542425|1108616|P3|Extended 24 Weeks of Treatment|Other|0
339739|NCT00542425|1108617|P2|Extended 24 Weeks of Treatment|Other|1
339740|NCT00542425|1108618|P1|Extended 24 Weeks of Treatment|Other|1
339741|NCT00542425|1108614|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
339742|NCT00542425|1108615|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
339743|NCT00542425|1108616|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
339744|NCT00542425|1108617|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
339745|NCT00542425|1108618|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
339746|NCT00542425|1108614|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
339747|NCT00542425|1108615|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
339748|NCT00542425|1108616|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
339749|NCT00542425|1108617|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
339750|NCT00542425|1108618|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
339751|NCT00542425|1108614|P5|Extended 24 Weeks of Treatment|Adverse Event|0
339752|NCT00542425|1108615|P4|Extended 24 Weeks of Treatment|Adverse Event|1
339753|NCT00542425|1108616|P3|Extended 24 Weeks of Treatment|Adverse Event|1
339754|NCT00542425|1108617|P2|Extended 24 Weeks of Treatment|Adverse Event|0
339755|NCT00542425|1108618|P1|Extended 24 Weeks of Treatment|Adverse Event|0
339756|NCT00542425|1108614|P5|Initial 24 Weeks|Other|0
339757|NCT00542425|1108615|P4|Initial 24 Weeks|Other|0
339758|NCT00542425|1108616|P3|Initial 24 Weeks|Other|1
339759|NCT00542425|1108617|P2|Initial 24 Weeks|Other|2
339760|NCT00542425|1108618|P1|Initial 24 Weeks|Other|0
339761|NCT00542425|1108614|P5|Initial 24 Weeks|Refusal of treatment|1
339762|NCT00542425|1108615|P4|Initial 24 Weeks|Refusal of treatment|4
339763|NCT00542425|1108616|P3|Initial 24 Weeks|Refusal of treatment|1
339764|NCT00542425|1108617|P2|Initial 24 Weeks|Refusal of treatment|2
339765|NCT00542425|1108618|P1|Initial 24 Weeks|Refusal of treatment|2
339766|NCT00542425|1108614|P5|Initial 24 Weeks|Protocol Violation|0
339767|NCT00542425|1108615|P4|Initial 24 Weeks|Protocol Violation|1
339768|NCT00542425|1108616|P3|Initial 24 Weeks|Protocol Violation|0
339769|NCT00542425|1108617|P2|Initial 24 Weeks|Protocol Violation|0
339770|NCT00542425|1108618|P1|Initial 24 Weeks|Protocol Violation|0
339771|NCT00542425|1108614|P5|Initial 24 Weeks|Non-compliance|1
339772|NCT00542425|1108615|P4|Initial 24 Weeks|Non-compliance|1
339773|NCT00542425|1108616|P3|Initial 24 Weeks|Non-compliance|0
339774|NCT00542425|1108617|P2|Initial 24 Weeks|Non-compliance|0
339775|NCT00542425|1108618|P1|Initial 24 Weeks|Non-compliance|0
339776|NCT00542425|1108614|P5|Initial 24 Weeks|Lost to Follow-up|0
339777|NCT00542425|1108615|P4|Initial 24 Weeks|Lost to Follow-up|0
339778|NCT00542425|1108616|P3|Initial 24 Weeks|Lost to Follow-up|1
339779|NCT00542425|1108617|P2|Initial 24 Weeks|Lost to Follow-up|2
339780|NCT00542425|1108618|P1|Initial 24 Weeks|Lost to Follow-up|2
339781|NCT00542425|1108614|P5|Initial 24 Weeks|Inability to complete procedures|2
339782|NCT00542425|1108615|P4|Initial 24 Weeks|Inability to complete procedures|1
339783|NCT00542425|1108616|P3|Initial 24 Weeks|Inability to complete procedures|2
339784|NCT00542425|1108617|P2|Initial 24 Weeks|Inability to complete procedures|3
339785|NCT00542425|1108618|P1|Initial 24 Weeks|Inability to complete procedures|0
339786|NCT00542425|1108614|P5|Initial 24 Weeks|Adverse Event|2
339787|NCT00542425|1108615|P4|Initial 24 Weeks|Adverse Event|3
339788|NCT00542425|1108616|P3|Initial 24 Weeks|Adverse Event|1
339789|NCT00542425|1108617|P2|Initial 24 Weeks|Adverse Event|1
339790|NCT00542425|1108618|P1|Initial 24 Weeks|Adverse Event|0
339791|NCT00542425|1108614|P5|Initial 24 Weeks|Administrative reasons|0
339792|NCT00542425|1108615|P4|Initial 24 Weeks|Administrative reasons|1
339793|NCT00542425|1108616|P3|Initial 24 Weeks|Administrative reasons|1
339794|NCT00542425|1108617|P2|Initial 24 Weeks|Administrative reasons|0
339795|NCT00542425|1108618|P1|Initial 24 Weeks|Administrative reasons|0
339796|NCT00542386|1108656|P6|Overall Study|Other Reasons|2
339797|NCT00542386|1108657|P5|Overall Study|Other Reasons|4
339798|NCT00542386|1108658|P4|Overall Study|Other Reasons|3
339799|NCT00542386|1108659|P3|Overall Study|Other Reasons|4
339800|NCT00542386|1108660|P2|Overall Study|Other Reasons|1
339801|NCT00542386|1108661|P1|Overall Study|Other Reasons|4
339802|NCT00542386|1108656|P6|Overall Study|Withdrawal by Subject|7
339803|NCT00542386|1108657|P5|Overall Study|Withdrawal by Subject|15
339804|NCT00542386|1108658|P4|Overall Study|Withdrawal by Subject|11
339805|NCT00542386|1108659|P3|Overall Study|Withdrawal by Subject|10
339806|NCT00542386|1108660|P2|Overall Study|Withdrawal by Subject|8
339807|NCT00542386|1108661|P1|Overall Study|Withdrawal by Subject|5
339808|NCT00542386|1108656|P6|Overall Study|Protocol Violation|4
339809|NCT00542386|1108657|P5|Overall Study|Protocol Violation|0
339810|NCT00542386|1108658|P4|Overall Study|Protocol Violation|0
339811|NCT00542386|1108659|P3|Overall Study|Protocol Violation|1
339812|NCT00542386|1108660|P2|Overall Study|Protocol Violation|0
339813|NCT00542386|1108661|P1|Overall Study|Protocol Violation|0
339814|NCT00542386|1108656|P6|Overall Study|Physician Decision|0
339815|NCT00542386|1108657|P5|Overall Study|Physician Decision|0
339816|NCT00542386|1108658|P4|Overall Study|Physician Decision|1
339817|NCT00542386|1108659|P3|Overall Study|Physician Decision|0
339818|NCT00542386|1108660|P2|Overall Study|Physician Decision|0
339819|NCT00542386|1108661|P1|Overall Study|Physician Decision|1
339820|NCT00542386|1108656|P6|Overall Study|Lack of Efficacy|31
339821|NCT00542386|1108657|P5|Overall Study|Lack of Efficacy|7
339822|NCT00542386|1108658|P4|Overall Study|Lack of Efficacy|13
339823|NCT00542386|1108659|P3|Overall Study|Lack of Efficacy|10
339824|NCT00542386|1108660|P2|Overall Study|Lack of Efficacy|12
339825|NCT00542386|1108661|P1|Overall Study|Lack of Efficacy|32
339826|NCT00542386|1108656|P6|Overall Study|Death|2
339827|NCT00542386|1108657|P5|Overall Study|Death|1
339828|NCT00542386|1108658|P4|Overall Study|Death|2
339829|NCT00542386|1108659|P3|Overall Study|Death|1
339830|NCT00542386|1108660|P2|Overall Study|Death|0
339831|NCT00542386|1108661|P1|Overall Study|Death|0
339832|NCT00542386|1108656|P6|Overall Study|Adverse Event|4
339833|NCT00542386|1108657|P5|Overall Study|Adverse Event|13
339834|NCT00542386|1108658|P4|Overall Study|Adverse Event|8
339835|NCT00542386|1108659|P3|Overall Study|Adverse Event|7
339836|NCT00542386|1108660|P2|Overall Study|Adverse Event|7
339837|NCT00542386|1108661|P1|Overall Study|Adverse Event|1
339838|NCT00542321|1108683|P2|Overall Study|Death|1
339839|NCT00542321|1108684|P1|Overall Study|Death|0
339840|NCT00542269|1108706|P3|Overall Study|Administrative problems|1
339841|NCT00542269|1108707|P2|Overall Study|Administrative problems|1
339842|NCT00542269|1108708|P1|Overall Study|Administrative problems|1
339843|NCT00542269|1108706|P3|Overall Study|Withdrawal by Subject|0
339844|NCT00542269|1108707|P2|Overall Study|Withdrawal by Subject|0
339845|NCT00542269|1108708|P1|Overall Study|Withdrawal by Subject|1
339846|NCT00542269|1108706|P3|Overall Study|Protocol Violation|0
339847|NCT00542269|1108707|P2|Overall Study|Protocol Violation|1
339848|NCT00542269|1108708|P1|Overall Study|Protocol Violation|1
339849|NCT00542269|1108706|P3|Overall Study|Adverse Event|5
339850|NCT00542269|1108707|P2|Overall Study|Adverse Event|4
339851|NCT00542269|1108708|P1|Overall Study|Adverse Event|10
339852|NCT00542178|1108743|P8|Overall Study|did not complete year 4 follow-up|85
339853|NCT00542178|1108744|P7|Overall Study|did not complete year 4 follow-up|87
339854|NCT00542178|1108745|P6|Overall Study|did not complete year 4 follow-up|89
339855|NCT00542178|1108746|P5|Overall Study|did not complete year 4 follow-up|64
339856|NCT00542178|1108747|P4|Overall Study|did not complete year 4 follow-up|62
339857|NCT00542178|1108748|P3|Overall Study|did not complete year 4 follow-up|74
339858|NCT00542178|1108749|P2|Overall Study|did not complete year 4 follow-up|80
339859|NCT00542178|1108750|P1|Overall Study|did not complete year 4 follow-up|75
339860|NCT00541970|1108768|P4|Month 60|Protocol Violation|72
339861|NCT00541970|1108769|P3|Month 60|Protocol Violation|82
339862|NCT00541970|1108770|P2|Month 60|Protocol Violation|77
339863|NCT00541970|1108771|P1|Month 60|Protocol Violation|78
339864|NCT00541970|1108768|P4|Month 48|Lost to Follow-up|73
339865|NCT00541970|1108769|P3|Month 48|Lost to Follow-up|68
339866|NCT00541970|1108770|P2|Month 48|Lost to Follow-up|68
339867|NCT00541970|1108771|P1|Month 48|Lost to Follow-up|66
339868|NCT00541970|1108768|P4|Month 48|Unspecified|0
339869|NCT00541970|1108769|P3|Month 48|Unspecified|1
339870|NCT00541970|1108770|P2|Month 48|Unspecified|1
339871|NCT00541970|1108771|P1|Month 48|Unspecified|3
339872|NCT00541970|1108768|P4|Month 48|Withdrawal by Subject|2
339873|NCT00541970|1108769|P3|Month 48|Withdrawal by Subject|4
339874|NCT00541970|1108770|P2|Month 48|Withdrawal by Subject|4
339875|NCT00541970|1108771|P1|Month 48|Withdrawal by Subject|2
339876|NCT00541970|1108768|P4|Month 36|Protocol Violation|60
339877|NCT00541970|1108769|P3|Month 36|Protocol Violation|66
339878|NCT00541970|1108770|P2|Month 36|Protocol Violation|66
339879|NCT00541970|1108771|P1|Month 36|Protocol Violation|61
339880|NCT00541970|1108768|P4|Month 24|Protocol Violation|21
339881|NCT00541970|1108769|P3|Month 24|Protocol Violation|31
339882|NCT00541970|1108770|P2|Month 24|Protocol Violation|31
339883|NCT00541970|1108771|P1|Month 24|Protocol Violation|29
339884|NCT00541970|1108768|P4|Month 24|Adverse Event|1
339885|NCT00541970|1108769|P3|Month 24|Adverse Event|1
339886|NCT00541970|1108770|P2|Month 24|Adverse Event|1
339887|NCT00541970|1108771|P1|Month 24|Adverse Event|0
339888|NCT00541970|1108768|P4|Month 18|Protocol Violation|16
339889|NCT00541970|1108769|P3|Month 18|Protocol Violation|24
339890|NCT00541970|1108770|P2|Month 18|Protocol Violation|23
339891|NCT00541970|1108771|P1|Month 18|Protocol Violation|14
339892|NCT00541970|1108768|P4|Month 18|Adverse Event|1
339893|NCT00541970|1108769|P3|Month 18|Adverse Event|1
339894|NCT00541970|1108770|P2|Month 18|Adverse Event|1
339895|NCT00541970|1108771|P1|Month 18|Adverse Event|0
339896|NCT00541970|1108768|P4|Month 12|Protocol Violation|15
339897|NCT00541970|1108769|P3|Month 12|Protocol Violation|20
339898|NCT00541970|1108770|P2|Month 12|Protocol Violation|21
339899|NCT00541970|1108771|P1|Month 12|Protocol Violation|12
339900|NCT00541970|1108768|P4|Month 12|Adverse Event|1
339901|NCT00541970|1108769|P3|Month 12|Adverse Event|1
339902|NCT00541970|1108770|P2|Month 12|Adverse Event|1
339903|NCT00541970|1108771|P1|Month 12|Adverse Event|0
339904|NCT00541970|1108768|P4|Month 7|Protocol Violation|5
339905|NCT00541970|1108769|P3|Month 7|Protocol Violation|11
339906|NCT00541970|1108770|P2|Month 7|Protocol Violation|13
339907|NCT00541970|1108771|P1|Month 7|Protocol Violation|9
339908|NCT00541775|1108923|P3|Overall Study|Withdrawal by Subject and Other|2
339909|NCT00541775|1108924|P2|Overall Study|Withdrawal by Subject and Other|0
339910|NCT00541775|1108925|P1|Overall Study|Withdrawal by Subject and Other|5
339911|NCT00541775|1108923|P3|Overall Study|Protocol Violation|0
339912|NCT00541775|1108924|P2|Overall Study|Protocol Violation|0
339913|NCT00541775|1108925|P1|Overall Study|Protocol Violation|1
339914|NCT00541775|1108923|P3|Overall Study|Lost to Follow-up|2
339915|NCT00541775|1108924|P2|Overall Study|Lost to Follow-up|0
339916|NCT00541775|1108925|P1|Overall Study|Lost to Follow-up|0
339917|NCT00541775|1108923|P3|Overall Study|Lack of Efficacy|3
339918|NCT00541775|1108924|P2|Overall Study|Lack of Efficacy|0
339919|NCT00541775|1108925|P1|Overall Study|Lack of Efficacy|0
339920|NCT00541775|1108923|P3|Overall Study|Adverse Event|1
339921|NCT00541775|1108924|P2|Overall Study|Adverse Event|2
339922|NCT00541775|1108925|P1|Overall Study|Adverse Event|3
339923|NCT00541658|1108951|P3|Overall Study|Took No Study Drug|0
339924|NCT00541658|1108952|P2|Overall Study|Took No Study Drug|0
339925|NCT00541658|1108953|P1|Overall Study|Took No Study Drug|1
339926|NCT00541658|1108951|P3|Overall Study|Withdrawal by Subject|32
339927|NCT00541658|1108952|P2|Overall Study|Withdrawal by Subject|32
339928|NCT00541658|1108953|P1|Overall Study|Withdrawal by Subject|28
339929|NCT00541658|1108951|P3|Overall Study|Protocol Violation|1
339930|NCT00541658|1108952|P2|Overall Study|Protocol Violation|1
339931|NCT00541658|1108953|P1|Overall Study|Protocol Violation|0
339932|NCT00541658|1108951|P3|Overall Study|Lost to Follow-up|6
339933|NCT00541658|1108952|P2|Overall Study|Lost to Follow-up|3
339934|NCT00541658|1108953|P1|Overall Study|Lost to Follow-up|3
339935|NCT00541658|1108951|P3|Overall Study|Physician Decision|4
339936|NCT00541658|1108952|P2|Overall Study|Physician Decision|0
339937|NCT00541658|1108953|P1|Overall Study|Physician Decision|0
339938|NCT00541658|1108951|P3|Overall Study|Adverse Event|25
339939|NCT00541658|1108952|P2|Overall Study|Adverse Event|37
339940|NCT00541658|1108953|P1|Overall Study|Adverse Event|28
339941|NCT00541450|1109116|P2|Phase B|Withdrawal by Subject|6
339942|NCT00541450|1109117|P1|Phase B|Withdrawal by Subject|8
339943|NCT00541450|1109116|P2|Phase B|Protocol Violation|3
339944|NCT00541450|1109117|P1|Phase B|Protocol Violation|3
339945|NCT00541450|1109116|P2|Phase B|Pregnancy|1
339946|NCT00541450|1109117|P1|Phase B|Pregnancy|0
339947|NCT00541450|1109116|P2|Phase B|Physician Decision|2
339948|NCT00541450|1109117|P1|Phase B|Physician Decision|4
339949|NCT00541450|1109116|P2|Phase B|Lost to Follow-up|4
339950|NCT00541450|1109117|P1|Phase B|Lost to Follow-up|6
339951|NCT00541450|1109116|P2|Phase B|Hyperglycemia|9
339952|NCT00541450|1109117|P1|Phase B|Hyperglycemia|10
339953|NCT00541450|1109116|P2|Phase B|Adverse Event|6
339954|NCT00541450|1109117|P1|Phase B|Adverse Event|6
339955|NCT00541450|1109116|P2|Phase A|Withdrawal by Subject|7
339956|NCT00541450|1109117|P1|Phase A|Withdrawal by Subject|7
339957|NCT00541450|1109116|P2|Phase A|Protocol Violation|3
339958|NCT00541450|1109117|P1|Phase A|Protocol Violation|2
339959|NCT00541450|1109116|P2|Phase A|Physician Decision|0
339960|NCT00541450|1109117|P1|Phase A|Physician Decision|2
339961|NCT00541450|1109116|P2|Phase A|Lost to Follow-up|4
339962|NCT00541450|1109117|P1|Phase A|Lost to Follow-up|6
339963|NCT00541450|1109116|P2|Phase A|Hyperglycemia|1
339964|NCT00541450|1109117|P1|Phase A|Hyperglycemia|0
339965|NCT00541450|1109116|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
339966|NCT00541450|1109117|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
339967|NCT00541450|1109116|P2|Phase A|Adverse Event|0
339968|NCT00541450|1109117|P1|Phase A|Adverse Event|3
339969|NCT00541346|1109135|P1|Follow-up|Adverse Event|1
339970|NCT00541307|1109149|P1|Overall Study|Surgical Bypass|5
339971|NCT00541307|1109149|P1|Overall Study|Subject returned early (outside window)|1
339972|NCT00541307|1109149|P1|Overall Study|Lost to Follow-up|4
339973|NCT00541307|1109149|P1|Overall Study|Withdrawal by Subject|6
339974|NCT00541307|1109149|P1|Overall Study|Physician Decision|3
339975|NCT00541307|1109149|P1|Overall Study|Death|5
339976|NCT00541229|1109174|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
339977|NCT00541229|1109175|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
339978|NCT00541229|1109176|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
339979|NCT00541229|1109177|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
339980|NCT00541229|1109178|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
339981|NCT00541229|1109179|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
339982|NCT00541229|1109174|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
339983|NCT00541229|1109175|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
339984|NCT00541229|1109176|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
339985|NCT00541229|1109177|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
339986|NCT00541229|1109178|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
339987|NCT00541229|1109179|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
339988|NCT00541229|1109174|P6|Treatment Period III (Week 11)|Adverse Event|0
339989|NCT00541229|1109175|P5|Treatment Period III (Week 11)|Adverse Event|1
339990|NCT00541229|1109176|P4|Treatment Period III (Week 11)|Adverse Event|0
339991|NCT00541229|1109177|P3|Treatment Period III (Week 11)|Adverse Event|0
339992|NCT00541229|1109178|P2|Treatment Period III (Week 11)|Adverse Event|0
339993|NCT00541229|1109179|P1|Treatment Period III (Week 11)|Adverse Event|0
339994|NCT00541229|1109174|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
339995|NCT00541229|1109175|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
339996|NCT00541229|1109176|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
339997|NCT00541229|1109177|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
339998|NCT00541229|1109178|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
339999|NCT00541229|1109179|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
340000|NCT00541229|1109174|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
340001|NCT00541229|1109175|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
340002|NCT00541229|1109176|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
340003|NCT00541229|1109177|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
340004|NCT00541229|1109178|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
340005|NCT00541229|1109179|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
340006|NCT00541229|1109174|P6|Washout Period II (Week 7-10)|Protocol Violation|0
340007|NCT00541229|1109175|P5|Washout Period II (Week 7-10)|Protocol Violation|0
340008|NCT00541229|1109176|P4|Washout Period II (Week 7-10)|Protocol Violation|0
340009|NCT00541229|1109177|P3|Washout Period II (Week 7-10)|Protocol Violation|0
340010|NCT00541229|1109178|P2|Washout Period II (Week 7-10)|Protocol Violation|0
340011|NCT00541229|1109179|P1|Washout Period II (Week 7-10)|Protocol Violation|1
340012|NCT00541229|1109174|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
340013|NCT00541229|1109175|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
340014|NCT00541229|1109176|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
340015|NCT00541229|1109177|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
340016|NCT00541229|1109178|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
340017|NCT00541229|1109179|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
340018|NCT00541229|1109174|P6|Treatment Period II (Week 6)|Protocol Violation|1
340019|NCT00541229|1109175|P5|Treatment Period II (Week 6)|Protocol Violation|1
340020|NCT00541229|1109176|P4|Treatment Period II (Week 6)|Protocol Violation|0
340021|NCT00541229|1109177|P3|Treatment Period II (Week 6)|Protocol Violation|0
340022|NCT00541229|1109178|P2|Treatment Period II (Week 6)|Protocol Violation|0
340023|NCT00541229|1109179|P1|Treatment Period II (Week 6)|Protocol Violation|0
340024|NCT00541229|1109174|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
340025|NCT00541229|1109175|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
340026|NCT00541229|1109176|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
340027|NCT00541229|1109177|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
340028|NCT00541229|1109178|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
340029|NCT00541229|1109179|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
340030|NCT00541229|1109174|P6|Washout Period I (Week 2-5)|Protocol Violation|1
340031|NCT00541229|1109175|P5|Washout Period I (Week 2-5)|Protocol Violation|0
340032|NCT00541229|1109176|P4|Washout Period I (Week 2-5)|Protocol Violation|0
340033|NCT00541229|1109177|P3|Washout Period I (Week 2-5)|Protocol Violation|0
340034|NCT00541229|1109178|P2|Washout Period I (Week 2-5)|Protocol Violation|0
340035|NCT00541229|1109179|P1|Washout Period I (Week 2-5)|Protocol Violation|0
340036|NCT00541229|1109174|P6|Washout Period I (Week 2-5)|Physician Decision|0
340037|NCT00541229|1109175|P5|Washout Period I (Week 2-5)|Physician Decision|0
340038|NCT00541229|1109176|P4|Washout Period I (Week 2-5)|Physician Decision|1
340039|NCT00541229|1109177|P3|Washout Period I (Week 2-5)|Physician Decision|0
340040|NCT00541229|1109178|P2|Washout Period I (Week 2-5)|Physician Decision|0
340041|NCT00541229|1109179|P1|Washout Period I (Week 2-5)|Physician Decision|0
340042|NCT00541229|1109174|P6|Washout Period I (Week 2-5)|Adverse Event|0
340043|NCT00541229|1109175|P5|Washout Period I (Week 2-5)|Adverse Event|0
340044|NCT00541229|1109176|P4|Washout Period I (Week 2-5)|Adverse Event|0
340045|NCT00541229|1109177|P3|Washout Period I (Week 2-5)|Adverse Event|1
340046|NCT00541229|1109178|P2|Washout Period I (Week 2-5)|Adverse Event|0
340047|NCT00541229|1109179|P1|Washout Period I (Week 2-5)|Adverse Event|1
340048|NCT00541229|1109174|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
340049|NCT00541229|1109175|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
340050|NCT00541229|1109176|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
340051|NCT00541229|1109177|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
340052|NCT00541229|1109178|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
340053|NCT00541229|1109179|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
340054|NCT00541229|1109174|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
340055|NCT00541229|1109175|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
340056|NCT00541229|1109176|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
340057|NCT00541229|1109177|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
340058|NCT00541229|1109178|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
340059|NCT00541229|1109179|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
340060|NCT00541229|1109174|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
340061|NCT00541229|1109175|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
340062|NCT00541229|1109176|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
340063|NCT00541229|1109177|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
340064|NCT00541229|1109178|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
340065|NCT00541229|1109179|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
340066|NCT00541229|1109174|P6|Treatment Period I (Week 1)|Physician Decision|0
340067|NCT00541229|1109175|P5|Treatment Period I (Week 1)|Physician Decision|0
340068|NCT00541229|1109176|P4|Treatment Period I (Week 1)|Physician Decision|0
340069|NCT00541229|1109177|P3|Treatment Period I (Week 1)|Physician Decision|1
340070|NCT00541229|1109178|P2|Treatment Period I (Week 1)|Physician Decision|0
340071|NCT00541229|1109179|P1|Treatment Period I (Week 1)|Physician Decision|0
340072|NCT00541099|1109198|P1|Overall Study|Ineligible|3
340073|NCT00541034|1109202|P1|Overall Study|Non-Compliance|3
340074|NCT00540644|1109221|P2|Overall Study|Noncomplilance|0
340075|NCT00540644|1109222|P1|Overall Study|Noncomplilance|1
340076|NCT00540644|1109221|P2|Overall Study|Withdrawal by Subject|2
340077|NCT00540644|1109222|P1|Overall Study|Withdrawal by Subject|2
340078|NCT00540644|1109221|P2|Overall Study|Physician Decision|5
340079|NCT00540644|1109222|P1|Overall Study|Physician Decision|0
340080|NCT00540644|1109221|P2|Overall Study|Disease Progression|1
340081|NCT00540644|1109222|P1|Overall Study|Disease Progression|3
340082|NCT00540644|1109221|P2|Overall Study|Adverse Event|1
340083|NCT00540644|1109222|P1|Overall Study|Adverse Event|3
340084|NCT00540592|1109242|P10|Overall Study|Withdrawal by Subject|0
340085|NCT00540592|1109243|P9|Overall Study|Withdrawal by Subject|0
340086|NCT00540592|1109244|P8|Overall Study|Withdrawal by Subject|0
340087|NCT00540592|1109245|P7|Overall Study|Withdrawal by Subject|0
340088|NCT00540592|1109246|P6|Overall Study|Withdrawal by Subject|0
340089|NCT00540592|1109247|P5|Overall Study|Withdrawal by Subject|0
340090|NCT00540592|1109248|P4|Overall Study|Withdrawal by Subject|1
340091|NCT00540592|1109249|P3|Overall Study|Withdrawal by Subject|1
340092|NCT00540592|1109250|P2|Overall Study|Withdrawal by Subject|0
340093|NCT00540592|1109251|P1|Overall Study|Withdrawal by Subject|0
340094|NCT00540592|1109242|P10|Overall Study|Lost to Follow-up|0
340095|NCT00540592|1109243|P9|Overall Study|Lost to Follow-up|0
340096|NCT00540592|1109244|P8|Overall Study|Lost to Follow-up|0
340097|NCT00540592|1109245|P7|Overall Study|Lost to Follow-up|0
340098|NCT00540592|1109246|P6|Overall Study|Lost to Follow-up|0
340099|NCT00540592|1109247|P5|Overall Study|Lost to Follow-up|0
340100|NCT00540592|1109248|P4|Overall Study|Lost to Follow-up|0
340101|NCT00540592|1109249|P3|Overall Study|Lost to Follow-up|0
340102|NCT00540592|1109250|P2|Overall Study|Lost to Follow-up|0
340103|NCT00540592|1109251|P1|Overall Study|Lost to Follow-up|2
340104|NCT00540592|1109242|P10|Overall Study|Adverse Event|2
340105|NCT00540592|1109243|P9|Overall Study|Adverse Event|1
340106|NCT00540592|1109244|P8|Overall Study|Adverse Event|1
340107|NCT00540592|1109245|P7|Overall Study|Adverse Event|0
340108|NCT00540592|1109246|P6|Overall Study|Adverse Event|0
340109|NCT00540592|1109247|P5|Overall Study|Adverse Event|1
340110|NCT00540592|1109248|P4|Overall Study|Adverse Event|0
340111|NCT00540592|1109249|P3|Overall Study|Adverse Event|0
340112|NCT00540592|1109250|P2|Overall Study|Adverse Event|1
340113|NCT00540592|1109251|P1|Overall Study|Adverse Event|0
340114|NCT00540514|1109490|P2|Overall Study|Paclitaxel not available|2
340115|NCT00540514|1109491|P1|Overall Study|Paclitaxel not available|0
340116|NCT00540514|1109490|P2|Overall Study|Excluded prior to treatment|7
340117|NCT00540514|1109491|P1|Overall Study|Excluded prior to treatment|7
340118|NCT00540514|1109490|P2|Overall Study|Withdrawal by Subject|67
340119|NCT00540514|1109491|P1|Overall Study|Withdrawal by Subject|65
340120|NCT00540514|1109490|P2|Overall Study|Lost to Follow-up|1
340121|NCT00540514|1109491|P1|Overall Study|Lost to Follow-up|1
340122|NCT00540514|1109490|P2|Overall Study|Protocol Deviation|4
340123|NCT00540514|1109491|P1|Overall Study|Protocol Deviation|3
340124|NCT00540514|1109490|P2|Overall Study|Physician Decision|99
340125|NCT00540514|1109491|P1|Overall Study|Physician Decision|86
340126|NCT00540514|1109490|P2|Overall Study|Adverse Event|24
340127|NCT00540514|1109491|P1|Overall Study|Adverse Event|20
340128|NCT00540514|1109490|P2|Overall Study|Unacceptable Toxicity|62
340129|NCT00540514|1109491|P1|Overall Study|Unacceptable Toxicity|61
340130|NCT00540514|1109490|P2|Overall Study|Still on treatment|0
340131|NCT00540514|1109491|P1|Overall Study|Still on treatment|3
340132|NCT00540449|1109523|P2|Overall Study|Not specified|4
340133|NCT00540449|1109524|P1|Overall Study|Not specified|1
340134|NCT00540449|1109523|P2|Overall Study|Withdrawal by Subject|10
340135|NCT00540449|1109524|P1|Overall Study|Withdrawal by Subject|10
340136|NCT00540449|1109523|P2|Overall Study|Subject Reached A Virologic Endpoint|8
340137|NCT00540449|1109524|P1|Overall Study|Subject Reached A Virologic Endpoint|32
340138|NCT00540449|1109523|P2|Overall Study|Subject Non-Compliant|5
340139|NCT00540449|1109524|P1|Overall Study|Subject Non-Compliant|7
340140|NCT00540449|1109523|P2|Overall Study|Lost to Follow-up|17
340141|NCT00540449|1109524|P1|Overall Study|Lost to Follow-up|19
340142|NCT00540449|1109523|P2|Overall Study|Subject Ineligible To Continue The Trial|1
340143|NCT00540449|1109524|P1|Overall Study|Subject Ineligible To Continue The Trial|2
340144|NCT00540449|1109523|P2|Overall Study|Sponsor's Decision|1
340145|NCT00540449|1109524|P1|Overall Study|Sponsor's Decision|1
340146|NCT00540449|1109523|P2|Overall Study|Adverse Event|32
340147|NCT00540449|1109524|P1|Overall Study|Adverse Event|12
340148|NCT00540436|1109546|P1|Second 12-Week Treatment Period|Adverse Event|1
340149|NCT00540436|1109546|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
340150|NCT00540436|1109546|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
340151|NCT00540436|1109546|P1|First 12-Week Treatment Period|Adverse Event|1
340152|NCT00540423|1109561|P3|Open-Label Treatment Period|Lack of Efficacy|2
340153|NCT00540423|1109562|P2|Open-Label Treatment Period|Lack of Efficacy|0
340154|NCT00540423|1109563|P1|Open-Label Treatment Period|Lack of Efficacy|0
340155|NCT00540423|1109561|P3|Double-Blind Treatment Period|Adverse Event|0
340156|NCT00540423|1109562|P2|Double-Blind Treatment Period|Adverse Event|1
340157|NCT00540423|1109563|P1|Double-Blind Treatment Period|Adverse Event|0
340158|NCT00540293|1109613|P1|Overall Study|Protocol violation, & subject schedule|12
340159|NCT00540293|1109613|P1|Overall Study|Withdrawal by Subject|6
340160|NCT00540293|1109613|P1|Overall Study|Adverse event not related to study drug|7
340161|NCT00540293|1109613|P1|Overall Study|Adverse event related to study drug|10
340162|NCT00540228|1109661|P5|Overall Study|Lost to Follow-up|0
340163|NCT00540228|1109662|P4|Overall Study|Lost to Follow-up|0
340164|NCT00540228|1109663|P3|Overall Study|Lost to Follow-up|0
340165|NCT00540228|1109664|P2|Overall Study|Lost to Follow-up|1
340166|NCT00540228|1109665|P1|Overall Study|Lost to Follow-up|1
340167|NCT00540228|1109661|P5|Overall Study|Adverse Event|0
340168|NCT00540228|1109662|P4|Overall Study|Adverse Event|0
340169|NCT00540228|1109663|P3|Overall Study|Adverse Event|0
340170|NCT00540228|1109664|P2|Overall Study|Adverse Event|0
340171|NCT00540228|1109665|P1|Overall Study|Adverse Event|2
340172|NCT00540124|1109735|P3|Overall Study|Withdrawal by Subject|0
340173|NCT00540124|1109736|P2|Overall Study|Withdrawal by Subject|1
340174|NCT00540124|1109737|P1|Overall Study|Withdrawal by Subject|1
340175|NCT00540124|1109735|P3|Overall Study|Lack of Efficacy|0
340176|NCT00540124|1109736|P2|Overall Study|Lack of Efficacy|0
340177|NCT00540124|1109737|P1|Overall Study|Lack of Efficacy|1
340178|NCT00540124|1109735|P3|Overall Study|Entry Criteria Not Met|0
340179|NCT00540124|1109736|P2|Overall Study|Entry Criteria Not Met|0
340180|NCT00540124|1109737|P1|Overall Study|Entry Criteria Not Met|2
340181|NCT00540124|1109735|P3|Overall Study|Adverse Event|1
340182|NCT00540124|1109736|P2|Overall Study|Adverse Event|2
340183|NCT00540124|1109737|P1|Overall Study|Adverse Event|0
340184|NCT00540046|1109783|P2|Overall Study|Lost to Follow-up|23
340185|NCT00540046|1109784|P1|Overall Study|Lost to Follow-up|33
340186|NCT00539994|1109795|P3|Overall Study|Physician Decision|1
340187|NCT00539994|1109796|P2|Overall Study|Physician Decision|0
340188|NCT00539994|1109797|P1|Overall Study|Physician Decision|0
340189|NCT00539994|1109795|P3|Overall Study|Withdrawal by Subject|1
340190|NCT00539994|1109796|P2|Overall Study|Withdrawal by Subject|0
340191|NCT00539994|1109797|P1|Overall Study|Withdrawal by Subject|1
340192|NCT00539994|1109795|P3|Overall Study|Lost to Follow-up|0
340193|NCT00539994|1109796|P2|Overall Study|Lost to Follow-up|1
340194|NCT00539994|1109797|P1|Overall Study|Lost to Follow-up|2
340195|NCT00539864|1109847|P2|Overall Study|Withdrawal by Subject|1
340196|NCT00539864|1109848|P1|Overall Study|Withdrawal by Subject|1
340197|NCT00539864|1109847|P2|Overall Study|Lost to Follow-up|1
340198|NCT00539864|1109848|P1|Overall Study|Lost to Follow-up|0
340199|NCT00539734|1109860|P1|Overall Study|Protocol Violation|1
340200|NCT00539591|1109877|P3|Overall Study|Disease progression|3
340201|NCT00539591|1109878|P2|Overall Study|Disease progression|2
340202|NCT00539591|1109879|P1|Overall Study|Disease progression|2
340203|NCT00539591|1109877|P3|Overall Study|Toxicity|0
340204|NCT00539591|1109878|P2|Overall Study|Toxicity|0
340205|NCT00539591|1109879|P1|Overall Study|Toxicity|3
340206|NCT00539513|1110031|P2|Overall Study|Lost to Follow-up|1
340207|NCT00539513|1110032|P1|Overall Study|Lost to Follow-up|0
340208|NCT00539513|1110031|P2|Overall Study|Withdrawal by Subject|1
340209|NCT00539513|1110032|P1|Overall Study|Withdrawal by Subject|2
340210|NCT00539305|1110046|P2|Overall Study|Withdrawal by Subject|1
340211|NCT00539305|1110047|P1|Overall Study|Withdrawal by Subject|0
340212|NCT00539305|1110046|P2|Overall Study|Substance Use|1
340213|NCT00539305|1110047|P1|Overall Study|Substance Use|0
340214|NCT00539305|1110046|P2|Overall Study|Adverse Event|0
340215|NCT00539305|1110047|P1|Overall Study|Adverse Event|1
340216|NCT00539279|1110061|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
340217|NCT00539279|1110062|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
340218|NCT00539279|1110061|P2|Post-Treatment Assessment|Lost to Follow-up|9
340219|NCT00539279|1110062|P1|Post-Treatment Assessment|Lost to Follow-up|12
340220|NCT00539279|1110061|P2|Treatment|Death|0
340221|NCT00539279|1110062|P1|Treatment|Death|1
340222|NCT00539279|1110061|P2|Treatment|Withdrawal by Subject|8
340223|NCT00539279|1110062|P1|Treatment|Withdrawal by Subject|10
340224|NCT00539240|1110083|P3|Overall Study|Adverse Event|10
340225|NCT00539240|1110084|P2|Overall Study|Adverse Event|1
340226|NCT00539240|1110085|P1|Overall Study|Adverse Event|3
340227|NCT00539240|1110083|P3|Overall Study|Lost to Follow-up|1
340228|NCT00539240|1110084|P2|Overall Study|Lost to Follow-up|3
340229|NCT00539240|1110085|P1|Overall Study|Lost to Follow-up|2
340230|NCT00539240|1110083|P3|Overall Study|Protocol Violation|4
340231|NCT00539240|1110084|P2|Overall Study|Protocol Violation|1
340232|NCT00539240|1110085|P1|Overall Study|Protocol Violation|1
340233|NCT00539240|1110083|P3|Overall Study|Withdrawal by Subject|0
340234|NCT00539240|1110084|P2|Overall Study|Withdrawal by Subject|2
340235|NCT00539240|1110085|P1|Overall Study|Withdrawal by Subject|0
340236|NCT00539188|1110104|P2|Overall Study|Lost to Follow-up|1
340237|NCT00539188|1110105|P1|Overall Study|Lost to Follow-up|2
340238|NCT00539188|1110104|P2|Overall Study|Withdrawal by Subject|0
340239|NCT00539188|1110105|P1|Overall Study|Withdrawal by Subject|1
340240|NCT00539032|1110128|P2|Overall Study|Withdrawal by Subject|1
340241|NCT00539032|1110129|P1|Overall Study|Withdrawal by Subject|2
340242|NCT00539006|1110143|P4|Treatment Period 2|Other|0
340243|NCT00539006|1110144|P3|Treatment Period 2|Other|0
340244|NCT00539006|1110145|P2|Treatment Period 2|Other|1
340245|NCT00539006|1110146|P1|Treatment Period 2|Other|0
340246|NCT00539006|1110143|P4|Treatment Period 2|Protocol Violation|0
340247|NCT00539006|1110144|P3|Treatment Period 2|Protocol Violation|0
340248|NCT00539006|1110145|P2|Treatment Period 2|Protocol Violation|0
340249|NCT00539006|1110146|P1|Treatment Period 2|Protocol Violation|1
340250|NCT00539006|1110143|P4|Washout|Other|3
340251|NCT00539006|1110144|P3|Washout|Other|2
340252|NCT00539006|1110145|P2|Washout|Other|1
340253|NCT00539006|1110146|P1|Washout|Other|1
340254|NCT00539006|1110143|P4|Washout|Failed to meet continuation criteria|6
340255|NCT00539006|1110144|P3|Washout|Failed to meet continuation criteria|14
340256|NCT00539006|1110145|P2|Washout|Failed to meet continuation criteria|5
340257|NCT00539006|1110146|P1|Washout|Failed to meet continuation criteria|16
340258|NCT00539006|1110143|P4|Washout|Withdrawal by Subject|0
340259|NCT00539006|1110144|P3|Washout|Withdrawal by Subject|0
340260|NCT00539006|1110145|P2|Washout|Withdrawal by Subject|2
340261|NCT00539006|1110146|P1|Washout|Withdrawal by Subject|0
340262|NCT00539006|1110143|P4|Washout|Protocol Violation|0
340263|NCT00539006|1110144|P3|Washout|Protocol Violation|0
340264|NCT00539006|1110145|P2|Washout|Protocol Violation|1
340265|NCT00539006|1110146|P1|Washout|Protocol Violation|1
340266|NCT00539006|1110143|P4|Washout|Adverse Event|0
340267|NCT00539006|1110144|P3|Washout|Adverse Event|0
340268|NCT00539006|1110145|P2|Washout|Adverse Event|1
340269|NCT00539006|1110146|P1|Washout|Adverse Event|2
340270|NCT00539006|1110143|P4|Treatment Period 1|Lack of Efficacy|1
340271|NCT00539006|1110144|P3|Treatment Period 1|Lack of Efficacy|0
340272|NCT00539006|1110145|P2|Treatment Period 1|Lack of Efficacy|0
340273|NCT00539006|1110146|P1|Treatment Period 1|Lack of Efficacy|0
340274|NCT00539006|1110143|P4|Treatment Period 1|Protocol Violation|0
340275|NCT00539006|1110144|P3|Treatment Period 1|Protocol Violation|1
340276|NCT00539006|1110145|P2|Treatment Period 1|Protocol Violation|0
340277|NCT00539006|1110146|P1|Treatment Period 1|Protocol Violation|0
340278|NCT00539006|1110143|P4|Treatment Period 1|Lost to Follow-up|0
340279|NCT00539006|1110144|P3|Treatment Period 1|Lost to Follow-up|1
340280|NCT00539006|1110145|P2|Treatment Period 1|Lost to Follow-up|0
340281|NCT00539006|1110146|P1|Treatment Period 1|Lost to Follow-up|0
340282|NCT00539006|1110143|P4|Pre-treatment|Other|0
340283|NCT00539006|1110144|P3|Pre-treatment|Other|0
340284|NCT00539006|1110145|P2|Pre-treatment|Other|1
340285|NCT00539006|1110146|P1|Pre-treatment|Other|0
340286|NCT00538902|1110183|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
340287|NCT00538902|1110184|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
340288|NCT00538902|1110185|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
340289|NCT00538902|1110183|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
340290|NCT00538902|1110184|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
340291|NCT00538902|1110185|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
340292|NCT00538902|1110183|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
340293|NCT00538902|1110184|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
340294|NCT00538902|1110185|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
340295|NCT00538902|1110183|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
340296|NCT00538902|1110184|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
340297|NCT00538902|1110185|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
340298|NCT00538902|1110183|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
340299|NCT00538902|1110184|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
340300|NCT00538902|1110185|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
340301|NCT00538902|1110183|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
340302|NCT00538902|1110184|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
340303|NCT00538902|1110185|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
340304|NCT00538902|1110183|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
340305|NCT00538902|1110184|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
340306|NCT00538902|1110185|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
340307|NCT00538902|1110183|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
340308|NCT00538902|1110184|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
340309|NCT00538902|1110185|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
340310|NCT00538785|1110246|P2|Overall Study|Lost to Follow-up|0
340311|NCT00538785|1110247|P1|Overall Study|Lost to Follow-up|1
340312|NCT00538785|1110246|P2|Overall Study|Withdrawal of consent|7
340313|NCT00538785|1110247|P1|Overall Study|Withdrawal of consent|9
340314|NCT00538785|1110246|P2|Overall Study|Death|10
340315|NCT00538785|1110247|P1|Overall Study|Death|9
340316|NCT00538629|1110311|P1|Overall Study|Subject's untimely distrust of medicine|1
340317|NCT00538629|1110311|P1|Overall Study|Lost to Follow-up|6
340318|NCT00538629|1110311|P1|Overall Study|Lack of Efficacy|12
340319|NCT00538629|1110311|P1|Overall Study|Adverse Event|2
340320|NCT00538629|1110311|P1|Overall Study|At subject's request|1
340321|NCT00538590|1110367|P2|Overall Study|Death|0
340322|NCT00538590|1110368|P1|Overall Study|Death|1
340323|NCT00538473|1110397|P2|Overall Study|Adverse Event|0
340324|NCT00538473|1110398|P1|Overall Study|Adverse Event|1
340325|NCT00538291|1110478|P1|Overall Study|Withdrawal by Subject|1
340326|NCT00538291|1110478|P1|Overall Study|Adverse Event|2
340327|NCT00537979|1110536|P2|Overall Study|Heart failure|1
340328|NCT00537979|1110537|P1|Overall Study|Heart failure|0
340329|NCT00537979|1110536|P2|Overall Study|Kidney transplant|3
340330|NCT00537979|1110537|P1|Overall Study|Kidney transplant|0
340331|NCT00537979|1110536|P2|Overall Study|Death|3
340332|NCT00537979|1110537|P1|Overall Study|Death|0
340333|NCT00537979|1110536|P2|Overall Study|Non-compliance with treatment/procedure|2
340334|NCT00537979|1110537|P1|Overall Study|Non-compliance with treatment/procedure|2
340335|NCT00537979|1110536|P2|Overall Study|Lack of Efficacy|1
340336|NCT00537979|1110537|P1|Overall Study|Lack of Efficacy|0
340337|NCT00537979|1110536|P2|Overall Study|Lost to Follow-up|4
340338|NCT00537979|1110537|P1|Overall Study|Lost to Follow-up|1
340339|NCT00537979|1110536|P2|Overall Study|Withdrawal by Subject|4
340340|NCT00537979|1110537|P1|Overall Study|Withdrawal by Subject|1
340341|NCT00537979|1110536|P2|Overall Study|Adverse Event|2
340342|NCT00537979|1110537|P1|Overall Study|Adverse Event|2
340343|NCT00537940|1110553|P2|Overall Study|Unspecified|12
340344|NCT00537940|1110554|P1|Overall Study|Unspecified|10
340345|NCT00537940|1110553|P2|Overall Study|Study terminated by sponsor|3
340346|NCT00537940|1110554|P1|Overall Study|Study terminated by sponsor|2
340347|NCT00537940|1110553|P2|Overall Study|Pregnancy|1
340348|NCT00537940|1110554|P1|Overall Study|Pregnancy|1
340349|NCT00537940|1110553|P2|Overall Study|Protocol Violation|4
340350|NCT00537940|1110554|P1|Overall Study|Protocol Violation|6
340351|NCT00537940|1110553|P2|Overall Study|Withdrawal by Subject|95
340352|NCT00537940|1110554|P1|Overall Study|Withdrawal by Subject|113
340353|NCT00537940|1110553|P2|Overall Study|Lost to Follow-up|29
340354|NCT00537940|1110554|P1|Overall Study|Lost to Follow-up|23
340355|NCT00537940|1110553|P2|Overall Study|Lack of Efficacy|16
340356|NCT00537940|1110554|P1|Overall Study|Lack of Efficacy|8
340357|NCT00537940|1110553|P2|Overall Study|Adverse Event|19
340358|NCT00537940|1110554|P1|Overall Study|Adverse Event|20
340359|NCT00536874|1110601|P1|Overall Study|Withdrawal by Subject|1
340360|NCT00536874|1110601|P1|Overall Study|Death|2
340361|NCT00536874|1110601|P1|Overall Study|Adverse Event|1
340362|NCT00536809|1110611|P1|Phase II|Referred for surgical resection|1
340363|NCT00536809|1110611|P1|Phase II|Adverse Event|1
340364|NCT00536744|1110634|P2|Overall Study|PI tried alternative treatment|3
340365|NCT00536744|1110635|P1|Overall Study|PI tried alternative treatment|1
340366|NCT00536744|1110634|P2|Overall Study|Withdrawal by Subject|8
340367|NCT00536744|1110635|P1|Overall Study|Withdrawal by Subject|7
340368|NCT00536744|1110634|P2|Overall Study|Lost to Follow-up|5
340369|NCT00536744|1110635|P1|Overall Study|Lost to Follow-up|3
340370|NCT00536744|1110634|P2|Overall Study|Physician Decision|1
340371|NCT00536744|1110635|P1|Overall Study|Physician Decision|3
340372|NCT00536744|1110634|P2|Overall Study|Death|1
340373|NCT00536744|1110635|P1|Overall Study|Death|2
340374|NCT00536744|1110634|P2|Overall Study|Adverse Event|10
340375|NCT00536744|1110635|P1|Overall Study|Adverse Event|13
340376|NCT00536731|1110644|P3|Overall Study|Other|0
340377|NCT00536731|1110645|P2|Overall Study|Other|1
340378|NCT00536731|1110646|P1|Overall Study|Other|1
340379|NCT00536731|1110644|P3|Overall Study|Safety reasons|1
340380|NCT00536731|1110645|P2|Overall Study|Safety reasons|0
340381|NCT00536731|1110646|P1|Overall Study|Safety reasons|0
340382|NCT00536731|1110644|P3|Overall Study|Intake of prohibited conc. medication|1
340383|NCT00536731|1110645|P2|Overall Study|Intake of prohibited conc. medication|0
340384|NCT00536731|1110646|P1|Overall Study|Intake of prohibited conc. medication|0
340385|NCT00536731|1110644|P3|Overall Study|Withdrawal by Subject|0
340386|NCT00536731|1110645|P2|Overall Study|Withdrawal by Subject|2
340387|NCT00536731|1110646|P1|Overall Study|Withdrawal by Subject|0
340388|NCT00536731|1110644|P3|Overall Study|Adverse Event|3
340389|NCT00536731|1110645|P2|Overall Study|Adverse Event|2
340390|NCT00536731|1110646|P1|Overall Study|Adverse Event|3
340391|NCT00537823|1110692|P2|Overall Study|Adverse Event|0
340392|NCT00537823|1110693|P1|Overall Study|Adverse Event|2
340393|NCT00537810|1110719|P4|Overall Study|Medically withdrawn|1
340394|NCT00537810|1110720|P3|Overall Study|Medically withdrawn|0
340395|NCT00537810|1110721|P2|Overall Study|Medically withdrawn|2
340396|NCT00537810|1110722|P1|Overall Study|Medically withdrawn|2
340397|NCT00537810|1110719|P4|Overall Study|Withdrawal by Subject|3
340398|NCT00537810|1110720|P3|Overall Study|Withdrawal by Subject|4
340399|NCT00537810|1110721|P2|Overall Study|Withdrawal by Subject|11
340400|NCT00537810|1110722|P1|Overall Study|Withdrawal by Subject|4
340401|NCT00537771|1110738|P2|Overall Study|Severe Non-Compliance to Protocol|2
340402|NCT00537771|1110739|P1|Overall Study|Severe Non-Compliance to Protocol|4
340403|NCT00537771|1110738|P2|Overall Study|Protocol Violation|6
340404|NCT00537771|1110739|P1|Overall Study|Protocol Violation|2
340405|NCT00537771|1110738|P2|Overall Study|Lost to Follow-up|15
340406|NCT00537771|1110739|P1|Overall Study|Lost to Follow-up|9
340407|NCT00537771|1110738|P2|Overall Study|Adverse Event|15
340408|NCT00537771|1110739|P1|Overall Study|Adverse Event|8
340409|NCT00537771|1110738|P2|Overall Study|Withdrawal by Subject|23
340410|NCT00537771|1110739|P1|Overall Study|Withdrawal by Subject|6
340411|NCT00537745|1110749|P1|Overall Study|Subject unable to provide Interlock info|1
340412|NCT00537745|1110749|P1|Overall Study|Withdrawal by Subject|2
340413|NCT00537745|1110749|P1|Overall Study|Did not meet eligibility criteria|2
340414|NCT00537485|1110794|P2|Overall Study|Physician Decision|0
340415|NCT00537485|1110795|P1|Overall Study|Physician Decision|1
340416|NCT00537485|1110794|P2|Overall Study|Withdrawal by Subject|3
340417|NCT00537485|1110795|P1|Overall Study|Withdrawal by Subject|1
340418|NCT00537485|1110794|P2|Overall Study|Withdrawal by Subject|2
340419|NCT00537485|1110795|P1|Overall Study|Withdrawal by Subject|3
340420|NCT00537485|1110794|P2|Overall Study|Adverse Event|5
340421|NCT00537485|1110795|P1|Overall Study|Adverse Event|10
340422|NCT00537394|1110868|P3|2nd Year of Follow-up|Clinic site closure|0
340423|NCT00537394|1110869|P2|2nd Year of Follow-up|Clinic site closure|0
340424|NCT00537394|1110870|P1|2nd Year of Follow-up|Clinic site closure|1
340425|NCT00537394|1110868|P3|2nd Year of Follow-up|Lost to Follow-up|2
340426|NCT00537394|1110869|P2|2nd Year of Follow-up|Lost to Follow-up|7
340427|NCT00537394|1110870|P1|2nd Year of Follow-up|Lost to Follow-up|6
340428|NCT00537394|1110868|P3|2nd Year of Follow-up|Withdrawal by Subject|2
340429|NCT00537394|1110869|P2|2nd Year of Follow-up|Withdrawal by Subject|1
340430|NCT00537394|1110870|P1|2nd Year of Follow-up|Withdrawal by Subject|0
340431|NCT00537394|1110868|P3|2nd Year of Follow-up|Death|2
340432|NCT00537394|1110869|P2|2nd Year of Follow-up|Death|1
340433|NCT00537394|1110870|P1|2nd Year of Follow-up|Death|4
340434|NCT00537394|1110868|P3|First Year of Follow-up|Lost to Follow-up|1
340435|NCT00537394|1110869|P2|First Year of Follow-up|Lost to Follow-up|5
340436|NCT00537394|1110870|P1|First Year of Follow-up|Lost to Follow-up|1
340437|NCT00537394|1110868|P3|First Year of Follow-up|Withdrawal by Subject|1
340438|NCT00537394|1110869|P2|First Year of Follow-up|Withdrawal by Subject|6
340439|NCT00537394|1110870|P1|First Year of Follow-up|Withdrawal by Subject|3
340440|NCT00537394|1110868|P3|First Year of Follow-up|Severe debilitation|1
340441|NCT00537394|1110869|P2|First Year of Follow-up|Severe debilitation|0
340442|NCT00537394|1110870|P1|First Year of Follow-up|Severe debilitation|1
340443|NCT00537394|1110868|P3|First Year of Follow-up|Death|0
340444|NCT00537394|1110869|P2|First Year of Follow-up|Death|0
340445|NCT00537394|1110870|P1|First Year of Follow-up|Death|7
340446|NCT00537381|1110906|P2|Overall Study|Unspecified|3
340447|NCT00537381|1110907|P1|Overall Study|Unspecified|5
340448|NCT00537381|1110906|P2|Overall Study|Sponsor decision|9
340449|NCT00537381|1110907|P1|Overall Study|Sponsor decision|14
340450|NCT00537381|1110906|P2|Overall Study|Disease Progression|18
340451|NCT00537381|1110907|P1|Overall Study|Disease Progression|9
340452|NCT00537381|1110906|P2|Overall Study|Physician Decision|6
340453|NCT00537381|1110907|P1|Overall Study|Physician Decision|7
340454|NCT00537381|1110906|P2|Overall Study|Withdrawal by Subject|14
340455|NCT00537381|1110907|P1|Overall Study|Withdrawal by Subject|5
340456|NCT00537381|1110906|P2|Overall Study|Death|3
340457|NCT00537381|1110907|P1|Overall Study|Death|3
340458|NCT00537381|1110906|P2|Overall Study|Adverse Event|9
340459|NCT00537381|1110907|P1|Overall Study|Adverse Event|13
340460|NCT00537329|1110927|P1|Overall Study|Unspecified|1
340461|NCT00537329|1110927|P1|Overall Study|Withdrawal by Subject|4
340462|NCT00537329|1110927|P1|Overall Study|Lost to Follow-up|6
340463|NCT00537329|1110927|P1|Overall Study|Lack of Efficacy|2
340464|NCT00537329|1110927|P1|Overall Study|Adverse Event|3
340465|NCT00537329|1110927|P1|Overall Study|Death|10
340466|NCT00537316|1110947|P7|Part 2|Administrative|1
340467|NCT00537316|1110948|P6|Part 2|Administrative|4
340468|NCT00537316|1110949|P5|Part 2|Administrative|1
340469|NCT00537316|1110950|P4|Part 2|Administrative|3
340470|NCT00537316|1110951|P3|Part 2|Administrative|24
340471|NCT00537316|1110952|P2|Part 2|Administrative|8
340472|NCT00537316|1110953|P1|Part 2|Administrative|16
340473|NCT00537316|1110947|P7|Part 2|Withdrawal by Subject|0
340474|NCT00537316|1110948|P6|Part 2|Withdrawal by Subject|0
340475|NCT00537316|1110949|P5|Part 2|Withdrawal by Subject|0
340476|NCT00537316|1110950|P4|Part 2|Withdrawal by Subject|0
340477|NCT00537316|1110951|P3|Part 2|Withdrawal by Subject|4
340478|NCT00537316|1110952|P2|Part 2|Withdrawal by Subject|1
340479|NCT00537316|1110953|P1|Part 2|Withdrawal by Subject|5
340480|NCT00537316|1110947|P7|Part 2|Lost to Follow-up|0
340481|NCT00537316|1110948|P6|Part 2|Lost to Follow-up|0
340482|NCT00537316|1110949|P5|Part 2|Lost to Follow-up|0
340483|NCT00537316|1110950|P4|Part 2|Lost to Follow-up|0
340484|NCT00537316|1110951|P3|Part 2|Lost to Follow-up|2
340485|NCT00537316|1110952|P2|Part 2|Lost to Follow-up|0
340486|NCT00537316|1110953|P1|Part 2|Lost to Follow-up|1
340487|NCT00537316|1110947|P7|Part 2|Adverse Event|0
340488|NCT00537316|1110948|P6|Part 2|Adverse Event|0
340489|NCT00537316|1110949|P5|Part 2|Adverse Event|0
340490|NCT00537316|1110950|P4|Part 2|Adverse Event|0
340491|NCT00537316|1110951|P3|Part 2|Adverse Event|2
340492|NCT00537316|1110952|P2|Part 2|Adverse Event|0
340493|NCT00537316|1110953|P1|Part 2|Adverse Event|4
340494|NCT00537316|1110947|P7|Part 2|Never entered follow-up|1
340495|NCT00537316|1110948|P6|Part 2|Never entered follow-up|0
340496|NCT00537316|1110949|P5|Part 2|Never entered follow-up|0
340497|NCT00537316|1110950|P4|Part 2|Never entered follow-up|0
340498|NCT00537316|1110951|P3|Part 2|Never entered follow-up|0
340499|NCT00537316|1110952|P2|Part 2|Never entered follow-up|0
340500|NCT00537316|1110953|P1|Part 2|Never entered follow-up|0
340501|NCT00537316|1110947|P7|Part 1|Administrative|0
340502|NCT00537316|1110948|P6|Part 1|Administrative|0
340503|NCT00537316|1110949|P5|Part 1|Administrative|0
340504|NCT00537316|1110950|P4|Part 1|Administrative|0
340505|NCT00537316|1110951|P3|Part 1|Administrative|2
340506|NCT00537316|1110952|P2|Part 1|Administrative|0
340507|NCT00537316|1110953|P1|Part 1|Administrative|0
340508|NCT00537316|1110947|P7|Part 1|Did not meet protocol eligibility|0
340509|NCT00537316|1110948|P6|Part 1|Did not meet protocol eligibility|0
340510|NCT00537316|1110949|P5|Part 1|Did not meet protocol eligibility|0
340511|NCT00537316|1110950|P4|Part 1|Did not meet protocol eligibility|0
340512|NCT00537316|1110951|P3|Part 1|Did not meet protocol eligibility|2
340513|NCT00537316|1110952|P2|Part 1|Did not meet protocol eligibility|3
340514|NCT00537316|1110953|P1|Part 1|Did not meet protocol eligibility|1
340515|NCT00537316|1110947|P7|Part 1|Protocol Violation|0
340516|NCT00537316|1110948|P6|Part 1|Protocol Violation|0
340517|NCT00537316|1110949|P5|Part 1|Protocol Violation|0
340518|NCT00537316|1110950|P4|Part 1|Protocol Violation|0
340519|NCT00537316|1110951|P3|Part 1|Protocol Violation|1
340520|NCT00537316|1110952|P2|Part 1|Protocol Violation|5
340521|NCT00537316|1110953|P1|Part 1|Protocol Violation|1
340522|NCT00537316|1110947|P7|Part 1|Withdrawal by Subject|0
340523|NCT00537316|1110948|P6|Part 1|Withdrawal by Subject|0
340524|NCT00537316|1110949|P5|Part 1|Withdrawal by Subject|0
340525|NCT00537316|1110950|P4|Part 1|Withdrawal by Subject|0
340526|NCT00537316|1110951|P3|Part 1|Withdrawal by Subject|4
340527|NCT00537316|1110952|P2|Part 1|Withdrawal by Subject|8
340528|NCT00537316|1110953|P1|Part 1|Withdrawal by Subject|3
340529|NCT00537316|1110947|P7|Part 1|Lost to Follow-up|0
340530|NCT00537316|1110948|P6|Part 1|Lost to Follow-up|0
340531|NCT00537316|1110949|P5|Part 1|Lost to Follow-up|0
340532|NCT00537316|1110950|P4|Part 1|Lost to Follow-up|0
340533|NCT00537316|1110951|P3|Part 1|Lost to Follow-up|0
340534|NCT00537316|1110952|P2|Part 1|Lost to Follow-up|0
340535|NCT00537316|1110953|P1|Part 1|Lost to Follow-up|1
340536|NCT00537316|1110947|P7|Part 1|Protocol defined clinical event|0
340537|NCT00537316|1110948|P6|Part 1|Protocol defined clinical event|0
340538|NCT00537316|1110949|P5|Part 1|Protocol defined clinical event|0
340539|NCT00537316|1110950|P4|Part 1|Protocol defined clinical event|0
340540|NCT00537316|1110951|P3|Part 1|Protocol defined clinical event|0
340541|NCT00537316|1110952|P2|Part 1|Protocol defined clinical event|0
340542|NCT00537316|1110953|P1|Part 1|Protocol defined clinical event|1
340543|NCT00537316|1110947|P7|Part 1|Adverse Event|0
340544|NCT00537316|1110948|P6|Part 1|Adverse Event|0
340545|NCT00537316|1110949|P5|Part 1|Adverse Event|0
340546|NCT00537316|1110950|P4|Part 1|Adverse Event|0
340547|NCT00537316|1110951|P3|Part 1|Adverse Event|8
340548|NCT00537316|1110952|P2|Part 1|Adverse Event|11
340549|NCT00537316|1110953|P1|Part 1|Adverse Event|7
340550|NCT00537303|1110980|P2|Overall Study|Unclassified|7
340551|NCT00537303|1110981|P1|Overall Study|Unclassified|8
340552|NCT00537303|1110980|P2|Overall Study|Withdrawal criteria|3
340553|NCT00537303|1110981|P1|Overall Study|Withdrawal criteria|3
340554|NCT00537303|1110980|P2|Overall Study|Protocol Violation|4
340555|NCT00537303|1110981|P1|Overall Study|Protocol Violation|8
340556|NCT00537303|1110980|P2|Overall Study|Lack of Efficacy|7
340557|NCT00537303|1110981|P1|Overall Study|Lack of Efficacy|6
340558|NCT00537303|1110980|P2|Overall Study|Adverse Event|4
340559|NCT00537303|1110981|P1|Overall Study|Adverse Event|1
340560|NCT00537277|1110997|P1|Overall Study|Non-compliance with trial procedures|15
340561|NCT00537277|1110997|P1|Overall Study|Inability to tolerate trial medication|4
340562|NCT00537277|1110997|P1|Overall Study|Unclassified|4
340563|NCT00537277|1110997|P1|Overall Study|Protocol Violation|11
340564|NCT00537277|1110997|P1|Overall Study|Lost to Follow-up|12
340565|NCT00537277|1110997|P1|Overall Study|Lack of Efficacy|2
340566|NCT00537277|1110997|P1|Overall Study|Adverse Event|1
340567|NCT00537238|1111008|P2|Overall Study|Unspecified|52
340568|NCT00537238|1111009|P1|Overall Study|Unspecified|44
340569|NCT00537238|1111008|P2|Overall Study|Does not meet entrance criteria|2
340570|NCT00537238|1111009|P1|Overall Study|Does not meet entrance criteria|0
340571|NCT00537238|1111008|P2|Overall Study|Protocol Violation|19
340572|NCT00537238|1111009|P1|Overall Study|Protocol Violation|15
340573|NCT00537238|1111008|P2|Overall Study|Withdrawal by Subject|47
340574|NCT00537238|1111009|P1|Overall Study|Withdrawal by Subject|51
340575|NCT00537238|1111008|P2|Overall Study|Lost to Follow-up|8
340576|NCT00537238|1111009|P1|Overall Study|Lost to Follow-up|12
340577|NCT00537238|1111008|P2|Overall Study|Lack of Efficacy|21
340578|NCT00537238|1111009|P1|Overall Study|Lack of Efficacy|20
340579|NCT00537238|1111008|P2|Overall Study|Adverse Event|22
340580|NCT00537238|1111009|P1|Overall Study|Adverse Event|31
340581|NCT00537238|1111008|P2|Overall Study|Death|2
340582|NCT00537238|1111009|P1|Overall Study|Death|1
340583|NCT00537199|1111029|P1|Overall Study|Study Terminated|1
340584|NCT00537095|1111035|P2|Overall Study|Incorrect enrolment|1
340585|NCT00537095|1111036|P1|Overall Study|Incorrect enrolment|0
340586|NCT00537095|1111035|P2|Overall Study|subjective disease progression|1
340587|NCT00537095|1111036|P1|Overall Study|subjective disease progression|0
340588|NCT00537095|1111035|P2|Overall Study|Withdrawal by Subject|2
340589|NCT00537095|1111036|P1|Overall Study|Withdrawal by Subject|2
340590|NCT00537095|1111035|P2|Overall Study|Death|1
340591|NCT00537095|1111036|P1|Overall Study|Death|3
340592|NCT00537095|1111035|P2|Overall Study|disease progression|48
340593|NCT00537095|1111036|P1|Overall Study|disease progression|21
340594|NCT00537095|1111035|P2|Overall Study|Adverse Event|4
340595|NCT00537095|1111036|P1|Overall Study|Adverse Event|24
340596|NCT00537095|1111035|P2|Overall Study|surgery|0
340597|NCT00537095|1111036|P1|Overall Study|surgery|1
340598|NCT00537082|1111051|P3|Overall Study|Discontinued before initiating treatment|0
340599|NCT00537082|1111052|P2|Overall Study|Discontinued before initiating treatment|0
340600|NCT00537082|1111053|P1|Overall Study|Discontinued before initiating treatment|3
340601|NCT00537082|1111051|P3|Overall Study|Withdrawal by Subject|0
340602|NCT00537082|1111052|P2|Overall Study|Withdrawal by Subject|1
340603|NCT00537082|1111053|P1|Overall Study|Withdrawal by Subject|0
340604|NCT00537082|1111051|P3|Overall Study|Lack of Efficacy|2
340605|NCT00537082|1111052|P2|Overall Study|Lack of Efficacy|0
340606|NCT00537082|1111053|P1|Overall Study|Lack of Efficacy|0
340607|NCT00537082|1111051|P3|Overall Study|Protocol Violation|1
340608|NCT00537082|1111052|P2|Overall Study|Protocol Violation|2
340609|NCT00537082|1111053|P1|Overall Study|Protocol Violation|0
340610|NCT00537082|1111051|P3|Overall Study|Adverse Event|3
340611|NCT00537082|1111052|P2|Overall Study|Adverse Event|6
340612|NCT00537082|1111053|P1|Overall Study|Adverse Event|6
340613|NCT00537056|1111070|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
340614|NCT00537030|1111082|P1|Overall Study|Inevaluable|3
340615|NCT00537030|1111082|P1|Overall Study|Confirm patient ineligibility|1
340616|NCT00537030|1111082|P1|Overall Study|Disease progression or relapse during ac|1
340705|NCT00536380|1111409|P2|Overall Study|Adverse Event|2
340617|NCT00537030|1111082|P1|Overall Study|Greater then or equal to a Grade 2 aller|7
340618|NCT00537030|1111082|P1|Overall Study|Withdrawal by Subject|2
340619|NCT00537030|1111082|P1|Overall Study|Physician Decision|2
340620|NCT00537017|1111086|P1|Follow-up Phase|Withdrawal by Subject|9
340621|NCT00537017|1111086|P1|Treatment Phase|Protocol Violation|2
340622|NCT00537017|1111086|P1|Treatment Phase|Withdrawal by Subject|13
340623|NCT00537017|1111086|P1|Treatment Phase|Adverse Event|19
340624|NCT00536991|1111097|P1|Overall Study|patient ineligible|2
340625|NCT00536991|1111097|P1|Overall Study|Physician Decision|1
340626|NCT00536991|1111097|P1|Overall Study|Withdrawal by Subject|10
340627|NCT00536978|1111104|P1|Overall Study|Not eligible for Adback Infusion|22
340628|NCT00536575|1111108|P1|Overall Study|Death|1
340629|NCT00536575|1111108|P1|Overall Study|Withdrawal by Subject|1
340630|NCT00536510|1111114|P2|Overall Study|Patient Discontinued for Other Reasons|2
340631|NCT00536510|1111115|P1|Overall Study|Patient Discontinued for Other Reasons|2
340632|NCT00536510|1111114|P2|Overall Study|Laboratory Adverse Event|1
340633|NCT00536510|1111115|P1|Overall Study|Laboratory Adverse Event|2
340634|NCT00536510|1111114|P2|Overall Study|Flushing with Product|0
340635|NCT00536510|1111115|P1|Overall Study|Flushing with Product|20
340636|NCT00536510|1111114|P2|Overall Study|Withdrawal by Subject|9
340637|NCT00536510|1111115|P1|Overall Study|Withdrawal by Subject|16
340638|NCT00536510|1111114|P2|Overall Study|Protocol Violation|5
340639|NCT00536510|1111115|P1|Overall Study|Protocol Violation|4
340640|NCT00536510|1111114|P2|Overall Study|Lost to Follow-up|8
340641|NCT00536510|1111115|P1|Overall Study|Lost to Follow-up|11
340642|NCT00536510|1111114|P2|Overall Study|Adverse Event|4
340643|NCT00536510|1111115|P1|Overall Study|Adverse Event|27
340644|NCT00536484|1111125|P2|Overall Study|Other|0
340645|NCT00536484|1111126|P1|Overall Study|Other|4
340646|NCT00536484|1111125|P2|Overall Study|Lack of Efficacy|5
340647|NCT00536484|1111126|P1|Overall Study|Lack of Efficacy|16
340648|NCT00536484|1111125|P2|Overall Study|Lost to Follow-up|6
340649|NCT00536484|1111126|P1|Overall Study|Lost to Follow-up|8
340650|NCT00536484|1111125|P2|Overall Study|Withdrawal by Subject|11
340651|NCT00536484|1111126|P1|Overall Study|Withdrawal by Subject|11
340652|NCT00536484|1111125|P2|Overall Study|Adverse Event|34
340653|NCT00536484|1111126|P1|Overall Study|Adverse Event|21
340654|NCT00536471|1111160|P4|Overall Study|Sponsor Decision|2
340655|NCT00536471|1111161|P3|Overall Study|Sponsor Decision|3
340656|NCT00536471|1111162|P2|Overall Study|Sponsor Decision|1
340657|NCT00536471|1111163|P1|Overall Study|Sponsor Decision|0
340658|NCT00536471|1111160|P4|Overall Study|Death|2
340659|NCT00536471|1111161|P3|Overall Study|Death|1
340660|NCT00536471|1111162|P2|Overall Study|Death|0
340661|NCT00536471|1111163|P1|Overall Study|Death|0
340662|NCT00536471|1111160|P4|Overall Study|Physician Decision|2
340663|NCT00536471|1111161|P3|Overall Study|Physician Decision|3
340664|NCT00536471|1111162|P2|Overall Study|Physician Decision|1
340665|NCT00536471|1111163|P1|Overall Study|Physician Decision|11
340666|NCT00536471|1111160|P4|Overall Study|Protocol Violation|3
340667|NCT00536471|1111161|P3|Overall Study|Protocol Violation|2
340668|NCT00536471|1111162|P2|Overall Study|Protocol Violation|1
340669|NCT00536471|1111163|P1|Overall Study|Protocol Violation|8
340670|NCT00536471|1111160|P4|Overall Study|Lack of Efficacy|9
340671|NCT00536471|1111161|P3|Overall Study|Lack of Efficacy|11
340672|NCT00536471|1111162|P2|Overall Study|Lack of Efficacy|18
340673|NCT00536471|1111163|P1|Overall Study|Lack of Efficacy|17
340674|NCT00536471|1111160|P4|Overall Study|Withdrawal by Subject|21
340675|NCT00536471|1111161|P3|Overall Study|Withdrawal by Subject|43
340676|NCT00536471|1111162|P2|Overall Study|Withdrawal by Subject|24
340677|NCT00536471|1111163|P1|Overall Study|Withdrawal by Subject|40
340678|NCT00536471|1111160|P4|Overall Study|Adverse Event|13
340679|NCT00536471|1111161|P3|Overall Study|Adverse Event|28
340680|NCT00536471|1111162|P2|Overall Study|Adverse Event|16
340681|NCT00536471|1111163|P1|Overall Study|Adverse Event|32
340682|NCT00536471|1111160|P4|Overall Study|Lost to Follow-up|22
340683|NCT00536471|1111161|P3|Overall Study|Lost to Follow-up|48
340684|NCT00536471|1111162|P2|Overall Study|Lost to Follow-up|23
340685|NCT00536471|1111163|P1|Overall Study|Lost to Follow-up|48
340686|NCT00536380|1111408|P3|Overall Study|Administrative|1
340687|NCT00536380|1111409|P2|Overall Study|Administrative|0
340688|NCT00536380|1111410|P1|Overall Study|Administrative|0
340689|NCT00536380|1111408|P3|Overall Study|Did not meet protocol eligibility|1
340690|NCT00536380|1111409|P2|Overall Study|Did not meet protocol eligibility|0
340691|NCT00536380|1111410|P1|Overall Study|Did not meet protocol eligibility|0
340692|NCT00536380|1111408|P3|Overall Study|Noncompliance with protocol|2
340693|NCT00536380|1111409|P2|Overall Study|Noncompliance with protocol|2
340694|NCT00536380|1111410|P1|Overall Study|Noncompliance with protocol|3
340695|NCT00536380|1111408|P3|Overall Study|Withdrawal related to study drug|2
340696|NCT00536380|1111409|P2|Overall Study|Withdrawal related to study drug|5
340697|NCT00536380|1111410|P1|Overall Study|Withdrawal related to study drug|7
340698|NCT00536380|1111408|P3|Overall Study|Withdrawal unrelated to study drug|1
340699|NCT00536380|1111409|P2|Overall Study|Withdrawal unrelated to study drug|0
340700|NCT00536380|1111410|P1|Overall Study|Withdrawal unrelated to study drug|2
340701|NCT00536380|1111408|P3|Overall Study|Lost to Follow-up|1
340702|NCT00536380|1111409|P2|Overall Study|Lost to Follow-up|0
340703|NCT00536380|1111410|P1|Overall Study|Lost to Follow-up|0
340704|NCT00536380|1111408|P3|Overall Study|Adverse Event|2
340706|NCT00536380|1111410|P1|Overall Study|Adverse Event|0
340707|NCT00536263|1111434|P3|Overall Study|Did not meet protocol eligibility|2
340708|NCT00536263|1111435|P2|Overall Study|Did not meet protocol eligibility|2
340709|NCT00536263|1111436|P1|Overall Study|Did not meet protocol eligibility|1
340710|NCT00536263|1111434|P3|Overall Study|Noncompliance with protocol|1
340711|NCT00536263|1111435|P2|Overall Study|Noncompliance with protocol|0
340712|NCT00536263|1111436|P1|Overall Study|Noncompliance with protocol|0
340713|NCT00536263|1111434|P3|Overall Study|Subject withdrew - treatment related|2
340714|NCT00536263|1111435|P2|Overall Study|Subject withdrew - treatment related|3
340715|NCT00536263|1111436|P1|Overall Study|Subject withdrew - treatment related|0
340716|NCT00536263|1111434|P3|Overall Study|Subject withdrew - not treatment related|5
340717|NCT00536263|1111435|P2|Overall Study|Subject withdrew - not treatment related|0
340718|NCT00536263|1111436|P1|Overall Study|Subject withdrew - not treatment related|2
340719|NCT00536263|1111434|P3|Overall Study|Lost to Follow-up|4
340720|NCT00536263|1111435|P2|Overall Study|Lost to Follow-up|4
340721|NCT00536263|1111436|P1|Overall Study|Lost to Follow-up|3
340722|NCT00536263|1111434|P3|Overall Study|Adverse Event|7
340723|NCT00536263|1111435|P2|Overall Study|Adverse Event|5
340724|NCT00536263|1111436|P1|Overall Study|Adverse Event|5
340725|NCT00536198|1111476|P2|Overall Study|Protocol Violation|1
340726|NCT00536198|1111477|P1|Overall Study|Protocol Violation|0
340727|NCT00536198|1111476|P2|Overall Study|Pregnancy|1
340728|NCT00536198|1111477|P1|Overall Study|Pregnancy|1
340729|NCT00536198|1111476|P2|Overall Study|Rescue|9
340730|NCT00536198|1111477|P1|Overall Study|Rescue|3
340731|NCT00536198|1111476|P2|Overall Study|Adverse Event|2
340732|NCT00536198|1111477|P1|Overall Study|Adverse Event|2
340733|NCT00536198|1111476|P2|Overall Study|Withdrawal by Subject|12
340734|NCT00536198|1111477|P1|Overall Study|Withdrawal by Subject|16
340735|NCT00536198|1111476|P2|Overall Study|Lost to Follow-up|14
340736|NCT00536198|1111477|P1|Overall Study|Lost to Follow-up|15
340737|NCT00536120|1111516|P2|Overall Study|Missed Study Visit|1
340738|NCT00536120|1111517|P1|Overall Study|Missed Study Visit|0
340739|NCT00536120|1111516|P2|Overall Study|Steroid Use|2
340740|NCT00536120|1111517|P1|Overall Study|Steroid Use|0
340741|NCT00536120|1111516|P2|Overall Study|Sponsor Decision Due to Lab Values|0
340742|NCT00536120|1111517|P1|Overall Study|Sponsor Decision Due to Lab Values|1
340743|NCT00536120|1111516|P2|Overall Study|Non-compliance|0
340744|NCT00536120|1111517|P1|Overall Study|Non-compliance|1
340745|NCT00536120|1111516|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
340746|NCT00536120|1111517|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
340747|NCT00536120|1111516|P2|Overall Study|Lost to Follow-up|0
340748|NCT00536120|1111517|P1|Overall Study|Lost to Follow-up|1
340749|NCT00536107|1111531|P2|Overall Study|Study Termination|4
340750|NCT00536107|1111532|P1|Overall Study|Study Termination|2
340751|NCT00536107|1111531|P2|Overall Study|Withdrawal by Subject|1
340752|NCT00536107|1111532|P1|Overall Study|Withdrawal by Subject|0
340753|NCT00536107|1111531|P2|Overall Study|Incorrect enrolment|0
340754|NCT00536107|1111532|P1|Overall Study|Incorrect enrolment|1
340755|NCT00536107|1111531|P2|Overall Study|Death|1
340756|NCT00536107|1111532|P1|Overall Study|Death|5
340757|NCT00535847|1111586|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
340758|NCT00535847|1111587|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
340759|NCT00535847|1111588|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
340760|NCT00535847|1111586|P3|Overall Study|Non compliance|0
340761|NCT00535847|1111587|P2|Overall Study|Non compliance|1
340762|NCT00535847|1111588|P1|Overall Study|Non compliance|1
340763|NCT00535847|1111586|P3|Overall Study|Adverse Event|2
340764|NCT00535847|1111587|P2|Overall Study|Adverse Event|3
340765|NCT00535847|1111588|P1|Overall Study|Adverse Event|5
340766|NCT00535730|1111654|P2|Overall Study|Withdrawal by Subject|4
340767|NCT00535730|1111655|P1|Overall Study|Withdrawal by Subject|0
340768|NCT00535730|1111654|P2|Overall Study|Protocol Violation|0
340769|NCT00535730|1111655|P1|Overall Study|Protocol Violation|1
340770|NCT00535730|1111654|P2|Overall Study|Physician Decision|1
340771|NCT00535730|1111655|P1|Overall Study|Physician Decision|0
340772|NCT00535730|1111654|P2|Overall Study|Lost to Follow-up|1
340773|NCT00535730|1111655|P1|Overall Study|Lost to Follow-up|0
340774|NCT00535730|1111654|P2|Overall Study|Adverse Event|1
340775|NCT00535730|1111655|P1|Overall Study|Adverse Event|1
340776|NCT00535496|1111693|P4|Overall Study|Not treated with sugammadex|0
340777|NCT00535496|1111694|P3|Overall Study|Not treated with sugammadex|0
340778|NCT00535496|1111695|P2|Overall Study|Not treated with sugammadex|1
340779|NCT00535496|1111696|P1|Overall Study|Not treated with sugammadex|0
340780|NCT00535496|1111693|P4|Overall Study|Lost to Follow-up|0
340781|NCT00535496|1111694|P3|Overall Study|Lost to Follow-up|0
340782|NCT00535496|1111695|P2|Overall Study|Lost to Follow-up|1
340783|NCT00535496|1111696|P1|Overall Study|Lost to Follow-up|0
340784|NCT00535405|1111716|P5|Overall Study|Withdrawal by Subject|8
340785|NCT00535405|1111717|P4|Overall Study|Withdrawal by Subject|10
340786|NCT00535405|1111718|P3|Overall Study|Withdrawal by Subject|10
340787|NCT00535405|1111719|P2|Overall Study|Withdrawal by Subject|11
340788|NCT00535405|1111720|P1|Overall Study|Withdrawal by Subject|5
340789|NCT00535405|1111716|P5|Overall Study|Protocol Violation|0
340790|NCT00535405|1111717|P4|Overall Study|Protocol Violation|1
340791|NCT00535405|1111718|P3|Overall Study|Protocol Violation|2
340792|NCT00535405|1111719|P2|Overall Study|Protocol Violation|2
340793|NCT00535405|1111720|P1|Overall Study|Protocol Violation|2
340794|NCT00535405|1111716|P5|Overall Study|Physician Decision|1
340795|NCT00535405|1111717|P4|Overall Study|Physician Decision|1
340796|NCT00535405|1111718|P3|Overall Study|Physician Decision|0
340797|NCT00535405|1111719|P2|Overall Study|Physician Decision|2
340798|NCT00535405|1111720|P1|Overall Study|Physician Decision|3
340799|NCT00535405|1111716|P5|Overall Study|Lost to Follow-up|1
340800|NCT00535405|1111717|P4|Overall Study|Lost to Follow-up|2
340801|NCT00535405|1111718|P3|Overall Study|Lost to Follow-up|3
340802|NCT00535405|1111719|P2|Overall Study|Lost to Follow-up|3
340803|NCT00535405|1111720|P1|Overall Study|Lost to Follow-up|1
340804|NCT00535405|1111716|P5|Overall Study|Adverse Event|6
340805|NCT00535405|1111717|P4|Overall Study|Adverse Event|8
340806|NCT00535405|1111718|P3|Overall Study|Adverse Event|3
340807|NCT00535405|1111719|P2|Overall Study|Adverse Event|8
340808|NCT00535405|1111720|P1|Overall Study|Adverse Event|6
340809|NCT00535288|1111781|P5|Overall Study|Not specified|1
340810|NCT00535288|1111782|P4|Overall Study|Not specified|2
340811|NCT00535288|1111783|P3|Overall Study|Not specified|1
340812|NCT00535288|1111784|P2|Overall Study|Not specified|1
340813|NCT00535288|1111785|P1|Overall Study|Not specified|2
340814|NCT00535288|1111781|P5|Overall Study|Unwilling to cooperate|4
340815|NCT00535288|1111782|P4|Overall Study|Unwilling to cooperate|3
340816|NCT00535288|1111783|P3|Overall Study|Unwilling to cooperate|3
340817|NCT00535288|1111784|P2|Overall Study|Unwilling to cooperate|6
340818|NCT00535288|1111785|P1|Overall Study|Unwilling to cooperate|6
340819|NCT00535288|1111781|P5|Overall Study|Lack of Efficacy|7
340820|NCT00535288|1111782|P4|Overall Study|Lack of Efficacy|4
340821|NCT00535288|1111783|P3|Overall Study|Lack of Efficacy|4
340822|NCT00535288|1111784|P2|Overall Study|Lack of Efficacy|3
340823|NCT00535288|1111785|P1|Overall Study|Lack of Efficacy|26
340824|NCT00535288|1111781|P5|Overall Study|Lost to Follow-up|0
340825|NCT00535288|1111782|P4|Overall Study|Lost to Follow-up|0
340826|NCT00535288|1111783|P3|Overall Study|Lost to Follow-up|0
340827|NCT00535288|1111784|P2|Overall Study|Lost to Follow-up|3
340828|NCT00535288|1111785|P1|Overall Study|Lost to Follow-up|0
340829|NCT00535288|1111781|P5|Overall Study|Adverse Event|30
340830|NCT00535288|1111782|P4|Overall Study|Adverse Event|20
340831|NCT00535288|1111783|P3|Overall Study|Adverse Event|25
340832|NCT00535288|1111784|P2|Overall Study|Adverse Event|19
340833|NCT00535288|1111785|P1|Overall Study|Adverse Event|20
340834|NCT00535262|1111862|P1|Overall Study|No funding|3
340835|NCT00535223|1111868|P2|Overall Study|Withdrawal by Subject|1
340836|NCT00535223|1111869|P1|Overall Study|Withdrawal by Subject|4
340837|NCT00535145|1111877|P1|Phase II|Subject non-compliance|2
340838|NCT00535145|1111877|P1|Phase II|Withdrawal by Subject|5
340839|NCT00535145|1111877|P1|Phase II|Lost to Follow-up|5
340840|NCT00535145|1111877|P1|Phase II|Lack of Efficacy|1
340841|NCT00535145|1111877|P1|Phase II|Adverse Event|2
340842|NCT00535145|1111877|P1|Phase I|(diagnosis)|3
340843|NCT00535145|1111877|P1|Phase I|(PI decision)|1
340844|NCT00535145|1111877|P1|Phase I|(protocol violation)|1
340845|NCT00535145|1111877|P1|Phase I|(eligibility)|8
340846|NCT00535145|1111877|P1|Phase I|Withdrawal by Subject|6
340847|NCT00535145|1111877|P1|Phase I|Lost to Follow-up|7
340848|NCT00535145|1111877|P1|Phase I|Adverse Event|3
340849|NCT00535132|1111889|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
340850|NCT00535132|1111890|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
340851|NCT00535132|1111889|P2|Safety Analysis Set|Did Not Receive Study Medication|2
340852|NCT00535132|1111890|P1|Safety Analysis Set|Did Not Receive Study Medication|2
340853|NCT00534976|1111971|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
340854|NCT00534976|1111972|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
340855|NCT00534976|1111971|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
340856|NCT00534976|1111972|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
340857|NCT00534976|1111971|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
340858|NCT00534976|1111972|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
340859|NCT00534248|1111994|P2|Overall Study|Withdrawal by Subject|255
340860|NCT00534248|1111995|P1|Overall Study|Withdrawal by Subject|263
340861|NCT00534248|1111994|P2|Overall Study|Protocol Violation|4
340862|NCT00534248|1111995|P1|Overall Study|Protocol Violation|3
340863|NCT00534248|1111994|P2|Overall Study|Physician Decision|7
340864|NCT00534248|1111995|P1|Overall Study|Physician Decision|10
340865|NCT00534248|1111994|P2|Overall Study|Other protocol specified criteria|3
340866|NCT00534248|1111995|P1|Overall Study|Other protocol specified criteria|13
340867|NCT00534248|1111994|P2|Overall Study|Lost to Follow-up|375
340868|NCT00534248|1111995|P1|Overall Study|Lost to Follow-up|353
340869|NCT00534248|1111994|P2|Overall Study|Adverse Event|29
340870|NCT00534248|1111995|P1|Overall Study|Adverse Event|19
340871|NCT00534105|1112011|P2|Overall Study|Lost to Follow-up|39
340872|NCT00534105|1112012|P1|Overall Study|Lost to Follow-up|23
340873|NCT00534092|1112026|P2|Overall Study|personal reasons/family concerns|0
340874|NCT00534092|1112027|P1|Overall Study|personal reasons/family concerns|1
340875|NCT00534092|1112026|P2|Overall Study|Lost to Follow-up|0
340876|NCT00534092|1112027|P1|Overall Study|Lost to Follow-up|1
340877|NCT00534638|1112091|P2|Overall Study|Refused participation to study|883
340878|NCT00534638|1112092|P1|Overall Study|Refused participation to study|1665
340879|NCT00534638|1112091|P2|Overall Study|Rejected origin of signature|2
340880|NCT00534638|1112092|P1|Overall Study|Rejected origin of signature|0
340881|NCT00534638|1112091|P2|Overall Study|Received without ICF|1
340882|NCT00534638|1112092|P1|Overall Study|Received without ICF|0
340883|NCT00534638|1112091|P2|Overall Study|Subject unable to read|1
340884|NCT00534638|1112092|P1|Overall Study|Subject unable to read|0
340885|NCT00534638|1112091|P2|Overall Study|ICF not returned|1
340886|NCT00534638|1112092|P1|Overall Study|ICF not returned|0
340887|NCT00534638|1112091|P2|Overall Study|Mentally disabled|0
340888|NCT00534638|1112092|P1|Overall Study|Mentally disabled|1
340889|NCT00534638|1112091|P2|Overall Study|Death|5
340890|NCT00534638|1112092|P1|Overall Study|Death|5
340891|NCT00534638|1112091|P2|Overall Study|Pregnancy|4
340892|NCT00534638|1112092|P1|Overall Study|Pregnancy|6
340893|NCT00534638|1112091|P2|Overall Study|Blinded treatment broken|0
340894|NCT00534638|1112092|P1|Overall Study|Blinded treatment broken|2
340895|NCT00534638|1112091|P2|Overall Study|Urticaria|0
340896|NCT00534638|1112092|P1|Overall Study|Urticaria|1
340897|NCT00534638|1112091|P2|Overall Study|Already received HPV vaccine|1
340898|NCT00534638|1112092|P1|Overall Study|Already received HPV vaccine|0
340899|NCT00534638|1112091|P2|Overall Study|Lost to Follow-up|10875
340900|NCT00534638|1112092|P1|Overall Study|Lost to Follow-up|4793
340901|NCT00534638|1112091|P2|Overall Study|Migrated/moved from study area|13
340902|NCT00534638|1112092|P1|Overall Study|Migrated/moved from study area|14
340903|NCT00534638|1112091|P2|Overall Study|Withdrawal by Subject|5
340904|NCT00534638|1112092|P1|Overall Study|Withdrawal by Subject|4
340905|NCT00534599|1112127|P2|Overall Study|Unspecified|0
340906|NCT00534599|1112128|P1|Overall Study|Unspecified|7
340907|NCT00534599|1112127|P2|Overall Study|Withdrawal by Subject|6
340908|NCT00534599|1112128|P1|Overall Study|Withdrawal by Subject|4
340909|NCT00534599|1112127|P2|Overall Study|Lost to Follow-up|14
340910|NCT00534599|1112128|P1|Overall Study|Lost to Follow-up|11
340911|NCT00534599|1112127|P2|Overall Study|Protocol Violation|3
340912|NCT00534599|1112128|P1|Overall Study|Protocol Violation|1
340913|NCT00534599|1112127|P2|Overall Study|Generalized anxiety disorder worsened|1
340914|NCT00534599|1112128|P1|Overall Study|Generalized anxiety disorder worsened|0
340915|NCT00534599|1112127|P2|Overall Study|Lack of Efficacy|1
340916|NCT00534599|1112128|P1|Overall Study|Lack of Efficacy|0
340917|NCT00534599|1112127|P2|Overall Study|Developed study-specific d/c criteria|0
340918|NCT00534599|1112128|P1|Overall Study|Developed study-specific d/c criteria|5
340919|NCT00534599|1112127|P2|Overall Study|Mis-randomization|2
340920|NCT00534599|1112128|P1|Overall Study|Mis-randomization|2
340921|NCT00534599|1112127|P2|Overall Study|Incorrect enrollment|1
340922|NCT00534599|1112128|P1|Overall Study|Incorrect enrollment|2
340923|NCT00534599|1112127|P2|Overall Study|Adverse Event|4
340924|NCT00534599|1112128|P1|Overall Study|Adverse Event|25
340925|NCT00534495|1112164|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
340926|NCT00534495|1112165|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
340927|NCT00534495|1112166|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
340928|NCT00534495|1112164|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
340929|NCT00534495|1112165|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
340930|NCT00534495|1112166|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
340931|NCT00534495|1112164|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
340932|NCT00534495|1112165|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
340933|NCT00534495|1112166|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
340934|NCT00534495|1112164|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
340935|NCT00534495|1112165|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
340936|NCT00534495|1112166|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
340937|NCT00534495|1112164|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
340938|NCT00534495|1112165|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
340939|NCT00534495|1112166|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
340940|NCT00534495|1112164|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
340941|NCT00534495|1112165|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
340942|NCT00534495|1112166|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
340943|NCT00534495|1112164|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
340944|NCT00534495|1112165|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
340945|NCT00534495|1112166|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
340946|NCT00534495|1112164|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
340947|NCT00534495|1112165|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
340948|NCT00534495|1112166|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
340949|NCT00534495|1112164|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
340950|NCT00534495|1112165|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
340951|NCT00534495|1112166|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
340952|NCT00534404|1112204|P3|Overall Study|Lost to Follow-up|201
340953|NCT00534404|1112205|P2|Overall Study|Lost to Follow-up|138
340954|NCT00534404|1112206|P1|Overall Study|Lost to Follow-up|170
340955|NCT00534404|1112204|P3|Overall Study|Removed by study staff|1
340956|NCT00534404|1112205|P2|Overall Study|Removed by study staff|3
340957|NCT00534404|1112206|P1|Overall Study|Removed by study staff|2
340958|NCT00534404|1112204|P3|Overall Study|Withdrawal by Subject|38
340959|NCT00534404|1112205|P2|Overall Study|Withdrawal by Subject|2
340960|NCT00534404|1112206|P1|Overall Study|Withdrawal by Subject|8
340961|NCT00534404|1112204|P3|Overall Study|Death|2
340962|NCT00534404|1112205|P2|Overall Study|Death|0
340963|NCT00534404|1112206|P1|Overall Study|Death|0
340964|NCT00534352|1112237|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
340965|NCT00534352|1112237|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
340966|NCT00534352|1112237|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
340967|NCT00534352|1112237|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
340968|NCT00534352|1112237|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
340969|NCT00534352|1112237|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
340970|NCT00534313|1112281|P4|Long-term Period|Not specified|2
340971|NCT00534313|1112282|P3|Long-term Period|Not specified|2
340972|NCT00534313|1112283|P2|Long-term Period|Not specified|2
340973|NCT00534313|1112284|P1|Long-term Period|Not specified|1
340974|NCT00534313|1112281|P4|Long-term Period|Administrative reason by sponsor|18
340975|NCT00534313|1112282|P3|Long-term Period|Administrative reason by sponsor|26
340976|NCT00534313|1112283|P2|Long-term Period|Administrative reason by sponsor|15
340977|NCT00534313|1112284|P1|Long-term Period|Administrative reason by sponsor|17
340978|NCT00534313|1112281|P4|Long-term Period|Poor compliance/noncompliance|0
340979|NCT00534313|1112282|P3|Long-term Period|Poor compliance/noncompliance|1
340980|NCT00534313|1112283|P2|Long-term Period|Poor compliance/noncompliance|1
340981|NCT00534313|1112284|P1|Long-term Period|Poor compliance/noncompliance|0
340982|NCT00534313|1112281|P4|Long-term Period|No longer meets study criteria|0
340983|NCT00534313|1112282|P3|Long-term Period|No longer meets study criteria|0
340984|NCT00534313|1112283|P2|Long-term Period|No longer meets study criteria|1
340985|NCT00534313|1112284|P1|Long-term Period|No longer meets study criteria|0
340986|NCT00534313|1112281|P4|Long-term Period|Withdrawal by Subject|0
340987|NCT00534313|1112282|P3|Long-term Period|Withdrawal by Subject|0
340988|NCT00534313|1112283|P2|Long-term Period|Withdrawal by Subject|2
340989|NCT00534313|1112284|P1|Long-term Period|Withdrawal by Subject|2
340990|NCT00534313|1112281|P4|Long-term Period|Lost to Follow-up|0
340991|NCT00534313|1112282|P3|Long-term Period|Lost to Follow-up|0
340992|NCT00534313|1112283|P2|Long-term Period|Lost to Follow-up|2
340993|NCT00534313|1112284|P1|Long-term Period|Lost to Follow-up|1
340994|NCT00534313|1112281|P4|Long-term Period|Lack of Efficacy|12
340995|NCT00534313|1112282|P3|Long-term Period|Lack of Efficacy|14
340996|NCT00534313|1112283|P2|Long-term Period|Lack of Efficacy|10
340997|NCT00534313|1112284|P1|Long-term Period|Lack of Efficacy|14
340998|NCT00534313|1112281|P4|Long-term Period|Adverse Event|1
340999|NCT00534313|1112282|P3|Long-term Period|Adverse Event|0
341000|NCT00534313|1112283|P2|Long-term Period|Adverse Event|1
341001|NCT00534313|1112284|P1|Long-term Period|Adverse Event|2
341002|NCT00534313|1112281|P4|Short-term Period|Pregnancy|0
341003|NCT00534313|1112282|P3|Short-term Period|Pregnancy|1
341004|NCT00534313|1112283|P2|Short-term Period|Pregnancy|0
341005|NCT00534313|1112284|P1|Short-term Period|Pregnancy|0
341006|NCT00534313|1112281|P4|Short-term Period|Participant withdrew consent|2
341007|NCT00534313|1112282|P3|Short-term Period|Participant withdrew consent|0
341008|NCT00534313|1112283|P2|Short-term Period|Participant withdrew consent|0
341009|NCT00534313|1112284|P1|Short-term Period|Participant withdrew consent|2
341010|NCT00534313|1112281|P4|Short-term Period|Participant not meeting study criteria|1
341011|NCT00534313|1112282|P3|Short-term Period|Participant not meeting study criteria|0
341012|NCT00534313|1112283|P2|Short-term Period|Participant not meeting study criteria|0
341013|NCT00534313|1112284|P1|Short-term Period|Participant not meeting study criteria|0
341014|NCT00534313|1112281|P4|Short-term Period|Lack of Efficacy|3
341015|NCT00534313|1112282|P3|Short-term Period|Lack of Efficacy|0
341016|NCT00534313|1112283|P2|Short-term Period|Lack of Efficacy|4
341017|NCT00534313|1112284|P1|Short-term Period|Lack of Efficacy|3
341018|NCT00534313|1112281|P4|Short-term Period|Adverse Event|3
341019|NCT00534313|1112282|P3|Short-term Period|Adverse Event|1
341020|NCT00534313|1112283|P2|Short-term Period|Adverse Event|2
341021|NCT00534313|1112284|P1|Short-term Period|Adverse Event|1
341022|NCT00533949|1112392|P4|Overall Study|Withdrawal by Subject|1
341023|NCT00533949|1112393|P3|Overall Study|Withdrawal by Subject|1
341024|NCT00533949|1112394|P2|Overall Study|Withdrawal by Subject|2
341025|NCT00533949|1112395|P1|Overall Study|Withdrawal by Subject|3
341026|NCT00533949|1112392|P4|Overall Study|Protocol Violation|9
341027|NCT00533949|1112393|P3|Overall Study|Protocol Violation|9
341028|NCT00533949|1112394|P2|Overall Study|Protocol Violation|12
341029|NCT00533949|1112395|P1|Overall Study|Protocol Violation|12
341030|NCT00533897|1112426|P8|Long Term Extension (LTE)|not specified|6
341031|NCT00533897|1112427|P7|Long Term Extension (LTE)|not specified|1
341032|NCT00533897|1112428|P6|Long Term Extension (LTE)|not specified|0
341033|NCT00533897|1112429|P5|Long Term Extension (LTE)|not specified|0
341034|NCT00533897|1112430|P4|Long Term Extension (LTE)|not specified|0
341035|NCT00533897|1112431|P3|Long Term Extension (LTE)|not specified|0
341036|NCT00533897|1112432|P2|Long Term Extension (LTE)|not specified|0
341037|NCT00533897|1112433|P1|Long Term Extension (LTE)|not specified|0
341038|NCT00533897|1112426|P8|Long Term Extension (LTE)|Lost to Follow-up|1
341039|NCT00533897|1112427|P7|Long Term Extension (LTE)|Lost to Follow-up|1
341040|NCT00533897|1112428|P6|Long Term Extension (LTE)|Lost to Follow-up|0
341041|NCT00533897|1112429|P5|Long Term Extension (LTE)|Lost to Follow-up|0
341042|NCT00533897|1112430|P4|Long Term Extension (LTE)|Lost to Follow-up|0
341043|NCT00533897|1112431|P3|Long Term Extension (LTE)|Lost to Follow-up|0
341044|NCT00533897|1112432|P2|Long Term Extension (LTE)|Lost to Follow-up|0
341045|NCT00533897|1112433|P1|Long Term Extension (LTE)|Lost to Follow-up|0
341046|NCT00533897|1112426|P8|Long Term Extension (LTE)|Pregnancy|2
341047|NCT00533897|1112427|P7|Long Term Extension (LTE)|Pregnancy|0
341048|NCT00533897|1112428|P6|Long Term Extension (LTE)|Pregnancy|0
341049|NCT00533897|1112429|P5|Long Term Extension (LTE)|Pregnancy|0
341050|NCT00533897|1112430|P4|Long Term Extension (LTE)|Pregnancy|0
341051|NCT00533897|1112431|P3|Long Term Extension (LTE)|Pregnancy|0
341052|NCT00533897|1112432|P2|Long Term Extension (LTE)|Pregnancy|0
341053|NCT00533897|1112433|P1|Long Term Extension (LTE)|Pregnancy|0
341054|NCT00533897|1112426|P8|Long Term Extension (LTE)|Adverse Event|5
341055|NCT00533897|1112427|P7|Long Term Extension (LTE)|Adverse Event|2
341056|NCT00533897|1112428|P6|Long Term Extension (LTE)|Adverse Event|0
341057|NCT00533897|1112429|P5|Long Term Extension (LTE)|Adverse Event|0
341058|NCT00533897|1112430|P4|Long Term Extension (LTE)|Adverse Event|0
341059|NCT00533897|1112431|P3|Long Term Extension (LTE)|Adverse Event|0
341060|NCT00533897|1112432|P2|Long Term Extension (LTE)|Adverse Event|0
341061|NCT00533897|1112433|P1|Long Term Extension (LTE)|Adverse Event|0
341062|NCT00533897|1112426|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
341063|NCT00533897|1112427|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
341064|NCT00533897|1112428|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
341065|NCT00533897|1112429|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
341066|NCT00533897|1112430|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
341067|NCT00533897|1112431|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
341068|NCT00533897|1112432|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
341069|NCT00533897|1112433|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
341070|NCT00533897|1112426|P8|Long Term Extension (LTE)|Lack of Efficacy|3
341071|NCT00533897|1112427|P7|Long Term Extension (LTE)|Lack of Efficacy|5
341072|NCT00533897|1112428|P6|Long Term Extension (LTE)|Lack of Efficacy|0
341073|NCT00533897|1112429|P5|Long Term Extension (LTE)|Lack of Efficacy|0
341074|NCT00533897|1112430|P4|Long Term Extension (LTE)|Lack of Efficacy|0
341075|NCT00533897|1112431|P3|Long Term Extension (LTE)|Lack of Efficacy|0
341076|NCT00533897|1112432|P2|Long Term Extension (LTE)|Lack of Efficacy|0
341077|NCT00533897|1112433|P1|Long Term Extension (LTE)|Lack of Efficacy|0
341078|NCT00533897|1112426|P8|Long Term Extension (LTE)|Death|3
341079|NCT00533897|1112427|P7|Long Term Extension (LTE)|Death|1
341080|NCT00533897|1112428|P6|Long Term Extension (LTE)|Death|0
341081|NCT00533897|1112429|P5|Long Term Extension (LTE)|Death|0
341082|NCT00533897|1112430|P4|Long Term Extension (LTE)|Death|0
341083|NCT00533897|1112431|P3|Long Term Extension (LTE)|Death|0
341084|NCT00533897|1112432|P2|Long Term Extension (LTE)|Death|0
341085|NCT00533897|1112433|P1|Long Term Extension (LTE)|Death|0
341086|NCT00533897|1112426|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
341087|NCT00533897|1112427|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
341088|NCT00533897|1112428|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
341089|NCT00533897|1112429|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
341090|NCT00533897|1112430|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
341091|NCT00533897|1112431|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
341092|NCT00533897|1112432|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
341093|NCT00533897|1112433|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
341094|NCT00533897|1112426|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
341095|NCT00533897|1112427|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
341096|NCT00533897|1112428|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
341097|NCT00533897|1112429|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
341098|NCT00533897|1112430|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
341099|NCT00533897|1112431|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
341100|NCT00533897|1112432|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
341101|NCT00533897|1112433|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
341102|NCT00533897|1112426|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
341103|NCT00533897|1112427|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
341104|NCT00533897|1112428|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
341105|NCT00533897|1112429|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
341106|NCT00533897|1112430|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
341107|NCT00533897|1112431|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
341108|NCT00533897|1112432|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
341109|NCT00533897|1112433|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
341110|NCT00533897|1112426|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
341111|NCT00533897|1112427|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
341112|NCT00533897|1112428|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
341113|NCT00533897|1112429|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
341114|NCT00533897|1112430|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
341115|NCT00533897|1112431|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
341116|NCT00533897|1112432|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
341117|NCT00533897|1112433|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
341118|NCT00533897|1112426|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
341119|NCT00533897|1112427|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
341120|NCT00533897|1112428|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
341121|NCT00533897|1112429|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
341122|NCT00533897|1112430|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
341123|NCT00533897|1112431|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
341124|NCT00533897|1112432|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
341125|NCT00533897|1112433|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
341126|NCT00533897|1112426|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
341127|NCT00533897|1112427|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
341128|NCT00533897|1112428|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
341129|NCT00533897|1112429|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
341130|NCT00533897|1112430|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
341131|NCT00533897|1112431|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
341132|NCT00533897|1112432|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
341133|NCT00533897|1112433|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
341134|NCT00533897|1112426|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
341135|NCT00533897|1112427|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
341136|NCT00533897|1112428|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
341137|NCT00533897|1112429|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
341138|NCT00533897|1112430|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
341139|NCT00533897|1112431|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
341140|NCT00533897|1112432|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
341141|NCT00533897|1112433|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
341142|NCT00533897|1112426|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
341143|NCT00533897|1112427|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
341144|NCT00533897|1112428|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
341145|NCT00533897|1112429|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
341146|NCT00533897|1112430|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
341147|NCT00533897|1112431|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
341148|NCT00533897|1112432|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
341149|NCT00533897|1112433|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
341150|NCT00533897|1112426|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
341151|NCT00533897|1112427|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
341152|NCT00533897|1112428|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
341153|NCT00533897|1112429|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
341154|NCT00533897|1112430|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
341155|NCT00533897|1112431|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
341156|NCT00533897|1112432|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
341157|NCT00533897|1112433|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
341158|NCT00533897|1112426|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
341159|NCT00533897|1112427|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
341160|NCT00533897|1112428|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
341161|NCT00533897|1112429|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
341162|NCT00533897|1112430|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
341163|NCT00533897|1112431|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
341164|NCT00533897|1112432|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
341165|NCT00533897|1112433|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
341166|NCT00533897|1112426|P8|Lead-in (LI) Period 1|Adverse Event|0
341167|NCT00533897|1112427|P7|Lead-in (LI) Period 1|Adverse Event|0
341168|NCT00533897|1112428|P6|Lead-in (LI) Period 1|Adverse Event|0
341169|NCT00533897|1112429|P5|Lead-in (LI) Period 1|Adverse Event|0
341170|NCT00533897|1112430|P4|Lead-in (LI) Period 1|Adverse Event|0
341171|NCT00533897|1112431|P3|Lead-in (LI) Period 1|Adverse Event|0
341172|NCT00533897|1112432|P2|Lead-in (LI) Period 1|Adverse Event|0
341173|NCT00533897|1112433|P1|Lead-in (LI) Period 1|Adverse Event|1
341174|NCT00533702|1112573|P2|Overall Study|Found ineligible after randomization|1
341175|NCT00533702|1112574|P1|Overall Study|Found ineligible after randomization|2
341176|NCT00533702|1112573|P2|Overall Study|Withdrawal by Subject|1
341177|NCT00533702|1112574|P1|Overall Study|Withdrawal by Subject|3
341178|NCT00533507|1112605|P1|Overall Study|Withdrawal by Subject|1
341179|NCT00532948|1112627|P3|Overall Study|Failure to return|0
341180|NCT00532948|1112628|P2|Overall Study|Failure to return|1
341181|NCT00532948|1112629|P1|Overall Study|Failure to return|0
341182|NCT00532948|1112627|P3|Overall Study|Violation of selection criteria at entry|0
341183|NCT00532948|1112628|P2|Overall Study|Violation of selection criteria at entry|1
341184|NCT00532948|1112629|P1|Overall Study|Violation of selection criteria at entry|0
341185|NCT00532948|1112627|P3|Overall Study|Death|4
341186|NCT00532948|1112628|P2|Overall Study|Death|3
341187|NCT00532948|1112629|P1|Overall Study|Death|3
341188|NCT00532948|1112627|P3|Overall Study|Protocol Violation|0
341189|NCT00532948|1112628|P2|Overall Study|Protocol Violation|0
341190|NCT00532948|1112629|P1|Overall Study|Protocol Violation|1
341191|NCT00532935|1112661|P2|Overall Study|Protocol Specific Criteria|15
341192|NCT00532935|1112662|P1|Overall Study|Protocol Specific Criteria|11
341193|NCT00532935|1112661|P2|Overall Study|Withdrawal by Subject|9
341194|NCT00532935|1112662|P1|Overall Study|Withdrawal by Subject|10
341195|NCT00532935|1112661|P2|Overall Study|Protocol Violation|2
341196|NCT00532935|1112662|P1|Overall Study|Protocol Violation|4
341197|NCT00532935|1112661|P2|Overall Study|Pregnancy|0
341198|NCT00532935|1112662|P1|Overall Study|Pregnancy|1
341199|NCT00532935|1112661|P2|Overall Study|Physician Decision|5
341200|NCT00532935|1112662|P1|Overall Study|Physician Decision|4
341201|NCT00532935|1112661|P2|Overall Study|Lost to Follow-up|6
341202|NCT00532935|1112662|P1|Overall Study|Lost to Follow-up|10
341203|NCT00532935|1112661|P2|Overall Study|Lack of Efficacy|3
341204|NCT00532935|1112662|P1|Overall Study|Lack of Efficacy|0
341205|NCT00532935|1112661|P2|Overall Study|Adverse Event|12
341206|NCT00532935|1112662|P1|Overall Study|Adverse Event|11
341207|NCT00533273|1112689|P2|Open-label|Withdrawal by Subject|0
341208|NCT00533273|1112690|P1|Open-label|Withdrawal by Subject|6
341209|NCT00533273|1112689|P2|Double-blind|Withdrew consent|2
341210|NCT00533273|1112690|P1|Double-blind|Withdrew consent|0
341211|NCT00532883|1112700|P4|Overall Study|Early Study Termination|4
341212|NCT00532883|1112701|P3|Overall Study|Early Study Termination|1
341213|NCT00532883|1112702|P2|Overall Study|Early Study Termination|4
341214|NCT00532883|1112703|P1|Overall Study|Early Study Termination|4
341215|NCT00532883|1112700|P4|Overall Study|Subject was Nonadherent|0
341216|NCT00532883|1112701|P3|Overall Study|Subject was Nonadherent|1
341217|NCT00532883|1112702|P2|Overall Study|Subject was Nonadherent|1
341218|NCT00532883|1112703|P1|Overall Study|Subject was Nonadherent|0
341219|NCT00532883|1112700|P4|Overall Study|Withdrawal by Subject|0
341220|NCT00532883|1112701|P3|Overall Study|Withdrawal by Subject|1
341221|NCT00532883|1112702|P2|Overall Study|Withdrawal by Subject|1
341222|NCT00532883|1112703|P1|Overall Study|Withdrawal by Subject|0
341223|NCT00532883|1112700|P4|Overall Study|Lost to Follow-up|0
341224|NCT00532883|1112701|P3|Overall Study|Lost to Follow-up|1
341225|NCT00532883|1112702|P2|Overall Study|Lost to Follow-up|1
341226|NCT00532883|1112703|P1|Overall Study|Lost to Follow-up|1
341227|NCT00532883|1112700|P4|Overall Study|Adverse Event|1
341228|NCT00532883|1112701|P3|Overall Study|Adverse Event|0
341229|NCT00532883|1112702|P2|Overall Study|Adverse Event|0
341230|NCT00532883|1112703|P1|Overall Study|Adverse Event|1
341231|NCT00532779|1112716|P3|Overall Study|Drug noncompliance, moved, other|29
341232|NCT00532779|1112717|P2|Overall Study|Drug noncompliance, moved, other|23
341233|NCT00532779|1112718|P1|Overall Study|Drug noncompliance, moved, other|14
341234|NCT00532779|1112716|P3|Overall Study|Death|0
341235|NCT00532779|1112717|P2|Overall Study|Death|1
341236|NCT00532779|1112718|P1|Overall Study|Death|0
341237|NCT00532779|1112716|P3|Overall Study|Pregnancy|3
341238|NCT00532779|1112717|P2|Overall Study|Pregnancy|5
341239|NCT00532779|1112718|P1|Overall Study|Pregnancy|2
341240|NCT00532779|1112716|P3|Overall Study|Protocol Violation|7
341241|NCT00532779|1112717|P2|Overall Study|Protocol Violation|9
341242|NCT00532779|1112718|P1|Overall Study|Protocol Violation|5
341243|NCT00532779|1112716|P3|Overall Study|Lack of Efficacy|40
341244|NCT00532779|1112717|P2|Overall Study|Lack of Efficacy|12
341245|NCT00532779|1112718|P1|Overall Study|Lack of Efficacy|12
341246|NCT00532779|1112716|P3|Overall Study|Withdrawal by Subject|90
341247|NCT00532779|1112717|P2|Overall Study|Withdrawal by Subject|60
341248|NCT00532779|1112718|P1|Overall Study|Withdrawal by Subject|63
341249|NCT00532779|1112716|P3|Overall Study|Lost to Follow-up|66
341250|NCT00532779|1112717|P2|Overall Study|Lost to Follow-up|65
341251|NCT00532779|1112718|P1|Overall Study|Lost to Follow-up|76
341252|NCT00532779|1112716|P3|Overall Study|Adverse Event|56
341253|NCT00532779|1112717|P2|Overall Study|Adverse Event|112
341254|NCT00532779|1112718|P1|Overall Study|Adverse Event|122
341255|NCT00532493|1112779|P2|Overall Study|Contraindicative Medication|0
341256|NCT00532493|1112780|P1|Overall Study|Contraindicative Medication|1
341257|NCT00532493|1112779|P2|Overall Study|Subject Moved Away|1
341258|NCT00532493|1112780|P1|Overall Study|Subject Moved Away|3
341259|NCT00532493|1112779|P2|Overall Study|Protocol Deviation|0
341260|NCT00532493|1112780|P1|Overall Study|Protocol Deviation|1
341261|NCT00532493|1112779|P2|Overall Study|Adverse Event|5
341262|NCT00532493|1112780|P1|Overall Study|Adverse Event|6
341263|NCT00532493|1112779|P2|Overall Study|Physician Decision|6
341264|NCT00532493|1112780|P1|Overall Study|Physician Decision|1
341265|NCT00532493|1112779|P2|Overall Study|Withdrawal by Subject|9
341266|NCT00532493|1112780|P1|Overall Study|Withdrawal by Subject|7
341267|NCT00532493|1112779|P2|Overall Study|Lost to Follow-up|7
341268|NCT00532493|1112780|P1|Overall Study|Lost to Follow-up|10
341269|NCT00532493|1112779|P2|Overall Study|Death|1
341270|NCT00532493|1112780|P1|Overall Study|Death|1
341271|NCT00532441|1112814|P2|Overall Study|Death|0
341272|NCT00532441|1112815|P1|Overall Study|Death|1
341273|NCT00532298|1112830|P6|Overall Study|Lost to Follow-up|1
341274|NCT00532298|1112831|P5|Overall Study|Lost to Follow-up|0
341275|NCT00532298|1112832|P4|Overall Study|Lost to Follow-up|0
341276|NCT00532298|1112833|P3|Overall Study|Lost to Follow-up|1
341277|NCT00532298|1112834|P2|Overall Study|Lost to Follow-up|1
341278|NCT00532298|1112835|P1|Overall Study|Lost to Follow-up|1
341279|NCT00532298|1112830|P6|Overall Study|Adverse Event|1
341280|NCT00532298|1112831|P5|Overall Study|Adverse Event|1
341281|NCT00532298|1112832|P4|Overall Study|Adverse Event|0
341282|NCT00532298|1112833|P3|Overall Study|Adverse Event|0
341283|NCT00532298|1112834|P2|Overall Study|Adverse Event|0
341284|NCT00532298|1112835|P1|Overall Study|Adverse Event|1
341285|NCT00532259|1112915|P1|Overall Study|Protocol Violation|1
341286|NCT00532259|1112915|P1|Overall Study|Physician Decision|3
341287|NCT00532259|1112915|P1|Overall Study|Lost to Follow-up|3
341288|NCT00532259|1112915|P1|Overall Study|Lack of Efficacy|21
341289|NCT00532259|1112915|P1|Overall Study|Death|1
341290|NCT00532259|1112915|P1|Overall Study|Adverse Event|1
341291|NCT00532259|1112915|P1|Overall Study|Withdrawal by Subject|2
341292|NCT00532155|1112922|P2|Overall Study|Did not receive study medication|6
341293|NCT00532155|1112923|P1|Overall Study|Did not receive study medication|2
341294|NCT00532155|1112922|P2|Overall Study|Study termination stop further treatment|0
341295|NCT00532155|1112923|P1|Overall Study|Study termination stop further treatment|4
341296|NCT00532155|1112922|P2|Overall Study|Study terminated by sponsor|0
341297|NCT00532155|1112923|P1|Overall Study|Study terminated by sponsor|1
341298|NCT00532155|1112922|P2|Overall Study|Study stopped|0
341299|NCT00532155|1112923|P1|Overall Study|Study stopped|1
341300|NCT00532155|1112922|P2|Overall Study|Had brain metastasis, was mis-randomized|0
341301|NCT00532155|1112923|P1|Overall Study|Had brain metastasis, was mis-randomized|1
341302|NCT00532155|1112922|P2|Overall Study|Progressive disease (by incorrect scan)|1
341303|NCT00532155|1112923|P1|Overall Study|Progressive disease (by incorrect scan)|0
341304|NCT00532155|1112922|P2|Overall Study|Promotor ended study|0
341305|NCT00532155|1112923|P1|Overall Study|Promotor ended study|1
341306|NCT00532155|1112922|P2|Overall Study|Occurence of a secondary cancer|1
341307|NCT00532155|1112923|P1|Overall Study|Occurence of a secondary cancer|0
341308|NCT00532155|1112922|P2|Overall Study|Occurence of a second cancer|1
341309|NCT00532155|1112923|P1|Overall Study|Occurence of a second cancer|0
341310|NCT00532155|1112922|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
341311|NCT00532155|1112923|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
341312|NCT00532155|1112922|P2|Overall Study|Moved|0
341313|NCT00532155|1112923|P1|Overall Study|Moved|1
341314|NCT00532155|1112922|P2|Overall Study|Consent withdrawn|7
341315|NCT00532155|1112923|P1|Overall Study|Consent withdrawn|5
341316|NCT00532155|1112922|P2|Overall Study|Withdrawal by Subject|44
341317|NCT00532155|1112923|P1|Overall Study|Withdrawal by Subject|23
341318|NCT00532155|1112922|P2|Overall Study|Physician Decision|15
341319|NCT00532155|1112923|P1|Overall Study|Physician Decision|16
341320|NCT00532155|1112922|P2|Overall Study|Lost to Follow-up|0
341321|NCT00532155|1112923|P1|Overall Study|Lost to Follow-up|2
341322|NCT00532155|1112922|P2|Overall Study|Protocol Violation|3
341323|NCT00532155|1112923|P1|Overall Study|Protocol Violation|1
341324|NCT00532155|1112922|P2|Overall Study|Lack of Efficacy|255
341325|NCT00532155|1112923|P1|Overall Study|Lack of Efficacy|332
341326|NCT00532155|1112922|P2|Overall Study|Adverse Event|123
341327|NCT00532155|1112923|P1|Overall Study|Adverse Event|66
341328|NCT00532129|1112937|P1|Follow-up Period|Unspecified|6
341329|NCT00532129|1112937|P1|Follow-up Period|Lost to Follow-up|1
341330|NCT00532129|1112937|P1|Follow-up Period|Disease progression|57
341331|NCT00532129|1112937|P1|Follow-up Period|Adverse event/Serious adverse event|1
341332|NCT00532129|1112937|P1|Treatment Period|Unspecified|5
341333|NCT00532129|1112937|P1|Treatment Period|Protocol Violation|1
341334|NCT00532129|1112937|P1|Treatment Period|Disease progression|3
341335|NCT00532129|1112937|P1|Treatment Period|Physician Decision|15
341336|NCT00532129|1112937|P1|Treatment Period|Adverse event/Serious adverse event|25
341337|NCT00531960|1112957|P2|Overall Study|Not Specified|10
341338|NCT00531960|1112958|P1|Overall Study|Not Specified|4
341339|NCT00531960|1112957|P2|Overall Study|Refused Treatment|6
341340|NCT00531960|1112958|P1|Overall Study|Refused Treatment|5
341341|NCT00531960|1112957|P2|Overall Study|Violation of Selection Criteria|0
341342|NCT00531960|1112958|P1|Overall Study|Violation of Selection Criteria|2
341343|NCT00531960|1112957|P2|Overall Study|Lack of Efficacy|41
341344|NCT00531960|1112958|P1|Overall Study|Lack of Efficacy|42
341345|NCT00531960|1112957|P2|Overall Study|Death|2
341346|NCT00531960|1112958|P1|Overall Study|Death|3
341347|NCT00531960|1112957|P2|Overall Study|Adverse Event|4
341348|NCT00531960|1112958|P1|Overall Study|Adverse Event|5
341349|NCT00531947|1112976|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
341350|NCT00531947|1112977|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
341351|NCT00531947|1112976|P2|Overall Study|Non-Compliance|7
341352|NCT00531947|1112977|P1|Overall Study|Non-Compliance|4
341353|NCT00531947|1112976|P2|Overall Study|Protocol Violation|1
341354|NCT00531947|1112977|P1|Overall Study|Protocol Violation|2
341355|NCT00531947|1112976|P2|Overall Study|Withdrawal by Subject|19
341356|NCT00531947|1112977|P1|Overall Study|Withdrawal by Subject|14
341357|NCT00531947|1112976|P2|Overall Study|Lost to Follow-up|9
341358|NCT00531947|1112977|P1|Overall Study|Lost to Follow-up|12
341359|NCT00531947|1112976|P2|Overall Study|Adverse Event|10
341360|NCT00531947|1112977|P1|Overall Study|Adverse Event|5
341361|NCT00531934|1113021|P2|Overall Study|Not specified|2
341362|NCT00531934|1113022|P1|Overall Study|Not specified|2
341363|NCT00531934|1113021|P2|Overall Study|Withdrawal by Subject|1
341364|NCT00531934|1113022|P1|Overall Study|Withdrawal by Subject|1
341365|NCT00531934|1113021|P2|Overall Study|Death|10
341366|NCT00531934|1113022|P1|Overall Study|Death|7
341367|NCT00531934|1113021|P2|Overall Study|Progression|42
341368|NCT00531934|1113022|P1|Overall Study|Progression|52
341369|NCT00531934|1113021|P2|Overall Study|Adverse Event|8
341370|NCT00531934|1113022|P1|Overall Study|Adverse Event|4
341371|NCT00531752|1113137|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
341372|NCT00531752|1113138|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
341373|NCT00531752|1113139|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
341458|NCT00531284|1113326|P3|Overall Study|Withdrawal by Subject|0
341374|NCT00531752|1113140|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
341375|NCT00531752|1113137|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
341376|NCT00531752|1113138|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
341377|NCT00531752|1113139|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
341378|NCT00531752|1113140|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
341379|NCT00531752|1113137|P4|Second Double-blind Intervention Period|unspecified|0
341380|NCT00531752|1113138|P3|Second Double-blind Intervention Period|unspecified|0
341381|NCT00531752|1113139|P2|Second Double-blind Intervention Period|unspecified|1
341382|NCT00531752|1113140|P1|Second Double-blind Intervention Period|unspecified|1
341383|NCT00531752|1113137|P4|Second Double-blind Intervention Period|Adverse Event|0
341384|NCT00531752|1113138|P3|Second Double-blind Intervention Period|Adverse Event|0
341385|NCT00531752|1113139|P2|Second Double-blind Intervention Period|Adverse Event|1
341386|NCT00531752|1113140|P1|Second Double-blind Intervention Period|Adverse Event|1
341387|NCT00531752|1113137|P4|First Double-blind Intervention Period|Randomized but not treated|0
341388|NCT00531752|1113138|P3|First Double-blind Intervention Period|Randomized but not treated|0
341389|NCT00531752|1113139|P2|First Double-blind Intervention Period|Randomized but not treated|0
341390|NCT00531752|1113140|P1|First Double-blind Intervention Period|Randomized but not treated|1
341391|NCT00531752|1113137|P4|First Double-blind Intervention Period|Lost to Follow-up|1
341392|NCT00531752|1113138|P3|First Double-blind Intervention Period|Lost to Follow-up|1
341393|NCT00531752|1113139|P2|First Double-blind Intervention Period|Lost to Follow-up|0
341394|NCT00531752|1113140|P1|First Double-blind Intervention Period|Lost to Follow-up|0
341395|NCT00531752|1113137|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
341396|NCT00531752|1113138|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
341397|NCT00531752|1113139|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
341398|NCT00531752|1113140|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
341399|NCT00531752|1113137|P4|First Double-blind Intervention Period|unspecified|0
341400|NCT00531752|1113138|P3|First Double-blind Intervention Period|unspecified|4
341401|NCT00531752|1113139|P2|First Double-blind Intervention Period|unspecified|4
341402|NCT00531752|1113140|P1|First Double-blind Intervention Period|unspecified|1
341403|NCT00531752|1113137|P4|First Double-blind Intervention Period|Adverse Event|1
341404|NCT00531752|1113138|P3|First Double-blind Intervention Period|Adverse Event|1
341405|NCT00531752|1113139|P2|First Double-blind Intervention Period|Adverse Event|0
341406|NCT00531752|1113140|P1|First Double-blind Intervention Period|Adverse Event|2
341407|NCT00531479|1113251|P2|Overall Study|Did not receive treatment|3
341408|NCT00531479|1113252|P1|Overall Study|Did not receive treatment|2
341409|NCT00531479|1113251|P2|Overall Study|Withdrawal by Subject|6
341410|NCT00531479|1113252|P1|Overall Study|Withdrawal by Subject|6
341411|NCT00531479|1113251|P2|Overall Study|Unspecified|1
341412|NCT00531479|1113252|P1|Overall Study|Unspecified|0
341413|NCT00531479|1113251|P2|Overall Study|Lost to Follow-up|2
341414|NCT00531479|1113252|P1|Overall Study|Lost to Follow-up|0
341415|NCT00531479|1113251|P2|Overall Study|Death|71
341416|NCT00531479|1113252|P1|Overall Study|Death|68
341417|NCT00531427|1113283|P2|Overall Study|Administrative|9
341418|NCT00531427|1113284|P1|Overall Study|Administrative|4
341419|NCT00531427|1113283|P2|Overall Study|Lack of Efficacy|39
341420|NCT00531427|1113284|P1|Overall Study|Lack of Efficacy|14
341421|NCT00531427|1113283|P2|Overall Study|Lost to Follow-up|3
341422|NCT00531427|1113284|P1|Overall Study|Lost to Follow-up|4
341423|NCT00531427|1113283|P2|Overall Study|Adverse Event|30
341424|NCT00531427|1113284|P1|Overall Study|Adverse Event|44
341425|NCT00531427|1113283|P2|Overall Study|Withdrawal by Subject|13
341426|NCT00531427|1113284|P1|Overall Study|Withdrawal by Subject|7
341427|NCT00531284|1113312|P17|Overall Study|Other|0
341428|NCT00531284|1113313|P16|Overall Study|Other|0
341429|NCT00531284|1113314|P15|Overall Study|Other|1
341430|NCT00531284|1113315|P14|Overall Study|Other|0
341431|NCT00531284|1113316|P13|Overall Study|Other|0
341432|NCT00531284|1113317|P12|Overall Study|Other|2
341433|NCT00531284|1113318|P11|Overall Study|Other|0
341434|NCT00531284|1113319|P10|Overall Study|Other|1
341435|NCT00531284|1113320|P9|Overall Study|Other|2
341436|NCT00531284|1113321|P8|Overall Study|Other|0
341437|NCT00531284|1113322|P7|Overall Study|Other|0
341438|NCT00531284|1113323|P6|Overall Study|Other|1
341439|NCT00531284|1113324|P5|Overall Study|Other|2
341440|NCT00531284|1113325|P4|Overall Study|Other|10
341441|NCT00531284|1113326|P3|Overall Study|Other|0
341442|NCT00531284|1113327|P2|Overall Study|Other|0
341443|NCT00531284|1113328|P1|Overall Study|Other|1
341444|NCT00531284|1113312|P17|Overall Study|Withdrawal by Subject|1
341445|NCT00531284|1113313|P16|Overall Study|Withdrawal by Subject|1
341446|NCT00531284|1113314|P15|Overall Study|Withdrawal by Subject|0
341447|NCT00531284|1113315|P14|Overall Study|Withdrawal by Subject|1
341448|NCT00531284|1113316|P13|Overall Study|Withdrawal by Subject|0
341449|NCT00531284|1113317|P12|Overall Study|Withdrawal by Subject|3
341450|NCT00531284|1113318|P11|Overall Study|Withdrawal by Subject|0
341451|NCT00531284|1113319|P10|Overall Study|Withdrawal by Subject|0
341452|NCT00531284|1113320|P9|Overall Study|Withdrawal by Subject|0
341453|NCT00531284|1113321|P8|Overall Study|Withdrawal by Subject|0
341454|NCT00531284|1113322|P7|Overall Study|Withdrawal by Subject|0
341455|NCT00531284|1113323|P6|Overall Study|Withdrawal by Subject|0
341456|NCT00531284|1113324|P5|Overall Study|Withdrawal by Subject|0
341457|NCT00531284|1113325|P4|Overall Study|Withdrawal by Subject|4
341459|NCT00531284|1113327|P2|Overall Study|Withdrawal by Subject|0
341460|NCT00531284|1113328|P1|Overall Study|Withdrawal by Subject|1
341461|NCT00531284|1113312|P17|Overall Study|Adverse Event|2
341462|NCT00531284|1113313|P16|Overall Study|Adverse Event|0
341463|NCT00531284|1113314|P15|Overall Study|Adverse Event|1
341464|NCT00531284|1113315|P14|Overall Study|Adverse Event|1
341465|NCT00531284|1113316|P13|Overall Study|Adverse Event|0
341466|NCT00531284|1113317|P12|Overall Study|Adverse Event|5
341467|NCT00531284|1113318|P11|Overall Study|Adverse Event|0
341468|NCT00531284|1113319|P10|Overall Study|Adverse Event|0
341469|NCT00531284|1113320|P9|Overall Study|Adverse Event|3
341470|NCT00531284|1113321|P8|Overall Study|Adverse Event|2
341471|NCT00531284|1113322|P7|Overall Study|Adverse Event|3
341472|NCT00531284|1113323|P6|Overall Study|Adverse Event|2
341473|NCT00531284|1113324|P5|Overall Study|Adverse Event|0
341474|NCT00531284|1113325|P4|Overall Study|Adverse Event|7
341475|NCT00531284|1113326|P3|Overall Study|Adverse Event|1
341476|NCT00531284|1113327|P2|Overall Study|Adverse Event|1
341477|NCT00531284|1113328|P1|Overall Study|Adverse Event|0
341478|NCT00531284|1113312|P17|Overall Study|Progressive Disease|5
341479|NCT00531284|1113313|P16|Overall Study|Progressive Disease|11
341480|NCT00531284|1113314|P15|Overall Study|Progressive Disease|2
341481|NCT00531284|1113315|P14|Overall Study|Progressive Disease|1
341482|NCT00531284|1113316|P13|Overall Study|Progressive Disease|2
341483|NCT00531284|1113317|P12|Overall Study|Progressive Disease|14
341484|NCT00531284|1113318|P11|Overall Study|Progressive Disease|3
341485|NCT00531284|1113319|P10|Overall Study|Progressive Disease|3
341486|NCT00531284|1113320|P9|Overall Study|Progressive Disease|6
341487|NCT00531284|1113321|P8|Overall Study|Progressive Disease|8
341488|NCT00531284|1113322|P7|Overall Study|Progressive Disease|3
341489|NCT00531284|1113323|P6|Overall Study|Progressive Disease|4
341490|NCT00531284|1113324|P5|Overall Study|Progressive Disease|4
341491|NCT00531284|1113325|P4|Overall Study|Progressive Disease|42
341492|NCT00531284|1113326|P3|Overall Study|Progressive Disease|5
341493|NCT00531284|1113327|P2|Overall Study|Progressive Disease|3
341494|NCT00531284|1113328|P1|Overall Study|Progressive Disease|1
341495|NCT00531206|1113478|P1|Overall Study|including non-related adverse events|8
341496|NCT00531206|1113478|P1|Overall Study|Lost to Follow-up|5
341497|NCT00531206|1113478|P1|Overall Study|Lack of Efficacy|2
341498|NCT00531206|1113478|P1|Overall Study|Adverse Event related|5
341499|NCT00531050|1113508|P6|Part 2: Period 3|Abnormal test procedure|1
341500|NCT00531050|1113509|P5|Part 2: Period 3|Abnormal test procedure|0
341501|NCT00531050|1113510|P4|Part 2: Period 3|Abnormal test procedure|0
341502|NCT00531050|1113511|P3|Part 2: Period 3|Abnormal test procedure|0
341503|NCT00531050|1113512|P2|Part 2: Period 3|Abnormal test procedure|0
341504|NCT00531050|1113513|P1|Part 2: Period 3|Abnormal test procedure|1
341505|NCT00531050|1113508|P6|Part 2: Period 1|Adverse Event|1
341506|NCT00531050|1113509|P5|Part 2: Period 1|Adverse Event|0
341507|NCT00531050|1113510|P4|Part 2: Period 1|Adverse Event|0
341508|NCT00531050|1113511|P3|Part 2: Period 1|Adverse Event|0
341509|NCT00531050|1113512|P2|Part 2: Period 1|Adverse Event|0
341510|NCT00531050|1113513|P1|Part 2: Period 1|Adverse Event|0
341511|NCT00531050|1113508|P6|Part 1: Period 3|Adverse Event|0
341512|NCT00531050|1113509|P5|Part 1: Period 3|Adverse Event|0
341513|NCT00531050|1113510|P4|Part 1: Period 3|Adverse Event|0
341514|NCT00531050|1113511|P3|Part 1: Period 3|Adverse Event|0
341515|NCT00531050|1113512|P2|Part 1: Period 3|Adverse Event|0
341516|NCT00531050|1113513|P1|Part 1: Period 3|Adverse Event|1
341517|NCT00531050|1113508|P6|Part 1: Period 1|Protocol Deviation|0
341518|NCT00531050|1113509|P5|Part 1: Period 1|Protocol Deviation|0
341519|NCT00531050|1113510|P4|Part 1: Period 1|Protocol Deviation|1
341520|NCT00531050|1113511|P3|Part 1: Period 1|Protocol Deviation|0
341521|NCT00531050|1113512|P2|Part 1: Period 1|Protocol Deviation|0
341522|NCT00531050|1113513|P1|Part 1: Period 1|Protocol Deviation|0
341523|NCT00531050|1113508|P6|Part 1: Period 1|Adverse Event|0
341524|NCT00531050|1113509|P5|Part 1: Period 1|Adverse Event|0
341525|NCT00531050|1113510|P4|Part 1: Period 1|Adverse Event|0
341526|NCT00531050|1113511|P3|Part 1: Period 1|Adverse Event|0
341527|NCT00531050|1113512|P2|Part 1: Period 1|Adverse Event|1
341528|NCT00531050|1113513|P1|Part 1: Period 1|Adverse Event|0
341529|NCT00531011|1113542|P2|Overall Study|Physician Decision|3
341530|NCT00531011|1113543|P1|Overall Study|Physician Decision|0
341531|NCT00531011|1113542|P2|Overall Study|Lost to Follow-up|0
341532|NCT00531011|1113543|P1|Overall Study|Lost to Follow-up|1
341533|NCT00531011|1113542|P2|Overall Study|Death|0
341534|NCT00531011|1113543|P1|Overall Study|Death|1
341535|NCT00531011|1113542|P2|Overall Study|Withdrawal by Subject|4
341536|NCT00531011|1113543|P1|Overall Study|Withdrawal by Subject|2
341537|NCT00530946|1113589|P4|Overall Study|Noncompliance|0
341538|NCT00530946|1113590|P3|Overall Study|Noncompliance|0
341539|NCT00530946|1113591|P2|Overall Study|Noncompliance|0
341540|NCT00530946|1113592|P1|Overall Study|Noncompliance|1
341541|NCT00530946|1113589|P4|Overall Study|Protocol Violation|1
341542|NCT00530946|1113590|P3|Overall Study|Protocol Violation|0
341543|NCT00530946|1113591|P2|Overall Study|Protocol Violation|0
341544|NCT00530946|1113592|P1|Overall Study|Protocol Violation|0
341545|NCT00530946|1113589|P4|Overall Study|Adverse Event|1
341546|NCT00530946|1113590|P3|Overall Study|Adverse Event|1
341547|NCT00530946|1113591|P2|Overall Study|Adverse Event|2
341548|NCT00530946|1113592|P1|Overall Study|Adverse Event|1
341549|NCT00530920|1113645|P3|Overall Study|Withdrawal by Subject|1
341550|NCT00530920|1113646|P2|Overall Study|Withdrawal by Subject|0
341551|NCT00530920|1113647|P1|Overall Study|Withdrawal by Subject|0
341552|NCT00530920|1113645|P3|Overall Study|Adverse Event|3
341553|NCT00530920|1113646|P2|Overall Study|Adverse Event|0
341554|NCT00530920|1113647|P1|Overall Study|Adverse Event|0
341555|NCT00530920|1113645|P3|Overall Study|Randomized but not treated|0
341556|NCT00530920|1113646|P2|Overall Study|Randomized but not treated|2
341557|NCT00530920|1113647|P1|Overall Study|Randomized but not treated|0
341558|NCT00530894|1113707|P4|Overall Study|Alive and censored prior to 1 year|0
341559|NCT00530894|1113708|P3|Overall Study|Alive and censored prior to 1 year|0
341560|NCT00530894|1113709|P2|Overall Study|Alive and censored prior to 1 year|0
341561|NCT00530894|1113710|P1|Overall Study|Alive and censored prior to 1 year|2
341562|NCT00530894|1113707|P4|Overall Study|Withdrawal by Subject|5
341563|NCT00530894|1113708|P3|Overall Study|Withdrawal by Subject|0
341564|NCT00530894|1113709|P2|Overall Study|Withdrawal by Subject|23
341565|NCT00530894|1113710|P1|Overall Study|Withdrawal by Subject|1
341566|NCT00530894|1113707|P4|Overall Study|Lost to Follow-up|0
341567|NCT00530894|1113708|P3|Overall Study|Lost to Follow-up|0
341568|NCT00530894|1113709|P2|Overall Study|Lost to Follow-up|3
341569|NCT00530894|1113710|P1|Overall Study|Lost to Follow-up|1
341570|NCT00530894|1113707|P4|Overall Study|Death|89
341571|NCT00530894|1113708|P3|Overall Study|Death|55
341572|NCT00530894|1113709|P2|Overall Study|Death|89
341573|NCT00530894|1113710|P1|Overall Study|Death|84
341574|NCT00530855|1113738|P1|Overall Study|Other reason for premature termination|17
341575|NCT00530855|1113738|P1|Overall Study|Lost to Follow-up|9
341576|NCT00530855|1113738|P1|Overall Study|Unsatisfactory compliance of subject|11
341577|NCT00530855|1113738|P1|Overall Study|Protocol Violation|3
341578|NCT00530855|1113738|P1|Overall Study|Non Fatal Non Serious AE|12
341579|NCT00530855|1113738|P1|Overall Study|Non Fatal Serious AE|7
341580|NCT00530855|1113738|P1|Overall Study|Fatal Serious AE|3
341581|NCT00530855|1113738|P1|Overall Study|Withdrawal by Subject|30
341582|NCT00530855|1113738|P1|Overall Study|Lack of Efficacy|20
341583|NCT00530842|1113747|P2|Period 2|Individual different reasons|0
341584|NCT00530842|1113748|P1|Period 2|Individual different reasons|2
341585|NCT00530842|1113747|P2|Period 2|Withdrawal by Subject|2
341586|NCT00530842|1113748|P1|Period 2|Withdrawal by Subject|1
341587|NCT00530842|1113747|P2|Period 2|Protocol Violation|0
341588|NCT00530842|1113748|P1|Period 2|Protocol Violation|1
341589|NCT00530842|1113747|P2|Period 2|Lost to Follow-up|4
341590|NCT00530842|1113748|P1|Period 2|Lost to Follow-up|0
341591|NCT00530842|1113747|P2|Period 2|Lack of Efficacy|0
341592|NCT00530842|1113748|P1|Period 2|Lack of Efficacy|1
341593|NCT00530842|1113747|P2|Period 2|Adverse Event|3
341594|NCT00530842|1113748|P1|Period 2|Adverse Event|3
341595|NCT00530842|1113747|P2|Period 1|Individual different reasons|3
341596|NCT00530842|1113748|P1|Period 1|Individual different reasons|2
341597|NCT00530842|1113747|P2|Period 1|Withdrawal by Subject|3
341598|NCT00530842|1113748|P1|Period 1|Withdrawal by Subject|2
341599|NCT00530842|1113747|P2|Period 1|Protocol Violation|1
341600|NCT00530842|1113748|P1|Period 1|Protocol Violation|2
341601|NCT00530842|1113747|P2|Period 1|Lack of Efficacy|1
341602|NCT00530842|1113748|P1|Period 1|Lack of Efficacy|1
341603|NCT00530842|1113747|P2|Period 1|Adverse Event|3
341604|NCT00530842|1113748|P1|Period 1|Adverse Event|7
341605|NCT00530842|1113747|P2|Overall Study|Individual different reasons|3
341606|NCT00530842|1113748|P1|Overall Study|Individual different reasons|4
341607|NCT00530842|1113747|P2|Overall Study|Withdrawal by Subject|5
341608|NCT00530842|1113748|P1|Overall Study|Withdrawal by Subject|4
341609|NCT00530842|1113747|P2|Overall Study|Protocol Violation|2
341610|NCT00530842|1113748|P1|Overall Study|Protocol Violation|3
341611|NCT00530842|1113747|P2|Overall Study|Lost to Follow-up|4
341612|NCT00530842|1113748|P1|Overall Study|Lost to Follow-up|0
341613|NCT00530842|1113747|P2|Overall Study|Lack of Efficacy|1
341614|NCT00530842|1113748|P1|Overall Study|Lack of Efficacy|2
341615|NCT00530842|1113747|P2|Overall Study|Adverse Event|6
341616|NCT00530842|1113748|P1|Overall Study|Adverse Event|10
341617|NCT00530816|1113875|P3|Overall Study|Withdrawal by Subject|6
341618|NCT00530816|1113876|P2|Overall Study|Withdrawal by Subject|2
341619|NCT00530816|1113877|P1|Overall Study|Withdrawal by Subject|1
341620|NCT00530816|1113875|P3|Overall Study|Other|4
341621|NCT00530816|1113876|P2|Overall Study|Other|3
341622|NCT00530816|1113877|P1|Overall Study|Other|3
341623|NCT00530816|1113875|P3|Overall Study|Adverse Event|7
341624|NCT00530816|1113876|P2|Overall Study|Adverse Event|13
341625|NCT00530816|1113877|P1|Overall Study|Adverse Event|6
341626|NCT00530816|1113875|P3|Overall Study|Progressive Disease|24
341627|NCT00530816|1113876|P2|Overall Study|Progressive Disease|24
341628|NCT00530816|1113877|P1|Overall Study|Progressive Disease|16
341629|NCT00530790|1113903|P1|Overall Study|Physician Decision|1
341630|NCT00530790|1113903|P1|Overall Study|Withdrawal by Subject|2
341631|NCT00530790|1113903|P1|Overall Study|Adverse Event|2
341632|NCT00530777|1113925|P2|Overall Study|Unable to adhere to visit schedule|1
341633|NCT00530777|1113926|P1|Overall Study|Unable to adhere to visit schedule|5
341634|NCT00530777|1113925|P2|Overall Study|Withdrawal by Subject|1
341635|NCT00530777|1113926|P1|Overall Study|Withdrawal by Subject|0
341636|NCT00530777|1113925|P2|Overall Study|Physician Decision|0
341637|NCT00530777|1113926|P1|Overall Study|Physician Decision|1
341638|NCT00530777|1113925|P2|Overall Study|Death|2
341639|NCT00530777|1113926|P1|Overall Study|Death|1
341640|NCT00530777|1113925|P2|Overall Study|Lost to Follow-up|1
341641|NCT00530777|1113926|P1|Overall Study|Lost to Follow-up|0
341642|NCT00530712|1113983|P1|12 Month Follow-up Visit|Death|9
341643|NCT00530712|1113983|P1|12 Month Follow-up Visit|Lost to Follow-up|7
341644|NCT00530712|1113983|P1|12 Month Follow-up Visit|Missed Visit|3
341645|NCT00530712|1113983|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
341646|NCT00530712|1113983|P1|6 Month Follow-up Visit|Death|2
341647|NCT00530712|1113983|P1|6 Month Follow-up Visit|Lost to Follow-up|3
341648|NCT00530712|1113983|P1|6 Month Follow-up Visit|Missed Visit|3
341649|NCT00530712|1113983|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
341650|NCT00530712|1113983|P1|30 Day Follow-up Visit|Missed Visit|5
341651|NCT00530712|1113983|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
341652|NCT00530504|1114002|P1|Overall Study|Exited study due to other reasons|33
341653|NCT00530504|1114002|P1|Overall Study|Withdrawal by Subject|39
341654|NCT00530504|1114002|P1|Overall Study|Lost to Follow-up|26
341655|NCT00530504|1114002|P1|Overall Study|Death|54
341656|NCT00530439|1114008|P2|Overall Study|Severe malformation/abortion|3
341657|NCT00530439|1114009|P1|Overall Study|Severe malformation/abortion|0
341658|NCT00530439|1114008|P2|Overall Study|Twin pregnancy|2
341659|NCT00530439|1114009|P1|Overall Study|Twin pregnancy|0
341660|NCT00530439|1114008|P2|Overall Study|Misclassification|0
341661|NCT00530439|1114009|P1|Overall Study|Misclassification|2
341662|NCT00530439|1114008|P2|Overall Study|Missed abortion|4
341663|NCT00530439|1114009|P1|Overall Study|Missed abortion|1
341664|NCT00530439|1114008|P2|Overall Study|Withdraw|14
341665|NCT00530439|1114009|P1|Overall Study|Withdraw|18
341666|NCT00530439|1114008|P2|Overall Study|GDM|3
341667|NCT00530439|1114009|P1|Overall Study|GDM|9
341668|NCT00530348|1114017|P2|Overall Study|Noncompliance with inclusion criterion 3|1
341669|NCT00530348|1114018|P1|Overall Study|Noncompliance with inclusion criterion 3|0
341670|NCT00530348|1114017|P2|Overall Study|Randomised in error|0
341671|NCT00530348|1114018|P1|Overall Study|Randomised in error|1
341672|NCT00530348|1114017|P2|Overall Study|Withdrawal by Subject|12
341673|NCT00530348|1114018|P1|Overall Study|Withdrawal by Subject|12
341674|NCT00530348|1114017|P2|Overall Study|Pregnancy|0
341675|NCT00530348|1114018|P1|Overall Study|Pregnancy|1
341676|NCT00530348|1114017|P2|Overall Study|Physician Decision|2
341677|NCT00530348|1114018|P1|Overall Study|Physician Decision|1
341678|NCT00530348|1114017|P2|Overall Study|Lost to Follow-up|2
341679|NCT00530348|1114018|P1|Overall Study|Lost to Follow-up|0
341680|NCT00530348|1114017|P2|Overall Study|Lack of Efficacy|0
341681|NCT00530348|1114018|P1|Overall Study|Lack of Efficacy|2
341682|NCT00530348|1114017|P2|Overall Study|Death|1
341683|NCT00530348|1114018|P1|Overall Study|Death|0
341684|NCT00530348|1114017|P2|Overall Study|Adverse Event|1
341685|NCT00530348|1114018|P1|Overall Study|Adverse Event|5
341686|NCT00530335|1114034|P1|Overall Study|Physician Decision|1
341687|NCT00530335|1114034|P1|Overall Study|Withdrawal by Subject|1
341688|NCT00530335|1114034|P1|Overall Study|Protocol Violation|1
341689|NCT00530335|1114034|P1|Overall Study|Adverse Event|3
341690|NCT00530270|1114051|P2|Overall Study|Protocol Violation|0
341691|NCT00530270|1114052|P1|Overall Study|Protocol Violation|1
341692|NCT00530257|1114066|P1|Overall Study|Lost to Follow-up|1
341693|NCT00530088|1114094|P1|Overall Study|Other Not Specified|2
341694|NCT00530088|1114094|P1|Overall Study|Physician Decision|4
341695|NCT00530088|1114094|P1|Overall Study|Disease Progression|4
341696|NCT00530075|1114099|P1|Overall Study|Withdrawal by Subject|1
341697|NCT00530075|1114099|P1|Overall Study|Protocol Violation|1
341698|NCT00530075|1114099|P1|Overall Study|Lack of Efficacy|3
341699|NCT00530075|1114099|P1|Overall Study|Death|1
341700|NCT00530075|1114099|P1|Overall Study|Adverse Event|1
341701|NCT00530023|1114112|P2|Overall Study|Withdrawal by Subject|1
341702|NCT00530023|1114113|P1|Overall Study|Withdrawal by Subject|0
341703|NCT00529789|1114127|P1|Study Period IV|Lost to Follow-up|3
341704|NCT00529789|1114127|P1|Study Period IV|Lack of Efficacy|1
341705|NCT00529789|1114127|P1|Study Period IV|Adverse Event|1
341706|NCT00529789|1114127|P1|Study Period IV|Parent/Caregiver Decision|1
341707|NCT00529789|1114127|P1|Study Period II/III|Lost to Follow-up|3
341708|NCT00529789|1114127|P1|Study Period II/III|Physician Decision|3
341709|NCT00529789|1114127|P1|Study Period II/III|Protocol Violation|3
341710|NCT00529789|1114127|P1|Study Period II/III|Withdrawal by Subject|1
341711|NCT00529789|1114127|P1|Study Period II/III|Lack of Efficacy|2
341712|NCT00529789|1114127|P1|Study Period II/III|Adverse Event|3
341713|NCT00529789|1114127|P1|Study Period II/III|Parent/Caregiver Decision|9
341714|NCT00529763|1114152|P3|Overall Study|Patient Withdrew Consent|2
341715|NCT00529763|1114153|P2|Overall Study|Patient Withdrew Consent|3
341716|NCT00529763|1114154|P1|Overall Study|Patient Withdrew Consent|2
341717|NCT00529763|1114152|P3|Overall Study|Study Drug Toxicity|1
341718|NCT00529763|1114153|P2|Overall Study|Study Drug Toxicity|6
341719|NCT00529763|1114154|P1|Overall Study|Study Drug Toxicity|1
341720|NCT00529763|1114152|P3|Overall Study|Stem Cell Transplant|0
341721|NCT00529763|1114153|P2|Overall Study|Stem Cell Transplant|3
341722|NCT00529763|1114154|P1|Overall Study|Stem Cell Transplant|0
341723|NCT00529763|1114152|P3|Overall Study|Lost to Follow-up|1
341724|NCT00529763|1114153|P2|Overall Study|Lost to Follow-up|1
341725|NCT00529763|1114154|P1|Overall Study|Lost to Follow-up|0
341726|NCT00529763|1114152|P3|Overall Study|Disease Progression|1
341727|NCT00529763|1114153|P2|Overall Study|Disease Progression|16
341728|NCT00529763|1114154|P1|Overall Study|Disease Progression|6
341729|NCT00529763|1114152|P3|Overall Study|Death|1
341730|NCT00529763|1114153|P2|Overall Study|Death|1
341731|NCT00529763|1114154|P1|Overall Study|Death|0
341732|NCT00529763|1114152|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
341733|NCT00529763|1114153|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
341734|NCT00529763|1114154|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
341735|NCT00529659|1114192|P2|Overall Study|Withdrawal by Subject|6
341736|NCT00529659|1114193|P1|Overall Study|Withdrawal by Subject|1
341737|NCT00529659|1114192|P2|Overall Study|Protocol Violation|6
341738|NCT00529659|1114193|P1|Overall Study|Protocol Violation|2
341739|NCT00529659|1114192|P2|Overall Study|Physician Decision|2
341740|NCT00529659|1114193|P1|Overall Study|Physician Decision|0
341741|NCT00529659|1114192|P2|Overall Study|Lost to Follow-up|2
341742|NCT00529659|1114193|P1|Overall Study|Lost to Follow-up|0
341743|NCT00529659|1114192|P2|Overall Study|Adverse Event|7
341744|NCT00529659|1114193|P1|Overall Study|Adverse Event|8
341745|NCT00529633|1114211|P2|Overall Study|Withdrawal by Subject|1
341746|NCT00529633|1114212|P1|Overall Study|Withdrawal by Subject|1
341747|NCT00529568|1114224|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
341748|NCT00529568|1114225|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
341749|NCT00529568|1114226|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
341750|NCT00529568|1114224|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
341751|NCT00529568|1114225|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
341752|NCT00529568|1114226|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
341753|NCT00529568|1114224|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
341754|NCT00529568|1114225|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
341755|NCT00529568|1114226|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
341756|NCT00529568|1114224|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
341757|NCT00529568|1114225|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
341758|NCT00529568|1114226|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
341759|NCT00529568|1114224|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
341760|NCT00529568|1114225|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
341761|NCT00529568|1114226|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
341762|NCT00529568|1114224|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
341763|NCT00529568|1114225|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
341764|NCT00529568|1114226|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
341765|NCT00529568|1114224|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
341766|NCT00529568|1114225|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
341767|NCT00529568|1114226|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
341768|NCT00529568|1114224|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
341769|NCT00529568|1114225|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
341770|NCT00529568|1114226|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
341771|NCT00529568|1114224|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
341772|NCT00529568|1114225|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
341773|NCT00529568|1114226|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
341774|NCT00529568|1114224|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
341775|NCT00529568|1114225|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
341776|NCT00529568|1114226|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
341777|NCT00529568|1114224|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
341778|NCT00529568|1114225|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
341779|NCT00529568|1114226|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
341780|NCT00529542|1114289|P2|Overall Study|Lost to Follow-up|1
341781|NCT00529542|1114290|P1|Overall Study|Lost to Follow-up|0
341782|NCT00529542|1114289|P2|Overall Study|Withdrawal by Subject|0
341783|NCT00529542|1114290|P1|Overall Study|Withdrawal by Subject|1
341784|NCT00529529|1114333|P3|Overall Study|Administrative problems|3
341785|NCT00529529|1114334|P2|Overall Study|Administrative problems|0
341786|NCT00529529|1114335|P1|Overall Study|Administrative problems|1
341787|NCT00529529|1114333|P3|Overall Study|Abnormal test procedure result(s)|0
341788|NCT00529529|1114334|P2|Overall Study|Abnormal test procedure result(s)|0
341789|NCT00529529|1114335|P1|Overall Study|Abnormal test procedure result(s)|1
341790|NCT00529529|1114333|P3|Overall Study|Death|0
341791|NCT00529529|1114334|P2|Overall Study|Death|0
341792|NCT00529529|1114335|P1|Overall Study|Death|2
341793|NCT00529529|1114333|P3|Overall Study|Unsatisfactory therapeutic effect|2
341794|NCT00529529|1114334|P2|Overall Study|Unsatisfactory therapeutic effect|2
341795|NCT00529529|1114335|P1|Overall Study|Unsatisfactory therapeutic effect|2
341796|NCT00529529|1114333|P3|Overall Study|Lost to Follow-up|1
341797|NCT00529529|1114334|P2|Overall Study|Lost to Follow-up|3
341798|NCT00529529|1114335|P1|Overall Study|Lost to Follow-up|5
341799|NCT00529529|1114333|P3|Overall Study|Protocol deviation|5
341800|NCT00529529|1114334|P2|Overall Study|Protocol deviation|12
341801|NCT00529529|1114335|P1|Overall Study|Protocol deviation|8
341802|NCT00529529|1114333|P3|Overall Study|Subject withdrew consent|12
341803|NCT00529529|1114334|P2|Overall Study|Subject withdrew consent|9
341804|NCT00529529|1114335|P1|Overall Study|Subject withdrew consent|12
341805|NCT00529529|1114333|P3|Overall Study|Adverse Event|8
341806|NCT00529529|1114334|P2|Overall Study|Adverse Event|17
341807|NCT00529529|1114335|P1|Overall Study|Adverse Event|12
341808|NCT00529516|1114394|P3|Overall Study|Lost to Follow-up|1
341809|NCT00529516|1114395|P2|Overall Study|Lost to Follow-up|0
341810|NCT00529516|1114396|P1|Overall Study|Lost to Follow-up|0
341811|NCT00529516|1114394|P3|Overall Study|Withdrawal by Subject|0
341812|NCT00529516|1114395|P2|Overall Study|Withdrawal by Subject|1
341813|NCT00529516|1114396|P1|Overall Study|Withdrawal by Subject|1
341814|NCT00529516|1114394|P3|Overall Study|Adverse Event|0
341815|NCT00529516|1114395|P2|Overall Study|Adverse Event|1
341816|NCT00529516|1114396|P1|Overall Study|Adverse Event|2
341817|NCT00529451|1114481|P4|Overall Study|Administrative problems|2
341818|NCT00529451|1114482|P3|Overall Study|Administrative problems|0
341819|NCT00529451|1114483|P2|Overall Study|Administrative problems|1
341820|NCT00529451|1114484|P1|Overall Study|Administrative problems|1
341821|NCT00529451|1114481|P4|Overall Study|Protocol deviation|1
341822|NCT00529451|1114482|P3|Overall Study|Protocol deviation|4
341823|NCT00529451|1114483|P2|Overall Study|Protocol deviation|1
341824|NCT00529451|1114484|P1|Overall Study|Protocol deviation|1
341825|NCT00529451|1114481|P4|Overall Study|Lost to Follow-up|4
341826|NCT00529451|1114482|P3|Overall Study|Lost to Follow-up|4
341827|NCT00529451|1114483|P2|Overall Study|Lost to Follow-up|7
341828|NCT00529451|1114484|P1|Overall Study|Lost to Follow-up|4
341829|NCT00529451|1114481|P4|Overall Study|Unsatisfactory therapeutic response|4
341830|NCT00529451|1114482|P3|Overall Study|Unsatisfactory therapeutic response|5
341831|NCT00529451|1114483|P2|Overall Study|Unsatisfactory therapeutic response|2
341832|NCT00529451|1114484|P1|Overall Study|Unsatisfactory therapeutic response|6
341833|NCT00529451|1114481|P4|Overall Study|Adverse Event|8
341834|NCT00529451|1114482|P3|Overall Study|Adverse Event|14
341835|NCT00529451|1114483|P2|Overall Study|Adverse Event|16
341836|NCT00529451|1114484|P1|Overall Study|Adverse Event|9
341837|NCT00529451|1114481|P4|Overall Study|Subject withdrew consent|12
341838|NCT00529451|1114482|P3|Overall Study|Subject withdrew consent|13
341839|NCT00529451|1114483|P2|Overall Study|Subject withdrew consent|21
341840|NCT00529451|1114484|P1|Overall Study|Subject withdrew consent|16
341841|NCT00529399|1114511|P3|Overall Study|Non-compliant|0
341842|NCT00529399|1114512|P2|Overall Study|Non-compliant|1
341843|NCT00529399|1114513|P1|Overall Study|Non-compliant|0
341844|NCT00529399|1114511|P3|Overall Study|Withdrawal by Subject|1
341845|NCT00529399|1114512|P2|Overall Study|Withdrawal by Subject|0
341846|NCT00529399|1114513|P1|Overall Study|Withdrawal by Subject|1
341847|NCT00529399|1114511|P3|Overall Study|Lost to Follow-up|1
341848|NCT00529399|1114512|P2|Overall Study|Lost to Follow-up|0
341849|NCT00529399|1114513|P1|Overall Study|Lost to Follow-up|1
341850|NCT00529308|1114523|P2|Overall Study|Withdrawal by Subject|1
341851|NCT00529308|1114524|P1|Overall Study|Withdrawal by Subject|1
341852|NCT00529243|1114553|P1|Overall Study|Relocated|1
341853|NCT00529243|1114553|P1|Overall Study|Death|1
341854|NCT00529243|1114553|P1|Overall Study|Adverse Event|1
341855|NCT00529217|1114558|P1|Overall Study|Unable to adhere to study schedule|2
341856|NCT00529217|1114558|P1|Overall Study|Lack of Efficacy|2
341857|NCT00529152|1114594|P1|Overall Study|Lost to Follow-up|1
341858|NCT00529152|1114594|P1|Overall Study|Withdrawal by Subject|2
341859|NCT00529152|1114594|P1|Overall Study|Adverse Event|2
341860|NCT00529100|1114618|P2|Overall Study|Participant Ineligibility|1
341861|NCT00529100|1114619|P1|Overall Study|Participant Ineligibility|0
341862|NCT00529100|1114618|P2|Overall Study|Withdrawal by Subject|1
341863|NCT00529100|1114619|P1|Overall Study|Withdrawal by Subject|0
341864|NCT00529100|1114618|P2|Overall Study|Progressive Disease|1
341865|NCT00529100|1114619|P1|Overall Study|Progressive Disease|0
341866|NCT00529100|1114618|P2|Overall Study|Protocol Violation|1
341867|NCT00529100|1114619|P1|Overall Study|Protocol Violation|0
341868|NCT00529100|1114618|P2|Overall Study|Adverse Event|5
341869|NCT00529100|1114619|P1|Overall Study|Adverse Event|0
341870|NCT00529087|1114636|P3|Overall Study|Protocol deviation|2
341871|NCT00529087|1114637|P2|Overall Study|Protocol deviation|1
341872|NCT00529087|1114638|P1|Overall Study|Protocol deviation|1
341873|NCT00529087|1114636|P3|Overall Study|Withdrawal by Subject|3
341874|NCT00529087|1114637|P2|Overall Study|Withdrawal by Subject|3
341875|NCT00529087|1114638|P1|Overall Study|Withdrawal by Subject|3
341876|NCT00529087|1114636|P3|Overall Study|Protocol Violation|6
341877|NCT00529087|1114637|P2|Overall Study|Protocol Violation|7
341878|NCT00529087|1114638|P1|Overall Study|Protocol Violation|8
341879|NCT00529087|1114636|P3|Overall Study|Lost to Follow-up|1
341880|NCT00529087|1114637|P2|Overall Study|Lost to Follow-up|4
341881|NCT00529087|1114638|P1|Overall Study|Lost to Follow-up|6
341882|NCT00529087|1114636|P3|Overall Study|Adverse Event|4
341883|NCT00529087|1114637|P2|Overall Study|Adverse Event|13
341884|NCT00529087|1114638|P1|Overall Study|Adverse Event|10
341885|NCT00529035|1114702|P1|Overall Study|Withdrawal by Subject|1
341886|NCT00528957|1114715|P2|Second Extension (Week 144 to Week 240)|Poor adherence|0
341887|NCT00528957|1114716|P1|Second Extension (Week 144 to Week 240)|Poor adherence|1
341888|NCT00528957|1114715|P2|Second Extension (Week 144 to Week 240)|Lack of Efficacy|0
341889|NCT00528957|1114716|P1|Second Extension (Week 144 to Week 240)|Lack of Efficacy|1
341890|NCT00528957|1114715|P2|Second Extension (Week 144 to Week 240)|Adverse Event|2
341891|NCT00528957|1114716|P1|Second Extension (Week 144 to Week 240)|Adverse Event|2
341892|NCT00528957|1114715|P2|Second Extension (Week 144 to Week 240)|Physician Decision|0
341893|NCT00528957|1114716|P1|Second Extension (Week 144 to Week 240)|Physician Decision|2
341894|NCT00528957|1114715|P2|Second Extension (Week 144 to Week 240)|Study Ongoing|38
341895|NCT00528957|1114716|P1|Second Extension (Week 144 to Week 240)|Study Ongoing|28
341896|NCT00528957|1114715|P2|First Extension (Week 48 to Week 144)|Adverse Event|0
341897|NCT00528957|1114716|P1|First Extension (Week 48 to Week 144)|Adverse Event|1
341898|NCT00528957|1114715|P2|First Extension (Week 48 to Week 144)|Withdrawal by Subject|1
341899|NCT00528957|1114716|P1|First Extension (Week 48 to Week 144)|Withdrawal by Subject|0
341900|NCT00528957|1114715|P2|First Extension (Week 48 to Week 144)|Physician Decision|0
341901|NCT00528957|1114716|P1|First Extension (Week 48 to Week 144)|Physician Decision|2
341902|NCT00528957|1114715|P2|Randomized Phase (Baseline to Week 48)|Intolerability to oral powder|0
341903|NCT00528957|1114716|P1|Randomized Phase (Baseline to Week 48)|Intolerability to oral powder|1
341904|NCT00528957|1114715|P2|Randomized Phase (Baseline to Week 48)|Lack of Efficacy|0
341905|NCT00528957|1114716|P1|Randomized Phase (Baseline to Week 48)|Lack of Efficacy|1
341906|NCT00528957|1114715|P2|Randomized Phase (Baseline to Week 48)|Withdrawal by Subject|1
341907|NCT00528957|1114716|P1|Randomized Phase (Baseline to Week 48)|Withdrawal by Subject|2
341908|NCT00528931|1114759|P1|Overall Study|Lost to Follow-up|1
341909|NCT00528879|1114771|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
341910|NCT00528879|1114772|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
341911|NCT00528879|1114773|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
341912|NCT00528879|1114774|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
341913|NCT00528879|1114771|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
341914|NCT00528879|1114772|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
341915|NCT00528879|1114773|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
341916|NCT00528879|1114774|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
341917|NCT00528879|1114771|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
341918|NCT00528879|1114772|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
341919|NCT00528879|1114773|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
341920|NCT00528879|1114774|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
341921|NCT00528879|1114771|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
341922|NCT00528879|1114772|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
341923|NCT00528879|1114773|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
341924|NCT00528879|1114774|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
341925|NCT00528879|1114771|P4|Long-term Period (Weeks 24 to 102)|Death|0
341926|NCT00528879|1114772|P3|Long-term Period (Weeks 24 to 102)|Death|0
341927|NCT00528879|1114773|P2|Long-term Period (Weeks 24 to 102)|Death|1
341928|NCT00528879|1114774|P1|Long-term Period (Weeks 24 to 102)|Death|0
341929|NCT00528879|1114771|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
341930|NCT00528879|1114772|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
341931|NCT00528879|1114773|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
341932|NCT00528879|1114774|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
341933|NCT00528879|1114771|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
341934|NCT00528879|1114772|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
341935|NCT00528879|1114773|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
341936|NCT00528879|1114774|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
341937|NCT00528879|1114771|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
341938|NCT00528879|1114772|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
341939|NCT00528879|1114773|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
341940|NCT00528879|1114774|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
341941|NCT00528879|1114771|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
341942|NCT00528879|1114772|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
341943|NCT00528879|1114773|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
341944|NCT00528879|1114774|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
341945|NCT00528879|1114771|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
341946|NCT00528879|1114772|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
341947|NCT00528879|1114773|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
341948|NCT00528879|1114774|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
341949|NCT00528879|1114771|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
341950|NCT00528879|1114772|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
341951|NCT00528879|1114773|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
341952|NCT00528879|1114774|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
341953|NCT00528879|1114771|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
341954|NCT00528879|1114772|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
341955|NCT00528879|1114773|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
341956|NCT00528879|1114774|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
341957|NCT00528879|1114771|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
341958|NCT00528879|1114772|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
341959|NCT00528879|1114773|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
341960|NCT00528879|1114774|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
341961|NCT00528879|1114771|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
341962|NCT00528879|1114772|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
341963|NCT00528879|1114773|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
341964|NCT00528879|1114774|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
341965|NCT00528879|1114771|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
341966|NCT00528879|1114772|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
341967|NCT00528879|1114773|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
341968|NCT00528879|1114774|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
341969|NCT00528879|1114771|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
341970|NCT00528879|1114772|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
341971|NCT00528879|1114773|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
341972|NCT00528879|1114774|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
341973|NCT00528866|1114840|P1|Overall Study|Protocol Violation|6
341974|NCT00528840|1114852|P1|Overall Study|Not Specified|2
341975|NCT00528840|1114852|P1|Overall Study|Administrative Reasons|1
341976|NCT00528840|1114852|P1|Overall Study|Death|2
341977|NCT00528840|1114852|P1|Overall Study|Withdrawal by Subject|17
341978|NCT00528840|1114852|P1|Overall Study|Adverse Event|1
341979|NCT00528840|1114852|P1|Overall Study|Lost to Follow-up|10
341980|NCT00528801|1114858|P2|Overall Study|Administrative Reasons|1
341981|NCT00528801|1114859|P1|Overall Study|Administrative Reasons|0
341982|NCT00528801|1114858|P2|Overall Study|Lost to Follow-up|4
341983|NCT00528801|1114859|P1|Overall Study|Lost to Follow-up|15
341984|NCT00528801|1114858|P2|Overall Study|Protocol Violation|5
341985|NCT00528801|1114859|P1|Overall Study|Protocol Violation|11
341986|NCT00528801|1114858|P2|Overall Study|Withdrawal by Subject|1
341987|NCT00528801|1114859|P1|Overall Study|Withdrawal by Subject|1
341988|NCT00528775|1114873|P1|Overall Study|Other not specified|1
341989|NCT00528645|1114881|P1|Overall Study|Adverse Event|3
341990|NCT00528606|1114887|P2|Overall Study|Not specified|0
341991|NCT00528606|1114888|P1|Overall Study|Not specified|2
341992|NCT00528606|1114887|P2|Overall Study|Adverse Event|0
341993|NCT00528606|1114888|P1|Overall Study|Adverse Event|3
341994|NCT00528606|1114887|P2|Overall Study|Lost to Follow-up|1
341995|NCT00528606|1114888|P1|Overall Study|Lost to Follow-up|4
341996|NCT00528606|1114887|P2|Overall Study|Withdrew consent|3
341997|NCT00528606|1114888|P1|Overall Study|Withdrew consent|4
341998|NCT00528567|1114896|P2|Overall Study|Administrative/Other|75
341999|NCT00528567|1114897|P1|Overall Study|Administrative/Other|22
342000|NCT00528567|1114896|P2|Overall Study|Other Protocol Violation|21
342001|NCT00528567|1114897|P1|Overall Study|Other Protocol Violation|5
342002|NCT00528567|1114896|P2|Overall Study|Failure to Return|4
342003|NCT00528567|1114897|P1|Overall Study|Failure to Return|1
342004|NCT00528567|1114896|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
342005|NCT00528567|1114897|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
342006|NCT00528567|1114896|P2|Overall Study|Withdrew Consent|55
342007|NCT00528567|1114897|P1|Overall Study|Withdrew Consent|59
342008|NCT00528567|1114896|P2|Overall Study|Violation Criteria at Entry|17
342009|NCT00528567|1114897|P1|Overall Study|Violation Criteria at Entry|3
342010|NCT00528567|1114896|P2|Overall Study|Adverse Event/Intermittent Illness|29
342011|NCT00528567|1114897|P1|Overall Study|Adverse Event/Intermittent Illness|255
342012|NCT00528567|1114896|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
342013|NCT00528567|1114897|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
342014|NCT00528567|1114896|P2|Overall Study|Death|5
342015|NCT00528567|1114897|P1|Overall Study|Death|4
342016|NCT00528528|1114964|P4|Overall Study|Ongoing participant|0
342017|NCT00528528|1114965|P3|Overall Study|Ongoing participant|1
342018|NCT00528528|1114966|P2|Overall Study|Ongoing participant|0
342019|NCT00528528|1114967|P1|Overall Study|Ongoing participant|0
342020|NCT00528528|1114964|P4|Overall Study|Withdrawal by Subject|1
342021|NCT00528528|1114965|P3|Overall Study|Withdrawal by Subject|1
342022|NCT00528528|1114966|P2|Overall Study|Withdrawal by Subject|2
342023|NCT00528528|1114967|P1|Overall Study|Withdrawal by Subject|3
342024|NCT00528528|1114964|P4|Overall Study|Unspecified|0
342025|NCT00528528|1114965|P3|Overall Study|Unspecified|0
342026|NCT00528528|1114966|P2|Overall Study|Unspecified|1
342027|NCT00528528|1114967|P1|Overall Study|Unspecified|0
342028|NCT00528528|1114964|P4|Overall Study|Ineligible to continue the trial|1
342029|NCT00528528|1114965|P3|Overall Study|Ineligible to continue the trial|0
342030|NCT00528528|1114966|P2|Overall Study|Ineligible to continue the trial|0
342031|NCT00528528|1114967|P1|Overall Study|Ineligible to continue the trial|0
342032|NCT00528528|1114964|P4|Overall Study|Lost to Follow-up|1
342033|NCT00528528|1114965|P3|Overall Study|Lost to Follow-up|1
342034|NCT00528528|1114966|P2|Overall Study|Lost to Follow-up|0
342035|NCT00528528|1114967|P1|Overall Study|Lost to Follow-up|0
342036|NCT00528424|1115005|P1|Overall Study|Not specified|12
342037|NCT00528424|1115005|P1|Overall Study|Administrative reason|2
342038|NCT00528424|1115005|P1|Overall Study|Withdrew consent|2
342039|NCT00528424|1115005|P1|Overall Study|Lost to Follow-up|13
342040|NCT00528411|1115012|P3|Overall Study|Prior commitment medication|0
342041|NCT00528411|1115013|P2|Overall Study|Prior commitment medication|1
342042|NCT00528411|1115014|P1|Overall Study|Prior commitment medication|0
342043|NCT00528411|1115012|P3|Overall Study|Severe non-compliance to protocol|0
342044|NCT00528411|1115013|P2|Overall Study|Severe non-compliance to protocol|1
342045|NCT00528411|1115014|P1|Overall Study|Severe non-compliance to protocol|0
342046|NCT00528411|1115012|P3|Overall Study|Incorrect Enrolment|0
342047|NCT00528411|1115013|P2|Overall Study|Incorrect Enrolment|1
342048|NCT00528411|1115014|P1|Overall Study|Incorrect Enrolment|1
342049|NCT00528411|1115012|P3|Overall Study|Adverse Event|1
342050|NCT00528411|1115013|P2|Overall Study|Adverse Event|0
342051|NCT00528411|1115014|P1|Overall Study|Adverse Event|4
342052|NCT00528372|1115151|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
342053|NCT00528372|1115152|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
342054|NCT00528372|1115153|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
342055|NCT00528372|1115154|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
342056|NCT00528372|1115155|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
342057|NCT00528372|1115156|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
342058|NCT00528372|1115157|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
342059|NCT00528372|1115158|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
342060|NCT00528372|1115159|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
342061|NCT00528372|1115151|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
342062|NCT00528372|1115152|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
342063|NCT00528372|1115153|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
342064|NCT00528372|1115154|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
342065|NCT00528372|1115155|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
342066|NCT00528372|1115156|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
342067|NCT00528372|1115157|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
342068|NCT00528372|1115158|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
342069|NCT00528372|1115159|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
342070|NCT00528372|1115151|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
342071|NCT00528372|1115152|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
342072|NCT00528372|1115153|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
342073|NCT00528372|1115154|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
342074|NCT00528372|1115155|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
342075|NCT00528372|1115156|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
342076|NCT00528372|1115157|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
342077|NCT00528372|1115158|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
342078|NCT00528372|1115159|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
342079|NCT00528372|1115151|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
342080|NCT00528372|1115152|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
342081|NCT00528372|1115153|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
342082|NCT00528372|1115154|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
342083|NCT00528372|1115155|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
342084|NCT00528372|1115156|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
342085|NCT00528372|1115157|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
342086|NCT00528372|1115158|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
342087|NCT00528372|1115159|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
342088|NCT00528372|1115151|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
342089|NCT00528372|1115152|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
342090|NCT00528372|1115153|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
342091|NCT00528372|1115154|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
342092|NCT00528372|1115155|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
342093|NCT00528372|1115156|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
342094|NCT00528372|1115157|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
342095|NCT00528372|1115158|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
342096|NCT00528372|1115159|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
342097|NCT00528372|1115151|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
342098|NCT00528372|1115152|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
342099|NCT00528372|1115153|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
342100|NCT00528372|1115154|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
342101|NCT00528372|1115155|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
342102|NCT00528372|1115156|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
342103|NCT00528372|1115157|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
342104|NCT00528372|1115158|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
342105|NCT00528372|1115159|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
342106|NCT00528372|1115151|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
342107|NCT00528372|1115152|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
342108|NCT00528372|1115153|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
342109|NCT00528372|1115154|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
342110|NCT00528372|1115155|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
342111|NCT00528372|1115156|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
342112|NCT00528372|1115157|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
342113|NCT00528372|1115158|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
342114|NCT00528372|1115159|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
342115|NCT00528372|1115151|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
342116|NCT00528372|1115152|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
342117|NCT00528372|1115153|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
342118|NCT00528372|1115154|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
342119|NCT00528372|1115155|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
342120|NCT00528372|1115156|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
342121|NCT00528372|1115157|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
342122|NCT00528372|1115158|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
342123|NCT00528372|1115159|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
342124|NCT00528372|1115151|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
342125|NCT00528372|1115152|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
342126|NCT00528372|1115153|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
342127|NCT00528372|1115154|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
342128|NCT00528372|1115155|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
342129|NCT00528372|1115156|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
342130|NCT00528372|1115157|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
342131|NCT00528372|1115158|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
342132|NCT00528372|1115159|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
342133|NCT00528372|1115151|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
342134|NCT00528372|1115152|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
342135|NCT00528372|1115153|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
342136|NCT00528372|1115154|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
342137|NCT00528372|1115155|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
342138|NCT00528372|1115156|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
342139|NCT00528372|1115157|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
342140|NCT00528372|1115158|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
342141|NCT00528372|1115159|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
342142|NCT00528372|1115151|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
342143|NCT00528372|1115152|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
342144|NCT00528372|1115153|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
342145|NCT00528372|1115154|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
342146|NCT00528372|1115155|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
342147|NCT00528372|1115156|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
342148|NCT00528372|1115157|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
342149|NCT00528372|1115158|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
342150|NCT00528372|1115159|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
342151|NCT00528372|1115151|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
342152|NCT00528372|1115152|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
342153|NCT00528372|1115153|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
342154|NCT00528372|1115154|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
342155|NCT00528372|1115155|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
342156|NCT00528372|1115156|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
342157|NCT00528372|1115157|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
342158|NCT00528372|1115158|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
342159|NCT00528372|1115159|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
342160|NCT00528372|1115151|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
342161|NCT00528372|1115152|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
342162|NCT00528372|1115153|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
342163|NCT00528372|1115154|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
342164|NCT00528372|1115155|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
342165|NCT00528372|1115156|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
342166|NCT00528372|1115157|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
342167|NCT00528372|1115158|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
342168|NCT00528372|1115159|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
342169|NCT00528372|1115151|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
342170|NCT00528372|1115152|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
342171|NCT00528372|1115153|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
342172|NCT00528372|1115154|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
342173|NCT00528372|1115155|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
342174|NCT00528372|1115156|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
342175|NCT00528372|1115157|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
342176|NCT00528372|1115158|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
342177|NCT00528372|1115159|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
342178|NCT00528372|1115151|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
342179|NCT00528372|1115152|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
342180|NCT00528372|1115153|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
342181|NCT00528372|1115154|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
342182|NCT00528372|1115155|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
342183|NCT00528372|1115156|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
342184|NCT00528372|1115157|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
342185|NCT00528372|1115158|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
342186|NCT00528372|1115159|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
342187|NCT00527111|1115291|P2|Overall Study|Other|2
342188|NCT00527111|1115292|P1|Overall Study|Other|2
342189|NCT00527111|1115291|P2|Overall Study|Patient Request|5
342190|NCT00527111|1115292|P1|Overall Study|Patient Request|2
342191|NCT00527111|1115291|P2|Overall Study|Investigator Request|1
342192|NCT00527111|1115292|P1|Overall Study|Investigator Request|2
342193|NCT00527111|1115291|P2|Overall Study|Death|1
342194|NCT00527111|1115292|P1|Overall Study|Death|0
342195|NCT00527111|1115291|P2|Overall Study|Adverse Event|13
342196|NCT00527111|1115292|P1|Overall Study|Adverse Event|14
342197|NCT00527072|1115314|P1|Overall Study|Withdrawal by Subject|7
342198|NCT00527072|1115314|P1|Overall Study|Protocol Violation|2
342199|NCT00527072|1115314|P1|Overall Study|Lost to Follow-up|3
342200|NCT00527072|1115314|P1|Overall Study|Lack of Efficacy|11
342201|NCT00527072|1115314|P1|Overall Study|Adverse Event|13
342202|NCT00526994|1115323|P3|Overall Study|incarcerated, impaired, incomplete|3
342203|NCT00526994|1115324|P2|Overall Study|incarcerated, impaired, incomplete|3
342204|NCT00526994|1115325|P1|Overall Study|incarcerated, impaired, incomplete|4
342205|NCT00526994|1115323|P3|Overall Study|Withdrawal by Subject|5
342206|NCT00526994|1115324|P2|Overall Study|Withdrawal by Subject|7
342207|NCT00526994|1115325|P1|Overall Study|Withdrawal by Subject|2
342208|NCT00526994|1115323|P3|Overall Study|Death|3
342209|NCT00526994|1115324|P2|Overall Study|Death|3
342210|NCT00526994|1115325|P1|Overall Study|Death|4
342211|NCT00526994|1115323|P3|Overall Study|Lost to Follow-up|96
342212|NCT00526994|1115324|P2|Overall Study|Lost to Follow-up|108
342213|NCT00526994|1115325|P1|Overall Study|Lost to Follow-up|98
342214|NCT00528112|1115353|P2|Extension Phase|Protocol Violation|2
342215|NCT00528112|1115354|P1|Extension Phase|Protocol Violation|0
342216|NCT00528112|1115353|P2|Extension Phase|Adverse Event|36
342217|NCT00528112|1115354|P1|Extension Phase|Adverse Event|0
342218|NCT00528112|1115353|P2|Extension Phase|Death|1
342219|NCT00528112|1115354|P1|Extension Phase|Death|0
342220|NCT00528112|1115353|P2|Extension Phase|Lost to Follow-up|12
342221|NCT00528112|1115354|P1|Extension Phase|Lost to Follow-up|0
342222|NCT00528112|1115353|P2|Extension Phase|Pregnancy|3
342223|NCT00528112|1115354|P1|Extension Phase|Pregnancy|0
342224|NCT00528112|1115353|P2|Extension Phase|Other reasons|100
342225|NCT00528112|1115354|P1|Extension Phase|Other reasons|0
342226|NCT00528112|1115353|P2|Extension Phase|Withdrawal by Subject|3
342227|NCT00528112|1115354|P1|Extension Phase|Withdrawal by Subject|0
342228|NCT00528112|1115353|P2|Treatment up to 3 Years|Other reasons|186
342229|NCT00528112|1115354|P1|Treatment up to 3 Years|Other reasons|186
342230|NCT00528112|1115353|P2|Treatment up to 3 Years|Pregnancy|10
342231|NCT00528112|1115354|P1|Treatment up to 3 Years|Pregnancy|9
342232|NCT00528112|1115353|P2|Treatment up to 3 Years|Lost to Follow-up|61
342233|NCT00528112|1115354|P1|Treatment up to 3 Years|Lost to Follow-up|63
342234|NCT00528112|1115353|P2|Treatment up to 3 Years|Death|1
342235|NCT00528112|1115354|P1|Treatment up to 3 Years|Death|0
342236|NCT00528112|1115353|P2|Treatment up to 3 Years|Protocol Violation|16
342237|NCT00528112|1115354|P1|Treatment up to 3 Years|Protocol Violation|16
342238|NCT00528112|1115353|P2|Treatment up to 3 Years|Withdrawal by Subject|31
342239|NCT00528112|1115354|P1|Treatment up to 3 Years|Withdrawal by Subject|26
342240|NCT00528112|1115353|P2|Treatment up to 3 Years|Adverse Event|278
342241|NCT00528112|1115354|P1|Treatment up to 3 Years|Adverse Event|313
342242|NCT00528021|1115412|P4|Overall Study|Lack of Efficacy|9
342243|NCT00528021|1115413|P3|Overall Study|Lack of Efficacy|7
342244|NCT00528021|1115414|P2|Overall Study|Lack of Efficacy|13
342245|NCT00528021|1115415|P1|Overall Study|Lack of Efficacy|17
342246|NCT00527982|1115427|P2|Overall Study|Physician Decision|0
342247|NCT00527982|1115428|P1|Overall Study|Physician Decision|1
342248|NCT00527904|1115469|P1|Overall Study|misc|22
342249|NCT00527904|1115469|P1|Overall Study|Lost to Follow-up|8
342250|NCT00527904|1115469|P1|Overall Study|Withdrawal by Subject|21
342251|NCT00527904|1115469|P1|Overall Study|Adverse Event|45
342252|NCT00527826|1115488|P2|Overall Study|Participant moved away|1
342253|NCT00527826|1115489|P1|Overall Study|Participant moved away|0
342254|NCT00527826|1115488|P2|Overall Study|Additional Intake of Viani forte|1
342255|NCT00527826|1115489|P1|Overall Study|Additional Intake of Viani forte|0
342256|NCT00527826|1115488|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
342257|NCT00527826|1115489|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
342258|NCT00527826|1115488|P2|Overall Study|Inclusion Criteria Not Met|3
342259|NCT00527826|1115489|P1|Overall Study|Inclusion Criteria Not Met|3
342260|NCT00527826|1115488|P2|Overall Study|Withdrawal by Subject|8
342261|NCT00527826|1115489|P1|Overall Study|Withdrawal by Subject|5
342262|NCT00527826|1115488|P2|Overall Study|Lost to Follow-up|2
342263|NCT00527826|1115489|P1|Overall Study|Lost to Follow-up|3
342264|NCT00527826|1115488|P2|Overall Study|Adverse Event|10
342265|NCT00527826|1115489|P1|Overall Study|Adverse Event|10
342266|NCT00527787|1115538|P2|Overall Study|misc|2
342267|NCT00527787|1115539|P1|Overall Study|misc|5
342268|NCT00527787|1115538|P2|Overall Study|Duodenal Ulcer|10
342269|NCT00527787|1115539|P1|Overall Study|Duodenal Ulcer|1
342270|NCT00527787|1115538|P2|Overall Study|Lost to Follow-up|2
342271|NCT00527787|1115539|P1|Overall Study|Lost to Follow-up|5
342272|NCT00527787|1115538|P2|Overall Study|Withdrawal by Subject|25
342273|NCT00527787|1115539|P1|Overall Study|Withdrawal by Subject|13
342274|NCT00527787|1115538|P2|Overall Study|Adverse Event|24
342275|NCT00527787|1115539|P1|Overall Study|Adverse Event|14
342276|NCT00527748|1115561|P1|Overall Study|Other|3
342277|NCT00527735|1115568|P3|Overall Study|Completed treatment during maintenance|1
342278|NCT00527735|1115569|P2|Overall Study|Completed treatment during maintenance|2
342279|NCT00527735|1115570|P1|Overall Study|Completed treatment during maintenance|2
342280|NCT00527735|1115568|P3|Overall Study|Poor compliance or noncompliance|1
342281|NCT00527735|1115569|P2|Overall Study|Poor compliance or noncompliance|1
342282|NCT00527735|1115570|P1|Overall Study|Poor compliance or noncompliance|0
342283|NCT00527735|1115568|P3|Overall Study|Lost to Follow-up|3
342284|NCT00527735|1115569|P2|Overall Study|Lost to Follow-up|0
342285|NCT00527735|1115570|P1|Overall Study|Lost to Follow-up|0
342286|NCT00527735|1115568|P3|Overall Study|No longer met study criteria|1
342287|NCT00527735|1115569|P2|Overall Study|No longer met study criteria|2
342288|NCT00527735|1115570|P1|Overall Study|No longer met study criteria|2
342289|NCT00527735|1115568|P3|Overall Study|Withdrawal by Subject|3
342290|NCT00527735|1115569|P2|Overall Study|Withdrawal by Subject|4
342291|NCT00527735|1115570|P1|Overall Study|Withdrawal by Subject|5
342292|NCT00527735|1115568|P3|Overall Study|Not identified|5
342293|NCT00527735|1115569|P2|Overall Study|Not identified|5
342294|NCT00527735|1115570|P1|Overall Study|Not identified|5
342295|NCT00527735|1115568|P3|Overall Study|Adverse Event|7
342296|NCT00527735|1115569|P2|Overall Study|Adverse Event|6
342297|NCT00527735|1115570|P1|Overall Study|Adverse Event|10
342298|NCT00527735|1115568|P3|Overall Study|Completed treatment in treatment phase|18
342299|NCT00527735|1115569|P2|Overall Study|Completed treatment in treatment phase|13
342300|NCT00527735|1115570|P1|Overall Study|Completed treatment in treatment phase|14
342301|NCT00527735|1115568|P3|Overall Study|Death|15
342302|NCT00527735|1115569|P2|Overall Study|Death|13
342303|NCT00527735|1115570|P1|Overall Study|Death|23
342304|NCT00527735|1115568|P3|Overall Study|Disease progression|53
342305|NCT00527735|1115569|P2|Overall Study|Disease progression|61
342306|NCT00527735|1115570|P1|Overall Study|Disease progression|47
342307|NCT00527618|1115651|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
342308|NCT00527618|1115652|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
342309|NCT00527618|1115651|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
342310|NCT00527618|1115652|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
342311|NCT00527618|1115651|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
342312|NCT00527618|1115652|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
342313|NCT00527618|1115651|P2|Week 13-14 (Washout)|Lost to Follow-up|0
342314|NCT00527618|1115652|P1|Week 13-14 (Washout)|Lost to Follow-up|1
342315|NCT00527618|1115651|P2|Week 1-12 (First Intervention)|Adverse Event|1
342316|NCT00527618|1115652|P1|Week 1-12 (First Intervention)|Adverse Event|0
342317|NCT00527618|1115651|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
342318|NCT00527618|1115652|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
342319|NCT00527605|1115667|P2|Overall Study|Protocol Violation|2
342320|NCT00527605|1115668|P1|Overall Study|Protocol Violation|1
342321|NCT00527605|1115667|P2|Overall Study|Lost to Follow-up|2
342322|NCT00527605|1115668|P1|Overall Study|Lost to Follow-up|6
342323|NCT00527605|1115667|P2|Overall Study|Withdrawal by Subject|7
342324|NCT00527605|1115668|P1|Overall Study|Withdrawal by Subject|3
342325|NCT00527605|1115667|P2|Overall Study|Adverse Event|0
342326|NCT00527605|1115668|P1|Overall Study|Adverse Event|3
342327|NCT00527514|1115719|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
342328|NCT00527514|1115719|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
342329|NCT00527514|1115719|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
342330|NCT00527514|1115719|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
342331|NCT00527514|1115719|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
342332|NCT00527514|1115719|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
342333|NCT00527514|1115719|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
342334|NCT00527488|1115735|P4|Overall Study|Withdrawn prior to dosing|0
342335|NCT00527488|1115736|P3|Overall Study|Withdrawn prior to dosing|1
342336|NCT00527488|1115737|P2|Overall Study|Withdrawn prior to dosing|1
342337|NCT00527488|1115738|P1|Overall Study|Withdrawn prior to dosing|0
342338|NCT00527423|1115821|P1|Overall Study|Death|9
342339|NCT00527423|1115821|P1|Overall Study|OTHER|4
342340|NCT00527423|1115821|P1|Overall Study|Lost to Follow-up|4
342341|NCT00527423|1115821|P1|Overall Study|Withdrawal by Subject|10
342342|NCT00527423|1115821|P1|Overall Study|Physician Decision|4
342343|NCT00527423|1115821|P1|Overall Study|Adverse Event|5
342344|NCT00527423|1115821|P1|Overall Study|Protocol Violation|1
342345|NCT00527397|1115827|P1|Overall Study|Study terminated by sponsor|13
342346|NCT00527397|1115827|P1|Overall Study|Withdrawal by Subject|6
342347|NCT00527397|1115827|P1|Overall Study|Protocol Violation|1
342348|NCT00527397|1115827|P1|Overall Study|Lack of Efficacy|1
342349|NCT00527397|1115827|P1|Overall Study|Adverse Event|3
342350|NCT00527332|1115853|P2|Overall Study|Withdrew consent|1
342351|NCT00527332|1115854|P1|Overall Study|Withdrew consent|5
342352|NCT00527332|1115853|P2|Overall Study|Protocol Violation|8
342353|NCT00527332|1115854|P1|Overall Study|Protocol Violation|4
342354|NCT00527319|1115863|P3|Overall Study|Adverse Event|1
342355|NCT00527319|1115864|P2|Overall Study|Adverse Event|0
342356|NCT00527319|1115865|P1|Overall Study|Adverse Event|0
342357|NCT00527319|1115863|P3|Overall Study|Intercurrent Medical Illness|3
342358|NCT00527319|1115864|P2|Overall Study|Intercurrent Medical Illness|1
342359|NCT00527319|1115865|P1|Overall Study|Intercurrent Medical Illness|0
342360|NCT00527319|1115863|P3|Overall Study|Death|1
342361|NCT00527319|1115864|P2|Overall Study|Death|3
342362|NCT00527319|1115865|P1|Overall Study|Death|0
342363|NCT00527319|1115863|P3|Overall Study|Lost to Follow-up|0
342364|NCT00527319|1115864|P2|Overall Study|Lost to Follow-up|0
342365|NCT00527319|1115865|P1|Overall Study|Lost to Follow-up|1
342366|NCT00527319|1115863|P3|Overall Study|Withdrawal by Subject|1
342367|NCT00527319|1115864|P2|Overall Study|Withdrawal by Subject|0
342368|NCT00527319|1115865|P1|Overall Study|Withdrawal by Subject|5
342369|NCT00526890|1115876|P1|Overall Study|Adverse Event|2
342370|NCT00526890|1115876|P1|Overall Study|Not treated (became ineligible)|5
342371|NCT00526799|1115887|P2|Overall Study|Intercurrent Complicating Disease|1
342372|NCT00526799|1115888|P1|Overall Study|Intercurrent Complicating Disease|0
342373|NCT00526799|1115887|P2|Overall Study|Withdrawal by Subject|0
342374|NCT00526799|1115888|P1|Overall Study|Withdrawal by Subject|1
342375|NCT00526669|1115896|P2|Combined Treatment Phase|Death|2
342376|NCT00526669|1115897|P1|Combined Treatment Phase|Death|0
342377|NCT00526669|1115896|P2|Combined Treatment Phase|Sponsor Terminated Study|2
342378|NCT00526669|1115897|P1|Combined Treatment Phase|Sponsor Terminated Study|0
342379|NCT00526669|1115896|P2|Combined Treatment Phase|Withdrawal by Subject|2
342380|NCT00526669|1115897|P1|Combined Treatment Phase|Withdrawal by Subject|0
342381|NCT00526669|1115896|P2|Combined Treatment Phase|Lost to Follow-up|2
342382|NCT00526669|1115897|P1|Combined Treatment Phase|Lost to Follow-up|0
342383|NCT00526630|1115926|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
342384|NCT00526630|1115927|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
342385|NCT00526630|1115926|P2|First Intervention Period - 12 Weeks|Withdrawn|3
342386|NCT00526630|1115927|P1|First Intervention Period - 12 Weeks|Withdrawn|0
342387|NCT00526331|1116026|P1|Overall Study|Sponsor Termination|55
342388|NCT00526227|1116034|P1|Overall Study|Death|1
342389|NCT00526227|1116034|P1|Overall Study|Device not implanted|1
342390|NCT00526162|1116045|P1|Overall Study|Device not implanted|3
342391|NCT00526110|1116075|P2|Overall Study|Poor Tolerance|5
342392|NCT00526110|1116076|P1|Overall Study|Poor Tolerance|0
342393|NCT00526110|1116075|P2|Overall Study|Withdrawal by Subject|2
342394|NCT00526110|1116076|P1|Overall Study|Withdrawal by Subject|0
342395|NCT00526110|1116075|P2|Overall Study|Maximal Response|6
342396|NCT00526110|1116076|P1|Overall Study|Maximal Response|0
342397|NCT00526110|1116075|P2|Overall Study|Disease Progression|19
342398|NCT00526110|1116076|P1|Overall Study|Disease Progression|0
342399|NCT00526110|1116075|P2|Overall Study|Adverse Event|9
342400|NCT00526110|1116076|P1|Overall Study|Adverse Event|2
342401|NCT00526097|1116085|P2|Overall Study|Other|1
342402|NCT00526097|1116086|P1|Overall Study|Other|2
342403|NCT00526097|1116085|P2|Overall Study|Withdrawal by Subject|1
342404|NCT00526097|1116086|P1|Overall Study|Withdrawal by Subject|3
342405|NCT00526097|1116085|P2|Overall Study|Protocol Violation|10
342406|NCT00526097|1116086|P1|Overall Study|Protocol Violation|4
342407|NCT00526097|1116085|P2|Overall Study|Adverse Event|44
342408|NCT00526097|1116086|P1|Overall Study|Adverse Event|6
342409|NCT00525915|1116273|P2|Overall Study|Unrelated illness|0
342410|NCT00525915|1116274|P1|Overall Study|Unrelated illness|1
342411|NCT00525915|1116273|P2|Overall Study|Refused Surgery|2
342412|NCT00525915|1116274|P1|Overall Study|Refused Surgery|1
342413|NCT00525915|1116273|P2|Overall Study|Withdrawal by Subject|0
342414|NCT00525915|1116274|P1|Overall Study|Withdrawal by Subject|1
342415|NCT00525915|1116273|P2|Overall Study|Disease Progression|6
342416|NCT00525915|1116274|P1|Overall Study|Disease Progression|5
342417|NCT00525915|1116273|P2|Overall Study|Non-Compliance|1
342418|NCT00525915|1116274|P1|Overall Study|Non-Compliance|0
342419|NCT00525902|1116280|P1|Overall Study|Lack of Efficacy|1
342420|NCT00525824|1116302|P4|Overall Study|Other|1
342421|NCT00525824|1116303|P3|Overall Study|Other|3
342422|NCT00525824|1116304|P2|Overall Study|Other|3
342423|NCT00525824|1116305|P1|Overall Study|Other|1
342424|NCT00525824|1116302|P4|Overall Study|Safety reasons|0
342425|NCT00525824|1116303|P3|Overall Study|Safety reasons|1
342426|NCT00525824|1116304|P2|Overall Study|Safety reasons|0
342427|NCT00525824|1116305|P1|Overall Study|Safety reasons|1
342428|NCT00525824|1116302|P4|Overall Study|Severe non-compliance|1
342429|NCT00525824|1116303|P3|Overall Study|Severe non-compliance|1
342430|NCT00525824|1116304|P2|Overall Study|Severe non-compliance|1
342431|NCT00525824|1116305|P1|Overall Study|Severe non-compliance|0
342432|NCT00525824|1116302|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
342433|NCT00525824|1116303|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
342434|NCT00525824|1116304|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
342435|NCT00525824|1116305|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
342436|NCT00525824|1116302|P4|Overall Study|Lost to Follow-up|0
342437|NCT00525824|1116303|P3|Overall Study|Lost to Follow-up|4
342438|NCT00525824|1116304|P2|Overall Study|Lost to Follow-up|2
342439|NCT00525824|1116305|P1|Overall Study|Lost to Follow-up|4
342440|NCT00525824|1116302|P4|Overall Study|Withdrawal by Subject|4
342441|NCT00525824|1116303|P3|Overall Study|Withdrawal by Subject|3
342442|NCT00525824|1116304|P2|Overall Study|Withdrawal by Subject|9
342443|NCT00525824|1116305|P1|Overall Study|Withdrawal by Subject|5
342444|NCT00525824|1116302|P4|Overall Study|Adverse Event|7
342445|NCT00525824|1116303|P3|Overall Study|Adverse Event|6
342446|NCT00525824|1116304|P2|Overall Study|Adverse Event|11
342447|NCT00525824|1116305|P1|Overall Study|Adverse Event|7
342448|NCT00525512|1116412|P4|Open-Label Phase|Other reason (not specified)|5
342449|NCT00525512|1116413|P3|Open-Label Phase|Other reason (not specified)|4
342450|NCT00525512|1116414|P2|Open-Label Phase|Other reason (not specified)|0
342451|NCT00525512|1116415|P1|Open-Label Phase|Other reason (not specified)|0
342452|NCT00525512|1116412|P4|Open-Label Phase|Lost to Follow-up|0
342453|NCT00525512|1116413|P3|Open-Label Phase|Lost to Follow-up|1
342454|NCT00525512|1116414|P2|Open-Label Phase|Lost to Follow-up|0
342455|NCT00525512|1116415|P1|Open-Label Phase|Lost to Follow-up|0
342456|NCT00525512|1116412|P4|Open-Label Phase|Adverse Event|0
342457|NCT00525512|1116413|P3|Open-Label Phase|Adverse Event|1
342458|NCT00525512|1116414|P2|Open-Label Phase|Adverse Event|0
342459|NCT00525512|1116415|P1|Open-Label Phase|Adverse Event|0
342460|NCT00525512|1116412|P4|Double-Blind Phase|Other reason (not specified)|0
342461|NCT00525512|1116413|P3|Double-Blind Phase|Other reason (not specified)|0
342462|NCT00525512|1116414|P2|Double-Blind Phase|Other reason (not specified)|13
342463|NCT00525512|1116415|P1|Double-Blind Phase|Other reason (not specified)|12
342464|NCT00525512|1116412|P4|Double-Blind Phase|Lack of Efficacy|0
342465|NCT00525512|1116413|P3|Double-Blind Phase|Lack of Efficacy|0
342466|NCT00525512|1116414|P2|Double-Blind Phase|Lack of Efficacy|5
342467|NCT00525512|1116415|P1|Double-Blind Phase|Lack of Efficacy|13
342468|NCT00525512|1116412|P4|Double-Blind Phase|Withdrawal by Subject|0
342469|NCT00525512|1116413|P3|Double-Blind Phase|Withdrawal by Subject|0
342470|NCT00525512|1116414|P2|Double-Blind Phase|Withdrawal by Subject|12
342471|NCT00525512|1116415|P1|Double-Blind Phase|Withdrawal by Subject|17
342472|NCT00525512|1116412|P4|Double-Blind Phase|Lost to Follow-up|0
342473|NCT00525512|1116413|P3|Double-Blind Phase|Lost to Follow-up|0
342474|NCT00525512|1116414|P2|Double-Blind Phase|Lost to Follow-up|7
342475|NCT00525512|1116415|P1|Double-Blind Phase|Lost to Follow-up|3
342476|NCT00525512|1116412|P4|Double-Blind Phase|Protocol Violation|0
342477|NCT00525512|1116413|P3|Double-Blind Phase|Protocol Violation|0
342478|NCT00525512|1116414|P2|Double-Blind Phase|Protocol Violation|1
342479|NCT00525512|1116415|P1|Double-Blind Phase|Protocol Violation|3
342480|NCT00525512|1116412|P4|Double-Blind Phase|Adverse Event|0
342481|NCT00525512|1116413|P3|Double-Blind Phase|Adverse Event|0
342482|NCT00525512|1116414|P2|Double-Blind Phase|Adverse Event|28
342483|NCT00525512|1116415|P1|Double-Blind Phase|Adverse Event|48
342484|NCT00525499|1116557|P4|Overall Study|Protocol Violation|0
342485|NCT00525499|1116558|P3|Overall Study|Protocol Violation|1
342486|NCT00525499|1116559|P2|Overall Study|Protocol Violation|1
342487|NCT00525499|1116560|P1|Overall Study|Protocol Violation|0
342488|NCT00525499|1116557|P4|Overall Study|Withdrawal by Subject|2
342489|NCT00525499|1116558|P3|Overall Study|Withdrawal by Subject|5
342490|NCT00525499|1116559|P2|Overall Study|Withdrawal by Subject|1
342491|NCT00525499|1116560|P1|Overall Study|Withdrawal by Subject|5
342492|NCT00525499|1116557|P4|Overall Study|Adverse Event|1
342493|NCT00525499|1116558|P3|Overall Study|Adverse Event|0
342494|NCT00525499|1116559|P2|Overall Study|Adverse Event|1
342495|NCT00525499|1116560|P1|Overall Study|Adverse Event|0
342496|NCT00525499|1116557|P4|Overall Study|Lost to Follow-up|4
342497|NCT00525499|1116558|P3|Overall Study|Lost to Follow-up|1
342498|NCT00525499|1116559|P2|Overall Study|Lost to Follow-up|4
342499|NCT00525499|1116560|P1|Overall Study|Lost to Follow-up|2
342500|NCT00525265|1116587|P2|Overall Study|Protocol Violation|0
342501|NCT00525265|1116588|P1|Overall Study|Protocol Violation|1
342502|NCT00525161|1116645|P1|Overall Study|Adverse Event|1
342503|NCT00525148|1116655|P4|Overall Study|Other than stated|3
342504|NCT00525148|1116656|P3|Overall Study|Other than stated|0
342505|NCT00525148|1116657|P2|Overall Study|Other than stated|1
342506|NCT00525148|1116658|P1|Overall Study|Other than stated|2
342507|NCT00525148|1116655|P4|Overall Study|Refused continuation of study medication|1
342508|NCT00525148|1116656|P3|Overall Study|Refused continuation of study medication|0
342509|NCT00525148|1116657|P2|Overall Study|Refused continuation of study medication|2
342510|NCT00525148|1116658|P1|Overall Study|Refused continuation of study medication|0
342511|NCT00525148|1116655|P4|Overall Study|Progressive disease|49
342512|NCT00525148|1116656|P3|Overall Study|Progressive disease|6
342513|NCT00525148|1116657|P2|Overall Study|Progressive disease|30
342514|NCT00525148|1116658|P1|Overall Study|Progressive disease|18
342515|NCT00525148|1116655|P4|Overall Study|Other Adverse Event|8
342516|NCT00525148|1116656|P3|Overall Study|Other Adverse Event|1
342517|NCT00525148|1116657|P2|Overall Study|Other Adverse Event|5
342518|NCT00525148|1116658|P1|Overall Study|Other Adverse Event|3
342519|NCT00524771|1116691|P2|Overall Study|Protocol Violation|585
342520|NCT00524771|1116692|P1|Overall Study|Protocol Violation|220
342521|NCT00524745|1116706|P4|Overall Study|subject withdrawal or lost to follow up|22
342522|NCT00524745|1116707|P3|Overall Study|subject withdrawal or lost to follow up|29
342523|NCT00524745|1116708|P2|Overall Study|subject withdrawal or lost to follow up|13
342524|NCT00524745|1116709|P1|Overall Study|subject withdrawal or lost to follow up|34
342525|NCT00524680|1116735|P4|Overall Study|Withdrawal by Subject|1
342526|NCT00524680|1116736|P3|Overall Study|Withdrawal by Subject|1
342527|NCT00524680|1116737|P2|Overall Study|Withdrawal by Subject|0
342528|NCT00524680|1116738|P1|Overall Study|Withdrawal by Subject|1
342529|NCT00524680|1116735|P4|Overall Study|not specified|3
342530|NCT00524680|1116736|P3|Overall Study|not specified|2
342531|NCT00524680|1116737|P2|Overall Study|not specified|1
342532|NCT00524680|1116738|P1|Overall Study|not specified|0
342533|NCT00524680|1116735|P4|Overall Study|Adverse Event|1
342534|NCT00524680|1116736|P3|Overall Study|Adverse Event|0
342535|NCT00524680|1116737|P2|Overall Study|Adverse Event|0
342536|NCT00524680|1116738|P1|Overall Study|Adverse Event|2
342537|NCT00524680|1116735|P4|Overall Study|progression|1
342538|NCT00524680|1116736|P3|Overall Study|progression|0
342539|NCT00524680|1116737|P2|Overall Study|progression|0
342540|NCT00524680|1116738|P1|Overall Study|progression|0
342541|NCT00524589|1116760|P1|Overall Study|Disease Progression|16
342542|NCT00524589|1116760|P1|Overall Study|Withdrawal by Subject|2
342543|NCT00524485|1116810|P1|Overall Study|Withdrawal by Subject|5
342544|NCT00524459|1116820|P1|Overall Study|Other|1
342545|NCT00524459|1116820|P1|Overall Study|Withdrawal by Subject|1
342546|NCT00524420|1116830|P2|Overall Study|Lack of Efficacy|0
342547|NCT00524420|1116831|P1|Overall Study|Lack of Efficacy|1
342548|NCT00524368|1116849|P2|Overall Study|Unspecified|2
342549|NCT00524368|1116850|P1|Overall Study|Unspecified|3
342550|NCT00524368|1116849|P2|Overall Study|Ineligible to Continue the study|5
342551|NCT00524368|1116850|P1|Overall Study|Ineligible to Continue the study|2
342552|NCT00524368|1116849|P2|Overall Study|Sponsor's Decision|0
342553|NCT00524368|1116850|P1|Overall Study|Sponsor's Decision|2
342554|NCT00524368|1116849|P2|Overall Study|Reached a Virologic Endpoint|2
342555|NCT00524368|1116850|P1|Overall Study|Reached a Virologic Endpoint|3
342556|NCT00524368|1116849|P2|Overall Study|Non-compliant|9
342557|NCT00524368|1116850|P1|Overall Study|Non-compliant|8
342558|NCT00524368|1116849|P2|Overall Study|Withdrawal by Subject|5
342559|NCT00524368|1116850|P1|Overall Study|Withdrawal by Subject|4
342560|NCT00524368|1116849|P2|Overall Study|Lost to Follow-up|13
342561|NCT00524368|1116850|P1|Overall Study|Lost to Follow-up|9
342562|NCT00524368|1116849|P2|Overall Study|Adverse Event|12
342563|NCT00524368|1116850|P1|Overall Study|Adverse Event|10
342564|NCT00524316|1116883|P1|Overall Study|Disease Progression|7
342565|NCT00524316|1116883|P1|Overall Study|Adverse Event|7
342566|NCT00524316|1116883|P1|Overall Study|Withdrawal by Subject|2
342567|NCT00524303|1116895|P3|Overall Study|Completed 5 years|1
342568|NCT00524303|1116896|P2|Overall Study|Completed 5 years|0
342569|NCT00524303|1116897|P1|Overall Study|Completed 5 years|0
342570|NCT00524303|1116895|P3|Overall Study|Physician Decision|1
342571|NCT00524303|1116896|P2|Overall Study|Physician Decision|0
342572|NCT00524303|1116897|P1|Overall Study|Physician Decision|0
342573|NCT00524303|1116895|P3|Overall Study|Sponsor Request|1
342574|NCT00524303|1116896|P2|Overall Study|Sponsor Request|0
342575|NCT00524303|1116897|P1|Overall Study|Sponsor Request|0
342576|NCT00524303|1116895|P3|Overall Study|Disease Recurrence|0
342577|NCT00524303|1116896|P2|Overall Study|Disease Recurrence|1
342578|NCT00524303|1116897|P1|Overall Study|Disease Recurrence|0
342579|NCT00524303|1116895|P3|Overall Study|Disease Progression|1
342580|NCT00524303|1116896|P2|Overall Study|Disease Progression|4
342581|NCT00524303|1116897|P1|Overall Study|Disease Progression|0
342582|NCT00524303|1116895|P3|Overall Study|Worsening Peripheral Neuropathy|0
342583|NCT00524303|1116896|P2|Overall Study|Worsening Peripheral Neuropathy|0
342584|NCT00524303|1116897|P1|Overall Study|Worsening Peripheral Neuropathy|1
342585|NCT00524303|1116895|P3|Overall Study|Did not Complete Study Dosing|0
342586|NCT00524303|1116896|P2|Overall Study|Did not Complete Study Dosing|0
342587|NCT00524303|1116897|P1|Overall Study|Did not Complete Study Dosing|1
342588|NCT00524303|1116895|P3|Overall Study|Adverse Event|3
342589|NCT00524303|1116896|P2|Overall Study|Adverse Event|2
342590|NCT00524303|1116897|P1|Overall Study|Adverse Event|1
342591|NCT00524303|1116895|P3|Overall Study|Death|3
342592|NCT00524303|1116896|P2|Overall Study|Death|2
342593|NCT00524303|1116897|P1|Overall Study|Death|0
342594|NCT00524303|1116895|P3|Overall Study|Withdrawal by Subject|4
342595|NCT00524303|1116896|P2|Overall Study|Withdrawal by Subject|0
342596|NCT00524303|1116897|P1|Overall Study|Withdrawal by Subject|3
342597|NCT00524303|1116895|P3|Overall Study|Protocol Violation|1
342598|NCT00524303|1116896|P2|Overall Study|Protocol Violation|1
342599|NCT00524303|1116897|P1|Overall Study|Protocol Violation|0
342600|NCT00524303|1116895|P3|Overall Study|Lost to Follow-up|3
342601|NCT00524303|1116896|P2|Overall Study|Lost to Follow-up|0
342602|NCT00524303|1116897|P1|Overall Study|Lost to Follow-up|6
342603|NCT00524134|1116945|P1|Overall Study|Physician Decision|1
342604|NCT00524134|1116945|P1|Overall Study|Withdrawal by Subject|1
342605|NCT00524121|1116952|P1|Overall Study|Not treated (changed mind)|1
342606|NCT00524121|1116952|P1|Overall Study|Not treated (became ineligible)|4
342607|NCT00524121|1116952|P1|Overall Study|Death|1
342608|NCT00524121|1116952|P1|Overall Study|unspecified|1
342609|NCT00524121|1116952|P1|Overall Study|Patient refused|2
342610|NCT00524121|1116952|P1|Overall Study|Adverse Event|4
342611|NCT00524121|1116952|P1|Overall Study|Disease progression|6
342612|NCT00524043|1116972|P3|Overall Study|Various (eg, incarceration)|0
342613|NCT00524043|1116973|P2|Overall Study|Various (eg, incarceration)|1
342614|NCT00524043|1116974|P1|Overall Study|Various (eg, incarceration)|2
342615|NCT00524043|1116972|P3|Overall Study|Lost to Follow-up|3
342616|NCT00524043|1116973|P2|Overall Study|Lost to Follow-up|5
342617|NCT00524043|1116974|P1|Overall Study|Lost to Follow-up|3
342618|NCT00524043|1116972|P3|Overall Study|Adverse Event|7
342619|NCT00524043|1116973|P2|Overall Study|Adverse Event|2
342620|NCT00524043|1116974|P1|Overall Study|Adverse Event|5
342621|NCT00524043|1116972|P3|Overall Study|Withdrawal by Subject|7
342622|NCT00524043|1116973|P2|Overall Study|Withdrawal by Subject|7
342623|NCT00524043|1116974|P1|Overall Study|Withdrawal by Subject|5
342624|NCT00524043|1116972|P3|Overall Study|Lack of Efficacy|14
342625|NCT00524043|1116973|P2|Overall Study|Lack of Efficacy|13
342626|NCT00524043|1116974|P1|Overall Study|Lack of Efficacy|15
342627|NCT00524030|1116996|P2|Overall Study|Death|1
342628|NCT00524030|1116997|P1|Overall Study|Death|0
342629|NCT00524030|1116996|P2|Overall Study|Adverse Event|21
342630|NCT00524030|1116997|P1|Overall Study|Adverse Event|3
342631|NCT00524030|1116996|P2|Overall Study|Pregnancy|0
342632|NCT00524030|1116997|P1|Overall Study|Pregnancy|1
342633|NCT00524030|1116996|P2|Overall Study|Protocol Violation|1
342634|NCT00524030|1116997|P1|Overall Study|Protocol Violation|0
342635|NCT00524030|1116996|P2|Overall Study|Noncompliance/Investigator discretion|2
342636|NCT00524030|1116997|P1|Overall Study|Noncompliance/Investigator discretion|0
342637|NCT00524030|1116996|P2|Overall Study|Withdrawal by Subject|8
342638|NCT00524030|1116997|P1|Overall Study|Withdrawal by Subject|3
342639|NCT00524030|1116996|P2|Overall Study|Lost to Follow-up|2
342640|NCT00524030|1116997|P1|Overall Study|Lost to Follow-up|0
342641|NCT00524030|1116996|P2|Overall Study|Lack of Efficacy|24
342642|NCT00524030|1116997|P1|Overall Study|Lack of Efficacy|10
342643|NCT00523991|1117015|P2|Overall Study|Other reason (not specified)|0
342644|NCT00523991|1117016|P1|Overall Study|Other reason (not specified)|3
342645|NCT00523991|1117015|P2|Overall Study|Withdrawal by Subject|17
342646|NCT00523991|1117016|P1|Overall Study|Withdrawal by Subject|7
342647|NCT00523991|1117015|P2|Overall Study|Lost to Follow-up|1
342648|NCT00523991|1117016|P1|Overall Study|Lost to Follow-up|4
342649|NCT00523991|1117015|P2|Overall Study|Protocol Violation|4
342650|NCT00523991|1117016|P1|Overall Study|Protocol Violation|1
342651|NCT00523991|1117015|P2|Overall Study|Adverse Event|5
342652|NCT00523991|1117016|P1|Overall Study|Adverse Event|6
342653|NCT00523978|1117296|P2|Overall Study|Death|0
342654|NCT00523978|1117297|P1|Overall Study|Death|1
342655|NCT00523978|1117296|P2|Overall Study|Screen Failures|1
342656|NCT00523978|1117297|P1|Overall Study|Screen Failures|5
342657|NCT00523978|1117296|P2|Overall Study|Withdrawal by Subject|7
342658|NCT00523978|1117297|P1|Overall Study|Withdrawal by Subject|3
342659|NCT00523848|1117319|P1|Overall Study|Other, unspecified|4
342660|NCT00523848|1117319|P1|Overall Study|Disease Progression|5
342661|NCT00523848|1117319|P1|Overall Study|NOT TREATED (Became ineligible)|2
342662|NCT00523848|1117319|P1|Overall Study|Withdrawal by Subject|2
342663|NCT00523848|1117319|P1|Overall Study|Adverse Event|11
342664|NCT00523744|1117329|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
342665|NCT00523744|1117329|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
342666|NCT00523744|1117329|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
342667|NCT00523744|1117329|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
342668|NCT00523744|1117329|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
342669|NCT00523744|1117329|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
342670|NCT00523718|1117348|P2|Overall Study|Protocol Violation|0
342671|NCT00523718|1117349|P1|Overall Study|Protocol Violation|2
342672|NCT00523718|1117348|P2|Overall Study|Withdrawal by Subject|0
342673|NCT00523718|1117349|P1|Overall Study|Withdrawal by Subject|1
342674|NCT00523705|1117363|P2|Overall Study|No time for study.|1
342675|NCT00523705|1117364|P1|Overall Study|No time for study.|0
342676|NCT00523640|1117376|P1|Overall Study|Death|1
342677|NCT00523549|1117393|P2|Overall Study|Lost to Follow-up|5
342678|NCT00523549|1117394|P1|Overall Study|Lost to Follow-up|3
342679|NCT00523549|1117393|P2|Overall Study|Patient withdrew consent|6
342680|NCT00523549|1117394|P1|Overall Study|Patient withdrew consent|7
342681|NCT00523549|1117393|P2|Overall Study|Protocol Deviation|1
342682|NCT00523549|1117394|P1|Overall Study|Protocol Deviation|3
342683|NCT00523549|1117393|P2|Overall Study|Unsatisfactory therapeutic effect|1
342684|NCT00523549|1117394|P1|Overall Study|Unsatisfactory therapeutic effect|0
342685|NCT00523549|1117393|P2|Overall Study|Adverse Event|3
342686|NCT00523549|1117394|P1|Overall Study|Adverse Event|6
342687|NCT00523419|1117412|P1|Overall Study|Death due to Adverse Event|2
342688|NCT00523419|1117412|P1|Overall Study|Death due to Study Disease|4
342689|NCT00523419|1117412|P1|Overall Study|Progressive Disease|22
342690|NCT00523419|1117412|P1|Overall Study|Physician Decision|2
342691|NCT00523419|1117412|P1|Overall Study|Withdrawal by Subject|1
342692|NCT00523419|1117412|P1|Overall Study|Adverse Event|1
342693|NCT00523367|1117422|P1|Overall Study|4 Withdrawn by PI|4
342694|NCT00523367|1117422|P1|Overall Study|19 screen failures|19
342695|NCT00523341|1117428|P2|Overall Study|Disease Progression|0
342696|NCT00523341|1117429|P1|Overall Study|Disease Progression|1
342697|NCT00523341|1117428|P2|Overall Study|Ineligibility Determined|4
342698|NCT00523341|1117429|P1|Overall Study|Ineligibility Determined|3
342699|NCT00523341|1117428|P2|Overall Study|Protocol Deviation|5
342700|NCT00523341|1117429|P1|Overall Study|Protocol Deviation|6
342701|NCT00523341|1117428|P2|Overall Study|Requirement for Alternative Therapy|14
342702|NCT00523341|1117429|P1|Overall Study|Requirement for Alternative Therapy|4
342703|NCT00523341|1117428|P2|Overall Study|Physician Decision|13
342704|NCT00523341|1117429|P1|Overall Study|Physician Decision|14
342705|NCT00523341|1117428|P2|Overall Study|Non-compliance|13
342706|NCT00523341|1117429|P1|Overall Study|Non-compliance|20
342707|NCT00523341|1117428|P2|Overall Study|Lost to Follow-up|61
342708|NCT00523341|1117429|P1|Overall Study|Lost to Follow-up|73
342709|NCT00523341|1117428|P2|Overall Study|Death|110
342710|NCT00523341|1117429|P1|Overall Study|Death|101
342711|NCT00523341|1117428|P2|Overall Study|Adverse Event|155
342712|NCT00523341|1117429|P1|Overall Study|Adverse Event|122
342713|NCT00523341|1117428|P2|Overall Study|Other|198
342714|NCT00523341|1117429|P1|Overall Study|Other|181
342715|NCT00523341|1117428|P2|Overall Study|Withdrawal by Subject|427
342716|NCT00523341|1117429|P1|Overall Study|Withdrawal by Subject|399
342717|NCT00522951|1117533|P2|Period 2|residual contrast medium|1
342718|NCT00522951|1117534|P1|Period 2|residual contrast medium|1
342719|NCT00522951|1117533|P2|Period 2|Withdrawal by Subject|0
342720|NCT00522951|1117534|P1|Period 2|Withdrawal by Subject|1
342721|NCT00522951|1117533|P2|Washout Period|Death|1
342722|NCT00522951|1117534|P1|Washout Period|Death|0
342723|NCT00522951|1117533|P2|Washout Period|Adverse Event|1
342724|NCT00522951|1117534|P1|Washout Period|Adverse Event|0
342725|NCT00522951|1117533|P2|Period 1|body motion|1
342726|NCT00522951|1117534|P1|Period 1|body motion|0
342727|NCT00522873|1117589|P2|Overall Study|Never Received Medication|0
342728|NCT00522873|1117590|P1|Overall Study|Never Received Medication|1
342729|NCT00522873|1117589|P2|Overall Study|Medication Errors|1
342730|NCT00522873|1117590|P1|Overall Study|Medication Errors|1
342731|NCT00522873|1117589|P2|Overall Study|Personal Reasons|1
342732|NCT00522873|1117590|P1|Overall Study|Personal Reasons|8
342733|NCT00522873|1117589|P2|Overall Study|Lost to Follow-up|3
342734|NCT00522873|1117590|P1|Overall Study|Lost to Follow-up|11
342735|NCT00522873|1117589|P2|Overall Study|Protocol Violation|4
342736|NCT00522873|1117590|P1|Overall Study|Protocol Violation|14
342737|NCT00522873|1117589|P2|Overall Study|Withdrawal by Subject|9
342738|NCT00522873|1117590|P1|Overall Study|Withdrawal by Subject|20
342739|NCT00522873|1117589|P2|Overall Study|Adverse Event|26
342740|NCT00522873|1117590|P1|Overall Study|Adverse Event|41
342741|NCT00522626|1117603|P1|Overall Study|Lost to Follow-up|7
342742|NCT00522457|1117607|P1|Overall Study|Adverse Event|2
342743|NCT00522457|1117607|P1|Overall Study|Due to disease progression|16
342744|NCT00522431|1117613|P1|Overall Study|Other/unknown|1
342745|NCT00522431|1117613|P1|Overall Study|Subject non-compliance|1
342746|NCT00522431|1117613|P1|Overall Study|Withdrawal by Subject|2
342747|NCT00522431|1117613|P1|Overall Study|Protocol Violation|2
342748|NCT00522431|1117613|P1|Overall Study|Adverse Event|5
342749|NCT00522418|1117620|P2|Overall Study|Lack of Efficacy|1
342750|NCT00522418|1117621|P1|Overall Study|Lack of Efficacy|0
342751|NCT00522418|1117620|P2|Overall Study|Consent Withdraw|2
342752|NCT00522418|1117621|P1|Overall Study|Consent Withdraw|1
342753|NCT00522418|1117620|P2|Overall Study|Reason Not Specified|1
342754|NCT00522418|1117621|P1|Overall Study|Reason Not Specified|3
342755|NCT00522418|1117620|P2|Overall Study|Noncompliance|2
342756|NCT00522418|1117621|P1|Overall Study|Noncompliance|2
342757|NCT00522418|1117620|P2|Overall Study|Early Study Termination|47
342758|NCT00522418|1117621|P1|Overall Study|Early Study Termination|46
342759|NCT00522418|1117620|P2|Overall Study|Local IRB Consent Violation|5
342760|NCT00522418|1117621|P1|Overall Study|Local IRB Consent Violation|5
342761|NCT00522392|1117669|P2|Overall Study|Non-compliance|1
342762|NCT00522392|1117670|P1|Overall Study|Non-compliance|0
342763|NCT00522392|1117669|P2|Overall Study|Physician Decision|1
342764|NCT00522392|1117670|P1|Overall Study|Physician Decision|0
342765|NCT00522392|1117669|P2|Overall Study|Withdrawal by Subject|1
342766|NCT00522392|1117670|P1|Overall Study|Withdrawal by Subject|1
342767|NCT00522392|1117669|P2|Overall Study|Adverse Event|7
342768|NCT00522392|1117670|P1|Overall Study|Adverse Event|7
342769|NCT00522392|1117669|P2|Overall Study|Disease progression|3
342770|NCT00522392|1117670|P1|Overall Study|Disease progression|0
342771|NCT00522379|1117687|P5|Overall Study|Subject Withdrawal|0
342772|NCT00522379|1117688|P4|Overall Study|Subject Withdrawal|1
342773|NCT00522379|1117689|P3|Overall Study|Subject Withdrawal|0
342774|NCT00522379|1117690|P2|Overall Study|Subject Withdrawal|0
342775|NCT00522379|1117691|P1|Overall Study|Subject Withdrawal|0
342776|NCT00522379|1117687|P5|Overall Study|Site Closed|0
342777|NCT00522379|1117688|P4|Overall Study|Site Closed|1
342778|NCT00522379|1117689|P3|Overall Study|Site Closed|0
342779|NCT00522379|1117690|P2|Overall Study|Site Closed|0
342780|NCT00522379|1117691|P1|Overall Study|Site Closed|0
342781|NCT00522379|1117687|P5|Overall Study|Family Problem|0
342782|NCT00522379|1117688|P4|Overall Study|Family Problem|0
342783|NCT00522379|1117689|P3|Overall Study|Family Problem|1
342784|NCT00522379|1117690|P2|Overall Study|Family Problem|0
342785|NCT00522379|1117691|P1|Overall Study|Family Problem|0
342786|NCT00522379|1117687|P5|Overall Study|Sponsor Request|0
342787|NCT00522379|1117688|P4|Overall Study|Sponsor Request|0
342788|NCT00522379|1117689|P3|Overall Study|Sponsor Request|0
342789|NCT00522379|1117690|P2|Overall Study|Sponsor Request|1
342790|NCT00522379|1117691|P1|Overall Study|Sponsor Request|0
342791|NCT00522379|1117687|P5|Overall Study|Subject Moved|0
342792|NCT00522379|1117688|P4|Overall Study|Subject Moved|0
342793|NCT00522379|1117689|P3|Overall Study|Subject Moved|0
342794|NCT00522379|1117690|P2|Overall Study|Subject Moved|1
342795|NCT00522379|1117691|P1|Overall Study|Subject Moved|1
342796|NCT00522379|1117687|P5|Overall Study|Dispensing error|0
342797|NCT00522379|1117688|P4|Overall Study|Dispensing error|1
342798|NCT00522379|1117689|P3|Overall Study|Dispensing error|0
342799|NCT00522379|1117690|P2|Overall Study|Dispensing error|0
342800|NCT00522379|1117691|P1|Overall Study|Dispensing error|1
342801|NCT00522379|1117687|P5|Overall Study|Randomization error|1
342802|NCT00522379|1117688|P4|Overall Study|Randomization error|0
342803|NCT00522379|1117689|P3|Overall Study|Randomization error|0
342804|NCT00522379|1117690|P2|Overall Study|Randomization error|0
342805|NCT00522379|1117691|P1|Overall Study|Randomization error|0
342806|NCT00522379|1117687|P5|Overall Study|Lost to Follow-up|2
342807|NCT00522379|1117688|P4|Overall Study|Lost to Follow-up|2
342808|NCT00522379|1117689|P3|Overall Study|Lost to Follow-up|4
342809|NCT00522379|1117690|P2|Overall Study|Lost to Follow-up|0
342810|NCT00522379|1117691|P1|Overall Study|Lost to Follow-up|1
342811|NCT00522379|1117687|P5|Overall Study|Unsatisfactory Subject Compliance|0
342812|NCT00522379|1117688|P4|Overall Study|Unsatisfactory Subject Compliance|0
342813|NCT00522379|1117689|P3|Overall Study|Unsatisfactory Subject Compliance|0
342814|NCT00522379|1117690|P2|Overall Study|Unsatisfactory Subject Compliance|2
342815|NCT00522379|1117691|P1|Overall Study|Unsatisfactory Subject Compliance|1
342816|NCT00522379|1117687|P5|Overall Study|Protocol Violation|0
342817|NCT00522379|1117688|P4|Overall Study|Protocol Violation|0
342818|NCT00522379|1117689|P3|Overall Study|Protocol Violation|2
342819|NCT00522379|1117690|P2|Overall Study|Protocol Violation|1
342820|NCT00522379|1117691|P1|Overall Study|Protocol Violation|1
342821|NCT00522379|1117687|P5|Overall Study|Withdrawal by Subject|0
342822|NCT00522379|1117688|P4|Overall Study|Withdrawal by Subject|2
342823|NCT00522379|1117689|P3|Overall Study|Withdrawal by Subject|1
342824|NCT00522379|1117690|P2|Overall Study|Withdrawal by Subject|3
342825|NCT00522379|1117691|P1|Overall Study|Withdrawal by Subject|2
342826|NCT00522379|1117687|P5|Overall Study|Lack of Efficacy|7
342827|NCT00522379|1117688|P4|Overall Study|Lack of Efficacy|2
342828|NCT00522379|1117689|P3|Overall Study|Lack of Efficacy|2
342829|NCT00522379|1117690|P2|Overall Study|Lack of Efficacy|0
342830|NCT00522379|1117691|P1|Overall Study|Lack of Efficacy|3
342831|NCT00522379|1117687|P5|Overall Study|Adverse Event|17
342832|NCT00522379|1117688|P4|Overall Study|Adverse Event|5
342833|NCT00522379|1117689|P3|Overall Study|Adverse Event|12
342834|NCT00522379|1117690|P2|Overall Study|Adverse Event|15
342835|NCT00522379|1117691|P1|Overall Study|Adverse Event|12
342836|NCT00522301|1117793|P1|Overall Study|Adverse Event|5
342837|NCT00522301|1117793|P1|Overall Study|Withdrawal by Subject|1
342838|NCT00522275|1117797|P1|Overall Study|Other: Subject had surgery for epilepsy|2
342839|NCT00522275|1117797|P1|Overall Study|Other: Subject ran out of medication|1
342840|NCT00522275|1117797|P1|Overall Study|Other: Sponsor request|2
342841|NCT00522275|1117797|P1|Overall Study|Other: Travel to / from site difficulty|3
342842|NCT00522275|1117797|P1|Overall Study|Other: Site / clinic closed|4
342843|NCT00522275|1117797|P1|Overall Study|Other: Subject arrested|1
342844|NCT00522275|1117797|P1|Overall Study|Other: Subject relocated|2
342845|NCT00522275|1117797|P1|Overall Study|Other: Subject is pregnant|2
342846|NCT00522275|1117797|P1|Overall Study|Other: Subject wants to become pregnant|2
342847|NCT00522275|1117797|P1|Overall Study|Lost to Follow-up|8
342848|NCT00522275|1117797|P1|Overall Study|Unsatisfactory compliance|11
342849|NCT00522275|1117797|P1|Overall Study|Protocol deviation|1
342850|NCT00522275|1117797|P1|Overall Study|Subject withdrew consent|16
342851|NCT00522275|1117797|P1|Overall Study|Lack of Efficacy|80
342852|NCT00522275|1117797|P1|Overall Study|Adverse Event|35
342853|NCT00522041|1117818|P2|Overall Study|Did not receive treatment|1
342854|NCT00522041|1117819|P1|Overall Study|Did not receive treatment|0
342855|NCT00522041|1117818|P2|Overall Study|Voluntary withdrawal|4
342856|NCT00522041|1117819|P1|Overall Study|Voluntary withdrawal|5
342857|NCT00522041|1117818|P2|Overall Study|Lost to Follow-up|4
342858|NCT00522041|1117819|P1|Overall Study|Lost to Follow-up|1
342859|NCT00522041|1117818|P2|Overall Study|Protocol Violation|0
342860|NCT00522041|1117819|P1|Overall Study|Protocol Violation|2
342861|NCT00522041|1117818|P2|Overall Study|Adverse Event|3
342862|NCT00522041|1117819|P1|Overall Study|Adverse Event|9
342863|NCT00521599|1117867|P3|Overall Study|Did not meet protocol eligibility|1
342864|NCT00521599|1117868|P2|Overall Study|Did not meet protocol eligibility|2
342865|NCT00521599|1117869|P1|Overall Study|Did not meet protocol eligibility|2
342866|NCT00521599|1117867|P3|Overall Study|Protocol Violation|2
342867|NCT00521599|1117868|P2|Overall Study|Protocol Violation|4
342868|NCT00521599|1117869|P1|Overall Study|Protocol Violation|2
342869|NCT00521599|1117867|P3|Overall Study|Withdrawal by subject treatment related|2
342870|NCT00521599|1117868|P2|Overall Study|Withdrawal by subject treatment related|1
342871|NCT00521599|1117869|P1|Overall Study|Withdrawal by subject treatment related|3
342872|NCT00521599|1117867|P3|Overall Study|Withdrawal by Subject|1
342873|NCT00521599|1117868|P2|Overall Study|Withdrawal by Subject|5
342874|NCT00521599|1117869|P1|Overall Study|Withdrawal by Subject|3
342875|NCT00521599|1117867|P3|Overall Study|Lost to Follow-up|2
342876|NCT00521599|1117868|P2|Overall Study|Lost to Follow-up|1
342877|NCT00521599|1117869|P1|Overall Study|Lost to Follow-up|2
342878|NCT00521599|1117867|P3|Overall Study|Treatment Failure|22
342879|NCT00521599|1117868|P2|Overall Study|Treatment Failure|9
342880|NCT00521599|1117869|P1|Overall Study|Treatment Failure|8
342881|NCT00521599|1117867|P3|Overall Study|Adverse Event|6
342882|NCT00521599|1117868|P2|Overall Study|Adverse Event|7
342883|NCT00521599|1117869|P1|Overall Study|Adverse Event|5
342884|NCT00521586|1117880|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
342885|NCT00521586|1117881|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
342886|NCT00521586|1117880|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
342887|NCT00521586|1117881|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
342888|NCT00521586|1117880|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
342889|NCT00521586|1117881|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
342890|NCT00521586|1117880|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
342891|NCT00521586|1117881|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
342892|NCT00521586|1117880|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
342893|NCT00521586|1117881|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
342894|NCT00521586|1117880|P2|Follow-up (From 6-month[Year 0]-Year 5)|unspecified|26
342895|NCT00521586|1117881|P1|Follow-up (From 6-month[Year 0]-Year 5)|unspecified|22
342896|NCT00521586|1117880|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
342897|NCT00521586|1117881|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
342898|NCT00521586|1117880|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
342899|NCT00521586|1117881|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
342900|NCT00521586|1117880|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
342901|NCT00521586|1117881|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
342902|NCT00521586|1117880|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
342903|NCT00521586|1117881|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
342904|NCT00521586|1117880|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
342905|NCT00521586|1117881|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
342906|NCT00521586|1117880|P2|Initial Vaccination (Year 0)|Failed to return|1
342907|NCT00521586|1117881|P1|Initial Vaccination (Year 0)|Failed to return|0
342908|NCT00521586|1117880|P2|Initial Vaccination (Year 0)|Death|0
342909|NCT00521586|1117881|P1|Initial Vaccination (Year 0)|Death|1
342910|NCT00521586|1117880|P2|Initial Vaccination (Year 0)|Adverse Event|1
342911|NCT00521586|1117881|P1|Initial Vaccination (Year 0)|Adverse Event|0
342912|NCT00521586|1117880|P2|Initial Vaccination (Year 0)|Investigator request|0
342913|NCT00521586|1117881|P1|Initial Vaccination (Year 0)|Investigator request|2
342914|NCT00521586|1117880|P2|Initial Vaccination (Year 0)|Other, unspecified|1
342915|NCT00521586|1117881|P1|Initial Vaccination (Year 0)|Other, unspecified|3
342916|NCT00521586|1117880|P2|Initial Vaccination (Year 0)|Protocol Violation|5
342917|NCT00521586|1117881|P1|Initial Vaccination (Year 0)|Protocol Violation|2
342918|NCT00521586|1117880|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
342919|NCT00521586|1117881|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
342920|NCT00521586|1117880|P2|Initial Vaccination (Year 0)|Subject request|11
342921|NCT00521586|1117881|P1|Initial Vaccination (Year 0)|Subject request|8
342922|NCT00521365|1117954|P1|Overall Study|Usage of not allowed drugs|6
342923|NCT00521365|1117954|P1|Overall Study|Drug compliance|3
342924|NCT00521365|1117954|P1|Overall Study|Protocol deviation|2
342925|NCT00521365|1117954|P1|Overall Study|Lost to Follow-up|6
342926|NCT00521365|1117954|P1|Overall Study|Adverse Event|3
342927|NCT00521339|1117984|P3|Treatment Extension Phase|Death|1
342928|NCT00521339|1117985|P2|Treatment Extension Phase|Death|0
342929|NCT00521339|1117986|P1|Treatment Extension Phase|Death|0
342930|NCT00521339|1117984|P3|Treatment Extension Phase|Withdrawal by Subject|2
342931|NCT00521339|1117985|P2|Treatment Extension Phase|Withdrawal by Subject|0
342932|NCT00521339|1117986|P1|Treatment Extension Phase|Withdrawal by Subject|0
342933|NCT00521339|1117984|P3|Treatment Phase|Protocol Violation|0
342934|NCT00521339|1117985|P2|Treatment Phase|Protocol Violation|0
342935|NCT00521339|1117986|P1|Treatment Phase|Protocol Violation|1
342936|NCT00521339|1117984|P3|Treatment Phase|Lost to Follow-up|0
342937|NCT00521339|1117985|P2|Treatment Phase|Lost to Follow-up|0
342938|NCT00521339|1117986|P1|Treatment Phase|Lost to Follow-up|1
342939|NCT00521339|1117984|P3|Treatment Phase|Withdrawal by Subject|0
342940|NCT00521339|1117985|P2|Treatment Phase|Withdrawal by Subject|0
342941|NCT00521339|1117986|P1|Treatment Phase|Withdrawal by Subject|3
342942|NCT00521339|1117984|P3|Treatment Phase|Lack of Efficacy|0
342943|NCT00521339|1117985|P2|Treatment Phase|Lack of Efficacy|0
342944|NCT00521339|1117986|P1|Treatment Phase|Lack of Efficacy|3
342945|NCT00521339|1117984|P3|Treatment Phase|Intolerability to study drug|0
342946|NCT00521339|1117985|P2|Treatment Phase|Intolerability to study drug|0
342947|NCT00521339|1117986|P1|Treatment Phase|Intolerability to study drug|2
342948|NCT00521339|1117984|P3|Treatment Phase|Adverse Event|0
342949|NCT00521339|1117985|P2|Treatment Phase|Adverse Event|0
342950|NCT00521339|1117986|P1|Treatment Phase|Adverse Event|2
342951|NCT00521144|1118054|P5|Overall Study|Progressive Disease|6
342952|NCT00521144|1118055|P4|Overall Study|Progressive Disease|0
342953|NCT00521144|1118056|P3|Overall Study|Progressive Disease|2
342954|NCT00521144|1118057|P2|Overall Study|Progressive Disease|2
342955|NCT00521144|1118058|P1|Overall Study|Progressive Disease|4
342956|NCT00521144|1118054|P5|Overall Study|Adverse Event|1
342957|NCT00521144|1118055|P4|Overall Study|Adverse Event|0
342958|NCT00521144|1118056|P3|Overall Study|Adverse Event|0
342959|NCT00521144|1118057|P2|Overall Study|Adverse Event|1
342960|NCT00521144|1118058|P1|Overall Study|Adverse Event|0
342961|NCT00521144|1118054|P5|Overall Study|Not Treated|0
342962|NCT00521144|1118055|P4|Overall Study|Not Treated|1
342963|NCT00521144|1118056|P3|Overall Study|Not Treated|0
342964|NCT00521144|1118057|P2|Overall Study|Not Treated|0
342965|NCT00521144|1118058|P1|Overall Study|Not Treated|0
342966|NCT00521079|1118072|P2|Overall Study|Withdrawal by Subject|3
342967|NCT00521079|1118073|P1|Overall Study|Withdrawal by Subject|5
342968|NCT00521079|1118072|P2|Overall Study|Lost to Follow-up|1
342969|NCT00521079|1118073|P1|Overall Study|Lost to Follow-up|2
342970|NCT00521079|1118072|P2|Overall Study|Adverse Event|1
342971|NCT00521079|1118073|P1|Overall Study|Adverse Event|7
342972|NCT00521053|1118083|P1|Observation Phase|Physician Decision|1
342973|NCT00521053|1118083|P1|Observation Phase|Other non-study melanoma treatment|1
342974|NCT00521053|1118083|P1|Observation Phase|Adverse Event|1
342975|NCT00521053|1118083|P1|Observation Phase|Death|2
342976|NCT00521053|1118083|P1|Observation Phase|Additional PV-10 via alternate protocol|8
342977|NCT00521053|1118083|P1|Observation Phase|Disease Progression|55
342978|NCT00521014|1118093|P1|Overall Study|Inevaluable, not treated|1
342979|NCT00521001|1118097|P1|Overall Study|Ineligible|1
342980|NCT00520975|1118106|P2|Overall Study|Not start protocol therapy|2
342981|NCT00520975|1118107|P1|Overall Study|Not start protocol therapy|1
342982|NCT00520975|1118106|P2|Overall Study|Other reasons|2
342983|NCT00520975|1118107|P1|Overall Study|Other reasons|4
342984|NCT00520975|1118106|P2|Overall Study|Other therapy|4
342985|NCT00520975|1118107|P1|Overall Study|Other therapy|2
342986|NCT00520975|1118106|P2|Overall Study|Withdrawal by Subject|5
342987|NCT00520975|1118107|P1|Overall Study|Withdrawal by Subject|3
342988|NCT00520975|1118106|P2|Overall Study|Death|2
342989|NCT00520975|1118107|P1|Overall Study|Death|0
342990|NCT00520975|1118106|P2|Overall Study|Adverse Event|10
342991|NCT00520975|1118107|P1|Overall Study|Adverse Event|7
342992|NCT00520975|1118106|P2|Overall Study|Disease progression|23
342993|NCT00520975|1118107|P1|Overall Study|Disease progression|31
342994|NCT00520936|1118139|P8|Overall Study|Protocol Violation|0
342995|NCT00520936|1118140|P7|Overall Study|Protocol Violation|1
342996|NCT00520936|1118141|P6|Overall Study|Protocol Violation|0
342997|NCT00520936|1118142|P5|Overall Study|Protocol Violation|1
342998|NCT00520936|1118143|P4|Overall Study|Protocol Violation|0
342999|NCT00520936|1118144|P3|Overall Study|Protocol Violation|1
343000|NCT00520936|1118145|P2|Overall Study|Protocol Violation|1
343001|NCT00520936|1118146|P1|Overall Study|Protocol Violation|0
343002|NCT00520936|1118139|P8|Overall Study|Death|0
343003|NCT00520936|1118140|P7|Overall Study|Death|1
343004|NCT00520936|1118141|P6|Overall Study|Death|0
343005|NCT00520936|1118142|P5|Overall Study|Death|0
343006|NCT00520936|1118143|P4|Overall Study|Death|0
343007|NCT00520936|1118144|P3|Overall Study|Death|0
343008|NCT00520936|1118145|P2|Overall Study|Death|0
343009|NCT00520936|1118146|P1|Overall Study|Death|0
343010|NCT00520936|1118139|P8|Overall Study|Toxicity Requiring Removal from Study|0
343011|NCT00520936|1118140|P7|Overall Study|Toxicity Requiring Removal from Study|2
343012|NCT00520936|1118141|P6|Overall Study|Toxicity Requiring Removal from Study|0
343013|NCT00520936|1118142|P5|Overall Study|Toxicity Requiring Removal from Study|0
343014|NCT00520936|1118143|P4|Overall Study|Toxicity Requiring Removal from Study|0
343015|NCT00520936|1118144|P3|Overall Study|Toxicity Requiring Removal from Study|0
343016|NCT00520936|1118145|P2|Overall Study|Toxicity Requiring Removal from Study|1
343017|NCT00520936|1118146|P1|Overall Study|Toxicity Requiring Removal from Study|0
343018|NCT00520936|1118139|P8|Overall Study|Withdrawal by Subject|1
343019|NCT00520936|1118140|P7|Overall Study|Withdrawal by Subject|0
343020|NCT00520936|1118141|P6|Overall Study|Withdrawal by Subject|0
343021|NCT00520936|1118142|P5|Overall Study|Withdrawal by Subject|0
343022|NCT00520936|1118143|P4|Overall Study|Withdrawal by Subject|0
343023|NCT00520936|1118144|P3|Overall Study|Withdrawal by Subject|0
343024|NCT00520936|1118145|P2|Overall Study|Withdrawal by Subject|0
343025|NCT00520936|1118146|P1|Overall Study|Withdrawal by Subject|0
343026|NCT00520936|1118139|P8|Overall Study|Physician Decision|0
343027|NCT00520936|1118140|P7|Overall Study|Physician Decision|0
343028|NCT00520936|1118141|P6|Overall Study|Physician Decision|0
343029|NCT00520936|1118142|P5|Overall Study|Physician Decision|0
343030|NCT00520936|1118143|P4|Overall Study|Physician Decision|0
343031|NCT00520936|1118144|P3|Overall Study|Physician Decision|1
343032|NCT00520936|1118145|P2|Overall Study|Physician Decision|2
343033|NCT00520936|1118146|P1|Overall Study|Physician Decision|0
343034|NCT00520845|1118173|P1|Overall Study|Alternative Therapy|1
343035|NCT00520845|1118173|P1|Overall Study|Withdrawal by Subject|1
343036|NCT00520845|1118173|P1|Overall Study|Disease Progression, relapse|13
343037|NCT00520845|1118173|P1|Overall Study|Adverse Event|4
343038|NCT00520845|1118173|P1|Overall Study|Death|3
343039|NCT00520767|1118181|P1|Overall Study|Death|2
343040|NCT00520741|1118187|P2|Overall Study|Other reasons for premature termination|6
343041|NCT00520741|1118188|P1|Overall Study|Other reasons for premature termination|0
343042|NCT00520741|1118187|P2|Overall Study|Lost to Follow-up|4
343043|NCT00520741|1118188|P1|Overall Study|Lost to Follow-up|4
343044|NCT00520741|1118187|P2|Overall Study|Unsatisfactory compliance of subject|3
343045|NCT00520741|1118188|P1|Overall Study|Unsatisfactory compliance of subject|4
343046|NCT00520741|1118187|P2|Overall Study|Protocol Violation|15
343047|NCT00520741|1118188|P1|Overall Study|Protocol Violation|2
343048|NCT00520741|1118187|P2|Overall Study|Withdrawal by Subject|11
343049|NCT00520741|1118188|P1|Overall Study|Withdrawal by Subject|0
343050|NCT00520741|1118187|P2|Overall Study|Lack of Efficacy|30
343051|NCT00520741|1118188|P1|Overall Study|Lack of Efficacy|11
343052|NCT00520741|1118187|P2|Overall Study|Adverse Event|56
343053|NCT00520741|1118188|P1|Overall Study|Adverse Event|16
343054|NCT00520676|1118206|P2|Overall Study|Withdrawal by Subject|11
343055|NCT00520676|1118207|P1|Overall Study|Withdrawal by Subject|7
343056|NCT00520676|1118206|P2|Overall Study|Physician Decision|1
343057|NCT00520676|1118207|P1|Overall Study|Physician Decision|4
343058|NCT00520676|1118206|P2|Overall Study|Lost to Follow-up|10
343059|NCT00520676|1118207|P1|Overall Study|Lost to Follow-up|6
343060|NCT00520676|1118206|P2|Overall Study|Death|81
343061|NCT00520676|1118207|P1|Overall Study|Death|84
343062|NCT00520572|1118233|P6|Overall Study|Did not receive Treatment|0
343063|NCT00520572|1118234|P5|Overall Study|Did not receive Treatment|0
343064|NCT00520572|1118235|P4|Overall Study|Did not receive Treatment|0
343065|NCT00520572|1118236|P3|Overall Study|Did not receive Treatment|1
343066|NCT00520572|1118237|P2|Overall Study|Did not receive Treatment|0
343067|NCT00520572|1118238|P1|Overall Study|Did not receive Treatment|1
343068|NCT00520572|1118233|P6|Overall Study|Long break in taking Medication|0
343069|NCT00520572|1118234|P5|Overall Study|Long break in taking Medication|0
343070|NCT00520572|1118235|P4|Overall Study|Long break in taking Medication|1
343071|NCT00520572|1118236|P3|Overall Study|Long break in taking Medication|0
343072|NCT00520572|1118237|P2|Overall Study|Long break in taking Medication|0
343073|NCT00520572|1118238|P1|Overall Study|Long break in taking Medication|0
343074|NCT00520572|1118233|P6|Overall Study|Oral corticotherapy for acute urticaria|0
343075|NCT00520572|1118234|P5|Overall Study|Oral corticotherapy for acute urticaria|0
343076|NCT00520572|1118235|P4|Overall Study|Oral corticotherapy for acute urticaria|0
343077|NCT00520572|1118236|P3|Overall Study|Oral corticotherapy for acute urticaria|0
343078|NCT00520572|1118237|P2|Overall Study|Oral corticotherapy for acute urticaria|1
343079|NCT00520572|1118238|P1|Overall Study|Oral corticotherapy for acute urticaria|0
343080|NCT00520572|1118233|P6|Overall Study|Incorrect enrollment|0
343081|NCT00520572|1118234|P5|Overall Study|Incorrect enrollment|1
343082|NCT00520572|1118235|P4|Overall Study|Incorrect enrollment|0
343083|NCT00520572|1118236|P3|Overall Study|Incorrect enrollment|1
343084|NCT00520572|1118237|P2|Overall Study|Incorrect enrollment|0
343085|NCT00520572|1118238|P1|Overall Study|Incorrect enrollment|1
343086|NCT00520572|1118233|P6|Overall Study|Lost to Follow-up|0
343087|NCT00520572|1118234|P5|Overall Study|Lost to Follow-up|1
343088|NCT00520572|1118235|P4|Overall Study|Lost to Follow-up|0
343089|NCT00520572|1118236|P3|Overall Study|Lost to Follow-up|0
343090|NCT00520572|1118237|P2|Overall Study|Lost to Follow-up|0
343091|NCT00520572|1118238|P1|Overall Study|Lost to Follow-up|0
343092|NCT00520572|1118233|P6|Overall Study|Lack of Efficacy|0
343093|NCT00520572|1118234|P5|Overall Study|Lack of Efficacy|1
343094|NCT00520572|1118235|P4|Overall Study|Lack of Efficacy|2
343095|NCT00520572|1118236|P3|Overall Study|Lack of Efficacy|1
343096|NCT00520572|1118237|P2|Overall Study|Lack of Efficacy|1
343097|NCT00520572|1118238|P1|Overall Study|Lack of Efficacy|1
343098|NCT00520572|1118233|P6|Overall Study|Protocol Violation|0
343099|NCT00520572|1118234|P5|Overall Study|Protocol Violation|0
343100|NCT00520572|1118235|P4|Overall Study|Protocol Violation|0
343101|NCT00520572|1118236|P3|Overall Study|Protocol Violation|1
343102|NCT00520572|1118237|P2|Overall Study|Protocol Violation|0
343103|NCT00520572|1118238|P1|Overall Study|Protocol Violation|0
343104|NCT00520572|1118233|P6|Overall Study|Withdrawal by Subject|0
343105|NCT00520572|1118234|P5|Overall Study|Withdrawal by Subject|2
343106|NCT00520572|1118235|P4|Overall Study|Withdrawal by Subject|2
343107|NCT00520572|1118236|P3|Overall Study|Withdrawal by Subject|5
343108|NCT00520572|1118237|P2|Overall Study|Withdrawal by Subject|9
343109|NCT00520572|1118238|P1|Overall Study|Withdrawal by Subject|0
343110|NCT00520572|1118233|P6|Overall Study|Adverse Event|2
343111|NCT00520572|1118234|P5|Overall Study|Adverse Event|7
343112|NCT00520572|1118235|P4|Overall Study|Adverse Event|9
343113|NCT00520572|1118236|P3|Overall Study|Adverse Event|6
343114|NCT00520572|1118237|P2|Overall Study|Adverse Event|3
343115|NCT00520572|1118238|P1|Overall Study|Adverse Event|9
343116|NCT00520546|1118276|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
343117|NCT00520546|1118276|P1|Overall Study|Withdrawal by Subject|1
343118|NCT00519831|1118291|P1|Overall Study|Adverse Event|3
343119|NCT00519779|1118308|P2|Overall Study|Withdrawal by Subject|1
343120|NCT00519779|1118309|P1|Overall Study|Withdrawal by Subject|0
343121|NCT00520494|1118325|P1|Overall Study|Withdrawal by Subject|1
343122|NCT00520403|1118352|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
343123|NCT00520403|1118352|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
343124|NCT00520403|1118352|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
343125|NCT00520403|1118352|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
343126|NCT00520403|1118352|P1|Bevacizumab + IFN/Vinblastine|Death|2
343127|NCT00520403|1118352|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
343128|NCT00520403|1118352|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
343129|NCT00520403|1118352|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
343130|NCT00520351|1118361|P2|First Intervention|Withdrawal by Subject|1
343131|NCT00520351|1118362|P1|First Intervention|Withdrawal by Subject|1
343132|NCT00520299|1118377|P3|Overall Study|Progressive disease|4
343133|NCT00520299|1118378|P2|Overall Study|Progressive disease|3
343134|NCT00520299|1118379|P1|Overall Study|Progressive disease|0
343135|NCT00520299|1118377|P3|Overall Study|Withdrawal by Subject|2
343136|NCT00520299|1118378|P2|Overall Study|Withdrawal by Subject|0
343137|NCT00520299|1118379|P1|Overall Study|Withdrawal by Subject|0
343138|NCT00520013|1118435|P3|Overall Study|Physician Decision|3
343139|NCT00520013|1118436|P2|Overall Study|Physician Decision|0
343140|NCT00520013|1118437|P1|Overall Study|Physician Decision|0
343141|NCT00520013|1118435|P3|Overall Study|Death|0
343142|NCT00520013|1118436|P2|Overall Study|Death|1
343143|NCT00520013|1118437|P1|Overall Study|Death|0
343144|NCT00520013|1118435|P3|Overall Study|Clinical Progression|0
343145|NCT00520013|1118436|P2|Overall Study|Clinical Progression|1
343146|NCT00520013|1118437|P1|Overall Study|Clinical Progression|3
343147|NCT00520013|1118435|P3|Overall Study|Progressive Disease|0
343148|NCT00520013|1118436|P2|Overall Study|Progressive Disease|3
343149|NCT00520013|1118437|P1|Overall Study|Progressive Disease|7
343150|NCT00520013|1118435|P3|Overall Study|Adverse Event|7
343151|NCT00520013|1118436|P2|Overall Study|Adverse Event|10
343152|NCT00520013|1118437|P1|Overall Study|Adverse Event|2
343153|NCT00520013|1118435|P3|Overall Study|Withdrawal by Subject|1
343154|NCT00520013|1118436|P2|Overall Study|Withdrawal by Subject|0
343155|NCT00520013|1118437|P1|Overall Study|Withdrawal by Subject|0
343156|NCT00519896|1118447|P1|Overall Study|Adverse Event|1
343157|NCT00519896|1118447|P1|Overall Study|Protocol Violation|1
343158|NCT00519649|1118453|P1|Overall Study|Withdrawal by Subject|1
343159|NCT00519636|1118466|P4|Post Study Period|Subject randomized in error|1
343160|NCT00519636|1118467|P3|Post Study Period|Subject randomized in error|0
343161|NCT00519636|1118468|P2|Post Study Period|Subject randomized in error|0
343162|NCT00519636|1118469|P1|Post Study Period|Subject randomized in error|0
343163|NCT00519636|1118466|P4|Treatment Period 2|Subject misrandomized|1
343164|NCT00519636|1118467|P3|Treatment Period 2|Subject misrandomized|0
343165|NCT00519636|1118468|P2|Treatment Period 2|Subject misrandomized|0
343166|NCT00519636|1118469|P1|Treatment Period 2|Subject misrandomized|0
343167|NCT00519636|1118466|P4|Treatment Period 2|Per doctors request|0
343168|NCT00519636|1118467|P3|Treatment Period 2|Per doctors request|1
343169|NCT00519636|1118468|P2|Treatment Period 2|Per doctors request|0
343170|NCT00519636|1118469|P1|Treatment Period 2|Per doctors request|0
343171|NCT00519636|1118466|P4|Treatment Period 2|Subject randomized in error|0
343172|NCT00519636|1118467|P3|Treatment Period 2|Subject randomized in error|0
343173|NCT00519636|1118468|P2|Treatment Period 2|Subject randomized in error|1
343174|NCT00519636|1118469|P1|Treatment Period 2|Subject randomized in error|0
343175|NCT00519636|1118466|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
343176|NCT00519636|1118467|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
343177|NCT00519636|1118468|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
343178|NCT00519636|1118469|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
343179|NCT00519636|1118466|P4|Washout Period|Prohibited medications|0
343180|NCT00519636|1118467|P3|Washout Period|Prohibited medications|1
343181|NCT00519636|1118468|P2|Washout Period|Prohibited medications|0
343182|NCT00519636|1118469|P1|Washout Period|Prohibited medications|0
343183|NCT00519636|1118466|P4|Washout Period|Subject randomized in error|0
343184|NCT00519636|1118467|P3|Washout Period|Subject randomized in error|1
343185|NCT00519636|1118468|P2|Washout Period|Subject randomized in error|0
343186|NCT00519636|1118469|P1|Washout Period|Subject randomized in error|0
343187|NCT00519636|1118466|P4|Washout Period|Per doctors request|0
343188|NCT00519636|1118467|P3|Washout Period|Per doctors request|0
343189|NCT00519636|1118468|P2|Washout Period|Per doctors request|1
343190|NCT00519636|1118469|P1|Washout Period|Per doctors request|0
343191|NCT00519636|1118466|P4|Washout Period|Non-compliant|0
343192|NCT00519636|1118467|P3|Washout Period|Non-compliant|0
343193|NCT00519636|1118468|P2|Washout Period|Non-compliant|1
343194|NCT00519636|1118469|P1|Washout Period|Non-compliant|0
343195|NCT00519636|1118466|P4|Washout Period|Participating in study at another site|0
343196|NCT00519636|1118467|P3|Washout Period|Participating in study at another site|0
343197|NCT00519636|1118468|P2|Washout Period|Participating in study at another site|0
343198|NCT00519636|1118469|P1|Washout Period|Participating in study at another site|1
343199|NCT00519636|1118466|P4|Washout Period|Out of pollen area > 48 hours|0
343200|NCT00519636|1118467|P3|Washout Period|Out of pollen area > 48 hours|0
343201|NCT00519636|1118468|P2|Washout Period|Out of pollen area > 48 hours|0
343202|NCT00519636|1118469|P1|Washout Period|Out of pollen area > 48 hours|1
343203|NCT00519636|1118466|P4|Washout Period|Failed to meet continuation criteria|3
343204|NCT00519636|1118467|P3|Washout Period|Failed to meet continuation criteria|9
343205|NCT00519636|1118468|P2|Washout Period|Failed to meet continuation criteria|11
343206|NCT00519636|1118469|P1|Washout Period|Failed to meet continuation criteria|14
343207|NCT00519636|1118466|P4|Washout Period|Withdrawal by Subject|0
343208|NCT00519636|1118467|P3|Washout Period|Withdrawal by Subject|1
343209|NCT00519636|1118468|P2|Washout Period|Withdrawal by Subject|0
343210|NCT00519636|1118469|P1|Washout Period|Withdrawal by Subject|1
343211|NCT00519636|1118466|P4|Washout Period|Protocol Violation|2
343212|NCT00519636|1118467|P3|Washout Period|Protocol Violation|1
343213|NCT00519636|1118468|P2|Washout Period|Protocol Violation|0
343214|NCT00519636|1118469|P1|Washout Period|Protocol Violation|0
343215|NCT00519636|1118466|P4|Washout Period|Lost to Follow-up|0
343216|NCT00519636|1118467|P3|Washout Period|Lost to Follow-up|0
343217|NCT00519636|1118468|P2|Washout Period|Lost to Follow-up|0
343218|NCT00519636|1118469|P1|Washout Period|Lost to Follow-up|1
343219|NCT00519636|1118466|P4|Washout Period|Adverse Event|0
343220|NCT00519636|1118467|P3|Washout Period|Adverse Event|1
343221|NCT00519636|1118468|P2|Washout Period|Adverse Event|1
343222|NCT00519636|1118469|P1|Washout Period|Adverse Event|2
343223|NCT00519636|1118466|P4|Treatment Period 1|Sponsor request due to missed visit|0
343224|NCT00519636|1118467|P3|Treatment Period 1|Sponsor request due to missed visit|0
343225|NCT00519636|1118468|P2|Treatment Period 1|Sponsor request due to missed visit|0
343226|NCT00519636|1118469|P1|Treatment Period 1|Sponsor request due to missed visit|1
343227|NCT00519636|1118466|P4|Treatment Period 1|Adverse Event|0
343228|NCT00519636|1118467|P3|Treatment Period 1|Adverse Event|1
343229|NCT00519636|1118468|P2|Treatment Period 1|Adverse Event|0
343230|NCT00519636|1118469|P1|Treatment Period 1|Adverse Event|1
343231|NCT00519623|1118499|P1|Overall Study|Adverse Event|1
343232|NCT00519532|1118504|P1|Overall Study|Lost to Follow-up|2
343233|NCT00519532|1118504|P1|Overall Study|Withdrawal by Subject|5
343234|NCT00519532|1118504|P1|Overall Study|Adverse Event|11
343235|NCT00519376|1118511|P16|Treatment Period 4|Lost to Follow-up|0
343236|NCT00519376|1118512|P15|Treatment Period 4|Lost to Follow-up|0
343237|NCT00519376|1118513|P14|Treatment Period 4|Lost to Follow-up|0
343238|NCT00519376|1118514|P13|Treatment Period 4|Lost to Follow-up|0
343239|NCT00519376|1118515|P12|Treatment Period 4|Lost to Follow-up|0
343240|NCT00519376|1118516|P11|Treatment Period 4|Lost to Follow-up|0
343241|NCT00519376|1118517|P10|Treatment Period 4|Lost to Follow-up|0
343242|NCT00519376|1118518|P9|Treatment Period 4|Lost to Follow-up|0
343243|NCT00519376|1118519|P8|Treatment Period 4|Lost to Follow-up|0
343244|NCT00519376|1118520|P7|Treatment Period 4|Lost to Follow-up|0
343245|NCT00519376|1118521|P6|Treatment Period 4|Lost to Follow-up|0
343246|NCT00519376|1118522|P5|Treatment Period 4|Lost to Follow-up|0
343247|NCT00519376|1118523|P4|Treatment Period 4|Lost to Follow-up|0
343248|NCT00519376|1118524|P3|Treatment Period 4|Lost to Follow-up|1
343249|NCT00519376|1118525|P2|Treatment Period 4|Lost to Follow-up|0
343250|NCT00519376|1118526|P1|Treatment Period 4|Lost to Follow-up|0
343251|NCT00519376|1118511|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343252|NCT00519376|1118512|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343253|NCT00519376|1118513|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343254|NCT00519376|1118514|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
343255|NCT00519376|1118515|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343256|NCT00519376|1118516|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343257|NCT00519376|1118517|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343258|NCT00519376|1118518|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343259|NCT00519376|1118519|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343260|NCT00519376|1118520|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343261|NCT00519376|1118521|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343262|NCT00519376|1118522|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343263|NCT00519376|1118523|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343264|NCT00519376|1118524|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343265|NCT00519376|1118525|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343266|NCT00519376|1118526|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
343267|NCT00519285|1118650|P2|Overall Study|Treatment ongoing|2
343268|NCT00519285|1118651|P1|Overall Study|Treatment ongoing|1
343269|NCT00519285|1118650|P2|Overall Study|Not treated|7
343270|NCT00519285|1118651|P1|Overall Study|Not treated|8
343271|NCT00519285|1118650|P2|Overall Study|Reason unspecified|8
343272|NCT00519285|1118651|P1|Overall Study|Reason unspecified|5
343273|NCT00519285|1118650|P2|Overall Study|Poor compliance to protocol|7
343274|NCT00519285|1118651|P1|Overall Study|Poor compliance to protocol|5
343275|NCT00519285|1118650|P2|Overall Study|Consent withdrawn|5
343276|NCT00519285|1118651|P1|Overall Study|Consent withdrawn|4
343277|NCT00519285|1118650|P2|Overall Study|Participant's request|84
343278|NCT00519285|1118651|P1|Overall Study|Participant's request|53
343279|NCT00519285|1118650|P2|Overall Study|Physician Decision|47
343280|NCT00519285|1118651|P1|Overall Study|Physician Decision|75
343281|NCT00519285|1118650|P2|Overall Study|Disease progression|186
343282|NCT00519285|1118651|P1|Overall Study|Disease progression|334
343283|NCT00519285|1118650|P2|Overall Study|Adverse Event|266
343284|NCT00519285|1118651|P1|Overall Study|Adverse Event|127
343285|NCT00519194|1118677|P1|Overall Study|Lost to Follow-up|3
343286|NCT00519194|1118677|P1|Overall Study|Death|9
343287|NCT00519194|1118677|P1|Overall Study|Withdrawal by Subject|9
343288|NCT00519077|1118692|P1|Overall Study|Other|2
343289|NCT00519077|1118692|P1|Overall Study|Death|6
343290|NCT00518986|1118699|P2|Overall Study|Non-Specific|1
343291|NCT00518986|1118700|P1|Overall Study|Non-Specific|2
343292|NCT00518986|1118699|P2|Overall Study|Withdrawal by Subject|4
343293|NCT00518986|1118700|P1|Overall Study|Withdrawal by Subject|4
343294|NCT00518986|1118699|P2|Overall Study|Protocol Violation|7
343295|NCT00518986|1118700|P1|Overall Study|Protocol Violation|5
343296|NCT00518986|1118699|P2|Overall Study|Physician Decision|3
343297|NCT00518986|1118700|P1|Overall Study|Physician Decision|0
343298|NCT00518986|1118699|P2|Overall Study|Lost to Follow-up|2
343299|NCT00518986|1118700|P1|Overall Study|Lost to Follow-up|3
343300|NCT00518986|1118699|P2|Overall Study|Lack of Efficacy|2
343301|NCT00518986|1118700|P1|Overall Study|Lack of Efficacy|0
343302|NCT00518986|1118699|P2|Overall Study|Adverse Event|7
343303|NCT00518986|1118700|P1|Overall Study|Adverse Event|12
343304|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
343305|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
343306|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Subject decision|0
343307|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Subject decision|2
343308|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
343309|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
343310|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
343311|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
343312|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Creatine increased|0
343313|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Creatine increased|1
343314|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Change in treatment|1
343315|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Change in treatment|1
343316|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
343317|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
343318|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
343319|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
343320|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
343321|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
343322|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
343323|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
343324|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
343325|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
343326|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
343327|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
343328|NCT00518882|1118826|P2|Open-Label Extension, Week 26-78|Adverse Event|9
343329|NCT00518882|1118827|P1|Open-Label Extension, Week 26-78|Adverse Event|3
343330|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Mutual consent|1
343331|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Mutual consent|0
343332|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
343333|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
343334|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
343335|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
343336|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Loss of trust|1
343337|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Loss of trust|0
343338|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
343339|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
343340|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Subject decision|1
343341|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Subject decision|1
343342|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Lost to follow up|1
343343|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Lost to follow up|2
343344|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
343345|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
343346|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Protocol Violation|3
343347|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Protocol Violation|4
343348|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
343349|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
343350|NCT00518882|1118826|P2|Double-Blind, Week 0-26|Adverse Event|31
343351|NCT00518882|1118827|P1|Double-Blind, Week 0-26|Adverse Event|23
343352|NCT00517699|1119006|P1|Overall Study|Study terminated by Sponsor|2
343353|NCT00517699|1119006|P1|Overall Study|Administrative error|1
343354|NCT00517699|1119006|P1|Overall Study|Lack of Efficacy|1
343355|NCT00517699|1119006|P1|Overall Study|Withdrawal by Subject|1
343356|NCT00517634|1119014|P6|Second Treatment Period|Withdrawal by Subject|0
343357|NCT00517634|1119015|P5|Second Treatment Period|Withdrawal by Subject|1
343358|NCT00517634|1119016|P4|Second Treatment Period|Withdrawal by Subject|0
343359|NCT00517634|1119017|P3|Second Treatment Period|Withdrawal by Subject|0
343360|NCT00517634|1119018|P2|Second Treatment Period|Withdrawal by Subject|0
343361|NCT00517634|1119019|P1|Second Treatment Period|Withdrawal by Subject|0
343362|NCT00518687|1119032|P2|Overall Study|Withdrawal by Subject|110
343363|NCT00518687|1119033|P1|Overall Study|Withdrawal by Subject|110
343364|NCT00518687|1119032|P2|Overall Study|Study terminated by sponsor|918
343365|NCT00518687|1119033|P1|Overall Study|Study terminated by sponsor|930
343366|NCT00518687|1119032|P2|Overall Study|Protocol Violation|10
343367|NCT00518687|1119033|P1|Overall Study|Protocol Violation|8
343368|NCT00518687|1119032|P2|Overall Study|Progressive disease|2
343369|NCT00518687|1119033|P1|Overall Study|Progressive disease|2
343370|NCT00518687|1119032|P2|Overall Study|Physician Decision|48
343371|NCT00518687|1119033|P1|Overall Study|Physician Decision|42
343372|NCT00518687|1119032|P2|Overall Study|Lost to Follow-up|155
343373|NCT00518687|1119033|P1|Overall Study|Lost to Follow-up|144
343374|NCT00518687|1119032|P2|Overall Study|Adverse Event|177
343375|NCT00518687|1119033|P1|Overall Study|Adverse Event|201
343376|NCT00518622|1119053|P8|Overall Study|Study medication taken incorrectly|0
343377|NCT00518622|1119054|P7|Overall Study|Study medication taken incorrectly|0
343378|NCT00518622|1119055|P6|Overall Study|Study medication taken incorrectly|0
343379|NCT00518622|1119056|P5|Overall Study|Study medication taken incorrectly|0
343380|NCT00518622|1119057|P4|Overall Study|Study medication taken incorrectly|0
343381|NCT00518622|1119058|P3|Overall Study|Study medication taken incorrectly|0
343382|NCT00518622|1119059|P2|Overall Study|Study medication taken incorrectly|1
343383|NCT00518622|1119060|P1|Overall Study|Study medication taken incorrectly|0
343384|NCT00518622|1119053|P8|Overall Study|Lost to Follow-up|0
343385|NCT00518622|1119054|P7|Overall Study|Lost to Follow-up|0
343386|NCT00518622|1119055|P6|Overall Study|Lost to Follow-up|0
343387|NCT00518622|1119056|P5|Overall Study|Lost to Follow-up|0
343388|NCT00518622|1119057|P4|Overall Study|Lost to Follow-up|0
343389|NCT00518622|1119058|P3|Overall Study|Lost to Follow-up|1
343390|NCT00518622|1119059|P2|Overall Study|Lost to Follow-up|0
343391|NCT00518622|1119060|P1|Overall Study|Lost to Follow-up|0
343392|NCT00518531|1119088|P2|Treatment Period 2|Non-compliance|2
343393|NCT00518531|1119089|P1|Treatment Period 2|Non-compliance|1
343394|NCT00518531|1119088|P2|Treatment Period 2|Protocol-specified criteria|1
343395|NCT00518531|1119089|P1|Treatment Period 2|Protocol-specified criteria|0
343396|NCT00518531|1119088|P2|Treatment Period 2|Adverse Event|7
343397|NCT00518531|1119089|P1|Treatment Period 2|Adverse Event|1
343398|NCT00518531|1119088|P2|Treatment Period 2|Complete out of scheduled visit window|2
343399|NCT00518531|1119089|P1|Treatment Period 2|Complete out of scheduled visit window|1
343400|NCT00518531|1119088|P2|Treatment Period 2|Withdrawal by Subject|8
343401|NCT00518531|1119089|P1|Treatment Period 2|Withdrawal by Subject|0
343402|NCT00518531|1119088|P2|Treatment Period 1|Early crossover|3
343403|NCT00518531|1119089|P1|Treatment Period 1|Early crossover|1
343404|NCT00518531|1119088|P2|Treatment Period 1|Withdrawal by Subject|6
343405|NCT00518531|1119089|P1|Treatment Period 1|Withdrawal by Subject|4
343406|NCT00518531|1119088|P2|Treatment Period 1|Protocol Violation|0
343407|NCT00518531|1119089|P1|Treatment Period 1|Protocol Violation|2
343408|NCT00518531|1119088|P2|Treatment Period 1|Physician Decision|0
343409|NCT00518531|1119089|P1|Treatment Period 1|Physician Decision|1
343410|NCT00518531|1119088|P2|Treatment Period 1|Lost to Follow-up|3
343411|NCT00518531|1119089|P1|Treatment Period 1|Lost to Follow-up|5
343412|NCT00518531|1119088|P2|Treatment Period 1|Adverse Event|0
343413|NCT00518531|1119089|P1|Treatment Period 1|Adverse Event|5
343414|NCT00518336|1119125|P2|Year 9|Personal reasons|0
343415|NCT00518336|1119126|P1|Year 9|Personal reasons|1
343416|NCT00518336|1119125|P2|Year 9|Lost to Follow-up|0
343417|NCT00518336|1119126|P1|Year 9|Lost to Follow-up|3
343418|NCT00518336|1119125|P2|Year 9|Migrated/moved from study area|1
343419|NCT00518336|1119126|P1|Year 9|Migrated/moved from study area|1
343420|NCT00518336|1119125|P2|Year 8|Could not attend in time|1
343421|NCT00518336|1119126|P1|Year 8|Could not attend in time|0
343422|NCT00518336|1119125|P2|Year 8|Lost to Follow-up|1
343423|NCT00518336|1119126|P1|Year 8|Lost to Follow-up|1
343424|NCT00518336|1119125|P2|Year 7|Could not attend in time|3
343425|NCT00518336|1119126|P1|Year 7|Could not attend in time|0
343426|NCT00518336|1119125|P2|Year 7|Lost to Follow-up|0
343427|NCT00518336|1119126|P1|Year 7|Lost to Follow-up|2
343428|NCT00518323|1119292|P4|Overall Study|Prohibited medication and others|0
343429|NCT00518323|1119293|P3|Overall Study|Prohibited medication and others|1
343430|NCT00518323|1119294|P2|Overall Study|Prohibited medication and others|1
343431|NCT00518323|1119295|P1|Overall Study|Prohibited medication and others|3
343432|NCT00518323|1119292|P4|Overall Study|Adverse Event|0
343433|NCT00518323|1119293|P3|Overall Study|Adverse Event|1
343434|NCT00518323|1119294|P2|Overall Study|Adverse Event|1
343435|NCT00518323|1119295|P1|Overall Study|Adverse Event|1
343436|NCT00518323|1119292|P4|Overall Study|Lost to Follow-up|3
343437|NCT00518323|1119293|P3|Overall Study|Lost to Follow-up|1
343438|NCT00518323|1119294|P2|Overall Study|Lost to Follow-up|2
343439|NCT00518323|1119295|P1|Overall Study|Lost to Follow-up|0
343440|NCT00518323|1119292|P4|Overall Study|Withdrawal by Subject|2
343441|NCT00518323|1119293|P3|Overall Study|Withdrawal by Subject|4
343442|NCT00518323|1119294|P2|Overall Study|Withdrawal by Subject|2
343443|NCT00518323|1119295|P1|Overall Study|Withdrawal by Subject|1
343444|NCT00518323|1119292|P4|Overall Study|Lack of Efficacy|20
343445|NCT00518323|1119293|P3|Overall Study|Lack of Efficacy|4
343446|NCT00518323|1119294|P2|Overall Study|Lack of Efficacy|2
343447|NCT00518323|1119295|P1|Overall Study|Lack of Efficacy|14
343448|NCT00518284|1119325|P4|Overall Study|Study Termination|2
343449|NCT00518284|1119326|P3|Overall Study|Study Termination|1
343450|NCT00518284|1119327|P2|Overall Study|Study Termination|2
343451|NCT00518284|1119328|P1|Overall Study|Study Termination|0
343452|NCT00518284|1119325|P4|Overall Study|Adverse Event|0
343453|NCT00518284|1119326|P3|Overall Study|Adverse Event|0
343454|NCT00518284|1119327|P2|Overall Study|Adverse Event|1
343455|NCT00518284|1119328|P1|Overall Study|Adverse Event|0
343456|NCT00518180|1119385|P3|Overall Study|Adverse Event|0
343457|NCT00518180|1119386|P2|Overall Study|Adverse Event|0
343458|NCT00518180|1119387|P1|Overall Study|Adverse Event|1
343459|NCT00518180|1119385|P3|Overall Study|Unable to classify|0
343460|NCT00518180|1119386|P2|Overall Study|Unable to classify|2
343461|NCT00518180|1119387|P1|Overall Study|Unable to classify|0
343462|NCT00518180|1119385|P3|Overall Study|Protocol Violation|4
343463|NCT00518180|1119386|P2|Overall Study|Protocol Violation|7
343464|NCT00518180|1119387|P1|Overall Study|Protocol Violation|5
343465|NCT00518180|1119385|P3|Overall Study|Administrative reason|2
343466|NCT00518180|1119386|P2|Overall Study|Administrative reason|2
343467|NCT00518180|1119387|P1|Overall Study|Administrative reason|0
343468|NCT00518180|1119385|P3|Overall Study|Lost to Follow-up|34
343469|NCT00518180|1119386|P2|Overall Study|Lost to Follow-up|28
343470|NCT00518180|1119387|P1|Overall Study|Lost to Follow-up|30
343471|NCT00518180|1119385|P3|Overall Study|Withdrawal by Subject|42
343472|NCT00518180|1119386|P2|Overall Study|Withdrawal by Subject|30
343473|NCT00518180|1119387|P1|Overall Study|Withdrawal by Subject|29
343474|NCT00518115|1119439|P10|Overall Study|Moved Out of State|1
343475|NCT00518115|1119440|P9|Overall Study|Moved Out of State|0
343476|NCT00518115|1119441|P8|Overall Study|Moved Out of State|0
343477|NCT00518115|1119442|P7|Overall Study|Moved Out of State|0
343478|NCT00518115|1119443|P6|Overall Study|Moved Out of State|0
343479|NCT00518115|1119444|P5|Overall Study|Moved Out of State|0
343480|NCT00518115|1119445|P4|Overall Study|Moved Out of State|0
343481|NCT00518115|1119446|P3|Overall Study|Moved Out of State|0
343482|NCT00518115|1119447|P2|Overall Study|Moved Out of State|0
343483|NCT00518115|1119448|P1|Overall Study|Moved Out of State|0
343484|NCT00518115|1119439|P10|Overall Study|Withdrew Consent|0
343485|NCT00518115|1119440|P9|Overall Study|Withdrew Consent|0
343486|NCT00518115|1119441|P8|Overall Study|Withdrew Consent|0
343487|NCT00518115|1119442|P7|Overall Study|Withdrew Consent|0
343488|NCT00518115|1119443|P6|Overall Study|Withdrew Consent|1
343489|NCT00518115|1119444|P5|Overall Study|Withdrew Consent|0
343490|NCT00518115|1119445|P4|Overall Study|Withdrew Consent|0
343491|NCT00518115|1119446|P3|Overall Study|Withdrew Consent|0
343492|NCT00518115|1119447|P2|Overall Study|Withdrew Consent|0
343493|NCT00518115|1119448|P1|Overall Study|Withdrew Consent|0
343494|NCT00518115|1119439|P10|Overall Study|Family Emergency; Had to Go to England|0
343495|NCT00518115|1119440|P9|Overall Study|Family Emergency; Had to Go to England|0
343496|NCT00518115|1119441|P8|Overall Study|Family Emergency; Had to Go to England|0
343497|NCT00518115|1119442|P7|Overall Study|Family Emergency; Had to Go to England|0
343498|NCT00518115|1119443|P6|Overall Study|Family Emergency; Had to Go to England|0
343499|NCT00518115|1119444|P5|Overall Study|Family Emergency; Had to Go to England|1
343500|NCT00518115|1119445|P4|Overall Study|Family Emergency; Had to Go to England|0
343501|NCT00518115|1119446|P3|Overall Study|Family Emergency; Had to Go to England|0
343502|NCT00518115|1119447|P2|Overall Study|Family Emergency; Had to Go to England|0
343503|NCT00518115|1119448|P1|Overall Study|Family Emergency; Had to Go to England|0
343504|NCT00518115|1119439|P10|Overall Study|Violation of Exclusion Criteria|0
343505|NCT00518115|1119440|P9|Overall Study|Violation of Exclusion Criteria|0
343506|NCT00518115|1119441|P8|Overall Study|Violation of Exclusion Criteria|0
343507|NCT00518115|1119442|P7|Overall Study|Violation of Exclusion Criteria|1
343508|NCT00518115|1119443|P6|Overall Study|Violation of Exclusion Criteria|0
343509|NCT00518115|1119444|P5|Overall Study|Violation of Exclusion Criteria|0
343510|NCT00518115|1119445|P4|Overall Study|Violation of Exclusion Criteria|1
343511|NCT00518115|1119446|P3|Overall Study|Violation of Exclusion Criteria|0
343512|NCT00518115|1119447|P2|Overall Study|Violation of Exclusion Criteria|0
343513|NCT00518115|1119448|P1|Overall Study|Violation of Exclusion Criteria|0
343514|NCT00518115|1119439|P10|Overall Study|Wrong Monotherapy Administered|0
343515|NCT00518115|1119440|P9|Overall Study|Wrong Monotherapy Administered|0
343516|NCT00518115|1119441|P8|Overall Study|Wrong Monotherapy Administered|0
343517|NCT00518115|1119442|P7|Overall Study|Wrong Monotherapy Administered|1
343518|NCT00518115|1119443|P6|Overall Study|Wrong Monotherapy Administered|0
343519|NCT00518115|1119444|P5|Overall Study|Wrong Monotherapy Administered|0
343520|NCT00518115|1119445|P4|Overall Study|Wrong Monotherapy Administered|0
343521|NCT00518115|1119446|P3|Overall Study|Wrong Monotherapy Administered|1
343522|NCT00518115|1119447|P2|Overall Study|Wrong Monotherapy Administered|0
343523|NCT00518115|1119448|P1|Overall Study|Wrong Monotherapy Administered|0
343524|NCT00518115|1119439|P10|Overall Study|Different Monotherapy Diabetic Drug|0
343525|NCT00518115|1119440|P9|Overall Study|Different Monotherapy Diabetic Drug|1
343526|NCT00518115|1119441|P8|Overall Study|Different Monotherapy Diabetic Drug|0
343527|NCT00518115|1119442|P7|Overall Study|Different Monotherapy Diabetic Drug|0
343528|NCT00518115|1119443|P6|Overall Study|Different Monotherapy Diabetic Drug|0
343529|NCT00518115|1119444|P5|Overall Study|Different Monotherapy Diabetic Drug|0
343530|NCT00518115|1119445|P4|Overall Study|Different Monotherapy Diabetic Drug|0
343531|NCT00518115|1119446|P3|Overall Study|Different Monotherapy Diabetic Drug|1
343532|NCT00518115|1119447|P2|Overall Study|Different Monotherapy Diabetic Drug|0
343533|NCT00518115|1119448|P1|Overall Study|Different Monotherapy Diabetic Drug|0
343534|NCT00518115|1119439|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
343535|NCT00518115|1119440|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
343536|NCT00518115|1119441|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
343537|NCT00518115|1119442|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
343538|NCT00518115|1119443|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
343539|NCT00518115|1119444|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
343540|NCT00518115|1119445|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
343541|NCT00518115|1119446|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
343542|NCT00518115|1119447|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
343543|NCT00518115|1119448|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
343544|NCT00518115|1119439|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
343545|NCT00518115|1119440|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
343546|NCT00518115|1119441|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
343547|NCT00518115|1119442|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
343548|NCT00518115|1119443|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
343549|NCT00518115|1119444|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
343550|NCT00518115|1119445|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
343551|NCT00518115|1119446|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
343552|NCT00518115|1119447|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
343553|NCT00518115|1119448|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
343554|NCT00518115|1119439|P10|Overall Study|Non-Compliance|1
343555|NCT00518115|1119440|P9|Overall Study|Non-Compliance|0
343556|NCT00518115|1119441|P8|Overall Study|Non-Compliance|1
343557|NCT00518115|1119442|P7|Overall Study|Non-Compliance|1
343558|NCT00518115|1119443|P6|Overall Study|Non-Compliance|1
343559|NCT00518115|1119444|P5|Overall Study|Non-Compliance|1
343560|NCT00518115|1119445|P4|Overall Study|Non-Compliance|0
343561|NCT00518115|1119446|P3|Overall Study|Non-Compliance|1
343562|NCT00518115|1119447|P2|Overall Study|Non-Compliance|0
343563|NCT00518115|1119448|P1|Overall Study|Non-Compliance|1
343564|NCT00518115|1119439|P10|Overall Study|Lack of Efficacy|0
343565|NCT00518115|1119440|P9|Overall Study|Lack of Efficacy|0
343566|NCT00518115|1119441|P8|Overall Study|Lack of Efficacy|1
343567|NCT00518115|1119442|P7|Overall Study|Lack of Efficacy|0
343568|NCT00518115|1119443|P6|Overall Study|Lack of Efficacy|0
343569|NCT00518115|1119444|P5|Overall Study|Lack of Efficacy|0
343570|NCT00518115|1119445|P4|Overall Study|Lack of Efficacy|1
343571|NCT00518115|1119446|P3|Overall Study|Lack of Efficacy|1
343572|NCT00518115|1119447|P2|Overall Study|Lack of Efficacy|0
343573|NCT00518115|1119448|P1|Overall Study|Lack of Efficacy|1
343574|NCT00518115|1119439|P10|Overall Study|Withdrawal by Subject|3
343575|NCT00518115|1119440|P9|Overall Study|Withdrawal by Subject|1
343576|NCT00518115|1119441|P8|Overall Study|Withdrawal by Subject|2
343577|NCT00518115|1119442|P7|Overall Study|Withdrawal by Subject|0
343578|NCT00518115|1119443|P6|Overall Study|Withdrawal by Subject|1
343579|NCT00518115|1119444|P5|Overall Study|Withdrawal by Subject|2
343580|NCT00518115|1119445|P4|Overall Study|Withdrawal by Subject|0
343581|NCT00518115|1119446|P3|Overall Study|Withdrawal by Subject|5
343582|NCT00518115|1119447|P2|Overall Study|Withdrawal by Subject|1
343583|NCT00518115|1119448|P1|Overall Study|Withdrawal by Subject|1
343584|NCT00518115|1119439|P10|Overall Study|Protocol Violation|0
343585|NCT00518115|1119440|P9|Overall Study|Protocol Violation|0
343586|NCT00518115|1119441|P8|Overall Study|Protocol Violation|0
343587|NCT00518115|1119442|P7|Overall Study|Protocol Violation|0
343588|NCT00518115|1119443|P6|Overall Study|Protocol Violation|0
343589|NCT00518115|1119444|P5|Overall Study|Protocol Violation|0
343590|NCT00518115|1119445|P4|Overall Study|Protocol Violation|0
343591|NCT00518115|1119446|P3|Overall Study|Protocol Violation|1
343592|NCT00518115|1119447|P2|Overall Study|Protocol Violation|3
343593|NCT00518115|1119448|P1|Overall Study|Protocol Violation|1
343594|NCT00518115|1119439|P10|Overall Study|Lost to Follow-up|1
343595|NCT00518115|1119440|P9|Overall Study|Lost to Follow-up|1
343596|NCT00518115|1119441|P8|Overall Study|Lost to Follow-up|1
343597|NCT00518115|1119442|P7|Overall Study|Lost to Follow-up|0
343598|NCT00518115|1119443|P6|Overall Study|Lost to Follow-up|3
343599|NCT00518115|1119444|P5|Overall Study|Lost to Follow-up|1
343600|NCT00518115|1119445|P4|Overall Study|Lost to Follow-up|3
343601|NCT00518115|1119446|P3|Overall Study|Lost to Follow-up|2
343602|NCT00518115|1119447|P2|Overall Study|Lost to Follow-up|0
343603|NCT00518115|1119448|P1|Overall Study|Lost to Follow-up|0
343604|NCT00518115|1119439|P10|Overall Study|Adverse Event|9
343605|NCT00518115|1119440|P9|Overall Study|Adverse Event|2
343606|NCT00518115|1119441|P8|Overall Study|Adverse Event|10
343607|NCT00518115|1119442|P7|Overall Study|Adverse Event|5
343608|NCT00518115|1119443|P6|Overall Study|Adverse Event|5
343609|NCT00518115|1119444|P5|Overall Study|Adverse Event|5
343610|NCT00518115|1119445|P4|Overall Study|Adverse Event|6
343611|NCT00518115|1119446|P3|Overall Study|Adverse Event|5
343612|NCT00518115|1119447|P2|Overall Study|Adverse Event|1
343613|NCT00518115|1119448|P1|Overall Study|Adverse Event|6
343614|NCT00518011|1119623|P2|Overall Study|Withdrawal by Subject|0
343615|NCT00518011|1119624|P1|Overall Study|Withdrawal by Subject|1
343616|NCT00518011|1119623|P2|Overall Study|Other Reasons|2
343617|NCT00518011|1119624|P1|Overall Study|Other Reasons|3
343618|NCT00518011|1119623|P2|Overall Study|Disease Progression|2
343619|NCT00518011|1119624|P1|Overall Study|Disease Progression|2
343620|NCT00518011|1119623|P2|Overall Study|Adverse Event|3
343621|NCT00518011|1119624|P1|Overall Study|Adverse Event|2
343622|NCT00518011|1119623|P2|Overall Study|Death|1
343623|NCT00518011|1119624|P1|Overall Study|Death|1
343624|NCT00517933|1119646|P2|Period 2|Underwent lung transplant|2
343625|NCT00517933|1119647|P1|Period 2|Underwent lung transplant|0
343626|NCT00517933|1119646|P2|Period 2|Withdrawal by Subject|3
343627|NCT00517933|1119647|P1|Period 2|Withdrawal by Subject|1
343628|NCT00517933|1119646|P2|Period 2|Physician Decision|0
343629|NCT00517933|1119647|P1|Period 2|Physician Decision|1
343630|NCT00517933|1119646|P2|Period 2|Adverse Event|4
343631|NCT00517933|1119647|P1|Period 2|Adverse Event|2
343632|NCT00517933|1119646|P2|Period 2|Death|4
343633|NCT00517933|1119647|P1|Period 2|Death|2
343634|NCT00517933|1119646|P2|Period 1|Underwent lung transplant|1
343635|NCT00517933|1119647|P1|Period 1|Underwent lung transplant|0
343636|NCT00517933|1119646|P2|Period 1|Lost to Follow-up|0
343637|NCT00517933|1119647|P1|Period 1|Lost to Follow-up|2
343638|NCT00517933|1119646|P2|Period 1|Adverse Event|4
343639|NCT00517933|1119647|P1|Period 1|Adverse Event|4
343640|NCT00517933|1119646|P2|Period 1|Death|1
343641|NCT00517933|1119647|P1|Period 1|Death|2
343642|NCT00517881|1119711|P1|Overall Study|Renal transplantation|2
343643|NCT00517881|1119711|P1|Overall Study|Adverse Event|1
343644|NCT00517881|1119711|P1|Overall Study|Protocol Violation|2
343645|NCT00517829|1119723|P2|Overall Study|Other|1
343646|NCT00517829|1119724|P1|Overall Study|Other|3
343647|NCT00517829|1119723|P2|Overall Study|Investigator Request|3
343648|NCT00517829|1119724|P1|Overall Study|Investigator Request|5
343649|NCT00517829|1119723|P2|Overall Study|Patient Request|5
343650|NCT00517829|1119724|P1|Overall Study|Patient Request|6
343651|NCT00517829|1119723|P2|Overall Study|Disease Progression|32
343652|NCT00517829|1119724|P1|Overall Study|Disease Progression|39
343653|NCT00517829|1119723|P2|Overall Study|Adverse Event|34
343654|NCT00517829|1119724|P1|Overall Study|Adverse Event|22
343655|NCT00517751|1119738|P1|Overall Study|Missing|3
343656|NCT00517751|1119738|P1|Overall Study|Patient not due for visit|76
343657|NCT00517751|1119738|P1|Overall Study|patient not over due|6
343658|NCT00517751|1119738|P1|Overall Study|Lost to Follow-up|4
343659|NCT00517751|1119738|P1|Overall Study|Withdrawal by Subject|37
343660|NCT00517751|1119738|P1|Overall Study|Death|3
343661|NCT00517413|1119852|P1|Overall Study|Other-Reasons|23
343662|NCT00517413|1119852|P1|Overall Study|Failure to return|1
343663|NCT00517413|1119852|P1|Overall Study|Withdrawal by Subject|2
343664|NCT00517413|1119852|P1|Overall Study|Protocol Violation|15
343665|NCT00517413|1119852|P1|Overall Study|Death|13
343666|NCT00517413|1119852|P1|Overall Study|Adverse Event|7
343667|NCT00517361|1119873|P1|Overall Study|The study was terminated|5
343668|NCT00517361|1119873|P1|Overall Study|Death|6
343669|NCT00517296|1119882|P2|Overall Study|Withdrawal by Subject|0
343670|NCT00517296|1119883|P1|Overall Study|Withdrawal by Subject|1
343671|NCT00517192|1119895|P2|Overall Study|Early termination of the trial|18
343672|NCT00517192|1119896|P1|Overall Study|Early termination of the trial|16
343673|NCT00517192|1119895|P2|Overall Study|Withdrawal by Subject|0
343674|NCT00517192|1119896|P1|Overall Study|Withdrawal by Subject|1
343675|NCT00517192|1119895|P2|Overall Study|Lost to Follow-up|1
343676|NCT00517192|1119896|P1|Overall Study|Lost to Follow-up|1
343677|NCT00517192|1119895|P2|Overall Study|Adverse Event|1
343678|NCT00517192|1119896|P1|Overall Study|Adverse Event|1
343679|NCT00516906|1120003|P2|Overall Study|Final Dressing Removal Data not captured|2
343680|NCT00516906|1120004|P1|Overall Study|Final Dressing Removal Data not captured|6
343681|NCT00516893|1120014|P1|Overall Study|Received Medication From Another Study|1
343682|NCT00516893|1120014|P1|Overall Study|Pregnancy|1
343683|NCT00516893|1120014|P1|Overall Study|Relocated|1
343684|NCT00516893|1120014|P1|Overall Study|Persistent Antibodies per Protocol|6
343685|NCT00516893|1120014|P1|Overall Study|Death|1
343686|NCT00516893|1120014|P1|Overall Study|Noncompliance|2
343687|NCT00516893|1120014|P1|Overall Study|Withdrawal by Subject|2
343688|NCT00516893|1120014|P1|Overall Study|Adverse Event|3
343689|NCT00516893|1120014|P1|Overall Study|Lost to Follow-up|4
343690|NCT00516737|1120023|P2|Overall Study|Lack of Qualifying Event|6
343691|NCT00516737|1120024|P1|Overall Study|Lack of Qualifying Event|9
343692|NCT00516737|1120023|P2|Overall Study|Withdrawal by Subject|1
343693|NCT00516737|1120024|P1|Overall Study|Withdrawal by Subject|0
343694|NCT00516737|1120023|P2|Overall Study|Physician Decision|1
343695|NCT00516737|1120024|P1|Overall Study|Physician Decision|0
343696|NCT00516737|1120023|P2|Overall Study|Lost to Follow-up|0
343697|NCT00516737|1120024|P1|Overall Study|Lost to Follow-up|2
343698|NCT00516386|1120042|P1|Overall Study|Lost to Follow-up|2
343699|NCT00516386|1120042|P1|Overall Study|not interested in the study|4
343700|NCT00516321|1120049|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
343701|NCT00516321|1120050|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
343702|NCT00516321|1120051|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
343703|NCT00516321|1120049|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
343704|NCT00516321|1120050|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
343705|NCT00516321|1120051|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
343706|NCT00516321|1120049|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
343707|NCT00516321|1120050|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
343708|NCT00516321|1120051|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
343709|NCT00516321|1120049|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
343710|NCT00516321|1120050|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
343711|NCT00516321|1120051|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
343712|NCT00516321|1120049|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
343713|NCT00516321|1120050|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
343714|NCT00516321|1120051|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
343715|NCT00516321|1120049|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
343716|NCT00516321|1120050|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
343717|NCT00516321|1120051|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
343718|NCT00516321|1120049|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
343719|NCT00516321|1120050|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
343720|NCT00516321|1120051|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
343721|NCT00516321|1120049|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
343722|NCT00516321|1120050|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
343723|NCT00516321|1120051|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
343724|NCT00516321|1120049|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
343725|NCT00516321|1120050|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
343726|NCT00516321|1120051|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
343727|NCT00516321|1120049|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
343728|NCT00516321|1120050|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
343729|NCT00516321|1120051|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
343730|NCT00516321|1120049|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
343731|NCT00516321|1120050|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
343732|NCT00516321|1120051|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
343733|NCT00516295|1120102|P3|Overall Study|Ineligible|0
343734|NCT00516295|1120103|P2|Overall Study|Ineligible|0
343735|NCT00516295|1120104|P1|Overall Study|Ineligible|1
343736|NCT00516295|1120102|P3|Overall Study|Lack of Efficacy|0
343737|NCT00516295|1120103|P2|Overall Study|Lack of Efficacy|0
343738|NCT00516295|1120104|P1|Overall Study|Lack of Efficacy|2
343739|NCT00516269|1120117|P2|Overall Study|Protocol Violation|1
343740|NCT00516269|1120118|P1|Overall Study|Protocol Violation|0
343741|NCT00516269|1120117|P2|Overall Study|Lost to Follow-up|1
343742|NCT00516269|1120118|P1|Overall Study|Lost to Follow-up|0
343743|NCT00516269|1120117|P2|Overall Study|Adverse Event|1
343744|NCT00516269|1120118|P1|Overall Study|Adverse Event|2
343745|NCT00516139|1120139|P1|Overall Study|Lack of Efficacy|1
343746|NCT00516139|1120139|P1|Overall Study|Withdrawal by Subject|8
343747|NCT00516139|1120139|P1|Overall Study|Protocol Violation|1
343748|NCT00516139|1120139|P1|Overall Study|Lost to Follow-up|1
343749|NCT00516139|1120139|P1|Overall Study|Adverse Event|27
343750|NCT00516074|1120170|P2|Overall Study|Loss of Glucose Control|0
343751|NCT00516074|1120171|P1|Overall Study|Loss of Glucose Control|2
343752|NCT00516074|1120170|P2|Overall Study|Subject Decision|2
343753|NCT00516074|1120171|P1|Overall Study|Subject Decision|4
343754|NCT00516074|1120170|P2|Overall Study|Adverse Event|1
343755|NCT00516074|1120171|P1|Overall Study|Adverse Event|0
343756|NCT00516048|1120189|P3|Overall Study|Subject Decision|0
343757|NCT00516048|1120190|P2|Overall Study|Subject Decision|2
343758|NCT00516048|1120191|P1|Overall Study|Subject Decision|0
343759|NCT00516048|1120189|P3|Overall Study|Death|1
343760|NCT00516048|1120190|P2|Overall Study|Death|0
343761|NCT00516048|1120191|P1|Overall Study|Death|0
343762|NCT00515827|1120218|P2|Second Intervention (12 Weeks)|Consent withdraw|0
343763|NCT00515827|1120219|P1|Second Intervention (12 Weeks)|Consent withdraw|1
343764|NCT00515827|1120218|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
343765|NCT00515827|1120219|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
343766|NCT00515671|1120254|P2|Overall Study|incarcerated|2
343767|NCT00515671|1120255|P1|Overall Study|incarcerated|1
343768|NCT00515671|1120254|P2|Overall Study|Withdrawal by Subject|5
343769|NCT00515671|1120255|P1|Overall Study|Withdrawal by Subject|3
343770|NCT00515671|1120254|P2|Overall Study|Lost to Follow-up|10
343771|NCT00515671|1120255|P1|Overall Study|Lost to Follow-up|13
343772|NCT00515619|1120263|P1|Overall Study|Other: Subject interested in other AED|1
343773|NCT00515619|1120263|P1|Overall Study|Other: Drug available on license|1
343774|NCT00515619|1120263|P1|Overall Study|Other: Request from sponsor|1
343775|NCT00515619|1120263|P1|Overall Study|Other: Subject became pregnant|1
343776|NCT00515619|1120263|P1|Overall Study|Other: Investigator decision|1
343777|NCT00515619|1120263|P1|Overall Study|Other: Subject moved to another country|1
343778|NCT00515619|1120263|P1|Overall Study|Other: Subject required surgery|1
343779|NCT00515619|1120263|P1|Overall Study|Other: Subject cannot attend visits|2
343780|NCT00515619|1120263|P1|Overall Study|Other: Site discontinuing trials|2
343781|NCT00515619|1120263|P1|Overall Study|Unsatisfactory compliance|6
343782|NCT00515619|1120263|P1|Overall Study|Lost to Follow-up|4
343783|NCT00515619|1120263|P1|Overall Study|Protocol Violation|3
343784|NCT00515619|1120263|P1|Overall Study|Withdrawal by Subject|66
343785|NCT00515619|1120263|P1|Overall Study|Lack of Efficacy|92
343786|NCT00515619|1120263|P1|Overall Study|Adverse Event|34
343787|NCT00515541|1120275|P4|Overall Study|Withdrawal by Subject|2
343788|NCT00515541|1120276|P3|Overall Study|Withdrawal by Subject|0
343789|NCT00515541|1120277|P2|Overall Study|Withdrawal by Subject|2
343790|NCT00515541|1120278|P1|Overall Study|Withdrawal by Subject|0
343791|NCT00515541|1120275|P4|Overall Study|No show for appointments|2
343792|NCT00515541|1120276|P3|Overall Study|No show for appointments|0
343793|NCT00515541|1120277|P2|Overall Study|No show for appointments|1
343794|NCT00515541|1120278|P1|Overall Study|No show for appointments|0
343795|NCT00515541|1120275|P4|Overall Study|Physician Decision|1
343796|NCT00515541|1120276|P3|Overall Study|Physician Decision|0
343797|NCT00515541|1120277|P2|Overall Study|Physician Decision|2
343798|NCT00515541|1120278|P1|Overall Study|Physician Decision|0
343799|NCT00515502|1120300|P12|Treatment Period 2|Adverse Event|0
343800|NCT00515502|1120301|P11|Treatment Period 2|Adverse Event|0
343801|NCT00515502|1120302|P10|Treatment Period 2|Adverse Event|0
343802|NCT00515502|1120303|P9|Treatment Period 2|Adverse Event|0
343803|NCT00515502|1120304|P8|Treatment Period 2|Adverse Event|0
343804|NCT00515502|1120305|P7|Treatment Period 2|Adverse Event|0
343805|NCT00515502|1120306|P6|Treatment Period 2|Adverse Event|0
343806|NCT00515502|1120307|P5|Treatment Period 2|Adverse Event|0
343807|NCT00515502|1120308|P4|Treatment Period 2|Adverse Event|0
343808|NCT00515502|1120309|P3|Treatment Period 2|Adverse Event|0
343809|NCT00515502|1120310|P2|Treatment Period 2|Adverse Event|1
343810|NCT00515502|1120311|P1|Treatment Period 2|Adverse Event|0
343811|NCT00515502|1120300|P12|Treatment Period 1|Adverse Event|1
343812|NCT00515502|1120301|P11|Treatment Period 1|Adverse Event|0
343813|NCT00515502|1120302|P10|Treatment Period 1|Adverse Event|0
343814|NCT00515502|1120303|P9|Treatment Period 1|Adverse Event|1
343815|NCT00515502|1120304|P8|Treatment Period 1|Adverse Event|0
343816|NCT00515502|1120305|P7|Treatment Period 1|Adverse Event|1
343817|NCT00515502|1120306|P6|Treatment Period 1|Adverse Event|0
343818|NCT00515502|1120307|P5|Treatment Period 1|Adverse Event|0
343819|NCT00515502|1120308|P4|Treatment Period 1|Adverse Event|0
343820|NCT00515502|1120309|P3|Treatment Period 1|Adverse Event|0
343821|NCT00515502|1120310|P2|Treatment Period 1|Adverse Event|0
343822|NCT00515502|1120311|P1|Treatment Period 1|Adverse Event|0
343823|NCT00515463|1120471|P2|Overall Study|Other|1
343824|NCT00515463|1120472|P1|Overall Study|Other|0
343825|NCT00515463|1120471|P2|Overall Study|Lost to Follow-up|5
343826|NCT00515463|1120472|P1|Overall Study|Lost to Follow-up|6
343827|NCT00515463|1120471|P2|Overall Study|Withdrawal by Subject|4
343828|NCT00515463|1120472|P1|Overall Study|Withdrawal by Subject|3
343829|NCT00515463|1120471|P2|Overall Study|Adverse Event|2
343830|NCT00515463|1120472|P1|Overall Study|Adverse Event|1
343831|NCT00515463|1120471|P2|Overall Study|Physician Decision|2
343832|NCT00515463|1120472|P1|Overall Study|Physician Decision|4
343833|NCT00515216|1120651|P1|Overall Study|Withdrawal by Subject|1
343834|NCT00515112|1120713|P2|Overall Study|The study was terminated|2
343835|NCT00515112|1120714|P1|Overall Study|The study was terminated|3
343836|NCT00515112|1120713|P2|Overall Study|Death|1
343837|NCT00515112|1120714|P1|Overall Study|Death|0
343838|NCT00515099|1120724|P2|Overall Study|IRB Recommendation|0
343839|NCT00515099|1120725|P1|Overall Study|IRB Recommendation|1
343840|NCT00515099|1120724|P2|Overall Study|Withdrawal by Subject|0
343841|NCT00515099|1120725|P1|Overall Study|Withdrawal by Subject|2
343842|NCT00515099|1120724|P2|Overall Study|Lost to Follow-up|4
343843|NCT00515099|1120725|P1|Overall Study|Lost to Follow-up|0
343844|NCT00515086|1120747|P4|Overall Study|Death|0
343845|NCT00515086|1120748|P3|Overall Study|Death|0
343846|NCT00515086|1120749|P2|Overall Study|Death|0
343847|NCT00515086|1120750|P1|Overall Study|Death|2
343848|NCT00515086|1120747|P4|Overall Study|Study drug no longer required|0
343849|NCT00515086|1120748|P3|Overall Study|Study drug no longer required|0
343850|NCT00515086|1120749|P2|Overall Study|Study drug no longer required|1
343851|NCT00515086|1120750|P1|Overall Study|Study drug no longer required|0
343852|NCT00515086|1120747|P4|Overall Study|Lost to Follow-up|0
343853|NCT00515086|1120748|P3|Overall Study|Lost to Follow-up|0
343854|NCT00515086|1120749|P2|Overall Study|Lost to Follow-up|0
343855|NCT00515086|1120750|P1|Overall Study|Lost to Follow-up|1
343856|NCT00515086|1120747|P4|Overall Study|Unsatisfactory therapeutic effect|2
343857|NCT00515086|1120748|P3|Overall Study|Unsatisfactory therapeutic effect|3
343858|NCT00515086|1120749|P2|Overall Study|Unsatisfactory therapeutic effect|3
343859|NCT00515086|1120750|P1|Overall Study|Unsatisfactory therapeutic effect|18
343860|NCT00515086|1120747|P4|Overall Study|Withdrawal by Subject|1
343861|NCT00515086|1120748|P3|Overall Study|Withdrawal by Subject|0
343862|NCT00515086|1120749|P2|Overall Study|Withdrawal by Subject|0
343863|NCT00515086|1120750|P1|Overall Study|Withdrawal by Subject|1
343864|NCT00515086|1120747|P4|Overall Study|Administrative|0
343865|NCT00515086|1120748|P3|Overall Study|Administrative|0
343866|NCT00515086|1120749|P2|Overall Study|Administrative|1
343867|NCT00515086|1120750|P1|Overall Study|Administrative|1
343868|NCT00515086|1120747|P4|Overall Study|Adverse Event|3
343869|NCT00515086|1120748|P3|Overall Study|Adverse Event|2
343870|NCT00515086|1120749|P2|Overall Study|Adverse Event|1
343871|NCT00515086|1120750|P1|Overall Study|Adverse Event|1
343872|NCT00515073|1120777|P1|Overall Study|Physician Decision|1
343873|NCT00515073|1120777|P1|Overall Study|Withdrawal by Subject|1
343874|NCT00515034|1120785|P4|Overall Study|Other|1
343875|NCT00515034|1120786|P3|Overall Study|Other|2
343876|NCT00515034|1120787|P2|Overall Study|Other|0
343877|NCT00515034|1120788|P1|Overall Study|Other|1
343878|NCT00515034|1120785|P4|Overall Study|Physician Decision|1
343879|NCT00515034|1120786|P3|Overall Study|Physician Decision|1
343880|NCT00515034|1120787|P2|Overall Study|Physician Decision|0
343881|NCT00515034|1120788|P1|Overall Study|Physician Decision|0
343882|NCT00515034|1120785|P4|Overall Study|Withdrawal by Subject|0
343883|NCT00515034|1120786|P3|Overall Study|Withdrawal by Subject|3
343884|NCT00515034|1120787|P2|Overall Study|Withdrawal by Subject|0
343885|NCT00515034|1120788|P1|Overall Study|Withdrawal by Subject|1
343886|NCT00515034|1120785|P4|Overall Study|Death|3
343887|NCT00515034|1120786|P3|Overall Study|Death|1
343888|NCT00515034|1120787|P2|Overall Study|Death|2
343889|NCT00515034|1120788|P1|Overall Study|Death|4
343890|NCT00515034|1120785|P4|Overall Study|Adverse Event|0
343891|NCT00515034|1120786|P3|Overall Study|Adverse Event|1
343892|NCT00515034|1120787|P2|Overall Study|Adverse Event|0
343893|NCT00515034|1120788|P1|Overall Study|Adverse Event|2
343894|NCT00515008|1120808|P2|Overall Study|Scheduling conflict|0
343895|NCT00515008|1120809|P1|Overall Study|Scheduling conflict|1
343896|NCT00515008|1120808|P2|Overall Study|Left the Boston Area|1
343897|NCT00515008|1120809|P1|Overall Study|Left the Boston Area|1
343898|NCT00515008|1120808|P2|Overall Study|Declined|3
343899|NCT00515008|1120809|P1|Overall Study|Declined|0
343900|NCT00515008|1120808|P2|Overall Study|Lost to Follow-up|0
343901|NCT00515008|1120809|P1|Overall Study|Lost to Follow-up|1
343902|NCT00514943|1120833|P2|Stage 2|Other than stated above|2
343903|NCT00514943|1120834|P1|Stage 2|Other than stated above|0
343904|NCT00514943|1120833|P2|Stage 2|Patient refused to continue study meds|0
343905|NCT00514943|1120834|P1|Stage 2|Patient refused to continue study meds|2
343906|NCT00514943|1120833|P2|Stage 2|Other Adverse Event|10
343907|NCT00514943|1120834|P1|Stage 2|Other Adverse Event|3
343908|NCT00514943|1120833|P2|Stage 2|Progressive disease|24
343909|NCT00514943|1120834|P1|Stage 2|Progressive disease|27
343910|NCT00514943|1120833|P2|Stage 1|Other than stated above|7
343911|NCT00514943|1120834|P1|Stage 1|Other than stated above|1
343912|NCT00514943|1120833|P2|Stage 1|Patient refused to continue study meds|3
343913|NCT00514943|1120834|P1|Stage 1|Patient refused to continue study meds|8
343914|NCT00514943|1120833|P2|Stage 1|Not treated|2
343915|NCT00514943|1120834|P1|Stage 1|Not treated|1
343916|NCT00514943|1120833|P2|Stage 1|Other Adverse Event|6
343917|NCT00514943|1120834|P1|Stage 1|Other Adverse Event|16
343918|NCT00514943|1120833|P2|Stage 1|Progressive disease|8
343919|NCT00514943|1120834|P1|Stage 1|Progressive disease|4
343920|NCT00514917|1120892|P2|Overall Study|Undefined|5
343921|NCT00514917|1120893|P1|Overall Study|Undefined|11
343922|NCT00514917|1120892|P2|Overall Study|Discontinued due to study closure|81
343923|NCT00514917|1120893|P1|Overall Study|Discontinued due to study closure|88
343924|NCT00514917|1120892|P2|Overall Study|Withdrawal by Subject|16
343925|NCT00514917|1120893|P1|Overall Study|Withdrawal by Subject|18
343926|NCT00514917|1120892|P2|Overall Study|Lost to Follow-up|3
343927|NCT00514917|1120893|P1|Overall Study|Lost to Follow-up|4
343928|NCT00514917|1120892|P2|Overall Study|Protocol Violation|0
343929|NCT00514917|1120893|P1|Overall Study|Protocol Violation|1
343930|NCT00514917|1120892|P2|Overall Study|Death|10
343931|NCT00514917|1120893|P1|Overall Study|Death|4
343932|NCT00514813|1120950|P4|Overall Study|Death|2
343933|NCT00514813|1120951|P3|Overall Study|Death|3
343934|NCT00514813|1120952|P2|Overall Study|Death|2
343935|NCT00514813|1120953|P1|Overall Study|Death|0
343936|NCT00514813|1120950|P4|Overall Study|Kidney transplant|0
343937|NCT00514813|1120951|P3|Overall Study|Kidney transplant|2
343938|NCT00514813|1120952|P2|Overall Study|Kidney transplant|6
343939|NCT00514813|1120953|P1|Overall Study|Kidney transplant|0
343940|NCT00514813|1120950|P4|Overall Study|Lack of Efficacy|0
343941|NCT00514813|1120951|P3|Overall Study|Lack of Efficacy|0
343942|NCT00514813|1120952|P2|Overall Study|Lack of Efficacy|1
343943|NCT00514813|1120953|P1|Overall Study|Lack of Efficacy|0
343944|NCT00514813|1120950|P4|Overall Study|Withdrawal by Subject|0
343945|NCT00514813|1120951|P3|Overall Study|Withdrawal by Subject|0
343946|NCT00514813|1120952|P2|Overall Study|Withdrawal by Subject|1
343947|NCT00514813|1120953|P1|Overall Study|Withdrawal by Subject|0
343948|NCT00514813|1120950|P4|Overall Study|Protocol Violation|0
343949|NCT00514813|1120951|P3|Overall Study|Protocol Violation|0
343950|NCT00514813|1120952|P2|Overall Study|Protocol Violation|0
343951|NCT00514813|1120953|P1|Overall Study|Protocol Violation|1
343952|NCT00514813|1120950|P4|Overall Study|Adverse Event|0
343953|NCT00514813|1120951|P3|Overall Study|Adverse Event|2
343954|NCT00514813|1120952|P2|Overall Study|Adverse Event|2
343955|NCT00514813|1120953|P1|Overall Study|Adverse Event|0
343956|NCT00514813|1120950|P4|Overall Study|Study terminated|2
343957|NCT00514813|1120951|P3|Overall Study|Study terminated|40
343958|NCT00514813|1120952|P2|Overall Study|Study terminated|74
343959|NCT00514813|1120953|P1|Overall Study|Study terminated|14
343960|NCT00514735|1120973|P2|Overall Study|Lost to Follow-up|1
343961|NCT00514735|1120974|P1|Overall Study|Lost to Follow-up|0
343962|NCT00514735|1120973|P2|Overall Study|Death|0
343963|NCT00514735|1120974|P1|Overall Study|Death|1
343964|NCT00514735|1120973|P2|Overall Study|Withdrawal by Subject|5
343965|NCT00514735|1120974|P1|Overall Study|Withdrawal by Subject|13
343966|NCT00514683|1121010|P5|Overall Study|Reason other than listed above|1
343967|NCT00514683|1121011|P4|Overall Study|Reason other than listed above|0
343968|NCT00514683|1121012|P3|Overall Study|Reason other than listed above|2
343969|NCT00514683|1121013|P2|Overall Study|Reason other than listed above|1
343970|NCT00514683|1121014|P1|Overall Study|Reason other than listed above|0
343971|NCT00514683|1121010|P5|Overall Study|Withdrawal by Subject|4
343972|NCT00514683|1121011|P4|Overall Study|Withdrawal by Subject|0
343973|NCT00514683|1121012|P3|Overall Study|Withdrawal by Subject|1
343974|NCT00514683|1121013|P2|Overall Study|Withdrawal by Subject|2
343975|NCT00514683|1121014|P1|Overall Study|Withdrawal by Subject|2
343976|NCT00514683|1121010|P5|Overall Study|Protocol Violation|0
343977|NCT00514683|1121011|P4|Overall Study|Protocol Violation|1
343978|NCT00514683|1121012|P3|Overall Study|Protocol Violation|0
343979|NCT00514683|1121013|P2|Overall Study|Protocol Violation|1
343980|NCT00514683|1121014|P1|Overall Study|Protocol Violation|1
343981|NCT00514683|1121010|P5|Overall Study|Adverse Event|27
343982|NCT00514683|1121011|P4|Overall Study|Adverse Event|13
343983|NCT00514683|1121012|P3|Overall Study|Adverse Event|15
343984|NCT00514683|1121013|P2|Overall Study|Adverse Event|20
343985|NCT00514683|1121014|P1|Overall Study|Adverse Event|21
343986|NCT00514683|1121010|P5|Overall Study|Not treated|1
343987|NCT00514683|1121011|P4|Overall Study|Not treated|0
343988|NCT00514683|1121012|P3|Overall Study|Not treated|0
343989|NCT00514683|1121013|P2|Overall Study|Not treated|1
343990|NCT00514683|1121014|P1|Overall Study|Not treated|2
343991|NCT00514514|1121213|P3|Extension - 4 Years|Adverse Event|3
343992|NCT00514514|1121214|P2|Extension - 4 Years|Adverse Event|6
343993|NCT00514514|1121215|P1|Extension - 4 Years|Adverse Event|9
343994|NCT00514514|1121213|P3|Extension - 4 Years|Death|6
343995|NCT00514514|1121214|P2|Extension - 4 Years|Death|3
343996|NCT00514514|1121215|P1|Extension - 4 Years|Death|8
343997|NCT00514514|1121213|P3|Extension - 4 Years|Administrative problems|1
343998|NCT00514514|1121214|P2|Extension - 4 Years|Administrative problems|1
343999|NCT00514514|1121215|P1|Extension - 4 Years|Administrative problems|3
344000|NCT00514514|1121213|P3|Extension - 4 Years|Lost to Follow-up|9
344001|NCT00514514|1121214|P2|Extension - 4 Years|Lost to Follow-up|10
344002|NCT00514514|1121215|P1|Extension - 4 Years|Lost to Follow-up|12
344003|NCT00514514|1121213|P3|Extension - 4 Years|Withdrawal by Subject|2
344004|NCT00514514|1121214|P2|Extension - 4 Years|Withdrawal by Subject|2
344005|NCT00514514|1121215|P1|Extension - 4 Years|Withdrawal by Subject|5
344006|NCT00514514|1121213|P3|Randomized - 9 Month|Adverse Event|27
344007|NCT00514514|1121214|P2|Randomized - 9 Month|Adverse Event|44
344008|NCT00514514|1121215|P1|Randomized - 9 Month|Adverse Event|25
344009|NCT00514514|1121213|P3|Randomized - 9 Month|Abnormal laboratory values|1
344010|NCT00514514|1121214|P2|Randomized - 9 Month|Abnormal laboratory values|3
344011|NCT00514514|1121215|P1|Randomized - 9 Month|Abnormal laboratory values|0
344012|NCT00514514|1121213|P3|Randomized - 9 Month|Lack of Efficacy|1
344013|NCT00514514|1121214|P2|Randomized - 9 Month|Lack of Efficacy|3
344014|NCT00514514|1121215|P1|Randomized - 9 Month|Lack of Efficacy|2
344015|NCT00514514|1121213|P3|Randomized - 9 Month|Protocol Violation|0
344016|NCT00514514|1121214|P2|Randomized - 9 Month|Protocol Violation|1
344017|NCT00514514|1121215|P1|Randomized - 9 Month|Protocol Violation|1
344018|NCT00514514|1121213|P3|Randomized - 9 Month|Withdrawal by Subject|5
344019|NCT00514514|1121214|P2|Randomized - 9 Month|Withdrawal by Subject|7
344020|NCT00514514|1121215|P1|Randomized - 9 Month|Withdrawal by Subject|7
344021|NCT00514514|1121213|P3|Randomized - 9 Month|Administrative problems|2
344022|NCT00514514|1121214|P2|Randomized - 9 Month|Administrative problems|1
344023|NCT00514514|1121215|P1|Randomized - 9 Month|Administrative problems|1
344024|NCT00514514|1121213|P3|Randomized - 9 Month|Death|2
344025|NCT00514514|1121214|P2|Randomized - 9 Month|Death|2
344026|NCT00514514|1121215|P1|Randomized - 9 Month|Death|3
344027|NCT00514514|1121213|P3|Pre-phase|Withdrawal by Subject|0
344028|NCT00514514|1121214|P2|Pre-phase|Withdrawal by Subject|0
344029|NCT00514514|1121215|P1|Pre-phase|Withdrawal by Subject|66
344030|NCT00514514|1121213|P3|Pre-phase|Adverse Event|0
344031|NCT00514514|1121214|P2|Pre-phase|Adverse Event|0
344032|NCT00514514|1121215|P1|Pre-phase|Adverse Event|137
344033|NCT00514514|1121213|P3|Pre-phase|Lack of Efficacy|0
344034|NCT00514514|1121214|P2|Pre-phase|Lack of Efficacy|0
344035|NCT00514514|1121215|P1|Pre-phase|Lack of Efficacy|35
344036|NCT00514514|1121213|P3|Pre-phase|abnormal lab values|0
344037|NCT00514514|1121214|P2|Pre-phase|abnormal lab values|0
344038|NCT00514514|1121215|P1|Pre-phase|abnormal lab values|23
344039|NCT00514514|1121213|P3|Pre-phase|Lost to Follow-up|0
344040|NCT00514514|1121214|P2|Pre-phase|Lost to Follow-up|0
344041|NCT00514514|1121215|P1|Pre-phase|Lost to Follow-up|2
344042|NCT00514514|1121213|P3|Pre-phase|abnormal test procedure results|0
344043|NCT00514514|1121214|P2|Pre-phase|abnormal test procedure results|0
344044|NCT00514514|1121215|P1|Pre-phase|abnormal test procedure results|15
344045|NCT00514514|1121213|P3|Pre-phase|condition no longer requires study drug|0
344046|NCT00514514|1121214|P2|Pre-phase|condition no longer requires study drug|0
344047|NCT00514514|1121215|P1|Pre-phase|condition no longer requires study drug|7
344048|NCT00514514|1121213|P3|Pre-phase|Protocol Violation|0
344049|NCT00514514|1121214|P2|Pre-phase|Protocol Violation|0
344050|NCT00514514|1121215|P1|Pre-phase|Protocol Violation|6
344051|NCT00514514|1121213|P3|Pre-phase|administrative problems|0
344052|NCT00514514|1121214|P2|Pre-phase|administrative problems|0
344053|NCT00514514|1121215|P1|Pre-phase|administrative problems|2
344054|NCT00514514|1121213|P3|Pre-phase|Death|0
344055|NCT00514514|1121214|P2|Pre-phase|Death|0
344056|NCT00514514|1121215|P1|Pre-phase|Death|10
344057|NCT00514020|1121276|P1|Overall Study|"patients moved to the no tx group"|6
344058|NCT00514020|1121276|P1|Overall Study|patient went to radiation treatment|1
344059|NCT00514020|1121276|P1|Overall Study|other complicating disease|2
344060|NCT00514020|1121276|P1|Overall Study|disease progression|9
344061|NCT00514020|1121276|P1|Overall Study|Physician Decision|1
344062|NCT00514020|1121276|P1|Overall Study|Withdrawal by Subject|3
344063|NCT00514020|1121276|P1|Overall Study|Adverse Event|6
344064|NCT00513708|1121308|P3|Overall Study|Lost to Follow-up|4
344065|NCT00513708|1121309|P2|Overall Study|Lost to Follow-up|4
344066|NCT00513708|1121310|P1|Overall Study|Lost to Follow-up|4
344067|NCT00513695|1121324|P1|Overall Study|Progression prior to surgery|3
344068|NCT00513695|1121324|P1|Overall Study|Discontinued therapy|2
344069|NCT00513682|1121333|P1|Washout Phase|Adverse Event|2
344070|NCT00513604|1121363|P5|Overall Study|Death during treatment|0
344071|NCT00513604|1121364|P4|Overall Study|Death during treatment|0
344072|NCT00513604|1121365|P3|Overall Study|Death during treatment|2
344073|NCT00513604|1121366|P2|Overall Study|Death during treatment|3
344074|NCT00513604|1121367|P1|Overall Study|Death during treatment|0
344075|NCT00513604|1121363|P5|Overall Study|Not treated|0
344076|NCT00513604|1121364|P4|Overall Study|Not treated|0
344077|NCT00513604|1121365|P3|Overall Study|Not treated|1
344078|NCT00513604|1121366|P2|Overall Study|Not treated|0
344079|NCT00513604|1121367|P1|Overall Study|Not treated|2
344080|NCT00513500|1121401|P2|Overall Study|Hospitalized|14
344081|NCT00513500|1121402|P1|Overall Study|Hospitalized|4
344082|NCT00513500|1121401|P2|Overall Study|Death|1
344083|NCT00513500|1121402|P1|Overall Study|Death|2
344084|NCT00513500|1121401|P2|Overall Study|Lost to Follow-up|39
344085|NCT00513500|1121402|P1|Overall Study|Lost to Follow-up|35
344086|NCT00513474|1121414|P2|Overall Study|Participant Withdrew Consent|0
344087|NCT00513474|1121415|P1|Overall Study|Participant Withdrew Consent|1
344088|NCT00513474|1121414|P2|Overall Study|Death|9
344089|NCT00513474|1121415|P1|Overall Study|Death|6
344090|NCT00513409|1121434|P2|Overall Study|Visit 3 not done|2
344091|NCT00513409|1121435|P1|Overall Study|Visit 3 not done|1
344092|NCT00513409|1121434|P2|Overall Study|Physician Decision|0
344093|NCT00513409|1121435|P1|Overall Study|Physician Decision|1
344094|NCT00513409|1121434|P2|Overall Study|Lost to Follow-up|1
344095|NCT00513409|1121435|P1|Overall Study|Lost to Follow-up|0
344096|NCT00513409|1121434|P2|Overall Study|Withdrawal by Subject|2
344097|NCT00513409|1121435|P1|Overall Study|Withdrawal by Subject|0
344098|NCT00513409|1121434|P2|Overall Study|Adverse Event|1
344099|NCT00513409|1121435|P1|Overall Study|Adverse Event|0
344100|NCT00513357|1121491|P2|Overall Study|Disease Progression|1
344101|NCT00513357|1121492|P1|Overall Study|Disease Progression|2
344102|NCT00513357|1121491|P2|Overall Study|Withdrawal by Subject|4
344103|NCT00513357|1121492|P1|Overall Study|Withdrawal by Subject|5
344104|NCT00513357|1121491|P2|Overall Study|Death|0
344105|NCT00513357|1121492|P1|Overall Study|Death|2
344106|NCT00513357|1121491|P2|Overall Study|Adverse Event|2
344107|NCT00513357|1121492|P1|Overall Study|Adverse Event|4
344108|NCT00513357|1121491|P2|Overall Study|did not receive allocated placebo|3
344109|NCT00513357|1121492|P1|Overall Study|did not receive allocated placebo|2
344110|NCT00513305|1121511|P2|Overall Study|Sponsor Decision|2
344111|NCT00513305|1121512|P1|Overall Study|Sponsor Decision|0
344112|NCT00513305|1121511|P2|Overall Study|Persistent hypocellularity|1
344113|NCT00513305|1121512|P1|Overall Study|Persistent hypocellularity|0
344114|NCT00513305|1121511|P2|Overall Study|Physician Decision|0
344115|NCT00513305|1121512|P1|Overall Study|Physician Decision|1
344116|NCT00513305|1121511|P2|Overall Study|Hematologic counts did not recover|0
344117|NCT00513305|1121512|P1|Overall Study|Hematologic counts did not recover|1
344118|NCT00513305|1121511|P2|Overall Study|Eligible for stem cell transplant|0
344119|NCT00513305|1121512|P1|Overall Study|Eligible for stem cell transplant|1
344120|NCT00513305|1121511|P2|Overall Study|Disease progression|5
344121|NCT00513305|1121512|P1|Overall Study|Disease progression|8
344122|NCT00513305|1121511|P2|Overall Study|Withdrawal by Subject|2
344123|NCT00513305|1121512|P1|Overall Study|Withdrawal by Subject|1
344124|NCT00513305|1121511|P2|Overall Study|Lack of Efficacy|13
344125|NCT00513305|1121512|P1|Overall Study|Lack of Efficacy|8
344126|NCT00513305|1121511|P2|Overall Study|Death (through Consolidation Treatment)|2
344127|NCT00513305|1121512|P1|Overall Study|Death (through Consolidation Treatment)|2
344128|NCT00513305|1121511|P2|Overall Study|Adverse Event|2
344129|NCT00513305|1121512|P1|Overall Study|Adverse Event|6
344130|NCT00513240|1121549|P2|Overall Study|Withdrawal by Subject|4
344131|NCT00513240|1121550|P1|Overall Study|Withdrawal by Subject|7
344132|NCT00513240|1121549|P2|Overall Study|Death|3
344133|NCT00513240|1121550|P1|Overall Study|Death|3
344134|NCT00513240|1121549|P2|Overall Study|Did not have intended surgery|0
344135|NCT00513240|1121550|P1|Overall Study|Did not have intended surgery|3
344136|NCT00513071|1121557|P1|Overall Study|Physician Decision|3
344137|NCT00513071|1121557|P1|Overall Study|Withdrawal by Subject|1
344138|NCT00513071|1121557|P1|Overall Study|Adverse Event|1
344139|NCT00513019|1121564|P2|Overall Study|Withdrawal by Subject|5
344140|NCT00513019|1121565|P1|Overall Study|Withdrawal by Subject|4
344141|NCT00513019|1121564|P2|Overall Study|Adverse Event|0
344142|NCT00513019|1121565|P1|Overall Study|Adverse Event|1
344143|NCT00512902|1121571|P1|Overall Study|Lost to Follow-up|1
344144|NCT00512902|1121571|P1|Overall Study|Adverse Event|7
344145|NCT00512798|1121586|P2|Overall Study|Withdrawal by Subject|0
344146|NCT00512798|1121587|P1|Overall Study|Withdrawal by Subject|3
344147|NCT00512798|1121586|P2|Overall Study|Progression of disease|20
344148|NCT00512798|1121587|P1|Overall Study|Progression of disease|14
344149|NCT00512798|1121586|P2|Overall Study|Adverse Event|4
344150|NCT00512798|1121587|P1|Overall Study|Adverse Event|2
344151|NCT00512798|1121586|P2|Overall Study|Death|3
344152|NCT00512798|1121587|P1|Overall Study|Death|0
344153|NCT00512252|1121599|P3|Overall Study|Death|1
344154|NCT00512252|1121600|P2|Overall Study|Death|0
344155|NCT00512252|1121601|P1|Overall Study|Death|0
344156|NCT00512252|1121599|P3|Overall Study|Protocol Violation|1
344157|NCT00512252|1121600|P2|Overall Study|Protocol Violation|0
344158|NCT00512252|1121601|P1|Overall Study|Protocol Violation|0
344159|NCT00512252|1121599|P3|Overall Study|Lost to Follow-up|1
344160|NCT00512252|1121600|P2|Overall Study|Lost to Follow-up|0
344161|NCT00512252|1121601|P1|Overall Study|Lost to Follow-up|0
344162|NCT00512148|1121629|P1|Primay Study Period|Withdrawal by Subject|1
344163|NCT00512096|1121634|P1|Overall Study|Lack of Efficacy|3
344164|NCT00512096|1121634|P1|Overall Study|Withdrawal by Subject|2
344165|NCT00512096|1121634|P1|Overall Study|Adverse Event|2
344166|NCT00511901|1121657|P2|Overall Study|Withdrawal by Subject|3
344167|NCT00511901|1121658|P1|Overall Study|Withdrawal by Subject|1
344168|NCT00511836|1121696|P2|Double-blind Period|Lost to Follow-up|0
344169|NCT00511836|1121697|P1|Double-blind Period|Lost to Follow-up|1
344170|NCT00511810|1121714|P2|Overall Study|Refused second scn|1
344171|NCT00511810|1121715|P1|Overall Study|Refused second scn|0
344172|NCT00511810|1121714|P2|Overall Study|Lack of Efficacy|2
344173|NCT00511810|1121715|P1|Overall Study|Lack of Efficacy|0
344174|NCT00511810|1121714|P2|Overall Study|Lost to Follow-up|2
344175|NCT00511810|1121715|P1|Overall Study|Lost to Follow-up|1
344176|NCT00511797|1121725|P4|Overall Study|Other (moving etc)|2
344177|NCT00511797|1121726|P3|Overall Study|Other (moving etc)|1
344178|NCT00511797|1121727|P2|Overall Study|Other (moving etc)|0
344179|NCT00511797|1121728|P1|Overall Study|Other (moving etc)|1
344180|NCT00511797|1121725|P4|Overall Study|Partially missing diary|0
344181|NCT00511797|1121726|P3|Overall Study|Partially missing diary|1
344182|NCT00511797|1121727|P2|Overall Study|Partially missing diary|0
344183|NCT00511797|1121728|P1|Overall Study|Partially missing diary|0
344184|NCT00511797|1121725|P4|Overall Study|Study drug not taken|1
344185|NCT00511797|1121726|P3|Overall Study|Study drug not taken|0
344186|NCT00511797|1121727|P2|Overall Study|Study drug not taken|1
344187|NCT00511797|1121728|P1|Overall Study|Study drug not taken|0
344188|NCT00511797|1121725|P4|Overall Study|Never dispensed|3
344189|NCT00511797|1121726|P3|Overall Study|Never dispensed|1
344190|NCT00511797|1121727|P2|Overall Study|Never dispensed|0
344191|NCT00511797|1121728|P1|Overall Study|Never dispensed|1
344192|NCT00511797|1121725|P4|Overall Study|Withdrawal by Subject|2
344193|NCT00511797|1121726|P3|Overall Study|Withdrawal by Subject|4
344194|NCT00511797|1121727|P2|Overall Study|Withdrawal by Subject|3
344195|NCT00511797|1121728|P1|Overall Study|Withdrawal by Subject|3
344196|NCT00511797|1121725|P4|Overall Study|Protocol Violation|3
344197|NCT00511797|1121726|P3|Overall Study|Protocol Violation|2
344198|NCT00511797|1121727|P2|Overall Study|Protocol Violation|2
344199|NCT00511797|1121728|P1|Overall Study|Protocol Violation|0
344200|NCT00511797|1121725|P4|Overall Study|Pregnancy|1
344201|NCT00511797|1121726|P3|Overall Study|Pregnancy|0
344202|NCT00511797|1121727|P2|Overall Study|Pregnancy|0
344203|NCT00511797|1121728|P1|Overall Study|Pregnancy|0
344204|NCT00511797|1121725|P4|Overall Study|Lost to Follow-up|1
344205|NCT00511797|1121726|P3|Overall Study|Lost to Follow-up|0
344206|NCT00511797|1121727|P2|Overall Study|Lost to Follow-up|0
344207|NCT00511797|1121728|P1|Overall Study|Lost to Follow-up|1
344208|NCT00511797|1121725|P4|Overall Study|Adverse Event|2
344209|NCT00511797|1121726|P3|Overall Study|Adverse Event|2
344210|NCT00511797|1121727|P2|Overall Study|Adverse Event|2
344211|NCT00511797|1121728|P1|Overall Study|Adverse Event|1
344212|NCT00511667|1121847|P2|Overall Study|Other|1
344213|NCT00511667|1121848|P1|Overall Study|Other|2
344214|NCT00511667|1121847|P2|Overall Study|Site terminated|1
344215|NCT00511667|1121848|P1|Overall Study|Site terminated|6
344216|NCT00511667|1121847|P2|Overall Study|Withdrawal by Subject|0
344217|NCT00511667|1121848|P1|Overall Study|Withdrawal by Subject|2
344218|NCT00511667|1121847|P2|Overall Study|Protocol Violation|1
344219|NCT00511667|1121848|P1|Overall Study|Protocol Violation|1
344220|NCT00511667|1121847|P2|Overall Study|Adverse Event|0
344221|NCT00511667|1121848|P1|Overall Study|Adverse Event|1
344222|NCT00511472|1121883|P2|Overall Study|Not reported|2
344223|NCT00511472|1121884|P1|Overall Study|Not reported|2
344224|NCT00511472|1121883|P2|Overall Study|Laboratory Adverse Event|2
344225|NCT00511472|1121884|P1|Overall Study|Laboratory Adverse Event|0
344226|NCT00511472|1121883|P2|Overall Study|Clinical Adverse Event|2
344227|NCT00511472|1121884|P1|Overall Study|Clinical Adverse Event|1
344228|NCT00511433|1121903|P2|Overall Study|Other Reason|1
344229|NCT00511433|1121904|P1|Overall Study|Other Reason|1
344230|NCT00511433|1121903|P2|Overall Study|Adverse Event|0
344231|NCT00511433|1121904|P1|Overall Study|Adverse Event|5
344232|NCT00511355|1121944|P2|Overall Study|Other reason pre-treatment|1
344233|NCT00511355|1121945|P1|Overall Study|Other reason pre-treatment|0
344234|NCT00511355|1121944|P2|Overall Study|Withdrawal of informed consent|1
344235|NCT00511355|1121945|P1|Overall Study|Withdrawal of informed consent|0
344236|NCT00511355|1121944|P2|Overall Study|Pre-treatment (serious) adverse event|1
344237|NCT00511355|1121945|P1|Overall Study|Pre-treatment (serious) adverse event|0
344238|NCT00511355|1121944|P2|Overall Study|Other Reason|1
344239|NCT00511355|1121945|P1|Overall Study|Other Reason|0
344240|NCT00511355|1121944|P2|Overall Study|Lost to Follow-up|1
344241|NCT00511355|1121945|P1|Overall Study|Lost to Follow-up|2
344242|NCT00511355|1121944|P2|Overall Study|Pregnancy Wish|0
344243|NCT00511355|1121945|P1|Overall Study|Pregnancy Wish|1
344244|NCT00511355|1121944|P2|Overall Study|Adverse Event|4
344245|NCT00511355|1121945|P1|Overall Study|Adverse Event|4
344246|NCT00511342|1122045|P2|Overall Study|Other Reason|2
344247|NCT00511342|1122046|P1|Overall Study|Other Reason|2
344248|NCT00511342|1122045|P2|Overall Study|Lost to Follow-up|5
344249|NCT00511342|1122046|P1|Overall Study|Lost to Follow-up|1
344250|NCT00511342|1122045|P2|Overall Study|Pregnancy wish|1
344251|NCT00511342|1122046|P1|Overall Study|Pregnancy wish|0
344252|NCT00511342|1122045|P2|Overall Study|Pregnancy|1
344253|NCT00511342|1122046|P1|Overall Study|Pregnancy|0
344254|NCT00511342|1122045|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
344255|NCT00511342|1122046|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
344256|NCT00511342|1122045|P2|Overall Study|Unacceptable vaginal bleeding|1
344257|NCT00511342|1122046|P1|Overall Study|Unacceptable vaginal bleeding|2
344258|NCT00511238|1122072|P2|Overall Study|various reasons|14
344259|NCT00511238|1122073|P1|Overall Study|various reasons|4
344260|NCT00511238|1122072|P2|Overall Study|Progressive Disease|157
344261|NCT00511238|1122073|P1|Overall Study|Progressive Disease|23
344262|NCT00511238|1122072|P2|Overall Study|Withdrawal by Subject|22
344263|NCT00511238|1122073|P1|Overall Study|Withdrawal by Subject|2
344264|NCT00511238|1122072|P2|Overall Study|Adverse Event|33
344265|NCT00511238|1122073|P1|Overall Study|Adverse Event|13
344266|NCT00511199|1122092|P2|Overall Study|Other Reason|37
344267|NCT00511199|1122093|P1|Overall Study|Other Reason|78
344268|NCT00511199|1122092|P2|Overall Study|Lost to Follow-up|17
344269|NCT00511199|1122093|P1|Overall Study|Lost to Follow-up|40
344270|NCT00511199|1122092|P2|Overall Study|Pregnancy Wish|8
344271|NCT00511199|1122093|P1|Overall Study|Pregnancy Wish|16
344272|NCT00511199|1122092|P2|Overall Study|Pregnancy|3
344273|NCT00511199|1122093|P1|Overall Study|Pregnancy|6
344274|NCT00511199|1122092|P2|Overall Study|Withdrawal of Informed Consent|4
344275|NCT00511199|1122093|P1|Overall Study|Withdrawal of Informed Consent|19
344276|NCT00511199|1122092|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
344277|NCT00511199|1122093|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
344278|NCT00511199|1122092|P2|Overall Study|Unacceptable Vaginal Bleeding|4
344279|NCT00511199|1122093|P1|Overall Study|Unacceptable Vaginal Bleeding|63
344280|NCT00511147|1122122|P1|Overall Study|Required platelet transfusion|1
344281|NCT00511147|1122122|P1|Overall Study|Disease progression|5
344282|NCT00511147|1122122|P1|Overall Study|Withdrawal by Subject|1
344283|NCT00511134|1122131|P2|Overall Study|Withdrawal by Subject|2
344284|NCT00511134|1122132|P1|Overall Study|Withdrawal by Subject|0
344285|NCT00511108|1122144|P4|Overall Study|Withdrawal by Subject|2
344286|NCT00511108|1122145|P3|Overall Study|Withdrawal by Subject|3
344287|NCT00511108|1122146|P2|Overall Study|Withdrawal by Subject|0
344288|NCT00511108|1122147|P1|Overall Study|Withdrawal by Subject|4
344289|NCT00511108|1122144|P4|Overall Study|Physician Decision|1
344290|NCT00511108|1122145|P3|Overall Study|Physician Decision|0
344291|NCT00511108|1122146|P2|Overall Study|Physician Decision|0
344292|NCT00511108|1122147|P1|Overall Study|Physician Decision|0
344293|NCT00511108|1122144|P4|Overall Study|Lost to Follow-up|0
344294|NCT00511108|1122145|P3|Overall Study|Lost to Follow-up|1
344295|NCT00511108|1122146|P2|Overall Study|Lost to Follow-up|2
344296|NCT00511108|1122147|P1|Overall Study|Lost to Follow-up|0
344297|NCT00511108|1122144|P4|Overall Study|Adverse Event|2
344298|NCT00511108|1122145|P3|Overall Study|Adverse Event|1
344299|NCT00511108|1122146|P2|Overall Study|Adverse Event|0
344300|NCT00511108|1122147|P1|Overall Study|Adverse Event|2
344301|NCT00511004|1122174|P3|Overall Study|Lost to Follow-up|4
344302|NCT00511004|1122175|P2|Overall Study|Lost to Follow-up|0
344303|NCT00511004|1122176|P1|Overall Study|Lost to Follow-up|0
344304|NCT00510952|1122195|P2|Overall Study|Did Not Receive Study Drug|0
344305|NCT00510952|1122196|P1|Overall Study|Did Not Receive Study Drug|2
344306|NCT00510952|1122195|P2|Overall Study|Withdrawal by Subject|7
344307|NCT00510952|1122196|P1|Overall Study|Withdrawal by Subject|6
344308|NCT00510952|1122195|P2|Overall Study|Sponsor Decision|0
344309|NCT00510952|1122196|P1|Overall Study|Sponsor Decision|1
344310|NCT00510952|1122195|P2|Overall Study|Protocol Violation|4
344311|NCT00510952|1122196|P1|Overall Study|Protocol Violation|7
344312|NCT00510952|1122195|P2|Overall Study|Physician Decision|1
344313|NCT00510952|1122196|P1|Overall Study|Physician Decision|1
344314|NCT00510952|1122195|P2|Overall Study|Lost to Follow-up|3
344315|NCT00510952|1122196|P1|Overall Study|Lost to Follow-up|5
344316|NCT00510952|1122195|P2|Overall Study|Entry Criteria Not Met|1
344317|NCT00510952|1122196|P1|Overall Study|Entry Criteria Not Met|3
344318|NCT00510952|1122195|P2|Overall Study|Adverse Event|0
344319|NCT00510952|1122196|P1|Overall Study|Adverse Event|1
344320|NCT00510887|1122222|P1|Overall Study|Lost to Follow-up|1
344321|NCT00510874|1122238|P7|Overall Study|Lost to Follow-up|1
344322|NCT00510874|1122239|P6|Overall Study|Lost to Follow-up|0
344323|NCT00510874|1122240|P5|Overall Study|Lost to Follow-up|4
344324|NCT00510874|1122241|P4|Overall Study|Lost to Follow-up|3
344325|NCT00510874|1122242|P3|Overall Study|Lost to Follow-up|1
344326|NCT00510874|1122243|P2|Overall Study|Lost to Follow-up|3
344327|NCT00510874|1122244|P1|Overall Study|Lost to Follow-up|2
344328|NCT00510874|1122238|P7|Overall Study|Withdrawal by Subject|0
344329|NCT00510874|1122239|P6|Overall Study|Withdrawal by Subject|0
344330|NCT00510874|1122240|P5|Overall Study|Withdrawal by Subject|3
344331|NCT00510874|1122241|P4|Overall Study|Withdrawal by Subject|0
344332|NCT00510874|1122242|P3|Overall Study|Withdrawal by Subject|0
344333|NCT00510874|1122243|P2|Overall Study|Withdrawal by Subject|1
344334|NCT00510874|1122244|P1|Overall Study|Withdrawal by Subject|1
344335|NCT00510835|1122347|P3|Overall Study|Withdrawal by Subject|2
344336|NCT00510835|1122348|P2|Overall Study|Withdrawal by Subject|2
344337|NCT00510835|1122349|P1|Overall Study|Withdrawal by Subject|6
344338|NCT00510783|1122375|P2|Overall Study|Protocol Violation|1
344339|NCT00510783|1122376|P1|Overall Study|Protocol Violation|0
344340|NCT00510783|1122375|P2|Overall Study|Withdrawal by Subject|3
344341|NCT00510783|1122376|P1|Overall Study|Withdrawal by Subject|2
344342|NCT00510783|1122375|P2|Overall Study|Lost to Follow-up|25
344343|NCT00510783|1122376|P1|Overall Study|Lost to Follow-up|29
344344|NCT00510692|1122388|P2|Overall Study|Withdrawal by Subject|0
344345|NCT00510692|1122389|P1|Overall Study|Withdrawal by Subject|1
344346|NCT00510692|1122388|P2|Overall Study|Adverse Event|3
344347|NCT00510692|1122389|P1|Overall Study|Adverse Event|1
344348|NCT00510653|1122403|P1|Overall Study|Monetary|3
344349|NCT00510653|1122403|P1|Overall Study|Withdrawal by Subject|8
344350|NCT00510510|1122410|P3|Overall Study|Protocol Violation|4
344351|NCT00510510|1122411|P2|Overall Study|Protocol Violation|3
344352|NCT00510510|1122412|P1|Overall Study|Protocol Violation|0
344353|NCT00510510|1122410|P3|Overall Study|Lost to Follow-up|1
344354|NCT00510510|1122411|P2|Overall Study|Lost to Follow-up|0
344355|NCT00510510|1122412|P1|Overall Study|Lost to Follow-up|0
344356|NCT00510510|1122410|P3|Overall Study|Withdrawal by Subject|3
344357|NCT00510510|1122411|P2|Overall Study|Withdrawal by Subject|2
344358|NCT00510510|1122412|P1|Overall Study|Withdrawal by Subject|1
344359|NCT00510510|1122410|P3|Overall Study|Subjects no longer requires study drug|2
344360|NCT00510510|1122411|P2|Overall Study|Subjects no longer requires study drug|0
344361|NCT00510510|1122412|P1|Overall Study|Subjects no longer requires study drug|0
344362|NCT00510510|1122410|P3|Overall Study|Lack of Efficacy|1
344363|NCT00510510|1122411|P2|Overall Study|Lack of Efficacy|1
344364|NCT00510510|1122412|P1|Overall Study|Lack of Efficacy|0
344365|NCT00510510|1122410|P3|Overall Study|Adverse Event|6
344366|NCT00510510|1122411|P2|Overall Study|Adverse Event|3
344367|NCT00510510|1122412|P1|Overall Study|Adverse Event|4
344368|NCT00510484|1122430|P2|Wash-out Period|Adverse Event|1
344369|NCT00510484|1122431|P1|Wash-out Period|Adverse Event|0
344370|NCT00510289|1122451|P1|Overall Study|Progressed prior to starting drug|2
344371|NCT00510289|1122451|P1|Overall Study|Lost to Follow-up|1
344372|NCT00510289|1122451|P1|Overall Study|Refused bone marrow biopsy|2
344373|NCT00510289|1122451|P1|Overall Study|Withdrawal by Subject|7
344374|NCT00510276|1122461|P2|Extension Open-Label Phase|Subject Decision|9
344375|NCT00510276|1122462|P1|Extension Open-Label Phase|Subject Decision|7
344376|NCT00510276|1122461|P2|Extension Open-Label Phase|Sponsor Decision|0
344377|NCT00510276|1122462|P1|Extension Open-Label Phase|Sponsor Decision|1
344378|NCT00510276|1122461|P2|Extension Open-Label Phase|Protocol Violation|1
344379|NCT00510276|1122462|P1|Extension Open-Label Phase|Protocol Violation|0
344380|NCT00510276|1122461|P2|Extension Open-Label Phase|Physician Decision|3
344381|NCT00510276|1122462|P1|Extension Open-Label Phase|Physician Decision|2
344382|NCT00510276|1122461|P2|Extension Open-Label Phase|Lost to Follow-up|10
344383|NCT00510276|1122462|P1|Extension Open-Label Phase|Lost to Follow-up|12
344384|NCT00510276|1122461|P2|Extension Open-Label Phase|Lack of Efficacy|7
344385|NCT00510276|1122462|P1|Extension Open-Label Phase|Lack of Efficacy|2
344386|NCT00510276|1122461|P2|Extension Open-Label Phase|Adverse Event|18
344387|NCT00510276|1122462|P1|Extension Open-Label Phase|Adverse Event|9
344388|NCT00510276|1122461|P2|Acute Double-Blind Phase|Subject Decision|28
344389|NCT00510276|1122462|P1|Acute Double-Blind Phase|Subject Decision|26
344390|NCT00510276|1122461|P2|Acute Double-Blind Phase|Sponsor Decision|1
344391|NCT00510276|1122462|P1|Acute Double-Blind Phase|Sponsor Decision|2
344392|NCT00510276|1122461|P2|Acute Double-Blind Phase|Protocol Violation|3
344393|NCT00510276|1122462|P1|Acute Double-Blind Phase|Protocol Violation|4
344394|NCT00510276|1122461|P2|Acute Double-Blind Phase|Physician Decision|3
344395|NCT00510276|1122462|P1|Acute Double-Blind Phase|Physician Decision|0
344396|NCT00510276|1122461|P2|Acute Double-Blind Phase|Lost to Follow-up|49
344397|NCT00510276|1122462|P1|Acute Double-Blind Phase|Lost to Follow-up|48
344398|NCT00510276|1122461|P2|Acute Double-Blind Phase|Lack of Efficacy|4
344399|NCT00510276|1122462|P1|Acute Double-Blind Phase|Lack of Efficacy|3
344400|NCT00510276|1122461|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
344401|NCT00510276|1122462|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
344402|NCT00510276|1122461|P2|Acute Double-Blind Phase|Adverse Event|6
344403|NCT00510276|1122462|P1|Acute Double-Blind Phase|Adverse Event|21
344404|NCT00510146|1122556|P2|Open-Label Treatment|Sponsor Decision|0
344405|NCT00510146|1122557|P1|Open-Label Treatment|Sponsor Decision|2
344406|NCT00510146|1122556|P2|Open-Label Treatment|Clinical Relapse|1
344407|NCT00510146|1122557|P1|Open-Label Treatment|Clinical Relapse|1
344408|NCT00510146|1122556|P2|Open-Label Treatment|Withdrawal by Subject|12
344409|NCT00510146|1122557|P1|Open-Label Treatment|Withdrawal by Subject|24
344410|NCT00510146|1122556|P2|Open-Label Treatment|Protocol Violation|2
344411|NCT00510146|1122557|P1|Open-Label Treatment|Protocol Violation|4
344412|NCT00510146|1122556|P2|Open-Label Treatment|Physician Decision|1
344413|NCT00510146|1122557|P1|Open-Label Treatment|Physician Decision|3
344414|NCT00510146|1122556|P2|Open-Label Treatment|Lost to Follow-up|1
344415|NCT00510146|1122557|P1|Open-Label Treatment|Lost to Follow-up|10
344416|NCT00510146|1122556|P2|Open-Label Treatment|Lack of Efficacy|0
344417|NCT00510146|1122557|P1|Open-Label Treatment|Lack of Efficacy|4
344418|NCT00510146|1122556|P2|Open-Label Treatment|Death|1
344419|NCT00510146|1122557|P1|Open-Label Treatment|Death|1
344420|NCT00510146|1122556|P2|Open-Label Treatment|Adverse Event|8
344421|NCT00510146|1122557|P1|Open-Label Treatment|Adverse Event|22
344422|NCT00510146|1122556|P2|Double-Blind Treatment|Entry Criteria Not Met|0
344423|NCT00510146|1122557|P1|Double-Blind Treatment|Entry Criteria Not Met|3
344424|NCT00510146|1122556|P2|Double-Blind Treatment|Clinical Relapse|1
344425|NCT00510146|1122557|P1|Double-Blind Treatment|Clinical Relapse|0
344426|NCT00510146|1122556|P2|Double-Blind Treatment|Withdrawal by Subject|13
344427|NCT00510146|1122557|P1|Double-Blind Treatment|Withdrawal by Subject|27
344428|NCT00510146|1122556|P2|Double-Blind Treatment|Protocol Violation|2
344429|NCT00510146|1122557|P1|Double-Blind Treatment|Protocol Violation|1
344430|NCT00510146|1122556|P2|Double-Blind Treatment|Physician Decision|0
344431|NCT00510146|1122557|P1|Double-Blind Treatment|Physician Decision|6
344432|NCT00510146|1122556|P2|Double-Blind Treatment|Lost to Follow-up|7
344433|NCT00510146|1122557|P1|Double-Blind Treatment|Lost to Follow-up|3
344434|NCT00510146|1122556|P2|Double-Blind Treatment|Lack of Efficacy|13
344435|NCT00510146|1122557|P1|Double-Blind Treatment|Lack of Efficacy|6
344436|NCT00510146|1122556|P2|Double-Blind Treatment|Adverse Event|13
344437|NCT00510146|1122557|P1|Double-Blind Treatment|Adverse Event|30
344438|NCT00510068|1122646|P2|Open-label Period|Abnormal laboratory value (s)|0
344439|NCT00510068|1122647|P1|Open-label Period|Abnormal laboratory value (s)|1
344440|NCT00510068|1122646|P2|Open-label Period|Protocol Violation|0
344441|NCT00510068|1122647|P1|Open-label Period|Protocol Violation|2
344442|NCT00510068|1122646|P2|Open-label Period|New cancer therapy|0
344443|NCT00510068|1122647|P1|Open-label Period|New cancer therapy|7
344444|NCT00510068|1122646|P2|Open-label Period|Death|0
344445|NCT00510068|1122647|P1|Open-label Period|Death|7
344446|NCT00510068|1122646|P2|Open-label Period|Administrative problems|0
344447|NCT00510068|1122647|P1|Open-label Period|Administrative problems|17
344448|NCT00510068|1122646|P2|Open-label Period|Withdrawal by Subject|0
344449|NCT00510068|1122647|P1|Open-label Period|Withdrawal by Subject|21
344450|NCT00510068|1122646|P2|Open-label Period|Adverse Event|0
344451|NCT00510068|1122647|P1|Open-label Period|Adverse Event|46
344452|NCT00510068|1122646|P2|Open-label Period|Disease Progression|0
344453|NCT00510068|1122647|P1|Open-label Period|Disease Progression|124
344454|NCT00510068|1122646|P2|Double-blind Period|Protocol Violation|0
344455|NCT00510068|1122647|P1|Double-blind Period|Protocol Violation|6
344456|NCT00510068|1122646|P2|Double-blind Period|Lost to Follow-up|0
344457|NCT00510068|1122647|P1|Double-blind Period|Lost to Follow-up|1
344458|NCT00510068|1122646|P2|Double-blind Period|Abnormal test result (s)|0
344459|NCT00510068|1122647|P1|Double-blind Period|Abnormal test result (s)|1
344460|NCT00510068|1122646|P2|Double-blind Period|Death|3
344461|NCT00510068|1122647|P1|Double-blind Period|Death|4
344462|NCT00510068|1122646|P2|Double-blind Period|Withdrawal by Subject|6
344463|NCT00510068|1122647|P1|Double-blind Period|Withdrawal by Subject|8
344464|NCT00510068|1122646|P2|Double-blind Period|Adverse Event|7
344465|NCT00510068|1122647|P1|Double-blind Period|Adverse Event|37
344466|NCT00510068|1122646|P2|Double-blind Period|Final primary analysis|18
344467|NCT00510068|1122647|P1|Double-blind Period|Final primary analysis|52
344468|NCT00510068|1122646|P2|Double-blind Period|Disease progression|169
344469|NCT00510068|1122647|P1|Double-blind Period|Disease progression|98
344470|NCT00509925|1122688|P2|Overall Study|Personal reasons|1
344471|NCT00509925|1122689|P1|Overall Study|Personal reasons|0
344472|NCT00509899|1122737|P8|Overall Study|Lack of Efficacy|0
344473|NCT00509899|1122738|P7|Overall Study|Lack of Efficacy|0
344474|NCT00509899|1122739|P6|Overall Study|Lack of Efficacy|1
344475|NCT00509899|1122740|P5|Overall Study|Lack of Efficacy|0
344476|NCT00509899|1122741|P4|Overall Study|Lack of Efficacy|0
344477|NCT00509899|1122742|P3|Overall Study|Lack of Efficacy|2
344478|NCT00509899|1122743|P2|Overall Study|Lack of Efficacy|0
344479|NCT00509899|1122744|P1|Overall Study|Lack of Efficacy|1
344480|NCT00509899|1122737|P8|Overall Study|Death|1
344481|NCT00509899|1122738|P7|Overall Study|Death|1
344482|NCT00509899|1122739|P6|Overall Study|Death|1
344483|NCT00509899|1122740|P5|Overall Study|Death|1
344484|NCT00509899|1122741|P4|Overall Study|Death|0
344485|NCT00509899|1122742|P3|Overall Study|Death|3
344486|NCT00509899|1122743|P2|Overall Study|Death|2
344487|NCT00509899|1122744|P1|Overall Study|Death|2
344488|NCT00509899|1122737|P8|Overall Study|Intercurrent Illness|0
344489|NCT00509899|1122738|P7|Overall Study|Intercurrent Illness|0
344490|NCT00509899|1122739|P6|Overall Study|Intercurrent Illness|1
344491|NCT00509899|1122740|P5|Overall Study|Intercurrent Illness|0
344492|NCT00509899|1122741|P4|Overall Study|Intercurrent Illness|1
344493|NCT00509899|1122742|P3|Overall Study|Intercurrent Illness|0
344494|NCT00509899|1122743|P2|Overall Study|Intercurrent Illness|0
344495|NCT00509899|1122744|P1|Overall Study|Intercurrent Illness|1
344496|NCT00509899|1122737|P8|Overall Study|Physician Decision|0
344497|NCT00509899|1122738|P7|Overall Study|Physician Decision|0
344498|NCT00509899|1122739|P6|Overall Study|Physician Decision|4
344499|NCT00509899|1122740|P5|Overall Study|Physician Decision|1
344500|NCT00509899|1122741|P4|Overall Study|Physician Decision|0
344501|NCT00509899|1122742|P3|Overall Study|Physician Decision|7
344502|NCT00509899|1122743|P2|Overall Study|Physician Decision|2
344503|NCT00509899|1122744|P1|Overall Study|Physician Decision|4
344504|NCT00509899|1122737|P8|Overall Study|Withdrawal by Subject|0
344505|NCT00509899|1122738|P7|Overall Study|Withdrawal by Subject|0
344506|NCT00509899|1122739|P6|Overall Study|Withdrawal by Subject|2
344507|NCT00509899|1122740|P5|Overall Study|Withdrawal by Subject|3
344508|NCT00509899|1122741|P4|Overall Study|Withdrawal by Subject|0
344509|NCT00509899|1122742|P3|Overall Study|Withdrawal by Subject|3
344510|NCT00509899|1122743|P2|Overall Study|Withdrawal by Subject|2
344511|NCT00509899|1122744|P1|Overall Study|Withdrawal by Subject|6
344512|NCT00509899|1122737|P8|Overall Study|Unacceptable Toxicity|0
344513|NCT00509899|1122738|P7|Overall Study|Unacceptable Toxicity|0
344514|NCT00509899|1122739|P6|Overall Study|Unacceptable Toxicity|0
344515|NCT00509899|1122740|P5|Overall Study|Unacceptable Toxicity|0
344516|NCT00509899|1122741|P4|Overall Study|Unacceptable Toxicity|2
344517|NCT00509899|1122742|P3|Overall Study|Unacceptable Toxicity|0
344518|NCT00509899|1122743|P2|Overall Study|Unacceptable Toxicity|0
344519|NCT00509899|1122744|P1|Overall Study|Unacceptable Toxicity|1
344520|NCT00509899|1122737|P8|Overall Study|Progressive disease|0
344521|NCT00509899|1122738|P7|Overall Study|Progressive disease|0
344522|NCT00509899|1122739|P6|Overall Study|Progressive disease|1
344523|NCT00509899|1122740|P5|Overall Study|Progressive disease|0
344524|NCT00509899|1122741|P4|Overall Study|Progressive disease|1
344525|NCT00509899|1122742|P3|Overall Study|Progressive disease|5
344526|NCT00509899|1122743|P2|Overall Study|Progressive disease|3
344527|NCT00509899|1122744|P1|Overall Study|Progressive disease|1
344528|NCT00509795|1122803|P4|Overall Study|Withdrawal by Subject|8
344529|NCT00509795|1122804|P3|Overall Study|Withdrawal by Subject|7
344530|NCT00509795|1122805|P2|Overall Study|Withdrawal by Subject|5
344531|NCT00509795|1122806|P1|Overall Study|Withdrawal by Subject|10
344532|NCT00509795|1122803|P4|Overall Study|Protocol Violation|1
344533|NCT00509795|1122804|P3|Overall Study|Protocol Violation|3
344534|NCT00509795|1122805|P2|Overall Study|Protocol Violation|0
344535|NCT00509795|1122806|P1|Overall Study|Protocol Violation|3
344536|NCT00509795|1122803|P4|Overall Study|OTHER|1
344537|NCT00509795|1122804|P3|Overall Study|OTHER|4
344538|NCT00509795|1122805|P2|Overall Study|OTHER|0
344539|NCT00509795|1122806|P1|Overall Study|OTHER|1
344540|NCT00509795|1122803|P4|Overall Study|Lost to Follow-up|4
344541|NCT00509795|1122804|P3|Overall Study|Lost to Follow-up|4
344542|NCT00509795|1122805|P2|Overall Study|Lost to Follow-up|2
344543|NCT00509795|1122806|P1|Overall Study|Lost to Follow-up|1
344544|NCT00509795|1122803|P4|Overall Study|Lack of Efficacy|2
344545|NCT00509795|1122804|P3|Overall Study|Lack of Efficacy|2
344546|NCT00509795|1122805|P2|Overall Study|Lack of Efficacy|0
344547|NCT00509795|1122806|P1|Overall Study|Lack of Efficacy|0
344548|NCT00509795|1122803|P4|Overall Study|Death|7
344549|NCT00509795|1122804|P3|Overall Study|Death|2
344550|NCT00509795|1122805|P2|Overall Study|Death|1
344551|NCT00509795|1122806|P1|Overall Study|Death|3
344552|NCT00509795|1122803|P4|Overall Study|Adverse Event|4
344553|NCT00509795|1122804|P3|Overall Study|Adverse Event|5
344554|NCT00509795|1122805|P2|Overall Study|Adverse Event|3
344555|NCT00509795|1122806|P1|Overall Study|Adverse Event|4
344556|NCT00509769|1122837|P1|Overall Study|Use of prohibited therapies during study|1
344557|NCT00509769|1122837|P1|Overall Study|Physician Decision|8
344558|NCT00509769|1122837|P1|Overall Study|Patient’s decision|1
344559|NCT00509769|1122837|P1|Overall Study|Adverse Event|4
344560|NCT00509769|1122837|P1|Overall Study|Progressive disease|77
344561|NCT00509600|1122846|P1|Overall Study|Adverse Event|1
344562|NCT00509366|1122874|P5|Overall Study|Not Treated (Screen Failure)|0
344563|NCT00509366|1122875|P4|Overall Study|Not Treated (Screen Failure)|0
344564|NCT00509366|1122876|P3|Overall Study|Not Treated (Screen Failure)|1
344565|NCT00509366|1122877|P2|Overall Study|Not Treated (Screen Failure)|1
344566|NCT00509366|1122878|P1|Overall Study|Not Treated (Screen Failure)|1
344567|NCT00509262|1122902|P2|Overall Study|Withdrawal by Subject|11
344568|NCT00509262|1122903|P1|Overall Study|Withdrawal by Subject|24
344569|NCT00509262|1122902|P2|Overall Study|Protocol Violation|2
344570|NCT00509262|1122903|P1|Overall Study|Protocol Violation|2
344571|NCT00509262|1122902|P2|Overall Study|Physician Decision|3
344572|NCT00509262|1122903|P1|Overall Study|Physician Decision|1
344573|NCT00509262|1122902|P2|Overall Study|Lost to Follow-up|6
344574|NCT00509262|1122903|P1|Overall Study|Lost to Follow-up|1
344575|NCT00509262|1122902|P2|Overall Study|Lack of Efficacy|0
344576|NCT00509262|1122903|P1|Overall Study|Lack of Efficacy|1
344577|NCT00509262|1122902|P2|Overall Study|Not specified|2
344578|NCT00509262|1122903|P1|Overall Study|Not specified|2
344579|NCT00509262|1122902|P2|Overall Study|Adverse Event|18
344580|NCT00509262|1122903|P1|Overall Study|Adverse Event|16
344581|NCT00509236|1122921|P2|Overall Study|Scheduled Kidney Transplant|0
344582|NCT00509236|1122922|P1|Overall Study|Scheduled Kidney Transplant|1
344583|NCT00509236|1122921|P2|Overall Study|Excluded Medication|1
344584|NCT00509236|1122922|P1|Overall Study|Excluded Medication|1
344585|NCT00509236|1122921|P2|Overall Study|Protocol Violation|0
344586|NCT00509236|1122922|P1|Overall Study|Protocol Violation|3
344587|NCT00509236|1122921|P2|Overall Study|Withdrawal by Subject|10
344588|NCT00509236|1122922|P1|Overall Study|Withdrawal by Subject|5
344589|NCT00509236|1122921|P2|Overall Study|Adverse Event|9
344590|NCT00509236|1122922|P1|Overall Study|Adverse Event|7
344591|NCT00509223|1122937|P2|Overall Study|Did not meet revised inclusion criteria|62
344592|NCT00509223|1122938|P1|Overall Study|Did not meet revised inclusion criteria|56
344593|NCT00509223|1122937|P2|Overall Study|Including: subject change of address|2
344594|NCT00509223|1122938|P1|Overall Study|Including: subject change of address|5
344595|NCT00509223|1122937|P2|Overall Study|Withdrawal by Subject|6
344596|NCT00509223|1122938|P1|Overall Study|Withdrawal by Subject|25
344597|NCT00509223|1122937|P2|Overall Study|Adverse Event|1
344598|NCT00509223|1122938|P1|Overall Study|Adverse Event|1
344599|NCT00509223|1122937|P2|Overall Study|Lost to Follow-up|1
344600|NCT00509223|1122938|P1|Overall Study|Lost to Follow-up|1
344601|NCT00509106|1122961|P2|Overall Study|Death|6
344602|NCT00509106|1122962|P1|Overall Study|Death|6
344603|NCT00509106|1122961|P2|Overall Study|Other|0
344604|NCT00509106|1122962|P1|Overall Study|Other|1
344605|NCT00509106|1122961|P2|Overall Study|Lost to Follow-up|10
344606|NCT00509106|1122962|P1|Overall Study|Lost to Follow-up|16
344607|NCT00509106|1122961|P2|Overall Study|Withdrew consent|8
344608|NCT00509106|1122962|P1|Overall Study|Withdrew consent|4
344609|NCT00509106|1122961|P2|Overall Study|At the request of sponsor/investigator|2
344610|NCT00509106|1122962|P1|Overall Study|At the request of sponsor/investigator|1
344611|NCT00509106|1122961|P2|Overall Study|Noncompliance|1
344612|NCT00509106|1122962|P1|Overall Study|Noncompliance|0
344613|NCT00509106|1122961|P2|Overall Study|Adverse Event|2
344614|NCT00509106|1122962|P1|Overall Study|Adverse Event|3
344615|NCT00509067|1122970|P2|Overall Study|Protocol Violation|3
344616|NCT00509067|1122971|P1|Overall Study|Protocol Violation|0
344617|NCT00509067|1122970|P2|Overall Study|Adverse Event|1
344618|NCT00509067|1122971|P1|Overall Study|Adverse Event|3
344619|NCT00509067|1122970|P2|Overall Study|Lost to Follow-up|1
344620|NCT00509067|1122971|P1|Overall Study|Lost to Follow-up|1
344621|NCT00509028|1122986|P2|Overall Study|Non-compliance|1
344622|NCT00509028|1122987|P1|Overall Study|Non-compliance|2
344623|NCT00509028|1122986|P2|Overall Study|Protocol Violation|2
344624|NCT00509028|1122987|P1|Overall Study|Protocol Violation|4
344625|NCT00509028|1122986|P2|Overall Study|Lost to Follow-up|1
344626|NCT00509028|1122987|P1|Overall Study|Lost to Follow-up|0
344627|NCT00509028|1122986|P2|Overall Study|Withdrawal by Subject|3
344628|NCT00509028|1122987|P1|Overall Study|Withdrawal by Subject|4
344629|NCT00509028|1122986|P2|Overall Study|Adverse Event|0
344630|NCT00509028|1122987|P1|Overall Study|Adverse Event|2
344631|NCT00508924|1123023|P4|Overall Study|Protocol Violation|1
344632|NCT00508924|1123024|P3|Overall Study|Protocol Violation|1
344633|NCT00508924|1123025|P2|Overall Study|Protocol Violation|0
344634|NCT00508924|1123026|P1|Overall Study|Protocol Violation|0
344635|NCT00508872|1123040|P1|Overall Study|Physician Decision|1
344636|NCT00508872|1123040|P1|Overall Study|Lost to Follow-up|1
344637|NCT00508820|1123046|P2|Overall Study|Protocol-specified Criteria|12
344638|NCT00508820|1123047|P1|Overall Study|Protocol-specified Criteria|3
344639|NCT00508820|1123046|P2|Overall Study|Requirement for alternative therapy|15
344640|NCT00508820|1123047|P1|Overall Study|Requirement for alternative therapy|7
344641|NCT00508820|1123046|P2|Overall Study|Noncompliance|0
344642|NCT00508820|1123047|P1|Overall Study|Noncompliance|1
344643|NCT00508820|1123046|P2|Overall Study|Other|2
344644|NCT00508820|1123047|P1|Overall Study|Other|11
344645|NCT00508820|1123046|P2|Overall Study|Withdrawal by Subject|12
344646|NCT00508820|1123047|P1|Overall Study|Withdrawal by Subject|10
344647|NCT00508820|1123046|P2|Overall Study|Protocol Violation|0
344648|NCT00508820|1123047|P1|Overall Study|Protocol Violation|2
344649|NCT00508820|1123046|P2|Overall Study|Pregnancy|2
344650|NCT00508820|1123047|P1|Overall Study|Pregnancy|0
344651|NCT00508820|1123046|P2|Overall Study|Physician Decision|2
344652|NCT00508820|1123047|P1|Overall Study|Physician Decision|8
344653|NCT00508820|1123046|P2|Overall Study|Lost to Follow-up|1
344654|NCT00508820|1123047|P1|Overall Study|Lost to Follow-up|1
344655|NCT00508820|1123046|P2|Overall Study|Death|8
344656|NCT00508820|1123047|P1|Overall Study|Death|6
344657|NCT00508820|1123046|P2|Overall Study|Adverse Event|10
344658|NCT00508820|1123047|P1|Overall Study|Adverse Event|6
344659|NCT00508755|1123057|P1|Overall Study|Withdrawal by Subject|1
344660|NCT00508742|1123065|P2|Period 3: Toddler Dose|Unspecified|4
344661|NCT00508742|1123066|P1|Period 3: Toddler Dose|Unspecified|5
344662|NCT00508742|1123065|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
344663|NCT00508742|1123066|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
344664|NCT00508742|1123065|P2|Period 3: Toddler Dose|Lost to Follow-up|3
344665|NCT00508742|1123066|P1|Period 3: Toddler Dose|Lost to Follow-up|2
344666|NCT00508742|1123065|P2|Period 3: Toddler Dose|Adverse Event|0
344667|NCT00508742|1123066|P1|Period 3: Toddler Dose|Adverse Event|1
344668|NCT00508742|1123065|P2|Period 2: After Infant Series|Unspecified|1
344669|NCT00508742|1123066|P1|Period 2: After Infant Series|Unspecified|2
344670|NCT00508742|1123065|P2|Period 2: After Infant Series|Failed to Return|0
344671|NCT00508742|1123066|P1|Period 2: After Infant Series|Failed to Return|1
344672|NCT00508742|1123065|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
344673|NCT00508742|1123066|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
344674|NCT00508742|1123065|P2|Period 2: After Infant Series|Protocol Violation|0
344675|NCT00508742|1123066|P1|Period 2: After Infant Series|Protocol Violation|1
344676|NCT00508742|1123065|P2|Period 2: After Infant Series|Lost to Follow-up|1
344677|NCT00508742|1123066|P1|Period 2: After Infant Series|Lost to Follow-up|1
344678|NCT00508742|1123065|P2|Period 2: After Infant Series|Adverse Event|6
344679|NCT00508742|1123066|P1|Period 2: After Infant Series|Adverse Event|2
344680|NCT00508742|1123065|P2|Period 1: Infant Series|Unspecified|1
344681|NCT00508742|1123066|P1|Period 1: Infant Series|Unspecified|4
344682|NCT00508742|1123065|P2|Period 1: Infant Series|Physician Decision|0
344683|NCT00508742|1123066|P1|Period 1: Infant Series|Physician Decision|1
344684|NCT00508742|1123065|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
344685|NCT00508742|1123066|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
344686|NCT00508742|1123065|P2|Period 1: Infant Series|Protocol Violation|0
344687|NCT00508742|1123066|P1|Period 1: Infant Series|Protocol Violation|1
344688|NCT00508742|1123065|P2|Period 1: Infant Series|Adverse Event|4
344689|NCT00508742|1123066|P1|Period 1: Infant Series|Adverse Event|5
344690|NCT00508651|1123091|P2|Overall Study|Withdrawal by Subject|1
344691|NCT00508651|1123092|P1|Overall Study|Withdrawal by Subject|1
344692|NCT00508651|1123091|P2|Overall Study|Lost to Follow-up|1
344693|NCT00508651|1123092|P1|Overall Study|Lost to Follow-up|3
344694|NCT00508482|1123173|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
344695|NCT00508482|1123174|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
344696|NCT00508482|1123175|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
344697|NCT00508482|1123173|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
344698|NCT00508482|1123174|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
344699|NCT00508482|1123175|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
344700|NCT00508482|1123173|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
344701|NCT00508482|1123174|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
344702|NCT00508482|1123175|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
344703|NCT00508404|1123219|P1|Overall Study|Other - Not Specified|3
344704|NCT00508404|1123219|P1|Overall Study|Lost to Follow-up|2
344705|NCT00508404|1123219|P1|Overall Study|Protocol-specified Criteria|2
344706|NCT00508404|1123219|P1|Overall Study|Withdrawal by Subject|3
344707|NCT00508404|1123219|P1|Overall Study|Physician Decision|2
344708|NCT00508404|1123219|P1|Overall Study|Death|16
344709|NCT00508404|1123219|P1|Overall Study|Adverse Event|2
344710|NCT00508404|1123219|P1|Overall Study|Ongoing at Data Cut-off|12
344711|NCT00508391|1123246|P2|Second Treatment|Withdrawal by Subject|0
344712|NCT00508391|1123247|P1|Second Treatment|Withdrawal by Subject|2
344713|NCT00508391|1123246|P2|First Treatment|Withdrawal by Subject|3
344714|NCT00508391|1123247|P1|First Treatment|Withdrawal by Subject|6
344715|NCT00508274|1123258|P1|Overall Study|Withdrawal by Subject|1
344716|NCT00508274|1123258|P1|Overall Study|Adverse Event|1
344717|NCT00508157|1123269|P2|Overall Study|Other known cause|1
344718|NCT00508157|1123270|P1|Overall Study|Other known cause|0
344719|NCT00508157|1123269|P2|Overall Study|Subject no longer met study criteria|1
344720|NCT00508157|1123270|P1|Overall Study|Subject no longer met study criteria|0
344721|NCT00508157|1123269|P2|Overall Study|Lost to Follow-up|0
344722|NCT00508157|1123270|P1|Overall Study|Lost to Follow-up|1
344723|NCT00508157|1123269|P2|Overall Study|Subject Withdrew Consent|0
344724|NCT00508157|1123270|P1|Overall Study|Subject Withdrew Consent|1
344725|NCT00508157|1123269|P2|Overall Study|Adverse Event|1
344726|NCT00508157|1123270|P1|Overall Study|Adverse Event|0
344727|NCT00508144|1123292|P1|Overall Study|Death|5
344728|NCT00508144|1123292|P1|Overall Study|Not eligible|6
344729|NCT00508027|1123318|P1|Dose Level 2|Withdrawal by Subject|2
344730|NCT00508027|1123318|P1|Dose Level 2|Lost to Follow-up|2
344731|NCT00508027|1123318|P1|Dose Level 1|Physician Decision|2
344732|NCT00508027|1123318|P1|Dose Level 1|Withdrawal by Subject|2
344733|NCT00508027|1123318|P1|Dose Level 1|Lost to Follow-up|4
344734|NCT00508001|1123359|P3|Overall Study|Withdrawal by Subject|1
344735|NCT00508001|1123360|P2|Overall Study|Withdrawal by Subject|4
344736|NCT00508001|1123361|P1|Overall Study|Withdrawal by Subject|4
344737|NCT00508001|1123359|P3|Overall Study|Death|1
344738|NCT00508001|1123360|P2|Overall Study|Death|1
344739|NCT00508001|1123361|P1|Overall Study|Death|0
344740|NCT00508001|1123359|P3|Overall Study|condition under investigation worsened|1
344741|NCT00508001|1123360|P2|Overall Study|condition under investigation worsened|7
344742|NCT00508001|1123361|P1|Overall Study|condition under investigation worsened|13
344743|NCT00508001|1123359|P3|Overall Study|Adverse Event|4
344744|NCT00508001|1123360|P2|Overall Study|Adverse Event|0
344745|NCT00508001|1123361|P1|Overall Study|Adverse Event|2
344746|NCT00507819|1123378|P2|Washout (6 Weeks)|Withdrawal by Subject|0
344747|NCT00507819|1123379|P1|Washout (6 Weeks)|Withdrawal by Subject|1
344748|NCT00507689|1123398|P2|Randomized Period|Withdrawal by Subject|1
344749|NCT00507689|1123399|P1|Randomized Period|Withdrawal by Subject|0
344750|NCT00507689|1123398|P2|Randomized Period|Adverse Event|1
344751|NCT00507689|1123399|P1|Randomized Period|Adverse Event|1
344752|NCT00507689|1123398|P2|Pre-Randomization Period|Withdrawal by Subject|0
344753|NCT00507689|1123399|P1|Pre-Randomization Period|Withdrawal by Subject|1
344754|NCT00507689|1123398|P2|Pre-Randomization Period|Physician Decision|0
344755|NCT00507689|1123399|P1|Pre-Randomization Period|Physician Decision|1
344756|NCT00507689|1123398|P2|Pre-Randomization Period|Adverse Event|0
344757|NCT00507689|1123399|P1|Pre-Randomization Period|Adverse Event|1
344758|NCT00507546|1123431|P2|Overall Study|Physician Decision|1
344759|NCT00507546|1123432|P1|Overall Study|Physician Decision|0
344760|NCT00507546|1123431|P2|Overall Study|Protocol Violation|0
344761|NCT00507546|1123432|P1|Overall Study|Protocol Violation|1
344762|NCT00507546|1123431|P2|Overall Study|Withdrawal by Subject|0
344763|NCT00507546|1123432|P1|Overall Study|Withdrawal by Subject|1
344764|NCT00507507|1123442|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
344765|NCT00507507|1123443|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
344766|NCT00507507|1123442|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
344767|NCT00507507|1123443|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
344768|NCT00507507|1123442|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
344769|NCT00507507|1123443|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
344770|NCT00507507|1123442|P2|Treatment Period|Withdrawal by Subject|47
344771|NCT00507507|1123443|P1|Treatment Period|Withdrawal by Subject|46
344772|NCT00507507|1123442|P2|Treatment Period|Adverse Event|1
344773|NCT00507507|1123443|P1|Treatment Period|Adverse Event|1
344774|NCT00507507|1123442|P2|Treatment Period|Protocol Violation|2
344775|NCT00507507|1123443|P1|Treatment Period|Protocol Violation|1
344776|NCT00507507|1123442|P2|Treatment Period|Physician Decision|1
344777|NCT00507507|1123443|P1|Treatment Period|Physician Decision|4
344778|NCT00507507|1123442|P2|Treatment Period|Lost to Follow-up|2
344779|NCT00507507|1123443|P1|Treatment Period|Lost to Follow-up|0
344780|NCT00507455|1123478|P3|Overall Study|Other - miscellaneous reason|1
344781|NCT00507455|1123479|P2|Overall Study|Other - miscellaneous reason|0
344782|NCT00507455|1123480|P1|Overall Study|Other - miscellaneous reason|1
344783|NCT00507455|1123478|P3|Overall Study|Lack of Efficacy|0
344784|NCT00507455|1123479|P2|Overall Study|Lack of Efficacy|1
344785|NCT00507455|1123480|P1|Overall Study|Lack of Efficacy|0
344786|NCT00507455|1123478|P3|Overall Study|Lost to Follow-up|2
344787|NCT00507455|1123479|P2|Overall Study|Lost to Follow-up|0
344788|NCT00507455|1123480|P1|Overall Study|Lost to Follow-up|2
344789|NCT00507455|1123478|P3|Overall Study|Protocol Violation|1
344790|NCT00507455|1123479|P2|Overall Study|Protocol Violation|1
344791|NCT00507455|1123480|P1|Overall Study|Protocol Violation|4
344792|NCT00507455|1123478|P3|Overall Study|Withdrawal by Subject|2
344793|NCT00507455|1123479|P2|Overall Study|Withdrawal by Subject|1
344794|NCT00507455|1123480|P1|Overall Study|Withdrawal by Subject|2
344795|NCT00507455|1123478|P3|Overall Study|Adverse Event|6
344796|NCT00507455|1123479|P2|Overall Study|Adverse Event|3
344797|NCT00507455|1123480|P1|Overall Study|Adverse Event|3
344798|NCT00507442|1123543|P4|Overall Study|Not Specified|2
344799|NCT00507442|1123544|P3|Overall Study|Not Specified|2
344800|NCT00507442|1123545|P2|Overall Study|Not Specified|5
344801|NCT00507442|1123546|P1|Overall Study|Not Specified|2
344802|NCT00507442|1123543|P4|Overall Study|Withdrawal by Subject|1
344803|NCT00507442|1123544|P3|Overall Study|Withdrawal by Subject|2
344804|NCT00507442|1123545|P2|Overall Study|Withdrawal by Subject|4
344805|NCT00507442|1123546|P1|Overall Study|Withdrawal by Subject|4
344806|NCT00507442|1123543|P4|Overall Study|Progressive Disease|0
344807|NCT00507442|1123544|P3|Overall Study|Progressive Disease|2
344808|NCT00507442|1123545|P2|Overall Study|Progressive Disease|4
344809|NCT00507442|1123546|P1|Overall Study|Progressive Disease|2
344810|NCT00507442|1123543|P4|Overall Study|Physician Decision|1
344811|NCT00507442|1123544|P3|Overall Study|Physician Decision|4
344812|NCT00507442|1123545|P2|Overall Study|Physician Decision|2
344813|NCT00507442|1123546|P1|Overall Study|Physician Decision|0
344814|NCT00507442|1123543|P4|Overall Study|Lost to Follow-up|0
344815|NCT00507442|1123544|P3|Overall Study|Lost to Follow-up|1
344816|NCT00507442|1123545|P2|Overall Study|Lost to Follow-up|0
344817|NCT00507442|1123546|P1|Overall Study|Lost to Follow-up|0
344818|NCT00507442|1123543|P4|Overall Study|Protocol Violation|0
344819|NCT00507442|1123544|P3|Overall Study|Protocol Violation|0
344820|NCT00507442|1123545|P2|Overall Study|Protocol Violation|1
344821|NCT00507442|1123546|P1|Overall Study|Protocol Violation|0
344822|NCT00507442|1123543|P4|Overall Study|Adverse Event|1
344823|NCT00507442|1123544|P3|Overall Study|Adverse Event|4
344824|NCT00507442|1123545|P2|Overall Study|Adverse Event|11
344825|NCT00507442|1123546|P1|Overall Study|Adverse Event|8
344826|NCT00507429|1123598|P2|Maintenance Phase|Progressive Disease|0
344827|NCT00507429|1123599|P1|Maintenance Phase|Progressive Disease|14
344828|NCT00507429|1123598|P2|Treatment Phase|Other|3
344829|NCT00507429|1123599|P1|Treatment Phase|Other|6
344830|NCT00507429|1123598|P2|Treatment Phase|Physician Decision|2
344831|NCT00507429|1123599|P1|Treatment Phase|Physician Decision|4
344832|NCT00507429|1123598|P2|Treatment Phase|Withdrawal by Subject|3
344833|NCT00507429|1123599|P1|Treatment Phase|Withdrawal by Subject|3
344834|NCT00507429|1123598|P2|Treatment Phase|Adverse Event|5
344835|NCT00507429|1123599|P1|Treatment Phase|Adverse Event|12
344836|NCT00507429|1123598|P2|Treatment Phase|Disease Progression|5
344837|NCT00507429|1123599|P1|Treatment Phase|Disease Progression|12
344838|NCT00507416|1123610|P3|Overall Study|Did not Receive Study Treatment|4
344839|NCT00507416|1123611|P2|Overall Study|Did not Receive Study Treatment|9
344840|NCT00507416|1123612|P1|Overall Study|Did not Receive Study Treatment|3
344841|NCT00507416|1123610|P3|Overall Study|Other|13
344842|NCT00507416|1123611|P2|Overall Study|Other|16
344843|NCT00507416|1123612|P1|Overall Study|Other|11
344844|NCT00507416|1123610|P3|Overall Study|Patient declined further treatment|11
344845|NCT00507416|1123611|P2|Overall Study|Patient declined further treatment|14
344846|NCT00507416|1123612|P1|Overall Study|Patient declined further treatment|18
344847|NCT00507416|1123610|P3|Overall Study|Progressive Disease|13
344848|NCT00507416|1123611|P2|Overall Study|Progressive Disease|10
344849|NCT00507416|1123612|P1|Overall Study|Progressive Disease|20
344850|NCT00507416|1123610|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
344851|NCT00507416|1123611|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
344852|NCT00507416|1123612|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
344853|NCT00507416|1123610|P3|Overall Study|Protocol Violation|0
344854|NCT00507416|1123611|P2|Overall Study|Protocol Violation|2
344855|NCT00507416|1123612|P1|Overall Study|Protocol Violation|1
344856|NCT00507416|1123610|P3|Overall Study|Adverse Event|65
344857|NCT00507416|1123611|P2|Overall Study|Adverse Event|67
344858|NCT00507416|1123612|P1|Overall Study|Adverse Event|58
344859|NCT00503997|1123650|P1|Overall Study|Withdrawal by Subject|1
344860|NCT00503997|1123650|P1|Overall Study|Death|1
344861|NCT00503997|1123650|P1|Overall Study|Adverse Event|5
344862|NCT00503997|1123650|P1|Overall Study|disease progression|1
344863|NCT00503984|1123656|P6|Overall Study|Death|0
344864|NCT00503984|1123657|P5|Overall Study|Death|1
344865|NCT00503984|1123658|P4|Overall Study|Death|0
344866|NCT00503984|1123659|P3|Overall Study|Death|0
344867|NCT00503984|1123660|P2|Overall Study|Death|0
344868|NCT00503984|1123661|P1|Overall Study|Death|0
344869|NCT00503984|1123656|P6|Overall Study|Adverse Event|0
344870|NCT00503984|1123657|P5|Overall Study|Adverse Event|0
344871|NCT00503984|1123658|P4|Overall Study|Adverse Event|0
344872|NCT00503984|1123659|P3|Overall Study|Adverse Event|0
344873|NCT00503984|1123660|P2|Overall Study|Adverse Event|1
344874|NCT00503984|1123661|P1|Overall Study|Adverse Event|0
344875|NCT00503984|1123656|P6|Overall Study|Protocol Violation|0
344876|NCT00503984|1123657|P5|Overall Study|Protocol Violation|0
344877|NCT00503984|1123658|P4|Overall Study|Protocol Violation|0
344878|NCT00503984|1123659|P3|Overall Study|Protocol Violation|0
344879|NCT00503984|1123660|P2|Overall Study|Protocol Violation|1
344880|NCT00503984|1123661|P1|Overall Study|Protocol Violation|0
344881|NCT00507130|1123691|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
344882|NCT00507130|1123692|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
344883|NCT00507130|1123693|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
344884|NCT00507130|1123694|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
344885|NCT00507130|1123691|P4|Overall Study|Lost to Follow-up|1
344886|NCT00507130|1123692|P3|Overall Study|Lost to Follow-up|1
344887|NCT00507130|1123693|P2|Overall Study|Lost to Follow-up|0
344888|NCT00507130|1123694|P1|Overall Study|Lost to Follow-up|0
344889|NCT00506948|1123736|P1|Overall Study|Physician Decision|1
344890|NCT00506948|1123736|P1|Overall Study|Adverse Event|5
344891|NCT00506948|1123736|P1|Overall Study|Death|4
344892|NCT00506922|1123745|P5|Overall Study|Withdrawal by Subject|1
344893|NCT00506922|1123746|P4|Overall Study|Withdrawal by Subject|0
344894|NCT00506922|1123747|P3|Overall Study|Withdrawal by Subject|0
344895|NCT00506922|1123748|P2|Overall Study|Withdrawal by Subject|0
344896|NCT00506922|1123749|P1|Overall Study|Withdrawal by Subject|0
344897|NCT00506922|1123745|P5|Overall Study|Physician Decision|0
344898|NCT00506922|1123746|P4|Overall Study|Physician Decision|2
344899|NCT00506922|1123747|P3|Overall Study|Physician Decision|0
344900|NCT00506922|1123748|P2|Overall Study|Physician Decision|0
344901|NCT00506922|1123749|P1|Overall Study|Physician Decision|0
344902|NCT00506883|1123760|P3|Overall Study|Other|1
344903|NCT00506883|1123761|P2|Overall Study|Other|1
344904|NCT00506883|1123762|P1|Overall Study|Other|5
344905|NCT00506883|1123760|P3|Overall Study|Lack of Efficacy|1
344906|NCT00506883|1123761|P2|Overall Study|Lack of Efficacy|1
344907|NCT00506883|1123762|P1|Overall Study|Lack of Efficacy|0
344908|NCT00506883|1123760|P3|Overall Study|Withdrawal by Subject|1
344909|NCT00506883|1123761|P2|Overall Study|Withdrawal by Subject|0
344910|NCT00506883|1123762|P1|Overall Study|Withdrawal by Subject|1
344911|NCT00506883|1123760|P3|Overall Study|Lost to Follow-up|1
344912|NCT00506883|1123761|P2|Overall Study|Lost to Follow-up|1
344913|NCT00506883|1123762|P1|Overall Study|Lost to Follow-up|1
344914|NCT00506831|1123775|P1|Overall Study|Withdrawal by Subject|1
344915|NCT00506831|1123775|P1|Overall Study|Death|1
344916|NCT00506662|1123807|P2|Overall Study|Not recorded|6
344917|NCT00506662|1123808|P1|Overall Study|Not recorded|4
344918|NCT00506662|1123807|P2|Overall Study|Trial terminated|16
344919|NCT00506662|1123808|P1|Overall Study|Trial terminated|10
344920|NCT00506662|1123807|P2|Overall Study|Protocol Violation|4
344921|NCT00506662|1123808|P1|Overall Study|Protocol Violation|2
344922|NCT00506662|1123807|P2|Overall Study|Lack of Efficacy|0
344923|NCT00506662|1123808|P1|Overall Study|Lack of Efficacy|1
344924|NCT00506662|1123807|P2|Overall Study|Adverse Event|2
344925|NCT00506662|1123808|P1|Overall Study|Adverse Event|0
344926|NCT00506493|1123842|P1|Overall Study|Withdrawal by Subject|5
344927|NCT00506493|1123842|P1|Overall Study|Death|6
344928|NCT00506454|1123851|P2|Overall Study|Withdrawal by Subject|1
344929|NCT00506454|1123852|P1|Overall Study|Withdrawal by Subject|1
344930|NCT00506441|1123858|P2|Period 2; Double-blind Period|Other Reason|1
344931|NCT00506441|1123859|P1|Period 2; Double-blind Period|Other Reason|1
344932|NCT00506441|1123858|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
344933|NCT00506441|1123859|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
344934|NCT00506441|1123858|P2|Period 2; Double-blind Period|Physician Decision|1
344935|NCT00506441|1123859|P1|Period 2; Double-blind Period|Physician Decision|1
344936|NCT00506441|1123858|P2|Period 2; Double-blind Period|Lack of Efficacy|2
344937|NCT00506441|1123859|P1|Period 2; Double-blind Period|Lack of Efficacy|0
344938|NCT00506441|1123858|P2|Period 2; Double-blind Period|Adverse Event|1
344939|NCT00506441|1123859|P1|Period 2; Double-blind Period|Adverse Event|0
344940|NCT00506441|1123858|P2|Period 1; Open-label Period|Other Reasons|0
344941|NCT00506441|1123859|P1|Period 1; Open-label Period|Other Reasons|13
344942|NCT00506441|1123858|P2|Period 1; Open-label Period|Withdrawal by Subject|0
344943|NCT00506441|1123859|P1|Period 1; Open-label Period|Withdrawal by Subject|13
344944|NCT00506441|1123858|P2|Period 1; Open-label Period|Protocol Violation|0
344945|NCT00506441|1123859|P1|Period 1; Open-label Period|Protocol Violation|9
344946|NCT00506441|1123858|P2|Period 1; Open-label Period|Physician Decision|0
344947|NCT00506441|1123859|P1|Period 1; Open-label Period|Physician Decision|5
344948|NCT00506441|1123858|P2|Period 1; Open-label Period|Lost to Follow-up|0
344949|NCT00506441|1123859|P1|Period 1; Open-label Period|Lost to Follow-up|2
344950|NCT00506441|1123858|P2|Period 1; Open-label Period|Lack of Efficacy|0
344951|NCT00506441|1123859|P1|Period 1; Open-label Period|Lack of Efficacy|13
344952|NCT00506441|1123858|P2|Period 1; Open-label Period|Adverse Event|0
344953|NCT00506441|1123859|P1|Period 1; Open-label Period|Adverse Event|21
344954|NCT00506415|1123867|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
344955|NCT00506415|1123868|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
344956|NCT00506415|1123869|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
344957|NCT00506415|1123870|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
344958|NCT00506415|1123867|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
344959|NCT00506415|1123868|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
344960|NCT00506415|1123869|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
344961|NCT00506415|1123870|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
344962|NCT00506415|1123867|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
344963|NCT00506415|1123868|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
344964|NCT00506415|1123869|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
344965|NCT00506415|1123870|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
344966|NCT00506415|1123867|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
344967|NCT00506415|1123868|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
344968|NCT00506415|1123869|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
344969|NCT00506415|1123870|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
344970|NCT00506415|1123867|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
344971|NCT00506415|1123868|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
344972|NCT00506415|1123869|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
344973|NCT00506415|1123870|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
344974|NCT00506415|1123867|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
344975|NCT00506415|1123868|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
344976|NCT00506415|1123869|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
344977|NCT00506415|1123870|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
344978|NCT00506415|1123867|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
344979|NCT00506415|1123868|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
344980|NCT00506415|1123869|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
344981|NCT00506415|1123870|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
344982|NCT00506415|1123867|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
344983|NCT00506415|1123868|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
344984|NCT00506415|1123869|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
344985|NCT00506415|1123870|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
344986|NCT00506415|1123867|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
344987|NCT00506415|1123868|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
344988|NCT00506415|1123869|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
344989|NCT00506415|1123870|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
344990|NCT00506415|1123867|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
344991|NCT00506415|1123868|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
344992|NCT00506415|1123869|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
344993|NCT00506415|1123870|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
344994|NCT00506415|1123867|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
344995|NCT00506415|1123868|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
344996|NCT00506415|1123869|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
344997|NCT00506415|1123870|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
344998|NCT00506415|1123867|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
344999|NCT00506415|1123868|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
345000|NCT00506415|1123869|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
345001|NCT00506415|1123870|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
345002|NCT00506415|1123867|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
345003|NCT00506415|1123868|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
345004|NCT00506415|1123869|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
345005|NCT00506415|1123870|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
345006|NCT00506415|1123867|P4|Double Blind (Maximum 48 Weeks )|Death|0
345007|NCT00506415|1123868|P3|Double Blind (Maximum 48 Weeks )|Death|3
345008|NCT00506415|1123869|P2|Double Blind (Maximum 48 Weeks )|Death|5
345009|NCT00506415|1123870|P1|Double Blind (Maximum 48 Weeks )|Death|0
345010|NCT00506415|1123867|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
345011|NCT00506415|1123868|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
345012|NCT00506415|1123869|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
345013|NCT00506415|1123870|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
345014|NCT00506415|1123867|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
345015|NCT00506415|1123868|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
345016|NCT00506415|1123869|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
345017|NCT00506415|1123870|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
345018|NCT00506415|1123867|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
345019|NCT00506415|1123868|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
345020|NCT00506415|1123869|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
345021|NCT00506415|1123870|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
345098|NCT00505921|1123981|P1|Overall Study|Ineligible|1
345022|NCT00506415|1123867|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
345023|NCT00506415|1123868|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
345024|NCT00506415|1123869|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
345025|NCT00506415|1123870|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
345026|NCT00506415|1123867|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
345027|NCT00506415|1123868|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
345028|NCT00506415|1123869|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
345029|NCT00506415|1123870|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
345030|NCT00506415|1123867|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
345031|NCT00506415|1123868|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
345032|NCT00506415|1123869|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
345033|NCT00506415|1123870|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
345034|NCT00506415|1123867|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
345035|NCT00506415|1123868|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
345036|NCT00506415|1123869|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
345037|NCT00506415|1123870|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
345038|NCT00506415|1123867|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
345039|NCT00506415|1123868|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
345040|NCT00506415|1123869|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
345041|NCT00506415|1123870|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
345042|NCT00506415|1123867|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
345043|NCT00506415|1123868|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
345044|NCT00506415|1123869|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
345045|NCT00506415|1123870|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
345046|NCT00506415|1123867|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
345047|NCT00506415|1123868|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
345048|NCT00506415|1123869|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
345049|NCT00506415|1123870|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
345050|NCT00506389|1123895|P3|In-treatment Period|Randomized but not treated|1
345051|NCT00506389|1123896|P2|In-treatment Period|Randomized but not treated|1
345052|NCT00506389|1123897|P1|In-treatment Period|Randomized but not treated|4
345053|NCT00506389|1123895|P3|In-treatment Period|Adverse Event|2
345054|NCT00506389|1123896|P2|In-treatment Period|Adverse Event|5
345055|NCT00506389|1123897|P1|In-treatment Period|Adverse Event|11
345056|NCT00506389|1123895|P3|In-treatment Period|Lack of Efficacy|0
345057|NCT00506389|1123896|P2|In-treatment Period|Lack of Efficacy|2
345058|NCT00506389|1123897|P1|In-treatment Period|Lack of Efficacy|0
345059|NCT00506389|1123895|P3|In-treatment Period|Withdrawal by Subject|4
345060|NCT00506389|1123896|P2|In-treatment Period|Withdrawal by Subject|3
345061|NCT00506389|1123897|P1|In-treatment Period|Withdrawal by Subject|3
345062|NCT00506389|1123895|P3|In-treatment Period|Reasons not related to trial|0
345063|NCT00506389|1123896|P2|In-treatment Period|Reasons not related to trial|1
345064|NCT00506389|1123897|P1|In-treatment Period|Reasons not related to trial|4
345065|NCT00506389|1123895|P3|In-treatment Period|Lack of compliance|0
345066|NCT00506389|1123896|P2|In-treatment Period|Lack of compliance|0
345067|NCT00506389|1123897|P1|In-treatment Period|Lack of compliance|1
345068|NCT00506389|1123895|P3|In-treatment Period|Lost to Follow-up|1
345069|NCT00506389|1123896|P2|In-treatment Period|Lost to Follow-up|0
345070|NCT00506389|1123897|P1|In-treatment Period|Lost to Follow-up|0
345071|NCT00506389|1123895|P3|In-treatment Period|Not specified|4
345072|NCT00506389|1123896|P2|In-treatment Period|Not specified|3
345073|NCT00506389|1123897|P1|In-treatment Period|Not specified|3
345074|NCT00506285|1123916|P2|6-month Open Label Phase|Withdrawal by Subject|5
345075|NCT00506285|1123917|P1|6-month Open Label Phase|Withdrawal by Subject|9
345076|NCT00506285|1123916|P2|6-month Open Label Phase|Lost to Follow-up|7
345077|NCT00506285|1123917|P1|6-month Open Label Phase|Lost to Follow-up|1
345078|NCT00506285|1123916|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
345079|NCT00506285|1123917|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
345080|NCT00506285|1123916|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
345081|NCT00506285|1123917|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
345082|NCT00506285|1123916|P2|3 Week Screening Phase|Withdrawal by Subject|10
345083|NCT00506285|1123917|P1|3 Week Screening Phase|Withdrawal by Subject|17
345084|NCT00506077|1123932|P2|Treatment Period 2|Withdrawal by Subject|0
345085|NCT00506077|1123933|P1|Treatment Period 2|Withdrawal by Subject|1
345086|NCT00506077|1123932|P2|Treatment Period 2|Adverse Event|1
345087|NCT00506077|1123933|P1|Treatment Period 2|Adverse Event|0
345088|NCT00506077|1123932|P2|Treatment Period 1|Withdrawal by Subject|0
345089|NCT00506077|1123933|P1|Treatment Period 1|Withdrawal by Subject|2
345090|NCT00506077|1123932|P2|Treatment Period 1|Lost to Follow-up|2
345091|NCT00506077|1123933|P1|Treatment Period 1|Lost to Follow-up|0
345092|NCT00506077|1123932|P2|Treatment Period 1|Adverse Event|1
345093|NCT00506077|1123933|P1|Treatment Period 1|Adverse Event|2
345094|NCT00505934|1123975|P1|Overall Study|Other: IV dose needed to be changed|1
345095|NCT00505934|1123975|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
345096|NCT00505934|1123975|P1|Overall Study|Adverse Event|1
345097|NCT00505921|1123981|P1|Overall Study|Failed to Mobilize|8
345099|NCT00505778|1123998|P2|Overall Study|Took No Study Drug|2
345100|NCT00505778|1123999|P1|Overall Study|Took No Study Drug|2
345101|NCT00505778|1123998|P2|Overall Study|Relapse|65
345102|NCT00505778|1123999|P1|Overall Study|Relapse|65
345103|NCT00505778|1123998|P2|Overall Study|Withdrawal by Subject|14
345104|NCT00505778|1123999|P1|Overall Study|Withdrawal by Subject|29
345105|NCT00505778|1123998|P2|Overall Study|Protocol Violation|9
345106|NCT00505778|1123999|P1|Overall Study|Protocol Violation|7
345107|NCT00505778|1123998|P2|Overall Study|Unable to Meet Protocol Criteria|1
345108|NCT00505778|1123999|P1|Overall Study|Unable to Meet Protocol Criteria|4
345109|NCT00505778|1123998|P2|Overall Study|Lost to Follow-up|23
345110|NCT00505778|1123999|P1|Overall Study|Lost to Follow-up|17
345111|NCT00505778|1123998|P2|Overall Study|Physician Decision|14
345112|NCT00505778|1123999|P1|Overall Study|Physician Decision|8
345113|NCT00505778|1123998|P2|Overall Study|Adverse Event|7
345114|NCT00505778|1123999|P1|Overall Study|Adverse Event|2
345115|NCT00505765|1124018|P3|Overall Study|Noncompliance|3
345116|NCT00505765|1124019|P2|Overall Study|Noncompliance|1
345117|NCT00505765|1124020|P1|Overall Study|Noncompliance|0
345118|NCT00505765|1124018|P3|Overall Study|Adverse Event|0
345119|NCT00505765|1124019|P2|Overall Study|Adverse Event|2
345120|NCT00505765|1124020|P1|Overall Study|Adverse Event|1
345121|NCT00505765|1124018|P3|Overall Study|Withdrawal by Subject|0
345122|NCT00505765|1124019|P2|Overall Study|Withdrawal by Subject|0
345123|NCT00505765|1124020|P1|Overall Study|Withdrawal by Subject|1
345124|NCT00505752|1124047|P4|Overall Study|Unspecified|2
345125|NCT00505752|1124048|P3|Overall Study|Unspecified|1
345126|NCT00505752|1124049|P2|Overall Study|Unspecified|2
345127|NCT00505752|1124050|P1|Overall Study|Unspecified|1
345128|NCT00505752|1124047|P4|Overall Study|All embryos/blastocysts discarded|1
345129|NCT00505752|1124048|P3|Overall Study|All embryos/blastocysts discarded|1
345130|NCT00505752|1124049|P2|Overall Study|All embryos/blastocysts discarded|0
345131|NCT00505752|1124050|P1|Overall Study|All embryos/blastocysts discarded|0
345132|NCT00505752|1124047|P4|Overall Study|No Fertilization|1
345133|NCT00505752|1124048|P3|Overall Study|No Fertilization|2
345134|NCT00505752|1124049|P2|Overall Study|No Fertilization|1
345135|NCT00505752|1124050|P1|Overall Study|No Fertilization|1
345136|NCT00505752|1124047|P4|Overall Study|No oocytes retrieved|1
345137|NCT00505752|1124048|P3|Overall Study|No oocytes retrieved|0
345138|NCT00505752|1124049|P2|Overall Study|No oocytes retrieved|2
345139|NCT00505752|1124050|P1|Overall Study|No oocytes retrieved|0
345140|NCT00505752|1124047|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
345141|NCT00505752|1124048|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
345142|NCT00505752|1124049|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
345143|NCT00505752|1124050|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
345144|NCT00505752|1124047|P4|Overall Study|Lack of ovarian response|0
345145|NCT00505752|1124048|P3|Overall Study|Lack of ovarian response|0
345146|NCT00505752|1124049|P2|Overall Study|Lack of ovarian response|3
345147|NCT00505752|1124050|P1|Overall Study|Lack of ovarian response|1
345148|NCT00505752|1124047|P4|Overall Study|Lost to Follow-up|0
345149|NCT00505752|1124048|P3|Overall Study|Lost to Follow-up|0
345150|NCT00505752|1124049|P2|Overall Study|Lost to Follow-up|0
345151|NCT00505752|1124050|P1|Overall Study|Lost to Follow-up|1
345152|NCT00505752|1124047|P4|Overall Study|Adverse Event|0
345153|NCT00505752|1124048|P3|Overall Study|Adverse Event|1
345154|NCT00505752|1124049|P2|Overall Study|Adverse Event|0
345155|NCT00505752|1124050|P1|Overall Study|Adverse Event|1
345156|NCT00505687|1124064|P1|Overall Study|Other: As Per Sponsor|8
345157|NCT00505687|1124064|P1|Overall Study|Other: Disease Progression|1
345158|NCT00505687|1124064|P1|Overall Study|Other: Neupro Given In Hospital|1
345159|NCT00505687|1124064|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
345160|NCT00505687|1124064|P1|Overall Study|Other: Prolonged Hospitalization|1
345161|NCT00505687|1124064|P1|Overall Study|Other: Scheduled DBS Surgery|1
345162|NCT00505687|1124064|P1|Overall Study|Other: Underwent Implantation Of DBS|1
345163|NCT00505687|1124064|P1|Overall Study|Lost to Follow-up|1
345164|NCT00505687|1124064|P1|Overall Study|Subject withdrew consent|15
345165|NCT00505687|1124064|P1|Overall Study|Adverse Event|48
345166|NCT00505687|1124064|P1|Overall Study|Lack of Efficacy|15
345167|NCT00505687|1124064|P1|Overall Study|Important protocol violation|2
345168|NCT00505661|1124070|P1|Overall Study|Not Eligible|4
345169|NCT00505622|1124081|P3|Overall Study|Study termination by sponsor|90
345170|NCT00505622|1124082|P2|Overall Study|Study termination by sponsor|98
345171|NCT00505622|1124083|P1|Overall Study|Study termination by sponsor|115
345172|NCT00505622|1124081|P3|Overall Study|Withdrawal by Subject|2
345173|NCT00505622|1124082|P2|Overall Study|Withdrawal by Subject|3
345174|NCT00505622|1124083|P1|Overall Study|Withdrawal by Subject|0
345175|NCT00505622|1124081|P3|Overall Study|Protocol Violation|0
345176|NCT00505622|1124082|P2|Overall Study|Protocol Violation|1
345177|NCT00505622|1124083|P1|Overall Study|Protocol Violation|1
345178|NCT00505622|1124081|P3|Overall Study|Adverse Event|4
345179|NCT00505622|1124082|P2|Overall Study|Adverse Event|6
345180|NCT00505622|1124083|P1|Overall Study|Adverse Event|5
345181|NCT00505414|1124108|P5|Maintenance Phase|underlying disease and therapy required|0
345182|NCT00505414|1124109|P4|Maintenance Phase|underlying disease and therapy required|0
345183|NCT00505414|1124110|P3|Maintenance Phase|underlying disease and therapy required|2
345184|NCT00505414|1124111|P2|Maintenance Phase|underlying disease and therapy required|2
345185|NCT00505414|1124112|P1|Maintenance Phase|underlying disease and therapy required|0
345186|NCT00505414|1124108|P5|Maintenance Phase|Withdrawal by Subject|0
345187|NCT00505414|1124109|P4|Maintenance Phase|Withdrawal by Subject|0
345188|NCT00505414|1124110|P3|Maintenance Phase|Withdrawal by Subject|1
345189|NCT00505414|1124111|P2|Maintenance Phase|Withdrawal by Subject|0
345190|NCT00505414|1124112|P1|Maintenance Phase|Withdrawal by Subject|0
345191|NCT00505414|1124108|P5|Maintenance Phase|Lack of Efficacy|0
345192|NCT00505414|1124109|P4|Maintenance Phase|Lack of Efficacy|0
345193|NCT00505414|1124110|P3|Maintenance Phase|Lack of Efficacy|1
345194|NCT00505414|1124111|P2|Maintenance Phase|Lack of Efficacy|1
345195|NCT00505414|1124112|P1|Maintenance Phase|Lack of Efficacy|2
345196|NCT00505414|1124108|P5|Maintenance Phase|Death|0
345197|NCT00505414|1124109|P4|Maintenance Phase|Death|0
345198|NCT00505414|1124110|P3|Maintenance Phase|Death|1
345199|NCT00505414|1124111|P2|Maintenance Phase|Death|0
345200|NCT00505414|1124112|P1|Maintenance Phase|Death|2
345201|NCT00505414|1124108|P5|Maintenance Phase|Adverse Event|0
345202|NCT00505414|1124109|P4|Maintenance Phase|Adverse Event|0
345203|NCT00505414|1124110|P3|Maintenance Phase|Adverse Event|3
345204|NCT00505414|1124111|P2|Maintenance Phase|Adverse Event|2
345205|NCT00505414|1124112|P1|Maintenance Phase|Adverse Event|2
345206|NCT00505414|1124108|P5|Titration Phase|Underlying disease and therapy required|3
345207|NCT00505414|1124109|P4|Titration Phase|Underlying disease and therapy required|7
345208|NCT00505414|1124110|P3|Titration Phase|Underlying disease and therapy required|0
345209|NCT00505414|1124111|P2|Titration Phase|Underlying disease and therapy required|0
345210|NCT00505414|1124112|P1|Titration Phase|Underlying disease and therapy required|0
345211|NCT00505414|1124108|P5|Titration Phase|Withdrawal by Subject|4
345212|NCT00505414|1124109|P4|Titration Phase|Withdrawal by Subject|3
345213|NCT00505414|1124110|P3|Titration Phase|Withdrawal by Subject|0
345214|NCT00505414|1124111|P2|Titration Phase|Withdrawal by Subject|0
345215|NCT00505414|1124112|P1|Titration Phase|Withdrawal by Subject|0
345216|NCT00505414|1124108|P5|Titration Phase|Protocol Violation|1
345217|NCT00505414|1124109|P4|Titration Phase|Protocol Violation|0
345218|NCT00505414|1124110|P3|Titration Phase|Protocol Violation|0
345219|NCT00505414|1124111|P2|Titration Phase|Protocol Violation|0
345220|NCT00505414|1124112|P1|Titration Phase|Protocol Violation|0
345221|NCT00505414|1124108|P5|Titration Phase|Lack of Efficacy|1
345222|NCT00505414|1124109|P4|Titration Phase|Lack of Efficacy|10
345223|NCT00505414|1124110|P3|Titration Phase|Lack of Efficacy|0
345224|NCT00505414|1124111|P2|Titration Phase|Lack of Efficacy|0
345225|NCT00505414|1124112|P1|Titration Phase|Lack of Efficacy|0
345226|NCT00505414|1124108|P5|Titration Phase|Death|0
345227|NCT00505414|1124109|P4|Titration Phase|Death|2
345228|NCT00505414|1124110|P3|Titration Phase|Death|0
345229|NCT00505414|1124111|P2|Titration Phase|Death|0
345230|NCT00505414|1124112|P1|Titration Phase|Death|0
345231|NCT00505414|1124108|P5|Titration Phase|Adverse Event|3
345232|NCT00505414|1124109|P4|Titration Phase|Adverse Event|8
345233|NCT00505414|1124110|P3|Titration Phase|Adverse Event|0
345234|NCT00505414|1124111|P2|Titration Phase|Adverse Event|0
345235|NCT00505414|1124112|P1|Titration Phase|Adverse Event|0
345236|NCT00505375|1124129|P2|Overall Study|Travel issues|1
345237|NCT00505375|1124130|P1|Overall Study|Travel issues|0
345238|NCT00505375|1124129|P2|Overall Study|Pregnancy|0
345239|NCT00505375|1124130|P1|Overall Study|Pregnancy|1
345240|NCT00505375|1124129|P2|Overall Study|Lost to Follow-up|2
345241|NCT00505375|1124130|P1|Overall Study|Lost to Follow-up|0
345242|NCT00505375|1124129|P2|Overall Study|Withdrawal by Subject|2
345243|NCT00505375|1124130|P1|Overall Study|Withdrawal by Subject|2
345244|NCT00505375|1124129|P2|Overall Study|Death|0
345245|NCT00505375|1124130|P1|Overall Study|Death|1
345246|NCT00505284|1124152|P5|Overall Study|Not specified|4
345247|NCT00505284|1124153|P4|Overall Study|Not specified|4
345248|NCT00505284|1124154|P3|Overall Study|Not specified|0
345249|NCT00505284|1124155|P2|Overall Study|Not specified|0
345250|NCT00505284|1124156|P1|Overall Study|Not specified|5
345251|NCT00505284|1124152|P5|Overall Study|Physician Decision|0
345252|NCT00505284|1124153|P4|Overall Study|Physician Decision|0
345253|NCT00505284|1124154|P3|Overall Study|Physician Decision|0
345254|NCT00505284|1124155|P2|Overall Study|Physician Decision|1
345255|NCT00505284|1124156|P1|Overall Study|Physician Decision|0
345256|NCT00505284|1124152|P5|Overall Study|Lack of Efficacy|1
345257|NCT00505284|1124153|P4|Overall Study|Lack of Efficacy|1
345258|NCT00505284|1124154|P3|Overall Study|Lack of Efficacy|1
345259|NCT00505284|1124155|P2|Overall Study|Lack of Efficacy|1
345260|NCT00505284|1124156|P1|Overall Study|Lack of Efficacy|0
345261|NCT00505284|1124152|P5|Overall Study|Withdrawal by Subject|6
345262|NCT00505284|1124153|P4|Overall Study|Withdrawal by Subject|0
345263|NCT00505284|1124154|P3|Overall Study|Withdrawal by Subject|1
345264|NCT00505284|1124155|P2|Overall Study|Withdrawal by Subject|6
345265|NCT00505284|1124156|P1|Overall Study|Withdrawal by Subject|2
345266|NCT00505284|1124152|P5|Overall Study|Protocol Violation|0
345267|NCT00505284|1124153|P4|Overall Study|Protocol Violation|0
345268|NCT00505284|1124154|P3|Overall Study|Protocol Violation|1
345269|NCT00505284|1124155|P2|Overall Study|Protocol Violation|1
345270|NCT00505284|1124156|P1|Overall Study|Protocol Violation|0
345271|NCT00505284|1124152|P5|Overall Study|Adverse Event|22
345272|NCT00505284|1124153|P4|Overall Study|Adverse Event|14
345273|NCT00505284|1124154|P3|Overall Study|Adverse Event|9
345274|NCT00505284|1124155|P2|Overall Study|Adverse Event|7
345275|NCT00505284|1124156|P1|Overall Study|Adverse Event|3
345276|NCT00505076|1124226|P3|Overall Study|Withdrawal by Subject|2
345277|NCT00505076|1124227|P2|Overall Study|Withdrawal by Subject|1
345278|NCT00505076|1124228|P1|Overall Study|Withdrawal by Subject|0
345279|NCT00505076|1124226|P3|Overall Study|Protocol Violation|2
345280|NCT00505076|1124227|P2|Overall Study|Protocol Violation|1
345281|NCT00505076|1124228|P1|Overall Study|Protocol Violation|2
345282|NCT00505076|1124226|P3|Overall Study|Adverse Event|1
345283|NCT00505076|1124227|P2|Overall Study|Adverse Event|0
345284|NCT00505076|1124228|P1|Overall Study|Adverse Event|1
345285|NCT00504881|1124257|P2|Overall Study|AE of unknown type|0
345286|NCT00504881|1124258|P1|Overall Study|AE of unknown type|1
345287|NCT00504881|1124257|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
345288|NCT00504881|1124258|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
345289|NCT00504881|1124257|P2|Overall Study|AE, non-serious non-fatal|14
345290|NCT00504881|1124258|P1|Overall Study|AE, non-serious non-fatal|4
345291|NCT00504881|1124257|P2|Overall Study|SAE, non-fatal|6
345292|NCT00504881|1124258|P1|Overall Study|SAE, non-fatal|2
345293|NCT00504881|1124257|P2|Overall Study|AE, serious fatal|1
345294|NCT00504881|1124258|P1|Overall Study|AE, serious fatal|0
345295|NCT00504881|1124257|P2|Overall Study|Safety Visit not performed|1
345296|NCT00504881|1124258|P1|Overall Study|Safety Visit not performed|0
345297|NCT00504881|1124257|P2|Overall Study|No Birth Control|1
345298|NCT00504881|1124258|P1|Overall Study|No Birth Control|0
345299|NCT00504881|1124257|P2|Overall Study|Non-Compliance|0
345300|NCT00504881|1124258|P1|Overall Study|Non-Compliance|1
345301|NCT00504881|1124257|P2|Overall Study|Withdrawal by Subject|4
345302|NCT00504881|1124258|P1|Overall Study|Withdrawal by Subject|1
345303|NCT00504881|1124257|P2|Overall Study|Lost to Follow-up|2
345304|NCT00504881|1124258|P1|Overall Study|Lost to Follow-up|0
345305|NCT00504881|1124257|P2|Overall Study|Lack of Efficacy|5
345306|NCT00504881|1124258|P1|Overall Study|Lack of Efficacy|1
345307|NCT00504777|1124308|P1|Overall Study|Adverse Event|1
345308|NCT00504725|1124321|P2|Overall Study|Protocol Violation|0
345309|NCT00504725|1124322|P1|Overall Study|Protocol Violation|1
345310|NCT00504595|1124345|P4|Overall Study|Not specified|0
345311|NCT00504595|1124346|P3|Overall Study|Not specified|2
345312|NCT00504595|1124347|P2|Overall Study|Not specified|0
345313|NCT00504595|1124348|P1|Overall Study|Not specified|0
345314|NCT00504595|1124345|P4|Overall Study|Lack of Efficacy|0
345315|NCT00504595|1124346|P3|Overall Study|Lack of Efficacy|0
345316|NCT00504595|1124347|P2|Overall Study|Lack of Efficacy|0
345317|NCT00504595|1124348|P1|Overall Study|Lack of Efficacy|1
345318|NCT00504556|1124365|P5|Overall Study|not in safety analysis set|1
345319|NCT00504556|1124366|P4|Overall Study|not in safety analysis set|0
345320|NCT00504556|1124367|P3|Overall Study|not in safety analysis set|1
345321|NCT00504556|1124368|P2|Overall Study|not in safety analysis set|1
345322|NCT00504556|1124369|P1|Overall Study|not in safety analysis set|0
345323|NCT00504556|1124365|P5|Overall Study|not specified|0
345324|NCT00504556|1124366|P4|Overall Study|not specified|3
345325|NCT00504556|1124367|P3|Overall Study|not specified|2
345326|NCT00504556|1124368|P2|Overall Study|not specified|2
345327|NCT00504556|1124369|P1|Overall Study|not specified|2
345328|NCT00504556|1124365|P5|Overall Study|data monitor committee decision|0
345329|NCT00504556|1124366|P4|Overall Study|data monitor committee decision|100
345330|NCT00504556|1124367|P3|Overall Study|data monitor committee decision|0
345331|NCT00504556|1124368|P2|Overall Study|data monitor committee decision|0
345332|NCT00504556|1124369|P1|Overall Study|data monitor committee decision|0
345333|NCT00504556|1124365|P5|Overall Study|did not meet entry criteria|0
345334|NCT00504556|1124366|P4|Overall Study|did not meet entry criteria|1
345335|NCT00504556|1124367|P3|Overall Study|did not meet entry criteria|1
345336|NCT00504556|1124368|P2|Overall Study|did not meet entry criteria|0
345337|NCT00504556|1124369|P1|Overall Study|did not meet entry criteria|2
345338|NCT00504556|1124365|P5|Overall Study|administrative reasons|2
345339|NCT00504556|1124366|P4|Overall Study|administrative reasons|1
345340|NCT00504556|1124367|P3|Overall Study|administrative reasons|2
345341|NCT00504556|1124368|P2|Overall Study|administrative reasons|2
345342|NCT00504556|1124369|P1|Overall Study|administrative reasons|0
345343|NCT00504556|1124365|P5|Overall Study|Withdrawal by Subject|12
345344|NCT00504556|1124366|P4|Overall Study|Withdrawal by Subject|8
345345|NCT00504556|1124367|P3|Overall Study|Withdrawal by Subject|7
345346|NCT00504556|1124368|P2|Overall Study|Withdrawal by Subject|16
345347|NCT00504556|1124369|P1|Overall Study|Withdrawal by Subject|16
345348|NCT00504556|1124365|P5|Overall Study|Lost to Follow-up|1
345349|NCT00504556|1124366|P4|Overall Study|Lost to Follow-up|1
345350|NCT00504556|1124367|P3|Overall Study|Lost to Follow-up|1
345351|NCT00504556|1124368|P2|Overall Study|Lost to Follow-up|0
345352|NCT00504556|1124369|P1|Overall Study|Lost to Follow-up|0
345353|NCT00504556|1124365|P5|Overall Study|Protocol Violation|2
345354|NCT00504556|1124366|P4|Overall Study|Protocol Violation|1
345355|NCT00504556|1124367|P3|Overall Study|Protocol Violation|2
345356|NCT00504556|1124368|P2|Overall Study|Protocol Violation|3
345357|NCT00504556|1124369|P1|Overall Study|Protocol Violation|1
345358|NCT00504556|1124365|P5|Overall Study|Death|2
345359|NCT00504556|1124366|P4|Overall Study|Death|0
345360|NCT00504556|1124367|P3|Overall Study|Death|1
345361|NCT00504556|1124368|P2|Overall Study|Death|3
345362|NCT00504556|1124369|P1|Overall Study|Death|3
345363|NCT00504556|1124365|P5|Overall Study|Adverse Event|5
345364|NCT00504556|1124366|P4|Overall Study|Adverse Event|13
345365|NCT00504556|1124367|P3|Overall Study|Adverse Event|14
345366|NCT00504556|1124368|P2|Overall Study|Adverse Event|11
345367|NCT00504556|1124369|P1|Overall Study|Adverse Event|11
345368|NCT00504426|1124437|P4|Overall Study|Withdrawal by Subject|0
345369|NCT00504426|1124438|P3|Overall Study|Withdrawal by Subject|0
345370|NCT00504426|1124439|P2|Overall Study|Withdrawal by Subject|0
345371|NCT00504426|1124440|P1|Overall Study|Withdrawal by Subject|2
345372|NCT00504426|1124437|P4|Overall Study|Protocol Violation|0
345373|NCT00504426|1124438|P3|Overall Study|Protocol Violation|2
345374|NCT00504426|1124439|P2|Overall Study|Protocol Violation|1
345375|NCT00504426|1124440|P1|Overall Study|Protocol Violation|1
345376|NCT00504426|1124437|P4|Overall Study|Adverse Event|0
345377|NCT00504426|1124438|P3|Overall Study|Adverse Event|2
345378|NCT00504426|1124439|P2|Overall Study|Adverse Event|0
345379|NCT00504426|1124440|P1|Overall Study|Adverse Event|0
345380|NCT00504257|1124454|P1|Overall Study|ineligible histology|2
345381|NCT00504257|1124454|P1|Overall Study|Withdrawal by Subject|2
345382|NCT00504231|1124466|P4|Overall Study|Discrepant chart documentation re route|0
345383|NCT00504231|1124467|P3|Overall Study|Discrepant chart documentation re route|1
345384|NCT00504231|1124468|P2|Overall Study|Discrepant chart documentation re route|0
345385|NCT00504231|1124469|P1|Overall Study|Discrepant chart documentation re route|0
345386|NCT00504166|1124489|P2|Overall Study|Lost to Follow-up|3
345387|NCT00504166|1124490|P1|Overall Study|Lost to Follow-up|1
345388|NCT00504166|1124489|P2|Overall Study|Physician Decision|1
345389|NCT00504166|1124490|P1|Overall Study|Physician Decision|1
345390|NCT00504166|1124489|P2|Overall Study|Withdrawal by Subject|6
345391|NCT00504166|1124490|P1|Overall Study|Withdrawal by Subject|3
345392|NCT00504166|1124489|P2|Overall Study|Adverse Event|4
345393|NCT00504166|1124490|P1|Overall Study|Adverse Event|1
345394|NCT00504153|1124496|P1|Overall Study|Death|1
345395|NCT00504153|1124496|P1|Overall Study|Adverse Event|4
345396|NCT00504153|1124496|P1|Overall Study|Withdrawal by Subject|1
345397|NCT00504075|1124504|P1|Overall Study|Required other therapeutic intervention|1
345398|NCT00504075|1124504|P1|Overall Study|Withdrawal by Subject|1
345399|NCT00504075|1124504|P1|Overall Study|Lost to Follow-up|5
345400|NCT00504075|1124504|P1|Overall Study|Adverse Event|1
345401|NCT00503906|1124510|P1|Overall Study|Withdrawal by Subject|1
345402|NCT00503841|1124519|P1|Overall Study|All screen failures|44
345403|NCT00503776|1124527|P4|Overall Study|Physician Decision|1
345404|NCT00503776|1124528|P3|Overall Study|Physician Decision|1
345405|NCT00503776|1124529|P2|Overall Study|Physician Decision|0
345406|NCT00503776|1124530|P1|Overall Study|Physician Decision|0
345407|NCT00503776|1124527|P4|Overall Study|Withdrawal by Subject|1
345408|NCT00503776|1124528|P3|Overall Study|Withdrawal by Subject|1
345409|NCT00503776|1124529|P2|Overall Study|Withdrawal by Subject|0
345410|NCT00503776|1124530|P1|Overall Study|Withdrawal by Subject|1
345411|NCT00503698|1124555|P2|Overall Study|Not exposed to trial drug|6
345412|NCT00503698|1124556|P1|Overall Study|Not exposed to trial drug|11
345413|NCT00503698|1124555|P2|Overall Study|Unclassified|32
345414|NCT00503698|1124556|P1|Overall Study|Unclassified|48
345415|NCT00503698|1124555|P2|Overall Study|Critically ill|0
345416|NCT00503698|1124556|P1|Overall Study|Critically ill|2
345417|NCT00503698|1124555|P2|Overall Study|Move to nonparticipating dialysis center|1
345418|NCT00503698|1124556|P1|Overall Study|Move to nonparticipating dialysis center|2
345419|NCT00503698|1124555|P2|Overall Study|Switch to peritoneal or home dialysis|2
345420|NCT00503698|1124556|P1|Overall Study|Switch to peritoneal or home dialysis|2
345421|NCT00503698|1124555|P2|Overall Study|Any condition in exclusion criteria|6
345422|NCT00503698|1124556|P1|Overall Study|Any condition in exclusion criteria|4
345423|NCT00503698|1124555|P2|Overall Study|Pregnancy/intention to become pregnant|0
345424|NCT00503698|1124556|P1|Overall Study|Pregnancy/intention to become pregnant|1
345425|NCT00503698|1124555|P2|Overall Study|End hemodialysis due to renal transplant|4
345426|NCT00503698|1124556|P1|Overall Study|End hemodialysis due to renal transplant|10
345427|NCT00503698|1124555|P2|Overall Study|Trial terminated|253
345428|NCT00503698|1124556|P1|Overall Study|Trial terminated|216
345429|NCT00503698|1124555|P2|Overall Study|Lack of Efficacy|4
345430|NCT00503698|1124556|P1|Overall Study|Lack of Efficacy|3
345431|NCT00503698|1124555|P2|Overall Study|Death|0
345432|NCT00503698|1124556|P1|Overall Study|Death|1
345433|NCT00503698|1124555|P2|Overall Study|Adverse Event|41
345434|NCT00503698|1124556|P1|Overall Study|Adverse Event|52
345435|NCT00503698|1124555|P2|Overall Study|Protocol Violation|6
345436|NCT00503698|1124556|P1|Overall Study|Protocol Violation|5
345437|NCT00503425|1124570|P1|Overall Study|Missing Data/Unknown|4
345438|NCT00503425|1124570|P1|Overall Study|Death|3
345439|NCT00503425|1124570|P1|Overall Study|Lost to Follow-up|3
345440|NCT00503425|1124570|P1|Overall Study|Withdrawal by Subject|8
345441|NCT00503425|1124570|P1|Overall Study|Lack of Efficacy|25
345442|NCT00503425|1124570|P1|Overall Study|Adverse Event|5
345443|NCT00503425|1124570|P1|Overall Study|Participant files lost|6
345444|NCT00503399|1124580|P2|Overall Study|Lost to Follow-up|2
345445|NCT00503399|1124581|P1|Overall Study|Lost to Follow-up|0
345446|NCT00503399|1124580|P2|Overall Study|Adverse Event|3
345447|NCT00503399|1124581|P1|Overall Study|Adverse Event|0
345448|NCT00503399|1124580|P2|Overall Study|Withdrawal by Subject|2
345449|NCT00503399|1124581|P1|Overall Study|Withdrawal by Subject|4
345450|NCT00503399|1124580|P2|Overall Study|Protocol Violation|0
345451|NCT00503399|1124581|P1|Overall Study|Protocol Violation|1
345452|NCT00503399|1124580|P2|Overall Study|Death|1
345453|NCT00503399|1124581|P1|Overall Study|Death|2
345454|NCT00503308|1124605|P2|Overall Study|Protocol Violation|1
345455|NCT00503308|1124606|P1|Overall Study|Protocol Violation|2
345456|NCT00503139|1124612|P1|Overall Study|Protocol Violation|4
345457|NCT00503139|1124612|P1|Overall Study|Case Report Forms were not collected|4
345458|NCT00503009|1124660|P3|Overall Study|Physician Decision|1
345459|NCT00503009|1124661|P2|Overall Study|Physician Decision|1
345460|NCT00503009|1124662|P1|Overall Study|Physician Decision|0
345461|NCT00503009|1124660|P3|Overall Study|Withdrawal by Subject|1
345462|NCT00503009|1124661|P2|Overall Study|Withdrawal by Subject|1
345463|NCT00503009|1124662|P1|Overall Study|Withdrawal by Subject|0
345464|NCT00503009|1124660|P3|Overall Study|Protocol Violation|1
345465|NCT00503009|1124661|P2|Overall Study|Protocol Violation|0
345466|NCT00503009|1124662|P1|Overall Study|Protocol Violation|1
345467|NCT00502996|1124679|P1|Overall Study|Adverse Event|2
345468|NCT00502996|1124679|P1|Overall Study|Withdrawal Informed Consent|6
345469|NCT00502996|1124679|P1|Overall Study|Treatment failure|25
345470|NCT00502996|1124679|P1|Overall Study|Protocol Violation|2
345471|NCT00502996|1124679|P1|Overall Study|Lost to Follow-up|9
345472|NCT00502840|1124747|P1|Overall Study|Not specified|20
345473|NCT00502840|1124747|P1|Overall Study|Administrative problems|1
345474|NCT00502840|1124747|P1|Overall Study|Lost to Follow-up|6
345475|NCT00502840|1124747|P1|Overall Study|Withdrawal by Subject|5
345476|NCT00502840|1124747|P1|Overall Study|Protocol Violation|4
345477|NCT00502840|1124747|P1|Overall Study|Lack of Efficacy|11
345478|NCT00502840|1124747|P1|Overall Study|Additional or changed therapy|48
345479|NCT00502840|1124747|P1|Overall Study|Adverse Event|5
345480|NCT00502801|1124775|P1|End of Therapy to Test of Cure|OTHER|2
345481|NCT00502801|1124775|P1|End of Therapy to Test of Cure|Death|3
345482|NCT00502801|1124775|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
345483|NCT00502801|1124775|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
345484|NCT00502801|1124775|P1|Treatment Period|OTHER|30
345485|NCT00502801|1124775|P1|Treatment Period|Death|14
345486|NCT00502801|1124775|P1|Treatment Period|Adverse Event|7
345487|NCT00502801|1124775|P1|Treatment Period|Withdrawal by Subject|3
345488|NCT00502775|1124783|P3|Overall Study|Subject took disallowed drug|1
345489|NCT00502775|1124784|P2|Overall Study|Subject took disallowed drug|0
345490|NCT00502775|1124785|P1|Overall Study|Subject took disallowed drug|0
345491|NCT00502775|1124783|P3|Overall Study|Subject in jail|0
345492|NCT00502775|1124784|P2|Overall Study|Subject in jail|1
345493|NCT00502775|1124785|P1|Overall Study|Subject in jail|0
345494|NCT00502775|1124783|P3|Overall Study|Declining pollen counts|1
345495|NCT00502775|1124784|P2|Overall Study|Declining pollen counts|1
345496|NCT00502775|1124785|P1|Overall Study|Declining pollen counts|0
345497|NCT00502775|1124783|P3|Overall Study|Outside pollen area more than 48 hours|0
345498|NCT00502775|1124784|P2|Overall Study|Outside pollen area more than 48 hours|1
345499|NCT00502775|1124785|P1|Overall Study|Outside pollen area more than 48 hours|0
345500|NCT00502775|1124783|P3|Overall Study|Non-compliance|2
345501|NCT00502775|1124784|P2|Overall Study|Non-compliance|2
345502|NCT00502775|1124785|P1|Overall Study|Non-compliance|0
345503|NCT00502775|1124783|P3|Overall Study|Randomized in error|1
345504|NCT00502775|1124784|P2|Overall Study|Randomized in error|1
345505|NCT00502775|1124785|P1|Overall Study|Randomized in error|0
345506|NCT00502775|1124783|P3|Overall Study|Logpad compliance <80%|0
345507|NCT00502775|1124784|P2|Overall Study|Logpad compliance <80%|0
345508|NCT00502775|1124785|P1|Overall Study|Logpad compliance <80%|1
345509|NCT00502775|1124783|P3|Overall Study|Subject unable to swallow capsule|1
345510|NCT00502775|1124784|P2|Overall Study|Subject unable to swallow capsule|0
345511|NCT00502775|1124785|P1|Overall Study|Subject unable to swallow capsule|1
345512|NCT00502775|1124783|P3|Overall Study|Non-compliance with eDiary|1
345513|NCT00502775|1124784|P2|Overall Study|Non-compliance with eDiary|1
345514|NCT00502775|1124785|P1|Overall Study|Non-compliance with eDiary|4
345515|NCT00502775|1124783|P3|Overall Study|Sponsor Terminated Study|1
345516|NCT00502775|1124784|P2|Overall Study|Sponsor Terminated Study|0
345517|NCT00502775|1124785|P1|Overall Study|Sponsor Terminated Study|1
345518|NCT00502775|1124783|P3|Overall Study|Withdrawal by Subject|2
345519|NCT00502775|1124784|P2|Overall Study|Withdrawal by Subject|1
345520|NCT00502775|1124785|P1|Overall Study|Withdrawal by Subject|1
345521|NCT00502775|1124783|P3|Overall Study|Protocol Violation|2
345522|NCT00502775|1124784|P2|Overall Study|Protocol Violation|5
345523|NCT00502775|1124785|P1|Overall Study|Protocol Violation|1
345524|NCT00502775|1124783|P3|Overall Study|Adverse Event|1
345525|NCT00502775|1124784|P2|Overall Study|Adverse Event|2
345526|NCT00502775|1124785|P1|Overall Study|Adverse Event|1
345527|NCT00502697|1124828|P2|Overall Study|did not meet assignment criteria|2
345528|NCT00502697|1124829|P1|Overall Study|did not meet assignment criteria|4
345529|NCT00502697|1124828|P2|Overall Study|found not to meet eligibility criteria|4
345530|NCT00502697|1124829|P1|Overall Study|found not to meet eligibility criteria|3
345531|NCT00502697|1124828|P2|Overall Study|disenrolled due to pregnancy loss|5
345532|NCT00502697|1124829|P1|Overall Study|disenrolled due to pregnancy loss|3
345533|NCT00502697|1124828|P2|Overall Study|Withdrawal by Subject|1
345534|NCT00502697|1124829|P1|Overall Study|Withdrawal by Subject|3
345535|NCT00502671|1124837|P1|Overall Study|Adverse Event|19
345536|NCT00502671|1124837|P1|Overall Study|Protocol Violation|16
345537|NCT00502671|1124837|P1|Overall Study|Lost to Follow-up|7
345538|NCT00502671|1124837|P1|Overall Study|Personal Reasons|22
345539|NCT00502671|1124837|P1|Overall Study|Disease Progression|13
345540|NCT00502593|1124854|P12|Overall Study|Lost to Follow-up|0
345541|NCT00502593|1124855|P11|Overall Study|Lost to Follow-up|1
345542|NCT00502593|1124856|P10|Overall Study|Lost to Follow-up|0
345543|NCT00502593|1124857|P9|Overall Study|Lost to Follow-up|3
345544|NCT00502593|1124858|P8|Overall Study|Lost to Follow-up|0
345545|NCT00502593|1124859|P7|Overall Study|Lost to Follow-up|0
345546|NCT00502593|1124860|P6|Overall Study|Lost to Follow-up|0
345547|NCT00502593|1124861|P5|Overall Study|Lost to Follow-up|0
345548|NCT00502593|1124862|P4|Overall Study|Lost to Follow-up|1
345549|NCT00502593|1124863|P3|Overall Study|Lost to Follow-up|1
345550|NCT00502593|1124864|P2|Overall Study|Lost to Follow-up|1
345551|NCT00502593|1124865|P1|Overall Study|Lost to Follow-up|2
345552|NCT00502593|1124854|P12|Overall Study|Withdrawal by Subject|0
345553|NCT00502593|1124855|P11|Overall Study|Withdrawal by Subject|1
345554|NCT00502593|1124856|P10|Overall Study|Withdrawal by Subject|0
345555|NCT00502593|1124857|P9|Overall Study|Withdrawal by Subject|3
345556|NCT00502593|1124858|P8|Overall Study|Withdrawal by Subject|0
345557|NCT00502593|1124859|P7|Overall Study|Withdrawal by Subject|3
345558|NCT00502593|1124860|P6|Overall Study|Withdrawal by Subject|0
345559|NCT00502593|1124861|P5|Overall Study|Withdrawal by Subject|2
345560|NCT00502593|1124862|P4|Overall Study|Withdrawal by Subject|2
345561|NCT00502593|1124863|P3|Overall Study|Withdrawal by Subject|6
345562|NCT00502593|1124864|P2|Overall Study|Withdrawal by Subject|0
345563|NCT00502593|1124865|P1|Overall Study|Withdrawal by Subject|0
345564|NCT00502593|1124854|P12|Overall Study|Withdrawn unspecified reason|0
345565|NCT00502593|1124855|P11|Overall Study|Withdrawn unspecified reason|0
345566|NCT00502593|1124856|P10|Overall Study|Withdrawn unspecified reason|0
345567|NCT00502593|1124857|P9|Overall Study|Withdrawn unspecified reason|0
345568|NCT00502593|1124858|P8|Overall Study|Withdrawn unspecified reason|0
345569|NCT00502593|1124859|P7|Overall Study|Withdrawn unspecified reason|2
345570|NCT00502593|1124860|P6|Overall Study|Withdrawn unspecified reason|0
345571|NCT00502593|1124861|P5|Overall Study|Withdrawn unspecified reason|2
345572|NCT00502593|1124862|P4|Overall Study|Withdrawn unspecified reason|1
345573|NCT00502593|1124863|P3|Overall Study|Withdrawn unspecified reason|3
345574|NCT00502593|1124864|P2|Overall Study|Withdrawn unspecified reason|1
345575|NCT00502593|1124865|P1|Overall Study|Withdrawn unspecified reason|1
345576|NCT00502320|1125381|P2|Overall Study|Adverse Event|5
345577|NCT00502320|1125382|P1|Overall Study|Adverse Event|3
345578|NCT00502320|1125381|P2|Overall Study|Screen Failure|1
345579|NCT00502320|1125382|P1|Overall Study|Screen Failure|0
345580|NCT00502320|1125381|P2|Overall Study|No longer met criteria|0
345581|NCT00502320|1125382|P1|Overall Study|No longer met criteria|1
345582|NCT00502320|1125381|P2|Overall Study|Withdrew Consent|0
345583|NCT00502320|1125382|P1|Overall Study|Withdrew Consent|1
345584|NCT00502320|1125381|P2|Overall Study|Lost to Follow-up|1
345585|NCT00502320|1125382|P1|Overall Study|Lost to Follow-up|1
345586|NCT00502242|1125394|P2|Overall Study|Withdrawal by Subject|7
345587|NCT00502242|1125395|P1|Overall Study|Withdrawal by Subject|6
345588|NCT00502242|1125394|P2|Overall Study|Protocol Violation|1
345589|NCT00502242|1125395|P1|Overall Study|Protocol Violation|3
345590|NCT00502242|1125394|P2|Overall Study|Other - Unspecified|14
345591|NCT00502242|1125395|P1|Overall Study|Other - Unspecified|8
345592|NCT00502242|1125394|P2|Overall Study|Physician Decision|3
345593|NCT00502242|1125395|P1|Overall Study|Physician Decision|2
345594|NCT00502242|1125394|P2|Overall Study|Adverse Event|20
345595|NCT00502242|1125395|P1|Overall Study|Adverse Event|31
345596|NCT00502242|1125394|P2|Overall Study|Lack of Efficacy|11
345597|NCT00502242|1125395|P1|Overall Study|Lack of Efficacy|1
345598|NCT00502203|1125455|P1|Overall Study|Inevaluable|1
345599|NCT00501969|1125464|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
345600|NCT00501969|1125464|P1|Overall Study|Other: Admin Request from the Sponsor|3
345601|NCT00501969|1125464|P1|Overall Study|Other: As Required by Local EC|2
345602|NCT00501969|1125464|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
345603|NCT00501969|1125464|P1|Overall Study|Other: Pat Pending Surgery for PD|1
345604|NCT00501969|1125464|P1|Overall Study|Other: Patient is Going to Have DBS|1
345605|NCT00501969|1125464|P1|Overall Study|Other: Patients + Investigator Agreement|1
345606|NCT00501969|1125464|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
345607|NCT00501969|1125464|P1|Overall Study|Other: Sponsor Stopped Study|12
345608|NCT00501969|1125464|P1|Overall Study|Other: Sponsor Termination at Site|1
345609|NCT00501969|1125464|P1|Overall Study|Other: Sponsors Request|10
345610|NCT00501969|1125464|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
345611|NCT00501969|1125464|P1|Overall Study|Lost to Follow-up|4
345612|NCT00501969|1125464|P1|Overall Study|Subject withdrew consent|51
345613|NCT00501969|1125464|P1|Overall Study|Unsatisfactory compliance of subject|7
345614|NCT00501969|1125464|P1|Overall Study|Adverse Event|76
345615|NCT00501969|1125464|P1|Overall Study|Lack of Efficacy|29
345616|NCT00501969|1125464|P1|Overall Study|Major Protocol Violation|4
345617|NCT00501852|1125496|P1|Overall Study|Withdrawal by Subject|2
345618|NCT00501852|1125496|P1|Overall Study|Adverse Event|3
345619|NCT00501644|1125516|P1|Overall Study|Withdrawal by Subject|1
345620|NCT00501644|1125516|P1|Overall Study|Adverse Event|4
345621|NCT00501540|1125545|P1|Overall Study|Death|5
345622|NCT00501293|1125557|P2|Maintenance Period|Application site reaction|0
345623|NCT00501293|1125558|P1|Maintenance Period|Application site reaction|1
345624|NCT00501293|1125557|P2|Maintenance Period|Would not wear patch|0
345625|NCT00501293|1125558|P1|Maintenance Period|Would not wear patch|1
345626|NCT00501293|1125557|P2|Maintenance Period|Went into rehabilitation|0
345627|NCT00501293|1125558|P1|Maintenance Period|Went into rehabilitation|1
345628|NCT00501293|1125557|P2|Maintenance Period|Noncompliant with study medication|0
345629|NCT00501293|1125558|P1|Maintenance Period|Noncompliant with study medication|5
345630|NCT00501293|1125557|P2|Maintenance Period|Lack of Efficacy|1
345631|NCT00501293|1125558|P1|Maintenance Period|Lack of Efficacy|4
345632|NCT00501293|1125557|P2|Maintenance Period|Protocol Violation|1
345633|NCT00501293|1125558|P1|Maintenance Period|Protocol Violation|2
345634|NCT00501293|1125557|P2|Maintenance Period|Adverse Event|6
345635|NCT00501293|1125558|P1|Maintenance Period|Adverse Event|6
345636|NCT00501293|1125557|P2|Maintenance Period|Lost to Follow-up|7
345637|NCT00501293|1125558|P1|Maintenance Period|Lost to Follow-up|12
345638|NCT00501293|1125557|P2|Maintenance Period|Withdrawal by Subject|13
345639|NCT00501293|1125558|P1|Maintenance Period|Withdrawal by Subject|14
345640|NCT00501293|1125557|P2|Optimization Period|Enrolled in error|0
345641|NCT00501293|1125558|P1|Optimization Period|Enrolled in error|1
345642|NCT00501228|1125585|P1|Overall Study|Withdrawal by Subject|1
345643|NCT00501085|1125589|P1|Overall Study|Other loss to follow-up|32
345644|NCT00501085|1125589|P1|Overall Study|Study closed by sponsor|109
345645|NCT00501085|1125589|P1|Overall Study|Non-Compliance|24
345646|NCT00501085|1125589|P1|Overall Study|Adverse Event|4
345647|NCT00501085|1125589|P1|Overall Study|Explantation Surgery|26
345648|NCT00501085|1125589|P1|Overall Study|Revision Surgery|7
345649|NCT00501085|1125589|P1|Overall Study|Subject Decision|1
345650|NCT00501085|1125589|P1|Overall Study|Withdrawal by Subject|34
345651|NCT00501085|1125589|P1|Overall Study|Lost to Follow-up|195
345652|NCT00501046|1125599|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
345653|NCT00501046|1125600|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
345654|NCT00501046|1125599|P2|Overall Study|Withdrawal by Subject|83
345655|NCT00501046|1125600|P1|Overall Study|Withdrawal by Subject|84
345656|NCT00501046|1125599|P2|Overall Study|Protocol Violation|1
345657|NCT00501046|1125600|P1|Overall Study|Protocol Violation|2
345658|NCT00501046|1125599|P2|Overall Study|Pregnancy|3
345659|NCT00501046|1125600|P1|Overall Study|Pregnancy|0
345660|NCT00501046|1125599|P2|Overall Study|Physician Decision|2
345661|NCT00501046|1125600|P1|Overall Study|Physician Decision|7
345662|NCT00501046|1125599|P2|Overall Study|Lost to Follow-up|13
345663|NCT00501046|1125600|P1|Overall Study|Lost to Follow-up|14
345664|NCT00501046|1125599|P2|Overall Study|Death|30
345665|NCT00501046|1125600|P1|Overall Study|Death|23
345666|NCT00501046|1125599|P2|Overall Study|Adverse Event|25
345667|NCT00501046|1125600|P1|Overall Study|Adverse Event|21
345668|NCT00501007|1125606|P2|Overall Study|Inclusion criteria not met.|25
345669|NCT00501007|1125607|P1|Overall Study|Inclusion criteria not met.|29
345670|NCT00500760|1125615|P2|Overall Study|Other|2
345671|NCT00500760|1125616|P1|Overall Study|Other|1
345672|NCT00500760|1125615|P2|Overall Study|Lost to Follow-up|0
345673|NCT00500760|1125616|P1|Overall Study|Lost to Follow-up|3
345674|NCT00500760|1125615|P2|Overall Study|Administrative decision|0
345675|NCT00500760|1125616|P1|Overall Study|Administrative decision|2
345676|NCT00500760|1125615|P2|Overall Study|Withdrawal by Subject|7
345677|NCT00500760|1125616|P1|Overall Study|Withdrawal by Subject|5
345678|NCT00500760|1125615|P2|Overall Study|Death|15
345679|NCT00500760|1125616|P1|Overall Study|Death|32
345680|NCT00500682|1125636|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
345681|NCT00500682|1125637|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
345682|NCT00500682|1125636|P2|Overall Study|Withdrawal by Subject|74
345683|NCT00500682|1125637|P1|Overall Study|Withdrawal by Subject|80
345684|NCT00500682|1125636|P2|Overall Study|Protocol Violation|3
345685|NCT00500682|1125637|P1|Overall Study|Protocol Violation|1
345686|NCT00500682|1125636|P2|Overall Study|Pregnancy|0
345687|NCT00500682|1125637|P1|Overall Study|Pregnancy|2
345688|NCT00500682|1125636|P2|Overall Study|Physician Decision|10
345689|NCT00500682|1125637|P1|Overall Study|Physician Decision|6
345690|NCT00500682|1125636|P2|Overall Study|Lost to Follow-up|11
345691|NCT00500682|1125637|P1|Overall Study|Lost to Follow-up|11
345692|NCT00500682|1125636|P2|Overall Study|Death|16
345693|NCT00500682|1125637|P1|Overall Study|Death|25
345694|NCT00500682|1125636|P2|Overall Study|Adverse Event|29
345695|NCT00500682|1125637|P1|Overall Study|Adverse Event|37
345696|NCT00500539|1125671|P1|Follow-up Period (16 Weeks)|Missing|3
345697|NCT00500539|1125671|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
345698|NCT00500539|1125671|P1|Follow-up Period (16 Weeks)|Death|1
345699|NCT00500539|1125671|P1|Follow-up Period (16 Weeks)|Administrative problems|1
345700|NCT00500539|1125671|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
345701|NCT00500539|1125671|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
345702|NCT00500539|1125671|P1|Follow-up Period (16 Weeks)|Adverse Event|1
345703|NCT00500539|1125671|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
345704|NCT00500539|1125671|P1|Treatment Period (24 Weeks)|Administrative problems|2
345705|NCT00500539|1125671|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
345706|NCT00500539|1125671|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
345707|NCT00500539|1125671|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
345708|NCT00500539|1125671|P1|Treatment Period (24 Weeks)|Adverse Event|4
345709|NCT00500370|1125697|P2|Overall Study|Subject Decision|17
345710|NCT00500370|1125698|P1|Overall Study|Subject Decision|10
345711|NCT00500370|1125697|P2|Overall Study|Sponsor Decision|0
345712|NCT00500370|1125698|P1|Overall Study|Sponsor Decision|2
345713|NCT00500370|1125697|P2|Overall Study|Protocol Violation|4
345714|NCT00500370|1125698|P1|Overall Study|Protocol Violation|2
345715|NCT00500370|1125697|P2|Overall Study|Lost to Follow-up|10
345716|NCT00500370|1125698|P1|Overall Study|Lost to Follow-up|10
345717|NCT00500370|1125697|P2|Overall Study|Adverse Event|3
345718|NCT00500370|1125698|P1|Overall Study|Adverse Event|9
345719|NCT00500357|1125734|P1|Overall Study|Death|1
345720|NCT00500318|1125755|P2|Overall Study|Other Reason|1
345721|NCT00500318|1125756|P1|Overall Study|Other Reason|0
345722|NCT00500318|1125755|P2|Overall Study|Lack of Efficacy|3
345723|NCT00500318|1125756|P1|Overall Study|Lack of Efficacy|0
345724|NCT00500318|1125755|P2|Overall Study|Withdrawal by Subject|2
345725|NCT00500318|1125756|P1|Overall Study|Withdrawal by Subject|1
345726|NCT00500318|1125755|P2|Overall Study|Protocol Violation|3
345727|NCT00500318|1125756|P1|Overall Study|Protocol Violation|1
345728|NCT00500318|1125755|P2|Overall Study|Adverse Event|8
345729|NCT00500318|1125756|P1|Overall Study|Adverse Event|3
345730|NCT00500292|1125773|P3|Overall Study|Other|4
345731|NCT00500292|1125774|P2|Overall Study|Other|1
345732|NCT00500292|1125775|P1|Overall Study|Other|1
345733|NCT00500292|1125773|P3|Overall Study|Withdrawal by Subject|0
345734|NCT00500292|1125774|P2|Overall Study|Withdrawal by Subject|1
345735|NCT00500292|1125775|P1|Overall Study|Withdrawal by Subject|0
345736|NCT00500292|1125773|P3|Overall Study|Condition under investigation worsened|19
345737|NCT00500292|1125774|P2|Overall Study|Condition under investigation worsened|23
345738|NCT00500292|1125775|P1|Overall Study|Condition under investigation worsened|21
345739|NCT00500292|1125773|P3|Overall Study|Adverse Event|4
345740|NCT00500292|1125774|P2|Overall Study|Adverse Event|6
345741|NCT00500292|1125775|P1|Overall Study|Adverse Event|3
345742|NCT00500266|1125783|P1|Overall Study|Assigned, not treated|4
345743|NCT00500266|1125783|P1|Overall Study|Withdrawal by Subject|3
345744|NCT00500266|1125783|P1|Overall Study|Lost to Follow-up|3
345745|NCT00500266|1125783|P1|Overall Study|Death|3
345746|NCT00500149|1125803|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
345747|NCT00500149|1125804|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
345748|NCT00500149|1125803|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
345749|NCT00500149|1125804|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
345750|NCT00500149|1125803|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
345751|NCT00500149|1125804|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
345752|NCT00500149|1125803|P2|First Intervention (Cross-over Phase)|Adverse Event|1
345753|NCT00500149|1125804|P1|First Intervention (Cross-over Phase)|Adverse Event|0
345754|NCT00500149|1125803|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
345755|NCT00500149|1125804|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
345756|NCT00500149|1125803|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
345757|NCT00500149|1125804|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
345758|NCT00500149|1125803|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
345759|NCT00500149|1125804|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
345760|NCT00500110|1125812|P1|Overall Study|Withdrawal by Subject|3
345761|NCT00500071|1125816|P1|30-day Safety Follow-up|Lost to Follow-up|17
345762|NCT00500071|1125816|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
345763|NCT00500071|1125816|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
345764|NCT00500071|1125816|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
345765|NCT00500071|1125816|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
345766|NCT00500071|1125816|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
345767|NCT00500071|1125816|P1|Screening and Washout Phase|Protocol Violation|1
345768|NCT00499889|1125834|P1|Overall Study|Infection prior to treatment|1
345769|NCT00499863|1125842|P2|Overall Study|Lost to Follow-up|1
345770|NCT00499863|1125843|P1|Overall Study|Lost to Follow-up|1
345771|NCT00499863|1125842|P2|Overall Study|Sponsor decision|2
345772|NCT00499863|1125843|P1|Overall Study|Sponsor decision|2
345773|NCT00499863|1125842|P2|Overall Study|Adverse Event|2
345774|NCT00499863|1125843|P1|Overall Study|Adverse Event|8
345775|NCT00499863|1125842|P2|Overall Study|Withdrawal by Subject|4
345776|NCT00499863|1125843|P1|Overall Study|Withdrawal by Subject|6
345777|NCT00499863|1125842|P2|Overall Study|Protocol Violation|7
345778|NCT00499863|1125843|P1|Overall Study|Protocol Violation|12
345779|NCT00499863|1125842|P2|Overall Study|Lack of Efficacy|27
345780|NCT00499863|1125843|P1|Overall Study|Lack of Efficacy|21
345781|NCT00499694|1125871|P1|Overall Study|Patient never received treatment.|1
345782|NCT00499681|1125877|P2|Overall Study|disease progression|1
345783|NCT00499681|1125878|P1|Overall Study|disease progression|0
345784|NCT00499681|1125877|P2|Overall Study|toxicity|1
345785|NCT00499681|1125878|P1|Overall Study|toxicity|0
345786|NCT00499603|1125903|P2|Overall Study|Adverse Event|1
345787|NCT00499603|1125904|P1|Overall Study|Adverse Event|0
345788|NCT00499590|1125917|P3|Overall Study|Not treated|1
345789|NCT00499590|1125918|P2|Overall Study|Not treated|0
345790|NCT00499590|1125919|P1|Overall Study|Not treated|1
345791|NCT00499590|1125917|P3|Overall Study|Study Terminated|112
345792|NCT00499590|1125918|P2|Overall Study|Study Terminated|112
345793|NCT00499590|1125919|P1|Overall Study|Study Terminated|112
345794|NCT00499486|1125930|P1|Overall Study|Withdrawal by Subject|16
345795|NCT00499460|1125957|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
345796|NCT00499460|1125958|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
345797|NCT00499460|1125957|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
345798|NCT00499460|1125958|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
345799|NCT00499460|1125957|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
345800|NCT00499460|1125958|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
345801|NCT00499369|1125987|P5|Overall Study|Ineligible|0
345802|NCT00499369|1125988|P4|Overall Study|Ineligible|1
345803|NCT00499369|1125989|P3|Overall Study|Ineligible|1
345804|NCT00499369|1125990|P2|Overall Study|Ineligible|2
345805|NCT00499369|1125991|P1|Overall Study|Ineligible|2
345806|NCT00499369|1125987|P5|Overall Study|Not protocol specified|0
345807|NCT00499369|1125988|P4|Overall Study|Not protocol specified|1
345808|NCT00499369|1125989|P3|Overall Study|Not protocol specified|3
345809|NCT00499369|1125990|P2|Overall Study|Not protocol specified|0
345810|NCT00499369|1125991|P1|Overall Study|Not protocol specified|2
345811|NCT00499369|1125987|P5|Overall Study|Death|0
345812|NCT00499369|1125988|P4|Overall Study|Death|0
345813|NCT00499369|1125989|P3|Overall Study|Death|0
345814|NCT00499369|1125990|P2|Overall Study|Death|1
345815|NCT00499369|1125991|P1|Overall Study|Death|0
345816|NCT00499369|1125987|P5|Overall Study|Progression|10
345817|NCT00499369|1125988|P4|Overall Study|Progression|6
345818|NCT00499369|1125989|P3|Overall Study|Progression|9
345819|NCT00499369|1125990|P2|Overall Study|Progression|12
345820|NCT00499369|1125991|P1|Overall Study|Progression|10
345821|NCT00499369|1125987|P5|Overall Study|Withdrawal by Subject|0
345822|NCT00499369|1125988|P4|Overall Study|Withdrawal by Subject|0
345823|NCT00499369|1125989|P3|Overall Study|Withdrawal by Subject|1
345824|NCT00499369|1125990|P2|Overall Study|Withdrawal by Subject|1
345825|NCT00499369|1125991|P1|Overall Study|Withdrawal by Subject|0
345826|NCT00499369|1125987|P5|Overall Study|Adverse Event|2
345827|NCT00499369|1125988|P4|Overall Study|Adverse Event|1
345828|NCT00499369|1125989|P3|Overall Study|Adverse Event|3
345829|NCT00499369|1125990|P2|Overall Study|Adverse Event|2
345830|NCT00499369|1125991|P1|Overall Study|Adverse Event|2
345831|NCT00499252|1126027|P1|Overall Study|<no further label>|3
345832|NCT00499252|1126027|P1|Overall Study|Ineligible|4
345833|NCT00499252|1126027|P1|Overall Study|Refused further treatment|2
345834|NCT00499252|1126027|P1|Overall Study|Adverse Event|3
345835|NCT00499122|1126033|P1|Overall Study|Withdrawal by Subject|2
345836|NCT00499031|1126075|P1|Overall Study|Never treated|1
345837|NCT00499031|1126075|P1|Overall Study|Required test not done|1
345838|NCT00499031|1126075|P1|Overall Study|Improper pre-protocol treatment|1
345839|NCT00498797|1126096|P2|Overall Study|Other|1
345840|NCT00498797|1126097|P1|Overall Study|Other|3
345841|NCT00498797|1126096|P2|Overall Study|Condition under investigation worsened|21
345842|NCT00498797|1126097|P1|Overall Study|Condition under investigation worsened|19
345843|NCT00498797|1126096|P2|Overall Study|Adverse Event|5
345844|NCT00498797|1126097|P1|Overall Study|Adverse Event|12
345845|NCT00498797|1126096|P2|Overall Study|Withdrawal by Subject|2
345846|NCT00498797|1126097|P1|Overall Study|Withdrawal by Subject|4
345847|NCT00498602|1126212|P7|Overall Study|Not specified|0
345848|NCT00498602|1126213|P6|Overall Study|Not specified|3
345849|NCT00498602|1126214|P5|Overall Study|Not specified|0
345850|NCT00498602|1126215|P4|Overall Study|Not specified|0
345851|NCT00498602|1126216|P3|Overall Study|Not specified|1
345852|NCT00498602|1126217|P2|Overall Study|Not specified|3
345853|NCT00498602|1126218|P1|Overall Study|Not specified|2
345854|NCT00498602|1126212|P7|Overall Study|Subject Request|1
345855|NCT00498602|1126213|P6|Overall Study|Subject Request|4
345856|NCT00498602|1126214|P5|Overall Study|Subject Request|1
345857|NCT00498602|1126215|P4|Overall Study|Subject Request|1
345858|NCT00498602|1126216|P3|Overall Study|Subject Request|1
345859|NCT00498602|1126217|P2|Overall Study|Subject Request|0
345860|NCT00498602|1126218|P1|Overall Study|Subject Request|3
345861|NCT00498602|1126212|P7|Overall Study|Investigator Request|0
345862|NCT00498602|1126213|P6|Overall Study|Investigator Request|0
345863|NCT00498602|1126214|P5|Overall Study|Investigator Request|0
345864|NCT00498602|1126215|P4|Overall Study|Investigator Request|0
345865|NCT00498602|1126216|P3|Overall Study|Investigator Request|1
345866|NCT00498602|1126217|P2|Overall Study|Investigator Request|0
345867|NCT00498602|1126218|P1|Overall Study|Investigator Request|0
345868|NCT00498602|1126212|P7|Overall Study|Caregiver Request|0
345869|NCT00498602|1126213|P6|Overall Study|Caregiver Request|2
345870|NCT00498602|1126214|P5|Overall Study|Caregiver Request|1
345871|NCT00498602|1126215|P4|Overall Study|Caregiver Request|0
345872|NCT00498602|1126216|P3|Overall Study|Caregiver Request|2
345873|NCT00498602|1126217|P2|Overall Study|Caregiver Request|2
345874|NCT00498602|1126218|P1|Overall Study|Caregiver Request|2
345875|NCT00498602|1126212|P7|Overall Study|AE not related to Study Drug|1
345876|NCT00498602|1126213|P6|Overall Study|AE not related to Study Drug|2
345877|NCT00498602|1126214|P5|Overall Study|AE not related to Study Drug|2
345878|NCT00498602|1126215|P4|Overall Study|AE not related to Study Drug|0
345879|NCT00498602|1126216|P3|Overall Study|AE not related to Study Drug|0
345880|NCT00498602|1126217|P2|Overall Study|AE not related to Study Drug|3
345881|NCT00498602|1126218|P1|Overall Study|AE not related to Study Drug|1
345882|NCT00498602|1126212|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
345883|NCT00498602|1126213|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
345884|NCT00498602|1126214|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
345885|NCT00498602|1126215|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
345886|NCT00498602|1126216|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
345887|NCT00498602|1126217|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
345888|NCT00498602|1126218|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
345889|NCT00498602|1126212|P7|Overall Study|Lost to Follow-up|0
345890|NCT00498602|1126213|P6|Overall Study|Lost to Follow-up|0
345891|NCT00498602|1126214|P5|Overall Study|Lost to Follow-up|0
345892|NCT00498602|1126215|P4|Overall Study|Lost to Follow-up|2
345893|NCT00498602|1126216|P3|Overall Study|Lost to Follow-up|0
345894|NCT00498602|1126217|P2|Overall Study|Lost to Follow-up|2
345895|NCT00498602|1126218|P1|Overall Study|Lost to Follow-up|0
345896|NCT00498602|1126212|P7|Overall Study|Lack of Efficacy|0
345897|NCT00498602|1126213|P6|Overall Study|Lack of Efficacy|0
345898|NCT00498602|1126214|P5|Overall Study|Lack of Efficacy|0
345899|NCT00498602|1126215|P4|Overall Study|Lack of Efficacy|0
345900|NCT00498602|1126216|P3|Overall Study|Lack of Efficacy|0
345901|NCT00498602|1126217|P2|Overall Study|Lack of Efficacy|0
345902|NCT00498602|1126218|P1|Overall Study|Lack of Efficacy|1
345903|NCT00498602|1126212|P7|Overall Study|Death|0
345904|NCT00498602|1126213|P6|Overall Study|Death|1
345905|NCT00498602|1126214|P5|Overall Study|Death|0
345906|NCT00498602|1126215|P4|Overall Study|Death|0
345907|NCT00498602|1126216|P3|Overall Study|Death|0
345908|NCT00498602|1126217|P2|Overall Study|Death|0
345909|NCT00498602|1126218|P1|Overall Study|Death|0
345910|NCT00498485|1126266|P2|Overall Study|Adverse Event|5
345911|NCT00498485|1126267|P1|Overall Study|Adverse Event|1
345912|NCT00498433|1126278|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
345913|NCT00498433|1126279|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
345914|NCT00498433|1126280|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
345915|NCT00498433|1126278|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
345916|NCT00498433|1126279|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
345917|NCT00498433|1126280|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
345918|NCT00498433|1126278|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
345919|NCT00498433|1126279|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
345920|NCT00498433|1126280|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
345921|NCT00498433|1126278|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
345922|NCT00498433|1126279|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
345923|NCT00498433|1126280|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
345924|NCT00498368|1126325|P2|Overall Study|Withdrawal by Subject|2
345925|NCT00498368|1126326|P1|Overall Study|Withdrawal by Subject|3
345926|NCT00498355|1126338|P1|Overall Study|Lost to Follow-up|1
345927|NCT00498186|1126342|P1|Overall Study|Other|10
345928|NCT00498186|1126342|P1|Overall Study|Lost to Follow-up|3
345929|NCT00498186|1126342|P1|Overall Study|Withdrawal by Subject|18
345930|NCT00498186|1126342|P1|Overall Study|Unsatisfactory compliance of subject|12
345931|NCT00498186|1126342|P1|Overall Study|Adverse Event|89
345932|NCT00498186|1126342|P1|Overall Study|Lack of Efficacy|31
345933|NCT00498186|1126342|P1|Overall Study|Protocol Violation|10
345934|NCT00497874|1126349|P2|Overall Study|Unable to schedule|24
345935|NCT00497874|1126350|P1|Overall Study|Unable to schedule|37
345936|NCT00497874|1126349|P2|Overall Study|Unable to contact|67
345937|NCT00497874|1126350|P1|Overall Study|Unable to contact|52
345938|NCT00497874|1126349|P2|Overall Study|Death|4
345939|NCT00497874|1126350|P1|Overall Study|Death|2
345940|NCT00497874|1126349|P2|Overall Study|Illness|4
345941|NCT00497874|1126350|P1|Overall Study|Illness|8
345942|NCT00497874|1126349|P2|Overall Study|Withdrawal by Subject|17
345943|NCT00497874|1126350|P1|Overall Study|Withdrawal by Subject|48
345944|NCT00497796|1126368|P2|Overall Study|Not applicable (randomized not treated)|4
345945|NCT00497796|1126369|P1|Overall Study|Not applicable (randomized not treated)|0
345946|NCT00497796|1126368|P2|Overall Study|Lost to Follow-up|1
345947|NCT00497796|1126369|P1|Overall Study|Lost to Follow-up|0
345948|NCT00497796|1126368|P2|Overall Study|Investigator/sponsor discretion|34
345949|NCT00497796|1126369|P1|Overall Study|Investigator/sponsor discretion|31
345950|NCT00497796|1126368|P2|Overall Study|Consent withdrawn|3
345951|NCT00497796|1126369|P1|Overall Study|Consent withdrawn|10
345952|NCT00497796|1126368|P2|Overall Study|CMV infection or disease treatment|4
345953|NCT00497796|1126369|P1|Overall Study|CMV infection or disease treatment|30
345954|NCT00497796|1126368|P2|Overall Study|Adverse event (related)|4
345955|NCT00497796|1126369|P1|Overall Study|Adverse event (related)|5
345956|NCT00497796|1126368|P2|Overall Study|Adverse event (not related)|9
345957|NCT00497796|1126369|P1|Overall Study|Adverse event (not related)|9
345958|NCT00497198|1126399|P2|Overall Study|Withdrawal by Subject|1
345959|NCT00497198|1126400|P1|Overall Study|Withdrawal by Subject|0
345960|NCT00497198|1126399|P2|Overall Study|Physician Decision|2
345961|NCT00497198|1126400|P1|Overall Study|Physician Decision|1
345962|NCT00497198|1126399|P2|Overall Study|Adverse Event|2
345963|NCT00497198|1126400|P1|Overall Study|Adverse Event|4
345964|NCT00497146|1126416|P2|Long-term Follow-up Period|Other|1
345965|NCT00497146|1126417|P1|Long-term Follow-up Period|Other|0
345966|NCT00497146|1126416|P2|Long-term Follow-up Period|Lost to Follow-up|1
345967|NCT00497146|1126417|P1|Long-term Follow-up Period|Lost to Follow-up|5
345968|NCT00497146|1126416|P2|Long-term Follow-up Period|Withdrawal by Subject|2
345969|NCT00497146|1126417|P1|Long-term Follow-up Period|Withdrawal by Subject|8
345970|NCT00497146|1126416|P2|Long-term Follow-up Period|Adverse Event|2
345971|NCT00497146|1126417|P1|Long-term Follow-up Period|Adverse Event|2
345972|NCT00497146|1126416|P2|Treatment Period|Other Reason|3
345973|NCT00497146|1126417|P1|Treatment Period|Other Reason|2
345974|NCT00497146|1126416|P2|Treatment Period|Unable to dose reduce per protocol|1
345975|NCT00497146|1126417|P1|Treatment Period|Unable to dose reduce per protocol|4
345976|NCT00497146|1126416|P2|Treatment Period|Change in RAAS inhibitor therapy|2
345977|NCT00497146|1126417|P1|Treatment Period|Change in RAAS inhibitor therapy|5
345978|NCT00497146|1126416|P2|Treatment Period|Required dialysis|1
345979|NCT00497146|1126417|P1|Treatment Period|Required dialysis|4
345980|NCT00497146|1126416|P2|Treatment Period|Lost to Follow-up|3
345981|NCT00497146|1126417|P1|Treatment Period|Lost to Follow-up|1
345982|NCT00497146|1126416|P2|Treatment Period|Withdrawal by Subject|9
345983|NCT00497146|1126417|P1|Treatment Period|Withdrawal by Subject|5
345984|NCT00497146|1126416|P2|Treatment Period|Adverse Event|2
345985|NCT00497146|1126417|P1|Treatment Period|Adverse Event|6
345986|NCT00496964|1126485|P2|Overall Study|Withdrawal by Subject|1
345987|NCT00496964|1126486|P1|Overall Study|Withdrawal by Subject|0
345988|NCT00496873|1126494|P1|Overall Study|Withdrawal by Subject|3
345989|NCT00496873|1126494|P1|Overall Study|Death|2
345990|NCT00496873|1126494|P1|Overall Study|Ineligible|2
345991|NCT00496834|1126527|P2|Overall Study|Blood Pressure control failure|1
345992|NCT00496834|1126528|P1|Overall Study|Blood Pressure control failure|2
345993|NCT00496834|1126527|P2|Overall Study|Lost to Follow-up|0
345994|NCT00496834|1126528|P1|Overall Study|Lost to Follow-up|2
345995|NCT00496834|1126527|P2|Overall Study|IP administration violation|0
345996|NCT00496834|1126528|P1|Overall Study|IP administration violation|2
345997|NCT00496834|1126527|P2|Overall Study|Adverse Event|3
345998|NCT00496834|1126528|P1|Overall Study|Adverse Event|5
345999|NCT00496834|1126527|P2|Overall Study|Inclusion/exclusion criteria not met|2
346000|NCT00496834|1126528|P1|Overall Study|Inclusion/exclusion criteria not met|3
346001|NCT00496834|1126527|P2|Overall Study|Contraindicated medication administered|1
346002|NCT00496834|1126528|P1|Overall Study|Contraindicated medication administered|0
346003|NCT00496834|1126527|P2|Overall Study|Withdrawal by Subject|6
346004|NCT00496834|1126528|P1|Overall Study|Withdrawal by Subject|4
346005|NCT00496782|1126547|P2|Overall Study|Protocol Violation|2
346006|NCT00496782|1126548|P1|Overall Study|Protocol Violation|1
346007|NCT00496769|1126582|P2|Overall Study|>=1 reason assigned per patient|649
346008|NCT00496769|1126583|P1|Overall Study|>=1 reason assigned per patient|558
346009|NCT00496730|1126607|P2|Overall Study|Withdrawal by Subject|2
346010|NCT00496730|1126608|P1|Overall Study|Withdrawal by Subject|2
346011|NCT00496730|1126607|P2|Overall Study|Lost to Follow-up|3
346012|NCT00496730|1126608|P1|Overall Study|Lost to Follow-up|4
346013|NCT00496626|1126620|P2|Overall Study|Relocated|1
346014|NCT00496626|1126621|P1|Overall Study|Relocated|0
346015|NCT00496626|1126620|P2|Overall Study|Withdrawal by Subject|4
346016|NCT00496626|1126621|P1|Overall Study|Withdrawal by Subject|5
346017|NCT00496626|1126620|P2|Overall Study|Protocol Violation|0
346018|NCT00496626|1126621|P1|Overall Study|Protocol Violation|1
346019|NCT00496626|1126620|P2|Overall Study|Lost to Follow-up|1
346020|NCT00496626|1126621|P1|Overall Study|Lost to Follow-up|0
346021|NCT00496483|1126633|P1|Overall Study|Lack of Efficacy|1
346022|NCT00496483|1126633|P1|Overall Study|Adverse Event|2
346023|NCT00496483|1126633|P1|Overall Study|Not dosed|9
346024|NCT00496470|1126650|P2|Overall Study|Other reason|2
346025|NCT00496470|1126651|P1|Overall Study|Other reason|0
346026|NCT00496470|1126650|P2|Overall Study|Incorrectly enrolled|5
346027|NCT00496470|1126651|P1|Overall Study|Incorrectly enrolled|13
346028|NCT00496470|1126650|P2|Overall Study|Withdrawal by Subject|12
346029|NCT00496470|1126651|P1|Overall Study|Withdrawal by Subject|5
346030|NCT00496470|1126650|P2|Overall Study|Adverse Event|10
346031|NCT00496470|1126651|P1|Overall Study|Adverse Event|8
346032|NCT00496366|1126737|P1|Overall Study|Death|1
346033|NCT00496197|1126768|P1|Overall Study|Protocol Violation|8
346034|NCT00496197|1126768|P1|Overall Study|Unspecified|14
346035|NCT00496197|1126768|P1|Overall Study|Pathogen not isolated baseline specimen|4
346036|NCT00496197|1126768|P1|Overall Study|Withdrawal by Subject|11
346037|NCT00496197|1126768|P1|Overall Study|Lost to Follow-up|11
346038|NCT00496197|1126768|P1|Overall Study|Insufficient bacteriological response|10
346039|NCT00496197|1126768|P1|Overall Study|Insufficient clinical response|3
346040|NCT00496197|1126768|P1|Overall Study|Does not meet entrance criteria|5
346041|NCT00496197|1126768|P1|Overall Study|Adverse Event|13
346042|NCT00496197|1126768|P1|Overall Study|Discontinued study due to death|43
346043|NCT00496080|1126795|P1|Overall Study|Physician Decision|6
346044|NCT00496080|1126795|P1|Overall Study|Withdrawal by Subject|5
346045|NCT00496080|1126795|P1|Overall Study|Surgical re-intervention|7
346046|NCT00496080|1126795|P1|Overall Study|Lost to Follow-up|9
346047|NCT00496054|1126805|P1|Overall Study|Lost to Follow-up|7
346048|NCT00496054|1126805|P1|Overall Study|Adverse Event|1
346049|NCT00495820|1126834|P2|Overall Study|Adverse Event|1
346050|NCT00495820|1126835|P1|Overall Study|Adverse Event|1
346051|NCT00495794|1126847|P2|Overall Study|Pharmacist did not activate patient|0
346052|NCT00495794|1126848|P1|Overall Study|Pharmacist did not activate patient|522
346053|NCT00495755|1126858|P1|Overall Study|Adverse Event|3
346054|NCT00495677|1126870|P7|Stage 1 (25 Days)|Adverse Event|0
346055|NCT00495677|1126871|P6|Stage 1 (25 Days)|Adverse Event|0
346056|NCT00495677|1126872|P5|Stage 1 (25 Days)|Adverse Event|0
346057|NCT00495677|1126873|P4|Stage 1 (25 Days)|Adverse Event|0
346058|NCT00495677|1126874|P3|Stage 1 (25 Days)|Adverse Event|1
346059|NCT00495677|1126875|P2|Stage 1 (25 Days)|Adverse Event|0
346060|NCT00495677|1126876|P1|Stage 1 (25 Days)|Adverse Event|0
346061|NCT00495625|1126931|P1|Overall Study|Did not complete at least 1 42 day cycle|10
346062|NCT00495612|1126942|P2|Overall Study|Subject's Decision to Withdraw|0
346063|NCT00495612|1126943|P1|Overall Study|Subject's Decision to Withdraw|3
346064|NCT00495612|1126942|P2|Overall Study|Lost to Follow-up|0
346065|NCT00495612|1126943|P1|Overall Study|Lost to Follow-up|1
346066|NCT00495586|1126961|P2|Overall Study|Withdrawal by Subject|4
346067|NCT00495586|1126962|P1|Overall Study|Withdrawal by Subject|4
346068|NCT00495495|1126970|P1|Overall Study|Protocol Violation|99
346069|NCT00495391|1126985|P2|Overall Study|Withdrawal by Subject|3
346070|NCT00495391|1126986|P1|Overall Study|Withdrawal by Subject|2
346071|NCT00495391|1126985|P2|Overall Study|Lack of Efficacy|18
346072|NCT00495391|1126986|P1|Overall Study|Lack of Efficacy|34
346073|NCT00495131|1127024|P2|Overall Study|Withdrawal by Subject|0
346074|NCT00495131|1127025|P1|Overall Study|Withdrawal by Subject|1
346075|NCT00495131|1127024|P2|Overall Study|Lost to Follow-up|2
346076|NCT00495131|1127025|P1|Overall Study|Lost to Follow-up|0
346077|NCT00495131|1127024|P2|Overall Study|Lack of Efficacy|2
346078|NCT00495131|1127025|P1|Overall Study|Lack of Efficacy|0
346079|NCT00495131|1127024|P2|Overall Study|Adverse Event|2
346080|NCT00495131|1127025|P1|Overall Study|Adverse Event|6
346081|NCT00494871|1127053|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
346082|NCT00494871|1127054|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
346083|NCT00494871|1127053|P2|Follow-up (FU) Period|Withdrawal by Subject|5
346084|NCT00494871|1127054|P1|Follow-up (FU) Period|Withdrawal by Subject|5
346085|NCT00494871|1127053|P2|Follow-up (FU) Period|Protocol Violation|0
346086|NCT00494871|1127054|P1|Follow-up (FU) Period|Protocol Violation|1
346087|NCT00494871|1127053|P2|Follow-up (FU) Period|Physician Decision|1
346088|NCT00494871|1127054|P1|Follow-up (FU) Period|Physician Decision|0
346089|NCT00494871|1127053|P2|Follow-up (FU) Period|Lost to Follow-up|2
346090|NCT00494871|1127054|P1|Follow-up (FU) Period|Lost to Follow-up|6
346091|NCT00494871|1127053|P2|Follow-up (FU) Period|Death|12
346092|NCT00494871|1127054|P1|Follow-up (FU) Period|Death|13
346093|NCT00494871|1127053|P2|Follow-up (FU) Period|Adverse Event|1
346094|NCT00494871|1127054|P1|Follow-up (FU) Period|Adverse Event|1
346095|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
346096|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
346097|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
346098|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
346099|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
346100|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
346101|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
346102|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
346103|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
346104|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
346105|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
346106|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
346107|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
346108|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
346109|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
346110|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
346111|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Physician Decision|13
346112|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Physician Decision|4
346113|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Death|3
346114|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Death|8
346115|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
346116|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
346117|NCT00494871|1127053|P2|Double-blind (DB) Treatment Period|Adverse Event|70
346118|NCT00494871|1127054|P1|Double-blind (DB) Treatment Period|Adverse Event|73
346119|NCT00494780|1127095|P2|Overall Study|Insurance Issues|1
346120|NCT00494780|1127096|P1|Overall Study|Insurance Issues|0
346121|NCT00494780|1127095|P2|Overall Study|Residual Tumour Mass|1
346122|NCT00494780|1127096|P1|Overall Study|Residual Tumour Mass|0
346123|NCT00494780|1127095|P2|Overall Study|Non-compliance|0
346124|NCT00494780|1127096|P1|Overall Study|Non-compliance|1
346125|NCT00494780|1127095|P2|Overall Study|New Treatment|2
346126|NCT00494780|1127096|P1|Overall Study|New Treatment|2
346127|NCT00494780|1127095|P2|Overall Study|Progression of Study Disease|8
346128|NCT00494780|1127096|P1|Overall Study|Progression of Study Disease|7
346129|NCT00494780|1127095|P2|Overall Study|Withdrew before Dosed|1
346130|NCT00494780|1127096|P1|Overall Study|Withdrew before Dosed|0
346131|NCT00494780|1127095|P2|Overall Study|Adverse Event|0
346132|NCT00494780|1127096|P1|Overall Study|Adverse Event|1
346133|NCT00494676|1127134|P2|Second Intervention|Withdrawal by Subject|1
346134|NCT00494676|1127135|P1|Second Intervention|Withdrawal by Subject|1
346135|NCT00494676|1127134|P2|First Intervention|Withdrawal by Subject|3
346136|NCT00494676|1127135|P1|First Intervention|Withdrawal by Subject|1
346137|NCT00494676|1127134|P2|Allocation|Withdrawal by Subject|4
346138|NCT00494676|1127135|P1|Allocation|Withdrawal by Subject|2
346139|NCT00494507|1127150|P4|Open-Label Phase|Worsening Disease|2
346140|NCT00494507|1127151|P3|Open-Label Phase|Worsening Disease|0
346141|NCT00494507|1127152|P2|Open-Label Phase|Worsening Disease|0
346142|NCT00494507|1127153|P1|Open-Label Phase|Worsening Disease|0
346143|NCT00494507|1127150|P4|Open-Label Phase|Adverse Event|3
346144|NCT00494507|1127151|P3|Open-Label Phase|Adverse Event|5
346145|NCT00494507|1127152|P2|Open-Label Phase|Adverse Event|1
346146|NCT00494507|1127153|P1|Open-Label Phase|Adverse Event|0
346147|NCT00494507|1127150|P4|Double-Blind Phase|Negative DNA test|1
346148|NCT00494507|1127151|P3|Double-Blind Phase|Negative DNA test|0
346149|NCT00494507|1127152|P2|Double-Blind Phase|Negative DNA test|0
346150|NCT00494507|1127153|P1|Double-Blind Phase|Negative DNA test|0
346151|NCT00494507|1127150|P4|Double-Blind Phase|Subject Non-compliance|0
346152|NCT00494507|1127151|P3|Double-Blind Phase|Subject Non-compliance|1
346153|NCT00494507|1127152|P2|Double-Blind Phase|Subject Non-compliance|0
346154|NCT00494507|1127153|P1|Double-Blind Phase|Subject Non-compliance|0
346155|NCT00494507|1127150|P4|Double-Blind Phase|Withdrawal by Subject|0
346156|NCT00494507|1127151|P3|Double-Blind Phase|Withdrawal by Subject|0
346157|NCT00494507|1127152|P2|Double-Blind Phase|Withdrawal by Subject|0
346158|NCT00494507|1127153|P1|Double-Blind Phase|Withdrawal by Subject|1
346159|NCT00494507|1127150|P4|Double-Blind Phase|Adverse Event|0
346160|NCT00494507|1127151|P3|Double-Blind Phase|Adverse Event|1
346161|NCT00494507|1127152|P2|Double-Blind Phase|Adverse Event|0
346162|NCT00494507|1127153|P1|Double-Blind Phase|Adverse Event|2
346163|NCT00494481|1127220|P2|Overall Study|Never received IP|0
346164|NCT00494481|1127221|P1|Overall Study|Never received IP|2
346165|NCT00494481|1127220|P2|Overall Study|Other|0
346166|NCT00494481|1127221|P1|Overall Study|Other|1
346167|NCT00494481|1127220|P2|Overall Study|Adverse Event|11
346168|NCT00494481|1127221|P1|Overall Study|Adverse Event|15
346169|NCT00494481|1127220|P2|Overall Study|Condition under investigation worsened|13
346170|NCT00494481|1127221|P1|Overall Study|Condition under investigation worsened|11
346171|NCT00494442|1127229|P2|Overall Study|Intercurrent illness|1
346172|NCT00494442|1127230|P1|Overall Study|Intercurrent illness|0
346173|NCT00494442|1127229|P2|Overall Study|Non-compliance|1
346174|NCT00494442|1127230|P1|Overall Study|Non-compliance|0
346175|NCT00494442|1127229|P2|Overall Study|Physician Decision|1
346176|NCT00494442|1127230|P1|Overall Study|Physician Decision|0
346177|NCT00494442|1127229|P2|Overall Study|Adverse Event|2
346178|NCT00494442|1127230|P1|Overall Study|Adverse Event|0
346179|NCT00494442|1127229|P2|Overall Study|Lack of Efficacy|10
346180|NCT00494442|1127230|P1|Overall Study|Lack of Efficacy|16
346181|NCT00494442|1127229|P2|Overall Study|Death|1
346182|NCT00494442|1127230|P1|Overall Study|Death|1
346183|NCT00494299|1127246|P2|Overall Study|Protocol Driven Decision Point|22
346184|NCT00494299|1127247|P1|Overall Study|Protocol Driven Decision Point|11
346185|NCT00494299|1127246|P2|Overall Study|Site Closed by Sponsor|0
346186|NCT00494299|1127247|P1|Overall Study|Site Closed by Sponsor|6
346187|NCT00494299|1127246|P2|Overall Study|Participant Did Not Take Study Drug|2
346188|NCT00494299|1127247|P1|Overall Study|Participant Did Not Take Study Drug|0
346189|NCT00494299|1127246|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
346190|NCT00494299|1127247|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
346191|NCT00494299|1127246|P2|Overall Study|Withdrawal by Subject|3
346192|NCT00494299|1127247|P1|Overall Study|Withdrawal by Subject|8
346193|NCT00494299|1127246|P2|Overall Study|Protocol Violation|2
346194|NCT00494299|1127247|P1|Overall Study|Protocol Violation|1
346195|NCT00494299|1127246|P2|Overall Study|Physician Decision|2
346196|NCT00494299|1127247|P1|Overall Study|Physician Decision|0
346197|NCT00494299|1127246|P2|Overall Study|Lost to Follow-up|0
346198|NCT00494299|1127247|P1|Overall Study|Lost to Follow-up|1
346199|NCT00494299|1127246|P2|Overall Study|Adverse Event|13
346200|NCT00494299|1127247|P1|Overall Study|Adverse Event|93
346201|NCT00494234|1127259|P2|Overall Study|Death|1
346202|NCT00494234|1127260|P1|Overall Study|Death|2
346203|NCT00494234|1127259|P2|Overall Study|Withdrawal by Subject|0
346204|NCT00494234|1127260|P1|Overall Study|Withdrawal by Subject|1
346205|NCT00494234|1127259|P2|Overall Study|Lack of Efficacy|9
346206|NCT00494234|1127260|P1|Overall Study|Lack of Efficacy|12
346207|NCT00494221|1127279|P3|Overall Study|Withdrawal by Subject|0
346208|NCT00494221|1127280|P2|Overall Study|Withdrawal by Subject|2
346209|NCT00494221|1127281|P1|Overall Study|Withdrawal by Subject|1
346210|NCT00494221|1127279|P3|Overall Study|Death|14
346211|NCT00494221|1127280|P2|Overall Study|Death|9
346212|NCT00494221|1127281|P1|Overall Study|Death|15
346213|NCT00494091|1127322|P2|Overall Study|Withdrawal by Subject|7
346214|NCT00494091|1127323|P1|Overall Study|Withdrawal by Subject|0
346215|NCT00494091|1127322|P2|Overall Study|Not Specified|11
346216|NCT00494091|1127323|P1|Overall Study|Not Specified|1
346217|NCT00494091|1127322|P2|Overall Study|Lost to Follow-up|4
346218|NCT00494091|1127323|P1|Overall Study|Lost to Follow-up|0
346219|NCT00494091|1127322|P2|Overall Study|Death|54
346220|NCT00494091|1127323|P1|Overall Study|Death|5
346221|NCT00494026|1127345|P1|Overall Study|Sponsor Decision|4
346222|NCT00494013|1127355|P2|Overall Study|Sponsor Decision|1
346223|NCT00494013|1127356|P1|Overall Study|Sponsor Decision|0
346224|NCT00494013|1127355|P2|Overall Study|Withdrawal by Subject|14
346225|NCT00494013|1127356|P1|Overall Study|Withdrawal by Subject|13
346226|NCT00494013|1127355|P2|Overall Study|Protocol Violation|5
346227|NCT00494013|1127356|P1|Overall Study|Protocol Violation|8
346228|NCT00494013|1127355|P2|Overall Study|Physician Decision|5
346229|NCT00494013|1127356|P1|Overall Study|Physician Decision|3
346230|NCT00494013|1127355|P2|Overall Study|Lost to Follow-up|6
346231|NCT00494013|1127356|P1|Overall Study|Lost to Follow-up|5
346232|NCT00494013|1127355|P2|Overall Study|Entry Criteria Not Met|4
346233|NCT00494013|1127356|P1|Overall Study|Entry Criteria Not Met|1
346234|NCT00494013|1127355|P2|Overall Study|Adverse Event|1
346235|NCT00494013|1127356|P1|Overall Study|Adverse Event|0
346236|NCT00493974|1127386|P2|Overall Study|Lost to Follow-up|6
346237|NCT00493974|1127387|P1|Overall Study|Lost to Follow-up|4
346238|NCT00493974|1127386|P2|Overall Study|Withdrawal by Subject|6
346239|NCT00493974|1127387|P1|Overall Study|Withdrawal by Subject|8
346240|NCT00493974|1127386|P2|Overall Study|Death|2
346241|NCT00493974|1127387|P1|Overall Study|Death|1
346242|NCT00493779|1127414|P1|Overall Study|Logistical issue at site|1
346243|NCT00493649|1127421|P1|Overall Study|Other|13
346244|NCT00493649|1127421|P1|Overall Study|Lost to Follow-up|1
346245|NCT00493649|1127421|P1|Overall Study|Disease Progression|1
346246|NCT00493649|1127421|P1|Overall Study|Investigator Request|2
346247|NCT00493649|1127421|P1|Overall Study|Patient Request|21
346248|NCT00493649|1127421|P1|Overall Study|Adverse Event|44
346249|NCT00493636|1127434|P2|Overall Study|Mis-randomization|1
346250|NCT00493636|1127435|P1|Overall Study|Mis-randomization|1
346251|NCT00493636|1127434|P2|Overall Study|Disease progression/recurrence/relapse|1
346252|NCT00493636|1127435|P1|Overall Study|Disease progression/recurrence/relapse|0
346253|NCT00493636|1127434|P2|Overall Study|Withdrawal by Subject|0
346254|NCT00493636|1127435|P1|Overall Study|Withdrawal by Subject|1
346255|NCT00493454|1127449|P1|Overall Study|Withdrawal by Subject|1
346256|NCT00493311|1127455|P2|Overall Study|Need for rescue medication|2
346257|NCT00493311|1127456|P1|Overall Study|Need for rescue medication|2
346258|NCT00493285|1127476|P6|Overall Study|Lost to Follow-up|0
346259|NCT00493285|1127477|P5|Overall Study|Lost to Follow-up|1
346260|NCT00493285|1127478|P4|Overall Study|Lost to Follow-up|0
346261|NCT00493285|1127479|P3|Overall Study|Lost to Follow-up|0
346262|NCT00493285|1127480|P2|Overall Study|Lost to Follow-up|0
346263|NCT00493285|1127481|P1|Overall Study|Lost to Follow-up|0
346264|NCT00493246|1127713|P8|Overall Study|Lost to Follow-up|0
346265|NCT00493246|1127714|P7|Overall Study|Lost to Follow-up|1
346266|NCT00493246|1127715|P6|Overall Study|Lost to Follow-up|0
346267|NCT00493246|1127716|P5|Overall Study|Lost to Follow-up|0
346268|NCT00493246|1127717|P4|Overall Study|Lost to Follow-up|0
346269|NCT00493246|1127718|P3|Overall Study|Lost to Follow-up|0
346270|NCT00493246|1127719|P2|Overall Study|Lost to Follow-up|0
346271|NCT00493246|1127720|P1|Overall Study|Lost to Follow-up|0
346272|NCT00493246|1127713|P8|Overall Study|No access to draw blood|0
346273|NCT00493246|1127714|P7|Overall Study|No access to draw blood|0
346274|NCT00493246|1127715|P6|Overall Study|No access to draw blood|1
346275|NCT00493246|1127716|P5|Overall Study|No access to draw blood|0
346276|NCT00493246|1127717|P4|Overall Study|No access to draw blood|0
346277|NCT00493246|1127718|P3|Overall Study|No access to draw blood|0
346278|NCT00493246|1127719|P2|Overall Study|No access to draw blood|0
346279|NCT00493246|1127720|P1|Overall Study|No access to draw blood|0
346280|NCT00493246|1127713|P8|Overall Study|Withdrawal by Subject|0
346281|NCT00493246|1127714|P7|Overall Study|Withdrawal by Subject|0
346282|NCT00493246|1127715|P6|Overall Study|Withdrawal by Subject|0
346283|NCT00493246|1127716|P5|Overall Study|Withdrawal by Subject|1
346284|NCT00493246|1127717|P4|Overall Study|Withdrawal by Subject|0
346285|NCT00493246|1127718|P3|Overall Study|Withdrawal by Subject|0
346286|NCT00493246|1127719|P2|Overall Study|Withdrawal by Subject|0
346287|NCT00493246|1127720|P1|Overall Study|Withdrawal by Subject|0
346288|NCT00493220|1127784|P6|Third Intervention|Withdrawal by Subject|0
346289|NCT00493220|1127785|P5|Third Intervention|Withdrawal by Subject|0
346290|NCT00493220|1127786|P4|Third Intervention|Withdrawal by Subject|0
346291|NCT00493220|1127787|P3|Third Intervention|Withdrawal by Subject|0
346292|NCT00493220|1127788|P2|Third Intervention|Withdrawal by Subject|0
346293|NCT00493220|1127789|P1|Third Intervention|Withdrawal by Subject|1
346294|NCT00493038|1127812|P2|Follow-up|Lost to Follow-up|0
346295|NCT00493038|1127813|P1|Follow-up|Lost to Follow-up|1
346296|NCT00493038|1127812|P2|Treatment|Other|1
346297|NCT00493038|1127813|P1|Treatment|Other|0
346298|NCT00493038|1127812|P2|Treatment|Withdrawal by Subject|12
346299|NCT00493038|1127813|P1|Treatment|Withdrawal by Subject|11
346300|NCT00493038|1127812|P2|Treatment|Lost to Follow-up|3
346301|NCT00493038|1127813|P1|Treatment|Lost to Follow-up|5
346302|NCT00493038|1127812|P2|Treatment|Adverse Event|4
346303|NCT00493038|1127813|P1|Treatment|Adverse Event|8
346304|NCT00493012|1127829|P2|Overall Study|Lost to Follow-up|17
346305|NCT00493012|1127830|P1|Overall Study|Lost to Follow-up|18
346306|NCT00492856|1127873|P4|Post-consolidation|Observation Arm|0
346307|NCT00492856|1127874|P3|Post-consolidation|Observation Arm|27
346308|NCT00492856|1127875|P2|Post-consolidation|Observation Arm|0
346309|NCT00492856|1127876|P1|Post-consolidation|Observation Arm|0
346310|NCT00492856|1127873|P4|Post-consolidation|Lost to Follow-up|0
346311|NCT00492856|1127874|P3|Post-consolidation|Lost to Follow-up|0
346312|NCT00492856|1127875|P2|Post-consolidation|Lost to Follow-up|2
346313|NCT00492856|1127876|P1|Post-consolidation|Lost to Follow-up|0
346314|NCT00492856|1127873|P4|Post-consolidation|Not protocol specified|0
346315|NCT00492856|1127874|P3|Post-consolidation|Not protocol specified|0
346316|NCT00492856|1127875|P2|Post-consolidation|Not protocol specified|1
346317|NCT00492856|1127876|P1|Post-consolidation|Not protocol specified|0
346318|NCT00492856|1127873|P4|Post-consolidation|Death|0
346319|NCT00492856|1127874|P3|Post-consolidation|Death|0
346320|NCT00492856|1127875|P2|Post-consolidation|Death|1
346321|NCT00492856|1127876|P1|Post-consolidation|Death|0
346322|NCT00492856|1127873|P4|Post-consolidation|Withdrawal by Subject|0
346323|NCT00492856|1127874|P3|Post-consolidation|Withdrawal by Subject|0
346324|NCT00492856|1127875|P2|Post-consolidation|Withdrawal by Subject|4
346325|NCT00492856|1127876|P1|Post-consolidation|Withdrawal by Subject|0
346326|NCT00492856|1127873|P4|Post-consolidation|Adverse Event|1
346327|NCT00492856|1127874|P3|Post-consolidation|Adverse Event|0
346328|NCT00492856|1127875|P2|Post-consolidation|Adverse Event|4
346329|NCT00492856|1127876|P1|Post-consolidation|Adverse Event|0
346330|NCT00492856|1127873|P4|Consolidation|Lost to Follow-up|0
346331|NCT00492856|1127874|P3|Consolidation|Lost to Follow-up|0
346332|NCT00492856|1127875|P2|Consolidation|Lost to Follow-up|0
346333|NCT00492856|1127876|P1|Consolidation|Lost to Follow-up|1
346334|NCT00492856|1127873|P4|Consolidation|Not protocol specified|0
346335|NCT00492856|1127874|P3|Consolidation|Not protocol specified|0
346336|NCT00492856|1127875|P2|Consolidation|Not protocol specified|0
346337|NCT00492856|1127876|P1|Consolidation|Not protocol specified|2
346338|NCT00492856|1127873|P4|Consolidation|Adverse Event|0
346339|NCT00492856|1127874|P3|Consolidation|Adverse Event|0
346340|NCT00492856|1127875|P2|Consolidation|Adverse Event|0
346341|NCT00492856|1127876|P1|Consolidation|Adverse Event|6
346342|NCT00492856|1127873|P4|Induction|Death|0
346343|NCT00492856|1127874|P3|Induction|Death|0
346344|NCT00492856|1127875|P2|Induction|Death|0
346345|NCT00492856|1127876|P1|Induction|Death|3
346346|NCT00492856|1127873|P4|Induction|Withdrawal by Subject|0
346347|NCT00492856|1127874|P3|Induction|Withdrawal by Subject|0
346348|NCT00492856|1127875|P2|Induction|Withdrawal by Subject|0
346349|NCT00492856|1127876|P1|Induction|Withdrawal by Subject|1
346350|NCT00492856|1127873|P4|Induction|Adverse Event|0
346351|NCT00492856|1127874|P3|Induction|Adverse Event|0
346352|NCT00492856|1127875|P2|Induction|Adverse Event|0
346353|NCT00492856|1127876|P1|Induction|Adverse Event|2
346354|NCT00492752|1127890|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
346355|NCT00492752|1127891|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
346356|NCT00492752|1127892|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
346357|NCT00492752|1127893|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
346358|NCT00492752|1127890|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
346359|NCT00492752|1127891|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
346360|NCT00492752|1127892|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
346361|NCT00492752|1127893|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
346362|NCT00492752|1127890|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
346363|NCT00492752|1127891|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
346364|NCT00492752|1127892|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
346365|NCT00492752|1127893|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
346366|NCT00492752|1127890|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
346367|NCT00492752|1127891|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
346368|NCT00492752|1127892|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
346369|NCT00492752|1127893|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
346370|NCT00492752|1127890|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
346371|NCT00492752|1127891|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
346372|NCT00492752|1127892|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
346373|NCT00492752|1127893|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
346374|NCT00492752|1127890|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
346375|NCT00492752|1127891|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
346376|NCT00492752|1127892|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
346377|NCT00492752|1127893|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
346378|NCT00492752|1127890|P4|Follow-up and/or Open Label Sorafenib|Death|1
346379|NCT00492752|1127891|P3|Follow-up and/or Open Label Sorafenib|Death|45
346380|NCT00492752|1127892|P2|Follow-up and/or Open Label Sorafenib|Death|5
346381|NCT00492752|1127893|P1|Follow-up and/or Open Label Sorafenib|Death|75
346382|NCT00492752|1127890|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
346383|NCT00492752|1127891|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
346384|NCT00492752|1127892|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
346385|NCT00492752|1127893|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
346386|NCT00492752|1127890|P4|Double Blind Treatment|Protocol Violation|0
346387|NCT00492752|1127891|P3|Double Blind Treatment|Protocol Violation|1
346388|NCT00492752|1127892|P2|Double Blind Treatment|Protocol Violation|0
346389|NCT00492752|1127893|P1|Double Blind Treatment|Protocol Violation|0
346390|NCT00492752|1127890|P4|Double Blind Treatment|Adverse Event|0
346391|NCT00492752|1127891|P3|Double Blind Treatment|Adverse Event|0
346392|NCT00492752|1127892|P2|Double Blind Treatment|Adverse Event|0
346393|NCT00492752|1127893|P1|Double Blind Treatment|Adverse Event|1
346394|NCT00492752|1127890|P4|Double Blind Treatment|Death|0
346395|NCT00492752|1127891|P3|Double Blind Treatment|Death|2
346396|NCT00492752|1127892|P2|Double Blind Treatment|Death|0
346397|NCT00492752|1127893|P1|Double Blind Treatment|Death|13
346398|NCT00492726|1127928|P2|Overall Study|Non compliant with study medication|3
346399|NCT00492726|1127929|P1|Overall Study|Non compliant with study medication|0
346400|NCT00492726|1127928|P2|Overall Study|Withdrawal by Subject|3
346401|NCT00492726|1127929|P1|Overall Study|Withdrawal by Subject|6
346402|NCT00492726|1127928|P2|Overall Study|Physician Decision|1
346403|NCT00492726|1127929|P1|Overall Study|Physician Decision|0
346404|NCT00492726|1127928|P2|Overall Study|Lost to Follow-up|19
346405|NCT00492726|1127929|P1|Overall Study|Lost to Follow-up|27
346406|NCT00492726|1127928|P2|Overall Study|Lack of Efficacy|2
346407|NCT00492726|1127929|P1|Overall Study|Lack of Efficacy|0
346408|NCT00492726|1127928|P2|Overall Study|Death|2
346409|NCT00492726|1127929|P1|Overall Study|Death|7
346410|NCT00492726|1127928|P2|Overall Study|Adverse Event|6
346411|NCT00492726|1127929|P1|Overall Study|Adverse Event|10
346412|NCT00492557|1127964|P2|Overall Study|Lost to Follow-up|1
346413|NCT00492557|1127965|P1|Overall Study|Lost to Follow-up|0
346414|NCT00492557|1127964|P2|Overall Study|Failed to return|0
346415|NCT00492557|1127965|P1|Overall Study|Failed to return|1
346416|NCT00492557|1127964|P2|Overall Study|Adverse Event|0
346417|NCT00492557|1127965|P1|Overall Study|Adverse Event|1
346418|NCT00492557|1127964|P2|Overall Study|Death|1
346419|NCT00492557|1127965|P1|Overall Study|Death|1
346420|NCT00492557|1127964|P2|Overall Study|Unspecified|2
346421|NCT00492557|1127965|P1|Overall Study|Unspecified|2
346422|NCT00492557|1127964|P2|Overall Study|Protocol Violation|8
346423|NCT00492557|1127965|P1|Overall Study|Protocol Violation|7
346424|NCT00492557|1127964|P2|Overall Study|Subject request|11
346425|NCT00492557|1127965|P1|Overall Study|Subject request|12
346426|NCT00492531|1127995|P2|Overall Study|Withdrawn(More than one reason selected)|23
346427|NCT00492531|1127996|P1|Overall Study|Withdrawn(More than one reason selected)|22
346428|NCT00492297|1128026|P1|Survival Only Follow-up|Study terminated by sponsor|12
346429|NCT00492297|1128026|P1|Survival Only Follow-up|Lack of Efficacy|1
346430|NCT00492297|1128026|P1|Survival Only Follow-up|Death|46
346431|NCT00492297|1128026|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
346432|NCT00492297|1128026|P1|Active Follow-up 30(+4) Days Duration|Death|17
346433|NCT00492297|1128026|P1|Treatment|Study terminated by sponsor|3
346434|NCT00492297|1128026|P1|Treatment|Death|2
346435|NCT00492284|1128044|P4|Overall Study|Withdrawal by Subject|2
346436|NCT00492284|1128045|P3|Overall Study|Withdrawal by Subject|0
346437|NCT00492284|1128046|P2|Overall Study|Withdrawal by Subject|0
346438|NCT00492284|1128047|P1|Overall Study|Withdrawal by Subject|1
346439|NCT00492284|1128044|P4|Overall Study|Death|5
346440|NCT00492284|1128045|P3|Overall Study|Death|2
346441|NCT00492284|1128046|P2|Overall Study|Death|3
346442|NCT00492284|1128047|P1|Overall Study|Death|0
346443|NCT00492284|1128044|P4|Overall Study|Lost to Follow-up|1
346444|NCT00492284|1128045|P3|Overall Study|Lost to Follow-up|3
346445|NCT00492284|1128046|P2|Overall Study|Lost to Follow-up|0
346446|NCT00492284|1128047|P1|Overall Study|Lost to Follow-up|0
346447|NCT00492284|1128044|P4|Overall Study|Adverse Event|2
346448|NCT00492284|1128045|P3|Overall Study|Adverse Event|1
346449|NCT00492284|1128046|P2|Overall Study|Adverse Event|1
346450|NCT00492284|1128047|P1|Overall Study|Adverse Event|0
346451|NCT00492232|1128091|P2|Open-Label Treatment|Withdrawal by Subject|0
346452|NCT00492232|1128092|P1|Open-Label Treatment|Withdrawal by Subject|1
346453|NCT00492232|1128091|P2|Double-Blind Treatment|Randomized not treated|0
346454|NCT00492232|1128092|P1|Double-Blind Treatment|Randomized not treated|1
346455|NCT00492232|1128091|P2|Double-Blind Treatment|Other|5
346456|NCT00492232|1128092|P1|Double-Blind Treatment|Other|6
346457|NCT00492232|1128091|P2|Double-Blind Treatment|Lack of Efficacy|0
346458|NCT00492232|1128092|P1|Double-Blind Treatment|Lack of Efficacy|1
346459|NCT00492232|1128091|P2|Double-Blind Treatment|Withdrawal by Subject|8
346460|NCT00492232|1128092|P1|Double-Blind Treatment|Withdrawal by Subject|4
346461|NCT00492232|1128091|P2|Double-Blind Treatment|Lost to Follow-up|3
346462|NCT00492232|1128092|P1|Double-Blind Treatment|Lost to Follow-up|2
346463|NCT00492232|1128091|P2|Double-Blind Treatment|Protocol Violation|7
346464|NCT00492232|1128092|P1|Double-Blind Treatment|Protocol Violation|3
346465|NCT00492232|1128091|P2|Double-Blind Treatment|Adverse Event|2
346466|NCT00492232|1128092|P1|Double-Blind Treatment|Adverse Event|1
346467|NCT00492232|1128091|P2|Placebo Run-in|Missing|2
346468|NCT00492232|1128092|P1|Placebo Run-in|Missing|0
346469|NCT00492232|1128091|P2|Placebo Run-in|Other|6
346470|NCT00492232|1128092|P1|Placebo Run-in|Other|0
346471|NCT00492232|1128091|P2|Placebo Run-in|Entrance criteria not met|45
346472|NCT00492232|1128092|P1|Placebo Run-in|Entrance criteria not met|0
346473|NCT00492232|1128091|P2|Placebo Run-in|Pregnancy|1
346474|NCT00492232|1128092|P1|Placebo Run-in|Pregnancy|0
346475|NCT00492232|1128091|P2|Placebo Run-in|Withdrawal by Subject|8
346476|NCT00492232|1128092|P1|Placebo Run-in|Withdrawal by Subject|0
346477|NCT00492232|1128091|P2|Placebo Run-in|Lost to Follow-up|3
346478|NCT00492232|1128092|P1|Placebo Run-in|Lost to Follow-up|0
346479|NCT00492232|1128091|P2|Placebo Run-in|Protocol Violation|3
346480|NCT00492232|1128092|P1|Placebo Run-in|Protocol Violation|0
346481|NCT00492232|1128091|P2|Placebo Run-in|Adverse Event|2
346482|NCT00492232|1128092|P1|Placebo Run-in|Adverse Event|0
346483|NCT00492063|1128144|P4|Overall Study|Protocol Violation|1
346484|NCT00492063|1128145|P3|Overall Study|Protocol Violation|0
346485|NCT00492063|1128146|P2|Overall Study|Protocol Violation|0
346486|NCT00492063|1128147|P1|Overall Study|Protocol Violation|0
346487|NCT00492063|1128144|P4|Overall Study|Lost to Follow-up|3
346488|NCT00492063|1128145|P3|Overall Study|Lost to Follow-up|5
346489|NCT00492063|1128146|P2|Overall Study|Lost to Follow-up|11
346490|NCT00492063|1128147|P1|Overall Study|Lost to Follow-up|6
346491|NCT00492063|1128144|P4|Overall Study|Withdrawal by Subject|4
346492|NCT00492063|1128145|P3|Overall Study|Withdrawal by Subject|5
346493|NCT00492063|1128146|P2|Overall Study|Withdrawal by Subject|3
346494|NCT00492063|1128147|P1|Overall Study|Withdrawal by Subject|4
346495|NCT00492063|1128144|P4|Overall Study|Death|2
346496|NCT00492063|1128145|P3|Overall Study|Death|1
346497|NCT00492063|1128146|P2|Overall Study|Death|0
346498|NCT00492063|1128147|P1|Overall Study|Death|0
346499|NCT00492024|1128171|P2|Follow up|Lost to Follow-up|1
346500|NCT00492024|1128172|P1|Follow up|Lost to Follow-up|1
346501|NCT00492024|1128171|P2|Follow up|Lack of Efficacy|1
346502|NCT00492024|1128172|P1|Follow up|Lack of Efficacy|0
346503|NCT00492024|1128171|P2|Treatment|Withdrawal by Subject|0
346504|NCT00492024|1128172|P1|Treatment|Withdrawal by Subject|2
346505|NCT00492024|1128171|P2|Treatment|Lost to Follow-up|1
346506|NCT00492024|1128172|P1|Treatment|Lost to Follow-up|3
346507|NCT00492024|1128171|P2|Treatment|Lack of Efficacy|20
346508|NCT00492024|1128172|P1|Treatment|Lack of Efficacy|21
346509|NCT00492024|1128171|P2|Treatment|Adverse Event|1
346510|NCT00492024|1128172|P1|Treatment|Adverse Event|3
346511|NCT00491894|1128188|P1|Overall Study|Other-Intake of prohibited medication|1
346512|NCT00491894|1128188|P1|Overall Study|Protocol Violation|2
346513|NCT00491894|1128188|P1|Overall Study|Physician Decision|2
346514|NCT00491894|1128188|P1|Overall Study|Other-Failed to meet any criteria|2
346515|NCT00491894|1128188|P1|Overall Study|Lack of Efficacy|2
346516|NCT00491894|1128188|P1|Overall Study|Lost to Follow-up|3
346517|NCT00491894|1128188|P1|Overall Study|Death|3
346518|NCT00491894|1128188|P1|Overall Study|Withdrawal by Subject|5
346519|NCT00491894|1128188|P1|Overall Study|Adverse Event|14
346520|NCT00491764|1128215|P6|Overall Study|Administrative|0
346521|NCT00491764|1128216|P5|Overall Study|Administrative|0
346522|NCT00491764|1128217|P4|Overall Study|Administrative|1
346523|NCT00491764|1128218|P3|Overall Study|Administrative|2
346524|NCT00491764|1128219|P2|Overall Study|Administrative|0
346525|NCT00491764|1128220|P1|Overall Study|Administrative|1
346526|NCT00491764|1128215|P6|Overall Study|Did not Meet Protocol Eligibility|1
346527|NCT00491764|1128216|P5|Overall Study|Did not Meet Protocol Eligibility|1
346528|NCT00491764|1128217|P4|Overall Study|Did not Meet Protocol Eligibility|0
346529|NCT00491764|1128218|P3|Overall Study|Did not Meet Protocol Eligibility|1
346530|NCT00491764|1128219|P2|Overall Study|Did not Meet Protocol Eligibility|1
346531|NCT00491764|1128220|P1|Overall Study|Did not Meet Protocol Eligibility|0
346532|NCT00491764|1128215|P6|Overall Study|Non Compliance with the Protocol|0
346533|NCT00491764|1128216|P5|Overall Study|Non Compliance with the Protocol|0
346534|NCT00491764|1128217|P4|Overall Study|Non Compliance with the Protocol|0
346535|NCT00491764|1128218|P3|Overall Study|Non Compliance with the Protocol|0
346536|NCT00491764|1128219|P2|Overall Study|Non Compliance with the Protocol|0
346537|NCT00491764|1128220|P1|Overall Study|Non Compliance with the Protocol|1
346538|NCT00491764|1128215|P6|Overall Study|Withdrawal by Subject|4
346539|NCT00491764|1128216|P5|Overall Study|Withdrawal by Subject|2
346540|NCT00491764|1128217|P4|Overall Study|Withdrawal by Subject|2
346541|NCT00491764|1128218|P3|Overall Study|Withdrawal by Subject|1
346542|NCT00491764|1128219|P2|Overall Study|Withdrawal by Subject|3
346543|NCT00491764|1128220|P1|Overall Study|Withdrawal by Subject|2
346544|NCT00491764|1128215|P6|Overall Study|Lost to Follow-up|3
346545|NCT00491764|1128216|P5|Overall Study|Lost to Follow-up|0
346546|NCT00491764|1128217|P4|Overall Study|Lost to Follow-up|1
346547|NCT00491764|1128218|P3|Overall Study|Lost to Follow-up|0
346548|NCT00491764|1128219|P2|Overall Study|Lost to Follow-up|1
346549|NCT00491764|1128220|P1|Overall Study|Lost to Follow-up|0
346550|NCT00491764|1128215|P6|Overall Study|Adverse Event|1
346551|NCT00491764|1128216|P5|Overall Study|Adverse Event|0
346552|NCT00491764|1128217|P4|Overall Study|Adverse Event|4
346553|NCT00491764|1128218|P3|Overall Study|Adverse Event|4
346554|NCT00491764|1128219|P2|Overall Study|Adverse Event|2
346555|NCT00491764|1128220|P1|Overall Study|Adverse Event|1
346556|NCT00491608|1128253|P1|Overall Study|Withdrawal by Subject|1
346557|NCT00491608|1128253|P1|Overall Study|Death|2
346558|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
346559|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
346560|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
346561|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
346562|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
346563|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
346564|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
346565|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
346566|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
346567|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
346568|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
346569|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
346570|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
346571|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
346572|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
346573|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
346574|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
346575|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
346576|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
346577|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
346578|NCT00491556|1128264|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
346579|NCT00491556|1128265|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
346580|NCT00491556|1128264|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
346581|NCT00491556|1128265|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
346582|NCT00491556|1128264|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
346583|NCT00491556|1128265|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
346584|NCT00491556|1128264|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
346585|NCT00491556|1128265|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
346586|NCT00491556|1128264|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
346587|NCT00491556|1128265|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
346588|NCT00491556|1128264|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
346589|NCT00491556|1128265|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
346590|NCT00491556|1128264|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
346591|NCT00491556|1128265|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
346592|NCT00491556|1128264|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
346593|NCT00491556|1128265|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
346594|NCT00491556|1128264|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
346595|NCT00491556|1128265|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
346596|NCT00491556|1128264|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
346597|NCT00491556|1128265|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
346598|NCT00491530|1128324|P3|Overall Study|Use of Prohibited Medication|1
346599|NCT00491530|1128325|P2|Overall Study|Use of Prohibited Medication|0
346600|NCT00491530|1128326|P1|Overall Study|Use of Prohibited Medication|0
346601|NCT00491530|1128324|P3|Overall Study|Patient Request|0
346602|NCT00491530|1128325|P2|Overall Study|Patient Request|1
346603|NCT00491530|1128326|P1|Overall Study|Patient Request|0
346604|NCT00491530|1128324|P3|Overall Study|Investigator Discretion|0
346605|NCT00491530|1128325|P2|Overall Study|Investigator Discretion|1
346606|NCT00491530|1128326|P1|Overall Study|Investigator Discretion|0
346607|NCT00491530|1128324|P3|Overall Study|Lack of Efficacy|0
346608|NCT00491530|1128325|P2|Overall Study|Lack of Efficacy|1
346609|NCT00491530|1128326|P1|Overall Study|Lack of Efficacy|0
346610|NCT00491530|1128324|P3|Overall Study|Lost to Follow-up|2
346611|NCT00491530|1128325|P2|Overall Study|Lost to Follow-up|2
346612|NCT00491530|1128326|P1|Overall Study|Lost to Follow-up|3
346613|NCT00491530|1128324|P3|Overall Study|Withdrawal by Subject|0
346614|NCT00491530|1128325|P2|Overall Study|Withdrawal by Subject|0
346615|NCT00491530|1128326|P1|Overall Study|Withdrawal by Subject|3
346616|NCT00491530|1128324|P3|Overall Study|Adverse Event|2
346617|NCT00491530|1128325|P2|Overall Study|Adverse Event|1
346618|NCT00491530|1128326|P1|Overall Study|Adverse Event|6
346619|NCT00491504|1128356|P4|Overall Study|Protocol Violation|2
346620|NCT00491504|1128357|P3|Overall Study|Protocol Violation|3
346621|NCT00491504|1128358|P2|Overall Study|Protocol Violation|0
346622|NCT00491504|1128359|P1|Overall Study|Protocol Violation|0
346623|NCT00491504|1128356|P4|Overall Study|Withdrawal by Subject|2
346624|NCT00491504|1128357|P3|Overall Study|Withdrawal by Subject|1
346625|NCT00491504|1128358|P2|Overall Study|Withdrawal by Subject|0
346626|NCT00491504|1128359|P1|Overall Study|Withdrawal by Subject|0
346627|NCT00491504|1128356|P4|Overall Study|Adverse Event|0
346628|NCT00491504|1128357|P3|Overall Study|Adverse Event|0
346629|NCT00491504|1128358|P2|Overall Study|Adverse Event|1
346630|NCT00491504|1128359|P1|Overall Study|Adverse Event|0
346631|NCT00491400|1128369|P2|Overall Study|Withdrawal by Subject|4
346632|NCT00491400|1128370|P1|Overall Study|Withdrawal by Subject|5
346633|NCT00491179|1128404|P2|Overall Study|Withdrawal by Subject|1
346634|NCT00491179|1128405|P1|Overall Study|Withdrawal by Subject|2
346635|NCT00491179|1128404|P2|Overall Study|Adverse Event|1
346636|NCT00491179|1128405|P1|Overall Study|Adverse Event|5
346637|NCT00491075|1128413|P1|Overall Study|Physician Decision|1
346638|NCT00491075|1128413|P1|Overall Study|Withdrawal by Subject|1
346639|NCT00490971|1128419|P5|Maintenance|Not specified|3
346640|NCT00490971|1128420|P4|Maintenance|Not specified|9
346641|NCT00490971|1128421|P3|Maintenance|Not specified|11
346642|NCT00490971|1128422|P2|Maintenance|Not specified|0
346643|NCT00490971|1128423|P1|Maintenance|Not specified|0
346644|NCT00490971|1128419|P5|Maintenance|Withdrawal by Subject|18
346645|NCT00490971|1128420|P4|Maintenance|Withdrawal by Subject|28
346646|NCT00490971|1128421|P3|Maintenance|Withdrawal by Subject|26
346647|NCT00490971|1128422|P2|Maintenance|Withdrawal by Subject|0
346648|NCT00490971|1128423|P1|Maintenance|Withdrawal by Subject|0
346649|NCT00490971|1128419|P5|Maintenance|Protocol Violation|1
346650|NCT00490971|1128420|P4|Maintenance|Protocol Violation|1
346651|NCT00490971|1128421|P3|Maintenance|Protocol Violation|4
346652|NCT00490971|1128422|P2|Maintenance|Protocol Violation|0
346653|NCT00490971|1128423|P1|Maintenance|Protocol Violation|0
346654|NCT00490971|1128419|P5|Maintenance|Pregnancy|0
346655|NCT00490971|1128420|P4|Maintenance|Pregnancy|0
346656|NCT00490971|1128421|P3|Maintenance|Pregnancy|1
346657|NCT00490971|1128422|P2|Maintenance|Pregnancy|0
346658|NCT00490971|1128423|P1|Maintenance|Pregnancy|0
346659|NCT00490971|1128419|P5|Maintenance|Lost to Follow-up|10
346660|NCT00490971|1128420|P4|Maintenance|Lost to Follow-up|8
346661|NCT00490971|1128421|P3|Maintenance|Lost to Follow-up|5
346662|NCT00490971|1128422|P2|Maintenance|Lost to Follow-up|0
346663|NCT00490971|1128423|P1|Maintenance|Lost to Follow-up|0
346664|NCT00490971|1128419|P5|Maintenance|Death|0
346665|NCT00490971|1128420|P4|Maintenance|Death|2
346666|NCT00490971|1128421|P3|Maintenance|Death|0
346667|NCT00490971|1128422|P2|Maintenance|Death|0
346668|NCT00490971|1128423|P1|Maintenance|Death|0
346669|NCT00490971|1128419|P5|Maintenance|Adverse Event|7
346670|NCT00490971|1128420|P4|Maintenance|Adverse Event|5
346671|NCT00490971|1128421|P3|Maintenance|Adverse Event|4
346672|NCT00490971|1128422|P2|Maintenance|Adverse Event|0
346673|NCT00490971|1128423|P1|Maintenance|Adverse Event|0
346674|NCT00490971|1128419|P5|Acute/Continuation|Not specified|0
346675|NCT00490971|1128420|P4|Acute/Continuation|Not specified|0
346676|NCT00490971|1128421|P3|Acute/Continuation|Not specified|0
346677|NCT00490971|1128422|P2|Acute/Continuation|Not specified|4
346678|NCT00490971|1128423|P1|Acute/Continuation|Not specified|11
346679|NCT00490971|1128419|P5|Acute/Continuation|Withdrawal by Subject|0
346680|NCT00490971|1128420|P4|Acute/Continuation|Withdrawal by Subject|0
346681|NCT00490971|1128421|P3|Acute/Continuation|Withdrawal by Subject|0
346682|NCT00490971|1128422|P2|Acute/Continuation|Withdrawal by Subject|24
346683|NCT00490971|1128423|P1|Acute/Continuation|Withdrawal by Subject|92
346684|NCT00490971|1128419|P5|Acute/Continuation|Protocol Violation|0
346685|NCT00490971|1128420|P4|Acute/Continuation|Protocol Violation|0
346686|NCT00490971|1128421|P3|Acute/Continuation|Protocol Violation|0
346687|NCT00490971|1128422|P2|Acute/Continuation|Protocol Violation|2
346688|NCT00490971|1128423|P1|Acute/Continuation|Protocol Violation|10
346689|NCT00490971|1128419|P5|Acute/Continuation|Lost to Follow-up|0
346690|NCT00490971|1128420|P4|Acute/Continuation|Lost to Follow-up|0
346691|NCT00490971|1128421|P3|Acute/Continuation|Lost to Follow-up|0
346692|NCT00490971|1128422|P2|Acute/Continuation|Lost to Follow-up|7
346693|NCT00490971|1128423|P1|Acute/Continuation|Lost to Follow-up|23
346694|NCT00490971|1128419|P5|Acute/Continuation|Lack of Efficacy|0
346695|NCT00490971|1128420|P4|Acute/Continuation|Lack of Efficacy|0
346696|NCT00490971|1128421|P3|Acute/Continuation|Lack of Efficacy|0
346697|NCT00490971|1128422|P2|Acute/Continuation|Lack of Efficacy|12
346698|NCT00490971|1128423|P1|Acute/Continuation|Lack of Efficacy|106
346699|NCT00490971|1128419|P5|Acute/Continuation|Death|0
346700|NCT00490971|1128420|P4|Acute/Continuation|Death|0
346701|NCT00490971|1128421|P3|Acute/Continuation|Death|0
346702|NCT00490971|1128422|P2|Acute/Continuation|Death|0
346703|NCT00490971|1128423|P1|Acute/Continuation|Death|2
346704|NCT00490971|1128419|P5|Acute/Continuation|Adverse Event|0
346705|NCT00490971|1128420|P4|Acute/Continuation|Adverse Event|0
346706|NCT00490971|1128421|P3|Acute/Continuation|Adverse Event|0
346707|NCT00490971|1128422|P2|Acute/Continuation|Adverse Event|13
346708|NCT00490971|1128423|P1|Acute/Continuation|Adverse Event|62
346709|NCT00490945|1128470|P5|Overall Study|Adverse Event|0
346710|NCT00490945|1128471|P4|Overall Study|Adverse Event|0
346711|NCT00490945|1128472|P3|Overall Study|Adverse Event|0
346712|NCT00490945|1128473|P2|Overall Study|Adverse Event|1
346713|NCT00490945|1128474|P1|Overall Study|Adverse Event|0
346714|NCT00490919|1128510|P3|Double-blind Phase|Administrative|6
346715|NCT00490919|1128511|P2|Double-blind Phase|Administrative|6
346716|NCT00490919|1128512|P1|Double-blind Phase|Administrative|0
346717|NCT00490919|1128510|P3|Double-blind Phase|Lack of Efficacy|36
346718|NCT00490919|1128511|P2|Double-blind Phase|Lack of Efficacy|22
346719|NCT00490919|1128512|P1|Double-blind Phase|Lack of Efficacy|0
346720|NCT00490919|1128510|P3|Double-blind Phase|Lost to Follow-up|11
346721|NCT00490919|1128511|P2|Double-blind Phase|Lost to Follow-up|8
346722|NCT00490919|1128512|P1|Double-blind Phase|Lost to Follow-up|0
346723|NCT00490919|1128510|P3|Double-blind Phase|Withdrawal by Subject|11
346724|NCT00490919|1128511|P2|Double-blind Phase|Withdrawal by Subject|10
346725|NCT00490919|1128512|P1|Double-blind Phase|Withdrawal by Subject|0
346726|NCT00490919|1128510|P3|Double-blind Phase|Adverse Event|20
346727|NCT00490919|1128511|P2|Double-blind Phase|Adverse Event|40
346728|NCT00490919|1128512|P1|Double-blind Phase|Adverse Event|0
346729|NCT00490919|1128510|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
346730|NCT00490919|1128511|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
346731|NCT00490919|1128512|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
346732|NCT00490919|1128510|P3|Open-label Run-in Period|Administrative|0
346733|NCT00490919|1128511|P2|Open-label Run-in Period|Administrative|0
346734|NCT00490919|1128512|P1|Open-label Run-in Period|Administrative|40
346735|NCT00490919|1128510|P3|Open-label Run-in Period|Lack of Efficacy|0
346736|NCT00490919|1128511|P2|Open-label Run-in Period|Lack of Efficacy|0
346737|NCT00490919|1128512|P1|Open-label Run-in Period|Lack of Efficacy|143
346738|NCT00490919|1128510|P3|Open-label Run-in Period|Lost to Follow-up|0
346739|NCT00490919|1128511|P2|Open-label Run-in Period|Lost to Follow-up|0
346740|NCT00490919|1128512|P1|Open-label Run-in Period|Lost to Follow-up|21
346741|NCT00490919|1128510|P3|Open-label Run-in Period|Withdrawal by Subject|0
346742|NCT00490919|1128511|P2|Open-label Run-in Period|Withdrawal by Subject|0
346743|NCT00490919|1128512|P1|Open-label Run-in Period|Withdrawal by Subject|37
346744|NCT00490919|1128510|P3|Open-label Run-in Period|Adverse Event|0
346745|NCT00490919|1128511|P2|Open-label Run-in Period|Adverse Event|0
346746|NCT00490919|1128512|P1|Open-label Run-in Period|Adverse Event|239
346747|NCT00490841|1128523|P1|Overall Study|30 day f/u, only non-study stent used|3
346748|NCT00490841|1128523|P1|Overall Study|Lost to Follow-up|1
346749|NCT00490841|1128523|P1|Overall Study|Withdrawal by Subject|4
346750|NCT00490841|1128523|P1|Overall Study|Death|5
346751|NCT00490815|1128545|P2|Overall Study|Death|3
346752|NCT00490815|1128546|P1|Overall Study|Death|1
346753|NCT00490815|1128545|P2|Overall Study|Lost to Follow-up|3
346754|NCT00490815|1128546|P1|Overall Study|Lost to Follow-up|1
346755|NCT00490815|1128545|P2|Overall Study|Withdrawal by Subject|0
346756|NCT00490815|1128546|P1|Overall Study|Withdrawal by Subject|4
346757|NCT00490815|1128545|P2|Overall Study|Adverse Event|3
346758|NCT00490815|1128546|P1|Overall Study|Adverse Event|2
346759|NCT00490724|1128574|P3|Period II|Treatment Discontinuation|3
346760|NCT00490724|1128575|P2|Period II|Treatment Discontinuation|1
346761|NCT00490724|1128576|P1|Period II|Treatment Discontinuation|3
346762|NCT00490724|1128574|P3|Period I|Physician Decision|1
346763|NCT00490724|1128575|P2|Period I|Physician Decision|0
346764|NCT00490724|1128576|P1|Period I|Physician Decision|0
346765|NCT00490698|1128641|P1|Overall Study|Physician Decision|2
346766|NCT00490698|1128641|P1|Overall Study|Disease Progression|7
346767|NCT00490698|1128641|P1|Overall Study|Withdrawal by Subject|1
346768|NCT00490646|1128647|P2|Overall Study|Never Treated (withdrew consent)|1
346769|NCT00490646|1128648|P1|Overall Study|Never Treated (withdrew consent)|0
346770|NCT00490646|1128647|P2|Overall Study|Never Treated (had an adverse event)|0
346771|NCT00490646|1128648|P1|Overall Study|Never Treated (had an adverse event)|1
346772|NCT00490646|1128647|P2|Overall Study|Still on trastuzumab monotherapy|1
346773|NCT00490646|1128648|P1|Overall Study|Still on trastuzumab monotherapy|1
346774|NCT00490555|1128672|P4|Overall Study|noncompliant with drug administration|0
346775|NCT00490555|1128673|P3|Overall Study|noncompliant with drug administration|2
346776|NCT00490555|1128674|P2|Overall Study|noncompliant with drug administration|0
346777|NCT00490555|1128675|P1|Overall Study|noncompliant with drug administration|0
346778|NCT00490542|1128703|P2|Overall Study|Lack of Efficacy|1
346779|NCT00490542|1128704|P1|Overall Study|Lack of Efficacy|1
346780|NCT00490542|1128703|P2|Overall Study|Adverse Event|3
346781|NCT00490542|1128704|P1|Overall Study|Adverse Event|3
346782|NCT00490542|1128703|P2|Overall Study|Lost to Follow-up|0
346783|NCT00490542|1128704|P1|Overall Study|Lost to Follow-up|3
346784|NCT00490490|1128710|P1|Completed Assessment for TTP|Lost to Follow-up|2
346785|NCT00490490|1128710|P1|Completed Assessment for TTP|Withdrawal by Subject|1
346786|NCT00490139|1128747|P4|Overall Study|Participant Withdrew Consent|116
346787|NCT00490139|1128748|P3|Overall Study|Participant Withdrew Consent|208
346788|NCT00490139|1128749|P2|Overall Study|Participant Withdrew Consent|110
346789|NCT00490139|1128750|P1|Overall Study|Participant Withdrew Consent|146
346790|NCT00490139|1128747|P4|Overall Study|Lost to Follow-up|56
346791|NCT00490139|1128748|P3|Overall Study|Lost to Follow-up|58
346792|NCT00490139|1128749|P2|Overall Study|Lost to Follow-up|46
346793|NCT00490139|1128750|P1|Overall Study|Lost to Follow-up|56
346794|NCT00490139|1128747|P4|Overall Study|Death|135
346795|NCT00490139|1128748|P3|Overall Study|Death|168
346796|NCT00490139|1128749|P2|Overall Study|Death|119
346797|NCT00490139|1128750|P1|Overall Study|Death|106
346798|NCT00490061|1128785|P1|Overall Study|Physician Decision|1
346799|NCT00490035|1128794|P4|Overall Study|AE of unknown type|0
346800|NCT00490035|1128795|P3|Overall Study|AE of unknown type|2
346801|NCT00490035|1128796|P2|Overall Study|AE of unknown type|0
346802|NCT00490035|1128797|P1|Overall Study|AE of unknown type|0
346803|NCT00490035|1128794|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
346804|NCT00490035|1128795|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
346805|NCT00490035|1128796|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
346806|NCT00490035|1128797|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
346807|NCT00490035|1128794|P4|Overall Study|AE, serious fatal|0
346808|NCT00490035|1128795|P3|Overall Study|AE, serious fatal|0
346809|NCT00490035|1128796|P2|Overall Study|AE, serious fatal|0
346810|NCT00490035|1128797|P1|Overall Study|AE, serious fatal|1
346811|NCT00490035|1128794|P4|Overall Study|Other reason|1
346812|NCT00490035|1128795|P3|Overall Study|Other reason|3
346813|NCT00490035|1128796|P2|Overall Study|Other reason|1
346814|NCT00490035|1128797|P1|Overall Study|Other reason|0
346815|NCT00490035|1128794|P4|Overall Study|Withdrawal by Subject|0
346816|NCT00490035|1128795|P3|Overall Study|Withdrawal by Subject|1
346817|NCT00490035|1128796|P2|Overall Study|Withdrawal by Subject|1
346818|NCT00490035|1128797|P1|Overall Study|Withdrawal by Subject|2
346819|NCT00490035|1128794|P4|Overall Study|Lost to Follow-up|0
346820|NCT00490035|1128795|P3|Overall Study|Lost to Follow-up|1
346821|NCT00490035|1128796|P2|Overall Study|Lost to Follow-up|0
346822|NCT00490035|1128797|P1|Overall Study|Lost to Follow-up|2
346823|NCT00490035|1128794|P4|Overall Study|AE, non-serious non-fatal|5
346824|NCT00490035|1128795|P3|Overall Study|AE, non-serious non-fatal|4
346825|NCT00490035|1128796|P2|Overall Study|AE, non-serious non-fatal|4
346826|NCT00490035|1128797|P1|Overall Study|AE, non-serious non-fatal|3
346827|NCT00490022|1128897|P2|Overall Study|Subject failed to disclose concommitant|1
346828|NCT00490022|1128898|P1|Overall Study|Subject failed to disclose concommitant|0
346829|NCT00490022|1128897|P2|Overall Study|Withdrawal by Subject|0
346830|NCT00490022|1128898|P1|Overall Study|Withdrawal by Subject|1
346831|NCT00490022|1128897|P2|Overall Study|Adverse Event|2
346832|NCT00490022|1128898|P1|Overall Study|Adverse Event|0
346833|NCT00489853|1128956|P3|Treatment Period 3|Study specific discontinuation criteria|0
346834|NCT00489853|1128957|P2|Treatment Period 3|Study specific discontinuation criteria|1
346835|NCT00489853|1128958|P1|Treatment Period 3|Study specific discontinuation criteria|0
346836|NCT00489853|1128956|P3|Wash-out Period 2|Study specific discontinuation criteria|2
346837|NCT00489853|1128957|P2|Wash-out Period 2|Study specific discontinuation criteria|2
346838|NCT00489853|1128958|P1|Wash-out Period 2|Study specific discontinuation criteria|3
346839|NCT00489853|1128956|P3|Wash-out Period 2|Adverse Event|0
346840|NCT00489853|1128957|P2|Wash-out Period 2|Adverse Event|1
346841|NCT00489853|1128958|P1|Wash-out Period 2|Adverse Event|1
346842|NCT00489853|1128956|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
346843|NCT00489853|1128957|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
346844|NCT00489853|1128958|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
346845|NCT00489853|1128956|P3|Wash-out Period 1|Protocol Violation|1
346846|NCT00489853|1128957|P2|Wash-out Period 1|Protocol Violation|1
346847|NCT00489853|1128958|P1|Wash-out Period 1|Protocol Violation|0
346848|NCT00489853|1128956|P3|Wash-out Period 1|Adverse Event|1
346849|NCT00489853|1128957|P2|Wash-out Period 1|Adverse Event|1
346850|NCT00489853|1128958|P1|Wash-out Period 1|Adverse Event|0
346851|NCT00489853|1128956|P3|Wash-out Period 1|Withdrawal by Subject|0
346852|NCT00489853|1128957|P2|Wash-out Period 1|Withdrawal by Subject|0
346853|NCT00489853|1128958|P1|Wash-out Period 1|Withdrawal by Subject|1
346854|NCT00489736|1129055|P2|Overall Study|Not coded/ Not pre-specified|8
346855|NCT00489736|1129056|P1|Overall Study|Not coded/ Not pre-specified|5
346856|NCT00489736|1129055|P2|Overall Study|Poor compliance|2
346857|NCT00489736|1129056|P1|Overall Study|Poor compliance|6
346858|NCT00489736|1129055|P2|Overall Study|Adverse Event|45
346859|NCT00489736|1129056|P1|Overall Study|Adverse Event|32
346860|NCT00489736|1129055|P2|Overall Study|Lack of Efficacy|14
346861|NCT00489736|1129056|P1|Overall Study|Lack of Efficacy|53
346862|NCT00489554|1129066|P1|Overall Study|Lost to Follow-up|1
346863|NCT00489554|1129066|P1|Overall Study|Withdrawal by Subject|1
346864|NCT00489554|1129066|P1|Overall Study|Adverse Event|2
346865|NCT00489541|1129086|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
346866|NCT00489541|1129087|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
346867|NCT00489541|1129086|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
346868|NCT00489541|1129087|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
346869|NCT00489541|1129086|P2|12-Month Clinical Follow-up|Death|2
346870|NCT00489541|1129087|P1|12-Month Clinical Follow-up|Death|3
346871|NCT00489541|1129086|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
346872|NCT00489541|1129087|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
346873|NCT00489541|1129086|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
346874|NCT00489541|1129087|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
346875|NCT00489541|1129086|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
346876|NCT00489541|1129087|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
346877|NCT00489489|1129098|P3|Overall Study|Other than above|0
346878|NCT00489489|1129099|P2|Overall Study|Other than above|1
346879|NCT00489489|1129100|P1|Overall Study|Other than above|0
346880|NCT00489489|1129098|P3|Overall Study|Participant did not wish to continue|0
346881|NCT00489489|1129099|P2|Overall Study|Participant did not wish to continue|1
346882|NCT00489489|1129100|P1|Overall Study|Participant did not wish to continue|1
346883|NCT00489489|1129098|P3|Overall Study|Progressive disease|0
346884|NCT00489489|1129099|P2|Overall Study|Progressive disease|1
346885|NCT00489489|1129100|P1|Overall Study|Progressive disease|0
346886|NCT00489489|1129098|P3|Overall Study|Protocol Violation|1
346887|NCT00489489|1129099|P2|Overall Study|Protocol Violation|0
346888|NCT00489489|1129100|P1|Overall Study|Protocol Violation|1
346889|NCT00489489|1129098|P3|Overall Study|Adverse Event|1
346890|NCT00489489|1129099|P2|Overall Study|Adverse Event|1
346891|NCT00489489|1129100|P1|Overall Study|Adverse Event|1
346892|NCT00489489|1129098|P3|Overall Study|Not treated due to protocol violation|1
346893|NCT00489489|1129099|P2|Overall Study|Not treated due to protocol violation|1
346894|NCT00489489|1129100|P1|Overall Study|Not treated due to protocol violation|0
346895|NCT00489476|1129132|P4|Overall Study|Lost to Follow-up|0
346896|NCT00489476|1129133|P3|Overall Study|Lost to Follow-up|0
346897|NCT00489476|1129134|P2|Overall Study|Lost to Follow-up|1
346898|NCT00489476|1129135|P1|Overall Study|Lost to Follow-up|0
346899|NCT00489424|1129156|P3|Overall Study|Administrative problems|1
346900|NCT00489424|1129157|P2|Overall Study|Administrative problems|2
346901|NCT00489424|1129158|P1|Overall Study|Administrative problems|0
346902|NCT00489424|1129156|P3|Overall Study|Lack of Efficacy|0
346903|NCT00489424|1129157|P2|Overall Study|Lack of Efficacy|0
346904|NCT00489424|1129158|P1|Overall Study|Lack of Efficacy|1
346905|NCT00489424|1129156|P3|Overall Study|Adverse Event|4
346906|NCT00489424|1129157|P2|Overall Study|Adverse Event|3
346907|NCT00489424|1129158|P1|Overall Study|Adverse Event|3
346908|NCT00489411|1129189|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
346909|NCT00489411|1129190|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
346910|NCT00489411|1129189|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
346911|NCT00489411|1129190|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
346912|NCT00489411|1129189|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
346913|NCT00489411|1129190|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
346914|NCT00489411|1129189|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
346915|NCT00489411|1129190|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
346916|NCT00489411|1129189|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
346917|NCT00489411|1129190|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
346918|NCT00489359|1129204|P2|Overall Study|Adverse Event|16
346919|NCT00489359|1129205|P1|Overall Study|Adverse Event|0
346920|NCT00489359|1129204|P2|Overall Study|Withdrawal by Subject|5
346921|NCT00489359|1129205|P1|Overall Study|Withdrawal by Subject|1
346922|NCT00489359|1129204|P2|Overall Study|Lost to Follow-up|0
346923|NCT00489359|1129205|P1|Overall Study|Lost to Follow-up|1
346924|NCT00489359|1129204|P2|Overall Study|Progressive Disease|6
346925|NCT00489359|1129205|P1|Overall Study|Progressive Disease|5
346926|NCT00489359|1129204|P2|Overall Study|Death|2
346927|NCT00489359|1129205|P1|Overall Study|Death|0
346928|NCT00489255|1129266|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
346929|NCT00489255|1129267|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
346930|NCT00489255|1129266|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
346931|NCT00489255|1129267|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
346932|NCT00489255|1129266|P2|Period 3: Days 57 to 84|Adverse Event|3
346933|NCT00489255|1129267|P1|Period 3: Days 57 to 84|Adverse Event|3
346934|NCT00489255|1129266|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
346935|NCT00489255|1129267|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
346936|NCT00489255|1129266|P2|Period 2: Days 29 to 56|Adverse Event|1
346937|NCT00489255|1129267|P1|Period 2: Days 29 to 56|Adverse Event|3
346938|NCT00489255|1129266|P2|Period 1: Days 1 to 28|Noncompliance|0
346939|NCT00489255|1129267|P1|Period 1: Days 1 to 28|Noncompliance|2
346940|NCT00489255|1129266|P2|Period 1: Days 1 to 28|Physician Decision|4
346941|NCT00489255|1129267|P1|Period 1: Days 1 to 28|Physician Decision|1
346942|NCT00489255|1129266|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
346943|NCT00489255|1129267|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
346944|NCT00489255|1129266|P2|Period 1: Days 1 to 28|Adverse Event|8
346945|NCT00489255|1129267|P1|Period 1: Days 1 to 28|Adverse Event|21
346946|NCT00489255|1129266|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
346947|NCT00489255|1129267|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
346948|NCT00489216|1129315|P1|Overall Study|Adverse Event|1
346949|NCT00488826|1129337|P3|Overall Study|Protocol Deviations|1
346950|NCT00488826|1129338|P2|Overall Study|Protocol Deviations|1
346951|NCT00488826|1129339|P1|Overall Study|Protocol Deviations|2
346952|NCT00488826|1129337|P3|Overall Study|Lost to Follow-up|0
346953|NCT00488826|1129338|P2|Overall Study|Lost to Follow-up|1
346954|NCT00488826|1129339|P1|Overall Study|Lost to Follow-up|5
346955|NCT00488826|1129337|P3|Overall Study|Adverse Event|4
346956|NCT00488826|1129338|P2|Overall Study|Adverse Event|15
346957|NCT00488826|1129339|P1|Overall Study|Adverse Event|9
346958|NCT00488826|1129337|P3|Overall Study|Protocol Violation|2
346959|NCT00488826|1129338|P2|Overall Study|Protocol Violation|0
346960|NCT00488826|1129339|P1|Overall Study|Protocol Violation|0
346961|NCT00488826|1129337|P3|Overall Study|Withdrawal by Subject|19
346962|NCT00488826|1129338|P2|Overall Study|Withdrawal by Subject|35
346963|NCT00488826|1129339|P1|Overall Study|Withdrawal by Subject|40
346964|NCT00488774|1129354|P4|Overall Study|Lost to Follow-up|1
346965|NCT00488774|1129355|P3|Overall Study|Lost to Follow-up|1
346966|NCT00488774|1129356|P2|Overall Study|Lost to Follow-up|0
346967|NCT00488774|1129357|P1|Overall Study|Lost to Follow-up|0
346968|NCT00488774|1129354|P4|Overall Study|unspecified|2
346969|NCT00488774|1129355|P3|Overall Study|unspecified|2
346970|NCT00488774|1129356|P2|Overall Study|unspecified|3
346971|NCT00488774|1129357|P1|Overall Study|unspecified|6
346972|NCT00488774|1129354|P4|Overall Study|Withdrawal of consent|0
346973|NCT00488774|1129355|P3|Overall Study|Withdrawal of consent|2
346974|NCT00488774|1129356|P2|Overall Study|Withdrawal of consent|2
346975|NCT00488774|1129357|P1|Overall Study|Withdrawal of consent|2
346976|NCT00488683|1129374|P3|Overall Study|Unable to Classify|0
346977|NCT00488683|1129375|P2|Overall Study|Unable to Classify|0
346978|NCT00488683|1129376|P1|Overall Study|Unable to Classify|1
346979|NCT00488683|1129374|P3|Overall Study|Protocol Violation|0
346980|NCT00488683|1129375|P2|Overall Study|Protocol Violation|1
346981|NCT00488683|1129376|P1|Overall Study|Protocol Violation|5
346982|NCT00488683|1129374|P3|Overall Study|Lost to Follow-up|0
346983|NCT00488683|1129375|P2|Overall Study|Lost to Follow-up|3
346984|NCT00488683|1129376|P1|Overall Study|Lost to Follow-up|5
346985|NCT00488683|1129374|P3|Overall Study|Withdrawal by Subject|2
346986|NCT00488683|1129375|P2|Overall Study|Withdrawal by Subject|2
346987|NCT00488683|1129376|P1|Overall Study|Withdrawal by Subject|1
346988|NCT00488644|1129435|P1|Overall Study|Not Evaluable|1
346989|NCT00488644|1129435|P1|Overall Study|Not Eligible|1
346990|NCT00488631|1129445|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
346991|NCT00488631|1129446|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
346992|NCT00488631|1129447|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
346993|NCT00488631|1129448|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
346994|NCT00488631|1129449|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
346995|NCT00488631|1129450|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
346996|NCT00488631|1129451|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
346997|NCT00488631|1129452|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
346998|NCT00488631|1129453|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
346999|NCT00488631|1129454|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
347000|NCT00488631|1129445|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
347001|NCT00488631|1129446|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
347002|NCT00488631|1129447|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
347003|NCT00488631|1129448|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
347004|NCT00488631|1129449|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
347005|NCT00488631|1129450|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
347006|NCT00488631|1129451|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
347007|NCT00488631|1129452|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
347008|NCT00488631|1129453|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
347009|NCT00488631|1129454|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
347010|NCT00488631|1129445|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
347011|NCT00488631|1129446|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
347012|NCT00488631|1129447|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
347013|NCT00488631|1129448|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
347014|NCT00488631|1129449|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
347015|NCT00488631|1129450|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
347016|NCT00488631|1129451|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
347017|NCT00488631|1129452|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
347018|NCT00488631|1129453|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
347019|NCT00488631|1129454|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
347020|NCT00488631|1129445|P10|Open Label Study Extension (Week 54-228)|Death|0
347021|NCT00488631|1129446|P9|Open Label Study Extension (Week 54-228)|Death|1
347022|NCT00488631|1129447|P8|Open Label Study Extension (Week 54-228)|Death|0
347023|NCT00488631|1129448|P7|Open Label Study Extension (Week 54-228)|Death|0
347024|NCT00488631|1129449|P6|Open Label Study Extension (Week 54-228)|Death|0
347025|NCT00488631|1129450|P5|Open Label Study Extension (Week 54-228)|Death|0
347026|NCT00488631|1129451|P4|Open Label Study Extension (Week 54-228)|Death|0
347027|NCT00488631|1129452|P3|Open Label Study Extension (Week 54-228)|Death|0
347028|NCT00488631|1129453|P2|Open Label Study Extension (Week 54-228)|Death|0
347029|NCT00488631|1129454|P1|Open Label Study Extension (Week 54-228)|Death|0
347030|NCT00488631|1129445|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
347031|NCT00488631|1129446|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
347032|NCT00488631|1129447|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
347033|NCT00488631|1129448|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
347034|NCT00488631|1129449|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
347035|NCT00488631|1129450|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
347036|NCT00488631|1129451|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
347037|NCT00488631|1129452|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
347038|NCT00488631|1129453|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
347039|NCT00488631|1129454|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
347040|NCT00488631|1129445|P10|Double Blind Period (Week 0-54)|Unspecified|0
347041|NCT00488631|1129446|P9|Double Blind Period (Week 0-54)|Unspecified|0
347042|NCT00488631|1129447|P8|Double Blind Period (Week 0-54)|Unspecified|0
347043|NCT00488631|1129448|P7|Double Blind Period (Week 0-54)|Unspecified|0
347044|NCT00488631|1129449|P6|Double Blind Period (Week 0-54)|Unspecified|34
347045|NCT00488631|1129450|P5|Double Blind Period (Week 0-54)|Unspecified|14
347046|NCT00488631|1129451|P4|Double Blind Period (Week 0-54)|Unspecified|11
347047|NCT00488631|1129452|P3|Double Blind Period (Week 0-54)|Unspecified|10
347048|NCT00488631|1129453|P2|Double Blind Period (Week 0-54)|Unspecified|12
347049|NCT00488631|1129454|P1|Double Blind Period (Week 0-54)|Unspecified|6
347050|NCT00488631|1129445|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
347051|NCT00488631|1129446|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
347052|NCT00488631|1129447|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
347053|NCT00488631|1129448|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
347054|NCT00488631|1129449|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
347055|NCT00488631|1129450|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
347056|NCT00488631|1129451|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
347057|NCT00488631|1129452|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
347058|NCT00488631|1129453|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
347059|NCT00488631|1129454|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
347060|NCT00488631|1129445|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
347061|NCT00488631|1129446|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
347062|NCT00488631|1129447|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
347063|NCT00488631|1129448|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
347064|NCT00488631|1129449|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
347065|NCT00488631|1129450|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
347066|NCT00488631|1129451|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
347067|NCT00488631|1129452|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
347068|NCT00488631|1129453|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
347069|NCT00488631|1129454|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
347070|NCT00488631|1129445|P10|Double Blind Period (Week 0-54)|Death|0
347071|NCT00488631|1129446|P9|Double Blind Period (Week 0-54)|Death|0
347072|NCT00488631|1129447|P8|Double Blind Period (Week 0-54)|Death|0
347073|NCT00488631|1129448|P7|Double Blind Period (Week 0-54)|Death|0
347074|NCT00488631|1129449|P6|Double Blind Period (Week 0-54)|Death|1
347075|NCT00488631|1129450|P5|Double Blind Period (Week 0-54)|Death|0
347076|NCT00488631|1129451|P4|Double Blind Period (Week 0-54)|Death|0
347077|NCT00488631|1129452|P3|Double Blind Period (Week 0-54)|Death|0
347078|NCT00488631|1129453|P2|Double Blind Period (Week 0-54)|Death|0
347079|NCT00488631|1129454|P1|Double Blind Period (Week 0-54)|Death|0
347080|NCT00488631|1129445|P10|Double Blind Period (Week 0-54)|Adverse Event|0
347081|NCT00488631|1129446|P9|Double Blind Period (Week 0-54)|Adverse Event|0
347082|NCT00488631|1129447|P8|Double Blind Period (Week 0-54)|Adverse Event|0
347083|NCT00488631|1129448|P7|Double Blind Period (Week 0-54)|Adverse Event|0
347084|NCT00488631|1129449|P6|Double Blind Period (Week 0-54)|Adverse Event|50
347085|NCT00488631|1129450|P5|Double Blind Period (Week 0-54)|Adverse Event|30
347086|NCT00488631|1129451|P4|Double Blind Period (Week 0-54)|Adverse Event|12
347087|NCT00488631|1129452|P3|Double Blind Period (Week 0-54)|Adverse Event|12
347088|NCT00488631|1129453|P2|Double Blind Period (Week 0-54)|Adverse Event|12
347089|NCT00488631|1129454|P1|Double Blind Period (Week 0-54)|Adverse Event|17
347090|NCT00488618|1129491|P2|Overall Study|Lost to Follow-up|0
347091|NCT00488618|1129492|P1|Overall Study|Lost to Follow-up|1
347092|NCT00488618|1129491|P2|Overall Study|Withdrawal of Consent|13
347093|NCT00488618|1129492|P1|Overall Study|Withdrawal of Consent|15
347094|NCT00488618|1129491|P2|Overall Study|Protocol Violation|2
347095|NCT00488618|1129492|P1|Overall Study|Protocol Violation|0
347096|NCT00488618|1129491|P2|Overall Study|Insufficient Therapeutic Response|11
347097|NCT00488618|1129492|P1|Overall Study|Insufficient Therapeutic Response|18
347098|NCT00488618|1129491|P2|Overall Study|Adverse Event|17
347099|NCT00488618|1129492|P1|Overall Study|Adverse Event|13
347100|NCT00488592|1129500|P1|Overall Study|Enrolled but not treated|1
347101|NCT00488592|1129500|P1|Overall Study|Disease progression|1
347102|NCT00488592|1129500|P1|Overall Study|Withdrawal by Subject|1
347103|NCT00488514|1129504|P1|Overall Study|Increased use of concomitant medication|1
347104|NCT00488514|1129504|P1|Overall Study|Increase in number of migraines|2
347105|NCT00488514|1129504|P1|Overall Study|Participant had too few migraines|5
347106|NCT00488514|1129504|P1|Overall Study|Investigator decision|1
347107|NCT00488514|1129504|P1|Overall Study|Withdrawn per medical monitor decision|2
347108|NCT00488514|1129504|P1|Overall Study|Postive drug screen|1
347109|NCT00488514|1129504|P1|Overall Study|Did not meet criteria for treatment|30
347110|NCT00488514|1129504|P1|Overall Study|Lack of Efficacy|28
347111|NCT00488514|1129504|P1|Overall Study|Withdrawal by Subject|106
347112|NCT00488514|1129504|P1|Overall Study|Protocol Violation|32
347113|NCT00488514|1129504|P1|Overall Study|Lost to Follow-up|44
347114|NCT00488514|1129504|P1|Overall Study|Adverse Event|41
347115|NCT00488475|1129592|P1|Overall Study|Unspecified|1754
347116|NCT00488345|1129621|P3|Overall Study|Parent/legal guardian request|1
347117|NCT00488345|1129622|P2|Overall Study|Parent/legal guardian request|1
347118|NCT00488345|1129623|P1|Overall Study|Parent/legal guardian request|0
347119|NCT00488345|1129621|P3|Overall Study|Surgical team recommendation|0
347120|NCT00488345|1129622|P2|Overall Study|Surgical team recommendation|1
347121|NCT00488345|1129623|P1|Overall Study|Surgical team recommendation|0
347122|NCT00488345|1129621|P3|Overall Study|Institutional Review Board review|1
347123|NCT00488345|1129622|P2|Overall Study|Institutional Review Board review|0
347124|NCT00488345|1129623|P1|Overall Study|Institutional Review Board review|0
347125|NCT00488345|1129621|P3|Overall Study|Unable to administer antibiotics at home|0
347126|NCT00488345|1129622|P2|Overall Study|Unable to administer antibiotics at home|1
347127|NCT00488345|1129623|P1|Overall Study|Unable to administer antibiotics at home|0
347128|NCT00488345|1129621|P3|Overall Study|Adverse Event|1
347129|NCT00488345|1129622|P2|Overall Study|Adverse Event|1
347130|NCT00488345|1129623|P1|Overall Study|Adverse Event|0
347131|NCT00488319|1129649|P3|Overall Study|Other reasons for withdrawal|12
347132|NCT00488319|1129650|P2|Overall Study|Other reasons for withdrawal|4
347133|NCT00488319|1129651|P1|Overall Study|Other reasons for withdrawal|0
347134|NCT00488319|1129649|P3|Overall Study|Withdrawal by Subject|44
347135|NCT00488319|1129650|P2|Overall Study|Withdrawal by Subject|20
347136|NCT00488319|1129651|P1|Overall Study|Withdrawal by Subject|5
347137|NCT00488319|1129649|P3|Overall Study|Lost to Follow-up|16
347138|NCT00488319|1129650|P2|Overall Study|Lost to Follow-up|5
347139|NCT00488319|1129651|P1|Overall Study|Lost to Follow-up|3
347140|NCT00488319|1129649|P3|Overall Study|Lack of Efficacy|27
347141|NCT00488319|1129650|P2|Overall Study|Lack of Efficacy|12
347142|NCT00488319|1129651|P1|Overall Study|Lack of Efficacy|6
347143|NCT00488319|1129649|P3|Overall Study|Adverse Event|23
347144|NCT00488319|1129650|P2|Overall Study|Adverse Event|2
347145|NCT00488319|1129651|P1|Overall Study|Adverse Event|1
347146|NCT00488293|1129738|P2|Overall Study|Misrandomization/Other Unspecified|1
347147|NCT00488293|1129739|P1|Overall Study|Misrandomization/Other Unspecified|1
347148|NCT00488293|1129738|P2|Overall Study|Death|1
347149|NCT00488293|1129739|P1|Overall Study|Death|2
347150|NCT00488293|1129738|P2|Overall Study|Withdrawal by Subject|3
347151|NCT00488293|1129739|P1|Overall Study|Withdrawal by Subject|5
347152|NCT00488293|1129738|P2|Overall Study|Lost to Follow-up|25
347153|NCT00488293|1129739|P1|Overall Study|Lost to Follow-up|28
347154|NCT00488033|1129784|P2|Overall Study|Withdrawal by Subject|0
347155|NCT00488033|1129785|P1|Overall Study|Withdrawal by Subject|1
347156|NCT00487981|1129801|P1|Overall Study|Hypothyroidism diagnosis|1
347157|NCT00487942|1129809|P4|Overall Study|Withdrawal by Subject|0
347158|NCT00487942|1129810|P3|Overall Study|Withdrawal by Subject|2
347159|NCT00487942|1129811|P2|Overall Study|Withdrawal by Subject|1
347160|NCT00487942|1129812|P1|Overall Study|Withdrawal by Subject|0
347161|NCT00487942|1129809|P4|Overall Study|Protocol Violation|0
347162|NCT00487942|1129810|P3|Overall Study|Protocol Violation|0
347163|NCT00487942|1129811|P2|Overall Study|Protocol Violation|1
347164|NCT00487942|1129812|P1|Overall Study|Protocol Violation|1
347165|NCT00487942|1129809|P4|Overall Study|Lost to Follow-up|1
347166|NCT00487942|1129810|P3|Overall Study|Lost to Follow-up|0
347167|NCT00487942|1129811|P2|Overall Study|Lost to Follow-up|0
347168|NCT00487942|1129812|P1|Overall Study|Lost to Follow-up|1
347169|NCT00487942|1129809|P4|Overall Study|Adverse Event|1
347170|NCT00487942|1129810|P3|Overall Study|Adverse Event|1
347171|NCT00487942|1129811|P2|Overall Study|Adverse Event|1
347172|NCT00487942|1129812|P1|Overall Study|Adverse Event|1
347173|NCT00487825|1130196|P2|Overall Study|not specified|2
347174|NCT00487825|1130197|P1|Overall Study|not specified|3
347175|NCT00487825|1130196|P2|Overall Study|Lack of Efficacy|1
347176|NCT00487825|1130197|P1|Overall Study|Lack of Efficacy|1
347177|NCT00487825|1130196|P2|Overall Study|Adverse Event|2
347178|NCT00487825|1130197|P1|Overall Study|Adverse Event|2
347179|NCT00487747|1130209|P1|Overall Study|Lack of Efficacy|1
347180|NCT00487747|1130209|P1|Overall Study|Lost to Follow-up|9
347181|NCT00487747|1130209|P1|Overall Study|Adverse Event|1
347182|NCT00487695|1130226|P2|Second Procedure|Withdrawal by Subject|2
347183|NCT00487695|1130227|P1|Second Procedure|Withdrawal by Subject|1
347184|NCT00487695|1130226|P2|Second Procedure|active wheezing|1
347185|NCT00487695|1130227|P1|Second Procedure|active wheezing|0
347186|NCT00487695|1130226|P2|First Procedure|esophageal stricture found (excl crit)|0
347187|NCT00487695|1130227|P1|First Procedure|esophageal stricture found (excl crit)|1
347188|NCT00487695|1130226|P2|First Procedure|active wheezing (did not have procedure)|0
347189|NCT00487695|1130227|P1|First Procedure|active wheezing (did not have procedure)|1
347190|NCT00487695|1130226|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
347191|NCT00487695|1130227|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
347192|NCT00487578|1130255|P2|Overall Study|Lost to Follow-up|1
347193|NCT00487578|1130256|P1|Overall Study|Lost to Follow-up|0
347194|NCT00487578|1130255|P2|Overall Study|Lack of Efficacy|1
347195|NCT00487578|1130256|P1|Overall Study|Lack of Efficacy|0
347196|NCT00487578|1130255|P2|Overall Study|Adverse Event|2
347197|NCT00487578|1130256|P1|Overall Study|Adverse Event|1
347198|NCT00487552|1130276|P1|Overall Study|Stent not placed|1
347199|NCT00487552|1130276|P1|Overall Study|Death due to progressive malignancy|2
347200|NCT00487552|1130276|P1|Overall Study|Unsuccessful magnet placements|3
347201|NCT00487539|1130285|P4|Overall Study|Unspecified|2
347202|NCT00487539|1130286|P3|Overall Study|Unspecified|2
347203|NCT00487539|1130287|P2|Overall Study|Unspecified|1
347204|NCT00487539|1130288|P1|Overall Study|Unspecified|3
347205|NCT00487539|1130285|P4|Overall Study|Unsatisfactory therapeutic effect|1
347206|NCT00487539|1130286|P3|Overall Study|Unsatisfactory therapeutic effect|0
347207|NCT00487539|1130287|P2|Overall Study|Unsatisfactory therapeutic effect|0
347208|NCT00487539|1130288|P1|Overall Study|Unsatisfactory therapeutic effect|1
347209|NCT00487539|1130285|P4|Overall Study|Adverse Event|1
347210|NCT00487539|1130286|P3|Overall Study|Adverse Event|1
347211|NCT00487539|1130287|P2|Overall Study|Adverse Event|2
347212|NCT00487539|1130288|P1|Overall Study|Adverse Event|3
347213|NCT00487435|1130322|P1|Overall Study|Other|83
347214|NCT00487435|1130322|P1|Overall Study|Study Medication Non-Compliant|32
347215|NCT00487435|1130322|P1|Overall Study|Resolution Of Pain|1
347216|NCT00487435|1130322|P1|Overall Study|Withdrawal by Subject|132
347217|NCT00487435|1130322|P1|Overall Study|Pregnancy|2
347218|NCT00487435|1130322|P1|Overall Study|Lost to Follow-up|54
347219|NCT00487435|1130322|P1|Overall Study|Lack of Efficacy|33
347220|NCT00487435|1130322|P1|Overall Study|Death|2
347221|NCT00487435|1130322|P1|Overall Study|Adverse Event|146
347222|NCT00487279|1130335|P2|Overall Study|Withdrawal by Subject|2
347223|NCT00487279|1130336|P1|Overall Study|Withdrawal by Subject|0
347224|NCT00487279|1130335|P2|Overall Study|Death|0
347225|NCT00487279|1130336|P1|Overall Study|Death|1
347226|NCT00487240|1130346|P2|Overall Study|Physician Decision|0
347227|NCT00487240|1130347|P1|Overall Study|Physician Decision|2
347228|NCT00487240|1130346|P2|Overall Study|Sponsor Decision|1
347229|NCT00487240|1130347|P1|Overall Study|Sponsor Decision|2
347230|NCT00487240|1130346|P2|Overall Study|Entry Criteria Not Met|4
347231|NCT00487240|1130347|P1|Overall Study|Entry Criteria Not Met|3
347232|NCT00487240|1130346|P2|Overall Study|Protocol Violation|5
347233|NCT00487240|1130347|P1|Overall Study|Protocol Violation|5
347234|NCT00487240|1130346|P2|Overall Study|Adverse Event|4
347235|NCT00487240|1130347|P1|Overall Study|Adverse Event|0
347236|NCT00487240|1130346|P2|Overall Study|Lost to Follow-up|6
347237|NCT00487240|1130347|P1|Overall Study|Lost to Follow-up|7
347238|NCT00487240|1130346|P2|Overall Study|Withdrawal by Subject|6
347239|NCT00487240|1130347|P1|Overall Study|Withdrawal by Subject|12
347240|NCT00487188|1130375|P3|Maintenance Phase|Administrative|1
347241|NCT00487188|1130376|P2|Maintenance Phase|Administrative|0
347242|NCT00487188|1130377|P1|Maintenance Phase|Administrative|0
347243|NCT00487188|1130375|P3|Maintenance Phase|Lost to Follow-up|0
347244|NCT00487188|1130376|P2|Maintenance Phase|Lost to Follow-up|0
347245|NCT00487188|1130377|P1|Maintenance Phase|Lost to Follow-up|1
347246|NCT00487188|1130375|P3|Maintenance Phase|Death|0
347247|NCT00487188|1130376|P2|Maintenance Phase|Death|0
347248|NCT00487188|1130377|P1|Maintenance Phase|Death|1
347249|NCT00487188|1130375|P3|Maintenance Phase|Adverse Event|0
347250|NCT00487188|1130376|P2|Maintenance Phase|Adverse Event|0
347251|NCT00487188|1130377|P1|Maintenance Phase|Adverse Event|1
347252|NCT00487188|1130375|P3|Induction Phase|Administrative|0
347253|NCT00487188|1130376|P2|Induction Phase|Administrative|1
347254|NCT00487188|1130377|P1|Induction Phase|Administrative|0
347255|NCT00487188|1130375|P3|Induction Phase|Lost to Follow-up|0
347256|NCT00487188|1130376|P2|Induction Phase|Lost to Follow-up|2
347257|NCT00487188|1130377|P1|Induction Phase|Lost to Follow-up|2
347258|NCT00487188|1130375|P3|Induction Phase|Refused Treatment|0
347259|NCT00487188|1130376|P2|Induction Phase|Refused Treatment|2
347260|NCT00487188|1130377|P1|Induction Phase|Refused Treatment|1
347261|NCT00487188|1130375|P3|Induction Phase|Protocol Violation|0
347262|NCT00487188|1130376|P2|Induction Phase|Protocol Violation|0
347263|NCT00487188|1130377|P1|Induction Phase|Protocol Violation|1
347264|NCT00487188|1130375|P3|Induction Phase|Lack of Efficacy|0
347265|NCT00487188|1130376|P2|Induction Phase|Lack of Efficacy|1
347266|NCT00487188|1130377|P1|Induction Phase|Lack of Efficacy|0
347267|NCT00487188|1130375|P3|Induction Phase|Adverse Event|0
347268|NCT00487188|1130376|P2|Induction Phase|Adverse Event|0
347269|NCT00487188|1130377|P1|Induction Phase|Adverse Event|5
347270|NCT00487188|1130375|P3|Induction Phase|Abnormality of Laboratory Test|0
347271|NCT00487188|1130376|P2|Induction Phase|Abnormality of Laboratory Test|1
347272|NCT00487188|1130377|P1|Induction Phase|Abnormality of Laboratory Test|0
347273|NCT00487162|1130416|P2|Overall Study|Withdrawal by Subject|3
347274|NCT00487162|1130417|P1|Overall Study|Withdrawal by Subject|2
347275|NCT00487162|1130416|P2|Overall Study|Physician Decision|1
347276|NCT00487162|1130417|P1|Overall Study|Physician Decision|0
347277|NCT00487162|1130416|P2|Overall Study|Adverse Event|1
347278|NCT00487162|1130417|P1|Overall Study|Adverse Event|0
347279|NCT00487084|1130428|P3|Overall Study|Did not receive intervention|5
347280|NCT00487084|1130429|P2|Overall Study|Did not receive intervention|3
347281|NCT00487084|1130430|P1|Overall Study|Did not receive intervention|4
347282|NCT00486954|1130451|P5|Randomized Part|Sponsor Terminated Study|13
347283|NCT00486954|1130452|P4|Randomized Part|Sponsor Terminated Study|19
347284|NCT00486954|1130453|P3|Randomized Part|Sponsor Terminated Study|0
347285|NCT00486954|1130454|P2|Randomized Part|Sponsor Terminated Study|0
347286|NCT00486954|1130455|P1|Randomized Part|Sponsor Terminated Study|0
347287|NCT00486954|1130451|P5|Randomized Part|Withdrawal by Subject|0
347288|NCT00486954|1130452|P4|Randomized Part|Withdrawal by Subject|1
347289|NCT00486954|1130453|P3|Randomized Part|Withdrawal by Subject|0
347290|NCT00486954|1130454|P2|Randomized Part|Withdrawal by Subject|0
347291|NCT00486954|1130455|P1|Randomized Part|Withdrawal by Subject|0
347292|NCT00486954|1130451|P5|Randomized Part|Lost to Follow-up|1
347293|NCT00486954|1130452|P4|Randomized Part|Lost to Follow-up|0
347294|NCT00486954|1130453|P3|Randomized Part|Lost to Follow-up|0
347295|NCT00486954|1130454|P2|Randomized Part|Lost to Follow-up|0
347296|NCT00486954|1130455|P1|Randomized Part|Lost to Follow-up|0
347297|NCT00486954|1130451|P5|Pilot Part|Disease Progression|0
347298|NCT00486954|1130452|P4|Pilot Part|Disease Progression|0
347299|NCT00486954|1130453|P3|Pilot Part|Disease Progression|1
347300|NCT00486954|1130454|P2|Pilot Part|Disease Progression|0
347301|NCT00486954|1130455|P1|Pilot Part|Disease Progression|2
347302|NCT00486954|1130451|P5|Pilot Part|Adverse Event|0
347303|NCT00486954|1130452|P4|Pilot Part|Adverse Event|0
347304|NCT00486954|1130453|P3|Pilot Part|Adverse Event|5
347305|NCT00486954|1130454|P2|Pilot Part|Adverse Event|0
347306|NCT00486954|1130455|P1|Pilot Part|Adverse Event|4
347307|NCT00486902|1130553|P2|Overall Study|No toradol due to hemmorhage or allergy|1
347308|NCT00486902|1130554|P1|Overall Study|No toradol due to hemmorhage or allergy|3
347309|NCT00486902|1130553|P2|Overall Study|Did not meet inclusion criteria|0
347310|NCT00486902|1130554|P1|Overall Study|Did not meet inclusion criteria|1
347311|NCT00486902|1130553|P2|Overall Study|spinal anesthetic protocal violation|1
347399|NCT00486434|1130754|P2|Overall Study|Withdrawal by Subject|39
347312|NCT00486902|1130554|P1|Overall Study|spinal anesthetic protocal violation|1
347313|NCT00486902|1130553|P2|Overall Study|decision for postpartum tubal ligation|1
347314|NCT00486902|1130554|P1|Overall Study|decision for postpartum tubal ligation|3
347315|NCT00486902|1130553|P2|Overall Study|Withdrawal by Subject|2
347316|NCT00486902|1130554|P1|Overall Study|Withdrawal by Subject|1
347317|NCT00486837|1130621|P2|Overall Study|No sputum, devise issues, exacerbation|4
347318|NCT00486837|1130622|P1|Overall Study|No sputum, devise issues, exacerbation|3
347319|NCT00486837|1130621|P2|Overall Study|Protocol Violation|2
347320|NCT00486837|1130622|P1|Overall Study|Protocol Violation|4
347321|NCT00486837|1130621|P2|Overall Study|Adverse Event|1
347322|NCT00486837|1130622|P1|Overall Study|Adverse Event|1
347323|NCT00486837|1130621|P2|Overall Study|Withdrawal by Subject|0
347324|NCT00486837|1130622|P1|Overall Study|Withdrawal by Subject|1
347325|NCT00486811|1130641|P3|Overall Study|All other|7
347326|NCT00486811|1130642|P2|Overall Study|All other|11
347327|NCT00486811|1130643|P1|Overall Study|All other|18
347328|NCT00486811|1130641|P3|Overall Study|Study drug non-compliant|3
347329|NCT00486811|1130642|P2|Overall Study|Study drug non-compliant|6
347330|NCT00486811|1130643|P1|Overall Study|Study drug non-compliant|5
347331|NCT00486811|1130641|P3|Overall Study|Withdrawal by Subject|58
347332|NCT00486811|1130642|P2|Overall Study|Withdrawal by Subject|44
347333|NCT00486811|1130643|P1|Overall Study|Withdrawal by Subject|33
347334|NCT00486811|1130641|P3|Overall Study|Lost to Follow-up|4
347335|NCT00486811|1130642|P2|Overall Study|Lost to Follow-up|6
347336|NCT00486811|1130643|P1|Overall Study|Lost to Follow-up|4
347337|NCT00486811|1130641|P3|Overall Study|Lack of Efficacy|7
347338|NCT00486811|1130642|P2|Overall Study|Lack of Efficacy|14
347339|NCT00486811|1130643|P1|Overall Study|Lack of Efficacy|34
347340|NCT00486811|1130641|P3|Overall Study|Adverse Event|135
347341|NCT00486811|1130642|P2|Overall Study|Adverse Event|60
347342|NCT00486811|1130643|P1|Overall Study|Adverse Event|28
347343|NCT00486759|1130686|P2|Safety Follow-up|Adverse event/intercurrent illness|0
347344|NCT00486759|1130687|P1|Safety Follow-up|Adverse event/intercurrent illness|4
347345|NCT00486759|1130686|P2|Safety Follow-up|Refused treatment/did not cooperate|4
347346|NCT00486759|1130687|P1|Safety Follow-up|Refused treatment/did not cooperate|6
347347|NCT00486759|1130686|P2|Safety Follow-up|Administrative/not specified|6
347348|NCT00486759|1130687|P1|Safety Follow-up|Administrative/not specified|8
347349|NCT00486759|1130686|P2|Safety Follow-up|Failure to return|6
347350|NCT00486759|1130687|P1|Safety Follow-up|Failure to return|9
347351|NCT00486759|1130686|P2|Safety Follow-up|Withdrew consent|23
347352|NCT00486759|1130687|P1|Safety Follow-up|Withdrew consent|32
347353|NCT00486759|1130686|P2|Safety Follow-up|Death|29
347354|NCT00486759|1130687|P1|Safety Follow-up|Death|40
347355|NCT00486759|1130686|P2|Safety Follow-up|Insufficient therapeutic response|50
347356|NCT00486759|1130687|P1|Safety Follow-up|Insufficient therapeutic response|40
347357|NCT00486759|1130686|P2|Treatment|Failure to return|1
347358|NCT00486759|1130687|P1|Treatment|Failure to return|1
347359|NCT00486759|1130686|P2|Treatment|Other protocol violation|5
347360|NCT00486759|1130687|P1|Treatment|Other protocol violation|1
347361|NCT00486759|1130686|P2|Treatment|Violation of selection criteria at entry|3
347362|NCT00486759|1130687|P1|Treatment|Violation of selection criteria at entry|3
347363|NCT00486759|1130686|P2|Treatment|Refused treatment|7
347364|NCT00486759|1130687|P1|Treatment|Refused treatment|10
347365|NCT00486759|1130686|P2|Treatment|Administrative/reason not specified|21
347366|NCT00486759|1130687|P1|Treatment|Administrative/reason not specified|17
347367|NCT00486759|1130686|P2|Treatment|Withdrew consent|12
347368|NCT00486759|1130687|P1|Treatment|Withdrew consent|15
347369|NCT00486759|1130686|P2|Treatment|Death|10
347370|NCT00486759|1130687|P1|Treatment|Death|17
347371|NCT00486759|1130686|P2|Treatment|Insufficient therapeutic response|39
347372|NCT00486759|1130687|P1|Treatment|Insufficient therapeutic response|37
347373|NCT00486759|1130686|P2|Treatment|Adverse event/intercurrent illness|39
347374|NCT00486759|1130687|P1|Treatment|Adverse event/intercurrent illness|86
347375|NCT00486720|1130699|P2|Overall Study|Progressive Disease|1
347376|NCT00486720|1130700|P1|Overall Study|Progressive Disease|0
347377|NCT00486720|1130699|P2|Overall Study|Withdrawal by Subject|1
347378|NCT00486720|1130700|P1|Overall Study|Withdrawal by Subject|3
347379|NCT00486720|1130699|P2|Overall Study|Protocol Violation|0
347380|NCT00486720|1130700|P1|Overall Study|Protocol Violation|1
347381|NCT00486720|1130699|P2|Overall Study|Physician Decision|2
347382|NCT00486720|1130700|P1|Overall Study|Physician Decision|1
347383|NCT00486720|1130699|P2|Overall Study|Lack of Efficacy|6
347384|NCT00486720|1130700|P1|Overall Study|Lack of Efficacy|4
347385|NCT00486720|1130699|P2|Overall Study|Adverse Event|2
347386|NCT00486720|1130700|P1|Overall Study|Adverse Event|1
347387|NCT00486434|1130754|P2|Overall Study|Personal reasons|6
347388|NCT00486434|1130755|P1|Overall Study|Personal reasons|5
347389|NCT00486434|1130754|P2|Overall Study|Death|2
347390|NCT00486434|1130755|P1|Overall Study|Death|1
347391|NCT00486434|1130754|P2|Overall Study|Lost to Follow-up|3
347392|NCT00486434|1130755|P1|Overall Study|Lost to Follow-up|2
347393|NCT00486434|1130754|P2|Overall Study|Lack of Efficacy|19
347394|NCT00486434|1130755|P1|Overall Study|Lack of Efficacy|12
347395|NCT00486434|1130754|P2|Overall Study|Protocol Violation|21
347396|NCT00486434|1130755|P1|Overall Study|Protocol Violation|22
347397|NCT00486434|1130754|P2|Overall Study|Adverse Event|44
347398|NCT00486434|1130755|P1|Overall Study|Adverse Event|118
347400|NCT00486434|1130755|P1|Overall Study|Withdrawal by Subject|34
347401|NCT00486330|1130765|P1|Overall Study|Adverse Event|2
347402|NCT00486291|1130771|P2|Overall Study|requirement for restricted medication|3
347403|NCT00486291|1130772|P1|Overall Study|requirement for restricted medication|0
347404|NCT00486291|1130771|P2|Overall Study|protocol non-compliance|15
347405|NCT00486291|1130772|P1|Overall Study|protocol non-compliance|10
347406|NCT00486291|1130771|P2|Overall Study|Lost to Follow-up|7
347407|NCT00486291|1130772|P1|Overall Study|Lost to Follow-up|3
347408|NCT00486291|1130771|P2|Overall Study|Adverse Event|4
347409|NCT00486291|1130772|P1|Overall Study|Adverse Event|3
347410|NCT00486278|1130780|P1|Overall Study|Physician Decision|2
347411|NCT00486278|1130780|P1|Overall Study|Withdrawal by Subject|2
347412|NCT00486278|1130780|P1|Overall Study|Adverse Event|5
347413|NCT00486265|1130914|P1|Overall Study|Lack of Efficacy|8
347414|NCT00486265|1130914|P1|Overall Study|Adverse Event|1
347415|NCT00486252|1130918|P1|Overall Study|Other|18
347416|NCT00486252|1130918|P1|Overall Study|Lost to Follow-up|24
347417|NCT00486252|1130918|P1|Overall Study|Lack of Efficacy|9
347418|NCT00486252|1130918|P1|Overall Study|Adverse Event|7
347419|NCT00486226|1130933|P1|Overall Study|Lost to Follow-up|8
347420|NCT00486226|1130933|P1|Overall Study|Withdrawal by Subject|1
347421|NCT00486226|1130933|P1|Overall Study|Adverse Event|1
347422|NCT00486226|1130933|P1|Overall Study|Death|3
347423|NCT00486044|1130943|P2|Overall Study|Lost to Follow-up|1
347424|NCT00486044|1130944|P1|Overall Study|Lost to Follow-up|0
347425|NCT00486044|1130943|P2|Overall Study|Adverse Event|1
347426|NCT00486044|1130944|P1|Overall Study|Adverse Event|0
347427|NCT00486044|1130943|P2|Overall Study|Withdrawal by Subject|1
347428|NCT00486044|1130944|P1|Overall Study|Withdrawal by Subject|2
347429|NCT00485758|1131029|P2|Overall Study|Study Terminated by Sponsor|0
347430|NCT00485758|1131030|P1|Overall Study|Study Terminated by Sponsor|3
347431|NCT00485758|1131029|P2|Overall Study|Withdrawal by Subject|27
347432|NCT00485758|1131030|P1|Overall Study|Withdrawal by Subject|32
347433|NCT00485758|1131029|P2|Overall Study|Protocol Violation|2
347434|NCT00485758|1131030|P1|Overall Study|Protocol Violation|11
347435|NCT00485758|1131029|P2|Overall Study|Physician Decision|3
347436|NCT00485758|1131030|P1|Overall Study|Physician Decision|3
347437|NCT00485758|1131029|P2|Overall Study|Lost to Follow-up|1
347438|NCT00485758|1131030|P1|Overall Study|Lost to Follow-up|5
347439|NCT00485758|1131029|P2|Overall Study|Death|1
347440|NCT00485758|1131030|P1|Overall Study|Death|0
347441|NCT00485758|1131029|P2|Overall Study|Adverse Event|31
347442|NCT00485758|1131030|P1|Overall Study|Adverse Event|102
347443|NCT00485732|1131042|P2|Overall Study|Lost to Follow-up|2
347444|NCT00485732|1131043|P1|Overall Study|Lost to Follow-up|2
347445|NCT00485732|1131042|P2|Overall Study|Withdrawal by Subject|4
347446|NCT00485732|1131043|P1|Overall Study|Withdrawal by Subject|5
347447|NCT00485732|1131042|P2|Overall Study|Protocol Violation|3
347448|NCT00485732|1131043|P1|Overall Study|Protocol Violation|1
347449|NCT00485472|1131081|P2|Overall Study|Lost to Follow-up|1
347450|NCT00485472|1131082|P1|Overall Study|Lost to Follow-up|0
347451|NCT00485472|1131081|P2|Overall Study|Unspecified|1
347452|NCT00485472|1131082|P1|Overall Study|Unspecified|2
347453|NCT00485472|1131081|P2|Overall Study|Protocol Violation|1
347454|NCT00485472|1131082|P1|Overall Study|Protocol Violation|0
347455|NCT00485472|1131081|P2|Overall Study|Withdrawal by Subject|0
347456|NCT00485472|1131082|P1|Overall Study|Withdrawal by Subject|1
347457|NCT00485472|1131081|P2|Overall Study|Lack of Efficacy|4
347458|NCT00485472|1131082|P1|Overall Study|Lack of Efficacy|5
347459|NCT00485472|1131081|P2|Overall Study|Adverse Event|5
347460|NCT00485472|1131082|P1|Overall Study|Adverse Event|8
347461|NCT00485303|1131119|P1|Overall Study|Treatment ongoing at cutoff date|2
347462|NCT00485303|1131119|P1|Overall Study|Initiation of new anti-cancer treatment|2
347463|NCT00485303|1131119|P1|Overall Study|Unspecified|3
347464|NCT00485303|1131119|P1|Overall Study|Progressive Disease|44
347465|NCT00485303|1131119|P1|Overall Study|Adverse Event|5
347466|NCT00485264|1131137|P6|Overall Study|Data frozen before reaching week 48|0
347467|NCT00485264|1131138|P5|Overall Study|Data frozen before reaching week 48|0
347468|NCT00485264|1131139|P4|Overall Study|Data frozen before reaching week 48|9
347469|NCT00485264|1131140|P3|Overall Study|Data frozen before reaching week 48|0
347470|NCT00485264|1131141|P2|Overall Study|Data frozen before reaching week 48|0
347471|NCT00485264|1131142|P1|Overall Study|Data frozen before reaching week 48|0
347472|NCT00485264|1131137|P6|Overall Study|Lack of Efficacy|0
347473|NCT00485264|1131138|P5|Overall Study|Lack of Efficacy|0
347474|NCT00485264|1131139|P4|Overall Study|Lack of Efficacy|1
347475|NCT00485264|1131140|P3|Overall Study|Lack of Efficacy|0
347476|NCT00485264|1131141|P2|Overall Study|Lack of Efficacy|0
347477|NCT00485264|1131142|P1|Overall Study|Lack of Efficacy|0
347478|NCT00485264|1131137|P6|Overall Study|Physician Decision|0
347479|NCT00485264|1131138|P5|Overall Study|Physician Decision|0
347480|NCT00485264|1131139|P4|Overall Study|Physician Decision|0
347481|NCT00485264|1131140|P3|Overall Study|Physician Decision|0
347482|NCT00485264|1131141|P2|Overall Study|Physician Decision|1
347483|NCT00485264|1131142|P1|Overall Study|Physician Decision|0
347484|NCT00485264|1131137|P6|Overall Study|Non-compliant|0
347485|NCT00485264|1131138|P5|Overall Study|Non-compliant|0
347486|NCT00485264|1131139|P4|Overall Study|Non-compliant|0
347487|NCT00485264|1131140|P3|Overall Study|Non-compliant|0
347488|NCT00485264|1131141|P2|Overall Study|Non-compliant|0
347489|NCT00485264|1131142|P1|Overall Study|Non-compliant|6
347490|NCT00485173|1131228|P2|Overall Study|Lost to Follow-up|61
347491|NCT00485173|1131229|P1|Overall Study|Lost to Follow-up|32
347492|NCT00485173|1131228|P2|Overall Study|Death|3
347493|NCT00485173|1131229|P1|Overall Study|Death|4
347494|NCT00485069|1131271|P2|Overall Study|Withdrawal by Subject|6
347495|NCT00485069|1131272|P1|Overall Study|Withdrawal by Subject|6
347496|NCT00485069|1131271|P2|Overall Study|Protocol Violation|1
347497|NCT00485069|1131272|P1|Overall Study|Protocol Violation|0
347498|NCT00485069|1131271|P2|Overall Study|Lack of Efficacy|1
347499|NCT00485069|1131272|P1|Overall Study|Lack of Efficacy|2
347500|NCT00485069|1131271|P2|Overall Study|Adverse Event|4
347501|NCT00485069|1131272|P1|Overall Study|Adverse Event|10
347502|NCT00484939|1131317|P2|Overall Study|Reason Not Specified|6
347503|NCT00484939|1131318|P1|Overall Study|Reason Not Specified|11
347504|NCT00484939|1131317|P2|Overall Study|Screen Failure|2
347505|NCT00484939|1131318|P1|Overall Study|Screen Failure|2
347506|NCT00484939|1131317|P2|Overall Study|Disease progression|88
347507|NCT00484939|1131318|P1|Overall Study|Disease progression|67
347508|NCT00484939|1131317|P2|Overall Study|Discretion of Investigator or Sponsor|3
347509|NCT00484939|1131318|P1|Overall Study|Discretion of Investigator or Sponsor|7
347510|NCT00484939|1131317|P2|Overall Study|Lost to Follow-up|3
347511|NCT00484939|1131318|P1|Overall Study|Lost to Follow-up|0
347512|NCT00484939|1131317|P2|Overall Study|Protocol Violation|3
347513|NCT00484939|1131318|P1|Overall Study|Protocol Violation|3
347514|NCT00484939|1131317|P2|Overall Study|Patient Withdrew Consent|10
347515|NCT00484939|1131318|P1|Overall Study|Patient Withdrew Consent|19
347516|NCT00484939|1131317|P2|Overall Study|Adverse Event|12
347517|NCT00484939|1131318|P1|Overall Study|Adverse Event|22
347518|NCT00484939|1131317|P2|Overall Study|Death|13
347519|NCT00484939|1131318|P1|Overall Study|Death|9
347520|NCT00484679|1131338|P1|Overall Study|Withdrawal by Subject|3
347521|NCT00484419|1131345|P3|Overall Study|sponsor decision, randomized in error|2
347522|NCT00484419|1131346|P2|Overall Study|sponsor decision, randomized in error|0
347523|NCT00484419|1131347|P1|Overall Study|sponsor decision, randomized in error|0
347524|NCT00484419|1131345|P3|Overall Study|subject relocated|0
347525|NCT00484419|1131346|P2|Overall Study|subject relocated|1
347526|NCT00484419|1131347|P1|Overall Study|subject relocated|0
347527|NCT00484419|1131345|P3|Overall Study|subject unable to receive medication|0
347528|NCT00484419|1131346|P2|Overall Study|subject unable to receive medication|0
347529|NCT00484419|1131347|P1|Overall Study|subject unable to receive medication|1
347530|NCT00484419|1131345|P3|Overall Study|Physician Decision|1
347531|NCT00484419|1131346|P2|Overall Study|Physician Decision|1
347532|NCT00484419|1131347|P1|Overall Study|Physician Decision|1
347533|NCT00484419|1131345|P3|Overall Study|required restricted medication|1
347534|NCT00484419|1131346|P2|Overall Study|required restricted medication|0
347535|NCT00484419|1131347|P1|Overall Study|required restricted medication|1
347536|NCT00484419|1131345|P3|Overall Study|subject met discontinuation criteria|4
347537|NCT00484419|1131346|P2|Overall Study|subject met discontinuation criteria|2
347538|NCT00484419|1131347|P1|Overall Study|subject met discontinuation criteria|2
347539|NCT00484419|1131345|P3|Overall Study|Withdrawal by Subject|1
347540|NCT00484419|1131346|P2|Overall Study|Withdrawal by Subject|1
347541|NCT00484419|1131347|P1|Overall Study|Withdrawal by Subject|3
347542|NCT00484419|1131345|P3|Overall Study|Lost to Follow-up|2
347543|NCT00484419|1131346|P2|Overall Study|Lost to Follow-up|0
347544|NCT00484419|1131347|P1|Overall Study|Lost to Follow-up|1
347545|NCT00484419|1131345|P3|Overall Study|Adverse Event|0
347546|NCT00484419|1131346|P2|Overall Study|Adverse Event|0
347547|NCT00484419|1131347|P1|Overall Study|Adverse Event|3
347548|NCT00484315|1131414|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
347549|NCT00484315|1131415|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
347550|NCT00484315|1131414|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
347551|NCT00484315|1131415|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
347552|NCT00484315|1131414|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
347553|NCT00484315|1131415|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
347554|NCT00484315|1131414|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
347555|NCT00484315|1131415|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
347556|NCT00484315|1131414|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
347557|NCT00484315|1131415|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
347558|NCT00484315|1131414|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
347559|NCT00484315|1131415|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
347560|NCT00484315|1131414|P2|12-Month Clinical Follow-up|Death|2
347561|NCT00484315|1131415|P1|12-Month Clinical Follow-up|Death|6
347562|NCT00484289|1131426|P3|Post Marketing Phase|Adverse Event|0
347563|NCT00484289|1131427|P2|Post Marketing Phase|Adverse Event|1
347564|NCT00484289|1131428|P1|Post Marketing Phase|Adverse Event|0
347565|NCT00484289|1131426|P3|Long Term Phase|Other Reason|1
347566|NCT00484289|1131427|P2|Long Term Phase|Other Reason|5
347567|NCT00484289|1131428|P1|Long Term Phase|Other Reason|0
347568|NCT00484289|1131426|P3|Long Term Phase|Inadequate response|4
347569|NCT00484289|1131427|P2|Long Term Phase|Inadequate response|7
347570|NCT00484289|1131428|P1|Long Term Phase|Inadequate response|2
347571|NCT00484289|1131426|P3|Long Term Phase|Withdrawal by Subject|6
347572|NCT00484289|1131427|P2|Long Term Phase|Withdrawal by Subject|7
347573|NCT00484289|1131428|P1|Long Term Phase|Withdrawal by Subject|0
347574|NCT00484289|1131426|P3|Long Term Phase|Adverse Event|5
347575|NCT00484289|1131427|P2|Long Term Phase|Adverse Event|17
347576|NCT00484289|1131428|P1|Long Term Phase|Adverse Event|1
347577|NCT00484185|1131500|P1|Overall Study|Death|2
347578|NCT00484185|1131500|P1|Overall Study|Randomized but not treated|5
347579|NCT00484185|1131500|P1|Overall Study|Unspecified|20
347580|NCT00484185|1131500|P1|Overall Study|Lost to Follow-up|44
347581|NCT00484159|1131522|P3|Overall Study|Lost to Follow-up|0
347582|NCT00484159|1131523|P2|Overall Study|Lost to Follow-up|1
347583|NCT00484159|1131524|P1|Overall Study|Lost to Follow-up|1
347584|NCT00484094|1131535|P1|Overall Study|Other|3
347585|NCT00484094|1131535|P1|Overall Study|Discontinued|39
347586|NCT00483938|1131551|P7|Overall Study|Unspecified|32
347587|NCT00483938|1131552|P6|Overall Study|Unspecified|4
347588|NCT00483938|1131553|P5|Overall Study|Unspecified|0
347589|NCT00483938|1131554|P4|Overall Study|Unspecified|4
347590|NCT00483938|1131555|P3|Overall Study|Unspecified|0
347591|NCT00483938|1131556|P2|Overall Study|Unspecified|9
347592|NCT00483938|1131557|P1|Overall Study|Unspecified|3
347593|NCT00483938|1131551|P7|Overall Study|Death|0
347594|NCT00483938|1131552|P6|Overall Study|Death|0
347595|NCT00483938|1131553|P5|Overall Study|Death|0
347596|NCT00483938|1131554|P4|Overall Study|Death|0
347597|NCT00483938|1131555|P3|Overall Study|Death|0
347598|NCT00483938|1131556|P2|Overall Study|Death|2
347599|NCT00483938|1131557|P1|Overall Study|Death|0
347600|NCT00483938|1131551|P7|Overall Study|Lost to Follow-up|3
347601|NCT00483938|1131552|P6|Overall Study|Lost to Follow-up|1
347602|NCT00483938|1131553|P5|Overall Study|Lost to Follow-up|1
347603|NCT00483938|1131554|P4|Overall Study|Lost to Follow-up|2
347604|NCT00483938|1131555|P3|Overall Study|Lost to Follow-up|0
347605|NCT00483938|1131556|P2|Overall Study|Lost to Follow-up|2
347606|NCT00483938|1131557|P1|Overall Study|Lost to Follow-up|1
347607|NCT00483938|1131551|P7|Overall Study|Withdrawal by Subject|2
347608|NCT00483938|1131552|P6|Overall Study|Withdrawal by Subject|3
347609|NCT00483938|1131553|P5|Overall Study|Withdrawal by Subject|1
347610|NCT00483938|1131554|P4|Overall Study|Withdrawal by Subject|0
347611|NCT00483938|1131555|P3|Overall Study|Withdrawal by Subject|0
347612|NCT00483938|1131556|P2|Overall Study|Withdrawal by Subject|6
347613|NCT00483938|1131557|P1|Overall Study|Withdrawal by Subject|1
347614|NCT00483938|1131551|P7|Overall Study|Protocol Violation|3
347615|NCT00483938|1131552|P6|Overall Study|Protocol Violation|0
347616|NCT00483938|1131553|P5|Overall Study|Protocol Violation|0
347617|NCT00483938|1131554|P4|Overall Study|Protocol Violation|0
347618|NCT00483938|1131555|P3|Overall Study|Protocol Violation|0
347619|NCT00483938|1131556|P2|Overall Study|Protocol Violation|0
347620|NCT00483938|1131557|P1|Overall Study|Protocol Violation|0
347621|NCT00483756|1131581|P3|Overall Study|Randomized, Not Treated|4
347622|NCT00483756|1131582|P2|Overall Study|Randomized, Not Treated|4
347623|NCT00483756|1131583|P1|Overall Study|Randomized, Not Treated|1
347624|NCT00483756|1131581|P3|Overall Study|Unspecified|3
347625|NCT00483756|1131582|P2|Overall Study|Unspecified|4
347626|NCT00483756|1131583|P1|Overall Study|Unspecified|2
347627|NCT00483756|1131581|P3|Overall Study|Withdrawal by Subject|4
347628|NCT00483756|1131582|P2|Overall Study|Withdrawal by Subject|3
347629|NCT00483756|1131583|P1|Overall Study|Withdrawal by Subject|5
347630|NCT00483756|1131581|P3|Overall Study|Lost to Follow-up|0
347631|NCT00483756|1131582|P2|Overall Study|Lost to Follow-up|1
347632|NCT00483756|1131583|P1|Overall Study|Lost to Follow-up|3
347633|NCT00483756|1131581|P3|Overall Study|Lack of Efficacy|0
347634|NCT00483756|1131582|P2|Overall Study|Lack of Efficacy|0
347635|NCT00483756|1131583|P1|Overall Study|Lack of Efficacy|1
347636|NCT00483756|1131581|P3|Overall Study|Adverse Event|40
347637|NCT00483756|1131582|P2|Overall Study|Adverse Event|38
347638|NCT00483756|1131583|P1|Overall Study|Adverse Event|19
347639|NCT00483756|1131581|P3|Overall Study|Death|1
347640|NCT00483756|1131582|P2|Overall Study|Death|0
347641|NCT00483756|1131583|P1|Overall Study|Death|2
347642|NCT00483717|1131647|P2|Overall Study|Withdrawal by Subject|0
347643|NCT00483717|1131648|P1|Overall Study|Withdrawal by Subject|1
347644|NCT00483717|1131647|P2|Overall Study|Lost to Follow-up|0
347645|NCT00483717|1131648|P1|Overall Study|Lost to Follow-up|1
347646|NCT00483717|1131647|P2|Overall Study|No treatment for migraine|13
347647|NCT00483717|1131648|P1|Overall Study|No treatment for migraine|16
347648|NCT00483717|1131647|P2|Overall Study|Time of dosing missing|1
347649|NCT00483717|1131648|P1|Overall Study|Time of dosing missing|1
347650|NCT00483717|1131647|P2|Overall Study|Protocol Violation|7
347651|NCT00483717|1131648|P1|Overall Study|Protocol Violation|5
347652|NCT00483704|1131671|P3|Treatment|Physician Decision|4
347653|NCT00483704|1131672|P2|Treatment|Physician Decision|1
347654|NCT00483704|1131673|P1|Treatment|Physician Decision|0
347655|NCT00483704|1131671|P3|Treatment|Pregnancy|0
347656|NCT00483704|1131672|P2|Treatment|Pregnancy|1
347657|NCT00483704|1131673|P1|Treatment|Pregnancy|0
347658|NCT00483704|1131671|P3|Treatment|Lack of Efficacy|1
347659|NCT00483704|1131672|P2|Treatment|Lack of Efficacy|1
347660|NCT00483704|1131673|P1|Treatment|Lack of Efficacy|1
347661|NCT00483704|1131671|P3|Treatment|Lost to Follow-up|5
347662|NCT00483704|1131672|P2|Treatment|Lost to Follow-up|7
347663|NCT00483704|1131673|P1|Treatment|Lost to Follow-up|2
347664|NCT00483704|1131671|P3|Treatment|Protocol Violation|5
347665|NCT00483704|1131672|P2|Treatment|Protocol Violation|3
347666|NCT00483704|1131673|P1|Treatment|Protocol Violation|6
347667|NCT00483704|1131671|P3|Treatment|Withdrawal by Subject|21
347668|NCT00483704|1131672|P2|Treatment|Withdrawal by Subject|12
347669|NCT00483704|1131673|P1|Treatment|Withdrawal by Subject|16
347670|NCT00483704|1131671|P3|Treatment|Adverse Event|4
347671|NCT00483704|1131672|P2|Treatment|Adverse Event|5
347672|NCT00483704|1131673|P1|Treatment|Adverse Event|3
347673|NCT00483704|1131671|P3|Treatment|Lack of qualifying migraines|116
347674|NCT00483704|1131672|P2|Treatment|Lack of qualifying migraines|99
347675|NCT00483704|1131673|P1|Treatment|Lack of qualifying migraines|101
347676|NCT00483704|1131671|P3|Randomization|Lack of qualifying migraines|31
347677|NCT00483704|1131672|P2|Randomization|Lack of qualifying migraines|25
347678|NCT00483704|1131673|P1|Randomization|Lack of qualifying migraines|21
347679|NCT00483704|1131671|P3|Randomization|Progressive disease|1
347680|NCT00483704|1131672|P2|Randomization|Progressive disease|0
347681|NCT00483704|1131673|P1|Randomization|Progressive disease|0
347682|NCT00483704|1131671|P3|Randomization|Physician Decision|0
347683|NCT00483704|1131672|P2|Randomization|Physician Decision|4
347684|NCT00483704|1131673|P1|Randomization|Physician Decision|2
347685|NCT00483704|1131671|P3|Randomization|Pregnancy|0
347686|NCT00483704|1131672|P2|Randomization|Pregnancy|0
347687|NCT00483704|1131673|P1|Randomization|Pregnancy|1
347688|NCT00483704|1131671|P3|Randomization|Lost to Follow-up|19
347689|NCT00483704|1131672|P2|Randomization|Lost to Follow-up|14
347690|NCT00483704|1131673|P1|Randomization|Lost to Follow-up|14
347691|NCT00483704|1131671|P3|Randomization|Protocol Violation|22
347692|NCT00483704|1131672|P2|Randomization|Protocol Violation|25
347693|NCT00483704|1131673|P1|Randomization|Protocol Violation|14
347694|NCT00483704|1131671|P3|Randomization|Withdrawal by Subject|18
347695|NCT00483704|1131672|P2|Randomization|Withdrawal by Subject|28
347696|NCT00483704|1131673|P1|Randomization|Withdrawal by Subject|19
347697|NCT00483652|1131719|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
347698|NCT00483652|1131720|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
347699|NCT00483652|1131719|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
347700|NCT00483652|1131720|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
347701|NCT00483652|1131719|P2|Double-blind Treatment Period|Adverse Event|4
347702|NCT00483652|1131720|P1|Double-blind Treatment Period|Adverse Event|3
347703|NCT00483652|1131719|P2|Double-blind Treatment Period|Protocol Violation|1
347704|NCT00483652|1131720|P1|Double-blind Treatment Period|Protocol Violation|2
347705|NCT00483574|1131730|P2|Overall Study|Withdrawal by Subject|0
347706|NCT00483574|1131731|P1|Overall Study|Withdrawal by Subject|52
347707|NCT00483574|1131730|P2|Overall Study|Lost to Follow-up|4
347708|NCT00483574|1131731|P1|Overall Study|Lost to Follow-up|16
347709|NCT00483574|1131730|P2|Overall Study|Protocol Violation|9
347710|NCT00483574|1131731|P1|Overall Study|Protocol Violation|28
347711|NCT00483574|1131730|P2|Overall Study|Adverse Event|0
347712|NCT00483574|1131731|P1|Overall Study|Adverse Event|6
347713|NCT00483548|1131741|P2|Overall Study|Withdrawal by Subject|2
347714|NCT00483548|1131742|P1|Overall Study|Withdrawal by Subject|5
347715|NCT00483548|1131741|P2|Overall Study|Lost to Follow-up|4
347716|NCT00483548|1131742|P1|Overall Study|Lost to Follow-up|3
347717|NCT00483548|1131741|P2|Overall Study|Non-compliance with medication|0
347718|NCT00483548|1131742|P1|Overall Study|Non-compliance with medication|2
347719|NCT00483548|1131741|P2|Overall Study|Unable to comply with protocol schedule|0
347720|NCT00483548|1131742|P1|Overall Study|Unable to comply with protocol schedule|1
347721|NCT00483548|1131741|P2|Overall Study|Protocol required discontinuation|6
347722|NCT00483548|1131742|P1|Overall Study|Protocol required discontinuation|6
347723|NCT00483548|1131741|P2|Overall Study|Pregnancy|0
347724|NCT00483548|1131742|P1|Overall Study|Pregnancy|1
347725|NCT00483548|1131741|P2|Overall Study|Protocol Violation|7
347726|NCT00483548|1131742|P1|Overall Study|Protocol Violation|11
347727|NCT00483548|1131741|P2|Overall Study|Lack of Efficacy|8
347728|NCT00483548|1131742|P1|Overall Study|Lack of Efficacy|4
347729|NCT00483548|1131741|P2|Overall Study|Laboratory abnormality|2
347730|NCT00483548|1131742|P1|Overall Study|Laboratory abnormality|1
347731|NCT00483548|1131741|P2|Overall Study|Adverse Event|14
347732|NCT00483548|1131742|P1|Overall Study|Adverse Event|25
347733|NCT00483548|1131741|P2|Overall Study|Randomized; not treated with study drug|3
347734|NCT00483548|1131742|P1|Overall Study|Randomized; not treated with study drug|1
347735|NCT00483405|1131791|P1|Overall Study|Other complicating disease|1
347736|NCT00483405|1131791|P1|Overall Study|Withdrawal by Subject|2
347737|NCT00483405|1131791|P1|Overall Study|Death|3
347738|NCT00483405|1131791|P1|Overall Study|Lack of Efficacy|14
347739|NCT00483405|1131791|P1|Overall Study|Adverse Event|8
347740|NCT00483379|1131800|P2|Treatment Period|Withdrawal by Subject|0
347741|NCT00483379|1131801|P1|Treatment Period|Withdrawal by Subject|1
347742|NCT00483379|1131800|P2|Treatment Period|Adverse Event|0
347743|NCT00483379|1131801|P1|Treatment Period|Adverse Event|1
347748|NCT00483184|1131867|P3|Overall Study|Protocol Violation|1
347749|NCT00483184|1131868|P2|Overall Study|Protocol Violation|0
347750|NCT00483184|1131869|P1|Overall Study|Protocol Violation|1
347751|NCT00483184|1131867|P3|Overall Study|Adverse Event|2
347752|NCT00483184|1131868|P2|Overall Study|Adverse Event|2
347753|NCT00483184|1131869|P1|Overall Study|Adverse Event|1
347754|NCT00483184|1131867|P3|Overall Study|Lost to Follow-up|0
347755|NCT00483184|1131868|P2|Overall Study|Lost to Follow-up|0
347756|NCT00483184|1131869|P1|Overall Study|Lost to Follow-up|1
347757|NCT00483184|1131867|P3|Overall Study|Withdrawal by Subject|0
347758|NCT00483184|1131868|P2|Overall Study|Withdrawal by Subject|2
347759|NCT00483184|1131869|P1|Overall Study|Withdrawal by Subject|2
347760|NCT00483119|1131879|P2|Overall Study|Physician Decision|0
347761|NCT00483119|1131880|P1|Overall Study|Physician Decision|1
347762|NCT00483119|1131879|P2|Overall Study|Adverse Event|1
347763|NCT00483119|1131880|P1|Overall Study|Adverse Event|0
347764|NCT00483041|1131894|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
347765|NCT00483041|1131895|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
347766|NCT00483002|1131925|P1|Overall Study|Unspecified|967
347767|NCT00483002|1131925|P1|Overall Study|Other|2
347768|NCT00483002|1131925|P1|Overall Study|Lost to Follow-up|962
347769|NCT00483002|1131925|P1|Overall Study|Lack of Efficacy|555
347770|NCT00483002|1131925|P1|Overall Study|Adverse Event|68
347771|NCT00482729|1131950|P2|Overall Study|Withdrawal by Subject|69
347772|NCT00482729|1131951|P1|Overall Study|Withdrawal by Subject|67
347773|NCT00482729|1131950|P2|Overall Study|Protocol Violation|18
347774|NCT00482729|1131951|P1|Overall Study|Protocol Violation|10
347775|NCT00482729|1131950|P2|Overall Study|Pregnancy|2
347776|NCT00482729|1131951|P1|Overall Study|Pregnancy|4
347777|NCT00482729|1131950|P2|Overall Study|Physician Decision|7
347778|NCT00482729|1131951|P1|Overall Study|Physician Decision|10
347779|NCT00482729|1131950|P2|Overall Study|Lost to Follow-up|66
347780|NCT00482729|1131951|P1|Overall Study|Lost to Follow-up|86
347781|NCT00482729|1131950|P2|Overall Study|Lack of Efficacy|16
347782|NCT00482729|1131951|P1|Overall Study|Lack of Efficacy|4
347783|NCT00482729|1131950|P2|Overall Study|Hyperglycemia Criteria|5
347784|NCT00482729|1131951|P1|Overall Study|Hyperglycemia Criteria|7
347785|NCT00482729|1131950|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
347786|NCT00482729|1131951|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
347787|NCT00482729|1131950|P2|Overall Study|Adverse Event|33
347788|NCT00482729|1131951|P1|Overall Study|Adverse Event|29
347789|NCT00482703|1131967|P2|Overall Study|Poor compliance|0
347790|NCT00482703|1131968|P1|Overall Study|Poor compliance|1
347791|NCT00482612|1132026|P4|Follow-up Period|Reasons not related to trial|3
347792|NCT00482612|1132027|P3|Follow-up Period|Reasons not related to trial|1
347793|NCT00482612|1132028|P2|Follow-up Period|Reasons not related to trial|0
347794|NCT00482612|1132029|P1|Follow-up Period|Reasons not related to trial|1
347795|NCT00482612|1132026|P4|Follow-up Period|Withdrawal by Subject|2
347796|NCT00482612|1132027|P3|Follow-up Period|Withdrawal by Subject|7
347797|NCT00482612|1132028|P2|Follow-up Period|Withdrawal by Subject|5
347798|NCT00482612|1132029|P1|Follow-up Period|Withdrawal by Subject|3
347799|NCT00482612|1132026|P4|Follow-up Period|Lack of Efficacy|0
347800|NCT00482612|1132027|P3|Follow-up Period|Lack of Efficacy|1
347801|NCT00482612|1132028|P2|Follow-up Period|Lack of Efficacy|0
347802|NCT00482612|1132029|P1|Follow-up Period|Lack of Efficacy|2
347803|NCT00482612|1132026|P4|Follow-up Period|Adverse Event|0
347804|NCT00482612|1132027|P3|Follow-up Period|Adverse Event|9
347805|NCT00482612|1132028|P2|Follow-up Period|Adverse Event|7
347806|NCT00482612|1132029|P1|Follow-up Period|Adverse Event|4
347807|NCT00482612|1132026|P4|Follow-up Period|Lost to Follow-up|1
347808|NCT00482612|1132027|P3|Follow-up Period|Lost to Follow-up|2
347809|NCT00482612|1132028|P2|Follow-up Period|Lost to Follow-up|4
347810|NCT00482612|1132029|P1|Follow-up Period|Lost to Follow-up|0
347811|NCT00482612|1132026|P4|Follow-up Period|Lack of compliance|0
347812|NCT00482612|1132027|P3|Follow-up Period|Lack of compliance|1
347813|NCT00482612|1132028|P2|Follow-up Period|Lack of compliance|0
347814|NCT00482612|1132029|P1|Follow-up Period|Lack of compliance|0
347815|NCT00482612|1132026|P4|Follow-up Period|Unspecified|2
347816|NCT00482612|1132027|P3|Follow-up Period|Unspecified|1
347817|NCT00482612|1132028|P2|Follow-up Period|Unspecified|2
347818|NCT00482612|1132029|P1|Follow-up Period|Unspecified|4
347819|NCT00482612|1132026|P4|In-treatment Period|No study medication administered|0
347820|NCT00482612|1132027|P3|In-treatment Period|No study medication administered|1
347821|NCT00482612|1132028|P2|In-treatment Period|No study medication administered|0
347822|NCT00482612|1132029|P1|In-treatment Period|No study medication administered|0
347823|NCT00480636|1132078|P1|Overall Study|Lost to follow-up; subsequently died|1
347824|NCT00480636|1132078|P1|Overall Study|Unspecified|2
347825|NCT00480636|1132078|P1|Overall Study|Lost to Follow-up|4
347826|NCT00480636|1132078|P1|Overall Study|Death|12
347827|NCT00482391|1132086|P1|Overall Study|Death|1
347828|NCT00482391|1132086|P1|Overall Study|Adverse Event|1
347829|NCT00482391|1132086|P1|Overall Study|Withdrawal by Subject|1
347830|NCT00482274|1132091|P1|Overall Study|Adverse Event|1
347831|NCT00482170|1132101|P2|Overall Study|Unspecified reason|2
347832|NCT00482170|1132102|P1|Overall Study|Unspecified reason|0
347833|NCT00482170|1132101|P2|Overall Study|Lost to Follow-up|0
347834|NCT00482170|1132102|P1|Overall Study|Lost to Follow-up|2
347835|NCT00482170|1132101|P2|Overall Study|Protocol Violation|3
347836|NCT00482170|1132102|P1|Overall Study|Protocol Violation|2
347837|NCT00482170|1132101|P2|Overall Study|Withdrawal by Subject|1
347838|NCT00482170|1132102|P1|Overall Study|Withdrawal by Subject|6
347839|NCT00482170|1132101|P2|Overall Study|Adverse Event|14
347840|NCT00482170|1132102|P1|Overall Study|Adverse Event|5
347841|NCT00482014|1132224|P4|Overall Study|Sponsor Decision|1
347842|NCT00482014|1132225|P3|Overall Study|Sponsor Decision|1
347843|NCT00482014|1132226|P2|Overall Study|Sponsor Decision|2
347844|NCT00482014|1132227|P1|Overall Study|Sponsor Decision|1
347845|NCT00482014|1132224|P4|Overall Study|Lack of Efficacy|6
347846|NCT00482014|1132225|P3|Overall Study|Lack of Efficacy|4
347847|NCT00482014|1132226|P2|Overall Study|Lack of Efficacy|0
347848|NCT00482014|1132227|P1|Overall Study|Lack of Efficacy|1
347849|NCT00482014|1132224|P4|Overall Study|Death|4
347850|NCT00482014|1132225|P3|Overall Study|Death|1
347851|NCT00482014|1132226|P2|Overall Study|Death|2
347852|NCT00482014|1132227|P1|Overall Study|Death|1
347853|NCT00482014|1132224|P4|Overall Study|Adverse Event|8
347854|NCT00482014|1132225|P3|Overall Study|Adverse Event|2
347855|NCT00482014|1132226|P2|Overall Study|Adverse Event|0
347856|NCT00482014|1132227|P1|Overall Study|Adverse Event|3
347857|NCT00482014|1132224|P4|Overall Study|Withdrawal by Subject|4
347858|NCT00482014|1132225|P3|Overall Study|Withdrawal by Subject|3
347859|NCT00482014|1132226|P2|Overall Study|Withdrawal by Subject|2
347860|NCT00482014|1132227|P1|Overall Study|Withdrawal by Subject|1
347861|NCT00481988|1132251|P2|Overall Study|Withdrawal by Subject|1
347862|NCT00481988|1132252|P1|Overall Study|Withdrawal by Subject|1
347863|NCT00481871|1132265|P5|Overall Study|Progressive Disease - pt withdrew|0
347864|NCT00481871|1132266|P4|Overall Study|Progressive Disease - pt withdrew|0
347865|NCT00481871|1132267|P3|Overall Study|Progressive Disease - pt withdrew|1
347866|NCT00481871|1132268|P2|Overall Study|Progressive Disease - pt withdrew|0
347867|NCT00481871|1132269|P1|Overall Study|Progressive Disease - pt withdrew|0
347868|NCT00481767|1132296|P2|Overall Study|Lost to Follow-up|10
347869|NCT00481767|1132297|P1|Overall Study|Lost to Follow-up|16
347870|NCT00481767|1132296|P2|Overall Study|Withdrawal by Subject|11
347871|NCT00481767|1132297|P1|Overall Study|Withdrawal by Subject|16
347872|NCT00481676|1132329|P2|Overall Study|Administrative problem|0
347873|NCT00481676|1132330|P1|Overall Study|Administrative problem|1
347874|NCT00481676|1132329|P2|Overall Study|Unsatisfactory therapeutic effect|4
347875|NCT00481676|1132330|P1|Overall Study|Unsatisfactory therapeutic effect|1
347876|NCT00481676|1132329|P2|Overall Study|Adverse Event|1
347877|NCT00481676|1132330|P1|Overall Study|Adverse Event|0
347878|NCT00480532|1132356|P4|Overall Study|Protocol Violation|0
347879|NCT00480532|1132357|P3|Overall Study|Protocol Violation|1
347880|NCT00480532|1132358|P2|Overall Study|Protocol Violation|0
347881|NCT00480532|1132359|P1|Overall Study|Protocol Violation|0
347882|NCT00480532|1132356|P4|Overall Study|Withdrawal by Subject|1
347883|NCT00480532|1132357|P3|Overall Study|Withdrawal by Subject|3
347884|NCT00480532|1132358|P2|Overall Study|Withdrawal by Subject|4
347885|NCT00480532|1132359|P1|Overall Study|Withdrawal by Subject|2
347886|NCT00480493|1132379|P2|Overall Study|moved|7
347887|NCT00480493|1132380|P1|Overall Study|moved|2
347888|NCT00481247|1132418|P2|Overall Study|Did not receive treatment|2
347889|NCT00481247|1132419|P1|Overall Study|Did not receive treatment|1
347890|NCT00481247|1132418|P2|Overall Study|Varied|15
347891|NCT00481247|1132419|P1|Overall Study|Varied|6
347892|NCT00481247|1132418|P2|Overall Study|Administrative reason by sponsor|162
347893|NCT00481247|1132419|P1|Overall Study|Administrative reason by sponsor|157
347894|NCT00481247|1132418|P2|Overall Study|Poor compliance/noncompliance|7
347895|NCT00481247|1132419|P1|Overall Study|Poor compliance/noncompliance|1
347896|NCT00481247|1132418|P2|Overall Study|Lost to Follow-up|2
347897|NCT00481247|1132419|P1|Overall Study|Lost to Follow-up|1
347898|NCT00481247|1132418|P2|Overall Study|Pregnancy|1
347899|NCT00481247|1132419|P1|Overall Study|Pregnancy|2
347900|NCT00481247|1132418|P2|Overall Study|Withdrawal by Subject|13
347901|NCT00481247|1132419|P1|Overall Study|Withdrawal by Subject|8
347902|NCT00481247|1132418|P2|Overall Study|AE unrelated to study drug|4
347903|NCT00481247|1132419|P1|Overall Study|AE unrelated to study drug|13
347904|NCT00481247|1132418|P2|Overall Study|Treatment failure|14
347905|NCT00481247|1132419|P1|Overall Study|Treatment failure|10
347906|NCT00481247|1132418|P2|Overall Study|Intolerance|17
347907|NCT00481247|1132419|P1|Overall Study|Intolerance|42
347908|NCT00481247|1132418|P2|Overall Study|Disease progression|22
347909|NCT00481247|1132419|P1|Overall Study|Disease progression|18
347910|NCT00481247|1132418|P2|Overall Study|Death|1
347911|NCT00481247|1132419|P1|Overall Study|Death|0
347912|NCT00481195|1132443|P2|Overall Study|Miscellaneous|2
347913|NCT00481195|1132444|P1|Overall Study|Miscellaneous|2
347914|NCT00481195|1132443|P2|Overall Study|Withdrawal by Subject|9
347915|NCT00481195|1132444|P1|Overall Study|Withdrawal by Subject|3
347916|NCT00481195|1132443|P2|Overall Study|Protocol Violation|7
347917|NCT00481195|1132444|P1|Overall Study|Protocol Violation|10
347918|NCT00481195|1132443|P2|Overall Study|Physician Decision|1
347919|NCT00481195|1132444|P1|Overall Study|Physician Decision|3
347920|NCT00481195|1132443|P2|Overall Study|Lost to Follow-up|6
347921|NCT00481195|1132444|P1|Overall Study|Lost to Follow-up|4
347922|NCT00481195|1132443|P2|Overall Study|Lack of Efficacy|3
347923|NCT00481195|1132444|P1|Overall Study|Lack of Efficacy|1
347924|NCT00481195|1132443|P2|Overall Study|Adverse Event|11
347925|NCT00481195|1132444|P1|Overall Study|Adverse Event|16
347926|NCT00481078|1132530|P2|Overall Study|Brain metastasis|1
347927|NCT00481078|1132531|P1|Overall Study|Brain metastasis|0
347928|NCT00481078|1132530|P2|Overall Study|Received other treatment|1
347929|NCT00481078|1132531|P1|Overall Study|Received other treatment|2
347930|NCT00481078|1132530|P2|Overall Study|Information not available|0
347931|NCT00481078|1132531|P1|Overall Study|Information not available|1
347932|NCT00481078|1132530|P2|Overall Study|Withdrawal by Subject|1
347933|NCT00481078|1132531|P1|Overall Study|Withdrawal by Subject|7
347934|NCT00481078|1132530|P2|Overall Study|Intercurrent illness|0
347935|NCT00481078|1132531|P1|Overall Study|Intercurrent illness|1
347936|NCT00481078|1132530|P2|Overall Study|Death|3
347937|NCT00481078|1132531|P1|Overall Study|Death|5
347938|NCT00481078|1132530|P2|Overall Study|Adverse Event|3
347939|NCT00481078|1132531|P1|Overall Study|Adverse Event|15
347940|NCT00481078|1132530|P2|Overall Study|Progression of disease|11
347941|NCT00481078|1132531|P1|Overall Study|Progression of disease|11
347942|NCT00481065|1132549|P8|Overall Study|Unable to classify|0
347943|NCT00481065|1132550|P7|Overall Study|Unable to classify|0
347944|NCT00481065|1132551|P6|Overall Study|Unable to classify|0
347945|NCT00481065|1132552|P5|Overall Study|Unable to classify|1
347946|NCT00481065|1132553|P4|Overall Study|Unable to classify|0
347947|NCT00481065|1132554|P3|Overall Study|Unable to classify|2
347948|NCT00481065|1132555|P2|Overall Study|Unable to classify|1
347949|NCT00481065|1132556|P1|Overall Study|Unable to classify|0
347950|NCT00481065|1132549|P8|Overall Study|Protocol Violation|2
347951|NCT00481065|1132550|P7|Overall Study|Protocol Violation|3
347952|NCT00481065|1132551|P6|Overall Study|Protocol Violation|6
347953|NCT00481065|1132552|P5|Overall Study|Protocol Violation|2
347954|NCT00481065|1132553|P4|Overall Study|Protocol Violation|1
347955|NCT00481065|1132554|P3|Overall Study|Protocol Violation|1
347956|NCT00481065|1132555|P2|Overall Study|Protocol Violation|1
347957|NCT00481065|1132556|P1|Overall Study|Protocol Violation|2
347958|NCT00481065|1132549|P8|Overall Study|Administrative reason|0
347959|NCT00481065|1132550|P7|Overall Study|Administrative reason|1
347960|NCT00481065|1132551|P6|Overall Study|Administrative reason|2
347961|NCT00481065|1132552|P5|Overall Study|Administrative reason|0
347962|NCT00481065|1132553|P4|Overall Study|Administrative reason|0
347963|NCT00481065|1132554|P3|Overall Study|Administrative reason|0
347964|NCT00481065|1132555|P2|Overall Study|Administrative reason|0
347965|NCT00481065|1132556|P1|Overall Study|Administrative reason|0
347966|NCT00481065|1132549|P8|Overall Study|Inappropriate enrollment|1
347967|NCT00481065|1132550|P7|Overall Study|Inappropriate enrollment|0
347968|NCT00481065|1132551|P6|Overall Study|Inappropriate enrollment|1
347969|NCT00481065|1132552|P5|Overall Study|Inappropriate enrollment|2
347970|NCT00481065|1132553|P4|Overall Study|Inappropriate enrollment|0
347971|NCT00481065|1132554|P3|Overall Study|Inappropriate enrollment|2
347972|NCT00481065|1132555|P2|Overall Study|Inappropriate enrollment|0
347973|NCT00481065|1132556|P1|Overall Study|Inappropriate enrollment|4
347974|NCT00481065|1132549|P8|Overall Study|Lost to Follow-up|5
347975|NCT00481065|1132550|P7|Overall Study|Lost to Follow-up|2
347976|NCT00481065|1132551|P6|Overall Study|Lost to Follow-up|3
347977|NCT00481065|1132552|P5|Overall Study|Lost to Follow-up|3
347978|NCT00481065|1132553|P4|Overall Study|Lost to Follow-up|3
347979|NCT00481065|1132554|P3|Overall Study|Lost to Follow-up|4
347980|NCT00481065|1132555|P2|Overall Study|Lost to Follow-up|2
347981|NCT00481065|1132556|P1|Overall Study|Lost to Follow-up|4
347982|NCT00481065|1132549|P8|Overall Study|Withdrawal by Subject|10
347983|NCT00481065|1132550|P7|Overall Study|Withdrawal by Subject|9
347984|NCT00481065|1132551|P6|Overall Study|Withdrawal by Subject|12
347985|NCT00481065|1132552|P5|Overall Study|Withdrawal by Subject|13
347986|NCT00481065|1132553|P4|Overall Study|Withdrawal by Subject|11
347987|NCT00481065|1132554|P3|Overall Study|Withdrawal by Subject|7
347988|NCT00481065|1132555|P2|Overall Study|Withdrawal by Subject|12
347989|NCT00481065|1132556|P1|Overall Study|Withdrawal by Subject|11
347990|NCT00481065|1132549|P8|Overall Study|Adverse event or death|1
347991|NCT00481065|1132550|P7|Overall Study|Adverse event or death|1
347992|NCT00481065|1132551|P6|Overall Study|Adverse event or death|0
347993|NCT00481065|1132552|P5|Overall Study|Adverse event or death|2
347994|NCT00481065|1132553|P4|Overall Study|Adverse event or death|0
347995|NCT00481065|1132554|P3|Overall Study|Adverse event or death|3
347996|NCT00481065|1132555|P2|Overall Study|Adverse event or death|1
347997|NCT00481065|1132556|P1|Overall Study|Adverse event or death|1
347998|NCT00480857|1132646|P1|Overall Study|Lack of Efficacy|2
347999|NCT00480779|1132653|P2|Overall Study|Job and Health-related|3
348000|NCT00480779|1132654|P1|Overall Study|Job and Health-related|0
348001|NCT00480779|1132653|P2|Overall Study|Other|0
348002|NCT00480779|1132654|P1|Overall Study|Other|2
348003|NCT00480324|1132693|P2|Overall Study|Subject’s mother pregnant|1
348004|NCT00480324|1132694|P1|Overall Study|Subject’s mother pregnant|0
348005|NCT00480324|1132693|P2|Overall Study|Lost to Follow-up|8
348006|NCT00480324|1132694|P1|Overall Study|Lost to Follow-up|17
348007|NCT00480324|1132693|P2|Overall Study|Withdrawal by Subject|5
348008|NCT00480324|1132694|P1|Overall Study|Withdrawal by Subject|14
348009|NCT00480324|1132693|P2|Overall Study|Protocol Violation|1
348010|NCT00480324|1132694|P1|Overall Study|Protocol Violation|0
348011|NCT00480324|1132693|P2|Overall Study|Adverse Event|1
348012|NCT00480324|1132694|P1|Overall Study|Adverse Event|1
348013|NCT00479882|1132724|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
348014|NCT00479882|1132725|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
348015|NCT00479882|1132726|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
348016|NCT00479882|1132727|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
348017|NCT00479882|1132724|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
348018|NCT00479882|1132725|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
348019|NCT00479882|1132726|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
348020|NCT00479882|1132727|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
348021|NCT00479882|1132724|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
348022|NCT00479882|1132725|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
348023|NCT00479882|1132726|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
348024|NCT00479882|1132727|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
348025|NCT00479882|1132724|P4|Crossover: Period III (Weeks 13-20)|Other|2
348026|NCT00479882|1132725|P3|Crossover: Period III (Weeks 13-20)|Other|2
348027|NCT00479882|1132726|P2|Crossover: Period III (Weeks 13-20)|Other|0
348028|NCT00479882|1132727|P1|Crossover: Period III (Weeks 13-20)|Other|5
348029|NCT00479882|1132724|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
348030|NCT00479882|1132725|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
348031|NCT00479882|1132726|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
348032|NCT00479882|1132727|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
348033|NCT00479882|1132724|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
348034|NCT00479882|1132725|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
348035|NCT00479882|1132726|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
348036|NCT00479882|1132727|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
348037|NCT00479882|1132724|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
348038|NCT00479882|1132725|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
348039|NCT00479882|1132726|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
348040|NCT00479882|1132727|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
348041|NCT00479882|1132724|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
348042|NCT00479882|1132725|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
348043|NCT00479882|1132726|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
348044|NCT00479882|1132727|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
348045|NCT00479882|1132724|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
348046|NCT00479882|1132725|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
348047|NCT00479882|1132726|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
348048|NCT00479882|1132727|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
348049|NCT00479882|1132724|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
348050|NCT00479882|1132725|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
348051|NCT00479882|1132726|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
348052|NCT00479882|1132727|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
348053|NCT00479882|1132724|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
348054|NCT00479882|1132725|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
348055|NCT00479882|1132726|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
348056|NCT00479882|1132727|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
348057|NCT00479882|1132724|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
348058|NCT00479882|1132725|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
348059|NCT00479882|1132726|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
348060|NCT00479882|1132727|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
348061|NCT00479882|1132724|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
348062|NCT00479882|1132725|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
348063|NCT00479882|1132726|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
348064|NCT00479882|1132727|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
348065|NCT00479882|1132724|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
348066|NCT00479882|1132725|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
348067|NCT00479882|1132726|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
348068|NCT00479882|1132727|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
348069|NCT00479856|1132857|P1|Overall Study|Physician Decision|1
348070|NCT00479856|1132857|P1|Overall Study|Withdrawal by Subject|1
348071|NCT00479856|1132857|P1|Overall Study|Adverse Event|1
348072|NCT00479765|1132866|P1|Overall Study|study terminated|4
348073|NCT00479713|1132872|P2|Overall Study|Withdrawal by Subject|1
348074|NCT00479713|1132873|P1|Overall Study|Withdrawal by Subject|4
348075|NCT00479713|1132872|P2|Overall Study|Protocol Violation|1
348076|NCT00479713|1132873|P1|Overall Study|Protocol Violation|0
348077|NCT00479713|1132872|P2|Overall Study|Lost to Follow-up|1
348078|NCT00479713|1132873|P1|Overall Study|Lost to Follow-up|0
348079|NCT00479713|1132872|P2|Overall Study|Death|0
348080|NCT00479713|1132873|P1|Overall Study|Death|1
348081|NCT00479713|1132872|P2|Overall Study|Adverse Event|6
348082|NCT00479713|1132873|P1|Overall Study|Adverse Event|8
348083|NCT00479674|1132897|P1|Overall Study|none provided|3
348084|NCT00479674|1132897|P1|Overall Study|Physician Decision|14
348085|NCT00479674|1132897|P1|Overall Study|Withdrawal by Subject|6
348086|NCT00479674|1132897|P1|Overall Study|Adverse Event|18
348087|NCT00479557|1132912|P7|Overall Study|Not specified|0
348088|NCT00479557|1132913|P6|Overall Study|Not specified|3
348089|NCT00479557|1132914|P5|Overall Study|Not specified|0
348090|NCT00479557|1132915|P4|Overall Study|Not specified|0
348091|NCT00479557|1132916|P3|Overall Study|Not specified|1
348092|NCT00479557|1132917|P2|Overall Study|Not specified|3
348093|NCT00479557|1132918|P1|Overall Study|Not specified|2
348094|NCT00479557|1132912|P7|Overall Study|Subject Request|1
348095|NCT00479557|1132913|P6|Overall Study|Subject Request|4
348096|NCT00479557|1132914|P5|Overall Study|Subject Request|1
348097|NCT00479557|1132915|P4|Overall Study|Subject Request|1
348098|NCT00479557|1132916|P3|Overall Study|Subject Request|1
348099|NCT00479557|1132917|P2|Overall Study|Subject Request|0
348100|NCT00479557|1132918|P1|Overall Study|Subject Request|3
348101|NCT00479557|1132912|P7|Overall Study|Investigator Request|0
348102|NCT00479557|1132913|P6|Overall Study|Investigator Request|0
348103|NCT00479557|1132914|P5|Overall Study|Investigator Request|0
348104|NCT00479557|1132915|P4|Overall Study|Investigator Request|0
348105|NCT00479557|1132916|P3|Overall Study|Investigator Request|1
348106|NCT00479557|1132917|P2|Overall Study|Investigator Request|0
348107|NCT00479557|1132918|P1|Overall Study|Investigator Request|0
348108|NCT00479557|1132912|P7|Overall Study|Caregiver Request|0
348109|NCT00479557|1132913|P6|Overall Study|Caregiver Request|2
348110|NCT00479557|1132914|P5|Overall Study|Caregiver Request|1
348111|NCT00479557|1132915|P4|Overall Study|Caregiver Request|0
348112|NCT00479557|1132916|P3|Overall Study|Caregiver Request|2
348113|NCT00479557|1132917|P2|Overall Study|Caregiver Request|2
348114|NCT00479557|1132918|P1|Overall Study|Caregiver Request|2
348115|NCT00479557|1132912|P7|Overall Study|AE not related to Study Drug|1
348116|NCT00479557|1132913|P6|Overall Study|AE not related to Study Drug|2
348117|NCT00479557|1132914|P5|Overall Study|AE not related to Study Drug|2
348118|NCT00479557|1132915|P4|Overall Study|AE not related to Study Drug|0
348119|NCT00479557|1132916|P3|Overall Study|AE not related to Study Drug|0
348120|NCT00479557|1132917|P2|Overall Study|AE not related to Study Drug|3
348121|NCT00479557|1132918|P1|Overall Study|AE not related to Study Drug|1
348122|NCT00479557|1132912|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
348123|NCT00479557|1132913|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
348124|NCT00479557|1132914|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
348125|NCT00479557|1132915|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
348126|NCT00479557|1132916|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
348127|NCT00479557|1132917|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
348128|NCT00479557|1132918|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
348129|NCT00479557|1132912|P7|Overall Study|Lost to Follow-up|0
348130|NCT00479557|1132913|P6|Overall Study|Lost to Follow-up|0
348131|NCT00479557|1132914|P5|Overall Study|Lost to Follow-up|0
348132|NCT00479557|1132915|P4|Overall Study|Lost to Follow-up|2
348133|NCT00479557|1132916|P3|Overall Study|Lost to Follow-up|0
348134|NCT00479557|1132917|P2|Overall Study|Lost to Follow-up|2
348135|NCT00479557|1132918|P1|Overall Study|Lost to Follow-up|0
348136|NCT00479557|1132912|P7|Overall Study|Lack of Efficacy|0
348137|NCT00479557|1132913|P6|Overall Study|Lack of Efficacy|0
348138|NCT00479557|1132914|P5|Overall Study|Lack of Efficacy|0
348139|NCT00479557|1132915|P4|Overall Study|Lack of Efficacy|0
348140|NCT00479557|1132916|P3|Overall Study|Lack of Efficacy|0
348141|NCT00479557|1132917|P2|Overall Study|Lack of Efficacy|0
348142|NCT00479557|1132918|P1|Overall Study|Lack of Efficacy|1
348143|NCT00479557|1132912|P7|Overall Study|Death|0
348144|NCT00479557|1132913|P6|Overall Study|Death|1
348145|NCT00479557|1132914|P5|Overall Study|Death|0
348146|NCT00479557|1132915|P4|Overall Study|Death|0
348147|NCT00479557|1132916|P3|Overall Study|Death|0
348148|NCT00479557|1132917|P2|Overall Study|Death|0
348149|NCT00479557|1132918|P1|Overall Study|Death|0
348150|NCT00479466|1132961|P6|Overall Study|Withdrawal by Subject|1
348151|NCT00479466|1132962|P5|Overall Study|Withdrawal by Subject|3
348152|NCT00479466|1132963|P4|Overall Study|Withdrawal by Subject|2
348153|NCT00479466|1132964|P3|Overall Study|Withdrawal by Subject|0
348154|NCT00479466|1132965|P2|Overall Study|Withdrawal by Subject|5
348155|NCT00479466|1132966|P1|Overall Study|Withdrawal by Subject|3
348156|NCT00479466|1132961|P6|Overall Study|Protocol Violation|0
348157|NCT00479466|1132962|P5|Overall Study|Protocol Violation|0
348158|NCT00479466|1132963|P4|Overall Study|Protocol Violation|0
348159|NCT00479466|1132964|P3|Overall Study|Protocol Violation|0
348160|NCT00479466|1132965|P2|Overall Study|Protocol Violation|0
348161|NCT00479466|1132966|P1|Overall Study|Protocol Violation|1
348162|NCT00479466|1132961|P6|Overall Study|Pregnancy|0
348163|NCT00479466|1132962|P5|Overall Study|Pregnancy|1
348164|NCT00479466|1132963|P4|Overall Study|Pregnancy|0
348165|NCT00479466|1132964|P3|Overall Study|Pregnancy|0
348166|NCT00479466|1132965|P2|Overall Study|Pregnancy|0
348167|NCT00479466|1132966|P1|Overall Study|Pregnancy|0
348168|NCT00479466|1132961|P6|Overall Study|Physician Decision|0
348169|NCT00479466|1132962|P5|Overall Study|Physician Decision|0
348170|NCT00479466|1132963|P4|Overall Study|Physician Decision|0
348171|NCT00479466|1132964|P3|Overall Study|Physician Decision|1
348172|NCT00479466|1132965|P2|Overall Study|Physician Decision|1
348173|NCT00479466|1132966|P1|Overall Study|Physician Decision|2
348174|NCT00479466|1132961|P6|Overall Study|Lost to Follow-up|2
348175|NCT00479466|1132962|P5|Overall Study|Lost to Follow-up|2
348176|NCT00479466|1132963|P4|Overall Study|Lost to Follow-up|0
348177|NCT00479466|1132964|P3|Overall Study|Lost to Follow-up|1
348178|NCT00479466|1132965|P2|Overall Study|Lost to Follow-up|1
348179|NCT00479466|1132966|P1|Overall Study|Lost to Follow-up|0
348180|NCT00479466|1132961|P6|Overall Study|Lack of Efficacy|0
348181|NCT00479466|1132962|P5|Overall Study|Lack of Efficacy|0
348182|NCT00479466|1132963|P4|Overall Study|Lack of Efficacy|0
348183|NCT00479466|1132964|P3|Overall Study|Lack of Efficacy|1
348184|NCT00479466|1132965|P2|Overall Study|Lack of Efficacy|0
348185|NCT00479466|1132966|P1|Overall Study|Lack of Efficacy|2
348186|NCT00479466|1132961|P6|Overall Study|Hyperglycemia|1
348187|NCT00479466|1132962|P5|Overall Study|Hyperglycemia|0
348188|NCT00479466|1132963|P4|Overall Study|Hyperglycemia|0
348189|NCT00479466|1132964|P3|Overall Study|Hyperglycemia|0
348190|NCT00479466|1132965|P2|Overall Study|Hyperglycemia|0
348191|NCT00479466|1132966|P1|Overall Study|Hyperglycemia|0
348192|NCT00479466|1132961|P6|Overall Study|Adverse Event|0
348193|NCT00479466|1132962|P5|Overall Study|Adverse Event|2
348194|NCT00479466|1132963|P4|Overall Study|Adverse Event|1
348195|NCT00479466|1132964|P3|Overall Study|Adverse Event|0
348196|NCT00479466|1132965|P2|Overall Study|Adverse Event|1
348197|NCT00479466|1132966|P1|Overall Study|Adverse Event|5
348198|NCT00479401|1132995|P3|Overall Study|Exclusion criteria, relocation|0
348199|NCT00479401|1132996|P2|Overall Study|Exclusion criteria, relocation|3
348200|NCT00479401|1132997|P1|Overall Study|Exclusion criteria, relocation|4
348201|NCT00479401|1132995|P3|Overall Study|Withdrawal by Subject|2
348202|NCT00479401|1132996|P2|Overall Study|Withdrawal by Subject|10
348203|NCT00479401|1132997|P1|Overall Study|Withdrawal by Subject|16
348204|NCT00479401|1132995|P3|Overall Study|Lost to Follow-up|1
348205|NCT00479401|1132996|P2|Overall Study|Lost to Follow-up|1
348206|NCT00479401|1132997|P1|Overall Study|Lost to Follow-up|1
348207|NCT00479401|1132995|P3|Overall Study|Protocol Violation|1
348208|NCT00479401|1132996|P2|Overall Study|Protocol Violation|1
348209|NCT00479401|1132997|P1|Overall Study|Protocol Violation|2
348210|NCT00479401|1132995|P3|Overall Study|Lack of Efficacy|4
348211|NCT00479401|1132996|P2|Overall Study|Lack of Efficacy|2
348212|NCT00479401|1132997|P1|Overall Study|Lack of Efficacy|2
348213|NCT00479401|1132995|P3|Overall Study|Adverse Event|4
348214|NCT00479401|1132996|P2|Overall Study|Adverse Event|20
348215|NCT00479401|1132997|P1|Overall Study|Adverse Event|24
348216|NCT00479388|1133052|P2|Overall Study|Withdrawal by Subject|17
348217|NCT00479388|1133053|P1|Overall Study|Withdrawal by Subject|32
348218|NCT00479388|1133052|P2|Overall Study|Protocol Violation|9
348219|NCT00479388|1133053|P1|Overall Study|Protocol Violation|10
348220|NCT00479388|1133052|P2|Overall Study|Lost to Follow-up|2
348221|NCT00479388|1133053|P1|Overall Study|Lost to Follow-up|0
348222|NCT00479388|1133052|P2|Overall Study|Adverse Event|45
348223|NCT00479388|1133053|P1|Overall Study|Adverse Event|90
348224|NCT00479336|1133067|P4|Overall Study|Resolution of all hepatic edema findings|0
348225|NCT00479336|1133068|P3|Overall Study|Resolution of all hepatic edema findings|0
348226|NCT00479336|1133069|P2|Overall Study|Resolution of all hepatic edema findings|1
348227|NCT00479336|1133070|P1|Overall Study|Resolution of all hepatic edema findings|1
348228|NCT00479336|1133067|P4|Overall Study|Physician Decision|2
348229|NCT00479336|1133068|P3|Overall Study|Physician Decision|0
348230|NCT00479336|1133069|P2|Overall Study|Physician Decision|1
348231|NCT00479336|1133070|P1|Overall Study|Physician Decision|0
348232|NCT00479336|1133067|P4|Overall Study|Withdrawal by Subject|0
348233|NCT00479336|1133068|P3|Overall Study|Withdrawal by Subject|0
348234|NCT00479336|1133069|P2|Overall Study|Withdrawal by Subject|2
348235|NCT00479336|1133070|P1|Overall Study|Withdrawal by Subject|1
348236|NCT00479336|1133067|P4|Overall Study|Protocol Violation|0
348237|NCT00479336|1133068|P3|Overall Study|Protocol Violation|0
348238|NCT00479336|1133069|P2|Overall Study|Protocol Violation|1
348239|NCT00479336|1133070|P1|Overall Study|Protocol Violation|0
348240|NCT00479336|1133067|P4|Overall Study|Lack of Efficacy|0
348241|NCT00479336|1133068|P3|Overall Study|Lack of Efficacy|0
348242|NCT00479336|1133069|P2|Overall Study|Lack of Efficacy|0
348243|NCT00479336|1133070|P1|Overall Study|Lack of Efficacy|1
348244|NCT00479336|1133067|P4|Overall Study|Adverse Event|3
348245|NCT00479336|1133068|P3|Overall Study|Adverse Event|1
348246|NCT00479336|1133069|P2|Overall Study|Adverse Event|1
348247|NCT00479336|1133070|P1|Overall Study|Adverse Event|1
348248|NCT00479232|1133093|P6|Overall Study|Withdrew Consent|3
348249|NCT00479232|1133094|P5|Overall Study|Withdrew Consent|1
348250|NCT00479232|1133095|P4|Overall Study|Withdrew Consent|0
348251|NCT00479232|1133096|P3|Overall Study|Withdrew Consent|6
348252|NCT00479232|1133097|P2|Overall Study|Withdrew Consent|2
348253|NCT00479232|1133098|P1|Overall Study|Withdrew Consent|0
348254|NCT00479232|1133093|P6|Overall Study|Progressive Disease|12
348255|NCT00479232|1133094|P5|Overall Study|Progressive Disease|3
348256|NCT00479232|1133095|P4|Overall Study|Progressive Disease|3
348257|NCT00479232|1133096|P3|Overall Study|Progressive Disease|12
348258|NCT00479232|1133097|P2|Overall Study|Progressive Disease|1
348259|NCT00479232|1133098|P1|Overall Study|Progressive Disease|3
348260|NCT00479232|1133093|P6|Overall Study|Physician Decision|1
348261|NCT00479232|1133094|P5|Overall Study|Physician Decision|0
348262|NCT00479232|1133095|P4|Overall Study|Physician Decision|0
348263|NCT00479232|1133096|P3|Overall Study|Physician Decision|2
348264|NCT00479232|1133097|P2|Overall Study|Physician Decision|0
348265|NCT00479232|1133098|P1|Overall Study|Physician Decision|0
348266|NCT00479232|1133093|P6|Overall Study|Lack of Efficacy|4
348267|NCT00479232|1133094|P5|Overall Study|Lack of Efficacy|0
348268|NCT00479232|1133095|P4|Overall Study|Lack of Efficacy|0
348269|NCT00479232|1133096|P3|Overall Study|Lack of Efficacy|2
348270|NCT00479232|1133097|P2|Overall Study|Lack of Efficacy|0
348271|NCT00479232|1133098|P1|Overall Study|Lack of Efficacy|0
348272|NCT00479232|1133093|P6|Overall Study|Deviation from Protocol|0
348273|NCT00479232|1133094|P5|Overall Study|Deviation from Protocol|0
348274|NCT00479232|1133095|P4|Overall Study|Deviation from Protocol|0
348275|NCT00479232|1133096|P3|Overall Study|Deviation from Protocol|1
348276|NCT00479232|1133097|P2|Overall Study|Deviation from Protocol|0
348277|NCT00479232|1133098|P1|Overall Study|Deviation from Protocol|0
348278|NCT00479232|1133093|P6|Overall Study|Adverse Event|10
348279|NCT00479232|1133094|P5|Overall Study|Adverse Event|0
348280|NCT00479232|1133095|P4|Overall Study|Adverse Event|0
348281|NCT00479232|1133096|P3|Overall Study|Adverse Event|5
348282|NCT00479232|1133097|P2|Overall Study|Adverse Event|0
348283|NCT00479232|1133098|P1|Overall Study|Adverse Event|0
348284|NCT00478881|1133153|P2|Overall Study|Non-Compliance with Study Medication|2
348285|NCT00478881|1133154|P1|Overall Study|Non-Compliance with Study Medication|0
348286|NCT00478881|1133153|P2|Overall Study|Withdrawal by Subject|2
348287|NCT00478881|1133154|P1|Overall Study|Withdrawal by Subject|6
348288|NCT00478881|1133153|P2|Overall Study|Protocol Violation|2
348289|NCT00478881|1133154|P1|Overall Study|Protocol Violation|2
348290|NCT00478881|1133153|P2|Overall Study|Lost to Follow-up|1
348291|NCT00478881|1133154|P1|Overall Study|Lost to Follow-up|0
348292|NCT00478881|1133153|P2|Overall Study|Lack of Efficacy|3
348293|NCT00478881|1133154|P1|Overall Study|Lack of Efficacy|0
348294|NCT00478881|1133153|P2|Overall Study|Adverse Event|12
348295|NCT00478881|1133154|P1|Overall Study|Adverse Event|31
348296|NCT00478777|1133178|P1|Overall Study|Not treated with lenalidomide|6
348297|NCT00478777|1133178|P1|Overall Study|End of therapy|2
348298|NCT00478777|1133178|P1|Overall Study|Lymphocytes infusion|1
348299|NCT00478777|1133178|P1|Overall Study|Lack of compliance|1
348300|NCT00478777|1133178|P1|Overall Study|Intolerance of therapy|1
348301|NCT00478777|1133178|P1|Overall Study|Physician Decision|1
348302|NCT00478777|1133178|P1|Overall Study|Lost to Follow-up|3
348303|NCT00478777|1133178|P1|Overall Study|Protocol Violation|3
348304|NCT00478777|1133178|P1|Overall Study|Death|3
348305|NCT00478777|1133178|P1|Overall Study|Withdrawal by Subject|4
348306|NCT00478777|1133178|P1|Overall Study|Lack of Efficacy|23
348307|NCT00478777|1133178|P1|Overall Study|Adverse Event|29
348308|NCT00478673|1133185|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
348309|NCT00478673|1133185|P1|12-Months Post-Procedure|Missed Visit|25
348310|NCT00478673|1133185|P1|12-Months Post-Procedure|Withdrawal by Subject|6
348311|NCT00478673|1133185|P1|12-Months Post-Procedure|Lost to Follow-up|4
348312|NCT00478673|1133185|P1|12-Months Post-Procedure|Death|23
348313|NCT00478673|1133185|P1|30-Days Post-Procedure|Missed Visit|7
348314|NCT00478673|1133185|P1|30-Days Post-Procedure|Withdrawal by Subject|1
348315|NCT00478673|1133185|P1|30-Days Post-Procedure|Death|2
348316|NCT00478647|1133190|P1|Overall Study|Withdrawal by Subject|1
348317|NCT00478647|1133190|P1|Overall Study|Adverse Event|1
348318|NCT00478608|1133198|P1|Overall Study|Protocol Violation|3
348319|NCT00478608|1133198|P1|Overall Study|Withdrawal by Subject|2
348320|NCT00478608|1133198|P1|Overall Study|Serious Adverse Event|14
348321|NCT00478608|1133198|P1|Overall Study|Adverse Event|1
348322|NCT00478257|1133233|P2|Overall Study|Withdrawal by Subject|3
348323|NCT00478257|1133234|P1|Overall Study|Withdrawal by Subject|8
348324|NCT00478244|1133240|P1|Overall Study|Did not receive transplant|1
348325|NCT00478231|1133253|P1|Overall Study|Randomized, not treated|3
348326|NCT00478231|1133253|P1|Overall Study|Adverse Event|5
348327|NCT00478231|1133253|P1|Overall Study|Unspecified|9
348328|NCT00478231|1133253|P1|Overall Study|Withdrawal by Subject|6
348329|NCT00478231|1133253|P1|Overall Study|Lost to Follow-up|7
348330|NCT00478231|1133253|P1|Overall Study|Lack of Efficacy|47
348331|NCT00478231|1133253|P1|Overall Study|Death|7
348332|NCT00478205|1133289|P2|Overall Study|Not specified|12
348333|NCT00478205|1133290|P1|Overall Study|Not specified|24
348334|NCT00478205|1133289|P2|Overall Study|Lack of Efficacy|0
348335|NCT00478205|1133290|P1|Overall Study|Lack of Efficacy|1
348336|NCT00478205|1133289|P2|Overall Study|Withdrawal by Subject|22
348337|NCT00478205|1133290|P1|Overall Study|Withdrawal by Subject|61
348338|NCT00478205|1133289|P2|Overall Study|Request of Investigator or Sponsor|5
348339|NCT00478205|1133290|P1|Overall Study|Request of Investigator or Sponsor|4
348340|NCT00478205|1133289|P2|Overall Study|Protocol Violation|5
348341|NCT00478205|1133290|P1|Overall Study|Protocol Violation|15
348342|NCT00478205|1133289|P2|Overall Study|Medication Non-compliance|4
348343|NCT00478205|1133290|P1|Overall Study|Medication Non-compliance|9
348344|NCT00478205|1133289|P2|Overall Study|Adverse Event|39
348345|NCT00478205|1133290|P1|Overall Study|Adverse Event|182
348346|NCT00478140|1133334|P1|Overall Study|Disease Progression|3
348347|NCT00478023|1133356|P5|Overall Study|Lack of pain, Technical difficulties|3
348348|NCT00478023|1133357|P4|Overall Study|Lack of pain, Technical difficulties|6
348349|NCT00478023|1133358|P3|Overall Study|Lack of pain, Technical difficulties|5
348350|NCT00478023|1133359|P2|Overall Study|Lack of pain, Technical difficulties|3
348351|NCT00478023|1133360|P1|Overall Study|Lack of pain, Technical difficulties|7
348352|NCT00478023|1133356|P5|Overall Study|Withdrawal by Subject|5
348353|NCT00478023|1133357|P4|Overall Study|Withdrawal by Subject|4
348354|NCT00478023|1133358|P3|Overall Study|Withdrawal by Subject|2
348355|NCT00478023|1133359|P2|Overall Study|Withdrawal by Subject|3
348356|NCT00478023|1133360|P1|Overall Study|Withdrawal by Subject|2
348357|NCT00478023|1133356|P5|Overall Study|Lost to Follow-up|0
348358|NCT00478023|1133357|P4|Overall Study|Lost to Follow-up|1
348359|NCT00478023|1133358|P3|Overall Study|Lost to Follow-up|1
348360|NCT00478023|1133359|P2|Overall Study|Lost to Follow-up|1
348361|NCT00478023|1133360|P1|Overall Study|Lost to Follow-up|3
348362|NCT00478023|1133356|P5|Overall Study|Lack of Efficacy|41
348363|NCT00478023|1133357|P4|Overall Study|Lack of Efficacy|5
348364|NCT00478023|1133358|P3|Overall Study|Lack of Efficacy|4
348365|NCT00478023|1133359|P2|Overall Study|Lack of Efficacy|10
348366|NCT00478023|1133360|P1|Overall Study|Lack of Efficacy|11
348367|NCT00478023|1133356|P5|Overall Study|Death|0
348368|NCT00478023|1133357|P4|Overall Study|Death|0
348369|NCT00478023|1133358|P3|Overall Study|Death|0
348370|NCT00478023|1133359|P2|Overall Study|Death|0
348371|NCT00478023|1133360|P1|Overall Study|Death|1
348372|NCT00478023|1133356|P5|Overall Study|Adverse Event|6
348373|NCT00478023|1133357|P4|Overall Study|Adverse Event|14
348374|NCT00478023|1133358|P3|Overall Study|Adverse Event|8
348375|NCT00478023|1133359|P2|Overall Study|Adverse Event|7
348376|NCT00478023|1133360|P1|Overall Study|Adverse Event|11
348377|NCT00477971|1133379|P2|Overall Study|Alternative treatment|1
348378|NCT00477971|1133380|P1|Overall Study|Alternative treatment|3
348379|NCT00477971|1133379|P2|Overall Study|Death|4
348380|NCT00477971|1133380|P1|Overall Study|Death|2
348381|NCT00477971|1133379|P2|Overall Study|Adverse Event|0
348382|NCT00477971|1133380|P1|Overall Study|Adverse Event|3
348383|NCT00477971|1133379|P2|Overall Study|Withdrawal by Subject|1
348384|NCT00477971|1133380|P1|Overall Study|Withdrawal by Subject|3
348385|NCT00477971|1133379|P2|Overall Study|Disease progression|0
348386|NCT00477971|1133380|P1|Overall Study|Disease progression|6
348387|NCT00477750|1133392|P1|Overall Study|Currently Receiving Treatment|11
348388|NCT00477672|1133404|P3|Overall Study|Discretion of Sponsor|0
348389|NCT00477672|1133405|P2|Overall Study|Discretion of Sponsor|2
348390|NCT00477672|1133406|P1|Overall Study|Discretion of Sponsor|1
348391|NCT00477672|1133404|P3|Overall Study|Consent withdrawn|10
348392|NCT00477672|1133405|P2|Overall Study|Consent withdrawn|5
348393|NCT00477672|1133406|P1|Overall Study|Consent withdrawn|2
348394|NCT00477672|1133404|P3|Overall Study|Protocol noncompliance|0
348395|NCT00477672|1133405|P2|Overall Study|Protocol noncompliance|2
348396|NCT00477672|1133406|P1|Overall Study|Protocol noncompliance|0
348397|NCT00477672|1133404|P3|Overall Study|Physician Decision|0
348398|NCT00477672|1133405|P2|Overall Study|Physician Decision|0
348399|NCT00477672|1133406|P1|Overall Study|Physician Decision|1
348400|NCT00477672|1133404|P3|Overall Study|Disease progression|0
348401|NCT00477672|1133405|P2|Overall Study|Disease progression|1
348402|NCT00477672|1133406|P1|Overall Study|Disease progression|0
348403|NCT00477672|1133404|P3|Overall Study|Death|0
348404|NCT00477672|1133405|P2|Overall Study|Death|1
348405|NCT00477672|1133406|P1|Overall Study|Death|0
348406|NCT00477672|1133404|P3|Overall Study|Adverse Event|6
348407|NCT00477672|1133405|P2|Overall Study|Adverse Event|5
348408|NCT00477672|1133406|P1|Overall Study|Adverse Event|3
348409|NCT00477633|1133417|P1|Overall Study|Various (Moving, Enrollment closed)|75
348410|NCT00477633|1133417|P1|Overall Study|Protocol Violation|25
348411|NCT00477633|1133417|P1|Overall Study|Withdrawal by Subject|149
348412|NCT00477633|1133417|P1|Overall Study|Lost to Follow-up|271
348413|NCT00477633|1133417|P1|Overall Study|Pregnancy|23
348414|NCT00477633|1133417|P1|Overall Study|Adverse Event|143
348415|NCT00477633|1133417|P1|Overall Study|Did not receive treatment|23
348416|NCT00477607|1133425|P2|Overall Study|Lost to Follow-up|7
348417|NCT00477607|1133426|P1|Overall Study|Lost to Follow-up|7
348418|NCT00477594|1133438|P2|Follow-up Period|Other|0
348419|NCT00477594|1133439|P1|Follow-up Period|Other|1
348420|NCT00477594|1133438|P2|Follow-up Period|Withdrawal by Subject|1
348421|NCT00477594|1133439|P1|Follow-up Period|Withdrawal by Subject|2
348422|NCT00477594|1133438|P2|Year 3|Withdrawal by Subject|0
348423|NCT00477594|1133439|P1|Year 3|Withdrawal by Subject|1
348424|NCT00477594|1133438|P2|Year 3|Adverse Event|0
348425|NCT00477594|1133439|P1|Year 3|Adverse Event|1
348426|NCT00477594|1133438|P2|Year 1 and Year 2|Other|0
348427|NCT00477594|1133439|P1|Year 1 and Year 2|Other|1
348428|NCT00477594|1133438|P2|Year 1 and Year 2|Withdrawal by Subject|1
348429|NCT00477594|1133439|P1|Year 1 and Year 2|Withdrawal by Subject|2
348430|NCT00477594|1133438|P2|Year 1 and Year 2|Physician Decision|1
348431|NCT00477594|1133439|P1|Year 1 and Year 2|Physician Decision|2
348432|NCT00477594|1133438|P2|Year 1 and Year 2|Adverse Event|2
348433|NCT00477594|1133439|P1|Year 1 and Year 2|Adverse Event|4
348434|NCT00477490|1133500|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
348435|NCT00477490|1133501|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
348436|NCT00477490|1133502|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
348437|NCT00477490|1133503|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
348438|NCT00477490|1133504|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
348439|NCT00477490|1133505|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
348440|NCT00477490|1133506|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
348441|NCT00477490|1133507|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
348442|NCT00477490|1133508|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
348443|NCT00477490|1133500|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
348444|NCT00477490|1133501|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
348445|NCT00477490|1133502|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
348446|NCT00477490|1133503|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
348447|NCT00477490|1133504|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
348448|NCT00477490|1133505|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
348449|NCT00477490|1133506|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
348450|NCT00477490|1133507|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
348451|NCT00477490|1133508|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
348452|NCT00477490|1133500|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
348453|NCT00477490|1133501|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
348454|NCT00477490|1133502|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
348455|NCT00477490|1133503|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
348456|NCT00477490|1133504|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
348457|NCT00477490|1133505|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
348458|NCT00477490|1133506|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
348459|NCT00477490|1133507|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
348460|NCT00477490|1133508|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
348461|NCT00477490|1133500|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
348462|NCT00477490|1133501|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
348463|NCT00477490|1133502|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
348464|NCT00477490|1133503|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
348465|NCT00477490|1133504|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
348466|NCT00477490|1133505|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
348467|NCT00477490|1133506|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
348468|NCT00477490|1133507|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
348469|NCT00477490|1133508|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
348470|NCT00477490|1133500|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
348471|NCT00477490|1133501|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
348472|NCT00477490|1133502|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
348473|NCT00477490|1133503|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
348474|NCT00477490|1133504|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
348475|NCT00477490|1133505|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
348476|NCT00477490|1133506|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
348477|NCT00477490|1133507|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
348478|NCT00477490|1133508|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
348479|NCT00477490|1133500|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
348480|NCT00477490|1133501|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
348481|NCT00477490|1133502|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
348482|NCT00477490|1133503|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
348483|NCT00477490|1133504|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
348484|NCT00477490|1133505|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
348485|NCT00477490|1133506|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
348486|NCT00477490|1133507|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
348487|NCT00477490|1133508|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
348488|NCT00477490|1133500|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
348489|NCT00477490|1133501|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
348490|NCT00477490|1133502|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
348491|NCT00477490|1133503|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
348492|NCT00477490|1133504|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
348493|NCT00477490|1133505|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
348494|NCT00477490|1133506|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
348495|NCT00477490|1133507|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
348496|NCT00477490|1133508|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
348497|NCT00477490|1133500|P9|Part I: 4 Week Efficacy|Not Reported|0
348498|NCT00477490|1133501|P8|Part I: 4 Week Efficacy|Not Reported|0
348499|NCT00477490|1133502|P7|Part I: 4 Week Efficacy|Not Reported|0
348500|NCT00477490|1133503|P6|Part I: 4 Week Efficacy|Not Reported|0
348501|NCT00477490|1133504|P5|Part I: 4 Week Efficacy|Not Reported|1
348502|NCT00477490|1133505|P4|Part I: 4 Week Efficacy|Not Reported|0
348503|NCT00477490|1133506|P3|Part I: 4 Week Efficacy|Not Reported|3
348504|NCT00477490|1133507|P2|Part I: 4 Week Efficacy|Not Reported|2
348505|NCT00477490|1133508|P1|Part I: 4 Week Efficacy|Not Reported|1
348506|NCT00477490|1133500|P9|Part I: 4 Week Efficacy|Other, not specified|0
348507|NCT00477490|1133501|P8|Part I: 4 Week Efficacy|Other, not specified|0
348508|NCT00477490|1133502|P7|Part I: 4 Week Efficacy|Other, not specified|0
348509|NCT00477490|1133503|P6|Part I: 4 Week Efficacy|Other, not specified|0
348510|NCT00477490|1133504|P5|Part I: 4 Week Efficacy|Other, not specified|1
348511|NCT00477490|1133505|P4|Part I: 4 Week Efficacy|Other, not specified|1
348512|NCT00477490|1133506|P3|Part I: 4 Week Efficacy|Other, not specified|0
348513|NCT00477490|1133507|P2|Part I: 4 Week Efficacy|Other, not specified|4
348514|NCT00477490|1133508|P1|Part I: 4 Week Efficacy|Other, not specified|2
348515|NCT00477490|1133500|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
348516|NCT00477490|1133501|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
348517|NCT00477490|1133502|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
348518|NCT00477490|1133503|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
348519|NCT00477490|1133504|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
348520|NCT00477490|1133505|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
348521|NCT00477490|1133506|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
348522|NCT00477490|1133507|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
348523|NCT00477490|1133508|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
348524|NCT00477490|1133500|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
348525|NCT00477490|1133501|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
348526|NCT00477490|1133502|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
348527|NCT00477490|1133503|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
348528|NCT00477490|1133504|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
348529|NCT00477490|1133505|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
348530|NCT00477490|1133506|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
348531|NCT00477490|1133507|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
348532|NCT00477490|1133508|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
348533|NCT00477490|1133500|P9|Part I: 4 Week Efficacy|Protocol Violation|0
348534|NCT00477490|1133501|P8|Part I: 4 Week Efficacy|Protocol Violation|0
348535|NCT00477490|1133502|P7|Part I: 4 Week Efficacy|Protocol Violation|0
348536|NCT00477490|1133503|P6|Part I: 4 Week Efficacy|Protocol Violation|0
348537|NCT00477490|1133504|P5|Part I: 4 Week Efficacy|Protocol Violation|1
348538|NCT00477490|1133505|P4|Part I: 4 Week Efficacy|Protocol Violation|0
348539|NCT00477490|1133506|P3|Part I: 4 Week Efficacy|Protocol Violation|0
348540|NCT00477490|1133507|P2|Part I: 4 Week Efficacy|Protocol Violation|0
348541|NCT00477490|1133508|P1|Part I: 4 Week Efficacy|Protocol Violation|2
348542|NCT00477490|1133500|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
348543|NCT00477490|1133501|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
348544|NCT00477490|1133502|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
348545|NCT00477490|1133503|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
348546|NCT00477490|1133504|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
348547|NCT00477490|1133505|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
348548|NCT00477490|1133506|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
348549|NCT00477490|1133507|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
348550|NCT00477490|1133508|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
348551|NCT00477490|1133500|P9|Part I: 4 Week Efficacy|Adverse Event|0
348552|NCT00477490|1133501|P8|Part I: 4 Week Efficacy|Adverse Event|0
348553|NCT00477490|1133502|P7|Part I: 4 Week Efficacy|Adverse Event|0
348554|NCT00477490|1133503|P6|Part I: 4 Week Efficacy|Adverse Event|0
348555|NCT00477490|1133504|P5|Part I: 4 Week Efficacy|Adverse Event|6
348556|NCT00477490|1133505|P4|Part I: 4 Week Efficacy|Adverse Event|5
348557|NCT00477490|1133506|P3|Part I: 4 Week Efficacy|Adverse Event|0
348558|NCT00477490|1133507|P2|Part I: 4 Week Efficacy|Adverse Event|4
348559|NCT00477490|1133508|P1|Part I: 4 Week Efficacy|Adverse Event|1
348560|NCT00477464|1133592|P1|Overall Study|Completion of protocol-defined follow-up|14
348561|NCT00477464|1133592|P1|Overall Study|Death|36
348562|NCT00477464|1133592|P1|Overall Study|Lost to Follow-up|1
348563|NCT00477386|1133636|P2|Overall Study|Withdrawal by Subject|0
348564|NCT00477386|1133637|P1|Overall Study|Withdrawal by Subject|1
348565|NCT00477386|1133636|P2|Overall Study|Physician Decision|0
348566|NCT00477386|1133637|P1|Overall Study|Physician Decision|1
348567|NCT00477386|1133636|P2|Overall Study|Other|2
348568|NCT00477386|1133637|P1|Overall Study|Other|1
348569|NCT00477386|1133636|P2|Overall Study|Disease progression, refractory|3
348570|NCT00477386|1133637|P1|Overall Study|Disease progression, refractory|1
348571|NCT00477386|1133636|P2|Overall Study|Disease progression, relapse|4
348572|NCT00477386|1133637|P1|Overall Study|Disease progression, relapse|3
348573|NCT00477386|1133636|P2|Overall Study|Adverse Event|8
348574|NCT00477386|1133637|P1|Overall Study|Adverse Event|4
348575|NCT00477334|1133647|P2|Overall Study|Protocol Violation|1
348576|NCT00477334|1133648|P1|Overall Study|Protocol Violation|7
348577|NCT00477334|1133647|P2|Overall Study|Administrative Problems|15
348578|NCT00477334|1133648|P1|Overall Study|Administrative Problems|39
348579|NCT00477334|1133647|P2|Overall Study|Lost to Follow-up|4
348580|NCT00477334|1133648|P1|Overall Study|Lost to Follow-up|15
348581|NCT00477334|1133647|P2|Overall Study|Withdrawal by Subject|1
348582|NCT00477334|1133648|P1|Overall Study|Withdrawal by Subject|2
348583|NCT00477334|1133647|P2|Overall Study|Adverse Event|2
348584|NCT00477334|1133648|P1|Overall Study|Adverse Event|1
348585|NCT00477334|1133647|P2|Overall Study|Discontinued prior to taking study drug|53
348586|NCT00477334|1133648|P1|Overall Study|Discontinued prior to taking study drug|106
348587|NCT00477295|1133674|P2|Overall Study|Not specified|3
348588|NCT00477295|1133675|P1|Overall Study|Not specified|4
348589|NCT00477295|1133674|P2|Overall Study|Lost to Follow-up|11
348590|NCT00477295|1133675|P1|Overall Study|Lost to Follow-up|21
348591|NCT00477295|1133674|P2|Overall Study|Physician Decision|5
348592|NCT00477295|1133675|P1|Overall Study|Physician Decision|4
348593|NCT00477295|1133674|P2|Overall Study|Protocol Violation|8
348594|NCT00477295|1133675|P1|Overall Study|Protocol Violation|3
348595|NCT00477295|1133674|P2|Overall Study|Lack of Efficacy|23
348596|NCT00477295|1133675|P1|Overall Study|Lack of Efficacy|23
348597|NCT00477295|1133674|P2|Overall Study|Withdrawal by Subject|24
348598|NCT00477295|1133675|P1|Overall Study|Withdrawal by Subject|35
348599|NCT00477295|1133674|P2|Overall Study|Adverse Event|35
348600|NCT00477295|1133675|P1|Overall Study|Adverse Event|31
348601|NCT00477269|1133703|P3|Open Label Extension|Death|4
348602|NCT00477269|1133704|P2|Open Label Extension|Death|0
348603|NCT00477269|1133705|P1|Open Label Extension|Death|0
348604|NCT00477269|1133703|P3|Open Label Extension|Adminiatrative problems|2
348605|NCT00477269|1133704|P2|Open Label Extension|Adminiatrative problems|0
348606|NCT00477269|1133705|P1|Open Label Extension|Adminiatrative problems|0
348607|NCT00477269|1133703|P3|Open Label Extension|unsatisfactory therapeutic effects|2
348608|NCT00477269|1133704|P2|Open Label Extension|unsatisfactory therapeutic effects|0
348609|NCT00477269|1133705|P1|Open Label Extension|unsatisfactory therapeutic effects|0
348610|NCT00477269|1133703|P3|Open Label Extension|Abnormal laboratory values|1
348611|NCT00477269|1133704|P2|Open Label Extension|Abnormal laboratory values|0
348612|NCT00477269|1133705|P1|Open Label Extension|Abnormal laboratory values|0
348613|NCT00477269|1133703|P3|Open Label Extension|Adverse Event|4
348614|NCT00477269|1133704|P2|Open Label Extension|Adverse Event|0
348615|NCT00477269|1133705|P1|Open Label Extension|Adverse Event|0
348616|NCT00477269|1133703|P3|Core Study|Withdrawn Consent|0
348617|NCT00477269|1133704|P2|Core Study|Withdrawn Consent|1
348618|NCT00477269|1133705|P1|Core Study|Withdrawn Consent|0
348619|NCT00477269|1133703|P3|Core Study|Death|0
348620|NCT00477269|1133704|P2|Core Study|Death|3
348621|NCT00477269|1133705|P1|Core Study|Death|3
348622|NCT00477269|1133703|P3|Core Study|Adverse Event|0
348623|NCT00477269|1133704|P2|Core Study|Adverse Event|4
348624|NCT00477269|1133705|P1|Core Study|Adverse Event|6
348625|NCT00477165|1133784|P2|Overall Study|Adverse Event|2
348626|NCT00477165|1133785|P1|Overall Study|Adverse Event|7
348627|NCT00477152|1133797|P1|Overall Study|Adverse Event|1
348628|NCT00477152|1133797|P1|Overall Study|Parent withdrew consent|2
348629|NCT00476957|1133806|P2|Overall Study|Lost to Follow-up|193
348630|NCT00476957|1133807|P1|Overall Study|Lost to Follow-up|176
348631|NCT00476593|1133871|P4|Overall Study|Lost to Follow-up|22
348632|NCT00476593|1133872|P3|Overall Study|Lost to Follow-up|8
348633|NCT00476593|1133873|P2|Overall Study|Lost to Follow-up|2
348634|NCT00476593|1133874|P1|Overall Study|Lost to Follow-up|10
348635|NCT00476476|1133886|P2|Overall Study|Progressive Disease|17
348636|NCT00476476|1133887|P1|Overall Study|Progressive Disease|0
348637|NCT00476476|1133886|P2|Overall Study|Adverse Event|7
348638|NCT00476476|1133887|P1|Overall Study|Adverse Event|2
348639|NCT00476229|1133903|P1|Overall Study|Progressive shortness of breath|1
348640|NCT00476151|1133909|P2|Overall Study|Physician Decision|2
348641|NCT00476151|1133910|P1|Overall Study|Physician Decision|0
348642|NCT00476151|1133909|P2|Overall Study|Withdrawal by Subject|0
348643|NCT00476151|1133910|P1|Overall Study|Withdrawal by Subject|2
348644|NCT00476151|1133909|P2|Overall Study|Protocol Violation|3
348645|NCT00476151|1133910|P1|Overall Study|Protocol Violation|1
348646|NCT00476151|1133909|P2|Overall Study|Adverse Event|2
348647|NCT00476151|1133910|P1|Overall Study|Adverse Event|0
348648|NCT00476086|1133916|P1|Overall Study|Progressive Disease|4
348649|NCT00476086|1133916|P1|Overall Study|Alternative therapy|1
348650|NCT00476008|1133941|P2|Overall Study|Death|0
348651|NCT00476008|1133942|P1|Overall Study|Death|1
348652|NCT00476008|1133941|P2|Overall Study|Withdrawal by Subject|1
348653|NCT00476008|1133942|P1|Overall Study|Withdrawal by Subject|0
348654|NCT00476008|1133941|P2|Overall Study|Physician Decision: Medication Noncompli|1
348655|NCT00476008|1133942|P1|Overall Study|Physician Decision: Medication Noncompli|2
348656|NCT00476008|1133941|P2|Overall Study|Placebo concerns|2
348657|NCT00476008|1133942|P1|Overall Study|Placebo concerns|2
348658|NCT00476008|1133941|P2|Overall Study|Adverse Event|4
348659|NCT00476008|1133942|P1|Overall Study|Adverse Event|4
348660|NCT00475865|1133996|P3|Overall Study|Other than above|0
348661|NCT00475865|1133997|P2|Overall Study|Other than above|1
348662|NCT00475865|1133998|P1|Overall Study|Other than above|0
348663|NCT00475865|1133996|P3|Overall Study|Participant did not wish to continue|0
348664|NCT00475865|1133997|P2|Overall Study|Participant did not wish to continue|0
348665|NCT00475865|1133998|P1|Overall Study|Participant did not wish to continue|1
348666|NCT00475865|1133996|P3|Overall Study|Progressive disease|2
348667|NCT00475865|1133997|P2|Overall Study|Progressive disease|1
348668|NCT00475865|1133998|P1|Overall Study|Progressive disease|0
348669|NCT00475865|1133996|P3|Overall Study|Lack of Efficacy|0
348670|NCT00475865|1133997|P2|Overall Study|Lack of Efficacy|0
348671|NCT00475865|1133998|P1|Overall Study|Lack of Efficacy|1
348672|NCT00475865|1133996|P3|Overall Study|Adverse Event|4
348673|NCT00475865|1133997|P2|Overall Study|Adverse Event|3
348674|NCT00475865|1133998|P1|Overall Study|Adverse Event|0
348675|NCT00475852|1134028|P2|Overall Study|Lost to Follow-up|68
348676|NCT00475852|1134029|P1|Overall Study|Lost to Follow-up|54
348677|NCT00475852|1134028|P2|Overall Study|Withdrawal by Subject|24
348678|NCT00475852|1134029|P1|Overall Study|Withdrawal by Subject|19
348679|NCT00475852|1134028|P2|Overall Study|Death|456
348680|NCT00475852|1134029|P1|Overall Study|Death|444
348681|NCT00475735|1134080|P6|Treatment Period 2|Withdrawal by Subject|0
348682|NCT00475735|1134081|P5|Treatment Period 2|Withdrawal by Subject|1
348683|NCT00475735|1134082|P4|Treatment Period 2|Withdrawal by Subject|0
348684|NCT00475735|1134083|P3|Treatment Period 2|Withdrawal by Subject|0
348685|NCT00475735|1134084|P2|Treatment Period 2|Withdrawal by Subject|0
348686|NCT00475735|1134085|P1|Treatment Period 2|Withdrawal by Subject|0
348687|NCT00475735|1134080|P6|Treatment Period 2|Lack of Efficacy|1
348688|NCT00475735|1134081|P5|Treatment Period 2|Lack of Efficacy|0
348689|NCT00475735|1134082|P4|Treatment Period 2|Lack of Efficacy|0
348690|NCT00475735|1134083|P3|Treatment Period 2|Lack of Efficacy|0
348691|NCT00475735|1134084|P2|Treatment Period 2|Lack of Efficacy|0
348692|NCT00475735|1134085|P1|Treatment Period 2|Lack of Efficacy|0
348693|NCT00475735|1134080|P6|Treatment Period 2|Adverse Event|0
348694|NCT00475735|1134081|P5|Treatment Period 2|Adverse Event|0
348695|NCT00475735|1134082|P4|Treatment Period 2|Adverse Event|2
348696|NCT00475735|1134083|P3|Treatment Period 2|Adverse Event|0
348697|NCT00475735|1134084|P2|Treatment Period 2|Adverse Event|1
348698|NCT00475735|1134085|P1|Treatment Period 2|Adverse Event|0
348699|NCT00475735|1134080|P6|Treatment Washout|Protocol Violation|0
348700|NCT00475735|1134081|P5|Treatment Washout|Protocol Violation|0
348701|NCT00475735|1134082|P4|Treatment Washout|Protocol Violation|0
348702|NCT00475735|1134083|P3|Treatment Washout|Protocol Violation|0
348703|NCT00475735|1134084|P2|Treatment Washout|Protocol Violation|1
348704|NCT00475735|1134085|P1|Treatment Washout|Protocol Violation|0
348705|NCT00475735|1134080|P6|Treatment Washout|Lost to Follow-up|0
348706|NCT00475735|1134081|P5|Treatment Washout|Lost to Follow-up|0
348707|NCT00475735|1134082|P4|Treatment Washout|Lost to Follow-up|0
348708|NCT00475735|1134083|P3|Treatment Washout|Lost to Follow-up|0
348709|NCT00475735|1134084|P2|Treatment Washout|Lost to Follow-up|1
348710|NCT00475735|1134085|P1|Treatment Washout|Lost to Follow-up|0
348711|NCT00475735|1134080|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
348712|NCT00475735|1134081|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
348713|NCT00475735|1134082|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
348714|NCT00475735|1134083|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
348715|NCT00475735|1134084|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
348716|NCT00475735|1134085|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
348717|NCT00475735|1134080|P6|Treatment Period 1|DC due to AE but continuing|2
348718|NCT00475735|1134081|P5|Treatment Period 1|DC due to AE but continuing|2
348719|NCT00475735|1134082|P4|Treatment Period 1|DC due to AE but continuing|1
348720|NCT00475735|1134083|P3|Treatment Period 1|DC due to AE but continuing|0
348721|NCT00475735|1134084|P2|Treatment Period 1|DC due to AE but continuing|0
348722|NCT00475735|1134085|P1|Treatment Period 1|DC due to AE but continuing|0
348723|NCT00475735|1134080|P6|Treatment Period 1|Withdrawal by Subject|0
348724|NCT00475735|1134081|P5|Treatment Period 1|Withdrawal by Subject|0
348725|NCT00475735|1134082|P4|Treatment Period 1|Withdrawal by Subject|0
348726|NCT00475735|1134083|P3|Treatment Period 1|Withdrawal by Subject|0
348727|NCT00475735|1134084|P2|Treatment Period 1|Withdrawal by Subject|1
348728|NCT00475735|1134085|P1|Treatment Period 1|Withdrawal by Subject|1
348729|NCT00475735|1134080|P6|Treatment Period 1|Protocol Violation|0
348730|NCT00475735|1134081|P5|Treatment Period 1|Protocol Violation|0
348731|NCT00475735|1134082|P4|Treatment Period 1|Protocol Violation|1
348732|NCT00475735|1134083|P3|Treatment Period 1|Protocol Violation|0
348733|NCT00475735|1134084|P2|Treatment Period 1|Protocol Violation|0
348734|NCT00475735|1134085|P1|Treatment Period 1|Protocol Violation|0
348735|NCT00475735|1134080|P6|Treatment Period 1|Lost to Follow-up|1
348736|NCT00475735|1134081|P5|Treatment Period 1|Lost to Follow-up|0
348737|NCT00475735|1134082|P4|Treatment Period 1|Lost to Follow-up|0
348738|NCT00475735|1134083|P3|Treatment Period 1|Lost to Follow-up|0
348739|NCT00475735|1134084|P2|Treatment Period 1|Lost to Follow-up|0
348740|NCT00475735|1134085|P1|Treatment Period 1|Lost to Follow-up|0
348741|NCT00475735|1134080|P6|Treatment Period 1|Lack of Efficacy|0
348742|NCT00475735|1134081|P5|Treatment Period 1|Lack of Efficacy|0
348743|NCT00475735|1134082|P4|Treatment Period 1|Lack of Efficacy|0
348744|NCT00475735|1134083|P3|Treatment Period 1|Lack of Efficacy|0
348745|NCT00475735|1134084|P2|Treatment Period 1|Lack of Efficacy|0
348746|NCT00475735|1134085|P1|Treatment Period 1|Lack of Efficacy|1
348747|NCT00475735|1134080|P6|Treatment Period 1|Adverse Event|0
348748|NCT00475735|1134081|P5|Treatment Period 1|Adverse Event|0
348749|NCT00475735|1134082|P4|Treatment Period 1|Adverse Event|0
348750|NCT00475735|1134083|P3|Treatment Period 1|Adverse Event|0
348751|NCT00475735|1134084|P2|Treatment Period 1|Adverse Event|0
348752|NCT00475735|1134085|P1|Treatment Period 1|Adverse Event|2
348753|NCT00475722|1134098|P2|Overall Study|Protocol Violation|0
348754|NCT00475722|1134099|P1|Overall Study|Protocol Violation|3
348755|NCT00475722|1134098|P2|Overall Study|Withdrawal by Subject|12
348756|NCT00475722|1134099|P1|Overall Study|Withdrawal by Subject|12
348757|NCT00475709|1134105|P1|Overall Study|Lost to Follow-up|21
348758|NCT00475709|1134105|P1|Overall Study|Device Explant|6
348759|NCT00475709|1134105|P1|Overall Study|Death|41
348760|NCT00475709|1134105|P1|Overall Study|Did not meet eligibility criteria|8
348761|NCT00475670|1134113|P2|Overall Study|Not Specified|3
348762|NCT00475670|1134114|P1|Overall Study|Not Specified|0
348763|NCT00475670|1134113|P2|Overall Study|Failure to Return|1
348764|NCT00475670|1134114|P1|Overall Study|Failure to Return|0
348765|NCT00475670|1134113|P2|Overall Study|Refused treatment|2
348766|NCT00475670|1134114|P1|Overall Study|Refused treatment|0
348767|NCT00475670|1134113|P2|Overall Study|Lack of Efficacy|34
348768|NCT00475670|1134114|P1|Overall Study|Lack of Efficacy|3
348769|NCT00475670|1134113|P2|Overall Study|Death|1
348770|NCT00475670|1134114|P1|Overall Study|Death|0
348771|NCT00475657|1134138|P1|Overall Study|Sponsor's Decision|3
348772|NCT00475657|1134138|P1|Overall Study|Death|1
348773|NCT00475423|1134203|P1|Overall Study|Lost to Follow-up|7
348774|NCT00475423|1134203|P1|Overall Study|Reason not specified|1
348775|NCT00475423|1134203|P1|Overall Study|Death|1
348776|NCT00475423|1134203|P1|Overall Study|Lack of Efficacy|8
348777|NCT00475423|1134203|P1|Overall Study|Withdrawal by Subject|6
348778|NCT00475423|1134203|P1|Overall Study|Adverse Event|4
348779|NCT00475423|1134203|P1|Overall Study|Protocol Violation|5
348780|NCT00475306|1134249|P4|Overall Study|Protocol Violation|1
348781|NCT00475306|1134250|P3|Overall Study|Protocol Violation|0
348782|NCT00475306|1134251|P2|Overall Study|Protocol Violation|1
348783|NCT00475306|1134252|P1|Overall Study|Protocol Violation|1
348784|NCT00475228|1134277|P2|Overall Study|Lost to Follow-up|17
348785|NCT00475228|1134278|P1|Overall Study|Lost to Follow-up|17
348786|NCT00475176|1134288|P1|Overall Study|Protocol Violation|1
348787|NCT00475176|1134288|P1|Overall Study|Withdrawal by Subject|1
348788|NCT00475176|1134288|P1|Overall Study|Adverse Event|2
348789|NCT00475033|1134328|P2|Toddler Dose|Lost to Follow-up|0
348790|NCT00475033|1134329|P1|Toddler Dose|Lost to Follow-up|1
348791|NCT00475033|1134328|P2|Toddler Dose|Failed to return|0
348792|NCT00475033|1134329|P1|Toddler Dose|Failed to return|1
348793|NCT00475033|1134328|P2|Toddler Dose|Parent or legal guardian request|0
348794|NCT00475033|1134329|P1|Toddler Dose|Parent or legal guardian request|2
348795|NCT00475033|1134328|P2|After the Infant Series|Unspecified|1
348796|NCT00475033|1134329|P1|After the Infant Series|Unspecified|0
348797|NCT00475033|1134328|P2|After the Infant Series|Lost to Follow-up|0
348798|NCT00475033|1134329|P1|After the Infant Series|Lost to Follow-up|1
348799|NCT00475033|1134328|P2|After the Infant Series|Protocol Violation|0
348800|NCT00475033|1134329|P1|After the Infant Series|Protocol Violation|1
348801|NCT00475033|1134328|P2|After the Infant Series|Failed to return|1
348802|NCT00475033|1134329|P1|After the Infant Series|Failed to return|2
348803|NCT00475033|1134328|P2|After the Infant Series|Parent or legal guardian request|2
348804|NCT00475033|1134329|P1|After the Infant Series|Parent or legal guardian request|2
348805|NCT00475033|1134328|P2|After the Infant Series|Adverse Event|4
348806|NCT00475033|1134329|P1|After the Infant Series|Adverse Event|0
348807|NCT00475033|1134328|P2|Infant Series|Adverse Event|2
348808|NCT00475033|1134329|P1|Infant Series|Adverse Event|0
348809|NCT00475033|1134328|P2|Infant Series|Lost to Follow-up|0
348810|NCT00475033|1134329|P1|Infant Series|Lost to Follow-up|2
348811|NCT00475033|1134328|P2|Infant Series|Protocol Violation|2
348812|NCT00475033|1134329|P1|Infant Series|Protocol Violation|1
348813|NCT00475033|1134328|P2|Infant Series|Parent or legal guardian request|5
348814|NCT00475033|1134329|P1|Infant Series|Parent or legal guardian request|1
348815|NCT00475033|1134328|P2|Infant Series|Failed to return|4
348816|NCT00475033|1134329|P1|Infant Series|Failed to return|3
348817|NCT00474994|1134377|P1|Overall Study|Patient found to be ineligible|1
348818|NCT00474994|1134377|P1|Overall Study|Patient evaluable for toxicity only|3
348819|NCT00474994|1134377|P1|Overall Study|Patient Not treated|1
348820|NCT00474968|1134383|P2|Overall Study|Sample not collected|1
348821|NCT00474968|1134384|P1|Overall Study|Sample not collected|1
348822|NCT00474968|1134383|P2|Overall Study|Protocol Violation|8
348823|NCT00474968|1134384|P1|Overall Study|Protocol Violation|9
348824|NCT00474968|1134383|P2|Overall Study|Withdrawal by Subject|7
348825|NCT00474968|1134384|P1|Overall Study|Withdrawal by Subject|8
348826|NCT00474955|1134394|P1|Overall Study|Personal reasons|5
348827|NCT00474955|1134394|P1|Overall Study|Drug unavailability|1
348828|NCT00474955|1134394|P1|Overall Study|Adverse Event|2
348829|NCT00474929|1134410|P5|Overall Study|Physician Decision|0
348830|NCT00474929|1134411|P4|Overall Study|Physician Decision|2
348831|NCT00474929|1134412|P3|Overall Study|Physician Decision|1
348832|NCT00474929|1134413|P2|Overall Study|Physician Decision|0
348833|NCT00474929|1134414|P1|Overall Study|Physician Decision|0
348834|NCT00474929|1134410|P5|Overall Study|Unrelated medical condition|0
348835|NCT00474929|1134411|P4|Overall Study|Unrelated medical condition|0
348836|NCT00474929|1134412|P3|Overall Study|Unrelated medical condition|1
348837|NCT00474929|1134413|P2|Overall Study|Unrelated medical condition|0
348838|NCT00474929|1134414|P1|Overall Study|Unrelated medical condition|0
348839|NCT00474929|1134410|P5|Overall Study|Withdrawal by Subject|0
348840|NCT00474929|1134411|P4|Overall Study|Withdrawal by Subject|0
348841|NCT00474929|1134412|P3|Overall Study|Withdrawal by Subject|0
348842|NCT00474929|1134413|P2|Overall Study|Withdrawal by Subject|1
348843|NCT00474929|1134414|P1|Overall Study|Withdrawal by Subject|0
348844|NCT00474903|1134431|P3|Overall Study|Protocol Violation|2
348845|NCT00474903|1134432|P2|Overall Study|Protocol Violation|5
348846|NCT00474903|1134433|P1|Overall Study|Protocol Violation|1
348847|NCT00474812|1134455|P1|Overall Study|No Initiation of treatment|2
348848|NCT00474812|1134455|P1|Overall Study|Withdrawal by Subject|5
348849|NCT00474786|1134465|P2|Overall Study|Not specified|0
348850|NCT00474786|1134466|P1|Overall Study|Not specified|5
348851|NCT00474786|1134465|P2|Overall Study|Withdrawal by Subject|15
348852|NCT00474786|1134466|P1|Overall Study|Withdrawal by Subject|15
348853|NCT00474786|1134465|P2|Overall Study|Protocol Violation|0
348854|NCT00474786|1134466|P1|Overall Study|Protocol Violation|2
348855|NCT00474786|1134465|P2|Overall Study|Lost to Follow-up|7
348856|NCT00474786|1134466|P1|Overall Study|Lost to Follow-up|4
348857|NCT00474786|1134465|P2|Overall Study|Discontinuation of Study by Sponsor|59
348858|NCT00474786|1134466|P1|Overall Study|Discontinuation of Study by Sponsor|42
348859|NCT00474786|1134465|P2|Overall Study|Death|170
348860|NCT00474786|1134466|P1|Overall Study|Death|189
348861|NCT00474786|1134465|P2|Overall Study|Investigator Request|1
348862|NCT00474786|1134466|P1|Overall Study|Investigator Request|2
348863|NCT00474786|1134465|P2|Overall Study|Not Meeting Study Criteria|1
348864|NCT00474786|1134466|P1|Overall Study|Not Meeting Study Criteria|0
348865|NCT00474760|1134491|P7|Overall Study|Terminated by sponsor|2
348866|NCT00474760|1134492|P6|Overall Study|Terminated by sponsor|0
348867|NCT00474760|1134493|P5|Overall Study|Terminated by sponsor|0
348868|NCT00474760|1134494|P4|Overall Study|Terminated by sponsor|0
348869|NCT00474760|1134495|P3|Overall Study|Terminated by sponsor|0
348870|NCT00474760|1134496|P2|Overall Study|Terminated by sponsor|0
348871|NCT00474760|1134497|P1|Overall Study|Terminated by sponsor|0
348872|NCT00474760|1134491|P7|Overall Study|Progressive disease|7
348873|NCT00474760|1134492|P6|Overall Study|Progressive disease|20
348874|NCT00474760|1134493|P5|Overall Study|Progressive disease|8
348875|NCT00474760|1134494|P4|Overall Study|Progressive disease|2
348876|NCT00474760|1134495|P3|Overall Study|Progressive disease|3
348877|NCT00474760|1134496|P2|Overall Study|Progressive disease|2
348878|NCT00474760|1134497|P1|Overall Study|Progressive disease|3
348879|NCT00474760|1134491|P7|Overall Study|Unspecified|0
348880|NCT00474760|1134492|P6|Overall Study|Unspecified|0
348881|NCT00474760|1134493|P5|Overall Study|Unspecified|1
348882|NCT00474760|1134494|P4|Overall Study|Unspecified|0
348883|NCT00474760|1134495|P3|Overall Study|Unspecified|0
348884|NCT00474760|1134496|P2|Overall Study|Unspecified|1
348885|NCT00474760|1134497|P1|Overall Study|Unspecified|0
348886|NCT00474760|1134491|P7|Overall Study|Withdrawal by Subject|1
348887|NCT00474760|1134492|P6|Overall Study|Withdrawal by Subject|1
348888|NCT00474760|1134493|P5|Overall Study|Withdrawal by Subject|0
348889|NCT00474760|1134494|P4|Overall Study|Withdrawal by Subject|1
348890|NCT00474760|1134495|P3|Overall Study|Withdrawal by Subject|0
348891|NCT00474760|1134496|P2|Overall Study|Withdrawal by Subject|0
348892|NCT00474760|1134497|P1|Overall Study|Withdrawal by Subject|0
348893|NCT00474760|1134491|P7|Overall Study|Laboratory abnormality|0
348894|NCT00474760|1134492|P6|Overall Study|Laboratory abnormality|1
348895|NCT00474760|1134493|P5|Overall Study|Laboratory abnormality|0
348896|NCT00474760|1134494|P4|Overall Study|Laboratory abnormality|0
348897|NCT00474760|1134495|P3|Overall Study|Laboratory abnormality|0
348898|NCT00474760|1134496|P2|Overall Study|Laboratory abnormality|0
348899|NCT00474760|1134497|P1|Overall Study|Laboratory abnormality|0
348900|NCT00474760|1134491|P7|Overall Study|Adverse Event|0
348901|NCT00474760|1134492|P6|Overall Study|Adverse Event|7
348902|NCT00474760|1134493|P5|Overall Study|Adverse Event|1
348903|NCT00474760|1134494|P4|Overall Study|Adverse Event|0
348904|NCT00474760|1134495|P3|Overall Study|Adverse Event|0
348905|NCT00474760|1134496|P2|Overall Study|Adverse Event|0
348906|NCT00474760|1134497|P1|Overall Study|Adverse Event|0
348907|NCT00474760|1134491|P7|Overall Study|Death|0
348908|NCT00474760|1134492|P6|Overall Study|Death|0
348909|NCT00474760|1134493|P5|Overall Study|Death|2
348910|NCT00474760|1134494|P4|Overall Study|Death|0
348911|NCT00474760|1134495|P3|Overall Study|Death|0
348912|NCT00474760|1134496|P2|Overall Study|Death|0
348913|NCT00474760|1134497|P1|Overall Study|Death|0
348914|NCT00474708|1134604|P2|Overall Study|Physician Decision|6
348915|NCT00474708|1134605|P1|Overall Study|Physician Decision|9
348916|NCT00474708|1134604|P2|Overall Study|Lost to Follow-up|9
348917|NCT00474708|1134605|P1|Overall Study|Lost to Follow-up|18
348918|NCT00474708|1134604|P2|Overall Study|Lack of compliance|4
348919|NCT00474708|1134605|P1|Overall Study|Lack of compliance|12
348920|NCT00474708|1134604|P2|Overall Study|Withdrawal by Subject|0
348921|NCT00474708|1134605|P1|Overall Study|Withdrawal by Subject|7
348922|NCT00474708|1134604|P2|Overall Study|Suicide ideation/behavior|1
348923|NCT00474708|1134605|P1|Overall Study|Suicide ideation/behavior|0
348924|NCT00474708|1134604|P2|Overall Study|Lack of Efficacy|5
348925|NCT00474708|1134605|P1|Overall Study|Lack of Efficacy|11
348926|NCT00474630|1134615|P2|Overall Study|Drug noncompliance, other|4
348927|NCT00474630|1134616|P1|Overall Study|Drug noncompliance, other|11
348928|NCT00474630|1134615|P2|Overall Study|Lack of Efficacy|6
348929|NCT00474630|1134616|P1|Overall Study|Lack of Efficacy|5
348930|NCT00474630|1134615|P2|Overall Study|Protocol Violation|4
348931|NCT00474630|1134616|P1|Overall Study|Protocol Violation|3
348932|NCT00474630|1134615|P2|Overall Study|Withdrawal by Subject|15
348933|NCT00474630|1134616|P1|Overall Study|Withdrawal by Subject|21
348934|NCT00474630|1134615|P2|Overall Study|Lost to Follow-up|15
348935|NCT00474630|1134616|P1|Overall Study|Lost to Follow-up|22
348936|NCT00474630|1134615|P2|Overall Study|Adverse Event|26
348937|NCT00474630|1134616|P1|Overall Study|Adverse Event|98
348938|NCT00474539|1134672|P2|Toddler Dose|Protocol Violation|0
348939|NCT00474539|1134673|P1|Toddler Dose|Protocol Violation|1
348940|NCT00474539|1134672|P2|After Infant Series|Withdrawal by Subject|0
348941|NCT00474539|1134673|P1|After Infant Series|Withdrawal by Subject|1
348942|NCT00474539|1134672|P2|After Infant Series|Lost to Follow-up|0
348943|NCT00474539|1134673|P1|After Infant Series|Lost to Follow-up|3
348944|NCT00474539|1134672|P2|Infant Series|Protocol Violation|1
348945|NCT00474539|1134673|P1|Infant Series|Protocol Violation|0
348946|NCT00474539|1134672|P2|Infant Series|Lost to Follow-up|1
348947|NCT00474539|1134673|P1|Infant Series|Lost to Follow-up|2
348948|NCT00474539|1134672|P2|Infant Series|Randomization error|0
348949|NCT00474539|1134673|P1|Infant Series|Randomization error|5
348950|NCT00474539|1134672|P2|Infant Series|Withdrawal by Subject|4
348951|NCT00474539|1134673|P1|Infant Series|Withdrawal by Subject|3
348952|NCT00474526|1134738|P17|Overall Study|Withdrawal by Subject|1
348953|NCT00474526|1134739|P16|Overall Study|Withdrawal by Subject|1
348954|NCT00474526|1134740|P15|Overall Study|Withdrawal by Subject|22
348955|NCT00474526|1134741|P14|Overall Study|Withdrawal by Subject|37
348956|NCT00474526|1134742|P13|Overall Study|Withdrawal by Subject|4
348957|NCT00474526|1134743|P12|Overall Study|Withdrawal by Subject|4
348958|NCT00474526|1134744|P11|Overall Study|Withdrawal by Subject|5
348959|NCT00474526|1134745|P10|Overall Study|Withdrawal by Subject|13
348960|NCT00474526|1134746|P9|Overall Study|Withdrawal by Subject|4
348961|NCT00474526|1134747|P8|Overall Study|Withdrawal by Subject|4
348962|NCT00474526|1134748|P7|Overall Study|Withdrawal by Subject|12
348963|NCT00474526|1134749|P6|Overall Study|Withdrawal by Subject|6
348964|NCT00474526|1134750|P5|Overall Study|Withdrawal by Subject|38
348965|NCT00474526|1134751|P4|Overall Study|Withdrawal by Subject|52
348966|NCT00474526|1134752|P3|Overall Study|Withdrawal by Subject|21
348967|NCT00474526|1134753|P2|Overall Study|Withdrawal by Subject|24
348968|NCT00474526|1134754|P1|Overall Study|Withdrawal by Subject|9
348969|NCT00474526|1134738|P17|Overall Study|UNABLE TO CLASSIFY|1
348970|NCT00474526|1134739|P16|Overall Study|UNABLE TO CLASSIFY|6
348971|NCT00474526|1134740|P15|Overall Study|UNABLE TO CLASSIFY|12
348972|NCT00474526|1134741|P14|Overall Study|UNABLE TO CLASSIFY|20
348973|NCT00474526|1134742|P13|Overall Study|UNABLE TO CLASSIFY|0
348974|NCT00474526|1134743|P12|Overall Study|UNABLE TO CLASSIFY|0
348975|NCT00474526|1134744|P11|Overall Study|UNABLE TO CLASSIFY|0
348976|NCT00474526|1134745|P10|Overall Study|UNABLE TO CLASSIFY|3
348977|NCT00474526|1134746|P9|Overall Study|UNABLE TO CLASSIFY|0
348978|NCT00474526|1134747|P8|Overall Study|UNABLE TO CLASSIFY|1
348979|NCT00474526|1134748|P7|Overall Study|UNABLE TO CLASSIFY|0
348980|NCT00474526|1134749|P6|Overall Study|UNABLE TO CLASSIFY|2
348981|NCT00474526|1134750|P5|Overall Study|UNABLE TO CLASSIFY|3
348982|NCT00474526|1134751|P4|Overall Study|UNABLE TO CLASSIFY|1
348983|NCT00474526|1134752|P3|Overall Study|UNABLE TO CLASSIFY|0
348984|NCT00474526|1134753|P2|Overall Study|UNABLE TO CLASSIFY|0
348985|NCT00474526|1134754|P1|Overall Study|UNABLE TO CLASSIFY|1
348986|NCT00474526|1134738|P17|Overall Study|Protocol Violation|2
348987|NCT00474526|1134739|P16|Overall Study|Protocol Violation|6
348988|NCT00474526|1134740|P15|Overall Study|Protocol Violation|9
348989|NCT00474526|1134741|P14|Overall Study|Protocol Violation|19
348990|NCT00474526|1134742|P13|Overall Study|Protocol Violation|4
348991|NCT00474526|1134743|P12|Overall Study|Protocol Violation|2
348992|NCT00474526|1134744|P11|Overall Study|Protocol Violation|2
348993|NCT00474526|1134745|P10|Overall Study|Protocol Violation|4
348994|NCT00474526|1134746|P9|Overall Study|Protocol Violation|0
348995|NCT00474526|1134747|P8|Overall Study|Protocol Violation|0
348996|NCT00474526|1134748|P7|Overall Study|Protocol Violation|3
348997|NCT00474526|1134749|P6|Overall Study|Protocol Violation|1
348998|NCT00474526|1134750|P5|Overall Study|Protocol Violation|3
348999|NCT00474526|1134751|P4|Overall Study|Protocol Violation|12
349000|NCT00474526|1134752|P3|Overall Study|Protocol Violation|4
349001|NCT00474526|1134753|P2|Overall Study|Protocol Violation|6
349002|NCT00474526|1134754|P1|Overall Study|Protocol Violation|2
349003|NCT00474526|1134738|P17|Overall Study|Lost to Follow-up|5
349004|NCT00474526|1134739|P16|Overall Study|Lost to Follow-up|4
349005|NCT00474526|1134740|P15|Overall Study|Lost to Follow-up|29
349006|NCT00474526|1134741|P14|Overall Study|Lost to Follow-up|74
349007|NCT00474526|1134742|P13|Overall Study|Lost to Follow-up|6
349008|NCT00474526|1134743|P12|Overall Study|Lost to Follow-up|4
349009|NCT00474526|1134744|P11|Overall Study|Lost to Follow-up|2
349010|NCT00474526|1134745|P10|Overall Study|Lost to Follow-up|6
349011|NCT00474526|1134746|P9|Overall Study|Lost to Follow-up|0
349012|NCT00474526|1134747|P8|Overall Study|Lost to Follow-up|1
349013|NCT00474526|1134748|P7|Overall Study|Lost to Follow-up|8
349014|NCT00474526|1134749|P6|Overall Study|Lost to Follow-up|5
349015|NCT00474526|1134750|P5|Overall Study|Lost to Follow-up|11
349016|NCT00474526|1134751|P4|Overall Study|Lost to Follow-up|29
349017|NCT00474526|1134752|P3|Overall Study|Lost to Follow-up|13
349018|NCT00474526|1134753|P2|Overall Study|Lost to Follow-up|6
349019|NCT00474526|1134754|P1|Overall Study|Lost to Follow-up|8
349020|NCT00474526|1134738|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
349021|NCT00474526|1134739|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
349022|NCT00474526|1134740|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
349023|NCT00474526|1134741|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
349024|NCT00474526|1134742|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
349025|NCT00474526|1134743|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
349026|NCT00474526|1134744|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
349027|NCT00474526|1134745|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
349028|NCT00474526|1134746|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
349029|NCT00474526|1134747|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
349030|NCT00474526|1134748|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
349031|NCT00474526|1134749|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
349032|NCT00474526|1134750|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
349033|NCT00474526|1134751|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
349034|NCT00474526|1134752|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
349035|NCT00474526|1134753|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
349036|NCT00474526|1134754|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
349037|NCT00474526|1134738|P17|Overall Study|Death|0
349038|NCT00474526|1134739|P16|Overall Study|Death|0
349039|NCT00474526|1134740|P15|Overall Study|Death|0
349040|NCT00474526|1134741|P14|Overall Study|Death|3
349041|NCT00474526|1134742|P13|Overall Study|Death|0
349042|NCT00474526|1134743|P12|Overall Study|Death|0
349043|NCT00474526|1134744|P11|Overall Study|Death|0
349044|NCT00474526|1134745|P10|Overall Study|Death|0
349045|NCT00474526|1134746|P9|Overall Study|Death|0
349046|NCT00474526|1134747|P8|Overall Study|Death|0
349047|NCT00474526|1134748|P7|Overall Study|Death|0
349048|NCT00474526|1134749|P6|Overall Study|Death|0
349049|NCT00474526|1134750|P5|Overall Study|Death|0
349050|NCT00474526|1134751|P4|Overall Study|Death|0
349051|NCT00474526|1134752|P3|Overall Study|Death|0
349052|NCT00474526|1134753|P2|Overall Study|Death|0
349053|NCT00474526|1134754|P1|Overall Study|Death|0
349054|NCT00474526|1134738|P17|Overall Study|Adverse Event|0
349055|NCT00474526|1134739|P16|Overall Study|Adverse Event|1
349056|NCT00474526|1134740|P15|Overall Study|Adverse Event|1
349057|NCT00474526|1134741|P14|Overall Study|Adverse Event|0
349058|NCT00474526|1134742|P13|Overall Study|Adverse Event|0
349059|NCT00474526|1134743|P12|Overall Study|Adverse Event|0
349060|NCT00474526|1134744|P11|Overall Study|Adverse Event|0
349061|NCT00474526|1134745|P10|Overall Study|Adverse Event|0
349062|NCT00474526|1134746|P9|Overall Study|Adverse Event|0
349063|NCT00474526|1134747|P8|Overall Study|Adverse Event|0
349064|NCT00474526|1134748|P7|Overall Study|Adverse Event|1
349065|NCT00474526|1134749|P6|Overall Study|Adverse Event|1
349066|NCT00474526|1134750|P5|Overall Study|Adverse Event|2
349067|NCT00474526|1134751|P4|Overall Study|Adverse Event|4
349068|NCT00474526|1134752|P3|Overall Study|Adverse Event|2
349069|NCT00474526|1134753|P2|Overall Study|Adverse Event|0
349070|NCT00474526|1134754|P1|Overall Study|Adverse Event|2
349071|NCT00474526|1134738|P17|Overall Study|ADMINISTRATIVE REASON|0
349072|NCT00474526|1134739|P16|Overall Study|ADMINISTRATIVE REASON|0
349073|NCT00474526|1134740|P15|Overall Study|ADMINISTRATIVE REASON|2
349074|NCT00474526|1134741|P14|Overall Study|ADMINISTRATIVE REASON|1
349075|NCT00474526|1134742|P13|Overall Study|ADMINISTRATIVE REASON|1
349076|NCT00474526|1134743|P12|Overall Study|ADMINISTRATIVE REASON|1
349077|NCT00474526|1134744|P11|Overall Study|ADMINISTRATIVE REASON|1
349078|NCT00474526|1134745|P10|Overall Study|ADMINISTRATIVE REASON|1
349079|NCT00474526|1134746|P9|Overall Study|ADMINISTRATIVE REASON|2
349080|NCT00474526|1134747|P8|Overall Study|ADMINISTRATIVE REASON|0
349081|NCT00474526|1134748|P7|Overall Study|ADMINISTRATIVE REASON|1
349082|NCT00474526|1134749|P6|Overall Study|ADMINISTRATIVE REASON|1
349083|NCT00474526|1134750|P5|Overall Study|ADMINISTRATIVE REASON|9
349084|NCT00474526|1134751|P4|Overall Study|ADMINISTRATIVE REASON|20
349085|NCT00474526|1134752|P3|Overall Study|ADMINISTRATIVE REASON|9
349086|NCT00474526|1134753|P2|Overall Study|ADMINISTRATIVE REASON|9
349087|NCT00474526|1134754|P1|Overall Study|ADMINISTRATIVE REASON|11
349088|NCT00474487|1134919|P4|Overall Study|Death|0
349089|NCT00474487|1134920|P3|Overall Study|Death|0
349090|NCT00474487|1134921|P2|Overall Study|Death|1
349091|NCT00474487|1134922|P1|Overall Study|Death|0
349092|NCT00474487|1134919|P4|Overall Study|Inappropriate enrollment|0
349093|NCT00474487|1134920|P3|Overall Study|Inappropriate enrollment|7
349094|NCT00474487|1134921|P2|Overall Study|Inappropriate enrollment|0
349095|NCT00474487|1134922|P1|Overall Study|Inappropriate enrollment|4
349096|NCT00474487|1134919|P4|Overall Study|Lost to Follow-up|0
349097|NCT00474487|1134920|P3|Overall Study|Lost to Follow-up|7
349098|NCT00474487|1134921|P2|Overall Study|Lost to Follow-up|1
349099|NCT00474487|1134922|P1|Overall Study|Lost to Follow-up|20
349100|NCT00474487|1134919|P4|Overall Study|Withdrawal by Subject|0
349101|NCT00474487|1134920|P3|Overall Study|Withdrawal by Subject|0
349102|NCT00474487|1134921|P2|Overall Study|Withdrawal by Subject|0
349103|NCT00474487|1134922|P1|Overall Study|Withdrawal by Subject|6
349104|NCT00474383|1134942|P2|Extension|Progressive Disease|5
349105|NCT00474383|1134943|P1|Extension|Progressive Disease|0
349106|NCT00474383|1134942|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
349107|NCT00474383|1134943|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
349108|NCT00474383|1134942|P2|Main Study|Other|0
349109|NCT00474383|1134943|P1|Main Study|Other|1
349110|NCT00474383|1134942|P2|Main Study|Progressive Disease|0
349111|NCT00474383|1134943|P1|Main Study|Progressive Disease|23
349112|NCT00474383|1134942|P2|Main Study|Symptomatic Deterioration|0
349113|NCT00474383|1134943|P1|Main Study|Symptomatic Deterioration|1
349114|NCT00474383|1134942|P2|Main Study|Adverse Event|0
349115|NCT00474383|1134943|P1|Main Study|Adverse Event|11
349116|NCT00474240|1134960|P6|Overall Study|Removed due to lab value|1
349117|NCT00474240|1134961|P5|Overall Study|Removed due to lab value|0
349118|NCT00474240|1134962|P4|Overall Study|Removed due to lab value|0
349119|NCT00474240|1134963|P3|Overall Study|Removed due to lab value|0
349120|NCT00474240|1134964|P2|Overall Study|Removed due to lab value|0
349121|NCT00474240|1134965|P1|Overall Study|Removed due to lab value|0
349122|NCT00474240|1134960|P6|Overall Study|Adverse Event|16
349123|NCT00474240|1134961|P5|Overall Study|Adverse Event|5
349124|NCT00474240|1134962|P4|Overall Study|Adverse Event|14
349125|NCT00474240|1134963|P3|Overall Study|Adverse Event|9
349126|NCT00474240|1134964|P2|Overall Study|Adverse Event|0
349127|NCT00474240|1134965|P1|Overall Study|Adverse Event|0
349128|NCT00474240|1134960|P6|Overall Study|Withdrawal by Subject|1
349129|NCT00474240|1134961|P5|Overall Study|Withdrawal by Subject|3
349130|NCT00474240|1134962|P4|Overall Study|Withdrawal by Subject|2
349131|NCT00474240|1134963|P3|Overall Study|Withdrawal by Subject|0
349132|NCT00474240|1134964|P2|Overall Study|Withdrawal by Subject|1
349133|NCT00474240|1134965|P1|Overall Study|Withdrawal by Subject|1
349134|NCT00474188|1134990|P1|Overall Study|Study discontinued by sponsor|5
349135|NCT00474188|1134990|P1|Overall Study|Withdrawal by Subject|1
349136|NCT00474175|1135000|P3|Overall Study|Administrative|0
349137|NCT00474175|1135001|P2|Overall Study|Administrative|1
349138|NCT00474175|1135002|P1|Overall Study|Administrative|0
349139|NCT00474175|1135000|P3|Overall Study|Protocol Violation|1
349140|NCT00474175|1135001|P2|Overall Study|Protocol Violation|2
349141|NCT00474175|1135002|P1|Overall Study|Protocol Violation|0
349142|NCT00474175|1135000|P3|Overall Study|Ineligible|1
349143|NCT00474175|1135001|P2|Overall Study|Ineligible|3
349144|NCT00474175|1135002|P1|Overall Study|Ineligible|1
349145|NCT00474175|1135000|P3|Overall Study|Withdrawal by Subject|1
349146|NCT00474175|1135001|P2|Overall Study|Withdrawal by Subject|1
349147|NCT00474175|1135002|P1|Overall Study|Withdrawal by Subject|0
349148|NCT00474175|1135000|P3|Overall Study|Lack of Efficacy|1
349149|NCT00474175|1135001|P2|Overall Study|Lack of Efficacy|0
349150|NCT00474175|1135002|P1|Overall Study|Lack of Efficacy|0
349151|NCT00474058|1135066|P2|Overall Study|Other|0
349152|NCT00474058|1135067|P1|Overall Study|Other|2
349153|NCT00474058|1135066|P2|Overall Study|Withdrawal by Subject|7
349154|NCT00474058|1135067|P1|Overall Study|Withdrawal by Subject|11
349155|NCT00474058|1135066|P2|Overall Study|Lack of Efficacy|4
349156|NCT00474058|1135067|P1|Overall Study|Lack of Efficacy|0
349157|NCT00474058|1135066|P2|Overall Study|Adverse Event|6
349158|NCT00474058|1135067|P1|Overall Study|Adverse Event|11
349159|NCT00474045|1135081|P2|Overall Study|Withdrawal criteria|50
349160|NCT00474045|1135082|P1|Overall Study|Withdrawal criteria|60
349161|NCT00474045|1135081|P2|Overall Study|Withdrawal by Subject|18
349162|NCT00474045|1135082|P1|Overall Study|Withdrawal by Subject|16
349163|NCT00474045|1135081|P2|Overall Study|Protocol Violation|12
349164|NCT00474045|1135082|P1|Overall Study|Protocol Violation|10
349165|NCT00474045|1135081|P2|Overall Study|Lost to Follow-up|1
349166|NCT00474045|1135082|P1|Overall Study|Lost to Follow-up|1
349167|NCT00474045|1135081|P2|Overall Study|Lack of Efficacy|9
349168|NCT00474045|1135082|P1|Overall Study|Lack of Efficacy|0
349169|NCT00474045|1135081|P2|Overall Study|Unclassified|3
349170|NCT00474045|1135082|P1|Overall Study|Unclassified|1
349171|NCT00474045|1135081|P2|Overall Study|Adverse Event|8
349172|NCT00474045|1135082|P1|Overall Study|Adverse Event|18
349173|NCT00473889|1135182|P2|Overall Study|Withdrawal by Subject|0
349174|NCT00473889|1135183|P1|Overall Study|Withdrawal by Subject|5
349175|NCT00473889|1135182|P2|Overall Study|Trial Terminated|6
349176|NCT00473889|1135183|P1|Overall Study|Trial Terminated|3
349177|NCT00473889|1135182|P2|Overall Study|Physician Decision|5
349178|NCT00473889|1135183|P1|Overall Study|Physician Decision|10
349179|NCT00473889|1135182|P2|Overall Study|Lost to Follow-up|1
349180|NCT00473889|1135183|P1|Overall Study|Lost to Follow-up|2
349181|NCT00473889|1135182|P2|Overall Study|Lack of Efficacy|29
349182|NCT00473889|1135183|P1|Overall Study|Lack of Efficacy|28
349183|NCT00473889|1135182|P2|Overall Study|Protocol Violation|2
349184|NCT00473889|1135183|P1|Overall Study|Protocol Violation|4
349185|NCT00473889|1135182|P2|Overall Study|Adverse Event|17
349186|NCT00473889|1135183|P1|Overall Study|Adverse Event|30
349187|NCT00473889|1135182|P2|Overall Study|Did not receive study medication|4
349188|NCT00473889|1135183|P1|Overall Study|Did not receive study medication|1
349189|NCT00473876|1135195|P2|Overall Study|Lost to Follow-up|1
349190|NCT00473876|1135196|P1|Overall Study|Lost to Follow-up|3
349191|NCT00473824|1135215|P2|Overall Study|Withdrawal by physician|0
349192|NCT00473824|1135216|P1|Overall Study|Withdrawal by physician|1
349193|NCT00473824|1135215|P2|Overall Study|Lost to Follow-up|0
349194|NCT00473824|1135216|P1|Overall Study|Lost to Follow-up|1
349195|NCT00473824|1135215|P2|Overall Study|Death|0
349196|NCT00473824|1135216|P1|Overall Study|Death|1
349197|NCT00473824|1135215|P2|Overall Study|Adverse Event|0
349198|NCT00473824|1135216|P1|Overall Study|Adverse Event|1
349199|NCT00473824|1135215|P2|Overall Study|Virologic Breakthrough|0
349200|NCT00473824|1135216|P1|Overall Study|Virologic Breakthrough|1
349201|NCT00473746|1135227|P5|Period 2 (Phase 2)|Reason not specified|3
349202|NCT00473746|1135228|P4|Period 2 (Phase 2)|Reason not specified|0
349203|NCT00473746|1135229|P3|Period 2 (Phase 2)|Reason not specified|0
349204|NCT00473746|1135230|P2|Period 2 (Phase 2)|Reason not specified|0
349205|NCT00473746|1135231|P1|Period 2 (Phase 2)|Reason not specified|0
349206|NCT00473746|1135227|P5|Period 2 (Phase 2)|Progressive Disease|20
349207|NCT00473746|1135228|P4|Period 2 (Phase 2)|Progressive Disease|0
349208|NCT00473746|1135229|P3|Period 2 (Phase 2)|Progressive Disease|0
349209|NCT00473746|1135230|P2|Period 2 (Phase 2)|Progressive Disease|0
349210|NCT00473746|1135231|P1|Period 2 (Phase 2)|Progressive Disease|0
349211|NCT00473746|1135227|P5|Period 2 (Phase 2)|Death|1
349212|NCT00473746|1135228|P4|Period 2 (Phase 2)|Death|0
349213|NCT00473746|1135229|P3|Period 2 (Phase 2)|Death|0
349214|NCT00473746|1135230|P2|Period 2 (Phase 2)|Death|0
349215|NCT00473746|1135231|P1|Period 2 (Phase 2)|Death|0
349216|NCT00473746|1135227|P5|Period 2 (Phase 2)|Adverse Event|3
349217|NCT00473746|1135228|P4|Period 2 (Phase 2)|Adverse Event|0
349218|NCT00473746|1135229|P3|Period 2 (Phase 2)|Adverse Event|0
349219|NCT00473746|1135230|P2|Period 2 (Phase 2)|Adverse Event|0
349220|NCT00473746|1135231|P1|Period 2 (Phase 2)|Adverse Event|0
349221|NCT00473746|1135227|P5|Period 1 (Phase 1)|Reason not specified|0
349222|NCT00473746|1135228|P4|Period 1 (Phase 1)|Reason not specified|0
349223|NCT00473746|1135229|P3|Period 1 (Phase 1)|Reason not specified|0
349224|NCT00473746|1135230|P2|Period 1 (Phase 1)|Reason not specified|1
349225|NCT00473746|1135231|P1|Period 1 (Phase 1)|Reason not specified|0
349226|NCT00473746|1135227|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
349227|NCT00473746|1135228|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
349228|NCT00473746|1135229|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
349229|NCT00473746|1135230|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
349230|NCT00473746|1135231|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
349231|NCT00473746|1135227|P5|Period 1 (Phase 1)|Progressive Disease|0
349232|NCT00473746|1135228|P4|Period 1 (Phase 1)|Progressive Disease|10
349233|NCT00473746|1135229|P3|Period 1 (Phase 1)|Progressive Disease|6
349234|NCT00473746|1135230|P2|Period 1 (Phase 1)|Progressive Disease|6
349235|NCT00473746|1135231|P1|Period 1 (Phase 1)|Progressive Disease|5
349236|NCT00473746|1135227|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
349237|NCT00473746|1135228|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
349238|NCT00473746|1135229|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
349239|NCT00473746|1135230|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
349240|NCT00473746|1135231|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
349241|NCT00473746|1135227|P5|Period 1 (Phase 1)|Adverse Event|0
349242|NCT00473746|1135228|P4|Period 1 (Phase 1)|Adverse Event|0
349243|NCT00473746|1135229|P3|Period 1 (Phase 1)|Adverse Event|0
349244|NCT00473746|1135230|P2|Period 1 (Phase 1)|Adverse Event|0
349245|NCT00473746|1135231|P1|Period 1 (Phase 1)|Adverse Event|1
349246|NCT00473655|1135279|P3|Overall Study|Lost to Follow-up|8
349247|NCT00473655|1135280|P2|Overall Study|Lost to Follow-up|5
349248|NCT00473655|1135281|P1|Overall Study|Lost to Follow-up|9
349249|NCT00473590|1135328|P2|Overall Study|Other|1
349250|NCT00473590|1135329|P1|Overall Study|Other|0
349251|NCT00473590|1135328|P2|Overall Study|Withdrawal by Subject|3
349252|NCT00473590|1135329|P1|Overall Study|Withdrawal by Subject|5
349253|NCT00473590|1135328|P2|Overall Study|Physician Decision|4
349254|NCT00473590|1135329|P1|Overall Study|Physician Decision|2
349255|NCT00473590|1135328|P2|Overall Study|Non–protocol-specified therapy|5
349256|NCT00473590|1135329|P1|Overall Study|Non–protocol-specified therapy|7
349257|NCT00473590|1135328|P2|Overall Study|Progression not resulting in death|20
349258|NCT00473590|1135329|P1|Overall Study|Progression not resulting in death|24
349259|NCT00473590|1135328|P2|Overall Study|Death|2
349260|NCT00473590|1135329|P1|Overall Study|Death|4
349261|NCT00473590|1135328|P2|Overall Study|Adverse Event|3
349262|NCT00473590|1135329|P1|Overall Study|Adverse Event|3
349263|NCT00473564|1135345|P1|Overall Study|robot surgery aborted in OR|23
349264|NCT00473512|1135355|P5|Period 2 (Phase 2)|Unspecified|0
349265|NCT00473512|1135356|P4|Period 2 (Phase 2)|Unspecified|3
349266|NCT00473512|1135357|P3|Period 2 (Phase 2)|Unspecified|0
349267|NCT00473512|1135358|P2|Period 2 (Phase 2)|Unspecified|0
349268|NCT00473512|1135359|P1|Period 2 (Phase 2)|Unspecified|1
349269|NCT00473512|1135355|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
349270|NCT00473512|1135356|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
349271|NCT00473512|1135357|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
349272|NCT00473512|1135358|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
349273|NCT00473512|1135359|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
349274|NCT00473512|1135355|P5|Period 2 (Phase 2)|Disease Progression|1
349275|NCT00473512|1135356|P4|Period 2 (Phase 2)|Disease Progression|17
349276|NCT00473512|1135357|P3|Period 2 (Phase 2)|Disease Progression|2
349277|NCT00473512|1135358|P2|Period 2 (Phase 2)|Disease Progression|2
349278|NCT00473512|1135359|P1|Period 2 (Phase 2)|Disease Progression|0
349279|NCT00473512|1135355|P5|Period 2 (Phase 2)|Death|1
349280|NCT00473512|1135356|P4|Period 2 (Phase 2)|Death|1
349281|NCT00473512|1135357|P3|Period 2 (Phase 2)|Death|0
349282|NCT00473512|1135358|P2|Period 2 (Phase 2)|Death|0
349283|NCT00473512|1135359|P1|Period 2 (Phase 2)|Death|0
349284|NCT00473512|1135355|P5|Period 2 (Phase 2)|Adverse Event|0
349285|NCT00473512|1135356|P4|Period 2 (Phase 2)|Adverse Event|1
349286|NCT00473512|1135357|P3|Period 2 (Phase 2)|Adverse Event|0
349287|NCT00473512|1135358|P2|Period 2 (Phase 2)|Adverse Event|0
349288|NCT00473512|1135359|P1|Period 2 (Phase 2)|Adverse Event|0
349289|NCT00473512|1135355|P5|Period 1 (Phase 1)|Unspecified|0
349290|NCT00473512|1135356|P4|Period 1 (Phase 1)|Unspecified|1
349291|NCT00473512|1135357|P3|Period 1 (Phase 1)|Unspecified|0
349292|NCT00473512|1135358|P2|Period 1 (Phase 1)|Unspecified|0
349293|NCT00473512|1135359|P1|Period 1 (Phase 1)|Unspecified|0
349294|NCT00473512|1135355|P5|Period 1 (Phase 1)|Disease Progression|1
349295|NCT00473512|1135356|P4|Period 1 (Phase 1)|Disease Progression|10
349296|NCT00473512|1135357|P3|Period 1 (Phase 1)|Disease Progression|0
349297|NCT00473512|1135358|P2|Period 1 (Phase 1)|Disease Progression|1
349298|NCT00473512|1135359|P1|Period 1 (Phase 1)|Disease Progression|1
349299|NCT00473512|1135355|P5|Period 1 (Phase 1)|Death|0
349300|NCT00473512|1135356|P4|Period 1 (Phase 1)|Death|1
349301|NCT00473512|1135357|P3|Period 1 (Phase 1)|Death|0
349302|NCT00473512|1135358|P2|Period 1 (Phase 1)|Death|0
349303|NCT00473512|1135359|P1|Period 1 (Phase 1)|Death|0
349304|NCT00473512|1135355|P5|Period 1 (Phase 1)|Adverse Event|0
349305|NCT00473512|1135356|P4|Period 1 (Phase 1)|Adverse Event|5
349306|NCT00473512|1135357|P3|Period 1 (Phase 1)|Adverse Event|0
349307|NCT00473512|1135358|P2|Period 1 (Phase 1)|Adverse Event|0
349308|NCT00473512|1135359|P1|Period 1 (Phase 1)|Adverse Event|0
349309|NCT00473434|1135417|P1|Overall Study|No longer required|1
349310|NCT00473434|1135417|P1|Overall Study|Switching to trial medication|1
349311|NCT00473434|1135417|P1|Overall Study|Ceased in favor of Paliperidone|1
349312|NCT00473434|1135417|P1|Overall Study|Reason not specified|6
349313|NCT00473434|1135417|P1|Overall Study|Safety evaluation|1
349314|NCT00473434|1135417|P1|Overall Study|Patient was selling medication to others|1
349315|NCT00473434|1135417|P1|Overall Study|Adverse Event|3
349316|NCT00473434|1135417|P1|Overall Study|Lack of Efficacy|3
349317|NCT00473434|1135417|P1|Overall Study|Compliance|3
349318|NCT00473434|1135417|P1|Overall Study|Withdrawal by Subject|9
349319|NCT00473434|1135417|P1|Overall Study|Physician Decision|3
349320|NCT00473382|1135482|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
349321|NCT00473382|1135483|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
349322|NCT00473382|1135484|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
349323|NCT00473382|1135482|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
349324|NCT00473382|1135483|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
349325|NCT00473382|1135484|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
349326|NCT00473382|1135482|P3|Open-label Extension Through Month 60|Subject's Decision|6
349327|NCT00473382|1135483|P2|Open-label Extension Through Month 60|Subject's Decision|1
349328|NCT00473382|1135484|P1|Open-label Extension Through Month 60|Subject's Decision|7
349329|NCT00473382|1135482|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
349330|NCT00473382|1135483|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
349331|NCT00473382|1135484|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
349332|NCT00473382|1135482|P3|Open-label Extension Through Month 60|Death|4
349333|NCT00473382|1135483|P2|Open-label Extension Through Month 60|Death|7
349334|NCT00473382|1135484|P1|Open-label Extension Through Month 60|Death|1
349335|NCT00473382|1135482|P3|Open-label Extension Through Month 60|Adverse Event|2
349336|NCT00473382|1135483|P2|Open-label Extension Through Month 60|Adverse Event|0
349337|NCT00473382|1135484|P1|Open-label Extension Through Month 60|Adverse Event|0
349338|NCT00473382|1135482|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
349339|NCT00473382|1135483|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
349340|NCT00473382|1135484|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
349341|NCT00473382|1135482|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
349342|NCT00473382|1135483|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
349343|NCT00473382|1135484|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
349344|NCT00473382|1135482|P3|Open-label Extension Through Month 48|Subject's Decision|6
349345|NCT00473382|1135483|P2|Open-label Extension Through Month 48|Subject's Decision|1
349346|NCT00473382|1135484|P1|Open-label Extension Through Month 48|Subject's Decision|5
349347|NCT00473382|1135482|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
349348|NCT00473382|1135483|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
349349|NCT00473382|1135484|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
349350|NCT00473382|1135482|P3|Open-label Extension Through Month 48|Death|3
349351|NCT00473382|1135483|P2|Open-label Extension Through Month 48|Death|3
349352|NCT00473382|1135484|P1|Open-label Extension Through Month 48|Death|1
349353|NCT00473382|1135482|P3|Open-label Extension Through Month 48|Adverse Event|1
349354|NCT00473382|1135483|P2|Open-label Extension Through Month 48|Adverse Event|0
349355|NCT00473382|1135484|P1|Open-label Extension Through Month 48|Adverse Event|0
349356|NCT00473382|1135482|P3|Core Study|Subject's decision|10
349357|NCT00473382|1135483|P2|Core Study|Subject's decision|11
349358|NCT00473382|1135484|P1|Core Study|Subject's decision|12
349359|NCT00473382|1135482|P3|Core Study|Subject needed other treatment|2
349360|NCT00473382|1135483|P2|Core Study|Subject needed other treatment|3
349361|NCT00473382|1135484|P1|Core Study|Subject needed other treatment|1
349362|NCT00473382|1135482|P3|Core Study|Subject non-compliance|1
349363|NCT00473382|1135483|P2|Core Study|Subject non-compliance|2
349364|NCT00473382|1135484|P1|Core Study|Subject non-compliance|5
349365|NCT00473382|1135482|P3|Core Study|Physician Decision|2
349366|NCT00473382|1135483|P2|Core Study|Physician Decision|2
349367|NCT00473382|1135484|P1|Core Study|Physician Decision|1
349368|NCT00473382|1135482|P3|Core Study|Lost to Follow-up|3
349369|NCT00473382|1135483|P2|Core Study|Lost to Follow-up|3
349370|NCT00473382|1135484|P1|Core Study|Lost to Follow-up|3
349371|NCT00473382|1135482|P3|Core Study|Death|10
349372|NCT00473382|1135483|P2|Core Study|Death|5
349373|NCT00473382|1135484|P1|Core Study|Death|3
349374|NCT00473382|1135482|P3|Core Study|Adverse Event|1
349375|NCT00473382|1135483|P2|Core Study|Adverse Event|1
349376|NCT00473382|1135484|P1|Core Study|Adverse Event|3
349377|NCT00473330|1135542|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
349378|NCT00473330|1135543|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
349379|NCT00473330|1135544|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
349380|NCT00473330|1135542|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
349381|NCT00473330|1135543|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
349382|NCT00473330|1135544|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
349383|NCT00473330|1135542|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
349384|NCT00473330|1135543|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
349385|NCT00473330|1135544|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
349386|NCT00473330|1135542|P3|Open-label Extension Through Month 60|Subject's Decision|4
349387|NCT00473330|1135543|P2|Open-label Extension Through Month 60|Subject's Decision|3
349388|NCT00473330|1135544|P1|Open-label Extension Through Month 60|Subject's Decision|1
349389|NCT00473330|1135542|P3|Open-label Extension Through Month 60|Physician's Decision|3
349390|NCT00473330|1135543|P2|Open-label Extension Through Month 60|Physician's Decision|1
349391|NCT00473330|1135544|P1|Open-label Extension Through Month 60|Physician's Decision|2
349392|NCT00473330|1135542|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
349393|NCT00473330|1135543|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
349394|NCT00473330|1135544|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
349395|NCT00473330|1135542|P3|Open-label Extension Through Month 60|Death|1
349396|NCT00473330|1135543|P2|Open-label Extension Through Month 60|Death|2
349397|NCT00473330|1135544|P1|Open-label Extension Through Month 60|Death|2
349398|NCT00473330|1135542|P3|Open-label Extension Through Month 60|Adverse Event|2
349399|NCT00473330|1135543|P2|Open-label Extension Through Month 60|Adverse Event|0
349400|NCT00473330|1135544|P1|Open-label Extension Through Month 60|Adverse Event|0
349401|NCT00473330|1135542|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
349402|NCT00473330|1135543|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
349403|NCT00473330|1135544|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
349404|NCT00473330|1135542|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
349405|NCT00473330|1135543|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
349406|NCT00473330|1135544|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
349407|NCT00473330|1135542|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
349408|NCT00473330|1135543|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
349409|NCT00473330|1135544|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
349410|NCT00473330|1135542|P3|Open-label Extension Through Month 48|Subject's Decision|3
349411|NCT00473330|1135543|P2|Open-label Extension Through Month 48|Subject's Decision|3
349412|NCT00473330|1135544|P1|Open-label Extension Through Month 48|Subject's Decision|1
349413|NCT00473330|1135542|P3|Open-label Extension Through Month 48|Physician's Decision|3
349414|NCT00473330|1135543|P2|Open-label Extension Through Month 48|Physician's Decision|1
349415|NCT00473330|1135544|P1|Open-label Extension Through Month 48|Physician's Decision|2
349416|NCT00473330|1135542|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
349417|NCT00473330|1135543|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
349418|NCT00473330|1135544|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
349419|NCT00473330|1135542|P3|Open-label Extension Through Month 48|Death|0
349420|NCT00473330|1135543|P2|Open-label Extension Through Month 48|Death|0
349421|NCT00473330|1135544|P1|Open-label Extension Through Month 48|Death|2
349422|NCT00473330|1135542|P3|Open-label Extension Through Month 48|Adverse Event|2
349423|NCT00473330|1135543|P2|Open-label Extension Through Month 48|Adverse Event|0
349424|NCT00473330|1135544|P1|Open-label Extension Through Month 48|Adverse Event|0
349425|NCT00473330|1135542|P3|Core Study|Subject's Decision|19
349426|NCT00473330|1135543|P2|Core Study|Subject's Decision|8
349427|NCT00473330|1135544|P1|Core Study|Subject's Decision|9
349428|NCT00473330|1135542|P3|Core Study|Subject Required Other Therapy|3
349429|NCT00473330|1135543|P2|Core Study|Subject Required Other Therapy|1
349430|NCT00473330|1135544|P1|Core Study|Subject Required Other Therapy|0
349431|NCT00473330|1135542|P3|Core Study|Subject Non-compliance|1
349432|NCT00473330|1135543|P2|Core Study|Subject Non-compliance|2
349433|NCT00473330|1135544|P1|Core Study|Subject Non-compliance|1
349434|NCT00473330|1135542|P3|Core Study|Physician Decision|3
349435|NCT00473330|1135543|P2|Core Study|Physician Decision|1
349436|NCT00473330|1135544|P1|Core Study|Physician Decision|2
349437|NCT00473330|1135542|P3|Core Study|Lost to Follow-up|10
349438|NCT00473330|1135543|P2|Core Study|Lost to Follow-up|5
349439|NCT00473330|1135544|P1|Core Study|Lost to Follow-up|5
349440|NCT00473330|1135542|P3|Core Study|Death|4
349441|NCT00473330|1135543|P2|Core Study|Death|4
349442|NCT00473330|1135544|P1|Core Study|Death|6
349443|NCT00473330|1135542|P3|Core Study|Adverse Event|1
349444|NCT00473330|1135543|P2|Core Study|Adverse Event|4
349445|NCT00473330|1135544|P1|Core Study|Adverse Event|4
349446|NCT00473265|1135599|P1|Overall Study|Off treatment early|15
349447|NCT00473265|1135599|P1|Overall Study|Unrelated adverse event|5
349448|NCT00473083|1135611|P3|Overall Study|Adverse Event|0
349449|NCT00473083|1135612|P2|Overall Study|Adverse Event|0
349450|NCT00473083|1135613|P1|Overall Study|Adverse Event|1
349451|NCT00472641|1135688|P1|Overall Study|Lost to Follow-up|1
349452|NCT00472641|1135688|P1|Overall Study|Adverse Event|3
349453|NCT00472641|1135688|P1|Overall Study|Lack of Efficacy|3
349454|NCT00472030|1135721|P2|Overall Study|Physician Decision|0
349455|NCT00472030|1135722|P1|Overall Study|Physician Decision|1
349456|NCT00472446|1135742|P4|Overall Study|Questionnaires not returned|4
349457|NCT00472446|1135743|P3|Overall Study|Questionnaires not returned|6
349458|NCT00472446|1135744|P2|Overall Study|Questionnaires not returned|6
349459|NCT00472446|1135745|P1|Overall Study|Questionnaires not returned|5
349460|NCT00472446|1135742|P4|Overall Study|Reintervention|1
349461|NCT00472446|1135743|P3|Overall Study|Reintervention|1
349462|NCT00472446|1135744|P2|Overall Study|Reintervention|0
349463|NCT00472446|1135745|P1|Overall Study|Reintervention|0
349464|NCT00472446|1135742|P4|Overall Study|Protocol Violation|1
349465|NCT00472446|1135743|P3|Overall Study|Protocol Violation|0
349466|NCT00472446|1135744|P2|Overall Study|Protocol Violation|0
349467|NCT00472446|1135745|P1|Overall Study|Protocol Violation|0
349468|NCT00472420|1135775|P1|Follow-up Period|Protocol Violation|1
349469|NCT00472420|1135775|P1|Follow-up Period|Lost to Follow-up|2
349470|NCT00472420|1135775|P1|Follow-up Period|Physician Decision|9
349471|NCT00472420|1135775|P1|Follow-up Period|Death|5
349472|NCT00472420|1135775|P1|Induction Treatment Period|Death|3
349473|NCT00472420|1135775|P1|Induction Treatment Period|Non-compliance|1
349474|NCT00472420|1135775|P1|Induction Treatment Period|Adverse Event|3
349475|NCT00472420|1135775|P1|Induction Treatment Period|Physician Decision|9
349476|NCT00472303|1135783|P3|Maintenance Phase|not specified|0
349477|NCT00472303|1135784|P2|Maintenance Phase|not specified|1
349478|NCT00472303|1135785|P1|Maintenance Phase|not specified|1
349479|NCT00472303|1135783|P3|Maintenance Phase|Resolution of pain|1
349480|NCT00472303|1135784|P2|Maintenance Phase|Resolution of pain|0
349481|NCT00472303|1135785|P1|Maintenance Phase|Resolution of pain|0
349482|NCT00472303|1135783|P3|Maintenance Phase|Trial medication non-compliant|1
349483|NCT00472303|1135784|P2|Maintenance Phase|Trial medication non-compliant|0
349484|NCT00472303|1135785|P1|Maintenance Phase|Trial medication non-compliant|0
349485|NCT00472303|1135783|P3|Maintenance Phase|Withdrawal by Subject|3
349486|NCT00472303|1135784|P2|Maintenance Phase|Withdrawal by Subject|7
349487|NCT00472303|1135785|P1|Maintenance Phase|Withdrawal by Subject|6
349488|NCT00472303|1135783|P3|Maintenance Phase|Lack of Efficacy|4
349489|NCT00472303|1135784|P2|Maintenance Phase|Lack of Efficacy|2
349490|NCT00472303|1135785|P1|Maintenance Phase|Lack of Efficacy|2
349491|NCT00472303|1135783|P3|Maintenance Phase|Death|2
349492|NCT00472303|1135784|P2|Maintenance Phase|Death|0
349493|NCT00472303|1135785|P1|Maintenance Phase|Death|3
349494|NCT00472303|1135783|P3|Maintenance Phase|Adverse Event|6
349495|NCT00472303|1135784|P2|Maintenance Phase|Adverse Event|6
349496|NCT00472303|1135785|P1|Maintenance Phase|Adverse Event|5
349497|NCT00472303|1135783|P3|Discontinuations After Titration Phase|not specified|0
349498|NCT00472303|1135784|P2|Discontinuations After Titration Phase|not specified|0
349499|NCT00472303|1135785|P1|Discontinuations After Titration Phase|not specified|5
349500|NCT00472303|1135783|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
349501|NCT00472303|1135784|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
349502|NCT00472303|1135785|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
349503|NCT00472303|1135783|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
349504|NCT00472303|1135784|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
349505|NCT00472303|1135785|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
349506|NCT00472303|1135783|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
349507|NCT00472303|1135784|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
349508|NCT00472303|1135785|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
349509|NCT00472303|1135783|P3|Discontinuations After Titration Phase|Adverse Event|0
349510|NCT00472303|1135784|P2|Discontinuations After Titration Phase|Adverse Event|0
349511|NCT00472303|1135785|P1|Discontinuations After Titration Phase|Adverse Event|6
349512|NCT00472303|1135783|P3|Titration Phase|not specified|0
349513|NCT00472303|1135784|P2|Titration Phase|not specified|1
349514|NCT00472303|1135785|P1|Titration Phase|not specified|3
349515|NCT00472303|1135783|P3|Titration Phase|Trial Medication non-compliant|0
349516|NCT00472303|1135784|P2|Titration Phase|Trial Medication non-compliant|1
349517|NCT00472303|1135785|P1|Titration Phase|Trial Medication non-compliant|4
349518|NCT00472303|1135783|P3|Titration Phase|Withdrawal by Subject|0
349519|NCT00472303|1135784|P2|Titration Phase|Withdrawal by Subject|13
349520|NCT00472303|1135785|P1|Titration Phase|Withdrawal by Subject|16
349521|NCT00472303|1135783|P3|Titration Phase|Lack of Efficacy|0
349522|NCT00472303|1135784|P2|Titration Phase|Lack of Efficacy|0
349523|NCT00472303|1135785|P1|Titration Phase|Lack of Efficacy|10
349524|NCT00472303|1135783|P3|Titration Phase|Death|0
349525|NCT00472303|1135784|P2|Titration Phase|Death|2
349526|NCT00472303|1135785|P1|Titration Phase|Death|4
349527|NCT00472303|1135783|P3|Titration Phase|Adverse Event|0
349528|NCT00472303|1135784|P2|Titration Phase|Adverse Event|12
349529|NCT00472303|1135785|P1|Titration Phase|Adverse Event|22
349530|NCT00472290|1135848|P1|Overall Study|Requirement for alternative therapy|7
349531|NCT00472290|1135848|P1|Overall Study|Adverse Event|6
349532|NCT00472290|1135848|P1|Overall Study|Withdrawal by Subject|5
349533|NCT00472290|1135848|P1|Overall Study|Disease Progression|4
349534|NCT00472290|1135848|P1|Overall Study|Lack of Efficacy|1
349535|NCT00472290|1135848|P1|Overall Study|Lost to Follow-up|1
349536|NCT00472290|1135848|P1|Overall Study|Death|3
349537|NCT00472290|1135848|P1|Overall Study|Administrative Decision|37
349538|NCT00472290|1135848|P1|Overall Study|Protocol Specified Criteria|7
349539|NCT00472290|1135848|P1|Overall Study|Progression of Therapy-Related MDS|1
349540|NCT00472199|1135860|P2|Overall Study|patient was asymptomatic|0
349541|NCT00472199|1135861|P1|Overall Study|patient was asymptomatic|1
349542|NCT00472199|1135860|P2|Overall Study|personal reason|1
349543|NCT00472199|1135861|P1|Overall Study|personal reason|0
349544|NCT00472199|1135860|P2|Overall Study|Withdrawal by Subject|5
349545|NCT00472199|1135861|P1|Overall Study|Withdrawal by Subject|6
349546|NCT00472199|1135860|P2|Overall Study|Protocol Violation|2
349547|NCT00472199|1135861|P1|Overall Study|Protocol Violation|3
349548|NCT00472199|1135860|P2|Overall Study|Lost to Follow-up|4
349549|NCT00472199|1135861|P1|Overall Study|Lost to Follow-up|2
349550|NCT00472199|1135860|P2|Overall Study|Lack of Efficacy|25
349551|NCT00472199|1135861|P1|Overall Study|Lack of Efficacy|4
349552|NCT00472199|1135860|P2|Overall Study|Adverse Event|23
349553|NCT00472199|1135861|P1|Overall Study|Adverse Event|19
349554|NCT00472082|1135927|P1|Overall Study|Study prematurely terminated|5
349555|NCT00471822|1135932|P1|Overall Study|Protocol Violation|2
349556|NCT00471718|1135940|P1|Overall Study|Withdrawal by Subject|1
349557|NCT00471718|1135940|P1|Overall Study|disease progression|22
349558|NCT00471718|1135940|P1|Overall Study|other complicating disease|1
349559|NCT00471718|1135940|P1|Overall Study|Adverse Event|3
349560|NCT00471536|1135968|P1|Overall Study|Withdrawal by Subject|1
349561|NCT00471497|1135980|P3|Overall Study|Sub optimal response or treat. failure|0
349562|NCT00471497|1135981|P2|Overall Study|Sub optimal response or treat. failure|3
349563|NCT00471497|1135982|P1|Overall Study|Sub optimal response or treat. failure|8
349564|NCT00471497|1135980|P3|Overall Study|Protocol Violation|5
349565|NCT00471497|1135981|P2|Overall Study|Protocol Violation|3
349566|NCT00471497|1135982|P1|Overall Study|Protocol Violation|3
349567|NCT00471497|1135980|P3|Overall Study|Disease Progression|2
349568|NCT00471497|1135981|P2|Overall Study|Disease Progression|2
349569|NCT00471497|1135982|P1|Overall Study|Disease Progression|8
349570|NCT00471497|1135980|P3|Overall Study|Death|0
349571|NCT00471497|1135981|P2|Overall Study|Death|2
349572|NCT00471497|1135982|P1|Overall Study|Death|0
349573|NCT00471497|1135980|P3|Overall Study|Lost to Follow-up|1
349574|NCT00471497|1135981|P2|Overall Study|Lost to Follow-up|2
349575|NCT00471497|1135982|P1|Overall Study|Lost to Follow-up|1
349576|NCT00471497|1135980|P3|Overall Study|Withdrawal by Subject|5
349577|NCT00471497|1135981|P2|Overall Study|Withdrawal by Subject|5
349578|NCT00471497|1135982|P1|Overall Study|Withdrawal by Subject|3
349579|NCT00471497|1135980|P3|Overall Study|Condition no longer requires study drug|0
349580|NCT00471497|1135981|P2|Overall Study|Condition no longer requires study drug|1
349581|NCT00471497|1135982|P1|Overall Study|Condition no longer requires study drug|0
349582|NCT00471497|1135980|P3|Overall Study|Abnormal Test Procedure|1
349583|NCT00471497|1135981|P2|Overall Study|Abnormal Test Procedure|0
349584|NCT00471497|1135982|P1|Overall Study|Abnormal Test Procedure|1
349585|NCT00471497|1135980|P3|Overall Study|Abnormal Laboratory Value|4
349586|NCT00471497|1135981|P2|Overall Study|Abnormal Laboratory Value|6
349587|NCT00471497|1135982|P1|Overall Study|Abnormal Laboratory Value|3
349588|NCT00471497|1135980|P3|Overall Study|Adverse Event|22
349589|NCT00471497|1135981|P2|Overall Study|Adverse Event|11
349590|NCT00471497|1135982|P1|Overall Study|Adverse Event|19
349591|NCT00471445|1135992|P2|Overall Study|Protocol Violation|1
349592|NCT00471445|1135993|P1|Overall Study|Protocol Violation|0
349593|NCT00471445|1135992|P2|Overall Study|Ineligible|0
349594|NCT00471445|1135993|P1|Overall Study|Ineligible|1
349595|NCT00471445|1135992|P2|Overall Study|Withdrawal by Subject|1
349596|NCT00471445|1135993|P1|Overall Study|Withdrawal by Subject|1
349597|NCT00471354|1136006|P1|Overall Study|Patient/Caregiver Decision|12
349598|NCT00471354|1136006|P1|Overall Study|Lack of Efficacy|5
349599|NCT00471354|1136006|P1|Overall Study|Lost to Follow-up|3
349600|NCT00471354|1136006|P1|Overall Study|Sponsor Decision|1
349601|NCT00471354|1136006|P1|Overall Study|Physician Decision|4
349602|NCT00471354|1136006|P1|Overall Study|Withdrawal by Subject|1
349603|NCT00471354|1136006|P1|Overall Study|Protocol Violation|12
349604|NCT00471354|1136006|P1|Overall Study|Adverse Event|13
349605|NCT00471354|1136006|P1|Overall Study|Protocol Entry Criteria Not Met|1
349606|NCT00471328|1136018|P2|Extension Phase|Administrative Problem|0
349607|NCT00471328|1136019|P1|Extension Phase|Administrative Problem|1
349608|NCT00471328|1136018|P2|Extension Phase|New cancer Therapy|0
349609|NCT00471328|1136019|P1|Extension Phase|New cancer Therapy|1
349610|NCT00471328|1136018|P2|Extension Phase|Disease Progression|44
349611|NCT00471328|1136019|P1|Extension Phase|Disease Progression|32
349612|NCT00471328|1136018|P2|Extension Phase|Treatment duration as per protocol|1
349613|NCT00471328|1136019|P1|Extension Phase|Treatment duration as per protocol|0
349614|NCT00471328|1136018|P2|Extension Phase|Protocol Deviation|1
349615|NCT00471328|1136019|P1|Extension Phase|Protocol Deviation|3
349616|NCT00471328|1136018|P2|Extension Phase|Death|7
349617|NCT00471328|1136019|P1|Extension Phase|Death|1
349618|NCT00471328|1136018|P2|Extension Phase|Withdrawal by Subject|2
349619|NCT00471328|1136019|P1|Extension Phase|Withdrawal by Subject|0
349620|NCT00471328|1136018|P2|Extension Phase|Adverse Event|12
349621|NCT00471328|1136019|P1|Extension Phase|Adverse Event|3
349622|NCT00471328|1136018|P2|Core Phase|Protocol Deviation|1
349623|NCT00471328|1136019|P1|Core Phase|Protocol Deviation|0
349624|NCT00471328|1136018|P2|Core Phase|Administrative Problem|1
349625|NCT00471328|1136019|P1|Core Phase|Administrative Problem|0
349626|NCT00471328|1136018|P2|Core Phase|Disease Progression|53
349627|NCT00471328|1136019|P1|Core Phase|Disease Progression|78
349628|NCT00471328|1136018|P2|Core Phase|Abnormal laboratory value|0
349629|NCT00471328|1136019|P1|Core Phase|Abnormal laboratory value|1
349630|NCT00471328|1136018|P2|Core Phase|Withdrawal by Subject|2
349631|NCT00471328|1136019|P1|Core Phase|Withdrawal by Subject|2
349632|NCT00471328|1136018|P2|Core Phase|Death|4
349633|NCT00471328|1136019|P1|Core Phase|Death|8
349634|NCT00471328|1136018|P2|Core Phase|Adverse Event|6
349635|NCT00471328|1136019|P1|Core Phase|Adverse Event|18
349636|NCT00471315|1136038|P1|Overall Study|Withdrawal by Subject|1
349637|NCT00471315|1136038|P1|Overall Study|Adverse Event|7
349638|NCT00471276|1136043|P1|Overall Study|Refused treatment|6
349639|NCT00471276|1136043|P1|Overall Study|Unspecified|3
349640|NCT00471276|1136043|P1|Overall Study|Global deterioration of health status|1
349641|NCT00471276|1136043|P1|Overall Study|Objective progression or relapse|54
349642|NCT00471276|1136043|P1|Overall Study|Protocol Violation|1
349643|NCT00471276|1136043|P1|Overall Study|Adverse Event|16
349644|NCT00471276|1136043|P1|Overall Study|Death|2
349645|NCT00471146|1136068|P2|Overall Study|Unspecified|5
349646|NCT00471146|1136069|P1|Overall Study|Unspecified|4
349647|NCT00471146|1136068|P2|Overall Study|Randomized but not treated|8
349648|NCT00471146|1136069|P1|Overall Study|Randomized but not treated|9
349649|NCT00471146|1136068|P2|Overall Study|Global deterioration of health status|14
349650|NCT00471146|1136069|P1|Overall Study|Global deterioration of health status|12
349651|NCT00471146|1136068|P2|Overall Study|Objective progression or relapse|87
349652|NCT00471146|1136069|P1|Overall Study|Objective progression or relapse|84
349653|NCT00471146|1136068|P2|Overall Study|Protocol Violation|2
349654|NCT00471146|1136069|P1|Overall Study|Protocol Violation|2
349655|NCT00471146|1136068|P2|Overall Study|Lost to Follow-up|2
349656|NCT00471146|1136069|P1|Overall Study|Lost to Follow-up|4
349657|NCT00471146|1136068|P2|Overall Study|Death|12
349658|NCT00471146|1136069|P1|Overall Study|Death|11
349659|NCT00471146|1136068|P2|Overall Study|Withdrawal by Subject|11
349660|NCT00471146|1136069|P1|Overall Study|Withdrawal by Subject|14
349661|NCT00471146|1136068|P2|Overall Study|Adverse Event|33
349662|NCT00471146|1136069|P1|Overall Study|Adverse Event|32
349663|NCT00471107|1136094|P3|Overall Study|Technical problems/data loss|3
349664|NCT00471107|1136095|P2|Overall Study|Technical problems/data loss|1
349665|NCT00471107|1136096|P1|Overall Study|Technical problems/data loss|3
349666|NCT00470847|1136113|P1|Overall Study|Pt still receiving treatment|1
349667|NCT00470834|1136126|P2|Extension Period (24 Months)|Disease Progression|1
349668|NCT00470834|1136127|P1|Extension Period (24 Months)|Disease Progression|0
349669|NCT00470834|1136126|P2|Extension Period (24 Months)|Non-compliance|1
349670|NCT00470834|1136127|P1|Extension Period (24 Months)|Non-compliance|0
349671|NCT00470834|1136126|P2|Extension Period (24 Months)|Lost to Follow-up|1
349672|NCT00470834|1136127|P1|Extension Period (24 Months)|Lost to Follow-up|0
349673|NCT00470834|1136126|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
349674|NCT00470834|1136127|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
349675|NCT00470834|1136126|P2|Extension Period (24 Months)|Physician Decision|3
349676|NCT00470834|1136127|P1|Extension Period (24 Months)|Physician Decision|4
349677|NCT00470834|1136126|P2|Extension Period (24 Months)|Withdrawal by Subject|5
349678|NCT00470834|1136127|P1|Extension Period (24 Months)|Withdrawal by Subject|2
349679|NCT00470834|1136126|P2|Extension Period (24 Months)|Adverse Event|4
349680|NCT00470834|1136127|P1|Extension Period (24 Months)|Adverse Event|3
349681|NCT00470834|1136126|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
349682|NCT00470834|1136127|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
349683|NCT00470834|1136126|P2|Treatment Period (18 Months)|Lack of Efficacy|0
349684|NCT00470834|1136127|P1|Treatment Period (18 Months)|Lack of Efficacy|1
349685|NCT00470834|1136126|P2|Treatment Period (18 Months)|Non-compliance|0
349686|NCT00470834|1136127|P1|Treatment Period (18 Months)|Non-compliance|1
349687|NCT00470834|1136126|P2|Treatment Period (18 Months)|Lost to Follow-up|0
349688|NCT00470834|1136127|P1|Treatment Period (18 Months)|Lost to Follow-up|1
349689|NCT00470834|1136126|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
349690|NCT00470834|1136127|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
349691|NCT00470834|1136126|P2|Treatment Period (18 Months)|Protocol Violation|1
349692|NCT00470834|1136127|P1|Treatment Period (18 Months)|Protocol Violation|3
349693|NCT00470834|1136126|P2|Treatment Period (18 Months)|Physician Decision|4
349694|NCT00470834|1136127|P1|Treatment Period (18 Months)|Physician Decision|4
349695|NCT00470834|1136126|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
349696|NCT00470834|1136127|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
349697|NCT00470834|1136126|P2|Treatment Period (18 Months)|Adverse Event|6
349698|NCT00470834|1136127|P1|Treatment Period (18 Months)|Adverse Event|7
349699|NCT00470834|1136126|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
349700|NCT00470834|1136127|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
349701|NCT00470626|1136141|P1|Overall Study|Withdrawal by Subject|7
349702|NCT00470626|1136141|P1|Overall Study|Lost to Follow-up|10
349703|NCT00470535|1136183|P1|Overall Study|Other|2
349704|NCT00470535|1136183|P1|Overall Study|Death|1
349705|NCT00470535|1136183|P1|Overall Study|Adverse Event|1
349706|NCT00470535|1136183|P1|Overall Study|Withdrawal by Subject|1
349707|NCT00470535|1136183|P1|Overall Study|Disease Progression|13
349708|NCT00470470|1136192|P1|Overall Study|Not treated|1
349709|NCT00470470|1136192|P1|Overall Study|Death|2
349710|NCT00470470|1136192|P1|Overall Study|Adverse Event|2
349711|NCT00470418|1136199|P2|Overall Study|Withdrawal by Subject|0
349712|NCT00470418|1136200|P1|Overall Study|Withdrawal by Subject|1
349713|NCT00470275|1136225|P1|Overall Study|Withdrawal by Subject|2
349714|NCT00470275|1136225|P1|Overall Study|Lack of Efficacy|7
349715|NCT00470275|1136225|P1|Overall Study|Death|1
349716|NCT00470262|1136231|P2|Overall Study|Withdrawal by Subject|0
349717|NCT00470262|1136232|P1|Overall Study|Withdrawal by Subject|2
349718|NCT00470184|1136240|P1|Overall Study|recurrence|1
349719|NCT00470184|1136240|P1|Overall Study|other|5
349720|NCT00470184|1136240|P1|Overall Study|Withdrawal by Subject|4
349721|NCT00470184|1136240|P1|Overall Study|Adverse Event|3
349722|NCT00470184|1136240|P1|Overall Study|disease Progression|4
349723|NCT00470184|1136240|P1|Overall Study|Not treated (other)|1
349724|NCT00470184|1136240|P1|Overall Study|Not Treated(became ineligible)|4
349725|NCT00470158|1136252|P5|Overall Study|Protocol Violation|0
349726|NCT00470158|1136253|P4|Overall Study|Protocol Violation|0
349727|NCT00470158|1136254|P3|Overall Study|Protocol Violation|0
349728|NCT00470158|1136255|P2|Overall Study|Protocol Violation|0
349729|NCT00470158|1136256|P1|Overall Study|Protocol Violation|1
349730|NCT00470158|1136252|P5|Overall Study|Lost to Follow-up|4
349731|NCT00470158|1136253|P4|Overall Study|Lost to Follow-up|5
349732|NCT00470158|1136254|P3|Overall Study|Lost to Follow-up|8
349733|NCT00470158|1136255|P2|Overall Study|Lost to Follow-up|8
349734|NCT00470158|1136256|P1|Overall Study|Lost to Follow-up|7
349735|NCT00470158|1136252|P5|Overall Study|Death|2
349736|NCT00470158|1136253|P4|Overall Study|Death|0
349737|NCT00470158|1136254|P3|Overall Study|Death|0
349738|NCT00470158|1136255|P2|Overall Study|Death|0
349739|NCT00470158|1136256|P1|Overall Study|Death|0
349740|NCT00470067|1136289|P1|Overall Study|Disease Progression|6
349741|NCT00470067|1136289|P1|Overall Study|Death|1
349742|NCT00470054|1136293|P1|Overall Study|Ineligible|1
349743|NCT00469898|1136301|P1|Overall Study|Decreased performance status|1
349744|NCT00469898|1136301|P1|Overall Study|Disease progression|9
349745|NCT00469898|1136301|P1|Overall Study|Death|4
349746|NCT00469898|1136301|P1|Overall Study|Withdrawal by Subject|4
349747|NCT00469898|1136301|P1|Overall Study|Adverse Event|7
349748|NCT00469859|1136310|P2|Overall Study|Inevaluable|2
349749|NCT00469859|1136311|P1|Overall Study|Inevaluable|0
349750|NCT00469833|1136319|P1|Overall Study|No IV access|2
349751|NCT00469456|1136346|P2|Overall Study|Withdrawal by Subject|1
349752|NCT00469456|1136347|P1|Overall Study|Withdrawal by Subject|4
349753|NCT00469456|1136346|P2|Overall Study|Protocol Violation|0
349754|NCT00469456|1136347|P1|Overall Study|Protocol Violation|1
349755|NCT00469456|1136346|P2|Overall Study|Adverse Event|3
349756|NCT00469456|1136347|P1|Overall Study|Adverse Event|4
349757|NCT00469209|1136376|P3|Overall Study|Adverse Event|1
349758|NCT00469209|1136377|P2|Overall Study|Adverse Event|0
349759|NCT00469209|1136378|P1|Overall Study|Adverse Event|1
349760|NCT00469092|1136388|P2|Overall Study|Use of Corticosteroid|0
349761|NCT00469092|1136389|P1|Overall Study|Use of Corticosteroid|1
349762|NCT00469092|1136388|P2|Overall Study|Abnormal lab value|0
349763|NCT00469092|1136389|P1|Overall Study|Abnormal lab value|1
349764|NCT00469092|1136388|P2|Overall Study|Hypoglycaemic Episodes|1
349765|NCT00469092|1136389|P1|Overall Study|Hypoglycaemic Episodes|1
349766|NCT00469092|1136388|P2|Overall Study|Use of lipid lowering drug|0
349767|NCT00469092|1136389|P1|Overall Study|Use of lipid lowering drug|1
349768|NCT00469092|1136388|P2|Overall Study|Contraindication metformin/glimepiride|0
349769|NCT00469092|1136389|P1|Overall Study|Contraindication metformin/glimepiride|1
349770|NCT00469092|1136388|P2|Overall Study|Incorrectly Randomised|3
349771|NCT00469092|1136389|P1|Overall Study|Incorrectly Randomised|4
349772|NCT00469092|1136388|P2|Overall Study|Withdrawal Criteria|4
349773|NCT00469092|1136389|P1|Overall Study|Withdrawal Criteria|3
349774|NCT00469092|1136388|P2|Overall Study|Withdrawal by Subject|4
349775|NCT00469092|1136389|P1|Overall Study|Withdrawal by Subject|4
349776|NCT00469092|1136388|P2|Overall Study|Protocol Violation|3
349777|NCT00469092|1136389|P1|Overall Study|Protocol Violation|3
349778|NCT00469092|1136388|P2|Overall Study|Lost to Follow-up|2
349779|NCT00469092|1136389|P1|Overall Study|Lost to Follow-up|1
349780|NCT00469092|1136388|P2|Overall Study|Lack of Efficacy|0
349781|NCT00469092|1136389|P1|Overall Study|Lack of Efficacy|1
349782|NCT00469092|1136388|P2|Overall Study|Adverse Event|4
349783|NCT00469092|1136389|P1|Overall Study|Adverse Event|5
349784|NCT00469079|1136408|P3|Overall Study|Ineligible|0
349785|NCT00469079|1136409|P2|Overall Study|Ineligible|1
349786|NCT00469079|1136410|P1|Overall Study|Ineligible|0
349787|NCT00469079|1136408|P3|Overall Study|Withdrawal by Subject|2
349788|NCT00469079|1136409|P2|Overall Study|Withdrawal by Subject|2
349789|NCT00469079|1136410|P1|Overall Study|Withdrawal by Subject|1
349790|NCT00469079|1136408|P3|Overall Study|Lost to Follow-up|10
349791|NCT00469079|1136409|P2|Overall Study|Lost to Follow-up|8
349792|NCT00469079|1136410|P1|Overall Study|Lost to Follow-up|4
349793|NCT00469079|1136408|P3|Overall Study|Adverse Event|2
349794|NCT00469079|1136409|P2|Overall Study|Adverse Event|3
349795|NCT00469079|1136410|P1|Overall Study|Adverse Event|1
349796|NCT00469079|1136408|P3|Overall Study|Lack of Efficacy|5
349797|NCT00469079|1136409|P2|Overall Study|Lack of Efficacy|8
349798|NCT00469079|1136410|P1|Overall Study|Lack of Efficacy|3
349799|NCT00468910|1136429|P2|Overall Study|Medical Contraindication|1
349800|NCT00468910|1136430|P1|Overall Study|Medical Contraindication|0
349801|NCT00468910|1136429|P2|Overall Study|Withdrawal by Subject|1
349802|NCT00468910|1136430|P1|Overall Study|Withdrawal by Subject|2
349803|NCT00468910|1136429|P2|Overall Study|Lost to Follow-up|1
349804|NCT00468910|1136430|P1|Overall Study|Lost to Follow-up|2
349805|NCT00468858|1136449|P3|Overall Study|Other|1
349806|NCT00468858|1136450|P2|Overall Study|Other|0
349807|NCT00468858|1136451|P1|Overall Study|Other|0
349808|NCT00468858|1136449|P3|Overall Study|Lost to Follow-up|5
349809|NCT00468858|1136450|P2|Overall Study|Lost to Follow-up|2
349810|NCT00468858|1136451|P1|Overall Study|Lost to Follow-up|1
349811|NCT00468858|1136449|P3|Overall Study|Relocation|3
349812|NCT00468858|1136450|P2|Overall Study|Relocation|3
349813|NCT00468858|1136451|P1|Overall Study|Relocation|1
349814|NCT00468858|1136449|P3|Overall Study|Withdrawal by Subject|5
349815|NCT00468858|1136450|P2|Overall Study|Withdrawal by Subject|4
349816|NCT00468858|1136451|P1|Overall Study|Withdrawal by Subject|7
349817|NCT00468858|1136449|P3|Overall Study|Adverse Event|0
349818|NCT00468858|1136450|P2|Overall Study|Adverse Event|1
349819|NCT00468858|1136451|P1|Overall Study|Adverse Event|0
349820|NCT00468845|1136572|P3|Overall Study|Randomized, not treated|2
349821|NCT00468845|1136573|P2|Overall Study|Randomized, not treated|4
349822|NCT00468845|1136574|P1|Overall Study|Randomized, not treated|1
349823|NCT00468845|1136572|P3|Overall Study|No longer willing to participate|10
349824|NCT00468845|1136573|P2|Overall Study|No longer willing to participate|6
349825|NCT00468845|1136574|P1|Overall Study|No longer willing to participate|5
349826|NCT00468845|1136572|P3|Overall Study|Unspecified|5
349827|NCT00468845|1136573|P2|Overall Study|Unspecified|9
349828|NCT00468845|1136574|P1|Overall Study|Unspecified|4
349829|NCT00468845|1136572|P3|Overall Study|Lost to Follow-up|2
349830|NCT00468845|1136573|P2|Overall Study|Lost to Follow-up|1
349831|NCT00468845|1136574|P1|Overall Study|Lost to Follow-up|2
349832|NCT00468845|1136572|P3|Overall Study|Adverse Event|11
349833|NCT00468845|1136573|P2|Overall Study|Adverse Event|14
349834|NCT00468845|1136574|P1|Overall Study|Adverse Event|9
349835|NCT00468819|1136711|P3|Overall Study|Drop-outs (Treatment never received)|0
349836|NCT00468819|1136712|P2|Overall Study|Drop-outs (Treatment never received)|0
349837|NCT00468819|1136713|P1|Overall Study|Drop-outs (Treatment never received)|2
349838|NCT00468819|1136711|P3|Overall Study|Lost to Follow-up|1
349839|NCT00468819|1136712|P2|Overall Study|Lost to Follow-up|0
349840|NCT00468819|1136713|P1|Overall Study|Lost to Follow-up|0
349841|NCT00468819|1136711|P3|Overall Study|Withdrawal by Subject|1
349842|NCT00468819|1136712|P2|Overall Study|Withdrawal by Subject|0
349843|NCT00468819|1136713|P1|Overall Study|Withdrawal by Subject|4
349844|NCT00468728|1136793|P2|Follow-up|mITT failure|31
349845|NCT00468728|1136794|P1|Follow-up|mITT failure|34
349846|NCT00468728|1136793|P2|Treatment|criteria for mITT population|11
349847|NCT00468728|1136794|P1|Treatment|criteria for mITT population|4
349848|NCT00468676|1136806|P2|Overall Study|Death|1
349849|NCT00468676|1136807|P1|Overall Study|Death|2
349850|NCT00468676|1136806|P2|Overall Study|Lost to Follow-up|11
349851|NCT00468676|1136807|P1|Overall Study|Lost to Follow-up|14
349852|NCT00468650|1136824|P1|Overall Study|Protocol Violation|1
349853|NCT00468650|1136824|P1|Overall Study|Withdrawal by Subject|2
349854|NCT00468650|1136824|P1|Overall Study|Lost to Follow-up|4
349855|NCT00468585|1136872|P4|Overall Study|Withdrawal by Subject|1
349856|NCT00468585|1136873|P3|Overall Study|Withdrawal by Subject|2
349857|NCT00468585|1136874|P2|Overall Study|Withdrawal by Subject|0
349858|NCT00468585|1136875|P1|Overall Study|Withdrawal by Subject|0
349859|NCT00468585|1136872|P4|Overall Study|Adverse Event|0
349860|NCT00468585|1136873|P3|Overall Study|Adverse Event|1
349861|NCT00468585|1136874|P2|Overall Study|Adverse Event|0
349862|NCT00468585|1136875|P1|Overall Study|Adverse Event|0
349863|NCT00468585|1136872|P4|Overall Study|Patient found to be ineligible|0
349864|NCT00468585|1136873|P3|Overall Study|Patient found to be ineligible|1
349865|NCT00468585|1136874|P2|Overall Study|Patient found to be ineligible|0
349866|NCT00468585|1136875|P1|Overall Study|Patient found to be ineligible|0
349867|NCT00468585|1136872|P4|Overall Study|Patient not treated|0
349868|NCT00468585|1136873|P3|Overall Study|Patient not treated|1
349869|NCT00468585|1136874|P2|Overall Study|Patient not treated|0
349870|NCT00468585|1136875|P1|Overall Study|Patient not treated|1
349871|NCT00468559|1136887|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
349872|NCT00468559|1136888|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
349873|NCT00468559|1136889|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
349874|NCT00468559|1136887|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
349875|NCT00468559|1136888|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
349876|NCT00468559|1136889|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
349877|NCT00468559|1136887|P3|Open-label Treatment Phase|Withdrawal by Subject|0
349878|NCT00468559|1136888|P2|Open-label Treatment Phase|Withdrawal by Subject|0
349879|NCT00468559|1136889|P1|Open-label Treatment Phase|Withdrawal by Subject|4
349880|NCT00468559|1136887|P3|Open-label Treatment Phase|Lack of Efficacy|0
349881|NCT00468559|1136888|P2|Open-label Treatment Phase|Lack of Efficacy|0
349882|NCT00468559|1136889|P1|Open-label Treatment Phase|Lack of Efficacy|9
349883|NCT00468559|1136887|P3|Open-label Treatment Phase|Adverse Event|0
349884|NCT00468559|1136888|P2|Open-label Treatment Phase|Adverse Event|0
349885|NCT00468559|1136889|P1|Open-label Treatment Phase|Adverse Event|5
349886|NCT00468546|1136917|P2|Week 24 to Week 104 Analysis|Other|14
349887|NCT00468546|1136918|P1|Week 24 to Week 104 Analysis|Other|17
349888|NCT00468546|1136917|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
349889|NCT00468546|1136918|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
349890|NCT00468546|1136917|P2|Week 24 to Week 104 Analysis|Failure to return|2
349891|NCT00468546|1136918|P1|Week 24 to Week 104 Analysis|Failure to return|1
349892|NCT00468546|1136917|P2|Week 24 to Week 104 Analysis|Refused treatment|7
349893|NCT00468546|1136918|P1|Week 24 to Week 104 Analysis|Refused treatment|4
349894|NCT00468546|1136917|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
349895|NCT00468546|1136918|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
349896|NCT00468546|1136917|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
349897|NCT00468546|1136918|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
349898|NCT00468546|1136917|P2|Week 24 to Week 104 Analysis|Death|0
349899|NCT00468546|1136918|P1|Week 24 to Week 104 Analysis|Death|1
349900|NCT00468546|1136917|P2|Week 24 to Week 104 Analysis|Adverse Event|5
349901|NCT00468546|1136918|P1|Week 24 to Week 104 Analysis|Adverse Event|2
349902|NCT00468546|1136917|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
349903|NCT00468546|1136918|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
349904|NCT00468546|1136917|P2|Week 24 Analysis|Went onto rescue therapy|0
349905|NCT00468546|1136918|P1|Week 24 Analysis|Went onto rescue therapy|1
349906|NCT00468546|1136917|P2|Week 24 Analysis|Due to clinical hold|0
349907|NCT00468546|1136918|P1|Week 24 Analysis|Due to clinical hold|1
349908|NCT00468546|1136917|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
349909|NCT00468546|1136918|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
349910|NCT00468546|1136917|P2|Week 24 Analysis|Rescue therapy|0
349911|NCT00468546|1136918|P1|Week 24 Analysis|Rescue therapy|2
349912|NCT00468546|1136917|P2|Week 24 Analysis|Failure to return|4
349913|NCT00468546|1136918|P1|Week 24 Analysis|Failure to return|3
349914|NCT00468546|1136917|P2|Week 24 Analysis|Adverse Event|8
349915|NCT00468546|1136918|P1|Week 24 Analysis|Adverse Event|1
349916|NCT00468546|1136917|P2|Week 24 Analysis|Refused treatment|5
349917|NCT00468546|1136918|P1|Week 24 Analysis|Refused treatment|5
349918|NCT00468546|1136917|P2|Week 24 Analysis|Lack of Efficacy|37
349919|NCT00468546|1136918|P1|Week 24 Analysis|Lack of Efficacy|83
349920|NCT00468481|1136948|P2|Overall Study|Other|0
349921|NCT00468481|1136949|P1|Overall Study|Other|6
349922|NCT00468481|1136948|P2|Overall Study|Non-Compliance|0
349923|NCT00468481|1136949|P1|Overall Study|Non-Compliance|5
349924|NCT00468481|1136948|P2|Overall Study|Moved out of area|1
349925|NCT00468481|1136949|P1|Overall Study|Moved out of area|4
349926|NCT00468481|1136948|P2|Overall Study|Egg Donor|0
349927|NCT00468481|1136949|P1|Overall Study|Egg Donor|1
349928|NCT00468481|1136948|P2|Overall Study|Prohibited Medication|1
349929|NCT00468481|1136949|P1|Overall Study|Prohibited Medication|1
349930|NCT00468481|1136948|P2|Overall Study|susp/diag malignant/premalignant disease|0
349931|NCT00468481|1136949|P1|Overall Study|susp/diag malignant/premalignant disease|1
349932|NCT00468481|1136948|P2|Overall Study|Withdrawal by Subject|3
349933|NCT00468481|1136949|P1|Overall Study|Withdrawal by Subject|12
349934|NCT00468481|1136948|P2|Overall Study|Protocol Violation|8
349935|NCT00468481|1136949|P1|Overall Study|Protocol Violation|18
349936|NCT00468481|1136948|P2|Overall Study|Pregnancy|0
349937|NCT00468481|1136949|P1|Overall Study|Pregnancy|2
349938|NCT00468481|1136948|P2|Overall Study|Lost to Follow-up|8
349939|NCT00468481|1136949|P1|Overall Study|Lost to Follow-up|25
349940|NCT00468481|1136948|P2|Overall Study|Adverse Event|3
349941|NCT00468481|1136949|P1|Overall Study|Adverse Event|13
349942|NCT00468312|1137049|P2|Overall Study|Did not meet protocol eligibility|1
349943|NCT00468312|1137050|P1|Overall Study|Did not meet protocol eligibility|0
349944|NCT00468312|1137049|P2|Overall Study|Protocol Violation|1
349945|NCT00468312|1137050|P1|Overall Study|Protocol Violation|2
349946|NCT00468312|1137049|P2|Overall Study|Withdrawal by Subject|1
349947|NCT00468312|1137050|P1|Overall Study|Withdrawal by Subject|0
349948|NCT00468312|1137049|P2|Overall Study|Lack of Efficacy|1
349949|NCT00468312|1137050|P1|Overall Study|Lack of Efficacy|0
349950|NCT00468312|1137049|P2|Overall Study|Adverse Event|1
349951|NCT00468312|1137050|P1|Overall Study|Adverse Event|2
349952|NCT00468299|1137066|P2|Overall Study|Withdrawal by Subject|1
349953|NCT00468299|1137067|P1|Overall Study|Withdrawal by Subject|0
349954|NCT00468286|1137077|P2|Overall Study|Physician Decision|1
349955|NCT00468286|1137078|P1|Overall Study|Physician Decision|0
349956|NCT00468286|1137077|P2|Overall Study|Withdrawal by Subject|3
349957|NCT00468286|1137078|P1|Overall Study|Withdrawal by Subject|4
349958|NCT00468286|1137077|P2|Overall Study|Protocol Violation|2
349959|NCT00468286|1137078|P1|Overall Study|Protocol Violation|2
349960|NCT00468286|1137077|P2|Overall Study|Adverse Event|6
349961|NCT00468286|1137078|P1|Overall Study|Adverse Event|1
349962|NCT00468143|1137108|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
349963|NCT00468143|1137109|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
349964|NCT00468143|1137108|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
349965|NCT00468143|1137109|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
349966|NCT00468104|1137123|P2|Second Intervention|discarded for malposition of chest tube|2
349967|NCT00468104|1137124|P1|Second Intervention|discarded for malposition of chest tube|0
349968|NCT00468104|1137123|P2|Second Intervention|Withdrawal by Subject|2
349969|NCT00468104|1137124|P1|Second Intervention|Withdrawal by Subject|5
349970|NCT00468104|1137123|P2|First Intervention|trapped lung|0
349971|NCT00468104|1137124|P1|First Intervention|trapped lung|1
349972|NCT00468104|1137123|P2|First Intervention|associated prolonged pneumothorax|0
349973|NCT00468104|1137124|P1|First Intervention|associated prolonged pneumothorax|1
349974|NCT00468104|1137123|P2|First Intervention|large lung mass with minimal effusion|0
349975|NCT00468104|1137124|P1|First Intervention|large lung mass with minimal effusion|1
349976|NCT00468104|1137123|P2|First Intervention|malposition/blocked chest tube tube|0
349977|NCT00468104|1137124|P1|First Intervention|malposition/blocked chest tube tube|2
349978|NCT00468104|1137123|P2|First Intervention|died within 3 weeks|0
349979|NCT00468104|1137124|P1|First Intervention|died within 3 weeks|1
349980|NCT00468104|1137123|P2|First Intervention|bleeding at chest tube site--first dose|0
349981|NCT00468104|1137124|P1|First Intervention|bleeding at chest tube site--first dose|1
349982|NCT00468104|1137123|P2|First Intervention|Protocol Violation|1
349983|NCT00468104|1137124|P1|First Intervention|Protocol Violation|2
349984|NCT00468052|1137141|P2|Overall Study|Protocol Violation|8
349985|NCT00468052|1137142|P1|Overall Study|Protocol Violation|7
349986|NCT00467961|1137160|P1|Overall Study|Disease Progression|2
349987|NCT00467961|1137160|P1|Overall Study|Technical Failures|5
349988|NCT00467896|1137164|P1|Overall Study|Patient had no improvement|1
349989|NCT00467896|1137164|P1|Overall Study|Started inhaled Remodulin|1
349990|NCT00467896|1137164|P1|Overall Study|Started intravenous prostacyclin|1
349991|NCT00467896|1137164|P1|Overall Study|Mainly used Prodose not I-neb® device|1
349992|NCT00467896|1137164|P1|Overall Study|Patient weaned off iloprost|1
349993|NCT00467896|1137164|P1|Overall Study|Patient had atrial septostomy|1
349994|NCT00467896|1137164|P1|Overall Study|Patient received transplant|2
349995|NCT00467896|1137164|P1|Overall Study|Changed therapy|2
349996|NCT00467896|1137164|P1|Overall Study|Non-compliance|3
349997|NCT00467896|1137164|P1|Overall Study|Serious Adverse Event|13
349998|NCT00467896|1137164|P1|Overall Study|Adverse Event|7
349999|NCT00467896|1137164|P1|Overall Study|Consent Withdrawal|18
350000|NCT00467870|1137190|P6|Overall Study|Other/Unknown|0
350001|NCT00467870|1137191|P5|Overall Study|Other/Unknown|4
350002|NCT00467870|1137192|P4|Overall Study|Other/Unknown|5
350003|NCT00467870|1137193|P3|Overall Study|Other/Unknown|1
350004|NCT00467870|1137194|P2|Overall Study|Other/Unknown|5
350005|NCT00467870|1137195|P1|Overall Study|Other/Unknown|8
350006|NCT00467870|1137190|P6|Overall Study|Subject Non-compliance|0
350007|NCT00467870|1137191|P5|Overall Study|Subject Non-compliance|5
350008|NCT00467870|1137192|P4|Overall Study|Subject Non-compliance|1
350009|NCT00467870|1137193|P3|Overall Study|Subject Non-compliance|0
350010|NCT00467870|1137194|P2|Overall Study|Subject Non-compliance|4
350011|NCT00467870|1137195|P1|Overall Study|Subject Non-compliance|3
350012|NCT00467870|1137190|P6|Overall Study|Lost to Follow-up|0
350013|NCT00467870|1137191|P5|Overall Study|Lost to Follow-up|3
350014|NCT00467870|1137192|P4|Overall Study|Lost to Follow-up|1
350015|NCT00467870|1137193|P3|Overall Study|Lost to Follow-up|1
350016|NCT00467870|1137194|P2|Overall Study|Lost to Follow-up|3
350017|NCT00467870|1137195|P1|Overall Study|Lost to Follow-up|5
350018|NCT00467870|1137190|P6|Overall Study|Withdrawal by Subject|1
350019|NCT00467870|1137191|P5|Overall Study|Withdrawal by Subject|10
350020|NCT00467870|1137192|P4|Overall Study|Withdrawal by Subject|9
350021|NCT00467870|1137193|P3|Overall Study|Withdrawal by Subject|0
350022|NCT00467870|1137194|P2|Overall Study|Withdrawal by Subject|21
350023|NCT00467870|1137195|P1|Overall Study|Withdrawal by Subject|14
350024|NCT00467870|1137190|P6|Overall Study|Protocol Violation|0
350025|NCT00467870|1137191|P5|Overall Study|Protocol Violation|0
350026|NCT00467870|1137192|P4|Overall Study|Protocol Violation|2
350027|NCT00467870|1137193|P3|Overall Study|Protocol Violation|1
350028|NCT00467870|1137194|P2|Overall Study|Protocol Violation|1
350029|NCT00467870|1137195|P1|Overall Study|Protocol Violation|2
350030|NCT00467870|1137190|P6|Overall Study|Adverse Event|1
350031|NCT00467870|1137191|P5|Overall Study|Adverse Event|15
350032|NCT00467870|1137192|P4|Overall Study|Adverse Event|15
350033|NCT00467870|1137193|P3|Overall Study|Adverse Event|1
350034|NCT00467870|1137194|P2|Overall Study|Adverse Event|9
350035|NCT00467870|1137195|P1|Overall Study|Adverse Event|13
350036|NCT00467857|1137238|P2|Overall Study|Discontinuation reason missing|3
350037|NCT00467857|1137239|P1|Overall Study|Discontinuation reason missing|0
350038|NCT00467857|1137238|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
350039|NCT00467857|1137239|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
350040|NCT00467857|1137238|P2|Overall Study|Emergency care required|1
350041|NCT00467857|1137239|P1|Overall Study|Emergency care required|0
350042|NCT00467857|1137238|P2|Overall Study|Discharged from court service|1
350043|NCT00467857|1137239|P1|Overall Study|Discharged from court service|0
350044|NCT00467857|1137238|P2|Overall Study|Death|1
350045|NCT00467857|1137239|P1|Overall Study|Death|0
350046|NCT00467857|1137238|P2|Overall Study|Withdrew consent|0
350047|NCT00467857|1137239|P1|Overall Study|Withdrew consent|2
350048|NCT00467857|1137238|P2|Overall Study|Adverse Event|0
350049|NCT00467857|1137239|P1|Overall Study|Adverse Event|1
350050|NCT00467831|1137287|P1|Overall Study|Withdrawal by Subject|1
350051|NCT00467831|1137287|P1|Overall Study|Death|2
350052|NCT00467779|1137306|P15|Stage 3|Unspecified Reason|5
350053|NCT00467779|1137307|P14|Stage 3|Unspecified Reason|0
350054|NCT00467779|1137308|P13|Stage 3|Unspecified Reason|0
350055|NCT00467779|1137309|P12|Stage 3|Unspecified Reason|0
350056|NCT00467779|1137310|P11|Stage 3|Unspecified Reason|0
350057|NCT00467779|1137311|P10|Stage 3|Unspecified Reason|0
350058|NCT00467779|1137312|P9|Stage 3|Unspecified Reason|0
350059|NCT00467779|1137313|P8|Stage 3|Unspecified Reason|0
350060|NCT00467779|1137314|P7|Stage 3|Unspecified Reason|0
350061|NCT00467779|1137315|P6|Stage 3|Unspecified Reason|0
350062|NCT00467779|1137316|P5|Stage 3|Unspecified Reason|0
350063|NCT00467779|1137317|P4|Stage 3|Unspecified Reason|0
350064|NCT00467779|1137318|P3|Stage 3|Unspecified Reason|0
350065|NCT00467779|1137319|P2|Stage 3|Unspecified Reason|0
350066|NCT00467779|1137320|P1|Stage 3|Unspecified Reason|0
350067|NCT00467779|1137306|P15|Stage 3|Disease Progression|9
350068|NCT00467779|1137307|P14|Stage 3|Disease Progression|0
350069|NCT00467779|1137308|P13|Stage 3|Disease Progression|0
350070|NCT00467779|1137309|P12|Stage 3|Disease Progression|0
350071|NCT00467779|1137310|P11|Stage 3|Disease Progression|0
350072|NCT00467779|1137311|P10|Stage 3|Disease Progression|0
350073|NCT00467779|1137312|P9|Stage 3|Disease Progression|0
350074|NCT00467779|1137313|P8|Stage 3|Disease Progression|0
350075|NCT00467779|1137314|P7|Stage 3|Disease Progression|0
350076|NCT00467779|1137315|P6|Stage 3|Disease Progression|0
350077|NCT00467779|1137316|P5|Stage 3|Disease Progression|0
350078|NCT00467779|1137317|P4|Stage 3|Disease Progression|0
350079|NCT00467779|1137318|P3|Stage 3|Disease Progression|0
350080|NCT00467779|1137319|P2|Stage 3|Disease Progression|0
350081|NCT00467779|1137320|P1|Stage 3|Disease Progression|0
350082|NCT00467779|1137306|P15|Stage 3|Death|1
350083|NCT00467779|1137307|P14|Stage 3|Death|0
350084|NCT00467779|1137308|P13|Stage 3|Death|0
350085|NCT00467779|1137309|P12|Stage 3|Death|0
350086|NCT00467779|1137310|P11|Stage 3|Death|0
350087|NCT00467779|1137311|P10|Stage 3|Death|0
350088|NCT00467779|1137312|P9|Stage 3|Death|0
350089|NCT00467779|1137313|P8|Stage 3|Death|0
350090|NCT00467779|1137314|P7|Stage 3|Death|0
350091|NCT00467779|1137315|P6|Stage 3|Death|0
350092|NCT00467779|1137316|P5|Stage 3|Death|0
350093|NCT00467779|1137317|P4|Stage 3|Death|0
350094|NCT00467779|1137318|P3|Stage 3|Death|0
350095|NCT00467779|1137319|P2|Stage 3|Death|0
350096|NCT00467779|1137320|P1|Stage 3|Death|0
350097|NCT00467779|1137306|P15|Stage 3|Adverse Event|2
350098|NCT00467779|1137307|P14|Stage 3|Adverse Event|0
350099|NCT00467779|1137308|P13|Stage 3|Adverse Event|0
350100|NCT00467779|1137309|P12|Stage 3|Adverse Event|0
350101|NCT00467779|1137310|P11|Stage 3|Adverse Event|0
350102|NCT00467779|1137311|P10|Stage 3|Adverse Event|0
350103|NCT00467779|1137312|P9|Stage 3|Adverse Event|0
350104|NCT00467779|1137313|P8|Stage 3|Adverse Event|0
350105|NCT00467779|1137314|P7|Stage 3|Adverse Event|0
350106|NCT00467779|1137315|P6|Stage 3|Adverse Event|0
350107|NCT00467779|1137316|P5|Stage 3|Adverse Event|0
350108|NCT00467779|1137317|P4|Stage 3|Adverse Event|0
350109|NCT00467779|1137318|P3|Stage 3|Adverse Event|0
350110|NCT00467779|1137319|P2|Stage 3|Adverse Event|0
350111|NCT00467779|1137320|P1|Stage 3|Adverse Event|0
350112|NCT00467779|1137306|P15|Stage 2A|Withdrawal by Subject|0
350113|NCT00467779|1137307|P14|Stage 2A|Withdrawal by Subject|1
350114|NCT00467779|1137308|P13|Stage 2A|Withdrawal by Subject|0
350115|NCT00467779|1137309|P12|Stage 2A|Withdrawal by Subject|0
350116|NCT00467779|1137310|P11|Stage 2A|Withdrawal by Subject|0
350117|NCT00467779|1137311|P10|Stage 2A|Withdrawal by Subject|0
350118|NCT00467779|1137312|P9|Stage 2A|Withdrawal by Subject|0
350119|NCT00467779|1137313|P8|Stage 2A|Withdrawal by Subject|0
350120|NCT00467779|1137314|P7|Stage 2A|Withdrawal by Subject|0
350121|NCT00467779|1137315|P6|Stage 2A|Withdrawal by Subject|0
350122|NCT00467779|1137316|P5|Stage 2A|Withdrawal by Subject|0
350123|NCT00467779|1137317|P4|Stage 2A|Withdrawal by Subject|0
350124|NCT00467779|1137318|P3|Stage 2A|Withdrawal by Subject|0
350125|NCT00467779|1137319|P2|Stage 2A|Withdrawal by Subject|0
350126|NCT00467779|1137320|P1|Stage 2A|Withdrawal by Subject|0
350127|NCT00467779|1137306|P15|Stage 2A|Unspecified Reason|0
350128|NCT00467779|1137307|P14|Stage 2A|Unspecified Reason|7
350129|NCT00467779|1137308|P13|Stage 2A|Unspecified Reason|0
350130|NCT00467779|1137309|P12|Stage 2A|Unspecified Reason|0
350131|NCT00467779|1137310|P11|Stage 2A|Unspecified Reason|0
350132|NCT00467779|1137311|P10|Stage 2A|Unspecified Reason|0
350133|NCT00467779|1137312|P9|Stage 2A|Unspecified Reason|0
350134|NCT00467779|1137313|P8|Stage 2A|Unspecified Reason|0
350135|NCT00467779|1137314|P7|Stage 2A|Unspecified Reason|0
350136|NCT00467779|1137315|P6|Stage 2A|Unspecified Reason|0
350137|NCT00467779|1137316|P5|Stage 2A|Unspecified Reason|0
350138|NCT00467779|1137317|P4|Stage 2A|Unspecified Reason|0
350139|NCT00467779|1137318|P3|Stage 2A|Unspecified Reason|0
350140|NCT00467779|1137319|P2|Stage 2A|Unspecified Reason|0
350141|NCT00467779|1137320|P1|Stage 2A|Unspecified Reason|0
350142|NCT00467779|1137306|P15|Stage 2A|Disease Progression|0
350143|NCT00467779|1137307|P14|Stage 2A|Disease Progression|10
350144|NCT00467779|1137308|P13|Stage 2A|Disease Progression|0
350145|NCT00467779|1137309|P12|Stage 2A|Disease Progression|0
350146|NCT00467779|1137310|P11|Stage 2A|Disease Progression|0
350147|NCT00467779|1137311|P10|Stage 2A|Disease Progression|0
350148|NCT00467779|1137312|P9|Stage 2A|Disease Progression|0
350149|NCT00467779|1137313|P8|Stage 2A|Disease Progression|0
350150|NCT00467779|1137314|P7|Stage 2A|Disease Progression|0
350151|NCT00467779|1137315|P6|Stage 2A|Disease Progression|0
350152|NCT00467779|1137316|P5|Stage 2A|Disease Progression|0
350153|NCT00467779|1137317|P4|Stage 2A|Disease Progression|0
350154|NCT00467779|1137318|P3|Stage 2A|Disease Progression|0
350155|NCT00467779|1137319|P2|Stage 2A|Disease Progression|0
350156|NCT00467779|1137320|P1|Stage 2A|Disease Progression|0
350157|NCT00467779|1137306|P15|Stage 2A|Death|0
350158|NCT00467779|1137307|P14|Stage 2A|Death|1
350159|NCT00467779|1137308|P13|Stage 2A|Death|0
350160|NCT00467779|1137309|P12|Stage 2A|Death|0
350161|NCT00467779|1137310|P11|Stage 2A|Death|0
350162|NCT00467779|1137311|P10|Stage 2A|Death|0
350163|NCT00467779|1137312|P9|Stage 2A|Death|0
350164|NCT00467779|1137313|P8|Stage 2A|Death|0
350165|NCT00467779|1137314|P7|Stage 2A|Death|0
350166|NCT00467779|1137315|P6|Stage 2A|Death|0
350167|NCT00467779|1137316|P5|Stage 2A|Death|0
350168|NCT00467779|1137317|P4|Stage 2A|Death|0
350169|NCT00467779|1137318|P3|Stage 2A|Death|0
350170|NCT00467779|1137319|P2|Stage 2A|Death|0
350171|NCT00467779|1137320|P1|Stage 2A|Death|0
350172|NCT00467779|1137306|P15|Stage 2A|Adverse Event|0
350173|NCT00467779|1137307|P14|Stage 2A|Adverse Event|2
350174|NCT00467779|1137308|P13|Stage 2A|Adverse Event|0
350175|NCT00467779|1137309|P12|Stage 2A|Adverse Event|0
350176|NCT00467779|1137310|P11|Stage 2A|Adverse Event|0
350177|NCT00467779|1137311|P10|Stage 2A|Adverse Event|0
350178|NCT00467779|1137312|P9|Stage 2A|Adverse Event|0
350179|NCT00467779|1137313|P8|Stage 2A|Adverse Event|0
350180|NCT00467779|1137314|P7|Stage 2A|Adverse Event|0
350181|NCT00467779|1137315|P6|Stage 2A|Adverse Event|0
350182|NCT00467779|1137316|P5|Stage 2A|Adverse Event|0
350183|NCT00467779|1137317|P4|Stage 2A|Adverse Event|0
350184|NCT00467779|1137318|P3|Stage 2A|Adverse Event|0
350185|NCT00467779|1137319|P2|Stage 2A|Adverse Event|0
350186|NCT00467779|1137320|P1|Stage 2A|Adverse Event|0
350187|NCT00467779|1137306|P15|Stage 2|Unspecified Reason|0
350188|NCT00467779|1137307|P14|Stage 2|Unspecified Reason|0
350189|NCT00467779|1137308|P13|Stage 2|Unspecified Reason|0
350190|NCT00467779|1137309|P12|Stage 2|Unspecified Reason|0
350191|NCT00467779|1137310|P11|Stage 2|Unspecified Reason|0
350192|NCT00467779|1137311|P10|Stage 2|Unspecified Reason|0
350193|NCT00467779|1137312|P9|Stage 2|Unspecified Reason|3
350194|NCT00467779|1137313|P8|Stage 2|Unspecified Reason|0
350195|NCT00467779|1137314|P7|Stage 2|Unspecified Reason|0
350196|NCT00467779|1137315|P6|Stage 2|Unspecified Reason|0
350197|NCT00467779|1137316|P5|Stage 2|Unspecified Reason|0
350198|NCT00467779|1137317|P4|Stage 2|Unspecified Reason|0
350199|NCT00467779|1137318|P3|Stage 2|Unspecified Reason|0
350200|NCT00467779|1137319|P2|Stage 2|Unspecified Reason|0
350201|NCT00467779|1137320|P1|Stage 2|Unspecified Reason|0
350202|NCT00467779|1137306|P15|Stage 2|Disease Progression|0
350203|NCT00467779|1137307|P14|Stage 2|Disease Progression|0
350204|NCT00467779|1137308|P13|Stage 2|Disease Progression|0
350205|NCT00467779|1137309|P12|Stage 2|Disease Progression|0
350206|NCT00467779|1137310|P11|Stage 2|Disease Progression|0
350207|NCT00467779|1137311|P10|Stage 2|Disease Progression|0
350208|NCT00467779|1137312|P9|Stage 2|Disease Progression|16
350209|NCT00467779|1137313|P8|Stage 2|Disease Progression|0
350210|NCT00467779|1137314|P7|Stage 2|Disease Progression|0
350211|NCT00467779|1137315|P6|Stage 2|Disease Progression|0
350212|NCT00467779|1137316|P5|Stage 2|Disease Progression|0
350213|NCT00467779|1137317|P4|Stage 2|Disease Progression|0
350214|NCT00467779|1137318|P3|Stage 2|Disease Progression|0
350215|NCT00467779|1137319|P2|Stage 2|Disease Progression|0
350216|NCT00467779|1137320|P1|Stage 2|Disease Progression|0
350217|NCT00467779|1137306|P15|Stage 2|Death|0
350218|NCT00467779|1137307|P14|Stage 2|Death|0
350219|NCT00467779|1137308|P13|Stage 2|Death|0
350220|NCT00467779|1137309|P12|Stage 2|Death|0
350221|NCT00467779|1137310|P11|Stage 2|Death|0
350222|NCT00467779|1137311|P10|Stage 2|Death|0
350223|NCT00467779|1137312|P9|Stage 2|Death|1
350224|NCT00467779|1137313|P8|Stage 2|Death|0
350225|NCT00467779|1137314|P7|Stage 2|Death|0
350226|NCT00467779|1137315|P6|Stage 2|Death|0
350227|NCT00467779|1137316|P5|Stage 2|Death|0
350228|NCT00467779|1137317|P4|Stage 2|Death|0
350229|NCT00467779|1137318|P3|Stage 2|Death|0
350230|NCT00467779|1137319|P2|Stage 2|Death|0
350231|NCT00467779|1137320|P1|Stage 2|Death|0
350232|NCT00467779|1137306|P15|Stage 2|Adverse Event|0
350233|NCT00467779|1137307|P14|Stage 2|Adverse Event|0
350234|NCT00467779|1137308|P13|Stage 2|Adverse Event|0
350235|NCT00467779|1137309|P12|Stage 2|Adverse Event|0
350236|NCT00467779|1137310|P11|Stage 2|Adverse Event|0
350237|NCT00467779|1137311|P10|Stage 2|Adverse Event|0
350238|NCT00467779|1137312|P9|Stage 2|Adverse Event|1
350239|NCT00467779|1137313|P8|Stage 2|Adverse Event|0
350240|NCT00467779|1137314|P7|Stage 2|Adverse Event|0
350241|NCT00467779|1137315|P6|Stage 2|Adverse Event|0
350242|NCT00467779|1137316|P5|Stage 2|Adverse Event|0
350243|NCT00467779|1137317|P4|Stage 2|Adverse Event|0
350244|NCT00467779|1137318|P3|Stage 2|Adverse Event|0
350245|NCT00467779|1137319|P2|Stage 2|Adverse Event|0
350246|NCT00467779|1137320|P1|Stage 2|Adverse Event|0
350247|NCT00467779|1137306|P15|Stage 1A|Unspecified Reason|0
350248|NCT00467779|1137307|P14|Stage 1A|Unspecified Reason|0
350249|NCT00467779|1137308|P13|Stage 1A|Unspecified Reason|1
350250|NCT00467779|1137309|P12|Stage 1A|Unspecified Reason|1
350251|NCT00467779|1137310|P11|Stage 1A|Unspecified Reason|0
350252|NCT00467779|1137311|P10|Stage 1A|Unspecified Reason|0
350253|NCT00467779|1137312|P9|Stage 1A|Unspecified Reason|0
350254|NCT00467779|1137313|P8|Stage 1A|Unspecified Reason|0
350255|NCT00467779|1137314|P7|Stage 1A|Unspecified Reason|0
350256|NCT00467779|1137315|P6|Stage 1A|Unspecified Reason|0
350257|NCT00467779|1137316|P5|Stage 1A|Unspecified Reason|0
350258|NCT00467779|1137317|P4|Stage 1A|Unspecified Reason|0
350259|NCT00467779|1137318|P3|Stage 1A|Unspecified Reason|0
350260|NCT00467779|1137319|P2|Stage 1A|Unspecified Reason|0
350261|NCT00467779|1137320|P1|Stage 1A|Unspecified Reason|0
350262|NCT00467779|1137306|P15|Stage 1A|Withdrawal by Subject|0
350263|NCT00467779|1137307|P14|Stage 1A|Withdrawal by Subject|0
350264|NCT00467779|1137308|P13|Stage 1A|Withdrawal by Subject|1
350265|NCT00467779|1137309|P12|Stage 1A|Withdrawal by Subject|1
350266|NCT00467779|1137310|P11|Stage 1A|Withdrawal by Subject|1
350267|NCT00467779|1137311|P10|Stage 1A|Withdrawal by Subject|0
350268|NCT00467779|1137312|P9|Stage 1A|Withdrawal by Subject|0
350269|NCT00467779|1137313|P8|Stage 1A|Withdrawal by Subject|0
350270|NCT00467779|1137314|P7|Stage 1A|Withdrawal by Subject|0
350271|NCT00467779|1137315|P6|Stage 1A|Withdrawal by Subject|0
350272|NCT00467779|1137316|P5|Stage 1A|Withdrawal by Subject|0
350273|NCT00467779|1137317|P4|Stage 1A|Withdrawal by Subject|0
350274|NCT00467779|1137318|P3|Stage 1A|Withdrawal by Subject|0
350275|NCT00467779|1137319|P2|Stage 1A|Withdrawal by Subject|0
350276|NCT00467779|1137320|P1|Stage 1A|Withdrawal by Subject|0
350277|NCT00467779|1137306|P15|Stage 1A|Physician Decision|0
350278|NCT00467779|1137307|P14|Stage 1A|Physician Decision|0
350279|NCT00467779|1137308|P13|Stage 1A|Physician Decision|0
350280|NCT00467779|1137309|P12|Stage 1A|Physician Decision|0
350281|NCT00467779|1137310|P11|Stage 1A|Physician Decision|0
350282|NCT00467779|1137311|P10|Stage 1A|Physician Decision|1
350283|NCT00467779|1137312|P9|Stage 1A|Physician Decision|0
350284|NCT00467779|1137313|P8|Stage 1A|Physician Decision|0
350285|NCT00467779|1137314|P7|Stage 1A|Physician Decision|0
350286|NCT00467779|1137315|P6|Stage 1A|Physician Decision|0
350287|NCT00467779|1137316|P5|Stage 1A|Physician Decision|0
350288|NCT00467779|1137317|P4|Stage 1A|Physician Decision|0
350289|NCT00467779|1137318|P3|Stage 1A|Physician Decision|0
350290|NCT00467779|1137319|P2|Stage 1A|Physician Decision|0
350291|NCT00467779|1137320|P1|Stage 1A|Physician Decision|0
350292|NCT00467779|1137306|P15|Stage 1A|Disease Progression|0
350293|NCT00467779|1137307|P14|Stage 1A|Disease Progression|0
350294|NCT00467779|1137308|P13|Stage 1A|Disease Progression|2
350295|NCT00467779|1137309|P12|Stage 1A|Disease Progression|5
350296|NCT00467779|1137310|P11|Stage 1A|Disease Progression|2
350297|NCT00467779|1137311|P10|Stage 1A|Disease Progression|2
350298|NCT00467779|1137312|P9|Stage 1A|Disease Progression|0
350299|NCT00467779|1137313|P8|Stage 1A|Disease Progression|0
350300|NCT00467779|1137314|P7|Stage 1A|Disease Progression|0
350301|NCT00467779|1137315|P6|Stage 1A|Disease Progression|0
350302|NCT00467779|1137316|P5|Stage 1A|Disease Progression|0
350303|NCT00467779|1137317|P4|Stage 1A|Disease Progression|0
350304|NCT00467779|1137318|P3|Stage 1A|Disease Progression|0
350305|NCT00467779|1137319|P2|Stage 1A|Disease Progression|0
350306|NCT00467779|1137320|P1|Stage 1A|Disease Progression|0
350307|NCT00467779|1137306|P15|Stage 1A|Death|0
350308|NCT00467779|1137307|P14|Stage 1A|Death|0
350309|NCT00467779|1137308|P13|Stage 1A|Death|1
350310|NCT00467779|1137309|P12|Stage 1A|Death|1
350311|NCT00467779|1137310|P11|Stage 1A|Death|0
350312|NCT00467779|1137311|P10|Stage 1A|Death|0
350313|NCT00467779|1137312|P9|Stage 1A|Death|0
350314|NCT00467779|1137313|P8|Stage 1A|Death|0
350315|NCT00467779|1137314|P7|Stage 1A|Death|0
350316|NCT00467779|1137315|P6|Stage 1A|Death|0
350317|NCT00467779|1137316|P5|Stage 1A|Death|0
350318|NCT00467779|1137317|P4|Stage 1A|Death|0
350319|NCT00467779|1137318|P3|Stage 1A|Death|0
350320|NCT00467779|1137319|P2|Stage 1A|Death|0
350321|NCT00467779|1137320|P1|Stage 1A|Death|0
350322|NCT00467779|1137306|P15|Stage 1A|Adverse Event|0
350323|NCT00467779|1137307|P14|Stage 1A|Adverse Event|0
350324|NCT00467779|1137308|P13|Stage 1A|Adverse Event|1
350325|NCT00467779|1137309|P12|Stage 1A|Adverse Event|0
350326|NCT00467779|1137310|P11|Stage 1A|Adverse Event|0
350327|NCT00467779|1137311|P10|Stage 1A|Adverse Event|0
350328|NCT00467779|1137312|P9|Stage 1A|Adverse Event|0
350329|NCT00467779|1137313|P8|Stage 1A|Adverse Event|0
350330|NCT00467779|1137314|P7|Stage 1A|Adverse Event|0
350331|NCT00467779|1137315|P6|Stage 1A|Adverse Event|0
350332|NCT00467779|1137316|P5|Stage 1A|Adverse Event|0
350333|NCT00467779|1137317|P4|Stage 1A|Adverse Event|0
350334|NCT00467779|1137318|P3|Stage 1A|Adverse Event|0
350335|NCT00467779|1137319|P2|Stage 1A|Adverse Event|0
350336|NCT00467779|1137320|P1|Stage 1A|Adverse Event|0
350337|NCT00467779|1137306|P15|Stage 1|Withdrawal by Subject|0
350338|NCT00467779|1137307|P14|Stage 1|Withdrawal by Subject|0
350339|NCT00467779|1137308|P13|Stage 1|Withdrawal by Subject|0
350340|NCT00467779|1137309|P12|Stage 1|Withdrawal by Subject|0
350341|NCT00467779|1137310|P11|Stage 1|Withdrawal by Subject|0
350342|NCT00467779|1137311|P10|Stage 1|Withdrawal by Subject|0
350343|NCT00467779|1137312|P9|Stage 1|Withdrawal by Subject|0
350344|NCT00467779|1137313|P8|Stage 1|Withdrawal by Subject|1
350345|NCT00467779|1137314|P7|Stage 1|Withdrawal by Subject|1
350346|NCT00467779|1137315|P6|Stage 1|Withdrawal by Subject|0
350347|NCT00467779|1137316|P5|Stage 1|Withdrawal by Subject|0
350348|NCT00467779|1137317|P4|Stage 1|Withdrawal by Subject|0
350349|NCT00467779|1137318|P3|Stage 1|Withdrawal by Subject|0
350350|NCT00467779|1137319|P2|Stage 1|Withdrawal by Subject|0
350351|NCT00467779|1137320|P1|Stage 1|Withdrawal by Subject|0
350352|NCT00467779|1137306|P15|Stage 1|Physician Decision|0
350353|NCT00467779|1137307|P14|Stage 1|Physician Decision|0
350354|NCT00467779|1137308|P13|Stage 1|Physician Decision|0
350355|NCT00467779|1137309|P12|Stage 1|Physician Decision|0
350356|NCT00467779|1137310|P11|Stage 1|Physician Decision|0
350357|NCT00467779|1137311|P10|Stage 1|Physician Decision|0
350358|NCT00467779|1137312|P9|Stage 1|Physician Decision|0
350359|NCT00467779|1137313|P8|Stage 1|Physician Decision|0
350360|NCT00467779|1137314|P7|Stage 1|Physician Decision|0
350361|NCT00467779|1137315|P6|Stage 1|Physician Decision|0
350362|NCT00467779|1137316|P5|Stage 1|Physician Decision|0
350363|NCT00467779|1137317|P4|Stage 1|Physician Decision|0
350364|NCT00467779|1137318|P3|Stage 1|Physician Decision|0
350365|NCT00467779|1137319|P2|Stage 1|Physician Decision|1
350366|NCT00467779|1137320|P1|Stage 1|Physician Decision|0
350367|NCT00467779|1137306|P15|Stage 1|Unspecified Reason|0
350368|NCT00467779|1137307|P14|Stage 1|Unspecified Reason|0
350369|NCT00467779|1137308|P13|Stage 1|Unspecified Reason|0
350370|NCT00467779|1137309|P12|Stage 1|Unspecified Reason|0
350371|NCT00467779|1137310|P11|Stage 1|Unspecified Reason|0
350372|NCT00467779|1137311|P10|Stage 1|Unspecified Reason|0
350373|NCT00467779|1137312|P9|Stage 1|Unspecified Reason|0
350374|NCT00467779|1137313|P8|Stage 1|Unspecified Reason|0
350375|NCT00467779|1137314|P7|Stage 1|Unspecified Reason|0
350376|NCT00467779|1137315|P6|Stage 1|Unspecified Reason|2
350377|NCT00467779|1137316|P5|Stage 1|Unspecified Reason|1
350378|NCT00467779|1137317|P4|Stage 1|Unspecified Reason|0
350379|NCT00467779|1137318|P3|Stage 1|Unspecified Reason|1
350380|NCT00467779|1137319|P2|Stage 1|Unspecified Reason|0
350381|NCT00467779|1137320|P1|Stage 1|Unspecified Reason|1
350382|NCT00467779|1137306|P15|Stage 1|Disease Progression|0
350383|NCT00467779|1137307|P14|Stage 1|Disease Progression|0
350384|NCT00467779|1137308|P13|Stage 1|Disease Progression|0
350385|NCT00467779|1137309|P12|Stage 1|Disease Progression|0
350386|NCT00467779|1137310|P11|Stage 1|Disease Progression|0
350387|NCT00467779|1137311|P10|Stage 1|Disease Progression|0
350388|NCT00467779|1137312|P9|Stage 1|Disease Progression|0
350389|NCT00467779|1137313|P8|Stage 1|Disease Progression|5
350390|NCT00467779|1137314|P7|Stage 1|Disease Progression|4
350391|NCT00467779|1137315|P6|Stage 1|Disease Progression|2
350392|NCT00467779|1137316|P5|Stage 1|Disease Progression|2
350393|NCT00467779|1137317|P4|Stage 1|Disease Progression|3
350394|NCT00467779|1137318|P3|Stage 1|Disease Progression|2
350395|NCT00467779|1137319|P2|Stage 1|Disease Progression|2
350396|NCT00467779|1137320|P1|Stage 1|Disease Progression|2
350397|NCT00467779|1137306|P15|Stage 1|Adverse Event|0
350398|NCT00467779|1137307|P14|Stage 1|Adverse Event|0
350399|NCT00467779|1137308|P13|Stage 1|Adverse Event|0
350400|NCT00467779|1137309|P12|Stage 1|Adverse Event|0
350401|NCT00467779|1137310|P11|Stage 1|Adverse Event|0
350402|NCT00467779|1137311|P10|Stage 1|Adverse Event|0
350403|NCT00467779|1137312|P9|Stage 1|Adverse Event|0
350404|NCT00467779|1137313|P8|Stage 1|Adverse Event|1
350405|NCT00467779|1137314|P7|Stage 1|Adverse Event|2
350406|NCT00467779|1137315|P6|Stage 1|Adverse Event|1
350407|NCT00467779|1137316|P5|Stage 1|Adverse Event|0
350408|NCT00467779|1137317|P4|Stage 1|Adverse Event|0
350409|NCT00467779|1137318|P3|Stage 1|Adverse Event|0
350410|NCT00467779|1137319|P2|Stage 1|Adverse Event|0
350411|NCT00467779|1137320|P1|Stage 1|Adverse Event|1
350412|NCT00467753|1137494|P2|Overall Study|Adverse Event|0
350413|NCT00467753|1137495|P1|Overall Study|Adverse Event|2
350414|NCT00467753|1137494|P2|Overall Study|Lost to Follow-up|2
350415|NCT00467753|1137495|P1|Overall Study|Lost to Follow-up|1
350416|NCT00467740|1137506|P5|Overall Study|Lack of Efficacy|0
350417|NCT00467740|1137507|P4|Overall Study|Lack of Efficacy|0
350418|NCT00467740|1137508|P3|Overall Study|Lack of Efficacy|0
350419|NCT00467740|1137509|P2|Overall Study|Lack of Efficacy|1
350420|NCT00467740|1137510|P1|Overall Study|Lack of Efficacy|0
350421|NCT00467740|1137506|P5|Overall Study|Withdrawal by Subject|0
350422|NCT00467740|1137507|P4|Overall Study|Withdrawal by Subject|1
350423|NCT00467740|1137508|P3|Overall Study|Withdrawal by Subject|0
350424|NCT00467740|1137509|P2|Overall Study|Withdrawal by Subject|1
350425|NCT00467740|1137510|P1|Overall Study|Withdrawal by Subject|1
350426|NCT00467740|1137506|P5|Overall Study|Lost to Follow-up|0
350427|NCT00467740|1137507|P4|Overall Study|Lost to Follow-up|0
350428|NCT00467740|1137508|P3|Overall Study|Lost to Follow-up|0
350429|NCT00467740|1137509|P2|Overall Study|Lost to Follow-up|1
350430|NCT00467740|1137510|P1|Overall Study|Lost to Follow-up|0
350431|NCT00467740|1137506|P5|Overall Study|Protocol Violation|0
350432|NCT00467740|1137507|P4|Overall Study|Protocol Violation|0
350433|NCT00467740|1137508|P3|Overall Study|Protocol Violation|1
350434|NCT00467740|1137509|P2|Overall Study|Protocol Violation|0
350435|NCT00467740|1137510|P1|Overall Study|Protocol Violation|0
350436|NCT00467740|1137506|P5|Overall Study|Adverse Event|0
350437|NCT00467740|1137507|P4|Overall Study|Adverse Event|0
350438|NCT00467740|1137508|P3|Overall Study|Adverse Event|1
350439|NCT00467740|1137509|P2|Overall Study|Adverse Event|0
350440|NCT00467740|1137510|P1|Overall Study|Adverse Event|0
350441|NCT00467649|1137699|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
350442|NCT00467649|1137700|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
350443|NCT00467649|1137701|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
350444|NCT00467649|1137702|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
350445|NCT00467649|1137703|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
350446|NCT00467649|1137704|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
350447|NCT00467649|1137699|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
350448|NCT00467649|1137700|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
350449|NCT00467649|1137701|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
350450|NCT00467649|1137702|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
350451|NCT00467649|1137703|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
350452|NCT00467649|1137704|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
350453|NCT00467649|1137699|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
350454|NCT00467649|1137700|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
350455|NCT00467649|1137701|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
350456|NCT00467649|1137702|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
350457|NCT00467649|1137703|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
350458|NCT00467649|1137704|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
350459|NCT00467649|1137699|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
350460|NCT00467649|1137700|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
350461|NCT00467649|1137701|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
350462|NCT00467649|1137702|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
350463|NCT00467649|1137703|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
350464|NCT00467649|1137704|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
350465|NCT00467649|1137699|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
350466|NCT00467649|1137700|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
350467|NCT00467649|1137701|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
350468|NCT00467649|1137702|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
350469|NCT00467649|1137703|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
350470|NCT00467649|1137704|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
350471|NCT00467649|1137699|P6|Phase 1 (Randomized Population)|Investigator Decision|0
350472|NCT00467649|1137700|P5|Phase 1 (Randomized Population)|Investigator Decision|0
350473|NCT00467649|1137701|P4|Phase 1 (Randomized Population)|Investigator Decision|0
350474|NCT00467649|1137702|P3|Phase 1 (Randomized Population)|Investigator Decision|0
350475|NCT00467649|1137703|P2|Phase 1 (Randomized Population)|Investigator Decision|0
350476|NCT00467649|1137704|P1|Phase 1 (Randomized Population)|Investigator Decision|1
350477|NCT00467649|1137699|P6|Phase 1 (Randomized Population)|Adverse Event|0
350478|NCT00467649|1137700|P5|Phase 1 (Randomized Population)|Adverse Event|0
350479|NCT00467649|1137701|P4|Phase 1 (Randomized Population)|Adverse Event|0
350480|NCT00467649|1137702|P3|Phase 1 (Randomized Population)|Adverse Event|0
350481|NCT00467649|1137703|P2|Phase 1 (Randomized Population)|Adverse Event|0
350482|NCT00467649|1137704|P1|Phase 1 (Randomized Population)|Adverse Event|2
350483|NCT00467610|1137744|P1|Overall Study|Withdrawal by Subject|1
350484|NCT00467597|1137755|P2|Overall Study|Withdrawal by Subject|0
350485|NCT00467597|1137756|P1|Overall Study|Withdrawal by Subject|2
350486|NCT00467584|1137769|P3|Overall Study|Withdrawal by Subject|1
350487|NCT00467584|1137770|P2|Overall Study|Withdrawal by Subject|5
350488|NCT00467584|1137771|P1|Overall Study|Withdrawal by Subject|4
350489|NCT00467558|1137781|P2|Overall Study|Lost to Follow-up|0
350490|NCT00467558|1137782|P1|Overall Study|Lost to Follow-up|2
350491|NCT00467519|1137792|P2|Overall Study|Withdrawal by Subject|10
350492|NCT00467519|1137793|P1|Overall Study|Withdrawal by Subject|4
350493|NCT00467519|1137792|P2|Overall Study|Lost to Follow-up|9
350494|NCT00467519|1137793|P1|Overall Study|Lost to Follow-up|2
350495|NCT00467519|1137792|P2|Overall Study|Protocol Violation|4
350496|NCT00467519|1137793|P1|Overall Study|Protocol Violation|8
350497|NCT00467363|1137822|P2|Overall Study|Lost to Follow-up|70
350498|NCT00467363|1137823|P1|Overall Study|Lost to Follow-up|80
350499|NCT00467285|1137859|P2|Overall Study|Lost to Follow-up|4
350500|NCT00467285|1137860|P1|Overall Study|Lost to Follow-up|4
350501|NCT00467259|1137880|P2|Overall Study|Site Closed|1
350502|NCT00467259|1137881|P1|Overall Study|Site Closed|2
350503|NCT00467259|1137880|P2|Overall Study|Lost to Follow-up|34
350504|NCT00467259|1137881|P1|Overall Study|Lost to Follow-up|14
350505|NCT00467259|1137880|P2|Overall Study|Physician Decision|2
350506|NCT00467259|1137881|P1|Overall Study|Physician Decision|0
350507|NCT00467259|1137880|P2|Overall Study|Withdrawal by Subject|108
350508|NCT00467259|1137881|P1|Overall Study|Withdrawal by Subject|34
350509|NCT00467259|1137880|P2|Overall Study|Protocol Violation|7
350510|NCT00467259|1137881|P1|Overall Study|Protocol Violation|1
350511|NCT00467259|1137880|P2|Overall Study|Adverse Event|90
350512|NCT00467259|1137881|P1|Overall Study|Adverse Event|24
350513|NCT00467051|1137898|P1|Overall Study|Adverse Event|2
350514|NCT00466947|1137915|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
350515|NCT00466947|1137916|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
350516|NCT00466947|1137915|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
350517|NCT00466947|1137916|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
350518|NCT00466947|1137915|P2|Study End Analysis Period|Other – Forbidden vaccination|10
350519|NCT00466947|1137916|P1|Study End Analysis Period|Other – Forbidden vaccination|21
350520|NCT00466947|1137915|P2|Study End Analysis Period|Withdrawal by Subject|1267
350521|NCT00466947|1137916|P1|Study End Analysis Period|Withdrawal by Subject|1264
350522|NCT00466947|1137915|P2|Study End Analysis Period|Protocol Violation|17
350523|NCT00466947|1137916|P1|Study End Analysis Period|Protocol Violation|9
350524|NCT00466947|1137915|P2|Study End Analysis Period|Physician Decision|29
350525|NCT00466947|1137916|P1|Study End Analysis Period|Physician Decision|29
350526|NCT00466947|1137915|P2|Study End Analysis Period|Lost to Follow-up|1167
350527|NCT00466947|1137916|P1|Study End Analysis Period|Lost to Follow-up|1137
350528|NCT00466947|1137915|P2|Study End Analysis Period|Adverse Event|43
350529|NCT00466947|1137916|P1|Study End Analysis Period|Adverse Event|35
350530|NCT00466947|1137915|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
350531|NCT00466947|1137916|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
350532|NCT00466687|1138098|P1|Overall Study|Disease progression|29
350533|NCT00466687|1138098|P1|Overall Study|Withdrawal by Subject|1
350534|NCT00466687|1138098|P1|Overall Study|Other complicating illness|3
350535|NCT00466687|1138098|P1|Overall Study|Adverse Event|1
350536|NCT00465647|1138109|P4|Overall Study|"The other reasons included loss of IV"|2
350537|NCT00465647|1138110|P3|Overall Study|"The other reasons included loss of IV"|3
350538|NCT00465647|1138111|P2|Overall Study|"The other reasons included loss of IV"|4
350539|NCT00465647|1138112|P1|Overall Study|"The other reasons included loss of IV"|8
350540|NCT00465647|1138109|P4|Overall Study|Withdrawal by Subject|7
350541|NCT00465647|1138110|P3|Overall Study|Withdrawal by Subject|2
350542|NCT00465647|1138111|P2|Overall Study|Withdrawal by Subject|2
350543|NCT00465647|1138112|P1|Overall Study|Withdrawal by Subject|1
350544|NCT00465647|1138109|P4|Overall Study|Adverse Event|2
350545|NCT00465647|1138110|P3|Overall Study|Adverse Event|3
350546|NCT00465647|1138111|P2|Overall Study|Adverse Event|0
350547|NCT00465647|1138112|P1|Overall Study|Adverse Event|2
350548|NCT00465647|1138109|P4|Overall Study|Administrative|2
350549|NCT00465647|1138110|P3|Overall Study|Administrative|3
350550|NCT00465647|1138111|P2|Overall Study|Administrative|2
350551|NCT00465647|1138112|P1|Overall Study|Administrative|2
350552|NCT00466505|1138135|P1|Overall Study|Adverse Event|4
350553|NCT00466505|1138135|P1|Overall Study|disease progression|13
350554|NCT00466193|1138185|P2|Overall Study|Patient refused Visit 4 procedures|0
350555|NCT00466193|1138186|P1|Overall Study|Patient refused Visit 4 procedures|1
350556|NCT00466193|1138185|P2|Overall Study|Withdrawal by Subject|2
350557|NCT00466193|1138186|P1|Overall Study|Withdrawal by Subject|7
350558|NCT00466193|1138185|P2|Overall Study|Protocol Violation|1
350559|NCT00466193|1138186|P1|Overall Study|Protocol Violation|1
350560|NCT00466193|1138185|P2|Overall Study|Physician Decision|0
350561|NCT00466193|1138186|P1|Overall Study|Physician Decision|1
350562|NCT00466193|1138185|P2|Overall Study|Lost to Follow-up|4
350563|NCT00466193|1138186|P1|Overall Study|Lost to Follow-up|2
350564|NCT00466193|1138185|P2|Overall Study|Adverse Event|1
350565|NCT00466193|1138186|P1|Overall Study|Adverse Event|0
350566|NCT00466167|1138213|P3|Overall Study|Not treated|0
350567|NCT00466167|1138214|P2|Overall Study|Not treated|0
350568|NCT00466167|1138215|P1|Overall Study|Not treated|1
350569|NCT00466167|1138213|P3|Overall Study|patient did not meet inclusion criteria|1
350570|NCT00466167|1138214|P2|Overall Study|patient did not meet inclusion criteria|0
350571|NCT00466167|1138215|P1|Overall Study|patient did not meet inclusion criteria|1
350572|NCT00466167|1138213|P3|Overall Study|Withdrawal by Subject|6
350573|NCT00466167|1138214|P2|Overall Study|Withdrawal by Subject|1
350574|NCT00466167|1138215|P1|Overall Study|Withdrawal by Subject|4
350575|NCT00466167|1138213|P3|Overall Study|Lost to Follow-up|2
350576|NCT00466167|1138214|P2|Overall Study|Lost to Follow-up|2
350577|NCT00466167|1138215|P1|Overall Study|Lost to Follow-up|3
350578|NCT00466167|1138213|P3|Overall Study|Protocol Violation|2
350579|NCT00466167|1138214|P2|Overall Study|Protocol Violation|1
350580|NCT00466167|1138215|P1|Overall Study|Protocol Violation|1
350581|NCT00466167|1138213|P3|Overall Study|Lack of Efficacy|3
350582|NCT00466167|1138214|P2|Overall Study|Lack of Efficacy|0
350583|NCT00466167|1138215|P1|Overall Study|Lack of Efficacy|2
350584|NCT00466167|1138213|P3|Overall Study|Adverse Event|7
350585|NCT00466167|1138214|P2|Overall Study|Adverse Event|8
350586|NCT00466167|1138215|P1|Overall Study|Adverse Event|8
350587|NCT00465985|1138276|P2|Part III - Open-label Treatment Period|Adverse Event|0
350588|NCT00465985|1138277|P1|Part III - Open-label Treatment Period|Adverse Event|1
350589|NCT00465985|1138276|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
350590|NCT00465985|1138277|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
350591|NCT00465985|1138276|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
350592|NCT00465985|1138277|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
350593|NCT00465985|1138276|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
350594|NCT00465985|1138277|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
350595|NCT00465972|1138300|P2|Overall Study|Withdrawal by Subject|1
350596|NCT00465972|1138301|P1|Overall Study|Withdrawal by Subject|2
350597|NCT00465816|1138321|P3|Overall Study|Lost to Follow-up|2
350598|NCT00465816|1138322|P2|Overall Study|Lost to Follow-up|0
350599|NCT00465816|1138323|P1|Overall Study|Lost to Follow-up|0
350600|NCT00465738|1138405|P2|Overall Study|Other|5
350601|NCT00465738|1138406|P1|Overall Study|Other|2
350602|NCT00465738|1138405|P2|Overall Study|Withdrawal by Subject|0
350603|NCT00465738|1138406|P1|Overall Study|Withdrawal by Subject|2
350604|NCT00465738|1138405|P2|Overall Study|Adverse Event|1
350605|NCT00465738|1138406|P1|Overall Study|Adverse Event|0
350606|NCT00465738|1138405|P2|Overall Study|Lost to Follow-up|0
350607|NCT00465738|1138406|P1|Overall Study|Lost to Follow-up|2
350608|NCT00465569|1138498|P2|Overall Study|persistent eczema during dose escalation|0
350609|NCT00465569|1138499|P1|Overall Study|persistent eczema during dose escalation|1
350610|NCT00465361|1138522|P1|Baseline Assessment|Personal Issues/Scheduling|4
350611|NCT00465179|1138526|P1|Overall Study|Progression of Disease|47
350612|NCT00465179|1138526|P1|Overall Study|Withdrawal by Subject|2
350613|NCT00465179|1138526|P1|Overall Study|Adverse Event|4
350614|NCT00465101|1138532|P1|Overall Study|Withdrew consent prior to procedure|3
350615|NCT00465101|1138532|P1|Overall Study|Physician Decision|1
350616|NCT00465101|1138532|P1|Overall Study|Withdrawal by Subject|25
350617|NCT00465101|1138532|P1|Overall Study|Death|3
350618|NCT00465101|1138532|P1|Overall Study|Unable to obtain IRB approval|1
350619|NCT00465101|1138532|P1|Overall Study|Site closed due to IRB expiration|1
350620|NCT00465101|1138532|P1|Overall Study|Patient postponed procedure|1
350621|NCT00465101|1138532|P1|Overall Study|Pt. Insurance not accepted at center|2
350622|NCT00465101|1138532|P1|Overall Study|Other|6
350623|NCT00465101|1138532|P1|Overall Study|Lost to Follow-up|5
350624|NCT00465101|1138532|P1|Overall Study|Did not meet study criteria|4
350625|NCT00465101|1138532|P1|Overall Study|Change in health precluded follow up|4
350626|NCT00465101|1138532|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
350627|NCT00464945|1138602|P2|Toddler Dose|Lost to Follow-up|1
350628|NCT00464945|1138603|P1|Toddler Dose|Lost to Follow-up|0
350629|NCT00464945|1138602|P2|After Infant Series|Withdrawal by Subject|2
350630|NCT00464945|1138603|P1|After Infant Series|Withdrawal by Subject|0
350631|NCT00464945|1138602|P2|Infant Series|Lost to Follow-up|0
350632|NCT00464945|1138603|P1|Infant Series|Lost to Follow-up|1
350633|NCT00464945|1138602|P2|Infant Series|Protocol Violation|0
350634|NCT00464945|1138603|P1|Infant Series|Protocol Violation|1
350635|NCT00464945|1138602|P2|Infant Series|Withdrawal by parent/guardian request|1
350636|NCT00464945|1138603|P1|Infant Series|Withdrawal by parent/guardian request|2
350637|NCT00464737|1138634|P3|Overall Study|Other: Subject's disability per sponsor|1
350638|NCT00464737|1138635|P2|Overall Study|Other: Subject's disability per sponsor|0
350639|NCT00464737|1138636|P1|Overall Study|Other: Subject's disability per sponsor|0
350640|NCT00464737|1138634|P3|Overall Study|Other: Personal family reasons|1
350641|NCT00464737|1138635|P2|Overall Study|Other: Personal family reasons|0
350642|NCT00464737|1138636|P1|Overall Study|Other: Personal family reasons|0
350643|NCT00464737|1138634|P3|Overall Study|Other: Study demands too great|0
350644|NCT00464737|1138635|P2|Overall Study|Other: Study demands too great|1
350645|NCT00464737|1138636|P1|Overall Study|Other: Study demands too great|0
350646|NCT00464737|1138634|P3|Overall Study|Other: Subject left town; family illness|0
350647|NCT00464737|1138635|P2|Overall Study|Other: Subject left town; family illness|0
350648|NCT00464737|1138636|P1|Overall Study|Other: Subject left town; family illness|1
350649|NCT00464737|1138634|P3|Overall Study|Other: Subject's schedule doesn't permit|0
350650|NCT00464737|1138635|P2|Overall Study|Other: Subject's schedule doesn't permit|0
350651|NCT00464737|1138636|P1|Overall Study|Other: Subject's schedule doesn't permit|1
350652|NCT00464737|1138634|P3|Overall Study|Lost to Follow-up|5
350653|NCT00464737|1138635|P2|Overall Study|Lost to Follow-up|2
350654|NCT00464737|1138636|P1|Overall Study|Lost to Follow-up|5
350655|NCT00464737|1138634|P3|Overall Study|Non-compliance|1
350656|NCT00464737|1138635|P2|Overall Study|Non-compliance|1
350657|NCT00464737|1138636|P1|Overall Study|Non-compliance|0
350658|NCT00464737|1138634|P3|Overall Study|Protocol Violation|5
350659|NCT00464737|1138635|P2|Overall Study|Protocol Violation|1
350660|NCT00464737|1138636|P1|Overall Study|Protocol Violation|1
350661|NCT00464737|1138634|P3|Overall Study|Withdrawal by Subject|5
350662|NCT00464737|1138635|P2|Overall Study|Withdrawal by Subject|3
350663|NCT00464737|1138636|P1|Overall Study|Withdrawal by Subject|5
350664|NCT00464737|1138634|P3|Overall Study|Lack of Efficacy|4
350665|NCT00464737|1138635|P2|Overall Study|Lack of Efficacy|7
350666|NCT00464737|1138636|P1|Overall Study|Lack of Efficacy|7
350667|NCT00464737|1138634|P3|Overall Study|Adverse Event|33
350668|NCT00464737|1138635|P2|Overall Study|Adverse Event|17
350669|NCT00464737|1138636|P1|Overall Study|Adverse Event|12
350670|NCT00464672|1138716|P6|Overall Study|Lost to Follow-up|0
350671|NCT00464672|1138717|P5|Overall Study|Lost to Follow-up|1
350672|NCT00464672|1138718|P4|Overall Study|Lost to Follow-up|0
350673|NCT00464672|1138719|P3|Overall Study|Lost to Follow-up|0
350674|NCT00464672|1138720|P2|Overall Study|Lost to Follow-up|10
350675|NCT00464672|1138721|P1|Overall Study|Lost to Follow-up|25
350676|NCT00464672|1138716|P6|Overall Study|withdrawal of consent|4
350677|NCT00464672|1138717|P5|Overall Study|withdrawal of consent|9
350678|NCT00464672|1138718|P4|Overall Study|withdrawal of consent|1
350679|NCT00464672|1138719|P3|Overall Study|withdrawal of consent|0
350680|NCT00464672|1138720|P2|Overall Study|withdrawal of consent|0
350681|NCT00464672|1138721|P1|Overall Study|withdrawal of consent|0
350682|NCT00464542|1138800|P1|Pre-treatment|Withdrawal by Subject|2
350683|NCT00464490|1138807|P2|Overall Study|Physician Decision|11
350684|NCT00464490|1138808|P1|Overall Study|Physician Decision|11
350685|NCT00464334|1138855|P11|Overall Study|Withdrawal by Subject|0
350686|NCT00464334|1138856|P10|Overall Study|Withdrawal by Subject|0
350687|NCT00464334|1138857|P9|Overall Study|Withdrawal by Subject|3
350688|NCT00464334|1138858|P8|Overall Study|Withdrawal by Subject|1
350689|NCT00464334|1138859|P7|Overall Study|Withdrawal by Subject|2
350690|NCT00464334|1138860|P6|Overall Study|Withdrawal by Subject|2
350691|NCT00464334|1138861|P5|Overall Study|Withdrawal by Subject|2
350692|NCT00464334|1138862|P4|Overall Study|Withdrawal by Subject|2
350693|NCT00464334|1138863|P3|Overall Study|Withdrawal by Subject|4
350694|NCT00464334|1138864|P2|Overall Study|Withdrawal by Subject|7
350695|NCT00464334|1138865|P1|Overall Study|Withdrawal by Subject|1
350696|NCT00464334|1138855|P11|Overall Study|Study Terminated by Sponsor|0
350697|NCT00464334|1138856|P10|Overall Study|Study Terminated by Sponsor|0
350698|NCT00464334|1138857|P9|Overall Study|Study Terminated by Sponsor|0
350699|NCT00464334|1138858|P8|Overall Study|Study Terminated by Sponsor|0
350700|NCT00464334|1138859|P7|Overall Study|Study Terminated by Sponsor|0
350701|NCT00464334|1138860|P6|Overall Study|Study Terminated by Sponsor|0
350702|NCT00464334|1138861|P5|Overall Study|Study Terminated by Sponsor|0
350703|NCT00464334|1138862|P4|Overall Study|Study Terminated by Sponsor|1
350704|NCT00464334|1138863|P3|Overall Study|Study Terminated by Sponsor|0
350705|NCT00464334|1138864|P2|Overall Study|Study Terminated by Sponsor|0
350706|NCT00464334|1138865|P1|Overall Study|Study Terminated by Sponsor|0
350707|NCT00464334|1138855|P11|Overall Study|Progressive Disease|0
350708|NCT00464334|1138856|P10|Overall Study|Progressive Disease|0
350709|NCT00464334|1138857|P9|Overall Study|Progressive Disease|1
350710|NCT00464334|1138858|P8|Overall Study|Progressive Disease|0
350711|NCT00464334|1138859|P7|Overall Study|Progressive Disease|0
350712|NCT00464334|1138860|P6|Overall Study|Progressive Disease|1
350713|NCT00464334|1138861|P5|Overall Study|Progressive Disease|0
350714|NCT00464334|1138862|P4|Overall Study|Progressive Disease|0
350715|NCT00464334|1138863|P3|Overall Study|Progressive Disease|0
350716|NCT00464334|1138864|P2|Overall Study|Progressive Disease|0
350717|NCT00464334|1138865|P1|Overall Study|Progressive Disease|0
350718|NCT00464334|1138855|P11|Overall Study|Lost to Follow-up|2
350719|NCT00464334|1138856|P10|Overall Study|Lost to Follow-up|0
350720|NCT00464334|1138857|P9|Overall Study|Lost to Follow-up|0
350721|NCT00464334|1138858|P8|Overall Study|Lost to Follow-up|0
350722|NCT00464334|1138859|P7|Overall Study|Lost to Follow-up|1
350723|NCT00464334|1138860|P6|Overall Study|Lost to Follow-up|0
350724|NCT00464334|1138861|P5|Overall Study|Lost to Follow-up|1
350725|NCT00464334|1138862|P4|Overall Study|Lost to Follow-up|0
350726|NCT00464334|1138863|P3|Overall Study|Lost to Follow-up|1
350727|NCT00464334|1138864|P2|Overall Study|Lost to Follow-up|0
350728|NCT00464334|1138865|P1|Overall Study|Lost to Follow-up|0
350729|NCT00464334|1138855|P11|Overall Study|Lack of Efficacy|0
350730|NCT00464334|1138856|P10|Overall Study|Lack of Efficacy|0
350731|NCT00464334|1138857|P9|Overall Study|Lack of Efficacy|0
350732|NCT00464334|1138858|P8|Overall Study|Lack of Efficacy|0
350733|NCT00464334|1138859|P7|Overall Study|Lack of Efficacy|0
350734|NCT00464334|1138860|P6|Overall Study|Lack of Efficacy|0
350735|NCT00464334|1138861|P5|Overall Study|Lack of Efficacy|0
350736|NCT00464334|1138862|P4|Overall Study|Lack of Efficacy|0
350737|NCT00464334|1138863|P3|Overall Study|Lack of Efficacy|0
350738|NCT00464334|1138864|P2|Overall Study|Lack of Efficacy|1
350739|NCT00464334|1138865|P1|Overall Study|Lack of Efficacy|0
350740|NCT00464334|1138855|P11|Overall Study|Adverse Event|2
350741|NCT00464334|1138856|P10|Overall Study|Adverse Event|1
350742|NCT00464334|1138857|P9|Overall Study|Adverse Event|2
350743|NCT00464334|1138858|P8|Overall Study|Adverse Event|0
350744|NCT00464334|1138859|P7|Overall Study|Adverse Event|0
350745|NCT00464334|1138860|P6|Overall Study|Adverse Event|1
350746|NCT00464334|1138861|P5|Overall Study|Adverse Event|1
350747|NCT00464334|1138862|P4|Overall Study|Adverse Event|1
350748|NCT00464334|1138863|P3|Overall Study|Adverse Event|0
350749|NCT00464334|1138864|P2|Overall Study|Adverse Event|0
350750|NCT00464334|1138865|P1|Overall Study|Adverse Event|0
350751|NCT00464308|1138925|P3|Overall Study|Physician Decision|0
350752|NCT00464308|1138926|P2|Overall Study|Physician Decision|0
350753|NCT00464308|1138927|P1|Overall Study|Physician Decision|1
350754|NCT00464308|1138925|P3|Overall Study|Patient discontinued and other reasons|23
350755|NCT00464308|1138926|P2|Overall Study|Patient discontinued and other reasons|17
350756|NCT00464308|1138927|P1|Overall Study|Patient discontinued and other reasons|17
350757|NCT00464308|1138925|P3|Overall Study|Lost to Follow-up|20
350758|NCT00464308|1138926|P2|Overall Study|Lost to Follow-up|19
350759|NCT00464308|1138927|P1|Overall Study|Lost to Follow-up|29
350760|NCT00464308|1138925|P3|Overall Study|Adverse Event|16
350761|NCT00464308|1138926|P2|Overall Study|Adverse Event|27
350762|NCT00464308|1138927|P1|Overall Study|Adverse Event|22
350763|NCT00464269|1138957|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
350764|NCT00464269|1138958|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
350765|NCT00464269|1138959|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
350766|NCT00464269|1138960|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
350767|NCT00464269|1138957|P4|Overall Study|AE, non-serious non-fatal|4
350768|NCT00464269|1138958|P3|Overall Study|AE, non-serious non-fatal|3
350769|NCT00464269|1138959|P2|Overall Study|AE, non-serious non-fatal|8
350770|NCT00464269|1138960|P1|Overall Study|AE, non-serious non-fatal|2
350771|NCT00464269|1138957|P4|Overall Study|SAE, non-fatal|1
350772|NCT00464269|1138958|P3|Overall Study|SAE, non-fatal|0
350773|NCT00464269|1138959|P2|Overall Study|SAE, non-fatal|0
350774|NCT00464269|1138960|P1|Overall Study|SAE, non-fatal|0
350775|NCT00464269|1138957|P4|Overall Study|AE, serious fatal|1
350776|NCT00464269|1138958|P3|Overall Study|AE, serious fatal|1
350777|NCT00464269|1138959|P2|Overall Study|AE, serious fatal|0
350778|NCT00464269|1138960|P1|Overall Study|AE, serious fatal|0
350779|NCT00464269|1138957|P4|Overall Study|Other reason|1
350780|NCT00464269|1138958|P3|Overall Study|Other reason|1
350781|NCT00464269|1138959|P2|Overall Study|Other reason|3
350782|NCT00464269|1138960|P1|Overall Study|Other reason|3
350783|NCT00464269|1138957|P4|Overall Study|Withdrawal by Subject|1
350784|NCT00464269|1138958|P3|Overall Study|Withdrawal by Subject|1
350785|NCT00464269|1138959|P2|Overall Study|Withdrawal by Subject|2
350786|NCT00464269|1138960|P1|Overall Study|Withdrawal by Subject|0
350787|NCT00464269|1138957|P4|Overall Study|Lost to Follow-up|1
350788|NCT00464269|1138958|P3|Overall Study|Lost to Follow-up|0
350789|NCT00464269|1138959|P2|Overall Study|Lost to Follow-up|4
350790|NCT00464269|1138960|P1|Overall Study|Lost to Follow-up|0
350791|NCT00464269|1138957|P4|Overall Study|Lack of Efficacy|0
350792|NCT00464269|1138958|P3|Overall Study|Lack of Efficacy|0
350793|NCT00464269|1138959|P2|Overall Study|Lack of Efficacy|0
350794|NCT00464269|1138960|P1|Overall Study|Lack of Efficacy|1
350795|NCT00464087|1139098|P3|Overall Study|No PCI per inclusion criteria|29
350796|NCT00464087|1139099|P2|Overall Study|No PCI per inclusion criteria|0
350797|NCT00464087|1139100|P1|Overall Study|No PCI per inclusion criteria|0
350798|NCT00463866|1139118|P2|Overall Study|Unspecified|22
350799|NCT00463866|1139119|P1|Overall Study|Unspecified|22
350800|NCT00463866|1139118|P2|Overall Study|Mis-Randomization of subject|1
350801|NCT00463866|1139119|P1|Overall Study|Mis-Randomization of subject|0
350802|NCT00463866|1139118|P2|Overall Study|Safety Reason|3
350803|NCT00463866|1139119|P1|Overall Study|Safety Reason|1
350804|NCT00463866|1139118|P2|Overall Study|Severe Non-Compliance to Protocol|21
350805|NCT00463866|1139119|P1|Overall Study|Severe Non-Compliance to Protocol|25
350806|NCT00463866|1139118|P2|Overall Study|Incorrect Enrolment|66
350807|NCT00463866|1139119|P1|Overall Study|Incorrect Enrolment|64
350808|NCT00463866|1139118|P2|Overall Study|Lost to Follow-up|55
350809|NCT00463866|1139119|P1|Overall Study|Lost to Follow-up|46
350810|NCT00463866|1139118|P2|Overall Study|Withdrawal by Subject|79
350811|NCT00463866|1139119|P1|Overall Study|Withdrawal by Subject|81
350812|NCT00463866|1139118|P2|Overall Study|Adverse Event|93
350813|NCT00463866|1139119|P1|Overall Study|Adverse Event|70
350814|NCT00463840|1139139|P1|Overall Study|Adverse Event|3
350815|NCT00463840|1139139|P1|Overall Study|Withdrawal by Subject|2
350816|NCT00463840|1139139|P1|Overall Study|Disease progression|7
350817|NCT00463801|1139143|P1|Overall Study|No longer require therapy|1
350818|NCT00463801|1139143|P1|Overall Study|Lost to Follow-up|5
350819|NCT00463801|1139143|P1|Overall Study|Adverse Event|4
350820|NCT00463801|1139143|P1|Overall Study|Lack of Efficacy|2
350821|NCT00463801|1139143|P1|Overall Study|Protocol Violation|1
350822|NCT00463788|1139149|P2|Overall Study|Randomized but not treated|1
350823|NCT00463788|1139150|P1|Overall Study|Randomized but not treated|1
350824|NCT00463788|1139149|P2|Overall Study|Unspecified|0
350825|NCT00463788|1139150|P1|Overall Study|Unspecified|3
350826|NCT00463788|1139149|P2|Overall Study|Protocol Violation|1
350827|NCT00463788|1139150|P1|Overall Study|Protocol Violation|0
350828|NCT00463788|1139149|P2|Overall Study|Lost to Follow-up|0
350829|NCT00463788|1139150|P1|Overall Study|Lost to Follow-up|1
350830|NCT00463788|1139149|P2|Overall Study|Symptomatic Deterioration|3
350831|NCT00463788|1139150|P1|Overall Study|Symptomatic Deterioration|2
350832|NCT00463788|1139149|P2|Overall Study|Death|3
350833|NCT00463788|1139150|P1|Overall Study|Death|4
350834|NCT00463788|1139149|P2|Overall Study|Withdrawal by Subject|2
350835|NCT00463788|1139150|P1|Overall Study|Withdrawal by Subject|6
350836|NCT00463788|1139149|P2|Overall Study|Adverse Event|2
350837|NCT00463788|1139150|P1|Overall Study|Adverse Event|6
350838|NCT00463788|1139149|P2|Overall Study|Progressive Disease|42
350839|NCT00463788|1139150|P1|Overall Study|Progressive Disease|86
350840|NCT00463606|1139168|P3|Overall Study|Protocol Violation|1
350841|NCT00463606|1139169|P2|Overall Study|Protocol Violation|0
350842|NCT00463606|1139170|P1|Overall Study|Protocol Violation|0
350843|NCT00463606|1139168|P3|Overall Study|Participation in another ABT-335 trial|0
350844|NCT00463606|1139169|P2|Overall Study|Participation in another ABT-335 trial|0
350845|NCT00463606|1139170|P1|Overall Study|Participation in another ABT-335 trial|1
350846|NCT00463606|1139168|P3|Overall Study|Patient randomized in error|0
350847|NCT00463606|1139169|P2|Overall Study|Patient randomized in error|0
350848|NCT00463606|1139170|P1|Overall Study|Patient randomized in error|1
350849|NCT00463606|1139168|P3|Overall Study|Coordinator error|0
350850|NCT00463606|1139169|P2|Overall Study|Coordinator error|0
350851|NCT00463606|1139170|P1|Overall Study|Coordinator error|1
350852|NCT00463606|1139168|P3|Overall Study|Exclusion criteria violation|0
350853|NCT00463606|1139169|P2|Overall Study|Exclusion criteria violation|0
350854|NCT00463606|1139170|P1|Overall Study|Exclusion criteria violation|2
350855|NCT00463606|1139168|P3|Overall Study|Sponsor request|0
350856|NCT00463606|1139169|P2|Overall Study|Sponsor request|1
350857|NCT00463606|1139170|P1|Overall Study|Sponsor request|0
350858|NCT00463606|1139168|P3|Overall Study|Physician Decision|0
350859|NCT00463606|1139169|P2|Overall Study|Physician Decision|1
350860|NCT00463606|1139170|P1|Overall Study|Physician Decision|0
350861|NCT00463606|1139168|P3|Overall Study|Subject moved out of town|0
350862|NCT00463606|1139169|P2|Overall Study|Subject moved out of town|0
350863|NCT00463606|1139170|P1|Overall Study|Subject moved out of town|1
350864|NCT00463606|1139168|P3|Overall Study|Subject noncompliance|0
350865|NCT00463606|1139169|P2|Overall Study|Subject noncompliance|1
350866|NCT00463606|1139170|P1|Overall Study|Subject noncompliance|1
350867|NCT00463606|1139168|P3|Overall Study|Lost to Follow-up|3
350868|NCT00463606|1139169|P2|Overall Study|Lost to Follow-up|2
350869|NCT00463606|1139170|P1|Overall Study|Lost to Follow-up|2
350870|NCT00463606|1139168|P3|Overall Study|Withdrawal by Subject|5
350871|NCT00463606|1139169|P2|Overall Study|Withdrawal by Subject|11
350872|NCT00463606|1139170|P1|Overall Study|Withdrawal by Subject|11
350873|NCT00463606|1139168|P3|Overall Study|Adverse Event|11
350874|NCT00463606|1139169|P2|Overall Study|Adverse Event|18
350875|NCT00463606|1139170|P1|Overall Study|Adverse Event|21
350876|NCT00463580|1139195|P2|Overall Study|Medical/psychiatric complications|2
350877|NCT00463580|1139196|P1|Overall Study|Medical/psychiatric complications|0
350878|NCT00463580|1139195|P2|Overall Study|schedule conflict|0
350879|NCT00463580|1139196|P1|Overall Study|schedule conflict|2
350880|NCT00463580|1139195|P2|Overall Study|Lost to Follow-up|0
350881|NCT00463580|1139196|P1|Overall Study|Lost to Follow-up|1
350882|NCT00463567|1139211|P7|Overall Study|Death|0
350883|NCT00463567|1139212|P6|Overall Study|Death|0
350884|NCT00463567|1139213|P5|Overall Study|Death|0
350885|NCT00463567|1139214|P4|Overall Study|Death|0
350886|NCT00463567|1139215|P3|Overall Study|Death|2
350887|NCT00463567|1139216|P2|Overall Study|Death|0
350888|NCT00463567|1139217|P1|Overall Study|Death|1
350889|NCT00463567|1139211|P7|Overall Study|Abnormal test procedure result(s)|0
350890|NCT00463567|1139212|P6|Overall Study|Abnormal test procedure result(s)|2
350891|NCT00463567|1139213|P5|Overall Study|Abnormal test procedure result(s)|0
350892|NCT00463567|1139214|P4|Overall Study|Abnormal test procedure result(s)|2
350893|NCT00463567|1139215|P3|Overall Study|Abnormal test procedure result(s)|6
350894|NCT00463567|1139216|P2|Overall Study|Abnormal test procedure result(s)|1
350895|NCT00463567|1139217|P1|Overall Study|Abnormal test procedure result(s)|1
350896|NCT00463567|1139211|P7|Overall Study|Abnormal lab value(s)|0
350897|NCT00463567|1139212|P6|Overall Study|Abnormal lab value(s)|0
350898|NCT00463567|1139213|P5|Overall Study|Abnormal lab value(s)|1
350899|NCT00463567|1139214|P4|Overall Study|Abnormal lab value(s)|1
350900|NCT00463567|1139215|P3|Overall Study|Abnormal lab value(s)|2
350901|NCT00463567|1139216|P2|Overall Study|Abnormal lab value(s)|1
350902|NCT00463567|1139217|P1|Overall Study|Abnormal lab value(s)|1
350903|NCT00463567|1139211|P7|Overall Study|Lack of Efficacy|1
350904|NCT00463567|1139212|P6|Overall Study|Lack of Efficacy|0
350905|NCT00463567|1139213|P5|Overall Study|Lack of Efficacy|1
350906|NCT00463567|1139214|P4|Overall Study|Lack of Efficacy|17
350907|NCT00463567|1139215|P3|Overall Study|Lack of Efficacy|9
350908|NCT00463567|1139216|P2|Overall Study|Lack of Efficacy|9
350909|NCT00463567|1139217|P1|Overall Study|Lack of Efficacy|4
350910|NCT00463567|1139211|P7|Overall Study|Administrative problems|2
350911|NCT00463567|1139212|P6|Overall Study|Administrative problems|2
350912|NCT00463567|1139213|P5|Overall Study|Administrative problems|3
350913|NCT00463567|1139214|P4|Overall Study|Administrative problems|9
350914|NCT00463567|1139215|P3|Overall Study|Administrative problems|6
350915|NCT00463567|1139216|P2|Overall Study|Administrative problems|3
350916|NCT00463567|1139217|P1|Overall Study|Administrative problems|5
350917|NCT00463567|1139211|P7|Overall Study|Lost to Follow-up|1
350918|NCT00463567|1139212|P6|Overall Study|Lost to Follow-up|1
350919|NCT00463567|1139213|P5|Overall Study|Lost to Follow-up|1
350920|NCT00463567|1139214|P4|Overall Study|Lost to Follow-up|8
350921|NCT00463567|1139215|P3|Overall Study|Lost to Follow-up|13
350922|NCT00463567|1139216|P2|Overall Study|Lost to Follow-up|6
350923|NCT00463567|1139217|P1|Overall Study|Lost to Follow-up|12
350924|NCT00463567|1139211|P7|Overall Study|Protocol Deviation|2
350925|NCT00463567|1139212|P6|Overall Study|Protocol Deviation|1
350926|NCT00463567|1139213|P5|Overall Study|Protocol Deviation|1
350927|NCT00463567|1139214|P4|Overall Study|Protocol Deviation|11
350928|NCT00463567|1139215|P3|Overall Study|Protocol Deviation|14
350929|NCT00463567|1139216|P2|Overall Study|Protocol Deviation|9
350930|NCT00463567|1139217|P1|Overall Study|Protocol Deviation|13
350931|NCT00463567|1139211|P7|Overall Study|Withdrawal by Subject|1
350932|NCT00463567|1139212|P6|Overall Study|Withdrawal by Subject|5
350933|NCT00463567|1139213|P5|Overall Study|Withdrawal by Subject|6
350934|NCT00463567|1139214|P4|Overall Study|Withdrawal by Subject|37
350935|NCT00463567|1139215|P3|Overall Study|Withdrawal by Subject|20
350936|NCT00463567|1139216|P2|Overall Study|Withdrawal by Subject|22
350937|NCT00463567|1139217|P1|Overall Study|Withdrawal by Subject|29
350938|NCT00463567|1139211|P7|Overall Study|Adverse Event|4
350939|NCT00463567|1139212|P6|Overall Study|Adverse Event|10
350940|NCT00463567|1139213|P5|Overall Study|Adverse Event|10
350941|NCT00463567|1139214|P4|Overall Study|Adverse Event|46
350942|NCT00463567|1139215|P3|Overall Study|Adverse Event|17
350943|NCT00463567|1139216|P2|Overall Study|Adverse Event|26
350944|NCT00463567|1139217|P1|Overall Study|Adverse Event|29
350945|NCT00463437|1139252|P4|Overall Study|Other|7
350946|NCT00463437|1139253|P3|Overall Study|Other|6
350947|NCT00463437|1139254|P2|Overall Study|Other|11
350948|NCT00463437|1139255|P1|Overall Study|Other|4
350949|NCT00463385|1139321|P4|Overall Study|1 participant received commercial drug|0
350950|NCT00463385|1139322|P3|Overall Study|1 participant received commercial drug|0
350951|NCT00463385|1139323|P2|Overall Study|1 participant received commercial drug|1
350952|NCT00463385|1139324|P1|Overall Study|1 participant received commercial drug|0
350953|NCT00463385|1139321|P4|Overall Study|Missing|2
350954|NCT00463385|1139322|P3|Overall Study|Missing|0
350955|NCT00463385|1139323|P2|Overall Study|Missing|0
350956|NCT00463385|1139324|P1|Overall Study|Missing|2
350957|NCT00463385|1139321|P4|Overall Study|Death|0
350958|NCT00463385|1139322|P3|Overall Study|Death|2
350959|NCT00463385|1139323|P2|Overall Study|Death|1
350960|NCT00463385|1139324|P1|Overall Study|Death|2
350961|NCT00463385|1139321|P4|Overall Study|Lost to Follow-up|1
350962|NCT00463385|1139322|P3|Overall Study|Lost to Follow-up|0
350963|NCT00463385|1139323|P2|Overall Study|Lost to Follow-up|0
350964|NCT00463385|1139324|P1|Overall Study|Lost to Follow-up|0
350965|NCT00463385|1139321|P4|Overall Study|Withdrawal by Subject|4
350966|NCT00463385|1139322|P3|Overall Study|Withdrawal by Subject|3
350967|NCT00463385|1139323|P2|Overall Study|Withdrawal by Subject|3
350968|NCT00463385|1139324|P1|Overall Study|Withdrawal by Subject|3
350969|NCT00463385|1139321|P4|Overall Study|Lack of Efficacy|9
350970|NCT00463385|1139322|P3|Overall Study|Lack of Efficacy|7
350971|NCT00463385|1139323|P2|Overall Study|Lack of Efficacy|6
350972|NCT00463385|1139324|P1|Overall Study|Lack of Efficacy|6
350973|NCT00463385|1139321|P4|Overall Study|Adverse Event|2
350974|NCT00463385|1139322|P3|Overall Study|Adverse Event|4
350975|NCT00463385|1139323|P2|Overall Study|Adverse Event|8
350976|NCT00463385|1139324|P1|Overall Study|Adverse Event|5
350977|NCT00463385|1139321|P4|Overall Study|Unspecified|4
350978|NCT00463385|1139322|P3|Overall Study|Unspecified|6
350979|NCT00463385|1139323|P2|Overall Study|Unspecified|3
350980|NCT00463385|1139324|P1|Overall Study|Unspecified|4
350981|NCT00463346|1139376|P2|Overall Study|Withdrawal by Subject|3
350982|NCT00463346|1139377|P1|Overall Study|Withdrawal by Subject|3
350983|NCT00463229|1139387|P2|Overall Study|Death|3
350984|NCT00463229|1139388|P1|Overall Study|Death|4
350985|NCT00463229|1139387|P2|Overall Study|Lost to Follow-up|7
350986|NCT00463229|1139388|P1|Overall Study|Lost to Follow-up|5
350987|NCT00463047|1139394|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
350988|NCT00463047|1139395|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
350989|NCT00463047|1139394|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
350990|NCT00463047|1139395|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
350991|NCT00463047|1139394|P2|Double-Blind Treatment Period 2|Adverse Event|1
350992|NCT00463047|1139395|P1|Double-Blind Treatment Period 2|Adverse Event|0
350993|NCT00463047|1139394|P2|Double-Blind Treatment Period 1|Not specified|0
350994|NCT00463047|1139395|P1|Double-Blind Treatment Period 1|Not specified|1
350995|NCT00463047|1139394|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
350996|NCT00463047|1139395|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
350997|NCT00463047|1139394|P2|Double-Blind Treatment Period 1|Protocol Violation|2
350998|NCT00463047|1139395|P1|Double-Blind Treatment Period 1|Protocol Violation|1
350999|NCT00463047|1139394|P2|Double-Blind Treatment Period 1|Adverse Event|2
351000|NCT00463047|1139395|P1|Double-Blind Treatment Period 1|Adverse Event|0
351001|NCT00463047|1139394|P2|Titration Period 2|Not specified|2
351002|NCT00463047|1139395|P1|Titration Period 2|Not specified|3
351003|NCT00463047|1139394|P2|Titration Period 2|Non-compliance procedures|1
351004|NCT00463047|1139395|P1|Titration Period 2|Non-compliance procedures|4
351005|NCT00463047|1139394|P2|Titration Period 2|Non-compliance study medication|2
351006|NCT00463047|1139395|P1|Titration Period 2|Non-compliance study medication|4
351007|NCT00463047|1139394|P2|Titration Period 2|Lost to Follow-up|2
351008|NCT00463047|1139395|P1|Titration Period 2|Lost to Follow-up|1
351009|NCT00463047|1139394|P2|Titration Period 2|Protocol Violation|3
351010|NCT00463047|1139395|P1|Titration Period 2|Protocol Violation|2
351011|NCT00463047|1139394|P2|Titration Period 2|Withdrawal by Subject|0
351012|NCT00463047|1139395|P1|Titration Period 2|Withdrawal by Subject|1
351013|NCT00463047|1139394|P2|Titration Period 2|Lack of Efficacy|4
351014|NCT00463047|1139395|P1|Titration Period 2|Lack of Efficacy|6
351015|NCT00463047|1139394|P2|Titration Period 2|Adverse Event|9
351016|NCT00463047|1139395|P1|Titration Period 2|Adverse Event|9
351017|NCT00463047|1139394|P2|Titration Period 1|Not specified|2
351018|NCT00463047|1139395|P1|Titration Period 1|Not specified|0
351019|NCT00463047|1139394|P2|Titration Period 1|Non-compliance procedures|10
351020|NCT00463047|1139395|P1|Titration Period 1|Non-compliance procedures|4
351021|NCT00463047|1139394|P2|Titration Period 1|Withdrawal by Subject|5
351022|NCT00463047|1139395|P1|Titration Period 1|Withdrawal by Subject|3
351023|NCT00463047|1139394|P2|Titration Period 1|Protocol Violation|5
351024|NCT00463047|1139395|P1|Titration Period 1|Protocol Violation|5
351025|NCT00463047|1139394|P2|Titration Period 1|Non-compliance with study medication|5
351026|NCT00463047|1139395|P1|Titration Period 1|Non-compliance with study medication|3
351027|NCT00463047|1139394|P2|Titration Period 1|Lost to Follow-up|0
351028|NCT00463047|1139395|P1|Titration Period 1|Lost to Follow-up|2
351029|NCT00463047|1139394|P2|Titration Period 1|Lack of Efficacy|4
351030|NCT00463047|1139395|P1|Titration Period 1|Lack of Efficacy|10
351031|NCT00463047|1139394|P2|Titration Period 1|Adverse Event|8
351032|NCT00463047|1139395|P1|Titration Period 1|Adverse Event|10
351033|NCT00462982|1139480|P1|Overall Study|Patient Not Treated|2
351034|NCT00462982|1139480|P1|Overall Study|Adverse Event|1
351035|NCT00462943|1139487|P3|Overall Study|Withdrawal by Subject|0
351036|NCT00462943|1139488|P2|Overall Study|Withdrawal by Subject|1
351037|NCT00462943|1139489|P1|Overall Study|Withdrawal by Subject|0
351038|NCT00462943|1139487|P3|Overall Study|Physician Decision|0
351039|NCT00462943|1139488|P2|Overall Study|Physician Decision|0
351040|NCT00462943|1139489|P1|Overall Study|Physician Decision|1
351041|NCT00462943|1139487|P3|Overall Study|Transplant - not specified|1
351042|NCT00462943|1139488|P2|Overall Study|Transplant - not specified|0
351043|NCT00462943|1139489|P1|Overall Study|Transplant - not specified|1
351044|NCT00462943|1139487|P3|Overall Study|Required Lymphocyte Infusion|0
351045|NCT00462943|1139488|P2|Overall Study|Required Lymphocyte Infusion|0
351046|NCT00462943|1139489|P1|Overall Study|Required Lymphocyte Infusion|1
351047|NCT00462943|1139487|P3|Overall Study|Bone Marrow Transplant|0
351048|NCT00462943|1139488|P2|Overall Study|Bone Marrow Transplant|0
351049|NCT00462943|1139489|P1|Overall Study|Bone Marrow Transplant|1
351050|NCT00462943|1139487|P3|Overall Study|Stem Cell Transplant|0
351051|NCT00462943|1139488|P2|Overall Study|Stem Cell Transplant|1
351052|NCT00462943|1139489|P1|Overall Study|Stem Cell Transplant|1
351053|NCT00462943|1139487|P3|Overall Study|Death|7
351054|NCT00462943|1139488|P2|Overall Study|Death|2
351055|NCT00462943|1139489|P1|Overall Study|Death|5
351056|NCT00462943|1139487|P3|Overall Study|Disease Progression|9
351057|NCT00462943|1139488|P2|Overall Study|Disease Progression|15
351058|NCT00462943|1139489|P1|Overall Study|Disease Progression|15
351059|NCT00462943|1139487|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
351060|NCT00462943|1139488|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
351061|NCT00462943|1139489|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
351062|NCT00462943|1139487|P3|Overall Study|Protocol Violation|0
351063|NCT00462943|1139488|P2|Overall Study|Protocol Violation|0
351064|NCT00462943|1139489|P1|Overall Study|Protocol Violation|1
351065|NCT00462943|1139487|P3|Overall Study|Adverse Event|1
351066|NCT00462943|1139488|P2|Overall Study|Adverse Event|4
351067|NCT00462943|1139489|P1|Overall Study|Adverse Event|6
351068|NCT00462943|1139487|P3|Overall Study|Failure to achieve a response|1
351069|NCT00462943|1139488|P2|Overall Study|Failure to achieve a response|5
351070|NCT00462943|1139489|P1|Overall Study|Failure to achieve a response|5
351071|NCT00462865|1139581|P1|Overall Study|Adverse Event|1
351072|NCT00462826|1139600|P1|Overall Study|Never treated|1
351073|NCT00462826|1139600|P1|Overall Study|Ineligible - wrong primary|2
351074|NCT00462826|1139600|P1|Overall Study|Ineligible - wrong cell type|1
351075|NCT00462826|1139600|P1|Overall Study|Ineligible - second primary|1
351076|NCT00462748|1139607|P3|Overall Study|Discontinued after 41 days Rx|0
351077|NCT00462748|1139608|P2|Overall Study|Discontinued after 41 days Rx|0
351078|NCT00462748|1139609|P1|Overall Study|Discontinued after 41 days Rx|1
351079|NCT00462748|1139607|P3|Overall Study|Lost to Follow-up|1
351080|NCT00462748|1139608|P2|Overall Study|Lost to Follow-up|1
351081|NCT00462748|1139609|P1|Overall Study|Lost to Follow-up|1
351082|NCT00462748|1139607|P3|Overall Study|Withdrew consent|0
351083|NCT00462748|1139608|P2|Overall Study|Withdrew consent|3
351084|NCT00462748|1139609|P1|Overall Study|Withdrew consent|3
351085|NCT00462748|1139607|P3|Overall Study|Protocol Violation|1
351086|NCT00462748|1139608|P2|Overall Study|Protocol Violation|2
351087|NCT00462748|1139609|P1|Overall Study|Protocol Violation|0
351088|NCT00462748|1139607|P3|Overall Study|Adverse Event|9
351089|NCT00462748|1139608|P2|Overall Study|Adverse Event|5
351090|NCT00462748|1139609|P1|Overall Study|Adverse Event|7
351091|NCT00462709|1139654|P1|Overall Study|Withdrew to start treatment with Cetor|1
351092|NCT00462709|1139654|P1|Overall Study|Physician Decision|1
351093|NCT00462709|1139654|P1|Overall Study|Logistical reasons|2
351094|NCT00462709|1139654|P1|Overall Study|Death|2
351095|NCT00462709|1139654|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
351096|NCT00462709|1139654|P1|Overall Study|Withdrawal by Subject|8
351097|NCT00462709|1139654|P1|Overall Study|Lost to Follow-up|10
351098|NCT00462709|1139654|P1|Overall Study|Transitioned to commercial C1INH-nf|40
351099|NCT00462670|1139663|P2|Overall Study|Resolution of signs and symptoms|2
351100|NCT00462670|1139664|P1|Overall Study|Resolution of signs and symptoms|0
351101|NCT00462670|1139663|P2|Overall Study|Protocol Violation|0
351102|NCT00462670|1139664|P1|Overall Study|Protocol Violation|1
351103|NCT00462670|1139663|P2|Overall Study|Lack of Efficacy|0
351104|NCT00462670|1139664|P1|Overall Study|Lack of Efficacy|1
351105|NCT00462670|1139663|P2|Overall Study|Adverse Event|5
351106|NCT00462670|1139664|P1|Overall Study|Adverse Event|3
351107|NCT00462501|1139697|P1|Overall Study|Adverse Event|2
351108|NCT00462501|1139697|P1|Overall Study|Not treated|3
351109|NCT00462462|1139703|P2|Overall Study|Physician Decision|1
351110|NCT00462462|1139704|P1|Overall Study|Physician Decision|0
351111|NCT00462384|1139732|P1|Overall Study|Unspecified|4
351112|NCT00462384|1139732|P1|Overall Study|Withdrawal by Subject|1
351113|NCT00462384|1139732|P1|Overall Study|Death|2
351114|NCT00462384|1139732|P1|Overall Study|Adverse Event|2
351115|NCT00462345|1139740|P1|Overall Study|Did not complete second course|1
351116|NCT00462345|1139740|P1|Overall Study|Withdrawal by Subject|2
351117|NCT00462306|1139775|P2|Overall Study|insufficient data|13
351118|NCT00462306|1139776|P1|Overall Study|insufficient data|0
351119|NCT00461981|1139902|P2|Overall Study|Withdrawal by Subject|3
351120|NCT00461981|1139903|P1|Overall Study|Withdrawal by Subject|2
351121|NCT00461981|1139902|P2|Overall Study|Lost to Follow-up|6
351122|NCT00461981|1139903|P1|Overall Study|Lost to Follow-up|9
351123|NCT00461786|1140017|P1|Overall Study|Inevaluable (Never Treated)|1
351124|NCT00461786|1140017|P1|Overall Study|Entry Criteria Not Met|2
351125|NCT00461708|1140062|P2|Overall Study|Death|1
351126|NCT00461708|1140063|P1|Overall Study|Death|8
351127|NCT00461708|1140062|P2|Overall Study|Not specified|4
351128|NCT00461708|1140063|P1|Overall Study|Not specified|4
351129|NCT00461708|1140062|P2|Overall Study|Withdrawal by Subject|2
351130|NCT00461708|1140063|P1|Overall Study|Withdrawal by Subject|8
351131|NCT00461708|1140062|P2|Overall Study|Physician Decision|4
351132|NCT00461708|1140063|P1|Overall Study|Physician Decision|10
351133|NCT00461708|1140062|P2|Overall Study|Lack of Efficacy|20
351134|NCT00461708|1140063|P1|Overall Study|Lack of Efficacy|68
351135|NCT00461708|1140062|P2|Overall Study|Adverse Event|7
351136|NCT00461708|1140063|P1|Overall Study|Adverse Event|17
351137|NCT00461682|1140089|P1|Overall Study|Protocol Violation|1
351138|NCT00461630|1140117|P2|Overall Study|Lost to Follow-up|95
351139|NCT00461630|1140118|P1|Overall Study|Lost to Follow-up|108
351140|NCT00461630|1140117|P2|Overall Study|Death|732
351141|NCT00461630|1140118|P1|Overall Study|Death|798
351142|NCT00461500|1140143|P2|Overall Study|Lost to Follow-up|2
351143|NCT00461500|1140144|P1|Overall Study|Lost to Follow-up|2
351144|NCT00461500|1140143|P2|Overall Study|No Longer Willing to Take Part in Study|0
351145|NCT00461500|1140144|P1|Overall Study|No Longer Willing to Take Part in Study|1
351146|NCT00461500|1140143|P2|Overall Study|Drug Treatment Misuse|0
351147|NCT00461500|1140144|P1|Overall Study|Drug Treatment Misuse|1
351148|NCT00461500|1140143|P2|Overall Study|Study Stopped|2
351149|NCT00461500|1140144|P1|Overall Study|Study Stopped|1
351150|NCT00461500|1140143|P2|Overall Study|Expired Drug Treatment|1
351151|NCT00461500|1140144|P1|Overall Study|Expired Drug Treatment|1
351152|NCT00461500|1140143|P2|Overall Study|Lack of Efficacy|1
351153|NCT00461500|1140144|P1|Overall Study|Lack of Efficacy|0
351154|NCT00461500|1140143|P2|Overall Study|Adverse Event|0
351155|NCT00461500|1140144|P1|Overall Study|Adverse Event|1
351156|NCT00461305|1140187|P2|Continued Treatment|Other (missing drug etc)|0
351157|NCT00461305|1140188|P1|Continued Treatment|Other (missing drug etc)|2
351158|NCT00461305|1140187|P2|Continued Treatment|Partially missing diary|0
351159|NCT00461305|1140188|P1|Continued Treatment|Partially missing diary|2
351160|NCT00461305|1140187|P2|Continued Treatment|Withdrawal by Subject|0
351161|NCT00461305|1140188|P1|Continued Treatment|Withdrawal by Subject|48
351162|NCT00461305|1140187|P2|Continued Treatment|Protocol Violation|0
351163|NCT00461305|1140188|P1|Continued Treatment|Protocol Violation|13
351164|NCT00461305|1140187|P2|Continued Treatment|Lost to Follow-up|0
351165|NCT00461305|1140188|P1|Continued Treatment|Lost to Follow-up|4
351166|NCT00461305|1140187|P2|Continued Treatment|Adverse Event|0
351167|NCT00461305|1140188|P1|Continued Treatment|Adverse Event|26
351168|NCT00461305|1140187|P2|Treatment|Other (missing drug etc)|0
351169|NCT00461305|1140188|P1|Treatment|Other (missing drug etc)|2
351170|NCT00461305|1140187|P2|Treatment|Partially missing diary|0
351171|NCT00461305|1140188|P1|Treatment|Partially missing diary|2
351172|NCT00461305|1140187|P2|Treatment|Study drug not taken|0
351173|NCT00461305|1140188|P1|Treatment|Study drug not taken|1
351174|NCT00461305|1140187|P2|Treatment|Never dispensed|0
351175|NCT00461305|1140188|P1|Treatment|Never dispensed|5
351176|NCT00461305|1140187|P2|Treatment|Withdrawal by Subject|2
351177|NCT00461305|1140188|P1|Treatment|Withdrawal by Subject|48
351178|NCT00461305|1140187|P2|Treatment|Protocol Violation|2
351179|NCT00461305|1140188|P1|Treatment|Protocol Violation|13
351180|NCT00461305|1140187|P2|Treatment|Lost to Follow-up|2
351181|NCT00461305|1140188|P1|Treatment|Lost to Follow-up|4
351182|NCT00461305|1140187|P2|Treatment|Adverse Event|3
351183|NCT00461305|1140188|P1|Treatment|Adverse Event|26
351184|NCT00461253|1140272|P2|Overall Study|administrative|7773
351185|NCT00461253|1140273|P1|Overall Study|administrative|773
351186|NCT00461253|1140272|P2|Overall Study|no response|11789
351187|NCT00461253|1140273|P1|Overall Study|no response|2609
351188|NCT00461253|1140272|P2|Overall Study|Protocol Violation|236
351189|NCT00461253|1140273|P1|Overall Study|Protocol Violation|613
351190|NCT00461253|1140272|P2|Overall Study|Death|0
351191|NCT00461253|1140273|P1|Overall Study|Death|985
351192|NCT00461175|1140281|P2|Overall Study|Protocol Violation|365
351193|NCT00461175|1140282|P1|Overall Study|Protocol Violation|522
351194|NCT00461123|1140292|P2|Overall Study|Withdrawal by Subject|3
351195|NCT00461123|1140293|P1|Overall Study|Withdrawal by Subject|1
351196|NCT00461123|1140292|P2|Overall Study|Protocol Violation|2
351197|NCT00461123|1140293|P1|Overall Study|Protocol Violation|3
351198|NCT00461123|1140292|P2|Overall Study|Lost to Follow-up|1
351199|NCT00461123|1140293|P1|Overall Study|Lost to Follow-up|1
351200|NCT00461123|1140292|P2|Overall Study|Adverse Event|0
351201|NCT00461123|1140293|P1|Overall Study|Adverse Event|1
351202|NCT00461032|1140328|P2|Overall Study|Not Specified|5
351203|NCT00461032|1140329|P1|Overall Study|Not Specified|7
351204|NCT00461032|1140328|P2|Overall Study|Patient Moved or Relocated|1
351205|NCT00461032|1140329|P1|Overall Study|Patient Moved or Relocated|2
351206|NCT00461032|1140328|P2|Overall Study|Withdrawal by Subject|15
351207|NCT00461032|1140329|P1|Overall Study|Withdrawal by Subject|7
351208|NCT00461032|1140328|P2|Overall Study|Protocol Violation|4
351209|NCT00461032|1140329|P1|Overall Study|Protocol Violation|4
351210|NCT00461032|1140328|P2|Overall Study|Lost to Follow-up|12
351211|NCT00461032|1140329|P1|Overall Study|Lost to Follow-up|7
351212|NCT00461032|1140328|P2|Overall Study|Lack of Efficacy|1
351213|NCT00461032|1140329|P1|Overall Study|Lack of Efficacy|5
351214|NCT00461032|1140328|P2|Overall Study|Adverse Event|6
351215|NCT00461032|1140329|P1|Overall Study|Adverse Event|5
351216|NCT00460811|1140355|P5|Overall Study|Lost to Follow-up|6
351217|NCT00460811|1140356|P4|Overall Study|Lost to Follow-up|3
351218|NCT00460811|1140357|P3|Overall Study|Lost to Follow-up|5
351219|NCT00460811|1140358|P2|Overall Study|Lost to Follow-up|2
351220|NCT00460811|1140359|P1|Overall Study|Lost to Follow-up|3
351221|NCT00460811|1140355|P5|Overall Study|Physician Decision|0
351222|NCT00460811|1140356|P4|Overall Study|Physician Decision|0
351223|NCT00460811|1140357|P3|Overall Study|Physician Decision|0
351224|NCT00460811|1140358|P2|Overall Study|Physician Decision|0
351225|NCT00460811|1140359|P1|Overall Study|Physician Decision|1
351226|NCT00460811|1140355|P5|Overall Study|Withdrawal by Subject|11
351227|NCT00460811|1140356|P4|Overall Study|Withdrawal by Subject|3
351228|NCT00460811|1140357|P3|Overall Study|Withdrawal by Subject|6
351229|NCT00460811|1140358|P2|Overall Study|Withdrawal by Subject|7
351230|NCT00460811|1140359|P1|Overall Study|Withdrawal by Subject|7
351231|NCT00460811|1140355|P5|Overall Study|Noncompliance|1
351232|NCT00460811|1140356|P4|Overall Study|Noncompliance|2
351233|NCT00460811|1140357|P3|Overall Study|Noncompliance|0
351234|NCT00460811|1140358|P2|Overall Study|Noncompliance|0
351235|NCT00460811|1140359|P1|Overall Study|Noncompliance|1
351236|NCT00460811|1140355|P5|Overall Study|Adverse Event|2
351237|NCT00460811|1140356|P4|Overall Study|Adverse Event|10
351238|NCT00460811|1140357|P3|Overall Study|Adverse Event|3
351239|NCT00460811|1140358|P2|Overall Study|Adverse Event|6
351240|NCT00460811|1140359|P1|Overall Study|Adverse Event|4
351241|NCT00460798|1140401|P1|Overall Study|Missing/Incomplete Dosing Information|27
351242|NCT00460798|1140401|P1|Overall Study|Ongoing at Date of Cut-Off|82
351243|NCT00460798|1140401|P1|Overall Study|Unspecified|27
351244|NCT00460798|1140401|P1|Overall Study|Progressive Disease|99
351245|NCT00460798|1140401|P1|Overall Study|Lost to Follow-up|19
351246|NCT00460798|1140401|P1|Overall Study|Adverse Event|27
351247|NCT00460798|1140401|P1|Overall Study|Death|59
351248|NCT00460746|1140409|P1|Overall Study|Lost to Follow-up|1
351249|NCT00460746|1140409|P1|Overall Study|Adverse Event|1
351250|NCT00460655|1140424|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
351251|NCT00460655|1140425|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
351252|NCT00460655|1140426|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
351253|NCT00460655|1140427|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
351254|NCT00460655|1140424|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
351255|NCT00460655|1140425|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
351256|NCT00460655|1140426|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
351257|NCT00460655|1140427|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
351258|NCT00460655|1140424|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
351259|NCT00460655|1140425|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
351260|NCT00460655|1140426|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
351261|NCT00460655|1140427|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
351262|NCT00460655|1140424|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
351263|NCT00460655|1140425|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
351264|NCT00460655|1140426|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
351265|NCT00460655|1140427|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
351266|NCT00460655|1140424|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351267|NCT00460655|1140425|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351268|NCT00460655|1140426|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351269|NCT00460655|1140427|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
351270|NCT00460655|1140424|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
351271|NCT00460655|1140425|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
351272|NCT00460655|1140426|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
351273|NCT00460655|1140427|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
351274|NCT00460603|1140471|P12|Phase 2|Randomized, but not treated|0
351275|NCT00460603|1140472|P11|Phase 2|Randomized, but not treated|0
351276|NCT00460603|1140473|P10|Phase 2|Randomized, but not treated|3
351277|NCT00460603|1140474|P9|Phase 2|Randomized, but not treated|0
351278|NCT00460603|1140475|P8|Phase 2|Randomized, but not treated|0
351279|NCT00460603|1140476|P7|Phase 2|Randomized, but not treated|0
351280|NCT00460603|1140477|P6|Phase 2|Randomized, but not treated|0
351281|NCT00460603|1140478|P5|Phase 2|Randomized, but not treated|0
351282|NCT00460603|1140479|P4|Phase 2|Randomized, but not treated|0
351283|NCT00460603|1140480|P3|Phase 2|Randomized, but not treated|0
351284|NCT00460603|1140481|P2|Phase 2|Randomized, but not treated|0
351285|NCT00460603|1140482|P1|Phase 2|Randomized, but not treated|0
351286|NCT00460603|1140471|P12|Phase 2|Withdrawal by Subject|5
351287|NCT00460603|1140472|P11|Phase 2|Withdrawal by Subject|4
351288|NCT00460603|1140473|P10|Phase 2|Withdrawal by Subject|5
351289|NCT00460603|1140474|P9|Phase 2|Withdrawal by Subject|0
351290|NCT00460603|1140475|P8|Phase 2|Withdrawal by Subject|0
351291|NCT00460603|1140476|P7|Phase 2|Withdrawal by Subject|0
351292|NCT00460603|1140477|P6|Phase 2|Withdrawal by Subject|0
351293|NCT00460603|1140478|P5|Phase 2|Withdrawal by Subject|0
351294|NCT00460603|1140479|P4|Phase 2|Withdrawal by Subject|0
351295|NCT00460603|1140480|P3|Phase 2|Withdrawal by Subject|0
351296|NCT00460603|1140481|P2|Phase 2|Withdrawal by Subject|0
351297|NCT00460603|1140482|P1|Phase 2|Withdrawal by Subject|0
351298|NCT00460603|1140471|P12|Phase 2|Global Deterioration of Health Status|0
351299|NCT00460603|1140472|P11|Phase 2|Global Deterioration of Health Status|1
351300|NCT00460603|1140473|P10|Phase 2|Global Deterioration of Health Status|0
351301|NCT00460603|1140474|P9|Phase 2|Global Deterioration of Health Status|0
351302|NCT00460603|1140475|P8|Phase 2|Global Deterioration of Health Status|0
351303|NCT00460603|1140476|P7|Phase 2|Global Deterioration of Health Status|0
351304|NCT00460603|1140477|P6|Phase 2|Global Deterioration of Health Status|0
351305|NCT00460603|1140478|P5|Phase 2|Global Deterioration of Health Status|0
351306|NCT00460603|1140479|P4|Phase 2|Global Deterioration of Health Status|0
351307|NCT00460603|1140480|P3|Phase 2|Global Deterioration of Health Status|0
351308|NCT00460603|1140481|P2|Phase 2|Global Deterioration of Health Status|0
351309|NCT00460603|1140482|P1|Phase 2|Global Deterioration of Health Status|0
351310|NCT00460603|1140471|P12|Phase 2|Objective Progression or Relapse|17
351311|NCT00460603|1140472|P11|Phase 2|Objective Progression or Relapse|10
351312|NCT00460603|1140473|P10|Phase 2|Objective Progression or Relapse|9
351313|NCT00460603|1140474|P9|Phase 2|Objective Progression or Relapse|0
351314|NCT00460603|1140475|P8|Phase 2|Objective Progression or Relapse|0
351315|NCT00460603|1140476|P7|Phase 2|Objective Progression or Relapse|0
351316|NCT00460603|1140477|P6|Phase 2|Objective Progression or Relapse|0
351317|NCT00460603|1140478|P5|Phase 2|Objective Progression or Relapse|0
351318|NCT00460603|1140479|P4|Phase 2|Objective Progression or Relapse|0
351319|NCT00460603|1140480|P3|Phase 2|Objective Progression or Relapse|0
351320|NCT00460603|1140481|P2|Phase 2|Objective Progression or Relapse|0
351321|NCT00460603|1140482|P1|Phase 2|Objective Progression or Relapse|0
351322|NCT00460603|1140471|P12|Phase 2|Unspecified|7
351323|NCT00460603|1140472|P11|Phase 2|Unspecified|16
351324|NCT00460603|1140473|P10|Phase 2|Unspecified|6
351325|NCT00460603|1140474|P9|Phase 2|Unspecified|0
351326|NCT00460603|1140475|P8|Phase 2|Unspecified|0
351327|NCT00460603|1140476|P7|Phase 2|Unspecified|0
351328|NCT00460603|1140477|P6|Phase 2|Unspecified|0
351329|NCT00460603|1140478|P5|Phase 2|Unspecified|0
351330|NCT00460603|1140479|P4|Phase 2|Unspecified|0
351331|NCT00460603|1140480|P3|Phase 2|Unspecified|0
351332|NCT00460603|1140481|P2|Phase 2|Unspecified|0
351333|NCT00460603|1140482|P1|Phase 2|Unspecified|0
351334|NCT00460603|1140471|P12|Phase 2|Lost to Follow-up|0
351335|NCT00460603|1140472|P11|Phase 2|Lost to Follow-up|0
351336|NCT00460603|1140473|P10|Phase 2|Lost to Follow-up|1
351337|NCT00460603|1140474|P9|Phase 2|Lost to Follow-up|0
351338|NCT00460603|1140475|P8|Phase 2|Lost to Follow-up|0
351339|NCT00460603|1140476|P7|Phase 2|Lost to Follow-up|0
351340|NCT00460603|1140477|P6|Phase 2|Lost to Follow-up|0
351341|NCT00460603|1140478|P5|Phase 2|Lost to Follow-up|0
351342|NCT00460603|1140479|P4|Phase 2|Lost to Follow-up|0
351343|NCT00460603|1140480|P3|Phase 2|Lost to Follow-up|0
351344|NCT00460603|1140481|P2|Phase 2|Lost to Follow-up|0
351345|NCT00460603|1140482|P1|Phase 2|Lost to Follow-up|0
351346|NCT00460603|1140471|P12|Phase 2|Protocol Violation|0
351347|NCT00460603|1140472|P11|Phase 2|Protocol Violation|1
351348|NCT00460603|1140473|P10|Phase 2|Protocol Violation|1
351349|NCT00460603|1140474|P9|Phase 2|Protocol Violation|0
351350|NCT00460603|1140475|P8|Phase 2|Protocol Violation|0
351351|NCT00460603|1140476|P7|Phase 2|Protocol Violation|0
351352|NCT00460603|1140477|P6|Phase 2|Protocol Violation|0
351353|NCT00460603|1140478|P5|Phase 2|Protocol Violation|0
351354|NCT00460603|1140479|P4|Phase 2|Protocol Violation|0
351355|NCT00460603|1140480|P3|Phase 2|Protocol Violation|0
351356|NCT00460603|1140481|P2|Phase 2|Protocol Violation|0
351357|NCT00460603|1140482|P1|Phase 2|Protocol Violation|0
351358|NCT00460603|1140471|P12|Phase 2|Death|2
351359|NCT00460603|1140472|P11|Phase 2|Death|2
351360|NCT00460603|1140473|P10|Phase 2|Death|4
351361|NCT00460603|1140474|P9|Phase 2|Death|0
351362|NCT00460603|1140475|P8|Phase 2|Death|0
351363|NCT00460603|1140476|P7|Phase 2|Death|0
351364|NCT00460603|1140477|P6|Phase 2|Death|0
351365|NCT00460603|1140478|P5|Phase 2|Death|0
351366|NCT00460603|1140479|P4|Phase 2|Death|0
351367|NCT00460603|1140480|P3|Phase 2|Death|0
351368|NCT00460603|1140481|P2|Phase 2|Death|0
351369|NCT00460603|1140482|P1|Phase 2|Death|0
351370|NCT00460603|1140471|P12|Phase 2|Adverse Event|10
351371|NCT00460603|1140472|P11|Phase 2|Adverse Event|9
351372|NCT00460603|1140473|P10|Phase 2|Adverse Event|12
351373|NCT00460603|1140474|P9|Phase 2|Adverse Event|0
351374|NCT00460603|1140475|P8|Phase 2|Adverse Event|0
351375|NCT00460603|1140476|P7|Phase 2|Adverse Event|0
351376|NCT00460603|1140477|P6|Phase 2|Adverse Event|0
351377|NCT00460603|1140478|P5|Phase 2|Adverse Event|0
351378|NCT00460603|1140479|P4|Phase 2|Adverse Event|0
351379|NCT00460603|1140480|P3|Phase 2|Adverse Event|0
351380|NCT00460603|1140481|P2|Phase 2|Adverse Event|0
351381|NCT00460603|1140482|P1|Phase 2|Adverse Event|0
351382|NCT00460603|1140471|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351383|NCT00460603|1140472|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351384|NCT00460603|1140473|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
351385|NCT00460603|1140474|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351386|NCT00460603|1140475|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351387|NCT00460603|1140476|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351388|NCT00460603|1140477|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351389|NCT00460603|1140478|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351390|NCT00460603|1140479|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351391|NCT00460603|1140480|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351392|NCT00460603|1140481|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351393|NCT00460603|1140482|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
351394|NCT00460603|1140471|P12|Phase 1|Unspecified|0
351395|NCT00460603|1140472|P11|Phase 1|Unspecified|0
351396|NCT00460603|1140473|P10|Phase 1|Unspecified|0
351397|NCT00460603|1140474|P9|Phase 1|Unspecified|0
351398|NCT00460603|1140475|P8|Phase 1|Unspecified|1
351399|NCT00460603|1140476|P7|Phase 1|Unspecified|0
351400|NCT00460603|1140477|P6|Phase 1|Unspecified|2
351401|NCT00460603|1140478|P5|Phase 1|Unspecified|1
351402|NCT00460603|1140479|P4|Phase 1|Unspecified|1
351403|NCT00460603|1140480|P3|Phase 1|Unspecified|1
351404|NCT00460603|1140481|P2|Phase 1|Unspecified|3
351405|NCT00460603|1140482|P1|Phase 1|Unspecified|0
351406|NCT00460603|1140471|P12|Phase 1|Withdrawal by Subject|0
351407|NCT00460603|1140472|P11|Phase 1|Withdrawal by Subject|0
351408|NCT00460603|1140473|P10|Phase 1|Withdrawal by Subject|0
351409|NCT00460603|1140474|P9|Phase 1|Withdrawal by Subject|2
351410|NCT00460603|1140475|P8|Phase 1|Withdrawal by Subject|0
351411|NCT00460603|1140476|P7|Phase 1|Withdrawal by Subject|1
351412|NCT00460603|1140477|P6|Phase 1|Withdrawal by Subject|0
351413|NCT00460603|1140478|P5|Phase 1|Withdrawal by Subject|3
351414|NCT00460603|1140479|P4|Phase 1|Withdrawal by Subject|1
351415|NCT00460603|1140480|P3|Phase 1|Withdrawal by Subject|1
351416|NCT00460603|1140481|P2|Phase 1|Withdrawal by Subject|2
351417|NCT00460603|1140482|P1|Phase 1|Withdrawal by Subject|1
351418|NCT00460603|1140471|P12|Phase 1|Lack of Efficacy|0
351419|NCT00460603|1140472|P11|Phase 1|Lack of Efficacy|0
351420|NCT00460603|1140473|P10|Phase 1|Lack of Efficacy|0
351421|NCT00460603|1140474|P9|Phase 1|Lack of Efficacy|11
351422|NCT00460603|1140475|P8|Phase 1|Lack of Efficacy|2
351423|NCT00460603|1140476|P7|Phase 1|Lack of Efficacy|2
351424|NCT00460603|1140477|P6|Phase 1|Lack of Efficacy|2
351425|NCT00460603|1140478|P5|Phase 1|Lack of Efficacy|2
351426|NCT00460603|1140479|P4|Phase 1|Lack of Efficacy|2
351427|NCT00460603|1140480|P3|Phase 1|Lack of Efficacy|1
351428|NCT00460603|1140481|P2|Phase 1|Lack of Efficacy|0
351429|NCT00460603|1140482|P1|Phase 1|Lack of Efficacy|1
351430|NCT00460603|1140471|P12|Phase 1|Adverse Event|0
351431|NCT00460603|1140472|P11|Phase 1|Adverse Event|0
351432|NCT00460603|1140473|P10|Phase 1|Adverse Event|0
351433|NCT00460603|1140474|P9|Phase 1|Adverse Event|4
351434|NCT00460603|1140475|P8|Phase 1|Adverse Event|0
351435|NCT00460603|1140476|P7|Phase 1|Adverse Event|3
351436|NCT00460603|1140477|P6|Phase 1|Adverse Event|0
351437|NCT00460603|1140478|P5|Phase 1|Adverse Event|0
351438|NCT00460603|1140479|P4|Phase 1|Adverse Event|2
351439|NCT00460603|1140480|P3|Phase 1|Adverse Event|1
351440|NCT00460603|1140481|P2|Phase 1|Adverse Event|1
351441|NCT00460603|1140482|P1|Phase 1|Adverse Event|3
351442|NCT00460603|1140471|P12|Phase 1|Death|0
351443|NCT00460603|1140472|P11|Phase 1|Death|0
351444|NCT00460603|1140473|P10|Phase 1|Death|0
351445|NCT00460603|1140474|P9|Phase 1|Death|1
351446|NCT00460603|1140475|P8|Phase 1|Death|0
351447|NCT00460603|1140476|P7|Phase 1|Death|0
351448|NCT00460603|1140477|P6|Phase 1|Death|0
351449|NCT00460603|1140478|P5|Phase 1|Death|0
351450|NCT00460603|1140479|P4|Phase 1|Death|2
351451|NCT00460603|1140480|P3|Phase 1|Death|0
351452|NCT00460603|1140481|P2|Phase 1|Death|0
351453|NCT00460603|1140482|P1|Phase 1|Death|1
351454|NCT00460577|1140576|P2|Overall Study|Protocol Violation|6
351455|NCT00460577|1140577|P1|Overall Study|Protocol Violation|2
351456|NCT00460564|1140595|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
351457|NCT00460564|1140596|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
351458|NCT00460564|1140597|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
351459|NCT00460564|1140598|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
351460|NCT00460564|1140599|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
351461|NCT00460564|1140600|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
351462|NCT00460564|1140601|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
351463|NCT00460564|1140602|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
351464|NCT00460564|1140595|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
351465|NCT00460564|1140596|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
351466|NCT00460564|1140597|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
351467|NCT00460564|1140598|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
351468|NCT00460564|1140599|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
351469|NCT00460564|1140600|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
351470|NCT00460564|1140601|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
351471|NCT00460564|1140602|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
351472|NCT00460564|1140595|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
351473|NCT00460564|1140596|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
351474|NCT00460564|1140597|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
351475|NCT00460564|1140598|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
351476|NCT00460564|1140599|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
351477|NCT00460564|1140600|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
351478|NCT00460564|1140601|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
351479|NCT00460564|1140602|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
351480|NCT00460564|1140595|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351481|NCT00460564|1140596|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351482|NCT00460564|1140597|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351483|NCT00460564|1140598|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351484|NCT00460564|1140599|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351485|NCT00460564|1140600|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351486|NCT00460564|1140601|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
351487|NCT00460564|1140602|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
351488|NCT00460564|1140595|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
351489|NCT00460564|1140596|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
351490|NCT00460564|1140597|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
351491|NCT00460564|1140598|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
351492|NCT00460564|1140599|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
351493|NCT00460564|1140600|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
351494|NCT00460564|1140601|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
351495|NCT00460564|1140602|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
351496|NCT00460408|1140797|P4|Overall Study|Unspecified|0
351497|NCT00460408|1140798|P3|Overall Study|Unspecified|0
351498|NCT00460408|1140799|P2|Overall Study|Unspecified|2
351499|NCT00460408|1140800|P1|Overall Study|Unspecified|12
351500|NCT00460408|1140797|P4|Overall Study|Insufficient clinical response|0
351501|NCT00460408|1140798|P3|Overall Study|Insufficient clinical response|5
351502|NCT00460408|1140799|P2|Overall Study|Insufficient clinical response|1
351503|NCT00460408|1140800|P1|Overall Study|Insufficient clinical response|5
351504|NCT00460408|1140797|P4|Overall Study|Withdrawal by Subject|0
351505|NCT00460408|1140798|P3|Overall Study|Withdrawal by Subject|0
351506|NCT00460408|1140799|P2|Overall Study|Withdrawal by Subject|0
351507|NCT00460408|1140800|P1|Overall Study|Withdrawal by Subject|31
351508|NCT00460408|1140797|P4|Overall Study|Lost to Follow-up|0
351509|NCT00460408|1140798|P3|Overall Study|Lost to Follow-up|1
351510|NCT00460408|1140799|P2|Overall Study|Lost to Follow-up|0
351511|NCT00460408|1140800|P1|Overall Study|Lost to Follow-up|11
351512|NCT00460408|1140797|P4|Overall Study|Death|0
351513|NCT00460408|1140798|P3|Overall Study|Death|0
351514|NCT00460408|1140799|P2|Overall Study|Death|0
351515|NCT00460408|1140800|P1|Overall Study|Death|7
351516|NCT00460408|1140797|P4|Overall Study|Adverse Event|0
351517|NCT00460408|1140798|P3|Overall Study|Adverse Event|0
351518|NCT00460408|1140799|P2|Overall Study|Adverse Event|0
351519|NCT00460408|1140800|P1|Overall Study|Adverse Event|1
351520|NCT00460265|1140837|P2|Overall Study|Ongoing|47
351521|NCT00460265|1140838|P1|Overall Study|Ongoing|60
351522|NCT00460265|1140837|P2|Overall Study|Withdrawal by Subject|25
351523|NCT00460265|1140838|P1|Overall Study|Withdrawal by Subject|10
351524|NCT00460265|1140837|P2|Overall Study|Physician Decision|2
351525|NCT00460265|1140838|P1|Overall Study|Physician Decision|1
351526|NCT00460265|1140837|P2|Overall Study|Lost to Follow-up|15
351527|NCT00460265|1140838|P1|Overall Study|Lost to Follow-up|14
351528|NCT00460239|1140854|P9|Overall Study|Withdrawal by Subject|0
351529|NCT00460239|1140855|P8|Overall Study|Withdrawal by Subject|0
351530|NCT00460239|1140856|P7|Overall Study|Withdrawal by Subject|0
351531|NCT00460239|1140857|P6|Overall Study|Withdrawal by Subject|1
351532|NCT00460239|1140858|P5|Overall Study|Withdrawal by Subject|0
351533|NCT00460239|1140859|P4|Overall Study|Withdrawal by Subject|0
351534|NCT00460239|1140860|P3|Overall Study|Withdrawal by Subject|0
351535|NCT00460239|1140861|P2|Overall Study|Withdrawal by Subject|0
351536|NCT00460239|1140862|P1|Overall Study|Withdrawal by Subject|0
351537|NCT00460239|1140854|P9|Overall Study|Physician Decision|0
351538|NCT00460239|1140855|P8|Overall Study|Physician Decision|0
351539|NCT00460239|1140856|P7|Overall Study|Physician Decision|0
351540|NCT00460239|1140857|P6|Overall Study|Physician Decision|2
351541|NCT00460239|1140858|P5|Overall Study|Physician Decision|0
351542|NCT00460239|1140859|P4|Overall Study|Physician Decision|0
351543|NCT00460239|1140860|P3|Overall Study|Physician Decision|0
351544|NCT00460239|1140861|P2|Overall Study|Physician Decision|1
351545|NCT00460239|1140862|P1|Overall Study|Physician Decision|0
351546|NCT00460109|1140931|P1|Overall Study|Death|1
351547|NCT00460031|1140939|P1|Overall Study|Death|1
351548|NCT00460031|1140939|P1|Overall Study|Withdrawal by Subject|5
351549|NCT00460031|1140939|P1|Overall Study|Adverse Event|5
351550|NCT00459979|1140947|P1|Overall Study|Protocol Violation|1
351551|NCT00459979|1140947|P1|Overall Study|Withdrawal by Subject|1
351552|NCT00459953|1140959|P2|Overall Study|not analyzed-household member in study|1
351553|NCT00459953|1140960|P1|Overall Study|not analyzed-household member in study|1
351554|NCT00459875|1140966|P1|Overall Study|Adverse Event|2
351555|NCT00459875|1140966|P1|Overall Study|Ineligible participant|1
351556|NCT00459706|1141002|P2|Overall Study|Unspecified|1
351557|NCT00459706|1141003|P1|Overall Study|Unspecified|0
351558|NCT00459706|1141002|P2|Overall Study|Failed to Return|0
351559|NCT00459706|1141003|P1|Overall Study|Failed to Return|1
351560|NCT00459706|1141002|P2|Overall Study|Protocol Violation|1
351561|NCT00459706|1141003|P1|Overall Study|Protocol Violation|2
351562|NCT00459706|1141002|P2|Overall Study|Discontinuation of Study by Sponsor|0
351563|NCT00459706|1141003|P1|Overall Study|Discontinuation of Study by Sponsor|1
351564|NCT00459706|1141002|P2|Overall Study|Physician Decision|0
351565|NCT00459706|1141003|P1|Overall Study|Physician Decision|2
351566|NCT00459706|1141002|P2|Overall Study|Withdrawal by Subject|6
351567|NCT00459706|1141003|P1|Overall Study|Withdrawal by Subject|1
351568|NCT00459706|1141002|P2|Overall Study|Adverse Event|13
351569|NCT00459706|1141003|P1|Overall Study|Adverse Event|19
351570|NCT00459667|1141146|P3|Overall Study|No treatment administered|1
351571|NCT00459667|1141147|P2|Overall Study|No treatment administered|3
351572|NCT00459667|1141148|P1|Overall Study|No treatment administered|6
351573|NCT00459667|1141146|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
351574|NCT00459667|1141147|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
351575|NCT00459667|1141148|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
351576|NCT00459667|1141146|P3|Overall Study|Other disease modifying treatment|1
351577|NCT00459667|1141147|P2|Overall Study|Other disease modifying treatment|2
351578|NCT00459667|1141148|P1|Overall Study|Other disease modifying treatment|1
351579|NCT00459667|1141146|P3|Overall Study|Withdrawal by Subject|5
351580|NCT00459667|1141147|P2|Overall Study|Withdrawal by Subject|5
351581|NCT00459667|1141148|P1|Overall Study|Withdrawal by Subject|3
351582|NCT00459667|1141146|P3|Overall Study|Protocol Violation|0
351583|NCT00459667|1141147|P2|Overall Study|Protocol Violation|0
351584|NCT00459667|1141148|P1|Overall Study|Protocol Violation|1
351585|NCT00459667|1141146|P3|Overall Study|Pregnancy|1
351586|NCT00459667|1141147|P2|Overall Study|Pregnancy|1
351587|NCT00459667|1141148|P1|Overall Study|Pregnancy|1
351588|NCT00459667|1141146|P3|Overall Study|Lost to Follow-up|3
351589|NCT00459667|1141147|P2|Overall Study|Lost to Follow-up|9
351590|NCT00459667|1141148|P1|Overall Study|Lost to Follow-up|5
351591|NCT00459667|1141146|P3|Overall Study|Adverse Event|8
351592|NCT00459667|1141147|P2|Overall Study|Adverse Event|12
351593|NCT00459667|1141148|P1|Overall Study|Adverse Event|9
351594|NCT00459537|1141170|P2|Overall Study|Missing|0
351595|NCT00459537|1141171|P1|Overall Study|Missing|1
351596|NCT00459537|1141170|P2|Overall Study|Protocol Violation|3
351597|NCT00459537|1141171|P1|Overall Study|Protocol Violation|4
351598|NCT00459537|1141170|P2|Overall Study|Administrative problems|0
351599|NCT00459537|1141171|P1|Overall Study|Administrative problems|3
351600|NCT00459537|1141170|P2|Overall Study|Lost to Follow-up|30
351601|NCT00459537|1141171|P1|Overall Study|Lost to Follow-up|27
351602|NCT00459537|1141170|P2|Overall Study|Withdrawal by Subject|26
351603|NCT00459537|1141171|P1|Overall Study|Withdrawal by Subject|20
351604|NCT00459537|1141170|P2|Overall Study|Lack of Efficacy|11
351605|NCT00459537|1141171|P1|Overall Study|Lack of Efficacy|10
351606|NCT00459537|1141170|P2|Overall Study|Adverse Event|6
351607|NCT00459537|1141171|P1|Overall Study|Adverse Event|1
351608|NCT00459355|1141206|P2|Overall Study|Subject no longer met inc criteria|18
351609|NCT00459355|1141207|P1|Overall Study|Subject no longer met inc criteria|20
351610|NCT00459342|1141219|P1|Overall Study|Not eligible|1
351611|NCT00459316|1141228|P3|Step 3|Withdrawal by Subject|1
351612|NCT00459316|1141229|P2|Step 3|Withdrawal by Subject|0
351613|NCT00459316|1141230|P1|Step 3|Withdrawal by Subject|3
351614|NCT00459316|1141228|P3|Steps 1 & 2|Lost to Follow-up|2
351615|NCT00459316|1141229|P2|Steps 1 & 2|Lost to Follow-up|0
351616|NCT00459316|1141230|P1|Steps 1 & 2|Lost to Follow-up|5
351617|NCT00459316|1141228|P3|Steps 1 & 2|Not willing to adhere to regulations|0
351618|NCT00459316|1141229|P2|Steps 1 & 2|Not willing to adhere to regulations|0
351619|NCT00459316|1141230|P1|Steps 1 & 2|Not willing to adhere to regulations|1
351620|NCT00459316|1141228|P3|Steps 1 & 2|Withdrawal by Subject|0
351621|NCT00459316|1141229|P2|Steps 1 & 2|Withdrawal by Subject|1
351622|NCT00459316|1141230|P1|Steps 1 & 2|Withdrawal by Subject|6
351623|NCT00459316|1141228|P3|Steps 1 & 2|Not able to get to clinic|0
351624|NCT00459316|1141229|P2|Steps 1 & 2|Not able to get to clinic|4
351625|NCT00459316|1141230|P1|Steps 1 & 2|Not able to get to clinic|7
351626|NCT00459316|1141228|P3|Steps 1 & 2|Death|0
351627|NCT00459316|1141229|P2|Steps 1 & 2|Death|1
351628|NCT00459316|1141230|P1|Steps 1 & 2|Death|1
351629|NCT00459316|1141228|P3|Steps 1 & 2|Other eligibility failure|0
351630|NCT00459316|1141229|P2|Steps 1 & 2|Other eligibility failure|1
351631|NCT00459316|1141230|P1|Steps 1 & 2|Other eligibility failure|1
351632|NCT00459290|1141295|P1|Overall Study|Ineligible|2
351633|NCT00459290|1141295|P1|Overall Study|Adverse Event|3
351634|NCT00459186|1141309|P1|PET Imaging and Assessment|Adverse Event|3
351635|NCT00459186|1141309|P1|Single Agent RAD001|Withdrawal by Subject|1
351636|NCT00459134|1141316|P2|Overall Study|Multiple Reasons|3
351637|NCT00459134|1141317|P1|Overall Study|Multiple Reasons|2
351638|NCT00459134|1141316|P2|Overall Study|Progression|0
351639|NCT00459134|1141317|P1|Overall Study|Progression|1
351640|NCT00459134|1141316|P2|Overall Study|Toxicity|5
351641|NCT00459134|1141317|P1|Overall Study|Toxicity|4
351642|NCT00459134|1141316|P2|Overall Study|Surgery|2
351643|NCT00459134|1141317|P1|Overall Study|Surgery|1
351644|NCT00459134|1141316|P2|Overall Study|Lost to Follow-up|7
351645|NCT00459134|1141317|P1|Overall Study|Lost to Follow-up|6
351646|NCT00459134|1141316|P2|Overall Study|Withdrawal by Subject|7
351647|NCT00459134|1141317|P1|Overall Study|Withdrawal by Subject|8
351648|NCT00459134|1141316|P2|Overall Study|Physician Decision|1
351649|NCT00459134|1141317|P1|Overall Study|Physician Decision|1
351650|NCT00459108|1141329|P1|Overall Study|Progression|1
351651|NCT00459108|1141329|P1|Overall Study|Death|2
351652|NCT00459108|1141329|P1|Overall Study|Adverse Event|3
351653|NCT00459108|1141329|P1|Overall Study|Withdrawal by Subject|5
351654|NCT00459056|1141336|P2|First Intervention (First Three Months)|Lost to Follow-up|1
351655|NCT00459056|1141337|P1|First Intervention (First Three Months)|Lost to Follow-up|1
351656|NCT00459043|1141345|P2|Overall Study|Withdrawal by Subject|0
351657|NCT00459043|1141346|P1|Overall Study|Withdrawal by Subject|1
351658|NCT00458705|1141367|P1|Overall Study|Not Treated|1
351659|NCT00458705|1141367|P1|Overall Study|Adverse Event|4
351660|NCT00458536|1141371|P1|Overall Study|Progressive disease during treatment|2
351661|NCT00458536|1141371|P1|Overall Study|Withdrawal by Subject|1
351662|NCT00458536|1141371|P1|Overall Study|Ineligible due to toxicity|1
351663|NCT00458536|1141371|P1|Overall Study|Patient did not have surgery|1
351664|NCT00458536|1141371|P1|Overall Study|Did not have renal cell carcinoma|2
351665|NCT00458536|1141371|P1|Overall Study|No measurable disease after surgery|2
351666|NCT00458536|1141371|P1|Overall Study|Unable to make vaccine|3
351667|NCT00458536|1141371|P1|Overall Study|Disease progression prior to treatment|7
351668|NCT00458302|1141398|P2|Overall Study|Other|2
351669|NCT00458302|1141399|P1|Overall Study|Other|4
351670|NCT00458302|1141398|P2|Overall Study|Lost to Follow-up|0
351671|NCT00458302|1141399|P1|Overall Study|Lost to Follow-up|2
351672|NCT00458302|1141398|P2|Overall Study|Study Termination By Sponsor|0
351673|NCT00458302|1141399|P1|Overall Study|Study Termination By Sponsor|1
351674|NCT00458302|1141398|P2|Overall Study|Inc/Exc Criteria Not Met|1
351675|NCT00458302|1141399|P1|Overall Study|Inc/Exc Criteria Not Met|1
351676|NCT00458302|1141398|P2|Overall Study|Withdrawal by Subject|4
351677|NCT00458302|1141399|P1|Overall Study|Withdrawal by Subject|6
351678|NCT00458302|1141398|P2|Overall Study|Protocol Violation|2
351679|NCT00458302|1141399|P1|Overall Study|Protocol Violation|0
351680|NCT00458302|1141398|P2|Overall Study|Pregnancy|1
351681|NCT00458302|1141399|P1|Overall Study|Pregnancy|2
351682|NCT00458302|1141398|P2|Overall Study|Adverse Event|14
351683|NCT00458302|1141399|P1|Overall Study|Adverse Event|4
351684|NCT00458211|1141444|P1|Overall Study|Protocol Violation|2
351685|NCT00458211|1141444|P1|Overall Study|Withdrawal by Subject|2
351686|NCT00458211|1141444|P1|Overall Study|Lack of Efficacy|12
351687|NCT00457821|1141486|P8|Part 2|Withdrawal by Subject|1
351688|NCT00457821|1141487|P7|Part 2|Withdrawal by Subject|0
351689|NCT00457821|1141488|P6|Part 2|Withdrawal by Subject|0
351690|NCT00457821|1141489|P5|Part 2|Withdrawal by Subject|0
351691|NCT00457821|1141490|P4|Part 2|Withdrawal by Subject|0
351692|NCT00457821|1141491|P3|Part 2|Withdrawal by Subject|0
351693|NCT00457821|1141492|P2|Part 2|Withdrawal by Subject|0
351694|NCT00457821|1141493|P1|Part 2|Withdrawal by Subject|0
351695|NCT00457743|1141532|P3|Overall Study|Lack of Efficacy|3
351696|NCT00457743|1141533|P2|Overall Study|Lack of Efficacy|23
351697|NCT00457743|1141534|P1|Overall Study|Lack of Efficacy|3
351698|NCT00457743|1141532|P3|Overall Study|Adverse Event|0
351699|NCT00457743|1141533|P2|Overall Study|Adverse Event|4
351700|NCT00457743|1141534|P1|Overall Study|Adverse Event|0
351701|NCT00457691|1141591|P2|Overall Study|Disease progression, study terminated|196
351702|NCT00457691|1141592|P1|Overall Study|Disease progression, study terminated|180
351703|NCT00457691|1141591|P2|Overall Study|Subject refused (reason other than AE)|19
351704|NCT00457691|1141592|P1|Overall Study|Subject refused (reason other than AE)|14
351705|NCT00457691|1141591|P2|Overall Study|Study terminated by Sponsor|1
351706|NCT00457691|1141592|P1|Overall Study|Study terminated by Sponsor|1
351707|NCT00457691|1141591|P2|Overall Study|Lost to Follow-up|14
351708|NCT00457691|1141592|P1|Overall Study|Lost to Follow-up|23
351709|NCT00457691|1141591|P2|Overall Study|Protocol Violation|3
351710|NCT00457691|1141592|P1|Overall Study|Protocol Violation|1
351711|NCT00457691|1141591|P2|Overall Study|Death|148
351712|NCT00457691|1141592|P1|Overall Study|Death|163
351713|NCT00457691|1141591|P2|Overall Study|Adverse Event|1
351714|NCT00457691|1141592|P1|Overall Study|Adverse Event|4
351715|NCT00457418|1141612|P1|Post PK Maintenance|Lost to Follow-up|1
351716|NCT00457418|1141612|P1|Post PK Maintenance|Withdrawal by Subject|11
351717|NCT00457418|1141612|P1|Post PK Maintenance|Progression of Disease|6
351718|NCT00457418|1141612|P1|Post PK Maintenance|Adverse Event|10
351719|NCT00457418|1141612|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
351720|NCT00457418|1141612|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
351721|NCT00457418|1141612|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
351722|NCT00457392|1141624|P2|Overall Study|Randomized, Not Treated|3
351723|NCT00457392|1141625|P1|Overall Study|Randomized, Not Treated|7
351724|NCT00457392|1141624|P2|Overall Study|Study Terminated by Sponsor|4
351725|NCT00457392|1141625|P1|Overall Study|Study Terminated by Sponsor|1
351726|NCT00457392|1141624|P2|Overall Study|Unspecified|4
351727|NCT00457392|1141625|P1|Overall Study|Unspecified|7
351728|NCT00457392|1141624|P2|Overall Study|Protocol Violation|3
351729|NCT00457392|1141625|P1|Overall Study|Protocol Violation|4
351730|NCT00457392|1141624|P2|Overall Study|Lost to Follow-up|7
351731|NCT00457392|1141625|P1|Overall Study|Lost to Follow-up|6
351732|NCT00457392|1141624|P2|Overall Study|Withdrawal by Subject|8
351733|NCT00457392|1141625|P1|Overall Study|Withdrawal by Subject|14
351734|NCT00457392|1141624|P2|Overall Study|Global Deterioration of Health Status|8
351735|NCT00457392|1141625|P1|Overall Study|Global Deterioration of Health Status|22
351736|NCT00457392|1141624|P2|Overall Study|Adverse Event|41
351737|NCT00457392|1141625|P1|Overall Study|Adverse Event|84
351738|NCT00457392|1141624|P2|Overall Study|Death|106
351739|NCT00457392|1141625|P1|Overall Study|Death|106
351740|NCT00457392|1141624|P2|Overall Study|Objective Progression or Relapse|296
351741|NCT00457392|1141625|P1|Overall Study|Objective Progression or Relapse|229
351742|NCT00457301|1141643|P2|Overall Study|Death|7
351743|NCT00457301|1141644|P1|Overall Study|Death|5
351744|NCT00457301|1141643|P2|Overall Study|Censored out of the study|14
351745|NCT00457301|1141644|P1|Overall Study|Censored out of the study|15
351746|NCT00457301|1141643|P2|Overall Study|Withdrawal by Subject|3
351747|NCT00457301|1141644|P1|Overall Study|Withdrawal by Subject|3
351748|NCT00457249|1141658|P2|Overall Study|Serious Adverse Events|0
351749|NCT00457249|1141659|P1|Overall Study|Serious Adverse Events|2
351750|NCT00457249|1141658|P2|Overall Study|Withdrawal by Subject|1
351751|NCT00457249|1141659|P1|Overall Study|Withdrawal by Subject|3
351752|NCT00457249|1141658|P2|Overall Study|Protocol Violation|1
351753|NCT00457249|1141659|P1|Overall Study|Protocol Violation|4
351754|NCT00457249|1141658|P2|Overall Study|Lost to Follow-up|0
351755|NCT00457249|1141659|P1|Overall Study|Lost to Follow-up|3
351756|NCT00457015|1141698|P2|Overall Study|Left study site against medical advice|1
351757|NCT00457015|1141699|P1|Overall Study|Left study site against medical advice|0
351758|NCT00457002|1141715|P2|Overall Study|treated for 1 day; missing status/reason|0
351759|NCT00457002|1141716|P1|Overall Study|treated for 1 day; missing status/reason|1
351760|NCT00457002|1141715|P2|Overall Study|non-specified|38
351761|NCT00457002|1141716|P1|Overall Study|non-specified|29
351762|NCT00457002|1141715|P2|Overall Study|Administrative reason by Sponsor|0
351763|NCT00457002|1141716|P1|Overall Study|Administrative reason by Sponsor|1
351764|NCT00457002|1141715|P2|Overall Study|No longer met criteria|37
351765|NCT00457002|1141716|P1|Overall Study|No longer met criteria|41
351766|NCT00457002|1141715|P2|Overall Study|Poor/Non-compliance|33
351767|NCT00457002|1141716|P1|Overall Study|Poor/Non-compliance|46
351768|NCT00457002|1141715|P2|Overall Study|Lost to Follow-up|71
351769|NCT00457002|1141716|P1|Overall Study|Lost to Follow-up|72
351770|NCT00457002|1141715|P2|Overall Study|Withdrawal by Subject|271
351771|NCT00457002|1141716|P1|Overall Study|Withdrawal by Subject|299
351772|NCT00457002|1141715|P2|Overall Study|Adverse Event|260
351773|NCT00457002|1141716|P1|Overall Study|Adverse Event|284
351774|NCT00457002|1141715|P2|Overall Study|Death|47
351775|NCT00457002|1141716|P1|Overall Study|Death|40
351776|NCT00456846|1141790|P2|Overall Study|Unspecified|2
351777|NCT00456846|1141791|P1|Overall Study|Unspecified|0
351778|NCT00456846|1141790|P2|Overall Study|Participant Discretion|5
351779|NCT00456846|1141791|P1|Overall Study|Participant Discretion|1
351780|NCT00456846|1141790|P2|Overall Study|Protocol Deviation|0
351781|NCT00456846|1141791|P1|Overall Study|Protocol Deviation|2
351782|NCT00456846|1141790|P2|Overall Study|Physician Decision|6
351783|NCT00456846|1141791|P1|Overall Study|Physician Decision|11
351784|NCT00456846|1141790|P2|Overall Study|Adverse Event|15
351785|NCT00456846|1141791|P1|Overall Study|Adverse Event|2
351786|NCT00456755|1141832|P2|Overall Study|Lost to Follow-up|1
351787|NCT00456755|1141833|P1|Overall Study|Lost to Follow-up|2
351788|NCT00456612|1141847|P1|Overall Study|Withdrawal by Subject|3
351789|NCT00456599|1141852|P1|Overall Study|Withdrawal by Subject|2
351790|NCT00456599|1141852|P1|Overall Study|Non-compliance|1
351791|NCT00456521|1141875|P2|Overall Study|Drug non-compliance, moved, other|11
351792|NCT00456521|1141876|P1|Overall Study|Drug non-compliance, moved, other|26
351793|NCT00456521|1141875|P2|Overall Study|Pregnancy|1
351794|NCT00456521|1141876|P1|Overall Study|Pregnancy|1
351795|NCT00456521|1141875|P2|Overall Study|Protocol Violation|0
351796|NCT00456521|1141876|P1|Overall Study|Protocol Violation|4
351797|NCT00456521|1141875|P2|Overall Study|Lack of Efficacy|6
351798|NCT00456521|1141876|P1|Overall Study|Lack of Efficacy|3
351799|NCT00456521|1141875|P2|Overall Study|Lost to Follow-up|17
351800|NCT00456521|1141876|P1|Overall Study|Lost to Follow-up|22
351801|NCT00456521|1141875|P2|Overall Study|Withdrawal by Subject|24
351802|NCT00456521|1141876|P1|Overall Study|Withdrawal by Subject|43
351803|NCT00456521|1141875|P2|Overall Study|Adverse Event|25
351804|NCT00456521|1141876|P1|Overall Study|Adverse Event|150
351805|NCT00456495|1141922|P1|Overall Study|Physician Decision|2
351806|NCT00455962|1141962|P2|Overall Study|Lost to Follow-up|2
351807|NCT00455962|1141963|P1|Overall Study|Lost to Follow-up|5
351808|NCT00454909|1141972|P3|Overall Study|Others|0
351809|NCT00454909|1141973|P2|Overall Study|Others|0
351810|NCT00454909|1141974|P1|Overall Study|Others|1
351811|NCT00454909|1141972|P3|Overall Study|Lost to follow-up (complete vaccination)|1
351812|NCT00454909|1141973|P2|Overall Study|Lost to follow-up (complete vaccination)|3
351813|NCT00454909|1141974|P1|Overall Study|Lost to follow-up (complete vaccination)|5
351814|NCT00454909|1141972|P3|Overall Study|Migrated/moved from study area|1
351815|NCT00454909|1141973|P2|Overall Study|Migrated/moved from study area|0
351816|NCT00454909|1141974|P1|Overall Study|Migrated/moved from study area|0
351817|NCT00454909|1141972|P3|Overall Study|Withdrawal by Subject|0
351818|NCT00454909|1141973|P2|Overall Study|Withdrawal by Subject|0
351819|NCT00454909|1141974|P1|Overall Study|Withdrawal by Subject|1
351820|NCT00454857|1142012|P1|Overall Study|Reason unknown|1
351821|NCT00454857|1142012|P1|Overall Study|Other|11
351822|NCT00454857|1142012|P1|Overall Study|Death|5
351823|NCT00454857|1142012|P1|Overall Study|Noncompliance|6
351824|NCT00454857|1142012|P1|Overall Study|Lost to Follow-up|16
351825|NCT00454857|1142012|P1|Overall Study|Withdrawal by Subject|15
351826|NCT00454818|1142037|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
351827|NCT00454818|1142038|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
351828|NCT00454818|1142039|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
351829|NCT00454818|1142040|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
351830|NCT00454818|1142041|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
351831|NCT00454818|1142037|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
351832|NCT00454818|1142038|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
351833|NCT00454818|1142039|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
351834|NCT00454818|1142040|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
351835|NCT00454818|1142041|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
351836|NCT00454818|1142037|P5|Phase 2: Randomized Double-blind|Death|1
351837|NCT00454818|1142038|P4|Phase 2: Randomized Double-blind|Death|0
351838|NCT00454818|1142039|P3|Phase 2: Randomized Double-blind|Death|0
351839|NCT00454818|1142040|P2|Phase 2: Randomized Double-blind|Death|1
351840|NCT00454818|1142041|P1|Phase 2: Randomized Double-blind|Death|0
351841|NCT00454818|1142037|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
351842|NCT00454818|1142038|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
351843|NCT00454818|1142039|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
351844|NCT00454818|1142040|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
351845|NCT00454818|1142041|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
351846|NCT00454818|1142037|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
351847|NCT00454818|1142038|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
351848|NCT00454818|1142039|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
351849|NCT00454818|1142040|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
351850|NCT00454818|1142041|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
351851|NCT00454818|1142037|P5|Phase I: Open-label Dose-escalation|Death|0
351852|NCT00454818|1142038|P4|Phase I: Open-label Dose-escalation|Death|0
351853|NCT00454818|1142039|P3|Phase I: Open-label Dose-escalation|Death|0
351854|NCT00454818|1142040|P2|Phase I: Open-label Dose-escalation|Death|1
351855|NCT00454818|1142041|P1|Phase I: Open-label Dose-escalation|Death|0
351856|NCT00454818|1142037|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
351857|NCT00454818|1142038|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
351858|NCT00454818|1142039|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
351859|NCT00454818|1142040|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
351860|NCT00454818|1142041|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
351861|NCT00454805|1142120|P2|Overall Study|In order to begin radiotherapy|0
351862|NCT00454805|1142121|P1|Overall Study|In order to begin radiotherapy|1
351863|NCT00454805|1142120|P2|Overall Study|Disease progression|19
351864|NCT00454805|1142121|P1|Overall Study|Disease progression|16
351865|NCT00454805|1142120|P2|Overall Study|Death|2
351866|NCT00454805|1142121|P1|Overall Study|Death|0
351867|NCT00454805|1142120|P2|Overall Study|Withdrawal by Subject|2
351868|NCT00454805|1142121|P1|Overall Study|Withdrawal by Subject|9
351869|NCT00454779|1142137|P2|Second-line Treatment Phase|Ongoing|1
351870|NCT00454779|1142138|P1|Second-line Treatment Phase|Ongoing|0
351871|NCT00454779|1142137|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
351872|NCT00454779|1142138|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
351873|NCT00454779|1142137|P2|Second-line Treatment Phase|Withdrawal by Subject|1
351874|NCT00454779|1142138|P1|Second-line Treatment Phase|Withdrawal by Subject|0
351875|NCT00454779|1142137|P2|First-line Treatment Phase|Ongoing|0
351876|NCT00454779|1142138|P1|First-line Treatment Phase|Ongoing|1
351877|NCT00454779|1142137|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
351878|NCT00454779|1142138|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
351879|NCT00454779|1142137|P2|First-line Treatment Phase|Protocol Violation|1
351880|NCT00454779|1142138|P1|First-line Treatment Phase|Protocol Violation|0
351881|NCT00454779|1142137|P2|First-line Treatment Phase|Lost to Follow-up|0
351882|NCT00454779|1142138|P1|First-line Treatment Phase|Lost to Follow-up|1
351883|NCT00454779|1142137|P2|First-line Treatment Phase|Withdrawal by Subject|4
351884|NCT00454779|1142138|P1|First-line Treatment Phase|Withdrawal by Subject|2
351885|NCT00454779|1142137|P2|First-line Treatment Phase|Lack of Efficacy|2
351886|NCT00454779|1142138|P1|First-line Treatment Phase|Lack of Efficacy|0
351887|NCT00455858|1142166|P1|Overall Study|Withdrawal|1
351888|NCT00455858|1142166|P1|Overall Study|Well controlled FPG without insulin|1
351889|NCT00455858|1142166|P1|Overall Study|Lack of Efficacy|1
351890|NCT00455858|1142166|P1|Overall Study|Protocol Violation|1
351891|NCT00455858|1142166|P1|Overall Study|Lost to Follow-up|2
351892|NCT00455533|1142244|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
351893|NCT00455533|1142245|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
351894|NCT00455533|1142246|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
351895|NCT00455533|1142244|P3|Period Two: Randomized Period|Study Drug Toxicity|0
351896|NCT00455533|1142245|P2|Period Two: Randomized Period|Study Drug Toxicity|2
351897|NCT00455533|1142246|P1|Period Two: Randomized Period|Study Drug Toxicity|0
351898|NCT00455533|1142244|P3|Period Two: Randomized Period|Other - need reasons|0
351899|NCT00455533|1142245|P2|Period Two: Randomized Period|Other - need reasons|1
351900|NCT00455533|1142246|P1|Period Two: Randomized Period|Other - need reasons|0
351901|NCT00455533|1142244|P3|Period Two: Randomized Period|Lost to Follow-up|1
351902|NCT00455533|1142245|P2|Period Two: Randomized Period|Lost to Follow-up|0
351903|NCT00455533|1142246|P1|Period Two: Randomized Period|Lost to Follow-up|0
351904|NCT00455533|1142244|P3|Period Two: Randomized Period|Disease Progression|1
351905|NCT00455533|1142245|P2|Period Two: Randomized Period|Disease Progression|1
351906|NCT00455533|1142246|P1|Period Two: Randomized Period|Disease Progression|0
351907|NCT00455533|1142244|P3|Period Two: Randomized Period|Death|3
351908|NCT00455533|1142245|P2|Period Two: Randomized Period|Death|0
351909|NCT00455533|1142246|P1|Period Two: Randomized Period|Death|0
351910|NCT00455533|1142244|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
351911|NCT00455533|1142245|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
351912|NCT00455533|1142246|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
351913|NCT00455533|1142244|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
351914|NCT00455533|1142245|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
351915|NCT00455533|1142246|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
351916|NCT00455533|1142244|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
351917|NCT00455533|1142245|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
351918|NCT00455533|1142246|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
351919|NCT00455533|1142244|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
351920|NCT00455533|1142245|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
351921|NCT00455533|1142246|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
351922|NCT00455533|1142244|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
351923|NCT00455533|1142245|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
351924|NCT00455533|1142246|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
351925|NCT00455533|1142244|P3|Period One: Initial Chemotherapy|Not Reported|0
351926|NCT00455533|1142245|P2|Period One: Initial Chemotherapy|Not Reported|0
351927|NCT00455533|1142246|P1|Period One: Initial Chemotherapy|Not Reported|1
351928|NCT00455533|1142244|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
351929|NCT00455533|1142245|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
351930|NCT00455533|1142246|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
351931|NCT00455533|1142244|P3|Period One: Initial Chemotherapy|Disease Progression|0
351932|NCT00455533|1142245|P2|Period One: Initial Chemotherapy|Disease Progression|0
351933|NCT00455533|1142246|P1|Period One: Initial Chemotherapy|Disease Progression|5
351934|NCT00455533|1142244|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
351935|NCT00455533|1142245|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
351936|NCT00455533|1142246|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
351937|NCT00455520|1142295|P2|Double Blind Tapentadol ER vs Placebo|All other|6
351938|NCT00455520|1142296|P1|Double Blind Tapentadol ER vs Placebo|All other|4
351939|NCT00455520|1142295|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
351940|NCT00455520|1142296|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
351941|NCT00455520|1142295|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
351942|NCT00455520|1142296|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
351943|NCT00455520|1142295|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
351944|NCT00455520|1142296|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
351945|NCT00455520|1142295|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
351946|NCT00455520|1142296|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
351947|NCT00455520|1142295|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
351948|NCT00455520|1142296|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
351949|NCT00455520|1142295|P2|Open Label Tapentadol Extended Release|All other|0
351950|NCT00455520|1142296|P1|Open Label Tapentadol Extended Release|All other|33
351951|NCT00455520|1142295|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
351952|NCT00455520|1142296|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
351953|NCT00455520|1142295|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
351954|NCT00455520|1142296|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
351955|NCT00455520|1142295|P2|Open Label Tapentadol Extended Release|Adverse Event|0
351956|NCT00455520|1142296|P1|Open Label Tapentadol Extended Release|Adverse Event|100
351957|NCT00455520|1142295|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
351958|NCT00455520|1142296|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
351959|NCT00455520|1142295|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
351960|NCT00455520|1142296|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
351961|NCT00455455|1142312|P2|Washout|Withdrawal by Subject|0
351962|NCT00455455|1142313|P1|Washout|Withdrawal by Subject|1
351963|NCT00455455|1142312|P2|Washout|Withdrawal by Subject|1
351964|NCT00455455|1142313|P1|Washout|Withdrawal by Subject|0
351965|NCT00455429|1142333|P4|Overall Study|Unspecified|1
351966|NCT00455429|1142334|P3|Overall Study|Unspecified|0
351967|NCT00455429|1142335|P2|Overall Study|Unspecified|2
351968|NCT00455429|1142336|P1|Overall Study|Unspecified|0
351969|NCT00455429|1142333|P4|Overall Study|Non-compliance|1
351970|NCT00455429|1142334|P3|Overall Study|Non-compliance|0
351971|NCT00455429|1142335|P2|Overall Study|Non-compliance|0
351972|NCT00455429|1142336|P1|Overall Study|Non-compliance|0
351973|NCT00455429|1142333|P4|Overall Study|Personal Reason|0
351974|NCT00455429|1142334|P3|Overall Study|Personal Reason|0
351975|NCT00455429|1142335|P2|Overall Study|Personal Reason|0
351976|NCT00455429|1142336|P1|Overall Study|Personal Reason|1
351977|NCT00455429|1142333|P4|Overall Study|Randomly assigned but not treated|2
351978|NCT00455429|1142334|P3|Overall Study|Randomly assigned but not treated|0
351979|NCT00455429|1142335|P2|Overall Study|Randomly assigned but not treated|0
351980|NCT00455429|1142336|P1|Overall Study|Randomly assigned but not treated|0
351981|NCT00455429|1142333|P4|Overall Study|Adverse Event|3
351982|NCT00455429|1142334|P3|Overall Study|Adverse Event|0
351983|NCT00455429|1142335|P2|Overall Study|Adverse Event|1
351984|NCT00455429|1142336|P1|Overall Study|Adverse Event|0
351985|NCT00455429|1142333|P4|Overall Study|Lack of Efficacy|1
351986|NCT00455429|1142334|P3|Overall Study|Lack of Efficacy|0
351987|NCT00455429|1142335|P2|Overall Study|Lack of Efficacy|1
351988|NCT00455429|1142336|P1|Overall Study|Lack of Efficacy|0
351989|NCT00455429|1142333|P4|Overall Study|Withdrawal by Subject|0
351990|NCT00455429|1142334|P3|Overall Study|Withdrawal by Subject|1
351991|NCT00455429|1142335|P2|Overall Study|Withdrawal by Subject|1
351992|NCT00455429|1142336|P1|Overall Study|Withdrawal by Subject|0
351993|NCT00455429|1142333|P4|Overall Study|Lost to Follow-up|3
351994|NCT00455429|1142334|P3|Overall Study|Lost to Follow-up|0
351995|NCT00455429|1142335|P2|Overall Study|Lost to Follow-up|0
351996|NCT00455429|1142336|P1|Overall Study|Lost to Follow-up|1
351997|NCT00455429|1142333|P4|Overall Study|Study Terminated by Sponsor|3
351998|NCT00455429|1142334|P3|Overall Study|Study Terminated by Sponsor|0
351999|NCT00455429|1142335|P2|Overall Study|Study Terminated by Sponsor|0
352000|NCT00455429|1142336|P1|Overall Study|Study Terminated by Sponsor|0
352001|NCT00455312|1142395|P2|Overall Study|Death|1
352002|NCT00455312|1142396|P1|Overall Study|Death|0
352003|NCT00455195|1142422|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
352004|NCT00455195|1142423|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
352005|NCT00455195|1142422|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
352006|NCT00455195|1142423|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
352007|NCT00455195|1142422|P2|Double-blind Study AGLU02704|Death|0
352008|NCT00455195|1142423|P1|Double-blind Study AGLU02704|Death|1
352009|NCT00455195|1142422|P2|Double-blind Study AGLU02704|Adverse Event|1
352010|NCT00455195|1142423|P1|Double-blind Study AGLU02704|Adverse Event|2
352011|NCT00455013|1142440|P3|Long Term Extension (LTE)|non-specified|1
352012|NCT00455013|1142441|P2|Long Term Extension (LTE)|non-specified|0
352013|NCT00455013|1142442|P1|Long Term Extension (LTE)|non-specified|0
352014|NCT00455013|1142440|P3|Long Term Extension (LTE)|Poor non-compliance|0
352015|NCT00455013|1142441|P2|Long Term Extension (LTE)|Poor non-compliance|1
352016|NCT00455013|1142442|P1|Long Term Extension (LTE)|Poor non-compliance|0
352017|NCT00455013|1142440|P3|Long Term Extension (LTE)|Subject Request or refused|3
352018|NCT00455013|1142441|P2|Long Term Extension (LTE)|Subject Request or refused|0
352019|NCT00455013|1142442|P1|Long Term Extension (LTE)|Subject Request or refused|0
352020|NCT00455013|1142440|P3|Long Term Extension (LTE)|No longer met criteria|1
352021|NCT00455013|1142441|P2|Long Term Extension (LTE)|No longer met criteria|0
352022|NCT00455013|1142442|P1|Long Term Extension (LTE)|No longer met criteria|0
352023|NCT00455013|1142440|P3|Long Term Extension (LTE)|Death|0
352024|NCT00455013|1142441|P2|Long Term Extension (LTE)|Death|1
352025|NCT00455013|1142442|P1|Long Term Extension (LTE)|Death|1
352026|NCT00455013|1142440|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
352027|NCT00455013|1142441|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
352028|NCT00455013|1142442|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
352029|NCT00455013|1142440|P3|Long Term Extension (LTE)|Adverse Event|1
352030|NCT00455013|1142441|P2|Long Term Extension (LTE)|Adverse Event|1
352031|NCT00455013|1142442|P1|Long Term Extension (LTE)|Adverse Event|0
352032|NCT00455013|1142440|P3|Short Term Period|Unspecified|1
352033|NCT00455013|1142441|P2|Short Term Period|Unspecified|0
352034|NCT00455013|1142442|P1|Short Term Period|Unspecified|0
352035|NCT00455013|1142440|P3|Short Term Period|Lack of Efficacy|0
352036|NCT00455013|1142441|P2|Short Term Period|Lack of Efficacy|0
352037|NCT00455013|1142442|P1|Short Term Period|Lack of Efficacy|4
352038|NCT00455013|1142440|P3|Short Term Period|Withdrawal by Subject|1
352039|NCT00455013|1142441|P2|Short Term Period|Withdrawal by Subject|0
352040|NCT00455013|1142442|P1|Short Term Period|Withdrawal by Subject|0
352041|NCT00455013|1142440|P3|Short Term Period|Adverse Event|0
352042|NCT00455013|1142441|P2|Short Term Period|Adverse Event|5
352043|NCT00455013|1142442|P1|Short Term Period|Adverse Event|2
352044|NCT00454987|1142510|P3|Booster Period|Lost to Follow-up|0
352045|NCT00454987|1142511|P2|Booster Period|Lost to Follow-up|0
352046|NCT00454987|1142512|P1|Booster Period|Lost to Follow-up|1
352047|NCT00454987|1142510|P3|Booster Period|Withdrawal by Subject|0
352048|NCT00454987|1142511|P2|Booster Period|Withdrawal by Subject|1
352049|NCT00454987|1142512|P1|Booster Period|Withdrawal by Subject|0
352050|NCT00454987|1142510|P3|Booster Period|Adverse Event|0
352051|NCT00454987|1142511|P2|Booster Period|Adverse Event|0
352052|NCT00454987|1142512|P1|Booster Period|Adverse Event|1
352053|NCT00454649|1142593|P10|Overall Study|Withdrawal by Subject|0
352054|NCT00454649|1142594|P9|Overall Study|Withdrawal by Subject|1
352055|NCT00454649|1142595|P8|Overall Study|Withdrawal by Subject|2
352056|NCT00454649|1142596|P7|Overall Study|Withdrawal by Subject|0
352057|NCT00454649|1142597|P6|Overall Study|Withdrawal by Subject|1
352058|NCT00454649|1142598|P5|Overall Study|Withdrawal by Subject|0
352059|NCT00454649|1142599|P4|Overall Study|Withdrawal by Subject|0
352060|NCT00454649|1142600|P3|Overall Study|Withdrawal by Subject|0
352061|NCT00454649|1142601|P2|Overall Study|Withdrawal by Subject|0
352062|NCT00454649|1142602|P1|Overall Study|Withdrawal by Subject|0
352063|NCT00454649|1142593|P10|Overall Study|Unspecified|1
352064|NCT00454649|1142594|P9|Overall Study|Unspecified|3
352065|NCT00454649|1142595|P8|Overall Study|Unspecified|0
352066|NCT00454649|1142596|P7|Overall Study|Unspecified|0
352067|NCT00454649|1142597|P6|Overall Study|Unspecified|0
352068|NCT00454649|1142598|P5|Overall Study|Unspecified|0
352069|NCT00454649|1142599|P4|Overall Study|Unspecified|3
352070|NCT00454649|1142600|P3|Overall Study|Unspecified|5
352071|NCT00454649|1142601|P2|Overall Study|Unspecified|1
352072|NCT00454649|1142602|P1|Overall Study|Unspecified|1
352073|NCT00454649|1142593|P10|Overall Study|Lost to Follow-up|0
352074|NCT00454649|1142594|P9|Overall Study|Lost to Follow-up|0
352075|NCT00454649|1142595|P8|Overall Study|Lost to Follow-up|0
352076|NCT00454649|1142596|P7|Overall Study|Lost to Follow-up|1
352077|NCT00454649|1142597|P6|Overall Study|Lost to Follow-up|0
352078|NCT00454649|1142598|P5|Overall Study|Lost to Follow-up|0
352079|NCT00454649|1142599|P4|Overall Study|Lost to Follow-up|0
352080|NCT00454649|1142600|P3|Overall Study|Lost to Follow-up|1
352081|NCT00454649|1142601|P2|Overall Study|Lost to Follow-up|0
352082|NCT00454649|1142602|P1|Overall Study|Lost to Follow-up|0
352083|NCT00454649|1142593|P10|Overall Study|Adverse Event|2
352084|NCT00454649|1142594|P9|Overall Study|Adverse Event|6
352085|NCT00454649|1142595|P8|Overall Study|Adverse Event|4
352086|NCT00454649|1142596|P7|Overall Study|Adverse Event|3
352087|NCT00454649|1142597|P6|Overall Study|Adverse Event|2
352088|NCT00454649|1142598|P5|Overall Study|Adverse Event|1
352089|NCT00454649|1142599|P4|Overall Study|Adverse Event|0
352090|NCT00454649|1142600|P3|Overall Study|Adverse Event|3
352091|NCT00454649|1142601|P2|Overall Study|Adverse Event|1
352092|NCT00454649|1142602|P1|Overall Study|Adverse Event|0
352093|NCT00454649|1142593|P10|Overall Study|Lack of Efficacy|2
352094|NCT00454649|1142594|P9|Overall Study|Lack of Efficacy|10
352095|NCT00454649|1142595|P8|Overall Study|Lack of Efficacy|13
352096|NCT00454649|1142596|P7|Overall Study|Lack of Efficacy|5
352097|NCT00454649|1142597|P6|Overall Study|Lack of Efficacy|4
352098|NCT00454649|1142598|P5|Overall Study|Lack of Efficacy|0
352099|NCT00454649|1142599|P4|Overall Study|Lack of Efficacy|3
352100|NCT00454649|1142600|P3|Overall Study|Lack of Efficacy|10
352101|NCT00454649|1142601|P2|Overall Study|Lack of Efficacy|2
352102|NCT00454649|1142602|P1|Overall Study|Lack of Efficacy|2
352103|NCT00454636|1142731|P4|Overall Study|Lost to Follow-up|0
352104|NCT00454636|1142732|P3|Overall Study|Lost to Follow-up|0
352105|NCT00454636|1142733|P2|Overall Study|Lost to Follow-up|1
352106|NCT00454636|1142734|P1|Overall Study|Lost to Follow-up|0
352107|NCT00454636|1142731|P4|Overall Study|Patient refusal|2
352108|NCT00454636|1142732|P3|Overall Study|Patient refusal|3
352109|NCT00454636|1142733|P2|Overall Study|Patient refusal|1
352110|NCT00454636|1142734|P1|Overall Study|Patient refusal|1
352111|NCT00454636|1142731|P4|Overall Study|Death|1
352112|NCT00454636|1142732|P3|Overall Study|Death|1
352113|NCT00454636|1142733|P2|Overall Study|Death|1
352114|NCT00454636|1142734|P1|Overall Study|Death|6
352115|NCT00454636|1142731|P4|Overall Study|Protocol Violation|3
352116|NCT00454636|1142732|P3|Overall Study|Protocol Violation|3
352117|NCT00454636|1142733|P2|Overall Study|Protocol Violation|2
352118|NCT00454636|1142734|P1|Overall Study|Protocol Violation|3
352119|NCT00454636|1142731|P4|Overall Study|Disease Progression|11
352120|NCT00454636|1142732|P3|Overall Study|Disease Progression|4
352121|NCT00454636|1142733|P2|Overall Study|Disease Progression|12
352122|NCT00454636|1142734|P1|Overall Study|Disease Progression|11
352123|NCT00454636|1142731|P4|Overall Study|Adverse Event|15
352124|NCT00454636|1142732|P3|Overall Study|Adverse Event|9
352125|NCT00454636|1142733|P2|Overall Study|Adverse Event|6
352126|NCT00454636|1142734|P1|Overall Study|Adverse Event|10
352127|NCT00454584|1142767|P6|After Controlled Period|Unspecified|17
352128|NCT00454584|1142768|P5|After Controlled Period|Unspecified|5
352129|NCT00454584|1142769|P4|After Controlled Period|Unspecified|13
352130|NCT00454584|1142770|P3|After Controlled Period|Unspecified|0
352131|NCT00454584|1142771|P2|After Controlled Period|Unspecified|0
352132|NCT00454584|1142772|P1|After Controlled Period|Unspecified|0
352133|NCT00454584|1142767|P6|After Controlled Period|Unspecified|0
352134|NCT00454584|1142768|P5|After Controlled Period|Unspecified|0
352135|NCT00454584|1142769|P4|After Controlled Period|Unspecified|1
352136|NCT00454584|1142770|P3|After Controlled Period|Unspecified|0
352137|NCT00454584|1142771|P2|After Controlled Period|Unspecified|0
352138|NCT00454584|1142772|P1|After Controlled Period|Unspecified|0
352139|NCT00454584|1142767|P6|After Controlled Period|Lost to Follow-up|6
352140|NCT00454584|1142768|P5|After Controlled Period|Lost to Follow-up|4
352141|NCT00454584|1142769|P4|After Controlled Period|Lost to Follow-up|2
352142|NCT00454584|1142770|P3|After Controlled Period|Lost to Follow-up|0
352143|NCT00454584|1142771|P2|After Controlled Period|Lost to Follow-up|0
352144|NCT00454584|1142772|P1|After Controlled Period|Lost to Follow-up|0
352145|NCT00454584|1142767|P6|After Controlled Period|Lack of Efficacy|0
352146|NCT00454584|1142768|P5|After Controlled Period|Lack of Efficacy|0
352147|NCT00454584|1142769|P4|After Controlled Period|Lack of Efficacy|1
352148|NCT00454584|1142770|P3|After Controlled Period|Lack of Efficacy|0
352149|NCT00454584|1142771|P2|After Controlled Period|Lack of Efficacy|0
352150|NCT00454584|1142772|P1|After Controlled Period|Lack of Efficacy|0
352151|NCT00454584|1142767|P6|After Controlled Period|Adverse Event|9
352152|NCT00454584|1142768|P5|After Controlled Period|Adverse Event|3
352153|NCT00454584|1142769|P4|After Controlled Period|Adverse Event|9
352154|NCT00454584|1142770|P3|After Controlled Period|Adverse Event|0
352155|NCT00454584|1142771|P2|After Controlled Period|Adverse Event|0
352156|NCT00454584|1142772|P1|After Controlled Period|Adverse Event|0
352157|NCT00454584|1142767|P6|Controlled Period|unspecified|0
352158|NCT00454584|1142768|P5|Controlled Period|unspecified|0
352159|NCT00454584|1142769|P4|Controlled Period|unspecified|0
352160|NCT00454584|1142770|P3|Controlled Period|unspecified|2
352161|NCT00454584|1142771|P2|Controlled Period|unspecified|4
352162|NCT00454584|1142772|P1|Controlled Period|unspecified|5
352163|NCT00454584|1142767|P6|Controlled Period|Lost to Follow-up|0
352164|NCT00454584|1142768|P5|Controlled Period|Lost to Follow-up|0
352165|NCT00454584|1142769|P4|Controlled Period|Lost to Follow-up|0
352166|NCT00454584|1142770|P3|Controlled Period|Lost to Follow-up|2
352167|NCT00454584|1142771|P2|Controlled Period|Lost to Follow-up|2
352168|NCT00454584|1142772|P1|Controlled Period|Lost to Follow-up|1
352169|NCT00454584|1142767|P6|Controlled Period|Adverse Event|0
352170|NCT00454584|1142768|P5|Controlled Period|Adverse Event|0
352171|NCT00454584|1142769|P4|Controlled Period|Adverse Event|0
352172|NCT00454584|1142770|P3|Controlled Period|Adverse Event|1
352173|NCT00454584|1142771|P2|Controlled Period|Adverse Event|2
352174|NCT00454584|1142772|P1|Controlled Period|Adverse Event|5
352175|NCT00454571|1142794|P2|Overall Study|Withdrawal by Subject|5
352176|NCT00454571|1142795|P1|Overall Study|Withdrawal by Subject|10
352177|NCT00454571|1142794|P2|Overall Study|Protocol Violation|0
352178|NCT00454571|1142795|P1|Overall Study|Protocol Violation|1
352179|NCT00454571|1142794|P2|Overall Study|Physician Decision|1
352180|NCT00454571|1142795|P1|Overall Study|Physician Decision|0
352181|NCT00454571|1142794|P2|Overall Study|Adverse Event|0
352182|NCT00454571|1142795|P1|Overall Study|Adverse Event|2
352183|NCT00454363|1142830|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
352184|NCT00454363|1142831|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
352185|NCT00454363|1142830|P2|Overall Study|Adverse Event|2
352186|NCT00454363|1142831|P1|Overall Study|Adverse Event|1
352187|NCT00454246|1142856|P3|Overall Study|Early termination of study|9
352188|NCT00454246|1142857|P2|Overall Study|Early termination of study|26
352189|NCT00454246|1142858|P1|Overall Study|Early termination of study|62
352190|NCT00454246|1142856|P3|Overall Study|Failure to return|0
352191|NCT00454246|1142857|P2|Overall Study|Failure to return|0
352192|NCT00454246|1142858|P1|Overall Study|Failure to return|1
352193|NCT00454246|1142856|P3|Overall Study|Refused Treatment|0
352194|NCT00454246|1142857|P2|Overall Study|Refused Treatment|1
352195|NCT00454246|1142858|P1|Overall Study|Refused Treatment|1
352196|NCT00454246|1142856|P3|Overall Study|Protocol Violation|0
352197|NCT00454246|1142857|P2|Overall Study|Protocol Violation|0
352198|NCT00454246|1142858|P1|Overall Study|Protocol Violation|1
352199|NCT00454246|1142856|P3|Overall Study|Violation of selection criteria at entry|0
352200|NCT00454246|1142857|P2|Overall Study|Violation of selection criteria at entry|0
352201|NCT00454246|1142858|P1|Overall Study|Violation of selection criteria at entry|6
352202|NCT00454246|1142856|P3|Overall Study|Adverse Event|0
352203|NCT00454246|1142857|P2|Overall Study|Adverse Event|2
352204|NCT00454246|1142858|P1|Overall Study|Adverse Event|2
352205|NCT00454207|1142874|P2|Overall Study|Protocol Violation|1
352206|NCT00454207|1142875|P1|Overall Study|Protocol Violation|0
352207|NCT00454207|1142874|P2|Overall Study|Lack of Efficacy|0
352208|NCT00454207|1142875|P1|Overall Study|Lack of Efficacy|1
352209|NCT00454207|1142874|P2|Overall Study|Adverse Event|1
352210|NCT00454207|1142875|P1|Overall Study|Adverse Event|3
352211|NCT00454194|1142920|P2|Overall Study|Other Unspecified Reason|2
352212|NCT00454194|1142921|P1|Overall Study|Other Unspecified Reason|2
352213|NCT00454194|1142920|P2|Overall Study|Other Medical Problems|2
352214|NCT00454194|1142921|P1|Overall Study|Other Medical Problems|1
352215|NCT00454194|1142920|P2|Overall Study|Withdrawal by Subject|8
352216|NCT00454194|1142921|P1|Overall Study|Withdrawal by Subject|12
352217|NCT00454194|1142920|P2|Overall Study|Adverse Event|2
352218|NCT00454194|1142921|P1|Overall Study|Adverse Event|7
352219|NCT00454181|1142939|P2|Overall Study|Withdrawal by Subject|0
352220|NCT00454181|1142940|P1|Overall Study|Withdrawal by Subject|2
352221|NCT00454181|1142939|P2|Overall Study|Protocol Violation|1
352222|NCT00454181|1142940|P1|Overall Study|Protocol Violation|1
352223|NCT00454181|1142939|P2|Overall Study|Lost to Follow-up|1
352224|NCT00454181|1142940|P1|Overall Study|Lost to Follow-up|11
352225|NCT00454181|1142939|P2|Overall Study|Adverse Event|1
352226|NCT00454181|1142940|P1|Overall Study|Adverse Event|1
352227|NCT00454142|1142956|P1|Overall Study|Withdrawal by Subject|1
352228|NCT00454116|1142974|P3|Overall Study|Other|0
352229|NCT00454116|1142975|P2|Overall Study|Other|2
352230|NCT00454116|1142976|P1|Overall Study|Other|2
352231|NCT00454116|1142974|P3|Overall Study|Withdrawal by Subject|1
352232|NCT00454116|1142975|P2|Overall Study|Withdrawal by Subject|3
352233|NCT00454116|1142976|P1|Overall Study|Withdrawal by Subject|3
352234|NCT00454116|1142974|P3|Overall Study|Condition under investigation worsened|18
352235|NCT00454116|1142975|P2|Overall Study|Condition under investigation worsened|13
352236|NCT00454116|1142976|P1|Overall Study|Condition under investigation worsened|17
352237|NCT00454116|1142974|P3|Overall Study|Adverse Event|9
352238|NCT00454116|1142975|P2|Overall Study|Adverse Event|11
352239|NCT00454116|1142976|P1|Overall Study|Adverse Event|5
352240|NCT00454051|1142986|P2|Overall Study|Protocol Violation|1
352241|NCT00454051|1142987|P1|Overall Study|Protocol Violation|1
352242|NCT00454051|1142986|P2|Overall Study|Withdrawal by Subject|0
352243|NCT00454051|1142987|P1|Overall Study|Withdrawal by Subject|1
352244|NCT00454051|1142986|P2|Overall Study|Adverse Event|2
352245|NCT00454051|1142987|P1|Overall Study|Adverse Event|1
352246|NCT00453999|1143020|P3|Overall Study|Subject Request|0
352247|NCT00453999|1143021|P2|Overall Study|Subject Request|1
352248|NCT00453999|1143022|P1|Overall Study|Subject Request|2
352249|NCT00453999|1143020|P3|Overall Study|Withdrawal by Subject|1
352250|NCT00453999|1143021|P2|Overall Study|Withdrawal by Subject|1
352251|NCT00453999|1143022|P1|Overall Study|Withdrawal by Subject|2
352252|NCT00453999|1143020|P3|Overall Study|Lost to Follow-up|1
352253|NCT00453999|1143021|P2|Overall Study|Lost to Follow-up|1
352254|NCT00453999|1143022|P1|Overall Study|Lost to Follow-up|0
352255|NCT00453999|1143020|P3|Overall Study|Adverse Event|1
352256|NCT00453999|1143021|P2|Overall Study|Adverse Event|2
352257|NCT00453999|1143022|P1|Overall Study|Adverse Event|1
352258|NCT00453986|1143050|P5|Overall Study|Lost to Follow-up|0
352259|NCT00453986|1143051|P4|Overall Study|Lost to Follow-up|2
352260|NCT00453986|1143052|P3|Overall Study|Lost to Follow-up|6
352261|NCT00453986|1143053|P2|Overall Study|Lost to Follow-up|5
352262|NCT00453986|1143054|P1|Overall Study|Lost to Follow-up|6
352263|NCT00453973|1143149|P2|Overall Study|Sponsor Decision to Terminate Study|30
352264|NCT00453973|1143150|P1|Overall Study|Sponsor Decision to Terminate Study|35
352265|NCT00453973|1143149|P2|Overall Study|Site closed by sponsor|0
352266|NCT00453973|1143150|P1|Overall Study|Site closed by sponsor|3
352267|NCT00453973|1143149|P2|Overall Study|Renal transplant|1
352268|NCT00453973|1143150|P1|Overall Study|Renal transplant|1
352269|NCT00453973|1143149|P2|Overall Study|Relocation|0
352270|NCT00453973|1143150|P1|Overall Study|Relocation|1
352271|NCT00453973|1143149|P2|Overall Study|PI Decision|2
352272|NCT00453973|1143150|P1|Overall Study|PI Decision|0
352273|NCT00453973|1143149|P2|Overall Study|Withdrawal by Subject|6
352274|NCT00453973|1143150|P1|Overall Study|Withdrawal by Subject|7
352275|NCT00453973|1143149|P2|Overall Study|Adverse Event|9
352276|NCT00453973|1143150|P1|Overall Study|Adverse Event|4
352277|NCT00453362|1143185|P1|Overall Study|Screening Failure|14
352278|NCT00453362|1143185|P1|Overall Study|Progression of disease|56
352279|NCT00453362|1143185|P1|Overall Study|Withdrawal by Subject|3
352280|NCT00453362|1143185|P1|Overall Study|Physician Decision|2
352281|NCT00453362|1143185|P1|Overall Study|Death|7
352282|NCT00453362|1143185|P1|Overall Study|Adverse Event|5
352283|NCT00453349|1143211|P2|Completed Study|Lost to follow up after study treatment|11
352284|NCT00453349|1143212|P1|Completed Study|Lost to follow up after study treatment|2
352285|NCT00453349|1143211|P2|Completed Study|Withdrawal by Subject|5
352286|NCT00453349|1143212|P1|Completed Study|Withdrawal by Subject|3
352287|NCT00453349|1143211|P2|Completed Study|Protocol Violation|1
352288|NCT00453349|1143212|P1|Completed Study|Protocol Violation|1
352289|NCT00453349|1143211|P2|Completed Study|Lost to Follow-up|5
352290|NCT00453349|1143212|P1|Completed Study|Lost to Follow-up|7
352291|NCT00453349|1143211|P2|Completed Study|Lack of Efficacy|1
352292|NCT00453349|1143212|P1|Completed Study|Lack of Efficacy|2
352293|NCT00453349|1143211|P2|Completed Study|Adverse Event|11
352294|NCT00453349|1143212|P1|Completed Study|Adverse Event|12
352295|NCT00453349|1143211|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
352296|NCT00453349|1143212|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
352297|NCT00453349|1143211|P2|Randomized|Withdrawal by Subject|5
352298|NCT00453349|1143212|P1|Randomized|Withdrawal by Subject|3
352299|NCT00453349|1143211|P2|Randomized|Protocol Violation|1
352300|NCT00453349|1143212|P1|Randomized|Protocol Violation|1
352301|NCT00453349|1143211|P2|Randomized|Lost to Follow-up|5
352302|NCT00453349|1143212|P1|Randomized|Lost to Follow-up|7
352303|NCT00453349|1143211|P2|Randomized|Lack of Efficacy|1
352304|NCT00453349|1143212|P1|Randomized|Lack of Efficacy|2
352305|NCT00453349|1143211|P2|Randomized|Adverse Event|11
352306|NCT00453349|1143212|P1|Randomized|Adverse Event|12
352307|NCT00453310|1143243|P1|Overall Study|Progression of Disease|10
352308|NCT00453206|1143247|P1|Overall Study|Death|1
352309|NCT00453180|1143257|P2|Overall Study|Adverse Event|2
352310|NCT00453180|1143258|P1|Overall Study|Adverse Event|1
352311|NCT00453180|1143257|P2|Overall Study|Lost to Follow-up|1
352312|NCT00453180|1143258|P1|Overall Study|Lost to Follow-up|2
352313|NCT00453154|1143277|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
352314|NCT00453154|1143278|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
352315|NCT00453154|1143279|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
352316|NCT00453154|1143280|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
352317|NCT00453154|1143277|P4|Double BIind Maintenance|Medical Issues|1
352318|NCT00453154|1143278|P3|Double BIind Maintenance|Medical Issues|3
352319|NCT00453154|1143279|P2|Double BIind Maintenance|Medical Issues|0
352320|NCT00453154|1143280|P1|Double BIind Maintenance|Medical Issues|0
352321|NCT00453154|1143277|P4|Double BIind Maintenance|Progression|26
352322|NCT00453154|1143278|P3|Double BIind Maintenance|Progression|29
352323|NCT00453154|1143279|P2|Double BIind Maintenance|Progression|0
352324|NCT00453154|1143280|P1|Double BIind Maintenance|Progression|0
352325|NCT00453154|1143277|P4|Double BIind Maintenance|Withdrawal by Subject|4
352326|NCT00453154|1143278|P3|Double BIind Maintenance|Withdrawal by Subject|4
352327|NCT00453154|1143279|P2|Double BIind Maintenance|Withdrawal by Subject|0
352328|NCT00453154|1143280|P1|Double BIind Maintenance|Withdrawal by Subject|0
352329|NCT00453154|1143277|P4|Double BIind Maintenance|Death|1
352330|NCT00453154|1143278|P3|Double BIind Maintenance|Death|2
352331|NCT00453154|1143279|P2|Double BIind Maintenance|Death|0
352332|NCT00453154|1143280|P1|Double BIind Maintenance|Death|0
352333|NCT00453154|1143277|P4|Double BIind Maintenance|Adverse Event|12
352334|NCT00453154|1143278|P3|Double BIind Maintenance|Adverse Event|3
352335|NCT00453154|1143279|P2|Double BIind Maintenance|Adverse Event|0
352336|NCT00453154|1143280|P1|Double BIind Maintenance|Adverse Event|0
352337|NCT00453102|1143293|P1|Overall Study|Withdrawal by Subject|2
352338|NCT00453063|1143304|P2|Overall Study|Protocol Violation|0
352339|NCT00453063|1143305|P1|Overall Study|Protocol Violation|1
352340|NCT00453063|1143304|P2|Overall Study|Withdrawal by Subject|1
352341|NCT00453063|1143305|P1|Overall Study|Withdrawal by Subject|1
352342|NCT00453063|1143304|P2|Overall Study|Adverse Event|2
352343|NCT00453063|1143305|P1|Overall Study|Adverse Event|1
352344|NCT00452790|1143325|P2|Toddler Dose|Parent/legal guardian request|1
352345|NCT00452790|1143326|P1|Toddler Dose|Parent/legal guardian request|0
352346|NCT00452790|1143325|P2|Toddler Dose|Failed to return|1
352347|NCT00452790|1143326|P1|Toddler Dose|Failed to return|0
352348|NCT00452790|1143325|P2|After Infant Series|Other reasons|0
352349|NCT00452790|1143326|P1|After Infant Series|Other reasons|1
352350|NCT00452790|1143325|P2|After Infant Series|Failed to return|0
352351|NCT00452790|1143326|P1|After Infant Series|Failed to return|1
352352|NCT00452790|1143325|P2|After Infant Series|Lost to Follow-up|0
352353|NCT00452790|1143326|P1|After Infant Series|Lost to Follow-up|4
352354|NCT00452790|1143325|P2|After Infant Series|Parent/legal guardian request|3
352355|NCT00452790|1143326|P1|After Infant Series|Parent/legal guardian request|1
352356|NCT00452790|1143325|P2|After Infant Series|Adverse Event|1
352357|NCT00452790|1143326|P1|After Infant Series|Adverse Event|4
352358|NCT00452790|1143325|P2|After Infant Series|Investigator request|10
352359|NCT00452790|1143326|P1|After Infant Series|Investigator request|10
352360|NCT00452790|1143325|P2|Infant Series|Death|1
352361|NCT00452790|1143326|P1|Infant Series|Death|0
352362|NCT00452790|1143325|P2|Infant Series|Investigator request|1
352363|NCT00452790|1143326|P1|Infant Series|Investigator request|0
352364|NCT00452790|1143325|P2|Infant Series|Other reasons|2
352365|NCT00452790|1143326|P1|Infant Series|Other reasons|1
352366|NCT00452790|1143325|P2|Infant Series|Adverse Event|2
352367|NCT00452790|1143326|P1|Infant Series|Adverse Event|1
352368|NCT00452790|1143325|P2|Infant Series|Lost to Follow-up|2
352369|NCT00452790|1143326|P1|Infant Series|Lost to Follow-up|2
352370|NCT00452790|1143325|P2|Infant Series|Protocol Violation|3
352371|NCT00452790|1143326|P1|Infant Series|Protocol Violation|1
352372|NCT00452790|1143325|P2|Infant Series|Failed to return|1
352373|NCT00452790|1143326|P1|Infant Series|Failed to return|4
352374|NCT00452790|1143325|P2|Infant Series|Parent/legal guardian request|6
352375|NCT00452790|1143326|P1|Infant Series|Parent/legal guardian request|8
352376|NCT00452790|1143325|P2|Infant Series|Clinical hold - consent withdrawn|123
352377|NCT00452790|1143326|P1|Infant Series|Clinical hold - consent withdrawn|118
352378|NCT00452699|1143362|P2|Overall Study|Other|7
352379|NCT00452699|1143363|P1|Overall Study|Other|12
352380|NCT00452699|1143362|P2|Overall Study|Withdrawal by Subject|25
352381|NCT00452699|1143363|P1|Overall Study|Withdrawal by Subject|26
352382|NCT00452699|1143362|P2|Overall Study|Protocol Violation|25
352383|NCT00452699|1143363|P1|Overall Study|Protocol Violation|21
352384|NCT00452699|1143362|P2|Overall Study|Lost to Follow-up|9
352385|NCT00452699|1143363|P1|Overall Study|Lost to Follow-up|6
352386|NCT00452699|1143362|P2|Overall Study|Lack of Efficacy|4
352387|NCT00452699|1143363|P1|Overall Study|Lack of Efficacy|6
352388|NCT00452699|1143362|P2|Overall Study|Adverse Event|3
352389|NCT00452699|1143363|P1|Overall Study|Adverse Event|10
352390|NCT00452673|1143379|P5|Dose Expansion Period|not specified|2
352391|NCT00452673|1143380|P4|Dose Expansion Period|not specified|0
352392|NCT00452673|1143381|P3|Dose Expansion Period|not specified|0
352393|NCT00452673|1143382|P2|Dose Expansion Period|not specified|0
352394|NCT00452673|1143383|P1|Dose Expansion Period|not specified|0
352395|NCT00452673|1143379|P5|Dose Expansion Period|Disease Progression|19
352396|NCT00452673|1143380|P4|Dose Expansion Period|Disease Progression|0
352397|NCT00452673|1143381|P3|Dose Expansion Period|Disease Progression|0
352398|NCT00452673|1143382|P2|Dose Expansion Period|Disease Progression|0
352399|NCT00452673|1143383|P1|Dose Expansion Period|Disease Progression|0
352400|NCT00452673|1143379|P5|Dose Escalation Period|Withdrawal by Subject|0
352401|NCT00452673|1143380|P4|Dose Escalation Period|Withdrawal by Subject|1
352402|NCT00452673|1143381|P3|Dose Escalation Period|Withdrawal by Subject|0
352403|NCT00452673|1143382|P2|Dose Escalation Period|Withdrawal by Subject|0
352404|NCT00452673|1143383|P1|Dose Escalation Period|Withdrawal by Subject|0
352405|NCT00452673|1143379|P5|Dose Escalation Period|Adverse Event|0
352406|NCT00452673|1143380|P4|Dose Escalation Period|Adverse Event|1
352407|NCT00452673|1143381|P3|Dose Escalation Period|Adverse Event|0
352408|NCT00452673|1143382|P2|Dose Escalation Period|Adverse Event|0
352409|NCT00452673|1143383|P1|Dose Escalation Period|Adverse Event|0
352410|NCT00452673|1143379|P5|Dose Escalation Period|not specified|0
352411|NCT00452673|1143380|P4|Dose Escalation Period|not specified|0
352412|NCT00452673|1143381|P3|Dose Escalation Period|not specified|1
352413|NCT00452673|1143382|P2|Dose Escalation Period|not specified|0
352414|NCT00452673|1143383|P1|Dose Escalation Period|not specified|0
352415|NCT00452673|1143379|P5|Dose Escalation Period|study drug toxicity|0
352416|NCT00452673|1143380|P4|Dose Escalation Period|study drug toxicity|1
352417|NCT00452673|1143381|P3|Dose Escalation Period|study drug toxicity|3
352418|NCT00452673|1143382|P2|Dose Escalation Period|study drug toxicity|3
352419|NCT00452673|1143383|P1|Dose Escalation Period|study drug toxicity|1
352420|NCT00452673|1143379|P5|Dose Escalation Period|Disease Progression|0
352421|NCT00452673|1143380|P4|Dose Escalation Period|Disease Progression|6
352422|NCT00452673|1143381|P3|Dose Escalation Period|Disease Progression|2
352423|NCT00452673|1143382|P2|Dose Escalation Period|Disease Progression|6
352424|NCT00452673|1143383|P1|Dose Escalation Period|Disease Progression|6
352425|NCT00452530|1143430|P2|Overall Study|Not specified|11
352426|NCT00452530|1143431|P1|Overall Study|Not specified|7
352427|NCT00452530|1143430|P2|Overall Study|No longer met study criteria|22
352428|NCT00452530|1143431|P1|Overall Study|No longer met study criteria|18
352429|NCT00452530|1143430|P2|Overall Study|Poor compliance/noncompliance|2
352430|NCT00452530|1143431|P1|Overall Study|Poor compliance/noncompliance|1
352431|NCT00452530|1143430|P2|Overall Study|Lost to Follow-up|0
352432|NCT00452530|1143431|P1|Overall Study|Lost to Follow-up|1
352433|NCT00452530|1143430|P2|Overall Study|Withdrawal by Subject|57
352434|NCT00452530|1143431|P1|Overall Study|Withdrawal by Subject|68
352435|NCT00452530|1143430|P2|Overall Study|Adverse Event|44
352436|NCT00452530|1143431|P1|Overall Study|Adverse Event|40
352437|NCT00452530|1143430|P2|Overall Study|Death|0
352438|NCT00452530|1143431|P1|Overall Study|Death|1
352439|NCT00452452|1143452|P3|Overall Study|Lost to Follow-up|0
352440|NCT00452452|1143453|P2|Overall Study|Lost to Follow-up|0
352441|NCT00452452|1143454|P1|Overall Study|Lost to Follow-up|1
352442|NCT00452452|1143452|P3|Overall Study|Withdrawal by Subject|0
352443|NCT00452452|1143453|P2|Overall Study|Withdrawal by Subject|0
352444|NCT00452452|1143454|P1|Overall Study|Withdrawal by Subject|1
352445|NCT00452452|1143452|P3|Overall Study|Protocol Violation|1
352446|NCT00452452|1143453|P2|Overall Study|Protocol Violation|0
352447|NCT00452452|1143454|P1|Overall Study|Protocol Violation|0
352448|NCT00452400|1143499|P5|Overall Study|Other reasons not listed above|1
352449|NCT00452400|1143500|P4|Overall Study|Other reasons not listed above|1
352450|NCT00452400|1143501|P3|Overall Study|Other reasons not listed above|0
352451|NCT00452400|1143502|P2|Overall Study|Other reasons not listed above|0
352452|NCT00452400|1143503|P1|Overall Study|Other reasons not listed above|0
352453|NCT00452400|1143499|P5|Overall Study|Lack of Efficacy|0
352454|NCT00452400|1143500|P4|Overall Study|Lack of Efficacy|0
352455|NCT00452400|1143501|P3|Overall Study|Lack of Efficacy|0
352456|NCT00452400|1143502|P2|Overall Study|Lack of Efficacy|0
352457|NCT00452400|1143503|P1|Overall Study|Lack of Efficacy|2
352458|NCT00452400|1143499|P5|Overall Study|Withdrawal by Subject|0
352459|NCT00452400|1143500|P4|Overall Study|Withdrawal by Subject|0
352460|NCT00452400|1143501|P3|Overall Study|Withdrawal by Subject|1
352461|NCT00452400|1143502|P2|Overall Study|Withdrawal by Subject|0
352462|NCT00452400|1143503|P1|Overall Study|Withdrawal by Subject|1
352463|NCT00452400|1143499|P5|Overall Study|Lost to Follow-up|0
352464|NCT00452400|1143500|P4|Overall Study|Lost to Follow-up|0
352465|NCT00452400|1143501|P3|Overall Study|Lost to Follow-up|0
352466|NCT00452400|1143502|P2|Overall Study|Lost to Follow-up|0
352467|NCT00452400|1143503|P1|Overall Study|Lost to Follow-up|1
352468|NCT00452400|1143499|P5|Overall Study|Protocol Violation|0
352469|NCT00452400|1143500|P4|Overall Study|Protocol Violation|0
352470|NCT00452400|1143501|P3|Overall Study|Protocol Violation|1
352471|NCT00452400|1143502|P2|Overall Study|Protocol Violation|0
352472|NCT00452400|1143503|P1|Overall Study|Protocol Violation|0
352473|NCT00452400|1143499|P5|Overall Study|Adverse Event|2
352474|NCT00452400|1143500|P4|Overall Study|Adverse Event|0
352475|NCT00452400|1143501|P3|Overall Study|Adverse Event|5
352476|NCT00452400|1143502|P2|Overall Study|Adverse Event|1
352477|NCT00452400|1143503|P1|Overall Study|Adverse Event|1
352478|NCT00452361|1143690|P2|Overall Study|Premature termination|9
352479|NCT00452361|1143691|P1|Overall Study|Premature termination|13
352480|NCT00452361|1143690|P2|Overall Study|Withdrawal by Subject|1
352481|NCT00452361|1143691|P1|Overall Study|Withdrawal by Subject|0
352482|NCT00452361|1143690|P2|Overall Study|Adverse Event|0
352483|NCT00452361|1143691|P1|Overall Study|Adverse Event|8
352484|NCT00452348|1143735|P2|Overall Study|Other|9
352485|NCT00452348|1143736|P1|Overall Study|Other|9
352486|NCT00452348|1143735|P2|Overall Study|Withdrawal by Subject|21
352487|NCT00452348|1143736|P1|Overall Study|Withdrawal by Subject|18
352488|NCT00452348|1143735|P2|Overall Study|Protocol Violation|28
352489|NCT00452348|1143736|P1|Overall Study|Protocol Violation|22
352490|NCT00452348|1143735|P2|Overall Study|Lost to Follow-up|8
352491|NCT00452348|1143736|P1|Overall Study|Lost to Follow-up|14
352492|NCT00452348|1143735|P2|Overall Study|Lack of Efficacy|9
352493|NCT00452348|1143736|P1|Overall Study|Lack of Efficacy|10
352494|NCT00452348|1143735|P2|Overall Study|Adverse Event|9
352495|NCT00452348|1143736|P1|Overall Study|Adverse Event|6
352496|NCT00452114|1143790|P2|Overall Study|Physician Decision|3
352497|NCT00452114|1143791|P1|Overall Study|Physician Decision|3
352498|NCT00451958|1143801|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
352499|NCT00451958|1143802|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
352500|NCT00451958|1143803|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
352501|NCT00451958|1143804|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
352502|NCT00451958|1143805|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
352503|NCT00451958|1143801|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
352504|NCT00451958|1143802|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
352505|NCT00451958|1143803|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
352506|NCT00451958|1143804|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
352507|NCT00451958|1143805|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
352508|NCT00451958|1143801|P5|CS21A (NCT00451958)|Physician Decision|0
352509|NCT00451958|1143802|P4|CS21A (NCT00451958)|Physician Decision|4
352510|NCT00451958|1143803|P3|CS21A (NCT00451958)|Physician Decision|4
352511|NCT00451958|1143804|P2|CS21A (NCT00451958)|Physician Decision|4
352512|NCT00451958|1143805|P1|CS21A (NCT00451958)|Physician Decision|2
352513|NCT00451958|1143801|P5|CS21A (NCT00451958)|Protocol Violation|0
352514|NCT00451958|1143802|P4|CS21A (NCT00451958)|Protocol Violation|0
352515|NCT00451958|1143803|P3|CS21A (NCT00451958)|Protocol Violation|2
352516|NCT00451958|1143804|P2|CS21A (NCT00451958)|Protocol Violation|3
352517|NCT00451958|1143805|P1|CS21A (NCT00451958)|Protocol Violation|1
352518|NCT00451958|1143801|P5|CS21A (NCT00451958)|Lost to Follow-up|0
352519|NCT00451958|1143802|P4|CS21A (NCT00451958)|Lost to Follow-up|1
352520|NCT00451958|1143803|P3|CS21A (NCT00451958)|Lost to Follow-up|1
352521|NCT00451958|1143804|P2|CS21A (NCT00451958)|Lost to Follow-up|5
352522|NCT00451958|1143805|P1|CS21A (NCT00451958)|Lost to Follow-up|6
352523|NCT00451958|1143801|P5|CS21A (NCT00451958)|Adverse Event|0
352524|NCT00451958|1143802|P4|CS21A (NCT00451958)|Adverse Event|17
352525|NCT00451958|1143803|P3|CS21A (NCT00451958)|Adverse Event|14
352526|NCT00451958|1143804|P2|CS21A (NCT00451958)|Adverse Event|34
352527|NCT00451958|1143805|P1|CS21A (NCT00451958)|Adverse Event|21
352528|NCT00450866|1143835|P2|Overall Study|Physician Decision|0
352529|NCT00450866|1143836|P1|Overall Study|Physician Decision|1
352530|NCT00450866|1143835|P2|Overall Study|Death|0
352531|NCT00450866|1143836|P1|Overall Study|Death|1
352532|NCT00450866|1143835|P2|Overall Study|Withdrawal by Subject|2
352533|NCT00450866|1143836|P1|Overall Study|Withdrawal by Subject|5
352534|NCT00450866|1143835|P2|Overall Study|Adverse Event|1
352535|NCT00450866|1143836|P1|Overall Study|Adverse Event|0
352536|NCT00450801|1143846|P1|Overall Study|Death|1
352537|NCT00450749|1143860|P3|Overall Study|Noncompliant|0
352538|NCT00450749|1143861|P2|Overall Study|Noncompliant|1
352539|NCT00450749|1143862|P1|Overall Study|Noncompliant|0
352540|NCT00450749|1143860|P3|Overall Study|Withdrawal by Subject|2
352541|NCT00450749|1143861|P2|Overall Study|Withdrawal by Subject|0
352542|NCT00450749|1143862|P1|Overall Study|Withdrawal by Subject|0
352543|NCT00450723|1143870|P1|Overall Study|Physician Decision|5
352544|NCT00451906|1143876|P1|Overall Study|Did not complete final visit|4
352545|NCT00451906|1143876|P1|Overall Study|Other Reasons|121
352546|NCT00451906|1143876|P1|Overall Study|Termination of the study|108
352547|NCT00451906|1143876|P1|Overall Study|Progressive disease|1328
352548|NCT00451906|1143876|P1|Overall Study|Protocol Violation|21
352549|NCT00451906|1143876|P1|Overall Study|Withdrawal by Subject|111
352550|NCT00451906|1143876|P1|Overall Study|Lost to Follow-up|31
352551|NCT00451906|1143876|P1|Overall Study|Adverse Event|515
352552|NCT00451451|1143899|P4|Overall Study|Other Reasons for Not Completing Study|14
352553|NCT00451451|1143900|P3|Overall Study|Other Reasons for Not Completing Study|17
352554|NCT00451451|1143901|P2|Overall Study|Other Reasons for Not Completing Study|30
352555|NCT00451451|1143902|P1|Overall Study|Other Reasons for Not Completing Study|34
352556|NCT00451451|1143899|P4|Overall Study|Death|1
352557|NCT00451451|1143900|P3|Overall Study|Death|0
352558|NCT00451451|1143901|P2|Overall Study|Death|0
352559|NCT00451451|1143902|P1|Overall Study|Death|1
352560|NCT00451451|1143899|P4|Overall Study|Subject Non-Compliance|3
352561|NCT00451451|1143900|P3|Overall Study|Subject Non-Compliance|3
352562|NCT00451451|1143901|P2|Overall Study|Subject Non-Compliance|4
352563|NCT00451451|1143902|P1|Overall Study|Subject Non-Compliance|8
352564|NCT00451451|1143899|P4|Overall Study|Investigator Decision|2
352565|NCT00451451|1143900|P3|Overall Study|Investigator Decision|1
352566|NCT00451451|1143901|P2|Overall Study|Investigator Decision|2
352567|NCT00451451|1143902|P1|Overall Study|Investigator Decision|6
352568|NCT00451451|1143899|P4|Overall Study|Consent Withdrawn|17
352569|NCT00451451|1143900|P3|Overall Study|Consent Withdrawn|17
352570|NCT00451451|1143901|P2|Overall Study|Consent Withdrawn|9
352571|NCT00451451|1143902|P1|Overall Study|Consent Withdrawn|14
352572|NCT00451451|1143899|P4|Overall Study|Lost to Follow-up|11
352573|NCT00451451|1143900|P3|Overall Study|Lost to Follow-up|8
352574|NCT00451451|1143901|P2|Overall Study|Lost to Follow-up|9
352575|NCT00451451|1143902|P1|Overall Study|Lost to Follow-up|11
352576|NCT00451451|1143899|P4|Overall Study|Adverse Event|10
352577|NCT00451451|1143900|P3|Overall Study|Adverse Event|26
352578|NCT00451451|1143901|P2|Overall Study|Adverse Event|21
352579|NCT00451451|1143902|P1|Overall Study|Adverse Event|11
352580|NCT00451282|1143931|P2|Overall Study|Lost to Follow-up|5
352581|NCT00451282|1143932|P1|Overall Study|Lost to Follow-up|6
352582|NCT00451204|1143946|P2|Overall Study|Other|2
352583|NCT00451204|1143947|P1|Overall Study|Other|1
352584|NCT00451204|1143946|P2|Overall Study|Patient refusal|4
352585|NCT00451204|1143947|P1|Overall Study|Patient refusal|8
352586|NCT00451204|1143946|P2|Overall Study|Protocol Violation|0
352587|NCT00451204|1143947|P1|Overall Study|Protocol Violation|1
352588|NCT00451204|1143946|P2|Overall Study|Lost to Follow-up|4
352589|NCT00451204|1143947|P1|Overall Study|Lost to Follow-up|4
352590|NCT00451204|1143946|P2|Overall Study|Lack of Efficacy|4
352591|NCT00451204|1143947|P1|Overall Study|Lack of Efficacy|4
352592|NCT00451204|1143946|P2|Overall Study|Adverse Event|6
352593|NCT00451204|1143947|P1|Overall Study|Adverse Event|4
352594|NCT00451191|1143965|P2|Overall Study|withdrawal or received alternate tx|11
352595|NCT00451191|1143966|P1|Overall Study|withdrawal or received alternate tx|15
352596|NCT00450658|1143990|P2|Overall Study|misc|10
352597|NCT00450658|1143991|P1|Overall Study|misc|21
352598|NCT00450658|1143990|P2|Overall Study|UGI ulcer|34
352599|NCT00450658|1143991|P1|Overall Study|UGI ulcer|33
352600|NCT00450658|1143990|P2|Overall Study|Lost to Follow-up|5
352601|NCT00450658|1143991|P1|Overall Study|Lost to Follow-up|22
352602|NCT00450658|1143990|P2|Overall Study|Withdrawal by Subject|26
352603|NCT00450658|1143991|P1|Overall Study|Withdrawal by Subject|43
352604|NCT00450658|1143990|P2|Overall Study|Adverse Event|15
352605|NCT00450658|1143991|P1|Overall Study|Adverse Event|24
352606|NCT00450619|1144005|P2|Overall Study|Adverse Event|0
352607|NCT00450619|1144006|P1|Overall Study|Adverse Event|1
352608|NCT00450619|1144005|P2|Overall Study|did not progress; refused further trmt|1
352609|NCT00450619|1144006|P1|Overall Study|did not progress; refused further trmt|1
352610|NCT00450619|1144005|P2|Overall Study|refused treatment after randomization|0
352611|NCT00450619|1144006|P1|Overall Study|refused treatment after randomization|2
352612|NCT00450580|1144032|P2|Overall Study|Withdrawal due to pregnancy|1
352613|NCT00450580|1144033|P1|Overall Study|Withdrawal due to pregnancy|0
352614|NCT00450580|1144032|P2|Overall Study|Patient could not swallow Norvir|0
352615|NCT00450580|1144033|P1|Overall Study|Patient could not swallow Norvir|1
352616|NCT00450580|1144032|P2|Overall Study|Patient went to Brazil|0
352617|NCT00450580|1144033|P1|Overall Study|Patient went to Brazil|1
352618|NCT00450580|1144032|P2|Overall Study|Could not comply with scheduled visits|0
352619|NCT00450580|1144033|P1|Overall Study|Could not comply with scheduled visits|1
352620|NCT00450580|1144032|P2|Overall Study|Protocol-defined virologic failure|0
352621|NCT00450580|1144033|P1|Overall Study|Protocol-defined virologic failure|1
352622|NCT00450580|1144032|P2|Overall Study|Protocol Violation|1
352623|NCT00450580|1144033|P1|Overall Study|Protocol Violation|1
352624|NCT00450580|1144032|P2|Overall Study|Withdrawal by Subject|2
352625|NCT00450580|1144033|P1|Overall Study|Withdrawal by Subject|2
352626|NCT00450580|1144032|P2|Overall Study|Lost to Follow-up|5
352627|NCT00450580|1144033|P1|Overall Study|Lost to Follow-up|4
352628|NCT00450580|1144032|P2|Overall Study|Adverse Event|7
352629|NCT00450580|1144033|P1|Overall Study|Adverse Event|5
352630|NCT00450450|1144053|P2|Overall Study|Missing Data|0
352631|NCT00450450|1144054|P1|Overall Study|Missing Data|2
352632|NCT00450450|1144053|P2|Overall Study|Relapse|0
352633|NCT00450450|1144054|P1|Overall Study|Relapse|2
352634|NCT00450450|1144053|P2|Overall Study|Death|3
352635|NCT00450450|1144054|P1|Overall Study|Death|1
352636|NCT00450437|1144078|P4|Overall Study|Unable to Classify|0
352637|NCT00450437|1144079|P3|Overall Study|Unable to Classify|1
352638|NCT00450437|1144080|P2|Overall Study|Unable to Classify|0
352639|NCT00450437|1144081|P1|Overall Study|Unable to Classify|1
352640|NCT00450437|1144078|P4|Overall Study|Administrative reason|0
352641|NCT00450437|1144079|P3|Overall Study|Administrative reason|1
352642|NCT00450437|1144080|P2|Overall Study|Administrative reason|0
352643|NCT00450437|1144081|P1|Overall Study|Administrative reason|0
352644|NCT00450437|1144078|P4|Overall Study|Inappropriate enrollment|0
352645|NCT00450437|1144079|P3|Overall Study|Inappropriate enrollment|3
352646|NCT00450437|1144080|P2|Overall Study|Inappropriate enrollment|1
352647|NCT00450437|1144081|P1|Overall Study|Inappropriate enrollment|4
352648|NCT00450437|1144078|P4|Overall Study|Protocol Violation|1
352649|NCT00450437|1144079|P3|Overall Study|Protocol Violation|0
352650|NCT00450437|1144080|P2|Overall Study|Protocol Violation|1
352651|NCT00450437|1144081|P1|Overall Study|Protocol Violation|0
352652|NCT00450437|1144078|P4|Overall Study|Lost to Follow-up|9
352653|NCT00450437|1144079|P3|Overall Study|Lost to Follow-up|19
352654|NCT00450437|1144080|P2|Overall Study|Lost to Follow-up|12
352655|NCT00450437|1144081|P1|Overall Study|Lost to Follow-up|31
352656|NCT00450437|1144078|P4|Overall Study|Withdrawal by Subject|1
352657|NCT00450437|1144079|P3|Overall Study|Withdrawal by Subject|0
352658|NCT00450437|1144080|P2|Overall Study|Withdrawal by Subject|2
352659|NCT00450437|1144081|P1|Overall Study|Withdrawal by Subject|10
352660|NCT00450372|1144112|P1|Overall Study|Physician Decision|1
352661|NCT00450333|1144125|P4|Overall Study|Death|2
352662|NCT00450333|1144126|P3|Overall Study|Death|2
352663|NCT00450333|1144127|P2|Overall Study|Death|2
352664|NCT00450333|1144128|P1|Overall Study|Death|3
352665|NCT00450333|1144125|P4|Overall Study|Kidney transplant|3
352666|NCT00450333|1144126|P3|Overall Study|Kidney transplant|1
352667|NCT00450333|1144127|P2|Overall Study|Kidney transplant|0
352668|NCT00450333|1144128|P1|Overall Study|Kidney transplant|1
352669|NCT00450333|1144125|P4|Overall Study|Withdrawal by Subject|0
352670|NCT00450333|1144126|P3|Overall Study|Withdrawal by Subject|3
352671|NCT00450333|1144127|P2|Overall Study|Withdrawal by Subject|0
352672|NCT00450333|1144128|P1|Overall Study|Withdrawal by Subject|1
352673|NCT00450333|1144125|P4|Overall Study|Protocol Violation|0
352674|NCT00450333|1144126|P3|Overall Study|Protocol Violation|1
352675|NCT00450333|1144127|P2|Overall Study|Protocol Violation|0
352676|NCT00450333|1144128|P1|Overall Study|Protocol Violation|1
352677|NCT00450333|1144125|P4|Overall Study|Adverse Event|2
352678|NCT00450333|1144126|P3|Overall Study|Adverse Event|2
352679|NCT00450333|1144127|P2|Overall Study|Adverse Event|7
352680|NCT00450333|1144128|P1|Overall Study|Adverse Event|1
352681|NCT00450333|1144125|P4|Overall Study|Study terminated|21
352682|NCT00450333|1144126|P3|Overall Study|Study terminated|16
352683|NCT00450333|1144127|P2|Overall Study|Study terminated|54
352684|NCT00450333|1144128|P1|Overall Study|Study terminated|47
352685|NCT00450255|1144151|P1|Overall Study|Prior RFA ablation of liver|1
352686|NCT00450216|1144174|P2|Overall Study|misc|20
352687|NCT00450216|1144175|P1|Overall Study|misc|21
352688|NCT00450216|1144174|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
352689|NCT00450216|1144175|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
352690|NCT00450216|1144174|P2|Overall Study|Lost to Follow-up|9
352691|NCT00450216|1144175|P1|Overall Study|Lost to Follow-up|16
352692|NCT00450216|1144174|P2|Overall Study|Withdrawal by Subject|26
352693|NCT00450216|1144175|P1|Overall Study|Withdrawal by Subject|48
352694|NCT00450216|1144174|P2|Overall Study|Adverse Event|23
352695|NCT00450216|1144175|P1|Overall Study|Adverse Event|38
352696|NCT00450112|1144189|P2|Overall Study|Others|3
352697|NCT00450112|1144190|P1|Overall Study|Others|2
352698|NCT00450112|1144189|P2|Overall Study|Lost to Follow-up|1
352699|NCT00450112|1144190|P1|Overall Study|Lost to Follow-up|2
352700|NCT00450112|1144189|P2|Overall Study|Withdrawal by Subject|1
352701|NCT00450112|1144190|P1|Overall Study|Withdrawal by Subject|4
352702|NCT00450112|1144189|P2|Overall Study|Other Treatment Required|1
352703|NCT00450112|1144190|P1|Overall Study|Other Treatment Required|5
352704|NCT00449956|1144228|P3|Overall Study|Physician Decision|1
352705|NCT00449956|1144229|P2|Overall Study|Physician Decision|1
352706|NCT00449956|1144230|P1|Overall Study|Physician Decision|2
352707|NCT00449956|1144228|P3|Overall Study|Withdrawal by Subject|0
352708|NCT00449956|1144229|P2|Overall Study|Withdrawal by Subject|1
352709|NCT00449956|1144230|P1|Overall Study|Withdrawal by Subject|0
352710|NCT00449956|1144228|P3|Overall Study|Protocol Violation|1
352711|NCT00449956|1144229|P2|Overall Study|Protocol Violation|1
352712|NCT00449956|1144230|P1|Overall Study|Protocol Violation|1
352713|NCT00449956|1144228|P3|Overall Study|Lack of Efficacy|1
352714|NCT00449956|1144229|P2|Overall Study|Lack of Efficacy|0
352715|NCT00449956|1144230|P1|Overall Study|Lack of Efficacy|0
352716|NCT00449956|1144228|P3|Overall Study|Adverse Event|6
352717|NCT00449956|1144229|P2|Overall Study|Adverse Event|1
352718|NCT00449956|1144230|P1|Overall Study|Adverse Event|7
352719|NCT00449930|1144246|P2|Overall Study|Glycemic discontinuation criteria|1
352720|NCT00449930|1144247|P1|Overall Study|Glycemic discontinuation criteria|1
352721|NCT00449930|1144246|P2|Overall Study|Withdrawal by Subject|23
352722|NCT00449930|1144247|P1|Overall Study|Withdrawal by Subject|16
352723|NCT00449930|1144246|P2|Overall Study|Protocol Violation|15
352724|NCT00449930|1144247|P1|Overall Study|Protocol Violation|14
352725|NCT00449930|1144246|P2|Overall Study|Physician Decision|2
352726|NCT00449930|1144247|P1|Overall Study|Physician Decision|1
352727|NCT00449930|1144246|P2|Overall Study|Lost to Follow-up|14
352728|NCT00449930|1144247|P1|Overall Study|Lost to Follow-up|9
352729|NCT00449930|1144246|P2|Overall Study|Lack of Efficacy|1
352730|NCT00449930|1144247|P1|Overall Study|Lack of Efficacy|10
352731|NCT00449930|1144246|P2|Overall Study|Trial Terminated ( Site Closed)|0
352732|NCT00449930|1144247|P1|Overall Study|Trial Terminated ( Site Closed)|1
352733|NCT00449930|1144246|P2|Overall Study|Adverse Event|19
352734|NCT00449930|1144247|P1|Overall Study|Adverse Event|9
352735|NCT00449865|1144263|P2|Overall Study|Study was stopped|328
352736|NCT00449865|1144264|P1|Overall Study|Study was stopped|324
352737|NCT00449865|1144263|P2|Overall Study|Protocol Violation|7
352738|NCT00449865|1144264|P1|Overall Study|Protocol Violation|8
352739|NCT00449865|1144263|P2|Overall Study|Death|40
352740|NCT00449865|1144264|P1|Overall Study|Death|31
352741|NCT00449865|1144263|P2|Overall Study|Physician Decision|12
352742|NCT00449865|1144264|P1|Overall Study|Physician Decision|13
352743|NCT00449865|1144263|P2|Overall Study|Lost to Follow-up|37
352744|NCT00449865|1144264|P1|Overall Study|Lost to Follow-up|36
352745|NCT00449865|1144263|P2|Overall Study|Withdrawal by Subject|110
352746|NCT00449865|1144264|P1|Overall Study|Withdrawal by Subject|110
352747|NCT00449787|1144272|P2|Overall Study|Did not require medication|92
352748|NCT00449787|1144273|P1|Overall Study|Did not require medication|95
352749|NCT00449787|1144272|P2|Overall Study|Lost to Follow-up|8
352750|NCT00449787|1144273|P1|Overall Study|Lost to Follow-up|10
352751|NCT00449696|1144289|P2|Overall Study|Others|0
352752|NCT00449696|1144290|P1|Overall Study|Others|7
352753|NCT00449696|1144289|P2|Overall Study|Lost to Follow-up|3
352754|NCT00449696|1144290|P1|Overall Study|Lost to Follow-up|2
352755|NCT00449696|1144289|P2|Overall Study|Withdrawal by Subject|5
352756|NCT00449696|1144290|P1|Overall Study|Withdrawal by Subject|5
352757|NCT00449696|1144289|P2|Overall Study|Other Treatment Required|1
352758|NCT00449696|1144290|P1|Overall Study|Other Treatment Required|6
352759|NCT00449644|1144316|P4|Overall Study|Rolled-over to treatment with TMC207|1
352760|NCT00449644|1144317|P3|Overall Study|Rolled-over to treatment with TMC207|0
352761|NCT00449644|1144318|P2|Overall Study|Rolled-over to treatment with TMC207|0
352762|NCT00449644|1144319|P1|Overall Study|Rolled-over to treatment with TMC207|0
352763|NCT00449644|1144316|P4|Overall Study|Not specified|0
352764|NCT00449644|1144317|P3|Overall Study|Not specified|1
352765|NCT00449644|1144318|P2|Overall Study|Not specified|4
352766|NCT00449644|1144319|P1|Overall Study|Not specified|1
352767|NCT00449644|1144316|P4|Overall Study|Inclusion/exclusion criteria not met|6
352768|NCT00449644|1144317|P3|Overall Study|Inclusion/exclusion criteria not met|2
352769|NCT00449644|1144318|P2|Overall Study|Inclusion/exclusion criteria not met|0
352770|NCT00449644|1144319|P1|Overall Study|Inclusion/exclusion criteria not met|0
352771|NCT00449644|1144316|P4|Overall Study|Withdrawal by Subject|7
352772|NCT00449644|1144317|P3|Overall Study|Withdrawal by Subject|6
352773|NCT00449644|1144318|P2|Overall Study|Withdrawal by Subject|4
352774|NCT00449644|1144319|P1|Overall Study|Withdrawal by Subject|3
352775|NCT00449644|1144316|P4|Overall Study|Protocol Violation|7
352776|NCT00449644|1144317|P3|Overall Study|Protocol Violation|3
352777|NCT00449644|1144318|P2|Overall Study|Protocol Violation|4
352778|NCT00449644|1144319|P1|Overall Study|Protocol Violation|4
352779|NCT00449644|1144316|P4|Overall Study|Pregnancy|2
352780|NCT00449644|1144317|P3|Overall Study|Pregnancy|3
352781|NCT00449644|1144318|P2|Overall Study|Pregnancy|0
352782|NCT00449644|1144319|P1|Overall Study|Pregnancy|0
352783|NCT00449644|1144316|P4|Overall Study|Lost to Follow-up|3
352784|NCT00449644|1144317|P3|Overall Study|Lost to Follow-up|5
352785|NCT00449644|1144318|P2|Overall Study|Lost to Follow-up|1
352786|NCT00449644|1144319|P1|Overall Study|Lost to Follow-up|1
352787|NCT00449644|1144316|P4|Overall Study|Death|1
352788|NCT00449644|1144317|P3|Overall Study|Death|6
352789|NCT00449644|1144318|P2|Overall Study|Death|0
352790|NCT00449644|1144319|P1|Overall Study|Death|1
352791|NCT00449644|1144316|P4|Overall Study|Adverse Event|5
352792|NCT00449644|1144317|P3|Overall Study|Adverse Event|3
352793|NCT00449644|1144318|P2|Overall Study|Adverse Event|0
352794|NCT00449644|1144319|P1|Overall Study|Adverse Event|0
352795|NCT00449540|1144339|P3|Treatment Phase|did not experience or treat migraine|17
352796|NCT00449540|1144340|P2|Treatment Phase|did not experience or treat migraine|20
352797|NCT00449540|1144341|P1|Treatment Phase|did not experience or treat migraine|0
352798|NCT00449540|1144339|P3|Pretreatment Phase|No migraine experienced|0
352799|NCT00449540|1144340|P2|Pretreatment Phase|No migraine experienced|0
352800|NCT00449540|1144341|P1|Pretreatment Phase|No migraine experienced|66
352801|NCT00449176|1144358|P3|Overall Study|all other|20
352802|NCT00449176|1144359|P2|Overall Study|all other|19
352803|NCT00449176|1144360|P1|Overall Study|all other|22
352804|NCT00449176|1144358|P3|Overall Study|Study drug non-compliant|11
352805|NCT00449176|1144359|P2|Overall Study|Study drug non-compliant|11
352806|NCT00449176|1144360|P1|Overall Study|Study drug non-compliant|14
352807|NCT00449176|1144358|P3|Overall Study|Lack of Efficacy|50
352808|NCT00449176|1144359|P2|Overall Study|Lack of Efficacy|7
352809|NCT00449176|1144360|P1|Overall Study|Lack of Efficacy|13
352810|NCT00449176|1144358|P3|Overall Study|Adverse Event|15
352811|NCT00449176|1144359|P2|Overall Study|Adverse Event|107
352812|NCT00449176|1144360|P1|Overall Study|Adverse Event|51
352813|NCT00449176|1144358|P3|Overall Study|Lost to Follow-up|12
352814|NCT00449176|1144359|P2|Overall Study|Lost to Follow-up|8
352815|NCT00449176|1144360|P1|Overall Study|Lost to Follow-up|13
352816|NCT00449176|1144358|P3|Overall Study|Withdrawal by Subject|59
352817|NCT00449176|1144359|P2|Overall Study|Withdrawal by Subject|43
352818|NCT00449176|1144360|P1|Overall Study|Withdrawal by Subject|39
352819|NCT00449163|1144386|P1|Overall Study|Physician Decision|3
352820|NCT00449150|1144396|P3|Overall Study|Protocol Violation|1
352821|NCT00449150|1144397|P2|Overall Study|Protocol Violation|2
352822|NCT00449150|1144398|P1|Overall Study|Protocol Violation|1
352823|NCT00449150|1144396|P3|Overall Study|Withdrawal by Subject|21
352824|NCT00449150|1144397|P2|Overall Study|Withdrawal by Subject|18
352825|NCT00449150|1144398|P1|Overall Study|Withdrawal by Subject|17
352826|NCT00449150|1144396|P3|Overall Study|Not specified|14
352827|NCT00449150|1144397|P2|Overall Study|Not specified|13
352828|NCT00449150|1144398|P1|Overall Study|Not specified|16
352829|NCT00449150|1144396|P3|Overall Study|Lack of Efficacy|2
352830|NCT00449150|1144397|P2|Overall Study|Lack of Efficacy|2
352831|NCT00449150|1144398|P1|Overall Study|Lack of Efficacy|1
352832|NCT00449150|1144396|P3|Overall Study|Adverse Event|9
352833|NCT00449150|1144397|P2|Overall Study|Adverse Event|18
352834|NCT00449150|1144398|P1|Overall Study|Adverse Event|11
352835|NCT00449072|1144408|P2|Overall Study|Relocation|2
352836|NCT00449072|1144409|P1|Overall Study|Relocation|3
352837|NCT00449072|1144408|P2|Overall Study|Sponsor decision|3
352838|NCT00449072|1144409|P1|Overall Study|Sponsor decision|1
352839|NCT00449072|1144408|P2|Overall Study|Non-compliance|5
352840|NCT00449072|1144409|P1|Overall Study|Non-compliance|2
352841|NCT00449072|1144408|P2|Overall Study|Excluded medication|2
352842|NCT00449072|1144409|P1|Overall Study|Excluded medication|0
352843|NCT00449072|1144408|P2|Overall Study|Not treated|1
352844|NCT00449072|1144409|P1|Overall Study|Not treated|0
352845|NCT00449072|1144408|P2|Overall Study|Physician Decision|0
352846|NCT00449072|1144409|P1|Overall Study|Physician Decision|1
352847|NCT00449072|1144408|P2|Overall Study|Lack of Efficacy|1
352848|NCT00449072|1144409|P1|Overall Study|Lack of Efficacy|1
352849|NCT00449072|1144408|P2|Overall Study|Withdrawal by Subject|8
352850|NCT00449072|1144409|P1|Overall Study|Withdrawal by Subject|11
352851|NCT00449072|1144408|P2|Overall Study|Lost to Follow-up|7
352852|NCT00449072|1144409|P1|Overall Study|Lost to Follow-up|5
352853|NCT00449072|1144408|P2|Overall Study|Protocol Violation|12
352854|NCT00449072|1144409|P1|Overall Study|Protocol Violation|14
352855|NCT00449072|1144408|P2|Overall Study|Adverse Event|1
352856|NCT00449072|1144409|P1|Overall Study|Adverse Event|3
352857|NCT00449033|1144446|P2|Follow-up Period|Reason Missing|113
352858|NCT00449033|1144447|P1|Follow-up Period|Reason Missing|120
352859|NCT00449033|1144446|P2|Follow-up Period|Lost to Follow-up|10
352860|NCT00449033|1144447|P1|Follow-up Period|Lost to Follow-up|6
352861|NCT00449033|1144446|P2|Follow-up Period|Death|311
352862|NCT00449033|1144447|P1|Follow-up Period|Death|299
352863|NCT00449033|1144446|P2|Treatment Period|Treatment Ongoing|4
352864|NCT00449033|1144447|P1|Treatment Period|Treatment Ongoing|6
352865|NCT00449033|1144446|P2|Treatment Period|Reason Missing|4
352866|NCT00449033|1144447|P1|Treatment Period|Reason Missing|0
352867|NCT00449033|1144446|P2|Treatment Period|Second Malignancy|1
352868|NCT00449033|1144447|P1|Treatment Period|Second Malignancy|0
352869|NCT00449033|1144446|P2|Treatment Period|Non-compliance|8
352870|NCT00449033|1144447|P1|Treatment Period|Non-compliance|7
352871|NCT00449033|1144446|P2|Treatment Period|Amended Protocol Criteria|18
352872|NCT00449033|1144447|P1|Treatment Period|Amended Protocol Criteria|22
352873|NCT00449033|1144446|P2|Treatment Period|Consent Withdrawn|20
352874|NCT00449033|1144447|P1|Treatment Period|Consent Withdrawn|36
352875|NCT00449033|1144446|P2|Treatment Period|Disease Progression|288
352876|NCT00449033|1144447|P1|Treatment Period|Disease Progression|231
352877|NCT00449033|1144446|P2|Treatment Period|Protocol Violation|7
352878|NCT00449033|1144447|P1|Treatment Period|Protocol Violation|8
352879|NCT00449033|1144446|P2|Treatment Period|Physician Decision|5
352880|NCT00449033|1144447|P1|Treatment Period|Physician Decision|4
352881|NCT00449033|1144446|P2|Treatment Period|Lost to Follow-up|2
352882|NCT00449033|1144447|P1|Treatment Period|Lost to Follow-up|0
352883|NCT00449033|1144446|P2|Treatment Period|Death|12
352884|NCT00449033|1144447|P1|Treatment Period|Death|21
352885|NCT00449033|1144446|P2|Treatment Period|Adverse Event|83
352886|NCT00449033|1144447|P1|Treatment Period|Adverse Event|117
352887|NCT00448916|1144485|P4|Overall Study|Protocol Violation|1
352888|NCT00448916|1144486|P3|Overall Study|Protocol Violation|0
352889|NCT00448916|1144487|P2|Overall Study|Protocol Violation|0
352890|NCT00448916|1144488|P1|Overall Study|Protocol Violation|0
352891|NCT00448916|1144485|P4|Overall Study|Lost to Follow-up|1
352892|NCT00448916|1144486|P3|Overall Study|Lost to Follow-up|0
352893|NCT00448916|1144487|P2|Overall Study|Lost to Follow-up|1
352894|NCT00448916|1144488|P1|Overall Study|Lost to Follow-up|0
352895|NCT00448916|1144485|P4|Overall Study|Not specified|0
352896|NCT00448916|1144486|P3|Overall Study|Not specified|0
352897|NCT00448916|1144487|P2|Overall Study|Not specified|0
352898|NCT00448916|1144488|P1|Overall Study|Not specified|1
352899|NCT00448916|1144485|P4|Overall Study|Withdrawal by Subject|1
352900|NCT00448916|1144486|P3|Overall Study|Withdrawal by Subject|1
352901|NCT00448916|1144487|P2|Overall Study|Withdrawal by Subject|3
352902|NCT00448916|1144488|P1|Overall Study|Withdrawal by Subject|3
352903|NCT00448916|1144485|P4|Overall Study|Lack of Efficacy|1
352904|NCT00448916|1144486|P3|Overall Study|Lack of Efficacy|2
352905|NCT00448916|1144487|P2|Overall Study|Lack of Efficacy|0
352906|NCT00448916|1144488|P1|Overall Study|Lack of Efficacy|1
352907|NCT00448916|1144485|P4|Overall Study|Adverse Event|2
352908|NCT00448916|1144486|P3|Overall Study|Adverse Event|3
352909|NCT00448916|1144487|P2|Overall Study|Adverse Event|2
352910|NCT00448916|1144488|P1|Overall Study|Adverse Event|2
352911|NCT00448864|1144562|P3|Overall Study|Protocol Violation|0
352912|NCT00448864|1144563|P2|Overall Study|Protocol Violation|2
352913|NCT00448864|1144564|P1|Overall Study|Protocol Violation|0
352914|NCT00448864|1144562|P3|Overall Study|Withdrawal by Subject|0
352915|NCT00448864|1144563|P2|Overall Study|Withdrawal by Subject|2
352916|NCT00448864|1144564|P1|Overall Study|Withdrawal by Subject|0
352917|NCT00448864|1144562|P3|Overall Study|Physician Decision|1
352918|NCT00448864|1144563|P2|Overall Study|Physician Decision|0
352919|NCT00448864|1144564|P1|Overall Study|Physician Decision|1
352920|NCT00448864|1144562|P3|Overall Study|Lost to Follow-up|0
352921|NCT00448864|1144563|P2|Overall Study|Lost to Follow-up|1
352922|NCT00448864|1144564|P1|Overall Study|Lost to Follow-up|3
352923|NCT00448864|1144562|P3|Overall Study|Death|0
352924|NCT00448864|1144563|P2|Overall Study|Death|0
352925|NCT00448864|1144564|P1|Overall Study|Death|1
352926|NCT00448760|1144580|P1|Overall Study|Death|3
352927|NCT00448708|1144589|P2|Overall Study|not listed|2
352928|NCT00448708|1144590|P1|Overall Study|not listed|0
352929|NCT00448708|1144589|P2|Overall Study|Lost to Follow-up|8
352930|NCT00448708|1144590|P1|Overall Study|Lost to Follow-up|6
352931|NCT00448708|1144589|P2|Overall Study|Withdrawal by Subject|4
352932|NCT00448708|1144590|P1|Overall Study|Withdrawal by Subject|8
352933|NCT00448708|1144589|P2|Overall Study|Death|17
352934|NCT00448708|1144590|P1|Overall Study|Death|21
352935|NCT00448591|1144649|P1|Overall Study|Termination of Study|70
352936|NCT00448591|1144649|P1|Overall Study|Not specified|154
352937|NCT00448591|1144649|P1|Overall Study|Treatment Regimen Completed|70
352938|NCT00448591|1144649|P1|Overall Study|Lost to Follow-up|19
352939|NCT00448591|1144649|P1|Overall Study|Protocol Violation|41
352940|NCT00448591|1144649|P1|Overall Study|Adverse Event|382
352941|NCT00448591|1144649|P1|Overall Study|Progressive Disease|1382
352942|NCT00448591|1144649|P1|Overall Study|Withdrawal by Subject|178
352943|NCT00448539|1144660|P2|Overall Study|Lost to Follow-up|3
352944|NCT00448539|1144661|P1|Overall Study|Lost to Follow-up|1
352945|NCT00448539|1144660|P2|Overall Study|Change of meds|3
352946|NCT00448539|1144661|P1|Overall Study|Change of meds|2
352947|NCT00448539|1144660|P2|Overall Study|Miscellaneous|1
352948|NCT00448539|1144661|P1|Overall Study|Miscellaneous|2
352949|NCT00448539|1144660|P2|Overall Study|Lack of Efficacy|40
352950|NCT00448539|1144661|P1|Overall Study|Lack of Efficacy|27
352951|NCT00448539|1144660|P2|Overall Study|Adverse Event|26
352952|NCT00448539|1144661|P1|Overall Study|Adverse Event|9
352953|NCT00448539|1144660|P2|Overall Study|Diary non-compliance|0
352954|NCT00448539|1144661|P1|Overall Study|Diary non-compliance|1
352955|NCT00448539|1144660|P2|Overall Study|Withdrawal by Subject|24
352956|NCT00448539|1144661|P1|Overall Study|Withdrawal by Subject|20
352957|NCT00448539|1144660|P2|Overall Study|Request of the investigator or sponsor|54
352958|NCT00448539|1144661|P1|Overall Study|Request of the investigator or sponsor|67
352959|NCT00448539|1144660|P2|Overall Study|Protocol Violation|0
352960|NCT00448539|1144661|P1|Overall Study|Protocol Violation|1
352961|NCT00448539|1144660|P2|Overall Study|Medication non-compliance|1
352962|NCT00448539|1144661|P1|Overall Study|Medication non-compliance|4
352963|NCT00448448|1144669|P2|Overall Study|Wrong diagnosis (n=3) or other|2
352964|NCT00448448|1144670|P1|Overall Study|Wrong diagnosis (n=3) or other|2
352965|NCT00448448|1144669|P2|Overall Study|Lost to Follow-up|1
352966|NCT00448448|1144670|P1|Overall Study|Lost to Follow-up|2
352967|NCT00448448|1144669|P2|Overall Study|On protocol when study ended|36
352968|NCT00448448|1144670|P1|Overall Study|On protocol when study ended|83
352969|NCT00448448|1144669|P2|Overall Study|Withdrawal by Subject|2
352970|NCT00448448|1144670|P1|Overall Study|Withdrawal by Subject|13
352971|NCT00448435|1144676|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
352972|NCT00448435|1144677|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
352973|NCT00448344|1144705|P2|Overall Study|Physician Decision|2
352974|NCT00448344|1144706|P1|Overall Study|Physician Decision|1
352975|NCT00448344|1144705|P2|Overall Study|Death|4
352976|NCT00448344|1144706|P1|Overall Study|Death|3
352977|NCT00448344|1144705|P2|Overall Study|Withdrawal by Subject|8
352978|NCT00448344|1144706|P1|Overall Study|Withdrawal by Subject|6
352979|NCT00448344|1144705|P2|Overall Study|Lost to Follow-up|22
352980|NCT00448344|1144706|P1|Overall Study|Lost to Follow-up|20
352981|NCT00448279|1144716|P2|Overall Study|Protocol Violation|1
352982|NCT00448279|1144717|P1|Overall Study|Protocol Violation|0
352983|NCT00448279|1144716|P2|Overall Study|Not specified|4
352984|NCT00448279|1144717|P1|Overall Study|Not specified|6
352985|NCT00448279|1144716|P2|Overall Study|Withdrawal by Subject|3
352986|NCT00448279|1144717|P1|Overall Study|Withdrawal by Subject|4
352987|NCT00448279|1144716|P2|Overall Study|Disease progression|18
352988|NCT00448279|1144717|P1|Overall Study|Disease progression|16
352989|NCT00448279|1144716|P2|Overall Study|Adverse Event|1
352990|NCT00448279|1144717|P1|Overall Study|Adverse Event|1
352991|NCT00448279|1144716|P2|Overall Study|Lost to Follow-up|2
352992|NCT00448279|1144717|P1|Overall Study|Lost to Follow-up|2
352993|NCT00448136|1144780|P2|Overall Study|Investigator's decision (progression)|0
352994|NCT00448136|1144781|P1|Overall Study|Investigator's decision (progression)|1
352995|NCT00448136|1144780|P2|Overall Study|Death|8
352996|NCT00448136|1144781|P1|Overall Study|Death|3
352997|NCT00448123|1144819|P2|Overall Study|Physician Decision|6
352998|NCT00448123|1144820|P1|Overall Study|Physician Decision|6
352999|NCT00448123|1144819|P2|Overall Study|Lost to Follow-up|6
353000|NCT00448123|1144820|P1|Overall Study|Lost to Follow-up|9
353001|NCT00448019|1144830|P1|Overall Study|Insurance Issues|1
353002|NCT00448019|1144830|P1|Overall Study|Death|2
353003|NCT00448019|1144830|P1|Overall Study|Disease progression|1
353004|NCT00448019|1144830|P1|Overall Study|Withdrawal by Subject|3
353005|NCT00447902|1144838|P2|Overall Study|Lack of Efficacy|1
353006|NCT00447902|1144839|P1|Overall Study|Lack of Efficacy|2
353007|NCT00447902|1144838|P2|Overall Study|included patients who discontinued|1
353008|NCT00447902|1144839|P1|Overall Study|included patients who discontinued|1
353009|NCT00447902|1144838|P2|Overall Study|Withdrawal by Subject|1
353010|NCT00447902|1144839|P1|Overall Study|Withdrawal by Subject|0
353011|NCT00447902|1144838|P2|Overall Study|Protocol Violation|0
353012|NCT00447902|1144839|P1|Overall Study|Protocol Violation|1
353013|NCT00447902|1144838|P2|Overall Study|Adverse Event|3
353014|NCT00447902|1144839|P1|Overall Study|Adverse Event|0
353015|NCT00447603|1144879|P3|Filter Period|Study terminated by Sponsor|10
353016|NCT00447603|1144880|P2|Filter Period|Study terminated by Sponsor|1
353017|NCT00447603|1144881|P1|Filter Period|Study terminated by Sponsor|0
353018|NCT00447603|1144879|P3|Filter Period|Screen Failure|4
353019|NCT00447603|1144880|P2|Filter Period|Screen Failure|3
353020|NCT00447603|1144881|P1|Filter Period|Screen Failure|0
353021|NCT00447603|1144879|P3|Filter Period|Adverse Event|1
353022|NCT00447603|1144880|P2|Filter Period|Adverse Event|0
353023|NCT00447603|1144881|P1|Filter Period|Adverse Event|0
353024|NCT00447603|1144879|P3|Screening|Study Terminated by Sponsor|0
353025|NCT00447603|1144880|P2|Screening|Study Terminated by Sponsor|0
353026|NCT00447603|1144881|P1|Screening|Study Terminated by Sponsor|15
353027|NCT00447603|1144879|P3|Screening|Screen Failure|0
353028|NCT00447603|1144880|P2|Screening|Screen Failure|0
353029|NCT00447603|1144881|P1|Screening|Screen Failure|4
353030|NCT00447603|1144879|P3|Screening|Protocol Violation|0
353031|NCT00447603|1144880|P2|Screening|Protocol Violation|0
353032|NCT00447603|1144881|P1|Screening|Protocol Violation|1
353033|NCT00447603|1144879|P3|Screening|Withdrawal by Subject|0
353034|NCT00447603|1144880|P2|Screening|Withdrawal by Subject|0
353035|NCT00447603|1144881|P1|Screening|Withdrawal by Subject|1
353036|NCT00447590|1144901|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
353037|NCT00447590|1144901|P1|Overall Study|Lost to Follow-up|24
353038|NCT00447590|1144901|P1|Overall Study|Withdrawal by Subject|26
353039|NCT00447499|1144910|P1|Overall Study|Physician Decision|1
353040|NCT00447499|1144910|P1|Overall Study|Sponsor Decision|1
353041|NCT00447499|1144910|P1|Overall Study|Patient Decision|4
353042|NCT00447499|1144910|P1|Overall Study|Adverse Event|1
353043|NCT00447421|1144920|P1|Overall Study|Sponsor Decision|2
353044|NCT00447421|1144920|P1|Overall Study|Adverse Event|3
353045|NCT00447421|1144920|P1|Overall Study|Lack of Efficacy|1
353046|NCT00447382|1144932|P2|Overall Study|Unclassified|5
353047|NCT00447382|1144933|P1|Overall Study|Unclassified|2
353048|NCT00447382|1144932|P2|Overall Study|Protocol Violation|0
353049|NCT00447382|1144933|P1|Overall Study|Protocol Violation|2
353050|NCT00447382|1144932|P2|Overall Study|Lack of Efficacy|0
353051|NCT00447382|1144933|P1|Overall Study|Lack of Efficacy|1
353052|NCT00447382|1144932|P2|Overall Study|Adverse Event|1
353053|NCT00447382|1144933|P1|Overall Study|Adverse Event|1
353054|NCT00447278|1144994|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
353055|NCT00447278|1144995|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
353056|NCT00447278|1144994|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
353057|NCT00447278|1144995|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
353058|NCT00447278|1144994|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
353059|NCT00447278|1144995|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
353060|NCT00447278|1144994|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
353061|NCT00447278|1144995|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
353062|NCT00447278|1144994|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
353063|NCT00447278|1144995|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
353064|NCT00447278|1144994|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
353065|NCT00447278|1144995|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
353066|NCT00447278|1144994|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
353067|NCT00447278|1144995|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
353068|NCT00447278|1144994|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
353069|NCT00447278|1144995|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
353070|NCT00447278|1144994|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
353071|NCT00447278|1144995|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
353072|NCT00447278|1144994|P2|Period II (6 Month Open-Label)|Physician Decision|1
353073|NCT00447278|1144995|P1|Period II (6 Month Open-Label)|Physician Decision|4
353074|NCT00447278|1144994|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
353075|NCT00447278|1144995|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
353076|NCT00447278|1144994|P2|Period II (6 Month Open-Label)|Protocol Violation|7
353077|NCT00447278|1144995|P1|Period II (6 Month Open-Label)|Protocol Violation|10
353078|NCT00447278|1144994|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
353079|NCT00447278|1144995|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
353080|NCT00447278|1144994|P2|Period II (6 Month Open-Label)|Adverse Event|3
353081|NCT00447278|1144995|P1|Period II (6 Month Open-Label)|Adverse Event|7
353082|NCT00447265|1145016|P2|Overall Study|Physician Decision|0
353083|NCT00447265|1145017|P1|Overall Study|Physician Decision|1
353084|NCT00447226|1145030|P2|Double-blind Phase|Disease Progression|3
353085|NCT00447226|1145031|P1|Double-blind Phase|Disease Progression|4
353086|NCT00447226|1145030|P2|12-Week Open-label Phase|Physician Decision|1
353087|NCT00447226|1145031|P1|12-Week Open-label Phase|Physician Decision|0
353088|NCT00447226|1145030|P2|12-Week Open-label Phase|Disease Progression|20
353089|NCT00447226|1145031|P1|12-Week Open-label Phase|Disease Progression|0
353090|NCT00447226|1145030|P2|12-Week Open-label Phase|Protocol Violation|1
353091|NCT00447226|1145031|P1|12-Week Open-label Phase|Protocol Violation|0
353092|NCT00447226|1145030|P2|12-Week Open-label Phase|Adverse Event|3
353093|NCT00447226|1145031|P1|12-Week Open-label Phase|Adverse Event|0
353094|NCT00447057|1145057|P4|Overall Study|Death, study drug related|0
353095|NCT00447057|1145058|P3|Overall Study|Death, study drug related|0
353096|NCT00447057|1145059|P2|Overall Study|Death, study drug related|1
353097|NCT00447057|1145060|P1|Overall Study|Death, study drug related|0
353098|NCT00447057|1145057|P4|Overall Study|Death due to adverse event|2
353099|NCT00447057|1145058|P3|Overall Study|Death due to adverse event|1
353100|NCT00447057|1145059|P2|Overall Study|Death due to adverse event|0
353101|NCT00447057|1145060|P1|Overall Study|Death due to adverse event|0
353102|NCT00447057|1145057|P4|Overall Study|Progressive disease|18
353103|NCT00447057|1145058|P3|Overall Study|Progressive disease|13
353104|NCT00447057|1145059|P2|Overall Study|Progressive disease|43
353105|NCT00447057|1145060|P1|Overall Study|Progressive disease|58
353106|NCT00447057|1145057|P4|Overall Study|Sponsor decision|0
353107|NCT00447057|1145058|P3|Overall Study|Sponsor decision|0
353108|NCT00447057|1145059|P2|Overall Study|Sponsor decision|1
353109|NCT00447057|1145060|P1|Overall Study|Sponsor decision|1
353110|NCT00447057|1145057|P4|Overall Study|Physician Decision|1
353111|NCT00447057|1145058|P3|Overall Study|Physician Decision|3
353112|NCT00447057|1145059|P2|Overall Study|Physician Decision|6
353113|NCT00447057|1145060|P1|Overall Study|Physician Decision|9
353114|NCT00447057|1145057|P4|Overall Study|Withdrawal by Subject|1
353115|NCT00447057|1145058|P3|Overall Study|Withdrawal by Subject|1
353116|NCT00447057|1145059|P2|Overall Study|Withdrawal by Subject|5
353117|NCT00447057|1145060|P1|Overall Study|Withdrawal by Subject|4
353118|NCT00447057|1145057|P4|Overall Study|Protocol Violation|0
353119|NCT00447057|1145058|P3|Overall Study|Protocol Violation|0
353120|NCT00447057|1145059|P2|Overall Study|Protocol Violation|1
353121|NCT00447057|1145060|P1|Overall Study|Protocol Violation|0
353122|NCT00447057|1145057|P4|Overall Study|Entry criteria not met|0
353123|NCT00447057|1145058|P3|Overall Study|Entry criteria not met|0
353124|NCT00447057|1145059|P2|Overall Study|Entry criteria not met|1
353125|NCT00447057|1145060|P1|Overall Study|Entry criteria not met|1
353126|NCT00447057|1145057|P4|Overall Study|Lost to Follow-up|0
353127|NCT00447057|1145058|P3|Overall Study|Lost to Follow-up|0
353128|NCT00447057|1145059|P2|Overall Study|Lost to Follow-up|1
353129|NCT00447057|1145060|P1|Overall Study|Lost to Follow-up|0
353130|NCT00447057|1145057|P4|Overall Study|Death due to study disease|1
353131|NCT00447057|1145058|P3|Overall Study|Death due to study disease|1
353132|NCT00447057|1145059|P2|Overall Study|Death due to study disease|4
353133|NCT00447057|1145060|P1|Overall Study|Death due to study disease|6
353134|NCT00447057|1145057|P4|Overall Study|Adverse Event|3
353135|NCT00447057|1145058|P3|Overall Study|Adverse Event|0
353136|NCT00447057|1145059|P2|Overall Study|Adverse Event|10
353137|NCT00447057|1145060|P1|Overall Study|Adverse Event|4
353138|NCT00447005|1145078|P1|Overall Study|Lack of Efficacy|11
353139|NCT00447005|1145078|P1|Overall Study|Adverse Event|1
353140|NCT00446992|1145092|P1|Overall Study|Lost to Follow-up|5
353141|NCT00446992|1145092|P1|Overall Study|Adverse Event|11
353142|NCT00446849|1145104|P1|Maintenance Phase|concomitant medication use|1
353143|NCT00446849|1145104|P1|Maintenance Phase|hydrocodone use|1
353144|NCT00446849|1145104|P1|Maintenance Phase|study closure|1
353145|NCT00446849|1145104|P1|Maintenance Phase|antibiotic use|1
353146|NCT00446849|1145104|P1|Maintenance Phase|prohibited medication use|2
353147|NCT00446849|1145104|P1|Maintenance Phase|noncompliance|2
353148|NCT00446849|1145104|P1|Maintenance Phase|Pregnancy|1
353149|NCT00446849|1145104|P1|Maintenance Phase|Lost to Follow-up|3
353150|NCT00446849|1145104|P1|Maintenance Phase|Consent withdrawn|5
353151|NCT00446849|1145104|P1|Maintenance Phase|Adverse Event|6
353152|NCT00446849|1145104|P1|Maintenance Phase|Protocol Violation|7
353153|NCT00446849|1145104|P1|Maintenance Phase|Lack of Efficacy|40
353154|NCT00446849|1145104|P1|Acute Phase|noncompliance|1
353155|NCT00446849|1145104|P1|Acute Phase|Physician Decision|1
353156|NCT00446849|1145104|P1|Acute Phase|Lost to Follow-up|2
353157|NCT00446849|1145104|P1|Acute Phase|Consent withdrawn|4
353158|NCT00446849|1145104|P1|Acute Phase|Protocol Violation|10
353159|NCT00446849|1145104|P1|Acute Phase|Lack of Efficacy|64
353160|NCT00446797|1145116|P2|Overall Study|did not meet entrance criteria|1
353161|NCT00446797|1145117|P1|Overall Study|did not meet entrance criteria|0
353162|NCT00446797|1145116|P2|Overall Study|subject entered at another site|1
353163|NCT00446797|1145117|P1|Overall Study|subject entered at another site|0
353164|NCT00446797|1145116|P2|Overall Study|Protocol Violation|3
353165|NCT00446797|1145117|P1|Overall Study|Protocol Violation|1
353166|NCT00446797|1145116|P2|Overall Study|Withdrawal by Subject|2
353167|NCT00446797|1145117|P1|Overall Study|Withdrawal by Subject|2
353168|NCT00446797|1145116|P2|Overall Study|Lost to Follow-up|3
353169|NCT00446797|1145117|P1|Overall Study|Lost to Follow-up|5
353170|NCT00446797|1145116|P2|Overall Study|Lack of Efficacy|2
353171|NCT00446797|1145117|P1|Overall Study|Lack of Efficacy|0
353172|NCT00446654|1145163|P2|Overall Study|Adverse Event|0
353173|NCT00446654|1145164|P1|Overall Study|Adverse Event|1
353174|NCT00446654|1145163|P2|Overall Study|Withdrawal by Subject|0
353175|NCT00446654|1145164|P1|Overall Study|Withdrawal by Subject|1
353176|NCT00446641|1145172|P2|Overall Study|Lost to Follow-up|1
353177|NCT00446641|1145173|P1|Overall Study|Lost to Follow-up|1
353178|NCT00446641|1145172|P2|Overall Study|poor compliance|6
353179|NCT00446641|1145173|P1|Overall Study|poor compliance|8
353180|NCT00446641|1145172|P2|Overall Study|Withdrawal by Subject|3
353181|NCT00446641|1145173|P1|Overall Study|Withdrawal by Subject|8
353182|NCT00446563|1145193|P2|Overall Study|Administrative problems|1
353183|NCT00446563|1145194|P1|Overall Study|Administrative problems|0
353184|NCT00446563|1145193|P2|Overall Study|Withdrawal by Subject|1
353185|NCT00446563|1145194|P1|Overall Study|Withdrawal by Subject|2
353186|NCT00446563|1145193|P2|Overall Study|Unsatisfactory therapeutic effect|3
353187|NCT00446563|1145194|P1|Overall Study|Unsatisfactory therapeutic effect|0
353188|NCT00446563|1145193|P2|Overall Study|Abnormal test procedure result(s)|0
353189|NCT00446563|1145194|P1|Overall Study|Abnormal test procedure result(s)|1
353190|NCT00446563|1145193|P2|Overall Study|Abnormal laboratory value(s)|1
353191|NCT00446563|1145194|P1|Overall Study|Abnormal laboratory value(s)|0
353192|NCT00446563|1145193|P2|Overall Study|Adverse Event|3
353193|NCT00446563|1145194|P1|Overall Study|Adverse Event|4
353194|NCT00446511|1145232|P4|Overall Study|Administrative Problems|1
353195|NCT00446511|1145233|P3|Overall Study|Administrative Problems|4
353196|NCT00446511|1145234|P2|Overall Study|Administrative Problems|0
353197|NCT00446511|1145235|P1|Overall Study|Administrative Problems|3
353198|NCT00446511|1145232|P4|Overall Study|Withdrawal by Subject|3
353199|NCT00446511|1145233|P3|Overall Study|Withdrawal by Subject|0
353200|NCT00446511|1145234|P2|Overall Study|Withdrawal by Subject|0
353201|NCT00446511|1145235|P1|Overall Study|Withdrawal by Subject|0
353202|NCT00446511|1145232|P4|Overall Study|Protocol Violation|1
353203|NCT00446511|1145233|P3|Overall Study|Protocol Violation|0
353204|NCT00446511|1145234|P2|Overall Study|Protocol Violation|0
353205|NCT00446511|1145235|P1|Overall Study|Protocol Violation|0
353206|NCT00446511|1145232|P4|Overall Study|Adverse Event|1
353207|NCT00446511|1145233|P3|Overall Study|Adverse Event|3
353208|NCT00446511|1145234|P2|Overall Study|Adverse Event|2
353209|NCT00446511|1145235|P1|Overall Study|Adverse Event|7
353210|NCT00446459|1145259|P1|12 Months|14 subjects to MMF + Rituximab Study|14
353211|NCT00446459|1145259|P1|12 Months|Protocol Violation|4
353212|NCT00446459|1145259|P1|8 Months|Protocol Violation|12
353213|NCT00446446|1145267|P1|Overall Study|On Treatment at Time of Data Cut-off|1
353214|NCT00446446|1145267|P1|Overall Study|Adverse Event|1
353215|NCT00446446|1145267|P1|Overall Study|Disease Progession|2
353216|NCT00446446|1145267|P1|Overall Study|Other|4
353217|NCT00446446|1145267|P1|Overall Study|Withdrawal by Subject|6
353218|NCT00446446|1145267|P1|Overall Study|Death|10
353219|NCT00446251|1145291|P1|Overall Study|Lost to Follow-up|1
353220|NCT00446251|1145291|P1|Overall Study|Rituximab Infusion Reaction|2
353221|NCT00446251|1145291|P1|Overall Study|On-study Transplants|2
353222|NCT00446199|1145301|P4|Overall Study|Move|0
353223|NCT00446199|1145302|P3|Overall Study|Move|0
353224|NCT00446199|1145303|P2|Overall Study|Move|1
353225|NCT00446199|1145304|P1|Overall Study|Move|0
353226|NCT00446199|1145301|P4|Overall Study|In-/Exclusion criterion violated|1
353227|NCT00446199|1145302|P3|Overall Study|In-/Exclusion criterion violated|2
353228|NCT00446199|1145303|P2|Overall Study|In-/Exclusion criterion violated|1
353229|NCT00446199|1145304|P1|Overall Study|In-/Exclusion criterion violated|2
353230|NCT00446199|1145301|P4|Overall Study|Lost interest in study participation|0
353231|NCT00446199|1145302|P3|Overall Study|Lost interest in study participation|0
353232|NCT00446199|1145303|P2|Overall Study|Lost interest in study participation|1
353233|NCT00446199|1145304|P1|Overall Study|Lost interest in study participation|0
353234|NCT00446199|1145301|P4|Overall Study|Hormone fear|1
353235|NCT00446199|1145302|P3|Overall Study|Hormone fear|0
353236|NCT00446199|1145303|P2|Overall Study|Hormone fear|0
353237|NCT00446199|1145304|P1|Overall Study|Hormone fear|0
353238|NCT00446199|1145301|P4|Overall Study|Non-compliant with visit schedule|2
353239|NCT00446199|1145302|P3|Overall Study|Non-compliant with visit schedule|1
353240|NCT00446199|1145303|P2|Overall Study|Non-compliant with visit schedule|1
353241|NCT00446199|1145304|P1|Overall Study|Non-compliant with visit schedule|1
353242|NCT00446199|1145301|P4|Overall Study|Non-compliant with study drug|0
353243|NCT00446199|1145302|P3|Overall Study|Non-compliant with study drug|5
353244|NCT00446199|1145303|P2|Overall Study|Non-compliant with study drug|0
353245|NCT00446199|1145304|P1|Overall Study|Non-compliant with study drug|1
353246|NCT00446199|1145301|P4|Overall Study|Lack of Efficacy|1
353247|NCT00446199|1145302|P3|Overall Study|Lack of Efficacy|0
353248|NCT00446199|1145303|P2|Overall Study|Lack of Efficacy|0
353249|NCT00446199|1145304|P1|Overall Study|Lack of Efficacy|1
353250|NCT00446199|1145301|P4|Overall Study|Randomization in Error|1
353251|NCT00446199|1145302|P3|Overall Study|Randomization in Error|1
353252|NCT00446199|1145303|P2|Overall Study|Randomization in Error|0
353253|NCT00446199|1145304|P1|Overall Study|Randomization in Error|2
353254|NCT00446199|1145301|P4|Overall Study|Site termination|1
353255|NCT00446199|1145302|P3|Overall Study|Site termination|0
353256|NCT00446199|1145303|P2|Overall Study|Site termination|0
353257|NCT00446199|1145304|P1|Overall Study|Site termination|2
353258|NCT00446199|1145301|P4|Overall Study|Withdrawal by Subject|10
353259|NCT00446199|1145302|P3|Overall Study|Withdrawal by Subject|9
353260|NCT00446199|1145303|P2|Overall Study|Withdrawal by Subject|5
353261|NCT00446199|1145304|P1|Overall Study|Withdrawal by Subject|2
353262|NCT00446199|1145301|P4|Overall Study|Protocol Violation|3
353263|NCT00446199|1145302|P3|Overall Study|Protocol Violation|1
353264|NCT00446199|1145303|P2|Overall Study|Protocol Violation|2
353265|NCT00446199|1145304|P1|Overall Study|Protocol Violation|1
353266|NCT00446199|1145301|P4|Overall Study|Lost to Follow-up|6
353267|NCT00446199|1145302|P3|Overall Study|Lost to Follow-up|2
353268|NCT00446199|1145303|P2|Overall Study|Lost to Follow-up|5
353269|NCT00446199|1145304|P1|Overall Study|Lost to Follow-up|4
353270|NCT00446199|1145301|P4|Overall Study|Adverse Event|4
353271|NCT00446199|1145302|P3|Overall Study|Adverse Event|6
353272|NCT00446199|1145303|P2|Overall Study|Adverse Event|4
353273|NCT00446199|1145304|P1|Overall Study|Adverse Event|7
353274|NCT00446134|1145397|P4|Overall Study|Reason Not Completed|2
353275|NCT00446134|1145398|P3|Overall Study|Reason Not Completed|1
353276|NCT00446134|1145399|P2|Overall Study|Reason Not Completed|0
353277|NCT00446134|1145400|P1|Overall Study|Reason Not Completed|3
353278|NCT00446134|1145397|P4|Overall Study|Adverse Event-Diarrhea|0
353279|NCT00446134|1145398|P3|Overall Study|Adverse Event-Diarrhea|2
353280|NCT00446134|1145399|P2|Overall Study|Adverse Event-Diarrhea|1
353281|NCT00446134|1145400|P1|Overall Study|Adverse Event-Diarrhea|1
353282|NCT00446134|1145397|P4|Overall Study|Physician Decision|2
353283|NCT00446134|1145398|P3|Overall Study|Physician Decision|0
353284|NCT00446134|1145399|P2|Overall Study|Physician Decision|0
353285|NCT00446134|1145400|P1|Overall Study|Physician Decision|0
353286|NCT00446134|1145397|P4|Overall Study|Withdrawal by Subject|3
353287|NCT00446134|1145398|P3|Overall Study|Withdrawal by Subject|1
353288|NCT00446134|1145399|P2|Overall Study|Withdrawal by Subject|3
353289|NCT00446134|1145400|P1|Overall Study|Withdrawal by Subject|3
353290|NCT00446134|1145397|P4|Overall Study|Lost to Follow-up|1
353291|NCT00446134|1145398|P3|Overall Study|Lost to Follow-up|1
353292|NCT00446134|1145399|P2|Overall Study|Lost to Follow-up|3
353293|NCT00446134|1145400|P1|Overall Study|Lost to Follow-up|1
353294|NCT00446134|1145397|P4|Overall Study|Protocol Violation|0
353295|NCT00446134|1145398|P3|Overall Study|Protocol Violation|1
353296|NCT00446134|1145399|P2|Overall Study|Protocol Violation|2
353297|NCT00446134|1145400|P1|Overall Study|Protocol Violation|0
353298|NCT00446134|1145397|P4|Overall Study|Lack of Efficacy|19
353299|NCT00446134|1145398|P3|Overall Study|Lack of Efficacy|24
353300|NCT00446134|1145399|P2|Overall Study|Lack of Efficacy|19
353301|NCT00446134|1145400|P1|Overall Study|Lack of Efficacy|19
353302|NCT00446134|1145397|P4|Overall Study|Adverse Event|18
353303|NCT00446134|1145398|P3|Overall Study|Adverse Event|13
353304|NCT00446134|1145399|P2|Overall Study|Adverse Event|17
353305|NCT00446134|1145400|P1|Overall Study|Adverse Event|7
353306|NCT00446095|1145427|P5|Phase I (28 Days)|Lack of Efficacy|3
353307|NCT00446095|1145428|P4|Phase I (28 Days)|Lack of Efficacy|0
353308|NCT00446095|1145429|P3|Phase I (28 Days)|Lack of Efficacy|0
353309|NCT00446095|1145430|P2|Phase I (28 Days)|Lack of Efficacy|0
353310|NCT00446095|1145431|P1|Phase I (28 Days)|Lack of Efficacy|0
353311|NCT00446095|1145427|P5|Phase I (28 Days)|Adverse Event|0
353312|NCT00446095|1145428|P4|Phase I (28 Days)|Adverse Event|1
353313|NCT00446095|1145429|P3|Phase I (28 Days)|Adverse Event|0
353314|NCT00446095|1145430|P2|Phase I (28 Days)|Adverse Event|0
353315|NCT00446095|1145431|P1|Phase I (28 Days)|Adverse Event|0
353316|NCT00446095|1145427|P5|Phase II (8 Weeks)|Ongoing|0
353317|NCT00446095|1145428|P4|Phase II (8 Weeks)|Ongoing|0
353318|NCT00446095|1145429|P3|Phase II (8 Weeks)|Ongoing|1
353319|NCT00446095|1145430|P2|Phase II (8 Weeks)|Ongoing|0
353320|NCT00446095|1145431|P1|Phase II (8 Weeks)|Ongoing|0
353321|NCT00446095|1145427|P5|Phase II (8 Weeks)|Lack of Efficacy|0
353322|NCT00446095|1145428|P4|Phase II (8 Weeks)|Lack of Efficacy|0
353323|NCT00446095|1145429|P3|Phase II (8 Weeks)|Lack of Efficacy|1
353324|NCT00446095|1145430|P2|Phase II (8 Weeks)|Lack of Efficacy|2
353325|NCT00446095|1145431|P1|Phase II (8 Weeks)|Lack of Efficacy|9
353326|NCT00446095|1145427|P5|Phase II (8 Weeks)|Physician Decision|0
353327|NCT00446095|1145428|P4|Phase II (8 Weeks)|Physician Decision|0
353328|NCT00446095|1145429|P3|Phase II (8 Weeks)|Physician Decision|0
353329|NCT00446095|1145430|P2|Phase II (8 Weeks)|Physician Decision|0
353330|NCT00446095|1145431|P1|Phase II (8 Weeks)|Physician Decision|1
353331|NCT00446095|1145427|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
353332|NCT00446095|1145428|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
353333|NCT00446095|1145429|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
353334|NCT00446095|1145430|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
353335|NCT00446095|1145431|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
353336|NCT00446095|1145427|P5|Phase II (8 Weeks)|Adverse Event|0
353337|NCT00446095|1145428|P4|Phase II (8 Weeks)|Adverse Event|0
353338|NCT00446095|1145429|P3|Phase II (8 Weeks)|Adverse Event|1
353339|NCT00446095|1145430|P2|Phase II (8 Weeks)|Adverse Event|1
353340|NCT00446095|1145431|P1|Phase II (8 Weeks)|Adverse Event|0
353341|NCT00446095|1145427|P5|Phase II (8 Weeks)|Lost to Follow-up|0
353342|NCT00446095|1145428|P4|Phase II (8 Weeks)|Lost to Follow-up|0
353343|NCT00446095|1145429|P3|Phase II (8 Weeks)|Lost to Follow-up|0
353344|NCT00446095|1145430|P2|Phase II (8 Weeks)|Lost to Follow-up|0
353345|NCT00446095|1145431|P1|Phase II (8 Weeks)|Lost to Follow-up|1
353346|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
353347|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
353348|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
353349|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
353350|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
353351|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
353352|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
353353|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
353354|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
353355|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
353356|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
353357|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
353358|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
353359|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
353360|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Death|2
353361|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Death|2
353362|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
353363|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
353364|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
353365|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
353366|NCT00446030|1145454|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
353367|NCT00446030|1145455|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
353368|NCT00446030|1145454|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
353369|NCT00446030|1145455|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
353370|NCT00446030|1145454|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
353371|NCT00446030|1145455|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
353372|NCT00446030|1145454|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
353373|NCT00446030|1145455|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
353374|NCT00446030|1145454|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
353375|NCT00446030|1145455|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
353376|NCT00446030|1145454|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
353544|NCT00444600|1146107|P4|Overall Study|Missed visit|1
353377|NCT00446030|1145455|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
353378|NCT00446030|1145454|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
353379|NCT00446030|1145455|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
353380|NCT00446030|1145454|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
353381|NCT00446030|1145455|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
353382|NCT00446030|1145454|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
353383|NCT00446030|1145455|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
353384|NCT00445939|1145466|P4|Period B - Week 4 - Week 8|Adverse Event|1
353385|NCT00445939|1145467|P3|Period B - Week 4 - Week 8|Adverse Event|0
353386|NCT00445939|1145468|P2|Period B - Week 4 - Week 8|Adverse Event|0
353387|NCT00445939|1145469|P1|Period B - Week 4 - Week 8|Adverse Event|2
353388|NCT00445939|1145466|P4|Period A - Week 0 - Week 4|Adverse Event|0
353389|NCT00445939|1145467|P3|Period A - Week 0 - Week 4|Adverse Event|0
353390|NCT00445939|1145468|P2|Period A - Week 0 - Week 4|Adverse Event|2
353391|NCT00445939|1145469|P1|Period A - Week 0 - Week 4|Adverse Event|1
353392|NCT00445848|1145492|P1|Overall Study|Other-Not protocol specified|5
353393|NCT00445848|1145492|P1|Overall Study|Progression|62
353394|NCT00445848|1145492|P1|Overall Study|Withdrawal by Subject|4
353395|NCT00445848|1145492|P1|Overall Study|Adverse Event|14
353396|NCT00445770|1145502|P3|Overall Study|Not specified|6
353397|NCT00445770|1145503|P2|Overall Study|Not specified|5
353398|NCT00445770|1145504|P1|Overall Study|Not specified|6
353399|NCT00445770|1145502|P3|Overall Study|Lost to Follow-up|0
353400|NCT00445770|1145503|P2|Overall Study|Lost to Follow-up|2
353401|NCT00445770|1145504|P1|Overall Study|Lost to Follow-up|0
353402|NCT00445770|1145502|P3|Overall Study|Lack of Efficacy|6
353403|NCT00445770|1145503|P2|Overall Study|Lack of Efficacy|13
353404|NCT00445770|1145504|P1|Overall Study|Lack of Efficacy|38
353405|NCT00445770|1145502|P3|Overall Study|Adverse Event|19
353406|NCT00445770|1145503|P2|Overall Study|Adverse Event|15
353407|NCT00445770|1145504|P1|Overall Study|Adverse Event|9
353408|NCT00445679|1145604|P4|Overall Study|Lack of Efficacy|0
353409|NCT00445679|1145605|P3|Overall Study|Lack of Efficacy|2
353410|NCT00445679|1145606|P2|Overall Study|Lack of Efficacy|6
353411|NCT00445679|1145607|P1|Overall Study|Lack of Efficacy|2
353412|NCT00445679|1145604|P4|Overall Study|Withdrawal by Subject|18
353413|NCT00445679|1145605|P3|Overall Study|Withdrawal by Subject|20
353414|NCT00445679|1145606|P2|Overall Study|Withdrawal by Subject|14
353415|NCT00445679|1145607|P1|Overall Study|Withdrawal by Subject|8
353416|NCT00445679|1145604|P4|Overall Study|Protocol Violation|1
353417|NCT00445679|1145605|P3|Overall Study|Protocol Violation|3
353418|NCT00445679|1145606|P2|Overall Study|Protocol Violation|3
353419|NCT00445679|1145607|P1|Overall Study|Protocol Violation|2
353420|NCT00445679|1145604|P4|Overall Study|Withdrawal of Informed Consent|0
353421|NCT00445679|1145605|P3|Overall Study|Withdrawal of Informed Consent|1
353422|NCT00445679|1145606|P2|Overall Study|Withdrawal of Informed Consent|0
353423|NCT00445679|1145607|P1|Overall Study|Withdrawal of Informed Consent|0
353424|NCT00445679|1145604|P4|Overall Study|Compliance|2
353425|NCT00445679|1145605|P3|Overall Study|Compliance|1
353426|NCT00445679|1145606|P2|Overall Study|Compliance|2
353427|NCT00445679|1145607|P1|Overall Study|Compliance|3
353428|NCT00445679|1145604|P4|Overall Study|Lost to Follow-up|5
353429|NCT00445679|1145605|P3|Overall Study|Lost to Follow-up|6
353430|NCT00445679|1145606|P2|Overall Study|Lost to Follow-up|6
353431|NCT00445679|1145607|P1|Overall Study|Lost to Follow-up|10
353432|NCT00445679|1145604|P4|Overall Study|Physician Decision|0
353433|NCT00445679|1145605|P3|Overall Study|Physician Decision|1
353434|NCT00445679|1145606|P2|Overall Study|Physician Decision|0
353435|NCT00445679|1145607|P1|Overall Study|Physician Decision|0
353436|NCT00445679|1145604|P4|Overall Study|Failed to return|2
353437|NCT00445679|1145605|P3|Overall Study|Failed to return|2
353438|NCT00445679|1145606|P2|Overall Study|Failed to return|3
353439|NCT00445679|1145607|P1|Overall Study|Failed to return|1
353440|NCT00445679|1145604|P4|Overall Study|Adverse Event|19
353441|NCT00445679|1145605|P3|Overall Study|Adverse Event|30
353442|NCT00445679|1145606|P2|Overall Study|Adverse Event|12
353443|NCT00445679|1145607|P1|Overall Study|Adverse Event|22
353444|NCT00445549|1145646|P1|Overall Study|progressive disease|12
353445|NCT00445432|1145669|P4|148 Weeks of Adalimumab Treatment|Not specified|9
353446|NCT00445432|1145670|P3|148 Weeks of Adalimumab Treatment|Not specified|0
353447|NCT00445432|1145671|P2|148 Weeks of Adalimumab Treatment|Not specified|0
353448|NCT00445432|1145672|P1|148 Weeks of Adalimumab Treatment|Not specified|0
353449|NCT00445432|1145669|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
353450|NCT00445432|1145670|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
353451|NCT00445432|1145671|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
353452|NCT00445432|1145672|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
353453|NCT00445432|1145669|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
353454|NCT00445432|1145670|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
353455|NCT00445432|1145671|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
353456|NCT00445432|1145672|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
353457|NCT00445432|1145669|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
353458|NCT00445432|1145670|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
353459|NCT00445432|1145671|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
353460|NCT00445432|1145672|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
353461|NCT00445432|1145669|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
353462|NCT00445432|1145670|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
353463|NCT00445432|1145671|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
353464|NCT00445432|1145672|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
353465|NCT00445432|1145669|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
353466|NCT00445432|1145670|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
353467|NCT00445432|1145671|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
353468|NCT00445432|1145672|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
353469|NCT00445432|1145669|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
353470|NCT00445432|1145670|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
353471|NCT00445432|1145671|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
353472|NCT00445432|1145672|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
353473|NCT00445341|1145705|P1|Overall Study|taken off treatment too early|1
353474|NCT00445341|1145705|P1|Overall Study|refused further treatment|1
353475|NCT00445328|1145712|P2|Overall Study|Protocol Violation|0
353476|NCT00445328|1145713|P1|Overall Study|Protocol Violation|1
353477|NCT00445328|1145712|P2|Overall Study|Withdrawal by Subject|0
353478|NCT00445328|1145713|P1|Overall Study|Withdrawal by Subject|2
353479|NCT00445328|1145712|P2|Overall Study|Other|2
353480|NCT00445328|1145713|P1|Overall Study|Other|0
353481|NCT00445328|1145712|P2|Overall Study|Adverse Event|3
353482|NCT00445328|1145713|P1|Overall Study|Adverse Event|0
353483|NCT00445328|1145712|P2|Overall Study|Death|1
353484|NCT00445328|1145713|P1|Overall Study|Death|0
353485|NCT00445224|1145874|P2|Specific Exercises|Withdrawal by Subject|0
353486|NCT00445224|1145875|P1|Specific Exercises|Withdrawal by Subject|1
353487|NCT00445224|1145874|P2|Specific Exercises|Withdrawal by Subject|3
353488|NCT00445224|1145875|P1|Specific Exercises|Withdrawal by Subject|3
353489|NCT00445146|1145902|P1|Overall Study|Pregnancy|1
353490|NCT00445146|1145902|P1|Overall Study|Protocol Violation|4
353491|NCT00445146|1145902|P1|Overall Study|Death|9
353492|NCT00445146|1145902|P1|Overall Study|Lost to Follow-up|13
353493|NCT00445146|1145902|P1|Overall Study|Adverse Event|13
353494|NCT00445146|1145902|P1|Overall Study|Investigator’s Discretion|22
353495|NCT00445146|1145902|P1|Overall Study|Lack of Efficacy|28
353496|NCT00445146|1145902|P1|Overall Study|Withdrew Consent|29
353497|NCT00445003|1145924|P3|Overall Study|Dropped|2
353498|NCT00445003|1145925|P2|Overall Study|Dropped|3
353499|NCT00445003|1145926|P1|Overall Study|Dropped|1
353500|NCT00445003|1145924|P3|Overall Study|Missed Visit|1
353501|NCT00445003|1145925|P2|Overall Study|Missed Visit|5
353502|NCT00445003|1145926|P1|Overall Study|Missed Visit|3
353503|NCT00445003|1145924|P3|Overall Study|Death|1
353504|NCT00445003|1145925|P2|Overall Study|Death|2
353505|NCT00445003|1145926|P1|Overall Study|Death|1
353506|NCT00444951|1145958|P3|Overall Study|Withdrawal by Subject|3
353507|NCT00444951|1145959|P2|Overall Study|Withdrawal by Subject|5
353508|NCT00444951|1145960|P1|Overall Study|Withdrawal by Subject|4
353509|NCT00444951|1145958|P3|Overall Study|Lost to Follow-up|0
353510|NCT00444951|1145959|P2|Overall Study|Lost to Follow-up|1
353511|NCT00444951|1145960|P1|Overall Study|Lost to Follow-up|1
353512|NCT00444925|1145977|P3|Double-blind Treatment Period|Other|12
353513|NCT00444925|1145978|P2|Double-blind Treatment Period|Other|7
353514|NCT00444925|1145979|P1|Double-blind Treatment Period|Other|7
353515|NCT00444925|1145977|P3|Double-blind Treatment Period|Withdrawal by Subject|7
353516|NCT00444925|1145978|P2|Double-blind Treatment Period|Withdrawal by Subject|8
353517|NCT00444925|1145979|P1|Double-blind Treatment Period|Withdrawal by Subject|6
353518|NCT00444925|1145977|P3|Double-blind Treatment Period|Lost to Follow-up|5
353519|NCT00444925|1145978|P2|Double-blind Treatment Period|Lost to Follow-up|8
353520|NCT00444925|1145979|P1|Double-blind Treatment Period|Lost to Follow-up|4
353521|NCT00444925|1145977|P3|Double-blind Treatment Period|Lack of Efficacy|13
353522|NCT00444925|1145978|P2|Double-blind Treatment Period|Lack of Efficacy|5
353523|NCT00444925|1145979|P1|Double-blind Treatment Period|Lack of Efficacy|5
353524|NCT00444925|1145977|P3|Double-blind Treatment Period|Adverse Event|44
353525|NCT00444925|1145978|P2|Double-blind Treatment Period|Adverse Event|28
353526|NCT00444925|1145979|P1|Double-blind Treatment Period|Adverse Event|6
353527|NCT00444925|1145977|P3|Double-blind Treatment Period|Death|0
353528|NCT00444925|1145978|P2|Double-blind Treatment Period|Death|0
353529|NCT00444925|1145979|P1|Double-blind Treatment Period|Death|2
353530|NCT00444925|1145977|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
353531|NCT00444925|1145978|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
353532|NCT00444925|1145979|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
353533|NCT00444912|1146043|P2|Overall Study|Participant Failed Mobilization|0
353534|NCT00444912|1146044|P1|Overall Study|Participant Failed Mobilization|1
353535|NCT00444912|1146043|P2|Overall Study|Lost to Follow-up|0
353536|NCT00444912|1146044|P1|Overall Study|Lost to Follow-up|1
353537|NCT00444912|1146043|P2|Overall Study|Death|2
353538|NCT00444912|1146044|P1|Overall Study|Death|1
353539|NCT00444795|1146072|P1|Overall Study|Treated Prior to the Contract Date|2
353540|NCT00444795|1146072|P1|Overall Study|Not Treated|1
353541|NCT00444626|1146077|P1|Initial Treatment Period|Lost to Follow-up|9
353542|NCT00444626|1146077|P1|Initial Treatment Period|Adverse Event|1
353543|NCT00444626|1146077|P1|Initial Treatment Period|Withdrawal by Subject|2
353545|NCT00444600|1146108|P3|Overall Study|Missed visit|0
353546|NCT00444600|1146109|P2|Overall Study|Missed visit|0
353547|NCT00444600|1146110|P1|Overall Study|Missed visit|1
353548|NCT00444600|1146107|P4|Overall Study|Dropped|7
353549|NCT00444600|1146108|P3|Overall Study|Dropped|7
353550|NCT00444600|1146109|P2|Overall Study|Dropped|11
353551|NCT00444600|1146110|P1|Overall Study|Dropped|11
353552|NCT00444600|1146107|P4|Overall Study|Death|2
353553|NCT00444600|1146108|P3|Overall Study|Death|3
353554|NCT00444600|1146109|P2|Overall Study|Death|5
353555|NCT00444600|1146110|P1|Overall Study|Death|7
353556|NCT00444587|1146202|P2|Overall Study|Missing|5
353557|NCT00444587|1146203|P1|Overall Study|Missing|0
353558|NCT00444587|1146202|P2|Overall Study|Protocol Violation|0
353559|NCT00444587|1146203|P1|Overall Study|Protocol Violation|1
353560|NCT00444587|1146202|P2|Overall Study|Investigator decision|0
353561|NCT00444587|1146203|P1|Overall Study|Investigator decision|3
353562|NCT00444587|1146202|P2|Overall Study|Refused treatment/did not cooperate|1
353563|NCT00444587|1146203|P1|Overall Study|Refused treatment/did not cooperate|4
353564|NCT00444587|1146202|P2|Overall Study|Progression of the disease|8
353565|NCT00444587|1146203|P1|Overall Study|Progression of the disease|73
353566|NCT00444587|1146202|P2|Overall Study|Death|1
353567|NCT00444587|1146203|P1|Overall Study|Death|2
353568|NCT00444535|1146224|P1|Overall Study|Adverse Event|3
353569|NCT00444535|1146224|P1|Overall Study|Investigator decision|2
353570|NCT00444535|1146224|P1|Overall Study|Withdrawal by Subject|3
353571|NCT00444535|1146224|P1|Overall Study|Treatment is ongoing|16
353572|NCT00444457|1146235|P4|Toddler Dose|Protocol Violation|1
353573|NCT00444457|1146236|P3|Toddler Dose|Protocol Violation|0
353574|NCT00444457|1146237|P2|Toddler Dose|Protocol Violation|0
353575|NCT00444457|1146238|P1|Toddler Dose|Protocol Violation|1
353576|NCT00444457|1146235|P4|Toddler Dose|Parent or legal guardian request|1
353577|NCT00444457|1146236|P3|Toddler Dose|Parent or legal guardian request|2
353578|NCT00444457|1146237|P2|Toddler Dose|Parent or legal guardian request|3
353579|NCT00444457|1146238|P1|Toddler Dose|Parent or legal guardian request|0
353580|NCT00444457|1146235|P4|Toddler Dose|Failed to return|3
353581|NCT00444457|1146236|P3|Toddler Dose|Failed to return|1
353582|NCT00444457|1146237|P2|Toddler Dose|Failed to return|2
353583|NCT00444457|1146238|P1|Toddler Dose|Failed to return|2
353584|NCT00444457|1146235|P4|Toddler Dose|Lost to Follow-up|3
353585|NCT00444457|1146236|P3|Toddler Dose|Lost to Follow-up|1
353586|NCT00444457|1146237|P2|Toddler Dose|Lost to Follow-up|1
353587|NCT00444457|1146238|P1|Toddler Dose|Lost to Follow-up|4
353588|NCT00444457|1146235|P4|After Infant Series|Unspecified|0
353589|NCT00444457|1146236|P3|After Infant Series|Unspecified|0
353590|NCT00444457|1146237|P2|After Infant Series|Unspecified|1
353591|NCT00444457|1146238|P1|After Infant Series|Unspecified|0
353592|NCT00444457|1146235|P4|After Infant Series|Investigator request|1
353593|NCT00444457|1146236|P3|After Infant Series|Investigator request|0
353594|NCT00444457|1146237|P2|After Infant Series|Investigator request|0
353595|NCT00444457|1146238|P1|After Infant Series|Investigator request|0
353596|NCT00444457|1146235|P4|After Infant Series|Adverse Event|0
353597|NCT00444457|1146236|P3|After Infant Series|Adverse Event|0
353598|NCT00444457|1146237|P2|After Infant Series|Adverse Event|2
353599|NCT00444457|1146238|P1|After Infant Series|Adverse Event|2
353600|NCT00444457|1146235|P4|After Infant Series|Protocol Violation|2
353601|NCT00444457|1146236|P3|After Infant Series|Protocol Violation|2
353602|NCT00444457|1146237|P2|After Infant Series|Protocol Violation|4
353603|NCT00444457|1146238|P1|After Infant Series|Protocol Violation|2
353604|NCT00444457|1146235|P4|After Infant Series|Lost to Follow-up|2
353605|NCT00444457|1146236|P3|After Infant Series|Lost to Follow-up|5
353606|NCT00444457|1146237|P2|After Infant Series|Lost to Follow-up|5
353607|NCT00444457|1146238|P1|After Infant Series|Lost to Follow-up|5
353608|NCT00444457|1146235|P4|After Infant Series|Failed to return|1
353609|NCT00444457|1146236|P3|After Infant Series|Failed to return|5
353610|NCT00444457|1146237|P2|After Infant Series|Failed to return|6
353611|NCT00444457|1146238|P1|After Infant Series|Failed to return|7
353612|NCT00444457|1146235|P4|After Infant Series|Parent or legal guardian request|3
353613|NCT00444457|1146236|P3|After Infant Series|Parent or legal guardian request|6
353614|NCT00444457|1146237|P2|After Infant Series|Parent or legal guardian request|11
353615|NCT00444457|1146238|P1|After Infant Series|Parent or legal guardian request|4
353616|NCT00444457|1146235|P4|After Infant Series|Other|1
353617|NCT00444457|1146236|P3|After Infant Series|Other|1
353618|NCT00444457|1146237|P2|After Infant Series|Other|1
353619|NCT00444457|1146238|P1|After Infant Series|Other|0
353620|NCT00444457|1146235|P4|Infant Series|Death|1
353621|NCT00444457|1146236|P3|Infant Series|Death|1
353622|NCT00444457|1146237|P2|Infant Series|Death|1
353623|NCT00444457|1146238|P1|Infant Series|Death|0
353624|NCT00444457|1146235|P4|Infant Series|Adverse Event|0
353625|NCT00444457|1146236|P3|Infant Series|Adverse Event|2
353626|NCT00444457|1146237|P2|Infant Series|Adverse Event|2
353627|NCT00444457|1146238|P1|Infant Series|Adverse Event|1
353628|NCT00444457|1146235|P4|Infant Series|Unspecified|0
353629|NCT00444457|1146236|P3|Infant Series|Unspecified|4
353630|NCT00444457|1146237|P2|Infant Series|Unspecified|2
353631|NCT00444457|1146238|P1|Infant Series|Unspecified|0
353632|NCT00444457|1146235|P4|Infant Series|Investigator request|2
353633|NCT00444457|1146236|P3|Infant Series|Investigator request|3
353634|NCT00444457|1146237|P2|Infant Series|Investigator request|3
353635|NCT00444457|1146238|P1|Infant Series|Investigator request|4
353636|NCT00444457|1146235|P4|Infant Series|Failed to return|2
353637|NCT00444457|1146236|P3|Infant Series|Failed to return|4
353638|NCT00444457|1146237|P2|Infant Series|Failed to return|4
353639|NCT00444457|1146238|P1|Infant Series|Failed to return|5
353640|NCT00444457|1146235|P4|Infant Series|Protocol Violation|3
353641|NCT00444457|1146236|P3|Infant Series|Protocol Violation|6
353642|NCT00444457|1146237|P2|Infant Series|Protocol Violation|8
353643|NCT00444457|1146238|P1|Infant Series|Protocol Violation|16
353644|NCT00444457|1146235|P4|Infant Series|Lost to Follow-up|6
353645|NCT00444457|1146236|P3|Infant Series|Lost to Follow-up|7
353646|NCT00444457|1146237|P2|Infant Series|Lost to Follow-up|11
353647|NCT00444457|1146238|P1|Infant Series|Lost to Follow-up|10
353648|NCT00444457|1146235|P4|Infant Series|Parent or legal guardian request|14
353649|NCT00444457|1146236|P3|Infant Series|Parent or legal guardian request|34
353650|NCT00444457|1146237|P2|Infant Series|Parent or legal guardian request|29
353651|NCT00444457|1146238|P1|Infant Series|Parent or legal guardian request|18
353652|NCT00444457|1146235|P4|Infant Series|Other|0
353653|NCT00444457|1146236|P3|Infant Series|Other|0
353654|NCT00444457|1146237|P2|Infant Series|Other|1
353655|NCT00444457|1146238|P1|Infant Series|Other|0
353656|NCT00444275|1146303|P5|Maintenance Treatment Phase|Ineffectiveness|14
353657|NCT00444275|1146304|P4|Maintenance Treatment Phase|Ineffectiveness|3
353658|NCT00444275|1146305|P3|Maintenance Treatment Phase|Ineffectiveness|5
353659|NCT00444275|1146306|P2|Maintenance Treatment Phase|Ineffectiveness|0
353660|NCT00444275|1146307|P1|Maintenance Treatment Phase|Ineffectiveness|0
353661|NCT00444275|1146303|P5|Maintenance Treatment Phase|Protocol Violation|87
353662|NCT00444275|1146304|P4|Maintenance Treatment Phase|Protocol Violation|88
353663|NCT00444275|1146305|P3|Maintenance Treatment Phase|Protocol Violation|103
353664|NCT00444275|1146306|P2|Maintenance Treatment Phase|Protocol Violation|0
353665|NCT00444275|1146307|P1|Maintenance Treatment Phase|Protocol Violation|0
353666|NCT00444275|1146303|P5|Maintenance Treatment Phase|Patient's wish|20
353667|NCT00444275|1146304|P4|Maintenance Treatment Phase|Patient's wish|9
353668|NCT00444275|1146305|P3|Maintenance Treatment Phase|Patient's wish|19
353669|NCT00444275|1146306|P2|Maintenance Treatment Phase|Patient's wish|0
353670|NCT00444275|1146307|P1|Maintenance Treatment Phase|Patient's wish|0
353671|NCT00444275|1146303|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
353672|NCT00444275|1146304|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
353673|NCT00444275|1146305|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
353674|NCT00444275|1146306|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
353675|NCT00444275|1146307|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
353676|NCT00444275|1146303|P5|Maintenance Treatment Phase|Adverse Event|13
353677|NCT00444275|1146304|P4|Maintenance Treatment Phase|Adverse Event|2
353678|NCT00444275|1146305|P3|Maintenance Treatment Phase|Adverse Event|3
353679|NCT00444275|1146306|P2|Maintenance Treatment Phase|Adverse Event|0
353680|NCT00444275|1146307|P1|Maintenance Treatment Phase|Adverse Event|0
353681|NCT00444275|1146303|P5|Maintenance Treatment Phase|Lost to Follow-up|10
353682|NCT00444275|1146304|P4|Maintenance Treatment Phase|Lost to Follow-up|14
353683|NCT00444275|1146305|P3|Maintenance Treatment Phase|Lost to Follow-up|8
353684|NCT00444275|1146306|P2|Maintenance Treatment Phase|Lost to Follow-up|0
353685|NCT00444275|1146307|P1|Maintenance Treatment Phase|Lost to Follow-up|0
353686|NCT00444275|1146303|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
353687|NCT00444275|1146304|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
353688|NCT00444275|1146305|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
353689|NCT00444275|1146306|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
353690|NCT00444275|1146307|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
353691|NCT00444145|1146357|P1|Overall Study|Screen Failures|5
353692|NCT00444145|1146357|P1|Overall Study|non-compliant|11
353693|NCT00444145|1146357|P1|Overall Study|Lost to Follow-up|1
353694|NCT00444145|1146357|P1|Overall Study|Withdrawal by Subject|2
353695|NCT00444106|1146364|P3|Overall Study|Abnormal Test Procedure Results|1
353696|NCT00444106|1146365|P2|Overall Study|Abnormal Test Procedure Results|0
353697|NCT00444106|1146366|P1|Overall Study|Abnormal Test Procedure Results|0
353698|NCT00444106|1146364|P3|Overall Study|Lost to Follow-up|0
353699|NCT00444106|1146365|P2|Overall Study|Lost to Follow-up|1
353700|NCT00444106|1146366|P1|Overall Study|Lost to Follow-up|2
353701|NCT00444067|1146383|P2|Overall Study|Lost to Follow-up|1
353702|NCT00444067|1146384|P1|Overall Study|Lost to Follow-up|0
353703|NCT00443898|1146398|P4|Overall Study|Death|0
353704|NCT00443898|1146399|P3|Overall Study|Death|0
353705|NCT00443898|1146400|P2|Overall Study|Death|1
353706|NCT00443898|1146401|P1|Overall Study|Death|0
353707|NCT00443898|1146398|P4|Overall Study|Lost to Follow-up|10
353708|NCT00443898|1146399|P3|Overall Study|Lost to Follow-up|14
353709|NCT00443898|1146400|P2|Overall Study|Lost to Follow-up|10
353710|NCT00443898|1146401|P1|Overall Study|Lost to Follow-up|10
353711|NCT00443898|1146398|P4|Overall Study|Withdrawal by Subject|6
353712|NCT00443898|1146399|P3|Overall Study|Withdrawal by Subject|10
353713|NCT00443898|1146400|P2|Overall Study|Withdrawal by Subject|10
353714|NCT00443898|1146401|P1|Overall Study|Withdrawal by Subject|11
353715|NCT00443898|1146398|P4|Overall Study|Protocol Violation|0
353716|NCT00443898|1146399|P3|Overall Study|Protocol Violation|1
353717|NCT00443898|1146400|P2|Overall Study|Protocol Violation|1
353718|NCT00443898|1146401|P1|Overall Study|Protocol Violation|1
353719|NCT00443898|1146398|P4|Overall Study|Lack of Efficacy|1
353720|NCT00443898|1146399|P3|Overall Study|Lack of Efficacy|3
353721|NCT00443898|1146400|P2|Overall Study|Lack of Efficacy|3
353722|NCT00443898|1146401|P1|Overall Study|Lack of Efficacy|2
353723|NCT00443898|1146398|P4|Overall Study|Adverse Event|1
353724|NCT00443898|1146399|P3|Overall Study|Adverse Event|1
353725|NCT00443898|1146400|P2|Overall Study|Adverse Event|0
353726|NCT00443898|1146401|P1|Overall Study|Adverse Event|0
353727|NCT00443872|1146423|P1|Overall Study|Adverse Event|8
353728|NCT00443872|1146423|P1|Overall Study|Lost to Follow-up|2
353729|NCT00443872|1146423|P1|Overall Study|Protocol Violation|7
353730|NCT00443820|1146440|P4|Overall Study|Death|0
353731|NCT00443820|1146441|P3|Overall Study|Death|1
353732|NCT00443820|1146442|P2|Overall Study|Death|0
353733|NCT00443820|1146443|P1|Overall Study|Death|0
353734|NCT00443820|1146440|P4|Overall Study|Administrative problems|1
353735|NCT00443820|1146441|P3|Overall Study|Administrative problems|0
353736|NCT00443820|1146442|P2|Overall Study|Administrative problems|0
353737|NCT00443820|1146443|P1|Overall Study|Administrative problems|0
353738|NCT00443820|1146440|P4|Overall Study|Lost to Follow-up|5
353739|NCT00443820|1146441|P3|Overall Study|Lost to Follow-up|6
353740|NCT00443820|1146442|P2|Overall Study|Lost to Follow-up|8
353741|NCT00443820|1146443|P1|Overall Study|Lost to Follow-up|9
353742|NCT00443820|1146440|P4|Overall Study|Withdrawal by Subject|9
353743|NCT00443820|1146441|P3|Overall Study|Withdrawal by Subject|8
353744|NCT00443820|1146442|P2|Overall Study|Withdrawal by Subject|7
353745|NCT00443820|1146443|P1|Overall Study|Withdrawal by Subject|6
353746|NCT00443820|1146440|P4|Overall Study|Protocol Violation|1
353747|NCT00443820|1146441|P3|Overall Study|Protocol Violation|2
353748|NCT00443820|1146442|P2|Overall Study|Protocol Violation|1
353749|NCT00443820|1146443|P1|Overall Study|Protocol Violation|2
353750|NCT00443820|1146440|P4|Overall Study|Lack of Efficacy|1
353751|NCT00443820|1146441|P3|Overall Study|Lack of Efficacy|1
353752|NCT00443820|1146442|P2|Overall Study|Lack of Efficacy|2
353753|NCT00443820|1146443|P1|Overall Study|Lack of Efficacy|3
353754|NCT00443820|1146440|P4|Overall Study|Adverse Event|0
353755|NCT00443820|1146441|P3|Overall Study|Adverse Event|0
353756|NCT00443820|1146442|P2|Overall Study|Adverse Event|1
353757|NCT00443820|1146443|P1|Overall Study|Adverse Event|1
353758|NCT00443781|1146465|P1|Overall Study|PD/FAD not done|1
353759|NCT00443781|1146465|P1|Overall Study|Insurance not covered|2
353760|NCT00443781|1146465|P1|Overall Study|Investigator terminated participation|1
353761|NCT00443781|1146465|P1|Overall Study|Unable to comply with study follow up|2
353762|NCT00443781|1146465|P1|Overall Study|Withdrawal by Subject|6
353763|NCT00443781|1146465|P1|Overall Study|Protocol Violation|1
353764|NCT00443781|1146465|P1|Overall Study|Physician Decision|2
353765|NCT00443781|1146465|P1|Overall Study|Lost to Follow-up|10
353766|NCT00443755|1146471|P2|Overall Study|Withdrawal by Subject|1
353767|NCT00443755|1146472|P1|Overall Study|Withdrawal by Subject|2
353768|NCT00443729|1146506|P2|Overall Study|Withdrawal by Subject|1
353769|NCT00443729|1146507|P1|Overall Study|Withdrawal by Subject|3
353770|NCT00443729|1146506|P2|Overall Study|Protocol Violation|1
353771|NCT00443729|1146507|P1|Overall Study|Protocol Violation|1
353772|NCT00443729|1146506|P2|Overall Study|Physician Decision|1
353773|NCT00443729|1146507|P1|Overall Study|Physician Decision|2
353774|NCT00443729|1146506|P2|Overall Study|Lost to Follow-up|1
353775|NCT00443729|1146507|P1|Overall Study|Lost to Follow-up|0
353776|NCT00443729|1146506|P2|Overall Study|Lack of Efficacy|2
353777|NCT00443729|1146507|P1|Overall Study|Lack of Efficacy|4
353778|NCT00443729|1146506|P2|Overall Study|Never Treated|1
353779|NCT00443729|1146507|P1|Overall Study|Never Treated|0
353780|NCT00443703|1146555|P2|Overall Study|Progressive Disease|0
353781|NCT00443703|1146556|P1|Overall Study|Progressive Disease|1
353782|NCT00443703|1146555|P2|Overall Study|Withdrawal by Subject|6
353783|NCT00443703|1146556|P1|Overall Study|Withdrawal by Subject|9
353784|NCT00443703|1146555|P2|Overall Study|Protocol Violation|1
353785|NCT00443703|1146556|P1|Overall Study|Protocol Violation|1
353786|NCT00443703|1146555|P2|Overall Study|Physician Decision|2
353787|NCT00443703|1146556|P1|Overall Study|Physician Decision|4
353788|NCT00443703|1146555|P2|Overall Study|Lost to Follow-up|4
353789|NCT00443703|1146556|P1|Overall Study|Lost to Follow-up|0
353790|NCT00443703|1146555|P2|Overall Study|Lack of Efficacy|1
353791|NCT00443703|1146556|P1|Overall Study|Lack of Efficacy|3
353792|NCT00443703|1146555|P2|Overall Study|Adverse Event|3
353793|NCT00443703|1146556|P1|Overall Study|Adverse Event|7
353794|NCT00443703|1146555|P2|Overall Study|Never Treated|1
353795|NCT00443703|1146556|P1|Overall Study|Never Treated|3
353796|NCT00443651|1146608|P2|Overall Study|Pregnancy|1
353797|NCT00443651|1146609|P1|Overall Study|Pregnancy|0
353798|NCT00443651|1146608|P2|Overall Study|Physician Decision|4
353799|NCT00443651|1146609|P1|Overall Study|Physician Decision|13
353800|NCT00443651|1146608|P2|Overall Study|Patient's/Guardian's Decision|30
353801|NCT00443651|1146609|P1|Overall Study|Patient's/Guardian's Decision|58
353802|NCT00443651|1146608|P2|Overall Study|Lost to Follow-up|12
353803|NCT00443651|1146609|P1|Overall Study|Lost to Follow-up|18
353804|NCT00443651|1146608|P2|Overall Study|Adverse Event|6
353805|NCT00443651|1146609|P1|Overall Study|Adverse Event|5
353806|NCT00443651|1146608|P2|Overall Study|Death|5
353807|NCT00443651|1146609|P1|Overall Study|Death|1
353808|NCT00443599|1146629|P2|Overall Study|Cardiopulmonary bypass canceled|1
353809|NCT00443599|1146630|P1|Overall Study|Cardiopulmonary bypass canceled|3
353810|NCT00443599|1146629|P2|Overall Study|Death|1
353811|NCT00443599|1146630|P1|Overall Study|Death|1
353812|NCT00443599|1146629|P2|Overall Study|Physician Decision|1
353813|NCT00443599|1146630|P1|Overall Study|Physician Decision|2
353814|NCT00443560|1146664|P2|Overall Study|Multiple pregnancies or fetal demise|4
353815|NCT00443560|1146665|P1|Overall Study|Multiple pregnancies or fetal demise|2
353816|NCT00443560|1146664|P2|Overall Study|No intrathecal dose|26
353817|NCT00443560|1146665|P1|Overall Study|No intrathecal dose|58
353818|NCT00443534|1146675|P1|Overall Study|Enrolled, Not Treated|1
353819|NCT00443534|1146675|P1|Overall Study|Unspecified|10
353820|NCT00443534|1146675|P1|Overall Study|Study Terminated by Sponsor|12
353821|NCT00443534|1146675|P1|Overall Study|Withdrawal by Subject|8
353822|NCT00443534|1146675|P1|Overall Study|Death|9
353823|NCT00443534|1146675|P1|Overall Study|Adverse Event|16
353824|NCT00443534|1146675|P1|Overall Study|Lack of Efficacy|67
353825|NCT00443456|1146682|P1|Overall Study|Withdrawal by Subject|1
353826|NCT00443456|1146682|P1|Overall Study|Move|1
353827|NCT00443456|1146682|P1|Overall Study|Adverse Event|16
353828|NCT00443430|1146717|P2|Overall Study|Adverse Event|1
353829|NCT00443430|1146718|P1|Overall Study|Adverse Event|1
353830|NCT00443430|1146717|P2|Overall Study|Lack of Efficacy|3
353831|NCT00443430|1146718|P1|Overall Study|Lack of Efficacy|3
353832|NCT00443261|1146732|P1|Overall Study|Death|1
353833|NCT00443209|1146738|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
353834|NCT00443209|1146739|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
353835|NCT00443209|1146738|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
353836|NCT00443209|1146739|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
353837|NCT00443209|1146738|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
353838|NCT00443209|1146739|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
353839|NCT00443209|1146738|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
353840|NCT00443209|1146739|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
353841|NCT00443209|1146738|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
353842|NCT00443209|1146739|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
353843|NCT00443209|1146738|P2|Months 13 to 18 Treatment Period|Adverse Event|0
353844|NCT00443209|1146739|P1|Months 13 to 18 Treatment Period|Adverse Event|1
353845|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Not Treated|43
353846|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Not Treated|71
353847|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Missing|1
353848|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Missing|2
353849|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
353850|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
353851|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
353852|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
353853|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Pregnancy|4
353854|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Pregnancy|3
353855|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Physician Decision|4
353856|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Physician Decision|8
353857|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
353858|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
353859|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
353860|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
353861|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
353862|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
353863|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
353864|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
353865|NCT00443209|1146738|P2|Months 1 to 12 Treatment Period|Adverse Event|11
353866|NCT00443209|1146739|P1|Months 1 to 12 Treatment Period|Adverse Event|22
353867|NCT00443118|1146756|P3|Overall Study|Withdrawal by Subject|0
353868|NCT00443118|1146757|P2|Overall Study|Withdrawal by Subject|0
353869|NCT00443118|1146758|P1|Overall Study|Withdrawal by Subject|1
353870|NCT00443118|1146756|P3|Overall Study|unknown primary outcome|0
353871|NCT00443118|1146757|P2|Overall Study|unknown primary outcome|1
353872|NCT00443118|1146758|P1|Overall Study|unknown primary outcome|3
353873|NCT00443053|1146804|P2|Overall Study|Physician Decision|4
353874|NCT00443053|1146805|P1|Overall Study|Physician Decision|0
353875|NCT00443053|1146804|P2|Overall Study|Other|4
353876|NCT00443053|1146805|P1|Overall Study|Other|3
353877|NCT00443053|1146804|P2|Overall Study|Noncompliance|1
353878|NCT00443053|1146805|P1|Overall Study|Noncompliance|2
353879|NCT00443053|1146804|P2|Overall Study|Did Not Meet Eligibility Criteria|0
353880|NCT00443053|1146805|P1|Overall Study|Did Not Meet Eligibility Criteria|1
353881|NCT00443053|1146804|P2|Overall Study|Lost to Follow-up|5
353882|NCT00443053|1146805|P1|Overall Study|Lost to Follow-up|4
353883|NCT00443053|1146804|P2|Overall Study|Withdrawal by Subject|18
353884|NCT00443053|1146805|P1|Overall Study|Withdrawal by Subject|9
353885|NCT00443053|1146804|P2|Overall Study|Adverse Event|1
353886|NCT00443053|1146805|P1|Overall Study|Adverse Event|2
353887|NCT00443040|1146826|P3|Overall Study|Converted to an open laparotomy|1
353888|NCT00443040|1146827|P2|Overall Study|Converted to an open laparotomy|0
353889|NCT00443040|1146828|P1|Overall Study|Converted to an open laparotomy|3
353890|NCT00443040|1146826|P3|Overall Study|Withdrawal by Subject|0
353891|NCT00443040|1146827|P2|Overall Study|Withdrawal by Subject|0
353892|NCT00443040|1146828|P1|Overall Study|Withdrawal by Subject|1
353893|NCT00442962|1146836|P1|Overall Study|Lost to Follow-up|7
353894|NCT00442962|1146836|P1|Overall Study|Pregnancy|1
353895|NCT00442936|1146854|P4|Overall Study|Protocol Violation|1
353896|NCT00442936|1146855|P3|Overall Study|Protocol Violation|1
353897|NCT00442936|1146856|P2|Overall Study|Protocol Violation|0
353898|NCT00442936|1146857|P1|Overall Study|Protocol Violation|1
353899|NCT00442897|1146905|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
353900|NCT00442897|1146906|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
353901|NCT00442897|1146905|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
353902|NCT00442897|1146906|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
353903|NCT00442897|1146905|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
353904|NCT00442897|1146906|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
353905|NCT00442897|1146905|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
353906|NCT00442897|1146906|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
353907|NCT00442897|1146905|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
353908|NCT00442897|1146906|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
353909|NCT00442897|1146905|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
353910|NCT00442897|1146906|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
353911|NCT00442897|1146905|P2|Base Study (12 Week Follow-up)|Death|1
353912|NCT00442897|1146906|P1|Base Study (12 Week Follow-up)|Death|0
353913|NCT00442897|1146905|P2|Base Study (12 Week Follow-up)|Adverse Event|0
353914|NCT00442897|1146906|P1|Base Study (12 Week Follow-up)|Adverse Event|1
353915|NCT00442702|1146916|P2|Evaluation Period|Site closure|1
353916|NCT00442702|1146917|P1|Evaluation Period|Site closure|0
353917|NCT00442702|1146916|P2|Evaluation Period|Failure to return|0
353918|NCT00442702|1146917|P1|Evaluation Period|Failure to return|1
353919|NCT00442702|1146916|P2|Evaluation Period|Renal transplant|1
353920|NCT00442702|1146917|P1|Evaluation Period|Renal transplant|0
353921|NCT00442702|1146916|P2|Evaluation Period|Refused treatment|1
353922|NCT00442702|1146917|P1|Evaluation Period|Refused treatment|1
353923|NCT00442702|1146916|P2|Evaluation Period|Insufficient Therapeutic Response|0
353924|NCT00442702|1146917|P1|Evaluation Period|Insufficient Therapeutic Response|1
353925|NCT00442702|1146916|P2|Evaluation Period|Death|1
353926|NCT00442702|1146917|P1|Evaluation Period|Death|1
353927|NCT00442702|1146916|P2|Evaluation Period|Adverse Event|0
353928|NCT00442702|1146917|P1|Evaluation Period|Adverse Event|1
353929|NCT00442702|1146916|P2|Titration Period|Hospitalized in another hospital|0
353930|NCT00442702|1146917|P1|Titration Period|Hospitalized in another hospital|1
353931|NCT00442702|1146916|P2|Titration Period|Failure to return|0
353932|NCT00442702|1146917|P1|Titration Period|Failure to return|1
353933|NCT00442702|1146916|P2|Titration Period|Refused Treatment|1
353934|NCT00442702|1146917|P1|Titration Period|Refused Treatment|4
353935|NCT00442702|1146916|P2|Titration Period|Insufficient Therapeutic Response|0
353936|NCT00442702|1146917|P1|Titration Period|Insufficient Therapeutic Response|1
353937|NCT00442702|1146916|P2|Titration Period|Death|2
353938|NCT00442702|1146917|P1|Titration Period|Death|3
353939|NCT00442702|1146916|P2|Titration Period|Adverse Event|0
353940|NCT00442702|1146917|P1|Titration Period|Adverse Event|2
353941|NCT00442598|1146976|P3|Overall Study|Death|0
353942|NCT00442598|1146977|P2|Overall Study|Death|1
353943|NCT00442598|1146978|P1|Overall Study|Death|0
353944|NCT00442598|1146976|P3|Overall Study|Reduced creatinine clearance|0
353945|NCT00442598|1146977|P2|Overall Study|Reduced creatinine clearance|0
353946|NCT00442598|1146978|P1|Overall Study|Reduced creatinine clearance|1
353947|NCT00442598|1146976|P3|Overall Study|CA125 progression|0
353948|NCT00442598|1146977|P2|Overall Study|CA125 progression|1
353949|NCT00442598|1146978|P1|Overall Study|CA125 progression|0
353950|NCT00442598|1146976|P3|Overall Study|Clinical deterioration|0
353951|NCT00442598|1146977|P2|Overall Study|Clinical deterioration|2
353952|NCT00442598|1146978|P1|Overall Study|Clinical deterioration|1
353953|NCT00442598|1146976|P3|Overall Study|Tumor progression|0
353954|NCT00442598|1146977|P2|Overall Study|Tumor progression|4
353955|NCT00442598|1146978|P1|Overall Study|Tumor progression|3
353956|NCT00442598|1146976|P3|Overall Study|Adverse Event|0
353957|NCT00442598|1146977|P2|Overall Study|Adverse Event|0
353958|NCT00442598|1146978|P1|Overall Study|Adverse Event|1
353959|NCT00442572|1146996|P2|Overall Study|Withdrawal by Subject|1
353960|NCT00442572|1146997|P1|Overall Study|Withdrawal by Subject|0
353961|NCT00442572|1146996|P2|Overall Study|Lost to Follow-up|1
353962|NCT00442572|1146997|P1|Overall Study|Lost to Follow-up|0
353963|NCT00442572|1146996|P2|Overall Study|Relapse|1
353964|NCT00442572|1146997|P1|Overall Study|Relapse|8
353965|NCT00442559|1147037|P2|Overall Study|Withdrawal by Subject|0
353966|NCT00442559|1147038|P1|Overall Study|Withdrawal by Subject|1
353967|NCT00442559|1147037|P2|Overall Study|Protocol Violation|1
353968|NCT00442559|1147038|P1|Overall Study|Protocol Violation|1
353969|NCT00442559|1147037|P2|Overall Study|Lost to Follow-up|34
353970|NCT00442559|1147038|P1|Overall Study|Lost to Follow-up|32
353971|NCT00442546|1147053|P3|Overall Study|Randomized But Not Treated|6
353972|NCT00442546|1147054|P2|Overall Study|Randomized But Not Treated|4
353973|NCT00442546|1147055|P1|Overall Study|Randomized But Not Treated|5
353974|NCT00442546|1147053|P3|Overall Study|Withdrawal by Subject|7
353975|NCT00442546|1147054|P2|Overall Study|Withdrawal by Subject|5
353976|NCT00442546|1147055|P1|Overall Study|Withdrawal by Subject|5
353977|NCT00442546|1147053|P3|Overall Study|Other|6
353978|NCT00442546|1147054|P2|Overall Study|Other|9
353979|NCT00442546|1147055|P1|Overall Study|Other|4
353980|NCT00442546|1147053|P3|Overall Study|Lost to Follow-up|1
353981|NCT00442546|1147054|P2|Overall Study|Lost to Follow-up|2
353982|NCT00442546|1147055|P1|Overall Study|Lost to Follow-up|1
353983|NCT00442546|1147053|P3|Overall Study|Adverse Event|13
353984|NCT00442546|1147054|P2|Overall Study|Adverse Event|17
353985|NCT00442546|1147055|P1|Overall Study|Adverse Event|11
353986|NCT00442468|1147184|P1|Overall Study|Did not complete all study procedures|88
353987|NCT00442468|1147184|P1|Overall Study|Withdrawal by Subject|91
353988|NCT00442468|1147184|P1|Overall Study|Adverse Event|4
353989|NCT00442416|1147214|P2|Overall Study|Administrative/Other|33
353990|NCT00442416|1147215|P1|Overall Study|Administrative/Other|27
353991|NCT00442416|1147214|P2|Overall Study|Withdrew consent|2
353992|NCT00442416|1147215|P1|Overall Study|Withdrew consent|1
353993|NCT00442416|1147214|P2|Overall Study|Protocol Violation|3
353994|NCT00442416|1147215|P1|Overall Study|Protocol Violation|2
353995|NCT00442416|1147214|P2|Overall Study|Lack of Efficacy|0
353996|NCT00442416|1147215|P1|Overall Study|Lack of Efficacy|2
353997|NCT00442416|1147214|P2|Overall Study|Death|0
353998|NCT00442416|1147215|P1|Overall Study|Death|1
353999|NCT00442416|1147214|P2|Overall Study|Adverse Event|1
354000|NCT00442416|1147215|P1|Overall Study|Adverse Event|4
354001|NCT00442351|1147254|P2|Overall Study|Not specified|1
354002|NCT00442351|1147255|P1|Overall Study|Not specified|0
354003|NCT00442351|1147254|P2|Overall Study|Did not meet protocol eligibility|0
354004|NCT00442351|1147255|P1|Overall Study|Did not meet protocol eligibility|1
354005|NCT00442351|1147254|P2|Overall Study|Administrative|5
354006|NCT00442351|1147255|P1|Overall Study|Administrative|6
354007|NCT00442286|1147277|P2|Overall Study|Patient Injury|0
354008|NCT00442286|1147278|P1|Overall Study|Patient Injury|1
354009|NCT00442286|1147277|P2|Overall Study|System explanted|0
354010|NCT00442286|1147278|P1|Overall Study|System explanted|1
354011|NCT00442286|1147277|P2|Overall Study|Withdrawal by Subject|0
354012|NCT00442286|1147278|P1|Overall Study|Withdrawal by Subject|2
354013|NCT00442286|1147277|P2|Overall Study|Lost to Follow-up|0
354014|NCT00442286|1147278|P1|Overall Study|Lost to Follow-up|1
354015|NCT00442286|1147277|P2|Overall Study|Death|2
354016|NCT00442286|1147278|P1|Overall Study|Death|2
354017|NCT00442117|1147340|P2|Overall Study|Met Withdrawal Criteria|1
354018|NCT00442117|1147341|P1|Overall Study|Met Withdrawal Criteria|2
354019|NCT00442117|1147340|P2|Overall Study|Non compliance with protocol|5
354020|NCT00442117|1147341|P1|Overall Study|Non compliance with protocol|3
354021|NCT00442117|1147340|P2|Overall Study|Major Deviation|20
354022|NCT00442117|1147341|P1|Overall Study|Major Deviation|25
354023|NCT00442117|1147340|P2|Overall Study|Withdrawal by Subject|2
354024|NCT00442117|1147341|P1|Overall Study|Withdrawal by Subject|2
354025|NCT00442117|1147340|P2|Overall Study|Lost to Follow-up|2
354026|NCT00442117|1147341|P1|Overall Study|Lost to Follow-up|1
354027|NCT00442117|1147340|P2|Overall Study|Lack of Efficacy|6
354028|NCT00442117|1147341|P1|Overall Study|Lack of Efficacy|2
354029|NCT00442117|1147340|P2|Overall Study|Adverse Event|2
354030|NCT00442117|1147341|P1|Overall Study|Adverse Event|3
354031|NCT00441974|1147372|P1|Overall Study|Protocol Violation|7
354032|NCT00441974|1147372|P1|Overall Study|Lost to Follow-up|80
354033|NCT00441974|1147372|P1|Overall Study|Consent Withdrawn|35
354034|NCT00441974|1147372|P1|Overall Study|Adverse Event|6
354035|NCT00441792|1147388|P2|Overall Study|Lost to Follow-up|2
354036|NCT00441792|1147389|P1|Overall Study|Lost to Follow-up|0
354037|NCT00441727|1147429|P3|Overall Study|Various reason specified|5
354038|NCT00441727|1147430|P2|Overall Study|Various reason specified|8
354039|NCT00441727|1147431|P1|Overall Study|Various reason specified|6
354040|NCT00441727|1147429|P3|Overall Study|Safety Reasons|3
354041|NCT00441727|1147430|P2|Overall Study|Safety Reasons|1
354042|NCT00441727|1147431|P1|Overall Study|Safety Reasons|3
354043|NCT00441727|1147429|P3|Overall Study|Lost to Follow-up|5
354044|NCT00441727|1147430|P2|Overall Study|Lost to Follow-up|6
354045|NCT00441727|1147431|P1|Overall Study|Lost to Follow-up|5
354046|NCT00441727|1147429|P3|Overall Study|Withdrawal by Subject|47
354047|NCT00441727|1147430|P2|Overall Study|Withdrawal by Subject|34
354048|NCT00441727|1147431|P1|Overall Study|Withdrawal by Subject|40
354049|NCT00441727|1147429|P3|Overall Study|Lack of Efficacy|48
354050|NCT00441727|1147430|P2|Overall Study|Lack of Efficacy|8
354051|NCT00441727|1147431|P1|Overall Study|Lack of Efficacy|7
354052|NCT00441727|1147429|P3|Overall Study|Adverse Event|28
354053|NCT00441727|1147430|P2|Overall Study|Adverse Event|33
354054|NCT00441727|1147431|P1|Overall Study|Adverse Event|26
354055|NCT00441727|1147429|P3|Overall Study|Protocol Violation|32
354056|NCT00441727|1147430|P2|Overall Study|Protocol Violation|28
354057|NCT00441727|1147431|P1|Overall Study|Protocol Violation|19
354058|NCT00441701|1147464|P10|Overall Study|Withdrawal by Subject|0
354059|NCT00441701|1147465|P9|Overall Study|Withdrawal by Subject|0
354060|NCT00441701|1147466|P8|Overall Study|Withdrawal by Subject|0
354061|NCT00441701|1147467|P7|Overall Study|Withdrawal by Subject|0
354062|NCT00441701|1147468|P6|Overall Study|Withdrawal by Subject|0
354063|NCT00441701|1147469|P5|Overall Study|Withdrawal by Subject|0
354064|NCT00441701|1147470|P4|Overall Study|Withdrawal by Subject|1
354065|NCT00441701|1147471|P3|Overall Study|Withdrawal by Subject|1
354066|NCT00441701|1147472|P2|Overall Study|Withdrawal by Subject|2
354067|NCT00441701|1147473|P1|Overall Study|Withdrawal by Subject|0
354068|NCT00441701|1147464|P10|Overall Study|Lack of Efficacy|0
354069|NCT00441701|1147465|P9|Overall Study|Lack of Efficacy|0
354070|NCT00441701|1147466|P8|Overall Study|Lack of Efficacy|0
354071|NCT00441701|1147467|P7|Overall Study|Lack of Efficacy|0
354072|NCT00441701|1147468|P6|Overall Study|Lack of Efficacy|1
354073|NCT00441701|1147469|P5|Overall Study|Lack of Efficacy|0
354074|NCT00441701|1147470|P4|Overall Study|Lack of Efficacy|2
354075|NCT00441701|1147471|P3|Overall Study|Lack of Efficacy|2
354076|NCT00441701|1147472|P2|Overall Study|Lack of Efficacy|0
354077|NCT00441701|1147473|P1|Overall Study|Lack of Efficacy|2
354078|NCT00441701|1147464|P10|Overall Study|Adverse Event|0
354079|NCT00441701|1147465|P9|Overall Study|Adverse Event|0
354080|NCT00441701|1147466|P8|Overall Study|Adverse Event|0
354081|NCT00441701|1147467|P7|Overall Study|Adverse Event|0
354082|NCT00441701|1147468|P6|Overall Study|Adverse Event|2
354083|NCT00441701|1147469|P5|Overall Study|Adverse Event|2
354084|NCT00441701|1147470|P4|Overall Study|Adverse Event|0
354085|NCT00441701|1147471|P3|Overall Study|Adverse Event|1
354086|NCT00441701|1147472|P2|Overall Study|Adverse Event|2
354087|NCT00441701|1147473|P1|Overall Study|Adverse Event|3
354088|NCT00441584|1147555|P1|Overall Study|Failure to meet eligibility criteria|3
354089|NCT00441584|1147555|P1|Overall Study|Lost to Follow-up|4
354090|NCT00441584|1147555|P1|Overall Study|Protocol Violation|5
354091|NCT00441584|1147555|P1|Overall Study|Adverse Event|6
354092|NCT00441584|1147555|P1|Overall Study|Withdrawal by Subject|8
354093|NCT00441584|1147555|P1|Overall Study|Lack of Efficacy|79
354094|NCT00441545|1147563|P2|Second Intervention|Subject moved|1
354095|NCT00441545|1147564|P1|Second Intervention|Subject moved|0
354096|NCT00441545|1147563|P2|Second Intervention|Subject exceeded safety criteria|0
354097|NCT00441545|1147564|P1|Second Intervention|Subject exceeded safety criteria|1
354098|NCT00441545|1147563|P2|Second Intervention|Lack of Efficacy|1
354099|NCT00441545|1147564|P1|Second Intervention|Lack of Efficacy|0
354100|NCT00441545|1147563|P2|Second Intervention|Kidney Transplant|1
354101|NCT00441545|1147564|P1|Second Intervention|Kidney Transplant|1
354102|NCT00441545|1147563|P2|Second Intervention|Withdrawal by Subject|1
354103|NCT00441545|1147564|P1|Second Intervention|Withdrawal by Subject|1
354104|NCT00441545|1147563|P2|Second Intervention|Protocol Violation|1
354105|NCT00441545|1147564|P1|Second Intervention|Protocol Violation|4
354106|NCT00441545|1147563|P2|Second Intervention|Adverse Event|2
354107|NCT00441545|1147564|P1|Second Intervention|Adverse Event|5
354108|NCT00441545|1147563|P2|First Intervention|Sponsor's request|0
354109|NCT00441545|1147564|P1|First Intervention|Sponsor's request|1
354110|NCT00441545|1147563|P2|First Intervention|Site error|0
354111|NCT00441545|1147564|P1|First Intervention|Site error|1
354112|NCT00441545|1147563|P2|First Intervention|Extended hospitalization|0
354113|NCT00441545|1147564|P1|First Intervention|Extended hospitalization|1
354114|NCT00441545|1147563|P2|First Intervention|Subject met an exclusionary criteria|0
354115|NCT00441545|1147564|P1|First Intervention|Subject met an exclusionary criteria|1
354116|NCT00441545|1147563|P2|First Intervention|Subject exceeded safety criteria|1
354117|NCT00441545|1147564|P1|First Intervention|Subject exceeded safety criteria|0
354118|NCT00441545|1147563|P2|First Intervention|Lack of Efficacy|0
354119|NCT00441545|1147564|P1|First Intervention|Lack of Efficacy|2
354120|NCT00441545|1147563|P2|First Intervention|Kidney transplant|1
354121|NCT00441545|1147564|P1|First Intervention|Kidney transplant|1
354122|NCT00441545|1147563|P2|First Intervention|Withdrawal by Subject|3
354123|NCT00441545|1147564|P1|First Intervention|Withdrawal by Subject|3
354124|NCT00441545|1147563|P2|First Intervention|Protocol Violation|2
354125|NCT00441545|1147564|P1|First Intervention|Protocol Violation|2
354126|NCT00441545|1147563|P2|First Intervention|Adverse Event|5
354127|NCT00441545|1147564|P1|First Intervention|Adverse Event|6
354128|NCT00441480|1147578|P2|Overall Study|Withdrawal by Subject|3
354129|NCT00441480|1147579|P1|Overall Study|Withdrawal by Subject|2
354130|NCT00441480|1147578|P2|Overall Study|Protocol Violation|1
354131|NCT00441480|1147579|P1|Overall Study|Protocol Violation|1
354132|NCT00441467|1147611|P1|Overall Study|Progressive disease|9
354133|NCT00441467|1147611|P1|Overall Study|Withdrawal by Subject|3
354134|NCT00441467|1147611|P1|Overall Study|Adverse Event|6
354135|NCT00441441|1147619|P2|Overall Study|Not specified|3
354136|NCT00441441|1147620|P1|Overall Study|Not specified|3
354137|NCT00441441|1147619|P2|Overall Study|Withdrawal by Subject|2
354138|NCT00441441|1147620|P1|Overall Study|Withdrawal by Subject|1
354139|NCT00441441|1147619|P2|Overall Study|Exacerbation of asthma|2
354140|NCT00441441|1147620|P1|Overall Study|Exacerbation of asthma|1
354141|NCT00441441|1147619|P2|Overall Study|Protocol Violation|6
354142|NCT00441441|1147620|P1|Overall Study|Protocol Violation|4
354143|NCT00441441|1147619|P2|Overall Study|Adverse Event|1
354144|NCT00441441|1147620|P1|Overall Study|Adverse Event|2
354145|NCT00441363|1147680|P2|Overall Study|not specified|0
354146|NCT00441363|1147681|P1|Overall Study|not specified|2
354147|NCT00441363|1147680|P2|Overall Study|Lost to Follow-up|2
354148|NCT00441363|1147681|P1|Overall Study|Lost to Follow-up|2
354149|NCT00441363|1147680|P2|Overall Study|Physician Decision|7
354150|NCT00441363|1147681|P1|Overall Study|Physician Decision|6
354151|NCT00441363|1147680|P2|Overall Study|Withdrawal by Subject|4
354152|NCT00441363|1147681|P1|Overall Study|Withdrawal by Subject|3
354153|NCT00441363|1147680|P2|Overall Study|Adverse Event|2
354154|NCT00441363|1147681|P1|Overall Study|Adverse Event|4
354155|NCT00441337|1147693|P4|Overall Study|Did not meet inclusion criteria|0
354156|NCT00441337|1147694|P3|Overall Study|Did not meet inclusion criteria|1
354157|NCT00441337|1147695|P2|Overall Study|Did not meet inclusion criteria|0
354158|NCT00441337|1147696|P1|Overall Study|Did not meet inclusion criteria|0
354159|NCT00441337|1147693|P4|Overall Study|Sponsor Decision|2
354160|NCT00441337|1147694|P3|Overall Study|Sponsor Decision|1
354161|NCT00441337|1147695|P2|Overall Study|Sponsor Decision|0
354162|NCT00441337|1147696|P1|Overall Study|Sponsor Decision|0
354163|NCT00441337|1147693|P4|Overall Study|Lost to Follow-up|1
354164|NCT00441337|1147694|P3|Overall Study|Lost to Follow-up|0
354165|NCT00441337|1147695|P2|Overall Study|Lost to Follow-up|0
354166|NCT00441337|1147696|P1|Overall Study|Lost to Follow-up|0
354167|NCT00441337|1147693|P4|Overall Study|Disease Progression|18
354168|NCT00441337|1147694|P3|Overall Study|Disease Progression|4
354169|NCT00441337|1147695|P2|Overall Study|Disease Progression|6
354170|NCT00441337|1147696|P1|Overall Study|Disease Progression|6
354171|NCT00441272|1147809|P2|Overall Study|Study terminated prior to enrollment|25
354172|NCT00441272|1147810|P1|Overall Study|Study terminated prior to enrollment|25
354173|NCT00441168|1147837|P2|Follow-up Period|Other|3
354174|NCT00441168|1147838|P1|Follow-up Period|Other|1
354175|NCT00441168|1147837|P2|Follow-up Period|Withdrawal by Subject|0
354176|NCT00441168|1147838|P1|Follow-up Period|Withdrawal by Subject|3
354177|NCT00441168|1147837|P2|Follow-up Period|Lost to Follow-up|6
354178|NCT00441168|1147838|P1|Follow-up Period|Lost to Follow-up|5
354179|NCT00441168|1147837|P2|Follow-up Period|Death|0
354180|NCT00441168|1147838|P1|Follow-up Period|Death|3
354181|NCT00441168|1147837|P2|Treatment Period|refractory disease|0
354182|NCT00441168|1147838|P1|Treatment Period|refractory disease|1
354183|NCT00441168|1147837|P2|Treatment Period|qualified for stem-cell transplantation|0
354184|NCT00441168|1147838|P1|Treatment Period|qualified for stem-cell transplantation|3
354185|NCT00441168|1147837|P2|Treatment Period|Withdrawal by Subject|0
354186|NCT00441168|1147838|P1|Treatment Period|Withdrawal by Subject|3
354187|NCT00441168|1147837|P2|Treatment Period|Lost to Follow-up|1
354188|NCT00441168|1147838|P1|Treatment Period|Lost to Follow-up|0
354189|NCT00441168|1147837|P2|Treatment Period|Protocol Violation|1
354190|NCT00441168|1147838|P1|Treatment Period|Protocol Violation|0
354191|NCT00441168|1147837|P2|Treatment Period|Progressive Disease|2
354192|NCT00441168|1147838|P1|Treatment Period|Progressive Disease|0
354193|NCT00441168|1147837|P2|Treatment Period|Adverse Event|2
354194|NCT00441168|1147838|P1|Treatment Period|Adverse Event|1
354195|NCT00441168|1147837|P2|Treatment Period|Death|0
354196|NCT00441168|1147838|P1|Treatment Period|Death|3
354197|NCT00441142|1147852|P4|Overall Study|Death|1
354198|NCT00441142|1147853|P3|Overall Study|Death|0
354199|NCT00441142|1147854|P2|Overall Study|Death|0
354200|NCT00441142|1147855|P1|Overall Study|Death|0
354201|NCT00441142|1147852|P4|Overall Study|Physician Decision|1
354202|NCT00441142|1147853|P3|Overall Study|Physician Decision|0
354203|NCT00441142|1147854|P2|Overall Study|Physician Decision|1
354204|NCT00441142|1147855|P1|Overall Study|Physician Decision|0
354205|NCT00441142|1147852|P4|Overall Study|Patient still receiving active study tx|2
354206|NCT00441142|1147853|P3|Overall Study|Patient still receiving active study tx|0
354207|NCT00441142|1147854|P2|Overall Study|Patient still receiving active study tx|0
354208|NCT00441142|1147855|P1|Overall Study|Patient still receiving active study tx|1
354209|NCT00441142|1147852|P4|Overall Study|Withdrawal by Subject|10
354210|NCT00441142|1147853|P3|Overall Study|Withdrawal by Subject|2
354211|NCT00441142|1147854|P2|Overall Study|Withdrawal by Subject|0
354212|NCT00441142|1147855|P1|Overall Study|Withdrawal by Subject|0
354213|NCT00441142|1147852|P4|Overall Study|Lack of Efficacy|32
354214|NCT00441142|1147853|P3|Overall Study|Lack of Efficacy|17
354215|NCT00441142|1147854|P2|Overall Study|Lack of Efficacy|3
354216|NCT00441142|1147855|P1|Overall Study|Lack of Efficacy|3
354217|NCT00441142|1147852|P4|Overall Study|Adverse Event|22
354218|NCT00441142|1147853|P3|Overall Study|Adverse Event|3
354219|NCT00441142|1147854|P2|Overall Study|Adverse Event|3
354220|NCT00441142|1147855|P1|Overall Study|Adverse Event|2
354221|NCT00441116|1147873|P2|Overall Study|Did not meet Eligibility Criteria|1
354222|NCT00441116|1147874|P1|Overall Study|Did not meet Eligibility Criteria|1
354223|NCT00441116|1147873|P2|Overall Study|Withdrawal by Subject|0
354224|NCT00441116|1147874|P1|Overall Study|Withdrawal by Subject|1
354225|NCT00441116|1147873|P2|Overall Study|Adverse Event|1
354226|NCT00441116|1147874|P1|Overall Study|Adverse Event|1
354227|NCT00441103|1147942|P2|Overall Study|Participant decided to stop|1
354228|NCT00441103|1147943|P1|Overall Study|Participant decided to stop|0
354229|NCT00441103|1147942|P2|Overall Study|Participant's reason|1
354230|NCT00441103|1147943|P1|Overall Study|Participant's reason|0
354231|NCT00441103|1147942|P2|Overall Study|Participant decided to withdraw|0
354232|NCT00441103|1147943|P1|Overall Study|Participant decided to withdraw|1
354233|NCT00441103|1147942|P2|Overall Study|Non-compliant|1
354234|NCT00441103|1147943|P1|Overall Study|Non-compliant|0
354235|NCT00441103|1147942|P2|Overall Study|Inclusion criteria absent|0
354236|NCT00441103|1147943|P1|Overall Study|Inclusion criteria absent|1
354237|NCT00441103|1147942|P2|Overall Study|Participant refused MRI|0
354238|NCT00441103|1147943|P1|Overall Study|Participant refused MRI|1
354239|NCT00441103|1147942|P2|Overall Study|Participant unable to use Rebiject II|0
354240|NCT00441103|1147943|P1|Overall Study|Participant unable to use Rebiject II|1
354241|NCT00441103|1147942|P2|Overall Study|Protocol Violation|0
354242|NCT00441103|1147943|P1|Overall Study|Protocol Violation|1
354243|NCT00441103|1147942|P2|Overall Study|Lost to Follow-up|0
354244|NCT00441103|1147943|P1|Overall Study|Lost to Follow-up|1
354245|NCT00441103|1147942|P2|Overall Study|Disease Progression|0
354246|NCT00441103|1147943|P1|Overall Study|Disease Progression|2
354247|NCT00441103|1147942|P2|Overall Study|Death|0
354248|NCT00441103|1147943|P1|Overall Study|Death|1
354249|NCT00441103|1147942|P2|Overall Study|Adverse Event|1
354250|NCT00441103|1147943|P1|Overall Study|Adverse Event|2
354251|NCT00441064|1147956|P2|Overall Study|Patient withdrew consent|2
354252|NCT00441064|1147957|P1|Overall Study|Patient withdrew consent|5
354253|NCT00441064|1147956|P2|Overall Study|Protocol Deviation|2
354254|NCT00441064|1147957|P1|Overall Study|Protocol Deviation|3
354255|NCT00441064|1147956|P2|Overall Study|Unsatisfactory therapeutic effect|0
354256|NCT00441064|1147957|P1|Overall Study|Unsatisfactory therapeutic effect|1
354257|NCT00441064|1147956|P2|Overall Study|Abnormal test procedure results|1
354258|NCT00441064|1147957|P1|Overall Study|Abnormal test procedure results|0
354259|NCT00441064|1147956|P2|Overall Study|Abnormal laboratory values|2
354260|NCT00441064|1147957|P1|Overall Study|Abnormal laboratory values|0
354261|NCT00441064|1147956|P2|Overall Study|Adverse Event|0
354262|NCT00441064|1147957|P1|Overall Study|Adverse Event|1
354263|NCT00441012|1147969|P2|Overall Study|Subject Randomized but Not Vaccinated|0
354264|NCT00441012|1147970|P1|Overall Study|Subject Randomized but Not Vaccinated|1
354265|NCT00441012|1147969|P2|Overall Study|Withdrawal by Subject|0
354266|NCT00441012|1147970|P1|Overall Study|Withdrawal by Subject|4
354267|NCT00441012|1147969|P2|Overall Study|Protocol Violation|9
354268|NCT00441012|1147970|P1|Overall Study|Protocol Violation|10
354269|NCT00441012|1147969|P2|Overall Study|Lost to Follow-up|3
354270|NCT00441012|1147970|P1|Overall Study|Lost to Follow-up|3
354271|NCT00441012|1147969|P2|Overall Study|Adverse Event|1
354272|NCT00441012|1147970|P1|Overall Study|Adverse Event|0
354273|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
354274|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
354275|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
354276|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
354277|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
354278|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Physician Decision|1
354279|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Physician Decision|0
354280|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Physician Decision|0
354281|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Physician Decision|0
354282|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Physician Decision|0
354283|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Other|0
354284|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Other|1
354285|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Other|0
354286|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Other|0
354287|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Other|0
354288|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
354289|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
354290|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
354291|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
354292|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
354293|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Sponsor Request|1
354294|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Sponsor Request|1
354295|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Sponsor Request|0
354296|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Sponsor Request|0
354297|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Sponsor Request|0
354298|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Participant Moved|1
354299|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Participant Moved|1
354300|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Participant Moved|0
354301|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Participant Moved|0
354302|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Participant Moved|0
354303|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Pregnancy|0
354304|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Pregnancy|3
354305|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Pregnancy|0
354306|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Pregnancy|0
354307|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Pregnancy|0
354308|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
354309|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
354310|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
354311|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
354312|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
354313|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Protocol Violation|0
354314|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Protocol Violation|1
354315|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Protocol Violation|0
354316|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Protocol Violation|0
354317|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Protocol Violation|0
354318|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
354319|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
354320|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
354321|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
354322|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
354323|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Non-compliance|1
354324|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Non-compliance|1
354325|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Non-compliance|0
354326|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Non-compliance|0
354327|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Non-compliance|0
354328|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
354329|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
354330|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
354331|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
354332|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
354333|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
354334|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
354335|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
354336|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
354337|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
354338|NCT00440947|1147984|P5|Optional 60-Week Extension Phase|Adverse Event|3
354339|NCT00440947|1147985|P4|Optional 60-Week Extension Phase|Adverse Event|1
354340|NCT00440947|1147986|P3|Optional 60-Week Extension Phase|Adverse Event|0
354341|NCT00440947|1147987|P2|Optional 60-Week Extension Phase|Adverse Event|0
354342|NCT00440947|1147988|P1|Optional 60-Week Extension Phase|Adverse Event|0
354343|NCT00440947|1147984|P5|48-Week Randomization Phase|Physician Decision|0
354344|NCT00440947|1147985|P4|48-Week Randomization Phase|Physician Decision|0
354345|NCT00440947|1147986|P3|48-Week Randomization Phase|Physician Decision|0
354346|NCT00440947|1147987|P2|48-Week Randomization Phase|Physician Decision|2
354347|NCT00440947|1147988|P1|48-Week Randomization Phase|Physician Decision|0
354348|NCT00440947|1147984|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
354349|NCT00440947|1147985|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
354350|NCT00440947|1147986|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
354351|NCT00440947|1147987|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
354352|NCT00440947|1147988|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
354353|NCT00440947|1147984|P5|48-Week Randomization Phase|Incarceration|0
354354|NCT00440947|1147985|P4|48-Week Randomization Phase|Incarceration|0
354355|NCT00440947|1147986|P3|48-Week Randomization Phase|Incarceration|0
354356|NCT00440947|1147987|P2|48-Week Randomization Phase|Incarceration|3
354357|NCT00440947|1147988|P1|48-Week Randomization Phase|Incarceration|0
354358|NCT00440947|1147984|P5|48-Week Randomization Phase|Pregnancy|0
354359|NCT00440947|1147985|P4|48-Week Randomization Phase|Pregnancy|0
354360|NCT00440947|1147986|P3|48-Week Randomization Phase|Pregnancy|1
354361|NCT00440947|1147987|P2|48-Week Randomization Phase|Pregnancy|0
354362|NCT00440947|1147988|P1|48-Week Randomization Phase|Pregnancy|0
354363|NCT00440947|1147984|P5|48-Week Randomization Phase|Withdrawal by Subject|0
354364|NCT00440947|1147985|P4|48-Week Randomization Phase|Withdrawal by Subject|0
354365|NCT00440947|1147986|P3|48-Week Randomization Phase|Withdrawal by Subject|4
354366|NCT00440947|1147987|P2|48-Week Randomization Phase|Withdrawal by Subject|2
354367|NCT00440947|1147988|P1|48-Week Randomization Phase|Withdrawal by Subject|0
354368|NCT00440947|1147984|P5|48-Week Randomization Phase|Protocol Violation|0
354369|NCT00440947|1147985|P4|48-Week Randomization Phase|Protocol Violation|0
354370|NCT00440947|1147986|P3|48-Week Randomization Phase|Protocol Violation|1
354371|NCT00440947|1147987|P2|48-Week Randomization Phase|Protocol Violation|0
354372|NCT00440947|1147988|P1|48-Week Randomization Phase|Protocol Violation|0
354373|NCT00440947|1147984|P5|48-Week Randomization Phase|Lost to Follow-up|0
354374|NCT00440947|1147985|P4|48-Week Randomization Phase|Lost to Follow-up|0
354375|NCT00440947|1147986|P3|48-Week Randomization Phase|Lost to Follow-up|8
354376|NCT00440947|1147987|P2|48-Week Randomization Phase|Lost to Follow-up|2
354377|NCT00440947|1147988|P1|48-Week Randomization Phase|Lost to Follow-up|0
354378|NCT00440947|1147984|P5|48-Week Randomization Phase|Non-compliance|0
354379|NCT00440947|1147985|P4|48-Week Randomization Phase|Non-compliance|0
354380|NCT00440947|1147986|P3|48-Week Randomization Phase|Non-compliance|4
354381|NCT00440947|1147987|P2|48-Week Randomization Phase|Non-compliance|3
354382|NCT00440947|1147988|P1|48-Week Randomization Phase|Non-compliance|0
354383|NCT00440947|1147984|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
354384|NCT00440947|1147985|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
354385|NCT00440947|1147986|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
354386|NCT00440947|1147987|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
354387|NCT00440947|1147988|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
354388|NCT00440947|1147984|P5|48-Week Randomization Phase|Adverse Event|0
354389|NCT00440947|1147985|P4|48-Week Randomization Phase|Adverse Event|0
354390|NCT00440947|1147986|P3|48-Week Randomization Phase|Adverse Event|5
354391|NCT00440947|1147987|P2|48-Week Randomization Phase|Adverse Event|2
354392|NCT00440947|1147988|P1|48-Week Randomization Phase|Adverse Event|0
354393|NCT00440947|1147984|P5|36-Week Induction Phase|Pregnancy|0
354394|NCT00440947|1147985|P4|36-Week Induction Phase|Pregnancy|0
354395|NCT00440947|1147986|P3|36-Week Induction Phase|Pregnancy|0
354396|NCT00440947|1147987|P2|36-Week Induction Phase|Pregnancy|0
354397|NCT00440947|1147988|P1|36-Week Induction Phase|Pregnancy|1
354398|NCT00440947|1147984|P5|36-Week Induction Phase|Incarceration|0
354399|NCT00440947|1147985|P4|36-Week Induction Phase|Incarceration|0
354400|NCT00440947|1147986|P3|36-Week Induction Phase|Incarceration|0
354401|NCT00440947|1147987|P2|36-Week Induction Phase|Incarceration|0
354402|NCT00440947|1147988|P1|36-Week Induction Phase|Incarceration|3
354403|NCT00440947|1147984|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
354404|NCT00440947|1147985|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
354405|NCT00440947|1147986|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
354406|NCT00440947|1147987|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
354407|NCT00440947|1147988|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
354408|NCT00440947|1147984|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
354409|NCT00440947|1147985|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
354410|NCT00440947|1147986|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
354411|NCT00440947|1147987|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
354412|NCT00440947|1147988|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
354413|NCT00440947|1147984|P5|36-Week Induction Phase|Took Exclusionary Medications|0
354414|NCT00440947|1147985|P4|36-Week Induction Phase|Took Exclusionary Medications|0
354415|NCT00440947|1147986|P3|36-Week Induction Phase|Took Exclusionary Medications|0
354416|NCT00440947|1147987|P2|36-Week Induction Phase|Took Exclusionary Medications|0
354417|NCT00440947|1147988|P1|36-Week Induction Phase|Took Exclusionary Medications|1
354418|NCT00440947|1147984|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
354419|NCT00440947|1147985|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
354420|NCT00440947|1147986|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
354421|NCT00440947|1147987|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
354422|NCT00440947|1147988|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
354423|NCT00440947|1147984|P5|36-Week Induction Phase|Withdrawal by Subject|0
354424|NCT00440947|1147985|P4|36-Week Induction Phase|Withdrawal by Subject|0
354425|NCT00440947|1147986|P3|36-Week Induction Phase|Withdrawal by Subject|0
354426|NCT00440947|1147987|P2|36-Week Induction Phase|Withdrawal by Subject|0
354427|NCT00440947|1147988|P1|36-Week Induction Phase|Withdrawal by Subject|7
354428|NCT00440947|1147984|P5|36-Week Induction Phase|Lost to Follow-up|0
354429|NCT00440947|1147985|P4|36-Week Induction Phase|Lost to Follow-up|0
354430|NCT00440947|1147986|P3|36-Week Induction Phase|Lost to Follow-up|0
354431|NCT00440947|1147987|P2|36-Week Induction Phase|Lost to Follow-up|0
354432|NCT00440947|1147988|P1|36-Week Induction Phase|Lost to Follow-up|16
354433|NCT00440947|1147984|P5|36-Week Induction Phase|Non-compliance|0
354434|NCT00440947|1147985|P4|36-Week Induction Phase|Non-compliance|0
354435|NCT00440947|1147986|P3|36-Week Induction Phase|Non-compliance|0
354436|NCT00440947|1147987|P2|36-Week Induction Phase|Non-compliance|0
354437|NCT00440947|1147988|P1|36-Week Induction Phase|Non-compliance|10
354438|NCT00440947|1147984|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
354439|NCT00440947|1147985|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
354440|NCT00440947|1147986|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
354441|NCT00440947|1147987|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
354442|NCT00440947|1147988|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
354443|NCT00440947|1147984|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
354444|NCT00440947|1147985|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
354445|NCT00440947|1147986|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
354446|NCT00440947|1147987|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
354447|NCT00440947|1147988|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
354448|NCT00440947|1147984|P5|36-Week Induction Phase|Adverse Event|0
354449|NCT00440947|1147985|P4|36-Week Induction Phase|Adverse Event|0
354450|NCT00440947|1147986|P3|36-Week Induction Phase|Adverse Event|0
354451|NCT00440947|1147987|P2|36-Week Induction Phase|Adverse Event|0
354452|NCT00440947|1147988|P1|36-Week Induction Phase|Adverse Event|16
354453|NCT00440700|1148063|P3|Overall Study|Withdrawal by Subject|4
354454|NCT00440700|1148064|P2|Overall Study|Withdrawal by Subject|8
354455|NCT00440700|1148065|P1|Overall Study|Withdrawal by Subject|8
354456|NCT00440557|1148088|P3|Overall Study|Patient had surgery|0
354457|NCT00440557|1148089|P2|Overall Study|Patient had surgery|0
354458|NCT00440557|1148090|P1|Overall Study|Patient had surgery|1
354459|NCT00440557|1148088|P3|Overall Study|Patient transferred to nursing home|0
354460|NCT00440557|1148089|P2|Overall Study|Patient transferred to nursing home|1
354461|NCT00440557|1148090|P1|Overall Study|Patient transferred to nursing home|0
354462|NCT00440557|1148088|P3|Overall Study|Principal Investigator's office closed|4
354463|NCT00440557|1148089|P2|Overall Study|Principal Investigator's office closed|6
354464|NCT00440557|1148090|P1|Overall Study|Principal Investigator's office closed|3
354465|NCT00440557|1148088|P3|Overall Study|Patient moved|1
354466|NCT00440557|1148089|P2|Overall Study|Patient moved|2
354467|NCT00440557|1148090|P1|Overall Study|Patient moved|1
354468|NCT00440557|1148088|P3|Overall Study|Principal Investigator decision|1
354469|NCT00440557|1148089|P2|Overall Study|Principal Investigator decision|3
354470|NCT00440557|1148090|P1|Overall Study|Principal Investigator decision|0
354471|NCT00440557|1148088|P3|Overall Study|Began Dialysis|4
354472|NCT00440557|1148089|P2|Overall Study|Began Dialysis|1
354473|NCT00440557|1148090|P1|Overall Study|Began Dialysis|4
354474|NCT00440557|1148088|P3|Overall Study|Death|3
354475|NCT00440557|1148089|P2|Overall Study|Death|6
354476|NCT00440557|1148090|P1|Overall Study|Death|2
354477|NCT00440557|1148088|P3|Overall Study|Adverse Event|5
354478|NCT00440557|1148089|P2|Overall Study|Adverse Event|3
354479|NCT00440557|1148090|P1|Overall Study|Adverse Event|3
354480|NCT00440557|1148088|P3|Overall Study|Lost to Follow-up|6
354481|NCT00440557|1148089|P2|Overall Study|Lost to Follow-up|2
354482|NCT00440557|1148090|P1|Overall Study|Lost to Follow-up|1
354483|NCT00440557|1148088|P3|Overall Study|Withdrawal by Subject|11
354484|NCT00440557|1148089|P2|Overall Study|Withdrawal by Subject|5
354485|NCT00440557|1148090|P1|Overall Study|Withdrawal by Subject|10
354486|NCT00440531|1148122|P3|Overall Study|see pre-assignment details|0
354487|NCT00440531|1148123|P2|Overall Study|see pre-assignment details|0
354488|NCT00440531|1148124|P1|Overall Study|see pre-assignment details|2
354489|NCT00440531|1148122|P3|Overall Study|Lost to Follow-up|5
354490|NCT00440531|1148123|P2|Overall Study|Lost to Follow-up|3
354491|NCT00440531|1148124|P1|Overall Study|Lost to Follow-up|4
354492|NCT00440531|1148122|P3|Overall Study|Protocol Violation|0
354493|NCT00440531|1148123|P2|Overall Study|Protocol Violation|2
354494|NCT00440531|1148124|P1|Overall Study|Protocol Violation|1
354495|NCT00440531|1148122|P3|Overall Study|Withdrawal by Subject|0
354496|NCT00440531|1148123|P2|Overall Study|Withdrawal by Subject|0
354497|NCT00440531|1148124|P1|Overall Study|Withdrawal by Subject|2
354498|NCT00440531|1148122|P3|Overall Study|Adverse Event|2
354499|NCT00440531|1148123|P2|Overall Study|Adverse Event|0
354500|NCT00440531|1148124|P1|Overall Study|Adverse Event|1
354501|NCT00440518|1148141|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
354502|NCT00440518|1148142|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
354503|NCT00440518|1148143|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
354504|NCT00440518|1148141|P3|Maintenance and Safety Follow-up Periods|Other|2
354505|NCT00440518|1148142|P2|Maintenance and Safety Follow-up Periods|Other|0
354506|NCT00440518|1148143|P1|Maintenance and Safety Follow-up Periods|Other|0
354507|NCT00440518|1148141|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
354508|NCT00440518|1148142|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
354509|NCT00440518|1148143|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
354510|NCT00440518|1148141|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
354511|NCT00440518|1148142|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
354512|NCT00440518|1148143|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
354513|NCT00440518|1148141|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
354514|NCT00440518|1148142|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
354515|NCT00440518|1148143|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
354516|NCT00440518|1148141|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
354517|NCT00440518|1148142|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
354518|NCT00440518|1148143|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
354519|NCT00440518|1148141|P3|Randomized /Titration Period|Adverse Event|0
354520|NCT00440518|1148142|P2|Randomized /Titration Period|Adverse Event|3
354521|NCT00440518|1148143|P1|Randomized /Titration Period|Adverse Event|2
354522|NCT00440518|1148141|P3|Randomized /Titration Period|Lost to Follow-up|1
354523|NCT00440518|1148142|P2|Randomized /Titration Period|Lost to Follow-up|2
354524|NCT00440518|1148143|P1|Randomized /Titration Period|Lost to Follow-up|2
354525|NCT00440518|1148141|P3|Randomized /Titration Period|Other|0
354526|NCT00440518|1148142|P2|Randomized /Titration Period|Other|0
354527|NCT00440518|1148143|P1|Randomized /Titration Period|Other|1
354528|NCT00440518|1148141|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
354529|NCT00440518|1148142|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
354530|NCT00440518|1148143|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
354531|NCT00440518|1148141|P3|Randomized /Titration Period|Protocol Deviation|0
354532|NCT00440518|1148142|P2|Randomized /Titration Period|Protocol Deviation|0
354533|NCT00440518|1148143|P1|Randomized /Titration Period|Protocol Deviation|1
354534|NCT00440518|1148141|P3|Randomized /Titration Period|Subject Withdrew Consent|0
354535|NCT00440518|1148142|P2|Randomized /Titration Period|Subject Withdrew Consent|1
354536|NCT00440518|1148143|P1|Randomized /Titration Period|Subject Withdrew Consent|4
354537|NCT00440518|1148141|P3|Randomized /Titration Period|Lack of Efficacy|1
354538|NCT00440518|1148142|P2|Randomized /Titration Period|Lack of Efficacy|0
354539|NCT00440518|1148143|P1|Randomized /Titration Period|Lack of Efficacy|1
354540|NCT00440466|1148188|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
354541|NCT00440466|1148189|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
354542|NCT00440466|1148190|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
354543|NCT00440466|1148188|P3|Overall Study|Began Dialysis|1
354544|NCT00440466|1148189|P2|Overall Study|Began Dialysis|0
354545|NCT00440466|1148190|P1|Overall Study|Began Dialysis|0
354546|NCT00440466|1148188|P3|Overall Study|Withdrawal by Subject|9
354547|NCT00440466|1148189|P2|Overall Study|Withdrawal by Subject|5
354548|NCT00440466|1148190|P1|Overall Study|Withdrawal by Subject|2
354549|NCT00440466|1148188|P3|Overall Study|Protocol Violation|4
354550|NCT00440466|1148189|P2|Overall Study|Protocol Violation|0
354551|NCT00440466|1148190|P1|Overall Study|Protocol Violation|2
354552|NCT00440466|1148188|P3|Overall Study|Physician Decision|1
354553|NCT00440466|1148189|P2|Overall Study|Physician Decision|0
354554|NCT00440466|1148190|P1|Overall Study|Physician Decision|2
354555|NCT00440466|1148188|P3|Overall Study|Lost to Follow-up|2
354556|NCT00440466|1148189|P2|Overall Study|Lost to Follow-up|0
354557|NCT00440466|1148190|P1|Overall Study|Lost to Follow-up|1
354558|NCT00440466|1148188|P3|Overall Study|Adverse Event|11
354559|NCT00440466|1148189|P2|Overall Study|Adverse Event|4
354560|NCT00440466|1148190|P1|Overall Study|Adverse Event|3
354561|NCT00440466|1148188|P3|Overall Study|Death|9
354562|NCT00440466|1148189|P2|Overall Study|Death|2
354563|NCT00440466|1148190|P1|Overall Study|Death|3
354564|NCT00440401|1148224|P2|Overall Study|Not specified|5
354565|NCT00440401|1148225|P1|Overall Study|Not specified|2
354566|NCT00440401|1148224|P2|Overall Study|Adverse Event|1
354567|NCT00440401|1148225|P1|Overall Study|Adverse Event|2
354568|NCT00440310|1148235|P2|Overall Study|Status Unknown|3
354569|NCT00440310|1148236|P1|Overall Study|Status Unknown|1
354570|NCT00440310|1148235|P2|Overall Study|Other|0
354571|NCT00440310|1148236|P1|Overall Study|Other|1
354572|NCT00440310|1148235|P2|Overall Study|No Reply at EOS|7
354573|NCT00440310|1148236|P1|Overall Study|No Reply at EOS|7
354574|NCT00440310|1148235|P2|Overall Study|Withdrawal by Subject|14
354575|NCT00440310|1148236|P1|Overall Study|Withdrawal by Subject|15
354576|NCT00440310|1148235|P2|Overall Study|Protocol Violation|1
354577|NCT00440310|1148236|P1|Overall Study|Protocol Violation|0
354578|NCT00440310|1148235|P2|Overall Study|Lost to Follow-up|5
354579|NCT00440310|1148236|P1|Overall Study|Lost to Follow-up|4
354580|NCT00440297|1148244|P2|Overall Study|Randomized by mistake|0
354581|NCT00440297|1148245|P1|Overall Study|Randomized by mistake|1
354582|NCT00440297|1148244|P2|Overall Study|Withdrawal by Subject|6
354583|NCT00440297|1148245|P1|Overall Study|Withdrawal by Subject|1
354584|NCT00440297|1148244|P2|Overall Study|Protocol Violation|7
354585|NCT00440297|1148245|P1|Overall Study|Protocol Violation|11
354586|NCT00440297|1148244|P2|Overall Study|Physician Decision|0
354587|NCT00440297|1148245|P1|Overall Study|Physician Decision|1
354588|NCT00440297|1148244|P2|Overall Study|Lost to Follow-up|0
354589|NCT00440297|1148245|P1|Overall Study|Lost to Follow-up|1
354590|NCT00440297|1148244|P2|Overall Study|Adverse Event|5
354591|NCT00440297|1148245|P1|Overall Study|Adverse Event|8
354592|NCT00440271|1148261|P2|Overall Study|Other|0
354593|NCT00440271|1148262|P1|Overall Study|Other|2
354594|NCT00440271|1148261|P2|Overall Study|Due to closure of trial|10
354595|NCT00440271|1148262|P1|Overall Study|Due to closure of trial|8
354596|NCT00440271|1148261|P2|Overall Study|Lack of Efficacy|1
354597|NCT00440271|1148262|P1|Overall Study|Lack of Efficacy|0
354598|NCT00440271|1148261|P2|Overall Study|Withdrawal by Subject|2
354599|NCT00440271|1148262|P1|Overall Study|Withdrawal by Subject|0
354600|NCT00440271|1148261|P2|Overall Study|Lost to Follow-up|0
354601|NCT00440271|1148262|P1|Overall Study|Lost to Follow-up|1
354602|NCT00440271|1148261|P2|Overall Study|Adverse Event|1
354603|NCT00440271|1148262|P1|Overall Study|Adverse Event|0
354604|NCT00440271|1148261|P2|Overall Study|Protocol Violation|1
354605|NCT00440271|1148262|P1|Overall Study|Protocol Violation|1
354606|NCT00440232|1148296|P2|Overall Study|Onset of headache within 4 hours of fast|2
354607|NCT00440232|1148297|P1|Overall Study|Onset of headache within 4 hours of fast|2
354608|NCT00440232|1148296|P2|Overall Study|Unable to treat within allowed time|1
354609|NCT00440232|1148297|P1|Overall Study|Unable to treat within allowed time|0
354610|NCT00440232|1148296|P2|Overall Study|Lost to Follow-up|1
354611|NCT00440232|1148297|P1|Overall Study|Lost to Follow-up|1
354612|NCT00440193|1148307|P2|Observational Period|Participant convenience|0
354613|NCT00440193|1148308|P1|Observational Period|Participant convenience|2
354614|NCT00440193|1148307|P2|Observational Period|Clinical endpoint reached|0
354615|NCT00440193|1148308|P1|Observational Period|Clinical endpoint reached|1
354616|NCT00440193|1148307|P2|Observational Period|Physician Decision|0
354617|NCT00440193|1148308|P1|Observational Period|Physician Decision|1
354618|NCT00440193|1148307|P2|Observational Period|Withdrawal by Subject|8
354619|NCT00440193|1148308|P1|Observational Period|Withdrawal by Subject|11
354620|NCT00440193|1148307|P2|Observational Period|Protocol Violation|0
354621|NCT00440193|1148308|P1|Observational Period|Protocol Violation|1
354622|NCT00440193|1148307|P2|Observational Period|Lost to Follow-up|8
354623|NCT00440193|1148308|P1|Observational Period|Lost to Follow-up|12
354624|NCT00440193|1148307|P2|Observational Period|Death|20
354625|NCT00440193|1148308|P1|Observational Period|Death|15
354626|NCT00440193|1148307|P2|Observational Period|Adverse Event|2
354627|NCT00440193|1148308|P1|Observational Period|Adverse Event|2
354628|NCT00440193|1148307|P2|Treatment Period|Site closed by investigator|2
354629|NCT00440193|1148308|P1|Treatment Period|Site closed by investigator|0
354630|NCT00440193|1148307|P2|Treatment Period|Participant did not receive treatment|13
354631|NCT00440193|1148308|P1|Treatment Period|Participant did not receive treatment|7
354632|NCT00440193|1148307|P2|Treatment Period|Participant convenience|2
354633|NCT00440193|1148308|P1|Treatment Period|Participant convenience|5
354634|NCT00440193|1148307|P2|Treatment Period|Technical problems|1
354635|NCT00440193|1148308|P1|Treatment Period|Technical problems|1
354636|NCT00440193|1148307|P2|Treatment Period|Switch to commercial drug|2
354637|NCT00440193|1148308|P1|Treatment Period|Switch to commercial drug|0
354638|NCT00440193|1148307|P2|Treatment Period|Protocol driven decision point|2
354639|NCT00440193|1148308|P1|Treatment Period|Protocol driven decision point|2
354640|NCT00440193|1148307|P2|Treatment Period|Study terminated by sponsor|94
354641|NCT00440193|1148308|P1|Treatment Period|Study terminated by sponsor|102
354642|NCT00440193|1148307|P2|Treatment Period|Clinical endpoint reached|25
354643|NCT00440193|1148308|P1|Treatment Period|Clinical endpoint reached|28
354644|NCT00440193|1148307|P2|Treatment Period|Withdrawal by Subject|77
354645|NCT00440193|1148308|P1|Treatment Period|Withdrawal by Subject|36
354646|NCT00440193|1148307|P2|Treatment Period|Protocol Violation|19
354647|NCT00440193|1148308|P1|Treatment Period|Protocol Violation|16
354648|NCT00440193|1148307|P2|Treatment Period|Physician Decision|6
354649|NCT00440193|1148308|P1|Treatment Period|Physician Decision|3
354650|NCT00440193|1148307|P2|Treatment Period|Lost to Follow-up|18
354651|NCT00440193|1148308|P1|Treatment Period|Lost to Follow-up|12
354652|NCT00440193|1148307|P2|Treatment Period|Lack of Efficacy|1
354653|NCT00440193|1148308|P1|Treatment Period|Lack of Efficacy|0
354654|NCT00440193|1148307|P2|Treatment Period|Death|22
354655|NCT00440193|1148308|P1|Treatment Period|Death|19
354656|NCT00440193|1148307|P2|Treatment Period|Adverse Event|67
354657|NCT00440193|1148308|P1|Treatment Period|Adverse Event|74
354658|NCT00440115|1148354|P3|Overall Study|Incarceration|1
354659|NCT00440115|1148355|P2|Overall Study|Incarceration|2
354660|NCT00440115|1148356|P1|Overall Study|Incarceration|0
354661|NCT00440115|1148354|P3|Overall Study|Death|5
354662|NCT00440115|1148355|P2|Overall Study|Death|9
354663|NCT00440115|1148356|P1|Overall Study|Death|7
354664|NCT00440011|1148387|P2|Overall Study|Withdrawal by Subject|0
354665|NCT00440011|1148388|P1|Overall Study|Withdrawal by Subject|1
354666|NCT00440011|1148387|P2|Overall Study|Protocol Violation|1
354667|NCT00440011|1148388|P1|Overall Study|Protocol Violation|1
354668|NCT00440011|1148387|P2|Overall Study|Lost to Follow-up|2
354669|NCT00440011|1148388|P1|Overall Study|Lost to Follow-up|0
354670|NCT00440011|1148387|P2|Overall Study|Adverse Event|0
354671|NCT00440011|1148388|P1|Overall Study|Adverse Event|2
354672|NCT00439777|1148415|P2|Observational Period|Technical problems|1
354673|NCT00439777|1148416|P1|Observational Period|Technical problems|0
354674|NCT00439777|1148415|P2|Observational Period|Lack of Efficacy|0
354675|NCT00439777|1148416|P1|Observational Period|Lack of Efficacy|1
354676|NCT00439777|1148415|P2|Observational Period|Protocol driven decision point|1
354677|NCT00439777|1148416|P1|Observational Period|Protocol driven decision point|0
354678|NCT00439777|1148415|P2|Observational Period|Study terminated by sponsor|1
354679|NCT00439777|1148416|P1|Observational Period|Study terminated by sponsor|3
354680|NCT00439777|1148415|P2|Observational Period|Death|20
354681|NCT00439777|1148416|P1|Observational Period|Death|27
354682|NCT00439777|1148415|P2|Observational Period|Lost to Follow-up|11
354683|NCT00439777|1148416|P1|Observational Period|Lost to Follow-up|1
354684|NCT00439777|1148415|P2|Observational Period|Withdrawal by Subject|5
354685|NCT00439777|1148416|P1|Observational Period|Withdrawal by Subject|9
354686|NCT00439777|1148415|P2|Observational Period|Protocol Violation|2
354687|NCT00439777|1148416|P1|Observational Period|Protocol Violation|0
354688|NCT00439777|1148415|P2|Treatment Period|Participant convenience|8
354689|NCT00439777|1148416|P1|Treatment Period|Participant convenience|12
354690|NCT00439777|1148415|P2|Treatment Period|Technical problems|1
354691|NCT00439777|1148416|P1|Treatment Period|Technical problems|3
354692|NCT00439777|1148415|P2|Treatment Period|Clinical endpoint reached|13
354693|NCT00439777|1148416|P1|Treatment Period|Clinical endpoint reached|26
354694|NCT00439777|1148415|P2|Treatment Period|Physician Decision|18
354695|NCT00439777|1148416|P1|Treatment Period|Physician Decision|7
354696|NCT00439777|1148415|P2|Treatment Period|Protocol driven decision point|3
354697|NCT00439777|1148416|P1|Treatment Period|Protocol driven decision point|1
354698|NCT00439777|1148415|P2|Treatment Period|Lost to Follow-up|10
354699|NCT00439777|1148416|P1|Treatment Period|Lost to Follow-up|8
354700|NCT00439777|1148415|P2|Treatment Period|Lack of Efficacy|4
354701|NCT00439777|1148416|P1|Treatment Period|Lack of Efficacy|1
354702|NCT00439777|1148415|P2|Treatment Period|Withdrawal by Subject|118
354703|NCT00439777|1148416|P1|Treatment Period|Withdrawal by Subject|66
354704|NCT00439777|1148415|P2|Treatment Period|Protocol Violation|30
354705|NCT00439777|1148416|P1|Treatment Period|Protocol Violation|23
354706|NCT00439777|1148415|P2|Treatment Period|Adverse Event|92
354707|NCT00439777|1148416|P1|Treatment Period|Adverse Event|111
354708|NCT00439777|1148415|P2|Treatment Period|Did not take study treatment|8
354709|NCT00439777|1148416|P1|Treatment Period|Did not take study treatment|7
354710|NCT00439777|1148415|P2|Treatment Period|Site closed by investigator|1
354711|NCT00439777|1148416|P1|Treatment Period|Site closed by investigator|0
354712|NCT00439777|1148415|P2|Treatment Period|Study terminated by sponsor|132
354713|NCT00439777|1148416|P1|Treatment Period|Study terminated by sponsor|125
354714|NCT00439777|1148415|P2|Treatment Period|Death|21
354715|NCT00439777|1148416|P1|Treatment Period|Death|29
354716|NCT00439738|1148454|P2|Overall Study|Abnormal Lab Values|0
354717|NCT00439738|1148455|P1|Overall Study|Abnormal Lab Values|1
354718|NCT00439738|1148454|P2|Overall Study|Lack of Efficacy|2
354719|NCT00439738|1148455|P1|Overall Study|Lack of Efficacy|2
354720|NCT00439738|1148454|P2|Overall Study|Protocol Violation|3
354721|NCT00439738|1148455|P1|Overall Study|Protocol Violation|6
354722|NCT00439738|1148454|P2|Overall Study|Lost to Follow-up|6
354723|NCT00439738|1148455|P1|Overall Study|Lost to Follow-up|5
354724|NCT00439738|1148454|P2|Overall Study|Adverse Event|4
354725|NCT00439738|1148455|P1|Overall Study|Adverse Event|6
354726|NCT00439738|1148454|P2|Overall Study|Withdrawal by Subject|13
354727|NCT00439738|1148455|P1|Overall Study|Withdrawal by Subject|16
354728|NCT00439725|1148473|P2|Observational Period|Participant convenience|0
354729|NCT00439725|1148474|P1|Observational Period|Participant convenience|1
354730|NCT00439725|1148473|P2|Observational Period|Technical problems|0
354731|NCT00439725|1148474|P1|Observational Period|Technical problems|1
354732|NCT00439725|1148473|P2|Observational Period|Clinical endpoint reached|1
354733|NCT00439725|1148474|P1|Observational Period|Clinical endpoint reached|3
354734|NCT00439725|1148473|P2|Observational Period|Study termination by sponsor|1
354735|NCT00439725|1148474|P1|Observational Period|Study termination by sponsor|1
354736|NCT00439725|1148473|P2|Observational Period|Death|2
354737|NCT00439725|1148474|P1|Observational Period|Death|0
354738|NCT00439725|1148473|P2|Observational Period|Lost to Follow-up|1
354739|NCT00439725|1148474|P1|Observational Period|Lost to Follow-up|0
354740|NCT00439725|1148473|P2|Observational Period|Withdrawal by Subject|2
354741|NCT00439725|1148474|P1|Observational Period|Withdrawal by Subject|2
354742|NCT00439725|1148473|P2|Treatment Period|Participant did not receive treatment|4
354743|NCT00439725|1148474|P1|Treatment Period|Participant did not receive treatment|4
354744|NCT00439725|1148473|P2|Treatment Period|Death|1
354745|NCT00439725|1148474|P1|Treatment Period|Death|1
354746|NCT00439725|1148473|P2|Treatment Period|Protocol driven decision point|1
354747|NCT00439725|1148474|P1|Treatment Period|Protocol driven decision point|1
354748|NCT00439725|1148473|P2|Treatment Period|Participant convenience|0
354749|NCT00439725|1148474|P1|Treatment Period|Participant convenience|1
354750|NCT00439725|1148473|P2|Treatment Period|Lost to Follow-up|1
354751|NCT00439725|1148474|P1|Treatment Period|Lost to Follow-up|1
354752|NCT00439725|1148473|P2|Treatment Period|Technical problems|0
354753|NCT00439725|1148474|P1|Treatment Period|Technical problems|1
354754|NCT00439725|1148473|P2|Treatment Period|Clinical endpoint reached|50
354755|NCT00439725|1148474|P1|Treatment Period|Clinical endpoint reached|6
354756|NCT00439725|1148473|P2|Treatment Period|Protocol Violation|1
354757|NCT00439725|1148474|P1|Treatment Period|Protocol Violation|2
354758|NCT00439725|1148473|P2|Treatment Period|Physician Decision|1
354759|NCT00439725|1148474|P1|Treatment Period|Physician Decision|1
354760|NCT00439725|1148473|P2|Treatment Period|Adverse Event|18
354761|NCT00439725|1148474|P1|Treatment Period|Adverse Event|39
354762|NCT00439725|1148473|P2|Treatment Period|Site closed by investigator|2
354763|NCT00439725|1148474|P1|Treatment Period|Site closed by investigator|1
354764|NCT00439725|1148473|P2|Treatment Period|Study terminated by sponsor|148
354765|NCT00439725|1148474|P1|Treatment Period|Study terminated by sponsor|156
354766|NCT00439725|1148473|P2|Treatment Period|Withdrawal by Subject|19
354767|NCT00439725|1148474|P1|Treatment Period|Withdrawal by Subject|22
354768|NCT00439647|1148520|P2|Overall Study|Lack of Efficacy|4
354769|NCT00439647|1148521|P1|Overall Study|Lack of Efficacy|0
354770|NCT00439647|1148520|P2|Overall Study|Protocol Violation|4
354771|NCT00439647|1148521|P1|Overall Study|Protocol Violation|3
354772|NCT00439647|1148520|P2|Overall Study|Lost to Follow-up|12
354773|NCT00439647|1148521|P1|Overall Study|Lost to Follow-up|4
354774|NCT00439647|1148520|P2|Overall Study|Adverse Event|11
354775|NCT00439647|1148521|P1|Overall Study|Adverse Event|11
354776|NCT00439647|1148520|P2|Overall Study|Death|18
354777|NCT00439647|1148521|P1|Overall Study|Death|15
354778|NCT00439647|1148520|P2|Overall Study|Withdrawal by Subject|22
354779|NCT00439647|1148521|P1|Overall Study|Withdrawal by Subject|25
354780|NCT00439569|1148557|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
354781|NCT00439569|1148557|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
354782|NCT00439569|1148557|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
354783|NCT00439517|1148570|P2|Overall Study|Subject in survival follow-up|0
354784|NCT00439517|1148571|P1|Overall Study|Subject in survival follow-up|1
354785|NCT00439517|1148570|P2|Overall Study|Subject on treatment|0
354786|NCT00439517|1148571|P1|Overall Study|Subject on treatment|1
354787|NCT00439309|1148639|P2|Follow-Up|Late response by subject|1
354788|NCT00439309|1148640|P1|Follow-Up|Late response by subject|0
354789|NCT00439309|1148639|P2|Follow-Up|Withdrawal by Subject|1
354790|NCT00439309|1148640|P1|Follow-Up|Withdrawal by Subject|0
354791|NCT00439309|1148639|P2|Follow-Up|Lost to Follow-up|0
354792|NCT00439309|1148640|P1|Follow-Up|Lost to Follow-up|2
354793|NCT00439309|1148639|P2|Follow-Up|Death|0
354794|NCT00439309|1148640|P1|Follow-Up|Death|1
354795|NCT00439270|1148659|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
354796|NCT00439270|1148660|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
354797|NCT00439270|1148661|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
354798|NCT00439270|1148662|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
354799|NCT00439270|1148663|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
354800|NCT00439270|1148659|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
354801|NCT00439270|1148660|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
354802|NCT00439270|1148661|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
354803|NCT00439270|1148662|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
354804|NCT00439270|1148663|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
354805|NCT00439270|1148659|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
354806|NCT00439270|1148660|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
354807|NCT00439270|1148661|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
354808|NCT00439270|1148662|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
354809|NCT00439270|1148663|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
354810|NCT00439270|1148659|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
354811|NCT00439270|1148660|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
354812|NCT00439270|1148661|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
354813|NCT00439270|1148662|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
354814|NCT00439270|1148663|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
354815|NCT00439270|1148659|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
354816|NCT00439270|1148660|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
354817|NCT00439270|1148661|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
354818|NCT00439270|1148662|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
354819|NCT00439270|1148663|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
354820|NCT00439270|1148659|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
354821|NCT00439270|1148660|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
354822|NCT00439270|1148661|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
354823|NCT00439270|1148662|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
354824|NCT00439270|1148663|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
354825|NCT00439270|1148659|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
354826|NCT00439270|1148660|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
354827|NCT00439270|1148661|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
354828|NCT00439270|1148662|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
354829|NCT00439270|1148663|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
354830|NCT00439270|1148659|P5|Phase 2 (51.6 Months)|Disease progression|0
354831|NCT00439270|1148660|P4|Phase 2 (51.6 Months)|Disease progression|18
354832|NCT00439270|1148661|P3|Phase 2 (51.6 Months)|Disease progression|0
354833|NCT00439270|1148662|P2|Phase 2 (51.6 Months)|Disease progression|0
354834|NCT00439270|1148663|P1|Phase 2 (51.6 Months)|Disease progression|0
354835|NCT00439270|1148659|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
354836|NCT00439270|1148660|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
354837|NCT00439270|1148661|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
354838|NCT00439270|1148662|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
354839|NCT00439270|1148663|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
354840|NCT00439270|1148659|P5|Phase 1 (18.1 Months)|Disease progression|3
354841|NCT00439270|1148660|P4|Phase 1 (18.1 Months)|Disease progression|0
354842|NCT00439270|1148661|P3|Phase 1 (18.1 Months)|Disease progression|3
354843|NCT00439270|1148662|P2|Phase 1 (18.1 Months)|Disease progression|2
354844|NCT00439270|1148663|P1|Phase 1 (18.1 Months)|Disease progression|3
354845|NCT00439244|1148705|P3|Overall Study|Administrative problems|0
354846|NCT00439244|1148706|P2|Overall Study|Administrative problems|0
354847|NCT00439244|1148707|P1|Overall Study|Administrative problems|1
354848|NCT00439244|1148705|P3|Overall Study|Protocol Violation|0
354849|NCT00439244|1148706|P2|Overall Study|Protocol Violation|1
354850|NCT00439244|1148707|P1|Overall Study|Protocol Violation|0
354851|NCT00439244|1148705|P3|Overall Study|Death|0
354852|NCT00439244|1148706|P2|Overall Study|Death|1
354853|NCT00439244|1148707|P1|Overall Study|Death|0
354854|NCT00439244|1148705|P3|Overall Study|Lost to Follow-up|2
354855|NCT00439244|1148706|P2|Overall Study|Lost to Follow-up|1
354856|NCT00439244|1148707|P1|Overall Study|Lost to Follow-up|2
354857|NCT00439244|1148705|P3|Overall Study|Withdrawal by Subject|2
354858|NCT00439244|1148706|P2|Overall Study|Withdrawal by Subject|1
354859|NCT00439244|1148707|P1|Overall Study|Withdrawal by Subject|3
354860|NCT00439244|1148705|P3|Overall Study|Adverse Event|3
354861|NCT00439244|1148706|P2|Overall Study|Adverse Event|2
354862|NCT00439244|1148707|P1|Overall Study|Adverse Event|5
354863|NCT00439231|1148727|P1|Overall Study|Lack of Efficacy|28
354864|NCT00439218|1148731|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
354865|NCT00439179|1148746|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
354866|NCT00439179|1148747|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
354867|NCT00439179|1148748|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
354868|NCT00439179|1148749|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
354869|NCT00439140|1148766|P3|Treatment Cycle 2|Lost to Follow-up|0
354870|NCT00439140|1148767|P2|Treatment Cycle 2|Lost to Follow-up|1
354871|NCT00439140|1148768|P1|Treatment Cycle 2|Lost to Follow-up|1
354872|NCT00439140|1148766|P3|Treatment Cycle 2|Withdrawal by Subject|0
354873|NCT00439140|1148767|P2|Treatment Cycle 2|Withdrawal by Subject|0
354874|NCT00439140|1148768|P1|Treatment Cycle 2|Withdrawal by Subject|1
354875|NCT00439140|1148766|P3|Treatment Cycle 1|Withdrawal by Subject|0
354876|NCT00439140|1148767|P2|Treatment Cycle 1|Withdrawal by Subject|1
354877|NCT00439140|1148768|P1|Treatment Cycle 1|Withdrawal by Subject|0
354878|NCT00439140|1148766|P3|Treatment Cycle 1|Personal reasons|0
354879|NCT00439140|1148767|P2|Treatment Cycle 1|Personal reasons|2
354880|NCT00439140|1148768|P1|Treatment Cycle 1|Personal reasons|0
354881|NCT00439140|1148766|P3|Treatment Cycle 1|Lost to Follow-up|1
354882|NCT00439140|1148767|P2|Treatment Cycle 1|Lost to Follow-up|1
354883|NCT00439140|1148768|P1|Treatment Cycle 1|Lost to Follow-up|1
354884|NCT00438815|1148848|P1|Overall Study|Death|1
354885|NCT00438815|1148848|P1|Overall Study|Withdrawal by Subject|6
354886|NCT00438815|1148848|P1|Overall Study|Lost to Follow-up|6
354887|NCT00438815|1148848|P1|Overall Study|Transitioned to commercial C1INH-nf|6
354888|NCT00438815|1148848|P1|Overall Study|Noncompliance with protocol requirements|9
354889|NCT00438815|1148848|P1|Overall Study|3-month follow-up no longer required|12
354890|NCT00438815|1148848|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
354891|NCT00437983|1148860|P2|Overall Study|Withdrawal by Subject|6
354892|NCT00437983|1148861|P1|Overall Study|Withdrawal by Subject|5
354893|NCT00437983|1148860|P2|Overall Study|Protocol Violation|1
354894|NCT00437983|1148861|P1|Overall Study|Protocol Violation|2
354895|NCT00437983|1148860|P2|Overall Study|Adverse Event|6
354896|NCT00437983|1148861|P1|Overall Study|Adverse Event|6
354897|NCT00438672|1148894|P2|Overall Study|Lost to Follow-up|9
354898|NCT00438672|1148895|P1|Overall Study|Lost to Follow-up|7
354899|NCT00438659|1148905|P2|Overall Study|Cancel|2
354900|NCT00438659|1148906|P1|Overall Study|Cancel|5
354901|NCT00438659|1148905|P2|Overall Study|Discontinued Mometasone/Placebo|2
354902|NCT00438659|1148906|P1|Overall Study|Discontinued Mometasone/Placebo|1
354903|NCT00438464|1148939|P2|Overall Study|Incomplete data submission|2
354904|NCT00438464|1148940|P1|Overall Study|Incomplete data submission|0
354905|NCT00438464|1148939|P2|Overall Study|Terminated Early|5
354906|NCT00438464|1148940|P1|Overall Study|Terminated Early|14
354907|NCT00438399|1149041|P6|Overall Study|Patien stopped study at visit 4 by error|0
354908|NCT00438399|1149042|P5|Overall Study|Patien stopped study at visit 4 by error|0
354909|NCT00438399|1149043|P4|Overall Study|Patien stopped study at visit 4 by error|0
354910|NCT00438399|1149044|P3|Overall Study|Patien stopped study at visit 4 by error|0
354911|NCT00438399|1149045|P2|Overall Study|Patien stopped study at visit 4 by error|0
354912|NCT00438399|1149046|P1|Overall Study|Patien stopped study at visit 4 by error|1
354913|NCT00438399|1149041|P6|Overall Study|Pregnancy|1
354914|NCT00438399|1149042|P5|Overall Study|Pregnancy|0
354915|NCT00438399|1149043|P4|Overall Study|Pregnancy|0
354916|NCT00438399|1149044|P3|Overall Study|Pregnancy|0
354917|NCT00438399|1149045|P2|Overall Study|Pregnancy|0
354918|NCT00438399|1149046|P1|Overall Study|Pregnancy|0
354919|NCT00438399|1149041|P6|Overall Study|Subje stopped study|0
354920|NCT00438399|1149042|P5|Overall Study|Subje stopped study|0
354921|NCT00438399|1149043|P4|Overall Study|Subje stopped study|0
354922|NCT00438399|1149044|P3|Overall Study|Subje stopped study|1
354923|NCT00438399|1149045|P2|Overall Study|Subje stopped study|0
354924|NCT00438399|1149046|P1|Overall Study|Subje stopped study|0
354925|NCT00438399|1149041|P6|Overall Study|Protocol Violation|1
354926|NCT00438399|1149042|P5|Overall Study|Protocol Violation|0
354927|NCT00438399|1149043|P4|Overall Study|Protocol Violation|0
354928|NCT00438399|1149044|P3|Overall Study|Protocol Violation|1
354929|NCT00438399|1149045|P2|Overall Study|Protocol Violation|0
354930|NCT00438399|1149046|P1|Overall Study|Protocol Violation|0
354931|NCT00438399|1149041|P6|Overall Study|Withdrawal by Subject|2
354932|NCT00438399|1149042|P5|Overall Study|Withdrawal by Subject|2
354933|NCT00438399|1149043|P4|Overall Study|Withdrawal by Subject|2
354934|NCT00438399|1149044|P3|Overall Study|Withdrawal by Subject|3
354935|NCT00438399|1149045|P2|Overall Study|Withdrawal by Subject|6
354936|NCT00438399|1149046|P1|Overall Study|Withdrawal by Subject|5
354937|NCT00438399|1149041|P6|Overall Study|Adverse Event|1
354938|NCT00438399|1149042|P5|Overall Study|Adverse Event|0
354939|NCT00438399|1149043|P4|Overall Study|Adverse Event|1
354940|NCT00438399|1149044|P3|Overall Study|Adverse Event|1
354941|NCT00438399|1149045|P2|Overall Study|Adverse Event|0
354942|NCT00438399|1149046|P1|Overall Study|Adverse Event|0
354943|NCT00438399|1149041|P6|Overall Study|Lost to Follow-up|1
354944|NCT00438399|1149042|P5|Overall Study|Lost to Follow-up|1
354945|NCT00438399|1149043|P4|Overall Study|Lost to Follow-up|1
354946|NCT00438399|1149044|P3|Overall Study|Lost to Follow-up|1
354947|NCT00438399|1149045|P2|Overall Study|Lost to Follow-up|2
354948|NCT00438399|1149046|P1|Overall Study|Lost to Follow-up|2
354949|NCT00438360|1149057|P2|Overall Study|not specified|15
354950|NCT00438360|1149058|P1|Overall Study|not specified|24
354951|NCT00438360|1149057|P2|Overall Study|Lack of Efficacy|27
354952|NCT00438360|1149058|P1|Overall Study|Lack of Efficacy|42
354953|NCT00438360|1149057|P2|Overall Study|Adverse Event|1
354954|NCT00438360|1149058|P1|Overall Study|Adverse Event|6
354955|NCT00437645|1149087|P2|Overall Study|Condition no longer requires study drug|1
354956|NCT00437645|1149088|P1|Overall Study|Condition no longer requires study drug|1
354957|NCT00437645|1149087|P2|Overall Study|Lack of Efficacy|1
354958|NCT00437645|1149088|P1|Overall Study|Lack of Efficacy|2
354959|NCT00437645|1149087|P2|Overall Study|Administrative problems|1
354960|NCT00437645|1149088|P1|Overall Study|Administrative problems|2
354961|NCT00437645|1149087|P2|Overall Study|Lost to Follow-up|3
354962|NCT00437645|1149088|P1|Overall Study|Lost to Follow-up|2
354963|NCT00437645|1149087|P2|Overall Study|Protocol Violation|3
354964|NCT00437645|1149088|P1|Overall Study|Protocol Violation|3
354965|NCT00437645|1149087|P2|Overall Study|Withdrawal by Subject|22
354966|NCT00437645|1149088|P1|Overall Study|Withdrawal by Subject|10
354967|NCT00437645|1149087|P2|Overall Study|Adverse Event|84
354968|NCT00437645|1149088|P1|Overall Study|Adverse Event|15
354969|NCT00437489|1149104|P2|Overall Study|Lost to Follow-up|1
354970|NCT00437489|1149105|P1|Overall Study|Lost to Follow-up|0
354971|NCT00437489|1149104|P2|Overall Study|Study terminated by sponsor|21
354972|NCT00437489|1149105|P1|Overall Study|Study terminated by sponsor|23
354973|NCT00437281|1149142|P20|Overall Study|Lost to Follow-up|1
354974|NCT00437281|1149143|P19|Overall Study|Lost to Follow-up|0
354975|NCT00437281|1149144|P18|Overall Study|Lost to Follow-up|0
354976|NCT00437281|1149145|P17|Overall Study|Lost to Follow-up|0
354977|NCT00437281|1149146|P16|Overall Study|Lost to Follow-up|0
354978|NCT00437281|1149147|P15|Overall Study|Lost to Follow-up|0
354979|NCT00437281|1149148|P14|Overall Study|Lost to Follow-up|0
354980|NCT00437281|1149149|P13|Overall Study|Lost to Follow-up|0
354981|NCT00437281|1149150|P12|Overall Study|Lost to Follow-up|0
354982|NCT00437281|1149151|P11|Overall Study|Lost to Follow-up|0
354983|NCT00437281|1149152|P10|Overall Study|Lost to Follow-up|0
354984|NCT00437281|1149153|P9|Overall Study|Lost to Follow-up|0
354985|NCT00437281|1149154|P8|Overall Study|Lost to Follow-up|0
354986|NCT00437281|1149155|P7|Overall Study|Lost to Follow-up|0
354987|NCT00437281|1149156|P6|Overall Study|Lost to Follow-up|0
354988|NCT00437281|1149157|P5|Overall Study|Lost to Follow-up|0
354989|NCT00437281|1149158|P4|Overall Study|Lost to Follow-up|0
354990|NCT00437281|1149159|P3|Overall Study|Lost to Follow-up|0
354991|NCT00437281|1149160|P2|Overall Study|Lost to Follow-up|0
354992|NCT00437281|1149161|P1|Overall Study|Lost to Follow-up|0
354993|NCT00437281|1149142|P20|Overall Study|Adverse Event|0
354994|NCT00437281|1149143|P19|Overall Study|Adverse Event|1
354995|NCT00437281|1149144|P18|Overall Study|Adverse Event|0
354996|NCT00437281|1149145|P17|Overall Study|Adverse Event|0
354997|NCT00437281|1149146|P16|Overall Study|Adverse Event|0
354998|NCT00437281|1149147|P15|Overall Study|Adverse Event|1
354999|NCT00437281|1149148|P14|Overall Study|Adverse Event|1
355000|NCT00437281|1149149|P13|Overall Study|Adverse Event|0
355001|NCT00437281|1149150|P12|Overall Study|Adverse Event|0
355002|NCT00437281|1149151|P11|Overall Study|Adverse Event|0
355003|NCT00437281|1149152|P10|Overall Study|Adverse Event|1
355004|NCT00437281|1149153|P9|Overall Study|Adverse Event|0
355005|NCT00437281|1149154|P8|Overall Study|Adverse Event|0
355006|NCT00437281|1149155|P7|Overall Study|Adverse Event|0
355007|NCT00437281|1149156|P6|Overall Study|Adverse Event|1
355008|NCT00437281|1149157|P5|Overall Study|Adverse Event|0
355009|NCT00437281|1149158|P4|Overall Study|Adverse Event|1
355010|NCT00437281|1149159|P3|Overall Study|Adverse Event|0
355011|NCT00437281|1149160|P2|Overall Study|Adverse Event|0
355012|NCT00437281|1149161|P1|Overall Study|Adverse Event|0
355013|NCT00437203|1149465|P10|Overall Study|Unspecified|0
355014|NCT00437203|1149466|P9|Overall Study|Unspecified|0
355015|NCT00437203|1149467|P8|Overall Study|Unspecified|0
355016|NCT00437203|1149468|P7|Overall Study|Unspecified|1
355017|NCT00437203|1149469|P6|Overall Study|Unspecified|0
355018|NCT00437203|1149470|P5|Overall Study|Unspecified|0
355019|NCT00437203|1149471|P4|Overall Study|Unspecified|0
355020|NCT00437203|1149472|P3|Overall Study|Unspecified|0
355021|NCT00437203|1149473|P2|Overall Study|Unspecified|1
355022|NCT00437203|1149474|P1|Overall Study|Unspecified|0
355023|NCT00437203|1149465|P10|Overall Study|Objective progression or relapse|2
355024|NCT00437203|1149466|P9|Overall Study|Objective progression or relapse|2
355025|NCT00437203|1149467|P8|Overall Study|Objective progression or relapse|1
355026|NCT00437203|1149468|P7|Overall Study|Objective progression or relapse|6
355027|NCT00437203|1149469|P6|Overall Study|Objective progression or relapse|3
355028|NCT00437203|1149470|P5|Overall Study|Objective progression or relapse|3
355029|NCT00437203|1149471|P4|Overall Study|Objective progression or relapse|3
355030|NCT00437203|1149472|P3|Overall Study|Objective progression or relapse|2
355031|NCT00437203|1149473|P2|Overall Study|Objective progression or relapse|6
355032|NCT00437203|1149474|P1|Overall Study|Objective progression or relapse|5
355033|NCT00437203|1149465|P10|Overall Study|Study terminated by sponsor|0
355034|NCT00437203|1149466|P9|Overall Study|Study terminated by sponsor|1
355035|NCT00437203|1149467|P8|Overall Study|Study terminated by sponsor|0
355036|NCT00437203|1149468|P7|Overall Study|Study terminated by sponsor|0
355037|NCT00437203|1149469|P6|Overall Study|Study terminated by sponsor|0
355038|NCT00437203|1149470|P5|Overall Study|Study terminated by sponsor|0
355039|NCT00437203|1149471|P4|Overall Study|Study terminated by sponsor|0
355040|NCT00437203|1149472|P3|Overall Study|Study terminated by sponsor|0
355041|NCT00437203|1149473|P2|Overall Study|Study terminated by sponsor|0
355042|NCT00437203|1149474|P1|Overall Study|Study terminated by sponsor|0
355043|NCT00437203|1149465|P10|Overall Study|Adverse Event|1
355044|NCT00437203|1149466|P9|Overall Study|Adverse Event|0
355045|NCT00437203|1149467|P8|Overall Study|Adverse Event|1
355046|NCT00437203|1149468|P7|Overall Study|Adverse Event|0
355047|NCT00437203|1149469|P6|Overall Study|Adverse Event|0
355048|NCT00437203|1149470|P5|Overall Study|Adverse Event|0
355049|NCT00437203|1149471|P4|Overall Study|Adverse Event|0
355050|NCT00437203|1149472|P3|Overall Study|Adverse Event|0
355051|NCT00437203|1149473|P2|Overall Study|Adverse Event|1
355052|NCT00437203|1149474|P1|Overall Study|Adverse Event|1
355053|NCT00437203|1149465|P10|Overall Study|Death|1
355054|NCT00437203|1149466|P9|Overall Study|Death|0
355055|NCT00437203|1149467|P8|Overall Study|Death|1
355056|NCT00437203|1149468|P7|Overall Study|Death|0
355057|NCT00437203|1149469|P6|Overall Study|Death|0
355058|NCT00437203|1149470|P5|Overall Study|Death|0
355059|NCT00437203|1149471|P4|Overall Study|Death|0
355060|NCT00437203|1149472|P3|Overall Study|Death|1
355061|NCT00437203|1149473|P2|Overall Study|Death|0
355062|NCT00437203|1149474|P1|Overall Study|Death|0
355063|NCT00437125|1149578|P1|Overall Study|Physician Decision|1
355064|NCT00437125|1149578|P1|Overall Study|Withdrawal by Caregiver|2
355065|NCT00437125|1149578|P1|Overall Study|Withdrawal by Subject|13
355066|NCT00437125|1149578|P1|Overall Study|Lost to Follow-up|1
355067|NCT00437125|1149578|P1|Overall Study|Lack of Efficacy|1
355068|NCT00437125|1149578|P1|Overall Study|Clinical Relapse|1
355069|NCT00437125|1149578|P1|Overall Study|Death|1
355070|NCT00437125|1149578|P1|Overall Study|Adverse Event|12
355071|NCT00437073|1149599|P2|Overall Study|Physician Decision|1
355072|NCT00437073|1149600|P1|Overall Study|Physician Decision|0
355073|NCT00437073|1149599|P2|Overall Study|Sponsor Terminated Study|0
355074|NCT00437073|1149600|P1|Overall Study|Sponsor Terminated Study|1
355075|NCT00437034|1149628|P1|Overall Study|Disease progression during treatment|5
355076|NCT00437034|1149628|P1|Overall Study|Adverse Event|1
355077|NCT00436982|1149634|P2|Overall Study|Did not receive allocated intervention|1
355078|NCT00436982|1149635|P1|Overall Study|Did not receive allocated intervention|0
355079|NCT00436982|1149634|P2|Overall Study|Withdrawal by Subject|1
355080|NCT00436982|1149635|P1|Overall Study|Withdrawal by Subject|2
355081|NCT00436982|1149634|P2|Overall Study|Adverse Event|3
355082|NCT00436982|1149635|P1|Overall Study|Adverse Event|3
355083|NCT00436956|1149692|P2|Overall Study|Not evaluable|0
355084|NCT00436956|1149693|P1|Overall Study|Not evaluable|1
355085|NCT00436917|1149702|P1|Overall Study|Still on treatment|47
355086|NCT00436917|1149702|P1|Overall Study|Adverse Event|1
355087|NCT00436917|1149702|P1|Overall Study|Withdrawal by Subject|6
355088|NCT00436852|1149717|P2|Overall Study|Ineligible|0
355089|NCT00436852|1149718|P1|Overall Study|Ineligible|1
355090|NCT00436852|1149717|P2|Overall Study|Withdrawal by Subject|4
355091|NCT00436852|1149718|P1|Overall Study|Withdrawal by Subject|2
355092|NCT00436852|1149717|P2|Overall Study|Lack of Efficacy|7
355093|NCT00436852|1149718|P1|Overall Study|Lack of Efficacy|9
355094|NCT00436852|1149717|P2|Overall Study|Death|34
355095|NCT00436852|1149718|P1|Overall Study|Death|23
355096|NCT00436826|1149728|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
355097|NCT00436826|1149729|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
355098|NCT00436826|1149730|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
355099|NCT00436826|1149731|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
355100|NCT00436826|1149732|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
355101|NCT00436826|1149733|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
355102|NCT00436826|1149728|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
355103|NCT00436826|1149729|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
355104|NCT00436826|1149730|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
355105|NCT00436826|1149731|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
355106|NCT00436826|1149732|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
355107|NCT00436826|1149733|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
355108|NCT00436826|1149728|P6|Double Blind Period|Unspecified|0
355109|NCT00436826|1149729|P5|Double Blind Period|Unspecified|0
355110|NCT00436826|1149730|P4|Double Blind Period|Unspecified|0
355111|NCT00436826|1149731|P3|Double Blind Period|Unspecified|0
355112|NCT00436826|1149732|P2|Double Blind Period|Unspecified|11
355113|NCT00436826|1149733|P1|Double Blind Period|Unspecified|10
355114|NCT00436826|1149728|P6|Double Blind Period|Protocol Violation|0
355115|NCT00436826|1149729|P5|Double Blind Period|Protocol Violation|0
355116|NCT00436826|1149730|P4|Double Blind Period|Protocol Violation|0
355117|NCT00436826|1149731|P3|Double Blind Period|Protocol Violation|0
355118|NCT00436826|1149732|P2|Double Blind Period|Protocol Violation|0
355119|NCT00436826|1149733|P1|Double Blind Period|Protocol Violation|1
355120|NCT00436826|1149728|P6|Double Blind Period|Adverse Event|0
355121|NCT00436826|1149729|P5|Double Blind Period|Adverse Event|0
355122|NCT00436826|1149730|P4|Double Blind Period|Adverse Event|0
355123|NCT00436826|1149731|P3|Double Blind Period|Adverse Event|0
355124|NCT00436826|1149732|P2|Double Blind Period|Adverse Event|0
355125|NCT00436826|1149733|P1|Double Blind Period|Adverse Event|2
355126|NCT00436748|1149755|P2|Overall Study|Other|0
355127|NCT00436748|1149756|P1|Overall Study|Other|3
355128|NCT00436748|1149755|P2|Overall Study|Protocol-specified Criteria|4
355129|NCT00436748|1149756|P1|Overall Study|Protocol-specified Criteria|5
355130|NCT00436748|1149755|P2|Overall Study|Lost to Follow-up|1
355131|NCT00436748|1149756|P1|Overall Study|Lost to Follow-up|0
355132|NCT00436748|1149755|P2|Overall Study|Administrative Decision|0
355133|NCT00436748|1149756|P1|Overall Study|Administrative Decision|1
355134|NCT00436748|1149755|P2|Overall Study|Consent Withdrawn|4
355135|NCT00436748|1149756|P1|Overall Study|Consent Withdrawn|1
355136|NCT00436748|1149755|P2|Overall Study|Adverse Event|2
355137|NCT00436748|1149756|P1|Overall Study|Adverse Event|0
355138|NCT00436748|1149755|P2|Overall Study|Ineligibility Determined|1
355139|NCT00436748|1149756|P1|Overall Study|Ineligibility Determined|1
355140|NCT00436644|1149790|P1|Overall Study|Death|1
355141|NCT00436644|1149790|P1|Overall Study|Adverse Event|2
355142|NCT00436618|1149800|P3|Overall Study|Still on treatment|7
355143|NCT00436618|1149801|P2|Overall Study|Still on treatment|2
355144|NCT00436618|1149802|P1|Overall Study|Still on treatment|1
355145|NCT00436618|1149800|P3|Overall Study|New Primary or Other Reasons|12
355146|NCT00436618|1149801|P2|Overall Study|New Primary or Other Reasons|2
355147|NCT00436618|1149802|P1|Overall Study|New Primary or Other Reasons|6
355148|NCT00436618|1149800|P3|Overall Study|Death|3
355149|NCT00436618|1149801|P2|Overall Study|Death|2
355150|NCT00436618|1149802|P1|Overall Study|Death|4
355151|NCT00436618|1149800|P3|Overall Study|Other Medical Problems|7
355152|NCT00436618|1149801|P2|Overall Study|Other Medical Problems|1
355153|NCT00436618|1149802|P1|Overall Study|Other Medical Problems|3
355154|NCT00436618|1149800|P3|Overall Study|Alternate Treatment|12
355155|NCT00436618|1149801|P2|Overall Study|Alternate Treatment|4
355156|NCT00436618|1149802|P1|Overall Study|Alternate Treatment|3
355157|NCT00436618|1149800|P3|Overall Study|Adverse Event|9
355158|NCT00436618|1149801|P2|Overall Study|Adverse Event|8
355159|NCT00436618|1149802|P1|Overall Study|Adverse Event|8
355160|NCT00436618|1149800|P3|Overall Study|Withdrawal by Subject|11
355161|NCT00436618|1149801|P2|Overall Study|Withdrawal by Subject|8
355162|NCT00436618|1149802|P1|Overall Study|Withdrawal by Subject|5
355163|NCT00436605|1149819|P1|Overall Study|Protocol Violation|3
355164|NCT00436566|1149824|P1|Overall Study|Protocol Violation|1
355165|NCT00436566|1149824|P1|Overall Study|Withdrawal by Subject|2
355166|NCT00436553|1149831|P3|Overall Study|Withdrawal by Subject|3
355167|NCT00436553|1149832|P2|Overall Study|Withdrawal by Subject|6
355168|NCT00436553|1149833|P1|Overall Study|Withdrawal by Subject|5
355169|NCT00436553|1149831|P3|Overall Study|Protocol Violation|0
355170|NCT00436553|1149832|P2|Overall Study|Protocol Violation|0
355171|NCT00436553|1149833|P1|Overall Study|Protocol Violation|1
355172|NCT00436553|1149831|P3|Overall Study|Lost to Follow-up|0
355173|NCT00436553|1149832|P2|Overall Study|Lost to Follow-up|2
355174|NCT00436553|1149833|P1|Overall Study|Lost to Follow-up|0
355175|NCT00436553|1149831|P3|Overall Study|Death|3
355176|NCT00436553|1149832|P2|Overall Study|Death|1
355177|NCT00436553|1149833|P1|Overall Study|Death|3
355178|NCT00436553|1149831|P3|Overall Study|Adverse Event|4
355179|NCT00436553|1149832|P2|Overall Study|Adverse Event|3
355180|NCT00436553|1149833|P1|Overall Study|Adverse Event|4
355181|NCT00436501|1149854|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
355182|NCT00436501|1149855|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
355183|NCT00436501|1149854|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
355184|NCT00436501|1149855|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
355185|NCT00436436|1149866|P1|Overall Study|Death|6
355186|NCT00436436|1149866|P1|Overall Study|Adverse Event|2
355187|NCT00436436|1149866|P1|Overall Study|Progression|4
355188|NCT00436345|1149877|P2|Overall Study|ICU resident beyond follow-up period|0
355189|NCT00436345|1149878|P1|Overall Study|ICU resident beyond follow-up period|3
355190|NCT00436332|1149931|P1|Overall Study|Never Received Treatment|3
355191|NCT00436332|1149931|P1|Overall Study|Ineligible|2
355192|NCT00436332|1149931|P1|Overall Study|Not Protocol Specified|6
355193|NCT00436332|1149931|P1|Overall Study|Death|2
355194|NCT00436332|1149931|P1|Overall Study|Progression|59
355195|NCT00436332|1149931|P1|Overall Study|Withdrawal by Subject|2
355196|NCT00436332|1149931|P1|Overall Study|Adverse Event|9
355197|NCT00436215|1149938|P1|Overall Study|Small bowel obstruction|1
355198|NCT00436215|1149938|P1|Overall Study|Refused further treatment|3
355199|NCT00436163|1149944|P1|Overall Study|Adverse Event|1
355200|NCT00436163|1149944|P1|Overall Study|Lost to Follow-up|2
355201|NCT00436007|1149992|P3|Overall Study|Unspecified|1
355202|NCT00436007|1149993|P2|Overall Study|Unspecified|0
355203|NCT00436007|1149994|P1|Overall Study|Unspecified|0
355204|NCT00436007|1149992|P3|Overall Study|Death|3
355205|NCT00436007|1149993|P2|Overall Study|Death|1
355206|NCT00436007|1149994|P1|Overall Study|Death|0
355207|NCT00436007|1149992|P3|Overall Study|Physician Decision|2
355208|NCT00436007|1149993|P2|Overall Study|Physician Decision|0
355209|NCT00436007|1149994|P1|Overall Study|Physician Decision|0
355210|NCT00436007|1149992|P3|Overall Study|Lost to Follow-up|13
355211|NCT00436007|1149993|P2|Overall Study|Lost to Follow-up|10
355212|NCT00436007|1149994|P1|Overall Study|Lost to Follow-up|14
355213|NCT00436007|1149992|P3|Overall Study|Withdrawal by Subject|4
355214|NCT00436007|1149993|P2|Overall Study|Withdrawal by Subject|3
355215|NCT00436007|1149994|P1|Overall Study|Withdrawal by Subject|5
355216|NCT00435994|1150042|P3|Overall Study|Lost to Follow-up|0
355217|NCT00435994|1150043|P2|Overall Study|Lost to Follow-up|0
355218|NCT00435994|1150044|P1|Overall Study|Lost to Follow-up|7
355219|NCT00435825|1150086|P4|Overall Study|Did not complete full follow-up period|5
355220|NCT00435825|1150087|P3|Overall Study|Did not complete full follow-up period|4
355221|NCT00435825|1150088|P2|Overall Study|Did not complete full follow-up period|6
355222|NCT00435825|1150089|P1|Overall Study|Did not complete full follow-up period|6
355223|NCT00435825|1150086|P4|Overall Study|Did not enter follow-up|3
355224|NCT00435825|1150087|P3|Overall Study|Did not enter follow-up|1
355225|NCT00435825|1150088|P2|Overall Study|Did not enter follow-up|4
355226|NCT00435825|1150089|P1|Overall Study|Did not enter follow-up|0
355227|NCT00435825|1150086|P4|Overall Study|Did not receive study drug|0
355228|NCT00435825|1150087|P3|Overall Study|Did not receive study drug|2
355229|NCT00435825|1150088|P2|Overall Study|Did not receive study drug|0
355230|NCT00435825|1150089|P1|Overall Study|Did not receive study drug|1
355231|NCT00435825|1150086|P4|Overall Study|Failure to return|0
355232|NCT00435825|1150087|P3|Overall Study|Failure to return|4
355233|NCT00435825|1150088|P2|Overall Study|Failure to return|0
355234|NCT00435825|1150089|P1|Overall Study|Failure to return|5
355235|NCT00435825|1150086|P4|Overall Study|Refused treatment|5
355236|NCT00435825|1150087|P3|Overall Study|Refused treatment|0
355237|NCT00435825|1150088|P2|Overall Study|Refused treatment|0
355238|NCT00435825|1150089|P1|Overall Study|Refused treatment|2
355239|NCT00435825|1150086|P4|Overall Study|Other Protocol Violation|0
355240|NCT00435825|1150087|P3|Overall Study|Other Protocol Violation|0
355241|NCT00435825|1150088|P2|Overall Study|Other Protocol Violation|0
355242|NCT00435825|1150089|P1|Overall Study|Other Protocol Violation|1
355243|NCT00435825|1150086|P4|Overall Study|Insufficient Therapeutic Response|3
355244|NCT00435825|1150087|P3|Overall Study|Insufficient Therapeutic Response|0
355245|NCT00435825|1150088|P2|Overall Study|Insufficient Therapeutic Response|1
355246|NCT00435825|1150089|P1|Overall Study|Insufficient Therapeutic Response|3
355247|NCT00435825|1150086|P4|Overall Study|Abnormality of Laboratory Test|0
355248|NCT00435825|1150087|P3|Overall Study|Abnormality of Laboratory Test|0
355249|NCT00435825|1150088|P2|Overall Study|Abnormality of Laboratory Test|1
355250|NCT00435825|1150089|P1|Overall Study|Abnormality of Laboratory Test|0
355251|NCT00435487|1150201|P2|Overall Study|Received Drug in Other Treatment Group|1
355252|NCT00435487|1150202|P1|Overall Study|Received Drug in Other Treatment Group|0
355253|NCT00435487|1150201|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
355254|NCT00435487|1150202|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
355255|NCT00435487|1150201|P2|Overall Study|Withdrawal by Subject|1
355256|NCT00435487|1150202|P1|Overall Study|Withdrawal by Subject|2
355257|NCT00435487|1150201|P2|Overall Study|Other|2
355258|NCT00435487|1150202|P1|Overall Study|Other|5
355259|NCT00435487|1150201|P2|Overall Study|Lost to Follow-up|2
355260|NCT00435487|1150202|P1|Overall Study|Lost to Follow-up|2
355261|NCT00435487|1150201|P2|Overall Study|Adverse Event|3
355262|NCT00435487|1150202|P1|Overall Study|Adverse Event|0
355263|NCT00435487|1150201|P2|Overall Study|Death|4
355264|NCT00435487|1150202|P1|Overall Study|Death|3
355265|NCT00435409|1150220|P3|Overall Study|Sponsor decision|0
355266|NCT00435409|1150221|P2|Overall Study|Sponsor decision|3
355267|NCT00435409|1150222|P1|Overall Study|Sponsor decision|0
355268|NCT00435409|1150220|P3|Overall Study|Adverse Event|8
355269|NCT00435409|1150221|P2|Overall Study|Adverse Event|0
355270|NCT00435409|1150222|P1|Overall Study|Adverse Event|0
355271|NCT00435409|1150220|P3|Overall Study|Not specified|1
355272|NCT00435409|1150221|P2|Overall Study|Not specified|30
355273|NCT00435409|1150222|P1|Overall Study|Not specified|45
355274|NCT00435409|1150220|P3|Overall Study|Withdrawal by Subject|1
355275|NCT00435409|1150221|P2|Overall Study|Withdrawal by Subject|7
355276|NCT00435409|1150222|P1|Overall Study|Withdrawal by Subject|8
355277|NCT00435409|1150220|P3|Overall Study|Global deterioration of health status|4
355278|NCT00435409|1150221|P2|Overall Study|Global deterioration of health status|0
355279|NCT00435409|1150222|P1|Overall Study|Global deterioration of health status|0
355280|NCT00435409|1150220|P3|Overall Study|Objective progression or relapse|58
355281|NCT00435409|1150221|P2|Overall Study|Objective progression or relapse|93
355282|NCT00435409|1150222|P1|Overall Study|Objective progression or relapse|158
355283|NCT00435409|1150220|P3|Overall Study|Death|6
355284|NCT00435409|1150221|P2|Overall Study|Death|6
355285|NCT00435409|1150222|P1|Overall Study|Death|8
355286|NCT00435409|1150220|P3|Overall Study|Lost to Follow-up|0
355287|NCT00435409|1150221|P2|Overall Study|Lost to Follow-up|2
355288|NCT00435409|1150222|P1|Overall Study|Lost to Follow-up|1
355289|NCT00435409|1150220|P3|Overall Study|Protocol Violation|0
355290|NCT00435409|1150221|P2|Overall Study|Protocol Violation|2
355291|NCT00435409|1150222|P1|Overall Study|Protocol Violation|1
355292|NCT00435370|1150244|P2|Overall Study|Antipsychotic medication changed|2
355293|NCT00435370|1150245|P1|Overall Study|Antipsychotic medication changed|4
355294|NCT00435370|1150244|P2|Overall Study|Withdrawal by Subject|10
355295|NCT00435370|1150245|P1|Overall Study|Withdrawal by Subject|10
355296|NCT00435370|1150244|P2|Overall Study|Adverse Event|8
355297|NCT00435370|1150245|P1|Overall Study|Adverse Event|8
355298|NCT00435188|1150253|P2|Overall Study|Lost to Follow-up|6
355299|NCT00435188|1150254|P1|Overall Study|Lost to Follow-up|5
355300|NCT00435188|1150253|P2|Overall Study|Withdrawal by Subject|11
355301|NCT00435188|1150254|P1|Overall Study|Withdrawal by Subject|16
355302|NCT00435188|1150253|P2|Overall Study|Death|6
355303|NCT00435188|1150254|P1|Overall Study|Death|1
355304|NCT00435162|1150297|P6|Period 2 (2 Weeks)|Adverse Event|0
355305|NCT00435162|1150298|P5|Period 2 (2 Weeks)|Adverse Event|0
355306|NCT00435162|1150299|P4|Period 2 (2 Weeks)|Adverse Event|0
355307|NCT00435162|1150300|P3|Period 2 (2 Weeks)|Adverse Event|0
355308|NCT00435162|1150301|P2|Period 2 (2 Weeks)|Adverse Event|1
355309|NCT00435162|1150302|P1|Period 2 (2 Weeks)|Adverse Event|0
355310|NCT00435045|1150322|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
355311|NCT00435045|1150323|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
355312|NCT00435045|1150322|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
355313|NCT00435045|1150323|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
355314|NCT00435045|1150322|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
355315|NCT00435045|1150323|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
355316|NCT00435045|1150322|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
355317|NCT00435045|1150323|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
355318|NCT00435045|1150322|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
355319|NCT00435045|1150323|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
355320|NCT00435045|1150322|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
355321|NCT00435045|1150323|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
355322|NCT00435045|1150322|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
355323|NCT00435045|1150323|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
355407|NCT00434642|1150508|P1|Blinded Treatment Phase|Adverse Event|12
355324|NCT00435045|1150322|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
355325|NCT00435045|1150323|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
355326|NCT00435045|1150322|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
355327|NCT00435045|1150323|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
355328|NCT00435045|1150322|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
355329|NCT00435045|1150323|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
355330|NCT00435045|1150322|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
355331|NCT00435045|1150323|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
355332|NCT00435019|1150379|P2|Overall Study|Personal reasons for withdrawal|7
355333|NCT00435019|1150380|P1|Overall Study|Personal reasons for withdrawal|8
355334|NCT00435019|1150379|P2|Overall Study|Protocol Violation|1
355335|NCT00435019|1150380|P1|Overall Study|Protocol Violation|3
355336|NCT00435019|1150379|P2|Overall Study|Lack of Efficacy|2
355337|NCT00435019|1150380|P1|Overall Study|Lack of Efficacy|1
355338|NCT00435019|1150379|P2|Overall Study|Adverse Event|0
355339|NCT00435019|1150380|P1|Overall Study|Adverse Event|1
355340|NCT00434967|1150421|P4|Overall Study|Patient Disposition Challenges|3
355341|NCT00434967|1150422|P3|Overall Study|Patient Disposition Challenges|0
355342|NCT00434967|1150423|P2|Overall Study|Patient Disposition Challenges|0
355343|NCT00434967|1150424|P1|Overall Study|Patient Disposition Challenges|2
355344|NCT00434967|1150421|P4|Overall Study|Physician Decision|0
355345|NCT00434967|1150422|P3|Overall Study|Physician Decision|1
355346|NCT00434967|1150423|P2|Overall Study|Physician Decision|1
355347|NCT00434967|1150424|P1|Overall Study|Physician Decision|1
355348|NCT00434967|1150421|P4|Overall Study|Protocol Violation|1
355349|NCT00434967|1150422|P3|Overall Study|Protocol Violation|0
355350|NCT00434967|1150423|P2|Overall Study|Protocol Violation|1
355351|NCT00434967|1150424|P1|Overall Study|Protocol Violation|0
355352|NCT00434967|1150421|P4|Overall Study|Randomized in error|1
355353|NCT00434967|1150422|P3|Overall Study|Randomized in error|0
355354|NCT00434967|1150423|P2|Overall Study|Randomized in error|0
355355|NCT00434967|1150424|P1|Overall Study|Randomized in error|0
355356|NCT00434967|1150421|P4|Overall Study|Withdrawal by Subject|6
355357|NCT00434967|1150422|P3|Overall Study|Withdrawal by Subject|4
355358|NCT00434967|1150423|P2|Overall Study|Withdrawal by Subject|2
355359|NCT00434967|1150424|P1|Overall Study|Withdrawal by Subject|2
355360|NCT00434967|1150421|P4|Overall Study|Lost to Follow-up|0
355361|NCT00434967|1150422|P3|Overall Study|Lost to Follow-up|1
355362|NCT00434967|1150423|P2|Overall Study|Lost to Follow-up|0
355363|NCT00434967|1150424|P1|Overall Study|Lost to Follow-up|0
355364|NCT00434967|1150421|P4|Overall Study|Adverse Event|3
355365|NCT00434967|1150422|P3|Overall Study|Adverse Event|3
355366|NCT00434967|1150423|P2|Overall Study|Adverse Event|4
355367|NCT00434967|1150424|P1|Overall Study|Adverse Event|2
355368|NCT00434954|1150444|P2|Overall Study|Subject decision|22
355369|NCT00434954|1150445|P1|Overall Study|Subject decision|8
355370|NCT00434954|1150444|P2|Overall Study|Sponsor decision|0
355371|NCT00434954|1150445|P1|Overall Study|Sponsor decision|1
355372|NCT00434954|1150444|P2|Overall Study|Protocol Violation|27
355373|NCT00434954|1150445|P1|Overall Study|Protocol Violation|36
355374|NCT00434954|1150444|P2|Overall Study|Physician Decision|3
355375|NCT00434954|1150445|P1|Overall Study|Physician Decision|6
355376|NCT00434954|1150444|P2|Overall Study|Lost to Follow-up|1
355377|NCT00434954|1150445|P1|Overall Study|Lost to Follow-up|0
355378|NCT00434954|1150444|P2|Overall Study|Entry criteria not met|16
355379|NCT00434954|1150445|P1|Overall Study|Entry criteria not met|14
355380|NCT00434954|1150444|P2|Overall Study|Adverse Event|2
355381|NCT00434954|1150445|P1|Overall Study|Adverse Event|17
355382|NCT00434876|1150475|P2|Overall Study|Lost to Follow-up|1
355383|NCT00434876|1150476|P1|Overall Study|Lost to Follow-up|1
355384|NCT00434759|1150490|P2|Overall Study|family affairs|0
355385|NCT00434759|1150491|P1|Overall Study|family affairs|2
355386|NCT00434759|1150490|P2|Overall Study|Withdrawal by Subject|1
355387|NCT00434759|1150491|P1|Overall Study|Withdrawal by Subject|17
355388|NCT00434759|1150490|P2|Overall Study|Lack of Efficacy|4
355389|NCT00434759|1150491|P1|Overall Study|Lack of Efficacy|5
355390|NCT00434642|1150507|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
355391|NCT00434642|1150508|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
355392|NCT00434642|1150507|P2|Open-label Treatment Phase|Adverse Event|5
355393|NCT00434642|1150508|P1|Open-label Treatment Phase|Adverse Event|0
355394|NCT00434642|1150507|P2|Blinded Treatment Phase|Did not Receive Treatment|1
355395|NCT00434642|1150508|P1|Blinded Treatment Phase|Did not Receive Treatment|4
355396|NCT00434642|1150507|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
355397|NCT00434642|1150508|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
355398|NCT00434642|1150507|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
355399|NCT00434642|1150508|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
355400|NCT00434642|1150507|P2|Blinded Treatment Phase|Physician Decision|27
355401|NCT00434642|1150508|P1|Blinded Treatment Phase|Physician Decision|19
355402|NCT00434642|1150507|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
355403|NCT00434642|1150508|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
355404|NCT00434642|1150507|P2|Blinded Treatment Phase|Clinical Disease Progression|5
355405|NCT00434642|1150508|P1|Blinded Treatment Phase|Clinical Disease Progression|4
355406|NCT00434642|1150507|P2|Blinded Treatment Phase|Adverse Event|58
355408|NCT00434590|1150526|P2|Overall Study|Administrative problems|5
355409|NCT00434590|1150527|P1|Overall Study|Administrative problems|5
355410|NCT00434421|1150549|P1|Overall Study|Non-compliance with study treatment|1
355411|NCT00434421|1150549|P1|Overall Study|Withdrawal by Subject|1
355412|NCT00434330|1150577|P6|Overall Study|Subject Not Compliant With Study|0
355413|NCT00434330|1150578|P5|Overall Study|Subject Not Compliant With Study|0
355414|NCT00434330|1150579|P4|Overall Study|Subject Not Compliant With Study|0
355415|NCT00434330|1150580|P3|Overall Study|Subject Not Compliant With Study|1
355416|NCT00434330|1150581|P2|Overall Study|Subject Not Compliant With Study|0
355417|NCT00434330|1150582|P1|Overall Study|Subject Not Compliant With Study|0
355418|NCT00434330|1150577|P6|Overall Study|Renal transplant|0
355419|NCT00434330|1150578|P5|Overall Study|Renal transplant|0
355420|NCT00434330|1150579|P4|Overall Study|Renal transplant|1
355421|NCT00434330|1150580|P3|Overall Study|Renal transplant|0
355422|NCT00434330|1150581|P2|Overall Study|Renal transplant|0
355423|NCT00434330|1150582|P1|Overall Study|Renal transplant|0
355424|NCT00434330|1150577|P6|Overall Study|Withdrawal by Subject|0
355425|NCT00434330|1150578|P5|Overall Study|Withdrawal by Subject|0
355426|NCT00434330|1150579|P4|Overall Study|Withdrawal by Subject|1
355427|NCT00434330|1150580|P3|Overall Study|Withdrawal by Subject|1
355428|NCT00434330|1150581|P2|Overall Study|Withdrawal by Subject|0
355429|NCT00434330|1150582|P1|Overall Study|Withdrawal by Subject|0
355430|NCT00434330|1150577|P6|Overall Study|Death|1
355431|NCT00434330|1150578|P5|Overall Study|Death|1
355432|NCT00434330|1150579|P4|Overall Study|Death|0
355433|NCT00434330|1150580|P3|Overall Study|Death|0
355434|NCT00434330|1150581|P2|Overall Study|Death|0
355435|NCT00434330|1150582|P1|Overall Study|Death|1
355436|NCT00434330|1150577|P6|Overall Study|Adverse Event|0
355437|NCT00434330|1150578|P5|Overall Study|Adverse Event|0
355438|NCT00434330|1150579|P4|Overall Study|Adverse Event|0
355439|NCT00434330|1150580|P3|Overall Study|Adverse Event|1
355440|NCT00434330|1150581|P2|Overall Study|Adverse Event|0
355441|NCT00434330|1150582|P1|Overall Study|Adverse Event|0
355442|NCT00434304|1150614|P1|Overall Study|Withdrawal by Subject|4
355443|NCT00434304|1150614|P1|Overall Study|Lack of Efficacy|2
355444|NCT00434304|1150614|P1|Overall Study|Adverse Event|14
355445|NCT00434252|1150663|P2|Overall Study|Withdrawal by Subject|7
355446|NCT00434252|1150664|P1|Overall Study|Withdrawal by Subject|3
355447|NCT00434252|1150663|P2|Overall Study|Physician Decision|8
355448|NCT00434252|1150664|P1|Overall Study|Physician Decision|4
355449|NCT00434252|1150663|P2|Overall Study|Lost to Follow-up|1
355450|NCT00434252|1150664|P1|Overall Study|Lost to Follow-up|0
355451|NCT00434252|1150663|P2|Overall Study|Death|2
355452|NCT00434252|1150664|P1|Overall Study|Death|1
355453|NCT00434252|1150663|P2|Overall Study|Adverse Event|13
355454|NCT00434252|1150664|P1|Overall Study|Adverse Event|6
355455|NCT00434252|1150663|P2|Overall Study|Lack of Efficacy|100
355456|NCT00434252|1150664|P1|Overall Study|Lack of Efficacy|50
355457|NCT00434213|1150698|P1|Overall Study|Non-compliant to study schedule|1
355458|NCT00434213|1150698|P1|Overall Study|Application site reaction|1
355459|NCT00434213|1150698|P1|Overall Study|Unable to comply with study visit window|2
355460|NCT00434213|1150698|P1|Overall Study|Protocol Violation|3
355461|NCT00434213|1150698|P1|Overall Study|Withdrawal by Subject|7
355462|NCT00434213|1150698|P1|Overall Study|Lost to Follow-up|14
355463|NCT00434213|1150698|P1|Overall Study|Lack of Efficacy|9
355464|NCT00434213|1150698|P1|Overall Study|Adverse Event|12
355465|NCT00434161|1150706|P3|Overall Study|Logistical error study assessments|3
355466|NCT00434161|1150707|P2|Overall Study|Logistical error study assessments|0
355467|NCT00434161|1150708|P1|Overall Study|Logistical error study assessments|1
355468|NCT00434161|1150706|P3|Overall Study|Withdrawal by Subject|3
355469|NCT00434161|1150707|P2|Overall Study|Withdrawal by Subject|0
355470|NCT00434161|1150708|P1|Overall Study|Withdrawal by Subject|2
355471|NCT00434161|1150706|P3|Overall Study|Non-Compliance|0
355472|NCT00434161|1150707|P2|Overall Study|Non-Compliance|1
355473|NCT00434161|1150708|P1|Overall Study|Non-Compliance|1
355474|NCT00434161|1150706|P3|Overall Study|Death|1
355475|NCT00434161|1150707|P2|Overall Study|Death|0
355476|NCT00434161|1150708|P1|Overall Study|Death|1
355477|NCT00434161|1150706|P3|Overall Study|Lost to Follow-up|0
355478|NCT00434161|1150707|P2|Overall Study|Lost to Follow-up|1
355479|NCT00434161|1150708|P1|Overall Study|Lost to Follow-up|0
355480|NCT00434161|1150706|P3|Overall Study|Adverse Event|4
355481|NCT00434161|1150707|P2|Overall Study|Adverse Event|1
355482|NCT00434161|1150708|P1|Overall Study|Adverse Event|5
355483|NCT00434148|1150752|P2|Overall Study|Abnormal test procedure result|1
355484|NCT00434148|1150753|P1|Overall Study|Abnormal test procedure result|0
355485|NCT00434148|1150752|P2|Overall Study|Condition no longer requires study drug|0
355486|NCT00434148|1150753|P1|Overall Study|Condition no longer requires study drug|1
355487|NCT00434148|1150752|P2|Overall Study|Lost to Follow-up|1
355488|NCT00434148|1150753|P1|Overall Study|Lost to Follow-up|0
355489|NCT00434148|1150752|P2|Overall Study|Administrative problems|10
355490|NCT00434148|1150753|P1|Overall Study|Administrative problems|6
355491|NCT00434148|1150752|P2|Overall Study|Protocol Violation|0
355492|NCT00434148|1150753|P1|Overall Study|Protocol Violation|4
355493|NCT00434148|1150752|P2|Overall Study|Withdrawal by Subject|15
355494|NCT00434148|1150753|P1|Overall Study|Withdrawal by Subject|15
355495|NCT00434148|1150752|P2|Overall Study|Lack of Efficacy|28
355496|NCT00434148|1150753|P1|Overall Study|Lack of Efficacy|25
355497|NCT00434148|1150752|P2|Overall Study|Adverse Event|18
355498|NCT00434148|1150753|P1|Overall Study|Adverse Event|18
355499|NCT00434122|1150789|P2|Overall Study|Travelling of subject.|0
355500|NCT00434122|1150790|P1|Overall Study|Travelling of subject.|1
355501|NCT00434122|1150789|P2|Overall Study|Low follicular response.|2
355502|NCT00434122|1150790|P1|Overall Study|Low follicular response.|1
355503|NCT00434122|1150789|P2|Overall Study|Large follicle size|2
355504|NCT00434122|1150790|P1|Overall Study|Large follicle size|2
355505|NCT00434122|1150789|P2|Overall Study|Personal reasons|1
355506|NCT00434122|1150790|P1|Overall Study|Personal reasons|1
355507|NCT00434122|1150789|P2|Overall Study|loss of subject contact|1
355508|NCT00434122|1150790|P1|Overall Study|loss of subject contact|1
355509|NCT00434122|1150789|P2|Overall Study|Non-compliance with protocol|1
355510|NCT00434122|1150790|P1|Overall Study|Non-compliance with protocol|0
355511|NCT00434109|1150799|P1|Overall Study|had embolism, did not receive sunitinib|3
355512|NCT00434109|1150799|P1|Overall Study|Protocol Violation|1
355513|NCT00434109|1150799|P1|Overall Study|Adverse Event|5
355514|NCT00434109|1150799|P1|Overall Study|Physician Decision|9
355515|NCT00434057|1150808|P1|Overall Study|Withdrawal by Subject|1
355516|NCT00433914|1150833|P2|Overall Study|Lost to Follow-up|1
355517|NCT00433914|1150834|P1|Overall Study|Lost to Follow-up|0
355518|NCT00433914|1150833|P2|Overall Study|Withdrawal by Subject|2
355519|NCT00433914|1150834|P1|Overall Study|Withdrawal by Subject|0
355520|NCT00433836|1150854|P2|Overall Study|Abnormal laboratory values|1
355521|NCT00433836|1150855|P1|Overall Study|Abnormal laboratory values|0
355522|NCT00433836|1150854|P2|Overall Study|Condition no longer requires study drug|1
355523|NCT00433836|1150855|P1|Overall Study|Condition no longer requires study drug|0
355524|NCT00433836|1150854|P2|Overall Study|Protocol Violation|2
355525|NCT00433836|1150855|P1|Overall Study|Protocol Violation|0
355526|NCT00433836|1150854|P2|Overall Study|Unsatisfactory therapeutic effect|1
355527|NCT00433836|1150855|P1|Overall Study|Unsatisfactory therapeutic effect|1
355528|NCT00433836|1150854|P2|Overall Study|Withdrawal by Subject|1
355529|NCT00433836|1150855|P1|Overall Study|Withdrawal by Subject|2
355530|NCT00433836|1150854|P2|Overall Study|Lost to Follow-up|0
355531|NCT00433836|1150855|P1|Overall Study|Lost to Follow-up|3
355532|NCT00433836|1150854|P2|Overall Study|Adverse Event|0
355533|NCT00433836|1150855|P1|Overall Study|Adverse Event|7
355534|NCT00433771|1150867|P1|Overall Study|Failure to deploy stent|1
355535|NCT00433771|1150867|P1|Overall Study|Death|2
355536|NCT00433771|1150867|P1|Overall Study|Treated and later found to be ineligible|2
355537|NCT00433771|1150867|P1|Overall Study|screen fail|14
355538|NCT00433654|1150890|P2|Overall Study|Withdrawal by Subject|2
355539|NCT00433654|1150891|P1|Overall Study|Withdrawal by Subject|1
355540|NCT00433654|1150890|P2|Overall Study|Subject not yet due for visit|0
355541|NCT00433654|1150891|P1|Overall Study|Subject not yet due for visit|4
355542|NCT00433654|1150890|P2|Overall Study|Missed visit|3
355543|NCT00433654|1150891|P1|Overall Study|Missed visit|6
355544|NCT00433654|1150890|P2|Overall Study|Death|0
355545|NCT00433654|1150891|P1|Overall Study|Death|4
355546|NCT00433537|1150922|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
355547|NCT00433537|1150923|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
355548|NCT00433537|1150924|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
355549|NCT00433537|1150922|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
355550|NCT00433537|1150923|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
355551|NCT00433537|1150924|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
355552|NCT00433537|1150922|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
355553|NCT00433537|1150923|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
355554|NCT00433537|1150924|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
355555|NCT00433537|1150922|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
355556|NCT00433537|1150923|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
355557|NCT00433537|1150924|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
355558|NCT00433537|1150922|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
355559|NCT00433537|1150923|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
355560|NCT00433537|1150924|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
355561|NCT00433537|1150922|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
355562|NCT00433537|1150923|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
355563|NCT00433537|1150924|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
355564|NCT00433537|1150922|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
355565|NCT00433537|1150923|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
355566|NCT00433537|1150924|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
355567|NCT00433537|1150922|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
355568|NCT00433537|1150923|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
355569|NCT00433537|1150924|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
355570|NCT00433537|1150922|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
355571|NCT00433537|1150923|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
355572|NCT00433537|1150924|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
355573|NCT00433446|1150933|P1|Overall Study|Ineligible|9
355574|NCT00433446|1150933|P1|Overall Study|Other - Not Protocol specified|3
355575|NCT00433446|1150933|P1|Overall Study|Progression|44
355576|NCT00433446|1150933|P1|Overall Study|Refusal Unrelated to Adverse Event|1
355577|NCT00433446|1150933|P1|Overall Study|Adverse Event|4
355578|NCT00433381|1150943|P2|Overall Study|Lost to follow-up before 6 months|0
355579|NCT00433381|1150944|P1|Overall Study|Lost to follow-up before 6 months|2
355580|NCT00433381|1150943|P2|Overall Study|Ineligible / no protocol treatment|3
355581|NCT00433381|1150944|P1|Overall Study|Ineligible / no protocol treatment|3
355582|NCT00433329|1150950|P1|Overall Study|Physician Decision|1
355583|NCT00433329|1150950|P1|Overall Study|Lost to Follow-up|1
355584|NCT00433329|1150950|P1|Overall Study|Moved out of state|1
355585|NCT00433329|1150950|P1|Overall Study|Discontinued sildenafil|2
355586|NCT00433329|1150950|P1|Overall Study|Withdrew consent|3
355587|NCT00433329|1150950|P1|Overall Study|Death|4
355588|NCT00433329|1150950|P1|Overall Study|Adverse Event|9
355589|NCT00433290|1150956|P2|Overall Study|Lost to Follow-up|0
355590|NCT00433290|1150957|P1|Overall Study|Lost to Follow-up|1
355591|NCT00433290|1150956|P2|Overall Study|Entry Criteria Not Met|1
355592|NCT00433290|1150957|P1|Overall Study|Entry Criteria Not Met|0
355593|NCT00433290|1150956|P2|Overall Study|Physician Decision|0
355594|NCT00433290|1150957|P1|Overall Study|Physician Decision|2
355595|NCT00433290|1150956|P2|Overall Study|Protocol Violation|2
355596|NCT00433290|1150957|P1|Overall Study|Protocol Violation|3
355597|NCT00433290|1150956|P2|Overall Study|Withdrawal by Subject|2
355598|NCT00433290|1150957|P1|Overall Study|Withdrawal by Subject|4
355599|NCT00433290|1150956|P2|Overall Study|Lack of Efficacy|5
355600|NCT00433290|1150957|P1|Overall Study|Lack of Efficacy|1
355601|NCT00433290|1150956|P2|Overall Study|Adverse Event|7
355602|NCT00433290|1150957|P1|Overall Study|Adverse Event|24
355603|NCT00433199|1151026|P2|Open-Label Period|Administrative|1
355604|NCT00433199|1151027|P1|Open-Label Period|Administrative|0
355605|NCT00433199|1151026|P2|Open-Label Period|Protocol Violation|2
355606|NCT00433199|1151027|P1|Open-Label Period|Protocol Violation|0
355607|NCT00433199|1151026|P2|Open-Label Period|Withdrawal by Subject|7
355608|NCT00433199|1151027|P1|Open-Label Period|Withdrawal by Subject|0
355609|NCT00433199|1151026|P2|Open-Label Period|Lost to Follow-up|3
355610|NCT00433199|1151027|P1|Open-Label Period|Lost to Follow-up|0
355611|NCT00433199|1151026|P2|Open-Label Period|Lack of Efficacy|2
355612|NCT00433199|1151027|P1|Open-Label Period|Lack of Efficacy|0
355613|NCT00433199|1151026|P2|Open-Label Period|Adverse Event|19
355614|NCT00433199|1151027|P1|Open-Label Period|Adverse Event|0
355615|NCT00433199|1151026|P2|Double-Blind Period|Administrative|5
355616|NCT00433199|1151027|P1|Double-Blind Period|Administrative|1
355617|NCT00433199|1151026|P2|Double-Blind Period|Protocol Violation|10
355618|NCT00433199|1151027|P1|Double-Blind Period|Protocol Violation|1
355619|NCT00433199|1151026|P2|Double-Blind Period|Withdrawal by Subject|19
355620|NCT00433199|1151027|P1|Double-Blind Period|Withdrawal by Subject|8
355621|NCT00433199|1151026|P2|Double-Blind Period|Lost to Follow-up|5
355622|NCT00433199|1151027|P1|Double-Blind Period|Lost to Follow-up|2
355623|NCT00433199|1151026|P2|Double-Blind Period|Lack of Efficacy|2
355624|NCT00433199|1151027|P1|Double-Blind Period|Lack of Efficacy|0
355625|NCT00433199|1151026|P2|Double-Blind Period|Adverse Event|25
355626|NCT00433199|1151027|P1|Double-Blind Period|Adverse Event|0
355627|NCT00433160|1151047|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
355628|NCT00433160|1151048|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
355629|NCT00433160|1151047|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
355630|NCT00433160|1151048|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
355631|NCT00433160|1151047|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
355632|NCT00433160|1151048|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
355633|NCT00433160|1151047|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
355634|NCT00433160|1151048|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
355635|NCT00433160|1151047|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
355636|NCT00433160|1151048|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
355637|NCT00433160|1151047|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
355638|NCT00433160|1151048|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
355639|NCT00433160|1151047|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
355640|NCT00433160|1151048|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
355641|NCT00433160|1151047|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
355642|NCT00433160|1151048|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
355643|NCT00433160|1151047|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
355644|NCT00433160|1151048|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
355645|NCT00433160|1151047|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
355646|NCT00433160|1151048|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
355647|NCT00433160|1151047|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
355648|NCT00433160|1151048|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
355649|NCT00433160|1151047|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
355650|NCT00433160|1151048|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
355651|NCT00433160|1151047|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
355652|NCT00433160|1151048|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
355653|NCT00433160|1151047|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
355654|NCT00433160|1151048|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
355655|NCT00433160|1151047|P2|52-Week Double-Blind (DB) Period|Death|0
355656|NCT00433160|1151048|P1|52-Week Double-Blind (DB) Period|Death|0
355657|NCT00433160|1151047|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
355658|NCT00433160|1151048|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
355659|NCT00433017|1151098|P2|Overall Study|Subject no longer requires study drug|1
355660|NCT00433017|1151099|P1|Overall Study|Subject no longer requires study drug|1
355661|NCT00433017|1151098|P2|Overall Study|Death|2
355662|NCT00433017|1151099|P1|Overall Study|Death|2
355663|NCT00433017|1151098|P2|Overall Study|Protocol Violation|0
355664|NCT00433017|1151099|P1|Overall Study|Protocol Violation|1
355665|NCT00433017|1151098|P2|Overall Study|Administrative problems|86
355666|NCT00433017|1151099|P1|Overall Study|Administrative problems|80
355667|NCT00433017|1151098|P2|Overall Study|Lost to Follow-up|4
355668|NCT00433017|1151099|P1|Overall Study|Lost to Follow-up|3
355669|NCT00433017|1151098|P2|Overall Study|Withdrawal by Subject|5
355670|NCT00433017|1151099|P1|Overall Study|Withdrawal by Subject|4
355671|NCT00433017|1151098|P2|Overall Study|Adverse Event|3
355672|NCT00433017|1151099|P1|Overall Study|Adverse Event|5
355673|NCT00432991|1151115|P2|Overall Study|Protocol Violation|12
355674|NCT00432991|1151116|P1|Overall Study|Protocol Violation|7
355675|NCT00432835|1151128|P2|Overall Study|Adverse event: lead dislodgement.|7
355676|NCT00432835|1151129|P1|Overall Study|Adverse event: lead dislodgement.|6
355677|NCT00432809|1151142|P3|1 Year Follow-up|Withdrawal by Subject|1
355678|NCT00432809|1151143|P2|1 Year Follow-up|Withdrawal by Subject|0
355679|NCT00432809|1151144|P1|1 Year Follow-up|Withdrawal by Subject|7
355680|NCT00432809|1151142|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
355681|NCT00432809|1151143|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
355682|NCT00432809|1151144|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
355683|NCT00432744|1151217|P2|Months 7 - 12|Too disabled to score|1
355684|NCT00432744|1151218|P1|Months 7 - 12|Too disabled to score|0
355685|NCT00432744|1151217|P2|Months 7 - 12|Withdrawal by Subject|0
355686|NCT00432744|1151218|P1|Months 7 - 12|Withdrawal by Subject|1
355687|NCT00432744|1151217|P2|Months 0-6|Too disabled to score|0
355688|NCT00432744|1151218|P1|Months 0-6|Too disabled to score|1
355689|NCT00432744|1151217|P2|Months 0-6|Withdrawal by Subject|4
355690|NCT00432744|1151218|P1|Months 0-6|Withdrawal by Subject|4
355691|NCT00432666|1151230|P2|Open-Label Extension Period|Physician Decision|0
355692|NCT00432666|1151231|P1|Open-Label Extension Period|Physician Decision|3
355693|NCT00432666|1151230|P2|Open-Label Extension Period|Consent withdrawn|0
355694|NCT00432666|1151231|P1|Open-Label Extension Period|Consent withdrawn|10
355695|NCT00432666|1151230|P2|Open-Label Extension Period|Adverse Event|0
355696|NCT00432666|1151231|P1|Open-Label Extension Period|Adverse Event|5
355697|NCT00432666|1151230|P2|Open-Label Extension Period|Lack of Efficacy|0
355698|NCT00432666|1151231|P1|Open-Label Extension Period|Lack of Efficacy|6
355699|NCT00432666|1151230|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
355700|NCT00432666|1151231|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
355701|NCT00432666|1151230|P2|Main Period|Consent Withdrawn|0
355702|NCT00432666|1151231|P1|Main Period|Consent Withdrawn|1
355703|NCT00432666|1151230|P2|Main Period|Adverse Event|1
355704|NCT00432666|1151231|P1|Main Period|Adverse Event|1
355705|NCT00432562|1151404|P2|Overall Study|Death|0
355706|NCT00432562|1151405|P1|Overall Study|Death|3
355707|NCT00432276|1151483|P2|Overall Study|Other|3
355708|NCT00432276|1151484|P1|Overall Study|Other|2
355709|NCT00432276|1151483|P2|Overall Study|Physician Decision|8
355710|NCT00432276|1151484|P1|Overall Study|Physician Decision|6
355711|NCT00432276|1151483|P2|Overall Study|Withdrawal by Subject|20
355712|NCT00432276|1151484|P1|Overall Study|Withdrawal by Subject|25
355713|NCT00432276|1151483|P2|Overall Study|Lost to Follow-up|2
355714|NCT00432276|1151484|P1|Overall Study|Lost to Follow-up|6
355715|NCT00432276|1151483|P2|Overall Study|Protocol Violation|20
355716|NCT00432276|1151484|P1|Overall Study|Protocol Violation|25
355717|NCT00432276|1151483|P2|Overall Study|Adverse Event|16
355718|NCT00432276|1151484|P1|Overall Study|Adverse Event|13
355719|NCT00432276|1151483|P2|Overall Study|Hyperglycemic Rescue|87
355720|NCT00432276|1151484|P1|Overall Study|Hyperglycemic Rescue|44
355721|NCT00432237|1151574|P4|Overall Study|Lack of Qualifying Event|84
355722|NCT00432237|1151575|P3|Overall Study|Lack of Qualifying Event|69
355723|NCT00432237|1151576|P2|Overall Study|Lack of Qualifying Event|71
355724|NCT00432237|1151577|P1|Overall Study|Lack of Qualifying Event|38
355725|NCT00432237|1151574|P4|Overall Study|Withdrawal by Subject|11
355726|NCT00432237|1151575|P3|Overall Study|Withdrawal by Subject|9
355727|NCT00432237|1151576|P2|Overall Study|Withdrawal by Subject|6
355728|NCT00432237|1151577|P1|Overall Study|Withdrawal by Subject|5
355729|NCT00432237|1151574|P4|Overall Study|Protocol Violation|8
355730|NCT00432237|1151575|P3|Overall Study|Protocol Violation|11
355731|NCT00432237|1151576|P2|Overall Study|Protocol Violation|10
355732|NCT00432237|1151577|P1|Overall Study|Protocol Violation|13
355733|NCT00432237|1151574|P4|Overall Study|Pregnancy|0
355734|NCT00432237|1151575|P3|Overall Study|Pregnancy|0
355735|NCT00432237|1151576|P2|Overall Study|Pregnancy|1
355736|NCT00432237|1151577|P1|Overall Study|Pregnancy|0
355737|NCT00432237|1151574|P4|Overall Study|Physician Decision|1
355738|NCT00432237|1151575|P3|Overall Study|Physician Decision|2
355739|NCT00432237|1151576|P2|Overall Study|Physician Decision|3
355740|NCT00432237|1151577|P1|Overall Study|Physician Decision|1
355741|NCT00432237|1151574|P4|Overall Study|Lost to Follow-up|18
355742|NCT00432237|1151575|P3|Overall Study|Lost to Follow-up|18
355743|NCT00432237|1151576|P2|Overall Study|Lost to Follow-up|10
355744|NCT00432237|1151577|P1|Overall Study|Lost to Follow-up|10
355745|NCT00432237|1151574|P4|Overall Study|Lack of Efficacy|1
355746|NCT00432237|1151575|P3|Overall Study|Lack of Efficacy|0
355747|NCT00432237|1151576|P2|Overall Study|Lack of Efficacy|0
355748|NCT00432237|1151577|P1|Overall Study|Lack of Efficacy|0
355749|NCT00432237|1151574|P4|Overall Study|Adverse Event|1
355750|NCT00432237|1151575|P3|Overall Study|Adverse Event|0
355751|NCT00432237|1151576|P2|Overall Study|Adverse Event|0
355752|NCT00432237|1151577|P1|Overall Study|Adverse Event|0
355753|NCT00432159|1151620|P5|Overall Study|Missing NDI and/or neuro. assessment|7
355754|NCT00432159|1151621|P4|Overall Study|Missing NDI and/or neuro. assessment|3
355755|NCT00432159|1151622|P3|Overall Study|Missing NDI and/or neuro. assessment|1
355756|NCT00432159|1151623|P2|Overall Study|Missing NDI and/or neuro. assessment|24
355757|NCT00432159|1151624|P1|Overall Study|Missing NDI and/or neuro. assessment|13
355758|NCT00432159|1151620|P5|Overall Study|Failure|3
355759|NCT00432159|1151621|P4|Overall Study|Failure|2
355760|NCT00432159|1151622|P3|Overall Study|Failure|3
355761|NCT00432159|1151623|P2|Overall Study|Failure|5
355762|NCT00432159|1151624|P1|Overall Study|Failure|9
355763|NCT00432159|1151620|P5|Overall Study|Death|0
355764|NCT00432159|1151621|P4|Overall Study|Death|0
355765|NCT00432159|1151622|P3|Overall Study|Death|0
355766|NCT00432159|1151623|P2|Overall Study|Death|1
355767|NCT00432159|1151624|P1|Overall Study|Death|0
355768|NCT00431964|1151730|P2|Overall Study|Due to Unstable Health|1
355769|NCT00431964|1151731|P1|Overall Study|Due to Unstable Health|0
355770|NCT00431964|1151730|P2|Overall Study|Parental Consent Withdrawn|2
355771|NCT00431964|1151731|P1|Overall Study|Parental Consent Withdrawn|0
355772|NCT00431964|1151730|P2|Overall Study|Withdrawal by Subject|1
355773|NCT00431964|1151731|P1|Overall Study|Withdrawal by Subject|2
355774|NCT00431964|1151730|P2|Overall Study|Physician Decision|2
355775|NCT00431964|1151731|P1|Overall Study|Physician Decision|2
355776|NCT00431964|1151730|P2|Overall Study|Lost to Follow-up|2
355777|NCT00431964|1151731|P1|Overall Study|Lost to Follow-up|1
355778|NCT00431964|1151730|P2|Overall Study|Adverse Event|0
355779|NCT00431964|1151731|P1|Overall Study|Adverse Event|1
355780|NCT00431951|1151741|P4|Overall Study|Adverse Event|0
355781|NCT00431951|1151742|P3|Overall Study|Adverse Event|1
355782|NCT00431951|1151743|P2|Overall Study|Adverse Event|0
355783|NCT00431951|1151744|P1|Overall Study|Adverse Event|0
355784|NCT00431951|1151741|P4|Overall Study|Withdrawal by Subject|0
355785|NCT00431951|1151742|P3|Overall Study|Withdrawal by Subject|0
355786|NCT00431951|1151743|P2|Overall Study|Withdrawal by Subject|1
355787|NCT00431951|1151744|P1|Overall Study|Withdrawal by Subject|0
355788|NCT00431951|1151741|P4|Overall Study|Lost to Follow-up|0
355789|NCT00431951|1151742|P3|Overall Study|Lost to Follow-up|0
355790|NCT00431951|1151743|P2|Overall Study|Lost to Follow-up|1
355791|NCT00431951|1151744|P1|Overall Study|Lost to Follow-up|0
355792|NCT00431951|1151741|P4|Overall Study|Inability to follow study procedures|2
355793|NCT00431951|1151742|P3|Overall Study|Inability to follow study procedures|1
355794|NCT00431951|1151743|P2|Overall Study|Inability to follow study procedures|0
355795|NCT00431951|1151744|P1|Overall Study|Inability to follow study procedures|1
355796|NCT00431847|1151806|P5|Overall Study|Protocol Violation|1
355797|NCT00431847|1151807|P4|Overall Study|Protocol Violation|0
355798|NCT00431847|1151808|P3|Overall Study|Protocol Violation|0
355799|NCT00431847|1151809|P2|Overall Study|Protocol Violation|0
355800|NCT00431847|1151810|P1|Overall Study|Protocol Violation|0
355801|NCT00431847|1151806|P5|Overall Study|completion of less than two study visits|0
355802|NCT00431847|1151807|P4|Overall Study|completion of less than two study visits|14
355803|NCT00431847|1151808|P3|Overall Study|completion of less than two study visits|4
355804|NCT00431847|1151809|P2|Overall Study|completion of less than two study visits|3
355805|NCT00431847|1151810|P1|Overall Study|completion of less than two study visits|6
355806|NCT00431834|1151884|P1|Overall Study|Lost to Follow-up|1
355807|NCT00431834|1151884|P1|Overall Study|Missed Endpoint Visit|2
355808|NCT00431834|1151884|P1|Overall Study|Death|3
355809|NCT00431834|1151884|P1|Overall Study|Withdrawal by Subject|7
355810|NCT00431496|1151900|P1|Overall Study|Protocol-specified criteria|5
355811|NCT00431496|1151900|P1|Overall Study|Withdrawal by Subject|2
355812|NCT00431496|1151900|P1|Overall Study|Lost to Follow-up|1
355813|NCT00431496|1151900|P1|Overall Study|Adverse Event|3
355814|NCT00431444|1151911|P2|Overall Study|Administrative Problems|1
355815|NCT00431444|1151912|P1|Overall Study|Administrative Problems|0
355816|NCT00431444|1151911|P2|Overall Study|Lost to Follow-up|0
355817|NCT00431444|1151912|P1|Overall Study|Lost to Follow-up|1
355818|NCT00431444|1151911|P2|Overall Study|Withdrawal by Subject|1
355819|NCT00431444|1151912|P1|Overall Study|Withdrawal by Subject|1
355820|NCT00431444|1151911|P2|Overall Study|Adverse Event|1
355821|NCT00431444|1151912|P1|Overall Study|Adverse Event|2
355822|NCT00431444|1151911|P2|Overall Study|Protocol Violation|4
355823|NCT00431444|1151912|P1|Overall Study|Protocol Violation|1
355824|NCT00431067|1151952|P1|Overall Study|Non-compliance,lost to follow-up|2
355825|NCT00431067|1151952|P1|Overall Study|Progressive disease|30
355826|NCT00431067|1151952|P1|Overall Study|Other Adverse Event|9
355827|NCT00430950|1151977|P2|Overall Study|concomitant medication,etc.|7
355828|NCT00430950|1151978|P1|Overall Study|concomitant medication,etc.|5
355829|NCT00430950|1151977|P2|Overall Study|Withdrawal by Subject|0
355830|NCT00430950|1151978|P1|Overall Study|Withdrawal by Subject|1
355831|NCT00430950|1151977|P2|Overall Study|Adverse Event|6
355832|NCT00430950|1151978|P1|Overall Study|Adverse Event|7
355833|NCT00430937|1151994|P2|Overall Study|Unable to classify|1
355834|NCT00430937|1151995|P1|Overall Study|Unable to classify|0
355835|NCT00430937|1151994|P2|Overall Study|Protocol discontinuation criteria met|2
355836|NCT00430937|1151995|P1|Overall Study|Protocol discontinuation criteria met|1
355837|NCT00430937|1151994|P2|Overall Study|Administrative reasons|0
355838|NCT00430937|1151995|P1|Overall Study|Administrative reasons|1
355839|NCT00430937|1151994|P2|Overall Study|Inappropriate enrollment|1
355840|NCT00430937|1151995|P1|Overall Study|Inappropriate enrollment|2
355841|NCT00430937|1151994|P2|Overall Study|Lack of Efficacy|5
355842|NCT00430937|1151995|P1|Overall Study|Lack of Efficacy|6
355843|NCT00430937|1151994|P2|Overall Study|Protocol Violation|2
355844|NCT00430937|1151995|P1|Overall Study|Protocol Violation|3
355845|NCT00430937|1151994|P2|Overall Study|Withdrawal by Subject|2
355846|NCT00430937|1151995|P1|Overall Study|Withdrawal by Subject|5
355847|NCT00430937|1151994|P2|Overall Study|Lost to Follow-up|6
355848|NCT00430937|1151995|P1|Overall Study|Lost to Follow-up|6
355849|NCT00430937|1151994|P2|Overall Study|Death|1
355850|NCT00430937|1151995|P1|Overall Study|Death|0
355851|NCT00430937|1151994|P2|Overall Study|Adverse Event|8
355852|NCT00430937|1151995|P1|Overall Study|Adverse Event|3
355853|NCT00430781|1152006|P3|End-of-Study Analysis; 28 July 2011|Other|0
355854|NCT00430781|1152007|P2|End-of-Study Analysis; 28 July 2011|Other|1
355855|NCT00430781|1152008|P1|End-of-Study Analysis; 28 July 2011|Other|4
355856|NCT00430781|1152006|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
355857|NCT00430781|1152007|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
355858|NCT00430781|1152008|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
355859|NCT00430781|1152006|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
355860|NCT00430781|1152007|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
355861|NCT00430781|1152008|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
355862|NCT00430781|1152006|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
355863|NCT00430781|1152007|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
355864|NCT00430781|1152008|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
355865|NCT00430781|1152006|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
355866|NCT00430781|1152007|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
355867|NCT00430781|1152008|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
355868|NCT00430781|1152006|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
355869|NCT00430781|1152007|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
355870|NCT00430781|1152008|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
355871|NCT00430781|1152006|P3|Final Analysis; 31 July 2008|Ongoing|32
355872|NCT00430781|1152007|P2|Final Analysis; 31 July 2008|Ongoing|29
355873|NCT00430781|1152008|P1|Final Analysis; 31 July 2008|Ongoing|0
355874|NCT00430781|1152006|P3|Final Analysis; 31 July 2008|Other|0
355875|NCT00430781|1152007|P2|Final Analysis; 31 July 2008|Other|1
355876|NCT00430781|1152008|P1|Final Analysis; 31 July 2008|Other|0
355877|NCT00430781|1152006|P3|Final Analysis; 31 July 2008|Physician Decision|6
355878|NCT00430781|1152007|P2|Final Analysis; 31 July 2008|Physician Decision|6
355879|NCT00430781|1152008|P1|Final Analysis; 31 July 2008|Physician Decision|0
355880|NCT00430781|1152006|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
355881|NCT00430781|1152007|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
355882|NCT00430781|1152008|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
355883|NCT00430781|1152006|P3|Final Analysis; 31 July 2008|Protocol Violation|0
355884|NCT00430781|1152007|P2|Final Analysis; 31 July 2008|Protocol Violation|1
355885|NCT00430781|1152008|P1|Final Analysis; 31 July 2008|Protocol Violation|0
355886|NCT00430781|1152006|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
355887|NCT00430781|1152007|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
355888|NCT00430781|1152008|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
355889|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Ongoing|25
355890|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Ongoing|20
355891|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Ongoing|23
355892|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Physician Decision|3
355893|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Physician Decision|3
355894|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Physician Decision|2
355895|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
355896|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
355897|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
355898|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Death|0
355899|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Death|1
355900|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Death|0
355901|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Disease Progression|22
355902|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Disease Progression|30
355903|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Disease Progression|16
355904|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
355905|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
355906|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
355907|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
355908|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
355909|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
355910|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
355911|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
355912|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
355913|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
355914|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
355915|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
355916|NCT00430781|1152006|P3|Interim Analysis; 11 February 2008|Adverse Event|7
355917|NCT00430781|1152007|P2|Interim Analysis; 11 February 2008|Adverse Event|3
355918|NCT00430781|1152008|P1|Interim Analysis; 11 February 2008|Adverse Event|10
355919|NCT00430755|1152050|P1|Overall Study|Withdrawal by Subject|53
355920|NCT00430716|1152057|P3|Open Label Phase|Study terminated by sponsor|4
355921|NCT00430716|1152058|P2|Open Label Phase|Study terminated by sponsor|5
355922|NCT00430716|1152059|P1|Open Label Phase|Study terminated by sponsor|4
355923|NCT00430716|1152057|P3|Open Label Phase|Protocol Violation|0
355924|NCT00430716|1152058|P2|Open Label Phase|Protocol Violation|0
355925|NCT00430716|1152059|P1|Open Label Phase|Protocol Violation|1
355926|NCT00430716|1152057|P3|Open Label Phase|Unspecified|1
355927|NCT00430716|1152058|P2|Open Label Phase|Unspecified|1
355928|NCT00430716|1152059|P1|Open Label Phase|Unspecified|3
355929|NCT00430716|1152057|P3|Open Label Phase|No longer willing to participate|1
355930|NCT00430716|1152058|P2|Open Label Phase|No longer willing to participate|1
355931|NCT00430716|1152059|P1|Open Label Phase|No longer willing to participate|0
355932|NCT00430716|1152057|P3|Open Label Phase|Lost to Follow-up|1
355933|NCT00430716|1152058|P2|Open Label Phase|Lost to Follow-up|0
355934|NCT00430716|1152059|P1|Open Label Phase|Lost to Follow-up|1
355935|NCT00430716|1152057|P3|Double Blind Phase|Not met eligibility criteria|0
355936|NCT00430716|1152058|P2|Double Blind Phase|Not met eligibility criteria|0
355937|NCT00430716|1152059|P1|Double Blind Phase|Not met eligibility criteria|1
355938|NCT00430716|1152057|P3|Double Blind Phase|Adverse Event|3
355939|NCT00430716|1152058|P2|Double Blind Phase|Adverse Event|1
355940|NCT00430716|1152059|P1|Double Blind Phase|Adverse Event|1
355941|NCT00430716|1152057|P3|Double Blind Phase|Study terminated by sponsor|2
355942|NCT00430716|1152058|P2|Double Blind Phase|Study terminated by sponsor|1
355943|NCT00430716|1152059|P1|Double Blind Phase|Study terminated by sponsor|1
355944|NCT00430716|1152057|P3|Double Blind Phase|Unspecified|0
355945|NCT00430716|1152058|P2|Double Blind Phase|Unspecified|2
355946|NCT00430716|1152059|P1|Double Blind Phase|Unspecified|0
355947|NCT00430716|1152057|P3|Double Blind Phase|No longer willing to participate|1
355948|NCT00430716|1152058|P2|Double Blind Phase|No longer willing to participate|1
355949|NCT00430716|1152059|P1|Double Blind Phase|No longer willing to participate|2
355950|NCT00430716|1152057|P3|Double Blind Phase|Death|0
355951|NCT00430716|1152058|P2|Double Blind Phase|Death|0
355952|NCT00430716|1152059|P1|Double Blind Phase|Death|1
355953|NCT00430677|1152091|P3|Long-term Extension Period|Poor compliance/noncompliance|0
355954|NCT00430677|1152092|P2|Long-term Extension Period|Poor compliance/noncompliance|0
355955|NCT00430677|1152093|P1|Long-term Extension Period|Poor compliance/noncompliance|1
355956|NCT00430677|1152091|P3|Long-term Extension Period|Not specified|1
355957|NCT00430677|1152092|P2|Long-term Extension Period|Not specified|1
355958|NCT00430677|1152093|P1|Long-term Extension Period|Not specified|2
355959|NCT00430677|1152091|P3|Long-term Extension Period|Administrative reason by sponsor|46
355960|NCT00430677|1152092|P2|Long-term Extension Period|Administrative reason by sponsor|49
355961|NCT00430677|1152093|P1|Long-term Extension Period|Administrative reason by sponsor|41
355962|NCT00430677|1152091|P3|Long-term Extension Period|Pregnancy|0
355963|NCT00430677|1152092|P2|Long-term Extension Period|Pregnancy|1
355964|NCT00430677|1152093|P1|Long-term Extension Period|Pregnancy|1
355965|NCT00430677|1152091|P3|Long-term Extension Period|Withdrawal by Subject|2
355966|NCT00430677|1152092|P2|Long-term Extension Period|Withdrawal by Subject|1
355967|NCT00430677|1152093|P1|Long-term Extension Period|Withdrawal by Subject|5
355968|NCT00430677|1152091|P3|Long-term Extension Period|Lost to Follow-up|1
355969|NCT00430677|1152092|P2|Long-term Extension Period|Lost to Follow-up|1
355970|NCT00430677|1152093|P1|Long-term Extension Period|Lost to Follow-up|1
355971|NCT00430677|1152091|P3|Long-term Extension Period|Lack of Efficacy|8
355972|NCT00430677|1152092|P2|Long-term Extension Period|Lack of Efficacy|3
355973|NCT00430677|1152093|P1|Long-term Extension Period|Lack of Efficacy|5
355974|NCT00430677|1152091|P3|Long-term Extension Period|Adverse Event|5
355975|NCT00430677|1152092|P2|Long-term Extension Period|Adverse Event|2
355976|NCT00430677|1152093|P1|Long-term Extension Period|Adverse Event|3
355977|NCT00430677|1152091|P3|Long-term Extension Period|Death|0
355978|NCT00430677|1152092|P2|Long-term Extension Period|Death|0
355979|NCT00430677|1152093|P1|Long-term Extension Period|Death|1
355980|NCT00430677|1152091|P3|Short-term Period|Pregnancy|0
355981|NCT00430677|1152092|P2|Short-term Period|Pregnancy|2
355982|NCT00430677|1152093|P1|Short-term Period|Pregnancy|0
355983|NCT00430677|1152091|P3|Short-term Period|Poor compliance/ noncompliance|0
355984|NCT00430677|1152092|P2|Short-term Period|Poor compliance/ noncompliance|1
355985|NCT00430677|1152093|P1|Short-term Period|Poor compliance/ noncompliance|0
355986|NCT00430677|1152091|P3|Short-term Period|Participant no longer met study criteria|2
355987|NCT00430677|1152092|P2|Short-term Period|Participant no longer met study criteria|1
355988|NCT00430677|1152093|P1|Short-term Period|Participant no longer met study criteria|1
355989|NCT00430677|1152091|P3|Short-term Period|Withdrawal by Subject|2
355990|NCT00430677|1152092|P2|Short-term Period|Withdrawal by Subject|1
355991|NCT00430677|1152093|P1|Short-term Period|Withdrawal by Subject|1
355992|NCT00430677|1152091|P3|Short-term Period|Lack of Efficacy|4
355993|NCT00430677|1152092|P2|Short-term Period|Lack of Efficacy|6
355994|NCT00430677|1152093|P1|Short-term Period|Lack of Efficacy|5
355995|NCT00430677|1152091|P3|Short-term Period|Adverse Event|9
355996|NCT00430677|1152092|P2|Short-term Period|Adverse Event|13
355997|NCT00430677|1152093|P1|Short-term Period|Adverse Event|15
355998|NCT00430677|1152091|P3|Short-term Period|Death|5
355999|NCT00430677|1152092|P2|Short-term Period|Death|1
356000|NCT00430677|1152093|P1|Short-term Period|Death|1
356001|NCT00430638|1152216|P2|Overall Study|Not specified|2
356002|NCT00430638|1152217|P1|Overall Study|Not specified|2
356003|NCT00430638|1152216|P2|Overall Study|Non-compliant|1
356004|NCT00430638|1152217|P1|Overall Study|Non-compliant|2
356005|NCT00430638|1152216|P2|Overall Study|Withdrawal by Subject|6
356006|NCT00430638|1152217|P1|Overall Study|Withdrawal by Subject|4
356007|NCT00430638|1152216|P2|Overall Study|Protocol Violation|4
356008|NCT00430638|1152217|P1|Overall Study|Protocol Violation|6
356009|NCT00430638|1152216|P2|Overall Study|Lost to Follow-up|7
356010|NCT00430638|1152217|P1|Overall Study|Lost to Follow-up|1
356011|NCT00430638|1152216|P2|Overall Study|Uncontrolled blood pressure|13
356012|NCT00430638|1152217|P1|Overall Study|Uncontrolled blood pressure|48
356013|NCT00430638|1152216|P2|Overall Study|Adverse Event|15
356014|NCT00430638|1152217|P1|Overall Study|Adverse Event|15
356015|NCT00430508|1152256|P4|Overall Study|not specified|0
356016|NCT00430508|1152257|P3|Overall Study|not specified|3
356017|NCT00430508|1152258|P2|Overall Study|not specified|1
356018|NCT00430508|1152259|P1|Overall Study|not specified|1
356019|NCT00430508|1152256|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
356020|NCT00430508|1152257|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
356021|NCT00430508|1152258|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
356022|NCT00430508|1152259|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
356023|NCT00430508|1152256|P4|Overall Study|responder at visit 4|0
356024|NCT00430508|1152257|P3|Overall Study|responder at visit 4|2
356025|NCT00430508|1152258|P2|Overall Study|responder at visit 4|0
356026|NCT00430508|1152259|P1|Overall Study|responder at visit 4|0
356027|NCT00430508|1152256|P4|Overall Study|Withdrawal by Subject|1
356028|NCT00430508|1152257|P3|Overall Study|Withdrawal by Subject|1
356029|NCT00430508|1152258|P2|Overall Study|Withdrawal by Subject|1
356030|NCT00430508|1152259|P1|Overall Study|Withdrawal by Subject|0
356031|NCT00430508|1152256|P4|Overall Study|Adverse Event|3
356032|NCT00430508|1152257|P3|Overall Study|Adverse Event|5
356033|NCT00430508|1152258|P2|Overall Study|Adverse Event|3
356034|NCT00430508|1152259|P1|Overall Study|Adverse Event|2
356035|NCT00430495|1152297|P4|Overall Study|Randomized but not Treated|0
356036|NCT00430495|1152298|P3|Overall Study|Randomized but not Treated|0
356037|NCT00430495|1152299|P2|Overall Study|Randomized but not Treated|0
356038|NCT00430495|1152300|P1|Overall Study|Randomized but not Treated|2
356039|NCT00430495|1152297|P4|Overall Study|Unspecified|4
356040|NCT00430495|1152298|P3|Overall Study|Unspecified|5
356041|NCT00430495|1152299|P2|Overall Study|Unspecified|2
356042|NCT00430495|1152300|P1|Overall Study|Unspecified|8
356043|NCT00430495|1152297|P4|Overall Study|Disease Progression|0
356044|NCT00430495|1152298|P3|Overall Study|Disease Progression|0
356045|NCT00430495|1152299|P2|Overall Study|Disease Progression|1
356046|NCT00430495|1152300|P1|Overall Study|Disease Progression|1
356047|NCT00430495|1152297|P4|Overall Study|Protocol Violation|0
356048|NCT00430495|1152298|P3|Overall Study|Protocol Violation|1
356049|NCT00430495|1152299|P2|Overall Study|Protocol Violation|0
356050|NCT00430495|1152300|P1|Overall Study|Protocol Violation|1
356051|NCT00430495|1152297|P4|Overall Study|Lost to Follow-up|0
356052|NCT00430495|1152298|P3|Overall Study|Lost to Follow-up|4
356053|NCT00430495|1152299|P2|Overall Study|Lost to Follow-up|1
356054|NCT00430495|1152300|P1|Overall Study|Lost to Follow-up|0
356055|NCT00430495|1152297|P4|Overall Study|Death|0
356056|NCT00430495|1152298|P3|Overall Study|Death|1
356057|NCT00430495|1152299|P2|Overall Study|Death|0
356058|NCT00430495|1152300|P1|Overall Study|Death|0
356059|NCT00430495|1152297|P4|Overall Study|Adverse Event|0
356060|NCT00430495|1152298|P3|Overall Study|Adverse Event|2
356061|NCT00430495|1152299|P2|Overall Study|Adverse Event|3
356062|NCT00430495|1152300|P1|Overall Study|Adverse Event|2
356063|NCT00430352|1152338|P1|Overall Study|Not specified|48
356064|NCT00430352|1152338|P1|Overall Study|Death|5
356065|NCT00430352|1152338|P1|Overall Study|Adverse Event|16
356066|NCT00430352|1152338|P1|Overall Study|Withdrawal by Subject|11
356067|NCT00430352|1152338|P1|Overall Study|Disease progression|58
356068|NCT00430300|1152356|P4|Overall Study|Unspecified|1
356069|NCT00430300|1152357|P3|Overall Study|Unspecified|0
356070|NCT00430300|1152358|P2|Overall Study|Unspecified|0
356071|NCT00430300|1152359|P1|Overall Study|Unspecified|0
356072|NCT00430300|1152356|P4|Overall Study|Laboratory abnormality|0
356073|NCT00430300|1152357|P3|Overall Study|Laboratory abnormality|0
356074|NCT00430300|1152358|P2|Overall Study|Laboratory abnormality|0
356075|NCT00430300|1152359|P1|Overall Study|Laboratory abnormality|1
356076|NCT00430300|1152356|P4|Overall Study|Withdrawal by Subject|0
356077|NCT00430300|1152357|P3|Overall Study|Withdrawal by Subject|5
356078|NCT00430300|1152358|P2|Overall Study|Withdrawal by Subject|0
356079|NCT00430300|1152359|P1|Overall Study|Withdrawal by Subject|1
356080|NCT00430300|1152356|P4|Overall Study|Adverse Event|1
356081|NCT00430300|1152357|P3|Overall Study|Adverse Event|1
356082|NCT00430300|1152358|P2|Overall Study|Adverse Event|2
356083|NCT00430300|1152359|P1|Overall Study|Adverse Event|0
356084|NCT00430248|1152464|P3|Overall Study|Reason Not Specified|11
356085|NCT00430248|1152465|P2|Overall Study|Reason Not Specified|8
356086|NCT00430248|1152466|P1|Overall Study|Reason Not Specified|8
356087|NCT00430248|1152464|P3|Overall Study|Gout Flare|2
356088|NCT00430248|1152465|P2|Overall Study|Gout Flare|7
356089|NCT00430248|1152466|P1|Overall Study|Gout Flare|3
356090|NCT00430248|1152464|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
356091|NCT00430248|1152465|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
356092|NCT00430248|1152466|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
356093|NCT00430248|1152464|P3|Overall Study|Withdrawal by Subject|16
356094|NCT00430248|1152465|P2|Overall Study|Withdrawal by Subject|20
356095|NCT00430248|1152466|P1|Overall Study|Withdrawal by Subject|14
356096|NCT00430248|1152464|P3|Overall Study|Therapeutic Failure|1
356097|NCT00430248|1152465|P2|Overall Study|Therapeutic Failure|1
356098|NCT00430248|1152466|P1|Overall Study|Therapeutic Failure|1
356099|NCT00430248|1152464|P3|Overall Study|Lost to Follow-up|28
356100|NCT00430248|1152465|P2|Overall Study|Lost to Follow-up|33
356101|NCT00430248|1152466|P1|Overall Study|Lost to Follow-up|28
356102|NCT00430248|1152464|P3|Overall Study|Personal Reasons|9
356103|NCT00430248|1152465|P2|Overall Study|Personal Reasons|24
356104|NCT00430248|1152466|P1|Overall Study|Personal Reasons|12
356105|NCT00430248|1152464|P3|Overall Study|Protocol Violation|4
356106|NCT00430248|1152465|P2|Overall Study|Protocol Violation|2
356107|NCT00430248|1152466|P1|Overall Study|Protocol Violation|10
356108|NCT00430248|1152464|P3|Overall Study|Adverse Event|64
356109|NCT00430248|1152465|P2|Overall Study|Adverse Event|61
356110|NCT00430248|1152466|P1|Overall Study|Adverse Event|49
356111|NCT00430092|1152525|P3|Overall Study|Withdrawal by Subject|1
356112|NCT00430092|1152526|P2|Overall Study|Withdrawal by Subject|1
356113|NCT00430092|1152527|P1|Overall Study|Withdrawal by Subject|0
356114|NCT00430092|1152525|P3|Overall Study|Protocol Violation|1
356115|NCT00430092|1152526|P2|Overall Study|Protocol Violation|1
356116|NCT00430092|1152527|P1|Overall Study|Protocol Violation|0
356117|NCT00430092|1152525|P3|Overall Study|Lost to Follow-up|0
356118|NCT00430092|1152526|P2|Overall Study|Lost to Follow-up|0
356119|NCT00430092|1152527|P1|Overall Study|Lost to Follow-up|1
356120|NCT00430092|1152525|P3|Overall Study|Lack of Efficacy|54
356121|NCT00430092|1152526|P2|Overall Study|Lack of Efficacy|2
356122|NCT00430092|1152527|P1|Overall Study|Lack of Efficacy|5
356123|NCT00430092|1152525|P3|Overall Study|Adverse Event|1
356124|NCT00430092|1152526|P2|Overall Study|Adverse Event|0
356125|NCT00430092|1152527|P1|Overall Study|Adverse Event|0
356126|NCT00430027|1152532|P1|Overall Study|Study terminated|8
356127|NCT00429923|1152549|P3|Overall Study|Early Termination|0
356128|NCT00429923|1152550|P2|Overall Study|Early Termination|1
356129|NCT00429923|1152551|P1|Overall Study|Early Termination|0
356130|NCT00429923|1152549|P3|Overall Study|Withdrew Consent|1
356131|NCT00429923|1152550|P2|Overall Study|Withdrew Consent|0
356132|NCT00429923|1152551|P1|Overall Study|Withdrew Consent|1
356133|NCT00429923|1152549|P3|Overall Study|Lost to Follow-up|2
356134|NCT00429923|1152550|P2|Overall Study|Lost to Follow-up|0
356135|NCT00429923|1152551|P1|Overall Study|Lost to Follow-up|0
356136|NCT00429923|1152549|P3|Overall Study|Lack of Efficacy|33
356137|NCT00429923|1152550|P2|Overall Study|Lack of Efficacy|1
356138|NCT00429923|1152551|P1|Overall Study|Lack of Efficacy|4
356139|NCT00429923|1152549|P3|Overall Study|Adverse Event|3
356140|NCT00429923|1152550|P2|Overall Study|Adverse Event|2
356141|NCT00429923|1152551|P1|Overall Study|Adverse Event|0
356142|NCT00429793|1152556|P1|Overall Study|Non-measurable|1
356143|NCT00429793|1152556|P1|Overall Study|Never treated|1
356144|NCT00429793|1152556|P1|Overall Study|Required test not done|1
356145|NCT00429793|1152556|P1|Overall Study|Improper pre-protocol treatment|3
356146|NCT00429663|1152576|P2|Overall Study|Death|0
356147|NCT00429663|1152577|P1|Overall Study|Death|4
356148|NCT00429663|1152576|P2|Overall Study|Withdrawal by Subject|5
356149|NCT00429663|1152577|P1|Overall Study|Withdrawal by Subject|2
356150|NCT00429663|1152576|P2|Overall Study|Physician Decision|3
356151|NCT00429663|1152577|P1|Overall Study|Physician Decision|6
356152|NCT00429663|1152576|P2|Overall Study|Lost to Follow-up|31
356153|NCT00429663|1152577|P1|Overall Study|Lost to Follow-up|24
356154|NCT00429572|1152591|P1|Overall Study|Disease progression|1
356155|NCT00429494|1152603|P1|Overall Study|Death|6
356156|NCT00429494|1152603|P1|Overall Study|Withdrawal by Subject|9
356157|NCT00429416|1152607|P1|Overall Study|Death|1
356158|NCT00429364|1152626|P2|Overall Study|Pregnancy|1
356159|NCT00429364|1152627|P1|Overall Study|Pregnancy|0
356160|NCT00429364|1152626|P2|Overall Study|Underwent aortic root surgery|18
356161|NCT00429364|1152627|P1|Overall Study|Underwent aortic root surgery|10
356162|NCT00429364|1152626|P2|Overall Study|Death|1
356163|NCT00429364|1152627|P1|Overall Study|Death|0
356164|NCT00429364|1152626|P2|Overall Study|Lost to Follow-up|6
356165|NCT00429364|1152627|P1|Overall Study|Lost to Follow-up|7
356166|NCT00429364|1152626|P2|Overall Study|Physician Decision|2
356167|NCT00429364|1152627|P1|Overall Study|Physician Decision|4
356168|NCT00429364|1152626|P2|Overall Study|Withdrawal by Subject|5
356169|NCT00429364|1152627|P1|Overall Study|Withdrawal by Subject|11
356170|NCT00429299|1152686|P3|Overall Study|Withdrawal by Subject|3
356171|NCT00429299|1152687|P2|Overall Study|Withdrawal by Subject|1
356172|NCT00429299|1152688|P1|Overall Study|Withdrawal by Subject|0
356173|NCT00429299|1152686|P3|Overall Study|Protocol Violation|0
356174|NCT00429299|1152687|P2|Overall Study|Protocol Violation|0
356175|NCT00429299|1152688|P1|Overall Study|Protocol Violation|1
356176|NCT00429299|1152686|P3|Overall Study|Adverse Event|1
356177|NCT00429299|1152687|P2|Overall Study|Adverse Event|5
356178|NCT00429299|1152688|P1|Overall Study|Adverse Event|2
356179|NCT00429299|1152686|P3|Overall Study|Disease Progression|0
356180|NCT00429299|1152687|P2|Overall Study|Disease Progression|1
356181|NCT00429299|1152688|P1|Overall Study|Disease Progression|1
356182|NCT00429273|1152720|P3|Overall Study|Adverse Event|2
356183|NCT00429273|1152721|P2|Overall Study|Adverse Event|1
356184|NCT00429273|1152722|P1|Overall Study|Adverse Event|1
356185|NCT00429273|1152720|P3|Overall Study|Physician Decision|5
356186|NCT00429273|1152721|P2|Overall Study|Physician Decision|5
356187|NCT00429273|1152722|P1|Overall Study|Physician Decision|6
356188|NCT00429273|1152720|P3|Overall Study|Lost to Follow-up|2
356189|NCT00429273|1152721|P2|Overall Study|Lost to Follow-up|2
356190|NCT00429273|1152722|P1|Overall Study|Lost to Follow-up|1
356191|NCT00429182|1152730|P1|Overall Study|Not eligible|5
356192|NCT00429182|1152730|P1|Overall Study|Not evaluable, Disease Progression|2
356193|NCT00429169|1152737|P2|Overall Study|Ineligibility discovered after entry|1
356194|NCT00429169|1152738|P1|Overall Study|Ineligibility discovered after entry|2
356195|NCT00429169|1152737|P2|Overall Study|Lost to Follow-up|1
356196|NCT00429169|1152738|P1|Overall Study|Lost to Follow-up|0
356197|NCT00429104|1152756|P1|Overall Study|Protocol Violation|1
356198|NCT00429026|1152761|P1|Overall Study|Inevaluable for response.|40
356199|NCT00428844|1152796|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
356200|NCT00428844|1152797|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
356201|NCT00428844|1152798|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
356202|NCT00428844|1152796|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
356203|NCT00428844|1152797|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
356204|NCT00428844|1152798|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
356205|NCT00428844|1152796|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
356206|NCT00428844|1152797|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
356207|NCT00428844|1152798|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
356208|NCT00428844|1152796|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
356209|NCT00428844|1152797|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
356210|NCT00428844|1152798|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
356211|NCT00428844|1152796|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
356212|NCT00428844|1152797|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
356213|NCT00428844|1152798|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
356214|NCT00428844|1152796|P3|Completed Study Drug Treatment|Randomized Not Treated|1
356215|NCT00428844|1152797|P2|Completed Study Drug Treatment|Randomized Not Treated|0
356216|NCT00428844|1152798|P1|Completed Study Drug Treatment|Randomized Not Treated|0
356217|NCT00428844|1152796|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
356218|NCT00428844|1152797|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
356219|NCT00428844|1152798|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
356220|NCT00428844|1152796|P3|Completed Study Drug Treatment|Protocol Violation|1
356221|NCT00428844|1152797|P2|Completed Study Drug Treatment|Protocol Violation|1
356222|NCT00428844|1152798|P1|Completed Study Drug Treatment|Protocol Violation|0
356223|NCT00428844|1152796|P3|Completed Study Drug Treatment|Adverse Event|4
356224|NCT00428844|1152797|P2|Completed Study Drug Treatment|Adverse Event|4
356225|NCT00428844|1152798|P1|Completed Study Drug Treatment|Adverse Event|2
356226|NCT00428792|1152821|P2|Overall Study|Lost to Follow-up|1
356227|NCT00428792|1152822|P1|Overall Study|Lost to Follow-up|0
356228|NCT00428792|1152821|P2|Overall Study|Lack of Efficacy|3
356229|NCT00428792|1152822|P1|Overall Study|Lack of Efficacy|1
356230|NCT00428597|1152848|P2|Overall Study|Death|3
356231|NCT00428597|1152849|P1|Overall Study|Death|1
356232|NCT00428597|1152848|P2|Overall Study|Pregnancy|0
356233|NCT00428597|1152849|P1|Overall Study|Pregnancy|1
356234|NCT00428597|1152848|P2|Overall Study|Lost to Follow-up|1
356235|NCT00428597|1152849|P1|Overall Study|Lost to Follow-up|0
356236|NCT00428597|1152848|P2|Overall Study|Other|1
356237|NCT00428597|1152849|P1|Overall Study|Other|1
356238|NCT00428597|1152848|P2|Overall Study|Withdrawal by Subject|1
356239|NCT00428597|1152849|P1|Overall Study|Withdrawal by Subject|2
356240|NCT00428597|1152848|P2|Overall Study|Protocol Violation|1
356241|NCT00428597|1152849|P1|Overall Study|Protocol Violation|2
356242|NCT00428597|1152848|P2|Overall Study|Global Deterioration of Health Status|5
356243|NCT00428597|1152849|P1|Overall Study|Global Deterioration of Health Status|1
356244|NCT00428597|1152848|P2|Overall Study|Adverse Event|7
356245|NCT00428597|1152849|P1|Overall Study|Adverse Event|15
356246|NCT00428597|1152848|P2|Overall Study|Study Terminated by Sponsor|16
356247|NCT00428597|1152849|P1|Overall Study|Study Terminated by Sponsor|41
356248|NCT00428597|1152848|P2|Overall Study|Objective Progression or Relapse|47
356249|NCT00428597|1152849|P1|Overall Study|Objective Progression or Relapse|19
356250|NCT00428597|1152848|P2|Overall Study|Randomized but not treated|3
356251|NCT00428597|1152849|P1|Overall Study|Randomized but not treated|3
356252|NCT00428441|1152916|P1|Overall Study|Lost to Follow-up|1
356253|NCT00428389|1152922|P2|Extension Phase|Administrative problems|1
356254|NCT00428389|1152923|P1|Extension Phase|Administrative problems|1
356255|NCT00428389|1152922|P2|Extension Phase|Protocol Violation|2
356256|NCT00428389|1152923|P1|Extension Phase|Protocol Violation|3
356257|NCT00428389|1152922|P2|Extension Phase|Death|0
356258|NCT00428389|1152923|P1|Extension Phase|Death|1
356259|NCT00428389|1152922|P2|Extension Phase|Lost to Follow-up|3
356260|NCT00428389|1152923|P1|Extension Phase|Lost to Follow-up|0
356261|NCT00428389|1152922|P2|Extension Phase|Withdrawal by Subject|6
356262|NCT00428389|1152923|P1|Extension Phase|Withdrawal by Subject|6
356263|NCT00428389|1152922|P2|Extension Phase|Lack of Efficacy|3
356264|NCT00428389|1152923|P1|Extension Phase|Lack of Efficacy|4
356265|NCT00428389|1152922|P2|Extension Phase|Adverse Event|11
356266|NCT00428389|1152923|P1|Extension Phase|Adverse Event|17
356267|NCT00428389|1152922|P2|Core Phase|Protocol deviation|2
356268|NCT00428389|1152923|P1|Core Phase|Protocol deviation|0
356269|NCT00428389|1152922|P2|Core Phase|Withdrawal by Subject|4
356270|NCT00428389|1152923|P1|Core Phase|Withdrawal by Subject|3
356271|NCT00428389|1152922|P2|Core Phase|Abnormal test procedure result(s)|1
356272|NCT00428389|1152923|P1|Core Phase|Abnormal test procedure result(s)|0
356273|NCT00428389|1152922|P2|Core Phase|Lack of Efficacy|0
356274|NCT00428389|1152923|P1|Core Phase|Lack of Efficacy|2
356275|NCT00428389|1152922|P2|Core Phase|Adverse Event|4
356276|NCT00428389|1152923|P1|Core Phase|Adverse Event|6
356277|NCT00428246|1152957|P3|Overall Study|Adverse Event|0
356278|NCT00428246|1152958|P2|Overall Study|Adverse Event|0
356279|NCT00428246|1152959|P1|Overall Study|Adverse Event|1
356280|NCT00428246|1152957|P3|Overall Study|Withdrawal by Subject|1
356281|NCT00428246|1152958|P2|Overall Study|Withdrawal by Subject|0
356282|NCT00428246|1152959|P1|Overall Study|Withdrawal by Subject|0
356283|NCT00428220|1152967|P1|Overall Study|Other|23
356284|NCT00428220|1152967|P1|Overall Study|Adverse Event|51
356285|NCT00428220|1152967|P1|Overall Study|Participant refused continued treatment|7
356286|NCT00428220|1152967|P1|Overall Study|Objective progression or relapse|123
356287|NCT00428220|1152967|P1|Overall Study|Lost to Follow-up|4
356288|NCT00428220|1152967|P1|Overall Study|Global deterioration of health status|7
356289|NCT00428220|1152967|P1|Overall Study|Participant died|8
356290|NCT00428116|1152992|P2|Overall Study|Lost to Follow-up|0
356291|NCT00428116|1152993|P1|Overall Study|Lost to Follow-up|1
356292|NCT00428116|1152992|P2|Overall Study|Withdrawal by Subject|0
356293|NCT00428116|1152993|P1|Overall Study|Withdrawal by Subject|1
356294|NCT00428116|1152992|P2|Overall Study|Death|0
356295|NCT00428116|1152993|P1|Overall Study|Death|1
356296|NCT00428090|1153005|P4|Overall Study|Raised Creatinine Value|1
356297|NCT00428090|1153006|P3|Overall Study|Raised Creatinine Value|0
356298|NCT00428090|1153007|P2|Overall Study|Raised Creatinine Value|0
356299|NCT00428090|1153008|P1|Overall Study|Raised Creatinine Value|0
356300|NCT00428090|1153005|P4|Overall Study|Excluded for heart insufficiency|0
356301|NCT00428090|1153006|P3|Overall Study|Excluded for heart insufficiency|1
356302|NCT00428090|1153007|P2|Overall Study|Excluded for heart insufficiency|0
356303|NCT00428090|1153008|P1|Overall Study|Excluded for heart insufficiency|0
356304|NCT00428090|1153005|P4|Overall Study|Serious adverse event|0
356305|NCT00428090|1153006|P3|Overall Study|Serious adverse event|1
356306|NCT00428090|1153007|P2|Overall Study|Serious adverse event|0
356307|NCT00428090|1153008|P1|Overall Study|Serious adverse event|0
356308|NCT00428090|1153005|P4|Overall Study|Deterioration of cognitive status|0
356309|NCT00428090|1153006|P3|Overall Study|Deterioration of cognitive status|1
356310|NCT00428090|1153007|P2|Overall Study|Deterioration of cognitive status|0
356311|NCT00428090|1153008|P1|Overall Study|Deterioration of cognitive status|0
356312|NCT00428090|1153005|P4|Overall Study|High MMSE scores|0
356313|NCT00428090|1153006|P3|Overall Study|High MMSE scores|1
356314|NCT00428090|1153007|P2|Overall Study|High MMSE scores|0
356315|NCT00428090|1153008|P1|Overall Study|High MMSE scores|0
356316|NCT00428090|1153005|P4|Overall Study|Insufficient AD documentation|0
356317|NCT00428090|1153006|P3|Overall Study|Insufficient AD documentation|1
356318|NCT00428090|1153007|P2|Overall Study|Insufficient AD documentation|0
356319|NCT00428090|1153008|P1|Overall Study|Insufficient AD documentation|0
356320|NCT00428090|1153005|P4|Overall Study|Excluded for concerning QTc value|0
356321|NCT00428090|1153006|P3|Overall Study|Excluded for concerning QTc value|1
356322|NCT00428090|1153007|P2|Overall Study|Excluded for concerning QTc value|0
356323|NCT00428090|1153008|P1|Overall Study|Excluded for concerning QTc value|0
356324|NCT00428090|1153005|P4|Overall Study|Worsening of AD|0
356325|NCT00428090|1153006|P3|Overall Study|Worsening of AD|1
356326|NCT00428090|1153007|P2|Overall Study|Worsening of AD|0
356327|NCT00428090|1153008|P1|Overall Study|Worsening of AD|0
356328|NCT00428090|1153005|P4|Overall Study|Mental status of par. was|0
356329|NCT00428090|1153006|P3|Overall Study|Mental status of par. was|0
356330|NCT00428090|1153007|P2|Overall Study|Mental status of par. was|1
356331|NCT00428090|1153008|P1|Overall Study|Mental status of par. was|0
356332|NCT00428090|1153005|P4|Overall Study|Medical monitor terminated par.|0
356333|NCT00428090|1153006|P3|Overall Study|Medical monitor terminated par.|0
356334|NCT00428090|1153007|P2|Overall Study|Medical monitor terminated par.|1
356335|NCT00428090|1153008|P1|Overall Study|Medical monitor terminated par.|0
356336|NCT00428090|1153005|P4|Overall Study|Visit 7 exceed the visit window|0
356337|NCT00428090|1153006|P3|Overall Study|Visit 7 exceed the visit window|0
356338|NCT00428090|1153007|P2|Overall Study|Visit 7 exceed the visit window|1
356339|NCT00428090|1153008|P1|Overall Study|Visit 7 exceed the visit window|0
356340|NCT00428090|1153005|P4|Overall Study|Death of par.|0
356341|NCT00428090|1153006|P3|Overall Study|Death of par.|1
356342|NCT00428090|1153007|P2|Overall Study|Death of par.|0
356343|NCT00428090|1153008|P1|Overall Study|Death of par.|1
356344|NCT00428090|1153005|P4|Overall Study|Prohibited medication used for SAE|0
356345|NCT00428090|1153006|P3|Overall Study|Prohibited medication used for SAE|0
356346|NCT00428090|1153007|P2|Overall Study|Prohibited medication used for SAE|0
356347|NCT00428090|1153008|P1|Overall Study|Prohibited medication used for SAE|1
356348|NCT00428090|1153005|P4|Overall Study|Follow-Up visit not possible|0
356349|NCT00428090|1153006|P3|Overall Study|Follow-Up visit not possible|0
356350|NCT00428090|1153007|P2|Overall Study|Follow-Up visit not possible|0
356351|NCT00428090|1153008|P1|Overall Study|Follow-Up visit not possible|1
356352|NCT00428090|1153005|P4|Overall Study|Par. did not returned to visit|1
356353|NCT00428090|1153006|P3|Overall Study|Par. did not returned to visit|0
356354|NCT00428090|1153007|P2|Overall Study|Par. did not returned to visit|0
356355|NCT00428090|1153008|P1|Overall Study|Par. did not returned to visit|1
356356|NCT00428090|1153005|P4|Overall Study|Non-compliance|3
356357|NCT00428090|1153006|P3|Overall Study|Non-compliance|1
356358|NCT00428090|1153007|P2|Overall Study|Non-compliance|0
356359|NCT00428090|1153008|P1|Overall Study|Non-compliance|4
356360|NCT00428090|1153005|P4|Overall Study|Sponsor terminated study|0
356361|NCT00428090|1153006|P3|Overall Study|Sponsor terminated study|0
356362|NCT00428090|1153007|P2|Overall Study|Sponsor terminated study|1
356363|NCT00428090|1153008|P1|Overall Study|Sponsor terminated study|0
356364|NCT00428090|1153005|P4|Overall Study|Withdrawal by Subject|5
356365|NCT00428090|1153006|P3|Overall Study|Withdrawal by Subject|15
356366|NCT00428090|1153007|P2|Overall Study|Withdrawal by Subject|12
356367|NCT00428090|1153008|P1|Overall Study|Withdrawal by Subject|10
356368|NCT00428090|1153005|P4|Overall Study|Protocol Violation|3
356369|NCT00428090|1153006|P3|Overall Study|Protocol Violation|3
356370|NCT00428090|1153007|P2|Overall Study|Protocol Violation|1
356371|NCT00428090|1153008|P1|Overall Study|Protocol Violation|3
356372|NCT00428090|1153005|P4|Overall Study|Lost to Follow-up|4
356373|NCT00428090|1153006|P3|Overall Study|Lost to Follow-up|1
356374|NCT00428090|1153007|P2|Overall Study|Lost to Follow-up|6
356375|NCT00428090|1153008|P1|Overall Study|Lost to Follow-up|3
356376|NCT00428090|1153005|P4|Overall Study|Adverse Event|11
356377|NCT00428090|1153006|P3|Overall Study|Adverse Event|10
356378|NCT00428090|1153007|P2|Overall Study|Adverse Event|8
356379|NCT00428090|1153008|P1|Overall Study|Adverse Event|10
356380|NCT00427999|1153126|P1|Overall Study|Death|1
356381|NCT00427999|1153126|P1|Overall Study|Withdrawal by Subject|9
356382|NCT00427999|1153126|P1|Overall Study|Protocol Violation|2
356383|NCT00427999|1153126|P1|Overall Study|Unsatisfactory therapeutic effect|13
356384|NCT00427999|1153126|P1|Overall Study|Abnormal laboratory values|1
356385|NCT00427999|1153126|P1|Overall Study|Adverse Event|6
356386|NCT00427960|1153144|P2|Overall Study|Not Specified|1
356387|NCT00427960|1153145|P1|Overall Study|Not Specified|0
356388|NCT00427960|1153144|P2|Overall Study|Withdrawal by Subject|3
356389|NCT00427960|1153145|P1|Overall Study|Withdrawal by Subject|0
356390|NCT00427960|1153144|P2|Overall Study|Adverse Event|0
356391|NCT00427960|1153145|P1|Overall Study|Adverse Event|2
356392|NCT00427934|1153183|P4|Overall Study|Withdrawal by Subject|3
356393|NCT00427934|1153184|P3|Overall Study|Withdrawal by Subject|1
356394|NCT00427934|1153185|P2|Overall Study|Withdrawal by Subject|0
356395|NCT00427934|1153186|P1|Overall Study|Withdrawal by Subject|0
356396|NCT00427934|1153183|P4|Overall Study|Other|5
356397|NCT00427934|1153184|P3|Overall Study|Other|11
356398|NCT00427934|1153185|P2|Overall Study|Other|0
356399|NCT00427934|1153186|P1|Overall Study|Other|0
356400|NCT00427934|1153183|P4|Overall Study|Randomized But Did Not Receive Treatment|1
356401|NCT00427934|1153184|P3|Overall Study|Randomized But Did Not Receive Treatment|1
356402|NCT00427934|1153185|P2|Overall Study|Randomized But Did Not Receive Treatment|0
356403|NCT00427934|1153186|P1|Overall Study|Randomized But Did Not Receive Treatment|0
356404|NCT00427934|1153183|P4|Overall Study|Lack of Efficacy|2
356405|NCT00427934|1153184|P3|Overall Study|Lack of Efficacy|5
356406|NCT00427934|1153185|P2|Overall Study|Lack of Efficacy|0
356407|NCT00427934|1153186|P1|Overall Study|Lack of Efficacy|0
356408|NCT00427934|1153183|P4|Overall Study|Adverse Event|4
356409|NCT00427934|1153184|P3|Overall Study|Adverse Event|5
356410|NCT00427934|1153185|P2|Overall Study|Adverse Event|0
356411|NCT00427934|1153186|P1|Overall Study|Adverse Event|1
356412|NCT00427921|1153254|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
356413|NCT00427921|1153254|P1|Overall Study|Adverse Event + Withdrawn from Study|1
356414|NCT00427921|1153254|P1|Overall Study|Adverse Event + Lost Response|1
356415|NCT00427921|1153254|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
356416|NCT00427921|1153254|P1|Overall Study|Adverse Event + Worsening of CD|1
356417|NCT00427921|1153254|P1|Overall Study|Adverse Event + No Response|1
356418|NCT00427921|1153254|P1|Overall Study|Adverse Event + Withdrew Consent|1
356419|NCT00427921|1153254|P1|Overall Study|Adverse Event + Hospitalization|1
356420|NCT00427921|1153254|P1|Overall Study|Other reason not specified|10
356421|NCT00427921|1153254|P1|Overall Study|Lost to Follow-up|2
356422|NCT00427921|1153254|P1|Overall Study|Withdrawal by Subject|4
356423|NCT00427921|1153254|P1|Overall Study|Adverse Event|26
356424|NCT00427895|1153277|P8|Vax 2/Year 3 to 4|Failed to Return|0
356425|NCT00427895|1153278|P7|Vax 2/Year 3 to 4|Failed to Return|0
356426|NCT00427895|1153279|P6|Vax 2/Year 3 to 4|Failed to Return|0
356427|NCT00427895|1153280|P5|Vax 2/Year 3 to 4|Failed to Return|1
356428|NCT00427895|1153281|P4|Vax 2/Year 3 to 4|Failed to Return|0
356429|NCT00427895|1153282|P3|Vax 2/Year 3 to 4|Failed to Return|0
356430|NCT00427895|1153283|P2|Vax 2/Year 3 to 4|Failed to Return|0
356431|NCT00427895|1153284|P1|Vax 2/Year 3 to 4|Failed to Return|0
356432|NCT00427895|1153277|P8|Vax 2/Year 3 to 4|Protocol Violation|1
356433|NCT00427895|1153278|P7|Vax 2/Year 3 to 4|Protocol Violation|0
356434|NCT00427895|1153279|P6|Vax 2/Year 3 to 4|Protocol Violation|0
356435|NCT00427895|1153280|P5|Vax 2/Year 3 to 4|Protocol Violation|0
356436|NCT00427895|1153281|P4|Vax 2/Year 3 to 4|Protocol Violation|0
356437|NCT00427895|1153282|P3|Vax 2/Year 3 to 4|Protocol Violation|0
356438|NCT00427895|1153283|P2|Vax 2/Year 3 to 4|Protocol Violation|0
356439|NCT00427895|1153284|P1|Vax 2/Year 3 to 4|Protocol Violation|0
356440|NCT00427895|1153277|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
356441|NCT00427895|1153278|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
356442|NCT00427895|1153279|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
356443|NCT00427895|1153280|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
356444|NCT00427895|1153281|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
356445|NCT00427895|1153282|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
356446|NCT00427895|1153283|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
356447|NCT00427895|1153284|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
356448|NCT00427895|1153277|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
356449|NCT00427895|1153278|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
356450|NCT00427895|1153279|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
356451|NCT00427895|1153280|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
356452|NCT00427895|1153281|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
356453|NCT00427895|1153282|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
356454|NCT00427895|1153283|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
356455|NCT00427895|1153284|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
356456|NCT00427895|1153277|P8|Vax 1/Year 1 Follow-up|Unspecified|0
356457|NCT00427895|1153278|P7|Vax 1/Year 1 Follow-up|Unspecified|0
356458|NCT00427895|1153279|P6|Vax 1/Year 1 Follow-up|Unspecified|0
356459|NCT00427895|1153280|P5|Vax 1/Year 1 Follow-up|Unspecified|0
356460|NCT00427895|1153281|P4|Vax 1/Year 1 Follow-up|Unspecified|2
356461|NCT00427895|1153282|P3|Vax 1/Year 1 Follow-up|Unspecified|0
356462|NCT00427895|1153283|P2|Vax 1/Year 1 Follow-up|Unspecified|0
356463|NCT00427895|1153284|P1|Vax 1/Year 1 Follow-up|Unspecified|0
356464|NCT00427895|1153277|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
356465|NCT00427895|1153278|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
356466|NCT00427895|1153279|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
356467|NCT00427895|1153280|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
356468|NCT00427895|1153281|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
356469|NCT00427895|1153282|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
356470|NCT00427895|1153283|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
356471|NCT00427895|1153284|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
356472|NCT00427895|1153277|P8|Vax 1/Year 1 Follow-up|Death|0
356473|NCT00427895|1153278|P7|Vax 1/Year 1 Follow-up|Death|0
356474|NCT00427895|1153279|P6|Vax 1/Year 1 Follow-up|Death|0
356475|NCT00427895|1153280|P5|Vax 1/Year 1 Follow-up|Death|0
356476|NCT00427895|1153281|P4|Vax 1/Year 1 Follow-up|Death|0
356477|NCT00427895|1153282|P3|Vax 1/Year 1 Follow-up|Death|0
356478|NCT00427895|1153283|P2|Vax 1/Year 1 Follow-up|Death|0
356479|NCT00427895|1153284|P1|Vax 1/Year 1 Follow-up|Death|1
356480|NCT00427895|1153277|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
356481|NCT00427895|1153278|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
356482|NCT00427895|1153279|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
356483|NCT00427895|1153280|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
356484|NCT00427895|1153281|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
356485|NCT00427895|1153282|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
356486|NCT00427895|1153283|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
356487|NCT00427895|1153284|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
356488|NCT00427895|1153277|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
356489|NCT00427895|1153278|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
356490|NCT00427895|1153279|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
356491|NCT00427895|1153280|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
356492|NCT00427895|1153281|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
356493|NCT00427895|1153282|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
356494|NCT00427895|1153283|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
356495|NCT00427895|1153284|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
356496|NCT00427895|1153277|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
356497|NCT00427895|1153278|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
356498|NCT00427895|1153279|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
356499|NCT00427895|1153280|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
356500|NCT00427895|1153281|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
356501|NCT00427895|1153282|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
356502|NCT00427895|1153283|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
356503|NCT00427895|1153284|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
356504|NCT00427895|1153277|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
356505|NCT00427895|1153278|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
356506|NCT00427895|1153279|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
356507|NCT00427895|1153280|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
356508|NCT00427895|1153281|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
356509|NCT00427895|1153282|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
356510|NCT00427895|1153283|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
356511|NCT00427895|1153284|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
356512|NCT00427895|1153277|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
356513|NCT00427895|1153278|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
356514|NCT00427895|1153279|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
356515|NCT00427895|1153280|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
356516|NCT00427895|1153281|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
356517|NCT00427895|1153282|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
356518|NCT00427895|1153283|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
356519|NCT00427895|1153284|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
356520|NCT00427895|1153277|P8|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
356521|NCT00427895|1153278|P7|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
356522|NCT00427895|1153279|P6|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
356523|NCT00427895|1153280|P5|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
356524|NCT00427895|1153281|P4|Vax 1 Baseline/6-Month Follow-up|Unspecified|2
356525|NCT00427895|1153282|P3|Vax 1 Baseline/6-Month Follow-up|Unspecified|1
356526|NCT00427895|1153283|P2|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
356527|NCT00427895|1153284|P1|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
356528|NCT00427895|1153277|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
356529|NCT00427895|1153278|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
356530|NCT00427895|1153279|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
356531|NCT00427895|1153280|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
356532|NCT00427895|1153281|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
356533|NCT00427895|1153282|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
356534|NCT00427895|1153283|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
356535|NCT00427895|1153284|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
356536|NCT00427895|1153277|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
356537|NCT00427895|1153278|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
356538|NCT00427895|1153279|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
356539|NCT00427895|1153280|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
356540|NCT00427895|1153281|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
356541|NCT00427895|1153282|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
356542|NCT00427895|1153283|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
356543|NCT00427895|1153284|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
356544|NCT00427895|1153277|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
356545|NCT00427895|1153278|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
356546|NCT00427895|1153279|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
356547|NCT00427895|1153280|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
356548|NCT00427895|1153281|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
356549|NCT00427895|1153282|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
356550|NCT00427895|1153283|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
356551|NCT00427895|1153284|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
356552|NCT00427895|1153277|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
356553|NCT00427895|1153278|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
356554|NCT00427895|1153279|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
356555|NCT00427895|1153280|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
356556|NCT00427895|1153281|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
356557|NCT00427895|1153282|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
356558|NCT00427895|1153283|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
356559|NCT00427895|1153284|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
356560|NCT00427895|1153277|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
356561|NCT00427895|1153278|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
356562|NCT00427895|1153279|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
356563|NCT00427895|1153280|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
356564|NCT00427895|1153281|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
356565|NCT00427895|1153282|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
356566|NCT00427895|1153283|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
356567|NCT00427895|1153284|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
356568|NCT00427895|1153277|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
356569|NCT00427895|1153278|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
356570|NCT00427895|1153279|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
356571|NCT00427895|1153280|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
356572|NCT00427895|1153281|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
356573|NCT00427895|1153282|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
356574|NCT00427895|1153283|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
356575|NCT00427895|1153284|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
356576|NCT00427700|1153365|P2|Overall Study|Pregnancy|2
356577|NCT00427700|1153366|P1|Overall Study|Pregnancy|0
356578|NCT00427700|1153365|P2|Overall Study|no induction of menses|4
356579|NCT00427700|1153366|P1|Overall Study|no induction of menses|1
356580|NCT00427700|1153365|P2|Overall Study|Lost to Follow-up|5
356581|NCT00427700|1153366|P1|Overall Study|Lost to Follow-up|2
356582|NCT00427635|1153382|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
356583|NCT00427635|1153383|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
356584|NCT00427635|1153382|P2|Treatment Phase|Withdrawal by Subject|0
356585|NCT00427635|1153383|P1|Treatment Phase|Withdrawal by Subject|1
356586|NCT00427349|1153415|P1|Overall Study|Never started therapy|1
356587|NCT00427349|1153415|P1|Overall Study|Ineligible|1
356588|NCT00427349|1153415|P1|Overall Study|Other|2
356589|NCT00427349|1153415|P1|Overall Study|Alternative therapy|1
356590|NCT00427349|1153415|P1|Overall Study|Withdrawal by Subject|3
356591|NCT00427349|1153415|P1|Overall Study|Death|1
356592|NCT00427349|1153415|P1|Overall Study|Adverse Event|14
356593|NCT00427349|1153415|P1|Overall Study|Lack of Efficacy|23
356594|NCT00427011|1153436|P1|Overall Study|Not specified|12
356595|NCT00427011|1153436|P1|Overall Study|Lack of Efficacy|2
356596|NCT00427011|1153436|P1|Overall Study|Withdrawal by Subject|1
356597|NCT00427011|1153436|P1|Overall Study|Adverse Event|10
356598|NCT00426842|1153451|P1|Overall Study|Lost to Follow-up|1
356599|NCT00426764|1153457|P1|Overall Study|Other|2
356600|NCT00426764|1153457|P1|Overall Study|Protocol Violation|1
356601|NCT00426764|1153457|P1|Overall Study|Physician Decision|1
356602|NCT00426764|1153457|P1|Overall Study|Withdrawal by Subject|3
356603|NCT00426764|1153457|P1|Overall Study|Adverse Event|19
356604|NCT00426764|1153457|P1|Overall Study|Progressive disease|72
356605|NCT00426751|1153473|P2|Overall Study|Other Reasons|12
356606|NCT00426751|1153474|P1|Overall Study|Other Reasons|7
356607|NCT00426751|1153473|P2|Overall Study|Consent Withdrawn|1
356608|NCT00426751|1153474|P1|Overall Study|Consent Withdrawn|0
356609|NCT00426751|1153473|P2|Overall Study|Lost to Follow-up|6
356610|NCT00426751|1153474|P1|Overall Study|Lost to Follow-up|7
356611|NCT00426751|1153473|P2|Overall Study|Adverse Event|1
356612|NCT00426751|1153474|P1|Overall Study|Adverse Event|8
356613|NCT00426660|1153518|P1|Overall Study|Enrolled Not Treated|15
356614|NCT00426660|1153518|P1|Overall Study|Protocol Violation|1
356615|NCT00426660|1153518|P1|Overall Study|Withdrawal by Subject|18
356616|NCT00426660|1153518|P1|Overall Study|Unspecified|23
356617|NCT00426660|1153518|P1|Overall Study|Lost to Follow-up|15
356618|NCT00426660|1153518|P1|Overall Study|Insufficient Clinical Response|22
356619|NCT00426660|1153518|P1|Overall Study|Adverse Event|23
356620|NCT00426660|1153518|P1|Overall Study|Death|14
356621|NCT00426556|1153549|P4|Phase II - Extension Phase|Adverse Event|2
356622|NCT00426556|1153550|P3|Phase II - Extension Phase|Adverse Event|0
356623|NCT00426556|1153551|P2|Phase II - Extension Phase|Adverse Event|0
356624|NCT00426556|1153552|P1|Phase II - Extension Phase|Adverse Event|0
356625|NCT00426556|1153549|P4|Phase II - Extension Phase|Disease Progression|21
356626|NCT00426556|1153550|P3|Phase II - Extension Phase|Disease Progression|0
356627|NCT00426556|1153551|P2|Phase II - Extension Phase|Disease Progression|0
356628|NCT00426556|1153552|P1|Phase II - Extension Phase|Disease Progression|0
356629|NCT00426556|1153549|P4|Phase II - Core Phase|Adverse Event|8
356630|NCT00426556|1153550|P3|Phase II - Core Phase|Adverse Event|0
356631|NCT00426556|1153551|P2|Phase II - Core Phase|Adverse Event|0
356632|NCT00426556|1153552|P1|Phase II - Core Phase|Adverse Event|0
356633|NCT00426556|1153549|P4|Phase II - Core Phase|Disease Progression|16
356634|NCT00426556|1153550|P3|Phase II - Core Phase|Disease Progression|0
356635|NCT00426556|1153551|P2|Phase II - Core Phase|Disease Progression|0
356636|NCT00426556|1153552|P1|Phase II - Core Phase|Disease Progression|0
356637|NCT00426556|1153549|P4|Phase II - Core Phase|Withdrawal by Subject|3
356638|NCT00426556|1153550|P3|Phase II - Core Phase|Withdrawal by Subject|0
356639|NCT00426556|1153551|P2|Phase II - Core Phase|Withdrawal by Subject|0
356640|NCT00426556|1153552|P1|Phase II - Core Phase|Withdrawal by Subject|0
356641|NCT00426556|1153549|P4|Phase I - Extension Phase|Disease Progression|0
356642|NCT00426556|1153550|P3|Phase I - Extension Phase|Disease Progression|6
356643|NCT00426556|1153551|P2|Phase I - Extension Phase|Disease Progression|5
356644|NCT00426556|1153552|P1|Phase I - Extension Phase|Disease Progression|5
356645|NCT00426556|1153549|P4|Phase I - Extension Phase|Adverse Event|0
356646|NCT00426556|1153550|P3|Phase I - Extension Phase|Adverse Event|1
356647|NCT00426556|1153551|P2|Phase I - Extension Phase|Adverse Event|1
356648|NCT00426556|1153552|P1|Phase I - Extension Phase|Adverse Event|0
356649|NCT00426556|1153549|P4|Phase I - Core Phase|Death|0
356650|NCT00426556|1153550|P3|Phase I - Core Phase|Death|0
356651|NCT00426556|1153551|P2|Phase I - Core Phase|Death|1
356652|NCT00426556|1153552|P1|Phase I - Core Phase|Death|0
356653|NCT00426556|1153549|P4|Phase I - Core Phase|Adverse Event|0
356654|NCT00426556|1153550|P3|Phase I - Core Phase|Adverse Event|1
356655|NCT00426556|1153551|P2|Phase I - Core Phase|Adverse Event|3
356656|NCT00426556|1153552|P1|Phase I - Core Phase|Adverse Event|1
356657|NCT00426556|1153549|P4|Phase I - Core Phase|Disease Progression|0
356658|NCT00426556|1153550|P3|Phase I - Core Phase|Disease Progression|2
356659|NCT00426556|1153551|P2|Phase I - Core Phase|Disease Progression|6
356660|NCT00426556|1153552|P1|Phase I - Core Phase|Disease Progression|0
356661|NCT00426361|1153577|P3|Overall Study|Withdrawal by Subject|0
356662|NCT00426361|1153578|P2|Overall Study|Withdrawal by Subject|3
356663|NCT00426361|1153579|P1|Overall Study|Withdrawal by Subject|1
356664|NCT00426361|1153577|P3|Overall Study|Lost to Follow-up|5
356665|NCT00426361|1153578|P2|Overall Study|Lost to Follow-up|2
356666|NCT00426361|1153579|P1|Overall Study|Lost to Follow-up|3
356667|NCT00426270|1153638|P1|Overall Study|Adverse Event|5
356668|NCT00426270|1153638|P1|Overall Study|Incorrectly Enrolled in the Study|1
356669|NCT00426231|1153648|P2|Overall Study|Withdrawal by Subject|12
356670|NCT00426231|1153649|P1|Overall Study|Withdrawal by Subject|9
356671|NCT00426127|1153672|P1|Overall Study|Removed due to disease progression|1
356672|NCT00426127|1153672|P1|Overall Study|Adverse Event|1
356673|NCT00425113|1153680|P2|Overall Study|Withdrawal by Subject|0
356674|NCT00425113|1153681|P1|Overall Study|Withdrawal by Subject|1
356675|NCT00425113|1153680|P2|Overall Study|missing study drug more than 14 days|1
356676|NCT00425113|1153681|P1|Overall Study|missing study drug more than 14 days|0
356677|NCT00425113|1153680|P2|Overall Study|diagnosis of abdominal TB|1
356678|NCT00425113|1153681|P1|Overall Study|diagnosis of abdominal TB|0
356679|NCT00425113|1153680|P2|Overall Study|uncontrolled diabetes mellitus|0
356680|NCT00425113|1153681|P1|Overall Study|uncontrolled diabetes mellitus|1
356681|NCT00425100|1153689|P1|Overall Study|Withdrawal by Subject|7
356682|NCT00425100|1153689|P1|Overall Study|Protocol Violation|4
356683|NCT00425100|1153689|P1|Overall Study|Lost to Follow-up|2
356684|NCT00425100|1153689|P1|Overall Study|Lack of Efficacy|4
356685|NCT00425100|1153689|P1|Overall Study|Adverse Event|36
356686|NCT00425061|1153733|P7|Overall Study|Unspecified|1
356687|NCT00425061|1153734|P6|Overall Study|Unspecified|0
356688|NCT00425061|1153735|P5|Overall Study|Unspecified|3
356689|NCT00425061|1153736|P4|Overall Study|Unspecified|0
356690|NCT00425061|1153737|P3|Overall Study|Unspecified|0
356691|NCT00425061|1153738|P2|Overall Study|Unspecified|0
356692|NCT00425061|1153739|P1|Overall Study|Unspecified|0
356693|NCT00425061|1153733|P7|Overall Study|Physician Decision|0
356694|NCT00425061|1153734|P6|Overall Study|Physician Decision|0
356695|NCT00425061|1153735|P5|Overall Study|Physician Decision|1
356696|NCT00425061|1153736|P4|Overall Study|Physician Decision|0
356697|NCT00425061|1153737|P3|Overall Study|Physician Decision|0
356698|NCT00425061|1153738|P2|Overall Study|Physician Decision|0
356699|NCT00425061|1153739|P1|Overall Study|Physician Decision|0
356700|NCT00425061|1153733|P7|Overall Study|Sponsor's request|15
356701|NCT00425061|1153734|P6|Overall Study|Sponsor's request|4
356702|NCT00425061|1153735|P5|Overall Study|Sponsor's request|19
356703|NCT00425061|1153736|P4|Overall Study|Sponsor's request|0
356704|NCT00425061|1153737|P3|Overall Study|Sponsor's request|0
356705|NCT00425061|1153738|P2|Overall Study|Sponsor's request|0
356706|NCT00425061|1153739|P1|Overall Study|Sponsor's request|0
356707|NCT00425061|1153733|P7|Overall Study|Withdrawal by Subject|3
356708|NCT00425061|1153734|P6|Overall Study|Withdrawal by Subject|0
356709|NCT00425061|1153735|P5|Overall Study|Withdrawal by Subject|1
356710|NCT00425061|1153736|P4|Overall Study|Withdrawal by Subject|0
356711|NCT00425061|1153737|P3|Overall Study|Withdrawal by Subject|0
356712|NCT00425061|1153738|P2|Overall Study|Withdrawal by Subject|1
356713|NCT00425061|1153739|P1|Overall Study|Withdrawal by Subject|0
356714|NCT00425061|1153733|P7|Overall Study|Protocol Violation|0
356715|NCT00425061|1153734|P6|Overall Study|Protocol Violation|0
356716|NCT00425061|1153735|P5|Overall Study|Protocol Violation|0
356717|NCT00425061|1153736|P4|Overall Study|Protocol Violation|0
356718|NCT00425061|1153737|P3|Overall Study|Protocol Violation|0
356719|NCT00425061|1153738|P2|Overall Study|Protocol Violation|0
356720|NCT00425061|1153739|P1|Overall Study|Protocol Violation|1
356721|NCT00425061|1153733|P7|Overall Study|Lost to Follow-up|0
356722|NCT00425061|1153734|P6|Overall Study|Lost to Follow-up|0
356723|NCT00425061|1153735|P5|Overall Study|Lost to Follow-up|0
356724|NCT00425061|1153736|P4|Overall Study|Lost to Follow-up|0
356725|NCT00425061|1153737|P3|Overall Study|Lost to Follow-up|0
356726|NCT00425061|1153738|P2|Overall Study|Lost to Follow-up|1
356727|NCT00425061|1153739|P1|Overall Study|Lost to Follow-up|0
356728|NCT00425061|1153733|P7|Overall Study|Adverse Event|0
356729|NCT00425061|1153734|P6|Overall Study|Adverse Event|0
356730|NCT00425061|1153735|P5|Overall Study|Adverse Event|2
356731|NCT00425061|1153736|P4|Overall Study|Adverse Event|2
356732|NCT00425061|1153737|P3|Overall Study|Adverse Event|0
356733|NCT00425061|1153738|P2|Overall Study|Adverse Event|0
356734|NCT00425061|1153739|P1|Overall Study|Adverse Event|1
356735|NCT00425945|1153857|P2|Overall Study|Moved from area|1
356736|NCT00425945|1153858|P1|Overall Study|Moved from area|0
356737|NCT00425945|1153857|P2|Overall Study|Began cancer treatments|0
356738|NCT00425945|1153858|P1|Overall Study|Began cancer treatments|1
356739|NCT00425945|1153857|P2|Overall Study|Began hypertension medication|0
356740|NCT00425945|1153858|P1|Overall Study|Began hypertension medication|1
356741|NCT00425945|1153857|P2|Overall Study|Lost to Follow-up|2
356742|NCT00425945|1153858|P1|Overall Study|Lost to Follow-up|0
356743|NCT00425945|1153857|P2|Overall Study|Inconvenience|2
356744|NCT00425945|1153858|P1|Overall Study|Inconvenience|0
356745|NCT00425945|1153857|P2|Overall Study|Concern about Supplement|0
356746|NCT00425945|1153858|P1|Overall Study|Concern about Supplement|2
356747|NCT00425854|1153896|P2|Overall Study|Other Adverse Event|2
356748|NCT00425854|1153897|P1|Overall Study|Other Adverse Event|2
356749|NCT00425854|1153896|P2|Overall Study|Dose reduction toxicity AE|7
356750|NCT00425854|1153897|P1|Overall Study|Dose reduction toxicity AE|8
356751|NCT00425854|1153896|P2|Overall Study|Progressive Disease|12
356752|NCT00425854|1153897|P1|Overall Study|Progressive Disease|19
356753|NCT00425750|1153918|P1|Overall Study|Progression of disease|18
356754|NCT00425750|1153918|P1|Overall Study|Adverse Event|3
356755|NCT00425750|1153918|P1|Overall Study|Withdrawal by Subject|3
356756|NCT00425750|1153918|P1|Overall Study|Death|1
356757|NCT00425698|1153926|P2|Overall Study|Withdrawal by Subject|1
356758|NCT00425698|1153927|P1|Overall Study|Withdrawal by Subject|0
356759|NCT00425698|1153926|P2|Overall Study|Adverse Event|1
356760|NCT00425698|1153927|P1|Overall Study|Adverse Event|3
356761|NCT00425607|1153933|P1|Overall Study|Withdrawal by Subject|1
356762|NCT00425607|1153933|P1|Overall Study|Death|1
356763|NCT00425503|1153937|P1|Overall Study|Protocol Violation|1
356764|NCT00425503|1153937|P1|Overall Study|Adverse Event|2
356765|NCT00425438|1153943|P2|Overall Study|Termination by Sponsor|27
356766|NCT00425438|1153944|P1|Overall Study|Termination by Sponsor|25
356767|NCT00425373|1153978|P9|Overall Study|Lack of Efficacy|5
356768|NCT00425373|1153979|P8|Overall Study|Lack of Efficacy|0
356769|NCT00425373|1153980|P7|Overall Study|Lack of Efficacy|3
356770|NCT00425373|1153981|P6|Overall Study|Lack of Efficacy|3
356771|NCT00425373|1153982|P5|Overall Study|Lack of Efficacy|1
356772|NCT00425373|1153983|P4|Overall Study|Lack of Efficacy|0
356773|NCT00425373|1153984|P3|Overall Study|Lack of Efficacy|0
356774|NCT00425373|1153985|P2|Overall Study|Lack of Efficacy|0
356775|NCT00425373|1153986|P1|Overall Study|Lack of Efficacy|0
356776|NCT00425373|1153978|P9|Overall Study|Withdrawal by Subject|2
356777|NCT00425373|1153979|P8|Overall Study|Withdrawal by Subject|2
356778|NCT00425373|1153980|P7|Overall Study|Withdrawal by Subject|2
356779|NCT00425373|1153981|P6|Overall Study|Withdrawal by Subject|0
356780|NCT00425373|1153982|P5|Overall Study|Withdrawal by Subject|4
356781|NCT00425373|1153983|P4|Overall Study|Withdrawal by Subject|1
356782|NCT00425373|1153984|P3|Overall Study|Withdrawal by Subject|2
356783|NCT00425373|1153985|P2|Overall Study|Withdrawal by Subject|0
356784|NCT00425373|1153986|P1|Overall Study|Withdrawal by Subject|2
356785|NCT00425373|1153978|P9|Overall Study|Protocol Violation|3
356786|NCT00425373|1153979|P8|Overall Study|Protocol Violation|5
356787|NCT00425373|1153980|P7|Overall Study|Protocol Violation|0
356788|NCT00425373|1153981|P6|Overall Study|Protocol Violation|0
356789|NCT00425373|1153982|P5|Overall Study|Protocol Violation|0
356790|NCT00425373|1153983|P4|Overall Study|Protocol Violation|0
356791|NCT00425373|1153984|P3|Overall Study|Protocol Violation|1
356792|NCT00425373|1153985|P2|Overall Study|Protocol Violation|0
356793|NCT00425373|1153986|P1|Overall Study|Protocol Violation|1
356794|NCT00425373|1153978|P9|Overall Study|Lost to Follow-up|0
356795|NCT00425373|1153979|P8|Overall Study|Lost to Follow-up|0
356796|NCT00425373|1153980|P7|Overall Study|Lost to Follow-up|0
356797|NCT00425373|1153981|P6|Overall Study|Lost to Follow-up|0
356798|NCT00425373|1153982|P5|Overall Study|Lost to Follow-up|1
356799|NCT00425373|1153983|P4|Overall Study|Lost to Follow-up|0
356800|NCT00425373|1153984|P3|Overall Study|Lost to Follow-up|0
356801|NCT00425373|1153985|P2|Overall Study|Lost to Follow-up|1
356802|NCT00425373|1153986|P1|Overall Study|Lost to Follow-up|0
356803|NCT00425373|1153978|P9|Overall Study|Adverse Event|8
356804|NCT00425373|1153979|P8|Overall Study|Adverse Event|3
356805|NCT00425373|1153980|P7|Overall Study|Adverse Event|2
356806|NCT00425373|1153981|P6|Overall Study|Adverse Event|6
356807|NCT00425373|1153982|P5|Overall Study|Adverse Event|4
356808|NCT00425373|1153983|P4|Overall Study|Adverse Event|1
356809|NCT00425373|1153984|P3|Overall Study|Adverse Event|0
356810|NCT00425373|1153985|P2|Overall Study|Adverse Event|2
356811|NCT00425373|1153986|P1|Overall Study|Adverse Event|2
356812|NCT00425308|1154044|P2|Overall Study|Death|0
356813|NCT00425308|1154045|P1|Overall Study|Death|1
356814|NCT00425308|1154044|P2|Overall Study|Withdrawal by Subject|0
356815|NCT00425308|1154045|P1|Overall Study|Withdrawal by Subject|1
356816|NCT00425308|1154044|P2|Overall Study|Adverse Event|1
356817|NCT00425308|1154045|P1|Overall Study|Adverse Event|2
356818|NCT00425269|1154075|P2|Overall Study|moved or medical reason|4
356819|NCT00425269|1154076|P1|Overall Study|moved or medical reason|5
356820|NCT00425269|1154075|P2|Overall Study|Lost to Follow-up|9
356821|NCT00425269|1154076|P1|Overall Study|Lost to Follow-up|9
356822|NCT00425269|1154075|P2|Overall Study|Pregnancy|7
356823|NCT00425269|1154076|P1|Overall Study|Pregnancy|5
356824|NCT00424827|1154152|P1|Overall Study|Adverse Event|1
356825|NCT00424775|1154160|P2|Overall Study|Lack of Efficacy|0
356826|NCT00424775|1154161|P1|Overall Study|Lack of Efficacy|1
356827|NCT00424775|1154160|P2|Overall Study|Adverse Event|0
356828|NCT00424775|1154161|P1|Overall Study|Adverse Event|2
356829|NCT00424762|1154171|P2|Overall Study|Lost to Follow-up|3
356830|NCT00424762|1154172|P1|Overall Study|Lost to Follow-up|2
356831|NCT00424762|1154171|P2|Overall Study|Withdrawal by Subject|19
356832|NCT00424762|1154172|P1|Overall Study|Withdrawal by Subject|18
356833|NCT00424749|1154182|P1|Overall Study|Withdrawal by Subject|1
356834|NCT00424645|1154189|P2|Overall Study|Death|0
356835|NCT00424645|1154190|P1|Overall Study|Death|1
356836|NCT00424632|1154198|P10|Overall Study|Unspecified|0
356837|NCT00424632|1154199|P9|Overall Study|Unspecified|1
356838|NCT00424632|1154200|P8|Overall Study|Unspecified|0
356839|NCT00424632|1154201|P7|Overall Study|Unspecified|0
356840|NCT00424632|1154202|P6|Overall Study|Unspecified|0
356841|NCT00424632|1154203|P5|Overall Study|Unspecified|0
356842|NCT00424632|1154204|P4|Overall Study|Unspecified|1
356843|NCT00424632|1154205|P3|Overall Study|Unspecified|0
356844|NCT00424632|1154206|P2|Overall Study|Unspecified|0
356845|NCT00424632|1154207|P1|Overall Study|Unspecified|0
356846|NCT00424632|1154198|P10|Overall Study|Objective progression or relapse|4
356847|NCT00424632|1154199|P9|Overall Study|Objective progression or relapse|12
356848|NCT00424632|1154200|P8|Overall Study|Objective progression or relapse|3
356849|NCT00424632|1154201|P7|Overall Study|Objective progression or relapse|7
356850|NCT00424632|1154202|P6|Overall Study|Objective progression or relapse|13
356851|NCT00424632|1154203|P5|Overall Study|Objective progression or relapse|2
356852|NCT00424632|1154204|P4|Overall Study|Objective progression or relapse|2
356853|NCT00424632|1154205|P3|Overall Study|Objective progression or relapse|1
356854|NCT00424632|1154206|P2|Overall Study|Objective progression or relapse|1
356855|NCT00424632|1154207|P1|Overall Study|Objective progression or relapse|1
356856|NCT00424632|1154198|P10|Overall Study|Global deterioration of health status|0
356857|NCT00424632|1154199|P9|Overall Study|Global deterioration of health status|0
356858|NCT00424632|1154200|P8|Overall Study|Global deterioration of health status|0
356859|NCT00424632|1154201|P7|Overall Study|Global deterioration of health status|0
356860|NCT00424632|1154202|P6|Overall Study|Global deterioration of health status|0
356861|NCT00424632|1154203|P5|Overall Study|Global deterioration of health status|1
356862|NCT00424632|1154204|P4|Overall Study|Global deterioration of health status|1
356863|NCT00424632|1154205|P3|Overall Study|Global deterioration of health status|0
356864|NCT00424632|1154206|P2|Overall Study|Global deterioration of health status|0
356865|NCT00424632|1154207|P1|Overall Study|Global deterioration of health status|0
356866|NCT00424632|1154198|P10|Overall Study|Adverse Event|2
356867|NCT00424632|1154199|P9|Overall Study|Adverse Event|3
356868|NCT00424632|1154200|P8|Overall Study|Adverse Event|0
356869|NCT00424632|1154201|P7|Overall Study|Adverse Event|0
356870|NCT00424632|1154202|P6|Overall Study|Adverse Event|0
356871|NCT00424632|1154203|P5|Overall Study|Adverse Event|0
356872|NCT00424632|1154204|P4|Overall Study|Adverse Event|0
356873|NCT00424632|1154205|P3|Overall Study|Adverse Event|0
356874|NCT00424632|1154206|P2|Overall Study|Adverse Event|0
356875|NCT00424632|1154207|P1|Overall Study|Adverse Event|0
356876|NCT00424632|1154198|P10|Overall Study|Death|0
356877|NCT00424632|1154199|P9|Overall Study|Death|0
356878|NCT00424632|1154200|P8|Overall Study|Death|0
356879|NCT00424632|1154201|P7|Overall Study|Death|0
356880|NCT00424632|1154202|P6|Overall Study|Death|2
356881|NCT00424632|1154203|P5|Overall Study|Death|0
356882|NCT00424632|1154204|P4|Overall Study|Death|0
356883|NCT00424632|1154205|P3|Overall Study|Death|0
356884|NCT00424632|1154206|P2|Overall Study|Death|0
356885|NCT00424632|1154207|P1|Overall Study|Death|0
356886|NCT00424593|1154377|P2|Dose-Blind Extension Period|Physician Decision|0
356887|NCT00424593|1154378|P1|Dose-Blind Extension Period|Physician Decision|3
356888|NCT00424593|1154377|P2|Dose-Blind Extension Period|Lost to Follow-up|0
356889|NCT00424593|1154378|P1|Dose-Blind Extension Period|Lost to Follow-up|6
356890|NCT00424593|1154377|P2|Dose-Blind Extension Period|Protocol Violation|0
356891|NCT00424593|1154378|P1|Dose-Blind Extension Period|Protocol Violation|9
356892|NCT00424593|1154377|P2|Dose-Blind Extension Period|Lack of Efficacy|0
356893|NCT00424593|1154378|P1|Dose-Blind Extension Period|Lack of Efficacy|9
356894|NCT00424593|1154377|P2|Dose-Blind Extension Period|Adverse Event|0
356895|NCT00424593|1154378|P1|Dose-Blind Extension Period|Adverse Event|18
356896|NCT00424593|1154377|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
356897|NCT00424593|1154378|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
356898|NCT00424593|1154377|P2|Acute Double-Blind Period|Lack of Efficacy|1
356899|NCT00424593|1154378|P1|Acute Double-Blind Period|Lack of Efficacy|0
356900|NCT00424593|1154377|P2|Acute Double-Blind Period|Lost to Follow-up|1
356901|NCT00424593|1154378|P1|Acute Double-Blind Period|Lost to Follow-up|1
356902|NCT00424593|1154377|P2|Acute Double-Blind Period|Physician Decision|2
356903|NCT00424593|1154378|P1|Acute Double-Blind Period|Physician Decision|1
356904|NCT00424593|1154377|P2|Acute Double-Blind Period|Protocol Violation|2
356905|NCT00424593|1154378|P1|Acute Double-Blind Period|Protocol Violation|2
356906|NCT00424593|1154377|P2|Acute Double-Blind Period|Withdrawal by Subject|10
356907|NCT00424593|1154378|P1|Acute Double-Blind Period|Withdrawal by Subject|11
356908|NCT00424593|1154377|P2|Acute Double-Blind Period|Adverse Event|7
356909|NCT00424593|1154378|P1|Acute Double-Blind Period|Adverse Event|16
356910|NCT00424528|1154442|P3|Overall Study|noncompliance with study requirements|2
356911|NCT00424528|1154443|P2|Overall Study|noncompliance with study requirements|1
356912|NCT00424528|1154444|P1|Overall Study|noncompliance with study requirements|2
356913|NCT00424528|1154442|P3|Overall Study|Lost to Follow-up|0
356914|NCT00424528|1154443|P2|Overall Study|Lost to Follow-up|1
356915|NCT00424528|1154444|P1|Overall Study|Lost to Follow-up|0
356916|NCT00424528|1154442|P3|Overall Study|Protocol Violation|0
356917|NCT00424528|1154443|P2|Overall Study|Protocol Violation|1
356918|NCT00424528|1154444|P1|Overall Study|Protocol Violation|1
356919|NCT00424528|1154442|P3|Overall Study|Adverse Event|2
356920|NCT00424528|1154443|P2|Overall Study|Adverse Event|1
356921|NCT00424528|1154444|P1|Overall Study|Adverse Event|2
356922|NCT00424515|1154499|P2|Overall Study|Withdrawal by Subject|0
356923|NCT00424515|1154500|P1|Overall Study|Withdrawal by Subject|1
356924|NCT00424515|1154499|P2|Overall Study|Intercurrent Illness|1
356925|NCT00424515|1154500|P1|Overall Study|Intercurrent Illness|0
356926|NCT00424515|1154499|P2|Overall Study|Adverse Event|1
356927|NCT00424515|1154500|P1|Overall Study|Adverse Event|0
356928|NCT00424515|1154499|P2|Overall Study|Progressive Disease|11
356929|NCT00424515|1154500|P1|Overall Study|Progressive Disease|10
356930|NCT00424476|1154522|P3|Overall Study|Other|9
356931|NCT00424476|1154523|P2|Overall Study|Other|3
356932|NCT00424476|1154524|P1|Overall Study|Other|4
356933|NCT00424476|1154522|P3|Overall Study|Physician Decision|3
356934|NCT00424476|1154523|P2|Overall Study|Physician Decision|2
356935|NCT00424476|1154524|P1|Overall Study|Physician Decision|3
356936|NCT00424476|1154522|P3|Overall Study|Protocol Violation|3
356937|NCT00424476|1154523|P2|Overall Study|Protocol Violation|2
356938|NCT00424476|1154524|P1|Overall Study|Protocol Violation|7
356939|NCT00424476|1154522|P3|Overall Study|Lost to Follow-up|3
356940|NCT00424476|1154523|P2|Overall Study|Lost to Follow-up|6
356941|NCT00424476|1154524|P1|Overall Study|Lost to Follow-up|4
356942|NCT00424476|1154522|P3|Overall Study|Lack of Compliance|1
356943|NCT00424476|1154523|P2|Overall Study|Lack of Compliance|1
356944|NCT00424476|1154524|P1|Overall Study|Lack of Compliance|1
356945|NCT00424476|1154522|P3|Overall Study|Lack of Efficacy|12
356946|NCT00424476|1154523|P2|Overall Study|Lack of Efficacy|12
356947|NCT00424476|1154524|P1|Overall Study|Lack of Efficacy|16
356948|NCT00424476|1154522|P3|Overall Study|Adverse Event|15
356949|NCT00424476|1154523|P2|Overall Study|Adverse Event|16
356950|NCT00424476|1154524|P1|Overall Study|Adverse Event|19
356951|NCT00424476|1154522|P3|Overall Study|Withdrawal by Subject|3
356952|NCT00424476|1154523|P2|Overall Study|Withdrawal by Subject|6
356953|NCT00424476|1154524|P1|Overall Study|Withdrawal by Subject|7
356954|NCT00424398|1154550|P3|Overall Study|Subject met exclusion criteria|0
356955|NCT00424398|1154551|P2|Overall Study|Subject met exclusion criteria|0
356956|NCT00424398|1154552|P1|Overall Study|Subject met exclusion criteria|1
356957|NCT00424398|1154550|P3|Overall Study|Withdrawal by Subject|0
356958|NCT00424398|1154551|P2|Overall Study|Withdrawal by Subject|1
356959|NCT00424398|1154552|P1|Overall Study|Withdrawal by Subject|2
356960|NCT00424385|1154596|P1|Cohort 1|Withdrawal by Subject|1
356961|NCT00424385|1154596|P1|Cohort 0|Physician Decision|1
356962|NCT00424385|1154596|P1|Cohort 0|Withdrawal by Subject|5
356963|NCT00424372|1154603|P1|Overall Study|Lack of Efficacy|6
356964|NCT00424372|1154603|P1|Overall Study|Protocol Violation|1
356965|NCT00424372|1154603|P1|Overall Study|Withdrawal by Subject|4
356966|NCT00424372|1154603|P1|Overall Study|Health deterioration|1
356967|NCT00424372|1154603|P1|Overall Study|Adverse Event|18
356968|NCT00424372|1154603|P1|Overall Study|Death|1
356969|NCT00424346|1154615|P4|Extension Phase|Protocol Violation|0
356970|NCT00424346|1154616|P3|Extension Phase|Protocol Violation|1
356971|NCT00424346|1154617|P2|Extension Phase|Protocol Violation|1
356972|NCT00424346|1154618|P1|Extension Phase|Protocol Violation|0
356973|NCT00424346|1154615|P4|Extension Phase|Death|1
356974|NCT00424346|1154616|P3|Extension Phase|Death|0
356975|NCT00424346|1154617|P2|Extension Phase|Death|0
356976|NCT00424346|1154618|P1|Extension Phase|Death|0
356977|NCT00424346|1154615|P4|Extension Phase|Administrative Problems|35
356978|NCT00424346|1154616|P3|Extension Phase|Administrative Problems|32
356979|NCT00424346|1154617|P2|Extension Phase|Administrative Problems|69
356980|NCT00424346|1154618|P1|Extension Phase|Administrative Problems|0
356981|NCT00424346|1154615|P4|Extension Phase|Lost to Follow-up|0
356982|NCT00424346|1154616|P3|Extension Phase|Lost to Follow-up|0
356983|NCT00424346|1154617|P2|Extension Phase|Lost to Follow-up|2
356984|NCT00424346|1154618|P1|Extension Phase|Lost to Follow-up|0
356985|NCT00424346|1154615|P4|Extension Phase|Withdrawal by Subject|4
356986|NCT00424346|1154616|P3|Extension Phase|Withdrawal by Subject|3
356987|NCT00424346|1154617|P2|Extension Phase|Withdrawal by Subject|5
356988|NCT00424346|1154618|P1|Extension Phase|Withdrawal by Subject|0
356989|NCT00424346|1154615|P4|Extension Phase|Lack of Efficacy|11
356990|NCT00424346|1154616|P3|Extension Phase|Lack of Efficacy|14
356991|NCT00424346|1154617|P2|Extension Phase|Lack of Efficacy|16
356992|NCT00424346|1154618|P1|Extension Phase|Lack of Efficacy|0
356993|NCT00424346|1154615|P4|Extension Phase|Adverse Event|4
356994|NCT00424346|1154616|P3|Extension Phase|Adverse Event|5
356995|NCT00424346|1154617|P2|Extension Phase|Adverse Event|9
356996|NCT00424346|1154618|P1|Extension Phase|Adverse Event|0
356997|NCT00424346|1154615|P4|Core Study|Protocol Violation|0
356998|NCT00424346|1154616|P3|Core Study|Protocol Violation|2
356999|NCT00424346|1154617|P2|Core Study|Protocol Violation|0
357000|NCT00424346|1154618|P1|Core Study|Protocol Violation|0
357001|NCT00424346|1154615|P4|Core Study|Administrative Problems|0
357002|NCT00424346|1154616|P3|Core Study|Administrative Problems|1
357003|NCT00424346|1154617|P2|Core Study|Administrative Problems|0
357004|NCT00424346|1154618|P1|Core Study|Administrative Problems|1
357005|NCT00424346|1154615|P4|Core Study|Lost to Follow-up|0
357006|NCT00424346|1154616|P3|Core Study|Lost to Follow-up|0
357007|NCT00424346|1154617|P2|Core Study|Lost to Follow-up|1
357008|NCT00424346|1154618|P1|Core Study|Lost to Follow-up|1
357009|NCT00424346|1154615|P4|Core Study|Withdrawal by Subject|2
357010|NCT00424346|1154616|P3|Core Study|Withdrawal by Subject|0
357011|NCT00424346|1154617|P2|Core Study|Withdrawal by Subject|0
357012|NCT00424346|1154618|P1|Core Study|Withdrawal by Subject|1
357013|NCT00424346|1154615|P4|Core Study|Lack of Efficacy|4
357014|NCT00424346|1154616|P3|Core Study|Lack of Efficacy|0
357015|NCT00424346|1154617|P2|Core Study|Lack of Efficacy|3
357016|NCT00424346|1154618|P1|Core Study|Lack of Efficacy|1
357017|NCT00424346|1154615|P4|Core Study|Abnormal Laboratory Values|0
357018|NCT00424346|1154616|P3|Core Study|Abnormal Laboratory Values|0
357019|NCT00424346|1154617|P2|Core Study|Abnormal Laboratory Values|1
357020|NCT00424346|1154618|P1|Core Study|Abnormal Laboratory Values|0
357021|NCT00424346|1154615|P4|Core Study|Adverse Event|1
357022|NCT00424346|1154616|P3|Core Study|Adverse Event|1
357023|NCT00424346|1154617|P2|Core Study|Adverse Event|3
357024|NCT00424346|1154618|P1|Core Study|Adverse Event|5
357025|NCT00424294|1154733|P2|Overall Study|Randomized but not Treated|0
357026|NCT00424294|1154734|P1|Overall Study|Randomized but not Treated|1
357027|NCT00424294|1154733|P2|Overall Study|Unspecified|2
357028|NCT00424294|1154734|P1|Overall Study|Unspecified|0
357029|NCT00424294|1154733|P2|Overall Study|Withdrawal by Subject|2
357030|NCT00424294|1154734|P1|Overall Study|Withdrawal by Subject|1
357031|NCT00424294|1154733|P2|Overall Study|Lack of Efficacy|1
357032|NCT00424294|1154734|P1|Overall Study|Lack of Efficacy|2
357033|NCT00424294|1154733|P2|Overall Study|Adverse Event|10
357034|NCT00424294|1154734|P1|Overall Study|Adverse Event|4
357035|NCT00424255|1154801|P2|Overall Study|Sponsor Terminated Study|167
357036|NCT00424255|1154802|P1|Overall Study|Sponsor Terminated Study|161
357037|NCT00424255|1154801|P2|Overall Study|Disease Progression|2
357038|NCT00424255|1154802|P1|Overall Study|Disease Progression|0
357039|NCT00424255|1154801|P2|Overall Study|Fatigue|0
357040|NCT00424255|1154802|P1|Overall Study|Fatigue|1
357041|NCT00424255|1154801|P2|Overall Study|Non-compliance by Participants|0
357042|NCT00424255|1154802|P1|Overall Study|Non-compliance by Participants|1
357043|NCT00424255|1154801|P2|Overall Study|Cognitive Disturbance|0
357044|NCT00424255|1154802|P1|Overall Study|Cognitive Disturbance|1
357045|NCT00424255|1154801|P2|Overall Study|Physician Decision|7
357046|NCT00424255|1154802|P1|Overall Study|Physician Decision|3
357047|NCT00424255|1154801|P2|Overall Study|Withdrawal by Subject|38
357048|NCT00424255|1154802|P1|Overall Study|Withdrawal by Subject|34
357049|NCT00424255|1154801|P2|Overall Study|Protocol Violation|1
357050|NCT00424255|1154802|P1|Overall Study|Protocol Violation|0
357051|NCT00424255|1154801|P2|Overall Study|Lost to Follow-up|20
357052|NCT00424255|1154802|P1|Overall Study|Lost to Follow-up|26
357053|NCT00424255|1154801|P2|Overall Study|Death|111
357054|NCT00424255|1154802|P1|Overall Study|Death|115
357055|NCT00424190|1154850|P2|Overall Study|Other|21
357056|NCT00424190|1154851|P1|Overall Study|Other|15
357057|NCT00424190|1154850|P2|Overall Study|Diagnosis of osteomyelitis|1
357058|NCT00424190|1154851|P1|Overall Study|Diagnosis of osteomyelitis|0
357059|NCT00424190|1154850|P2|Overall Study|Request of sponsor or investigator|2
357060|NCT00424190|1154851|P1|Overall Study|Request of sponsor or investigator|0
357061|NCT00424190|1154850|P2|Overall Study|Noncompliance|2
357062|NCT00424190|1154851|P1|Overall Study|Noncompliance|1
357063|NCT00424190|1154850|P2|Overall Study|Death|0
357064|NCT00424190|1154851|P1|Overall Study|Death|3
357065|NCT00424190|1154850|P2|Overall Study|Withdrew consent|4
357066|NCT00424190|1154851|P1|Overall Study|Withdrew consent|3
357067|NCT00424177|1154857|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
357068|NCT00424177|1154857|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
357069|NCT00424177|1154857|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
357070|NCT00424177|1154857|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
357071|NCT00424177|1154857|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
357072|NCT00424177|1154857|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
357073|NCT00424177|1154857|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
357074|NCT00424177|1154857|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
357075|NCT00424177|1154857|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
357076|NCT00424177|1154857|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
357077|NCT00424047|1154886|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
357078|NCT00424047|1154887|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
357079|NCT00424047|1154886|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
357080|NCT00424047|1154887|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
357081|NCT00424047|1154886|P2|Long Term Extension (Up to 25 Jun 2013)|Unspecified|4
357082|NCT00424047|1154887|P1|Long Term Extension (Up to 25 Jun 2013)|Unspecified|12
357083|NCT00424047|1154886|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
357084|NCT00424047|1154887|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
357085|NCT00424047|1154886|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
357086|NCT00424047|1154887|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
357087|NCT00424047|1154886|P2|On Study at Time of Unblinding|Unspecified|4
357088|NCT00424047|1154887|P1|On Study at Time of Unblinding|Unspecified|5
357089|NCT00424047|1154886|P2|On Study at Time of Unblinding|Death|11
357090|NCT00424047|1154887|P1|On Study at Time of Unblinding|Death|11
357091|NCT00424047|1154886|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
357092|NCT00424047|1154887|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
357093|NCT00424047|1154886|P2|On Study at Time of Unblinding|Lack of Efficacy|3
357094|NCT00424047|1154887|P1|On Study at Time of Unblinding|Lack of Efficacy|1
357095|NCT00424047|1154886|P2|On Study at Time of Unblinding|Progression of disease|128
357096|NCT00424047|1154887|P1|On Study at Time of Unblinding|Progression of disease|92
357097|NCT00424047|1154886|P2|On Study at Time of Unblinding|Adverse Event|12
357098|NCT00424047|1154887|P1|On Study at Time of Unblinding|Adverse Event|22
357182|NCT00423891|1154994|P1|Enrolled|Lost to Follow-up|0
357099|NCT00424047|1154886|P2|Blinded Treatment (Up to 03 Aug 2005)|Unspecified|1
357100|NCT00424047|1154887|P1|Blinded Treatment (Up to 03 Aug 2005)|Unspecified|2
357101|NCT00424047|1154886|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
357102|NCT00424047|1154887|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
357103|NCT00424047|1154886|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
357104|NCT00424047|1154887|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
357105|NCT00424047|1154886|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
357106|NCT00424047|1154887|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
357107|NCT00424047|1154886|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
357108|NCT00424047|1154887|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
357109|NCT00424047|1154886|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
357110|NCT00424047|1154887|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
357111|NCT00424021|1154919|P4|AMB-220-E Study Period|Physician Decision|1
357112|NCT00424021|1154920|P3|AMB-220-E Study Period|Physician Decision|0
357113|NCT00424021|1154921|P2|AMB-220-E Study Period|Physician Decision|0
357114|NCT00424021|1154922|P1|AMB-220-E Study Period|Physician Decision|0
357115|NCT00424021|1154919|P4|AMB-220-E Study Period|Lost to Follow-up|1
357116|NCT00424021|1154920|P3|AMB-220-E Study Period|Lost to Follow-up|1
357117|NCT00424021|1154921|P2|AMB-220-E Study Period|Lost to Follow-up|1
357118|NCT00424021|1154922|P1|AMB-220-E Study Period|Lost to Follow-up|0
357119|NCT00424021|1154919|P4|AMB-220-E Study Period|Death|1
357120|NCT00424021|1154920|P3|AMB-220-E Study Period|Death|1
357121|NCT00424021|1154921|P2|AMB-220-E Study Period|Death|0
357122|NCT00424021|1154922|P1|AMB-220-E Study Period|Death|0
357123|NCT00424021|1154919|P4|AMB-220-E Study Period|Adverse Event|7
357124|NCT00424021|1154920|P3|AMB-220-E Study Period|Adverse Event|3
357125|NCT00424021|1154921|P2|AMB-220-E Study Period|Adverse Event|1
357126|NCT00424021|1154922|P1|AMB-220-E Study Period|Adverse Event|1
357127|NCT00424021|1154919|P4|NCT00046319 Study Period|Lost to Follow-up|0
357128|NCT00424021|1154920|P3|NCT00046319 Study Period|Lost to Follow-up|0
357129|NCT00424021|1154921|P2|NCT00046319 Study Period|Lost to Follow-up|1
357130|NCT00424021|1154922|P1|NCT00046319 Study Period|Lost to Follow-up|0
357131|NCT00424021|1154919|P4|NCT00046319 Study Period|Sponsor discretion|0
357132|NCT00424021|1154920|P3|NCT00046319 Study Period|Sponsor discretion|0
357133|NCT00424021|1154921|P2|NCT00046319 Study Period|Sponsor discretion|1
357134|NCT00424021|1154922|P1|NCT00046319 Study Period|Sponsor discretion|0
357135|NCT00424021|1154919|P4|NCT00046319 Study Period|Withdrawal by Subject|0
357136|NCT00424021|1154920|P3|NCT00046319 Study Period|Withdrawal by Subject|0
357137|NCT00424021|1154921|P2|NCT00046319 Study Period|Withdrawal by Subject|1
357138|NCT00424021|1154922|P1|NCT00046319 Study Period|Withdrawal by Subject|0
357139|NCT00424021|1154919|P4|NCT00046319 Study Period|Adverse Event|1
357140|NCT00424021|1154920|P3|NCT00046319 Study Period|Adverse Event|1
357141|NCT00424021|1154921|P2|NCT00046319 Study Period|Adverse Event|0
357142|NCT00424021|1154922|P1|NCT00046319 Study Period|Adverse Event|1
357143|NCT00424008|1154965|P2|Overall Study|Administrative|257
357144|NCT00424008|1154966|P1|Overall Study|Administrative|266
357145|NCT00424008|1154965|P2|Overall Study|Did not meet protocol eligibility|21
357146|NCT00424008|1154966|P1|Overall Study|Did not meet protocol eligibility|16
357147|NCT00424008|1154965|P2|Overall Study|Noncompliance with protocol|7
357148|NCT00424008|1154966|P1|Overall Study|Noncompliance with protocol|13
357149|NCT00424008|1154965|P2|Overall Study|Withdrawal by Subject|8
357150|NCT00424008|1154966|P1|Overall Study|Withdrawal by Subject|5
357151|NCT00424008|1154965|P2|Overall Study|Lost to Follow-up|2
357152|NCT00424008|1154966|P1|Overall Study|Lost to Follow-up|1
357153|NCT00424008|1154965|P2|Overall Study|Lack of Efficacy|34
357154|NCT00424008|1154966|P1|Overall Study|Lack of Efficacy|40
357155|NCT00424008|1154965|P2|Overall Study|Adverse Event|6
357156|NCT00424008|1154966|P1|Overall Study|Adverse Event|8
357157|NCT00423917|1154979|P1|Overall Study|Ineligible|1
357158|NCT00423917|1154979|P1|Overall Study|Cancel|2
357159|NCT00423891|1154992|P3|Post-Dosing Follow Up|Continuing Post Dosing Follow up|1
357160|NCT00423891|1154993|P2|Post-Dosing Follow Up|Continuing Post Dosing Follow up|15
357161|NCT00423891|1154994|P1|Post-Dosing Follow Up|Continuing Post Dosing Follow up|0
357162|NCT00423891|1154992|P3|Post-Dosing Follow Up|Lost to Follow-up|0
357163|NCT00423891|1154993|P2|Post-Dosing Follow Up|Lost to Follow-up|0
357164|NCT00423891|1154994|P1|Post-Dosing Follow Up|Lost to Follow-up|2
357165|NCT00423891|1154992|P3|Post-Dosing Follow Up|Withdrawal by Subject|0
357166|NCT00423891|1154993|P2|Post-Dosing Follow Up|Withdrawal by Subject|2
357167|NCT00423891|1154994|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
357168|NCT00423891|1154992|P3|Treatment|continuing treatment|4
357169|NCT00423891|1154993|P2|Treatment|continuing treatment|0
357170|NCT00423891|1154994|P1|Treatment|continuing treatment|0
357171|NCT00423891|1154992|P3|Treatment|Lost to Follow-up|0
357172|NCT00423891|1154993|P2|Treatment|Lost to Follow-up|0
357173|NCT00423891|1154994|P1|Treatment|Lost to Follow-up|1
357174|NCT00423891|1154992|P3|Treatment|Withdrawal by Subject|0
357175|NCT00423891|1154993|P2|Treatment|Withdrawal by Subject|0
357176|NCT00423891|1154994|P1|Treatment|Withdrawal by Subject|1
357177|NCT00423891|1154992|P3|Enrolled|No longer met criteria|1
357178|NCT00423891|1154993|P2|Enrolled|No longer met criteria|2
357179|NCT00423891|1154994|P1|Enrolled|No longer met criteria|11
357180|NCT00423891|1154992|P3|Enrolled|Lost to Follow-up|1
357181|NCT00423891|1154993|P2|Enrolled|Lost to Follow-up|0
357183|NCT00423891|1154992|P3|Enrolled|Withdrawal by Subject|1
357184|NCT00423891|1154993|P2|Enrolled|Withdrawal by Subject|0
357185|NCT00423891|1154994|P1|Enrolled|Withdrawal by Subject|0
357186|NCT00423852|1155072|P1|Overall Study|Removed pior to the high-dose portion|3
357187|NCT00423813|1155080|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
357188|NCT00423813|1155081|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
357189|NCT00423813|1155082|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
357190|NCT00423813|1155080|P3|Overall Study|Will start exclusionary medications|0
357191|NCT00423813|1155081|P2|Overall Study|Will start exclusionary medications|1
357192|NCT00423813|1155082|P1|Overall Study|Will start exclusionary medications|0
357193|NCT00423813|1155080|P3|Overall Study|Subject started night shift work|0
357194|NCT00423813|1155081|P2|Overall Study|Subject started night shift work|0
357195|NCT00423813|1155082|P1|Overall Study|Subject started night shift work|1
357196|NCT00423813|1155080|P3|Overall Study|Pregnancy|1
357197|NCT00423813|1155081|P2|Overall Study|Pregnancy|0
357198|NCT00423813|1155082|P1|Overall Study|Pregnancy|0
357199|NCT00423813|1155080|P3|Overall Study|Protocol Violation|4
357200|NCT00423813|1155081|P2|Overall Study|Protocol Violation|4
357201|NCT00423813|1155082|P1|Overall Study|Protocol Violation|9
357202|NCT00423813|1155080|P3|Overall Study|Sponsor Decision|0
357203|NCT00423813|1155081|P2|Overall Study|Sponsor Decision|1
357204|NCT00423813|1155082|P1|Overall Study|Sponsor Decision|0
357205|NCT00423813|1155080|P3|Overall Study|Physician Decision|0
357206|NCT00423813|1155081|P2|Overall Study|Physician Decision|0
357207|NCT00423813|1155082|P1|Overall Study|Physician Decision|2
357208|NCT00423813|1155080|P3|Overall Study|Lack of Efficacy|19
357209|NCT00423813|1155081|P2|Overall Study|Lack of Efficacy|18
357210|NCT00423813|1155082|P1|Overall Study|Lack of Efficacy|23
357211|NCT00423813|1155080|P3|Overall Study|Lost to Follow-up|4
357212|NCT00423813|1155081|P2|Overall Study|Lost to Follow-up|4
357213|NCT00423813|1155082|P1|Overall Study|Lost to Follow-up|5
357214|NCT00423813|1155080|P3|Overall Study|Withdrawal by Subject|5
357215|NCT00423813|1155081|P2|Overall Study|Withdrawal by Subject|8
357216|NCT00423813|1155082|P1|Overall Study|Withdrawal by Subject|6
357217|NCT00423813|1155080|P3|Overall Study|Adverse Event|40
357218|NCT00423813|1155081|P2|Overall Study|Adverse Event|30
357219|NCT00423813|1155082|P1|Overall Study|Adverse Event|11
357220|NCT00423800|1155092|P2|Overall Study|Protocol Violation|1
357221|NCT00423800|1155093|P1|Overall Study|Protocol Violation|0
357222|NCT00423735|1155105|P3|Overall Study|Ineligible / No protocol treatment|0
357223|NCT00423735|1155106|P2|Overall Study|Ineligible / No protocol treatment|6
357224|NCT00423735|1155107|P1|Overall Study|Ineligible / No protocol treatment|8
357225|NCT00423722|1155130|P2|Overall Study|Withdrawal by Subject|2
357226|NCT00423722|1155131|P1|Overall Study|Withdrawal by Subject|4
357227|NCT00423722|1155130|P2|Overall Study|Unable to complete questionnaires|4
357228|NCT00423722|1155131|P1|Overall Study|Unable to complete questionnaires|4
357229|NCT00423722|1155130|P2|Overall Study|Declined to participate|3
357230|NCT00423722|1155131|P1|Overall Study|Declined to participate|2
357231|NCT00423722|1155130|P2|Overall Study|Death|4
357232|NCT00423722|1155131|P1|Overall Study|Death|4
357233|NCT00423670|1155173|P8|Follow-up Period|Non-compliance with protocol|2
357234|NCT00423670|1155174|P7|Follow-up Period|Non-compliance with protocol|3
357235|NCT00423670|1155175|P6|Follow-up Period|Non-compliance with protocol|0
357236|NCT00423670|1155176|P5|Follow-up Period|Non-compliance with protocol|0
357237|NCT00423670|1155177|P4|Follow-up Period|Non-compliance with protocol|1
357238|NCT00423670|1155178|P3|Follow-up Period|Non-compliance with protocol|1
357239|NCT00423670|1155179|P2|Follow-up Period|Non-compliance with protocol|0
357240|NCT00423670|1155180|P1|Follow-up Period|Non-compliance with protocol|2
357241|NCT00423670|1155173|P8|Follow-up Period|Subject withdrew (not treatment related)|1
357242|NCT00423670|1155174|P7|Follow-up Period|Subject withdrew (not treatment related)|1
357243|NCT00423670|1155175|P6|Follow-up Period|Subject withdrew (not treatment related)|0
357244|NCT00423670|1155176|P5|Follow-up Period|Subject withdrew (not treatment related)|1
357245|NCT00423670|1155177|P4|Follow-up Period|Subject withdrew (not treatment related)|1
357246|NCT00423670|1155178|P3|Follow-up Period|Subject withdrew (not treatment related)|2
357247|NCT00423670|1155179|P2|Follow-up Period|Subject withdrew (not treatment related)|4
357248|NCT00423670|1155180|P1|Follow-up Period|Subject withdrew (not treatment related)|1
357249|NCT00423670|1155173|P8|Follow-up Period|Lost to Follow-up|0
357250|NCT00423670|1155174|P7|Follow-up Period|Lost to Follow-up|5
357251|NCT00423670|1155175|P6|Follow-up Period|Lost to Follow-up|0
357252|NCT00423670|1155176|P5|Follow-up Period|Lost to Follow-up|1
357253|NCT00423670|1155177|P4|Follow-up Period|Lost to Follow-up|3
357254|NCT00423670|1155178|P3|Follow-up Period|Lost to Follow-up|8
357255|NCT00423670|1155179|P2|Follow-up Period|Lost to Follow-up|12
357256|NCT00423670|1155180|P1|Follow-up Period|Lost to Follow-up|0
357257|NCT00423670|1155173|P8|Treatment Period|Non-compliance with protocol|2
357258|NCT00423670|1155174|P7|Treatment Period|Non-compliance with protocol|2
357259|NCT00423670|1155175|P6|Treatment Period|Non-compliance with protocol|0
357260|NCT00423670|1155176|P5|Treatment Period|Non-compliance with protocol|2
357261|NCT00423670|1155177|P4|Treatment Period|Non-compliance with protocol|3
357262|NCT00423670|1155178|P3|Treatment Period|Non-compliance with protocol|1
357263|NCT00423670|1155179|P2|Treatment Period|Non-compliance with protocol|1
357264|NCT00423670|1155180|P1|Treatment Period|Non-compliance with protocol|3
357265|NCT00423670|1155173|P8|Treatment Period|Investigator decision|1
357266|NCT00423670|1155174|P7|Treatment Period|Investigator decision|0
357267|NCT00423670|1155175|P6|Treatment Period|Investigator decision|0
357268|NCT00423670|1155176|P5|Treatment Period|Investigator decision|0
357269|NCT00423670|1155177|P4|Treatment Period|Investigator decision|0
357270|NCT00423670|1155178|P3|Treatment Period|Investigator decision|0
357271|NCT00423670|1155179|P2|Treatment Period|Investigator decision|0
357272|NCT00423670|1155180|P1|Treatment Period|Investigator decision|0
357273|NCT00423670|1155173|P8|Treatment Period|Subject withdrew (not treatment related)|0
357274|NCT00423670|1155174|P7|Treatment Period|Subject withdrew (not treatment related)|3
357275|NCT00423670|1155175|P6|Treatment Period|Subject withdrew (not treatment related)|0
357276|NCT00423670|1155176|P5|Treatment Period|Subject withdrew (not treatment related)|5
357277|NCT00423670|1155177|P4|Treatment Period|Subject withdrew (not treatment related)|4
357278|NCT00423670|1155178|P3|Treatment Period|Subject withdrew (not treatment related)|4
357279|NCT00423670|1155179|P2|Treatment Period|Subject withdrew (not treatment related)|9
357280|NCT00423670|1155180|P1|Treatment Period|Subject withdrew (not treatment related)|3
357281|NCT00423670|1155173|P8|Treatment Period|Lost to Follow-up|1
357282|NCT00423670|1155174|P7|Treatment Period|Lost to Follow-up|3
357283|NCT00423670|1155175|P6|Treatment Period|Lost to Follow-up|0
357284|NCT00423670|1155176|P5|Treatment Period|Lost to Follow-up|6
357285|NCT00423670|1155177|P4|Treatment Period|Lost to Follow-up|1
357286|NCT00423670|1155178|P3|Treatment Period|Lost to Follow-up|3
357287|NCT00423670|1155179|P2|Treatment Period|Lost to Follow-up|1
357288|NCT00423670|1155180|P1|Treatment Period|Lost to Follow-up|2
357289|NCT00423670|1155173|P8|Treatment Period|Protocol-defined clinical event|15
357290|NCT00423670|1155174|P7|Treatment Period|Protocol-defined clinical event|16
357291|NCT00423670|1155175|P6|Treatment Period|Protocol-defined clinical event|4
357292|NCT00423670|1155176|P5|Treatment Period|Protocol-defined clinical event|5
357293|NCT00423670|1155177|P4|Treatment Period|Protocol-defined clinical event|12
357294|NCT00423670|1155178|P3|Treatment Period|Protocol-defined clinical event|4
357295|NCT00423670|1155179|P2|Treatment Period|Protocol-defined clinical event|7
357296|NCT00423670|1155180|P1|Treatment Period|Protocol-defined clinical event|0
357297|NCT00423670|1155173|P8|Treatment Period|Adverse Event|2
357298|NCT00423670|1155174|P7|Treatment Period|Adverse Event|7
357299|NCT00423670|1155175|P6|Treatment Period|Adverse Event|4
357300|NCT00423670|1155176|P5|Treatment Period|Adverse Event|9
357301|NCT00423670|1155177|P4|Treatment Period|Adverse Event|20
357302|NCT00423670|1155178|P3|Treatment Period|Adverse Event|15
357303|NCT00423670|1155179|P2|Treatment Period|Adverse Event|12
357304|NCT00423670|1155180|P1|Treatment Period|Adverse Event|8
357305|NCT00423670|1155173|P8|Treatment Period|Switched to Arm 8 at TW 24|0
357306|NCT00423670|1155174|P7|Treatment Period|Switched to Arm 8 at TW 24|0
357307|NCT00423670|1155175|P6|Treatment Period|Switched to Arm 8 at TW 24|0
357308|NCT00423670|1155176|P5|Treatment Period|Switched to Arm 8 at TW 24|0
357309|NCT00423670|1155177|P4|Treatment Period|Switched to Arm 8 at TW 24|0
357310|NCT00423670|1155178|P3|Treatment Period|Switched to Arm 8 at TW 24|0
357311|NCT00423670|1155179|P2|Treatment Period|Switched to Arm 8 at TW 24|0
357312|NCT00423670|1155180|P1|Treatment Period|Switched to Arm 8 at TW 24|36
357313|NCT00423657|1155238|P2|Overall Study|Request of sponsor/investigator|0
357314|NCT00423657|1155239|P1|Overall Study|Request of sponsor/investigator|1
357315|NCT00423657|1155238|P2|Overall Study|Other|16
357316|NCT00423657|1155239|P1|Overall Study|Other|15
357317|NCT00423657|1155238|P2|Overall Study|Non-compliance|1
357318|NCT00423657|1155239|P1|Overall Study|Non-compliance|0
357319|NCT00423657|1155238|P2|Overall Study|Withdrew consent|8
357320|NCT00423657|1155239|P1|Overall Study|Withdrew consent|10
357321|NCT00423605|1155245|P1|Overall Study|Not one of the pre-specified options|5
357322|NCT00423605|1155245|P1|Overall Study|Protocol Violation|7
357323|NCT00423605|1155245|P1|Overall Study|Physician Decision|8
357324|NCT00423605|1155245|P1|Overall Study|Sponsor Decision|3
357325|NCT00423605|1155245|P1|Overall Study|Lack of Efficacy|38
357326|NCT00423605|1155245|P1|Overall Study|Lost to Follow-up|15
357327|NCT00423605|1155245|P1|Overall Study|Withdrawal by Subject|36
357328|NCT00423605|1155245|P1|Overall Study|Adverse Event|129
357329|NCT00423592|1155249|P1|Overall Study|Adverse Event (post Week 12)|5
357330|NCT00423592|1155249|P1|Overall Study|Adverse Event (through Week 12)|2
357331|NCT00423579|1155270|P2|Overall Study|Diagnosis of diabetes|1
357332|NCT00423579|1155271|P1|Overall Study|Diagnosis of diabetes|0
357333|NCT00423579|1155270|P2|Overall Study|Protocol Violation|3
357334|NCT00423579|1155271|P1|Overall Study|Protocol Violation|1
357335|NCT00423579|1155270|P2|Overall Study|Lost to Follow-up|0
357336|NCT00423579|1155271|P1|Overall Study|Lost to Follow-up|3
357337|NCT00423488|1155279|P2|Overall Study|No post baseline data|0
357338|NCT00423488|1155280|P1|Overall Study|No post baseline data|3
357339|NCT00423488|1155279|P2|Overall Study|No evidence of study drug intake|1
357340|NCT00423488|1155280|P1|Overall Study|No evidence of study drug intake|2
357341|NCT00423449|1155286|P5|Overall Study|Protocol Violation|0
357342|NCT00423449|1155287|P4|Overall Study|Protocol Violation|1
357343|NCT00423449|1155288|P3|Overall Study|Protocol Violation|2
357344|NCT00423449|1155289|P2|Overall Study|Protocol Violation|0
357345|NCT00423449|1155290|P1|Overall Study|Protocol Violation|0
357346|NCT00423449|1155286|P5|Overall Study|Not Specified|0
357347|NCT00423449|1155287|P4|Overall Study|Not Specified|1
357348|NCT00423449|1155288|P3|Overall Study|Not Specified|0
357349|NCT00423449|1155289|P2|Overall Study|Not Specified|0
357350|NCT00423449|1155290|P1|Overall Study|Not Specified|0
357351|NCT00423449|1155286|P5|Overall Study|Laboratory Adverse Event|0
357352|NCT00423449|1155287|P4|Overall Study|Laboratory Adverse Event|0
357353|NCT00423449|1155288|P3|Overall Study|Laboratory Adverse Event|2
357354|NCT00423449|1155289|P2|Overall Study|Laboratory Adverse Event|1
357355|NCT00423449|1155290|P1|Overall Study|Laboratory Adverse Event|0
357356|NCT00423449|1155286|P5|Overall Study|Progressive Disease|4
357357|NCT00423449|1155287|P4|Overall Study|Progressive Disease|11
357358|NCT00423449|1155288|P3|Overall Study|Progressive Disease|8
357359|NCT00423449|1155289|P2|Overall Study|Progressive Disease|3
357360|NCT00423449|1155290|P1|Overall Study|Progressive Disease|1
357361|NCT00423449|1155286|P5|Overall Study|Death|1
357362|NCT00423449|1155287|P4|Overall Study|Death|1
357363|NCT00423449|1155288|P3|Overall Study|Death|2
357364|NCT00423449|1155289|P2|Overall Study|Death|0
357365|NCT00423449|1155290|P1|Overall Study|Death|1
357366|NCT00423449|1155286|P5|Overall Study|Clinical Adverse Event|2
357367|NCT00423449|1155287|P4|Overall Study|Clinical Adverse Event|8
357368|NCT00423449|1155288|P3|Overall Study|Clinical Adverse Event|1
357369|NCT00423449|1155289|P2|Overall Study|Clinical Adverse Event|0
357370|NCT00423449|1155290|P1|Overall Study|Clinical Adverse Event|1
357371|NCT00423332|1155337|P2|Overall Study|Unblinded before 12 weeks|3
357372|NCT00423332|1155338|P1|Overall Study|Unblinded before 12 weeks|1
357373|NCT00423332|1155337|P2|Overall Study|Progressive at Week 6|1
357374|NCT00423332|1155338|P1|Overall Study|Progressive at Week 6|0
357375|NCT00423332|1155337|P2|Overall Study|Condition under investigation worsened|1
357376|NCT00423332|1155338|P1|Overall Study|Condition under investigation worsened|1
357377|NCT00423332|1155337|P2|Overall Study|Withdrawal by Subject|0
357378|NCT00423332|1155338|P1|Overall Study|Withdrawal by Subject|1
357379|NCT00423332|1155337|P2|Overall Study|Adverse Event|2
357380|NCT00423332|1155338|P1|Overall Study|Adverse Event|6
357381|NCT00423319|1155357|P2|Overall Study|Not specified|22
357382|NCT00423319|1155358|P1|Overall Study|Not specified|23
357383|NCT00423319|1155357|P2|Overall Study|No longer meets study criteria|15
357384|NCT00423319|1155358|P1|Overall Study|No longer meets study criteria|15
357385|NCT00423319|1155357|P2|Overall Study|Poor compliance or noncompliance|1
357386|NCT00423319|1155358|P1|Overall Study|Poor compliance or noncompliance|1
357387|NCT00423319|1155357|P2|Overall Study|Lost to Follow-up|3
357388|NCT00423319|1155358|P1|Overall Study|Lost to Follow-up|4
357389|NCT00423319|1155357|P2|Overall Study|Withdrawal by Subject|99
357390|NCT00423319|1155358|P1|Overall Study|Withdrawal by Subject|86
357391|NCT00423319|1155357|P2|Overall Study|Adverse Event|112
357392|NCT00423319|1155358|P1|Overall Study|Adverse Event|93
357393|NCT00423319|1155357|P2|Overall Study|Death|0
357394|NCT00423319|1155358|P1|Overall Study|Death|2
357395|NCT00423293|1155390|P1|Overall Study|Ineligible / No protocol treatment|11
357396|NCT00423267|1155396|P2|Period A|Administrative|0
357397|NCT00423267|1155397|P1|Period A|Administrative|1
357398|NCT00423267|1155396|P2|Period A|Non-compliance with protocol|0
357399|NCT00423267|1155397|P1|Period A|Non-compliance with protocol|1
357400|NCT00423267|1155396|P2|Period A|Withdrawal by Subject|1
357401|NCT00423267|1155397|P1|Period A|Withdrawal by Subject|0
357402|NCT00423189|1155417|P3|Overall Study|Death|0
357403|NCT00423189|1155418|P2|Overall Study|Death|1
357404|NCT00423189|1155419|P1|Overall Study|Death|0
357405|NCT00423176|1155441|P2|Overall Study|Did not meet protocol eligibility|4
357406|NCT00423176|1155442|P1|Overall Study|Did not meet protocol eligibility|2
357407|NCT00423176|1155441|P2|Overall Study|Protocol Violation|3
357408|NCT00423176|1155442|P1|Overall Study|Protocol Violation|1
357409|NCT00423176|1155441|P2|Overall Study|Withdrawal by Subject|3
357410|NCT00423176|1155442|P1|Overall Study|Withdrawal by Subject|4
357411|NCT00423176|1155441|P2|Overall Study|Lost to Follow-up|7
357412|NCT00423176|1155442|P1|Overall Study|Lost to Follow-up|4
357413|NCT00423176|1155441|P2|Overall Study|Treatment Failure|6
357414|NCT00423176|1155442|P1|Overall Study|Treatment Failure|1
357415|NCT00423176|1155441|P2|Overall Study|Adverse Event|6
357416|NCT00423176|1155442|P1|Overall Study|Adverse Event|4
357417|NCT00423150|1155450|P1|Overall Study|Administrative|4
357418|NCT00423150|1155450|P1|Overall Study|Non-compliance with protocol|1
357419|NCT00423150|1155450|P1|Overall Study|Withdrawal by Subject|1
357420|NCT00423150|1155450|P1|Overall Study|Progression of disease being studied|69
357421|NCT00423150|1155450|P1|Overall Study|Adverse Event|11
357422|NCT00423098|1155456|P2|Overall Study|Death|0
357423|NCT00423098|1155457|P1|Overall Study|Death|2
357424|NCT00423098|1155456|P2|Overall Study|Administrative problems|1
357425|NCT00423098|1155457|P1|Overall Study|Administrative problems|0
357426|NCT00423098|1155456|P2|Overall Study|Unsatisfactory therapeutic effect|1
357427|NCT00423098|1155457|P1|Overall Study|Unsatisfactory therapeutic effect|0
357428|NCT00423098|1155456|P2|Overall Study|Adverse Event|2
357429|NCT00423098|1155457|P1|Overall Study|Adverse Event|1
357430|NCT00423085|1155484|P4|52-Week Open-Label Extension Phase|Death|2
357431|NCT00423085|1155485|P3|52-Week Open-Label Extension Phase|Death|0
357432|NCT00423085|1155486|P2|52-Week Open-Label Extension Phase|Death|0
357433|NCT00423085|1155487|P1|52-Week Open-Label Extension Phase|Death|0
357434|NCT00423085|1155484|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
357435|NCT00423085|1155485|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
357436|NCT00423085|1155486|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
357437|NCT00423085|1155487|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
357438|NCT00423085|1155484|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
357439|NCT00423085|1155485|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
357440|NCT00423085|1155486|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
357441|NCT00423085|1155487|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
357442|NCT00423085|1155484|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
357443|NCT00423085|1155485|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
357444|NCT00423085|1155486|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
357445|NCT00423085|1155487|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
357446|NCT00423085|1155484|P4|52-Week Open-Label Extension Phase|Adverse Event|97
357447|NCT00423085|1155485|P3|52-Week Open-Label Extension Phase|Adverse Event|0
357448|NCT00423085|1155486|P2|52-Week Open-Label Extension Phase|Adverse Event|0
357449|NCT00423085|1155487|P1|52-Week Open-Label Extension Phase|Adverse Event|0
357450|NCT00423085|1155484|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
357451|NCT00423085|1155485|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
357452|NCT00423085|1155486|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
357453|NCT00423085|1155487|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
357454|NCT00423085|1155484|P4|24-Week Double-Blind Treatment Phase|Death|0
357455|NCT00423085|1155485|P3|24-Week Double-Blind Treatment Phase|Death|0
357456|NCT00423085|1155486|P2|24-Week Double-Blind Treatment Phase|Death|1
357457|NCT00423085|1155487|P1|24-Week Double-Blind Treatment Phase|Death|1
357458|NCT00423085|1155484|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
357459|NCT00423085|1155485|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
357460|NCT00423085|1155486|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
357461|NCT00423085|1155487|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
357462|NCT00423085|1155484|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
357463|NCT00423085|1155485|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
357464|NCT00423085|1155486|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
357465|NCT00423085|1155487|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
357466|NCT00423085|1155484|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
357467|NCT00423085|1155485|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
357468|NCT00423085|1155486|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
357469|NCT00423085|1155487|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
357470|NCT00423085|1155484|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
357471|NCT00423085|1155485|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
357472|NCT00423085|1155486|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
357473|NCT00423085|1155487|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
357474|NCT00423046|1155516|P2|Overall Study|Unspecified|345
357475|NCT00423046|1155517|P1|Overall Study|Unspecified|340
357476|NCT00422942|1155583|P1|Overall Study|Study terminated by Sponsor|3
357477|NCT00422903|1155602|P2|Overall Study|Informed Consent Withdrawn|2
357478|NCT00422903|1155603|P1|Overall Study|Informed Consent Withdrawn|1
357479|NCT00422903|1155602|P2|Overall Study|Adverse Event|2
357480|NCT00422903|1155603|P1|Overall Study|Adverse Event|0
357481|NCT00422903|1155602|P2|Overall Study|Disease Progression|1
357482|NCT00422903|1155603|P1|Overall Study|Disease Progression|3
357483|NCT00421733|1155630|P3|Overall Study|Protocol deviation|2
357484|NCT00421733|1155631|P2|Overall Study|Protocol deviation|7
357485|NCT00421733|1155632|P1|Overall Study|Protocol deviation|4
357486|NCT00421733|1155630|P3|Overall Study|Sponsor request|3
357487|NCT00421733|1155631|P2|Overall Study|Sponsor request|0
357488|NCT00421733|1155632|P1|Overall Study|Sponsor request|1
357489|NCT00421733|1155630|P3|Overall Study|Did not satisfy entry criteria|2
357490|NCT00421733|1155631|P2|Overall Study|Did not satisfy entry criteria|3
357491|NCT00421733|1155632|P1|Overall Study|Did not satisfy entry criteria|1
357492|NCT00421733|1155630|P3|Overall Study|Administrative|0
357493|NCT00421733|1155631|P2|Overall Study|Administrative|0
357494|NCT00421733|1155632|P1|Overall Study|Administrative|2
357495|NCT00421733|1155630|P3|Overall Study|Required dialysis|0
357496|NCT00421733|1155631|P2|Overall Study|Required dialysis|0
357497|NCT00421733|1155632|P1|Overall Study|Required dialysis|1
357498|NCT00421733|1155630|P3|Overall Study|Death|0
357499|NCT00421733|1155631|P2|Overall Study|Death|3
357500|NCT00421733|1155632|P1|Overall Study|Death|0
357501|NCT00421733|1155630|P3|Overall Study|Withdrawal by Subject|7
357502|NCT00421733|1155631|P2|Overall Study|Withdrawal by Subject|2
357503|NCT00421733|1155632|P1|Overall Study|Withdrawal by Subject|1
357504|NCT00421733|1155630|P3|Overall Study|Lost to Follow-up|4
357505|NCT00421733|1155631|P2|Overall Study|Lost to Follow-up|2
357506|NCT00421733|1155632|P1|Overall Study|Lost to Follow-up|1
357507|NCT00421733|1155630|P3|Overall Study|Adverse Event|2
357508|NCT00421733|1155631|P2|Overall Study|Adverse Event|9
357509|NCT00421733|1155632|P1|Overall Study|Adverse Event|4
357510|NCT00422734|1155652|P2|Overall Study|Partner Decision|3
357511|NCT00422734|1155653|P1|Overall Study|Partner Decision|0
357512|NCT00422734|1155652|P2|Overall Study|Adverse Event|3
357513|NCT00422734|1155653|P1|Overall Study|Adverse Event|0
357514|NCT00422734|1155652|P2|Overall Study|Withdrawal by Subject|8
357515|NCT00422734|1155653|P1|Overall Study|Withdrawal by Subject|12
357516|NCT00422734|1155652|P2|Overall Study|Protocol Violation|6
357517|NCT00422734|1155653|P1|Overall Study|Protocol Violation|1
357518|NCT00422734|1155652|P2|Overall Study|Physician Decision|1
357519|NCT00422734|1155653|P1|Overall Study|Physician Decision|1
357520|NCT00422669|1155699|P3|Overall Study|The study was terminated early.|7
357521|NCT00422669|1155700|P2|Overall Study|The study was terminated early.|100
357522|NCT00422669|1155701|P1|Overall Study|The study was terminated early.|98
357523|NCT00422513|1155728|P2|Overall Study|Death|7
357524|NCT00422513|1155729|P1|Overall Study|Death|3
357525|NCT00422513|1155728|P2|Overall Study|Adverse Event|4
357526|NCT00422513|1155729|P1|Overall Study|Adverse Event|4
357527|NCT00422513|1155728|P2|Overall Study|early termination of the study|80
357528|NCT00422513|1155729|P1|Overall Study|early termination of the study|67
357529|NCT00422513|1155728|P2|Overall Study|Withdrawal by Subject|1
357530|NCT00422513|1155729|P1|Overall Study|Withdrawal by Subject|2
357531|NCT00422513|1155728|P2|Overall Study|Refused Treatment|2
357532|NCT00422513|1155729|P1|Overall Study|Refused Treatment|4
357533|NCT00422513|1155728|P2|Overall Study|Protocol Violation|7
357534|NCT00422513|1155729|P1|Overall Study|Protocol Violation|23
357535|NCT00422513|1155728|P2|Overall Study|Lack of Efficacy|5
357536|NCT00422513|1155729|P1|Overall Study|Lack of Efficacy|4
357537|NCT00422422|1155746|P1|Overall Study|AE, non-serious non-fatal|5
357538|NCT00422422|1155746|P1|Overall Study|SAE, non-fatal|1
357539|NCT00422422|1155746|P1|Overall Study|Withdrawal by Subject|2
357540|NCT00422422|1155746|P1|Overall Study|Protocol Violation|1
357541|NCT00422422|1155746|P1|Overall Study|Lack of Efficacy|1
357542|NCT00422383|1155763|P5|Overall Study|Withdrawal by Subject|1
357543|NCT00422383|1155764|P4|Overall Study|Withdrawal by Subject|0
357544|NCT00422383|1155765|P3|Overall Study|Withdrawal by Subject|0
357545|NCT00422383|1155766|P2|Overall Study|Withdrawal by Subject|5
357546|NCT00422383|1155767|P1|Overall Study|Withdrawal by Subject|5
357547|NCT00422383|1155763|P5|Overall Study|Protocol Violation|0
357548|NCT00422383|1155764|P4|Overall Study|Protocol Violation|0
357549|NCT00422383|1155765|P3|Overall Study|Protocol Violation|1
357550|NCT00422383|1155766|P2|Overall Study|Protocol Violation|1
357551|NCT00422383|1155767|P1|Overall Study|Protocol Violation|1
357552|NCT00422383|1155763|P5|Overall Study|Lost to Follow-up|1
357553|NCT00422383|1155764|P4|Overall Study|Lost to Follow-up|0
357554|NCT00422383|1155765|P3|Overall Study|Lost to Follow-up|0
357555|NCT00422383|1155766|P2|Overall Study|Lost to Follow-up|1
357556|NCT00422383|1155767|P1|Overall Study|Lost to Follow-up|0
357557|NCT00422383|1155763|P5|Overall Study|Lack of Efficacy|1
357558|NCT00422383|1155764|P4|Overall Study|Lack of Efficacy|1
357559|NCT00422383|1155765|P3|Overall Study|Lack of Efficacy|2
357560|NCT00422383|1155766|P2|Overall Study|Lack of Efficacy|4
357561|NCT00422383|1155767|P1|Overall Study|Lack of Efficacy|4
357562|NCT00422383|1155763|P5|Overall Study|Adverse Event|0
357563|NCT00422383|1155764|P4|Overall Study|Adverse Event|1
357564|NCT00422383|1155765|P3|Overall Study|Adverse Event|1
357565|NCT00422383|1155766|P2|Overall Study|Adverse Event|3
357566|NCT00422383|1155767|P1|Overall Study|Adverse Event|5
357567|NCT00422292|1155910|P4|Overall Study|Withdrawal by Subject|13
357568|NCT00422292|1155911|P3|Overall Study|Withdrawal by Subject|7
357569|NCT00422292|1155912|P2|Overall Study|Withdrawal by Subject|25
357570|NCT00422292|1155913|P1|Overall Study|Withdrawal by Subject|6
357571|NCT00422292|1155910|P4|Overall Study|Lost to Follow-up|6
357572|NCT00422292|1155911|P3|Overall Study|Lost to Follow-up|6
357573|NCT00422292|1155912|P2|Overall Study|Lost to Follow-up|12
357574|NCT00422292|1155913|P1|Overall Study|Lost to Follow-up|6
357575|NCT00422292|1155910|P4|Overall Study|Protocol Violation|5
357576|NCT00422292|1155911|P3|Overall Study|Protocol Violation|8
357577|NCT00422292|1155912|P2|Overall Study|Protocol Violation|25
357578|NCT00422292|1155913|P1|Overall Study|Protocol Violation|4
357579|NCT00422292|1155910|P4|Overall Study|Adverse Event|0
357580|NCT00422292|1155911|P3|Overall Study|Adverse Event|1
357581|NCT00422292|1155912|P2|Overall Study|Adverse Event|0
357582|NCT00422292|1155913|P1|Overall Study|Adverse Event|1
357583|NCT00422292|1155910|P4|Overall Study|Serious adverse events|0
357584|NCT00422292|1155911|P3|Overall Study|Serious adverse events|0
357585|NCT00422292|1155912|P2|Overall Study|Serious adverse events|4
357586|NCT00422292|1155913|P1|Overall Study|Serious adverse events|1
357587|NCT00422227|1155952|P2|Overall Study|Withdrawal by Subject|4
357588|NCT00422227|1155953|P1|Overall Study|Withdrawal by Subject|0
357589|NCT00422227|1155952|P2|Overall Study|Lost to Follow-up|3
357590|NCT00422227|1155953|P1|Overall Study|Lost to Follow-up|1
357591|NCT00422227|1155952|P2|Overall Study|Adverse Event|8
357592|NCT00422227|1155953|P1|Overall Study|Adverse Event|3
357593|NCT00422162|1155983|P2|Overall Study|Didn't Receive Treatment|1
357594|NCT00422162|1155984|P1|Overall Study|Didn't Receive Treatment|0
357595|NCT00422162|1155983|P2|Overall Study|Not Specified|1
357596|NCT00422162|1155984|P1|Overall Study|Not Specified|0
357597|NCT00422162|1155983|P2|Overall Study|Non-Compliant with Protocol|1
357598|NCT00422162|1155984|P1|Overall Study|Non-Compliant with Protocol|1
357599|NCT00422162|1155983|P2|Overall Study|Lost to Follow-up|2
357600|NCT00422162|1155984|P1|Overall Study|Lost to Follow-up|1
357601|NCT00422162|1155983|P2|Overall Study|Withdrawal by Subject|6
357602|NCT00422162|1155984|P1|Overall Study|Withdrawal by Subject|7
357603|NCT00422162|1155983|P2|Overall Study|Lack of Efficacy|10
357604|NCT00422162|1155984|P1|Overall Study|Lack of Efficacy|4
357605|NCT00422162|1155983|P2|Overall Study|Adverse Event|9
357606|NCT00422162|1155984|P1|Overall Study|Adverse Event|11
357607|NCT00422097|1156044|P8|Dose Level 2|Still on treatment|0
357608|NCT00422097|1156045|P7|Dose Level 2|Still on treatment|0
357609|NCT00422097|1156046|P6|Dose Level 2|Still on treatment|0
357610|NCT00422097|1156047|P5|Dose Level 2|Still on treatment|0
357611|NCT00422097|1156048|P4|Dose Level 2|Still on treatment|0
357612|NCT00422097|1156049|P3|Dose Level 2|Still on treatment|0
357613|NCT00422097|1156050|P2|Dose Level 2|Still on treatment|1
357614|NCT00422097|1156051|P1|Dose Level 2|Still on treatment|0
357615|NCT00422058|1156116|P6|Open-Label Extension, Week 20-104|Other|18
357616|NCT00422058|1156117|P5|Open-Label Extension, Week 20-104|Other|16
357617|NCT00422058|1156118|P4|Open-Label Extension, Week 20-104|Other|13
357618|NCT00422058|1156119|P3|Open-Label Extension, Week 20-104|Other|6
357619|NCT00422058|1156120|P2|Open-Label Extension, Week 20-104|Other|14
357620|NCT00422058|1156121|P1|Open-Label Extension, Week 20-104|Other|13
357621|NCT00422058|1156116|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
357622|NCT00422058|1156117|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
357623|NCT00422058|1156118|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
357624|NCT00422058|1156119|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
357625|NCT00422058|1156120|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
357626|NCT00422058|1156121|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
357627|NCT00422058|1156116|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
357628|NCT00422058|1156117|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
357629|NCT00422058|1156118|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
357630|NCT00422058|1156119|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
357631|NCT00422058|1156120|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
357632|NCT00422058|1156121|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
357633|NCT00422058|1156116|P6|Open-Label Extension, Week 20-104|Adverse Event|0
357634|NCT00422058|1156117|P5|Open-Label Extension, Week 20-104|Adverse Event|4
357635|NCT00422058|1156118|P4|Open-Label Extension, Week 20-104|Adverse Event|4
357636|NCT00422058|1156119|P3|Open-Label Extension, Week 20-104|Adverse Event|7
357637|NCT00422058|1156120|P2|Open-Label Extension, Week 20-104|Adverse Event|4
357638|NCT00422058|1156121|P1|Open-Label Extension, Week 20-104|Adverse Event|3
357639|NCT00422058|1156116|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
357640|NCT00422058|1156117|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
357641|NCT00422058|1156118|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
357642|NCT00422058|1156119|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
357643|NCT00422058|1156120|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
357644|NCT00422058|1156121|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
357645|NCT00422058|1156116|P6|Double-Blind, Week 0-20|Other|10
357646|NCT00422058|1156117|P5|Double-Blind, Week 0-20|Other|4
357647|NCT00422058|1156118|P4|Double-Blind, Week 0-20|Other|8
357648|NCT00422058|1156119|P3|Double-Blind, Week 0-20|Other|8
357649|NCT00422058|1156120|P2|Double-Blind, Week 0-20|Other|3
357650|NCT00422058|1156121|P1|Double-Blind, Week 0-20|Other|11
357651|NCT00422058|1156116|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
357652|NCT00422058|1156117|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
357653|NCT00422058|1156118|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
357654|NCT00422058|1156119|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
357655|NCT00422058|1156120|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
357656|NCT00422058|1156121|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
357657|NCT00422058|1156116|P6|Double-Blind, Week 0-20|Protocol Violation|2
357658|NCT00422058|1156117|P5|Double-Blind, Week 0-20|Protocol Violation|2
357659|NCT00422058|1156118|P4|Double-Blind, Week 0-20|Protocol Violation|3
357660|NCT00422058|1156119|P3|Double-Blind, Week 0-20|Protocol Violation|2
357661|NCT00422058|1156120|P2|Double-Blind, Week 0-20|Protocol Violation|2
357662|NCT00422058|1156121|P1|Double-Blind, Week 0-20|Protocol Violation|3
357663|NCT00422058|1156116|P6|Double-Blind, Week 0-20|Adverse Event|3
357664|NCT00422058|1156117|P5|Double-Blind, Week 0-20|Adverse Event|5
357665|NCT00422058|1156118|P4|Double-Blind, Week 0-20|Adverse Event|9
357666|NCT00422058|1156119|P3|Double-Blind, Week 0-20|Adverse Event|5
357667|NCT00422058|1156120|P2|Double-Blind, Week 0-20|Adverse Event|4
357668|NCT00422058|1156121|P1|Double-Blind, Week 0-20|Adverse Event|3
357669|NCT00421993|1156262|P4|Overall Study|Subject transportation issues|1
357670|NCT00421993|1156263|P3|Overall Study|Subject transportation issues|0
357671|NCT00421993|1156264|P2|Overall Study|Subject transportation issues|0
357672|NCT00421993|1156265|P1|Overall Study|Subject transportation issues|0
357673|NCT00421993|1156262|P4|Overall Study|Pregnancy|2
357674|NCT00421993|1156263|P3|Overall Study|Pregnancy|1
357675|NCT00421993|1156264|P2|Overall Study|Pregnancy|1
357676|NCT00421993|1156265|P1|Overall Study|Pregnancy|0
357677|NCT00421993|1156262|P4|Overall Study|Lack of Efficacy|5
357678|NCT00421993|1156263|P3|Overall Study|Lack of Efficacy|0
357679|NCT00421993|1156264|P2|Overall Study|Lack of Efficacy|3
357680|NCT00421993|1156265|P1|Overall Study|Lack of Efficacy|0
357681|NCT00421993|1156262|P4|Overall Study|Protocol Violation|1
357682|NCT00421993|1156263|P3|Overall Study|Protocol Violation|0
357683|NCT00421993|1156264|P2|Overall Study|Protocol Violation|2
357684|NCT00421993|1156265|P1|Overall Study|Protocol Violation|2
357685|NCT00421993|1156262|P4|Overall Study|Adverse Event|4
357686|NCT00421993|1156263|P3|Overall Study|Adverse Event|6
357687|NCT00421993|1156264|P2|Overall Study|Adverse Event|1
357688|NCT00421993|1156265|P1|Overall Study|Adverse Event|11
357689|NCT00421993|1156262|P4|Overall Study|Lost to Follow-up|20
357690|NCT00421993|1156263|P3|Overall Study|Lost to Follow-up|22
357691|NCT00421993|1156264|P2|Overall Study|Lost to Follow-up|19
357692|NCT00421993|1156265|P1|Overall Study|Lost to Follow-up|18
357693|NCT00421993|1156262|P4|Overall Study|Withdrawal by Subject|24
357694|NCT00421993|1156263|P3|Overall Study|Withdrawal by Subject|23
357695|NCT00421993|1156264|P2|Overall Study|Withdrawal by Subject|23
357696|NCT00421993|1156265|P1|Overall Study|Withdrawal by Subject|22
357697|NCT00421928|1156302|P3|Overall Study|Death|0
357698|NCT00421928|1156303|P2|Overall Study|Death|1
357699|NCT00421928|1156304|P1|Overall Study|Death|0
357700|NCT00421928|1156302|P3|Overall Study|All other|27
357701|NCT00421928|1156303|P2|Overall Study|All other|21
357702|NCT00421928|1156304|P1|Overall Study|All other|26
357703|NCT00421928|1156302|P3|Overall Study|Study drug non-compliant|4
357704|NCT00421928|1156303|P2|Overall Study|Study drug non-compliant|7
357705|NCT00421928|1156304|P1|Overall Study|Study drug non-compliant|6
357706|NCT00421928|1156302|P3|Overall Study|Lack of Efficacy|35
357707|NCT00421928|1156303|P2|Overall Study|Lack of Efficacy|7
357708|NCT00421928|1156304|P1|Overall Study|Lack of Efficacy|15
357709|NCT00421928|1156302|P3|Overall Study|Withdrawal by Subject|43
357710|NCT00421928|1156303|P2|Overall Study|Withdrawal by Subject|48
357711|NCT00421928|1156304|P1|Overall Study|Withdrawal by Subject|50
357712|NCT00421928|1156302|P3|Overall Study|Lost to Follow-up|3
357713|NCT00421928|1156303|P2|Overall Study|Lost to Follow-up|0
357714|NCT00421928|1156304|P1|Overall Study|Lost to Follow-up|5
357715|NCT00421928|1156302|P3|Overall Study|Adverse Event|22
357716|NCT00421928|1156303|P2|Overall Study|Adverse Event|140
357717|NCT00421928|1156304|P1|Overall Study|Adverse Event|61
357718|NCT00421889|1156339|P9|Overall Study|Lost to Follow-up|1
357719|NCT00421889|1156340|P8|Overall Study|Lost to Follow-up|0
357720|NCT00421889|1156341|P7|Overall Study|Lost to Follow-up|0
357721|NCT00421889|1156342|P6|Overall Study|Lost to Follow-up|0
357722|NCT00421889|1156343|P5|Overall Study|Lost to Follow-up|0
357723|NCT00421889|1156344|P4|Overall Study|Lost to Follow-up|0
357724|NCT00421889|1156345|P3|Overall Study|Lost to Follow-up|0
357725|NCT00421889|1156346|P2|Overall Study|Lost to Follow-up|0
357726|NCT00421889|1156347|P1|Overall Study|Lost to Follow-up|0
357727|NCT00421889|1156339|P9|Overall Study|Patient/Investigator request|3
357728|NCT00421889|1156340|P8|Overall Study|Patient/Investigator request|1
357729|NCT00421889|1156341|P7|Overall Study|Patient/Investigator request|0
357730|NCT00421889|1156342|P6|Overall Study|Patient/Investigator request|9
357731|NCT00421889|1156343|P5|Overall Study|Patient/Investigator request|0
357732|NCT00421889|1156344|P4|Overall Study|Patient/Investigator request|0
357733|NCT00421889|1156345|P3|Overall Study|Patient/Investigator request|0
357734|NCT00421889|1156346|P2|Overall Study|Patient/Investigator request|0
357735|NCT00421889|1156347|P1|Overall Study|Patient/Investigator request|0
357736|NCT00421889|1156339|P9|Overall Study|Progressive disease|5
357737|NCT00421889|1156340|P8|Overall Study|Progressive disease|1
357738|NCT00421889|1156341|P7|Overall Study|Progressive disease|3
357739|NCT00421889|1156342|P6|Overall Study|Progressive disease|21
357740|NCT00421889|1156343|P5|Overall Study|Progressive disease|2
357741|NCT00421889|1156344|P4|Overall Study|Progressive disease|3
357742|NCT00421889|1156345|P3|Overall Study|Progressive disease|2
357743|NCT00421889|1156346|P2|Overall Study|Progressive disease|2
357744|NCT00421889|1156347|P1|Overall Study|Progressive disease|3
357745|NCT00421889|1156339|P9|Overall Study|Death|0
357746|NCT00421889|1156340|P8|Overall Study|Death|0
357747|NCT00421889|1156341|P7|Overall Study|Death|0
357748|NCT00421889|1156342|P6|Overall Study|Death|1
357749|NCT00421889|1156343|P5|Overall Study|Death|1
357750|NCT00421889|1156344|P4|Overall Study|Death|0
357751|NCT00421889|1156345|P3|Overall Study|Death|0
357752|NCT00421889|1156346|P2|Overall Study|Death|0
357753|NCT00421889|1156347|P1|Overall Study|Death|0
357754|NCT00421889|1156339|P9|Overall Study|Withdrawal by Subject|0
357755|NCT00421889|1156340|P8|Overall Study|Withdrawal by Subject|0
357756|NCT00421889|1156341|P7|Overall Study|Withdrawal by Subject|0
357757|NCT00421889|1156342|P6|Overall Study|Withdrawal by Subject|0
357758|NCT00421889|1156343|P5|Overall Study|Withdrawal by Subject|2
357759|NCT00421889|1156344|P4|Overall Study|Withdrawal by Subject|0
357760|NCT00421889|1156345|P3|Overall Study|Withdrawal by Subject|0
357761|NCT00421889|1156346|P2|Overall Study|Withdrawal by Subject|3
357762|NCT00421889|1156347|P1|Overall Study|Withdrawal by Subject|1
357763|NCT00421889|1156339|P9|Overall Study|Adverse Event|2
357764|NCT00421889|1156340|P8|Overall Study|Adverse Event|0
357765|NCT00421889|1156341|P7|Overall Study|Adverse Event|1
357766|NCT00421889|1156342|P6|Overall Study|Adverse Event|4
357767|NCT00421889|1156343|P5|Overall Study|Adverse Event|1
357768|NCT00421889|1156344|P4|Overall Study|Adverse Event|1
357769|NCT00421889|1156345|P3|Overall Study|Adverse Event|1
357770|NCT00421889|1156346|P2|Overall Study|Adverse Event|0
357771|NCT00421889|1156347|P1|Overall Study|Adverse Event|1
357772|NCT00421408|1156400|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
357773|NCT00421408|1156401|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
357774|NCT00421408|1156400|P2|Overall Study|Lost to Follow-up|20
357775|NCT00421408|1156401|P1|Overall Study|Lost to Follow-up|30
357776|NCT00421343|1156419|P1|Overall Study|Lost to follow-up|3
357777|NCT00421343|1156419|P1|Overall Study|Withdrawal by Subject|2
357778|NCT00421343|1156419|P1|Overall Study|Death|1
357779|NCT00421174|1156425|P2|Overall Study|Ineligible due to infection|0
357780|NCT00421174|1156426|P1|Overall Study|Ineligible due to infection|2
357781|NCT00421174|1156425|P2|Overall Study|Withdrawal by Subject|1
357782|NCT00421174|1156426|P1|Overall Study|Withdrawal by Subject|0
357783|NCT00420927|1156471|P7|Period 2|Took prohibited medication|0
357784|NCT00420927|1156472|P6|Period 2|Took prohibited medication|0
357785|NCT00420927|1156473|P5|Period 2|Took prohibited medication|1
357786|NCT00420927|1156474|P4|Period 2|Took prohibited medication|0
357787|NCT00420927|1156475|P3|Period 2|Took prohibited medication|0
357788|NCT00420927|1156476|P2|Period 2|Took prohibited medication|0
357789|NCT00420927|1156477|P1|Period 2|Took prohibited medication|0
357790|NCT00420927|1156471|P7|Period 2|Methotrexate intolerance|1
357791|NCT00420927|1156472|P6|Period 2|Methotrexate intolerance|0
357792|NCT00420927|1156473|P5|Period 2|Methotrexate intolerance|0
357793|NCT00420927|1156474|P4|Period 2|Methotrexate intolerance|0
357794|NCT00420927|1156475|P3|Period 2|Methotrexate intolerance|0
357795|NCT00420927|1156476|P2|Period 2|Methotrexate intolerance|0
357796|NCT00420927|1156477|P1|Period 2|Methotrexate intolerance|0
357797|NCT00420927|1156471|P7|Period 2|Noncompliant with study drug|2
357798|NCT00420927|1156472|P6|Period 2|Noncompliant with study drug|0
357799|NCT00420927|1156473|P5|Period 2|Noncompliant with study drug|0
357800|NCT00420927|1156474|P4|Period 2|Noncompliant with study drug|1
357801|NCT00420927|1156475|P3|Period 2|Noncompliant with study drug|0
357802|NCT00420927|1156476|P2|Period 2|Noncompliant with study drug|0
357803|NCT00420927|1156477|P1|Period 2|Noncompliant with study drug|0
357804|NCT00420927|1156471|P7|Period 2|Randomization error|0
357805|NCT00420927|1156472|P6|Period 2|Randomization error|1
357806|NCT00420927|1156473|P5|Period 2|Randomization error|1
357807|NCT00420927|1156474|P4|Period 2|Randomization error|0
357808|NCT00420927|1156475|P3|Period 2|Randomization error|0
357809|NCT00420927|1156476|P2|Period 2|Randomization error|0
357810|NCT00420927|1156477|P1|Period 2|Randomization error|0
357811|NCT00420927|1156471|P7|Period 2|Sponsor decision|1
357812|NCT00420927|1156472|P6|Period 2|Sponsor decision|0
357813|NCT00420927|1156473|P5|Period 2|Sponsor decision|0
357814|NCT00420927|1156474|P4|Period 2|Sponsor decision|0
357815|NCT00420927|1156475|P3|Period 2|Sponsor decision|1
357816|NCT00420927|1156476|P2|Period 2|Sponsor decision|0
357817|NCT00420927|1156477|P1|Period 2|Sponsor decision|0
357818|NCT00420927|1156471|P7|Period 2|Physician Decision|0
357819|NCT00420927|1156472|P6|Period 2|Physician Decision|1
357820|NCT00420927|1156473|P5|Period 2|Physician Decision|1
357821|NCT00420927|1156474|P4|Period 2|Physician Decision|0
357822|NCT00420927|1156475|P3|Period 2|Physician Decision|0
357823|NCT00420927|1156476|P2|Period 2|Physician Decision|0
357824|NCT00420927|1156477|P1|Period 2|Physician Decision|0
357825|NCT00420927|1156471|P7|Period 2|Subject unable to find transportation|1
357826|NCT00420927|1156472|P6|Period 2|Subject unable to find transportation|0
357827|NCT00420927|1156473|P5|Period 2|Subject unable to find transportation|0
357828|NCT00420927|1156474|P4|Period 2|Subject unable to find transportation|0
357829|NCT00420927|1156475|P3|Period 2|Subject unable to find transportation|0
357830|NCT00420927|1156476|P2|Period 2|Subject unable to find transportation|0
357831|NCT00420927|1156477|P1|Period 2|Subject unable to find transportation|0
357832|NCT00420927|1156471|P7|Period 2|Received wrong treatment/incorrect dose|1
357833|NCT00420927|1156472|P6|Period 2|Received wrong treatment/incorrect dose|0
357834|NCT00420927|1156473|P5|Period 2|Received wrong treatment/incorrect dose|0
357835|NCT00420927|1156474|P4|Period 2|Received wrong treatment/incorrect dose|0
357836|NCT00420927|1156475|P3|Period 2|Received wrong treatment/incorrect dose|0
357837|NCT00420927|1156476|P2|Period 2|Received wrong treatment/incorrect dose|0
357838|NCT00420927|1156477|P1|Period 2|Received wrong treatment/incorrect dose|0
357839|NCT00420927|1156471|P7|Period 2|Lack of efficacy/Loss of efficacy|6
357840|NCT00420927|1156472|P6|Period 2|Lack of efficacy/Loss of efficacy|2
357841|NCT00420927|1156473|P5|Period 2|Lack of efficacy/Loss of efficacy|6
357842|NCT00420927|1156474|P4|Period 2|Lack of efficacy/Loss of efficacy|1
357843|NCT00420927|1156475|P3|Period 2|Lack of efficacy/Loss of efficacy|2
357844|NCT00420927|1156476|P2|Period 2|Lack of efficacy/Loss of efficacy|0
357845|NCT00420927|1156477|P1|Period 2|Lack of efficacy/Loss of efficacy|0
357846|NCT00420927|1156471|P7|Period 2|Lost to Follow-up|9
357847|NCT00420927|1156472|P6|Period 2|Lost to Follow-up|3
357848|NCT00420927|1156473|P5|Period 2|Lost to Follow-up|6
357849|NCT00420927|1156474|P4|Period 2|Lost to Follow-up|2
357850|NCT00420927|1156475|P3|Period 2|Lost to Follow-up|2
357851|NCT00420927|1156476|P2|Period 2|Lost to Follow-up|0
357852|NCT00420927|1156477|P1|Period 2|Lost to Follow-up|0
357853|NCT00420927|1156471|P7|Period 2|Withdrawal by Subject|12
357854|NCT00420927|1156472|P6|Period 2|Withdrawal by Subject|2
357855|NCT00420927|1156473|P5|Period 2|Withdrawal by Subject|11
357856|NCT00420927|1156474|P4|Period 2|Withdrawal by Subject|3
357857|NCT00420927|1156475|P3|Period 2|Withdrawal by Subject|1
357858|NCT00420927|1156476|P2|Period 2|Withdrawal by Subject|0
357859|NCT00420927|1156477|P1|Period 2|Withdrawal by Subject|0
357860|NCT00420927|1156471|P7|Period 2|Adverse Event|20
357861|NCT00420927|1156472|P6|Period 2|Adverse Event|6
357862|NCT00420927|1156473|P5|Period 2|Adverse Event|17
357863|NCT00420927|1156474|P4|Period 2|Adverse Event|3
357864|NCT00420927|1156475|P3|Period 2|Adverse Event|7
357865|NCT00420927|1156476|P2|Period 2|Adverse Event|0
357866|NCT00420927|1156477|P1|Period 2|Adverse Event|0
357867|NCT00420927|1156471|P7|Period 1|Took prohibited medication|0
357868|NCT00420927|1156472|P6|Period 1|Took prohibited medication|0
357869|NCT00420927|1156473|P5|Period 1|Took prohibited medication|0
357870|NCT00420927|1156474|P4|Period 1|Took prohibited medication|0
357871|NCT00420927|1156475|P3|Period 1|Took prohibited medication|0
357872|NCT00420927|1156476|P2|Period 1|Took prohibited medication|3
357873|NCT00420927|1156477|P1|Period 1|Took prohibited medication|1
357874|NCT00420927|1156471|P7|Period 1|Failed to meet entry criteria|0
357875|NCT00420927|1156472|P6|Period 1|Failed to meet entry criteria|0
357876|NCT00420927|1156473|P5|Period 1|Failed to meet entry criteria|0
357877|NCT00420927|1156474|P4|Period 1|Failed to meet entry criteria|0
357878|NCT00420927|1156475|P3|Period 1|Failed to meet entry criteria|0
357879|NCT00420927|1156476|P2|Period 1|Failed to meet entry criteria|7
357880|NCT00420927|1156477|P1|Period 1|Failed to meet entry criteria|8
357881|NCT00420927|1156471|P7|Period 1|Received wrong treatment/incorrect dose|0
357882|NCT00420927|1156472|P6|Period 1|Received wrong treatment/incorrect dose|0
357883|NCT00420927|1156473|P5|Period 1|Received wrong treatment/incorrect dose|0
357884|NCT00420927|1156474|P4|Period 1|Received wrong treatment/incorrect dose|0
357885|NCT00420927|1156475|P3|Period 1|Received wrong treatment/incorrect dose|0
357886|NCT00420927|1156476|P2|Period 1|Received wrong treatment/incorrect dose|1
357887|NCT00420927|1156477|P1|Period 1|Received wrong treatment/incorrect dose|0
357888|NCT00420927|1156471|P7|Period 1|Subject received new diagnosis|0
357889|NCT00420927|1156472|P6|Period 1|Subject received new diagnosis|0
357890|NCT00420927|1156473|P5|Period 1|Subject received new diagnosis|0
357891|NCT00420927|1156474|P4|Period 1|Subject received new diagnosis|0
357892|NCT00420927|1156475|P3|Period 1|Subject received new diagnosis|0
357893|NCT00420927|1156476|P2|Period 1|Subject received new diagnosis|2
357894|NCT00420927|1156477|P1|Period 1|Subject received new diagnosis|0
357895|NCT00420927|1156471|P7|Period 1|Study site closure|0
357896|NCT00420927|1156472|P6|Period 1|Study site closure|0
357897|NCT00420927|1156473|P5|Period 1|Study site closure|0
357898|NCT00420927|1156474|P4|Period 1|Study site closure|0
357899|NCT00420927|1156475|P3|Period 1|Study site closure|0
357900|NCT00420927|1156476|P2|Period 1|Study site closure|1
357901|NCT00420927|1156477|P1|Period 1|Study site closure|0
357902|NCT00420927|1156471|P7|Period 1|Suspected tuberculosis/positive test|0
357903|NCT00420927|1156472|P6|Period 1|Suspected tuberculosis/positive test|0
357904|NCT00420927|1156473|P5|Period 1|Suspected tuberculosis/positive test|0
357905|NCT00420927|1156474|P4|Period 1|Suspected tuberculosis/positive test|0
357906|NCT00420927|1156475|P3|Period 1|Suspected tuberculosis/positive test|0
357907|NCT00420927|1156476|P2|Period 1|Suspected tuberculosis/positive test|1
357908|NCT00420927|1156477|P1|Period 1|Suspected tuberculosis/positive test|1
357909|NCT00420927|1156471|P7|Period 1|Randomization error|0
357910|NCT00420927|1156472|P6|Period 1|Randomization error|0
357911|NCT00420927|1156473|P5|Period 1|Randomization error|0
357912|NCT00420927|1156474|P4|Period 1|Randomization error|0
357913|NCT00420927|1156475|P3|Period 1|Randomization error|0
357914|NCT00420927|1156476|P2|Period 1|Randomization error|0
357915|NCT00420927|1156477|P1|Period 1|Randomization error|1
357916|NCT00420927|1156471|P7|Period 1|Noncompliant with study drug|0
357917|NCT00420927|1156472|P6|Period 1|Noncompliant with study drug|0
357918|NCT00420927|1156473|P5|Period 1|Noncompliant with study drug|0
357919|NCT00420927|1156474|P4|Period 1|Noncompliant with study drug|0
357920|NCT00420927|1156475|P3|Period 1|Noncompliant with study drug|0
357921|NCT00420927|1156476|P2|Period 1|Noncompliant with study drug|1
357922|NCT00420927|1156477|P1|Period 1|Noncompliant with study drug|1
357923|NCT00420927|1156471|P7|Period 1|Subject moved/relocated|0
357924|NCT00420927|1156472|P6|Period 1|Subject moved/relocated|0
357925|NCT00420927|1156473|P5|Period 1|Subject moved/relocated|0
357926|NCT00420927|1156474|P4|Period 1|Subject moved/relocated|0
357927|NCT00420927|1156475|P3|Period 1|Subject moved/relocated|0
357928|NCT00420927|1156476|P2|Period 1|Subject moved/relocated|2
357929|NCT00420927|1156477|P1|Period 1|Subject moved/relocated|0
357930|NCT00420927|1156471|P7|Period 1|Death|0
357931|NCT00420927|1156472|P6|Period 1|Death|0
357932|NCT00420927|1156473|P5|Period 1|Death|0
357933|NCT00420927|1156474|P4|Period 1|Death|0
357934|NCT00420927|1156475|P3|Period 1|Death|0
357935|NCT00420927|1156476|P2|Period 1|Death|0
357936|NCT00420927|1156477|P1|Period 1|Death|2
357937|NCT00420927|1156471|P7|Period 1|Lack of efficacy/Loss of efficacy|0
357938|NCT00420927|1156472|P6|Period 1|Lack of efficacy/Loss of efficacy|0
357939|NCT00420927|1156473|P5|Period 1|Lack of efficacy/Loss of efficacy|0
357940|NCT00420927|1156474|P4|Period 1|Lack of efficacy/Loss of efficacy|0
357941|NCT00420927|1156475|P3|Period 1|Lack of efficacy/Loss of efficacy|0
357942|NCT00420927|1156476|P2|Period 1|Lack of efficacy/Loss of efficacy|6
357943|NCT00420927|1156477|P1|Period 1|Lack of efficacy/Loss of efficacy|1
357944|NCT00420927|1156471|P7|Period 1|Lost to Follow-up|0
357945|NCT00420927|1156472|P6|Period 1|Lost to Follow-up|0
357946|NCT00420927|1156473|P5|Period 1|Lost to Follow-up|0
357947|NCT00420927|1156474|P4|Period 1|Lost to Follow-up|0
357948|NCT00420927|1156475|P3|Period 1|Lost to Follow-up|0
357949|NCT00420927|1156476|P2|Period 1|Lost to Follow-up|6
357950|NCT00420927|1156477|P1|Period 1|Lost to Follow-up|8
357951|NCT00420927|1156471|P7|Period 1|Withdrawal by Subject|0
357952|NCT00420927|1156472|P6|Period 1|Withdrawal by Subject|0
357953|NCT00420927|1156473|P5|Period 1|Withdrawal by Subject|0
357954|NCT00420927|1156474|P4|Period 1|Withdrawal by Subject|0
357955|NCT00420927|1156475|P3|Period 1|Withdrawal by Subject|0
357956|NCT00420927|1156476|P2|Period 1|Withdrawal by Subject|12
357957|NCT00420927|1156477|P1|Period 1|Withdrawal by Subject|7
357958|NCT00420927|1156471|P7|Period 1|Adverse Event|0
357959|NCT00420927|1156472|P6|Period 1|Adverse Event|0
357960|NCT00420927|1156473|P5|Period 1|Adverse Event|0
357961|NCT00420927|1156474|P4|Period 1|Adverse Event|0
357962|NCT00420927|1156475|P3|Period 1|Adverse Event|0
357963|NCT00420927|1156476|P2|Period 1|Adverse Event|15
357964|NCT00420927|1156477|P1|Period 1|Adverse Event|19
357965|NCT00420849|1156581|P1|Overall Study|Lost to Follow-up|1
357966|NCT00420849|1156581|P1|Overall Study|Protocol Violation|1
357967|NCT00420849|1156581|P1|Overall Study|Transplant|8
357968|NCT00420849|1156581|P1|Overall Study|Not specified|14
357969|NCT00420849|1156581|P1|Overall Study|Death|18
357970|NCT00420849|1156581|P1|Overall Study|Withdrawal by Subject|28
357971|NCT00420849|1156581|P1|Overall Study|Adverse Event|107
357972|NCT00420849|1156581|P1|Overall Study|Lack of Efficacy|154
357973|NCT00420784|1156650|P4|Overall Study|Unspecified|5
357974|NCT00420784|1156651|P3|Overall Study|Unspecified|0
357975|NCT00420784|1156652|P2|Overall Study|Unspecified|2
357976|NCT00420784|1156653|P1|Overall Study|Unspecified|1
357977|NCT00420784|1156650|P4|Overall Study|Virologic Stopping Rule|67
357978|NCT00420784|1156651|P3|Overall Study|Virologic Stopping Rule|41
357979|NCT00420784|1156652|P2|Overall Study|Virologic Stopping Rule|26
357980|NCT00420784|1156653|P1|Overall Study|Virologic Stopping Rule|17
357981|NCT00420784|1156650|P4|Overall Study|Lost to Follow-up|1
357982|NCT00420784|1156651|P3|Overall Study|Lost to Follow-up|2
357983|NCT00420784|1156652|P2|Overall Study|Lost to Follow-up|0
357984|NCT00420784|1156653|P1|Overall Study|Lost to Follow-up|0
357985|NCT00420784|1156650|P4|Overall Study|Withdrawal by Subject|0
357986|NCT00420784|1156651|P3|Overall Study|Withdrawal by Subject|0
357987|NCT00420784|1156652|P2|Overall Study|Withdrawal by Subject|1
357988|NCT00420784|1156653|P1|Overall Study|Withdrawal by Subject|0
357989|NCT00420784|1156650|P4|Overall Study|Adverse Event|5
357990|NCT00420784|1156651|P3|Overall Study|Adverse Event|10
357991|NCT00420784|1156652|P2|Overall Study|Adverse Event|29
357992|NCT00420784|1156653|P1|Overall Study|Adverse Event|11
357993|NCT00420745|1156682|P2|Overall Study|Age limit exceeded for Dose 2|0
357994|NCT00420745|1156683|P1|Overall Study|Age limit exceeded for Dose 2|1
357995|NCT00420745|1156682|P2|Overall Study|Recurrent pneumonia & bronchitis|1
357996|NCT00420745|1156683|P1|Overall Study|Recurrent pneumonia & bronchitis|0
357997|NCT00420745|1156682|P2|Overall Study|Physician Decision|1
357998|NCT00420745|1156683|P1|Overall Study|Physician Decision|1
357999|NCT00420745|1156682|P2|Overall Study|Protocol Violation|0
358000|NCT00420745|1156683|P1|Overall Study|Protocol Violation|1
358001|NCT00420745|1156682|P2|Overall Study|Lost to Follow-up|2
358002|NCT00420745|1156683|P1|Overall Study|Lost to Follow-up|10
358003|NCT00420745|1156682|P2|Overall Study|Adverse Event|2
358004|NCT00420745|1156683|P1|Overall Study|Adverse Event|2
358005|NCT00420628|1156716|P2|Overall Study|Adverse Event|0
358006|NCT00420628|1156717|P1|Overall Study|Adverse Event|1
358007|NCT00420628|1156716|P2|Overall Study|Lost to Follow-up|2
358008|NCT00420628|1156717|P1|Overall Study|Lost to Follow-up|3
358009|NCT00420628|1156716|P2|Overall Study|Withdrawn by parent or gaurdian|2
358010|NCT00420628|1156717|P1|Overall Study|Withdrawn by parent or gaurdian|5
358011|NCT00420511|1156733|P2|Overall Study|Lost to Follow-up|0
358012|NCT00420511|1156734|P1|Overall Study|Lost to Follow-up|1
358013|NCT00420511|1156733|P2|Overall Study|Adverse Event|1
358014|NCT00420511|1156734|P1|Overall Study|Adverse Event|1
358015|NCT00420420|1156755|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
358016|NCT00420420|1156756|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
358017|NCT00420420|1156755|P2|Overall Study|Withdrawal by Subject|0
358018|NCT00420420|1156756|P1|Overall Study|Withdrawal by Subject|1
358019|NCT00420420|1156755|P2|Overall Study|Protocol Violation|1
358020|NCT00420420|1156756|P1|Overall Study|Protocol Violation|1
358021|NCT00420420|1156755|P2|Overall Study|Adverse Event|3
358022|NCT00420420|1156756|P1|Overall Study|Adverse Event|5
358023|NCT00420407|1156774|P2|Overall Study|Withdrawal by Subject|2
358024|NCT00420407|1156775|P1|Overall Study|Withdrawal by Subject|0
358025|NCT00420407|1156774|P2|Overall Study|subject identified as Jehovah's witness|0
358026|NCT00420407|1156775|P1|Overall Study|subject identified as Jehovah's witness|1
358027|NCT00420407|1156774|P2|Overall Study|subject identified as detainee|0
358028|NCT00420407|1156775|P1|Overall Study|subject identified as detainee|1
358029|NCT00420407|1156774|P2|Overall Study|Physician Decision|1
358030|NCT00420407|1156775|P1|Overall Study|Physician Decision|2
358031|NCT00420407|1156774|P2|Overall Study|Lost to Follow-up|3
358032|NCT00420407|1156775|P1|Overall Study|Lost to Follow-up|0
358033|NCT00420342|1156784|P3|Overall Study|Withdrawal by Subject|0
358034|NCT00420342|1156785|P2|Overall Study|Withdrawal by Subject|2
358035|NCT00420342|1156786|P1|Overall Study|Withdrawal by Subject|0
358036|NCT00420342|1156784|P3|Overall Study|Lost to Follow-up|1
358037|NCT00420342|1156785|P2|Overall Study|Lost to Follow-up|0
358038|NCT00420342|1156786|P1|Overall Study|Lost to Follow-up|1
358039|NCT00420316|1156829|P2|Overall Study|Lost to Follow-up|8
358040|NCT00420316|1156830|P1|Overall Study|Lost to Follow-up|12
358041|NCT00420316|1156829|P2|Overall Study|Withdrawal by Subject|1
358042|NCT00420316|1156830|P1|Overall Study|Withdrawal by Subject|0
358043|NCT00420303|1156854|P2|Overall Study|Physician Decision|1
358044|NCT00420303|1156855|P1|Overall Study|Physician Decision|0
358045|NCT00420303|1156854|P2|Overall Study|Lack of Efficacy|3
358046|NCT00420303|1156855|P1|Overall Study|Lack of Efficacy|0
358047|NCT00420303|1156854|P2|Overall Study|Serious Adverse Event|0
358048|NCT00420303|1156855|P1|Overall Study|Serious Adverse Event|1
358049|NCT00420290|1156867|P2|Overall Study|did not meet inclusion/exclusion|1
358050|NCT00420290|1156868|P1|Overall Study|did not meet inclusion/exclusion|1
358051|NCT00420290|1156867|P2|Overall Study|Withdrawal by Subject|2
358052|NCT00420290|1156868|P1|Overall Study|Withdrawal by Subject|0
358053|NCT00420290|1156867|P2|Overall Study|Adverse Event|1
358054|NCT00420290|1156868|P1|Overall Study|Adverse Event|3
358055|NCT00420238|1156884|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
358056|NCT00420238|1156885|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
358057|NCT00420238|1156884|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
358058|NCT00420238|1156885|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
358059|NCT00420238|1156884|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
358060|NCT00420238|1156885|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
358061|NCT00420238|1156884|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
358062|NCT00420238|1156885|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
358063|NCT00420238|1156884|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
358064|NCT00420238|1156885|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
358065|NCT00420238|1156884|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
358066|NCT00420238|1156885|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
358067|NCT00420212|1157024|P3|Overall Study|Other-Unspecified|18
358068|NCT00420212|1157025|P2|Overall Study|Other-Unspecified|14
358069|NCT00420212|1157026|P1|Overall Study|Other-Unspecified|21
358070|NCT00420212|1157024|P3|Overall Study|Death|1
358071|NCT00420212|1157025|P2|Overall Study|Death|0
358072|NCT00420212|1157026|P1|Overall Study|Death|0
358073|NCT00420212|1157024|P3|Overall Study|Protocol Violation|8
358074|NCT00420212|1157025|P2|Overall Study|Protocol Violation|4
358075|NCT00420212|1157026|P1|Overall Study|Protocol Violation|4
358076|NCT00420212|1157024|P3|Overall Study|Physician Decision|3
358077|NCT00420212|1157025|P2|Overall Study|Physician Decision|4
358078|NCT00420212|1157026|P1|Overall Study|Physician Decision|4
358079|NCT00420212|1157024|P3|Overall Study|Withdrawal by Subject|19
358080|NCT00420212|1157025|P2|Overall Study|Withdrawal by Subject|22
358081|NCT00420212|1157026|P1|Overall Study|Withdrawal by Subject|31
358082|NCT00420212|1157024|P3|Overall Study|Lost to Follow-up|11
358083|NCT00420212|1157025|P2|Overall Study|Lost to Follow-up|11
358084|NCT00420212|1157026|P1|Overall Study|Lost to Follow-up|9
358085|NCT00420212|1157024|P3|Overall Study|Adverse Event|36
358086|NCT00420212|1157025|P2|Overall Study|Adverse Event|40
358087|NCT00420212|1157026|P1|Overall Study|Adverse Event|22
358088|NCT00420199|1157052|P2|Overall Study|Participant no longer met study criteria|0
358089|NCT00420199|1157053|P1|Overall Study|Participant no longer met study criteria|1
358090|NCT00420095|1157119|P2|Overall Study|Lost to Follow-up|0
358091|NCT00420095|1157120|P1|Overall Study|Lost to Follow-up|1
358092|NCT00420095|1157119|P2|Overall Study|Protocol Violation|1
358093|NCT00420095|1157120|P1|Overall Study|Protocol Violation|1
358094|NCT00420095|1157119|P2|Overall Study|Adverse Event|0
358095|NCT00420095|1157120|P1|Overall Study|Adverse Event|1
358096|NCT00420056|1157138|P1|Overall Study|Objective progression or relapse|17
358097|NCT00419952|1157162|P2|Overall Study|Abnormal ECG|0
358098|NCT00419952|1157163|P1|Overall Study|Abnormal ECG|1
358099|NCT00419952|1157162|P2|Overall Study|Diary or medication non-compliance|4
358100|NCT00419952|1157163|P1|Overall Study|Diary or medication non-compliance|2
358101|NCT00419952|1157162|P2|Overall Study|Occurence of 2 or more exacerbations|0
358102|NCT00419952|1157163|P1|Overall Study|Occurence of 2 or more exacerbations|2
358103|NCT00419952|1157162|P2|Overall Study|Intake of prohibited medication|2
358104|NCT00419952|1157163|P1|Overall Study|Intake of prohibited medication|2
358105|NCT00419952|1157162|P2|Overall Study|Incorrectly enrolled|3
358106|NCT00419952|1157163|P1|Overall Study|Incorrectly enrolled|10
358107|NCT00419952|1157162|P2|Overall Study|Physician Decision|3
358108|NCT00419952|1157163|P1|Overall Study|Physician Decision|1
358109|NCT00419952|1157162|P2|Overall Study|Pregnancy|2
358110|NCT00419952|1157163|P1|Overall Study|Pregnancy|4
358111|NCT00419952|1157162|P2|Overall Study|Protocol Violation|24
358112|NCT00419952|1157163|P1|Overall Study|Protocol Violation|32
358113|NCT00419952|1157162|P2|Overall Study|Lost to Follow-up|34
358114|NCT00419952|1157163|P1|Overall Study|Lost to Follow-up|43
358115|NCT00419952|1157162|P2|Overall Study|Withdrawal by Subject|43
358116|NCT00419952|1157163|P1|Overall Study|Withdrawal by Subject|44
358117|NCT00419952|1157162|P2|Overall Study|Adverse Event|10
358118|NCT00419952|1157163|P1|Overall Study|Adverse Event|8
358119|NCT00419926|1157197|P2|Overall Study|Death|1
358120|NCT00419926|1157198|P1|Overall Study|Death|2
358121|NCT00419926|1157197|P2|Overall Study|Lost to Follow-up|2
358122|NCT00419926|1157198|P1|Overall Study|Lost to Follow-up|1
358123|NCT00419926|1157197|P2|Overall Study|Administrative Problem|4
358124|NCT00419926|1157198|P1|Overall Study|Administrative Problem|4
358125|NCT00419926|1157197|P2|Overall Study|Withdrawal by Subject|3
358126|NCT00419926|1157198|P1|Overall Study|Withdrawal by Subject|7
358127|NCT00419770|1157214|P2|Overall Study|Withdrawal by Subject|1
358128|NCT00419770|1157215|P1|Overall Study|Withdrawal by Subject|5
358129|NCT00419757|1157223|P2|Overall Study|Multiple reasons|1
358130|NCT00419757|1157224|P1|Overall Study|Multiple reasons|3
358131|NCT00419757|1157223|P2|Overall Study|Study specific discontinuation criteria|8
358132|NCT00419757|1157224|P1|Overall Study|Study specific discontinuation criteria|4
358133|NCT00419757|1157223|P2|Overall Study|Protocol Violation|3
358134|NCT00419757|1157224|P1|Overall Study|Protocol Violation|2
358135|NCT00419757|1157223|P2|Overall Study|Withdrawal by Subject|1
358136|NCT00419757|1157224|P1|Overall Study|Withdrawal by Subject|7
358137|NCT00419757|1157223|P2|Overall Study|Lost to Follow-up|4
358138|NCT00419757|1157224|P1|Overall Study|Lost to Follow-up|1
358139|NCT00419757|1157223|P2|Overall Study|Adverse Event|4
358140|NCT00419757|1157224|P1|Overall Study|Adverse Event|1
358141|NCT00419744|1157263|P3|Overall Study|Incorrect medication kit dispensed|1
358142|NCT00419744|1157264|P2|Overall Study|Incorrect medication kit dispensed|0
358143|NCT00419744|1157265|P1|Overall Study|Incorrect medication kit dispensed|0
358144|NCT00419744|1157263|P3|Overall Study|Spirometry mouthpiece issues|2
358145|NCT00419744|1157264|P2|Overall Study|Spirometry mouthpiece issues|1
358146|NCT00419744|1157265|P1|Overall Study|Spirometry mouthpiece issues|0
358147|NCT00419744|1157263|P3|Overall Study|Physician Decision|6
358148|NCT00419744|1157264|P2|Overall Study|Physician Decision|5
358149|NCT00419744|1157265|P1|Overall Study|Physician Decision|10
358150|NCT00419744|1157263|P3|Overall Study|Moving out of state|1
358151|NCT00419744|1157264|P2|Overall Study|Moving out of state|0
358152|NCT00419744|1157265|P1|Overall Study|Moving out of state|2
358153|NCT00419744|1157263|P3|Overall Study|Randomized in error|7
358154|NCT00419744|1157264|P2|Overall Study|Randomized in error|6
358155|NCT00419744|1157265|P1|Overall Study|Randomized in error|9
358156|NCT00419744|1157263|P3|Overall Study|Protocol Violation|8
358157|NCT00419744|1157264|P2|Overall Study|Protocol Violation|7
358158|NCT00419744|1157265|P1|Overall Study|Protocol Violation|4
358159|NCT00419744|1157263|P3|Overall Study|Lost to Follow-up|6
358160|NCT00419744|1157264|P2|Overall Study|Lost to Follow-up|10
358161|NCT00419744|1157265|P1|Overall Study|Lost to Follow-up|8
358162|NCT00419744|1157263|P3|Overall Study|Withdrawal by Subject|52
358163|NCT00419744|1157264|P2|Overall Study|Withdrawal by Subject|49
358164|NCT00419744|1157265|P1|Overall Study|Withdrawal by Subject|45
358165|NCT00419744|1157263|P3|Overall Study|Adverse Event|50
358166|NCT00419744|1157264|P2|Overall Study|Adverse Event|40
358167|NCT00419744|1157265|P1|Overall Study|Adverse Event|39
358168|NCT00419393|1157307|P1|Overall Study|Other: Investigator decision|1
358169|NCT00419393|1157307|P1|Overall Study|Other: Other health problems|1
358170|NCT00419393|1157307|P1|Overall Study|Other: Site closure|1
358171|NCT00419393|1157307|P1|Overall Study|Other: Subject had temporal lobectomy|1
358172|NCT00419393|1157307|P1|Overall Study|Other: Sponsor request|3
358173|NCT00419393|1157307|P1|Overall Study|Withdrawal by Subject|7
358174|NCT00419393|1157307|P1|Overall Study|Protocol Violation|5
358175|NCT00419393|1157307|P1|Overall Study|Adverse Event|5
358176|NCT00419380|1157317|P2|Overall Study|Withdrawal by Subject|1
358177|NCT00419380|1157318|P1|Overall Study|Withdrawal by Subject|0
358178|NCT00419380|1157317|P2|Overall Study|Lost to Follow-up|1
358179|NCT00419380|1157318|P1|Overall Study|Lost to Follow-up|0
358180|NCT00419380|1157317|P2|Overall Study|Physician Decision|1
358181|NCT00419380|1157318|P1|Overall Study|Physician Decision|0
358182|NCT00419380|1157317|P2|Overall Study|Lack of Efficacy|7
358183|NCT00419380|1157318|P1|Overall Study|Lack of Efficacy|1
358184|NCT00419341|1157326|P1|Efficacy Period|Termination of study site|1
358185|NCT00419341|1157326|P1|Efficacy Period|Non-compliance|1
358186|NCT00419341|1157326|P1|Efficacy Period|Lost to Follow-up|1
358187|NCT00419341|1157326|P1|Efficacy Period|Protocol Violation|1
358188|NCT00419341|1157326|P1|Efficacy Period|Withdrawal by Subject|6
358189|NCT00419341|1157326|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
358190|NCT00419341|1157326|P1|Wash in/Wash Out Period|Adverse Event|2
358191|NCT00419341|1157326|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
358192|NCT00419263|1157361|P3|Overall Study|Withdrawal by Subject|1
358193|NCT00419263|1157362|P2|Overall Study|Withdrawal by Subject|0
358194|NCT00419263|1157363|P1|Overall Study|Withdrawal by Subject|0
358195|NCT00419263|1157361|P3|Overall Study|Adverse Event|1
358196|NCT00419263|1157362|P2|Overall Study|Adverse Event|0
358197|NCT00419263|1157363|P1|Overall Study|Adverse Event|0
358198|NCT00419263|1157361|P3|Overall Study|Randomized in Error, Not Treated|0
358199|NCT00419263|1157362|P2|Overall Study|Randomized in Error, Not Treated|1
358200|NCT00419263|1157363|P1|Overall Study|Randomized in Error, Not Treated|1
358201|NCT00419263|1157361|P3|Overall Study|Lost to Follow-up|1
358202|NCT00419263|1157362|P2|Overall Study|Lost to Follow-up|1
358203|NCT00419263|1157363|P1|Overall Study|Lost to Follow-up|2
358204|NCT00419159|1157392|P2|Overall Study|Disease progression|76
358205|NCT00419159|1157393|P1|Overall Study|Disease progression|79
358206|NCT00419159|1157392|P2|Overall Study|Death|2
358207|NCT00419159|1157393|P1|Overall Study|Death|2
358208|NCT00419159|1157392|P2|Overall Study|Lost to Follow-up|1
358209|NCT00419159|1157393|P1|Overall Study|Lost to Follow-up|0
358210|NCT00419159|1157392|P2|Overall Study|Withdrawal by Subject|3
358211|NCT00419159|1157393|P1|Overall Study|Withdrawal by Subject|10
358212|NCT00419159|1157392|P2|Overall Study|Protocol Violation|0
358213|NCT00419159|1157393|P1|Overall Study|Protocol Violation|1
358214|NCT00419159|1157392|P2|Overall Study|Subject's no longer requires study drug|1
358215|NCT00419159|1157393|P1|Overall Study|Subject's no longer requires study drug|0
358216|NCT00419159|1157392|P2|Overall Study|Abnormal laboratory value(s)|2
358217|NCT00419159|1157393|P1|Overall Study|Abnormal laboratory value(s)|0
358218|NCT00419159|1157392|P2|Overall Study|Adverse Event|15
358219|NCT00419159|1157393|P1|Overall Study|Adverse Event|7
358220|NCT00419120|1157407|P1|Long Term Follow up Period|study ongoing|10
358221|NCT00419094|1157414|P2|Overall Study|Other: No contact for extended period|1
358222|NCT00419094|1157415|P1|Overall Study|Other: No contact for extended period|0
358223|NCT00419094|1157414|P2|Overall Study|Other: Patient non-compliant|1
358224|NCT00419094|1157415|P1|Overall Study|Other: Patient non-compliant|0
358225|NCT00419094|1157414|P2|Overall Study|Other: Error determining exit criteria|0
358226|NCT00419094|1157415|P1|Overall Study|Other: Error determining exit criteria|1
358227|NCT00419094|1157414|P2|Overall Study|Withdrawal of consent|5
358228|NCT00419094|1157415|P1|Overall Study|Withdrawal of consent|1
358229|NCT00419094|1157414|P2|Overall Study|Protocol Violation|14
358230|NCT00419094|1157415|P1|Overall Study|Protocol Violation|1
358231|NCT00419094|1157414|P2|Overall Study|Lost to Follow-up|2
358232|NCT00419094|1157415|P1|Overall Study|Lost to Follow-up|0
358233|NCT00419094|1157414|P2|Overall Study|Lack of Efficacy|0
358234|NCT00419094|1157415|P1|Overall Study|Lack of Efficacy|1
358235|NCT00419094|1157414|P2|Overall Study|Adverse Event|7
358236|NCT00419094|1157415|P1|Overall Study|Adverse Event|3
358237|NCT00417976|1157427|P1|Overall Study|Treatment -related toxicity|2
358238|NCT00417976|1157427|P1|Overall Study|Non compliance unrelated to toxicity|1
358239|NCT00417963|1157432|P1|Overall Study|Study device could not be deployed|3
358240|NCT00417963|1157432|P1|Overall Study|Death|17
358241|NCT00417963|1157432|P1|Overall Study|Withdrawal by Subject|18
358242|NCT00417963|1157432|P1|Overall Study|Lost to Follow-up|3
358243|NCT00419003|1157451|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
358244|NCT00419003|1157452|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
358245|NCT00419003|1157451|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
358246|NCT00419003|1157452|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
358247|NCT00418938|1157506|P2|Overall Study|Ineligibility Determined|0
358248|NCT00418938|1157507|P1|Overall Study|Ineligibility Determined|1
358249|NCT00418938|1157506|P2|Overall Study|On-going|1
358250|NCT00418938|1157507|P1|Overall Study|On-going|1
358251|NCT00418938|1157506|P2|Overall Study|Adverse Event|1
358252|NCT00418938|1157507|P1|Overall Study|Adverse Event|1
358253|NCT00418938|1157506|P2|Overall Study|Lost to Follow-up|3
358254|NCT00418938|1157507|P1|Overall Study|Lost to Follow-up|1
358255|NCT00418938|1157506|P2|Overall Study|Withdrawal by Subject|15
358256|NCT00418938|1157507|P1|Overall Study|Withdrawal by Subject|16
358257|NCT00418938|1157506|P2|Overall Study|Administrative decision|3
358258|NCT00418938|1157507|P1|Overall Study|Administrative decision|3
358259|NCT00418938|1157506|P2|Overall Study|Reimbursement|0
358260|NCT00418938|1157507|P1|Overall Study|Reimbursement|1
358261|NCT00418886|1157527|P2|Overall Study|randomised but no treatment received|1
358262|NCT00418886|1157528|P1|Overall Study|randomised but no treatment received|0
358263|NCT00418886|1157527|P2|Overall Study|withdrawn due to other reason|0
358264|NCT00418886|1157528|P1|Overall Study|withdrawn due to other reason|1
358265|NCT00418886|1157527|P2|Overall Study|Lost to Follow-up|6
358266|NCT00418886|1157528|P1|Overall Study|Lost to Follow-up|4
358267|NCT00418886|1157527|P2|Overall Study|Withdrawal by Subject|10
358268|NCT00418886|1157528|P1|Overall Study|Withdrawal by Subject|9
358269|NCT00418886|1157527|P2|Overall Study|Death|147
358270|NCT00418886|1157528|P1|Overall Study|Death|122
358271|NCT00418886|1157527|P2|Overall Study|discontinue treatment survival follow up|91
358272|NCT00418886|1157528|P1|Overall Study|discontinue treatment survival follow up|90
358273|NCT00418834|1157554|P2|Overall Study|Withdrawal by Subject|7
358274|NCT00418834|1157555|P1|Overall Study|Withdrawal by Subject|3
358275|NCT00418834|1157554|P2|Overall Study|Protocol Violation|3
358276|NCT00418834|1157555|P1|Overall Study|Protocol Violation|4
358277|NCT00418834|1157554|P2|Overall Study|Lost to Follow-up|1
358278|NCT00418834|1157555|P1|Overall Study|Lost to Follow-up|0
358279|NCT00418834|1157554|P2|Overall Study|Adverse Event|9
358280|NCT00418834|1157555|P1|Overall Study|Adverse Event|16
358281|NCT00418717|1157615|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
358282|NCT00418717|1157615|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
358283|NCT00418691|1157623|P3|Overall Study|Progressive Disease|1
358284|NCT00418691|1157624|P2|Overall Study|Progressive Disease|0
358285|NCT00418691|1157625|P1|Overall Study|Progressive Disease|1
358286|NCT00418691|1157623|P3|Overall Study|Started new medication voiding entry|1
358287|NCT00418691|1157624|P2|Overall Study|Started new medication voiding entry|0
358288|NCT00418691|1157625|P1|Overall Study|Started new medication voiding entry|0
358289|NCT00418691|1157623|P3|Overall Study|Lost to Follow-up|3
358290|NCT00418691|1157624|P2|Overall Study|Lost to Follow-up|2
358291|NCT00418691|1157625|P1|Overall Study|Lost to Follow-up|1
358292|NCT00418665|1157636|P3|Treatment Extension|Death|1
358293|NCT00418665|1157637|P2|Treatment Extension|Death|0
358294|NCT00418665|1157638|P1|Treatment Extension|Death|0
358295|NCT00418665|1157636|P3|Treatment Extension|Physician Decision|1
358296|NCT00418665|1157637|P2|Treatment Extension|Physician Decision|2
358297|NCT00418665|1157638|P1|Treatment Extension|Physician Decision|2
358298|NCT00418665|1157636|P3|Treatment Extension|Requirement for alternative therapy|0
358299|NCT00418665|1157637|P2|Treatment Extension|Requirement for alternative therapy|2
358300|NCT00418665|1157638|P1|Treatment Extension|Requirement for alternative therapy|2
358301|NCT00418665|1157636|P3|Treatment Extension|Withdrawal by Subject|0
358302|NCT00418665|1157637|P2|Treatment Extension|Withdrawal by Subject|0
358303|NCT00418665|1157638|P1|Treatment Extension|Withdrawal by Subject|1
358304|NCT00418665|1157636|P3|Treatment Extension|Adverse Event|0
358305|NCT00418665|1157637|P2|Treatment Extension|Adverse Event|0
358306|NCT00418665|1157638|P1|Treatment Extension|Adverse Event|1
358307|NCT00418665|1157636|P3|Treatment Period|Physician Decision|3
358308|NCT00418665|1157637|P2|Treatment Period|Physician Decision|0
358309|NCT00418665|1157638|P1|Treatment Period|Physician Decision|1
358310|NCT00418665|1157636|P3|Treatment Period|Requirement for alternative therapy|0
358311|NCT00418665|1157637|P2|Treatment Period|Requirement for alternative therapy|0
358312|NCT00418665|1157638|P1|Treatment Period|Requirement for alternative therapy|1
358313|NCT00418665|1157636|P3|Treatment Period|Withdrawal by Subject|1
358314|NCT00418665|1157637|P2|Treatment Period|Withdrawal by Subject|3
358315|NCT00418665|1157638|P1|Treatment Period|Withdrawal by Subject|0
358316|NCT00418665|1157636|P3|Treatment Period|Adverse Event|0
358317|NCT00418665|1157637|P2|Treatment Period|Adverse Event|2
358318|NCT00418665|1157638|P1|Treatment Period|Adverse Event|2
358319|NCT00418665|1157636|P3|Treatment Period|Ineligibility determined|0
358320|NCT00418665|1157637|P2|Treatment Period|Ineligibility determined|1
358321|NCT00418665|1157638|P1|Treatment Period|Ineligibility determined|1
358322|NCT00418561|1157672|P3|Overall Study|Participant's (guardian's) decision|0
358323|NCT00418561|1157673|P2|Overall Study|Participant's (guardian's) decision|1
358324|NCT00418561|1157674|P1|Overall Study|Participant's (guardian's) decision|0
358325|NCT00418522|1157744|P2|Overall Study|Randomized but did not receive treatment|4
358326|NCT00418522|1157745|P1|Overall Study|Randomized but did not receive treatment|7
358327|NCT00418522|1157744|P2|Overall Study|Other|23
358328|NCT00418522|1157745|P1|Overall Study|Other|27
358329|NCT00418522|1157744|P2|Overall Study|Withdrawal by Subject|7
358330|NCT00418522|1157745|P1|Overall Study|Withdrawal by Subject|31
358331|NCT00418522|1157744|P2|Overall Study|Lost to Follow-up|4
358332|NCT00418522|1157745|P1|Overall Study|Lost to Follow-up|10
358333|NCT00418522|1157744|P2|Overall Study|Lack of Efficacy|3
358334|NCT00418522|1157745|P1|Overall Study|Lack of Efficacy|1
358335|NCT00418522|1157744|P2|Overall Study|Adverse Event|1
358336|NCT00418522|1157745|P1|Overall Study|Adverse Event|7
358337|NCT00418379|1157792|P3|Year 5|Any other reason not above-mentioned|3
358338|NCT00418379|1157793|P2|Year 5|Any other reason not above-mentioned|4
358339|NCT00418379|1157794|P1|Year 5|Any other reason not above-mentioned|2
358340|NCT00418379|1157792|P3|Year 5|Adverse Event|0
358341|NCT00418379|1157793|P2|Year 5|Adverse Event|1
358342|NCT00418379|1157794|P1|Year 5|Adverse Event|0
358343|NCT00418379|1157792|P3|Year 4|Any other reason not above-mentioned|0
358344|NCT00418379|1157793|P2|Year 4|Any other reason not above-mentioned|1
358345|NCT00418379|1157794|P1|Year 4|Any other reason not above-mentioned|1
358346|NCT00418379|1157792|P3|Year 4|Withdrawal by Subject|2
358347|NCT00418379|1157793|P2|Year 4|Withdrawal by Subject|3
358348|NCT00418379|1157794|P1|Year 4|Withdrawal by Subject|2
358349|NCT00418379|1157792|P3|Year 4|Adverse Event|0
358350|NCT00418379|1157793|P2|Year 4|Adverse Event|1
358351|NCT00418379|1157794|P1|Year 4|Adverse Event|0
358352|NCT00418379|1157792|P3|Year 3|Any other reason not above-mentioned|1
358353|NCT00418379|1157793|P2|Year 3|Any other reason not above-mentioned|1
358354|NCT00418379|1157794|P1|Year 3|Any other reason not above-mentioned|2
358355|NCT00418379|1157792|P3|Year 3|Withdrawal by Subject|2
358356|NCT00418379|1157793|P2|Year 3|Withdrawal by Subject|1
358357|NCT00418379|1157794|P1|Year 3|Withdrawal by Subject|1
358358|NCT00418379|1157792|P3|Year 2|Any other reason not above-mentioned|6
358359|NCT00418379|1157793|P2|Year 2|Any other reason not above-mentioned|1
358360|NCT00418379|1157794|P1|Year 2|Any other reason not above-mentioned|2
358361|NCT00418379|1157792|P3|Year 2|Withdrawal by Subject|3
358362|NCT00418379|1157793|P2|Year 2|Withdrawal by Subject|1
358363|NCT00418379|1157794|P1|Year 2|Withdrawal by Subject|1
358364|NCT00418379|1157792|P3|Year 2|Adverse Event|1
358365|NCT00418379|1157793|P2|Year 2|Adverse Event|2
358366|NCT00418379|1157794|P1|Year 2|Adverse Event|5
358367|NCT00418379|1157792|P3|Year 1|Any other reason not above-mentioned|7
358368|NCT00418379|1157793|P2|Year 1|Any other reason not above-mentioned|5
358369|NCT00418379|1157794|P1|Year 1|Any other reason not above-mentioned|2
358370|NCT00418379|1157792|P3|Year 1|Withdrawal by Subject|5
358371|NCT00418379|1157793|P2|Year 1|Withdrawal by Subject|8
358372|NCT00418379|1157794|P1|Year 1|Withdrawal by Subject|7
358373|NCT00418379|1157792|P3|Year 1|Adverse Event|3
358374|NCT00418379|1157793|P2|Year 1|Adverse Event|15
358375|NCT00418379|1157794|P1|Year 1|Adverse Event|9
358376|NCT00418314|1157804|P2|Overall Study|Withdrawal by Subject|2
358377|NCT00418314|1157805|P1|Overall Study|Withdrawal by Subject|1
358378|NCT00418184|1157817|P2|Double-blind Phase|Poor compliance|1
358379|NCT00418184|1157818|P1|Double-blind Phase|Poor compliance|3
358380|NCT00418184|1157817|P2|Double-blind Phase|Adverse Event|1
358381|NCT00418184|1157818|P1|Double-blind Phase|Adverse Event|2
358382|NCT00418184|1157817|P2|Double-blind Phase|Withdrawal by Subject|9
358383|NCT00418184|1157818|P1|Double-blind Phase|Withdrawal by Subject|22
358384|NCT00418145|1157826|P1|Overall Study|study terminated|6
358385|NCT00417989|1157880|P2|Overall Study|Physician Decision|2
358386|NCT00417989|1157881|P1|Overall Study|Physician Decision|5
358387|NCT00417989|1157880|P2|Overall Study|Death|1
358388|NCT00417989|1157881|P1|Overall Study|Death|0
358389|NCT00417989|1157880|P2|Overall Study|Protocol Violation|0
358390|NCT00417989|1157881|P1|Overall Study|Protocol Violation|1
358391|NCT00417989|1157880|P2|Overall Study|Lost to Follow-up|6
358392|NCT00417989|1157881|P1|Overall Study|Lost to Follow-up|1
358393|NCT00417989|1157880|P2|Overall Study|Withdrawal by Subject|13
358394|NCT00417989|1157881|P1|Overall Study|Withdrawal by Subject|13
358395|NCT00417885|1157901|P1|Overall Study|Transferred to Another Sunitinib Study|2
358396|NCT00417885|1157901|P1|Overall Study|Objective Progression or Relapse|3
358397|NCT00417885|1157901|P1|Overall Study|Adverse Event|1
358398|NCT00417612|1157912|P2|Overall Study|Lost to Follow-up|0
358399|NCT00417612|1157913|P1|Overall Study|Lost to Follow-up|1
358400|NCT00417612|1157912|P2|Overall Study|Protocol Violation|2
358401|NCT00417612|1157913|P1|Overall Study|Protocol Violation|0
358402|NCT00417612|1157912|P2|Overall Study|Adverse Event|0
358403|NCT00417612|1157913|P1|Overall Study|Adverse Event|2
358404|NCT00417612|1157912|P2|Overall Study|Errant diagnosis|1
358405|NCT00417612|1157913|P1|Overall Study|Errant diagnosis|0
358406|NCT00417482|1157939|P3|Phase B 2nd 16 Weeks|Death|0
358407|NCT00417482|1157940|P2|Phase B 2nd 16 Weeks|Death|1
358408|NCT00417482|1157941|P1|Phase B 2nd 16 Weeks|Death|1
358409|NCT00417482|1157939|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
358410|NCT00417482|1157940|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
358411|NCT00417482|1157941|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
358412|NCT00417482|1157939|P3|Phase B 2nd 16 Weeks|Adverse Event|1
358413|NCT00417482|1157940|P2|Phase B 2nd 16 Weeks|Adverse Event|0
358414|NCT00417482|1157941|P1|Phase B 2nd 16 Weeks|Adverse Event|0
358415|NCT00417482|1157939|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
358416|NCT00417482|1157940|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
358417|NCT00417482|1157941|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
358418|NCT00417482|1157939|P3|Phase B 1st 16 Weeks|Death|0
358419|NCT00417482|1157940|P2|Phase B 1st 16 Weeks|Death|0
358420|NCT00417482|1157941|P1|Phase B 1st 16 Weeks|Death|1
358421|NCT00417482|1157939|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
358422|NCT00417482|1157940|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
358423|NCT00417482|1157941|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
358424|NCT00417482|1157939|P3|Phase B 1st 16 Weeks|Adverse Event|1
358425|NCT00417482|1157940|P2|Phase B 1st 16 Weeks|Adverse Event|0
358426|NCT00417482|1157941|P1|Phase B 1st 16 Weeks|Adverse Event|2
358427|NCT00417482|1157939|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
358428|NCT00417482|1157940|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
358429|NCT00417482|1157941|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
358430|NCT00417248|1157980|P1|Overall Study|Lack of Efficacy|1
358431|NCT00417248|1157980|P1|Overall Study|Death|1
358432|NCT00417248|1157980|P1|Overall Study|Study Terminated|6
358433|NCT00417170|1157987|P2|Overall Study|Lost to Follow-up|1
358434|NCT00417170|1157988|P1|Overall Study|Lost to Follow-up|0
358435|NCT00417170|1157987|P2|Overall Study|Withdrawal by Subject|1
358436|NCT00417170|1157988|P1|Overall Study|Withdrawal by Subject|1
358437|NCT00417170|1157987|P2|Overall Study|Adverse Event|1
358438|NCT00417170|1157988|P1|Overall Study|Adverse Event|1
358439|NCT00417079|1158004|P2|Overall Study|abnormal liver function tests|1
358440|NCT00417079|1158005|P1|Overall Study|abnormal liver function tests|0
358441|NCT00417079|1158004|P2|Overall Study|Patient unable to come to the clinic|1
358442|NCT00417079|1158005|P1|Overall Study|Patient unable to come to the clinic|0
358443|NCT00417079|1158004|P2|Overall Study|Withdrawal by subject's family|1
358444|NCT00417079|1158005|P1|Overall Study|Withdrawal by subject's family|0
358445|NCT00417079|1158004|P2|Overall Study|Screening error|1
358446|NCT00417079|1158005|P1|Overall Study|Screening error|2
358447|NCT00417079|1158004|P2|Overall Study|Clinical deterioration|0
358448|NCT00417079|1158005|P1|Overall Study|Clinical deterioration|1
358449|NCT00417079|1158004|P2|Overall Study|Non-confirmed Disease progression|1
358450|NCT00417079|1158005|P1|Overall Study|Non-confirmed Disease progression|1
358451|NCT00417079|1158004|P2|Overall Study|Investigator's decision|4
358452|NCT00417079|1158005|P1|Overall Study|Investigator's decision|1
358453|NCT00417079|1158004|P2|Overall Study|Screened failure|1
358454|NCT00417079|1158005|P1|Overall Study|Screened failure|2
358455|NCT00417079|1158004|P2|Overall Study|Not treated|7
358456|NCT00417079|1158005|P1|Overall Study|Not treated|6
358457|NCT00417079|1158004|P2|Overall Study|Withdrawal by Subject|8
358458|NCT00417079|1158005|P1|Overall Study|Withdrawal by Subject|17
358459|NCT00417079|1158004|P2|Overall Study|Lost to Follow-up|0
358460|NCT00417079|1158005|P1|Overall Study|Lost to Follow-up|2
358461|NCT00417079|1158004|P2|Overall Study|Non-compliance to protocol|1
358462|NCT00417079|1158005|P1|Overall Study|Non-compliance to protocol|0
358463|NCT00417079|1158004|P2|Overall Study|Adverse Event|67
358464|NCT00417079|1158005|P1|Overall Study|Adverse Event|32
358465|NCT00417079|1158004|P2|Overall Study|Disease progression|180
358466|NCT00417079|1158005|P1|Overall Study|Disease progression|267
358467|NCT00417027|1158028|P3|Overall Study|Protocol Violation|5
358468|NCT00417027|1158029|P2|Overall Study|Protocol Violation|5
358469|NCT00417027|1158030|P1|Overall Study|Protocol Violation|0
358470|NCT00416884|1158056|P1|Overall Study|Study terminated due to low accrual|1
358471|NCT00416624|1158068|P4|Overall Study|Cancel|0
358472|NCT00416624|1158069|P3|Overall Study|Cancel|0
358473|NCT00416624|1158070|P2|Overall Study|Cancel|0
358474|NCT00416624|1158071|P1|Overall Study|Cancel|1
358475|NCT00416624|1158068|P4|Overall Study|Not Specified|5
358476|NCT00416624|1158069|P3|Overall Study|Not Specified|5
358477|NCT00416624|1158070|P2|Overall Study|Not Specified|11
358478|NCT00416624|1158071|P1|Overall Study|Not Specified|8
358479|NCT00416624|1158068|P4|Overall Study|Adverse Event|2
358480|NCT00416624|1158069|P3|Overall Study|Adverse Event|2
358481|NCT00416624|1158070|P2|Overall Study|Adverse Event|3
358482|NCT00416624|1158071|P1|Overall Study|Adverse Event|8
358483|NCT00416624|1158068|P4|Overall Study|Death|1
358484|NCT00416624|1158069|P3|Overall Study|Death|7
358485|NCT00416624|1158070|P2|Overall Study|Death|7
358486|NCT00416624|1158071|P1|Overall Study|Death|4
358487|NCT00416624|1158068|P4|Overall Study|Withdrawal by Subject|9
358488|NCT00416624|1158069|P3|Overall Study|Withdrawal by Subject|4
358489|NCT00416624|1158070|P2|Overall Study|Withdrawal by Subject|6
358490|NCT00416624|1158071|P1|Overall Study|Withdrawal by Subject|1
358491|NCT00416598|1158125|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
358492|NCT00416598|1158125|P1|Decitabine Maintenance|Alternative treatment|2
358493|NCT00416598|1158125|P1|Decitabine Maintenance|Progression/relapse|38
358494|NCT00416598|1158125|P1|Decitabine Maintenance|Withdrawal by Subject|18
358495|NCT00416598|1158125|P1|Decitabine Maintenance|Adverse Event|5
358496|NCT00416598|1158125|P1|Induction & Intensification|Failed induction|87
358497|NCT00416598|1158125|P1|Induction & Intensification|Relapse/progression|29
358498|NCT00416598|1158125|P1|Induction & Intensification|Physician discretion/other medical issue|45
358499|NCT00416598|1158125|P1|Induction & Intensification|Alternative Treatment|135
358500|NCT00416598|1158125|P1|Induction & Intensification|Withdrawal by Subject|46
358501|NCT00416598|1158125|P1|Induction & Intensification|Death|32
358502|NCT00416598|1158125|P1|Induction & Intensification|Adverse Event|38
358503|NCT00416520|1158151|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
358504|NCT00416520|1158152|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
358505|NCT00416520|1158153|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
358506|NCT00416520|1158154|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
358507|NCT00416520|1158151|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
358508|NCT00416520|1158152|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
358509|NCT00416520|1158153|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
358510|NCT00416520|1158154|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
358511|NCT00416520|1158151|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
358512|NCT00416520|1158152|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
358513|NCT00416520|1158153|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
358514|NCT00416520|1158154|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
358515|NCT00416520|1158151|P4|Open-label Period|Other Reasons|0
358516|NCT00416520|1158152|P3|Open-label Period|Other Reasons|0
358517|NCT00416520|1158153|P2|Open-label Period|Other Reasons|12
358518|NCT00416520|1158154|P1|Open-label Period|Other Reasons|3
358519|NCT00416520|1158151|P4|Open-label Period|Withdrawal by Subject|0
358520|NCT00416520|1158152|P3|Open-label Period|Withdrawal by Subject|0
358521|NCT00416520|1158153|P2|Open-label Period|Withdrawal by Subject|5
358522|NCT00416520|1158154|P1|Open-label Period|Withdrawal by Subject|16
358523|NCT00416520|1158151|P4|Open-label Period|Protocol Violation|0
358524|NCT00416520|1158152|P3|Open-label Period|Protocol Violation|0
358525|NCT00416520|1158153|P2|Open-label Period|Protocol Violation|3
358526|NCT00416520|1158154|P1|Open-label Period|Protocol Violation|3
358527|NCT00416520|1158151|P4|Open-label Period|Lack of Efficacy|0
358528|NCT00416520|1158152|P3|Open-label Period|Lack of Efficacy|0
358529|NCT00416520|1158153|P2|Open-label Period|Lack of Efficacy|1
358530|NCT00416520|1158154|P1|Open-label Period|Lack of Efficacy|8
358531|NCT00416520|1158151|P4|Open-label Period|Death|0
358532|NCT00416520|1158152|P3|Open-label Period|Death|0
358533|NCT00416520|1158153|P2|Open-label Period|Death|1
358534|NCT00416520|1158154|P1|Open-label Period|Death|2
358535|NCT00416520|1158151|P4|Open-label Period|Adverse Event|0
358536|NCT00416520|1158152|P3|Open-label Period|Adverse Event|0
358537|NCT00416520|1158153|P2|Open-label Period|Adverse Event|10
358538|NCT00416520|1158154|P1|Open-label Period|Adverse Event|28
358539|NCT00416455|1158183|P2|Overall Study|Inadequate pathology|2
358540|NCT00416455|1158184|P1|Overall Study|Inadequate pathology|11
358541|NCT00416455|1158183|P2|Overall Study|PET / CT poor quality|1
358542|NCT00416455|1158184|P1|Overall Study|PET / CT poor quality|2
358543|NCT00416455|1158183|P2|Overall Study|PET / CT not done|5
358544|NCT00416455|1158184|P1|Overall Study|PET / CT not done|3
358545|NCT00416195|1158198|P2|Overall Study|Not Specified|1
358546|NCT00416195|1158199|P1|Overall Study|Not Specified|0
358547|NCT00416195|1158198|P2|Overall Study|Protocol Violation|1
358548|NCT00416195|1158199|P1|Overall Study|Protocol Violation|1
358549|NCT00416195|1158198|P2|Overall Study|Adverse Event|2
358550|NCT00416195|1158199|P1|Overall Study|Adverse Event|1
358551|NCT00416078|1158224|P2|Overall Study|Lost to Follow-up|2
358552|NCT00416078|1158225|P1|Overall Study|Lost to Follow-up|4
358553|NCT00416078|1158224|P2|Overall Study|Physician Decision|0
358554|NCT00416078|1158225|P1|Overall Study|Physician Decision|1
358555|NCT00416078|1158224|P2|Overall Study|Withdrawal by Subject|2
358556|NCT00416078|1158225|P1|Overall Study|Withdrawal by Subject|3
358557|NCT00416078|1158224|P2|Overall Study|Death|4
358558|NCT00416078|1158225|P1|Overall Study|Death|3
358559|NCT00415909|1158241|P1|Overall Study|Death|1
358560|NCT00415909|1158241|P1|Overall Study|Withdrawal by Subject|2
358561|NCT00415623|1158267|P2|Overall Study|Withdrawal by Subject|1
358562|NCT00415623|1158268|P1|Overall Study|Withdrawal by Subject|1
358563|NCT00415623|1158267|P2|Overall Study|Death|0
358564|NCT00415623|1158268|P1|Overall Study|Death|1
358565|NCT00415623|1158267|P2|Overall Study|Adverse Event|4
358566|NCT00415623|1158268|P1|Overall Study|Adverse Event|3
358567|NCT00415610|1158295|P3|Overall Study|Death|5
358568|NCT00415610|1158296|P2|Overall Study|Death|2
358569|NCT00415610|1158297|P1|Overall Study|Death|3
358570|NCT00415597|1158311|P1|Treatment|Multiple Reasons|1
358571|NCT00415597|1158311|P1|Treatment|Sponsor Decision|1
358572|NCT00415597|1158311|P1|Treatment|Administrative|3
358573|NCT00415597|1158311|P1|Treatment|Drug Screen|2
358574|NCT00415597|1158311|P1|Treatment|Lost to Follow-up|28
358575|NCT00415597|1158311|P1|Treatment|Withdrawal by Subject|51
358576|NCT00415597|1158311|P1|Treatment|Physician Decision|3
358577|NCT00415597|1158311|P1|Treatment|Protocol Violation|67
358578|NCT00415597|1158311|P1|Treatment|Lack of Efficacy|39
358579|NCT00415597|1158311|P1|Treatment|Adverse Event|110
358580|NCT00415597|1158311|P1|Enrollment|Protocol Violation|1
358581|NCT00415597|1158311|P1|Enrollment|Withdrawal by Subject|1
358582|NCT00415532|1158319|P2|Safety Follow Up Period|Requirement for alternative therapy|1
358583|NCT00415532|1158320|P1|Safety Follow Up Period|Requirement for alternative therapy|0
358584|NCT00415532|1158319|P2|Safety Follow Up Period|Noncompliance|0
358585|NCT00415532|1158320|P1|Safety Follow Up Period|Noncompliance|1
358586|NCT00415532|1158319|P2|Safety Follow Up Period|Ineligibility determined|1
358587|NCT00415532|1158320|P1|Safety Follow Up Period|Ineligibility determined|1
358588|NCT00415532|1158319|P2|Safety Follow Up Period|Other|4
358589|NCT00415532|1158320|P1|Safety Follow Up Period|Other|1
358590|NCT00415532|1158319|P2|Safety Follow Up Period|Withdrawal by Subject|3
358591|NCT00415532|1158320|P1|Safety Follow Up Period|Withdrawal by Subject|2
358592|NCT00415532|1158319|P2|Safety Follow Up Period|Death|0
358593|NCT00415532|1158320|P1|Safety Follow Up Period|Death|3
358594|NCT00415532|1158319|P2|Safety Follow Up Period|Adverse Event|3
358595|NCT00415532|1158320|P1|Safety Follow Up Period|Adverse Event|1
358596|NCT00415532|1158319|P2|Treatment Period|Requirement for alternative therapy|0
358597|NCT00415532|1158320|P1|Treatment Period|Requirement for alternative therapy|1
358598|NCT00415532|1158319|P2|Treatment Period|Noncompliance|1
358599|NCT00415532|1158320|P1|Treatment Period|Noncompliance|1
358600|NCT00415532|1158319|P2|Treatment Period|Ineligibility determined|1
358601|NCT00415532|1158320|P1|Treatment Period|Ineligibility determined|1
358602|NCT00415532|1158319|P2|Treatment Period|Other|2
358603|NCT00415532|1158320|P1|Treatment Period|Other|2
358604|NCT00415532|1158319|P2|Treatment Period|Withdrawal by Subject|6
358605|NCT00415532|1158320|P1|Treatment Period|Withdrawal by Subject|6
358606|NCT00415532|1158319|P2|Treatment Period|Protocol Violation|0
358607|NCT00415532|1158320|P1|Treatment Period|Protocol Violation|1
358608|NCT00415532|1158319|P2|Treatment Period|Lost to Follow-up|1
358609|NCT00415532|1158320|P1|Treatment Period|Lost to Follow-up|1
358610|NCT00415532|1158319|P2|Treatment Period|Death|1
358611|NCT00415532|1158320|P1|Treatment Period|Death|2
358612|NCT00415532|1158319|P2|Treatment Period|Adverse Event|3
358613|NCT00415532|1158320|P1|Treatment Period|Adverse Event|2
358614|NCT00415194|1158362|P2|Overall Study|Death Due to AE (Other Causes)|15
358615|NCT00415194|1158363|P1|Overall Study|Death Due to AE (Other Causes)|27
358616|NCT00415194|1158362|P2|Overall Study|Death Due to Procedural Related AE|1
358617|NCT00415194|1158363|P1|Overall Study|Death Due to Procedural Related AE|0
358618|NCT00415194|1158362|P2|Overall Study|Death Due to Study Drug Related AE|1
358619|NCT00415194|1158363|P1|Overall Study|Death Due to Study Drug Related AE|11
358620|NCT00415194|1158362|P2|Overall Study|Death Due to Study Disease|29
358621|NCT00415194|1158363|P1|Overall Study|Death Due to Study Disease|26
358622|NCT00415194|1158362|P2|Overall Study|Withdrawal by Subject|21
358623|NCT00415194|1158363|P1|Overall Study|Withdrawal by Subject|28
358624|NCT00415194|1158362|P2|Overall Study|Protocol Violation|2
358625|NCT00415194|1158363|P1|Overall Study|Protocol Violation|4
358626|NCT00415194|1158362|P2|Overall Study|Progressive Disease|217
358627|NCT00415194|1158363|P1|Overall Study|Progressive Disease|180
358628|NCT00415194|1158362|P2|Overall Study|Physician Decision|16
358629|NCT00415194|1158363|P1|Overall Study|Physician Decision|10
358630|NCT00415194|1158362|P2|Overall Study|Lost to Follow-up|0
358631|NCT00415194|1158363|P1|Overall Study|Lost to Follow-up|1
358632|NCT00415194|1158362|P2|Overall Study|Entry Criteria Not Met|8
358633|NCT00415194|1158363|P1|Overall Study|Entry Criteria Not Met|4
358634|NCT00415194|1158362|P2|Overall Study|Adverse Event|32
358635|NCT00415194|1158363|P1|Overall Study|Adverse Event|37
358636|NCT00415168|1158379|P1|Overall Study|Withdrawal by Subject|6
358637|NCT00415168|1158379|P1|Overall Study|Sponsor Decision|4
358638|NCT00415168|1158379|P1|Overall Study|Physician Decision|13
358639|NCT00415168|1158379|P1|Overall Study|Lost to Follow-up|3
358640|NCT00415168|1158379|P1|Overall Study|Death|26
358641|NCT00415051|1158389|P1|Overall Study|Protocol Violation|1
358642|NCT00414973|1158400|P4|Overall Study|Death|0
358643|NCT00414973|1158401|P3|Overall Study|Death|1
358644|NCT00414973|1158402|P2|Overall Study|Death|0
358645|NCT00414973|1158403|P1|Overall Study|Death|0
358646|NCT00414973|1158400|P4|Overall Study|Sponsor Decision|0
358647|NCT00414973|1158401|P3|Overall Study|Sponsor Decision|0
358648|NCT00414973|1158402|P2|Overall Study|Sponsor Decision|0
358649|NCT00414973|1158403|P1|Overall Study|Sponsor Decision|1
358650|NCT00414973|1158400|P4|Overall Study|Lost to Follow-up|0
358651|NCT00414973|1158401|P3|Overall Study|Lost to Follow-up|0
358652|NCT00414973|1158402|P2|Overall Study|Lost to Follow-up|2
358653|NCT00414973|1158403|P1|Overall Study|Lost to Follow-up|0
358654|NCT00414973|1158400|P4|Overall Study|Protocol Violation|0
358655|NCT00414973|1158401|P3|Overall Study|Protocol Violation|0
358656|NCT00414973|1158402|P2|Overall Study|Protocol Violation|4
358657|NCT00414973|1158403|P1|Overall Study|Protocol Violation|3
358658|NCT00414973|1158400|P4|Overall Study|Adverse Event|0
358659|NCT00414973|1158401|P3|Overall Study|Adverse Event|1
358660|NCT00414973|1158402|P2|Overall Study|Adverse Event|0
358661|NCT00414973|1158403|P1|Overall Study|Adverse Event|10
358662|NCT00414973|1158400|P4|Overall Study|Withdrawal by Subject|0
358663|NCT00414973|1158401|P3|Overall Study|Withdrawal by Subject|1
358664|NCT00414973|1158402|P2|Overall Study|Withdrawal by Subject|4
358665|NCT00414973|1158403|P1|Overall Study|Withdrawal by Subject|14
358666|NCT00414908|1158423|P2|Overall Study|Protocol Violation|1
358667|NCT00414908|1158424|P1|Overall Study|Protocol Violation|1
358668|NCT00414726|1158461|P2|Overall Study|Withdrawal by Subject|1
358669|NCT00414726|1158462|P1|Overall Study|Withdrawal by Subject|0
358670|NCT00414661|1158497|P4|Overall Study|Unspecified|0
358671|NCT00414661|1158498|P3|Overall Study|Unspecified|0
358672|NCT00414661|1158499|P2|Overall Study|Unspecified|3
358673|NCT00414661|1158500|P1|Overall Study|Unspecified|6
358674|NCT00414661|1158497|P4|Overall Study|Withdrawal by Subject|2
358675|NCT00414661|1158498|P3|Overall Study|Withdrawal by Subject|2
358676|NCT00414661|1158499|P2|Overall Study|Withdrawal by Subject|2
358677|NCT00414661|1158500|P1|Overall Study|Withdrawal by Subject|5
358678|NCT00414661|1158497|P4|Overall Study|Lost to Follow-up|1
358679|NCT00414661|1158498|P3|Overall Study|Lost to Follow-up|0
358680|NCT00414661|1158499|P2|Overall Study|Lost to Follow-up|4
358681|NCT00414661|1158500|P1|Overall Study|Lost to Follow-up|1
358682|NCT00414661|1158497|P4|Overall Study|Death|0
358683|NCT00414661|1158498|P3|Overall Study|Death|0
358684|NCT00414661|1158499|P2|Overall Study|Death|5
358685|NCT00414661|1158500|P1|Overall Study|Death|2
358686|NCT00414609|1158545|P3|Extension Study|Death|17
358687|NCT00414609|1158546|P2|Extension Study|Death|0
358688|NCT00414609|1158547|P1|Extension Study|Death|0
358689|NCT00414609|1158545|P3|Extension Study|Administrative problems|1
358690|NCT00414609|1158546|P2|Extension Study|Administrative problems|0
358691|NCT00414609|1158547|P1|Extension Study|Administrative problems|0
358692|NCT00414609|1158545|P3|Extension Study|Lost to Follow-up|10
358693|NCT00414609|1158546|P2|Extension Study|Lost to Follow-up|0
358694|NCT00414609|1158547|P1|Extension Study|Lost to Follow-up|0
358695|NCT00414609|1158545|P3|Extension Study|Withdrawal by Subject|13
358696|NCT00414609|1158546|P2|Extension Study|Withdrawal by Subject|0
358697|NCT00414609|1158547|P1|Extension Study|Withdrawal by Subject|0
358698|NCT00414609|1158545|P3|Extension Study|Unsatisfactory therapeutic effect|2
358699|NCT00414609|1158546|P2|Extension Study|Unsatisfactory therapeutic effect|0
358700|NCT00414609|1158547|P1|Extension Study|Unsatisfactory therapeutic effect|0
358701|NCT00414609|1158545|P3|Extension Study|Adverse Event|14
358702|NCT00414609|1158546|P2|Extension Study|Adverse Event|0
358703|NCT00414609|1158547|P1|Extension Study|Adverse Event|0
358704|NCT00414609|1158545|P3|Core Study|Death|0
358705|NCT00414609|1158546|P2|Core Study|Death|14
358706|NCT00414609|1158547|P1|Core Study|Death|7
358707|NCT00414609|1158545|P3|Core Study|Administrative problems|0
358708|NCT00414609|1158546|P2|Core Study|Administrative problems|2
358709|NCT00414609|1158547|P1|Core Study|Administrative problems|0
358710|NCT00414609|1158545|P3|Core Study|Lost to Follow-up|0
358711|NCT00414609|1158546|P2|Core Study|Lost to Follow-up|4
358712|NCT00414609|1158547|P1|Core Study|Lost to Follow-up|7
358713|NCT00414609|1158545|P3|Core Study|Patient withdrew consent|0
358714|NCT00414609|1158546|P2|Core Study|Patient withdrew consent|11
358715|NCT00414609|1158547|P1|Core Study|Patient withdrew consent|10
358716|NCT00414609|1158545|P3|Core Study|Protocol deviation|0
358717|NCT00414609|1158546|P2|Core Study|Protocol deviation|1
358718|NCT00414609|1158547|P1|Core Study|Protocol deviation|0
358719|NCT00414609|1158545|P3|Core Study|Abnormal test procedure results|0
358720|NCT00414609|1158546|P2|Core Study|Abnormal test procedure results|1
358721|NCT00414609|1158547|P1|Core Study|Abnormal test procedure results|1
358722|NCT00414609|1158545|P3|Core Study|Abnormal laboratory values|0
358723|NCT00414609|1158546|P2|Core Study|Abnormal laboratory values|1
358724|NCT00414609|1158547|P1|Core Study|Abnormal laboratory values|0
358725|NCT00414609|1158545|P3|Core Study|Adverse Event|0
358726|NCT00414609|1158546|P2|Core Study|Adverse Event|11
358727|NCT00414609|1158547|P1|Core Study|Adverse Event|9
358728|NCT00414596|1158570|P1|Overall Study|Protocol Violation|2
358729|NCT00414544|1158579|P1|Overall Study|Lost to Follow-up|14
358730|NCT00414466|1158602|P4|Overall Study|Withdrawn by Sponsor|0
358731|NCT00414466|1158603|P3|Overall Study|Withdrawn by Sponsor|0
358732|NCT00414466|1158604|P2|Overall Study|Withdrawn by Sponsor|0
358733|NCT00414466|1158605|P1|Overall Study|Withdrawn by Sponsor|1
358734|NCT00414466|1158602|P4|Overall Study|Lack of Efficacy|0
358735|NCT00414466|1158603|P3|Overall Study|Lack of Efficacy|0
358736|NCT00414466|1158604|P2|Overall Study|Lack of Efficacy|0
358737|NCT00414466|1158605|P1|Overall Study|Lack of Efficacy|1
358738|NCT00414466|1158602|P4|Overall Study|Adverse Event|1
358739|NCT00414466|1158603|P3|Overall Study|Adverse Event|1
358740|NCT00414466|1158604|P2|Overall Study|Adverse Event|0
358741|NCT00414466|1158605|P1|Overall Study|Adverse Event|0
358742|NCT00414453|1158623|P1|Overall Study|Abnormal lab work|16
358743|NCT00414440|1158671|P2|Extension Period|Not included in follow up period|8
358744|NCT00414440|1158672|P1|Extension Period|Not included in follow up period|18
358745|NCT00414440|1158671|P2|Extension Period|Withdrawal by Subject|7
358746|NCT00414440|1158672|P1|Extension Period|Withdrawal by Subject|9
358747|NCT00414440|1158671|P2|Extension Period|Death|2
358748|NCT00414440|1158672|P1|Extension Period|Death|1
358749|NCT00414440|1158671|P2|Extension Period|Administrative|16
358750|NCT00414440|1158672|P1|Extension Period|Administrative|16
358751|NCT00414440|1158671|P2|Extension Period|Other|1
358752|NCT00414440|1158672|P1|Extension Period|Other|1
358753|NCT00414440|1158671|P2|Extension Period|Did not consent to continue follow up|54
358754|NCT00414440|1158672|P1|Extension Period|Did not consent to continue follow up|61
358755|NCT00414440|1158671|P2|Extension Period|Lost to Follow-up|52
358756|NCT00414440|1158672|P1|Extension Period|Lost to Follow-up|44
358757|NCT00414440|1158671|P2|Core Period|Withdrawal by Subject|32
358758|NCT00414440|1158672|P1|Core Period|Withdrawal by Subject|70
358759|NCT00414388|1158686|P1|Overall Study|Adverse Event|1
358760|NCT00414310|1158694|P2|Overall Study|Not treated|0
358761|NCT00414310|1158695|P1|Overall Study|Not treated|1
358762|NCT00414050|1158729|P4|Overall Study|Subject Moved|1
358763|NCT00414050|1158730|P3|Overall Study|Subject Moved|0
358764|NCT00414050|1158731|P2|Overall Study|Subject Moved|0
358765|NCT00414050|1158732|P1|Overall Study|Subject Moved|0
358766|NCT00414050|1158729|P4|Overall Study|Subject discontinued for other reason|1
358767|NCT00414050|1158730|P3|Overall Study|Subject discontinued for other reason|2
358768|NCT00414050|1158731|P2|Overall Study|Subject discontinued for other reason|2
358769|NCT00414050|1158732|P1|Overall Study|Subject discontinued for other reason|1
358770|NCT00414050|1158729|P4|Overall Study|Withdrawal by Subject|4
358771|NCT00414050|1158730|P3|Overall Study|Withdrawal by Subject|2
358772|NCT00414050|1158731|P2|Overall Study|Withdrawal by Subject|3
358773|NCT00414050|1158732|P1|Overall Study|Withdrawal by Subject|5
358774|NCT00414050|1158729|P4|Overall Study|Lost to Follow-up|1
358775|NCT00414050|1158730|P3|Overall Study|Lost to Follow-up|1
358776|NCT00414050|1158731|P2|Overall Study|Lost to Follow-up|2
358777|NCT00414050|1158732|P1|Overall Study|Lost to Follow-up|2
358778|NCT00414050|1158729|P4|Overall Study|Adverse Event|1
358779|NCT00414050|1158730|P3|Overall Study|Adverse Event|1
358780|NCT00414050|1158731|P2|Overall Study|Adverse Event|1
358781|NCT00414050|1158732|P1|Overall Study|Adverse Event|1
358782|NCT00414011|1158746|P1|Overall Study|Withdrawal by Subject|2
358783|NCT00414011|1158746|P1|Overall Study|Physician Decision|3
358784|NCT00413972|1158755|P4|Overall Study|Not Specified|1
358785|NCT00413972|1158756|P3|Overall Study|Not Specified|0
358786|NCT00413972|1158757|P2|Overall Study|Not Specified|0
358787|NCT00413972|1158758|P1|Overall Study|Not Specified|0
358788|NCT00413972|1158755|P4|Overall Study|Protocol Violation|0
358789|NCT00413972|1158756|P3|Overall Study|Protocol Violation|2
358790|NCT00413972|1158757|P2|Overall Study|Protocol Violation|0
358791|NCT00413972|1158758|P1|Overall Study|Protocol Violation|0
358792|NCT00413972|1158755|P4|Overall Study|Withdrawal by Subject|2
358793|NCT00413972|1158756|P3|Overall Study|Withdrawal by Subject|7
358794|NCT00413972|1158757|P2|Overall Study|Withdrawal by Subject|5
358795|NCT00413972|1158758|P1|Overall Study|Withdrawal by Subject|4
358796|NCT00413972|1158755|P4|Overall Study|Lost to Follow-up|0
358797|NCT00413972|1158756|P3|Overall Study|Lost to Follow-up|1
358798|NCT00413972|1158757|P2|Overall Study|Lost to Follow-up|2
358799|NCT00413972|1158758|P1|Overall Study|Lost to Follow-up|1
358800|NCT00413972|1158755|P4|Overall Study|Adverse Event|0
358801|NCT00413972|1158756|P3|Overall Study|Adverse Event|0
358802|NCT00413972|1158757|P2|Overall Study|Adverse Event|1
358803|NCT00413972|1158758|P1|Overall Study|Adverse Event|2
358804|NCT00413959|1158768|P1|Overall Study|Pt had only one cycle.|1
358805|NCT00413920|1158775|P2|Overall Study|Graft Loss|3
358806|NCT00413920|1158776|P1|Overall Study|Graft Loss|5
358807|NCT00413920|1158775|P2|Overall Study|Death|5
358808|NCT00413920|1158776|P1|Overall Study|Death|3
358809|NCT00413920|1158775|P2|Overall Study|Lack of Efficacy|9
358810|NCT00413920|1158776|P1|Overall Study|Lack of Efficacy|11
358811|NCT00413920|1158775|P2|Overall Study|Adverse Event|11
358812|NCT00413920|1158776|P1|Overall Study|Adverse Event|9
358813|NCT00413894|1158791|P1|Overall Study|Unspecified|18
358814|NCT00413894|1158791|P1|Overall Study|Protocol Violation|11
358815|NCT00413894|1158791|P1|Overall Study|Adverse Event|28
358816|NCT00413894|1158791|P1|Overall Study|Hb <10 grams/deciliter|12
358817|NCT00413894|1158791|P1|Overall Study|Administrative Reasons|1
358818|NCT00413894|1158791|P1|Overall Study|Withdrawal by Subject|10
358819|NCT00413660|1158813|P11|Post Week 12|Unspecified|0
358820|NCT00413660|1158814|P10|Post Week 12|Unspecified|0
358821|NCT00413660|1158815|P9|Post Week 12|Unspecified|0
358822|NCT00413660|1158816|P8|Post Week 12|Unspecified|0
358823|NCT00413660|1158817|P7|Post Week 12|Unspecified|1
358824|NCT00413660|1158818|P6|Post Week 12|Unspecified|1
358825|NCT00413660|1158819|P5|Post Week 12|Unspecified|1
358826|NCT00413660|1158820|P4|Post Week 12|Unspecified|0
358827|NCT00413660|1158821|P3|Post Week 12|Unspecified|3
358828|NCT00413660|1158822|P2|Post Week 12|Unspecified|2
358829|NCT00413660|1158823|P1|Post Week 12|Unspecified|1
358830|NCT00413660|1158813|P11|Post Week 12|Withdrawal by Subject|1
358831|NCT00413660|1158814|P10|Post Week 12|Withdrawal by Subject|0
358832|NCT00413660|1158815|P9|Post Week 12|Withdrawal by Subject|0
358833|NCT00413660|1158816|P8|Post Week 12|Withdrawal by Subject|0
358834|NCT00413660|1158817|P7|Post Week 12|Withdrawal by Subject|0
358835|NCT00413660|1158818|P6|Post Week 12|Withdrawal by Subject|0
358836|NCT00413660|1158819|P5|Post Week 12|Withdrawal by Subject|1
358837|NCT00413660|1158820|P4|Post Week 12|Withdrawal by Subject|0
358838|NCT00413660|1158821|P3|Post Week 12|Withdrawal by Subject|1
358839|NCT00413660|1158822|P2|Post Week 12|Withdrawal by Subject|1
358840|NCT00413660|1158823|P1|Post Week 12|Withdrawal by Subject|0
358841|NCT00413660|1158813|P11|Post Week 12|Lost to Follow-up|0
358842|NCT00413660|1158814|P10|Post Week 12|Lost to Follow-up|0
358843|NCT00413660|1158815|P9|Post Week 12|Lost to Follow-up|0
358844|NCT00413660|1158816|P8|Post Week 12|Lost to Follow-up|0
358845|NCT00413660|1158817|P7|Post Week 12|Lost to Follow-up|0
358846|NCT00413660|1158818|P6|Post Week 12|Lost to Follow-up|0
358847|NCT00413660|1158819|P5|Post Week 12|Lost to Follow-up|0
358848|NCT00413660|1158820|P4|Post Week 12|Lost to Follow-up|0
358849|NCT00413660|1158821|P3|Post Week 12|Lost to Follow-up|1
358850|NCT00413660|1158822|P2|Post Week 12|Lost to Follow-up|1
358851|NCT00413660|1158823|P1|Post Week 12|Lost to Follow-up|0
358852|NCT00413660|1158813|P11|Post Week 12|Lack of Efficacy|0
358853|NCT00413660|1158814|P10|Post Week 12|Lack of Efficacy|1
358854|NCT00413660|1158815|P9|Post Week 12|Lack of Efficacy|0
358855|NCT00413660|1158816|P8|Post Week 12|Lack of Efficacy|0
358856|NCT00413660|1158817|P7|Post Week 12|Lack of Efficacy|0
358857|NCT00413660|1158818|P6|Post Week 12|Lack of Efficacy|0
358858|NCT00413660|1158819|P5|Post Week 12|Lack of Efficacy|0
358859|NCT00413660|1158820|P4|Post Week 12|Lack of Efficacy|0
358860|NCT00413660|1158821|P3|Post Week 12|Lack of Efficacy|1
358861|NCT00413660|1158822|P2|Post Week 12|Lack of Efficacy|0
358862|NCT00413660|1158823|P1|Post Week 12|Lack of Efficacy|0
358863|NCT00413660|1158813|P11|Post Week 12|Adverse Event|0
358864|NCT00413660|1158814|P10|Post Week 12|Adverse Event|0
358865|NCT00413660|1158815|P9|Post Week 12|Adverse Event|0
358866|NCT00413660|1158816|P8|Post Week 12|Adverse Event|0
358867|NCT00413660|1158817|P7|Post Week 12|Adverse Event|2
358868|NCT00413660|1158818|P6|Post Week 12|Adverse Event|2
358869|NCT00413660|1158819|P5|Post Week 12|Adverse Event|4
358870|NCT00413660|1158820|P4|Post Week 12|Adverse Event|1
358871|NCT00413660|1158821|P3|Post Week 12|Adverse Event|2
358872|NCT00413660|1158822|P2|Post Week 12|Adverse Event|0
358873|NCT00413660|1158823|P1|Post Week 12|Adverse Event|2
358874|NCT00413660|1158813|P11|Up To Week 12|Unspecified|0
358875|NCT00413660|1158814|P10|Up To Week 12|Unspecified|0
358876|NCT00413660|1158815|P9|Up To Week 12|Unspecified|0
358877|NCT00413660|1158816|P8|Up To Week 12|Unspecified|0
358878|NCT00413660|1158817|P7|Up To Week 12|Unspecified|3
358879|NCT00413660|1158818|P6|Up To Week 12|Unspecified|4
358880|NCT00413660|1158819|P5|Up To Week 12|Unspecified|2
358881|NCT00413660|1158820|P4|Up To Week 12|Unspecified|1
358882|NCT00413660|1158821|P3|Up To Week 12|Unspecified|6
358883|NCT00413660|1158822|P2|Up To Week 12|Unspecified|1
358884|NCT00413660|1158823|P1|Up To Week 12|Unspecified|3
358885|NCT00413660|1158813|P11|Up To Week 12|Randomized, Not Treated|0
358886|NCT00413660|1158814|P10|Up To Week 12|Randomized, Not Treated|0
358887|NCT00413660|1158815|P9|Up To Week 12|Randomized, Not Treated|0
358888|NCT00413660|1158816|P8|Up To Week 12|Randomized, Not Treated|0
358889|NCT00413660|1158817|P7|Up To Week 12|Randomized, Not Treated|0
358890|NCT00413660|1158818|P6|Up To Week 12|Randomized, Not Treated|0
358891|NCT00413660|1158819|P5|Up To Week 12|Randomized, Not Treated|0
358892|NCT00413660|1158820|P4|Up To Week 12|Randomized, Not Treated|1
358893|NCT00413660|1158821|P3|Up To Week 12|Randomized, Not Treated|0
358894|NCT00413660|1158822|P2|Up To Week 12|Randomized, Not Treated|0
358895|NCT00413660|1158823|P1|Up To Week 12|Randomized, Not Treated|1
358896|NCT00413660|1158813|P11|Up To Week 12|Withdrawal by Subject|0
358897|NCT00413660|1158814|P10|Up To Week 12|Withdrawal by Subject|0
358898|NCT00413660|1158815|P9|Up To Week 12|Withdrawal by Subject|0
358899|NCT00413660|1158816|P8|Up To Week 12|Withdrawal by Subject|0
358900|NCT00413660|1158817|P7|Up To Week 12|Withdrawal by Subject|2
358901|NCT00413660|1158818|P6|Up To Week 12|Withdrawal by Subject|2
358902|NCT00413660|1158819|P5|Up To Week 12|Withdrawal by Subject|0
358903|NCT00413660|1158820|P4|Up To Week 12|Withdrawal by Subject|2
358904|NCT00413660|1158821|P3|Up To Week 12|Withdrawal by Subject|0
358905|NCT00413660|1158822|P2|Up To Week 12|Withdrawal by Subject|2
358906|NCT00413660|1158823|P1|Up To Week 12|Withdrawal by Subject|0
358907|NCT00413660|1158813|P11|Up To Week 12|Lost to Follow-up|0
358908|NCT00413660|1158814|P10|Up To Week 12|Lost to Follow-up|0
358909|NCT00413660|1158815|P9|Up To Week 12|Lost to Follow-up|0
358910|NCT00413660|1158816|P8|Up To Week 12|Lost to Follow-up|0
358911|NCT00413660|1158817|P7|Up To Week 12|Lost to Follow-up|0
358912|NCT00413660|1158818|P6|Up To Week 12|Lost to Follow-up|0
358913|NCT00413660|1158819|P5|Up To Week 12|Lost to Follow-up|1
358914|NCT00413660|1158820|P4|Up To Week 12|Lost to Follow-up|0
358915|NCT00413660|1158821|P3|Up To Week 12|Lost to Follow-up|0
358916|NCT00413660|1158822|P2|Up To Week 12|Lost to Follow-up|1
358917|NCT00413660|1158823|P1|Up To Week 12|Lost to Follow-up|0
358918|NCT00413660|1158813|P11|Up To Week 12|Lack of Efficacy|0
358919|NCT00413660|1158814|P10|Up To Week 12|Lack of Efficacy|0
358920|NCT00413660|1158815|P9|Up To Week 12|Lack of Efficacy|0
358921|NCT00413660|1158816|P8|Up To Week 12|Lack of Efficacy|0
358922|NCT00413660|1158817|P7|Up To Week 12|Lack of Efficacy|5
358923|NCT00413660|1158818|P6|Up To Week 12|Lack of Efficacy|0
358924|NCT00413660|1158819|P5|Up To Week 12|Lack of Efficacy|0
358925|NCT00413660|1158820|P4|Up To Week 12|Lack of Efficacy|0
358926|NCT00413660|1158821|P3|Up To Week 12|Lack of Efficacy|0
358927|NCT00413660|1158822|P2|Up To Week 12|Lack of Efficacy|0
358928|NCT00413660|1158823|P1|Up To Week 12|Lack of Efficacy|2
358929|NCT00413660|1158813|P11|Up To Week 12|Adverse Event|0
358930|NCT00413660|1158814|P10|Up To Week 12|Adverse Event|0
358931|NCT00413660|1158815|P9|Up To Week 12|Adverse Event|0
358932|NCT00413660|1158816|P8|Up To Week 12|Adverse Event|0
358933|NCT00413660|1158817|P7|Up To Week 12|Adverse Event|1
358934|NCT00413660|1158818|P6|Up To Week 12|Adverse Event|4
358935|NCT00413660|1158819|P5|Up To Week 12|Adverse Event|6
358936|NCT00413660|1158820|P4|Up To Week 12|Adverse Event|4
358937|NCT00413660|1158821|P3|Up To Week 12|Adverse Event|1
358938|NCT00413660|1158822|P2|Up To Week 12|Adverse Event|3
358939|NCT00413660|1158823|P1|Up To Week 12|Adverse Event|1
358940|NCT00413413|1159226|P3|Double-Blind|Lost to Follow-up|2
358941|NCT00413413|1159227|P2|Double-Blind|Lost to Follow-up|4
358942|NCT00413413|1159228|P1|Double-Blind|Lost to Follow-up|3
358943|NCT00413413|1159226|P3|Double-Blind|Subject withdrew consent|9
358944|NCT00413413|1159227|P2|Double-Blind|Subject withdrew consent|6
358945|NCT00413413|1159228|P1|Double-Blind|Subject withdrew consent|4
358946|NCT00413413|1159226|P3|Double-Blind|Protocol deviation|1
358947|NCT00413413|1159227|P2|Double-Blind|Protocol deviation|2
358948|NCT00413413|1159228|P1|Double-Blind|Protocol deviation|1
358949|NCT00413413|1159226|P3|Double-Blind|Unsatisfactory therapeutic effect|1
358950|NCT00413413|1159227|P2|Double-Blind|Unsatisfactory therapeutic effect|2
358951|NCT00413413|1159228|P1|Double-Blind|Unsatisfactory therapeutic effect|1
358952|NCT00413413|1159226|P3|Double-Blind|Adverse Event|5
358953|NCT00413413|1159227|P2|Double-Blind|Adverse Event|0
358954|NCT00413413|1159228|P1|Double-Blind|Adverse Event|6
358955|NCT00413413|1159226|P3|Single-Blind|Lost to Follow-up|0
358956|NCT00413413|1159227|P2|Single-Blind|Lost to Follow-up|8
358957|NCT00413413|1159228|P1|Single-Blind|Lost to Follow-up|0
358958|NCT00413413|1159226|P3|Single-Blind|Withdrawal by Subject|0
358959|NCT00413413|1159227|P2|Single-Blind|Withdrawal by Subject|27
358960|NCT00413413|1159228|P1|Single-Blind|Withdrawal by Subject|0
358961|NCT00413413|1159226|P3|Single-Blind|Protocol Violation|0
358962|NCT00413413|1159227|P2|Single-Blind|Protocol Violation|16
358963|NCT00413413|1159228|P1|Single-Blind|Protocol Violation|0
358964|NCT00413413|1159226|P3|Single-Blind|Subject no longer requires study drug|0
358965|NCT00413413|1159227|P2|Single-Blind|Subject no longer requires study drug|151
358966|NCT00413413|1159228|P1|Single-Blind|Subject no longer requires study drug|0
358967|NCT00413413|1159226|P3|Single-Blind|Lack of Efficacy|0
358968|NCT00413413|1159227|P2|Single-Blind|Lack of Efficacy|5
358969|NCT00413413|1159228|P1|Single-Blind|Lack of Efficacy|0
358970|NCT00413413|1159226|P3|Single-Blind|Adverse Event|0
358971|NCT00413413|1159227|P2|Single-Blind|Adverse Event|9
358972|NCT00413413|1159228|P1|Single-Blind|Adverse Event|0
358973|NCT00413374|1159279|P1|Overall Study|Surgery|1
358974|NCT00413374|1159279|P1|Overall Study|Lost to Follow-up|1
358975|NCT00413374|1159279|P1|Overall Study|Adverse Event|1
358976|NCT00413374|1159279|P1|Overall Study|Ineligible due to screening criteria.|3
358977|NCT00413283|1159305|P4|Overall Study|Not specified|0
358978|NCT00413283|1159306|P3|Overall Study|Not specified|1
358979|NCT00413283|1159307|P2|Overall Study|Not specified|0
358980|NCT00413283|1159308|P1|Overall Study|Not specified|0
358981|NCT00413283|1159305|P4|Overall Study|Requirement for alternative therapy|0
358982|NCT00413283|1159306|P3|Overall Study|Requirement for alternative therapy|0
358983|NCT00413283|1159307|P2|Overall Study|Requirement for alternative therapy|2
358984|NCT00413283|1159308|P1|Overall Study|Requirement for alternative therapy|0
358985|NCT00413283|1159305|P4|Overall Study|Protocol deviation|0
358986|NCT00413283|1159306|P3|Overall Study|Protocol deviation|0
358987|NCT00413283|1159307|P2|Overall Study|Protocol deviation|1
358988|NCT00413283|1159308|P1|Overall Study|Protocol deviation|0
358989|NCT00413283|1159305|P4|Overall Study|Ineligibility determined|1
358990|NCT00413283|1159306|P3|Overall Study|Ineligibility determined|0
358991|NCT00413283|1159307|P2|Overall Study|Ineligibility determined|0
358992|NCT00413283|1159308|P1|Overall Study|Ineligibility determined|0
358993|NCT00413283|1159305|P4|Overall Study|Adverse Event|1
358994|NCT00413283|1159306|P3|Overall Study|Adverse Event|0
358995|NCT00413283|1159307|P2|Overall Study|Adverse Event|0
358996|NCT00413283|1159308|P1|Overall Study|Adverse Event|0
358997|NCT00413283|1159305|P4|Overall Study|Death|1
358998|NCT00413283|1159306|P3|Overall Study|Death|1
358999|NCT00413283|1159307|P2|Overall Study|Death|0
359000|NCT00413283|1159308|P1|Overall Study|Death|0
359001|NCT00413283|1159305|P4|Overall Study|Withdrawal by Subject|1
359002|NCT00413283|1159306|P3|Overall Study|Withdrawal by Subject|0
359003|NCT00413283|1159307|P2|Overall Study|Withdrawal by Subject|0
359004|NCT00413283|1159308|P1|Overall Study|Withdrawal by Subject|1
359005|NCT00413244|1159340|P2|Overall Study|Withdrawal by Subject|1
359006|NCT00413244|1159341|P1|Overall Study|Withdrawal by Subject|10
359095|NCT00412984|1159549|P1|Overall Study|Other Reason|80
359007|NCT00413231|1159369|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
359008|NCT00413231|1159369|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
359009|NCT00413231|1159369|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
359010|NCT00413231|1159369|P1|365-day to 60-month Post Treatment|Death|36
359011|NCT00413231|1159369|P1|30-day to 365-day Post Treatment|Death|13
359012|NCT00413231|1159369|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
359013|NCT00413231|1159369|P1|0 to 30-day Post Treatment|Death|5
359014|NCT00413192|1159403|P4|Overall Study|Not treated|1
359015|NCT00413192|1159404|P3|Overall Study|Not treated|0
359016|NCT00413192|1159405|P2|Overall Study|Not treated|0
359017|NCT00413192|1159406|P1|Overall Study|Not treated|0
359018|NCT00413192|1159403|P4|Overall Study|Not specified|2
359019|NCT00413192|1159404|P3|Overall Study|Not specified|1
359020|NCT00413192|1159405|P2|Overall Study|Not specified|1
359021|NCT00413192|1159406|P1|Overall Study|Not specified|5
359022|NCT00413192|1159403|P4|Overall Study|Intercurrent death|0
359023|NCT00413192|1159404|P3|Overall Study|Intercurrent death|0
359024|NCT00413192|1159405|P2|Overall Study|Intercurrent death|1
359025|NCT00413192|1159406|P1|Overall Study|Intercurrent death|0
359026|NCT00413192|1159403|P4|Overall Study|Intercurrent illness|1
359027|NCT00413192|1159404|P3|Overall Study|Intercurrent illness|0
359028|NCT00413192|1159405|P2|Overall Study|Intercurrent illness|0
359029|NCT00413192|1159406|P1|Overall Study|Intercurrent illness|0
359030|NCT00413192|1159403|P4|Overall Study|Withdrawal by Subject|1
359031|NCT00413192|1159404|P3|Overall Study|Withdrawal by Subject|0
359032|NCT00413192|1159405|P2|Overall Study|Withdrawal by Subject|5
359033|NCT00413192|1159406|P1|Overall Study|Withdrawal by Subject|3
359034|NCT00413192|1159403|P4|Overall Study|Toxicity|2
359035|NCT00413192|1159404|P3|Overall Study|Toxicity|2
359036|NCT00413192|1159405|P2|Overall Study|Toxicity|2
359037|NCT00413192|1159406|P1|Overall Study|Toxicity|3
359038|NCT00413192|1159403|P4|Overall Study|Disease progression|25
359039|NCT00413192|1159404|P3|Overall Study|Disease progression|16
359040|NCT00413192|1159405|P2|Overall Study|Disease progression|31
359041|NCT00413192|1159406|P1|Overall Study|Disease progression|26
359042|NCT00413153|1159446|P2|Overall Study|Adverse Event|0
359043|NCT00413153|1159447|P1|Overall Study|Adverse Event|1
359044|NCT00413153|1159446|P2|Overall Study|Withdrawal by Subject|1
359045|NCT00413153|1159447|P1|Overall Study|Withdrawal by Subject|1
359046|NCT00413062|1159471|P2|Overall Study|Other reason|34
359047|NCT00413062|1159472|P1|Overall Study|Other reason|70
359048|NCT00413062|1159471|P2|Overall Study|Lost to Follow-up|73
359049|NCT00413062|1159472|P1|Overall Study|Lost to Follow-up|175
359050|NCT00413062|1159471|P2|Overall Study|Pregnancy wish|6
359051|NCT00413062|1159472|P1|Overall Study|Pregnancy wish|17
359052|NCT00413062|1159471|P2|Overall Study|Pregnancy|5
359053|NCT00413062|1159472|P1|Overall Study|Pregnancy|15
359054|NCT00413062|1159471|P2|Overall Study|Withdrawal of informed consent|36
359055|NCT00413062|1159472|P1|Overall Study|Withdrawal of informed consent|111
359056|NCT00413062|1159471|P2|Overall Study|Pre-treatment (serious) adverse event|0
359057|NCT00413062|1159472|P1|Overall Study|Pre-treatment (serious) adverse event|1
359058|NCT00413062|1159471|P2|Overall Study|Adverse event/serious adverse event|56
359059|NCT00413062|1159472|P1|Overall Study|Adverse event/serious adverse event|289
359060|NCT00413049|1159498|P2|Overall Study|Lack of Efficacy|0
359061|NCT00413049|1159499|P1|Overall Study|Lack of Efficacy|1
359062|NCT00413049|1159498|P2|Overall Study|Abnormal laboratory value(s)|0
359063|NCT00413049|1159499|P1|Overall Study|Abnormal laboratory value(s)|1
359064|NCT00413049|1159498|P2|Overall Study|Subject no longer requires study drug|1
359065|NCT00413049|1159499|P1|Overall Study|Subject no longer requires study drug|0
359066|NCT00413049|1159498|P2|Overall Study|Protocol Violation|1
359067|NCT00413049|1159499|P1|Overall Study|Protocol Violation|3
359068|NCT00413049|1159498|P2|Overall Study|Lost to Follow-up|3
359069|NCT00413049|1159499|P1|Overall Study|Lost to Follow-up|2
359070|NCT00413049|1159498|P2|Overall Study|Withdrawal by Subject|5
359071|NCT00413049|1159499|P1|Overall Study|Withdrawal by Subject|7
359072|NCT00413049|1159498|P2|Overall Study|Adverse Event|8
359073|NCT00413049|1159499|P1|Overall Study|Adverse Event|10
359074|NCT00413036|1159515|P1|Overall Study|Missing|2
359075|NCT00413036|1159515|P1|Overall Study|Unspecified|26
359076|NCT00413036|1159515|P1|Overall Study|Death|9
359077|NCT00413036|1159515|P1|Overall Study|Withdrawal by Subject|7
359078|NCT00413036|1159515|P1|Overall Study|Lack of Efficacy|129
359079|NCT00413036|1159515|P1|Overall Study|Adverse Event|44
359080|NCT00413010|1159525|P2|Overall Study|Due to termination of the study|52
359081|NCT00413010|1159526|P1|Overall Study|Due to termination of the study|54
359082|NCT00413010|1159525|P2|Overall Study|Withdrawal by Subject|2
359083|NCT00413010|1159526|P1|Overall Study|Withdrawal by Subject|7
359084|NCT00413010|1159525|P2|Overall Study|Lost to Follow-up|0
359085|NCT00413010|1159526|P1|Overall Study|Lost to Follow-up|3
359086|NCT00413010|1159525|P2|Overall Study|Lack of Efficacy|3
359087|NCT00413010|1159526|P1|Overall Study|Lack of Efficacy|0
359088|NCT00413010|1159525|P2|Overall Study|Laboratory abnormality|2
359089|NCT00413010|1159526|P1|Overall Study|Laboratory abnormality|0
359090|NCT00413010|1159525|P2|Overall Study|Adverse Event|4
359091|NCT00413010|1159526|P1|Overall Study|Adverse Event|8
359092|NCT00412984|1159548|P2|Overall Study|Not Reported|12
359093|NCT00412984|1159549|P1|Overall Study|Not Reported|11
359094|NCT00412984|1159548|P2|Overall Study|Other Reason|92
359096|NCT00412984|1159548|P2|Overall Study|Physician Refused to Continue Treatment|89
359097|NCT00412984|1159549|P1|Overall Study|Physician Refused to Continue Treatment|81
359098|NCT00412984|1159548|P2|Overall Study|Administrative Reason by Sponsor|8
359099|NCT00412984|1159549|P1|Overall Study|Administrative Reason by Sponsor|11
359100|NCT00412984|1159548|P2|Overall Study|Subject No Longer Meets Study Criteria|100
359101|NCT00412984|1159549|P1|Overall Study|Subject No Longer Meets Study Criteria|87
359102|NCT00412984|1159548|P2|Overall Study|Pregnancy|0
359103|NCT00412984|1159549|P1|Overall Study|Pregnancy|1
359104|NCT00412984|1159548|P2|Overall Study|Poor/Noncompliance|77
359105|NCT00412984|1159549|P1|Overall Study|Poor/Noncompliance|57
359106|NCT00412984|1159548|P2|Overall Study|Lost to Follow-up|39
359107|NCT00412984|1159549|P1|Overall Study|Lost to Follow-up|51
359108|NCT00412984|1159548|P2|Overall Study|Withdrawal by Subject|989
359109|NCT00412984|1159549|P1|Overall Study|Withdrawal by Subject|921
359110|NCT00412984|1159548|P2|Overall Study|Adverse Event|738
359111|NCT00412984|1159549|P1|Overall Study|Adverse Event|679
359112|NCT00412984|1159548|P2|Overall Study|Death|349
359113|NCT00412984|1159549|P1|Overall Study|Death|331
359114|NCT00412971|1159593|P2|Overall Study|Protocol Violation|1
359115|NCT00412971|1159594|P1|Overall Study|Protocol Violation|13
359116|NCT00412971|1159593|P2|Overall Study|Lost to Follow-up|9
359117|NCT00412971|1159594|P1|Overall Study|Lost to Follow-up|17
359118|NCT00412958|1159607|P4|Overall Study|Transport issue|0
359119|NCT00412958|1159608|P3|Overall Study|Transport issue|0
359120|NCT00412958|1159609|P2|Overall Study|Transport issue|1
359121|NCT00412958|1159610|P1|Overall Study|Transport issue|0
359122|NCT00412958|1159607|P4|Overall Study|Death|0
359123|NCT00412958|1159608|P3|Overall Study|Death|0
359124|NCT00412958|1159609|P2|Overall Study|Death|1
359125|NCT00412958|1159610|P1|Overall Study|Death|0
359126|NCT00412958|1159607|P4|Overall Study|Lost to Follow-up|0
359127|NCT00412958|1159608|P3|Overall Study|Lost to Follow-up|0
359128|NCT00412958|1159609|P2|Overall Study|Lost to Follow-up|1
359129|NCT00412958|1159610|P1|Overall Study|Lost to Follow-up|0
359130|NCT00412958|1159607|P4|Overall Study|Adverse Event|0
359131|NCT00412958|1159608|P3|Overall Study|Adverse Event|0
359132|NCT00412958|1159609|P2|Overall Study|Adverse Event|1
359133|NCT00412958|1159610|P1|Overall Study|Adverse Event|0
359134|NCT00412958|1159607|P4|Overall Study|Withdrawal by Subject|1
359135|NCT00412958|1159608|P3|Overall Study|Withdrawal by Subject|0
359136|NCT00412958|1159609|P2|Overall Study|Withdrawal by Subject|0
359137|NCT00412958|1159610|P1|Overall Study|Withdrawal by Subject|3
359138|NCT00412932|1159620|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
359139|NCT00412932|1159620|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
359140|NCT00412932|1159620|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
359141|NCT00412932|1159620|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
359142|NCT00412932|1159620|P1|Olmesartan 40 mg|Withdrawal by Subject|1
359143|NCT00412932|1159620|P1|Olmesartan 40 mg|Lack of Efficacy|3
359144|NCT00412932|1159620|P1|Olmesartan 40 mg|Adverse Event|4
359145|NCT00412932|1159620|P1|Olmesartan (Olm) 20 mg|Other|1
359146|NCT00412932|1159620|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
359147|NCT00412932|1159620|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
359148|NCT00412932|1159620|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
359149|NCT00412932|1159620|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
359150|NCT00412893|1159631|P2|Overall Study|Randomized but Never Received Study Drug|6
359151|NCT00412893|1159632|P1|Overall Study|Randomized but Never Received Study Drug|5
359152|NCT00412893|1159631|P2|Overall Study|Administrative Reason|15
359153|NCT00412893|1159632|P1|Overall Study|Administrative Reason|12
359154|NCT00412893|1159631|P2|Overall Study|Did Not Cooperate|9
359155|NCT00412893|1159632|P1|Overall Study|Did Not Cooperate|12
359156|NCT00412893|1159631|P2|Overall Study|Other Protocol Violation|6
359157|NCT00412893|1159632|P1|Overall Study|Other Protocol Violation|10
359158|NCT00412893|1159631|P2|Overall Study|Violation of Selection at Entry|10
359159|NCT00412893|1159632|P1|Overall Study|Violation of Selection at Entry|17
359160|NCT00412893|1159631|P2|Overall Study|Lost to Follow-up|1
359161|NCT00412893|1159632|P1|Overall Study|Lost to Follow-up|2
359162|NCT00412893|1159631|P2|Overall Study|Insufficient Therapeutic Response|23
359163|NCT00412893|1159632|P1|Overall Study|Insufficient Therapeutic Response|39
359164|NCT00412893|1159631|P2|Overall Study|Death|21
359165|NCT00412893|1159632|P1|Overall Study|Death|17
359166|NCT00412893|1159631|P2|Overall Study|Adverse Event|53
359167|NCT00412893|1159632|P1|Overall Study|Adverse Event|31
359168|NCT00412854|1159667|P2|Overall Study|Withdrawn for other reasons|11
359169|NCT00412854|1159668|P1|Overall Study|Withdrawn for other reasons|13
359170|NCT00412854|1159667|P2|Overall Study|Withdrawn due to adverse events|5
359171|NCT00412854|1159668|P1|Overall Study|Withdrawn due to adverse events|1
359172|NCT00412750|1159708|P3|Overall Study|Lack of Efficacy|3
359173|NCT00412750|1159709|P2|Overall Study|Lack of Efficacy|0
359174|NCT00412750|1159710|P1|Overall Study|Lack of Efficacy|0
359175|NCT00412750|1159708|P3|Overall Study|Withdrawal by Subject|2
359176|NCT00412750|1159709|P2|Overall Study|Withdrawal by Subject|1
359177|NCT00412750|1159710|P1|Overall Study|Withdrawal by Subject|0
359178|NCT00412750|1159708|P3|Overall Study|Lost to Follow-up|1
359179|NCT00412750|1159709|P2|Overall Study|Lost to Follow-up|0
359180|NCT00412750|1159710|P1|Overall Study|Lost to Follow-up|1
359181|NCT00412750|1159708|P3|Overall Study|Adverse Event|3
359182|NCT00412750|1159709|P2|Overall Study|Adverse Event|3
359183|NCT00412750|1159710|P1|Overall Study|Adverse Event|8
359184|NCT00412750|1159708|P3|Overall Study|Administrative problems|14
359185|NCT00412750|1159709|P2|Overall Study|Administrative problems|17
359186|NCT00412750|1159710|P1|Overall Study|Administrative problems|21
359187|NCT00412750|1159708|P3|Overall Study|Abnormal laboratory value(s)|0
359188|NCT00412750|1159709|P2|Overall Study|Abnormal laboratory value(s)|0
359189|NCT00412750|1159710|P1|Overall Study|Abnormal laboratory value(s)|1
359190|NCT00412737|1159735|P2|Overall Study|Failure to Return|2
359191|NCT00412737|1159736|P1|Overall Study|Failure to Return|6
359192|NCT00412737|1159735|P2|Overall Study|Refused Treatment|2
359193|NCT00412737|1159736|P1|Overall Study|Refused Treatment|6
359194|NCT00412737|1159735|P2|Overall Study|Adverse Event|2
359195|NCT00412737|1159736|P1|Overall Study|Adverse Event|3
359196|NCT00412737|1159735|P2|Overall Study|Death|0
359197|NCT00412737|1159736|P1|Overall Study|Death|1
359198|NCT00412607|1159754|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
359199|NCT00412607|1159754|P1|Overall Study|Death|61
359200|NCT00412607|1159754|P1|Overall Study|Lost to Follow-up|19
359201|NCT00412607|1159754|P1|Overall Study|Withdrawal by Subject|9
359202|NCT00412542|1159767|P2|Overall Study|Not Eligible|1
359203|NCT00412542|1159768|P1|Overall Study|Not Eligible|0
359204|NCT00412542|1159767|P2|Overall Study|Withdrawal by Subject|2
359205|NCT00412542|1159768|P1|Overall Study|Withdrawal by Subject|0
359206|NCT00412373|1159853|P2|Overall Study|Not Specified|2
359207|NCT00412373|1159854|P1|Overall Study|Not Specified|2
359208|NCT00412373|1159853|P2|Overall Study|Withdrawal by Subject|27
359209|NCT00412373|1159854|P1|Overall Study|Withdrawal by Subject|8
359210|NCT00412373|1159853|P2|Overall Study|Lost to Follow-up|13
359211|NCT00412373|1159854|P1|Overall Study|Lost to Follow-up|7
359212|NCT00412373|1159853|P2|Overall Study|Lack of Efficacy|22
359213|NCT00412373|1159854|P1|Overall Study|Lack of Efficacy|16
359214|NCT00412373|1159853|P2|Overall Study|Adverse Event|13
359215|NCT00412373|1159854|P1|Overall Study|Adverse Event|8
359216|NCT00412217|1159927|P2|Overall Study|Not Specified|1
359217|NCT00412217|1159928|P1|Overall Study|Not Specified|1
359218|NCT00412217|1159927|P2|Overall Study|Study Terminated by Sponsor|33
359219|NCT00412217|1159928|P1|Overall Study|Study Terminated by Sponsor|26
359220|NCT00412217|1159927|P2|Overall Study|Lost to Follow-up|4
359221|NCT00412217|1159928|P1|Overall Study|Lost to Follow-up|1
359222|NCT00412217|1159927|P2|Overall Study|Withdrawal by Subject|0
359223|NCT00412217|1159928|P1|Overall Study|Withdrawal by Subject|2
359224|NCT00412217|1159927|P2|Overall Study|Investigator Decision|0
359225|NCT00412217|1159928|P1|Overall Study|Investigator Decision|1
359226|NCT00412217|1159927|P2|Overall Study|Disease Progression|3
359227|NCT00412217|1159928|P1|Overall Study|Disease Progression|2
359228|NCT00412217|1159927|P2|Overall Study|Death|4
359229|NCT00412217|1159928|P1|Overall Study|Death|5
359230|NCT00412217|1159927|P2|Overall Study|Insufficient Data Available|3
359231|NCT00412217|1159928|P1|Overall Study|Insufficient Data Available|8
359232|NCT00412113|1159942|P2|Overall Study|did not receive treatment|0
359233|NCT00412113|1159943|P1|Overall Study|did not receive treatment|1
359234|NCT00412113|1159942|P2|Overall Study|Adverse Event|15
359235|NCT00412113|1159943|P1|Overall Study|Adverse Event|11
359236|NCT00412061|1160027|P2|Open Label Phase|New Cancer Therapy|1
359237|NCT00412061|1160028|P1|Open Label Phase|New Cancer Therapy|0
359238|NCT00412061|1160027|P2|Open Label Phase|Lost to Follow-up|2
359239|NCT00412061|1160028|P1|Open Label Phase|Lost to Follow-up|0
359240|NCT00412061|1160027|P2|Open Label Phase|Death|7
359241|NCT00412061|1160028|P1|Open Label Phase|Death|0
359242|NCT00412061|1160027|P2|Open Label Phase|Administrative Problems|13
359243|NCT00412061|1160028|P1|Open Label Phase|Administrative Problems|0
359244|NCT00412061|1160027|P2|Open Label Phase|Withdrawal by Subject|15
359245|NCT00412061|1160028|P1|Open Label Phase|Withdrawal by Subject|0
359246|NCT00412061|1160027|P2|Open Label Phase|Adverse Event|46
359247|NCT00412061|1160028|P1|Open Label Phase|Adverse Event|0
359248|NCT00412061|1160027|P2|Open Label Phase|Disease Progression|86
359249|NCT00412061|1160028|P1|Open Label Phase|Disease Progression|0
359250|NCT00412061|1160027|P2|Double Blind Phase|Lost to Follow-up|1
359251|NCT00412061|1160028|P1|Double Blind Phase|Lost to Follow-up|0
359252|NCT00412061|1160027|P2|Double Blind Phase|New Cander Therapy|1
359253|NCT00412061|1160028|P1|Double Blind Phase|New Cander Therapy|1
359254|NCT00412061|1160027|P2|Double Blind Phase|Protocol Violation|4
359255|NCT00412061|1160028|P1|Double Blind Phase|Protocol Violation|3
359256|NCT00412061|1160027|P2|Double Blind Phase|Death|3
359257|NCT00412061|1160028|P1|Double Blind Phase|Death|6
359258|NCT00412061|1160027|P2|Double Blind Phase|Withdrawal by Subject|20
359259|NCT00412061|1160028|P1|Double Blind Phase|Withdrawal by Subject|18
359260|NCT00412061|1160027|P2|Double Blind Phase|Final Primary Analysis|14
359261|NCT00412061|1160028|P1|Double Blind Phase|Final Primary Analysis|26
359262|NCT00412061|1160027|P2|Double Blind Phase|Adverse Event|16
359263|NCT00412061|1160028|P1|Double Blind Phase|Adverse Event|61
359264|NCT00412061|1160027|P2|Double Blind Phase|Disease Progression|154
359265|NCT00412061|1160028|P1|Double Blind Phase|Disease Progression|101
359266|NCT00411788|1160046|P1|Overall Study|Adverse Event|1
359267|NCT00411788|1160046|P1|Overall Study|Protocol Violation|1
359268|NCT00411762|1160055|P1|Overall Study|Withdrawal by Subject|5
359269|NCT00411671|1160079|P1|Overall Study|Lost to Follow-up|3
359270|NCT00411671|1160079|P1|Overall Study|Death|2
359271|NCT00411671|1160079|P1|Overall Study|Adverse Event|15
359272|NCT00411645|1160087|P2|Overall Study|Lost to Follow-up|0
359273|NCT00411645|1160088|P1|Overall Study|Lost to Follow-up|2
359274|NCT00411645|1160087|P2|Overall Study|Investigator/Sponsor Decision|7
359275|NCT00411645|1160088|P1|Overall Study|Investigator/Sponsor Decision|10
359276|NCT00411645|1160087|P2|Overall Study|Death|135
359277|NCT00411645|1160088|P1|Overall Study|Death|56
359278|NCT00411645|1160087|P2|Overall Study|Consent Withdrawn|22
359279|NCT00411645|1160088|P1|Overall Study|Consent Withdrawn|13
359280|NCT00411554|1160119|P2|Overall Study|Patient Moved|0
359281|NCT00411554|1160120|P1|Overall Study|Patient Moved|1
359282|NCT00411554|1160119|P2|Overall Study|Withdrawal by Subject|0
359283|NCT00411554|1160120|P1|Overall Study|Withdrawal by Subject|3
359284|NCT00411554|1160119|P2|Overall Study|Lack of Efficacy|5
359285|NCT00411554|1160120|P1|Overall Study|Lack of Efficacy|2
359286|NCT00411554|1160119|P2|Overall Study|Adverse Event|4
359287|NCT00411554|1160120|P1|Overall Study|Adverse Event|2
359288|NCT00411450|1160146|P1|Overall Study|Ongoing at time of data cut-off.|3
359289|NCT00411216|1160189|P2|Overall Study|Ten participants were entered into the c|2
359290|NCT00411216|1160190|P1|Overall Study|Ten participants were entered into the c|0
359291|NCT00411151|1160196|P1|Overall Study|Trial prematurely closed|4
359292|NCT00411151|1160196|P1|Overall Study|Protocol Violation|1
359293|NCT00411151|1160196|P1|Overall Study|Lost to Follow-up|2
359294|NCT00411151|1160196|P1|Overall Study|Withdrawal by Subject|2
359295|NCT00411151|1160196|P1|Overall Study|Death|38
359296|NCT00410761|1160232|P2|Overall Study|Never received randomised treatment|1
359297|NCT00410761|1160233|P1|Overall Study|Never received randomised treatment|0
359298|NCT00410761|1160232|P2|Overall Study|Other|9
359299|NCT00410761|1160233|P1|Overall Study|Other|12
359300|NCT00410761|1160232|P2|Overall Study|Withdrawal by Subject|4
359301|NCT00410761|1160233|P1|Overall Study|Withdrawal by Subject|8
359302|NCT00410761|1160232|P2|Overall Study|objective disease progression|55
359303|NCT00410761|1160233|P1|Overall Study|objective disease progression|71
359304|NCT00410761|1160232|P2|Overall Study|Adverse Event|3
359305|NCT00410761|1160233|P1|Overall Study|Adverse Event|29
359306|NCT00410514|1160256|P3|Overall Study|Non-compliant with study procedures|2
359307|NCT00410514|1160257|P2|Overall Study|Non-compliant with study procedures|0
359308|NCT00410514|1160258|P1|Overall Study|Non-compliant with study procedures|0
359309|NCT00410514|1160256|P3|Overall Study|Lost to Follow-up|2
359310|NCT00410514|1160257|P2|Overall Study|Lost to Follow-up|0
359311|NCT00410514|1160258|P1|Overall Study|Lost to Follow-up|0
359312|NCT00410514|1160256|P3|Overall Study|Protocol Violation|1
359313|NCT00410514|1160257|P2|Overall Study|Protocol Violation|1
359314|NCT00410514|1160258|P1|Overall Study|Protocol Violation|0
359315|NCT00410514|1160256|P3|Overall Study|Adverse Event|2
359316|NCT00410514|1160257|P2|Overall Study|Adverse Event|2
359317|NCT00410514|1160258|P1|Overall Study|Adverse Event|2
359318|NCT00410410|1160331|P9|Open-Label Period (OL)|not specified|7
359319|NCT00410410|1160332|P8|Open-Label Period (OL)|not specified|0
359320|NCT00410410|1160333|P7|Open-Label Period (OL)|not specified|0
359321|NCT00410410|1160334|P6|Open-Label Period (OL)|not specified|0
359322|NCT00410410|1160335|P5|Open-Label Period (OL)|not specified|0
359323|NCT00410410|1160336|P4|Open-Label Period (OL)|not specified|0
359324|NCT00410410|1160337|P3|Open-Label Period (OL)|not specified|0
359325|NCT00410410|1160338|P2|Open-Label Period (OL)|not specified|0
359326|NCT00410410|1160339|P1|Open-Label Period (OL)|not specified|0
359327|NCT00410410|1160331|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
359328|NCT00410410|1160332|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
359329|NCT00410410|1160333|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
359330|NCT00410410|1160334|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
359331|NCT00410410|1160335|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
359332|NCT00410410|1160336|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
359333|NCT00410410|1160337|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
359334|NCT00410410|1160338|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
359335|NCT00410410|1160339|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
359336|NCT00410410|1160331|P9|Open-Label Period (OL)|Pregnancy|1
359337|NCT00410410|1160332|P8|Open-Label Period (OL)|Pregnancy|0
359338|NCT00410410|1160333|P7|Open-Label Period (OL)|Pregnancy|0
359339|NCT00410410|1160334|P6|Open-Label Period (OL)|Pregnancy|0
359340|NCT00410410|1160335|P5|Open-Label Period (OL)|Pregnancy|0
359341|NCT00410410|1160336|P4|Open-Label Period (OL)|Pregnancy|0
359342|NCT00410410|1160337|P3|Open-Label Period (OL)|Pregnancy|0
359343|NCT00410410|1160338|P2|Open-Label Period (OL)|Pregnancy|0
359344|NCT00410410|1160339|P1|Open-Label Period (OL)|Pregnancy|0
359345|NCT00410410|1160331|P9|Open-Label Period (OL)|Withdrawal by Subject|20
359346|NCT00410410|1160332|P8|Open-Label Period (OL)|Withdrawal by Subject|0
359347|NCT00410410|1160333|P7|Open-Label Period (OL)|Withdrawal by Subject|0
359348|NCT00410410|1160334|P6|Open-Label Period (OL)|Withdrawal by Subject|0
359349|NCT00410410|1160335|P5|Open-Label Period (OL)|Withdrawal by Subject|0
359350|NCT00410410|1160336|P4|Open-Label Period (OL)|Withdrawal by Subject|0
359351|NCT00410410|1160337|P3|Open-Label Period (OL)|Withdrawal by Subject|0
359352|NCT00410410|1160338|P2|Open-Label Period (OL)|Withdrawal by Subject|0
359353|NCT00410410|1160339|P1|Open-Label Period (OL)|Withdrawal by Subject|0
359354|NCT00410410|1160331|P9|Open-Label Period (OL)|Lost to Follow-up|4
359355|NCT00410410|1160332|P8|Open-Label Period (OL)|Lost to Follow-up|0
359356|NCT00410410|1160333|P7|Open-Label Period (OL)|Lost to Follow-up|0
359357|NCT00410410|1160334|P6|Open-Label Period (OL)|Lost to Follow-up|0
359358|NCT00410410|1160335|P5|Open-Label Period (OL)|Lost to Follow-up|0
359359|NCT00410410|1160336|P4|Open-Label Period (OL)|Lost to Follow-up|0
359360|NCT00410410|1160337|P3|Open-Label Period (OL)|Lost to Follow-up|0
359361|NCT00410410|1160338|P2|Open-Label Period (OL)|Lost to Follow-up|0
359362|NCT00410410|1160339|P1|Open-Label Period (OL)|Lost to Follow-up|0
359363|NCT00410410|1160331|P9|Open-Label Period (OL)|Lack of Efficacy|161
359364|NCT00410410|1160332|P8|Open-Label Period (OL)|Lack of Efficacy|0
359365|NCT00410410|1160333|P7|Open-Label Period (OL)|Lack of Efficacy|0
359366|NCT00410410|1160334|P6|Open-Label Period (OL)|Lack of Efficacy|0
359367|NCT00410410|1160335|P5|Open-Label Period (OL)|Lack of Efficacy|0
359368|NCT00410410|1160336|P4|Open-Label Period (OL)|Lack of Efficacy|0
359369|NCT00410410|1160337|P3|Open-Label Period (OL)|Lack of Efficacy|0
359370|NCT00410410|1160338|P2|Open-Label Period (OL)|Lack of Efficacy|0
359371|NCT00410410|1160339|P1|Open-Label Period (OL)|Lack of Efficacy|0
359372|NCT00410410|1160331|P9|Open-Label Period (OL)|Adverse Event|10
359373|NCT00410410|1160332|P8|Open-Label Period (OL)|Adverse Event|0
359374|NCT00410410|1160333|P7|Open-Label Period (OL)|Adverse Event|0
359375|NCT00410410|1160334|P6|Open-Label Period (OL)|Adverse Event|0
359376|NCT00410410|1160335|P5|Open-Label Period (OL)|Adverse Event|0
359377|NCT00410410|1160336|P4|Open-Label Period (OL)|Adverse Event|0
359378|NCT00410410|1160337|P3|Open-Label Period (OL)|Adverse Event|0
359379|NCT00410410|1160338|P2|Open-Label Period (OL)|Adverse Event|0
359380|NCT00410410|1160339|P1|Open-Label Period (OL)|Adverse Event|0
359381|NCT00410410|1160331|P9|Open-Label Period (OL)|Death|1
359382|NCT00410410|1160332|P8|Open-Label Period (OL)|Death|0
359383|NCT00410410|1160333|P7|Open-Label Period (OL)|Death|0
359384|NCT00410410|1160334|P6|Open-Label Period (OL)|Death|0
359385|NCT00410410|1160335|P5|Open-Label Period (OL)|Death|0
359386|NCT00410410|1160336|P4|Open-Label Period (OL)|Death|0
359387|NCT00410410|1160337|P3|Open-Label Period (OL)|Death|0
359388|NCT00410410|1160338|P2|Open-Label Period (OL)|Death|0
359389|NCT00410410|1160339|P1|Open-Label Period (OL)|Death|0
359390|NCT00410410|1160331|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
359391|NCT00410410|1160332|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
359392|NCT00410410|1160333|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
359393|NCT00410410|1160334|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
359394|NCT00410410|1160335|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
359395|NCT00410410|1160336|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
359396|NCT00410410|1160337|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
359397|NCT00410410|1160338|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
359398|NCT00410410|1160339|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
359399|NCT00410410|1160331|P9|Maintenance Period (MP)|Withdrawal by Subject|0
359400|NCT00410410|1160332|P8|Maintenance Period (MP)|Withdrawal by Subject|1
359401|NCT00410410|1160333|P7|Maintenance Period (MP)|Withdrawal by Subject|1
359402|NCT00410410|1160334|P6|Maintenance Period (MP)|Withdrawal by Subject|0
359403|NCT00410410|1160335|P5|Maintenance Period (MP)|Withdrawal by Subject|0
359404|NCT00410410|1160336|P4|Maintenance Period (MP)|Withdrawal by Subject|0
359405|NCT00410410|1160337|P3|Maintenance Period (MP)|Withdrawal by Subject|0
359406|NCT00410410|1160338|P2|Maintenance Period (MP)|Withdrawal by Subject|0
359407|NCT00410410|1160339|P1|Maintenance Period (MP)|Withdrawal by Subject|0
359408|NCT00410410|1160331|P9|Maintenance Period (MP)|Lost to Follow-up|0
359409|NCT00410410|1160332|P8|Maintenance Period (MP)|Lost to Follow-up|2
359410|NCT00410410|1160333|P7|Maintenance Period (MP)|Lost to Follow-up|1
359411|NCT00410410|1160334|P6|Maintenance Period (MP)|Lost to Follow-up|0
359412|NCT00410410|1160335|P5|Maintenance Period (MP)|Lost to Follow-up|0
359413|NCT00410410|1160336|P4|Maintenance Period (MP)|Lost to Follow-up|0
359414|NCT00410410|1160337|P3|Maintenance Period (MP)|Lost to Follow-up|0
359415|NCT00410410|1160338|P2|Maintenance Period (MP)|Lost to Follow-up|0
359416|NCT00410410|1160339|P1|Maintenance Period (MP)|Lost to Follow-up|0
359417|NCT00410410|1160331|P9|Maintenance Period (MP)|Lack of Efficacy|0
359418|NCT00410410|1160332|P8|Maintenance Period (MP)|Lack of Efficacy|24
359419|NCT00410410|1160333|P7|Maintenance Period (MP)|Lack of Efficacy|25
359420|NCT00410410|1160334|P6|Maintenance Period (MP)|Lack of Efficacy|0
359421|NCT00410410|1160335|P5|Maintenance Period (MP)|Lack of Efficacy|0
359422|NCT00410410|1160336|P4|Maintenance Period (MP)|Lack of Efficacy|0
359423|NCT00410410|1160337|P3|Maintenance Period (MP)|Lack of Efficacy|0
359424|NCT00410410|1160338|P2|Maintenance Period (MP)|Lack of Efficacy|0
359425|NCT00410410|1160339|P1|Maintenance Period (MP)|Lack of Efficacy|0
359426|NCT00410410|1160331|P9|Maintenance Period (MP)|Adverse Event|0
359427|NCT00410410|1160332|P8|Maintenance Period (MP)|Adverse Event|3
359428|NCT00410410|1160333|P7|Maintenance Period (MP)|Adverse Event|1
359429|NCT00410410|1160334|P6|Maintenance Period (MP)|Adverse Event|0
359430|NCT00410410|1160335|P5|Maintenance Period (MP)|Adverse Event|0
359431|NCT00410410|1160336|P4|Maintenance Period (MP)|Adverse Event|0
359432|NCT00410410|1160337|P3|Maintenance Period (MP)|Adverse Event|0
359433|NCT00410410|1160338|P2|Maintenance Period (MP)|Adverse Event|0
359434|NCT00410410|1160339|P1|Maintenance Period (MP)|Adverse Event|0
359435|NCT00410410|1160331|P9|Maintenance Period (MP)|Death|0
359436|NCT00410410|1160332|P8|Maintenance Period (MP)|Death|0
359437|NCT00410410|1160333|P7|Maintenance Period (MP)|Death|1
359438|NCT00410410|1160334|P6|Maintenance Period (MP)|Death|0
359439|NCT00410410|1160335|P5|Maintenance Period (MP)|Death|0
359440|NCT00410410|1160336|P4|Maintenance Period (MP)|Death|0
359441|NCT00410410|1160337|P3|Maintenance Period (MP)|Death|0
359442|NCT00410410|1160338|P2|Maintenance Period (MP)|Death|0
359443|NCT00410410|1160339|P1|Maintenance Period (MP)|Death|0
359444|NCT00410410|1160331|P9|Induction Period (IP)|not specified|0
359445|NCT00410410|1160332|P8|Induction Period (IP)|not specified|0
359446|NCT00410410|1160333|P7|Induction Period (IP)|not specified|0
359447|NCT00410410|1160334|P6|Induction Period (IP)|not specified|0
359448|NCT00410410|1160335|P5|Induction Period (IP)|not specified|0
359449|NCT00410410|1160336|P4|Induction Period (IP)|not specified|0
359450|NCT00410410|1160337|P3|Induction Period (IP)|not specified|1
359451|NCT00410410|1160338|P2|Induction Period (IP)|not specified|0
359452|NCT00410410|1160339|P1|Induction Period (IP)|not specified|0
359453|NCT00410410|1160331|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
359454|NCT00410410|1160332|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
359455|NCT00410410|1160333|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
359456|NCT00410410|1160334|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
359457|NCT00410410|1160335|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
359458|NCT00410410|1160336|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
359459|NCT00410410|1160337|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
359460|NCT00410410|1160338|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
359461|NCT00410410|1160339|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
359462|NCT00410410|1160331|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
359463|NCT00410410|1160332|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
359464|NCT00410410|1160333|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
359465|NCT00410410|1160334|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
359466|NCT00410410|1160335|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
359467|NCT00410410|1160336|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
359468|NCT00410410|1160337|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
359469|NCT00410410|1160338|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
359470|NCT00410410|1160339|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
359471|NCT00410410|1160331|P9|Induction Period (IP)|Withdrawal by Subject|0
359472|NCT00410410|1160332|P8|Induction Period (IP)|Withdrawal by Subject|0
359473|NCT00410410|1160333|P7|Induction Period (IP)|Withdrawal by Subject|0
359474|NCT00410410|1160334|P6|Induction Period (IP)|Withdrawal by Subject|0
359475|NCT00410410|1160335|P5|Induction Period (IP)|Withdrawal by Subject|2
359476|NCT00410410|1160336|P4|Induction Period (IP)|Withdrawal by Subject|5
359477|NCT00410410|1160337|P3|Induction Period (IP)|Withdrawal by Subject|3
359478|NCT00410410|1160338|P2|Induction Period (IP)|Withdrawal by Subject|5
359479|NCT00410410|1160339|P1|Induction Period (IP)|Withdrawal by Subject|3
359480|NCT00410410|1160331|P9|Induction Period (IP)|Lost to Follow-up|0
359481|NCT00410410|1160332|P8|Induction Period (IP)|Lost to Follow-up|0
359482|NCT00410410|1160333|P7|Induction Period (IP)|Lost to Follow-up|0
359483|NCT00410410|1160334|P6|Induction Period (IP)|Lost to Follow-up|1
359484|NCT00410410|1160335|P5|Induction Period (IP)|Lost to Follow-up|0
359485|NCT00410410|1160336|P4|Induction Period (IP)|Lost to Follow-up|3
359486|NCT00410410|1160337|P3|Induction Period (IP)|Lost to Follow-up|2
359487|NCT00410410|1160338|P2|Induction Period (IP)|Lost to Follow-up|2
359488|NCT00410410|1160339|P1|Induction Period (IP)|Lost to Follow-up|2
359489|NCT00410410|1160331|P9|Induction Period (IP)|Lack of Efficacy|0
359490|NCT00410410|1160332|P8|Induction Period (IP)|Lack of Efficacy|0
359491|NCT00410410|1160333|P7|Induction Period (IP)|Lack of Efficacy|0
359492|NCT00410410|1160334|P6|Induction Period (IP)|Lack of Efficacy|7
359493|NCT00410410|1160335|P5|Induction Period (IP)|Lack of Efficacy|7
359494|NCT00410410|1160336|P4|Induction Period (IP)|Lack of Efficacy|8
359495|NCT00410410|1160337|P3|Induction Period (IP)|Lack of Efficacy|8
359496|NCT00410410|1160338|P2|Induction Period (IP)|Lack of Efficacy|24
359497|NCT00410410|1160339|P1|Induction Period (IP)|Lack of Efficacy|26
359498|NCT00410410|1160331|P9|Induction Period (IP)|Adverse Event|0
359499|NCT00410410|1160332|P8|Induction Period (IP)|Adverse Event|0
359500|NCT00410410|1160333|P7|Induction Period (IP)|Adverse Event|0
359501|NCT00410410|1160334|P6|Induction Period (IP)|Adverse Event|0
359502|NCT00410410|1160335|P5|Induction Period (IP)|Adverse Event|1
359503|NCT00410410|1160336|P4|Induction Period (IP)|Adverse Event|4
359504|NCT00410410|1160337|P3|Induction Period (IP)|Adverse Event|2
359505|NCT00410410|1160338|P2|Induction Period (IP)|Adverse Event|4
359506|NCT00410410|1160339|P1|Induction Period (IP)|Adverse Event|3
359507|NCT00410410|1160331|P9|Induction Period (IP)|Death|0
359508|NCT00410410|1160332|P8|Induction Period (IP)|Death|0
359509|NCT00410410|1160333|P7|Induction Period (IP)|Death|0
359510|NCT00410410|1160334|P6|Induction Period (IP)|Death|0
359511|NCT00410410|1160335|P5|Induction Period (IP)|Death|0
359512|NCT00410410|1160336|P4|Induction Period (IP)|Death|0
359513|NCT00410410|1160337|P3|Induction Period (IP)|Death|0
359514|NCT00410410|1160338|P2|Induction Period (IP)|Death|0
359515|NCT00410410|1160339|P1|Induction Period (IP)|Death|1
359516|NCT00410384|1160500|P3|Overall Study|Other|4
359517|NCT00410384|1160501|P2|Overall Study|Other|8
359518|NCT00410384|1160502|P1|Overall Study|Other|3
359519|NCT00410384|1160500|P3|Overall Study|Physician Decision|4
359520|NCT00410384|1160501|P2|Overall Study|Physician Decision|3
359521|NCT00410384|1160502|P1|Overall Study|Physician Decision|3
359522|NCT00410384|1160500|P3|Overall Study|Protocol Violation|6
359523|NCT00410384|1160501|P2|Overall Study|Protocol Violation|6
359524|NCT00410384|1160502|P1|Overall Study|Protocol Violation|6
359525|NCT00410384|1160500|P3|Overall Study|Lost to Follow-up|6
359526|NCT00410384|1160501|P2|Overall Study|Lost to Follow-up|6
359527|NCT00410384|1160502|P1|Overall Study|Lost to Follow-up|4
359528|NCT00410384|1160500|P3|Overall Study|Lack of Compliance|2
359529|NCT00410384|1160501|P2|Overall Study|Lack of Compliance|2
359530|NCT00410384|1160502|P1|Overall Study|Lack of Compliance|2
359531|NCT00410384|1160500|P3|Overall Study|Lack of Efficacy|17
359532|NCT00410384|1160501|P2|Overall Study|Lack of Efficacy|12
359533|NCT00410384|1160502|P1|Overall Study|Lack of Efficacy|20
359534|NCT00410384|1160500|P3|Overall Study|Adverse Event|23
359535|NCT00410384|1160501|P2|Overall Study|Adverse Event|18
359536|NCT00410384|1160502|P1|Overall Study|Adverse Event|23
359537|NCT00410384|1160500|P3|Overall Study|Withdrawal by Subject|20
359538|NCT00410384|1160501|P2|Overall Study|Withdrawal by Subject|17
359539|NCT00410384|1160502|P1|Overall Study|Withdrawal by Subject|28
359540|NCT00410202|1160575|P3|Off-treatment Follow up|Lost to Follow-up|0
359541|NCT00410202|1160576|P2|Off-treatment Follow up|Lost to Follow-up|0
359542|NCT00410202|1160577|P1|Off-treatment Follow up|Lost to Follow-up|1
359543|NCT00410202|1160575|P3|Off-treatment Follow up|Follow up not required per protocol|1
359544|NCT00410202|1160576|P2|Off-treatment Follow up|Follow up not required per protocol|0
359545|NCT00410202|1160577|P1|Off-treatment Follow up|Follow up not required per protocol|3
359546|NCT00410202|1160575|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
359547|NCT00410202|1160576|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
359548|NCT00410202|1160577|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
359549|NCT00410202|1160575|P3|On-Treatment|Other Reason|1
359550|NCT00410202|1160576|P2|On-Treatment|Other Reason|0
359551|NCT00410202|1160577|P1|On-Treatment|Other Reason|0
359552|NCT00410202|1160575|P3|On-Treatment|Withdrawal by Subject|1
359553|NCT00410202|1160576|P2|On-Treatment|Withdrawal by Subject|1
359554|NCT00410202|1160577|P1|On-Treatment|Withdrawal by Subject|2
359555|NCT00410202|1160575|P3|On-Treatment|Lack of Efficacy|0
359556|NCT00410202|1160576|P2|On-Treatment|Lack of Efficacy|4
359557|NCT00410202|1160577|P1|On-Treatment|Lack of Efficacy|1
359558|NCT00410202|1160575|P3|On-Treatment|Lost to Follow-up|1
359559|NCT00410202|1160576|P2|On-Treatment|Lost to Follow-up|0
359560|NCT00410202|1160577|P1|On-Treatment|Lost to Follow-up|1
359561|NCT00410202|1160575|P3|On-Treatment|Death|0
359562|NCT00410202|1160576|P2|On-Treatment|Death|0
359563|NCT00410202|1160577|P1|On-Treatment|Death|1
359564|NCT00410202|1160575|P3|On-Treatment|Adverse Event|2
359565|NCT00410202|1160576|P2|On-Treatment|Adverse Event|3
359566|NCT00410202|1160577|P1|On-Treatment|Adverse Event|1
359567|NCT00410202|1160575|P3|On-Treatment|Continuing treatment|66
359568|NCT00410202|1160576|P2|On-Treatment|Continuing treatment|71
359569|NCT00410202|1160577|P1|On-Treatment|Continuing treatment|69
359570|NCT00410163|1160664|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
359571|NCT00410163|1160665|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
359572|NCT00410163|1160664|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
359573|NCT00410163|1160665|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
359574|NCT00410163|1160664|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
359575|NCT00410163|1160665|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
359576|NCT00410163|1160664|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
359577|NCT00410163|1160665|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
359578|NCT00410163|1160664|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
359579|NCT00410163|1160665|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
359580|NCT00410163|1160664|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
359581|NCT00410163|1160665|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
359582|NCT00410163|1160664|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
359583|NCT00410163|1160665|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
359584|NCT00410163|1160664|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
359585|NCT00410163|1160665|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
359586|NCT00410163|1160664|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
359587|NCT00410163|1160665|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
359588|NCT00410163|1160664|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
359589|NCT00410163|1160665|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
359590|NCT00410163|1160664|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
359591|NCT00410163|1160665|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
359592|NCT00410163|1160664|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
359593|NCT00410163|1160665|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
359594|NCT00410163|1160664|P2|Treatment and Follow-up Phase (2 Years)|Death|1
359595|NCT00410163|1160665|P1|Treatment and Follow-up Phase (2 Years)|Death|1
359596|NCT00410163|1160664|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
359597|NCT00410163|1160665|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
359598|NCT00410124|1160718|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
359599|NCT00410124|1160719|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
359600|NCT00410124|1160718|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
359601|NCT00410124|1160719|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
359602|NCT00410124|1160718|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
359603|NCT00410124|1160719|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
359604|NCT00410124|1160718|P2|Extension Phase - Open Label (45 Months)|Death|10
359605|NCT00410124|1160719|P1|Extension Phase - Open Label (45 Months)|Death|2
359606|NCT00410124|1160718|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
359607|NCT00410124|1160719|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
359608|NCT00410124|1160718|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
359609|NCT00410124|1160719|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
359610|NCT00410124|1160718|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
359611|NCT00410124|1160719|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
359612|NCT00410124|1160718|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
359613|NCT00410124|1160719|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
359614|NCT00410124|1160718|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
359615|NCT00410124|1160719|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
359616|NCT00410124|1160718|P2|Core Phase Double Blind (15 Months)|Death|4
359617|NCT00410124|1160719|P1|Core Phase Double Blind (15 Months)|Death|7
359618|NCT00410124|1160718|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
359619|NCT00410124|1160719|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
359620|NCT00410124|1160718|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
359621|NCT00410124|1160719|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
359622|NCT00410124|1160718|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
359623|NCT00410124|1160719|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
359624|NCT00410124|1160718|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
359625|NCT00410124|1160719|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
359626|NCT00410124|1160718|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
359627|NCT00410124|1160719|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
359628|NCT00410124|1160718|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
359629|NCT00410124|1160719|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
359630|NCT00410072|1160750|P2|After Week 48 to Week 96|Withdrawal by Subject|1
359631|NCT00410072|1160751|P1|After Week 48 to Week 96|Withdrawal by Subject|0
359632|NCT00410072|1160750|P2|After Week 48 to Week 96|Pregnancy|2
359633|NCT00410072|1160751|P1|After Week 48 to Week 96|Pregnancy|0
359634|NCT00410072|1160750|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
359635|NCT00410072|1160751|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
359636|NCT00410072|1160750|P2|After Week 48 to Week 96|Not specified|0
359637|NCT00410072|1160751|P1|After Week 48 to Week 96|Not specified|2
359638|NCT00410072|1160750|P2|After Week 48 to Week 96|Lost to Follow-up|4
359639|NCT00410072|1160751|P1|After Week 48 to Week 96|Lost to Follow-up|2
359640|NCT00410072|1160750|P2|After Week 48 to Week 96|Lack of Efficacy|0
359641|NCT00410072|1160751|P1|After Week 48 to Week 96|Lack of Efficacy|1
359642|NCT00410072|1160750|P2|After Week 48 to Week 96|Death|1
359643|NCT00410072|1160751|P1|After Week 48 to Week 96|Death|0
359644|NCT00410072|1160750|P2|After Week 48 to Week 96|Adverse Event|2
359645|NCT00410072|1160751|P1|After Week 48 to Week 96|Adverse Event|1
359646|NCT00410072|1160750|P2|Day 1 to Week 48|Withdrawal by Subject|2
359647|NCT00410072|1160751|P1|Day 1 to Week 48|Withdrawal by Subject|0
359648|NCT00410072|1160750|P2|Day 1 to Week 48|Pregnancy|2
359649|NCT00410072|1160751|P1|Day 1 to Week 48|Pregnancy|0
359650|NCT00410072|1160750|P2|Day 1 to Week 48|poor compliance/noncompliance|3
359651|NCT00410072|1160751|P1|Day 1 to Week 48|poor compliance/noncompliance|0
359652|NCT00410072|1160750|P2|Day 1 to Week 48|Not specified|1
359653|NCT00410072|1160751|P1|Day 1 to Week 48|Not specified|0
359654|NCT00410072|1160750|P2|Day 1 to Week 48|Lost to Follow-up|2
359655|NCT00410072|1160751|P1|Day 1 to Week 48|Lost to Follow-up|5
359656|NCT00410072|1160750|P2|Day 1 to Week 48|Adverse Event|2
359657|NCT00410072|1160751|P1|Day 1 to Week 48|Adverse Event|1
359658|NCT00410046|1160787|P1|Overall Study|Lost to Follow-up|1
359659|NCT00410046|1160787|P1|Overall Study|Withdrawal by Subject|1
359660|NCT00410046|1160787|P1|Overall Study|Adverse Event|3
359661|NCT00409838|1160818|P2|Long-term Extension Period|Pregnancy|0
359662|NCT00409838|1160819|P1|Long-term Extension Period|Pregnancy|1
359663|NCT00409838|1160818|P2|Long-term Extension Period|Poor compliance/noncompliance|0
359664|NCT00409838|1160819|P1|Long-term Extension Period|Poor compliance/noncompliance|1
359665|NCT00409838|1160818|P2|Long-term Extension Period|Withdrawal by Subject|0
359666|NCT00409838|1160819|P1|Long-term Extension Period|Withdrawal by Subject|3
359667|NCT00409838|1160818|P2|Long-term Extension Period|Lack of Efficacy|0
359668|NCT00409838|1160819|P1|Long-term Extension Period|Lack of Efficacy|2
359669|NCT00409838|1160818|P2|Long-term Extension Period|Death|0
359670|NCT00409838|1160819|P1|Long-term Extension Period|Death|1
359671|NCT00409838|1160818|P2|Long-term Extension Period|Adverse Event|0
359672|NCT00409838|1160819|P1|Long-term Extension Period|Adverse Event|10
359673|NCT00409838|1160818|P2|Short-term Period|Never Treated|0
359674|NCT00409838|1160819|P1|Short-term Period|Never Treated|1
359675|NCT00409838|1160818|P2|Short-term Period|Withdrawal by Subject|3
359676|NCT00409838|1160819|P1|Short-term Period|Withdrawal by Subject|2
359677|NCT00409838|1160818|P2|Short-term Period|Lost to Follow-up|1
359678|NCT00409838|1160819|P1|Short-term Period|Lost to Follow-up|0
359679|NCT00409838|1160818|P2|Short-term Period|Adverse Event|1
359680|NCT00409838|1160819|P1|Short-term Period|Adverse Event|0
359681|NCT00409786|1160884|P1|Overall Study|Withdrawal by Subject|3
359682|NCT00409773|1160893|P5|Overall Study|Lack of Eligibility|1
359683|NCT00409773|1160894|P4|Overall Study|Lack of Eligibility|0
359684|NCT00409773|1160895|P3|Overall Study|Lack of Eligibility|0
359685|NCT00409773|1160896|P2|Overall Study|Lack of Eligibility|0
359686|NCT00409773|1160897|P1|Overall Study|Lack of Eligibility|0
359687|NCT00409773|1160893|P5|Overall Study|Withdrawal by Subject|1
359688|NCT00409773|1160894|P4|Overall Study|Withdrawal by Subject|2
359689|NCT00409773|1160895|P3|Overall Study|Withdrawal by Subject|0
359690|NCT00409773|1160896|P2|Overall Study|Withdrawal by Subject|0
359691|NCT00409773|1160897|P1|Overall Study|Withdrawal by Subject|0
359692|NCT00409773|1160893|P5|Overall Study|Protocol Violation|1
359693|NCT00409773|1160894|P4|Overall Study|Protocol Violation|3
359694|NCT00409773|1160895|P3|Overall Study|Protocol Violation|3
359695|NCT00409773|1160896|P2|Overall Study|Protocol Violation|2
359696|NCT00409773|1160897|P1|Overall Study|Protocol Violation|0
359697|NCT00409773|1160893|P5|Overall Study|Physician Decision|0
359698|NCT00409773|1160894|P4|Overall Study|Physician Decision|2
359699|NCT00409773|1160895|P3|Overall Study|Physician Decision|0
359700|NCT00409773|1160896|P2|Overall Study|Physician Decision|0
359701|NCT00409773|1160897|P1|Overall Study|Physician Decision|0
359702|NCT00409773|1160893|P5|Overall Study|Lost to Follow-up|1
359703|NCT00409773|1160894|P4|Overall Study|Lost to Follow-up|3
359704|NCT00409773|1160895|P3|Overall Study|Lost to Follow-up|2
359705|NCT00409773|1160896|P2|Overall Study|Lost to Follow-up|1
359706|NCT00409773|1160897|P1|Overall Study|Lost to Follow-up|6
359707|NCT00409773|1160893|P5|Overall Study|Adverse Event|6
359708|NCT00409773|1160894|P4|Overall Study|Adverse Event|2
359709|NCT00409773|1160895|P3|Overall Study|Adverse Event|4
359710|NCT00409773|1160896|P2|Overall Study|Adverse Event|4
359711|NCT00409773|1160897|P1|Overall Study|Adverse Event|3
359712|NCT00409747|1160979|P1|Overall Study|Withdrawal by Subject|1
359713|NCT00409708|1160986|P2|Washout|Lost to Follow-up|3
359714|NCT00409708|1160987|P1|Washout|Lost to Follow-up|1
359715|NCT00409708|1160986|P2|Washout|Withdrawal by Subject|5
359716|NCT00409708|1160987|P1|Washout|Withdrawal by Subject|11
359717|NCT00409708|1160986|P2|Washout|Protocol Violation|1
359718|NCT00409708|1160987|P1|Washout|Protocol Violation|0
359719|NCT00409708|1160986|P2|Washout|Lack of Efficacy|1
359720|NCT00409708|1160987|P1|Washout|Lack of Efficacy|9
359721|NCT00409708|1160986|P2|Treatment|Administrative problems|0
359722|NCT00409708|1160987|P1|Treatment|Administrative problems|5
359723|NCT00409708|1160986|P2|Treatment|Lost to Follow-up|6
359724|NCT00409708|1160987|P1|Treatment|Lost to Follow-up|0
359725|NCT00409708|1160986|P2|Treatment|Withdrawal by Subject|8
359726|NCT00409708|1160987|P1|Treatment|Withdrawal by Subject|3
359727|NCT00409708|1160986|P2|Treatment|Protocol Violation|2
359728|NCT00409708|1160987|P1|Treatment|Protocol Violation|6
359729|NCT00409708|1160986|P2|Treatment|Lack of Efficacy|1
359730|NCT00409708|1160987|P1|Treatment|Lack of Efficacy|0
359731|NCT00409708|1160986|P2|Treatment|Abnormal test procedure result(s)|0
359732|NCT00409708|1160987|P1|Treatment|Abnormal test procedure result(s)|1
359733|NCT00409682|1161008|P3|EOW Double-blind Maintenance Period|Non-compliance|1
359734|NCT00409682|1161009|P2|EOW Double-blind Maintenance Period|Non-compliance|0
359735|NCT00409682|1161010|P1|EOW Double-blind Maintenance Period|Non-compliance|0
359736|NCT00409682|1161008|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
359737|NCT00409682|1161009|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
359738|NCT00409682|1161010|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
359739|NCT00409682|1161008|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
359740|NCT00409682|1161009|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
359741|NCT00409682|1161010|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
359742|NCT00409682|1161008|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
359743|NCT00409682|1161009|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
359744|NCT00409682|1161010|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
359745|NCT00409682|1161008|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
359746|NCT00409682|1161009|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
359747|NCT00409682|1161010|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
359748|NCT00409682|1161008|P3|EOW Double-blind Maintenance Period|Adverse Event|12
359749|NCT00409682|1161009|P2|EOW Double-blind Maintenance Period|Adverse Event|10
359750|NCT00409682|1161010|P1|EOW Double-blind Maintenance Period|Adverse Event|0
359751|NCT00409682|1161008|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
359752|NCT00409682|1161009|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
359753|NCT00409682|1161010|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
359754|NCT00409682|1161008|P3|Open-label Induction Period|Protocol Violation|0
359755|NCT00409682|1161009|P2|Open-label Induction Period|Protocol Violation|0
359756|NCT00409682|1161010|P1|Open-label Induction Period|Protocol Violation|1
359757|NCT00409682|1161008|P3|Open-label Induction Period|Lack of Efficacy|0
359758|NCT00409682|1161009|P2|Open-label Induction Period|Lack of Efficacy|0
359759|NCT00409682|1161010|P1|Open-label Induction Period|Lack of Efficacy|1
359760|NCT00409682|1161008|P3|Open-label Induction Period|Adverse Event|0
359761|NCT00409682|1161009|P2|Open-label Induction Period|Adverse Event|0
359762|NCT00409682|1161010|P1|Open-label Induction Period|Adverse Event|1
359763|NCT00409617|1161027|P1|Overall Study|Not described|14
359764|NCT00409617|1161027|P1|Overall Study|Administrative reasons|1
359765|NCT00409617|1161027|P1|Overall Study|Withdrawal by Subject|8
359766|NCT00409617|1161027|P1|Overall Study|Protocol Violation|24
359767|NCT00409617|1161027|P1|Overall Study|Lost to Follow-up|2
359768|NCT00409617|1161027|P1|Overall Study|Lack of Efficacy|54
359769|NCT00409617|1161027|P1|Overall Study|Adverse Event|57
359770|NCT00409578|1161043|P4|Overall Study|Missing|1
359771|NCT00409578|1161044|P3|Overall Study|Missing|0
359772|NCT00409578|1161045|P2|Overall Study|Missing|1
359773|NCT00409578|1161046|P1|Overall Study|Missing|0
359774|NCT00409578|1161043|P4|Overall Study|Protocol Violation|1
359775|NCT00409578|1161044|P3|Overall Study|Protocol Violation|3
359776|NCT00409578|1161045|P2|Overall Study|Protocol Violation|2
359777|NCT00409578|1161046|P1|Overall Study|Protocol Violation|3
359778|NCT00409578|1161043|P4|Overall Study|Death|2
359779|NCT00409578|1161044|P3|Overall Study|Death|4
359780|NCT00409578|1161045|P2|Overall Study|Death|4
359781|NCT00409578|1161046|P1|Overall Study|Death|2
359782|NCT00409578|1161043|P4|Overall Study|Administrative problems|4
359783|NCT00409578|1161044|P3|Overall Study|Administrative problems|2
359784|NCT00409578|1161045|P2|Overall Study|Administrative problems|9
359785|NCT00409578|1161046|P1|Overall Study|Administrative problems|8
359786|NCT00409578|1161043|P4|Overall Study|Lost to Follow-up|2
359787|NCT00409578|1161044|P3|Overall Study|Lost to Follow-up|2
359788|NCT00409578|1161045|P2|Overall Study|Lost to Follow-up|0
359789|NCT00409578|1161046|P1|Overall Study|Lost to Follow-up|2
359790|NCT00409578|1161043|P4|Overall Study|Withdrawal by Subject|17
359791|NCT00409578|1161044|P3|Overall Study|Withdrawal by Subject|16
359792|NCT00409578|1161045|P2|Overall Study|Withdrawal by Subject|15
359793|NCT00409578|1161046|P1|Overall Study|Withdrawal by Subject|8
359794|NCT00409578|1161043|P4|Overall Study|Subject no longer requires study drug|1
359795|NCT00409578|1161044|P3|Overall Study|Subject no longer requires study drug|0
359796|NCT00409578|1161045|P2|Overall Study|Subject no longer requires study drug|0
359797|NCT00409578|1161046|P1|Overall Study|Subject no longer requires study drug|0
359798|NCT00409578|1161043|P4|Overall Study|Lack of Efficacy|2
359799|NCT00409578|1161044|P3|Overall Study|Lack of Efficacy|0
359800|NCT00409578|1161045|P2|Overall Study|Lack of Efficacy|0
359801|NCT00409578|1161046|P1|Overall Study|Lack of Efficacy|0
359802|NCT00409578|1161043|P4|Overall Study|Abnormal laboratory value(s)|4
359803|NCT00409578|1161044|P3|Overall Study|Abnormal laboratory value(s)|2
359804|NCT00409578|1161045|P2|Overall Study|Abnormal laboratory value(s)|2
359805|NCT00409578|1161046|P1|Overall Study|Abnormal laboratory value(s)|2
359806|NCT00409578|1161043|P4|Overall Study|Adverse Event|33
359807|NCT00409578|1161044|P3|Overall Study|Adverse Event|25
359808|NCT00409578|1161045|P2|Overall Study|Adverse Event|37
359809|NCT00409578|1161046|P1|Overall Study|Adverse Event|27
359810|NCT00409409|1161104|P2|Overall Study|Any other reason not above-mentioned|1
359811|NCT00409409|1161105|P1|Overall Study|Any other reason not above-mentioned|0
359812|NCT00409409|1161104|P2|Overall Study|Withdrawal by Subject|1
359813|NCT00409409|1161105|P1|Overall Study|Withdrawal by Subject|1
359814|NCT00409409|1161104|P2|Overall Study|Adverse Event|2
359815|NCT00409409|1161105|P1|Overall Study|Adverse Event|7
359816|NCT00409344|1161113|P2|Overall Study|no enrollment|0
359817|NCT00409344|1161114|P1|Overall Study|no enrollment|0
359818|NCT00409331|1161132|P1|Overall Study|Physician Decision|1
359819|NCT00409188|1161154|P2|Overall Study|Ongoing at data cut-off|175
359820|NCT00409188|1161155|P1|Overall Study|Ongoing at data cut-off|383
359821|NCT00409175|1161171|P2|Overall Study|Liver transplantation|13
359822|NCT00409175|1161172|P1|Overall Study|Liver transplantation|13
359823|NCT00409175|1161171|P2|Overall Study|Negative genotype|1
359824|NCT00409175|1161172|P1|Overall Study|Negative genotype|0
359825|NCT00409175|1161171|P2|Overall Study|Withdrawal by Subject|2
359826|NCT00409175|1161172|P1|Overall Study|Withdrawal by Subject|1
359827|NCT00409175|1161171|P2|Overall Study|Adverse Event|3
359828|NCT00409175|1161172|P1|Overall Study|Adverse Event|4
359829|NCT00409006|1161198|P2|Overall Study|Physician Decision|2
359830|NCT00409006|1161199|P1|Overall Study|Physician Decision|1
359831|NCT00409006|1161198|P2|Overall Study|Withdrawal by Subject|2
359832|NCT00409006|1161199|P1|Overall Study|Withdrawal by Subject|3
359833|NCT00409006|1161198|P2|Overall Study|Lost to Follow-up|2
359834|NCT00409006|1161199|P1|Overall Study|Lost to Follow-up|1
359835|NCT00409006|1161198|P2|Overall Study|Death|6
359836|NCT00409006|1161199|P1|Overall Study|Death|15
359837|NCT00408993|1161215|P2|Overall Study|Withdrawal by Subject|3
359838|NCT00408993|1161216|P1|Overall Study|Withdrawal by Subject|2
359839|NCT00408993|1161215|P2|Overall Study|Lack of Efficacy|4
359840|NCT00408993|1161216|P1|Overall Study|Lack of Efficacy|1
359841|NCT00408993|1161215|P2|Overall Study|Protocol Violation|6
359842|NCT00408993|1161216|P1|Overall Study|Protocol Violation|1
359843|NCT00408993|1161215|P2|Overall Study|Adverse Event|4
359844|NCT00408993|1161216|P1|Overall Study|Adverse Event|15
359845|NCT00408928|1161248|P1|Overall Study|Infection indistinguishable from GVHD|1
359846|NCT00408928|1161248|P1|Overall Study|Death|1
359847|NCT00408928|1161248|P1|Overall Study|Withdrawal by Subject|1
359848|NCT00408902|1161253|P1|Overall Study|Adverse Event|3
359849|NCT00408902|1161253|P1|Overall Study|Lack of Efficacy|7
359850|NCT00408876|1161262|P4|Overall Study|Physician Decision|0
359851|NCT00408876|1161263|P3|Overall Study|Physician Decision|3
359852|NCT00408876|1161264|P2|Overall Study|Physician Decision|0
359853|NCT00408876|1161265|P1|Overall Study|Physician Decision|1
359854|NCT00408876|1161262|P4|Overall Study|Protocol Violation|3
359855|NCT00408876|1161263|P3|Overall Study|Protocol Violation|4
359856|NCT00408876|1161264|P2|Overall Study|Protocol Violation|3
359857|NCT00408876|1161265|P1|Overall Study|Protocol Violation|0
359858|NCT00408876|1161262|P4|Overall Study|Lost to Follow-up|2
359859|NCT00408876|1161263|P3|Overall Study|Lost to Follow-up|5
359860|NCT00408876|1161264|P2|Overall Study|Lost to Follow-up|6
359861|NCT00408876|1161265|P1|Overall Study|Lost to Follow-up|1
359862|NCT00408876|1161262|P4|Overall Study|Lack of Efficacy|6
359863|NCT00408876|1161263|P3|Overall Study|Lack of Efficacy|5
359864|NCT00408876|1161264|P2|Overall Study|Lack of Efficacy|4
359865|NCT00408876|1161265|P1|Overall Study|Lack of Efficacy|2
359866|NCT00408876|1161262|P4|Overall Study|Withdrawal by Subject|14
359867|NCT00408876|1161263|P3|Overall Study|Withdrawal by Subject|6
359868|NCT00408876|1161264|P2|Overall Study|Withdrawal by Subject|6
359869|NCT00408876|1161265|P1|Overall Study|Withdrawal by Subject|3
359870|NCT00408876|1161262|P4|Overall Study|Adverse Event|10
359871|NCT00408876|1161263|P3|Overall Study|Adverse Event|27
359872|NCT00408876|1161264|P2|Overall Study|Adverse Event|17
359873|NCT00408876|1161265|P1|Overall Study|Adverse Event|9
359874|NCT00408694|1161515|P1|Overall Study|No protocol treatment|1
359875|NCT00408694|1161515|P1|Overall Study|Ineligible|1
359876|NCT00408681|1161519|P1|Overall Study|Adverse Event|7
359877|NCT00408681|1161519|P1|Overall Study|Lack of Efficacy|2
359878|NCT00408629|1161538|P2|Overall Study|Miscellaneous|15
359879|NCT00408629|1161539|P1|Overall Study|Miscellaneous|11
359880|NCT00408629|1161538|P2|Overall Study|Protocol Violation|5
359881|NCT00408629|1161539|P1|Overall Study|Protocol Violation|1
359882|NCT00408629|1161538|P2|Overall Study|Lack of Efficacy|73
359883|NCT00408629|1161539|P1|Overall Study|Lack of Efficacy|63
359884|NCT00408629|1161538|P2|Overall Study|Lost to Follow-up|1
359885|NCT00408629|1161539|P1|Overall Study|Lost to Follow-up|1
359886|NCT00408629|1161538|P2|Overall Study|Withdrawal by Subject|4
359887|NCT00408629|1161539|P1|Overall Study|Withdrawal by Subject|8
359888|NCT00408629|1161538|P2|Overall Study|Adverse Event|27
359889|NCT00408629|1161539|P1|Overall Study|Adverse Event|13
359890|NCT00408499|1161578|P5|Phase II- MTD Expansion|treatment delay|3
359891|NCT00408499|1161579|P4|Phase II- MTD Expansion|treatment delay|0
359892|NCT00408499|1161580|P3|Phase II- MTD Expansion|treatment delay|0
359893|NCT00408499|1161581|P2|Phase II- MTD Expansion|treatment delay|0
359894|NCT00408499|1161582|P1|Phase II- MTD Expansion|treatment delay|0
359895|NCT00408499|1161578|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
359896|NCT00408499|1161579|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
359897|NCT00408499|1161580|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
359898|NCT00408499|1161581|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
359899|NCT00408499|1161582|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
359900|NCT00408499|1161578|P5|Phase II- MTD Expansion|Physician Decision|1
359901|NCT00408499|1161579|P4|Phase II- MTD Expansion|Physician Decision|0
359902|NCT00408499|1161580|P3|Phase II- MTD Expansion|Physician Decision|0
359903|NCT00408499|1161581|P2|Phase II- MTD Expansion|Physician Decision|0
359904|NCT00408499|1161582|P1|Phase II- MTD Expansion|Physician Decision|0
359905|NCT00408499|1161578|P5|Phase II- MTD Expansion|Death|2
359906|NCT00408499|1161579|P4|Phase II- MTD Expansion|Death|0
359907|NCT00408499|1161580|P3|Phase II- MTD Expansion|Death|0
359908|NCT00408499|1161581|P2|Phase II- MTD Expansion|Death|0
359909|NCT00408499|1161582|P1|Phase II- MTD Expansion|Death|0
359910|NCT00408499|1161578|P5|Phase II- MTD Expansion|Adverse Event|9
359911|NCT00408499|1161579|P4|Phase II- MTD Expansion|Adverse Event|0
359912|NCT00408499|1161580|P3|Phase II- MTD Expansion|Adverse Event|0
359913|NCT00408499|1161581|P2|Phase II- MTD Expansion|Adverse Event|0
359914|NCT00408499|1161582|P1|Phase II- MTD Expansion|Adverse Event|0
359915|NCT00408499|1161578|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
359916|NCT00408499|1161579|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
359917|NCT00408499|1161580|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
359918|NCT00408499|1161581|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
359919|NCT00408499|1161582|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
359920|NCT00408499|1161578|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
359921|NCT00408499|1161579|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
359922|NCT00408499|1161580|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
359923|NCT00408499|1161581|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
359924|NCT00408499|1161582|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
359925|NCT00408499|1161578|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
359926|NCT00408499|1161579|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
359927|NCT00408499|1161580|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
359928|NCT00408499|1161581|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
359929|NCT00408499|1161582|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
359930|NCT00408421|1161599|P3|Treatment Re-Randomization|Withdrawal by Subject|0
359931|NCT00408421|1161600|P2|Treatment Re-Randomization|Withdrawal by Subject|1
359932|NCT00408421|1161601|P1|Treatment Re-Randomization|Withdrawal by Subject|2
359933|NCT00408421|1161599|P3|Treatment Re-Randomization|Protocol Violation|0
359934|NCT00408421|1161600|P2|Treatment Re-Randomization|Protocol Violation|1
359935|NCT00408421|1161601|P1|Treatment Re-Randomization|Protocol Violation|1
359936|NCT00408421|1161599|P3|Treatment Re-Randomization|Physician Decision|0
359937|NCT00408421|1161600|P2|Treatment Re-Randomization|Physician Decision|3
359938|NCT00408421|1161601|P1|Treatment Re-Randomization|Physician Decision|1
359939|NCT00408421|1161599|P3|Treatment Re-Randomization|Lost to Follow-up|1
359940|NCT00408421|1161600|P2|Treatment Re-Randomization|Lost to Follow-up|0
359941|NCT00408421|1161601|P1|Treatment Re-Randomization|Lost to Follow-up|0
359942|NCT00408421|1161599|P3|Treatment Re-Randomization|Lack of Efficacy|0
359943|NCT00408421|1161600|P2|Treatment Re-Randomization|Lack of Efficacy|0
359944|NCT00408421|1161601|P1|Treatment Re-Randomization|Lack of Efficacy|1
359945|NCT00408421|1161599|P3|Treatment Re-Randomization|Adverse Event|4
359946|NCT00408421|1161600|P2|Treatment Re-Randomization|Adverse Event|2
359947|NCT00408421|1161601|P1|Treatment Re-Randomization|Adverse Event|2
359948|NCT00408421|1161599|P3|Treatment Initial Randomization|Sponsor Decision|0
359949|NCT00408421|1161600|P2|Treatment Initial Randomization|Sponsor Decision|0
359950|NCT00408421|1161601|P1|Treatment Initial Randomization|Sponsor Decision|1
359951|NCT00408421|1161599|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
359952|NCT00408421|1161600|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
359953|NCT00408421|1161601|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
359954|NCT00408421|1161599|P3|Treatment Initial Randomization|Withdrawal by Subject|0
359955|NCT00408421|1161600|P2|Treatment Initial Randomization|Withdrawal by Subject|7
359956|NCT00408421|1161601|P1|Treatment Initial Randomization|Withdrawal by Subject|7
359957|NCT00408421|1161599|P3|Treatment Initial Randomization|Protocol Violation|0
359958|NCT00408421|1161600|P2|Treatment Initial Randomization|Protocol Violation|1
359959|NCT00408421|1161601|P1|Treatment Initial Randomization|Protocol Violation|0
359960|NCT00408421|1161599|P3|Treatment Initial Randomization|Physician Decision|0
359961|NCT00408421|1161600|P2|Treatment Initial Randomization|Physician Decision|0
359962|NCT00408421|1161601|P1|Treatment Initial Randomization|Physician Decision|1
359963|NCT00408421|1161599|P3|Treatment Initial Randomization|Lost to Follow-up|0
359964|NCT00408421|1161600|P2|Treatment Initial Randomization|Lost to Follow-up|3
359965|NCT00408421|1161601|P1|Treatment Initial Randomization|Lost to Follow-up|0
359966|NCT00408421|1161599|P3|Treatment Initial Randomization|Lack of Efficacy|0
359967|NCT00408421|1161600|P2|Treatment Initial Randomization|Lack of Efficacy|2
359968|NCT00408421|1161601|P1|Treatment Initial Randomization|Lack of Efficacy|2
359969|NCT00408421|1161599|P3|Treatment Initial Randomization|Adverse Event|0
359970|NCT00408421|1161600|P2|Treatment Initial Randomization|Adverse Event|9
359971|NCT00408421|1161601|P1|Treatment Initial Randomization|Adverse Event|5
359972|NCT00408317|1161675|P2|Second Intervention Period|Withdrawal of consent|1
359973|NCT00408317|1161676|P1|Second Intervention Period|Withdrawal of consent|0
359974|NCT00408317|1161675|P2|Second Intervention Period|Protocol Violation|1
359975|NCT00408317|1161676|P1|Second Intervention Period|Protocol Violation|0
359976|NCT00408317|1161675|P2|Second Intervention Period|Adverse Event|0
359977|NCT00408317|1161676|P1|Second Intervention Period|Adverse Event|2
359978|NCT00408317|1161675|P2|First Intervention Period|Adverse Event|1
359979|NCT00408317|1161676|P1|First Intervention Period|Adverse Event|0
359980|NCT00407797|1161707|P1|Overall Study|Withdrawal by Subject|3
359981|NCT00407797|1161707|P1|Overall Study|Unspecified|7
359982|NCT00407797|1161707|P1|Overall Study|Adverse Event|6
359983|NCT00407797|1161707|P1|Overall Study|Lost to Follow-up|2
359984|NCT00407745|1161724|P2|Overall Study|Randomized, unknown if treated|1
359985|NCT00407745|1161725|P1|Overall Study|Randomized, unknown if treated|0
359986|NCT00407745|1161724|P2|Overall Study|Unspecified|0
359987|NCT00407745|1161725|P1|Overall Study|Unspecified|2
359988|NCT00407745|1161724|P2|Overall Study|Adverse Event|8
359989|NCT00407745|1161725|P1|Overall Study|Adverse Event|8
359990|NCT00407745|1161724|P2|Overall Study|Protocol Violation|3
359991|NCT00407745|1161725|P1|Overall Study|Protocol Violation|5
359992|NCT00407745|1161724|P2|Overall Study|Withdrawal by Subject|3
359993|NCT00407745|1161725|P1|Overall Study|Withdrawal by Subject|3
359994|NCT00407745|1161724|P2|Overall Study|Lack of Efficacy|2
359995|NCT00407745|1161725|P1|Overall Study|Lack of Efficacy|1
359996|NCT00407563|1161809|P1|Overall Study|Patient continues on treatment|1
359997|NCT00407550|1161819|P2|Overall Study|Insurance or Other medical condition|1
359998|NCT00407550|1161820|P1|Overall Study|Insurance or Other medical condition|2
359999|NCT00407550|1161819|P2|Overall Study|Death|0
360000|NCT00407550|1161820|P1|Overall Study|Death|1
360001|NCT00407550|1161819|P2|Overall Study|Withdrawal by Subject|2
360002|NCT00407550|1161820|P1|Overall Study|Withdrawal by Subject|0
360003|NCT00407550|1161819|P2|Overall Study|Adverse Event|1
360004|NCT00407550|1161820|P1|Overall Study|Adverse Event|0
360005|NCT00407537|1161828|P2|Overall Study|Withdrawal by Subject|16
360006|NCT00407537|1161829|P1|Overall Study|Withdrawal by Subject|34
360007|NCT00407537|1161828|P2|Overall Study|Unspecified|7
360008|NCT00407537|1161829|P1|Overall Study|Unspecified|6
360009|NCT00407537|1161828|P2|Overall Study|Lost to Follow-up|19
360010|NCT00407537|1161829|P1|Overall Study|Lost to Follow-up|12
360011|NCT00407537|1161828|P2|Overall Study|Adverse Event|0
360012|NCT00407537|1161829|P1|Overall Study|Adverse Event|36
360013|NCT00407537|1161828|P2|Overall Study|Death|2
360014|NCT00407537|1161829|P1|Overall Study|Death|5
360015|NCT00407511|1161877|P1|Overall Study|Withdrawal by Subject|4
360016|NCT00407511|1161877|P1|Overall Study|Other|5
360017|NCT00407511|1161877|P1|Overall Study|Lost to Follow-up|4
360018|NCT00407511|1161877|P1|Overall Study|Adverse Event|9
360019|NCT00407030|1161923|P3|Extension Period - up to 68 Weeks|Physician Decision|0
360020|NCT00407030|1161924|P2|Extension Period - up to 68 Weeks|Physician Decision|2
360021|NCT00407030|1161925|P1|Extension Period - up to 68 Weeks|Physician Decision|1
360022|NCT00407030|1161923|P3|Extension Period - up to 68 Weeks|Patient Decision|0
360023|NCT00407030|1161924|P2|Extension Period - up to 68 Weeks|Patient Decision|2
360024|NCT00407030|1161925|P1|Extension Period - up to 68 Weeks|Patient Decision|1
360025|NCT00407030|1161923|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
360026|NCT00407030|1161924|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
360027|NCT00407030|1161925|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
360028|NCT00407030|1161923|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
360029|NCT00407030|1161924|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
360030|NCT00407030|1161925|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
360031|NCT00407030|1161923|P3|Extension Period - up to 68 Weeks|Adverse Event|0
360032|NCT00407030|1161924|P2|Extension Period - up to 68 Weeks|Adverse Event|0
360033|NCT00407030|1161925|P1|Extension Period - up to 68 Weeks|Adverse Event|1
360034|NCT00407030|1161923|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
360035|NCT00407030|1161924|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
360036|NCT00407030|1161925|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
360037|NCT00407030|1161923|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
360038|NCT00407030|1161924|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
360039|NCT00407030|1161925|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
360040|NCT00407030|1161923|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
360041|NCT00407030|1161924|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
360042|NCT00407030|1161925|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
360043|NCT00407030|1161923|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
360044|NCT00407030|1161924|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
360045|NCT00407030|1161925|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
360046|NCT00407030|1161923|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
360047|NCT00407030|1161924|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
360048|NCT00407030|1161925|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
360049|NCT00407030|1161923|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
360050|NCT00407030|1161924|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
360051|NCT00407030|1161925|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
360052|NCT00407030|1161923|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
360053|NCT00407030|1161924|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
360054|NCT00407030|1161925|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
360055|NCT00407030|1161923|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
360056|NCT00407030|1161924|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
360057|NCT00407030|1161925|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
360058|NCT00406848|1161953|P2|Overall Study|Sponsor Decision|1
360059|NCT00406848|1161954|P1|Overall Study|Sponsor Decision|1
360060|NCT00406848|1161953|P2|Overall Study|Physician Decision|2
360061|NCT00406848|1161954|P1|Overall Study|Physician Decision|2
360062|NCT00406848|1161953|P2|Overall Study|Lost to Follow-up|2
360063|NCT00406848|1161954|P1|Overall Study|Lost to Follow-up|6
360064|NCT00406848|1161953|P2|Overall Study|Protocol Violation|6
360065|NCT00406848|1161954|P1|Overall Study|Protocol Violation|10
360066|NCT00406848|1161953|P2|Overall Study|Lack of Efficacy|14
360067|NCT00406848|1161954|P1|Overall Study|Lack of Efficacy|9
360068|NCT00406848|1161953|P2|Overall Study|Adverse Event|7
360069|NCT00406848|1161954|P1|Overall Study|Adverse Event|38
360070|NCT00406848|1161953|P2|Overall Study|Withdrawal by Subject|22
360071|NCT00406848|1161954|P1|Overall Study|Withdrawal by Subject|27
360072|NCT00406783|1162018|P2|Overall Study|Protocol Violation|4
360073|NCT00406783|1162019|P1|Overall Study|Protocol Violation|4
360074|NCT00406783|1162018|P2|Overall Study|Withdrawal by Subject|4
360075|NCT00406783|1162019|P1|Overall Study|Withdrawal by Subject|1
360076|NCT00406783|1162018|P2|Overall Study|Lost to Follow-up|0
360077|NCT00406783|1162019|P1|Overall Study|Lost to Follow-up|3
360078|NCT00406783|1162018|P2|Overall Study|Treatment Failure|3
360079|NCT00406783|1162019|P1|Overall Study|Treatment Failure|2
360080|NCT00406783|1162018|P2|Overall Study|Adverse Event|4
360081|NCT00406783|1162019|P1|Overall Study|Adverse Event|4
360082|NCT00406718|1162034|P3|Overall Study|Lost to Follow-up|4
360083|NCT00406718|1162035|P2|Overall Study|Lost to Follow-up|5
360084|NCT00406718|1162036|P1|Overall Study|Lost to Follow-up|2
360085|NCT00406718|1162034|P3|Overall Study|Withdrawal by Subject|4
360086|NCT00406718|1162035|P2|Overall Study|Withdrawal by Subject|9
360087|NCT00406718|1162036|P1|Overall Study|Withdrawal by Subject|2
360088|NCT00406692|1162050|P1|Overall Study|Lack of Efficacy|1
360089|NCT00406692|1162050|P1|Overall Study|Adverse Event|1
360090|NCT00406692|1162050|P1|Overall Study|Physician Decision|1
360091|NCT00406692|1162050|P1|Overall Study|Withdrawal by Subject|4
360092|NCT00406653|1162060|P7|Open-Label Period|Refused followup|1
360093|NCT00406653|1162061|P6|Open-Label Period|Refused followup|0
360094|NCT00406653|1162062|P5|Open-Label Period|Refused followup|0
360095|NCT00406653|1162063|P4|Open-Label Period|Refused followup|0
360096|NCT00406653|1162064|P3|Open-Label Period|Refused followup|0
360097|NCT00406653|1162065|P2|Open-Label Period|Refused followup|0
360098|NCT00406653|1162066|P1|Open-Label Period|Refused followup|0
360099|NCT00406653|1162060|P7|Open-Label Period|Discontinued by Sponsor|1
360100|NCT00406653|1162061|P6|Open-Label Period|Discontinued by Sponsor|0
360101|NCT00406653|1162062|P5|Open-Label Period|Discontinued by Sponsor|0
360102|NCT00406653|1162063|P4|Open-Label Period|Discontinued by Sponsor|0
360103|NCT00406653|1162064|P3|Open-Label Period|Discontinued by Sponsor|0
360104|NCT00406653|1162065|P2|Open-Label Period|Discontinued by Sponsor|0
360105|NCT00406653|1162066|P1|Open-Label Period|Discontinued by Sponsor|0
360106|NCT00406653|1162060|P7|Open-Label Period|Declined participation but followup done|8
360107|NCT00406653|1162061|P6|Open-Label Period|Declined participation but followup done|0
360108|NCT00406653|1162062|P5|Open-Label Period|Declined participation but followup done|0
360109|NCT00406653|1162063|P4|Open-Label Period|Declined participation but followup done|0
360110|NCT00406653|1162064|P3|Open-Label Period|Declined participation but followup done|0
360111|NCT00406653|1162065|P2|Open-Label Period|Declined participation but followup done|0
360112|NCT00406653|1162066|P1|Open-Label Period|Declined participation but followup done|0
360113|NCT00406653|1162060|P7|Open-Label Period|Administrative Reason By Sponsor|115
360114|NCT00406653|1162061|P6|Open-Label Period|Administrative Reason By Sponsor|0
360115|NCT00406653|1162062|P5|Open-Label Period|Administrative Reason By Sponsor|0
360116|NCT00406653|1162063|P4|Open-Label Period|Administrative Reason By Sponsor|0
360117|NCT00406653|1162064|P3|Open-Label Period|Administrative Reason By Sponsor|0
360118|NCT00406653|1162065|P2|Open-Label Period|Administrative Reason By Sponsor|0
360119|NCT00406653|1162066|P1|Open-Label Period|Administrative Reason By Sponsor|0
360120|NCT00406653|1162060|P7|Open-Label Period|Pregnancy|2
360121|NCT00406653|1162061|P6|Open-Label Period|Pregnancy|0
360122|NCT00406653|1162062|P5|Open-Label Period|Pregnancy|0
360123|NCT00406653|1162063|P4|Open-Label Period|Pregnancy|0
360124|NCT00406653|1162064|P3|Open-Label Period|Pregnancy|0
360125|NCT00406653|1162065|P2|Open-Label Period|Pregnancy|0
360126|NCT00406653|1162066|P1|Open-Label Period|Pregnancy|0
360127|NCT00406653|1162060|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
360128|NCT00406653|1162061|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
360129|NCT00406653|1162062|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
360130|NCT00406653|1162063|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
360131|NCT00406653|1162064|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
360132|NCT00406653|1162065|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
360133|NCT00406653|1162066|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
360134|NCT00406653|1162060|P7|Open-Label Period|Withdrawal of Consent|11
360135|NCT00406653|1162061|P6|Open-Label Period|Withdrawal of Consent|0
360136|NCT00406653|1162062|P5|Open-Label Period|Withdrawal of Consent|0
360137|NCT00406653|1162063|P4|Open-Label Period|Withdrawal of Consent|0
360138|NCT00406653|1162064|P3|Open-Label Period|Withdrawal of Consent|0
360139|NCT00406653|1162065|P2|Open-Label Period|Withdrawal of Consent|0
360140|NCT00406653|1162066|P1|Open-Label Period|Withdrawal of Consent|0
360141|NCT00406653|1162060|P7|Open-Label Period|Lost to Follow-up|6
360142|NCT00406653|1162061|P6|Open-Label Period|Lost to Follow-up|0
360143|NCT00406653|1162062|P5|Open-Label Period|Lost to Follow-up|0
360144|NCT00406653|1162063|P4|Open-Label Period|Lost to Follow-up|0
360145|NCT00406653|1162064|P3|Open-Label Period|Lost to Follow-up|0
360146|NCT00406653|1162065|P2|Open-Label Period|Lost to Follow-up|0
360147|NCT00406653|1162066|P1|Open-Label Period|Lost to Follow-up|0
360148|NCT00406653|1162060|P7|Open-Label Period|Lack of Efficacy|160
360149|NCT00406653|1162061|P6|Open-Label Period|Lack of Efficacy|0
360150|NCT00406653|1162062|P5|Open-Label Period|Lack of Efficacy|0
360151|NCT00406653|1162063|P4|Open-Label Period|Lack of Efficacy|0
360152|NCT00406653|1162064|P3|Open-Label Period|Lack of Efficacy|0
360153|NCT00406653|1162065|P2|Open-Label Period|Lack of Efficacy|0
360154|NCT00406653|1162066|P1|Open-Label Period|Lack of Efficacy|0
360155|NCT00406653|1162060|P7|Open-Label Period|Adverse Event|18
360156|NCT00406653|1162061|P6|Open-Label Period|Adverse Event|0
360157|NCT00406653|1162062|P5|Open-Label Period|Adverse Event|0
360158|NCT00406653|1162063|P4|Open-Label Period|Adverse Event|0
360159|NCT00406653|1162064|P3|Open-Label Period|Adverse Event|0
360160|NCT00406653|1162065|P2|Open-Label Period|Adverse Event|0
360161|NCT00406653|1162066|P1|Open-Label Period|Adverse Event|0
360162|NCT00406653|1162060|P7|Open-Label Period|Death|1
360163|NCT00406653|1162061|P6|Open-Label Period|Death|0
360164|NCT00406653|1162062|P5|Open-Label Period|Death|0
360165|NCT00406653|1162063|P4|Open-Label Period|Death|0
360166|NCT00406653|1162064|P3|Open-Label Period|Death|0
360167|NCT00406653|1162065|P2|Open-Label Period|Death|0
360168|NCT00406653|1162066|P1|Open-Label Period|Death|0
360169|NCT00406653|1162060|P7|Maintenance Period|Error in disease score evaluation|0
360170|NCT00406653|1162061|P6|Maintenance Period|Error in disease score evaluation|0
360171|NCT00406653|1162062|P5|Maintenance Period|Error in disease score evaluation|1
360172|NCT00406653|1162063|P4|Maintenance Period|Error in disease score evaluation|0
360173|NCT00406653|1162064|P3|Maintenance Period|Error in disease score evaluation|0
360174|NCT00406653|1162065|P2|Maintenance Period|Error in disease score evaluation|0
360175|NCT00406653|1162066|P1|Maintenance Period|Error in disease score evaluation|0
360176|NCT00406653|1162060|P7|Maintenance Period|Administrative Reason By Sponsor|0
360177|NCT00406653|1162061|P6|Maintenance Period|Administrative Reason By Sponsor|7
360178|NCT00406653|1162062|P5|Maintenance Period|Administrative Reason By Sponsor|4
360179|NCT00406653|1162063|P4|Maintenance Period|Administrative Reason By Sponsor|0
360180|NCT00406653|1162064|P3|Maintenance Period|Administrative Reason By Sponsor|0
360181|NCT00406653|1162065|P2|Maintenance Period|Administrative Reason By Sponsor|0
360182|NCT00406653|1162066|P1|Maintenance Period|Administrative Reason By Sponsor|0
360183|NCT00406653|1162060|P7|Maintenance Period|Pregnancy|0
360184|NCT00406653|1162061|P6|Maintenance Period|Pregnancy|1
360185|NCT00406653|1162062|P5|Maintenance Period|Pregnancy|0
360186|NCT00406653|1162063|P4|Maintenance Period|Pregnancy|0
360187|NCT00406653|1162064|P3|Maintenance Period|Pregnancy|0
360188|NCT00406653|1162065|P2|Maintenance Period|Pregnancy|0
360189|NCT00406653|1162066|P1|Maintenance Period|Pregnancy|0
360190|NCT00406653|1162060|P7|Maintenance Period|Withdrawal of Consent|0
360191|NCT00406653|1162061|P6|Maintenance Period|Withdrawal of Consent|0
360192|NCT00406653|1162062|P5|Maintenance Period|Withdrawal of Consent|2
360193|NCT00406653|1162063|P4|Maintenance Period|Withdrawal of Consent|0
360194|NCT00406653|1162064|P3|Maintenance Period|Withdrawal of Consent|0
360195|NCT00406653|1162065|P2|Maintenance Period|Withdrawal of Consent|0
360196|NCT00406653|1162066|P1|Maintenance Period|Withdrawal of Consent|0
360197|NCT00406653|1162060|P7|Maintenance Period|Lost to Follow-up|0
360198|NCT00406653|1162061|P6|Maintenance Period|Lost to Follow-up|1
360199|NCT00406653|1162062|P5|Maintenance Period|Lost to Follow-up|2
360200|NCT00406653|1162063|P4|Maintenance Period|Lost to Follow-up|0
360201|NCT00406653|1162064|P3|Maintenance Period|Lost to Follow-up|0
360202|NCT00406653|1162065|P2|Maintenance Period|Lost to Follow-up|0
360203|NCT00406653|1162066|P1|Maintenance Period|Lost to Follow-up|0
360204|NCT00406653|1162060|P7|Maintenance Period|Lack of Efficacy|0
360205|NCT00406653|1162061|P6|Maintenance Period|Lack of Efficacy|26
360206|NCT00406653|1162062|P5|Maintenance Period|Lack of Efficacy|20
360207|NCT00406653|1162063|P4|Maintenance Period|Lack of Efficacy|0
360208|NCT00406653|1162064|P3|Maintenance Period|Lack of Efficacy|0
360209|NCT00406653|1162065|P2|Maintenance Period|Lack of Efficacy|0
360210|NCT00406653|1162066|P1|Maintenance Period|Lack of Efficacy|0
360211|NCT00406653|1162060|P7|Maintenance Period|Adverse Event|0
360212|NCT00406653|1162061|P6|Maintenance Period|Adverse Event|1
360213|NCT00406653|1162062|P5|Maintenance Period|Adverse Event|1
360214|NCT00406653|1162063|P4|Maintenance Period|Adverse Event|0
360215|NCT00406653|1162064|P3|Maintenance Period|Adverse Event|0
360216|NCT00406653|1162065|P2|Maintenance Period|Adverse Event|0
360217|NCT00406653|1162066|P1|Maintenance Period|Adverse Event|0
360218|NCT00406653|1162060|P7|Induction Period|Patient relocated|0
360219|NCT00406653|1162061|P6|Induction Period|Patient relocated|0
360220|NCT00406653|1162062|P5|Induction Period|Patient relocated|0
360221|NCT00406653|1162063|P4|Induction Period|Patient relocated|0
360222|NCT00406653|1162064|P3|Induction Period|Patient relocated|1
360223|NCT00406653|1162065|P2|Induction Period|Patient relocated|0
360224|NCT00406653|1162066|P1|Induction Period|Patient relocated|0
360225|NCT00406653|1162060|P7|Induction Period|Incarcerated|0
360226|NCT00406653|1162061|P6|Induction Period|Incarcerated|0
360227|NCT00406653|1162062|P5|Induction Period|Incarcerated|0
360228|NCT00406653|1162063|P4|Induction Period|Incarcerated|0
360229|NCT00406653|1162064|P3|Induction Period|Incarcerated|1
360230|NCT00406653|1162065|P2|Induction Period|Incarcerated|0
360231|NCT00406653|1162066|P1|Induction Period|Incarcerated|0
360232|NCT00406653|1162060|P7|Induction Period|Given prohibited drug|0
360233|NCT00406653|1162061|P6|Induction Period|Given prohibited drug|0
360234|NCT00406653|1162062|P5|Induction Period|Given prohibited drug|0
360235|NCT00406653|1162063|P4|Induction Period|Given prohibited drug|0
360236|NCT00406653|1162064|P3|Induction Period|Given prohibited drug|2
360237|NCT00406653|1162065|P2|Induction Period|Given prohibited drug|1
360238|NCT00406653|1162066|P1|Induction Period|Given prohibited drug|0
360239|NCT00406653|1162060|P7|Induction Period|Declined participation but followup done|0
360240|NCT00406653|1162061|P6|Induction Period|Declined participation but followup done|0
360241|NCT00406653|1162062|P5|Induction Period|Declined participation but followup done|0
360242|NCT00406653|1162063|P4|Induction Period|Declined participation but followup done|1
360243|NCT00406653|1162064|P3|Induction Period|Declined participation but followup done|1
360244|NCT00406653|1162065|P2|Induction Period|Declined participation but followup done|2
360245|NCT00406653|1162066|P1|Induction Period|Declined participation but followup done|0
360246|NCT00406653|1162060|P7|Induction Period|Pregnancy|0
360247|NCT00406653|1162061|P6|Induction Period|Pregnancy|0
360248|NCT00406653|1162062|P5|Induction Period|Pregnancy|0
360249|NCT00406653|1162063|P4|Induction Period|Pregnancy|0
360250|NCT00406653|1162064|P3|Induction Period|Pregnancy|0
360251|NCT00406653|1162065|P2|Induction Period|Pregnancy|0
360252|NCT00406653|1162066|P1|Induction Period|Pregnancy|1
360253|NCT00406653|1162060|P7|Induction Period|Subject No Longer Meets Study Criteria|0
360254|NCT00406653|1162061|P6|Induction Period|Subject No Longer Meets Study Criteria|0
360255|NCT00406653|1162062|P5|Induction Period|Subject No Longer Meets Study Criteria|0
360256|NCT00406653|1162063|P4|Induction Period|Subject No Longer Meets Study Criteria|2
360257|NCT00406653|1162064|P3|Induction Period|Subject No Longer Meets Study Criteria|0
360258|NCT00406653|1162065|P2|Induction Period|Subject No Longer Meets Study Criteria|0
360259|NCT00406653|1162066|P1|Induction Period|Subject No Longer Meets Study Criteria|0
360260|NCT00406653|1162060|P7|Induction Period|Withdrawal of Consent|0
360261|NCT00406653|1162061|P6|Induction Period|Withdrawal of Consent|0
360262|NCT00406653|1162062|P5|Induction Period|Withdrawal of Consent|0
360263|NCT00406653|1162063|P4|Induction Period|Withdrawal of Consent|2
360264|NCT00406653|1162064|P3|Induction Period|Withdrawal of Consent|1
360265|NCT00406653|1162065|P2|Induction Period|Withdrawal of Consent|5
360266|NCT00406653|1162066|P1|Induction Period|Withdrawal of Consent|2
360267|NCT00406653|1162060|P7|Induction Period|Lost to Follow-up|0
360268|NCT00406653|1162061|P6|Induction Period|Lost to Follow-up|0
360269|NCT00406653|1162062|P5|Induction Period|Lost to Follow-up|0
360270|NCT00406653|1162063|P4|Induction Period|Lost to Follow-up|0
360271|NCT00406653|1162064|P3|Induction Period|Lost to Follow-up|0
360272|NCT00406653|1162065|P2|Induction Period|Lost to Follow-up|2
360273|NCT00406653|1162066|P1|Induction Period|Lost to Follow-up|0
360274|NCT00406653|1162060|P7|Induction Period|Lack of Efficacy|0
360275|NCT00406653|1162061|P6|Induction Period|Lack of Efficacy|0
360276|NCT00406653|1162062|P5|Induction Period|Lack of Efficacy|0
360277|NCT00406653|1162063|P4|Induction Period|Lack of Efficacy|10
360278|NCT00406653|1162064|P3|Induction Period|Lack of Efficacy|8
360279|NCT00406653|1162065|P2|Induction Period|Lack of Efficacy|14
360280|NCT00406653|1162066|P1|Induction Period|Lack of Efficacy|11
360281|NCT00406653|1162060|P7|Induction Period|Adverse Event|0
360282|NCT00406653|1162061|P6|Induction Period|Adverse Event|0
360283|NCT00406653|1162062|P5|Induction Period|Adverse Event|0
360284|NCT00406653|1162063|P4|Induction Period|Adverse Event|11
360285|NCT00406653|1162064|P3|Induction Period|Adverse Event|4
360286|NCT00406653|1162065|P2|Induction Period|Adverse Event|10
360287|NCT00406653|1162066|P1|Induction Period|Adverse Event|1
360288|NCT00406640|1162147|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
360289|NCT00406640|1162148|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
360290|NCT00406640|1162147|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
360291|NCT00406640|1162148|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
360292|NCT00406640|1162147|P2|OL Extension Phase for Non-Responders|non-compliance|2
360293|NCT00406640|1162148|P1|OL Extension Phase for Non-Responders|non-compliance|3
360294|NCT00406640|1162147|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
360295|NCT00406640|1162148|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
360296|NCT00406640|1162147|P2|OL Extension Phase for Non-Responders|Physician Decision|0
360297|NCT00406640|1162148|P1|OL Extension Phase for Non-Responders|Physician Decision|1
360298|NCT00406640|1162147|P2|OL Extension Phase for Non-Responders|Failed to Return|0
360299|NCT00406640|1162148|P1|OL Extension Phase for Non-Responders|Failed to Return|1
360300|NCT00406640|1162147|P2|OL Extension Phase for Non-Responders|Adverse Event|6
360301|NCT00406640|1162148|P1|OL Extension Phase for Non-Responders|Adverse Event|6
360302|NCT00406640|1162147|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
360303|NCT00406640|1162148|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
360304|NCT00406640|1162147|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
360305|NCT00406640|1162148|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
360306|NCT00406640|1162147|P2|DB Continuation Phase for Responders|Protocol Violation|2
360307|NCT00406640|1162148|P1|DB Continuation Phase for Responders|Protocol Violation|2
360308|NCT00406640|1162147|P2|DB Continuation Phase for Responders|non-compliance|5
360309|NCT00406640|1162148|P1|DB Continuation Phase for Responders|non-compliance|7
360310|NCT00406640|1162147|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
360311|NCT00406640|1162148|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
360312|NCT00406640|1162147|P2|DB Continuation Phase for Responders|Physician Decision|3
360313|NCT00406640|1162148|P1|DB Continuation Phase for Responders|Physician Decision|2
360314|NCT00406640|1162147|P2|DB Continuation Phase for Responders|Failed to Return|2
360315|NCT00406640|1162148|P1|DB Continuation Phase for Responders|Failed to Return|0
360316|NCT00406640|1162147|P2|DB Continuation Phase for Responders|Death|0
360317|NCT00406640|1162148|P1|DB Continuation Phase for Responders|Death|1
360318|NCT00406640|1162147|P2|DB Continuation Phase for Responders|Adverse Event|11
360319|NCT00406640|1162148|P1|DB Continuation Phase for Responders|Adverse Event|11
360320|NCT00406640|1162147|P2|Acute Phase|Lack of Efficacy|3
360321|NCT00406640|1162148|P1|Acute Phase|Lack of Efficacy|3
360322|NCT00406640|1162147|P2|Acute Phase|Withdrawal by Subject|9
360323|NCT00406640|1162148|P1|Acute Phase|Withdrawal by Subject|11
360324|NCT00406640|1162147|P2|Acute Phase|Protocol Violation|2
360325|NCT00406640|1162148|P1|Acute Phase|Protocol Violation|3
360326|NCT00406640|1162147|P2|Acute Phase|Protocol deviation|10
360327|NCT00406640|1162148|P1|Acute Phase|Protocol deviation|4
360328|NCT00406640|1162147|P2|Acute Phase|Lost to Follow-up|4
360329|NCT00406640|1162148|P1|Acute Phase|Lost to Follow-up|7
360330|NCT00406640|1162147|P2|Acute Phase|Physician Decision|1
360331|NCT00406640|1162148|P1|Acute Phase|Physician Decision|0
360332|NCT00406640|1162147|P2|Acute Phase|Failed to Return|1
360333|NCT00406640|1162148|P1|Acute Phase|Failed to Return|5
360334|NCT00406640|1162147|P2|Acute Phase|Adverse Event|13
360335|NCT00406640|1162148|P1|Acute Phase|Adverse Event|18
360336|NCT00406393|1162180|P2|Overall Study|Did not undergo transplantation|1
360337|NCT00406393|1162181|P1|Overall Study|Did not undergo transplantation|2
360338|NCT00406367|1162211|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
360339|NCT00406367|1162212|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
360340|NCT00406367|1162211|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
360341|NCT00406367|1162212|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
360342|NCT00406367|1162211|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
360343|NCT00406367|1162212|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
360344|NCT00406367|1162211|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
360345|NCT00406367|1162212|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
360346|NCT00406367|1162211|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
360347|NCT00406367|1162212|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
360348|NCT00406367|1162211|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
360349|NCT00406367|1162212|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
360350|NCT00406367|1162211|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
360351|NCT00406367|1162212|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
360352|NCT00406367|1162211|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
360353|NCT00406367|1162212|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
360354|NCT00406367|1162211|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
360355|NCT00406367|1162212|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
360356|NCT00406367|1162211|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
360357|NCT00406367|1162212|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
360358|NCT00406367|1162211|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
360359|NCT00406367|1162212|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
360360|NCT00406367|1162211|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
360361|NCT00406367|1162212|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
360362|NCT00406354|1162227|P3|All Randomized and Treated Patients|Physician Decision|1
360363|NCT00406354|1162228|P2|All Randomized and Treated Patients|Physician Decision|0
360364|NCT00406354|1162229|P1|All Randomized and Treated Patients|Physician Decision|0
360365|NCT00406354|1162227|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
360366|NCT00406354|1162228|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
360367|NCT00406354|1162229|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
360368|NCT00406354|1162227|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
360369|NCT00406354|1162228|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
360370|NCT00406354|1162229|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
360371|NCT00406354|1162227|P3|All Randomized and Treated Patients|Adverse Event|1
360372|NCT00406354|1162228|P2|All Randomized and Treated Patients|Adverse Event|2
360373|NCT00406354|1162229|P1|All Randomized and Treated Patients|Adverse Event|6
360374|NCT00406354|1162227|P3|All Randomized and Treated Patients|Lack of Efficacy|17
360375|NCT00406354|1162228|P2|All Randomized and Treated Patients|Lack of Efficacy|4
360376|NCT00406354|1162229|P1|All Randomized and Treated Patients|Lack of Efficacy|7
360377|NCT00406354|1162227|P3|All Randomized Patients|Protocol Violation|1
360378|NCT00406354|1162228|P2|All Randomized Patients|Protocol Violation|0
360379|NCT00406354|1162229|P1|All Randomized Patients|Protocol Violation|0
360380|NCT00406315|1162300|P1|Overall Study|Withdrawal by Subject|30
360381|NCT00406315|1162300|P1|Overall Study|Lost to Follow-up|21
360382|NCT00406315|1162300|P1|Overall Study|Unspecified|33
360383|NCT00406315|1162300|P1|Overall Study|Lack of Efficacy|13
360384|NCT00406315|1162300|P1|Overall Study|Laboratory Abnormality|4
360385|NCT00406315|1162300|P1|Overall Study|Adverse Event|39
360386|NCT00406315|1162300|P1|Overall Study|Death|1
360387|NCT00405067|1162326|P3|Overall Study|Lost to Follow-up|1
360388|NCT00405067|1162327|P2|Overall Study|Lost to Follow-up|0
360389|NCT00405067|1162328|P1|Overall Study|Lost to Follow-up|0
360390|NCT00405067|1162326|P3|Overall Study|Adverse Event|4
360391|NCT00405067|1162327|P2|Overall Study|Adverse Event|9
360392|NCT00405067|1162328|P1|Overall Study|Adverse Event|4
360393|NCT00406029|1162450|P5|Overall Study|Randomized in Error|1
360394|NCT00406029|1162451|P4|Overall Study|Randomized in Error|3
360395|NCT00406029|1162452|P3|Overall Study|Randomized in Error|2
360396|NCT00406029|1162453|P2|Overall Study|Randomized in Error|0
360397|NCT00406029|1162454|P1|Overall Study|Randomized in Error|0
360398|NCT00406029|1162450|P5|Overall Study|Did Not Meet Eligibility Criteria|0
360399|NCT00406029|1162451|P4|Overall Study|Did Not Meet Eligibility Criteria|0
360400|NCT00406029|1162452|P3|Overall Study|Did Not Meet Eligibility Criteria|1
360401|NCT00406029|1162453|P2|Overall Study|Did Not Meet Eligibility Criteria|0
360402|NCT00406029|1162454|P1|Overall Study|Did Not Meet Eligibility Criteria|0
360403|NCT00406029|1162450|P5|Overall Study|Protocol Violation|0
360404|NCT00406029|1162451|P4|Overall Study|Protocol Violation|2
360405|NCT00406029|1162452|P3|Overall Study|Protocol Violation|0
360406|NCT00406029|1162453|P2|Overall Study|Protocol Violation|2
360407|NCT00406029|1162454|P1|Overall Study|Protocol Violation|1
360408|NCT00406029|1162450|P5|Overall Study|Withdrawal by Subject|0
360409|NCT00406029|1162451|P4|Overall Study|Withdrawal by Subject|2
360410|NCT00406029|1162452|P3|Overall Study|Withdrawal by Subject|2
360411|NCT00406029|1162453|P2|Overall Study|Withdrawal by Subject|4
360412|NCT00406029|1162454|P1|Overall Study|Withdrawal by Subject|3
360413|NCT00406029|1162450|P5|Overall Study|Adverse Event|7
360414|NCT00406029|1162451|P4|Overall Study|Adverse Event|10
360415|NCT00406029|1162452|P3|Overall Study|Adverse Event|5
360416|NCT00406029|1162453|P2|Overall Study|Adverse Event|2
360417|NCT00406029|1162454|P1|Overall Study|Adverse Event|12
360418|NCT00405964|1162558|P2|Overall Study|Protocol Violation|6
360419|NCT00405964|1162559|P1|Overall Study|Protocol Violation|11
360420|NCT00405964|1162558|P2|Overall Study|Withdrawal by Subject|23
360421|NCT00405964|1162559|P1|Overall Study|Withdrawal by Subject|19
360422|NCT00405964|1162558|P2|Overall Study|Lost to Follow-up|5
360423|NCT00405964|1162559|P1|Overall Study|Lost to Follow-up|5
360424|NCT00405964|1162558|P2|Overall Study|Adverse Event|16
360425|NCT00405964|1162559|P1|Overall Study|Adverse Event|7
360426|NCT00405964|1162558|P2|Overall Study|Treatment Failure|45
360427|NCT00405964|1162559|P1|Overall Study|Treatment Failure|17
360428|NCT00405912|1162581|P3|Overall Study|Lost to Follow-up|4
360429|NCT00405912|1162582|P2|Overall Study|Lost to Follow-up|8
360430|NCT00405912|1162583|P1|Overall Study|Lost to Follow-up|4
360431|NCT00405912|1162581|P3|Overall Study|Withdrawal by Subject|12
360432|NCT00405912|1162582|P2|Overall Study|Withdrawal by Subject|11
360433|NCT00405912|1162583|P1|Overall Study|Withdrawal by Subject|12
360434|NCT00405821|1162596|P2|Overall Study|initiated ART|8
360435|NCT00405821|1162597|P1|Overall Study|initiated ART|9
360436|NCT00405821|1162596|P2|Overall Study|Protocol Violation|0
360437|NCT00405821|1162597|P1|Overall Study|Protocol Violation|1
360438|NCT00405821|1162596|P2|Overall Study|Lost to Follow-up|7
360439|NCT00405821|1162597|P1|Overall Study|Lost to Follow-up|7
360440|NCT00405821|1162596|P2|Overall Study|Death|7
360441|NCT00405821|1162597|P1|Overall Study|Death|5
360442|NCT00405756|1162610|P3|Follow-up|Lost to Follow-up|4
360443|NCT00405756|1162611|P2|Follow-up|Lost to Follow-up|8
360444|NCT00405756|1162612|P1|Follow-up|Lost to Follow-up|2
360445|NCT00405756|1162610|P3|Follow-up|Death|24
360446|NCT00405756|1162611|P2|Follow-up|Death|31
360447|NCT00405756|1162612|P1|Follow-up|Death|21
360448|NCT00405756|1162610|P3|Follow-up|Ongoing in Follow-up Period|60
360449|NCT00405756|1162611|P2|Follow-up|Ongoing in Follow-up Period|51
360450|NCT00405756|1162612|P1|Follow-up|Ongoing in Follow-up Period|52
360451|NCT00405756|1162610|P3|Open-label Extension|Unspecified|7
360452|NCT00405756|1162611|P2|Open-label Extension|Unspecified|1
360453|NCT00405756|1162612|P1|Open-label Extension|Unspecified|0
360454|NCT00405756|1162610|P3|Open-label Extension|Death|4
360455|NCT00405756|1162611|P2|Open-label Extension|Death|2
360456|NCT00405756|1162612|P1|Open-label Extension|Death|1
360457|NCT00405756|1162610|P3|Open-label Extension|Withdrawal by Subject|3
360458|NCT00405756|1162611|P2|Open-label Extension|Withdrawal by Subject|3
360459|NCT00405756|1162612|P1|Open-label Extension|Withdrawal by Subject|2
360460|NCT00405756|1162610|P3|Open-label Extension|Disease Progression|26
360461|NCT00405756|1162611|P2|Open-label Extension|Disease Progression|23
360462|NCT00405756|1162612|P1|Open-label Extension|Disease Progression|8
360463|NCT00405756|1162610|P3|Open-label Extension|Adverse Event|7
360464|NCT00405756|1162611|P2|Open-label Extension|Adverse Event|3
360465|NCT00405756|1162612|P1|Open-label Extension|Adverse Event|1
360466|NCT00405756|1162610|P3|Open-label Extension|Ongoing in Open Label Period|25
360467|NCT00405756|1162611|P2|Open-label Extension|Ongoing in Open Label Period|15
360468|NCT00405756|1162612|P1|Open-label Extension|Ongoing in Open Label Period|7
360469|NCT00405756|1162610|P3|Double-blind Treatment|Not Specified|4
360470|NCT00405756|1162611|P2|Double-blind Treatment|Not Specified|4
360471|NCT00405756|1162612|P1|Double-blind Treatment|Not Specified|7
360472|NCT00405756|1162610|P3|Double-blind Treatment|Protocol Violation|2
360473|NCT00405756|1162611|P2|Double-blind Treatment|Protocol Violation|0
360474|NCT00405756|1162612|P1|Double-blind Treatment|Protocol Violation|1
360475|NCT00405756|1162610|P3|Double-blind Treatment|Death|4
360476|NCT00405756|1162611|P2|Double-blind Treatment|Death|4
360477|NCT00405756|1162612|P1|Double-blind Treatment|Death|4
360478|NCT00405756|1162610|P3|Double-blind Treatment|Lost to Follow-up|0
360479|NCT00405756|1162611|P2|Double-blind Treatment|Lost to Follow-up|0
360480|NCT00405756|1162612|P1|Double-blind Treatment|Lost to Follow-up|1
360481|NCT00405756|1162610|P3|Double-blind Treatment|Withdrawal by Subject|10
360482|NCT00405756|1162611|P2|Double-blind Treatment|Withdrawal by Subject|9
360483|NCT00405756|1162612|P1|Double-blind Treatment|Withdrawal by Subject|15
360484|NCT00405756|1162610|P3|Double-blind Treatment|Lack of Efficacy|2
360485|NCT00405756|1162611|P2|Double-blind Treatment|Lack of Efficacy|4
360486|NCT00405756|1162612|P1|Double-blind Treatment|Lack of Efficacy|1
360487|NCT00405756|1162610|P3|Double-blind Treatment|Disease Progression|102
360488|NCT00405756|1162611|P2|Double-blind Treatment|Disease Progression|81
360489|NCT00405756|1162612|P1|Double-blind Treatment|Disease Progression|47
360490|NCT00405756|1162610|P3|Double-blind Treatment|Adverse Event|12
360491|NCT00405756|1162611|P2|Double-blind Treatment|Adverse Event|27
360492|NCT00405756|1162612|P1|Double-blind Treatment|Adverse Event|31
360493|NCT00405756|1162610|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
360494|NCT00405756|1162611|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
360495|NCT00405756|1162612|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
360496|NCT00405652|1162723|P1|Overall Study|Adverse Event|4
360497|NCT00405639|1162730|P2|Overall Study|Seizure prior to receiving BNP|0
360498|NCT00405639|1162731|P1|Overall Study|Seizure prior to receiving BNP|1
360499|NCT00405639|1162730|P2|Overall Study|Adverse Event|0
360500|NCT00405639|1162731|P1|Overall Study|Adverse Event|1
360501|NCT00405639|1162730|P2|Overall Study|Withdrawal by Subject|0
360502|NCT00405639|1162731|P1|Overall Study|Withdrawal by Subject|1
360503|NCT00405548|1162745|P2|Overall Study|Withdrawal by Subject|0
360504|NCT00405548|1162746|P1|Overall Study|Withdrawal by Subject|1
360505|NCT00405548|1162745|P2|Overall Study|Venous access failed during study day|0
360506|NCT00405548|1162746|P1|Overall Study|Venous access failed during study day|1
360507|NCT00405548|1162745|P2|Overall Study|Unable to self-administer shots|0
360508|NCT00405548|1162746|P1|Overall Study|Unable to self-administer shots|1
360509|NCT00405548|1162745|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
360510|NCT00405548|1162746|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
360511|NCT00405548|1162745|P2|Overall Study|Cognitive Memory problems on study day|0
360512|NCT00405548|1162746|P1|Overall Study|Cognitive Memory problems on study day|1
360513|NCT00405275|1162808|P2|Overall Study|Unwilling to continue|9
360514|NCT00405275|1162809|P1|Overall Study|Unwilling to continue|10
360515|NCT00405275|1162808|P2|Overall Study|Withdrawal by Subject|9
360516|NCT00405275|1162809|P1|Overall Study|Withdrawal by Subject|7
360517|NCT00405275|1162808|P2|Overall Study|Lost to Follow-up|1
360518|NCT00405275|1162809|P1|Overall Study|Lost to Follow-up|5
360519|NCT00405275|1162808|P2|Overall Study|Death|0
360520|NCT00405275|1162809|P1|Overall Study|Death|1
360521|NCT00404924|1162817|P2|Overall Study|Randomised but not received treatment|1
360522|NCT00404924|1162818|P1|Overall Study|Randomised but not received treatment|1
360523|NCT00404924|1162817|P2|Overall Study|Not Specified|11
360524|NCT00404924|1162818|P1|Overall Study|Not Specified|25
360525|NCT00404924|1162817|P2|Overall Study|Withdrawal by Subject|13
360526|NCT00404924|1162818|P1|Overall Study|Withdrawal by Subject|26
360527|NCT00404924|1162817|P2|Overall Study|Lost to Follow-up|1
360528|NCT00404924|1162818|P1|Overall Study|Lost to Follow-up|1
360529|NCT00404924|1162817|P2|Overall Study|Condition under investigation worsened|264
360530|NCT00404924|1162818|P1|Overall Study|Condition under investigation worsened|475
360531|NCT00404924|1162817|P2|Overall Study|Adverse Event|16
360532|NCT00404924|1162818|P1|Overall Study|Adverse Event|75
360533|NCT00404820|1162836|P2|Overall Study|Other|2
360534|NCT00404820|1162837|P1|Overall Study|Other|0
360535|NCT00404820|1162836|P2|Overall Study|Death|0
360536|NCT00404820|1162837|P1|Overall Study|Death|1
360537|NCT00404820|1162836|P2|Overall Study|Administrative problems|0
360538|NCT00404820|1162837|P1|Overall Study|Administrative problems|2
360539|NCT00404820|1162836|P2|Overall Study|Lost to Follow-up|3
360540|NCT00404820|1162837|P1|Overall Study|Lost to Follow-up|7
360541|NCT00404820|1162836|P2|Overall Study|Withdrawal by Subject|3
360542|NCT00404820|1162837|P1|Overall Study|Withdrawal by Subject|5
360543|NCT00404820|1162836|P2|Overall Study|Adverse Event|16
360544|NCT00404820|1162837|P1|Overall Study|Adverse Event|4
360545|NCT00404651|1162859|P4|Overall Study|Withdrawal by Subject|6
360546|NCT00404651|1162860|P3|Overall Study|Withdrawal by Subject|16
360547|NCT00404651|1162861|P2|Overall Study|Withdrawal by Subject|12
360548|NCT00404651|1162862|P1|Overall Study|Withdrawal by Subject|14
360549|NCT00404651|1162859|P4|Overall Study|Lost to Follow-up|10
360550|NCT00404651|1162860|P3|Overall Study|Lost to Follow-up|13
360551|NCT00404651|1162861|P2|Overall Study|Lost to Follow-up|11
360552|NCT00404651|1162862|P1|Overall Study|Lost to Follow-up|15
360553|NCT00404651|1162859|P4|Overall Study|Protocol Violation|5
360554|NCT00404651|1162860|P3|Overall Study|Protocol Violation|14
360555|NCT00404651|1162861|P2|Overall Study|Protocol Violation|5
360556|NCT00404651|1162862|P1|Overall Study|Protocol Violation|10
360557|NCT00404651|1162859|P4|Overall Study|Serious Adverse Event|0
360558|NCT00404651|1162860|P3|Overall Study|Serious Adverse Event|2
360559|NCT00404651|1162861|P2|Overall Study|Serious Adverse Event|0
360560|NCT00404651|1162862|P1|Overall Study|Serious Adverse Event|0
360561|NCT00404547|1162890|P2|Overall Study|Reason not stated|6
360562|NCT00404547|1162891|P1|Overall Study|Reason not stated|3
360563|NCT00404547|1162890|P2|Overall Study|Not known|0
360564|NCT00404547|1162891|P1|Overall Study|Not known|4
360565|NCT00404547|1162890|P2|Overall Study|Lack of compliance|1
360566|NCT00404547|1162891|P1|Overall Study|Lack of compliance|5
360567|NCT00404547|1162890|P2|Overall Study|Lost to Follow-up|9
360568|NCT00404547|1162891|P1|Overall Study|Lost to Follow-up|20
360569|NCT00404547|1162890|P2|Overall Study|Protocol Violation|1
360570|NCT00404547|1162891|P1|Overall Study|Protocol Violation|0
360571|NCT00404547|1162890|P2|Overall Study|Withdrawal by Subject|2
360572|NCT00404547|1162891|P1|Overall Study|Withdrawal by Subject|19
360573|NCT00404547|1162890|P2|Overall Study|Adverse Event|6
360574|NCT00404547|1162891|P1|Overall Study|Adverse Event|39
360575|NCT00404495|1162901|P2|Overall Study|Withdrawal by Subject|0
360576|NCT00404495|1162902|P1|Overall Study|Withdrawal by Subject|1
360577|NCT00404495|1162901|P2|Overall Study|Not specified|0
360578|NCT00404495|1162902|P1|Overall Study|Not specified|1
360579|NCT00404495|1162901|P2|Overall Study|Lost to Follow-up|0
360580|NCT00404495|1162902|P1|Overall Study|Lost to Follow-up|5
360581|NCT00404495|1162901|P2|Overall Study|Death|11
360582|NCT00404495|1162902|P1|Overall Study|Death|37
360583|NCT00404352|1162921|P9|Open Label Extension (up to 36 Months)|unspecified|2
360584|NCT00404352|1162922|P8|Open Label Extension (up to 36 Months)|unspecified|0
360585|NCT00404352|1162923|P7|Open Label Extension (up to 36 Months)|unspecified|0
360586|NCT00404352|1162924|P6|Open Label Extension (up to 36 Months)|unspecified|0
360587|NCT00404352|1162925|P5|Open Label Extension (up to 36 Months)|unspecified|0
360588|NCT00404352|1162926|P4|Open Label Extension (up to 36 Months)|unspecified|0
360589|NCT00404352|1162927|P3|Open Label Extension (up to 36 Months)|unspecified|0
360590|NCT00404352|1162928|P2|Open Label Extension (up to 36 Months)|unspecified|0
360591|NCT00404352|1162929|P1|Open Label Extension (up to 36 Months)|unspecified|0
360592|NCT00404352|1162921|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
360593|NCT00404352|1162922|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
360594|NCT00404352|1162923|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
360595|NCT00404352|1162924|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
360596|NCT00404352|1162925|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
360597|NCT00404352|1162926|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
360598|NCT00404352|1162927|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
360599|NCT00404352|1162928|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
360600|NCT00404352|1162929|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
360601|NCT00404352|1162921|P9|Open Label (up to 24 Month)|Disease progression|0
360602|NCT00404352|1162922|P8|Open Label (up to 24 Month)|Disease progression|0
360603|NCT00404352|1162923|P7|Open Label (up to 24 Month)|Disease progression|0
360604|NCT00404352|1162924|P6|Open Label (up to 24 Month)|Disease progression|0
360605|NCT00404352|1162925|P5|Open Label (up to 24 Month)|Disease progression|0
360606|NCT00404352|1162926|P4|Open Label (up to 24 Month)|Disease progression|1
360607|NCT00404352|1162927|P3|Open Label (up to 24 Month)|Disease progression|0
360608|NCT00404352|1162928|P2|Open Label (up to 24 Month)|Disease progression|0
360609|NCT00404352|1162929|P1|Open Label (up to 24 Month)|Disease progression|0
360610|NCT00404352|1162921|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
360611|NCT00404352|1162922|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
360612|NCT00404352|1162923|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
360613|NCT00404352|1162924|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
360614|NCT00404352|1162925|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
360615|NCT00404352|1162926|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
360616|NCT00404352|1162927|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
360617|NCT00404352|1162928|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
360618|NCT00404352|1162929|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
360619|NCT00404352|1162921|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
360620|NCT00404352|1162922|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
360621|NCT00404352|1162923|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
360622|NCT00404352|1162924|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
360623|NCT00404352|1162925|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
360624|NCT00404352|1162926|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
360625|NCT00404352|1162927|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
360626|NCT00404352|1162928|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
360627|NCT00404352|1162929|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
360628|NCT00404352|1162921|P9|Open Label (up to 24 Month)|Pregnancy|0
360629|NCT00404352|1162922|P8|Open Label (up to 24 Month)|Pregnancy|0
360630|NCT00404352|1162923|P7|Open Label (up to 24 Month)|Pregnancy|0
360631|NCT00404352|1162924|P6|Open Label (up to 24 Month)|Pregnancy|1
360632|NCT00404352|1162925|P5|Open Label (up to 24 Month)|Pregnancy|0
360633|NCT00404352|1162926|P4|Open Label (up to 24 Month)|Pregnancy|0
360634|NCT00404352|1162927|P3|Open Label (up to 24 Month)|Pregnancy|0
360635|NCT00404352|1162928|P2|Open Label (up to 24 Month)|Pregnancy|0
360636|NCT00404352|1162929|P1|Open Label (up to 24 Month)|Pregnancy|0
360637|NCT00404352|1162921|P9|Open Label (up to 24 Month)|Adverse Event|0
360638|NCT00404352|1162922|P8|Open Label (up to 24 Month)|Adverse Event|0
360639|NCT00404352|1162923|P7|Open Label (up to 24 Month)|Adverse Event|0
360640|NCT00404352|1162924|P6|Open Label (up to 24 Month)|Adverse Event|1
360641|NCT00404352|1162925|P5|Open Label (up to 24 Month)|Adverse Event|1
360642|NCT00404352|1162926|P4|Open Label (up to 24 Month)|Adverse Event|2
360643|NCT00404352|1162927|P3|Open Label (up to 24 Month)|Adverse Event|0
360644|NCT00404352|1162928|P2|Open Label (up to 24 Month)|Adverse Event|0
360645|NCT00404352|1162929|P1|Open Label (up to 24 Month)|Adverse Event|0
360646|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Unspecified|0
360647|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Unspecified|0
360648|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Unspecified|0
360649|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Unspecified|0
360650|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Unspecified|0
360651|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Unspecified|0
360652|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Unspecified|0
360653|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Unspecified|1
360654|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Unspecified|0
360655|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Physician Decision|0
360656|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Physician Decision|0
360657|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Physician Decision|0
360658|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Physician Decision|0
360659|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Physician Decision|0
360660|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Physician Decision|0
360661|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Physician Decision|1
360662|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Physician Decision|0
360663|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Physician Decision|0
360664|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
360665|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
360666|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
360667|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
360668|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
360669|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
360670|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
360671|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
360672|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
360673|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
360674|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
360675|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
360676|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
360677|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
360678|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
360679|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
360680|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
360681|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
360682|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Poor compliance|0
360683|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Poor compliance|0
360684|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Poor compliance|0
360685|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Poor compliance|0
360686|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Poor compliance|0
360687|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Poor compliance|0
360688|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Poor compliance|0
360689|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Poor compliance|0
360690|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Poor compliance|1
360691|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Disease progression|0
360692|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Disease progression|0
360693|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Disease progression|0
360694|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Disease progression|0
360695|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Disease progression|0
360696|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Disease progression|0
360697|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Disease progression|2
360698|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Disease progression|0
360699|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Disease progression|3
360700|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
360701|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
360702|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
360703|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
360704|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
360705|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
360706|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
360707|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
360708|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
360709|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
360710|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
360711|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
360712|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
360713|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
360714|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
360715|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
360716|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
360717|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
360718|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Death|0
360719|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Death|0
360720|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Death|0
360721|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Death|0
360722|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Death|0
360723|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Death|0
360724|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Death|1
360725|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Death|0
360726|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Death|0
360727|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Pregnancy|0
360728|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Pregnancy|0
360729|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Pregnancy|0
360730|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Pregnancy|0
360731|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Pregnancy|0
360732|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Pregnancy|0
360733|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Pregnancy|2
360734|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Pregnancy|0
360735|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Pregnancy|0
360736|NCT00404352|1162921|P9|Double Blind (up to 24 Month)|Adverse Event|0
360737|NCT00404352|1162922|P8|Double Blind (up to 24 Month)|Adverse Event|0
360738|NCT00404352|1162923|P7|Double Blind (up to 24 Month)|Adverse Event|0
360739|NCT00404352|1162924|P6|Double Blind (up to 24 Month)|Adverse Event|0
360740|NCT00404352|1162925|P5|Double Blind (up to 24 Month)|Adverse Event|0
360741|NCT00404352|1162926|P4|Double Blind (up to 24 Month)|Adverse Event|0
360742|NCT00404352|1162927|P3|Double Blind (up to 24 Month)|Adverse Event|6
360743|NCT00404352|1162928|P2|Double Blind (up to 24 Month)|Adverse Event|4
360744|NCT00404352|1162929|P1|Double Blind (up to 24 Month)|Adverse Event|5
360745|NCT00404248|1162964|P9|Overall Study|pts declining status|0
360746|NCT00404248|1162965|P8|Overall Study|pts declining status|0
360747|NCT00404248|1162966|P7|Overall Study|pts declining status|0
360748|NCT00404248|1162967|P6|Overall Study|pts declining status|0
360749|NCT00404248|1162968|P5|Overall Study|pts declining status|0
360750|NCT00404248|1162969|P4|Overall Study|pts declining status|0
360751|NCT00404248|1162970|P3|Overall Study|pts declining status|0
360752|NCT00404248|1162971|P2|Overall Study|pts declining status|1
360753|NCT00404248|1162972|P1|Overall Study|pts declining status|0
360754|NCT00404092|1163007|P4|Overall Study|Adverse Event|0
360755|NCT00404092|1163008|P3|Overall Study|Adverse Event|1
360756|NCT00404092|1163009|P2|Overall Study|Adverse Event|0
360757|NCT00404092|1163010|P1|Overall Study|Adverse Event|0
360758|NCT00404092|1163007|P4|Overall Study|Death|0
360759|NCT00404092|1163008|P3|Overall Study|Death|0
360760|NCT00404092|1163009|P2|Overall Study|Death|0
360761|NCT00404092|1163010|P1|Overall Study|Death|1
360762|NCT00404079|1163026|P2|Overall Study|Lost to follow up, adverse event etc|20
360763|NCT00404079|1163027|P1|Overall Study|Lost to follow up, adverse event etc|22
360764|NCT00403845|1163033|P4|Treatment Period 3|Adverse Event|1
360765|NCT00403845|1163034|P3|Treatment Period 3|Adverse Event|0
360766|NCT00403845|1163035|P2|Treatment Period 3|Adverse Event|0
360767|NCT00403845|1163036|P1|Treatment Period 3|Adverse Event|0
360768|NCT00403845|1163033|P4|Treatment Period 3|Subject withdrew consent|1
360769|NCT00403845|1163034|P3|Treatment Period 3|Subject withdrew consent|0
360770|NCT00403845|1163035|P2|Treatment Period 3|Subject withdrew consent|0
360771|NCT00403845|1163036|P1|Treatment Period 3|Subject withdrew consent|0
360772|NCT00403845|1163033|P4|Treatment Period 2|Subject withdrew consent|0
360773|NCT00403845|1163034|P3|Treatment Period 2|Subject withdrew consent|0
360774|NCT00403845|1163035|P2|Treatment Period 2|Subject withdrew consent|0
360775|NCT00403845|1163036|P1|Treatment Period 2|Subject withdrew consent|1
360776|NCT00403845|1163033|P4|Treatment Period 1|Subject no longer needs study drug|1
360777|NCT00403845|1163034|P3|Treatment Period 1|Subject no longer needs study drug|0
360778|NCT00403845|1163035|P2|Treatment Period 1|Subject no longer needs study drug|0
360779|NCT00403845|1163036|P1|Treatment Period 1|Subject no longer needs study drug|0
360780|NCT00403845|1163033|P4|Treatment Period 1|Subject withdrew consent|0
360781|NCT00403845|1163034|P3|Treatment Period 1|Subject withdrew consent|0
360782|NCT00403845|1163035|P2|Treatment Period 1|Subject withdrew consent|0
360783|NCT00403845|1163036|P1|Treatment Period 1|Subject withdrew consent|1
360784|NCT00403767|1163060|P2|Overall Study|Missing/incomplete data|1
360785|NCT00403767|1163061|P1|Overall Study|Missing/incomplete data|1
360786|NCT00403767|1163060|P2|Overall Study|Study terminated by sponsor|69
360787|NCT00403767|1163061|P1|Overall Study|Study terminated by sponsor|82
360788|NCT00403767|1163060|P2|Overall Study|Clinical efficacy endpoint reached|332
360789|NCT00403767|1163061|P1|Overall Study|Clinical efficacy endpoint reached|300
360790|NCT00403767|1163060|P2|Overall Study|Protocol Violation|124
360791|NCT00403767|1163061|P1|Overall Study|Protocol Violation|142
360792|NCT00403767|1163060|P2|Overall Study|Lost to Follow-up|8
360793|NCT00403767|1163061|P1|Overall Study|Lost to Follow-up|6
360794|NCT00403767|1163060|P2|Overall Study|Investigator dec./not protocol-related|178
360795|NCT00403767|1163061|P1|Overall Study|Investigator dec./not protocol-related|191
360796|NCT00403767|1163060|P2|Overall Study|Consent withdrawn|673
360797|NCT00403767|1163061|P1|Overall Study|Consent withdrawn|671
360798|NCT00403767|1163060|P2|Overall Study|Non-compliant with study medication|164
360799|NCT00403767|1163061|P1|Overall Study|Non-compliant with study medication|134
360800|NCT00403767|1163060|P2|Overall Study|Adverse Event|919
360801|NCT00403767|1163061|P1|Overall Study|Adverse Event|993
360802|NCT00403754|1163085|P4|Core Treatment Period 2|Lack of Efficacy|0
360803|NCT00403754|1163086|P3|Core Treatment Period 2|Lack of Efficacy|1
360804|NCT00403754|1163087|P2|Core Treatment Period 2|Lack of Efficacy|0
360805|NCT00403754|1163088|P1|Core Treatment Period 2|Lack of Efficacy|0
360806|NCT00403754|1163085|P4|Core Treatment Period 1|Withdrawal by Subject|0
360807|NCT00403754|1163086|P3|Core Treatment Period 1|Withdrawal by Subject|0
360808|NCT00403754|1163087|P2|Core Treatment Period 1|Withdrawal by Subject|1
360809|NCT00403754|1163088|P1|Core Treatment Period 1|Withdrawal by Subject|0
360810|NCT00403585|1163115|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
360811|NCT00403585|1163115|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
360812|NCT00403585|1163115|P1|Initial Treatment Phase|Lost to Follow-up|2
360813|NCT00403546|1163126|P3|Randomized Trial|Early Terminations|16
360814|NCT00403546|1163127|P2|Randomized Trial|Early Terminations|17
360815|NCT00403546|1163128|P1|Randomized Trial|Early Terminations|0
360816|NCT00403546|1163126|P3|Screening Phase|Terminated Prior to Randomization|0
360817|NCT00403546|1163127|P2|Screening Phase|Terminated Prior to Randomization|0
360818|NCT00403546|1163128|P1|Screening Phase|Terminated Prior to Randomization|5
360819|NCT00403546|1163126|P3|Screening Phase|Adverse Event|0
360820|NCT00403546|1163127|P2|Screening Phase|Adverse Event|0
360821|NCT00403546|1163128|P1|Screening Phase|Adverse Event|1
360822|NCT00403546|1163126|P3|Screening Phase|Screening Failure|0
360823|NCT00403546|1163127|P2|Screening Phase|Screening Failure|0
360824|NCT00403546|1163128|P1|Screening Phase|Screening Failure|22
360825|NCT00403546|1163126|P3|Signed Informed Consent/Open-Label|Adverse Event|0
360826|NCT00403546|1163127|P2|Signed Informed Consent/Open-Label|Adverse Event|0
360827|NCT00403546|1163128|P1|Signed Informed Consent/Open-Label|Adverse Event|5
360828|NCT00403546|1163126|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
360829|NCT00403546|1163127|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
360830|NCT00403546|1163128|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
360831|NCT00403546|1163126|P3|Signed Informed Consent/Open-Label|Early Termination|0
360832|NCT00403546|1163127|P2|Signed Informed Consent/Open-Label|Early Termination|0
360833|NCT00403546|1163128|P1|Signed Informed Consent/Open-Label|Early Termination|8
360834|NCT00403546|1163126|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
360835|NCT00403546|1163127|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
360836|NCT00403546|1163128|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
360837|NCT00403481|1163168|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
360838|NCT00403481|1163168|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
360839|NCT00403481|1163168|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
360840|NCT00403481|1163168|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
360841|NCT00403481|1163168|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
360842|NCT00403481|1163168|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
360843|NCT00403481|1163168|P1|Olm 40 mg|Other|1
360844|NCT00403481|1163168|P1|Olm 40 mg|Withdrawal by Subject|1
360845|NCT00403481|1163168|P1|Olm 40 mg|Protocol Violation|1
360846|NCT00403481|1163168|P1|Olm 40 mg|Adverse Event|2
360847|NCT00403481|1163168|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
360848|NCT00403481|1163168|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
360849|NCT00403481|1163168|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
360850|NCT00403481|1163168|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
360851|NCT00403455|1163183|P1|Overall Study|Withdrawal by Subject|1
360852|NCT00403273|1163206|P2|Overall Study|pt. wanted to have a surgical procedure|1
360853|NCT00403273|1163207|P1|Overall Study|pt. wanted to have a surgical procedure|0
360854|NCT00403273|1163206|P2|Overall Study|Physician Decision|1
360855|NCT00403273|1163207|P1|Overall Study|Physician Decision|0
360856|NCT00403273|1163206|P2|Overall Study|Lost to Follow-up|2
360857|NCT00403273|1163207|P1|Overall Study|Lost to Follow-up|3
360858|NCT00403234|1163237|P4|Overall Study|Adverse Event|0
360859|NCT00403234|1163238|P3|Overall Study|Adverse Event|1
360860|NCT00403234|1163239|P2|Overall Study|Adverse Event|0
360861|NCT00403234|1163240|P1|Overall Study|Adverse Event|1
360862|NCT00403234|1163237|P4|Overall Study|Withdrawal by Subject|0
360863|NCT00403234|1163238|P3|Overall Study|Withdrawal by Subject|0
360864|NCT00403234|1163239|P2|Overall Study|Withdrawal by Subject|1
360865|NCT00403234|1163240|P1|Overall Study|Withdrawal by Subject|0
360866|NCT00403130|1163250|P1|Overall Study|Withdrawal by Subject|1
360867|NCT00403130|1163250|P1|Overall Study|Lost to Follow up|1
360868|NCT00403130|1163250|P1|Overall Study|Not Eligible|3
360869|NCT00402987|1163261|P4|Overall Study|Lack of Efficacy|0
360870|NCT00402987|1163262|P3|Overall Study|Lack of Efficacy|1
360871|NCT00402987|1163263|P2|Overall Study|Lack of Efficacy|0
360872|NCT00402987|1163264|P1|Overall Study|Lack of Efficacy|0
360873|NCT00402740|1163434|P1|Overall Study|Subject disposition unknown.|1
360874|NCT00402740|1163434|P1|Overall Study|No stent. Completed FU at 30 days.|5
360875|NCT00402740|1163434|P1|Overall Study|Lost to Follow-up|6
360876|NCT00402740|1163434|P1|Overall Study|Death|50
360877|NCT00402740|1163434|P1|Overall Study|Withdrawal by Subject|18
360878|NCT00402727|1163446|P2|Overall Study|non-compliance|1
360879|NCT00402727|1163447|P1|Overall Study|non-compliance|0
360880|NCT00402727|1163446|P2|Overall Study|supply problems|1
360881|NCT00402727|1163447|P1|Overall Study|supply problems|2
360882|NCT00402727|1163446|P2|Overall Study|Withdrawal by Subject|7
360883|NCT00402727|1163447|P1|Overall Study|Withdrawal by Subject|3
360884|NCT00402727|1163446|P2|Overall Study|Protocol Violation|4
360885|NCT00402727|1163447|P1|Overall Study|Protocol Violation|0
360886|NCT00402727|1163446|P2|Overall Study|Physician Decision|1
360887|NCT00402727|1163447|P1|Overall Study|Physician Decision|1
360888|NCT00402727|1163446|P2|Overall Study|Lost to Follow-up|11
360889|NCT00402727|1163447|P1|Overall Study|Lost to Follow-up|24
360890|NCT00402727|1163446|P2|Overall Study|Lack of Efficacy|3
360891|NCT00402727|1163447|P1|Overall Study|Lack of Efficacy|1
360892|NCT00402727|1163446|P2|Overall Study|Death|0
360893|NCT00402727|1163447|P1|Overall Study|Death|1
360894|NCT00402727|1163446|P2|Overall Study|Adverse Event|6
360895|NCT00402727|1163447|P1|Overall Study|Adverse Event|10
360896|NCT00402688|1163489|P3|Overall Study|Patient Left Town and Forgot Medication|1
360897|NCT00402688|1163490|P2|Overall Study|Patient Left Town and Forgot Medication|0
360898|NCT00402688|1163491|P1|Overall Study|Patient Left Town and Forgot Medication|0
360899|NCT00402688|1163489|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
360900|NCT00402688|1163490|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
360901|NCT00402688|1163491|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
360902|NCT00402688|1163489|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
360903|NCT00402688|1163490|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
360904|NCT00402688|1163491|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
360905|NCT00402688|1163489|P3|Overall Study|Lost to Follow-up|2
360906|NCT00402688|1163490|P2|Overall Study|Lost to Follow-up|0
360907|NCT00402688|1163491|P1|Overall Study|Lost to Follow-up|1
360908|NCT00402688|1163489|P3|Overall Study|Protocol Violation|1
360909|NCT00402688|1163490|P2|Overall Study|Protocol Violation|1
360910|NCT00402688|1163491|P1|Overall Study|Protocol Violation|1
360911|NCT00402688|1163489|P3|Overall Study|Lack of Efficacy|5
360912|NCT00402688|1163490|P2|Overall Study|Lack of Efficacy|4
360913|NCT00402688|1163491|P1|Overall Study|Lack of Efficacy|4
360914|NCT00402688|1163489|P3|Overall Study|Physician Decision|1
360915|NCT00402688|1163490|P2|Overall Study|Physician Decision|0
360916|NCT00402688|1163491|P1|Overall Study|Physician Decision|0
360917|NCT00402688|1163489|P3|Overall Study|Withdrawal by Subject|1
360918|NCT00402688|1163490|P2|Overall Study|Withdrawal by Subject|1
360919|NCT00402688|1163491|P1|Overall Study|Withdrawal by Subject|3
360920|NCT00402688|1163489|P3|Overall Study|Adverse Event|3
360921|NCT00402688|1163490|P2|Overall Study|Adverse Event|9
360922|NCT00402688|1163491|P1|Overall Study|Adverse Event|12
360923|NCT00402649|1163514|P1|Overall Study|Withdrawal by Subject|1
360924|NCT00402649|1163514|P1|Overall Study|Lost to Follow-up|1
360925|NCT00402597|1163529|P5|Overall Study|reason not specified|20
360926|NCT00402597|1163530|P4|Overall Study|reason not specified|14
360927|NCT00402597|1163531|P3|Overall Study|reason not specified|27
360928|NCT00402597|1163532|P2|Overall Study|reason not specified|4
360929|NCT00402597|1163533|P1|Overall Study|reason not specified|30
360930|NCT00402597|1163529|P5|Overall Study|Withdrawal by Subject|24
360931|NCT00402597|1163530|P4|Overall Study|Withdrawal by Subject|15
360932|NCT00402597|1163531|P3|Overall Study|Withdrawal by Subject|65
360933|NCT00402597|1163532|P2|Overall Study|Withdrawal by Subject|16
360934|NCT00402597|1163533|P1|Overall Study|Withdrawal by Subject|57
360935|NCT00402597|1163529|P5|Overall Study|Lost to Follow-up|3
360936|NCT00402597|1163530|P4|Overall Study|Lost to Follow-up|2
360937|NCT00402597|1163531|P3|Overall Study|Lost to Follow-up|8
360938|NCT00402597|1163532|P2|Overall Study|Lost to Follow-up|1
360939|NCT00402597|1163533|P1|Overall Study|Lost to Follow-up|8
360940|NCT00402597|1163529|P5|Overall Study|Adverse Event|71
360941|NCT00402597|1163530|P4|Overall Study|Adverse Event|39
360942|NCT00402597|1163531|P3|Overall Study|Adverse Event|106
360943|NCT00402597|1163532|P2|Overall Study|Adverse Event|18
360944|NCT00402597|1163533|P1|Overall Study|Adverse Event|81
360945|NCT00402597|1163529|P5|Overall Study|Death|6
360946|NCT00402597|1163530|P4|Overall Study|Death|4
360947|NCT00402597|1163531|P3|Overall Study|Death|6
360948|NCT00402597|1163532|P2|Overall Study|Death|7
360949|NCT00402597|1163533|P1|Overall Study|Death|15
360950|NCT00402363|1163574|P4|Overall Study|"Captured as Other"|2
360951|NCT00402363|1163575|P3|Overall Study|"Captured as Other"|2
360952|NCT00402363|1163576|P2|Overall Study|"Captured as Other"|2
360953|NCT00402363|1163577|P1|Overall Study|"Captured as Other"|6
360954|NCT00402363|1163574|P4|Overall Study|Lost to Follow-up|2
360955|NCT00402363|1163575|P3|Overall Study|Lost to Follow-up|0
360956|NCT00402363|1163576|P2|Overall Study|Lost to Follow-up|4
360957|NCT00402363|1163577|P1|Overall Study|Lost to Follow-up|5
360958|NCT00402363|1163574|P4|Overall Study|Protocol Violation|3
360959|NCT00402363|1163575|P3|Overall Study|Protocol Violation|0
360960|NCT00402363|1163576|P2|Overall Study|Protocol Violation|5
360961|NCT00402363|1163577|P1|Overall Study|Protocol Violation|3
360962|NCT00402363|1163574|P4|Overall Study|Withdrew Consent|1
360963|NCT00402363|1163575|P3|Overall Study|Withdrew Consent|2
360964|NCT00402363|1163576|P2|Overall Study|Withdrew Consent|5
360965|NCT00402363|1163577|P1|Overall Study|Withdrew Consent|10
360966|NCT00402363|1163574|P4|Overall Study|Adverse Event|2
360967|NCT00402363|1163575|P3|Overall Study|Adverse Event|2
360968|NCT00402363|1163576|P2|Overall Study|Adverse Event|14
360969|NCT00402363|1163577|P1|Overall Study|Adverse Event|9
360970|NCT00402337|1163640|P5|Overall Study|Other Reason|0
360971|NCT00402337|1163641|P4|Overall Study|Other Reason|0
360972|NCT00402337|1163642|P3|Overall Study|Other Reason|0
360973|NCT00402337|1163643|P2|Overall Study|Other Reason|1
360974|NCT00402337|1163644|P1|Overall Study|Other Reason|0
360975|NCT00402337|1163640|P5|Overall Study|Physician Decision|0
360976|NCT00402337|1163641|P4|Overall Study|Physician Decision|1
360977|NCT00402337|1163642|P3|Overall Study|Physician Decision|0
360978|NCT00402337|1163643|P2|Overall Study|Physician Decision|0
360979|NCT00402337|1163644|P1|Overall Study|Physician Decision|0
360980|NCT00402337|1163640|P5|Overall Study|Lost to Follow-up|0
360981|NCT00402337|1163641|P4|Overall Study|Lost to Follow-up|2
360982|NCT00402337|1163642|P3|Overall Study|Lost to Follow-up|1
360983|NCT00402337|1163643|P2|Overall Study|Lost to Follow-up|0
360984|NCT00402337|1163644|P1|Overall Study|Lost to Follow-up|0
360985|NCT00402337|1163640|P5|Overall Study|Withdrawal by Subject|4
360986|NCT00402337|1163641|P4|Overall Study|Withdrawal by Subject|6
360987|NCT00402337|1163642|P3|Overall Study|Withdrawal by Subject|1
360988|NCT00402337|1163643|P2|Overall Study|Withdrawal by Subject|3
360989|NCT00402337|1163644|P1|Overall Study|Withdrawal by Subject|5
360990|NCT00402337|1163640|P5|Overall Study|Noncompliance|2
360991|NCT00402337|1163641|P4|Overall Study|Noncompliance|0
360992|NCT00402337|1163642|P3|Overall Study|Noncompliance|0
360993|NCT00402337|1163643|P2|Overall Study|Noncompliance|0
360994|NCT00402337|1163644|P1|Overall Study|Noncompliance|0
360995|NCT00402337|1163640|P5|Overall Study|Adverse Event|2
360996|NCT00402337|1163641|P4|Overall Study|Adverse Event|3
360997|NCT00402337|1163642|P3|Overall Study|Adverse Event|2
360998|NCT00402337|1163643|P2|Overall Study|Adverse Event|2
360999|NCT00402337|1163644|P1|Overall Study|Adverse Event|0
361000|NCT00402324|1163683|P2|Overall Study|Death|0
361001|NCT00402324|1163684|P1|Overall Study|Death|1
361002|NCT00402324|1163683|P2|Overall Study|Adverse Event|4
361003|NCT00402324|1163684|P1|Overall Study|Adverse Event|6
361004|NCT00402324|1163683|P2|Overall Study|Lack of Efficacy|4
361005|NCT00402324|1163684|P1|Overall Study|Lack of Efficacy|1
361006|NCT00402324|1163683|P2|Overall Study|Sponsor Decision|5
361007|NCT00402324|1163684|P1|Overall Study|Sponsor Decision|4
361008|NCT00402324|1163683|P2|Overall Study|Physician Decision|4
361009|NCT00402324|1163684|P1|Overall Study|Physician Decision|2
361010|NCT00402324|1163683|P2|Overall Study|Withdrawal by Subject|2
361011|NCT00402324|1163684|P1|Overall Study|Withdrawal by Subject|5
361012|NCT00402324|1163683|P2|Overall Study|Protocol Violation|7
361013|NCT00402324|1163684|P1|Overall Study|Protocol Violation|8
361014|NCT00402324|1163683|P2|Overall Study|Protocol Entry Criteria Not Met|4
361015|NCT00402324|1163684|P1|Overall Study|Protocol Entry Criteria Not Met|5
361016|NCT00402324|1163683|P2|Overall Study|Lost to Follow-up|11
361017|NCT00402324|1163684|P1|Overall Study|Lost to Follow-up|11
361018|NCT00402285|1163717|P3|Overall Study|insufficient RNA quality|2
361019|NCT00402285|1163718|P2|Overall Study|insufficient RNA quality|6
361020|NCT00402285|1163719|P1|Overall Study|insufficient RNA quality|7
361021|NCT00402246|1163727|P2|Overall Study|Deterioriating Condition|2
361022|NCT00402246|1163728|P1|Overall Study|Deterioriating Condition|3
361023|NCT00402246|1163727|P2|Overall Study|Center Closure|3
361024|NCT00402246|1163728|P1|Overall Study|Center Closure|5
361025|NCT00402246|1163727|P2|Overall Study|Patient's device explanted|2
361026|NCT00402246|1163728|P1|Overall Study|Patient's device explanted|6
361027|NCT00402246|1163727|P2|Overall Study|Heart Transplant|1
361028|NCT00402246|1163728|P1|Overall Study|Heart Transplant|0
361029|NCT00402246|1163727|P2|Overall Study|Insurance Issues|1
361030|NCT00402246|1163728|P1|Overall Study|Insurance Issues|2
361031|NCT00402246|1163727|P2|Overall Study|Missed Final Visit|2
361032|NCT00402246|1163728|P1|Overall Study|Missed Final Visit|1
361033|NCT00402246|1163727|P2|Overall Study|Protocol Violation|24
361034|NCT00402246|1163728|P1|Overall Study|Protocol Violation|25
361035|NCT00402246|1163727|P2|Overall Study|Physician Decision|26
361036|NCT00402246|1163728|P1|Overall Study|Physician Decision|24
361037|NCT00402246|1163727|P2|Overall Study|Withdrawal by Subject|87
361038|NCT00402246|1163728|P1|Overall Study|Withdrawal by Subject|72
361039|NCT00402246|1163727|P2|Overall Study|Lost to Follow-up|28
361040|NCT00402246|1163728|P1|Overall Study|Lost to Follow-up|20
361041|NCT00402246|1163727|P2|Overall Study|Death|58
361042|NCT00402246|1163728|P1|Overall Study|Death|62
361043|NCT00402233|1163762|P4|Overall Study|Worsening of other pre-existing disease|0
361044|NCT00402233|1163763|P3|Overall Study|Worsening of other pre-existing disease|0
361045|NCT00402233|1163764|P2|Overall Study|Worsening of other pre-existing disease|1
361046|NCT00402233|1163765|P1|Overall Study|Worsening of other pre-existing disease|0
361047|NCT00402233|1163762|P4|Overall Study|Worsening of disease under study|0
361048|NCT00402233|1163763|P3|Overall Study|Worsening of disease under study|0
361049|NCT00402233|1163764|P2|Overall Study|Worsening of disease under study|0
361050|NCT00402233|1163765|P1|Overall Study|Worsening of disease under study|2
361051|NCT00402233|1163762|P4|Overall Study|Withdrawal by Subject|2
361052|NCT00402233|1163763|P3|Overall Study|Withdrawal by Subject|2
361053|NCT00402233|1163764|P2|Overall Study|Withdrawal by Subject|1
361054|NCT00402233|1163765|P1|Overall Study|Withdrawal by Subject|2
361055|NCT00402233|1163762|P4|Overall Study|Protocol Violation|0
361056|NCT00402233|1163763|P3|Overall Study|Protocol Violation|0
361057|NCT00402233|1163764|P2|Overall Study|Protocol Violation|1
361058|NCT00402233|1163765|P1|Overall Study|Protocol Violation|0
361059|NCT00402233|1163762|P4|Overall Study|Adverse Event|9
361060|NCT00402233|1163763|P3|Overall Study|Adverse Event|9
361061|NCT00402233|1163764|P2|Overall Study|Adverse Event|7
361062|NCT00402233|1163765|P1|Overall Study|Adverse Event|1
361063|NCT00402168|1163800|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
361064|NCT00402168|1163801|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
361065|NCT00402168|1163800|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
361066|NCT00402168|1163801|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
361067|NCT00402168|1163800|P2|Long Term (LT)|non-specified|2
361068|NCT00402168|1163801|P1|Long Term (LT)|non-specified|1
361069|NCT00402168|1163800|P2|Long Term (LT)|Lack of Efficacy|2
361070|NCT00402168|1163801|P1|Long Term (LT)|Lack of Efficacy|0
361071|NCT00402168|1163800|P2|Long Term (LT)|Death|0
361072|NCT00402168|1163801|P1|Long Term (LT)|Death|4
361073|NCT00402168|1163800|P2|Long Term (LT)|Lost to Follow-up|0
361074|NCT00402168|1163801|P1|Long Term (LT)|Lost to Follow-up|1
361075|NCT00402168|1163800|P2|Long Term (LT)|Pregnancy|1
361076|NCT00402168|1163801|P1|Long Term (LT)|Pregnancy|0
361077|NCT00402168|1163800|P2|Long Term (LT)|Withdrawal by Subject|7
361078|NCT00402168|1163801|P1|Long Term (LT)|Withdrawal by Subject|4
361079|NCT00402168|1163800|P2|Long Term (LT)|Adverse Event|5
361080|NCT00402168|1163801|P1|Long Term (LT)|Adverse Event|1
361081|NCT00402168|1163800|P2|Treatment (up to 12 Months)|non-specified|1
361082|NCT00402168|1163801|P1|Treatment (up to 12 Months)|non-specified|0
361083|NCT00402168|1163800|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
361084|NCT00402168|1163801|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
361085|NCT00402168|1163800|P2|Treatment (up to 12 Months)|Death|1
361086|NCT00402168|1163801|P1|Treatment (up to 12 Months)|Death|0
361087|NCT00402168|1163800|P2|Randomized|Withdrawal by Subject|1
361088|NCT00402168|1163801|P1|Randomized|Withdrawal by Subject|0
361089|NCT00402168|1163800|P2|Randomized|Lost to Follow-up|0
361090|NCT00402168|1163801|P1|Randomized|Lost to Follow-up|1
361091|NCT00402103|1163858|P2|Overall Study|Administrative problems|0
361092|NCT00402103|1163859|P1|Overall Study|Administrative problems|2
361093|NCT00402103|1163858|P2|Overall Study|Lost to Follow-up|3
361094|NCT00402103|1163859|P1|Overall Study|Lost to Follow-up|6
361095|NCT00402103|1163858|P2|Overall Study|Patient withdrew consent|1
361096|NCT00402103|1163859|P1|Overall Study|Patient withdrew consent|12
361097|NCT00402103|1163858|P2|Overall Study|Protocol Deviation|0
361098|NCT00402103|1163859|P1|Overall Study|Protocol Deviation|8
361099|NCT00402103|1163858|P2|Overall Study|Condition no longer requires study drug|0
361100|NCT00402103|1163859|P1|Overall Study|Condition no longer requires study drug|2
361101|NCT00402103|1163858|P2|Overall Study|Unsatisfactory therapeutic effect|2
361102|NCT00402103|1163859|P1|Overall Study|Unsatisfactory therapeutic effect|1
361103|NCT00402103|1163858|P2|Overall Study|Adverse Event|7
361104|NCT00402103|1163859|P1|Overall Study|Adverse Event|60
361105|NCT00402051|1163875|P2|Overall Study|Lost to Follow-up|0
361106|NCT00402051|1163876|P1|Overall Study|Lost to Follow-up|1
361107|NCT00402051|1163875|P2|Overall Study|Death Due to Adverse Event|2
361108|NCT00402051|1163876|P1|Overall Study|Death Due to Adverse Event|0
361109|NCT00402051|1163875|P2|Overall Study|Death Due to Study Disease|1
361110|NCT00402051|1163876|P1|Overall Study|Death Due to Study Disease|2
361111|NCT00402051|1163875|P2|Overall Study|Death - Related to Study Drug|2
361112|NCT00402051|1163876|P1|Overall Study|Death - Related to Study Drug|1
361113|NCT00402051|1163875|P2|Overall Study|Withdrawal by Subject|3
361114|NCT00402051|1163876|P1|Overall Study|Withdrawal by Subject|3
361115|NCT00402051|1163875|P2|Overall Study|Physician Decision|3
361116|NCT00402051|1163876|P1|Overall Study|Physician Decision|7
361117|NCT00402051|1163875|P2|Overall Study|Adverse Event|4
361118|NCT00402051|1163876|P1|Overall Study|Adverse Event|11
361119|NCT00402051|1163875|P2|Overall Study|Progressive Disease|20
361120|NCT00402051|1163876|P1|Overall Study|Progressive Disease|13
361121|NCT00402025|1163893|P3|Overall Study|Participant Decision|1
361122|NCT00402025|1163894|P2|Overall Study|Participant Decision|0
361123|NCT00402025|1163895|P1|Overall Study|Participant Decision|0
361124|NCT00402025|1163893|P3|Overall Study|Physician Decision|0
361125|NCT00402025|1163894|P2|Overall Study|Physician Decision|1
361126|NCT00402025|1163895|P1|Overall Study|Physician Decision|1
361127|NCT00402025|1163893|P3|Overall Study|Disease Progression|2
361128|NCT00402025|1163894|P2|Overall Study|Disease Progression|1
361129|NCT00402025|1163895|P1|Overall Study|Disease Progression|1
361130|NCT00402025|1163893|P3|Overall Study|Death|5
361131|NCT00402025|1163894|P2|Overall Study|Death|1
361132|NCT00402025|1163895|P1|Overall Study|Death|0
361133|NCT00402025|1163893|P3|Overall Study|Adverse Event|2
361134|NCT00402025|1163894|P2|Overall Study|Adverse Event|0
361135|NCT00402025|1163895|P1|Overall Study|Adverse Event|0
361136|NCT00401973|1163921|P3|Overall Study|Withdrawal by Subject|9
361137|NCT00401973|1163922|P2|Overall Study|Withdrawal by Subject|12
361138|NCT00401973|1163923|P1|Overall Study|Withdrawal by Subject|4
361139|NCT00401973|1163921|P3|Overall Study|Sponsor Decision|0
361140|NCT00401973|1163922|P2|Overall Study|Sponsor Decision|1
361141|NCT00401973|1163923|P1|Overall Study|Sponsor Decision|0
361142|NCT00401973|1163921|P3|Overall Study|Protocol Violation|3
361143|NCT00401973|1163922|P2|Overall Study|Protocol Violation|2
361144|NCT00401973|1163923|P1|Overall Study|Protocol Violation|1
361145|NCT00401973|1163921|P3|Overall Study|Physician Decision|1
361146|NCT00401973|1163922|P2|Overall Study|Physician Decision|0
361147|NCT00401973|1163923|P1|Overall Study|Physician Decision|2
361148|NCT00401973|1163921|P3|Overall Study|Lost to Follow-up|2
361149|NCT00401973|1163922|P2|Overall Study|Lost to Follow-up|2
361150|NCT00401973|1163923|P1|Overall Study|Lost to Follow-up|2
361151|NCT00401973|1163921|P3|Overall Study|Lack of Efficacy|3
361152|NCT00401973|1163922|P2|Overall Study|Lack of Efficacy|0
361153|NCT00401973|1163923|P1|Overall Study|Lack of Efficacy|0
361154|NCT00401973|1163921|P3|Overall Study|Clinical Relapse|1
361155|NCT00401973|1163922|P2|Overall Study|Clinical Relapse|1
361156|NCT00401973|1163923|P1|Overall Study|Clinical Relapse|0
361157|NCT00401973|1163921|P3|Overall Study|Adverse Event|4
361158|NCT00401973|1163922|P2|Overall Study|Adverse Event|8
361159|NCT00401973|1163923|P1|Overall Study|Adverse Event|2
361160|NCT00401960|1163962|P2|Overall Study|Death|0
361161|NCT00401960|1163963|P1|Overall Study|Death|2
361162|NCT00401960|1163962|P2|Overall Study|Lost to Follow-up|0
361163|NCT00401960|1163963|P1|Overall Study|Lost to Follow-up|3
361164|NCT00401843|1163993|P3|Overall Study|Received incorrect treatment|0
361165|NCT00401843|1163994|P2|Overall Study|Received incorrect treatment|3
361166|NCT00401843|1163995|P1|Overall Study|Received incorrect treatment|0
361167|NCT00401843|1163993|P3|Overall Study|Randomized but not Treated|3
361168|NCT00401843|1163994|P2|Overall Study|Randomized but not Treated|2
361169|NCT00401843|1163995|P1|Overall Study|Randomized but not Treated|0
361170|NCT00401843|1163993|P3|Overall Study|Withdrawal of consent to study agent|17
361171|NCT00401843|1163994|P2|Overall Study|Withdrawal of consent to study agent|15
361172|NCT00401843|1163995|P1|Overall Study|Withdrawal of consent to study agent|1
361173|NCT00401843|1163993|P3|Overall Study|Withdrawal by Subject|5
361174|NCT00401843|1163994|P2|Overall Study|Withdrawal by Subject|5
361175|NCT00401843|1163995|P1|Overall Study|Withdrawal by Subject|1
361176|NCT00401843|1163993|P3|Overall Study|Protocol Violation|1
361177|NCT00401843|1163994|P2|Overall Study|Protocol Violation|0
361178|NCT00401843|1163995|P1|Overall Study|Protocol Violation|0
361179|NCT00401843|1163993|P3|Overall Study|Physician Decision|10
361180|NCT00401843|1163994|P2|Overall Study|Physician Decision|16
361181|NCT00401843|1163995|P1|Overall Study|Physician Decision|0
361182|NCT00401843|1163993|P3|Overall Study|Other Unspecified|5
361183|NCT00401843|1163994|P2|Overall Study|Other Unspecified|3
361184|NCT00401843|1163995|P1|Overall Study|Other Unspecified|0
361185|NCT00401843|1163993|P3|Overall Study|Lost to Follow-up|2
361186|NCT00401843|1163994|P2|Overall Study|Lost to Follow-up|0
361187|NCT00401843|1163995|P1|Overall Study|Lost to Follow-up|0
361188|NCT00401843|1163993|P3|Overall Study|End of Study|2
361189|NCT00401843|1163994|P2|Overall Study|End of Study|1
361190|NCT00401843|1163995|P1|Overall Study|End of Study|1
361191|NCT00401843|1163993|P3|Overall Study|Disease progression|49
361192|NCT00401843|1163994|P2|Overall Study|Disease progression|60
361193|NCT00401843|1163995|P1|Overall Study|Disease progression|10
361194|NCT00401843|1163993|P3|Overall Study|Death|10
361195|NCT00401843|1163994|P2|Overall Study|Death|8
361196|NCT00401843|1163995|P1|Overall Study|Death|0
361197|NCT00401843|1163993|P3|Overall Study|Adverse Event|27
361198|NCT00401843|1163994|P2|Overall Study|Adverse Event|26
361199|NCT00401843|1163995|P1|Overall Study|Adverse Event|7
361200|NCT00401843|1163993|P3|Overall Study|Achieved Complete Response|11
361201|NCT00401843|1163994|P2|Overall Study|Achieved Complete Response|5
361202|NCT00401843|1163995|P1|Overall Study|Achieved Complete Response|1
361203|NCT00401830|1164013|P2|Overall Study|Other: Personal / Family problems|0
361204|NCT00401830|1164014|P1|Overall Study|Other: Personal / Family problems|1
361205|NCT00401830|1164013|P2|Overall Study|Lost to Follow-up|3
361206|NCT00401830|1164014|P1|Overall Study|Lost to Follow-up|1
361207|NCT00401830|1164013|P2|Overall Study|Non-compliance with drug study|0
361208|NCT00401830|1164014|P1|Overall Study|Non-compliance with drug study|1
361209|NCT00401830|1164013|P2|Overall Study|Protocol Violation|3
361210|NCT00401830|1164014|P1|Overall Study|Protocol Violation|3
361211|NCT00401830|1164013|P2|Overall Study|Withdrawal by Subject|3
361212|NCT00401830|1164014|P1|Overall Study|Withdrawal by Subject|4
361213|NCT00401830|1164013|P2|Overall Study|Lack of Efficacy|5
361214|NCT00401830|1164014|P1|Overall Study|Lack of Efficacy|11
361215|NCT00401830|1164013|P2|Overall Study|Adverse Event|18
361216|NCT00401830|1164014|P1|Overall Study|Adverse Event|10
361217|NCT00401752|1164065|P2|Overall Study|Physician Decision|1
361218|NCT00401752|1164066|P1|Overall Study|Physician Decision|1
361219|NCT00401752|1164065|P2|Overall Study|Development of any exclusion criteria|2
361220|NCT00401752|1164066|P1|Overall Study|Development of any exclusion criteria|4
361221|NCT00401752|1164065|P2|Overall Study|Lost to Follow-up|4
361222|NCT00401752|1164066|P1|Overall Study|Lost to Follow-up|1
361223|NCT00401752|1164065|P2|Overall Study|Withdrawal by Subject|6
361224|NCT00401752|1164066|P1|Overall Study|Withdrawal by Subject|2
361225|NCT00401752|1164065|P2|Overall Study|Adverse Event|5
361226|NCT00401752|1164066|P1|Overall Study|Adverse Event|2
361227|NCT00401726|1164084|P2|Overall Study|Protocol Deviation|4
361228|NCT00401726|1164085|P1|Overall Study|Protocol Deviation|9
361229|NCT00401726|1164084|P2|Overall Study|Lack of Efficacy|6
361230|NCT00401726|1164085|P1|Overall Study|Lack of Efficacy|4
361231|NCT00401726|1164084|P2|Overall Study|Withdrawal by Subject|24
361232|NCT00401726|1164085|P1|Overall Study|Withdrawal by Subject|18
361233|NCT00401726|1164084|P2|Overall Study|Protocol Violation|3
361234|NCT00401726|1164085|P1|Overall Study|Protocol Violation|6
361235|NCT00401726|1164084|P2|Overall Study|Lost to Follow-up|20
361236|NCT00401726|1164085|P1|Overall Study|Lost to Follow-up|23
361237|NCT00401726|1164084|P2|Overall Study|Physician Decision|6
361238|NCT00401726|1164085|P1|Overall Study|Physician Decision|3
361239|NCT00401726|1164084|P2|Overall Study|Sponsor Request|1
361240|NCT00401726|1164085|P1|Overall Study|Sponsor Request|0
361241|NCT00401726|1164084|P2|Overall Study|Death|3
361242|NCT00401726|1164085|P1|Overall Study|Death|0
361243|NCT00401726|1164084|P2|Overall Study|Adverse Event|45
361244|NCT00401726|1164085|P1|Overall Study|Adverse Event|34
361245|NCT00401544|1164120|P4|Overall Study|Other|2
361246|NCT00401544|1164121|P3|Overall Study|Other|2
361247|NCT00401544|1164122|P2|Overall Study|Other|0
361248|NCT00401544|1164123|P1|Overall Study|Other|0
361249|NCT00401544|1164120|P4|Overall Study|Disease progression|0
361250|NCT00401544|1164121|P3|Overall Study|Disease progression|0
361251|NCT00401544|1164122|P2|Overall Study|Disease progression|1
361252|NCT00401544|1164123|P1|Overall Study|Disease progression|0
361253|NCT00401544|1164120|P4|Overall Study|Ineligibility determined|2
361254|NCT00401544|1164121|P3|Overall Study|Ineligibility determined|0
361255|NCT00401544|1164122|P2|Overall Study|Ineligibility determined|1
361256|NCT00401544|1164123|P1|Overall Study|Ineligibility determined|0
361257|NCT00401544|1164120|P4|Overall Study|Physician Decision|0
361258|NCT00401544|1164121|P3|Overall Study|Physician Decision|0
361259|NCT00401544|1164122|P2|Overall Study|Physician Decision|3
361260|NCT00401544|1164123|P1|Overall Study|Physician Decision|1
361261|NCT00401544|1164120|P4|Overall Study|Withdrawal by Subject|5
361262|NCT00401544|1164121|P3|Overall Study|Withdrawal by Subject|6
361263|NCT00401544|1164122|P2|Overall Study|Withdrawal by Subject|6
361264|NCT00401544|1164123|P1|Overall Study|Withdrawal by Subject|7
361265|NCT00401544|1164120|P4|Overall Study|Lost to Follow-up|1
361266|NCT00401544|1164121|P3|Overall Study|Lost to Follow-up|1
361267|NCT00401544|1164122|P2|Overall Study|Lost to Follow-up|0
361268|NCT00401544|1164123|P1|Overall Study|Lost to Follow-up|2
361269|NCT00401544|1164120|P4|Overall Study|Death|5
361270|NCT00401544|1164121|P3|Overall Study|Death|2
361271|NCT00401544|1164122|P2|Overall Study|Death|6
361272|NCT00401544|1164123|P1|Overall Study|Death|3
361273|NCT00401544|1164120|P4|Overall Study|Adverse Event|1
361274|NCT00401544|1164121|P3|Overall Study|Adverse Event|1
361275|NCT00401544|1164122|P2|Overall Study|Adverse Event|1
361276|NCT00401544|1164123|P1|Overall Study|Adverse Event|5
361277|NCT00401531|1164163|P2|Overall Study|Withdrawal by Subject|2
361278|NCT00401531|1164164|P1|Overall Study|Withdrawal by Subject|3
361279|NCT00401531|1164163|P2|Overall Study|Lost to Follow-up|1
361280|NCT00401531|1164164|P1|Overall Study|Lost to Follow-up|1
361281|NCT00401531|1164163|P2|Overall Study|Protocol Violation|7
361282|NCT00401531|1164164|P1|Overall Study|Protocol Violation|3
361283|NCT00401531|1164163|P2|Overall Study|Adverse Event|0
361284|NCT00401531|1164164|P1|Overall Study|Adverse Event|2
361285|NCT00401258|1164234|P1|Overall Study|Adverse Event|7
361286|NCT00401245|1164242|P8|Double Blind Tapering Phase|Lack of Efficacy|0
361287|NCT00401245|1164243|P7|Double Blind Tapering Phase|Lack of Efficacy|0
361288|NCT00401245|1164244|P6|Double Blind Tapering Phase|Lack of Efficacy|1
361289|NCT00401245|1164245|P5|Double Blind Tapering Phase|Lack of Efficacy|0
361290|NCT00401245|1164246|P4|Double Blind Tapering Phase|Lack of Efficacy|0
361291|NCT00401245|1164247|P3|Double Blind Tapering Phase|Lack of Efficacy|0
361292|NCT00401245|1164248|P2|Double Blind Tapering Phase|Lack of Efficacy|0
361293|NCT00401245|1164249|P1|Double Blind Tapering Phase|Lack of Efficacy|0
361294|NCT00401245|1164242|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
361295|NCT00401245|1164243|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
361296|NCT00401245|1164244|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
361297|NCT00401245|1164245|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
361298|NCT00401245|1164246|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
361299|NCT00401245|1164247|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
361300|NCT00401245|1164248|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
361301|NCT00401245|1164249|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
361302|NCT00401245|1164242|P8|Double Blind Tapering Phase|Unspecified|2
361303|NCT00401245|1164243|P7|Double Blind Tapering Phase|Unspecified|2
361304|NCT00401245|1164244|P6|Double Blind Tapering Phase|Unspecified|0
361305|NCT00401245|1164245|P5|Double Blind Tapering Phase|Unspecified|1
361306|NCT00401245|1164246|P4|Double Blind Tapering Phase|Unspecified|0
361307|NCT00401245|1164247|P3|Double Blind Tapering Phase|Unspecified|0
361308|NCT00401245|1164248|P2|Double Blind Tapering Phase|Unspecified|0
361309|NCT00401245|1164249|P1|Double Blind Tapering Phase|Unspecified|0
361310|NCT00401245|1164242|P8|Double Blind Tapering Phase|Investigator request|1
361311|NCT00401245|1164243|P7|Double Blind Tapering Phase|Investigator request|0
361312|NCT00401245|1164244|P6|Double Blind Tapering Phase|Investigator request|0
361313|NCT00401245|1164245|P5|Double Blind Tapering Phase|Investigator request|0
361314|NCT00401245|1164246|P4|Double Blind Tapering Phase|Investigator request|0
361315|NCT00401245|1164247|P3|Double Blind Tapering Phase|Investigator request|0
361316|NCT00401245|1164248|P2|Double Blind Tapering Phase|Investigator request|0
361317|NCT00401245|1164249|P1|Double Blind Tapering Phase|Investigator request|0
361318|NCT00401245|1164242|P8|Double Blind Tapering Phase|Adverse Event|4
361319|NCT00401245|1164243|P7|Double Blind Tapering Phase|Adverse Event|2
361320|NCT00401245|1164244|P6|Double Blind Tapering Phase|Adverse Event|1
361321|NCT00401245|1164245|P5|Double Blind Tapering Phase|Adverse Event|1
361322|NCT00401245|1164246|P4|Double Blind Tapering Phase|Adverse Event|0
361323|NCT00401245|1164247|P3|Double Blind Tapering Phase|Adverse Event|0
361324|NCT00401245|1164248|P2|Double Blind Tapering Phase|Adverse Event|0
361325|NCT00401245|1164249|P1|Double Blind Tapering Phase|Adverse Event|0
361326|NCT00401245|1164242|P8|Open Label Phase|Lack of Efficacy|0
361327|NCT00401245|1164243|P7|Open Label Phase|Lack of Efficacy|0
361328|NCT00401245|1164244|P6|Open Label Phase|Lack of Efficacy|0
361329|NCT00401245|1164245|P5|Open Label Phase|Lack of Efficacy|0
361330|NCT00401245|1164246|P4|Open Label Phase|Lack of Efficacy|0
361331|NCT00401245|1164247|P3|Open Label Phase|Lack of Efficacy|3
361332|NCT00401245|1164248|P2|Open Label Phase|Lack of Efficacy|2
361333|NCT00401245|1164249|P1|Open Label Phase|Lack of Efficacy|4
361334|NCT00401245|1164242|P8|Open Label Phase|Withdrawal by Subject|0
361335|NCT00401245|1164243|P7|Open Label Phase|Withdrawal by Subject|0
361336|NCT00401245|1164244|P6|Open Label Phase|Withdrawal by Subject|0
361337|NCT00401245|1164245|P5|Open Label Phase|Withdrawal by Subject|0
361338|NCT00401245|1164246|P4|Open Label Phase|Withdrawal by Subject|1
361339|NCT00401245|1164247|P3|Open Label Phase|Withdrawal by Subject|2
361340|NCT00401245|1164248|P2|Open Label Phase|Withdrawal by Subject|3
361341|NCT00401245|1164249|P1|Open Label Phase|Withdrawal by Subject|3
361342|NCT00401245|1164242|P8|Open Label Phase|Protocol Violation|0
361343|NCT00401245|1164243|P7|Open Label Phase|Protocol Violation|0
361344|NCT00401245|1164244|P6|Open Label Phase|Protocol Violation|0
361345|NCT00401245|1164245|P5|Open Label Phase|Protocol Violation|0
361346|NCT00401245|1164246|P4|Open Label Phase|Protocol Violation|1
361347|NCT00401245|1164247|P3|Open Label Phase|Protocol Violation|0
361348|NCT00401245|1164248|P2|Open Label Phase|Protocol Violation|1
361349|NCT00401245|1164249|P1|Open Label Phase|Protocol Violation|0
361350|NCT00401245|1164242|P8|Open Label Phase|Unspecified|0
361351|NCT00401245|1164243|P7|Open Label Phase|Unspecified|0
361352|NCT00401245|1164244|P6|Open Label Phase|Unspecified|0
361353|NCT00401245|1164245|P5|Open Label Phase|Unspecified|0
361354|NCT00401245|1164246|P4|Open Label Phase|Unspecified|8
361355|NCT00401245|1164247|P3|Open Label Phase|Unspecified|7
361356|NCT00401245|1164248|P2|Open Label Phase|Unspecified|8
361357|NCT00401245|1164249|P1|Open Label Phase|Unspecified|4
361358|NCT00401245|1164242|P8|Open Label Phase|Lost to Follow-up|0
361359|NCT00401245|1164243|P7|Open Label Phase|Lost to Follow-up|0
361360|NCT00401245|1164244|P6|Open Label Phase|Lost to Follow-up|0
361361|NCT00401245|1164245|P5|Open Label Phase|Lost to Follow-up|0
361362|NCT00401245|1164246|P4|Open Label Phase|Lost to Follow-up|4
361363|NCT00401245|1164247|P3|Open Label Phase|Lost to Follow-up|5
361364|NCT00401245|1164248|P2|Open Label Phase|Lost to Follow-up|7
361365|NCT00401245|1164249|P1|Open Label Phase|Lost to Follow-up|5
361366|NCT00401245|1164242|P8|Open Label Phase|Adverse Event|0
361367|NCT00401245|1164243|P7|Open Label Phase|Adverse Event|0
361368|NCT00401245|1164244|P6|Open Label Phase|Adverse Event|0
361369|NCT00401245|1164245|P5|Open Label Phase|Adverse Event|0
361370|NCT00401245|1164246|P4|Open Label Phase|Adverse Event|7
361371|NCT00401245|1164247|P3|Open Label Phase|Adverse Event|6
361372|NCT00401245|1164248|P2|Open Label Phase|Adverse Event|14
361373|NCT00401245|1164249|P1|Open Label Phase|Adverse Event|5
361374|NCT00401245|1164242|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
361375|NCT00401245|1164243|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
361376|NCT00401245|1164244|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
361377|NCT00401245|1164245|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
361378|NCT00401245|1164246|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
361379|NCT00401245|1164247|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
361380|NCT00401245|1164248|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
361381|NCT00401245|1164249|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
361382|NCT00401245|1164242|P8|Double Blind Titration Phase|Withdrawal by Subject|0
361383|NCT00401245|1164243|P7|Double Blind Titration Phase|Withdrawal by Subject|0
361384|NCT00401245|1164244|P6|Double Blind Titration Phase|Withdrawal by Subject|0
361385|NCT00401245|1164245|P5|Double Blind Titration Phase|Withdrawal by Subject|0
361386|NCT00401245|1164246|P4|Double Blind Titration Phase|Withdrawal by Subject|2
361387|NCT00401245|1164247|P3|Double Blind Titration Phase|Withdrawal by Subject|0
361388|NCT00401245|1164248|P2|Double Blind Titration Phase|Withdrawal by Subject|1
361389|NCT00401245|1164249|P1|Double Blind Titration Phase|Withdrawal by Subject|1
361390|NCT00401245|1164242|P8|Double Blind Titration Phase|Protocol Violation|0
361391|NCT00401245|1164243|P7|Double Blind Titration Phase|Protocol Violation|0
361392|NCT00401245|1164244|P6|Double Blind Titration Phase|Protocol Violation|0
361393|NCT00401245|1164245|P5|Double Blind Titration Phase|Protocol Violation|0
361394|NCT00401245|1164246|P4|Double Blind Titration Phase|Protocol Violation|1
361395|NCT00401245|1164247|P3|Double Blind Titration Phase|Protocol Violation|0
361396|NCT00401245|1164248|P2|Double Blind Titration Phase|Protocol Violation|0
361397|NCT00401245|1164249|P1|Double Blind Titration Phase|Protocol Violation|0
361398|NCT00401245|1164242|P8|Double Blind Titration Phase|Unspecified|0
361399|NCT00401245|1164243|P7|Double Blind Titration Phase|Unspecified|0
361400|NCT00401245|1164244|P6|Double Blind Titration Phase|Unspecified|0
361401|NCT00401245|1164245|P5|Double Blind Titration Phase|Unspecified|0
361402|NCT00401245|1164246|P4|Double Blind Titration Phase|Unspecified|0
361403|NCT00401245|1164247|P3|Double Blind Titration Phase|Unspecified|1
361404|NCT00401245|1164248|P2|Double Blind Titration Phase|Unspecified|0
361405|NCT00401245|1164249|P1|Double Blind Titration Phase|Unspecified|0
361406|NCT00401245|1164242|P8|Double Blind Titration Phase|Adverse Event|0
361407|NCT00401245|1164243|P7|Double Blind Titration Phase|Adverse Event|0
361408|NCT00401245|1164244|P6|Double Blind Titration Phase|Adverse Event|0
361409|NCT00401245|1164245|P5|Double Blind Titration Phase|Adverse Event|0
361410|NCT00401245|1164246|P4|Double Blind Titration Phase|Adverse Event|12
361411|NCT00401245|1164247|P3|Double Blind Titration Phase|Adverse Event|5
361412|NCT00401245|1164248|P2|Double Blind Titration Phase|Adverse Event|2
361413|NCT00401245|1164249|P1|Double Blind Titration Phase|Adverse Event|3
361414|NCT00401193|1164317|P3|Overall Study|Other Event|2
361415|NCT00401193|1164318|P2|Overall Study|Other Event|2
361416|NCT00401193|1164319|P1|Overall Study|Other Event|3
361417|NCT00401193|1164317|P3|Overall Study|Withdrawal by Subject|1
361418|NCT00401193|1164318|P2|Overall Study|Withdrawal by Subject|0
361419|NCT00401193|1164319|P1|Overall Study|Withdrawal by Subject|2
361420|NCT00401193|1164317|P3|Overall Study|Lost to Follow-up|1
361421|NCT00401193|1164318|P2|Overall Study|Lost to Follow-up|5
361422|NCT00401193|1164319|P1|Overall Study|Lost to Follow-up|6
361423|NCT00401193|1164317|P3|Overall Study|Protocol Violation|1
361424|NCT00401193|1164318|P2|Overall Study|Protocol Violation|1
361425|NCT00401193|1164319|P1|Overall Study|Protocol Violation|3
361426|NCT00401193|1164317|P3|Overall Study|Adverse Event|1
361427|NCT00401193|1164318|P2|Overall Study|Adverse Event|3
361428|NCT00401193|1164319|P1|Overall Study|Adverse Event|1
361429|NCT00400946|1164342|P5|Overall Study|Other|1
361430|NCT00400946|1164343|P4|Overall Study|Other|0
361431|NCT00400946|1164344|P3|Overall Study|Other|0
361432|NCT00400946|1164345|P2|Overall Study|Other|0
361433|NCT00400946|1164346|P1|Overall Study|Other|0
361434|NCT00400946|1164342|P5|Overall Study|Clinical|9
361435|NCT00400946|1164343|P4|Overall Study|Clinical|2
361436|NCT00400946|1164344|P3|Overall Study|Clinical|0
361437|NCT00400946|1164345|P2|Overall Study|Clinical|2
361438|NCT00400946|1164346|P1|Overall Study|Clinical|1
361439|NCT00400946|1164342|P5|Overall Study|Withdrawal by Subject|8
361440|NCT00400946|1164343|P4|Overall Study|Withdrawal by Subject|5
361441|NCT00400946|1164344|P3|Overall Study|Withdrawal by Subject|1
361442|NCT00400946|1164345|P2|Overall Study|Withdrawal by Subject|5
361443|NCT00400946|1164346|P1|Overall Study|Withdrawal by Subject|2
361444|NCT00400946|1164342|P5|Overall Study|Transplant in CR1|1
361445|NCT00400946|1164343|P4|Overall Study|Transplant in CR1|10
361446|NCT00400946|1164344|P3|Overall Study|Transplant in CR1|0
361447|NCT00400946|1164345|P2|Overall Study|Transplant in CR1|0
361448|NCT00400946|1164346|P1|Overall Study|Transplant in CR1|0
361449|NCT00400946|1164342|P5|Overall Study|Relapse|5
361450|NCT00400946|1164343|P4|Overall Study|Relapse|1
361451|NCT00400946|1164344|P3|Overall Study|Relapse|1
361452|NCT00400946|1164345|P2|Overall Study|Relapse|2
361453|NCT00400946|1164346|P1|Overall Study|Relapse|9
361454|NCT00400946|1164342|P5|Overall Study|Remission Death|1
361455|NCT00400946|1164343|P4|Overall Study|Remission Death|0
361456|NCT00400946|1164344|P3|Overall Study|Remission Death|0
361457|NCT00400946|1164345|P2|Overall Study|Remission Death|1
361458|NCT00400946|1164346|P1|Overall Study|Remission Death|1
361459|NCT00400946|1164342|P5|Overall Study|Lost to Follow-up|1
361460|NCT00400946|1164343|P4|Overall Study|Lost to Follow-up|0
361461|NCT00400946|1164344|P3|Overall Study|Lost to Follow-up|0
361462|NCT00400946|1164345|P2|Overall Study|Lost to Follow-up|1
361463|NCT00400946|1164346|P1|Overall Study|Lost to Follow-up|1
361464|NCT00400946|1164342|P5|Overall Study|Induction Death|3
361465|NCT00400946|1164343|P4|Overall Study|Induction Death|13
361466|NCT00400946|1164344|P3|Overall Study|Induction Death|0
361467|NCT00400946|1164345|P2|Overall Study|Induction Death|0
361468|NCT00400946|1164346|P1|Overall Study|Induction Death|0
361469|NCT00400946|1164342|P5|Overall Study|Induction Failure|8
361470|NCT00400946|1164343|P4|Overall Study|Induction Failure|11
361471|NCT00400946|1164344|P3|Overall Study|Induction Failure|0
361472|NCT00400946|1164345|P2|Overall Study|Induction Failure|0
361473|NCT00400946|1164346|P1|Overall Study|Induction Failure|0
361474|NCT00400946|1164342|P5|Overall Study|Ineligible|1
361475|NCT00400946|1164343|P4|Overall Study|Ineligible|5
361476|NCT00400946|1164344|P3|Overall Study|Ineligible|0
361477|NCT00400946|1164345|P2|Overall Study|Ineligible|0
361478|NCT00400946|1164346|P1|Overall Study|Ineligible|0
361479|NCT00400764|1164405|P5|Phase II|Withdrawal by Subject|0
361480|NCT00400764|1164406|P4|Phase II|Withdrawal by Subject|1
361481|NCT00400764|1164407|P3|Phase II|Withdrawal by Subject|1
361482|NCT00400764|1164408|P2|Phase II|Withdrawal by Subject|0
361483|NCT00400764|1164409|P1|Phase II|Withdrawal by Subject|0
361484|NCT00400764|1164405|P5|Phase II|Patient began new, non-protocol, therapy|0
361485|NCT00400764|1164406|P4|Phase II|Patient began new, non-protocol, therapy|0
361486|NCT00400764|1164407|P3|Phase II|Patient began new, non-protocol, therapy|1
361487|NCT00400764|1164408|P2|Phase II|Patient began new, non-protocol, therapy|0
361488|NCT00400764|1164409|P1|Phase II|Patient began new, non-protocol, therapy|0
361489|NCT00400764|1164405|P5|Phase II|Sponsor’s decision to terminate|11
361490|NCT00400764|1164406|P4|Phase II|Sponsor’s decision to terminate|22
361491|NCT00400764|1164407|P3|Phase II|Sponsor’s decision to terminate|18
361492|NCT00400764|1164408|P2|Phase II|Sponsor’s decision to terminate|0
361493|NCT00400764|1164409|P1|Phase II|Sponsor’s decision to terminate|0
361494|NCT00400764|1164405|P5|Phase II|Physician Decision|0
361495|NCT00400764|1164406|P4|Phase II|Physician Decision|1
361496|NCT00400764|1164407|P3|Phase II|Physician Decision|1
361497|NCT00400764|1164408|P2|Phase II|Physician Decision|0
361498|NCT00400764|1164409|P1|Phase II|Physician Decision|0
361499|NCT00400764|1164405|P5|Phase II|Lost to Follow-up|0
361500|NCT00400764|1164406|P4|Phase II|Lost to Follow-up|0
361501|NCT00400764|1164407|P3|Phase II|Lost to Follow-up|1
361502|NCT00400764|1164408|P2|Phase II|Lost to Follow-up|0
361503|NCT00400764|1164409|P1|Phase II|Lost to Follow-up|0
361504|NCT00400764|1164405|P5|Phase II|Death|0
361505|NCT00400764|1164406|P4|Phase II|Death|2
361506|NCT00400764|1164407|P3|Phase II|Death|1
361507|NCT00400764|1164408|P2|Phase II|Death|0
361508|NCT00400764|1164409|P1|Phase II|Death|0
361509|NCT00400764|1164405|P5|Phase Ib|Disease Progression|0
361510|NCT00400764|1164406|P4|Phase Ib|Disease Progression|0
361511|NCT00400764|1164407|P3|Phase Ib|Disease Progression|0
361512|NCT00400764|1164408|P2|Phase Ib|Disease Progression|4
361513|NCT00400764|1164409|P1|Phase Ib|Disease Progression|4
361514|NCT00400764|1164405|P5|Phase Ib|Death|0
361515|NCT00400764|1164406|P4|Phase Ib|Death|0
361516|NCT00400764|1164407|P3|Phase Ib|Death|0
361517|NCT00400764|1164408|P2|Phase Ib|Death|0
361518|NCT00400764|1164409|P1|Phase Ib|Death|1
361519|NCT00400764|1164405|P5|Phase Ib|Adverse Event|0
361520|NCT00400764|1164406|P4|Phase Ib|Adverse Event|0
361521|NCT00400764|1164407|P3|Phase Ib|Adverse Event|0
361522|NCT00400764|1164408|P2|Phase Ib|Adverse Event|0
361523|NCT00400764|1164409|P1|Phase Ib|Adverse Event|1
361524|NCT00400712|1164462|P2|Overall Study|Physician Decision|4
361525|NCT00400712|1164463|P1|Overall Study|Physician Decision|5
361526|NCT00400712|1164462|P2|Overall Study|Withdrawal by Subject|12
361527|NCT00400712|1164463|P1|Overall Study|Withdrawal by Subject|11
361528|NCT00400712|1164462|P2|Overall Study|Death|0
361529|NCT00400712|1164463|P1|Overall Study|Death|1
361530|NCT00400569|1164498|P1|Overall Study|Death|1
361531|NCT00400400|1164511|P2|Overall Study|Did not receive study drug|3
361532|NCT00400400|1164512|P1|Overall Study|Did not receive study drug|1
361533|NCT00400400|1164511|P2|Overall Study|Lost to Follow-up|1
361534|NCT00400400|1164512|P1|Overall Study|Lost to Follow-up|0
361535|NCT00400400|1164511|P2|Overall Study|Administrative Problem|0
361536|NCT00400400|1164512|P1|Overall Study|Administrative Problem|1
361537|NCT00400400|1164511|P2|Overall Study|Withdrawal by Subject|3
361538|NCT00400400|1164512|P1|Overall Study|Withdrawal by Subject|1
361539|NCT00400400|1164511|P2|Overall Study|Protocol Violation|0
361540|NCT00400400|1164512|P1|Overall Study|Protocol Violation|2
361541|NCT00400400|1164511|P2|Overall Study|Adverse Event|8
361542|NCT00400400|1164512|P1|Overall Study|Adverse Event|9
361543|NCT00400179|1164536|P2|Overall Study|Randomization error/patient ineligible|6
361544|NCT00400179|1164537|P1|Overall Study|Randomization error/patient ineligible|1
361545|NCT00400179|1164536|P2|Overall Study|Investigator judgment|1
361546|NCT00400179|1164537|P1|Overall Study|Investigator judgment|0
361547|NCT00400179|1164536|P2|Overall Study|Intercurrent illness|1
361548|NCT00400179|1164537|P1|Overall Study|Intercurrent illness|0
361549|NCT00400179|1164536|P2|Overall Study|Disease progression|1
361550|NCT00400179|1164537|P1|Overall Study|Disease progression|1
361551|NCT00400179|1164536|P2|Overall Study|Withdrew Consent|5
361552|NCT00400179|1164537|P1|Overall Study|Withdrew Consent|1
361553|NCT00400179|1164536|P2|Overall Study|Death|2
361554|NCT00400179|1164537|P1|Overall Study|Death|1
361555|NCT00400179|1164536|P2|Overall Study|Adverse Event|2
361556|NCT00400179|1164537|P1|Overall Study|Adverse Event|2
361557|NCT00400153|1164554|P3|Overall Study|Other reasons - not mentioned above|3
361558|NCT00400153|1164555|P2|Overall Study|Other reasons - not mentioned above|5
361559|NCT00400153|1164556|P1|Overall Study|Other reasons - not mentioned above|8
361560|NCT00400153|1164554|P3|Overall Study|Withdrawal by Subject|10
361561|NCT00400153|1164555|P2|Overall Study|Withdrawal by Subject|11
361562|NCT00400153|1164556|P1|Overall Study|Withdrawal by Subject|12
361563|NCT00400153|1164554|P3|Overall Study|Lost to Follow-up|4
361564|NCT00400153|1164555|P2|Overall Study|Lost to Follow-up|1
361565|NCT00400153|1164556|P1|Overall Study|Lost to Follow-up|2
361566|NCT00400153|1164554|P3|Overall Study|Protocol Violation|9
361567|NCT00400153|1164555|P2|Overall Study|Protocol Violation|4
361568|NCT00400153|1164556|P1|Overall Study|Protocol Violation|7
361569|NCT00400153|1164554|P3|Overall Study|AE due to other condition|15
361570|NCT00400153|1164555|P2|Overall Study|AE due to other condition|14
361571|NCT00400153|1164556|P1|Overall Study|AE due to other condition|3
361572|NCT00400153|1164554|P3|Overall Study|AE due to other disease worsening|0
361573|NCT00400153|1164555|P2|Overall Study|AE due to other disease worsening|1
361574|NCT00400153|1164556|P1|Overall Study|AE due to other disease worsening|2
361575|NCT00400153|1164554|P3|Overall Study|AE due to study disease worsening|20
361576|NCT00400153|1164555|P2|Overall Study|AE due to study disease worsening|19
361577|NCT00400153|1164556|P1|Overall Study|AE due to study disease worsening|14
361578|NCT00399893|1164803|P2|Overall Study|Withdrawal by Subject|0
361579|NCT00399893|1164804|P1|Overall Study|Withdrawal by Subject|1
361580|NCT00399763|1164832|P2|Overall Study|Lost to Follow-up|3
361581|NCT00399763|1164833|P1|Overall Study|Lost to Follow-up|2
361582|NCT00399568|1164845|P2|Overall Study|Lost to Follow-up|2
361583|NCT00399568|1164846|P1|Overall Study|Lost to Follow-up|2
361584|NCT00399568|1164845|P2|Overall Study|Protocol non-compliance|2
361585|NCT00399568|1164846|P1|Overall Study|Protocol non-compliance|2
361586|NCT00399568|1164845|P2|Overall Study|Withdrawal by Subject|3
361587|NCT00399568|1164846|P1|Overall Study|Withdrawal by Subject|7
361588|NCT00399568|1164845|P2|Overall Study|Adverse Event|2
361589|NCT00399568|1164846|P1|Overall Study|Adverse Event|1
361590|NCT00399542|1164860|P2|Overall Study|Physician Decision|1
361591|NCT00399542|1164861|P1|Overall Study|Physician Decision|0
361592|NCT00399542|1164860|P2|Overall Study|Unspecified|0
361593|NCT00399542|1164861|P1|Overall Study|Unspecified|1
361594|NCT00399542|1164860|P2|Overall Study|Lost to Follow-up|6
361595|NCT00399542|1164861|P1|Overall Study|Lost to Follow-up|6
361596|NCT00399542|1164860|P2|Overall Study|Lack of Efficacy|8
361597|NCT00399542|1164861|P1|Overall Study|Lack of Efficacy|18
361598|NCT00399542|1164860|P2|Overall Study|Withdrawal by Subject|10
361599|NCT00399542|1164861|P1|Overall Study|Withdrawal by Subject|28
361600|NCT00399542|1164860|P2|Overall Study|Protocol Violation|3
361601|NCT00399542|1164861|P1|Overall Study|Protocol Violation|13
361602|NCT00399542|1164860|P2|Overall Study|Adverse Event|15
361603|NCT00399542|1164861|P1|Overall Study|Adverse Event|18
361604|NCT00399516|1164923|P1|Overall Study|Lost to Follow-up|2
361605|NCT00399360|1164931|P4|Overall Study|Withdrawal by Subject|2
361606|NCT00399360|1164932|P3|Overall Study|Withdrawal by Subject|0
361607|NCT00399360|1164933|P2|Overall Study|Withdrawal by Subject|2
361608|NCT00399360|1164934|P1|Overall Study|Withdrawal by Subject|0
361609|NCT00399360|1164931|P4|Overall Study|Adverse Event|0
361610|NCT00399360|1164932|P3|Overall Study|Adverse Event|1
361611|NCT00399360|1164933|P2|Overall Study|Adverse Event|0
361612|NCT00399360|1164934|P1|Overall Study|Adverse Event|0
361613|NCT00399360|1164931|P4|Overall Study|Lost to Follow-up|4
361614|NCT00399360|1164932|P3|Overall Study|Lost to Follow-up|2
361615|NCT00399360|1164933|P2|Overall Study|Lost to Follow-up|1
361616|NCT00399360|1164934|P1|Overall Study|Lost to Follow-up|2
361617|NCT00399035|1165005|P3|Overall Study|Severe non-compliance with protocol|0
361618|NCT00399035|1165006|P2|Overall Study|Severe non-compliance with protocol|1
361619|NCT00399035|1165007|P1|Overall Study|Severe non-compliance with protocol|2
361620|NCT00399035|1165005|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
361621|NCT00399035|1165006|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
361622|NCT00399035|1165007|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
361623|NCT00399035|1165005|P3|Overall Study|Withdrawal by Subject|12
361624|NCT00399035|1165006|P2|Overall Study|Withdrawal by Subject|15
361625|NCT00399035|1165007|P1|Overall Study|Withdrawal by Subject|19
361626|NCT00399035|1165005|P3|Overall Study|Lost to Follow-up|5
361627|NCT00399035|1165006|P2|Overall Study|Lost to Follow-up|1
361628|NCT00399035|1165007|P1|Overall Study|Lost to Follow-up|2
361629|NCT00399035|1165005|P3|Overall Study|Death|234
361630|NCT00399035|1165006|P2|Overall Study|Death|141
361631|NCT00399035|1165007|P1|Overall Study|Death|289
361632|NCT00398632|1165040|P1|Overall Study|Lack of Efficacy|1
361633|NCT00398632|1165040|P1|Overall Study|Withdrawal by Subject|1
361634|NCT00398411|1165046|P2|Overall Study|Death|1
361635|NCT00398411|1165047|P1|Overall Study|Death|0
361636|NCT00398320|1165070|P1|Overall Study|Physician Decision|1
361637|NCT00398320|1165070|P1|Overall Study|Adverse Event|4
361638|NCT00398320|1165070|P1|Overall Study|Death|1
361639|NCT00398216|1165083|P5|Overall Study|entrance criteria|2
361640|NCT00398216|1165084|P4|Overall Study|entrance criteria|0
361641|NCT00398216|1165085|P3|Overall Study|entrance criteria|0
361642|NCT00398216|1165086|P2|Overall Study|entrance criteria|0
361643|NCT00398216|1165087|P1|Overall Study|entrance criteria|0
361644|NCT00398216|1165083|P5|Overall Study|administrative reasons|3
361645|NCT00398216|1165084|P4|Overall Study|administrative reasons|3
361646|NCT00398216|1165085|P3|Overall Study|administrative reasons|4
361647|NCT00398216|1165086|P2|Overall Study|administrative reasons|4
361648|NCT00398216|1165087|P1|Overall Study|administrative reasons|3
361649|NCT00398216|1165083|P5|Overall Study|Withdrawal by Subject|2
361650|NCT00398216|1165084|P4|Overall Study|Withdrawal by Subject|1
361651|NCT00398216|1165085|P3|Overall Study|Withdrawal by Subject|3
361652|NCT00398216|1165086|P2|Overall Study|Withdrawal by Subject|0
361653|NCT00398216|1165087|P1|Overall Study|Withdrawal by Subject|1
361654|NCT00398216|1165083|P5|Overall Study|Death|0
361655|NCT00398216|1165084|P4|Overall Study|Death|0
361656|NCT00398216|1165085|P3|Overall Study|Death|0
361657|NCT00398216|1165086|P2|Overall Study|Death|3
361658|NCT00398216|1165087|P1|Overall Study|Death|0
361659|NCT00398216|1165083|P5|Overall Study|Lost to Follow-up|1
361660|NCT00398216|1165084|P4|Overall Study|Lost to Follow-up|4
361661|NCT00398216|1165085|P3|Overall Study|Lost to Follow-up|4
361662|NCT00398216|1165086|P2|Overall Study|Lost to Follow-up|6
361663|NCT00398216|1165087|P1|Overall Study|Lost to Follow-up|1
361664|NCT00398216|1165083|P5|Overall Study|Protocol Violation|5
361665|NCT00398216|1165084|P4|Overall Study|Protocol Violation|7
361666|NCT00398216|1165085|P3|Overall Study|Protocol Violation|5
361667|NCT00398216|1165086|P2|Overall Study|Protocol Violation|4
361668|NCT00398216|1165087|P1|Overall Study|Protocol Violation|2
361669|NCT00398216|1165083|P5|Overall Study|Adverse Event|2
361670|NCT00398216|1165084|P4|Overall Study|Adverse Event|7
361671|NCT00398216|1165085|P3|Overall Study|Adverse Event|5
361672|NCT00398216|1165086|P2|Overall Study|Adverse Event|2
361673|NCT00398216|1165087|P1|Overall Study|Adverse Event|4
361674|NCT00398138|1165114|P1|Overall Study|Adverse Event|2
361675|NCT00398112|1165119|P1|Overall Study|Death|1
361676|NCT00398112|1165119|P1|Overall Study|Withdrawal by Subject|3
361677|NCT00398112|1165119|P1|Overall Study|Alternative treatment|1
361678|NCT00398112|1165119|P1|Overall Study|Disease progression|9
361679|NCT00398112|1165119|P1|Overall Study|Adverse Event|4
361680|NCT00398086|1165130|P3|Overall Study|Withdrawal by Subject|0
361681|NCT00398086|1165131|P2|Overall Study|Withdrawal by Subject|7
361682|NCT00398086|1165132|P1|Overall Study|Withdrawal by Subject|5
361683|NCT00398086|1165130|P3|Overall Study|Physician Decision|0
361684|NCT00398086|1165131|P2|Overall Study|Physician Decision|4
361685|NCT00398086|1165132|P1|Overall Study|Physician Decision|1
361686|NCT00398086|1165130|P3|Overall Study|Adverse Event|0
361687|NCT00398086|1165131|P2|Overall Study|Adverse Event|4
361688|NCT00398086|1165132|P1|Overall Study|Adverse Event|1
361689|NCT00398086|1165130|P3|Overall Study|Unacceptable Toxicity|2
361690|NCT00398086|1165131|P2|Overall Study|Unacceptable Toxicity|8
361691|NCT00398086|1165132|P1|Overall Study|Unacceptable Toxicity|2
361692|NCT00398073|1165166|P2|Overall Study|Withdrawal by Subject|0
361693|NCT00398073|1165167|P1|Overall Study|Withdrawal by Subject|1
361694|NCT00398047|1165177|P1|Overall Study|all patient progressed before completion|3
361695|NCT00397982|1165187|P1|Overall Study|Unrelated health issues|1
361696|NCT00397982|1165187|P1|Overall Study|noncompliance|1
361697|NCT00397982|1165187|P1|Overall Study|Adverse Event|1
361698|NCT00397982|1165187|P1|Overall Study|Withdrawal by Subject|1
361699|NCT00397930|1165198|P2|Overall Study|Missing data|4
361700|NCT00397930|1165199|P1|Overall Study|Missing data|0
361701|NCT00397930|1165198|P2|Overall Study|Withdrawal by Subject|8
361702|NCT00397930|1165199|P1|Overall Study|Withdrawal by Subject|0
361703|NCT00397930|1165198|P2|Overall Study|Did not want to be in control group|1
361704|NCT00397930|1165199|P1|Overall Study|Did not want to be in control group|0
361705|NCT00397930|1165198|P2|Overall Study|Started own yoga program|1
361706|NCT00397930|1165199|P1|Overall Study|Started own yoga program|1
361707|NCT00397930|1165198|P2|Overall Study|Too time-consuming|9
361708|NCT00397930|1165199|P1|Overall Study|Too time-consuming|2
361709|NCT00397930|1165198|P2|Overall Study|Noncompliant|2
361710|NCT00397930|1165199|P1|Overall Study|Noncompliant|3
361711|NCT00397930|1165198|P2|Overall Study|Unknown reasons|14
361712|NCT00397930|1165199|P1|Overall Study|Unknown reasons|9
361713|NCT00397930|1165198|P2|Overall Study|Other medical|4
361714|NCT00397930|1165199|P1|Overall Study|Other medical|9
361715|NCT00397930|1165198|P2|Overall Study|Personal reasons|8
361716|NCT00397930|1165199|P1|Overall Study|Personal reasons|14
361717|NCT00397891|1165214|P5|Overall Study|Withdrawal by Subject|1
361718|NCT00397891|1165215|P4|Overall Study|Withdrawal by Subject|0
361719|NCT00397891|1165216|P3|Overall Study|Withdrawal by Subject|0
361720|NCT00397891|1165217|P2|Overall Study|Withdrawal by Subject|0
361721|NCT00397891|1165218|P1|Overall Study|Withdrawal by Subject|1
361722|NCT00397631|1165339|P2|Overall Study|protocol discontinuation criteria|4
361723|NCT00397631|1165340|P1|Overall Study|protocol discontinuation criteria|1
361724|NCT00397631|1165339|P2|Overall Study|Withdrawal by Subject|14
361725|NCT00397631|1165340|P1|Overall Study|Withdrawal by Subject|7
361726|NCT00397631|1165339|P2|Overall Study|Protocol Violation|1
361727|NCT00397631|1165340|P1|Overall Study|Protocol Violation|0
361728|NCT00397631|1165339|P2|Overall Study|Physician Decision|0
361729|NCT00397631|1165340|P1|Overall Study|Physician Decision|2
361730|NCT00397631|1165339|P2|Overall Study|Lost to Follow-up|9
361731|NCT00397631|1165340|P1|Overall Study|Lost to Follow-up|8
361732|NCT00397631|1165339|P2|Overall Study|Lack of Efficacy|10
361733|NCT00397631|1165340|P1|Overall Study|Lack of Efficacy|7
361734|NCT00397631|1165339|P2|Overall Study|Adverse Event|6
361735|NCT00397631|1165340|P1|Overall Study|Adverse Event|5
361736|NCT00397540|1165352|P2|Overall Study|short follow-up duration < 12 months|0
361737|NCT00397540|1165353|P1|Overall Study|short follow-up duration < 12 months|1
361738|NCT00397514|1165359|P1|Overall Study|poor echocardiographic windows|1
361739|NCT00397514|1165359|P1|Overall Study|early extubation|2
361740|NCT00397514|1165359|P1|Overall Study|Not able to capture & pace LV intraoper.|4
361741|NCT00397514|1165359|P1|Overall Study|Pacing wire malfunction|1
361742|NCT00397514|1165359|P1|Overall Study|Withdrawal by Subject|1
361743|NCT00397488|1165369|P1|Overall Study|Death|1
361744|NCT00397488|1165369|P1|Overall Study|Adverse Event|3
361745|NCT00397488|1165369|P1|Overall Study|Withdrawal by Subject|3
361746|NCT00397254|1165389|P2|Overall Study|Lost to Follow-up|2
361747|NCT00397254|1165390|P1|Overall Study|Lost to Follow-up|2
361748|NCT00397215|1165412|P4|Month 6 (Day 180)|Unspecified|0
361749|NCT00397215|1165413|P3|Month 6 (Day 180)|Unspecified|3
361750|NCT00397215|1165414|P2|Month 6 (Day 180)|Unspecified|0
361751|NCT00397215|1165415|P1|Month 6 (Day 180)|Unspecified|2
361752|NCT00397215|1165412|P4|Month 6 (Day 180)|Adverse Event|0
361753|NCT00397215|1165413|P3|Month 6 (Day 180)|Adverse Event|2
361754|NCT00397215|1165414|P2|Month 6 (Day 180)|Adverse Event|3
361755|NCT00397215|1165415|P1|Month 6 (Day 180)|Adverse Event|0
361756|NCT00397215|1165412|P4|Month 0 (Day 0)|Unspecified|3
361757|NCT00397215|1165413|P3|Month 0 (Day 0)|Unspecified|3
361758|NCT00397215|1165414|P2|Month 0 (Day 0)|Unspecified|1
361759|NCT00397215|1165415|P1|Month 0 (Day 0)|Unspecified|4
361760|NCT00397215|1165412|P4|Month 0 (Day 0)|Withdrawal by Subject|1
361761|NCT00397215|1165413|P3|Month 0 (Day 0)|Withdrawal by Subject|3
361762|NCT00397215|1165414|P2|Month 0 (Day 0)|Withdrawal by Subject|3
361763|NCT00397215|1165415|P1|Month 0 (Day 0)|Withdrawal by Subject|3
361764|NCT00397215|1165412|P4|Month 0 (Day 0)|Adverse Event|0
361765|NCT00397215|1165413|P3|Month 0 (Day 0)|Adverse Event|0
361766|NCT00397215|1165414|P2|Month 0 (Day 0)|Adverse Event|1
361767|NCT00397215|1165415|P1|Month 0 (Day 0)|Adverse Event|0
361768|NCT00397189|1165551|P2|3 Weeks Period|Other|2
361769|NCT00397189|1165552|P1|3 Weeks Period|Other|0
361770|NCT00397189|1165551|P2|3 Weeks Period|Protocol Violation|3
361771|NCT00397189|1165552|P1|3 Weeks Period|Protocol Violation|0
361772|NCT00397189|1165551|P2|3 Weeks Period|Physician Decision|2
361773|NCT00397189|1165552|P1|3 Weeks Period|Physician Decision|0
361774|NCT00397189|1165551|P2|3 Weeks Period|Withdrawal by Subject|9
361775|NCT00397189|1165552|P1|3 Weeks Period|Withdrawal by Subject|13
361776|NCT00397189|1165551|P2|3 Weeks Period|Adverse Event|2
361777|NCT00397189|1165552|P1|3 Weeks Period|Adverse Event|3
361778|NCT00397189|1165551|P2|3 Weeks Period|Lost to Follow-up|4
361779|NCT00397189|1165552|P1|3 Weeks Period|Lost to Follow-up|5
361780|NCT00397033|1165576|P3|Overall Study|Other|2
361781|NCT00397033|1165577|P2|Overall Study|Other|5
361782|NCT00397033|1165578|P1|Overall Study|Other|0
361783|NCT00397033|1165576|P3|Overall Study|Withdrawal by Subject|5
361784|NCT00397033|1165577|P2|Overall Study|Withdrawal by Subject|7
361785|NCT00397033|1165578|P1|Overall Study|Withdrawal by Subject|12
361786|NCT00397033|1165576|P3|Overall Study|Lost to Follow-up|3
361787|NCT00397033|1165577|P2|Overall Study|Lost to Follow-up|3
361788|NCT00397033|1165578|P1|Overall Study|Lost to Follow-up|3
361789|NCT00397033|1165576|P3|Overall Study|Lack of Efficacy|9
361790|NCT00397033|1165577|P2|Overall Study|Lack of Efficacy|12
361791|NCT00397033|1165578|P1|Overall Study|Lack of Efficacy|22
361792|NCT00397033|1165576|P3|Overall Study|Adverse Event|4
361793|NCT00397033|1165577|P2|Overall Study|Adverse Event|10
361794|NCT00397033|1165578|P1|Overall Study|Adverse Event|7
361795|NCT00396877|1165660|P2|Overall Study|Parent(s)/guardian(s)'s request|7
361796|NCT00396877|1165661|P1|Overall Study|Parent(s)/guardian(s)'s request|4
361797|NCT00396877|1165660|P2|Overall Study|Lost to Follow-up|1
361798|NCT00396877|1165661|P1|Overall Study|Lost to Follow-up|2
361799|NCT00396812|1165671|P1|Overall Study|Physician Decision|1
361800|NCT00396656|1165683|P2|Second Treatment Period|Adverse Event|1
361801|NCT00396656|1165684|P1|Second Treatment Period|Adverse Event|0
361802|NCT00396656|1165683|P2|First Treatment Period|Withdrawal by Subject|2
361803|NCT00396656|1165684|P1|First Treatment Period|Withdrawal by Subject|0
361804|NCT00396630|1165702|P2|Overall Study|Not vaccinated at Visit 3|3
361805|NCT00396630|1165703|P1|Overall Study|Not vaccinated at Visit 3|3
361806|NCT00396630|1165702|P2|Overall Study|Withdrawal by Subject|1
361807|NCT00396630|1165703|P1|Overall Study|Withdrawal by Subject|1
361808|NCT00396630|1165702|P2|Overall Study|Lost to Follow-up|1
361809|NCT00396630|1165703|P1|Overall Study|Lost to Follow-up|1
361810|NCT00396591|1165720|P1|Overall Study|Participant request|1
361811|NCT00396591|1165720|P1|Overall Study|Adverse Event|2
361812|NCT00396591|1165720|P1|Overall Study|Disease Progression|13
361813|NCT00396565|1165733|P3|Overall Study|Lack of Efficacy|11
361814|NCT00396565|1165734|P2|Overall Study|Lack of Efficacy|64
361815|NCT00396565|1165735|P1|Overall Study|Lack of Efficacy|32
361816|NCT00396565|1165733|P3|Overall Study|Withdrawal by Subject|1
361817|NCT00396565|1165734|P2|Overall Study|Withdrawal by Subject|13
361818|NCT00396565|1165735|P1|Overall Study|Withdrawal by Subject|8
361819|NCT00396565|1165733|P3|Overall Study|Adverse Event|3
361820|NCT00396565|1165734|P2|Overall Study|Adverse Event|13
361821|NCT00396565|1165735|P1|Overall Study|Adverse Event|5
361822|NCT00396565|1165733|P3|Overall Study|Physician Decision|2
361823|NCT00396565|1165734|P2|Overall Study|Physician Decision|1
361824|NCT00396565|1165735|P1|Overall Study|Physician Decision|3
361825|NCT00396409|1165760|P2|Period 2 - 2008|Lost to Follow-up|1
361826|NCT00396409|1165761|P1|Period 2 - 2008|Lost to Follow-up|3
361827|NCT00396409|1165760|P2|Period 2 - 2008|Withdrawal by Subject|1
361828|NCT00396409|1165761|P1|Period 2 - 2008|Withdrawal by Subject|3
361829|NCT00396409|1165760|P2|Period 2 - 2008|Protocol Violation|0
361830|NCT00396409|1165761|P1|Period 2 - 2008|Protocol Violation|1
361831|NCT00396409|1165760|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
361832|NCT00396409|1165761|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
361833|NCT00396409|1165760|P2|Period 1 - 2007|Lost to Follow-up|3
361834|NCT00396409|1165761|P1|Period 1 - 2007|Lost to Follow-up|2
361835|NCT00396409|1165760|P2|Period 1 - 2007|Withdrawal by Subject|1
361836|NCT00396409|1165761|P1|Period 1 - 2007|Withdrawal by Subject|1
361837|NCT00396409|1165760|P2|Period 1 - 2007|Lack of Efficacy|1
361838|NCT00396409|1165761|P1|Period 1 - 2007|Lack of Efficacy|0
361839|NCT00396409|1165760|P2|Period 1 - 2007|Adverse Event|1
361840|NCT00396409|1165761|P1|Period 1 - 2007|Adverse Event|0
361841|NCT00396383|1165791|P1|Overall Study|Lost to Follow-up|1
361842|NCT00396383|1165791|P1|Overall Study|Death|2
361843|NCT00396331|1165804|P1|Overall Study|Death|16
361844|NCT00396331|1165804|P1|Overall Study|Lost to Follow-up|3
361845|NCT00396331|1165804|P1|Overall Study|Did not go on to transplant|5
361846|NCT00396331|1165804|P1|Overall Study|Failed to mobilize - no transplant|8
361847|NCT00396318|1165857|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
361848|NCT00396279|1165877|P1|Overall Study|Physician Decision|1
361849|NCT00396279|1165877|P1|Overall Study|Withdrawal by Subject|1
361850|NCT00396279|1165877|P1|Overall Study|Disease progression|2
361851|NCT00396279|1165877|P1|Overall Study|Ongoing in study|26
361852|NCT00396253|1165910|P1|Overall Study|Change in eligibility status|1
361853|NCT00396253|1165910|P1|Overall Study|Physician Decision|1
361854|NCT00396253|1165910|P1|Overall Study|Death|3
361855|NCT00396253|1165910|P1|Overall Study|Withdrawal by Subject|7
361856|NCT00396253|1165910|P1|Overall Study|Protocol Violation|1
361857|NCT00396162|1165941|P2|Overall Study|Withdrawal by Subject|3
361858|NCT00396162|1165942|P1|Overall Study|Withdrawal by Subject|2
361859|NCT00396136|1165954|P1|Overall Study|Study device explanted|8
361860|NCT00396136|1165954|P1|Overall Study|Lost to Follow-up|15
361861|NCT00396136|1165954|P1|Overall Study|Withdrawal by Subject|59
361862|NCT00396136|1165954|P1|Overall Study|Death|43
361863|NCT00396097|1165961|P2|Overall Study|Insufficient Clinical Response|4
361864|NCT00396097|1165962|P1|Overall Study|Insufficient Clinical Response|1
361865|NCT00396097|1165961|P2|Overall Study|Adverse Event|5
361866|NCT00396097|1165962|P1|Overall Study|Adverse Event|1
361867|NCT00396097|1165961|P2|Overall Study|Protocol Violation|6
361868|NCT00396097|1165962|P1|Overall Study|Protocol Violation|0
361869|NCT00396097|1165961|P2|Overall Study|Not specified|5
361870|NCT00396097|1165962|P1|Overall Study|Not specified|3
361871|NCT00396097|1165961|P2|Overall Study|Lost to Follow-up|9
361872|NCT00396097|1165962|P1|Overall Study|Lost to Follow-up|4
361873|NCT00396097|1165961|P2|Overall Study|Withdrawal by Subject|17
361874|NCT00396097|1165962|P1|Overall Study|Withdrawal by Subject|17
361875|NCT00396084|1165990|P6|Overall Study|Withdrawal by Subject|0
361876|NCT00396084|1165991|P5|Overall Study|Withdrawal by Subject|0
361877|NCT00396084|1165992|P4|Overall Study|Withdrawal by Subject|1
361878|NCT00396084|1165993|P3|Overall Study|Withdrawal by Subject|0
361879|NCT00396084|1165994|P2|Overall Study|Withdrawal by Subject|0
361880|NCT00396084|1165995|P1|Overall Study|Withdrawal by Subject|0
361881|NCT00396084|1165990|P6|Overall Study|Adverse Event|2
361882|NCT00396084|1165991|P5|Overall Study|Adverse Event|1
361883|NCT00396084|1165992|P4|Overall Study|Adverse Event|0
361884|NCT00396084|1165993|P3|Overall Study|Adverse Event|0
361885|NCT00396084|1165994|P2|Overall Study|Adverse Event|0
361886|NCT00396084|1165995|P1|Overall Study|Adverse Event|0
361887|NCT00395967|1166109|P1|Follow-up Period|Lost to Follow-up|1
361888|NCT00395967|1166109|P1|Follow-up Period|Death|1
361889|NCT00395967|1166109|P1|Treatment Period|Failed Mobilization|1
361890|NCT00395863|1166149|P2|Overall Study|Patients did not complete both exams|3
361891|NCT00395863|1166150|P1|Overall Study|Patients did not complete both exams|2
361892|NCT00395850|1166185|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
361893|NCT00395850|1166186|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
361894|NCT00395850|1166187|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
361895|NCT00395850|1166188|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
361896|NCT00395850|1166185|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
361897|NCT00395850|1166186|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
361898|NCT00395850|1166187|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
361899|NCT00395850|1166188|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
361900|NCT00395850|1166185|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
361901|NCT00395850|1166186|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
361902|NCT00395850|1166187|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
361903|NCT00395850|1166188|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
361904|NCT00395850|1166185|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
361905|NCT00395850|1166186|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
361906|NCT00395850|1166187|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
361907|NCT00395850|1166188|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
361908|NCT00395850|1166185|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
361909|NCT00395850|1166186|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
361910|NCT00395850|1166187|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
361911|NCT00395850|1166188|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
361912|NCT00395850|1166185|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
361913|NCT00395850|1166186|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
361914|NCT00395850|1166187|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
361915|NCT00395850|1166188|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
361916|NCT00395850|1166185|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
361917|NCT00395850|1166186|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
361918|NCT00395850|1166187|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
361919|NCT00395850|1166188|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
361920|NCT00395746|1166205|P3|Overall Study|Unable to visit site on schedule|0
361921|NCT00395746|1166206|P2|Overall Study|Unable to visit site on schedule|0
361922|NCT00395746|1166207|P1|Overall Study|Unable to visit site on schedule|1
361923|NCT00395746|1166205|P3|Overall Study|Difficultulty in use of device|1
361924|NCT00395746|1166206|P2|Overall Study|Difficultulty in use of device|0
361925|NCT00395746|1166207|P1|Overall Study|Difficultulty in use of device|0
361926|NCT00395746|1166205|P3|Overall Study|Withdrawal of consent|1
361927|NCT00395746|1166206|P2|Overall Study|Withdrawal of consent|0
361928|NCT00395746|1166207|P1|Overall Study|Withdrawal of consent|0
361929|NCT00395746|1166205|P3|Overall Study|Subject decision|1
361930|NCT00395746|1166206|P2|Overall Study|Subject decision|0
361931|NCT00395746|1166207|P1|Overall Study|Subject decision|0
361932|NCT00395746|1166205|P3|Overall Study|Hypoglycaemia|0
361933|NCT00395746|1166206|P2|Overall Study|Hypoglycaemia|1
361934|NCT00395746|1166207|P1|Overall Study|Hypoglycaemia|2
361935|NCT00395746|1166205|P3|Overall Study|Lack of Efficacy|17
361936|NCT00395746|1166206|P2|Overall Study|Lack of Efficacy|0
361937|NCT00395746|1166207|P1|Overall Study|Lack of Efficacy|2
361938|NCT00395746|1166205|P3|Overall Study|Protocol Violation|0
361939|NCT00395746|1166206|P2|Overall Study|Protocol Violation|1
361940|NCT00395746|1166207|P1|Overall Study|Protocol Violation|0
361941|NCT00395746|1166205|P3|Overall Study|Adverse Event|2
361942|NCT00395746|1166206|P2|Overall Study|Adverse Event|2
361943|NCT00395746|1166207|P1|Overall Study|Adverse Event|5
361944|NCT00395733|1166253|P2|Period 2|Technical problems|0
361945|NCT00395733|1166254|P1|Period 2|Technical problems|1
361946|NCT00395733|1166253|P2|Period 2|Adverse Event|2
361947|NCT00395733|1166254|P1|Period 2|Adverse Event|0
361948|NCT00395733|1166253|P2|Period 2|Protocol Violation|1
361949|NCT00395733|1166254|P1|Period 2|Protocol Violation|0
361950|NCT00395733|1166253|P2|Period 2|Withdrawal by Subject|2
361951|NCT00395733|1166254|P1|Period 2|Withdrawal by Subject|1
361952|NCT00395694|1166278|P2|Continuation Phase|Withdrawal by Subject|2
361953|NCT00395694|1166279|P1|Continuation Phase|Withdrawal by Subject|0
361954|NCT00395694|1166278|P2|Continuation Phase|Poor Compliance|0
361955|NCT00395694|1166279|P1|Continuation Phase|Poor Compliance|1
361956|NCT00395694|1166278|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
361957|NCT00395694|1166279|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
361958|NCT00395694|1166278|P2|Continuation Phase|Lack of Efficacy|11
361959|NCT00395694|1166279|P1|Continuation Phase|Lack of Efficacy|12
361960|NCT00395694|1166278|P2|Continuation Phase|Adverse Event|0
361961|NCT00395694|1166279|P1|Continuation Phase|Adverse Event|1
361962|NCT00395694|1166278|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
361963|NCT00395694|1166279|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
361964|NCT00395642|1166310|P1|Overall Study|Withdrawal by Subject|1
361965|NCT00395642|1166310|P1|Overall Study|Physician Decision|7
361966|NCT00395642|1166310|P1|Overall Study|Lost to Follow-up|1
361967|NCT00395642|1166310|P1|Overall Study|Death|4
361968|NCT00395629|1166317|P3|Extension Study|Administrative problems|1
361969|NCT00395629|1166318|P2|Extension Study|Administrative problems|0
361970|NCT00395629|1166319|P1|Extension Study|Administrative problems|0
361971|NCT00395629|1166317|P3|Extension Study|Adverse Event|2
361972|NCT00395629|1166318|P2|Extension Study|Adverse Event|0
361973|NCT00395629|1166319|P1|Extension Study|Adverse Event|0
361974|NCT00395629|1166317|P3|Core Study|Lost to Follow-up|1
361975|NCT00395629|1166318|P2|Core Study|Lost to Follow-up|0
361976|NCT00395629|1166319|P1|Core Study|Lost to Follow-up|0
361977|NCT00395629|1166317|P3|Core Study|Withdrawal by Subject|1
361978|NCT00395629|1166318|P2|Core Study|Withdrawal by Subject|1
361979|NCT00395629|1166319|P1|Core Study|Withdrawal by Subject|0
361980|NCT00395629|1166317|P3|Core Study|Protocol Violation|0
361981|NCT00395629|1166318|P2|Core Study|Protocol Violation|0
361982|NCT00395629|1166319|P1|Core Study|Protocol Violation|1
361983|NCT00395629|1166317|P3|Core Study|Abnormal laboratory value(s)|1
361984|NCT00395629|1166318|P2|Core Study|Abnormal laboratory value(s)|0
361985|NCT00395629|1166319|P1|Core Study|Abnormal laboratory value(s)|0
361986|NCT00395629|1166317|P3|Core Study|Adverse Event|4
361987|NCT00395629|1166318|P2|Core Study|Adverse Event|3
361988|NCT00395629|1166319|P1|Core Study|Adverse Event|0
361989|NCT00395512|1166337|P4|Overall Study|Hyperglycemic Rescue|6
361990|NCT00395512|1166338|P3|Overall Study|Hyperglycemic Rescue|4
361991|NCT00395512|1166339|P2|Overall Study|Hyperglycemic Rescue|10
361992|NCT00395512|1166340|P1|Overall Study|Hyperglycemic Rescue|18
361993|NCT00395512|1166337|P4|Overall Study|Other|0
361994|NCT00395512|1166338|P3|Overall Study|Other|0
361995|NCT00395512|1166339|P2|Overall Study|Other|1
361996|NCT00395512|1166340|P1|Overall Study|Other|1
361997|NCT00395512|1166337|P4|Overall Study|Physician Decision|2
361998|NCT00395512|1166338|P3|Overall Study|Physician Decision|2
361999|NCT00395512|1166339|P2|Overall Study|Physician Decision|4
362000|NCT00395512|1166340|P1|Overall Study|Physician Decision|6
362001|NCT00395512|1166337|P4|Overall Study|Withdrawal by Subject|12
362002|NCT00395512|1166338|P3|Overall Study|Withdrawal by Subject|5
362003|NCT00395512|1166339|P2|Overall Study|Withdrawal by Subject|5
362004|NCT00395512|1166340|P1|Overall Study|Withdrawal by Subject|6
362005|NCT00395512|1166337|P4|Overall Study|Lost to Follow-up|5
362006|NCT00395512|1166338|P3|Overall Study|Lost to Follow-up|5
362007|NCT00395512|1166339|P2|Overall Study|Lost to Follow-up|6
362008|NCT00395512|1166340|P1|Overall Study|Lost to Follow-up|2
362009|NCT00395512|1166337|P4|Overall Study|Protocol Violation|7
362010|NCT00395512|1166338|P3|Overall Study|Protocol Violation|6
362011|NCT00395512|1166339|P2|Overall Study|Protocol Violation|3
362012|NCT00395512|1166340|P1|Overall Study|Protocol Violation|2
362013|NCT00395512|1166337|P4|Overall Study|Adverse Event|6
362014|NCT00395512|1166338|P3|Overall Study|Adverse Event|6
362015|NCT00395512|1166339|P2|Overall Study|Adverse Event|8
362016|NCT00395512|1166340|P1|Overall Study|Adverse Event|3
362017|NCT00395486|1166512|P2|Overall Study|Lost to Follow-up|1
362018|NCT00395486|1166513|P1|Overall Study|Lost to Follow-up|0
362019|NCT00395486|1166512|P2|Overall Study|Withdrawal by Subject|2
362020|NCT00395486|1166513|P1|Overall Study|Withdrawal by Subject|5
362021|NCT00395486|1166512|P2|Overall Study|Adverse Event|2
362022|NCT00395486|1166513|P1|Overall Study|Adverse Event|1
362023|NCT00395460|1166543|P2|Overall Study|Withdrawal by Subject|0
362024|NCT00395460|1166544|P1|Overall Study|Withdrawal by Subject|1
362025|NCT00395447|1166568|P2|Overall Study|Withdrawl - Other (not subject)|17
362026|NCT00395447|1166569|P1|Overall Study|Withdrawl - Other (not subject)|8
362027|NCT00395447|1166568|P2|Overall Study|Withdrawal by Subject|19
362028|NCT00395447|1166569|P1|Overall Study|Withdrawal by Subject|24
362029|NCT00395447|1166568|P2|Overall Study|Lost to Follow-up|43
362030|NCT00395447|1166569|P1|Overall Study|Lost to Follow-up|52
362031|NCT00395447|1166568|P2|Overall Study|Death|32
362032|NCT00395447|1166569|P1|Overall Study|Death|37
362033|NCT00395343|1166577|P2|Overall Study|Unspecified|2
362034|NCT00395343|1166578|P1|Overall Study|Unspecified|5
362035|NCT00395343|1166577|P2|Overall Study|Withdrawal by Subject|12
362036|NCT00395343|1166578|P1|Overall Study|Withdrawal by Subject|11
362037|NCT00395343|1166577|P2|Overall Study|Protocol Violation|8
362038|NCT00395343|1166578|P1|Overall Study|Protocol Violation|6
362039|NCT00395343|1166577|P2|Overall Study|Physician Decision|4
362040|NCT00395343|1166578|P1|Overall Study|Physician Decision|2
362041|NCT00395343|1166577|P2|Overall Study|Lost to Follow-up|4
362042|NCT00395343|1166578|P1|Overall Study|Lost to Follow-up|4
362043|NCT00395343|1166577|P2|Overall Study|Lack of Efficacy|1
362044|NCT00395343|1166578|P1|Overall Study|Lack of Efficacy|0
362045|NCT00395343|1166577|P2|Overall Study|Adverse Event|5
362046|NCT00395343|1166578|P1|Overall Study|Adverse Event|13
362047|NCT00395304|1166596|P6|Treatment Period 3|Other|0
362048|NCT00395304|1166597|P5|Treatment Period 3|Other|0
362049|NCT00395304|1166598|P4|Treatment Period 3|Other|1
362050|NCT00395304|1166599|P3|Treatment Period 3|Other|0
362051|NCT00395304|1166600|P2|Treatment Period 3|Other|0
362052|NCT00395304|1166601|P1|Treatment Period 3|Other|0
362053|NCT00395304|1166596|P6|Treatment Period 3|Physician Decision|0
362054|NCT00395304|1166597|P5|Treatment Period 3|Physician Decision|0
362055|NCT00395304|1166598|P4|Treatment Period 3|Physician Decision|0
362056|NCT00395304|1166599|P3|Treatment Period 3|Physician Decision|0
362057|NCT00395304|1166600|P2|Treatment Period 3|Physician Decision|1
362058|NCT00395304|1166601|P1|Treatment Period 3|Physician Decision|0
362059|NCT00395304|1166596|P6|Treatment Period 3|Lost to Follow-up|0
362060|NCT00395304|1166597|P5|Treatment Period 3|Lost to Follow-up|0
362061|NCT00395304|1166598|P4|Treatment Period 3|Lost to Follow-up|0
362062|NCT00395304|1166599|P3|Treatment Period 3|Lost to Follow-up|0
362063|NCT00395304|1166600|P2|Treatment Period 3|Lost to Follow-up|1
362064|NCT00395304|1166601|P1|Treatment Period 3|Lost to Follow-up|1
362065|NCT00395304|1166596|P6|Treatment Period 3|Withdrawal by Subject|1
362066|NCT00395304|1166597|P5|Treatment Period 3|Withdrawal by Subject|0
362067|NCT00395304|1166598|P4|Treatment Period 3|Withdrawal by Subject|1
362068|NCT00395304|1166599|P3|Treatment Period 3|Withdrawal by Subject|0
362069|NCT00395304|1166600|P2|Treatment Period 3|Withdrawal by Subject|0
362070|NCT00395304|1166601|P1|Treatment Period 3|Withdrawal by Subject|0
362071|NCT00395304|1166596|P6|Treatment Period 2|Other|0
362072|NCT00395304|1166597|P5|Treatment Period 2|Other|0
362073|NCT00395304|1166598|P4|Treatment Period 2|Other|0
362074|NCT00395304|1166599|P3|Treatment Period 2|Other|0
362075|NCT00395304|1166600|P2|Treatment Period 2|Other|1
362076|NCT00395304|1166601|P1|Treatment Period 2|Other|0
362077|NCT00395304|1166596|P6|Treatment Period 2|Physician Decision|0
362078|NCT00395304|1166597|P5|Treatment Period 2|Physician Decision|0
362079|NCT00395304|1166598|P4|Treatment Period 2|Physician Decision|0
362080|NCT00395304|1166599|P3|Treatment Period 2|Physician Decision|1
362081|NCT00395304|1166600|P2|Treatment Period 2|Physician Decision|0
362082|NCT00395304|1166601|P1|Treatment Period 2|Physician Decision|0
362083|NCT00395304|1166596|P6|Treatment Period 2|Lost to Follow-up|0
362084|NCT00395304|1166597|P5|Treatment Period 2|Lost to Follow-up|0
362085|NCT00395304|1166598|P4|Treatment Period 2|Lost to Follow-up|0
362086|NCT00395304|1166599|P3|Treatment Period 2|Lost to Follow-up|0
362087|NCT00395304|1166600|P2|Treatment Period 2|Lost to Follow-up|3
362088|NCT00395304|1166601|P1|Treatment Period 2|Lost to Follow-up|0
362089|NCT00395304|1166596|P6|Treatment Period 2|Withdrawal by Subject|2
362090|NCT00395304|1166597|P5|Treatment Period 2|Withdrawal by Subject|0
362091|NCT00395304|1166598|P4|Treatment Period 2|Withdrawal by Subject|1
362092|NCT00395304|1166599|P3|Treatment Period 2|Withdrawal by Subject|0
362093|NCT00395304|1166600|P2|Treatment Period 2|Withdrawal by Subject|0
362094|NCT00395304|1166601|P1|Treatment Period 2|Withdrawal by Subject|0
362095|NCT00395304|1166596|P6|Treatment Period 1|Physician Decision|0
362096|NCT00395304|1166597|P5|Treatment Period 1|Physician Decision|0
362097|NCT00395304|1166598|P4|Treatment Period 1|Physician Decision|0
362098|NCT00395304|1166599|P3|Treatment Period 1|Physician Decision|0
362099|NCT00395304|1166600|P2|Treatment Period 1|Physician Decision|1
362100|NCT00395304|1166601|P1|Treatment Period 1|Physician Decision|0
362101|NCT00395304|1166596|P6|Treatment Period 1|Lost to Follow-up|1
362102|NCT00395304|1166597|P5|Treatment Period 1|Lost to Follow-up|0
362103|NCT00395304|1166598|P4|Treatment Period 1|Lost to Follow-up|1
362104|NCT00395304|1166599|P3|Treatment Period 1|Lost to Follow-up|0
362105|NCT00395304|1166600|P2|Treatment Period 1|Lost to Follow-up|0
362106|NCT00395304|1166601|P1|Treatment Period 1|Lost to Follow-up|1
362107|NCT00395304|1166596|P6|Treatment Period 1|Withdrawal by Subject|1
362108|NCT00395304|1166597|P5|Treatment Period 1|Withdrawal by Subject|1
362109|NCT00395304|1166598|P4|Treatment Period 1|Withdrawal by Subject|2
362110|NCT00395304|1166599|P3|Treatment Period 1|Withdrawal by Subject|0
362111|NCT00395304|1166600|P2|Treatment Period 1|Withdrawal by Subject|3
362112|NCT00395304|1166601|P1|Treatment Period 1|Withdrawal by Subject|0
362113|NCT00395226|1166638|P2|Overall Study|Lost to Follow-up|1
362114|NCT00395226|1166639|P1|Overall Study|Lost to Follow-up|0
362115|NCT00395226|1166638|P2|Overall Study|Withdrawal by Subject|1
362116|NCT00395226|1166639|P1|Overall Study|Withdrawal by Subject|0
362117|NCT00395226|1166638|P2|Overall Study|Adverse Event|3
362118|NCT00395226|1166639|P1|Overall Study|Adverse Event|4
362119|NCT00395083|1166686|P2|Overall Study|Developed another disease|3
362120|NCT00395083|1166687|P1|Overall Study|Developed another disease|4
362121|NCT00395083|1166686|P2|Overall Study|Withdrawal by Subject|5
362122|NCT00395083|1166687|P1|Overall Study|Withdrawal by Subject|6
362123|NCT00395018|1166753|P1|Off-Treatment Follow-up|Poor/non-compliance|1
362124|NCT00395018|1166753|P1|Off-Treatment Follow-up|Lost to Follow-up|2
362125|NCT00395018|1166753|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
362126|NCT00395018|1166753|P1|On-Treatment|Subject no longer meets study criteria|2
362127|NCT00395018|1166753|P1|On-Treatment|Poor/non-compliance|2
362128|NCT00395018|1166753|P1|On-Treatment|Other Reason|2
362129|NCT00395018|1166753|P1|On-Treatment|Death|4
362130|NCT00394953|1166774|P2|Second Treatment Period|Not defined|8
362131|NCT00394953|1166775|P1|Second Treatment Period|Not defined|3
362132|NCT00394953|1166774|P2|Second Treatment Period|Renal transplant|6
362133|NCT00394953|1166775|P1|Second Treatment Period|Renal transplant|4
362134|NCT00394953|1166774|P2|Second Treatment Period|Lost to Follow-up|1
362135|NCT00394953|1166775|P1|Second Treatment Period|Lost to Follow-up|0
362136|NCT00394953|1166774|P2|Second Treatment Period|Withdrawal by Subject|3
362137|NCT00394953|1166775|P1|Second Treatment Period|Withdrawal by Subject|3
362138|NCT00394953|1166774|P2|Second Treatment Period|Lack of Efficacy|47
362139|NCT00394953|1166775|P1|Second Treatment Period|Lack of Efficacy|9
362140|NCT00394953|1166774|P2|Second Treatment Period|Death|4
362141|NCT00394953|1166775|P1|Second Treatment Period|Death|8
362142|NCT00394953|1166774|P2|Second Treatment Period|Adverse Event|5
362143|NCT00394953|1166775|P1|Second Treatment Period|Adverse Event|2
362144|NCT00394953|1166774|P2|First Treatment Period|Not defined|1
362145|NCT00394953|1166775|P1|First Treatment Period|Not defined|4
362146|NCT00394953|1166774|P2|First Treatment Period|Renal transplant|7
362147|NCT00394953|1166775|P1|First Treatment Period|Renal transplant|11
362148|NCT00394953|1166774|P2|First Treatment Period|Lost to Follow-up|1
362149|NCT00394953|1166775|P1|First Treatment Period|Lost to Follow-up|0
362150|NCT00394953|1166774|P2|First Treatment Period|Withdrawal by Subject|3
362151|NCT00394953|1166775|P1|First Treatment Period|Withdrawal by Subject|6
362152|NCT00394953|1166774|P2|First Treatment Period|Lack of Efficacy|1
362153|NCT00394953|1166775|P1|First Treatment Period|Lack of Efficacy|1
362154|NCT00394953|1166774|P2|First Treatment Period|Death|7
362155|NCT00394953|1166775|P1|First Treatment Period|Death|6
362156|NCT00394953|1166774|P2|First Treatment Period|Adverse Event|2
362157|NCT00394953|1166775|P1|First Treatment Period|Adverse Event|1
362158|NCT00394914|1166793|P3|Treatment Period|Did not meet protocol eligibility|1
362159|NCT00394914|1166794|P2|Treatment Period|Did not meet protocol eligibility|1
362160|NCT00394914|1166795|P1|Treatment Period|Did not meet protocol eligibility|0
362161|NCT00394914|1166793|P3|Treatment Period|Noncompliance with protocol|2
362162|NCT00394914|1166794|P2|Treatment Period|Noncompliance with protocol|3
362163|NCT00394914|1166795|P1|Treatment Period|Noncompliance with protocol|0
362164|NCT00394914|1166793|P3|Treatment Period|Withdrawal by Subject|2
362165|NCT00394914|1166794|P2|Treatment Period|Withdrawal by Subject|2
362166|NCT00394914|1166795|P1|Treatment Period|Withdrawal by Subject|0
362167|NCT00394914|1166793|P3|Treatment Period|Lost to Follow-up|0
362168|NCT00394914|1166794|P2|Treatment Period|Lost to Follow-up|1
362169|NCT00394914|1166795|P1|Treatment Period|Lost to Follow-up|0
362170|NCT00394914|1166793|P3|Treatment Period|Adverse Event|1
362171|NCT00394914|1166794|P2|Treatment Period|Adverse Event|3
362172|NCT00394914|1166795|P1|Treatment Period|Adverse Event|0
362173|NCT00394901|1166823|P4|Double-blind Phase|Found not to meet entrance criteria|1
362174|NCT00394901|1166824|P3|Double-blind Phase|Found not to meet entrance criteria|0
362175|NCT00394901|1166825|P2|Double-blind Phase|Found not to meet entrance criteria|0
362176|NCT00394901|1166826|P1|Double-blind Phase|Found not to meet entrance criteria|0
362177|NCT00394901|1166823|P4|Double-blind Phase|Entry into another study was found|0
362178|NCT00394901|1166824|P3|Double-blind Phase|Entry into another study was found|1
362179|NCT00394901|1166825|P2|Double-blind Phase|Entry into another study was found|0
362180|NCT00394901|1166826|P1|Double-blind Phase|Entry into another study was found|0
362181|NCT00394901|1166823|P4|Double-blind Phase|Lack of Compliance|0
362182|NCT00394901|1166824|P3|Double-blind Phase|Lack of Compliance|0
362183|NCT00394901|1166825|P2|Double-blind Phase|Lack of Compliance|3
362184|NCT00394901|1166826|P1|Double-blind Phase|Lack of Compliance|0
362185|NCT00394901|1166823|P4|Double-blind Phase|Subject's Personal Reason|1
362186|NCT00394901|1166824|P3|Double-blind Phase|Subject's Personal Reason|0
362187|NCT00394901|1166825|P2|Double-blind Phase|Subject's Personal Reason|0
362188|NCT00394901|1166826|P1|Double-blind Phase|Subject's Personal Reason|1
362189|NCT00394901|1166823|P4|Double-blind Phase|Death|0
362190|NCT00394901|1166824|P3|Double-blind Phase|Death|0
362191|NCT00394901|1166825|P2|Double-blind Phase|Death|0
362192|NCT00394901|1166826|P1|Double-blind Phase|Death|1
362193|NCT00394901|1166823|P4|Double-blind Phase|Protocol Violation|1
362194|NCT00394901|1166824|P3|Double-blind Phase|Protocol Violation|0
362195|NCT00394901|1166825|P2|Double-blind Phase|Protocol Violation|0
362196|NCT00394901|1166826|P1|Double-blind Phase|Protocol Violation|0
362197|NCT00394901|1166823|P4|Double-blind Phase|Lost to Follow-up|1
362198|NCT00394901|1166824|P3|Double-blind Phase|Lost to Follow-up|0
362199|NCT00394901|1166825|P2|Double-blind Phase|Lost to Follow-up|0
362200|NCT00394901|1166826|P1|Double-blind Phase|Lost to Follow-up|0
362201|NCT00394901|1166823|P4|Double-blind Phase|Withdrawal by Subject|0
362202|NCT00394901|1166824|P3|Double-blind Phase|Withdrawal by Subject|0
362203|NCT00394901|1166825|P2|Double-blind Phase|Withdrawal by Subject|0
362204|NCT00394901|1166826|P1|Double-blind Phase|Withdrawal by Subject|2
362205|NCT00394901|1166823|P4|Double-blind Phase|Lack of Efficacy|3
362206|NCT00394901|1166824|P3|Double-blind Phase|Lack of Efficacy|1
362207|NCT00394901|1166825|P2|Double-blind Phase|Lack of Efficacy|4
362208|NCT00394901|1166826|P1|Double-blind Phase|Lack of Efficacy|6
362209|NCT00394901|1166823|P4|Double-blind Phase|Adverse Event|20
362210|NCT00394901|1166824|P3|Double-blind Phase|Adverse Event|16
362211|NCT00394901|1166825|P2|Double-blind Phase|Adverse Event|7
362212|NCT00394901|1166826|P1|Double-blind Phase|Adverse Event|5
362213|NCT00394901|1166823|P4|Baseline Phase|Protocol Violation|0
362214|NCT00394901|1166824|P3|Baseline Phase|Protocol Violation|1
362215|NCT00394901|1166825|P2|Baseline Phase|Protocol Violation|0
362216|NCT00394901|1166826|P1|Baseline Phase|Protocol Violation|0
362217|NCT00394836|1167069|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
362218|NCT00394836|1167070|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
362302|NCT00394589|1167283|P2|Overall Study|Adverse Event|1
362219|NCT00394836|1167069|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
362220|NCT00394836|1167070|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
362221|NCT00394836|1167069|P2|Extended Follow-up Phase (2-5 Years)|Death|1
362222|NCT00394836|1167070|P1|Extended Follow-up Phase (2-5 Years)|Death|0
362223|NCT00394836|1167069|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
362224|NCT00394836|1167070|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
362225|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Non compliance|1
362226|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Non compliance|0
362227|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
362228|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
362229|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Physician Decision|1
362230|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Physician Decision|0
362231|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
362232|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
362233|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Started alternative treatment|6
362234|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Started alternative treatment|0
362235|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
362236|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
362237|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Death|1
362238|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Death|0
362239|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Patient Refusal|2
362240|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Patient Refusal|1
362241|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Disease Progression|60
362242|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Disease Progression|27
362243|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Protocol Violation|2
362244|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Protocol Violation|0
362245|NCT00394836|1167069|P2|Teatment or Follow-up Phase|Adverse Event|2
362246|NCT00394836|1167070|P1|Teatment or Follow-up Phase|Adverse Event|0
362247|NCT00394771|1167116|P4|Overall Study|Not specified|0
362248|NCT00394771|1167117|P3|Overall Study|Not specified|1
362249|NCT00394771|1167118|P2|Overall Study|Not specified|3
362250|NCT00394771|1167119|P1|Overall Study|Not specified|3
362251|NCT00394771|1167116|P4|Overall Study|Lost to Follow-up|10
362252|NCT00394771|1167117|P3|Overall Study|Lost to Follow-up|13
362253|NCT00394771|1167118|P2|Overall Study|Lost to Follow-up|15
362254|NCT00394771|1167119|P1|Overall Study|Lost to Follow-up|15
362255|NCT00394771|1167116|P4|Overall Study|Participant pregnant|2
362256|NCT00394771|1167117|P3|Overall Study|Participant pregnant|2
362257|NCT00394771|1167118|P2|Overall Study|Participant pregnant|1
362258|NCT00394771|1167119|P1|Overall Study|Participant pregnant|0
362259|NCT00394771|1167116|P4|Overall Study|Adverse Event|8
362260|NCT00394771|1167117|P3|Overall Study|Adverse Event|12
362261|NCT00394771|1167118|P2|Overall Study|Adverse Event|5
362262|NCT00394771|1167119|P1|Overall Study|Adverse Event|10
362263|NCT00394771|1167116|P4|Overall Study|Withdrawal by Subject|12
362264|NCT00394771|1167117|P3|Overall Study|Withdrawal by Subject|8
362265|NCT00394771|1167118|P2|Overall Study|Withdrawal by Subject|6
362266|NCT00394771|1167119|P1|Overall Study|Withdrawal by Subject|10
362267|NCT00394771|1167116|P4|Overall Study|Protocol Violation|7
362268|NCT00394771|1167117|P3|Overall Study|Protocol Violation|9
362269|NCT00394771|1167118|P2|Overall Study|Protocol Violation|4
362270|NCT00394771|1167119|P1|Overall Study|Protocol Violation|2
362271|NCT00394771|1167116|P4|Overall Study|Did not meet protocol requirements|0
362272|NCT00394771|1167117|P3|Overall Study|Did not meet protocol requirements|2
362273|NCT00394771|1167118|P2|Overall Study|Did not meet protocol requirements|0
362274|NCT00394771|1167119|P1|Overall Study|Did not meet protocol requirements|1
362275|NCT00394706|1167189|P8|Overall Study|Lost to Follow-up|0
362276|NCT00394706|1167190|P7|Overall Study|Lost to Follow-up|2
362277|NCT00394706|1167191|P6|Overall Study|Lost to Follow-up|5
362278|NCT00394706|1167192|P5|Overall Study|Lost to Follow-up|2
362279|NCT00394706|1167193|P4|Overall Study|Lost to Follow-up|1
362280|NCT00394706|1167194|P3|Overall Study|Lost to Follow-up|8
362281|NCT00394706|1167195|P2|Overall Study|Lost to Follow-up|2
362282|NCT00394706|1167196|P1|Overall Study|Lost to Follow-up|2
362283|NCT00394706|1167189|P8|Overall Study|Withdrawal by Subject|0
362284|NCT00394706|1167190|P7|Overall Study|Withdrawal by Subject|1
362285|NCT00394706|1167191|P6|Overall Study|Withdrawal by Subject|2
362286|NCT00394706|1167192|P5|Overall Study|Withdrawal by Subject|0
362287|NCT00394706|1167193|P4|Overall Study|Withdrawal by Subject|0
362288|NCT00394706|1167194|P3|Overall Study|Withdrawal by Subject|1
362289|NCT00394706|1167195|P2|Overall Study|Withdrawal by Subject|0
362290|NCT00394706|1167196|P1|Overall Study|Withdrawal by Subject|2
362291|NCT00394654|1167216|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
362292|NCT00394654|1167217|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
362293|NCT00394654|1167216|P2|Overall Study|Lost to Follow-up|0
362294|NCT00394654|1167217|P1|Overall Study|Lost to Follow-up|1
362295|NCT00394589|1167282|P3|Overall Study|Protocol Violation|2
362296|NCT00394589|1167283|P2|Overall Study|Protocol Violation|0
362297|NCT00394589|1167284|P1|Overall Study|Protocol Violation|4
362298|NCT00394589|1167282|P3|Overall Study|Lack of Efficacy|3
362299|NCT00394589|1167283|P2|Overall Study|Lack of Efficacy|2
362300|NCT00394589|1167284|P1|Overall Study|Lack of Efficacy|2
362301|NCT00394589|1167282|P3|Overall Study|Adverse Event|2
362303|NCT00394589|1167284|P1|Overall Study|Adverse Event|2
362304|NCT00394524|1167294|P2|Overall Study|Withdrawal by Subject|10
362305|NCT00394524|1167295|P1|Overall Study|Withdrawal by Subject|11
362306|NCT00394472|1167307|P2|Overall Study|Lost to Follow-up|1
362307|NCT00394472|1167308|P1|Overall Study|Lost to Follow-up|0
362308|NCT00394472|1167307|P2|Overall Study|Physician Decision|1
362309|NCT00394472|1167308|P1|Overall Study|Physician Decision|0
362310|NCT00394472|1167307|P2|Overall Study|Withdrawal by Subject|2
362311|NCT00394472|1167308|P1|Overall Study|Withdrawal by Subject|0
362312|NCT00394472|1167307|P2|Overall Study|Adverse Event|2
362313|NCT00394472|1167308|P1|Overall Study|Adverse Event|4
362314|NCT00394472|1167307|P2|Overall Study|incorrect enrolment|2
362315|NCT00394472|1167308|P1|Overall Study|incorrect enrolment|4
362316|NCT00394472|1167307|P2|Overall Study|Protocol Violation|3
362317|NCT00394472|1167308|P1|Overall Study|Protocol Violation|1
362318|NCT00394433|1167316|P1|Overall Study|Alternative Therapy|1
362319|NCT00394433|1167316|P1|Overall Study|Adverse Event|2
362320|NCT00394355|1167327|P4|Overall Study|Lack of Efficacy|3
362321|NCT00394355|1167328|P3|Overall Study|Lack of Efficacy|2
362322|NCT00394355|1167329|P2|Overall Study|Lack of Efficacy|0
362323|NCT00394355|1167330|P1|Overall Study|Lack of Efficacy|0
362324|NCT00394355|1167327|P4|Overall Study|Administrative|1
362325|NCT00394355|1167328|P3|Overall Study|Administrative|1
362326|NCT00394355|1167329|P2|Overall Study|Administrative|1
362327|NCT00394355|1167330|P1|Overall Study|Administrative|0
362328|NCT00394355|1167327|P4|Overall Study|Noncompliance with protocol|8
362329|NCT00394355|1167328|P3|Overall Study|Noncompliance with protocol|10
362330|NCT00394355|1167329|P2|Overall Study|Noncompliance with protocol|3
362331|NCT00394355|1167330|P1|Overall Study|Noncompliance with protocol|4
362332|NCT00394355|1167327|P4|Overall Study|Lost to Follow-up|3
362333|NCT00394355|1167328|P3|Overall Study|Lost to Follow-up|4
362334|NCT00394355|1167329|P2|Overall Study|Lost to Follow-up|5
362335|NCT00394355|1167330|P1|Overall Study|Lost to Follow-up|7
362336|NCT00394355|1167327|P4|Overall Study|Subject withdrawal - related to drug|0
362337|NCT00394355|1167328|P3|Overall Study|Subject withdrawal - related to drug|0
362338|NCT00394355|1167329|P2|Overall Study|Subject withdrawal - related to drug|0
362339|NCT00394355|1167330|P1|Overall Study|Subject withdrawal - related to drug|1
362340|NCT00394355|1167327|P4|Overall Study|Subject withdrawal - unrelated to drug|6
362341|NCT00394355|1167328|P3|Overall Study|Subject withdrawal - unrelated to drug|10
362342|NCT00394355|1167329|P2|Overall Study|Subject withdrawal - unrelated to drug|14
362343|NCT00394355|1167330|P1|Overall Study|Subject withdrawal - unrelated to drug|12
362344|NCT00394355|1167327|P4|Overall Study|Did not meet protocol eligibility|2
362345|NCT00394355|1167328|P3|Overall Study|Did not meet protocol eligibility|4
362346|NCT00394355|1167329|P2|Overall Study|Did not meet protocol eligibility|5
362347|NCT00394355|1167330|P1|Overall Study|Did not meet protocol eligibility|1
362348|NCT00394355|1167327|P4|Overall Study|Adverse Event|8
362349|NCT00394355|1167328|P3|Overall Study|Adverse Event|7
362350|NCT00394355|1167329|P2|Overall Study|Adverse Event|6
362351|NCT00394355|1167330|P1|Overall Study|Adverse Event|10
362352|NCT00394251|1167400|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
362353|NCT00394251|1167401|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
362354|NCT00394251|1167400|P2|Overall Study|Withdrawal by Subject|11
362355|NCT00394251|1167401|P1|Overall Study|Withdrawal by Subject|7
362356|NCT00394251|1167400|P2|Overall Study|Protocol Violation|1
362357|NCT00394251|1167401|P1|Overall Study|Protocol Violation|0
362358|NCT00394251|1167400|P2|Overall Study|Physician Decision|1
362359|NCT00394251|1167401|P1|Overall Study|Physician Decision|1
362360|NCT00394251|1167400|P2|Overall Study|Unacceptable Toxicity|18
362361|NCT00394251|1167401|P1|Overall Study|Unacceptable Toxicity|20
362362|NCT00394251|1167400|P2|Overall Study|Adverse Event|5
362363|NCT00394251|1167401|P1|Overall Study|Adverse Event|7
362364|NCT00394212|1167429|P2|Overall Study|Withdrawal by Subject|1
362365|NCT00394212|1167430|P1|Overall Study|Withdrawal by Subject|4
362366|NCT00394212|1167429|P2|Overall Study|Lost to Follow-up|0
362367|NCT00394212|1167430|P1|Overall Study|Lost to Follow-up|3
362368|NCT00394095|1167444|P2|Overall Study|Adverse Event|0
362369|NCT00394095|1167445|P1|Overall Study|Adverse Event|1
362370|NCT00394082|1167453|P1|Overall Study|Not specified|1
362371|NCT00394082|1167453|P1|Overall Study|Withdrawal by Subject|2
362372|NCT00394082|1167453|P1|Overall Study|Physician Decision|4
362373|NCT00394082|1167453|P1|Overall Study|Adverse Event|4
362374|NCT00394082|1167453|P1|Overall Study|Unacceptable toxicity|15
362375|NCT00393939|1167464|P2|Overall Study|Not specified|45
362376|NCT00393939|1167465|P1|Overall Study|Not specified|37
362377|NCT00393939|1167464|P2|Overall Study|Withdrawal by Subject|7
362378|NCT00393939|1167465|P1|Overall Study|Withdrawal by Subject|2
362379|NCT00393939|1167464|P2|Overall Study|Objective progression or relapse|223
362380|NCT00393939|1167465|P1|Overall Study|Objective progression or relapse|239
362381|NCT00393939|1167464|P2|Overall Study|Sponsor|13
362382|NCT00393939|1167465|P1|Overall Study|Sponsor|5
362383|NCT00393939|1167464|P2|Overall Study|Death|4
362384|NCT00393939|1167465|P1|Overall Study|Death|10
362385|NCT00393939|1167464|P2|Overall Study|Lost to Follow-up|4
362386|NCT00393939|1167465|P1|Overall Study|Lost to Follow-up|2
362387|NCT00393939|1167464|P2|Overall Study|Protocol Violation|1
362388|NCT00393939|1167465|P1|Overall Study|Protocol Violation|1
362389|NCT00393913|1167483|P1|CPAP|TEchnical problem with CPAP|3
362390|NCT00393913|1167483|P1|CPAP|Physician Decision|1
362391|NCT00393913|1167483|P1|CPAP|Withdrawal by Subject|3
362392|NCT00393913|1167483|P1|Initial Assessment|Withdrawal by Subject|16
362393|NCT00393913|1167483|P1|Initial Assessment|diagnosed with other sleep disorder|21
362394|NCT00393887|1167491|P2|Overall Study|Lost to Follow-up|9
362395|NCT00393887|1167492|P1|Overall Study|Lost to Follow-up|11
362396|NCT00393887|1167491|P2|Overall Study|Physician Decision|0
362397|NCT00393887|1167492|P1|Overall Study|Physician Decision|5
362398|NCT00393861|1167520|P1|Overall Study|Disease Progression|24
362399|NCT00393861|1167520|P1|Overall Study|Adverse Event|2
362400|NCT00393848|1167531|P4|Overall Study|Personal reasons|0
362401|NCT00393848|1167532|P3|Overall Study|Personal reasons|2
362402|NCT00393848|1167533|P2|Overall Study|Personal reasons|0
362403|NCT00393848|1167534|P1|Overall Study|Personal reasons|0
362404|NCT00393848|1167531|P4|Overall Study|Surgical schedule|1
362405|NCT00393848|1167532|P3|Overall Study|Surgical schedule|0
362406|NCT00393848|1167533|P2|Overall Study|Surgical schedule|0
362407|NCT00393848|1167534|P1|Overall Study|Surgical schedule|0
362408|NCT00393718|1167557|P2|Overall Study|Move|0
362409|NCT00393718|1167558|P1|Overall Study|Move|1
362410|NCT00393718|1167557|P2|Overall Study|Missed measurement|0
362411|NCT00393718|1167558|P1|Overall Study|Missed measurement|1
362412|NCT00393718|1167557|P2|Overall Study|Withdrawal of consent|1
362413|NCT00393718|1167558|P1|Overall Study|Withdrawal of consent|2
362414|NCT00393718|1167557|P2|Overall Study|Subject decision|0
362415|NCT00393718|1167558|P1|Overall Study|Subject decision|5
362416|NCT00393718|1167557|P2|Overall Study|Hypoglycaemia|2
362417|NCT00393718|1167558|P1|Overall Study|Hypoglycaemia|3
362418|NCT00393718|1167557|P2|Overall Study|Lack of Efficacy|9
362419|NCT00393718|1167558|P1|Overall Study|Lack of Efficacy|10
362420|NCT00393718|1167557|P2|Overall Study|Protocol Violation|2
362421|NCT00393718|1167558|P1|Overall Study|Protocol Violation|1
362422|NCT00393718|1167557|P2|Overall Study|Adverse Event|8
362423|NCT00393718|1167558|P1|Overall Study|Adverse Event|20
362424|NCT00393705|1167590|P2|Overall Study|Physician Decision|2
362425|NCT00393705|1167591|P1|Overall Study|Physician Decision|2
362426|NCT00393705|1167590|P2|Overall Study|Withdrawal by Subject|3
362427|NCT00393705|1167591|P1|Overall Study|Withdrawal by Subject|5
362428|NCT00393705|1167590|P2|Overall Study|Protocol Violation|3
362429|NCT00393705|1167591|P1|Overall Study|Protocol Violation|4
362430|NCT00393705|1167590|P2|Overall Study|Entry Criteria Not Met|10
362431|NCT00393705|1167591|P1|Overall Study|Entry Criteria Not Met|10
362432|NCT00393705|1167590|P2|Overall Study|Lost to Follow-up|2
362433|NCT00393705|1167591|P1|Overall Study|Lost to Follow-up|2
362434|NCT00393705|1167590|P2|Overall Study|Death|1
362435|NCT00393705|1167591|P1|Overall Study|Death|0
362436|NCT00393705|1167590|P2|Overall Study|Adverse Event|2
362437|NCT00393705|1167591|P1|Overall Study|Adverse Event|0
362438|NCT00393523|1167620|P5|Overall Study|Vaccine supply issue|0
362439|NCT00393523|1167621|P4|Overall Study|Vaccine supply issue|0
362440|NCT00393523|1167622|P3|Overall Study|Vaccine supply issue|1
362441|NCT00393523|1167623|P2|Overall Study|Vaccine supply issue|0
362442|NCT00393523|1167624|P1|Overall Study|Vaccine supply issue|0
362443|NCT00393523|1167620|P5|Overall Study|Difficulties in specimen collection|0
362444|NCT00393523|1167621|P4|Overall Study|Difficulties in specimen collection|0
362445|NCT00393523|1167622|P3|Overall Study|Difficulties in specimen collection|1
362446|NCT00393523|1167623|P2|Overall Study|Difficulties in specimen collection|0
362447|NCT00393523|1167624|P1|Overall Study|Difficulties in specimen collection|0
362448|NCT00393523|1167620|P5|Overall Study|Withdrawal by Subject|0
362449|NCT00393523|1167621|P4|Overall Study|Withdrawal by Subject|3
362450|NCT00393523|1167622|P3|Overall Study|Withdrawal by Subject|2
362451|NCT00393523|1167623|P2|Overall Study|Withdrawal by Subject|7
362452|NCT00393523|1167624|P1|Overall Study|Withdrawal by Subject|6
362453|NCT00393523|1167620|P5|Overall Study|Protocol Violation|0
362454|NCT00393523|1167621|P4|Overall Study|Protocol Violation|1
362455|NCT00393523|1167622|P3|Overall Study|Protocol Violation|0
362456|NCT00393523|1167623|P2|Overall Study|Protocol Violation|2
362457|NCT00393523|1167624|P1|Overall Study|Protocol Violation|6
362458|NCT00393523|1167620|P5|Overall Study|Lost to Follow-up|1
362459|NCT00393523|1167621|P4|Overall Study|Lost to Follow-up|2
362460|NCT00393523|1167622|P3|Overall Study|Lost to Follow-up|0
362461|NCT00393523|1167623|P2|Overall Study|Lost to Follow-up|0
362462|NCT00393523|1167624|P1|Overall Study|Lost to Follow-up|0
362463|NCT00393510|1167641|P2|Overall Study|Physician Decision|9
362464|NCT00393510|1167642|P1|Overall Study|Physician Decision|3
362465|NCT00393484|1167654|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
362466|NCT00393484|1167655|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
362467|NCT00393484|1167654|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
362468|NCT00393484|1167655|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
362469|NCT00393484|1167654|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
362470|NCT00393484|1167655|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
362471|NCT00393484|1167654|P2|Open-label Period (Weeks 96 to 240)|Death|0
362472|NCT00393484|1167655|P1|Open-label Period (Weeks 96 to 240)|Death|1
362473|NCT00393484|1167654|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
362474|NCT00393484|1167655|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
362475|NCT00393484|1167654|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
362476|NCT00393484|1167655|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
362477|NCT00393484|1167654|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
362478|NCT00393484|1167655|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
362479|NCT00393484|1167654|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
362480|NCT00393484|1167655|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
362481|NCT00393484|1167654|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
362482|NCT00393484|1167655|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
362483|NCT00393484|1167654|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
362484|NCT00393484|1167655|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
362485|NCT00393458|1167691|P4|Overall Study|Subject no longer requires study drug|0
362486|NCT00393458|1167692|P3|Overall Study|Subject no longer requires study drug|0
362487|NCT00393458|1167693|P2|Overall Study|Subject no longer requires study drug|1
362488|NCT00393458|1167694|P1|Overall Study|Subject no longer requires study drug|0
362489|NCT00393458|1167691|P4|Overall Study|Abnormal test procedure result(s)|2
362490|NCT00393458|1167692|P3|Overall Study|Abnormal test procedure result(s)|1
362491|NCT00393458|1167693|P2|Overall Study|Abnormal test procedure result(s)|1
362492|NCT00393458|1167694|P1|Overall Study|Abnormal test procedure result(s)|0
362493|NCT00393458|1167691|P4|Overall Study|Death|5
362494|NCT00393458|1167692|P3|Overall Study|Death|5
362495|NCT00393458|1167693|P2|Overall Study|Death|1
362496|NCT00393458|1167694|P1|Overall Study|Death|1
362497|NCT00393458|1167691|P4|Overall Study|Abnormal laboratory value(s)|0
362498|NCT00393458|1167692|P3|Overall Study|Abnormal laboratory value(s)|0
362499|NCT00393458|1167693|P2|Overall Study|Abnormal laboratory value(s)|1
362500|NCT00393458|1167694|P1|Overall Study|Abnormal laboratory value(s)|1
362501|NCT00393458|1167691|P4|Overall Study|Lost to Follow-up|3
362502|NCT00393458|1167692|P3|Overall Study|Lost to Follow-up|5
362503|NCT00393458|1167693|P2|Overall Study|Lost to Follow-up|6
362504|NCT00393458|1167694|P1|Overall Study|Lost to Follow-up|5
362505|NCT00393458|1167691|P4|Overall Study|Administrative problems|2
362506|NCT00393458|1167692|P3|Overall Study|Administrative problems|5
362507|NCT00393458|1167693|P2|Overall Study|Administrative problems|8
362508|NCT00393458|1167694|P1|Overall Study|Administrative problems|7
362509|NCT00393458|1167691|P4|Overall Study|Protocol deviation|10
362510|NCT00393458|1167692|P3|Overall Study|Protocol deviation|11
362511|NCT00393458|1167693|P2|Overall Study|Protocol deviation|11
362512|NCT00393458|1167694|P1|Overall Study|Protocol deviation|11
362513|NCT00393458|1167691|P4|Overall Study|Unsatisfactory therapeutic effect|30
362514|NCT00393458|1167692|P3|Overall Study|Unsatisfactory therapeutic effect|12
362515|NCT00393458|1167693|P2|Overall Study|Unsatisfactory therapeutic effect|9
362516|NCT00393458|1167694|P1|Overall Study|Unsatisfactory therapeutic effect|12
362517|NCT00393458|1167691|P4|Overall Study|Subject withdrew consent|50
362518|NCT00393458|1167692|P3|Overall Study|Subject withdrew consent|33
362519|NCT00393458|1167693|P2|Overall Study|Subject withdrew consent|40
362520|NCT00393458|1167694|P1|Overall Study|Subject withdrew consent|27
362521|NCT00393458|1167691|P4|Overall Study|Adverse Event|35
362522|NCT00393458|1167692|P3|Overall Study|Adverse Event|40
362523|NCT00393458|1167693|P2|Overall Study|Adverse Event|24
362524|NCT00393458|1167694|P1|Overall Study|Adverse Event|35
362525|NCT00393367|1167721|P2|Overall Study|Withdrawal by Subject|2
362526|NCT00393367|1167722|P1|Overall Study|Withdrawal by Subject|0
362527|NCT00393367|1167721|P2|Overall Study|Protocol Violation|5
362528|NCT00393367|1167722|P1|Overall Study|Protocol Violation|2
362529|NCT00393094|1167750|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
362530|NCT00393094|1167750|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
362531|NCT00393042|1167761|P2|Second Intervetion|Protocol Violation|1
362532|NCT00393042|1167762|P1|Second Intervetion|Protocol Violation|1
362533|NCT00393042|1167761|P2|Second Intervetion|Lost to Follow-up|2
362534|NCT00393042|1167762|P1|Second Intervetion|Lost to Follow-up|0
362535|NCT00393042|1167761|P2|Second Intervetion|Lack of Efficacy|0
362536|NCT00393042|1167762|P1|Second Intervetion|Lack of Efficacy|1
362537|NCT00393042|1167761|P2|Second Intervetion|Withdrawal by Subject|2
362538|NCT00393042|1167762|P1|Second Intervetion|Withdrawal by Subject|0
362539|NCT00393042|1167761|P2|Second Intervetion|Adverse Event|3
362540|NCT00393042|1167762|P1|Second Intervetion|Adverse Event|0
362541|NCT00393042|1167761|P2|First Intervention|Adverse Event|1
362542|NCT00393042|1167762|P1|First Intervention|Adverse Event|0
362543|NCT00393042|1167761|P2|First Intervention|Protocol Violation|0
362544|NCT00393042|1167762|P1|First Intervention|Protocol Violation|1
362545|NCT00393042|1167761|P2|First Intervention|Lost to Follow-up|3
362546|NCT00393042|1167762|P1|First Intervention|Lost to Follow-up|3
362547|NCT00393042|1167761|P2|First Intervention|Withdrawal by Subject|2
362548|NCT00393042|1167762|P1|First Intervention|Withdrawal by Subject|1
362549|NCT00393029|1167834|P2|Overall Study|Not treated|1
362550|NCT00393029|1167835|P1|Overall Study|Not treated|0
362551|NCT00392925|1167848|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
362552|NCT00392925|1167849|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
362553|NCT00392925|1167850|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
362554|NCT00392925|1167851|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
362555|NCT00392925|1167848|P4|Randomization to Treatment Group Period|Protocol Violation|1
362556|NCT00392925|1167849|P3|Randomization to Treatment Group Period|Protocol Violation|2
362557|NCT00392925|1167850|P2|Randomization to Treatment Group Period|Protocol Violation|0
362558|NCT00392925|1167851|P1|Randomization to Treatment Group Period|Protocol Violation|0
362559|NCT00392925|1167848|P4|Randomization to Treatment Group Period|Adverse Event|5
362560|NCT00392925|1167849|P3|Randomization to Treatment Group Period|Adverse Event|3
362561|NCT00392925|1167850|P2|Randomization to Treatment Group Period|Adverse Event|3
362562|NCT00392925|1167851|P1|Randomization to Treatment Group Period|Adverse Event|0
362563|NCT00392925|1167848|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
362564|NCT00392925|1167849|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
362565|NCT00392925|1167850|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
362566|NCT00392925|1167851|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
362567|NCT00392925|1167848|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
362568|NCT00392925|1167849|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
362569|NCT00392925|1167850|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
362570|NCT00392925|1167851|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
362571|NCT00392925|1167848|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
362572|NCT00392925|1167849|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
362573|NCT00392925|1167850|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
362574|NCT00392925|1167851|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
362575|NCT00392925|1167848|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
362576|NCT00392925|1167849|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
362577|NCT00392925|1167850|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
362578|NCT00392925|1167851|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
362579|NCT00392925|1167848|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
362580|NCT00392925|1167849|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
362581|NCT00392925|1167850|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
362582|NCT00392925|1167851|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
362583|NCT00392925|1167848|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
362584|NCT00392925|1167849|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
362585|NCT00392925|1167850|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
362586|NCT00392925|1167851|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
362587|NCT00392808|1167965|P4|Overall Study|Unable to withdraw blood|2
362588|NCT00392808|1167966|P3|Overall Study|Unable to withdraw blood|1
362589|NCT00392808|1167967|P2|Overall Study|Unable to withdraw blood|1
362590|NCT00392808|1167968|P1|Overall Study|Unable to withdraw blood|3
362591|NCT00392808|1167965|P4|Overall Study|Lost to Follow-up|2
362592|NCT00392808|1167966|P3|Overall Study|Lost to Follow-up|1
362593|NCT00392808|1167967|P2|Overall Study|Lost to Follow-up|2
362594|NCT00392808|1167968|P1|Overall Study|Lost to Follow-up|3
362595|NCT00392769|1167992|P1|Overall Study|Adverse Event|1
362596|NCT00392769|1167992|P1|Overall Study|Clinical Deterioration|9
362597|NCT00392665|1168044|P2|Overall Study|Lost to Follow-up|1
362598|NCT00392665|1168045|P1|Overall Study|Lost to Follow-up|1
362599|NCT00392665|1168044|P2|Overall Study|Death|14
362600|NCT00392665|1168045|P1|Overall Study|Death|16
362601|NCT00392379|1168071|P2|Overall Study|Adverse Event|1
362602|NCT00392379|1168072|P1|Overall Study|Adverse Event|1
362603|NCT00392379|1168071|P2|Overall Study|Lost to Follow-up|9
362604|NCT00392379|1168072|P1|Overall Study|Lost to Follow-up|4
362605|NCT00392379|1168071|P2|Overall Study|Withdrawal by Subject|28
362606|NCT00392379|1168072|P1|Overall Study|Withdrawal by Subject|17
362607|NCT00392288|1168085|P3|Overall Study|Other|1
362608|NCT00392288|1168086|P2|Overall Study|Other|4
362609|NCT00392288|1168087|P1|Overall Study|Other|3
362610|NCT00392288|1168085|P3|Overall Study|Parent/legal guardian withdrawal|1
362611|NCT00392288|1168086|P2|Overall Study|Parent/legal guardian withdrawal|2
362612|NCT00392288|1168087|P1|Overall Study|Parent/legal guardian withdrawal|1
362613|NCT00392288|1168085|P3|Overall Study|Withdrawal by Subject|2
362614|NCT00392288|1168086|P2|Overall Study|Withdrawal by Subject|0
362615|NCT00392288|1168087|P1|Overall Study|Withdrawal by Subject|1
362616|NCT00392288|1168085|P3|Overall Study|Lost to Follow-up|1
362617|NCT00392288|1168086|P2|Overall Study|Lost to Follow-up|1
362618|NCT00392288|1168087|P1|Overall Study|Lost to Follow-up|1
362619|NCT00392288|1168085|P3|Overall Study|Protocol Violation|1
362620|NCT00392288|1168086|P2|Overall Study|Protocol Violation|3
362621|NCT00392288|1168087|P1|Overall Study|Protocol Violation|1
362622|NCT00392288|1168085|P3|Overall Study|Lack of Efficacy|3
362623|NCT00392288|1168086|P2|Overall Study|Lack of Efficacy|5
362624|NCT00392288|1168087|P1|Overall Study|Lack of Efficacy|8
362625|NCT00392288|1168085|P3|Overall Study|Adverse Event|8
362626|NCT00392288|1168086|P2|Overall Study|Adverse Event|7
362627|NCT00392288|1168087|P1|Overall Study|Adverse Event|17
362628|NCT00392223|1168112|P2|Overall Study|Withdrawal by Subject|2
362629|NCT00392223|1168113|P1|Overall Study|Withdrawal by Subject|3
362630|NCT00392223|1168112|P2|Overall Study|Protocol Violation|3
362631|NCT00392223|1168113|P1|Overall Study|Protocol Violation|0
362632|NCT00392223|1168112|P2|Overall Study|Lost to Follow-up|4
362633|NCT00392223|1168113|P1|Overall Study|Lost to Follow-up|1
362634|NCT00392223|1168112|P2|Overall Study|Adverse Event|4
362635|NCT00392223|1168113|P1|Overall Study|Adverse Event|5
362636|NCT00392210|1168131|P2|First Voiding Trial|Physician Decision|2
362637|NCT00392210|1168132|P1|First Voiding Trial|Physician Decision|2
362638|NCT00392197|1168140|P2|Overall Study|Withdrawal by Subject|6
362639|NCT00392197|1168141|P1|Overall Study|Withdrawal by Subject|4
362640|NCT00392197|1168140|P2|Overall Study|Protocol Violation|5
362641|NCT00392197|1168141|P1|Overall Study|Protocol Violation|7
362642|NCT00392197|1168140|P2|Overall Study|Physician Decision|2
362643|NCT00392197|1168141|P1|Overall Study|Physician Decision|3
362644|NCT00392197|1168140|P2|Overall Study|Lost to Follow-up|1
362645|NCT00392197|1168141|P1|Overall Study|Lost to Follow-up|0
362646|NCT00392197|1168140|P2|Overall Study|Lack of Efficacy|4
362647|NCT00392197|1168141|P1|Overall Study|Lack of Efficacy|3
362648|NCT00392197|1168140|P2|Overall Study|Adverse Event|12
362649|NCT00392197|1168141|P1|Overall Study|Adverse Event|4
362650|NCT00392171|1168149|P1|Overall Study|Disease progression|101
362651|NCT00392171|1168149|P1|Overall Study|Did not meet inclusion criteria|4
362652|NCT00391976|1168160|P3|Overall Study|Positive P. aeruginosa antibody test|31
362653|NCT00391976|1168161|P2|Overall Study|Positive P. aeruginosa antibody test|0
362654|NCT00391976|1168162|P1|Overall Study|Positive P. aeruginosa antibody test|0
362655|NCT00391976|1168160|P3|Overall Study|Unable to classify|1
362656|NCT00391976|1168161|P2|Overall Study|Unable to classify|0
362657|NCT00391976|1168162|P1|Overall Study|Unable to classify|0
362658|NCT00391976|1168160|P3|Overall Study|Recurrence/no eradication of infection|0
362659|NCT00391976|1168161|P2|Overall Study|Recurrence/no eradication of infection|19
362660|NCT00391976|1168162|P1|Overall Study|Recurrence/no eradication of infection|21
362661|NCT00391976|1168160|P3|Overall Study|Protocol deviation/violation|1
362662|NCT00391976|1168161|P2|Overall Study|Protocol deviation/violation|2
362663|NCT00391976|1168162|P1|Overall Study|Protocol deviation/violation|4
362664|NCT00391976|1168160|P3|Overall Study|Inappropriate enrollment|0
362665|NCT00391976|1168161|P2|Overall Study|Inappropriate enrollment|1
362666|NCT00391976|1168162|P1|Overall Study|Inappropriate enrollment|1
362667|NCT00391976|1168160|P3|Overall Study|Lost to Follow-up|0
362668|NCT00391976|1168161|P2|Overall Study|Lost to Follow-up|2
362669|NCT00391976|1168162|P1|Overall Study|Lost to Follow-up|1
362670|NCT00391976|1168160|P3|Overall Study|Withdrawal of consent|1
362671|NCT00391976|1168161|P2|Overall Study|Withdrawal of consent|1
362672|NCT00391976|1168162|P1|Overall Study|Withdrawal of consent|0
362673|NCT00391976|1168160|P3|Overall Study|Adverse Event|1
362674|NCT00391976|1168161|P2|Overall Study|Adverse Event|0
362675|NCT00391976|1168162|P1|Overall Study|Adverse Event|0
362676|NCT00391898|1168186|P2|Overall Study|Other|10
362677|NCT00391898|1168187|P1|Overall Study|Other|8
362678|NCT00391898|1168186|P2|Overall Study|Adverse Event|0
362679|NCT00391898|1168187|P1|Overall Study|Adverse Event|3
362680|NCT00391872|1168207|P2|Overall Study|Lost to Follow-up|0
362681|NCT00391872|1168208|P1|Overall Study|Lost to Follow-up|2
362682|NCT00391872|1168207|P2|Overall Study|Reason unknown|4
362683|NCT00391872|1168208|P1|Overall Study|Reason unknown|2
362684|NCT00391872|1168207|P2|Overall Study|Withdrawal by Subject|249
362685|NCT00391872|1168208|P1|Overall Study|Withdrawal by Subject|296
362686|NCT00391872|1168207|P2|Overall Study|Protocol Violation|2
362687|NCT00391872|1168208|P1|Overall Study|Protocol Violation|7
362688|NCT00391846|1168246|P2|Overall Study|Developed study specific DC criteria|1
362689|NCT00391846|1168247|P1|Overall Study|Developed study specific DC criteria|0
362690|NCT00391846|1168246|P2|Overall Study|Withdrawal by Subject|3
362691|NCT00391846|1168247|P1|Overall Study|Withdrawal by Subject|2
362692|NCT00391846|1168246|P2|Overall Study|Did not meet the required elig. crit|2
362693|NCT00391846|1168247|P1|Overall Study|Did not meet the required elig. crit|2
362694|NCT00391846|1168246|P2|Overall Study|Adverse Event|1
362695|NCT00391846|1168247|P1|Overall Study|Adverse Event|4
362696|NCT00391807|1168267|P1|Overall Study|Various|96
362697|NCT00391807|1168267|P1|Overall Study|Protocol Violation|20
362698|NCT00391807|1168267|P1|Overall Study|Withdrawal by Subject|147
362699|NCT00391807|1168267|P1|Overall Study|Lost to Follow-up|227
362700|NCT00391807|1168267|P1|Overall Study|Pregnancy|25
362701|NCT00391807|1168267|P1|Overall Study|Adverse Event|177
362702|NCT00391807|1168267|P1|Overall Study|Did not receive study medication|23
362703|NCT00391768|1168294|P7|Overall Study|Lost to Follow-up|3
362704|NCT00391768|1168295|P6|Overall Study|Lost to Follow-up|2
362705|NCT00391768|1168296|P5|Overall Study|Lost to Follow-up|2
362706|NCT00391768|1168297|P4|Overall Study|Lost to Follow-up|1
362707|NCT00391768|1168298|P3|Overall Study|Lost to Follow-up|0
362708|NCT00391768|1168299|P2|Overall Study|Lost to Follow-up|0
362709|NCT00391768|1168300|P1|Overall Study|Lost to Follow-up|0
362710|NCT00391768|1168294|P7|Overall Study|Withdrawal by Subject|1
362711|NCT00391768|1168295|P6|Overall Study|Withdrawal by Subject|1
362712|NCT00391768|1168296|P5|Overall Study|Withdrawal by Subject|0
362713|NCT00391768|1168297|P4|Overall Study|Withdrawal by Subject|0
362714|NCT00391768|1168298|P3|Overall Study|Withdrawal by Subject|1
362715|NCT00391768|1168299|P2|Overall Study|Withdrawal by Subject|0
362716|NCT00391768|1168300|P1|Overall Study|Withdrawal by Subject|0
362717|NCT00391625|1168387|P1|Month 50|Physician Decision|1
362718|NCT00391625|1168387|P1|Month 14|Withdrawal by Subject|1
362719|NCT00391586|1168440|P1|Overall Study|Death|4
362720|NCT00391586|1168440|P1|Overall Study|Physician Decision|2
362721|NCT00391586|1168440|P1|Overall Study|Adverse Event|5
362722|NCT00391586|1168440|P1|Overall Study|Progressive disease|13
362723|NCT00391391|1168477|P4|Overall Study|Withdrawal by Subject|7
362724|NCT00391391|1168478|P3|Overall Study|Withdrawal by Subject|10
362725|NCT00391391|1168479|P2|Overall Study|Withdrawal by Subject|4
362726|NCT00391391|1168480|P1|Overall Study|Withdrawal by Subject|6
362727|NCT00391391|1168477|P4|Overall Study|Protocol Violation|7
362728|NCT00391391|1168478|P3|Overall Study|Protocol Violation|6
362729|NCT00391391|1168479|P2|Overall Study|Protocol Violation|3
362730|NCT00391391|1168480|P1|Overall Study|Protocol Violation|2
362731|NCT00391391|1168477|P4|Overall Study|Lost to Follow-up|4
362732|NCT00391391|1168478|P3|Overall Study|Lost to Follow-up|7
362733|NCT00391391|1168479|P2|Overall Study|Lost to Follow-up|3
362734|NCT00391391|1168480|P1|Overall Study|Lost to Follow-up|1
362735|NCT00391391|1168477|P4|Overall Study|Adverse Event|1
362736|NCT00391391|1168478|P3|Overall Study|Adverse Event|0
362737|NCT00391391|1168479|P2|Overall Study|Adverse Event|0
362738|NCT00391391|1168480|P1|Overall Study|Adverse Event|0
362739|NCT00391274|1168525|P2|Overall Study|Death Not Study Related|1
362740|NCT00391274|1168526|P1|Overall Study|Death Not Study Related|0
362741|NCT00391274|1168525|P2|Overall Study|Death Due to Indeterminate Cause|0
362742|NCT00391274|1168526|P1|Overall Study|Death Due to Indeterminate Cause|1
362743|NCT00391274|1168525|P2|Overall Study|Death Due to Adverse Event|3
362744|NCT00391274|1168526|P1|Overall Study|Death Due to Adverse Event|1
362745|NCT00391274|1168525|P2|Overall Study|Withdrawal by Subject|3
362746|NCT00391274|1168526|P1|Overall Study|Withdrawal by Subject|0
362747|NCT00391274|1168525|P2|Overall Study|Physician Decision|2
362748|NCT00391274|1168526|P1|Overall Study|Physician Decision|4
362749|NCT00391274|1168525|P2|Overall Study|Lost to Follow-up|3
362750|NCT00391274|1168526|P1|Overall Study|Lost to Follow-up|0
362751|NCT00391274|1168525|P2|Overall Study|Death Due to Study Disease|45
362752|NCT00391274|1168526|P1|Overall Study|Death Due to Study Disease|55
362753|NCT00391222|1168545|P4|Period III (Double-Blind Treatment)|Other|0
362754|NCT00391222|1168546|P3|Period III (Double-Blind Treatment)|Other|6
362755|NCT00391222|1168547|P2|Period III (Double-Blind Treatment)|Other|1
362756|NCT00391222|1168548|P1|Period III (Double-Blind Treatment)|Other|6
362757|NCT00391222|1168545|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
362758|NCT00391222|1168546|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
362759|NCT00391222|1168547|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
362760|NCT00391222|1168548|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
362761|NCT00391222|1168545|P4|Period III (Double-Blind Treatment)|Pregnancy|0
362762|NCT00391222|1168546|P3|Period III (Double-Blind Treatment)|Pregnancy|0
362763|NCT00391222|1168547|P2|Period III (Double-Blind Treatment)|Pregnancy|2
362764|NCT00391222|1168548|P1|Period III (Double-Blind Treatment)|Pregnancy|0
362765|NCT00391222|1168545|P4|Period III (Double-Blind Treatment)|Adverse Event|0
362766|NCT00391222|1168546|P3|Period III (Double-Blind Treatment)|Adverse Event|4
362767|NCT00391222|1168547|P2|Period III (Double-Blind Treatment)|Adverse Event|2
362768|NCT00391222|1168548|P1|Period III (Double-Blind Treatment)|Adverse Event|5
362769|NCT00391222|1168545|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
362770|NCT00391222|1168546|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
362771|NCT00391222|1168547|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
362772|NCT00391222|1168548|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
362773|NCT00391222|1168545|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
362774|NCT00391222|1168546|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
362775|NCT00391222|1168547|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
362776|NCT00391222|1168548|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
362777|NCT00391222|1168545|P4|Period II (Open-label Risperidone LAI)|Other|24
362778|NCT00391222|1168546|P3|Period II (Open-label Risperidone LAI)|Other|0
362779|NCT00391222|1168547|P2|Period II (Open-label Risperidone LAI)|Other|0
362780|NCT00391222|1168548|P1|Period II (Open-label Risperidone LAI)|Other|0
362781|NCT00391222|1168545|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
362782|NCT00391222|1168546|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
362783|NCT00391222|1168547|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
362784|NCT00391222|1168548|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
362785|NCT00391222|1168545|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
362786|NCT00391222|1168546|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
362787|NCT00391222|1168547|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
362788|NCT00391222|1168548|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
362789|NCT00391222|1168545|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
362790|NCT00391222|1168546|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
362791|NCT00391222|1168547|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
362792|NCT00391222|1168548|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
362793|NCT00391222|1168545|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
362794|NCT00391222|1168546|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
362795|NCT00391222|1168547|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
362796|NCT00391222|1168548|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
362797|NCT00391092|1168574|P2|Overall Study|Alive in follow-up|84
362798|NCT00391092|1168575|P1|Overall Study|Alive in follow-up|88
362799|NCT00391092|1168574|P2|Overall Study|Alive on treatment|33
362800|NCT00391092|1168575|P1|Overall Study|Alive on treatment|29
362801|NCT00391092|1168574|P2|Overall Study|Lost to Follow-up|18
362802|NCT00391092|1168575|P1|Overall Study|Lost to Follow-up|13
362803|NCT00391092|1168574|P2|Overall Study|Death|81
362804|NCT00391092|1168575|P1|Overall Study|Death|78
362805|NCT00391053|1168618|P4|Overall Study|Withdrawal by Subject|1
362806|NCT00391053|1168619|P3|Overall Study|Withdrawal by Subject|1
362807|NCT00391053|1168620|P2|Overall Study|Withdrawal by Subject|1
362808|NCT00391053|1168621|P1|Overall Study|Withdrawal by Subject|5
362809|NCT00391053|1168618|P4|Overall Study|Lost to Follow-up|5
362810|NCT00391053|1168619|P3|Overall Study|Lost to Follow-up|0
362811|NCT00391053|1168620|P2|Overall Study|Lost to Follow-up|0
362812|NCT00391053|1168621|P1|Overall Study|Lost to Follow-up|1
362813|NCT00391053|1168618|P4|Overall Study|Protocol Violation|0
362814|NCT00391053|1168619|P3|Overall Study|Protocol Violation|0
362815|NCT00391053|1168620|P2|Overall Study|Protocol Violation|0
362816|NCT00391053|1168621|P1|Overall Study|Protocol Violation|2
362817|NCT00391053|1168618|P4|Overall Study|Serious Adverse Events|4
362818|NCT00391053|1168619|P3|Overall Study|Serious Adverse Events|1
362819|NCT00391053|1168620|P2|Overall Study|Serious Adverse Events|0
362820|NCT00391053|1168621|P1|Overall Study|Serious Adverse Events|1
362821|NCT00391027|1168645|P2|Overall Study|Other|3
362822|NCT00391027|1168646|P1|Overall Study|Other|4
362823|NCT00391027|1168645|P2|Overall Study|Withdrawal by Subject|1
362824|NCT00391027|1168646|P1|Overall Study|Withdrawal by Subject|10
362825|NCT00391027|1168645|P2|Overall Study|Lack of Efficacy|0
362826|NCT00391027|1168646|P1|Overall Study|Lack of Efficacy|3
362827|NCT00391027|1168645|P2|Overall Study|Adverse Event|8
362828|NCT00391027|1168646|P1|Overall Study|Adverse Event|8
362829|NCT00390884|1168686|P2|Overall Study|Withdrawal by Subject|2
362830|NCT00390884|1168687|P1|Overall Study|Withdrawal by Subject|2
362831|NCT00390858|1168699|P2|Overall Study|Withdrawal by Subject|4
362832|NCT00390858|1168700|P1|Overall Study|Withdrawal by Subject|3
362833|NCT00390858|1168699|P2|Overall Study|Lack of Efficacy|1
362834|NCT00390858|1168700|P1|Overall Study|Lack of Efficacy|0
362835|NCT00390858|1168699|P2|Overall Study|Adverse Event|2
362836|NCT00390858|1168700|P1|Overall Study|Adverse Event|6
362837|NCT00390806|1168714|P2|Overall Study|Ongoing|2
362838|NCT00390806|1168715|P1|Overall Study|Ongoing|4
362839|NCT00390806|1168714|P2|Overall Study|Physician Decision|1
362840|NCT00390806|1168715|P1|Overall Study|Physician Decision|0
362841|NCT00390806|1168714|P2|Overall Study|Death|0
362842|NCT00390806|1168715|P1|Overall Study|Death|1
362843|NCT00390806|1168714|P2|Overall Study|Investigator Decision|6
362844|NCT00390806|1168715|P1|Overall Study|Investigator Decision|4
362845|NCT00390806|1168714|P2|Overall Study|Withdrawal by Subject|15
362846|NCT00390806|1168715|P1|Overall Study|Withdrawal by Subject|12
362847|NCT00390806|1168714|P2|Overall Study|Protocol Violation|2
362848|NCT00390806|1168715|P1|Overall Study|Protocol Violation|2
362849|NCT00390806|1168714|P2|Overall Study|Lost to Follow-up|6
362850|NCT00390806|1168715|P1|Overall Study|Lost to Follow-up|7
362851|NCT00390780|1168783|P2|Overall Study|SAE, death|1
362852|NCT00390780|1168784|P1|Overall Study|SAE, death|0
362853|NCT00390780|1168783|P2|Overall Study|Investigator decision, SAE, other reason|1
362854|NCT00390780|1168784|P1|Overall Study|Investigator decision, SAE, other reason|0
362855|NCT00390780|1168783|P2|Overall Study|Lost to follow up and other reasons|1
362856|NCT00390780|1168784|P1|Overall Study|Lost to follow up and other reasons|0
362857|NCT00390780|1168783|P2|Overall Study|Inclusion criteria not satisfied|2
362858|NCT00390780|1168784|P1|Overall Study|Inclusion criteria not satisfied|0
362859|NCT00390780|1168783|P2|Overall Study|Withdrawal by Subject|2
362860|NCT00390780|1168784|P1|Overall Study|Withdrawal by Subject|1
362861|NCT00390780|1168783|P2|Overall Study|Death|3
362862|NCT00390780|1168784|P1|Overall Study|Death|1
362863|NCT00390780|1168783|P2|Overall Study|Adverse Event|3
362864|NCT00390780|1168784|P1|Overall Study|Adverse Event|2
362865|NCT00390780|1168783|P2|Overall Study|Lost to Follow-up|6
362866|NCT00390780|1168784|P1|Overall Study|Lost to Follow-up|3
362867|NCT00390780|1168783|P2|Overall Study|Protocol Violation|4
362868|NCT00390780|1168784|P1|Overall Study|Protocol Violation|6
362869|NCT00390780|1168783|P2|Overall Study|Not completed|4
362870|NCT00390780|1168784|P1|Overall Study|Not completed|10
362871|NCT00390689|1168817|P3|Overall Study|Investigator's judgement|0
362872|NCT00390689|1168818|P2|Overall Study|Investigator's judgement|0
362873|NCT00390689|1168819|P1|Overall Study|Investigator's judgement|2
362874|NCT00390689|1168817|P3|Overall Study|Protocol Violation|0
362875|NCT00390689|1168818|P2|Overall Study|Protocol Violation|0
362876|NCT00390689|1168819|P1|Overall Study|Protocol Violation|1
362877|NCT00390689|1168817|P3|Overall Study|Lack of Efficacy|1
362878|NCT00390689|1168818|P2|Overall Study|Lack of Efficacy|0
362879|NCT00390689|1168819|P1|Overall Study|Lack of Efficacy|0
362880|NCT00390689|1168817|P3|Overall Study|Adverse Event|2
362881|NCT00390689|1168818|P2|Overall Study|Adverse Event|5
362882|NCT00390689|1168819|P1|Overall Study|Adverse Event|2
362883|NCT00390572|1168894|P2|Overall Study|health condition|1
362884|NCT00390572|1168895|P1|Overall Study|health condition|0
362885|NCT00390572|1168894|P2|Overall Study|Lost to Follow-up|4
362886|NCT00390572|1168895|P1|Overall Study|Lost to Follow-up|8
362887|NCT00390546|1168921|P2|Overall Study|Physician Decision|5
362888|NCT00390546|1168922|P1|Overall Study|Physician Decision|5
362889|NCT00390546|1168921|P2|Overall Study|Renal impairment|0
362890|NCT00390546|1168922|P1|Overall Study|Renal impairment|1
362891|NCT00390468|1168932|P1|Overall Study|Lack of Efficacy|1
362892|NCT00390468|1168932|P1|Overall Study|Protocol Violation|2
362901|NCT00390416|1168957|P1|Overall Study|Not treated|3
362902|NCT00390416|1168957|P1|Overall Study|Withdrawal by Subject|1
362903|NCT00390221|1168978|P3|Overall Study|Not Specified|2
362904|NCT00390221|1168979|P2|Overall Study|Not Specified|4
362905|NCT00390221|1168980|P1|Overall Study|Not Specified|3
362906|NCT00390221|1168978|P3|Overall Study|Subject Non-compliance|2
362907|NCT00390221|1168979|P2|Overall Study|Subject Non-compliance|0
362908|NCT00390221|1168980|P1|Overall Study|Subject Non-compliance|1
362909|NCT00390221|1168978|P3|Overall Study|Withdrawal by Subject|7
362910|NCT00390221|1168979|P2|Overall Study|Withdrawal by Subject|9
362911|NCT00390221|1168980|P1|Overall Study|Withdrawal by Subject|13
362912|NCT00390221|1168978|P3|Overall Study|Investigator Decision|1
362913|NCT00390221|1168979|P2|Overall Study|Investigator Decision|0
362914|NCT00390221|1168980|P1|Overall Study|Investigator Decision|0
362915|NCT00390221|1168978|P3|Overall Study|Adverse Event|3
362916|NCT00390221|1168979|P2|Overall Study|Adverse Event|4
362917|NCT00390221|1168980|P1|Overall Study|Adverse Event|1
362918|NCT00390221|1168978|P3|Overall Study|Lost to Follow-up|0
362919|NCT00390221|1168979|P2|Overall Study|Lost to Follow-up|3
362920|NCT00390221|1168980|P1|Overall Study|Lost to Follow-up|0
362921|NCT00389831|1169026|P2|Overall Study|Lost to Follow-up|1
362922|NCT00389831|1169027|P1|Overall Study|Lost to Follow-up|0
362923|NCT00389831|1169026|P2|Overall Study|Other reasons|2
362924|NCT00389831|1169027|P1|Overall Study|Other reasons|0
362925|NCT00389831|1169026|P2|Overall Study|Did not receive treatment.|2
362926|NCT00389831|1169027|P1|Overall Study|Did not receive treatment.|0
362927|NCT00389831|1169026|P2|Overall Study|Lack of Efficacy|2
362928|NCT00389831|1169027|P1|Overall Study|Lack of Efficacy|0
362929|NCT00389597|1169061|P4|Overall Study|Lost to Follow-up|6
362930|NCT00389597|1169062|P3|Overall Study|Lost to Follow-up|4
362931|NCT00389597|1169063|P2|Overall Study|Lost to Follow-up|6
362932|NCT00389597|1169064|P1|Overall Study|Lost to Follow-up|8
362933|NCT00389519|1169089|P4|Treated|Reason not specified|2
362934|NCT00389519|1169090|P3|Treated|Reason not specified|0
362935|NCT00389519|1169091|P2|Treated|Reason not specified|1
362936|NCT00389519|1169092|P1|Treated|Reason not specified|1
362937|NCT00389519|1169089|P4|Treated|Adverse Event|2
362938|NCT00389519|1169090|P3|Treated|Adverse Event|0
362939|NCT00389519|1169091|P2|Treated|Adverse Event|0
362940|NCT00389519|1169092|P1|Treated|Adverse Event|1
362941|NCT00389519|1169089|P4|Randomized|Did not receive study drug|0
362942|NCT00389519|1169090|P3|Randomized|Did not receive study drug|0
362943|NCT00389519|1169091|P2|Randomized|Did not receive study drug|0
362944|NCT00389519|1169092|P1|Randomized|Did not receive study drug|2
362945|NCT00389519|1169089|P4|Placebo Run-In|Reason not specified|0
362946|NCT00389519|1169090|P3|Placebo Run-In|Reason not specified|0
362947|NCT00389519|1169091|P2|Placebo Run-In|Reason not specified|0
362948|NCT00389519|1169092|P1|Placebo Run-In|Reason not specified|40
362949|NCT00389519|1169089|P4|Placebo Run-In|Withdrawal by Subject|0
362950|NCT00389519|1169090|P3|Placebo Run-In|Withdrawal by Subject|0
362951|NCT00389519|1169091|P2|Placebo Run-In|Withdrawal by Subject|0
362952|NCT00389519|1169092|P1|Placebo Run-In|Withdrawal by Subject|19
362953|NCT00389519|1169089|P4|Placebo Run-In|Did not meet blood pressure criteria|0
362954|NCT00389519|1169090|P3|Placebo Run-In|Did not meet blood pressure criteria|0
362955|NCT00389519|1169091|P2|Placebo Run-In|Did not meet blood pressure criteria|0
362956|NCT00389519|1169092|P1|Placebo Run-In|Did not meet blood pressure criteria|119
362957|NCT00389441|1169169|P1|Overall Study|Clinical progression|1
362958|NCT00389441|1169169|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
362959|NCT00389441|1169169|P1|Overall Study|Objective progression or relapse|26
362960|NCT00389441|1169169|P1|Overall Study|Global deterioration of health status|4
362961|NCT00389441|1169169|P1|Overall Study|Protocol Violation|1
362962|NCT00389441|1169169|P1|Overall Study|Physician Decision|1
362963|NCT00389441|1169169|P1|Overall Study|Withdrawal by Subject|4
362964|NCT00389441|1169169|P1|Overall Study|Lost to Follow-up|2
362965|NCT00389441|1169169|P1|Overall Study|Death|4
362966|NCT00389441|1169169|P1|Overall Study|Adverse Event|7
362967|NCT00389324|1169178|P1|Subcutaneous Phase|Lost to Follow-up|1
362968|NCT00389324|1169178|P1|Subcutaneous Phase|Withdrawal by Subject|2
362969|NCT00389324|1169178|P1|Subcutaneous Phase|Non-compliance with study medication|2
362970|NCT00389324|1169178|P1|Subcutaneous Phase|Adverse Event|2
362971|NCT00389324|1169178|P1|Run-In Phase|Withdrawal by Subject|1
362972|NCT00389324|1169178|P1|Run-In Phase|Lost to Follow-up|1
362973|NCT00389324|1169178|P1|Run-In Phase|Adverse Event|1
362974|NCT00389207|1169188|P3|Overall Study|Not specified|9
362975|NCT00389207|1169189|P2|Overall Study|Not specified|23
362976|NCT00389207|1169190|P1|Overall Study|Not specified|17
362977|NCT00389207|1169188|P3|Overall Study|Withdrawal by Subject|11
362978|NCT00389207|1169189|P2|Overall Study|Withdrawal by Subject|7
362979|NCT00389207|1169190|P1|Overall Study|Withdrawal by Subject|5
362980|NCT00389207|1169188|P3|Overall Study|Lost to Follow-up|7
362981|NCT00389207|1169189|P2|Overall Study|Lost to Follow-up|9
362982|NCT00389207|1169190|P1|Overall Study|Lost to Follow-up|12
362983|NCT00389207|1169188|P3|Overall Study|Protocol Violation|4
362984|NCT00389207|1169189|P2|Overall Study|Protocol Violation|1
362985|NCT00389207|1169190|P1|Overall Study|Protocol Violation|3
362986|NCT00389207|1169188|P3|Overall Study|Adverse Event|10
362987|NCT00389207|1169189|P2|Overall Study|Adverse Event|32
362988|NCT00389207|1169190|P1|Overall Study|Adverse Event|26
362989|NCT00389064|1169313|P2|Overall Study|Multiple Reasons|11
362990|NCT00389064|1169314|P1|Overall Study|Multiple Reasons|9
362991|NCT00389064|1169313|P2|Overall Study|Protocol Violation|0
362992|NCT00389064|1169314|P1|Overall Study|Protocol Violation|2
362993|NCT00389064|1169313|P2|Overall Study|Lost to Follow-up|2
362994|NCT00389064|1169314|P1|Overall Study|Lost to Follow-up|1
362995|NCT00389064|1169313|P2|Overall Study|Physician Decision|2
362996|NCT00389064|1169314|P1|Overall Study|Physician Decision|2
362997|NCT00389064|1169313|P2|Overall Study|Withdrawal by Subject|27
362998|NCT00389064|1169314|P1|Overall Study|Withdrawal by Subject|17
362999|NCT00389064|1169313|P2|Overall Study|Lack of Efficacy|14
363000|NCT00389064|1169314|P1|Overall Study|Lack of Efficacy|3
363001|NCT00389064|1169313|P2|Overall Study|Adverse Event|3
363002|NCT00389064|1169314|P1|Overall Study|Adverse Event|11
363003|NCT00388973|1169342|P2|Overall Study|Did not complete 2-week follow-up visit|17
363004|NCT00388973|1169343|P1|Overall Study|Did not complete 2-week follow-up visit|17
363005|NCT00388973|1169342|P2|Overall Study|Left region|1
363006|NCT00388973|1169343|P1|Overall Study|Left region|0
363007|NCT00388973|1169342|P2|Overall Study|Did not complete 61 days of treatment|4
363008|NCT00388973|1169343|P1|Overall Study|Did not complete 61 days of treatment|5
363009|NCT00388973|1169342|P2|Overall Study|Study specific Discontinuation Criteria|1
363010|NCT00388973|1169343|P1|Overall Study|Study specific Discontinuation Criteria|0
363011|NCT00388973|1169342|P2|Overall Study|Withdrawal by Subject|17
363012|NCT00388973|1169343|P1|Overall Study|Withdrawal by Subject|14
363013|NCT00388973|1169342|P2|Overall Study|Protocol Violation|0
363014|NCT00388973|1169343|P1|Overall Study|Protocol Violation|3
363015|NCT00388973|1169342|P2|Overall Study|Lack of Efficacy|12
363016|NCT00388973|1169343|P1|Overall Study|Lack of Efficacy|1
363017|NCT00388973|1169342|P2|Overall Study|Adverse Event|6
363018|NCT00388973|1169343|P1|Overall Study|Adverse Event|16
363019|NCT00388947|1169363|P1|Overall Study|Protocol Violation|47
363020|NCT00388726|1169379|P2|Overall Study|Death|2
363021|NCT00388726|1169380|P1|Overall Study|Death|3
363022|NCT00388726|1169379|P2|Overall Study|Physician Decision|13
363023|NCT00388726|1169380|P1|Overall Study|Physician Decision|18
363024|NCT00388726|1169379|P2|Overall Study|Administrative|9
363025|NCT00388726|1169380|P1|Overall Study|Administrative|6
363026|NCT00388726|1169379|P2|Overall Study|Withdrawal by Subject|7
363027|NCT00388726|1169380|P1|Overall Study|Withdrawal by Subject|10
363028|NCT00388726|1169379|P2|Overall Study|Clinical Progression|36
363029|NCT00388726|1169380|P1|Overall Study|Clinical Progression|61
363030|NCT00388726|1169379|P2|Overall Study|Progressive Disease|153
363031|NCT00388726|1169380|P1|Overall Study|Progressive Disease|336
363032|NCT00388726|1169379|P2|Overall Study|Adverse Event|24
363033|NCT00388726|1169380|P1|Overall Study|Adverse Event|50
363034|NCT00388583|1169394|P2|Overall Study|Did not receive vaccine|1
363035|NCT00388583|1169395|P1|Overall Study|Did not receive vaccine|0
363036|NCT00388583|1169394|P2|Overall Study|Serious Adverse Event|0
363037|NCT00388583|1169395|P1|Overall Study|Serious Adverse Event|2
363038|NCT00388583|1169394|P2|Overall Study|Withdrawal by Subject|3
363039|NCT00388583|1169395|P1|Overall Study|Withdrawal by Subject|3
363040|NCT00388583|1169394|P2|Overall Study|Protocol Violation|0
363041|NCT00388583|1169395|P1|Overall Study|Protocol Violation|1
363042|NCT00388505|1169409|P2|Overall Study|Unable to classify|3
363043|NCT00388505|1169410|P1|Overall Study|Unable to classify|4
363044|NCT00388505|1169409|P2|Overall Study|Protocol Violation|5
363045|NCT00388505|1169410|P1|Overall Study|Protocol Violation|6
363046|NCT00388505|1169409|P2|Overall Study|Administrative Reason|0
363047|NCT00388505|1169410|P1|Overall Study|Administrative Reason|1
363048|NCT00388505|1169409|P2|Overall Study|Inappropriate Enrollment|1
363049|NCT00388505|1169410|P1|Overall Study|Inappropriate Enrollment|0
363050|NCT00388505|1169409|P2|Overall Study|Lost to Follow-up|3
363051|NCT00388505|1169410|P1|Overall Study|Lost to Follow-up|5
363052|NCT00388505|1169409|P2|Overall Study|Withdrawal by Subject|9
363053|NCT00388505|1169410|P1|Overall Study|Withdrawal by Subject|24
363054|NCT00388505|1169409|P2|Overall Study|Adverse Event or Death|17
363055|NCT00388505|1169410|P1|Overall Study|Adverse Event or Death|43
363056|NCT00388362|1169432|P1|Remained on Study Median of 514 Days|Death|2
363057|NCT00388362|1169432|P1|Enrolled|Withdrawal by Subject|1
363058|NCT00388362|1169432|P1|Enrolled|Loss insurance|1
363059|NCT00388362|1169432|P1|Enrolled|Death|1
363060|NCT00388362|1169432|P1|Enrolled|Adverse Event|9
363061|NCT00388362|1169432|P1|Enrolled|Ineligible|1
363062|NCT00388349|1169437|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
363063|NCT00388349|1169438|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
363064|NCT00388154|1169447|P1|Overall Study|Withdrawal by Subject|1
363065|NCT00388037|1169452|P1|Overall Study|Protocol Violation|1
363066|NCT00387894|1169460|P1|Overall Study|Withdrawal by Subject|1
363067|NCT00387881|1169467|P2|Overall Study|Not otherwise specified|7
363068|NCT00387881|1169468|P1|Overall Study|Not otherwise specified|11
363069|NCT00387881|1169467|P2|Overall Study|No opportunity to treat headache|34
363070|NCT00387881|1169468|P1|Overall Study|No opportunity to treat headache|32
363071|NCT00387881|1169467|P2|Overall Study|Not eligible|7
363072|NCT00387881|1169468|P1|Overall Study|Not eligible|6
363073|NCT00387881|1169467|P2|Overall Study|Sponsor terminated Study|1
363074|NCT00387881|1169468|P1|Overall Study|Sponsor terminated Study|0
363075|NCT00387881|1169467|P2|Overall Study|Withdrawal by Subject|18
363076|NCT00387881|1169468|P1|Overall Study|Withdrawal by Subject|15
363077|NCT00387881|1169467|P2|Overall Study|Protocol Violation|12
363078|NCT00387881|1169468|P1|Overall Study|Protocol Violation|2
363079|NCT00387881|1169467|P2|Overall Study|Lost to Follow-up|23
363080|NCT00387881|1169468|P1|Overall Study|Lost to Follow-up|23
363081|NCT00387790|1169501|P1|Overall Study|Ineligible for study|2
363082|NCT00387790|1169501|P1|Overall Study|Withdrawal by Subject|3
363083|NCT00387790|1169501|P1|Overall Study|Physician Decision|2
363084|NCT00387790|1169501|P1|Overall Study|Lack of Efficacy|2
363085|NCT00387790|1169501|P1|Overall Study|Adverse Event|5
363086|NCT00387764|1169505|P1|Overall Study|Death|7
363087|NCT00387764|1169505|P1|Overall Study|Other|2
363088|NCT00387764|1169505|P1|Overall Study|Physician Decision|1
363089|NCT00387764|1169505|P1|Overall Study|Sponsor Terminated Study|1
363090|NCT00387764|1169505|P1|Overall Study|Withdrawal by Subject|8
363091|NCT00387764|1169505|P1|Overall Study|Adverse Event|12
363092|NCT00387725|1169531|P4|Overall Study|Parent/legal guardian request|1
363093|NCT00387725|1169532|P3|Overall Study|Parent/legal guardian request|1
363094|NCT00387725|1169533|P2|Overall Study|Parent/legal guardian request|0
363095|NCT00387725|1169534|P1|Overall Study|Parent/legal guardian request|0
363096|NCT00387725|1169531|P4|Overall Study|Withdrawal by Subject|0
363097|NCT00387725|1169532|P3|Overall Study|Withdrawal by Subject|1
363098|NCT00387725|1169533|P2|Overall Study|Withdrawal by Subject|0
363099|NCT00387725|1169534|P1|Overall Study|Withdrawal by Subject|1
363100|NCT00387725|1169531|P4|Overall Study|Protocol Violation|0
363101|NCT00387725|1169532|P3|Overall Study|Protocol Violation|0
363102|NCT00387725|1169533|P2|Overall Study|Protocol Violation|1
363103|NCT00387725|1169534|P1|Overall Study|Protocol Violation|0
363104|NCT00387725|1169531|P4|Overall Study|Adverse Event|1
363105|NCT00387725|1169532|P3|Overall Study|Adverse Event|0
363106|NCT00387725|1169533|P2|Overall Study|Adverse Event|0
363107|NCT00387725|1169534|P1|Overall Study|Adverse Event|0
363108|NCT00387647|1169573|P1|Overall Study|Death|18
363109|NCT00387426|1169613|P1|Overall Study|Disease Progression|3
363110|NCT00387426|1169613|P1|Overall Study|Toxicities|4
363111|NCT00387426|1169613|P1|Overall Study|Lack of Response|7
363112|NCT00387348|1169620|P3|Overall Study|Adverse Event|1
363113|NCT00387348|1169621|P2|Overall Study|Adverse Event|0
363114|NCT00387348|1169622|P1|Overall Study|Adverse Event|1
363115|NCT00387348|1169620|P3|Overall Study|Withdrawal by Subject|2
363116|NCT00387348|1169621|P2|Overall Study|Withdrawal by Subject|2
363117|NCT00387348|1169622|P1|Overall Study|Withdrawal by Subject|0
363118|NCT00387348|1169620|P3|Overall Study|Physician Decision|1
363119|NCT00387348|1169621|P2|Overall Study|Physician Decision|0
363120|NCT00387348|1169622|P1|Overall Study|Physician Decision|1
363121|NCT00387348|1169620|P3|Overall Study|Death|0
363122|NCT00387348|1169621|P2|Overall Study|Death|1
363123|NCT00387348|1169622|P1|Overall Study|Death|1
363124|NCT00387153|1169651|P1|Overall Study|Lack of Response|4
363125|NCT00387153|1169651|P1|Overall Study|Disease Progression|3
363126|NCT00387153|1169651|P1|Overall Study|Adverse Event|1
363127|NCT00387127|1169657|P2|Overall Study|Sponsor Unblinded|0
363128|NCT00387127|1169658|P1|Overall Study|Sponsor Unblinded|1
363129|NCT00387127|1169657|P2|Overall Study|Serious Adverse Event|1
363130|NCT00387127|1169658|P1|Overall Study|Serious Adverse Event|1
363131|NCT00387127|1169657|P2|Overall Study|Required by Protocol Amendment #4|10
363132|NCT00387127|1169658|P1|Overall Study|Required by Protocol Amendment #4|12
363133|NCT00387127|1169657|P2|Overall Study|Withdrawal by Subject|2
363134|NCT00387127|1169658|P1|Overall Study|Withdrawal by Subject|3
363135|NCT00387127|1169657|P2|Overall Study|Physician Decision|1
363136|NCT00387127|1169658|P1|Overall Study|Physician Decision|0
363137|NCT00387127|1169657|P2|Overall Study|Death|16
363138|NCT00387127|1169658|P1|Overall Study|Death|16
363139|NCT00387127|1169657|P2|Overall Study|Lost to Follow-up|4
363140|NCT00387127|1169658|P1|Overall Study|Lost to Follow-up|0
363141|NCT00387088|1169700|P2|Overall Study|Other|52
363142|NCT00387088|1169701|P1|Overall Study|Other|58
363143|NCT00387088|1169700|P2|Overall Study|Lost to Follow-up|28
363144|NCT00387088|1169701|P1|Overall Study|Lost to Follow-up|22
363145|NCT00387088|1169700|P2|Overall Study|Lack of Efficacy|67
363146|NCT00387088|1169701|P1|Overall Study|Lack of Efficacy|28
363147|NCT00387088|1169700|P2|Overall Study|Withdrawal by Subject|35
363148|NCT00387088|1169701|P1|Overall Study|Withdrawal by Subject|20
363149|NCT00387088|1169700|P2|Overall Study|Protocol Violation|35
363150|NCT00387088|1169701|P1|Overall Study|Protocol Violation|47
363151|NCT00387088|1169700|P2|Overall Study|Adverse Event|156
363152|NCT00387088|1169701|P1|Overall Study|Adverse Event|143
363153|NCT00387010|1169758|P1|Treatment Period|Participant reported study drug stolen|1
363154|NCT00387010|1169758|P1|Treatment Period|Noncompliance with study procedures|3
363155|NCT00387010|1169758|P1|Treatment Period|Noncompliance with study medication|2
363156|NCT00387010|1169758|P1|Treatment Period|Withdrawal by Subject|1
363157|NCT00387010|1169758|P1|Treatment Period|Adverse Event|4
363158|NCT00387010|1169758|P1|Dose Titration Period|Noncompliance with study procedures|7
363159|NCT00387010|1169758|P1|Dose Titration Period|Noncompliance with study medication|8
363160|NCT00387010|1169758|P1|Dose Titration Period|Lost to Follow-up|2
363161|NCT00387010|1169758|P1|Dose Titration Period|Protocol Violation|1
363162|NCT00387010|1169758|P1|Dose Titration Period|Withdrawal by Subject|3
363163|NCT00387010|1169758|P1|Dose Titration Period|Lack of Efficacy|5
363164|NCT00387010|1169758|P1|Dose Titration Period|Adverse Event|12
363165|NCT00386776|1169785|P1|Overall Study|Withdrawal by Subject|8
363166|NCT00386607|1169795|P2|Extension|Unsatisfactory therapeutic effect|1
363167|NCT00386607|1169796|P1|Extension|Unsatisfactory therapeutic effect|0
363168|NCT00386607|1169795|P2|Extension|Patient withdrew consent|5
363169|NCT00386607|1169796|P1|Extension|Patient withdrew consent|0
363170|NCT00386607|1169795|P2|Extension|Lost to Follow-up|3
363171|NCT00386607|1169796|P1|Extension|Lost to Follow-up|0
363172|NCT00386607|1169795|P2|Extension|Administrative problems|1
363173|NCT00386607|1169796|P1|Extension|Administrative problems|0
363174|NCT00386607|1169795|P2|Extension|Abnormal laboratory value(s)|1
363175|NCT00386607|1169796|P1|Extension|Abnormal laboratory value(s)|0
363176|NCT00386607|1169795|P2|Extension|Adverse Event|6
363177|NCT00386607|1169796|P1|Extension|Adverse Event|0
363178|NCT00386607|1169795|P2|Core|Protocol Deviation|0
363179|NCT00386607|1169796|P1|Core|Protocol Deviation|6
363180|NCT00386607|1169795|P2|Core|Administrative problems|0
363181|NCT00386607|1169796|P1|Core|Administrative problems|1
363182|NCT00386607|1169795|P2|Core|Lost to Follow-up|0
363183|NCT00386607|1169796|P1|Core|Lost to Follow-up|23
363184|NCT00386607|1169795|P2|Core|Patient withdrew consent|0
363185|NCT00386607|1169796|P1|Core|Patient withdrew consent|15
363186|NCT00386607|1169795|P2|Core|Condition no longer requires study drug|0
363187|NCT00386607|1169796|P1|Core|Condition no longer requires study drug|4
363188|NCT00386607|1169795|P2|Core|Unsatisfactory therapeutic effect|0
363189|NCT00386607|1169796|P1|Core|Unsatisfactory therapeutic effect|23
363190|NCT00386607|1169795|P2|Core|Abnormal laboratory value(s)|0
363191|NCT00386607|1169796|P1|Core|Abnormal laboratory value(s)|3
363192|NCT00386607|1169795|P2|Core|Adverse Event|0
363193|NCT00386607|1169796|P1|Core|Adverse Event|40
363194|NCT00386425|1169824|P3|Overall Study|Withdrawal by Subject|0
363195|NCT00386425|1169825|P2|Overall Study|Withdrawal by Subject|1
363196|NCT00386425|1169826|P1|Overall Study|Withdrawal by Subject|0
363197|NCT00386425|1169824|P3|Overall Study|Physician Decision|0
363198|NCT00386425|1169825|P2|Overall Study|Physician Decision|0
363199|NCT00386425|1169826|P1|Overall Study|Physician Decision|3
363200|NCT00386360|1169852|P2|Overall Study|Did not take any study medication|2
363201|NCT00386360|1169853|P1|Overall Study|Did not take any study medication|0
363202|NCT00386360|1169852|P2|Overall Study|Withdrawal by Subject|6
363203|NCT00386360|1169853|P1|Overall Study|Withdrawal by Subject|3
363204|NCT00386360|1169852|P2|Overall Study|Protocol Violation|3
363205|NCT00386360|1169853|P1|Overall Study|Protocol Violation|0
363206|NCT00386360|1169852|P2|Overall Study|Lost to Follow-up|2
363207|NCT00386360|1169853|P1|Overall Study|Lost to Follow-up|0
363208|NCT00386360|1169852|P2|Overall Study|Physician Decision|2
363209|NCT00386360|1169853|P1|Overall Study|Physician Decision|2
363210|NCT00386360|1169852|P2|Overall Study|Adverse Event|2
363211|NCT00386360|1169853|P1|Overall Study|Adverse Event|4
363212|NCT00386334|1169887|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
363213|NCT00386334|1169888|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
363214|NCT00386334|1169887|P2|Double Blind Period|Other|3
363215|NCT00386334|1169888|P1|Double Blind Period|Other|3
363216|NCT00386334|1169887|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
363217|NCT00386334|1169888|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
363218|NCT00386334|1169887|P2|Double Blind Period|Lack of Efficacy|11
363219|NCT00386334|1169888|P1|Double Blind Period|Lack of Efficacy|20
363220|NCT00386334|1169887|P2|Double Blind Period|Withdrawal by Subject|13
363221|NCT00386334|1169888|P1|Double Blind Period|Withdrawal by Subject|9
363222|NCT00386334|1169887|P2|Double Blind Period|Protocol Violation|1
363223|NCT00386334|1169888|P1|Double Blind Period|Protocol Violation|1
363224|NCT00386334|1169887|P2|Double Blind Period|Adverse Event|14
363225|NCT00386334|1169888|P1|Double Blind Period|Adverse Event|9
363226|NCT00386308|1170032|P2|Overall Study|Other Event|1
363227|NCT00386308|1170033|P1|Overall Study|Other Event|8
363228|NCT00386308|1170032|P2|Overall Study|Withdrawal by Subject|2
363229|NCT00386308|1170033|P1|Overall Study|Withdrawal by Subject|6
363230|NCT00386308|1170032|P2|Overall Study|Lost to Follow-up|6
363231|NCT00386308|1170033|P1|Overall Study|Lost to Follow-up|10
363232|NCT00386308|1170032|P2|Overall Study|Lack of Efficacy|2
363233|NCT00386308|1170033|P1|Overall Study|Lack of Efficacy|0
363234|NCT00386308|1170032|P2|Overall Study|Protocol Violation|5
363235|NCT00386308|1170033|P1|Overall Study|Protocol Violation|2
363236|NCT00386308|1170032|P2|Overall Study|Adverse Event|3
363237|NCT00386308|1170033|P1|Overall Study|Adverse Event|3
363238|NCT00386152|1170080|P3|Overall Study|Withdrawal by Subject|10
363239|NCT00386152|1170081|P2|Overall Study|Withdrawal by Subject|6
363240|NCT00386152|1170082|P1|Overall Study|Withdrawal by Subject|3
363241|NCT00386152|1170080|P3|Overall Study|Protocol Violation|2
363242|NCT00386152|1170081|P2|Overall Study|Protocol Violation|5
363243|NCT00386152|1170082|P1|Overall Study|Protocol Violation|3
363244|NCT00386152|1170080|P3|Overall Study|Completed chemotherapy|1
363245|NCT00386152|1170081|P2|Overall Study|Completed chemotherapy|5
363246|NCT00386152|1170082|P1|Overall Study|Completed chemotherapy|4
363247|NCT00386152|1170080|P3|Overall Study|Lost to Follow-up|0
363248|NCT00386152|1170081|P2|Overall Study|Lost to Follow-up|0
363249|NCT00386152|1170082|P1|Overall Study|Lost to Follow-up|1
363250|NCT00386152|1170080|P3|Overall Study|Physician Decision|4
363251|NCT00386152|1170081|P2|Overall Study|Physician Decision|10
363252|NCT00386152|1170082|P1|Overall Study|Physician Decision|13
363253|NCT00386152|1170080|P3|Overall Study|Disease progression|5
363254|NCT00386152|1170081|P2|Overall Study|Disease progression|4
363255|NCT00386152|1170082|P1|Overall Study|Disease progression|7
363256|NCT00386152|1170080|P3|Overall Study|Death|1
363257|NCT00386152|1170081|P2|Overall Study|Death|0
363258|NCT00386152|1170082|P1|Overall Study|Death|3
363259|NCT00386152|1170080|P3|Overall Study|Chang from original chemo stratification|6
363260|NCT00386152|1170081|P2|Overall Study|Chang from original chemo stratification|5
363261|NCT00386152|1170082|P1|Overall Study|Chang from original chemo stratification|4
363262|NCT00386152|1170080|P3|Overall Study|Adverse Event|4
363263|NCT00386152|1170081|P2|Overall Study|Adverse Event|5
363264|NCT00386152|1170082|P1|Overall Study|Adverse Event|6
363265|NCT00386100|1170101|P2|Overall Study|Participant randomized in error|0
363266|NCT00386100|1170102|P1|Overall Study|Participant randomized in error|1
363267|NCT00386100|1170101|P2|Overall Study|Hb1Ac >8%|1
363268|NCT00386100|1170102|P1|Overall Study|Hb1Ac >8%|0
363269|NCT00386100|1170101|P2|Overall Study|Out of country for 5 months|0
363270|NCT00386100|1170102|P1|Overall Study|Out of country for 5 months|1
363271|NCT00386100|1170101|P2|Overall Study|Positive pregnancy test|3
363272|NCT00386100|1170102|P1|Overall Study|Positive pregnancy test|1
363273|NCT00386100|1170101|P2|Overall Study|Osteoporosis|1
363274|NCT00386100|1170102|P1|Overall Study|Osteoporosis|0
363275|NCT00386100|1170101|P2|Overall Study|7.6% bone loss|0
363276|NCT00386100|1170102|P1|Overall Study|7.6% bone loss|1
363277|NCT00386100|1170101|P2|Overall Study|DBP 93 mmHg at randomization|0
363278|NCT00386100|1170102|P1|Overall Study|DBP 93 mmHg at randomization|1
363279|NCT00386100|1170101|P2|Overall Study|Bone loss by DXA bone scan|0
363280|NCT00386100|1170102|P1|Overall Study|Bone loss by DXA bone scan|1
363281|NCT00386100|1170101|P2|Overall Study|Bad metabolic control & patient security|0
363282|NCT00386100|1170102|P1|Overall Study|Bad metabolic control & patient security|1
363283|NCT00386100|1170101|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
363284|NCT00386100|1170102|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
363285|NCT00386100|1170101|P2|Overall Study|Participant's PCP wanted to stop drug|0
363286|NCT00386100|1170102|P1|Overall Study|Participant's PCP wanted to stop drug|1
363287|NCT00386100|1170101|P2|Overall Study|Didn't meet entry criteria|1
363288|NCT00386100|1170102|P1|Overall Study|Didn't meet entry criteria|1
363289|NCT00386100|1170101|P2|Overall Study|Excessive bone loss vs. baseline value|1
363290|NCT00386100|1170102|P1|Overall Study|Excessive bone loss vs. baseline value|0
363291|NCT00386100|1170101|P2|Overall Study|Participant moving out of state|0
363292|NCT00386100|1170102|P1|Overall Study|Participant moving out of state|2
363293|NCT00386100|1170101|P2|Overall Study|Participant's concern due to CPK levels|0
363294|NCT00386100|1170102|P1|Overall Study|Participant's concern due to CPK levels|1
363295|NCT00386100|1170101|P2|Overall Study|Laboratory findings|0
363296|NCT00386100|1170102|P1|Overall Study|Laboratory findings|1
363297|NCT00386100|1170101|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
363298|NCT00386100|1170102|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
363299|NCT00386100|1170101|P2|Overall Study|Consecutive elevated Hba1C|0
363300|NCT00386100|1170102|P1|Overall Study|Consecutive elevated Hba1C|1
363301|NCT00386100|1170101|P2|Overall Study|BMD <2.5|0
363302|NCT00386100|1170102|P1|Overall Study|BMD <2.5|1
363303|NCT00386100|1170101|P2|Overall Study|Bone mass density (BMD) loss >6%|4
363304|NCT00386100|1170102|P1|Overall Study|Bone mass density (BMD) loss >6%|4
363305|NCT00386100|1170101|P2|Overall Study|Withdrawal by Subject|31
363306|NCT00386100|1170102|P1|Overall Study|Withdrawal by Subject|32
363307|NCT00386100|1170101|P2|Overall Study|Protocol Violation|3
363308|NCT00386100|1170102|P1|Overall Study|Protocol Violation|5
363309|NCT00386100|1170101|P2|Overall Study|Non-compliance|19
363310|NCT00386100|1170102|P1|Overall Study|Non-compliance|18
363311|NCT00386100|1170101|P2|Overall Study|Lost to Follow-up|29
363312|NCT00386100|1170102|P1|Overall Study|Lost to Follow-up|29
363313|NCT00386100|1170101|P2|Overall Study|Insufficient therapeutic effect|6
363314|NCT00386100|1170102|P1|Overall Study|Insufficient therapeutic effect|30
363315|NCT00386100|1170101|P2|Overall Study|Death|1
363316|NCT00386100|1170102|P1|Overall Study|Death|0
363317|NCT00386100|1170101|P2|Overall Study|Adverse Event|25
363318|NCT00386100|1170102|P1|Overall Study|Adverse Event|15
363319|NCT00386100|1170101|P2|Overall Study|Did not receive study medication|4
363406|NCT00385736|1170358|P3|Safety Analysis Set|Lack of Efficacy|31
363320|NCT00386100|1170102|P1|Overall Study|Did not receive study medication|6
363321|NCT00386022|1170166|P2|Plus Estrogen|Adverse Event|1
363322|NCT00386022|1170167|P1|Plus Estrogen|Adverse Event|0
363323|NCT00386022|1170166|P2|Plus Estrogen|Lost to Follow-up|0
363324|NCT00386022|1170167|P1|Plus Estrogen|Lost to Follow-up|2
363325|NCT00386009|1170177|P2|Overall Study|Withdrawal by Subject|4
363326|NCT00386009|1170178|P1|Overall Study|Withdrawal by Subject|5
363327|NCT00386009|1170177|P2|Overall Study|Sponsor Decision|1
363328|NCT00386009|1170178|P1|Overall Study|Sponsor Decision|1
363329|NCT00386009|1170177|P2|Overall Study|Protocol Violation|0
363330|NCT00386009|1170178|P1|Overall Study|Protocol Violation|1
363331|NCT00386009|1170177|P2|Overall Study|Lost to Follow-up|1
363332|NCT00386009|1170178|P1|Overall Study|Lost to Follow-up|1
363333|NCT00386009|1170177|P2|Overall Study|Entry Criteria Not Met|2
363334|NCT00386009|1170178|P1|Overall Study|Entry Criteria Not Met|0
363335|NCT00386009|1170177|P2|Overall Study|Death|0
363336|NCT00386009|1170178|P1|Overall Study|Death|1
363337|NCT00386009|1170177|P2|Overall Study|Adverse Event|2
363338|NCT00386009|1170178|P1|Overall Study|Adverse Event|0
363339|NCT00385944|1170223|P3|2nd Maintenance Dose Period|Invalid PD Data|0
363340|NCT00385944|1170224|P2|2nd Maintenance Dose Period|Invalid PD Data|3
363341|NCT00385944|1170225|P1|2nd Maintenance Dose Period|Invalid PD Data|2
363342|NCT00385944|1170223|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
363343|NCT00385944|1170224|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
363344|NCT00385944|1170225|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
363345|NCT00385944|1170223|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
363346|NCT00385944|1170224|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
363347|NCT00385944|1170225|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
363348|NCT00385944|1170223|P3|1st Maintenance Dose Period|Physician Decision|0
363349|NCT00385944|1170224|P2|1st Maintenance Dose Period|Physician Decision|0
363350|NCT00385944|1170225|P1|1st Maintenance Dose Period|Physician Decision|1
363351|NCT00385918|1170268|P3|Intervention Phase After Randomization|Lost to Follow-up|0
363352|NCT00385918|1170269|P2|Intervention Phase After Randomization|Lost to Follow-up|0
363353|NCT00385918|1170270|P1|Intervention Phase After Randomization|Lost to Follow-up|1
363354|NCT00385918|1170268|P3|Intervention Phase After Randomization|Physician Decision|0
363355|NCT00385918|1170269|P2|Intervention Phase After Randomization|Physician Decision|0
363356|NCT00385918|1170270|P1|Intervention Phase After Randomization|Physician Decision|1
363357|NCT00385918|1170268|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
363358|NCT00385918|1170269|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
363359|NCT00385918|1170270|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
363360|NCT00385918|1170268|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
363361|NCT00385918|1170269|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
363362|NCT00385918|1170270|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
363363|NCT00385918|1170268|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
363364|NCT00385918|1170269|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
363365|NCT00385918|1170270|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
363366|NCT00385918|1170268|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
363367|NCT00385918|1170269|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
363368|NCT00385918|1170270|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
363369|NCT00385840|1170294|P2|Overall Study|Lost to Follow-up|13
363370|NCT00385840|1170295|P1|Overall Study|Lost to Follow-up|3
363371|NCT00385840|1170294|P2|Overall Study|Adverse Event|1
363372|NCT00385840|1170295|P1|Overall Study|Adverse Event|1
363373|NCT00385827|1170318|P3|Part 2|Unspecified|21
363374|NCT00385827|1170319|P2|Part 2|Unspecified|11
363375|NCT00385827|1170320|P1|Part 2|Unspecified|0
363376|NCT00385827|1170318|P3|Part 2|Randomized but not treated|2
363377|NCT00385827|1170319|P2|Part 2|Randomized but not treated|2
363378|NCT00385827|1170320|P1|Part 2|Randomized but not treated|0
363379|NCT00385827|1170318|P3|Part 2|Lack of Efficacy|13
363380|NCT00385827|1170319|P2|Part 2|Lack of Efficacy|14
363381|NCT00385827|1170320|P1|Part 2|Lack of Efficacy|0
363382|NCT00385827|1170318|P3|Part 2|Death|2
363383|NCT00385827|1170319|P2|Part 2|Death|0
363384|NCT00385827|1170320|P1|Part 2|Death|0
363385|NCT00385827|1170318|P3|Part 2|Adverse Event|10
363386|NCT00385827|1170319|P2|Part 2|Adverse Event|6
363387|NCT00385827|1170320|P1|Part 2|Adverse Event|0
363388|NCT00385827|1170318|P3|Part 1|Unspecified|0
363389|NCT00385827|1170319|P2|Part 1|Unspecified|0
363390|NCT00385827|1170320|P1|Part 1|Unspecified|1
363391|NCT00385827|1170318|P3|Part 1|Lack of Efficacy|0
363392|NCT00385827|1170319|P2|Part 1|Lack of Efficacy|0
363393|NCT00385827|1170320|P1|Part 1|Lack of Efficacy|5
363394|NCT00385827|1170318|P3|Part 1|Death|0
363395|NCT00385827|1170319|P2|Part 1|Death|0
363396|NCT00385827|1170320|P1|Part 1|Death|2
363397|NCT00385827|1170318|P3|Part 1|Adverse Event|0
363398|NCT00385827|1170319|P2|Part 1|Adverse Event|0
363399|NCT00385827|1170320|P1|Part 1|Adverse Event|1
363400|NCT00385736|1170358|P3|Safety Analysis Set|Other|4
363401|NCT00385736|1170359|P2|Safety Analysis Set|Other|4
363402|NCT00385736|1170360|P1|Safety Analysis Set|Other|1
363403|NCT00385736|1170358|P3|Safety Analysis Set|Protocol Violation|6
363404|NCT00385736|1170359|P2|Safety Analysis Set|Protocol Violation|1
363405|NCT00385736|1170360|P1|Safety Analysis Set|Protocol Violation|2
363407|NCT00385736|1170359|P2|Safety Analysis Set|Lack of Efficacy|16
363408|NCT00385736|1170360|P1|Safety Analysis Set|Lack of Efficacy|38
363409|NCT00385736|1170358|P3|Safety Analysis Set|Lost to Follow-up|2
363410|NCT00385736|1170359|P2|Safety Analysis Set|Lost to Follow-up|2
363411|NCT00385736|1170360|P1|Safety Analysis Set|Lost to Follow-up|0
363412|NCT00385736|1170358|P3|Safety Analysis Set|Withdrawal by Subject|14
363413|NCT00385736|1170359|P2|Safety Analysis Set|Withdrawal by Subject|6
363414|NCT00385736|1170360|P1|Safety Analysis Set|Withdrawal by Subject|6
363415|NCT00385736|1170358|P3|Safety Analysis Set|Adverse Event|23
363416|NCT00385736|1170359|P2|Safety Analysis Set|Adverse Event|15
363417|NCT00385736|1170360|P1|Safety Analysis Set|Adverse Event|23
363418|NCT00385736|1170358|P3|Efficacy Analysis Set - Maintenance|Other|4
363419|NCT00385736|1170359|P2|Efficacy Analysis Set - Maintenance|Other|4
363420|NCT00385736|1170360|P1|Efficacy Analysis Set - Maintenance|Other|0
363421|NCT00385736|1170358|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
363422|NCT00385736|1170359|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
363423|NCT00385736|1170360|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
363424|NCT00385736|1170358|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
363425|NCT00385736|1170359|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
363426|NCT00385736|1170360|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
363427|NCT00385736|1170358|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
363428|NCT00385736|1170359|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
363429|NCT00385736|1170360|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
363430|NCT00385736|1170358|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
363431|NCT00385736|1170359|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
363432|NCT00385736|1170360|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
363433|NCT00385736|1170358|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
363434|NCT00385736|1170359|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
363435|NCT00385736|1170360|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
363436|NCT00385736|1170358|P3|Efficacy Analysis Set - Induction|Other|1
363437|NCT00385736|1170359|P2|Efficacy Analysis Set - Induction|Other|0
363438|NCT00385736|1170360|P1|Efficacy Analysis Set - Induction|Other|0
363439|NCT00385736|1170358|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
363440|NCT00385736|1170359|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
363441|NCT00385736|1170360|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
363442|NCT00385736|1170358|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
363443|NCT00385736|1170359|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
363444|NCT00385736|1170360|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
363445|NCT00385736|1170358|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
363446|NCT00385736|1170359|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
363447|NCT00385736|1170360|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
363448|NCT00385736|1170358|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
363449|NCT00385736|1170359|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
363450|NCT00385736|1170360|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
363451|NCT00385736|1170358|P3|Efficacy Analysis Set - Induction|Adverse Event|4
363452|NCT00385736|1170359|P2|Efficacy Analysis Set - Induction|Adverse Event|6
363453|NCT00385736|1170360|P1|Efficacy Analysis Set - Induction|Adverse Event|5
363454|NCT00385723|1170405|P3|Overall Study|Withdrawal by Subject|2
363455|NCT00385723|1170406|P2|Overall Study|Withdrawal by Subject|0
363456|NCT00385723|1170407|P1|Overall Study|Withdrawal by Subject|1
363457|NCT00385723|1170405|P3|Overall Study|Lost to Follow-up|0
363458|NCT00385723|1170406|P2|Overall Study|Lost to Follow-up|1
363459|NCT00385723|1170407|P1|Overall Study|Lost to Follow-up|1
363460|NCT00385684|1170421|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
363461|NCT00385684|1170422|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
363462|NCT00385684|1170421|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
363463|NCT00385684|1170422|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
363464|NCT00385684|1170421|P2|FIRST INTERVENTION OF PHASE A|Death|0
363465|NCT00385684|1170422|P1|FIRST INTERVENTION OF PHASE A|Death|1
363466|NCT00385671|1170431|P3|Overall Study|Withdrawal by Subject|4
363467|NCT00385671|1170432|P2|Overall Study|Withdrawal by Subject|4
363468|NCT00385671|1170433|P1|Overall Study|Withdrawal by Subject|4
363469|NCT00385671|1170431|P3|Overall Study|Sponsor Decision|1
363470|NCT00385671|1170432|P2|Overall Study|Sponsor Decision|2
363471|NCT00385671|1170433|P1|Overall Study|Sponsor Decision|2
363472|NCT00385671|1170431|P3|Overall Study|Protocol Violation|1
363473|NCT00385671|1170432|P2|Overall Study|Protocol Violation|2
363474|NCT00385671|1170433|P1|Overall Study|Protocol Violation|5
363475|NCT00385671|1170431|P3|Overall Study|Physician Decision|2
363476|NCT00385671|1170432|P2|Overall Study|Physician Decision|1
363477|NCT00385671|1170433|P1|Overall Study|Physician Decision|2
363478|NCT00385671|1170431|P3|Overall Study|Lost to Follow-up|5
363479|NCT00385671|1170432|P2|Overall Study|Lost to Follow-up|6
363480|NCT00385671|1170433|P1|Overall Study|Lost to Follow-up|6
363481|NCT00385671|1170431|P3|Overall Study|Lack of Efficacy|5
363482|NCT00385671|1170432|P2|Overall Study|Lack of Efficacy|9
363483|NCT00385671|1170433|P1|Overall Study|Lack of Efficacy|5
363484|NCT00385671|1170431|P3|Overall Study|Adverse Event|18
363485|NCT00385671|1170432|P2|Overall Study|Adverse Event|27
363486|NCT00385671|1170433|P1|Overall Study|Adverse Event|14
363487|NCT00385593|1170589|P2|Overall Study|Incorrect randomization|1
363488|NCT00385593|1170590|P1|Overall Study|Incorrect randomization|0
363489|NCT00385593|1170589|P2|Overall Study|Incorrect inclusion|0
363490|NCT00385593|1170590|P1|Overall Study|Incorrect inclusion|2
363491|NCT00385593|1170589|P2|Overall Study|Several reasons|15
363492|NCT00385593|1170590|P1|Overall Study|Several reasons|17
363493|NCT00385593|1170589|P2|Overall Study|Protocol Violation|4
363494|NCT00385593|1170590|P1|Overall Study|Protocol Violation|7
363495|NCT00385593|1170589|P2|Overall Study|Lost to Follow-up|8
363496|NCT00385593|1170590|P1|Overall Study|Lost to Follow-up|12
363497|NCT00385593|1170589|P2|Overall Study|Withdrawal by Subject|7
363498|NCT00385593|1170590|P1|Overall Study|Withdrawal by Subject|17
363499|NCT00385593|1170589|P2|Overall Study|Adverse Event|2
363500|NCT00385593|1170590|P1|Overall Study|Adverse Event|3
363501|NCT00385541|1170700|P2|Overall Study|severe pain, clinician requested unblind|1
363502|NCT00385541|1170701|P1|Overall Study|severe pain, clinician requested unblind|0
363503|NCT00385203|1170748|P2|Overall Study|Incorrect enrollment|0
363504|NCT00385203|1170749|P1|Overall Study|Incorrect enrollment|2
363505|NCT00385203|1170748|P2|Overall Study|Condition under investigation worsened|3
363506|NCT00385203|1170749|P1|Overall Study|Condition under investigation worsened|18
363507|NCT00385203|1170748|P2|Overall Study|Death|0
363508|NCT00385203|1170749|P1|Overall Study|Death|1
363509|NCT00385203|1170748|P2|Overall Study|Adverse Event|4
363510|NCT00385203|1170749|P1|Overall Study|Adverse Event|5
363511|NCT00384956|1170814|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
363512|NCT00384930|1170831|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
363513|NCT00384930|1170832|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
363514|NCT00384930|1170833|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
363515|NCT00384930|1170834|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
363516|NCT00384930|1170835|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
363517|NCT00384930|1170831|P5|Overall Study|Withdrawal by Subject|16
363518|NCT00384930|1170832|P4|Overall Study|Withdrawal by Subject|6
363519|NCT00384930|1170833|P3|Overall Study|Withdrawal by Subject|7
363520|NCT00384930|1170834|P2|Overall Study|Withdrawal by Subject|7
363521|NCT00384930|1170835|P1|Overall Study|Withdrawal by Subject|9
363522|NCT00384930|1170831|P5|Overall Study|Sponsor Decision|0
363523|NCT00384930|1170832|P4|Overall Study|Sponsor Decision|5
363524|NCT00384930|1170833|P3|Overall Study|Sponsor Decision|0
363525|NCT00384930|1170834|P2|Overall Study|Sponsor Decision|4
363526|NCT00384930|1170835|P1|Overall Study|Sponsor Decision|3
363527|NCT00384930|1170831|P5|Overall Study|Protocol Violation|4
363528|NCT00384930|1170832|P4|Overall Study|Protocol Violation|6
363529|NCT00384930|1170833|P3|Overall Study|Protocol Violation|1
363530|NCT00384930|1170834|P2|Overall Study|Protocol Violation|0
363531|NCT00384930|1170835|P1|Overall Study|Protocol Violation|1
363532|NCT00384930|1170831|P5|Overall Study|Physician Decision|1
363533|NCT00384930|1170832|P4|Overall Study|Physician Decision|0
363534|NCT00384930|1170833|P3|Overall Study|Physician Decision|1
363535|NCT00384930|1170834|P2|Overall Study|Physician Decision|1
363536|NCT00384930|1170835|P1|Overall Study|Physician Decision|0
363537|NCT00384930|1170831|P5|Overall Study|Lost to Follow-up|6
363538|NCT00384930|1170832|P4|Overall Study|Lost to Follow-up|4
363539|NCT00384930|1170833|P3|Overall Study|Lost to Follow-up|0
363540|NCT00384930|1170834|P2|Overall Study|Lost to Follow-up|3
363541|NCT00384930|1170835|P1|Overall Study|Lost to Follow-up|5
363542|NCT00384930|1170831|P5|Overall Study|Lack of Efficacy|2
363543|NCT00384930|1170832|P4|Overall Study|Lack of Efficacy|1
363544|NCT00384930|1170833|P3|Overall Study|Lack of Efficacy|2
363545|NCT00384930|1170834|P2|Overall Study|Lack of Efficacy|1
363546|NCT00384930|1170835|P1|Overall Study|Lack of Efficacy|1
363547|NCT00384930|1170831|P5|Overall Study|Entry Criteria Not Met|4
363548|NCT00384930|1170832|P4|Overall Study|Entry Criteria Not Met|8
363549|NCT00384930|1170833|P3|Overall Study|Entry Criteria Not Met|7
363550|NCT00384930|1170834|P2|Overall Study|Entry Criteria Not Met|6
363551|NCT00384930|1170835|P1|Overall Study|Entry Criteria Not Met|2
363552|NCT00384930|1170831|P5|Overall Study|Adverse Event|14
363553|NCT00384930|1170832|P4|Overall Study|Adverse Event|11
363554|NCT00384930|1170833|P3|Overall Study|Adverse Event|12
363555|NCT00384930|1170834|P2|Overall Study|Adverse Event|4
363556|NCT00384930|1170835|P1|Overall Study|Adverse Event|5
363557|NCT00384397|1170920|P3|Overall Study|Withdrawal by Subject|15
363558|NCT00384397|1170921|P2|Overall Study|Withdrawal by Subject|17
363559|NCT00384397|1170922|P1|Overall Study|Withdrawal by Subject|14
363560|NCT00384397|1170920|P3|Overall Study|Lost to Follow-up|3
363561|NCT00384397|1170921|P2|Overall Study|Lost to Follow-up|13
363562|NCT00384397|1170922|P1|Overall Study|Lost to Follow-up|11
363563|NCT00384397|1170920|P3|Overall Study|Protocol Violation|13
363564|NCT00384397|1170921|P2|Overall Study|Protocol Violation|15
363565|NCT00384397|1170922|P1|Overall Study|Protocol Violation|7
363566|NCT00384397|1170920|P3|Overall Study|Adverse Event|2
363567|NCT00384397|1170921|P2|Overall Study|Adverse Event|1
363568|NCT00384397|1170922|P1|Overall Study|Adverse Event|0
363569|NCT00384293|1170941|P3|Post-randomization Period|Patient Randomized in Error|1
363570|NCT00384293|1170942|P2|Post-randomization Period|Patient Randomized in Error|0
363571|NCT00384293|1170943|P1|Post-randomization Period|Patient Randomized in Error|0
363572|NCT00384293|1170941|P3|Post-randomization Period|Trial Termination|204
363573|NCT00384293|1170942|P2|Post-randomization Period|Trial Termination|180
363574|NCT00384293|1170943|P1|Post-randomization Period|Trial Termination|0
363575|NCT00384293|1170941|P3|Post-randomization Period|Withdrawal by Subject|6
363576|NCT00384293|1170942|P2|Post-randomization Period|Withdrawal by Subject|8
363577|NCT00384293|1170943|P1|Post-randomization Period|Withdrawal by Subject|0
363578|NCT00384293|1170941|P3|Post-randomization Period|Protocol Violation|0
363579|NCT00384293|1170942|P2|Post-randomization Period|Protocol Violation|1
363580|NCT00384293|1170943|P1|Post-randomization Period|Protocol Violation|0
363581|NCT00384293|1170941|P3|Post-randomization Period|Lost to Follow-up|1
363582|NCT00384293|1170942|P2|Post-randomization Period|Lost to Follow-up|2
363583|NCT00384293|1170943|P1|Post-randomization Period|Lost to Follow-up|0
363584|NCT00384293|1170941|P3|Post-randomization Period|Adverse Event|7
363585|NCT00384293|1170942|P2|Post-randomization Period|Adverse Event|23
363586|NCT00384293|1170943|P1|Post-randomization Period|Adverse Event|0
363587|NCT00384293|1170941|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
363588|NCT00384293|1170942|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
363589|NCT00384293|1170943|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
363590|NCT00384293|1170941|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
363591|NCT00384293|1170942|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
363592|NCT00384293|1170943|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
363593|NCT00384293|1170941|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
363594|NCT00384293|1170942|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
363595|NCT00384293|1170943|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
363596|NCT00384293|1170941|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
363597|NCT00384293|1170942|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
363598|NCT00384293|1170943|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
363599|NCT00384293|1170941|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
363600|NCT00384293|1170942|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
363601|NCT00384293|1170943|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
363602|NCT00384293|1170941|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
363603|NCT00384293|1170942|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
363604|NCT00384293|1170943|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
363605|NCT00384293|1170941|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
363606|NCT00384293|1170942|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
363607|NCT00384293|1170943|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
363608|NCT00384189|1170967|P4|Overall Study|Reason Not Specified|40
363609|NCT00384189|1170968|P3|Overall Study|Reason Not Specified|58
363610|NCT00384189|1170969|P2|Overall Study|Reason Not Specified|57
363611|NCT00384189|1170970|P1|Overall Study|Reason Not Specified|50
363612|NCT00384176|1171031|P3|Overall Study|Liver metastases, colon resec. planned|0
363613|NCT00384176|1171032|P2|Overall Study|Liver metastases, colon resec. planned|0
363614|NCT00384176|1171033|P1|Overall Study|Liver metastases, colon resec. planned|1
363615|NCT00384176|1171031|P3|Overall Study|Physician Decision|0
363616|NCT00384176|1171032|P2|Overall Study|Physician Decision|2
363617|NCT00384176|1171033|P1|Overall Study|Physician Decision|0
363618|NCT00384176|1171031|P3|Overall Study|Did not receive study treatment|1
363619|NCT00384176|1171032|P2|Overall Study|Did not receive study treatment|1
363620|NCT00384176|1171033|P1|Overall Study|Did not receive study treatment|0
363621|NCT00384176|1171031|P3|Overall Study|Toxicity of treatment|0
363622|NCT00384176|1171032|P2|Overall Study|Toxicity of treatment|0
363623|NCT00384176|1171033|P1|Overall Study|Toxicity of treatment|1
363624|NCT00384176|1171031|P3|Overall Study|Longer QTC as Visit 1|0
363625|NCT00384176|1171032|P2|Overall Study|Longer QTC as Visit 1|0
363626|NCT00384176|1171033|P1|Overall Study|Longer QTC as Visit 1|1
363627|NCT00384176|1171031|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
363628|NCT00384176|1171032|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
363629|NCT00384176|1171033|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
363630|NCT00384176|1171031|P3|Overall Study|Lost to Follow-up|4
363631|NCT00384176|1171032|P2|Overall Study|Lost to Follow-up|18
363632|NCT00384176|1171033|P1|Overall Study|Lost to Follow-up|16
363633|NCT00384176|1171031|P3|Overall Study|Withdrawal by Subject|22
363634|NCT00384176|1171032|P2|Overall Study|Withdrawal by Subject|48
363635|NCT00384176|1171033|P1|Overall Study|Withdrawal by Subject|52
363636|NCT00384176|1171031|P3|Overall Study|Death|105
363637|NCT00384176|1171032|P2|Overall Study|Death|247
363638|NCT00384176|1171033|P1|Overall Study|Death|239
363639|NCT00384085|1171059|P3|Overall Study|Patient required surgery|0
363640|NCT00384085|1171060|P2|Overall Study|Patient required surgery|1
363641|NCT00384085|1171061|P1|Overall Study|Patient required surgery|0
363642|NCT00384085|1171059|P3|Overall Study|Patient moved|1
363643|NCT00384085|1171060|P2|Overall Study|Patient moved|0
363644|NCT00384085|1171061|P1|Overall Study|Patient moved|1
363645|NCT00384085|1171059|P3|Overall Study|Sponsor decision|1
363646|NCT00384085|1171060|P2|Overall Study|Sponsor decision|2
363647|NCT00384085|1171061|P1|Overall Study|Sponsor decision|1
363648|NCT00384085|1171059|P3|Overall Study|Loss of site personnel|1
363649|NCT00384085|1171060|P2|Overall Study|Loss of site personnel|0
363650|NCT00384085|1171061|P1|Overall Study|Loss of site personnel|1
363651|NCT00384085|1171059|P3|Overall Study|Physician Decision|0
363652|NCT00384085|1171060|P2|Overall Study|Physician Decision|0
363653|NCT00384085|1171061|P1|Overall Study|Physician Decision|1
363654|NCT00384085|1171059|P3|Overall Study|Patient non-compliant|5
363655|NCT00384085|1171060|P2|Overall Study|Patient non-compliant|4
363656|NCT00384085|1171061|P1|Overall Study|Patient non-compliant|4
363657|NCT00384085|1171059|P3|Overall Study|Withdrawal by Subject|29
363658|NCT00384085|1171060|P2|Overall Study|Withdrawal by Subject|19
363659|NCT00384085|1171061|P1|Overall Study|Withdrawal by Subject|14
363660|NCT00384085|1171059|P3|Overall Study|Progressive Disease|0
363661|NCT00384085|1171060|P2|Overall Study|Progressive Disease|1
363662|NCT00384085|1171061|P1|Overall Study|Progressive Disease|0
363663|NCT00384085|1171059|P3|Overall Study|Lost to Follow-up|10
363664|NCT00384085|1171060|P2|Overall Study|Lost to Follow-up|9
363665|NCT00384085|1171061|P1|Overall Study|Lost to Follow-up|9
363666|NCT00384085|1171059|P3|Overall Study|Protocol Violation|2
363667|NCT00384085|1171060|P2|Overall Study|Protocol Violation|2
363668|NCT00384085|1171061|P1|Overall Study|Protocol Violation|2
363669|NCT00384085|1171059|P3|Overall Study|No longer Requires Study Treatment|1
363670|NCT00384085|1171060|P2|Overall Study|No longer Requires Study Treatment|0
363671|NCT00384085|1171061|P1|Overall Study|No longer Requires Study Treatment|1
363672|NCT00384085|1171059|P3|Overall Study|Lack of Efficacy|2
363673|NCT00384085|1171060|P2|Overall Study|Lack of Efficacy|3
363674|NCT00384085|1171061|P1|Overall Study|Lack of Efficacy|0
363675|NCT00384085|1171059|P3|Overall Study|Adverse Event|4
363676|NCT00384085|1171060|P2|Overall Study|Adverse Event|5
363677|NCT00384085|1171061|P1|Overall Study|Adverse Event|5
363678|NCT00384059|1171087|P2|Toddler Dose|Failed to return|1
363679|NCT00384059|1171088|P1|Toddler Dose|Failed to return|0
363680|NCT00384059|1171087|P2|Toddler Dose|Lost to Follow-up|1
363681|NCT00384059|1171088|P1|Toddler Dose|Lost to Follow-up|1
363682|NCT00384059|1171087|P2|After Infant Series|Lost to Follow-up|1
363683|NCT00384059|1171088|P1|After Infant Series|Lost to Follow-up|0
363684|NCT00384059|1171087|P2|After Infant Series|Physician Decision|1
363685|NCT00384059|1171088|P1|After Infant Series|Physician Decision|0
363686|NCT00384059|1171087|P2|After Infant Series|Adverse Event|1
363687|NCT00384059|1171088|P1|After Infant Series|Adverse Event|0
363688|NCT00384059|1171087|P2|After Infant Series|Failed to Return|2
363689|NCT00384059|1171088|P1|After Infant Series|Failed to Return|0
363690|NCT00384059|1171087|P2|After Infant Series|Withdrawal by Subject|2
363691|NCT00384059|1171088|P1|After Infant Series|Withdrawal by Subject|2
363692|NCT00384059|1171087|P2|After Infant Series|Protocol Violation|3
363693|NCT00384059|1171088|P1|After Infant Series|Protocol Violation|2
363694|NCT00384059|1171087|P2|Infant Series|Lost to Follow-up|1
363695|NCT00384059|1171088|P1|Infant Series|Lost to Follow-up|0
363696|NCT00384059|1171087|P2|Infant Series|Protocol Violation|2
363697|NCT00384059|1171088|P1|Infant Series|Protocol Violation|1
363698|NCT00384059|1171087|P2|Infant Series|Adverse Event|2
363699|NCT00384059|1171088|P1|Infant Series|Adverse Event|1
363700|NCT00384059|1171087|P2|Infant Series|Withdrawal by Subject|2
363701|NCT00384059|1171088|P1|Infant Series|Withdrawal by Subject|2
363702|NCT00384059|1171087|P2|Infant Series|Not consented|6
363703|NCT00384059|1171088|P1|Infant Series|Not consented|2
363704|NCT00384033|1171138|P4|Overall Study|Randomized but not treated|2
363705|NCT00384033|1171139|P3|Overall Study|Randomized but not treated|10
363706|NCT00384033|1171140|P2|Overall Study|Randomized but not treated|7
363707|NCT00384033|1171141|P1|Overall Study|Randomized but not treated|3
363708|NCT00384033|1171138|P4|Overall Study|Lack of Efficacy|1
363709|NCT00384033|1171139|P3|Overall Study|Lack of Efficacy|3
363710|NCT00384033|1171140|P2|Overall Study|Lack of Efficacy|3
363711|NCT00384033|1171141|P1|Overall Study|Lack of Efficacy|7
363712|NCT00384033|1171138|P4|Overall Study|Withdrawal by Subject|2
363713|NCT00384033|1171139|P3|Overall Study|Withdrawal by Subject|5
363714|NCT00384033|1171140|P2|Overall Study|Withdrawal by Subject|2
363715|NCT00384033|1171141|P1|Overall Study|Withdrawal by Subject|6
363716|NCT00384033|1171138|P4|Overall Study|Protocol Violation|6
363717|NCT00384033|1171139|P3|Overall Study|Protocol Violation|5
363718|NCT00384033|1171140|P2|Overall Study|Protocol Violation|0
363719|NCT00384033|1171141|P1|Overall Study|Protocol Violation|5
363720|NCT00384033|1171138|P4|Overall Study|Unspecified|0
363721|NCT00384033|1171139|P3|Overall Study|Unspecified|0
363722|NCT00384033|1171140|P2|Overall Study|Unspecified|0
363723|NCT00384033|1171141|P1|Overall Study|Unspecified|2
363724|NCT00384033|1171138|P4|Overall Study|Lost to Follow-up|7
363725|NCT00384033|1171139|P3|Overall Study|Lost to Follow-up|7
363726|NCT00384033|1171140|P2|Overall Study|Lost to Follow-up|12
363727|NCT00384033|1171141|P1|Overall Study|Lost to Follow-up|6
363728|NCT00384033|1171138|P4|Overall Study|Physician Decision|0
363729|NCT00384033|1171139|P3|Overall Study|Physician Decision|0
363730|NCT00384033|1171140|P2|Overall Study|Physician Decision|0
363731|NCT00384033|1171141|P1|Overall Study|Physician Decision|1
363732|NCT00384033|1171138|P4|Overall Study|Failed to return|2
363733|NCT00384033|1171139|P3|Overall Study|Failed to return|2
363734|NCT00384033|1171140|P2|Overall Study|Failed to return|3
363735|NCT00384033|1171141|P1|Overall Study|Failed to return|1
363736|NCT00384033|1171138|P4|Overall Study|Adverse Event|20
363737|NCT00384033|1171139|P3|Overall Study|Adverse Event|11
363738|NCT00384033|1171140|P2|Overall Study|Adverse Event|8
363739|NCT00384033|1171141|P1|Overall Study|Adverse Event|10
363740|NCT00383786|1171194|P2|Overall Study|Physician Decision|1
363741|NCT00383786|1171195|P1|Overall Study|Physician Decision|0
363742|NCT00383786|1171194|P2|Overall Study|Withdrawal by Subject|5
363743|NCT00383786|1171195|P1|Overall Study|Withdrawal by Subject|2
363744|NCT00383786|1171194|P2|Overall Study|Protocol Violation|6
363745|NCT00383786|1171195|P1|Overall Study|Protocol Violation|2
363746|NCT00383721|1171245|P5|26-Week Treatment Safety Extension|Administrative|0
363747|NCT00383721|1171246|P4|26-Week Treatment Safety Extension|Administrative|1
363748|NCT00383721|1171247|P3|26-Week Treatment Safety Extension|Administrative|3
363749|NCT00383721|1171248|P2|26-Week Treatment Safety Extension|Administrative|2
363750|NCT00383721|1171249|P1|26-Week Treatment Safety Extension|Administrative|1
363751|NCT00383721|1171245|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
363752|NCT00383721|1171246|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
363753|NCT00383721|1171247|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
363754|NCT00383721|1171248|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
363755|NCT00383721|1171249|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
363973|NCT00383240|1171459|P2|Overall Study|Lost to Follow-up|0
363756|NCT00383721|1171245|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
363757|NCT00383721|1171246|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
363758|NCT00383721|1171247|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
363759|NCT00383721|1171248|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
363760|NCT00383721|1171249|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
363761|NCT00383721|1171245|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
363762|NCT00383721|1171246|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
363763|NCT00383721|1171247|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
363764|NCT00383721|1171248|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
363765|NCT00383721|1171249|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
363766|NCT00383721|1171245|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
363767|NCT00383721|1171246|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
363768|NCT00383721|1171247|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
363769|NCT00383721|1171248|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
363770|NCT00383721|1171249|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
363771|NCT00383721|1171245|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
363772|NCT00383721|1171246|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
363773|NCT00383721|1171247|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
363774|NCT00383721|1171248|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
363775|NCT00383721|1171249|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
363776|NCT00383721|1171245|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
363777|NCT00383721|1171246|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
363778|NCT00383721|1171247|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
363779|NCT00383721|1171248|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
363780|NCT00383721|1171249|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
363781|NCT00383721|1171245|P5|26-Week Treatment Safety Extension|Adverse Event|0
363782|NCT00383721|1171246|P4|26-Week Treatment Safety Extension|Adverse Event|1
363783|NCT00383721|1171247|P3|26-Week Treatment Safety Extension|Adverse Event|10
363784|NCT00383721|1171248|P2|26-Week Treatment Safety Extension|Adverse Event|7
363785|NCT00383721|1171249|P1|26-Week Treatment Safety Extension|Adverse Event|6
363786|NCT00383721|1171245|P5|26-Week Double-Blind Treatment Period|Ongoing|0
363787|NCT00383721|1171246|P4|26-Week Double-Blind Treatment Period|Ongoing|0
363788|NCT00383721|1171247|P3|26-Week Double-Blind Treatment Period|Ongoing|0
363789|NCT00383721|1171248|P2|26-Week Double-Blind Treatment Period|Ongoing|0
363790|NCT00383721|1171249|P1|26-Week Double-Blind Treatment Period|Ongoing|1
363791|NCT00383721|1171245|P5|26-Week Double-Blind Treatment Period|Administrative|3
363792|NCT00383721|1171246|P4|26-Week Double-Blind Treatment Period|Administrative|3
363793|NCT00383721|1171247|P3|26-Week Double-Blind Treatment Period|Administrative|3
363794|NCT00383721|1171248|P2|26-Week Double-Blind Treatment Period|Administrative|3
363795|NCT00383721|1171249|P1|26-Week Double-Blind Treatment Period|Administrative|1
363796|NCT00383721|1171245|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
363797|NCT00383721|1171246|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
363798|NCT00383721|1171247|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
363799|NCT00383721|1171248|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
363800|NCT00383721|1171249|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
363801|NCT00383721|1171245|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
363802|NCT00383721|1171246|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
363803|NCT00383721|1171247|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
363804|NCT00383721|1171248|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
363805|NCT00383721|1171249|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
363806|NCT00383721|1171245|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
363807|NCT00383721|1171246|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
363808|NCT00383721|1171247|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
363809|NCT00383721|1171248|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
363810|NCT00383721|1171249|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
363811|NCT00383721|1171245|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
363812|NCT00383721|1171246|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
363813|NCT00383721|1171247|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
363814|NCT00383721|1171248|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
363815|NCT00383721|1171249|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
363816|NCT00383721|1171245|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
363817|NCT00383721|1171246|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
363818|NCT00383721|1171247|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
363819|NCT00383721|1171248|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
363820|NCT00383721|1171249|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
363821|NCT00383721|1171245|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
363822|NCT00383721|1171246|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
363823|NCT00383721|1171247|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
363824|NCT00383721|1171248|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
363825|NCT00383721|1171249|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
363826|NCT00383721|1171245|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
363827|NCT00383721|1171246|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
363828|NCT00383721|1171247|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
363829|NCT00383721|1171248|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
363830|NCT00383721|1171249|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
363831|NCT00383552|1171321|P4|Overall Study|Administrative|1
363832|NCT00383552|1171322|P3|Overall Study|Administrative|1
363833|NCT00383552|1171323|P2|Overall Study|Administrative|0
363834|NCT00383552|1171324|P1|Overall Study|Administrative|1
363835|NCT00383552|1171321|P4|Overall Study|Did not meet protocol eligibility|3
363836|NCT00383552|1171322|P3|Overall Study|Did not meet protocol eligibility|2
363837|NCT00383552|1171323|P2|Overall Study|Did not meet protocol eligibility|6
363838|NCT00383552|1171324|P1|Overall Study|Did not meet protocol eligibility|8
363839|NCT00383552|1171321|P4|Overall Study|Noncompliance with the protocol|10
363840|NCT00383552|1171322|P3|Overall Study|Noncompliance with the protocol|8
363841|NCT00383552|1171323|P2|Overall Study|Noncompliance with the protocol|6
363842|NCT00383552|1171324|P1|Overall Study|Noncompliance with the protocol|11
363843|NCT00383552|1171321|P4|Overall Study|Did not wish to continue (related)|3
363844|NCT00383552|1171322|P3|Overall Study|Did not wish to continue (related)|2
363845|NCT00383552|1171323|P2|Overall Study|Did not wish to continue (related)|0
363846|NCT00383552|1171324|P1|Overall Study|Did not wish to continue (related)|1
363847|NCT00383552|1171321|P4|Overall Study|Did not wish to continue (unrelated)|6
363848|NCT00383552|1171322|P3|Overall Study|Did not wish to continue (unrelated)|5
363849|NCT00383552|1171323|P2|Overall Study|Did not wish to continue (unrelated)|9
363850|NCT00383552|1171324|P1|Overall Study|Did not wish to continue (unrelated)|4
363851|NCT00383552|1171321|P4|Overall Study|Lost to Follow-up|1
363852|NCT00383552|1171322|P3|Overall Study|Lost to Follow-up|5
363853|NCT00383552|1171323|P2|Overall Study|Lost to Follow-up|1
363854|NCT00383552|1171324|P1|Overall Study|Lost to Follow-up|0
363855|NCT00383552|1171321|P4|Overall Study|Lack of Efficacy|42
363856|NCT00383552|1171322|P3|Overall Study|Lack of Efficacy|29
363857|NCT00383552|1171323|P2|Overall Study|Lack of Efficacy|13
363858|NCT00383552|1171324|P1|Overall Study|Lack of Efficacy|4
363859|NCT00383552|1171321|P4|Overall Study|Adverse Event|6
363860|NCT00383552|1171322|P3|Overall Study|Adverse Event|9
363861|NCT00383552|1171323|P2|Overall Study|Adverse Event|6
363862|NCT00383552|1171324|P1|Overall Study|Adverse Event|7
363863|NCT00383500|1171366|P3|Overall Study|Lost to Follow-up|2
363864|NCT00383500|1171367|P2|Overall Study|Lost to Follow-up|0
363865|NCT00383500|1171368|P1|Overall Study|Lost to Follow-up|0
363866|NCT00383500|1171366|P3|Overall Study|Withdrawal by Subject|0
363867|NCT00383500|1171367|P2|Overall Study|Withdrawal by Subject|3
363868|NCT00383500|1171368|P1|Overall Study|Withdrawal by Subject|8
363869|NCT00383435|1171384|P5|26-Week Treatment Safety Extension|Administrative|0
363870|NCT00383435|1171385|P4|26-Week Treatment Safety Extension|Administrative|1
363871|NCT00383435|1171386|P3|26-Week Treatment Safety Extension|Administrative|0
363872|NCT00383435|1171387|P2|26-Week Treatment Safety Extension|Administrative|1
363873|NCT00383435|1171388|P1|26-Week Treatment Safety Extension|Administrative|1
363874|NCT00383435|1171384|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
363875|NCT00383435|1171385|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
363876|NCT00383435|1171386|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
363877|NCT00383435|1171387|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
363878|NCT00383435|1171388|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
363879|NCT00383435|1171384|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
363880|NCT00383435|1171385|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
363881|NCT00383435|1171386|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
363882|NCT00383435|1171387|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
363883|NCT00383435|1171388|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
363884|NCT00383435|1171384|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
363885|NCT00383435|1171385|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
363886|NCT00383435|1171386|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
363887|NCT00383435|1171387|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
363888|NCT00383435|1171388|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
363889|NCT00383435|1171384|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
363890|NCT00383435|1171385|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
363891|NCT00383435|1171386|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
363892|NCT00383435|1171387|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
363893|NCT00383435|1171388|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
363894|NCT00383435|1171384|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
363895|NCT00383435|1171385|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
363896|NCT00383435|1171386|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
363897|NCT00383435|1171387|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
363898|NCT00383435|1171388|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
363899|NCT00383435|1171384|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
363900|NCT00383435|1171385|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
363901|NCT00383435|1171386|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
363902|NCT00383435|1171387|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
363903|NCT00383435|1171388|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
363904|NCT00383435|1171384|P5|26-Week Treatment Safety Extension|Adverse Event|1
363905|NCT00383435|1171385|P4|26-Week Treatment Safety Extension|Adverse Event|5
363906|NCT00383435|1171386|P3|26-Week Treatment Safety Extension|Adverse Event|5
363907|NCT00383435|1171387|P2|26-Week Treatment Safety Extension|Adverse Event|2
363908|NCT00383435|1171388|P1|26-Week Treatment Safety Extension|Adverse Event|4
363909|NCT00383435|1171384|P5|26-Week Double-Blind Treatment Period|Administrative|1
363910|NCT00383435|1171385|P4|26-Week Double-Blind Treatment Period|Administrative|1
363911|NCT00383435|1171386|P3|26-Week Double-Blind Treatment Period|Administrative|1
363912|NCT00383435|1171387|P2|26-Week Double-Blind Treatment Period|Administrative|3
363913|NCT00383435|1171388|P1|26-Week Double-Blind Treatment Period|Administrative|5
363914|NCT00383435|1171384|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
363915|NCT00383435|1171385|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
363916|NCT00383435|1171386|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
363917|NCT00383435|1171387|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
363918|NCT00383435|1171388|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
363919|NCT00383435|1171384|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
363920|NCT00383435|1171385|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
363921|NCT00383435|1171386|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
363922|NCT00383435|1171387|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
363923|NCT00383435|1171388|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
363924|NCT00383435|1171384|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
363925|NCT00383435|1171385|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
363926|NCT00383435|1171386|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
363927|NCT00383435|1171387|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
363928|NCT00383435|1171388|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
363929|NCT00383435|1171384|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
363930|NCT00383435|1171385|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
363931|NCT00383435|1171386|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
363932|NCT00383435|1171387|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
363933|NCT00383435|1171388|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
363934|NCT00383435|1171384|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
363935|NCT00383435|1171385|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
363936|NCT00383435|1171386|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
363937|NCT00383435|1171387|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
363938|NCT00383435|1171388|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
363939|NCT00383435|1171384|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
363940|NCT00383435|1171385|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
363941|NCT00383435|1171386|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
363942|NCT00383435|1171387|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
363943|NCT00383435|1171388|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
363944|NCT00383435|1171384|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
363945|NCT00383435|1171385|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
363946|NCT00383435|1171386|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
363947|NCT00383435|1171387|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
363948|NCT00383435|1171388|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
363949|NCT00383331|1171427|P2|Overall Study|Protocol Violation|1
363950|NCT00383331|1171428|P1|Overall Study|Protocol Violation|0
363951|NCT00383240|1171457|P4|Overall Study|Administrative|0
363952|NCT00383240|1171458|P3|Overall Study|Administrative|0
363953|NCT00383240|1171459|P2|Overall Study|Administrative|1
363954|NCT00383240|1171460|P1|Overall Study|Administrative|1
363955|NCT00383240|1171457|P4|Overall Study|Did not meet protocol eligibility|3
363956|NCT00383240|1171458|P3|Overall Study|Did not meet protocol eligibility|9
363957|NCT00383240|1171459|P2|Overall Study|Did not meet protocol eligibility|4
363958|NCT00383240|1171460|P1|Overall Study|Did not meet protocol eligibility|9
363959|NCT00383240|1171457|P4|Overall Study|Protocol Violation|6
363960|NCT00383240|1171458|P3|Overall Study|Protocol Violation|9
363961|NCT00383240|1171459|P2|Overall Study|Protocol Violation|5
363962|NCT00383240|1171460|P1|Overall Study|Protocol Violation|4
363963|NCT00383240|1171457|P4|Overall Study|Withdrawal by subjects, reasons related|5
363964|NCT00383240|1171458|P3|Overall Study|Withdrawal by subjects, reasons related|3
363965|NCT00383240|1171459|P2|Overall Study|Withdrawal by subjects, reasons related|1
363966|NCT00383240|1171460|P1|Overall Study|Withdrawal by subjects, reasons related|0
363967|NCT00383240|1171457|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
363968|NCT00383240|1171458|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
363969|NCT00383240|1171459|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
363970|NCT00383240|1171460|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
363971|NCT00383240|1171457|P4|Overall Study|Lost to Follow-up|2
363972|NCT00383240|1171458|P3|Overall Study|Lost to Follow-up|0
363974|NCT00383240|1171460|P1|Overall Study|Lost to Follow-up|3
363975|NCT00383240|1171457|P4|Overall Study|Treatment Failure|46
363976|NCT00383240|1171458|P3|Overall Study|Treatment Failure|47
363977|NCT00383240|1171459|P2|Overall Study|Treatment Failure|13
363978|NCT00383240|1171460|P1|Overall Study|Treatment Failure|8
363979|NCT00383240|1171457|P4|Overall Study|Adverse Event|7
363980|NCT00383240|1171458|P3|Overall Study|Adverse Event|9
363981|NCT00383240|1171459|P2|Overall Study|Adverse Event|6
363982|NCT00383240|1171460|P1|Overall Study|Adverse Event|4
363983|NCT00383162|1171491|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
363984|NCT00383162|1171492|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
363985|NCT00383162|1171491|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
363986|NCT00383162|1171492|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
363987|NCT00383162|1171491|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
363988|NCT00383162|1171492|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
363989|NCT00383162|1171491|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
363990|NCT00383162|1171492|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
363991|NCT00383162|1171491|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
363992|NCT00383162|1171492|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
363993|NCT00383162|1171491|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
363994|NCT00383162|1171492|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
363995|NCT00383162|1171491|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
363996|NCT00383162|1171492|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
363997|NCT00383162|1171491|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
363998|NCT00383162|1171492|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
363999|NCT00383162|1171491|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
364000|NCT00383162|1171492|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
364001|NCT00383149|1171534|P1|Overall Study|Participant Withdrew Consent|1
364002|NCT00383149|1171534|P1|Overall Study|Request to Discontinue Treatment|4
364003|NCT00383149|1171534|P1|Overall Study|Study Drug Toxicity|4
364004|NCT00383149|1171534|P1|Overall Study|Other|1
364005|NCT00383149|1171534|P1|Overall Study|Lost to Follow-up|1
364006|NCT00383149|1171534|P1|Overall Study|Disease Progression|38
364007|NCT00383149|1171534|P1|Overall Study|Death|2
364008|NCT00383149|1171534|P1|Overall Study|Adverse Event not Related to Study Drug|3
364009|NCT00383123|1171553|P2|Overall Study|Other reason|6
364010|NCT00383123|1171554|P1|Overall Study|Other reason|10
364011|NCT00383123|1171553|P2|Overall Study|Withdrawal by Subject|18
364012|NCT00383123|1171554|P1|Overall Study|Withdrawal by Subject|27
364013|NCT00383123|1171553|P2|Overall Study|Protocol Violation|1
364014|NCT00383123|1171554|P1|Overall Study|Protocol Violation|5
364015|NCT00383123|1171553|P2|Overall Study|Lost to Follow-up|61
364016|NCT00383123|1171554|P1|Overall Study|Lost to Follow-up|68
364017|NCT00383123|1171553|P2|Overall Study|Adverse Event|0
364018|NCT00383123|1171554|P1|Overall Study|Adverse Event|1
364019|NCT00383084|1171595|P2|Overall Study|Withdrawal by Subject|10
364020|NCT00383084|1171596|P1|Overall Study|Withdrawal by Subject|12
364021|NCT00383019|1171627|P2|Overall Study|Withdrawal by Subject|1
364022|NCT00383019|1171628|P1|Overall Study|Withdrawal by Subject|0
364023|NCT00383019|1171627|P2|Overall Study|Adverse Event|1
364024|NCT00383019|1171628|P1|Overall Study|Adverse Event|5
364025|NCT00382993|1171650|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
364026|NCT00382993|1171651|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
364027|NCT00382993|1171650|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
364028|NCT00382993|1171651|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
364029|NCT00382993|1171650|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
364030|NCT00382993|1171651|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
364031|NCT00382993|1171650|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
364032|NCT00382993|1171651|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
364033|NCT00382993|1171650|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
364034|NCT00382993|1171651|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
364035|NCT00382993|1171650|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
364122|NCT00382291|1171871|P1|Overall Study|Protocol Violation|1
364036|NCT00382993|1171651|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
364037|NCT00382993|1171650|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
364038|NCT00382993|1171651|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
364039|NCT00382993|1171650|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
364040|NCT00382993|1171651|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
364041|NCT00382993|1171650|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
364042|NCT00382993|1171651|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
364043|NCT00382993|1171650|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
364044|NCT00382993|1171651|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
364045|NCT00382967|1171695|P2|Overall Study|Protocol Violation|1
364046|NCT00382967|1171696|P1|Overall Study|Protocol Violation|1
364047|NCT00382863|1171721|P2|Overall Study|Withdrawal by Subject|25
364048|NCT00382863|1171722|P1|Overall Study|Withdrawal by Subject|5
364049|NCT00382863|1171721|P2|Overall Study|Lost to Follow-up|2
364050|NCT00382863|1171722|P1|Overall Study|Lost to Follow-up|1
364051|NCT00382863|1171721|P2|Overall Study|Death|9
364052|NCT00382863|1171722|P1|Overall Study|Death|9
364053|NCT00382733|1171789|P5|Overall Study|Withdrawal by Subject|0
364054|NCT00382733|1171790|P4|Overall Study|Withdrawal by Subject|0
364055|NCT00382733|1171791|P3|Overall Study|Withdrawal by Subject|0
364056|NCT00382733|1171792|P2|Overall Study|Withdrawal by Subject|1
364057|NCT00382733|1171793|P1|Overall Study|Withdrawal by Subject|0
364058|NCT00382720|1171814|P3|Overall Study|Discontinued at end of study|2
364059|NCT00382720|1171815|P2|Overall Study|Discontinued at end of study|1
364060|NCT00382720|1171816|P1|Overall Study|Discontinued at end of study|0
364061|NCT00382720|1171814|P3|Overall Study|Investigator/Clinical decision|6
364062|NCT00382720|1171815|P2|Overall Study|Investigator/Clinical decision|6
364063|NCT00382720|1171816|P1|Overall Study|Investigator/Clinical decision|5
364064|NCT00382720|1171814|P3|Overall Study|Good prognosis|0
364065|NCT00382720|1171815|P2|Overall Study|Good prognosis|1
364066|NCT00382720|1171816|P1|Overall Study|Good prognosis|0
364067|NCT00382720|1171814|P3|Overall Study|Clinically progressive disease|0
364068|NCT00382720|1171815|P2|Overall Study|Clinically progressive disease|1
364069|NCT00382720|1171816|P1|Overall Study|Clinically progressive disease|0
364070|NCT00382720|1171814|P3|Overall Study|Patient did not receive study medication|4
364071|NCT00382720|1171815|P2|Overall Study|Patient did not receive study medication|1
364072|NCT00382720|1171816|P1|Overall Study|Patient did not receive study medication|1
364073|NCT00382720|1171814|P3|Overall Study|Surgery|4
364074|NCT00382720|1171815|P2|Overall Study|Surgery|1
364075|NCT00382720|1171816|P1|Overall Study|Surgery|1
364076|NCT00382720|1171814|P3|Overall Study|Withdrawal by Subject|12
364077|NCT00382720|1171815|P2|Overall Study|Withdrawal by Subject|20
364078|NCT00382720|1171816|P1|Overall Study|Withdrawal by Subject|11
364079|NCT00382720|1171814|P3|Overall Study|Withdrew consent|2
364080|NCT00382720|1171815|P2|Overall Study|Withdrew consent|1
364081|NCT00382720|1171816|P1|Overall Study|Withdrew consent|1
364082|NCT00382720|1171814|P3|Overall Study|Progressive disease|38
364083|NCT00382720|1171815|P2|Overall Study|Progressive disease|28
364084|NCT00382720|1171816|P1|Overall Study|Progressive disease|37
364085|NCT00382720|1171814|P3|Overall Study|Death|2
364086|NCT00382720|1171815|P2|Overall Study|Death|1
364087|NCT00382720|1171816|P1|Overall Study|Death|0
364088|NCT00382720|1171814|P3|Overall Study|Protocol Violation|1
364089|NCT00382720|1171815|P2|Overall Study|Protocol Violation|5
364090|NCT00382720|1171816|P1|Overall Study|Protocol Violation|2
364091|NCT00382720|1171814|P3|Overall Study|Adverse Event|15
364092|NCT00382720|1171815|P2|Overall Study|Adverse Event|23
364093|NCT00382720|1171816|P1|Overall Study|Adverse Event|21
364094|NCT00382408|1171841|P2|Overall Study|Not specified|35
364095|NCT00382408|1171842|P1|Overall Study|Not specified|100
364096|NCT00382408|1171841|P2|Overall Study|Lost to Follow-up|8
364097|NCT00382408|1171842|P1|Overall Study|Lost to Follow-up|19
364098|NCT00382408|1171841|P2|Overall Study|Pregnancy|0
364099|NCT00382408|1171842|P1|Overall Study|Pregnancy|2
364100|NCT00382408|1171841|P2|Overall Study|Withdrawal by Subject|6
364101|NCT00382408|1171842|P1|Overall Study|Withdrawal by Subject|17
364102|NCT00382408|1171841|P2|Overall Study|Physician Decision|0
364103|NCT00382408|1171842|P1|Overall Study|Physician Decision|1
364104|NCT00382408|1171841|P2|Overall Study|Protocol Violation|2
364105|NCT00382408|1171842|P1|Overall Study|Protocol Violation|2
364106|NCT00382408|1171841|P2|Overall Study|Did not meet protocol requirement|3
364107|NCT00382408|1171842|P1|Overall Study|Did not meet protocol requirement|3
364108|NCT00382291|1171869|P3|Overall Study|Lack of Efficacy|1
364109|NCT00382291|1171870|P2|Overall Study|Lack of Efficacy|0
364110|NCT00382291|1171871|P1|Overall Study|Lack of Efficacy|0
364111|NCT00382291|1171869|P3|Overall Study|Physician Decision|0
364112|NCT00382291|1171870|P2|Overall Study|Physician Decision|1
364113|NCT00382291|1171871|P1|Overall Study|Physician Decision|0
364114|NCT00382291|1171869|P3|Overall Study|Withdrawal by Subject|0
364115|NCT00382291|1171870|P2|Overall Study|Withdrawal by Subject|2
364116|NCT00382291|1171871|P1|Overall Study|Withdrawal by Subject|0
364117|NCT00382291|1171869|P3|Overall Study|Temporary study suspension|5
364118|NCT00382291|1171870|P2|Overall Study|Temporary study suspension|2
364119|NCT00382291|1171871|P1|Overall Study|Temporary study suspension|2
364120|NCT00382291|1171869|P3|Overall Study|Protocol Violation|0
364121|NCT00382291|1171870|P2|Overall Study|Protocol Violation|0
364123|NCT00382291|1171869|P3|Overall Study|Adverse Event|2
364124|NCT00382291|1171870|P2|Overall Study|Adverse Event|2
364125|NCT00382291|1171871|P1|Overall Study|Adverse Event|1
364126|NCT00382174|1171884|P3|Overall Study|Wounds merged|2
364127|NCT00382174|1171885|P2|Overall Study|Wounds merged|2
364128|NCT00382174|1171886|P1|Overall Study|Wounds merged|0
364129|NCT00382174|1171884|P3|Overall Study|Failed to meet criteria|1
364130|NCT00382174|1171885|P2|Overall Study|Failed to meet criteria|1
364131|NCT00382174|1171886|P1|Overall Study|Failed to meet criteria|0
364132|NCT00382174|1171884|P3|Overall Study|Physician Decision|2
364133|NCT00382174|1171885|P2|Overall Study|Physician Decision|2
364134|NCT00382174|1171886|P1|Overall Study|Physician Decision|0
364135|NCT00382174|1171884|P3|Overall Study|Non compliance|1
364136|NCT00382174|1171885|P2|Overall Study|Non compliance|0
364137|NCT00382174|1171886|P1|Overall Study|Non compliance|1
364138|NCT00382174|1171884|P3|Overall Study|Withdrawal by Subject|5
364139|NCT00382174|1171885|P2|Overall Study|Withdrawal by Subject|4
364140|NCT00382174|1171886|P1|Overall Study|Withdrawal by Subject|1
364141|NCT00382174|1171884|P3|Overall Study|Adverse Event|5
364142|NCT00382174|1171885|P2|Overall Study|Adverse Event|4
364143|NCT00382174|1171886|P1|Overall Study|Adverse Event|1
364144|NCT00382174|1171884|P3|Overall Study|Lost to Follow-up|5
364145|NCT00382174|1171885|P2|Overall Study|Lost to Follow-up|4
364146|NCT00382174|1171886|P1|Overall Study|Lost to Follow-up|1
364147|NCT00382109|1171914|P2|Overall Study|consent withdrawal|1
364148|NCT00382109|1171915|P1|Overall Study|consent withdrawal|0
364149|NCT00382109|1171914|P2|Overall Study|Other|2
364150|NCT00382109|1171915|P1|Overall Study|Other|0
364151|NCT00382109|1171914|P2|Overall Study|ineligible|0
364152|NCT00382109|1171915|P1|Overall Study|ineligible|2
364153|NCT00382109|1171914|P2|Overall Study|Withdrawal by Subject|0
364154|NCT00382109|1171915|P1|Overall Study|Withdrawal by Subject|1
364155|NCT00382109|1171914|P2|Overall Study|Physician Decision|1
364156|NCT00382109|1171915|P1|Overall Study|Physician Decision|6
364157|NCT00382109|1171914|P2|Overall Study|Adverse Event|0
364158|NCT00382109|1171915|P1|Overall Study|Adverse Event|3
364159|NCT00382018|1171954|P4|Overall Study|Other, not protocol specified|1
364160|NCT00382018|1171955|P3|Overall Study|Other, not protocol specified|3
364161|NCT00382018|1171956|P2|Overall Study|Other, not protocol specified|16
364162|NCT00382018|1171957|P1|Overall Study|Other, not protocol specified|0
364163|NCT00382018|1171954|P4|Overall Study|Withdrawal by Subject|4
364164|NCT00382018|1171955|P3|Overall Study|Withdrawal by Subject|3
364165|NCT00382018|1171956|P2|Overall Study|Withdrawal by Subject|4
364166|NCT00382018|1171957|P1|Overall Study|Withdrawal by Subject|0
364167|NCT00382018|1171954|P4|Overall Study|Death|11
364168|NCT00382018|1171955|P3|Overall Study|Death|7
364169|NCT00382018|1171956|P2|Overall Study|Death|9
364170|NCT00382018|1171957|P1|Overall Study|Death|0
364171|NCT00382018|1171954|P4|Overall Study|Progression|43
364172|NCT00382018|1171955|P3|Overall Study|Progression|51
364173|NCT00382018|1171956|P2|Overall Study|Progression|136
364174|NCT00382018|1171957|P1|Overall Study|Progression|0
364175|NCT00381940|1171975|P1|Overall Study|Ineligible|1
364176|NCT00381940|1171975|P1|Overall Study|Protocol Violation|1
364177|NCT00381940|1171975|P1|Overall Study|Lack of Efficacy|3
364178|NCT00381888|1171979|P1|Overall Study|Adverse Event|1
364179|NCT00381888|1171979|P1|Overall Study|Surgery was cancelled|2
364180|NCT00381888|1171979|P1|Overall Study|Had laparoscopic surgery|2
364181|NCT00381888|1171979|P1|Overall Study|Protocol Violation|9
364182|NCT00381888|1171979|P1|Overall Study|Physician Decision|1
364183|NCT00381888|1171979|P1|Overall Study|Withdrawal by Subject|1
364184|NCT00381888|1171979|P1|Overall Study|Death|1
364185|NCT00381849|1171990|P2|Wash Out|Withdrawal by Subject|1
364186|NCT00381849|1171991|P1|Wash Out|Withdrawal by Subject|0
364187|NCT00381797|1172018|P5|Overall Study|Ineligible|0
364188|NCT00381797|1172019|P4|Overall Study|Ineligible|1
364189|NCT00381797|1172020|P3|Overall Study|Ineligible|0
364190|NCT00381797|1172021|P2|Overall Study|Ineligible|0
364191|NCT00381797|1172022|P1|Overall Study|Ineligible|0
364192|NCT00381797|1172018|P5|Overall Study|Withdrawal by Subject|2
364193|NCT00381797|1172019|P4|Overall Study|Withdrawal by Subject|0
364194|NCT00381797|1172020|P3|Overall Study|Withdrawal by Subject|0
364195|NCT00381797|1172021|P2|Overall Study|Withdrawal by Subject|1
364196|NCT00381797|1172022|P1|Overall Study|Withdrawal by Subject|1
364197|NCT00381706|1172078|P3|Overall Study|Never treated|1
364198|NCT00381706|1172079|P2|Overall Study|Never treated|2
364199|NCT00381706|1172080|P1|Overall Study|Never treated|7
364200|NCT00381693|1172103|P1|Overall Study|Progression|2
364201|NCT00381693|1172103|P1|Overall Study|Patient Choice|1
364202|NCT00381693|1172103|P1|Overall Study|Adverse Event|4
364203|NCT00381693|1172103|P1|Overall Study|Death|1
364204|NCT00381680|1172112|P2|Overall Study|Ineligible|1
364205|NCT00381680|1172113|P1|Overall Study|Ineligible|3
364206|NCT00381680|1172112|P2|Overall Study|Other not otherwise specified|2
364207|NCT00381680|1172113|P1|Overall Study|Other not otherwise specified|7
364208|NCT00381680|1172112|P2|Overall Study|Progression|1
364209|NCT00381680|1172113|P1|Overall Study|Progression|1
364210|NCT00381680|1172112|P2|Overall Study|Induction Failure|1
364211|NCT00381680|1172113|P1|Overall Study|Induction Failure|4
364212|NCT00381680|1172112|P2|Overall Study|Relapse|9
364213|NCT00381680|1172113|P1|Overall Study|Relapse|18
364214|NCT00381680|1172112|P2|Overall Study|Stem Cell Transplant|10
364215|NCT00381680|1172113|P1|Overall Study|Stem Cell Transplant|26
364216|NCT00381680|1172112|P2|Overall Study|Delay initiation|0
364217|NCT00381680|1172113|P1|Overall Study|Delay initiation|1
364218|NCT00381680|1172112|P2|Overall Study|Secondary Malignancy|0
364219|NCT00381680|1172113|P1|Overall Study|Secondary Malignancy|3
364220|NCT00381680|1172112|P2|Overall Study|Alternative Therapy|5
364221|NCT00381680|1172113|P1|Overall Study|Alternative Therapy|11
364222|NCT00381680|1172112|P2|Overall Study|Entry onto another COG Trial|2
364223|NCT00381680|1172113|P1|Overall Study|Entry onto another COG Trial|1
364224|NCT00381680|1172112|P2|Overall Study|Withdrawal by Subject|1
364225|NCT00381680|1172113|P1|Overall Study|Withdrawal by Subject|3
364226|NCT00381680|1172112|P2|Overall Study|Physician Decision|6
364227|NCT00381680|1172113|P1|Overall Study|Physician Decision|25
364228|NCT00381680|1172112|P2|Overall Study|Lost to Follow-up|2
364229|NCT00381680|1172113|P1|Overall Study|Lost to Follow-up|3
364230|NCT00381680|1172112|P2|Overall Study|Death|7
364231|NCT00381680|1172113|P1|Overall Study|Death|10
364232|NCT00381680|1172112|P2|Overall Study|Adverse Event|3
364233|NCT00381680|1172113|P1|Overall Study|Adverse Event|9
364234|NCT00381615|1172149|P4|Overall Study|Protocol Violation|0
364235|NCT00381615|1172150|P3|Overall Study|Protocol Violation|1
364236|NCT00381615|1172151|P2|Overall Study|Protocol Violation|0
364237|NCT00381615|1172152|P1|Overall Study|Protocol Violation|0
364238|NCT00381615|1172149|P4|Overall Study|Lost to Follow-up|1
364239|NCT00381615|1172150|P3|Overall Study|Lost to Follow-up|0
364240|NCT00381615|1172151|P2|Overall Study|Lost to Follow-up|2
364241|NCT00381615|1172152|P1|Overall Study|Lost to Follow-up|3
364242|NCT00381615|1172149|P4|Overall Study|Withdrawal by Subject|1
364243|NCT00381615|1172150|P3|Overall Study|Withdrawal by Subject|0
364244|NCT00381615|1172151|P2|Overall Study|Withdrawal by Subject|3
364245|NCT00381615|1172152|P1|Overall Study|Withdrawal by Subject|1
364246|NCT00380081|1172213|P6|Overall Study|Family Emergency|1
364247|NCT00380081|1172214|P5|Overall Study|Family Emergency|0
364248|NCT00380081|1172215|P4|Overall Study|Family Emergency|0
364249|NCT00380081|1172216|P3|Overall Study|Family Emergency|0
364250|NCT00380081|1172217|P2|Overall Study|Family Emergency|0
364251|NCT00380081|1172218|P1|Overall Study|Family Emergency|0
364252|NCT00380081|1172213|P6|Overall Study|Withdrawal by Subject|0
364253|NCT00380081|1172214|P5|Overall Study|Withdrawal by Subject|1
364254|NCT00380081|1172215|P4|Overall Study|Withdrawal by Subject|0
364255|NCT00380081|1172216|P3|Overall Study|Withdrawal by Subject|0
364256|NCT00380081|1172217|P2|Overall Study|Withdrawal by Subject|0
364257|NCT00380081|1172218|P1|Overall Study|Withdrawal by Subject|0
364258|NCT00380068|1172268|P1|Overall Study|Lack of Efficacy|5
364259|NCT00380068|1172268|P1|Overall Study|Partipant moved away|1
364260|NCT00380068|1172268|P1|Overall Study|Physician Decision|2
364261|NCT00380068|1172268|P1|Overall Study|Lung transplant|3
364262|NCT00380068|1172268|P1|Overall Study|Addition of other PAH therapeutic agent|1
364263|NCT00380068|1172268|P1|Overall Study|Lost to Follow-up|1
364264|NCT00380068|1172268|P1|Overall Study|Not compliant|6
364265|NCT00380068|1172268|P1|Overall Study|Withdrawal by Subject|10
364266|NCT00380068|1172268|P1|Overall Study|Adverse Event|40
364267|NCT00381485|1172291|P4|Double-Blind Treatment Period|Administrative|1
364268|NCT00381485|1172292|P3|Double-Blind Treatment Period|Administrative|0
364269|NCT00381485|1172293|P2|Double-Blind Treatment Period|Administrative|1
364270|NCT00381485|1172294|P1|Double-Blind Treatment Period|Administrative|0
364271|NCT00381485|1172291|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
364272|NCT00381485|1172292|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
364273|NCT00381485|1172293|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
364274|NCT00381485|1172294|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
364275|NCT00381485|1172291|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
364276|NCT00381485|1172292|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
364277|NCT00381485|1172293|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
364278|NCT00381485|1172294|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
364279|NCT00381485|1172291|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
364280|NCT00381485|1172292|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
364281|NCT00381485|1172293|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
364282|NCT00381485|1172294|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
364283|NCT00381485|1172291|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
364284|NCT00381485|1172292|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
364285|NCT00381485|1172293|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
364286|NCT00381485|1172294|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
364287|NCT00381485|1172291|P4|Double-Blind Treatment Period|Lost to Follow-up|1
364288|NCT00381485|1172292|P3|Double-Blind Treatment Period|Lost to Follow-up|1
364289|NCT00381485|1172293|P2|Double-Blind Treatment Period|Lost to Follow-up|0
364290|NCT00381485|1172294|P1|Double-Blind Treatment Period|Lost to Follow-up|0
364291|NCT00381485|1172291|P4|Double-Blind Treatment Period|Lack of Efficacy|13
364292|NCT00381485|1172292|P3|Double-Blind Treatment Period|Lack of Efficacy|11
364293|NCT00381485|1172293|P2|Double-Blind Treatment Period|Lack of Efficacy|8
364294|NCT00381485|1172294|P1|Double-Blind Treatment Period|Lack of Efficacy|0
364295|NCT00381485|1172291|P4|Double-Blind Treatment Period|Adverse Event|5
364296|NCT00381485|1172292|P3|Double-Blind Treatment Period|Adverse Event|2
364297|NCT00381485|1172293|P2|Double-Blind Treatment Period|Adverse Event|2
364298|NCT00381485|1172294|P1|Double-Blind Treatment Period|Adverse Event|0
364299|NCT00381485|1172291|P4|Open-Label Run-In Period|Treatment failure|0
364300|NCT00381485|1172292|P3|Open-Label Run-In Period|Treatment failure|0
364301|NCT00381485|1172293|P2|Open-Label Run-In Period|Treatment failure|0
364302|NCT00381485|1172294|P1|Open-Label Run-In Period|Treatment failure|1
364303|NCT00381485|1172291|P4|Open-Label Run-In Period|Lost to Follow-up|0
364304|NCT00381485|1172292|P3|Open-Label Run-In Period|Lost to Follow-up|0
364305|NCT00381485|1172293|P2|Open-Label Run-In Period|Lost to Follow-up|0
364306|NCT00381485|1172294|P1|Open-Label Run-In Period|Lost to Follow-up|3
364307|NCT00381485|1172291|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
364308|NCT00381485|1172292|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
364309|NCT00381485|1172293|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
364310|NCT00381485|1172294|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
364311|NCT00381485|1172291|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
364312|NCT00381485|1172292|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
364313|NCT00381485|1172293|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
364314|NCT00381485|1172294|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
364315|NCT00381485|1172291|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
364316|NCT00381485|1172292|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
364317|NCT00381485|1172293|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
364318|NCT00381485|1172294|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
364319|NCT00381485|1172291|P4|Open-Label Run-In Period|Adverse Event|0
364320|NCT00381485|1172292|P3|Open-Label Run-In Period|Adverse Event|0
364321|NCT00381485|1172293|P2|Open-Label Run-In Period|Adverse Event|0
364322|NCT00381485|1172294|P1|Open-Label Run-In Period|Adverse Event|9
364323|NCT00381381|1172312|P1|Overall Study|Withdrawal by Subject|9
364324|NCT00381381|1172312|P1|Overall Study|Lost to Follow-up|52
364325|NCT00381381|1172312|P1|Overall Study|Adverse Event|3
364326|NCT00381303|1172321|P2|Overall Study|Subject primary physician's decision|0
364327|NCT00381303|1172322|P1|Overall Study|Subject primary physician's decision|1
364328|NCT00381303|1172321|P2|Overall Study|Subject did not continue visits|0
364329|NCT00381303|1172322|P1|Overall Study|Subject did not continue visits|1
364330|NCT00381303|1172321|P2|Overall Study|Subject was too busy for appointments|0
364331|NCT00381303|1172322|P1|Overall Study|Subject was too busy for appointments|1
364332|NCT00381303|1172321|P2|Overall Study|No virologic response by week 12|0
364333|NCT00381303|1172322|P1|Overall Study|No virologic response by week 12|1
364334|NCT00381303|1172321|P2|Overall Study|Subject taking too many different meds|0
364335|NCT00381303|1172322|P1|Overall Study|Subject taking too many different meds|1
364336|NCT00381303|1172321|P2|Overall Study|Subject moved out of state|0
364337|NCT00381303|1172322|P1|Overall Study|Subject moved out of state|2
364338|NCT00381303|1172321|P2|Overall Study|Physician's decision to close the site|1
364339|NCT00381303|1172322|P1|Overall Study|Physician's decision to close the site|3
364340|NCT00381303|1172321|P2|Overall Study|Physician Decision|0
364341|NCT00381303|1172322|P1|Overall Study|Physician Decision|1
364342|NCT00381303|1172321|P2|Overall Study|Pregnancy|0
364343|NCT00381303|1172322|P1|Overall Study|Pregnancy|2
364344|NCT00381303|1172321|P2|Overall Study|Ineligible to continue the trial|1
364345|NCT00381303|1172322|P1|Overall Study|Ineligible to continue the trial|2
364346|NCT00381303|1172321|P2|Overall Study|Virologic failure|4
364347|NCT00381303|1172322|P1|Overall Study|Virologic failure|6
364348|NCT00381303|1172321|P2|Overall Study|Withdrawal by Subject|6
364349|NCT00381303|1172322|P1|Overall Study|Withdrawal by Subject|13
364350|NCT00381303|1172321|P2|Overall Study|Non-Adherence|6
364351|NCT00381303|1172322|P1|Overall Study|Non-Adherence|13
364352|NCT00381303|1172321|P2|Overall Study|AE/HIV-related event|6
364353|NCT00381303|1172322|P1|Overall Study|AE/HIV-related event|22
364354|NCT00381303|1172321|P2|Overall Study|Lost to Follow-up|9
364355|NCT00381303|1172322|P1|Overall Study|Lost to Follow-up|25
364356|NCT00381238|1172382|P1|Overall Study|Disease progression|1
364357|NCT00381238|1172382|P1|Overall Study|Withdrew by physician|1
364358|NCT00381238|1172382|P1|Overall Study|Lack of Efficacy|2
364359|NCT00381238|1172382|P1|Overall Study|Withdrawal by Subject|4
364360|NCT00381238|1172382|P1|Overall Study|Protocol Violation|1
364361|NCT00381238|1172382|P1|Overall Study|Adverse Event|3
364362|NCT00381095|1172398|P2|Overall Study|Adverse Event|7
364363|NCT00381095|1172399|P1|Overall Study|Adverse Event|2
364364|NCT00381095|1172398|P2|Overall Study|Withdrawal by Subject|3
364365|NCT00381095|1172399|P1|Overall Study|Withdrawal by Subject|3
364366|NCT00381095|1172398|P2|Overall Study|Protocol Violation|1
364367|NCT00381095|1172399|P1|Overall Study|Protocol Violation|1
364368|NCT00381095|1172398|P2|Overall Study|Unspecified|2
364369|NCT00381095|1172399|P1|Overall Study|Unspecified|2
364370|NCT00381095|1172398|P2|Overall Study|Lack of Efficacy|4
364371|NCT00381095|1172399|P1|Overall Study|Lack of Efficacy|2
364372|NCT00381095|1172398|P2|Overall Study|Death|4
364373|NCT00381095|1172399|P1|Overall Study|Death|3
364374|NCT00381043|1172431|P2|Overall Study|incarcerated|0
364375|NCT00381043|1172432|P1|Overall Study|incarcerated|1
364376|NCT00381043|1172431|P2|Overall Study|wanted more care|1
364377|NCT00381043|1172432|P1|Overall Study|wanted more care|0
364378|NCT00381043|1172431|P2|Overall Study|Withdrawal by Subject|1
364379|NCT00381043|1172432|P1|Overall Study|Withdrawal by Subject|3
364380|NCT00381043|1172431|P2|Overall Study|Lost to Follow-up|6
364381|NCT00381043|1172432|P1|Overall Study|Lost to Follow-up|8
364382|NCT00380978|1172458|P2|Overall Study|Parous patient|0
364383|NCT00380978|1172459|P1|Overall Study|Parous patient|1
364384|NCT00380978|1172458|P2|Overall Study|Allocation prior to analgesia request|2
364385|NCT00380978|1172459|P1|Overall Study|Allocation prior to analgesia request|1
364386|NCT00380978|1172458|P2|Overall Study|Wrong study envelope|2
364387|NCT00380978|1172459|P1|Overall Study|Wrong study envelope|0
364388|NCT00380978|1172458|P2|Overall Study|Refused allocated intervention|6
364389|NCT00380978|1172459|P1|Overall Study|Refused allocated intervention|0
364390|NCT00380874|1172481|P2|Overall Study|Not related to study drug|2
364391|NCT00380874|1172482|P1|Overall Study|Not related to study drug|3
364392|NCT00380874|1172481|P2|Overall Study|Withdrawal by Subject|1
364393|NCT00380874|1172482|P1|Overall Study|Withdrawal by Subject|2
364394|NCT00380874|1172481|P2|Overall Study|Death|0
364395|NCT00380874|1172482|P1|Overall Study|Death|1
364396|NCT00380874|1172481|P2|Overall Study|Adverse Event|7
364397|NCT00380874|1172482|P1|Overall Study|Adverse Event|7
364398|NCT00379912|1172509|P2|Overall Study|Lack of Efficacy|0
364399|NCT00379912|1172510|P1|Overall Study|Lack of Efficacy|1
364400|NCT00379899|1172530|P2|Overall Study|Other|1
364401|NCT00379899|1172531|P1|Overall Study|Other|3
364402|NCT00379899|1172530|P2|Overall Study|Other protocol-specified criteria|4
364403|NCT00379899|1172531|P1|Overall Study|Other protocol-specified criteria|3
364404|NCT00379899|1172530|P2|Overall Study|Coronary artery bypass graft|1
364405|NCT00379899|1172531|P1|Overall Study|Coronary artery bypass graft|1
364406|NCT00379899|1172530|P2|Overall Study|Renal transplantation|4
364407|NCT00379899|1172531|P1|Overall Study|Renal transplantation|5
364408|NCT00379899|1172530|P2|Overall Study|Parathyroidectomy|2
364409|NCT00379899|1172531|P1|Overall Study|Parathyroidectomy|0
364410|NCT00379899|1172530|P2|Overall Study|Noncompliance|1
364411|NCT00379899|1172531|P1|Overall Study|Noncompliance|1
364412|NCT00379899|1172530|P2|Overall Study|Ineligibility determined|1
364413|NCT00379899|1172531|P1|Overall Study|Ineligibility determined|0
364414|NCT00379899|1172530|P2|Overall Study|Withdrawal by Subject|5
364415|NCT00379899|1172531|P1|Overall Study|Withdrawal by Subject|5
364416|NCT00379899|1172530|P2|Overall Study|Physician Decision|4
364417|NCT00379899|1172531|P1|Overall Study|Physician Decision|3
364418|NCT00379899|1172530|P2|Overall Study|Lost to Follow-up|4
364419|NCT00379899|1172531|P1|Overall Study|Lost to Follow-up|2
364420|NCT00379899|1172530|P2|Overall Study|Death|10
364421|NCT00379899|1172531|P1|Overall Study|Death|10
364422|NCT00379899|1172530|P2|Overall Study|Adverse Event|3
364423|NCT00379899|1172531|P1|Overall Study|Adverse Event|7
364424|NCT00380718|1172559|P1|Overall Study|Death after 30-day post-therapy followup|17
364425|NCT00380718|1172559|P1|Overall Study|Adverse Event|1
364426|NCT00380692|1172571|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
364427|NCT00380692|1172572|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
364428|NCT00380692|1172571|P2|Study Period III - Open Label|Lack of Efficacy|4
364429|NCT00380692|1172572|P1|Study Period III - Open Label|Lack of Efficacy|0
364430|NCT00380692|1172571|P2|Study Period III - Open Label|Physician Decision|3
364431|NCT00380692|1172572|P1|Study Period III - Open Label|Physician Decision|0
364432|NCT00380692|1172571|P2|Study Period III - Open Label|Withdrawal by Subject|1
364433|NCT00380692|1172572|P1|Study Period III - Open Label|Withdrawal by Subject|0
364434|NCT00380692|1172571|P2|Study Period III - Open Label|Protocol Violation|0
364435|NCT00380692|1172572|P1|Study Period III - Open Label|Protocol Violation|0
364436|NCT00380692|1172571|P2|Study Period III - Open Label|Adverse Event|3
364437|NCT00380692|1172572|P1|Study Period III - Open Label|Adverse Event|5
364438|NCT00380692|1172571|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
364439|NCT00380692|1172572|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
364440|NCT00380692|1172571|P2|Study Period II - Double Blind|Lack of Efficacy|0
364441|NCT00380692|1172572|P1|Study Period II - Double Blind|Lack of Efficacy|1
364442|NCT00380692|1172571|P2|Study Period II - Double Blind|Physician Decision|1
364443|NCT00380692|1172572|P1|Study Period II - Double Blind|Physician Decision|0
364444|NCT00380692|1172571|P2|Study Period II - Double Blind|Withdrawal by Subject|0
364445|NCT00380692|1172572|P1|Study Period II - Double Blind|Withdrawal by Subject|0
364446|NCT00380692|1172571|P2|Study Period II - Double Blind|Protocol Violation|2
364447|NCT00380692|1172572|P1|Study Period II - Double Blind|Protocol Violation|2
364448|NCT00380692|1172571|P2|Study Period II - Double Blind|Adverse Event|0
364449|NCT00380692|1172572|P1|Study Period II - Double Blind|Adverse Event|1
364450|NCT00380588|1172620|P2|Overall Study|Physician Decision|0
364451|NCT00380588|1172621|P1|Overall Study|Physician Decision|2
364452|NCT00380588|1172620|P2|Overall Study|Withdrawal by Subject|3
364453|NCT00380588|1172621|P1|Overall Study|Withdrawal by Subject|1
364454|NCT00380588|1172620|P2|Overall Study|Adverse Event|3
364455|NCT00380588|1172621|P1|Overall Study|Adverse Event|7
364456|NCT00380588|1172620|P2|Overall Study|Next Cycle Not Started|0
364457|NCT00380588|1172621|P1|Overall Study|Next Cycle Not Started|4
364458|NCT00380588|1172620|P2|Overall Study|Unequivocal Disease Progression|34
364459|NCT00380588|1172621|P1|Overall Study|Unequivocal Disease Progression|25
364460|NCT00380367|1172633|P1|Overall Study|Withdrawal by Subject|1
364461|NCT00380367|1172633|P1|Overall Study|Lost to Follow-up|1
364462|NCT00380250|1172640|P2|Overall Study|Physician Decision|0
364463|NCT00380250|1172641|P1|Overall Study|Physician Decision|1
364464|NCT00380250|1172640|P2|Overall Study|Lost to Follow-up|5
364465|NCT00380250|1172641|P1|Overall Study|Lost to Follow-up|14
364466|NCT00380250|1172640|P2|Overall Study|Protocol Violation|5
364467|NCT00380250|1172641|P1|Overall Study|Protocol Violation|15
364468|NCT00380250|1172640|P2|Overall Study|Lack of Efficacy|8
364469|NCT00380250|1172641|P1|Overall Study|Lack of Efficacy|10
364470|NCT00380250|1172640|P2|Overall Study|Adverse Event|9
364471|NCT00380250|1172641|P1|Overall Study|Adverse Event|20
364472|NCT00380250|1172640|P2|Overall Study|Withdrawal by Subject|28
364473|NCT00380250|1172641|P1|Overall Study|Withdrawal by Subject|39
364474|NCT00379834|1172703|P1|Overall Study|Time constraints|2
364475|NCT00379808|1172855|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
364476|NCT00379808|1172856|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
364477|NCT00379795|1172877|P5|Overall Study|Sponsor's decision|10
364478|NCT00379795|1172878|P4|Overall Study|Sponsor's decision|47
364479|NCT00379795|1172879|P3|Overall Study|Sponsor's decision|54
364480|NCT00379795|1172880|P2|Overall Study|Sponsor's decision|17
364481|NCT00379795|1172881|P1|Overall Study|Sponsor's decision|257
364482|NCT00379795|1172877|P5|Overall Study|Subjects condition mandated intervention|7
364483|NCT00379795|1172878|P4|Overall Study|Subjects condition mandated intervention|5
364484|NCT00379795|1172879|P3|Overall Study|Subjects condition mandated intervention|7
364485|NCT00379795|1172880|P2|Overall Study|Subjects condition mandated intervention|9
364486|NCT00379795|1172881|P1|Overall Study|Subjects condition mandated intervention|34
364487|NCT00379795|1172877|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
364488|NCT00379795|1172878|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
364489|NCT00379795|1172879|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
364490|NCT00379795|1172880|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
364491|NCT00379795|1172881|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
364492|NCT00379795|1172877|P5|Overall Study|Subject non-compliance|1
364493|NCT00379795|1172878|P4|Overall Study|Subject non-compliance|0
364494|NCT00379795|1172879|P3|Overall Study|Subject non-compliance|0
364495|NCT00379795|1172880|P2|Overall Study|Subject non-compliance|2
364496|NCT00379795|1172881|P1|Overall Study|Subject non-compliance|7
364497|NCT00379795|1172877|P5|Overall Study|Withdrawal by Subject|14
364498|NCT00379795|1172878|P4|Overall Study|Withdrawal by Subject|7
364499|NCT00379795|1172879|P3|Overall Study|Withdrawal by Subject|19
364500|NCT00379795|1172880|P2|Overall Study|Withdrawal by Subject|11
364501|NCT00379795|1172881|P1|Overall Study|Withdrawal by Subject|94
364502|NCT00379795|1172877|P5|Overall Study|Physician Decision|2
364503|NCT00379795|1172878|P4|Overall Study|Physician Decision|2
364504|NCT00379795|1172879|P3|Overall Study|Physician Decision|2
364505|NCT00379795|1172880|P2|Overall Study|Physician Decision|0
364506|NCT00379795|1172881|P1|Overall Study|Physician Decision|25
364507|NCT00379795|1172877|P5|Overall Study|Lost to Follow-up|4
364508|NCT00379795|1172878|P4|Overall Study|Lost to Follow-up|1
364509|NCT00379795|1172879|P3|Overall Study|Lost to Follow-up|2
364510|NCT00379795|1172880|P2|Overall Study|Lost to Follow-up|1
364511|NCT00379795|1172881|P1|Overall Study|Lost to Follow-up|8
364512|NCT00379795|1172877|P5|Overall Study|Adverse Event|4
364513|NCT00379795|1172878|P4|Overall Study|Adverse Event|1
364514|NCT00379795|1172879|P3|Overall Study|Adverse Event|3
364515|NCT00379795|1172880|P2|Overall Study|Adverse Event|3
364516|NCT00379795|1172881|P1|Overall Study|Adverse Event|17
364517|NCT00379795|1172877|P5|Overall Study|Death|7
364518|NCT00379795|1172878|P4|Overall Study|Death|4
364519|NCT00379795|1172879|P3|Overall Study|Death|6
364520|NCT00379795|1172880|P2|Overall Study|Death|8
364521|NCT00379795|1172881|P1|Overall Study|Death|31
364522|NCT00379769|1172911|P6|Observational Follow-up|Unknown; Reason Not Provided|1
364523|NCT00379769|1172912|P5|Observational Follow-up|Unknown; Reason Not Provided|1
364524|NCT00379769|1172913|P4|Observational Follow-up|Unknown; Reason Not Provided|0
364525|NCT00379769|1172914|P3|Observational Follow-up|Unknown; Reason Not Provided|0
364526|NCT00379769|1172915|P2|Observational Follow-up|Unknown; Reason Not Provided|0
364527|NCT00379769|1172916|P1|Observational Follow-up|Unknown; Reason Not Provided|0
364528|NCT00379769|1172911|P6|Observational Follow-up|Participant Moved|1
364529|NCT00379769|1172912|P5|Observational Follow-up|Participant Moved|0
364530|NCT00379769|1172913|P4|Observational Follow-up|Participant Moved|0
364531|NCT00379769|1172914|P3|Observational Follow-up|Participant Moved|0
364532|NCT00379769|1172915|P2|Observational Follow-up|Participant Moved|0
364533|NCT00379769|1172916|P1|Observational Follow-up|Participant Moved|0
364534|NCT00379769|1172911|P6|Observational Follow-up|Site Closed Early|7
364535|NCT00379769|1172912|P5|Observational Follow-up|Site Closed Early|6
364536|NCT00379769|1172913|P4|Observational Follow-up|Site Closed Early|0
364537|NCT00379769|1172914|P3|Observational Follow-up|Site Closed Early|0
364538|NCT00379769|1172915|P2|Observational Follow-up|Site Closed Early|0
364539|NCT00379769|1172916|P1|Observational Follow-up|Site Closed Early|0
364540|NCT00379769|1172911|P6|Observational Follow-up|Physician Decision|8
364541|NCT00379769|1172912|P5|Observational Follow-up|Physician Decision|8
364542|NCT00379769|1172913|P4|Observational Follow-up|Physician Decision|0
364543|NCT00379769|1172914|P3|Observational Follow-up|Physician Decision|0
364544|NCT00379769|1172915|P2|Observational Follow-up|Physician Decision|0
364545|NCT00379769|1172916|P1|Observational Follow-up|Physician Decision|0
364546|NCT00379769|1172911|P6|Observational Follow-up|Entered into Another Clinical Trial|22
364547|NCT00379769|1172912|P5|Observational Follow-up|Entered into Another Clinical Trial|18
364548|NCT00379769|1172913|P4|Observational Follow-up|Entered into Another Clinical Trial|0
364549|NCT00379769|1172914|P3|Observational Follow-up|Entered into Another Clinical Trial|0
364550|NCT00379769|1172915|P2|Observational Follow-up|Entered into Another Clinical Trial|0
364551|NCT00379769|1172916|P1|Observational Follow-up|Entered into Another Clinical Trial|0
364552|NCT00379769|1172911|P6|Observational Follow-up|Withdrawal by Subject|12
364553|NCT00379769|1172912|P5|Observational Follow-up|Withdrawal by Subject|12
364554|NCT00379769|1172913|P4|Observational Follow-up|Withdrawal by Subject|0
364555|NCT00379769|1172914|P3|Observational Follow-up|Withdrawal by Subject|0
364556|NCT00379769|1172915|P2|Observational Follow-up|Withdrawal by Subject|0
364557|NCT00379769|1172916|P1|Observational Follow-up|Withdrawal by Subject|0
364558|NCT00379769|1172911|P6|Observational Follow-up|Lost to Follow-up|27
364559|NCT00379769|1172912|P5|Observational Follow-up|Lost to Follow-up|25
364560|NCT00379769|1172913|P4|Observational Follow-up|Lost to Follow-up|0
364561|NCT00379769|1172914|P3|Observational Follow-up|Lost to Follow-up|0
364562|NCT00379769|1172915|P2|Observational Follow-up|Lost to Follow-up|0
364563|NCT00379769|1172916|P1|Observational Follow-up|Lost to Follow-up|0
364564|NCT00379769|1172911|P6|Observational Follow-up|Adverse Event|0
364565|NCT00379769|1172912|P5|Observational Follow-up|Adverse Event|1
364566|NCT00379769|1172913|P4|Observational Follow-up|Adverse Event|0
364567|NCT00379769|1172914|P3|Observational Follow-up|Adverse Event|0
364568|NCT00379769|1172915|P2|Observational Follow-up|Adverse Event|0
364569|NCT00379769|1172916|P1|Observational Follow-up|Adverse Event|0
364570|NCT00379769|1172911|P6|Observational Follow-up|Death|70
364571|NCT00379769|1172912|P5|Observational Follow-up|Death|78
364572|NCT00379769|1172913|P4|Observational Follow-up|Death|0
364573|NCT00379769|1172914|P3|Observational Follow-up|Death|0
364574|NCT00379769|1172915|P2|Observational Follow-up|Death|0
364575|NCT00379769|1172916|P1|Observational Follow-up|Death|0
364576|NCT00379769|1172911|P6|Main Study|Reason unspecified|0
364577|NCT00379769|1172912|P5|Main Study|Reason unspecified|0
364578|NCT00379769|1172913|P4|Main Study|Reason unspecified|0
364579|NCT00379769|1172914|P3|Main Study|Reason unspecified|1
364580|NCT00379769|1172915|P2|Main Study|Reason unspecified|0
364581|NCT00379769|1172916|P1|Main Study|Reason unspecified|0
364582|NCT00379769|1172911|P6|Main Study|Investigator refused to log temperature|0
364583|NCT00379769|1172912|P5|Main Study|Investigator refused to log temperature|0
364584|NCT00379769|1172913|P4|Main Study|Investigator refused to log temperature|0
364585|NCT00379769|1172914|P3|Main Study|Investigator refused to log temperature|1
364586|NCT00379769|1172915|P2|Main Study|Investigator refused to log temperature|0
364587|NCT00379769|1172916|P1|Main Study|Investigator refused to log temperature|0
364588|NCT00379769|1172911|P6|Main Study|Risk of heart failure|0
364589|NCT00379769|1172912|P5|Main Study|Risk of heart failure|0
364590|NCT00379769|1172913|P4|Main Study|Risk of heart failure|0
364591|NCT00379769|1172914|P3|Main Study|Risk of heart failure|0
364592|NCT00379769|1172915|P2|Main Study|Risk of heart failure|1
364593|NCT00379769|1172916|P1|Main Study|Risk of heart failure|0
364594|NCT00379769|1172911|P6|Main Study|Personal reasons|0
364595|NCT00379769|1172912|P5|Main Study|Personal reasons|0
364596|NCT00379769|1172913|P4|Main Study|Personal reasons|0
364597|NCT00379769|1172914|P3|Main Study|Personal reasons|0
364598|NCT00379769|1172915|P2|Main Study|Personal reasons|0
364599|NCT00379769|1172916|P1|Main Study|Personal reasons|1
364600|NCT00379769|1172911|P6|Main Study|Participant completed study at visit 27|0
364601|NCT00379769|1172912|P5|Main Study|Participant completed study at visit 27|0
364602|NCT00379769|1172913|P4|Main Study|Participant completed study at visit 27|0
364603|NCT00379769|1172914|P3|Main Study|Participant completed study at visit 27|0
364604|NCT00379769|1172915|P2|Main Study|Participant completed study at visit 27|0
364605|NCT00379769|1172916|P1|Main Study|Participant completed study at visit 27|1
364606|NCT00379769|1172911|P6|Main Study|Physician Decision|0
364607|NCT00379769|1172912|P5|Main Study|Physician Decision|0
364608|NCT00379769|1172913|P4|Main Study|Physician Decision|1
364609|NCT00379769|1172914|P3|Main Study|Physician Decision|1
364610|NCT00379769|1172915|P2|Main Study|Physician Decision|2
364611|NCT00379769|1172916|P1|Main Study|Physician Decision|2
364612|NCT00379769|1172911|P6|Main Study|Participant did not take study drug|0
364613|NCT00379769|1172912|P5|Main Study|Participant did not take study drug|0
364614|NCT00379769|1172913|P4|Main Study|Participant did not take study drug|0
364615|NCT00379769|1172914|P3|Main Study|Participant did not take study drug|1
364616|NCT00379769|1172915|P2|Main Study|Participant did not take study drug|0
364617|NCT00379769|1172916|P1|Main Study|Participant did not take study drug|0
364618|NCT00379769|1172911|P6|Main Study|Entry criteria violation|0
364619|NCT00379769|1172912|P5|Main Study|Entry criteria violation|0
364620|NCT00379769|1172913|P4|Main Study|Entry criteria violation|1
364621|NCT00379769|1172914|P3|Main Study|Entry criteria violation|1
364622|NCT00379769|1172915|P2|Main Study|Entry criteria violation|0
364623|NCT00379769|1172916|P1|Main Study|Entry criteria violation|0
364624|NCT00379769|1172911|P6|Main Study|Site closed|0
364625|NCT00379769|1172912|P5|Main Study|Site closed|0
364626|NCT00379769|1172913|P4|Main Study|Site closed|8
364627|NCT00379769|1172914|P3|Main Study|Site closed|4
364628|NCT00379769|1172915|P2|Main Study|Site closed|4
364629|NCT00379769|1172916|P1|Main Study|Site closed|4
364630|NCT00379769|1172911|P6|Main Study|Prohibited glucose lowering medication|0
364631|NCT00379769|1172912|P5|Main Study|Prohibited glucose lowering medication|0
364632|NCT00379769|1172913|P4|Main Study|Prohibited glucose lowering medication|1
364633|NCT00379769|1172914|P3|Main Study|Prohibited glucose lowering medication|0
364634|NCT00379769|1172915|P2|Main Study|Prohibited glucose lowering medication|3
364635|NCT00379769|1172916|P1|Main Study|Prohibited glucose lowering medication|0
364636|NCT00379769|1172911|P6|Main Study|Poor compliance|0
364637|NCT00379769|1172912|P5|Main Study|Poor compliance|0
364638|NCT00379769|1172913|P4|Main Study|Poor compliance|1
364639|NCT00379769|1172914|P3|Main Study|Poor compliance|2
364640|NCT00379769|1172915|P2|Main Study|Poor compliance|2
364641|NCT00379769|1172916|P1|Main Study|Poor compliance|3
364642|NCT00379769|1172911|P6|Main Study|Participant moved|0
364643|NCT00379769|1172912|P5|Main Study|Participant moved|0
364644|NCT00379769|1172913|P4|Main Study|Participant moved|3
364645|NCT00379769|1172914|P3|Main Study|Participant moved|3
364646|NCT00379769|1172915|P2|Main Study|Participant moved|2
364647|NCT00379769|1172916|P1|Main Study|Participant moved|3
364648|NCT00379769|1172911|P6|Main Study|Moved to survival status follow-up only|0
364649|NCT00379769|1172912|P5|Main Study|Moved to survival status follow-up only|0
364650|NCT00379769|1172913|P4|Main Study|Moved to survival status follow-up only|36
364651|NCT00379769|1172914|P3|Main Study|Moved to survival status follow-up only|32
364652|NCT00379769|1172915|P2|Main Study|Moved to survival status follow-up only|25
364653|NCT00379769|1172916|P1|Main Study|Moved to survival status follow-up only|27
364654|NCT00379769|1172911|P6|Main Study|Withdrawal by Subject|0
364655|NCT00379769|1172912|P5|Main Study|Withdrawal by Subject|0
364656|NCT00379769|1172913|P4|Main Study|Withdrawal by Subject|70
364657|NCT00379769|1172914|P3|Main Study|Withdrawal by Subject|72
364658|NCT00379769|1172915|P2|Main Study|Withdrawal by Subject|56
364659|NCT00379769|1172916|P1|Main Study|Withdrawal by Subject|46
364660|NCT00379769|1172911|P6|Main Study|Lost to Follow-up|0
364661|NCT00379769|1172912|P5|Main Study|Lost to Follow-up|0
364662|NCT00379769|1172913|P4|Main Study|Lost to Follow-up|26
364663|NCT00379769|1172914|P3|Main Study|Lost to Follow-up|25
364664|NCT00379769|1172915|P2|Main Study|Lost to Follow-up|29
364665|NCT00379769|1172916|P1|Main Study|Lost to Follow-up|29
364666|NCT00379769|1172911|P6|Main Study|Adverse Event|0
364667|NCT00379769|1172912|P5|Main Study|Adverse Event|0
364668|NCT00379769|1172913|P4|Main Study|Adverse Event|11
364669|NCT00379769|1172914|P3|Main Study|Adverse Event|10
364670|NCT00379769|1172915|P2|Main Study|Adverse Event|8
364671|NCT00379769|1172916|P1|Main Study|Adverse Event|5
364672|NCT00379769|1172911|P6|Main Study|Death|0
364673|NCT00379769|1172912|P5|Main Study|Death|0
364674|NCT00379769|1172913|P4|Main Study|Death|72
364675|NCT00379769|1172914|P3|Main Study|Death|54
364676|NCT00379769|1172915|P2|Main Study|Death|67
364677|NCT00379769|1172916|P1|Main Study|Death|57
364678|NCT00379639|1173075|P5|Overall Study|Other|0
364679|NCT00379639|1173076|P4|Overall Study|Other|0
364680|NCT00379639|1173077|P3|Overall Study|Other|3
364681|NCT00379639|1173078|P2|Overall Study|Other|0
364682|NCT00379639|1173079|P1|Overall Study|Other|0
364683|NCT00379639|1173075|P5|Overall Study|Lost to Follow-up|0
364684|NCT00379639|1173076|P4|Overall Study|Lost to Follow-up|1
364685|NCT00379639|1173077|P3|Overall Study|Lost to Follow-up|0
364686|NCT00379639|1173078|P2|Overall Study|Lost to Follow-up|0
364687|NCT00379639|1173079|P1|Overall Study|Lost to Follow-up|0
364688|NCT00379639|1173075|P5|Overall Study|Adverse Event|1
364689|NCT00379639|1173076|P4|Overall Study|Adverse Event|0
364690|NCT00379639|1173077|P3|Overall Study|Adverse Event|1
364691|NCT00379639|1173078|P2|Overall Study|Adverse Event|0
364692|NCT00379639|1173079|P1|Overall Study|Adverse Event|0
364693|NCT00379639|1173075|P5|Overall Study|Symptomatic Deterioration|1
364694|NCT00379639|1173076|P4|Overall Study|Symptomatic Deterioration|0
364695|NCT00379639|1173077|P3|Overall Study|Symptomatic Deterioration|1
364696|NCT00379639|1173078|P2|Overall Study|Symptomatic Deterioration|0
364697|NCT00379639|1173079|P1|Overall Study|Symptomatic Deterioration|0
364698|NCT00379639|1173075|P5|Overall Study|Physician Decision|0
364699|NCT00379639|1173076|P4|Overall Study|Physician Decision|1
364700|NCT00379639|1173077|P3|Overall Study|Physician Decision|1
364701|NCT00379639|1173078|P2|Overall Study|Physician Decision|2
364702|NCT00379639|1173079|P1|Overall Study|Physician Decision|0
364703|NCT00379639|1173075|P5|Overall Study|Disease Progression|4
364704|NCT00379639|1173076|P4|Overall Study|Disease Progression|4
364705|NCT00379639|1173077|P3|Overall Study|Disease Progression|3
364706|NCT00379639|1173078|P2|Overall Study|Disease Progression|3
364707|NCT00379639|1173079|P1|Overall Study|Disease Progression|3
364708|NCT00379587|1173101|P1|Overall Study|Lost to Follow-up|2
364709|NCT00379353|1173115|P2|Overall Study|Conflicting drug treatment|1
364710|NCT00379353|1173116|P1|Overall Study|Conflicting drug treatment|0
364711|NCT00379353|1173115|P2|Overall Study|Non-compliance|0
364712|NCT00379353|1173116|P1|Overall Study|Non-compliance|1
364713|NCT00379353|1173115|P2|Overall Study|Cardiac Tamponade|0
364714|NCT00379353|1173116|P1|Overall Study|Cardiac Tamponade|1
364715|NCT00379353|1173115|P2|Overall Study|Death|0
364716|NCT00379353|1173116|P1|Overall Study|Death|1
364717|NCT00379353|1173115|P2|Overall Study|Withdrawal by Subject|2
364718|NCT00379353|1173116|P1|Overall Study|Withdrawal by Subject|5
364719|NCT00379353|1173115|P2|Overall Study|Hospitalization|3
364720|NCT00379353|1173116|P1|Overall Study|Hospitalization|3
364721|NCT00379340|1173151|P5|Overall Study|Delayed nephrectomy and anaplasia|1
364722|NCT00379340|1173152|P4|Overall Study|Delayed nephrectomy and anaplasia|1
364723|NCT00379340|1173153|P3|Overall Study|Delayed nephrectomy and anaplasia|0
364724|NCT00379340|1173154|P2|Overall Study|Delayed nephrectomy and anaplasia|0
364725|NCT00379340|1173155|P1|Overall Study|Delayed nephrectomy and anaplasia|0
364726|NCT00379340|1173151|P5|Overall Study|On more than 1 tumor therapeutic study|0
364727|NCT00379340|1173152|P4|Overall Study|On more than 1 tumor therapeutic study|2
364728|NCT00379340|1173153|P3|Overall Study|On more than 1 tumor therapeutic study|0
364729|NCT00379340|1173154|P2|Overall Study|On more than 1 tumor therapeutic study|0
364730|NCT00379340|1173155|P1|Overall Study|On more than 1 tumor therapeutic study|0
364731|NCT00379340|1173151|P5|Overall Study|Refusal of further protocol therapy|7
364732|NCT00379340|1173152|P4|Overall Study|Refusal of further protocol therapy|1
364733|NCT00379340|1173153|P3|Overall Study|Refusal of further protocol therapy|1
364734|NCT00379340|1173154|P2|Overall Study|Refusal of further protocol therapy|0
364735|NCT00379340|1173155|P1|Overall Study|Refusal of further protocol therapy|1
364736|NCT00379340|1173151|P5|Overall Study|Withdrawal by Subject|0
364737|NCT00379340|1173152|P4|Overall Study|Withdrawal by Subject|1
364738|NCT00379340|1173153|P3|Overall Study|Withdrawal by Subject|0
364739|NCT00379340|1173154|P2|Overall Study|Withdrawal by Subject|0
364740|NCT00379340|1173155|P1|Overall Study|Withdrawal by Subject|0
364741|NCT00379340|1173151|P5|Overall Study|Physician Decision|3
364742|NCT00379340|1173152|P4|Overall Study|Physician Decision|2
364743|NCT00379340|1173153|P3|Overall Study|Physician Decision|1
364744|NCT00379340|1173154|P2|Overall Study|Physician Decision|2
364745|NCT00379340|1173155|P1|Overall Study|Physician Decision|6
364746|NCT00379340|1173151|P5|Overall Study|Lack of Efficacy|3
364747|NCT00379340|1173152|P4|Overall Study|Lack of Efficacy|4
364748|NCT00379340|1173153|P3|Overall Study|Lack of Efficacy|0
364749|NCT00379340|1173154|P2|Overall Study|Lack of Efficacy|1
364750|NCT00379340|1173155|P1|Overall Study|Lack of Efficacy|6
364751|NCT00379340|1173151|P5|Overall Study|Death|0
364752|NCT00379340|1173152|P4|Overall Study|Death|2
364753|NCT00379340|1173153|P3|Overall Study|Death|0
364754|NCT00379340|1173154|P2|Overall Study|Death|0
364755|NCT00379340|1173155|P1|Overall Study|Death|0
364756|NCT00379288|1173172|P4|Overall Study|Administrative|1
364757|NCT00379288|1173173|P3|Overall Study|Administrative|0
364758|NCT00379288|1173174|P2|Overall Study|Administrative|2
364759|NCT00379288|1173175|P1|Overall Study|Administrative|2
364760|NCT00379288|1173172|P4|Overall Study|Did not meet protocol eligibility|2
364761|NCT00379288|1173173|P3|Overall Study|Did not meet protocol eligibility|0
364762|NCT00379288|1173174|P2|Overall Study|Did not meet protocol eligibility|1
364763|NCT00379288|1173175|P1|Overall Study|Did not meet protocol eligibility|0
364764|NCT00379288|1173172|P4|Overall Study|Noncompliance with protocol|1
364765|NCT00379288|1173173|P3|Overall Study|Noncompliance with protocol|2
364766|NCT00379288|1173174|P2|Overall Study|Noncompliance with protocol|6
364767|NCT00379288|1173175|P1|Overall Study|Noncompliance with protocol|8
364768|NCT00379288|1173172|P4|Overall Study|Subject withdrew-related to study drug|1
364769|NCT00379288|1173173|P3|Overall Study|Subject withdrew-related to study drug|0
364770|NCT00379288|1173174|P2|Overall Study|Subject withdrew-related to study drug|0
364771|NCT00379288|1173175|P1|Overall Study|Subject withdrew-related to study drug|1
364772|NCT00379288|1173172|P4|Overall Study|Subject withdrew-unrelated to study drug|2
364773|NCT00379288|1173173|P3|Overall Study|Subject withdrew-unrelated to study drug|4
364774|NCT00379288|1173174|P2|Overall Study|Subject withdrew-unrelated to study drug|3
364775|NCT00379288|1173175|P1|Overall Study|Subject withdrew-unrelated to study drug|0
364776|NCT00379288|1173172|P4|Overall Study|Lost to Follow-up|0
364777|NCT00379288|1173173|P3|Overall Study|Lost to Follow-up|2
364778|NCT00379288|1173174|P2|Overall Study|Lost to Follow-up|3
364779|NCT00379288|1173175|P1|Overall Study|Lost to Follow-up|3
364780|NCT00379288|1173172|P4|Overall Study|Treatment Failure|1
364781|NCT00379288|1173173|P3|Overall Study|Treatment Failure|0
364782|NCT00379288|1173174|P2|Overall Study|Treatment Failure|1
364783|NCT00379288|1173175|P1|Overall Study|Treatment Failure|0
364784|NCT00379288|1173172|P4|Overall Study|Adverse Event|0
364785|NCT00379288|1173173|P3|Overall Study|Adverse Event|2
364786|NCT00379288|1173174|P2|Overall Study|Adverse Event|6
364787|NCT00379288|1173175|P1|Overall Study|Adverse Event|5
364788|NCT00379236|1173187|P3|Open-label Extension|Not specified|7
364789|NCT00379236|1173188|P2|Open-label Extension|Not specified|0
364790|NCT00379236|1173189|P1|Open-label Extension|Not specified|0
364791|NCT00379236|1173187|P3|Open-label Extension|Use of exclusionary medication|3
364792|NCT00379236|1173188|P2|Open-label Extension|Use of exclusionary medication|0
364793|NCT00379236|1173189|P1|Open-label Extension|Use of exclusionary medication|0
364794|NCT00379236|1173187|P3|Open-label Extension|Lost to Follow-up|12
364795|NCT00379236|1173188|P2|Open-label Extension|Lost to Follow-up|0
364796|NCT00379236|1173189|P1|Open-label Extension|Lost to Follow-up|0
364797|NCT00379236|1173187|P3|Open-label Extension|Withdrawal by Subject|13
364798|NCT00379236|1173188|P2|Open-label Extension|Withdrawal by Subject|0
364799|NCT00379236|1173189|P1|Open-label Extension|Withdrawal by Subject|0
364800|NCT00379236|1173187|P3|Open-label Extension|Protocol Violation|7
364801|NCT00379236|1173188|P2|Open-label Extension|Protocol Violation|0
364802|NCT00379236|1173189|P1|Open-label Extension|Protocol Violation|0
364803|NCT00379236|1173187|P3|Open-label Extension|Adverse Event|13
364804|NCT00379236|1173188|P2|Open-label Extension|Adverse Event|0
364805|NCT00379236|1173189|P1|Open-label Extension|Adverse Event|0
364806|NCT00379236|1173187|P3|Double-blind|Data could not be retrieved|0
364807|NCT00379236|1173188|P2|Double-blind|Data could not be retrieved|2
364808|NCT00379236|1173189|P1|Double-blind|Data could not be retrieved|2
364809|NCT00379236|1173187|P3|Double-blind|Not specified|0
364810|NCT00379236|1173188|P2|Double-blind|Not specified|7
364811|NCT00379236|1173189|P1|Double-blind|Not specified|3
364812|NCT00379236|1173187|P3|Double-blind|Use of exclusionary medication|0
364813|NCT00379236|1173188|P2|Double-blind|Use of exclusionary medication|2
364814|NCT00379236|1173189|P1|Double-blind|Use of exclusionary medication|1
364815|NCT00379236|1173187|P3|Double-blind|Lost to Follow-up|0
364816|NCT00379236|1173188|P2|Double-blind|Lost to Follow-up|3
364817|NCT00379236|1173189|P1|Double-blind|Lost to Follow-up|4
364818|NCT00379236|1173187|P3|Double-blind|Withdrawal by Subject|0
364819|NCT00379236|1173188|P2|Double-blind|Withdrawal by Subject|13
364820|NCT00379236|1173189|P1|Double-blind|Withdrawal by Subject|12
364821|NCT00379236|1173187|P3|Double-blind|Protocol Violation|0
364822|NCT00379236|1173188|P2|Double-blind|Protocol Violation|3
364823|NCT00379236|1173189|P1|Double-blind|Protocol Violation|3
364824|NCT00379236|1173187|P3|Double-blind|Adverse Event|0
364825|NCT00379236|1173188|P2|Double-blind|Adverse Event|6
364826|NCT00379236|1173189|P1|Double-blind|Adverse Event|11
364827|NCT00379210|1173234|P2|Overall Study|Withdrawal by Subject|7
364828|NCT00379210|1173235|P1|Overall Study|Withdrawal by Subject|10
364829|NCT00379080|1173249|P3|Overall Study|Withdrawal by Subject|0
364830|NCT00379080|1173250|P2|Overall Study|Withdrawal by Subject|4
364831|NCT00379080|1173251|P1|Overall Study|Withdrawal by Subject|0
364832|NCT00378898|1173296|P2|Overall Study|Protocol Violation|1
364833|NCT00378898|1173297|P1|Overall Study|Protocol Violation|1
364834|NCT00378898|1173296|P2|Overall Study|Withdrawal by Subject|5
364835|NCT00378898|1173297|P1|Overall Study|Withdrawal by Subject|10
364896|NCT00378599|1173334|P1|Overall Study|Withdrawal by Subject|5
364897|NCT00378599|1173334|P1|Overall Study|Treatment failure|7
364898|NCT00378599|1173334|P1|Overall Study|Protocol Violation|2
364899|NCT00378599|1173334|P1|Overall Study|Adverse Event|38
364900|NCT00378573|1173338|P1|Follow-up|Withdrawal by Subject|1
364901|NCT00378573|1173338|P1|Follow-up|Lost to Follow-up|1
364902|NCT00378573|1173338|P1|Follow-up|Death|12
364903|NCT00378573|1173338|P1|Treatment Period|Sponsor decision to close study|1
364904|NCT00378573|1173338|P1|Treatment Period|Disease Progression|4
364905|NCT00378573|1173338|P1|Treatment Period|Withdrawal by Subject|2
364906|NCT00378573|1173338|P1|Treatment Period|Physician Decision|1
364907|NCT00378573|1173338|P1|Treatment Period|Adverse Event|9
364908|NCT00378560|1173346|P2|Overall Study|Laboratory test values abnormal|0
364909|NCT00378560|1173347|P1|Overall Study|Laboratory test values abnormal|1
364910|NCT00378560|1173346|P2|Overall Study|Pregnancy|5
364911|NCT00378560|1173347|P1|Overall Study|Pregnancy|7
364912|NCT00378560|1173346|P2|Overall Study|Moved|3
364913|NCT00378560|1173347|P1|Overall Study|Moved|4
364914|NCT00378560|1173346|P2|Overall Study|Withdrawal by Subject|21
364915|NCT00378560|1173347|P1|Overall Study|Withdrawal by Subject|17
364916|NCT00378560|1173346|P2|Overall Study|Protocol Violation|0
364917|NCT00378560|1173347|P1|Overall Study|Protocol Violation|2
364918|NCT00378560|1173346|P2|Overall Study|Lost to Follow-up|29
364919|NCT00378560|1173347|P1|Overall Study|Lost to Follow-up|24
364920|NCT00378560|1173346|P2|Overall Study|Adverse Event|0
364921|NCT00378560|1173347|P1|Overall Study|Adverse Event|1
364922|NCT00378534|1173361|P1|Overall Study|Subjects did not receive a transplant|3
364923|NCT00378534|1173361|P1|Overall Study|Donors|57
364924|NCT00378508|1173367|P2|Overall Study|Lost to Follow-up|0
364925|NCT00378508|1173368|P1|Overall Study|Lost to Follow-up|1
364926|NCT00378508|1173367|P2|Overall Study|Withdrawal by Subject|3
364927|NCT00378508|1173368|P1|Overall Study|Withdrawal by Subject|1
364928|NCT00378378|1173387|P3|Overall Study|Non-compliance with protocol|1
364929|NCT00378378|1173388|P2|Overall Study|Non-compliance with protocol|0
364930|NCT00378378|1173389|P1|Overall Study|Non-compliance with protocol|0
364931|NCT00378378|1173387|P3|Overall Study|Treatment Failure|1
364932|NCT00378378|1173388|P2|Overall Study|Treatment Failure|0
364933|NCT00378378|1173389|P1|Overall Study|Treatment Failure|0
364934|NCT00378378|1173387|P3|Overall Study|Withdrawal by Subject|0
364935|NCT00378378|1173388|P2|Overall Study|Withdrawal by Subject|1
364936|NCT00378378|1173389|P1|Overall Study|Withdrawal by Subject|0
364937|NCT00378209|1173435|P1|Overall Study|Treatment delay|1
364938|NCT00378209|1173435|P1|Overall Study|Death|1
364939|NCT00378209|1173435|P1|Overall Study|Physician Decision|3
364940|NCT00378209|1173435|P1|Overall Study|Initiation of non-protocol therapy|3
364941|NCT00378209|1173435|P1|Overall Study|Adverse Event|3
364942|NCT00378209|1173435|P1|Overall Study|Progressive disease|11
364943|NCT00378105|1173445|P2|Overall Study|necessity to increase lenalidomide dose|1
364944|NCT00378105|1173446|P1|Overall Study|necessity to increase lenalidomide dose|0
364945|NCT00378105|1173445|P2|Overall Study|Going non-protocol therapy|1
364946|NCT00378105|1173446|P1|Overall Study|Going non-protocol therapy|0
364947|NCT00378105|1173445|P2|Overall Study|Physician Decision|2
364948|NCT00378105|1173446|P1|Overall Study|Physician Decision|0
364949|NCT00378105|1173445|P2|Overall Study|remain on study|11
364950|NCT00378105|1173446|P1|Overall Study|remain on study|3
364951|NCT00378105|1173445|P2|Overall Study|Progressive disease|3
364952|NCT00378105|1173446|P1|Overall Study|Progressive disease|3
364953|NCT00378105|1173445|P2|Overall Study|Going to transplant|8
364954|NCT00378105|1173446|P1|Overall Study|Going to transplant|7
364955|NCT00378105|1173445|P2|Overall Study|Death|0
364956|NCT00378105|1173446|P1|Overall Study|Death|1
364957|NCT00378105|1173445|P2|Overall Study|Withdrawal by Subject|3
364958|NCT00378105|1173446|P1|Overall Study|Withdrawal by Subject|3
364959|NCT00378105|1173445|P2|Overall Study|Adverse Event|1
364960|NCT00378105|1173446|P1|Overall Study|Adverse Event|3
364961|NCT00378079|1173458|P3|Overall Study|Lost to Follow-up|0
364962|NCT00378079|1173459|P2|Overall Study|Lost to Follow-up|1
364963|NCT00378079|1173460|P1|Overall Study|Lost to Follow-up|6
364964|NCT00378014|1173482|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
364965|NCT00378014|1173483|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
364966|NCT00378014|1173482|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
364967|NCT00378014|1173483|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
364968|NCT00378014|1173482|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
365138|NCT00377299|1173814|P2|Overall Study|Lost to Follow-up|19
364969|NCT00378014|1173483|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
364970|NCT00378014|1173482|P2|Extension (Month 12 to Month 59)|Administrative problems|0
364971|NCT00378014|1173483|P1|Extension (Month 12 to Month 59)|Administrative problems|1
364972|NCT00378014|1173482|P2|Extension (Month 12 to Month 59)|Death|2
364973|NCT00378014|1173483|P1|Extension (Month 12 to Month 59)|Death|1
364974|NCT00378014|1173482|P2|Extension (Month 12 to Month 59)|Adverse Event|7
364975|NCT00378014|1173483|P1|Extension (Month 12 to Month 59)|Adverse Event|8
364976|NCT00378014|1173482|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
364977|NCT00378014|1173483|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
364978|NCT00378014|1173482|P2|Core (Randomization to Month 11)|Protocol deviation|1
364979|NCT00378014|1173483|P1|Core (Randomization to Month 11)|Protocol deviation|0
364980|NCT00378014|1173482|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
364981|NCT00378014|1173483|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
364982|NCT00378014|1173482|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
364983|NCT00378014|1173483|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
364984|NCT00378014|1173482|P2|Core (Randomization to Month 11)|Administrative Problems|2
364985|NCT00378014|1173483|P1|Core (Randomization to Month 11)|Administrative Problems|2
364986|NCT00378014|1173482|P2|Core (Randomization to Month 11)|Death|3
364987|NCT00378014|1173483|P1|Core (Randomization to Month 11)|Death|5
364988|NCT00378014|1173482|P2|Core (Randomization to Month 11)|Graft loss|2
364989|NCT00378014|1173483|P1|Core (Randomization to Month 11)|Graft loss|1
364990|NCT00378014|1173482|P2|Core (Randomization to Month 11)|Adverse Event|0
364991|NCT00378014|1173483|P1|Core (Randomization to Month 11)|Adverse Event|1
364992|NCT00377962|1173509|P2|Extension Study: 12-24 Months|Unspecified reason|3
364993|NCT00377962|1173510|P1|Extension Study: 12-24 Months|Unspecified reason|0
364994|NCT00377962|1173509|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
364995|NCT00377962|1173510|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
364996|NCT00377962|1173509|P2|Extension Study: 12-24 Months|Adverse Event|0
364997|NCT00377962|1173510|P1|Extension Study: 12-24 Months|Adverse Event|8
364998|NCT00377962|1173509|P2|Extension Study: 12-24 Months|Death|1
364999|NCT00377962|1173510|P1|Extension Study: 12-24 Months|Death|1
365000|NCT00377962|1173509|P2|Core Study: 0-12 Months|Unspecified reasons|4
365001|NCT00377962|1173510|P1|Core Study: 0-12 Months|Unspecified reasons|1
365002|NCT00377962|1173509|P2|Core Study: 0-12 Months|Administrative Reason|1
365003|NCT00377962|1173510|P1|Core Study: 0-12 Months|Administrative Reason|1
365004|NCT00377962|1173509|P2|Core Study: 0-12 Months|Withdrew Consent|2
365005|NCT00377962|1173510|P1|Core Study: 0-12 Months|Withdrew Consent|5
365006|NCT00377962|1173509|P2|Core Study: 0-12 Months|Death|0
365007|NCT00377962|1173510|P1|Core Study: 0-12 Months|Death|3
365008|NCT00377962|1173509|P2|Core Study: 0-12 Months|Adverse Event|2
365009|NCT00377962|1173510|P1|Core Study: 0-12 Months|Adverse Event|18
365010|NCT00377858|1173546|P2|Overall Study|Death|3
365011|NCT00377858|1173547|P1|Overall Study|Death|0
365012|NCT00377858|1173546|P2|Overall Study|Sponsor Decision|2
365013|NCT00377858|1173547|P1|Overall Study|Sponsor Decision|1
365014|NCT00377858|1173546|P2|Overall Study|Entry Criteria Not Met|0
365015|NCT00377858|1173547|P1|Overall Study|Entry Criteria Not Met|2
365016|NCT00377858|1173546|P2|Overall Study|Adverse Event|1
365017|NCT00377858|1173547|P1|Overall Study|Adverse Event|2
365018|NCT00377858|1173546|P2|Overall Study|Protocol Violation|4
365019|NCT00377858|1173547|P1|Overall Study|Protocol Violation|3
365020|NCT00377858|1173546|P2|Overall Study|Physician Decision|5
365021|NCT00377858|1173547|P1|Overall Study|Physician Decision|5
365022|NCT00377858|1173546|P2|Overall Study|Lost to Follow-up|1
365023|NCT00377858|1173547|P1|Overall Study|Lost to Follow-up|6
365024|NCT00377858|1173546|P2|Overall Study|Withdrawal by Subject|11
365025|NCT00377858|1173547|P1|Overall Study|Withdrawal by Subject|12
365026|NCT00377819|1173600|P2|Overall Study|Protocol Violation|1
365027|NCT00377819|1173601|P1|Overall Study|Protocol Violation|1
365028|NCT00377819|1173600|P2|Overall Study|Lost to Follow-up|1
365029|NCT00377819|1173601|P1|Overall Study|Lost to Follow-up|0
365030|NCT00377819|1173600|P2|Overall Study|Death|1
365031|NCT00377819|1173601|P1|Overall Study|Death|0
365032|NCT00377819|1173600|P2|Overall Study|Withdrawal by Subject|4
365033|NCT00377819|1173601|P1|Overall Study|Withdrawal by Subject|10
365034|NCT00377819|1173600|P2|Overall Study|Adverse Event|3
365035|NCT00377819|1173601|P1|Overall Study|Adverse Event|2
365036|NCT00377676|1173630|P2|Overall Study|not specified|58
365037|NCT00377676|1173631|P1|Overall Study|not specified|118
365038|NCT00377676|1173630|P2|Overall Study|Lost to Follow-up|56
365039|NCT00377676|1173631|P1|Overall Study|Lost to Follow-up|120
365040|NCT00377676|1173630|P2|Overall Study|Withdrawal by Subject|72
365041|NCT00377676|1173631|P1|Overall Study|Withdrawal by Subject|187
365042|NCT00377676|1173630|P2|Overall Study|Death|2
365043|NCT00377676|1173631|P1|Overall Study|Death|5
365044|NCT00377676|1173630|P2|Overall Study|Protocol Violation|27
365045|NCT00377676|1173631|P1|Overall Study|Protocol Violation|33
365046|NCT00377676|1173630|P2|Overall Study|Adverse Event|107
365047|NCT00377676|1173631|P1|Overall Study|Adverse Event|498
365048|NCT00377637|1173647|P4|Maintenance Phase|Death|1
365049|NCT00377637|1173648|P3|Maintenance Phase|Death|0
365050|NCT00377637|1173649|P2|Maintenance Phase|Death|0
365051|NCT00377637|1173650|P1|Maintenance Phase|Death|0
365052|NCT00377637|1173647|P4|Maintenance Phase|Study medication stopped > 14 days|1
365053|NCT00377637|1173648|P3|Maintenance Phase|Study medication stopped > 14 days|0
365054|NCT00377637|1173649|P2|Maintenance Phase|Study medication stopped > 14 days|0
365055|NCT00377637|1173650|P1|Maintenance Phase|Study medication stopped > 14 days|0
365056|NCT00377637|1173647|P4|Maintenance Phase|Non-compliance|1
365057|NCT00377637|1173648|P3|Maintenance Phase|Non-compliance|1
365058|NCT00377637|1173649|P2|Maintenance Phase|Non-compliance|0
365059|NCT00377637|1173650|P1|Maintenance Phase|Non-compliance|0
365060|NCT00377637|1173647|P4|Maintenance Phase|Sponsor decision|3
365061|NCT00377637|1173648|P3|Maintenance Phase|Sponsor decision|2
365062|NCT00377637|1173649|P2|Maintenance Phase|Sponsor decision|0
365063|NCT00377637|1173650|P1|Maintenance Phase|Sponsor decision|0
365064|NCT00377637|1173647|P4|Maintenance Phase|Withdrawal by Subject|3
365065|NCT00377637|1173648|P3|Maintenance Phase|Withdrawal by Subject|3
365066|NCT00377637|1173649|P2|Maintenance Phase|Withdrawal by Subject|0
365067|NCT00377637|1173650|P1|Maintenance Phase|Withdrawal by Subject|0
365068|NCT00377637|1173647|P4|Maintenance Phase|Lost to Follow-up|1
365069|NCT00377637|1173648|P3|Maintenance Phase|Lost to Follow-up|3
365070|NCT00377637|1173649|P2|Maintenance Phase|Lost to Follow-up|0
365071|NCT00377637|1173650|P1|Maintenance Phase|Lost to Follow-up|0
365072|NCT00377637|1173647|P4|Maintenance Phase|Physician Decision|4
365073|NCT00377637|1173648|P3|Maintenance Phase|Physician Decision|5
365074|NCT00377637|1173649|P2|Maintenance Phase|Physician Decision|0
365075|NCT00377637|1173650|P1|Maintenance Phase|Physician Decision|0
365076|NCT00377637|1173647|P4|Maintenance Phase|Adverse Event|43
365077|NCT00377637|1173648|P3|Maintenance Phase|Adverse Event|29
365078|NCT00377637|1173649|P2|Maintenance Phase|Adverse Event|0
365079|NCT00377637|1173650|P1|Maintenance Phase|Adverse Event|0
365080|NCT00377637|1173647|P4|Induction Phase|Reason for withdrawal is not noted|0
365081|NCT00377637|1173648|P3|Induction Phase|Reason for withdrawal is not noted|0
365082|NCT00377637|1173649|P2|Induction Phase|Reason for withdrawal is not noted|0
365083|NCT00377637|1173650|P1|Induction Phase|Reason for withdrawal is not noted|2
365084|NCT00377637|1173647|P4|Induction Phase|Non-Compliance|0
365085|NCT00377637|1173648|P3|Induction Phase|Non-Compliance|0
365086|NCT00377637|1173649|P2|Induction Phase|Non-Compliance|0
365087|NCT00377637|1173650|P1|Induction Phase|Non-Compliance|1
365088|NCT00377637|1173647|P4|Induction Phase|Sponsor decision|0
365089|NCT00377637|1173648|P3|Induction Phase|Sponsor decision|0
365090|NCT00377637|1173649|P2|Induction Phase|Sponsor decision|2
365091|NCT00377637|1173650|P1|Induction Phase|Sponsor decision|1
365092|NCT00377637|1173647|P4|Induction Phase|Physician Decision|0
365093|NCT00377637|1173648|P3|Induction Phase|Physician Decision|0
365094|NCT00377637|1173649|P2|Induction Phase|Physician Decision|1
365095|NCT00377637|1173650|P1|Induction Phase|Physician Decision|3
365096|NCT00377637|1173647|P4|Induction Phase|Withdrawal by Subject|0
365097|NCT00377637|1173648|P3|Induction Phase|Withdrawal by Subject|0
365098|NCT00377637|1173649|P2|Induction Phase|Withdrawal by Subject|6
365099|NCT00377637|1173650|P1|Induction Phase|Withdrawal by Subject|5
365100|NCT00377637|1173647|P4|Induction Phase|Death|0
365101|NCT00377637|1173648|P3|Induction Phase|Death|0
365102|NCT00377637|1173649|P2|Induction Phase|Death|3
365103|NCT00377637|1173650|P1|Induction Phase|Death|1
365104|NCT00377637|1173647|P4|Induction Phase|Lost to Follow-up|0
365105|NCT00377637|1173648|P3|Induction Phase|Lost to Follow-up|0
365106|NCT00377637|1173649|P2|Induction Phase|Lost to Follow-up|1
365107|NCT00377637|1173650|P1|Induction Phase|Lost to Follow-up|2
365108|NCT00377637|1173647|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
365109|NCT00377637|1173648|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
365110|NCT00377637|1173649|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
365111|NCT00377637|1173650|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
365112|NCT00377637|1173647|P4|Induction Phase|Deterioration/serum creatinine|0
365113|NCT00377637|1173648|P3|Induction Phase|Deterioration/serum creatinine|0
365114|NCT00377637|1173649|P2|Induction Phase|Deterioration/serum creatinine|0
365115|NCT00377637|1173650|P1|Induction Phase|Deterioration/serum creatinine|2
365116|NCT00377637|1173647|P4|Induction Phase|Adverse Event|0
365117|NCT00377637|1173648|P3|Induction Phase|Adverse Event|0
365118|NCT00377637|1173649|P2|Induction Phase|Adverse Event|21
365119|NCT00377637|1173650|P1|Induction Phase|Adverse Event|12
365120|NCT00377520|1173725|P1|Overall Study|Ineligible (Prior radiation)|1
365121|NCT00377455|1173730|P1|Overall Study|Withdrawal by Subject|1
365122|NCT00377429|1173734|P1|Overall Study|Patient non-compliance|1
365123|NCT00377429|1173734|P1|Overall Study|Physician Decision|1
365124|NCT00377429|1173734|P1|Overall Study|Adverse Event|8
365125|NCT00377429|1173734|P1|Overall Study|Withdrawal by Subject|5
365126|NCT00377403|1173745|P2|Overall Study|Unable to contact for telephone intervie|7
365127|NCT00377403|1173746|P1|Overall Study|Unable to contact for telephone intervie|4
365128|NCT00377364|1173754|P2|Overall Study|Withdrawal by Subject|0
365129|NCT00377364|1173755|P1|Overall Study|Withdrawal by Subject|1
365130|NCT00377364|1173754|P2|Overall Study|Lost to Follow-up|0
365131|NCT00377364|1173755|P1|Overall Study|Lost to Follow-up|1
365132|NCT00377312|1173781|P2|Overall Study|Adverse Event|1
365133|NCT00377312|1173782|P1|Overall Study|Adverse Event|1
365134|NCT00377299|1173814|P2|Overall Study|Withdrawal by Subject|4
365135|NCT00377299|1173815|P1|Overall Study|Withdrawal by Subject|5
365136|NCT00377299|1173814|P2|Overall Study|Adverse Event|1
365137|NCT00377299|1173815|P1|Overall Study|Adverse Event|0
365139|NCT00377299|1173815|P1|Overall Study|Lost to Follow-up|14
365140|NCT00377260|1173831|P2|Overall Study|Withdrawal by Subject|4
365141|NCT00377260|1173832|P1|Overall Study|Withdrawal by Subject|2
365142|NCT00377260|1173831|P2|Overall Study|Lost to Follow-up|1
365143|NCT00377260|1173832|P1|Overall Study|Lost to Follow-up|0
365144|NCT00377234|1173886|P2|Overall Study|Not assigned|2
365145|NCT00377234|1173887|P1|Overall Study|Not assigned|3
365146|NCT00377234|1173886|P2|Overall Study|Administrative|1
365147|NCT00377234|1173887|P1|Overall Study|Administrative|2
365148|NCT00377234|1173886|P2|Overall Study|Lost to Follow-up|2
365149|NCT00377234|1173887|P1|Overall Study|Lost to Follow-up|4
365150|NCT00377234|1173886|P2|Overall Study|Withdrawal by Subject|9
365151|NCT00377234|1173887|P1|Overall Study|Withdrawal by Subject|11
365152|NCT00377234|1173886|P2|Overall Study|Adverse Event|17
365153|NCT00377234|1173887|P1|Overall Study|Adverse Event|14
365154|NCT00376961|1173903|P2|Maintenance|Ineligible|3
365155|NCT00376961|1173904|P1|Maintenance|Ineligible|0
365156|NCT00376961|1173903|P2|Maintenance|Progression/relapse|18
365157|NCT00376961|1173904|P1|Maintenance|Progression/relapse|0
365158|NCT00376961|1173903|P2|Maintenance|Refusal Unrelated to Adverse Event|1
365159|NCT00376961|1173904|P1|Maintenance|Refusal Unrelated to Adverse Event|0
365160|NCT00376961|1173903|P2|Maintenance|Adverse Event|1
365161|NCT00376961|1173904|P1|Maintenance|Adverse Event|0
365162|NCT00376961|1173903|P2|Initial Registration|Ineligible|0
365163|NCT00376961|1173904|P1|Initial Registration|Ineligible|3
365164|NCT00376961|1173903|P2|Initial Registration|Progression/relapse|0
365165|NCT00376961|1173904|P1|Initial Registration|Progression/relapse|1
365166|NCT00376961|1173903|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
365167|NCT00376961|1173904|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
365168|NCT00376961|1173903|P2|Initial Registration|Adverse Event|0
365169|NCT00376961|1173904|P1|Initial Registration|Adverse Event|1
365170|NCT00376688|1173970|P1|Overall Study|Death|1
365171|NCT00376688|1173970|P1|Overall Study|Adverse Event|3
365172|NCT00376675|1173976|P2|Overall Study|Other Reason|7
365173|NCT00376675|1173977|P1|Overall Study|Other Reason|1
365174|NCT00376675|1173976|P2|Overall Study|Adverse Event|5
365175|NCT00376675|1173977|P1|Overall Study|Adverse Event|10
365176|NCT00376675|1173976|P2|Overall Study|Withdrawal by Subject|2
365177|NCT00376675|1173977|P1|Overall Study|Withdrawal by Subject|9
365178|NCT00375518|1174001|P2|Overall Study|Death|1
365179|NCT00375518|1174002|P1|Overall Study|Death|0
365180|NCT00375518|1174001|P2|Overall Study|Patient Not Treated|6
365181|NCT00375518|1174002|P1|Overall Study|Patient Not Treated|6
365182|NCT00375518|1174001|P2|Overall Study|Withdrawal by Subject|10
365183|NCT00375518|1174002|P1|Overall Study|Withdrawal by Subject|2
365184|NCT00376532|1174020|P2|Overall Study|Lack sufficient blood sample|6
365185|NCT00376532|1174021|P1|Overall Study|Lack sufficient blood sample|6
365186|NCT00376506|1174031|P2|Overall Study|Death|2
365187|NCT00376506|1174032|P1|Overall Study|Death|0
365188|NCT00376259|1174063|P2|Overall Study|Patient request|0
365189|NCT00376259|1174064|P1|Overall Study|Patient request|1
365190|NCT00376259|1174063|P2|Overall Study|Sponsor request - study termination|21
365191|NCT00376259|1174064|P1|Overall Study|Sponsor request - study termination|21
365192|NCT00376220|1174078|P2|Overall Study|Withdrawal by Subject|2
365193|NCT00376220|1174079|P1|Overall Study|Withdrawal by Subject|3
365194|NCT00376220|1174078|P2|Overall Study|Lost to Follow-up|10
365195|NCT00376220|1174079|P1|Overall Study|Lost to Follow-up|7
365196|NCT00376168|1174087|P2|Overall Study|Pregnancy|0
365197|NCT00376168|1174088|P1|Overall Study|Pregnancy|1
365198|NCT00376168|1174087|P2|Overall Study|Adverse Event|1
365199|NCT00376168|1174088|P1|Overall Study|Adverse Event|1
365200|NCT00375934|1174129|P2|Overall Study|Physician Decision|1
365201|NCT00375934|1174130|P1|Overall Study|Physician Decision|0
365202|NCT00375934|1174129|P2|Overall Study|Lack of Efficacy|2
365203|NCT00375934|1174130|P1|Overall Study|Lack of Efficacy|0
365204|NCT00375934|1174129|P2|Overall Study|Withdrawal by Subject|2
365205|NCT00375934|1174130|P1|Overall Study|Withdrawal by Subject|2
365206|NCT00375934|1174129|P2|Overall Study|Adverse Event|1
365207|NCT00375934|1174130|P1|Overall Study|Adverse Event|1
365208|NCT00375752|1174158|P2|Overall Study|Administrative Problems|1
365209|NCT00375752|1174159|P1|Overall Study|Administrative Problems|0
365210|NCT00375752|1174158|P2|Overall Study|Protocol Violation|2
365211|NCT00375752|1174159|P1|Overall Study|Protocol Violation|0
365212|NCT00375752|1174158|P2|Overall Study|Abnormal Laboratory Value(s)|1
365213|NCT00375752|1174159|P1|Overall Study|Abnormal Laboratory Value(s)|1
365214|NCT00375752|1174158|P2|Overall Study|Withdrawal by Subject|1
365215|NCT00375752|1174159|P1|Overall Study|Withdrawal by Subject|6
365216|NCT00375752|1174158|P2|Overall Study|Adverse Event|6
365217|NCT00375752|1174159|P1|Overall Study|Adverse Event|1
365218|NCT00375752|1174158|P2|Overall Study|Lack of Efficacy|4
365219|NCT00375752|1174159|P1|Overall Study|Lack of Efficacy|4
365220|NCT00375505|1174188|P2|Overall Study|Adverse Event|2
365221|NCT00375505|1174189|P1|Overall Study|Adverse Event|1
365222|NCT00375492|1174233|P2|Overall Study|Withdrawal by Subject|6
365223|NCT00375492|1174234|P1|Overall Study|Withdrawal by Subject|6
365224|NCT00375492|1174233|P2|Overall Study|Sponsor Decision|1
365225|NCT00375492|1174234|P1|Overall Study|Sponsor Decision|0
365226|NCT00375492|1174233|P2|Overall Study|Protocol Violation|3
365227|NCT00375492|1174234|P1|Overall Study|Protocol Violation|6
365228|NCT00375492|1174233|P2|Overall Study|Physician Decision|4
365229|NCT00375492|1174234|P1|Overall Study|Physician Decision|0
365230|NCT00375492|1174233|P2|Overall Study|Lost to Follow-up|5
365231|NCT00375492|1174234|P1|Overall Study|Lost to Follow-up|10
365232|NCT00375492|1174233|P2|Overall Study|Loss of Glucose Control|1
365233|NCT00375492|1174234|P1|Overall Study|Loss of Glucose Control|0
365234|NCT00375492|1174233|P2|Overall Study|Entry Criteria Not Met|1
365235|NCT00375492|1174234|P1|Overall Study|Entry Criteria Not Met|0
365236|NCT00375492|1174233|P2|Overall Study|Adverse Event|5
365237|NCT00375492|1174234|P1|Overall Study|Adverse Event|4
365238|NCT00375427|1174264|P2|Overall Study|Death|10
365239|NCT00375427|1174265|P1|Overall Study|Death|11
365240|NCT00375427|1174264|P2|Overall Study|Administrative reasons|1
365241|NCT00375427|1174265|P1|Overall Study|Administrative reasons|0
365242|NCT00375427|1174264|P2|Overall Study|Lost to Follow-up|1
365243|NCT00375427|1174265|P1|Overall Study|Lost to Follow-up|1
365244|NCT00375427|1174264|P2|Overall Study|Withdrawal by Subject|13
365245|NCT00375427|1174265|P1|Overall Study|Withdrawal by Subject|9
365246|NCT00375427|1174264|P2|Overall Study|Protocol Violation|8
365247|NCT00375427|1174265|P1|Overall Study|Protocol Violation|10
365248|NCT00375427|1174264|P2|Overall Study|Patient no longer requires study drug|7
365249|NCT00375427|1174265|P1|Overall Study|Patient no longer requires study drug|3
365250|NCT00375427|1174264|P2|Overall Study|Unsatisfactory therapeutic effect|4
365251|NCT00375427|1174265|P1|Overall Study|Unsatisfactory therapeutic effect|4
365252|NCT00375427|1174264|P2|Overall Study|Abnormal laboratory value(s)|2
365253|NCT00375427|1174265|P1|Overall Study|Abnormal laboratory value(s)|1
365254|NCT00375427|1174264|P2|Overall Study|Abnormal test procedure result(s)|1
365255|NCT00375427|1174265|P1|Overall Study|Abnormal test procedure result(s)|0
365256|NCT00375427|1174264|P2|Overall Study|Adverse Event|27
365257|NCT00375427|1174265|P1|Overall Study|Adverse Event|21
365258|NCT00375219|1174290|P3|Overall Study|Withdrawal by Subject|0
365259|NCT00375219|1174291|P2|Overall Study|Withdrawal by Subject|0
365260|NCT00375219|1174292|P1|Overall Study|Withdrawal by Subject|1
365261|NCT00375219|1174290|P3|Overall Study|Cord blood transplantation|0
365262|NCT00375219|1174291|P2|Overall Study|Cord blood transplantation|0
365263|NCT00375219|1174292|P1|Overall Study|Cord blood transplantation|1
365264|NCT00375219|1174290|P3|Overall Study|Allograft|0
365265|NCT00375219|1174291|P2|Overall Study|Allograft|0
365266|NCT00375219|1174292|P1|Overall Study|Allograft|2
365267|NCT00375219|1174290|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
365268|NCT00375219|1174291|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
365269|NCT00375219|1174292|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
365270|NCT00375219|1174290|P3|Overall Study|Hematologic resistance|0
365271|NCT00375219|1174291|P2|Overall Study|Hematologic resistance|0
365272|NCT00375219|1174292|P1|Overall Study|Hematologic resistance|1
365273|NCT00375219|1174290|P3|Overall Study|Death|7
365274|NCT00375219|1174291|P2|Overall Study|Death|3
365275|NCT00375219|1174292|P1|Overall Study|Death|4
365276|NCT00375219|1174290|P3|Overall Study|Disease progression|12
365277|NCT00375219|1174291|P2|Overall Study|Disease progression|9
365278|NCT00375219|1174292|P1|Overall Study|Disease progression|18
365279|NCT00375219|1174290|P3|Overall Study|Lost to Follow-up|0
365280|NCT00375219|1174291|P2|Overall Study|Lost to Follow-up|1
365281|NCT00375219|1174292|P1|Overall Study|Lost to Follow-up|1
365282|NCT00375219|1174290|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
365283|NCT00375219|1174291|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
365284|NCT00375219|1174292|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
365285|NCT00375219|1174290|P3|Overall Study|Protocol Violation|1
365286|NCT00375219|1174291|P2|Overall Study|Protocol Violation|0
365287|NCT00375219|1174292|P1|Overall Study|Protocol Violation|1
365288|NCT00375219|1174290|P3|Overall Study|Adverse Event|1
365289|NCT00375219|1174291|P2|Overall Study|Adverse Event|2
365290|NCT00375219|1174292|P1|Overall Study|Adverse Event|8
365291|NCT00375219|1174290|P3|Overall Study|Failure to achieve a response|0
365292|NCT00375219|1174291|P2|Overall Study|Failure to achieve a response|2
365293|NCT00375219|1174292|P1|Overall Study|Failure to achieve a response|16
365294|NCT00374907|1174360|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
365295|NCT00374907|1174361|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
365296|NCT00374907|1174360|P2|116-Week Short-term + Long-term Period|Adverse Event|2
365297|NCT00374907|1174361|P1|116-Week Short-term + Long-term Period|Adverse Event|0
365298|NCT00374907|1174360|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
365299|NCT00374907|1174361|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
365300|NCT00374907|1174360|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
365301|NCT00374907|1174361|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
365302|NCT00374907|1174360|P2|12-Week Short-term Period|Subject Withdrew Consent|1
365303|NCT00374907|1174361|P1|12-Week Short-term Period|Subject Withdrew Consent|3
365304|NCT00374868|1174373|P1|Overall Study|Other - Not Specified|1
365305|NCT00374868|1174373|P1|Overall Study|Death|2
365306|NCT00374868|1174373|P1|Overall Study|Lost to Follow-up|1
365307|NCT00374868|1174373|P1|Overall Study|Physician Decision|13
365308|NCT00374868|1174373|P1|Overall Study|Progressive Disease|7
365309|NCT00374868|1174373|P1|Overall Study|Adverse Event|12
365310|NCT00374322|1174451|P2|Overall Study|Did Not Receive Study Medication|6
365311|NCT00374322|1174452|P1|Overall Study|Did Not Receive Study Medication|8
365312|NCT00374322|1174451|P2|Overall Study|Withdrew Consent During Follow-up|5
365313|NCT00374322|1174452|P1|Overall Study|Withdrew Consent During Follow-up|0
365314|NCT00374322|1174451|P2|Overall Study|Noncompliance with Study Requirements|1
365315|NCT00374322|1174452|P1|Overall Study|Noncompliance with Study Requirements|0
365316|NCT00374322|1174451|P2|Overall Study|Started Another Chemotherapy Regimen|1
365317|NCT00374322|1174452|P1|Overall Study|Started Another Chemotherapy Regimen|0
365318|NCT00374322|1174451|P2|Overall Study|Participant Changed Physician|0
365319|NCT00374322|1174452|P1|Overall Study|Participant Changed Physician|1
365320|NCT00374322|1174451|P2|Overall Study|Site Closed|2
365321|NCT00374322|1174452|P1|Overall Study|Site Closed|2
365322|NCT00374322|1174451|P2|Overall Study|Severe Toxicity|0
365323|NCT00374322|1174452|P1|Overall Study|Severe Toxicity|1
365324|NCT00374322|1174451|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
365325|NCT00374322|1174452|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
365326|NCT00374322|1174451|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
365327|NCT00374322|1174452|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
365328|NCT00374322|1174451|P2|Overall Study|Sponsor Decision|3
365329|NCT00374322|1174452|P1|Overall Study|Sponsor Decision|2
365330|NCT00374322|1174451|P2|Overall Study|Par. Consented to Survival FU Only|1
365331|NCT00374322|1174452|P1|Overall Study|Par. Consented to Survival FU Only|3
365332|NCT00374322|1174451|P2|Overall Study|Physician Decision|32
365333|NCT00374322|1174452|P1|Overall Study|Physician Decision|36
365334|NCT00374322|1174451|P2|Overall Study|Sponsor Terminated Study|990
365335|NCT00374322|1174452|P1|Overall Study|Sponsor Terminated Study|866
365336|NCT00374322|1174451|P2|Overall Study|Withdrawal by Subject|167
365337|NCT00374322|1174452|P1|Overall Study|Withdrawal by Subject|235
365338|NCT00374322|1174451|P2|Overall Study|Protocol Violation|3
365339|NCT00374322|1174452|P1|Overall Study|Protocol Violation|8
365340|NCT00374322|1174451|P2|Overall Study|Lost to Follow-up|90
365341|NCT00374322|1174452|P1|Overall Study|Lost to Follow-up|92
365342|NCT00374140|1174543|P1|Overall Study|Protocol Violation|1
365343|NCT00374140|1174543|P1|Overall Study|Lost to Follow-up|1
365344|NCT00373958|1174562|P2|Toddler Dose|Withdrawn after infant series|25
365345|NCT00373958|1174563|P1|Toddler Dose|Withdrawn after infant series|22
365346|NCT00373958|1174562|P2|Toddler Dose|Protocol Violation|1
365347|NCT00373958|1174563|P1|Toddler Dose|Protocol Violation|0
365348|NCT00373958|1174562|P2|Toddler Dose|Failed to return|2
365349|NCT00373958|1174563|P1|Toddler Dose|Failed to return|1
365350|NCT00373958|1174562|P2|Toddler Dose|Withdrawal by Subject|2
365351|NCT00373958|1174563|P1|Toddler Dose|Withdrawal by Subject|2
365352|NCT00373958|1174562|P2|Toddler Dose|Lost to Follow-up|8
365353|NCT00373958|1174563|P1|Toddler Dose|Lost to Follow-up|5
365354|NCT00373958|1174562|P2|Infant Series|Physician Decision|1
365355|NCT00373958|1174563|P1|Infant Series|Physician Decision|1
365356|NCT00373958|1174562|P2|Infant Series|Adverse Event|1
365357|NCT00373958|1174563|P1|Infant Series|Adverse Event|3
365358|NCT00373958|1174562|P2|Infant Series|Consent was not received|0
365359|NCT00373958|1174563|P1|Infant Series|Consent was not received|1
365360|NCT00373958|1174562|P2|Infant Series|Child relocated|0
365361|NCT00373958|1174563|P1|Infant Series|Child relocated|1
365362|NCT00373958|1174562|P2|Infant Series|Lost Kaiser coverage|0
365363|NCT00373958|1174563|P1|Infant Series|Lost Kaiser coverage|4
365364|NCT00373958|1174562|P2|Infant Series|Protocol Violation|7
365365|NCT00373958|1174563|P1|Infant Series|Protocol Violation|3
365366|NCT00373958|1174562|P2|Infant Series|Lost to Follow-up|5
365367|NCT00373958|1174563|P1|Infant Series|Lost to Follow-up|6
365368|NCT00373958|1174562|P2|Infant Series|Failed to return|13
365369|NCT00373958|1174563|P1|Infant Series|Failed to return|8
365370|NCT00373958|1174562|P2|Infant Series|Withdrawal by Subject|15
365371|NCT00373958|1174563|P1|Infant Series|Withdrawal by Subject|13
365372|NCT00373685|1174628|P2|Overall Study|Randomized, not treated|77
365373|NCT00373685|1174629|P1|Overall Study|Randomized, not treated|51
365374|NCT00373685|1174628|P2|Overall Study|Final Status Unknown|4
365375|NCT00373685|1174629|P1|Overall Study|Final Status Unknown|12
365376|NCT00373685|1174628|P2|Overall Study|Protocol Violation|182
365377|NCT00373685|1174629|P1|Overall Study|Protocol Violation|191
365378|NCT00373685|1174628|P2|Overall Study|Unspecified|146
365379|NCT00373685|1174629|P1|Overall Study|Unspecified|149
365380|NCT00373685|1174628|P2|Overall Study|No longer willing to participate|352
365381|NCT00373685|1174629|P1|Overall Study|No longer willing to participate|337
365382|NCT00373685|1174628|P2|Overall Study|Lost to follow up|103
365383|NCT00373685|1174629|P1|Overall Study|Lost to follow up|83
365384|NCT00373685|1174628|P2|Overall Study|Did not meet entrance criteria|184
365385|NCT00373685|1174629|P1|Overall Study|Did not meet entrance criteria|167
365386|NCT00373685|1174628|P2|Overall Study|Insufficient clinical response|119
365387|NCT00373685|1174629|P1|Overall Study|Insufficient clinical response|169
365388|NCT00373685|1174628|P2|Overall Study|Adverse Event|253
365389|NCT00373685|1174629|P1|Overall Study|Adverse Event|278
365390|NCT00373685|1174628|P2|Overall Study|Death|1
365391|NCT00373685|1174629|P1|Overall Study|Death|2
365392|NCT00373529|1174663|P1|Overall Study|Consent violation|1
365393|NCT00373529|1174663|P1|Overall Study|Failed independent confirmation of AML|3
365394|NCT00373529|1174663|P1|Overall Study|Not specified|8
365395|NCT00373529|1174663|P1|Overall Study|Need for treatment prohibited by study|1
365396|NCT00373529|1174663|P1|Overall Study|Death|16
365397|NCT00373529|1174663|P1|Overall Study|Disease recurrence|10
365398|NCT00373529|1174663|P1|Overall Study|Treatment failure|36
365399|NCT00373529|1174663|P1|Overall Study|Adverse Event|7
365400|NCT00373529|1174663|P1|Overall Study|Withdrawal by Subject|7
365401|NCT00373529|1174663|P1|Overall Study|Physician Decision|19
365402|NCT00373490|1174675|P2|Overall Study|Withdrawal by Subject|1
365403|NCT00373490|1174676|P1|Overall Study|Withdrawal by Subject|0
365404|NCT00373490|1174675|P2|Overall Study|Lack of Efficacy|4
365405|NCT00373490|1174676|P1|Overall Study|Lack of Efficacy|9
365406|NCT00373490|1174675|P2|Overall Study|Adverse Event|1
365407|NCT00373490|1174676|P1|Overall Study|Adverse Event|0
365408|NCT00373425|1174699|P5|Overall Study|Death|0
365409|NCT00373425|1174700|P4|Overall Study|Death|1
365410|NCT00373425|1174701|P3|Overall Study|Death|3
365411|NCT00373425|1174702|P2|Overall Study|Death|0
365412|NCT00373425|1174703|P1|Overall Study|Death|7
365413|NCT00373425|1174699|P5|Overall Study|Medical/ethical/noncompliance reason|5
365414|NCT00373425|1174700|P4|Overall Study|Medical/ethical/noncompliance reason|2
365415|NCT00373425|1174701|P3|Overall Study|Medical/ethical/noncompliance reason|10
365416|NCT00373425|1174702|P2|Overall Study|Medical/ethical/noncompliance reason|9
365417|NCT00373425|1174703|P1|Overall Study|Medical/ethical/noncompliance reason|21
365418|NCT00373425|1174699|P5|Overall Study|Patient request|7
365419|NCT00373425|1174700|P4|Overall Study|Patient request|6
365420|NCT00373425|1174701|P3|Overall Study|Patient request|43
365421|NCT00373425|1174702|P2|Overall Study|Patient request|18
365422|NCT00373425|1174703|P1|Overall Study|Patient request|35
365423|NCT00373425|1174699|P5|Overall Study|Adverse Event|34
365424|NCT00373425|1174700|P4|Overall Study|Adverse Event|0
365425|NCT00373425|1174701|P3|Overall Study|Adverse Event|59
365426|NCT00373425|1174702|P2|Overall Study|Adverse Event|22
365427|NCT00373425|1174703|P1|Overall Study|Adverse Event|191
365428|NCT00373425|1174699|P5|Overall Study|Relapse of NSCLC|26
365429|NCT00373425|1174700|P4|Overall Study|Relapse of NSCLC|2
365430|NCT00373425|1174701|P3|Overall Study|Relapse of NSCLC|19
365431|NCT00373425|1174702|P2|Overall Study|Relapse of NSCLC|104
365432|NCT00373425|1174703|P1|Overall Study|Relapse of NSCLC|116
365433|NCT00373295|1174775|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
365434|NCT00373295|1174776|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
365435|NCT00373295|1174777|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
365436|NCT00373295|1174778|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
365437|NCT00373295|1174779|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
365438|NCT00373295|1174780|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
365439|NCT00373256|1174801|P2|Overall Study|Study Terminated by Sponsor|13
365440|NCT00373256|1174802|P1|Overall Study|Study Terminated by Sponsor|41
365441|NCT00373256|1174801|P2|Overall Study|Protocol Violation|2
365442|NCT00373256|1174802|P1|Overall Study|Protocol Violation|0
365443|NCT00373256|1174801|P2|Overall Study|Unspecified|107
365444|NCT00373256|1174802|P1|Overall Study|Unspecified|73
365445|NCT00373256|1174801|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
365446|NCT00373256|1174802|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
365447|NCT00373256|1174801|P2|Overall Study|Objective Progression or Relapse|104
365448|NCT00373256|1174802|P1|Overall Study|Objective Progression or Relapse|111
365449|NCT00373256|1174801|P2|Overall Study|Death|8
365450|NCT00373256|1174802|P1|Overall Study|Death|9
365451|NCT00373256|1174801|P2|Overall Study|Lost to Follow-up|1
365452|NCT00373256|1174802|P1|Overall Study|Lost to Follow-up|2
365453|NCT00373256|1174801|P2|Overall Study|Adverse Event (AE)|5
365454|NCT00373256|1174802|P1|Overall Study|Adverse Event (AE)|1
365455|NCT00373113|1174828|P2|Overall Study|Withdrawal by Subject|15
365456|NCT00373113|1174829|P1|Overall Study|Withdrawal by Subject|10
365457|NCT00373113|1174828|P2|Overall Study|Protocol Violation|1
365458|NCT00373113|1174829|P1|Overall Study|Protocol Violation|5
365459|NCT00373113|1174828|P2|Overall Study|Unspecified|17
365460|NCT00373113|1174829|P1|Overall Study|Unspecified|14
365461|NCT00373113|1174828|P2|Overall Study|Objective progression or relapse|169
365462|NCT00373113|1174829|P1|Overall Study|Objective progression or relapse|150
365463|NCT00373113|1174828|P2|Overall Study|Lost to Follow-up|3
365464|NCT00373113|1174829|P1|Overall Study|Lost to Follow-up|1
365465|NCT00373113|1174828|P2|Overall Study|Global deterioration of health status|7
365466|NCT00373113|1174829|P1|Overall Study|Global deterioration of health status|10
365467|NCT00373113|1174828|P2|Overall Study|Study terminated by sponsor|1
365468|NCT00373113|1174829|P1|Overall Study|Study terminated by sponsor|9
365469|NCT00373113|1174828|P2|Overall Study|Adverse Event|24
365470|NCT00373113|1174829|P1|Overall Study|Adverse Event|38
365471|NCT00373113|1174828|P2|Overall Study|Death|7
365472|NCT00373113|1174829|P1|Overall Study|Death|1
365473|NCT00372996|1174851|P4|Overall Study|Not specified|7
365474|NCT00372996|1174852|P3|Overall Study|Not specified|7
365475|NCT00372996|1174853|P2|Overall Study|Not specified|2
365476|NCT00372996|1174854|P1|Overall Study|Not specified|10
365477|NCT00372996|1174851|P4|Overall Study|Study Terminated by Sponsor|0
365478|NCT00372996|1174852|P3|Overall Study|Study Terminated by Sponsor|4
365479|NCT00372996|1174853|P2|Overall Study|Study Terminated by Sponsor|0
365480|NCT00372996|1174854|P1|Overall Study|Study Terminated by Sponsor|4
365481|NCT00372996|1174851|P4|Overall Study|Withdrawal by Subject|5
365482|NCT00372996|1174852|P3|Overall Study|Withdrawal by Subject|9
365483|NCT00372996|1174853|P2|Overall Study|Withdrawal by Subject|6
365484|NCT00372996|1174854|P1|Overall Study|Withdrawal by Subject|12
365485|NCT00372996|1174851|P4|Overall Study|Lost to Follow-up|1
365486|NCT00372996|1174852|P3|Overall Study|Lost to Follow-up|0
365487|NCT00372996|1174853|P2|Overall Study|Lost to Follow-up|2
365488|NCT00372996|1174854|P1|Overall Study|Lost to Follow-up|0
365489|NCT00372996|1174851|P4|Overall Study|Death|7
365490|NCT00372996|1174852|P3|Overall Study|Death|8
365491|NCT00372996|1174853|P2|Overall Study|Death|4
365492|NCT00372996|1174854|P1|Overall Study|Death|11
365493|NCT00372775|1174887|P1|Overall Study|Not Treated|2
365494|NCT00372775|1174887|P1|Overall Study|Not specified|1
365495|NCT00372775|1174887|P1|Overall Study|Withdrawal by Subject|1
365496|NCT00372775|1174887|P1|Overall Study|Global deterioration of health status|6
365497|NCT00372775|1174887|P1|Overall Study|Objective progression or relapse|30
365498|NCT00372775|1174887|P1|Overall Study|Death|15
365499|NCT00372775|1174887|P1|Overall Study|Adverse Event|8
365500|NCT00372697|1174909|P2|Overall Study|Protocol Violation|1
365501|NCT00372697|1174910|P1|Overall Study|Protocol Violation|1
365502|NCT00372619|1174935|P7|Overall Study|Inevaluable|0
365503|NCT00372619|1174936|P6|Overall Study|Inevaluable|1
365504|NCT00372619|1174937|P5|Overall Study|Inevaluable|0
365505|NCT00372619|1174938|P4|Overall Study|Inevaluable|0
365506|NCT00372619|1174939|P3|Overall Study|Inevaluable|0
365507|NCT00372619|1174940|P2|Overall Study|Inevaluable|0
365508|NCT00372619|1174941|P1|Overall Study|Inevaluable|0
365509|NCT00372619|1174935|P7|Overall Study|Ineligible|0
365510|NCT00372619|1174936|P6|Overall Study|Ineligible|2
365511|NCT00372619|1174937|P5|Overall Study|Ineligible|0
365512|NCT00372619|1174938|P4|Overall Study|Ineligible|0
365513|NCT00372619|1174939|P3|Overall Study|Ineligible|0
365514|NCT00372619|1174940|P2|Overall Study|Ineligible|0
365515|NCT00372619|1174941|P1|Overall Study|Ineligible|0
365516|NCT00372593|1174974|P3|Overall Study|Ineligible|1
365517|NCT00372593|1174975|P2|Overall Study|Ineligible|21
365518|NCT00372593|1174976|P1|Overall Study|Ineligible|20
365519|NCT00372593|1174974|P3|Overall Study|Physician Decision|0
365520|NCT00372593|1174975|P2|Overall Study|Physician Decision|41
365521|NCT00372593|1174976|P1|Overall Study|Physician Decision|42
365522|NCT00372593|1174974|P3|Overall Study|Lost to Follow-up|0
365523|NCT00372593|1174975|P2|Overall Study|Lost to Follow-up|0
365524|NCT00372593|1174976|P1|Overall Study|Lost to Follow-up|1
365525|NCT00372593|1174974|P3|Overall Study|Lack of Efficacy|2
365526|NCT00372593|1174975|P2|Overall Study|Lack of Efficacy|71
365527|NCT00372593|1174976|P1|Overall Study|Lack of Efficacy|82
365528|NCT00372593|1174974|P3|Overall Study|Death|1
365529|NCT00372593|1174975|P2|Overall Study|Death|20
365530|NCT00372593|1174976|P1|Overall Study|Death|16
365531|NCT00372593|1174974|P3|Overall Study|Adverse Event|0
365532|NCT00372593|1174975|P2|Overall Study|Adverse Event|45
365533|NCT00372593|1174976|P1|Overall Study|Adverse Event|43
365534|NCT00372567|1175005|P3|Phase 3 Study|study terminated by sponsor|5
365535|NCT00372567|1175006|P2|Phase 3 Study|study terminated by sponsor|8
365536|NCT00372567|1175007|P1|Phase 3 Study|study terminated by sponsor|13
365537|NCT00372567|1175005|P3|Phase 3 Study|not specified|1
365538|NCT00372567|1175006|P2|Phase 3 Study|not specified|2
365539|NCT00372567|1175007|P1|Phase 3 Study|not specified|2
365540|NCT00372567|1175005|P3|Phase 3 Study|Global deterioration of health status|0
365541|NCT00372567|1175006|P2|Phase 3 Study|Global deterioration of health status|1
365542|NCT00372567|1175007|P1|Phase 3 Study|Global deterioration of health status|0
365543|NCT00372567|1175005|P3|Phase 3 Study|Objective progression or relapse|4
365544|NCT00372567|1175006|P2|Phase 3 Study|Objective progression or relapse|13
365545|NCT00372567|1175007|P1|Phase 3 Study|Objective progression or relapse|10
365546|NCT00372567|1175005|P3|Phase 3 Study|Protocol Violation|1
365547|NCT00372567|1175006|P2|Phase 3 Study|Protocol Violation|0
365548|NCT00372567|1175007|P1|Phase 3 Study|Protocol Violation|0
365549|NCT00372567|1175005|P3|Phase 3 Study|Death|0
365550|NCT00372567|1175006|P2|Phase 3 Study|Death|1
365551|NCT00372567|1175007|P1|Phase 3 Study|Death|1
365552|NCT00372567|1175005|P3|Phase 3 Study|Adverse Event|1
365553|NCT00372567|1175006|P2|Phase 3 Study|Adverse Event|1
365554|NCT00372567|1175007|P1|Phase 3 Study|Adverse Event|5
365555|NCT00372528|1175035|P1|Overall Study|Unspecified|1
365556|NCT00372528|1175035|P1|Overall Study|Study Terminated by Sponsor|18
365557|NCT00372528|1175035|P1|Overall Study|Adverse Event|1
365558|NCT00372528|1175035|P1|Overall Study|Lack of Efficacy|1
365559|NCT00372489|1175040|P1|Overall Study|Sponsor Decision to Terminate Study|41
365560|NCT00372489|1175040|P1|Overall Study|Renal transplant|6
365561|NCT00372489|1175040|P1|Overall Study|Patient Relocation|2
365562|NCT00372489|1175040|P1|Overall Study|Withdrawal by Subject|5
365563|NCT00372489|1175040|P1|Overall Study|Physician Decision|3
365564|NCT00372489|1175040|P1|Overall Study|Lost to Follow-up|3
365565|NCT00372489|1175040|P1|Overall Study|Lack of Efficacy|1
365566|NCT00372489|1175040|P1|Overall Study|Adverse Event|18
365567|NCT00372424|1175044|P1|Overall Study|Enrolled, Not Treated|1
365568|NCT00372424|1175044|P1|Overall Study|Unspecified|7
365569|NCT00372424|1175044|P1|Overall Study|Objective Progression or Relapse|14
365570|NCT00372424|1175044|P1|Overall Study|Death|1
365571|NCT00372424|1175044|P1|Overall Study|Withdrawal by Subject|1
365572|NCT00372424|1175044|P1|Overall Study|Adverse Event|2
365573|NCT00372411|1175058|P3|Overall Study|Adverse Event|0
365574|NCT00372411|1175059|P2|Overall Study|Adverse Event|1
365575|NCT00372411|1175060|P1|Overall Study|Adverse Event|1
365576|NCT00372411|1175058|P3|Overall Study|Lost to Follow-up|1
365577|NCT00372411|1175059|P2|Overall Study|Lost to Follow-up|1
365578|NCT00372411|1175060|P1|Overall Study|Lost to Follow-up|1
365579|NCT00372411|1175058|P3|Overall Study|Death|1
365580|NCT00372411|1175059|P2|Overall Study|Death|2
365581|NCT00372411|1175060|P1|Overall Study|Death|0
365582|NCT00372411|1175058|P3|Overall Study|Withdrawal by Subject|1
365583|NCT00372411|1175059|P2|Overall Study|Withdrawal by Subject|4
365584|NCT00372411|1175060|P1|Overall Study|Withdrawal by Subject|3
365585|NCT00372385|1175084|P4|Overall Study|Virologic Stopping Rule|0
365586|NCT00372385|1175085|P3|Overall Study|Virologic Stopping Rule|0
365587|NCT00372385|1175086|P2|Overall Study|Virologic Stopping Rule|0
365588|NCT00372385|1175087|P1|Overall Study|Virologic Stopping Rule|17
365589|NCT00372385|1175084|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
365590|NCT00372385|1175085|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
365591|NCT00372385|1175086|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
365592|NCT00372385|1175087|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
365593|NCT00372385|1175084|P4|Overall Study|No Response|0
365594|NCT00372385|1175085|P3|Overall Study|No Response|0
365595|NCT00372385|1175086|P2|Overall Study|No Response|1
365596|NCT00372385|1175087|P1|Overall Study|No Response|1
365597|NCT00372385|1175084|P4|Overall Study|Refusal of Treatment|0
365598|NCT00372385|1175085|P3|Overall Study|Refusal of Treatment|0
365599|NCT00372385|1175086|P2|Overall Study|Refusal of Treatment|6
365600|NCT00372385|1175087|P1|Overall Study|Refusal of Treatment|3
365601|NCT00372385|1175084|P4|Overall Study|Withdrawal by Subject|0
365602|NCT00372385|1175085|P3|Overall Study|Withdrawal by Subject|0
365603|NCT00372385|1175086|P2|Overall Study|Withdrawal by Subject|1
365604|NCT00372385|1175087|P1|Overall Study|Withdrawal by Subject|2
365605|NCT00372385|1175084|P4|Overall Study|Lost to Follow-up|0
365606|NCT00372385|1175085|P3|Overall Study|Lost to Follow-up|0
365607|NCT00372385|1175086|P2|Overall Study|Lost to Follow-up|0
365608|NCT00372385|1175087|P1|Overall Study|Lost to Follow-up|2
365609|NCT00372385|1175084|P4|Overall Study|Physician Decision|0
365610|NCT00372385|1175085|P3|Overall Study|Physician Decision|0
365611|NCT00372385|1175086|P2|Overall Study|Physician Decision|0
365612|NCT00372385|1175087|P1|Overall Study|Physician Decision|1
365613|NCT00372385|1175084|P4|Overall Study|Noncompliance|1
365614|NCT00372385|1175085|P3|Overall Study|Noncompliance|1
365615|NCT00372385|1175086|P2|Overall Study|Noncompliance|1
365616|NCT00372385|1175087|P1|Overall Study|Noncompliance|0
365617|NCT00372385|1175084|P4|Overall Study|Adverse Event|7
365618|NCT00372385|1175085|P3|Overall Study|Adverse Event|9
365619|NCT00372385|1175086|P2|Overall Study|Adverse Event|11
365620|NCT00372385|1175087|P1|Overall Study|Adverse Event|6
365621|NCT00372060|1175116|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
365622|NCT00372060|1175117|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
365623|NCT00372060|1175116|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
365624|NCT00372060|1175117|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
365625|NCT00372060|1175116|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
365626|NCT00372060|1175117|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
365627|NCT00372060|1175116|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
365628|NCT00372060|1175117|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
365629|NCT00372060|1175116|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
365630|NCT00372060|1175117|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
365631|NCT00372060|1175116|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
365632|NCT00372060|1175117|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
365633|NCT00371865|1175132|P2|Overall Study|Withdrawal by Subject|10
365634|NCT00371865|1175133|P1|Overall Study|Withdrawal by Subject|12
365635|NCT00371865|1175132|P2|Overall Study|Protocol Violation|2
365636|NCT00371865|1175133|P1|Overall Study|Protocol Violation|3
365637|NCT00371865|1175132|P2|Overall Study|Lack of Efficacy|2
365638|NCT00371865|1175133|P1|Overall Study|Lack of Efficacy|0
365639|NCT00371839|1175150|P3|Overall Study|Lost to Follow-up|2
365640|NCT00371839|1175151|P2|Overall Study|Lost to Follow-up|3
365641|NCT00371839|1175152|P1|Overall Study|Lost to Follow-up|6
365642|NCT00371839|1175150|P3|Overall Study|Withdrawal by Subject|0
365643|NCT00371839|1175151|P2|Overall Study|Withdrawal by Subject|4
365644|NCT00371839|1175152|P1|Overall Study|Withdrawal by Subject|7
365645|NCT00371839|1175150|P3|Overall Study|Death|0
365646|NCT00371839|1175151|P2|Overall Study|Death|0
365647|NCT00371839|1175152|P1|Overall Study|Death|4
365648|NCT00371826|1175161|P3|Extension Phase (24 Months)|Administrative problems|2
365649|NCT00371826|1175162|P2|Extension Phase (24 Months)|Administrative problems|0
365650|NCT00371826|1175163|P1|Extension Phase (24 Months)|Administrative problems|0
365651|NCT00371826|1175161|P3|Extension Phase (24 Months)|Subject withdrew consent|0
365652|NCT00371826|1175162|P2|Extension Phase (24 Months)|Subject withdrew consent|2
365653|NCT00371826|1175163|P1|Extension Phase (24 Months)|Subject withdrew consent|1
365654|NCT00371826|1175161|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
365655|NCT00371826|1175162|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
365656|NCT00371826|1175163|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
365657|NCT00371826|1175161|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
365658|NCT00371826|1175162|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
365659|NCT00371826|1175163|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
365660|NCT00371826|1175161|P3|Extension Phase (24 Months)|Adverse Event|0
365661|NCT00371826|1175162|P2|Extension Phase (24 Months)|Adverse Event|5
365662|NCT00371826|1175163|P1|Extension Phase (24 Months)|Adverse Event|4
365663|NCT00371826|1175161|P3|Core Phase (12 Months)|Graft Loss|0
365664|NCT00371826|1175162|P2|Core Phase (12 Months)|Graft Loss|1
365665|NCT00371826|1175163|P1|Core Phase (12 Months)|Graft Loss|0
365666|NCT00371826|1175161|P3|Core Phase (12 Months)|Administrative problems|8
365667|NCT00371826|1175162|P2|Core Phase (12 Months)|Administrative problems|0
365668|NCT00371826|1175163|P1|Core Phase (12 Months)|Administrative problems|1
365669|NCT00371826|1175161|P3|Core Phase (12 Months)|Subject withdrew consent|3
365670|NCT00371826|1175162|P2|Core Phase (12 Months)|Subject withdrew consent|0
365671|NCT00371826|1175163|P1|Core Phase (12 Months)|Subject withdrew consent|0
365672|NCT00371826|1175161|P3|Core Phase (12 Months)|Protocol Violation|1
365673|NCT00371826|1175162|P2|Core Phase (12 Months)|Protocol Violation|0
365674|NCT00371826|1175163|P1|Core Phase (12 Months)|Protocol Violation|1
365675|NCT00371826|1175161|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
365676|NCT00371826|1175162|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
365677|NCT00371826|1175163|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
365678|NCT00371826|1175161|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
365679|NCT00371826|1175162|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
365680|NCT00371826|1175163|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
365681|NCT00371826|1175161|P3|Core Phase (12 Months)|Adverse Event|9
365682|NCT00371826|1175162|P2|Core Phase (12 Months)|Adverse Event|4
365683|NCT00371826|1175163|P1|Core Phase (12 Months)|Adverse Event|15
365684|NCT00371787|1175287|P2|Overall Study|Withdrawal by Subject|1
365685|NCT00371787|1175288|P1|Overall Study|Withdrawal by Subject|3
365686|NCT00371761|1175302|P2|Overall Study|Study termination|3
365687|NCT00371761|1175303|P1|Overall Study|Study termination|4
365688|NCT00371761|1175302|P2|Overall Study|Investigator Judgment|3
365689|NCT00371761|1175303|P1|Overall Study|Investigator Judgment|2
365690|NCT00371761|1175302|P2|Overall Study|Withdrawal by Subject|3
365691|NCT00371761|1175303|P1|Overall Study|Withdrawal by Subject|1
365692|NCT00371761|1175302|P2|Overall Study|Adverse Event|1
365693|NCT00371761|1175303|P1|Overall Study|Adverse Event|1
365694|NCT00371683|1175311|P2|Follow-Up Period - Randomized Patients|non-specified|12
365695|NCT00371683|1175312|P1|Follow-Up Period - Randomized Patients|non-specified|6
365696|NCT00371683|1175311|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
365697|NCT00371683|1175312|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
365698|NCT00371683|1175311|P2|Follow-Up Period - Randomized Patients|Death|2
365699|NCT00371683|1175312|P1|Follow-Up Period - Randomized Patients|Death|0
365700|NCT00371683|1175311|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
365701|NCT00371683|1175312|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
365702|NCT00371683|1175311|P2|DB Treatment Period-Randomized Patients|non-specified|8
365703|NCT00371683|1175312|P1|DB Treatment Period-Randomized Patients|non-specified|9
365704|NCT00371683|1175311|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
365705|NCT00371683|1175312|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
365706|NCT00371683|1175311|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
365707|NCT00371683|1175312|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
365708|NCT00371683|1175311|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
365709|NCT00371683|1175312|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
365710|NCT00371683|1175311|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
365711|NCT00371683|1175312|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
365712|NCT00371683|1175311|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
365713|NCT00371683|1175312|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
365714|NCT00371683|1175311|P2|DB Treatment Period-Randomized Patients|Death|1
365715|NCT00371683|1175312|P1|DB Treatment Period-Randomized Patients|Death|1
365716|NCT00371566|1175380|P2|Follow Up Phase|Lost to Follow-up|0
365717|NCT00371566|1175381|P1|Follow Up Phase|Lost to Follow-up|1
365718|NCT00371566|1175380|P2|Follow Up Phase|Physician Decision|1
365719|NCT00371566|1175381|P1|Follow Up Phase|Physician Decision|1
365720|NCT00371566|1175380|P2|Follow Up Phase|Withdrawal by Subject|1
365721|NCT00371566|1175381|P1|Follow Up Phase|Withdrawal by Subject|0
365722|NCT00371566|1175380|P2|Follow Up Phase|Disease progression|0
365723|NCT00371566|1175381|P1|Follow Up Phase|Disease progression|1
365724|NCT00371566|1175380|P2|Follow Up Phase|Death|5
365725|NCT00371566|1175381|P1|Follow Up Phase|Death|0
365726|NCT00371566|1175380|P2|Chemoradiation Phase|Death|0
365727|NCT00371566|1175381|P1|Chemoradiation Phase|Death|2
365728|NCT00371566|1175380|P2|Chemoradiation Phase|Progressive Disease|1
365729|NCT00371566|1175381|P1|Chemoradiation Phase|Progressive Disease|1
365730|NCT00371566|1175380|P2|Chemoradiation Phase|Non compliant|1
365731|NCT00371566|1175381|P1|Chemoradiation Phase|Non compliant|0
365732|NCT00371566|1175380|P2|Chemoradiation Phase|Withdrawal by Subject|1
365733|NCT00371566|1175381|P1|Chemoradiation Phase|Withdrawal by Subject|0
365734|NCT00371566|1175380|P2|Chemoradiation Phase|Physician Decision|0
365735|NCT00371566|1175381|P1|Chemoradiation Phase|Physician Decision|2
365736|NCT00371566|1175380|P2|Treatment Phase|Protocol Violation|1
365737|NCT00371566|1175381|P1|Treatment Phase|Protocol Violation|0
365738|NCT00371566|1175380|P2|Treatment Phase|Adverse Event|1
365739|NCT00371566|1175381|P1|Treatment Phase|Adverse Event|0
365740|NCT00371566|1175380|P2|Treatment Phase|Withdrawal by Subject|1
365741|NCT00371566|1175381|P1|Treatment Phase|Withdrawal by Subject|0
365742|NCT00371462|1175466|P2|Overall Study|Other|8
365743|NCT00371462|1175467|P1|Overall Study|Other|7
365744|NCT00371462|1175466|P2|Overall Study|Withdrawal by Subject|0
365745|NCT00371462|1175467|P1|Overall Study|Withdrawal by Subject|1
365746|NCT00371397|1175491|P12|Session 1|Withdrawal by Subject|0
365747|NCT00371397|1175492|P11|Session 1|Withdrawal by Subject|0
365748|NCT00371397|1175493|P10|Session 1|Withdrawal by Subject|0
365749|NCT00371397|1175494|P9|Session 1|Withdrawal by Subject|0
365750|NCT00371397|1175495|P8|Session 1|Withdrawal by Subject|1
365751|NCT00371397|1175496|P7|Session 1|Withdrawal by Subject|0
365752|NCT00371397|1175497|P6|Session 1|Withdrawal by Subject|0
365753|NCT00371397|1175498|P5|Session 1|Withdrawal by Subject|0
365754|NCT00371397|1175499|P4|Session 1|Withdrawal by Subject|0
365755|NCT00371397|1175500|P3|Session 1|Withdrawal by Subject|0
365756|NCT00371397|1175501|P2|Session 1|Withdrawal by Subject|0
365757|NCT00371397|1175502|P1|Session 1|Withdrawal by Subject|1
365758|NCT00371345|1175510|P2|Overall Study|Participant Withdrew Consent|1
365759|NCT00371345|1175511|P1|Overall Study|Participant Withdrew Consent|0
365760|NCT00371345|1175510|P2|Overall Study|Participant Request|1
365761|NCT00371345|1175511|P1|Overall Study|Participant Request|1
365762|NCT00371345|1175510|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
365763|NCT00371345|1175511|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
365764|NCT00371345|1175510|P2|Overall Study|Study Drug Toxicity|7
365765|NCT00371345|1175511|P1|Overall Study|Study Drug Toxicity|1
365766|NCT00371345|1175510|P2|Overall Study|Disease Progression|35
365767|NCT00371345|1175511|P1|Overall Study|Disease Progression|21
365768|NCT00371254|1175612|P2|Overall Study|Withdrawal by Subject|1
365769|NCT00371254|1175613|P1|Overall Study|Withdrawal by Subject|0
365770|NCT00371254|1175612|P2|Overall Study|Lost to Follow-up|1
365771|NCT00371254|1175613|P1|Overall Study|Lost to Follow-up|0
365772|NCT00371254|1175612|P2|Overall Study|Adverse event unrelated to study drug|1
365773|NCT00371254|1175613|P1|Overall Study|Adverse event unrelated to study drug|0
365774|NCT00371254|1175612|P2|Overall Study|Investigator Decision|0
365775|NCT00371254|1175613|P1|Overall Study|Investigator Decision|2
365776|NCT00371254|1175612|P2|Overall Study|Subject request|0
365777|NCT00371254|1175613|P1|Overall Study|Subject request|5
365778|NCT00371254|1175612|P2|Overall Study|Study drug toxicity|5
365779|NCT00371254|1175613|P1|Overall Study|Study drug toxicity|3
365780|NCT00371254|1175612|P2|Overall Study|Disease progression|13
365781|NCT00371254|1175613|P1|Overall Study|Disease progression|13
365782|NCT00371150|1175696|P2|Overall Study|Lost to Follow-up|2
365783|NCT00371150|1175697|P1|Overall Study|Lost to Follow-up|3
365784|NCT00371137|1175732|P3|Overall Study|Protocol Violation|1
365785|NCT00371137|1175733|P2|Overall Study|Protocol Violation|1
365786|NCT00371137|1175734|P1|Overall Study|Protocol Violation|2
365787|NCT00371137|1175732|P3|Overall Study|Physician Decision|1
365788|NCT00371137|1175733|P2|Overall Study|Physician Decision|1
365789|NCT00371137|1175734|P1|Overall Study|Physician Decision|1
365790|NCT00371137|1175732|P3|Overall Study|Sponsor Decision|2
365791|NCT00371137|1175733|P2|Overall Study|Sponsor Decision|1
365792|NCT00371137|1175734|P1|Overall Study|Sponsor Decision|2
365793|NCT00371137|1175732|P3|Overall Study|Lack of Efficacy|13
365794|NCT00371137|1175733|P2|Overall Study|Lack of Efficacy|12
365795|NCT00371137|1175734|P1|Overall Study|Lack of Efficacy|30
365796|NCT00371137|1175732|P3|Overall Study|Lost to Follow-up|5
365797|NCT00371137|1175733|P2|Overall Study|Lost to Follow-up|3
365798|NCT00371137|1175734|P1|Overall Study|Lost to Follow-up|6
365799|NCT00371137|1175732|P3|Overall Study|Withdrawal by Subject|15
365800|NCT00371137|1175733|P2|Overall Study|Withdrawal by Subject|10
365801|NCT00371137|1175734|P1|Overall Study|Withdrawal by Subject|11
365802|NCT00371137|1175732|P3|Overall Study|Adverse Event|42
365803|NCT00371137|1175733|P2|Overall Study|Adverse Event|35
365804|NCT00371137|1175734|P1|Overall Study|Adverse Event|20
365805|NCT00370682|1175777|P3|Overall Study|Lost to Follow-up|1
365806|NCT00370682|1175778|P2|Overall Study|Lost to Follow-up|1
365807|NCT00370682|1175779|P1|Overall Study|Lost to Follow-up|0
365808|NCT00370682|1175777|P3|Overall Study|Moved from area|0
365809|NCT00370682|1175778|P2|Overall Study|Moved from area|2
365810|NCT00370682|1175779|P1|Overall Study|Moved from area|0
365811|NCT00370552|1175821|P3|Overall Study|Planned radiation for palliation|0
365812|NCT00370552|1175822|P2|Overall Study|Planned radiation for palliation|1
365813|NCT00370552|1175823|P1|Overall Study|Planned radiation for palliation|0
365814|NCT00370552|1175821|P3|Overall Study|High risk of allergic reaction|0
365815|NCT00370552|1175822|P2|Overall Study|High risk of allergic reaction|1
365816|NCT00370552|1175823|P1|Overall Study|High risk of allergic reaction|0
365817|NCT00370552|1175821|P3|Overall Study|Investigator decision|0
365818|NCT00370552|1175822|P2|Overall Study|Investigator decision|1
365819|NCT00370552|1175823|P1|Overall Study|Investigator decision|2
365820|NCT00370552|1175821|P3|Overall Study|Physician Decision|0
365821|NCT00370552|1175822|P2|Overall Study|Physician Decision|1
365822|NCT00370552|1175823|P1|Overall Study|Physician Decision|1
365823|NCT00370552|1175821|P3|Overall Study|Never treated|0
365824|NCT00370552|1175822|P2|Overall Study|Never treated|0
365825|NCT00370552|1175823|P1|Overall Study|Never treated|1
365826|NCT00370552|1175821|P3|Overall Study|Still on treatment|2
365827|NCT00370552|1175822|P2|Overall Study|Still on treatment|3
365828|NCT00370552|1175823|P1|Overall Study|Still on treatment|1
365829|NCT00370552|1175821|P3|Overall Study|Withdrawal by Subject|1
365830|NCT00370552|1175822|P2|Overall Study|Withdrawal by Subject|0
365831|NCT00370552|1175823|P1|Overall Study|Withdrawal by Subject|2
365832|NCT00370552|1175821|P3|Overall Study|Study drug toxicity|6
365833|NCT00370552|1175822|P2|Overall Study|Study drug toxicity|8
365834|NCT00370552|1175823|P1|Overall Study|Study drug toxicity|11
365835|NCT00370552|1175821|P3|Overall Study|Poor or noncompliance|1
365836|NCT00370552|1175822|P2|Overall Study|Poor or noncompliance|0
365837|NCT00370552|1175823|P1|Overall Study|Poor or noncompliance|0
365838|NCT00370552|1175821|P3|Overall Study|Maximum clinical benefit|5
365839|NCT00370552|1175822|P2|Overall Study|Maximum clinical benefit|5
365840|NCT00370552|1175823|P1|Overall Study|Maximum clinical benefit|3
365841|NCT00370552|1175821|P3|Overall Study|Disease progression|15
365842|NCT00370552|1175822|P2|Overall Study|Disease progression|23
365843|NCT00370552|1175823|P1|Overall Study|Disease progression|23
365844|NCT00370552|1175821|P3|Overall Study|Adverse Event|2
365845|NCT00370552|1175822|P2|Overall Study|Adverse Event|2
365846|NCT00370552|1175823|P1|Overall Study|Adverse Event|2
365847|NCT00370331|1175863|P2|Overall Study|Protocol Violation|1
365848|NCT00370331|1175864|P1|Overall Study|Protocol Violation|1
365849|NCT00370331|1175863|P2|Overall Study|Non-compliance|1
365850|NCT00370331|1175864|P1|Overall Study|Non-compliance|0
365851|NCT00370331|1175863|P2|Overall Study|Lack of Efficacy|1
365852|NCT00370331|1175864|P1|Overall Study|Lack of Efficacy|0
365853|NCT00370331|1175863|P2|Overall Study|Lost to Follow-up|3
365854|NCT00370331|1175864|P1|Overall Study|Lost to Follow-up|0
365855|NCT00370331|1175863|P2|Overall Study|Withdrawal by Subject|4
365856|NCT00370331|1175864|P1|Overall Study|Withdrawal by Subject|2
365857|NCT00370331|1175863|P2|Overall Study|Adverse Event|13
365858|NCT00370331|1175864|P1|Overall Study|Adverse Event|4
365859|NCT00370292|1175890|P1|Overall Study|Physician Decision|2
365860|NCT00370292|1175890|P1|Overall Study|Adverse Event|7
365861|NCT00370292|1175890|P1|Overall Study|Disease Progression|4
365862|NCT00370149|1175903|P2|Overall Study|Antibiotic coated dressing placed|1
365863|NCT00370149|1175904|P1|Overall Study|Antibiotic coated dressing placed|0
365864|NCT00370149|1175903|P2|Overall Study|Pre-existing infection|1
365865|NCT00370149|1175904|P1|Overall Study|Pre-existing infection|0
365866|NCT00370149|1175903|P2|Overall Study|Catheter inserted in wrong vessel-|1
365867|NCT00370149|1175904|P1|Overall Study|Catheter inserted in wrong vessel-|2
365868|NCT00370149|1175903|P2|Overall Study|Protocol Violation|0
365869|NCT00370149|1175904|P1|Overall Study|Protocol Violation|1
365870|NCT00370149|1175903|P2|Overall Study|Physician Decision|16
365871|NCT00370149|1175904|P1|Overall Study|Physician Decision|16
365872|NCT00370071|1175914|P1|Overall Study|Withdrawal by Subject|2
365873|NCT00370032|1175931|P2|Follow-up Period|Withdrawal by Subject|0
365874|NCT00370032|1175932|P1|Follow-up Period|Withdrawal by Subject|1
365875|NCT00370032|1175931|P2|Washout Period|Adverse Event|0
365876|NCT00370032|1175932|P1|Washout Period|Adverse Event|1
365877|NCT00370032|1175931|P2|Washout Period|Lost to Follow-up|1
365878|NCT00370032|1175932|P1|Washout Period|Lost to Follow-up|0
365879|NCT00370032|1175931|P2|Washout Period|Withdrawal by Subject|1
365880|NCT00370032|1175932|P1|Washout Period|Withdrawal by Subject|0
365881|NCT00370032|1175931|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
365882|NCT00370032|1175932|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
365883|NCT00369967|1175952|P2|Overall Study|Lost to Follow-up|12
365884|NCT00369967|1175953|P1|Overall Study|Lost to Follow-up|23
365885|NCT00369941|1175971|P2|Overall Study|Miscellaneous|3
365886|NCT00369941|1175972|P1|Overall Study|Miscellaneous|3
365887|NCT00369941|1175971|P2|Overall Study|Study Site Terminated|0
365888|NCT00369941|1175972|P1|Overall Study|Study Site Terminated|2
365889|NCT00369941|1175971|P2|Overall Study|Employment Interfered with Study Visits|0
365890|NCT00369941|1175972|P1|Overall Study|Employment Interfered with Study Visits|1
365891|NCT00369941|1175971|P2|Overall Study|Treatment with Prohibited Medication|1
365892|NCT00369941|1175972|P1|Overall Study|Treatment with Prohibited Medication|3
365893|NCT00369941|1175971|P2|Overall Study|Moved|5
365894|NCT00369941|1175972|P1|Overall Study|Moved|11
365895|NCT00369941|1175971|P2|Overall Study|Completed, Did Not Enter Extension|6
365896|NCT00369941|1175972|P1|Overall Study|Completed, Did Not Enter Extension|5
365897|NCT00369941|1175971|P2|Overall Study|Pregnancy|2
365898|NCT00369941|1175972|P1|Overall Study|Pregnancy|4
365899|NCT00369941|1175971|P2|Overall Study|Withdrawal by Subject|18
365900|NCT00369941|1175972|P1|Overall Study|Withdrawal by Subject|5
365901|NCT00369941|1175971|P2|Overall Study|Protocol Violation|3
365902|NCT00369941|1175972|P1|Overall Study|Protocol Violation|5
365903|NCT00369941|1175971|P2|Overall Study|Lost to Follow-up|22
365904|NCT00369941|1175972|P1|Overall Study|Lost to Follow-up|12
365905|NCT00369941|1175971|P2|Overall Study|Lack of Efficacy|10
365906|NCT00369941|1175972|P1|Overall Study|Lack of Efficacy|6
365907|NCT00369941|1175971|P2|Overall Study|Adverse Event|28
365908|NCT00369941|1175972|P1|Overall Study|Adverse Event|14
365909|NCT00369941|1175971|P2|Overall Study|Never Treated|2
365910|NCT00369941|1175972|P1|Overall Study|Never Treated|1
365911|NCT00369915|1176137|P2|Overall Study|W/drawl by investigators|1
365912|NCT00369915|1176138|P1|Overall Study|W/drawl by investigators|0
365913|NCT00369915|1176137|P2|Overall Study|Withdrawal by Subject|1
365914|NCT00369915|1176138|P1|Overall Study|Withdrawal by Subject|4
365915|NCT00369915|1176137|P2|Overall Study|expected side effects|1
365916|NCT00369915|1176138|P1|Overall Study|expected side effects|2
365917|NCT00369824|1176152|P6|Overall Study|Other|3
365918|NCT00369824|1176153|P5|Overall Study|Other|1
365919|NCT00369824|1176154|P4|Overall Study|Other|2
365920|NCT00369824|1176155|P3|Overall Study|Other|0
365921|NCT00369824|1176156|P2|Overall Study|Other|0
365922|NCT00369824|1176157|P1|Overall Study|Other|0
365923|NCT00369824|1176152|P6|Overall Study|Lost to Follow-up|6
365924|NCT00369824|1176153|P5|Overall Study|Lost to Follow-up|9
365925|NCT00369824|1176154|P4|Overall Study|Lost to Follow-up|8
365926|NCT00369824|1176155|P3|Overall Study|Lost to Follow-up|7
365927|NCT00369824|1176156|P2|Overall Study|Lost to Follow-up|11
365928|NCT00369824|1176157|P1|Overall Study|Lost to Follow-up|6
365929|NCT00369824|1176152|P6|Overall Study|Withdrawal by Subject|2
365930|NCT00369824|1176153|P5|Overall Study|Withdrawal by Subject|6
365931|NCT00369824|1176154|P4|Overall Study|Withdrawal by Subject|4
365932|NCT00369824|1176155|P3|Overall Study|Withdrawal by Subject|5
365933|NCT00369824|1176156|P2|Overall Study|Withdrawal by Subject|5
365934|NCT00369824|1176157|P1|Overall Study|Withdrawal by Subject|9
365935|NCT00369824|1176152|P6|Overall Study|Protocol Violation|0
365936|NCT00369824|1176153|P5|Overall Study|Protocol Violation|1
365937|NCT00369824|1176154|P4|Overall Study|Protocol Violation|1
365938|NCT00369824|1176155|P3|Overall Study|Protocol Violation|0
365939|NCT00369824|1176156|P2|Overall Study|Protocol Violation|1
365940|NCT00369824|1176157|P1|Overall Study|Protocol Violation|0
365941|NCT00369824|1176152|P6|Overall Study|Adverse Event|0
365942|NCT00369824|1176153|P5|Overall Study|Adverse Event|1
365943|NCT00369824|1176154|P4|Overall Study|Adverse Event|0
365944|NCT00369824|1176155|P3|Overall Study|Adverse Event|0
365945|NCT00369824|1176156|P2|Overall Study|Adverse Event|2
365946|NCT00369824|1176157|P1|Overall Study|Adverse Event|0
365947|NCT00369785|1176257|P2|Overall Study|Multiple reasons|5
365948|NCT00369785|1176258|P1|Overall Study|Multiple reasons|6
365949|NCT00369785|1176257|P2|Overall Study|Progression|4
365950|NCT00369785|1176258|P1|Overall Study|Progression|4
365951|NCT00369785|1176257|P2|Overall Study|Never started|2
365952|NCT00369785|1176258|P1|Overall Study|Never started|0
365953|NCT00369785|1176257|P2|Overall Study|Toxicity|4
365954|NCT00369785|1176258|P1|Overall Study|Toxicity|6
365955|NCT00369785|1176257|P2|Overall Study|Withdrawal by Subject|6
365956|NCT00369785|1176258|P1|Overall Study|Withdrawal by Subject|7
365957|NCT00369785|1176257|P2|Overall Study|Death|2
365958|NCT00369785|1176258|P1|Overall Study|Death|1
365959|NCT00369785|1176257|P2|Overall Study|Physician Decision|2
365960|NCT00369785|1176258|P1|Overall Study|Physician Decision|3
365961|NCT00369681|1176279|P1|Overall Study|Inevaluable|1
365962|NCT00369668|1176288|P3|Overall Study|Lack of Efficacy|7
365963|NCT00369668|1176289|P2|Overall Study|Lack of Efficacy|5
365964|NCT00369668|1176290|P1|Overall Study|Lack of Efficacy|4
365965|NCT00369655|1176304|P1|Overall Study|Refusal of further treatment|2
365966|NCT00369486|1176351|P5|34-Week Visit|Dropped|3
365967|NCT00369486|1176352|P4|34-Week Visit|Dropped|3
365968|NCT00369486|1176353|P3|34-Week Visit|Dropped|1
365969|NCT00369486|1176354|P2|34-Week Visit|Dropped|1
365970|NCT00369486|1176355|P1|34-Week Visit|Dropped|0
365971|NCT00369486|1176351|P5|17-Week Visit|Missed visit|1
365972|NCT00369486|1176352|P4|17-Week Visit|Missed visit|1
365973|NCT00369486|1176353|P3|17-Week Visit|Missed visit|1
365974|NCT00369486|1176354|P2|17-Week Visit|Missed visit|0
365975|NCT00369486|1176355|P1|17-Week Visit|Missed visit|0
365976|NCT00369486|1176351|P5|8-Week Visit|Dropped|0
365977|NCT00369486|1176352|P4|8-Week Visit|Dropped|1
365978|NCT00369486|1176353|P3|8-Week Visit|Dropped|0
365979|NCT00369486|1176354|P2|8-Week Visit|Dropped|0
365980|NCT00369486|1176355|P1|8-Week Visit|Dropped|0
365981|NCT00369486|1176351|P5|8-Week Visit|Missed visit|1
365982|NCT00369486|1176352|P4|8-Week Visit|Missed visit|0
365983|NCT00369486|1176353|P3|8-Week Visit|Missed visit|0
365984|NCT00369486|1176354|P2|8-Week Visit|Missed visit|1
365985|NCT00369486|1176355|P1|8-Week Visit|Missed visit|0
365986|NCT00369486|1176351|P5|4-Week Visit|Dropped|0
365987|NCT00369486|1176352|P4|4-Week Visit|Dropped|0
365988|NCT00369486|1176353|P3|4-Week Visit|Dropped|1
365989|NCT00369486|1176354|P2|4-Week Visit|Dropped|0
365990|NCT00369486|1176355|P1|4-Week Visit|Dropped|0
365991|NCT00369486|1176351|P5|4-Week Visit|Missed visit|1
365992|NCT00369486|1176352|P4|4-Week Visit|Missed visit|2
365993|NCT00369486|1176353|P3|4-Week Visit|Missed visit|0
365994|NCT00369486|1176354|P2|4-Week Visit|Missed visit|2
365995|NCT00369486|1176355|P1|4-Week Visit|Missed visit|2
365996|NCT00369382|1176394|P2|Overall Study|Unspecified|0
365997|NCT00369382|1176395|P1|Overall Study|Unspecified|1
365998|NCT00369382|1176394|P2|Overall Study|Randomized, not treated|0
365999|NCT00369382|1176395|P1|Overall Study|Randomized, not treated|2
366000|NCT00369382|1176394|P2|Overall Study|Withdrawal by Subject|0
366001|NCT00369382|1176395|P1|Overall Study|Withdrawal by Subject|5
366002|NCT00369382|1176394|P2|Overall Study|Physician Decision|1
366003|NCT00369382|1176395|P1|Overall Study|Physician Decision|2
366004|NCT00369382|1176394|P2|Overall Study|Death|2
366005|NCT00369382|1176395|P1|Overall Study|Death|0
366006|NCT00369343|1176428|P2|Open-label Phase|did not take study drug|2
366007|NCT00369343|1176429|P1|Open-label Phase|did not take study drug|1
366008|NCT00369343|1176428|P2|Open-label Phase|Lack of continuance tolerability|4
366009|NCT00369343|1176429|P1|Open-label Phase|Lack of continuance tolerability|3
366010|NCT00369343|1176428|P2|Open-label Phase|Lack of Efficacy|3
366011|NCT00369343|1176429|P1|Open-label Phase|Lack of Efficacy|4
366012|NCT00369343|1176428|P2|Open-label Phase|Withdrawal by Subject|6
366013|NCT00369343|1176429|P1|Open-label Phase|Withdrawal by Subject|15
366014|NCT00369343|1176428|P2|Open-label Phase|Protocol Violation|3
366015|NCT00369343|1176429|P1|Open-label Phase|Protocol Violation|1
366016|NCT00369343|1176428|P2|Open-label Phase|inadvertently reported study completers|2
366017|NCT00369343|1176429|P1|Open-label Phase|inadvertently reported study completers|3
366018|NCT00369343|1176428|P2|Open-label Phase|Lost to Follow-up|3
366019|NCT00369343|1176429|P1|Open-label Phase|Lost to Follow-up|5
366020|NCT00369343|1176428|P2|Open-label Phase|Physician Decision|0
366021|NCT00369343|1176429|P1|Open-label Phase|Physician Decision|2
366022|NCT00369343|1176428|P2|Open-label Phase|Failed to return|0
366023|NCT00369343|1176429|P1|Open-label Phase|Failed to return|4
366024|NCT00369343|1176428|P2|Open-label Phase|Adverse Event|7
366025|NCT00369343|1176429|P1|Open-label Phase|Adverse Event|19
366026|NCT00369343|1176428|P2|Double-blind Phase|Protocol deviation|0
366027|NCT00369343|1176429|P1|Double-blind Phase|Protocol deviation|4
366028|NCT00369343|1176428|P2|Double-blind Phase|Lack of Efficacy|4
366029|NCT00369343|1176429|P1|Double-blind Phase|Lack of Efficacy|0
366030|NCT00369343|1176428|P2|Double-blind Phase|Withdrawal by Subject|6
366031|NCT00369343|1176429|P1|Double-blind Phase|Withdrawal by Subject|8
366032|NCT00369343|1176428|P2|Double-blind Phase|Protocol Violation|0
366033|NCT00369343|1176429|P1|Double-blind Phase|Protocol Violation|2
366034|NCT00369343|1176428|P2|Double-blind Phase|Lost to Follow-up|2
366035|NCT00369343|1176429|P1|Double-blind Phase|Lost to Follow-up|9
366036|NCT00369343|1176428|P2|Double-blind Phase|Failed to return|0
366037|NCT00369343|1176429|P1|Double-blind Phase|Failed to return|2
366038|NCT00369343|1176428|P2|Double-blind Phase|Adverse Event|4
366039|NCT00369343|1176429|P1|Double-blind Phase|Adverse Event|19
366040|NCT00369317|1176462|P1|Overall Study|Ineligible|1
366041|NCT00369317|1176462|P1|Overall Study|Withdrawal by Subject|8
366042|NCT00369317|1176462|P1|Overall Study|Physician Decision|2
366043|NCT00369317|1176462|P1|Overall Study|Lack of Efficacy|5
366044|NCT00369317|1176462|P1|Overall Study|Death|1
366045|NCT00369317|1176462|P1|Overall Study|Adverse Event|3
366046|NCT00369278|1176469|P2|Overall Study|Graft loss|2
366047|NCT00369278|1176470|P1|Overall Study|Graft loss|1
366048|NCT00369278|1176469|P2|Overall Study|Lost to Follow-up|0
366049|NCT00369278|1176470|P1|Overall Study|Lost to Follow-up|1
366050|NCT00369278|1176469|P2|Overall Study|Withdrawal by Subject|2
366051|NCT00369278|1176470|P1|Overall Study|Withdrawal by Subject|2
366052|NCT00369278|1176469|P2|Overall Study|Protocol Violation|1
366053|NCT00369278|1176470|P1|Overall Study|Protocol Violation|2
366054|NCT00369278|1176469|P2|Overall Study|Unsatisfactory therapeutic effect|5
366055|NCT00369278|1176470|P1|Overall Study|Unsatisfactory therapeutic effect|4
366056|NCT00369278|1176469|P2|Overall Study|Adverse Event|11
366057|NCT00369278|1176470|P1|Overall Study|Adverse Event|14
366058|NCT00369265|1176486|P2|Overall Study|Study terminated|7
366059|NCT00369265|1176487|P1|Overall Study|Study terminated|4
366060|NCT00369161|1176508|P2|Overall Study|Administrative Problem|2
366061|NCT00369161|1176509|P1|Overall Study|Administrative Problem|2
366062|NCT00369161|1176508|P2|Overall Study|Graft loss|0
366063|NCT00369161|1176509|P1|Overall Study|Graft loss|4
366064|NCT00369161|1176508|P2|Overall Study|Death|2
366065|NCT00369161|1176509|P1|Overall Study|Death|1
366066|NCT00369161|1176508|P2|Overall Study|Withdrawal by Subject|3
366067|NCT00369161|1176509|P1|Overall Study|Withdrawal by Subject|2
366068|NCT00369161|1176508|P2|Overall Study|Protocol Violation|2
366069|NCT00369161|1176509|P1|Overall Study|Protocol Violation|0
366070|NCT00369161|1176508|P2|Overall Study|Lack of Efficacy|1
366071|NCT00369161|1176509|P1|Overall Study|Lack of Efficacy|3
366072|NCT00369161|1176508|P2|Overall Study|Abnormal laboratory value|1
366073|NCT00369161|1176509|P1|Overall Study|Abnormal laboratory value|0
366074|NCT00369161|1176508|P2|Overall Study|Adverse Event|13
366075|NCT00369161|1176509|P1|Overall Study|Adverse Event|15
366076|NCT00369122|1176519|P1|Overall Study|No protocol treatment|1
366077|NCT00369122|1176519|P1|Overall Study|Ineligible|10
366078|NCT00368992|1176523|P1|Overall Study|Not Specified|9
366079|NCT00368992|1176523|P1|Overall Study|Death|4
366080|NCT00368992|1176523|P1|Overall Study|Adverse Event|26
366081|NCT00368992|1176523|P1|Overall Study|Lack of Efficacy|63
366082|NCT00368992|1176523|P1|Overall Study|Refused treatment|3
366083|NCT00368992|1176523|P1|Overall Study|Ineligible|5
366084|NCT00368979|1176532|P2|Overall Study|Withdrawal by Subject|9
366085|NCT00368979|1176533|P1|Overall Study|Withdrawal by Subject|5
366086|NCT00368979|1176532|P2|Overall Study|Protocol Violation|1
366087|NCT00368979|1176533|P1|Overall Study|Protocol Violation|2
366088|NCT00368979|1176532|P2|Overall Study|Lost to Follow-up|0
366089|NCT00368979|1176533|P1|Overall Study|Lost to Follow-up|1
366090|NCT00368979|1176532|P2|Overall Study|Not specified|1
366091|NCT00368979|1176533|P1|Overall Study|Not specified|3
366092|NCT00368979|1176532|P2|Overall Study|Lack of Efficacy|3
366093|NCT00368979|1176533|P1|Overall Study|Lack of Efficacy|5
366094|NCT00368979|1176532|P2|Overall Study|Adverse Event|16
366095|NCT00368979|1176533|P1|Overall Study|Adverse Event|9
366096|NCT00368966|1176549|P2|Toddler Dose|Lost to Follow-up|2
366097|NCT00368966|1176550|P1|Toddler Dose|Lost to Follow-up|0
366098|NCT00368966|1176549|P2|Toddler Dose|Withdrawal by Subject|1
366099|NCT00368966|1176550|P1|Toddler Dose|Withdrawal by Subject|1
366100|NCT00368966|1176549|P2|After Infant|Lost to Follow-up|1
366101|NCT00368966|1176550|P1|After Infant|Lost to Follow-up|0
366102|NCT00368966|1176549|P2|After Infant|Death|0
366103|NCT00368966|1176550|P1|After Infant|Death|1
366104|NCT00368966|1176549|P2|After Infant|Withdrawal by Subject|1
366105|NCT00368966|1176550|P1|After Infant|Withdrawal by Subject|1
366106|NCT00368966|1176549|P2|After Infant|Adverse Event|2
366107|NCT00368966|1176550|P1|After Infant|Adverse Event|1
366108|NCT00368966|1176549|P2|After Infant|Failed to return|1
366109|NCT00368966|1176550|P1|After Infant|Failed to return|3
366110|NCT00368966|1176549|P2|Infant Series|Failed to return|0
366111|NCT00368966|1176550|P1|Infant Series|Failed to return|1
366112|NCT00368966|1176549|P2|Infant Series|Adverse Event|1
366113|NCT00368966|1176550|P1|Infant Series|Adverse Event|0
366114|NCT00368966|1176549|P2|Infant Series|Failed to meet eligibility criteria|1
366115|NCT00368966|1176550|P1|Infant Series|Failed to meet eligibility criteria|0
366116|NCT00368966|1176549|P2|Infant Series|Randomization error|1
366117|NCT00368966|1176550|P1|Infant Series|Randomization error|0
366118|NCT00368966|1176549|P2|Infant Series|Lost to Follow-up|0
366119|NCT00368966|1176550|P1|Infant Series|Lost to Follow-up|2
366120|NCT00368966|1176549|P2|Infant Series|Protocol Violation|1
366121|NCT00368966|1176550|P1|Infant Series|Protocol Violation|2
366122|NCT00368966|1176549|P2|Infant Series|Withdrawal by Subject|6
366123|NCT00368966|1176550|P1|Infant Series|Withdrawal by Subject|11
366124|NCT00368927|1176606|P2|Overall Study|Physician Decision|0
366125|NCT00368927|1176607|P1|Overall Study|Physician Decision|1
366126|NCT00368927|1176606|P2|Overall Study|Withdrawal by Subject|2
366127|NCT00368927|1176607|P1|Overall Study|Withdrawal by Subject|1
366128|NCT00368927|1176606|P2|Overall Study|Adverse Event|1
366129|NCT00368927|1176607|P1|Overall Study|Adverse Event|1
366130|NCT00368927|1176606|P2|Overall Study|Lost to Follow-up|0
366131|NCT00368927|1176607|P1|Overall Study|Lost to Follow-up|2
366132|NCT00368875|1176615|P2|Overall Study|Alternative Therapy|1
366133|NCT00368875|1176616|P1|Overall Study|Alternative Therapy|1
366134|NCT00368875|1176615|P2|Overall Study|Other Reason|2
366135|NCT00368875|1176616|P1|Overall Study|Other Reason|0
366136|NCT00368875|1176615|P2|Overall Study|Withdrawal by Subject|6
366137|NCT00368875|1176616|P1|Overall Study|Withdrawal by Subject|2
366138|NCT00368875|1176615|P2|Overall Study|Progressive disease|27
366139|NCT00368875|1176616|P1|Overall Study|Progressive disease|3
366140|NCT00368875|1176615|P2|Overall Study|Adverse Event|12
366141|NCT00368875|1176616|P1|Overall Study|Adverse Event|0
366142|NCT00368849|1176624|P2|Overall Study|Physician Decision|1
366143|NCT00368849|1176625|P1|Overall Study|Physician Decision|0
366144|NCT00368849|1176624|P2|Overall Study|Withdrawal by Subject|1
366145|NCT00368849|1176625|P1|Overall Study|Withdrawal by Subject|0
366146|NCT00368745|1176641|P2|Double-blind Treatment Period|Other|6
366147|NCT00368745|1176642|P1|Double-blind Treatment Period|Other|7
366148|NCT00368745|1176641|P2|Double-blind Treatment Period|Withdrawal by Subject|3
366149|NCT00368745|1176642|P1|Double-blind Treatment Period|Withdrawal by Subject|5
366150|NCT00368745|1176641|P2|Double-blind Treatment Period|Lost to Follow-up|0
366151|NCT00368745|1176642|P1|Double-blind Treatment Period|Lost to Follow-up|1
366152|NCT00368745|1176641|P2|Double-blind Treatment Period|Lack of Efficacy|16
366153|NCT00368745|1176642|P1|Double-blind Treatment Period|Lack of Efficacy|7
366154|NCT00368745|1176641|P2|Double-blind Treatment Period|Adverse Event|6
366155|NCT00368745|1176642|P1|Double-blind Treatment Period|Adverse Event|6
366156|NCT00368641|1176674|P2|Overall Study|Sponsor decision to terminate study|5
366157|NCT00368641|1176675|P1|Overall Study|Sponsor decision to terminate study|2
366158|NCT00368641|1176674|P2|Overall Study|Withdrawal by Subject|0
366159|NCT00368641|1176675|P1|Overall Study|Withdrawal by Subject|1
366160|NCT00368641|1176674|P2|Overall Study|Death|0
366161|NCT00368641|1176675|P1|Overall Study|Death|1
366162|NCT00368641|1176674|P2|Overall Study|Adverse Event|1
366163|NCT00368641|1176675|P1|Overall Study|Adverse Event|2
366164|NCT00368550|1176683|P2|Overall Study|Withdrawal by Subject|10
366165|NCT00368550|1176684|P1|Overall Study|Withdrawal by Subject|17
366166|NCT00368550|1176683|P2|Overall Study|Lack of Efficacy|9
366167|NCT00368550|1176684|P1|Overall Study|Lack of Efficacy|4
366168|NCT00368550|1176683|P2|Overall Study|Adverse Event|4
366169|NCT00368550|1176684|P1|Overall Study|Adverse Event|7
366170|NCT00368537|1176696|P2|Baseline Participants|Patient uncompliant|1
366171|NCT00368537|1176697|P1|Baseline Participants|Patient uncompliant|0
366172|NCT00368537|1176696|P2|Baseline Participants|No susceptibility|0
366173|NCT00368537|1176697|P1|Baseline Participants|No susceptibility|1
366174|NCT00368537|1176696|P2|Baseline Participants|Death|2
366175|NCT00368537|1176697|P1|Baseline Participants|Death|1
366176|NCT00368537|1176696|P2|Baseline Participants|Withdrawal by Subject|4
366177|NCT00368537|1176697|P1|Baseline Participants|Withdrawal by Subject|6
366178|NCT00368537|1176696|P2|Baseline Participants|Lost to Follow-up|17
366179|NCT00368537|1176697|P1|Baseline Participants|Lost to Follow-up|16
366180|NCT00368537|1176696|P2|Randomization|No study drug dosed|6
366181|NCT00368537|1176697|P1|Randomization|No study drug dosed|13
366182|NCT00368472|1176711|P1|Overall Study|Missing Final Disposition Date|1
366183|NCT00368472|1176711|P1|Overall Study|Not Specified|32
366184|NCT00368472|1176711|P1|Overall Study|Diary non-compliance|1
366185|NCT00368472|1176711|P1|Overall Study|Withdrawal by Subject|40
366186|NCT00368472|1176711|P1|Overall Study|Request of Investigator or Sponsor|3
366187|NCT00368472|1176711|P1|Overall Study|Protocol Violation|2
366188|NCT00368472|1176711|P1|Overall Study|Medication non-compliance|4
366189|NCT00368472|1176711|P1|Overall Study|Adverse Event|22
366190|NCT00368277|1176787|P2|Overall Study|Lost to Follow-up|6
366191|NCT00368277|1176788|P1|Overall Study|Lost to Follow-up|8
366192|NCT00368277|1176787|P2|Overall Study|Patient withdrew consent|28
366193|NCT00368277|1176788|P1|Overall Study|Patient withdrew consent|32
366194|NCT00368277|1176787|P2|Overall Study|Protocol deviation|0
366195|NCT00368277|1176788|P1|Overall Study|Protocol deviation|7
366196|NCT00368277|1176787|P2|Overall Study|Unsatisfactory therapeutic effect|24
366197|NCT00368277|1176788|P1|Overall Study|Unsatisfactory therapeutic effect|31
366198|NCT00368277|1176787|P2|Overall Study|Death|1
366199|NCT00368277|1176788|P1|Overall Study|Death|2
366200|NCT00368277|1176787|P2|Overall Study|Adverse Event|49
366201|NCT00368277|1176788|P1|Overall Study|Adverse Event|33
366202|NCT00368251|1176803|P3|Overall Study|AE, non-serious non-fatal|1
366203|NCT00368251|1176804|P2|Overall Study|AE, non-serious non-fatal|0
366204|NCT00368251|1176805|P1|Overall Study|AE, non-serious non-fatal|0
366205|NCT00368251|1176803|P3|Overall Study|SAE, non-fatal|0
366206|NCT00368251|1176804|P2|Overall Study|SAE, non-fatal|0
366207|NCT00368251|1176805|P1|Overall Study|SAE, non-fatal|1
366208|NCT00368108|1176828|P3|Overall Study|Not Specified|1
366209|NCT00368108|1176829|P2|Overall Study|Not Specified|7
366210|NCT00368108|1176830|P1|Overall Study|Not Specified|3
366211|NCT00368108|1176828|P3|Overall Study|Physician Decision|1
366212|NCT00368108|1176829|P2|Overall Study|Physician Decision|0
366213|NCT00368108|1176830|P1|Overall Study|Physician Decision|2
366214|NCT00368108|1176828|P3|Overall Study|Lack of Efficacy|5
366215|NCT00368108|1176829|P2|Overall Study|Lack of Efficacy|8
366216|NCT00368108|1176830|P1|Overall Study|Lack of Efficacy|7
366217|NCT00368108|1176828|P3|Overall Study|Withdrawal by Subject|5
366218|NCT00368108|1176829|P2|Overall Study|Withdrawal by Subject|3
366219|NCT00368108|1176830|P1|Overall Study|Withdrawal by Subject|9
366220|NCT00368108|1176828|P3|Overall Study|Protocol Violation|9
366221|NCT00368108|1176829|P2|Overall Study|Protocol Violation|9
366222|NCT00368108|1176830|P1|Overall Study|Protocol Violation|5
366223|NCT00368108|1176828|P3|Overall Study|Abnormal Laboratory Value|3
366224|NCT00368108|1176829|P2|Overall Study|Abnormal Laboratory Value|0
366225|NCT00368108|1176830|P1|Overall Study|Abnormal Laboratory Value|0
366226|NCT00368108|1176828|P3|Overall Study|Adverse Event|44
366227|NCT00368108|1176829|P2|Overall Study|Adverse Event|26
366228|NCT00368108|1176830|P1|Overall Study|Adverse Event|38
366229|NCT00368069|1176849|P2|Overall Study|no blood sampling possible|1
366230|NCT00368069|1176850|P1|Overall Study|no blood sampling possible|0
366231|NCT00368069|1176849|P2|Overall Study|Withdrawal of Consent|1
366232|NCT00368069|1176850|P1|Overall Study|Withdrawal of Consent|2
366233|NCT00368069|1176849|P2|Overall Study|Protocol Violation|2
366234|NCT00368069|1176850|P1|Overall Study|Protocol Violation|0
366235|NCT00368069|1176849|P2|Overall Study|Lost to Follow-up|0
366236|NCT00368069|1176850|P1|Overall Study|Lost to Follow-up|1
366237|NCT00368069|1176849|P2|Overall Study|Lack of Efficacy|1
366238|NCT00368069|1176850|P1|Overall Study|Lack of Efficacy|0
366239|NCT00368069|1176849|P2|Overall Study|Adverse Event|2
366240|NCT00368069|1176850|P1|Overall Study|Adverse Event|5
366241|NCT00367991|1176868|P2|Overall Study|Adverse Event|1
366242|NCT00367991|1176869|P1|Overall Study|Adverse Event|1
366243|NCT00367991|1176868|P2|Overall Study|Withdrawal by Subject|1
366244|NCT00367991|1176869|P1|Overall Study|Withdrawal by Subject|1
366245|NCT00367835|1176877|P2|Overall Study|History of lead poisoning|1
366246|NCT00367835|1176878|P1|Overall Study|History of lead poisoning|0
366247|NCT00367835|1176877|P2|Overall Study|Did not respond to calls|0
366248|NCT00367835|1176878|P1|Overall Study|Did not respond to calls|1
366249|NCT00367835|1176877|P2|Overall Study|refused blood collection|0
366250|NCT00367835|1176878|P1|Overall Study|refused blood collection|1
366251|NCT00367835|1176877|P2|Overall Study|Subject in juvenile detention center|0
366252|NCT00367835|1176878|P1|Overall Study|Subject in juvenile detention center|1
366253|NCT00367835|1176877|P2|Overall Study|Lack of Efficacy|12
366254|NCT00367835|1176878|P1|Overall Study|Lack of Efficacy|3
366255|NCT00367835|1176877|P2|Overall Study|Lost to Follow-up|4
366256|NCT00367835|1176878|P1|Overall Study|Lost to Follow-up|1
366257|NCT00367835|1176877|P2|Overall Study|Withdrawal by Subject|6
366258|NCT00367835|1176878|P1|Overall Study|Withdrawal by Subject|7
366259|NCT00367835|1176877|P2|Overall Study|Protocol Violation|7
366260|NCT00367835|1176878|P1|Overall Study|Protocol Violation|1
366261|NCT00367835|1176877|P2|Overall Study|Adverse Event|1
366262|NCT00367835|1176878|P1|Overall Study|Adverse Event|14
366263|NCT00367770|1176904|P1|Overall Study|Withdrawal by Subject|1
366264|NCT00367770|1176904|P1|Overall Study|Adverse Event|1
366265|NCT00367744|1176912|P2|Overall Study|Lost to Follow-up|5
366266|NCT00367744|1176913|P1|Overall Study|Lost to Follow-up|4
366267|NCT00367640|1176925|P4|Overall Study|Any other reason not above-mentioned|4
366268|NCT00367640|1176926|P3|Overall Study|Any other reason not above-mentioned|3
366356|NCT00366899|1177069|P1|Infant Series|Adverse Event|0
366269|NCT00367640|1176927|P2|Overall Study|Any other reason not above-mentioned|5
366270|NCT00367640|1176928|P1|Overall Study|Any other reason not above-mentioned|7
366271|NCT00367640|1176925|P4|Overall Study|Withdrawal by Subject|6
366272|NCT00367640|1176926|P3|Overall Study|Withdrawal by Subject|8
366273|NCT00367640|1176927|P2|Overall Study|Withdrawal by Subject|11
366274|NCT00367640|1176928|P1|Overall Study|Withdrawal by Subject|8
366275|NCT00367640|1176925|P4|Overall Study|Adverse Event|0
366276|NCT00367640|1176926|P3|Overall Study|Adverse Event|8
366277|NCT00367640|1176927|P2|Overall Study|Adverse Event|6
366278|NCT00367640|1176928|P1|Overall Study|Adverse Event|3
366279|NCT00367484|1176944|P1|Overall Study|Lack of Efficacy|1
366280|NCT00367484|1176944|P1|Overall Study|The choice of the patient|1
366281|NCT00367484|1176944|P1|Overall Study|Protocol Violation|1
366282|NCT00367484|1176944|P1|Overall Study|Lost to Follow-up|1
366283|NCT00367484|1176944|P1|Overall Study|Travel to USA|1
366284|NCT00367484|1176944|P1|Overall Study|Withdrew informed consent|5
366285|NCT00367484|1176944|P1|Overall Study|Adverse Event|7
366286|NCT00367432|1176948|P2|Second Period (up to 54 Months)|Other Reason|2
366287|NCT00367432|1176949|P1|Second Period (up to 54 Months)|Other Reason|6
366288|NCT00367432|1176948|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
366289|NCT00367432|1176949|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
366290|NCT00367432|1176948|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
366291|NCT00367432|1176949|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
366292|NCT00367432|1176948|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
366293|NCT00367432|1176949|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
366294|NCT00367432|1176948|P2|Second Period (up to 54 Months)|Adverse Event|3
366295|NCT00367432|1176949|P1|Second Period (up to 54 Months)|Adverse Event|14
366296|NCT00367432|1176948|P2|First Period (16 Weeks)|Other Reason|0
366297|NCT00367432|1176949|P1|First Period (16 Weeks)|Other Reason|2
366298|NCT00367432|1176948|P2|First Period (16 Weeks)|Withdrawal by Subject|0
366299|NCT00367432|1176949|P1|First Period (16 Weeks)|Withdrawal by Subject|6
366300|NCT00367432|1176948|P2|First Period (16 Weeks)|Lack of Efficacy|0
366301|NCT00367432|1176949|P1|First Period (16 Weeks)|Lack of Efficacy|24
366302|NCT00367432|1176948|P2|First Period (16 Weeks)|Adverse Event|0
366303|NCT00367432|1176949|P1|First Period (16 Weeks)|Adverse Event|6
366304|NCT00367341|1176976|P2|Overall Study|Protocol Violation|0
366305|NCT00367341|1176977|P1|Overall Study|Protocol Violation|1
366306|NCT00367341|1176976|P2|Overall Study|Physician Decision|0
366307|NCT00367341|1176977|P1|Overall Study|Physician Decision|1
366308|NCT00367237|1176987|P2|Overall Study|Protocol Violation|5
366309|NCT00367237|1176988|P1|Overall Study|Protocol Violation|2
366310|NCT00367237|1176987|P2|Overall Study|Withdrawal by Subject|4
366311|NCT00367237|1176988|P1|Overall Study|Withdrawal by Subject|0
366312|NCT00367237|1176987|P2|Overall Study|Lost to Follow-up|0
366313|NCT00367237|1176988|P1|Overall Study|Lost to Follow-up|1
366314|NCT00367237|1176987|P2|Overall Study|Adverse Event|2
366315|NCT00367237|1176988|P1|Overall Study|Adverse Event|7
366316|NCT00367133|1176997|P3|2 Years|Missed visit|4
366317|NCT00367133|1176998|P2|2 Years|Missed visit|5
366318|NCT00367133|1176999|P1|2 Years|Missed visit|4
366319|NCT00367133|1176997|P3|2 Years|Dropped|33
366320|NCT00367133|1176998|P2|2 Years|Dropped|19
366321|NCT00367133|1176999|P1|2 Years|Dropped|34
366322|NCT00367133|1176997|P3|2 Years|Death|12
366323|NCT00367133|1176998|P2|2 Years|Death|12
366324|NCT00367133|1176999|P1|2 Years|Death|20
366325|NCT00367055|1177051|P2|Overall Study|Participant Living too Far from Hospital|1
366326|NCT00367055|1177052|P1|Overall Study|Participant Living too Far from Hospital|0
366327|NCT00367055|1177051|P2|Overall Study|Stopping Criterion Met|1
366328|NCT00367055|1177052|P1|Overall Study|Stopping Criterion Met|0
366329|NCT00367055|1177051|P2|Overall Study|Protocol Violation|1
366330|NCT00367055|1177052|P1|Overall Study|Protocol Violation|0
366331|NCT00367055|1177051|P2|Overall Study|Lost to Follow-up|1
366332|NCT00367055|1177052|P1|Overall Study|Lost to Follow-up|1
366333|NCT00367055|1177051|P2|Overall Study|Lack of Efficacy|2
366334|NCT00367055|1177052|P1|Overall Study|Lack of Efficacy|1
366335|NCT00367055|1177051|P2|Overall Study|Patient's Willing|2
366336|NCT00367055|1177052|P1|Overall Study|Patient's Willing|3
366337|NCT00367055|1177051|P2|Overall Study|Adverse Event|3
366338|NCT00367055|1177052|P1|Overall Study|Adverse Event|6
366339|NCT00366899|1177068|P2|Toddler Dose|Protocol Violation|0
366340|NCT00366899|1177069|P1|Toddler Dose|Protocol Violation|1
366341|NCT00366899|1177068|P2|Toddler Dose|Withdrawal by Subject|1
366342|NCT00366899|1177069|P1|Toddler Dose|Withdrawal by Subject|1
366343|NCT00366899|1177068|P2|After Infant Series|Protocol Violation|0
366344|NCT00366899|1177069|P1|After Infant Series|Protocol Violation|1
366345|NCT00366899|1177068|P2|After Infant Series|Adverse Event|2
366346|NCT00366899|1177069|P1|After Infant Series|Adverse Event|1
366347|NCT00366899|1177068|P2|After Infant Series|Withdrawal by Subject|4
366348|NCT00366899|1177069|P1|After Infant Series|Withdrawal by Subject|1
366349|NCT00366899|1177068|P2|After Infant Series|Lost to Follow-up|3
366350|NCT00366899|1177069|P1|After Infant Series|Lost to Follow-up|4
366351|NCT00366899|1177068|P2|Infant Series|Randomized but not consented|0
366352|NCT00366899|1177069|P1|Infant Series|Randomized but not consented|1
366353|NCT00366899|1177068|P2|Infant Series|Physician Decision|0
366354|NCT00366899|1177069|P1|Infant Series|Physician Decision|1
366355|NCT00366899|1177068|P2|Infant Series|Adverse Event|1
366357|NCT00366899|1177068|P2|Infant Series|Lost to Follow-up|2
366358|NCT00366899|1177069|P1|Infant Series|Lost to Follow-up|0
366359|NCT00366899|1177068|P2|Infant Series|Failed to return|1
366360|NCT00366899|1177069|P1|Infant Series|Failed to return|1
366361|NCT00366899|1177068|P2|Infant Series|Protocol Violation|1
366362|NCT00366899|1177069|P1|Infant Series|Protocol Violation|2
366363|NCT00366899|1177068|P2|Infant Series|Withdrawal by Subject|7
366364|NCT00366899|1177069|P1|Infant Series|Withdrawal by Subject|4
366365|NCT00366678|1177129|P3|Toddler Dose|protocol deviation|0
366366|NCT00366678|1177130|P2|Toddler Dose|protocol deviation|0
366367|NCT00366678|1177131|P1|Toddler Dose|protocol deviation|1
366368|NCT00366678|1177129|P3|Toddler Dose|Withdrawal by Subject|0
366369|NCT00366678|1177130|P2|Toddler Dose|Withdrawal by Subject|0
366370|NCT00366678|1177131|P1|Toddler Dose|Withdrawal by Subject|1
366371|NCT00366678|1177129|P3|Toddler Dose|Failed to return|0
366372|NCT00366678|1177130|P2|Toddler Dose|Failed to return|0
366373|NCT00366678|1177131|P1|Toddler Dose|Failed to return|1
366374|NCT00366678|1177129|P3|Toddler Dose|Protocol Violation|0
366375|NCT00366678|1177130|P2|Toddler Dose|Protocol Violation|1
366376|NCT00366678|1177131|P1|Toddler Dose|Protocol Violation|2
366377|NCT00366678|1177129|P3|After Infant|Protocol Violation|0
366378|NCT00366678|1177130|P2|After Infant|Protocol Violation|0
366379|NCT00366678|1177131|P1|After Infant|Protocol Violation|1
366380|NCT00366678|1177129|P3|After Infant|Adverse Event|0
366381|NCT00366678|1177130|P2|After Infant|Adverse Event|0
366382|NCT00366678|1177131|P1|After Infant|Adverse Event|1
366383|NCT00366678|1177129|P3|After Infant|Failed to return|0
366384|NCT00366678|1177130|P2|After Infant|Failed to return|5
366385|NCT00366678|1177131|P1|After Infant|Failed to return|5
366386|NCT00366678|1177129|P3|After Infant|Lost to Follow-up|0
366387|NCT00366678|1177130|P2|After Infant|Lost to Follow-up|1
366388|NCT00366678|1177131|P1|After Infant|Lost to Follow-up|2
366389|NCT00366678|1177129|P3|After Infant|Withdrawal by Subject|0
366390|NCT00366678|1177130|P2|After Infant|Withdrawal by Subject|4
366391|NCT00366678|1177131|P1|After Infant|Withdrawal by Subject|8
366392|NCT00366678|1177129|P3|Infant Series|Adverse Event|0
366393|NCT00366678|1177130|P2|Infant Series|Adverse Event|0
366394|NCT00366678|1177131|P1|Infant Series|Adverse Event|1
366395|NCT00366678|1177129|P3|Infant Series|Failed to return|0
366396|NCT00366678|1177130|P2|Infant Series|Failed to return|1
366397|NCT00366678|1177131|P1|Infant Series|Failed to return|1
366398|NCT00366678|1177129|P3|Infant Series|Protocol Violation|0
366399|NCT00366678|1177130|P2|Infant Series|Protocol Violation|3
366400|NCT00366678|1177131|P1|Infant Series|Protocol Violation|4
366401|NCT00366678|1177129|P3|Infant Series|Withdrawal by Subject|0
366402|NCT00366678|1177130|P2|Infant Series|Withdrawal by Subject|6
366403|NCT00366678|1177131|P1|Infant Series|Withdrawal by Subject|8
366404|NCT00365846|1177321|P1|Overall Study|Lost to Follow-up|1
366405|NCT00365716|1177346|P7|Extension 2|Withdrawal by Subject|5
366406|NCT00365716|1177347|P6|Extension 2|Withdrawal by Subject|0
366407|NCT00365716|1177348|P5|Extension 2|Withdrawal by Subject|0
366408|NCT00365716|1177349|P4|Extension 2|Withdrawal by Subject|0
366409|NCT00365716|1177350|P3|Extension 2|Withdrawal by Subject|0
366410|NCT00365716|1177351|P2|Extension 2|Withdrawal by Subject|0
366411|NCT00365716|1177352|P1|Extension 2|Withdrawal by Subject|0
366412|NCT00365716|1177346|P7|Extension 2|Unspecified|3
366413|NCT00365716|1177347|P6|Extension 2|Unspecified|0
366414|NCT00365716|1177348|P5|Extension 2|Unspecified|0
366415|NCT00365716|1177349|P4|Extension 2|Unspecified|0
366416|NCT00365716|1177350|P3|Extension 2|Unspecified|0
366417|NCT00365716|1177351|P2|Extension 2|Unspecified|0
366418|NCT00365716|1177352|P1|Extension 2|Unspecified|0
366419|NCT00365716|1177346|P7|Extension 2|Lost to Follow-up|2
366420|NCT00365716|1177347|P6|Extension 2|Lost to Follow-up|0
366421|NCT00365716|1177348|P5|Extension 2|Lost to Follow-up|0
366422|NCT00365716|1177349|P4|Extension 2|Lost to Follow-up|0
366423|NCT00365716|1177350|P3|Extension 2|Lost to Follow-up|0
366424|NCT00365716|1177351|P2|Extension 2|Lost to Follow-up|0
366425|NCT00365716|1177352|P1|Extension 2|Lost to Follow-up|0
366426|NCT00365716|1177346|P7|Extension 1|Protocol Violation|0
366427|NCT00365716|1177347|P6|Extension 1|Protocol Violation|1
366428|NCT00365716|1177348|P5|Extension 1|Protocol Violation|0
366429|NCT00365716|1177349|P4|Extension 1|Protocol Violation|0
366430|NCT00365716|1177350|P3|Extension 1|Protocol Violation|0
366431|NCT00365716|1177351|P2|Extension 1|Protocol Violation|0
366432|NCT00365716|1177352|P1|Extension 1|Protocol Violation|0
366433|NCT00365716|1177346|P7|Extension 1|Pregnancy|0
366434|NCT00365716|1177347|P6|Extension 1|Pregnancy|4
366435|NCT00365716|1177348|P5|Extension 1|Pregnancy|0
366436|NCT00365716|1177349|P4|Extension 1|Pregnancy|0
366437|NCT00365716|1177350|P3|Extension 1|Pregnancy|0
366438|NCT00365716|1177351|P2|Extension 1|Pregnancy|0
366439|NCT00365716|1177352|P1|Extension 1|Pregnancy|0
366440|NCT00365716|1177346|P7|Extension 1|Withdrawal by Subject|0
366441|NCT00365716|1177347|P6|Extension 1|Withdrawal by Subject|3
366442|NCT00365716|1177348|P5|Extension 1|Withdrawal by Subject|0
366443|NCT00365716|1177349|P4|Extension 1|Withdrawal by Subject|0
366444|NCT00365716|1177350|P3|Extension 1|Withdrawal by Subject|0
366445|NCT00365716|1177351|P2|Extension 1|Withdrawal by Subject|0
366446|NCT00365716|1177352|P1|Extension 1|Withdrawal by Subject|0
366447|NCT00365716|1177346|P7|Extension 1|Moved|0
366448|NCT00365716|1177347|P6|Extension 1|Moved|4
366449|NCT00365716|1177348|P5|Extension 1|Moved|0
366450|NCT00365716|1177349|P4|Extension 1|Moved|0
366451|NCT00365716|1177350|P3|Extension 1|Moved|0
366452|NCT00365716|1177351|P2|Extension 1|Moved|0
366453|NCT00365716|1177352|P1|Extension 1|Moved|0
366454|NCT00365716|1177346|P7|Extension 1|Unspecified|0
366455|NCT00365716|1177347|P6|Extension 1|Unspecified|9
366456|NCT00365716|1177348|P5|Extension 1|Unspecified|0
366457|NCT00365716|1177349|P4|Extension 1|Unspecified|0
366458|NCT00365716|1177350|P3|Extension 1|Unspecified|0
366459|NCT00365716|1177351|P2|Extension 1|Unspecified|0
366460|NCT00365716|1177352|P1|Extension 1|Unspecified|0
366461|NCT00365716|1177346|P7|Extension 1|Lost to Follow-up|0
366462|NCT00365716|1177347|P6|Extension 1|Lost to Follow-up|1
366463|NCT00365716|1177348|P5|Extension 1|Lost to Follow-up|0
366464|NCT00365716|1177349|P4|Extension 1|Lost to Follow-up|0
366465|NCT00365716|1177350|P3|Extension 1|Lost to Follow-up|0
366466|NCT00365716|1177351|P2|Extension 1|Lost to Follow-up|0
366467|NCT00365716|1177352|P1|Extension 1|Lost to Follow-up|0
366468|NCT00365716|1177346|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
366469|NCT00365716|1177347|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
366470|NCT00365716|1177348|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
366471|NCT00365716|1177349|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
366472|NCT00365716|1177350|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
366473|NCT00365716|1177351|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
366474|NCT00365716|1177352|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
366475|NCT00365716|1177346|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
366476|NCT00365716|1177347|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
366477|NCT00365716|1177348|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
366478|NCT00365716|1177349|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
366479|NCT00365716|1177350|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
366480|NCT00365716|1177351|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
366481|NCT00365716|1177352|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
366482|NCT00365716|1177346|P7|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
366483|NCT00365716|1177347|P6|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
366484|NCT00365716|1177348|P5|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|1
366485|NCT00365716|1177349|P4|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
366486|NCT00365716|1177350|P3|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
366487|NCT00365716|1177351|P2|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
366488|NCT00365716|1177352|P1|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|2
366489|NCT00365716|1177346|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
366490|NCT00365716|1177347|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
366491|NCT00365716|1177348|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
366492|NCT00365716|1177349|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
366493|NCT00365716|1177350|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
366494|NCT00365716|1177351|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
366495|NCT00365716|1177352|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
366496|NCT00365716|1177346|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
366497|NCT00365716|1177347|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
366498|NCT00365716|1177348|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
366499|NCT00365716|1177349|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
366500|NCT00365716|1177350|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
366501|NCT00365716|1177351|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
366502|NCT00365716|1177352|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
366503|NCT00365716|1177346|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
366504|NCT00365716|1177347|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
366505|NCT00365716|1177348|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
366506|NCT00365716|1177349|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
366507|NCT00365716|1177350|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
366508|NCT00365716|1177351|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
366509|NCT00365716|1177352|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
366510|NCT00365716|1177346|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
366511|NCT00365716|1177347|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
366512|NCT00365716|1177348|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
366513|NCT00365716|1177349|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
366514|NCT00365716|1177350|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
366515|NCT00365716|1177351|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
366516|NCT00365716|1177352|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
366517|NCT00365716|1177346|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
366518|NCT00365716|1177347|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
366519|NCT00365716|1177348|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
366520|NCT00365716|1177349|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
366521|NCT00365716|1177350|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
366522|NCT00365716|1177351|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
366523|NCT00365716|1177352|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
366524|NCT00365716|1177346|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
366525|NCT00365716|1177347|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
366526|NCT00365716|1177348|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
366527|NCT00365716|1177349|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
366528|NCT00365716|1177350|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
366529|NCT00365716|1177351|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
366530|NCT00365716|1177352|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
366531|NCT00365716|1177346|P7|Base Study (Day 1 to Month 7)|Unspecified|0
366532|NCT00365716|1177347|P6|Base Study (Day 1 to Month 7)|Unspecified|0
366533|NCT00365716|1177348|P5|Base Study (Day 1 to Month 7)|Unspecified|0
366534|NCT00365716|1177349|P4|Base Study (Day 1 to Month 7)|Unspecified|0
366535|NCT00365716|1177350|P3|Base Study (Day 1 to Month 7)|Unspecified|0
366536|NCT00365716|1177351|P2|Base Study (Day 1 to Month 7)|Unspecified|1
366537|NCT00365716|1177352|P1|Base Study (Day 1 to Month 7)|Unspecified|0
366538|NCT00365716|1177346|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
366539|NCT00365716|1177347|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
366540|NCT00365716|1177348|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
366541|NCT00365716|1177349|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
366542|NCT00365716|1177350|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
366543|NCT00365716|1177351|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
366544|NCT00365716|1177352|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
366545|NCT00365716|1177346|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
366546|NCT00365716|1177347|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
366547|NCT00365716|1177348|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
366548|NCT00365716|1177349|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
366549|NCT00365716|1177350|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
366550|NCT00365716|1177351|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
366551|NCT00365716|1177352|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
366552|NCT00365716|1177346|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
366553|NCT00365716|1177347|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
366554|NCT00365716|1177348|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
366555|NCT00365716|1177349|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
366556|NCT00365716|1177350|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
366557|NCT00365716|1177351|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
366558|NCT00365716|1177352|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
366559|NCT00366548|1177369|P2|After Infant Series|Lost to Follow-up|0
366560|NCT00366548|1177370|P1|After Infant Series|Lost to Follow-up|1
366561|NCT00366548|1177369|P2|After Infant Series|Adverse Event|0
366562|NCT00366548|1177370|P1|After Infant Series|Adverse Event|2
366563|NCT00366548|1177369|P2|After Infant Series|Withdrawal by Subject|1
366564|NCT00366548|1177370|P1|After Infant Series|Withdrawal by Subject|3
366565|NCT00366548|1177369|P2|Infant Series|Withdrawal by Subject|1
366566|NCT00366548|1177370|P1|Infant Series|Withdrawal by Subject|3
366567|NCT00366548|1177369|P2|Infant Series|Protocol Violation|1
366568|NCT00366548|1177370|P1|Infant Series|Protocol Violation|0
366569|NCT00366548|1177369|P2|Infant Series|Adverse Event|3
366570|NCT00366548|1177370|P1|Infant Series|Adverse Event|1
366571|NCT00366457|1177404|P1|Overall Study|never began study therapy|2
366572|NCT00366444|1177413|P2|Overall Study|Lack of Efficacy|1
366573|NCT00366444|1177414|P1|Overall Study|Lack of Efficacy|0
366574|NCT00366444|1177413|P2|Overall Study|Withdrawal by Subject|1
366575|NCT00366444|1177414|P1|Overall Study|Withdrawal by Subject|1
366576|NCT00366340|1177442|P2|Toddler Dose|Parent/legal guardian request|1
366577|NCT00366340|1177443|P1|Toddler Dose|Parent/legal guardian request|0
366578|NCT00366340|1177442|P2|Toddler Dose|Failed to return|0
366579|NCT00366340|1177443|P1|Toddler Dose|Failed to return|1
366580|NCT00366340|1177442|P2|After the Infant Series|Lost to Follow-up|1
366581|NCT00366340|1177443|P1|After the Infant Series|Lost to Follow-up|0
366582|NCT00366340|1177442|P2|After the Infant Series|Adverse Event|1
366583|NCT00366340|1177443|P1|After the Infant Series|Adverse Event|0
366584|NCT00366340|1177442|P2|After the Infant Series|Protocol Violation|2
366585|NCT00366340|1177443|P1|After the Infant Series|Protocol Violation|2
366586|NCT00366340|1177442|P2|After the Infant Series|Failed to return|1
366587|NCT00366340|1177443|P1|After the Infant Series|Failed to return|0
366588|NCT00366340|1177442|P2|After the Infant Series|Parent/legal guardian request|1
366589|NCT00366340|1177443|P1|After the Infant Series|Parent/legal guardian request|1
366590|NCT00366340|1177442|P2|Infant Series|Failure to return|0
366591|NCT00366340|1177443|P1|Infant Series|Failure to return|1
366592|NCT00366340|1177442|P2|Infant Series|Lost to Follow-up|1
366593|NCT00366340|1177443|P1|Infant Series|Lost to Follow-up|1
366594|NCT00366340|1177442|P2|Infant Series|Adverse Event|2
366595|NCT00366340|1177443|P1|Infant Series|Adverse Event|0
366596|NCT00366340|1177442|P2|Infant Series|Withdrawal by Subject|3
366597|NCT00366340|1177443|P1|Infant Series|Withdrawal by Subject|3
366598|NCT00366340|1177442|P2|Infant Series|Protocol Violation|4
366599|NCT00366340|1177443|P1|Infant Series|Protocol Violation|3
366600|NCT00366301|1177501|P4|Overall Study|Withdrawal by Subject|1
366601|NCT00366301|1177502|P3|Overall Study|Withdrawal by Subject|1
366602|NCT00366301|1177503|P2|Overall Study|Withdrawal by Subject|2
366603|NCT00366301|1177504|P1|Overall Study|Withdrawal by Subject|4
366604|NCT00366301|1177501|P4|Overall Study|Lost to Follow-up|7
366605|NCT00366301|1177502|P3|Overall Study|Lost to Follow-up|3
366606|NCT00366301|1177503|P2|Overall Study|Lost to Follow-up|4
366607|NCT00366301|1177504|P1|Overall Study|Lost to Follow-up|4
366608|NCT00366249|1177520|P2|Overall Study|Most due to osteomylitis status|20
366609|NCT00366249|1177521|P1|Overall Study|Most due to osteomylitis status|31
366610|NCT00366249|1177520|P2|Overall Study|Lack of Efficacy|21
366611|NCT00366249|1177521|P1|Overall Study|Lack of Efficacy|21
366612|NCT00366249|1177520|P2|Overall Study|Withdrawal by Subject|4
366613|NCT00366249|1177521|P1|Overall Study|Withdrawal by Subject|18
366614|NCT00366249|1177520|P2|Overall Study|Protocol Violation|2
366615|NCT00366249|1177521|P1|Overall Study|Protocol Violation|1
366616|NCT00366249|1177520|P2|Overall Study|Lost to Follow-up|0
366617|NCT00366249|1177521|P1|Overall Study|Lost to Follow-up|2
366618|NCT00366249|1177520|P2|Overall Study|Physician Decision|2
366619|NCT00366249|1177521|P1|Overall Study|Physician Decision|5
366620|NCT00366249|1177520|P2|Overall Study|Death|1
366621|NCT00366249|1177521|P1|Overall Study|Death|0
366622|NCT00366249|1177520|P2|Overall Study|Adverse Event|28
366623|NCT00366249|1177521|P1|Overall Study|Adverse Event|53
366624|NCT00365976|1177555|P2|Overall Study|Withdrawal by Subject|5
366625|NCT00365976|1177556|P1|Overall Study|Withdrawal by Subject|1
366626|NCT00365547|1177590|P1|Overall Study|Withdrawal by Subject|1
366627|NCT00365547|1177590|P1|Overall Study|Screen failure|1
366628|NCT00365547|1177590|P1|Overall Study|Insurance did not cover Avastin|1
366629|NCT00365508|1177600|P2|Overall Study|Lost to Follow-up|154
366630|NCT00365508|1177601|P1|Overall Study|Lost to Follow-up|139
366631|NCT00365456|1177609|P2|Trial Period III (12 Months)|Other|1
366632|NCT00365456|1177610|P1|Trial Period III (12 Months)|Other|1
366633|NCT00365456|1177609|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
366634|NCT00365456|1177610|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
366635|NCT00365456|1177609|P2|Trial Period III (12 Months)|Adverse Event|3
366636|NCT00365456|1177610|P1|Trial Period III (12 Months)|Adverse Event|13
366637|NCT00365456|1177609|P2|Trial Period II (12 Months)|Other|1
366638|NCT00365456|1177610|P1|Trial Period II (12 Months)|Other|0
366639|NCT00365456|1177609|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
366640|NCT00365456|1177610|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
366641|NCT00365456|1177609|P2|Trial Period II (12 Months)|Non-compliance|2
366642|NCT00365456|1177610|P1|Trial Period II (12 Months)|Non-compliance|0
366643|NCT00365456|1177609|P2|Trial Period II (12 Months)|Adverse Event|6
366644|NCT00365456|1177610|P1|Trial Period II (12 Months)|Adverse Event|0
366645|NCT00365456|1177609|P2|Trial Period I (12 Months)|Other|0
366646|NCT00365456|1177610|P1|Trial Period I (12 Months)|Other|11
366647|NCT00365456|1177609|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
366648|NCT00365456|1177610|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
366649|NCT00365456|1177609|P2|Trial Period I (12 Months)|Non-compliance|0
366650|NCT00365456|1177610|P1|Trial Period I (12 Months)|Non-compliance|3
366651|NCT00365456|1177609|P2|Trial Period I (12 Months)|Adverse Event|0
366652|NCT00365456|1177610|P1|Trial Period I (12 Months)|Adverse Event|84
366653|NCT00365378|1177632|P3|Extension|Unspecified|31
366654|NCT00365378|1177633|P2|Extension|Unspecified|0
366655|NCT00365378|1177634|P1|Extension|Unspecified|0
366656|NCT00365378|1177632|P3|Extension|Withdrawal by Subject|98
366657|NCT00365378|1177633|P2|Extension|Withdrawal by Subject|0
366658|NCT00365378|1177634|P1|Extension|Withdrawal by Subject|0
366659|NCT00365378|1177632|P3|Extension|Protocol Violation|2
366660|NCT00365378|1177633|P2|Extension|Protocol Violation|0
366661|NCT00365378|1177634|P1|Extension|Protocol Violation|0
366662|NCT00365378|1177632|P3|Extension|Lost to Follow-up|57
366663|NCT00365378|1177633|P2|Extension|Lost to Follow-up|0
366664|NCT00365378|1177634|P1|Extension|Lost to Follow-up|0
366665|NCT00365378|1177632|P3|Extension|Moved|8
366666|NCT00365378|1177633|P2|Extension|Moved|0
366667|NCT00365378|1177634|P1|Extension|Moved|0
366668|NCT00365378|1177632|P3|Extension|Adverse Event|1
366669|NCT00365378|1177633|P2|Extension|Adverse Event|0
366670|NCT00365378|1177634|P1|Extension|Adverse Event|0
366671|NCT00365378|1177632|P3|Follow-up (Month 7 Though Month 48)|Unspecified|0
366672|NCT00365378|1177633|P2|Follow-up (Month 7 Though Month 48)|Unspecified|21
366673|NCT00365378|1177634|P1|Follow-up (Month 7 Though Month 48)|Unspecified|11
366674|NCT00365378|1177632|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
366675|NCT00365378|1177633|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
366676|NCT00365378|1177634|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
366677|NCT00365378|1177632|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
366678|NCT00365378|1177633|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
366679|NCT00365378|1177634|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
366680|NCT00365378|1177632|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
366681|NCT00365378|1177633|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
366682|NCT00365378|1177634|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
366683|NCT00365378|1177632|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
366684|NCT00365378|1177633|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
366685|NCT00365378|1177634|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
366686|NCT00365378|1177632|P3|Follow-up (Month 7 Though Month 48)|Moved|0
366687|NCT00365378|1177633|P2|Follow-up (Month 7 Though Month 48)|Moved|5
366688|NCT00365378|1177634|P1|Follow-up (Month 7 Though Month 48)|Moved|6
366689|NCT00365378|1177632|P3|Vaccination (Day 1 to Month 7)|Unspecified|0
366690|NCT00365378|1177633|P2|Vaccination (Day 1 to Month 7)|Unspecified|9
366691|NCT00365378|1177634|P1|Vaccination (Day 1 to Month 7)|Unspecified|17
366692|NCT00365378|1177632|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
366693|NCT00365378|1177633|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
366694|NCT00365378|1177634|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
366695|NCT00365378|1177632|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
366696|NCT00365378|1177633|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
366781|NCT00365300|1177753|P2|Open-label Phase|Protocol Violation|0
366697|NCT00365378|1177634|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
366698|NCT00365378|1177632|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
366699|NCT00365378|1177633|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
366700|NCT00365378|1177634|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
366701|NCT00365378|1177632|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
366702|NCT00365378|1177633|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
366703|NCT00365378|1177634|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
366704|NCT00365378|1177632|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
366705|NCT00365378|1177633|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
366706|NCT00365378|1177634|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
366707|NCT00365378|1177632|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
366708|NCT00365378|1177633|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
366709|NCT00365378|1177634|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
366710|NCT00365365|1177648|P3|Overall Study|Patient/physician decision|1
366711|NCT00365365|1177649|P2|Overall Study|Patient/physician decision|0
366712|NCT00365365|1177650|P1|Overall Study|Patient/physician decision|0
366713|NCT00365365|1177648|P3|Overall Study|Second malignancy|0
366714|NCT00365365|1177649|P2|Overall Study|Second malignancy|1
366715|NCT00365365|1177650|P1|Overall Study|Second malignancy|0
366716|NCT00365365|1177648|P3|Overall Study|Withdrew consent|0
366717|NCT00365365|1177649|P2|Overall Study|Withdrew consent|1
366718|NCT00365365|1177650|P1|Overall Study|Withdrew consent|1
366719|NCT00365365|1177648|P3|Overall Study|New cancer|0
366720|NCT00365365|1177649|P2|Overall Study|New cancer|0
366721|NCT00365365|1177650|P1|Overall Study|New cancer|1
366722|NCT00365365|1177648|P3|Overall Study|Moved|0
366723|NCT00365365|1177649|P2|Overall Study|Moved|0
366724|NCT00365365|1177650|P1|Overall Study|Moved|2
366725|NCT00365365|1177648|P3|Overall Study|Adverse Event|3
366726|NCT00365365|1177649|P2|Overall Study|Adverse Event|6
366727|NCT00365365|1177650|P1|Overall Study|Adverse Event|6
366728|NCT00365365|1177648|P3|Overall Study|Disease progression/relapse|7
366729|NCT00365365|1177649|P2|Overall Study|Disease progression/relapse|6
366730|NCT00365365|1177650|P1|Overall Study|Disease progression/relapse|9
366731|NCT00365365|1177648|P3|Overall Study|Subject's request|1
366732|NCT00365365|1177649|P2|Overall Study|Subject's request|13
366733|NCT00365365|1177650|P1|Overall Study|Subject's request|11
366734|NCT00365365|1177648|P3|Overall Study|Death|0
366735|NCT00365365|1177649|P2|Overall Study|Death|3
366736|NCT00365365|1177650|P1|Overall Study|Death|1
366737|NCT00365365|1177648|P3|Overall Study|Lost to Follow-up|3
366738|NCT00365365|1177649|P2|Overall Study|Lost to Follow-up|3
366739|NCT00365365|1177650|P1|Overall Study|Lost to Follow-up|3
366740|NCT00365365|1177648|P3|Overall Study|Poor compliance to protocol|0
366741|NCT00365365|1177649|P2|Overall Study|Poor compliance to protocol|1
366742|NCT00365365|1177650|P1|Overall Study|Poor compliance to protocol|0
366743|NCT00365365|1177648|P3|Overall Study|Randomized but not treated|0
366744|NCT00365365|1177649|P2|Overall Study|Randomized but not treated|2
366745|NCT00365365|1177650|P1|Overall Study|Randomized but not treated|0
366746|NCT00365352|1177667|P3|Overall Study|Withdrawal of Participant by Sponsor|0
366747|NCT00365352|1177668|P2|Overall Study|Withdrawal of Participant by Sponsor|0
366748|NCT00365352|1177669|P1|Overall Study|Withdrawal of Participant by Sponsor|1
366749|NCT00365352|1177667|P3|Overall Study|Lost to Follow-up|0
366750|NCT00365352|1177668|P2|Overall Study|Lost to Follow-up|1
366751|NCT00365352|1177669|P1|Overall Study|Lost to Follow-up|1
366752|NCT00365352|1177667|P3|Overall Study|Non-Compliance (after Randomization)|1
366753|NCT00365352|1177668|P2|Overall Study|Non-Compliance (after Randomization)|0
366754|NCT00365352|1177669|P1|Overall Study|Non-Compliance (after Randomization)|1
366755|NCT00365352|1177667|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
366756|NCT00365352|1177668|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
366757|NCT00365352|1177669|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
366758|NCT00365352|1177667|P3|Overall Study|Lack of Efficacy|0
366759|NCT00365352|1177668|P2|Overall Study|Lack of Efficacy|0
366760|NCT00365352|1177669|P1|Overall Study|Lack of Efficacy|3
366761|NCT00365352|1177667|P3|Overall Study|Participant Withdrew Consent|4
366762|NCT00365352|1177668|P2|Overall Study|Participant Withdrew Consent|3
366763|NCT00365352|1177669|P1|Overall Study|Participant Withdrew Consent|8
366764|NCT00365352|1177667|P3|Overall Study|Adverse Event|8
366765|NCT00365352|1177668|P2|Overall Study|Adverse Event|7
366766|NCT00365352|1177669|P1|Overall Study|Adverse Event|6
366767|NCT00365300|1177753|P2|Double-blind Phase|Lack of Efficacy|6
366768|NCT00365300|1177754|P1|Double-blind Phase|Lack of Efficacy|6
366769|NCT00365300|1177753|P2|Double-blind Phase|Protocol Violation|1
366770|NCT00365300|1177754|P1|Double-blind Phase|Protocol Violation|3
366771|NCT00365300|1177753|P2|Double-blind Phase|Withdrawal by Subject|1
366772|NCT00365300|1177754|P1|Double-blind Phase|Withdrawal by Subject|0
366773|NCT00365300|1177753|P2|Double-blind Phase|Noncompliance|1
366774|NCT00365300|1177754|P1|Double-blind Phase|Noncompliance|1
366775|NCT00365300|1177753|P2|Double-blind Phase|Failed to return|0
366776|NCT00365300|1177754|P1|Double-blind Phase|Failed to return|1
366777|NCT00365300|1177753|P2|Open-label Phase|Patient skipped open label phase|0
366778|NCT00365300|1177754|P1|Open-label Phase|Patient skipped open label phase|1
366779|NCT00365300|1177753|P2|Open-label Phase|Lack of Efficacy|0
366780|NCT00365300|1177754|P1|Open-label Phase|Lack of Efficacy|1
366782|NCT00365300|1177754|P1|Open-label Phase|Protocol Violation|1
366783|NCT00365300|1177753|P2|Open-label Phase|Parent/Legal Guardian Request|0
366784|NCT00365300|1177754|P1|Open-label Phase|Parent/Legal Guardian Request|4
366785|NCT00365300|1177753|P2|Open-label Phase|Noncompliance|0
366786|NCT00365300|1177754|P1|Open-label Phase|Noncompliance|9
366787|NCT00365300|1177753|P2|Open-label Phase|Physician Decision|0
366788|NCT00365300|1177754|P1|Open-label Phase|Physician Decision|1
366789|NCT00365300|1177753|P2|Open-label Phase|Failed to Return|0
366790|NCT00365300|1177754|P1|Open-label Phase|Failed to Return|1
366791|NCT00365300|1177753|P2|Open-label Phase|Adverse Event|0
366792|NCT00365300|1177754|P1|Open-label Phase|Adverse Event|4
366793|NCT00365105|1177817|P2|Overall Study|Lost to Follow-up|0
366794|NCT00365105|1177818|P1|Overall Study|Lost to Follow-up|1
366795|NCT00365105|1177817|P2|Overall Study|Withdrawal by Subject|1
366796|NCT00365105|1177818|P1|Overall Study|Withdrawal by Subject|1
366797|NCT00365105|1177817|P2|Overall Study|Protocol Violation|3
366798|NCT00365105|1177818|P1|Overall Study|Protocol Violation|4
366799|NCT00364923|1177851|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
366800|NCT00364923|1177851|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
366801|NCT00364858|1177860|P2|Overall Study|Clinical baseline issue|1
366802|NCT00364858|1177861|P1|Overall Study|Clinical baseline issue|0
366803|NCT00364858|1177860|P2|Overall Study|Return to Q2 regimen|1
366804|NCT00364858|1177861|P1|Overall Study|Return to Q2 regimen|0
366805|NCT00364858|1177860|P2|Overall Study|Non-compliant|0
366806|NCT00364858|1177861|P1|Overall Study|Non-compliant|1
366807|NCT00364858|1177860|P2|Overall Study|Discontinuation at baseline|0
366808|NCT00364858|1177861|P1|Overall Study|Discontinuation at baseline|1
366809|NCT00364858|1177860|P2|Overall Study|Clinical failure|13
366810|NCT00364858|1177861|P1|Overall Study|Clinical failure|2
366811|NCT00364858|1177860|P2|Overall Study|Pregnancy|1
366812|NCT00364858|1177861|P1|Overall Study|Pregnancy|1
366813|NCT00364858|1177860|P2|Overall Study|Withdrawal by Subject|1
366814|NCT00364858|1177861|P1|Overall Study|Withdrawal by Subject|1
366815|NCT00364858|1177860|P2|Overall Study|Adverse Event|5
366816|NCT00364858|1177861|P1|Overall Study|Adverse Event|1
366817|NCT00364845|1177876|P2|Overall Study|Death|1
366818|NCT00364845|1177877|P1|Overall Study|Death|0
366819|NCT00364845|1177876|P2|Overall Study|Lost to Follow-up|1
366820|NCT00364845|1177877|P1|Overall Study|Lost to Follow-up|0
366821|NCT00364845|1177876|P2|Overall Study|Physician Decision|8
366822|NCT00364845|1177877|P1|Overall Study|Physician Decision|8
366823|NCT00364845|1177876|P2|Overall Study|Withdrawal by Subject|1
366824|NCT00364845|1177877|P1|Overall Study|Withdrawal by Subject|2
366825|NCT00364845|1177876|P2|Overall Study|Adverse Event|0
366826|NCT00364845|1177877|P1|Overall Study|Adverse Event|1
366827|NCT00364832|1177898|P12|Extension Year 2|Early Withdrawals|3
366828|NCT00364832|1177899|P11|Extension Year 2|Early Withdrawals|5
366829|NCT00364832|1177900|P10|Extension Year 2|Early Withdrawals|5
366830|NCT00364832|1177901|P9|Extension Year 2|Early Withdrawals|0
366831|NCT00364832|1177902|P8|Extension Year 2|Early Withdrawals|0
366832|NCT00364832|1177903|P7|Extension Year 2|Early Withdrawals|0
366833|NCT00364832|1177904|P6|Extension Year 2|Early Withdrawals|0
366834|NCT00364832|1177905|P5|Extension Year 2|Early Withdrawals|0
366835|NCT00364832|1177906|P4|Extension Year 2|Early Withdrawals|0
366836|NCT00364832|1177907|P3|Extension Year 2|Early Withdrawals|0
366837|NCT00364832|1177908|P2|Extension Year 2|Early Withdrawals|0
366838|NCT00364832|1177909|P1|Extension Year 2|Early Withdrawals|0
366839|NCT00364832|1177898|P12|Extension Year 1|Early Withdrawals|10
366840|NCT00364832|1177899|P11|Extension Year 1|Early Withdrawals|2
366841|NCT00364832|1177900|P10|Extension Year 1|Early Withdrawals|4
366842|NCT00364832|1177901|P9|Extension Year 1|Early Withdrawals|0
366843|NCT00364832|1177902|P8|Extension Year 1|Early Withdrawals|0
366844|NCT00364832|1177903|P7|Extension Year 1|Early Withdrawals|0
366845|NCT00364832|1177904|P6|Extension Year 1|Early Withdrawals|0
366846|NCT00364832|1177905|P5|Extension Year 1|Early Withdrawals|0
366847|NCT00364832|1177906|P4|Extension Year 1|Early Withdrawals|0
366848|NCT00364832|1177907|P3|Extension Year 1|Early Withdrawals|0
366849|NCT00364832|1177908|P2|Extension Year 1|Early Withdrawals|0
366850|NCT00364832|1177909|P1|Extension Year 1|Early Withdrawals|0
366851|NCT00364832|1177898|P12|Core Period|Early Withdrawals|0
366852|NCT00364832|1177899|P11|Core Period|Early Withdrawals|0
366853|NCT00364832|1177900|P10|Core Period|Early Withdrawals|0
366854|NCT00364832|1177901|P9|Core Period|Early Withdrawals|0
366855|NCT00364832|1177902|P8|Core Period|Early Withdrawals|1
366856|NCT00364832|1177903|P7|Core Period|Early Withdrawals|4
366857|NCT00364832|1177904|P6|Core Period|Early Withdrawals|0
366858|NCT00364832|1177905|P5|Core Period|Early Withdrawals|0
366859|NCT00364832|1177906|P4|Core Period|Early Withdrawals|1
366860|NCT00364832|1177907|P3|Core Period|Early Withdrawals|1
366861|NCT00364832|1177908|P2|Core Period|Early Withdrawals|2
366862|NCT00364832|1177909|P1|Core Period|Early Withdrawals|2
366863|NCT00364793|1177974|P4|Overall Study|Withdrawal by Subject|0
366864|NCT00364793|1177975|P3|Overall Study|Withdrawal by Subject|0
366865|NCT00364793|1177976|P2|Overall Study|Withdrawal by Subject|1
366866|NCT00364793|1177977|P1|Overall Study|Withdrawal by Subject|0
366867|NCT00364793|1177974|P4|Overall Study|No longer meets criteria|1
366868|NCT00364793|1177975|P3|Overall Study|No longer meets criteria|0
366869|NCT00364793|1177976|P2|Overall Study|No longer meets criteria|0
366870|NCT00364793|1177977|P1|Overall Study|No longer meets criteria|0
366871|NCT00364793|1177974|P4|Overall Study|Poor or non-compliance|1
366872|NCT00364793|1177975|P3|Overall Study|Poor or non-compliance|0
366873|NCT00364793|1177976|P2|Overall Study|Poor or non-compliance|1
366874|NCT00364793|1177977|P1|Overall Study|Poor or non-compliance|1
366875|NCT00364793|1177974|P4|Overall Study|Lost to Follow-up|0
366876|NCT00364793|1177975|P3|Overall Study|Lost to Follow-up|2
366877|NCT00364793|1177976|P2|Overall Study|Lost to Follow-up|0
366878|NCT00364793|1177977|P1|Overall Study|Lost to Follow-up|1
366879|NCT00364793|1177974|P4|Overall Study|Lack of Efficacy|1
366880|NCT00364793|1177975|P3|Overall Study|Lack of Efficacy|1
366881|NCT00364793|1177976|P2|Overall Study|Lack of Efficacy|3
366882|NCT00364793|1177977|P1|Overall Study|Lack of Efficacy|3
366883|NCT00364793|1177974|P4|Overall Study|Death|0
366884|NCT00364793|1177975|P3|Overall Study|Death|1
366885|NCT00364793|1177976|P2|Overall Study|Death|0
366886|NCT00364793|1177977|P1|Overall Study|Death|1
366887|NCT00364793|1177974|P4|Overall Study|Adverse Event|0
366888|NCT00364793|1177975|P3|Overall Study|Adverse Event|0
366889|NCT00364793|1177976|P2|Overall Study|Adverse Event|0
366890|NCT00364793|1177977|P1|Overall Study|Adverse Event|2
366891|NCT00364611|1178113|P2|Overall Study|Receiving Liver Ablation|1
366892|NCT00364611|1178114|P1|Overall Study|Receiving Liver Ablation|0
366893|NCT00364611|1178113|P2|Overall Study|Presumed CR on Study|1
366894|NCT00364611|1178114|P1|Overall Study|Presumed CR on Study|0
366895|NCT00364611|1178113|P2|Overall Study|Found Ineligible|0
366896|NCT00364611|1178114|P1|Overall Study|Found Ineligible|1
366897|NCT00364611|1178113|P2|Overall Study|Investigator decision|2
366898|NCT00364611|1178114|P1|Overall Study|Investigator decision|2
366899|NCT00364611|1178113|P2|Overall Study|Disease Progression|8
366900|NCT00364611|1178114|P1|Overall Study|Disease Progression|38
366901|NCT00364611|1178113|P2|Overall Study|Participant's Request|4
366902|NCT00364611|1178114|P1|Overall Study|Participant's Request|3
366903|NCT00364611|1178113|P2|Overall Study|Adverse Event|4
366904|NCT00364611|1178114|P1|Overall Study|Adverse Event|7
366905|NCT00364611|1178113|P2|Overall Study|Did not receive study medication|1
366906|NCT00364611|1178114|P1|Overall Study|Did not receive study medication|0
366907|NCT00364533|1178137|P5|Overall Study|Protocol Violation|0
366908|NCT00364533|1178138|P4|Overall Study|Protocol Violation|0
366909|NCT00364533|1178139|P3|Overall Study|Protocol Violation|0
366910|NCT00364533|1178140|P2|Overall Study|Protocol Violation|1
366911|NCT00364533|1178141|P1|Overall Study|Protocol Violation|1
366912|NCT00364533|1178137|P5|Overall Study|Non-compliance|0
366913|NCT00364533|1178138|P4|Overall Study|Non-compliance|0
366914|NCT00364533|1178139|P3|Overall Study|Non-compliance|0
366915|NCT00364533|1178140|P2|Overall Study|Non-compliance|0
366916|NCT00364533|1178141|P1|Overall Study|Non-compliance|1
366917|NCT00364533|1178137|P5|Overall Study|Variations in drug compliance|0
366918|NCT00364533|1178138|P4|Overall Study|Variations in drug compliance|0
366919|NCT00364533|1178139|P3|Overall Study|Variations in drug compliance|1
366920|NCT00364533|1178140|P2|Overall Study|Variations in drug compliance|1
366921|NCT00364533|1178141|P1|Overall Study|Variations in drug compliance|2
366922|NCT00364533|1178137|P5|Overall Study|Subject discharged from hospital|1
366923|NCT00364533|1178138|P4|Overall Study|Subject discharged from hospital|3
366924|NCT00364533|1178139|P3|Overall Study|Subject discharged from hospital|2
366925|NCT00364533|1178140|P2|Overall Study|Subject discharged from hospital|1
366926|NCT00364533|1178141|P1|Overall Study|Subject discharged from hospital|4
366927|NCT00364533|1178137|P5|Overall Study|Lack of Efficacy|42
366928|NCT00364533|1178138|P4|Overall Study|Lack of Efficacy|17
366929|NCT00364533|1178139|P3|Overall Study|Lack of Efficacy|21
366930|NCT00364533|1178140|P2|Overall Study|Lack of Efficacy|22
366931|NCT00364533|1178141|P1|Overall Study|Lack of Efficacy|22
366932|NCT00364533|1178137|P5|Overall Study|Withdrawal by Subject|6
366933|NCT00364533|1178138|P4|Overall Study|Withdrawal by Subject|6
366934|NCT00364533|1178139|P3|Overall Study|Withdrawal by Subject|6
366935|NCT00364533|1178140|P2|Overall Study|Withdrawal by Subject|8
366936|NCT00364533|1178141|P1|Overall Study|Withdrawal by Subject|4
366937|NCT00364533|1178137|P5|Overall Study|Adverse Event|2
366938|NCT00364533|1178138|P4|Overall Study|Adverse Event|5
366939|NCT00364533|1178139|P3|Overall Study|Adverse Event|15
366940|NCT00364533|1178140|P2|Overall Study|Adverse Event|7
366941|NCT00364533|1178141|P1|Overall Study|Adverse Event|8
366942|NCT00364351|1178174|P2|Overall Study|Randomised treatment not started|3
366943|NCT00364351|1178175|P1|Overall Study|Randomised treatment not started|0
366944|NCT00364351|1178174|P2|Overall Study|Patient could not travel to site|1
366945|NCT00364351|1178175|P1|Overall Study|Patient could not travel to site|0
366946|NCT00364351|1178174|P2|Overall Study|Investigator error|2
366947|NCT00364351|1178175|P1|Overall Study|Investigator error|0
366948|NCT00364351|1178174|P2|Overall Study|Poor treatment compliance|3
366949|NCT00364351|1178175|P1|Overall Study|Poor treatment compliance|0
366950|NCT00364351|1178174|P2|Overall Study|Sponsor decision|0
366951|NCT00364351|1178175|P1|Overall Study|Sponsor decision|1
366952|NCT00364351|1178174|P2|Overall Study|Incorrect enrollment|1
366953|NCT00364351|1178175|P1|Overall Study|Incorrect enrollment|1
366954|NCT00364351|1178174|P2|Overall Study|Withdrawal by Subject|29
366955|NCT00364351|1178175|P1|Overall Study|Withdrawal by Subject|30
366956|NCT00364351|1178174|P2|Overall Study|Lost to Follow-up|1
366957|NCT00364351|1178175|P1|Overall Study|Lost to Follow-up|1
366958|NCT00364351|1178174|P2|Overall Study|Prohibited concomitant medication|2
366959|NCT00364351|1178175|P1|Overall Study|Prohibited concomitant medication|0
366960|NCT00364351|1178174|P2|Overall Study|Condition under investigation worsened|497
366961|NCT00364351|1178175|P1|Overall Study|Condition under investigation worsened|469
366962|NCT00364351|1178174|P2|Overall Study|Adverse Event|44
366963|NCT00364351|1178175|P1|Overall Study|Adverse Event|90
366964|NCT00364182|1178200|P3|Third Intervention|Lost to Follow-up|1
366965|NCT00364182|1178201|P2|Third Intervention|Lost to Follow-up|0
366966|NCT00364182|1178202|P1|Third Intervention|Lost to Follow-up|0
366967|NCT00364182|1178200|P3|Third Intervention|non-compliance|0
366968|NCT00364182|1178201|P2|Third Intervention|non-compliance|1
366969|NCT00364182|1178202|P1|Third Intervention|non-compliance|0
366970|NCT00364182|1178200|P3|Second Intervention|Adverse Event|1
366971|NCT00364182|1178201|P2|Second Intervention|Adverse Event|0
366972|NCT00364182|1178202|P1|Second Intervention|Adverse Event|0
366973|NCT00364182|1178200|P3|Second Intervention|Protocol Violation|0
366974|NCT00364182|1178201|P2|Second Intervention|Protocol Violation|1
366975|NCT00364182|1178202|P1|Second Intervention|Protocol Violation|0
366976|NCT00364182|1178200|P3|Second Intervention|non-compliance|1
366977|NCT00364182|1178201|P2|Second Intervention|non-compliance|1
366978|NCT00364182|1178202|P1|Second Intervention|non-compliance|0
366979|NCT00364182|1178200|P3|First Intervention|Withdrawal by Subject|0
366980|NCT00364182|1178201|P2|First Intervention|Withdrawal by Subject|0
366981|NCT00364182|1178202|P1|First Intervention|Withdrawal by Subject|2
366982|NCT00364182|1178200|P3|First Intervention|Secondary prophylaxis|0
366983|NCT00364182|1178201|P2|First Intervention|Secondary prophylaxis|0
366984|NCT00364182|1178202|P1|First Intervention|Secondary prophylaxis|1
366985|NCT00364156|1178236|P2|Overall Study|Protocol Violation|1
366986|NCT00364156|1178237|P1|Overall Study|Protocol Violation|6
366987|NCT00364156|1178236|P2|Overall Study|Withdrawal by Subject|80
366988|NCT00364156|1178237|P1|Overall Study|Withdrawal by Subject|73
366989|NCT00364130|1178245|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
366990|NCT00364130|1178246|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
366991|NCT00364130|1178245|P2|Intervention Period|Withdrawal by Subject|5
366992|NCT00364130|1178246|P1|Intervention Period|Withdrawal by Subject|4
366993|NCT00364130|1178245|P2|Intervention Period|Pregnancy|0
366994|NCT00364130|1178246|P1|Intervention Period|Pregnancy|1
366995|NCT00364130|1178245|P2|Intervention Period|Lost to Follow-up|3
366996|NCT00364130|1178246|P1|Intervention Period|Lost to Follow-up|4
366997|NCT00364013|1178268|P2|Overall Study|Ongoing|13
366998|NCT00364013|1178269|P1|Overall Study|Ongoing|20
366999|NCT00364013|1178268|P2|Overall Study|Other|47
367000|NCT00364013|1178269|P1|Overall Study|Other|41
367001|NCT00364013|1178268|P2|Overall Study|Protocol-specified criteria|6
367002|NCT00364013|1178269|P1|Overall Study|Protocol-specified criteria|6
367003|NCT00364013|1178268|P2|Overall Study|Lost to Follow-up|3
367004|NCT00364013|1178269|P1|Overall Study|Lost to Follow-up|10
367005|NCT00364013|1178268|P2|Overall Study|Physician Decision|3
367006|NCT00364013|1178269|P1|Overall Study|Physician Decision|3
367007|NCT00364013|1178268|P2|Overall Study|Withdrawal by Subject|18
367008|NCT00364013|1178269|P1|Overall Study|Withdrawal by Subject|13
367009|NCT00364013|1178268|P2|Overall Study|Adverse Event|3
367010|NCT00364013|1178269|P1|Overall Study|Adverse Event|4
367011|NCT00364013|1178268|P2|Overall Study|Ineligibility determined|2
367012|NCT00364013|1178269|P1|Overall Study|Ineligibility determined|4
367013|NCT00363896|1178297|P2|Overall Study|Other|2
367014|NCT00363896|1178298|P1|Overall Study|Other|1
367015|NCT00363896|1178297|P2|Overall Study|Non-fulfilment of entry criteria|0
367016|NCT00363896|1178298|P1|Overall Study|Non-fulfilment of entry criteria|1
367017|NCT00363896|1178297|P2|Overall Study|Lost to Follow-up|0
367018|NCT00363896|1178298|P1|Overall Study|Lost to Follow-up|3
367019|NCT00363896|1178297|P2|Overall Study|Protocol Violation|1
367020|NCT00363896|1178298|P1|Overall Study|Protocol Violation|6
367021|NCT00363896|1178297|P2|Overall Study|Lack of Efficacy|8
367022|NCT00363896|1178298|P1|Overall Study|Lack of Efficacy|12
367023|NCT00363896|1178297|P2|Overall Study|COPD exacerbation|7
367024|NCT00363896|1178298|P1|Overall Study|COPD exacerbation|13
367025|NCT00363896|1178297|P2|Overall Study|Adverse Event|13
367026|NCT00363896|1178298|P1|Overall Study|Adverse Event|24
367027|NCT00363896|1178297|P2|Overall Study|Withdrawal by Subject|16
367028|NCT00363896|1178298|P1|Overall Study|Withdrawal by Subject|29
367029|NCT00363545|1178346|P2|Overall Study|Others|0
367030|NCT00363545|1178347|P1|Overall Study|Others|1
367031|NCT00363545|1178346|P2|Overall Study|Lost to follow-up (complete vaccination)|17
367032|NCT00363545|1178347|P1|Overall Study|Lost to follow-up (complete vaccination)|14
367033|NCT00363545|1178346|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
367034|NCT00363545|1178347|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
367035|NCT00363545|1178346|P2|Overall Study|Migrated/moved from study area|6
367036|NCT00363545|1178347|P1|Overall Study|Migrated/moved from study area|3
367037|NCT00363545|1178346|P2|Overall Study|Withdrawal by Subject|15
367038|NCT00363545|1178347|P1|Overall Study|Withdrawal by Subject|12
367039|NCT00363545|1178346|P2|Overall Study|Serious Adverse Event|1
367040|NCT00363545|1178347|P1|Overall Study|Serious Adverse Event|0
367041|NCT00363467|1178365|P1|Overall Study|Physician Decision|1
367042|NCT00363415|1178375|P2|Overall Study|Protocol Violation|4
367043|NCT00363415|1178376|P1|Overall Study|Protocol Violation|1
367044|NCT00363415|1178375|P2|Overall Study|Lost to Follow-up|3
367045|NCT00363415|1178376|P1|Overall Study|Lost to Follow-up|3
367046|NCT00363415|1178375|P2|Overall Study|Withdrawal by Subject|15
367047|NCT00363415|1178376|P1|Overall Study|Withdrawal by Subject|9
367048|NCT00363415|1178375|P2|Overall Study|Entry Criteria Not Met|10
367049|NCT00363415|1178376|P1|Overall Study|Entry Criteria Not Met|11
367050|NCT00363415|1178375|P2|Overall Study|Physician Decision|35
367051|NCT00363415|1178376|P1|Overall Study|Physician Decision|18
367052|NCT00363415|1178375|P2|Overall Study|Adverse Event|15
367053|NCT00363415|1178376|P1|Overall Study|Adverse Event|24
367054|NCT00363415|1178375|P2|Overall Study|Death|29
367055|NCT00363415|1178376|P1|Overall Study|Death|32
367056|NCT00363415|1178375|P2|Overall Study|Sponsor Decision|31
367057|NCT00363415|1178376|P1|Overall Study|Sponsor Decision|67
367058|NCT00363415|1178375|P2|Overall Study|Progressive Disease|107
367059|NCT00363415|1178376|P1|Overall Study|Progressive Disease|196
367060|NCT00363311|1178394|P2|Overall Study|Participant Moved to Louisiana|1
367061|NCT00363311|1178395|P1|Overall Study|Participant Moved to Louisiana|0
367062|NCT00363311|1178394|P2|Overall Study|Withdrawn per Instructions of Monitor|1
367063|NCT00363311|1178395|P1|Overall Study|Withdrawn per Instructions of Monitor|0
367064|NCT00363311|1178394|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
367065|NCT00363311|1178395|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
367066|NCT00363311|1178394|P2|Overall Study|Participant Moved to Another Country|0
367067|NCT00363311|1178395|P1|Overall Study|Participant Moved to Another Country|1
367068|NCT00363311|1178394|P2|Overall Study|Participant Opted for Treatment|0
367069|NCT00363311|1178395|P1|Overall Study|Participant Opted for Treatment|1
367070|NCT00363311|1178394|P2|Overall Study|Prostate Volume/PSA Doubled|0
367071|NCT00363311|1178395|P1|Overall Study|Prostate Volume/PSA Doubled|1
367072|NCT00363311|1178394|P2|Overall Study|Participant Refused Biopsy|0
367073|NCT00363311|1178395|P1|Overall Study|Participant Refused Biopsy|1
367074|NCT00363311|1178394|P2|Overall Study|Non-Compliance|1
367075|NCT00363311|1178395|P1|Overall Study|Non-Compliance|1
367076|NCT00363311|1178394|P2|Overall Study|Disease Progression|26
367077|NCT00363311|1178395|P1|Overall Study|Disease Progression|46
367078|NCT00363311|1178394|P2|Overall Study|Sponsor Terminated Study|2
367079|NCT00363311|1178395|P1|Overall Study|Sponsor Terminated Study|2
367080|NCT00363311|1178394|P2|Overall Study|Physician Decision|1
367081|NCT00363311|1178395|P1|Overall Study|Physician Decision|1
367082|NCT00363311|1178394|P2|Overall Study|Withdrawal by Subject|6
367083|NCT00363311|1178395|P1|Overall Study|Withdrawal by Subject|12
367084|NCT00363311|1178394|P2|Overall Study|Protocol Violation|2
367085|NCT00363311|1178395|P1|Overall Study|Protocol Violation|1
367086|NCT00363311|1178394|P2|Overall Study|Lost to Follow-up|0
367087|NCT00363311|1178395|P1|Overall Study|Lost to Follow-up|3
367088|NCT00363311|1178394|P2|Overall Study|Adverse Event|4
367089|NCT00363311|1178395|P1|Overall Study|Adverse Event|6
367090|NCT00363298|1178461|P2|4-week Study Continuation Phase|Lack of Efficacy|0
367091|NCT00363298|1178462|P1|4-week Study Continuation Phase|Lack of Efficacy|1
367092|NCT00363298|1178461|P2|First Study Week|Lack of Efficacy|5
367093|NCT00363298|1178462|P1|First Study Week|Lack of Efficacy|6
367094|NCT00363246|1178470|P1|Overall Study|Eligibility changed due to Hospice move|5
367095|NCT00363246|1178470|P1|Overall Study|Subject expressed security concerns|2
367096|NCT00363246|1178470|P1|Overall Study|Stopped using wheelchair|11
367097|NCT00363246|1178470|P1|Overall Study|Bad health|6
367098|NCT00363246|1178470|P1|Overall Study|Lost to Follow-up|14
367099|NCT00363246|1178470|P1|Overall Study|Withdrawal by Subject|19
367100|NCT00363246|1178470|P1|Overall Study|Death|40
367101|NCT00363142|1178488|P2|Overall Study|Withdrawal by Subject|1
367102|NCT00363142|1178489|P1|Overall Study|Withdrawal by Subject|3
367103|NCT00363142|1178488|P2|Overall Study|Non-compliance|1
367104|NCT00363142|1178489|P1|Overall Study|Non-compliance|1
367105|NCT00363142|1178488|P2|Overall Study|Lost to Follow-up|0
367106|NCT00363142|1178489|P1|Overall Study|Lost to Follow-up|1
367107|NCT00363142|1178488|P2|Overall Study|Lack of Efficacy|1
367108|NCT00363142|1178489|P1|Overall Study|Lack of Efficacy|0
367109|NCT00363142|1178488|P2|Overall Study|Adverse Event|0
367110|NCT00363142|1178489|P1|Overall Study|Adverse Event|2
367111|NCT00363129|1178518|P2|Overall Study|Other Reasons|3
367112|NCT00363129|1178519|P1|Overall Study|Other Reasons|6
367113|NCT00363129|1178518|P2|Overall Study|Death|1
367114|NCT00363129|1178519|P1|Overall Study|Death|0
367115|NCT00363129|1178518|P2|Overall Study|Other Medical Problems|4
367116|NCT00363129|1178519|P1|Overall Study|Other Medical Problems|2
367117|NCT00363129|1178518|P2|Overall Study|Alternate Treatment|4
367118|NCT00363129|1178519|P1|Overall Study|Alternate Treatment|2
367119|NCT00363129|1178518|P2|Overall Study|Adverse Event|3
367120|NCT00363129|1178519|P1|Overall Study|Adverse Event|8
367121|NCT00363129|1178518|P2|Overall Study|Withdrawal by Subject|18
367122|NCT00363129|1178519|P1|Overall Study|Withdrawal by Subject|11
367123|NCT00363051|1178562|P2|Overall Study|Death|2
367124|NCT00363051|1178563|P1|Overall Study|Death|3
367125|NCT00363051|1178562|P2|Overall Study|Protocol Violation|2
367126|NCT00363051|1178563|P1|Overall Study|Protocol Violation|0
367127|NCT00363051|1178562|P2|Overall Study|Lost to Follow-up|1
367128|NCT00363051|1178563|P1|Overall Study|Lost to Follow-up|0
367129|NCT00363051|1178562|P2|Overall Study|Withdrawal by Subject|3
367130|NCT00363051|1178563|P1|Overall Study|Withdrawal by Subject|11
367131|NCT00363051|1178562|P2|Overall Study|New Cancer Therapy|1
367132|NCT00363051|1178563|P1|Overall Study|New Cancer Therapy|2
367133|NCT00363051|1178562|P2|Overall Study|Adverse Event|12
367134|NCT00363051|1178563|P1|Overall Study|Adverse Event|21
367135|NCT00363051|1178562|P2|Overall Study|Adminstrative problems|1
367136|NCT00363051|1178563|P1|Overall Study|Adminstrative problems|1
367137|NCT00362648|1178610|P4|Overall Study|Withdrawal by Subject|6
367138|NCT00362648|1178611|P3|Overall Study|Withdrawal by Subject|2
367139|NCT00362648|1178612|P2|Overall Study|Withdrawal by Subject|42
367140|NCT00362648|1178613|P1|Overall Study|Withdrawal by Subject|48
367141|NCT00362648|1178610|P4|Overall Study|Protocol Violation|2
367142|NCT00362648|1178611|P3|Overall Study|Protocol Violation|2
367143|NCT00362648|1178612|P2|Overall Study|Protocol Violation|2
367144|NCT00362648|1178613|P1|Overall Study|Protocol Violation|4
367145|NCT00362648|1178610|P4|Overall Study|Lost to Follow-up|3
367146|NCT00362648|1178611|P3|Overall Study|Lost to Follow-up|4
367147|NCT00362648|1178612|P2|Overall Study|Lost to Follow-up|69
367148|NCT00362648|1178613|P1|Overall Study|Lost to Follow-up|62
367149|NCT00362648|1178610|P4|Overall Study|Adverse Event|0
367150|NCT00362648|1178611|P3|Overall Study|Adverse Event|1
367151|NCT00362648|1178612|P2|Overall Study|Adverse Event|21
367152|NCT00362648|1178613|P1|Overall Study|Adverse Event|12
367153|NCT00362609|1178631|P2|Overall Study|Protocol Violation|1
367154|NCT00362609|1178632|P1|Overall Study|Protocol Violation|0
367155|NCT00362609|1178631|P2|Overall Study|Withdrawal by Subject|1
367156|NCT00362609|1178632|P1|Overall Study|Withdrawal by Subject|0
367157|NCT00362414|1178713|P1|Overall Study|Adverse Event|1
367158|NCT00362414|1178713|P1|Overall Study|Death|2
367159|NCT00362375|1178742|P2|Overall Study|Lost to Follow-up|35
367160|NCT00362375|1178743|P1|Overall Study|Lost to Follow-up|40
367161|NCT00362336|1178760|P3|Overall Study|Withdrawal by Subject|1
367162|NCT00362336|1178761|P2|Overall Study|Withdrawal by Subject|3
367163|NCT00362336|1178762|P1|Overall Study|Withdrawal by Subject|3
367164|NCT00362336|1178760|P3|Overall Study|Lost to Follow-up|0
367165|NCT00362336|1178761|P2|Overall Study|Lost to Follow-up|4
367166|NCT00362336|1178762|P1|Overall Study|Lost to Follow-up|6
367167|NCT00362336|1178760|P3|Overall Study|Protocol Violation|1
367168|NCT00362336|1178761|P2|Overall Study|Protocol Violation|0
367169|NCT00362336|1178762|P1|Overall Study|Protocol Violation|0
367170|NCT00362336|1178760|P3|Overall Study|Serious Adverse Event|1
367171|NCT00362336|1178761|P2|Overall Study|Serious Adverse Event|0
367172|NCT00362336|1178762|P1|Overall Study|Serious Adverse Event|1
367173|NCT00362297|1178790|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
367174|NCT00362297|1178791|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
367175|NCT00362232|1178799|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
367176|NCT00362232|1178800|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
367177|NCT00362232|1178799|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
367178|NCT00362232|1178800|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
367179|NCT00362232|1178799|P2|Follow-up (30 (+ 5) Days)|Death|1
367180|NCT00362232|1178800|P1|Follow-up (30 (+ 5) Days)|Death|1
367181|NCT00362232|1178799|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
367182|NCT00362232|1178800|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
367183|NCT00362232|1178799|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
367184|NCT00362232|1178800|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
367185|NCT00362232|1178799|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
367186|NCT00362232|1178800|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
367187|NCT00362232|1178799|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
367188|NCT00362232|1178800|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
367189|NCT00362232|1178799|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
367190|NCT00362232|1178800|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
367191|NCT00362232|1178799|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
367192|NCT00362232|1178800|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
367193|NCT00362232|1178799|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
367194|NCT00362232|1178800|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
367195|NCT00362232|1178799|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
367196|NCT00362232|1178800|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
367197|NCT00362232|1178799|P2|Treatment (12 +/- 2 Days)|Death|3
367198|NCT00362232|1178800|P1|Treatment (12 +/- 2 Days)|Death|1
367199|NCT00362232|1178799|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
367200|NCT00362232|1178800|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
367201|NCT00362180|1178845|P9|Treated Period|Adverse Event|0
367202|NCT00362180|1178846|P8|Treated Period|Adverse Event|1
367203|NCT00362180|1178847|P7|Treated Period|Adverse Event|0
367204|NCT00362180|1178848|P6|Treated Period|Adverse Event|1
367205|NCT00362180|1178849|P5|Treated Period|Adverse Event|0
367206|NCT00362180|1178850|P4|Treated Period|Adverse Event|0
367207|NCT00362180|1178851|P3|Treated Period|Adverse Event|0
367208|NCT00362180|1178852|P2|Treated Period|Adverse Event|0
367209|NCT00362180|1178853|P1|Treated Period|Adverse Event|0
367210|NCT00362180|1178845|P9|Treated Period|Withdrawal by Subject|0
367211|NCT00362180|1178846|P8|Treated Period|Withdrawal by Subject|0
367212|NCT00362180|1178847|P7|Treated Period|Withdrawal by Subject|0
367213|NCT00362180|1178848|P6|Treated Period|Withdrawal by Subject|0
367214|NCT00362180|1178849|P5|Treated Period|Withdrawal by Subject|0
367215|NCT00362180|1178850|P4|Treated Period|Withdrawal by Subject|0
367216|NCT00362180|1178851|P3|Treated Period|Withdrawal by Subject|0
367217|NCT00362180|1178852|P2|Treated Period|Withdrawal by Subject|0
367218|NCT00362180|1178853|P1|Treated Period|Withdrawal by Subject|1
367219|NCT00362115|1178925|P7|Overall Study|Other|0
367220|NCT00362115|1178926|P6|Overall Study|Other|1
367221|NCT00362115|1178927|P5|Overall Study|Other|0
367222|NCT00362115|1178928|P4|Overall Study|Other|1
367223|NCT00362115|1178929|P3|Overall Study|Other|0
367224|NCT00362115|1178930|P2|Overall Study|Other|1
367225|NCT00362115|1178931|P1|Overall Study|Other|0
367226|NCT00362115|1178925|P7|Overall Study|Physician Decision|3
367227|NCT00362115|1178926|P6|Overall Study|Physician Decision|0
367228|NCT00362115|1178927|P5|Overall Study|Physician Decision|0
367229|NCT00362115|1178928|P4|Overall Study|Physician Decision|0
367230|NCT00362115|1178929|P3|Overall Study|Physician Decision|0
367231|NCT00362115|1178930|P2|Overall Study|Physician Decision|0
367232|NCT00362115|1178931|P1|Overall Study|Physician Decision|0
367233|NCT00362115|1178925|P7|Overall Study|Lack of Efficacy|3
367234|NCT00362115|1178926|P6|Overall Study|Lack of Efficacy|0
367235|NCT00362115|1178927|P5|Overall Study|Lack of Efficacy|2
367236|NCT00362115|1178928|P4|Overall Study|Lack of Efficacy|2
367237|NCT00362115|1178929|P3|Overall Study|Lack of Efficacy|5
367238|NCT00362115|1178930|P2|Overall Study|Lack of Efficacy|0
367239|NCT00362115|1178931|P1|Overall Study|Lack of Efficacy|1
367240|NCT00362115|1178925|P7|Overall Study|Withdrawal by Subject|4
367241|NCT00362115|1178926|P6|Overall Study|Withdrawal by Subject|3
367242|NCT00362115|1178927|P5|Overall Study|Withdrawal by Subject|1
367243|NCT00362115|1178928|P4|Overall Study|Withdrawal by Subject|0
367244|NCT00362115|1178929|P3|Overall Study|Withdrawal by Subject|1
367245|NCT00362115|1178930|P2|Overall Study|Withdrawal by Subject|3
367246|NCT00362115|1178931|P1|Overall Study|Withdrawal by Subject|1
367247|NCT00362115|1178925|P7|Overall Study|Lost to Follow-up|1
367248|NCT00362115|1178926|P6|Overall Study|Lost to Follow-up|0
367249|NCT00362115|1178927|P5|Overall Study|Lost to Follow-up|2
367250|NCT00362115|1178928|P4|Overall Study|Lost to Follow-up|0
367251|NCT00362115|1178929|P3|Overall Study|Lost to Follow-up|0
367252|NCT00362115|1178930|P2|Overall Study|Lost to Follow-up|1
367253|NCT00362115|1178931|P1|Overall Study|Lost to Follow-up|0
367254|NCT00362115|1178925|P7|Overall Study|Protocol Violation|0
367255|NCT00362115|1178926|P6|Overall Study|Protocol Violation|1
367256|NCT00362115|1178927|P5|Overall Study|Protocol Violation|0
367257|NCT00362115|1178928|P4|Overall Study|Protocol Violation|0
367258|NCT00362115|1178929|P3|Overall Study|Protocol Violation|0
367259|NCT00362115|1178930|P2|Overall Study|Protocol Violation|0
367260|NCT00362115|1178931|P1|Overall Study|Protocol Violation|0
367261|NCT00362115|1178925|P7|Overall Study|Adverse Event|1
367262|NCT00362115|1178926|P6|Overall Study|Adverse Event|2
367263|NCT00362115|1178927|P5|Overall Study|Adverse Event|2
367264|NCT00362115|1178928|P4|Overall Study|Adverse Event|1
367265|NCT00362115|1178929|P3|Overall Study|Adverse Event|1
367266|NCT00362115|1178930|P2|Overall Study|Adverse Event|1
367267|NCT00362115|1178931|P1|Overall Study|Adverse Event|0
367268|NCT00361634|1179091|P1|Overall Study|Withdrawal by Subject|1
367269|NCT00361634|1179091|P1|Overall Study|Lost to Follow-up|1
367270|NCT00361569|1179120|P4|Overall Study|Not specified by investigator|1
367271|NCT00361569|1179121|P3|Overall Study|Not specified by investigator|0
367272|NCT00361569|1179122|P2|Overall Study|Not specified by investigator|0
367273|NCT00361569|1179123|P1|Overall Study|Not specified by investigator|2
367274|NCT00361569|1179120|P4|Overall Study|Lost to Follow-up|2
367275|NCT00361569|1179121|P3|Overall Study|Lost to Follow-up|3
367276|NCT00361569|1179122|P2|Overall Study|Lost to Follow-up|3
367277|NCT00361569|1179123|P1|Overall Study|Lost to Follow-up|2
367278|NCT00361569|1179120|P4|Overall Study|Adverse Event|2
367279|NCT00361569|1179121|P3|Overall Study|Adverse Event|2
367280|NCT00361569|1179122|P2|Overall Study|Adverse Event|5
367281|NCT00361569|1179123|P1|Overall Study|Adverse Event|3
367282|NCT00361569|1179120|P4|Overall Study|Withdrawal by Subject|14
367283|NCT00361569|1179121|P3|Overall Study|Withdrawal by Subject|9
367284|NCT00361569|1179122|P2|Overall Study|Withdrawal by Subject|1
367285|NCT00361569|1179123|P1|Overall Study|Withdrawal by Subject|2
367286|NCT00361569|1179120|P4|Overall Study|Protocol Violation|2
367287|NCT00361569|1179121|P3|Overall Study|Protocol Violation|4
367288|NCT00361569|1179122|P2|Overall Study|Protocol Violation|2
367289|NCT00361569|1179123|P1|Overall Study|Protocol Violation|3
367290|NCT00361504|1179147|P2|Overall Study|All other|3
367291|NCT00361504|1179148|P1|Overall Study|All other|28
367292|NCT00361504|1179147|P2|Overall Study|Study medication non compliant|15
367293|NCT00361504|1179148|P1|Overall Study|Study medication non compliant|42
367294|NCT00361504|1179147|P2|Overall Study|Resolution of Pain|0
367295|NCT00361504|1179148|P1|Overall Study|Resolution of Pain|2
367296|NCT00361504|1179147|P2|Overall Study|Lack of Efficacy|7
367297|NCT00361504|1179148|P1|Overall Study|Lack of Efficacy|72
367298|NCT00361504|1179147|P2|Overall Study|Adverse Event|82
367299|NCT00361504|1179148|P1|Overall Study|Adverse Event|203
367300|NCT00361504|1179147|P2|Overall Study|Lost to Follow-up|7
367301|NCT00361504|1179148|P1|Overall Study|Lost to Follow-up|40
367302|NCT00361504|1179147|P2|Overall Study|Withdrawal by Subject|31
367303|NCT00361504|1179148|P1|Overall Study|Withdrawal by Subject|94
367304|NCT00361335|1179189|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
367305|NCT00361335|1179190|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
367306|NCT00361335|1179191|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
367307|NCT00361335|1179192|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
367387|NCT00361335|1179195|P1|IV Period: Baseline to E0|Death|1
367308|NCT00361335|1179193|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
367309|NCT00361335|1179194|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
367310|NCT00361335|1179195|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
367311|NCT00361335|1179189|P7|SC Period: Week E0 to Week E24|Not specified|2
367312|NCT00361335|1179190|P6|SC Period: Week E0 to Week E24|Not specified|1
367313|NCT00361335|1179191|P5|SC Period: Week E0 to Week E24|Not specified|0
367314|NCT00361335|1179192|P4|SC Period: Week E0 to Week E24|Not specified|1
367315|NCT00361335|1179193|P3|SC Period: Week E0 to Week E24|Not specified|0
367316|NCT00361335|1179194|P2|SC Period: Week E0 to Week E24|Not specified|0
367317|NCT00361335|1179195|P1|SC Period: Week E0 to Week E24|Not specified|1
367318|NCT00361335|1179189|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
367319|NCT00361335|1179190|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
367320|NCT00361335|1179191|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
367321|NCT00361335|1179192|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
367322|NCT00361335|1179193|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
367323|NCT00361335|1179194|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
367324|NCT00361335|1179195|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
367325|NCT00361335|1179189|P7|SC Period: Week E0 to Week E24|Death|1
367326|NCT00361335|1179190|P6|SC Period: Week E0 to Week E24|Death|0
367327|NCT00361335|1179191|P5|SC Period: Week E0 to Week E24|Death|0
367328|NCT00361335|1179192|P4|SC Period: Week E0 to Week E24|Death|0
367329|NCT00361335|1179193|P3|SC Period: Week E0 to Week E24|Death|0
367330|NCT00361335|1179194|P2|SC Period: Week E0 to Week E24|Death|0
367331|NCT00361335|1179195|P1|SC Period: Week E0 to Week E24|Death|0
367332|NCT00361335|1179189|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
367333|NCT00361335|1179190|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
367334|NCT00361335|1179191|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
367335|NCT00361335|1179192|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
367336|NCT00361335|1179193|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
367337|NCT00361335|1179194|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
367338|NCT00361335|1179195|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
367339|NCT00361335|1179189|P7|SC Period: Week E0 to Week E24|Adverse Event|2
367340|NCT00361335|1179190|P6|SC Period: Week E0 to Week E24|Adverse Event|0
367341|NCT00361335|1179191|P5|SC Period: Week E0 to Week E24|Adverse Event|0
367342|NCT00361335|1179192|P4|SC Period: Week E0 to Week E24|Adverse Event|2
367343|NCT00361335|1179193|P3|SC Period: Week E0 to Week E24|Adverse Event|1
367344|NCT00361335|1179194|P2|SC Period: Week E0 to Week E24|Adverse Event|2
367345|NCT00361335|1179195|P1|SC Period: Week E0 to Week E24|Adverse Event|0
367346|NCT00361335|1179189|P7|IV Period: Baseline to E0|Lack of Efficacy|0
367347|NCT00361335|1179190|P6|IV Period: Baseline to E0|Lack of Efficacy|0
367348|NCT00361335|1179191|P5|IV Period: Baseline to E0|Lack of Efficacy|8
367349|NCT00361335|1179192|P4|IV Period: Baseline to E0|Lack of Efficacy|7
367350|NCT00361335|1179193|P3|IV Period: Baseline to E0|Lack of Efficacy|3
367351|NCT00361335|1179194|P2|IV Period: Baseline to E0|Lack of Efficacy|9
367352|NCT00361335|1179195|P1|IV Period: Baseline to E0|Lack of Efficacy|5
367353|NCT00361335|1179189|P7|IV Period: Baseline to E0|Not specified|0
367354|NCT00361335|1179190|P6|IV Period: Baseline to E0|Not specified|0
367355|NCT00361335|1179191|P5|IV Period: Baseline to E0|Not specified|2
367356|NCT00361335|1179192|P4|IV Period: Baseline to E0|Not specified|3
367357|NCT00361335|1179193|P3|IV Period: Baseline to E0|Not specified|9
367358|NCT00361335|1179194|P2|IV Period: Baseline to E0|Not specified|9
367359|NCT00361335|1179195|P1|IV Period: Baseline to E0|Not specified|2
367360|NCT00361335|1179189|P7|IV Period: Baseline to E0|Worsening of RA|0
367361|NCT00361335|1179190|P6|IV Period: Baseline to E0|Worsening of RA|0
367362|NCT00361335|1179191|P5|IV Period: Baseline to E0|Worsening of RA|2
367363|NCT00361335|1179192|P4|IV Period: Baseline to E0|Worsening of RA|4
367364|NCT00361335|1179193|P3|IV Period: Baseline to E0|Worsening of RA|1
367365|NCT00361335|1179194|P2|IV Period: Baseline to E0|Worsening of RA|5
367366|NCT00361335|1179195|P1|IV Period: Baseline to E0|Worsening of RA|0
367367|NCT00361335|1179189|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
367368|NCT00361335|1179190|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
367369|NCT00361335|1179191|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
367370|NCT00361335|1179192|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
367371|NCT00361335|1179193|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
367372|NCT00361335|1179194|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
367373|NCT00361335|1179195|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
367374|NCT00361335|1179189|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
367375|NCT00361335|1179190|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
367376|NCT00361335|1179191|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
367377|NCT00361335|1179192|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
367378|NCT00361335|1179193|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
367379|NCT00361335|1179194|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
367380|NCT00361335|1179195|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
367381|NCT00361335|1179189|P7|IV Period: Baseline to E0|Death|0
367382|NCT00361335|1179190|P6|IV Period: Baseline to E0|Death|0
367383|NCT00361335|1179191|P5|IV Period: Baseline to E0|Death|0
367384|NCT00361335|1179192|P4|IV Period: Baseline to E0|Death|1
367385|NCT00361335|1179193|P3|IV Period: Baseline to E0|Death|1
367386|NCT00361335|1179194|P2|IV Period: Baseline to E0|Death|1
367388|NCT00361335|1179189|P7|IV Period: Baseline to E0|Lost to Follow-up|0
367389|NCT00361335|1179190|P6|IV Period: Baseline to E0|Lost to Follow-up|0
367390|NCT00361335|1179191|P5|IV Period: Baseline to E0|Lost to Follow-up|2
367391|NCT00361335|1179192|P4|IV Period: Baseline to E0|Lost to Follow-up|2
367392|NCT00361335|1179193|P3|IV Period: Baseline to E0|Lost to Follow-up|0
367393|NCT00361335|1179194|P2|IV Period: Baseline to E0|Lost to Follow-up|0
367394|NCT00361335|1179195|P1|IV Period: Baseline to E0|Lost to Follow-up|1
367395|NCT00361335|1179189|P7|IV Period: Baseline to E0|Adverse Event|0
367396|NCT00361335|1179190|P6|IV Period: Baseline to E0|Adverse Event|0
367397|NCT00361335|1179191|P5|IV Period: Baseline to E0|Adverse Event|8
367398|NCT00361335|1179192|P4|IV Period: Baseline to E0|Adverse Event|9
367399|NCT00361335|1179193|P3|IV Period: Baseline to E0|Adverse Event|5
367400|NCT00361335|1179194|P2|IV Period: Baseline to E0|Adverse Event|4
367401|NCT00361335|1179195|P1|IV Period: Baseline to E0|Adverse Event|9
367402|NCT00361283|1179239|P1|Overall Study|Lost to Follow-up|27
367403|NCT00361270|1179247|P4|Overall Study|Adverse Event|0
367404|NCT00361270|1179248|P3|Overall Study|Adverse Event|1
367405|NCT00361270|1179249|P2|Overall Study|Adverse Event|1
367406|NCT00361270|1179250|P1|Overall Study|Adverse Event|0
367407|NCT00361270|1179247|P4|Overall Study|Problems with Transportation|0
367408|NCT00361270|1179248|P3|Overall Study|Problems with Transportation|0
367409|NCT00361270|1179249|P2|Overall Study|Problems with Transportation|0
367410|NCT00361270|1179250|P1|Overall Study|Problems with Transportation|4
367411|NCT00361270|1179247|P4|Overall Study|Afraid of Hypnosis|0
367412|NCT00361270|1179248|P3|Overall Study|Afraid of Hypnosis|0
367413|NCT00361270|1179249|P2|Overall Study|Afraid of Hypnosis|2
367414|NCT00361270|1179250|P1|Overall Study|Afraid of Hypnosis|1
367415|NCT00361270|1179247|P4|Overall Study|Withdrawal by Subject|7
367416|NCT00361270|1179248|P3|Overall Study|Withdrawal by Subject|3
367417|NCT00361270|1179249|P2|Overall Study|Withdrawal by Subject|6
367418|NCT00361270|1179250|P1|Overall Study|Withdrawal by Subject|6
367419|NCT00361270|1179247|P4|Overall Study|Protocol Violation|4
367420|NCT00361270|1179248|P3|Overall Study|Protocol Violation|5
367421|NCT00361270|1179249|P2|Overall Study|Protocol Violation|4
367422|NCT00361270|1179250|P1|Overall Study|Protocol Violation|9
367423|NCT00361270|1179247|P4|Overall Study|Physician Decision|0
367424|NCT00361270|1179248|P3|Overall Study|Physician Decision|1
367425|NCT00361270|1179249|P2|Overall Study|Physician Decision|0
367426|NCT00361270|1179250|P1|Overall Study|Physician Decision|0
367427|NCT00361270|1179247|P4|Overall Study|Lost to Follow-up|0
367428|NCT00361270|1179248|P3|Overall Study|Lost to Follow-up|0
367429|NCT00361270|1179249|P2|Overall Study|Lost to Follow-up|1
367430|NCT00361270|1179250|P1|Overall Study|Lost to Follow-up|4
367431|NCT00361270|1179247|P4|Overall Study|Death|2
367432|NCT00361270|1179248|P3|Overall Study|Death|0
367433|NCT00361270|1179249|P2|Overall Study|Death|0
367434|NCT00361270|1179250|P1|Overall Study|Death|0
367435|NCT00361231|1179323|P1|Overall Study|Adverse Event|6
367436|NCT00361231|1179323|P1|Overall Study|Withdrawal by Subject|4
367437|NCT00361231|1179323|P1|Overall Study|Radiographic disease progression|16
367438|NCT00361231|1179323|P1|Overall Study|Symptomatic deterioration|5
367439|NCT00361231|1179323|P1|Overall Study|Physician Decision|3
367440|NCT00361218|1179328|P1|Overall Study|terminated / withdrawn due to toxicity /|5
367441|NCT00361218|1179328|P1|Overall Study|Personal Reasons|7
367442|NCT00361218|1179328|P1|Overall Study|Lost to Follow-up|11
367443|NCT00360698|1179392|P2|Treatment Period|Early termination by error|1
367444|NCT00360698|1179393|P1|Treatment Period|Early termination by error|0
367445|NCT00360698|1179392|P2|Treatment Period|Non compliance with treatment procedure|0
367446|NCT00360698|1179393|P1|Treatment Period|Non compliance with treatment procedure|1
367447|NCT00360698|1179392|P2|Run-In|Need of insulin with meals|1
367448|NCT00360698|1179393|P1|Run-In|Need of insulin with meals|0
367449|NCT00360698|1179392|P2|Run-In|Patient personal reasons|2
367450|NCT00360698|1179393|P1|Run-In|Patient personal reasons|0
367451|NCT00360698|1179392|P2|Run-In|Patient did not meet inclusion criteria|1
367452|NCT00360698|1179393|P1|Run-In|Patient did not meet inclusion criteria|0
367453|NCT00360698|1179392|P2|Run-In|Sponsor request|2
367454|NCT00360698|1179393|P1|Run-In|Sponsor request|0
367455|NCT00360698|1179392|P2|Run-In|Non compliance with treatment procedure|1
367456|NCT00360698|1179393|P1|Run-In|Non compliance with treatment procedure|0
367457|NCT00360698|1179392|P2|Run-In|Withdrawal by Subject|2
367458|NCT00360698|1179393|P1|Run-In|Withdrawal by Subject|0
367459|NCT00360698|1179392|P2|Run-In|Physician Decision|1
367460|NCT00360698|1179393|P1|Run-In|Physician Decision|0
367461|NCT00360568|1179438|P2|Overall Study|Withdrawal by Subject|3
367462|NCT00360568|1179439|P1|Overall Study|Withdrawal by Subject|0
367463|NCT00360568|1179438|P2|Overall Study|Lack of Efficacy|0
367464|NCT00360568|1179439|P1|Overall Study|Lack of Efficacy|1
367465|NCT00360568|1179438|P2|Overall Study|Adverse Event|2
367466|NCT00360568|1179439|P1|Overall Study|Adverse Event|1
367467|NCT00360529|1179570|P3|Overall Study|Reason discontinued not explained above|11
367468|NCT00360529|1179571|P2|Overall Study|Reason discontinued not explained above|9
367469|NCT00360529|1179572|P1|Overall Study|Reason discontinued not explained above|4
367470|NCT00360529|1179570|P3|Overall Study|Lack of Efficacy|5
367471|NCT00360529|1179571|P2|Overall Study|Lack of Efficacy|6
367472|NCT00360529|1179572|P1|Overall Study|Lack of Efficacy|8
367473|NCT00360529|1179570|P3|Overall Study|Withdrawal by Subject|18
367474|NCT00360529|1179571|P2|Overall Study|Withdrawal by Subject|14
367475|NCT00360529|1179572|P1|Overall Study|Withdrawal by Subject|22
367476|NCT00360529|1179570|P3|Overall Study|Lost to Follow-up|13
367477|NCT00360529|1179571|P2|Overall Study|Lost to Follow-up|10
367478|NCT00360529|1179572|P1|Overall Study|Lost to Follow-up|14
367479|NCT00360529|1179570|P3|Overall Study|Protocol Violation|11
367480|NCT00360529|1179571|P2|Overall Study|Protocol Violation|3
367481|NCT00360529|1179572|P1|Overall Study|Protocol Violation|3
367482|NCT00360529|1179570|P3|Overall Study|Adverse Event|33
367483|NCT00360529|1179571|P2|Overall Study|Adverse Event|23
367484|NCT00360529|1179572|P1|Overall Study|Adverse Event|10
367485|NCT00360490|1179600|P2|Overall Study|Withdrawal by Subject|3
367486|NCT00360490|1179601|P1|Overall Study|Withdrawal by Subject|1
367487|NCT00360490|1179600|P2|Overall Study|Protocol Violation|4
367488|NCT00360490|1179601|P1|Overall Study|Protocol Violation|0
367489|NCT00360490|1179600|P2|Overall Study|Physician Decision|1
367490|NCT00360490|1179601|P1|Overall Study|Physician Decision|2
367491|NCT00360490|1179600|P2|Overall Study|Lost to Follow-up|1
367492|NCT00360490|1179601|P1|Overall Study|Lost to Follow-up|2
367493|NCT00360490|1179600|P2|Overall Study|Adverse Event|2
367494|NCT00360490|1179601|P1|Overall Study|Adverse Event|4
367495|NCT00360412|1179636|P2|Overall Study|Study termination by Sponsor|469
367496|NCT00360412|1179637|P1|Overall Study|Study termination by Sponsor|214
367497|NCT00360412|1179636|P2|Overall Study|Not specified|6
367498|NCT00360412|1179637|P1|Overall Study|Not specified|5
367499|NCT00360412|1179636|P2|Overall Study|Physician Decision|4
367500|NCT00360412|1179637|P1|Overall Study|Physician Decision|2
367501|NCT00360412|1179636|P2|Overall Study|Lack of therapeutic efficacy|61
367502|NCT00360412|1179637|P1|Overall Study|Lack of therapeutic efficacy|46
367503|NCT00360412|1179636|P2|Overall Study|Patient withdrew consent|52
367504|NCT00360412|1179637|P1|Overall Study|Patient withdrew consent|27
367505|NCT00360412|1179636|P2|Overall Study|Protocol Violation|5
367506|NCT00360412|1179637|P1|Overall Study|Protocol Violation|2
367507|NCT00360412|1179636|P2|Overall Study|Adverse Event|65
367508|NCT00360412|1179637|P1|Overall Study|Adverse Event|37
367509|NCT00360334|1179684|P2|Overall Study|Subject decision|2
367510|NCT00360334|1179685|P1|Overall Study|Subject decision|8
367511|NCT00360334|1179684|P2|Overall Study|Entry criterion not met|2
367512|NCT00360334|1179685|P1|Overall Study|Entry criterion not met|1
367513|NCT00360334|1179684|P2|Overall Study|Lack of Efficacy|1
367514|NCT00360334|1179685|P1|Overall Study|Lack of Efficacy|0
367515|NCT00360334|1179684|P2|Overall Study|Physician Decision|3
367516|NCT00360334|1179685|P1|Overall Study|Physician Decision|2
367517|NCT00360334|1179684|P2|Overall Study|Protocol Violation|1
367518|NCT00360334|1179685|P1|Overall Study|Protocol Violation|1
367519|NCT00360334|1179684|P2|Overall Study|Adverse Event|4
367520|NCT00360334|1179685|P1|Overall Study|Adverse Event|7
367521|NCT00360308|1179748|P3|Overall Study|Study termination by sponsor|44
367522|NCT00360308|1179749|P2|Overall Study|Study termination by sponsor|55
367523|NCT00360308|1179750|P1|Overall Study|Study termination by sponsor|43
367524|NCT00360308|1179748|P3|Overall Study|Not Specified|1
367525|NCT00360308|1179749|P2|Overall Study|Not Specified|1
367526|NCT00360308|1179750|P1|Overall Study|Not Specified|2
367527|NCT00360308|1179748|P3|Overall Study|Lack of Efficacy|2
367528|NCT00360308|1179749|P2|Overall Study|Lack of Efficacy|0
367529|NCT00360308|1179750|P1|Overall Study|Lack of Efficacy|3
367530|NCT00360308|1179748|P3|Overall Study|Withdrawal by Subject|14
367531|NCT00360308|1179749|P2|Overall Study|Withdrawal by Subject|7
367532|NCT00360308|1179750|P1|Overall Study|Withdrawal by Subject|11
367533|NCT00360308|1179748|P3|Overall Study|Protocol Violation|2
367534|NCT00360308|1179749|P2|Overall Study|Protocol Violation|1
367535|NCT00360308|1179750|P1|Overall Study|Protocol Violation|2
367536|NCT00360308|1179748|P3|Overall Study|Abnormal Laboratory Value(s)|0
367537|NCT00360308|1179749|P2|Overall Study|Abnormal Laboratory Value(s)|1
367538|NCT00360308|1179750|P1|Overall Study|Abnormal Laboratory Value(s)|0
367539|NCT00360308|1179748|P3|Overall Study|Adverse Event|25
367540|NCT00360308|1179749|P2|Overall Study|Adverse Event|14
367541|NCT00360308|1179750|P1|Overall Study|Adverse Event|15
367542|NCT00360282|1179767|P4|Second Intervention|Adverse Event|0
367543|NCT00360282|1179768|P3|Second Intervention|Adverse Event|0
367544|NCT00360282|1179769|P2|Second Intervention|Adverse Event|1
367545|NCT00360282|1179770|P1|Second Intervention|Adverse Event|0
367546|NCT00360282|1179767|P4|Washout 1-3 Weeks|Lost to Follow-up|0
367547|NCT00360282|1179768|P3|Washout 1-3 Weeks|Lost to Follow-up|1
367548|NCT00360282|1179769|P2|Washout 1-3 Weeks|Lost to Follow-up|0
367549|NCT00360282|1179770|P1|Washout 1-3 Weeks|Lost to Follow-up|0
367550|NCT00360269|1179782|P2|Overall Study|Withdrawal by Subject|1
367551|NCT00360269|1179783|P1|Overall Study|Withdrawal by Subject|1
367552|NCT00360269|1179782|P2|Overall Study|Adverse Event|0
367553|NCT00360269|1179783|P1|Overall Study|Adverse Event|1
367554|NCT00360269|1179782|P2|Overall Study|Physician Decision|2
367555|NCT00360269|1179783|P1|Overall Study|Physician Decision|1
367556|NCT00360269|1179782|P2|Overall Study|Lost to Follow-up|9
367557|NCT00360269|1179783|P1|Overall Study|Lost to Follow-up|7
367558|NCT00359801|1179923|P2|Overall Study|Sponsor Decision|16
367559|NCT00359801|1179924|P1|Overall Study|Sponsor Decision|17
367560|NCT00359801|1179923|P2|Overall Study|Final Status Unknown: missing data|4
367561|NCT00359801|1179924|P1|Overall Study|Final Status Unknown: missing data|7
367562|NCT00359801|1179923|P2|Overall Study|Unspecified|46
367563|NCT00359801|1179924|P1|Overall Study|Unspecified|66
367564|NCT00359801|1179923|P2|Overall Study|Withdrawal by Subject|96
367565|NCT00359801|1179924|P1|Overall Study|Withdrawal by Subject|143
367566|NCT00359801|1179923|P2|Overall Study|Lost to Follow-up|58
367567|NCT00359801|1179924|P1|Overall Study|Lost to Follow-up|72
367568|NCT00359788|1179958|P2|Overall Study|Protocol Violation|2
367569|NCT00359788|1179959|P1|Overall Study|Protocol Violation|4
367570|NCT00359788|1179958|P2|Overall Study|Withdrawal by Subject|1
367571|NCT00359788|1179959|P1|Overall Study|Withdrawal by Subject|4
367572|NCT00359788|1179958|P2|Overall Study|Lost to Follow-up|2
367573|NCT00359788|1179959|P1|Overall Study|Lost to Follow-up|3
367574|NCT00359788|1179958|P2|Overall Study|Lack of Efficacy|2
367575|NCT00359788|1179959|P1|Overall Study|Lack of Efficacy|1
367576|NCT00359788|1179958|P2|Overall Study|Adverse Event|10
367577|NCT00359788|1179959|P1|Overall Study|Adverse Event|11
367578|NCT00359762|1180193|P5|Period III|Subject Decision|0
367579|NCT00359762|1180194|P4|Period III|Subject Decision|20
367580|NCT00359762|1180195|P3|Period III|Subject Decision|8
367581|NCT00359762|1180196|P2|Period III|Subject Decision|7
367582|NCT00359762|1180197|P1|Period III|Subject Decision|0
367583|NCT00359762|1180193|P5|Period III|Entry Criteria Not Met|0
367584|NCT00359762|1180194|P4|Period III|Entry Criteria Not Met|1
367585|NCT00359762|1180195|P3|Period III|Entry Criteria Not Met|0
367586|NCT00359762|1180196|P2|Period III|Entry Criteria Not Met|1
367587|NCT00359762|1180197|P1|Period III|Entry Criteria Not Met|0
367588|NCT00359762|1180193|P5|Period III|Lost to follow up|0
367589|NCT00359762|1180194|P4|Period III|Lost to follow up|2
367590|NCT00359762|1180195|P3|Period III|Lost to follow up|1
367591|NCT00359762|1180196|P2|Period III|Lost to follow up|1
367592|NCT00359762|1180197|P1|Period III|Lost to follow up|0
367593|NCT00359762|1180193|P5|Period III|Lack of Efficacy|0
367594|NCT00359762|1180194|P4|Period III|Lack of Efficacy|9
367595|NCT00359762|1180195|P3|Period III|Lack of Efficacy|5
367596|NCT00359762|1180196|P2|Period III|Lack of Efficacy|7
367597|NCT00359762|1180197|P1|Period III|Lack of Efficacy|0
367598|NCT00359762|1180193|P5|Period III|Physician Decision|0
367599|NCT00359762|1180194|P4|Period III|Physician Decision|15
367600|NCT00359762|1180195|P3|Period III|Physician Decision|9
367601|NCT00359762|1180196|P2|Period III|Physician Decision|5
367602|NCT00359762|1180197|P1|Period III|Physician Decision|0
367603|NCT00359762|1180193|P5|Period III|Adverse Event|0
367604|NCT00359762|1180194|P4|Period III|Adverse Event|10
367605|NCT00359762|1180195|P3|Period III|Adverse Event|4
367606|NCT00359762|1180196|P2|Period III|Adverse Event|3
367607|NCT00359762|1180197|P1|Period III|Adverse Event|0
367608|NCT00359762|1180193|P5|Period III|Protocol Violation|0
367609|NCT00359762|1180194|P4|Period III|Protocol Violation|8
367610|NCT00359762|1180195|P3|Period III|Protocol Violation|3
367611|NCT00359762|1180196|P2|Period III|Protocol Violation|5
367612|NCT00359762|1180197|P1|Period III|Protocol Violation|0
367613|NCT00359762|1180193|P5|Period II|Subject Decision|70
367614|NCT00359762|1180194|P4|Period II|Subject Decision|0
367615|NCT00359762|1180195|P3|Period II|Subject Decision|0
367616|NCT00359762|1180196|P2|Period II|Subject Decision|0
367617|NCT00359762|1180197|P1|Period II|Subject Decision|50
367618|NCT00359762|1180193|P5|Period II|Entry Criteria Not Met|4
367619|NCT00359762|1180194|P4|Period II|Entry Criteria Not Met|0
367620|NCT00359762|1180195|P3|Period II|Entry Criteria Not Met|0
367621|NCT00359762|1180196|P2|Period II|Entry Criteria Not Met|0
367622|NCT00359762|1180197|P1|Period II|Entry Criteria Not Met|8
367623|NCT00359762|1180193|P5|Period II|Lost to follow up|5
367624|NCT00359762|1180194|P4|Period II|Lost to follow up|0
367625|NCT00359762|1180195|P3|Period II|Lost to follow up|0
367626|NCT00359762|1180196|P2|Period II|Lost to follow up|0
367627|NCT00359762|1180197|P1|Period II|Lost to follow up|5
367628|NCT00359762|1180193|P5|Period II|Lack of Efficacy|8
367629|NCT00359762|1180194|P4|Period II|Lack of Efficacy|0
367630|NCT00359762|1180195|P3|Period II|Lack of Efficacy|0
367631|NCT00359762|1180196|P2|Period II|Lack of Efficacy|0
367632|NCT00359762|1180197|P1|Period II|Lack of Efficacy|11
367633|NCT00359762|1180193|P5|Period II|Death|4
367634|NCT00359762|1180194|P4|Period II|Death|0
367635|NCT00359762|1180195|P3|Period II|Death|0
367636|NCT00359762|1180196|P2|Period II|Death|0
367637|NCT00359762|1180197|P1|Period II|Death|2
367638|NCT00359762|1180193|P5|Period II|Physician Decision|23
367639|NCT00359762|1180194|P4|Period II|Physician Decision|0
367640|NCT00359762|1180195|P3|Period II|Physician Decision|0
367641|NCT00359762|1180196|P2|Period II|Physician Decision|0
367642|NCT00359762|1180197|P1|Period II|Physician Decision|17
367643|NCT00359762|1180193|P5|Period II|Protocol Violation|11
367644|NCT00359762|1180194|P4|Period II|Protocol Violation|0
367645|NCT00359762|1180195|P3|Period II|Protocol Violation|0
367646|NCT00359762|1180196|P2|Period II|Protocol Violation|0
367647|NCT00359762|1180197|P1|Period II|Protocol Violation|18
367648|NCT00359762|1180193|P5|Period II|Adverse Event|49
367649|NCT00359762|1180194|P4|Period II|Adverse Event|0
367650|NCT00359762|1180195|P3|Period II|Adverse Event|0
367651|NCT00359762|1180196|P2|Period II|Adverse Event|0
367652|NCT00359762|1180197|P1|Period II|Adverse Event|17
367653|NCT00359632|1180271|P2|Overall Study|Non-compliance with visit schedule|0
367654|NCT00359632|1180272|P1|Overall Study|Non-compliance with visit schedule|1
367655|NCT00359632|1180271|P2|Overall Study|Adverse Event|0
367656|NCT00359632|1180272|P1|Overall Study|Adverse Event|1
367657|NCT00359632|1180271|P2|Overall Study|Death|0
367658|NCT00359632|1180272|P1|Overall Study|Death|2
367659|NCT00359619|1180286|P7|Overall Study|Lost to Follow-up|0
367660|NCT00359619|1180287|P6|Overall Study|Lost to Follow-up|5
367661|NCT00359619|1180288|P5|Overall Study|Lost to Follow-up|1
367662|NCT00359619|1180289|P4|Overall Study|Lost to Follow-up|1
367663|NCT00359619|1180290|P3|Overall Study|Lost to Follow-up|2
367664|NCT00359619|1180291|P2|Overall Study|Lost to Follow-up|4
367665|NCT00359619|1180292|P1|Overall Study|Lost to Follow-up|4
367666|NCT00359619|1180286|P7|Overall Study|Unspecified|0
367667|NCT00359619|1180287|P6|Overall Study|Unspecified|0
367668|NCT00359619|1180288|P5|Overall Study|Unspecified|0
367669|NCT00359619|1180289|P4|Overall Study|Unspecified|0
367670|NCT00359619|1180290|P3|Overall Study|Unspecified|0
367671|NCT00359619|1180291|P2|Overall Study|Unspecified|0
367672|NCT00359619|1180292|P1|Overall Study|Unspecified|1
367673|NCT00359619|1180286|P7|Overall Study|Withdrawal by Subject|3
367674|NCT00359619|1180287|P6|Overall Study|Withdrawal by Subject|0
367675|NCT00359619|1180288|P5|Overall Study|Withdrawal by Subject|2
367676|NCT00359619|1180289|P4|Overall Study|Withdrawal by Subject|2
367677|NCT00359619|1180290|P3|Overall Study|Withdrawal by Subject|4
367678|NCT00359619|1180291|P2|Overall Study|Withdrawal by Subject|1
367679|NCT00359619|1180292|P1|Overall Study|Withdrawal by Subject|3
367680|NCT00359619|1180286|P7|Overall Study|Adverse Event|1
367681|NCT00359619|1180287|P6|Overall Study|Adverse Event|0
367682|NCT00359619|1180288|P5|Overall Study|Adverse Event|0
367683|NCT00359619|1180289|P4|Overall Study|Adverse Event|0
367684|NCT00359619|1180290|P3|Overall Study|Adverse Event|1
367685|NCT00359619|1180291|P2|Overall Study|Adverse Event|0
367686|NCT00359619|1180292|P1|Overall Study|Adverse Event|0
367687|NCT00359424|1180422|P2|Overall Study|follow up not conducted|0
367688|NCT00359424|1180423|P1|Overall Study|follow up not conducted|2
367689|NCT00359424|1180422|P2|Overall Study|Withdrawal by Subject|2
367690|NCT00359424|1180423|P1|Overall Study|Withdrawal by Subject|10
367691|NCT00359424|1180422|P2|Overall Study|Lost to Follow-up|7
367692|NCT00359424|1180423|P1|Overall Study|Lost to Follow-up|19
367693|NCT00359424|1180422|P2|Overall Study|Death|58
367694|NCT00359424|1180423|P1|Overall Study|Death|99
367695|NCT00359281|1180462|P9|Overall Study|Withdrawal by Subject|0
367696|NCT00359281|1180463|P8|Overall Study|Withdrawal by Subject|0
367697|NCT00359281|1180464|P7|Overall Study|Withdrawal by Subject|1
367698|NCT00359281|1180465|P6|Overall Study|Withdrawal by Subject|0
367699|NCT00359281|1180466|P5|Overall Study|Withdrawal by Subject|0
367700|NCT00359281|1180467|P4|Overall Study|Withdrawal by Subject|0
367701|NCT00359281|1180468|P3|Overall Study|Withdrawal by Subject|0
367702|NCT00359281|1180469|P2|Overall Study|Withdrawal by Subject|0
367703|NCT00359281|1180470|P1|Overall Study|Withdrawal by Subject|0
367704|NCT00359281|1180462|P9|Overall Study|Adverse Event|0
367705|NCT00359281|1180463|P8|Overall Study|Adverse Event|0
367706|NCT00359281|1180464|P7|Overall Study|Adverse Event|1
367707|NCT00359281|1180465|P6|Overall Study|Adverse Event|0
367708|NCT00359281|1180466|P5|Overall Study|Adverse Event|0
367709|NCT00359281|1180467|P4|Overall Study|Adverse Event|0
367710|NCT00359281|1180468|P3|Overall Study|Adverse Event|0
367711|NCT00359281|1180469|P2|Overall Study|Adverse Event|0
367712|NCT00359281|1180470|P1|Overall Study|Adverse Event|1
367713|NCT00359021|1180533|P2|Overall Study|Pregnancy|0
367714|NCT00359021|1180534|P1|Overall Study|Pregnancy|1
367715|NCT00359021|1180533|P2|Overall Study|Not specified|1
367716|NCT00359021|1180534|P1|Overall Study|Not specified|4
367717|NCT00359021|1180533|P2|Overall Study|Lost to Follow-up|0
367718|NCT00359021|1180534|P1|Overall Study|Lost to Follow-up|1
367719|NCT00359021|1180533|P2|Overall Study|Withdrawal by Subject|9
367720|NCT00359021|1180534|P1|Overall Study|Withdrawal by Subject|2
367721|NCT00359021|1180533|P2|Overall Study|Subject Reached A Virologic Endpoint|32
367722|NCT00359021|1180534|P1|Overall Study|Subject Reached A Virologic Endpoint|45
367723|NCT00359021|1180533|P2|Overall Study|Subject Ineligible To Continue The Trial|0
367724|NCT00359021|1180534|P1|Overall Study|Subject Ineligible To Continue The Trial|1
367725|NCT00359021|1180533|P2|Overall Study|Subject Non-Compliant|2
367726|NCT00359021|1180534|P1|Overall Study|Subject Non-Compliant|1
367727|NCT00359021|1180533|P2|Overall Study|Adverse Event|8
367728|NCT00359021|1180534|P1|Overall Study|Adverse Event|26
367729|NCT00358956|1180546|P1|Overall Study|Withdrawal by Subject|1
367730|NCT00358956|1180546|P1|Overall Study|condition under investigation worsened|4
367731|NCT00358956|1180546|P1|Overall Study|Adverse Event|3
367732|NCT00358917|1180558|P2|Overall Study|Unable to Continue Participation|2
367733|NCT00358917|1180559|P1|Overall Study|Unable to Continue Participation|2
367734|NCT00358917|1180558|P2|Overall Study|Virologic failure|8
367735|NCT00358917|1180559|P1|Overall Study|Virologic failure|11
367736|NCT00358917|1180558|P2|Overall Study|Death|3
367737|NCT00358917|1180559|P1|Overall Study|Death|2
367738|NCT00358917|1180558|P2|Overall Study|Noncompliance|11
367739|NCT00358917|1180559|P1|Overall Study|Noncompliance|12
367740|NCT00358917|1180558|P2|Overall Study|Lost to Follow-up|17
367741|NCT00358917|1180559|P1|Overall Study|Lost to Follow-up|20
367742|NCT00358917|1180558|P2|Overall Study|Withdrawal by Subject|7
367743|NCT00358917|1180559|P1|Overall Study|Withdrawal by Subject|5
367744|NCT00358917|1180558|P2|Overall Study|Adverse Event|21
367745|NCT00358917|1180559|P1|Overall Study|Adverse Event|14
367746|NCT00358150|1180573|P1|Overall Study|Undefined|3
367747|NCT00358150|1180573|P1|Overall Study|Withdrawal by Subject|1
367748|NCT00358150|1180573|P1|Overall Study|Adverse Event|3
367749|NCT00358826|1180599|P8|MDCT Substudy|Withdrawal by Subject|0
367750|NCT00358826|1180600|P7|MDCT Substudy|Withdrawal by Subject|0
367751|NCT00358826|1180601|P6|MDCT Substudy|Withdrawal by Subject|1
367752|NCT00358826|1180602|P5|MDCT Substudy|Withdrawal by Subject|0
367753|NCT00358826|1180603|P4|MDCT Substudy|Withdrawal by Subject|0
367754|NCT00358826|1180604|P3|MDCT Substudy|Withdrawal by Subject|0
367755|NCT00358826|1180605|P2|MDCT Substudy|Withdrawal by Subject|0
367756|NCT00358826|1180606|P1|MDCT Substudy|Withdrawal by Subject|0
367757|NCT00358826|1180599|P8|MDCT Substudy|Lost to Follow-up|0
367758|NCT00358826|1180600|P7|MDCT Substudy|Lost to Follow-up|0
367759|NCT00358826|1180601|P6|MDCT Substudy|Lost to Follow-up|1
367760|NCT00358826|1180602|P5|MDCT Substudy|Lost to Follow-up|0
367761|NCT00358826|1180603|P4|MDCT Substudy|Lost to Follow-up|0
367762|NCT00358826|1180604|P3|MDCT Substudy|Lost to Follow-up|0
367763|NCT00358826|1180605|P2|MDCT Substudy|Lost to Follow-up|0
367764|NCT00358826|1180606|P1|MDCT Substudy|Lost to Follow-up|0
367765|NCT00358826|1180599|P8|MDCT Substudy|Adverse Event|0
367766|NCT00358826|1180600|P7|MDCT Substudy|Adverse Event|0
367767|NCT00358826|1180601|P6|MDCT Substudy|Adverse Event|0
367768|NCT00358826|1180602|P5|MDCT Substudy|Adverse Event|1
367769|NCT00358826|1180603|P4|MDCT Substudy|Adverse Event|0
367770|NCT00358826|1180604|P3|MDCT Substudy|Adverse Event|0
367771|NCT00358826|1180605|P2|MDCT Substudy|Adverse Event|0
367772|NCT00358826|1180606|P1|MDCT Substudy|Adverse Event|0
367773|NCT00358826|1180599|P8|Core Study|Physician Decision|0
367774|NCT00358826|1180600|P7|Core Study|Physician Decision|0
367775|NCT00358826|1180601|P6|Core Study|Physician Decision|0
367776|NCT00358826|1180602|P5|Core Study|Physician Decision|0
367777|NCT00358826|1180603|P4|Core Study|Physician Decision|0
367778|NCT00358826|1180604|P3|Core Study|Physician Decision|1
367779|NCT00358826|1180605|P2|Core Study|Physician Decision|0
367780|NCT00358826|1180606|P1|Core Study|Physician Decision|0
367781|NCT00358826|1180599|P8|Core Study|Lost to Follow-up|0
367782|NCT00358826|1180600|P7|Core Study|Lost to Follow-up|0
367783|NCT00358826|1180601|P6|Core Study|Lost to Follow-up|0
367784|NCT00358826|1180602|P5|Core Study|Lost to Follow-up|0
367785|NCT00358826|1180603|P4|Core Study|Lost to Follow-up|1
367786|NCT00358826|1180604|P3|Core Study|Lost to Follow-up|0
367787|NCT00358826|1180605|P2|Core Study|Lost to Follow-up|0
367788|NCT00358826|1180606|P1|Core Study|Lost to Follow-up|0
367789|NCT00358826|1180599|P8|Core Study|Withdrawal by Subject|0
367790|NCT00358826|1180600|P7|Core Study|Withdrawal by Subject|0
367791|NCT00358826|1180601|P6|Core Study|Withdrawal by Subject|0
367792|NCT00358826|1180602|P5|Core Study|Withdrawal by Subject|0
367793|NCT00358826|1180603|P4|Core Study|Withdrawal by Subject|0
367794|NCT00358826|1180604|P3|Core Study|Withdrawal by Subject|0
367795|NCT00358826|1180605|P2|Core Study|Withdrawal by Subject|2
367796|NCT00358826|1180606|P1|Core Study|Withdrawal by Subject|2
367797|NCT00358826|1180599|P8|Core Study|Adverse Event|0
367798|NCT00358826|1180600|P7|Core Study|Adverse Event|0
367799|NCT00358826|1180601|P6|Core Study|Adverse Event|0
367800|NCT00358826|1180602|P5|Core Study|Adverse Event|0
367801|NCT00358826|1180603|P4|Core Study|Adverse Event|1
367802|NCT00358826|1180604|P3|Core Study|Adverse Event|1
367803|NCT00358826|1180605|P2|Core Study|Adverse Event|3
367804|NCT00358826|1180606|P1|Core Study|Adverse Event|1
367805|NCT00358670|1180673|P2|Overall Study|Administrative|125
367806|NCT00358670|1180674|P1|Overall Study|Administrative|153
367807|NCT00358670|1180673|P2|Overall Study|Did Not Meet Protocol Eligibility|3
367808|NCT00358670|1180674|P1|Overall Study|Did Not Meet Protocol Eligibility|0
367809|NCT00358670|1180673|P2|Overall Study|Protocol Defined Clinical Event|1
367810|NCT00358670|1180674|P1|Overall Study|Protocol Defined Clinical Event|0
367811|NCT00358670|1180673|P2|Overall Study|Withdrawal by Subject|24
367812|NCT00358670|1180674|P1|Overall Study|Withdrawal by Subject|13
367813|NCT00358670|1180673|P2|Overall Study|Lost to Follow-up|5
367814|NCT00358670|1180674|P1|Overall Study|Lost to Follow-up|4
367815|NCT00358670|1180673|P2|Overall Study|Protocol Violation|9
367816|NCT00358670|1180674|P1|Overall Study|Protocol Violation|6
367817|NCT00358670|1180673|P2|Overall Study|Lack of Efficacy|23
367818|NCT00358670|1180674|P1|Overall Study|Lack of Efficacy|20
367819|NCT00358670|1180673|P2|Overall Study|Adverse Event|29
367820|NCT00358670|1180674|P1|Overall Study|Adverse Event|26
367821|NCT00358644|1180688|P1|Overall Study|Patient not eligible for study|1
367822|NCT00358644|1180688|P1|Overall Study|Physician Decision|6
367823|NCT00358644|1180688|P1|Overall Study|Withdrawal by Subject|4
367824|NCT00358644|1180688|P1|Overall Study|Death|11
367825|NCT00358644|1180688|P1|Overall Study|Adverse Event|7
367826|NCT00358644|1180688|P1|Overall Study|Progressive Disease|21
367827|NCT00358527|1180711|P2|Overall Study|Administrative|1
367828|NCT00358527|1180712|P1|Overall Study|Administrative|2
367829|NCT00358527|1180711|P2|Overall Study|Non-compliance with protocol|1
367830|NCT00358527|1180712|P1|Overall Study|Non-compliance with protocol|6
367831|NCT00358527|1180711|P2|Overall Study|Withdrawal by Subject|1
367832|NCT00358527|1180712|P1|Overall Study|Withdrawal by Subject|1
367833|NCT00358527|1180711|P2|Overall Study|Adverse Event|0
367834|NCT00358527|1180712|P1|Overall Study|Adverse Event|4
367835|NCT00358449|1180750|P3|Overall Study|Steriod Inhaler was Increased|1
367836|NCT00358449|1180751|P2|Overall Study|Steriod Inhaler was Increased|0
367837|NCT00358449|1180752|P1|Overall Study|Steriod Inhaler was Increased|0
367838|NCT00358449|1180750|P3|Overall Study|Lack of Efficacy|0
367839|NCT00358449|1180751|P2|Overall Study|Lack of Efficacy|1
367840|NCT00358449|1180752|P1|Overall Study|Lack of Efficacy|0
367841|NCT00358449|1180750|P3|Overall Study|Withdrawal by Subject|0
367842|NCT00358449|1180751|P2|Overall Study|Withdrawal by Subject|0
367843|NCT00358449|1180752|P1|Overall Study|Withdrawal by Subject|2
367844|NCT00358449|1180750|P3|Overall Study|Lost to Follow-up|0
367845|NCT00358449|1180751|P2|Overall Study|Lost to Follow-up|0
367846|NCT00358449|1180752|P1|Overall Study|Lost to Follow-up|1
367847|NCT00358449|1180750|P3|Overall Study|Adverse Event|1
367848|NCT00358449|1180751|P2|Overall Study|Adverse Event|0
367849|NCT00358449|1180752|P1|Overall Study|Adverse Event|1
367850|NCT00358436|1180855|P2|Overall Study|Other|1
367851|NCT00358436|1180856|P1|Overall Study|Other|6
367852|NCT00358436|1180855|P2|Overall Study|COPD exacerbation|10
367853|NCT00358436|1180856|P1|Overall Study|COPD exacerbation|22
367854|NCT00358436|1180855|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
367855|NCT00358436|1180856|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
367856|NCT00358436|1180855|P2|Overall Study|Withdrawal by Subject|17
367857|NCT00358436|1180856|P1|Overall Study|Withdrawal by Subject|40
367858|NCT00358436|1180855|P2|Overall Study|Protocol Violation|3
367859|NCT00358436|1180856|P1|Overall Study|Protocol Violation|8
367860|NCT00358436|1180855|P2|Overall Study|Lost to Follow-up|6
367861|NCT00358436|1180856|P1|Overall Study|Lost to Follow-up|11
367862|NCT00358436|1180855|P2|Overall Study|Lack of Efficacy|36
367863|NCT00358436|1180856|P1|Overall Study|Lack of Efficacy|34
367864|NCT00358436|1180855|P2|Overall Study|Adverse Event|13
367865|NCT00358436|1180856|P1|Overall Study|Adverse Event|29
367866|NCT00358215|1180927|P2|Overall Study|Did not receive investigational product|3
367867|NCT00358215|1180928|P1|Overall Study|Did not receive investigational product|2
367868|NCT00358215|1180927|P2|Overall Study|Other|14
367869|NCT00358215|1180928|P1|Overall Study|Other|21
367870|NCT00358215|1180927|P2|Overall Study|Pregnancy|0
367871|NCT00358215|1180928|P1|Overall Study|Pregnancy|1
367872|NCT00358215|1180927|P2|Overall Study|Protocol Violation|59
367873|NCT00358215|1180928|P1|Overall Study|Protocol Violation|64
367874|NCT00358215|1180927|P2|Overall Study|Death|281
367875|NCT00358215|1180928|P1|Overall Study|Death|265
367876|NCT00358215|1180927|P2|Overall Study|Lost to Follow-up|22
367877|NCT00358215|1180928|P1|Overall Study|Lost to Follow-up|16
367878|NCT00358215|1180927|P2|Overall Study|Physician Decision|39
367879|NCT00358215|1180928|P1|Overall Study|Physician Decision|47
367880|NCT00358215|1180927|P2|Overall Study|Participant request|64
367881|NCT00358215|1180928|P1|Overall Study|Participant request|65
367882|NCT00358215|1180927|P2|Overall Study|Withdrawal by Subject|102
367883|NCT00358215|1180928|P1|Overall Study|Withdrawal by Subject|111
367884|NCT00358215|1180927|P2|Overall Study|Adverse Event|65
367885|NCT00358215|1180928|P1|Overall Study|Adverse Event|83
367886|NCT00358215|1180927|P2|Overall Study|Ineligibility determined|3
367887|NCT00358215|1180928|P1|Overall Study|Ineligibility determined|4
367888|NCT00357994|1180949|P2|Overall Study|Protocol Violation|0
367889|NCT00357994|1180950|P1|Overall Study|Protocol Violation|1
367890|NCT00357994|1180949|P2|Overall Study|Lack of Efficacy|1
367891|NCT00357994|1180950|P1|Overall Study|Lack of Efficacy|0
367892|NCT00357994|1180949|P2|Overall Study|Adverse Event|2
367893|NCT00357994|1180950|P1|Overall Study|Adverse Event|1
367894|NCT00357968|1181004|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
367895|NCT00357968|1181005|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
367896|NCT00357968|1181004|P2|First Maintenance Dose Phase|Not a PCI patient|42
367897|NCT00357968|1181005|P1|First Maintenance Dose Phase|Not a PCI patient|47
367898|NCT00357903|1181058|P2|Overall Study|Other|10
367899|NCT00357903|1181059|P1|Overall Study|Other|49
367900|NCT00357903|1181058|P2|Overall Study|Response status|9
367901|NCT00357903|1181059|P1|Overall Study|Response status|61
367902|NCT00357903|1181058|P2|Overall Study|Protocol issues|3
367903|NCT00357903|1181059|P1|Overall Study|Protocol issues|14
367904|NCT00357903|1181058|P2|Overall Study|Completed month 12 only|1
367905|NCT00357903|1181059|P1|Overall Study|Completed month 12 only|0
367906|NCT00357903|1181058|P2|Overall Study|Withdrawal by Subject|7
367907|NCT00357903|1181059|P1|Overall Study|Withdrawal by Subject|57
367908|NCT00357903|1181058|P2|Overall Study|Physician Decision|5
367909|NCT00357903|1181059|P1|Overall Study|Physician Decision|39
367910|NCT00357903|1181058|P2|Overall Study|Lost to Follow-up|4
367911|NCT00357903|1181059|P1|Overall Study|Lost to Follow-up|23
367912|NCT00357903|1181058|P2|Overall Study|Death|0
367913|NCT00357903|1181059|P1|Overall Study|Death|33
367914|NCT00357903|1181058|P2|Overall Study|Adverse Event|4
367915|NCT00357903|1181059|P1|Overall Study|Adverse Event|87
367916|NCT00357877|1181099|P2|Overall Study|Other|2
367917|NCT00357877|1181100|P1|Overall Study|Other|0
367918|NCT00357877|1181099|P2|Overall Study|Administrative withdrawal|1
367919|NCT00357877|1181100|P1|Overall Study|Administrative withdrawal|1
367920|NCT00357877|1181099|P2|Overall Study|Withdrawal by Subject|3
367921|NCT00357877|1181100|P1|Overall Study|Withdrawal by Subject|3
367922|NCT00357877|1181099|P2|Overall Study|Lost to Follow-up|23
367923|NCT00357877|1181100|P1|Overall Study|Lost to Follow-up|20
367924|NCT00357877|1181099|P2|Overall Study|Death|1
367925|NCT00357877|1181100|P1|Overall Study|Death|2
367926|NCT00357760|1181114|P2|Overall Study|To receive hospice care|1
367927|NCT00357760|1181115|P1|Overall Study|To receive hospice care|0
367928|NCT00357760|1181114|P2|Overall Study|Protocol Violation|1
367929|NCT00357760|1181115|P1|Overall Study|Protocol Violation|0
367930|NCT00357760|1181114|P2|Overall Study|Physician Decision|1
367931|NCT00357760|1181115|P1|Overall Study|Physician Decision|2
367932|NCT00357760|1181114|P2|Overall Study|Ineligible|2
367933|NCT00357760|1181115|P1|Overall Study|Ineligible|0
367934|NCT00357760|1181114|P2|Overall Study|Never started treatment|1
367935|NCT00357760|1181115|P1|Overall Study|Never started treatment|2
367936|NCT00357760|1181114|P2|Overall Study|Withdrawal by Subject|2
367937|NCT00357760|1181115|P1|Overall Study|Withdrawal by Subject|0
367938|NCT00357760|1181114|P2|Overall Study|Alternative therapy|0
367939|NCT00357760|1181115|P1|Overall Study|Alternative therapy|1
367940|NCT00357760|1181114|P2|Overall Study|Death|3
367941|NCT00357760|1181115|P1|Overall Study|Death|0
367942|NCT00357760|1181114|P2|Overall Study|Adverse Event|7
367943|NCT00357760|1181115|P1|Overall Study|Adverse Event|10
367944|NCT00357760|1181114|P2|Overall Study|Disease progression|17
367945|NCT00357760|1181115|P1|Overall Study|Disease progression|44
367946|NCT00357656|1181136|P2|Overall Study|Other, No surgery performed|3
367947|NCT00357656|1181137|P1|Overall Study|Other, No surgery performed|0
367948|NCT00357552|1181188|P1|Weeks 24 to 104|Not able to get to clinic|2
367949|NCT00357552|1181188|P1|Weeks 24 to 104|Death|3
367950|NCT00357552|1181188|P1|Weeks 0 to 24|Death|1
367951|NCT00357552|1181188|P1|Screening|Did not meet eligibility criteria|84
367952|NCT00357500|1181203|P1|Overall Study|Not Started Protocol Therapy|4
367953|NCT00357500|1181203|P1|Overall Study|Progressive Disease|65
367954|NCT00357500|1181203|P1|Overall Study|Withdrawal by Subject|5
367955|NCT00357500|1181203|P1|Overall Study|Adverse Event|3
367956|NCT00357396|1181212|P2|Overall Study|Adverse Event|0
367957|NCT00357396|1181213|P1|Overall Study|Adverse Event|1
367958|NCT00357370|1181221|P3|Cohort 2|Withdrawal by Subject|0
367959|NCT00357370|1181222|P2|Cohort 2|Withdrawal by Subject|2
367960|NCT00357370|1181223|P1|Cohort 2|Withdrawal by Subject|0
367961|NCT00357370|1181221|P3|Cohort 2|non-compliance, not met criteria, etc|0
367962|NCT00357370|1181222|P2|Cohort 2|non-compliance, not met criteria, etc|1
367963|NCT00357370|1181223|P1|Cohort 2|non-compliance, not met criteria, etc|1
367964|NCT00357370|1181221|P3|Cohort 2|Lost to Follow-up|0
367965|NCT00357370|1181222|P2|Cohort 2|Lost to Follow-up|1
367966|NCT00357370|1181223|P1|Cohort 2|Lost to Follow-up|0
367967|NCT00357370|1181221|P3|Cohort 2|Adverse Event|1
367968|NCT00357370|1181222|P2|Cohort 2|Adverse Event|1
367969|NCT00357370|1181223|P1|Cohort 2|Adverse Event|1
367970|NCT00357370|1181221|P3|Cohort 2|Lack of Efficacy|1
367971|NCT00357370|1181222|P2|Cohort 2|Lack of Efficacy|2
367972|NCT00357370|1181223|P1|Cohort 2|Lack of Efficacy|0
367973|NCT00357110|1181269|P2|Overall Study|Early study termination|5
367974|NCT00357110|1181270|P1|Overall Study|Early study termination|5
367975|NCT00357097|1181278|P2|Overall Study|Increase of RLS Symptoms|1
367976|NCT00357097|1181279|P1|Overall Study|Increase of RLS Symptoms|0
367977|NCT00357097|1181278|P2|Overall Study|Other|1
367978|NCT00357097|1181279|P1|Overall Study|Other|1
367979|NCT00357097|1181278|P2|Overall Study|Met Exclusion Criteria|1
367980|NCT00357097|1181279|P1|Overall Study|Met Exclusion Criteria|3
367981|NCT00357097|1181278|P2|Overall Study|Lack of Efficacy|8
367982|NCT00357097|1181279|P1|Overall Study|Lack of Efficacy|2
367983|NCT00357097|1181278|P2|Overall Study|Non-compliance|2
367984|NCT00357097|1181279|P1|Overall Study|Non-compliance|1
367985|NCT00357097|1181278|P2|Overall Study|Withdrawal by Subject|7
367986|NCT00357097|1181279|P1|Overall Study|Withdrawal by Subject|8
367987|NCT00357097|1181278|P2|Overall Study|Adverse Event|6
367988|NCT00357097|1181279|P1|Overall Study|Adverse Event|34
367989|NCT00357097|1181278|P2|Overall Study|Did not meet inclusion criteria|3
367990|NCT00357097|1181279|P1|Overall Study|Did not meet inclusion criteria|5
367991|NCT00357006|1181331|P3|Overall Study|Withdrawal by Subject|2
367992|NCT00357006|1181332|P2|Overall Study|Withdrawal by Subject|3
367993|NCT00357006|1181333|P1|Overall Study|Withdrawal by Subject|1
367994|NCT00357006|1181331|P3|Overall Study|Lost to Follow-up|1
367995|NCT00357006|1181332|P2|Overall Study|Lost to Follow-up|2
367996|NCT00357006|1181333|P1|Overall Study|Lost to Follow-up|1
367997|NCT00356915|1181344|P3|Overall Study|Miscellaneous reasons|3
367998|NCT00356915|1181345|P2|Overall Study|Miscellaneous reasons|8
367999|NCT00356915|1181346|P1|Overall Study|Miscellaneous reasons|11
368000|NCT00356915|1181344|P3|Overall Study|Adverse Event|8
368001|NCT00356915|1181345|P2|Overall Study|Adverse Event|31
368002|NCT00356915|1181346|P1|Overall Study|Adverse Event|21
368003|NCT00356915|1181344|P3|Overall Study|Physician Decision|0
368004|NCT00356915|1181345|P2|Overall Study|Physician Decision|2
368005|NCT00356915|1181346|P1|Overall Study|Physician Decision|0
368006|NCT00356915|1181344|P3|Overall Study|Administrative Decision|1
368007|NCT00356915|1181345|P2|Overall Study|Administrative Decision|0
368008|NCT00356915|1181346|P1|Overall Study|Administrative Decision|0
368009|NCT00356915|1181344|P3|Overall Study|Lost to Follow-up|14
368010|NCT00356915|1181345|P2|Overall Study|Lost to Follow-up|34
368011|NCT00356915|1181346|P1|Overall Study|Lost to Follow-up|27
368012|NCT00356915|1181344|P3|Overall Study|Lack of Efficacy|3
368013|NCT00356915|1181345|P2|Overall Study|Lack of Efficacy|0
368014|NCT00356915|1181346|P1|Overall Study|Lack of Efficacy|0
368015|NCT00356915|1181344|P3|Overall Study|Withdrawal by Subject|10
368016|NCT00356915|1181345|P2|Overall Study|Withdrawal by Subject|14
368017|NCT00356915|1181346|P1|Overall Study|Withdrawal by Subject|14
368018|NCT00356915|1181344|P3|Overall Study|Protocol Violation|2
368019|NCT00356915|1181345|P2|Overall Study|Protocol Violation|3
368020|NCT00356915|1181346|P1|Overall Study|Protocol Violation|2
368021|NCT00356915|1181344|P3|Overall Study|Non compliance|1
368022|NCT00356915|1181345|P2|Overall Study|Non compliance|2
368023|NCT00356915|1181346|P1|Overall Study|Non compliance|1
368024|NCT00356889|1181363|P1|Overall Study|Adverse Event|1
368025|NCT00356889|1181363|P1|Overall Study|Protocol Violation|2
368026|NCT00356863|1181372|P2|Overall Study|Lost to Follow-up|43
368027|NCT00356863|1181373|P1|Overall Study|Lost to Follow-up|76
368028|NCT00356863|1181372|P2|Overall Study|Death|32
368029|NCT00356863|1181373|P1|Overall Study|Death|16
368030|NCT00356811|1181399|P1|Overall Study|Site Closed during Follow-up|2
368031|NCT00356811|1181399|P1|Overall Study|Study Is Terminating|3
368032|NCT00356811|1181399|P1|Overall Study|Participant Could Not Make a Checkup|1
368033|NCT00356811|1181399|P1|Overall Study|Withdrawal by Subject|6
368034|NCT00356811|1181399|P1|Overall Study|Lost to Follow-up|2
368035|NCT00356811|1181399|P1|Overall Study|Death|35
368036|NCT00356590|1181412|P1|Overall Study|Other|52
368037|NCT00356590|1181412|P1|Overall Study|Response status|28
368038|NCT00356590|1181412|P1|Overall Study|Protocol issues|6
368039|NCT00356590|1181412|P1|Overall Study|Completed month 12 only|2
368040|NCT00356590|1181412|P1|Overall Study|Withdrawal by Subject|41
368041|NCT00356590|1181412|P1|Overall Study|Physician Decision|46
368042|NCT00356590|1181412|P1|Overall Study|Lost to Follow-up|35
368043|NCT00356590|1181412|P1|Overall Study|Death|10
368044|NCT00356590|1181412|P1|Overall Study|Adverse Event|54
368045|NCT00356525|1181448|P4|Overall Study|Sponsor Decision|1
368046|NCT00356525|1181449|P3|Overall Study|Sponsor Decision|0
368047|NCT00356525|1181450|P2|Overall Study|Sponsor Decision|0
368048|NCT00356525|1181451|P1|Overall Study|Sponsor Decision|0
368049|NCT00356525|1181448|P4|Overall Study|Death|1
368050|NCT00356525|1181449|P3|Overall Study|Death|0
368051|NCT00356525|1181450|P2|Overall Study|Death|0
368052|NCT00356525|1181451|P1|Overall Study|Death|0
368053|NCT00356525|1181448|P4|Overall Study|Withdrawal by Subject|3
368054|NCT00356525|1181449|P3|Overall Study|Withdrawal by Subject|0
368055|NCT00356525|1181450|P2|Overall Study|Withdrawal by Subject|1
368056|NCT00356525|1181451|P1|Overall Study|Withdrawal by Subject|1
368057|NCT00356525|1181448|P4|Overall Study|Protocol Entry Criteria Not Met|0
368058|NCT00356525|1181449|P3|Overall Study|Protocol Entry Criteria Not Met|0
368059|NCT00356525|1181450|P2|Overall Study|Protocol Entry Criteria Not Met|0
368060|NCT00356525|1181451|P1|Overall Study|Protocol Entry Criteria Not Met|1
368061|NCT00356525|1181448|P4|Overall Study|Physician Decision|1
368062|NCT00356525|1181449|P3|Overall Study|Physician Decision|2
368063|NCT00356525|1181450|P2|Overall Study|Physician Decision|2
368064|NCT00356525|1181451|P1|Overall Study|Physician Decision|2
368065|NCT00356525|1181448|P4|Overall Study|Lost to Follow-up|0
368066|NCT00356525|1181449|P3|Overall Study|Lost to Follow-up|0
368067|NCT00356525|1181450|P2|Overall Study|Lost to Follow-up|0
368068|NCT00356525|1181451|P1|Overall Study|Lost to Follow-up|1
368069|NCT00356525|1181448|P4|Overall Study|Adverse Event|1
368070|NCT00356525|1181449|P3|Overall Study|Adverse Event|1
368071|NCT00356525|1181450|P2|Overall Study|Adverse Event|3
368072|NCT00356525|1181451|P1|Overall Study|Adverse Event|1
368073|NCT00356525|1181448|P4|Overall Study|Progressive Disease|2
368074|NCT00356525|1181449|P3|Overall Study|Progressive Disease|4
368075|NCT00356525|1181450|P2|Overall Study|Progressive Disease|5
368076|NCT00356525|1181451|P1|Overall Study|Progressive Disease|8
368077|NCT00356421|1181479|P2|Overall Study|Not related to study drug|3
368078|NCT00356421|1181480|P1|Overall Study|Not related to study drug|5
368079|NCT00356421|1181479|P2|Overall Study|Related to study drug|12
368080|NCT00356421|1181480|P1|Overall Study|Related to study drug|15
368081|NCT00356421|1181479|P2|Overall Study|Withdrawal by Subject|2
368082|NCT00356421|1181480|P1|Overall Study|Withdrawal by Subject|9
368083|NCT00356421|1181479|P2|Overall Study|Lack of Efficacy|0
368084|NCT00356421|1181480|P1|Overall Study|Lack of Efficacy|3
368085|NCT00356408|1181520|P1|Overall Study|Other: Subject chose commerical dosing|1
368086|NCT00356408|1181520|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
368087|NCT00356408|1181520|P1|Overall Study|Other: Azathioprine stopped|1
368088|NCT00356408|1181520|P1|Overall Study|Other: Sponsor request|1
368089|NCT00356408|1181520|P1|Overall Study|Other: Principal investigator discretion|3
368090|NCT00356408|1181520|P1|Overall Study|Withdrawal by Subject|6
368091|NCT00356408|1181520|P1|Overall Study|Lost to Follow-up|2
368092|NCT00356408|1181520|P1|Overall Study|Lack of Efficacy|36
368093|NCT00356408|1181520|P1|Overall Study|Adverse Event|9
368094|NCT00356278|1181549|P3|Overall Study|Withdrawal by Subject|19
368095|NCT00356278|1181550|P2|Overall Study|Withdrawal by Subject|15
368096|NCT00356278|1181551|P1|Overall Study|Withdrawal by Subject|25
368097|NCT00356200|1181588|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
368098|NCT00356200|1181589|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
368099|NCT00356200|1181588|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
368100|NCT00356200|1181589|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
368101|NCT00356148|1181603|P2|Overall Study|Reoperation within 30 days|1
368102|NCT00356148|1181604|P1|Overall Study|Reoperation within 30 days|2
368103|NCT00356135|1181615|P3|Overall Study|Subject non-compliance|3
368104|NCT00356135|1181616|P2|Overall Study|Subject non-compliance|1
368105|NCT00356135|1181617|P1|Overall Study|Subject non-compliance|1
368106|NCT00356135|1181615|P3|Overall Study|Physician Decision|1
368107|NCT00356135|1181616|P2|Overall Study|Physician Decision|1
368108|NCT00356135|1181617|P1|Overall Study|Physician Decision|1
368109|NCT00356135|1181615|P3|Overall Study|Lost to Follow-up|1
368110|NCT00356135|1181616|P2|Overall Study|Lost to Follow-up|0
368111|NCT00356135|1181617|P1|Overall Study|Lost to Follow-up|0
368112|NCT00356135|1181615|P3|Overall Study|Adverse Event|0
368113|NCT00356135|1181616|P2|Overall Study|Adverse Event|0
368114|NCT00356135|1181617|P1|Overall Study|Adverse Event|1
368115|NCT00356135|1181615|P3|Overall Study|Protocol Violation|0
368116|NCT00356135|1181616|P2|Overall Study|Protocol Violation|0
368117|NCT00356135|1181617|P1|Overall Study|Protocol Violation|1
368118|NCT00356122|1181639|P1|FOLLOW-UP|Other|2
368119|NCT00356122|1181639|P1|FOLLOW-UP|Lost to Follow-up|2
368120|NCT00356122|1181639|P1|FOLLOW-UP|Death|37
368121|NCT00356122|1181639|P1|TREATMENT|Did not receive study medication|1
368122|NCT00356122|1181639|P1|TREATMENT|Other|4
368123|NCT00356122|1181639|P1|TREATMENT|Subject's request|4
368124|NCT00356122|1181639|P1|TREATMENT|Adverse Event|10
368125|NCT00356122|1181639|P1|TREATMENT|Lack of Efficacy|26
368126|NCT00355784|1181715|P3|Overall Study|Withdrawal by Subject|2
368127|NCT00355784|1181716|P2|Overall Study|Withdrawal by Subject|0
368128|NCT00355784|1181717|P1|Overall Study|Withdrawal by Subject|0
368129|NCT00355615|1181766|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
368130|NCT00355615|1181767|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
368131|NCT00355615|1181768|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
368132|NCT00355615|1181769|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
368133|NCT00355615|1181770|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
368134|NCT00355615|1181766|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
368135|NCT00355615|1181767|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
368136|NCT00355615|1181768|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
368137|NCT00355615|1181769|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
368138|NCT00355615|1181770|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
368139|NCT00355615|1181766|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
368140|NCT00355615|1181767|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
368141|NCT00355615|1181768|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
368142|NCT00355615|1181769|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
368143|NCT00355615|1181770|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
368144|NCT00355615|1181766|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
368145|NCT00355615|1181767|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
368146|NCT00355615|1181768|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
368147|NCT00355615|1181769|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
368148|NCT00355615|1181770|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
368149|NCT00355615|1181766|P5|Randomized Double Blind Period|Protocol Violation|0
368150|NCT00355615|1181767|P4|Randomized Double Blind Period|Protocol Violation|1
368151|NCT00355615|1181768|P3|Randomized Double Blind Period|Protocol Violation|1
368152|NCT00355615|1181769|P2|Randomized Double Blind Period|Protocol Violation|0
368153|NCT00355615|1181770|P1|Randomized Double Blind Period|Protocol Violation|0
368154|NCT00355615|1181766|P5|Randomized Double Blind Period|Adverse Event|0
368155|NCT00355615|1181767|P4|Randomized Double Blind Period|Adverse Event|0
368156|NCT00355615|1181768|P3|Randomized Double Blind Period|Adverse Event|0
368157|NCT00355615|1181769|P2|Randomized Double Blind Period|Adverse Event|0
368158|NCT00355615|1181770|P1|Randomized Double Blind Period|Adverse Event|1
368159|NCT00355472|1181829|P1|Overall Study|Physician Decision|1
368160|NCT00355368|1181875|P2|Overall Study|cardiac arrest prior to intubation|2
368161|NCT00355368|1181876|P1|Overall Study|cardiac arrest prior to intubation|2
368162|NCT00355368|1181875|P2|Overall Study|Protocol Violation|7
368163|NCT00355368|1181876|P1|Overall Study|Protocol Violation|8
368164|NCT00355147|1181890|P2|Overall Study|Withdrawal by Subject|12
368165|NCT00355147|1181891|P1|Overall Study|Withdrawal by Subject|8
368166|NCT00355147|1181890|P2|Overall Study|Lost to Follow-up|8
368167|NCT00355147|1181891|P1|Overall Study|Lost to Follow-up|10
368168|NCT00355134|1181910|P5|Extension Phase|Protocol Violation|0
368169|NCT00355134|1181911|P4|Extension Phase|Protocol Violation|1
368170|NCT00355134|1181912|P3|Extension Phase|Protocol Violation|0
368171|NCT00355134|1181913|P2|Extension Phase|Protocol Violation|0
368172|NCT00355134|1181914|P1|Extension Phase|Protocol Violation|0
368173|NCT00355134|1181910|P5|Extension Phase|Abnormal test procedure result(s)|1
368174|NCT00355134|1181911|P4|Extension Phase|Abnormal test procedure result(s)|0
368259|NCT00355121|1181957|P3|Overall Study|Lost to Follow-up|1
368175|NCT00355134|1181912|P3|Extension Phase|Abnormal test procedure result(s)|0
368176|NCT00355134|1181913|P2|Extension Phase|Abnormal test procedure result(s)|1
368177|NCT00355134|1181914|P1|Extension Phase|Abnormal test procedure result(s)|0
368178|NCT00355134|1181910|P5|Extension Phase|Unsatisfactory therapeutic effect|1
368179|NCT00355134|1181911|P4|Extension Phase|Unsatisfactory therapeutic effect|0
368180|NCT00355134|1181912|P3|Extension Phase|Unsatisfactory therapeutic effect|0
368181|NCT00355134|1181913|P2|Extension Phase|Unsatisfactory therapeutic effect|4
368182|NCT00355134|1181914|P1|Extension Phase|Unsatisfactory therapeutic effect|3
368183|NCT00355134|1181910|P5|Extension Phase|Administrative problems|1
368184|NCT00355134|1181911|P4|Extension Phase|Administrative problems|1
368185|NCT00355134|1181912|P3|Extension Phase|Administrative problems|0
368186|NCT00355134|1181913|P2|Extension Phase|Administrative problems|4
368187|NCT00355134|1181914|P1|Extension Phase|Administrative problems|2
368188|NCT00355134|1181910|P5|Extension Phase|Abnormal laboratory value(s)|2
368189|NCT00355134|1181911|P4|Extension Phase|Abnormal laboratory value(s)|2
368190|NCT00355134|1181912|P3|Extension Phase|Abnormal laboratory value(s)|0
368191|NCT00355134|1181913|P2|Extension Phase|Abnormal laboratory value(s)|2
368192|NCT00355134|1181914|P1|Extension Phase|Abnormal laboratory value(s)|4
368193|NCT00355134|1181910|P5|Extension Phase|Lost to Follow-up|4
368194|NCT00355134|1181911|P4|Extension Phase|Lost to Follow-up|2
368195|NCT00355134|1181912|P3|Extension Phase|Lost to Follow-up|0
368196|NCT00355134|1181913|P2|Extension Phase|Lost to Follow-up|6
368197|NCT00355134|1181914|P1|Extension Phase|Lost to Follow-up|2
368198|NCT00355134|1181910|P5|Extension Phase|Adverse Event|5
368199|NCT00355134|1181911|P4|Extension Phase|Adverse Event|3
368200|NCT00355134|1181912|P3|Extension Phase|Adverse Event|0
368201|NCT00355134|1181913|P2|Extension Phase|Adverse Event|9
368202|NCT00355134|1181914|P1|Extension Phase|Adverse Event|13
368203|NCT00355134|1181910|P5|Extension Phase|Withdrawal by Subject|5
368204|NCT00355134|1181911|P4|Extension Phase|Withdrawal by Subject|7
368205|NCT00355134|1181912|P3|Extension Phase|Withdrawal by Subject|0
368206|NCT00355134|1181913|P2|Extension Phase|Withdrawal by Subject|11
368207|NCT00355134|1181914|P1|Extension Phase|Withdrawal by Subject|7
368208|NCT00355134|1181910|P5|Core Phase|Condition no longer requires study drug|0
368209|NCT00355134|1181911|P4|Core Phase|Condition no longer requires study drug|0
368210|NCT00355134|1181912|P3|Core Phase|Condition no longer requires study drug|1
368211|NCT00355134|1181913|P2|Core Phase|Condition no longer requires study drug|0
368212|NCT00355134|1181914|P1|Core Phase|Condition no longer requires study drug|1
368213|NCT00355134|1181910|P5|Core Phase|Abnormal test procedure result(s)|0
368214|NCT00355134|1181911|P4|Core Phase|Abnormal test procedure result(s)|0
368215|NCT00355134|1181912|P3|Core Phase|Abnormal test procedure result(s)|1
368216|NCT00355134|1181913|P2|Core Phase|Abnormal test procedure result(s)|2
368217|NCT00355134|1181914|P1|Core Phase|Abnormal test procedure result(s)|1
368218|NCT00355134|1181910|P5|Core Phase|Protocol Violation|0
368219|NCT00355134|1181911|P4|Core Phase|Protocol Violation|0
368220|NCT00355134|1181912|P3|Core Phase|Protocol Violation|2
368221|NCT00355134|1181913|P2|Core Phase|Protocol Violation|2
368222|NCT00355134|1181914|P1|Core Phase|Protocol Violation|3
368223|NCT00355134|1181910|P5|Core Phase|Administrative problems|0
368224|NCT00355134|1181911|P4|Core Phase|Administrative problems|0
368225|NCT00355134|1181912|P3|Core Phase|Administrative problems|5
368226|NCT00355134|1181913|P2|Core Phase|Administrative problems|3
368227|NCT00355134|1181914|P1|Core Phase|Administrative problems|5
368228|NCT00355134|1181910|P5|Core Phase|Unsatisfactory therapeutic effect|0
368229|NCT00355134|1181911|P4|Core Phase|Unsatisfactory therapeutic effect|0
368230|NCT00355134|1181912|P3|Core Phase|Unsatisfactory therapeutic effect|17
368231|NCT00355134|1181913|P2|Core Phase|Unsatisfactory therapeutic effect|6
368232|NCT00355134|1181914|P1|Core Phase|Unsatisfactory therapeutic effect|10
368233|NCT00355134|1181910|P5|Core Phase|Abnormal laboratory value(s)|0
368234|NCT00355134|1181911|P4|Core Phase|Abnormal laboratory value(s)|0
368235|NCT00355134|1181912|P3|Core Phase|Abnormal laboratory value(s)|2
368236|NCT00355134|1181913|P2|Core Phase|Abnormal laboratory value(s)|14
368237|NCT00355134|1181914|P1|Core Phase|Abnormal laboratory value(s)|19
368238|NCT00355134|1181910|P5|Core Phase|Lost to Follow-up|0
368239|NCT00355134|1181911|P4|Core Phase|Lost to Follow-up|0
368240|NCT00355134|1181912|P3|Core Phase|Lost to Follow-up|21
368241|NCT00355134|1181913|P2|Core Phase|Lost to Follow-up|13
368242|NCT00355134|1181914|P1|Core Phase|Lost to Follow-up|17
368243|NCT00355134|1181910|P5|Core Phase|Adverse Event|0
368244|NCT00355134|1181911|P4|Core Phase|Adverse Event|0
368245|NCT00355134|1181912|P3|Core Phase|Adverse Event|16
368246|NCT00355134|1181913|P2|Core Phase|Adverse Event|22
368247|NCT00355134|1181914|P1|Core Phase|Adverse Event|28
368248|NCT00355134|1181910|P5|Core Phase|Withdrawal by Subject|0
368249|NCT00355134|1181911|P4|Core Phase|Withdrawal by Subject|0
368250|NCT00355134|1181912|P3|Core Phase|Withdrawal by Subject|35
368251|NCT00355134|1181913|P2|Core Phase|Withdrawal by Subject|24
368252|NCT00355134|1181914|P1|Core Phase|Withdrawal by Subject|35
368253|NCT00355121|1181957|P3|Overall Study|Serious adverse events|0
368254|NCT00355121|1181958|P2|Overall Study|Serious adverse events|2
368255|NCT00355121|1181959|P1|Overall Study|Serious adverse events|0
368256|NCT00355121|1181957|P3|Overall Study|Withdrawal by Subject|2
368257|NCT00355121|1181958|P2|Overall Study|Withdrawal by Subject|10
368258|NCT00355121|1181959|P1|Overall Study|Withdrawal by Subject|9
368260|NCT00355121|1181958|P2|Overall Study|Lost to Follow-up|7
368261|NCT00355121|1181959|P1|Overall Study|Lost to Follow-up|4
368262|NCT00355121|1181957|P3|Overall Study|Protocol Violation|1
368263|NCT00355121|1181958|P2|Overall Study|Protocol Violation|9
368264|NCT00355121|1181959|P1|Overall Study|Protocol Violation|7
368265|NCT00355121|1181957|P3|Overall Study|Adverse Event|0
368266|NCT00355121|1181958|P2|Overall Study|Adverse Event|1
368267|NCT00355121|1181959|P1|Overall Study|Adverse Event|0
368268|NCT00355121|1181957|P3|Overall Study|Did not receive study vaccine|1
368269|NCT00355121|1181958|P2|Overall Study|Did not receive study vaccine|0
368270|NCT00355121|1181959|P1|Overall Study|Did not receive study vaccine|1
368271|NCT00355082|1181990|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
368272|NCT00355082|1181991|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
368273|NCT00355082|1181992|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
368274|NCT00355082|1181990|P3|Continuation Phase|Scheduling Error|0
368275|NCT00355082|1181991|P2|Continuation Phase|Scheduling Error|0
368276|NCT00355082|1181992|P1|Continuation Phase|Scheduling Error|1
368277|NCT00355082|1181990|P3|Continuation Phase|Site Closed by Sponsor|0
368278|NCT00355082|1181991|P2|Continuation Phase|Site Closed by Sponsor|0
368279|NCT00355082|1181992|P1|Continuation Phase|Site Closed by Sponsor|8
368280|NCT00355082|1181990|P3|Continuation Phase|Lack of Efficacy|0
368281|NCT00355082|1181991|P2|Continuation Phase|Lack of Efficacy|0
368282|NCT00355082|1181992|P1|Continuation Phase|Lack of Efficacy|5
368283|NCT00355082|1181990|P3|Continuation Phase|Withdrawal by Subject|0
368284|NCT00355082|1181991|P2|Continuation Phase|Withdrawal by Subject|0
368285|NCT00355082|1181992|P1|Continuation Phase|Withdrawal by Subject|4
368286|NCT00355082|1181990|P3|Continuation Phase|Protocol Violation|1
368287|NCT00355082|1181991|P2|Continuation Phase|Protocol Violation|0
368288|NCT00355082|1181992|P1|Continuation Phase|Protocol Violation|1
368289|NCT00355082|1181990|P3|Continuation Phase|Lost to Follow-up|1
368290|NCT00355082|1181991|P2|Continuation Phase|Lost to Follow-up|0
368291|NCT00355082|1181992|P1|Continuation Phase|Lost to Follow-up|2
368292|NCT00355082|1181990|P3|Continuation Phase|Adverse Event|1
368293|NCT00355082|1181991|P2|Continuation Phase|Adverse Event|0
368294|NCT00355082|1181992|P1|Continuation Phase|Adverse Event|2
368295|NCT00355082|1181990|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
368296|NCT00355082|1181991|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
368297|NCT00355082|1181992|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
368298|NCT00355082|1181990|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
368299|NCT00355082|1181991|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
368300|NCT00355082|1181992|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
368301|NCT00355082|1181990|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
368302|NCT00355082|1181991|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
368303|NCT00355082|1181992|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
368304|NCT00355082|1181990|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
368305|NCT00355082|1181991|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
368306|NCT00355082|1181992|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
368307|NCT00355082|1181990|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
368308|NCT00355082|1181991|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
368309|NCT00355082|1181992|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
368310|NCT00355082|1181990|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
368311|NCT00355082|1181991|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
368312|NCT00355082|1181992|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
368313|NCT00355030|1182014|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
368314|NCT00355030|1182015|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
368315|NCT00355030|1182014|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
368316|NCT00355030|1182015|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
368317|NCT00355030|1182014|P2|Study Period 1 Treatment|Other|6
368318|NCT00355030|1182015|P1|Study Period 1 Treatment|Other|2
368319|NCT00355030|1182014|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
368320|NCT00355030|1182015|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
368321|NCT00355030|1182014|P2|Study Period 1 Treatment|Sponsor Decision|32
368322|NCT00355030|1182015|P1|Study Period 1 Treatment|Sponsor Decision|34
368323|NCT00355030|1182014|P2|Study Period 1 Treatment|Physician Decision|1
368324|NCT00355030|1182015|P1|Study Period 1 Treatment|Physician Decision|0
368325|NCT00355030|1182014|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
368326|NCT00355030|1182015|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
368327|NCT00355030|1182014|P2|Study Period 1 Treatment|Withdrawal by Subject|1
368328|NCT00355030|1182015|P1|Study Period 1 Treatment|Withdrawal by Subject|4
368329|NCT00355030|1182014|P2|Study Period 1 Treatment|Lost to Follow-up|0
368330|NCT00355030|1182015|P1|Study Period 1 Treatment|Lost to Follow-up|3
368331|NCT00355030|1182014|P2|Study Period 1 Treatment|Adverse Event|1
368332|NCT00355030|1182015|P1|Study Period 1 Treatment|Adverse Event|1
368333|NCT00354744|1182061|P1|Overall Study|Withdrawal by Subject|14
368334|NCT00354744|1182061|P1|Overall Study|Physician Decision|11
368335|NCT00354744|1182061|P1|Overall Study|Lost to Follow-up|2
368336|NCT00354744|1182061|P1|Overall Study|Lack of Efficacy|11
368337|NCT00354744|1182061|P1|Overall Study|Death|2
368338|NCT00354744|1182061|P1|Overall Study|Adverse Event|2
368339|NCT00354679|1182066|P1|Overall Study|Patient Not Treated|1
368340|NCT00354601|1182075|P1|Overall Study|progression|1
368341|NCT00354601|1182075|P1|Overall Study|Protocol Violation|1
368342|NCT00354432|1182095|P4|Overall Study|Off/Toxicity|5
368343|NCT00354432|1182096|P3|Overall Study|Off/Toxicity|5
368344|NCT00354432|1182097|P2|Overall Study|Off/Toxicity|7
368345|NCT00354432|1182098|P1|Overall Study|Off/Toxicity|3
368346|NCT00354432|1182095|P4|Overall Study|Adverse Event|5
368347|NCT00354432|1182096|P3|Overall Study|Adverse Event|5
368348|NCT00354432|1182097|P2|Overall Study|Adverse Event|1
368349|NCT00354432|1182098|P1|Overall Study|Adverse Event|3
368350|NCT00354341|1182114|P2|Overall Study|Unspecified|2
368351|NCT00354341|1182115|P1|Overall Study|Unspecified|1
368352|NCT00354341|1182114|P2|Overall Study|Failure to return|1
368353|NCT00354341|1182115|P1|Overall Study|Failure to return|0
368354|NCT00354341|1182114|P2|Overall Study|Refused treatment|2
368355|NCT00354341|1182115|P1|Overall Study|Refused treatment|1
368356|NCT00354341|1182114|P2|Overall Study|Death|2
368357|NCT00354341|1182115|P1|Overall Study|Death|0
368358|NCT00354341|1182114|P2|Overall Study|Adverse Event|0
368359|NCT00354341|1182115|P1|Overall Study|Adverse Event|1
368360|NCT00354172|1182131|P1|Overall Study|Did not receive transplant|1
368361|NCT00354159|1182151|P2|Long-term Follow-up|Study Closed|34
368362|NCT00354159|1182152|P1|Long-term Follow-up|Study Closed|29
368363|NCT00354159|1182151|P2|Long-term Follow-up|Death|11
368364|NCT00354159|1182152|P1|Long-term Follow-up|Death|14
368365|NCT00354159|1182151|P2|Long-term Follow-up|Lost to Follow-up|0
368366|NCT00354159|1182152|P1|Long-term Follow-up|Lost to Follow-up|1
368367|NCT00354159|1182151|P2|Long-term Follow-up|Physician Decision|122
368368|NCT00354159|1182152|P1|Long-term Follow-up|Physician Decision|127
368369|NCT00354159|1182151|P2|Long-term Follow-up|Withdrawal by Subject|9
368370|NCT00354159|1182152|P1|Long-term Follow-up|Withdrawal by Subject|9
368371|NCT00354159|1182151|P2|Randomized Study Period|Death|9
368372|NCT00354159|1182152|P1|Randomized Study Period|Death|7
368373|NCT00354159|1182151|P2|Randomized Study Period|Lost to Follow-up|0
368374|NCT00354159|1182152|P1|Randomized Study Period|Lost to Follow-up|4
368375|NCT00354159|1182151|P2|Randomized Study Period|Physician Decision|10
368376|NCT00354159|1182152|P1|Randomized Study Period|Physician Decision|6
368377|NCT00354159|1182151|P2|Randomized Study Period|Withdrawal by Subject|3
368378|NCT00354159|1182152|P1|Randomized Study Period|Withdrawal by Subject|5
368379|NCT00354107|1182195|P1|Overall Study|Withdrawal by Subject|1
368380|NCT00354107|1182195|P1|Overall Study|Physician Decision|2
368381|NCT00354107|1182195|P1|Overall Study|Adverse Event|2
368382|NCT00354029|1182201|P2|Overall Study|Protocol Violation|2
368383|NCT00354029|1182202|P1|Overall Study|Protocol Violation|4
368384|NCT00353873|1182214|P2|Overall Study|Withdrawal by Subject|1
368385|NCT00353873|1182215|P1|Overall Study|Withdrawal by Subject|1
368386|NCT00353873|1182214|P2|Overall Study|Physician Decision|0
368387|NCT00353873|1182215|P1|Overall Study|Physician Decision|2
368388|NCT00353873|1182214|P2|Overall Study|Adverse Event|0
368389|NCT00353873|1182215|P1|Overall Study|Adverse Event|1
368390|NCT00353873|1182214|P2|Overall Study|Exacerbation|0
368391|NCT00353873|1182215|P1|Overall Study|Exacerbation|1
368392|NCT00353873|1182214|P2|Overall Study|Protocol Violation|2
368393|NCT00353873|1182215|P1|Overall Study|Protocol Violation|1
368394|NCT00353704|1182233|P2|Overall Study|Protocol Violation|1
368395|NCT00353704|1182234|P1|Overall Study|Protocol Violation|3
368396|NCT00353496|1182269|P2|Overall Study|Not otherwise specified|2
368397|NCT00353496|1182270|P1|Overall Study|Not otherwise specified|4
368398|NCT00353496|1182269|P2|Overall Study|Physician Decision|9
368399|NCT00353496|1182270|P1|Overall Study|Physician Decision|6
368400|NCT00353496|1182269|P2|Overall Study|Withdrawal by Subject|4
368401|NCT00353496|1182270|P1|Overall Study|Withdrawal by Subject|3
368402|NCT00353496|1182269|P2|Overall Study|Protocol Violation|2
368403|NCT00353496|1182270|P1|Overall Study|Protocol Violation|2
368404|NCT00353496|1182269|P2|Overall Study|Adverse Event|0
368405|NCT00353496|1182270|P1|Overall Study|Adverse Event|1
368406|NCT00353366|1182323|P1|Overall Study|Unspecified|135
368407|NCT00353366|1182323|P1|Overall Study|Adverse Event|8
368408|NCT00353262|1182344|P1|Overall Study|Break from Chemotherapy|1
368409|NCT00353262|1182344|P1|Overall Study|Surgery|4
368410|NCT00353262|1182344|P1|Overall Study|Progression|1
368411|NCT00353262|1182344|P1|Overall Study|Insufficient Therapeutic Response|13
368412|NCT00353262|1182344|P1|Overall Study|Withdrawal by Subject|2
368413|NCT00353262|1182344|P1|Overall Study|Adverse Event|8
368414|NCT00352846|1182394|P2|Overall Study|Death|1
368415|NCT00352846|1182395|P1|Overall Study|Death|0
368416|NCT00352846|1182394|P2|Overall Study|Non-compliance|0
368417|NCT00352846|1182395|P1|Overall Study|Non-compliance|2
368418|NCT00352846|1182394|P2|Overall Study|Ineligible|2
368419|NCT00352846|1182395|P1|Overall Study|Ineligible|3
368420|NCT00352846|1182394|P2|Overall Study|Withdrawal by Subject|8
368421|NCT00352846|1182395|P1|Overall Study|Withdrawal by Subject|3
368422|NCT00352846|1182394|P2|Overall Study|Disease progression|2
368423|NCT00352846|1182395|P1|Overall Study|Disease progression|0
368424|NCT00352755|1182406|P1|Overall Study|Adverse Event|1
368425|NCT00352755|1182406|P1|Overall Study|Physician Decision|1
368426|NCT00352690|1182416|P2|Overall Study|Determined to be ineligible|0
368427|NCT00352690|1182417|P1|Overall Study|Determined to be ineligible|2
368428|NCT00352664|1182437|P2|Overall Study|Withdrawal by Subject|0
368429|NCT00352664|1182438|P1|Overall Study|Withdrawal by Subject|7
368430|NCT00352534|1182455|P7|Final Risk Group Assignment|Death|0
368431|NCT00352534|1182456|P6|Final Risk Group Assignment|Death|2
368432|NCT00352534|1182457|P5|Final Risk Group Assignment|Death|0
368433|NCT00352534|1182458|P4|Final Risk Group Assignment|Death|0
368434|NCT00352534|1182459|P3|Final Risk Group Assignment|Death|0
368435|NCT00352534|1182460|P2|Final Risk Group Assignment|Death|0
368436|NCT00352534|1182461|P1|Final Risk Group Assignment|Death|0
368437|NCT00352534|1182455|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
368438|NCT00352534|1182456|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
368439|NCT00352534|1182457|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
368440|NCT00352534|1182458|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
368441|NCT00352534|1182459|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
368442|NCT00352534|1182460|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
368443|NCT00352534|1182461|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
368444|NCT00352534|1182455|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
368445|NCT00352534|1182456|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
368446|NCT00352534|1182457|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
368447|NCT00352534|1182458|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
368448|NCT00352534|1182459|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
368449|NCT00352534|1182460|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
368450|NCT00352534|1182461|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
368451|NCT00352534|1182455|P7|Final Risk Group Assignment|Ineligible|0
368452|NCT00352534|1182456|P6|Final Risk Group Assignment|Ineligible|13
368453|NCT00352534|1182457|P5|Final Risk Group Assignment|Ineligible|0
368454|NCT00352534|1182458|P4|Final Risk Group Assignment|Ineligible|1
368455|NCT00352534|1182459|P3|Final Risk Group Assignment|Ineligible|3
368456|NCT00352534|1182460|P2|Final Risk Group Assignment|Ineligible|0
368457|NCT00352534|1182461|P1|Final Risk Group Assignment|Ineligible|0
368458|NCT00352534|1182455|P7|Final Risk Group Assignment|Withdrawal by Subject|0
368459|NCT00352534|1182456|P6|Final Risk Group Assignment|Withdrawal by Subject|3
368460|NCT00352534|1182457|P5|Final Risk Group Assignment|Withdrawal by Subject|0
368461|NCT00352534|1182458|P4|Final Risk Group Assignment|Withdrawal by Subject|0
368462|NCT00352534|1182459|P3|Final Risk Group Assignment|Withdrawal by Subject|0
368463|NCT00352534|1182460|P2|Final Risk Group Assignment|Withdrawal by Subject|0
368464|NCT00352534|1182461|P1|Final Risk Group Assignment|Withdrawal by Subject|0
368465|NCT00352534|1182455|P7|Final Risk Group Assignment|Physician Decision|0
368466|NCT00352534|1182456|P6|Final Risk Group Assignment|Physician Decision|8
368467|NCT00352534|1182457|P5|Final Risk Group Assignment|Physician Decision|0
368468|NCT00352534|1182458|P4|Final Risk Group Assignment|Physician Decision|0
368469|NCT00352534|1182459|P3|Final Risk Group Assignment|Physician Decision|0
368470|NCT00352534|1182460|P2|Final Risk Group Assignment|Physician Decision|0
368471|NCT00352534|1182461|P1|Final Risk Group Assignment|Physician Decision|0
368472|NCT00352534|1182455|P7|Final Risk Group Assignment|Lack of Efficacy|0
368473|NCT00352534|1182456|P6|Final Risk Group Assignment|Lack of Efficacy|19
368474|NCT00352534|1182457|P5|Final Risk Group Assignment|Lack of Efficacy|1
368475|NCT00352534|1182458|P4|Final Risk Group Assignment|Lack of Efficacy|2
368476|NCT00352534|1182459|P3|Final Risk Group Assignment|Lack of Efficacy|0
368477|NCT00352534|1182460|P2|Final Risk Group Assignment|Lack of Efficacy|0
368478|NCT00352534|1182461|P1|Final Risk Group Assignment|Lack of Efficacy|0
368479|NCT00352534|1182455|P7|Initial Staging|Ineligible|0
368480|NCT00352534|1182456|P6|Initial Staging|Ineligible|0
368481|NCT00352534|1182457|P5|Initial Staging|Ineligible|0
368482|NCT00352534|1182458|P4|Initial Staging|Ineligible|0
368483|NCT00352534|1182459|P3|Initial Staging|Ineligible|0
368484|NCT00352534|1182460|P2|Initial Staging|Ineligible|9
368485|NCT00352534|1182461|P1|Initial Staging|Ineligible|8
368486|NCT00352417|1182478|P2|Overall Study|Schedule Change|1
368487|NCT00352417|1182479|P1|Overall Study|Schedule Change|2
368488|NCT00352417|1182478|P2|Overall Study|Lost to Follow-up|0
368489|NCT00352417|1182479|P1|Overall Study|Lost to Follow-up|1
368490|NCT00352417|1182478|P2|Overall Study|Withdrawal by Subject|2
368491|NCT00352417|1182479|P1|Overall Study|Withdrawal by Subject|1
368492|NCT00352417|1182478|P2|Overall Study|Protocol Violation|2
368493|NCT00352417|1182479|P1|Overall Study|Protocol Violation|0
368494|NCT00352417|1182478|P2|Overall Study|Adverse Event|0
368495|NCT00352417|1182479|P1|Overall Study|Adverse Event|1
368496|NCT00352365|1182493|P1|Maintenance Therapy|Not eligible|4
368497|NCT00352365|1182493|P1|Maintenance Therapy|Not protocol specified|3
368498|NCT00352365|1182493|P1|Maintenance Therapy|Death|2
368499|NCT00352365|1182493|P1|Maintenance Therapy|Progression/Relapse|3
368500|NCT00352365|1182493|P1|Induction Therapy|Death before starting protocol therapy|1
368501|NCT00352365|1182493|P1|Induction Therapy|Not eligible|3
368502|NCT00352365|1182493|P1|Induction Therapy|Not protocol specified|1
368503|NCT00352365|1182493|P1|Induction Therapy|Death|7
368504|NCT00352365|1182493|P1|Induction Therapy|Progression/Relapse|8
368505|NCT00352365|1182493|P1|Induction Therapy|Adverse Event|7
368506|NCT00352118|1182503|P1|Overall Study|Physician Decision|4
368507|NCT00352105|1182513|P1|Overall Study|Protocol Violation|2
368508|NCT00352105|1182513|P1|Overall Study|Adverse Event|19
368509|NCT00352105|1182513|P1|Overall Study|Lack of Efficacy|9
368510|NCT00352105|1182513|P1|Overall Study|Withdrawal by Subject|5
368511|NCT00352105|1182513|P1|Overall Study|Death|5
368512|NCT00352053|1182524|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
368513|NCT00352053|1182525|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
368514|NCT00352053|1182524|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
368515|NCT00352053|1182525|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
368516|NCT00352053|1182524|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
368517|NCT00352053|1182525|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
368518|NCT00352053|1182524|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
368519|NCT00352053|1182525|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
368520|NCT00352053|1182524|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
368521|NCT00352053|1182525|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
368522|NCT00352053|1182524|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
368523|NCT00352053|1182525|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
368524|NCT00352053|1182524|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
368525|NCT00352053|1182525|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
368526|NCT00352053|1182524|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
368527|NCT00352053|1182525|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
368528|NCT00352053|1182524|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
368529|NCT00352053|1182525|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
368530|NCT00352053|1182524|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
368531|NCT00352053|1182525|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
368532|NCT00352053|1182524|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
368533|NCT00352053|1182525|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
368534|NCT00352053|1182524|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
368535|NCT00352053|1182525|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
368536|NCT00352053|1182524|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
368537|NCT00352053|1182525|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
368538|NCT00352027|1182692|P1|Overall Study|Progressive disease|3
368539|NCT00351533|1183001|P2|Overall Study|Withdrawal by Subject|1
368540|NCT00351533|1183002|P1|Overall Study|Withdrawal by Subject|0
368541|NCT00351533|1183001|P2|Overall Study|Physician Decision|1
368542|NCT00351533|1183002|P1|Overall Study|Physician Decision|0
368543|NCT00351533|1183001|P2|Overall Study|Lost to Follow-up|3
368544|NCT00351533|1183002|P1|Overall Study|Lost to Follow-up|1
368545|NCT00351533|1183001|P2|Overall Study|Extubated before first BAL|0
368546|NCT00351533|1183002|P1|Overall Study|Extubated before first BAL|1
368547|NCT00351468|1183062|P1|Overall Study|Protocol Violation|3
368548|NCT00351468|1183062|P1|Overall Study|Lost to Follow-up|4
368549|NCT00351468|1183062|P1|Overall Study|Non-compliance|8
368550|NCT00351468|1183062|P1|Overall Study|Lack of Efficacy|32
368551|NCT00351468|1183062|P1|Overall Study|Various -follow up w clinical team|39
368552|NCT00351468|1183062|P1|Overall Study|Withdrawal by Subject|39
368553|NCT00351468|1183062|P1|Overall Study|Adverse Event|42
368554|NCT00351377|1183086|P1|Overall Study|Unsatisfactory therapeutic effect|1
368555|NCT00351377|1183086|P1|Overall Study|Death|1
368556|NCT00351377|1183086|P1|Overall Study|Adverse Event|5
368557|NCT00351351|1183100|P2|Overall Study|surgical access pbs; device issues|4
368558|NCT00351351|1183101|P1|Overall Study|surgical access pbs; device issues|9
368559|NCT00351273|1183127|P3|Overall Study|Lost to Follow-up|5
368560|NCT00351273|1183128|P2|Overall Study|Lost to Follow-up|2
368561|NCT00351273|1183129|P1|Overall Study|Lost to Follow-up|1
368562|NCT00350870|1183157|P4|Overall Study|Physician Decision|1
368563|NCT00350870|1183158|P3|Overall Study|Physician Decision|1
368564|NCT00350870|1183159|P2|Overall Study|Physician Decision|0
368565|NCT00350870|1183160|P1|Overall Study|Physician Decision|1
368566|NCT00350870|1183157|P4|Overall Study|Withdrawal by Subject|14
368567|NCT00350870|1183158|P3|Overall Study|Withdrawal by Subject|15
368568|NCT00350870|1183159|P2|Overall Study|Withdrawal by Subject|17
368569|NCT00350870|1183160|P1|Overall Study|Withdrawal by Subject|21
368570|NCT00350844|1183174|P1|Overall Study|Lost to Follow-up|1
368571|NCT00350792|1183178|P1|Overall Study|Lack of Efficacy|11
368572|NCT00350792|1183178|P1|Overall Study|Physician Decision|2
368573|NCT00350792|1183178|P1|Overall Study|Withdrawal by Subject|4
368574|NCT00350792|1183178|P1|Overall Study|Protocol Violation|1
368575|NCT00350792|1183178|P1|Overall Study|Death Not Study Drug Related|2
368576|NCT00350792|1183178|P1|Overall Study|Death from Study Drug Toxicity|1
368577|NCT00350792|1183178|P1|Overall Study|Death from Study Disease|1
368578|NCT00350792|1183178|P1|Overall Study|Adverse Event|11
368579|NCT00350779|1183188|P2|Overall Study|Non-compliance with study procedures|1
368580|NCT00350779|1183189|P1|Overall Study|Non-compliance with study procedures|0
368581|NCT00350779|1183188|P2|Overall Study|Patient Moved|1
368582|NCT00350779|1183189|P1|Overall Study|Patient Moved|2
368583|NCT00350779|1183188|P2|Overall Study|Withdrawal by Subject|8
368584|NCT00350779|1183189|P1|Overall Study|Withdrawal by Subject|9
368585|NCT00350779|1183188|P2|Overall Study|Protocol Violation|1
368586|NCT00350779|1183189|P1|Overall Study|Protocol Violation|3
368587|NCT00350779|1183188|P2|Overall Study|Physician Decision|4
368588|NCT00350779|1183189|P1|Overall Study|Physician Decision|2
368589|NCT00350779|1183188|P2|Overall Study|Lost to Follow-up|0
368590|NCT00350779|1183189|P1|Overall Study|Lost to Follow-up|2
368591|NCT00350779|1183188|P2|Overall Study|Lack of Efficacy|4
368592|NCT00350779|1183189|P1|Overall Study|Lack of Efficacy|0
368593|NCT00350779|1183188|P2|Overall Study|Adverse Event|2
368594|NCT00350779|1183189|P1|Overall Study|Adverse Event|4
368595|NCT00350727|1183210|P3|Phase II|Enrolled in Rollover Study|1
368596|NCT00350727|1183211|P2|Phase II|Enrolled in Rollover Study|0
368597|NCT00350727|1183212|P1|Phase II|Enrolled in Rollover Study|0
368598|NCT00350727|1183210|P3|Phase II|Sponsor Terminated Study|1
368599|NCT00350727|1183211|P2|Phase II|Sponsor Terminated Study|0
368600|NCT00350727|1183212|P1|Phase II|Sponsor Terminated Study|0
368601|NCT00350727|1183210|P3|Phase II|Death|2
368602|NCT00350727|1183211|P2|Phase II|Death|0
368603|NCT00350727|1183212|P1|Phase II|Death|0
368604|NCT00350727|1183210|P3|Phase II|Adverse Event|1
368605|NCT00350727|1183211|P2|Phase II|Adverse Event|1
368606|NCT00350727|1183212|P1|Phase II|Adverse Event|0
368607|NCT00350727|1183210|P3|Phase II|Withdrawal by Subject|1
368608|NCT00350727|1183211|P2|Phase II|Withdrawal by Subject|2
368609|NCT00350727|1183212|P1|Phase II|Withdrawal by Subject|0
368610|NCT00350727|1183210|P3|Phase II|Clinical Deterioration|0
368611|NCT00350727|1183211|P2|Phase II|Clinical Deterioration|1
368612|NCT00350727|1183212|P1|Phase II|Clinical Deterioration|0
368613|NCT00350727|1183210|P3|Phase II|Disease Progression|16
368614|NCT00350727|1183211|P2|Phase II|Disease Progression|15
368615|NCT00350727|1183212|P1|Phase II|Disease Progression|0
368616|NCT00350727|1183210|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
368617|NCT00350727|1183211|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
368618|NCT00350727|1183212|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
368619|NCT00350727|1183210|P3|Phase I: Dose Escalation|Physician Decision|0
368620|NCT00350727|1183211|P2|Phase I: Dose Escalation|Physician Decision|0
368621|NCT00350727|1183212|P1|Phase I: Dose Escalation|Physician Decision|1
368622|NCT00350727|1183210|P3|Phase I: Dose Escalation|Death|0
368623|NCT00350727|1183211|P2|Phase I: Dose Escalation|Death|0
368624|NCT00350727|1183212|P1|Phase I: Dose Escalation|Death|1
368625|NCT00350727|1183210|P3|Phase I: Dose Escalation|Lack of Efficacy|0
368626|NCT00350727|1183211|P2|Phase I: Dose Escalation|Lack of Efficacy|0
368627|NCT00350727|1183212|P1|Phase I: Dose Escalation|Lack of Efficacy|25
368628|NCT00350727|1183210|P3|Phase I: Dose Escalation|Adverse Event|0
368629|NCT00350727|1183211|P2|Phase I: Dose Escalation|Adverse Event|0
368630|NCT00350727|1183212|P1|Phase I: Dose Escalation|Adverse Event|4
368631|NCT00350636|1183356|P2|Overall Study|Other|2
368632|NCT00350636|1183357|P1|Overall Study|Other|1
368633|NCT00350636|1183356|P2|Overall Study|Physician Decision|2
368634|NCT00350636|1183357|P1|Overall Study|Physician Decision|0
368635|NCT00350636|1183356|P2|Overall Study|Lost to Follow-up|8
368636|NCT00350636|1183357|P1|Overall Study|Lost to Follow-up|9
368637|NCT00350636|1183356|P2|Overall Study|Withdrawal by Subject|17
368638|NCT00350636|1183357|P1|Overall Study|Withdrawal by Subject|13
368639|NCT00350636|1183356|P2|Overall Study|Protocol Violation|3
368640|NCT00350636|1183357|P1|Overall Study|Protocol Violation|1
368641|NCT00350636|1183356|P2|Overall Study|Adverse Event|13
368642|NCT00350636|1183357|P1|Overall Study|Adverse Event|19
368643|NCT00350623|1183376|P3|Overall Study|patient traveling outside the country|1
368644|NCT00350623|1183377|P2|Overall Study|patient traveling outside the country|0
368645|NCT00350623|1183378|P1|Overall Study|patient traveling outside the country|0
368646|NCT00350623|1183376|P3|Overall Study|Withdrawal by Subject|1
368647|NCT00350623|1183377|P2|Overall Study|Withdrawal by Subject|1
368648|NCT00350623|1183378|P1|Overall Study|Withdrawal by Subject|0
368649|NCT00350623|1183376|P3|Overall Study|Lost to Follow-up|4
368650|NCT00350623|1183377|P2|Overall Study|Lost to Follow-up|3
368651|NCT00350623|1183378|P1|Overall Study|Lost to Follow-up|8
368652|NCT00350519|1183397|P2|Overall Study|Withdrawal by Subject|2
368653|NCT00350519|1183398|P1|Overall Study|Withdrawal by Subject|3
368654|NCT00350519|1183397|P2|Overall Study|Protocol Violation|2
368655|NCT00350519|1183398|P1|Overall Study|Protocol Violation|1
368656|NCT00350519|1183397|P2|Overall Study|Physician Decision|1
368657|NCT00350519|1183398|P1|Overall Study|Physician Decision|0
368658|NCT00350519|1183397|P2|Overall Study|Death|1
368659|NCT00350519|1183398|P1|Overall Study|Death|0
368660|NCT00350402|1183412|P2|Overall Study|Lost to Follow-up|1
368661|NCT00350402|1183413|P1|Overall Study|Lost to Follow-up|1
368662|NCT00350272|1183431|P2|Open-Label 84 Week Treatment|Sponsor decision|1
368663|NCT00350272|1183432|P1|Open-Label 84 Week Treatment|Sponsor decision|2
368664|NCT00350272|1183431|P2|Open-Label 84 Week Treatment|Physician Decision|2
368665|NCT00350272|1183432|P1|Open-Label 84 Week Treatment|Physician Decision|1
368666|NCT00350272|1183431|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
368667|NCT00350272|1183432|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
368668|NCT00350272|1183431|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
368669|NCT00350272|1183432|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
368670|NCT00350272|1183431|P2|Open-Label 84 Week Treatment|Adverse Event|1
368671|NCT00350272|1183432|P1|Open-Label 84 Week Treatment|Adverse Event|2
368672|NCT00350272|1183431|P2|Blinded 12 Week Treatment|Sponsor decision|1
368673|NCT00350272|1183432|P1|Blinded 12 Week Treatment|Sponsor decision|0
368674|NCT00350272|1183431|P2|Blinded 12 Week Treatment|Physician Decision|1
368675|NCT00350272|1183432|P1|Blinded 12 Week Treatment|Physician Decision|2
368676|NCT00350272|1183431|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
368677|NCT00350272|1183432|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
368678|NCT00350272|1183431|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
368679|NCT00350272|1183432|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
368680|NCT00350272|1183431|P2|Blinded 12 Week Treatment|Death|0
368681|NCT00350272|1183432|P1|Blinded 12 Week Treatment|Death|1
368682|NCT00350272|1183431|P2|Blinded 12 Week Treatment|Adverse Event|0
368683|NCT00350272|1183432|P1|Blinded 12 Week Treatment|Adverse Event|1
368684|NCT00350207|1183454|P3|Overall Study|Other|1
368685|NCT00350207|1183455|P2|Overall Study|Other|3
368686|NCT00350207|1183456|P1|Overall Study|Other|1
368687|NCT00350207|1183454|P3|Overall Study|Withdrawal by Subject|1
368688|NCT00350207|1183455|P2|Overall Study|Withdrawal by Subject|1
368689|NCT00350207|1183456|P1|Overall Study|Withdrawal by Subject|0
368690|NCT00350207|1183454|P3|Overall Study|Lost to Follow-up|1
368691|NCT00350207|1183455|P2|Overall Study|Lost to Follow-up|0
368692|NCT00350207|1183456|P1|Overall Study|Lost to Follow-up|1
368693|NCT00350207|1183454|P3|Overall Study|Lack of Efficacy|2
368694|NCT00350207|1183455|P2|Overall Study|Lack of Efficacy|0
368695|NCT00350207|1183456|P1|Overall Study|Lack of Efficacy|1
368696|NCT00350207|1183454|P3|Overall Study|Adverse Event|2
368697|NCT00350207|1183455|P2|Overall Study|Adverse Event|2
368698|NCT00350207|1183456|P1|Overall Study|Adverse Event|5
368699|NCT00349921|1183670|P4|First Spinal Injection|Adverse Event|0
368700|NCT00349921|1183671|P3|First Spinal Injection|Adverse Event|1
368701|NCT00349921|1183672|P2|First Spinal Injection|Adverse Event|0
368702|NCT00349921|1183673|P1|First Spinal Injection|Adverse Event|0
368703|NCT00349921|1183670|P4|First Spinal Injection|Physician Decision|0
368704|NCT00349921|1183671|P3|First Spinal Injection|Physician Decision|0
368705|NCT00349921|1183672|P2|First Spinal Injection|Physician Decision|0
368706|NCT00349921|1183673|P1|First Spinal Injection|Physician Decision|1
368707|NCT00349908|1183684|P2|Overall Study|Withdrawal by Subject|4
368708|NCT00349908|1183685|P1|Overall Study|Withdrawal by Subject|0
368709|NCT00349752|1183705|P2|Overall Study|Other:History of squamous cell carcinoma|0
368710|NCT00349752|1183706|P1|Overall Study|Other:History of squamous cell carcinoma|1
368711|NCT00349752|1183705|P2|Overall Study|Other: Inadvertently unblinded|0
368712|NCT00349752|1183706|P1|Overall Study|Other: Inadvertently unblinded|1
368713|NCT00349752|1183705|P2|Overall Study|Other: Ineligible|0
368714|NCT00349752|1183706|P1|Overall Study|Other: Ineligible|1
368715|NCT00349752|1183705|P2|Overall Study|Other: Patient's steroid use|0
368716|NCT00349752|1183706|P1|Overall Study|Other: Patient's steroid use|1
368717|NCT00349752|1183705|P2|Overall Study|Other: Patient stopped steroids|1
368718|NCT00349752|1183706|P1|Overall Study|Other: Patient stopped steroids|0
368719|NCT00349752|1183705|P2|Overall Study|Other: Non compliance|1
368720|NCT00349752|1183706|P1|Overall Study|Other: Non compliance|0
368721|NCT00349752|1183705|P2|Overall Study|Other: Required exclusionary medication|1
368722|NCT00349752|1183706|P1|Overall Study|Other: Required exclusionary medication|0
368723|NCT00349752|1183705|P2|Overall Study|Personal reasons|5
368724|NCT00349752|1183706|P1|Overall Study|Personal reasons|6
368725|NCT00349752|1183705|P2|Overall Study|Lost to Follow-up|2
368726|NCT00349752|1183706|P1|Overall Study|Lost to Follow-up|4
368727|NCT00349752|1183705|P2|Overall Study|Lack of Efficacy|42
368728|NCT00349752|1183706|P1|Overall Study|Lack of Efficacy|37
368729|NCT00349752|1183705|P2|Overall Study|Adverse Event|12
368730|NCT00349752|1183706|P1|Overall Study|Adverse Event|8
368731|NCT00349622|1183734|P2|Overall Study|Withdrawal by Subject|9
368732|NCT00349622|1183735|P1|Overall Study|Withdrawal by Subject|5
368733|NCT00349622|1183734|P2|Overall Study|Lost to Follow-up|1
368734|NCT00349622|1183735|P1|Overall Study|Lost to Follow-up|5
368735|NCT00349622|1183734|P2|Overall Study|Death|86
368736|NCT00349622|1183735|P1|Overall Study|Death|168
368737|NCT00349349|1183772|P3|Overall Study|New Malignancy (Bladder Cancer)|0
368738|NCT00349349|1183773|P2|Overall Study|New Malignancy (Bladder Cancer)|1
368739|NCT00349349|1183774|P1|Overall Study|New Malignancy (Bladder Cancer)|0
368740|NCT00349349|1183772|P3|Overall Study|No Response|0
368741|NCT00349349|1183773|P2|Overall Study|No Response|3
368742|NCT00349349|1183774|P1|Overall Study|No Response|0
368743|NCT00349349|1183772|P3|Overall Study|Physician Decision|1
368744|NCT00349349|1183773|P2|Overall Study|Physician Decision|2
368745|NCT00349349|1183774|P1|Overall Study|Physician Decision|1
368746|NCT00349349|1183772|P3|Overall Study|Participant Reduced General Condition|0
368747|NCT00349349|1183773|P2|Overall Study|Participant Reduced General Condition|1
368748|NCT00349349|1183774|P1|Overall Study|Participant Reduced General Condition|0
368749|NCT00349349|1183772|P3|Overall Study|Other Treatment Selected|0
368750|NCT00349349|1183773|P2|Overall Study|Other Treatment Selected|0
368751|NCT00349349|1183774|P1|Overall Study|Other Treatment Selected|2
368752|NCT00349349|1183772|P3|Overall Study|Death|1
368753|NCT00349349|1183773|P2|Overall Study|Death|10
368754|NCT00349349|1183774|P1|Overall Study|Death|13
368755|NCT00349349|1183772|P3|Overall Study|Withdrawn due to Disease Progression|1
368756|NCT00349349|1183773|P2|Overall Study|Withdrawn due to Disease Progression|37
368757|NCT00349349|1183774|P1|Overall Study|Withdrawn due to Disease Progression|27
368758|NCT00349349|1183772|P3|Overall Study|Withdrawal by Subject|1
368759|NCT00349349|1183773|P2|Overall Study|Withdrawal by Subject|2
368760|NCT00349349|1183774|P1|Overall Study|Withdrawal by Subject|5
368761|NCT00349349|1183772|P3|Overall Study|Adverse Event|2
368762|NCT00349349|1183773|P2|Overall Study|Adverse Event|6
368763|NCT00349349|1183774|P1|Overall Study|Adverse Event|5
368764|NCT00348933|1183863|P1|Overall Study|Adverse Event|7
368765|NCT00348933|1183863|P1|Overall Study|Protocol Violation|2
368766|NCT00348933|1183863|P1|Overall Study|Lost to Follow-up|6
368767|NCT00348933|1183863|P1|Overall Study|Withdrawal by Subject|10
368768|NCT00348881|1183871|P2|Overall Study|Serious Adverse Event|2
368769|NCT00348881|1183872|P1|Overall Study|Serious Adverse Event|0
368770|NCT00348881|1183871|P2|Overall Study|Adverse Event|0
368771|NCT00348881|1183872|P1|Overall Study|Adverse Event|2
368772|NCT00348881|1183871|P2|Overall Study|Withdrawal by Subject|4
368773|NCT00348881|1183872|P1|Overall Study|Withdrawal by Subject|3
368774|NCT00348881|1183871|P2|Overall Study|Lost to Follow-up|6
368775|NCT00348881|1183872|P1|Overall Study|Lost to Follow-up|12
368776|NCT00348816|1183884|P1|Overall Study|Noncompliance with radiation treatment|1
368777|NCT00348790|1183888|P1|Completed Treatment|Unable to travel to study site|1
368778|NCT00348790|1183888|P1|Completed Treatment|Required surgery|2
368779|NCT00348790|1183888|P1|Completed Treatment|Adverse Event|4
368780|NCT00348790|1183888|P1|Completed Treatment|Disease progression|14
368781|NCT00348790|1183888|P1|Completed Treatment|Withdrawal by Subject|4
368782|NCT00348686|1183893|P1|Overall Study|Multiple Reasons|8
368783|NCT00348686|1183893|P1|Overall Study|Lost to Follow-up|2
368784|NCT00348686|1183893|P1|Overall Study|Protocol Violation|6
368785|NCT00348686|1183893|P1|Overall Study|Adverse Event|5
368786|NCT00348686|1183893|P1|Overall Study|Withdrawal by Subject|45
368787|NCT00348673|1183910|P9|Stage 1|Randomized but not Treated|0
368788|NCT00348673|1183911|P8|Stage 1|Randomized but not Treated|0
368789|NCT00348673|1183912|P7|Stage 1|Randomized but not Treated|0
368790|NCT00348673|1183913|P6|Stage 1|Randomized but not Treated|0
368791|NCT00348673|1183914|P5|Stage 1|Randomized but not Treated|0
368792|NCT00348673|1183915|P4|Stage 1|Randomized but not Treated|0
368793|NCT00348673|1183916|P3|Stage 1|Randomized but not Treated|1
368794|NCT00348673|1183917|P2|Stage 1|Randomized but not Treated|0
368795|NCT00348673|1183918|P1|Stage 1|Randomized but not Treated|0
368796|NCT00348556|1183965|P1|Overall Study|Adverse Event|1
368797|NCT00348374|1183972|P2|Overall Study|randomized but did not receive treatment|7
368798|NCT00348374|1183973|P1|Overall Study|randomized but did not receive treatment|0
368799|NCT00348374|1183972|P2|Overall Study|ongoing at date of cutoff|1
368800|NCT00348374|1183973|P1|Overall Study|ongoing at date of cutoff|1
368801|NCT00348374|1183972|P2|Overall Study|Other|12
368802|NCT00348374|1183973|P1|Overall Study|Other|11
368803|NCT00348374|1183972|P2|Overall Study|Withdrawal by Subject|5
368804|NCT00348374|1183973|P1|Overall Study|Withdrawal by Subject|5
368805|NCT00348374|1183972|P2|Overall Study|Lost to Follow-up|3
368806|NCT00348374|1183973|P1|Overall Study|Lost to Follow-up|1
368807|NCT00348374|1183972|P2|Overall Study|Adverse Event|4
368808|NCT00348374|1183973|P1|Overall Study|Adverse Event|1
368809|NCT00348348|1184020|P2|Overall Study|Adverse event probably related to study|0
368810|NCT00348348|1184021|P1|Overall Study|Adverse event probably related to study|1
368811|NCT00348348|1184020|P2|Overall Study|Worsening of BC - Unlikely related|2
368812|NCT00348348|1184021|P1|Overall Study|Worsening of BC - Unlikely related|1
368813|NCT00348348|1184020|P2|Overall Study|Worsening of BC - Unrelated to study|3
368814|NCT00348348|1184021|P1|Overall Study|Worsening of BC - Unrelated to study|0
368815|NCT00348348|1184020|P2|Overall Study|Dissallowed Meds - possibly releated|1
368816|NCT00348348|1184021|P1|Overall Study|Dissallowed Meds - possibly releated|1
368817|NCT00348348|1184020|P2|Overall Study|Dissallowed Meds - unlikley related|1
368818|NCT00348348|1184021|P1|Overall Study|Dissallowed Meds - unlikley related|1
368819|NCT00348348|1184020|P2|Overall Study|Dissallowed Meds - unrelated to study|3
368820|NCT00348348|1184021|P1|Overall Study|Dissallowed Meds - unrelated to study|1
368821|NCT00348348|1184020|P2|Overall Study|Not specified|4
368822|NCT00348348|1184021|P1|Overall Study|Not specified|7
368823|NCT00348348|1184020|P2|Overall Study|Withdrawal by Subject|1
368824|NCT00348348|1184021|P1|Overall Study|Withdrawal by Subject|4
368825|NCT00348348|1184020|P2|Overall Study|Lost to Follow-up|10
368826|NCT00348348|1184021|P1|Overall Study|Lost to Follow-up|8
368827|NCT00348348|1184020|P2|Overall Study|Lack of Efficacy|1
368828|NCT00348348|1184021|P1|Overall Study|Lack of Efficacy|1
368829|NCT00348348|1184020|P2|Overall Study|Adverse event - unrelated to study drug|1
368830|NCT00348348|1184021|P1|Overall Study|Adverse event - unrelated to study drug|0
368831|NCT00348283|1184035|P2|Open Label|Sponsor decision|1
368832|NCT00348283|1184036|P1|Open Label|Sponsor decision|0
368833|NCT00348283|1184035|P2|Open Label|Pregnancy|1
368834|NCT00348283|1184036|P1|Open Label|Pregnancy|0
368835|NCT00348283|1184035|P2|Open Label|Subject moved to the United States|1
368836|NCT00348283|1184036|P1|Open Label|Subject moved to the United States|0
368837|NCT00348283|1184035|P2|Open Label|Administrative reasons|5
368838|NCT00348283|1184036|P1|Open Label|Administrative reasons|0
368839|NCT00348283|1184035|P2|Open Label|Lack of Efficacy|13
368840|NCT00348283|1184036|P1|Open Label|Lack of Efficacy|0
368841|NCT00348283|1184035|P2|Open Label|Lost to Follow-up|1
368842|NCT00348283|1184036|P1|Open Label|Lost to Follow-up|0
368843|NCT00348283|1184035|P2|Open Label|Withdrawal by Subject|4
368844|NCT00348283|1184036|P1|Open Label|Withdrawal by Subject|0
368845|NCT00348283|1184035|P2|Open Label|Adverse Event|8
368846|NCT00348283|1184036|P1|Open Label|Adverse Event|0
368847|NCT00348283|1184035|P2|Double Blind|Pregnancy|1
368848|NCT00348283|1184036|P1|Double Blind|Pregnancy|0
368849|NCT00348283|1184035|P2|Double Blind|Lack of Efficacy|2
368850|NCT00348283|1184036|P1|Double Blind|Lack of Efficacy|2
368851|NCT00348283|1184035|P2|Double Blind|Protocol Violation|1
368852|NCT00348283|1184036|P1|Double Blind|Protocol Violation|0
368853|NCT00348283|1184035|P2|Double Blind|Withdrawal by Subject|1
368854|NCT00348283|1184036|P1|Double Blind|Withdrawal by Subject|1
368855|NCT00348283|1184035|P2|Double Blind|Adverse Event|5
368856|NCT00348283|1184036|P1|Double Blind|Adverse Event|2
368857|NCT00348283|1184035|P2|Induction|Protocol Violation|4
368858|NCT00348283|1184036|P1|Induction|Protocol Violation|0
368859|NCT00348283|1184035|P2|Induction|Adverse Event|2
368860|NCT00348283|1184036|P1|Induction|Adverse Event|0
368861|NCT00347958|1184052|P1|Overall Study|Withdrawal by Subject|1
368862|NCT00347958|1184052|P1|Overall Study|Protocol Violation|2
368863|NCT00347958|1184052|P1|Overall Study|Adverse Event|1
368864|NCT00347932|1184061|P2|Overall Study|Did not meet inclusion criteria|8
368865|NCT00347932|1184062|P1|Overall Study|Did not meet inclusion criteria|4
368866|NCT00347932|1184061|P2|Overall Study|Withdrawal by Subject|16
368867|NCT00347932|1184062|P1|Overall Study|Withdrawal by Subject|10
368868|NCT00347932|1184061|P2|Overall Study|Lost to Follow-up|9
368869|NCT00347932|1184062|P1|Overall Study|Lost to Follow-up|10
368870|NCT00347932|1184061|P2|Overall Study|Lack of Efficacy|14
368871|NCT00347932|1184062|P1|Overall Study|Lack of Efficacy|3
368872|NCT00347932|1184061|P2|Overall Study|Adverse Event|5
368873|NCT00347932|1184062|P1|Overall Study|Adverse Event|4
368874|NCT00347919|1184077|P3|Overall Study|Missing|2
368875|NCT00347919|1184078|P2|Overall Study|Missing|1
368876|NCT00347919|1184079|P1|Overall Study|Missing|2
368877|NCT00347919|1184077|P3|Overall Study|Par. Started Other Treatment|1
368878|NCT00347919|1184078|P2|Overall Study|Par. Started Other Treatment|1
368879|NCT00347919|1184079|P1|Overall Study|Par. Started Other Treatment|1
368880|NCT00347919|1184077|P3|Overall Study|Death|19
368881|NCT00347919|1184078|P2|Overall Study|Death|42
368882|NCT00347919|1184079|P1|Overall Study|Death|35
368883|NCT00347919|1184077|P3|Overall Study|Sponsor terminated study|16
368884|NCT00347919|1184078|P2|Overall Study|Sponsor terminated study|10
368885|NCT00347919|1184079|P1|Overall Study|Sponsor terminated study|15
368886|NCT00347919|1184077|P3|Overall Study|Physician Decision|0
368887|NCT00347919|1184078|P2|Overall Study|Physician Decision|1
368888|NCT00347919|1184079|P1|Overall Study|Physician Decision|1
368889|NCT00347919|1184077|P3|Overall Study|Withdrawal by Subject|0
368890|NCT00347919|1184078|P2|Overall Study|Withdrawal by Subject|8
368891|NCT00347919|1184079|P1|Overall Study|Withdrawal by Subject|6
368892|NCT00347919|1184077|P3|Overall Study|Lost to Follow-up|0
368893|NCT00347919|1184078|P2|Overall Study|Lost to Follow-up|13
368894|NCT00347919|1184079|P1|Overall Study|Lost to Follow-up|11
368895|NCT00347438|1184099|P1|Overall Study|Physician Decision|1
368896|NCT00347438|1184099|P1|Overall Study|Withdrawal by Subject|1
368897|NCT00347360|1184121|P15|Overall Study|Visits conflicted with new job|0
368898|NCT00347360|1184122|P14|Overall Study|Visits conflicted with new job|0
368899|NCT00347360|1184123|P13|Overall Study|Visits conflicted with new job|0
368900|NCT00347360|1184124|P12|Overall Study|Visits conflicted with new job|0
368901|NCT00347360|1184125|P11|Overall Study|Visits conflicted with new job|0
368902|NCT00347360|1184126|P10|Overall Study|Visits conflicted with new job|0
368903|NCT00347360|1184127|P9|Overall Study|Visits conflicted with new job|0
368904|NCT00347360|1184128|P8|Overall Study|Visits conflicted with new job|0
368905|NCT00347360|1184129|P7|Overall Study|Visits conflicted with new job|1
368906|NCT00347360|1184130|P6|Overall Study|Visits conflicted with new job|0
368907|NCT00347360|1184131|P5|Overall Study|Visits conflicted with new job|0
368908|NCT00347360|1184132|P4|Overall Study|Visits conflicted with new job|0
368909|NCT00347360|1184133|P3|Overall Study|Visits conflicted with new job|0
368910|NCT00347360|1184134|P2|Overall Study|Visits conflicted with new job|0
368911|NCT00347360|1184135|P1|Overall Study|Visits conflicted with new job|0
368912|NCT00347360|1184121|P15|Overall Study|Subject refuse to sign updated consent|1
368913|NCT00347360|1184122|P14|Overall Study|Subject refuse to sign updated consent|0
368914|NCT00347360|1184123|P13|Overall Study|Subject refuse to sign updated consent|0
368915|NCT00347360|1184124|P12|Overall Study|Subject refuse to sign updated consent|0
368916|NCT00347360|1184125|P11|Overall Study|Subject refuse to sign updated consent|0
368917|NCT00347360|1184126|P10|Overall Study|Subject refuse to sign updated consent|0
368918|NCT00347360|1184127|P9|Overall Study|Subject refuse to sign updated consent|0
368919|NCT00347360|1184128|P8|Overall Study|Subject refuse to sign updated consent|0
368920|NCT00347360|1184129|P7|Overall Study|Subject refuse to sign updated consent|0
368921|NCT00347360|1184130|P6|Overall Study|Subject refuse to sign updated consent|0
368922|NCT00347360|1184131|P5|Overall Study|Subject refuse to sign updated consent|0
368923|NCT00347360|1184132|P4|Overall Study|Subject refuse to sign updated consent|0
368924|NCT00347360|1184133|P3|Overall Study|Subject refuse to sign updated consent|0
368925|NCT00347360|1184134|P2|Overall Study|Subject refuse to sign updated consent|0
368926|NCT00347360|1184135|P1|Overall Study|Subject refuse to sign updated consent|0
368927|NCT00347360|1184121|P15|Overall Study|Subject left town, ran out of study drug|0
368928|NCT00347360|1184122|P14|Overall Study|Subject left town, ran out of study drug|1
368929|NCT00347360|1184123|P13|Overall Study|Subject left town, ran out of study drug|0
368930|NCT00347360|1184124|P12|Overall Study|Subject left town, ran out of study drug|0
368931|NCT00347360|1184125|P11|Overall Study|Subject left town, ran out of study drug|0
368932|NCT00347360|1184126|P10|Overall Study|Subject left town, ran out of study drug|0
368933|NCT00347360|1184127|P9|Overall Study|Subject left town, ran out of study drug|0
368934|NCT00347360|1184128|P8|Overall Study|Subject left town, ran out of study drug|0
368935|NCT00347360|1184129|P7|Overall Study|Subject left town, ran out of study drug|0
368936|NCT00347360|1184130|P6|Overall Study|Subject left town, ran out of study drug|0
368937|NCT00347360|1184131|P5|Overall Study|Subject left town, ran out of study drug|0
368938|NCT00347360|1184132|P4|Overall Study|Subject left town, ran out of study drug|0
368939|NCT00347360|1184133|P3|Overall Study|Subject left town, ran out of study drug|0
368940|NCT00347360|1184134|P2|Overall Study|Subject left town, ran out of study drug|0
368941|NCT00347360|1184135|P1|Overall Study|Subject left town, ran out of study drug|0
369021|NCT00347360|1184125|P11|Overall Study|Abnormal lab values|0
368942|NCT00347360|1184121|P15|Overall Study|Prolonged duration between visits|0
368943|NCT00347360|1184122|P14|Overall Study|Prolonged duration between visits|0
368944|NCT00347360|1184123|P13|Overall Study|Prolonged duration between visits|1
368945|NCT00347360|1184124|P12|Overall Study|Prolonged duration between visits|0
368946|NCT00347360|1184125|P11|Overall Study|Prolonged duration between visits|0
368947|NCT00347360|1184126|P10|Overall Study|Prolonged duration between visits|0
368948|NCT00347360|1184127|P9|Overall Study|Prolonged duration between visits|0
368949|NCT00347360|1184128|P8|Overall Study|Prolonged duration between visits|0
368950|NCT00347360|1184129|P7|Overall Study|Prolonged duration between visits|0
368951|NCT00347360|1184130|P6|Overall Study|Prolonged duration between visits|0
368952|NCT00347360|1184131|P5|Overall Study|Prolonged duration between visits|0
368953|NCT00347360|1184132|P4|Overall Study|Prolonged duration between visits|0
368954|NCT00347360|1184133|P3|Overall Study|Prolonged duration between visits|0
368955|NCT00347360|1184134|P2|Overall Study|Prolonged duration between visits|0
368956|NCT00347360|1184135|P1|Overall Study|Prolonged duration between visits|0
368957|NCT00347360|1184121|P15|Overall Study|Failed inclusion criteria #4|0
368958|NCT00347360|1184122|P14|Overall Study|Failed inclusion criteria #4|0
368959|NCT00347360|1184123|P13|Overall Study|Failed inclusion criteria #4|0
368960|NCT00347360|1184124|P12|Overall Study|Failed inclusion criteria #4|1
368961|NCT00347360|1184125|P11|Overall Study|Failed inclusion criteria #4|0
368962|NCT00347360|1184126|P10|Overall Study|Failed inclusion criteria #4|0
368963|NCT00347360|1184127|P9|Overall Study|Failed inclusion criteria #4|0
368964|NCT00347360|1184128|P8|Overall Study|Failed inclusion criteria #4|0
368965|NCT00347360|1184129|P7|Overall Study|Failed inclusion criteria #4|0
368966|NCT00347360|1184130|P6|Overall Study|Failed inclusion criteria #4|0
368967|NCT00347360|1184131|P5|Overall Study|Failed inclusion criteria #4|0
368968|NCT00347360|1184132|P4|Overall Study|Failed inclusion criteria #4|0
368969|NCT00347360|1184133|P3|Overall Study|Failed inclusion criteria #4|0
368970|NCT00347360|1184134|P2|Overall Study|Failed inclusion criteria #4|0
368971|NCT00347360|1184135|P1|Overall Study|Failed inclusion criteria #4|0
368972|NCT00347360|1184121|P15|Overall Study|Randomized in error|0
368973|NCT00347360|1184122|P14|Overall Study|Randomized in error|0
368974|NCT00347360|1184123|P13|Overall Study|Randomized in error|0
368975|NCT00347360|1184124|P12|Overall Study|Randomized in error|1
368976|NCT00347360|1184125|P11|Overall Study|Randomized in error|0
368977|NCT00347360|1184126|P10|Overall Study|Randomized in error|0
368978|NCT00347360|1184127|P9|Overall Study|Randomized in error|0
368979|NCT00347360|1184128|P8|Overall Study|Randomized in error|0
368980|NCT00347360|1184129|P7|Overall Study|Randomized in error|0
368981|NCT00347360|1184130|P6|Overall Study|Randomized in error|0
368982|NCT00347360|1184131|P5|Overall Study|Randomized in error|0
368983|NCT00347360|1184132|P4|Overall Study|Randomized in error|0
368984|NCT00347360|1184133|P3|Overall Study|Randomized in error|0
368985|NCT00347360|1184134|P2|Overall Study|Randomized in error|0
368986|NCT00347360|1184135|P1|Overall Study|Randomized in error|0
368987|NCT00347360|1184121|P15|Overall Study|Did not meet criteria before ABPM|0
368988|NCT00347360|1184122|P14|Overall Study|Did not meet criteria before ABPM|0
368989|NCT00347360|1184123|P13|Overall Study|Did not meet criteria before ABPM|0
368990|NCT00347360|1184124|P12|Overall Study|Did not meet criteria before ABPM|0
368991|NCT00347360|1184125|P11|Overall Study|Did not meet criteria before ABPM|1
368992|NCT00347360|1184126|P10|Overall Study|Did not meet criteria before ABPM|0
368993|NCT00347360|1184127|P9|Overall Study|Did not meet criteria before ABPM|0
368994|NCT00347360|1184128|P8|Overall Study|Did not meet criteria before ABPM|0
368995|NCT00347360|1184129|P7|Overall Study|Did not meet criteria before ABPM|0
368996|NCT00347360|1184130|P6|Overall Study|Did not meet criteria before ABPM|0
368997|NCT00347360|1184131|P5|Overall Study|Did not meet criteria before ABPM|0
368998|NCT00347360|1184132|P4|Overall Study|Did not meet criteria before ABPM|0
368999|NCT00347360|1184133|P3|Overall Study|Did not meet criteria before ABPM|0
369000|NCT00347360|1184134|P2|Overall Study|Did not meet criteria before ABPM|0
369001|NCT00347360|1184135|P1|Overall Study|Did not meet criteria before ABPM|0
369002|NCT00347360|1184121|P15|Overall Study|PI recommended early withdrawal|0
369003|NCT00347360|1184122|P14|Overall Study|PI recommended early withdrawal|0
369004|NCT00347360|1184123|P13|Overall Study|PI recommended early withdrawal|0
369005|NCT00347360|1184124|P12|Overall Study|PI recommended early withdrawal|0
369006|NCT00347360|1184125|P11|Overall Study|PI recommended early withdrawal|0
369007|NCT00347360|1184126|P10|Overall Study|PI recommended early withdrawal|1
369008|NCT00347360|1184127|P9|Overall Study|PI recommended early withdrawal|0
369009|NCT00347360|1184128|P8|Overall Study|PI recommended early withdrawal|0
369010|NCT00347360|1184129|P7|Overall Study|PI recommended early withdrawal|0
369011|NCT00347360|1184130|P6|Overall Study|PI recommended early withdrawal|0
369012|NCT00347360|1184131|P5|Overall Study|PI recommended early withdrawal|0
369013|NCT00347360|1184132|P4|Overall Study|PI recommended early withdrawal|0
369014|NCT00347360|1184133|P3|Overall Study|PI recommended early withdrawal|0
369015|NCT00347360|1184134|P2|Overall Study|PI recommended early withdrawal|0
369016|NCT00347360|1184135|P1|Overall Study|PI recommended early withdrawal|0
369017|NCT00347360|1184121|P15|Overall Study|Abnormal lab values|0
369018|NCT00347360|1184122|P14|Overall Study|Abnormal lab values|0
369019|NCT00347360|1184123|P13|Overall Study|Abnormal lab values|0
369020|NCT00347360|1184124|P12|Overall Study|Abnormal lab values|0
369022|NCT00347360|1184126|P10|Overall Study|Abnormal lab values|0
369023|NCT00347360|1184127|P9|Overall Study|Abnormal lab values|0
369024|NCT00347360|1184128|P8|Overall Study|Abnormal lab values|0
369025|NCT00347360|1184129|P7|Overall Study|Abnormal lab values|1
369026|NCT00347360|1184130|P6|Overall Study|Abnormal lab values|0
369027|NCT00347360|1184131|P5|Overall Study|Abnormal lab values|0
369028|NCT00347360|1184132|P4|Overall Study|Abnormal lab values|0
369029|NCT00347360|1184133|P3|Overall Study|Abnormal lab values|0
369030|NCT00347360|1184134|P2|Overall Study|Abnormal lab values|0
369031|NCT00347360|1184135|P1|Overall Study|Abnormal lab values|0
369032|NCT00347360|1184121|P15|Overall Study|Subject did not meet end of study ABPM|0
369033|NCT00347360|1184122|P14|Overall Study|Subject did not meet end of study ABPM|1
369034|NCT00347360|1184123|P13|Overall Study|Subject did not meet end of study ABPM|1
369035|NCT00347360|1184124|P12|Overall Study|Subject did not meet end of study ABPM|0
369036|NCT00347360|1184125|P11|Overall Study|Subject did not meet end of study ABPM|1
369037|NCT00347360|1184126|P10|Overall Study|Subject did not meet end of study ABPM|0
369038|NCT00347360|1184127|P9|Overall Study|Subject did not meet end of study ABPM|0
369039|NCT00347360|1184128|P8|Overall Study|Subject did not meet end of study ABPM|0
369040|NCT00347360|1184129|P7|Overall Study|Subject did not meet end of study ABPM|1
369041|NCT00347360|1184130|P6|Overall Study|Subject did not meet end of study ABPM|0
369042|NCT00347360|1184131|P5|Overall Study|Subject did not meet end of study ABPM|0
369043|NCT00347360|1184132|P4|Overall Study|Subject did not meet end of study ABPM|0
369044|NCT00347360|1184133|P3|Overall Study|Subject did not meet end of study ABPM|0
369045|NCT00347360|1184134|P2|Overall Study|Subject did not meet end of study ABPM|0
369046|NCT00347360|1184135|P1|Overall Study|Subject did not meet end of study ABPM|0
369047|NCT00347360|1184121|P15|Overall Study|P.I. recommended due to blood pressure|0
369048|NCT00347360|1184122|P14|Overall Study|P.I. recommended due to blood pressure|0
369049|NCT00347360|1184123|P13|Overall Study|P.I. recommended due to blood pressure|0
369050|NCT00347360|1184124|P12|Overall Study|P.I. recommended due to blood pressure|0
369051|NCT00347360|1184125|P11|Overall Study|P.I. recommended due to blood pressure|0
369052|NCT00347360|1184126|P10|Overall Study|P.I. recommended due to blood pressure|0
369053|NCT00347360|1184127|P9|Overall Study|P.I. recommended due to blood pressure|0
369054|NCT00347360|1184128|P8|Overall Study|P.I. recommended due to blood pressure|0
369055|NCT00347360|1184129|P7|Overall Study|P.I. recommended due to blood pressure|0
369056|NCT00347360|1184130|P6|Overall Study|P.I. recommended due to blood pressure|0
369057|NCT00347360|1184131|P5|Overall Study|P.I. recommended due to blood pressure|1
369058|NCT00347360|1184132|P4|Overall Study|P.I. recommended due to blood pressure|0
369059|NCT00347360|1184133|P3|Overall Study|P.I. recommended due to blood pressure|0
369060|NCT00347360|1184134|P2|Overall Study|P.I. recommended due to blood pressure|0
369061|NCT00347360|1184135|P1|Overall Study|P.I. recommended due to blood pressure|0
369062|NCT00347360|1184121|P15|Overall Study|Per sponsors instruction|0
369063|NCT00347360|1184122|P14|Overall Study|Per sponsors instruction|0
369064|NCT00347360|1184123|P13|Overall Study|Per sponsors instruction|0
369065|NCT00347360|1184124|P12|Overall Study|Per sponsors instruction|0
369066|NCT00347360|1184125|P11|Overall Study|Per sponsors instruction|0
369067|NCT00347360|1184126|P10|Overall Study|Per sponsors instruction|0
369068|NCT00347360|1184127|P9|Overall Study|Per sponsors instruction|0
369069|NCT00347360|1184128|P8|Overall Study|Per sponsors instruction|0
369070|NCT00347360|1184129|P7|Overall Study|Per sponsors instruction|0
369071|NCT00347360|1184130|P6|Overall Study|Per sponsors instruction|0
369072|NCT00347360|1184131|P5|Overall Study|Per sponsors instruction|0
369073|NCT00347360|1184132|P4|Overall Study|Per sponsors instruction|0
369074|NCT00347360|1184133|P3|Overall Study|Per sponsors instruction|0
369075|NCT00347360|1184134|P2|Overall Study|Per sponsors instruction|1
369076|NCT00347360|1184135|P1|Overall Study|Per sponsors instruction|0
369077|NCT00347360|1184121|P15|Overall Study|Reason not listed/blank|0
369078|NCT00347360|1184122|P14|Overall Study|Reason not listed/blank|1
369079|NCT00347360|1184123|P13|Overall Study|Reason not listed/blank|0
369080|NCT00347360|1184124|P12|Overall Study|Reason not listed/blank|0
369081|NCT00347360|1184125|P11|Overall Study|Reason not listed/blank|0
369082|NCT00347360|1184126|P10|Overall Study|Reason not listed/blank|0
369083|NCT00347360|1184127|P9|Overall Study|Reason not listed/blank|0
369084|NCT00347360|1184128|P8|Overall Study|Reason not listed/blank|0
369085|NCT00347360|1184129|P7|Overall Study|Reason not listed/blank|1
369086|NCT00347360|1184130|P6|Overall Study|Reason not listed/blank|0
369087|NCT00347360|1184131|P5|Overall Study|Reason not listed/blank|0
369088|NCT00347360|1184132|P4|Overall Study|Reason not listed/blank|0
369089|NCT00347360|1184133|P3|Overall Study|Reason not listed/blank|0
369090|NCT00347360|1184134|P2|Overall Study|Reason not listed/blank|0
369091|NCT00347360|1184135|P1|Overall Study|Reason not listed/blank|1
369092|NCT00347360|1184121|P15|Overall Study|Lack of Efficacy|0
369093|NCT00347360|1184122|P14|Overall Study|Lack of Efficacy|0
369094|NCT00347360|1184123|P13|Overall Study|Lack of Efficacy|0
369095|NCT00347360|1184124|P12|Overall Study|Lack of Efficacy|0
369096|NCT00347360|1184125|P11|Overall Study|Lack of Efficacy|0
369097|NCT00347360|1184126|P10|Overall Study|Lack of Efficacy|0
369098|NCT00347360|1184127|P9|Overall Study|Lack of Efficacy|1
369099|NCT00347360|1184128|P8|Overall Study|Lack of Efficacy|1
369100|NCT00347360|1184129|P7|Overall Study|Lack of Efficacy|0
369101|NCT00347360|1184130|P6|Overall Study|Lack of Efficacy|1
369102|NCT00347360|1184131|P5|Overall Study|Lack of Efficacy|0
369103|NCT00347360|1184132|P4|Overall Study|Lack of Efficacy|1
369104|NCT00347360|1184133|P3|Overall Study|Lack of Efficacy|3
369105|NCT00347360|1184134|P2|Overall Study|Lack of Efficacy|1
369106|NCT00347360|1184135|P1|Overall Study|Lack of Efficacy|1
369107|NCT00347360|1184121|P15|Overall Study|Withdrawal by Subject|1
369108|NCT00347360|1184122|P14|Overall Study|Withdrawal by Subject|2
369109|NCT00347360|1184123|P13|Overall Study|Withdrawal by Subject|4
369110|NCT00347360|1184124|P12|Overall Study|Withdrawal by Subject|3
369111|NCT00347360|1184125|P11|Overall Study|Withdrawal by Subject|0
369112|NCT00347360|1184126|P10|Overall Study|Withdrawal by Subject|1
369113|NCT00347360|1184127|P9|Overall Study|Withdrawal by Subject|1
369114|NCT00347360|1184128|P8|Overall Study|Withdrawal by Subject|1
369115|NCT00347360|1184129|P7|Overall Study|Withdrawal by Subject|1
369116|NCT00347360|1184130|P6|Overall Study|Withdrawal by Subject|2
369117|NCT00347360|1184131|P5|Overall Study|Withdrawal by Subject|1
369118|NCT00347360|1184132|P4|Overall Study|Withdrawal by Subject|4
369119|NCT00347360|1184133|P3|Overall Study|Withdrawal by Subject|2
369120|NCT00347360|1184134|P2|Overall Study|Withdrawal by Subject|1
369121|NCT00347360|1184135|P1|Overall Study|Withdrawal by Subject|0
369122|NCT00347360|1184121|P15|Overall Study|Protocol Violation|0
369123|NCT00347360|1184122|P14|Overall Study|Protocol Violation|1
369124|NCT00347360|1184123|P13|Overall Study|Protocol Violation|0
369125|NCT00347360|1184124|P12|Overall Study|Protocol Violation|0
369126|NCT00347360|1184125|P11|Overall Study|Protocol Violation|0
369127|NCT00347360|1184126|P10|Overall Study|Protocol Violation|2
369128|NCT00347360|1184127|P9|Overall Study|Protocol Violation|1
369129|NCT00347360|1184128|P8|Overall Study|Protocol Violation|0
369130|NCT00347360|1184129|P7|Overall Study|Protocol Violation|0
369131|NCT00347360|1184130|P6|Overall Study|Protocol Violation|2
369132|NCT00347360|1184131|P5|Overall Study|Protocol Violation|1
369133|NCT00347360|1184132|P4|Overall Study|Protocol Violation|2
369134|NCT00347360|1184133|P3|Overall Study|Protocol Violation|1
369135|NCT00347360|1184134|P2|Overall Study|Protocol Violation|3
369136|NCT00347360|1184135|P1|Overall Study|Protocol Violation|2
369137|NCT00347360|1184121|P15|Overall Study|Lost to Follow-up|0
369138|NCT00347360|1184122|P14|Overall Study|Lost to Follow-up|0
369139|NCT00347360|1184123|P13|Overall Study|Lost to Follow-up|1
369140|NCT00347360|1184124|P12|Overall Study|Lost to Follow-up|0
369141|NCT00347360|1184125|P11|Overall Study|Lost to Follow-up|0
369142|NCT00347360|1184126|P10|Overall Study|Lost to Follow-up|2
369143|NCT00347360|1184127|P9|Overall Study|Lost to Follow-up|1
369144|NCT00347360|1184128|P8|Overall Study|Lost to Follow-up|1
369145|NCT00347360|1184129|P7|Overall Study|Lost to Follow-up|0
369146|NCT00347360|1184130|P6|Overall Study|Lost to Follow-up|1
369147|NCT00347360|1184131|P5|Overall Study|Lost to Follow-up|1
369148|NCT00347360|1184132|P4|Overall Study|Lost to Follow-up|2
369149|NCT00347360|1184133|P3|Overall Study|Lost to Follow-up|0
369150|NCT00347360|1184134|P2|Overall Study|Lost to Follow-up|0
369151|NCT00347360|1184135|P1|Overall Study|Lost to Follow-up|0
369152|NCT00347360|1184121|P15|Overall Study|Adverse Event|2
369153|NCT00347360|1184122|P14|Overall Study|Adverse Event|2
369154|NCT00347360|1184123|P13|Overall Study|Adverse Event|3
369155|NCT00347360|1184124|P12|Overall Study|Adverse Event|1
369156|NCT00347360|1184125|P11|Overall Study|Adverse Event|3
369157|NCT00347360|1184126|P10|Overall Study|Adverse Event|3
369158|NCT00347360|1184127|P9|Overall Study|Adverse Event|2
369159|NCT00347360|1184128|P8|Overall Study|Adverse Event|0
369160|NCT00347360|1184129|P7|Overall Study|Adverse Event|2
369161|NCT00347360|1184130|P6|Overall Study|Adverse Event|2
369162|NCT00347360|1184131|P5|Overall Study|Adverse Event|1
369163|NCT00347360|1184132|P4|Overall Study|Adverse Event|4
369164|NCT00347360|1184133|P3|Overall Study|Adverse Event|0
369165|NCT00347360|1184134|P2|Overall Study|Adverse Event|2
369166|NCT00347360|1184135|P1|Overall Study|Adverse Event|1
369167|NCT00347269|1184323|P2|Overall Study|Death|3
369168|NCT00347269|1184324|P1|Overall Study|Death|2
369169|NCT00347269|1184323|P2|Overall Study|Withdrawal by Subject|38
369170|NCT00347269|1184324|P1|Overall Study|Withdrawal by Subject|18
369171|NCT00347269|1184323|P2|Overall Study|Lost to Follow-up|65
369172|NCT00347269|1184324|P1|Overall Study|Lost to Follow-up|74
369173|NCT00347009|1184339|P1|Overall Study|Serious Adverse Event|1
369174|NCT00347009|1184339|P1|Overall Study|Increased ALT/HBV DNA|1
369175|NCT00347009|1184339|P1|Overall Study|Insufficient Viral Suppression|3
369176|NCT00347009|1184339|P1|Overall Study|Adverse Laboratory Experience|1
369177|NCT00347009|1184339|P1|Overall Study|Protocol Violation|2
369178|NCT00347009|1184339|P1|Overall Study|Lost to Follow-up|4
369179|NCT00347009|1184339|P1|Overall Study|Physician Decision|5
369180|NCT00347009|1184339|P1|Overall Study|Withdrawal by Subject|3
369181|NCT00347009|1184339|P1|Overall Study|Adverse Event|6
369182|NCT00347009|1184339|P1|Overall Study|Death|1
369183|NCT00346697|1184358|P2|Overall Study|Lost to Follow-up|1
369184|NCT00346697|1184359|P1|Overall Study|Lost to Follow-up|0
369185|NCT00346632|1184395|P10|Overall Study|Not Stated|1
369186|NCT00346632|1184396|P9|Overall Study|Not Stated|2
369187|NCT00346632|1184397|P8|Overall Study|Not Stated|2
369188|NCT00346632|1184398|P7|Overall Study|Not Stated|0
369189|NCT00346632|1184399|P6|Overall Study|Not Stated|0
369190|NCT00346632|1184400|P5|Overall Study|Not Stated|0
369191|NCT00346632|1184401|P4|Overall Study|Not Stated|0
369192|NCT00346632|1184402|P3|Overall Study|Not Stated|0
369193|NCT00346632|1184403|P2|Overall Study|Not Stated|1
369194|NCT00346632|1184404|P1|Overall Study|Not Stated|1
369195|NCT00346632|1184395|P10|Overall Study|Switched to alternative treatment|0
369196|NCT00346632|1184396|P9|Overall Study|Switched to alternative treatment|0
369197|NCT00346632|1184397|P8|Overall Study|Switched to alternative treatment|0
369198|NCT00346632|1184398|P7|Overall Study|Switched to alternative treatment|0
369199|NCT00346632|1184399|P6|Overall Study|Switched to alternative treatment|0
369200|NCT00346632|1184400|P5|Overall Study|Switched to alternative treatment|0
369201|NCT00346632|1184401|P4|Overall Study|Switched to alternative treatment|0
369202|NCT00346632|1184402|P3|Overall Study|Switched to alternative treatment|1
369203|NCT00346632|1184403|P2|Overall Study|Switched to alternative treatment|0
369204|NCT00346632|1184404|P1|Overall Study|Switched to alternative treatment|0
369205|NCT00346632|1184395|P10|Overall Study|Withdrawal by Subject|0
369206|NCT00346632|1184396|P9|Overall Study|Withdrawal by Subject|0
369207|NCT00346632|1184397|P8|Overall Study|Withdrawal by Subject|0
369208|NCT00346632|1184398|P7|Overall Study|Withdrawal by Subject|1
369209|NCT00346632|1184399|P6|Overall Study|Withdrawal by Subject|0
369210|NCT00346632|1184400|P5|Overall Study|Withdrawal by Subject|0
369211|NCT00346632|1184401|P4|Overall Study|Withdrawal by Subject|0
369212|NCT00346632|1184402|P3|Overall Study|Withdrawal by Subject|0
369213|NCT00346632|1184403|P2|Overall Study|Withdrawal by Subject|0
369214|NCT00346632|1184404|P1|Overall Study|Withdrawal by Subject|0
369215|NCT00346632|1184395|P10|Overall Study|Protocol Violation|0
369216|NCT00346632|1184396|P9|Overall Study|Protocol Violation|0
369217|NCT00346632|1184397|P8|Overall Study|Protocol Violation|0
369218|NCT00346632|1184398|P7|Overall Study|Protocol Violation|1
369219|NCT00346632|1184399|P6|Overall Study|Protocol Violation|0
369220|NCT00346632|1184400|P5|Overall Study|Protocol Violation|0
369221|NCT00346632|1184401|P4|Overall Study|Protocol Violation|0
369222|NCT00346632|1184402|P3|Overall Study|Protocol Violation|0
369223|NCT00346632|1184403|P2|Overall Study|Protocol Violation|0
369224|NCT00346632|1184404|P1|Overall Study|Protocol Violation|0
369225|NCT00346632|1184395|P10|Overall Study|Death|0
369226|NCT00346632|1184396|P9|Overall Study|Death|0
369227|NCT00346632|1184397|P8|Overall Study|Death|0
369228|NCT00346632|1184398|P7|Overall Study|Death|0
369229|NCT00346632|1184399|P6|Overall Study|Death|0
369230|NCT00346632|1184400|P5|Overall Study|Death|0
369231|NCT00346632|1184401|P4|Overall Study|Death|0
369232|NCT00346632|1184402|P3|Overall Study|Death|1
369233|NCT00346632|1184403|P2|Overall Study|Death|0
369234|NCT00346632|1184404|P1|Overall Study|Death|0
369235|NCT00346632|1184395|P10|Overall Study|Adverse Event|0
369236|NCT00346632|1184396|P9|Overall Study|Adverse Event|0
369237|NCT00346632|1184397|P8|Overall Study|Adverse Event|0
369238|NCT00346632|1184398|P7|Overall Study|Adverse Event|1
369239|NCT00346632|1184399|P6|Overall Study|Adverse Event|1
369240|NCT00346632|1184400|P5|Overall Study|Adverse Event|1
369241|NCT00346632|1184401|P4|Overall Study|Adverse Event|0
369242|NCT00346632|1184402|P3|Overall Study|Adverse Event|0
369243|NCT00346632|1184403|P2|Overall Study|Adverse Event|0
369244|NCT00346632|1184404|P1|Overall Study|Adverse Event|0
369245|NCT00346632|1184395|P10|Overall Study|Progressive Disease|2
369246|NCT00346632|1184396|P9|Overall Study|Progressive Disease|2
369247|NCT00346632|1184397|P8|Overall Study|Progressive Disease|2
369248|NCT00346632|1184398|P7|Overall Study|Progressive Disease|2
369249|NCT00346632|1184399|P6|Overall Study|Progressive Disease|1
369250|NCT00346632|1184400|P5|Overall Study|Progressive Disease|3
369251|NCT00346632|1184401|P4|Overall Study|Progressive Disease|3
369252|NCT00346632|1184402|P3|Overall Study|Progressive Disease|4
369253|NCT00346632|1184403|P2|Overall Study|Progressive Disease|2
369254|NCT00346632|1184404|P1|Overall Study|Progressive Disease|2
369255|NCT00346398|1184554|P2|Overall Study|Withdrawal by Subject|2
369256|NCT00346398|1184555|P1|Overall Study|Withdrawal by Subject|0
369257|NCT00346398|1184554|P2|Overall Study|Lost to Follow-up|0
369258|NCT00346398|1184555|P1|Overall Study|Lost to Follow-up|3
369259|NCT00346333|1184567|P2|Overall Study|unwilling or unable to continue|8
369260|NCT00346333|1184568|P1|Overall Study|unwilling or unable to continue|4
369261|NCT00346333|1184567|P2|Overall Study|Death|0
369262|NCT00346333|1184568|P1|Overall Study|Death|1
369263|NCT00346268|1184584|P2|Overall Study|Participant refused|3
369264|NCT00346268|1184585|P1|Overall Study|Participant refused|0
369265|NCT00346268|1184584|P2|Overall Study|Protocol Violation|0
369266|NCT00346268|1184585|P1|Overall Study|Protocol Violation|1
369267|NCT00346268|1184584|P2|Overall Study|Adverse Event|0
369268|NCT00346268|1184585|P1|Overall Study|Adverse Event|1
369269|NCT00346216|1184620|P3|Overall Study|Missing Subject Summary Status|62
369270|NCT00346216|1184621|P2|Overall Study|Missing Subject Summary Status|61
369271|NCT00346216|1184622|P1|Overall Study|Missing Subject Summary Status|62
369272|NCT00346216|1184620|P3|Overall Study|Study terminated by sponsor|8
369273|NCT00346216|1184621|P2|Overall Study|Study terminated by sponsor|4
369274|NCT00346216|1184622|P1|Overall Study|Study terminated by sponsor|11
369275|NCT00346216|1184620|P3|Overall Study|Death|228
369276|NCT00346216|1184621|P2|Overall Study|Death|192
369277|NCT00346216|1184622|P1|Overall Study|Death|189
369278|NCT00346216|1184620|P3|Overall Study|Does not meet entrance criteria|8
369279|NCT00346216|1184621|P2|Overall Study|Does not meet entrance criteria|10
369280|NCT00346216|1184622|P1|Overall Study|Does not meet entrance criteria|13
369281|NCT00346216|1184620|P3|Overall Study|Physician Decision|59
369282|NCT00346216|1184621|P2|Overall Study|Physician Decision|76
369283|NCT00346216|1184622|P1|Overall Study|Physician Decision|80
369284|NCT00346216|1184620|P3|Overall Study|Lost to Follow-up|542
369285|NCT00346216|1184621|P2|Overall Study|Lost to Follow-up|588
369286|NCT00346216|1184622|P1|Overall Study|Lost to Follow-up|611
369287|NCT00346216|1184620|P3|Overall Study|Withdrawal by Subject|651
369288|NCT00346216|1184621|P2|Overall Study|Withdrawal by Subject|692
369289|NCT00346216|1184622|P1|Overall Study|Withdrawal by Subject|661
369290|NCT00346216|1184620|P3|Overall Study|No longer willing to participate|585
369291|NCT00346216|1184621|P2|Overall Study|No longer willing to participate|606
369292|NCT00346216|1184622|P1|Overall Study|No longer willing to participate|600
369293|NCT00346216|1184620|P3|Overall Study|Not specified|205
369294|NCT00346216|1184621|P2|Overall Study|Not specified|231
369295|NCT00346216|1184622|P1|Overall Study|Not specified|181
369296|NCT00346151|1184639|P1|Overall Study|Withdrawal by Subject|3
369297|NCT00346034|1184657|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
369298|NCT00346034|1184657|P1|Overall Study|Patient Stopped Taking Study Drug|1
369299|NCT00346034|1184657|P1|Overall Study|Withdrawal by Subject|13
369300|NCT00346034|1184657|P1|Overall Study|Lack of Efficacy|8
369301|NCT00346034|1184657|P1|Overall Study|Adverse Event|34
369302|NCT00345878|1184664|P2|Overall Study|Other|0
369303|NCT00345878|1184665|P1|Overall Study|Other|1
369304|NCT00345878|1184664|P2|Overall Study|Lost to Follow-up|1
369305|NCT00345878|1184665|P1|Overall Study|Lost to Follow-up|2
369306|NCT00345878|1184664|P2|Overall Study|Adverse Event|0
369307|NCT00345878|1184665|P1|Overall Study|Adverse Event|1
369308|NCT00345839|1184683|P2|Overall Study|Lost to Follow-up|61
369309|NCT00345839|1184684|P1|Overall Study|Lost to Follow-up|58
369310|NCT00345839|1184683|P2|Overall Study|Withdrawal by Subject|98
369311|NCT00345839|1184684|P1|Overall Study|Withdrawal by Subject|91
369312|NCT00345683|1184710|P2|Overall Study|Unspecified|2
369313|NCT00345683|1184711|P1|Overall Study|Unspecified|6
369314|NCT00345683|1184710|P2|Overall Study|Lost to Follow-up|7
369315|NCT00345683|1184711|P1|Overall Study|Lost to Follow-up|19
369316|NCT00345631|1184734|P3|Overall Study|Other reasons|1
369317|NCT00345631|1184735|P2|Overall Study|Other reasons|0
369318|NCT00345631|1184736|P1|Overall Study|Other reasons|0
369319|NCT00345631|1184734|P3|Overall Study|Lost to Follow-up|4
369320|NCT00345631|1184735|P2|Overall Study|Lost to Follow-up|7
369321|NCT00345631|1184736|P1|Overall Study|Lost to Follow-up|3
369322|NCT00345631|1184734|P3|Overall Study|Adverse Event|0
369323|NCT00345631|1184735|P2|Overall Study|Adverse Event|1
369324|NCT00345631|1184736|P1|Overall Study|Adverse Event|0
369325|NCT00345631|1184734|P3|Overall Study|Withdrawal by Subject|1
369326|NCT00345631|1184735|P2|Overall Study|Withdrawal by Subject|0
369327|NCT00345631|1184736|P1|Overall Study|Withdrawal by Subject|1
369328|NCT00345605|1184768|P2|Arm 2, Opposite Treatment|Adverse Event|0
369329|NCT00345605|1184769|P1|Arm 2, Opposite Treatment|Adverse Event|1
369330|NCT00345605|1184768|P2|Arm 1|Adverse Event|1
369331|NCT00345605|1184769|P1|Arm 1|Adverse Event|0
369332|NCT00345592|1184789|P2|Overall Study|Withdrawal by Subject|8
369333|NCT00345592|1184790|P1|Overall Study|Withdrawal by Subject|11
369334|NCT00345592|1184789|P2|Overall Study|Death|16
369335|NCT00345592|1184790|P1|Overall Study|Death|14
369336|NCT00345579|1184798|P2|Overall Study|Unspecified|1
369337|NCT00345579|1184799|P1|Overall Study|Unspecified|9
369338|NCT00345579|1184798|P2|Overall Study|Lost to Follow-up|36
369339|NCT00345579|1184799|P1|Overall Study|Lost to Follow-up|82
369340|NCT00345579|1184798|P2|Overall Study|Withdrawal by Subject|17
369341|NCT00345579|1184799|P1|Overall Study|Withdrawal by Subject|50
369342|NCT00345579|1184798|P2|Overall Study|Protocol Violation|5
369343|NCT00345579|1184799|P1|Overall Study|Protocol Violation|14
369344|NCT00345579|1184798|P2|Overall Study|Adverse Event|6
369345|NCT00345579|1184799|P1|Overall Study|Adverse Event|9
369346|NCT00345540|1184819|P1|Overall Study|Withdrawal by Subject|1
369347|NCT00345397|1184825|P1|Overall Study|Death|1
369348|NCT00345293|1184852|P2|Overall Study|Withdrawal by Subject|0
369349|NCT00345293|1184853|P1|Overall Study|Withdrawal by Subject|1
369350|NCT00345293|1184852|P2|Overall Study|Unable to access line for sample|0
369351|NCT00345293|1184853|P1|Overall Study|Unable to access line for sample|1
369352|NCT00345046|1184899|P3|Overall Study|Protocol Violation|2
369353|NCT00345046|1184900|P2|Overall Study|Protocol Violation|1
369354|NCT00345046|1184901|P1|Overall Study|Protocol Violation|1
369355|NCT00344968|1184931|P3|Overall Study|Other|0
369356|NCT00344968|1184932|P2|Overall Study|Other|1
369357|NCT00344968|1184933|P1|Overall Study|Other|0
369358|NCT00344968|1184931|P3|Overall Study|Death|31
369359|NCT00344968|1184932|P2|Overall Study|Death|27
369360|NCT00344968|1184933|P1|Overall Study|Death|11
369361|NCT00344968|1184931|P3|Overall Study|Lost to Follow-up|37
369362|NCT00344968|1184932|P2|Overall Study|Lost to Follow-up|37
369363|NCT00344968|1184933|P1|Overall Study|Lost to Follow-up|24
369364|NCT00344968|1184931|P3|Overall Study|Withdrawal by Subject|27
369365|NCT00344968|1184932|P2|Overall Study|Withdrawal by Subject|31
369366|NCT00344968|1184933|P1|Overall Study|Withdrawal by Subject|14
369367|NCT00344968|1184931|P3|Overall Study|Protocol Violation|5
369368|NCT00344968|1184932|P2|Overall Study|Protocol Violation|2
369369|NCT00344968|1184933|P1|Overall Study|Protocol Violation|2
369370|NCT00344968|1184931|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
369371|NCT00344968|1184932|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
369372|NCT00344968|1184933|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
369373|NCT00344968|1184931|P3|Overall Study|Adverse Event|15
369374|NCT00344968|1184932|P2|Overall Study|Adverse Event|4
369375|NCT00344968|1184933|P1|Overall Study|Adverse Event|5
369376|NCT00344773|1184944|P1|Overall Study|Not Eligible for the study|2
369377|NCT00344773|1184944|P1|Overall Study|Withdrawal by Subject|1
369378|NCT00344773|1184944|P1|Overall Study|Objective Disease Progression|16
369379|NCT00344773|1184944|P1|Overall Study|Adverse Event|2
369380|NCT00344500|1184967|P3|Overall Study|Not Noted|0
369381|NCT00344500|1184968|P2|Overall Study|Not Noted|3
369382|NCT00344500|1184969|P1|Overall Study|Not Noted|1
369383|NCT00344500|1184967|P3|Overall Study|Protocol Violation|1
369384|NCT00344500|1184968|P2|Overall Study|Protocol Violation|7
369385|NCT00344500|1184969|P1|Overall Study|Protocol Violation|4
369386|NCT00344500|1184967|P3|Overall Study|Withdrawal by Subject|0
369387|NCT00344500|1184968|P2|Overall Study|Withdrawal by Subject|10
369388|NCT00344500|1184969|P1|Overall Study|Withdrawal by Subject|7
369389|NCT00344500|1184967|P3|Overall Study|Lost to Follow-up|1
369390|NCT00344500|1184968|P2|Overall Study|Lost to Follow-up|13
369391|NCT00344500|1184969|P1|Overall Study|Lost to Follow-up|5
369392|NCT00344500|1184967|P3|Overall Study|Adverse Event|0
369393|NCT00344500|1184968|P2|Overall Study|Adverse Event|2
369394|NCT00344500|1184969|P1|Overall Study|Adverse Event|6
369395|NCT00344487|1184980|P1|Overall Study|immunologic failure|1
369396|NCT00344448|1184986|P2|Open Label|Study terminated|0
369397|NCT00344448|1184987|P1|Open Label|Study terminated|1
369398|NCT00344448|1184986|P2|Open Label|Withdrawal by Subject|1
369399|NCT00344448|1184987|P1|Open Label|Withdrawal by Subject|1
369400|NCT00344448|1184986|P2|Double Blind, Placebo Controlled|Study terminated|0
369401|NCT00344448|1184987|P1|Double Blind, Placebo Controlled|Study terminated|1
369402|NCT00344448|1184986|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
369403|NCT00344448|1184987|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
369404|NCT00344448|1184986|P2|Screening|Withdrawal by Subject|1
369405|NCT00344448|1184987|P1|Screening|Withdrawal by Subject|0
369406|NCT00344305|1185006|P2|Overall Study|Subject was not contacted in window|1
369407|NCT00344305|1185007|P1|Overall Study|Subject was not contacted in window|0
369408|NCT00344305|1185006|P2|Overall Study|Lost to Follow-up|0
369409|NCT00344305|1185007|P1|Overall Study|Lost to Follow-up|2
369410|NCT00344032|1185051|P2|Overall Study|Physician Decision|1
369411|NCT00344032|1185052|P1|Overall Study|Physician Decision|4
369412|NCT00344032|1185051|P2|Overall Study|Lost to Follow-up|6
369413|NCT00344032|1185052|P1|Overall Study|Lost to Follow-up|4
369414|NCT00344032|1185051|P2|Overall Study|Withdrawal by Subject|2
369415|NCT00344032|1185052|P1|Overall Study|Withdrawal by Subject|6
369416|NCT00344032|1185051|P2|Overall Study|Adverse Event|1
369417|NCT00344032|1185052|P1|Overall Study|Adverse Event|0
369418|NCT00343915|1185070|P2|Primary Study|Unspecified|0
369419|NCT00343915|1185071|P1|Primary Study|Unspecified|1
369420|NCT00343915|1185070|P2|Primary Study|Lost to Follow-up|3
369421|NCT00343915|1185071|P1|Primary Study|Lost to Follow-up|2
369422|NCT00343915|1185070|P2|Primary Study|Withdrawal by Subject|0
369423|NCT00343915|1185071|P1|Primary Study|Withdrawal by Subject|1
369424|NCT00343889|1185097|P2|Overall Study|Protocol Violation|0
369425|NCT00343889|1185098|P1|Overall Study|Protocol Violation|1
369426|NCT00343889|1185097|P2|Overall Study|Withdrawal by Subject|1
369427|NCT00343889|1185098|P1|Overall Study|Withdrawal by Subject|0
369428|NCT00343889|1185097|P2|Overall Study|Lost to Follow-up|0
369429|NCT00343889|1185098|P1|Overall Study|Lost to Follow-up|2
369430|NCT00343512|1185156|P1|Overall Study|Withdrawal by Subject|2
369431|NCT00343382|1185244|P3|Overall Study|Other Reason Not Specified|4
369432|NCT00343382|1185245|P2|Overall Study|Other Reason Not Specified|2
369433|NCT00343382|1185246|P1|Overall Study|Other Reason Not Specified|1
369434|NCT00343382|1185244|P3|Overall Study|Withdrawal by Subject|6
369435|NCT00343382|1185245|P2|Overall Study|Withdrawal by Subject|2
369436|NCT00343382|1185246|P1|Overall Study|Withdrawal by Subject|1
369437|NCT00343382|1185244|P3|Overall Study|Adverse Event|7
369438|NCT00343382|1185245|P2|Overall Study|Adverse Event|10
369439|NCT00343382|1185246|P1|Overall Study|Adverse Event|2
369440|NCT00343291|1185265|P2|Overall Study|Other|5
369441|NCT00343291|1185266|P1|Overall Study|Other|8
369442|NCT00343291|1185265|P2|Overall Study|Withdrawal by Subject|2
369443|NCT00343291|1185266|P1|Overall Study|Withdrawal by Subject|0
369444|NCT00343291|1185265|P2|Overall Study|Progressive disease|34
369445|NCT00343291|1185266|P1|Overall Study|Progressive disease|33
369446|NCT00343291|1185265|P2|Overall Study|Death|2
369447|NCT00343291|1185266|P1|Overall Study|Death|3
369448|NCT00343291|1185265|P2|Overall Study|Adverse Event|13
369449|NCT00343291|1185266|P1|Overall Study|Adverse Event|13
369450|NCT00343252|1185282|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
369451|NCT00343252|1185283|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
369452|NCT00343252|1185282|P2|18 Months (All Treated Participants)|Sponsor Decision|5
369453|NCT00343252|1185283|P1|18 Months (All Treated Participants)|Sponsor Decision|8
369454|NCT00343252|1185282|P2|18 Months (All Treated Participants)|Protocol Violation|3
369455|NCT00343252|1185283|P1|18 Months (All Treated Participants)|Protocol Violation|3
369456|NCT00343252|1185282|P2|18 Months (All Treated Participants)|Physician Decision|7
369457|NCT00343252|1185283|P1|18 Months (All Treated Participants)|Physician Decision|4
369458|NCT00343252|1185282|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
369459|NCT00343252|1185283|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
369460|NCT00343252|1185282|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
369461|NCT00343252|1185283|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
369462|NCT00343252|1185282|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
369463|NCT00343252|1185283|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
369464|NCT00343252|1185282|P2|18 Months (All Treated Participants)|Death|5
369465|NCT00343252|1185283|P1|18 Months (All Treated Participants)|Death|4
369466|NCT00343252|1185282|P2|18 Months (All Treated Participants)|Adverse Event|23
369467|NCT00343252|1185283|P1|18 Months (All Treated Participants)|Adverse Event|31
369468|NCT00343252|1185282|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
369469|NCT00343252|1185283|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
369470|NCT00343252|1185282|P2|12 Months (All Treated Participants)|Sponsor Decision|6
369471|NCT00343252|1185283|P1|12 Months (All Treated Participants)|Sponsor Decision|9
369472|NCT00343252|1185282|P2|12 Months (All Treated Participants)|Protocol Violation|2
369473|NCT00343252|1185283|P1|12 Months (All Treated Participants)|Protocol Violation|3
369474|NCT00343252|1185282|P2|12 Months (All Treated Participants)|Physician Decision|5
369475|NCT00343252|1185283|P1|12 Months (All Treated Participants)|Physician Decision|4
369476|NCT00343252|1185282|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
369477|NCT00343252|1185283|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
369478|NCT00343252|1185282|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
369479|NCT00343252|1185283|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
369480|NCT00343252|1185282|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
369481|NCT00343252|1185283|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
369482|NCT00343252|1185282|P2|12 Months (All Treated Participants)|Death|3
369483|NCT00343252|1185283|P1|12 Months (All Treated Participants)|Death|3
369484|NCT00343252|1185282|P2|12 Months (All Treated Participants)|Adverse Event|20
369485|NCT00343252|1185283|P1|12 Months (All Treated Participants)|Adverse Event|22
369486|NCT00343252|1185282|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
369487|NCT00343252|1185283|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
369488|NCT00343252|1185282|P2|6 Months (All Treated Participants)|Sponsor Decision|4
369489|NCT00343252|1185283|P1|6 Months (All Treated Participants)|Sponsor Decision|7
369490|NCT00343252|1185282|P2|6 Months (All Treated Participants)|Protocol Violation|2
369491|NCT00343252|1185283|P1|6 Months (All Treated Participants)|Protocol Violation|2
369492|NCT00343252|1185282|P2|6 Months (All Treated Participants)|Physician Decision|3
369493|NCT00343252|1185283|P1|6 Months (All Treated Participants)|Physician Decision|1
369494|NCT00343252|1185282|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
369495|NCT00343252|1185283|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
369496|NCT00343252|1185282|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
369497|NCT00343252|1185283|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
369498|NCT00343252|1185282|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
369499|NCT00343252|1185283|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
369500|NCT00343252|1185282|P2|6 Months (All Treated Participants)|Death|2
369501|NCT00343252|1185283|P1|6 Months (All Treated Participants)|Death|0
369502|NCT00343252|1185282|P2|6 Months (All Treated Participants)|Adverse Event|11
369503|NCT00343252|1185283|P1|6 Months (All Treated Participants)|Adverse Event|17
369504|NCT00342628|1185348|P3|Overall Study|moved residence|1
369505|NCT00342628|1185349|P2|Overall Study|moved residence|1
369506|NCT00342628|1185350|P1|Overall Study|moved residence|0
369507|NCT00342628|1185348|P3|Overall Study|Death|0
369508|NCT00342628|1185349|P2|Overall Study|Death|1
369509|NCT00342628|1185350|P1|Overall Study|Death|1
369510|NCT00342628|1185348|P3|Overall Study|Withdrawal by Subject|18
369511|NCT00342628|1185349|P2|Overall Study|Withdrawal by Subject|19
369512|NCT00342628|1185350|P1|Overall Study|Withdrawal by Subject|19
369513|NCT00340834|1185416|P5|Extension Phase of Study|Death|1
369514|NCT00340834|1185417|P4|Extension Phase of Study|Death|0
369515|NCT00340834|1185418|P3|Extension Phase of Study|Death|0
369516|NCT00340834|1185419|P2|Extension Phase of Study|Death|0
369517|NCT00340834|1185420|P1|Extension Phase of Study|Death|0
369518|NCT00340834|1185416|P5|Extension Phase of Study|Protocol Violation|0
369519|NCT00340834|1185417|P4|Extension Phase of Study|Protocol Violation|0
369520|NCT00340834|1185418|P3|Extension Phase of Study|Protocol Violation|0
369521|NCT00340834|1185419|P2|Extension Phase of Study|Protocol Violation|0
369522|NCT00340834|1185420|P1|Extension Phase of Study|Protocol Violation|3
369523|NCT00340834|1185416|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
369524|NCT00340834|1185417|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
369525|NCT00340834|1185418|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
369526|NCT00340834|1185419|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
369527|NCT00340834|1185420|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
369528|NCT00340834|1185416|P5|Extension Phase of Study|Administrative problems|1
369529|NCT00340834|1185417|P4|Extension Phase of Study|Administrative problems|1
369530|NCT00340834|1185418|P3|Extension Phase of Study|Administrative problems|0
369531|NCT00340834|1185419|P2|Extension Phase of Study|Administrative problems|0
369532|NCT00340834|1185420|P1|Extension Phase of Study|Administrative problems|3
369533|NCT00340834|1185416|P5|Extension Phase of Study|Subject no longer requires study drug|2
369534|NCT00340834|1185417|P4|Extension Phase of Study|Subject no longer requires study drug|0
369535|NCT00340834|1185418|P3|Extension Phase of Study|Subject no longer requires study drug|0
369536|NCT00340834|1185419|P2|Extension Phase of Study|Subject no longer requires study drug|0
369537|NCT00340834|1185420|P1|Extension Phase of Study|Subject no longer requires study drug|4
369538|NCT00340834|1185416|P5|Extension Phase of Study|Lost to Follow-up|3
369539|NCT00340834|1185417|P4|Extension Phase of Study|Lost to Follow-up|2
369540|NCT00340834|1185418|P3|Extension Phase of Study|Lost to Follow-up|0
369541|NCT00340834|1185419|P2|Extension Phase of Study|Lost to Follow-up|1
369542|NCT00340834|1185420|P1|Extension Phase of Study|Lost to Follow-up|1
369543|NCT00340834|1185416|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
369544|NCT00340834|1185417|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
369545|NCT00340834|1185418|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
369546|NCT00340834|1185419|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
369547|NCT00340834|1185420|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
369548|NCT00340834|1185416|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
369549|NCT00340834|1185417|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
369550|NCT00340834|1185418|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
369551|NCT00340834|1185419|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
369552|NCT00340834|1185420|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
369553|NCT00340834|1185416|P5|Extension Phase of Study|Adverse Event|7
369554|NCT00340834|1185417|P4|Extension Phase of Study|Adverse Event|19
369555|NCT00340834|1185418|P3|Extension Phase of Study|Adverse Event|0
369556|NCT00340834|1185419|P2|Extension Phase of Study|Adverse Event|22
369557|NCT00340834|1185420|P1|Extension Phase of Study|Adverse Event|21
369558|NCT00340834|1185416|P5|Extension Phase of Study|Subject withdrew consent|15
369559|NCT00340834|1185417|P4|Extension Phase of Study|Subject withdrew consent|12
369560|NCT00340834|1185418|P3|Extension Phase of Study|Subject withdrew consent|0
369561|NCT00340834|1185419|P2|Extension Phase of Study|Subject withdrew consent|31
369562|NCT00340834|1185420|P1|Extension Phase of Study|Subject withdrew consent|26
369563|NCT00340834|1185416|P5|Extension Phase of Study|Subject did not receive study drug|0
369564|NCT00340834|1185417|P4|Extension Phase of Study|Subject did not receive study drug|2
369565|NCT00340834|1185418|P3|Extension Phase of Study|Subject did not receive study drug|0
369566|NCT00340834|1185419|P2|Extension Phase of Study|Subject did not receive study drug|1
369567|NCT00340834|1185420|P1|Extension Phase of Study|Subject did not receive study drug|0
369568|NCT00340834|1185416|P5|Core Phase of Study|Protocol Violation|0
369569|NCT00340834|1185417|P4|Core Phase of Study|Protocol Violation|0
369570|NCT00340834|1185418|P3|Core Phase of Study|Protocol Violation|2
369571|NCT00340834|1185419|P2|Core Phase of Study|Protocol Violation|0
369572|NCT00340834|1185420|P1|Core Phase of Study|Protocol Violation|0
369573|NCT00340834|1185416|P5|Core Phase of Study|Death|0
369574|NCT00340834|1185417|P4|Core Phase of Study|Death|0
369575|NCT00340834|1185418|P3|Core Phase of Study|Death|0
369576|NCT00340834|1185419|P2|Core Phase of Study|Death|0
369577|NCT00340834|1185420|P1|Core Phase of Study|Death|2
369578|NCT00340834|1185416|P5|Core Phase of Study|Lost to Follow-up|0
369579|NCT00340834|1185417|P4|Core Phase of Study|Lost to Follow-up|0
369580|NCT00340834|1185418|P3|Core Phase of Study|Lost to Follow-up|4
369581|NCT00340834|1185419|P2|Core Phase of Study|Lost to Follow-up|1
369582|NCT00340834|1185420|P1|Core Phase of Study|Lost to Follow-up|1
369583|NCT00340834|1185416|P5|Core Phase of Study|Abnormal test procedure result(s)|0
369584|NCT00340834|1185417|P4|Core Phase of Study|Abnormal test procedure result(s)|0
369585|NCT00340834|1185418|P3|Core Phase of Study|Abnormal test procedure result(s)|3
369586|NCT00340834|1185419|P2|Core Phase of Study|Abnormal test procedure result(s)|3
369587|NCT00340834|1185420|P1|Core Phase of Study|Abnormal test procedure result(s)|4
369588|NCT00340834|1185416|P5|Core Phase of Study|Abnormal laboratory value(s)|0
369589|NCT00340834|1185417|P4|Core Phase of Study|Abnormal laboratory value(s)|0
369590|NCT00340834|1185418|P3|Core Phase of Study|Abnormal laboratory value(s)|1
369591|NCT00340834|1185419|P2|Core Phase of Study|Abnormal laboratory value(s)|6
369592|NCT00340834|1185420|P1|Core Phase of Study|Abnormal laboratory value(s)|4
369593|NCT00340834|1185416|P5|Core Phase of Study|Lack of Efficacy|0
369594|NCT00340834|1185417|P4|Core Phase of Study|Lack of Efficacy|0
369595|NCT00340834|1185418|P3|Core Phase of Study|Lack of Efficacy|7
369596|NCT00340834|1185419|P2|Core Phase of Study|Lack of Efficacy|3
369597|NCT00340834|1185420|P1|Core Phase of Study|Lack of Efficacy|3
369598|NCT00340834|1185416|P5|Core Phase of Study|Administrative Problems|0
369599|NCT00340834|1185417|P4|Core Phase of Study|Administrative Problems|0
369600|NCT00340834|1185418|P3|Core Phase of Study|Administrative Problems|7
369601|NCT00340834|1185419|P2|Core Phase of Study|Administrative Problems|2
369602|NCT00340834|1185420|P1|Core Phase of Study|Administrative Problems|6
369603|NCT00340834|1185416|P5|Core Phase of Study|Withdrawal by Subject|0
369604|NCT00340834|1185417|P4|Core Phase of Study|Withdrawal by Subject|0
369605|NCT00340834|1185418|P3|Core Phase of Study|Withdrawal by Subject|16
369606|NCT00340834|1185419|P2|Core Phase of Study|Withdrawal by Subject|9
369607|NCT00340834|1185420|P1|Core Phase of Study|Withdrawal by Subject|11
369608|NCT00340834|1185416|P5|Core Phase of Study|Adverse Event|0
369609|NCT00340834|1185417|P4|Core Phase of Study|Adverse Event|0
369610|NCT00340834|1185418|P3|Core Phase of Study|Adverse Event|9
369611|NCT00340834|1185419|P2|Core Phase of Study|Adverse Event|9
369612|NCT00340834|1185420|P1|Core Phase of Study|Adverse Event|26
369613|NCT00340704|1185454|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
369614|NCT00340704|1185455|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
369615|NCT00340704|1185456|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
369616|NCT00340704|1185457|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
369617|NCT00340704|1185458|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
369618|NCT00340704|1185459|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
369619|NCT00340704|1185460|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
369620|NCT00340704|1185461|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
369621|NCT00340704|1185462|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
369622|NCT00340704|1185454|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
369623|NCT00340704|1185455|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
369624|NCT00340704|1185456|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
369625|NCT00340704|1185457|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
369626|NCT00340704|1185458|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
369627|NCT00340704|1185459|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
369628|NCT00340704|1185460|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
369629|NCT00340704|1185461|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
369630|NCT00340704|1185462|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
369631|NCT00340704|1185454|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
369632|NCT00340704|1185455|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
369633|NCT00340704|1185456|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
369634|NCT00340704|1185457|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
369635|NCT00340704|1185458|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
369636|NCT00340704|1185459|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
369637|NCT00340704|1185460|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
369638|NCT00340704|1185461|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
369639|NCT00340704|1185462|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
369640|NCT00340704|1185454|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
369641|NCT00340704|1185455|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
369642|NCT00340704|1185456|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
369643|NCT00340704|1185457|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
369644|NCT00340704|1185458|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
369645|NCT00340704|1185459|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
369646|NCT00340704|1185460|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
369647|NCT00340704|1185461|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
369648|NCT00340704|1185462|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
369649|NCT00340704|1185454|P9|PK Study|Not treated|0
369650|NCT00340704|1185455|P8|PK Study|Not treated|0
369651|NCT00340704|1185456|P7|PK Study|Not treated|0
369652|NCT00340704|1185457|P6|PK Study|Not treated|0
369653|NCT00340704|1185458|P5|PK Study|Not treated|0
369654|NCT00340704|1185459|P4|PK Study|Not treated|0
369655|NCT00340704|1185460|P3|PK Study|Not treated|1
369656|NCT00340704|1185461|P2|PK Study|Not treated|0
369657|NCT00340704|1185462|P1|PK Study|Not treated|0
369658|NCT00340704|1185454|P9|PK Study|Adverse Event|0
369659|NCT00340704|1185455|P8|PK Study|Adverse Event|0
369660|NCT00340704|1185456|P7|PK Study|Adverse Event|0
369661|NCT00340704|1185457|P6|PK Study|Adverse Event|0
369662|NCT00340704|1185458|P5|PK Study|Adverse Event|0
369663|NCT00340704|1185459|P4|PK Study|Adverse Event|0
369664|NCT00340704|1185460|P3|PK Study|Adverse Event|0
369665|NCT00340704|1185461|P2|PK Study|Adverse Event|1
369666|NCT00340704|1185462|P1|PK Study|Adverse Event|0
369667|NCT00340678|1185568|P4|Overall Study|Lost to Follow-up|0
369668|NCT00340678|1185569|P3|Overall Study|Lost to Follow-up|0
369669|NCT00340678|1185570|P2|Overall Study|Lost to Follow-up|0
369670|NCT00340678|1185571|P1|Overall Study|Lost to Follow-up|1
369671|NCT00339183|1185598|P2|Overall Study|Ongoing|13
369672|NCT00339183|1185599|P1|Overall Study|Ongoing|20
369673|NCT00339183|1185598|P2|Overall Study|Other|40
369674|NCT00339183|1185599|P1|Overall Study|Other|46
369675|NCT00339183|1185598|P2|Overall Study|Missing reason|1
369676|NCT00339183|1185599|P1|Overall Study|Missing reason|3
369677|NCT00339183|1185598|P2|Overall Study|Protocol-specified criteria|8
369678|NCT00339183|1185599|P1|Overall Study|Protocol-specified criteria|12
369679|NCT00339183|1185598|P2|Overall Study|Lost to Follow-up|17
369680|NCT00339183|1185599|P1|Overall Study|Lost to Follow-up|17
369681|NCT00339183|1185598|P2|Overall Study|Physician Decision|4
369682|NCT00339183|1185599|P1|Overall Study|Physician Decision|2
369683|NCT00339183|1185598|P2|Overall Study|Withdrawal by Subject|19
369684|NCT00339183|1185599|P1|Overall Study|Withdrawal by Subject|16
369685|NCT00339183|1185598|P2|Overall Study|Adverse Event|3
369686|NCT00339183|1185599|P1|Overall Study|Adverse Event|5
369687|NCT00339144|1185628|P3|Overall Study|Participant's request to discontinuation|1
369688|NCT00339144|1185629|P2|Overall Study|Participant's request to discontinuation|0
369689|NCT00339144|1185630|P1|Overall Study|Participant's request to discontinuation|1
369690|NCT00339144|1185628|P3|Overall Study|Study drug toxicity|1
369691|NCT00339144|1185629|P2|Overall Study|Study drug toxicity|1
369692|NCT00339144|1185630|P1|Overall Study|Study drug toxicity|3
369693|NCT00339144|1185628|P3|Overall Study|Disease progression|2
369694|NCT00339144|1185629|P2|Overall Study|Disease progression|2
369695|NCT00339144|1185630|P1|Overall Study|Disease progression|5
369696|NCT00339833|1185714|P2|Overall Study|Error in data records|0
369697|NCT00339833|1185715|P1|Overall Study|Error in data records|1
369698|NCT00339833|1185714|P2|Overall Study|anaemia or excess drop in glycaemia|0
369699|NCT00339833|1185715|P1|Overall Study|anaemia or excess drop in glycaemia|2
369700|NCT00339833|1185714|P2|Overall Study|Poor venous access|2
369701|NCT00339833|1185715|P1|Overall Study|Poor venous access|2
369702|NCT00339833|1185714|P2|Overall Study|minor infection|1
369703|NCT00339833|1185715|P1|Overall Study|minor infection|0
369704|NCT00339833|1185714|P2|Overall Study|Chest pain|1
369705|NCT00339833|1185715|P1|Overall Study|Chest pain|0
369706|NCT00339833|1185714|P2|Overall Study|indigestion|1
369707|NCT00339833|1185715|P1|Overall Study|indigestion|0
369708|NCT00339833|1185714|P2|Overall Study|toothache|1
369709|NCT00339833|1185715|P1|Overall Study|toothache|0
369710|NCT00339833|1185714|P2|Overall Study|Withdrawal by Subject|2
369711|NCT00339833|1185715|P1|Overall Study|Withdrawal by Subject|1
369712|NCT00339040|1185746|P2|Stage II|Site closing|0
369713|NCT00339040|1185747|P1|Stage II|Site closing|2
369714|NCT00339040|1185746|P2|Stage II|Not able to attend clinic|0
369715|NCT00339040|1185747|P1|Stage II|Not able to attend clinic|1
369716|NCT00339040|1185746|P2|Stage II|Protocol Violation|0
369717|NCT00339040|1185747|P1|Stage II|Protocol Violation|3
369718|NCT00339040|1185746|P2|Stage II|Withdrawal by Subject|2
369719|NCT00339040|1185747|P1|Stage II|Withdrawal by Subject|1
369720|NCT00339040|1185746|P2|Stage II|Lost to Follow-up|0
369721|NCT00339040|1185747|P1|Stage II|Lost to Follow-up|3
369722|NCT00339040|1185746|P2|Stage I|Protocol Violation|1
369723|NCT00339040|1185747|P1|Stage I|Protocol Violation|1
369724|NCT00339040|1185746|P2|Stage I|Not able to attend clinic|0
369725|NCT00339040|1185747|P1|Stage I|Not able to attend clinic|1
369726|NCT00338962|1185774|P4|Overall Study|Poor Compliance|0
369727|NCT00338962|1185775|P3|Overall Study|Poor Compliance|2
369728|NCT00338962|1185776|P2|Overall Study|Poor Compliance|0
369729|NCT00338962|1185777|P1|Overall Study|Poor Compliance|0
369730|NCT00338962|1185774|P4|Overall Study|Adverse Event|0
369731|NCT00338962|1185775|P3|Overall Study|Adverse Event|2
369732|NCT00338962|1185776|P2|Overall Study|Adverse Event|0
369733|NCT00338962|1185777|P1|Overall Study|Adverse Event|0
369734|NCT00338962|1185774|P4|Overall Study|Moved|0
369735|NCT00338962|1185775|P3|Overall Study|Moved|0
369736|NCT00338962|1185776|P2|Overall Study|Moved|1
369737|NCT00338962|1185777|P1|Overall Study|Moved|0
369738|NCT00338962|1185774|P4|Overall Study|Time Constraint|0
369739|NCT00338962|1185775|P3|Overall Study|Time Constraint|0
369740|NCT00338962|1185776|P2|Overall Study|Time Constraint|0
369741|NCT00338962|1185777|P1|Overall Study|Time Constraint|2
369742|NCT00338962|1185774|P4|Overall Study|No Transportation|0
369743|NCT00338962|1185775|P3|Overall Study|No Transportation|0
369744|NCT00338962|1185776|P2|Overall Study|No Transportation|0
369745|NCT00338962|1185777|P1|Overall Study|No Transportation|2
369746|NCT00338962|1185774|P4|Overall Study|Withdrawal by Subject|0
369747|NCT00338962|1185775|P3|Overall Study|Withdrawal by Subject|0
369748|NCT00338962|1185776|P2|Overall Study|Withdrawal by Subject|0
369749|NCT00338962|1185777|P1|Overall Study|Withdrawal by Subject|1
369750|NCT00338962|1185774|P4|Overall Study|Lost to Follow-up|3
369751|NCT00338962|1185775|P3|Overall Study|Lost to Follow-up|2
369752|NCT00338962|1185776|P2|Overall Study|Lost to Follow-up|3
369753|NCT00338962|1185777|P1|Overall Study|Lost to Follow-up|3
369754|NCT00338884|1185799|P1|Overall Study|Randomized But Did Not Receive Treatment|1
369755|NCT00338884|1185799|P1|Overall Study|Lost to Follow-up|1
369756|NCT00338884|1185799|P1|Overall Study|Withdrawal by Subject|3
369757|NCT00338884|1185799|P1|Overall Study|Global Deterioration of Health Status|3
369758|NCT00338884|1185799|P1|Overall Study|Unspecified|4
369759|NCT00338884|1185799|P1|Overall Study|Death|8
369760|NCT00338884|1185799|P1|Overall Study|Adverse Event|14
369761|NCT00338884|1185799|P1|Overall Study|Objective Disease Progression or Relapse|44
369762|NCT00338741|1185833|P2|Overall Study|Lost to Follow-up|0
369763|NCT00338741|1185834|P1|Overall Study|Lost to Follow-up|2
369764|NCT00338455|1185865|P2|Overall Study|Physician Decision|0
369765|NCT00338455|1185866|P1|Overall Study|Physician Decision|1
369766|NCT00338455|1185865|P2|Overall Study|Death|1
369767|NCT00338455|1185866|P1|Overall Study|Death|2
369768|NCT00338286|1185880|P2|Overall Study|undefined|4
369769|NCT00338286|1185881|P1|Overall Study|undefined|3
369770|NCT00338286|1185880|P2|Overall Study|ongoing|272
369771|NCT00338286|1185881|P1|Overall Study|ongoing|297
369772|NCT00338286|1185880|P2|Overall Study|Lost to Follow-up|50
369773|NCT00338286|1185881|P1|Overall Study|Lost to Follow-up|53
369774|NCT00338286|1185880|P2|Overall Study|Withdrawal by Subject|44
369775|NCT00338286|1185881|P1|Overall Study|Withdrawal by Subject|40
369776|NCT00338104|1185898|P3|Overall Study|Protocol Violation|3
369777|NCT00338104|1185899|P2|Overall Study|Protocol Violation|1
369778|NCT00338104|1185900|P1|Overall Study|Protocol Violation|2
369779|NCT00337935|1185923|P2|Overall Study|Lack of Efficacy|1
369780|NCT00337935|1185924|P1|Overall Study|Lack of Efficacy|0
369781|NCT00337935|1185923|P2|Overall Study|Other|1
369782|NCT00337935|1185924|P1|Overall Study|Other|0
369783|NCT00337935|1185923|P2|Overall Study|Withdrawal by Subject|7
369784|NCT00337935|1185924|P1|Overall Study|Withdrawal by Subject|1
369785|NCT00337935|1185923|P2|Overall Study|Protocol Violation|3
369786|NCT00337935|1185924|P1|Overall Study|Protocol Violation|4
369787|NCT00337935|1185923|P2|Overall Study|Lost to Follow-up|1
369788|NCT00337935|1185924|P1|Overall Study|Lost to Follow-up|0
369789|NCT00337935|1185923|P2|Overall Study|Physician Decision|1
369790|NCT00337935|1185924|P1|Overall Study|Physician Decision|1
369791|NCT00337935|1185923|P2|Overall Study|Death|8
369792|NCT00337935|1185924|P1|Overall Study|Death|2
369793|NCT00337935|1185923|P2|Overall Study|Adverse Event|5
369794|NCT00337935|1185924|P1|Overall Study|Adverse Event|2
369795|NCT00337818|1185937|P3|Overall Study|Lost to Follow-up|107
369796|NCT00337818|1185938|P2|Overall Study|Lost to Follow-up|91
369797|NCT00337818|1185939|P1|Overall Study|Lost to Follow-up|289
369798|NCT00337779|1185961|P2|Overall Study|Death|1
369799|NCT00337779|1185962|P1|Overall Study|Death|0
369800|NCT00337779|1185961|P2|Overall Study|Pregnancy|2
369801|NCT00337779|1185962|P1|Overall Study|Pregnancy|3
369802|NCT00337779|1185961|P2|Overall Study|Adverse Event|51
369803|NCT00337779|1185962|P1|Overall Study|Adverse Event|28
369804|NCT00337779|1185961|P2|Overall Study|Lost to Follow-up|5
369805|NCT00337779|1185962|P1|Overall Study|Lost to Follow-up|6
369806|NCT00337779|1185961|P2|Overall Study|Protocol Violation|1
369807|NCT00337779|1185962|P1|Overall Study|Protocol Violation|1
369808|NCT00337779|1185961|P2|Overall Study|Physician Decision|6
369809|NCT00337779|1185962|P1|Overall Study|Physician Decision|3
369810|NCT00337779|1185961|P2|Overall Study|Sponsor decision|1
369811|NCT00337779|1185962|P1|Overall Study|Sponsor decision|1
369812|NCT00337779|1185961|P2|Overall Study|Withdrawal by Subject|12
369813|NCT00337779|1185962|P1|Overall Study|Withdrawal by Subject|10
369814|NCT00337727|1185974|P2|Overall Study|Withdrawal by Subject|5
369815|NCT00337727|1185975|P1|Overall Study|Withdrawal by Subject|3
369816|NCT00337727|1185974|P2|Overall Study|Protocol Violation|0
369817|NCT00337727|1185975|P1|Overall Study|Protocol Violation|4
369818|NCT00337727|1185974|P2|Overall Study|Physician Decision|0
369819|NCT00337727|1185975|P1|Overall Study|Physician Decision|1
369820|NCT00337727|1185974|P2|Overall Study|Lost to Follow-up|4
369821|NCT00337727|1185975|P1|Overall Study|Lost to Follow-up|5
369822|NCT00337727|1185974|P2|Overall Study|Adverse Event|3
369823|NCT00337727|1185975|P1|Overall Study|Adverse Event|5
369824|NCT00337675|1185986|P3|Overall Study|Trial Terminated|2
369825|NCT00337675|1185987|P2|Overall Study|Trial Terminated|0
369826|NCT00337675|1185988|P1|Overall Study|Trial Terminated|0
369827|NCT00337675|1185986|P3|Overall Study|Progressive Disease|0
369828|NCT00337675|1185987|P2|Overall Study|Progressive Disease|2
369829|NCT00337675|1185988|P1|Overall Study|Progressive Disease|0
369830|NCT00337675|1185986|P3|Overall Study|Withdrawal by Subject|19
369831|NCT00337675|1185987|P2|Overall Study|Withdrawal by Subject|25
369832|NCT00337675|1185988|P1|Overall Study|Withdrawal by Subject|25
369833|NCT00337675|1185986|P3|Overall Study|Protocol Violation|19
369834|NCT00337675|1185987|P2|Overall Study|Protocol Violation|24
369835|NCT00337675|1185988|P1|Overall Study|Protocol Violation|21
369836|NCT00337675|1185986|P3|Overall Study|Physician Decision|14
369837|NCT00337675|1185987|P2|Overall Study|Physician Decision|17
369838|NCT00337675|1185988|P1|Overall Study|Physician Decision|9
369839|NCT00337675|1185986|P3|Overall Study|Lost to Follow-up|17
369840|NCT00337675|1185987|P2|Overall Study|Lost to Follow-up|19
369841|NCT00337675|1185988|P1|Overall Study|Lost to Follow-up|22
369842|NCT00337675|1185986|P3|Overall Study|Lack of Efficacy|9
369843|NCT00337675|1185987|P2|Overall Study|Lack of Efficacy|7
369844|NCT00337675|1185988|P1|Overall Study|Lack of Efficacy|10
369845|NCT00337675|1185986|P3|Overall Study|Adverse Event|19
369846|NCT00337675|1185987|P2|Overall Study|Adverse Event|9
369847|NCT00337675|1185988|P1|Overall Study|Adverse Event|10
369848|NCT00337662|1186005|P4|Study Period III|Clinical Relapse|0
369849|NCT00337662|1186006|P3|Study Period III|Clinical Relapse|0
369850|NCT00337662|1186007|P2|Study Period III|Clinical Relapse|0
369851|NCT00337662|1186008|P1|Study Period III|Clinical Relapse|1
369852|NCT00337662|1186005|P4|Study Period III|Sponsor Decision|0
369853|NCT00337662|1186006|P3|Study Period III|Sponsor Decision|1
369854|NCT00337662|1186007|P2|Study Period III|Sponsor Decision|0
369855|NCT00337662|1186008|P1|Study Period III|Sponsor Decision|1
369856|NCT00337662|1186005|P4|Study Period III|Parent/Caregiver Decision|0
369857|NCT00337662|1186006|P3|Study Period III|Parent/Caregiver Decision|2
369858|NCT00337662|1186007|P2|Study Period III|Parent/Caregiver Decision|0
369859|NCT00337662|1186008|P1|Study Period III|Parent/Caregiver Decision|0
369860|NCT00337662|1186005|P4|Study Period III|Lack of Efficacy|0
369861|NCT00337662|1186006|P3|Study Period III|Lack of Efficacy|2
369862|NCT00337662|1186007|P2|Study Period III|Lack of Efficacy|4
369863|NCT00337662|1186008|P1|Study Period III|Lack of Efficacy|4
369864|NCT00337662|1186005|P4|Study Period III|Entry Criteria Not Met|0
369865|NCT00337662|1186006|P3|Study Period III|Entry Criteria Not Met|3
369866|NCT00337662|1186007|P2|Study Period III|Entry Criteria Not Met|1
369867|NCT00337662|1186008|P1|Study Period III|Entry Criteria Not Met|4
369868|NCT00337662|1186005|P4|Study Period III|Physician Decision|0
369869|NCT00337662|1186006|P3|Study Period III|Physician Decision|0
369870|NCT00337662|1186007|P2|Study Period III|Physician Decision|5
369871|NCT00337662|1186008|P1|Study Period III|Physician Decision|6
369872|NCT00337662|1186005|P4|Study Period III|Protocol Violation|0
369873|NCT00337662|1186006|P3|Study Period III|Protocol Violation|2
369874|NCT00337662|1186007|P2|Study Period III|Protocol Violation|8
369875|NCT00337662|1186008|P1|Study Period III|Protocol Violation|3
369876|NCT00337662|1186005|P4|Study Period III|Adverse Event|0
369877|NCT00337662|1186006|P3|Study Period III|Adverse Event|8
369878|NCT00337662|1186007|P2|Study Period III|Adverse Event|10
369879|NCT00337662|1186008|P1|Study Period III|Adverse Event|9
369880|NCT00337662|1186005|P4|Study Period III|Withdrawal by Subject|0
369881|NCT00337662|1186006|P3|Study Period III|Withdrawal by Subject|12
369882|NCT00337662|1186007|P2|Study Period III|Withdrawal by Subject|14
369883|NCT00337662|1186008|P1|Study Period III|Withdrawal by Subject|18
369884|NCT00337662|1186005|P4|Study Period III|Lost to Follow-up|0
369885|NCT00337662|1186006|P3|Study Period III|Lost to Follow-up|14
369886|NCT00337662|1186007|P2|Study Period III|Lost to Follow-up|16
369887|NCT00337662|1186008|P1|Study Period III|Lost to Follow-up|14
369888|NCT00337662|1186005|P4|Study Period II|Parent/Caregiver Decision|1
369889|NCT00337662|1186006|P3|Study Period II|Parent/Caregiver Decision|0
369890|NCT00337662|1186007|P2|Study Period II|Parent/Caregiver Decision|0
369891|NCT00337662|1186008|P1|Study Period II|Parent/Caregiver Decision|0
369892|NCT00337662|1186005|P4|Study Period II|Sponsor Decision|2
369893|NCT00337662|1186006|P3|Study Period II|Sponsor Decision|0
369894|NCT00337662|1186007|P2|Study Period II|Sponsor Decision|0
369895|NCT00337662|1186008|P1|Study Period II|Sponsor Decision|0
369896|NCT00337662|1186005|P4|Study Period II|Lack of Efficacy|7
369897|NCT00337662|1186006|P3|Study Period II|Lack of Efficacy|0
369898|NCT00337662|1186007|P2|Study Period II|Lack of Efficacy|0
369899|NCT00337662|1186008|P1|Study Period II|Lack of Efficacy|0
369900|NCT00337662|1186005|P4|Study Period II|Protocol Violation|6
369901|NCT00337662|1186006|P3|Study Period II|Protocol Violation|0
369902|NCT00337662|1186007|P2|Study Period II|Protocol Violation|0
369903|NCT00337662|1186008|P1|Study Period II|Protocol Violation|0
369904|NCT00337662|1186005|P4|Study Period II|Entry Criteria Not Met|6
369905|NCT00337662|1186006|P3|Study Period II|Entry Criteria Not Met|0
369906|NCT00337662|1186007|P2|Study Period II|Entry Criteria Not Met|0
369907|NCT00337662|1186008|P1|Study Period II|Entry Criteria Not Met|0
369908|NCT00337662|1186005|P4|Study Period II|Physician Decision|13
369909|NCT00337662|1186006|P3|Study Period II|Physician Decision|0
369910|NCT00337662|1186007|P2|Study Period II|Physician Decision|0
369911|NCT00337662|1186008|P1|Study Period II|Physician Decision|0
369912|NCT00337662|1186005|P4|Study Period II|Adverse Event|16
369913|NCT00337662|1186006|P3|Study Period II|Adverse Event|0
369914|NCT00337662|1186007|P2|Study Period II|Adverse Event|0
369915|NCT00337662|1186008|P1|Study Period II|Adverse Event|0
369916|NCT00337662|1186005|P4|Study Period II|Withdrawal by Subject|20
369917|NCT00337662|1186006|P3|Study Period II|Withdrawal by Subject|0
369918|NCT00337662|1186007|P2|Study Period II|Withdrawal by Subject|0
369919|NCT00337662|1186008|P1|Study Period II|Withdrawal by Subject|0
369920|NCT00337662|1186005|P4|Study Period II|Lost to Follow-up|35
369921|NCT00337662|1186006|P3|Study Period II|Lost to Follow-up|0
369922|NCT00337662|1186007|P2|Study Period II|Lost to Follow-up|0
369923|NCT00337662|1186008|P1|Study Period II|Lost to Follow-up|0
369924|NCT00337610|1186062|P2|Overall Study|Withdrawal by Subject|5
369925|NCT00337610|1186063|P1|Overall Study|Withdrawal by Subject|6
369926|NCT00337610|1186062|P2|Overall Study|Lost to Follow-up|3
369927|NCT00337610|1186063|P1|Overall Study|Lost to Follow-up|3
369928|NCT00337610|1186062|P2|Overall Study|Lack of Efficacy|3
369929|NCT00337610|1186063|P1|Overall Study|Lack of Efficacy|6
369930|NCT00337610|1186062|P2|Overall Study|Death|1
369931|NCT00337610|1186063|P1|Overall Study|Death|0
369932|NCT00337610|1186062|P2|Overall Study|Adverse Event|2
369933|NCT00337610|1186063|P1|Overall Study|Adverse Event|2
369934|NCT00337571|1186079|P4|Overall Study|High Potassium level|1
369935|NCT00337571|1186080|P3|Overall Study|High Potassium level|0
369936|NCT00337571|1186081|P2|Overall Study|High Potassium level|0
369937|NCT00337571|1186082|P1|Overall Study|High Potassium level|0
369938|NCT00337571|1186079|P4|Overall Study|No longer met study criteria|0
369939|NCT00337571|1186080|P3|Overall Study|No longer met study criteria|0
369940|NCT00337571|1186081|P2|Overall Study|No longer met study criteria|0
369941|NCT00337571|1186082|P1|Overall Study|No longer met study criteria|1
369942|NCT00337571|1186079|P4|Overall Study|Poor/noncompliance|1
369943|NCT00337571|1186080|P3|Overall Study|Poor/noncompliance|1
369944|NCT00337571|1186081|P2|Overall Study|Poor/noncompliance|1
369945|NCT00337571|1186082|P1|Overall Study|Poor/noncompliance|1
369946|NCT00337571|1186079|P4|Overall Study|Lost to Follow-up|1
369947|NCT00337571|1186080|P3|Overall Study|Lost to Follow-up|0
369948|NCT00337571|1186081|P2|Overall Study|Lost to Follow-up|1
369949|NCT00337571|1186082|P1|Overall Study|Lost to Follow-up|3
369950|NCT00337571|1186079|P4|Overall Study|Withdrawal by Subject|0
369951|NCT00337571|1186080|P3|Overall Study|Withdrawal by Subject|1
369952|NCT00337571|1186081|P2|Overall Study|Withdrawal by Subject|2
369953|NCT00337571|1186082|P1|Overall Study|Withdrawal by Subject|2
369954|NCT00337571|1186079|P4|Overall Study|Adverse Event|4
369955|NCT00337571|1186080|P3|Overall Study|Adverse Event|8
369956|NCT00337571|1186081|P2|Overall Study|Adverse Event|5
369957|NCT00337571|1186082|P1|Overall Study|Adverse Event|4
369958|NCT00337571|1186079|P4|Overall Study|Lack of Efficacy|0
369959|NCT00337571|1186080|P3|Overall Study|Lack of Efficacy|0
369960|NCT00337571|1186081|P2|Overall Study|Lack of Efficacy|0
369961|NCT00337571|1186082|P1|Overall Study|Lack of Efficacy|3
369962|NCT00337467|1186120|P1|Overall Study|Subject No Longer Met Study Criteria|2
369963|NCT00337467|1186120|P1|Overall Study|Lost to Follow-up|2
369964|NCT00337467|1186120|P1|Overall Study|Pregnancy|1
369965|NCT00337467|1186120|P1|Overall Study|Subject Withdrew Consent|2
369966|NCT00337467|1186120|P1|Overall Study|Adverse Event|3
369967|NCT00337428|1186139|P2|Overall Study|Anorexia|0
369968|NCT00337428|1186140|P1|Overall Study|Anorexia|1
369969|NCT00337428|1186139|P2|Overall Study|Unwilling to Continue|0
369970|NCT00337428|1186140|P1|Overall Study|Unwilling to Continue|1
369971|NCT00337428|1186139|P2|Overall Study|Lack of Time|1
369972|NCT00337428|1186140|P1|Overall Study|Lack of Time|1
369973|NCT00337428|1186139|P2|Overall Study|Withdrawal by Subject|2
369974|NCT00337428|1186140|P1|Overall Study|Withdrawal by Subject|1
369975|NCT00337285|1186191|P1|Overall Study|Lack of protocol compliance|7
369976|NCT00337285|1186191|P1|Overall Study|Physician Decision|1
369977|NCT00337285|1186191|P1|Overall Study|Death|1
369978|NCT00337285|1186191|P1|Overall Study|Lack of Efficacy|11
369979|NCT00337285|1186191|P1|Overall Study|Protocol Violation|27
369980|NCT00337285|1186191|P1|Overall Study|Adverse Event|28
369981|NCT00337285|1186191|P1|Overall Study|Lost to Follow-up|41
369982|NCT00337285|1186191|P1|Overall Study|Withdrawal by Subject|42
369983|NCT00337272|1186199|P2|Withdrawal Period|Non-compliance|1
369984|NCT00337272|1186200|P1|Withdrawal Period|Non-compliance|0
369985|NCT00337272|1186199|P2|Treatment Period|Withdrawal by Subject|1
369986|NCT00337272|1186200|P1|Treatment Period|Withdrawal by Subject|0
369987|NCT00337272|1186199|P2|Treatment Period|Non-compliance|1
369988|NCT00337272|1186200|P1|Treatment Period|Non-compliance|1
369989|NCT00337272|1186199|P2|Screening Period (Pre-randomization)|Screen failure|0
369990|NCT00337272|1186200|P1|Screening Period (Pre-randomization)|Screen failure|3
369991|NCT00337272|1186199|P2|Screening Period (Pre-randomization)|Non-compliance|0
369992|NCT00337272|1186200|P1|Screening Period (Pre-randomization)|Non-compliance|1
369993|NCT00337272|1186199|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
369994|NCT00337272|1186200|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
369995|NCT00337207|1186220|P1|Overall Study|Withdrawal by Subject|3
369996|NCT00337194|1186226|P2|Overall Study|Subsequent non-protocol therapy|1
369997|NCT00337194|1186227|P1|Overall Study|Subsequent non-protocol therapy|3
369998|NCT00337194|1186226|P2|Overall Study|Disease progression|2
369999|NCT00337194|1186227|P1|Overall Study|Disease progression|1
370000|NCT00337194|1186226|P2|Overall Study|Withdrawal by Subject|0
370001|NCT00337194|1186227|P1|Overall Study|Withdrawal by Subject|1
370002|NCT00337194|1186226|P2|Overall Study|Death|0
370003|NCT00337194|1186227|P1|Overall Study|Death|2
370004|NCT00337194|1186226|P2|Overall Study|Adverse Event|1
370005|NCT00337194|1186227|P1|Overall Study|Adverse Event|5
370006|NCT00337168|1186242|P1|Overall Study|Did not start therapy|1
370007|NCT00337168|1186242|P1|Overall Study|Not protocol specified|2
370008|NCT00337168|1186242|P1|Overall Study|Death|5
370009|NCT00337129|1186249|P1|Overall Study|not protocol specified|1
370010|NCT00337129|1186249|P1|Overall Study|Death|2
370011|NCT00337129|1186249|P1|Overall Study|Lack of Efficacy|32
370012|NCT00337129|1186249|P1|Overall Study|Withdrawal by Subject|1
370013|NCT00337129|1186249|P1|Overall Study|Adverse Event|4
370014|NCT00337103|1186258|P2|Overall Study|Death|0
370015|NCT00337103|1186259|P1|Overall Study|Death|1
370016|NCT00337103|1186258|P2|Overall Study|Lost to Follow-up|2
370017|NCT00337103|1186259|P1|Overall Study|Lost to Follow-up|1
370018|NCT00337103|1186258|P2|Overall Study|Entry Criteria Not Met|1
370019|NCT00337103|1186259|P1|Overall Study|Entry Criteria Not Met|4
370020|NCT00337103|1186258|P2|Overall Study|Not specified|6
370021|NCT00337103|1186259|P1|Overall Study|Not specified|5
370022|NCT00337103|1186258|P2|Overall Study|Withdrawal by Subject|5
370023|NCT00337103|1186259|P1|Overall Study|Withdrawal by Subject|8
370024|NCT00337103|1186258|P2|Overall Study|Physician Decision|14
370025|NCT00337103|1186259|P1|Overall Study|Physician Decision|15
370026|NCT00337103|1186258|P2|Overall Study|Clinical Progression|24
370027|NCT00337103|1186259|P1|Overall Study|Clinical Progression|27
370028|NCT00337103|1186258|P2|Overall Study|Subject Choice|27
370029|NCT00337103|1186259|P1|Overall Study|Subject Choice|34
370030|NCT00337103|1186258|P2|Overall Study|Adverse Event|59
370031|NCT00337103|1186259|P1|Overall Study|Adverse Event|45
370032|NCT00337103|1186258|P2|Overall Study|Progressive Disease|405
370033|NCT00337103|1186259|P1|Overall Study|Progressive Disease|409
370034|NCT00337077|1186270|P3|Overall Study|Ineligible|1
370035|NCT00337077|1186271|P2|Overall Study|Ineligible|1
370036|NCT00337077|1186272|P1|Overall Study|Ineligible|1
370037|NCT00337077|1186270|P3|Overall Study|Never started treatment|0
370038|NCT00337077|1186271|P2|Overall Study|Never started treatment|1
370039|NCT00337077|1186272|P1|Overall Study|Never started treatment|1
370040|NCT00337077|1186270|P3|Overall Study|Physician Decision|2
370041|NCT00337077|1186271|P2|Overall Study|Physician Decision|4
370042|NCT00337077|1186272|P1|Overall Study|Physician Decision|1
370043|NCT00337077|1186270|P3|Overall Study|Alternative therapy|0
370044|NCT00337077|1186271|P2|Overall Study|Alternative therapy|0
370045|NCT00337077|1186272|P1|Overall Study|Alternative therapy|1
370046|NCT00337077|1186270|P3|Overall Study|Withdrawal by Subject|2
370047|NCT00337077|1186271|P2|Overall Study|Withdrawal by Subject|2
370048|NCT00337077|1186272|P1|Overall Study|Withdrawal by Subject|7
370049|NCT00337077|1186270|P3|Overall Study|Death|0
370050|NCT00337077|1186271|P2|Overall Study|Death|1
370051|NCT00337077|1186272|P1|Overall Study|Death|0
370052|NCT00337077|1186270|P3|Overall Study|Adverse Event|1
370053|NCT00337077|1186271|P2|Overall Study|Adverse Event|7
370054|NCT00337077|1186272|P1|Overall Study|Adverse Event|7
370055|NCT00337077|1186270|P3|Overall Study|Progressive disease|19
370056|NCT00337077|1186271|P2|Overall Study|Progressive disease|37
370057|NCT00337077|1186272|P1|Overall Study|Progressive disease|25
370058|NCT00336895|1186287|P1|Overall Study|screen failed|1
370059|NCT00336895|1186287|P1|Overall Study|Physician Decision|1
370060|NCT00336895|1186287|P1|Overall Study|nausea and upset stomach|1
370061|NCT00336895|1186287|P1|Overall Study|diarrhea|1
370062|NCT00336856|1186293|P1|Overall Study|Found ineligible at time of analysis|1
370063|NCT00336856|1186293|P1|Overall Study|Withdrawal by Subject|3
370064|NCT00336583|1186341|P1|Overall Study|Death|1
370065|NCT00336583|1186341|P1|Overall Study|Lost to Follow-up|1
370066|NCT00336544|1186348|P2|Overall Study|Other|5
370067|NCT00336544|1186349|P1|Overall Study|Other|3
370068|NCT00336544|1186348|P2|Overall Study|Withdrawal by Subject|3
370069|NCT00336544|1186349|P1|Overall Study|Withdrawal by Subject|4
370070|NCT00336544|1186348|P2|Overall Study|Adverse Event|9
370071|NCT00336544|1186349|P1|Overall Study|Adverse Event|4
370072|NCT00336544|1186348|P2|Overall Study|Lack of Efficacy|5
370073|NCT00336544|1186349|P1|Overall Study|Lack of Efficacy|8
370074|NCT00336505|1186363|P2|Overall Study|Other|7
370075|NCT00336505|1186364|P1|Overall Study|Other|7
370076|NCT00336505|1186363|P2|Overall Study|Withdrawal by Subject|3
370077|NCT00336505|1186364|P1|Overall Study|Withdrawal by Subject|5
370078|NCT00336505|1186363|P2|Overall Study|Lost to Follow-up|4
370079|NCT00336505|1186364|P1|Overall Study|Lost to Follow-up|7
370080|NCT00336505|1186363|P2|Overall Study|Lack of Efficacy|4
370081|NCT00336505|1186364|P1|Overall Study|Lack of Efficacy|8
370082|NCT00336505|1186363|P2|Overall Study|Adverse Event|9
370083|NCT00336505|1186364|P1|Overall Study|Adverse Event|10
370084|NCT00336492|1186379|P3|Overall Study|Other|1
370085|NCT00336492|1186380|P2|Overall Study|Other|0
370086|NCT00336492|1186381|P1|Overall Study|Other|5
370087|NCT00336492|1186379|P3|Overall Study|Lack of Efficacy|4
370088|NCT00336492|1186380|P2|Overall Study|Lack of Efficacy|1
370089|NCT00336492|1186381|P1|Overall Study|Lack of Efficacy|6
370090|NCT00336492|1186379|P3|Overall Study|Adverse Event|6
370091|NCT00336492|1186380|P2|Overall Study|Adverse Event|3
370092|NCT00336492|1186381|P1|Overall Study|Adverse Event|4
370093|NCT00336479|1186393|P4|Overall Study|Virologic Stopping Rule|0
370094|NCT00336479|1186394|P3|Overall Study|Virologic Stopping Rule|0
370095|NCT00336479|1186395|P2|Overall Study|Virologic Stopping Rule|0
370096|NCT00336479|1186396|P1|Overall Study|Virologic Stopping Rule|20
370097|NCT00336479|1186393|P4|Overall Study|Unspecified|0
370098|NCT00336479|1186394|P3|Overall Study|Unspecified|1
370099|NCT00336479|1186395|P2|Overall Study|Unspecified|0
370100|NCT00336479|1186396|P1|Overall Study|Unspecified|0
370101|NCT00336479|1186393|P4|Overall Study|Withdrawal by Subject|0
370102|NCT00336479|1186394|P3|Overall Study|Withdrawal by Subject|3
370103|NCT00336479|1186395|P2|Overall Study|Withdrawal by Subject|2
370104|NCT00336479|1186396|P1|Overall Study|Withdrawal by Subject|3
370105|NCT00336479|1186393|P4|Overall Study|Lost to Follow-up|0
370106|NCT00336479|1186394|P3|Overall Study|Lost to Follow-up|0
370107|NCT00336479|1186395|P2|Overall Study|Lost to Follow-up|2
370108|NCT00336479|1186396|P1|Overall Study|Lost to Follow-up|3
370109|NCT00336479|1186393|P4|Overall Study|Physician Decision|0
370110|NCT00336479|1186394|P3|Overall Study|Physician Decision|1
370111|NCT00336479|1186395|P2|Overall Study|Physician Decision|3
370112|NCT00336479|1186396|P1|Overall Study|Physician Decision|2
370113|NCT00336479|1186393|P4|Overall Study|Noncompliant|0
370114|NCT00336479|1186394|P3|Overall Study|Noncompliant|3
370115|NCT00336479|1186395|P2|Overall Study|Noncompliant|7
370116|NCT00336479|1186396|P1|Overall Study|Noncompliant|1
370117|NCT00336479|1186393|P4|Overall Study|Adverse Event|4
370118|NCT00336479|1186394|P3|Overall Study|Adverse Event|18
370119|NCT00336479|1186395|P2|Overall Study|Adverse Event|11
370120|NCT00336479|1186396|P1|Overall Study|Adverse Event|8
370121|NCT00336284|1186485|P2|Overall Study|Withdrawal by Physician or Subject|64
370122|NCT00336284|1186486|P1|Overall Study|Withdrawal by Physician or Subject|102
370123|NCT00336284|1186485|P2|Overall Study|Lost to Follow-up|61
370124|NCT00336284|1186486|P1|Overall Study|Lost to Follow-up|82
370125|NCT00336284|1186485|P2|Overall Study|Death|26
370126|NCT00336284|1186486|P1|Overall Study|Death|52
370127|NCT00335959|1186502|P1|Overall Study|Ineligible|1
370128|NCT00335959|1186502|P1|Overall Study|Adverse Event|2
370129|NCT00335777|1186507|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
370130|NCT00335777|1186507|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
370131|NCT00335777|1186507|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
370132|NCT00335777|1186507|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
370133|NCT00335777|1186507|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
370134|NCT00335556|1186529|P6|Overall Study|Refusal of further protocol therapy|0
370135|NCT00335556|1186530|P5|Overall Study|Refusal of further protocol therapy|0
370136|NCT00335556|1186531|P4|Overall Study|Refusal of further protocol therapy|1
370137|NCT00335556|1186532|P3|Overall Study|Refusal of further protocol therapy|0
370138|NCT00335556|1186533|P2|Overall Study|Refusal of further protocol therapy|4
370139|NCT00335556|1186534|P1|Overall Study|Refusal of further protocol therapy|0
370140|NCT00335556|1186529|P6|Overall Study|Ineligible|0
370141|NCT00335556|1186530|P5|Overall Study|Ineligible|0
370142|NCT00335556|1186531|P4|Overall Study|Ineligible|0
370143|NCT00335556|1186532|P3|Overall Study|Ineligible|0
370144|NCT00335556|1186533|P2|Overall Study|Ineligible|0
370145|NCT00335556|1186534|P1|Overall Study|Ineligible|2
370146|NCT00335556|1186529|P6|Overall Study|Physician Decision|0
370147|NCT00335556|1186530|P5|Overall Study|Physician Decision|0
370148|NCT00335556|1186531|P4|Overall Study|Physician Decision|1
370149|NCT00335556|1186532|P3|Overall Study|Physician Decision|2
370150|NCT00335556|1186533|P2|Overall Study|Physician Decision|6
370151|NCT00335556|1186534|P1|Overall Study|Physician Decision|0
370152|NCT00335556|1186529|P6|Overall Study|Lack of Efficacy|1
370153|NCT00335556|1186530|P5|Overall Study|Lack of Efficacy|0
370154|NCT00335556|1186531|P4|Overall Study|Lack of Efficacy|3
370155|NCT00335556|1186532|P3|Overall Study|Lack of Efficacy|3
370156|NCT00335556|1186533|P2|Overall Study|Lack of Efficacy|19
370157|NCT00335556|1186534|P1|Overall Study|Lack of Efficacy|0
370158|NCT00335556|1186529|P6|Overall Study|Death|0
370159|NCT00335556|1186530|P5|Overall Study|Death|1
370160|NCT00335556|1186531|P4|Overall Study|Death|0
370161|NCT00335556|1186532|P3|Overall Study|Death|0
370162|NCT00335556|1186533|P2|Overall Study|Death|5
370163|NCT00335556|1186534|P1|Overall Study|Death|0
370164|NCT00335452|1186596|P4|Overall Study|Lost to Follow-up|2
370165|NCT00335452|1186597|P3|Overall Study|Lost to Follow-up|1
370166|NCT00335452|1186598|P2|Overall Study|Lost to Follow-up|3
370167|NCT00335452|1186599|P1|Overall Study|Lost to Follow-up|2
370168|NCT00335452|1186596|P4|Overall Study|Death|129
370169|NCT00335452|1186597|P3|Overall Study|Death|158
370170|NCT00335452|1186598|P2|Overall Study|Death|144
370171|NCT00335452|1186599|P1|Overall Study|Death|156
370172|NCT00335322|1186624|P3|Overall Study|Randomised but withdrew prior to ART sta|2
370173|NCT00335322|1186625|P2|Overall Study|Randomised but withdrew prior to ART sta|2
370174|NCT00335322|1186626|P1|Overall Study|Randomised but withdrew prior to ART sta|1
370175|NCT00335153|1186671|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
370176|NCT00335153|1186671|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
370177|NCT00335153|1186671|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
370178|NCT00335153|1186671|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
370179|NCT00335153|1186671|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
370180|NCT00335153|1186671|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
370181|NCT00335153|1186671|P1|Nasojejunal (NJ) Test Period|Administrative|1
370182|NCT00335153|1186671|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
370183|NCT00335153|1186671|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
370184|NCT00335153|1186671|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
370185|NCT00334958|1186710|P2|Overall Study|Not specified|2
370186|NCT00334958|1186711|P1|Overall Study|Not specified|1
370187|NCT00334958|1186710|P2|Overall Study|Adverse Event|12
370188|NCT00334958|1186711|P1|Overall Study|Adverse Event|27
370189|NCT00334958|1186710|P2|Overall Study|Withdrawal by Subject|4
370190|NCT00334958|1186711|P1|Overall Study|Withdrawal by Subject|7
370191|NCT00334958|1186710|P2|Overall Study|Request of the investigator or sponsor|1
370192|NCT00334958|1186711|P1|Overall Study|Request of the investigator or sponsor|0
370193|NCT00334958|1186710|P2|Overall Study|Protocol Violation|2
370194|NCT00334958|1186711|P1|Overall Study|Protocol Violation|2
370195|NCT00334958|1186710|P2|Overall Study|Medication Noncompliance|3
370196|NCT00334958|1186711|P1|Overall Study|Medication Noncompliance|0
370197|NCT00334893|1186725|P2|Overall Study|Not Treated|0
370198|NCT00334893|1186726|P1|Overall Study|Not Treated|1
370199|NCT00334815|1186734|P2|Overall Study|Physician Decision|4
370200|NCT00334815|1186735|P1|Overall Study|Physician Decision|2
370201|NCT00334815|1186734|P2|Overall Study|patient refused treatment|1
370202|NCT00334815|1186735|P1|Overall Study|patient refused treatment|0
370203|NCT00334815|1186734|P2|Overall Study|ineligible|1
370204|NCT00334815|1186735|P1|Overall Study|ineligible|1
370205|NCT00334815|1186734|P2|Overall Study|Progression|0
370206|NCT00334815|1186735|P1|Overall Study|Progression|1
370207|NCT00334815|1186734|P2|Overall Study|Death|2
370208|NCT00334815|1186735|P1|Overall Study|Death|0
370209|NCT00334815|1186734|P2|Overall Study|Adverse Event|2
370210|NCT00334815|1186735|P1|Overall Study|Adverse Event|3
370211|NCT00334802|1186749|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
370212|NCT00334802|1186750|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
370213|NCT00334802|1186749|P2|Overall Study|Adverse Event|3
370214|NCT00334802|1186750|P1|Overall Study|Adverse Event|0
370215|NCT00334802|1186749|P2|Overall Study|Withdrawal by Subject|4
370216|NCT00334802|1186750|P1|Overall Study|Withdrawal by Subject|0
370217|NCT00334802|1186749|P2|Overall Study|Physician Decision|0
370218|NCT00334802|1186750|P1|Overall Study|Physician Decision|1
370219|NCT00334802|1186749|P2|Overall Study|Patient Condition Aggrevated|0
370220|NCT00334802|1186750|P1|Overall Study|Patient Condition Aggrevated|1
370221|NCT00334802|1186749|P2|Overall Study|Lack of Efficacy|3
370222|NCT00334802|1186750|P1|Overall Study|Lack of Efficacy|1
370223|NCT00334802|1186749|P2|Overall Study|Toxicity|5
370224|NCT00334802|1186750|P1|Overall Study|Toxicity|1
370225|NCT00334802|1186749|P2|Overall Study|Progressive Disease|24
370226|NCT00334802|1186750|P1|Overall Study|Progressive Disease|2
370227|NCT00334542|1186780|P1|Overall Study|New cancer diagnosis|1
370228|NCT00334542|1186780|P1|Overall Study|Withdrawal by Subject|1
370229|NCT00334542|1186780|P1|Overall Study|Adverse Event|3
370230|NCT00334295|1186785|P1|Overall Study|Patients received fewer than 3 injection|5
370231|NCT00334282|1186795|P2|Overall Study|Death|100
370232|NCT00334282|1186796|P1|Overall Study|Death|194
370233|NCT00334282|1186795|P2|Overall Study|Withdrawal by Subject|3
370234|NCT00334282|1186796|P1|Overall Study|Withdrawal by Subject|17
370235|NCT00334282|1186795|P2|Overall Study|Lost to Follow-up|5
370236|NCT00334282|1186796|P1|Overall Study|Lost to Follow-up|11
370237|NCT00334113|1186827|P2|Overall Study|Withdrawal by Subject|1
370238|NCT00334113|1186828|P1|Overall Study|Withdrawal by Subject|0
370239|NCT00334113|1186827|P2|Overall Study|Lost to Follow-up|2
370240|NCT00334113|1186828|P1|Overall Study|Lost to Follow-up|2
370241|NCT00333983|1186851|P3|Overall Study|Withdrawal by Subject|1
370242|NCT00333983|1186852|P2|Overall Study|Withdrawal by Subject|3
370243|NCT00333983|1186853|P1|Overall Study|Withdrawal by Subject|0
370244|NCT00333983|1186851|P3|Overall Study|Adverse Event|1
370245|NCT00333983|1186852|P2|Overall Study|Adverse Event|1
370246|NCT00333983|1186853|P1|Overall Study|Adverse Event|1
370247|NCT00333983|1186851|P3|Overall Study|Lost to Follow-up|0
370248|NCT00333983|1186852|P2|Overall Study|Lost to Follow-up|1
370249|NCT00333983|1186853|P1|Overall Study|Lost to Follow-up|2
370250|NCT00333970|1186863|P2|Overall Study|Withdrawal by Subject|7
370251|NCT00333970|1186864|P1|Overall Study|Withdrawal by Subject|13
370252|NCT00333866|1186879|P4|Overall Study|Randomized but not Treated|1
370253|NCT00333866|1186880|P3|Overall Study|Randomized but not Treated|2
370254|NCT00333866|1186881|P2|Overall Study|Randomized but not Treated|3
370255|NCT00333866|1186882|P1|Overall Study|Randomized but not Treated|5
370256|NCT00333866|1186879|P4|Overall Study|Withdrawal by Subject|9
370257|NCT00333866|1186880|P3|Overall Study|Withdrawal by Subject|4
370258|NCT00333866|1186881|P2|Overall Study|Withdrawal by Subject|14
370259|NCT00333866|1186882|P1|Overall Study|Withdrawal by Subject|8
370260|NCT00333866|1186879|P4|Overall Study|Lost to Follow-up|2
370261|NCT00333866|1186880|P3|Overall Study|Lost to Follow-up|2
370262|NCT00333866|1186881|P2|Overall Study|Lost to Follow-up|2
370263|NCT00333866|1186882|P1|Overall Study|Lost to Follow-up|1
370264|NCT00333866|1186879|P4|Overall Study|Lack of Efficacy|5
370265|NCT00333866|1186880|P3|Overall Study|Lack of Efficacy|3
370266|NCT00333866|1186881|P2|Overall Study|Lack of Efficacy|6
370267|NCT00333866|1186882|P1|Overall Study|Lack of Efficacy|8
370268|NCT00333866|1186879|P4|Overall Study|Unspecified|2
370269|NCT00333866|1186880|P3|Overall Study|Unspecified|2
370270|NCT00333866|1186881|P2|Overall Study|Unspecified|2
370271|NCT00333866|1186882|P1|Overall Study|Unspecified|3
370272|NCT00333866|1186879|P4|Overall Study|Adverse Event|47
370273|NCT00333866|1186880|P3|Overall Study|Adverse Event|38
370274|NCT00333866|1186881|P2|Overall Study|Adverse Event|37
370275|NCT00333866|1186882|P1|Overall Study|Adverse Event|23
370276|NCT00333840|1186942|P4|Second-line Treatment Period|Death|9
370277|NCT00333840|1186943|P3|Second-line Treatment Period|Death|0
370278|NCT00333840|1186944|P2|Second-line Treatment Period|Death|0
370279|NCT00333840|1186945|P1|Second-line Treatment Period|Death|0
370280|NCT00333840|1186942|P4|Second-line Treatment Period|Administrative problems|7
370281|NCT00333840|1186943|P3|Second-line Treatment Period|Administrative problems|0
370282|NCT00333840|1186944|P2|Second-line Treatment Period|Administrative problems|0
370283|NCT00333840|1186945|P1|Second-line Treatment Period|Administrative problems|0
370284|NCT00333840|1186942|P4|Second-line Treatment Period|Lost to Follow-up|6
370285|NCT00333840|1186943|P3|Second-line Treatment Period|Lost to Follow-up|0
370286|NCT00333840|1186944|P2|Second-line Treatment Period|Lost to Follow-up|0
370287|NCT00333840|1186945|P1|Second-line Treatment Period|Lost to Follow-up|0
370288|NCT00333840|1186942|P4|Second-line Treatment Period|Subject withdrew consent|34
370289|NCT00333840|1186943|P3|Second-line Treatment Period|Subject withdrew consent|0
370290|NCT00333840|1186944|P2|Second-line Treatment Period|Subject withdrew consent|0
370291|NCT00333840|1186945|P1|Second-line Treatment Period|Subject withdrew consent|0
370292|NCT00333840|1186942|P4|Second-line Treatment Period|Protocol Violation|10
370293|NCT00333840|1186943|P3|Second-line Treatment Period|Protocol Violation|1
370294|NCT00333840|1186944|P2|Second-line Treatment Period|Protocol Violation|0
370295|NCT00333840|1186945|P1|Second-line Treatment Period|Protocol Violation|0
370296|NCT00333840|1186942|P4|Second-line Treatment Period|No longer required study drug|14
370297|NCT00333840|1186943|P3|Second-line Treatment Period|No longer required study drug|1
370373|NCT00333788|1187010|P1|Overall Study|Other: Quality of life concern|1
370298|NCT00333840|1186944|P2|Second-line Treatment Period|No longer required study drug|0
370299|NCT00333840|1186945|P1|Second-line Treatment Period|No longer required study drug|0
370300|NCT00333840|1186942|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
370301|NCT00333840|1186943|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
370302|NCT00333840|1186944|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
370303|NCT00333840|1186945|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
370304|NCT00333840|1186942|P4|Second-line Treatment Period|Abnormal procedure|1
370305|NCT00333840|1186943|P3|Second-line Treatment Period|Abnormal procedure|0
370306|NCT00333840|1186944|P2|Second-line Treatment Period|Abnormal procedure|0
370307|NCT00333840|1186945|P1|Second-line Treatment Period|Abnormal procedure|0
370308|NCT00333840|1186942|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
370309|NCT00333840|1186943|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
370310|NCT00333840|1186944|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
370311|NCT00333840|1186945|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
370312|NCT00333840|1186942|P4|Second-line Treatment Period|Adverse Event|34
370313|NCT00333840|1186943|P3|Second-line Treatment Period|Adverse Event|3
370314|NCT00333840|1186944|P2|Second-line Treatment Period|Adverse Event|0
370315|NCT00333840|1186945|P1|Second-line Treatment Period|Adverse Event|0
370316|NCT00333840|1186942|P4|First-line Treatment Period|Crossed over to other treatment arm|0
370317|NCT00333840|1186943|P3|First-line Treatment Period|Crossed over to other treatment arm|0
370318|NCT00333840|1186944|P2|First-line Treatment Period|Crossed over to other treatment arm|363
370319|NCT00333840|1186945|P1|First-line Treatment Period|Crossed over to other treatment arm|14
370320|NCT00333840|1186942|P4|First-line Treatment Period|Death|0
370321|NCT00333840|1186943|P3|First-line Treatment Period|Death|0
370322|NCT00333840|1186944|P2|First-line Treatment Period|Death|2
370323|NCT00333840|1186945|P1|First-line Treatment Period|Death|19
370324|NCT00333840|1186942|P4|First-line Treatment Period|Administrative problems|0
370325|NCT00333840|1186943|P3|First-line Treatment Period|Administrative problems|0
370326|NCT00333840|1186944|P2|First-line Treatment Period|Administrative problems|6
370327|NCT00333840|1186945|P1|First-line Treatment Period|Administrative problems|12
370328|NCT00333840|1186942|P4|First-line Treatment Period|Lost to Follow-up|0
370329|NCT00333840|1186943|P3|First-line Treatment Period|Lost to Follow-up|0
370330|NCT00333840|1186944|P2|First-line Treatment Period|Lost to Follow-up|6
370331|NCT00333840|1186945|P1|First-line Treatment Period|Lost to Follow-up|15
370332|NCT00333840|1186942|P4|First-line Treatment Period|Subject withdrew consent|0
370333|NCT00333840|1186943|P3|First-line Treatment Period|Subject withdrew consent|0
370334|NCT00333840|1186944|P2|First-line Treatment Period|Subject withdrew consent|77
370335|NCT00333840|1186945|P1|First-line Treatment Period|Subject withdrew consent|57
370336|NCT00333840|1186942|P4|First-line Treatment Period|Protocol Violation|0
370337|NCT00333840|1186943|P3|First-line Treatment Period|Protocol Violation|0
370338|NCT00333840|1186944|P2|First-line Treatment Period|Protocol Violation|17
370339|NCT00333840|1186945|P1|First-line Treatment Period|Protocol Violation|17
370340|NCT00333840|1186942|P4|First-line Treatment Period|No longer required study drug|0
370341|NCT00333840|1186943|P3|First-line Treatment Period|No longer required study drug|0
370342|NCT00333840|1186944|P2|First-line Treatment Period|No longer required study drug|8
370343|NCT00333840|1186945|P1|First-line Treatment Period|No longer required study drug|21
370344|NCT00333840|1186942|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
370345|NCT00333840|1186943|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
370346|NCT00333840|1186944|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
370347|NCT00333840|1186945|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
370348|NCT00333840|1186942|P4|First-line Treatment Period|Abnormal procedure|0
370349|NCT00333840|1186943|P3|First-line Treatment Period|Abnormal procedure|0
370350|NCT00333840|1186944|P2|First-line Treatment Period|Abnormal procedure|0
370351|NCT00333840|1186945|P1|First-line Treatment Period|Abnormal procedure|2
370352|NCT00333840|1186942|P4|First-line Treatment Period|Abnormal laboratory values|0
370353|NCT00333840|1186943|P3|First-line Treatment Period|Abnormal laboratory values|0
370354|NCT00333840|1186944|P2|First-line Treatment Period|Abnormal laboratory values|1
370355|NCT00333840|1186945|P1|First-line Treatment Period|Abnormal laboratory values|3
370356|NCT00333840|1186942|P4|First-line Treatment Period|Adverse Event|0
370357|NCT00333840|1186943|P3|First-line Treatment Period|Adverse Event|0
370358|NCT00333840|1186944|P2|First-line Treatment Period|Adverse Event|37
370359|NCT00333840|1186945|P1|First-line Treatment Period|Adverse Event|38
370360|NCT00333801|1186991|P2|Overall Study|Withdrawal by Subject|1
370361|NCT00333801|1186992|P1|Overall Study|Withdrawal by Subject|0
370362|NCT00333801|1186991|P2|Overall Study|Incarcerated|2
370363|NCT00333801|1186992|P1|Overall Study|Incarcerated|1
370364|NCT00333801|1186991|P2|Overall Study|Lost to Follow-up|0
370365|NCT00333801|1186992|P1|Overall Study|Lost to Follow-up|2
370366|NCT00333801|1186991|P2|Overall Study|Moved to another state|3
370367|NCT00333801|1186992|P1|Overall Study|Moved to another state|5
370368|NCT00333788|1187010|P1|Overall Study|Other: Signed consent for another study|1
370369|NCT00333788|1187010|P1|Overall Study|Other: Physician decision|1
370370|NCT00333788|1187010|P1|Overall Study|Other: Medical monitor decision|1
370371|NCT00333788|1187010|P1|Overall Study|Other: Subject in need of an Entocort|1
370372|NCT00333788|1187010|P1|Overall Study|Other: Sponsor decision|1
370374|NCT00333788|1187010|P1|Overall Study|Other: Investigator decision|1
370375|NCT00333788|1187010|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
370376|NCT00333788|1187010|P1|Overall Study|Other: Moved|2
370377|NCT00333788|1187010|P1|Overall Study|Other: Non-compliance|2
370378|NCT00333788|1187010|P1|Overall Study|Withdrawal by Subject|24
370379|NCT00333788|1187010|P1|Overall Study|Lost to Follow-up|2
370380|NCT00333788|1187010|P1|Overall Study|Lack of Efficacy|80
370381|NCT00333788|1187010|P1|Overall Study|Adverse Event|44
370382|NCT00333775|1187040|P3|Overall Study|Lost to Follow-up|8
370383|NCT00333775|1187041|P2|Overall Study|Lost to Follow-up|7
370384|NCT00333775|1187042|P1|Overall Study|Lost to Follow-up|10
370385|NCT00333775|1187040|P3|Overall Study|In Follow−up When Study Stopped|96
370386|NCT00333775|1187041|P2|Overall Study|In Follow−up When Study Stopped|92
370387|NCT00333775|1187042|P1|Overall Study|In Follow−up When Study Stopped|87
370388|NCT00333775|1187040|P3|Overall Study|Death|143
370389|NCT00333775|1187041|P2|Overall Study|Death|149
370390|NCT00333775|1187042|P1|Overall Study|Death|144
370391|NCT00333619|1187081|P2|Overall Study|Lost to Follow-up|3
370392|NCT00333619|1187082|P1|Overall Study|Lost to Follow-up|3
370393|NCT00333619|1187081|P2|Overall Study|Withdrawal by Subject|1
370394|NCT00333619|1187082|P1|Overall Study|Withdrawal by Subject|6
370395|NCT00333619|1187081|P2|Overall Study|Death|6
370396|NCT00333619|1187082|P1|Overall Study|Death|12
370397|NCT00333359|1187100|P2|Overall Study|Withdrew before Receiving One Dose|6
370398|NCT00333359|1187101|P1|Overall Study|Withdrew before Receiving One Dose|2
370399|NCT00333359|1187100|P2|Overall Study|Treatment Failure|8
370400|NCT00333359|1187101|P1|Overall Study|Treatment Failure|3
370401|NCT00333359|1187100|P2|Overall Study|Termination or Withdrawal by Sponsor|1
370402|NCT00333359|1187101|P1|Overall Study|Termination or Withdrawal by Sponsor|1
370403|NCT00333359|1187100|P2|Overall Study|Lost to Follow-up|25
370404|NCT00333359|1187101|P1|Overall Study|Lost to Follow-up|15
370405|NCT00333359|1187100|P2|Overall Study|Protocol Non-compliance|8
370406|NCT00333359|1187101|P1|Overall Study|Protocol Non-compliance|2
370407|NCT00333359|1187100|P2|Overall Study|Physician Decision|2
370408|NCT00333359|1187101|P1|Overall Study|Physician Decision|2
370409|NCT00333359|1187100|P2|Overall Study|Withdrawal by Subject|37
370410|NCT00333359|1187101|P1|Overall Study|Withdrawal by Subject|19
370411|NCT00333359|1187100|P2|Overall Study|Adverse Event|35
370412|NCT00333359|1187101|P1|Overall Study|Adverse Event|29
370413|NCT00333229|1187144|P2|Overall Study|Lack of Efficacy|1
370414|NCT00333229|1187145|P1|Overall Study|Lack of Efficacy|0
370415|NCT00333138|1187162|P3|Extension Study (Month6 to End of Study)|Death|0
370416|NCT00333138|1187163|P2|Extension Study (Month6 to End of Study)|Death|1
370417|NCT00333138|1187164|P1|Extension Study (Month6 to End of Study)|Death|0
370418|NCT00333138|1187162|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
370419|NCT00333138|1187163|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
370420|NCT00333138|1187164|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
370421|NCT00333138|1187162|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
370422|NCT00333138|1187163|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
370423|NCT00333138|1187164|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
370424|NCT00333138|1187162|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
370425|NCT00333138|1187163|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
370426|NCT00333138|1187164|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
370427|NCT00333138|1187162|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
370428|NCT00333138|1187163|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
370429|NCT00333138|1187164|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
370430|NCT00333138|1187162|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
370431|NCT00333138|1187163|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
370432|NCT00333138|1187164|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
370433|NCT00333138|1187162|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
370434|NCT00333138|1187163|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
370435|NCT00333138|1187164|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
370436|NCT00333138|1187162|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
370437|NCT00333138|1187163|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
370438|NCT00333138|1187164|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
370439|NCT00333138|1187162|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
370440|NCT00333138|1187163|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
370441|NCT00333138|1187164|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
370442|NCT00333138|1187162|P3|Core Study (6 Months)|Laboratory abnormality|1
370443|NCT00333138|1187163|P2|Core Study (6 Months)|Laboratory abnormality|0
370444|NCT00333138|1187164|P1|Core Study (6 Months)|Laboratory abnormality|0
370445|NCT00333138|1187162|P3|Core Study (6 Months)|Protocol Violation|1
370446|NCT00333138|1187163|P2|Core Study (6 Months)|Protocol Violation|0
370447|NCT00333138|1187164|P1|Core Study (6 Months)|Protocol Violation|1
370448|NCT00333138|1187162|P3|Core Study (6 Months)|Lack of Efficacy|0
370449|NCT00333138|1187163|P2|Core Study (6 Months)|Lack of Efficacy|0
370450|NCT00333138|1187164|P1|Core Study (6 Months)|Lack of Efficacy|1
370451|NCT00333138|1187162|P3|Core Study (6 Months)|Withdrawal by Subject|2
370452|NCT00333138|1187163|P2|Core Study (6 Months)|Withdrawal by Subject|1
370453|NCT00333138|1187164|P1|Core Study (6 Months)|Withdrawal by Subject|1
370454|NCT00333138|1187162|P3|Core Study (6 Months)|Adverse Event|8
370455|NCT00333138|1187163|P2|Core Study (6 Months)|Adverse Event|5
370456|NCT00333138|1187164|P1|Core Study (6 Months)|Adverse Event|4
370457|NCT00332839|1187203|P2|Follow-up (Months 12 - 60)|Death|1
370458|NCT00332839|1187204|P1|Follow-up (Months 12 - 60)|Death|1
370459|NCT00332839|1187203|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
370460|NCT00332839|1187204|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
370461|NCT00332839|1187203|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
370462|NCT00332839|1187204|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
370463|NCT00332839|1187203|P2|Core (Months 0 - 12)|Adverse Event|15
370464|NCT00332839|1187204|P1|Core (Months 0 - 12)|Adverse Event|5
370465|NCT00332839|1187203|P2|Core (Months 0 - 12)|Protocol deviation|1
370466|NCT00332839|1187204|P1|Core (Months 0 - 12)|Protocol deviation|1
370467|NCT00332839|1187203|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
370468|NCT00332839|1187204|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
370469|NCT00332839|1187203|P2|Core (Months 0 - 12)|Administrative problems|1
370470|NCT00332839|1187204|P1|Core (Months 0 - 12)|Administrative problems|1
370471|NCT00332709|1187235|P2|Overall Study|Abnormal test procedure result|0
370472|NCT00332709|1187236|P1|Overall Study|Abnormal test procedure result|1
370473|NCT00332709|1187235|P2|Overall Study|Administrative Problems|3
370474|NCT00332709|1187236|P1|Overall Study|Administrative Problems|0
370475|NCT00332709|1187235|P2|Overall Study|Lost to Follow-up|0
370476|NCT00332709|1187236|P1|Overall Study|Lost to Follow-up|2
370477|NCT00332709|1187235|P2|Overall Study|Withdrawal by Subject|3
370478|NCT00332709|1187236|P1|Overall Study|Withdrawal by Subject|2
370479|NCT00332709|1187235|P2|Overall Study|Adverse Event|14
370480|NCT00332709|1187236|P1|Overall Study|Adverse Event|11
370481|NCT00332696|1187260|P2|Overall Study|Withdrawal by Subject|0
370482|NCT00332696|1187261|P1|Overall Study|Withdrawal by Subject|1
370483|NCT00332696|1187260|P2|Overall Study|Lost to Follow-up|1
370484|NCT00332696|1187261|P1|Overall Study|Lost to Follow-up|0
370485|NCT00332696|1187260|P2|Overall Study|Condition does not justify treatment|2
370486|NCT00332696|1187261|P1|Overall Study|Condition does not justify treatment|0
370487|NCT00332696|1187260|P2|Overall Study|Adverse Event|2
370488|NCT00332696|1187261|P1|Overall Study|Adverse Event|1
370489|NCT00332696|1187260|P2|Overall Study|Insufficient therapeutic effect|11
370490|NCT00332696|1187261|P1|Overall Study|Insufficient therapeutic effect|4
370491|NCT00332696|1187260|P2|Overall Study|Death|14
370492|NCT00332696|1187261|P1|Overall Study|Death|24
370493|NCT00332488|1187337|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
370494|NCT00332488|1187338|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
370495|NCT00332488|1187339|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
370496|NCT00332488|1187337|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
370497|NCT00332488|1187338|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
370498|NCT00332488|1187339|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
370499|NCT00332488|1187337|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
370500|NCT00332488|1187338|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
370501|NCT00332488|1187339|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
370502|NCT00332488|1187337|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
370503|NCT00332488|1187338|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
370504|NCT00332488|1187339|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
370505|NCT00332488|1187337|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
370506|NCT00332488|1187338|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
370507|NCT00332488|1187339|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
370508|NCT00332488|1187337|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
370509|NCT00332488|1187338|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
370510|NCT00332488|1187339|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
370511|NCT00332488|1187337|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
370512|NCT00332488|1187338|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
370513|NCT00332488|1187339|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
370514|NCT00332488|1187337|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
370515|NCT00332488|1187338|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
370516|NCT00332488|1187339|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
370517|NCT00332488|1187337|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
370518|NCT00332488|1187338|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
370519|NCT00332488|1187339|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
370520|NCT00332488|1187337|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
370521|NCT00332488|1187338|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
370522|NCT00332488|1187339|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
370523|NCT00332488|1187337|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
370524|NCT00332488|1187338|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
370525|NCT00332488|1187339|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
370526|NCT00332488|1187337|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
370527|NCT00332488|1187338|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
370528|NCT00332488|1187339|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
370529|NCT00332462|1187351|P1|Overall Study|Graft Loss|2
370530|NCT00332462|1187351|P1|Overall Study|Death|3
370531|NCT00332462|1187351|P1|Overall Study|no longer requires study drug|1
370532|NCT00332462|1187351|P1|Overall Study|Unsatisfactory therapeutic effect|4
370533|NCT00332462|1187351|P1|Overall Study|Abnormal Lab Value|1
370534|NCT00332462|1187351|P1|Overall Study|Adverse Event|5
370535|NCT00332332|1187358|P1|Overall Study|Did not receive study treatment|16
370536|NCT00332332|1187358|P1|Overall Study|Not specified|18
370537|NCT00332332|1187358|P1|Overall Study|Disease progression|2
370538|NCT00332332|1187358|P1|Overall Study|Noncompliance|2
370539|NCT00332332|1187358|P1|Overall Study|Protocol deviation|4
370540|NCT00332332|1187358|P1|Overall Study|Lost to Follow-up|3
370541|NCT00332332|1187358|P1|Overall Study|Physician Decision|1
370542|NCT00332332|1187358|P1|Overall Study|Withdrawal by Subject|8
370543|NCT00332332|1187358|P1|Overall Study|Death|1
370544|NCT00332332|1187358|P1|Overall Study|Adverse Event|13
370545|NCT00332241|1187367|P2|Overall Study|Lost to Follow-up|1
370546|NCT00332241|1187368|P1|Overall Study|Lost to Follow-up|4
370547|NCT00332241|1187367|P2|Overall Study|Withdrawal by Subject|1
370548|NCT00332241|1187368|P1|Overall Study|Withdrawal by Subject|2
370549|NCT00332241|1187367|P2|Overall Study|Adverse Event|5
370550|NCT00332241|1187368|P1|Overall Study|Adverse Event|3
370551|NCT00332241|1187367|P2|Overall Study|Lack of Efficacy|1
370552|NCT00332241|1187368|P1|Overall Study|Lack of Efficacy|6
370553|NCT00332189|1187388|P1|Overall Study|Moved out of country|2
370554|NCT00332189|1187388|P1|Overall Study|Lack of Efficacy|4
370555|NCT00332189|1187388|P1|Overall Study|Withdrawal by Subject|9
370556|NCT00332189|1187388|P1|Overall Study|Uncooperative/Noncompliant|3
370557|NCT00332189|1187388|P1|Overall Study|Adverse Event|3
370558|NCT00331864|1187430|P2|Overall Study|Death|0
370559|NCT00331864|1187431|P1|Overall Study|Death|6
370560|NCT00331864|1187430|P2|Overall Study|Administrative Problems|0
370561|NCT00331864|1187431|P1|Overall Study|Administrative Problems|1
370562|NCT00331864|1187430|P2|Overall Study|Lost to Follow-up|3
370563|NCT00331864|1187431|P1|Overall Study|Lost to Follow-up|4
370564|NCT00331864|1187430|P2|Overall Study|Withdrawal by Subject|0
370565|NCT00331864|1187431|P1|Overall Study|Withdrawal by Subject|10
370566|NCT00331864|1187430|P2|Overall Study|Protocol Violation|0
370567|NCT00331864|1187431|P1|Overall Study|Protocol Violation|3
370568|NCT00331864|1187430|P2|Overall Study|Lack of Efficacy|0
370569|NCT00331864|1187431|P1|Overall Study|Lack of Efficacy|4
370570|NCT00331864|1187430|P2|Overall Study|Adverse Event|1
370571|NCT00331864|1187431|P1|Overall Study|Adverse Event|30
370572|NCT00331799|1187450|P1|Overall Study|Sedation|1
370573|NCT00331799|1187450|P1|Overall Study|Withdrawal by Subject|2
370574|NCT00331773|1187456|P2|Overall Study|Protocol Violation|3
370575|NCT00331773|1187457|P1|Overall Study|Protocol Violation|10
370576|NCT00331773|1187456|P2|Overall Study|Withdrawal by Subject|4
370577|NCT00331773|1187457|P1|Overall Study|Withdrawal by Subject|6
370578|NCT00331760|1187485|P2|Overall Study|Ineligible / no protocol treatment|8
370579|NCT00331760|1187486|P1|Overall Study|Ineligible / no protocol treatment|15
370580|NCT00331682|1187492|P1|Overall Study|Adverse Event|1
370581|NCT00331422|1187498|P1|Overall Study|Did not receive entire study regimen|5
370582|NCT00331409|1187507|P1|Overall Study|Lack of Efficacy|4
370583|NCT00331006|1187514|P1|Follow-Up Phase II|Lost to Follow-up|3
370584|NCT00331006|1187514|P1|Follow-Up Phase I|Lost to Follow-up|1
370585|NCT00331006|1187514|P1|Treatment Phase|Withdrawal by Subject|1
370586|NCT00331006|1187514|P1|Screening Phase|Ineligible for treatment phase|4
370587|NCT00331006|1187514|P1|Screening Phase|Lost to Follow-up|1
370588|NCT00331006|1187514|P1|Screening Phase|enrollment halted|1
370589|NCT00331006|1187514|P1|Screening Phase|Withdrawal by Subject|1
370590|NCT00330967|1187527|P2|Overall Study|Physician Decision|9
370591|NCT00330967|1187528|P1|Overall Study|Physician Decision|0
370592|NCT00330967|1187527|P2|Overall Study|Withdrawal by Subject|5
370593|NCT00330967|1187528|P1|Overall Study|Withdrawal by Subject|0
370594|NCT00330928|1187539|P1|Overall Study|IVUS could not be performed.|1
370595|NCT00330928|1187539|P1|Overall Study|Death|1
370596|NCT00330928|1187539|P1|Overall Study|Physician Decision|9
370597|NCT00330928|1187539|P1|Overall Study|Lost to Follow-up|6
370598|NCT00330759|1187562|P2|Overall Study|Other|44
370599|NCT00330759|1187563|P1|Overall Study|Other|36
370600|NCT00330759|1187562|P2|Overall Study|Ineligibility determined|1
370601|NCT00330759|1187563|P1|Overall Study|Ineligibility determined|2
370602|NCT00330759|1187562|P2|Overall Study|Protocol deviation|2
370603|NCT00330759|1187563|P1|Overall Study|Protocol deviation|0
370604|NCT00330759|1187562|P2|Overall Study|Physician Decision|2
370605|NCT00330759|1187563|P1|Overall Study|Physician Decision|1
370606|NCT00330759|1187562|P2|Overall Study|Noncompliance|17
370607|NCT00330759|1187563|P1|Overall Study|Noncompliance|15
370608|NCT00330759|1187562|P2|Overall Study|Lost to Follow-up|22
370609|NCT00330759|1187563|P1|Overall Study|Lost to Follow-up|16
370610|NCT00330759|1187562|P2|Overall Study|Participant request|22
370611|NCT00330759|1187563|P1|Overall Study|Participant request|31
370612|NCT00330759|1187562|P2|Overall Study|Adverse Event|36
370613|NCT00330759|1187563|P1|Overall Study|Adverse Event|48
370614|NCT00330759|1187562|P2|Overall Study|Withdrawal by Subject|124
370615|NCT00330759|1187563|P1|Overall Study|Withdrawal by Subject|143
370616|NCT00330759|1187562|P2|Overall Study|Disease progression|126
370617|NCT00330759|1187563|P1|Overall Study|Disease progression|104
370618|NCT00330759|1187562|P2|Overall Study|Death|310
370619|NCT00330759|1187563|P1|Overall Study|Death|316
370620|NCT00330681|1187584|P2|Overall Study|Tracheotomy due to worsening of ALS|2
370621|NCT00330681|1187585|P1|Overall Study|Tracheotomy due to worsening of ALS|1
370622|NCT00330681|1187584|P2|Overall Study|Withdrawal by Subject|5
370623|NCT00330681|1187585|P1|Overall Study|Withdrawal by Subject|5
370624|NCT00330681|1187584|P2|Overall Study|Protocol Violation|1
370625|NCT00330681|1187585|P1|Overall Study|Protocol Violation|0
370626|NCT00330681|1187584|P2|Overall Study|Adverse Event|6
370627|NCT00330681|1187585|P1|Overall Study|Adverse Event|3
370628|NCT00330668|1187607|P1|Overall Study|Patient started Lupron|1
370629|NCT00330668|1187607|P1|Overall Study|Use of exclusionary medication|1
370630|NCT00330668|1187607|P1|Overall Study|Lack of Efficacy|1
370631|NCT00330668|1187607|P1|Overall Study|Sponsor's decision|76
370632|NCT00330668|1187607|P1|Overall Study|Withdrawal by Subject|20
370633|NCT00330668|1187607|P1|Overall Study|Non-Compliance|5
370634|NCT00330668|1187607|P1|Overall Study|Lost to Follow-up|9
370635|NCT00330668|1187607|P1|Overall Study|Adverse Event|1
370636|NCT00330616|1187614|P1|Overall Study|Not specified|1
370637|NCT00330616|1187614|P1|Overall Study|Withdrawal by Subject|4
370638|NCT00330616|1187614|P1|Overall Study|Lost to Follow-up|2
370639|NCT00330616|1187614|P1|Overall Study|Lack of Efficacy|1
370640|NCT00330616|1187614|P1|Overall Study|Adverse Event|13
370641|NCT00330460|1187640|P2|Overall Study|Other|0
370642|NCT00330460|1187641|P1|Overall Study|Other|1
370643|NCT00330460|1187640|P2|Overall Study|Noncompliance|1
370644|NCT00330460|1187641|P1|Overall Study|Noncompliance|2
370645|NCT00330460|1187640|P2|Overall Study|Lost to Follow-up|3
370646|NCT00330460|1187641|P1|Overall Study|Lost to Follow-up|8
370647|NCT00330460|1187640|P2|Overall Study|Ineligibility determined|3
370648|NCT00330460|1187641|P1|Overall Study|Ineligibility determined|1
370649|NCT00330460|1187640|P2|Overall Study|Death|1
370650|NCT00330460|1187641|P1|Overall Study|Death|1
370651|NCT00330460|1187640|P2|Overall Study|Withdrawal by Subject|17
370652|NCT00330460|1187641|P1|Overall Study|Withdrawal by Subject|18
370653|NCT00330460|1187640|P2|Overall Study|Adverse Event|8
370654|NCT00330460|1187641|P1|Overall Study|Adverse Event|10
370655|NCT00330460|1187640|P2|Overall Study|Physician Decision|0
370656|NCT00330460|1187641|P1|Overall Study|Physician Decision|1
370657|NCT00330174|1187686|P2|Overall Study|Miscellaneous reasons|1
370658|NCT00330174|1187687|P1|Overall Study|Miscellaneous reasons|7
370659|NCT00330174|1187686|P2|Overall Study|Excessive missed visits|8
370660|NCT00330174|1187687|P1|Overall Study|Excessive missed visits|3
370661|NCT00330174|1187686|P2|Overall Study|Clinical deterioration|2
370662|NCT00330174|1187687|P1|Overall Study|Clinical deterioration|1
370663|NCT00330174|1187686|P2|Overall Study|Lost to Follow-up|1
370664|NCT00330174|1187687|P1|Overall Study|Lost to Follow-up|4
370665|NCT00330174|1187686|P2|Overall Study|Withdrawal by Subject|7
370666|NCT00330174|1187687|P1|Overall Study|Withdrawal by Subject|7
370667|NCT00329901|1187711|P3|Overall Study|Unable to classify|0
370668|NCT00329901|1187712|P2|Overall Study|Unable to classify|2
370669|NCT00329901|1187713|P1|Overall Study|Unable to classify|2
370670|NCT00329901|1187711|P3|Overall Study|Protocol Violation|1
370671|NCT00329901|1187712|P2|Overall Study|Protocol Violation|0
370672|NCT00329901|1187713|P1|Overall Study|Protocol Violation|1
370673|NCT00329901|1187711|P3|Overall Study|Lost to Follow-up|1
370674|NCT00329901|1187712|P2|Overall Study|Lost to Follow-up|0
370675|NCT00329901|1187713|P1|Overall Study|Lost to Follow-up|2
370676|NCT00329901|1187711|P3|Overall Study|Withdrawal by Subject|2
370677|NCT00329901|1187712|P2|Overall Study|Withdrawal by Subject|3
370678|NCT00329901|1187713|P1|Overall Study|Withdrawal by Subject|4
370679|NCT00329849|1187743|P2|Overall Study|Withdrawal by Subject|4
370680|NCT00329849|1187744|P1|Overall Study|Withdrawal by Subject|6
370681|NCT00329784|1187772|P4|Overall Study|Unspecified|0
370682|NCT00329784|1187773|P3|Overall Study|Unspecified|0
370683|NCT00329784|1187774|P2|Overall Study|Unspecified|2
370684|NCT00329784|1187775|P1|Overall Study|Unspecified|1
370685|NCT00329784|1187772|P4|Overall Study|Withdrawal by Subject|0
370686|NCT00329784|1187773|P3|Overall Study|Withdrawal by Subject|0
370687|NCT00329784|1187774|P2|Overall Study|Withdrawal by Subject|2
370688|NCT00329784|1187775|P1|Overall Study|Withdrawal by Subject|4
370689|NCT00329784|1187772|P4|Overall Study|Lost to Follow-up|0
370690|NCT00329784|1187773|P3|Overall Study|Lost to Follow-up|0
370691|NCT00329784|1187774|P2|Overall Study|Lost to Follow-up|1
370692|NCT00329784|1187775|P1|Overall Study|Lost to Follow-up|0
370693|NCT00329745|1187803|P2|Overall Study|Lost to Follow-up|101
370694|NCT00329745|1187804|P1|Overall Study|Lost to Follow-up|86
370695|NCT00329745|1187803|P2|Overall Study|Withdrawal by Subject|1
370696|NCT00329745|1187804|P1|Overall Study|Withdrawal by Subject|0
370697|NCT00329745|1187803|P2|Overall Study|Protocol Violation|0
370698|NCT00329745|1187804|P1|Overall Study|Protocol Violation|1
370699|NCT00329719|1187824|P4|Overall Study|Lost to Follow-up|1
370700|NCT00329719|1187825|P3|Overall Study|Lost to Follow-up|0
370701|NCT00329719|1187826|P2|Overall Study|Lost to Follow-up|0
370702|NCT00329719|1187827|P1|Overall Study|Lost to Follow-up|0
370703|NCT00329641|1187849|P1|Overall Study|Other reason, not protocol specified|1
370704|NCT00329641|1187849|P1|Overall Study|Adverse Event|3
370705|NCT00329641|1187849|P1|Overall Study|Not eligible|1
370706|NCT00329641|1187849|P1|Overall Study|Did not start treatment|1
370707|NCT00329602|1187858|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
370708|NCT00329602|1187859|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
370709|NCT00329602|1187860|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
370710|NCT00329602|1187858|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
370711|NCT00329602|1187859|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
370712|NCT00329602|1187860|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
370713|NCT00329602|1187858|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
370714|NCT00329602|1187859|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
370715|NCT00329602|1187860|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
370716|NCT00329602|1187858|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
370799|NCT00328926|1188640|P3|Overall Study|Lost to Follow-up|0
370717|NCT00329602|1187859|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
370718|NCT00329602|1187860|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
370719|NCT00329602|1187858|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
370720|NCT00329602|1187859|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
370721|NCT00329602|1187860|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
370722|NCT00329602|1187858|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
370723|NCT00329602|1187859|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
370724|NCT00329602|1187860|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
370725|NCT00329550|1187898|P3|Overall Study|Due to Relocation|1
370726|NCT00329550|1187899|P2|Overall Study|Due to Relocation|0
370727|NCT00329550|1187900|P1|Overall Study|Due to Relocation|0
370728|NCT00329550|1187898|P3|Overall Study|Withdrawal of Consent|1
370729|NCT00329550|1187899|P2|Overall Study|Withdrawal of Consent|0
370730|NCT00329550|1187900|P1|Overall Study|Withdrawal of Consent|1
370731|NCT00329550|1187898|P3|Overall Study|Adverse Event|2
370732|NCT00329550|1187899|P2|Overall Study|Adverse Event|4
370733|NCT00329550|1187900|P1|Overall Study|Adverse Event|3
370734|NCT00329420|1188165|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
370735|NCT00329420|1188166|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
370736|NCT00329420|1188167|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
370737|NCT00329420|1188165|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
370738|NCT00329420|1188166|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
370739|NCT00329420|1188167|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
370740|NCT00329420|1188165|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
370741|NCT00329420|1188166|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
370742|NCT00329420|1188167|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
370743|NCT00329420|1188165|P3|Re-induction Phase|Did not respond to re-induction|7
370744|NCT00329420|1188166|P2|Re-induction Phase|Did not respond to re-induction|5
370745|NCT00329420|1188167|P1|Re-induction Phase|Did not respond to re-induction|6
370746|NCT00329420|1188165|P3|Re-induction Phase|Withdrawal of Consent|1
370747|NCT00329420|1188166|P2|Re-induction Phase|Withdrawal of Consent|0
370748|NCT00329420|1188167|P1|Re-induction Phase|Withdrawal of Consent|0
370749|NCT00329420|1188165|P3|Re-induction Phase|Lack of Efficacy|0
370750|NCT00329420|1188166|P2|Re-induction Phase|Lack of Efficacy|1
370751|NCT00329420|1188167|P1|Re-induction Phase|Lack of Efficacy|0
370752|NCT00329407|1188546|P1|Overall Study|Withdrawal by Subject|1
370753|NCT00329238|1188553|P2|Overall Study|Other reason (not specified)|54
370754|NCT00329238|1188554|P1|Overall Study|Other reason (not specified)|40
370755|NCT00329238|1188553|P2|Overall Study|Withdrawal by Subject|58
370756|NCT00329238|1188554|P1|Overall Study|Withdrawal by Subject|64
370757|NCT00329238|1188553|P2|Overall Study|Lost to Follow-up|6
370758|NCT00329238|1188554|P1|Overall Study|Lost to Follow-up|2
370759|NCT00329238|1188553|P2|Overall Study|Protocol Violation|34
370760|NCT00329238|1188554|P1|Overall Study|Protocol Violation|23
370761|NCT00329238|1188553|P2|Overall Study|Adverse Event|129
370762|NCT00329238|1188554|P1|Overall Study|Adverse Event|147
370763|NCT00329160|1188590|P1|Overall Study|Incomplete IVUS|45
370764|NCT00329160|1188590|P1|Overall Study|Did not Receive Study Drug|1
370765|NCT00329160|1188590|P1|Overall Study|Protocol Violation|2
370766|NCT00329160|1188590|P1|Overall Study|Withdrawal by Subject|13
370767|NCT00329160|1188590|P1|Overall Study|Adverse Event|27
370768|NCT00329108|1188599|P2|Overall Study|Protocol Violation|2
370769|NCT00329108|1188600|P1|Overall Study|Protocol Violation|0
370770|NCT00329108|1188599|P2|Overall Study|withdrew patient after SAE resolved|0
370771|NCT00329108|1188600|P1|Overall Study|withdrew patient after SAE resolved|1
370772|NCT00329108|1188599|P2|Overall Study|study terminated by sponsor|0
370773|NCT00329108|1188600|P1|Overall Study|study terminated by sponsor|1
370774|NCT00329108|1188599|P2|Overall Study|Subject no longer willing to participate|2
370775|NCT00329108|1188600|P1|Overall Study|Subject no longer willing to participate|2
370776|NCT00329108|1188599|P2|Overall Study|symptomatic deterioration|1
370777|NCT00329108|1188600|P1|Overall Study|symptomatic deterioration|1
370778|NCT00329108|1188599|P2|Overall Study|Withdrawal by Subject|2
370779|NCT00329108|1188600|P1|Overall Study|Withdrawal by Subject|0
370780|NCT00329108|1188599|P2|Overall Study|Lack of Efficacy|3
370781|NCT00329108|1188600|P1|Overall Study|Lack of Efficacy|3
370782|NCT00329108|1188599|P2|Overall Study|Adverse Event|2
370783|NCT00329108|1188600|P1|Overall Study|Adverse Event|2
370784|NCT00329030|1188608|P2|Overall Study|Ineligible Pathology|1
370785|NCT00329030|1188609|P1|Overall Study|Ineligible Pathology|1
370786|NCT00329030|1188608|P2|Overall Study|Progressive Disease|2
370787|NCT00329030|1188609|P1|Overall Study|Progressive Disease|6
370788|NCT00329030|1188608|P2|Overall Study|Withdrawal by Subject|3
370789|NCT00329030|1188609|P1|Overall Study|Withdrawal by Subject|1
370790|NCT00328926|1188640|P3|Overall Study|Lack of ovarian response|0
370791|NCT00328926|1188641|P2|Overall Study|Lack of ovarian response|1
370792|NCT00328926|1188642|P1|Overall Study|Lack of ovarian response|0
370793|NCT00328926|1188640|P3|Overall Study|In vitro fertilization treatment|1
370794|NCT00328926|1188641|P2|Overall Study|In vitro fertilization treatment|0
370795|NCT00328926|1188642|P1|Overall Study|In vitro fertilization treatment|0
370796|NCT00328926|1188640|P3|Overall Study|Death|1
370797|NCT00328926|1188641|P2|Overall Study|Death|0
370798|NCT00328926|1188642|P1|Overall Study|Death|0
370800|NCT00328926|1188641|P2|Overall Study|Lost to Follow-up|1
370801|NCT00328926|1188642|P1|Overall Study|Lost to Follow-up|0
370802|NCT00328926|1188640|P3|Overall Study|Pregnancy|0
370803|NCT00328926|1188641|P2|Overall Study|Pregnancy|1
370804|NCT00328926|1188642|P1|Overall Study|Pregnancy|2
370805|NCT00328783|1188667|P1|Overall Study|Withdrawal by Subject|1
370806|NCT00328783|1188667|P1|Overall Study|No heart in RT field|4
370807|NCT00328783|1188667|P1|Overall Study|Could not tolerate ABC|21
370808|NCT00328627|1188690|P12|Overall Study|Other|0
370809|NCT00328627|1188691|P11|Overall Study|Other|1
370810|NCT00328627|1188692|P10|Overall Study|Other|1
370811|NCT00328627|1188693|P9|Overall Study|Other|0
370812|NCT00328627|1188694|P8|Overall Study|Other|0
370813|NCT00328627|1188695|P7|Overall Study|Other|1
370814|NCT00328627|1188696|P6|Overall Study|Other|0
370815|NCT00328627|1188697|P5|Overall Study|Other|0
370816|NCT00328627|1188698|P4|Overall Study|Other|1
370817|NCT00328627|1188699|P3|Overall Study|Other|0
370818|NCT00328627|1188700|P2|Overall Study|Other|0
370819|NCT00328627|1188701|P1|Overall Study|Other|0
370820|NCT00328627|1188690|P12|Overall Study|Physician Decision|0
370821|NCT00328627|1188691|P11|Overall Study|Physician Decision|1
370822|NCT00328627|1188692|P10|Overall Study|Physician Decision|2
370823|NCT00328627|1188693|P9|Overall Study|Physician Decision|3
370824|NCT00328627|1188694|P8|Overall Study|Physician Decision|0
370825|NCT00328627|1188695|P7|Overall Study|Physician Decision|1
370826|NCT00328627|1188696|P6|Overall Study|Physician Decision|1
370827|NCT00328627|1188697|P5|Overall Study|Physician Decision|1
370828|NCT00328627|1188698|P4|Overall Study|Physician Decision|2
370829|NCT00328627|1188699|P3|Overall Study|Physician Decision|1
370830|NCT00328627|1188700|P2|Overall Study|Physician Decision|3
370831|NCT00328627|1188701|P1|Overall Study|Physician Decision|4
370832|NCT00328627|1188690|P12|Overall Study|Pregnancy|0
370833|NCT00328627|1188691|P11|Overall Study|Pregnancy|0
370834|NCT00328627|1188692|P10|Overall Study|Pregnancy|0
370835|NCT00328627|1188693|P9|Overall Study|Pregnancy|0
370836|NCT00328627|1188694|P8|Overall Study|Pregnancy|0
370837|NCT00328627|1188695|P7|Overall Study|Pregnancy|0
370838|NCT00328627|1188696|P6|Overall Study|Pregnancy|0
370839|NCT00328627|1188697|P5|Overall Study|Pregnancy|0
370840|NCT00328627|1188698|P4|Overall Study|Pregnancy|0
370841|NCT00328627|1188699|P3|Overall Study|Pregnancy|0
370842|NCT00328627|1188700|P2|Overall Study|Pregnancy|1
370843|NCT00328627|1188701|P1|Overall Study|Pregnancy|0
370844|NCT00328627|1188690|P12|Overall Study|Withdrawal by Subject|7
370845|NCT00328627|1188691|P11|Overall Study|Withdrawal by Subject|2
370846|NCT00328627|1188692|P10|Overall Study|Withdrawal by Subject|5
370847|NCT00328627|1188693|P9|Overall Study|Withdrawal by Subject|4
370848|NCT00328627|1188694|P8|Overall Study|Withdrawal by Subject|4
370849|NCT00328627|1188695|P7|Overall Study|Withdrawal by Subject|4
370850|NCT00328627|1188696|P6|Overall Study|Withdrawal by Subject|5
370851|NCT00328627|1188697|P5|Overall Study|Withdrawal by Subject|2
370852|NCT00328627|1188698|P4|Overall Study|Withdrawal by Subject|6
370853|NCT00328627|1188699|P3|Overall Study|Withdrawal by Subject|5
370854|NCT00328627|1188700|P2|Overall Study|Withdrawal by Subject|4
370855|NCT00328627|1188701|P1|Overall Study|Withdrawal by Subject|5
370856|NCT00328627|1188690|P12|Overall Study|Lost to Follow-up|1
370857|NCT00328627|1188691|P11|Overall Study|Lost to Follow-up|0
370858|NCT00328627|1188692|P10|Overall Study|Lost to Follow-up|2
370859|NCT00328627|1188693|P9|Overall Study|Lost to Follow-up|3
370860|NCT00328627|1188694|P8|Overall Study|Lost to Follow-up|0
370861|NCT00328627|1188695|P7|Overall Study|Lost to Follow-up|3
370862|NCT00328627|1188696|P6|Overall Study|Lost to Follow-up|2
370863|NCT00328627|1188697|P5|Overall Study|Lost to Follow-up|0
370864|NCT00328627|1188698|P4|Overall Study|Lost to Follow-up|4
370865|NCT00328627|1188699|P3|Overall Study|Lost to Follow-up|2
370866|NCT00328627|1188700|P2|Overall Study|Lost to Follow-up|2
370867|NCT00328627|1188701|P1|Overall Study|Lost to Follow-up|4
370868|NCT00328627|1188690|P12|Overall Study|Protocol Violation|2
370869|NCT00328627|1188691|P11|Overall Study|Protocol Violation|6
370870|NCT00328627|1188692|P10|Overall Study|Protocol Violation|4
370871|NCT00328627|1188693|P9|Overall Study|Protocol Violation|1
370872|NCT00328627|1188694|P8|Overall Study|Protocol Violation|2
370873|NCT00328627|1188695|P7|Overall Study|Protocol Violation|6
370874|NCT00328627|1188696|P6|Overall Study|Protocol Violation|5
370875|NCT00328627|1188697|P5|Overall Study|Protocol Violation|5
370876|NCT00328627|1188698|P4|Overall Study|Protocol Violation|8
370877|NCT00328627|1188699|P3|Overall Study|Protocol Violation|2
370878|NCT00328627|1188700|P2|Overall Study|Protocol Violation|2
370879|NCT00328627|1188701|P1|Overall Study|Protocol Violation|2
370880|NCT00328627|1188690|P12|Overall Study|Adverse Event|4
370881|NCT00328627|1188691|P11|Overall Study|Adverse Event|5
370882|NCT00328627|1188692|P10|Overall Study|Adverse Event|7
370883|NCT00328627|1188693|P9|Overall Study|Adverse Event|0
370884|NCT00328627|1188694|P8|Overall Study|Adverse Event|2
370885|NCT00328627|1188695|P7|Overall Study|Adverse Event|1
370886|NCT00328627|1188696|P6|Overall Study|Adverse Event|2
370887|NCT00328627|1188697|P5|Overall Study|Adverse Event|1
370888|NCT00328627|1188698|P4|Overall Study|Adverse Event|3
370889|NCT00328627|1188699|P3|Overall Study|Adverse Event|2
370890|NCT00328627|1188700|P2|Overall Study|Adverse Event|1
370891|NCT00328627|1188701|P1|Overall Study|Adverse Event|3
370892|NCT00328627|1188690|P12|Overall Study|Hyperglycemic Rescue|2
370893|NCT00328627|1188691|P11|Overall Study|Hyperglycemic Rescue|3
370894|NCT00328627|1188692|P10|Overall Study|Hyperglycemic Rescue|11
370895|NCT00328627|1188693|P9|Overall Study|Hyperglycemic Rescue|6
370896|NCT00328627|1188694|P8|Overall Study|Hyperglycemic Rescue|6
370897|NCT00328627|1188695|P7|Overall Study|Hyperglycemic Rescue|19
370898|NCT00328627|1188696|P6|Overall Study|Hyperglycemic Rescue|5
370899|NCT00328627|1188697|P5|Overall Study|Hyperglycemic Rescue|6
370900|NCT00328627|1188698|P4|Overall Study|Hyperglycemic Rescue|13
370901|NCT00328627|1188699|P3|Overall Study|Hyperglycemic Rescue|16
370902|NCT00328627|1188700|P2|Overall Study|Hyperglycemic Rescue|18
370903|NCT00328627|1188701|P1|Overall Study|Hyperglycemic Rescue|41
370904|NCT00328562|1190238|P1|Overall Study|Disease progression|1
370905|NCT00328510|1190247|P2|Overall Study|Treatment changed to a single fraction|1
370906|NCT00328510|1190248|P1|Overall Study|Treatment changed to a single fraction|1
370907|NCT00328510|1190247|P2|Overall Study|Severe kyphosis, could not use mask|1
370908|NCT00328510|1190248|P1|Overall Study|Severe kyphosis, could not use mask|0
370909|NCT00328510|1190247|P2|Overall Study|Withdrawal by Subject|2
370910|NCT00328510|1190248|P1|Overall Study|Withdrawal by Subject|4
370911|NCT00328510|1190247|P2|Overall Study|Dentition problems, could not use frame|0
370912|NCT00328510|1190248|P1|Overall Study|Dentition problems, could not use frame|1
370913|NCT00328510|1190247|P2|Overall Study|Gag disorder, could not use frame|0
370914|NCT00328510|1190248|P1|Overall Study|Gag disorder, could not use frame|4
370915|NCT00328198|1190263|P1|Follow-up|Death|31
370916|NCT00328198|1190263|P1|Follow-up|Lost to Follow-up|4
370917|NCT00328198|1190263|P1|Treatment|Confirmed complete response, MRD -|3
370918|NCT00328198|1190263|P1|Treatment|Non-compliance|1
370919|NCT00328198|1190263|P1|Treatment|Evidence of disease progression|2
370920|NCT00328198|1190263|P1|Treatment|Withdrawal by Subject|5
370921|NCT00328198|1190263|P1|Treatment|Physician Decision|5
370922|NCT00328198|1190263|P1|Treatment|Death|1
370923|NCT00328198|1190263|P1|Treatment|Adverse Event|21
370924|NCT00328172|1190278|P5|Overall Study|Other reason (not specified)|0
370925|NCT00328172|1190279|P4|Overall Study|Other reason (not specified)|0
370926|NCT00328172|1190280|P3|Overall Study|Other reason (not specified)|1
370927|NCT00328172|1190281|P2|Overall Study|Other reason (not specified)|0
370928|NCT00328172|1190282|P1|Overall Study|Other reason (not specified)|3
370929|NCT00328172|1190278|P5|Overall Study|Lack of Efficacy|3
370930|NCT00328172|1190279|P4|Overall Study|Lack of Efficacy|4
370931|NCT00328172|1190280|P3|Overall Study|Lack of Efficacy|4
370932|NCT00328172|1190281|P2|Overall Study|Lack of Efficacy|9
370933|NCT00328172|1190282|P1|Overall Study|Lack of Efficacy|14
370934|NCT00328172|1190278|P5|Overall Study|Withdrawal by Subject|0
370935|NCT00328172|1190279|P4|Overall Study|Withdrawal by Subject|6
370936|NCT00328172|1190280|P3|Overall Study|Withdrawal by Subject|1
370937|NCT00328172|1190281|P2|Overall Study|Withdrawal by Subject|1
370938|NCT00328172|1190282|P1|Overall Study|Withdrawal by Subject|1
370939|NCT00328172|1190278|P5|Overall Study|Lost to Follow-up|1
370940|NCT00328172|1190279|P4|Overall Study|Lost to Follow-up|1
370941|NCT00328172|1190280|P3|Overall Study|Lost to Follow-up|2
370942|NCT00328172|1190281|P2|Overall Study|Lost to Follow-up|1
370943|NCT00328172|1190282|P1|Overall Study|Lost to Follow-up|1
370944|NCT00328172|1190278|P5|Overall Study|Protocol Violation|0
370945|NCT00328172|1190279|P4|Overall Study|Protocol Violation|0
370946|NCT00328172|1190280|P3|Overall Study|Protocol Violation|1
370947|NCT00328172|1190281|P2|Overall Study|Protocol Violation|1
370948|NCT00328172|1190282|P1|Overall Study|Protocol Violation|0
370949|NCT00328172|1190278|P5|Overall Study|Adverse Event|1
370950|NCT00328172|1190279|P4|Overall Study|Adverse Event|2
370951|NCT00328172|1190280|P3|Overall Study|Adverse Event|1
370952|NCT00328172|1190281|P2|Overall Study|Adverse Event|2
370953|NCT00328172|1190282|P1|Overall Study|Adverse Event|3
370954|NCT00328094|1190306|P2|Overall Study|Physician Decision|3
370955|NCT00328094|1190307|P1|Overall Study|Physician Decision|3
370956|NCT00327717|1190328|P2|Overall Study|Withdrawal by Subject|7
370957|NCT00327717|1190329|P1|Overall Study|Withdrawal by Subject|3
370958|NCT00327717|1190328|P2|Overall Study|Lack of Efficacy|1
370959|NCT00327717|1190329|P1|Overall Study|Lack of Efficacy|0
370960|NCT00327717|1190328|P2|Overall Study|Adverse Event|6
370961|NCT00327717|1190329|P1|Overall Study|Adverse Event|6
370962|NCT00327470|1190355|P2|Overall Study|Death|4
370963|NCT00327470|1190356|P1|Overall Study|Death|1
370964|NCT00327470|1190355|P2|Overall Study|Withdrawal by Subject|12
370965|NCT00327470|1190356|P1|Overall Study|Withdrawal by Subject|6
370966|NCT00327470|1190355|P2|Overall Study|Lost to Follow-up|3
370967|NCT00327470|1190356|P1|Overall Study|Lost to Follow-up|1
370968|NCT00327470|1190355|P2|Overall Study|Other|9
370969|NCT00327470|1190356|P1|Overall Study|Other|5
370970|NCT00327470|1190355|P2|Overall Study|Lack of Efficacy|19
370971|NCT00327470|1190356|P1|Overall Study|Lack of Efficacy|7
370972|NCT00327470|1190355|P2|Overall Study|Adverse Event|14
370973|NCT00327470|1190356|P1|Overall Study|Adverse Event|9
370974|NCT00327470|1190355|P2|Overall Study|Randomized, but not treated|2
370975|NCT00327470|1190356|P1|Overall Study|Randomized, but not treated|0
370976|NCT00327444|1190376|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
370977|NCT00327444|1190377|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
370978|NCT00327444|1190376|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
370979|NCT00327444|1190377|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
371746|NCT00321711|1192751|P2|Part B|Death|0
370980|NCT00327444|1190376|P2|Open Label Treatment (OL) Period|Adverse Event|2
370981|NCT00327444|1190377|P1|Open Label Treatment (OL) Period|Adverse Event|2
370982|NCT00327444|1190376|P2|Open Label Treatment (OL) Period|Disease progression|7
370983|NCT00327444|1190377|P1|Open Label Treatment (OL) Period|Disease progression|8
370984|NCT00327444|1190376|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
370985|NCT00327444|1190377|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
370986|NCT00327444|1190376|P2|Double Blind Treatment (DB) Period|Subject request|1
370987|NCT00327444|1190377|P1|Double Blind Treatment (DB) Period|Subject request|0
370988|NCT00327444|1190376|P2|Double Blind Treatment (DB) Period|Adverse Event|5
370989|NCT00327444|1190377|P1|Double Blind Treatment (DB) Period|Adverse Event|5
370990|NCT00327444|1190376|P2|Double Blind Treatment (DB) Period|Disease progression|13
370991|NCT00327444|1190377|P1|Double Blind Treatment (DB) Period|Disease progression|10
370992|NCT00327340|1190395|P2|Overall Study|Adverse Event|3
370993|NCT00327340|1190396|P1|Overall Study|Adverse Event|3
370994|NCT00327340|1190395|P2|Overall Study|Symptomatic Disease|2
370995|NCT00327340|1190396|P1|Overall Study|Symptomatic Disease|0
370996|NCT00327340|1190395|P2|Overall Study|Disease Progression|19
370997|NCT00327340|1190396|P1|Overall Study|Disease Progression|10
370998|NCT00327340|1190395|P2|Overall Study|Physician Decision|1
370999|NCT00327340|1190396|P1|Overall Study|Physician Decision|1
371000|NCT00327340|1190395|P2|Overall Study|Withdrawal by Subject|5
371001|NCT00327340|1190396|P1|Overall Study|Withdrawal by Subject|1
371002|NCT00327171|1190410|P2|Overall Study|Unspecified|0
371003|NCT00327171|1190411|P1|Overall Study|Unspecified|1
371004|NCT00327171|1190410|P2|Overall Study|Undisclosed history of ischemia|1
371005|NCT00327171|1190411|P1|Overall Study|Undisclosed history of ischemia|0
371006|NCT00327171|1190410|P2|Overall Study|Clinical progression|8
371007|NCT00327171|1190411|P1|Overall Study|Clinical progression|12
371008|NCT00327171|1190410|P2|Overall Study|Investigator/participant request|8
371009|NCT00327171|1190411|P1|Overall Study|Investigator/participant request|1
371010|NCT00327171|1190410|P2|Overall Study|Disease progression/lack of efficacy|69
371011|NCT00327171|1190411|P1|Overall Study|Disease progression/lack of efficacy|68
371012|NCT00327171|1190410|P2|Overall Study|Adverse Event|23
371013|NCT00327171|1190411|P1|Overall Study|Adverse Event|23
371014|NCT00327171|1190410|P2|Overall Study|Did not receive study medication|0
371015|NCT00327171|1190411|P1|Overall Study|Did not receive study medication|3
371016|NCT00327015|1190443|P4|Overall Study|Administrative Reason by Sponsor|1
371017|NCT00327015|1190444|P3|Overall Study|Administrative Reason by Sponsor|2
371018|NCT00327015|1190445|P2|Overall Study|Administrative Reason by Sponsor|2
371019|NCT00327015|1190446|P1|Overall Study|Administrative Reason by Sponsor|1
371020|NCT00327015|1190443|P4|Overall Study|Pregnancy|1
371021|NCT00327015|1190444|P3|Overall Study|Pregnancy|1
371022|NCT00327015|1190445|P2|Overall Study|Pregnancy|2
371023|NCT00327015|1190446|P1|Overall Study|Pregnancy|0
371024|NCT00327015|1190443|P4|Overall Study|Death|3
371025|NCT00327015|1190444|P3|Overall Study|Death|2
371026|NCT00327015|1190445|P2|Overall Study|Death|2
371027|NCT00327015|1190446|P1|Overall Study|Death|1
371028|NCT00327015|1190443|P4|Overall Study|Physician Decision|2
371029|NCT00327015|1190444|P3|Overall Study|Physician Decision|3
371030|NCT00327015|1190445|P2|Overall Study|Physician Decision|1
371031|NCT00327015|1190446|P1|Overall Study|Physician Decision|0
371032|NCT00327015|1190443|P4|Overall Study|Poor/Noncompliance|5
371033|NCT00327015|1190444|P3|Overall Study|Poor/Noncompliance|4
371034|NCT00327015|1190445|P2|Overall Study|Poor/Noncompliance|8
371035|NCT00327015|1190446|P1|Overall Study|Poor/Noncompliance|11
371036|NCT00327015|1190443|P4|Overall Study|Subject no longer meets study criteria|7
371037|NCT00327015|1190444|P3|Overall Study|Subject no longer meets study criteria|8
371038|NCT00327015|1190445|P2|Overall Study|Subject no longer meets study criteria|2
371039|NCT00327015|1190446|P1|Overall Study|Subject no longer meets study criteria|4
371040|NCT00327015|1190443|P4|Overall Study|Adverse Event|14
371041|NCT00327015|1190444|P3|Overall Study|Adverse Event|14
371042|NCT00327015|1190445|P2|Overall Study|Adverse Event|10
371043|NCT00327015|1190446|P1|Overall Study|Adverse Event|14
371044|NCT00327015|1190443|P4|Overall Study|Lost to Follow-up|22
371045|NCT00327015|1190444|P3|Overall Study|Lost to Follow-up|29
371046|NCT00327015|1190445|P2|Overall Study|Lost to Follow-up|23
371047|NCT00327015|1190446|P1|Overall Study|Lost to Follow-up|22
371048|NCT00327015|1190443|P4|Overall Study|Withdrawal of Consent by Subject|25
371049|NCT00327015|1190444|P3|Overall Study|Withdrawal of Consent by Subject|28
371050|NCT00327015|1190445|P2|Overall Study|Withdrawal of Consent by Subject|24
371051|NCT00327015|1190446|P1|Overall Study|Withdrawal of Consent by Subject|20
371052|NCT00327015|1190443|P4|Overall Study|Lack of Efficacy|29
371053|NCT00327015|1190444|P3|Overall Study|Lack of Efficacy|35
371054|NCT00327015|1190445|P2|Overall Study|Lack of Efficacy|18
371055|NCT00327015|1190446|P1|Overall Study|Lack of Efficacy|18
371056|NCT00326963|1190488|P1|Overall Study|Administrative / other|1
371057|NCT00326963|1190488|P1|Overall Study|Other protocol violation|1
371058|NCT00326963|1190488|P1|Overall Study|Violation of selection criteria at entry|2
371059|NCT00326963|1190488|P1|Overall Study|Refused treatment / did not cooperate|5
371060|NCT00326963|1190488|P1|Overall Study|Withdrawal by Subject|10
371061|NCT00326963|1190488|P1|Overall Study|Failure to return|10
371062|NCT00326963|1190488|P1|Overall Study|Death|1
371063|NCT00326963|1190488|P1|Overall Study|Injection site reaction|1
371064|NCT00326963|1190488|P1|Overall Study|Adverse Event|2
371065|NCT00326950|1190508|P1|Overall Study|Progressive Disease|1
371066|NCT00326911|1190515|P2|Overall Study|Withdrawal by subject prior to treatment|1
371067|NCT00326911|1190516|P1|Overall Study|Withdrawal by subject prior to treatment|0
371068|NCT00326911|1190515|P2|Overall Study|Physician decision prior to treatment|0
371069|NCT00326911|1190516|P1|Overall Study|Physician decision prior to treatment|1
371070|NCT00326911|1190515|P2|Overall Study|Hospitalization prior to treatment|1
371071|NCT00326911|1190516|P1|Overall Study|Hospitalization prior to treatment|0
371072|NCT00326898|1190569|P3|Overall Study|Other/Missing/Unknown|32
371073|NCT00326898|1190570|P2|Overall Study|Other/Missing/Unknown|28
371074|NCT00326898|1190571|P1|Overall Study|Other/Missing/Unknown|33
371075|NCT00326898|1190569|P3|Overall Study|Other complicating disease|4
371076|NCT00326898|1190570|P2|Overall Study|Other complicating disease|5
371077|NCT00326898|1190571|P1|Overall Study|Other complicating disease|5
371078|NCT00326898|1190569|P3|Overall Study|Alternative therapy|0
371079|NCT00326898|1190570|P2|Overall Study|Alternative therapy|0
371080|NCT00326898|1190571|P1|Overall Study|Alternative therapy|1
371081|NCT00326898|1190569|P3|Overall Study|Withdrawal by Subject|32
371082|NCT00326898|1190570|P2|Overall Study|Withdrawal by Subject|128
371083|NCT00326898|1190571|P1|Overall Study|Withdrawal by Subject|134
371084|NCT00326898|1190569|P3|Overall Study|Death|0
371085|NCT00326898|1190570|P2|Overall Study|Death|0
371086|NCT00326898|1190571|P1|Overall Study|Death|2
371087|NCT00326898|1190569|P3|Overall Study|Adverse Event|33
371088|NCT00326898|1190570|P2|Overall Study|Adverse Event|128
371089|NCT00326898|1190571|P1|Overall Study|Adverse Event|124
371090|NCT00326898|1190569|P3|Overall Study|Disease progression|102
371091|NCT00326898|1190570|P2|Overall Study|Disease progression|54
371092|NCT00326898|1190571|P1|Overall Study|Disease progression|52
371093|NCT00326885|1190588|P1|Overall Study|Hospice withdrew consent|2
371094|NCT00326885|1190588|P1|Overall Study|Physician Decision|1
371095|NCT00326885|1190588|P1|Overall Study|Withdrawal by Subject|3
371096|NCT00326885|1190588|P1|Overall Study|Adverse Event|1
371097|NCT00326716|1190619|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
371098|NCT00326716|1190620|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
371099|NCT00326716|1190621|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
371100|NCT00326716|1190622|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
371101|NCT00326612|1190694|P2|Overall Study|They did not have a seizure requiring tx|137
371102|NCT00326612|1190695|P1|Overall Study|They did not have a seizure requiring tx|129
371103|NCT00326599|1190717|P4|Overall Study|Other Unspecified Reason|1
371104|NCT00326599|1190718|P3|Overall Study|Other Unspecified Reason|2
371105|NCT00326599|1190719|P2|Overall Study|Other Unspecified Reason|0
371106|NCT00326599|1190720|P1|Overall Study|Other Unspecified Reason|0
371107|NCT00326599|1190717|P4|Overall Study|Death|2
371108|NCT00326599|1190718|P3|Overall Study|Death|1
371109|NCT00326599|1190719|P2|Overall Study|Death|0
371110|NCT00326599|1190720|P1|Overall Study|Death|0
371111|NCT00326599|1190717|P4|Overall Study|Alternate Treatment|0
371112|NCT00326599|1190718|P3|Overall Study|Alternate Treatment|0
371113|NCT00326599|1190719|P2|Overall Study|Alternate Treatment|0
371114|NCT00326599|1190720|P1|Overall Study|Alternate Treatment|1
371115|NCT00326599|1190717|P4|Overall Study|Disease Progression|11
371116|NCT00326599|1190718|P3|Overall Study|Disease Progression|13
371117|NCT00326599|1190719|P2|Overall Study|Disease Progression|1
371118|NCT00326599|1190720|P1|Overall Study|Disease Progression|3
371119|NCT00326599|1190717|P4|Overall Study|Adverse Event|3
371120|NCT00326599|1190718|P3|Overall Study|Adverse Event|32
371121|NCT00326599|1190719|P2|Overall Study|Adverse Event|0
371122|NCT00326599|1190720|P1|Overall Study|Adverse Event|1
371123|NCT00326599|1190717|P4|Overall Study|Withdrawal by Subject|2
371124|NCT00326599|1190718|P3|Overall Study|Withdrawal by Subject|5
371125|NCT00326599|1190719|P2|Overall Study|Withdrawal by Subject|0
371126|NCT00326599|1190720|P1|Overall Study|Withdrawal by Subject|1
371127|NCT00326495|1190739|P1|Overall Study|Subject off study before assessment|1
371128|NCT00326495|1190739|P1|Overall Study|Refused further treatment|2
371129|NCT00326495|1190739|P1|Overall Study|Disease progression before treatment|1
371130|NCT00326495|1190739|P1|Overall Study|Switched to alternative treatment|1
371131|NCT00326417|1190746|P4|Overall Study|Death|0
371132|NCT00326417|1190747|P3|Overall Study|Death|0
371133|NCT00326417|1190748|P2|Overall Study|Death|0
371134|NCT00326417|1190749|P1|Overall Study|Death|7
371135|NCT00326417|1190746|P4|Overall Study|Arm Closed|3
371136|NCT00326417|1190747|P3|Overall Study|Arm Closed|0
371137|NCT00326417|1190748|P2|Overall Study|Arm Closed|0
371138|NCT00326417|1190749|P1|Overall Study|Arm Closed|7
371139|NCT00326417|1190746|P4|Overall Study|Withdrawal by Subject|0
371140|NCT00326417|1190747|P3|Overall Study|Withdrawal by Subject|1
371141|NCT00326417|1190748|P2|Overall Study|Withdrawal by Subject|0
371142|NCT00326417|1190749|P1|Overall Study|Withdrawal by Subject|0
371143|NCT00326183|1190776|P2|Overall Study|Adverse Event|0
371144|NCT00326183|1190777|P1|Overall Study|Adverse Event|1
371145|NCT00326183|1190776|P2|Overall Study|Unspecified|13
371146|NCT00326183|1190777|P1|Overall Study|Unspecified|47
371147|NCT00326183|1190776|P2|Overall Study|Subject Moved|4
371148|NCT00326183|1190777|P1|Overall Study|Subject Moved|7
371149|NCT00326183|1190776|P2|Overall Study|Withdrawal by Subject|7
371150|NCT00326183|1190777|P1|Overall Study|Withdrawal by Subject|35
371151|NCT00326183|1190776|P2|Overall Study|Protocol Violation|3
371152|NCT00326183|1190777|P1|Overall Study|Protocol Violation|6
371153|NCT00326183|1190776|P2|Overall Study|Lost to Follow-up|56
371154|NCT00326183|1190777|P1|Overall Study|Lost to Follow-up|104
371155|NCT00326118|1190809|P2|Active Phase|Withdrawal by Subject|1
371156|NCT00326118|1190810|P1|Active Phase|Withdrawal by Subject|4
371157|NCT00326001|1190846|P2|Overall Study|Physician Decision|3
371158|NCT00326001|1190847|P1|Overall Study|Physician Decision|3
371159|NCT00326001|1190846|P2|Overall Study|Adverse Event|5
371160|NCT00326001|1190847|P1|Overall Study|Adverse Event|4
371161|NCT00325897|1190861|P2|Overall Study|Lost to Follow-up|13
371162|NCT00325897|1190862|P1|Overall Study|Lost to Follow-up|12
371163|NCT00325819|1190882|P2|Overall Study|Lost to Follow-up|3
371164|NCT00325819|1190883|P1|Overall Study|Lost to Follow-up|3
371165|NCT00325819|1190882|P2|Overall Study|Did not take a dose of study product|9
371166|NCT00325819|1190883|P1|Overall Study|Did not take a dose of study product|4
371167|NCT00325819|1190882|P2|Overall Study|Study product lost in mail|1
371168|NCT00325819|1190883|P1|Overall Study|Study product lost in mail|2
371169|NCT00325754|1190910|P2|Overall Study|Adverse Event|1
371170|NCT00325754|1190911|P1|Overall Study|Adverse Event|4
371171|NCT00325468|1190943|P5|Overall Study|site closure etc|1
371172|NCT00325468|1190944|P4|Overall Study|site closure etc|8
371173|NCT00325468|1190945|P3|Overall Study|site closure etc|1
371174|NCT00325468|1190946|P2|Overall Study|site closure etc|2
371175|NCT00325468|1190947|P1|Overall Study|site closure etc|4
371176|NCT00325468|1190943|P5|Overall Study|Withdrawal by Subject|4
371177|NCT00325468|1190944|P4|Overall Study|Withdrawal by Subject|14
371178|NCT00325468|1190945|P3|Overall Study|Withdrawal by Subject|0
371179|NCT00325468|1190946|P2|Overall Study|Withdrawal by Subject|1
371180|NCT00325468|1190947|P1|Overall Study|Withdrawal by Subject|3
371181|NCT00325468|1190943|P5|Overall Study|Physician Decision|0
371182|NCT00325468|1190944|P4|Overall Study|Physician Decision|1
371183|NCT00325468|1190945|P3|Overall Study|Physician Decision|0
371184|NCT00325468|1190946|P2|Overall Study|Physician Decision|1
371185|NCT00325468|1190947|P1|Overall Study|Physician Decision|1
371186|NCT00325468|1190943|P5|Overall Study|Lost to Follow-up|2
371187|NCT00325468|1190944|P4|Overall Study|Lost to Follow-up|2
371188|NCT00325468|1190945|P3|Overall Study|Lost to Follow-up|1
371189|NCT00325468|1190946|P2|Overall Study|Lost to Follow-up|0
371190|NCT00325468|1190947|P1|Overall Study|Lost to Follow-up|0
371191|NCT00325468|1190943|P5|Overall Study|Death|0
371192|NCT00325468|1190944|P4|Overall Study|Death|4
371193|NCT00325468|1190945|P3|Overall Study|Death|2
371194|NCT00325468|1190946|P2|Overall Study|Death|0
371195|NCT00325468|1190947|P1|Overall Study|Death|2
371196|NCT00325468|1190943|P5|Overall Study|Adverse Event|1
371197|NCT00325468|1190944|P4|Overall Study|Adverse Event|5
371198|NCT00325468|1190945|P3|Overall Study|Adverse Event|0
371199|NCT00325468|1190946|P2|Overall Study|Adverse Event|1
371200|NCT00325468|1190947|P1|Overall Study|Adverse Event|1
371201|NCT00325416|1191030|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
371202|NCT00325416|1191031|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
371203|NCT00325416|1191030|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
371204|NCT00325416|1191031|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
371205|NCT00325416|1191030|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
371206|NCT00325416|1191031|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
371207|NCT00325416|1191030|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
371208|NCT00325416|1191031|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
371209|NCT00325416|1191030|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
371210|NCT00325416|1191031|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
371211|NCT00325416|1191030|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
371212|NCT00325416|1191031|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
371213|NCT00325234|1191084|P2|Overall Study|Progressive Disease|37
371214|NCT00325234|1191085|P1|Overall Study|Progressive Disease|34
371215|NCT00325234|1191084|P2|Overall Study|Physician Decision|12
371216|NCT00325234|1191085|P1|Overall Study|Physician Decision|17
371217|NCT00325234|1191084|P2|Overall Study|Subject Decision|8
371218|NCT00325234|1191085|P1|Overall Study|Subject Decision|6
371219|NCT00325234|1191084|P2|Overall Study|Entry Criteria Not Met|2
371220|NCT00325234|1191085|P1|Overall Study|Entry Criteria Not Met|1
371221|NCT00325234|1191084|P2|Overall Study|Death due to Study Disease|0
371222|NCT00325234|1191085|P1|Overall Study|Death due to Study Disease|1
371223|NCT00325234|1191084|P2|Overall Study|Adverse Event|7
371224|NCT00325234|1191085|P1|Overall Study|Adverse Event|10
371225|NCT00325195|1191104|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
371226|NCT00325195|1191105|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
371227|NCT00325195|1191106|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
371228|NCT00325195|1191104|P3|Received Intervention: ITT Population|Lost to Follow-up|2
371229|NCT00325195|1191105|P2|Received Intervention: ITT Population|Lost to Follow-up|0
371230|NCT00325195|1191106|P1|Received Intervention: ITT Population|Lost to Follow-up|0
371231|NCT00325195|1191104|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
371232|NCT00325195|1191105|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
371233|NCT00325195|1191106|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
371234|NCT00325195|1191104|P3|Received Intervention: ITT Population|Death|0
371747|NCT00321711|1192752|P1|Part B|Death|0
371235|NCT00325195|1191105|P2|Received Intervention: ITT Population|Death|1
371236|NCT00325195|1191106|P1|Received Intervention: ITT Population|Death|3
371237|NCT00325195|1191104|P3|Received Intervention: ITT Population|Adverse Event|1
371238|NCT00325195|1191105|P2|Received Intervention: ITT Population|Adverse Event|17
371239|NCT00325195|1191106|P1|Received Intervention: ITT Population|Adverse Event|15
371240|NCT00325195|1191104|P3|Randomized|Not dosed|3
371241|NCT00325195|1191105|P2|Randomized|Not dosed|5
371242|NCT00325195|1191106|P1|Randomized|Not dosed|5
371243|NCT00325156|1191129|P1|Overall Study|Withdrawal by Subject|31
371244|NCT00325156|1191129|P1|Overall Study|Unspecified|1
371245|NCT00325156|1191129|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
371246|NCT00325156|1191129|P1|Overall Study|Adverse event, non-fatal|3
371247|NCT00325156|1191129|P1|Overall Study|Migrated/moved from study area|12
371248|NCT00325156|1191129|P1|Overall Study|Lost to follow-up (complete vaccination)|41
371249|NCT00325156|1191129|P1|Overall Study|Protocol Violation|8
371250|NCT00325143|1191136|P1|Overall Study|Withdrawal by Subject|8
371251|NCT00325143|1191136|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
371252|NCT00325143|1191136|P1|Overall Study|Migrated/moved from study area|1
371253|NCT00325143|1191136|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
371254|NCT00325130|1191145|P2|Overall Study|Patient Discontinued for Other|0
371255|NCT00325130|1191146|P1|Overall Study|Patient Discontinued for Other|1
371256|NCT00325130|1191145|P2|Overall Study|Moved|1
371257|NCT00325130|1191146|P1|Overall Study|Moved|0
371258|NCT00325130|1191145|P2|Overall Study|Protocol Deviation|1
371259|NCT00325130|1191146|P1|Overall Study|Protocol Deviation|0
371260|NCT00325130|1191145|P2|Overall Study|Withdrawal by Subject|14
371261|NCT00325130|1191146|P1|Overall Study|Withdrawal by Subject|12
371262|NCT00325130|1191145|P2|Overall Study|Lost to Follow-up|14
371263|NCT00325130|1191146|P1|Overall Study|Lost to Follow-up|6
371264|NCT00325039|1191203|P2|Overall Study|Lost to Follow-up|14
371265|NCT00325039|1191204|P1|Overall Study|Lost to Follow-up|18
371266|NCT00324961|1191218|P1|Overall Study|Other|2
371267|NCT00324961|1191218|P1|Overall Study|Protocol Violation|3
371268|NCT00324961|1191218|P1|Overall Study|Lost to Follow-up|22
371269|NCT00324961|1191218|P1|Overall Study|Consent Withdrawn|11
371270|NCT00324961|1191218|P1|Overall Study|Adverse Event|5
371271|NCT00324740|1191263|P3|Overall Study|Withdrawal by Subject|1
371272|NCT00324740|1191264|P2|Overall Study|Withdrawal by Subject|0
371273|NCT00324740|1191265|P1|Overall Study|Withdrawal by Subject|1
371274|NCT00324675|1191285|P2|Overall Study|Adverse Event|0
371275|NCT00324675|1191286|P1|Overall Study|Adverse Event|1
371276|NCT00324649|1191294|P2|Overall Study|Noncompliance|0
371277|NCT00324649|1191295|P1|Overall Study|Noncompliance|1
371278|NCT00324649|1191294|P2|Overall Study|Withdrawal by Subject|1
371279|NCT00324649|1191295|P1|Overall Study|Withdrawal by Subject|0
371280|NCT00324649|1191294|P2|Overall Study|Adverse Event|4
371281|NCT00324649|1191295|P1|Overall Study|Adverse Event|1
371282|NCT00324233|1191426|P2|Second Period|Protocol Violation|6
371283|NCT00324233|1191427|P1|Second Period|Protocol Violation|4
371284|NCT00324233|1191426|P2|Second Period|unable to insert catheter|1
371285|NCT00324233|1191427|P1|Second Period|unable to insert catheter|1
371286|NCT00324233|1191426|P2|First Period|unable to insert catheter|0
371287|NCT00324233|1191427|P1|First Period|unable to insert catheter|1
371288|NCT00324168|1191435|P2|Overall Study|Patient did not visit in f/u window|9
371289|NCT00324168|1191436|P1|Overall Study|Patient did not visit in f/u window|6
371290|NCT00324168|1191435|P2|Overall Study|Death|3
371291|NCT00324168|1191436|P1|Overall Study|Death|3
371292|NCT00324168|1191435|P2|Overall Study|Lost to Follow-up|18
371293|NCT00324168|1191436|P1|Overall Study|Lost to Follow-up|19
371294|NCT00324155|1191464|P2|Follow-up Phase|On-going participants still on drug|6
371295|NCT00324155|1191465|P1|Follow-up Phase|On-going participants still on drug|11
371296|NCT00324155|1191464|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
371297|NCT00324155|1191465|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
371298|NCT00324155|1191464|P2|Received Treatment in Maintenance Phase|Adverse Event|3
371299|NCT00324155|1191465|P1|Received Treatment in Maintenance Phase|Adverse Event|0
371300|NCT00324155|1191464|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
371301|NCT00324155|1191465|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
371302|NCT00324155|1191464|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
371303|NCT00324155|1191465|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
371304|NCT00324155|1191464|P2|Received Treatment in Maintenance Phase|Disease Progression|41
371305|NCT00324155|1191465|P1|Received Treatment in Maintenance Phase|Disease Progression|26
371556|NCT00322374|1192193|P3|Second Escalation|Physician Decision|5
371306|NCT00324155|1191464|P2|Received Treatment in Induction Phase|Physician Decision|0
371307|NCT00324155|1191465|P1|Received Treatment in Induction Phase|Physician Decision|2
371308|NCT00324155|1191464|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
371309|NCT00324155|1191465|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
371310|NCT00324155|1191464|P2|Received Treatment in Induction Phase|Adverse Event|7
371311|NCT00324155|1191465|P1|Received Treatment in Induction Phase|Adverse Event|6
371312|NCT00324155|1191464|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
371313|NCT00324155|1191465|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
371314|NCT00324155|1191464|P2|Received Treatment in Induction Phase|Death|15
371315|NCT00324155|1191465|P1|Received Treatment in Induction Phase|Death|8
371316|NCT00324155|1191464|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
371317|NCT00324155|1191465|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
371318|NCT00324155|1191464|P2|Received Treatment in Induction Phase|Disease Progression|152
371319|NCT00324155|1191465|P1|Received Treatment in Induction Phase|Disease Progression|88
371320|NCT00324155|1191464|P2|Enrolled and Randomized|Lost to Follow-up|1
371321|NCT00324155|1191465|P1|Enrolled and Randomized|Lost to Follow-up|0
371322|NCT00324155|1191464|P2|Enrolled and Randomized|No longer met study criteria|0
371323|NCT00324155|1191465|P1|Enrolled and Randomized|No longer met study criteria|3
371324|NCT00324116|1191495|P1|Overall Study|Other|5
371325|NCT00324116|1191495|P1|Overall Study|Withdrawal by Subject|5
371326|NCT00324116|1191495|P1|Overall Study|Lack of Efficacy|17
371327|NCT00324116|1191495|P1|Overall Study|Adverse Event|5
371328|NCT00324038|1191507|P2|Overall Study|Other|13
371329|NCT00324038|1191508|P1|Overall Study|Other|6
371330|NCT00324038|1191507|P2|Overall Study|Lost to Follow-up|2
371331|NCT00324038|1191508|P1|Overall Study|Lost to Follow-up|0
371332|NCT00324038|1191507|P2|Overall Study|Lack of Efficacy|13
371333|NCT00324038|1191508|P1|Overall Study|Lack of Efficacy|5
371334|NCT00324038|1191507|P2|Overall Study|Adverse Event|23
371335|NCT00324038|1191508|P1|Overall Study|Adverse Event|38
371336|NCT00323882|1191519|P5|Overall Study|Not Specified|1
371337|NCT00323882|1191520|P4|Overall Study|Not Specified|1
371338|NCT00323882|1191521|P3|Overall Study|Not Specified|0
371339|NCT00323882|1191522|P2|Overall Study|Not Specified|0
371340|NCT00323882|1191523|P1|Overall Study|Not Specified|0
371341|NCT00323882|1191519|P5|Overall Study|Lost to Follow-up|1
371342|NCT00323882|1191520|P4|Overall Study|Lost to Follow-up|0
371343|NCT00323882|1191521|P3|Overall Study|Lost to Follow-up|1
371344|NCT00323882|1191522|P2|Overall Study|Lost to Follow-up|0
371345|NCT00323882|1191523|P1|Overall Study|Lost to Follow-up|0
371346|NCT00323882|1191519|P5|Overall Study|Death|5
371347|NCT00323882|1191520|P4|Overall Study|Death|0
371348|NCT00323882|1191521|P3|Overall Study|Death|1
371349|NCT00323882|1191522|P2|Overall Study|Death|1
371350|NCT00323882|1191523|P1|Overall Study|Death|0
371351|NCT00323882|1191519|P5|Overall Study|Disease Progression|22
371352|NCT00323882|1191520|P4|Overall Study|Disease Progression|5
371353|NCT00323882|1191521|P3|Overall Study|Disease Progression|10
371354|NCT00323882|1191522|P2|Overall Study|Disease Progression|4
371355|NCT00323882|1191523|P1|Overall Study|Disease Progression|6
371356|NCT00323882|1191519|P5|Overall Study|Adverse Event|3
371357|NCT00323882|1191520|P4|Overall Study|Adverse Event|1
371358|NCT00323882|1191521|P3|Overall Study|Adverse Event|1
371359|NCT00323882|1191522|P2|Overall Study|Adverse Event|1
371360|NCT00323882|1191523|P1|Overall Study|Adverse Event|2
371361|NCT00323869|1191594|P1|Overall Study|Death|1
371362|NCT00323622|1191638|P8|Overall Study|Death|2
371363|NCT00323622|1191639|P7|Overall Study|Death|0
371364|NCT00323622|1191640|P6|Overall Study|Death|0
371365|NCT00323622|1191641|P5|Overall Study|Death|7
371366|NCT00323622|1191642|P4|Overall Study|Death|0
371367|NCT00323622|1191643|P3|Overall Study|Death|0
371368|NCT00323622|1191644|P2|Overall Study|Death|1
371369|NCT00323622|1191645|P1|Overall Study|Death|1
371370|NCT00323622|1191638|P8|Overall Study|Unspecified|13
371371|NCT00323622|1191639|P7|Overall Study|Unspecified|5
371372|NCT00323622|1191640|P6|Overall Study|Unspecified|74
371373|NCT00323622|1191641|P5|Overall Study|Unspecified|32
371374|NCT00323622|1191642|P4|Overall Study|Unspecified|12
371375|NCT00323622|1191643|P3|Overall Study|Unspecified|4
371376|NCT00323622|1191644|P2|Overall Study|Unspecified|91
371377|NCT00323622|1191645|P1|Overall Study|Unspecified|30
371378|NCT00323609|1191687|P4|Overall Study|Other reason|9
371379|NCT00323609|1191688|P3|Overall Study|Other reason|4
371380|NCT00323609|1191689|P2|Overall Study|Other reason|8
371381|NCT00323609|1191690|P1|Overall Study|Other reason|11
371382|NCT00323609|1191687|P4|Overall Study|Logistical withdrawal|1
371383|NCT00323609|1191688|P3|Overall Study|Logistical withdrawal|0
371384|NCT00323609|1191689|P2|Overall Study|Logistical withdrawal|5
371385|NCT00323609|1191690|P1|Overall Study|Logistical withdrawal|9
371386|NCT00323609|1191687|P4|Overall Study|Unrelenting or severe back pain|0
371387|NCT00323609|1191688|P3|Overall Study|Unrelenting or severe back pain|0
371388|NCT00323609|1191689|P2|Overall Study|Unrelenting or severe back pain|1
371389|NCT00323609|1191690|P1|Overall Study|Unrelenting or severe back pain|1
371390|NCT00323609|1191687|P4|Overall Study|Sponsor discontinued trial|0
371391|NCT00323609|1191688|P3|Overall Study|Sponsor discontinued trial|0
371392|NCT00323609|1191689|P2|Overall Study|Sponsor discontinued trial|29
371393|NCT00323609|1191690|P1|Overall Study|Sponsor discontinued trial|29
371394|NCT00323609|1191687|P4|Overall Study|Other non-VCF-related medical condition|0
371395|NCT00323609|1191688|P3|Overall Study|Other non-VCF-related medical condition|0
371396|NCT00323609|1191689|P2|Overall Study|Other non-VCF-related medical condition|2
371397|NCT00323609|1191690|P1|Overall Study|Other non-VCF-related medical condition|3
371398|NCT00323609|1191687|P4|Overall Study|Withdrawal by Subject|4
371399|NCT00323609|1191688|P3|Overall Study|Withdrawal by Subject|4
371400|NCT00323609|1191689|P2|Overall Study|Withdrawal by Subject|23
371401|NCT00323609|1191690|P1|Overall Study|Withdrawal by Subject|11
371402|NCT00323609|1191687|P4|Overall Study|Physician Decision|1
371403|NCT00323609|1191688|P3|Overall Study|Physician Decision|0
371404|NCT00323609|1191689|P2|Overall Study|Physician Decision|0
371405|NCT00323609|1191690|P1|Overall Study|Physician Decision|2
371406|NCT00323609|1191687|P4|Overall Study|Lost to Follow-up|0
371407|NCT00323609|1191688|P3|Overall Study|Lost to Follow-up|0
371408|NCT00323609|1191689|P2|Overall Study|Lost to Follow-up|10
371409|NCT00323609|1191690|P1|Overall Study|Lost to Follow-up|9
371410|NCT00323609|1191687|P4|Overall Study|Death|0
371411|NCT00323609|1191688|P3|Overall Study|Death|0
371412|NCT00323609|1191689|P2|Overall Study|Death|21
371413|NCT00323609|1191690|P1|Overall Study|Death|16
371414|NCT00323557|1191726|P2|Overall Study|Physician Decision|0
371415|NCT00323557|1191727|P1|Overall Study|Physician Decision|1
371416|NCT00323492|1191736|P3|Study Phase 2|Protocol Violation|0
371417|NCT00323492|1191737|P2|Study Phase 2|Protocol Violation|0
371418|NCT00323492|1191738|P1|Study Phase 2|Protocol Violation|1
371419|NCT00323492|1191736|P3|Study Phase 2|Noncompliance with study schedule|1
371420|NCT00323492|1191737|P2|Study Phase 2|Noncompliance with study schedule|0
371421|NCT00323492|1191738|P1|Study Phase 2|Noncompliance with study schedule|0
371422|NCT00323492|1191736|P3|Study Phase 2|Withdrawal by Subject|0
371423|NCT00323492|1191737|P2|Study Phase 2|Withdrawal by Subject|1
371424|NCT00323492|1191738|P1|Study Phase 2|Withdrawal by Subject|0
371425|NCT00323492|1191736|P3|Study Phase 2|Lost to Follow-up|0
371426|NCT00323492|1191737|P2|Study Phase 2|Lost to Follow-up|0
371427|NCT00323492|1191738|P1|Study Phase 2|Lost to Follow-up|1
371428|NCT00323492|1191736|P3|Study Phase 2|Physician Decision|0
371429|NCT00323492|1191737|P2|Study Phase 2|Physician Decision|0
371430|NCT00323492|1191738|P1|Study Phase 2|Physician Decision|1
371431|NCT00323492|1191736|P3|Study Phase 2|Adverse Event|0
371432|NCT00323492|1191737|P2|Study Phase 2|Adverse Event|0
371433|NCT00323492|1191738|P1|Study Phase 2|Adverse Event|1
371434|NCT00323492|1191736|P3|Study Phase 1|Adverse Event|0
371435|NCT00323492|1191737|P2|Study Phase 1|Adverse Event|0
371436|NCT00323492|1191738|P1|Study Phase 1|Adverse Event|2
371437|NCT00323479|1191769|P1|Overall Study|house moving|1
371438|NCT00323479|1191769|P1|Overall Study|Protocol Violation|3
371439|NCT00323479|1191769|P1|Overall Study|Withdrawal by Subject|2
371440|NCT00323479|1191769|P1|Overall Study|Adverse Event|2
371441|NCT00323310|1191797|P1|Overall Study|did not complete the 24-hr f-up visit|1
371442|NCT00323310|1191797|P1|Overall Study|a parent refused blood draw|1
371443|NCT00323310|1191797|P1|Overall Study|Withdrawal by Subject|1
371444|NCT00323297|1191812|P2|Part B (Open-label)|Protocol Violation|1
371445|NCT00323297|1191813|P1|Part B (Open-label)|Protocol Violation|0
371446|NCT00323297|1191812|P2|Part B (Open-label)|Adverse Event|5
371447|NCT00323297|1191813|P1|Part B (Open-label)|Adverse Event|5
371448|NCT00323297|1191812|P2|Part B (Open-label)|Lack of Efficacy|1
371449|NCT00323297|1191813|P1|Part B (Open-label)|Lack of Efficacy|3
371450|NCT00323297|1191812|P2|Part B (Open-label)|Withdrawal by Subject|3
371451|NCT00323297|1191813|P1|Part B (Open-label)|Withdrawal by Subject|1
371452|NCT00323297|1191812|P2|Part B (Open-label)|Reason unspecified|1
371453|NCT00323297|1191813|P1|Part B (Open-label)|Reason unspecified|0
371454|NCT00323297|1191812|P2|Part B (Open-label)|Death|1
371455|NCT00323297|1191813|P1|Part B (Open-label)|Death|0
371456|NCT00323297|1191812|P2|Part A (Double Blind Randomized)|Related adverse event|2
371457|NCT00323297|1191813|P1|Part A (Double Blind Randomized)|Related adverse event|2
371458|NCT00323297|1191812|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
371459|NCT00323297|1191813|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
371460|NCT00323297|1191812|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
371461|NCT00323297|1191813|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
371462|NCT00323297|1191812|P2|Part A (Double Blind Randomized)|Protocol Violation|3
371463|NCT00323297|1191813|P1|Part A (Double Blind Randomized)|Protocol Violation|1
371464|NCT00323297|1191812|P2|Part A (Double Blind Randomized)|Death|1
371465|NCT00323297|1191813|P1|Part A (Double Blind Randomized)|Death|0
371466|NCT00323297|1191812|P2|Part A (Double Blind Randomized)|Reason unspecified|1
371467|NCT00323297|1191813|P1|Part A (Double Blind Randomized)|Reason unspecified|0
371468|NCT00323258|1191853|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
371469|NCT00323258|1191854|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
371470|NCT00323258|1191853|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
371471|NCT00323258|1191854|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
371472|NCT00323258|1191853|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
371473|NCT00323258|1191854|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
371474|NCT00323258|1191853|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
371475|NCT00323258|1191854|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
371476|NCT00323258|1191853|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
371477|NCT00323258|1191854|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
371478|NCT00323258|1191853|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
371479|NCT00323258|1191854|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
371480|NCT00323258|1191853|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
371481|NCT00323258|1191854|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
371482|NCT00323115|1191879|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
371483|NCT00323115|1191879|P1|Vaccine Administration|Adverse Event|1
371484|NCT00322881|1191891|P1|Overall Study|Disease Progression|2
371485|NCT00322881|1191891|P1|Overall Study|Adverse Event|1
371486|NCT00322881|1191891|P1|Overall Study|Death|2
371487|NCT00322842|1191901|P2|Overall Study|Death|0
371488|NCT00322842|1191902|P1|Overall Study|Death|1
371489|NCT00322842|1191901|P2|Overall Study|Refused transplant|0
371490|NCT00322842|1191902|P1|Overall Study|Refused transplant|1
371491|NCT00322842|1191901|P2|Overall Study|Lost to Follow-up|1
371492|NCT00322842|1191902|P1|Overall Study|Lost to Follow-up|0
371493|NCT00322842|1191901|P2|Overall Study|Withdrawal by Subject|1
371494|NCT00322842|1191902|P1|Overall Study|Withdrawal by Subject|0
371495|NCT00322712|1191940|P1|Overall Study|treated with bevacizumab not cetuximab|1
371496|NCT00322621|1191944|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
371497|NCT00322621|1191945|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
371498|NCT00322621|1191946|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
371499|NCT00322621|1191944|P3|Period III - Maintenance / Rescue Phase|Death|0
371500|NCT00322621|1191945|P2|Period III - Maintenance / Rescue Phase|Death|1
371501|NCT00322621|1191946|P1|Period III - Maintenance / Rescue Phase|Death|0
371502|NCT00322621|1191944|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
371503|NCT00322621|1191945|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
371504|NCT00322621|1191946|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
371505|NCT00322621|1191944|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
371506|NCT00322621|1191945|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
371507|NCT00322621|1191946|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
371508|NCT00322621|1191944|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
371509|NCT00322621|1191945|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
371510|NCT00322621|1191946|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
371511|NCT00322621|1191944|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
371512|NCT00322621|1191945|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
371513|NCT00322621|1191946|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
371514|NCT00322621|1191944|P3|Period II - Acute Therapy Phase|Physician Decision|0
371515|NCT00322621|1191945|P2|Period II - Acute Therapy Phase|Physician Decision|0
371516|NCT00322621|1191946|P1|Period II - Acute Therapy Phase|Physician Decision|1
371517|NCT00322621|1191944|P3|Period II - Acute Therapy Phase|Protocol Violation|0
371518|NCT00322621|1191945|P2|Period II - Acute Therapy Phase|Protocol Violation|0
371519|NCT00322621|1191946|P1|Period II - Acute Therapy Phase|Protocol Violation|2
371520|NCT00322621|1191944|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
371521|NCT00322621|1191945|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
371522|NCT00322621|1191946|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
371523|NCT00322621|1191944|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
371524|NCT00322621|1191945|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
371525|NCT00322621|1191946|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
371526|NCT00322621|1191944|P3|Period II - Acute Therapy Phase|Adverse Event|0
371527|NCT00322621|1191945|P2|Period II - Acute Therapy Phase|Adverse Event|0
371528|NCT00322621|1191946|P1|Period II - Acute Therapy Phase|Adverse Event|20
371529|NCT00322556|1191998|P1|Overall Study|Other Reason|7
371530|NCT00322556|1191998|P1|Overall Study|Lost to Follow-up|3
371531|NCT00322556|1191998|P1|Overall Study|Withdrawal by Subject|1
371532|NCT00322556|1191998|P1|Overall Study|Adverse Event|1
371533|NCT00322491|1192014|P2|Overall Study|Death|2
371534|NCT00322491|1192015|P1|Overall Study|Death|1
371535|NCT00322491|1192014|P2|Overall Study|Adverse Event|0
371536|NCT00322491|1192015|P1|Overall Study|Adverse Event|1
371537|NCT00322452|1192105|P2|Overall Study|Death|227
371538|NCT00322452|1192106|P1|Overall Study|Death|223
371539|NCT00322452|1192105|P2|Overall Study|Withdrawal by Subject|46
371540|NCT00322452|1192106|P1|Overall Study|Withdrawal by Subject|19
371541|NCT00322452|1192105|P2|Overall Study|Lost to Follow-up|2
371542|NCT00322452|1192106|P1|Overall Study|Lost to Follow-up|5
371543|NCT00322452|1192105|P2|Overall Study|Eligibility criteria not fulfilled|1
371544|NCT00322452|1192106|P1|Overall Study|Eligibility criteria not fulfilled|0
371545|NCT00322387|1192157|P2|Follow-up Period|Death|0
371546|NCT00322387|1192158|P1|Follow-up Period|Death|1
371547|NCT00322387|1192157|P2|Follow-up Period|Final assessment not done|3
371548|NCT00322387|1192158|P1|Follow-up Period|Final assessment not done|1
371549|NCT00322387|1192157|P2|Treatment Period|Adverse Event|1
371550|NCT00322387|1192158|P1|Treatment Period|Adverse Event|0
371551|NCT00322374|1192192|P4|Second Escalation|Study Drug Toxicity|0
371552|NCT00322374|1192193|P3|Second Escalation|Study Drug Toxicity|1
371553|NCT00322374|1192194|P2|Second Escalation|Study Drug Toxicity|0
371554|NCT00322374|1192195|P1|Second Escalation|Study Drug Toxicity|0
371555|NCT00322374|1192192|P4|Second Escalation|Physician Decision|0
371557|NCT00322374|1192194|P2|Second Escalation|Physician Decision|0
371558|NCT00322374|1192195|P1|Second Escalation|Physician Decision|0
371559|NCT00322374|1192192|P4|First Escalation|Participant Request|0
371560|NCT00322374|1192193|P3|First Escalation|Participant Request|0
371561|NCT00322374|1192194|P2|First Escalation|Participant Request|1
371562|NCT00322374|1192195|P1|First Escalation|Participant Request|0
371563|NCT00322374|1192192|P4|First Escalation|Study Drug Toxicity|0
371564|NCT00322374|1192193|P3|First Escalation|Study Drug Toxicity|0
371565|NCT00322374|1192194|P2|First Escalation|Study Drug Toxicity|11
371566|NCT00322374|1192195|P1|First Escalation|Study Drug Toxicity|0
371567|NCT00322374|1192192|P4|First Escalation|Physician Decision|0
371568|NCT00322374|1192193|P3|First Escalation|Physician Decision|0
371569|NCT00322374|1192194|P2|First Escalation|Physician Decision|12
371570|NCT00322374|1192195|P1|First Escalation|Physician Decision|0
371571|NCT00322374|1192192|P4|First Escalation|Documented Disease Progression|0
371572|NCT00322374|1192193|P3|First Escalation|Documented Disease Progression|0
371573|NCT00322374|1192194|P2|First Escalation|Documented Disease Progression|6
371574|NCT00322374|1192195|P1|First Escalation|Documented Disease Progression|0
371575|NCT00322374|1192192|P4|Starting Dose|Study Drug Toxicity|0
371576|NCT00322374|1192193|P3|Starting Dose|Study Drug Toxicity|0
371577|NCT00322374|1192194|P2|Starting Dose|Study Drug Toxicity|0
371578|NCT00322374|1192195|P1|Starting Dose|Study Drug Toxicity|4
371579|NCT00322374|1192192|P4|Starting Dose|Physician Decision|0
371580|NCT00322374|1192193|P3|Starting Dose|Physician Decision|0
371581|NCT00322374|1192194|P2|Starting Dose|Physician Decision|0
371582|NCT00322374|1192195|P1|Starting Dose|Physician Decision|2
371583|NCT00322348|1192245|P2|Overall Study|Reasons not specified|1
371584|NCT00322348|1192246|P1|Overall Study|Reasons not specified|5
371585|NCT00322348|1192245|P2|Overall Study|Disease Progression|25
371586|NCT00322348|1192246|P1|Overall Study|Disease Progression|30
371587|NCT00322348|1192245|P2|Overall Study|Death|2
371588|NCT00322348|1192246|P1|Overall Study|Death|0
371589|NCT00322348|1192245|P2|Overall Study|Lost to Follow-up|0
371590|NCT00322348|1192246|P1|Overall Study|Lost to Follow-up|1
371591|NCT00322348|1192245|P2|Overall Study|Withdrawal by Subject|4
371592|NCT00322348|1192246|P1|Overall Study|Withdrawal by Subject|1
371593|NCT00322348|1192245|P2|Overall Study|Adverse Event|1
371594|NCT00322348|1192246|P1|Overall Study|Adverse Event|0
371595|NCT00322153|1192337|P2|Overall Study|Withdrawn for other reasons|4
371596|NCT00322153|1192338|P1|Overall Study|Withdrawn for other reasons|5
371597|NCT00322153|1192337|P2|Overall Study|Lost to Follow-up|4
371598|NCT00322153|1192338|P1|Overall Study|Lost to Follow-up|5
371599|NCT00322153|1192337|P2|Overall Study|Lack of Efficacy|3
371600|NCT00322153|1192338|P1|Overall Study|Lack of Efficacy|8
371601|NCT00322153|1192337|P2|Overall Study|Withdrawal by Subject|10
371602|NCT00322153|1192338|P1|Overall Study|Withdrawal by Subject|18
371603|NCT00322153|1192337|P2|Overall Study|Protocol Violation|14
371604|NCT00322153|1192338|P1|Overall Study|Protocol Violation|6
371605|NCT00322153|1192337|P2|Overall Study|Adverse Event|34
371606|NCT00322153|1192338|P1|Overall Study|Adverse Event|21
371607|NCT00321984|1192370|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
371608|NCT00321984|1192371|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
371609|NCT00321984|1192372|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
371610|NCT00321984|1192370|P3|Overall Study|Per Investigator Request|0
371611|NCT00321984|1192371|P2|Overall Study|Per Investigator Request|0
371612|NCT00321984|1192372|P1|Overall Study|Per Investigator Request|1
371613|NCT00321984|1192370|P3|Overall Study|Per Subject Request|0
371614|NCT00321984|1192371|P2|Overall Study|Per Subject Request|0
371615|NCT00321984|1192372|P1|Overall Study|Per Subject Request|1
371616|NCT00321984|1192370|P3|Overall Study|Pregnancy|0
371617|NCT00321984|1192371|P2|Overall Study|Pregnancy|1
371618|NCT00321984|1192372|P1|Overall Study|Pregnancy|0
371619|NCT00321984|1192370|P3|Overall Study|Noncompliant|2
371620|NCT00321984|1192371|P2|Overall Study|Noncompliant|0
371621|NCT00321984|1192372|P1|Overall Study|Noncompliant|0
371622|NCT00321984|1192370|P3|Overall Study|Lack of Efficacy|3
371623|NCT00321984|1192371|P2|Overall Study|Lack of Efficacy|1
371624|NCT00321984|1192372|P1|Overall Study|Lack of Efficacy|3
371625|NCT00321984|1192370|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
371626|NCT00321984|1192371|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
371627|NCT00321984|1192372|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
371628|NCT00321984|1192370|P3|Overall Study|Withdrawal by Subject|5
371629|NCT00321984|1192371|P2|Overall Study|Withdrawal by Subject|6
371630|NCT00321984|1192372|P1|Overall Study|Withdrawal by Subject|8
371631|NCT00321984|1192370|P3|Overall Study|Lost to Follow-up|2
371632|NCT00321984|1192371|P2|Overall Study|Lost to Follow-up|4
371633|NCT00321984|1192372|P1|Overall Study|Lost to Follow-up|2
371634|NCT00321984|1192370|P3|Overall Study|Protocol Violation|1
371635|NCT00321984|1192371|P2|Overall Study|Protocol Violation|1
371636|NCT00321984|1192372|P1|Overall Study|Protocol Violation|0
371637|NCT00321984|1192370|P3|Overall Study|Adverse Event|8
371638|NCT00321984|1192371|P2|Overall Study|Adverse Event|6
371639|NCT00321984|1192372|P1|Overall Study|Adverse Event|9
371640|NCT00321932|1192391|P2|Overall Study|Missing data|1
371641|NCT00321932|1192392|P1|Overall Study|Missing data|2
371642|NCT00321932|1192391|P2|Overall Study|Early relapse|8
371643|NCT00321932|1192392|P1|Overall Study|Early relapse|2
371644|NCT00321932|1192391|P2|Overall Study|Withdrawal by Subject|6
371645|NCT00321932|1192392|P1|Overall Study|Withdrawal by Subject|3
371646|NCT00321932|1192391|P2|Overall Study|Death|6
371647|NCT00321932|1192392|P1|Overall Study|Death|3
371648|NCT00321919|1192416|P2|Overall Study|Other withdrawal reason|6
371649|NCT00321919|1192417|P1|Overall Study|Other withdrawal reason|7
371650|NCT00321919|1192416|P2|Overall Study|Failure to Return|1
371651|NCT00321919|1192417|P1|Overall Study|Failure to Return|3
371652|NCT00321919|1192416|P2|Overall Study|Other Protocol Violation|3
371653|NCT00321919|1192417|P1|Overall Study|Other Protocol Violation|2
371654|NCT00321919|1192416|P2|Overall Study|Refused Treatment|14
371655|NCT00321919|1192417|P1|Overall Study|Refused Treatment|23
371748|NCT00321711|1192748|P5|Part B|Physician Decision|2
371656|NCT00321919|1192416|P2|Overall Study|Violation of Selection Criteria at Entry|1
371657|NCT00321919|1192417|P1|Overall Study|Violation of Selection Criteria at Entry|1
371658|NCT00321919|1192416|P2|Overall Study|Insufficient Therapeutic Response|0
371659|NCT00321919|1192417|P1|Overall Study|Insufficient Therapeutic Response|1
371660|NCT00321919|1192416|P2|Overall Study|Death|17
371661|NCT00321919|1192417|P1|Overall Study|Death|21
371662|NCT00321919|1192416|P2|Overall Study|Adverse Event|10
371663|NCT00321919|1192417|P1|Overall Study|Adverse Event|17
371664|NCT00321906|1192459|P2|Overall Study|Withdrawal by Subject|4
371665|NCT00321906|1192460|P1|Overall Study|Withdrawal by Subject|0
371666|NCT00321906|1192459|P2|Overall Study|Lost to Follow-up|2
371667|NCT00321906|1192460|P1|Overall Study|Lost to Follow-up|1
371668|NCT00321906|1192459|P2|Overall Study|Death|6
371669|NCT00321906|1192460|P1|Overall Study|Death|9
371670|NCT00321906|1192459|P2|Overall Study|Adverse Event|44
371671|NCT00321906|1192460|P1|Overall Study|Adverse Event|36
371672|NCT00321893|1192482|P2|Overall Study|Adverse Event|3
371673|NCT00321893|1192483|P1|Overall Study|Adverse Event|6
371674|NCT00321893|1192482|P2|Overall Study|Lost to Follow-up|1
371675|NCT00321893|1192483|P1|Overall Study|Lost to Follow-up|2
371676|NCT00321893|1192482|P2|Overall Study|Non-Compliance/Refusal|10
371677|NCT00321893|1192483|P1|Overall Study|Non-Compliance/Refusal|16
371678|NCT00321854|1192497|P2|Overall Study|Other|1
371679|NCT00321854|1192498|P1|Overall Study|Other|1
371680|NCT00321854|1192497|P2|Overall Study|Withdrawal by Subject|17
371681|NCT00321854|1192498|P1|Overall Study|Withdrawal by Subject|6
371682|NCT00321854|1192497|P2|Overall Study|Lost to Follow-up|2
371683|NCT00321854|1192498|P1|Overall Study|Lost to Follow-up|0
371684|NCT00321854|1192497|P2|Overall Study|Protocol Violation|5
371685|NCT00321854|1192498|P1|Overall Study|Protocol Violation|6
371686|NCT00321854|1192497|P2|Overall Study|Lack of Efficacy|14
371687|NCT00321854|1192498|P1|Overall Study|Lack of Efficacy|9
371688|NCT00321854|1192497|P2|Overall Study|Adverse Event|43
371689|NCT00321854|1192498|P1|Overall Study|Adverse Event|41
371690|NCT00321828|1192616|P1|Overall Study|No follow up data|1
371691|NCT00321828|1192616|P1|Overall Study|Ineligible|3
371692|NCT00321789|1192622|P2|Overall Study|Protocol Violation|3
371693|NCT00321789|1192623|P1|Overall Study|Protocol Violation|5
371694|NCT00321789|1192622|P2|Overall Study|Withdrawal by Subject|6
371695|NCT00321789|1192623|P1|Overall Study|Withdrawal by Subject|6
371696|NCT00321789|1192622|P2|Overall Study|Lost to Follow-up|7
371697|NCT00321789|1192623|P1|Overall Study|Lost to Follow-up|4
371698|NCT00321763|1192655|P4|Overall Study|Lost to Follow-up|4
371699|NCT00321763|1192656|P3|Overall Study|Lost to Follow-up|5
371700|NCT00321763|1192657|P2|Overall Study|Lost to Follow-up|1
371701|NCT00321763|1192658|P1|Overall Study|Lost to Follow-up|3
371702|NCT00321763|1192655|P4|Overall Study|Withdrawal by Subject|0
371703|NCT00321763|1192656|P3|Overall Study|Withdrawal by Subject|1
371704|NCT00321763|1192657|P2|Overall Study|Withdrawal by Subject|0
371705|NCT00321763|1192658|P1|Overall Study|Withdrawal by Subject|2
371706|NCT00321763|1192655|P4|Overall Study|Adverse Event|1
371707|NCT00321763|1192656|P3|Overall Study|Adverse Event|0
371708|NCT00321763|1192657|P2|Overall Study|Adverse Event|1
371709|NCT00321763|1192658|P1|Overall Study|Adverse Event|1
371710|NCT00321737|1192718|P3|Overall Study|Subject Request/ Subject Unavailable|2
371711|NCT00321737|1192719|P2|Overall Study|Subject Request/ Subject Unavailable|0
371712|NCT00321737|1192720|P1|Overall Study|Subject Request/ Subject Unavailable|0
371713|NCT00321737|1192718|P3|Overall Study|Noncompliance|0
371714|NCT00321737|1192719|P2|Overall Study|Noncompliance|0
371715|NCT00321737|1192720|P1|Overall Study|Noncompliance|2
371716|NCT00321737|1192718|P3|Overall Study|Pregnancy|0
371717|NCT00321737|1192719|P2|Overall Study|Pregnancy|2
371718|NCT00321737|1192720|P1|Overall Study|Pregnancy|0
371719|NCT00321737|1192718|P3|Overall Study|Therapeutic Failure|2
371720|NCT00321737|1192719|P2|Overall Study|Therapeutic Failure|0
371721|NCT00321737|1192720|P1|Overall Study|Therapeutic Failure|6
371722|NCT00321737|1192718|P3|Overall Study|Possible Barrett's Esophagus|1
371723|NCT00321737|1192719|P2|Overall Study|Possible Barrett's Esophagus|1
371724|NCT00321737|1192720|P1|Overall Study|Possible Barrett's Esophagus|2
371725|NCT00321737|1192718|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
371726|NCT00321737|1192719|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
371727|NCT00321737|1192720|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
371728|NCT00321737|1192718|P3|Overall Study|Protocol Violation|1
371729|NCT00321737|1192719|P2|Overall Study|Protocol Violation|0
371730|NCT00321737|1192720|P1|Overall Study|Protocol Violation|0
371731|NCT00321737|1192718|P3|Overall Study|Withdrawal by Subject|17
371732|NCT00321737|1192719|P2|Overall Study|Withdrawal by Subject|12
371733|NCT00321737|1192720|P1|Overall Study|Withdrawal by Subject|19
371734|NCT00321737|1192718|P3|Overall Study|Lost to Follow-up|6
371735|NCT00321737|1192719|P2|Overall Study|Lost to Follow-up|5
371736|NCT00321737|1192720|P1|Overall Study|Lost to Follow-up|5
371737|NCT00321737|1192718|P3|Overall Study|Adverse Event|6
371738|NCT00321737|1192719|P2|Overall Study|Adverse Event|3
371739|NCT00321737|1192720|P1|Overall Study|Adverse Event|11
371740|NCT00321737|1192718|P3|Overall Study|Relapse of Erosive Esophagitis|19
371741|NCT00321737|1192719|P2|Overall Study|Relapse of Erosive Esophagitis|25
371742|NCT00321737|1192720|P1|Overall Study|Relapse of Erosive Esophagitis|76
371743|NCT00321711|1192748|P5|Part B|Death|1
371744|NCT00321711|1192749|P4|Part B|Death|2
371745|NCT00321711|1192750|P3|Part B|Death|0
371749|NCT00321711|1192749|P4|Part B|Physician Decision|1
371750|NCT00321711|1192750|P3|Part B|Physician Decision|0
371751|NCT00321711|1192751|P2|Part B|Physician Decision|0
371752|NCT00321711|1192752|P1|Part B|Physician Decision|0
371753|NCT00321711|1192748|P5|Part B|Disease progression|0
371754|NCT00321711|1192749|P4|Part B|Disease progression|1
371755|NCT00321711|1192750|P3|Part B|Disease progression|0
371756|NCT00321711|1192751|P2|Part B|Disease progression|0
371757|NCT00321711|1192752|P1|Part B|Disease progression|0
371758|NCT00321711|1192748|P5|Part B|Adverse Event|1
371759|NCT00321711|1192749|P4|Part B|Adverse Event|2
371760|NCT00321711|1192750|P3|Part B|Adverse Event|0
371761|NCT00321711|1192751|P2|Part B|Adverse Event|0
371762|NCT00321711|1192752|P1|Part B|Adverse Event|0
371763|NCT00321711|1192748|P5|Part B|Noncompliance|1
371764|NCT00321711|1192749|P4|Part B|Noncompliance|0
371765|NCT00321711|1192750|P3|Part B|Noncompliance|0
371766|NCT00321711|1192751|P2|Part B|Noncompliance|0
371767|NCT00321711|1192752|P1|Part B|Noncompliance|0
371768|NCT00321711|1192748|P5|Part A|Protocol deviation|0
371769|NCT00321711|1192749|P4|Part A|Protocol deviation|0
371770|NCT00321711|1192750|P3|Part A|Protocol deviation|1
371771|NCT00321711|1192751|P2|Part A|Protocol deviation|0
371772|NCT00321711|1192752|P1|Part A|Protocol deviation|0
371773|NCT00321711|1192748|P5|Part A|Other|0
371774|NCT00321711|1192749|P4|Part A|Other|0
371775|NCT00321711|1192750|P3|Part A|Other|3
371776|NCT00321711|1192751|P2|Part A|Other|2
371777|NCT00321711|1192752|P1|Part A|Other|1
371778|NCT00321711|1192748|P5|Part A|Physician Decision|0
371779|NCT00321711|1192749|P4|Part A|Physician Decision|0
371780|NCT00321711|1192750|P3|Part A|Physician Decision|3
371781|NCT00321711|1192751|P2|Part A|Physician Decision|1
371782|NCT00321711|1192752|P1|Part A|Physician Decision|0
371783|NCT00321711|1192748|P5|Part A|Requirement for alternative therapy|0
371784|NCT00321711|1192749|P4|Part A|Requirement for alternative therapy|0
371785|NCT00321711|1192750|P3|Part A|Requirement for alternative therapy|1
371786|NCT00321711|1192751|P2|Part A|Requirement for alternative therapy|2
371787|NCT00321711|1192752|P1|Part A|Requirement for alternative therapy|0
371788|NCT00321711|1192748|P5|Part A|Disease progression|0
371789|NCT00321711|1192749|P4|Part A|Disease progression|0
371790|NCT00321711|1192750|P3|Part A|Disease progression|0
371791|NCT00321711|1192751|P2|Part A|Disease progression|1
371792|NCT00321711|1192752|P1|Part A|Disease progression|0
371793|NCT00321711|1192748|P5|Part A|Withdrawal by Subject|0
371794|NCT00321711|1192749|P4|Part A|Withdrawal by Subject|0
371795|NCT00321711|1192750|P3|Part A|Withdrawal by Subject|1
371796|NCT00321711|1192751|P2|Part A|Withdrawal by Subject|1
371797|NCT00321711|1192752|P1|Part A|Withdrawal by Subject|1
371798|NCT00321711|1192748|P5|Part A|Adverse Event|0
371799|NCT00321711|1192749|P4|Part A|Adverse Event|0
371800|NCT00321711|1192750|P3|Part A|Adverse Event|2
371801|NCT00321711|1192751|P2|Part A|Adverse Event|3
371802|NCT00321711|1192752|P1|Part A|Adverse Event|3
371803|NCT00321685|1192802|P1|Overall Study|Ineligible|2
371804|NCT00321685|1192802|P1|Overall Study|Not start protocol therapy|2
371805|NCT00321685|1192802|P1|Overall Study|Other|5
371806|NCT00321685|1192802|P1|Overall Study|Complicating disese|1
371807|NCT00321685|1192802|P1|Overall Study|Alternative therapy|1
371808|NCT00321685|1192802|P1|Overall Study|Withdrawal by Subject|8
371809|NCT00321685|1192802|P1|Overall Study|Death|2
371810|NCT00321685|1192802|P1|Overall Study|Adverse Event|18
371811|NCT00321672|1192814|P4|Overall Study|Extensive travel required for new job|0
371812|NCT00321672|1192815|P3|Overall Study|Extensive travel required for new job|0
371813|NCT00321672|1192816|P2|Overall Study|Extensive travel required for new job|1
371814|NCT00321672|1192817|P1|Overall Study|Extensive travel required for new job|0
371815|NCT00321672|1192814|P4|Overall Study|Diagnosis of testicular cancer|0
371816|NCT00321672|1192815|P3|Overall Study|Diagnosis of testicular cancer|0
371817|NCT00321672|1192816|P2|Overall Study|Diagnosis of testicular cancer|1
371818|NCT00321672|1192817|P1|Overall Study|Diagnosis of testicular cancer|0
371819|NCT00321672|1192814|P4|Overall Study|Protocol Violation|0
371820|NCT00321672|1192815|P3|Overall Study|Protocol Violation|1
371821|NCT00321672|1192816|P2|Overall Study|Protocol Violation|0
371822|NCT00321672|1192817|P1|Overall Study|Protocol Violation|0
371823|NCT00321672|1192814|P4|Overall Study|Moved out of state|0
371824|NCT00321672|1192815|P3|Overall Study|Moved out of state|1
371825|NCT00321672|1192816|P2|Overall Study|Moved out of state|1
371826|NCT00321672|1192817|P1|Overall Study|Moved out of state|0
371827|NCT00321672|1192814|P4|Overall Study|Incarcerated|0
371828|NCT00321672|1192815|P3|Overall Study|Incarcerated|2
371829|NCT00321672|1192816|P2|Overall Study|Incarcerated|0
371830|NCT00321672|1192817|P1|Overall Study|Incarcerated|0
371831|NCT00321672|1192814|P4|Overall Study|Too far to travel for visits|0
371832|NCT00321672|1192815|P3|Overall Study|Too far to travel for visits|0
371833|NCT00321672|1192816|P2|Overall Study|Too far to travel for visits|0
371834|NCT00321672|1192817|P1|Overall Study|Too far to travel for visits|1
371835|NCT00321672|1192814|P4|Overall Study|Death|0
371836|NCT00321672|1192815|P3|Overall Study|Death|0
371837|NCT00321672|1192816|P2|Overall Study|Death|0
371838|NCT00321672|1192817|P1|Overall Study|Death|1
371839|NCT00321672|1192814|P4|Overall Study|Lost to Follow-up|2
371840|NCT00321672|1192815|P3|Overall Study|Lost to Follow-up|4
371841|NCT00321672|1192816|P2|Overall Study|Lost to Follow-up|0
371842|NCT00321672|1192817|P1|Overall Study|Lost to Follow-up|2
371843|NCT00321672|1192814|P4|Overall Study|Lack of Efficacy|0
371844|NCT00321672|1192815|P3|Overall Study|Lack of Efficacy|0
371845|NCT00321672|1192816|P2|Overall Study|Lack of Efficacy|1
371846|NCT00321672|1192817|P1|Overall Study|Lack of Efficacy|1
371847|NCT00321672|1192814|P4|Overall Study|Adverse Event|0
371848|NCT00321672|1192815|P3|Overall Study|Adverse Event|0
371849|NCT00321672|1192816|P2|Overall Study|Adverse Event|1
371850|NCT00321672|1192817|P1|Overall Study|Adverse Event|1
371851|NCT00321672|1192814|P4|Overall Study|Noncompliance|0
371852|NCT00321672|1192815|P3|Overall Study|Noncompliance|1
371853|NCT00321672|1192816|P2|Overall Study|Noncompliance|2
371854|NCT00321672|1192817|P1|Overall Study|Noncompliance|1
371855|NCT00321672|1192814|P4|Overall Study|Withdrawal by Subject|0
371856|NCT00321672|1192815|P3|Overall Study|Withdrawal by Subject|2
371857|NCT00321672|1192816|P2|Overall Study|Withdrawal by Subject|1
371858|NCT00321672|1192817|P1|Overall Study|Withdrawal by Subject|5
371859|NCT00321646|1192843|P1|Neoadjuvant Chemotherapy|Disease progression|1
371860|NCT00321646|1192843|P1|Neoadjuvant Chemotherapy|Adverse Event|2
371861|NCT00321646|1192843|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
371862|NCT00321620|1192850|P2|Overall Study|Other|33
371863|NCT00321620|1192851|P1|Overall Study|Other|42
371864|NCT00321620|1192850|P2|Overall Study|Participant request|52
371865|NCT00321620|1192851|P1|Overall Study|Participant request|75
371866|NCT00321620|1192850|P2|Overall Study|Ineligibility determined|3
371867|NCT00321620|1192851|P1|Overall Study|Ineligibility determined|2
371868|NCT00321620|1192850|P2|Overall Study|Protocol deviation|3
371869|NCT00321620|1192851|P1|Overall Study|Protocol deviation|4
371870|NCT00321620|1192850|P2|Overall Study|Noncompliance|7
371871|NCT00321620|1192851|P1|Overall Study|Noncompliance|14
371872|NCT00321620|1192850|P2|Overall Study|Physician Decision|1
371873|NCT00321620|1192851|P1|Overall Study|Physician Decision|4
371874|NCT00321620|1192850|P2|Overall Study|Lost to Follow-up|9
371875|NCT00321620|1192851|P1|Overall Study|Lost to Follow-up|13
371876|NCT00321620|1192850|P2|Overall Study|Adverse Event|56
371877|NCT00321620|1192851|P1|Overall Study|Adverse Event|43
371878|NCT00321620|1192850|P2|Overall Study|Disease progression|117
371879|NCT00321620|1192851|P1|Overall Study|Disease progression|113
371880|NCT00321620|1192850|P2|Overall Study|Withdrawal by Subject|147
371881|NCT00321620|1192851|P1|Overall Study|Withdrawal by Subject|164
371882|NCT00321620|1192850|P2|Overall Study|Death|294
371883|NCT00321620|1192851|P1|Overall Study|Death|269
371884|NCT00321464|1192863|P2|Overall Study|Other|18
371885|NCT00321464|1192864|P1|Overall Study|Other|21
371886|NCT00321464|1192863|P2|Overall Study|Ineligibility determined|1
371887|NCT00321464|1192864|P1|Overall Study|Ineligibility determined|2
371888|NCT00321464|1192863|P2|Overall Study|Protocol deviation|2
371889|NCT00321464|1192864|P1|Overall Study|Protocol deviation|0
371890|NCT00321464|1192863|P2|Overall Study|Lost to Follow-up|8
371891|NCT00321464|1192864|P1|Overall Study|Lost to Follow-up|7
371892|NCT00321464|1192863|P2|Overall Study|Noncompliance|10
371893|NCT00321464|1192864|P1|Overall Study|Noncompliance|4
371894|NCT00321464|1192863|P2|Overall Study|Physician Decision|14
371895|NCT00321464|1192864|P1|Overall Study|Physician Decision|15
371896|NCT00321464|1192863|P2|Overall Study|Adverse Event|28
371897|NCT00321464|1192864|P1|Overall Study|Adverse Event|43
371898|NCT00321464|1192863|P2|Overall Study|Participant request|61
371899|NCT00321464|1192864|P1|Overall Study|Participant request|57
371900|NCT00321464|1192863|P2|Overall Study|Withdrawal by Subject|118
371901|NCT00321464|1192864|P1|Overall Study|Withdrawal by Subject|117
371902|NCT00321464|1192863|P2|Overall Study|Disease progression|124
371903|NCT00321464|1192864|P1|Overall Study|Disease progression|124
371904|NCT00321464|1192863|P2|Overall Study|Death|174
371905|NCT00321464|1192864|P1|Overall Study|Death|169
371906|NCT00321373|1192877|P3|Overall Study|Unspecified|1
371907|NCT00321373|1192878|P2|Overall Study|Unspecified|0
371908|NCT00321373|1192879|P1|Overall Study|Unspecified|0
371909|NCT00321373|1192877|P3|Overall Study|Withdrawal by Subject|0
371910|NCT00321373|1192878|P2|Overall Study|Withdrawal by Subject|0
371911|NCT00321373|1192879|P1|Overall Study|Withdrawal by Subject|1
371912|NCT00321373|1192877|P3|Overall Study|Lost to Follow-up|1
371913|NCT00321373|1192878|P2|Overall Study|Lost to Follow-up|0
371914|NCT00321373|1192879|P1|Overall Study|Lost to Follow-up|1
371915|NCT00321373|1192877|P3|Overall Study|Adverse Event|1
371916|NCT00321373|1192878|P2|Overall Study|Adverse Event|0
371917|NCT00321373|1192879|P1|Overall Study|Adverse Event|0
371918|NCT00319982|1192919|P2|Overall Study|Withdrawal by Subject|0
371919|NCT00319982|1192920|P1|Overall Study|Withdrawal by Subject|1
371920|NCT00320801|1192940|P4|Extension Phase|Lost to Follow-up|3
371921|NCT00320801|1192941|P3|Extension Phase|Lost to Follow-up|0
371922|NCT00320801|1192942|P2|Extension Phase|Lost to Follow-up|0
371923|NCT00320801|1192943|P1|Extension Phase|Lost to Follow-up|0
371924|NCT00320801|1192940|P4|Extension Phase|Lack of Efficacy|2
371925|NCT00320801|1192941|P3|Extension Phase|Lack of Efficacy|0
371926|NCT00320801|1192942|P2|Extension Phase|Lack of Efficacy|0
371927|NCT00320801|1192943|P1|Extension Phase|Lack of Efficacy|0
371928|NCT00320801|1192940|P4|Extension Phase|Administrative|29
371929|NCT00320801|1192941|P3|Extension Phase|Administrative|0
371930|NCT00320801|1192942|P2|Extension Phase|Administrative|0
371931|NCT00320801|1192943|P1|Extension Phase|Administrative|0
371932|NCT00320801|1192940|P4|Extension Phase|Adverse Event|8
371933|NCT00320801|1192941|P3|Extension Phase|Adverse Event|0
371934|NCT00320801|1192942|P2|Extension Phase|Adverse Event|0
371935|NCT00320801|1192943|P1|Extension Phase|Adverse Event|0
371936|NCT00320801|1192940|P4|Extension Phase|Withdrawal by Subject|6
371937|NCT00320801|1192941|P3|Extension Phase|Withdrawal by Subject|0
371938|NCT00320801|1192942|P2|Extension Phase|Withdrawal by Subject|0
371939|NCT00320801|1192943|P1|Extension Phase|Withdrawal by Subject|0
371940|NCT00320801|1192940|P4|Double-blind Phase|Lack of Efficacy|0
371941|NCT00320801|1192941|P3|Double-blind Phase|Lack of Efficacy|1
371942|NCT00320801|1192942|P2|Double-blind Phase|Lack of Efficacy|9
371943|NCT00320801|1192943|P1|Double-blind Phase|Lack of Efficacy|0
371944|NCT00320801|1192940|P4|Double-blind Phase|Administrative|0
371945|NCT00320801|1192941|P3|Double-blind Phase|Administrative|4
371946|NCT00320801|1192942|P2|Double-blind Phase|Administrative|0
371947|NCT00320801|1192943|P1|Double-blind Phase|Administrative|0
371948|NCT00320801|1192940|P4|Double-blind Phase|Adverse Event|0
371949|NCT00320801|1192941|P3|Double-blind Phase|Adverse Event|8
371950|NCT00320801|1192942|P2|Double-blind Phase|Adverse Event|2
371951|NCT00320801|1192943|P1|Double-blind Phase|Adverse Event|0
371952|NCT00320801|1192940|P4|Double-blind Phase|Withdrawal by Subject|0
371953|NCT00320801|1192941|P3|Double-blind Phase|Withdrawal by Subject|1
371954|NCT00320801|1192942|P2|Double-blind Phase|Withdrawal by Subject|0
371955|NCT00320801|1192943|P1|Double-blind Phase|Withdrawal by Subject|0
371956|NCT00320801|1192940|P4|Open-label Run-in Period|Did not qualify|0
371957|NCT00320801|1192941|P3|Open-label Run-in Period|Did not qualify|0
371958|NCT00320801|1192942|P2|Open-label Run-in Period|Did not qualify|0
371959|NCT00320801|1192943|P1|Open-label Run-in Period|Did not qualify|1
371960|NCT00320801|1192940|P4|Open-label Run-in Period|Lost to Follow-up|0
371961|NCT00320801|1192941|P3|Open-label Run-in Period|Lost to Follow-up|0
371962|NCT00320801|1192942|P2|Open-label Run-in Period|Lost to Follow-up|0
371963|NCT00320801|1192943|P1|Open-label Run-in Period|Lost to Follow-up|2
371964|NCT00320801|1192940|P4|Open-label Run-in Period|Lack of Efficacy|0
371965|NCT00320801|1192941|P3|Open-label Run-in Period|Lack of Efficacy|0
371966|NCT00320801|1192942|P2|Open-label Run-in Period|Lack of Efficacy|0
371967|NCT00320801|1192943|P1|Open-label Run-in Period|Lack of Efficacy|44
371968|NCT00320801|1192940|P4|Open-label Run-in Period|Administrative|0
371969|NCT00320801|1192941|P3|Open-label Run-in Period|Administrative|0
371970|NCT00320801|1192942|P2|Open-label Run-in Period|Administrative|0
371971|NCT00320801|1192943|P1|Open-label Run-in Period|Administrative|10
371972|NCT00320801|1192940|P4|Open-label Run-in Period|Adverse Event|0
371973|NCT00320801|1192941|P3|Open-label Run-in Period|Adverse Event|0
371974|NCT00320801|1192942|P2|Open-label Run-in Period|Adverse Event|0
371975|NCT00320801|1192943|P1|Open-label Run-in Period|Adverse Event|33
371976|NCT00320801|1192940|P4|Open-label Run-in Period|Withdrawal by Subject|0
371977|NCT00320801|1192941|P3|Open-label Run-in Period|Withdrawal by Subject|0
371978|NCT00320801|1192942|P2|Open-label Run-in Period|Withdrawal by Subject|0
371979|NCT00320801|1192943|P1|Open-label Run-in Period|Withdrawal by Subject|2
371980|NCT00320788|1192958|P5|Overall Study|Withdrawal by Subject|1
371981|NCT00320788|1192959|P4|Overall Study|Withdrawal by Subject|3
371982|NCT00320788|1192960|P3|Overall Study|Withdrawal by Subject|0
371983|NCT00320788|1192961|P2|Overall Study|Withdrawal by Subject|0
371984|NCT00320788|1192962|P1|Overall Study|Withdrawal by Subject|3
371985|NCT00320788|1192958|P5|Overall Study|Protocol Violation|1
371986|NCT00320788|1192959|P4|Overall Study|Protocol Violation|0
371987|NCT00320788|1192960|P3|Overall Study|Protocol Violation|0
371988|NCT00320788|1192961|P2|Overall Study|Protocol Violation|0
371989|NCT00320788|1192962|P1|Overall Study|Protocol Violation|0
371990|NCT00320788|1192958|P5|Overall Study|Physician Decision|0
371991|NCT00320788|1192959|P4|Overall Study|Physician Decision|0
371992|NCT00320788|1192960|P3|Overall Study|Physician Decision|0
371993|NCT00320788|1192961|P2|Overall Study|Physician Decision|1
371994|NCT00320788|1192962|P1|Overall Study|Physician Decision|1
371995|NCT00320788|1192958|P5|Overall Study|Other|1
371996|NCT00320788|1192959|P4|Overall Study|Other|1
371997|NCT00320788|1192960|P3|Overall Study|Other|1
371998|NCT00320788|1192961|P2|Overall Study|Other|2
371999|NCT00320788|1192962|P1|Overall Study|Other|1
372000|NCT00320788|1192958|P5|Overall Study|Decision by the Sponsor|1
372001|NCT00320788|1192959|P4|Overall Study|Decision by the Sponsor|0
372002|NCT00320788|1192960|P3|Overall Study|Decision by the Sponsor|0
372003|NCT00320788|1192961|P2|Overall Study|Decision by the Sponsor|1
372004|NCT00320788|1192962|P1|Overall Study|Decision by the Sponsor|1
372005|NCT00320788|1192958|P5|Overall Study|Lost to Follow-up|0
372006|NCT00320788|1192959|P4|Overall Study|Lost to Follow-up|0
372007|NCT00320788|1192960|P3|Overall Study|Lost to Follow-up|1
372008|NCT00320788|1192961|P2|Overall Study|Lost to Follow-up|2
372009|NCT00320788|1192962|P1|Overall Study|Lost to Follow-up|0
372010|NCT00320788|1192958|P5|Overall Study|Death|1
372011|NCT00320788|1192959|P4|Overall Study|Death|0
372012|NCT00320788|1192960|P3|Overall Study|Death|1
372013|NCT00320788|1192961|P2|Overall Study|Death|0
372014|NCT00320788|1192962|P1|Overall Study|Death|0
372015|NCT00320788|1192958|P5|Overall Study|Adverse Event|0
372016|NCT00320788|1192959|P4|Overall Study|Adverse Event|1
372017|NCT00320788|1192960|P3|Overall Study|Adverse Event|0
372018|NCT00320788|1192961|P2|Overall Study|Adverse Event|0
372019|NCT00320788|1192962|P1|Overall Study|Adverse Event|0
372020|NCT00320710|1193016|P3|Overall Study|Lost to Follow-up|0
372021|NCT00320710|1193017|P2|Overall Study|Lost to Follow-up|0
372022|NCT00320710|1193018|P1|Overall Study|Lost to Follow-up|1
372023|NCT00320710|1193016|P3|Overall Study|Adverse Event|1
372024|NCT00320710|1193017|P2|Overall Study|Adverse Event|14
372025|NCT00320710|1193018|P1|Overall Study|Adverse Event|18
372026|NCT00320710|1193016|P3|Overall Study|Abnormal laboratory value(s)|0
372027|NCT00320710|1193017|P2|Overall Study|Abnormal laboratory value(s)|3
372028|NCT00320710|1193018|P1|Overall Study|Abnormal laboratory value(s)|12
372029|NCT00320710|1193016|P3|Overall Study|Abnormal test procedure result(s)|0
372030|NCT00320710|1193017|P2|Overall Study|Abnormal test procedure result(s)|0
372031|NCT00320710|1193018|P1|Overall Study|Abnormal test procedure result(s)|2
372032|NCT00320710|1193016|P3|Overall Study|Protocol Violation|0
372033|NCT00320710|1193017|P2|Overall Study|Protocol Violation|5
372034|NCT00320710|1193018|P1|Overall Study|Protocol Violation|6
372035|NCT00320710|1193016|P3|Overall Study|Withdrawal by Subject|1
372036|NCT00320710|1193017|P2|Overall Study|Withdrawal by Subject|26
372037|NCT00320710|1193018|P1|Overall Study|Withdrawal by Subject|20
372038|NCT00320710|1193016|P3|Overall Study|Administrative problems|0
372039|NCT00320710|1193017|P2|Overall Study|Administrative problems|2
372040|NCT00320710|1193018|P1|Overall Study|Administrative problems|1
372041|NCT00320710|1193016|P3|Overall Study|Death|1
372042|NCT00320710|1193017|P2|Overall Study|Death|7
372043|NCT00320710|1193018|P1|Overall Study|Death|10
372044|NCT00320710|1193016|P3|Overall Study|Disease progression|2
372045|NCT00320710|1193017|P2|Overall Study|Disease progression|19
372046|NCT00320710|1193018|P1|Overall Study|Disease progression|24
372047|NCT00320606|1193048|P1|Overall Study|Ongoing in study|12
372048|NCT00320606|1193048|P1|Overall Study|Protocol Violation|1
372049|NCT00320606|1193048|P1|Overall Study|Adverse Event|1
372050|NCT00320593|1193054|P2|Overall Study|Withdrawal by clinical center|0
372051|NCT00320593|1193055|P1|Overall Study|Withdrawal by clinical center|1
372052|NCT00320593|1193054|P2|Overall Study|Withdrawal by Subject|1
372053|NCT00320593|1193055|P1|Overall Study|Withdrawal by Subject|2
372054|NCT00320593|1193054|P2|Overall Study|Moved to another state|0
372055|NCT00320593|1193055|P1|Overall Study|Moved to another state|1
372056|NCT00320593|1193054|P2|Overall Study|Lost to Follow-up|0
372057|NCT00320593|1193055|P1|Overall Study|Lost to Follow-up|3
372058|NCT00320541|1193079|P2|Overall Study|Protocol Entry Criterion Not Met|0
372059|NCT00320541|1193080|P1|Overall Study|Protocol Entry Criterion Not Met|1
372060|NCT00320541|1193079|P2|Overall Study|Death due to Adverse Event(s)|0
372061|NCT00320541|1193080|P1|Overall Study|Death due to Adverse Event(s)|1
372062|NCT00320541|1193079|P2|Overall Study|Death due to Study Disease|3
372063|NCT00320541|1193080|P1|Overall Study|Death due to Study Disease|1
372064|NCT00320541|1193079|P2|Overall Study|Sponsor Decision|1
372065|NCT00320541|1193080|P1|Overall Study|Sponsor Decision|2
372066|NCT00320541|1193079|P2|Overall Study|Other|4
372067|NCT00320541|1193080|P1|Overall Study|Other|3
372068|NCT00320541|1193079|P2|Overall Study|Physician Decision|13
372069|NCT00320541|1193080|P1|Overall Study|Physician Decision|9
372070|NCT00320541|1193079|P2|Overall Study|Withdrawal by Subject|16
372071|NCT00320541|1193080|P1|Overall Study|Withdrawal by Subject|12
372072|NCT00320541|1193079|P2|Overall Study|Protocol Violation|1
372073|NCT00320541|1193080|P1|Overall Study|Protocol Violation|0
372074|NCT00320541|1193079|P2|Overall Study|Adverse Event|19
372075|NCT00320541|1193080|P1|Overall Study|Adverse Event|21
372076|NCT00320528|1193107|P3|Study Period III|Atomoxetine Commercially Available|90
372077|NCT00320528|1193108|P2|Study Period III|Atomoxetine Commercially Available|25
372078|NCT00320528|1193109|P1|Study Period III|Atomoxetine Commercially Available|68
372079|NCT00320528|1193107|P3|Study Period III|Sponsor Decision|1
372080|NCT00320528|1193108|P2|Study Period III|Sponsor Decision|0
372081|NCT00320528|1193109|P1|Study Period III|Sponsor Decision|0
372082|NCT00320528|1193107|P3|Study Period III|Physician Decision|2
372083|NCT00320528|1193108|P2|Study Period III|Physician Decision|1
372084|NCT00320528|1193109|P1|Study Period III|Physician Decision|0
372085|NCT00320528|1193107|P3|Study Period III|Protocol Violation|0
372086|NCT00320528|1193108|P2|Study Period III|Protocol Violation|1
372087|NCT00320528|1193109|P1|Study Period III|Protocol Violation|0
372088|NCT00320528|1193107|P3|Study Period III|Parent/Caregiver Decision|11
372089|NCT00320528|1193108|P2|Study Period III|Parent/Caregiver Decision|3
372090|NCT00320528|1193109|P1|Study Period III|Parent/Caregiver Decision|14
372091|NCT00320528|1193107|P3|Study Period III|Lack of Efficacy|0
372092|NCT00320528|1193108|P2|Study Period III|Lack of Efficacy|0
372093|NCT00320528|1193109|P1|Study Period III|Lack of Efficacy|2
372094|NCT00320528|1193107|P3|Study Period III|Withdrawal by Subject|2
372095|NCT00320528|1193108|P2|Study Period III|Withdrawal by Subject|1
372096|NCT00320528|1193109|P1|Study Period III|Withdrawal by Subject|1
372097|NCT00320528|1193107|P3|Study Period III|Lost to Follow-up|0
372098|NCT00320528|1193108|P2|Study Period III|Lost to Follow-up|0
372099|NCT00320528|1193109|P1|Study Period III|Lost to Follow-up|1
372100|NCT00320528|1193107|P3|Study Period III|Adverse Event|0
372101|NCT00320528|1193108|P2|Study Period III|Adverse Event|0
372102|NCT00320528|1193109|P1|Study Period III|Adverse Event|1
372103|NCT00320528|1193107|P3|Study Period II|Entry Criteria Exclusion|2
372104|NCT00320528|1193108|P2|Study Period II|Entry Criteria Exclusion|2
372105|NCT00320528|1193109|P1|Study Period II|Entry Criteria Exclusion|0
372106|NCT00320528|1193107|P3|Study Period II|Withdrawal by Subject|1
372107|NCT00320528|1193108|P2|Study Period II|Withdrawal by Subject|1
372108|NCT00320528|1193109|P1|Study Period II|Withdrawal by Subject|0
372109|NCT00320528|1193107|P3|Study Period II|Parent/Caregiver Decision|11
372110|NCT00320528|1193108|P2|Study Period II|Parent/Caregiver Decision|3
372111|NCT00320528|1193109|P1|Study Period II|Parent/Caregiver Decision|8
372112|NCT00320528|1193107|P3|Study Period II|Adverse Event|8
372113|NCT00320528|1193108|P2|Study Period II|Adverse Event|4
372114|NCT00320528|1193109|P1|Study Period II|Adverse Event|3
372115|NCT00320515|1193144|P1|Overall Study|Withdrawal by Subject|8
372116|NCT00320515|1193144|P1|Overall Study|Physician Decision|2
372117|NCT00320515|1193144|P1|Overall Study|Lost to Follow-up|6
372118|NCT00320515|1193144|P1|Overall Study|Death|33
372119|NCT00320489|1193153|P2|Overall Study|Withdrawal by Subject|41
372120|NCT00320489|1193154|P1|Overall Study|Withdrawal by Subject|39
372121|NCT00320489|1193153|P2|Overall Study|Sponsor Decision|3
372122|NCT00320489|1193154|P1|Overall Study|Sponsor Decision|3
372123|NCT00320489|1193153|P2|Overall Study|Protocol Violation|4
372124|NCT00320489|1193154|P1|Overall Study|Protocol Violation|4
372125|NCT00320489|1193153|P2|Overall Study|Physician Decision|8
372126|NCT00320489|1193154|P1|Overall Study|Physician Decision|8
372127|NCT00320489|1193153|P2|Overall Study|Lost to Follow-up|22
372128|NCT00320489|1193154|P1|Overall Study|Lost to Follow-up|21
372129|NCT00320489|1193153|P2|Overall Study|Lack of Efficacy|7
372130|NCT00320489|1193154|P1|Overall Study|Lack of Efficacy|16
372131|NCT00320489|1193153|P2|Overall Study|Entry Criteria Exclusion|4
372132|NCT00320489|1193154|P1|Overall Study|Entry Criteria Exclusion|2
372133|NCT00320489|1193153|P2|Overall Study|Death|2
372134|NCT00320489|1193154|P1|Overall Study|Death|0
372135|NCT00320489|1193153|P2|Overall Study|Clinical Relapse|20
372136|NCT00320489|1193154|P1|Overall Study|Clinical Relapse|26
372137|NCT00320489|1193153|P2|Overall Study|Adverse Event|25
372138|NCT00320489|1193154|P1|Overall Study|Adverse Event|26
372139|NCT00320411|1193210|P1|Overall Study|No investigational product admin.|4
372140|NCT00320385|1193233|P2|Overall Study|Adverse Event|1
372141|NCT00320385|1193234|P1|Overall Study|Adverse Event|0
372142|NCT00320385|1193233|P2|Overall Study|Withdrew Consent|0
372143|NCT00320385|1193234|P1|Overall Study|Withdrew Consent|1
372144|NCT00320385|1193233|P2|Overall Study|Serious Adverse Event|0
372145|NCT00320385|1193234|P1|Overall Study|Serious Adverse Event|1
372146|NCT00320385|1193233|P2|Overall Study|Death|2
372147|NCT00320385|1193234|P1|Overall Study|Death|1
372148|NCT00320385|1193233|P2|Overall Study|Investigator Decision|1
372149|NCT00320385|1193234|P1|Overall Study|Investigator Decision|0
372150|NCT00320385|1193233|P2|Overall Study|Sponsor Terminated Study|1
372151|NCT00320385|1193234|P1|Overall Study|Sponsor Terminated Study|2
372152|NCT00320385|1193233|P2|Overall Study|Withdrawal by Subject|7
372153|NCT00320385|1193234|P1|Overall Study|Withdrawal by Subject|6
372154|NCT00320385|1193233|P2|Overall Study|Lost to Follow-up|10
372155|NCT00320385|1193234|P1|Overall Study|Lost to Follow-up|7
372156|NCT00320372|1193257|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
372157|NCT00320372|1193258|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
372158|NCT00320372|1193257|P2|Overall Study|Did not Meet (I/E)|1
372159|NCT00320372|1193258|P1|Overall Study|Did not Meet (I/E)|3
372160|NCT00320372|1193257|P2|Overall Study|Non-Compliance|39
372161|NCT00320372|1193258|P1|Overall Study|Non-Compliance|40
372162|NCT00320372|1193257|P2|Overall Study|Withdrawal by Subject|37
372163|NCT00320372|1193258|P1|Overall Study|Withdrawal by Subject|55
372164|NCT00320372|1193257|P2|Overall Study|Death|8
372165|NCT00320372|1193258|P1|Overall Study|Death|7
372166|NCT00320372|1193257|P2|Overall Study|Physician Decision|7
372167|NCT00320372|1193258|P1|Overall Study|Physician Decision|4
372168|NCT00320255|1193298|P6|Overall Study|Not specified|0
372169|NCT00320255|1193299|P5|Overall Study|Not specified|0
372170|NCT00320255|1193300|P4|Overall Study|Not specified|0
372171|NCT00320255|1193301|P3|Overall Study|Not specified|1
372172|NCT00320255|1193302|P2|Overall Study|Not specified|2
372173|NCT00320255|1193303|P1|Overall Study|Not specified|3
372174|NCT00320255|1193298|P6|Overall Study|No longer meets study criteria|0
372175|NCT00320255|1193299|P5|Overall Study|No longer meets study criteria|0
372176|NCT00320255|1193300|P4|Overall Study|No longer meets study criteria|1
372177|NCT00320255|1193301|P3|Overall Study|No longer meets study criteria|0
372178|NCT00320255|1193302|P2|Overall Study|No longer meets study criteria|0
372179|NCT00320255|1193303|P1|Overall Study|No longer meets study criteria|0
372180|NCT00320255|1193298|P6|Overall Study|Poor compliance/noncompliance|0
372181|NCT00320255|1193299|P5|Overall Study|Poor compliance/noncompliance|0
372182|NCT00320255|1193300|P4|Overall Study|Poor compliance/noncompliance|1
372183|NCT00320255|1193301|P3|Overall Study|Poor compliance/noncompliance|0
372184|NCT00320255|1193302|P2|Overall Study|Poor compliance/noncompliance|1
372185|NCT00320255|1193303|P1|Overall Study|Poor compliance/noncompliance|1
372186|NCT00320255|1193298|P6|Overall Study|Withdrawal by Subject|0
372187|NCT00320255|1193299|P5|Overall Study|Withdrawal by Subject|0
372188|NCT00320255|1193300|P4|Overall Study|Withdrawal by Subject|4
372189|NCT00320255|1193301|P3|Overall Study|Withdrawal by Subject|2
372190|NCT00320255|1193302|P2|Overall Study|Withdrawal by Subject|2
372191|NCT00320255|1193303|P1|Overall Study|Withdrawal by Subject|1
372192|NCT00320255|1193298|P6|Overall Study|Adverse Event|0
372193|NCT00320255|1193299|P5|Overall Study|Adverse Event|0
372194|NCT00320255|1193300|P4|Overall Study|Adverse Event|2
372195|NCT00320255|1193301|P3|Overall Study|Adverse Event|3
372196|NCT00320255|1193302|P2|Overall Study|Adverse Event|2
372197|NCT00320255|1193303|P1|Overall Study|Adverse Event|5
372198|NCT00320255|1193298|P6|Overall Study|Lack of Efficacy|0
372199|NCT00320255|1193299|P5|Overall Study|Lack of Efficacy|0
372200|NCT00320255|1193300|P4|Overall Study|Lack of Efficacy|0
372201|NCT00320255|1193301|P3|Overall Study|Lack of Efficacy|0
372202|NCT00320255|1193302|P2|Overall Study|Lack of Efficacy|0
372203|NCT00320255|1193303|P1|Overall Study|Lack of Efficacy|1
372204|NCT00320216|1193388|P5|Overall Study|Other|3
372205|NCT00320216|1193389|P4|Overall Study|Other|1
372206|NCT00320216|1193390|P3|Overall Study|Other|5
372207|NCT00320216|1193391|P2|Overall Study|Other|2
372208|NCT00320216|1193392|P1|Overall Study|Other|7
372209|NCT00320216|1193388|P5|Overall Study|Lost to Follow-up|0
372210|NCT00320216|1193389|P4|Overall Study|Lost to Follow-up|0
372211|NCT00320216|1193390|P3|Overall Study|Lost to Follow-up|0
372212|NCT00320216|1193391|P2|Overall Study|Lost to Follow-up|0
372213|NCT00320216|1193392|P1|Overall Study|Lost to Follow-up|3
372214|NCT00320216|1193388|P5|Overall Study|Lack of Efficacy|1
372215|NCT00320216|1193389|P4|Overall Study|Lack of Efficacy|0
372216|NCT00320216|1193390|P3|Overall Study|Lack of Efficacy|1
372217|NCT00320216|1193391|P2|Overall Study|Lack of Efficacy|2
372218|NCT00320216|1193392|P1|Overall Study|Lack of Efficacy|6
372219|NCT00320216|1193388|P5|Overall Study|Adverse Event|2
372220|NCT00320216|1193389|P4|Overall Study|Adverse Event|2
372221|NCT00320216|1193390|P3|Overall Study|Adverse Event|0
372222|NCT00320216|1193391|P2|Overall Study|Adverse Event|6
372223|NCT00320216|1193392|P1|Overall Study|Adverse Event|0
372224|NCT00320190|1193426|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
372225|NCT00320190|1193427|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
372226|NCT00320190|1193426|P2|Long-term (12-month) Extension|Lack of major molecular response|2
372227|NCT00320190|1193427|P1|Long-term (12-month) Extension|Lack of major molecular response|1
372228|NCT00320190|1193426|P2|Long-term (12-month) Extension|Sponsor terminated study|0
372229|NCT00320190|1193427|P1|Long-term (12-month) Extension|Sponsor terminated study|7
372230|NCT00320190|1193426|P2|First 12 Months|Withdrawal by Subject|1
372231|NCT00320190|1193427|P1|First 12 Months|Withdrawal by Subject|0
372232|NCT00320190|1193426|P2|First 12 Months|Study drug toxicity|1
372233|NCT00320190|1193427|P1|First 12 Months|Study drug toxicity|0
372234|NCT00320190|1193426|P2|First 12 Months|Investigator request|1
372235|NCT00320190|1193427|P1|First 12 Months|Investigator request|0
372236|NCT00320190|1193426|P2|First 12 Months|Adverse event unrelated to study drug|0
372237|NCT00320190|1193427|P1|First 12 Months|Adverse event unrelated to study drug|1
372238|NCT00320190|1193426|P2|First 12 Months|Enrollment failure|1
372239|NCT00320190|1193427|P1|First 12 Months|Enrollment failure|0
372240|NCT00320190|1193426|P2|First 12 Months|Lost to Follow-up|1
372241|NCT00320190|1193427|P1|First 12 Months|Lost to Follow-up|0
372242|NCT00320190|1193426|P2|First 12 Months|Sponsor terminated study|2
372243|NCT00320190|1193427|P1|First 12 Months|Sponsor terminated study|2
372244|NCT00320190|1193426|P2|First 12 Months|Completed but did not enter extension|3
372245|NCT00320190|1193427|P1|First 12 Months|Completed but did not enter extension|5
372246|NCT00320112|1193447|P2|Overall Study|Death|1
372247|NCT00320112|1193448|P1|Overall Study|Death|2
372248|NCT00320112|1193447|P2|Overall Study|Withdrawal by Subject|0
372249|NCT00320112|1193448|P1|Overall Study|Withdrawal by Subject|3
372250|NCT00320112|1193447|P2|Overall Study|Lost to Follow-up|4
372251|NCT00320112|1193448|P1|Overall Study|Lost to Follow-up|3
372252|NCT00319735|1193470|P1|Overall Study|Death|2
372253|NCT00319696|1193483|P1|Overall Study|Lost to Follow-up|3
372254|NCT00319696|1193483|P1|Overall Study|administrative|7
372255|NCT00319696|1193483|P1|Overall Study|withdrawal of consent|14
372256|NCT00319696|1193483|P1|Overall Study|Adverse Event|36
372257|NCT00319592|1193520|P2|Overall Study|Physician Decision|1
372258|NCT00319592|1193521|P1|Overall Study|Physician Decision|0
372259|NCT00319592|1193520|P2|Overall Study|Protocol Violation|0
372260|NCT00319592|1193521|P1|Overall Study|Protocol Violation|1
372261|NCT00319553|1193537|P2|Overall Study|Withdrawal by Subject|1
372262|NCT00319553|1193538|P1|Overall Study|Withdrawal by Subject|1
372263|NCT00319553|1193537|P2|Overall Study|Lost to Follow-up|1
372264|NCT00319553|1193538|P1|Overall Study|Lost to Follow-up|2
372265|NCT00319553|1193537|P2|Overall Study|Protocol Violation|2
372266|NCT00319553|1193538|P1|Overall Study|Protocol Violation|1
372267|NCT00319501|1193552|P2|Open-label Extension Period|Withdrawal by Subject|0
372268|NCT00319501|1193553|P1|Open-label Extension Period|Withdrawal by Subject|2
372269|NCT00319501|1193552|P2|Open-label Extension Period|Sponsor request|0
372270|NCT00319501|1193553|P1|Open-label Extension Period|Sponsor request|26
372271|NCT00319501|1193552|P2|Open-label Extension Period|Principal investigator decision|0
372272|NCT00319501|1193553|P1|Open-label Extension Period|Principal investigator decision|2
372273|NCT00319501|1193552|P2|Open-label Extension Period|Not specified|0
372274|NCT00319501|1193553|P1|Open-label Extension Period|Not specified|1
372275|NCT00319501|1193552|P2|Open-label Extension Period|Did not receive treatment|0
372276|NCT00319501|1193553|P1|Open-label Extension Period|Did not receive treatment|18
372277|NCT00319501|1193552|P2|Open-label Extension Period|Adverse Event|0
372278|NCT00319501|1193553|P1|Open-label Extension Period|Adverse Event|2
372279|NCT00319501|1193552|P2|Open-label Period|Not specified|0
372280|NCT00319501|1193553|P1|Open-label Period|Not specified|11
372281|NCT00319501|1193552|P2|Open-label Period|Did not receive treatment|0
372282|NCT00319501|1193553|P1|Open-label Period|Did not receive treatment|33
372283|NCT00319501|1193552|P2|Open-label Period|Lost to Follow-up|0
372284|NCT00319501|1193553|P1|Open-label Period|Lost to Follow-up|5
372285|NCT00319501|1193552|P2|Open-label Period|Sponsor request|0
372286|NCT00319501|1193553|P1|Open-label Period|Sponsor request|12
372287|NCT00319501|1193552|P2|Open-label Period|Principal Investigator decision|0
372288|NCT00319501|1193553|P1|Open-label Period|Principal Investigator decision|6
372289|NCT00319501|1193552|P2|Open-label Period|Withdrawal by Subject|0
372290|NCT00319501|1193553|P1|Open-label Period|Withdrawal by Subject|38
372291|NCT00319501|1193552|P2|Open-label Period|Protocol Violation|0
372292|NCT00319501|1193553|P1|Open-label Period|Protocol Violation|6
372293|NCT00319501|1193552|P2|Open-label Period|Adverse Event|0
372294|NCT00319501|1193553|P1|Open-label Period|Adverse Event|5
372295|NCT00319501|1193552|P2|Double-blind Period|Did not receive treatment|29
372296|NCT00319501|1193553|P1|Double-blind Period|Did not receive treatment|42
372297|NCT00319501|1193552|P2|Double-blind Period|Sponsor Request|0
372298|NCT00319501|1193553|P1|Double-blind Period|Sponsor Request|1
372299|NCT00319501|1193552|P2|Double-blind Period|Withdrawal by Subject|3
372300|NCT00319501|1193553|P1|Double-blind Period|Withdrawal by Subject|0
372301|NCT00319449|1193579|P2|Overall Study|Noncompliance with the protocol|0
372302|NCT00319449|1193580|P1|Overall Study|Noncompliance with the protocol|1
372303|NCT00319449|1193579|P2|Overall Study|Subject did not wish to continue|0
372304|NCT00319449|1193580|P1|Overall Study|Subject did not wish to continue|1
372305|NCT00319436|1193592|P2|Overall Study|Withdrawal by Subject|7
372306|NCT00319436|1193593|P1|Overall Study|Withdrawal by Subject|6
372307|NCT00319254|1193611|P1|Overall Study|Enrolled, Not Treated|2
372308|NCT00319254|1193611|P1|Overall Study|Lost to Follow-up|2
372309|NCT00319254|1193611|P1|Overall Study|Death|46
372310|NCT00319254|1193611|P1|Overall Study|Withdrawal by Subject|4
372311|NCT00319111|1193624|P1|Overall Study|Treatment failure|1
372312|NCT00319111|1193624|P1|Overall Study|Administrative|2
372313|NCT00319111|1193624|P1|Overall Study|Lack of clinical improvement|4
372314|NCT00319111|1193624|P1|Overall Study|Death|9
372315|NCT00319111|1193624|P1|Overall Study|Withdrawal of consent|11
372316|NCT00319111|1193624|P1|Overall Study|Adverse Event|20
372317|NCT00319046|1193634|P1|Overall Study|administrative reason|1
372318|NCT00319046|1193634|P1|Overall Study|withdrawal of subject's consent|7
372319|NCT00319020|1193643|P2|Overall Study|Adverse Event|1
372320|NCT00319020|1193644|P1|Overall Study|Adverse Event|0
372321|NCT00319020|1193643|P2|Overall Study|Treatment failure|1
372322|NCT00319020|1193644|P1|Overall Study|Treatment failure|0
372323|NCT00319020|1193643|P2|Overall Study|Transplant|1
372324|NCT00319020|1193644|P1|Overall Study|Transplant|0
372325|NCT00319020|1193643|P2|Overall Study|Disease progression|2
372326|NCT00319020|1193644|P1|Overall Study|Disease progression|0
372327|NCT00319020|1193643|P2|Overall Study|Administrative reason|5
372328|NCT00319020|1193644|P1|Overall Study|Administrative reason|0
372329|NCT00319020|1193643|P2|Overall Study|F-1 completed but not enrolled in F-2|0
372330|NCT00319020|1193644|P1|Overall Study|F-1 completed but not enrolled in F-2|1
372331|NCT00319020|1193643|P2|Overall Study|Withdrawal by Subject|1
372332|NCT00319020|1193644|P1|Overall Study|Withdrawal by Subject|4
372333|NCT00319020|1193643|P2|Overall Study|Death|2
372334|NCT00319020|1193644|P1|Overall Study|Death|2
372335|NCT00318656|1193701|P2|Overall Study|Did not receive any treatment|1
372336|NCT00318656|1193702|P1|Overall Study|Did not receive any treatment|0
372337|NCT00318656|1193701|P2|Overall Study|Took Avandamet instead of Glim/Met|1
372338|NCT00318656|1193702|P1|Overall Study|Took Avandamet instead of Glim/Met|0
372339|NCT00318565|1193759|P1|Overall Study|Excluded per protocol|24
372340|NCT00318474|1193766|P2|Overall Study|Trial terminated|7
372341|NCT00318474|1193767|P1|Overall Study|Trial terminated|10
372342|NCT00318474|1193766|P2|Overall Study|Post-therapy hyperflycemia|1
372343|NCT00318474|1193767|P1|Overall Study|Post-therapy hyperflycemia|0
372344|NCT00318474|1193766|P2|Overall Study|Fall in GFR|3
372345|NCT00318474|1193767|P1|Overall Study|Fall in GFR|3
372346|NCT00318474|1193766|P2|Overall Study|Withdrawal by Subject|2
372347|NCT00318474|1193767|P1|Overall Study|Withdrawal by Subject|3
372348|NCT00318474|1193766|P2|Overall Study|Protocol Violation|0
372349|NCT00318474|1193767|P1|Overall Study|Protocol Violation|1
372350|NCT00318474|1193766|P2|Overall Study|Pregnancy|2
372351|NCT00318474|1193767|P1|Overall Study|Pregnancy|0
372352|NCT00318474|1193766|P2|Overall Study|Lost to Follow-up|1
372353|NCT00318474|1193767|P1|Overall Study|Lost to Follow-up|0
372354|NCT00318474|1193766|P2|Overall Study|Adverse Event|1
372355|NCT00318474|1193767|P1|Overall Study|Adverse Event|1
372356|NCT00318461|1193778|P5|Open-Label Extension, 18 Months|Protocol Violation|6
372357|NCT00318461|1193779|P4|Open-Label Extension, 18 Months|Protocol Violation|4
372358|NCT00318461|1193780|P3|Open-Label Extension, 18 Months|Protocol Violation|3
372359|NCT00318461|1193781|P2|Open-Label Extension, 18 Months|Protocol Violation|5
372360|NCT00318461|1193782|P1|Open-Label Extension, 18 Months|Protocol Violation|7
372361|NCT00318461|1193778|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
372362|NCT00318461|1193779|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
372363|NCT00318461|1193780|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
372364|NCT00318461|1193781|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
372365|NCT00318461|1193782|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
372366|NCT00318461|1193778|P5|Open-Label Extension, 18 Months|Adverse Event|6
372367|NCT00318461|1193779|P4|Open-Label Extension, 18 Months|Adverse Event|1
372368|NCT00318461|1193780|P3|Open-Label Extension, 18 Months|Adverse Event|6
372369|NCT00318461|1193781|P2|Open-Label Extension, 18 Months|Adverse Event|8
372370|NCT00318461|1193782|P1|Open-Label Extension, 18 Months|Adverse Event|11
372371|NCT00318461|1193778|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
372372|NCT00318461|1193779|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
372373|NCT00318461|1193780|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
372374|NCT00318461|1193781|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
372375|NCT00318461|1193782|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
372376|NCT00318461|1193778|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
372377|NCT00318461|1193779|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
372378|NCT00318461|1193780|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
372379|NCT00318461|1193781|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
372380|NCT00318461|1193782|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
372381|NCT00318461|1193778|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
372382|NCT00318461|1193779|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
372383|NCT00318461|1193780|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
372384|NCT00318461|1193781|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
372385|NCT00318461|1193782|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
372386|NCT00318461|1193778|P5|Double-Blind, 6 Months|Hyperglicaemia|0
372387|NCT00318461|1193779|P4|Double-Blind, 6 Months|Hyperglicaemia|1
372388|NCT00318461|1193780|P3|Double-Blind, 6 Months|Hyperglicaemia|0
372389|NCT00318461|1193781|P2|Double-Blind, 6 Months|Hyperglicaemia|0
372390|NCT00318461|1193782|P1|Double-Blind, 6 Months|Hyperglicaemia|0
372391|NCT00318461|1193778|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
372392|NCT00318461|1193779|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
372393|NCT00318461|1193780|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
372394|NCT00318461|1193781|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
372395|NCT00318461|1193782|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
372396|NCT00318461|1193778|P5|Double-Blind, 6 Months|Lack of time|0
372397|NCT00318461|1193779|P4|Double-Blind, 6 Months|Lack of time|0
372398|NCT00318461|1193780|P3|Double-Blind, 6 Months|Lack of time|0
372399|NCT00318461|1193781|P2|Double-Blind, 6 Months|Lack of time|0
372400|NCT00318461|1193782|P1|Double-Blind, 6 Months|Lack of time|1
372401|NCT00318461|1193778|P5|Double-Blind, 6 Months|Investigator decision|1
372402|NCT00318461|1193779|P4|Double-Blind, 6 Months|Investigator decision|0
372403|NCT00318461|1193780|P3|Double-Blind, 6 Months|Investigator decision|0
372404|NCT00318461|1193781|P2|Double-Blind, 6 Months|Investigator decision|0
372405|NCT00318461|1193782|P1|Double-Blind, 6 Months|Investigator decision|0
372406|NCT00318461|1193778|P5|Double-Blind, 6 Months|Work commitment|1
372407|NCT00318461|1193779|P4|Double-Blind, 6 Months|Work commitment|0
372408|NCT00318461|1193780|P3|Double-Blind, 6 Months|Work commitment|0
372409|NCT00318461|1193781|P2|Double-Blind, 6 Months|Work commitment|0
372410|NCT00318461|1193782|P1|Double-Blind, 6 Months|Work commitment|0
372411|NCT00318461|1193778|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
372412|NCT00318461|1193779|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
372413|NCT00318461|1193780|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
372414|NCT00318461|1193781|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
372415|NCT00318461|1193782|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
372416|NCT00318461|1193778|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
372417|NCT00318461|1193779|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
372418|NCT00318461|1193780|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
372419|NCT00318461|1193781|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
372420|NCT00318461|1193782|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
372421|NCT00318461|1193778|P5|Double-Blind, 6 Months|Move|0
372422|NCT00318461|1193779|P4|Double-Blind, 6 Months|Move|0
372423|NCT00318461|1193780|P3|Double-Blind, 6 Months|Move|0
372424|NCT00318461|1193781|P2|Double-Blind, 6 Months|Move|1
372425|NCT00318461|1193782|P1|Double-Blind, 6 Months|Move|0
372426|NCT00318461|1193778|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
372427|NCT00318461|1193779|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
372428|NCT00318461|1193780|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
372429|NCT00318461|1193781|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
372430|NCT00318461|1193782|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
372431|NCT00318461|1193778|P5|Double-Blind, 6 Months|Consent withdrawn|4
372432|NCT00318461|1193779|P4|Double-Blind, 6 Months|Consent withdrawn|10
372433|NCT00318461|1193780|P3|Double-Blind, 6 Months|Consent withdrawn|4
372434|NCT00318461|1193781|P2|Double-Blind, 6 Months|Consent withdrawn|3
372435|NCT00318461|1193782|P1|Double-Blind, 6 Months|Consent withdrawn|0
372436|NCT00318461|1193778|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
372437|NCT00318461|1193779|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
372438|NCT00318461|1193780|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
372439|NCT00318461|1193781|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
372440|NCT00318461|1193782|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
372441|NCT00318461|1193778|P5|Double-Blind, 6 Months|Lost to follow up|0
372442|NCT00318461|1193779|P4|Double-Blind, 6 Months|Lost to follow up|0
372443|NCT00318461|1193780|P3|Double-Blind, 6 Months|Lost to follow up|0
372444|NCT00318461|1193781|P2|Double-Blind, 6 Months|Lost to follow up|1
372445|NCT00318461|1193782|P1|Double-Blind, 6 Months|Lost to follow up|0
372446|NCT00318461|1193778|P5|Double-Blind, 6 Months|Protocol Violation|5
372447|NCT00318461|1193779|P4|Double-Blind, 6 Months|Protocol Violation|4
372448|NCT00318461|1193780|P3|Double-Blind, 6 Months|Protocol Violation|4
372449|NCT00318461|1193781|P2|Double-Blind, 6 Months|Protocol Violation|4
372450|NCT00318461|1193782|P1|Double-Blind, 6 Months|Protocol Violation|2
372451|NCT00318461|1193778|P5|Double-Blind, 6 Months|Lack of Efficacy|9
372452|NCT00318461|1193779|P4|Double-Blind, 6 Months|Lack of Efficacy|29
372453|NCT00318461|1193780|P3|Double-Blind, 6 Months|Lack of Efficacy|13
372454|NCT00318461|1193781|P2|Double-Blind, 6 Months|Lack of Efficacy|8
372455|NCT00318461|1193782|P1|Double-Blind, 6 Months|Lack of Efficacy|19
372456|NCT00318461|1193778|P5|Double-Blind, 6 Months|Adverse Event|8
372457|NCT00318461|1193779|P4|Double-Blind, 6 Months|Adverse Event|2
372458|NCT00318461|1193780|P3|Double-Blind, 6 Months|Adverse Event|29
372459|NCT00318461|1193781|P2|Double-Blind, 6 Months|Adverse Event|23
372460|NCT00318461|1193782|P1|Double-Blind, 6 Months|Adverse Event|11
372461|NCT00318370|1193881|P3|Period 3|Other|3
372462|NCT00318370|1193882|P2|Period 3|Other|0
372463|NCT00318370|1193883|P1|Period 3|Other|0
372464|NCT00318370|1193881|P3|Period 3|Withdrawal by Subject|3
372465|NCT00318370|1193882|P2|Period 3|Withdrawal by Subject|0
372466|NCT00318370|1193883|P1|Period 3|Withdrawal by Subject|0
372467|NCT00318370|1193881|P3|Period 3|Physician Decision|1
372468|NCT00318370|1193882|P2|Period 3|Physician Decision|0
372469|NCT00318370|1193883|P1|Period 3|Physician Decision|0
372470|NCT00318370|1193881|P3|Period 3|Death|1
372471|NCT00318370|1193882|P2|Period 3|Death|0
372472|NCT00318370|1193883|P1|Period 3|Death|0
372473|NCT00318370|1193881|P3|Period 3|Lack of Efficacy|24
372474|NCT00318370|1193882|P2|Period 3|Lack of Efficacy|0
372475|NCT00318370|1193883|P1|Period 3|Lack of Efficacy|0
372476|NCT00318370|1193881|P3|Period 3|Adverse Event|1
372477|NCT00318370|1193882|P2|Period 3|Adverse Event|0
372478|NCT00318370|1193883|P1|Period 3|Adverse Event|0
372479|NCT00318370|1193881|P3|Period 2|Other|0
372480|NCT00318370|1193882|P2|Period 2|Other|1
372481|NCT00318370|1193883|P1|Period 2|Other|0
372482|NCT00318370|1193881|P3|Period 2|Withdrawal by Subject|0
372483|NCT00318370|1193882|P2|Period 2|Withdrawal by Subject|1
372484|NCT00318370|1193883|P1|Period 2|Withdrawal by Subject|0
372485|NCT00318370|1193881|P3|Period 2|Physician Decision|0
372486|NCT00318370|1193882|P2|Period 2|Physician Decision|1
372487|NCT00318370|1193883|P1|Period 2|Physician Decision|0
372488|NCT00318370|1193881|P3|Period 2|Lack of Efficacy|0
372489|NCT00318370|1193882|P2|Period 2|Lack of Efficacy|5
372490|NCT00318370|1193883|P1|Period 2|Lack of Efficacy|0
372491|NCT00318370|1193881|P3|Period 2|Adverse Event|0
372492|NCT00318370|1193882|P2|Period 2|Adverse Event|3
372493|NCT00318370|1193883|P1|Period 2|Adverse Event|0
372494|NCT00318370|1193881|P3|Period 1|Withdrawal by Subject|0
372495|NCT00318370|1193882|P2|Period 1|Withdrawal by Subject|0
372496|NCT00318370|1193883|P1|Period 1|Withdrawal by Subject|1
372497|NCT00318370|1193881|P3|Period 1|Physician Decision|0
372498|NCT00318370|1193882|P2|Period 1|Physician Decision|0
372499|NCT00318370|1193883|P1|Period 1|Physician Decision|1
372500|NCT00318370|1193881|P3|Period 1|Lack of Efficacy|0
372501|NCT00318370|1193882|P2|Period 1|Lack of Efficacy|0
372502|NCT00318370|1193883|P1|Period 1|Lack of Efficacy|5
372503|NCT00317642|1193975|P2|Overall Study|AML Not Centrally Confirmed|5
372504|NCT00317642|1193976|P1|Overall Study|AML Not Centrally Confirmed|1
372505|NCT00317642|1193975|P2|Overall Study|Referred For Transplantation|0
372506|NCT00317642|1193976|P1|Overall Study|Referred For Transplantation|1
372507|NCT00317642|1193975|P2|Overall Study|Withdrawal by Subject|1
372508|NCT00317642|1193976|P1|Overall Study|Withdrawal by Subject|0
372509|NCT00317642|1193975|P2|Overall Study|Not Continue to Consolidation|0
372510|NCT00317642|1193976|P1|Overall Study|Not Continue to Consolidation|2
372511|NCT00317642|1193975|P2|Overall Study|Death|7
372512|NCT00317642|1193976|P1|Overall Study|Death|14
372513|NCT00317642|1193975|P2|Overall Study|Disease Recurrence|2
372514|NCT00317642|1193976|P1|Overall Study|Disease Recurrence|1
372515|NCT00317642|1193975|P2|Overall Study|Treatment Failure|102
372516|NCT00317642|1193976|P1|Overall Study|Treatment Failure|56
372517|NCT00317642|1193975|P2|Overall Study|Adverse Event|5
372518|NCT00317642|1193976|P1|Overall Study|Adverse Event|17
372519|NCT00317642|1193975|P2|Overall Study|Participant declined treatment|3
372520|NCT00317642|1193976|P1|Overall Study|Participant declined treatment|14
372521|NCT00317642|1193975|P2|Overall Study|Physician Decision|7
372522|NCT00317642|1193976|P1|Overall Study|Physician Decision|15
372523|NCT00317642|1193975|P2|Overall Study|Not Received Either Study Drug|3
372524|NCT00317642|1193976|P1|Overall Study|Not Received Either Study Drug|1
372525|NCT00317109|1194051|P2|Overall Study|Migated/moved from study area|0
372526|NCT00317109|1194052|P1|Overall Study|Migated/moved from study area|1
372527|NCT00317109|1194051|P2|Overall Study|Withdrawal by Subject|0
372528|NCT00317109|1194052|P1|Overall Study|Withdrawal by Subject|2
372529|NCT00317044|1194089|P3|Overall Study|Multiple Reasons|6
372530|NCT00317044|1194090|P2|Overall Study|Multiple Reasons|2
372531|NCT00317044|1194091|P1|Overall Study|Multiple Reasons|6
372532|NCT00317044|1194089|P3|Overall Study|Lost to Follow-up|3
372533|NCT00317044|1194090|P2|Overall Study|Lost to Follow-up|2
372534|NCT00317044|1194091|P1|Overall Study|Lost to Follow-up|0
372535|NCT00317044|1194089|P3|Overall Study|Withdrawal by Subject|12
372536|NCT00317044|1194090|P2|Overall Study|Withdrawal by Subject|7
372537|NCT00317044|1194091|P1|Overall Study|Withdrawal by Subject|10
372538|NCT00317044|1194089|P3|Overall Study|Adverse Event|4
372539|NCT00317044|1194090|P2|Overall Study|Adverse Event|7
372540|NCT00317044|1194091|P1|Overall Study|Adverse Event|4
372541|NCT00317044|1194089|P3|Overall Study|Protocol Violation|20
372542|NCT00317044|1194090|P2|Overall Study|Protocol Violation|22
372543|NCT00317044|1194091|P1|Overall Study|Protocol Violation|28
372544|NCT00316914|1194137|P2|Overall Study|Missing end of treatment documentation|15
372545|NCT00316914|1194138|P1|Overall Study|Missing end of treatment documentation|14
372546|NCT00316914|1194137|P2|Overall Study|Other Problems|11
372547|NCT00316914|1194138|P1|Overall Study|Other Problems|6
372548|NCT00316914|1194137|P2|Overall Study|Adverse Event|7
372549|NCT00316914|1194138|P1|Overall Study|Adverse Event|8
372550|NCT00316914|1194137|P2|Overall Study|Withdrawal by Subject|3
372551|NCT00316914|1194138|P1|Overall Study|Withdrawal by Subject|5
372552|NCT00316888|1194168|P2|Overall Study|Not start protocol therapy|1
372553|NCT00316888|1194169|P1|Overall Study|Not start protocol therapy|0
372554|NCT00316888|1194168|P2|Overall Study|Withdrawal by Subject|2
372555|NCT00316888|1194169|P1|Overall Study|Withdrawal by Subject|2
372556|NCT00316888|1194168|P2|Overall Study|Adverse Event|5
372557|NCT00316888|1194169|P1|Overall Study|Adverse Event|4
372558|NCT00316719|1194191|P2|Overall Study|Consent withdrawn|0
372559|NCT00316719|1194192|P1|Overall Study|Consent withdrawn|2
372560|NCT00316719|1194191|P2|Overall Study|Adverse Event|6
372561|NCT00316719|1194192|P1|Overall Study|Adverse Event|0
372562|NCT00316706|1194218|P2|Overall Study|Lost to Follow-up|48
372563|NCT00316706|1194219|P1|Overall Study|Lost to Follow-up|38
372564|NCT00316693|1194235|P2|Overall Study|Other|44
372565|NCT00316693|1194236|P1|Overall Study|Other|38
372566|NCT00316693|1194235|P2|Overall Study|Lost to Follow-up|34
372567|NCT00316693|1194236|P1|Overall Study|Lost to Follow-up|26
372568|NCT00316693|1194235|P2|Overall Study|Withdrawal by Subject|6
372569|NCT00316693|1194236|P1|Overall Study|Withdrawal by Subject|6
372570|NCT00316693|1194235|P2|Overall Study|Protocol Violation|0
372571|NCT00316693|1194236|P1|Overall Study|Protocol Violation|1
372572|NCT00316693|1194235|P2|Overall Study|Adverse Event|1
372573|NCT00316693|1194236|P1|Overall Study|Adverse Event|6
372574|NCT00316303|1194289|P2|Overall Study|Lost to Follow-up|16
372575|NCT00316303|1194290|P1|Overall Study|Lost to Follow-up|11
372576|NCT00316277|1194306|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
372577|NCT00316277|1194307|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
372578|NCT00316277|1194306|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
372579|NCT00316277|1194307|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
372580|NCT00316277|1194306|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
372581|NCT00316277|1194307|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
372582|NCT00316277|1194306|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
372583|NCT00316277|1194307|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
372584|NCT00316277|1194306|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
372585|NCT00316277|1194307|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
372586|NCT00316264|1194328|P3|Overall Study|not specified|0
372587|NCT00316264|1194329|P2|Overall Study|not specified|1
372588|NCT00316264|1194330|P1|Overall Study|not specified|1
372589|NCT00316264|1194328|P3|Overall Study|Death|0
372590|NCT00316264|1194329|P2|Overall Study|Death|0
372591|NCT00316264|1194330|P1|Overall Study|Death|2
372592|NCT00316264|1194328|P3|Overall Study|Withdrawal of Consent|6
372593|NCT00316264|1194329|P2|Overall Study|Withdrawal of Consent|5
372594|NCT00316264|1194330|P1|Overall Study|Withdrawal of Consent|3
372595|NCT00316264|1194328|P3|Overall Study|Lost to Follow-up|0
372596|NCT00316264|1194329|P2|Overall Study|Lost to Follow-up|1
372597|NCT00316264|1194330|P1|Overall Study|Lost to Follow-up|0
372598|NCT00316225|1194398|P1|Overall Study|Death|2
372599|NCT00316225|1194398|P1|Overall Study|Withdrawal by Subject|3
372600|NCT00316225|1194398|P1|Overall Study|Progressive Disease|15
372601|NCT00316225|1194398|P1|Overall Study|Physician Decision|3
372602|NCT00316225|1194398|P1|Overall Study|Adverse Event|2
372603|NCT00316199|1194407|P1|Overall Study|Lost to Follow-up|2
372604|NCT00316199|1194407|P1|Overall Study|Death|8
372605|NCT00316199|1194407|P1|Overall Study|Adverse Event|2
372606|NCT00316186|1194415|P1|Overall Study|Other|1
372607|NCT00316186|1194415|P1|Overall Study|Lost to Follow-up|1
372608|NCT00316186|1194415|P1|Overall Study|Disease Progression|4
372609|NCT00316186|1194415|P1|Overall Study|Adverse Event|6
372610|NCT00316173|1194429|P2|Treatment Phase|Study Follow-up Stopped|34
372611|NCT00316173|1194430|P1|Treatment Phase|Study Follow-up Stopped|0
372612|NCT00316173|1194429|P2|Treatment Phase|Withdrawal by Subject|1
372613|NCT00316173|1194430|P1|Treatment Phase|Withdrawal by Subject|0
372614|NCT00316173|1194429|P2|Treatment Phase|Lost to Follow-up|3
372615|NCT00316173|1194430|P1|Treatment Phase|Lost to Follow-up|0
372616|NCT00316173|1194429|P2|Treatment Phase|Lack of Efficacy|3
372617|NCT00316173|1194430|P1|Treatment Phase|Lack of Efficacy|0
372618|NCT00316173|1194429|P2|Treatment Phase|Adverse Event|1
372619|NCT00316173|1194430|P1|Treatment Phase|Adverse Event|0
372620|NCT00316173|1194429|P2|Run-in Phase|Study Follow-up Stopped|0
372621|NCT00316173|1194430|P1|Run-in Phase|Study Follow-up Stopped|5
372622|NCT00316173|1194429|P2|Run-in Phase|Protocol Violation|0
372623|NCT00316173|1194430|P1|Run-in Phase|Protocol Violation|1
372624|NCT00316173|1194429|P2|Run-in Phase|Adverse Event|0
372625|NCT00316173|1194430|P1|Run-in Phase|Adverse Event|1
372626|NCT00316121|1194443|P2|Overall Study|Subject did not have 24 month visit|0
372627|NCT00316121|1194444|P1|Overall Study|Subject did not have 24 month visit|1
372628|NCT00316121|1194443|P2|Overall Study|Subject no show for visit x 3|0
372629|NCT00316121|1194444|P1|Overall Study|Subject no show for visit x 3|1
372630|NCT00316121|1194443|P2|Overall Study|Subject refused to return|0
372631|NCT00316121|1194444|P1|Overall Study|Subject refused to return|1
372632|NCT00316121|1194443|P2|Overall Study|Subject relocated|1
372633|NCT00316121|1194444|P1|Overall Study|Subject relocated|1
372634|NCT00316121|1194443|P2|Overall Study|Reason is missing|0
372635|NCT00316121|1194444|P1|Overall Study|Reason is missing|1
372636|NCT00316121|1194443|P2|Overall Study|Withdrawal by Subject|0
372637|NCT00316121|1194444|P1|Overall Study|Withdrawal by Subject|2
372638|NCT00316121|1194443|P2|Overall Study|Lost to Follow-up|8
372639|NCT00316121|1194444|P1|Overall Study|Lost to Follow-up|14
372640|NCT00316121|1194443|P2|Overall Study|Death|0
372641|NCT00316121|1194444|P1|Overall Study|Death|1
372642|NCT00316082|1194455|P5|Overall Study|Administrative reason by sponsor|0
372643|NCT00316082|1194456|P4|Overall Study|Administrative reason by sponsor|0
372644|NCT00316082|1194457|P3|Overall Study|Administrative reason by sponsor|1
372645|NCT00316082|1194458|P2|Overall Study|Administrative reason by sponsor|0
372646|NCT00316082|1194459|P1|Overall Study|Administrative reason by sponsor|0
372647|NCT00316082|1194455|P5|Overall Study|Death|0
372648|NCT00316082|1194456|P4|Overall Study|Death|0
372649|NCT00316082|1194457|P3|Overall Study|Death|1
372650|NCT00316082|1194458|P2|Overall Study|Death|0
372651|NCT00316082|1194459|P1|Overall Study|Death|0
372652|NCT00316082|1194455|P5|Overall Study|Physician Decision|1
372653|NCT00316082|1194456|P4|Overall Study|Physician Decision|1
372654|NCT00316082|1194457|P3|Overall Study|Physician Decision|2
372655|NCT00316082|1194458|P2|Overall Study|Physician Decision|1
372656|NCT00316082|1194459|P1|Overall Study|Physician Decision|1
372657|NCT00316082|1194455|P5|Overall Study|Subject no longer meets study criteria|1
372658|NCT00316082|1194456|P4|Overall Study|Subject no longer meets study criteria|2
372659|NCT00316082|1194457|P3|Overall Study|Subject no longer meets study criteria|2
372660|NCT00316082|1194458|P2|Overall Study|Subject no longer meets study criteria|1
372661|NCT00316082|1194459|P1|Overall Study|Subject no longer meets study criteria|3
372662|NCT00316082|1194455|P5|Overall Study|Adverse Event|3
372663|NCT00316082|1194456|P4|Overall Study|Adverse Event|1
372664|NCT00316082|1194457|P3|Overall Study|Adverse Event|5
372665|NCT00316082|1194458|P2|Overall Study|Adverse Event|2
372666|NCT00316082|1194459|P1|Overall Study|Adverse Event|4
372667|NCT00316082|1194455|P5|Overall Study|Poor/noncompliance|4
372668|NCT00316082|1194456|P4|Overall Study|Poor/noncompliance|1
372669|NCT00316082|1194457|P3|Overall Study|Poor/noncompliance|4
372670|NCT00316082|1194458|P2|Overall Study|Poor/noncompliance|1
372671|NCT00316082|1194459|P1|Overall Study|Poor/noncompliance|6
372672|NCT00316082|1194455|P5|Overall Study|Lost to Follow-up|6
372673|NCT00316082|1194456|P4|Overall Study|Lost to Follow-up|8
372674|NCT00316082|1194457|P3|Overall Study|Lost to Follow-up|7
372675|NCT00316082|1194458|P2|Overall Study|Lost to Follow-up|6
372676|NCT00316082|1194459|P1|Overall Study|Lost to Follow-up|7
372677|NCT00316082|1194455|P5|Overall Study|Withdrawal of Consent by Subject|5
372678|NCT00316082|1194456|P4|Overall Study|Withdrawal of Consent by Subject|9
372679|NCT00316082|1194457|P3|Overall Study|Withdrawal of Consent by Subject|2
372680|NCT00316082|1194458|P2|Overall Study|Withdrawal of Consent by Subject|8
372681|NCT00316082|1194459|P1|Overall Study|Withdrawal of Consent by Subject|10
372682|NCT00316082|1194455|P5|Overall Study|Lack of Efficacy|6
372683|NCT00316082|1194456|P4|Overall Study|Lack of Efficacy|4
372684|NCT00316082|1194457|P3|Overall Study|Lack of Efficacy|3
372685|NCT00316082|1194458|P2|Overall Study|Lack of Efficacy|3
372686|NCT00316082|1194459|P1|Overall Study|Lack of Efficacy|2
372687|NCT00316017|1194490|P3|Overall Study|Protocol Violation|19
372688|NCT00316017|1194491|P2|Overall Study|Protocol Violation|13
372689|NCT00316017|1194492|P1|Overall Study|Protocol Violation|11
372690|NCT00316004|1194566|P3|Overall Study|Subject was not given study fluid.|21
372691|NCT00316004|1194567|P2|Overall Study|Subject was not given study fluid.|14
372692|NCT00316004|1194568|P1|Overall Study|Subject was not given study fluid.|14
372693|NCT00315731|1194639|P1|Overall Study|Death|5
372694|NCT00315731|1194639|P1|Overall Study|Lost to Follow-up|1
372695|NCT00315705|1194667|P1|Phase 2|Death|7
372696|NCT00315705|1194667|P1|Phase 2|Unspecified|1
372697|NCT00315705|1194667|P1|Phase 2|Scheduled for transplant|8
372698|NCT00315705|1194667|P1|Phase 2|Disease relapse|1
372699|NCT00315705|1194667|P1|Phase 2|Failure to achieve response|3
372700|NCT00315705|1194667|P1|Phase 2|Adverse Event|1
372701|NCT00315705|1194667|P1|Phase 2|Physician Decision|4
372702|NCT00315705|1194667|P1|Phase 1|Death|3
372703|NCT00315705|1194667|P1|Phase 1|Scheduled for transplant|9
372704|NCT00315705|1194667|P1|Phase 1|Disease relapse|4
372705|NCT00315705|1194667|P1|Phase 1|Failure to achieve response|8
372706|NCT00315705|1194667|P1|Phase 1|Refused further treatment|1
372707|NCT00315458|1194728|P4|Overall Study|Did not qualify|0
372708|NCT00315458|1194729|P3|Overall Study|Did not qualify|1
372709|NCT00315458|1194730|P2|Overall Study|Did not qualify|0
372710|NCT00315458|1194731|P1|Overall Study|Did not qualify|0
372711|NCT00315458|1194728|P4|Overall Study|Lack of Efficacy|1
372712|NCT00315458|1194729|P3|Overall Study|Lack of Efficacy|20
372713|NCT00315458|1194730|P2|Overall Study|Lack of Efficacy|0
372714|NCT00315458|1194731|P1|Overall Study|Lack of Efficacy|0
372715|NCT00315458|1194728|P4|Overall Study|Withdrawal by Subject|2
372716|NCT00315458|1194729|P3|Overall Study|Withdrawal by Subject|0
372717|NCT00315458|1194730|P2|Overall Study|Withdrawal by Subject|3
372718|NCT00315458|1194731|P1|Overall Study|Withdrawal by Subject|0
372719|NCT00315458|1194728|P4|Overall Study|Lost to Follow-up|2
372720|NCT00315458|1194729|P3|Overall Study|Lost to Follow-up|0
372721|NCT00315458|1194730|P2|Overall Study|Lost to Follow-up|2
372722|NCT00315458|1194731|P1|Overall Study|Lost to Follow-up|1
372723|NCT00315458|1194728|P4|Overall Study|Adverse Event|3
372724|NCT00315458|1194729|P3|Overall Study|Adverse Event|23
372725|NCT00315458|1194730|P2|Overall Study|Adverse Event|4
372726|NCT00315458|1194731|P1|Overall Study|Adverse Event|2
372727|NCT00315458|1194728|P4|Overall Study|Administrative|21
372728|NCT00315458|1194729|P3|Overall Study|Administrative|8
372729|NCT00315458|1194730|P2|Overall Study|Administrative|3
372730|NCT00315458|1194731|P1|Overall Study|Administrative|0
372731|NCT00315445|1194744|P3|Overall Study|Other|0
372732|NCT00315445|1194745|P2|Overall Study|Other|3
372733|NCT00315445|1194746|P1|Overall Study|Other|1
372734|NCT00315445|1194744|P3|Overall Study|Protocol Violation|1
372735|NCT00315445|1194745|P2|Overall Study|Protocol Violation|0
372736|NCT00315445|1194746|P1|Overall Study|Protocol Violation|2
372737|NCT00315445|1194744|P3|Overall Study|Lost to Follow-up|1
372738|NCT00315445|1194745|P2|Overall Study|Lost to Follow-up|0
372739|NCT00315445|1194746|P1|Overall Study|Lost to Follow-up|1
372740|NCT00315445|1194744|P3|Overall Study|Lack of Efficacy|7
372741|NCT00315445|1194745|P2|Overall Study|Lack of Efficacy|1
372742|NCT00315445|1194746|P1|Overall Study|Lack of Efficacy|16
372743|NCT00315445|1194744|P3|Overall Study|Adverse Event|15
372744|NCT00315445|1194745|P2|Overall Study|Adverse Event|12
372745|NCT00315445|1194746|P1|Overall Study|Adverse Event|7
372746|NCT00315055|1195036|P2|Overall Study|Lost to Follow-up|1
372747|NCT00315055|1195037|P1|Overall Study|Lost to Follow-up|1
372748|NCT00315055|1195036|P2|Overall Study|Protocol Violation|4
372749|NCT00315055|1195037|P1|Overall Study|Protocol Violation|2
372750|NCT00314951|1195055|P2|Follow-up|mITT failure|34
372751|NCT00314951|1195056|P1|Follow-up|mITT failure|44
372752|NCT00314951|1195055|P2|Treatment|Didn't meet criteria for mITT population|11
372753|NCT00314951|1195056|P1|Treatment|Didn't meet criteria for mITT population|16
372754|NCT00314808|1195066|P1|Overall Study|Withdrawal by Subject/PI without AE|4
372755|NCT00314808|1195066|P1|Overall Study|Disease Progression without AE|4
372756|NCT00314574|1195076|P2|Overall Study|Data unknown at database lock|1
372757|NCT00314574|1195077|P1|Overall Study|Data unknown at database lock|0
372758|NCT00314574|1195076|P2|Overall Study|Pregnancy|4
372759|NCT00314574|1195077|P1|Overall Study|Pregnancy|6
372760|NCT00314574|1195076|P2|Overall Study|Physician Decision|15
372761|NCT00314574|1195077|P1|Overall Study|Physician Decision|22
372762|NCT00314574|1195076|P2|Overall Study|Withdrawal by Subject|22
372763|NCT00314574|1195077|P1|Overall Study|Withdrawal by Subject|33
372764|NCT00314574|1195076|P2|Overall Study|Lost to Follow-up|25
372765|NCT00314574|1195077|P1|Overall Study|Lost to Follow-up|19
372766|NCT00314574|1195076|P2|Overall Study|Adverse Event|16
372767|NCT00314574|1195077|P1|Overall Study|Adverse Event|11
372768|NCT00314574|1195076|P2|Overall Study|Death|0
372769|NCT00314574|1195077|P1|Overall Study|Death|3
372770|NCT00314366|1195093|P2|Overall Study|not treated due to patient medical condi|0
372771|NCT00314366|1195094|P1|Overall Study|not treated due to patient medical condi|1
372772|NCT00314340|1195131|P1|Overall Study|lost interest|1
372773|NCT00314327|1195137|P1|Overall Study|Withdrawal by Subject|1
372774|NCT00314262|1195141|P1|Overall Study|Physician Decision|1
372775|NCT00314262|1195141|P1|Overall Study|Withdrawal by Subject|2
372776|NCT00314262|1195141|P1|Overall Study|Adverse Event|2
372777|NCT00314249|1195149|P2|Overall Study|Non-Compliant|6
372778|NCT00314249|1195150|P1|Overall Study|Non-Compliant|5
372779|NCT00314249|1195149|P2|Overall Study|Withdrawn for other reasons|1
372780|NCT00314249|1195150|P1|Overall Study|Withdrawn for other reasons|4
372781|NCT00314249|1195149|P2|Overall Study|Physician Decision|1
372782|NCT00314249|1195150|P1|Overall Study|Physician Decision|1
372783|NCT00314249|1195149|P2|Overall Study|Lost to Follow-up|9
372784|NCT00314249|1195150|P1|Overall Study|Lost to Follow-up|15
372785|NCT00314249|1195149|P2|Overall Study|Withdrawal by Subject|28
372786|NCT00314249|1195150|P1|Overall Study|Withdrawal by Subject|21
372787|NCT00314249|1195149|P2|Overall Study|Lack of Efficacy|24
372788|NCT00314249|1195150|P1|Overall Study|Lack of Efficacy|33
372789|NCT00314249|1195149|P2|Overall Study|Adverse Event|94
372790|NCT00314249|1195150|P1|Overall Study|Adverse Event|73
372791|NCT00314145|1195183|P2|Overall Study|Sponsor Decision|0
372792|NCT00314145|1195184|P1|Overall Study|Sponsor Decision|2
372793|NCT00314145|1195183|P2|Overall Study|Protocol Violation|0
372794|NCT00314145|1195184|P1|Overall Study|Protocol Violation|3
372795|NCT00314145|1195183|P2|Overall Study|Adverse Event|3
372796|NCT00314145|1195184|P1|Overall Study|Adverse Event|0
372797|NCT00314145|1195183|P2|Overall Study|Physician Decision|4
372798|NCT00314145|1195184|P1|Overall Study|Physician Decision|3
372799|NCT00314145|1195183|P2|Overall Study|Lost to Follow-up|12
372800|NCT00314145|1195184|P1|Overall Study|Lost to Follow-up|5
372801|NCT00314145|1195183|P2|Overall Study|Withdrawal by Subject|10
372802|NCT00314145|1195184|P1|Overall Study|Withdrawal by Subject|8
372803|NCT00314132|1195198|P2|Overall Study|Physician Decision|0
372804|NCT00314132|1195199|P1|Overall Study|Physician Decision|1
372805|NCT00314132|1195198|P2|Overall Study|Adverse Event|0
372806|NCT00314132|1195199|P1|Overall Study|Adverse Event|1
372807|NCT00314132|1195198|P2|Overall Study|Withdrawal by Subject|5
372808|NCT00314132|1195199|P1|Overall Study|Withdrawal by Subject|3
372809|NCT00314132|1195198|P2|Overall Study|Lost to Follow-up|13
372810|NCT00314132|1195199|P1|Overall Study|Lost to Follow-up|3
372811|NCT00313911|1195220|P2|Overall Study|Did not meet age criteria|1
372812|NCT00313911|1195221|P1|Overall Study|Did not meet age criteria|1
372813|NCT00313911|1195220|P2|Overall Study|Withdrawal by Subject|12
372814|NCT00313911|1195221|P1|Overall Study|Withdrawal by Subject|39
372815|NCT00313911|1195220|P2|Overall Study|Lost to Follow-up|14
372816|NCT00313911|1195221|P1|Overall Study|Lost to Follow-up|27
372817|NCT00313911|1195220|P2|Overall Study|Protocol Violation|10
372818|NCT00313911|1195221|P1|Overall Study|Protocol Violation|19
372819|NCT00313911|1195220|P2|Overall Study|Adverse Event|3
372820|NCT00313911|1195221|P1|Overall Study|Adverse Event|2
372821|NCT00313911|1195220|P2|Overall Study|Serious adverse event|1
372822|NCT00313911|1195221|P1|Overall Study|Serious adverse event|6
372823|NCT00313846|1195235|P2|Overall Study|Administrative|3
372824|NCT00313846|1195236|P1|Overall Study|Administrative|2
372825|NCT00313846|1195235|P2|Overall Study|Adverse Event|8
372826|NCT00313846|1195236|P1|Overall Study|Adverse Event|1
372827|NCT00313846|1195235|P2|Overall Study|Withdrawal by Subject|0
372828|NCT00313846|1195236|P1|Overall Study|Withdrawal by Subject|2
372829|NCT00313820|1195247|P2|Pregabalin or Placebo Treatment Period|Other|3
372830|NCT00313820|1195248|P1|Pregabalin or Placebo Treatment Period|Other|2
372831|NCT00313820|1195247|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
372832|NCT00313820|1195248|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
372833|NCT00313820|1195247|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
372834|NCT00313820|1195248|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
372835|NCT00313820|1195247|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
372836|NCT00313820|1195248|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
372837|NCT00313820|1195247|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
372838|NCT00313820|1195248|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
372839|NCT00313820|1195247|P2|Assigned to Treatment|Other|0
372840|NCT00313820|1195248|P1|Assigned to Treatment|Other|1
372841|NCT00313781|1195286|P3|After Crossover|Unspecified|18
372842|NCT00313781|1195287|P2|After Crossover|Unspecified|0
372843|NCT00313781|1195288|P1|After Crossover|Unspecified|0
372844|NCT00313781|1195286|P3|After Crossover|Withdrawal by Subject|3
372845|NCT00313781|1195287|P2|After Crossover|Withdrawal by Subject|0
372846|NCT00313781|1195288|P1|After Crossover|Withdrawal by Subject|0
372847|NCT00313781|1195286|P3|After Crossover|Death|6
372848|NCT00313781|1195287|P2|After Crossover|Death|0
372849|NCT00313781|1195288|P1|After Crossover|Death|0
372850|NCT00313781|1195286|P3|Before Crossover|Randomized, not treated|0
372851|NCT00313781|1195287|P2|Before Crossover|Randomized, not treated|0
372852|NCT00313781|1195288|P1|Before Crossover|Randomized, not treated|5
372853|NCT00313781|1195286|P3|Before Crossover|Crossover|0
372854|NCT00313781|1195287|P2|Before Crossover|Crossover|37
372855|NCT00313781|1195288|P1|Before Crossover|Crossover|0
372856|NCT00313781|1195286|P3|Before Crossover|Unspecified|0
372857|NCT00313781|1195287|P2|Before Crossover|Unspecified|30
372858|NCT00313781|1195288|P1|Before Crossover|Unspecified|45
372859|NCT00313781|1195286|P3|Before Crossover|Withdrawal by Subject|0
372860|NCT00313781|1195287|P2|Before Crossover|Withdrawal by Subject|1
372861|NCT00313781|1195288|P1|Before Crossover|Withdrawal by Subject|3
372862|NCT00313781|1195286|P3|Before Crossover|Lost to Follow-up|0
372863|NCT00313781|1195287|P2|Before Crossover|Lost to Follow-up|3
372864|NCT00313781|1195288|P1|Before Crossover|Lost to Follow-up|0
372865|NCT00313781|1195286|P3|Before Crossover|Death|0
372866|NCT00313781|1195287|P2|Before Crossover|Death|8
372867|NCT00313781|1195288|P1|Before Crossover|Death|22
372868|NCT00313716|1195328|P6|Overall Study|Withdrawal by Subject|0
372869|NCT00313716|1195329|P5|Overall Study|Withdrawal by Subject|1
372870|NCT00313716|1195330|P4|Overall Study|Withdrawal by Subject|0
372871|NCT00313716|1195331|P3|Overall Study|Withdrawal by Subject|1
372872|NCT00313716|1195332|P2|Overall Study|Withdrawal by Subject|1
372873|NCT00313716|1195333|P1|Overall Study|Withdrawal by Subject|0
372874|NCT00313716|1195328|P6|Overall Study|Lost to Follow-up|4
372875|NCT00313716|1195329|P5|Overall Study|Lost to Follow-up|0
372876|NCT00313716|1195330|P4|Overall Study|Lost to Follow-up|1
372877|NCT00313716|1195331|P3|Overall Study|Lost to Follow-up|2
372878|NCT00313716|1195332|P2|Overall Study|Lost to Follow-up|5
372879|NCT00313716|1195333|P1|Overall Study|Lost to Follow-up|2
372880|NCT00313716|1195328|P6|Overall Study|Death|9
372881|NCT00313716|1195329|P5|Overall Study|Death|5
372882|NCT00313716|1195330|P4|Overall Study|Death|3
372883|NCT00313716|1195331|P3|Overall Study|Death|9
372884|NCT00313716|1195332|P2|Overall Study|Death|2
372885|NCT00313716|1195333|P1|Overall Study|Death|3
372886|NCT00313703|1195360|P4|Overall Study|Lost to Follow-up|12
372887|NCT00313703|1195361|P3|Overall Study|Lost to Follow-up|5
372888|NCT00313703|1195362|P2|Overall Study|Lost to Follow-up|2
372889|NCT00313703|1195363|P1|Overall Study|Lost to Follow-up|11
372890|NCT00313612|1195379|P2|Overall Study|Patient never received treatment|1
372891|NCT00313612|1195380|P1|Overall Study|Patient never received treatment|0
372892|NCT00313586|1195392|P4|Overall Study|Death before starting treatment|0
372893|NCT00313586|1195393|P3|Overall Study|Death before starting treatment|0
372894|NCT00313586|1195394|P2|Overall Study|Death before starting treatment|0
372895|NCT00313586|1195395|P1|Overall Study|Death before starting treatment|1
372896|NCT00313586|1195392|P4|Overall Study|Moved|0
372897|NCT00313586|1195393|P3|Overall Study|Moved|0
372898|NCT00313586|1195394|P2|Overall Study|Moved|1
372899|NCT00313586|1195395|P1|Overall Study|Moved|0
372900|NCT00313586|1195392|P4|Overall Study|Lost insurance|0
372901|NCT00313586|1195393|P3|Overall Study|Lost insurance|0
372902|NCT00313586|1195394|P2|Overall Study|Lost insurance|1
372903|NCT00313586|1195395|P1|Overall Study|Lost insurance|0
372904|NCT00313586|1195392|P4|Overall Study|Absolute neutrophil count not recovered|0
372905|NCT00313586|1195393|P3|Overall Study|Absolute neutrophil count not recovered|0
372906|NCT00313586|1195394|P2|Overall Study|Absolute neutrophil count not recovered|1
372907|NCT00313586|1195395|P1|Overall Study|Absolute neutrophil count not recovered|2
372908|NCT00313586|1195392|P4|Overall Study|Physician Decision|0
372909|NCT00313586|1195393|P3|Overall Study|Physician Decision|0
372910|NCT00313586|1195394|P2|Overall Study|Physician Decision|1
372911|NCT00313586|1195395|P1|Overall Study|Physician Decision|2
372912|NCT00313586|1195392|P4|Overall Study|Did not achieve HI-major/better response|1
372913|NCT00313586|1195393|P3|Overall Study|Did not achieve HI-major/better response|2
372914|NCT00313586|1195394|P2|Overall Study|Did not achieve HI-major/better response|7
372915|NCT00313586|1195395|P1|Overall Study|Did not achieve HI-major/better response|10
372916|NCT00313586|1195392|P4|Overall Study|Other complicating disease|0
372917|NCT00313586|1195393|P3|Overall Study|Other complicating disease|0
372918|NCT00313586|1195394|P2|Overall Study|Other complicating disease|2
372919|NCT00313586|1195395|P1|Overall Study|Other complicating disease|2
372920|NCT00313586|1195392|P4|Overall Study|Alternative therapy|0
372921|NCT00313586|1195393|P3|Overall Study|Alternative therapy|2
372922|NCT00313586|1195394|P2|Overall Study|Alternative therapy|6
372923|NCT00313586|1195395|P1|Overall Study|Alternative therapy|3
372924|NCT00313586|1195392|P4|Overall Study|Withdrawal by Subject|2
372925|NCT00313586|1195393|P3|Overall Study|Withdrawal by Subject|6
372926|NCT00313586|1195394|P2|Overall Study|Withdrawal by Subject|6
372927|NCT00313586|1195395|P1|Overall Study|Withdrawal by Subject|13
372928|NCT00313586|1195392|P4|Overall Study|Death|7
372929|NCT00313586|1195393|P3|Overall Study|Death|1
372930|NCT00313586|1195394|P2|Overall Study|Death|8
372931|NCT00313586|1195395|P1|Overall Study|Death|11
372932|NCT00313586|1195392|P4|Overall Study|Adverse Event|10
372933|NCT00313586|1195393|P3|Overall Study|Adverse Event|3
372934|NCT00313586|1195394|P2|Overall Study|Adverse Event|18
372935|NCT00313586|1195395|P1|Overall Study|Adverse Event|12
372936|NCT00313586|1195392|P4|Overall Study|Disease progression|3
372937|NCT00313586|1195393|P3|Overall Study|Disease progression|10
372938|NCT00313586|1195394|P2|Overall Study|Disease progression|19
372939|NCT00313586|1195395|P1|Overall Study|Disease progression|14
372940|NCT00313313|1195414|P3|Overall Study|Subject No Longer Meets Study Criteria|2
372941|NCT00313313|1195415|P2|Overall Study|Subject No Longer Meets Study Criteria|3
372942|NCT00313313|1195416|P1|Overall Study|Subject No Longer Meets Study Criteria|0
372943|NCT00313313|1195414|P3|Overall Study|Death|2
372944|NCT00313313|1195415|P2|Overall Study|Death|0
372945|NCT00313313|1195416|P1|Overall Study|Death|0
372946|NCT00313313|1195414|P3|Overall Study|Pregnancy|0
372947|NCT00313313|1195415|P2|Overall Study|Pregnancy|2
372948|NCT00313313|1195416|P1|Overall Study|Pregnancy|1
372949|NCT00313313|1195414|P3|Overall Study|Poor/Noncompliance|2
372950|NCT00313313|1195415|P2|Overall Study|Poor/Noncompliance|6
372951|NCT00313313|1195416|P1|Overall Study|Poor/Noncompliance|3
372952|NCT00313313|1195414|P3|Overall Study|Physician Decision|4
372953|NCT00313313|1195415|P2|Overall Study|Physician Decision|6
372954|NCT00313313|1195416|P1|Overall Study|Physician Decision|2
372955|NCT00313313|1195414|P3|Overall Study|Adverse Event|12
372956|NCT00313313|1195415|P2|Overall Study|Adverse Event|16
372957|NCT00313313|1195416|P1|Overall Study|Adverse Event|15
372958|NCT00313313|1195414|P3|Overall Study|Lost to Follow-up|9
372959|NCT00313313|1195415|P2|Overall Study|Lost to Follow-up|7
372960|NCT00313313|1195416|P1|Overall Study|Lost to Follow-up|10
372961|NCT00313313|1195414|P3|Overall Study|Withdrawal of consent by subject|31
372962|NCT00313313|1195415|P2|Overall Study|Withdrawal of consent by subject|17
372963|NCT00313313|1195416|P1|Overall Study|Withdrawal of consent by subject|18
372964|NCT00313313|1195414|P3|Overall Study|Lack of Efficacy|20
372965|NCT00313313|1195415|P2|Overall Study|Lack of Efficacy|9
372966|NCT00313313|1195416|P1|Overall Study|Lack of Efficacy|14
372967|NCT00313300|1195438|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
372968|NCT00313300|1195439|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
372969|NCT00313300|1195440|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
372970|NCT00313300|1195441|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
372971|NCT00313300|1195442|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
372972|NCT00313300|1195438|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
372973|NCT00313300|1195439|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
372974|NCT00313300|1195440|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
372975|NCT00313300|1195441|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
372976|NCT00313300|1195442|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
372977|NCT00313300|1195438|P5|Follow-Up(30days)-Randomized Phase B|Death|0
372978|NCT00313300|1195439|P4|Follow-Up(30days)-Randomized Phase B|Death|0
372979|NCT00313300|1195440|P3|Follow-Up(30days)-Randomized Phase B|Death|0
372980|NCT00313300|1195441|P2|Follow-Up(30days)-Randomized Phase B|Death|0
372981|NCT00313300|1195442|P1|Follow-Up(30days)-Randomized Phase B|Death|1
372982|NCT00313300|1195438|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
372983|NCT00313300|1195439|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
372984|NCT00313300|1195440|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
372985|NCT00313300|1195441|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
372986|NCT00313300|1195442|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
372987|NCT00313300|1195438|P5|Follow-Up(30days)-Randomized Phase A|Death|0
372988|NCT00313300|1195439|P4|Follow-Up(30days)-Randomized Phase A|Death|0
372989|NCT00313300|1195440|P3|Follow-Up(30days)-Randomized Phase A|Death|0
372990|NCT00313300|1195441|P2|Follow-Up(30days)-Randomized Phase A|Death|1
372991|NCT00313300|1195442|P1|Follow-Up(30days)-Randomized Phase A|Death|0
372992|NCT00313300|1195438|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
372993|NCT00313300|1195439|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
372994|NCT00313300|1195440|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
372995|NCT00313300|1195441|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
372996|NCT00313300|1195442|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
372997|NCT00313300|1195438|P5|Randomized in Phase B (26 Weeks)|non-specified|0
372998|NCT00313300|1195439|P4|Randomized in Phase B (26 Weeks)|non-specified|0
372999|NCT00313300|1195440|P3|Randomized in Phase B (26 Weeks)|non-specified|0
373000|NCT00313300|1195441|P2|Randomized in Phase B (26 Weeks)|non-specified|0
373001|NCT00313300|1195442|P1|Randomized in Phase B (26 Weeks)|non-specified|1
373002|NCT00313300|1195438|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
373003|NCT00313300|1195439|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
373004|NCT00313300|1195440|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
373005|NCT00313300|1195441|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
373006|NCT00313300|1195442|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
373007|NCT00313300|1195438|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
373008|NCT00313300|1195439|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
373009|NCT00313300|1195440|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
373010|NCT00313300|1195441|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
373011|NCT00313300|1195442|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
373012|NCT00313300|1195438|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
373013|NCT00313300|1195439|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
373014|NCT00313300|1195440|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
373015|NCT00313300|1195441|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
373016|NCT00313300|1195442|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
373017|NCT00313300|1195438|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
373018|NCT00313300|1195439|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
373019|NCT00313300|1195440|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
373020|NCT00313300|1195441|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
373021|NCT00313300|1195442|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
373022|NCT00313300|1195438|P5|Randomized in Phase B (26 Weeks)|Death|1
373023|NCT00313300|1195439|P4|Randomized in Phase B (26 Weeks)|Death|0
373024|NCT00313300|1195440|P3|Randomized in Phase B (26 Weeks)|Death|1
373025|NCT00313300|1195441|P2|Randomized in Phase B (26 Weeks)|Death|3
373026|NCT00313300|1195442|P1|Randomized in Phase B (26 Weeks)|Death|5
373027|NCT00313300|1195438|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
373028|NCT00313300|1195439|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
373029|NCT00313300|1195440|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
373030|NCT00313300|1195441|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
373031|NCT00313300|1195442|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
373032|NCT00313300|1195438|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
373033|NCT00313300|1195439|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
373034|NCT00313300|1195440|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
373035|NCT00313300|1195441|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
373036|NCT00313300|1195442|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
373037|NCT00313300|1195438|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
373038|NCT00313300|1195439|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
373039|NCT00313300|1195440|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
373040|NCT00313300|1195441|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
373041|NCT00313300|1195442|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
373042|NCT00313300|1195438|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
373043|NCT00313300|1195439|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
373044|NCT00313300|1195440|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
373045|NCT00313300|1195441|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
373046|NCT00313300|1195442|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
373047|NCT00313300|1195438|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
373048|NCT00313300|1195439|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
373049|NCT00313300|1195440|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
373050|NCT00313300|1195441|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
373051|NCT00313300|1195442|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
373052|NCT00313300|1195438|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
373053|NCT00313300|1195439|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
373054|NCT00313300|1195440|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
373055|NCT00313300|1195441|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
373056|NCT00313300|1195442|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
373057|NCT00313300|1195438|P5|Randomized in Phase A (26 Weeks)|Death|0
373058|NCT00313300|1195439|P4|Randomized in Phase A (26 Weeks)|Death|0
373059|NCT00313300|1195440|P3|Randomized in Phase A (26 Weeks)|Death|0
373060|NCT00313300|1195441|P2|Randomized in Phase A (26 Weeks)|Death|4
373061|NCT00313300|1195442|P1|Randomized in Phase A (26 Weeks)|Death|3
373062|NCT00313300|1195438|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
373063|NCT00313300|1195439|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
373064|NCT00313300|1195440|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
373065|NCT00313300|1195441|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
373066|NCT00313300|1195442|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
373067|NCT00313300|1195438|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
373068|NCT00313300|1195439|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
373069|NCT00313300|1195440|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
373070|NCT00313300|1195441|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
373071|NCT00313300|1195442|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
373072|NCT00313170|1195512|P3|Overall Study|brain mets. after randomisation|1
373073|NCT00313170|1195513|P2|Overall Study|brain mets. after randomisation|0
373074|NCT00313170|1195514|P1|Overall Study|brain mets. after randomisation|0
373075|NCT00313170|1195512|P3|Overall Study|dosing error|1
373076|NCT00313170|1195513|P2|Overall Study|dosing error|0
373077|NCT00313170|1195514|P1|Overall Study|dosing error|0
373078|NCT00313170|1195512|P3|Overall Study|Clinical progression|0
373079|NCT00313170|1195513|P2|Overall Study|Clinical progression|0
373080|NCT00313170|1195514|P1|Overall Study|Clinical progression|1
373081|NCT00313170|1195512|P3|Overall Study|Lost to Follow-up|1
373082|NCT00313170|1195513|P2|Overall Study|Lost to Follow-up|0
373083|NCT00313170|1195514|P1|Overall Study|Lost to Follow-up|0
373084|NCT00313170|1195512|P3|Overall Study|Incorrect enrollment|1
373085|NCT00313170|1195513|P2|Overall Study|Incorrect enrollment|2
373086|NCT00313170|1195514|P1|Overall Study|Incorrect enrollment|0
373087|NCT00313170|1195512|P3|Overall Study|Withdrawal by Subject|1
373088|NCT00313170|1195513|P2|Overall Study|Withdrawal by Subject|1
373089|NCT00313170|1195514|P1|Overall Study|Withdrawal by Subject|1
373090|NCT00313170|1195512|P3|Overall Study|Disease progression|27
373091|NCT00313170|1195513|P2|Overall Study|Disease progression|26
373092|NCT00313170|1195514|P1|Overall Study|Disease progression|31
373093|NCT00313170|1195512|P3|Overall Study|Adverse Event|0
373094|NCT00313170|1195513|P2|Overall Study|Adverse Event|2
373095|NCT00313170|1195514|P1|Overall Study|Adverse Event|2
373096|NCT00313170|1195512|P3|Overall Study|Death|0
373097|NCT00313170|1195513|P2|Overall Study|Death|4
373098|NCT00313170|1195514|P1|Overall Study|Death|1
373099|NCT00313144|1195530|P1|Overall Study|Due to termination of the study|66
373100|NCT00313144|1195530|P1|Overall Study|Change to different product|1
373101|NCT00313144|1195530|P1|Overall Study|Insurance (homecare provider) change|1
373102|NCT00313144|1195530|P1|Overall Study|Liver transplant|1
373103|NCT00313144|1195530|P1|Overall Study|Adverse event - transient|5
373104|NCT00313144|1195530|P1|Overall Study|Physician Decision|4
373105|NCT00313144|1195530|P1|Overall Study|Terminated by sponsor/ homecare provider|4
373106|NCT00313144|1195530|P1|Overall Study|Withdrawal by Subject|4
373107|NCT00313144|1195530|P1|Overall Study|Lost to Follow-up|5
373108|NCT00313144|1195530|P1|Overall Study|Death|7
373109|NCT00313144|1195530|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
373110|NCT00313014|1195617|P3|Overall Study|Lack of Efficacy|16
373111|NCT00313014|1195618|P2|Overall Study|Lack of Efficacy|25
373112|NCT00313014|1195619|P1|Overall Study|Lack of Efficacy|52
373113|NCT00313014|1195617|P3|Overall Study|Administrative|14
373114|NCT00313014|1195618|P2|Overall Study|Administrative|6
373115|NCT00313014|1195619|P1|Overall Study|Administrative|9
373116|NCT00313014|1195617|P3|Overall Study|Lost to Follow-up|10
373117|NCT00313014|1195618|P2|Overall Study|Lost to Follow-up|6
373118|NCT00313014|1195619|P1|Overall Study|Lost to Follow-up|7
373119|NCT00313014|1195617|P3|Overall Study|Adverse Event|16
373120|NCT00313014|1195618|P2|Overall Study|Adverse Event|29
373121|NCT00313014|1195619|P1|Overall Study|Adverse Event|14
373122|NCT00313014|1195617|P3|Overall Study|Withdrawal by Subject|5
373123|NCT00313014|1195618|P2|Overall Study|Withdrawal by Subject|7
373124|NCT00313014|1195619|P1|Overall Study|Withdrawal by Subject|11
373125|NCT00312858|1195665|P2|Overall Study|Unspecified|12
373126|NCT00312858|1195666|P1|Overall Study|Unspecified|9
373127|NCT00312858|1195665|P2|Overall Study|Participant Moved|10
373128|NCT00312858|1195666|P1|Overall Study|Participant Moved|11
373129|NCT00312858|1195665|P2|Overall Study|Withdraw by Participant|20
373130|NCT00312858|1195666|P1|Overall Study|Withdraw by Participant|20
373131|NCT00312858|1195665|P2|Overall Study|Protocol Violation|8
373132|NCT00312858|1195666|P1|Overall Study|Protocol Violation|3
373133|NCT00312858|1195665|P2|Overall Study|Lost to Follow-up|42
373134|NCT00312858|1195666|P1|Overall Study|Lost to Follow-up|25
373135|NCT00312858|1195665|P2|Overall Study|Adverse Event|1
373136|NCT00312858|1195666|P1|Overall Study|Adverse Event|0
373137|NCT00312845|1195720|P2|Overall Study|Other|5
373138|NCT00312845|1195721|P1|Overall Study|Other|6
373139|NCT00312845|1195720|P2|Overall Study|Lost to Follow-up|0
373140|NCT00312845|1195721|P1|Overall Study|Lost to Follow-up|2
373141|NCT00312845|1195720|P2|Overall Study|Disease Progression|77
373142|NCT00312845|1195721|P1|Overall Study|Disease Progression|56
373143|NCT00312845|1195720|P2|Overall Study|Withdrawal by Subject|6
373144|NCT00312845|1195721|P1|Overall Study|Withdrawal by Subject|14
373145|NCT00312845|1195720|P2|Overall Study|Death|2
373146|NCT00312845|1195721|P1|Overall Study|Death|2
373147|NCT00312845|1195720|P2|Overall Study|Adverse Event|5
373148|NCT00312845|1195721|P1|Overall Study|Adverse Event|19
373149|NCT00312728|1195729|P1|Overall Study|Other|1
373150|NCT00312728|1195729|P1|Overall Study|Other|10
373151|NCT00312728|1195729|P1|Overall Study|Protocol Violation|2
373152|NCT00312728|1195729|P1|Overall Study|Required non-protocol cancer treatment|2
373153|NCT00312728|1195729|P1|Overall Study|Withdrawal by Subject|10
373154|NCT00312728|1195729|P1|Overall Study|Adverse Event|32
373155|NCT00312728|1195729|P1|Overall Study|Progressive disease|53
373156|NCT00312572|1195740|P2|Overall Study|Lack of Efficacy|2
373157|NCT00312572|1195741|P1|Overall Study|Lack of Efficacy|1
373158|NCT00312572|1195740|P2|Overall Study|Administrative|2
373159|NCT00312572|1195741|P1|Overall Study|Administrative|4
373160|NCT00312572|1195740|P2|Overall Study|Lost to Follow-up|1
373161|NCT00312572|1195741|P1|Overall Study|Lost to Follow-up|1
373162|NCT00312572|1195740|P2|Overall Study|Adverse Event|16
373163|NCT00312572|1195741|P1|Overall Study|Adverse Event|10
373164|NCT00312494|1195752|P3|Overall Study|Unspecified|1
373165|NCT00312494|1195753|P2|Overall Study|Unspecified|10
373166|NCT00312494|1195754|P1|Overall Study|Unspecified|10
373167|NCT00312494|1195752|P3|Overall Study|Withdrawal by Subject|10
373168|NCT00312494|1195753|P2|Overall Study|Withdrawal by Subject|9
373169|NCT00312494|1195754|P1|Overall Study|Withdrawal by Subject|6
373170|NCT00312494|1195752|P3|Overall Study|Lost to Follow-up|8
373171|NCT00312494|1195753|P2|Overall Study|Lost to Follow-up|8
373172|NCT00312494|1195754|P1|Overall Study|Lost to Follow-up|8
373173|NCT00312494|1195752|P3|Overall Study|Laboratory abnormality|0
373174|NCT00312494|1195753|P2|Overall Study|Laboratory abnormality|0
373175|NCT00312494|1195754|P1|Overall Study|Laboratory abnormality|1
373176|NCT00312494|1195752|P3|Overall Study|Lack of Efficacy|8
373177|NCT00312494|1195753|P2|Overall Study|Lack of Efficacy|6
373178|NCT00312494|1195754|P1|Overall Study|Lack of Efficacy|4
373179|NCT00312494|1195752|P3|Overall Study|Adverse Event|11
373180|NCT00312494|1195753|P2|Overall Study|Adverse Event|15
373181|NCT00312494|1195754|P1|Overall Study|Adverse Event|33
373182|NCT00312494|1195752|P3|Overall Study|Randomized; not treated with study drug|5
373183|NCT00312494|1195753|P2|Overall Study|Randomized; not treated with study drug|10
373184|NCT00312494|1195754|P1|Overall Study|Randomized; not treated with study drug|9
373185|NCT00312377|1195788|P2|Overall Study|Site ended participation in study|0
373186|NCT00312377|1195789|P1|Overall Study|Site ended participation in study|1
373187|NCT00312377|1195788|P2|Overall Study|Discontinue treatment survival follow up|200
373188|NCT00312377|1195789|P1|Overall Study|Discontinue treatment survival follow up|202
373189|NCT00312377|1195788|P2|Overall Study|Randomised but never received treatment|6
373190|NCT00312377|1195789|P1|Overall Study|Randomised but never received treatment|6
373191|NCT00312377|1195788|P2|Overall Study|Non-compliance|2
373192|NCT00312377|1195789|P1|Overall Study|Non-compliance|0
373193|NCT00312377|1195788|P2|Overall Study|Lost to Follow-up|12
373194|NCT00312377|1195789|P1|Overall Study|Lost to Follow-up|9
373195|NCT00312377|1195788|P2|Overall Study|Withdrawal by Subject|30
373196|NCT00312377|1195789|P1|Overall Study|Withdrawal by Subject|23
373197|NCT00312377|1195788|P2|Overall Study|Death|418
373198|NCT00312377|1195789|P1|Overall Study|Death|403
373199|NCT00312338|1195813|P2|Overall Study|Subsequent infection|0
373200|NCT00312338|1195814|P1|Overall Study|Subsequent infection|2
373201|NCT00312338|1195813|P2|Overall Study|Withdrawal by Subject|0
373202|NCT00312338|1195814|P1|Overall Study|Withdrawal by Subject|4
373203|NCT00312338|1195813|P2|Overall Study|Lost to Follow-up|1
373204|NCT00312338|1195814|P1|Overall Study|Lost to Follow-up|9
373205|NCT00312338|1195813|P2|Overall Study|Adverse Event|2
373206|NCT00312338|1195814|P1|Overall Study|Adverse Event|7
373207|NCT00312221|1195827|P4|Double-blind Phase|Lack of Efficacy|10
373208|NCT00312221|1195828|P3|Double-blind Phase|Lack of Efficacy|6
373209|NCT00312221|1195829|P2|Double-blind Phase|Lack of Efficacy|17
373210|NCT00312221|1195830|P1|Double-blind Phase|Lack of Efficacy|0
373211|NCT00312221|1195827|P4|Double-blind Phase|Administrative|33
373212|NCT00312221|1195828|P3|Double-blind Phase|Administrative|37
373213|NCT00312221|1195829|P2|Double-blind Phase|Administrative|26
373214|NCT00312221|1195830|P1|Double-blind Phase|Administrative|0
373215|NCT00312221|1195827|P4|Double-blind Phase|Lost to Follow-up|2
373216|NCT00312221|1195828|P3|Double-blind Phase|Lost to Follow-up|2
373217|NCT00312221|1195829|P2|Double-blind Phase|Lost to Follow-up|0
373218|NCT00312221|1195830|P1|Double-blind Phase|Lost to Follow-up|0
373219|NCT00312221|1195827|P4|Double-blind Phase|Adverse Event|18
373220|NCT00312221|1195828|P3|Double-blind Phase|Adverse Event|19
373221|NCT00312221|1195829|P2|Double-blind Phase|Adverse Event|10
373222|NCT00312221|1195830|P1|Double-blind Phase|Adverse Event|0
373223|NCT00312221|1195827|P4|Double-blind Phase|Withdrawal by Subject|7
373224|NCT00312221|1195828|P3|Double-blind Phase|Withdrawal by Subject|8
373225|NCT00312221|1195829|P2|Double-blind Phase|Withdrawal by Subject|6
373226|NCT00312221|1195830|P1|Double-blind Phase|Withdrawal by Subject|0
373227|NCT00312221|1195827|P4|Open-label Run-in Period|Did not qualify|0
373228|NCT00312221|1195828|P3|Open-label Run-in Period|Did not qualify|0
373229|NCT00312221|1195829|P2|Open-label Run-in Period|Did not qualify|0
373230|NCT00312221|1195830|P1|Open-label Run-in Period|Did not qualify|5
373231|NCT00312221|1195827|P4|Open-label Run-in Period|Lack of Efficacy|0
373232|NCT00312221|1195828|P3|Open-label Run-in Period|Lack of Efficacy|0
373233|NCT00312221|1195829|P2|Open-label Run-in Period|Lack of Efficacy|0
373234|NCT00312221|1195830|P1|Open-label Run-in Period|Lack of Efficacy|102
373235|NCT00312221|1195827|P4|Open-label Run-in Period|Administrative|0
373236|NCT00312221|1195828|P3|Open-label Run-in Period|Administrative|0
373237|NCT00312221|1195829|P2|Open-label Run-in Period|Administrative|0
373238|NCT00312221|1195830|P1|Open-label Run-in Period|Administrative|42
373239|NCT00312221|1195827|P4|Open-label Run-in Period|Lost to Follow-up|0
373240|NCT00312221|1195828|P3|Open-label Run-in Period|Lost to Follow-up|0
373241|NCT00312221|1195829|P2|Open-label Run-in Period|Lost to Follow-up|0
373242|NCT00312221|1195830|P1|Open-label Run-in Period|Lost to Follow-up|5
373243|NCT00312221|1195827|P4|Open-label Run-in Period|Adverse Event|0
373244|NCT00312221|1195828|P3|Open-label Run-in Period|Adverse Event|0
373245|NCT00312221|1195829|P2|Open-label Run-in Period|Adverse Event|0
373246|NCT00312221|1195830|P1|Open-label Run-in Period|Adverse Event|74
373247|NCT00312221|1195827|P4|Open-label Run-in Period|Withdrawal by Subject|0
373248|NCT00312221|1195828|P3|Open-label Run-in Period|Withdrawal by Subject|0
373249|NCT00312221|1195829|P2|Open-label Run-in Period|Withdrawal by Subject|0
373250|NCT00312221|1195830|P1|Open-label Run-in Period|Withdrawal by Subject|6
373251|NCT00312208|1195850|P2|Overall Study|Not specified|7
373252|NCT00312208|1195851|P1|Overall Study|Not specified|5
373253|NCT00312208|1195850|P2|Overall Study|Withdrawal by Subject|42
373254|NCT00312208|1195851|P1|Overall Study|Withdrawal by Subject|53
373255|NCT00312208|1195850|P2|Overall Study|Lost to Follow-up|5
373256|NCT00312208|1195851|P1|Overall Study|Lost to Follow-up|3
373257|NCT00312208|1195850|P2|Overall Study|Lack of Efficacy|4
373258|NCT00312208|1195851|P1|Overall Study|Lack of Efficacy|7
373259|NCT00312208|1195850|P2|Overall Study|Death|1
373260|NCT00312208|1195851|P1|Overall Study|Death|2
373261|NCT00312208|1195850|P2|Overall Study|Protocol Violation|3
373262|NCT00312208|1195851|P1|Overall Study|Protocol Violation|5
373263|NCT00312208|1195850|P2|Overall Study|Adverse Event|61
373264|NCT00312208|1195851|P1|Overall Study|Adverse Event|97
373265|NCT00312195|1195861|P2|Overall Study|Protocol Violation|0
373266|NCT00312195|1195862|P1|Overall Study|Protocol Violation|1
373267|NCT00312195|1195861|P2|Overall Study|Lost to Follow-up|0
373268|NCT00312195|1195862|P1|Overall Study|Lost to Follow-up|1
373269|NCT00312195|1195861|P2|Overall Study|Adverse Event|6
373270|NCT00312195|1195862|P1|Overall Study|Adverse Event|4
373271|NCT00311584|1195889|P2|Overall Study|ineligible|2
373272|NCT00311584|1195890|P1|Overall Study|ineligible|2
373273|NCT00311584|1195889|P2|Overall Study|Withdrawal by Subject|1
373274|NCT00311584|1195890|P1|Overall Study|Withdrawal by Subject|1
373275|NCT00311584|1195889|P2|Overall Study|Physician Decision|5
373276|NCT00311584|1195890|P1|Overall Study|Physician Decision|4
373277|NCT00311584|1195889|P2|Overall Study|Lack of Efficacy|15
373278|NCT00311584|1195890|P1|Overall Study|Lack of Efficacy|12
373279|NCT00311584|1195889|P2|Overall Study|Death|0
373280|NCT00311584|1195890|P1|Overall Study|Death|1
373281|NCT00311402|1195898|P2|Overall Study|IRB's rejection etc.|3
373282|NCT00311402|1195899|P1|Overall Study|IRB's rejection etc.|10
373283|NCT00311402|1195898|P2|Overall Study|Protocol Violation|6
373284|NCT00311402|1195899|P1|Overall Study|Protocol Violation|7
373285|NCT00311402|1195898|P2|Overall Study|Lack of Efficacy|42
373286|NCT00311402|1195899|P1|Overall Study|Lack of Efficacy|58
373287|NCT00311402|1195898|P2|Overall Study|Withdrawal by Subject|18
373288|NCT00311402|1195899|P1|Overall Study|Withdrawal by Subject|17
373289|NCT00311402|1195898|P2|Overall Study|Lost to Follow-up|3
373290|NCT00311402|1195899|P1|Overall Study|Lost to Follow-up|0
373291|NCT00311402|1195898|P2|Overall Study|Adverse Event|105
373292|NCT00311402|1195899|P1|Overall Study|Adverse Event|118
373293|NCT00311363|1195948|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
373294|NCT00311363|1195949|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
373295|NCT00311363|1195950|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
373296|NCT00311363|1195948|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
373297|NCT00311363|1195949|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
373298|NCT00311363|1195950|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
373299|NCT00311363|1195948|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
373300|NCT00311363|1195949|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
373301|NCT00311363|1195950|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
373302|NCT00311363|1195948|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
373303|NCT00311363|1195949|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
373304|NCT00311363|1195950|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
373305|NCT00311363|1195948|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
373306|NCT00311363|1195949|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
373307|NCT00311363|1195950|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
373308|NCT00311363|1195948|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
373309|NCT00311363|1195949|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
373310|NCT00311363|1195950|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
373311|NCT00311363|1195948|P3|24-Week Single-Blind Treatment Period|Death|0
373312|NCT00311363|1195949|P2|24-Week Single-Blind Treatment Period|Death|0
373313|NCT00311363|1195950|P1|24-Week Single-Blind Treatment Period|Death|1
373314|NCT00311363|1195948|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
373315|NCT00311363|1195949|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
373316|NCT00311363|1195950|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
373317|NCT00311363|1195948|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
373318|NCT00311363|1195949|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
373319|NCT00311363|1195950|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
373320|NCT00311363|1195948|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
373321|NCT00311363|1195949|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
373322|NCT00311363|1195950|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
373323|NCT00311363|1195948|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
373324|NCT00311363|1195949|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
373325|NCT00311363|1195950|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
373326|NCT00311363|1195948|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
373327|NCT00311363|1195949|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
373328|NCT00311363|1195950|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
373329|NCT00311363|1195948|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
373330|NCT00311363|1195949|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
373331|NCT00311363|1195950|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
373332|NCT00311363|1195948|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
373333|NCT00311363|1195949|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
373334|NCT00311363|1195950|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
373335|NCT00311363|1195948|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
373336|NCT00311363|1195949|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
373337|NCT00311363|1195950|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
373338|NCT00311311|1196010|P2|Overall Study|Lack of ancillary assistance|1
373339|NCT00311311|1196011|P1|Overall Study|Lack of ancillary assistance|0
373340|NCT00311311|1196010|P2|Overall Study|Death|0
373341|NCT00311311|1196011|P1|Overall Study|Death|1
373342|NCT00311311|1196010|P2|Overall Study|Study Termination by Sponsor|4
373343|NCT00311311|1196011|P1|Overall Study|Study Termination by Sponsor|3
373344|NCT00311311|1196010|P2|Overall Study|Noncompliance|1
373345|NCT00311311|1196011|P1|Overall Study|Noncompliance|0
373346|NCT00311311|1196010|P2|Overall Study|Withdrawal by Subject|1
373347|NCT00311311|1196011|P1|Overall Study|Withdrawal by Subject|1
373348|NCT00311311|1196010|P2|Overall Study|Adverse Event|2
373349|NCT00311311|1196011|P1|Overall Study|Adverse Event|3
373350|NCT00311181|1196061|P1|Overall Study|Final DFTs were not obtained|96
373351|NCT00311155|1196067|P1|Overall Study|Did not meet entry criteria|55
373352|NCT00311155|1196067|P1|Overall Study|Withdrawal by Subject|17
373353|NCT00311155|1196067|P1|Overall Study|Adverse Event|21
373354|NCT00310856|1196079|P3|Overall Study|Unable to classify|0
373355|NCT00310856|1196080|P2|Overall Study|Unable to classify|0
373356|NCT00310856|1196081|P1|Overall Study|Unable to classify|1
373357|NCT00310856|1196079|P3|Overall Study|Inappropriate enrollment|0
373358|NCT00310856|1196080|P2|Overall Study|Inappropriate enrollment|1
373359|NCT00310856|1196081|P1|Overall Study|Inappropriate enrollment|1
373360|NCT00310856|1196079|P3|Overall Study|Lost to Follow-up|6
373361|NCT00310856|1196080|P2|Overall Study|Lost to Follow-up|2
373362|NCT00310856|1196081|P1|Overall Study|Lost to Follow-up|1
373363|NCT00310856|1196079|P3|Overall Study|Withdrawal by Subject|2
373364|NCT00310856|1196080|P2|Overall Study|Withdrawal by Subject|2
373365|NCT00310856|1196081|P1|Overall Study|Withdrawal by Subject|2
373366|NCT00310817|1196105|P4|Overall Study|Unable to classify|0
373367|NCT00310817|1196106|P3|Overall Study|Unable to classify|0
373368|NCT00310817|1196107|P2|Overall Study|Unable to classify|1
373369|NCT00310817|1196108|P1|Overall Study|Unable to classify|3
373370|NCT00310817|1196105|P4|Overall Study|Protocol Violation|1
373371|NCT00310817|1196106|P3|Overall Study|Protocol Violation|1
373372|NCT00310817|1196107|P2|Overall Study|Protocol Violation|1
373373|NCT00310817|1196108|P1|Overall Study|Protocol Violation|1
373374|NCT00310817|1196105|P4|Overall Study|Inappropriate Enrollment|0
373375|NCT00310817|1196106|P3|Overall Study|Inappropriate Enrollment|1
373376|NCT00310817|1196107|P2|Overall Study|Inappropriate Enrollment|0
373377|NCT00310817|1196108|P1|Overall Study|Inappropriate Enrollment|1
373378|NCT00310817|1196105|P4|Overall Study|Lost to Follow-up|0
373379|NCT00310817|1196106|P3|Overall Study|Lost to Follow-up|0
373380|NCT00310817|1196107|P2|Overall Study|Lost to Follow-up|1
373381|NCT00310817|1196108|P1|Overall Study|Lost to Follow-up|2
373382|NCT00310817|1196105|P4|Overall Study|Withdrawal by Subject|7
373383|NCT00310817|1196106|P3|Overall Study|Withdrawal by Subject|6
373384|NCT00310817|1196107|P2|Overall Study|Withdrawal by Subject|4
373385|NCT00310817|1196108|P1|Overall Study|Withdrawal by Subject|1
373386|NCT00310817|1196105|P4|Overall Study|AE or Death|0
373387|NCT00310817|1196106|P3|Overall Study|AE or Death|0
373388|NCT00310817|1196107|P2|Overall Study|AE or Death|1
373389|NCT00310817|1196108|P1|Overall Study|AE or Death|3
373390|NCT00310804|1196196|P2|Overall Study|Withdrawal by Subject|0
373391|NCT00310804|1196197|P1|Overall Study|Withdrawal by Subject|3
373392|NCT00310804|1196196|P2|Overall Study|Lost to Follow-up|0
373393|NCT00310804|1196197|P1|Overall Study|Lost to Follow-up|2
373394|NCT00310440|1196256|P2|Overall Study|Missed 12 Month Visit|4
373395|NCT00310440|1196257|P1|Overall Study|Missed 12 Month Visit|7
373396|NCT00310440|1196256|P2|Overall Study|Withdrawal by Subject|1
373397|NCT00310440|1196257|P1|Overall Study|Withdrawal by Subject|2
373398|NCT00310440|1196256|P2|Overall Study|Lost to Follow-up|8
373399|NCT00310440|1196257|P1|Overall Study|Lost to Follow-up|17
373400|NCT00310375|1196315|P2|Overall Study|Request of Ethics Committee|1
373401|NCT00310375|1196316|P1|Overall Study|Request of Ethics Committee|0
373402|NCT00310375|1196315|P2|Overall Study|Par. switched to commercial product|1
373403|NCT00310375|1196316|P1|Overall Study|Par. switched to commercial product|0
373404|NCT00310375|1196315|P2|Overall Study|Missed study drug for 2 months|0
373405|NCT00310375|1196316|P1|Overall Study|Missed study drug for 2 months|1
373406|NCT00310375|1196315|P2|Overall Study|Site closure|0
373407|NCT00310375|1196316|P1|Overall Study|Site closure|3
373408|NCT00310375|1196315|P2|Overall Study|Missed study drug >5 days|0
373409|NCT00310375|1196316|P1|Overall Study|Missed study drug >5 days|1
373410|NCT00310375|1196315|P2|Overall Study|Going for temporal lobectomy|0
373411|NCT00310375|1196316|P1|Overall Study|Going for temporal lobectomy|1
373412|NCT00310375|1196315|P2|Overall Study|Participant request unrelated to study|2
373413|NCT00310375|1196316|P1|Overall Study|Participant request unrelated to study|1
373414|NCT00310375|1196315|P2|Overall Study|Failed to return|3
373415|NCT00310375|1196316|P1|Overall Study|Failed to return|1
373416|NCT00310375|1196315|P2|Overall Study|Request of the sponsor|2
373417|NCT00310375|1196316|P1|Overall Study|Request of the sponsor|2
373418|NCT00310375|1196315|P2|Overall Study|Physician Decision|3
373419|NCT00310375|1196316|P1|Overall Study|Physician Decision|5
373420|NCT00310375|1196315|P2|Overall Study|Transaminase >5 upper limit of normal|1
373421|NCT00310375|1196316|P1|Overall Study|Transaminase >5 upper limit of normal|2
373422|NCT00310375|1196315|P2|Overall Study|Change in Par medical condition|0
373423|NCT00310375|1196316|P1|Overall Study|Change in Par medical condition|2
373424|NCT00310375|1196315|P2|Overall Study|Protocol Violation|5
373425|NCT00310375|1196316|P1|Overall Study|Protocol Violation|8
373426|NCT00310375|1196315|P2|Overall Study|Withdrawal by Subject|7
373427|NCT00310375|1196316|P1|Overall Study|Withdrawal by Subject|10
373428|NCT00310375|1196315|P2|Overall Study|Pregnancy|2
373429|NCT00310375|1196316|P1|Overall Study|Pregnancy|2
373430|NCT00310375|1196315|P2|Overall Study|Lack of Efficacy|19
373431|NCT00310375|1196316|P1|Overall Study|Lack of Efficacy|24
373432|NCT00310375|1196315|P2|Overall Study|Adverse Event|22
373433|NCT00310375|1196316|P1|Overall Study|Adverse Event|28
373434|NCT00309985|1196400|P2|Overall Study|Chemotherapy discontinued only|0
373435|NCT00309985|1196401|P1|Overall Study|Chemotherapy discontinued only|1
373436|NCT00309985|1196400|P2|Overall Study|Non-compliance|0
373437|NCT00309985|1196401|P1|Overall Study|Non-compliance|1
373438|NCT00309985|1196400|P2|Overall Study|Complicating disease|0
373439|NCT00309985|1196401|P1|Overall Study|Complicating disease|1
373440|NCT00309985|1196400|P2|Overall Study|Never started treatment|0
373441|NCT00309985|1196401|P1|Overall Study|Never started treatment|7
373442|NCT00309985|1196400|P2|Overall Study|Physician Decision|0
373443|NCT00309985|1196401|P1|Overall Study|Physician Decision|3
373444|NCT00309985|1196400|P2|Overall Study|Withdrawal by Subject|1
373445|NCT00309985|1196401|P1|Overall Study|Withdrawal by Subject|5
373446|NCT00309985|1196400|P2|Overall Study|Death|0
373447|NCT00309985|1196401|P1|Overall Study|Death|2
373448|NCT00309985|1196400|P2|Overall Study|Adverse Event|0
373449|NCT00309985|1196401|P1|Overall Study|Adverse Event|30
373450|NCT00309985|1196400|P2|Overall Study|Disease progression|0
373451|NCT00309985|1196401|P1|Overall Study|Disease progression|12
373452|NCT00309946|1196417|P1|Overall Study|Withdrawal by Subject|1
373453|NCT00309907|1196423|P1|Overall Study|Major infectious event|4
373454|NCT00309907|1196423|P1|Overall Study|Ineligible|11
373455|NCT00309907|1196423|P1|Overall Study|Physician Decision|1
373456|NCT00309907|1196423|P1|Overall Study|Death|4
373457|NCT00309777|1196431|P4|Overall Study|Death|0
373458|NCT00309777|1196432|P3|Overall Study|Death|0
373459|NCT00309777|1196433|P2|Overall Study|Death|1
373460|NCT00309777|1196434|P1|Overall Study|Death|0
373461|NCT00309777|1196431|P4|Overall Study|Lost to Follow-up|0
373462|NCT00309777|1196432|P3|Overall Study|Lost to Follow-up|1
373463|NCT00309777|1196433|P2|Overall Study|Lost to Follow-up|0
373464|NCT00309777|1196434|P1|Overall Study|Lost to Follow-up|0
373465|NCT00309777|1196431|P4|Overall Study|Withdrawal by Subject|2
373466|NCT00309777|1196432|P3|Overall Study|Withdrawal by Subject|7
373467|NCT00309777|1196433|P2|Overall Study|Withdrawal by Subject|5
373468|NCT00309777|1196434|P1|Overall Study|Withdrawal by Subject|6
373469|NCT00309777|1196431|P4|Overall Study|Protocol Violation|1
373470|NCT00309777|1196432|P3|Overall Study|Protocol Violation|3
373471|NCT00309777|1196433|P2|Overall Study|Protocol Violation|1
373472|NCT00309777|1196434|P1|Overall Study|Protocol Violation|4
373473|NCT00309777|1196431|P4|Overall Study|Adverse Event|1
373474|NCT00309777|1196432|P3|Overall Study|Adverse Event|8
373475|NCT00309777|1196433|P2|Overall Study|Adverse Event|2
373476|NCT00309777|1196434|P1|Overall Study|Adverse Event|13
373477|NCT00309608|1196475|P5|Overall Study|Other incl. Lack of efficacy|0
373478|NCT00309608|1196476|P4|Overall Study|Other incl. Lack of efficacy|4
373479|NCT00309608|1196477|P3|Overall Study|Other incl. Lack of efficacy|3
373480|NCT00309608|1196478|P2|Overall Study|Other incl. Lack of efficacy|4
373481|NCT00309608|1196479|P1|Overall Study|Other incl. Lack of efficacy|10
373482|NCT00309608|1196475|P5|Overall Study|Withdrawal by Subject|0
373483|NCT00309608|1196476|P4|Overall Study|Withdrawal by Subject|0
373484|NCT00309608|1196477|P3|Overall Study|Withdrawal by Subject|2
373485|NCT00309608|1196478|P2|Overall Study|Withdrawal by Subject|4
373486|NCT00309608|1196479|P1|Overall Study|Withdrawal by Subject|1
373487|NCT00309608|1196475|P5|Overall Study|Lost to Follow-up|1
373488|NCT00309608|1196476|P4|Overall Study|Lost to Follow-up|0
373489|NCT00309608|1196477|P3|Overall Study|Lost to Follow-up|2
373490|NCT00309608|1196478|P2|Overall Study|Lost to Follow-up|0
373491|NCT00309608|1196479|P1|Overall Study|Lost to Follow-up|0
373492|NCT00309608|1196475|P5|Overall Study|Protocol Violation|0
373493|NCT00309608|1196476|P4|Overall Study|Protocol Violation|0
373494|NCT00309608|1196477|P3|Overall Study|Protocol Violation|0
373495|NCT00309608|1196478|P2|Overall Study|Protocol Violation|0
373496|NCT00309608|1196479|P1|Overall Study|Protocol Violation|2
373497|NCT00309608|1196475|P5|Overall Study|Adverse Event|3
373498|NCT00309608|1196476|P4|Overall Study|Adverse Event|2
373499|NCT00309608|1196477|P3|Overall Study|Adverse Event|3
373500|NCT00309608|1196478|P2|Overall Study|Adverse Event|5
373501|NCT00309608|1196479|P1|Overall Study|Adverse Event|1
373502|NCT00309452|1196527|P2|Overall Study|Withdrawal by Subject|0
373503|NCT00309452|1196528|P1|Overall Study|Withdrawal by Subject|3
373504|NCT00309387|1196556|P2|Overall Study|Lost to Follow-up|86
373505|NCT00309387|1196557|P1|Overall Study|Lost to Follow-up|70
373506|NCT00309387|1196556|P2|Overall Study|Death|73
373507|NCT00309387|1196557|P1|Overall Study|Death|72
373508|NCT00309244|1196575|P2|Overall Study|Death|1
373509|NCT00309244|1196576|P1|Overall Study|Death|4
373510|NCT00309244|1196575|P2|Overall Study|Randomized but not dosed|12
373511|NCT00309244|1196576|P1|Overall Study|Randomized but not dosed|11
373512|NCT00309244|1196575|P2|Overall Study|Various|7
373513|NCT00309244|1196576|P1|Overall Study|Various|7
373514|NCT00309244|1196575|P2|Overall Study|Withdrawal by Subject|32
373515|NCT00309244|1196576|P1|Overall Study|Withdrawal by Subject|50
373516|NCT00309244|1196575|P2|Overall Study|Protocol Violation|3
373517|NCT00309244|1196576|P1|Overall Study|Protocol Violation|6
373518|NCT00309244|1196575|P2|Overall Study|Physician Decision|8
373519|NCT00309244|1196576|P1|Overall Study|Physician Decision|5
373520|NCT00309244|1196575|P2|Overall Study|Lost to Follow-up|22
373521|NCT00309244|1196576|P1|Overall Study|Lost to Follow-up|6
373522|NCT00309244|1196575|P2|Overall Study|Adverse Event|12
373523|NCT00309244|1196576|P1|Overall Study|Adverse Event|29
373524|NCT00308997|1196598|P2|Overall Study|Unable to tolerate intervention|0
373525|NCT00308997|1196599|P1|Overall Study|Unable to tolerate intervention|1
373526|NCT00308997|1196598|P2|Overall Study|Subject feigned clinical data|1
373527|NCT00308997|1196599|P1|Overall Study|Subject feigned clinical data|0
373528|NCT00308737|1196618|P3|Overall Study|Various|8
373529|NCT00308737|1196619|P2|Overall Study|Various|20
373530|NCT00308737|1196620|P1|Overall Study|Various|32
373531|NCT00308737|1196618|P3|Overall Study|Withdrawal by Subject|18
373532|NCT00308737|1196619|P2|Overall Study|Withdrawal by Subject|166
373533|NCT00308737|1196620|P1|Overall Study|Withdrawal by Subject|218
373534|NCT00308737|1196618|P3|Overall Study|Protocol Violation|5
373535|NCT00308737|1196619|P2|Overall Study|Protocol Violation|9
373536|NCT00308737|1196620|P1|Overall Study|Protocol Violation|34
373537|NCT00308737|1196618|P3|Overall Study|Physician Decision|1
373538|NCT00308737|1196619|P2|Overall Study|Physician Decision|2
373539|NCT00308737|1196620|P1|Overall Study|Physician Decision|15
373540|NCT00308737|1196618|P3|Overall Study|Lost to Follow-up|5
373541|NCT00308737|1196619|P2|Overall Study|Lost to Follow-up|80
373542|NCT00308737|1196620|P1|Overall Study|Lost to Follow-up|56
373543|NCT00308737|1196618|P3|Overall Study|Death|0
373544|NCT00308737|1196619|P2|Overall Study|Death|3
373545|NCT00308737|1196620|P1|Overall Study|Death|4
373546|NCT00308737|1196618|P3|Overall Study|Adverse Event|0
373547|NCT00308737|1196619|P2|Overall Study|Adverse Event|9
373548|NCT00308737|1196620|P1|Overall Study|Adverse Event|104
373549|NCT00308711|1196660|P3|Overall Study|Subject incarcerated, data not allowed|1
373550|NCT00308711|1196661|P2|Overall Study|Subject incarcerated, data not allowed|0
373551|NCT00308711|1196662|P1|Overall Study|Subject incarcerated, data not allowed|0
373552|NCT00308711|1196660|P3|Overall Study|Baby not born within 7 days of treatment|2
373553|NCT00308711|1196661|P2|Overall Study|Baby not born within 7 days of treatment|2
373554|NCT00308711|1196662|P1|Overall Study|Baby not born within 7 days of treatment|1
373555|NCT00308711|1196660|P3|Overall Study|Lost to Follow-up|0
373556|NCT00308711|1196661|P2|Overall Study|Lost to Follow-up|1
373557|NCT00308711|1196662|P1|Overall Study|Lost to Follow-up|0
373558|NCT00308711|1196660|P3|Overall Study|Protocol Violation|1
373559|NCT00308711|1196661|P2|Overall Study|Protocol Violation|1
373560|NCT00308711|1196662|P1|Overall Study|Protocol Violation|0
373561|NCT00308711|1196660|P3|Overall Study|Withdrawal by Subject|1
373562|NCT00308711|1196661|P2|Overall Study|Withdrawal by Subject|0
373563|NCT00308711|1196662|P1|Overall Study|Withdrawal by Subject|1
373564|NCT00308620|1196697|P3|Overall Study|Lost to Follow-up|1
373565|NCT00308620|1196698|P2|Overall Study|Lost to Follow-up|0
373566|NCT00308620|1196699|P1|Overall Study|Lost to Follow-up|0
373567|NCT00308620|1196697|P3|Overall Study|Death|0
373568|NCT00308620|1196698|P2|Overall Study|Death|1
373569|NCT00308620|1196699|P1|Overall Study|Death|1
373570|NCT00308581|1196708|P3|Randomized Maintenance Phase|Unknown reason|0
373571|NCT00308581|1196709|P2|Randomized Maintenance Phase|Unknown reason|0
373572|NCT00308581|1196710|P1|Randomized Maintenance Phase|Unknown reason|3
373573|NCT00308581|1196708|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
373574|NCT00308581|1196709|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
373575|NCT00308581|1196710|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
373576|NCT00308581|1196708|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
373577|NCT00308581|1196709|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
373578|NCT00308581|1196710|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
373579|NCT00308581|1196708|P3|Randomized Maintenance Phase|Lost to Follow-up|0
373580|NCT00308581|1196709|P2|Randomized Maintenance Phase|Lost to Follow-up|2
373581|NCT00308581|1196710|P1|Randomized Maintenance Phase|Lost to Follow-up|0
373582|NCT00308581|1196708|P3|Randomized Maintenance Phase|Lack of Efficacy|0
373583|NCT00308581|1196709|P2|Randomized Maintenance Phase|Lack of Efficacy|21
373584|NCT00308581|1196710|P1|Randomized Maintenance Phase|Lack of Efficacy|9
373585|NCT00308581|1196708|P3|Randomized Maintenance Phase|Adverse Event|0
373586|NCT00308581|1196709|P2|Randomized Maintenance Phase|Adverse Event|17
373587|NCT00308581|1196710|P1|Randomized Maintenance Phase|Adverse Event|10
373588|NCT00308581|1196708|P3|Induction Phase|Unknown reason|3
373589|NCT00308581|1196709|P2|Induction Phase|Unknown reason|0
373590|NCT00308581|1196710|P1|Induction Phase|Unknown reason|0
373591|NCT00308581|1196708|P3|Induction Phase|Withdrawal by Subject|5
373592|NCT00308581|1196709|P2|Induction Phase|Withdrawal by Subject|0
373593|NCT00308581|1196710|P1|Induction Phase|Withdrawal by Subject|0
373594|NCT00308581|1196708|P3|Induction Phase|Lack of Efficacy|121
373595|NCT00308581|1196709|P2|Induction Phase|Lack of Efficacy|0
373596|NCT00308581|1196710|P1|Induction Phase|Lack of Efficacy|0
373597|NCT00308581|1196708|P3|Induction Phase|Adverse Event|37
373598|NCT00308581|1196709|P2|Induction Phase|Adverse Event|0
373599|NCT00308581|1196710|P1|Induction Phase|Adverse Event|0
373600|NCT00308555|1196836|P2|Overall Study|Physician Decision|0
373601|NCT00308555|1196837|P1|Overall Study|Physician Decision|2
373602|NCT00308555|1196836|P2|Overall Study|Withdrawal by Subject|0
373603|NCT00308555|1196837|P1|Overall Study|Withdrawal by Subject|1
373604|NCT00308308|1196854|P2|Overall Study|Other|0
373605|NCT00308308|1196855|P1|Overall Study|Other|1
373606|NCT00308308|1196854|P2|Overall Study|Randomized but not dosed|16
373607|NCT00308308|1196855|P1|Overall Study|Randomized but not dosed|8
373608|NCT00308308|1196854|P2|Overall Study|Various|5
373609|NCT00308308|1196855|P1|Overall Study|Various|7
373610|NCT00308308|1196854|P2|Overall Study|Withdrawal by Subject|19
373611|NCT00308308|1196855|P1|Overall Study|Withdrawal by Subject|47
373612|NCT00308308|1196854|P2|Overall Study|Protocol Violation|14
373613|NCT00308308|1196855|P1|Overall Study|Protocol Violation|3
373614|NCT00308308|1196854|P2|Overall Study|Physician Decision|7
373615|NCT00308308|1196855|P1|Overall Study|Physician Decision|15
373616|NCT00308308|1196854|P2|Overall Study|Lost to Follow-up|5
373617|NCT00308308|1196855|P1|Overall Study|Lost to Follow-up|5
373618|NCT00308308|1196854|P2|Overall Study|Adverse Event|2
373619|NCT00308308|1196855|P1|Overall Study|Adverse Event|17
373620|NCT00308139|1196890|P2|Overall Study|Other|0
373621|NCT00308139|1196891|P1|Overall Study|Other|1
373622|NCT00308139|1196890|P2|Overall Study|Administrative|4
373623|NCT00308139|1196891|P1|Overall Study|Administrative|1
373624|NCT00308139|1196890|P2|Overall Study|Loss of Glucose Control|7
373625|NCT00308139|1196891|P1|Overall Study|Loss of Glucose Control|5
373626|NCT00308139|1196890|P2|Overall Study|Investigator Decision|10
373627|NCT00308139|1196891|P1|Overall Study|Investigator Decision|11
373628|NCT00308139|1196890|P2|Overall Study|Withdrawal of Consent|42
373629|NCT00308139|1196891|P1|Overall Study|Withdrawal of Consent|40
373630|NCT00308139|1196890|P2|Overall Study|Protocol Violation|2
373631|NCT00308139|1196891|P1|Overall Study|Protocol Violation|3
373632|NCT00308139|1196890|P2|Overall Study|Lost to Follow-up|8
373633|NCT00308139|1196891|P1|Overall Study|Lost to Follow-up|13
373634|NCT00308139|1196890|P2|Overall Study|Adverse Event|14
373635|NCT00308139|1196891|P1|Overall Study|Adverse Event|20
373636|NCT00308113|1196965|P4|Overall Study|Protocol closure|1
373637|NCT00308113|1196966|P3|Overall Study|Protocol closure|0
373638|NCT00308113|1196967|P2|Overall Study|Protocol closure|0
373639|NCT00308113|1196968|P1|Overall Study|Protocol closure|0
373640|NCT00308087|1196988|P2|Overall Study|Not Specified|3
373641|NCT00308087|1196989|P1|Overall Study|Not Specified|4
373642|NCT00308087|1196988|P2|Overall Study|Withdrawal by Subject|1
373643|NCT00308087|1196989|P1|Overall Study|Withdrawal by Subject|2
373644|NCT00308087|1196988|P2|Overall Study|Study Closure|12
373645|NCT00308087|1196989|P1|Overall Study|Study Closure|11
373646|NCT00308087|1196988|P2|Overall Study|Progressive Disease|21
373647|NCT00308087|1196989|P1|Overall Study|Progressive Disease|19
373648|NCT00308074|1197005|P1|Overall Study|Withdrawal by Subject|1
373649|NCT00307931|1197012|P1|Overall Study|Adverse Event|1
373650|NCT00307801|1197029|P2|Overall Study|Pregnancy|1
373651|NCT00307801|1197030|P1|Overall Study|Pregnancy|0
373652|NCT00307801|1197029|P2|Overall Study|No reason specified|0
373653|NCT00307801|1197030|P1|Overall Study|No reason specified|2
373654|NCT00307801|1197029|P2|Overall Study|Protocol Violation|2
373655|NCT00307801|1197030|P1|Overall Study|Protocol Violation|3
373656|NCT00307801|1197029|P2|Overall Study|Frustration with e-diary|0
373657|NCT00307801|1197030|P1|Overall Study|Frustration with e-diary|1
373658|NCT00307801|1197029|P2|Overall Study|Lost to Follow-up, moved abroad|1
373659|NCT00307801|1197030|P1|Overall Study|Lost to Follow-up, moved abroad|1
373660|NCT00307801|1197029|P2|Overall Study|Lack of Efficacy|2
373661|NCT00307801|1197030|P1|Overall Study|Lack of Efficacy|0
373662|NCT00307801|1197029|P2|Overall Study|Wrong Randomization|0
373663|NCT00307801|1197030|P1|Overall Study|Wrong Randomization|1
373664|NCT00307801|1197029|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
373665|NCT00307801|1197030|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
373666|NCT00307801|1197029|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
373667|NCT00307801|1197030|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
373668|NCT00307801|1197029|P2|Overall Study|Non-compliance, not taken all tablets|2
373669|NCT00307801|1197030|P1|Overall Study|Non-compliance, not taken all tablets|1
373670|NCT00307801|1197029|P2|Overall Study|Withdrawal by Subject|4
373671|NCT00307801|1197030|P1|Overall Study|Withdrawal by Subject|9
373672|NCT00307801|1197029|P2|Overall Study|Adverse Event|4
373673|NCT00307801|1197030|P1|Overall Study|Adverse Event|12
373674|NCT00307736|1197142|P4|Overall Study|Withdrawal by Subject|0
373675|NCT00307736|1197143|P3|Overall Study|Withdrawal by Subject|2
373676|NCT00307736|1197144|P2|Overall Study|Withdrawal by Subject|0
373677|NCT00307736|1197145|P1|Overall Study|Withdrawal by Subject|0
373678|NCT00307736|1197142|P4|Overall Study|Adverse Event|3
373679|NCT00307736|1197143|P3|Overall Study|Adverse Event|1
373680|NCT00307736|1197144|P2|Overall Study|Adverse Event|0
373681|NCT00307736|1197145|P1|Overall Study|Adverse Event|0
373682|NCT00307684|1197156|P3|Double Blind Phase|Lack of Efficacy|0
373683|NCT00307684|1197157|P2|Double Blind Phase|Lack of Efficacy|5
373684|NCT00307684|1197158|P1|Double Blind Phase|Lack of Efficacy|2
373685|NCT00307684|1197156|P3|Open Label Phase|other|6
373686|NCT00307684|1197157|P2|Open Label Phase|other|0
373687|NCT00307684|1197158|P1|Open Label Phase|other|0
373688|NCT00307684|1197156|P3|Open Label Phase|non compliance|5
373689|NCT00307684|1197157|P2|Open Label Phase|non compliance|0
373690|NCT00307684|1197158|P1|Open Label Phase|non compliance|0
373691|NCT00307684|1197156|P3|Open Label Phase|Lost to Follow-up|11
373692|NCT00307684|1197157|P2|Open Label Phase|Lost to Follow-up|0
373693|NCT00307684|1197158|P1|Open Label Phase|Lost to Follow-up|0
373694|NCT00307684|1197156|P3|Open Label Phase|Withdrawal by Subject|15
373695|NCT00307684|1197157|P2|Open Label Phase|Withdrawal by Subject|0
373696|NCT00307684|1197158|P1|Open Label Phase|Withdrawal by Subject|0
373697|NCT00307684|1197156|P3|Open Label Phase|Adverse Event|16
373698|NCT00307684|1197157|P2|Open Label Phase|Adverse Event|0
373699|NCT00307684|1197158|P1|Open Label Phase|Adverse Event|0
373700|NCT00307684|1197156|P3|Open Label Phase|Lack of Efficacy|3
373701|NCT00307684|1197157|P2|Open Label Phase|Lack of Efficacy|0
373702|NCT00307684|1197158|P1|Open Label Phase|Lack of Efficacy|0
373703|NCT00307489|1197186|P2|Week 48 Through Week 168|Seroconversion|0
373704|NCT00307489|1197187|P1|Week 48 Through Week 168|Seroconversion|1
373705|NCT00307489|1197186|P2|Week 48 Through Week 168|Lost to Follow-up|1
373706|NCT00307489|1197187|P1|Week 48 Through Week 168|Lost to Follow-up|0
373707|NCT00307489|1197186|P2|Week 48 Through Week 168|Death|1
373708|NCT00307489|1197187|P1|Week 48 Through Week 168|Death|0
373709|NCT00307489|1197186|P2|Week 48 Through Week 168|Lack of Efficacy|2
373710|NCT00307489|1197187|P1|Week 48 Through Week 168|Lack of Efficacy|2
373711|NCT00307489|1197186|P2|Week 48 Through Week 168|Withdrawal by Subject|2
373712|NCT00307489|1197187|P1|Week 48 Through Week 168|Withdrawal by Subject|1
373713|NCT00307489|1197186|P2|Week 48 Through Week 168|Physician Decision|0
373714|NCT00307489|1197187|P1|Week 48 Through Week 168|Physician Decision|1
373715|NCT00307489|1197186|P2|Week 48 Through Week 168|Adverse Event|0
373716|NCT00307489|1197187|P1|Week 48 Through Week 168|Adverse Event|1
373717|NCT00307489|1197186|P2|Baseline Through Week 48|Withdrawal by Subject|1
373718|NCT00307489|1197187|P1|Baseline Through Week 48|Withdrawal by Subject|0
373719|NCT00307489|1197186|P2|Baseline Through Week 48|Physician Decision|0
373720|NCT00307489|1197187|P1|Baseline Through Week 48|Physician Decision|1
373721|NCT00307489|1197186|P2|Baseline Through Week 48|Lost to Follow-up|1
373722|NCT00307489|1197187|P1|Baseline Through Week 48|Lost to Follow-up|0
373723|NCT00307437|1197232|P7|After Controlled Period|Unspecified|28
373724|NCT00307437|1197233|P6|After Controlled Period|Unspecified|40
373725|NCT00307437|1197234|P5|After Controlled Period|Unspecified|9
373726|NCT00307437|1197235|P4|After Controlled Period|Unspecified|15
373727|NCT00307437|1197236|P3|After Controlled Period|Unspecified|0
373728|NCT00307437|1197237|P2|After Controlled Period|Unspecified|0
373729|NCT00307437|1197238|P1|After Controlled Period|Unspecified|0
373730|NCT00307437|1197232|P7|After Controlled Period|Lost to Follow-up|18
373731|NCT00307437|1197233|P6|After Controlled Period|Lost to Follow-up|13
373732|NCT00307437|1197234|P5|After Controlled Period|Lost to Follow-up|12
373733|NCT00307437|1197235|P4|After Controlled Period|Lost to Follow-up|7
373734|NCT00307437|1197236|P3|After Controlled Period|Lost to Follow-up|0
373735|NCT00307437|1197237|P2|After Controlled Period|Lost to Follow-up|0
373736|NCT00307437|1197238|P1|After Controlled Period|Lost to Follow-up|0
373737|NCT00307437|1197232|P7|After Controlled Period|Lack of Efficacy|24
373738|NCT00307437|1197233|P6|After Controlled Period|Lack of Efficacy|37
373739|NCT00307437|1197234|P5|After Controlled Period|Lack of Efficacy|17
373740|NCT00307437|1197235|P4|After Controlled Period|Lack of Efficacy|15
373741|NCT00307437|1197236|P3|After Controlled Period|Lack of Efficacy|0
373742|NCT00307437|1197237|P2|After Controlled Period|Lack of Efficacy|0
373743|NCT00307437|1197238|P1|After Controlled Period|Lack of Efficacy|0
373744|NCT00307437|1197232|P7|After Controlled Period|Death|3
373745|NCT00307437|1197233|P6|After Controlled Period|Death|1
373746|NCT00307437|1197234|P5|After Controlled Period|Death|1
373747|NCT00307437|1197235|P4|After Controlled Period|Death|3
373748|NCT00307437|1197236|P3|After Controlled Period|Death|0
373749|NCT00307437|1197237|P2|After Controlled Period|Death|0
373750|NCT00307437|1197238|P1|After Controlled Period|Death|0
373751|NCT00307437|1197232|P7|After Controlled Period|Adverse Event|40
373752|NCT00307437|1197233|P6|After Controlled Period|Adverse Event|31
373753|NCT00307437|1197234|P5|After Controlled Period|Adverse Event|16
373754|NCT00307437|1197235|P4|After Controlled Period|Adverse Event|18
373755|NCT00307437|1197236|P3|After Controlled Period|Adverse Event|0
373756|NCT00307437|1197237|P2|After Controlled Period|Adverse Event|0
373757|NCT00307437|1197238|P1|After Controlled Period|Adverse Event|0
373758|NCT00307437|1197232|P7|Controlled Period|Unspecified|0
373759|NCT00307437|1197233|P6|Controlled Period|Unspecified|0
373760|NCT00307437|1197234|P5|Controlled Period|Unspecified|0
373761|NCT00307437|1197235|P4|Controlled Period|Unspecified|0
373762|NCT00307437|1197236|P3|Controlled Period|Unspecified|3
373763|NCT00307437|1197237|P2|Controlled Period|Unspecified|1
373764|NCT00307437|1197238|P1|Controlled Period|Unspecified|5
373765|NCT00307437|1197232|P7|Controlled Period|Lost to Follow-up|0
373766|NCT00307437|1197233|P6|Controlled Period|Lost to Follow-up|0
373767|NCT00307437|1197234|P5|Controlled Period|Lost to Follow-up|0
373768|NCT00307437|1197235|P4|Controlled Period|Lost to Follow-up|0
373769|NCT00307437|1197236|P3|Controlled Period|Lost to Follow-up|0
373770|NCT00307437|1197237|P2|Controlled Period|Lost to Follow-up|3
373771|NCT00307437|1197238|P1|Controlled Period|Lost to Follow-up|2
373772|NCT00307437|1197232|P7|Controlled Period|Lack of Efficacy|0
373773|NCT00307437|1197233|P6|Controlled Period|Lack of Efficacy|0
373774|NCT00307437|1197234|P5|Controlled Period|Lack of Efficacy|0
373775|NCT00307437|1197235|P4|Controlled Period|Lack of Efficacy|0
373776|NCT00307437|1197236|P3|Controlled Period|Lack of Efficacy|0
373777|NCT00307437|1197237|P2|Controlled Period|Lack of Efficacy|0
373778|NCT00307437|1197238|P1|Controlled Period|Lack of Efficacy|2
373779|NCT00307437|1197232|P7|Controlled Period|Death|0
373780|NCT00307437|1197233|P6|Controlled Period|Death|0
373781|NCT00307437|1197234|P5|Controlled Period|Death|0
373782|NCT00307437|1197235|P4|Controlled Period|Death|0
373783|NCT00307437|1197236|P3|Controlled Period|Death|1
373784|NCT00307437|1197237|P2|Controlled Period|Death|0
373785|NCT00307437|1197238|P1|Controlled Period|Death|0
373786|NCT00307437|1197232|P7|Controlled Period|Adverse Event|0
373787|NCT00307437|1197233|P6|Controlled Period|Adverse Event|0
373788|NCT00307437|1197234|P5|Controlled Period|Adverse Event|0
373789|NCT00307437|1197235|P4|Controlled Period|Adverse Event|0
373790|NCT00307437|1197236|P3|Controlled Period|Adverse Event|5
373791|NCT00307437|1197237|P2|Controlled Period|Adverse Event|2
373792|NCT00307437|1197238|P1|Controlled Period|Adverse Event|7
373793|NCT00307333|1197264|P2|Overall Study|Lost to Follow-up|3
373794|NCT00307333|1197265|P1|Overall Study|Lost to Follow-up|11
373795|NCT00307164|1197283|P2|Overall Study|Lost to Follow-up|1
373796|NCT00307164|1197284|P1|Overall Study|Lost to Follow-up|6
373797|NCT00307164|1197283|P2|Overall Study|Not compliant with requirements|4
373798|NCT00307164|1197284|P1|Overall Study|Not compliant with requirements|4
373799|NCT00307164|1197283|P2|Overall Study|Withdrawal by Subject|8
373800|NCT00307164|1197284|P1|Overall Study|Withdrawal by Subject|1
373801|NCT00307164|1197283|P2|Overall Study|Subject/parent not able to get to clinic|1
373802|NCT00307164|1197284|P1|Overall Study|Subject/parent not able to get to clinic|2
373886|NCT00307125|1197372|P2|Screening Phase|Graft Loss|0
373803|NCT00307164|1197283|P2|Overall Study|Severe debilitation, unable to continue|0
373804|NCT00307164|1197284|P1|Overall Study|Severe debilitation, unable to continue|1
373805|NCT00307164|1197283|P2|Overall Study|Death|0
373806|NCT00307164|1197284|P1|Overall Study|Death|1
373807|NCT00307151|1197324|P4|Overall Study|Clinic unable to contact subject|1
373808|NCT00307151|1197325|P3|Overall Study|Clinic unable to contact subject|1
373809|NCT00307151|1197326|P2|Overall Study|Clinic unable to contact subject|3
373810|NCT00307151|1197327|P1|Overall Study|Clinic unable to contact subject|3
373811|NCT00307151|1197324|P4|Overall Study|Not willing to adhere to study reqs|2
373812|NCT00307151|1197325|P3|Overall Study|Not willing to adhere to study reqs|2
373813|NCT00307151|1197326|P2|Overall Study|Not willing to adhere to study reqs|0
373814|NCT00307151|1197327|P1|Overall Study|Not willing to adhere to study reqs|2
373815|NCT00307151|1197324|P4|Overall Study|Withdrew consent|3
373816|NCT00307151|1197325|P3|Overall Study|Withdrew consent|1
373817|NCT00307151|1197326|P2|Overall Study|Withdrew consent|1
373818|NCT00307151|1197327|P1|Overall Study|Withdrew consent|0
373819|NCT00307151|1197324|P4|Overall Study|Subject unable to get to clinic|2
373820|NCT00307151|1197325|P3|Overall Study|Subject unable to get to clinic|6
373821|NCT00307151|1197326|P2|Overall Study|Subject unable to get to clinic|0
373822|NCT00307151|1197327|P1|Overall Study|Subject unable to get to clinic|1
373823|NCT00307151|1197324|P4|Overall Study|Severe debilitation, unable to continue|0
373824|NCT00307151|1197325|P3|Overall Study|Severe debilitation, unable to continue|0
373825|NCT00307151|1197326|P2|Overall Study|Severe debilitation, unable to continue|0
373826|NCT00307151|1197327|P1|Overall Study|Severe debilitation, unable to continue|1
373827|NCT00307151|1197324|P4|Overall Study|Death|3
373828|NCT00307151|1197325|P3|Overall Study|Death|10
373829|NCT00307151|1197326|P2|Overall Study|Death|3
373830|NCT00307151|1197327|P1|Overall Study|Death|4
373831|NCT00307125|1197371|P3|Pilot Phase|Withdrawal by Subject|1
373832|NCT00307125|1197372|P2|Pilot Phase|Withdrawal by Subject|1
373833|NCT00307125|1197373|P1|Pilot Phase|Withdrawal by Subject|0
373834|NCT00307125|1197371|P3|Pilot Phase|Lost to Follow-up|0
373835|NCT00307125|1197372|P2|Pilot Phase|Lost to Follow-up|1
373836|NCT00307125|1197373|P1|Pilot Phase|Lost to Follow-up|0
373837|NCT00307125|1197371|P3|Screening Phase|Coronary artery bypass|0
373838|NCT00307125|1197372|P2|Screening Phase|Coronary artery bypass|0
373839|NCT00307125|1197373|P1|Screening Phase|Coronary artery bypass|1
373840|NCT00307125|1197371|P3|Screening Phase|AMR and treated with rituximab|0
373841|NCT00307125|1197372|P2|Screening Phase|AMR and treated with rituximab|0
373842|NCT00307125|1197373|P1|Screening Phase|AMR and treated with rituximab|1
373843|NCT00307125|1197371|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
373844|NCT00307125|1197372|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
373845|NCT00307125|1197373|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
373846|NCT00307125|1197371|P3|Screening Phase|Screen Error|0
373847|NCT00307125|1197372|P2|Screening Phase|Screen Error|0
373848|NCT00307125|1197373|P1|Screening Phase|Screen Error|1
373849|NCT00307125|1197371|P3|Screening Phase|Ineligible|0
373850|NCT00307125|1197372|P2|Screening Phase|Ineligible|0
373851|NCT00307125|1197373|P1|Screening Phase|Ineligible|1
373852|NCT00307125|1197371|P3|Screening Phase|PAK|0
373853|NCT00307125|1197372|P2|Screening Phase|PAK|0
373854|NCT00307125|1197373|P1|Screening Phase|PAK|1
373855|NCT00307125|1197371|P3|Screening Phase|Malignancy|0
373856|NCT00307125|1197372|P2|Screening Phase|Malignancy|0
373857|NCT00307125|1197373|P1|Screening Phase|Malignancy|1
373858|NCT00307125|1197371|P3|Screening Phase|Metastatic colon cancer|0
373859|NCT00307125|1197372|P2|Screening Phase|Metastatic colon cancer|0
373860|NCT00307125|1197373|P1|Screening Phase|Metastatic colon cancer|1
373861|NCT00307125|1197371|P3|Screening Phase|Developed acute leukemia|0
373862|NCT00307125|1197372|P2|Screening Phase|Developed acute leukemia|0
373863|NCT00307125|1197373|P1|Screening Phase|Developed acute leukemia|1
373864|NCT00307125|1197371|P3|Screening Phase|Try to get pregnant|0
373865|NCT00307125|1197372|P2|Screening Phase|Try to get pregnant|0
373866|NCT00307125|1197373|P1|Screening Phase|Try to get pregnant|1
373867|NCT00307125|1197371|P3|Screening Phase|Ineligible for pilot|0
373868|NCT00307125|1197372|P2|Screening Phase|Ineligible for pilot|0
373869|NCT00307125|1197373|P1|Screening Phase|Ineligible for pilot|4
373870|NCT00307125|1197371|P3|Screening Phase|Received Pancreas Transplant|0
373871|NCT00307125|1197372|P2|Screening Phase|Received Pancreas Transplant|0
373872|NCT00307125|1197373|P1|Screening Phase|Received Pancreas Transplant|8
373873|NCT00307125|1197371|P3|Screening Phase|Moved or transferred facilities|0
373874|NCT00307125|1197372|P2|Screening Phase|Moved or transferred facilities|0
373875|NCT00307125|1197373|P1|Screening Phase|Moved or transferred facilities|34
373876|NCT00307125|1197371|P3|Screening Phase|Scheduling issues/Non-compliance|0
373877|NCT00307125|1197372|P2|Screening Phase|Scheduling issues/Non-compliance|0
373878|NCT00307125|1197373|P1|Screening Phase|Scheduling issues/Non-compliance|55
373879|NCT00307125|1197371|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
373880|NCT00307125|1197372|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
373881|NCT00307125|1197373|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
373882|NCT00307125|1197371|P3|Screening Phase|Graft Failure|0
373883|NCT00307125|1197372|P2|Screening Phase|Graft Failure|0
373884|NCT00307125|1197373|P1|Screening Phase|Graft Failure|8
373885|NCT00307125|1197371|P3|Screening Phase|Graft Loss|0
373887|NCT00307125|1197373|P1|Screening Phase|Graft Loss|3
373888|NCT00307125|1197371|P3|Screening Phase|Study Terminated|0
373889|NCT00307125|1197372|P2|Screening Phase|Study Terminated|0
373890|NCT00307125|1197373|P1|Screening Phase|Study Terminated|17
373891|NCT00307125|1197371|P3|Screening Phase|Sponsor Decision|0
373892|NCT00307125|1197372|P2|Screening Phase|Sponsor Decision|0
373893|NCT00307125|1197373|P1|Screening Phase|Sponsor Decision|4
373894|NCT00307125|1197371|P3|Screening Phase|Physician Decision|0
373895|NCT00307125|1197372|P2|Screening Phase|Physician Decision|0
373896|NCT00307125|1197373|P1|Screening Phase|Physician Decision|26
373897|NCT00307125|1197371|P3|Screening Phase|Withdrawal by Subject|0
373898|NCT00307125|1197372|P2|Screening Phase|Withdrawal by Subject|0
373899|NCT00307125|1197373|P1|Screening Phase|Withdrawal by Subject|77
373900|NCT00307125|1197371|P3|Screening Phase|Death|0
373901|NCT00307125|1197372|P2|Screening Phase|Death|0
373902|NCT00307125|1197373|P1|Screening Phase|Death|10
373903|NCT00307125|1197371|P3|Screening Phase|Lost to Follow-up|0
373904|NCT00307125|1197372|P2|Screening Phase|Lost to Follow-up|0
373905|NCT00307125|1197373|P1|Screening Phase|Lost to Follow-up|87
373906|NCT00307125|1197371|P3|Screening Phase|Protocol Violation|0
373907|NCT00307125|1197372|P2|Screening Phase|Protocol Violation|0
373908|NCT00307125|1197373|P1|Screening Phase|Protocol Violation|27
373909|NCT00307125|1197371|P3|Screening Phase|Adverse Event|0
373910|NCT00307125|1197372|P2|Screening Phase|Adverse Event|0
373911|NCT00307125|1197373|P1|Screening Phase|Adverse Event|1
373912|NCT00307086|1197395|P1|Overall Study|ineligible|5
373913|NCT00307047|1197401|P2|Overall Study|All death, all MI, all Revascularization|16
373914|NCT00307047|1197402|P1|Overall Study|All death, all MI, all Revascularization|27
373915|NCT00307047|1197401|P2|Overall Study|Lost to follow-up for other reasons|1
373916|NCT00307047|1197402|P1|Overall Study|Lost to follow-up for other reasons|0
373917|NCT00307047|1197401|P2|Overall Study|Physician Decision|2
373918|NCT00307047|1197402|P1|Overall Study|Physician Decision|1
373919|NCT00307047|1197401|P2|Overall Study|Withdrawal by Subject|6
373920|NCT00307047|1197402|P1|Overall Study|Withdrawal by Subject|6
373921|NCT00307047|1197401|P2|Overall Study|Lost to Follow-up|24
373922|NCT00307047|1197402|P1|Overall Study|Lost to Follow-up|35
373923|NCT00307034|1197540|P2|Overall Study|Lost to Follow-up|3
373924|NCT00307034|1197541|P1|Overall Study|Lost to Follow-up|0
373925|NCT00307034|1197540|P2|Overall Study|Withdrawal by Subject|2
373926|NCT00307034|1197541|P1|Overall Study|Withdrawal by Subject|1
373927|NCT00307034|1197540|P2|Overall Study|Adverse Event|2
373928|NCT00307034|1197541|P1|Overall Study|Adverse Event|1
373929|NCT00306891|1197592|P4|Part B|Development of study specific disc crit.|1
373930|NCT00306891|1197593|P3|Part B|Development of study specific disc crit.|0
373931|NCT00306891|1197594|P2|Part B|Development of study specific disc crit.|0
373932|NCT00306891|1197595|P1|Part B|Development of study specific disc crit.|0
373933|NCT00306891|1197592|P4|Part B|Condition under investigation worsened|8
373934|NCT00306891|1197593|P3|Part B|Condition under investigation worsened|2
373935|NCT00306891|1197594|P2|Part B|Condition under investigation worsened|0
373936|NCT00306891|1197595|P1|Part B|Condition under investigation worsened|0
373937|NCT00306891|1197592|P4|Part B|Withdrawal by Subject|1
373938|NCT00306891|1197593|P3|Part B|Withdrawal by Subject|3
373939|NCT00306891|1197594|P2|Part B|Withdrawal by Subject|0
373940|NCT00306891|1197595|P1|Part B|Withdrawal by Subject|0
373941|NCT00306891|1197592|P4|Part B|Adverse Event|5
373942|NCT00306891|1197593|P3|Part B|Adverse Event|5
373943|NCT00306891|1197594|P2|Part B|Adverse Event|0
373944|NCT00306891|1197595|P1|Part B|Adverse Event|0
373945|NCT00306891|1197592|P4|Part B|Death|2
373946|NCT00306891|1197593|P3|Part B|Death|1
373947|NCT00306891|1197594|P2|Part B|Death|0
373948|NCT00306891|1197595|P1|Part B|Death|0
373949|NCT00306891|1197592|P4|Part A|QTC interval outwith elig. criteria|0
373950|NCT00306891|1197593|P3|Part A|QTC interval outwith elig. criteria|0
373951|NCT00306891|1197594|P2|Part A|QTC interval outwith elig. criteria|0
373952|NCT00306891|1197595|P1|Part A|QTC interval outwith elig. criteria|1
373953|NCT00306891|1197592|P4|Part A|Suspicion of second malignancy|0
373954|NCT00306891|1197593|P3|Part A|Suspicion of second malignancy|0
373955|NCT00306891|1197594|P2|Part A|Suspicion of second malignancy|1
373956|NCT00306891|1197595|P1|Part A|Suspicion of second malignancy|0
373957|NCT00306891|1197592|P4|Part A|Reaccumul. of ascites following drainage|0
373958|NCT00306891|1197593|P3|Part A|Reaccumul. of ascites following drainage|0
373959|NCT00306891|1197594|P2|Part A|Reaccumul. of ascites following drainage|1
373960|NCT00306891|1197595|P1|Part A|Reaccumul. of ascites following drainage|0
373961|NCT00306891|1197592|P4|Part A|Partial bowel obstruction|0
373962|NCT00306891|1197593|P3|Part A|Partial bowel obstruction|0
373963|NCT00306891|1197594|P2|Part A|Partial bowel obstruction|0
373964|NCT00306891|1197595|P1|Part A|Partial bowel obstruction|1
373965|NCT00306891|1197592|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
373966|NCT00306891|1197593|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
373967|NCT00306891|1197594|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
373968|NCT00306891|1197595|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
373969|NCT00306891|1197592|P4|Part A|Condition under investigation worsened|0
373970|NCT00306891|1197593|P3|Part A|Condition under investigation worsened|0
373971|NCT00306891|1197594|P2|Part A|Condition under investigation worsened|2
373972|NCT00306891|1197595|P1|Part A|Condition under investigation worsened|2
373973|NCT00306891|1197592|P4|Part A|Withdrawal by Subject|0
373974|NCT00306891|1197593|P3|Part A|Withdrawal by Subject|0
373975|NCT00306891|1197594|P2|Part A|Withdrawal by Subject|1
373976|NCT00306891|1197595|P1|Part A|Withdrawal by Subject|1
373977|NCT00306852|1197618|P2|Overall Study|Lost to Follow-up|24
373978|NCT00306852|1197619|P1|Overall Study|Lost to Follow-up|15
373979|NCT00306852|1197618|P2|Overall Study|Death|14
373980|NCT00306852|1197619|P1|Overall Study|Death|14
373981|NCT00306787|1197637|P2|Overall Study|Abnormal laboratory value(s)|0
373982|NCT00306787|1197638|P1|Overall Study|Abnormal laboratory value(s)|1
373983|NCT00306787|1197637|P2|Overall Study|Administrative problems|0
373984|NCT00306787|1197638|P1|Overall Study|Administrative problems|4
373985|NCT00306787|1197637|P2|Overall Study|Lost to Follow-up|6
373986|NCT00306787|1197638|P1|Overall Study|Lost to Follow-up|9
373987|NCT00306787|1197637|P2|Overall Study|Withdrawal by Subject|9
373988|NCT00306787|1197638|P1|Overall Study|Withdrawal by Subject|2
373989|NCT00306787|1197637|P2|Overall Study|Protocol Violation|10
373990|NCT00306787|1197638|P1|Overall Study|Protocol Violation|8
373991|NCT00306787|1197637|P2|Overall Study|Lack of Efficacy|0
373992|NCT00306787|1197638|P1|Overall Study|Lack of Efficacy|1
373993|NCT00306787|1197637|P2|Overall Study|Adverse Event|1
373994|NCT00306787|1197638|P1|Overall Study|Adverse Event|1
373995|NCT00306787|1197637|P2|Overall Study|Discontinued without taking study drug|215
373996|NCT00306787|1197638|P1|Overall Study|Discontinued without taking study drug|208
373997|NCT00306670|1197656|P2|Overall Study|patients recruited; Genentech, the st|2
373998|NCT00306670|1197657|P1|Overall Study|patients recruited; Genentech, the st|0
373999|NCT00306592|1197663|P2|Overall Study|48-week Treatment Period Ongoing|20
374000|NCT00306592|1197664|P1|Overall Study|48-week Treatment Period Ongoing|0
374001|NCT00306592|1197663|P2|Overall Study|Other|2
374002|NCT00306592|1197664|P1|Overall Study|Other|1
374003|NCT00306592|1197663|P2|Overall Study|Not Specified|10
374004|NCT00306592|1197664|P1|Overall Study|Not Specified|5
374005|NCT00306592|1197663|P2|Overall Study|Voluntary|6
374006|NCT00306592|1197664|P1|Overall Study|Voluntary|10
374007|NCT00306592|1197663|P2|Overall Study|Persistent Antibodies|3
374008|NCT00306592|1197664|P1|Overall Study|Persistent Antibodies|6
374009|NCT00306592|1197663|P2|Overall Study|Noncompliance|2
374010|NCT00306592|1197664|P1|Overall Study|Noncompliance|0
374011|NCT00306592|1197663|P2|Overall Study|Lost to Follow-up|0
374012|NCT00306592|1197664|P1|Overall Study|Lost to Follow-up|1
374013|NCT00306592|1197663|P2|Overall Study|Adverse Event|15
374014|NCT00306592|1197664|P1|Overall Study|Adverse Event|8
374015|NCT00306527|1197674|P4|Overall Study|Death|2
374016|NCT00306527|1197675|P3|Overall Study|Death|1
374017|NCT00306527|1197676|P2|Overall Study|Death|0
374018|NCT00306527|1197677|P1|Overall Study|Death|1
374019|NCT00306527|1197674|P4|Overall Study|Adverse Event|1
374020|NCT00306527|1197675|P3|Overall Study|Adverse Event|1
374021|NCT00306527|1197676|P2|Overall Study|Adverse Event|0
374022|NCT00306527|1197677|P1|Overall Study|Adverse Event|0
374023|NCT00306527|1197674|P4|Overall Study|Withdrawal by Subject|3
374024|NCT00306527|1197675|P3|Overall Study|Withdrawal by Subject|0
374025|NCT00306527|1197676|P2|Overall Study|Withdrawal by Subject|3
374026|NCT00306527|1197677|P1|Overall Study|Withdrawal by Subject|2
374027|NCT00306527|1197674|P4|Overall Study|Lost to Follow-up|0
374028|NCT00306527|1197675|P3|Overall Study|Lost to Follow-up|3
374029|NCT00306527|1197676|P2|Overall Study|Lost to Follow-up|4
374030|NCT00306527|1197677|P1|Overall Study|Lost to Follow-up|3
374031|NCT00306384|1197746|P3|Overall Study|Site closure|0
374032|NCT00306384|1197747|P2|Overall Study|Site closure|0
374033|NCT00306384|1197748|P1|Overall Study|Site closure|2
374034|NCT00306384|1197746|P3|Overall Study|Other|32
374035|NCT00306384|1197747|P2|Overall Study|Other|70
374036|NCT00306384|1197748|P1|Overall Study|Other|80
374037|NCT00306384|1197746|P3|Overall Study|Investigator discretion|21
374038|NCT00306384|1197747|P2|Overall Study|Investigator discretion|31
374039|NCT00306384|1197748|P1|Overall Study|Investigator discretion|28
374040|NCT00306384|1197746|P3|Overall Study|Lack of Efficacy|38
374041|NCT00306384|1197747|P2|Overall Study|Lack of Efficacy|40
374042|NCT00306384|1197748|P1|Overall Study|Lack of Efficacy|26
374043|NCT00306384|1197746|P3|Overall Study|Pregnancy|1
374044|NCT00306384|1197747|P2|Overall Study|Pregnancy|1
374045|NCT00306384|1197748|P1|Overall Study|Pregnancy|3
374046|NCT00306384|1197746|P3|Overall Study|Study termination|1
374047|NCT00306384|1197747|P2|Overall Study|Study termination|0
374048|NCT00306384|1197748|P1|Overall Study|Study termination|1
374049|NCT00306384|1197746|P3|Overall Study|Voluntary withdrawal|91
374050|NCT00306384|1197747|P2|Overall Study|Voluntary withdrawal|187
374051|NCT00306384|1197748|P1|Overall Study|Voluntary withdrawal|199
374052|NCT00306384|1197746|P3|Overall Study|Lost to Follow-up|35
374053|NCT00306384|1197747|P2|Overall Study|Lost to Follow-up|41
374054|NCT00306384|1197748|P1|Overall Study|Lost to Follow-up|57
374055|NCT00306384|1197746|P3|Overall Study|Major protocol deviation|18
374056|NCT00306384|1197747|P2|Overall Study|Major protocol deviation|51
374057|NCT00306384|1197748|P1|Overall Study|Major protocol deviation|43
374058|NCT00306384|1197746|P3|Overall Study|Adverse Event|40
374059|NCT00306384|1197747|P2|Overall Study|Adverse Event|87
374060|NCT00306384|1197748|P1|Overall Study|Adverse Event|103
374061|NCT00306202|1197783|P3|Overall Study|Still on treatment|0
374062|NCT00306202|1197784|P2|Overall Study|Still on treatment|1
374063|NCT00306202|1197785|P1|Overall Study|Still on treatment|6
374064|NCT00306189|1197945|P4|Overall Study|Other|0
374065|NCT00306189|1197946|P3|Overall Study|Other|0
374066|NCT00306189|1197947|P2|Overall Study|Other|0
374067|NCT00306189|1197948|P1|Overall Study|Other|1
374068|NCT00306189|1197945|P4|Overall Study|Ineligibility determined|1
374069|NCT00306189|1197946|P3|Overall Study|Ineligibility determined|1
374070|NCT00306189|1197947|P2|Overall Study|Ineligibility determined|1
374071|NCT00306189|1197948|P1|Overall Study|Ineligibility determined|1
374072|NCT00306189|1197945|P4|Overall Study|Withdrawal by Subject|1
374073|NCT00306189|1197946|P3|Overall Study|Withdrawal by Subject|8
374074|NCT00306189|1197947|P2|Overall Study|Withdrawal by Subject|2
374075|NCT00306189|1197948|P1|Overall Study|Withdrawal by Subject|4
374076|NCT00306189|1197945|P4|Overall Study|Adverse Event|2
374077|NCT00306189|1197946|P3|Overall Study|Adverse Event|2
374078|NCT00306189|1197947|P2|Overall Study|Adverse Event|3
374079|NCT00306189|1197948|P1|Overall Study|Adverse Event|3
374080|NCT00306189|1197945|P4|Overall Study|Physician Decision|1
374081|NCT00306189|1197946|P3|Overall Study|Physician Decision|0
374082|NCT00306189|1197947|P2|Overall Study|Physician Decision|0
374083|NCT00306189|1197948|P1|Overall Study|Physician Decision|0
374084|NCT00305877|1197975|P2|Overall Study|Transportation issue with daily RT|1
374085|NCT00305877|1197976|P1|Overall Study|Transportation issue with daily RT|0
374086|NCT00305877|1197975|P2|Overall Study|Ineligible|1
374087|NCT00305877|1197976|P1|Overall Study|Ineligible|2
374088|NCT00305877|1197975|P2|Overall Study|Never start treatment|5
374089|NCT00305877|1197976|P1|Overall Study|Never start treatment|2
374090|NCT00305877|1197975|P2|Overall Study|Physician Decision|1
374091|NCT00305877|1197976|P1|Overall Study|Physician Decision|1
374092|NCT00305877|1197975|P2|Overall Study|Withdrawal by Subject|2
374093|NCT00305877|1197976|P1|Overall Study|Withdrawal by Subject|4
374094|NCT00305877|1197975|P2|Overall Study|Death|1
374095|NCT00305877|1197976|P1|Overall Study|Death|0
374096|NCT00305877|1197975|P2|Overall Study|Adverse Event|14
374097|NCT00305877|1197976|P1|Overall Study|Adverse Event|9
374098|NCT00305877|1197975|P2|Overall Study|Lack of Efficacy|9
374099|NCT00305877|1197976|P1|Overall Study|Lack of Efficacy|6
374100|NCT00305864|1197990|P4|Overall Study|Ineligible / No protocol treatment|13
374101|NCT00305864|1197991|P3|Overall Study|Ineligible / No protocol treatment|1
374102|NCT00305864|1197992|P2|Overall Study|Ineligible / No protocol treatment|1
374103|NCT00305864|1197993|P1|Overall Study|Ineligible / No protocol treatment|0
374104|NCT00305773|1198005|P2|Overall Study|All other reasons|2
374105|NCT00305773|1198006|P1|Overall Study|All other reasons|3
374106|NCT00305773|1198005|P2|Overall Study|Disease Progression|3
374107|NCT00305773|1198006|P1|Overall Study|Disease Progression|1
374108|NCT00305773|1198005|P2|Overall Study|Withdrawal by Subject|4
374109|NCT00305773|1198006|P1|Overall Study|Withdrawal by Subject|1
374110|NCT00305773|1198005|P2|Overall Study|Physician Decision|1
374111|NCT00305773|1198006|P1|Overall Study|Physician Decision|1
374112|NCT00305773|1198005|P2|Overall Study|Alternative Treatment|4
374113|NCT00305773|1198006|P1|Overall Study|Alternative Treatment|4
374114|NCT00305773|1198005|P2|Overall Study|Adverse Event|2
374115|NCT00305773|1198006|P1|Overall Study|Adverse Event|1
374116|NCT00305773|1198005|P2|Overall Study|Death|2
374117|NCT00305773|1198006|P1|Overall Study|Death|3
374118|NCT00305604|1198037|P2|Overall Study|Patient moved|0
374119|NCT00305604|1198038|P1|Overall Study|Patient moved|1
374120|NCT00305604|1198037|P2|Overall Study|Withdrawal by Subject|21
374121|NCT00305604|1198038|P1|Overall Study|Withdrawal by Subject|12
374122|NCT00305604|1198037|P2|Overall Study|Protocol Violation|1
374123|NCT00305604|1198038|P1|Overall Study|Protocol Violation|2
374124|NCT00305604|1198037|P2|Overall Study|Lost to Follow-up|4
374125|NCT00305604|1198038|P1|Overall Study|Lost to Follow-up|0
374126|NCT00305604|1198037|P2|Overall Study|Lack of Efficacy|18
374127|NCT00305604|1198038|P1|Overall Study|Lack of Efficacy|11
374128|NCT00305604|1198037|P2|Overall Study|Adverse Event|3
374129|NCT00305604|1198038|P1|Overall Study|Adverse Event|6
374130|NCT00305448|1198182|P3|Overall Study|Tumor Marker Elevation|1
374131|NCT00305448|1198183|P2|Overall Study|Tumor Marker Elevation|0
374132|NCT00305448|1198184|P1|Overall Study|Tumor Marker Elevation|0
374133|NCT00305448|1198182|P3|Overall Study|Subjective Disease Progression|2
374134|NCT00305448|1198183|P2|Overall Study|Subjective Disease Progression|2
374135|NCT00305448|1198184|P1|Overall Study|Subjective Disease Progression|1
374136|NCT00305448|1198182|P3|Overall Study|Disease Progression|28
374137|NCT00305448|1198183|P2|Overall Study|Disease Progression|31
374138|NCT00305448|1198184|P1|Overall Study|Disease Progression|27
374139|NCT00305448|1198182|P3|Overall Study|Adverse Event|1
374140|NCT00305448|1198183|P2|Overall Study|Adverse Event|0
374141|NCT00305448|1198184|P1|Overall Study|Adverse Event|1
374142|NCT00305448|1198182|P3|Overall Study|Withdrawal by Subject|1
374143|NCT00305448|1198183|P2|Overall Study|Withdrawal by Subject|0
374144|NCT00305448|1198184|P1|Overall Study|Withdrawal by Subject|2
374145|NCT00305448|1198182|P3|Overall Study|Protocol Violation|0
374146|NCT00305448|1198183|P2|Overall Study|Protocol Violation|1
374147|NCT00305448|1198184|P1|Overall Study|Protocol Violation|0
374148|NCT00305253|1198206|P2|Overall Study|Withdrawal by Subject|1
374149|NCT00305253|1198207|P1|Overall Study|Withdrawal by Subject|0
374150|NCT00305227|1198219|P2|Overall Study|Lost to Follow-up|6
374151|NCT00305227|1198220|P1|Overall Study|Lost to Follow-up|7
374152|NCT00304954|1198271|P4|Overall Study|Adverse Event|0
374153|NCT00304954|1198272|P3|Overall Study|Adverse Event|0
374154|NCT00304954|1198273|P2|Overall Study|Adverse Event|0
374155|NCT00304954|1198274|P1|Overall Study|Adverse Event|1
374156|NCT00304954|1198271|P4|Overall Study|Withdrawal by Subject|0
374157|NCT00304954|1198272|P3|Overall Study|Withdrawal by Subject|1
374158|NCT00304954|1198273|P2|Overall Study|Withdrawal by Subject|0
374159|NCT00304954|1198274|P1|Overall Study|Withdrawal by Subject|0
374160|NCT00304915|1198294|P2|Overall Study|Withdrawal by Subject|0
374161|NCT00304915|1198295|P1|Overall Study|Withdrawal by Subject|3
374162|NCT00304915|1198294|P2|Overall Study|Death|5
374163|NCT00304915|1198295|P1|Overall Study|Death|4
374164|NCT00304915|1198294|P2|Overall Study|Lost to Follow-up|11
374165|NCT00304915|1198295|P1|Overall Study|Lost to Follow-up|11
374166|NCT00304070|1198364|P3|Overall Study|Progressive Disease|4
374167|NCT00304070|1198365|P2|Overall Study|Progressive Disease|7
374168|NCT00304070|1198366|P1|Overall Study|Progressive Disease|3
374169|NCT00304070|1198364|P3|Overall Study|Withdrawal by Subject|1
374170|NCT00304070|1198365|P2|Overall Study|Withdrawal by Subject|0
374171|NCT00304070|1198366|P1|Overall Study|Withdrawal by Subject|0
374172|NCT00304070|1198364|P3|Overall Study|Physician Decision|3
374173|NCT00304070|1198365|P2|Overall Study|Physician Decision|0
374174|NCT00304070|1198366|P1|Overall Study|Physician Decision|0
374175|NCT00304070|1198364|P3|Overall Study|Lost to Follow-up|1
374176|NCT00304070|1198365|P2|Overall Study|Lost to Follow-up|0
374177|NCT00304070|1198366|P1|Overall Study|Lost to Follow-up|0
374178|NCT00304070|1198364|P3|Overall Study|Death|3
374179|NCT00304070|1198365|P2|Overall Study|Death|0
374180|NCT00304070|1198366|P1|Overall Study|Death|0
374181|NCT00304031|1198381|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
374182|NCT00304031|1198382|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
374183|NCT00304031|1198383|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
374184|NCT00304031|1198381|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
374185|NCT00304031|1198382|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
374186|NCT00304031|1198383|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
374187|NCT00304031|1198381|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
374188|NCT00304031|1198382|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
374189|NCT00304031|1198383|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
374190|NCT00304031|1198381|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
374191|NCT00304031|1198382|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
374192|NCT00304031|1198383|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
374193|NCT00304031|1198381|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
374194|NCT00304031|1198382|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
374195|NCT00304031|1198383|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
374196|NCT00304031|1198381|P3|Concomitant Radiation Therapy and TMZ|Death|0
374197|NCT00304031|1198382|P2|Concomitant Radiation Therapy and TMZ|Death|0
374198|NCT00304031|1198383|P1|Concomitant Radiation Therapy and TMZ|Death|18
374199|NCT00304031|1198381|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
374200|NCT00304031|1198382|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
374201|NCT00304031|1198383|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
374202|NCT00304031|1198381|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
374203|NCT00304031|1198382|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
374204|NCT00304031|1198383|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
374205|NCT00304031|1198381|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
374206|NCT00304031|1198382|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
374207|NCT00304031|1198383|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
374208|NCT00304031|1198381|P3|Registration|Ineligible|0
374209|NCT00304031|1198382|P2|Registration|Ineligible|0
374210|NCT00304031|1198383|P1|Registration|Ineligible|48
374211|NCT00303953|1198414|P1|Overall Study|Physician Decision|1
374212|NCT00303953|1198414|P1|Overall Study|Lack of Efficacy|12
374213|NCT00303953|1198414|P1|Overall Study|Adverse Event|4
374214|NCT00303953|1198414|P1|Overall Study|Death|1
374215|NCT00303953|1198414|P1|Overall Study|Ineligible|1
374216|NCT00303667|1198449|P2|Overall Study|Death|4
374217|NCT00303667|1198450|P1|Overall Study|Death|0
374218|NCT00303628|1198474|P2|Overall Study|Other|9
374219|NCT00303628|1198475|P1|Overall Study|Other|8
374220|NCT00303628|1198474|P2|Overall Study|Not start protocol therapy|5
374221|NCT00303628|1198475|P1|Overall Study|Not start protocol therapy|3
374222|NCT00303628|1198474|P2|Overall Study|Other complicating disease|1
374223|NCT00303628|1198475|P1|Overall Study|Other complicating disease|0
374224|NCT00303628|1198474|P2|Overall Study|Alternative therapy|0
374225|NCT00303628|1198475|P1|Overall Study|Alternative therapy|2
374226|NCT00303628|1198474|P2|Overall Study|Withdrawal by Subject|20
374227|NCT00303628|1198475|P1|Overall Study|Withdrawal by Subject|11
374228|NCT00303628|1198474|P2|Overall Study|Death|1
374229|NCT00303628|1198475|P1|Overall Study|Death|0
374230|NCT00303628|1198474|P2|Overall Study|Adverse Event|36
374231|NCT00303628|1198475|P1|Overall Study|Adverse Event|26
374232|NCT00303628|1198474|P2|Overall Study|Disease progression|1
374233|NCT00303628|1198475|P1|Overall Study|Disease progression|0
374234|NCT00303602|1198493|P2|Overall Study|Protocol Violation|0
374235|NCT00303602|1198494|P1|Overall Study|Protocol Violation|1
374236|NCT00303602|1198493|P2|Overall Study|Noncompliance|2
374237|NCT00303602|1198494|P1|Overall Study|Noncompliance|2
374238|NCT00303602|1198493|P2|Overall Study|Physician Decision|1
374239|NCT00303602|1198494|P1|Overall Study|Physician Decision|2
374240|NCT00303602|1198493|P2|Overall Study|Protocol entry criteria not met|2
374241|NCT00303602|1198494|P1|Overall Study|Protocol entry criteria not met|2
374242|NCT00303602|1198493|P2|Overall Study|Lost to Follow-up|2
374243|NCT00303602|1198494|P1|Overall Study|Lost to Follow-up|5
374244|NCT00303602|1198493|P2|Overall Study|Withdrawal by Subject|6
374245|NCT00303602|1198494|P1|Overall Study|Withdrawal by Subject|5
374246|NCT00303602|1198493|P2|Overall Study|Adverse Event|2
374247|NCT00303602|1198494|P1|Overall Study|Adverse Event|2
374248|NCT00303485|1198540|P2|Overall Study|Withdrawal by Subject|0
374249|NCT00303485|1198541|P1|Overall Study|Withdrawal by Subject|1
374250|NCT00303485|1198540|P2|Overall Study|Failure to return|1
374251|NCT00303485|1198541|P1|Overall Study|Failure to return|0
374252|NCT00303485|1198540|P2|Overall Study|Adverse Event/Intercurrent Illness|1
374253|NCT00303485|1198541|P1|Overall Study|Adverse Event/Intercurrent Illness|0
374254|NCT00303472|1198572|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
374255|NCT00303472|1198573|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
374256|NCT00303472|1198574|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
374257|NCT00303472|1198575|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
374258|NCT00303472|1198576|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
374259|NCT00303472|1198577|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
374260|NCT00303472|1198578|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
374261|NCT00303472|1198572|P7|Treatment Extension (Optional)|Not specified|0
374262|NCT00303472|1198573|P6|Treatment Extension (Optional)|Not specified|0
374263|NCT00303472|1198574|P5|Treatment Extension (Optional)|Not specified|1
374264|NCT00303472|1198575|P4|Treatment Extension (Optional)|Not specified|2
374265|NCT00303472|1198576|P3|Treatment Extension (Optional)|Not specified|4
374266|NCT00303472|1198577|P2|Treatment Extension (Optional)|Not specified|2
374267|NCT00303472|1198578|P1|Treatment Extension (Optional)|Not specified|0
374268|NCT00303472|1198572|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
374269|NCT00303472|1198573|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
374270|NCT00303472|1198574|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
374271|NCT00303472|1198575|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
374272|NCT00303472|1198576|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
374273|NCT00303472|1198577|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
374274|NCT00303472|1198578|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
374275|NCT00303472|1198572|P7|Treatment Extension (Optional)|Physician Decision|0
374276|NCT00303472|1198573|P6|Treatment Extension (Optional)|Physician Decision|0
374277|NCT00303472|1198574|P5|Treatment Extension (Optional)|Physician Decision|2
374278|NCT00303472|1198575|P4|Treatment Extension (Optional)|Physician Decision|3
374279|NCT00303472|1198576|P3|Treatment Extension (Optional)|Physician Decision|2
374280|NCT00303472|1198577|P2|Treatment Extension (Optional)|Physician Decision|4
374281|NCT00303472|1198578|P1|Treatment Extension (Optional)|Physician Decision|0
374282|NCT00303472|1198572|P7|Treatment Extension (Optional)|Lost to Follow-up|0
374283|NCT00303472|1198573|P6|Treatment Extension (Optional)|Lost to Follow-up|0
374284|NCT00303472|1198574|P5|Treatment Extension (Optional)|Lost to Follow-up|0
374285|NCT00303472|1198575|P4|Treatment Extension (Optional)|Lost to Follow-up|1
374286|NCT00303472|1198576|P3|Treatment Extension (Optional)|Lost to Follow-up|0
374287|NCT00303472|1198577|P2|Treatment Extension (Optional)|Lost to Follow-up|0
374288|NCT00303472|1198578|P1|Treatment Extension (Optional)|Lost to Follow-up|0
374289|NCT00303472|1198572|P7|Treatment Extension (Optional)|Death|0
374290|NCT00303472|1198573|P6|Treatment Extension (Optional)|Death|0
374291|NCT00303472|1198574|P5|Treatment Extension (Optional)|Death|0
374292|NCT00303472|1198575|P4|Treatment Extension (Optional)|Death|0
374293|NCT00303472|1198576|P3|Treatment Extension (Optional)|Death|1
374294|NCT00303472|1198577|P2|Treatment Extension (Optional)|Death|0
374295|NCT00303472|1198578|P1|Treatment Extension (Optional)|Death|2
374296|NCT00303472|1198572|P7|Treatment Extension (Optional)|Adverse Event|0
374297|NCT00303472|1198573|P6|Treatment Extension (Optional)|Adverse Event|0
374298|NCT00303472|1198574|P5|Treatment Extension (Optional)|Adverse Event|0
374299|NCT00303472|1198575|P4|Treatment Extension (Optional)|Adverse Event|0
374300|NCT00303472|1198576|P3|Treatment Extension (Optional)|Adverse Event|1
374301|NCT00303472|1198577|P2|Treatment Extension (Optional)|Adverse Event|0
374302|NCT00303472|1198578|P1|Treatment Extension (Optional)|Adverse Event|1
374303|NCT00303472|1198572|P7|Treatment Period|Disease Progression (to AML)|0
374304|NCT00303472|1198573|P6|Treatment Period|Disease Progression (to AML)|0
374305|NCT00303472|1198574|P5|Treatment Period|Disease Progression (to AML)|1
374306|NCT00303472|1198575|P4|Treatment Period|Disease Progression (to AML)|0
374307|NCT00303472|1198576|P3|Treatment Period|Disease Progression (to AML)|0
374308|NCT00303472|1198577|P2|Treatment Period|Disease Progression (to AML)|0
374309|NCT00303472|1198578|P1|Treatment Period|Disease Progression (to AML)|0
374310|NCT00303472|1198572|P7|Treatment Period|Not specified|1
374311|NCT00303472|1198573|P6|Treatment Period|Not specified|0
374312|NCT00303472|1198574|P5|Treatment Period|Not specified|1
374313|NCT00303472|1198575|P4|Treatment Period|Not specified|0
374314|NCT00303472|1198576|P3|Treatment Period|Not specified|0
374315|NCT00303472|1198577|P2|Treatment Period|Not specified|0
374316|NCT00303472|1198578|P1|Treatment Period|Not specified|0
374317|NCT00303472|1198572|P7|Treatment Period|Withdrawal by Subject|0
374318|NCT00303472|1198573|P6|Treatment Period|Withdrawal by Subject|1
374319|NCT00303472|1198574|P5|Treatment Period|Withdrawal by Subject|0
374320|NCT00303472|1198575|P4|Treatment Period|Withdrawal by Subject|1
374321|NCT00303472|1198576|P3|Treatment Period|Withdrawal by Subject|0
374322|NCT00303472|1198577|P2|Treatment Period|Withdrawal by Subject|0
374323|NCT00303472|1198578|P1|Treatment Period|Withdrawal by Subject|0
374324|NCT00303472|1198572|P7|Treatment Period|Death|1
374325|NCT00303472|1198573|P6|Treatment Period|Death|0
374326|NCT00303472|1198574|P5|Treatment Period|Death|0
374327|NCT00303472|1198575|P4|Treatment Period|Death|1
374328|NCT00303472|1198576|P3|Treatment Period|Death|0
374329|NCT00303472|1198577|P2|Treatment Period|Death|0
374330|NCT00303472|1198578|P1|Treatment Period|Death|0
374331|NCT00303472|1198572|P7|Treatment Period|Adverse Event|0
374332|NCT00303472|1198573|P6|Treatment Period|Adverse Event|0
374333|NCT00303472|1198574|P5|Treatment Period|Adverse Event|1
374334|NCT00303472|1198575|P4|Treatment Period|Adverse Event|0
374335|NCT00303472|1198576|P3|Treatment Period|Adverse Event|0
374336|NCT00303472|1198577|P2|Treatment Period|Adverse Event|0
374337|NCT00303472|1198578|P1|Treatment Period|Adverse Event|0
374338|NCT00303459|1198638|P2|Overall Study|Lung transplantation|1
374339|NCT00303459|1198639|P1|Overall Study|Lung transplantation|1
374340|NCT00303459|1198638|P2|Overall Study|Decision by the investigator|7
374341|NCT00303459|1198639|P1|Overall Study|Decision by the investigator|5
374342|NCT00303459|1198638|P2|Overall Study|Administrative reason|7
374343|NCT00303459|1198639|P1|Overall Study|Administrative reason|7
374344|NCT00303459|1198638|P2|Overall Study|Lost to Follow-up|4
374345|NCT00303459|1198639|P1|Overall Study|Lost to Follow-up|5
374346|NCT00303459|1198638|P2|Overall Study|Withdrawal of consent|26
374347|NCT00303459|1198639|P1|Overall Study|Withdrawal of consent|32
374348|NCT00303459|1198638|P2|Overall Study|Death|44
374349|NCT00303459|1198639|P1|Overall Study|Death|33
374350|NCT00303446|1198665|P2|Overall Study|Physician Decision|1
374351|NCT00303446|1198666|P1|Overall Study|Physician Decision|0
374352|NCT00303446|1198665|P2|Overall Study|Death|1
374353|NCT00303446|1198666|P1|Overall Study|Death|0
374354|NCT00303446|1198665|P2|Overall Study|Withdrawal by Subject|2
374355|NCT00303446|1198666|P1|Overall Study|Withdrawal by Subject|2
374356|NCT00303329|1198702|P2|Overall Study|Stopped at end of extension 1|0
374357|NCT00303329|1198703|P1|Overall Study|Stopped at end of extension 1|1
374358|NCT00303329|1198702|P2|Overall Study|Stopped at end of core|9
374359|NCT00303329|1198703|P1|Overall Study|Stopped at end of core|3
374360|NCT00303329|1198702|P2|Overall Study|Death|12
374361|NCT00303329|1198703|P1|Overall Study|Death|2
374362|NCT00303329|1198702|P2|Overall Study|Administrative problems|0
374363|NCT00303329|1198703|P1|Overall Study|Administrative problems|1
374364|NCT00303329|1198702|P2|Overall Study|Lost to Follow-up|1
374365|NCT00303329|1198703|P1|Overall Study|Lost to Follow-up|0
374366|NCT00303329|1198702|P2|Overall Study|Withdrawal by Subject|15
374367|NCT00303329|1198703|P1|Overall Study|Withdrawal by Subject|9
374368|NCT00303329|1198702|P2|Overall Study|Protocol Violation|0
374369|NCT00303329|1198703|P1|Overall Study|Protocol Violation|3
374370|NCT00303329|1198702|P2|Overall Study|Condition no longer requires study drug|8
374371|NCT00303329|1198703|P1|Overall Study|Condition no longer requires study drug|0
374372|NCT00303329|1198702|P2|Overall Study|Unsatisfactory therapeutic effect|2
374373|NCT00303329|1198703|P1|Overall Study|Unsatisfactory therapeutic effect|9
374374|NCT00303329|1198702|P2|Overall Study|Abnormal Laboratory Values|1
374375|NCT00303329|1198703|P1|Overall Study|Abnormal Laboratory Values|0
374376|NCT00303329|1198702|P2|Overall Study|Adverse Event|14
374377|NCT00303329|1198703|P1|Overall Study|Adverse Event|7
374378|NCT00303316|1198717|P2|Overall Study|Withdrawal by Subject|2
374379|NCT00303316|1198718|P1|Overall Study|Withdrawal by Subject|1
374380|NCT00303316|1198717|P2|Overall Study|Lost to Follow-up|1
374381|NCT00303316|1198718|P1|Overall Study|Lost to Follow-up|0
374382|NCT00303316|1198717|P2|Overall Study|Protocol Violation|0
374383|NCT00303316|1198718|P1|Overall Study|Protocol Violation|1
374384|NCT00303186|1198730|P1|Overall Study|Unspecified|52
374385|NCT00303108|1198764|P3|Overall Study|ineligible|0
374386|NCT00303108|1198765|P2|Overall Study|ineligible|1
374387|NCT00303108|1198766|P1|Overall Study|ineligible|2
374388|NCT00303108|1198764|P3|Overall Study|Failed Entry|1
374389|NCT00303108|1198765|P2|Overall Study|Failed Entry|0
374390|NCT00303108|1198766|P1|Overall Study|Failed Entry|1
374391|NCT00303108|1198764|P3|Overall Study|Patient Request|8
374392|NCT00303108|1198765|P2|Overall Study|Patient Request|2
374393|NCT00303108|1198766|P1|Overall Study|Patient Request|4
374394|NCT00303108|1198764|P3|Overall Study|Adverse Event|7
374395|NCT00303108|1198765|P2|Overall Study|Adverse Event|6
374396|NCT00303108|1198766|P1|Overall Study|Adverse Event|5
374397|NCT00303069|1198786|P4|Overall Study|Recruitment into Army Reserves|0
374398|NCT00303069|1198787|P3|Overall Study|Recruitment into Army Reserves|1
374399|NCT00303069|1198788|P2|Overall Study|Recruitment into Army Reserves|0
374400|NCT00303069|1198789|P1|Overall Study|Recruitment into Army Reserves|0
374401|NCT00303069|1198786|P4|Overall Study|subject moved|0
374402|NCT00303069|1198787|P3|Overall Study|subject moved|0
374403|NCT00303069|1198788|P2|Overall Study|subject moved|0
374404|NCT00303069|1198789|P1|Overall Study|subject moved|1
374405|NCT00303069|1198786|P4|Overall Study|Lost to Follow-up|2
374406|NCT00303069|1198787|P3|Overall Study|Lost to Follow-up|0
374407|NCT00303069|1198788|P2|Overall Study|Lost to Follow-up|0
374408|NCT00303069|1198789|P1|Overall Study|Lost to Follow-up|1
374409|NCT00302952|1198809|P2|Overall Study|Elevated SGOT (AST) lab value|1
374410|NCT00302952|1198810|P1|Overall Study|Elevated SGOT (AST) lab value|0
374411|NCT00302952|1198809|P2|Overall Study|Withdrawal by Subject|3
374412|NCT00302952|1198810|P1|Overall Study|Withdrawal by Subject|2
374413|NCT00302952|1198809|P2|Overall Study|Physician Decision|1
374414|NCT00302952|1198810|P1|Overall Study|Physician Decision|1
374415|NCT00302718|1198860|P4|Overall Study|Participant left primary care setting|1
374416|NCT00302718|1198861|P3|Overall Study|Participant left primary care setting|2
374417|NCT00302718|1198862|P2|Overall Study|Participant left primary care setting|0
374418|NCT00302718|1198863|P1|Overall Study|Participant left primary care setting|0
374419|NCT00302718|1198860|P4|Overall Study|Withdrawal by Subject|0
374420|NCT00302718|1198861|P3|Overall Study|Withdrawal by Subject|0
374421|NCT00302718|1198862|P2|Overall Study|Withdrawal by Subject|1
374422|NCT00302718|1198863|P1|Overall Study|Withdrawal by Subject|0
374423|NCT00302718|1198860|P4|Overall Study|Participant left the hospital|1
374424|NCT00302718|1198861|P3|Overall Study|Participant left the hospital|0
374425|NCT00302718|1198862|P2|Overall Study|Participant left the hospital|0
374426|NCT00302718|1198863|P1|Overall Study|Participant left the hospital|1
374427|NCT00302458|1198895|P1|Overall Study|Withdrawal by Subject|1
374428|NCT00302458|1198895|P1|Overall Study|Ineligible after screening|1
374429|NCT00302458|1198895|P1|Overall Study|Lost to Follow-up|1
374430|NCT00302328|1198906|P3|Overall Study|Physician Decision|0
374431|NCT00302328|1198907|P2|Overall Study|Physician Decision|1
374432|NCT00302328|1198908|P1|Overall Study|Physician Decision|0
374433|NCT00302211|1198925|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
374434|NCT00302211|1198926|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
374435|NCT00302211|1198927|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
374436|NCT00302211|1198928|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
374437|NCT00302211|1198929|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
374438|NCT00302211|1198925|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
374439|NCT00302211|1198926|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
374440|NCT00302211|1198927|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
374441|NCT00302211|1198928|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
374442|NCT00302211|1198929|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
374443|NCT00302211|1198925|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
374444|NCT00302211|1198926|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
374445|NCT00302211|1198927|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
374446|NCT00302211|1198928|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
374447|NCT00302211|1198929|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
374448|NCT00302211|1198925|P5|Open Label-Patients From Double-Blind|Death|1
374449|NCT00302211|1198926|P4|Open Label-Patients From Double-Blind|Death|1
374450|NCT00302211|1198927|P3|Open Label-Patients From Double-Blind|Death|0
374451|NCT00302211|1198928|P2|Open Label-Patients From Double-Blind|Death|0
374452|NCT00302211|1198929|P1|Open Label-Patients From Double-Blind|Death|0
374453|NCT00302211|1198925|P5|Open Label-Patients From Double-Blind|Disease progression|2
374454|NCT00302211|1198926|P4|Open Label-Patients From Double-Blind|Disease progression|1
374455|NCT00302211|1198927|P3|Open Label-Patients From Double-Blind|Disease progression|0
374456|NCT00302211|1198928|P2|Open Label-Patients From Double-Blind|Disease progression|0
374457|NCT00302211|1198929|P1|Open Label-Patients From Double-Blind|Disease progression|0
374458|NCT00302211|1198925|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
374459|NCT00302211|1198926|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
374460|NCT00302211|1198927|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
374461|NCT00302211|1198928|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
374462|NCT00302211|1198929|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
374463|NCT00302211|1198925|P5|Open Label-Patients From Double-Blind|Adverse Event|0
374464|NCT00302211|1198926|P4|Open Label-Patients From Double-Blind|Adverse Event|1
374465|NCT00302211|1198927|P3|Open Label-Patients From Double-Blind|Adverse Event|0
374466|NCT00302211|1198928|P2|Open Label-Patients From Double-Blind|Adverse Event|0
374467|NCT00302211|1198929|P1|Open Label-Patients From Double-Blind|Adverse Event|0
374468|NCT00302211|1198925|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
374469|NCT00302211|1198926|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
374470|NCT00302211|1198927|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
374471|NCT00302211|1198928|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
374472|NCT00302211|1198929|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
374473|NCT00302211|1198925|P5|Double Blind Period (New Patients)|Disease progression|0
374474|NCT00302211|1198926|P4|Double Blind Period (New Patients)|Disease progression|0
374475|NCT00302211|1198927|P3|Double Blind Period (New Patients)|Disease progression|1
374476|NCT00302211|1198928|P2|Double Blind Period (New Patients)|Disease progression|1
374477|NCT00302211|1198929|P1|Double Blind Period (New Patients)|Disease progression|0
374478|NCT00302211|1198925|P5|Double Blind Period (New Patients)|Investigator's judgement|0
374479|NCT00302211|1198926|P4|Double Blind Period (New Patients)|Investigator's judgement|0
374480|NCT00302211|1198927|P3|Double Blind Period (New Patients)|Investigator's judgement|0
374481|NCT00302211|1198928|P2|Double Blind Period (New Patients)|Investigator's judgement|0
374482|NCT00302211|1198929|P1|Double Blind Period (New Patients)|Investigator's judgement|1
374483|NCT00302211|1198925|P5|Double Blind Period (New Patients)|Adverse Event|0
374484|NCT00302211|1198926|P4|Double Blind Period (New Patients)|Adverse Event|0
374485|NCT00302211|1198927|P3|Double Blind Period (New Patients)|Adverse Event|3
374486|NCT00302211|1198928|P2|Double Blind Period (New Patients)|Adverse Event|0
374487|NCT00302211|1198929|P1|Double Blind Period (New Patients)|Adverse Event|0
374488|NCT00302211|1198925|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
374489|NCT00302211|1198926|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
374490|NCT00302211|1198927|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
374491|NCT00302211|1198928|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
374492|NCT00302211|1198929|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
374493|NCT00302159|1198941|P1|Overall Study|pt started Avastin|1
374494|NCT00302159|1198941|P1|Overall Study|pt declined before treatment started|1
374495|NCT00302107|1198963|P2|Overall Study|Adverse Event|0
374496|NCT00302107|1198964|P1|Overall Study|Adverse Event|1
374497|NCT00302107|1198963|P2|Overall Study|Withdrawal by Subject|3
374498|NCT00302107|1198964|P1|Overall Study|Withdrawal by Subject|0
374499|NCT00302107|1198963|P2|Overall Study|Relocation|1
374500|NCT00302107|1198964|P1|Overall Study|Relocation|0
374501|NCT00302107|1198963|P2|Overall Study|Protocol Violation|0
374502|NCT00302107|1198964|P1|Overall Study|Protocol Violation|1
374503|NCT00302107|1198963|P2|Overall Study|Lost to Follow-up|5
374504|NCT00302107|1198964|P1|Overall Study|Lost to Follow-up|6
374505|NCT00302081|1198973|P3|Overall Study|Other|5
374506|NCT00302081|1198974|P2|Overall Study|Other|6
374507|NCT00302081|1198975|P1|Overall Study|Other|13
374508|NCT00302081|1198973|P3|Overall Study|Death|0
374509|NCT00302081|1198974|P2|Overall Study|Death|1
374510|NCT00302081|1198975|P1|Overall Study|Death|2
374511|NCT00302081|1198973|P3|Overall Study|Lack of Efficacy|5
374512|NCT00302081|1198974|P2|Overall Study|Lack of Efficacy|0
374513|NCT00302081|1198975|P1|Overall Study|Lack of Efficacy|1
374514|NCT00302081|1198973|P3|Overall Study|Protocol Violation|2
374515|NCT00302081|1198974|P2|Overall Study|Protocol Violation|1
374516|NCT00302081|1198975|P1|Overall Study|Protocol Violation|5
374517|NCT00302081|1198973|P3|Overall Study|Withdrawal by Subject|8
374518|NCT00302081|1198974|P2|Overall Study|Withdrawal by Subject|12
374519|NCT00302081|1198975|P1|Overall Study|Withdrawal by Subject|8
374520|NCT00302081|1198973|P3|Overall Study|Lost to Follow-up|28
374521|NCT00302081|1198974|P2|Overall Study|Lost to Follow-up|18
374522|NCT00302081|1198975|P1|Overall Study|Lost to Follow-up|21
374523|NCT00302081|1198973|P3|Overall Study|Adverse Event|4
374524|NCT00302081|1198974|P2|Overall Study|Adverse Event|5
374525|NCT00302081|1198975|P1|Overall Study|Adverse Event|6
374526|NCT00302003|1199032|P1|Overall Study|Protocol Violation|1
374527|NCT00302003|1199032|P1|Overall Study|Ineligible|9
374528|NCT00302003|1199032|P1|Overall Study|Withdrawal by Subject|5
374529|NCT00302003|1199032|P1|Overall Study|Physician Decision|2
374530|NCT00302003|1199032|P1|Overall Study|Lost to Follow-up|1
374531|NCT00302003|1199032|P1|Overall Study|Lack of Efficacy|62
374532|NCT00301964|1199039|P1|Overall Study|Inadequate pathology|1
374533|NCT00301964|1199039|P1|Overall Study|Wrong primary|1
374534|NCT00301964|1199039|P1|Overall Study|Second primary|2
374535|NCT00301834|1199050|P1|Overall Study|Death|1
374536|NCT00301821|1199059|P1|Overall Study|Cancel|1
374537|NCT00301821|1199059|P1|Overall Study|Ineligible|25
374538|NCT00301808|1199066|P1|Overall Study|Lack of Efficacy|4
374539|NCT00301808|1199066|P1|Overall Study|Death|3
374540|NCT00301808|1199066|P1|Overall Study|Adverse Event|5
374541|NCT00301366|1199085|P1|Overall Study|Adverse Event|1
374542|NCT00301262|1199091|P2|Open Label Phase (OL)|Other|0
374543|NCT00301262|1199092|P1|Open Label Phase (OL)|Other|2
374544|NCT00301262|1199091|P2|Open Label Phase (OL)|Lost to Follow-up|2
374545|NCT00301262|1199092|P1|Open Label Phase (OL)|Lost to Follow-up|1
374546|NCT00301262|1199091|P2|Open Label Phase (OL)|Adverse Event|0
374547|NCT00301262|1199092|P1|Open Label Phase (OL)|Adverse Event|1
374548|NCT00301262|1199091|P2|Double Blind Phase (DB)|Other|4
374549|NCT00301262|1199092|P1|Double Blind Phase (DB)|Other|1
374550|NCT00301262|1199091|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
374551|NCT00301262|1199092|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
374552|NCT00301262|1199091|P2|Double Blind Phase (DB)|Lost to Follow-up|3
374553|NCT00301262|1199092|P1|Double Blind Phase (DB)|Lost to Follow-up|3
374554|NCT00301262|1199091|P2|Double Blind Phase (DB)|Lack of Efficacy|1
374555|NCT00301262|1199092|P1|Double Blind Phase (DB)|Lack of Efficacy|0
374556|NCT00301262|1199091|P2|Double Blind Phase (DB)|Adverse Event|0
374557|NCT00301262|1199092|P1|Double Blind Phase (DB)|Adverse Event|1
374558|NCT00301080|1199250|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
374559|NCT00301080|1199251|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
374560|NCT00301080|1199252|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
374561|NCT00301080|1199253|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
374562|NCT00301080|1199254|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
374563|NCT00300885|1199289|P2|Follow-up|Withdrawal by Subject|25
374564|NCT00300885|1199290|P1|Follow-up|Withdrawal by Subject|26
374565|NCT00300885|1199289|P2|Follow-up|Lost to Follow-up|7
374566|NCT00300885|1199290|P1|Follow-up|Lost to Follow-up|11
374567|NCT00300885|1199289|P2|Follow-up|Death|163
374568|NCT00300885|1199290|P1|Follow-up|Death|141
374569|NCT00300885|1199289|P2|Treatment|Non-compliant with study medication|4
374570|NCT00300885|1199290|P1|Treatment|Non-compliant with study medication|3
374571|NCT00300885|1199289|P2|Treatment|Random code broken (subject died)|1
374572|NCT00300885|1199290|P1|Treatment|Random code broken (subject died)|0
374573|NCT00300885|1199289|P2|Treatment|Disease progression|238
374574|NCT00300885|1199290|P1|Treatment|Disease progression|171
374575|NCT00300885|1199289|P2|Treatment|Withdrawal by Subject|23
374576|NCT00300885|1199290|P1|Treatment|Withdrawal by Subject|26
374577|NCT00300885|1199289|P2|Treatment|Protocol Violation|11
374578|NCT00300885|1199290|P1|Treatment|Protocol Violation|11
374579|NCT00300885|1199289|P2|Treatment|Physician Decision|5
374580|NCT00300885|1199290|P1|Treatment|Physician Decision|4
374581|NCT00300885|1199289|P2|Treatment|Lost to Follow-up|2
374582|NCT00300885|1199290|P1|Treatment|Lost to Follow-up|3
374583|NCT00300885|1199289|P2|Treatment|Lack of Efficacy|1
374584|NCT00300885|1199290|P1|Treatment|Lack of Efficacy|1
374585|NCT00300885|1199289|P2|Treatment|Death|7
374586|NCT00300885|1199290|P1|Treatment|Death|20
374587|NCT00300885|1199289|P2|Treatment|Adverse Event|82
374588|NCT00300885|1199290|P1|Treatment|Adverse Event|134
374589|NCT00300755|1199309|P3|Overall Study|Protocol Violation|1
374590|NCT00300755|1199310|P2|Overall Study|Protocol Violation|0
374591|NCT00300755|1199311|P1|Overall Study|Protocol Violation|0
374592|NCT00300755|1199309|P3|Overall Study|Withdrawal by Subject|0
374593|NCT00300755|1199310|P2|Overall Study|Withdrawal by Subject|2
374594|NCT00300755|1199311|P1|Overall Study|Withdrawal by Subject|0
374595|NCT00300755|1199309|P3|Overall Study|Adverse Event|1
374596|NCT00300755|1199310|P2|Overall Study|Adverse Event|2
374597|NCT00300755|1199311|P1|Overall Study|Adverse Event|1
374598|NCT00300495|1199345|P2|Overall Study|Protocol Violation|1
374599|NCT00300495|1199346|P1|Overall Study|Protocol Violation|4
374600|NCT00300274|1199595|P3|Overall Study|Re-transplant|1
374601|NCT00300274|1199596|P2|Overall Study|Re-transplant|0
374602|NCT00300274|1199597|P1|Overall Study|Re-transplant|0
374603|NCT00300274|1199595|P3|Overall Study|Death|25
374604|NCT00300274|1199596|P2|Overall Study|Death|20
374605|NCT00300274|1199597|P1|Overall Study|Death|31
374606|NCT00300274|1199595|P3|Overall Study|Lost to Follow-up|5
374607|NCT00300274|1199596|P2|Overall Study|Lost to Follow-up|4
374608|NCT00300274|1199597|P1|Overall Study|Lost to Follow-up|3
374609|NCT00300274|1199595|P3|Overall Study|Withdrawal by Subject|14
374610|NCT00300274|1199596|P2|Overall Study|Withdrawal by Subject|3
374611|NCT00300274|1199597|P1|Overall Study|Withdrawal by Subject|12
374612|NCT00299975|1199656|P3|Overall Study|Physician Decision|1
374613|NCT00299975|1199657|P2|Overall Study|Physician Decision|0
374614|NCT00299975|1199658|P1|Overall Study|Physician Decision|0
374615|NCT00299975|1199656|P3|Overall Study|Withdrawal by Subject|3
374616|NCT00299975|1199657|P2|Overall Study|Withdrawal by Subject|1
374617|NCT00299975|1199658|P1|Overall Study|Withdrawal by Subject|0
374618|NCT00299975|1199656|P3|Overall Study|Lost to Follow-up|0
374619|NCT00299975|1199657|P2|Overall Study|Lost to Follow-up|0
374620|NCT00299975|1199658|P1|Overall Study|Lost to Follow-up|1
374621|NCT00299975|1199656|P3|Overall Study|Lack of Efficacy|1
374622|NCT00299975|1199657|P2|Overall Study|Lack of Efficacy|0
374623|NCT00299975|1199658|P1|Overall Study|Lack of Efficacy|1
374624|NCT00299975|1199656|P3|Overall Study|Pregnancy|1
374625|NCT00299975|1199657|P2|Overall Study|Pregnancy|0
374626|NCT00299975|1199658|P1|Overall Study|Pregnancy|0
374627|NCT00299975|1199656|P3|Overall Study|Adverse Event|2
374628|NCT00299975|1199657|P2|Overall Study|Adverse Event|0
374629|NCT00299975|1199658|P1|Overall Study|Adverse Event|1
374630|NCT00299702|1199715|P2|Overall Study|Admin issues, sponsor decision, etc.|9
374631|NCT00299702|1199716|P1|Overall Study|Admin issues, sponsor decision, etc.|5
374632|NCT00299702|1199715|P2|Overall Study|Insufficient Response|3
374633|NCT00299702|1199716|P1|Overall Study|Insufficient Response|4
374634|NCT00299702|1199715|P2|Overall Study|Pregnancy|1
374635|NCT00299702|1199716|P1|Overall Study|Pregnancy|0
374636|NCT00299702|1199715|P2|Overall Study|Withdrawal by Subject|23
374637|NCT00299702|1199716|P1|Overall Study|Withdrawal by Subject|25
374638|NCT00299702|1199715|P2|Overall Study|Lost to Follow-up|10
374639|NCT00299702|1199716|P1|Overall Study|Lost to Follow-up|18
374640|NCT00299702|1199715|P2|Overall Study|Adverse Event|4
374641|NCT00299702|1199716|P1|Overall Study|Adverse Event|0
374642|NCT00299702|1199715|P2|Overall Study|Death|0
374643|NCT00299702|1199716|P1|Overall Study|Death|1
374644|NCT00299546|1199731|P3|Overall Study|Not treated|1
374645|NCT00299546|1199732|P2|Overall Study|Not treated|1
374646|NCT00299546|1199733|P1|Overall Study|Not treated|0
374647|NCT00299546|1199731|P3|Overall Study|Not specified|19
374648|NCT00299546|1199732|P2|Overall Study|Not specified|26
374649|NCT00299546|1199733|P1|Overall Study|Not specified|24
374650|NCT00299546|1199731|P3|Overall Study|Unsatisfactory therapeutic effect|34
374651|NCT00299546|1199732|P2|Overall Study|Unsatisfactory therapeutic effect|39
374652|NCT00299546|1199733|P1|Overall Study|Unsatisfactory therapeutic effect|34
374653|NCT00299546|1199731|P3|Overall Study|Adverse Event|27
374654|NCT00299546|1199732|P2|Overall Study|Adverse Event|22
374655|NCT00299546|1199733|P1|Overall Study|Adverse Event|37
374656|NCT00299546|1199731|P3|Overall Study|Lost to Follow-up|5
374657|NCT00299546|1199732|P2|Overall Study|Lost to Follow-up|2
374658|NCT00299546|1199733|P1|Overall Study|Lost to Follow-up|2
374659|NCT00299546|1199731|P3|Overall Study|Death|0
374660|NCT00299546|1199732|P2|Overall Study|Death|2
374661|NCT00299546|1199733|P1|Overall Study|Death|3
374662|NCT00299156|1199784|P3|Period 2 (Randomized)|Screen Failure|0
374663|NCT00299156|1199785|P2|Period 2 (Randomized)|Screen Failure|1
374664|NCT00299156|1199786|P1|Period 2 (Randomized)|Screen Failure|0
374665|NCT00299130|1199797|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
374666|NCT00299130|1199798|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
374667|NCT00299130|1199799|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
374668|NCT00299130|1199797|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
374669|NCT00299130|1199798|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
374670|NCT00299130|1199799|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
374671|NCT00299130|1199797|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
374672|NCT00299130|1199798|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
374673|NCT00299130|1199799|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
374674|NCT00299130|1199797|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
374675|NCT00299130|1199798|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
374676|NCT00299130|1199799|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
374677|NCT00299130|1199797|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
374678|NCT00299130|1199798|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
374679|NCT00299130|1199799|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
374680|NCT00299130|1199797|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
374681|NCT00299130|1199798|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
374682|NCT00299130|1199799|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
374683|NCT00299130|1199797|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
374684|NCT00299130|1199798|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
374685|NCT00299130|1199799|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
374686|NCT00299130|1199797|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
374687|NCT00299130|1199798|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
374688|NCT00299130|1199799|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
374689|NCT00299130|1199797|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
374690|NCT00299130|1199798|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
374691|NCT00299130|1199799|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
374692|NCT00299130|1199797|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
374693|NCT00299130|1199798|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
374694|NCT00299130|1199799|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
374695|NCT00299130|1199797|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
374696|NCT00299130|1199798|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
374697|NCT00299130|1199799|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
374698|NCT00299130|1199797|P3|Treatment Period (up to 5 Years)|Failure to Return|6
374699|NCT00299130|1199798|P2|Treatment Period (up to 5 Years)|Failure to Return|6
374700|NCT00299130|1199799|P1|Treatment Period (up to 5 Years)|Failure to Return|4
374701|NCT00299130|1199797|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
374702|NCT00299130|1199798|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
374703|NCT00299130|1199799|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
374704|NCT00299130|1199797|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
374705|NCT00299130|1199798|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
374706|NCT00299130|1199799|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
374707|NCT00299130|1199797|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
374708|NCT00299130|1199798|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
374709|NCT00299130|1199799|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
374710|NCT00299130|1199797|P3|Treatment Period (up to 5 Years)|Death|1
374711|NCT00299130|1199798|P2|Treatment Period (up to 5 Years)|Death|3
374712|NCT00299130|1199799|P1|Treatment Period (up to 5 Years)|Death|1
374713|NCT00299130|1199797|P3|Treatment Period (up to 5 Years)|Adverse Event|13
374714|NCT00299130|1199798|P2|Treatment Period (up to 5 Years)|Adverse Event|8
374715|NCT00299130|1199799|P1|Treatment Period (up to 5 Years)|Adverse Event|13
374716|NCT00299104|1199904|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
374717|NCT00299104|1199905|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
374718|NCT00299104|1199906|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
374719|NCT00299104|1199904|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
374720|NCT00299104|1199905|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
374721|NCT00299104|1199906|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
374722|NCT00299104|1199904|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
374723|NCT00299104|1199905|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
374724|NCT00299104|1199906|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
374725|NCT00299104|1199904|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
374726|NCT00299104|1199905|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
374727|NCT00299104|1199906|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
374728|NCT00299104|1199904|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
374729|NCT00299104|1199905|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
374730|NCT00299104|1199906|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
374731|NCT00299104|1199904|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
374732|NCT00299104|1199905|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
374733|NCT00299104|1199906|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
374734|NCT00299104|1199904|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
374735|NCT00299104|1199905|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
374736|NCT00299104|1199906|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
374737|NCT00299104|1199904|P3|Safety Follow-Up (SFU) Period|Death|1
374738|NCT00299104|1199905|P2|Safety Follow-Up (SFU) Period|Death|2
374739|NCT00299104|1199906|P1|Safety Follow-Up (SFU) Period|Death|3
374740|NCT00299104|1199904|P3|Treatment Period|Administrative reasons|137
374741|NCT00299104|1199905|P2|Treatment Period|Administrative reasons|120
374742|NCT00299104|1199906|P1|Treatment Period|Administrative reasons|106
374743|NCT00299104|1199904|P3|Treatment Period|Withdrew consent|9
374744|NCT00299104|1199905|P2|Treatment Period|Withdrew consent|19
374745|NCT00299104|1199906|P1|Treatment Period|Withdrew consent|14
374746|NCT00299104|1199904|P3|Treatment Period|Refused treatment|2
374747|NCT00299104|1199905|P2|Treatment Period|Refused treatment|2
374748|NCT00299104|1199906|P1|Treatment Period|Refused treatment|9
374749|NCT00299104|1199904|P3|Treatment Period|Protocol Violation|0
374750|NCT00299104|1199905|P2|Treatment Period|Protocol Violation|1
374751|NCT00299104|1199906|P1|Treatment Period|Protocol Violation|1
374752|NCT00299104|1199904|P3|Treatment Period|Violation of selection criteria|0
374753|NCT00299104|1199905|P2|Treatment Period|Violation of selection criteria|2
374754|NCT00299104|1199906|P1|Treatment Period|Violation of selection criteria|1
374755|NCT00299104|1199904|P3|Treatment Period|Failure to return|8
374756|NCT00299104|1199905|P2|Treatment Period|Failure to return|8
374757|NCT00299104|1199906|P1|Treatment Period|Failure to return|9
374758|NCT00299104|1199904|P3|Treatment Period|Insufficient therapeutic response|8
374759|NCT00299104|1199905|P2|Treatment Period|Insufficient therapeutic response|13
374760|NCT00299104|1199906|P1|Treatment Period|Insufficient therapeutic response|34
374761|NCT00299104|1199904|P3|Treatment Period|Death|1
374762|NCT00299104|1199905|P2|Treatment Period|Death|1
374763|NCT00299104|1199906|P1|Treatment Period|Death|1
374764|NCT00299104|1199904|P3|Treatment Period|Adverse Event|7
374765|NCT00299104|1199905|P2|Treatment Period|Adverse Event|9
374766|NCT00299104|1199906|P1|Treatment Period|Adverse Event|14
374767|NCT00298766|1200016|P1|Overall Study|Other|4
374768|NCT00298766|1200016|P1|Overall Study|Subjects overall condition deterioration|4
374769|NCT00298766|1200016|P1|Overall Study|Deterioration in KPS and organ function|1
374770|NCT00298766|1200016|P1|Overall Study|Progression of amyloid markers|4
374771|NCT00298766|1200016|P1|Overall Study|Treatment ongoing|4
374772|NCT00298766|1200016|P1|Overall Study|Withdrawal by Subject|9
374773|NCT00298766|1200016|P1|Overall Study|Death|2
374774|NCT00298766|1200016|P1|Overall Study|Adverse Event|18
374775|NCT00298363|1200075|P3|Overall Study|Lack of Efficacy|0
374776|NCT00298363|1200076|P2|Overall Study|Lack of Efficacy|3
374777|NCT00298363|1200077|P1|Overall Study|Lack of Efficacy|2
374778|NCT00298363|1200075|P3|Overall Study|Adverse Event|2
374779|NCT00298363|1200076|P2|Overall Study|Adverse Event|2
374780|NCT00298363|1200077|P1|Overall Study|Adverse Event|5
374781|NCT00298363|1200075|P3|Overall Study|Withdrawal by Subject|3
374782|NCT00298363|1200076|P2|Overall Study|Withdrawal by Subject|1
374783|NCT00298363|1200077|P1|Overall Study|Withdrawal by Subject|5
374784|NCT00298363|1200075|P3|Overall Study|Protocol Violation|0
374785|NCT00298363|1200076|P2|Overall Study|Protocol Violation|1
374786|NCT00298363|1200077|P1|Overall Study|Protocol Violation|1
374787|NCT00298363|1200075|P3|Overall Study|Physician Decision|0
374788|NCT00298363|1200076|P2|Overall Study|Physician Decision|1
374789|NCT00298363|1200077|P1|Overall Study|Physician Decision|4
374790|NCT00298363|1200075|P3|Overall Study|Lost to Follow-up|1
374791|NCT00298363|1200076|P2|Overall Study|Lost to Follow-up|0
374792|NCT00298363|1200077|P1|Overall Study|Lost to Follow-up|0
374793|NCT00298272|1200235|P2|Safety Follow-up Phase|Administrative/Other Reason|1
374794|NCT00298272|1200236|P1|Safety Follow-up Phase|Administrative/Other Reason|1
374795|NCT00298272|1200235|P2|Safety Follow-up Phase|Withdrawal by Subject|2
374796|NCT00298272|1200236|P1|Safety Follow-up Phase|Withdrawal by Subject|2
374797|NCT00298272|1200235|P2|Safety Follow-up Phase|Failure to Return|1
374798|NCT00298272|1200236|P1|Safety Follow-up Phase|Failure to Return|1
374799|NCT00298272|1200235|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
374800|NCT00298272|1200236|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
374801|NCT00298272|1200235|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
374802|NCT00298272|1200236|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
374803|NCT00298272|1200235|P2|Open Label Retreatment Phase|Protocol Violation|1
374804|NCT00298272|1200236|P1|Open Label Retreatment Phase|Protocol Violation|2
374805|NCT00298272|1200235|P2|Open Label Retreatment Phase|Failure to Return|0
374806|NCT00298272|1200236|P1|Open Label Retreatment Phase|Failure to Return|1
374807|NCT00298272|1200235|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
374808|NCT00298272|1200236|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
374809|NCT00298272|1200235|P2|Open Label Retreatment Phase|Adverse Event|2
374810|NCT00298272|1200236|P1|Open Label Retreatment Phase|Adverse Event|1
374811|NCT00298272|1200235|P2|Double-blind Phase|Withdrawal by Subject|0
374812|NCT00298272|1200236|P1|Double-blind Phase|Withdrawal by Subject|2
374813|NCT00298272|1200235|P2|Double-blind Phase|Protocol Violation|0
374814|NCT00298272|1200236|P1|Double-blind Phase|Protocol Violation|2
374815|NCT00298272|1200235|P2|Double-blind Phase|Failure to Return|0
374816|NCT00298272|1200236|P1|Double-blind Phase|Failure to Return|2
374817|NCT00298272|1200235|P2|Double-blind Phase|Adverse Event|0
374818|NCT00298272|1200236|P1|Double-blind Phase|Adverse Event|2
374819|NCT00297830|1200301|P3|12 Month Visit|Withdrawal by Subject|0
374820|NCT00297830|1200302|P2|12 Month Visit|Withdrawal by Subject|3
374821|NCT00297830|1200303|P1|12 Month Visit|Withdrawal by Subject|0
374822|NCT00297830|1200301|P3|12 Month Visit|Adverse Event|0
374823|NCT00297830|1200302|P2|12 Month Visit|Adverse Event|3
374824|NCT00297830|1200303|P1|12 Month Visit|Adverse Event|0
374825|NCT00297830|1200301|P3|12 Month Visit|Lost to Follow-up|0
374826|NCT00297830|1200302|P2|12 Month Visit|Lost to Follow-up|0
374827|NCT00297830|1200303|P1|12 Month Visit|Lost to Follow-up|1
374828|NCT00297830|1200301|P3|6 Month Visit|Adverse Event|0
374829|NCT00297830|1200302|P2|6 Month Visit|Adverse Event|1
374830|NCT00297830|1200303|P1|6 Month Visit|Adverse Event|0
374831|NCT00297830|1200301|P3|6 Month Visit|Withdrawal by Subject|1
374832|NCT00297830|1200302|P2|6 Month Visit|Withdrawal by Subject|1
374833|NCT00297830|1200303|P1|6 Month Visit|Withdrawal by Subject|2
374834|NCT00297830|1200301|P3|6 Month Visit|Death|2
374835|NCT00297830|1200302|P2|6 Month Visit|Death|0
374836|NCT00297830|1200303|P1|6 Month Visit|Death|1
374837|NCT00297778|1200322|P2|Overall Study|Other|1
374838|NCT00297778|1200323|P1|Overall Study|Other|0
374839|NCT00297778|1200322|P2|Overall Study|Non-compliant with trial protocol|3
374840|NCT00297778|1200323|P1|Overall Study|Non-compliant with trial protocol|0
374841|NCT00297778|1200322|P2|Overall Study|Lack of Efficacy|1
374842|NCT00297778|1200323|P1|Overall Study|Lack of Efficacy|2
374843|NCT00297778|1200322|P2|Overall Study|Withdrawal by Subject|5
374844|NCT00297778|1200323|P1|Overall Study|Withdrawal by Subject|1
374845|NCT00297778|1200322|P2|Overall Study|Adverse Event|10
374846|NCT00297778|1200323|P1|Overall Study|Adverse Event|16
374847|NCT00297648|1200357|P1|Overall Study|Other: Incompliance|1
374848|NCT00297648|1200357|P1|Overall Study|Withdrawal by Subject|3
374849|NCT00297648|1200357|P1|Overall Study|Lost to Follow-up|1
374850|NCT00297648|1200357|P1|Overall Study|Lack of Efficacy|18
374851|NCT00297648|1200357|P1|Overall Study|Adverse Event|13
374852|NCT00297492|1200403|P3|6 Month Follow-up|Lost to Follow-up|27
374853|NCT00297492|1200404|P2|6 Month Follow-up|Lost to Follow-up|49
374854|NCT00297492|1200405|P1|6 Month Follow-up|Lost to Follow-up|63
374855|NCT00297492|1200403|P3|Set Quit Date|Lost to Follow-up|5
374856|NCT00297492|1200404|P2|Set Quit Date|Lost to Follow-up|13
374857|NCT00297492|1200405|P1|Set Quit Date|Lost to Follow-up|7
374858|NCT00297427|1200415|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
374859|NCT00297427|1200416|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
374860|NCT00297427|1200415|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
374861|NCT00297427|1200416|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
374862|NCT00297427|1200415|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
374863|NCT00297427|1200416|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
374864|NCT00297427|1200415|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
374865|NCT00297427|1200416|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
374866|NCT00297427|1200415|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
374867|NCT00297427|1200416|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
374868|NCT00297427|1200415|P2|Phase 1: Initial Intervention|Death|1
374869|NCT00297427|1200416|P1|Phase 1: Initial Intervention|Death|0
374870|NCT00297427|1200415|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
374871|NCT00297427|1200416|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
374872|NCT00297427|1200415|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
374873|NCT00297427|1200416|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
374874|NCT00297258|1200457|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
374875|NCT00297258|1200457|P1|Overall Study|Switch to Commercial Treatment|1
374876|NCT00297258|1200457|P1|Overall Study|Surgery Performed on Target Lesion|1
374877|NCT00297258|1200457|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
374878|NCT00297258|1200457|P1|Overall Study|Deteriorization of General Condition|1
374879|NCT00297258|1200457|P1|Overall Study|Intercurrent Death|2
374880|NCT00297258|1200457|P1|Overall Study|Intercurrent Illness|3
374881|NCT00297258|1200457|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
374882|NCT00297258|1200457|P1|Overall Study|Toxicity (or Toxic Death)|10
374883|NCT00297258|1200457|P1|Overall Study|Disease Progression, Relapse, Death|120
374884|NCT00297232|1200476|P1|Overall Study|Other|1
374885|NCT00297232|1200476|P1|Overall Study|No data available after Week 264|161
374886|NCT00297232|1200476|P1|Overall Study|Did Not Enroll to Week 480|17
374887|NCT00297232|1200476|P1|Overall Study|Did Not Enroll to Week 264|34
374888|NCT00297232|1200476|P1|Overall Study|Investigator Withdrew From Program|19
374889|NCT00297232|1200476|P1|Overall Study|Persistently Positive Antibodies|11
374890|NCT00297232|1200476|P1|Overall Study|Subject Withdrew Consent|37
374891|NCT00297232|1200476|P1|Overall Study|Subject Relocated|7
374892|NCT00297232|1200476|P1|Overall Study|Sponsor Decision|34
374893|NCT00297232|1200476|P1|Overall Study|Miscellaneous|5
374894|NCT00297232|1200476|P1|Overall Study|Anti-JCV Antibody Positive|13
374895|NCT00297232|1200476|P1|Overall Study|Fear of PML|10
374896|NCT00297232|1200476|P1|Overall Study|Disease Progression|8
374897|NCT00297232|1200476|P1|Overall Study|Switched to Commercial Tysabri|22
374898|NCT00297232|1200476|P1|Overall Study|Anti-natalizumab Positive|8
374899|NCT00297232|1200476|P1|Overall Study|Death|9
374900|NCT00297232|1200476|P1|Overall Study|Subject was Noncompliant|9
374901|NCT00297232|1200476|P1|Overall Study|Voluntary Withdrawal|120
374902|NCT00297232|1200476|P1|Overall Study|Adverse Event|63
374903|NCT00297232|1200476|P1|Overall Study|Lost to Follow-up|10
374904|NCT00297232|1200476|P1|Overall Study|Lack of Efficacy|7
374905|NCT00297167|1200482|P3|Second Double-blind Intervention Period|Protocol Violation|0
374906|NCT00297167|1200483|P2|Second Double-blind Intervention Period|Protocol Violation|0
374907|NCT00297167|1200484|P1|Second Double-blind Intervention Period|Protocol Violation|1
374908|NCT00297167|1200482|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
374909|NCT00297167|1200483|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
374910|NCT00297167|1200484|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
374911|NCT00297037|1200548|P2|Overall Study|Withdrawal by Subject|0
374912|NCT00297037|1200549|P1|Overall Study|Withdrawal by Subject|2
374913|NCT00296816|1200561|P1|Overall Study|ineligibility due to radiation treatment|1
374914|NCT00296816|1200561|P1|Overall Study|Proteinuria|1
374915|NCT00296816|1200561|P1|Overall Study|Neuropathy/patient preference|1
374916|NCT00296816|1200561|P1|Overall Study|Urine protein/creatinine ratio delay|1
374917|NCT00296816|1200561|P1|Overall Study|Noncompliance/decision to discontinue|1
374918|NCT00296816|1200561|P1|Overall Study|Relocation to Florida|1
374919|NCT00296816|1200561|P1|Overall Study|Poor performance status|1
374920|NCT00296816|1200561|P1|Overall Study|Progression based on CA-125 (biomarker)|2
374921|NCT00296816|1200561|P1|Overall Study|Missing for end of treatment|4
374922|NCT00296816|1200561|P1|Overall Study|Non-compliance|1
374923|NCT00296816|1200561|P1|Overall Study|Investigator/Participant request|5
374924|NCT00296816|1200561|P1|Overall Study|Adverse Event|18
374925|NCT00296816|1200561|P1|Overall Study|Disease Progression|37
374926|NCT00296647|1200578|P5|Overall Study|Withdrawal by Subject|19
374927|NCT00296647|1200579|P4|Overall Study|Withdrawal by Subject|16
374928|NCT00296647|1200580|P3|Overall Study|Withdrawal by Subject|32
374929|NCT00296647|1200581|P2|Overall Study|Withdrawal by Subject|27
374930|NCT00296647|1200582|P1|Overall Study|Withdrawal by Subject|28
374931|NCT00296647|1200578|P5|Overall Study|Death|1
374932|NCT00296647|1200579|P4|Overall Study|Death|1
374933|NCT00296647|1200580|P3|Overall Study|Death|2
374934|NCT00296647|1200581|P2|Overall Study|Death|1
374935|NCT00296647|1200582|P1|Overall Study|Death|4
374936|NCT00296517|1200596|P2|Dose Level 3 - Weeks 3-12|Not specified|2
374937|NCT00296517|1200597|P1|Dose Level 3 - Weeks 3-12|Not specified|0
374938|NCT00296517|1200596|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
374939|NCT00296517|1200597|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
374940|NCT00296517|1200596|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
374941|NCT00296517|1200597|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
374942|NCT00296517|1200596|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
374943|NCT00296517|1200597|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
374944|NCT00296517|1200596|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
374945|NCT00296517|1200597|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
374946|NCT00296517|1200596|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
374947|NCT00296517|1200597|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
374948|NCT00296517|1200596|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
374949|NCT00296517|1200597|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
374950|NCT00296517|1200596|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
374951|NCT00296517|1200597|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
374952|NCT00296517|1200596|P2|Dose Level 2 - Week 2|Adverse Event|5
374953|NCT00296517|1200597|P1|Dose Level 2 - Week 2|Adverse Event|1
374954|NCT00296504|1200633|P9|Final Analysis|Poor Adherence|1
374955|NCT00296504|1200634|P8|Final Analysis|Poor Adherence|0
374956|NCT00296504|1200635|P7|Final Analysis|Poor Adherence|0
374957|NCT00296504|1200636|P6|Final Analysis|Poor Adherence|0
374958|NCT00296504|1200637|P5|Final Analysis|Poor Adherence|0
374959|NCT00296504|1200638|P4|Final Analysis|Poor Adherence|0
374960|NCT00296504|1200639|P3|Final Analysis|Poor Adherence|0
374961|NCT00296504|1200640|P2|Final Analysis|Poor Adherence|0
374962|NCT00296504|1200641|P1|Final Analysis|Poor Adherence|0
374963|NCT00296504|1200633|P9|Final Analysis|Participant Moved to Another Country|1
374964|NCT00296504|1200634|P8|Final Analysis|Participant Moved to Another Country|0
374965|NCT00296504|1200635|P7|Final Analysis|Participant Moved to Another Country|0
374966|NCT00296504|1200636|P6|Final Analysis|Participant Moved to Another Country|0
374967|NCT00296504|1200637|P5|Final Analysis|Participant Moved to Another Country|0
374968|NCT00296504|1200638|P4|Final Analysis|Participant Moved to Another Country|0
374969|NCT00296504|1200639|P3|Final Analysis|Participant Moved to Another Country|0
374970|NCT00296504|1200640|P2|Final Analysis|Participant Moved to Another Country|0
374971|NCT00296504|1200641|P1|Final Analysis|Participant Moved to Another Country|0
374972|NCT00296504|1200633|P9|Final Analysis|Tuberculosis|1
374973|NCT00296504|1200634|P8|Final Analysis|Tuberculosis|0
374974|NCT00296504|1200635|P7|Final Analysis|Tuberculosis|0
374975|NCT00296504|1200636|P6|Final Analysis|Tuberculosis|0
374976|NCT00296504|1200637|P5|Final Analysis|Tuberculosis|0
374977|NCT00296504|1200638|P4|Final Analysis|Tuberculosis|0
374978|NCT00296504|1200639|P3|Final Analysis|Tuberculosis|0
374979|NCT00296504|1200640|P2|Final Analysis|Tuberculosis|0
374980|NCT00296504|1200641|P1|Final Analysis|Tuberculosis|0
374981|NCT00296504|1200633|P9|Final Analysis|Pregnancy|4
374982|NCT00296504|1200634|P8|Final Analysis|Pregnancy|0
374983|NCT00296504|1200635|P7|Final Analysis|Pregnancy|0
374984|NCT00296504|1200636|P6|Final Analysis|Pregnancy|0
374985|NCT00296504|1200637|P5|Final Analysis|Pregnancy|0
374986|NCT00296504|1200638|P4|Final Analysis|Pregnancy|0
374987|NCT00296504|1200639|P3|Final Analysis|Pregnancy|0
374988|NCT00296504|1200640|P2|Final Analysis|Pregnancy|0
374989|NCT00296504|1200641|P1|Final Analysis|Pregnancy|0
374990|NCT00296504|1200633|P9|Final Analysis|Adverse Event|2
374991|NCT00296504|1200634|P8|Final Analysis|Adverse Event|0
374992|NCT00296504|1200635|P7|Final Analysis|Adverse Event|0
374993|NCT00296504|1200636|P6|Final Analysis|Adverse Event|0
374994|NCT00296504|1200637|P5|Final Analysis|Adverse Event|0
374995|NCT00296504|1200638|P4|Final Analysis|Adverse Event|0
374996|NCT00296504|1200639|P3|Final Analysis|Adverse Event|0
374997|NCT00296504|1200640|P2|Final Analysis|Adverse Event|0
374998|NCT00296504|1200641|P1|Final Analysis|Adverse Event|0
374999|NCT00296504|1200633|P9|Final Analysis|Insufficient Viral Load Response|6
375000|NCT00296504|1200634|P8|Final Analysis|Insufficient Viral Load Response|0
375001|NCT00296504|1200635|P7|Final Analysis|Insufficient Viral Load Response|0
375002|NCT00296504|1200636|P6|Final Analysis|Insufficient Viral Load Response|0
375003|NCT00296504|1200637|P5|Final Analysis|Insufficient Viral Load Response|0
375004|NCT00296504|1200638|P4|Final Analysis|Insufficient Viral Load Response|0
375005|NCT00296504|1200639|P3|Final Analysis|Insufficient Viral Load Response|0
375006|NCT00296504|1200640|P2|Final Analysis|Insufficient Viral Load Response|0
375007|NCT00296504|1200641|P1|Final Analysis|Insufficient Viral Load Response|0
375008|NCT00296504|1200633|P9|Final Analysis|Lost to Follow-up|5
375009|NCT00296504|1200634|P8|Final Analysis|Lost to Follow-up|0
375010|NCT00296504|1200635|P7|Final Analysis|Lost to Follow-up|0
375011|NCT00296504|1200636|P6|Final Analysis|Lost to Follow-up|0
375012|NCT00296504|1200637|P5|Final Analysis|Lost to Follow-up|0
375013|NCT00296504|1200638|P4|Final Analysis|Lost to Follow-up|0
375014|NCT00296504|1200639|P3|Final Analysis|Lost to Follow-up|0
375015|NCT00296504|1200640|P2|Final Analysis|Lost to Follow-up|0
375016|NCT00296504|1200641|P1|Final Analysis|Lost to Follow-up|0
375017|NCT00296504|1200633|P9|Final Analysis|Withdrawal by Subject|1
375018|NCT00296504|1200634|P8|Final Analysis|Withdrawal by Subject|0
375019|NCT00296504|1200635|P7|Final Analysis|Withdrawal by Subject|0
375020|NCT00296504|1200636|P6|Final Analysis|Withdrawal by Subject|0
375021|NCT00296504|1200637|P5|Final Analysis|Withdrawal by Subject|0
375022|NCT00296504|1200638|P4|Final Analysis|Withdrawal by Subject|0
375023|NCT00296504|1200639|P3|Final Analysis|Withdrawal by Subject|0
375024|NCT00296504|1200640|P2|Final Analysis|Withdrawal by Subject|0
375025|NCT00296504|1200641|P1|Final Analysis|Withdrawal by Subject|0
375026|NCT00296504|1200633|P9|Interim Analysis|Ongoing|0
375027|NCT00296504|1200634|P8|Interim Analysis|Ongoing|1
375028|NCT00296504|1200635|P7|Interim Analysis|Ongoing|30
375029|NCT00296504|1200636|P6|Interim Analysis|Ongoing|0
375030|NCT00296504|1200637|P5|Interim Analysis|Ongoing|0
375031|NCT00296504|1200638|P4|Interim Analysis|Ongoing|22
375032|NCT00296504|1200639|P3|Interim Analysis|Ongoing|16
375033|NCT00296504|1200640|P2|Interim Analysis|Ongoing|12
375034|NCT00296504|1200641|P1|Interim Analysis|Ongoing|32
375035|NCT00296504|1200633|P9|Interim Analysis|Participant Needed Interferon|0
375036|NCT00296504|1200634|P8|Interim Analysis|Participant Needed Interferon|1
375037|NCT00296504|1200635|P7|Interim Analysis|Participant Needed Interferon|0
375038|NCT00296504|1200636|P6|Interim Analysis|Participant Needed Interferon|0
375039|NCT00296504|1200637|P5|Interim Analysis|Participant Needed Interferon|0
375040|NCT00296504|1200638|P4|Interim Analysis|Participant Needed Interferon|0
375041|NCT00296504|1200639|P3|Interim Analysis|Participant Needed Interferon|0
375042|NCT00296504|1200640|P2|Interim Analysis|Participant Needed Interferon|0
375043|NCT00296504|1200641|P1|Interim Analysis|Participant Needed Interferon|0
375044|NCT00296504|1200633|P9|Interim Analysis|Study Ended|0
375045|NCT00296504|1200634|P8|Interim Analysis|Study Ended|0
375046|NCT00296504|1200635|P7|Interim Analysis|Study Ended|1
375047|NCT00296504|1200636|P6|Interim Analysis|Study Ended|0
375048|NCT00296504|1200637|P5|Interim Analysis|Study Ended|0
375049|NCT00296504|1200638|P4|Interim Analysis|Study Ended|0
375050|NCT00296504|1200639|P3|Interim Analysis|Study Ended|0
375051|NCT00296504|1200640|P2|Interim Analysis|Study Ended|0
375052|NCT00296504|1200641|P1|Interim Analysis|Study Ended|0
375053|NCT00296504|1200633|P9|Interim Analysis|Participant Stopped HIV Medications|0
375054|NCT00296504|1200634|P8|Interim Analysis|Participant Stopped HIV Medications|0
375055|NCT00296504|1200635|P7|Interim Analysis|Participant Stopped HIV Medications|1
375056|NCT00296504|1200636|P6|Interim Analysis|Participant Stopped HIV Medications|0
375057|NCT00296504|1200637|P5|Interim Analysis|Participant Stopped HIV Medications|0
375058|NCT00296504|1200638|P4|Interim Analysis|Participant Stopped HIV Medications|0
375059|NCT00296504|1200639|P3|Interim Analysis|Participant Stopped HIV Medications|0
375060|NCT00296504|1200640|P2|Interim Analysis|Participant Stopped HIV Medications|0
375061|NCT00296504|1200641|P1|Interim Analysis|Participant Stopped HIV Medications|0
375062|NCT00296504|1200633|P9|Interim Analysis|Physician and Participant Decision|0
375063|NCT00296504|1200634|P8|Interim Analysis|Physician and Participant Decision|0
375064|NCT00296504|1200635|P7|Interim Analysis|Physician and Participant Decision|0
375065|NCT00296504|1200636|P6|Interim Analysis|Physician and Participant Decision|1
375066|NCT00296504|1200637|P5|Interim Analysis|Physician and Participant Decision|0
375067|NCT00296504|1200638|P4|Interim Analysis|Physician and Participant Decision|0
375068|NCT00296504|1200639|P3|Interim Analysis|Physician and Participant Decision|0
375069|NCT00296504|1200640|P2|Interim Analysis|Physician and Participant Decision|0
375070|NCT00296504|1200641|P1|Interim Analysis|Physician and Participant Decision|0
375071|NCT00296504|1200633|P9|Interim Analysis|Participant Stopped|0
375072|NCT00296504|1200634|P8|Interim Analysis|Participant Stopped|0
375073|NCT00296504|1200635|P7|Interim Analysis|Participant Stopped|0
375074|NCT00296504|1200636|P6|Interim Analysis|Participant Stopped|0
375075|NCT00296504|1200637|P5|Interim Analysis|Participant Stopped|1
375076|NCT00296504|1200638|P4|Interim Analysis|Participant Stopped|0
375077|NCT00296504|1200639|P3|Interim Analysis|Participant Stopped|0
375078|NCT00296504|1200640|P2|Interim Analysis|Participant Stopped|0
375079|NCT00296504|1200641|P1|Interim Analysis|Participant Stopped|0
375080|NCT00296504|1200633|P9|Interim Analysis|Inclusion in Other Protocol|0
375081|NCT00296504|1200634|P8|Interim Analysis|Inclusion in Other Protocol|0
375082|NCT00296504|1200635|P7|Interim Analysis|Inclusion in Other Protocol|0
375083|NCT00296504|1200636|P6|Interim Analysis|Inclusion in Other Protocol|0
375084|NCT00296504|1200637|P5|Interim Analysis|Inclusion in Other Protocol|0
375085|NCT00296504|1200638|P4|Interim Analysis|Inclusion in Other Protocol|1
375086|NCT00296504|1200639|P3|Interim Analysis|Inclusion in Other Protocol|0
375087|NCT00296504|1200640|P2|Interim Analysis|Inclusion in Other Protocol|0
375088|NCT00296504|1200641|P1|Interim Analysis|Inclusion in Other Protocol|0
375089|NCT00296504|1200633|P9|Interim Analysis|Missed Schedule Date|0
375090|NCT00296504|1200634|P8|Interim Analysis|Missed Schedule Date|0
375091|NCT00296504|1200635|P7|Interim Analysis|Missed Schedule Date|0
375092|NCT00296504|1200636|P6|Interim Analysis|Missed Schedule Date|0
375093|NCT00296504|1200637|P5|Interim Analysis|Missed Schedule Date|0
375094|NCT00296504|1200638|P4|Interim Analysis|Missed Schedule Date|0
375095|NCT00296504|1200639|P3|Interim Analysis|Missed Schedule Date|0
375096|NCT00296504|1200640|P2|Interim Analysis|Missed Schedule Date|0
375097|NCT00296504|1200641|P1|Interim Analysis|Missed Schedule Date|1
375098|NCT00296504|1200633|P9|Interim Analysis|Lack of Personnel at Site|0
375099|NCT00296504|1200634|P8|Interim Analysis|Lack of Personnel at Site|0
375100|NCT00296504|1200635|P7|Interim Analysis|Lack of Personnel at Site|0
375101|NCT00296504|1200636|P6|Interim Analysis|Lack of Personnel at Site|0
375102|NCT00296504|1200637|P5|Interim Analysis|Lack of Personnel at Site|0
375103|NCT00296504|1200638|P4|Interim Analysis|Lack of Personnel at Site|0
375104|NCT00296504|1200639|P3|Interim Analysis|Lack of Personnel at Site|0
375105|NCT00296504|1200640|P2|Interim Analysis|Lack of Personnel at Site|0
375106|NCT00296504|1200641|P1|Interim Analysis|Lack of Personnel at Site|1
375107|NCT00296504|1200633|P9|Interim Analysis|Site Closing|0
375108|NCT00296504|1200634|P8|Interim Analysis|Site Closing|0
375109|NCT00296504|1200635|P7|Interim Analysis|Site Closing|2
375110|NCT00296504|1200636|P6|Interim Analysis|Site Closing|1
375111|NCT00296504|1200637|P5|Interim Analysis|Site Closing|0
375112|NCT00296504|1200638|P4|Interim Analysis|Site Closing|0
375113|NCT00296504|1200639|P3|Interim Analysis|Site Closing|0
375114|NCT00296504|1200640|P2|Interim Analysis|Site Closing|0
375115|NCT00296504|1200641|P1|Interim Analysis|Site Closing|1
375116|NCT00296504|1200633|P9|Interim Analysis|Non-adherence|0
375117|NCT00296504|1200634|P8|Interim Analysis|Non-adherence|1
375118|NCT00296504|1200635|P7|Interim Analysis|Non-adherence|0
375119|NCT00296504|1200636|P6|Interim Analysis|Non-adherence|0
375120|NCT00296504|1200637|P5|Interim Analysis|Non-adherence|1
375121|NCT00296504|1200638|P4|Interim Analysis|Non-adherence|0
375122|NCT00296504|1200639|P3|Interim Analysis|Non-adherence|0
375123|NCT00296504|1200640|P2|Interim Analysis|Non-adherence|0
375124|NCT00296504|1200641|P1|Interim Analysis|Non-adherence|2
375125|NCT00296504|1200633|P9|Interim Analysis|Principle Investigator Terminated Study|0
375126|NCT00296504|1200634|P8|Interim Analysis|Principle Investigator Terminated Study|0
375127|NCT00296504|1200635|P7|Interim Analysis|Principle Investigator Terminated Study|0
375128|NCT00296504|1200636|P6|Interim Analysis|Principle Investigator Terminated Study|0
375129|NCT00296504|1200637|P5|Interim Analysis|Principle Investigator Terminated Study|0
375130|NCT00296504|1200638|P4|Interim Analysis|Principle Investigator Terminated Study|0
375131|NCT00296504|1200639|P3|Interim Analysis|Principle Investigator Terminated Study|1
375132|NCT00296504|1200640|P2|Interim Analysis|Principle Investigator Terminated Study|0
375133|NCT00296504|1200641|P1|Interim Analysis|Principle Investigator Terminated Study|0
375134|NCT00296504|1200633|P9|Interim Analysis|Principle Investigator Discretion|0
375135|NCT00296504|1200634|P8|Interim Analysis|Principle Investigator Discretion|0
375136|NCT00296504|1200635|P7|Interim Analysis|Principle Investigator Discretion|0
375137|NCT00296504|1200636|P6|Interim Analysis|Principle Investigator Discretion|0
375138|NCT00296504|1200637|P5|Interim Analysis|Principle Investigator Discretion|0
375139|NCT00296504|1200638|P4|Interim Analysis|Principle Investigator Discretion|1
375140|NCT00296504|1200639|P3|Interim Analysis|Principle Investigator Discretion|1
375141|NCT00296504|1200640|P2|Interim Analysis|Principle Investigator Discretion|0
375142|NCT00296504|1200641|P1|Interim Analysis|Principle Investigator Discretion|2
375143|NCT00296504|1200633|P9|Interim Analysis|Physician Decision|0
375144|NCT00296504|1200634|P8|Interim Analysis|Physician Decision|0
375145|NCT00296504|1200635|P7|Interim Analysis|Physician Decision|0
375146|NCT00296504|1200636|P6|Interim Analysis|Physician Decision|0
375147|NCT00296504|1200637|P5|Interim Analysis|Physician Decision|0
375148|NCT00296504|1200638|P4|Interim Analysis|Physician Decision|0
375149|NCT00296504|1200639|P3|Interim Analysis|Physician Decision|1
375150|NCT00296504|1200640|P2|Interim Analysis|Physician Decision|0
375151|NCT00296504|1200641|P1|Interim Analysis|Physician Decision|0
375152|NCT00296504|1200633|P9|Interim Analysis|Resistance to FPV|0
375153|NCT00296504|1200634|P8|Interim Analysis|Resistance to FPV|0
375154|NCT00296504|1200635|P7|Interim Analysis|Resistance to FPV|0
375155|NCT00296504|1200636|P6|Interim Analysis|Resistance to FPV|0
375156|NCT00296504|1200637|P5|Interim Analysis|Resistance to FPV|0
375157|NCT00296504|1200638|P4|Interim Analysis|Resistance to FPV|0
375158|NCT00296504|1200639|P3|Interim Analysis|Resistance to FPV|1
375159|NCT00296504|1200640|P2|Interim Analysis|Resistance to FPV|0
375160|NCT00296504|1200641|P1|Interim Analysis|Resistance to FPV|0
375161|NCT00296504|1200633|P9|Interim Analysis|Participant Was Incarcerated|0
375162|NCT00296504|1200634|P8|Interim Analysis|Participant Was Incarcerated|0
375163|NCT00296504|1200635|P7|Interim Analysis|Participant Was Incarcerated|0
375164|NCT00296504|1200636|P6|Interim Analysis|Participant Was Incarcerated|0
375165|NCT00296504|1200637|P5|Interim Analysis|Participant Was Incarcerated|0
375166|NCT00296504|1200638|P4|Interim Analysis|Participant Was Incarcerated|0
375167|NCT00296504|1200639|P3|Interim Analysis|Participant Was Incarcerated|1
375168|NCT00296504|1200640|P2|Interim Analysis|Participant Was Incarcerated|0
375169|NCT00296504|1200641|P1|Interim Analysis|Participant Was Incarcerated|2
375170|NCT00296504|1200633|P9|Interim Analysis|Participant Moved|0
375171|NCT00296504|1200634|P8|Interim Analysis|Participant Moved|0
375172|NCT00296504|1200635|P7|Interim Analysis|Participant Moved|1
375173|NCT00296504|1200636|P6|Interim Analysis|Participant Moved|1
375174|NCT00296504|1200637|P5|Interim Analysis|Participant Moved|0
375175|NCT00296504|1200638|P4|Interim Analysis|Participant Moved|0
375176|NCT00296504|1200639|P3|Interim Analysis|Participant Moved|1
375177|NCT00296504|1200640|P2|Interim Analysis|Participant Moved|0
375178|NCT00296504|1200641|P1|Interim Analysis|Participant Moved|1
375179|NCT00296504|1200633|P9|Interim Analysis|Participant Had Problems with Alcohol|0
375180|NCT00296504|1200634|P8|Interim Analysis|Participant Had Problems with Alcohol|0
375181|NCT00296504|1200635|P7|Interim Analysis|Participant Had Problems with Alcohol|0
375182|NCT00296504|1200636|P6|Interim Analysis|Participant Had Problems with Alcohol|0
375183|NCT00296504|1200637|P5|Interim Analysis|Participant Had Problems with Alcohol|0
375184|NCT00296504|1200638|P4|Interim Analysis|Participant Had Problems with Alcohol|0
375185|NCT00296504|1200639|P3|Interim Analysis|Participant Had Problems with Alcohol|1
375186|NCT00296504|1200640|P2|Interim Analysis|Participant Had Problems with Alcohol|0
375187|NCT00296504|1200641|P1|Interim Analysis|Participant Had Problems with Alcohol|0
375188|NCT00296504|1200633|P9|Interim Analysis|To Simplify Treatment|0
375189|NCT00296504|1200634|P8|Interim Analysis|To Simplify Treatment|0
375190|NCT00296504|1200635|P7|Interim Analysis|To Simplify Treatment|2
375191|NCT00296504|1200636|P6|Interim Analysis|To Simplify Treatment|0
375192|NCT00296504|1200637|P5|Interim Analysis|To Simplify Treatment|0
375193|NCT00296504|1200638|P4|Interim Analysis|To Simplify Treatment|0
375194|NCT00296504|1200639|P3|Interim Analysis|To Simplify Treatment|1
375195|NCT00296504|1200640|P2|Interim Analysis|To Simplify Treatment|0
375196|NCT00296504|1200641|P1|Interim Analysis|To Simplify Treatment|0
375197|NCT00296504|1200633|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
375198|NCT00296504|1200634|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
375199|NCT00296504|1200635|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
375200|NCT00296504|1200636|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
375201|NCT00296504|1200637|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
375202|NCT00296504|1200638|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
375203|NCT00296504|1200639|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
375204|NCT00296504|1200640|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
375205|NCT00296504|1200641|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
375206|NCT00296504|1200633|P9|Interim Analysis|Participant Non-compliant|0
375207|NCT00296504|1200634|P8|Interim Analysis|Participant Non-compliant|2
375208|NCT00296504|1200635|P7|Interim Analysis|Participant Non-compliant|6
375209|NCT00296504|1200636|P6|Interim Analysis|Participant Non-compliant|3
375210|NCT00296504|1200637|P5|Interim Analysis|Participant Non-compliant|1
375211|NCT00296504|1200638|P4|Interim Analysis|Participant Non-compliant|1
375212|NCT00296504|1200639|P3|Interim Analysis|Participant Non-compliant|2
375213|NCT00296504|1200640|P2|Interim Analysis|Participant Non-compliant|1
375214|NCT00296504|1200641|P1|Interim Analysis|Participant Non-compliant|0
375215|NCT00296504|1200633|P9|Interim Analysis|Death|0
375216|NCT00296504|1200634|P8|Interim Analysis|Death|0
375217|NCT00296504|1200635|P7|Interim Analysis|Death|0
375218|NCT00296504|1200636|P6|Interim Analysis|Death|0
375219|NCT00296504|1200637|P5|Interim Analysis|Death|0
375220|NCT00296504|1200638|P4|Interim Analysis|Death|0
375221|NCT00296504|1200639|P3|Interim Analysis|Death|3
375222|NCT00296504|1200640|P2|Interim Analysis|Death|0
375223|NCT00296504|1200641|P1|Interim Analysis|Death|1
375224|NCT00296504|1200633|P9|Interim Analysis|Pregnancy|0
375225|NCT00296504|1200634|P8|Interim Analysis|Pregnancy|1
375226|NCT00296504|1200635|P7|Interim Analysis|Pregnancy|1
375227|NCT00296504|1200636|P6|Interim Analysis|Pregnancy|1
375228|NCT00296504|1200637|P5|Interim Analysis|Pregnancy|0
375229|NCT00296504|1200638|P4|Interim Analysis|Pregnancy|2
375230|NCT00296504|1200639|P3|Interim Analysis|Pregnancy|4
375231|NCT00296504|1200640|P2|Interim Analysis|Pregnancy|1
375232|NCT00296504|1200641|P1|Interim Analysis|Pregnancy|4
375233|NCT00296504|1200633|P9|Interim Analysis|Switched to Commercially Available Drug|0
375234|NCT00296504|1200634|P8|Interim Analysis|Switched to Commercially Available Drug|4
375235|NCT00296504|1200635|P7|Interim Analysis|Switched to Commercially Available Drug|3
375236|NCT00296504|1200636|P6|Interim Analysis|Switched to Commercially Available Drug|5
375237|NCT00296504|1200637|P5|Interim Analysis|Switched to Commercially Available Drug|0
375238|NCT00296504|1200638|P4|Interim Analysis|Switched to Commercially Available Drug|1
375239|NCT00296504|1200639|P3|Interim Analysis|Switched to Commercially Available Drug|4
375240|NCT00296504|1200640|P2|Interim Analysis|Switched to Commercially Available Drug|0
375241|NCT00296504|1200641|P1|Interim Analysis|Switched to Commercially Available Drug|2
375242|NCT00296504|1200633|P9|Interim Analysis|Insufficient CD4 Response|0
375243|NCT00296504|1200634|P8|Interim Analysis|Insufficient CD4 Response|0
375244|NCT00296504|1200635|P7|Interim Analysis|Insufficient CD4 Response|0
375245|NCT00296504|1200636|P6|Interim Analysis|Insufficient CD4 Response|1
375246|NCT00296504|1200637|P5|Interim Analysis|Insufficient CD4 Response|1
375247|NCT00296504|1200638|P4|Interim Analysis|Insufficient CD4 Response|0
375248|NCT00296504|1200639|P3|Interim Analysis|Insufficient CD4 Response|0
375249|NCT00296504|1200640|P2|Interim Analysis|Insufficient CD4 Response|0
375250|NCT00296504|1200641|P1|Interim Analysis|Insufficient CD4 Response|0
375251|NCT00296504|1200633|P9|Interim Analysis|Protocol Violation|0
375252|NCT00296504|1200634|P8|Interim Analysis|Protocol Violation|1
375253|NCT00296504|1200635|P7|Interim Analysis|Protocol Violation|0
375254|NCT00296504|1200636|P6|Interim Analysis|Protocol Violation|0
375255|NCT00296504|1200637|P5|Interim Analysis|Protocol Violation|1
375256|NCT00296504|1200638|P4|Interim Analysis|Protocol Violation|0
375257|NCT00296504|1200639|P3|Interim Analysis|Protocol Violation|2
375258|NCT00296504|1200640|P2|Interim Analysis|Protocol Violation|0
375259|NCT00296504|1200641|P1|Interim Analysis|Protocol Violation|0
375260|NCT00296504|1200633|P9|Interim Analysis|Adverse Event|0
375261|NCT00296504|1200634|P8|Interim Analysis|Adverse Event|5
375262|NCT00296504|1200635|P7|Interim Analysis|Adverse Event|4
375263|NCT00296504|1200636|P6|Interim Analysis|Adverse Event|3
375264|NCT00296504|1200637|P5|Interim Analysis|Adverse Event|6
375265|NCT00296504|1200638|P4|Interim Analysis|Adverse Event|4
375266|NCT00296504|1200639|P3|Interim Analysis|Adverse Event|13
375267|NCT00296504|1200640|P2|Interim Analysis|Adverse Event|0
375268|NCT00296504|1200641|P1|Interim Analysis|Adverse Event|0
375269|NCT00296504|1200633|P9|Interim Analysis|Insufficient Viral Load Response|0
375270|NCT00296504|1200634|P8|Interim Analysis|Insufficient Viral Load Response|24
375271|NCT00296504|1200635|P7|Interim Analysis|Insufficient Viral Load Response|2
375272|NCT00296504|1200636|P6|Interim Analysis|Insufficient Viral Load Response|9
375273|NCT00296504|1200637|P5|Interim Analysis|Insufficient Viral Load Response|7
375274|NCT00296504|1200638|P4|Interim Analysis|Insufficient Viral Load Response|2
375275|NCT00296504|1200639|P3|Interim Analysis|Insufficient Viral Load Response|12
375276|NCT00296504|1200640|P2|Interim Analysis|Insufficient Viral Load Response|1
375277|NCT00296504|1200641|P1|Interim Analysis|Insufficient Viral Load Response|5
375278|NCT00296504|1200633|P9|Interim Analysis|Clinical Progression|0
375279|NCT00296504|1200634|P8|Interim Analysis|Clinical Progression|2
375280|NCT00296504|1200635|P7|Interim Analysis|Clinical Progression|1
375281|NCT00296504|1200636|P6|Interim Analysis|Clinical Progression|2
375282|NCT00296504|1200637|P5|Interim Analysis|Clinical Progression|0
375283|NCT00296504|1200638|P4|Interim Analysis|Clinical Progression|1
375284|NCT00296504|1200639|P3|Interim Analysis|Clinical Progression|1
375285|NCT00296504|1200640|P2|Interim Analysis|Clinical Progression|0
375286|NCT00296504|1200641|P1|Interim Analysis|Clinical Progression|1
375287|NCT00296504|1200633|P9|Interim Analysis|Lost to Follow-up|0
375288|NCT00296504|1200634|P8|Interim Analysis|Lost to Follow-up|4
375289|NCT00296504|1200635|P7|Interim Analysis|Lost to Follow-up|11
375290|NCT00296504|1200636|P6|Interim Analysis|Lost to Follow-up|4
375291|NCT00296504|1200637|P5|Interim Analysis|Lost to Follow-up|14
375292|NCT00296504|1200638|P4|Interim Analysis|Lost to Follow-up|8
375293|NCT00296504|1200639|P3|Interim Analysis|Lost to Follow-up|26
375294|NCT00296504|1200640|P2|Interim Analysis|Lost to Follow-up|3
375295|NCT00296504|1200641|P1|Interim Analysis|Lost to Follow-up|13
375296|NCT00296504|1200633|P9|Interim Analysis|Withdrawal by Subject|0
375297|NCT00296504|1200634|P8|Interim Analysis|Withdrawal by Subject|3
375298|NCT00296504|1200635|P7|Interim Analysis|Withdrawal by Subject|9
375299|NCT00296504|1200636|P6|Interim Analysis|Withdrawal by Subject|5
375300|NCT00296504|1200637|P5|Interim Analysis|Withdrawal by Subject|5
375301|NCT00296504|1200638|P4|Interim Analysis|Withdrawal by Subject|0
375302|NCT00296504|1200639|P3|Interim Analysis|Withdrawal by Subject|12
375303|NCT00296504|1200640|P2|Interim Analysis|Withdrawal by Subject|0
375304|NCT00296504|1200641|P1|Interim Analysis|Withdrawal by Subject|8
375305|NCT00296491|1200734|P4|Overall Study|Lost to Follow-up|0
375306|NCT00296491|1200735|P3|Overall Study|Lost to Follow-up|2
375307|NCT00296491|1200736|P2|Overall Study|Lost to Follow-up|2
375308|NCT00296491|1200737|P1|Overall Study|Lost to Follow-up|0
375309|NCT00296491|1200734|P4|Overall Study|Non-Compliance|14
375310|NCT00296491|1200735|P3|Overall Study|Non-Compliance|10
375311|NCT00296491|1200736|P2|Overall Study|Non-Compliance|13
375312|NCT00296491|1200737|P1|Overall Study|Non-Compliance|12
375313|NCT00296491|1200734|P4|Overall Study|Withdrawal by Subject|2
375314|NCT00296491|1200735|P3|Overall Study|Withdrawal by Subject|3
375315|NCT00296491|1200736|P2|Overall Study|Withdrawal by Subject|3
375316|NCT00296491|1200737|P1|Overall Study|Withdrawal by Subject|7
375317|NCT00296491|1200734|P4|Overall Study|Withdrawn due to Asthma|4
375318|NCT00296491|1200735|P3|Overall Study|Withdrawn due to Asthma|0
375319|NCT00296491|1200736|P2|Overall Study|Withdrawn due to Asthma|0
375320|NCT00296491|1200737|P1|Overall Study|Withdrawn due to Asthma|0
375321|NCT00296491|1200734|P4|Overall Study|Adverse Event|4
375322|NCT00296491|1200735|P3|Overall Study|Adverse Event|1
375323|NCT00296491|1200736|P2|Overall Study|Adverse Event|3
375324|NCT00296491|1200737|P1|Overall Study|Adverse Event|1
375325|NCT00296491|1200734|P4|Overall Study|Protocol Violation|3
375326|NCT00296491|1200735|P3|Overall Study|Protocol Violation|2
375327|NCT00296491|1200736|P2|Overall Study|Protocol Violation|6
375328|NCT00296491|1200737|P1|Overall Study|Protocol Violation|4
375329|NCT00296491|1200734|P4|Overall Study|Low Pollen Counts|16
375330|NCT00296491|1200735|P3|Overall Study|Low Pollen Counts|25
375331|NCT00296491|1200736|P2|Overall Study|Low Pollen Counts|26
375332|NCT00296491|1200737|P1|Overall Study|Low Pollen Counts|18
375333|NCT00296400|1200766|P3|Overall Study|Pregnancy|0
375334|NCT00296400|1200767|P2|Overall Study|Pregnancy|2
375335|NCT00296400|1200768|P1|Overall Study|Pregnancy|1
375336|NCT00296400|1200766|P3|Overall Study|Visit 10 was performed earlier|0
375337|NCT00296400|1200767|P2|Overall Study|Visit 10 was performed earlier|1
375338|NCT00296400|1200768|P1|Overall Study|Visit 10 was performed earlier|0
375339|NCT00296400|1200766|P3|Overall Study|Study specific discontinuation criteria|1
375340|NCT00296400|1200767|P2|Overall Study|Study specific discontinuation criteria|0
375341|NCT00296400|1200768|P1|Overall Study|Study specific discontinuation criteria|0
375342|NCT00296400|1200766|P3|Overall Study|Lost to Follow-up|2
375343|NCT00296400|1200767|P2|Overall Study|Lost to Follow-up|1
375344|NCT00296400|1200768|P1|Overall Study|Lost to Follow-up|1
375345|NCT00296400|1200766|P3|Overall Study|Protocol Violation|1
375346|NCT00296400|1200767|P2|Overall Study|Protocol Violation|1
375347|NCT00296400|1200768|P1|Overall Study|Protocol Violation|1
375348|NCT00296400|1200766|P3|Overall Study|Incorrect enrollment|0
375349|NCT00296400|1200767|P2|Overall Study|Incorrect enrollment|0
375350|NCT00296400|1200768|P1|Overall Study|Incorrect enrollment|2
375351|NCT00296400|1200766|P3|Overall Study|Withdrawal by Subject|2
375352|NCT00296400|1200767|P2|Overall Study|Withdrawal by Subject|6
375353|NCT00296400|1200768|P1|Overall Study|Withdrawal by Subject|5
375354|NCT00296400|1200766|P3|Overall Study|Adverse Event|7
375355|NCT00296400|1200767|P2|Overall Study|Adverse Event|7
375356|NCT00296400|1200768|P1|Overall Study|Adverse Event|7
375357|NCT00296374|1200992|P3|Overall Study|Not specified|1
375358|NCT00296374|1200993|P2|Overall Study|Not specified|0
375359|NCT00296374|1200994|P1|Overall Study|Not specified|0
375360|NCT00296374|1200992|P3|Overall Study|Pregnancy|2
375361|NCT00296374|1200993|P2|Overall Study|Pregnancy|0
375362|NCT00296374|1200994|P1|Overall Study|Pregnancy|0
375363|NCT00296374|1200992|P3|Overall Study|Nephrologist introduced ACE|0
375364|NCT00296374|1200993|P2|Overall Study|Nephrologist introduced ACE|1
375365|NCT00296374|1200994|P1|Overall Study|Nephrologist introduced ACE|0
375366|NCT00296374|1200992|P3|Overall Study|Stopped drug before end of study visit|0
375367|NCT00296374|1200993|P2|Overall Study|Stopped drug before end of study visit|1
375368|NCT00296374|1200994|P1|Overall Study|Stopped drug before end of study visit|0
375369|NCT00296374|1200992|P3|Overall Study|Relocated to another state|0
375370|NCT00296374|1200993|P2|Overall Study|Relocated to another state|0
375371|NCT00296374|1200994|P1|Overall Study|Relocated to another state|1
375372|NCT00296374|1200992|P3|Overall Study|Lost to Follow-up|1
375373|NCT00296374|1200993|P2|Overall Study|Lost to Follow-up|1
375374|NCT00296374|1200994|P1|Overall Study|Lost to Follow-up|3
375375|NCT00296374|1200992|P3|Overall Study|Protocol Violation|3
375376|NCT00296374|1200993|P2|Overall Study|Protocol Violation|2
375377|NCT00296374|1200994|P1|Overall Study|Protocol Violation|1
375378|NCT00296374|1200992|P3|Overall Study|Incorrect enrollment|4
375379|NCT00296374|1200993|P2|Overall Study|Incorrect enrollment|3
375380|NCT00296374|1200994|P1|Overall Study|Incorrect enrollment|3
375381|NCT00296374|1200992|P3|Overall Study|Withdrawal by Subject|11
375382|NCT00296374|1200993|P2|Overall Study|Withdrawal by Subject|5
375383|NCT00296374|1200994|P1|Overall Study|Withdrawal by Subject|3
375384|NCT00296374|1200992|P3|Overall Study|Adverse Event|7
375385|NCT00296374|1200993|P2|Overall Study|Adverse Event|10
375386|NCT00296374|1200994|P1|Overall Study|Adverse Event|14
375387|NCT00296335|1201217|P2|Overall Study|Physician Decision|11
375388|NCT00296335|1201218|P1|Overall Study|Physician Decision|3
375389|NCT00296335|1201217|P2|Overall Study|Lost to Follow-up|33
375390|NCT00296335|1201218|P1|Overall Study|Lost to Follow-up|7
375391|NCT00296335|1201217|P2|Overall Study|Adverse Event|27
375392|NCT00296335|1201218|P1|Overall Study|Adverse Event|17
375393|NCT00296335|1201217|P2|Overall Study|Recurrence|51
375394|NCT00296335|1201218|P1|Overall Study|Recurrence|3
375395|NCT00296244|1201243|P2|Overall Study|Underwent retransplant|1
375396|NCT00296244|1201244|P1|Overall Study|Underwent retransplant|0
375397|NCT00296036|1201308|P6|Overall Study|Protocol Violation|3
375398|NCT00296036|1201309|P5|Overall Study|Protocol Violation|0
375399|NCT00296036|1201310|P4|Overall Study|Protocol Violation|0
375400|NCT00296036|1201311|P3|Overall Study|Protocol Violation|0
375401|NCT00296036|1201312|P2|Overall Study|Protocol Violation|0
375402|NCT00296036|1201313|P1|Overall Study|Protocol Violation|0
375403|NCT00296036|1201308|P6|Overall Study|Withdrawal by Subject|1
375404|NCT00296036|1201309|P5|Overall Study|Withdrawal by Subject|2
375405|NCT00296036|1201310|P4|Overall Study|Withdrawal by Subject|1
375406|NCT00296036|1201311|P3|Overall Study|Withdrawal by Subject|2
375407|NCT00296036|1201312|P2|Overall Study|Withdrawal by Subject|0
375408|NCT00296036|1201313|P1|Overall Study|Withdrawal by Subject|1
375409|NCT00295880|1201339|P1|Overall Study|Unit randomization did not occur|1
375410|NCT00295880|1201339|P1|Overall Study|IBMI unit could not be volume reduced|1
375411|NCT00295854|1201353|P3|Overall Study|not specified|1
375412|NCT00295854|1201354|P2|Overall Study|not specified|5
375413|NCT00295854|1201355|P1|Overall Study|not specified|3
375414|NCT00295854|1201353|P3|Overall Study|required a prohibited medication|0
375415|NCT00295854|1201354|P2|Overall Study|required a prohibited medication|0
375416|NCT00295854|1201355|P1|Overall Study|required a prohibited medication|1
375417|NCT00295854|1201353|P3|Overall Study|did not continue to meet criteria|2
375418|NCT00295854|1201354|P2|Overall Study|did not continue to meet criteria|1
375419|NCT00295854|1201355|P1|Overall Study|did not continue to meet criteria|1
375420|NCT00295854|1201353|P3|Overall Study|Withdrawal by Subject|4
375421|NCT00295854|1201354|P2|Overall Study|Withdrawal by Subject|7
375422|NCT00295854|1201355|P1|Overall Study|Withdrawal by Subject|3
375423|NCT00295854|1201353|P3|Overall Study|Lost to Follow-up|1
375424|NCT00295854|1201354|P2|Overall Study|Lost to Follow-up|0
375425|NCT00295854|1201355|P1|Overall Study|Lost to Follow-up|2
375426|NCT00295854|1201353|P3|Overall Study|Protocol Violation|1
375427|NCT00295854|1201354|P2|Overall Study|Protocol Violation|1
375428|NCT00295854|1201355|P1|Overall Study|Protocol Violation|1
375429|NCT00295854|1201353|P3|Overall Study|Adverse Event|6
375430|NCT00295854|1201354|P2|Overall Study|Adverse Event|7
375431|NCT00295854|1201355|P1|Overall Study|Adverse Event|7
375432|NCT00295750|1201369|P3|Overall Study|Protocol Violation|2
375433|NCT00295750|1201370|P2|Overall Study|Protocol Violation|4
375434|NCT00295750|1201371|P1|Overall Study|Protocol Violation|2
375435|NCT00295750|1201369|P3|Overall Study|Withdrawal by Subject|7
375436|NCT00295750|1201370|P2|Overall Study|Withdrawal by Subject|4
375437|NCT00295750|1201371|P1|Overall Study|Withdrawal by Subject|9
375438|NCT00295750|1201369|P3|Overall Study|Randomized but never received trial drug|3
375439|NCT00295750|1201370|P2|Overall Study|Randomized but never received trial drug|3
375440|NCT00295750|1201371|P1|Overall Study|Randomized but never received trial drug|4
375441|NCT00295750|1201369|P3|Overall Study|Personal reasons|0
375442|NCT00295750|1201370|P2|Overall Study|Personal reasons|1
375443|NCT00295750|1201371|P1|Overall Study|Personal reasons|0
375444|NCT00295750|1201369|P3|Overall Study|Disease progression|0
375445|NCT00295750|1201370|P2|Overall Study|Disease progression|1
375446|NCT00295750|1201371|P1|Overall Study|Disease progression|2
375447|NCT00295750|1201369|P3|Overall Study|Trial drug errors|0
375448|NCT00295750|1201370|P2|Overall Study|Trial drug errors|1
375449|NCT00295750|1201371|P1|Overall Study|Trial drug errors|1
375450|NCT00295750|1201369|P3|Overall Study|Administrative errors|5
375451|NCT00295750|1201370|P2|Overall Study|Administrative errors|4
375452|NCT00295750|1201371|P1|Overall Study|Administrative errors|2
375453|NCT00295750|1201369|P3|Overall Study|Taking prohibited therapy|2
375454|NCT00295750|1201370|P2|Overall Study|Taking prohibited therapy|3
375455|NCT00295750|1201371|P1|Overall Study|Taking prohibited therapy|2
375456|NCT00295750|1201369|P3|Overall Study|Lost to Follow-up|1
375457|NCT00295750|1201370|P2|Overall Study|Lost to Follow-up|4
375458|NCT00295750|1201371|P1|Overall Study|Lost to Follow-up|1
375459|NCT00295750|1201369|P3|Overall Study|Lack of Efficacy|0
375460|NCT00295750|1201370|P2|Overall Study|Lack of Efficacy|1
375461|NCT00295750|1201371|P1|Overall Study|Lack of Efficacy|1
375462|NCT00295750|1201369|P3|Overall Study|Adverse Event|12
375463|NCT00295750|1201370|P2|Overall Study|Adverse Event|15
375464|NCT00295750|1201371|P1|Overall Study|Adverse Event|19
375465|NCT00295633|1201406|P3|Overall Study|Administrative reason by sponsor|1
375466|NCT00295633|1201407|P2|Overall Study|Administrative reason by sponsor|0
375467|NCT00295633|1201408|P1|Overall Study|Administrative reason by sponsor|0
375468|NCT00295633|1201406|P3|Overall Study|Death|0
375469|NCT00295633|1201407|P2|Overall Study|Death|1
375470|NCT00295633|1201408|P1|Overall Study|Death|1
375471|NCT00295633|1201406|P3|Overall Study|Subject No Longer Meets Study Criteria|3
375472|NCT00295633|1201407|P2|Overall Study|Subject No Longer Meets Study Criteria|3
375473|NCT00295633|1201408|P1|Overall Study|Subject No Longer Meets Study Criteria|0
375474|NCT00295633|1201406|P3|Overall Study|Poor/Noncompliance|6
375475|NCT00295633|1201407|P2|Overall Study|Poor/Noncompliance|2
375476|NCT00295633|1201408|P1|Overall Study|Poor/Noncompliance|2
375477|NCT00295633|1201406|P3|Overall Study|Physician Decision|8
375478|NCT00295633|1201407|P2|Overall Study|Physician Decision|10
375479|NCT00295633|1201408|P1|Overall Study|Physician Decision|9
375480|NCT00295633|1201406|P3|Overall Study|Lost to Follow-up|7
375481|NCT00295633|1201407|P2|Overall Study|Lost to Follow-up|11
375482|NCT00295633|1201408|P1|Overall Study|Lost to Follow-up|6
375483|NCT00295633|1201406|P3|Overall Study|Adverse Event|9
375484|NCT00295633|1201407|P2|Overall Study|Adverse Event|17
375485|NCT00295633|1201408|P1|Overall Study|Adverse Event|9
375486|NCT00295633|1201406|P3|Overall Study|Withdrawal of consent by subject|26
375487|NCT00295633|1201407|P2|Overall Study|Withdrawal of consent by subject|16
375488|NCT00295633|1201408|P1|Overall Study|Withdrawal of consent by subject|16
375489|NCT00295633|1201406|P3|Overall Study|Lack of Efficacy|16
375490|NCT00295633|1201407|P2|Overall Study|Lack of Efficacy|7
375491|NCT00295633|1201408|P1|Overall Study|Lack of Efficacy|19
375492|NCT00295490|1201435|P4|Overall Study|Other|1
375493|NCT00295490|1201436|P3|Overall Study|Other|0
375494|NCT00295490|1201437|P2|Overall Study|Other|2
375495|NCT00295490|1201438|P1|Overall Study|Other|0
375496|NCT00295490|1201435|P4|Overall Study|Adverse Event|0
375497|NCT00295490|1201436|P3|Overall Study|Adverse Event|0
375498|NCT00295490|1201437|P2|Overall Study|Adverse Event|0
375499|NCT00295490|1201438|P1|Overall Study|Adverse Event|1
375500|NCT00295490|1201435|P4|Overall Study|Lost to Follow-up|0
375501|NCT00295490|1201436|P3|Overall Study|Lost to Follow-up|1
375502|NCT00295490|1201437|P2|Overall Study|Lost to Follow-up|0
375503|NCT00295490|1201438|P1|Overall Study|Lost to Follow-up|0
375504|NCT00295490|1201435|P4|Overall Study|Withdrawal by Subject|1
375505|NCT00295490|1201436|P3|Overall Study|Withdrawal by Subject|0
375506|NCT00295490|1201437|P2|Overall Study|Withdrawal by Subject|2
375507|NCT00295490|1201438|P1|Overall Study|Withdrawal by Subject|0
375508|NCT00295490|1201435|P4|Overall Study|Protocol Violation|3
375509|NCT00295490|1201436|P3|Overall Study|Protocol Violation|3
375510|NCT00295490|1201437|P2|Overall Study|Protocol Violation|0
375511|NCT00295490|1201438|P1|Overall Study|Protocol Violation|0
375512|NCT00292370|1201519|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
375513|NCT00292370|1201520|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
375514|NCT00292370|1201521|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
375515|NCT00292370|1201519|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
375516|NCT00292370|1201520|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
375517|NCT00292370|1201521|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
375518|NCT00292370|1201519|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
375519|NCT00292370|1201520|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
375520|NCT00292370|1201521|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
375521|NCT00292370|1201519|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
375522|NCT00292370|1201520|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
375523|NCT00292370|1201521|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
375524|NCT00292370|1201519|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
375525|NCT00292370|1201520|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
375526|NCT00292370|1201521|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
375527|NCT00292370|1201519|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
375528|NCT00292370|1201520|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
375529|NCT00292370|1201521|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
375530|NCT00294762|1201530|P2|Overall Study|Did not receive study treatment|3
375531|NCT00294762|1201531|P1|Overall Study|Did not receive study treatment|3
375532|NCT00294723|1201550|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
375533|NCT00294723|1201551|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
375534|NCT00294723|1201552|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
375535|NCT00294723|1201550|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
375536|NCT00294723|1201551|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
375537|NCT00294723|1201552|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
375538|NCT00294723|1201550|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
375539|NCT00294723|1201551|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
375540|NCT00294723|1201552|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
375541|NCT00294723|1201550|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
375542|NCT00294723|1201551|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
375543|NCT00294723|1201552|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
375544|NCT00294723|1201550|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
375545|NCT00294723|1201551|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
375546|NCT00294723|1201552|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
375547|NCT00294723|1201550|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
375548|NCT00294723|1201551|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
375549|NCT00294723|1201552|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
375550|NCT00294723|1201550|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
375551|NCT00294723|1201551|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
375552|NCT00294723|1201552|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
375553|NCT00294723|1201550|P3|Open-Label Extension 52 Weeks|Adverse Event|2
375554|NCT00294723|1201551|P2|Open-Label Extension 52 Weeks|Adverse Event|5
375555|NCT00294723|1201552|P1|Open-Label Extension 52 Weeks|Adverse Event|5
375556|NCT00294723|1201550|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
375557|NCT00294723|1201551|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
375558|NCT00294723|1201552|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
375559|NCT00294723|1201550|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
375560|NCT00294723|1201551|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
375561|NCT00294723|1201552|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
375562|NCT00294723|1201550|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
375563|NCT00294723|1201551|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
375564|NCT00294723|1201552|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
375565|NCT00294723|1201550|P3|Double-Blind Period 52 Weeks|Adverse Event|15
375566|NCT00294723|1201551|P2|Double-Blind Period 52 Weeks|Adverse Event|25
375567|NCT00294723|1201552|P1|Double-Blind Period 52 Weeks|Adverse Event|18
375568|NCT00294684|1201613|P2|Overall Study|Lost to Follow-up|8
375569|NCT00294684|1201614|P1|Overall Study|Lost to Follow-up|5
375570|NCT00294671|1201654|P2|Overall Study|Death|1
375571|NCT00294671|1201655|P1|Overall Study|Death|0
375572|NCT00294671|1201654|P2|Overall Study|Non-compliance|0
375573|NCT00294671|1201655|P1|Overall Study|Non-compliance|1
375574|NCT00294671|1201654|P2|Overall Study|Lost to Follow-up|3
375575|NCT00294671|1201655|P1|Overall Study|Lost to Follow-up|1
375576|NCT00294671|1201654|P2|Overall Study|Non-drug related AE|2
375577|NCT00294671|1201655|P1|Overall Study|Non-drug related AE|3
375578|NCT00294671|1201654|P2|Overall Study|Drug related adverse event (AE)|2
375579|NCT00294671|1201655|P1|Overall Study|Drug related adverse event (AE)|4
375580|NCT00294671|1201654|P2|Overall Study|Liver transplant|9
375581|NCT00294671|1201655|P1|Overall Study|Liver transplant|7
375582|NCT00294671|1201654|P2|Overall Study|Lack of Efficacy|23
375583|NCT00294671|1201655|P1|Overall Study|Lack of Efficacy|11
375584|NCT00294658|1201671|P2|Overall Study|Patient and family were not satisfied|1
375585|NCT00294658|1201672|P1|Overall Study|Patient and family were not satisfied|0
375586|NCT00294658|1201671|P2|Overall Study|Found to have invasive thymoma|0
375587|NCT00294658|1201672|P1|Overall Study|Found to have invasive thymoma|1
375588|NCT00294658|1201671|P2|Overall Study|Withdrawal by Subject|4
375589|NCT00294658|1201672|P1|Overall Study|Withdrawal by Subject|0
375590|NCT00294658|1201671|P2|Overall Study|Pregnancy|1
375591|NCT00294658|1201672|P1|Overall Study|Pregnancy|0
375592|NCT00294658|1201671|P2|Overall Study|Physician Decision|2
375593|NCT00294658|1201672|P1|Overall Study|Physician Decision|1
375594|NCT00294658|1201671|P2|Overall Study|Lost to Follow-up|0
375595|NCT00294658|1201672|P1|Overall Study|Lost to Follow-up|4
375596|NCT00294658|1201671|P2|Overall Study|Death|1
375597|NCT00294658|1201672|P1|Overall Study|Death|0
375598|NCT00294645|1201736|P2|Overall Study|Other|10
375599|NCT00294645|1201737|P1|Overall Study|Other|4
375600|NCT00294645|1201736|P2|Overall Study|Physician Decision|20
375601|NCT00294645|1201737|P1|Overall Study|Physician Decision|15
375602|NCT00294645|1201736|P2|Overall Study|Withdrawal by Subject|34
375603|NCT00294645|1201737|P1|Overall Study|Withdrawal by Subject|18
375604|NCT00294645|1201736|P2|Overall Study|Lost to Follow-up|10
375605|NCT00294645|1201737|P1|Overall Study|Lost to Follow-up|1
375606|NCT00294645|1201736|P2|Overall Study|Death|18
375607|NCT00294645|1201737|P1|Overall Study|Death|10
375608|NCT00294398|1201788|P2|Overall Study|Lost to Follow-up|26
375609|NCT00294398|1201789|P1|Overall Study|Lost to Follow-up|21
375610|NCT00294060|1201797|P1|Overall Study|Device explanted/not replaced|23
375611|NCT00294060|1201797|P1|Overall Study|Medical condition|3
375612|NCT00294060|1201797|P1|Overall Study|Physician Decision|797
375613|NCT00294060|1201797|P1|Overall Study|Withdrawal by Subject|11
375614|NCT00294060|1201797|P1|Overall Study|Lost to Follow-up|55
375615|NCT00294060|1201797|P1|Overall Study|Other|59
375616|NCT00294060|1201797|P1|Overall Study|Death|225
375617|NCT00294047|1201805|P2|Month 84|No consent for Month 84 Follow-up|754
375618|NCT00294047|1201806|P1|Month 84|No consent for Month 84 Follow-up|731
375619|NCT00294047|1201805|P2|Month 84|Visit missed|1
375620|NCT00294047|1201806|P1|Month 84|Visit missed|0
375621|NCT00294047|1201805|P2|Month 84|Under investigation locally|0
375622|NCT00294047|1201806|P1|Month 84|Under investigation locally|1
375623|NCT00294047|1201805|P2|Month 84|Unable to reach study site|0
375624|NCT00294047|1201806|P1|Month 84|Unable to reach study site|1
375625|NCT00294047|1201805|P2|Month 84|Transport reimbursement delayed|1
375626|NCT00294047|1201806|P1|Month 84|Transport reimbursement delayed|0
375627|NCT00294047|1201805|P2|Month 84|Subject does not want male physician|0
375628|NCT00294047|1201806|P1|Month 84|Subject does not want male physician|1
375629|NCT00294047|1201805|P2|Month 84|Personal reason|4
375630|NCT00294047|1201806|P1|Month 84|Personal reason|2
375631|NCT00294047|1201805|P2|Month 84|Lack of time|1
375632|NCT00294047|1201806|P1|Month 84|Lack of time|3
375633|NCT00294047|1201805|P2|Month 84|Family problems|2
375634|NCT00294047|1201806|P1|Month 84|Family problems|2
375635|NCT00294047|1201805|P2|Month 84|Center closed, subject did not transfer|0
375636|NCT00294047|1201806|P1|Month 84|Center closed, subject did not transfer|1
375637|NCT00294047|1201805|P2|Month 84|Work related reasons|2
375638|NCT00294047|1201806|P1|Month 84|Work related reasons|4
375639|NCT00294047|1201805|P2|Month 84|Absent Cervix|0
375640|NCT00294047|1201806|P1|Month 84|Absent Cervix|2
375641|NCT00294047|1201805|P2|Month 84|Lost to Follow-up|190
375642|NCT00294047|1201806|P1|Month 84|Lost to Follow-up|187
375643|NCT00294047|1201805|P2|Month 84|Withdrawal by Subject|31
375644|NCT00294047|1201806|P1|Month 84|Withdrawal by Subject|33
375645|NCT00294047|1201805|P2|Month 84|Protocol Violation|1
375646|NCT00294047|1201806|P1|Month 84|Protocol Violation|1
375647|NCT00294047|1201805|P2|Month 84|Adverse Event|2
375648|NCT00294047|1201806|P1|Month 84|Adverse Event|4
375649|NCT00294047|1201805|P2|Month 48|Unspecified|14
375650|NCT00294047|1201806|P1|Month 48|Unspecified|10
375651|NCT00294047|1201805|P2|Month 48|Lost to Follow-up|287
375652|NCT00294047|1201806|P1|Month 48|Lost to Follow-up|272
375653|NCT00294047|1201805|P2|Month 48|Withdrawal by Subject|115
375654|NCT00294047|1201806|P1|Month 48|Withdrawal by Subject|111
375655|NCT00294047|1201805|P2|Month 48|Protocol Violation|4
375656|NCT00294047|1201806|P1|Month 48|Protocol Violation|4
375657|NCT00294047|1201805|P2|Month 48|Adverse Event|13
375658|NCT00294047|1201806|P1|Month 48|Adverse Event|28
375659|NCT00292318|1201910|P2|Overall Study|Study terminated by officials|1
375660|NCT00292318|1201911|P1|Overall Study|Study terminated by officials|2
375661|NCT00293813|1201922|P3|Overall Study|Noncompliance|0
375662|NCT00293813|1201923|P2|Overall Study|Noncompliance|1
375663|NCT00293813|1201924|P1|Overall Study|Noncompliance|0
375664|NCT00293813|1201922|P3|Overall Study|Lost to Follow-up|3
375665|NCT00293813|1201923|P2|Overall Study|Lost to Follow-up|2
375666|NCT00293813|1201924|P1|Overall Study|Lost to Follow-up|3
375667|NCT00293813|1201922|P3|Overall Study|Withdrawal by Subject|4
375668|NCT00293813|1201923|P2|Overall Study|Withdrawal by Subject|4
375669|NCT00293813|1201924|P1|Overall Study|Withdrawal by Subject|7
375670|NCT00293813|1201922|P3|Overall Study|Adverse Event|1
375671|NCT00293813|1201923|P2|Overall Study|Adverse Event|1
375672|NCT00293813|1201924|P1|Overall Study|Adverse Event|3
375673|NCT00293813|1201922|P3|Overall Study|Physician Decision|0
375674|NCT00293813|1201923|P2|Overall Study|Physician Decision|1
375675|NCT00293813|1201924|P1|Overall Study|Physician Decision|0
375676|NCT00293722|1201935|P1|Overall Study|Unspecified|427
375677|NCT00293709|1201949|P1|Overall Study|Unspecified|47
375678|NCT00293579|1201963|P1|Overall Study|Withdrawal by Subject|1
375679|NCT00293462|1201982|P3|Overall Study|Physician Decision|0
375680|NCT00293462|1201983|P2|Overall Study|Physician Decision|1
375681|NCT00293462|1201984|P1|Overall Study|Physician Decision|0
375682|NCT00293462|1201982|P3|Overall Study|Low radiation dose in oral cavity|0
375683|NCT00293462|1201983|P2|Overall Study|Low radiation dose in oral cavity|1
375684|NCT00293462|1201984|P1|Overall Study|Low radiation dose in oral cavity|0
375685|NCT00293462|1201982|P3|Overall Study|Possible Tracheostomy leakage|0
375686|NCT00293462|1201983|P2|Overall Study|Possible Tracheostomy leakage|1
375687|NCT00293462|1201984|P1|Overall Study|Possible Tracheostomy leakage|0
375688|NCT00293462|1201982|P3|Overall Study|Ischemic stroke after chemotherapy|1
375689|NCT00293462|1201983|P2|Overall Study|Ischemic stroke after chemotherapy|0
375690|NCT00293462|1201984|P1|Overall Study|Ischemic stroke after chemotherapy|0
375691|NCT00293462|1201982|P3|Overall Study|Blood clot after chemotherapy|1
375692|NCT00293462|1201983|P2|Overall Study|Blood clot after chemotherapy|0
375693|NCT00293462|1201984|P1|Overall Study|Blood clot after chemotherapy|0
375694|NCT00293462|1201982|P3|Overall Study|Went back to his home country|1
375695|NCT00293462|1201983|P2|Overall Study|Went back to his home country|0
375696|NCT00293462|1201984|P1|Overall Study|Went back to his home country|0
375697|NCT00293462|1201982|P3|Overall Study|No Show|1
375698|NCT00293462|1201983|P2|Overall Study|No Show|0
375699|NCT00293462|1201984|P1|Overall Study|No Show|0
375700|NCT00293462|1201982|P3|Overall Study|Refuse Radiation Treatment|0
375701|NCT00293462|1201983|P2|Overall Study|Refuse Radiation Treatment|0
375702|NCT00293462|1201984|P1|Overall Study|Refuse Radiation Treatment|1
375703|NCT00293462|1201982|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
375704|NCT00293462|1201983|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
375705|NCT00293462|1201984|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
375706|NCT00293462|1201982|P3|Overall Study|Change Treatment Regimen (ineligible)|0
375707|NCT00293462|1201983|P2|Overall Study|Change Treatment Regimen (ineligible)|0
375708|NCT00293462|1201984|P1|Overall Study|Change Treatment Regimen (ineligible)|1
375709|NCT00293462|1201982|P3|Overall Study|Lost to Follow-up|0
375710|NCT00293462|1201983|P2|Overall Study|Lost to Follow-up|1
375711|NCT00293462|1201984|P1|Overall Study|Lost to Follow-up|0
375712|NCT00293462|1201982|P3|Overall Study|Death|0
375713|NCT00293462|1201983|P2|Overall Study|Death|0
375714|NCT00293462|1201984|P1|Overall Study|Death|1
375715|NCT00293462|1201982|P3|Overall Study|Withdrawal by Subject|6
375716|NCT00293462|1201983|P2|Overall Study|Withdrawal by Subject|3
375717|NCT00293462|1201984|P1|Overall Study|Withdrawal by Subject|4
375718|NCT00293384|1202003|P1|Overall Study|Ineligible|2
375719|NCT00293384|1202003|P1|Overall Study|Missed dosage/study drug|1
375720|NCT00293384|1202003|P1|Overall Study|Non-compliance|2
375721|NCT00293293|1202012|P2|Overall Study|Patient discontinued chemotherapy|1
375722|NCT00293293|1202013|P1|Overall Study|Patient discontinued chemotherapy|0
375723|NCT00293293|1202012|P2|Overall Study|"Patient too anxious to complete trial"|0
375724|NCT00293293|1202013|P1|Overall Study|"Patient too anxious to complete trial"|1
375725|NCT00293293|1202012|P2|Overall Study|Withdrawal by Subject|1
375726|NCT00293293|1202013|P1|Overall Study|Withdrawal by Subject|1
375727|NCT00293267|1202041|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
375728|NCT00293267|1202042|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
375729|NCT00293267|1202041|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
375730|NCT00293267|1202042|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
375731|NCT00293267|1202041|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
375732|NCT00293267|1202042|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
375733|NCT00293267|1202041|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
375734|NCT00293267|1202042|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
375735|NCT00293267|1202041|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
375736|NCT00293267|1202042|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
375737|NCT00293267|1202041|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
375738|NCT00293267|1202042|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
375739|NCT00293267|1202041|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
375740|NCT00293267|1202042|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
375741|NCT00293267|1202041|P2|Extension - Open-Label Week 157-240|Other Reason|1
375742|NCT00293267|1202042|P1|Extension - Open-Label Week 157-240|Other Reason|3
375743|NCT00293267|1202041|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
375744|NCT00293267|1202042|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
375745|NCT00293267|1202041|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
375746|NCT00293267|1202042|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
375747|NCT00293267|1202041|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
375748|NCT00293267|1202042|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
375749|NCT00293267|1202041|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
375750|NCT00293267|1202042|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
375751|NCT00293267|1202041|P2|Extension - Open-Label Week 157-240|Adverse Event|0
375752|NCT00293267|1202042|P1|Extension - Open-Label Week 157-240|Adverse Event|5
375753|NCT00293267|1202041|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
375754|NCT00293267|1202042|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
375755|NCT00293267|1202041|P2|Extension - Double-Blind Week 49-156|Other Reason|0
375756|NCT00293267|1202042|P1|Extension - Double-Blind Week 49-156|Other Reason|7
375757|NCT00293267|1202041|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
375758|NCT00293267|1202042|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
375759|NCT00293267|1202041|P2|Extension - Double-Blind Week 49-156|Death|0
375760|NCT00293267|1202042|P1|Extension - Double-Blind Week 49-156|Death|3
375761|NCT00293267|1202041|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
375762|NCT00293267|1202042|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
375763|NCT00293267|1202041|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
375764|NCT00293267|1202042|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
375765|NCT00293267|1202041|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
375766|NCT00293267|1202042|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
375767|NCT00293267|1202041|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
375768|NCT00293267|1202042|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
375769|NCT00293267|1202041|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
375770|NCT00293267|1202042|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
375771|NCT00293267|1202041|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
375772|NCT00293267|1202042|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
375773|NCT00293267|1202041|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
375774|NCT00293267|1202042|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
375775|NCT00293267|1202041|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
375776|NCT00293267|1202042|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
375777|NCT00293267|1202041|P2|Primary Study - Double-Blind Week 0-48|Death|3
375778|NCT00293267|1202042|P1|Primary Study - Double-Blind Week 0-48|Death|3
375779|NCT00293267|1202041|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
375780|NCT00293267|1202042|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
375781|NCT00293267|1202041|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
375782|NCT00293267|1202042|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
375783|NCT00293254|1202082|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
375784|NCT00293254|1202083|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
375785|NCT00293254|1202082|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
375786|NCT00293254|1202083|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
375787|NCT00293254|1202082|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
375788|NCT00293254|1202083|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
375789|NCT00293254|1202082|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
375790|NCT00293254|1202083|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
375791|NCT00293254|1202082|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
375792|NCT00293254|1202083|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
375793|NCT00293254|1202082|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
375794|NCT00293254|1202083|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
375795|NCT00293254|1202082|P2|Extension - Open-Label Week 157-240|Other Reason|0
375796|NCT00293254|1202083|P1|Extension - Open-Label Week 157-240|Other Reason|4
375797|NCT00293254|1202082|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
375798|NCT00293254|1202083|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
375799|NCT00293254|1202082|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
375800|NCT00293254|1202083|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
375801|NCT00293254|1202082|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
375802|NCT00293254|1202083|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
375803|NCT00293254|1202082|P2|Extension - Open-Label Week 157-240|Adverse Event|1
375804|NCT00293254|1202083|P1|Extension - Open-Label Week 157-240|Adverse Event|2
375805|NCT00293254|1202082|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
375806|NCT00293254|1202083|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
375807|NCT00293254|1202082|P2|Extension - Double-Blind Week 49-156|Other Reason|2
375808|NCT00293254|1202083|P1|Extension - Double-Blind Week 49-156|Other Reason|10
375809|NCT00293254|1202082|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
375810|NCT00293254|1202083|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
375811|NCT00293254|1202082|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
375812|NCT00293254|1202083|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
375813|NCT00293254|1202082|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
375814|NCT00293254|1202083|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
375815|NCT00293254|1202082|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
375816|NCT00293254|1202083|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
375817|NCT00293254|1202082|P2|Extension - Double-Blind Week 49-156|Death|1
375818|NCT00293254|1202083|P1|Extension - Double-Blind Week 49-156|Death|4
375819|NCT00293254|1202082|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
375820|NCT00293254|1202083|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
375821|NCT00293254|1202082|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
375822|NCT00293254|1202083|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
375823|NCT00293254|1202082|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
375824|NCT00293254|1202083|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
375825|NCT00293254|1202082|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
375826|NCT00293254|1202083|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
375827|NCT00293254|1202082|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
375828|NCT00293254|1202083|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
375829|NCT00293254|1202082|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
375830|NCT00293254|1202083|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
375831|NCT00293254|1202082|P2|Primary Study - Double-Blind Week 0-48|Death|2
375832|NCT00293254|1202083|P1|Primary Study - Double-Blind Week 0-48|Death|5
375833|NCT00293254|1202082|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
375834|NCT00293254|1202083|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
375835|NCT00293254|1202082|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
375836|NCT00293254|1202083|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
375837|NCT00293241|1202123|P2|Overall Study|Withdrawal by Subject|8
375838|NCT00293241|1202124|P1|Overall Study|Withdrawal by Subject|4
375839|NCT00293241|1202123|P2|Overall Study|Physician Decision|17
375840|NCT00293241|1202124|P1|Overall Study|Physician Decision|23
375841|NCT00293241|1202123|P2|Overall Study|Lost to Follow-up|16
375842|NCT00293241|1202124|P1|Overall Study|Lost to Follow-up|9
375843|NCT00292227|1202168|P3|Patch Period|Withdrawal by Subject|1
375844|NCT00292227|1202169|P2|Patch Period|Withdrawal by Subject|0
375845|NCT00292227|1202170|P1|Patch Period|Withdrawal by Subject|0
375846|NCT00292227|1202168|P3|Patch Period|Adverse Event|2
375847|NCT00292227|1202169|P2|Patch Period|Adverse Event|0
375848|NCT00292227|1202170|P1|Patch Period|Adverse Event|1
375849|NCT00292188|1202252|P3|Double-Blind|Laboratory Abnormality|1
375850|NCT00292188|1202253|P2|Double-Blind|Laboratory Abnormality|0
375851|NCT00292188|1202254|P1|Double-Blind|Laboratory Abnormality|0
375852|NCT00292188|1202252|P3|Double-Blind|Withdrawal by Subject|3
375853|NCT00292188|1202253|P2|Double-Blind|Withdrawal by Subject|0
375854|NCT00292188|1202254|P1|Double-Blind|Withdrawal by Subject|0
375855|NCT00292188|1202252|P3|Double-Blind|Other|4
375856|NCT00292188|1202253|P2|Double-Blind|Other|3
375857|NCT00292188|1202254|P1|Double-Blind|Other|0
375858|NCT00292188|1202252|P3|Double-Blind|Lost to Follow-up|0
375859|NCT00292188|1202253|P2|Double-Blind|Lost to Follow-up|1
375860|NCT00292188|1202254|P1|Double-Blind|Lost to Follow-up|0
375861|NCT00292188|1202252|P3|Double-Blind|Lack of Efficacy|12
375862|NCT00292188|1202253|P2|Double-Blind|Lack of Efficacy|2
375863|NCT00292188|1202254|P1|Double-Blind|Lack of Efficacy|0
375864|NCT00292188|1202252|P3|Double-Blind|Adverse Event|9
375865|NCT00292188|1202253|P2|Double-Blind|Adverse Event|25
375866|NCT00292188|1202254|P1|Double-Blind|Adverse Event|0
375867|NCT00292188|1202252|P3|Single-Blind|Did not receive treatment|0
375868|NCT00292188|1202253|P2|Single-Blind|Did not receive treatment|0
375869|NCT00292188|1202254|P1|Single-Blind|Did not receive treatment|1
375870|NCT00292188|1202252|P3|Single-Blind|Withdrawal by Subject|0
375871|NCT00292188|1202253|P2|Single-Blind|Withdrawal by Subject|0
375872|NCT00292188|1202254|P1|Single-Blind|Withdrawal by Subject|12
375873|NCT00292188|1202252|P3|Single-Blind|Other|0
375874|NCT00292188|1202253|P2|Single-Blind|Other|0
375875|NCT00292188|1202254|P1|Single-Blind|Other|77
375876|NCT00292188|1202252|P3|Single-Blind|Lost to Follow-up|0
375877|NCT00292188|1202253|P2|Single-Blind|Lost to Follow-up|0
375878|NCT00292188|1202254|P1|Single-Blind|Lost to Follow-up|3
375879|NCT00292188|1202252|P3|Single-Blind|Laboratory Abnormality|0
375880|NCT00292188|1202253|P2|Single-Blind|Laboratory Abnormality|0
375881|NCT00292188|1202254|P1|Single-Blind|Laboratory Abnormality|5
375882|NCT00292188|1202252|P3|Single-Blind|Lack of Efficacy|0
375883|NCT00292188|1202253|P2|Single-Blind|Lack of Efficacy|0
375884|NCT00292188|1202254|P1|Single-Blind|Lack of Efficacy|2
375885|NCT00292188|1202252|P3|Single-Blind|Adverse Event|0
375886|NCT00292188|1202253|P2|Single-Blind|Adverse Event|0
375887|NCT00292188|1202254|P1|Single-Blind|Adverse Event|14
375888|NCT00293059|1202334|P2|Overall Study|missing|5
375889|NCT00293059|1202335|P1|Overall Study|missing|3
375890|NCT00293059|1202334|P2|Overall Study|Noncompliant - sanitary pads collection|1
375891|NCT00293059|1202335|P1|Overall Study|Noncompliant - sanitary pads collection|0
375892|NCT00293059|1202334|P2|Overall Study|Participant stopped study drug|0
375893|NCT00293059|1202335|P1|Overall Study|Participant stopped study drug|1
375894|NCT00293059|1202334|P2|Overall Study|Participant moved out of state|0
375895|NCT00293059|1202335|P1|Overall Study|Participant moved out of state|1
375896|NCT00293059|1202334|P2|Overall Study|Withdrawal by Subject|5
375897|NCT00293059|1202335|P1|Overall Study|Withdrawal by Subject|11
375898|NCT00293059|1202334|P2|Overall Study|Protocol Violation|0
375899|NCT00293059|1202335|P1|Overall Study|Protocol Violation|2
375900|NCT00293059|1202334|P2|Overall Study|Pregnancy|1
375901|NCT00293059|1202335|P1|Overall Study|Pregnancy|1
375902|NCT00293059|1202334|P2|Overall Study|Lost to Follow-up|3
375903|NCT00293059|1202335|P1|Overall Study|Lost to Follow-up|2
375904|NCT00293059|1202334|P2|Overall Study|Lack of Efficacy|0
375905|NCT00293059|1202335|P1|Overall Study|Lack of Efficacy|2
375906|NCT00293059|1202334|P2|Overall Study|Adverse Event|4
375907|NCT00293059|1202335|P1|Overall Study|Adverse Event|12
375908|NCT00293020|1202447|P1|Overall Study|No dose taken|1
375909|NCT00293020|1202447|P1|Overall Study|Other Reason|22
375910|NCT00293020|1202447|P1|Overall Study|Physician Decision|21
375911|NCT00293020|1202447|P1|Overall Study|Protocol Violation|6
375912|NCT00293020|1202447|P1|Overall Study|Lost to Follow-up|4
375913|NCT00293020|1202447|P1|Overall Study|Lack of Efficacy|12
375914|NCT00293020|1202447|P1|Overall Study|Death|32
375915|NCT00293020|1202447|P1|Overall Study|Adverse Event|30
375916|NCT00293020|1202447|P1|Overall Study|Withdrawal by Subject|34
375917|NCT00292981|1202451|P1|Overall Study|Not specified|3
375918|NCT00292981|1202451|P1|Overall Study|Withdrawal by Subject|22
375919|NCT00292981|1202451|P1|Overall Study|Lost to Follow-up|13
375920|NCT00292981|1202451|P1|Overall Study|Adverse Event|1
375921|NCT00292461|1202473|P2|Overall Study|Lost to Follow-up|0
375922|NCT00292461|1202474|P1|Overall Study|Lost to Follow-up|1
375923|NCT00292461|1202473|P2|Overall Study|Protocol Violation|3
375924|NCT00292461|1202474|P1|Overall Study|Protocol Violation|4
375925|NCT00292461|1202473|P2|Overall Study|Withdrawal by Subject|1
375926|NCT00292461|1202474|P1|Overall Study|Withdrawal by Subject|0
375927|NCT00292461|1202473|P2|Overall Study|Lack of Efficacy|0
375928|NCT00292461|1202474|P1|Overall Study|Lack of Efficacy|1
375929|NCT00292461|1202473|P2|Overall Study|Adverse Event|2
375930|NCT00292461|1202474|P1|Overall Study|Adverse Event|4
375931|NCT00291577|1202520|P1|Overall Study|Lack of Efficacy|14
375932|NCT00291577|1202520|P1|Overall Study|Withdrawal by Subject|2
375933|NCT00291577|1202520|P1|Overall Study|Other|4
375934|NCT00291577|1202520|P1|Overall Study|Adverse Event|1
375935|NCT00291551|1202539|P1|Overall Study|Withdrawal by Subject|6
375936|NCT00291551|1202539|P1|Overall Study|Death|7
375937|NCT00291330|1202556|P2|Overall Study|Other|1
375938|NCT00291330|1202557|P1|Overall Study|Other|3
375939|NCT00291330|1202556|P2|Overall Study|Withdrawal by Subject|25
375940|NCT00291330|1202557|P1|Overall Study|Withdrawal by Subject|22
375941|NCT00291330|1202556|P2|Overall Study|Lost to Follow-up|11
375942|NCT00291330|1202557|P1|Overall Study|Lost to Follow-up|16
375943|NCT00291330|1202556|P2|Overall Study|Protocol Violation|20
375944|NCT00291330|1202557|P1|Overall Study|Protocol Violation|13
375945|NCT00291330|1202556|P2|Overall Study|Adverse Event|40
375946|NCT00291330|1202557|P1|Overall Study|Adverse Event|47
375947|NCT00291187|1202599|P4|Overall Study|Protocol Violation- No Drug Administered|0
375948|NCT00291187|1202600|P3|Overall Study|Protocol Violation- No Drug Administered|1
375949|NCT00291187|1202601|P2|Overall Study|Protocol Violation- No Drug Administered|0
375950|NCT00291187|1202602|P1|Overall Study|Protocol Violation- No Drug Administered|0
375951|NCT00291018|1202646|P3|Overall Study|Lost to Follow-up|18
375952|NCT00291018|1202647|P2|Overall Study|Lost to Follow-up|4
375953|NCT00291018|1202648|P1|Overall Study|Lost to Follow-up|3
375954|NCT00291018|1202646|P3|Overall Study|Failures|5
375955|NCT00291018|1202647|P2|Overall Study|Failures|12
375956|NCT00291018|1202648|P1|Overall Study|Failures|5
375957|NCT00291018|1202646|P3|Overall Study|Withdrawal by Subject|1
375958|NCT00291018|1202647|P2|Overall Study|Withdrawal by Subject|8
375959|NCT00291018|1202648|P1|Overall Study|Withdrawal by Subject|2
375960|NCT00291018|1202646|P3|Overall Study|Death|4
375961|NCT00291018|1202647|P2|Overall Study|Death|3
375962|NCT00291018|1202648|P1|Overall Study|Death|3
375963|NCT00291018|1202646|P3|Overall Study|Not Consented or Declined PAS|15
375964|NCT00291018|1202647|P2|Overall Study|Not Consented or Declined PAS|15
375965|NCT00291018|1202648|P1|Overall Study|Not Consented or Declined PAS|12
375966|NCT00290888|1202688|P2|Overall Study|Physician Decision|1
375967|NCT00290888|1202689|P1|Overall Study|Physician Decision|3
375968|NCT00290771|1202706|P2|Overall Study|Lost to Follow-up|1
375969|NCT00290771|1202707|P1|Overall Study|Lost to Follow-up|0
375970|NCT00290771|1202706|P2|Overall Study|Protocol Violation|0
375971|NCT00290771|1202707|P1|Overall Study|Protocol Violation|2
375972|NCT00290771|1202706|P2|Overall Study|Administrative problems|1
375973|NCT00290771|1202707|P1|Overall Study|Administrative problems|2
375974|NCT00290771|1202706|P2|Overall Study|Withdrawal by Subject|6
375975|NCT00290771|1202707|P1|Overall Study|Withdrawal by Subject|5
375976|NCT00290771|1202706|P2|Overall Study|Adverse Event|6
375977|NCT00290771|1202707|P1|Overall Study|Adverse Event|12
375978|NCT00290771|1202706|P2|Overall Study|Death|10
375979|NCT00290771|1202707|P1|Overall Study|Death|11
375980|NCT00290771|1202706|P2|Overall Study|Disease progression|73
375981|NCT00290771|1202707|P1|Overall Study|Disease progression|95
375982|NCT00290758|1202731|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
375983|NCT00290758|1202732|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
375984|NCT00290758|1202731|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
375985|NCT00290758|1202732|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
375986|NCT00290758|1202731|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
375987|NCT00290758|1202732|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
375988|NCT00290758|1202731|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
375989|NCT00290758|1202732|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
375990|NCT00290758|1202731|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
375991|NCT00290758|1202732|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
375992|NCT00290758|1202731|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
375993|NCT00290758|1202732|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
375994|NCT00290758|1202731|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
375995|NCT00290758|1202732|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
375996|NCT00290758|1202731|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
375997|NCT00290758|1202732|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
375998|NCT00290732|1202754|P5|Overall Study|Inability to instill drug intraductally.|0
375999|NCT00290732|1202755|P4|Overall Study|Inability to instill drug intraductally.|0
376000|NCT00290732|1202756|P3|Overall Study|Inability to instill drug intraductally.|1
376001|NCT00290732|1202757|P2|Overall Study|Inability to instill drug intraductally.|1
376002|NCT00290732|1202758|P1|Overall Study|Inability to instill drug intraductally.|0
376003|NCT00290290|1202853|P2|Overall Study|Underwent clean surgical procedure|12
376004|NCT00290290|1202854|P1|Overall Study|Underwent clean surgical procedure|13
376005|NCT00290290|1202853|P2|Overall Study|Withdrawal by Subject|2
376006|NCT00290290|1202854|P1|Overall Study|Withdrawal by Subject|2
376007|NCT00290290|1202853|P2|Overall Study|Death|4
376008|NCT00290290|1202854|P1|Overall Study|Death|3
376009|NCT00290251|1202860|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
376010|NCT00290251|1202861|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
376011|NCT00290251|1202862|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
376012|NCT00290251|1202860|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
376013|NCT00290251|1202861|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
376014|NCT00290251|1202862|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
376015|NCT00290251|1202860|P3|Treatment 1 (Months 1 - 3)|headache|0
376016|NCT00290251|1202861|P2|Treatment 1 (Months 1 - 3)|headache|1
376017|NCT00290251|1202862|P1|Treatment 1 (Months 1 - 3)|headache|0
376018|NCT00290251|1202860|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
376019|NCT00290251|1202861|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
376020|NCT00290251|1202862|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
376021|NCT00290238|1202874|P2|Overall Study|Withdrawal by Subject|13
376022|NCT00290238|1202875|P1|Overall Study|Withdrawal by Subject|15
376023|NCT00290238|1202874|P2|Overall Study|Lost to Follow-up|1
376024|NCT00290238|1202875|P1|Overall Study|Lost to Follow-up|0
376025|NCT00290238|1202874|P2|Overall Study|Study terminated|27
376026|NCT00290238|1202875|P1|Overall Study|Study terminated|27
376027|NCT00290186|1202900|P2|Overall Study|Withdrawal by Subject|1
376028|NCT00290186|1202901|P1|Overall Study|Withdrawal by Subject|0
376029|NCT00290186|1202900|P2|Overall Study|Study was terminated prior to 3-month te|1
376030|NCT00290186|1202901|P1|Overall Study|Study was terminated prior to 3-month te|1
376031|NCT00290186|1202900|P2|Overall Study|Lost to Follow-up|2
376032|NCT00290186|1202901|P1|Overall Study|Lost to Follow-up|3
376033|NCT00290186|1202900|P2|Overall Study|Adverse Event|1
376034|NCT00290186|1202901|P1|Overall Study|Adverse Event|1
376035|NCT00289991|1202952|P2|Overall Study|Unspecified|14
376036|NCT00289991|1202953|P1|Overall Study|Unspecified|5
376037|NCT00289991|1202952|P2|Overall Study|Withdrawal by Subject|12
376038|NCT00289991|1202953|P1|Overall Study|Withdrawal by Subject|2
376039|NCT00289991|1202952|P2|Overall Study|Lost to Follow-up|1
376040|NCT00289991|1202953|P1|Overall Study|Lost to Follow-up|0
376041|NCT00289991|1202952|P2|Overall Study|Fungal breakthrough infection|1
376042|NCT00289991|1202953|P1|Overall Study|Fungal breakthrough infection|0
376043|NCT00289991|1202952|P2|Overall Study|Failure of prophylaxis|1
376044|NCT00289991|1202953|P1|Overall Study|Failure of prophylaxis|1
376045|NCT00289991|1202952|P2|Overall Study|Adverse Event|13
376046|NCT00289991|1202953|P1|Overall Study|Adverse Event|15
376047|NCT00289991|1202952|P2|Overall Study|Death|38
376048|NCT00289991|1202953|P1|Overall Study|Death|35
376049|NCT00289978|1202978|P3|Overall Study|Death|2
376050|NCT00289978|1202979|P2|Overall Study|Death|0
376051|NCT00289978|1202980|P1|Overall Study|Death|1
376052|NCT00289978|1202978|P3|Overall Study|Abnormal test procedure result(s)|1
376053|NCT00289978|1202979|P2|Overall Study|Abnormal test procedure result(s)|1
376054|NCT00289978|1202980|P1|Overall Study|Abnormal test procedure result(s)|2
376055|NCT00289978|1202978|P3|Overall Study|Protocol Violation|4
376056|NCT00289978|1202979|P2|Overall Study|Protocol Violation|5
376057|NCT00289978|1202980|P1|Overall Study|Protocol Violation|5
376058|NCT00289978|1202978|P3|Overall Study|Lost to Follow-up|7
376059|NCT00289978|1202979|P2|Overall Study|Lost to Follow-up|5
376060|NCT00289978|1202980|P1|Overall Study|Lost to Follow-up|3
376061|NCT00289978|1202978|P3|Overall Study|Abnormal laboratory value(s)|1
376062|NCT00289978|1202979|P2|Overall Study|Abnormal laboratory value(s)|9
376063|NCT00289978|1202980|P1|Overall Study|Abnormal laboratory value(s)|20
376064|NCT00289978|1202978|P3|Overall Study|Lack of Efficacy|25
376065|NCT00289978|1202979|P2|Overall Study|Lack of Efficacy|6
376066|NCT00289978|1202980|P1|Overall Study|Lack of Efficacy|13
376067|NCT00289978|1202978|P3|Overall Study|Adverse Event|18
376068|NCT00289978|1202979|P2|Overall Study|Adverse Event|13
376069|NCT00289978|1202980|P1|Overall Study|Adverse Event|22
376070|NCT00289978|1202978|P3|Overall Study|Withdrawal by Subject|28
376071|NCT00289978|1202979|P2|Overall Study|Withdrawal by Subject|17
376072|NCT00289978|1202980|P1|Overall Study|Withdrawal by Subject|31
376073|NCT00289913|1202999|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
376074|NCT00289913|1203000|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
376075|NCT00289913|1203001|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
376076|NCT00289913|1203002|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
376077|NCT00289913|1203003|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
376078|NCT00289913|1202999|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
376079|NCT00289913|1203000|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
376080|NCT00289913|1203001|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
376081|NCT00289913|1203002|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
376082|NCT00289913|1203003|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
376083|NCT00289913|1202999|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
376084|NCT00289913|1203000|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
376085|NCT00289913|1203001|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
376086|NCT00289913|1203002|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
376087|NCT00289913|1203003|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
376088|NCT00289913|1202999|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
376089|NCT00289913|1203000|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
376090|NCT00289913|1203001|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
376091|NCT00289913|1203002|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
376092|NCT00289913|1203003|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
376093|NCT00289913|1202999|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
376094|NCT00289913|1203000|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
376095|NCT00289913|1203001|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
376096|NCT00289913|1203002|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
376097|NCT00289913|1203003|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
376098|NCT00289913|1202999|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
376099|NCT00289913|1203000|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
376100|NCT00289913|1203001|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
376101|NCT00289913|1203002|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
376102|NCT00289913|1203003|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
376103|NCT00289913|1202999|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
376104|NCT00289913|1203000|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
376105|NCT00289913|1203001|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
376106|NCT00289913|1203002|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
376107|NCT00289913|1203003|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
376108|NCT00289913|1202999|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376109|NCT00289913|1203000|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376110|NCT00289913|1203001|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376111|NCT00289913|1203002|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
376112|NCT00289913|1203003|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376113|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
376114|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
376115|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
376116|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
376117|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
376118|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
376119|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
376120|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
376121|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
376122|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
376123|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
376124|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
376125|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
376126|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
376127|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
376128|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
376129|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
376130|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
376131|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
376132|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
376133|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
376282|NCT00289887|1203143|P2|Overall Study|Unspecified|3
376134|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
376135|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
376136|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
376137|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
376138|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
376139|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
376140|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
376141|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
376142|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
376143|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
376144|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
376145|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
376146|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
376147|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
376148|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
376149|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
376150|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
376151|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
376152|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
376153|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
376154|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
376155|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
376156|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
376157|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
376158|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
376159|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
376160|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
376161|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
376162|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
376163|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
376164|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
376165|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
376166|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
376167|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
376168|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
376169|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
376170|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
376171|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
376172|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
376173|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
376174|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
376175|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
376176|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
376177|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
376178|NCT00289913|1202999|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376179|NCT00289913|1203000|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376180|NCT00289913|1203001|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
376181|NCT00289913|1203002|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376182|NCT00289913|1203003|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376183|NCT00289913|1202999|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
376184|NCT00289913|1203000|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
376185|NCT00289913|1203001|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
376186|NCT00289913|1203002|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
376187|NCT00289913|1203003|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
376188|NCT00289913|1202999|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
376189|NCT00289913|1203000|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
376190|NCT00289913|1203001|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
376191|NCT00289913|1203002|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
376192|NCT00289913|1203003|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
376193|NCT00289913|1202999|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
376194|NCT00289913|1203000|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
376195|NCT00289913|1203001|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
376196|NCT00289913|1203002|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
376197|NCT00289913|1203003|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
376198|NCT00289913|1202999|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
376199|NCT00289913|1203000|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
376200|NCT00289913|1203001|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
376201|NCT00289913|1203002|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
376202|NCT00289913|1203003|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
376203|NCT00289913|1202999|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
376204|NCT00289913|1203000|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
376205|NCT00289913|1203001|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
376206|NCT00289913|1203002|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
376207|NCT00289913|1203003|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
376208|NCT00289913|1202999|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
376209|NCT00289913|1203000|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
376210|NCT00289913|1203001|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
376211|NCT00289913|1203002|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
376212|NCT00289913|1203003|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
376213|NCT00289913|1202999|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
376214|NCT00289913|1203000|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
376215|NCT00289913|1203001|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
376216|NCT00289913|1203002|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
376217|NCT00289913|1203003|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
376218|NCT00289913|1202999|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
376219|NCT00289913|1203000|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
376220|NCT00289913|1203001|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
376221|NCT00289913|1203002|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
376222|NCT00289913|1203003|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
376223|NCT00289913|1202999|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376224|NCT00289913|1203000|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376225|NCT00289913|1203001|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376226|NCT00289913|1203002|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
376227|NCT00289913|1203003|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
376228|NCT00289900|1203034|P6|Overall Study|Not treated|0
376229|NCT00289900|1203035|P5|Overall Study|Not treated|0
376230|NCT00289900|1203036|P4|Overall Study|Not treated|0
376231|NCT00289900|1203037|P3|Overall Study|Not treated|0
376232|NCT00289900|1203038|P2|Overall Study|Not treated|1
376233|NCT00289900|1203039|P1|Overall Study|Not treated|0
376234|NCT00289900|1203034|P6|Overall Study|site terminated|0
376235|NCT00289900|1203035|P5|Overall Study|site terminated|0
376236|NCT00289900|1203036|P4|Overall Study|site terminated|0
376237|NCT00289900|1203037|P3|Overall Study|site terminated|1
376238|NCT00289900|1203038|P2|Overall Study|site terminated|0
376239|NCT00289900|1203039|P1|Overall Study|site terminated|1
376240|NCT00289900|1203034|P6|Overall Study|Protocol Violation|4
376241|NCT00289900|1203035|P5|Overall Study|Protocol Violation|7
376242|NCT00289900|1203036|P4|Overall Study|Protocol Violation|6
376243|NCT00289900|1203037|P3|Overall Study|Protocol Violation|2
376244|NCT00289900|1203038|P2|Overall Study|Protocol Violation|9
376245|NCT00289900|1203039|P1|Overall Study|Protocol Violation|3
376246|NCT00289900|1203034|P6|Overall Study|Withdrawal by Subject|11
376247|NCT00289900|1203035|P5|Overall Study|Withdrawal by Subject|12
376248|NCT00289900|1203036|P4|Overall Study|Withdrawal by Subject|18
376249|NCT00289900|1203037|P3|Overall Study|Withdrawal by Subject|8
376250|NCT00289900|1203038|P2|Overall Study|Withdrawal by Subject|21
376251|NCT00289900|1203039|P1|Overall Study|Withdrawal by Subject|10
376252|NCT00289900|1203034|P6|Overall Study|Participant moved|1
376253|NCT00289900|1203035|P5|Overall Study|Participant moved|1
376254|NCT00289900|1203036|P4|Overall Study|Participant moved|1
376255|NCT00289900|1203037|P3|Overall Study|Participant moved|0
376256|NCT00289900|1203038|P2|Overall Study|Participant moved|0
376257|NCT00289900|1203039|P1|Overall Study|Participant moved|1
376258|NCT00289900|1203034|P6|Overall Study|Other|0
376259|NCT00289900|1203035|P5|Overall Study|Other|1
376260|NCT00289900|1203036|P4|Overall Study|Other|5
376261|NCT00289900|1203037|P3|Overall Study|Other|0
376262|NCT00289900|1203038|P2|Overall Study|Other|0
376263|NCT00289900|1203039|P1|Overall Study|Other|0
376264|NCT00289900|1203034|P6|Overall Study|Participant had flushing|4
376265|NCT00289900|1203035|P5|Overall Study|Participant had flushing|0
376266|NCT00289900|1203036|P4|Overall Study|Participant had flushing|2
376267|NCT00289900|1203037|P3|Overall Study|Participant had flushing|1
376268|NCT00289900|1203038|P2|Overall Study|Participant had flushing|42
376269|NCT00289900|1203039|P1|Overall Study|Participant had flushing|18
376270|NCT00289900|1203034|P6|Overall Study|Lost to Follow-up|8
376271|NCT00289900|1203035|P5|Overall Study|Lost to Follow-up|4
376272|NCT00289900|1203036|P4|Overall Study|Lost to Follow-up|8
376273|NCT00289900|1203037|P3|Overall Study|Lost to Follow-up|8
376274|NCT00289900|1203038|P2|Overall Study|Lost to Follow-up|7
376275|NCT00289900|1203039|P1|Overall Study|Lost to Follow-up|7
376276|NCT00289900|1203034|P6|Overall Study|Adverse Event|33
376277|NCT00289900|1203035|P5|Overall Study|Adverse Event|20
376278|NCT00289900|1203036|P4|Overall Study|Adverse Event|19
376279|NCT00289900|1203037|P3|Overall Study|Adverse Event|13
376280|NCT00289900|1203038|P2|Overall Study|Adverse Event|40
376281|NCT00289900|1203039|P1|Overall Study|Adverse Event|28
376283|NCT00289887|1203144|P1|Overall Study|Unspecified|7
376284|NCT00289887|1203143|P2|Overall Study|Withdrawal by Subject|8
376285|NCT00289887|1203144|P1|Overall Study|Withdrawal by Subject|3
376286|NCT00289887|1203143|P2|Overall Study|Protocol Violation|1
376287|NCT00289887|1203144|P1|Overall Study|Protocol Violation|3
376288|NCT00289887|1203143|P2|Overall Study|Lost to Follow-up|3
376289|NCT00289887|1203144|P1|Overall Study|Lost to Follow-up|3
376290|NCT00289887|1203143|P2|Overall Study|Lack of Efficacy|11
376291|NCT00289887|1203144|P1|Overall Study|Lack of Efficacy|3
376292|NCT00289887|1203143|P2|Overall Study|Adverse Event|3
376293|NCT00289887|1203144|P1|Overall Study|Adverse Event|3
376294|NCT00289874|1203162|P2|Overall Study|Did not meet eligibility|0
376295|NCT00289874|1203163|P1|Overall Study|Did not meet eligibility|1
376296|NCT00289874|1203162|P2|Overall Study|Protocol Violation|2
376297|NCT00289874|1203163|P1|Overall Study|Protocol Violation|3
376298|NCT00289874|1203162|P2|Overall Study|Lost to Follow-up|1
376299|NCT00289874|1203163|P1|Overall Study|Lost to Follow-up|1
376300|NCT00289874|1203162|P2|Overall Study|Adverse Event|5
376301|NCT00289874|1203163|P1|Overall Study|Adverse Event|1
376302|NCT00289848|1203173|P2|Overall Study|Open-Label AHA Treatment Requested|1
376303|NCT00289848|1203174|P1|Overall Study|Open-Label AHA Treatment Requested|0
376304|NCT00289848|1203173|P2|Overall Study|Patient Moved|2
376305|NCT00289848|1203174|P1|Overall Study|Patient Moved|6
376306|NCT00289848|1203173|P2|Overall Study|Withdrawal by Subject|11
376307|NCT00289848|1203174|P1|Overall Study|Withdrawal by Subject|5
376308|NCT00289848|1203173|P2|Overall Study|Protocol Violation|2
376309|NCT00289848|1203174|P1|Overall Study|Protocol Violation|5
376310|NCT00289848|1203173|P2|Overall Study|Lost to Follow-up|1
376311|NCT00289848|1203174|P1|Overall Study|Lost to Follow-up|3
376312|NCT00289848|1203173|P2|Overall Study|Lack of Efficacy|24
376313|NCT00289848|1203174|P1|Overall Study|Lack of Efficacy|20
376314|NCT00289848|1203173|P2|Overall Study|Death|0
376315|NCT00289848|1203174|P1|Overall Study|Death|1
376316|NCT00289848|1203173|P2|Overall Study|Adverse Event|4
376317|NCT00289848|1203174|P1|Overall Study|Adverse Event|6
376318|NCT00289783|1203186|P2|Fourth Dose Phase|Unspecified|10
376319|NCT00289783|1203187|P1|Fourth Dose Phase|Unspecified|22
376320|NCT00289783|1203186|P2|Fourth Dose Phase|Migration from the study area|1
376321|NCT00289783|1203187|P1|Fourth Dose Phase|Migration from the study area|1
376322|NCT00289783|1203186|P2|Fourth Dose Phase|Lost to Follow-up|12
376323|NCT00289783|1203187|P1|Fourth Dose Phase|Lost to Follow-up|53
376324|NCT00289783|1203186|P2|Fourth Dose Phase|Withdrawal by Subject|1
376325|NCT00289783|1203187|P1|Fourth Dose Phase|Withdrawal by Subject|10
376326|NCT00289783|1203186|P2|Fourth Dose Phase|Adverse Event|0
376327|NCT00289783|1203187|P1|Fourth Dose Phase|Adverse Event|1
376328|NCT00289783|1203186|P2|Primary Phase|Unspecified|12
376329|NCT00289783|1203187|P1|Primary Phase|Unspecified|32
376330|NCT00289783|1203186|P2|Primary Phase|Migration from the study area|10
376331|NCT00289783|1203187|P1|Primary Phase|Migration from the study area|26
376332|NCT00289783|1203186|P2|Primary Phase|Lost to Follow-up|14
376333|NCT00289783|1203187|P1|Primary Phase|Lost to Follow-up|60
376334|NCT00289783|1203186|P2|Primary Phase|Withdrawal by Subject|40
376335|NCT00289783|1203187|P1|Primary Phase|Withdrawal by Subject|93
376336|NCT00289783|1203186|P2|Primary Phase|Protocol Violation|6
376337|NCT00289783|1203187|P1|Primary Phase|Protocol Violation|27
376338|NCT00289783|1203186|P2|Primary Phase|Adverse Event|1
376339|NCT00289783|1203187|P1|Primary Phase|Adverse Event|10
376340|NCT00289770|1203365|P1|Year 15|Withdrawal by Subject|1
376341|NCT00289536|1203420|P3|Period 3|Lost to Follow-up|1
376342|NCT00289536|1203421|P2|Period 3|Lost to Follow-up|0
376343|NCT00289536|1203422|P1|Period 3|Lost to Follow-up|0
376344|NCT00289458|1203468|P3|Overall Study|Withdrawal by Subject|4
376345|NCT00289458|1203469|P2|Overall Study|Withdrawal by Subject|2
376346|NCT00289458|1203470|P1|Overall Study|Withdrawal by Subject|2
376347|NCT00289458|1203468|P3|Overall Study|Physician Decision|2
376348|NCT00289458|1203469|P2|Overall Study|Physician Decision|4
376349|NCT00289458|1203470|P1|Overall Study|Physician Decision|3
376350|NCT00289458|1203468|P3|Overall Study|Death|0
376351|NCT00289458|1203469|P2|Overall Study|Death|0
376352|NCT00289458|1203470|P1|Overall Study|Death|1
376353|NCT00289289|1203509|P3|Overall Study|Other Exit Reason|12
376354|NCT00289289|1203510|P2|Overall Study|Other Exit Reason|4
376355|NCT00289289|1203511|P1|Overall Study|Other Exit Reason|6
376356|NCT00289289|1203509|P3|Overall Study|Did not meet inclusion/exclusion|6
376357|NCT00289289|1203510|P2|Overall Study|Did not meet inclusion/exclusion|0
376358|NCT00289289|1203511|P1|Overall Study|Did not meet inclusion/exclusion|0
376359|NCT00289289|1203509|P3|Overall Study|Non-study device implanted|3
376360|NCT00289289|1203510|P2|Overall Study|Non-study device implanted|1
376361|NCT00289289|1203511|P1|Overall Study|Non-study device implanted|2
376362|NCT00289289|1203509|P3|Overall Study|Physician Decision|6
376363|NCT00289289|1203510|P2|Overall Study|Physician Decision|0
376364|NCT00289289|1203511|P1|Overall Study|Physician Decision|1
376365|NCT00289289|1203509|P3|Overall Study|No implant attempted|1
376366|NCT00289289|1203510|P2|Overall Study|No implant attempted|0
376367|NCT00289289|1203511|P1|Overall Study|No implant attempted|0
376368|NCT00289289|1203509|P3|Overall Study|Death|5
376369|NCT00289289|1203510|P2|Overall Study|Death|2
376370|NCT00289289|1203511|P1|Overall Study|Death|4
376371|NCT00289289|1203509|P3|Overall Study|Lost to Follow-up|1
376372|NCT00289289|1203510|P2|Overall Study|Lost to Follow-up|0
376373|NCT00289289|1203511|P1|Overall Study|Lost to Follow-up|1
376374|NCT00289289|1203509|P3|Overall Study|Withdrawal by Subject|15
376375|NCT00289289|1203510|P2|Overall Study|Withdrawal by Subject|3
376376|NCT00289289|1203511|P1|Overall Study|Withdrawal by Subject|5
376377|NCT00289276|1203526|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
376378|NCT00289276|1203527|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
376379|NCT00289276|1203526|P2|Second Part of FAST Study (Expansion)|Death|2
376380|NCT00289276|1203527|P1|Second Part of FAST Study (Expansion)|Death|0
376381|NCT00289185|1203562|P2|Overall Study|Death|1
376382|NCT00289185|1203563|P1|Overall Study|Death|1
376383|NCT00289185|1203562|P2|Overall Study|Lost to Follow-up|17
376384|NCT00289185|1203563|P1|Overall Study|Lost to Follow-up|23
376385|NCT00289185|1203562|P2|Overall Study|Withdrawal by Subject|8
376386|NCT00289185|1203563|P1|Overall Study|Withdrawal by Subject|4
376387|NCT00289133|1203610|P2|Overall Study|Lost to Follow-up|115
376388|NCT00289133|1203611|P1|Overall Study|Lost to Follow-up|92
376389|NCT00289133|1203610|P2|Overall Study|Revision|6
376390|NCT00289133|1203611|P1|Overall Study|Revision|8
376391|NCT00289133|1203610|P2|Overall Study|Physician Decision|45
376392|NCT00289133|1203611|P1|Overall Study|Physician Decision|41
376393|NCT00289133|1203610|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
376394|NCT00289133|1203611|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
376395|NCT00289133|1203610|P2|Overall Study|Death|10
376396|NCT00289133|1203611|P1|Overall Study|Death|5
376397|NCT00289133|1203610|P2|Overall Study|Withdrawal by Subject|10
376398|NCT00289133|1203611|P1|Overall Study|Withdrawal by Subject|9
376399|NCT00289133|1203610|P2|Overall Study|Protocol Violation|38
376400|NCT00289133|1203611|P1|Overall Study|Protocol Violation|32
376401|NCT00289133|1203610|P2|Overall Study|Non-study device implanted|0
376402|NCT00289133|1203611|P1|Overall Study|Non-study device implanted|12
376403|NCT00289016|1203667|P1|Overall Study|Other|1
376404|NCT00289016|1203667|P1|Overall Study|Adverse Event|1
376405|NCT00289016|1203667|P1|Overall Study|Withdrawal by Subject|2
376406|NCT00289016|1203667|P1|Overall Study|Unrelated Medical Condition or Accident|2
376407|NCT00289016|1203667|P1|Overall Study|Death|2
376408|NCT00289016|1203667|P1|Overall Study|Disease Progression|29
376409|NCT00288912|1203679|P3|Overall Study|Withdrawal by Subject|12
376410|NCT00288912|1203680|P2|Overall Study|Withdrawal by Subject|5
376411|NCT00288912|1203681|P1|Overall Study|Withdrawal by Subject|4
376412|NCT00288912|1203679|P3|Overall Study|Lost to Follow-up|9
376413|NCT00288912|1203680|P2|Overall Study|Lost to Follow-up|6
376414|NCT00288912|1203681|P1|Overall Study|Lost to Follow-up|9
376415|NCT00288912|1203679|P3|Overall Study|Developed exclusion criterion|7
376416|NCT00288912|1203680|P2|Overall Study|Developed exclusion criterion|6
376417|NCT00288912|1203681|P1|Overall Study|Developed exclusion criterion|4
376418|NCT00288860|1203721|P2|Overall Study|Lost to Follow-up|71
376419|NCT00288860|1203722|P1|Overall Study|Lost to Follow-up|74
376420|NCT00288860|1203721|P2|Overall Study|Withdrawal by Subject|15
376421|NCT00288860|1203722|P1|Overall Study|Withdrawal by Subject|20
376422|NCT00288860|1203721|P2|Overall Study|Death|3
376423|NCT00288860|1203722|P1|Overall Study|Death|4
376424|NCT00288860|1203721|P2|Overall Study|Did not complete intake|8
376425|NCT00288860|1203722|P1|Overall Study|Did not complete intake|4
376426|NCT00288704|1203735|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
376427|NCT00288704|1203736|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
376428|NCT00288704|1203737|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
376429|NCT00288704|1203735|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
376430|NCT00288704|1203736|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
376431|NCT00288704|1203737|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
376432|NCT00288704|1203735|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
376433|NCT00288704|1203736|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
376434|NCT00288704|1203737|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
376435|NCT00288704|1203735|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
376436|NCT00288704|1203736|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
376437|NCT00288704|1203737|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
376438|NCT00288704|1203735|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
376439|NCT00288704|1203736|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
376440|NCT00288704|1203737|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
376441|NCT00288704|1203735|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
376442|NCT00288704|1203736|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
376443|NCT00288704|1203737|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
376444|NCT00288704|1203735|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
376445|NCT00288704|1203736|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
376446|NCT00288704|1203737|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
376447|NCT00288639|1203764|P1|Overall Study|Other|1
376448|NCT00288639|1203764|P1|Overall Study|Withdrawal by Subject|2
376449|NCT00288639|1203764|P1|Overall Study|Lack of Efficacy|4
376450|NCT00288639|1203764|P1|Overall Study|Adverse Event|5
376451|NCT00288626|1203781|P1|Overall Study|Withdrawal by Subject|4
376452|NCT00288626|1203781|P1|Overall Study|Death|3
376453|NCT00288587|1203815|P2|Overall Study|Severe Aortic Stenosis|0
376454|NCT00288587|1203816|P1|Overall Study|Severe Aortic Stenosis|1
376455|NCT00288587|1203815|P2|Overall Study|Physician Decision|2
376456|NCT00288587|1203816|P1|Overall Study|Physician Decision|0
376457|NCT00288587|1203815|P2|Overall Study|Adverse Event|1
376458|NCT00288587|1203816|P1|Overall Study|Adverse Event|0
376459|NCT00288587|1203815|P2|Overall Study|Transplant|3
376460|NCT00288587|1203816|P1|Overall Study|Transplant|0
376461|NCT00288587|1203815|P2|Overall Study|Death|4
376462|NCT00288587|1203816|P1|Overall Study|Death|4
376463|NCT00288509|1203839|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
376464|NCT00288509|1203839|P1|Treatment Cycle 4|Physician Decision|4
376465|NCT00288509|1203839|P1|Treatment Cycle 4|Withdrawal by Subject|3
376466|NCT00288509|1203839|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
376467|NCT00288509|1203839|P1|Treatment Cycle 3|Lost to Follow-up|2
376468|NCT00288509|1203839|P1|Treatment Cycle 3|Withdrawal by Subject|1
376469|NCT00288509|1203839|P1|Treatment Cycle 3|Lack of Efficacy|1
376470|NCT00288509|1203839|P1|Treatment Cycle 2|Withdrawal by Subject|2
376471|NCT00288509|1203839|P1|Treatment Cycle 2|Lack of Efficacy|1
376472|NCT00288509|1203839|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
376473|NCT00288509|1203839|P1|Treatment Cycle 1|Lost to Follow-up|2
376474|NCT00288509|1203839|P1|Treatment Cycle 1|Withdrawal by Subject|1
376475|NCT00288509|1203839|P1|Treatment Cycle 1|Lack of Efficacy|1
376476|NCT00288509|1203839|P1|Treatment Cycle 1|Adverse Event|1
376477|NCT00288080|1203848|P2|Overall Study|Protocol Violation|20
376478|NCT00288080|1203849|P1|Overall Study|Protocol Violation|25
376479|NCT00288080|1203848|P2|Overall Study|Withdrawal by Subject|3
376480|NCT00288080|1203849|P1|Overall Study|Withdrawal by Subject|1
376481|NCT00288054|1203871|P1|Overall Study|Not protocol specified|2
376482|NCT00288054|1203871|P1|Overall Study|Withdrawal by Subject|1
376483|NCT00288054|1203871|P1|Overall Study|Adverse Event|3
376484|NCT00288054|1203871|P1|Overall Study|Lack of Efficacy|16
376485|NCT00288054|1203871|P1|Overall Study|Protocol Violation|2
376486|NCT00287365|1203941|P1|Overall Study|sample not acquired|13
376487|NCT00287079|1203963|P2|Overall Study|Unspecified|0
376488|NCT00287079|1203964|P1|Overall Study|Unspecified|3
376489|NCT00287079|1203963|P2|Overall Study|Protocol Violation|0
376490|NCT00287079|1203964|P1|Overall Study|Protocol Violation|1
376491|NCT00287079|1203963|P2|Overall Study|Adverse Event|0
376492|NCT00287079|1203964|P1|Overall Study|Adverse Event|5
376493|NCT00287079|1203963|P2|Overall Study|Non-qualifying relapse|0
376494|NCT00287079|1203964|P1|Overall Study|Non-qualifying relapse|1
376495|NCT00287079|1203963|P2|Overall Study|Qualifying relapse|1
376496|NCT00287079|1203964|P1|Overall Study|Qualifying relapse|12
376497|NCT00286754|1203986|P3|Overall Study|Moved out of state|1
376498|NCT00286754|1203987|P2|Overall Study|Moved out of state|0
376499|NCT00286754|1203988|P1|Overall Study|Moved out of state|0
376500|NCT00286754|1203986|P3|Overall Study|Lost to Follow-up|6
376501|NCT00286754|1203987|P2|Overall Study|Lost to Follow-up|14
376502|NCT00286754|1203988|P1|Overall Study|Lost to Follow-up|12
376503|NCT00286754|1203986|P3|Overall Study|Withdrawal by Subject|0
376504|NCT00286754|1203987|P2|Overall Study|Withdrawal by Subject|2
376505|NCT00286754|1203988|P1|Overall Study|Withdrawal by Subject|6
376506|NCT00286754|1203986|P3|Overall Study|Adverse Event|3
376507|NCT00286754|1203987|P2|Overall Study|Adverse Event|2
376508|NCT00286754|1203988|P1|Overall Study|Adverse Event|2
376509|NCT00286494|1204043|P3|Overall Study|Protocol Violation|2
376510|NCT00286494|1204044|P2|Overall Study|Protocol Violation|1
376511|NCT00286494|1204045|P1|Overall Study|Protocol Violation|1
376512|NCT00286494|1204043|P3|Overall Study|Lost to Follow-up|3
376513|NCT00286494|1204044|P2|Overall Study|Lost to Follow-up|1
376514|NCT00286494|1204045|P1|Overall Study|Lost to Follow-up|3
376515|NCT00286494|1204043|P3|Overall Study|Physician Decision|1
376516|NCT00286494|1204044|P2|Overall Study|Physician Decision|5
376517|NCT00286494|1204045|P1|Overall Study|Physician Decision|5
376518|NCT00286494|1204043|P3|Overall Study|Adverse Event|6
376519|NCT00286494|1204044|P2|Overall Study|Adverse Event|8
376520|NCT00286494|1204045|P1|Overall Study|Adverse Event|3
376521|NCT00286494|1204043|P3|Overall Study|Withdrawal by Subject|9
376522|NCT00286494|1204044|P2|Overall Study|Withdrawal by Subject|10
376523|NCT00286494|1204045|P1|Overall Study|Withdrawal by Subject|2
376524|NCT00286494|1204043|P3|Overall Study|Hyperglycemic rescue|18
376525|NCT00286494|1204044|P2|Overall Study|Hyperglycemic rescue|19
376526|NCT00286494|1204045|P1|Overall Study|Hyperglycemic rescue|12
376527|NCT00286468|1204206|P3|Overall Study|Physician Decision|1
376528|NCT00286468|1204207|P2|Overall Study|Physician Decision|2
376529|NCT00286468|1204208|P1|Overall Study|Physician Decision|3
376530|NCT00286468|1204206|P3|Overall Study|Withdrawal by Subject|11
376531|NCT00286468|1204207|P2|Overall Study|Withdrawal by Subject|8
376532|NCT00286468|1204208|P1|Overall Study|Withdrawal by Subject|3
376533|NCT00286468|1204206|P3|Overall Study|Lost to Follow-up|2
376534|NCT00286468|1204207|P2|Overall Study|Lost to Follow-up|1
376535|NCT00286468|1204208|P1|Overall Study|Lost to Follow-up|1
376536|NCT00286468|1204206|P3|Overall Study|Protocol Violation|1
376537|NCT00286468|1204207|P2|Overall Study|Protocol Violation|3
376538|NCT00286468|1204208|P1|Overall Study|Protocol Violation|0
376539|NCT00286468|1204206|P3|Overall Study|Adverse Event|4
376540|NCT00286468|1204207|P2|Overall Study|Adverse Event|6
376541|NCT00286468|1204208|P1|Overall Study|Adverse Event|2
376542|NCT00286468|1204206|P3|Overall Study|Hyperglycemic Rescue|31
376543|NCT00286468|1204207|P2|Overall Study|Hyperglycemic Rescue|30
376544|NCT00286468|1204208|P1|Overall Study|Hyperglycemic Rescue|28
376545|NCT00286455|1204369|P3|Overall Study|Withdrawal by Subject|7
376546|NCT00286455|1204370|P2|Overall Study|Withdrawal by Subject|8
376547|NCT00286455|1204371|P1|Overall Study|Withdrawal by Subject|0
376548|NCT00286455|1204369|P3|Overall Study|Participant Non-compliance|0
376549|NCT00286455|1204370|P2|Overall Study|Participant Non-compliance|0
376550|NCT00286455|1204371|P1|Overall Study|Participant Non-compliance|1
376551|NCT00286455|1204369|P3|Overall Study|Protocol Violation|0
376552|NCT00286455|1204370|P2|Overall Study|Protocol Violation|1
376553|NCT00286455|1204371|P1|Overall Study|Protocol Violation|1
376554|NCT00286455|1204369|P3|Overall Study|Physician Decision|2
376555|NCT00286455|1204370|P2|Overall Study|Physician Decision|0
376556|NCT00286455|1204371|P1|Overall Study|Physician Decision|3
376557|NCT00286455|1204369|P3|Overall Study|Lost to Follow-up|3
376558|NCT00286455|1204370|P2|Overall Study|Lost to Follow-up|3
376559|NCT00286455|1204371|P1|Overall Study|Lost to Follow-up|0
376560|NCT00286455|1204369|P3|Overall Study|Adverse Event|2
376561|NCT00286455|1204370|P2|Overall Study|Adverse Event|3
376562|NCT00286455|1204371|P1|Overall Study|Adverse Event|1
376563|NCT00286455|1204369|P3|Overall Study|Hyperglycemia rescue|10
376564|NCT00286455|1204370|P2|Overall Study|Hyperglycemia rescue|13
376565|NCT00286455|1204371|P1|Overall Study|Hyperglycemia rescue|19
376566|NCT00286442|1204550|P3|Overall Study|Withdrawal by Subject|2
376567|NCT00286442|1204551|P2|Overall Study|Withdrawal by Subject|14
376568|NCT00286442|1204552|P1|Overall Study|Withdrawal by Subject|2
376569|NCT00286442|1204550|P3|Overall Study|Administrative Error|0
376570|NCT00286442|1204551|P2|Overall Study|Administrative Error|1
376571|NCT00286442|1204552|P1|Overall Study|Administrative Error|1
376572|NCT00286442|1204550|P3|Overall Study|Physician Decision|1
376573|NCT00286442|1204551|P2|Overall Study|Physician Decision|1
376574|NCT00286442|1204552|P1|Overall Study|Physician Decision|1
376575|NCT00286442|1204550|P3|Overall Study|Lost to Follow-up|1
376576|NCT00286442|1204551|P2|Overall Study|Lost to Follow-up|2
376577|NCT00286442|1204552|P1|Overall Study|Lost to Follow-up|5
376578|NCT00286442|1204550|P3|Overall Study|Protocol Violation|2
376579|NCT00286442|1204551|P2|Overall Study|Protocol Violation|4
376580|NCT00286442|1204552|P1|Overall Study|Protocol Violation|2
376581|NCT00286442|1204550|P3|Overall Study|Adverse Event|1
376582|NCT00286442|1204551|P2|Overall Study|Adverse Event|6
376583|NCT00286442|1204552|P1|Overall Study|Adverse Event|7
376584|NCT00286442|1204550|P3|Overall Study|Hyperglycemic Rescue|25
376585|NCT00286442|1204551|P2|Overall Study|Hyperglycemic Rescue|17
376586|NCT00286442|1204552|P1|Overall Study|Hyperglycemic Rescue|19
376587|NCT00286429|1204713|P3|Overall Study|Administrative Decision|0
376588|NCT00286429|1204714|P2|Overall Study|Administrative Decision|1
376589|NCT00286429|1204715|P1|Overall Study|Administrative Decision|0
376590|NCT00286429|1204713|P3|Overall Study|Administrative Error|1
376591|NCT00286429|1204714|P2|Overall Study|Administrative Error|1
376592|NCT00286429|1204715|P1|Overall Study|Administrative Error|1
376593|NCT00286429|1204713|P3|Overall Study|Withdrawal by Subject|6
376594|NCT00286429|1204714|P2|Overall Study|Withdrawal by Subject|2
376595|NCT00286429|1204715|P1|Overall Study|Withdrawal by Subject|3
376596|NCT00286429|1204713|P3|Overall Study|Protocol Violation|4
376597|NCT00286429|1204714|P2|Overall Study|Protocol Violation|5
376598|NCT00286429|1204715|P1|Overall Study|Protocol Violation|3
376599|NCT00286429|1204713|P3|Overall Study|Physician Decision|7
376600|NCT00286429|1204714|P2|Overall Study|Physician Decision|7
376601|NCT00286429|1204715|P1|Overall Study|Physician Decision|10
376602|NCT00286429|1204713|P3|Overall Study|Lost to Follow-up|3
376603|NCT00286429|1204714|P2|Overall Study|Lost to Follow-up|4
376604|NCT00286429|1204715|P1|Overall Study|Lost to Follow-up|2
376605|NCT00286429|1204713|P3|Overall Study|Lack of Efficacy|25
376606|NCT00286429|1204714|P2|Overall Study|Lack of Efficacy|27
376607|NCT00286429|1204715|P1|Overall Study|Lack of Efficacy|52
376608|NCT00286429|1204713|P3|Overall Study|Adverse Event|6
376609|NCT00286429|1204714|P2|Overall Study|Adverse Event|1
376610|NCT00286429|1204715|P1|Overall Study|Adverse Event|4
376611|NCT00286156|1204839|P3|Overall Study|AE: pneumonia|0
376612|NCT00286156|1204840|P2|Overall Study|AE: pneumonia|0
376613|NCT00286156|1204841|P1|Overall Study|AE: pneumonia|1
376614|NCT00286156|1204839|P3|Overall Study|AE: nephrotic-range proteinuruia|0
376615|NCT00286156|1204840|P2|Overall Study|AE: nephrotic-range proteinuruia|0
376616|NCT00286156|1204841|P1|Overall Study|AE: nephrotic-range proteinuruia|1
376617|NCT00286156|1204839|P3|Overall Study|AE: pulmonary embolus|0
376618|NCT00286156|1204840|P2|Overall Study|AE: pulmonary embolus|1
376619|NCT00286156|1204841|P1|Overall Study|AE: pulmonary embolus|0
376620|NCT00286156|1204839|P3|Overall Study|Missed 12 month visit|1
376621|NCT00286156|1204840|P2|Overall Study|Missed 12 month visit|0
376622|NCT00286156|1204841|P1|Overall Study|Missed 12 month visit|0
376623|NCT00286091|1204854|P2|Open-label Treatment Phase|Missing End of Study Information|1
376624|NCT00286091|1204855|P1|Open-label Treatment Phase|Missing End of Study Information|0
376625|NCT00286091|1204854|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
376626|NCT00286091|1204855|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
376627|NCT00286091|1204854|P2|Open-label Treatment Phase|Lost to Follow-up|1
376628|NCT00286091|1204855|P1|Open-label Treatment Phase|Lost to Follow-up|0
376629|NCT00286091|1204854|P2|Open-label Treatment Phase|Noncompliance|1
376630|NCT00286091|1204855|P1|Open-label Treatment Phase|Noncompliance|3
376631|NCT00286091|1204854|P2|Open-label Treatment Phase|Disease Progression|3
376632|NCT00286091|1204855|P1|Open-label Treatment Phase|Disease Progression|9
376633|NCT00286091|1204854|P2|Open-label Treatment Phase|Death|7
376634|NCT00286091|1204855|P1|Open-label Treatment Phase|Death|10
376635|NCT00286091|1204854|P2|Open-label Treatment Phase|Withdrawal by Subject|10
376636|NCT00286091|1204855|P1|Open-label Treatment Phase|Withdrawal by Subject|14
376637|NCT00286091|1204854|P2|Open-label Treatment Phase|Other|11
376638|NCT00286091|1204855|P1|Open-label Treatment Phase|Other|11
376639|NCT00286091|1204854|P2|Open-label Treatment Phase|Adverse Event|16
376640|NCT00286091|1204855|P1|Open-label Treatment Phase|Adverse Event|5
376641|NCT00286091|1204854|P2|Open-label Treatment Phase|Physician Decision|21
376642|NCT00286091|1204855|P1|Open-label Treatment Phase|Physician Decision|24
376643|NCT00286091|1204854|P2|Double-blind Treatment Phase|Ineligibility Determined|2
376644|NCT00286091|1204855|P1|Double-blind Treatment Phase|Ineligibility Determined|1
376645|NCT00286091|1204854|P2|Double-blind Treatment Phase|Protocol Deviation|3
376646|NCT00286091|1204855|P1|Double-blind Treatment Phase|Protocol Deviation|1
376647|NCT00286091|1204854|P2|Double-blind Treatment Phase|Lost to Follow-up|4
376648|NCT00286091|1204855|P1|Double-blind Treatment Phase|Lost to Follow-up|11
376649|NCT00286091|1204854|P2|Double-blind Treatment Phase|Noncompliance|8
376650|NCT00286091|1204855|P1|Double-blind Treatment Phase|Noncompliance|8
376651|NCT00286091|1204854|P2|Double-blind Treatment Phase|Administrative Decision|21
376652|NCT00286091|1204855|P1|Double-blind Treatment Phase|Administrative Decision|20
376653|NCT00286091|1204854|P2|Double-blind Treatment Phase|Other|33
376654|NCT00286091|1204855|P1|Double-blind Treatment Phase|Other|25
376655|NCT00286091|1204854|P2|Double-blind Treatment Phase|Disease Progression|35
376656|NCT00286091|1204855|P1|Double-blind Treatment Phase|Disease Progression|22
376657|NCT00286091|1204854|P2|Double-blind Treatment Phase|Adverse Event|40
376658|NCT00286091|1204855|P1|Double-blind Treatment Phase|Adverse Event|28
376659|NCT00286091|1204854|P2|Double-blind Treatment Phase|Death|65
376660|NCT00286091|1204855|P1|Double-blind Treatment Phase|Death|58
376661|NCT00286091|1204854|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
376662|NCT00286091|1204855|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
376663|NCT00286091|1204854|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
376664|NCT00286091|1204855|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
376665|NCT00285207|1204887|P2|Overall Study|non-compliance|1
376666|NCT00285207|1204888|P1|Overall Study|non-compliance|0
376667|NCT00285207|1204887|P2|Overall Study|Pregnancy|1
376668|NCT00285207|1204888|P1|Overall Study|Pregnancy|1
376669|NCT00285207|1204887|P2|Overall Study|Withdrawal by Subject|2
376670|NCT00285207|1204888|P1|Overall Study|Withdrawal by Subject|5
376671|NCT00285207|1204887|P2|Overall Study|Lost to Follow-up|2
376672|NCT00285207|1204888|P1|Overall Study|Lost to Follow-up|3
376673|NCT00282867|1204897|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
376674|NCT00282867|1204898|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
376675|NCT00282867|1204899|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
376676|NCT00285857|1204941|P1|Overall Study|Adverse Event|1
376677|NCT00285857|1204941|P1|Overall Study|Inadequate initial breast cytology|1
376678|NCT00285857|1204941|P1|Overall Study|Withdrawal by Subject|2
376679|NCT00285818|1204954|P2|Overall Study|Lost to Follow-up|0
376680|NCT00285818|1204955|P1|Overall Study|Lost to Follow-up|1
376681|NCT00285818|1204954|P2|Overall Study|Withdrawal by Subject|2
376682|NCT00285818|1204955|P1|Overall Study|Withdrawal by Subject|3
376683|NCT00285584|1204972|P2|Month 6|Lost to Follow-up|1
376684|NCT00285584|1204973|P1|Month 6|Lost to Follow-up|0
376685|NCT00285584|1204972|P2|Month 3|Withdrawal by Subject|0
376686|NCT00285584|1204973|P1|Month 3|Withdrawal by Subject|1
376687|NCT00285584|1204972|P2|Month 3|Lost to Follow-up|3
376688|NCT00285584|1204973|P1|Month 3|Lost to Follow-up|3
376689|NCT00285012|1204998|P2|Received Study Tx|Other|5
376690|NCT00285012|1204999|P1|Received Study Tx|Other|5
376691|NCT00285012|1204998|P2|Received Study Tx|Withdrawal by Subject|43
376692|NCT00285012|1204999|P1|Received Study Tx|Withdrawal by Subject|31
376693|NCT00285012|1204998|P2|Received Study Tx|Lost to Follow-up|31
376694|NCT00285012|1204999|P1|Received Study Tx|Lost to Follow-up|29
376695|NCT00285012|1204998|P2|Received Study Tx|Lack of Efficacy|3
376696|NCT00285012|1204999|P1|Received Study Tx|Lack of Efficacy|0
376697|NCT00285012|1204998|P2|Received Study Tx|Adverse Event|11
376698|NCT00285012|1204999|P1|Received Study Tx|Adverse Event|5
376699|NCT00285012|1204998|P2|Received Study Tx|Death|1
376700|NCT00285012|1204999|P1|Received Study Tx|Death|2
376701|NCT00285012|1204998|P2|Assigned to Study Treatment (Tx)|Other|3
376702|NCT00285012|1204999|P1|Assigned to Study Treatment (Tx)|Other|2
376703|NCT00284934|1205025|P2|Overall Study|Other reasons|1
376704|NCT00284934|1205026|P1|Overall Study|Other reasons|3
376705|NCT00284934|1205025|P2|Overall Study|Adverse Event|2
376706|NCT00284934|1205026|P1|Overall Study|Adverse Event|1
376707|NCT00284856|1205041|P3|Overall Study|Unspecified|4
376708|NCT00284856|1205042|P2|Overall Study|Unspecified|5
376709|NCT00284856|1205043|P1|Overall Study|Unspecified|4
376710|NCT00284856|1205041|P3|Overall Study|Withdrawal by Subject|18
376711|NCT00284856|1205042|P2|Overall Study|Withdrawal by Subject|16
376712|NCT00284856|1205043|P1|Overall Study|Withdrawal by Subject|12
376713|NCT00284856|1205041|P3|Overall Study|Protocol Violation|5
376714|NCT00284856|1205042|P2|Overall Study|Protocol Violation|4
376715|NCT00284856|1205043|P1|Overall Study|Protocol Violation|5
376716|NCT00284856|1205041|P3|Overall Study|Lost to Follow-up|22
376717|NCT00284856|1205042|P2|Overall Study|Lost to Follow-up|21
376718|NCT00284856|1205043|P1|Overall Study|Lost to Follow-up|25
376719|NCT00284856|1205041|P3|Overall Study|Lack of Efficacy|8
376720|NCT00284856|1205042|P2|Overall Study|Lack of Efficacy|1
376721|NCT00284856|1205043|P1|Overall Study|Lack of Efficacy|2
376722|NCT00284856|1205041|P3|Overall Study|Adverse Event|3
376723|NCT00284856|1205042|P2|Overall Study|Adverse Event|3
376724|NCT00284856|1205043|P1|Overall Study|Adverse Event|3
376725|NCT00283296|1205070|P1|Overall Study|in-home trial not completed|5
376726|NCT00283244|1205079|P3|Overall Study|Clinical deterioration|3
376727|NCT00283244|1205080|P2|Overall Study|Clinical deterioration|3
376728|NCT00283244|1205081|P1|Overall Study|Clinical deterioration|1
376729|NCT00283244|1205079|P3|Overall Study|Medical illness (other complicating dz)|6
376730|NCT00283244|1205080|P2|Overall Study|Medical illness (other complicating dz)|3
376731|NCT00283244|1205081|P1|Overall Study|Medical illness (other complicating dz)|4
376732|NCT00283244|1205079|P3|Overall Study|Physician Decision|1
376733|NCT00283244|1205080|P2|Overall Study|Physician Decision|0
376734|NCT00283244|1205081|P1|Overall Study|Physician Decision|0
376735|NCT00283244|1205079|P3|Overall Study|Withdrawal by Subject|2
376736|NCT00283244|1205080|P2|Overall Study|Withdrawal by Subject|2
376737|NCT00283244|1205081|P1|Overall Study|Withdrawal by Subject|1
376738|NCT00283244|1205079|P3|Overall Study|Lack of Efficacy|26
376739|NCT00283244|1205080|P2|Overall Study|Lack of Efficacy|32
376740|NCT00283244|1205081|P1|Overall Study|Lack of Efficacy|8
376741|NCT00283244|1205079|P3|Overall Study|Death|2
376742|NCT00283244|1205080|P2|Overall Study|Death|3
376743|NCT00283244|1205081|P1|Overall Study|Death|4
376744|NCT00283244|1205079|P3|Overall Study|Adverse Event|11
376745|NCT00283244|1205080|P2|Overall Study|Adverse Event|8
376746|NCT00283244|1205081|P1|Overall Study|Adverse Event|0
376747|NCT00283062|1205117|P4|Overall Study|chemotherapy not completed (cycle 6)|0
376748|NCT00283062|1205118|P3|Overall Study|chemotherapy not completed (cycle 6)|0
376749|NCT00283062|1205119|P2|Overall Study|chemotherapy not completed (cycle 6)|0
376750|NCT00283062|1205120|P1|Overall Study|chemotherapy not completed (cycle 6)|1
376751|NCT00283062|1205117|P4|Overall Study|Undefined|4
376752|NCT00283062|1205118|P3|Overall Study|Undefined|1
376753|NCT00283062|1205119|P2|Overall Study|Undefined|1
376754|NCT00283062|1205120|P1|Overall Study|Undefined|0
376755|NCT00283062|1205117|P4|Overall Study|Participant did not wish to continue|0
376756|NCT00283062|1205118|P3|Overall Study|Participant did not wish to continue|1
376757|NCT00283062|1205119|P2|Overall Study|Participant did not wish to continue|2
376758|NCT00283062|1205120|P1|Overall Study|Participant did not wish to continue|3
376759|NCT00283062|1205117|P4|Overall Study|Progressive disease|0
376760|NCT00283062|1205118|P3|Overall Study|Progressive disease|1
376761|NCT00283062|1205119|P2|Overall Study|Progressive disease|0
376762|NCT00283062|1205120|P1|Overall Study|Progressive disease|0
376763|NCT00283062|1205117|P4|Overall Study|Lost to Follow-up|0
376764|NCT00283062|1205118|P3|Overall Study|Lost to Follow-up|1
376765|NCT00283062|1205119|P2|Overall Study|Lost to Follow-up|0
376766|NCT00283062|1205120|P1|Overall Study|Lost to Follow-up|1
376767|NCT00283062|1205117|P4|Overall Study|Adverse Event|0
376768|NCT00283062|1205118|P3|Overall Study|Adverse Event|1
376769|NCT00283062|1205119|P2|Overall Study|Adverse Event|0
376770|NCT00283062|1205120|P1|Overall Study|Adverse Event|2
376771|NCT00283062|1205117|P4|Overall Study|Did not receive any study medication|45
376772|NCT00283062|1205118|P3|Overall Study|Did not receive any study medication|36
376773|NCT00283062|1205119|P2|Overall Study|Did not receive any study medication|4
376774|NCT00283062|1205120|P1|Overall Study|Did not receive any study medication|5
376775|NCT00283049|1205153|P3|Overall Study|No longer requires study treatment|1
376776|NCT00283049|1205154|P2|Overall Study|No longer requires study treatment|0
376777|NCT00283049|1205155|P1|Overall Study|No longer requires study treatment|0
376778|NCT00283049|1205153|P3|Overall Study|Discontinuation of Study|20
376779|NCT00283049|1205154|P2|Overall Study|Discontinuation of Study|16
376780|NCT00283049|1205155|P1|Overall Study|Discontinuation of Study|18
376781|NCT00283049|1205153|P3|Overall Study|Withdrawal by Subject|19
376782|NCT00283049|1205154|P2|Overall Study|Withdrawal by Subject|24
376783|NCT00283049|1205155|P1|Overall Study|Withdrawal by Subject|26
376784|NCT00283049|1205153|P3|Overall Study|Lost to Follow-up|5
376785|NCT00283049|1205154|P2|Overall Study|Lost to Follow-up|2
376786|NCT00283049|1205155|P1|Overall Study|Lost to Follow-up|4
376787|NCT00283049|1205153|P3|Overall Study|Lack of Efficacy|1
376788|NCT00283049|1205154|P2|Overall Study|Lack of Efficacy|1
376789|NCT00283049|1205155|P1|Overall Study|Lack of Efficacy|0
376790|NCT00283049|1205153|P3|Overall Study|Death|1
376791|NCT00283049|1205154|P2|Overall Study|Death|1
376792|NCT00283049|1205155|P1|Overall Study|Death|1
376793|NCT00283049|1205153|P3|Overall Study|Protocol Violation|3
376794|NCT00283049|1205154|P2|Overall Study|Protocol Violation|0
376795|NCT00283049|1205155|P1|Overall Study|Protocol Violation|3
376796|NCT00283049|1205153|P3|Overall Study|Adverse Event|4
376797|NCT00283049|1205154|P2|Overall Study|Adverse Event|1
376798|NCT00283049|1205155|P1|Overall Study|Adverse Event|6
376799|NCT00282984|1205239|P2|Overall Study|Protocol Violation|0
376800|NCT00282984|1205240|P1|Overall Study|Protocol Violation|2
376801|NCT00282984|1205239|P2|Overall Study|in prison|1
376802|NCT00282984|1205240|P1|Overall Study|in prison|0
376803|NCT00282984|1205239|P2|Overall Study|lack of motivation|0
376804|NCT00282984|1205240|P1|Overall Study|lack of motivation|1
376805|NCT00282984|1205239|P2|Overall Study|Participant used antipsychosis meds|1
376806|NCT00282984|1205240|P1|Overall Study|Participant used antipsychosis meds|0
376807|NCT00282984|1205239|P2|Overall Study|Participant only allowed phone follow-up|1
376808|NCT00282984|1205240|P1|Overall Study|Participant only allowed phone follow-up|0
376809|NCT00282984|1205239|P2|Overall Study|Participant stopped study medication|2
376810|NCT00282984|1205240|P1|Overall Study|Participant stopped study medication|2
376811|NCT00282984|1205239|P2|Overall Study|Withdrawal by Participant|34
376812|NCT00282984|1205240|P1|Overall Study|Withdrawal by Participant|22
376813|NCT00282984|1205239|P2|Overall Study|Lost to Follow-up|10
376814|NCT00282984|1205240|P1|Overall Study|Lost to Follow-up|14
376815|NCT00282984|1205239|P2|Overall Study|Lack of Efficacy|2
376816|NCT00282984|1205240|P1|Overall Study|Lack of Efficacy|0
376817|NCT00282984|1205239|P2|Overall Study|Adverse Event|5
376818|NCT00282984|1205240|P1|Overall Study|Adverse Event|8
376819|NCT00282984|1205239|P2|Overall Study|Death|5
376820|NCT00282984|1205240|P1|Overall Study|Death|2
376821|NCT00282919|1205277|P1|Overall Study|Asymptomatic Parasitemia|2
376822|NCT00282919|1205277|P1|Overall Study|Withdrawal by Subject|1
376823|NCT00282919|1205277|P1|Overall Study|Lack of Efficacy|4
376824|NCT00284141|1205305|P1|Overall Study|Ongoing treatment|2
376825|NCT00284141|1205305|P1|Overall Study|Did not take study medication|2
376826|NCT00284141|1205305|P1|Overall Study|Pneumonia|1
376827|NCT00284141|1205305|P1|Overall Study|General decline|1
376828|NCT00284141|1205305|P1|Overall Study|Clinical deterioration / death|2
376829|NCT00284141|1205305|P1|Overall Study|Symptomatic / Clinical Progression|11
376830|NCT00284141|1205305|P1|Overall Study|Participant's request|9
376831|NCT00284141|1205305|P1|Overall Study|Adverse Event|19
376832|NCT00284141|1205305|P1|Overall Study|Disease Progression / Lack of efficacy|51
376833|NCT00284089|1205328|P4|Extension Phase|Withdrawal by Subject|3
376834|NCT00284089|1205329|P3|Extension Phase|Withdrawal by Subject|1
376835|NCT00284089|1205330|P2|Extension Phase|Withdrawal by Subject|0
376836|NCT00284089|1205331|P1|Extension Phase|Withdrawal by Subject|0
376837|NCT00284089|1205328|P4|Extension Phase|Protocol Violation|0
376838|NCT00284089|1205329|P3|Extension Phase|Protocol Violation|1
376839|NCT00284089|1205330|P2|Extension Phase|Protocol Violation|0
376840|NCT00284089|1205331|P1|Extension Phase|Protocol Violation|0
376841|NCT00284089|1205328|P4|Extension Phase|condition no longer requires study drug|7
376842|NCT00284089|1205329|P3|Extension Phase|condition no longer requires study drug|2
376843|NCT00284089|1205330|P2|Extension Phase|condition no longer requires study drug|0
376844|NCT00284089|1205331|P1|Extension Phase|condition no longer requires study drug|2
376845|NCT00284089|1205328|P4|Extension Phase|Adverse Event|2
376846|NCT00284089|1205329|P3|Extension Phase|Adverse Event|2
376847|NCT00284089|1205330|P2|Extension Phase|Adverse Event|0
376848|NCT00284089|1205331|P1|Extension Phase|Adverse Event|0
376849|NCT00284089|1205328|P4|Multiple Dose Phase|Death|1
376850|NCT00284089|1205329|P3|Multiple Dose Phase|Death|1
376851|NCT00284089|1205330|P2|Multiple Dose Phase|Death|0
376852|NCT00284089|1205331|P1|Multiple Dose Phase|Death|0
376853|NCT00284089|1205328|P4|Multiple Dose Phase|Withdrawal by Subject|2
376854|NCT00284089|1205329|P3|Multiple Dose Phase|Withdrawal by Subject|1
376855|NCT00284089|1205330|P2|Multiple Dose Phase|Withdrawal by Subject|0
376856|NCT00284089|1205331|P1|Multiple Dose Phase|Withdrawal by Subject|0
376857|NCT00284089|1205328|P4|Multiple Dose Phase|Protocol Violation|0
376858|NCT00284089|1205329|P3|Multiple Dose Phase|Protocol Violation|1
376859|NCT00284089|1205330|P2|Multiple Dose Phase|Protocol Violation|0
376860|NCT00284089|1205331|P1|Multiple Dose Phase|Protocol Violation|0
376861|NCT00284089|1205328|P4|Multiple Dose Phase|Adverse Event|1
376862|NCT00284089|1205329|P3|Multiple Dose Phase|Adverse Event|1
376863|NCT00284089|1205330|P2|Multiple Dose Phase|Adverse Event|0
376864|NCT00284089|1205331|P1|Multiple Dose Phase|Adverse Event|1
376865|NCT00284050|1205360|P3|Overall Study|Death|0
376866|NCT00284050|1205361|P2|Overall Study|Death|0
376867|NCT00284050|1205362|P1|Overall Study|Death|1
376868|NCT00284050|1205360|P3|Overall Study|Lost to Follow-up|1
376869|NCT00284050|1205361|P2|Overall Study|Lost to Follow-up|0
376870|NCT00284050|1205362|P1|Overall Study|Lost to Follow-up|1
376871|NCT00284050|1205360|P3|Overall Study|Withdrawal by Subject|2
376872|NCT00284050|1205361|P2|Overall Study|Withdrawal by Subject|2
376873|NCT00284050|1205362|P1|Overall Study|Withdrawal by Subject|2
376874|NCT00284050|1205360|P3|Overall Study|Protocol Violation|2
376875|NCT00284050|1205361|P2|Overall Study|Protocol Violation|1
376876|NCT00284050|1205362|P1|Overall Study|Protocol Violation|0
376877|NCT00284050|1205360|P3|Overall Study|Lack of Efficacy|3
376878|NCT00284050|1205361|P2|Overall Study|Lack of Efficacy|1
376879|NCT00284050|1205362|P1|Overall Study|Lack of Efficacy|0
376880|NCT00284050|1205360|P3|Overall Study|Adverse Event|1
376881|NCT00284050|1205361|P2|Overall Study|Adverse Event|1
376882|NCT00284050|1205362|P1|Overall Study|Adverse Event|1
376883|NCT00283868|1205378|P2|Overall Study|Lost to Follow-up|8
376884|NCT00283868|1205379|P1|Overall Study|Lost to Follow-up|7
376885|NCT00283842|1205396|P5|Overall Study|Lost to Follow-up|1
376886|NCT00283842|1205397|P4|Overall Study|Lost to Follow-up|1
376887|NCT00283842|1205398|P3|Overall Study|Lost to Follow-up|4
376888|NCT00283842|1205399|P2|Overall Study|Lost to Follow-up|2
376889|NCT00283842|1205400|P1|Overall Study|Lost to Follow-up|0
376890|NCT00283842|1205396|P5|Overall Study|Lack of Efficacy|3
376891|NCT00283842|1205397|P4|Overall Study|Lack of Efficacy|0
376892|NCT00283842|1205398|P3|Overall Study|Lack of Efficacy|1
376893|NCT00283842|1205399|P2|Overall Study|Lack of Efficacy|3
376894|NCT00283842|1205400|P1|Overall Study|Lack of Efficacy|1
376895|NCT00283842|1205396|P5|Overall Study|Withdrawal by Subject|4
376896|NCT00283842|1205397|P4|Overall Study|Withdrawal by Subject|5
376897|NCT00283842|1205398|P3|Overall Study|Withdrawal by Subject|1
376898|NCT00283842|1205399|P2|Overall Study|Withdrawal by Subject|1
376899|NCT00283842|1205400|P1|Overall Study|Withdrawal by Subject|2
376900|NCT00283842|1205396|P5|Overall Study|Protocol deviation|2
376901|NCT00283842|1205397|P4|Overall Study|Protocol deviation|0
376902|NCT00283842|1205398|P3|Overall Study|Protocol deviation|0
376903|NCT00283842|1205399|P2|Overall Study|Protocol deviation|0
376904|NCT00283842|1205400|P1|Overall Study|Protocol deviation|0
376905|NCT00283842|1205396|P5|Overall Study|Protocol Violation|0
376906|NCT00283842|1205397|P4|Overall Study|Protocol Violation|0
376907|NCT00283842|1205398|P3|Overall Study|Protocol Violation|4
376908|NCT00283842|1205399|P2|Overall Study|Protocol Violation|5
376909|NCT00283842|1205400|P1|Overall Study|Protocol Violation|1
376910|NCT00283842|1205396|P5|Overall Study|Adverse Event|5
376911|NCT00283842|1205397|P4|Overall Study|Adverse Event|21
376912|NCT00283842|1205398|P3|Overall Study|Adverse Event|21
376913|NCT00283842|1205399|P2|Overall Study|Adverse Event|7
376914|NCT00283842|1205400|P1|Overall Study|Adverse Event|8
376915|NCT00283712|1205434|P2|Overall Study|Death|1
376916|NCT00283712|1205435|P1|Overall Study|Death|0
376917|NCT00283686|1205473|P4|Overall Study|Less than full participation|12
376918|NCT00283686|1205474|P3|Overall Study|Less than full participation|6
376919|NCT00283686|1205475|P2|Overall Study|Less than full participation|9
376920|NCT00283686|1205476|P1|Overall Study|Less than full participation|7
376921|NCT00283686|1205473|P4|Overall Study|Lost to Follow-up|20
376922|NCT00283686|1205474|P3|Overall Study|Lost to Follow-up|26
376923|NCT00283686|1205475|P2|Overall Study|Lost to Follow-up|31
376924|NCT00283686|1205476|P1|Overall Study|Lost to Follow-up|21
376925|NCT00283686|1205473|P4|Overall Study|Death|0
376926|NCT00283686|1205474|P3|Overall Study|Death|1
376927|NCT00283686|1205475|P2|Overall Study|Death|1
376928|NCT00283686|1205476|P1|Overall Study|Death|1
376929|NCT00283595|1205520|P2|Overall Study|Withdrawal by Subject|2
376930|NCT00283595|1205521|P1|Overall Study|Withdrawal by Subject|1
376931|NCT00283439|1205533|P4|Overall Study|Not specified|0
376932|NCT00283439|1205534|P3|Overall Study|Not specified|0
376933|NCT00283439|1205535|P2|Overall Study|Not specified|0
376934|NCT00283439|1205536|P1|Overall Study|Not specified|1
376935|NCT00283439|1205533|P4|Overall Study|Treatment discontinued|3
376936|NCT00283439|1205534|P3|Overall Study|Treatment discontinued|1
376937|NCT00283439|1205535|P2|Overall Study|Treatment discontinued|2
376938|NCT00283439|1205536|P1|Overall Study|Treatment discontinued|0
376939|NCT00283439|1205533|P4|Overall Study|Stem cell transplant|3
376940|NCT00283439|1205534|P3|Overall Study|Stem cell transplant|4
376941|NCT00283439|1205535|P2|Overall Study|Stem cell transplant|6
376942|NCT00283439|1205536|P1|Overall Study|Stem cell transplant|6
376943|NCT00283439|1205533|P4|Overall Study|Requirement for alternative therapy|2
376944|NCT00283439|1205534|P3|Overall Study|Requirement for alternative therapy|5
376945|NCT00283439|1205535|P2|Overall Study|Requirement for alternative therapy|2
376946|NCT00283439|1205536|P1|Overall Study|Requirement for alternative therapy|1
376947|NCT00283439|1205533|P4|Overall Study|Disease progression|0
376948|NCT00283439|1205534|P3|Overall Study|Disease progression|0
376949|NCT00283439|1205535|P2|Overall Study|Disease progression|1
376950|NCT00283439|1205536|P1|Overall Study|Disease progression|0
376951|NCT00283439|1205533|P4|Overall Study|Death|0
376952|NCT00283439|1205534|P3|Overall Study|Death|1
376953|NCT00283439|1205535|P2|Overall Study|Death|0
376954|NCT00283439|1205536|P1|Overall Study|Death|0
376955|NCT00283439|1205533|P4|Overall Study|Adverse Event|1
376956|NCT00283439|1205534|P3|Overall Study|Adverse Event|0
376957|NCT00283439|1205535|P2|Overall Study|Adverse Event|0
376958|NCT00283439|1205536|P1|Overall Study|Adverse Event|0
376959|NCT00283400|1205562|P4|Overall Study|Death|0
376960|NCT00283400|1205563|P3|Overall Study|Death|1
376961|NCT00283400|1205564|P2|Overall Study|Death|0
376962|NCT00283400|1205565|P1|Overall Study|Death|1
376963|NCT00283400|1205562|P4|Overall Study|Withdrawal by Subject|0
376964|NCT00283400|1205563|P3|Overall Study|Withdrawal by Subject|0
376965|NCT00283400|1205564|P2|Overall Study|Withdrawal by Subject|1
376966|NCT00283400|1205565|P1|Overall Study|Withdrawal by Subject|1
376967|NCT00283387|1205583|P2|First Intervention|Withdrawal by Subject|1
376968|NCT00283387|1205584|P1|First Intervention|Withdrawal by Subject|0
376969|NCT00283387|1205583|P2|First Intervention|Subject non-compliant|1
376970|NCT00283387|1205584|P1|First Intervention|Subject non-compliant|1
376971|NCT00282568|1205643|P1|Extended Treatment Period|Lost to Follow-up|2
376972|NCT00282568|1205643|P1|Extended Treatment Period|Physician Decision|1
376973|NCT00282568|1205643|P1|Extended Treatment Period|Non-compliance|4
376974|NCT00282568|1205643|P1|Extended Treatment Period|Adverse Event|17
376975|NCT00282568|1205643|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
376976|NCT00282568|1205643|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
376977|NCT00282464|1205669|P2|Overall Study|dropped due to missed visits|1
376978|NCT00282464|1205670|P1|Overall Study|dropped due to missed visits|0
376979|NCT00282464|1205669|P2|Overall Study|dispensed wrong kit|1
376980|NCT00282464|1205670|P1|Overall Study|dispensed wrong kit|0
376981|NCT00282464|1205669|P2|Overall Study|family crisis|1
376982|NCT00282464|1205670|P1|Overall Study|family crisis|0
376983|NCT00282464|1205669|P2|Overall Study|patient incarcerated|1
376984|NCT00282464|1205670|P1|Overall Study|patient incarcerated|0
376985|NCT00282464|1205669|P2|Overall Study|patient no show|1
376986|NCT00282464|1205670|P1|Overall Study|patient no show|0
376987|NCT00282464|1205669|P2|Overall Study|patient non-compliant|0
376988|NCT00282464|1205670|P1|Overall Study|patient non-compliant|3
376989|NCT00282464|1205669|P2|Overall Study|Patient moved|0
376990|NCT00282464|1205670|P1|Overall Study|Patient moved|1
376991|NCT00282464|1205669|P2|Overall Study|Protocol Violation|7
376992|NCT00282464|1205670|P1|Overall Study|Protocol Violation|0
376993|NCT00282464|1205669|P2|Overall Study|laboratory abnormality|2
376994|NCT00282464|1205670|P1|Overall Study|laboratory abnormality|1
376995|NCT00282464|1205669|P2|Overall Study|Withdrawal by Subject|10
376996|NCT00282464|1205670|P1|Overall Study|Withdrawal by Subject|24
376997|NCT00282464|1205669|P2|Overall Study|Lost to Follow-up|10
376998|NCT00282464|1205670|P1|Overall Study|Lost to Follow-up|10
376999|NCT00282464|1205669|P2|Overall Study|Lack of Efficacy|8
377000|NCT00282464|1205670|P1|Overall Study|Lack of Efficacy|8
377001|NCT00282464|1205669|P2|Overall Study|Adverse Event|20
377002|NCT00282464|1205670|P1|Overall Study|Adverse Event|26
377003|NCT00282438|1205720|P2|Overall Study|Death|1
377004|NCT00282438|1205721|P1|Overall Study|Death|0
377005|NCT00282438|1205720|P2|Overall Study|Lack of Efficacy|0
377006|NCT00282438|1205721|P1|Overall Study|Lack of Efficacy|1
377007|NCT00282347|1205729|P2|B Cell Follow-up Period|Reason Not Specified|0
377008|NCT00282347|1205730|P1|B Cell Follow-up Period|Reason Not Specified|2
377009|NCT00282347|1205729|P2|B Cell Follow-up Period|Physician Decision|0
377010|NCT00282347|1205730|P1|B Cell Follow-up Period|Physician Decision|1
377011|NCT00282347|1205729|P2|B Cell Follow-up Period|Withdrawal by Subject|0
377012|NCT00282347|1205730|P1|B Cell Follow-up Period|Withdrawal by Subject|2
377013|NCT00282347|1205729|P2|Safety Follow-up Period|Protocol Deviation|2
377014|NCT00282347|1205730|P1|Safety Follow-up Period|Protocol Deviation|0
377015|NCT00282347|1205729|P2|Safety Follow-up Period|Physician Decision|1
377016|NCT00282347|1205730|P1|Safety Follow-up Period|Physician Decision|1
377017|NCT00282347|1205729|P2|Safety Follow-up Period|Withdrawal by Subject|1
377018|NCT00282347|1205730|P1|Safety Follow-up Period|Withdrawal by Subject|2
377019|NCT00282347|1205729|P2|Safety Follow-up Period|Lost to Follow-up|2
377020|NCT00282347|1205730|P1|Safety Follow-up Period|Lost to Follow-up|0
377021|NCT00282347|1205729|P2|Treatment Period|Physician Decision|1
377022|NCT00282347|1205730|P1|Treatment Period|Physician Decision|0
377023|NCT00282347|1205729|P2|Treatment Period|Withdrawal by Subject|3
377024|NCT00282347|1205730|P1|Treatment Period|Withdrawal by Subject|1
377025|NCT00282347|1205729|P2|Treatment Period|Lost to Follow-up|5
377026|NCT00282347|1205730|P1|Treatment Period|Lost to Follow-up|2
377027|NCT00282347|1205729|P2|Treatment Period|Death|0
377028|NCT00282347|1205730|P1|Treatment Period|Death|2
377029|NCT00282334|1205756|P2|Overall Study|Withdrawal by Subject|5
377030|NCT00282334|1205757|P1|Overall Study|Withdrawal by Subject|8
377031|NCT00282308|1205765|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
377032|NCT00282308|1205766|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
377033|NCT00282308|1205767|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
377034|NCT00282308|1205765|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
377035|NCT00282308|1205766|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
377036|NCT00282308|1205767|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
377037|NCT00282308|1205765|P3|Safety Follow-up Period|Lost to Follow-up|5
377038|NCT00282308|1205766|P2|Safety Follow-up Period|Lost to Follow-up|0
377039|NCT00282308|1205767|P1|Safety Follow-up Period|Lost to Follow-up|0
377040|NCT00282308|1205765|P3|Safety Follow-up Period|Adverse Event|1
377041|NCT00282308|1205766|P2|Safety Follow-up Period|Adverse Event|0
377042|NCT00282308|1205767|P1|Safety Follow-up Period|Adverse Event|0
377043|NCT00282308|1205765|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
377044|NCT00282308|1205766|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
377045|NCT00282308|1205767|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
377046|NCT00282308|1205765|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
377047|NCT00282308|1205766|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
377048|NCT00282308|1205767|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
377049|NCT00282308|1205765|P3|Optional Extension Re-treatment Period|Adverse Event|4
377050|NCT00282308|1205766|P2|Optional Extension Re-treatment Period|Adverse Event|0
377051|NCT00282308|1205767|P1|Optional Extension Re-treatment Period|Adverse Event|0
377052|NCT00282308|1205765|P3|Treatment Period|Not Treated with Study Drug|0
377053|NCT00282308|1205766|P2|Treatment Period|Not Treated with Study Drug|0
377054|NCT00282308|1205767|P1|Treatment Period|Not Treated with Study Drug|1
377055|NCT00282308|1205765|P3|Treatment Period|Adverse Event|0
377056|NCT00282308|1205766|P2|Treatment Period|Adverse Event|2
377057|NCT00282308|1205767|P1|Treatment Period|Adverse Event|0
377058|NCT00282308|1205765|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
377059|NCT00282308|1205766|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
377060|NCT00282308|1205767|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
377061|NCT00282308|1205765|P3|Treatment Period|Lost to Follow-up|0
377062|NCT00282308|1205766|P2|Treatment Period|Lost to Follow-up|0
377063|NCT00282308|1205767|P1|Treatment Period|Lost to Follow-up|1
377064|NCT00282295|1205797|P3|Overall Study|Unspecified|0
377065|NCT00282295|1205798|P2|Overall Study|Unspecified|1
377066|NCT00282295|1205799|P1|Overall Study|Unspecified|0
377067|NCT00282295|1205797|P3|Overall Study|Lost to Follow-up|2
377068|NCT00282295|1205798|P2|Overall Study|Lost to Follow-up|7
377069|NCT00282295|1205799|P1|Overall Study|Lost to Follow-up|1
377070|NCT00282295|1205797|P3|Overall Study|Withdrawal by Subject|4
377071|NCT00282295|1205798|P2|Overall Study|Withdrawal by Subject|6
377072|NCT00282295|1205799|P1|Overall Study|Withdrawal by Subject|2
377073|NCT00282295|1205797|P3|Overall Study|Protocol Violation|1
377074|NCT00282295|1205798|P2|Overall Study|Protocol Violation|2
377075|NCT00282295|1205799|P1|Overall Study|Protocol Violation|0
377076|NCT00282295|1205797|P3|Overall Study|Serious Adverse Events|1
377077|NCT00282295|1205798|P2|Overall Study|Serious Adverse Events|0
377078|NCT00282295|1205799|P1|Overall Study|Serious Adverse Events|0
377079|NCT00282295|1205797|P3|Overall Study|Adverse Event|0
377080|NCT00282295|1205798|P2|Overall Study|Adverse Event|1
377081|NCT00282295|1205799|P1|Overall Study|Adverse Event|0
377082|NCT00282256|1205854|P1|Extension Treatment Period|Adverse Event|2
377083|NCT00282256|1205854|P1|Pharmacokinetic Treatment Period|Poor venous access|1
377084|NCT00282243|1205875|P1|Extension Treatment Period|Physician Decision|1
377085|NCT00282243|1205875|P1|Extension Treatment Period|Non-compliance|2
377086|NCT00282243|1205875|P1|Extension Treatment Period|Withdrawal by Subject|4
377087|NCT00282243|1205875|P1|Extension Treatment Period|Adverse Event|15
377088|NCT00282243|1205875|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
377089|NCT00282243|1205875|P1|Pharmacokinetic Treatment Period|Adverse Event|3
377090|NCT00282152|1205901|P2|Overall Study|Withdrawal by Subject|0
377091|NCT00282152|1205902|P1|Overall Study|Withdrawal by Subject|1
377092|NCT00282113|1205923|P3|Overall Study|Removed at parents request|0
377093|NCT00282113|1205924|P2|Overall Study|Removed at parents request|0
377094|NCT00282113|1205925|P1|Overall Study|Removed at parents request|1
377095|NCT00282087|1205939|P1|Overall Study|Death|1
377096|NCT00282048|1205952|P1|Overall Study|Ongoing|1
377097|NCT00282048|1205952|P1|Overall Study|Unspecified|8
377098|NCT00282048|1205952|P1|Overall Study|Withdrawal by Subject|1
377099|NCT00282048|1205952|P1|Overall Study|Adverse Event|22
377100|NCT00282048|1205952|P1|Overall Study|Lack of Efficacy|30
377101|NCT00281957|1205966|P2|Overall Study|Refusal unrelated to adverse events|1
377102|NCT00281957|1205967|P1|Overall Study|Refusal unrelated to adverse events|0
377103|NCT00281957|1205966|P2|Overall Study|Did not start treatment|1
377104|NCT00281957|1205967|P1|Overall Study|Did not start treatment|3
377105|NCT00281957|1205966|P2|Overall Study|Not eligible|2
377106|NCT00281957|1205967|P1|Overall Study|Not eligible|1
377107|NCT00281957|1205966|P2|Overall Study|Not protocol specified|1
377108|NCT00281957|1205967|P1|Overall Study|Not protocol specified|8
377109|NCT00281957|1205966|P2|Overall Study|Progression/relapse|35
377110|NCT00281957|1205967|P1|Overall Study|Progression/relapse|47
377111|NCT00281957|1205966|P2|Overall Study|Death|0
377112|NCT00281957|1205967|P1|Overall Study|Death|1
377113|NCT00281957|1205966|P2|Overall Study|Adverse Event|2
377114|NCT00281957|1205967|P1|Overall Study|Adverse Event|7
377115|NCT00281840|1206041|P1|Overall Study|Complicating Disease|1
377116|NCT00281840|1206041|P1|Overall Study|exceed maximum delay in treatment|1
377117|NCT00281840|1206041|P1|Overall Study|Disease Progression|2
377118|NCT00281840|1206041|P1|Overall Study|Withdrawal by Subject|3
377119|NCT00281840|1206041|P1|Overall Study|Physician Decision|6
377120|NCT00281840|1206041|P1|Overall Study|Adverse Event|12
377121|NCT00281697|1206057|P2|Overall Study|Did not receive study drug|2
377122|NCT00281697|1206058|P1|Overall Study|Did not receive study drug|3
377123|NCT00281697|1206057|P2|Overall Study|Subject/guardian's decision to withdraw|6
377124|NCT00281697|1206058|P1|Overall Study|Subject/guardian's decision to withdraw|33
377125|NCT00281697|1206057|P2|Overall Study|Physician's decision to withdraw|12
377126|NCT00281697|1206058|P1|Overall Study|Physician's decision to withdraw|15
377127|NCT00281697|1206057|P2|Overall Study|Not specified|6
377128|NCT00281697|1206058|P1|Overall Study|Not specified|5
377129|NCT00281697|1206057|P2|Overall Study|Disease progression|149
377130|NCT00281697|1206058|P1|Overall Study|Disease progression|279
377131|NCT00281697|1206057|P2|Overall Study|Death|3
377132|NCT00281697|1206058|P1|Overall Study|Death|8
377133|NCT00281697|1206057|P2|Overall Study|Adverse Event|15
377134|NCT00281697|1206058|P1|Overall Study|Adverse Event|54
377135|NCT00281697|1206057|P2|Overall Study|> 60 days since last dose of study drug|4
377136|NCT00281697|1206058|P1|Overall Study|> 60 days since last dose of study drug|4
377137|NCT00281658|1206076|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
377138|NCT00281658|1206077|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
377139|NCT00281658|1206078|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
377140|NCT00281658|1206076|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
377141|NCT00281658|1206077|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
377142|NCT00281658|1206078|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
377143|NCT00281658|1206076|P3|Open-label Monotherapy Extension Phase|Death|97
377144|NCT00281658|1206077|P2|Open-label Monotherapy Extension Phase|Death|0
377145|NCT00281658|1206078|P1|Open-label Monotherapy Extension Phase|Death|0
377146|NCT00281658|1206076|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
377147|NCT00281658|1206077|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
377148|NCT00281658|1206078|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
377149|NCT00281658|1206076|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
377150|NCT00281658|1206077|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
377151|NCT00281658|1206078|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
377152|NCT00281658|1206076|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
377153|NCT00281658|1206077|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
377154|NCT00281658|1206078|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
377155|NCT00281658|1206076|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
377156|NCT00281658|1206077|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
377157|NCT00281658|1206078|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
377158|NCT00281658|1206076|P3|Double-blind, Randomized Phase|Death|0
377159|NCT00281658|1206077|P2|Double-blind, Randomized Phase|Death|46
377160|NCT00281658|1206078|P1|Double-blind, Randomized Phase|Death|120
377161|NCT00281632|1206095|P1|Overall Study|Ongoing|3
377162|NCT00281632|1206095|P1|Overall Study|Physician Decision|1
377163|NCT00281632|1206095|P1|Overall Study|Death|1
377164|NCT00281632|1206095|P1|Overall Study|Disease Progression|22
377165|NCT00281632|1206095|P1|Overall Study|Withdrawal by Subject|2
377166|NCT00281632|1206095|P1|Overall Study|Adverse Event|7
377167|NCT00281580|1206137|P16|Overall Study|Randomised in error; pregnancy; moving|2
377168|NCT00281580|1206138|P15|Overall Study|Randomised in error; pregnancy; moving|1
377169|NCT00281580|1206139|P14|Overall Study|Randomised in error; pregnancy; moving|0
377170|NCT00281580|1206140|P13|Overall Study|Randomised in error; pregnancy; moving|2
377171|NCT00281580|1206141|P12|Overall Study|Randomised in error; pregnancy; moving|1
377172|NCT00281580|1206142|P11|Overall Study|Randomised in error; pregnancy; moving|1
377173|NCT00281580|1206143|P10|Overall Study|Randomised in error; pregnancy; moving|1
377174|NCT00281580|1206144|P9|Overall Study|Randomised in error; pregnancy; moving|2
377175|NCT00281580|1206145|P8|Overall Study|Randomised in error; pregnancy; moving|0
377176|NCT00281580|1206146|P7|Overall Study|Randomised in error; pregnancy; moving|1
377177|NCT00281580|1206147|P6|Overall Study|Randomised in error; pregnancy; moving|0
377178|NCT00281580|1206148|P5|Overall Study|Randomised in error; pregnancy; moving|0
377179|NCT00281580|1206149|P4|Overall Study|Randomised in error; pregnancy; moving|2
377180|NCT00281580|1206150|P3|Overall Study|Randomised in error; pregnancy; moving|0
377181|NCT00281580|1206151|P2|Overall Study|Randomised in error; pregnancy; moving|0
377182|NCT00281580|1206152|P1|Overall Study|Randomised in error; pregnancy; moving|0
377183|NCT00281580|1206137|P16|Overall Study|Lost to Follow-up|0
377184|NCT00281580|1206138|P15|Overall Study|Lost to Follow-up|0
377185|NCT00281580|1206139|P14|Overall Study|Lost to Follow-up|0
377186|NCT00281580|1206140|P13|Overall Study|Lost to Follow-up|1
377187|NCT00281580|1206141|P12|Overall Study|Lost to Follow-up|0
377188|NCT00281580|1206142|P11|Overall Study|Lost to Follow-up|1
377189|NCT00281580|1206143|P10|Overall Study|Lost to Follow-up|1
377190|NCT00281580|1206144|P9|Overall Study|Lost to Follow-up|2
377191|NCT00281580|1206145|P8|Overall Study|Lost to Follow-up|1
377192|NCT00281580|1206146|P7|Overall Study|Lost to Follow-up|0
377193|NCT00281580|1206147|P6|Overall Study|Lost to Follow-up|1
377194|NCT00281580|1206148|P5|Overall Study|Lost to Follow-up|0
377195|NCT00281580|1206149|P4|Overall Study|Lost to Follow-up|3
377196|NCT00281580|1206150|P3|Overall Study|Lost to Follow-up|0
377197|NCT00281580|1206151|P2|Overall Study|Lost to Follow-up|0
377198|NCT00281580|1206152|P1|Overall Study|Lost to Follow-up|0
377199|NCT00281580|1206137|P16|Overall Study|Lack of Efficacy|0
377200|NCT00281580|1206138|P15|Overall Study|Lack of Efficacy|1
377201|NCT00281580|1206139|P14|Overall Study|Lack of Efficacy|2
377202|NCT00281580|1206140|P13|Overall Study|Lack of Efficacy|0
377203|NCT00281580|1206141|P12|Overall Study|Lack of Efficacy|1
377204|NCT00281580|1206142|P11|Overall Study|Lack of Efficacy|0
377205|NCT00281580|1206143|P10|Overall Study|Lack of Efficacy|0
377206|NCT00281580|1206144|P9|Overall Study|Lack of Efficacy|0
377207|NCT00281580|1206145|P8|Overall Study|Lack of Efficacy|0
377208|NCT00281580|1206146|P7|Overall Study|Lack of Efficacy|0
377209|NCT00281580|1206147|P6|Overall Study|Lack of Efficacy|0
377210|NCT00281580|1206148|P5|Overall Study|Lack of Efficacy|2
377211|NCT00281580|1206149|P4|Overall Study|Lack of Efficacy|6
377212|NCT00281580|1206150|P3|Overall Study|Lack of Efficacy|1
377213|NCT00281580|1206151|P2|Overall Study|Lack of Efficacy|1
377214|NCT00281580|1206152|P1|Overall Study|Lack of Efficacy|2
377215|NCT00281580|1206137|P16|Overall Study|Withdrawal by Subject|5
377216|NCT00281580|1206138|P15|Overall Study|Withdrawal by Subject|1
377217|NCT00281580|1206139|P14|Overall Study|Withdrawal by Subject|2
377218|NCT00281580|1206140|P13|Overall Study|Withdrawal by Subject|2
377219|NCT00281580|1206141|P12|Overall Study|Withdrawal by Subject|1
377220|NCT00281580|1206142|P11|Overall Study|Withdrawal by Subject|1
377221|NCT00281580|1206143|P10|Overall Study|Withdrawal by Subject|4
377222|NCT00281580|1206144|P9|Overall Study|Withdrawal by Subject|1
377223|NCT00281580|1206145|P8|Overall Study|Withdrawal by Subject|0
377224|NCT00281580|1206146|P7|Overall Study|Withdrawal by Subject|2
377225|NCT00281580|1206147|P6|Overall Study|Withdrawal by Subject|2
377226|NCT00281580|1206148|P5|Overall Study|Withdrawal by Subject|1
377227|NCT00281580|1206149|P4|Overall Study|Withdrawal by Subject|1
377228|NCT00281580|1206150|P3|Overall Study|Withdrawal by Subject|1
377229|NCT00281580|1206151|P2|Overall Study|Withdrawal by Subject|0
377230|NCT00281580|1206152|P1|Overall Study|Withdrawal by Subject|3
377231|NCT00281580|1206137|P16|Overall Study|Protocol Violation|3
377232|NCT00281580|1206138|P15|Overall Study|Protocol Violation|1
377233|NCT00281580|1206139|P14|Overall Study|Protocol Violation|1
377234|NCT00281580|1206140|P13|Overall Study|Protocol Violation|0
377235|NCT00281580|1206141|P12|Overall Study|Protocol Violation|2
377236|NCT00281580|1206142|P11|Overall Study|Protocol Violation|1
377237|NCT00281580|1206143|P10|Overall Study|Protocol Violation|0
377238|NCT00281580|1206144|P9|Overall Study|Protocol Violation|2
377239|NCT00281580|1206145|P8|Overall Study|Protocol Violation|0
377240|NCT00281580|1206146|P7|Overall Study|Protocol Violation|1
377241|NCT00281580|1206147|P6|Overall Study|Protocol Violation|0
377242|NCT00281580|1206148|P5|Overall Study|Protocol Violation|0
377243|NCT00281580|1206149|P4|Overall Study|Protocol Violation|1
377244|NCT00281580|1206150|P3|Overall Study|Protocol Violation|1
377245|NCT00281580|1206151|P2|Overall Study|Protocol Violation|0
377246|NCT00281580|1206152|P1|Overall Study|Protocol Violation|0
377247|NCT00281580|1206137|P16|Overall Study|Adverse Event|3
377248|NCT00281580|1206138|P15|Overall Study|Adverse Event|3
377249|NCT00281580|1206139|P14|Overall Study|Adverse Event|2
377250|NCT00281580|1206140|P13|Overall Study|Adverse Event|8
377251|NCT00281580|1206141|P12|Overall Study|Adverse Event|5
377252|NCT00281580|1206142|P11|Overall Study|Adverse Event|0
377253|NCT00281580|1206143|P10|Overall Study|Adverse Event|6
377254|NCT00281580|1206144|P9|Overall Study|Adverse Event|1
377255|NCT00281580|1206145|P8|Overall Study|Adverse Event|0
377256|NCT00281580|1206146|P7|Overall Study|Adverse Event|1
377257|NCT00281580|1206147|P6|Overall Study|Adverse Event|0
377258|NCT00281580|1206148|P5|Overall Study|Adverse Event|1
377259|NCT00281580|1206149|P4|Overall Study|Adverse Event|4
377260|NCT00281580|1206150|P3|Overall Study|Adverse Event|2
377261|NCT00281580|1206151|P2|Overall Study|Adverse Event|0
377262|NCT00281580|1206152|P1|Overall Study|Adverse Event|2
377263|NCT00281528|1206499|P3|Overall Study|Unspecified|5
377264|NCT00281528|1206500|P2|Overall Study|Unspecified|3
377265|NCT00281528|1206501|P1|Overall Study|Unspecified|6
377266|NCT00281528|1206499|P3|Overall Study|Withdrawal by Subject|7
377267|NCT00281528|1206500|P2|Overall Study|Withdrawal by Subject|5
377268|NCT00281528|1206501|P1|Overall Study|Withdrawal by Subject|5
377269|NCT00281528|1206499|P3|Overall Study|Protocol Violation|1
377270|NCT00281528|1206500|P2|Overall Study|Protocol Violation|0
377271|NCT00281528|1206501|P1|Overall Study|Protocol Violation|1
377272|NCT00281528|1206499|P3|Overall Study|Physician Decision|5
377273|NCT00281528|1206500|P2|Overall Study|Physician Decision|4
377274|NCT00281528|1206501|P1|Overall Study|Physician Decision|11
377275|NCT00281528|1206499|P3|Overall Study|Adverse Event-unrelated to treatment|2
377276|NCT00281528|1206500|P2|Overall Study|Adverse Event-unrelated to treatment|0
377277|NCT00281528|1206501|P1|Overall Study|Adverse Event-unrelated to treatment|3
377278|NCT00281528|1206499|P3|Overall Study|Unacceptable Toxicity-related to trt|32
377279|NCT00281528|1206500|P2|Overall Study|Unacceptable Toxicity-related to trt|24
377280|NCT00281528|1206501|P1|Overall Study|Unacceptable Toxicity-related to trt|21
377281|NCT00281528|1206499|P3|Overall Study|Progressive Disease|27
377282|NCT00281528|1206500|P2|Overall Study|Progressive Disease|18
377283|NCT00281528|1206501|P1|Overall Study|Progressive Disease|28
377284|NCT00281320|1206552|P2|Overall Study|Not specified|1
377285|NCT00281320|1206553|P1|Overall Study|Not specified|3
377286|NCT00281320|1206552|P2|Overall Study|Lost to Follow-up|2
377287|NCT00281320|1206553|P1|Overall Study|Lost to Follow-up|1
377288|NCT00281320|1206552|P2|Overall Study|Withdrawal by Subject|6
377289|NCT00281320|1206553|P1|Overall Study|Withdrawal by Subject|5
377290|NCT00281320|1206552|P2|Overall Study|Lack of Efficacy|3
377291|NCT00281320|1206553|P1|Overall Study|Lack of Efficacy|4
377292|NCT00281320|1206552|P2|Overall Study|Adverse Event|9
377293|NCT00281320|1206553|P1|Overall Study|Adverse Event|12
377294|NCT00281099|1206575|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
377295|NCT00281099|1206576|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
377296|NCT00281099|1206575|P2|Overall Study|Physician Decision|72
377297|NCT00281099|1206576|P1|Overall Study|Physician Decision|79
377298|NCT00281099|1206575|P2|Overall Study|Withdrawal by Subject|70
377299|NCT00281099|1206576|P1|Overall Study|Withdrawal by Subject|65
377300|NCT00281099|1206575|P2|Overall Study|Lost to Follow-up|19
377301|NCT00281099|1206576|P1|Overall Study|Lost to Follow-up|10
377302|NCT00281099|1206575|P2|Overall Study|Death|57
377303|NCT00281099|1206576|P1|Overall Study|Death|46
377304|NCT00280917|1206625|P4|Overall Study|Noncompliance|0
377305|NCT00280917|1206626|P3|Overall Study|Noncompliance|2
377306|NCT00280917|1206627|P2|Overall Study|Noncompliance|1
377307|NCT00280917|1206628|P1|Overall Study|Noncompliance|0
377308|NCT00280917|1206625|P4|Overall Study|Withdrawal by Subject|1
377309|NCT00280917|1206626|P3|Overall Study|Withdrawal by Subject|0
377310|NCT00280917|1206627|P2|Overall Study|Withdrawal by Subject|2
377311|NCT00280917|1206628|P1|Overall Study|Withdrawal by Subject|0
377312|NCT00280917|1206625|P4|Overall Study|Change Therapy|0
377313|NCT00280917|1206626|P3|Overall Study|Change Therapy|0
377314|NCT00280917|1206627|P2|Overall Study|Change Therapy|2
377315|NCT00280917|1206628|P1|Overall Study|Change Therapy|1
377316|NCT00280917|1206625|P4|Overall Study|Adverse Event|1
377317|NCT00280917|1206626|P3|Overall Study|Adverse Event|4
377318|NCT00280917|1206627|P2|Overall Study|Adverse Event|1
377319|NCT00280917|1206628|P1|Overall Study|Adverse Event|1
377320|NCT00280735|1206651|P1|Overall Study|Intercurrent Illness|2
377321|NCT00280735|1206651|P1|Overall Study|Withdrawal by Subject|8
377322|NCT00280735|1206651|P1|Overall Study|Lack of Efficacy|3
377323|NCT00280735|1206651|P1|Overall Study|Adverse Event|5
377324|NCT00280683|1206663|P2|Overall Study|Adverse Event|1
377325|NCT00280683|1206664|P1|Overall Study|Adverse Event|1
377326|NCT00280683|1206663|P2|Overall Study|Withdrawal by Subject|2
377327|NCT00280683|1206664|P1|Overall Study|Withdrawal by Subject|1
377328|NCT00280566|1206674|P3|Period 2 Double Blind|miscellaneous|5
377329|NCT00280566|1206675|P2|Period 2 Double Blind|miscellaneous|10
377330|NCT00280566|1206676|P1|Period 2 Double Blind|miscellaneous|0
377331|NCT00280566|1206674|P3|Period 2 Double Blind|Withdrawal by Subject|9
377332|NCT00280566|1206675|P2|Period 2 Double Blind|Withdrawal by Subject|9
377333|NCT00280566|1206676|P1|Period 2 Double Blind|Withdrawal by Subject|0
377334|NCT00280566|1206674|P3|Period 2 Double Blind|Lost to Follow-up|6
377335|NCT00280566|1206675|P2|Period 2 Double Blind|Lost to Follow-up|3
377336|NCT00280566|1206676|P1|Period 2 Double Blind|Lost to Follow-up|0
377337|NCT00280566|1206674|P3|Period 2 Double Blind|Adverse Event|15
377338|NCT00280566|1206675|P2|Period 2 Double Blind|Adverse Event|11
377339|NCT00280566|1206676|P1|Period 2 Double Blind|Adverse Event|0
377340|NCT00280566|1206674|P3|Period 2 Double Blind|Laboratory Abnormality|0
377341|NCT00280566|1206675|P2|Period 2 Double Blind|Laboratory Abnormality|1
377342|NCT00280566|1206676|P1|Period 2 Double Blind|Laboratory Abnormality|0
377343|NCT00280566|1206674|P3|Period 2 Double Blind|Lack of Efficacy|22
377344|NCT00280566|1206675|P2|Period 2 Double Blind|Lack of Efficacy|9
377345|NCT00280566|1206676|P1|Period 2 Double Blind|Lack of Efficacy|0
377346|NCT00280566|1206674|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
377347|NCT00280566|1206675|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
377348|NCT00280566|1206676|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
377349|NCT00280566|1206674|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
377350|NCT00280566|1206675|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
377351|NCT00280566|1206676|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
377352|NCT00280566|1206674|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
377353|NCT00280566|1206675|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
377354|NCT00280566|1206676|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
377355|NCT00280566|1206674|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
377356|NCT00280566|1206675|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
377357|NCT00280566|1206676|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
377358|NCT00280566|1206674|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
377359|NCT00280566|1206675|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
377360|NCT00280566|1206676|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
377361|NCT00280566|1206674|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
377362|NCT00280566|1206675|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
377363|NCT00280566|1206676|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
377364|NCT00280397|1206701|P1|Overall Study|Adverse Event|1
377365|NCT00280293|1206767|P2|Overall Study|Adverse Event|1
377366|NCT00280293|1206768|P1|Overall Study|Adverse Event|0
377367|NCT00280293|1206767|P2|Overall Study|Incarceration/Legal Reasons|1
377368|NCT00280293|1206768|P1|Overall Study|Incarceration/Legal Reasons|1
377369|NCT00280293|1206767|P2|Overall Study|Withdrawal by Subject|5
377370|NCT00280293|1206768|P1|Overall Study|Withdrawal by Subject|3
377371|NCT00280293|1206767|P2|Overall Study|Lost to Follow-up|12
377372|NCT00280293|1206768|P1|Overall Study|Lost to Follow-up|14
377373|NCT00280293|1206767|P2|Overall Study|Physician Decision|4
377374|NCT00280293|1206768|P1|Overall Study|Physician Decision|5
377375|NCT00280293|1206767|P2|Overall Study|Protocol Violation|0
377376|NCT00280293|1206768|P1|Overall Study|Protocol Violation|3
377377|NCT00280059|1206789|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
377378|NCT00280059|1206790|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
377379|NCT00280059|1206789|P2|Efficacy Assessment Phase|Unspecified|8
377380|NCT00280059|1206790|P1|Efficacy Assessment Phase|Unspecified|7
377381|NCT00280059|1206789|P2|Efficacy Assessment Phase|Lost to Follow-up|13
377382|NCT00280059|1206790|P1|Efficacy Assessment Phase|Lost to Follow-up|6
377383|NCT00280059|1206789|P2|Efficacy Assessment Phase|Lack of Efficacy|3
377384|NCT00280059|1206790|P1|Efficacy Assessment Phase|Lack of Efficacy|19
377385|NCT00280059|1206789|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
377386|NCT00280059|1206790|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
377387|NCT00280059|1206789|P2|Efficacy Assessment Phase|Adverse Event|31
377388|NCT00280059|1206790|P1|Efficacy Assessment Phase|Adverse Event|33
377389|NCT00280059|1206789|P2|Efficacy Assessment Phase|Death|0
377390|NCT00280059|1206790|P1|Efficacy Assessment Phase|Death|2
377391|NCT00279916|1206854|P2|Overall Study|Lost to Follow-up|2
377392|NCT00279916|1206855|P1|Overall Study|Lost to Follow-up|3
377393|NCT00279916|1206854|P2|Overall Study|Withdrawal by Subject|3
377394|NCT00279916|1206855|P1|Overall Study|Withdrawal by Subject|4
377395|NCT00279708|1206877|P2|Overall Study|Adverse Event|1
377396|NCT00279708|1206878|P1|Overall Study|Adverse Event|1
377397|NCT00279708|1206877|P2|Overall Study|Withdrawal by Subject|3
377398|NCT00279708|1206878|P1|Overall Study|Withdrawal by Subject|2
377399|NCT00279305|1206903|P2|Overall Study|FDA Safety Alert|1
377400|NCT00279305|1206904|P1|Overall Study|FDA Safety Alert|4
377401|NCT00279305|1206903|P2|Overall Study|Dificulting establishing IV|0
377402|NCT00279305|1206904|P1|Overall Study|Dificulting establishing IV|1
377403|NCT00279305|1206903|P2|Overall Study|Withdrawal by Subject|0
377404|NCT00279305|1206904|P1|Overall Study|Withdrawal by Subject|2
377405|NCT00279305|1206903|P2|Overall Study|Pregnancy|0
377406|NCT00279305|1206904|P1|Overall Study|Pregnancy|1
377407|NCT00279214|1206912|P2|Overall Study|Physician Decision|2
377408|NCT00279214|1206913|P1|Overall Study|Physician Decision|3
377409|NCT00279201|1206943|P6|Intensification Addendum|Death|0
377410|NCT00279201|1206944|P5|Intensification Addendum|Death|1
377411|NCT00279201|1206945|P4|Intensification Addendum|Death|0
377412|NCT00279201|1206946|P3|Intensification Addendum|Death|0
377413|NCT00279201|1206947|P2|Intensification Addendum|Death|0
377414|NCT00279201|1206948|P1|Intensification Addendum|Death|0
377415|NCT00279201|1206943|P6|Intensification Addendum|Lack of Efficacy|0
377416|NCT00279201|1206944|P5|Intensification Addendum|Lack of Efficacy|1
377417|NCT00279201|1206945|P4|Intensification Addendum|Lack of Efficacy|1
377418|NCT00279201|1206946|P3|Intensification Addendum|Lack of Efficacy|0
377419|NCT00279201|1206947|P2|Intensification Addendum|Lack of Efficacy|0
377420|NCT00279201|1206948|P1|Intensification Addendum|Lack of Efficacy|0
377421|NCT00279201|1206943|P6|Intensification Addendum|Entry Criteria Exclusion|0
377422|NCT00279201|1206944|P5|Intensification Addendum|Entry Criteria Exclusion|0
377423|NCT00279201|1206945|P4|Intensification Addendum|Entry Criteria Exclusion|0
377424|NCT00279201|1206946|P3|Intensification Addendum|Entry Criteria Exclusion|1
377425|NCT00279201|1206947|P2|Intensification Addendum|Entry Criteria Exclusion|0
377426|NCT00279201|1206948|P1|Intensification Addendum|Entry Criteria Exclusion|0
377427|NCT00279201|1206943|P6|Intensification Addendum|Sponsor Decision|1
377428|NCT00279201|1206944|P5|Intensification Addendum|Sponsor Decision|1
377429|NCT00279201|1206945|P4|Intensification Addendum|Sponsor Decision|0
377430|NCT00279201|1206946|P3|Intensification Addendum|Sponsor Decision|0
377431|NCT00279201|1206947|P2|Intensification Addendum|Sponsor Decision|0
377432|NCT00279201|1206948|P1|Intensification Addendum|Sponsor Decision|0
377433|NCT00279201|1206943|P6|Intensification Addendum|Physician Decision|2
377434|NCT00279201|1206944|P5|Intensification Addendum|Physician Decision|3
377435|NCT00279201|1206945|P4|Intensification Addendum|Physician Decision|1
377436|NCT00279201|1206946|P3|Intensification Addendum|Physician Decision|4
377437|NCT00279201|1206947|P2|Intensification Addendum|Physician Decision|0
377438|NCT00279201|1206948|P1|Intensification Addendum|Physician Decision|0
377439|NCT00279201|1206943|P6|Intensification Addendum|Adverse Event|3
377440|NCT00279201|1206944|P5|Intensification Addendum|Adverse Event|1
377441|NCT00279201|1206945|P4|Intensification Addendum|Adverse Event|4
377442|NCT00279201|1206946|P3|Intensification Addendum|Adverse Event|0
377443|NCT00279201|1206947|P2|Intensification Addendum|Adverse Event|0
377444|NCT00279201|1206948|P1|Intensification Addendum|Adverse Event|0
377445|NCT00279201|1206943|P6|Intensification Addendum|Protocol Violation|6
377446|NCT00279201|1206944|P5|Intensification Addendum|Protocol Violation|6
377447|NCT00279201|1206945|P4|Intensification Addendum|Protocol Violation|2
377448|NCT00279201|1206946|P3|Intensification Addendum|Protocol Violation|2
377449|NCT00279201|1206947|P2|Intensification Addendum|Protocol Violation|0
377450|NCT00279201|1206948|P1|Intensification Addendum|Protocol Violation|0
377451|NCT00279201|1206943|P6|Intensification Addendum|Lost to Follow-up|7
377452|NCT00279201|1206944|P5|Intensification Addendum|Lost to Follow-up|7
377453|NCT00279201|1206945|P4|Intensification Addendum|Lost to Follow-up|6
377454|NCT00279201|1206946|P3|Intensification Addendum|Lost to Follow-up|4
377455|NCT00279201|1206947|P2|Intensification Addendum|Lost to Follow-up|0
377456|NCT00279201|1206948|P1|Intensification Addendum|Lost to Follow-up|0
377457|NCT00279201|1206943|P6|Intensification Addendum|Withdrawal by Subject|18
377458|NCT00279201|1206944|P5|Intensification Addendum|Withdrawal by Subject|9
377459|NCT00279201|1206945|P4|Intensification Addendum|Withdrawal by Subject|14
377460|NCT00279201|1206946|P3|Intensification Addendum|Withdrawal by Subject|12
377461|NCT00279201|1206947|P2|Intensification Addendum|Withdrawal by Subject|0
377462|NCT00279201|1206948|P1|Intensification Addendum|Withdrawal by Subject|0
377463|NCT00279201|1206943|P6|Maintenance|HbA1c>7.5%|0
377464|NCT00279201|1206944|P5|Maintenance|HbA1c>7.5%|0
377465|NCT00279201|1206945|P4|Maintenance|HbA1c>7.5%|0
377466|NCT00279201|1206946|P3|Maintenance|HbA1c>7.5%|0
377467|NCT00279201|1206947|P2|Maintenance|HbA1c>7.5%|126
377468|NCT00279201|1206948|P1|Maintenance|HbA1c>7.5%|123
377469|NCT00279201|1206943|P6|Maintenance|Sponsor Decision|0
377470|NCT00279201|1206944|P5|Maintenance|Sponsor Decision|0
377471|NCT00279201|1206945|P4|Maintenance|Sponsor Decision|0
377472|NCT00279201|1206946|P3|Maintenance|Sponsor Decision|0
377473|NCT00279201|1206947|P2|Maintenance|Sponsor Decision|0
377474|NCT00279201|1206948|P1|Maintenance|Sponsor Decision|4
377475|NCT00279201|1206943|P6|Maintenance|Physician Decision|0
377476|NCT00279201|1206944|P5|Maintenance|Physician Decision|0
377477|NCT00279201|1206945|P4|Maintenance|Physician Decision|0
377478|NCT00279201|1206946|P3|Maintenance|Physician Decision|0
377479|NCT00279201|1206947|P2|Maintenance|Physician Decision|9
377480|NCT00279201|1206948|P1|Maintenance|Physician Decision|9
377481|NCT00279201|1206943|P6|Maintenance|Withdrawal by Subject|0
377482|NCT00279201|1206944|P5|Maintenance|Withdrawal by Subject|0
377483|NCT00279201|1206945|P4|Maintenance|Withdrawal by Subject|0
377484|NCT00279201|1206946|P3|Maintenance|Withdrawal by Subject|0
377485|NCT00279201|1206947|P2|Maintenance|Withdrawal by Subject|18
377486|NCT00279201|1206948|P1|Maintenance|Withdrawal by Subject|18
377487|NCT00279201|1206943|P6|Maintenance|Protocol Violation|0
377488|NCT00279201|1206944|P5|Maintenance|Protocol Violation|0
377489|NCT00279201|1206945|P4|Maintenance|Protocol Violation|0
377490|NCT00279201|1206946|P3|Maintenance|Protocol Violation|0
377491|NCT00279201|1206947|P2|Maintenance|Protocol Violation|24
377492|NCT00279201|1206948|P1|Maintenance|Protocol Violation|16
377493|NCT00279201|1206943|P6|Maintenance|Entry Criteria Exclusion|0
377494|NCT00279201|1206944|P5|Maintenance|Entry Criteria Exclusion|0
377495|NCT00279201|1206945|P4|Maintenance|Entry Criteria Exclusion|0
377496|NCT00279201|1206946|P3|Maintenance|Entry Criteria Exclusion|0
377497|NCT00279201|1206947|P2|Maintenance|Entry Criteria Exclusion|4
377498|NCT00279201|1206948|P1|Maintenance|Entry Criteria Exclusion|1
377499|NCT00279201|1206943|P6|Maintenance|Lost to Follow-up|0
377500|NCT00279201|1206944|P5|Maintenance|Lost to Follow-up|0
377501|NCT00279201|1206945|P4|Maintenance|Lost to Follow-up|0
377502|NCT00279201|1206946|P3|Maintenance|Lost to Follow-up|0
377503|NCT00279201|1206947|P2|Maintenance|Lost to Follow-up|13
377504|NCT00279201|1206948|P1|Maintenance|Lost to Follow-up|17
377505|NCT00279201|1206943|P6|Maintenance|Death|0
377506|NCT00279201|1206944|P5|Maintenance|Death|0
377507|NCT00279201|1206945|P4|Maintenance|Death|0
377508|NCT00279201|1206946|P3|Maintenance|Death|0
377509|NCT00279201|1206947|P2|Maintenance|Death|4
377510|NCT00279201|1206948|P1|Maintenance|Death|4
377511|NCT00279201|1206943|P6|Maintenance|Adverse Event|0
377512|NCT00279201|1206944|P5|Maintenance|Adverse Event|0
377513|NCT00279201|1206945|P4|Maintenance|Adverse Event|0
377514|NCT00279201|1206946|P3|Maintenance|Adverse Event|0
377515|NCT00279201|1206947|P2|Maintenance|Adverse Event|4
377516|NCT00279201|1206948|P1|Maintenance|Adverse Event|4
377517|NCT00279201|1206943|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
377518|NCT00279201|1206944|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
377519|NCT00279201|1206945|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
377520|NCT00279201|1206946|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
377521|NCT00279201|1206947|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
377522|NCT00279201|1206948|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
377523|NCT00279201|1206943|P6|Maintenance|Lack of Efficacy|0
377524|NCT00279201|1206944|P5|Maintenance|Lack of Efficacy|0
377525|NCT00279201|1206945|P4|Maintenance|Lack of Efficacy|0
377526|NCT00279201|1206946|P3|Maintenance|Lack of Efficacy|0
377527|NCT00279201|1206947|P2|Maintenance|Lack of Efficacy|30
377528|NCT00279201|1206948|P1|Maintenance|Lack of Efficacy|32
377529|NCT00279201|1206943|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
377530|NCT00279201|1206944|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
377531|NCT00279201|1206945|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
377532|NCT00279201|1206946|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
377533|NCT00279201|1206947|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
377534|NCT00279201|1206948|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
377535|NCT00279201|1206943|P6|Initiation|Sponsor Decision|0
377536|NCT00279201|1206944|P5|Initiation|Sponsor Decision|0
377537|NCT00279201|1206945|P4|Initiation|Sponsor Decision|0
377538|NCT00279201|1206946|P3|Initiation|Sponsor Decision|0
377539|NCT00279201|1206947|P2|Initiation|Sponsor Decision|5
377540|NCT00279201|1206948|P1|Initiation|Sponsor Decision|13
377541|NCT00279201|1206943|P6|Initiation|Physician Decision|0
377542|NCT00279201|1206944|P5|Initiation|Physician Decision|0
377543|NCT00279201|1206945|P4|Initiation|Physician Decision|0
377544|NCT00279201|1206946|P3|Initiation|Physician Decision|0
377545|NCT00279201|1206947|P2|Initiation|Physician Decision|18
377546|NCT00279201|1206948|P1|Initiation|Physician Decision|15
377547|NCT00279201|1206943|P6|Initiation|Withdrawal by Subject|0
377548|NCT00279201|1206944|P5|Initiation|Withdrawal by Subject|0
377549|NCT00279201|1206945|P4|Initiation|Withdrawal by Subject|0
377550|NCT00279201|1206946|P3|Initiation|Withdrawal by Subject|0
377551|NCT00279201|1206947|P2|Initiation|Withdrawal by Subject|41
377552|NCT00279201|1206948|P1|Initiation|Withdrawal by Subject|35
377553|NCT00279201|1206943|P6|Initiation|Protocol Violation|0
377554|NCT00279201|1206944|P5|Initiation|Protocol Violation|0
377555|NCT00279201|1206945|P4|Initiation|Protocol Violation|0
377556|NCT00279201|1206946|P3|Initiation|Protocol Violation|0
377557|NCT00279201|1206947|P2|Initiation|Protocol Violation|10
377558|NCT00279201|1206948|P1|Initiation|Protocol Violation|9
377559|NCT00279201|1206943|P6|Initiation|Entry Criteria Exclusion|0
377560|NCT00279201|1206944|P5|Initiation|Entry Criteria Exclusion|0
377561|NCT00279201|1206945|P4|Initiation|Entry Criteria Exclusion|0
377562|NCT00279201|1206946|P3|Initiation|Entry Criteria Exclusion|0
377563|NCT00279201|1206947|P2|Initiation|Entry Criteria Exclusion|9
377564|NCT00279201|1206948|P1|Initiation|Entry Criteria Exclusion|7
377565|NCT00279201|1206943|P6|Initiation|Lost to Follow-up|0
377566|NCT00279201|1206944|P5|Initiation|Lost to Follow-up|0
377567|NCT00279201|1206945|P4|Initiation|Lost to Follow-up|0
377568|NCT00279201|1206946|P3|Initiation|Lost to Follow-up|0
377569|NCT00279201|1206947|P2|Initiation|Lost to Follow-up|41
377570|NCT00279201|1206948|P1|Initiation|Lost to Follow-up|42
377571|NCT00279201|1206943|P6|Initiation|Adverse Event|0
377572|NCT00279201|1206944|P5|Initiation|Adverse Event|0
377573|NCT00279201|1206945|P4|Initiation|Adverse Event|0
377574|NCT00279201|1206946|P3|Initiation|Adverse Event|0
377575|NCT00279201|1206947|P2|Initiation|Adverse Event|15
377576|NCT00279201|1206948|P1|Initiation|Adverse Event|6
377577|NCT00279201|1206943|P6|Initiation|Death|0
377578|NCT00279201|1206944|P5|Initiation|Death|0
377579|NCT00279201|1206945|P4|Initiation|Death|0
377580|NCT00279201|1206946|P3|Initiation|Death|0
377581|NCT00279201|1206947|P2|Initiation|Death|5
377582|NCT00279201|1206948|P1|Initiation|Death|1
377583|NCT00278993|1207092|P1|Overall Study|Not Otherwise Specified|4
377584|NCT00278993|1207092|P1|Overall Study|Physician Decision|9
377585|NCT00278993|1207092|P1|Overall Study|Progressive Disease|65
377586|NCT00278993|1207092|P1|Overall Study|Withdrawal by Subject|5
377587|NCT00278993|1207092|P1|Overall Study|Adverse Event|24
377588|NCT00278954|1207100|P1|Overall Study|Withdrawal by Subject|1
377589|NCT00278954|1207100|P1|Overall Study|Lost to Follow-up|1
377590|NCT00278954|1207100|P1|Overall Study|Adverse Event|3
377591|NCT00278915|1207108|P1|Overall Study|Lack of Efficacy|1
377592|NCT00278889|1207144|P3|Overall Study|Death|17
377593|NCT00278889|1207145|P2|Overall Study|Death|21
377594|NCT00278889|1207146|P1|Overall Study|Death|24
377595|NCT00278889|1207144|P3|Overall Study|Lost to Follow-up|0
377596|NCT00278889|1207145|P2|Overall Study|Lost to Follow-up|1
377597|NCT00278889|1207146|P1|Overall Study|Lost to Follow-up|1
377598|NCT00278889|1207144|P3|Overall Study|Withdrawal by Subject|3
377599|NCT00278889|1207145|P2|Overall Study|Withdrawal by Subject|5
377600|NCT00278889|1207146|P1|Overall Study|Withdrawal by Subject|0
377601|NCT00278473|1207207|P2|Overall Study|drop out|3
377602|NCT00278473|1207208|P1|Overall Study|drop out|4
377603|NCT00278395|1207224|P1|Overall Study|Nonevaluable|1
377604|NCT00278395|1207224|P1|Overall Study|Adverse Event|2
377605|NCT00277355|1207270|P2|Overall Study|Physician Decision|0
377606|NCT00277355|1207271|P1|Overall Study|Physician Decision|1
377607|NCT00277355|1207270|P2|Overall Study|Death|0
377608|NCT00277355|1207271|P1|Overall Study|Death|3
377609|NCT00277355|1207270|P2|Overall Study|Adverse Event|0
377610|NCT00277355|1207271|P1|Overall Study|Adverse Event|5
377611|NCT00277355|1207270|P2|Overall Study|Lost to Follow-up|2
377612|NCT00277355|1207271|P1|Overall Study|Lost to Follow-up|2
377613|NCT00277355|1207270|P2|Overall Study|Withdrawal by Subject|3
377614|NCT00277355|1207271|P1|Overall Study|Withdrawal by Subject|3
377615|NCT00277212|1207279|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
377616|NCT00277212|1207280|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
377617|NCT00277212|1207281|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
377618|NCT00277212|1207279|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
377619|NCT00277212|1207280|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
377620|NCT00277212|1207281|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
377621|NCT00277212|1207279|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
377622|NCT00277212|1207280|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
377623|NCT00277212|1207281|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
377624|NCT00277212|1207279|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
377625|NCT00277212|1207280|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
377626|NCT00277212|1207281|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
377627|NCT00277212|1207279|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
377628|NCT00277212|1207280|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
377629|NCT00277212|1207281|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
377630|NCT00277212|1207279|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
377631|NCT00277212|1207280|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
377632|NCT00277212|1207281|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
377633|NCT00277212|1207279|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
377634|NCT00277212|1207280|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
377635|NCT00277212|1207281|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
377636|NCT00277212|1207279|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
377637|NCT00277212|1207280|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
377638|NCT00277212|1207281|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
377639|NCT00277212|1207279|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
377640|NCT00277212|1207280|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
377641|NCT00277212|1207281|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
377642|NCT00277212|1207279|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
377643|NCT00277212|1207280|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
377644|NCT00277212|1207281|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
377645|NCT00277212|1207279|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
377646|NCT00277212|1207280|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
377647|NCT00277212|1207281|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
377648|NCT00277212|1207279|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
377649|NCT00277212|1207280|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
377650|NCT00277212|1207281|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
377651|NCT00277212|1207279|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
377652|NCT00277212|1207280|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
377653|NCT00277212|1207281|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
377654|NCT00277212|1207279|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
377655|NCT00277212|1207280|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
377656|NCT00277212|1207281|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
377657|NCT00277212|1207279|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
377658|NCT00277212|1207280|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
377659|NCT00277212|1207281|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
377660|NCT00277212|1207279|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
377661|NCT00277212|1207280|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
377662|NCT00277212|1207281|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
377663|NCT00277212|1207279|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
377664|NCT00277212|1207280|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
377665|NCT00277212|1207281|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
377666|NCT00277212|1207279|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
377667|NCT00277212|1207280|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
377668|NCT00277212|1207281|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
377669|NCT00277095|1207319|P1|Overall Study|Physician Decision|1
377670|NCT00277095|1207319|P1|Overall Study|Missed Follow-up|9
377671|NCT00277095|1207319|P1|Overall Study|Lost to Follow-up|2
377672|NCT00277095|1207319|P1|Overall Study|Explanted|7
377673|NCT00277095|1207319|P1|Overall Study|Death|2
377674|NCT00276614|1207328|P1|Overall Study|Progression of disease under study|3
377675|NCT00276484|1207339|P2|Overall Study|Could not take time off work|1
377676|NCT00276484|1207340|P1|Overall Study|Could not take time off work|0
377677|NCT00276484|1207339|P2|Overall Study|Withdrawal by Subject|3
377678|NCT00276484|1207340|P1|Overall Study|Withdrawal by Subject|4
377679|NCT00276484|1207339|P2|Overall Study|Protocol Violation|1
377680|NCT00276484|1207340|P1|Overall Study|Protocol Violation|0
377681|NCT00276484|1207339|P2|Overall Study|Lost to Follow-up|1
377682|NCT00276484|1207340|P1|Overall Study|Lost to Follow-up|1
377683|NCT00276484|1207339|P2|Overall Study|Adverse Event|7
377684|NCT00276484|1207340|P1|Overall Study|Adverse Event|4
377685|NCT00276458|1207372|P2|Overall Study|Protocol Violation|3
377686|NCT00276458|1207373|P1|Overall Study|Protocol Violation|4
377687|NCT00276458|1207372|P2|Overall Study|Lost to Follow-up|2
377688|NCT00276458|1207373|P1|Overall Study|Lost to Follow-up|2
377689|NCT00276458|1207372|P2|Overall Study|Adverse Event|2
377690|NCT00276458|1207373|P1|Overall Study|Adverse Event|0
377691|NCT00276419|1207407|P2|First Intervention|Withdrawal by Subject|2
377692|NCT00276419|1207408|P1|First Intervention|Withdrawal by Subject|0
377693|NCT00276419|1207407|P2|First Intervention|Adverse Event|0
377694|NCT00276419|1207408|P1|First Intervention|Adverse Event|1
377695|NCT00276159|1207486|P1|Overall Study|Did not receive all 24 doses of 852A|6
377696|NCT00276094|1207496|P3|Overall Study|Other-Study medication lost|1
377697|NCT00276094|1207497|P2|Overall Study|Other-Study medication lost|0
377698|NCT00276094|1207498|P1|Overall Study|Other-Study medication lost|0
377699|NCT00276094|1207496|P3|Overall Study|Other-Relocation|0
377700|NCT00276094|1207497|P2|Overall Study|Other-Relocation|1
377701|NCT00276094|1207498|P1|Overall Study|Other-Relocation|0
377702|NCT00276094|1207496|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
377703|NCT00276094|1207497|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
377704|NCT00276094|1207498|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
377705|NCT00276094|1207496|P3|Overall Study|Other-Refused follow-up visit|0
377706|NCT00276094|1207497|P2|Overall Study|Other-Refused follow-up visit|0
377707|NCT00276094|1207498|P1|Overall Study|Other-Refused follow-up visit|1
377708|NCT00276094|1207496|P3|Overall Study|Other-Lack of efficacy|0
377709|NCT00276094|1207497|P2|Overall Study|Other-Lack of efficacy|0
377710|NCT00276094|1207498|P1|Overall Study|Other-Lack of efficacy|1
377711|NCT00276094|1207496|P3|Overall Study|Other-Scheduled gastroplasty|0
377712|NCT00276094|1207497|P2|Overall Study|Other-Scheduled gastroplasty|0
377713|NCT00276094|1207498|P1|Overall Study|Other-Scheduled gastroplasty|1
377714|NCT00276094|1207496|P3|Overall Study|Other-Subject moved out of country|0
377715|NCT00276094|1207497|P2|Overall Study|Other-Subject moved out of country|0
377716|NCT00276094|1207498|P1|Overall Study|Other-Subject moved out of country|1
377717|NCT00276094|1207496|P3|Overall Study|Lost to Follow-up|4
377718|NCT00276094|1207497|P2|Overall Study|Lost to Follow-up|6
377719|NCT00276094|1207498|P1|Overall Study|Lost to Follow-up|8
377720|NCT00276094|1207496|P3|Overall Study|Protocol Violation|10
377721|NCT00276094|1207497|P2|Overall Study|Protocol Violation|7
377722|NCT00276094|1207498|P1|Overall Study|Protocol Violation|16
377723|NCT00276094|1207496|P3|Overall Study|Withdrawal by Subject|12
377724|NCT00276094|1207497|P2|Overall Study|Withdrawal by Subject|14
377725|NCT00276094|1207498|P1|Overall Study|Withdrawal by Subject|14
377726|NCT00276094|1207496|P3|Overall Study|Adverse Event|11
377727|NCT00276094|1207497|P2|Overall Study|Adverse Event|13
377728|NCT00276094|1207498|P1|Overall Study|Adverse Event|15
377729|NCT00276016|1207551|P6|Intervention 1|Withdrawal by Subject|0
377730|NCT00276016|1207552|P5|Intervention 1|Withdrawal by Subject|0
377731|NCT00276016|1207553|P4|Intervention 1|Withdrawal by Subject|0
377732|NCT00276016|1207554|P3|Intervention 1|Withdrawal by Subject|0
377733|NCT00276016|1207555|P2|Intervention 1|Withdrawal by Subject|1
377734|NCT00276016|1207556|P1|Intervention 1|Withdrawal by Subject|0
377735|NCT00275821|1207602|P3|Overall Study|Protocol Violation|0
377736|NCT00275821|1207603|P2|Overall Study|Protocol Violation|1
377737|NCT00275821|1207604|P1|Overall Study|Protocol Violation|5
377738|NCT00275821|1207602|P3|Overall Study|Lack of Efficacy|0
377739|NCT00275821|1207603|P2|Overall Study|Lack of Efficacy|1
377740|NCT00275821|1207604|P1|Overall Study|Lack of Efficacy|2
377741|NCT00275821|1207602|P3|Overall Study|Death|1
377742|NCT00275821|1207603|P2|Overall Study|Death|2
377743|NCT00275821|1207604|P1|Overall Study|Death|0
377744|NCT00275821|1207602|P3|Overall Study|Lost to Follow-up|1
377745|NCT00275821|1207603|P2|Overall Study|Lost to Follow-up|1
377746|NCT00275821|1207604|P1|Overall Study|Lost to Follow-up|0
377747|NCT00275821|1207602|P3|Overall Study|Withdrawal by Subject|1
377748|NCT00275821|1207603|P2|Overall Study|Withdrawal by Subject|2
377749|NCT00275821|1207604|P1|Overall Study|Withdrawal by Subject|0
377750|NCT00275821|1207602|P3|Overall Study|Administrative problems|4
377751|NCT00275821|1207603|P2|Overall Study|Administrative problems|4
377752|NCT00275821|1207604|P1|Overall Study|Administrative problems|3
377753|NCT00275821|1207602|P3|Overall Study|Adverse Event|5
377754|NCT00275821|1207603|P2|Overall Study|Adverse Event|12
377755|NCT00275821|1207604|P1|Overall Study|Adverse Event|4
377756|NCT00275561|1207623|P2|Overall Study|Family Issues|2
377757|NCT00275561|1207624|P1|Overall Study|Family Issues|0
377758|NCT00275561|1207623|P2|Overall Study|Scheduling|2
377759|NCT00275561|1207624|P1|Overall Study|Scheduling|1
377760|NCT00275561|1207623|P2|Overall Study|Travel|1
377761|NCT00275561|1207624|P1|Overall Study|Travel|1
377762|NCT00275561|1207623|P2|Overall Study|Withdrawal by Subject|1
377763|NCT00275561|1207624|P1|Overall Study|Withdrawal by Subject|0
377764|NCT00275340|1207647|P2|Overall Study|Lost to Follow-up|4
377765|NCT00275340|1207648|P1|Overall Study|Lost to Follow-up|2
377766|NCT00275301|1207652|P1|Overall Study|Adverse Event|5
377767|NCT00275262|1207671|P2|Overall Study|Started Chemotherapy|0
377768|NCT00275262|1207672|P1|Overall Study|Started Chemotherapy|1
377769|NCT00275262|1207671|P2|Overall Study|Death|0
377770|NCT00275262|1207672|P1|Overall Study|Death|1
377771|NCT00275262|1207671|P2|Overall Study|Protocol Violation|2
377772|NCT00275262|1207672|P1|Overall Study|Protocol Violation|0
377773|NCT00275262|1207671|P2|Overall Study|Lost to Follow-up|2
377774|NCT00275262|1207672|P1|Overall Study|Lost to Follow-up|0
377775|NCT00275262|1207671|P2|Overall Study|Disease progression|5
377776|NCT00275262|1207672|P1|Overall Study|Disease progression|2
377777|NCT00275262|1207671|P2|Overall Study|Adverse Event|0
377778|NCT00275262|1207672|P1|Overall Study|Adverse Event|2
377779|NCT00275028|1207686|P1|Overall Study|Physician Decision|2
377780|NCT00275028|1207686|P1|Overall Study|Progressive Disease|30
377781|NCT00275028|1207686|P1|Overall Study|Adverse Event|9
377782|NCT00275028|1207686|P1|Overall Study|Withdrawal by Subject|5
377783|NCT00275028|1207686|P1|Overall Study|Withdrew consent before treatment began|1
377784|NCT00275002|1207693|P2|Overall Study|Adverse Event|1
377785|NCT00275002|1207694|P1|Overall Study|Adverse Event|0
377786|NCT00275002|1207693|P2|Overall Study|Disease progression|15
377787|NCT00275002|1207694|P1|Overall Study|Disease progression|21
377788|NCT00275002|1207693|P2|Overall Study|Death|0
377789|NCT00275002|1207694|P1|Overall Study|Death|1
377790|NCT00274937|1207702|P1|Overall Study|Progressive Disease|4
377791|NCT00274937|1207702|P1|Overall Study|Withdrawal by Subject|6
377792|NCT00274937|1207702|P1|Overall Study|Physician Decision|10
377793|NCT00274924|1207712|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
377794|NCT00274924|1207713|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
377795|NCT00274924|1207714|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
377796|NCT00274924|1207712|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
377797|NCT00274924|1207713|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
377798|NCT00274924|1207714|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
377799|NCT00274924|1207712|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
377800|NCT00274924|1207713|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
377801|NCT00274924|1207714|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
377802|NCT00274924|1207712|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
377803|NCT00274924|1207713|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
377804|NCT00274924|1207714|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
377805|NCT00274924|1207712|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
377806|NCT00274924|1207713|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
377807|NCT00274924|1207714|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
377808|NCT00274924|1207712|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
377809|NCT00274924|1207713|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
377810|NCT00274924|1207714|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
377811|NCT00274924|1207712|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
377812|NCT00274924|1207713|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
377813|NCT00274924|1207714|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
377814|NCT00274924|1207712|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
377815|NCT00274924|1207713|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
377816|NCT00274924|1207714|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
377817|NCT00274924|1207712|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
377818|NCT00274924|1207713|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
377819|NCT00274924|1207714|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
377820|NCT00274924|1207712|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
377821|NCT00274924|1207713|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
377822|NCT00274924|1207714|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
377823|NCT00274924|1207712|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
377824|NCT00274924|1207713|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
377825|NCT00274924|1207714|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
377826|NCT00274924|1207712|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
377827|NCT00274924|1207713|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
377828|NCT00274924|1207714|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
377829|NCT00274924|1207712|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
377830|NCT00274924|1207713|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
377831|NCT00274924|1207714|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
377832|NCT00274846|1207723|P1|Overall Study|Did not receive adequate NK cells|1
377833|NCT00274742|1207747|P6|Overall Study|Other|0
377834|NCT00274742|1207748|P5|Overall Study|Other|2
377835|NCT00274742|1207749|P4|Overall Study|Other|0
377836|NCT00274742|1207750|P3|Overall Study|Other|0
377837|NCT00274742|1207751|P2|Overall Study|Other|3
377838|NCT00274742|1207752|P1|Overall Study|Other|0
377839|NCT00274742|1207747|P6|Overall Study|Disease Progression|0
377840|NCT00274742|1207748|P5|Overall Study|Disease Progression|1
377841|NCT00274742|1207749|P4|Overall Study|Disease Progression|0
377842|NCT00274742|1207750|P3|Overall Study|Disease Progression|1
377843|NCT00274742|1207751|P2|Overall Study|Disease Progression|1
377844|NCT00274742|1207752|P1|Overall Study|Disease Progression|0
377845|NCT00274742|1207747|P6|Overall Study|End of Study|0
377846|NCT00274742|1207748|P5|Overall Study|End of Study|0
377847|NCT00274742|1207749|P4|Overall Study|End of Study|1
377848|NCT00274742|1207750|P3|Overall Study|End of Study|0
377849|NCT00274742|1207751|P2|Overall Study|End of Study|0
377850|NCT00274742|1207752|P1|Overall Study|End of Study|0
377851|NCT00274742|1207747|P6|Overall Study|Lost to Follow-up|0
377852|NCT00274742|1207748|P5|Overall Study|Lost to Follow-up|1
377853|NCT00274742|1207749|P4|Overall Study|Lost to Follow-up|0
377854|NCT00274742|1207750|P3|Overall Study|Lost to Follow-up|0
377855|NCT00274742|1207751|P2|Overall Study|Lost to Follow-up|0
377856|NCT00274742|1207752|P1|Overall Study|Lost to Follow-up|0
377857|NCT00274742|1207747|P6|Overall Study|Adverse Event|3
377858|NCT00274742|1207748|P5|Overall Study|Adverse Event|12
377859|NCT00274742|1207749|P4|Overall Study|Adverse Event|4
377860|NCT00274742|1207750|P3|Overall Study|Adverse Event|1
377861|NCT00274742|1207751|P2|Overall Study|Adverse Event|4
377862|NCT00274742|1207752|P1|Overall Study|Adverse Event|0
377863|NCT00274716|1207790|P6|Phase B|Lost to Follow-up|0
377864|NCT00274716|1207791|P5|Phase B|Lost to Follow-up|0
377865|NCT00274716|1207792|P4|Phase B|Lost to Follow-up|0
377866|NCT00274716|1207793|P3|Phase B|Lost to Follow-up|0
377867|NCT00274716|1207794|P2|Phase B|Lost to Follow-up|1
377868|NCT00274716|1207795|P1|Phase B|Lost to Follow-up|0
377869|NCT00274716|1207790|P6|Phase B|Other non-reported reason|0
377870|NCT00274716|1207791|P5|Phase B|Other non-reported reason|0
377871|NCT00274716|1207792|P4|Phase B|Other non-reported reason|1
377872|NCT00274716|1207793|P3|Phase B|Other non-reported reason|1
377873|NCT00274716|1207794|P2|Phase B|Other non-reported reason|0
377874|NCT00274716|1207795|P1|Phase B|Other non-reported reason|0
377875|NCT00274716|1207790|P6|Phase B|Participant moved|0
377876|NCT00274716|1207791|P5|Phase B|Participant moved|0
377877|NCT00274716|1207792|P4|Phase B|Participant moved|0
377878|NCT00274716|1207793|P3|Phase B|Participant moved|0
377879|NCT00274716|1207794|P2|Phase B|Participant moved|0
377880|NCT00274716|1207795|P1|Phase B|Participant moved|1
377881|NCT00274716|1207790|P6|Phase B|Withdrawal by Subject|0
377882|NCT00274716|1207791|P5|Phase B|Withdrawal by Subject|0
377883|NCT00274716|1207792|P4|Phase B|Withdrawal by Subject|0
377884|NCT00274716|1207793|P3|Phase B|Withdrawal by Subject|0
377885|NCT00274716|1207794|P2|Phase B|Withdrawal by Subject|1
377886|NCT00274716|1207795|P1|Phase B|Withdrawal by Subject|0
377887|NCT00274716|1207790|P6|Phase B|Protocol Violation|0
377888|NCT00274716|1207791|P5|Phase B|Protocol Violation|0
377889|NCT00274716|1207792|P4|Phase B|Protocol Violation|0
377890|NCT00274716|1207793|P3|Phase B|Protocol Violation|0
377891|NCT00274716|1207794|P2|Phase B|Protocol Violation|2
377892|NCT00274716|1207795|P1|Phase B|Protocol Violation|0
377893|NCT00274716|1207790|P6|Phase B|Adverse Event|1
377894|NCT00274716|1207791|P5|Phase B|Adverse Event|0
377895|NCT00274716|1207792|P4|Phase B|Adverse Event|0
377896|NCT00274716|1207793|P3|Phase B|Adverse Event|2
377897|NCT00274716|1207794|P2|Phase B|Adverse Event|0
377898|NCT00274716|1207795|P1|Phase B|Adverse Event|0
377899|NCT00274716|1207790|P6|Phase A|Completed but did not enter Phase B|1
377900|NCT00274716|1207791|P5|Phase A|Completed but did not enter Phase B|1
377901|NCT00274716|1207792|P4|Phase A|Completed but did not enter Phase B|2
377902|NCT00274716|1207793|P3|Phase A|Completed but did not enter Phase B|2
377903|NCT00274716|1207794|P2|Phase A|Completed but did not enter Phase B|2
377904|NCT00274716|1207795|P1|Phase A|Completed but did not enter Phase B|1
377905|NCT00274716|1207790|P6|Phase A|Adverse Event|0
377906|NCT00274716|1207791|P5|Phase A|Adverse Event|2
377907|NCT00274716|1207792|P4|Phase A|Adverse Event|0
377908|NCT00274716|1207793|P3|Phase A|Adverse Event|3
377909|NCT00274716|1207794|P2|Phase A|Adverse Event|3
377910|NCT00274716|1207795|P1|Phase A|Adverse Event|2
377911|NCT00274716|1207790|P6|Phase A|Withdrawal by Subject|1
377912|NCT00274716|1207791|P5|Phase A|Withdrawal by Subject|0
377913|NCT00274716|1207792|P4|Phase A|Withdrawal by Subject|3
377914|NCT00274716|1207793|P3|Phase A|Withdrawal by Subject|1
377915|NCT00274716|1207794|P2|Phase A|Withdrawal by Subject|2
377916|NCT00274716|1207795|P1|Phase A|Withdrawal by Subject|2
377917|NCT00274716|1207790|P6|Phase A|Met criteria for discontinuation|0
377918|NCT00274716|1207791|P5|Phase A|Met criteria for discontinuation|0
377919|NCT00274716|1207792|P4|Phase A|Met criteria for discontinuation|0
377920|NCT00274716|1207793|P3|Phase A|Met criteria for discontinuation|0
377921|NCT00274716|1207794|P2|Phase A|Met criteria for discontinuation|1
377922|NCT00274716|1207795|P1|Phase A|Met criteria for discontinuation|1
377923|NCT00274716|1207790|P6|Phase A|Protocol Violation|0
377924|NCT00274716|1207791|P5|Phase A|Protocol Violation|0
377925|NCT00274716|1207792|P4|Phase A|Protocol Violation|1
377926|NCT00274716|1207793|P3|Phase A|Protocol Violation|0
377927|NCT00274716|1207794|P2|Phase A|Protocol Violation|0
377928|NCT00274716|1207795|P1|Phase A|Protocol Violation|1
377929|NCT00274716|1207790|P6|Phase A|Site Terminated|0
377930|NCT00274716|1207791|P5|Phase A|Site Terminated|0
377931|NCT00274716|1207792|P4|Phase A|Site Terminated|1
377932|NCT00274716|1207793|P3|Phase A|Site Terminated|0
377933|NCT00274716|1207794|P2|Phase A|Site Terminated|0
377934|NCT00274716|1207795|P1|Phase A|Site Terminated|0
377935|NCT00274716|1207790|P6|Phase A|Participant moved|1
377936|NCT00274716|1207791|P5|Phase A|Participant moved|0
377937|NCT00274716|1207792|P4|Phase A|Participant moved|0
377938|NCT00274716|1207793|P3|Phase A|Participant moved|1
377939|NCT00274716|1207794|P2|Phase A|Participant moved|0
377940|NCT00274716|1207795|P1|Phase A|Participant moved|0
377941|NCT00274716|1207790|P6|Phase A|Other non-reported reason|1
377942|NCT00274716|1207791|P5|Phase A|Other non-reported reason|0
377943|NCT00274716|1207792|P4|Phase A|Other non-reported reason|2
377944|NCT00274716|1207793|P3|Phase A|Other non-reported reason|1
377945|NCT00274716|1207794|P2|Phase A|Other non-reported reason|2
377946|NCT00274716|1207795|P1|Phase A|Other non-reported reason|4
377947|NCT00274651|1207857|P2|Overall Study|Physician Decision|7
377948|NCT00274651|1207858|P1|Overall Study|Physician Decision|8
377949|NCT00274651|1207857|P2|Overall Study|Withdrawal by Subject|1
377950|NCT00274651|1207858|P1|Overall Study|Withdrawal by Subject|0
377951|NCT00274651|1207857|P2|Overall Study|Death|3
377952|NCT00274651|1207858|P1|Overall Study|Death|1
377953|NCT00274651|1207857|P2|Overall Study|Lack of Efficacy|6
377954|NCT00274651|1207858|P1|Overall Study|Lack of Efficacy|13
377955|NCT00274651|1207857|P2|Overall Study|Adverse Event|3
377956|NCT00274651|1207858|P1|Overall Study|Adverse Event|6
377957|NCT00274625|1207873|P2|Overall Study|Excluded from analysis|8
377958|NCT00274625|1207874|P1|Overall Study|Excluded from analysis|14
377959|NCT00274625|1207873|P2|Overall Study|Lost to Follow-up|54
377960|NCT00274625|1207874|P1|Overall Study|Lost to Follow-up|46
377961|NCT00274469|1207882|P2|Overall Study|Reasons not specified|8
377962|NCT00274469|1207883|P1|Overall Study|Reasons not specified|5
377963|NCT00274469|1207882|P2|Overall Study|Withdrawal by Subject|0
377964|NCT00274469|1207883|P1|Overall Study|Withdrawal by Subject|2
377965|NCT00274469|1207882|P2|Overall Study|Condition under investigation worsened|38
377966|NCT00274469|1207883|P1|Overall Study|Condition under investigation worsened|28
377967|NCT00274469|1207882|P2|Overall Study|Adverse Event|3
377968|NCT00274469|1207883|P1|Overall Study|Adverse Event|2
377969|NCT00274469|1207882|P2|Overall Study|Death|1
377970|NCT00274469|1207883|P1|Overall Study|Death|1
377971|NCT00274456|1207901|P4|Overall Study|Withdrawal by Subject|13
377972|NCT00274456|1207902|P3|Overall Study|Withdrawal by Subject|9
377973|NCT00274456|1207903|P2|Overall Study|Withdrawal by Subject|13
377974|NCT00274456|1207904|P1|Overall Study|Withdrawal by Subject|18
377975|NCT00274456|1207901|P4|Overall Study|Lost to Follow-up|0
377976|NCT00274456|1207902|P3|Overall Study|Lost to Follow-up|1
377977|NCT00274456|1207903|P2|Overall Study|Lost to Follow-up|0
377978|NCT00274456|1207904|P1|Overall Study|Lost to Follow-up|0
377979|NCT00274456|1207901|P4|Overall Study|Physician Decision|13
377980|NCT00274456|1207902|P3|Overall Study|Physician Decision|6
377981|NCT00274456|1207903|P2|Overall Study|Physician Decision|5
377982|NCT00274456|1207904|P1|Overall Study|Physician Decision|7
377983|NCT00274456|1207901|P4|Overall Study|Adverse Event|2
377984|NCT00274456|1207902|P3|Overall Study|Adverse Event|2
377985|NCT00274456|1207903|P2|Overall Study|Adverse Event|1
377986|NCT00274456|1207904|P1|Overall Study|Adverse Event|0
377987|NCT00274456|1207901|P4|Overall Study|Unacceptable toxicity|16
377988|NCT00274456|1207902|P3|Overall Study|Unacceptable toxicity|12
377989|NCT00274456|1207903|P2|Overall Study|Unacceptable toxicity|5
377990|NCT00274456|1207904|P1|Overall Study|Unacceptable toxicity|10
377991|NCT00274456|1207901|P4|Overall Study|Still on treatment|1
377992|NCT00274456|1207902|P3|Overall Study|Still on treatment|5
377993|NCT00274456|1207903|P2|Overall Study|Still on treatment|3
377994|NCT00274456|1207904|P1|Overall Study|Still on treatment|2
377995|NCT00274287|1207946|P1|Overall Study|subject non-compliance|1
377996|NCT00274287|1207946|P1|Overall Study|Withdrawal by Subject|1
377997|NCT00274261|1207952|P2|Overall Study|Lost to Follow-up|75
377998|NCT00274261|1207953|P1|Overall Study|Lost to Follow-up|106
377999|NCT00274261|1207952|P2|Overall Study|Protocol Violation|42
378000|NCT00274261|1207953|P1|Overall Study|Protocol Violation|71
378001|NCT00274261|1207952|P2|Overall Study|Withdrawal by Subject|126
378002|NCT00274261|1207953|P1|Overall Study|Withdrawal by Subject|179
378003|NCT00274261|1207952|P2|Overall Study|Pregnancy|83
378004|NCT00274261|1207953|P1|Overall Study|Pregnancy|114
378005|NCT00274261|1207952|P2|Overall Study|Adverse Event|11
378006|NCT00274261|1207953|P1|Overall Study|Adverse Event|19
378007|NCT00273858|1207990|P1|Overall Study|Adverse Event|81
378008|NCT00273858|1207990|P1|Overall Study|Withdrawal by Subject|21
378009|NCT00273858|1207990|P1|Overall Study|Lost to Follow-up|101
378010|NCT00273858|1207990|P1|Overall Study|Not completed 24 month observation time|334
378011|NCT00273182|1208049|P1|Overall Study|Site exit, system change, 36 m FU missed|36
378012|NCT00273182|1208049|P1|Overall Study|Device/System Explant|154
378013|NCT00273182|1208049|P1|Overall Study|Withdrawal by Subject|257
378014|NCT00273182|1208049|P1|Overall Study|Lost to Follow-up|88
378015|NCT00273182|1208049|P1|Overall Study|Death|450
378016|NCT00273052|1208059|P2|Overall Study|Worsening serum lipid levels|2
378017|NCT00273052|1208060|P1|Overall Study|Worsening serum lipid levels|0
378018|NCT00273052|1208059|P2|Overall Study|Not specified|0
378019|NCT00273052|1208060|P1|Overall Study|Not specified|2
378020|NCT00273052|1208059|P2|Overall Study|Non-Compliance|1
378021|NCT00273052|1208060|P1|Overall Study|Non-Compliance|3
378022|NCT00273052|1208059|P2|Overall Study|Lack of Efficacy|4
378023|NCT00273052|1208060|P1|Overall Study|Lack of Efficacy|6
378024|NCT00273052|1208059|P2|Overall Study|Lost to Follow-up|25
378025|NCT00273052|1208060|P1|Overall Study|Lost to Follow-up|7
378026|NCT00273052|1208059|P2|Overall Study|Protocol Violation|18
378027|NCT00273052|1208060|P1|Overall Study|Protocol Violation|14
378028|NCT00273052|1208059|P2|Overall Study|Adverse Event|19
378029|NCT00273052|1208060|P1|Overall Study|Adverse Event|21
378030|NCT00273052|1208059|P2|Overall Study|Withdrawal by Subject|19
378031|NCT00273052|1208060|P1|Overall Study|Withdrawal by Subject|16
378032|NCT00272987|1208095|P3|Overall Study|Ongoing|15
378033|NCT00272987|1208096|P2|Overall Study|Ongoing|14
378034|NCT00272987|1208097|P1|Overall Study|Ongoing|20
378035|NCT00272987|1208095|P3|Overall Study|Missed >3 Visits|1
378036|NCT00272987|1208096|P2|Overall Study|Missed >3 Visits|0
378037|NCT00272987|1208097|P1|Overall Study|Missed >3 Visits|0
378038|NCT00272987|1208095|P3|Overall Study|Withdrawal by Subject|3
378039|NCT00272987|1208096|P2|Overall Study|Withdrawal by Subject|0
378040|NCT00272987|1208097|P1|Overall Study|Withdrawal by Subject|0
378041|NCT00272987|1208095|P3|Overall Study|Adverse Event|0
378042|NCT00272987|1208096|P2|Overall Study|Adverse Event|0
378043|NCT00272987|1208097|P1|Overall Study|Adverse Event|1
378044|NCT00272961|1208161|P5|Treatment Phase: Week 3 Up to Week 12|Unspecified|2
378045|NCT00272961|1208162|P4|Treatment Phase: Week 3 Up to Week 12|Unspecified|2
378046|NCT00272961|1208163|P3|Treatment Phase: Week 3 Up to Week 12|Unspecified|3
378047|NCT00272961|1208164|P2|Treatment Phase: Week 3 Up to Week 12|Unspecified|3
378048|NCT00272961|1208165|P1|Treatment Phase: Week 3 Up to Week 12|Unspecified|1
378049|NCT00272961|1208161|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
378050|NCT00272961|1208162|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
378051|NCT00272961|1208163|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
378052|NCT00272961|1208164|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
378053|NCT00272961|1208165|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
378054|NCT00272961|1208161|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
378055|NCT00272961|1208162|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
378056|NCT00272961|1208163|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
378057|NCT00272961|1208164|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
378058|NCT00272961|1208165|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
378059|NCT00272961|1208161|P5|Placebo Run-in Phase: Up to Week 2|Unspecified|0
378060|NCT00272961|1208162|P4|Placebo Run-in Phase: Up to Week 2|Unspecified|0
378061|NCT00272961|1208163|P3|Placebo Run-in Phase: Up to Week 2|Unspecified|0
378062|NCT00272961|1208164|P2|Placebo Run-in Phase: Up to Week 2|Unspecified|0
378063|NCT00272961|1208165|P1|Placebo Run-in Phase: Up to Week 2|Unspecified|2
378064|NCT00272961|1208161|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
378065|NCT00272961|1208162|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
378066|NCT00272961|1208163|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
378067|NCT00272961|1208164|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
378068|NCT00272961|1208165|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
378069|NCT00272961|1208161|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
378070|NCT00272961|1208162|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
378071|NCT00272961|1208163|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
378072|NCT00272961|1208164|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
378073|NCT00272961|1208165|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
378074|NCT00272961|1208161|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
378075|NCT00272961|1208162|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
378076|NCT00272961|1208163|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
378077|NCT00272961|1208164|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
378078|NCT00272961|1208165|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
378079|NCT00272961|1208161|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
378080|NCT00272961|1208162|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
378081|NCT00272961|1208163|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
378082|NCT00272961|1208164|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
378083|NCT00272961|1208165|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
378084|NCT00272792|1208224|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
378085|NCT00272792|1208225|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
378086|NCT00272792|1208224|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
378087|NCT00272792|1208225|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
378088|NCT00272792|1208224|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
378089|NCT00272792|1208225|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
378090|NCT00272792|1208224|P2|Part 1: Responsiveness|Lost to Follow-up|0
378091|NCT00272792|1208225|P1|Part 1: Responsiveness|Lost to Follow-up|1
378092|NCT00272779|1208235|P2|Baseline Through Week 96|Continuing on treatment|38
378093|NCT00272779|1208236|P1|Baseline Through Week 96|Continuing on treatment|61
378094|NCT00272779|1208235|P2|Baseline Through Week 96|Never treated|3
378095|NCT00272779|1208236|P1|Baseline Through Week 96|Never treated|2
378096|NCT00272779|1208235|P2|Baseline Through Week 96|Pregnancy at Week 96|0
378097|NCT00272779|1208236|P1|Baseline Through Week 96|Pregnancy at Week 96|1
378098|NCT00272779|1208235|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
378099|NCT00272779|1208236|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
378100|NCT00272779|1208235|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
378101|NCT00272779|1208236|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
378102|NCT00272779|1208235|P2|Baseline Through Week 96|Changed address before Week 96|1
378103|NCT00272779|1208236|P1|Baseline Through Week 96|Changed address before Week 96|0
378104|NCT00272779|1208235|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
378105|NCT00272779|1208236|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
378106|NCT00272779|1208235|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
378107|NCT00272779|1208236|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
378108|NCT00272779|1208235|P2|Baseline Through Week 96|Pregnancy before Week 96|7
378109|NCT00272779|1208236|P1|Baseline Through Week 96|Pregnancy before Week 96|5
378110|NCT00272779|1208235|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
378111|NCT00272779|1208236|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
378112|NCT00272779|1208235|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
378113|NCT00272779|1208236|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
378114|NCT00272779|1208235|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
378115|NCT00272779|1208236|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
378116|NCT00272779|1208235|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
378117|NCT00272779|1208236|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
378118|NCT00272779|1208235|P2|Baseline Through Week 96|Death before Week 96|5
378119|NCT00272779|1208236|P1|Baseline Through Week 96|Death before Week 96|6
378120|NCT00272779|1208235|P2|Baseline Through Week 96|Adverse event before Week 96|22
378121|NCT00272779|1208236|P1|Baseline Through Week 96|Adverse event before Week 96|13
378122|NCT00272779|1208235|P2|Baseline Through Week 48|Never treated|3
378123|NCT00272779|1208236|P1|Baseline Through Week 48|Never treated|2
378124|NCT00272779|1208235|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
378125|NCT00272779|1208236|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
378126|NCT00272779|1208235|P2|Baseline Through Week 48|Continuing treatment|368
378127|NCT00272779|1208236|P1|Baseline Through Week 48|Continuing treatment|385
378128|NCT00272779|1208235|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
378129|NCT00272779|1208236|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
378130|NCT00272779|1208235|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
378131|NCT00272779|1208236|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
378132|NCT00272779|1208235|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
378133|NCT00272779|1208236|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
378134|NCT00272779|1208235|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
378135|NCT00272779|1208236|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
378136|NCT00272779|1208235|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
378137|NCT00272779|1208236|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
378138|NCT00272779|1208235|P2|Baseline Through Week 48|Death on/after Week 48|1
378139|NCT00272779|1208236|P1|Baseline Through Week 48|Death on/after Week 48|1
378140|NCT00272779|1208235|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
378141|NCT00272779|1208236|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
378142|NCT00272779|1208235|P2|Baseline Through Week 48|Chose different site before wk 48|1
378143|NCT00272779|1208236|P1|Baseline Through Week 48|Chose different site before wk 48|0
378144|NCT00272779|1208235|P2|Baseline Through Week 48|Participant's decision before wk 48|1
378145|NCT00272779|1208236|P1|Baseline Through Week 48|Participant's decision before wk 48|0
378146|NCT00272779|1208235|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
378147|NCT00272779|1208236|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
378148|NCT00272779|1208235|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
378149|NCT00272779|1208236|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
378150|NCT00272779|1208235|P2|Baseline Through Week 48|Pregnancy before Week 48|2
378151|NCT00272779|1208236|P1|Baseline Through Week 48|Pregnancy before Week 48|2
378152|NCT00272779|1208235|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
378153|NCT00272779|1208236|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
378154|NCT00272779|1208235|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
378155|NCT00272779|1208236|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
378156|NCT00272779|1208235|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
378157|NCT00272779|1208236|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
378158|NCT00272779|1208235|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
378159|NCT00272779|1208236|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
378160|NCT00272779|1208235|P2|Baseline Through Week 48|Death before Week 48|4
378161|NCT00272779|1208236|P1|Baseline Through Week 48|Death before Week 48|4
378162|NCT00272779|1208235|P2|Baseline Through Week 48|Adverse event before Week 48|14
378163|NCT00272779|1208236|P1|Baseline Through Week 48|Adverse event before Week 48|10
378164|NCT00272038|1208476|P1|Overall Study|withdrew before they received 2 cycles|7
378165|NCT00271947|1208482|P1|Overall Study|Lost to Follow-up|1
378166|NCT00271856|1208488|P2|Overall Study|Lost to Follow-up|11
378167|NCT00271856|1208489|P1|Overall Study|Lost to Follow-up|10
378168|NCT00271856|1208488|P2|Overall Study|Withdrawal by Subject|7
378169|NCT00271856|1208489|P1|Overall Study|Withdrawal by Subject|1
378170|NCT00271817|1208508|P3|Part 2|LDL < 50 mg/dL|4
378171|NCT00271817|1208509|P2|Part 2|LDL < 50 mg/dL|3
378172|NCT00271817|1208510|P1|Part 2|LDL < 50 mg/dL|0
378173|NCT00271817|1208508|P3|Part 2|Withdrawal by Subject|13
378174|NCT00271817|1208509|P2|Part 2|Withdrawal by Subject|2
378175|NCT00271817|1208510|P1|Part 2|Withdrawal by Subject|0
378176|NCT00271817|1208508|P3|Part 2|Patient Moved|5
378177|NCT00271817|1208509|P2|Part 2|Patient Moved|0
378178|NCT00271817|1208510|P1|Part 2|Patient Moved|0
378179|NCT00271817|1208508|P3|Part 2|Protocol Violation|5
378180|NCT00271817|1208509|P2|Part 2|Protocol Violation|3
378181|NCT00271817|1208510|P1|Part 2|Protocol Violation|0
378182|NCT00271817|1208508|P3|Part 2|Lost to Follow-up|18
378183|NCT00271817|1208509|P2|Part 2|Lost to Follow-up|6
378184|NCT00271817|1208510|P1|Part 2|Lost to Follow-up|0
378185|NCT00271817|1208508|P3|Part 2|Lack of Efficacy|6
378186|NCT00271817|1208509|P2|Part 2|Lack of Efficacy|1
378187|NCT00271817|1208510|P1|Part 2|Lack of Efficacy|0
378188|NCT00271817|1208508|P3|Part 2|Adverse Event|33
378189|NCT00271817|1208509|P2|Part 2|Adverse Event|17
378190|NCT00271817|1208510|P1|Part 2|Adverse Event|0
378191|NCT00271817|1208508|P3|Part 1|LDL < 50 mg/dL|48
378192|NCT00271817|1208509|P2|Part 1|LDL < 50 mg/dL|4
378193|NCT00271817|1208510|P1|Part 1|LDL < 50 mg/dL|1
378194|NCT00271817|1208508|P3|Part 1|Withdrawal by Subject|45
378195|NCT00271817|1208509|P2|Part 1|Withdrawal by Subject|17
378196|NCT00271817|1208510|P1|Part 1|Withdrawal by Subject|23
378197|NCT00271817|1208508|P3|Part 1|Patient Moved|5
378198|NCT00271817|1208509|P2|Part 1|Patient Moved|1
378199|NCT00271817|1208510|P1|Part 1|Patient Moved|3
378200|NCT00271817|1208508|P3|Part 1|Protocol Violation|7
378201|NCT00271817|1208509|P2|Part 1|Protocol Violation|4
378202|NCT00271817|1208510|P1|Part 1|Protocol Violation|5
378203|NCT00271817|1208508|P3|Part 1|Lost to Follow-up|24
378204|NCT00271817|1208509|P2|Part 1|Lost to Follow-up|8
378205|NCT00271817|1208510|P1|Part 1|Lost to Follow-up|6
378206|NCT00271817|1208508|P3|Part 1|Adverse Event|156
378207|NCT00271817|1208509|P2|Part 1|Adverse Event|25
378208|NCT00271817|1208510|P1|Part 1|Adverse Event|68
378209|NCT00271609|1208552|P2|Overall Study|Withdrawal by Subject|0
378210|NCT00271609|1208553|P1|Overall Study|Withdrawal by Subject|2
378211|NCT00271609|1208552|P2|Overall Study|Adverse Event|3
378212|NCT00271609|1208553|P1|Overall Study|Adverse Event|11
378213|NCT00271596|1208563|P2|Overall Study|Withdrawal by Subject|1
378214|NCT00271596|1208564|P1|Overall Study|Withdrawal by Subject|0
378215|NCT00271596|1208563|P2|Overall Study|Protocol Violation|0
378216|NCT00271596|1208564|P1|Overall Study|Protocol Violation|1
378217|NCT00271544|1208599|P1|Overall Study|Implant not attempted|4
378218|NCT00271544|1208599|P1|Overall Study|Model 4196 lead not attempted|9
378219|NCT00271544|1208599|P1|Overall Study|Subjects did not receive a 4196 lead|7
378220|NCT00271024|1208704|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
378221|NCT00271024|1208705|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
378222|NCT00271024|1208706|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
378223|NCT00271024|1208707|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
378224|NCT00271024|1208704|P4|Overall Study|Unpleasant Reaction To Tablet|2
378225|NCT00271024|1208705|P3|Overall Study|Unpleasant Reaction To Tablet|4
378226|NCT00271024|1208706|P2|Overall Study|Unpleasant Reaction To Tablet|3
378227|NCT00271024|1208707|P1|Overall Study|Unpleasant Reaction To Tablet|1
378228|NCT00271024|1208704|P4|Overall Study|Protocol Violation|11
378229|NCT00271024|1208705|P3|Overall Study|Protocol Violation|5
378230|NCT00271024|1208706|P2|Overall Study|Protocol Violation|6
378231|NCT00271024|1208707|P1|Overall Study|Protocol Violation|1
378232|NCT00271024|1208704|P4|Overall Study|Unknown/Unspecified|4
378233|NCT00271024|1208705|P3|Overall Study|Unknown/Unspecified|8
378234|NCT00271024|1208706|P2|Overall Study|Unknown/Unspecified|11
378235|NCT00271024|1208707|P1|Overall Study|Unknown/Unspecified|11
378236|NCT00271024|1208704|P4|Overall Study|Lost Interest|3
378237|NCT00271024|1208705|P3|Overall Study|Lost Interest|2
378238|NCT00271024|1208706|P2|Overall Study|Lost Interest|4
378239|NCT00271024|1208707|P1|Overall Study|Lost Interest|3
378240|NCT00270894|1208754|P1|Overall Study|Withdrawal by Subject|1
378241|NCT00270894|1208754|P1|Overall Study|Adverse Event|1
378242|NCT00270257|1208844|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
378243|NCT00270257|1208845|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
378244|NCT00270231|1208863|P2|Second Intervention|Lost to Follow-up|1
378245|NCT00270231|1208864|P1|Second Intervention|Lost to Follow-up|0
378246|NCT00270231|1208863|P2|Washout Period|Lost to Follow-up|0
378247|NCT00270231|1208864|P1|Washout Period|Lost to Follow-up|1
378248|NCT00270231|1208863|P2|First Intervention|Lost to Follow-up|1
378249|NCT00270231|1208864|P1|First Intervention|Lost to Follow-up|1
378250|NCT00270205|1208874|P4|Overall Study|Lost to Follow-up|1
378251|NCT00270205|1208875|P3|Overall Study|Lost to Follow-up|0
378252|NCT00270205|1208876|P2|Overall Study|Lost to Follow-up|0
378253|NCT00270205|1208877|P1|Overall Study|Lost to Follow-up|1
378254|NCT00269919|1208987|P1|Overall Study|Started but not treated|1
378255|NCT00269919|1208987|P1|Overall Study|Unspecified|26
378256|NCT00269633|1209006|P2|Overall Study|Withdrawal by Subject|0
378257|NCT00269633|1209007|P1|Overall Study|Withdrawal by Subject|1
378258|NCT00269477|1209017|P4|Overall Study|Missed post-vaccination blood draw|0
378259|NCT00269477|1209018|P3|Overall Study|Missed post-vaccination blood draw|0
378260|NCT00269477|1209019|P2|Overall Study|Missed post-vaccination blood draw|1
378261|NCT00269477|1209020|P1|Overall Study|Missed post-vaccination blood draw|0
378262|NCT00269477|1209017|P4|Overall Study|Protocol Violation|0
378263|NCT00269477|1209018|P3|Overall Study|Protocol Violation|1
378264|NCT00269477|1209019|P2|Overall Study|Protocol Violation|5
378265|NCT00269477|1209020|P1|Overall Study|Protocol Violation|5
378266|NCT00269152|1209036|P2|Overall Study|Protocol Violation|1
378267|NCT00269152|1209037|P1|Overall Study|Protocol Violation|0
378268|NCT00269152|1209036|P2|Overall Study|Physician Decision|3
378269|NCT00269152|1209037|P1|Overall Study|Physician Decision|2
378270|NCT00269152|1209036|P2|Overall Study|Withdrawal by Subject|3
378271|NCT00269152|1209037|P1|Overall Study|Withdrawal by Subject|7
378272|NCT00269152|1209036|P2|Overall Study|Adverse Event|3
378273|NCT00269152|1209037|P1|Overall Study|Adverse Event|9
378274|NCT00269113|1209053|P2|Overall Study|Not specified|2
378275|NCT00269113|1209054|P1|Overall Study|Not specified|0
378276|NCT00269113|1209053|P2|Overall Study|Protocol Violation|5
378277|NCT00269113|1209054|P1|Overall Study|Protocol Violation|15
378278|NCT00269113|1209053|P2|Overall Study|Lost to Follow-up|1
378279|NCT00269113|1209054|P1|Overall Study|Lost to Follow-up|2
378280|NCT00269113|1209053|P2|Overall Study|Death|2
378281|NCT00269113|1209054|P1|Overall Study|Death|6
378282|NCT00269113|1209053|P2|Overall Study|Withdrawal by Subject|2
378283|NCT00269113|1209054|P1|Overall Study|Withdrawal by Subject|0
378284|NCT00269113|1209053|P2|Overall Study|Early Improvement|0
378285|NCT00269113|1209054|P1|Overall Study|Early Improvement|2
378286|NCT00269113|1209053|P2|Overall Study|Lack of Efficacy|18
378287|NCT00269113|1209054|P1|Overall Study|Lack of Efficacy|35
378288|NCT00269113|1209053|P2|Overall Study|Adverse Event|7
378289|NCT00269113|1209054|P1|Overall Study|Adverse Event|14
378290|NCT00268983|1209074|P2|Overall Study|Death|0
378291|NCT00268983|1209075|P1|Overall Study|Death|3
378292|NCT00268905|1209118|P3|Overall Study|Clinical Progression|1
378293|NCT00268905|1209119|P2|Overall Study|Clinical Progression|4
378294|NCT00268905|1209120|P1|Overall Study|Clinical Progression|9
378295|NCT00268905|1209118|P3|Overall Study|Physician Decision|1
378296|NCT00268905|1209119|P2|Overall Study|Physician Decision|0
378297|NCT00268905|1209120|P1|Overall Study|Physician Decision|3
378298|NCT00268905|1209118|P3|Overall Study|Progressive Disease|3
378299|NCT00268905|1209119|P2|Overall Study|Progressive Disease|4
378300|NCT00268905|1209120|P1|Overall Study|Progressive Disease|28
378301|NCT00268905|1209118|P3|Overall Study|Withdrawal by Subject|3
378302|NCT00268905|1209119|P2|Overall Study|Withdrawal by Subject|0
378303|NCT00268905|1209120|P1|Overall Study|Withdrawal by Subject|0
378304|NCT00268905|1209118|P3|Overall Study|Lost to Follow-up|0
378305|NCT00268905|1209119|P2|Overall Study|Lost to Follow-up|1
378306|NCT00268905|1209120|P1|Overall Study|Lost to Follow-up|0
378307|NCT00268905|1209118|P3|Overall Study|Adverse Event|4
378308|NCT00268905|1209119|P2|Overall Study|Adverse Event|0
378309|NCT00268905|1209120|P1|Overall Study|Adverse Event|3
378310|NCT00268892|1209137|P3|Overall Study|Trial Site Closed|2
378311|NCT00268892|1209138|P2|Overall Study|Trial Site Closed|2
378312|NCT00268892|1209139|P1|Overall Study|Trial Site Closed|4
378313|NCT00268892|1209137|P3|Overall Study|Disease Progression|0
378314|NCT00268892|1209138|P2|Overall Study|Disease Progression|1
378315|NCT00268892|1209139|P1|Overall Study|Disease Progression|1
378316|NCT00268892|1209137|P3|Overall Study|Protocol Violation|0
378317|NCT00268892|1209138|P2|Overall Study|Protocol Violation|1
378318|NCT00268892|1209139|P1|Overall Study|Protocol Violation|0
378319|NCT00268892|1209137|P3|Overall Study|Lost to Follow-up|4
378320|NCT00268892|1209138|P2|Overall Study|Lost to Follow-up|2
378321|NCT00268892|1209139|P1|Overall Study|Lost to Follow-up|5
378322|NCT00268892|1209137|P3|Overall Study|Physician Decision|0
378323|NCT00268892|1209138|P2|Overall Study|Physician Decision|1
378324|NCT00268892|1209139|P1|Overall Study|Physician Decision|0
378325|NCT00268892|1209137|P3|Overall Study|Withdrawal by Subject|13
378326|NCT00268892|1209138|P2|Overall Study|Withdrawal by Subject|15
378327|NCT00268892|1209139|P1|Overall Study|Withdrawal by Subject|14
378328|NCT00268892|1209137|P3|Overall Study|Lack of Efficacy|0
378329|NCT00268892|1209138|P2|Overall Study|Lack of Efficacy|3
378330|NCT00268892|1209139|P1|Overall Study|Lack of Efficacy|1
378331|NCT00268892|1209137|P3|Overall Study|Adverse Event|20
378332|NCT00268892|1209138|P2|Overall Study|Adverse Event|17
378333|NCT00268892|1209139|P1|Overall Study|Adverse Event|14
378334|NCT00268463|1209158|P2|Overall Study|study terminated due to low accrual|12
378335|NCT00268463|1209159|P1|Overall Study|study terminated due to low accrual|10
378336|NCT00268437|1209165|P1|Overall Study|Ineligible|1
378337|NCT00268346|1209172|P2|Overall Study|Withdrawal by Subject|1
378338|NCT00268346|1209173|P1|Overall Study|Withdrawal by Subject|0
378339|NCT00268346|1209172|P2|Overall Study|Death|1
378340|NCT00268346|1209173|P1|Overall Study|Death|0
378341|NCT00268346|1209172|P2|Overall Study|Adverse Event|1
378342|NCT00268346|1209173|P1|Overall Study|Adverse Event|0
378343|NCT00268242|1209179|P1|Overall Study|Death|1
378344|NCT00268203|1209188|P1|Overall Study|Completed 2 Years of Follow-up|62
378345|NCT00268203|1209188|P1|Overall Study|Reason Not Specified|34
378346|NCT00268203|1209188|P1|Overall Study|Death|84
378347|NCT00268203|1209188|P1|Overall Study|Progressive Disease|359
378348|NCT00268203|1209188|P1|Overall Study|Received Other NHL Therapy|7
378349|NCT00268203|1209188|P1|Overall Study|Withdrawal by Subject|9
378350|NCT00268203|1209188|P1|Overall Study|Lost to Follow-up|92
378351|NCT00267969|1209202|P7|After Controlled Period|Not specified|25
378352|NCT00267969|1209203|P6|After Controlled Period|Not specified|22
378353|NCT00267969|1209204|P5|After Controlled Period|Not specified|11
378354|NCT00267969|1209205|P4|After Controlled Period|Not specified|13
378355|NCT00267969|1209206|P3|After Controlled Period|Not specified|0
378356|NCT00267969|1209207|P2|After Controlled Period|Not specified|0
378357|NCT00267969|1209208|P1|After Controlled Period|Not specified|0
378358|NCT00267969|1209202|P7|After Controlled Period|Lost to Follow-up|10
378359|NCT00267969|1209203|P6|After Controlled Period|Lost to Follow-up|9
378360|NCT00267969|1209204|P5|After Controlled Period|Lost to Follow-up|8
378361|NCT00267969|1209205|P4|After Controlled Period|Lost to Follow-up|5
378362|NCT00267969|1209206|P3|After Controlled Period|Lost to Follow-up|0
378363|NCT00267969|1209207|P2|After Controlled Period|Lost to Follow-up|0
378364|NCT00267969|1209208|P1|After Controlled Period|Lost to Follow-up|0
378365|NCT00267969|1209202|P7|After Controlled Period|Lack of Efficacy|15
378366|NCT00267969|1209203|P6|After Controlled Period|Lack of Efficacy|28
378367|NCT00267969|1209204|P5|After Controlled Period|Lack of Efficacy|6
378368|NCT00267969|1209205|P4|After Controlled Period|Lack of Efficacy|10
378369|NCT00267969|1209206|P3|After Controlled Period|Lack of Efficacy|0
378370|NCT00267969|1209207|P2|After Controlled Period|Lack of Efficacy|0
378371|NCT00267969|1209208|P1|After Controlled Period|Lack of Efficacy|0
378372|NCT00267969|1209202|P7|After Controlled Period|Death|1
378373|NCT00267969|1209203|P6|After Controlled Period|Death|0
378374|NCT00267969|1209204|P5|After Controlled Period|Death|2
378375|NCT00267969|1209205|P4|After Controlled Period|Death|1
378376|NCT00267969|1209206|P3|After Controlled Period|Death|0
378377|NCT00267969|1209207|P2|After Controlled Period|Death|0
378378|NCT00267969|1209208|P1|After Controlled Period|Death|0
378379|NCT00267969|1209202|P7|After Controlled Period|Adverse Event|21
378380|NCT00267969|1209203|P6|After Controlled Period|Adverse Event|23
378381|NCT00267969|1209204|P5|After Controlled Period|Adverse Event|8
378382|NCT00267969|1209205|P4|After Controlled Period|Adverse Event|7
378383|NCT00267969|1209206|P3|After Controlled Period|Adverse Event|0
378384|NCT00267969|1209207|P2|After Controlled Period|Adverse Event|0
378385|NCT00267969|1209208|P1|After Controlled Period|Adverse Event|0
378386|NCT00267969|1209202|P7|Controlled Period|Not specified|0
378387|NCT00267969|1209203|P6|Controlled Period|Not specified|0
378388|NCT00267969|1209204|P5|Controlled Period|Not specified|0
378389|NCT00267969|1209205|P4|Controlled Period|Not specified|0
378390|NCT00267969|1209206|P3|Controlled Period|Not specified|6
378391|NCT00267969|1209207|P2|Controlled Period|Not specified|1
378392|NCT00267969|1209208|P1|Controlled Period|Not specified|2
378393|NCT00267969|1209202|P7|Controlled Period|Randomized but not treated|0
378394|NCT00267969|1209203|P6|Controlled Period|Randomized but not treated|0
378395|NCT00267969|1209204|P5|Controlled Period|Randomized but not treated|0
378396|NCT00267969|1209205|P4|Controlled Period|Randomized but not treated|0
378397|NCT00267969|1209206|P3|Controlled Period|Randomized but not treated|1
378398|NCT00267969|1209207|P2|Controlled Period|Randomized but not treated|0
378399|NCT00267969|1209208|P1|Controlled Period|Randomized but not treated|0
378400|NCT00267969|1209202|P7|Controlled Period|Lost to Follow-up|0
378401|NCT00267969|1209203|P6|Controlled Period|Lost to Follow-up|0
378402|NCT00267969|1209204|P5|Controlled Period|Lost to Follow-up|0
378403|NCT00267969|1209205|P4|Controlled Period|Lost to Follow-up|0
378404|NCT00267969|1209206|P3|Controlled Period|Lost to Follow-up|1
378405|NCT00267969|1209207|P2|Controlled Period|Lost to Follow-up|0
378406|NCT00267969|1209208|P1|Controlled Period|Lost to Follow-up|1
378407|NCT00267969|1209202|P7|Controlled Period|Lack of Efficacy|0
378408|NCT00267969|1209203|P6|Controlled Period|Lack of Efficacy|0
378409|NCT00267969|1209204|P5|Controlled Period|Lack of Efficacy|0
378410|NCT00267969|1209205|P4|Controlled Period|Lack of Efficacy|0
378411|NCT00267969|1209206|P3|Controlled Period|Lack of Efficacy|1
378412|NCT00267969|1209207|P2|Controlled Period|Lack of Efficacy|0
378413|NCT00267969|1209208|P1|Controlled Period|Lack of Efficacy|3
378414|NCT00267969|1209202|P7|Controlled Period|Adverse Event|0
378415|NCT00267969|1209203|P6|Controlled Period|Adverse Event|0
378416|NCT00267969|1209204|P5|Controlled Period|Adverse Event|0
378417|NCT00267969|1209205|P4|Controlled Period|Adverse Event|0
378418|NCT00267969|1209206|P3|Controlled Period|Adverse Event|2
378419|NCT00267969|1209207|P2|Controlled Period|Adverse Event|0
378420|NCT00267969|1209208|P1|Controlled Period|Adverse Event|6
378421|NCT00267956|1209234|P4|After Controlled Period|Withdrew consent|0
378422|NCT00267956|1209235|P3|After Controlled Period|Withdrew consent|1
378423|NCT00267956|1209236|P2|After Controlled Period|Withdrew consent|0
378424|NCT00267956|1209237|P1|After Controlled Period|Withdrew consent|0
378425|NCT00267956|1209234|P4|After Controlled Period|Lost to Follow-up|0
378426|NCT00267956|1209235|P3|After Controlled Period|Lost to Follow-up|1
378427|NCT00267956|1209236|P2|After Controlled Period|Lost to Follow-up|0
378428|NCT00267956|1209237|P1|After Controlled Period|Lost to Follow-up|0
378429|NCT00267956|1209234|P4|After Controlled Period|Lack of Efficacy|1
378430|NCT00267956|1209235|P3|After Controlled Period|Lack of Efficacy|1
378431|NCT00267956|1209236|P2|After Controlled Period|Lack of Efficacy|0
378432|NCT00267956|1209237|P1|After Controlled Period|Lack of Efficacy|0
378433|NCT00267956|1209234|P4|After Controlled Period|Adverse Event|1
378434|NCT00267956|1209235|P3|After Controlled Period|Adverse Event|2
378435|NCT00267956|1209236|P2|After Controlled Period|Adverse Event|0
378436|NCT00267956|1209237|P1|After Controlled Period|Adverse Event|0
378437|NCT00267956|1209234|P4|Controlled Period|Withdrew consent|0
378438|NCT00267956|1209235|P3|Controlled Period|Withdrew consent|0
378439|NCT00267956|1209236|P2|Controlled Period|Withdrew consent|1
378440|NCT00267956|1209237|P1|Controlled Period|Withdrew consent|3
378441|NCT00267956|1209234|P4|Controlled Period|Lost to Follow-up|0
378442|NCT00267956|1209235|P3|Controlled Period|Lost to Follow-up|0
378443|NCT00267956|1209236|P2|Controlled Period|Lost to Follow-up|0
378444|NCT00267956|1209237|P1|Controlled Period|Lost to Follow-up|2
378445|NCT00267956|1209234|P4|Controlled Period|Lack of Efficacy|0
378446|NCT00267956|1209235|P3|Controlled Period|Lack of Efficacy|0
378447|NCT00267956|1209236|P2|Controlled Period|Lack of Efficacy|2
378448|NCT00267956|1209237|P1|Controlled Period|Lack of Efficacy|4
378449|NCT00267956|1209234|P4|Controlled Period|Adverse Event|0
378450|NCT00267956|1209235|P3|Controlled Period|Adverse Event|0
378451|NCT00267956|1209236|P2|Controlled Period|Adverse Event|1
378452|NCT00267956|1209237|P1|Controlled Period|Adverse Event|4
378453|NCT00267748|1209267|P3|Randomized Period|randomized but not treated|3
378454|NCT00267748|1209268|P2|Randomized Period|randomized but not treated|0
378455|NCT00267748|1209269|P1|Randomized Period|randomized but not treated|0
378456|NCT00267748|1209267|P3|Randomized Period|Unspecified|6
378457|NCT00267748|1209268|P2|Randomized Period|Unspecified|9
378458|NCT00267748|1209269|P1|Randomized Period|Unspecified|0
378459|NCT00267748|1209267|P3|Randomized Period|Withdrawal by Subject|2
378460|NCT00267748|1209268|P2|Randomized Period|Withdrawal by Subject|9
378461|NCT00267748|1209269|P1|Randomized Period|Withdrawal by Subject|0
378462|NCT00267748|1209267|P3|Randomized Period|Objective progression or relapse|86
378463|NCT00267748|1209268|P2|Randomized Period|Objective progression or relapse|77
378464|NCT00267748|1209269|P1|Randomized Period|Objective progression or relapse|0
378465|NCT00267748|1209267|P3|Randomized Period|Lost to Follow-up|0
378466|NCT00267748|1209268|P2|Randomized Period|Lost to Follow-up|1
378467|NCT00267748|1209269|P1|Randomized Period|Lost to Follow-up|0
378468|NCT00267748|1209267|P3|Randomized Period|Global deterioration of health status|7
378469|NCT00267748|1209268|P2|Randomized Period|Global deterioration of health status|6
378470|NCT00267748|1209269|P1|Randomized Period|Global deterioration of health status|0
378471|NCT00267748|1209267|P3|Randomized Period|Adverse Event|25
378472|NCT00267748|1209268|P2|Randomized Period|Adverse Event|23
378473|NCT00267748|1209269|P1|Randomized Period|Adverse Event|0
378474|NCT00267748|1209267|P3|Randomized Period|Death|3
378475|NCT00267748|1209268|P2|Randomized Period|Death|2
378476|NCT00267748|1209269|P1|Randomized Period|Death|0
378477|NCT00267748|1209267|P3|Non-randomized Period|Unspecified|0
378478|NCT00267748|1209268|P2|Non-randomized Period|Unspecified|0
378479|NCT00267748|1209269|P1|Non-randomized Period|Unspecified|3
378480|NCT00267748|1209267|P3|Non-randomized Period|Participant not willing to participate|0
378481|NCT00267748|1209268|P2|Non-randomized Period|Participant not willing to participate|0
378482|NCT00267748|1209269|P1|Non-randomized Period|Participant not willing to participate|1
378483|NCT00267748|1209267|P3|Non-randomized Period|Death|0
378484|NCT00267748|1209268|P2|Non-randomized Period|Death|0
378485|NCT00267748|1209269|P1|Non-randomized Period|Death|1
378486|NCT00267748|1209267|P3|Non-randomized Period|Adverse Event|0
378487|NCT00267748|1209268|P2|Non-randomized Period|Adverse Event|0
378488|NCT00267748|1209269|P1|Non-randomized Period|Adverse Event|8
378489|NCT00267748|1209267|P3|Non-randomized Period|Progressive disease|0
378490|NCT00267748|1209268|P2|Non-randomized Period|Progressive disease|0
378491|NCT00267748|1209269|P1|Non-randomized Period|Progressive disease|10
378492|NCT00267488|1209326|P1|Overall Study|Other (Disease Progression)|1
378493|NCT00267488|1209326|P1|Overall Study|Protocol Violation|1
378494|NCT00267488|1209326|P1|Overall Study|Sponsor Terminated Study|9
378495|NCT00267202|1209350|P2|Overall Study|Lost to Follow-up|0
378496|NCT00267202|1209351|P1|Overall Study|Lost to Follow-up|3
378497|NCT00267202|1209350|P2|Overall Study|Administrative problems|1
378498|NCT00267202|1209351|P1|Overall Study|Administrative problems|2
378499|NCT00267202|1209350|P2|Overall Study|Protocol Violation|3
378500|NCT00267202|1209351|P1|Overall Study|Protocol Violation|2
378501|NCT00267202|1209350|P2|Overall Study|Adverse Event|7
378502|NCT00267202|1209351|P1|Overall Study|Adverse Event|13
378503|NCT00267202|1209350|P2|Overall Study|Withdrawal by Subject|15
378504|NCT00267202|1209351|P1|Overall Study|Withdrawal by Subject|12
378505|NCT00267202|1209350|P2|Overall Study|Unsatisfactory therapeutic effect|8
378506|NCT00267202|1209351|P1|Overall Study|Unsatisfactory therapeutic effect|21
378507|NCT00267189|1209372|P2|Overall Study|Missing|0
378508|NCT00267189|1209373|P1|Overall Study|Missing|3
378509|NCT00267189|1209372|P2|Overall Study|Death|0
378510|NCT00267189|1209373|P1|Overall Study|Death|1
378511|NCT00267189|1209372|P2|Overall Study|Patient withdrew consent|1
378512|NCT00267189|1209373|P1|Overall Study|Patient withdrew consent|1
378513|NCT00267150|1209383|P1|Overall Study|Adverse Event|1
378514|NCT00267098|1209407|P8|Overall Study|Sponsor withdrew subject|0
378515|NCT00267098|1209408|P7|Overall Study|Sponsor withdrew subject|0
378516|NCT00267098|1209409|P6|Overall Study|Sponsor withdrew subject|0
378517|NCT00267098|1209410|P5|Overall Study|Sponsor withdrew subject|0
378518|NCT00267098|1209411|P4|Overall Study|Sponsor withdrew subject|1
378519|NCT00267098|1209412|P3|Overall Study|Sponsor withdrew subject|0
378520|NCT00267098|1209413|P2|Overall Study|Sponsor withdrew subject|0
378521|NCT00267098|1209414|P1|Overall Study|Sponsor withdrew subject|0
378522|NCT00267098|1209407|P8|Overall Study|Subject listed for heart transplant|0
378523|NCT00267098|1209408|P7|Overall Study|Subject listed for heart transplant|1
378524|NCT00267098|1209409|P6|Overall Study|Subject listed for heart transplant|0
378525|NCT00267098|1209410|P5|Overall Study|Subject listed for heart transplant|0
378526|NCT00267098|1209411|P4|Overall Study|Subject listed for heart transplant|0
378527|NCT00267098|1209412|P3|Overall Study|Subject listed for heart transplant|0
378528|NCT00267098|1209413|P2|Overall Study|Subject listed for heart transplant|0
378529|NCT00267098|1209414|P1|Overall Study|Subject listed for heart transplant|0
378530|NCT00267098|1209407|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
378531|NCT00267098|1209408|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
378532|NCT00267098|1209409|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
378533|NCT00267098|1209410|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
378534|NCT00267098|1209411|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
378535|NCT00267098|1209412|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
378536|NCT00267098|1209413|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
378537|NCT00267098|1209414|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
378538|NCT00267098|1209407|P8|Overall Study|Explanted Medtronic device|0
378539|NCT00267098|1209408|P7|Overall Study|Explanted Medtronic device|0
378540|NCT00267098|1209409|P6|Overall Study|Explanted Medtronic device|0
378541|NCT00267098|1209410|P5|Overall Study|Explanted Medtronic device|0
378542|NCT00267098|1209411|P4|Overall Study|Explanted Medtronic device|1
378543|NCT00267098|1209412|P3|Overall Study|Explanted Medtronic device|0
378544|NCT00267098|1209413|P2|Overall Study|Explanted Medtronic device|0
378545|NCT00267098|1209414|P1|Overall Study|Explanted Medtronic device|0
378546|NCT00267098|1209407|P8|Overall Study|Site closure|0
378547|NCT00267098|1209408|P7|Overall Study|Site closure|1
378548|NCT00267098|1209409|P6|Overall Study|Site closure|1
378549|NCT00267098|1209410|P5|Overall Study|Site closure|0
378550|NCT00267098|1209411|P4|Overall Study|Site closure|1
378551|NCT00267098|1209412|P3|Overall Study|Site closure|0
378552|NCT00267098|1209413|P2|Overall Study|Site closure|0
378553|NCT00267098|1209414|P1|Overall Study|Site closure|0
378554|NCT00267098|1209407|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
378555|NCT00267098|1209408|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
378556|NCT00267098|1209409|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
378557|NCT00267098|1209410|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
378558|NCT00267098|1209411|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
378559|NCT00267098|1209412|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
378560|NCT00267098|1209413|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
378561|NCT00267098|1209414|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
378562|NCT00267098|1209407|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
378563|NCT00267098|1209408|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
378564|NCT00267098|1209409|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
378565|NCT00267098|1209410|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
378566|NCT00267098|1209411|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
378567|NCT00267098|1209412|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
378568|NCT00267098|1209413|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
378569|NCT00267098|1209414|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
378570|NCT00267098|1209407|P8|Overall Study|Physician Decision|0
378571|NCT00267098|1209408|P7|Overall Study|Physician Decision|3
378572|NCT00267098|1209409|P6|Overall Study|Physician Decision|4
378573|NCT00267098|1209410|P5|Overall Study|Physician Decision|5
378574|NCT00267098|1209411|P4|Overall Study|Physician Decision|11
378575|NCT00267098|1209412|P3|Overall Study|Physician Decision|7
378576|NCT00267098|1209413|P2|Overall Study|Physician Decision|0
378577|NCT00267098|1209414|P1|Overall Study|Physician Decision|5
378578|NCT00267098|1209407|P8|Overall Study|Withdrawal by Subject|5
378579|NCT00267098|1209408|P7|Overall Study|Withdrawal by Subject|12
378580|NCT00267098|1209409|P6|Overall Study|Withdrawal by Subject|9
378581|NCT00267098|1209410|P5|Overall Study|Withdrawal by Subject|12
378582|NCT00267098|1209411|P4|Overall Study|Withdrawal by Subject|21
378583|NCT00267098|1209412|P3|Overall Study|Withdrawal by Subject|24
378584|NCT00267098|1209413|P2|Overall Study|Withdrawal by Subject|0
378585|NCT00267098|1209414|P1|Overall Study|Withdrawal by Subject|8
378586|NCT00267098|1209407|P8|Overall Study|Lost to Follow-up|1
378587|NCT00267098|1209408|P7|Overall Study|Lost to Follow-up|1
378588|NCT00267098|1209409|P6|Overall Study|Lost to Follow-up|3
378589|NCT00267098|1209410|P5|Overall Study|Lost to Follow-up|2
378590|NCT00267098|1209411|P4|Overall Study|Lost to Follow-up|5
378591|NCT00267098|1209412|P3|Overall Study|Lost to Follow-up|6
378592|NCT00267098|1209413|P2|Overall Study|Lost to Follow-up|0
378593|NCT00267098|1209414|P1|Overall Study|Lost to Follow-up|0
378594|NCT00267098|1209407|P8|Overall Study|Death|9
378595|NCT00267098|1209408|P7|Overall Study|Death|28
378596|NCT00267098|1209409|P6|Overall Study|Death|23
378597|NCT00267098|1209410|P5|Overall Study|Death|14
378598|NCT00267098|1209411|P4|Overall Study|Death|66
378599|NCT00267098|1209412|P3|Overall Study|Death|57
378600|NCT00267098|1209413|P2|Overall Study|Death|0
378601|NCT00267098|1209414|P1|Overall Study|Death|0
378602|NCT00267046|1209557|P2|Overall Study|Radiation|1
378603|NCT00267046|1209558|P1|Overall Study|Radiation|0
378604|NCT00267046|1209557|P2|Overall Study|Withdrawal by Subject|0
378605|NCT00267046|1209558|P1|Overall Study|Withdrawal by Subject|1
378606|NCT00267046|1209557|P2|Overall Study|Surgery|1
378607|NCT00267046|1209558|P1|Overall Study|Surgery|3
378608|NCT00267046|1209557|P2|Overall Study|Open-label palifermin|7
378609|NCT00267046|1209558|P1|Overall Study|Open-label palifermin|2
378610|NCT00267046|1209557|P2|Overall Study|Chemotoxicity|0
378611|NCT00267046|1209558|P1|Overall Study|Chemotoxicity|2
378612|NCT00267046|1209557|P2|Overall Study|Disease progression|2
378613|NCT00267046|1209558|P1|Overall Study|Disease progression|4
378614|NCT00267007|1209568|P2|Overall Study|Adverse Event|0
378615|NCT00267007|1209569|P1|Overall Study|Adverse Event|1
378616|NCT00267007|1209568|P2|Overall Study|Non-compliance|1
378617|NCT00267007|1209569|P1|Overall Study|Non-compliance|0
378618|NCT00267007|1209568|P2|Overall Study|Lost to Follow-up|0
378619|NCT00267007|1209569|P1|Overall Study|Lost to Follow-up|1
378620|NCT00267007|1209568|P2|Overall Study|Withdrawal by Subject|0
378621|NCT00267007|1209569|P1|Overall Study|Withdrawal by Subject|6
378622|NCT00266864|1209579|P2|Overall Study|Withdrawal by Subject|1
378623|NCT00266864|1209580|P1|Overall Study|Withdrawal by Subject|1
378624|NCT00266864|1209579|P2|Overall Study|Lost to Follow-up|1
378625|NCT00266864|1209580|P1|Overall Study|Lost to Follow-up|4
378626|NCT00266825|1209589|P2|Completed Follow-Up|Withdrawal by Subject|5
378627|NCT00266825|1209590|P1|Completed Follow-Up|Withdrawal by Subject|11
378628|NCT00266825|1209589|P2|Completed Follow-Up|Lost to Follow-up|19
378629|NCT00266825|1209590|P1|Completed Follow-Up|Lost to Follow-up|14
378630|NCT00266812|1209616|P2|Overall Study|Discontinued before starting study drug|0
378631|NCT00266812|1209617|P1|Overall Study|Discontinued before starting study drug|4
378632|NCT00266812|1209616|P2|Overall Study|Withdrawal by Subject|2
378633|NCT00266812|1209617|P1|Overall Study|Withdrawal by Subject|0
378634|NCT00266812|1209616|P2|Overall Study|Protocol Violation|1
378635|NCT00266812|1209617|P1|Overall Study|Protocol Violation|0
378636|NCT00266812|1209616|P2|Overall Study|Adverse Event|1
378637|NCT00266812|1209617|P1|Overall Study|Adverse Event|3
378638|NCT00266812|1209616|P2|Overall Study|Death|4
378639|NCT00266812|1209617|P1|Overall Study|Death|5
378640|NCT00266812|1209616|P2|Overall Study|Disease Progression|3
378641|NCT00266812|1209617|P1|Overall Study|Disease Progression|9
378642|NCT00266695|1209640|P1|Overall Study|Withdrawal by Subject|15
378643|NCT00266695|1209640|P1|Overall Study|Lost to Follow-up|3
378644|NCT00266695|1209640|P1|Overall Study|Physician Decision|1
378645|NCT00266695|1209640|P1|Overall Study|Death|9
378646|NCT00266695|1209640|P1|Overall Study|Adverse Event|1
378647|NCT00266656|1209652|P2|Overall Study|Parent/Caregiver Decision|2
378648|NCT00266656|1209653|P1|Overall Study|Parent/Caregiver Decision|1
378649|NCT00266656|1209652|P2|Overall Study|Did Not Reach Final Height|8
378650|NCT00266656|1209653|P1|Overall Study|Did Not Reach Final Height|4
378651|NCT00266656|1209652|P2|Overall Study|Withdrawal by Subject|2
378652|NCT00266656|1209653|P1|Overall Study|Withdrawal by Subject|4
378653|NCT00266656|1209652|P2|Overall Study|Lost to Follow-up|1
378654|NCT00266656|1209653|P1|Overall Study|Lost to Follow-up|4
378655|NCT00266656|1209652|P2|Overall Study|Death|0
378656|NCT00266656|1209653|P1|Overall Study|Death|1
378657|NCT00266630|1209677|P2|Overall Study|Not Specified|11
378658|NCT00266630|1209678|P1|Overall Study|Not Specified|19
378659|NCT00266630|1209677|P2|Overall Study|Lost to Follow-up|0
378660|NCT00266630|1209678|P1|Overall Study|Lost to Follow-up|1
378661|NCT00266630|1209677|P2|Overall Study|Withdrawal by Subject|2
378662|NCT00266630|1209678|P1|Overall Study|Withdrawal by Subject|10
378663|NCT00266630|1209677|P2|Overall Study|Physician Decision|2
378664|NCT00266630|1209678|P1|Overall Study|Physician Decision|1
378665|NCT00266630|1209677|P2|Overall Study|Protocol Violation|3
378666|NCT00266630|1209678|P1|Overall Study|Protocol Violation|1
378667|NCT00266630|1209677|P2|Overall Study|Entry Criteria not met|0
378668|NCT00266630|1209678|P1|Overall Study|Entry Criteria not met|1
378669|NCT00266630|1209677|P2|Overall Study|Lack of Efficacy|4
378670|NCT00266630|1209678|P1|Overall Study|Lack of Efficacy|1
378671|NCT00266630|1209677|P2|Overall Study|Adverse Event|6
378672|NCT00266630|1209678|P1|Overall Study|Adverse Event|8
378673|NCT00266409|1209720|P4|Overall Study|unspecified|0
378674|NCT00266409|1209721|P3|Overall Study|unspecified|2
378675|NCT00266409|1209722|P2|Overall Study|unspecified|4
378676|NCT00266409|1209723|P1|Overall Study|unspecified|7
378677|NCT00266409|1209720|P4|Overall Study|Protocol Violation|2
378678|NCT00266409|1209721|P3|Overall Study|Protocol Violation|4
378679|NCT00266409|1209722|P2|Overall Study|Protocol Violation|3
378680|NCT00266409|1209723|P1|Overall Study|Protocol Violation|5
378681|NCT00266409|1209720|P4|Overall Study|Withdrawal by Subject|9
378682|NCT00266409|1209721|P3|Overall Study|Withdrawal by Subject|3
378683|NCT00266409|1209722|P2|Overall Study|Withdrawal by Subject|10
378684|NCT00266409|1209723|P1|Overall Study|Withdrawal by Subject|6
378685|NCT00266409|1209720|P4|Overall Study|Lost to Follow-up|8
378686|NCT00266409|1209721|P3|Overall Study|Lost to Follow-up|6
378687|NCT00266409|1209722|P2|Overall Study|Lost to Follow-up|21
378688|NCT00266409|1209723|P1|Overall Study|Lost to Follow-up|18
378689|NCT00266409|1209720|P4|Overall Study|Adverse Event|1
378690|NCT00266409|1209721|P3|Overall Study|Adverse Event|1
378691|NCT00266409|1209722|P2|Overall Study|Adverse Event|2
378692|NCT00266409|1209723|P1|Overall Study|Adverse Event|7
378693|NCT00266409|1209720|P4|Overall Study|Lack of Efficacy|2
378694|NCT00266409|1209721|P3|Overall Study|Lack of Efficacy|1
378695|NCT00266409|1209722|P2|Overall Study|Lack of Efficacy|6
378696|NCT00266409|1209723|P1|Overall Study|Lack of Efficacy|2
378697|NCT00265395|1210007|P2|Overall Study|Administrative|1
378698|NCT00265395|1210008|P1|Overall Study|Administrative|0
378699|NCT00265395|1210007|P2|Overall Study|Lack of Efficacy|1
378700|NCT00265395|1210008|P1|Overall Study|Lack of Efficacy|0
378701|NCT00265395|1210007|P2|Overall Study|Protocol Violation|2
378702|NCT00265395|1210008|P1|Overall Study|Protocol Violation|2
378703|NCT00265395|1210007|P2|Overall Study|Withdrawal by Subject|6
378704|NCT00265395|1210008|P1|Overall Study|Withdrawal by Subject|1
378705|NCT00265395|1210007|P2|Overall Study|Lost to Follow-up|1
378706|NCT00265395|1210008|P1|Overall Study|Lost to Follow-up|2
378707|NCT00265395|1210007|P2|Overall Study|Adverse Event|6
378708|NCT00265395|1210008|P1|Overall Study|Adverse Event|3
378709|NCT00265382|1210013|P1|Overall Study|Death|1
378710|NCT00265382|1210013|P1|Overall Study|Study terminated by sponsor|94
378711|NCT00265382|1210013|P1|Overall Study|Withdrawal by Subject|13
378712|NCT00265382|1210013|P1|Overall Study|Miscellaneous|6
378713|NCT00265382|1210013|P1|Overall Study|Lack of Efficacy|6
378714|NCT00265382|1210013|P1|Overall Study|Lost to Follow-up|3
378715|NCT00265382|1210013|P1|Overall Study|Laboratory Abnormality|1
378716|NCT00265382|1210013|P1|Overall Study|Adverse Event|21
378717|NCT00265343|1210033|P2|Overall Study|Other|3
378718|NCT00265343|1210034|P1|Overall Study|Other|8
378719|NCT00265343|1210033|P2|Overall Study|Withdrawal by Subject|9
378720|NCT00265343|1210034|P1|Overall Study|Withdrawal by Subject|3
378721|NCT00265343|1210033|P2|Overall Study|Adverse Event|7
378722|NCT00265343|1210034|P1|Overall Study|Adverse Event|10
378723|NCT00265330|1210042|P1|Overall Study|Protocol Violation|1
378724|NCT00265330|1210042|P1|Overall Study|Withdrew Consent|1
378725|NCT00265330|1210042|P1|Overall Study|Principal Investigators Request|1
378726|NCT00265330|1210042|P1|Overall Study|Site Closed by Sponsor|1
378727|NCT00265330|1210042|P1|Overall Study|Discharged from Unit for Long Term Care|1
378728|NCT00265330|1210042|P1|Overall Study|Began Taking Formulary Geodon|1
378729|NCT00265330|1210042|P1|Overall Study|Family Scheduling Conflicts|1
378730|NCT00265330|1210042|P1|Overall Study|Lack of Efficacy|4
378731|NCT00265330|1210042|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
378732|NCT00265330|1210042|P1|Overall Study|Withdrawal by Subject|34
378733|NCT00265330|1210042|P1|Overall Study|Lost to Follow-up|8
378734|NCT00265330|1210042|P1|Overall Study|Adverse Event|41
378735|NCT00265317|1210068|P4|Phase 2|Unspecified|1
378736|NCT00265317|1210069|P3|Phase 2|Unspecified|1
378737|NCT00265317|1210070|P2|Phase 2|Unspecified|0
378738|NCT00265317|1210071|P1|Phase 2|Unspecified|0
378739|NCT00265317|1210068|P4|Phase 2|Study terminated by sponsor|0
378740|NCT00265317|1210069|P3|Phase 2|Study terminated by sponsor|1
378741|NCT00265317|1210070|P2|Phase 2|Study terminated by sponsor|0
378742|NCT00265317|1210071|P1|Phase 2|Study terminated by sponsor|0
378743|NCT00265317|1210068|P4|Phase 2|Withdrawal/other than adverse event|1
378744|NCT00265317|1210069|P3|Phase 2|Withdrawal/other than adverse event|2
378745|NCT00265317|1210070|P2|Phase 2|Withdrawal/other than adverse event|0
378746|NCT00265317|1210071|P1|Phase 2|Withdrawal/other than adverse event|0
378747|NCT00265317|1210068|P4|Phase 2|Lost to Follow-up|1
378748|NCT00265317|1210069|P3|Phase 2|Lost to Follow-up|0
378749|NCT00265317|1210070|P2|Phase 2|Lost to Follow-up|0
378750|NCT00265317|1210071|P1|Phase 2|Lost to Follow-up|0
378751|NCT00265317|1210068|P4|Phase 2|Protocol Violation|4
378752|NCT00265317|1210069|P3|Phase 2|Protocol Violation|1
378753|NCT00265317|1210070|P2|Phase 2|Protocol Violation|0
378754|NCT00265317|1210071|P1|Phase 2|Protocol Violation|0
378755|NCT00265317|1210068|P4|Phase 2|Death|15
378756|NCT00265317|1210069|P3|Phase 2|Death|12
378757|NCT00265317|1210070|P2|Phase 2|Death|0
378758|NCT00265317|1210071|P1|Phase 2|Death|0
378759|NCT00265317|1210068|P4|Phase 2|Adverse Event|5
378760|NCT00265317|1210069|P3|Phase 2|Adverse Event|7
378761|NCT00265317|1210070|P2|Phase 2|Adverse Event|0
378762|NCT00265317|1210071|P1|Phase 2|Adverse Event|0
378763|NCT00265317|1210068|P4|Phase 2|Global deterioration of health status|0
378764|NCT00265317|1210069|P3|Phase 2|Global deterioration of health status|3
378765|NCT00265317|1210070|P2|Phase 2|Global deterioration of health status|0
378766|NCT00265317|1210071|P1|Phase 2|Global deterioration of health status|0
378767|NCT00265317|1210068|P4|Phase 2|Objective progression or relapse|38
378768|NCT00265317|1210069|P3|Phase 2|Objective progression or relapse|37
378769|NCT00265317|1210070|P2|Phase 2|Objective progression or relapse|0
378770|NCT00265317|1210071|P1|Phase 2|Objective progression or relapse|0
378771|NCT00265317|1210068|P4|Lead-In|Withdrawal/other than adverse event|0
378772|NCT00265317|1210069|P3|Lead-In|Withdrawal/other than adverse event|0
378773|NCT00265317|1210070|P2|Lead-In|Withdrawal/other than adverse event|0
378774|NCT00265317|1210071|P1|Lead-In|Withdrawal/other than adverse event|1
378775|NCT00265317|1210068|P4|Lead-In|Death|0
378776|NCT00265317|1210069|P3|Lead-In|Death|0
378777|NCT00265317|1210070|P2|Lead-In|Death|5
378778|NCT00265317|1210071|P1|Lead-In|Death|3
378779|NCT00265317|1210068|P4|Lead-In|Adverse Event|0
378780|NCT00265317|1210069|P3|Lead-In|Adverse Event|0
378781|NCT00265317|1210070|P2|Lead-In|Adverse Event|1
378782|NCT00265317|1210071|P1|Lead-In|Adverse Event|2
378783|NCT00265317|1210068|P4|Lead-In|Objective progression or relapse|0
378784|NCT00265317|1210069|P3|Lead-In|Objective progression or relapse|0
378785|NCT00265317|1210070|P2|Lead-In|Objective progression or relapse|11
378786|NCT00265317|1210071|P1|Lead-In|Objective progression or relapse|6
378787|NCT00266227|1210190|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
378788|NCT00266227|1210191|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
378789|NCT00266227|1210192|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
378790|NCT00266227|1210190|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
378791|NCT00266227|1210191|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
378792|NCT00266227|1210192|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
378793|NCT00266227|1210190|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
378794|NCT00266227|1210191|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
378795|NCT00266227|1210192|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
378796|NCT00266227|1210190|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
378797|NCT00266227|1210191|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
378798|NCT00266227|1210192|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
378799|NCT00266227|1210190|P3|Retreatment: Week 48 to Week 72|Death|0
378800|NCT00266227|1210191|P2|Retreatment: Week 48 to Week 72|Death|1
378801|NCT00266227|1210192|P1|Retreatment: Week 48 to Week 72|Death|1
378802|NCT00266227|1210190|P3|Retreatment: Up to Week 48|Pregnancy|0
378803|NCT00266227|1210191|P2|Retreatment: Up to Week 48|Pregnancy|0
378804|NCT00266227|1210192|P1|Retreatment: Up to Week 48|Pregnancy|1
378805|NCT00266227|1210190|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
378806|NCT00266227|1210191|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
378807|NCT00266227|1210192|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
378808|NCT00266227|1210190|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
378809|NCT00266227|1210191|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
378810|NCT00266227|1210192|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
378811|NCT00266227|1210190|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
378812|NCT00266227|1210191|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
378813|NCT00266227|1210192|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
378814|NCT00266227|1210190|P3|Retreatment: Up to Week 48|Adverse Event|0
378815|NCT00266227|1210191|P2|Retreatment: Up to Week 48|Adverse Event|7
378816|NCT00266227|1210192|P1|Retreatment: Up to Week 48|Adverse Event|7
378817|NCT00266227|1210190|P3|Retreatment: Up to Week 48|Death|0
378818|NCT00266227|1210191|P2|Retreatment: Up to Week 48|Death|0
378819|NCT00266227|1210192|P1|Retreatment: Up to Week 48|Death|1
378820|NCT00266227|1210190|P3|Initial Treatment|Pregnancy|1
378821|NCT00266227|1210191|P2|Initial Treatment|Pregnancy|0
378822|NCT00266227|1210192|P1|Initial Treatment|Pregnancy|0
378823|NCT00266227|1210190|P3|Initial Treatment|Physician decision to withdraw|12
378824|NCT00266227|1210191|P2|Initial Treatment|Physician decision to withdraw|0
378825|NCT00266227|1210192|P1|Initial Treatment|Physician decision to withdraw|0
378826|NCT00266227|1210190|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
378827|NCT00266227|1210191|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
378828|NCT00266227|1210192|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
378829|NCT00266227|1210190|P3|Initial Treatment|Lost to Follow-up|6
378830|NCT00266227|1210191|P2|Initial Treatment|Lost to Follow-up|0
378831|NCT00266227|1210192|P1|Initial Treatment|Lost to Follow-up|0
378832|NCT00266227|1210190|P3|Initial Treatment|Adverse Event|13
378833|NCT00266227|1210191|P2|Initial Treatment|Adverse Event|0
378834|NCT00266227|1210192|P1|Initial Treatment|Adverse Event|0
378835|NCT00266032|1210244|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
378836|NCT00266032|1210245|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
378837|NCT00266032|1210246|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
378838|NCT00266032|1210244|P3|Open-label Safety Extension|Withdrawal by Subject|12
378839|NCT00266032|1210245|P2|Open-label Safety Extension|Withdrawal by Subject|3
378840|NCT00266032|1210246|P1|Open-label Safety Extension|Withdrawal by Subject|19
378841|NCT00266032|1210244|P3|Open-label Safety Extension|Protocol Violation|2
378842|NCT00266032|1210245|P2|Open-label Safety Extension|Protocol Violation|3
378843|NCT00266032|1210246|P1|Open-label Safety Extension|Protocol Violation|1
378844|NCT00266032|1210244|P3|Open-label Safety Extension|Pregnancy|2
378845|NCT00266032|1210245|P2|Open-label Safety Extension|Pregnancy|1
378846|NCT00266032|1210246|P1|Open-label Safety Extension|Pregnancy|4
378847|NCT00266032|1210244|P3|Open-label Safety Extension|Lost to Follow-up|4
378848|NCT00266032|1210245|P2|Open-label Safety Extension|Lost to Follow-up|5
378849|NCT00266032|1210246|P1|Open-label Safety Extension|Lost to Follow-up|2
378850|NCT00266032|1210244|P3|Open-label Safety Extension|Adverse Event|4
378851|NCT00266032|1210245|P2|Open-label Safety Extension|Adverse Event|0
378852|NCT00266032|1210246|P1|Open-label Safety Extension|Adverse Event|5
378853|NCT00266032|1210244|P3|Treatment|patient moved/wish for pregnancy/no need|8
378854|NCT00266032|1210245|P2|Treatment|patient moved/wish for pregnancy/no need|5
378855|NCT00266032|1210246|P1|Treatment|patient moved/wish for pregnancy/no need|13
378856|NCT00266032|1210244|P3|Treatment|Withdrawal by Subject|12
378857|NCT00266032|1210245|P2|Treatment|Withdrawal by Subject|13
378858|NCT00266032|1210246|P1|Treatment|Withdrawal by Subject|28
378859|NCT00266032|1210244|P3|Treatment|Protocol Violation|13
378860|NCT00266032|1210245|P2|Treatment|Protocol Violation|14
378861|NCT00266032|1210246|P1|Treatment|Protocol Violation|6
378862|NCT00266032|1210244|P3|Treatment|Pregnancy|2
378863|NCT00266032|1210245|P2|Treatment|Pregnancy|2
378864|NCT00266032|1210246|P1|Treatment|Pregnancy|3
378865|NCT00266032|1210244|P3|Treatment|Lost to Follow-up|2
378866|NCT00266032|1210245|P2|Treatment|Lost to Follow-up|4
378867|NCT00266032|1210246|P1|Treatment|Lost to Follow-up|19
378868|NCT00266032|1210244|P3|Treatment|Adverse Event|10
378869|NCT00266032|1210245|P2|Treatment|Adverse Event|26
378870|NCT00266032|1210246|P1|Treatment|Adverse Event|42
378871|NCT00265889|1210274|P1|Overall Study|Insurance denied the request|3
378872|NCT00265889|1210274|P1|Overall Study|Protocol Violation|1
378873|NCT00265889|1210274|P1|Overall Study|Physician Decision|1
378874|NCT00265785|1210301|P1|Overall Study|Did not receive protocol treatment|2
378875|NCT00265785|1210301|P1|Overall Study|Ineligible|1
378876|NCT00265785|1210301|P1|Overall Study|Not protocol specified|2
378877|NCT00265785|1210301|P1|Overall Study|Progression/Relapse|15
378878|NCT00265785|1210301|P1|Overall Study|Withdrawal by Subject|3
378879|NCT00265785|1210301|P1|Overall Study|Adverse Event|4
378880|NCT00265759|1210314|P4|Overall Study|Discontinued due to intolerability|1
378881|NCT00265759|1210315|P3|Overall Study|Discontinued due to intolerability|0
378882|NCT00265759|1210316|P2|Overall Study|Discontinued due to intolerability|0
378883|NCT00265759|1210317|P1|Overall Study|Discontinued due to intolerability|0
378884|NCT00265759|1210314|P4|Overall Study|Bilateral disease|2
378885|NCT00265759|1210315|P3|Overall Study|Bilateral disease|0
378886|NCT00265759|1210316|P2|Overall Study|Bilateral disease|0
378887|NCT00265759|1210317|P1|Overall Study|Bilateral disease|0
378888|NCT00265759|1210314|P4|Overall Study|Ineligible|1
378889|NCT00265759|1210315|P3|Overall Study|Ineligible|0
378890|NCT00265759|1210316|P2|Overall Study|Ineligible|0
378891|NCT00265759|1210317|P1|Overall Study|Ineligible|0
378892|NCT00265759|1210314|P4|Overall Study|Cancel|3
378893|NCT00265759|1210315|P3|Overall Study|Cancel|0
378894|NCT00265759|1210316|P2|Overall Study|Cancel|0
378895|NCT00265759|1210317|P1|Overall Study|Cancel|0
378896|NCT00265759|1210314|P4|Overall Study|Withdrawal by Subject|2
378897|NCT00265759|1210315|P3|Overall Study|Withdrawal by Subject|2
378898|NCT00265759|1210316|P2|Overall Study|Withdrawal by Subject|1
378899|NCT00265759|1210317|P1|Overall Study|Withdrawal by Subject|0
378900|NCT00265239|1210384|P2|Overall Study|Adverse Event|1
378901|NCT00265239|1210385|P1|Overall Study|Adverse Event|2
378902|NCT00265122|1210407|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
378903|NCT00265122|1210408|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
378904|NCT00265122|1210409|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
378905|NCT00265122|1210410|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
378906|NCT00265122|1210411|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
378907|NCT00265122|1210412|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
378908|NCT00265122|1210407|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
378909|NCT00265122|1210408|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
378910|NCT00265122|1210409|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
378911|NCT00265122|1210410|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
378912|NCT00265122|1210411|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
378913|NCT00265122|1210412|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
378914|NCT00265122|1210407|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
378915|NCT00265122|1210408|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
378916|NCT00265122|1210409|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
378917|NCT00265122|1210410|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
378918|NCT00265122|1210411|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
378919|NCT00265122|1210412|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
378920|NCT00265122|1210407|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
378921|NCT00265122|1210408|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
378922|NCT00265122|1210409|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
378923|NCT00265122|1210410|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
378924|NCT00265122|1210411|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
378925|NCT00265122|1210412|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
378926|NCT00265122|1210407|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
378927|NCT00265122|1210408|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
378928|NCT00265122|1210409|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
378929|NCT00265122|1210410|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
378930|NCT00265122|1210411|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
378931|NCT00265122|1210412|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
378932|NCT00265122|1210407|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
378933|NCT00265122|1210408|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
378934|NCT00265122|1210409|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
378935|NCT00265122|1210410|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
378936|NCT00265122|1210411|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
378937|NCT00265122|1210412|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
378938|NCT00265109|1210434|P1|Overall Study|Adverse Event|1
378939|NCT00265109|1210434|P1|Overall Study|Withdrawal by Subject|5
378940|NCT00265096|1210441|P3|Overall Study|Not Specified|10
378941|NCT00265096|1210442|P2|Overall Study|Not Specified|19
378942|NCT00265096|1210443|P1|Overall Study|Not Specified|11
378943|NCT00265096|1210441|P3|Overall Study|Unsatisfactory therapeutic effect|6
378944|NCT00265096|1210442|P2|Overall Study|Unsatisfactory therapeutic effect|8
378945|NCT00265096|1210443|P1|Overall Study|Unsatisfactory therapeutic effect|9
378946|NCT00265096|1210441|P3|Overall Study|Death|2
378947|NCT00265096|1210442|P2|Overall Study|Death|1
378948|NCT00265096|1210443|P1|Overall Study|Death|0
378949|NCT00265096|1210441|P3|Overall Study|Lost to Follow-up|3
378950|NCT00265096|1210442|P2|Overall Study|Lost to Follow-up|5
378951|NCT00265096|1210443|P1|Overall Study|Lost to Follow-up|2
378952|NCT00265096|1210441|P3|Overall Study|Adverse Event|18
378953|NCT00265096|1210442|P2|Overall Study|Adverse Event|18
378954|NCT00265096|1210443|P1|Overall Study|Adverse Event|14
378955|NCT00265083|1210475|P3|Overall Study|Not specified|9
378956|NCT00265083|1210476|P2|Overall Study|Not specified|12
378957|NCT00265083|1210477|P1|Overall Study|Not specified|1
378958|NCT00265083|1210475|P3|Overall Study|Unsatisfactory therapeutic effect|14
378959|NCT00265083|1210476|P2|Overall Study|Unsatisfactory therapeutic effect|13
378960|NCT00265083|1210477|P1|Overall Study|Unsatisfactory therapeutic effect|8
378961|NCT00265083|1210475|P3|Overall Study|Lost to Follow-up|4
378962|NCT00265083|1210476|P2|Overall Study|Lost to Follow-up|4
378963|NCT00265083|1210477|P1|Overall Study|Lost to Follow-up|3
378964|NCT00265083|1210475|P3|Overall Study|Adverse Event|15
378965|NCT00265083|1210476|P2|Overall Study|Adverse Event|13
378966|NCT00265083|1210477|P1|Overall Study|Adverse Event|5
378967|NCT00264875|1210498|P1|Overall Study|Withdrawal by Subject|7
378968|NCT00264875|1210498|P1|Overall Study|Protocol Violation|11
378969|NCT00264875|1210498|P1|Overall Study|Lost to Follow-up|6
378970|NCT00264875|1210498|P1|Overall Study|Adverse Event|6
378971|NCT00264849|1210504|P2|Overall Study|Administrative Problems|0
378972|NCT00264849|1210505|P1|Overall Study|Administrative Problems|2
378973|NCT00264849|1210504|P2|Overall Study|Death|1
378974|NCT00264849|1210505|P1|Overall Study|Death|0
378975|NCT00264849|1210504|P2|Overall Study|Lost to Follow-up|2
378976|NCT00264849|1210505|P1|Overall Study|Lost to Follow-up|0
378977|NCT00264849|1210504|P2|Overall Study|Lack of Efficacy|6
378978|NCT00264849|1210505|P1|Overall Study|Lack of Efficacy|1
378979|NCT00264849|1210504|P2|Overall Study|Protocol Violation|3
378980|NCT00264849|1210505|P1|Overall Study|Protocol Violation|5
378981|NCT00264849|1210504|P2|Overall Study|Withdrawal by Subject|11
378982|NCT00264849|1210505|P1|Overall Study|Withdrawal by Subject|7
378983|NCT00264849|1210504|P2|Overall Study|Adverse Event|2
378984|NCT00264849|1210505|P1|Overall Study|Adverse Event|7
378985|NCT00264810|1210541|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
378986|NCT00264810|1210542|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
378987|NCT00264810|1210541|P2|Open Label Evaluation Period|Death|2
378988|NCT00264810|1210542|P1|Open Label Evaluation Period|Death|3
378989|NCT00264810|1210541|P2|Open Label Evaluation Period|Explant due to infection|1
378990|NCT00264810|1210542|P1|Open Label Evaluation Period|Explant due to infection|1
378991|NCT00264810|1210541|P2|Blinded Evaluation Period|Explant due to infection|1
378992|NCT00264810|1210542|P1|Blinded Evaluation Period|Explant due to infection|1
378993|NCT00264810|1210541|P2|Stimulation Optimization Period|Death|1
378994|NCT00264810|1210542|P1|Stimulation Optimization Period|Death|0
378995|NCT00264810|1210541|P2|Stimulation Optimization Period|Withdrawal by Subject|0
378996|NCT00264810|1210542|P1|Stimulation Optimization Period|Withdrawal by Subject|1
378997|NCT00264810|1210541|P2|Baseline|Other|1
378998|NCT00264810|1210542|P1|Baseline|Other|0
378999|NCT00264810|1210541|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
379000|NCT00264810|1210542|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
379001|NCT00264810|1210541|P2|Baseline|Insufficient Seizure Frequency|2
379002|NCT00264810|1210542|P1|Baseline|Insufficient Seizure Frequency|2
379003|NCT00264810|1210541|P2|Baseline|Subject Compliance Failure|3
379004|NCT00264810|1210542|P1|Baseline|Subject Compliance Failure|3
379005|NCT00264810|1210541|P2|Baseline|Physician Decision|8
379006|NCT00264810|1210542|P1|Baseline|Physician Decision|7
379007|NCT00264810|1210541|P2|Baseline|Withdrawal by Subject|10
379008|NCT00264810|1210542|P1|Baseline|Withdrawal by Subject|10
379009|NCT00264797|1210552|P2|Overall Study|Other|4
379010|NCT00264797|1210553|P1|Overall Study|Other|3
379011|NCT00264797|1210552|P2|Overall Study|Feels treatment not necessary, not worki|1
379012|NCT00264797|1210553|P1|Overall Study|Feels treatment not necessary, not worki|0
379013|NCT00264797|1210552|P2|Overall Study|Pressure/advice from Outsiders|1
379014|NCT00264797|1210553|P1|Overall Study|Pressure/advice from Outsiders|1
379015|NCT00264797|1210552|P2|Overall Study|Incarceration|5
379016|NCT00264797|1210553|P1|Overall Study|Incarceration|4
379017|NCT00264797|1210552|P2|Overall Study|Practical Problems|3
379018|NCT00264797|1210553|P1|Overall Study|Practical Problems|2
379019|NCT00264797|1210552|P2|Overall Study|Moved from area|1
379020|NCT00264797|1210553|P1|Overall Study|Moved from area|3
379021|NCT00264797|1210552|P2|Overall Study|Lost to Follow-up|17
379022|NCT00264797|1210553|P1|Overall Study|Lost to Follow-up|9
379023|NCT00264797|1210552|P2|Overall Study|Withdrawal by Subject|11
379024|NCT00264797|1210553|P1|Overall Study|Withdrawal by Subject|11
379025|NCT00264576|1210575|P2|Overall Study|Lost to Follow-up|1
379026|NCT00264576|1210576|P1|Overall Study|Lost to Follow-up|1
379027|NCT00264550|1210600|P4|Overall Study|Not specified|9
379028|NCT00264550|1210601|P3|Overall Study|Not specified|3
379029|NCT00264550|1210602|P2|Overall Study|Not specified|7
379030|NCT00264550|1210603|P1|Overall Study|Not specified|13
379031|NCT00264550|1210600|P4|Overall Study|Discontinued oral study agent|0
379032|NCT00264550|1210601|P3|Overall Study|Discontinued oral study agent|0
379033|NCT00264550|1210602|P2|Overall Study|Discontinued oral study agent|1
379034|NCT00264550|1210603|P1|Overall Study|Discontinued oral study agent|0
379035|NCT00264550|1210600|P4|Overall Study|Unsatisfactory therapeutic effect|6
379036|NCT00264550|1210601|P3|Overall Study|Unsatisfactory therapeutic effect|4
379037|NCT00264550|1210602|P2|Overall Study|Unsatisfactory therapeutic effect|11
379038|NCT00264550|1210603|P1|Overall Study|Unsatisfactory therapeutic effect|4
379039|NCT00264550|1210600|P4|Overall Study|Adverse Event|14
379040|NCT00264550|1210601|P3|Overall Study|Adverse Event|9
379041|NCT00264550|1210602|P2|Overall Study|Adverse Event|18
379042|NCT00264550|1210603|P1|Overall Study|Adverse Event|23
379043|NCT00264550|1210600|P4|Overall Study|Lost to Follow-up|1
379044|NCT00264550|1210601|P3|Overall Study|Lost to Follow-up|1
379045|NCT00264550|1210602|P2|Overall Study|Lost to Follow-up|1
379046|NCT00264550|1210603|P1|Overall Study|Lost to Follow-up|3
379047|NCT00264550|1210600|P4|Overall Study|Death|0
379048|NCT00264550|1210601|P3|Overall Study|Death|0
379049|NCT00264550|1210602|P2|Overall Study|Death|3
379050|NCT00264550|1210603|P1|Overall Study|Death|0
379051|NCT00264537|1210642|P4|Overall Study|Not treated|0
379052|NCT00264537|1210643|P3|Overall Study|Not treated|1
379053|NCT00264537|1210644|P2|Overall Study|Not treated|2
379054|NCT00264537|1210645|P1|Overall Study|Not treated|0
379055|NCT00264537|1210642|P4|Overall Study|Not specified|11
379056|NCT00264537|1210643|P3|Overall Study|Not specified|10
379057|NCT00264537|1210644|P2|Overall Study|Not specified|11
379058|NCT00264537|1210645|P1|Overall Study|Not specified|21
379059|NCT00264537|1210642|P4|Overall Study|Unsatisfactory therapeutic effect|7
379060|NCT00264537|1210643|P3|Overall Study|Unsatisfactory therapeutic effect|5
379061|NCT00264537|1210644|P2|Overall Study|Unsatisfactory therapeutic effect|6
379062|NCT00264537|1210645|P1|Overall Study|Unsatisfactory therapeutic effect|5
379063|NCT00264537|1210642|P4|Overall Study|Adverse Event|34
379064|NCT00264537|1210643|P3|Overall Study|Adverse Event|24
379065|NCT00264537|1210644|P2|Overall Study|Adverse Event|32
379066|NCT00264537|1210645|P1|Overall Study|Adverse Event|21
379067|NCT00264537|1210642|P4|Overall Study|Lost to Follow-up|6
379068|NCT00264537|1210643|P3|Overall Study|Lost to Follow-up|7
379069|NCT00264537|1210644|P2|Overall Study|Lost to Follow-up|4
379070|NCT00264537|1210645|P1|Overall Study|Lost to Follow-up|3
379071|NCT00264537|1210642|P4|Overall Study|Death|2
379072|NCT00264537|1210643|P3|Overall Study|Death|3
379073|NCT00264537|1210644|P2|Overall Study|Death|3
379074|NCT00264537|1210645|P1|Overall Study|Death|0
379075|NCT00264498|1210677|P2|Crossover Treatment|Withdrawal by Subject|0
379076|NCT00264498|1210678|P1|Crossover Treatment|Withdrawal by Subject|1
379077|NCT00264498|1210677|P2|Crossover Treatment|Study closure|1
379078|NCT00264498|1210678|P1|Crossover Treatment|Study closure|0
379079|NCT00264498|1210677|P2|Crossover Treatment|Objective disease progression|5
379080|NCT00264498|1210678|P1|Crossover Treatment|Objective disease progression|4
379081|NCT00264498|1210677|P2|Crossover Treatment|Death|3
379082|NCT00264498|1210678|P1|Crossover Treatment|Death|1
379083|NCT00264498|1210677|P2|Randomized Treatment|Protocol Violation|0
379084|NCT00264498|1210678|P1|Randomized Treatment|Protocol Violation|1
379085|NCT00264498|1210677|P2|Randomized Treatment|Study Closure|0
379086|NCT00264498|1210678|P1|Randomized Treatment|Study Closure|1
379087|NCT00264498|1210677|P2|Randomized Treatment|Incorrectly randomized|0
379088|NCT00264498|1210678|P1|Randomized Treatment|Incorrectly randomized|1
379089|NCT00264498|1210677|P2|Randomized Treatment|Physician Decision|0
379090|NCT00264498|1210678|P1|Randomized Treatment|Physician Decision|1
379091|NCT00264498|1210677|P2|Randomized Treatment|Objective disease Progression|14
379092|NCT00264498|1210678|P1|Randomized Treatment|Objective disease Progression|13
379093|NCT00264498|1210677|P2|Randomized Treatment|Withdrawal by Subject|1
379094|NCT00264498|1210678|P1|Randomized Treatment|Withdrawal by Subject|0
379095|NCT00264498|1210677|P2|Randomized Treatment|Death|3
379096|NCT00264498|1210678|P1|Randomized Treatment|Death|0
379097|NCT00264303|1210701|P2|Overall Study|Various reasons listed in study report|7
379098|NCT00264303|1210702|P1|Overall Study|Various reasons listed in study report|6
379099|NCT00264303|1210701|P2|Overall Study|Withdrawal by Subject|3
379100|NCT00264303|1210702|P1|Overall Study|Withdrawal by Subject|2
379101|NCT00264303|1210701|P2|Overall Study|Lost to Follow-up|3
379102|NCT00264303|1210702|P1|Overall Study|Lost to Follow-up|3
379103|NCT00264303|1210701|P2|Overall Study|Lack of Efficacy|13
379104|NCT00264303|1210702|P1|Overall Study|Lack of Efficacy|10
379105|NCT00264303|1210701|P2|Overall Study|Adverse Event|3
379106|NCT00264303|1210702|P1|Overall Study|Adverse Event|4
379107|NCT00264290|1210720|P2|Intervention (8 Weeks)|Adverse Event|0
379108|NCT00264290|1210721|P1|Intervention (8 Weeks)|Adverse Event|1
379109|NCT00264238|1210727|P1|Overall Study|Protocol Violation|1
379110|NCT00264147|1210739|P6|Treatment II Period|Pre-scheduled total hip replacement|1
379111|NCT00264147|1210740|P5|Treatment II Period|Pre-scheduled total hip replacement|0
379112|NCT00264147|1210741|P4|Treatment II Period|Pre-scheduled total hip replacement|0
379113|NCT00264147|1210742|P3|Treatment II Period|Pre-scheduled total hip replacement|0
379114|NCT00264147|1210743|P2|Treatment II Period|Pre-scheduled total hip replacement|0
379115|NCT00264147|1210744|P1|Treatment II Period|Pre-scheduled total hip replacement|0
379116|NCT00264147|1210739|P6|Treatment II Period|Withdrawal by Subject|2
379117|NCT00264147|1210740|P5|Treatment II Period|Withdrawal by Subject|3
379118|NCT00264147|1210741|P4|Treatment II Period|Withdrawal by Subject|0
379119|NCT00264147|1210742|P3|Treatment II Period|Withdrawal by Subject|0
379120|NCT00264147|1210743|P2|Treatment II Period|Withdrawal by Subject|0
379121|NCT00264147|1210744|P1|Treatment II Period|Withdrawal by Subject|0
379122|NCT00264147|1210739|P6|Treatment II Period|Lost to Follow-up|1
379123|NCT00264147|1210740|P5|Treatment II Period|Lost to Follow-up|1
379124|NCT00264147|1210741|P4|Treatment II Period|Lost to Follow-up|0
379125|NCT00264147|1210742|P3|Treatment II Period|Lost to Follow-up|0
379126|NCT00264147|1210743|P2|Treatment II Period|Lost to Follow-up|0
379127|NCT00264147|1210744|P1|Treatment II Period|Lost to Follow-up|0
379128|NCT00264147|1210739|P6|Treatment II Period|Lack of Efficacy|19
379129|NCT00264147|1210740|P5|Treatment II Period|Lack of Efficacy|20
379130|NCT00264147|1210741|P4|Treatment II Period|Lack of Efficacy|0
379131|NCT00264147|1210742|P3|Treatment II Period|Lack of Efficacy|0
379132|NCT00264147|1210743|P2|Treatment II Period|Lack of Efficacy|0
379133|NCT00264147|1210744|P1|Treatment II Period|Lack of Efficacy|0
379134|NCT00264147|1210739|P6|Treatment II Period|Laboratory Adverse Event|1
379135|NCT00264147|1210740|P5|Treatment II Period|Laboratory Adverse Event|0
379136|NCT00264147|1210741|P4|Treatment II Period|Laboratory Adverse Event|0
379137|NCT00264147|1210742|P3|Treatment II Period|Laboratory Adverse Event|0
379138|NCT00264147|1210743|P2|Treatment II Period|Laboratory Adverse Event|0
379139|NCT00264147|1210744|P1|Treatment II Period|Laboratory Adverse Event|0
379140|NCT00264147|1210739|P6|Treatment II Period|Adverse Event|9
379141|NCT00264147|1210740|P5|Treatment II Period|Adverse Event|9
379142|NCT00264147|1210741|P4|Treatment II Period|Adverse Event|0
379143|NCT00264147|1210742|P3|Treatment II Period|Adverse Event|0
379144|NCT00264147|1210743|P2|Treatment II Period|Adverse Event|0
379145|NCT00264147|1210744|P1|Treatment II Period|Adverse Event|0
379146|NCT00264147|1210739|P6|Treatment I Period|Reassigned to Treatment II Period|0
379147|NCT00264147|1210740|P5|Treatment I Period|Reassigned to Treatment II Period|45
379148|NCT00264147|1210741|P4|Treatment I Period|Reassigned to Treatment II Period|63
379149|NCT00264147|1210742|P3|Treatment I Period|Reassigned to Treatment II Period|65
379150|NCT00264147|1210743|P2|Treatment I Period|Reassigned to Treatment II Period|72
379151|NCT00264147|1210744|P1|Treatment I Period|Reassigned to Treatment II Period|84
379152|NCT00264147|1210739|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
379153|NCT00264147|1210740|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
379154|NCT00264147|1210741|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
379155|NCT00264147|1210742|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
379156|NCT00264147|1210743|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
379157|NCT00264147|1210744|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
379158|NCT00264147|1210739|P6|Treatment I Period|Patient out of town for an extended time|0
379159|NCT00264147|1210740|P5|Treatment I Period|Patient out of town for an extended time|0
379160|NCT00264147|1210741|P4|Treatment I Period|Patient out of town for an extended time|0
379161|NCT00264147|1210742|P3|Treatment I Period|Patient out of town for an extended time|0
379162|NCT00264147|1210743|P2|Treatment I Period|Patient out of town for an extended time|1
379163|NCT00264147|1210744|P1|Treatment I Period|Patient out of town for an extended time|0
379164|NCT00264147|1210739|P6|Treatment I Period|Withdrawal by Subject|0
379165|NCT00264147|1210740|P5|Treatment I Period|Withdrawal by Subject|2
379166|NCT00264147|1210741|P4|Treatment I Period|Withdrawal by Subject|2
379167|NCT00264147|1210742|P3|Treatment I Period|Withdrawal by Subject|0
379168|NCT00264147|1210743|P2|Treatment I Period|Withdrawal by Subject|0
379169|NCT00264147|1210744|P1|Treatment I Period|Withdrawal by Subject|2
379170|NCT00264147|1210739|P6|Treatment I Period|Protocol Violation|0
379171|NCT00264147|1210740|P5|Treatment I Period|Protocol Violation|0
379172|NCT00264147|1210741|P4|Treatment I Period|Protocol Violation|0
379173|NCT00264147|1210742|P3|Treatment I Period|Protocol Violation|0
379174|NCT00264147|1210743|P2|Treatment I Period|Protocol Violation|2
379175|NCT00264147|1210744|P1|Treatment I Period|Protocol Violation|2
379176|NCT00264147|1210739|P6|Treatment I Period|Lost to Follow-up|0
379177|NCT00264147|1210740|P5|Treatment I Period|Lost to Follow-up|1
379178|NCT00264147|1210741|P4|Treatment I Period|Lost to Follow-up|1
379179|NCT00264147|1210742|P3|Treatment I Period|Lost to Follow-up|0
379180|NCT00264147|1210743|P2|Treatment I Period|Lost to Follow-up|0
379181|NCT00264147|1210744|P1|Treatment I Period|Lost to Follow-up|1
379182|NCT00264147|1210739|P6|Treatment I Period|Lack of Efficacy|0
379183|NCT00264147|1210740|P5|Treatment I Period|Lack of Efficacy|1
379184|NCT00264147|1210741|P4|Treatment I Period|Lack of Efficacy|0
379185|NCT00264147|1210742|P3|Treatment I Period|Lack of Efficacy|8
379186|NCT00264147|1210743|P2|Treatment I Period|Lack of Efficacy|2
379187|NCT00264147|1210744|P1|Treatment I Period|Lack of Efficacy|6
379188|NCT00264147|1210739|P6|Treatment I Period|Laboratory Adverse Event|0
379189|NCT00264147|1210740|P5|Treatment I Period|Laboratory Adverse Event|0
379190|NCT00264147|1210741|P4|Treatment I Period|Laboratory Adverse Event|1
379191|NCT00264147|1210742|P3|Treatment I Period|Laboratory Adverse Event|0
379192|NCT00264147|1210743|P2|Treatment I Period|Laboratory Adverse Event|0
379193|NCT00264147|1210744|P1|Treatment I Period|Laboratory Adverse Event|0
379194|NCT00264147|1210739|P6|Treatment I Period|Adverse Event|0
379195|NCT00264147|1210740|P5|Treatment I Period|Adverse Event|7
379196|NCT00264147|1210741|P4|Treatment I Period|Adverse Event|5
379197|NCT00264147|1210742|P3|Treatment I Period|Adverse Event|3
379198|NCT00264147|1210743|P2|Treatment I Period|Adverse Event|6
379199|NCT00264147|1210744|P1|Treatment I Period|Adverse Event|3
379200|NCT00264004|1210787|P4|Overall Study|Not treated|2
379201|NCT00264004|1210788|P3|Overall Study|Not treated|2
379202|NCT00264004|1210789|P2|Overall Study|Not treated|0
379203|NCT00264004|1210790|P1|Overall Study|Not treated|3
379204|NCT00264004|1210787|P4|Overall Study|Cond. under inv. worsened|4
379205|NCT00264004|1210788|P3|Overall Study|Cond. under inv. worsened|3
379206|NCT00264004|1210789|P2|Overall Study|Cond. under inv. worsened|5
379207|NCT00264004|1210790|P1|Overall Study|Cond. under inv. worsened|9
379208|NCT00264004|1210787|P4|Overall Study|Development study specific disc. crit.|0
379209|NCT00264004|1210788|P3|Overall Study|Development study specific disc. crit.|1
379210|NCT00264004|1210789|P2|Overall Study|Development study specific disc. crit.|0
379211|NCT00264004|1210790|P1|Overall Study|Development study specific disc. crit.|1
379212|NCT00264004|1210787|P4|Overall Study|Not specified|3
379213|NCT00264004|1210788|P3|Overall Study|Not specified|0
379214|NCT00264004|1210789|P2|Overall Study|Not specified|2
379215|NCT00264004|1210790|P1|Overall Study|Not specified|2
379216|NCT00264004|1210787|P4|Overall Study|Withdrawal by Subject|2
379217|NCT00264004|1210788|P3|Overall Study|Withdrawal by Subject|2
379218|NCT00264004|1210789|P2|Overall Study|Withdrawal by Subject|1
379219|NCT00264004|1210790|P1|Overall Study|Withdrawal by Subject|0
379220|NCT00264004|1210787|P4|Overall Study|Adverse Event|4
379221|NCT00264004|1210788|P3|Overall Study|Adverse Event|6
379222|NCT00264004|1210789|P2|Overall Study|Adverse Event|3
379223|NCT00264004|1210790|P1|Overall Study|Adverse Event|2
379224|NCT00263887|1210818|P2|Overall Study|Lack of Efficacy|1
379225|NCT00263887|1210819|P1|Overall Study|Lack of Efficacy|0
379226|NCT00263887|1210818|P2|Overall Study|Disease progression|1
379227|NCT00263887|1210819|P1|Overall Study|Disease progression|0
379228|NCT00263887|1210818|P2|Overall Study|Adverse Event|2
379229|NCT00263887|1210819|P1|Overall Study|Adverse Event|0
379230|NCT00263887|1210818|P2|Overall Study|Too ill to attend visit|0
379231|NCT00263887|1210819|P1|Overall Study|Too ill to attend visit|1
379232|NCT00263887|1210818|P2|Overall Study|Lung transplantation|2
379233|NCT00263887|1210819|P1|Overall Study|Lung transplantation|1
379234|NCT00263887|1210818|P2|Overall Study|Withdrawal by Subject|1
379235|NCT00263887|1210819|P1|Overall Study|Withdrawal by Subject|1
379236|NCT00263757|1210827|P2|Overall Study|Adverse Event|3
379237|NCT00263757|1210828|P1|Overall Study|Adverse Event|3
379238|NCT00263757|1210827|P2|Overall Study|Screen failure|1
379239|NCT00263757|1210828|P1|Overall Study|Screen failure|0
379240|NCT00263757|1210827|P2|Overall Study|Withdrawal by Subject|4
379241|NCT00263757|1210828|P1|Overall Study|Withdrawal by Subject|5
379242|NCT00263666|1210840|P2|Overall Study|Withdrawal by Subject|1
379243|NCT00263666|1210841|P1|Overall Study|Withdrawal by Subject|0
379244|NCT00263666|1210840|P2|Overall Study|Lost to Follow-up|2
379245|NCT00263666|1210841|P1|Overall Study|Lost to Follow-up|1
379246|NCT00263666|1210840|P2|Overall Study|Adverse Event|8
379247|NCT00263666|1210841|P1|Overall Study|Adverse Event|6
379248|NCT00263328|1210895|P3|Overall Study|Adverse Event|4
379249|NCT00263328|1210896|P2|Overall Study|Adverse Event|1
379250|NCT00263328|1210897|P1|Overall Study|Adverse Event|1
379251|NCT00263328|1210895|P3|Overall Study|Not specified|1
379252|NCT00263328|1210896|P2|Overall Study|Not specified|0
379253|NCT00263328|1210897|P1|Overall Study|Not specified|3
379254|NCT00263328|1210895|P3|Overall Study|Withdrawal by Subject|1
379255|NCT00263328|1210896|P2|Overall Study|Withdrawal by Subject|0
379256|NCT00263328|1210897|P1|Overall Study|Withdrawal by Subject|3
379257|NCT00263328|1210895|P3|Overall Study|Lost to Follow-up|0
379258|NCT00263328|1210896|P2|Overall Study|Lost to Follow-up|1
379259|NCT00263328|1210897|P1|Overall Study|Lost to Follow-up|1
379260|NCT00263328|1210895|P3|Overall Study|Death|1
379261|NCT00263328|1210896|P2|Overall Study|Death|0
379262|NCT00263328|1210897|P1|Overall Study|Death|0
379263|NCT00263211|1211055|P2|Overall Study|Disease Progression|1
379264|NCT00263211|1211056|P1|Overall Study|Disease Progression|0
379265|NCT00263211|1211055|P2|Overall Study|Protocol Violation|0
379266|NCT00263211|1211056|P1|Overall Study|Protocol Violation|1
379267|NCT00263211|1211055|P2|Overall Study|Withdrawal by Subject|0
379268|NCT00263211|1211056|P1|Overall Study|Withdrawal by Subject|3
379269|NCT00263211|1211055|P2|Overall Study|Death|0
379270|NCT00263211|1211056|P1|Overall Study|Death|1
379271|NCT00262951|1211107|P1|Overall Study|Off treatment for other disease|1
379272|NCT00262951|1211107|P1|Overall Study|Alternative treatment|3
379273|NCT00262951|1211107|P1|Overall Study|Withdrawal by Subject|1
379274|NCT00262951|1211107|P1|Overall Study|Death|1
379275|NCT00262951|1211107|P1|Overall Study|Adverse Event|7
379276|NCT00262951|1211107|P1|Overall Study|Progressive disease/relapse|3
379277|NCT00262925|1211112|P1|Overall Study|Other|1
379278|NCT00262925|1211112|P1|Overall Study|alternative therapy|1
379279|NCT00262925|1211112|P1|Overall Study|Death|2
379280|NCT00262925|1211112|P1|Overall Study|Adverse Event|4
379281|NCT00262925|1211112|P1|Overall Study|Lack of Efficacy|3
379282|NCT00262873|1211118|P1|Overall Study|Withdrawal by Subject|5
379283|NCT00262873|1211118|P1|Overall Study|Adverse Event|3
379284|NCT00262860|1211129|P1|Overall Study|Adverse Event|2
379285|NCT00262847|1211138|P3|Overall Study|Did not receive study treatment|4
379286|NCT00262847|1211139|P2|Overall Study|Did not receive study treatment|1
379287|NCT00262847|1211140|P1|Overall Study|Did not receive study treatment|4
379288|NCT00262847|1211138|P3|Overall Study|Other Reasons|27
379289|NCT00262847|1211139|P2|Overall Study|Other Reasons|88
379290|NCT00262847|1211140|P1|Overall Study|Other Reasons|79
379291|NCT00262847|1211138|P3|Overall Study|Concomitant disease|4
379292|NCT00262847|1211139|P2|Overall Study|Concomitant disease|2
379293|NCT00262847|1211140|P1|Overall Study|Concomitant disease|3
379294|NCT00262847|1211138|P3|Overall Study|Death|11
379295|NCT00262847|1211139|P2|Overall Study|Death|8
379296|NCT00262847|1211140|P1|Overall Study|Death|8
379297|NCT00262847|1211138|P3|Overall Study|Adverse Event|108
379298|NCT00262847|1211139|P2|Overall Study|Adverse Event|88
379299|NCT00262847|1211140|P1|Overall Study|Adverse Event|74
379300|NCT00262847|1211138|P3|Overall Study|Patient Refusal|47
379301|NCT00262847|1211139|P2|Overall Study|Patient Refusal|52
379302|NCT00262847|1211140|P1|Overall Study|Patient Refusal|41
379303|NCT00262847|1211138|P3|Overall Study|Disease Progression|195
379304|NCT00262847|1211139|P2|Overall Study|Disease Progression|274
379305|NCT00262847|1211140|P1|Overall Study|Disease Progression|309
379306|NCT00262834|1211156|P2|Overall Study|Surgery delayed/tissue not collected|4
379307|NCT00262834|1211157|P1|Overall Study|Surgery delayed/tissue not collected|1
379308|NCT00262743|1211167|P2|Overall Study|Disease progression|3
379309|NCT00262743|1211168|P1|Overall Study|Disease progression|0
379310|NCT00262743|1211167|P2|Overall Study|Adverse Event|9
379311|NCT00262743|1211168|P1|Overall Study|Adverse Event|0
379312|NCT00262600|1211203|P3|Overall Study|Not Specified|62
379313|NCT00262600|1211204|P2|Overall Study|Not Specified|59
379314|NCT00262600|1211205|P1|Overall Study|Not Specified|58
379315|NCT00262600|1211203|P3|Overall Study|Not Treated|24
379316|NCT00262600|1211204|P2|Overall Study|Not Treated|17
379317|NCT00262600|1211205|P1|Overall Study|Not Treated|32
379318|NCT00262600|1211203|P3|Overall Study|Withdrawal by Subject|139
379319|NCT00262600|1211204|P2|Overall Study|Withdrawal by Subject|145
379320|NCT00262600|1211205|P1|Overall Study|Withdrawal by Subject|128
379321|NCT00262600|1211203|P3|Overall Study|Lost to Follow-up|41
379322|NCT00262600|1211204|P2|Overall Study|Lost to Follow-up|31
379323|NCT00262600|1211205|P1|Overall Study|Lost to Follow-up|17
379324|NCT00262522|1211232|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
379325|NCT00262522|1211233|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
379326|NCT00262522|1211234|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
379327|NCT00262522|1211235|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
379328|NCT00262522|1211232|P4|Study Start Through 96 Weeks|Virologic failure|0
379329|NCT00262522|1211233|P3|Study Start Through 96 Weeks|Virologic failure|8
379330|NCT00262522|1211234|P2|Study Start Through 96 Weeks|Virologic failure|0
379331|NCT00262522|1211235|P1|Study Start Through 96 Weeks|Virologic failure|5
379332|NCT00262522|1211232|P4|Study Start Through 96 Weeks|Death|0
379333|NCT00262522|1211233|P3|Study Start Through 96 Weeks|Death|2
379334|NCT00262522|1211234|P2|Study Start Through 96 Weeks|Death|0
379335|NCT00262522|1211235|P1|Study Start Through 96 Weeks|Death|2
379336|NCT00262522|1211232|P4|Study Start Through 96 Weeks|Noncompliance|0
379337|NCT00262522|1211233|P3|Study Start Through 96 Weeks|Noncompliance|11
379338|NCT00262522|1211234|P2|Study Start Through 96 Weeks|Noncompliance|0
379339|NCT00262522|1211235|P1|Study Start Through 96 Weeks|Noncompliance|6
379340|NCT00262522|1211232|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
379341|NCT00262522|1211233|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
379342|NCT00262522|1211234|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
379343|NCT00262522|1211235|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
379344|NCT00262522|1211232|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
379345|NCT00262522|1211233|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
379346|NCT00262522|1211234|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
379347|NCT00262522|1211235|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
379348|NCT00262522|1211232|P4|Study Start Through 96 Weeks|Adverse Event|0
379349|NCT00262522|1211233|P3|Study Start Through 96 Weeks|Adverse Event|16
379350|NCT00262522|1211234|P2|Study Start Through 96 Weeks|Adverse Event|0
379351|NCT00262522|1211235|P1|Study Start Through 96 Weeks|Adverse Event|20
379352|NCT00262522|1211232|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
379353|NCT00262522|1211233|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
379354|NCT00262522|1211234|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
379355|NCT00262522|1211235|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
379356|NCT00262522|1211232|P4|Study Start Through 48 Weeks|Virologic failure|0
379357|NCT00262522|1211233|P3|Study Start Through 48 Weeks|Virologic failure|4
379358|NCT00262522|1211234|P2|Study Start Through 48 Weeks|Virologic failure|0
379359|NCT00262522|1211235|P1|Study Start Through 48 Weeks|Virologic failure|2
379360|NCT00262522|1211232|P4|Study Start Through 48 Weeks|Death|0
379361|NCT00262522|1211233|P3|Study Start Through 48 Weeks|Death|1
379362|NCT00262522|1211234|P2|Study Start Through 48 Weeks|Death|0
379363|NCT00262522|1211235|P1|Study Start Through 48 Weeks|Death|2
379364|NCT00262522|1211232|P4|Study Start Through 48 Weeks|Noncompliance|0
379365|NCT00262522|1211233|P3|Study Start Through 48 Weeks|Noncompliance|8
379366|NCT00262522|1211234|P2|Study Start Through 48 Weeks|Noncompliance|0
379367|NCT00262522|1211235|P1|Study Start Through 48 Weeks|Noncompliance|3
379368|NCT00262522|1211232|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
379369|NCT00262522|1211233|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
379370|NCT00262522|1211234|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
379371|NCT00262522|1211235|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
379372|NCT00262522|1211232|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
379373|NCT00262522|1211233|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
379374|NCT00262522|1211234|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
379375|NCT00262522|1211235|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
379376|NCT00262522|1211232|P4|Study Start Through 48 Weeks|Adverse Event|0
379377|NCT00262522|1211233|P3|Study Start Through 48 Weeks|Adverse Event|10
379378|NCT00262522|1211234|P2|Study Start Through 48 Weeks|Adverse Event|0
379379|NCT00262522|1211235|P1|Study Start Through 48 Weeks|Adverse Event|16
379380|NCT00262522|1211232|P4|Study Start Through 8 Weeks|Death|0
379381|NCT00262522|1211233|P3|Study Start Through 8 Weeks|Death|0
379382|NCT00262522|1211234|P2|Study Start Through 8 Weeks|Death|0
379383|NCT00262522|1211235|P1|Study Start Through 8 Weeks|Death|1
379384|NCT00262522|1211232|P4|Study Start Through 8 Weeks|Noncompliance|2
379385|NCT00262522|1211233|P3|Study Start Through 8 Weeks|Noncompliance|2
379386|NCT00262522|1211234|P2|Study Start Through 8 Weeks|Noncompliance|0
379387|NCT00262522|1211235|P1|Study Start Through 8 Weeks|Noncompliance|0
379388|NCT00262522|1211232|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
379389|NCT00262522|1211233|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
379390|NCT00262522|1211234|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
379391|NCT00262522|1211235|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
379392|NCT00262522|1211232|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
379393|NCT00262522|1211233|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
379394|NCT00262522|1211234|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
379395|NCT00262522|1211235|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
379396|NCT00262522|1211232|P4|Study Start Through 8 Weeks|Adverse Event|1
379397|NCT00262522|1211233|P3|Study Start Through 8 Weeks|Adverse Event|3
379398|NCT00262522|1211234|P2|Study Start Through 8 Weeks|Adverse Event|2
379399|NCT00262522|1211235|P1|Study Start Through 8 Weeks|Adverse Event|1
379400|NCT00262314|1211264|P1|Overall Study|Administrative withdrawal|30
379401|NCT00262314|1211264|P1|Overall Study|Lost to Follow-up|70
379402|NCT00262314|1211264|P1|Overall Study|Not specified|95
379403|NCT00262314|1211264|P1|Overall Study|Patient's decision|92
379404|NCT00262314|1211264|P1|Overall Study|Death|12
379405|NCT00262314|1211264|P1|Overall Study|Changing physicians|38
379406|NCT00262301|1211282|P3|Double-blind Phase|"worsening of HAE symptoms"|0
379407|NCT00262301|1211283|P2|Double-blind Phase|"worsening of HAE symptoms"|1
379408|NCT00262301|1211284|P1|Double-blind Phase|"worsening of HAE symptoms"|0
379409|NCT00262301|1211282|P3|Double-blind Phase|Lost to Follow-up|0
379410|NCT00262301|1211283|P2|Double-blind Phase|Lost to Follow-up|0
379411|NCT00262301|1211284|P1|Double-blind Phase|Lost to Follow-up|1
379412|NCT00262223|1211297|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
379413|NCT00262223|1211298|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
379414|NCT00262223|1211297|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
379415|NCT00262223|1211298|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
379416|NCT00262223|1211297|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
379417|NCT00262223|1211298|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
379418|NCT00262223|1211297|P2|Treatment Phase|Adverse Event|2
379419|NCT00262223|1211298|P1|Treatment Phase|Adverse Event|1
379420|NCT00262223|1211297|P2|Treatment Phase|Withdrawal by Subject|6
379421|NCT00262223|1211298|P1|Treatment Phase|Withdrawal by Subject|3
379422|NCT00262119|1211309|P3|Overall Study|Death|16
379423|NCT00262119|1211310|P2|Overall Study|Death|19
379424|NCT00262119|1211311|P1|Overall Study|Death|20
379425|NCT00262119|1211309|P3|Overall Study|Lost to Follow-up|42
379426|NCT00262119|1211310|P2|Overall Study|Lost to Follow-up|51
379427|NCT00262119|1211311|P1|Overall Study|Lost to Follow-up|38
379428|NCT00262080|1211331|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
379429|NCT00262080|1211332|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
379430|NCT00262080|1211333|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
379431|NCT00262080|1211331|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
379432|NCT00262080|1211332|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
379433|NCT00262080|1211333|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
379434|NCT00262080|1211331|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
379435|NCT00262080|1211332|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
379436|NCT00262080|1211333|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
379437|NCT00262080|1211331|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
379438|NCT00262080|1211332|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
379439|NCT00262080|1211333|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
379440|NCT00262080|1211331|P3|Repeat Dose Treatment Period|Adverse Event|0
379441|NCT00262080|1211332|P2|Repeat Dose Treatment Period|Adverse Event|0
379442|NCT00262080|1211333|P1|Repeat Dose Treatment Period|Adverse Event|1
379443|NCT00262080|1211331|P3|Double Blind Treatment Period|Lost to Follow-up|0
379444|NCT00262080|1211332|P2|Double Blind Treatment Period|Lost to Follow-up|0
379445|NCT00262080|1211333|P1|Double Blind Treatment Period|Lost to Follow-up|1
379446|NCT00262067|1211353|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
379447|NCT00262067|1211354|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
379448|NCT00262067|1211355|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
379449|NCT00262067|1211356|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
379450|NCT00262067|1211353|P4|Overall Study|Sponsor's Decision to Terminate Study|0
379451|NCT00262067|1211354|P3|Overall Study|Sponsor's Decision to Terminate Study|0
379452|NCT00262067|1211355|P2|Overall Study|Sponsor's Decision to Terminate Study|0
379453|NCT00262067|1211356|P1|Overall Study|Sponsor's Decision to Terminate Study|1
379454|NCT00262067|1211353|P4|Overall Study|Lost to Follow-up|5
379455|NCT00262067|1211354|P3|Overall Study|Lost to Follow-up|7
379456|NCT00262067|1211355|P2|Overall Study|Lost to Follow-up|4
379457|NCT00262067|1211356|P1|Overall Study|Lost to Follow-up|5
379458|NCT00262067|1211353|P4|Overall Study|Death|99
379459|NCT00262067|1211354|P3|Overall Study|Death|186
379460|NCT00262067|1211355|P2|Overall Study|Death|89
379461|NCT00262067|1211356|P1|Overall Study|Death|190
379462|NCT00262041|1211390|P3|Overall Study|Unable to classify|0
379463|NCT00262041|1211391|P2|Overall Study|Unable to classify|0
379464|NCT00262041|1211392|P1|Overall Study|Unable to classify|1
379465|NCT00262041|1211390|P3|Overall Study|Lost to Follow-up|5
379466|NCT00262041|1211391|P2|Overall Study|Lost to Follow-up|1
379467|NCT00262041|1211392|P1|Overall Study|Lost to Follow-up|1
379468|NCT00262041|1211390|P3|Overall Study|Withdrawal by Subject|1
379469|NCT00262041|1211391|P2|Overall Study|Withdrawal by Subject|3
379470|NCT00262041|1211392|P1|Overall Study|Withdrawal by Subject|0
379471|NCT00262028|1211421|P9|Overall Study|Unable to classify|1
379472|NCT00262028|1211422|P8|Overall Study|Unable to classify|0
379473|NCT00262028|1211423|P7|Overall Study|Unable to classify|0
379474|NCT00262028|1211424|P6|Overall Study|Unable to classify|0
379475|NCT00262028|1211425|P5|Overall Study|Unable to classify|0
379476|NCT00262028|1211426|P4|Overall Study|Unable to classify|0
379477|NCT00262028|1211427|P3|Overall Study|Unable to classify|0
379478|NCT00262028|1211428|P2|Overall Study|Unable to classify|3
379479|NCT00262028|1211429|P1|Overall Study|Unable to classify|0
379480|NCT00262028|1211421|P9|Overall Study|Protocol Violation|0
379481|NCT00262028|1211422|P8|Overall Study|Protocol Violation|0
379482|NCT00262028|1211423|P7|Overall Study|Protocol Violation|0
379483|NCT00262028|1211424|P6|Overall Study|Protocol Violation|0
379484|NCT00262028|1211425|P5|Overall Study|Protocol Violation|0
379485|NCT00262028|1211426|P4|Overall Study|Protocol Violation|1
379486|NCT00262028|1211427|P3|Overall Study|Protocol Violation|0
379487|NCT00262028|1211428|P2|Overall Study|Protocol Violation|0
379488|NCT00262028|1211429|P1|Overall Study|Protocol Violation|0
379489|NCT00262028|1211421|P9|Overall Study|Administrative Reason|10
379490|NCT00262028|1211422|P8|Overall Study|Administrative Reason|6
379491|NCT00262028|1211423|P7|Overall Study|Administrative Reason|4
379492|NCT00262028|1211424|P6|Overall Study|Administrative Reason|7
379493|NCT00262028|1211425|P5|Overall Study|Administrative Reason|6
379494|NCT00262028|1211426|P4|Overall Study|Administrative Reason|12
379495|NCT00262028|1211427|P3|Overall Study|Administrative Reason|9
379496|NCT00262028|1211428|P2|Overall Study|Administrative Reason|14
379497|NCT00262028|1211429|P1|Overall Study|Administrative Reason|11
379498|NCT00262028|1211421|P9|Overall Study|Lost to Follow-up|6
379499|NCT00262028|1211422|P8|Overall Study|Lost to Follow-up|5
379500|NCT00262028|1211423|P7|Overall Study|Lost to Follow-up|3
379501|NCT00262028|1211424|P6|Overall Study|Lost to Follow-up|3
379502|NCT00262028|1211425|P5|Overall Study|Lost to Follow-up|4
379503|NCT00262028|1211426|P4|Overall Study|Lost to Follow-up|5
379504|NCT00262028|1211427|P3|Overall Study|Lost to Follow-up|5
379505|NCT00262028|1211428|P2|Overall Study|Lost to Follow-up|7
379506|NCT00262028|1211429|P1|Overall Study|Lost to Follow-up|7
379507|NCT00262028|1211421|P9|Overall Study|Withdrawal by Subject|2
379508|NCT00262028|1211422|P8|Overall Study|Withdrawal by Subject|7
379509|NCT00262028|1211423|P7|Overall Study|Withdrawal by Subject|5
379510|NCT00262028|1211424|P6|Overall Study|Withdrawal by Subject|3
379511|NCT00262028|1211425|P5|Overall Study|Withdrawal by Subject|2
379512|NCT00262028|1211426|P4|Overall Study|Withdrawal by Subject|5
379513|NCT00262028|1211427|P3|Overall Study|Withdrawal by Subject|6
379514|NCT00262028|1211428|P2|Overall Study|Withdrawal by Subject|3
379515|NCT00262028|1211429|P1|Overall Study|Withdrawal by Subject|6
379516|NCT00262002|1211491|P7|Overall Study|Unable to classify|2
379517|NCT00262002|1211492|P6|Overall Study|Unable to classify|0
379518|NCT00262002|1211493|P5|Overall Study|Unable to classify|0
379519|NCT00262002|1211494|P4|Overall Study|Unable to classify|0
379520|NCT00262002|1211495|P3|Overall Study|Unable to classify|0
379521|NCT00262002|1211496|P2|Overall Study|Unable to classify|0
379522|NCT00262002|1211497|P1|Overall Study|Unable to classify|0
379523|NCT00262002|1211491|P7|Overall Study|Protocol Violation|2
379524|NCT00262002|1211492|P6|Overall Study|Protocol Violation|3
379525|NCT00262002|1211493|P5|Overall Study|Protocol Violation|5
379526|NCT00262002|1211494|P4|Overall Study|Protocol Violation|2
379527|NCT00262002|1211495|P3|Overall Study|Protocol Violation|0
379528|NCT00262002|1211496|P2|Overall Study|Protocol Violation|2
379529|NCT00262002|1211497|P1|Overall Study|Protocol Violation|3
379530|NCT00262002|1211491|P7|Overall Study|Inapropriate enrollment|0
379531|NCT00262002|1211492|P6|Overall Study|Inapropriate enrollment|0
379532|NCT00262002|1211493|P5|Overall Study|Inapropriate enrollment|0
379533|NCT00262002|1211494|P4|Overall Study|Inapropriate enrollment|0
379534|NCT00262002|1211495|P3|Overall Study|Inapropriate enrollment|0
379535|NCT00262002|1211496|P2|Overall Study|Inapropriate enrollment|1
379536|NCT00262002|1211497|P1|Overall Study|Inapropriate enrollment|0
379537|NCT00262002|1211491|P7|Overall Study|Lost to Follow-up|0
379538|NCT00262002|1211492|P6|Overall Study|Lost to Follow-up|1
379539|NCT00262002|1211493|P5|Overall Study|Lost to Follow-up|0
379540|NCT00262002|1211494|P4|Overall Study|Lost to Follow-up|2
379541|NCT00262002|1211495|P3|Overall Study|Lost to Follow-up|0
379542|NCT00262002|1211496|P2|Overall Study|Lost to Follow-up|0
379543|NCT00262002|1211497|P1|Overall Study|Lost to Follow-up|2
379544|NCT00262002|1211491|P7|Overall Study|Withdrawal by Subject|2
379545|NCT00262002|1211492|P6|Overall Study|Withdrawal by Subject|2
379546|NCT00262002|1211493|P5|Overall Study|Withdrawal by Subject|2
379547|NCT00262002|1211494|P4|Overall Study|Withdrawal by Subject|1
379548|NCT00262002|1211495|P3|Overall Study|Withdrawal by Subject|0
379549|NCT00262002|1211496|P2|Overall Study|Withdrawal by Subject|2
379550|NCT00262002|1211497|P1|Overall Study|Withdrawal by Subject|4
379551|NCT00262002|1211491|P7|Overall Study|Adverse Event|0
379552|NCT00262002|1211492|P6|Overall Study|Adverse Event|1
379553|NCT00262002|1211493|P5|Overall Study|Adverse Event|0
379554|NCT00262002|1211494|P4|Overall Study|Adverse Event|0
379555|NCT00262002|1211495|P3|Overall Study|Adverse Event|0
379556|NCT00262002|1211496|P2|Overall Study|Adverse Event|1
379557|NCT00262002|1211497|P1|Overall Study|Adverse Event|2
379558|NCT00261950|1211590|P1|Overall Study|Protocol specified Criteria|11
379559|NCT00261950|1211590|P1|Overall Study|Physician Decision|1
379560|NCT00261950|1211590|P1|Overall Study|not specified|1
379561|NCT00261950|1211590|P1|Overall Study|Withdrawal by Subject|5
379562|NCT00261950|1211590|P1|Overall Study|Death|6
379563|NCT00261950|1211590|P1|Overall Study|Lost to Follow-up|2
379564|NCT00261846|1211617|P14|Part 2: Efficacy|Randomized, not treated|0
379565|NCT00261846|1211618|P13|Part 2: Efficacy|Randomized, not treated|0
379566|NCT00261846|1211619|P12|Part 2: Efficacy|Randomized, not treated|0
379567|NCT00261846|1211620|P11|Part 2: Efficacy|Randomized, not treated|0
379568|NCT00261846|1211621|P10|Part 2: Efficacy|Randomized, not treated|1
379569|NCT00261846|1211622|P9|Part 2: Efficacy|Randomized, not treated|0
379570|NCT00261846|1211623|P8|Part 2: Efficacy|Randomized, not treated|0
379571|NCT00261846|1211624|P7|Part 2: Efficacy|Randomized, not treated|0
379572|NCT00261846|1211625|P6|Part 2: Efficacy|Randomized, not treated|0
379573|NCT00261846|1211626|P5|Part 2: Efficacy|Randomized, not treated|0
379574|NCT00261846|1211627|P4|Part 2: Efficacy|Randomized, not treated|0
379575|NCT00261846|1211628|P3|Part 2: Efficacy|Randomized, not treated|0
379576|NCT00261846|1211629|P2|Part 2: Efficacy|Randomized, not treated|0
379577|NCT00261846|1211630|P1|Part 2: Efficacy|Randomized, not treated|0
379578|NCT00261846|1211617|P14|Part 2: Efficacy|Unspecified|0
379579|NCT00261846|1211618|P13|Part 2: Efficacy|Unspecified|0
379580|NCT00261846|1211619|P12|Part 2: Efficacy|Unspecified|1
379581|NCT00261846|1211620|P11|Part 2: Efficacy|Unspecified|0
379582|NCT00261846|1211621|P10|Part 2: Efficacy|Unspecified|1
379583|NCT00261846|1211622|P9|Part 2: Efficacy|Unspecified|0
379584|NCT00261846|1211623|P8|Part 2: Efficacy|Unspecified|0
379585|NCT00261846|1211624|P7|Part 2: Efficacy|Unspecified|2
379586|NCT00261846|1211625|P6|Part 2: Efficacy|Unspecified|1
379587|NCT00261846|1211626|P5|Part 2: Efficacy|Unspecified|1
379588|NCT00261846|1211627|P4|Part 2: Efficacy|Unspecified|1
379589|NCT00261846|1211628|P3|Part 2: Efficacy|Unspecified|0
379590|NCT00261846|1211629|P2|Part 2: Efficacy|Unspecified|0
379591|NCT00261846|1211630|P1|Part 2: Efficacy|Unspecified|0
379592|NCT00261846|1211617|P14|Part 2: Efficacy|Withdrawal by Subject|0
379593|NCT00261846|1211618|P13|Part 2: Efficacy|Withdrawal by Subject|0
379594|NCT00261846|1211619|P12|Part 2: Efficacy|Withdrawal by Subject|0
379595|NCT00261846|1211620|P11|Part 2: Efficacy|Withdrawal by Subject|1
379596|NCT00261846|1211621|P10|Part 2: Efficacy|Withdrawal by Subject|1
379597|NCT00261846|1211622|P9|Part 2: Efficacy|Withdrawal by Subject|0
379598|NCT00261846|1211623|P8|Part 2: Efficacy|Withdrawal by Subject|0
379599|NCT00261846|1211624|P7|Part 2: Efficacy|Withdrawal by Subject|2
379600|NCT00261846|1211625|P6|Part 2: Efficacy|Withdrawal by Subject|3
379601|NCT00261846|1211626|P5|Part 2: Efficacy|Withdrawal by Subject|3
379602|NCT00261846|1211627|P4|Part 2: Efficacy|Withdrawal by Subject|7
379603|NCT00261846|1211628|P3|Part 2: Efficacy|Withdrawal by Subject|0
379604|NCT00261846|1211629|P2|Part 2: Efficacy|Withdrawal by Subject|0
379605|NCT00261846|1211630|P1|Part 2: Efficacy|Withdrawal by Subject|0
379606|NCT00261846|1211617|P14|Part 2: Efficacy|Lost to Follow-up|0
379607|NCT00261846|1211618|P13|Part 2: Efficacy|Lost to Follow-up|1
379608|NCT00261846|1211619|P12|Part 2: Efficacy|Lost to Follow-up|1
379609|NCT00261846|1211620|P11|Part 2: Efficacy|Lost to Follow-up|1
379610|NCT00261846|1211621|P10|Part 2: Efficacy|Lost to Follow-up|3
379611|NCT00261846|1211622|P9|Part 2: Efficacy|Lost to Follow-up|0
379612|NCT00261846|1211623|P8|Part 2: Efficacy|Lost to Follow-up|1
379613|NCT00261846|1211624|P7|Part 2: Efficacy|Lost to Follow-up|0
379614|NCT00261846|1211625|P6|Part 2: Efficacy|Lost to Follow-up|4
379615|NCT00261846|1211626|P5|Part 2: Efficacy|Lost to Follow-up|3
379616|NCT00261846|1211627|P4|Part 2: Efficacy|Lost to Follow-up|7
379617|NCT00261846|1211628|P3|Part 2: Efficacy|Lost to Follow-up|0
379618|NCT00261846|1211629|P2|Part 2: Efficacy|Lost to Follow-up|0
379619|NCT00261846|1211630|P1|Part 2: Efficacy|Lost to Follow-up|0
379620|NCT00261846|1211617|P14|Part 2: Efficacy|Death|22
379621|NCT00261846|1211618|P13|Part 2: Efficacy|Death|23
379622|NCT00261846|1211619|P12|Part 2: Efficacy|Death|19
379623|NCT00261846|1211620|P11|Part 2: Efficacy|Death|15
379624|NCT00261846|1211621|P10|Part 2: Efficacy|Death|14
379625|NCT00261846|1211622|P9|Part 2: Efficacy|Death|1
379626|NCT00261846|1211623|P8|Part 2: Efficacy|Death|4
379627|NCT00261846|1211624|P7|Part 2: Efficacy|Death|7
379628|NCT00261846|1211625|P6|Part 2: Efficacy|Death|10
379629|NCT00261846|1211626|P5|Part 2: Efficacy|Death|4
379630|NCT00261846|1211627|P4|Part 2: Efficacy|Death|28
379631|NCT00261846|1211628|P3|Part 2: Efficacy|Death|0
379632|NCT00261846|1211629|P2|Part 2: Efficacy|Death|0
379633|NCT00261846|1211630|P1|Part 2: Efficacy|Death|0
379634|NCT00261846|1211617|P14|Part 2: Efficacy|Active on long term follow-up|0
379635|NCT00261846|1211618|P13|Part 2: Efficacy|Active on long term follow-up|0
379636|NCT00261846|1211619|P12|Part 2: Efficacy|Active on long term follow-up|4
379637|NCT00261846|1211620|P11|Part 2: Efficacy|Active on long term follow-up|3
379638|NCT00261846|1211621|P10|Part 2: Efficacy|Active on long term follow-up|12
379639|NCT00261846|1211622|P9|Part 2: Efficacy|Active on long term follow-up|0
379640|NCT00261846|1211623|P8|Part 2: Efficacy|Active on long term follow-up|10
379641|NCT00261846|1211624|P7|Part 2: Efficacy|Active on long term follow-up|6
379642|NCT00261846|1211625|P6|Part 2: Efficacy|Active on long term follow-up|9
379643|NCT00261846|1211626|P5|Part 2: Efficacy|Active on long term follow-up|12
379644|NCT00261846|1211627|P4|Part 2: Efficacy|Active on long term follow-up|27
379645|NCT00261846|1211628|P3|Part 2: Efficacy|Active on long term follow-up|0
379646|NCT00261846|1211629|P2|Part 2: Efficacy|Active on long term follow-up|0
379647|NCT00261846|1211630|P1|Part 2: Efficacy|Active on long term follow-up|0
379648|NCT00261846|1211617|P14|Part 2: Efficacy|Active on treatment|1
379649|NCT00261846|1211618|P13|Part 2: Efficacy|Active on treatment|2
379650|NCT00261846|1211619|P12|Part 2: Efficacy|Active on treatment|1
379651|NCT00261846|1211620|P11|Part 2: Efficacy|Active on treatment|5
379652|NCT00261846|1211621|P10|Part 2: Efficacy|Active on treatment|10
379653|NCT00261846|1211622|P9|Part 2: Efficacy|Active on treatment|1
379654|NCT00261846|1211623|P8|Part 2: Efficacy|Active on treatment|11
379655|NCT00261846|1211624|P7|Part 2: Efficacy|Active on treatment|16
379656|NCT00261846|1211625|P6|Part 2: Efficacy|Active on treatment|6
379657|NCT00261846|1211626|P5|Part 2: Efficacy|Active on treatment|37
379658|NCT00261846|1211627|P4|Part 2: Efficacy|Active on treatment|92
379659|NCT00261846|1211628|P3|Part 2: Efficacy|Active on treatment|0
379660|NCT00261846|1211629|P2|Part 2: Efficacy|Active on treatment|0
379661|NCT00261846|1211630|P1|Part 2: Efficacy|Active on treatment|0
379662|NCT00261846|1211617|P14|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379663|NCT00261846|1211618|P13|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379664|NCT00261846|1211619|P12|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379665|NCT00261846|1211620|P11|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379666|NCT00261846|1211621|P10|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379667|NCT00261846|1211622|P9|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379668|NCT00261846|1211623|P8|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379669|NCT00261846|1211624|P7|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379670|NCT00261846|1211625|P6|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379671|NCT00261846|1211626|P5|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379672|NCT00261846|1211627|P4|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
379673|NCT00261846|1211628|P3|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|12
379674|NCT00261846|1211629|P2|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|3
379675|NCT00261846|1211630|P1|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|3
379676|NCT00261833|1211846|P2|Overall Study|Not interested in being participant|1
379677|NCT00261833|1211847|P1|Overall Study|Not interested in being participant|0
379678|NCT00261833|1211846|P2|Overall Study|Missing reason|0
379679|NCT00261833|1211847|P1|Overall Study|Missing reason|1
379680|NCT00261833|1211846|P2|Overall Study|Lung transplantation|1
379681|NCT00261833|1211847|P1|Overall Study|Lung transplantation|1
379682|NCT00261833|1211846|P2|Overall Study|Suspicion of pulmonary cancer|1
379683|NCT00261833|1211847|P1|Overall Study|Suspicion of pulmonary cancer|0
379684|NCT00261833|1211846|P2|Overall Study|Protocol Violation|1
379685|NCT00261833|1211847|P1|Overall Study|Protocol Violation|0
379686|NCT00261833|1211846|P2|Overall Study|Withdrawal by Subject|7
379687|NCT00261833|1211847|P1|Overall Study|Withdrawal by Subject|5
379688|NCT00261833|1211846|P2|Overall Study|Adverse Event|4
379689|NCT00261833|1211847|P1|Overall Study|Adverse Event|1
379690|NCT00261833|1211846|P2|Overall Study|Death|3
379691|NCT00261833|1211847|P1|Overall Study|Death|1
379692|NCT00261716|1211881|P2|Overall Study|Lost to Follow-up|2
379693|NCT00261716|1211882|P1|Overall Study|Lost to Follow-up|0
379694|NCT00261716|1211881|P2|Overall Study|Withdrawal by Subject|8
379695|NCT00261716|1211882|P1|Overall Study|Withdrawal by Subject|6
379696|NCT00261495|1211902|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
379697|NCT00261495|1211903|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
379698|NCT00261495|1211902|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
379699|NCT00261495|1211903|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
379700|NCT00261495|1211902|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
379701|NCT00261495|1211903|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
379702|NCT00261495|1211902|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
379703|NCT00261495|1211903|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
379704|NCT00261495|1211902|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
379705|NCT00261495|1211903|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
379706|NCT00261495|1211902|P2|Extension Phase (Weeks 24 to 52)|Other|2
379707|NCT00261495|1211903|P1|Extension Phase (Weeks 24 to 52)|Other|4
379708|NCT00261495|1211902|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
379709|NCT00261495|1211903|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
379710|NCT00261495|1211902|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
379711|NCT00261495|1211903|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
379712|NCT00261495|1211902|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
379713|NCT00261495|1211903|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
379714|NCT00261495|1211902|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
379715|NCT00261495|1211903|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
379716|NCT00261495|1211902|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
379717|NCT00261495|1211903|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
379718|NCT00261495|1211902|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
379719|NCT00261495|1211903|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
379720|NCT00261495|1211902|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
379721|NCT00261495|1211903|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
379722|NCT00261495|1211902|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
379723|NCT00261495|1211903|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
379724|NCT00261495|1211902|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
379725|NCT00261495|1211903|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
379726|NCT00261495|1211902|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
379727|NCT00261495|1211903|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
379728|NCT00261495|1211902|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
379729|NCT00261495|1211903|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
379730|NCT00261495|1211902|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
379731|NCT00261495|1211903|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
379732|NCT00261495|1211902|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
379733|NCT00261495|1211903|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
379734|NCT00261495|1211902|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
379735|NCT00261495|1211903|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
379736|NCT00261495|1211902|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
379737|NCT00261495|1211903|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
379738|NCT00261443|1212067|P3|4: Extension Phase|Lost to Follow-up|0
379739|NCT00261443|1212068|P2|4: Extension Phase|Lost to Follow-up|1
379740|NCT00261443|1212069|P1|4: Extension Phase|Lost to Follow-up|0
379741|NCT00261443|1212067|P3|4: Extension Phase|Withdrawal by Subject|2
379742|NCT00261443|1212068|P2|4: Extension Phase|Withdrawal by Subject|1
379743|NCT00261443|1212069|P1|4: Extension Phase|Withdrawal by Subject|0
379744|NCT00261443|1212067|P3|4: Extension Phase|Adverse Event|0
379745|NCT00261443|1212068|P2|4: Extension Phase|Adverse Event|1
379746|NCT00261443|1212069|P1|4: Extension Phase|Adverse Event|0
379747|NCT00261443|1212067|P3|3: Assessment of Relapse|Other Reasons|3
379748|NCT00261443|1212068|P2|3: Assessment of Relapse|Other Reasons|4
379749|NCT00261443|1212069|P1|3: Assessment of Relapse|Other Reasons|0
379750|NCT00261443|1212067|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
379751|NCT00261443|1212068|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
379752|NCT00261443|1212069|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
379753|NCT00261443|1212067|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
379754|NCT00261443|1212068|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
379755|NCT00261443|1212069|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
379756|NCT00261443|1212067|P3|3: Assessment of Relapse|Pregnancy|1
379757|NCT00261443|1212068|P2|3: Assessment of Relapse|Pregnancy|2
379758|NCT00261443|1212069|P1|3: Assessment of Relapse|Pregnancy|0
379759|NCT00261443|1212067|P3|3: Assessment of Relapse|Poor/Noncompliance|3
379760|NCT00261443|1212068|P2|3: Assessment of Relapse|Poor/Noncompliance|5
379761|NCT00261443|1212069|P1|3: Assessment of Relapse|Poor/Noncompliance|0
379762|NCT00261443|1212067|P3|3: Assessment of Relapse|Lost to Follow-up|6
379763|NCT00261443|1212068|P2|3: Assessment of Relapse|Lost to Follow-up|7
379764|NCT00261443|1212069|P1|3: Assessment of Relapse|Lost to Follow-up|0
379765|NCT00261443|1212067|P3|3: Assessment of Relapse|Death|1
379766|NCT00261443|1212068|P2|3: Assessment of Relapse|Death|0
379767|NCT00261443|1212069|P1|3: Assessment of Relapse|Death|0
379768|NCT00261443|1212067|P3|3: Assessment of Relapse|Withdrawal by Subject|15
379769|NCT00261443|1212068|P2|3: Assessment of Relapse|Withdrawal by Subject|14
379770|NCT00261443|1212069|P1|3: Assessment of Relapse|Withdrawal by Subject|0
379771|NCT00261443|1212067|P3|3: Assessment of Relapse|Adverse Event|19
379772|NCT00261443|1212068|P2|3: Assessment of Relapse|Adverse Event|15
379773|NCT00261443|1212069|P1|3: Assessment of Relapse|Adverse Event|0
379774|NCT00261443|1212067|P3|3: Assessment of Relapse|Lack of Efficacy|14
379775|NCT00261443|1212068|P2|3: Assessment of Relapse|Lack of Efficacy|31
379776|NCT00261443|1212069|P1|3: Assessment of Relapse|Lack of Efficacy|0
379777|NCT00261443|1212067|P3|2: Stability & Maintenance of Stability|Other Reasons|0
379778|NCT00261443|1212068|P2|2: Stability & Maintenance of Stability|Other Reasons|0
379779|NCT00261443|1212069|P1|2: Stability & Maintenance of Stability|Other Reasons|13
379780|NCT00261443|1212067|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
379781|NCT00261443|1212068|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
379782|NCT00261443|1212069|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
379783|NCT00261443|1212067|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
379784|NCT00261443|1212068|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
379785|NCT00261443|1212069|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
379786|NCT00261443|1212067|P3|2: Stability & Maintenance of Stability|Pregnancy|0
379787|NCT00261443|1212068|P2|2: Stability & Maintenance of Stability|Pregnancy|0
379788|NCT00261443|1212069|P1|2: Stability & Maintenance of Stability|Pregnancy|1
379789|NCT00261443|1212067|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
379790|NCT00261443|1212068|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
379791|NCT00261443|1212069|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
379792|NCT00261443|1212067|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
379793|NCT00261443|1212068|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
379794|NCT00261443|1212069|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
379795|NCT00261443|1212067|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
379796|NCT00261443|1212068|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
379797|NCT00261443|1212069|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
379798|NCT00261443|1212067|P3|2: Stability & Maintenance of Stability|Adverse Event|0
379799|NCT00261443|1212068|P2|2: Stability & Maintenance of Stability|Adverse Event|0
379800|NCT00261443|1212069|P1|2: Stability & Maintenance of Stability|Adverse Event|93
379801|NCT00261443|1212067|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
379802|NCT00261443|1212068|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
379803|NCT00261443|1212069|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
379804|NCT00261443|1212067|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
379805|NCT00261443|1212068|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
379806|NCT00261443|1212069|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
379807|NCT00261443|1212067|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
379808|NCT00261443|1212068|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
379809|NCT00261443|1212069|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
379810|NCT00261443|1212067|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
379811|NCT00261443|1212068|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
379812|NCT00261443|1212069|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
379813|NCT00261443|1212067|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
379814|NCT00261443|1212068|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
379815|NCT00261443|1212069|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
379816|NCT00261443|1212067|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
379817|NCT00261443|1212068|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
379818|NCT00261443|1212069|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
379819|NCT00261443|1212067|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
379820|NCT00261443|1212068|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
379821|NCT00261443|1212069|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
379822|NCT00261443|1212067|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
379823|NCT00261443|1212068|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
379824|NCT00261443|1212069|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
379825|NCT00260832|1212337|P2|Overall Study|Protocol Violation|1
379826|NCT00260832|1212338|P1|Overall Study|Protocol Violation|3
379827|NCT00260832|1212337|P2|Overall Study|Not Specified|7
379828|NCT00260832|1212338|P1|Overall Study|Not Specified|10
379829|NCT00260832|1212337|P2|Overall Study|Death|62
379830|NCT00260832|1212338|P1|Overall Study|Death|43
379831|NCT00260832|1212337|P2|Overall Study|Physician Decision|9
379832|NCT00260832|1212338|P1|Overall Study|Physician Decision|15
379833|NCT00260832|1212337|P2|Overall Study|Withdrawal by Subject|17
379834|NCT00260832|1212338|P1|Overall Study|Withdrawal by Subject|15
379835|NCT00260832|1212337|P2|Overall Study|Progression|96
379836|NCT00260832|1212338|P1|Overall Study|Progression|116
379837|NCT00260832|1212337|P2|Overall Study|Adverse Event|19
379838|NCT00260832|1212338|P1|Overall Study|Adverse Event|26
379839|NCT00260533|1212365|P2|Overall Study|Not Known|3
379840|NCT00260533|1212366|P1|Overall Study|Not Known|3
379841|NCT00260429|1212374|P2|Overall Study|scheduled hand surgery|0
379842|NCT00260429|1212375|P1|Overall Study|scheduled hand surgery|1
379843|NCT00260429|1212374|P2|Overall Study|failure to follow appointments|0
379844|NCT00260429|1212375|P1|Overall Study|failure to follow appointments|1
379845|NCT00260208|1212383|P2|Overall Study|Missing|16
379846|NCT00260208|1212384|P1|Overall Study|Missing|18
379847|NCT00260208|1212383|P2|Overall Study|Death|10
379848|NCT00260208|1212384|P1|Overall Study|Death|12
379849|NCT00260208|1212383|P2|Overall Study|Lost to Follow-up|1
379850|NCT00260208|1212384|P1|Overall Study|Lost to Follow-up|6
379851|NCT00260208|1212383|P2|Overall Study|Subject withdrew consent|7
379852|NCT00260208|1212384|P1|Overall Study|Subject withdrew consent|11
379853|NCT00260065|1212427|P1|Overall Study|Medication Noncompliance|1
379854|NCT00260065|1212427|P1|Overall Study|Not otherwise specified|8
379855|NCT00260065|1212427|P1|Overall Study|Physician Decision|19
379856|NCT00260065|1212427|P1|Overall Study|Withdrawal by Subject|13
379857|NCT00260065|1212427|P1|Overall Study|Death|13
379858|NCT00260065|1212427|P1|Overall Study|Adverse Event|17
379859|NCT00260065|1212427|P1|Overall Study|Progressive Disease|22
379860|NCT00259857|1212434|P2|24 Months Treatment|Lost to Follow-up|3
379861|NCT00259857|1212435|P1|24 Months Treatment|Lost to Follow-up|0
379862|NCT00259857|1212434|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
379863|NCT00259857|1212435|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
379864|NCT00259740|1212453|P2|Overall Study|Requirement for alternative therapy|4
379865|NCT00259740|1212454|P1|Overall Study|Requirement for alternative therapy|0
379866|NCT00259740|1212453|P2|Overall Study|Other|0
379867|NCT00259740|1212454|P1|Overall Study|Other|3
379868|NCT00259740|1212453|P2|Overall Study|Ongoing|3
379869|NCT00259740|1212454|P1|Overall Study|Ongoing|17
379870|NCT00259740|1212453|P2|Overall Study|Disease progression|36
379871|NCT00259740|1212454|P1|Overall Study|Disease progression|19
379872|NCT00259740|1212453|P2|Overall Study|Death|1
379873|NCT00259740|1212454|P1|Overall Study|Death|1
379874|NCT00259740|1212453|P2|Overall Study|Withdrawal by Subject|6
379875|NCT00259740|1212454|P1|Overall Study|Withdrawal by Subject|2
379876|NCT00259740|1212453|P2|Overall Study|Adverse Event|2
379877|NCT00259740|1212454|P1|Overall Study|Adverse Event|0
379878|NCT00259740|1212453|P2|Overall Study|Physician Decision|1
379879|NCT00259740|1212454|P1|Overall Study|Physician Decision|1
379880|NCT00259649|1212464|P1|Overall Study|irregular menses|3
379881|NCT00259649|1212464|P1|Overall Study|Lost to Follow-up|7
379882|NCT00259610|1212472|P4|Overall Study|Serious Adverse Event|2
379883|NCT00259610|1212473|P3|Overall Study|Serious Adverse Event|2
379884|NCT00259610|1212474|P2|Overall Study|Serious Adverse Event|2
379885|NCT00259610|1212475|P1|Overall Study|Serious Adverse Event|8
379886|NCT00259610|1212472|P4|Overall Study|Adverse Event|2
379887|NCT00259610|1212473|P3|Overall Study|Adverse Event|5
379888|NCT00259610|1212474|P2|Overall Study|Adverse Event|4
379889|NCT00259610|1212475|P1|Overall Study|Adverse Event|3
379890|NCT00259610|1212472|P4|Overall Study|non medical reason|3
379891|NCT00259610|1212473|P3|Overall Study|non medical reason|10
379892|NCT00259610|1212474|P2|Overall Study|non medical reason|2
379893|NCT00259610|1212475|P1|Overall Study|non medical reason|6
379894|NCT00259610|1212472|P4|Overall Study|Death|0
379895|NCT00259610|1212473|P3|Overall Study|Death|2
379896|NCT00259610|1212474|P2|Overall Study|Death|1
379897|NCT00259610|1212475|P1|Overall Study|Death|1
379898|NCT00259610|1212472|P4|Overall Study|Physician Decision|2
379899|NCT00259610|1212473|P3|Overall Study|Physician Decision|7
379900|NCT00259610|1212474|P2|Overall Study|Physician Decision|4
379901|NCT00259610|1212475|P1|Overall Study|Physician Decision|6
379902|NCT00259610|1212472|P4|Overall Study|Lost to Follow-up|15
379903|NCT00259610|1212473|P3|Overall Study|Lost to Follow-up|18
379904|NCT00259610|1212474|P2|Overall Study|Lost to Follow-up|8
379905|NCT00259610|1212475|P1|Overall Study|Lost to Follow-up|19
379906|NCT00259610|1212472|P4|Overall Study|Withdrawal by Subject|19
379907|NCT00259610|1212473|P3|Overall Study|Withdrawal by Subject|29
379908|NCT00259610|1212474|P2|Overall Study|Withdrawal by Subject|25
379909|NCT00259610|1212475|P1|Overall Study|Withdrawal by Subject|33
379910|NCT00259298|1212489|P1|Overall Study|Physician Decision|2
379911|NCT00259298|1212489|P1|Overall Study|Withdrawal by Subject|1
379912|NCT00259272|1212507|P4|Overall Study|Lost to Follow-up|1
379913|NCT00259272|1212508|P3|Overall Study|Lost to Follow-up|0
379914|NCT00259272|1212509|P2|Overall Study|Lost to Follow-up|0
379915|NCT00259272|1212510|P1|Overall Study|Lost to Follow-up|1
379916|NCT00259272|1212507|P4|Overall Study|Withdrawal by Subject|7
379917|NCT00259272|1212508|P3|Overall Study|Withdrawal by Subject|2
379918|NCT00259272|1212509|P2|Overall Study|Withdrawal by Subject|2
379919|NCT00259272|1212510|P1|Overall Study|Withdrawal by Subject|4
379920|NCT00259272|1212507|P4|Overall Study|Sponsor Decision|0
379921|NCT00259272|1212508|P3|Overall Study|Sponsor Decision|0
379922|NCT00259272|1212509|P2|Overall Study|Sponsor Decision|1
379923|NCT00259272|1212510|P1|Overall Study|Sponsor Decision|0
379924|NCT00259272|1212507|P4|Overall Study|Protocol Violation|1
379925|NCT00259272|1212508|P3|Overall Study|Protocol Violation|0
379926|NCT00259272|1212509|P2|Overall Study|Protocol Violation|0
379927|NCT00259272|1212510|P1|Overall Study|Protocol Violation|2
379928|NCT00259272|1212507|P4|Overall Study|Physician Decision|3
379929|NCT00259272|1212508|P3|Overall Study|Physician Decision|1
379930|NCT00259272|1212509|P2|Overall Study|Physician Decision|2
379931|NCT00259272|1212510|P1|Overall Study|Physician Decision|1
379932|NCT00259272|1212507|P4|Overall Study|Lack of Efficacy|6
379933|NCT00259272|1212508|P3|Overall Study|Lack of Efficacy|2
379934|NCT00259272|1212509|P2|Overall Study|Lack of Efficacy|1
379935|NCT00259272|1212510|P1|Overall Study|Lack of Efficacy|5
379936|NCT00259272|1212507|P4|Overall Study|Adverse Event|3
379937|NCT00259272|1212508|P3|Overall Study|Adverse Event|0
379938|NCT00259272|1212509|P2|Overall Study|Adverse Event|1
379939|NCT00259272|1212510|P1|Overall Study|Adverse Event|2
379940|NCT00259012|1212606|P2|Overall Study|Protocol Violation|1
379941|NCT00259012|1212607|P1|Overall Study|Protocol Violation|1
379942|NCT00259012|1212606|P2|Overall Study|Lost to Follow-up|1
379943|NCT00259012|1212607|P1|Overall Study|Lost to Follow-up|0
379944|NCT00259012|1212606|P2|Overall Study|Physician Decision|1
379945|NCT00259012|1212607|P1|Overall Study|Physician Decision|0
379946|NCT00259012|1212606|P2|Overall Study|Withdrawal by Subject|0
379947|NCT00259012|1212607|P1|Overall Study|Withdrawal by Subject|1
379948|NCT00259012|1212606|P2|Overall Study|Adverse Event|1
379949|NCT00259012|1212607|P1|Overall Study|Adverse Event|0
379950|NCT00258895|1212647|P2|Overall Study|Withdrawal by Subject|0
379951|NCT00258895|1212648|P1|Overall Study|Withdrawal by Subject|1
379952|NCT00258895|1212647|P2|Overall Study|Protocol Violation|2
379953|NCT00258895|1212648|P1|Overall Study|Protocol Violation|6
379954|NCT00258895|1212647|P2|Overall Study|Lost to Follow-up|1
379955|NCT00258895|1212648|P1|Overall Study|Lost to Follow-up|3
379956|NCT00258856|1212684|P4|Overall Study|Non-compliance|1
379957|NCT00258856|1212685|P3|Overall Study|Non-compliance|0
379958|NCT00258856|1212686|P2|Overall Study|Non-compliance|0
379959|NCT00258856|1212687|P1|Overall Study|Non-compliance|2
379960|NCT00258856|1212684|P4|Overall Study|Lost to Follow-up|0
379961|NCT00258856|1212685|P3|Overall Study|Lost to Follow-up|2
379962|NCT00258856|1212686|P2|Overall Study|Lost to Follow-up|0
379963|NCT00258856|1212687|P1|Overall Study|Lost to Follow-up|1
379964|NCT00258674|1212728|P3|Overall Study|Death|34
379965|NCT00258674|1212729|P2|Overall Study|Death|53
379966|NCT00258674|1212730|P1|Overall Study|Death|32
379967|NCT00258440|1212789|P3|Overall Study|Withdrawal by Subject|1
379968|NCT00258440|1212790|P2|Overall Study|Withdrawal by Subject|0
379969|NCT00258440|1212791|P1|Overall Study|Withdrawal by Subject|0
379970|NCT00258154|1212824|P2|Overall Study|Patient Moved|1
379971|NCT00258154|1212825|P1|Overall Study|Patient Moved|3
379972|NCT00258154|1212824|P2|Overall Study|Withdrawal by Subject|4
379973|NCT00258154|1212825|P1|Overall Study|Withdrawal by Subject|3
379974|NCT00258154|1212824|P2|Overall Study|Protocol Violation|1
379975|NCT00258154|1212825|P1|Overall Study|Protocol Violation|2
379976|NCT00258154|1212824|P2|Overall Study|Lost to Follow-up|1
379977|NCT00258154|1212825|P1|Overall Study|Lost to Follow-up|0
379978|NCT00258154|1212824|P2|Overall Study|Adverse Event|0
379979|NCT00258154|1212825|P1|Overall Study|Adverse Event|1
379980|NCT00257920|1212909|P2|Period: Second Intervention|Other|1
379981|NCT00257920|1212910|P1|Period: Second Intervention|Other|2
379982|NCT00257920|1212909|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
379983|NCT00257920|1212910|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
379984|NCT00257660|1212966|P2|Overall Study|No longer wanted to do blood draws|0
379985|NCT00257660|1212967|P1|Overall Study|No longer wanted to do blood draws|1
379986|NCT00257660|1212966|P2|Overall Study|PI & Subject Schedule Conflicts|0
379987|NCT00257660|1212967|P1|Overall Study|PI & Subject Schedule Conflicts|1
379988|NCT00257660|1212966|P2|Overall Study|Lost to Follow-up|0
379989|NCT00257660|1212967|P1|Overall Study|Lost to Follow-up|1
379990|NCT00257660|1212966|P2|Overall Study|Withdrawal by Subject|0
379991|NCT00257660|1212967|P1|Overall Study|Withdrawal by Subject|2
379992|NCT00257660|1212966|P2|Overall Study|Lack of Efficacy|23
379993|NCT00257660|1212967|P1|Overall Study|Lack of Efficacy|5
379994|NCT00257608|1212997|P3|Post Chemotherapy Phase|Not treated|7
379995|NCT00257608|1212998|P2|Post Chemotherapy Phase|Not treated|4
379996|NCT00257608|1212999|P1|Post Chemotherapy Phase|Not treated|0
379997|NCT00257608|1212997|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
379998|NCT00257608|1212998|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
379999|NCT00257608|1212999|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
380000|NCT00257608|1212997|P3|Post Chemotherapy Phase|Physician Decision|11
380001|NCT00257608|1212998|P2|Post Chemotherapy Phase|Physician Decision|8
380002|NCT00257608|1212999|P1|Post Chemotherapy Phase|Physician Decision|0
380003|NCT00257608|1212997|P3|Post Chemotherapy Phase|Lost to Follow-up|1
380004|NCT00257608|1212998|P2|Post Chemotherapy Phase|Lost to Follow-up|0
380005|NCT00257608|1212999|P1|Post Chemotherapy Phase|Lost to Follow-up|0
380006|NCT00257608|1212997|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
380007|NCT00257608|1212998|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
380008|NCT00257608|1212999|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
380009|NCT00257608|1212997|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
380010|NCT00257608|1212998|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
380011|NCT00257608|1212999|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
380012|NCT00257608|1212997|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
380013|NCT00257608|1212998|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
380014|NCT00257608|1212999|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
380015|NCT00257608|1212997|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
380016|NCT00257608|1212998|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
380017|NCT00257608|1212999|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
380018|NCT00257608|1212997|P3|Post Chemotherapy Phase|Disease progression|168
380019|NCT00257608|1212998|P2|Post Chemotherapy Phase|Disease progression|204
380020|NCT00257608|1212999|P1|Post Chemotherapy Phase|Disease progression|0
380021|NCT00257608|1212997|P3|Post Chemotherapy Phase|Adverse Event|38
380022|NCT00257608|1212998|P2|Post Chemotherapy Phase|Adverse Event|34
380023|NCT00257608|1212999|P1|Post Chemotherapy Phase|Adverse Event|0
380024|NCT00257608|1212997|P3|Chemotherapy Phase|Physician Decision|0
380025|NCT00257608|1212998|P2|Chemotherapy Phase|Physician Decision|0
380026|NCT00257608|1212999|P1|Chemotherapy Phase|Physician Decision|28
380027|NCT00257608|1212997|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
380028|NCT00257608|1212998|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
380029|NCT00257608|1212999|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
380030|NCT00257608|1212997|P3|Chemotherapy Phase|Patient's decision to discontinue|0
380031|NCT00257608|1212998|P2|Chemotherapy Phase|Patient's decision to discontinue|0
380032|NCT00257608|1212999|P1|Chemotherapy Phase|Patient's decision to discontinue|35
380033|NCT00257608|1212997|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
380034|NCT00257608|1212998|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
380035|NCT00257608|1212999|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
380036|NCT00257608|1212997|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
380037|NCT00257608|1212998|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
380038|NCT00257608|1212999|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
380039|NCT00257608|1212997|P3|Chemotherapy Phase|Disease progression|0
380040|NCT00257608|1212998|P2|Chemotherapy Phase|Disease progression|0
380041|NCT00257608|1212999|P1|Chemotherapy Phase|Disease progression|139
380042|NCT00257608|1212997|P3|Chemotherapy Phase|Adverse Event|0
380043|NCT00257608|1212998|P2|Chemotherapy Phase|Adverse Event|0
380044|NCT00257608|1212999|P1|Chemotherapy Phase|Adverse Event|138
380045|NCT00257556|1213025|P2|Overall Study|other reason|6
380046|NCT00257556|1213026|P1|Overall Study|other reason|4
380047|NCT00257556|1213025|P2|Overall Study|Did not meet hCG criterion|0
380048|NCT00257556|1213026|P1|Overall Study|Did not meet hCG criterion|3
380049|NCT00257556|1213025|P2|Overall Study|Physician Decision|0
380050|NCT00257556|1213026|P1|Overall Study|Physician Decision|6
380051|NCT00257556|1213025|P2|Overall Study|Adverse Event|4
380052|NCT00257556|1213026|P1|Overall Study|Adverse Event|1
380053|NCT00257192|1213070|P2|Overall Study|Miscellaneous|4
380054|NCT00257192|1213071|P1|Overall Study|Miscellaneous|0
380055|NCT00257192|1213070|P2|Overall Study|Study terminated by sponsor|0
380056|NCT00257192|1213071|P1|Overall Study|Study terminated by sponsor|1
380057|NCT00257192|1213070|P2|Overall Study|Randomized but not treated|1
380058|NCT00257192|1213071|P1|Overall Study|Randomized but not treated|0
380059|NCT00257192|1213070|P2|Overall Study|Withdrawal by Subject|2
380060|NCT00257192|1213071|P1|Overall Study|Withdrawal by Subject|14
380061|NCT00257192|1213070|P2|Overall Study|Insufficient clinical response|18
380062|NCT00257192|1213071|P1|Overall Study|Insufficient clinical response|18
380063|NCT00257192|1213070|P2|Overall Study|Lost to Follow-up|3
380064|NCT00257192|1213071|P1|Overall Study|Lost to Follow-up|3
380065|NCT00257192|1213070|P2|Overall Study|Laboratory abnormality|1
380066|NCT00257192|1213071|P1|Overall Study|Laboratory abnormality|1
380067|NCT00257192|1213070|P2|Overall Study|Adverse Event|10
380068|NCT00257192|1213071|P1|Overall Study|Adverse Event|21
380069|NCT00257166|1213115|P2|Overall Study|Randomized, but not treated|0
380070|NCT00257166|1213116|P1|Overall Study|Randomized, but not treated|1
380071|NCT00257166|1213115|P2|Overall Study|Unspecified|21
380072|NCT00257166|1213116|P1|Overall Study|Unspecified|16
380073|NCT00257166|1213115|P2|Overall Study|Withdrawal by Subject|2
380074|NCT00257166|1213116|P1|Overall Study|Withdrawal by Subject|9
380075|NCT00257166|1213115|P2|Overall Study|Lost to Follow-up|1
380076|NCT00257166|1213116|P1|Overall Study|Lost to Follow-up|8
380077|NCT00257166|1213115|P2|Overall Study|Laboratory abnormality|0
380078|NCT00257166|1213116|P1|Overall Study|Laboratory abnormality|1
380079|NCT00257166|1213115|P2|Overall Study|Adverse Event|13
380080|NCT00257166|1213116|P1|Overall Study|Adverse Event|18
380081|NCT00257010|1213128|P1|Overall Study|no headache reported|9
380082|NCT00257010|1213128|P1|Overall Study|various|11
380083|NCT00257010|1213128|P1|Overall Study|Adverse Event|10
380084|NCT00257010|1213128|P1|Overall Study|Withdrawal by Subject|34
380085|NCT00257010|1213128|P1|Overall Study|Lost to Follow-up|53
380086|NCT00257010|1213128|P1|Overall Study|Lack of Efficacy|11
380087|NCT00256997|1213139|P2|Overall Study|Investigator Withdrew Participant|1
380088|NCT00256997|1213140|P1|Overall Study|Investigator Withdrew Participant|2
380089|NCT00256997|1213139|P2|Overall Study|Participant Non-compliant|6
380090|NCT00256997|1213140|P1|Overall Study|Participant Non-compliant|3
380091|NCT00256997|1213139|P2|Overall Study|End of Study (As Per Sponsor)|24
380092|NCT00256997|1213140|P1|Overall Study|End of Study (As Per Sponsor)|12
380093|NCT00256997|1213139|P2|Overall Study|Unspecified|8
380094|NCT00256997|1213140|P1|Overall Study|Unspecified|5
380095|NCT00256997|1213139|P2|Overall Study|Started but not treated|0
380096|NCT00256997|1213140|P1|Overall Study|Started but not treated|2
380097|NCT00256997|1213139|P2|Overall Study|Withdrawal by Subject|3
380098|NCT00256997|1213140|P1|Overall Study|Withdrawal by Subject|13
380099|NCT00256997|1213139|P2|Overall Study|Lost to Follow-up|5
380100|NCT00256997|1213140|P1|Overall Study|Lost to Follow-up|3
380101|NCT00256997|1213139|P2|Overall Study|Adverse Event|0
380102|NCT00256997|1213140|P1|Overall Study|Adverse Event|4
380103|NCT00256997|1213139|P2|Overall Study|Death|0
380104|NCT00256997|1213140|P1|Overall Study|Death|2
380105|NCT00256997|1213139|P2|Overall Study|Lack of Efficacy|4
380106|NCT00256997|1213140|P1|Overall Study|Lack of Efficacy|1
380107|NCT00256997|1213139|P2|Overall Study|Protocol Violation|4
380108|NCT00256997|1213140|P1|Overall Study|Protocol Violation|1
380109|NCT00256750|1213177|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
380110|NCT00256750|1213178|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
380111|NCT00256750|1213179|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
380112|NCT00256750|1213177|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
380113|NCT00256750|1213178|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
380114|NCT00256750|1213179|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
380115|NCT00256750|1213177|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
380116|NCT00256750|1213178|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
380117|NCT00256750|1213179|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
380118|NCT00256750|1213177|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
380119|NCT00256750|1213178|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
380120|NCT00256750|1213179|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
380121|NCT00256750|1213177|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
380122|NCT00256750|1213178|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
380123|NCT00256750|1213179|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
380124|NCT00256750|1213177|P3|Long Term Extension (LTE; 84 Months)|Death|4
380125|NCT00256750|1213178|P2|Long Term Extension (LTE; 84 Months)|Death|4
380126|NCT00256750|1213179|P1|Long Term Extension (LTE; 84 Months)|Death|9
380127|NCT00256750|1213177|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
380128|NCT00256750|1213178|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
380129|NCT00256750|1213179|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
380130|NCT00256750|1213177|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
380131|NCT00256750|1213178|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
380132|NCT00256750|1213179|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
380133|NCT00256750|1213177|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
380134|NCT00256750|1213178|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
380135|NCT00256750|1213179|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
380136|NCT00256750|1213177|P3|Post-Transplant Treated (36 Months)|Not specified|1
380137|NCT00256750|1213178|P2|Post-Transplant Treated (36 Months)|Not specified|1
380138|NCT00256750|1213179|P1|Post-Transplant Treated (36 Months)|Not specified|0
380139|NCT00256750|1213177|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
380140|NCT00256750|1213178|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
380141|NCT00256750|1213179|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
380142|NCT00256750|1213177|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
380143|NCT00256750|1213178|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
380144|NCT00256750|1213179|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
380145|NCT00256750|1213177|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
380146|NCT00256750|1213178|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
380147|NCT00256750|1213179|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
380148|NCT00256750|1213177|P3|Post-Transplant Treated (36 Months)|Death|1
380149|NCT00256750|1213178|P2|Post-Transplant Treated (36 Months)|Death|2
380150|NCT00256750|1213179|P1|Post-Transplant Treated (36 Months)|Death|0
380151|NCT00256750|1213177|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
380152|NCT00256750|1213178|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
380153|NCT00256750|1213179|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
380154|NCT00256750|1213177|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
380155|NCT00256750|1213178|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
380156|NCT00256750|1213179|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
380157|NCT00256750|1213177|P3|Post-Transplant Treated (24 Months)|Not Specified|1
380158|NCT00256750|1213178|P2|Post-Transplant Treated (24 Months)|Not Specified|0
380159|NCT00256750|1213179|P1|Post-Transplant Treated (24 Months)|Not Specified|2
380160|NCT00256750|1213177|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
380161|NCT00256750|1213178|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
380162|NCT00256750|1213179|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
380163|NCT00256750|1213177|P3|Post-Transplant Treated (24 Months)|Death|0
380164|NCT00256750|1213178|P2|Post-Transplant Treated (24 Months)|Death|0
380165|NCT00256750|1213179|P1|Post-Transplant Treated (24 Months)|Death|3
380166|NCT00256750|1213177|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
380167|NCT00256750|1213178|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
380168|NCT00256750|1213179|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
380169|NCT00256750|1213177|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
380170|NCT00256750|1213178|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
380171|NCT00256750|1213179|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
380172|NCT00256750|1213177|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
380173|NCT00256750|1213178|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
380174|NCT00256750|1213179|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
380175|NCT00256750|1213177|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
380176|NCT00256750|1213178|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
380177|NCT00256750|1213179|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
380178|NCT00256750|1213177|P3|Post-Transplant Treated (12 Months)|Not Specified|2
380179|NCT00256750|1213178|P2|Post-Transplant Treated (12 Months)|Not Specified|4
380180|NCT00256750|1213179|P1|Post-Transplant Treated (12 Months)|Not Specified|5
380181|NCT00256750|1213177|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
380182|NCT00256750|1213178|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
380183|NCT00256750|1213179|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
380184|NCT00256750|1213177|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
380185|NCT00256750|1213178|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
380186|NCT00256750|1213179|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
380187|NCT00256750|1213177|P3|Post-Transplant Treated (12 Months)|Death|4
380188|NCT00256750|1213178|P2|Post-Transplant Treated (12 Months)|Death|2
380189|NCT00256750|1213179|P1|Post-Transplant Treated (12 Months)|Death|3
380190|NCT00256750|1213177|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
380191|NCT00256750|1213178|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
380192|NCT00256750|1213179|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
380193|NCT00256750|1213177|P3|Transplanted Pre-Treatment|Death|0
380194|NCT00256750|1213178|P2|Transplanted Pre-Treatment|Death|0
380195|NCT00256750|1213179|P1|Transplanted Pre-Treatment|Death|1
380196|NCT00256750|1213177|P3|Transplanted Pre-Treatment|Not Specified|0
380197|NCT00256750|1213178|P2|Transplanted Pre-Treatment|Not Specified|0
380198|NCT00256750|1213179|P1|Transplanted Pre-Treatment|Not Specified|2
380199|NCT00256750|1213177|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
380200|NCT00256750|1213178|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
380201|NCT00256750|1213179|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
380202|NCT00256724|1213315|P2|Overall Study|Protocol Violation|3
380203|NCT00256724|1213316|P1|Overall Study|Protocol Violation|3
380204|NCT00256724|1213315|P2|Overall Study|Physician Decision|5
380205|NCT00256724|1213316|P1|Overall Study|Physician Decision|2
380206|NCT00256698|1213326|P2|Overall Study|Prematurely Discontinued|0
380207|NCT00256698|1213327|P1|Overall Study|Prematurely Discontinued|1
380208|NCT00256698|1213326|P2|Overall Study|withdrawn due to osteoporosis|0
380209|NCT00256698|1213327|P1|Overall Study|withdrawn due to osteoporosis|1
380210|NCT00256698|1213326|P2|Overall Study|still ongoing at data cut-off|46
380211|NCT00256698|1213327|P1|Overall Study|still ongoing at data cut-off|41
380212|NCT00256698|1213326|P2|Overall Study|disease progression|105
380213|NCT00256698|1213327|P1|Overall Study|disease progression|97
380214|NCT00256698|1213326|P2|Overall Study|Lost to Follow-up|3
380215|NCT00256698|1213327|P1|Overall Study|Lost to Follow-up|1
380216|NCT00256698|1213326|P2|Overall Study|Protocol Violation|5
380217|NCT00256698|1213327|P1|Overall Study|Protocol Violation|6
380218|NCT00256698|1213326|P2|Overall Study|Adverse Event|6
380219|NCT00256698|1213327|P1|Overall Study|Adverse Event|13
380220|NCT00256698|1213326|P2|Overall Study|Withdrawal by Subject|7
380221|NCT00256698|1213327|P1|Overall Study|Withdrawal by Subject|7
380222|NCT00256295|1213345|P1|Overall Study|Death|1
380223|NCT00256295|1213345|P1|Overall Study|Withdrawal by Subject|3
380224|NCT00256243|1213351|P1|Overall Study|Not treated|1
380225|NCT00256243|1213351|P1|Overall Study|Death|7
380226|NCT00256243|1213351|P1|Overall Study|Lost to Follow-up|2
380227|NCT00256204|1213360|P4|Overall Study|Need for additional prohibited treatment|25
380228|NCT00256204|1213361|P3|Overall Study|Need for additional prohibited treatment|27
380229|NCT00256204|1213362|P2|Overall Study|Need for additional prohibited treatment|28
380230|NCT00256204|1213363|P1|Overall Study|Need for additional prohibited treatment|38
380231|NCT00256204|1213360|P4|Overall Study|Withdrawal by Subject|5
380232|NCT00256204|1213361|P3|Overall Study|Withdrawal by Subject|7
380233|NCT00256204|1213362|P2|Overall Study|Withdrawal by Subject|6
380234|NCT00256204|1213363|P1|Overall Study|Withdrawal by Subject|17
380235|NCT00256204|1213360|P4|Overall Study|Physician Decision|2
380236|NCT00256204|1213361|P3|Overall Study|Physician Decision|1
380237|NCT00256204|1213362|P2|Overall Study|Physician Decision|0
380238|NCT00256204|1213363|P1|Overall Study|Physician Decision|0
380239|NCT00256204|1213360|P4|Overall Study|Protocol Violation|1
380240|NCT00256204|1213361|P3|Overall Study|Protocol Violation|2
380241|NCT00256204|1213362|P2|Overall Study|Protocol Violation|0
380242|NCT00256204|1213363|P1|Overall Study|Protocol Violation|1
380243|NCT00256204|1213360|P4|Overall Study|Lost to Follow-up|2
380244|NCT00256204|1213361|P3|Overall Study|Lost to Follow-up|1
380245|NCT00256204|1213362|P2|Overall Study|Lost to Follow-up|1
380246|NCT00256204|1213363|P1|Overall Study|Lost to Follow-up|1
380247|NCT00256204|1213360|P4|Overall Study|Death|0
380248|NCT00256204|1213361|P3|Overall Study|Death|0
380249|NCT00256204|1213362|P2|Overall Study|Death|1
380250|NCT00256204|1213363|P1|Overall Study|Death|0
380251|NCT00256204|1213360|P4|Overall Study|Adverse Event|14
380252|NCT00256204|1213361|P3|Overall Study|Adverse Event|16
380253|NCT00256204|1213362|P2|Overall Study|Adverse Event|14
380254|NCT00256204|1213363|P1|Overall Study|Adverse Event|10
380255|NCT00255840|1213399|P2|Overall Study|Discontinued intervention|56
380256|NCT00255840|1213400|P1|Overall Study|Discontinued intervention|53
380257|NCT00255840|1213399|P2|Overall Study|Lost to Follow-up|14
380258|NCT00255840|1213400|P1|Overall Study|Lost to Follow-up|10
380259|NCT00255723|1213408|P2|Overall Study|Response Data Not Available|0
380260|NCT00255723|1213409|P1|Overall Study|Response Data Not Available|1
380261|NCT00255723|1213408|P2|Overall Study|Death|1
380262|NCT00255723|1213409|P1|Overall Study|Death|0
380263|NCT00255723|1213408|P2|Overall Study|Adverse Event|1
380264|NCT00255723|1213409|P1|Overall Study|Adverse Event|1
380265|NCT00255190|1213422|P2|Overall Study|Various|23
380266|NCT00255190|1213423|P1|Overall Study|Various|4
380267|NCT00255190|1213422|P2|Overall Study|Erosive esophagitis not healed|20
380268|NCT00255190|1213423|P1|Overall Study|Erosive esophagitis not healed|0
380269|NCT00255190|1213422|P2|Overall Study|Inclusion/Exclusion criteria not met|1
380270|NCT00255190|1213423|P1|Overall Study|Inclusion/Exclusion criteria not met|0
380271|NCT00255190|1213422|P2|Overall Study|Withdrew Consent|48
380272|NCT00255190|1213423|P1|Overall Study|Withdrew Consent|17
380273|NCT00255190|1213422|P2|Overall Study|Lost to Follow-up|27
380274|NCT00255190|1213423|P1|Overall Study|Lost to Follow-up|10
380275|NCT00255190|1213422|P2|Overall Study|Protocol Violation|2
380276|NCT00255190|1213423|P1|Overall Study|Protocol Violation|2
380277|NCT00255190|1213422|P2|Overall Study|Adverse Event|36
380278|NCT00255190|1213423|P1|Overall Study|Adverse Event|17
380279|NCT00255164|1213507|P3|Overall Study|Therapeutic Failure|3
380280|NCT00255164|1213508|P2|Overall Study|Therapeutic Failure|2
380281|NCT00255164|1213509|P1|Overall Study|Therapeutic Failure|11
380282|NCT00255164|1213507|P3|Overall Study|Esophageal Stricture|1
380283|NCT00255164|1213508|P2|Overall Study|Esophageal Stricture|0
380284|NCT00255164|1213509|P1|Overall Study|Esophageal Stricture|0
380285|NCT00255164|1213507|P3|Overall Study|Possible Barrett's Esophagus|8
380286|NCT00255164|1213508|P2|Overall Study|Possible Barrett's Esophagus|3
380287|NCT00255164|1213509|P1|Overall Study|Possible Barrett's Esophagus|1
380288|NCT00255164|1213507|P3|Overall Study|Relapse of Erosive Esophagitis|12
380289|NCT00255164|1213508|P2|Overall Study|Relapse of Erosive Esophagitis|16
380290|NCT00255164|1213509|P1|Overall Study|Relapse of Erosive Esophagitis|78
380291|NCT00255164|1213507|P3|Overall Study|Subject Request/Subject Unavailable|2
380292|NCT00255164|1213508|P2|Overall Study|Subject Request/Subject Unavailable|1
380293|NCT00255164|1213509|P1|Overall Study|Subject Request/Subject Unavailable|1
380294|NCT00255164|1213507|P3|Overall Study|Noncompliance|2
380295|NCT00255164|1213508|P2|Overall Study|Noncompliance|1
380296|NCT00255164|1213509|P1|Overall Study|Noncompliance|0
380297|NCT00255164|1213507|P3|Overall Study|Withdrawal by Subject|8
380298|NCT00255164|1213508|P2|Overall Study|Withdrawal by Subject|17
380299|NCT00255164|1213509|P1|Overall Study|Withdrawal by Subject|18
380300|NCT00255164|1213507|P3|Overall Study|Lost to Follow-up|4
380301|NCT00255164|1213508|P2|Overall Study|Lost to Follow-up|3
380302|NCT00255164|1213509|P1|Overall Study|Lost to Follow-up|4
380303|NCT00255164|1213507|P3|Overall Study|Adverse Event|9
380304|NCT00255164|1213508|P2|Overall Study|Adverse Event|6
380305|NCT00255164|1213509|P1|Overall Study|Adverse Event|10
380306|NCT00255151|1213535|P3|Overall Study|Therapeutic Failure|3
380307|NCT00255151|1213536|P2|Overall Study|Therapeutic Failure|2
380308|NCT00255151|1213537|P1|Overall Study|Therapeutic Failure|11
380309|NCT00255151|1213535|P3|Overall Study|Esophageal Stricture|1
380310|NCT00255151|1213536|P2|Overall Study|Esophageal Stricture|0
380311|NCT00255151|1213537|P1|Overall Study|Esophageal Stricture|0
380312|NCT00255151|1213535|P3|Overall Study|Possible Barrett's Esophagus|8
380313|NCT00255151|1213536|P2|Overall Study|Possible Barrett's Esophagus|3
380314|NCT00255151|1213537|P1|Overall Study|Possible Barrett's Esophagus|1
380315|NCT00255151|1213535|P3|Overall Study|Relapse of Erosive Esophagitis|12
380316|NCT00255151|1213536|P2|Overall Study|Relapse of Erosive Esophagitis|16
380317|NCT00255151|1213537|P1|Overall Study|Relapse of Erosive Esophagitis|78
380318|NCT00255151|1213535|P3|Overall Study|Subject Request/Subject Unavailable|2
380319|NCT00255151|1213536|P2|Overall Study|Subject Request/Subject Unavailable|1
380320|NCT00255151|1213537|P1|Overall Study|Subject Request/Subject Unavailable|1
380321|NCT00255151|1213535|P3|Overall Study|Noncompliance|2
380322|NCT00255151|1213536|P2|Overall Study|Noncompliance|1
380323|NCT00255151|1213537|P1|Overall Study|Noncompliance|0
380324|NCT00255151|1213535|P3|Overall Study|Withdrawal by Subject|8
380325|NCT00255151|1213536|P2|Overall Study|Withdrawal by Subject|17
380326|NCT00255151|1213537|P1|Overall Study|Withdrawal by Subject|18
380327|NCT00255151|1213535|P3|Overall Study|Lost to Follow-up|4
380328|NCT00255151|1213536|P2|Overall Study|Lost to Follow-up|3
380329|NCT00255151|1213537|P1|Overall Study|Lost to Follow-up|4
380330|NCT00255151|1213535|P3|Overall Study|Adverse Event|9
380331|NCT00255151|1213536|P2|Overall Study|Adverse Event|6
380332|NCT00255151|1213537|P1|Overall Study|Adverse Event|10
380333|NCT00255086|1213571|P2|Overall Study|Protocol Violation|1
380334|NCT00255086|1213572|P1|Overall Study|Protocol Violation|1
380335|NCT00255086|1213571|P2|Overall Study|Adverse Event|1
380336|NCT00255086|1213572|P1|Overall Study|Adverse Event|1
380337|NCT00255047|1213584|P4|Overall Study|Withdrawal by Subject|18
380338|NCT00255047|1213585|P3|Overall Study|Withdrawal by Subject|25
380339|NCT00255047|1213586|P2|Overall Study|Withdrawal by Subject|23
380340|NCT00255047|1213587|P1|Overall Study|Withdrawal by Subject|24
380341|NCT00255047|1213584|P4|Overall Study|Lost to Follow-up|6
380342|NCT00255047|1213585|P3|Overall Study|Lost to Follow-up|5
380343|NCT00255047|1213586|P2|Overall Study|Lost to Follow-up|8
380344|NCT00255047|1213587|P1|Overall Study|Lost to Follow-up|9
380345|NCT00255047|1213584|P4|Overall Study|Protocol Violation|20
380346|NCT00255047|1213585|P3|Overall Study|Protocol Violation|16
380347|NCT00255047|1213586|P2|Overall Study|Protocol Violation|13
380348|NCT00255047|1213587|P1|Overall Study|Protocol Violation|13
380349|NCT00255047|1213584|P4|Overall Study|Adverse Event|1
380350|NCT00255047|1213585|P3|Overall Study|Adverse Event|2
380351|NCT00255047|1213586|P2|Overall Study|Adverse Event|3
380352|NCT00255047|1213587|P1|Overall Study|Adverse Event|0
380353|NCT00255047|1213584|P4|Overall Study|Serious Adverse Events|1
380354|NCT00255047|1213585|P3|Overall Study|Serious Adverse Events|2
380355|NCT00255047|1213586|P2|Overall Study|Serious Adverse Events|1
380356|NCT00255047|1213587|P1|Overall Study|Serious Adverse Events|2
380357|NCT00255034|1213611|P2|Overall Study|Withdrawal by Subject|38
380358|NCT00255034|1213612|P1|Overall Study|Withdrawal by Subject|15
380359|NCT00255008|1213622|P4|Overall Study|Other|2
380360|NCT00255008|1213623|P3|Overall Study|Other|3
380361|NCT00255008|1213624|P2|Overall Study|Other|0
380362|NCT00255008|1213625|P1|Overall Study|Other|7
380363|NCT00255008|1213622|P4|Overall Study|Adverse lab experience|0
380364|NCT00255008|1213623|P3|Overall Study|Adverse lab experience|0
380365|NCT00255008|1213624|P2|Overall Study|Adverse lab experience|0
380366|NCT00255008|1213625|P1|Overall Study|Adverse lab experience|1
380367|NCT00255008|1213622|P4|Overall Study|Sponsor request|17
380368|NCT00255008|1213623|P3|Overall Study|Sponsor request|8
380369|NCT00255008|1213624|P2|Overall Study|Sponsor request|3
380370|NCT00255008|1213625|P1|Overall Study|Sponsor request|18
380371|NCT00255008|1213622|P4|Overall Study|Withdrew consent|0
380372|NCT00255008|1213623|P3|Overall Study|Withdrew consent|2
380373|NCT00255008|1213624|P2|Overall Study|Withdrew consent|0
380374|NCT00255008|1213625|P1|Overall Study|Withdrew consent|0
380375|NCT00255008|1213622|P4|Overall Study|Did not meet viral reduction criteria|1
380376|NCT00255008|1213623|P3|Overall Study|Did not meet viral reduction criteria|0
380377|NCT00255008|1213624|P2|Overall Study|Did not meet viral reduction criteria|5
380378|NCT00255008|1213625|P1|Overall Study|Did not meet viral reduction criteria|4
380379|NCT00255008|1213622|P4|Overall Study|Lost to Follow-up|2
380380|NCT00255008|1213623|P3|Overall Study|Lost to Follow-up|1
380381|NCT00255008|1213624|P2|Overall Study|Lost to Follow-up|0
380382|NCT00255008|1213625|P1|Overall Study|Lost to Follow-up|1
380383|NCT00255008|1213622|P4|Overall Study|Adverse Event|0
380384|NCT00255008|1213623|P3|Overall Study|Adverse Event|2
380385|NCT00255008|1213624|P2|Overall Study|Adverse Event|1
380386|NCT00255008|1213625|P1|Overall Study|Adverse Event|1
380387|NCT00254982|1213661|P2|Overall Study|Abnormal liver function tests|1
380388|NCT00254982|1213662|P1|Overall Study|Abnormal liver function tests|2
380389|NCT00254982|1213661|P2|Overall Study|Opportunistic infection|0
380390|NCT00254982|1213662|P1|Overall Study|Opportunistic infection|1
380391|NCT00254982|1213661|P2|Overall Study|Malignancy|2
380392|NCT00254982|1213662|P1|Overall Study|Malignancy|0
380393|NCT00254982|1213661|P2|Overall Study|Diagnosis of Tuberculosis|1
380394|NCT00254982|1213662|P1|Overall Study|Diagnosis of Tuberculosis|1
380395|NCT00254982|1213661|P2|Overall Study|Protocol deviation|1
380396|NCT00254982|1213662|P1|Overall Study|Protocol deviation|1
380397|NCT00254982|1213661|P2|Overall Study|Inclusion/exclusion criteria violation|2
380398|NCT00254982|1213662|P1|Overall Study|Inclusion/exclusion criteria violation|0
380399|NCT00254982|1213661|P2|Overall Study|Withdrawal by Subject|1
380400|NCT00254982|1213662|P1|Overall Study|Withdrawal by Subject|1
380401|NCT00254982|1213661|P2|Overall Study|Adverse Event|16
380402|NCT00254982|1213662|P1|Overall Study|Adverse Event|18
380403|NCT00254982|1213661|P2|Overall Study|Lost to Follow-up|3
380404|NCT00254982|1213662|P1|Overall Study|Lost to Follow-up|5
380405|NCT00254982|1213661|P2|Overall Study|Lack of Efficacy|3
380406|NCT00254982|1213662|P1|Overall Study|Lack of Efficacy|5
380407|NCT00254982|1213661|P2|Overall Study|Not specified|1
380408|NCT00254982|1213662|P1|Overall Study|Not specified|2
380409|NCT00254566|1213674|P2|Overall Study|Lost to Follow-up|2
380410|NCT00254566|1213675|P1|Overall Study|Lost to Follow-up|7
380411|NCT00254566|1213674|P2|Overall Study|Withdrawal by Subject|6
380412|NCT00254566|1213675|P1|Overall Study|Withdrawal by Subject|5
380413|NCT00254566|1213674|P2|Overall Study|Other|5
380414|NCT00254566|1213675|P1|Overall Study|Other|1
380415|NCT00254566|1213674|P2|Overall Study|Lack of Efficacy|9
380416|NCT00254566|1213675|P1|Overall Study|Lack of Efficacy|12
380417|NCT00254566|1213674|P2|Overall Study|Adverse Event|4
380418|NCT00254566|1213675|P1|Overall Study|Adverse Event|5
380419|NCT00254566|1213674|P2|Overall Study|Death|0
380420|NCT00254566|1213675|P1|Overall Study|Death|1
380421|NCT00254540|1213699|P2|Overall Study|Laboratory Test Abnormality|1
380422|NCT00254540|1213700|P1|Overall Study|Laboratory Test Abnormality|0
380423|NCT00254540|1213699|P2|Overall Study|Death|1
380424|NCT00254540|1213700|P1|Overall Study|Death|0
380425|NCT00254540|1213699|P2|Overall Study|Lack of Efficacy|13
380426|NCT00254540|1213700|P1|Overall Study|Lack of Efficacy|13
380427|NCT00254540|1213699|P2|Overall Study|Adverse Event|7
380428|NCT00254540|1213700|P1|Overall Study|Adverse Event|6
380429|NCT00254501|1213729|P2|Overall Study|Lost to Follow-up|1
380430|NCT00254501|1213730|P1|Overall Study|Lost to Follow-up|1
380431|NCT00254293|1213759|P7|LTE Open Label Fixed Dosing|not specified|1
380432|NCT00254293|1213760|P6|LTE Open Label Fixed Dosing|not specified|0
380433|NCT00254293|1213761|P5|LTE Open Label Fixed Dosing|not specified|0
380434|NCT00254293|1213762|P4|LTE Open Label Fixed Dosing|not specified|0
380435|NCT00254293|1213763|P3|LTE Open Label Fixed Dosing|not specified|0
380436|NCT00254293|1213764|P2|LTE Open Label Fixed Dosing|not specified|0
380437|NCT00254293|1213765|P1|LTE Open Label Fixed Dosing|not specified|0
380438|NCT00254293|1213759|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
380439|NCT00254293|1213760|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
380440|NCT00254293|1213761|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
380441|NCT00254293|1213762|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
380442|NCT00254293|1213763|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
380443|NCT00254293|1213764|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
380444|NCT00254293|1213765|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
380445|NCT00254293|1213759|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
380446|NCT00254293|1213760|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
380447|NCT00254293|1213761|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
380448|NCT00254293|1213762|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
380449|NCT00254293|1213763|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
380450|NCT00254293|1213764|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
380451|NCT00254293|1213765|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
380452|NCT00254293|1213759|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
380453|NCT00254293|1213760|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
380454|NCT00254293|1213761|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
380455|NCT00254293|1213762|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
380456|NCT00254293|1213763|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
380457|NCT00254293|1213764|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
380458|NCT00254293|1213765|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
380459|NCT00254293|1213759|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
380460|NCT00254293|1213760|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
380461|NCT00254293|1213761|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
380462|NCT00254293|1213762|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
380463|NCT00254293|1213763|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
380464|NCT00254293|1213764|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
380465|NCT00254293|1213765|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
380466|NCT00254293|1213759|P7|LTE Open Label Fixed Dosing|Adverse Event|1
380467|NCT00254293|1213760|P6|LTE Open Label Fixed Dosing|Adverse Event|0
380468|NCT00254293|1213761|P5|LTE Open Label Fixed Dosing|Adverse Event|0
380469|NCT00254293|1213762|P4|LTE Open Label Fixed Dosing|Adverse Event|0
380470|NCT00254293|1213763|P3|LTE Open Label Fixed Dosing|Adverse Event|0
380471|NCT00254293|1213764|P2|LTE Open Label Fixed Dosing|Adverse Event|0
380472|NCT00254293|1213765|P1|LTE Open Label Fixed Dosing|Adverse Event|0
380473|NCT00254293|1213759|P7|LTE Open Label Fixed Dosing|Death|3
380474|NCT00254293|1213760|P6|LTE Open Label Fixed Dosing|Death|0
380475|NCT00254293|1213761|P5|LTE Open Label Fixed Dosing|Death|0
380476|NCT00254293|1213762|P4|LTE Open Label Fixed Dosing|Death|0
380477|NCT00254293|1213763|P3|LTE Open Label Fixed Dosing|Death|0
380478|NCT00254293|1213764|P2|LTE Open Label Fixed Dosing|Death|0
380479|NCT00254293|1213765|P1|LTE Open Label Fixed Dosing|Death|0
380480|NCT00254293|1213759|P7|LTE Open Label Variable SC Dosing|not specified|0
380481|NCT00254293|1213760|P6|LTE Open Label Variable SC Dosing|not specified|0
380482|NCT00254293|1213761|P5|LTE Open Label Variable SC Dosing|not specified|0
380483|NCT00254293|1213762|P4|LTE Open Label Variable SC Dosing|not specified|0
380484|NCT00254293|1213763|P3|LTE Open Label Variable SC Dosing|not specified|2
380485|NCT00254293|1213764|P2|LTE Open Label Variable SC Dosing|not specified|0
380486|NCT00254293|1213765|P1|LTE Open Label Variable SC Dosing|not specified|0
380487|NCT00254293|1213759|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
380488|NCT00254293|1213760|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
380489|NCT00254293|1213761|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
380490|NCT00254293|1213762|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
380491|NCT00254293|1213763|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
380492|NCT00254293|1213764|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
380493|NCT00254293|1213765|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
380494|NCT00254293|1213759|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
380495|NCT00254293|1213760|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
380496|NCT00254293|1213761|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
380497|NCT00254293|1213762|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
380498|NCT00254293|1213763|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
380499|NCT00254293|1213764|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
380500|NCT00254293|1213765|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
380501|NCT00254293|1213759|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
380502|NCT00254293|1213760|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
380503|NCT00254293|1213761|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
380504|NCT00254293|1213762|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
380505|NCT00254293|1213763|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
380506|NCT00254293|1213764|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
380507|NCT00254293|1213765|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
380508|NCT00254293|1213759|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
380509|NCT00254293|1213760|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
380510|NCT00254293|1213761|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
380511|NCT00254293|1213762|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
380512|NCT00254293|1213763|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
380513|NCT00254293|1213764|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
380514|NCT00254293|1213765|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
380515|NCT00254293|1213759|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
380516|NCT00254293|1213760|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
380517|NCT00254293|1213761|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
380518|NCT00254293|1213762|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
380519|NCT00254293|1213763|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
380520|NCT00254293|1213764|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
380521|NCT00254293|1213765|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
380522|NCT00254293|1213759|P7|LTE Open Label Variable SC Dosing|Death|0
380523|NCT00254293|1213760|P6|LTE Open Label Variable SC Dosing|Death|0
380524|NCT00254293|1213761|P5|LTE Open Label Variable SC Dosing|Death|0
380525|NCT00254293|1213762|P4|LTE Open Label Variable SC Dosing|Death|0
380526|NCT00254293|1213763|P3|LTE Open Label Variable SC Dosing|Death|1
380527|NCT00254293|1213764|P2|LTE Open Label Variable SC Dosing|Death|0
380528|NCT00254293|1213765|P1|LTE Open Label Variable SC Dosing|Death|0
380529|NCT00254293|1213759|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
380530|NCT00254293|1213760|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
380531|NCT00254293|1213761|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
380532|NCT00254293|1213762|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
380533|NCT00254293|1213763|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
380534|NCT00254293|1213764|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
380535|NCT00254293|1213765|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
380536|NCT00254293|1213759|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
380537|NCT00254293|1213760|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
380538|NCT00254293|1213761|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
380539|NCT00254293|1213762|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
380540|NCT00254293|1213763|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
380541|NCT00254293|1213764|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
380542|NCT00254293|1213765|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
380543|NCT00254293|1213759|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
380544|NCT00254293|1213760|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
380545|NCT00254293|1213761|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
380546|NCT00254293|1213762|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
380547|NCT00254293|1213763|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
380548|NCT00254293|1213764|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
380549|NCT00254293|1213765|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
380550|NCT00254163|1213848|P2|Overall Study|Other|8
380551|NCT00254163|1213849|P1|Overall Study|Other|8
380552|NCT00254163|1213848|P2|Overall Study|Death|1
380553|NCT00254163|1213849|P1|Overall Study|Death|0
380554|NCT00254163|1213848|P2|Overall Study|Progressive disease|1
380555|NCT00254163|1213849|P1|Overall Study|Progressive disease|0
380556|NCT00254163|1213848|P2|Overall Study|Failed entry|3
380557|NCT00254163|1213849|P1|Overall Study|Failed entry|1
380558|NCT00254163|1213848|P2|Overall Study|Investigator request|3
380559|NCT00254163|1213849|P1|Overall Study|Investigator request|1
380560|NCT00254163|1213848|P2|Overall Study|Patient request/withdrew consent|4
380561|NCT00254163|1213849|P1|Overall Study|Patient request/withdrew consent|6
380562|NCT00254163|1213848|P2|Overall Study|Adverse Event|26
380563|NCT00254163|1213849|P1|Overall Study|Adverse Event|29
380564|NCT00253747|1213900|P2|Overall Study|Administrative Discharge (1), Other (2)|2
380565|NCT00253747|1213901|P1|Overall Study|Administrative Discharge (1), Other (2)|1
380566|NCT00253747|1213900|P2|Overall Study|Withdrawal by Subject|11
380567|NCT00253747|1213901|P1|Overall Study|Withdrawal by Subject|10
380568|NCT00253747|1213900|P2|Overall Study|Lost to Follow-up|14
380569|NCT00253747|1213901|P1|Overall Study|Lost to Follow-up|13
380570|NCT00253643|1213923|P4|Overall Study|Non-Compliance|2
380571|NCT00253643|1213924|P3|Overall Study|Non-Compliance|0
380572|NCT00253643|1213925|P2|Overall Study|Non-Compliance|0
380573|NCT00253643|1213926|P1|Overall Study|Non-Compliance|0
380574|NCT00253643|1213923|P4|Overall Study|Withdrawal by Subject|1
380575|NCT00253643|1213924|P3|Overall Study|Withdrawal by Subject|1
380576|NCT00253643|1213925|P2|Overall Study|Withdrawal by Subject|0
380577|NCT00253643|1213926|P1|Overall Study|Withdrawal by Subject|0
380578|NCT00253448|1213947|P1|Overall Study|Withdrawal by Subject|1
380579|NCT00253370|1213966|P1|Overall Study|Abdominal pain due to disease|1
380580|NCT00253370|1213966|P1|Overall Study|Protocol Violation|1
380581|NCT00253370|1213966|P1|Overall Study|Physician Decision|1
380582|NCT00253370|1213966|P1|Overall Study|Non-protocol therapy|1
380583|NCT00253370|1213966|P1|Overall Study|Withdrawal by Subject|6
380584|NCT00253370|1213966|P1|Overall Study|Death|2
380585|NCT00253370|1213966|P1|Overall Study|Disease progression|13
380586|NCT00253370|1213966|P1|Overall Study|Adverse Event|18
380587|NCT00251927|1213974|P2|Overall Study|Study procedure non-compliance|6
380588|NCT00251927|1213975|P1|Overall Study|Study procedure non-compliance|5
380589|NCT00251927|1213974|P2|Overall Study|Study-specific discont. achieved|2
380590|NCT00251927|1213975|P1|Overall Study|Study-specific discont. achieved|13
380591|NCT00251927|1213974|P2|Overall Study|Withdrawal by Subject|25
380592|NCT00251927|1213975|P1|Overall Study|Withdrawal by Subject|40
380593|NCT00251927|1213974|P2|Overall Study|Pregnancy|0
380594|NCT00251927|1213975|P1|Overall Study|Pregnancy|2
380595|NCT00251927|1213974|P2|Overall Study|Protocol Violation|2
380596|NCT00251927|1213975|P1|Overall Study|Protocol Violation|1
380597|NCT00251927|1213974|P2|Overall Study|Lost to Follow-up|8
380598|NCT00251927|1213975|P1|Overall Study|Lost to Follow-up|22
380599|NCT00251927|1213974|P2|Overall Study|Lack of Efficacy|16
380600|NCT00251927|1213975|P1|Overall Study|Lack of Efficacy|22
380601|NCT00251927|1213974|P2|Overall Study|Adverse Event|15
380602|NCT00251927|1213975|P1|Overall Study|Adverse Event|3
380603|NCT00252733|1214064|P2|Overall Study|Multiple Reasons|14
380604|NCT00252733|1214065|P1|Overall Study|Multiple Reasons|14
380605|NCT00252733|1214064|P2|Overall Study|Lost to Follow-up|6
380606|NCT00252733|1214065|P1|Overall Study|Lost to Follow-up|12
380607|NCT00252733|1214064|P2|Overall Study|Death|5
380608|NCT00252733|1214065|P1|Overall Study|Death|7
380609|NCT00252733|1214064|P2|Overall Study|Withdrawal by Subject|67
380610|NCT00252733|1214065|P1|Overall Study|Withdrawal by Subject|73
380611|NCT00252720|1214075|P2|Overall Study|Mainly patients lost to follow-up|18
380612|NCT00252720|1214076|P1|Overall Study|Mainly patients lost to follow-up|7
380613|NCT00252720|1214075|P2|Overall Study|Moving|42
380614|NCT00252720|1214076|P1|Overall Study|Moving|23
380615|NCT00252720|1214075|P2|Overall Study|Death|8
380616|NCT00252720|1214076|P1|Overall Study|Death|7
380617|NCT00252720|1214075|P2|Overall Study|Withdrawal by Subject|97
380618|NCT00252720|1214076|P1|Overall Study|Withdrawal by Subject|95
380619|NCT00252694|1214090|P2|Overall Study|Patient Moving|16
380620|NCT00252694|1214091|P1|Overall Study|Patient Moving|17
380621|NCT00252694|1214090|P2|Overall Study|Mostly Lost to Follow Up|13
380622|NCT00252694|1214091|P1|Overall Study|Mostly Lost to Follow Up|8
380623|NCT00252694|1214090|P2|Overall Study|Death|34
380624|NCT00252694|1214091|P1|Overall Study|Death|36
380625|NCT00252694|1214090|P2|Overall Study|Withdrawal by Subject|91
380626|NCT00252694|1214091|P1|Overall Study|Withdrawal by Subject|83
380627|NCT00252564|1214139|P2|Overall Study|Withdrawal by Subject|2
380628|NCT00252564|1214140|P1|Overall Study|Withdrawal by Subject|0
380629|NCT00252564|1214139|P2|Overall Study|Patient Request|5
380630|NCT00252564|1214140|P1|Overall Study|Patient Request|4
380631|NCT00252564|1214139|P2|Overall Study|Lost to Follow-up|0
380632|NCT00252564|1214140|P1|Overall Study|Lost to Follow-up|1
380633|NCT00252564|1214139|P2|Overall Study|Physician Decision|0
380634|NCT00252564|1214140|P1|Overall Study|Physician Decision|1
380635|NCT00252564|1214139|P2|Overall Study|Protocol Violation|0
380636|NCT00252564|1214140|P1|Overall Study|Protocol Violation|0
380637|NCT00252564|1214139|P2|Overall Study|Death|3
380638|NCT00252564|1214140|P1|Overall Study|Death|0
380639|NCT00252564|1214139|P2|Overall Study|Disease Progression|20
380640|NCT00252564|1214140|P1|Overall Study|Disease Progression|14
380641|NCT00252564|1214139|P2|Overall Study|Unrelated Complication|1
380642|NCT00252564|1214140|P1|Overall Study|Unrelated Complication|2
380643|NCT00252564|1214139|P2|Overall Study|Adverse Event|13
380644|NCT00252564|1214140|P1|Overall Study|Adverse Event|17
380645|NCT00252499|1214170|P3|Overall Study|Lost to Follow-up|0
380646|NCT00252499|1214171|P2|Overall Study|Lost to Follow-up|0
380647|NCT00252499|1214172|P1|Overall Study|Lost to Follow-up|1
380648|NCT00252239|1214199|P4|Overall Study|Lost to Follow-up|0
380649|NCT00252239|1214200|P3|Overall Study|Lost to Follow-up|2
380650|NCT00252239|1214201|P2|Overall Study|Lost to Follow-up|0
380651|NCT00252239|1214202|P1|Overall Study|Lost to Follow-up|0
380652|NCT00252239|1214199|P4|Overall Study|Withdrawal by Subject|1
380653|NCT00252239|1214200|P3|Overall Study|Withdrawal by Subject|0
380654|NCT00252239|1214201|P2|Overall Study|Withdrawal by Subject|0
380655|NCT00252239|1214202|P1|Overall Study|Withdrawal by Subject|1
380656|NCT00252187|1214214|P2|Overall Study|Withdrawal by Subject|0
380657|NCT00252187|1214215|P1|Overall Study|Withdrawal by Subject|1
380658|NCT00252187|1214214|P2|Overall Study|Adverse Event|1
380659|NCT00252187|1214215|P1|Overall Study|Adverse Event|3
380660|NCT00252174|1214238|P3|Overall Study|Withdrawal by Subject|0
380661|NCT00252174|1214239|P2|Overall Study|Withdrawal by Subject|1
380662|NCT00252174|1214240|P1|Overall Study|Withdrawal by Subject|0
380663|NCT00252057|1214277|P2|Overall Study|Participant previously enrolled|1
380664|NCT00252057|1214278|P1|Overall Study|Participant previously enrolled|0
380665|NCT00252057|1214277|P2|Overall Study|Death|2
380666|NCT00252057|1214278|P1|Overall Study|Death|1
380667|NCT00252057|1214277|P2|Overall Study|Withdrawal by Subject|5
380668|NCT00252057|1214278|P1|Overall Study|Withdrawal by Subject|2
380669|NCT00251979|1214286|P2|Overall Study|Death|5
380670|NCT00251979|1214287|P1|Overall Study|Death|3
380671|NCT00251979|1214286|P2|Overall Study|Lost to Follow-up|6
380672|NCT00251979|1214287|P1|Overall Study|Lost to Follow-up|8
380673|NCT00251979|1214286|P2|Overall Study|Withdrawal by Subject|7
380674|NCT00251979|1214287|P1|Overall Study|Withdrawal by Subject|13
380675|NCT00251979|1214286|P2|Overall Study|Adverse Event|17
380676|NCT00251979|1214287|P1|Overall Study|Adverse Event|11
380677|NCT00251979|1214286|P2|Overall Study|Protocol Violation|5
380678|NCT00251979|1214287|P1|Overall Study|Protocol Violation|3
380679|NCT00251758|1214320|P3|Overall Study|Per Investigator Request|0
380680|NCT00251758|1214321|P2|Overall Study|Per Investigator Request|0
380681|NCT00251758|1214322|P1|Overall Study|Per Investigator Request|1
380682|NCT00251758|1214320|P3|Overall Study|Per Subject Request|1
380683|NCT00251758|1214321|P2|Overall Study|Per Subject Request|0
380684|NCT00251758|1214322|P1|Overall Study|Per Subject Request|0
380685|NCT00251758|1214320|P3|Overall Study|Pregnancy|0
380686|NCT00251758|1214321|P2|Overall Study|Pregnancy|1
380687|NCT00251758|1214322|P1|Overall Study|Pregnancy|0
380688|NCT00251758|1214320|P3|Overall Study|Noncompliant|2
380689|NCT00251758|1214321|P2|Overall Study|Noncompliant|2
380690|NCT00251758|1214322|P1|Overall Study|Noncompliant|0
380691|NCT00251758|1214320|P3|Overall Study|Lack of Efficacy|0
380692|NCT00251758|1214321|P2|Overall Study|Lack of Efficacy|0
380693|NCT00251758|1214322|P1|Overall Study|Lack of Efficacy|3
380694|NCT00251758|1214320|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
380695|NCT00251758|1214321|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
380696|NCT00251758|1214322|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
380697|NCT00251758|1214320|P3|Overall Study|Withdrawal by Subject|3
380698|NCT00251758|1214321|P2|Overall Study|Withdrawal by Subject|7
380699|NCT00251758|1214322|P1|Overall Study|Withdrawal by Subject|13
380700|NCT00251758|1214320|P3|Overall Study|Lost to Follow-up|5
380701|NCT00251758|1214321|P2|Overall Study|Lost to Follow-up|2
380702|NCT00251758|1214322|P1|Overall Study|Lost to Follow-up|4
380703|NCT00251758|1214320|P3|Overall Study|Adverse Event|11
380704|NCT00251758|1214321|P2|Overall Study|Adverse Event|9
380705|NCT00251758|1214322|P1|Overall Study|Adverse Event|7
380706|NCT00251745|1214342|P3|Overall Study|Per Investigator Request|0
380707|NCT00251745|1214343|P2|Overall Study|Per Investigator Request|0
380708|NCT00251745|1214344|P1|Overall Study|Per Investigator Request|1
380709|NCT00251745|1214342|P3|Overall Study|Per Subject Request|1
380710|NCT00251745|1214343|P2|Overall Study|Per Subject Request|0
380711|NCT00251745|1214344|P1|Overall Study|Per Subject Request|0
380712|NCT00251745|1214342|P3|Overall Study|Pregnancy|0
380713|NCT00251745|1214343|P2|Overall Study|Pregnancy|1
380714|NCT00251745|1214344|P1|Overall Study|Pregnancy|0
380715|NCT00251745|1214342|P3|Overall Study|Noncompliant|2
380716|NCT00251745|1214343|P2|Overall Study|Noncompliant|2
380717|NCT00251745|1214344|P1|Overall Study|Noncompliant|0
380718|NCT00251745|1214342|P3|Overall Study|Lack of Efficacy|0
380719|NCT00251745|1214343|P2|Overall Study|Lack of Efficacy|0
380720|NCT00251745|1214344|P1|Overall Study|Lack of Efficacy|3
380721|NCT00251745|1214342|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
380722|NCT00251745|1214343|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
380723|NCT00251745|1214344|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
380724|NCT00251745|1214342|P3|Overall Study|Withdrawal by Subject|3
380725|NCT00251745|1214343|P2|Overall Study|Withdrawal by Subject|7
380726|NCT00251745|1214344|P1|Overall Study|Withdrawal by Subject|13
380727|NCT00251745|1214342|P3|Overall Study|Lost to Follow-up|5
380728|NCT00251745|1214343|P2|Overall Study|Lost to Follow-up|2
380729|NCT00251745|1214344|P1|Overall Study|Lost to Follow-up|4
380730|NCT00251745|1214342|P3|Overall Study|Adverse Event|11
380731|NCT00251745|1214343|P2|Overall Study|Adverse Event|9
380732|NCT00251745|1214344|P1|Overall Study|Adverse Event|7
380733|NCT00251719|1214364|P3|Overall Study|Barrett's esophagus|0
380734|NCT00251719|1214365|P2|Overall Study|Barrett's esophagus|2
380735|NCT00251719|1214366|P1|Overall Study|Barrett's esophagus|2
380736|NCT00251719|1214364|P3|Overall Study|Noncompliance|1
380737|NCT00251719|1214365|P2|Overall Study|Noncompliance|3
380738|NCT00251719|1214366|P1|Overall Study|Noncompliance|2
380739|NCT00251719|1214364|P3|Overall Study|Investigator decision|0
380740|NCT00251719|1214365|P2|Overall Study|Investigator decision|1
380741|NCT00251719|1214366|P1|Overall Study|Investigator decision|1
380742|NCT00251719|1214364|P3|Overall Study|Inclusion/exclusion criteria not met|2
380743|NCT00251719|1214365|P2|Overall Study|Inclusion/exclusion criteria not met|6
380744|NCT00251719|1214366|P1|Overall Study|Inclusion/exclusion criteria not met|12
380745|NCT00251719|1214364|P3|Overall Study|Lack of Efficacy|0
380746|NCT00251719|1214365|P2|Overall Study|Lack of Efficacy|1
380747|NCT00251719|1214366|P1|Overall Study|Lack of Efficacy|2
380748|NCT00251719|1214364|P3|Overall Study|Withdrawal by Subject|11
380749|NCT00251719|1214365|P2|Overall Study|Withdrawal by Subject|12
380750|NCT00251719|1214366|P1|Overall Study|Withdrawal by Subject|14
380751|NCT00251719|1214364|P3|Overall Study|Lost to Follow-up|8
380752|NCT00251719|1214365|P2|Overall Study|Lost to Follow-up|11
380753|NCT00251719|1214366|P1|Overall Study|Lost to Follow-up|5
380754|NCT00251719|1214364|P3|Overall Study|Protocol Violation|1
380755|NCT00251719|1214365|P2|Overall Study|Protocol Violation|1
380756|NCT00251719|1214366|P1|Overall Study|Protocol Violation|1
380757|NCT00251719|1214364|P3|Overall Study|Adverse Event|7
380758|NCT00251719|1214365|P2|Overall Study|Adverse Event|8
380759|NCT00251719|1214366|P1|Overall Study|Adverse Event|14
380760|NCT00251693|1214392|P3|Overall Study|Abnormal laboratory findings|1
380761|NCT00251693|1214393|P2|Overall Study|Abnormal laboratory findings|0
380762|NCT00251693|1214394|P1|Overall Study|Abnormal laboratory findings|0
380763|NCT00251693|1214392|P3|Overall Study|Subject request/subject unavailable|0
380764|NCT00251693|1214393|P2|Overall Study|Subject request/subject unavailable|2
380765|NCT00251693|1214394|P1|Overall Study|Subject request/subject unavailable|1
380766|NCT00251693|1214392|P3|Overall Study|Possible Barrett's esophagus|2
380767|NCT00251693|1214393|P2|Overall Study|Possible Barrett's esophagus|5
380768|NCT00251693|1214394|P1|Overall Study|Possible Barrett's esophagus|3
380769|NCT00251693|1214392|P3|Overall Study|Noncompliant|2
380770|NCT00251693|1214393|P2|Overall Study|Noncompliant|0
380771|NCT00251693|1214394|P1|Overall Study|Noncompliant|0
380772|NCT00251693|1214392|P3|Overall Study|Inclusion/exclusion criteria not met|8
380773|NCT00251693|1214393|P2|Overall Study|Inclusion/exclusion criteria not met|3
380774|NCT00251693|1214394|P1|Overall Study|Inclusion/exclusion criteria not met|5
380775|NCT00251693|1214392|P3|Overall Study|Lack of Efficacy|0
380776|NCT00251693|1214393|P2|Overall Study|Lack of Efficacy|1
380777|NCT00251693|1214394|P1|Overall Study|Lack of Efficacy|0
380778|NCT00251693|1214392|P3|Overall Study|Withdrawal by Subject|14
380779|NCT00251693|1214393|P2|Overall Study|Withdrawal by Subject|17
380780|NCT00251693|1214394|P1|Overall Study|Withdrawal by Subject|11
380781|NCT00251693|1214392|P3|Overall Study|Lost to Follow-up|8
380782|NCT00251693|1214393|P2|Overall Study|Lost to Follow-up|7
380783|NCT00251693|1214394|P1|Overall Study|Lost to Follow-up|12
380784|NCT00251693|1214392|P3|Overall Study|Protocol Violation|2
380785|NCT00251693|1214393|P2|Overall Study|Protocol Violation|0
380786|NCT00251693|1214394|P1|Overall Study|Protocol Violation|2
380787|NCT00251693|1214392|P3|Overall Study|Adverse Event|9
380788|NCT00251693|1214393|P2|Overall Study|Adverse Event|9
380789|NCT00251693|1214394|P1|Overall Study|Adverse Event|17
380790|NCT00251641|1214419|P2|Overall Study|Switched Treatment|63
380791|NCT00251641|1214420|P1|Overall Study|Switched Treatment|9
380792|NCT00251641|1214419|P2|Overall Study|Did not Meet protocol Eligibility|1
380793|NCT00251641|1214420|P1|Overall Study|Did not Meet protocol Eligibility|2
380794|NCT00251641|1214419|P2|Overall Study|Protocol Violation|2
380795|NCT00251641|1214420|P1|Overall Study|Protocol Violation|10
380796|NCT00251641|1214419|P2|Overall Study|Withdrawal by Subject|8
380797|NCT00251641|1214420|P1|Overall Study|Withdrawal by Subject|6
380798|NCT00251641|1214419|P2|Overall Study|Lost to Follow-up|3
380799|NCT00251641|1214420|P1|Overall Study|Lost to Follow-up|3
380800|NCT00251641|1214419|P2|Overall Study|Progression of Disease|2
380801|NCT00251641|1214420|P1|Overall Study|Progression of Disease|0
380802|NCT00251641|1214419|P2|Overall Study|Lack of Efficacy|1
380803|NCT00251641|1214420|P1|Overall Study|Lack of Efficacy|2
380804|NCT00251641|1214419|P2|Overall Study|Adverse Event|8
380805|NCT00251641|1214420|P1|Overall Study|Adverse Event|80
380806|NCT00251589|1214438|P4|Overall Study|Discontinued due to progressive disease|1
380807|NCT00251589|1214439|P3|Overall Study|Discontinued due to progressive disease|0
380808|NCT00251589|1214440|P2|Overall Study|Discontinued due to progressive disease|1
380809|NCT00251589|1214441|P1|Overall Study|Discontinued due to progressive disease|9
380810|NCT00251589|1214438|P4|Overall Study|Withdrawal by Subject|0
380811|NCT00251589|1214439|P3|Overall Study|Withdrawal by Subject|0
380812|NCT00251589|1214440|P2|Overall Study|Withdrawal by Subject|1
380813|NCT00251589|1214441|P1|Overall Study|Withdrawal by Subject|1
380814|NCT00251589|1214438|P4|Overall Study|Adverse Event|1
380815|NCT00251589|1214439|P3|Overall Study|Adverse Event|2
380816|NCT00251589|1214440|P2|Overall Study|Adverse Event|1
380817|NCT00251589|1214441|P1|Overall Study|Adverse Event|5
380818|NCT00251316|1214478|P2|Overall Study|Physician Decision|3
380819|NCT00251316|1214479|P1|Overall Study|Physician Decision|2
380820|NCT00251004|1214512|P3|Overall Study|Graft Loss|8
380821|NCT00251004|1214513|P2|Overall Study|Graft Loss|13
380822|NCT00251004|1214514|P1|Overall Study|Graft Loss|12
380823|NCT00251004|1214512|P3|Overall Study|Lost to Follow-up|1
380824|NCT00251004|1214513|P2|Overall Study|Lost to Follow-up|2
380825|NCT00251004|1214514|P1|Overall Study|Lost to Follow-up|1
380826|NCT00251004|1214512|P3|Overall Study|Death|8
380827|NCT00251004|1214513|P2|Overall Study|Death|10
380828|NCT00251004|1214514|P1|Overall Study|Death|9
380829|NCT00251004|1214512|P3|Overall Study|Withdrawal by Subject|14
380830|NCT00251004|1214513|P2|Overall Study|Withdrawal by Subject|16
380831|NCT00251004|1214514|P1|Overall Study|Withdrawal by Subject|23
380832|NCT00250835|1214538|P1|Overall Study|Withdrawal by Subject|1
380833|NCT00250718|1214547|P1|Overall Study|Withdrawal by Subject|1
380834|NCT00250718|1214547|P1|Overall Study|Adverse Event|1
380835|NCT00250718|1214547|P1|Overall Study|Death|1
380836|NCT00250679|1214555|P3|Overall Study|various single events: hip surgery,diary|1
380837|NCT00250679|1214556|P2|Overall Study|various single events: hip surgery,diary|1
380838|NCT00250679|1214557|P1|Overall Study|various single events: hip surgery,diary|3
380839|NCT00250679|1214555|P3|Overall Study|Non-compliance|0
380840|NCT00250679|1214556|P2|Overall Study|Non-compliance|1
380841|NCT00250679|1214557|P1|Overall Study|Non-compliance|1
380842|NCT00250679|1214555|P3|Overall Study|Moved|0
380843|NCT00250679|1214556|P2|Overall Study|Moved|1
380844|NCT00250679|1214557|P1|Overall Study|Moved|1
380845|NCT00250679|1214555|P3|Overall Study|Technical Holter issues|2
380846|NCT00250679|1214556|P2|Overall Study|Technical Holter issues|0
380847|NCT00250679|1214557|P1|Overall Study|Technical Holter issues|1
380848|NCT00250679|1214555|P3|Overall Study|Lack of Efficacy|3
380849|NCT00250679|1214556|P2|Overall Study|Lack of Efficacy|1
380850|NCT00250679|1214557|P1|Overall Study|Lack of Efficacy|0
380851|NCT00250679|1214555|P3|Overall Study|Does Not Meet Entry Criteria|2
380852|NCT00250679|1214556|P2|Overall Study|Does Not Meet Entry Criteria|4
380853|NCT00250679|1214557|P1|Overall Study|Does Not Meet Entry Criteria|1
380854|NCT00250679|1214555|P3|Overall Study|Lost to Follow-up|2
380855|NCT00250679|1214556|P2|Overall Study|Lost to Follow-up|4
380856|NCT00250679|1214557|P1|Overall Study|Lost to Follow-up|3
380857|NCT00250679|1214555|P3|Overall Study|Withdrawal by Subject|15
380858|NCT00250679|1214556|P2|Overall Study|Withdrawal by Subject|18
380859|NCT00250679|1214557|P1|Overall Study|Withdrawal by Subject|15
380860|NCT00250679|1214555|P3|Overall Study|Protocol Violation|3
380861|NCT00250679|1214556|P2|Overall Study|Protocol Violation|4
380862|NCT00250679|1214557|P1|Overall Study|Protocol Violation|2
380863|NCT00250679|1214555|P3|Overall Study|Adverse Event|16
380864|NCT00250679|1214556|P2|Overall Study|Adverse Event|15
380865|NCT00250679|1214557|P1|Overall Study|Adverse Event|12
380866|NCT00250588|1214658|P3|Overall Study|Lost to Follow-up|13
380867|NCT00250588|1214659|P2|Overall Study|Lost to Follow-up|13
380868|NCT00250588|1214660|P1|Overall Study|Lost to Follow-up|6
380869|NCT00250588|1214658|P3|Overall Study|Withdrawal by Subject|0
380870|NCT00250588|1214659|P2|Overall Study|Withdrawal by Subject|6
380871|NCT00250588|1214660|P1|Overall Study|Withdrawal by Subject|3
380872|NCT00250458|1214706|P2|Overall Study|Not Specified|0
380873|NCT00250458|1214707|P1|Overall Study|Not Specified|1
380874|NCT00250458|1214706|P2|Overall Study|Qualifying migraine but did not treat|3
380875|NCT00250458|1214707|P1|Overall Study|Qualifying migraine but did not treat|3
380876|NCT00250458|1214706|P2|Overall Study|Lack of Migraine Attack|9
380877|NCT00250458|1214707|P1|Overall Study|Lack of Migraine Attack|20
380878|NCT00250458|1214706|P2|Overall Study|Withdrawal by Subject|2
380879|NCT00250458|1214707|P1|Overall Study|Withdrawal by Subject|4
380880|NCT00250458|1214706|P2|Overall Study|Protocol Violation|1
380881|NCT00250458|1214707|P1|Overall Study|Protocol Violation|0
380882|NCT00250458|1214706|P2|Overall Study|Lost to Follow-up|2
380883|NCT00250458|1214707|P1|Overall Study|Lost to Follow-up|4
380884|NCT00250432|1214717|P2|Overall Study|Pt was considered untreatable|1
380885|NCT00250432|1214718|P1|Overall Study|Pt was considered untreatable|0
380886|NCT00250432|1214717|P2|Overall Study|Pt died out of posttherapy report period|5
380887|NCT00250432|1214718|P1|Overall Study|Pt died out of posttherapy report period|6
380888|NCT00250432|1214717|P2|Overall Study|Withdrawal by Subject|2
380889|NCT00250432|1214718|P1|Overall Study|Withdrawal by Subject|6
380890|NCT00250432|1214717|P2|Overall Study|Protocol Violation|3
380891|NCT00250432|1214718|P1|Overall Study|Protocol Violation|0
380892|NCT00250432|1214717|P2|Overall Study|Patient Moved|1
380893|NCT00250432|1214718|P1|Overall Study|Patient Moved|0
380894|NCT00250432|1214717|P2|Overall Study|Lost to Follow-up|5
380895|NCT00250432|1214718|P1|Overall Study|Lost to Follow-up|6
380896|NCT00250432|1214717|P2|Overall Study|Lack of Efficacy|1
380897|NCT00250432|1214718|P1|Overall Study|Lack of Efficacy|2
380898|NCT00250432|1214717|P2|Overall Study|Adverse Event|29
380899|NCT00250432|1214718|P1|Overall Study|Adverse Event|25
380900|NCT00249288|1214728|P2|Overall Study|Withdrawal by Subject|2
380901|NCT00249288|1214729|P1|Overall Study|Withdrawal by Subject|2
380902|NCT00249288|1214728|P2|Overall Study|Lost to Follow-up|3
380903|NCT00249288|1214729|P1|Overall Study|Lost to Follow-up|3
380904|NCT00250276|1214800|P4|Overall Study|Lost to Follow-up|8
380905|NCT00250276|1214801|P3|Overall Study|Lost to Follow-up|13
380906|NCT00250276|1214802|P2|Overall Study|Lost to Follow-up|18
380907|NCT00250276|1214803|P1|Overall Study|Lost to Follow-up|11
380908|NCT00250276|1214800|P4|Overall Study|Migrated/moved from study area|7
380909|NCT00250276|1214801|P3|Overall Study|Migrated/moved from study area|2
380910|NCT00250276|1214802|P2|Overall Study|Migrated/moved from study area|0
380911|NCT00250276|1214803|P1|Overall Study|Migrated/moved from study area|3
380912|NCT00250276|1214800|P4|Overall Study|Withdrawal by Subject|2
380913|NCT00250276|1214801|P3|Overall Study|Withdrawal by Subject|3
380914|NCT00250276|1214802|P2|Overall Study|Withdrawal by Subject|2
380915|NCT00250276|1214803|P1|Overall Study|Withdrawal by Subject|1
380916|NCT00250276|1214800|P4|Overall Study|Protocol Violation|0
380917|NCT00250276|1214801|P3|Overall Study|Protocol Violation|0
380918|NCT00250276|1214802|P2|Overall Study|Protocol Violation|1
380919|NCT00250276|1214803|P1|Overall Study|Protocol Violation|0
380920|NCT00250276|1214800|P4|Overall Study|Non-serious Adverse Event|2
380921|NCT00250276|1214801|P3|Overall Study|Non-serious Adverse Event|0
380922|NCT00250276|1214802|P2|Overall Study|Non-serious Adverse Event|0
380923|NCT00250276|1214803|P1|Overall Study|Non-serious Adverse Event|2
380924|NCT00250276|1214800|P4|Overall Study|Serious Adverse Event|0
380925|NCT00250276|1214801|P3|Overall Study|Serious Adverse Event|1
380926|NCT00250276|1214802|P2|Overall Study|Serious Adverse Event|0
380927|NCT00250276|1214803|P1|Overall Study|Serious Adverse Event|0
380928|NCT00249873|1214883|P2|Overall Study|Thromboembolic/outcome event|122
380929|NCT00249873|1214884|P1|Overall Study|Thromboembolic/outcome event|82
380930|NCT00249873|1214883|P2|Overall Study|Event related to cardiac condition|21
380931|NCT00249873|1214884|P1|Overall Study|Event related to cardiac condition|12
380932|NCT00249873|1214883|P2|Overall Study|Surgery/ procedure|9
380933|NCT00249873|1214884|P1|Overall Study|Surgery/ procedure|9
380934|NCT00249873|1214883|P2|Overall Study|Study drug intolerance|0
380935|NCT00249873|1214884|P1|Overall Study|Study drug intolerance|5
380936|NCT00249873|1214883|P2|Overall Study|Oral anticoagulant required|157
380937|NCT00249873|1214884|P1|Overall Study|Oral anticoagulant required|159
380938|NCT00249873|1214883|P2|Overall Study|Angiotensin II receptor blocker required|0
380939|NCT00249873|1214884|P1|Overall Study|Angiotensin II receptor blocker required|1
380940|NCT00249873|1214883|P2|Overall Study|Open label clopidogrel required|42
380941|NCT00249873|1214884|P1|Overall Study|Open label clopidogrel required|31
380942|NCT00249873|1214883|P2|Overall Study|Physician withdrew consent|60
380943|NCT00249873|1214884|P1|Overall Study|Physician withdrew consent|59
380944|NCT00249873|1214883|P2|Overall Study|Patient not wish to continue after May08|4
380945|NCT00249873|1214884|P1|Overall Study|Patient not wish to continue after May08|3
380946|NCT00249873|1214883|P2|Overall Study|Other contraindicated medication|0
380947|NCT00249873|1214884|P1|Overall Study|Other contraindicated medication|1
380948|NCT00249873|1214883|P2|Overall Study|Other non serious Adverse Event|108
380949|NCT00249873|1214884|P1|Overall Study|Other non serious Adverse Event|112
380950|NCT00249873|1214883|P2|Overall Study|Non-compliance|46
380951|NCT00249873|1214884|P1|Overall Study|Non-compliance|41
380952|NCT00249873|1214883|P2|Overall Study|Minor bleeding|37
380953|NCT00249873|1214884|P1|Overall Study|Minor bleeding|99
380954|NCT00249873|1214883|P2|Overall Study|Lost to Follow-up|7
380955|NCT00249873|1214884|P1|Overall Study|Lost to Follow-up|4
380956|NCT00249873|1214883|P2|Overall Study|Withdrawal by Subject|466
380957|NCT00249873|1214884|P1|Overall Study|Withdrawal by Subject|504
380958|NCT00249873|1214883|P2|Overall Study|Contraindication to oral anticoagulant|8
380959|NCT00249873|1214884|P1|Overall Study|Contraindication to oral anticoagulant|4
380960|NCT00249873|1214883|P2|Overall Study|Qualifying condition not present|23
380961|NCT00249873|1214884|P1|Overall Study|Qualifying condition not present|20
380962|NCT00249873|1214883|P2|Overall Study|Other Serious Adverse Event|97
380963|NCT00249873|1214884|P1|Overall Study|Other Serious Adverse Event|86
380964|NCT00249873|1214883|P2|Overall Study|Serious haemorrhagic Adverse Event|30
380965|NCT00249873|1214884|P1|Overall Study|Serious haemorrhagic Adverse Event|74
380966|NCT00249873|1214883|P2|Overall Study|Severe allergic reaction|1
380967|NCT00249873|1214884|P1|Overall Study|Severe allergic reaction|8
380968|NCT00249873|1214883|P2|Overall Study|Significant thrombocytopenia|8
380969|NCT00249873|1214884|P1|Overall Study|Significant thrombocytopenia|9
380970|NCT00249873|1214883|P2|Overall Study|Not treated|8
380971|NCT00249873|1214884|P1|Overall Study|Not treated|7
380972|NCT00249821|1214898|P2|Overall Study|Technical problem|1
380973|NCT00249821|1214899|P1|Overall Study|Technical problem|0
380974|NCT00249795|1214921|P2|Overall Study|Missing|1
380975|NCT00249795|1214922|P1|Overall Study|Missing|0
380976|NCT00249795|1214921|P2|Overall Study|Lost to Follow-up|2
380977|NCT00249795|1214922|P1|Overall Study|Lost to Follow-up|0
380978|NCT00249795|1214921|P2|Overall Study|Site not agree to continue after May08|1
380979|NCT00249795|1214922|P1|Overall Study|Site not agree to continue after May08|1
380980|NCT00249795|1214921|P2|Overall Study|Patient not wish to continue after May08|6
380981|NCT00249795|1214922|P1|Overall Study|Patient not wish to continue after May08|4
380982|NCT00249795|1214921|P2|Overall Study|Event related to cardiac condition|16
380983|NCT00249795|1214922|P1|Overall Study|Event related to cardiac condition|17
380984|NCT00249795|1214921|P2|Overall Study|Other contraindicated medication|1
380985|NCT00249795|1214922|P1|Overall Study|Other contraindicated medication|1
380986|NCT00249795|1214921|P2|Overall Study|Hypotension (non-symptomatic)|5
380987|NCT00249795|1214922|P1|Overall Study|Hypotension (non-symptomatic)|5
380988|NCT00249795|1214921|P2|Overall Study|Lightheadedness / dizziness|11
380989|NCT00249795|1214922|P1|Overall Study|Lightheadedness / dizziness|15
380990|NCT00249795|1214921|P2|Overall Study|Angiotensin II receptor blocker required|58
380991|NCT00249795|1214922|P1|Overall Study|Angiotensin II receptor blocker required|35
380992|NCT00249795|1214921|P2|Overall Study|Surgery / procedure|5
380993|NCT00249795|1214922|P1|Overall Study|Surgery / procedure|4
380994|NCT00249795|1214921|P2|Overall Study|Physician withdrew consent|63
380995|NCT00249795|1214922|P1|Overall Study|Physician withdrew consent|71
380996|NCT00249795|1214921|P2|Overall Study|Other adverse events (non-serious)|159
380997|NCT00249795|1214922|P1|Overall Study|Other adverse events (non-serious)|188
380998|NCT00249795|1214921|P2|Overall Study|Study drug intolerance|3
380999|NCT00249795|1214922|P1|Overall Study|Study drug intolerance|3
381000|NCT00249795|1214921|P2|Overall Study|Non-compliance|69
381001|NCT00249795|1214922|P1|Overall Study|Non-compliance|71
381002|NCT00249795|1214921|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
381003|NCT00249795|1214922|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
381004|NCT00249795|1214921|P2|Overall Study|Oral anticoagulant required|0
381005|NCT00249795|1214922|P1|Overall Study|Oral anticoagulant required|2
381006|NCT00249795|1214921|P2|Overall Study|Thromboembolic / outcome event|45
381007|NCT00249795|1214922|P1|Overall Study|Thromboembolic / outcome event|39
381008|NCT00249795|1214921|P2|Overall Study|Withdrawal by Subject|742
381009|NCT00249795|1214922|P1|Overall Study|Withdrawal by Subject|678
381010|NCT00249795|1214921|P2|Overall Study|Qualifying condition not present|29
381011|NCT00249795|1214922|P1|Overall Study|Qualifying condition not present|26
381012|NCT00249795|1214921|P2|Overall Study|Other Serious Adverse Event|93
381013|NCT00249795|1214922|P1|Overall Study|Other Serious Adverse Event|84
381014|NCT00249795|1214921|P2|Overall Study|Symptomatic hypotension|64
381015|NCT00249795|1214922|P1|Overall Study|Symptomatic hypotension|127
381016|NCT00249795|1214921|P2|Overall Study|Not treated|14
381017|NCT00249795|1214922|P1|Overall Study|Not treated|16
381018|NCT00249613|1214942|P2|12 Month Follow-up|Lost to Follow-up|8
381019|NCT00249613|1214943|P1|12 Month Follow-up|Lost to Follow-up|10
381020|NCT00249613|1214942|P2|12 Month Follow-up|Withdrawal by Subject|6
381021|NCT00249613|1214943|P1|12 Month Follow-up|Withdrawal by Subject|6
381022|NCT00249613|1214942|P2|12 Month Follow-up|Death|1
381023|NCT00249613|1214943|P1|12 Month Follow-up|Death|1
381024|NCT00249002|1214985|P1|Overall Study|Unspecified|2
381025|NCT00249002|1214985|P1|Overall Study|Study cancellation|3
381026|NCT00249002|1214985|P1|Overall Study|Adverse Event|2
381027|NCT00248794|1215021|P3|Overall Study|Lost to Follow-up|3
381028|NCT00248794|1215022|P2|Overall Study|Lost to Follow-up|8
381029|NCT00248794|1215023|P1|Overall Study|Lost to Follow-up|6
381030|NCT00248651|1215073|P3|Overall Study|Withdrawal by Subject|32
381031|NCT00248651|1215074|P2|Overall Study|Withdrawal by Subject|40
381032|NCT00248651|1215075|P1|Overall Study|Withdrawal by Subject|28
381033|NCT00248625|1215105|P2|Overall Study|Withdrawal by Subject|2
381034|NCT00248625|1215106|P1|Overall Study|Withdrawal by Subject|0
381035|NCT00248495|1215139|P1|Overall Study|Withdrawal by Subject|1
381036|NCT00248287|1215150|P2|Overall Study|Other|2
381037|NCT00248287|1215151|P1|Overall Study|Other|3
381038|NCT00248287|1215150|P2|Overall Study|Patient Request|3
381039|NCT00248287|1215151|P1|Overall Study|Patient Request|5
381040|NCT00248287|1215150|P2|Overall Study|Investigator Request|3
381041|NCT00248287|1215151|P1|Overall Study|Investigator Request|4
381042|NCT00248287|1215150|P2|Overall Study|Lost to Follow-up|1
381043|NCT00248287|1215151|P1|Overall Study|Lost to Follow-up|0
381044|NCT00248287|1215150|P2|Overall Study|Death|0
381045|NCT00248287|1215151|P1|Overall Study|Death|1
381046|NCT00248287|1215150|P2|Overall Study|Adverse Event|10
381047|NCT00248287|1215151|P1|Overall Study|Adverse Event|11
381048|NCT00248170|1215165|P2|Overall Study|Protocol deviation|19
381049|NCT00248170|1215166|P1|Overall Study|Protocol deviation|17
381050|NCT00248170|1215165|P2|Overall Study|Abnormal laboratory values|0
381051|NCT00248170|1215166|P1|Overall Study|Abnormal laboratory values|4
381052|NCT00248170|1215165|P2|Overall Study|Abnormal test procedure(s) result|61
381053|NCT00248170|1215166|P1|Overall Study|Abnormal test procedure(s) result|49
381054|NCT00248170|1215165|P2|Overall Study|Administrative problems|25
381055|NCT00248170|1215166|P1|Overall Study|Administrative problems|22
381056|NCT00248170|1215165|P2|Overall Study|Adverse Event|296
381057|NCT00248170|1215166|P1|Overall Study|Adverse Event|311
381058|NCT00248170|1215165|P2|Overall Study|Death|47
381059|NCT00248170|1215166|P1|Overall Study|Death|28
381060|NCT00248170|1215165|P2|Overall Study|Disease progression|216
381061|NCT00248170|1215166|P1|Overall Study|Disease progression|196
381062|NCT00248170|1215165|P2|Overall Study|Lost to Follow-up|35
381063|NCT00248170|1215166|P1|Overall Study|Lost to Follow-up|28
381064|NCT00248170|1215165|P2|Overall Study|Protocol Violation|30
381065|NCT00248170|1215166|P1|Overall Study|Protocol Violation|35
381066|NCT00248170|1215165|P2|Overall Study|Withdrawal by Subject|79
381067|NCT00248170|1215166|P1|Overall Study|Withdrawal by Subject|71
381068|NCT00247962|1215188|P2|Overall Study|Lack of Efficacy|2
381069|NCT00247962|1215189|P1|Overall Study|Lack of Efficacy|4
381070|NCT00247962|1215188|P2|Overall Study|Withdrawal by Subject|2
381071|NCT00247962|1215189|P1|Overall Study|Withdrawal by Subject|3
381072|NCT00247962|1215188|P2|Overall Study|Protocol Violation|1
381073|NCT00247962|1215189|P1|Overall Study|Protocol Violation|1
381074|NCT00247962|1215188|P2|Overall Study|Physician Decision|1
381075|NCT00247962|1215189|P1|Overall Study|Physician Decision|0
381076|NCT00247962|1215188|P2|Overall Study|Lost to Follow-up|1
381077|NCT00247962|1215189|P1|Overall Study|Lost to Follow-up|3
381078|NCT00247962|1215188|P2|Overall Study|Adverse Event|12
381079|NCT00247962|1215189|P1|Overall Study|Adverse Event|15
381080|NCT00247676|1215197|P1|Overall Study|Withdrawal by Subject|2
381081|NCT00247676|1215197|P1|Overall Study|Unspecified|3
381082|NCT00247676|1215197|P1|Overall Study|Lack of Efficacy|15
381083|NCT00247676|1215197|P1|Overall Study|Adverse Event|11
381084|NCT00247676|1215197|P1|Overall Study|Death|5
381085|NCT00247611|1215227|P2|Baselined|Completed baseline only|8
381086|NCT00247611|1215228|P1|Baselined|Completed baseline only|9
381087|NCT00247611|1215227|P2|Baselined|Completed baseline, never placed on ARVs|5
381088|NCT00247611|1215228|P1|Baselined|Completed baseline, never placed on ARVs|8
381089|NCT00247416|1215246|P2|Overall Study|3 patients were found to be ineligible|2
381090|NCT00247416|1215247|P1|Overall Study|3 patients were found to be ineligible|1
381091|NCT00247273|1215288|P2|Overall Study|Did not take any study drug|0
381092|NCT00247273|1215289|P1|Overall Study|Did not take any study drug|2
381093|NCT00247273|1215288|P2|Overall Study|Withdrawal by Subject|47
381094|NCT00247273|1215289|P1|Overall Study|Withdrawal by Subject|46
381095|NCT00247273|1215288|P2|Overall Study|Lost to Follow-up|7
381096|NCT00247273|1215289|P1|Overall Study|Lost to Follow-up|7
381097|NCT00247273|1215288|P2|Overall Study|Physician Decision|3
381098|NCT00247273|1215289|P1|Overall Study|Physician Decision|6
381099|NCT00247273|1215288|P2|Overall Study|Adverse Event|80
381100|NCT00247273|1215289|P1|Overall Study|Adverse Event|85
381101|NCT00246805|1215335|P2|Phase 1|Lost to Follow-up|0
381102|NCT00246805|1215336|P1|Phase 1|Lost to Follow-up|1
381103|NCT00246571|1215344|P2|Overall Study|Crossover participants|74
381104|NCT00246571|1215345|P1|Overall Study|Crossover participants|0
381105|NCT00246571|1215344|P2|Overall Study|Laboratory abnormalities|0
381106|NCT00246571|1215345|P1|Overall Study|Laboratory abnormalities|1
381107|NCT00246571|1215344|P2|Overall Study|Did not meet entrance criteria|1
381108|NCT00246571|1215345|P1|Overall Study|Did not meet entrance criteria|2
381109|NCT00246571|1215344|P2|Overall Study|Sponsor|1
381110|NCT00246571|1215345|P1|Overall Study|Sponsor|0
381111|NCT00246571|1215344|P2|Overall Study|Death|3
381112|NCT00246571|1215345|P1|Overall Study|Death|17
381113|NCT00246571|1215344|P2|Overall Study|Lack of Efficacy|21
381114|NCT00246571|1215345|P1|Overall Study|Lack of Efficacy|84
381115|NCT00246571|1215344|P2|Overall Study|Withdrawal by Subject|3
381116|NCT00246571|1215345|P1|Overall Study|Withdrawal by Subject|2
381117|NCT00246571|1215344|P2|Overall Study|Protocol Violation|1
381118|NCT00246571|1215345|P1|Overall Study|Protocol Violation|0
381119|NCT00246571|1215344|P2|Overall Study|Adverse Event|0
381120|NCT00246571|1215345|P1|Overall Study|Adverse Event|7
381121|NCT00246376|1215397|P5|Overall Study|Lost to Follow-up|13
381122|NCT00246376|1215398|P4|Overall Study|Lost to Follow-up|16
381123|NCT00246376|1215399|P3|Overall Study|Lost to Follow-up|11
381124|NCT00246376|1215400|P2|Overall Study|Lost to Follow-up|11
381125|NCT00246376|1215401|P1|Overall Study|Lost to Follow-up|2
381126|NCT00246376|1215397|P5|Overall Study|Adverse Event|1
381127|NCT00246376|1215398|P4|Overall Study|Adverse Event|3
381128|NCT00246376|1215399|P3|Overall Study|Adverse Event|1
381129|NCT00246376|1215400|P2|Overall Study|Adverse Event|3
381130|NCT00246376|1215401|P1|Overall Study|Adverse Event|2
381131|NCT00246376|1215397|P5|Overall Study|Dropped/withdrew during dietary run-in|3
381132|NCT00246376|1215398|P4|Overall Study|Dropped/withdrew during dietary run-in|7
381133|NCT00246376|1215399|P3|Overall Study|Dropped/withdrew during dietary run-in|4
381134|NCT00246376|1215400|P2|Overall Study|Dropped/withdrew during dietary run-in|5
381135|NCT00246376|1215401|P1|Overall Study|Dropped/withdrew during dietary run-in|11
381136|NCT00246337|1215452|P9|Overall Study|Reported as completing trial in error|0
381137|NCT00246337|1215453|P8|Overall Study|Reported as completing trial in error|1
381138|NCT00246337|1215454|P7|Overall Study|Reported as completing trial in error|0
381139|NCT00246337|1215455|P6|Overall Study|Reported as completing trial in error|0
381140|NCT00246337|1215456|P5|Overall Study|Reported as completing trial in error|0
381141|NCT00246337|1215457|P4|Overall Study|Reported as completing trial in error|0
381142|NCT00246337|1215458|P3|Overall Study|Reported as completing trial in error|0
381143|NCT00246337|1215459|P2|Overall Study|Reported as completing trial in error|0
381144|NCT00246337|1215460|P1|Overall Study|Reported as completing trial in error|0
381145|NCT00246337|1215452|P9|Overall Study|Protocol Violator|0
381146|NCT00246337|1215453|P8|Overall Study|Protocol Violator|0
381147|NCT00246337|1215454|P7|Overall Study|Protocol Violator|0
381148|NCT00246337|1215455|P6|Overall Study|Protocol Violator|0
381149|NCT00246337|1215456|P5|Overall Study|Protocol Violator|0
381150|NCT00246337|1215457|P4|Overall Study|Protocol Violator|0
381151|NCT00246337|1215458|P3|Overall Study|Protocol Violator|0
381152|NCT00246337|1215459|P2|Overall Study|Protocol Violator|0
381153|NCT00246337|1215460|P1|Overall Study|Protocol Violator|1
381154|NCT00246337|1215452|P9|Overall Study|Overwhelmed|0
381155|NCT00246337|1215453|P8|Overall Study|Overwhelmed|0
381156|NCT00246337|1215454|P7|Overall Study|Overwhelmed|0
381157|NCT00246337|1215455|P6|Overall Study|Overwhelmed|1
381158|NCT00246337|1215456|P5|Overall Study|Overwhelmed|0
381159|NCT00246337|1215457|P4|Overall Study|Overwhelmed|0
381160|NCT00246337|1215458|P3|Overall Study|Overwhelmed|0
381161|NCT00246337|1215459|P2|Overall Study|Overwhelmed|0
381162|NCT00246337|1215460|P1|Overall Study|Overwhelmed|0
381163|NCT00246337|1215452|P9|Overall Study|Abnormal baseline lab values|4
381164|NCT00246337|1215453|P8|Overall Study|Abnormal baseline lab values|0
381165|NCT00246337|1215454|P7|Overall Study|Abnormal baseline lab values|2
381166|NCT00246337|1215455|P6|Overall Study|Abnormal baseline lab values|2
381167|NCT00246337|1215456|P5|Overall Study|Abnormal baseline lab values|0
381168|NCT00246337|1215457|P4|Overall Study|Abnormal baseline lab values|0
381169|NCT00246337|1215458|P3|Overall Study|Abnormal baseline lab values|2
381170|NCT00246337|1215459|P2|Overall Study|Abnormal baseline lab values|0
381171|NCT00246337|1215460|P1|Overall Study|Abnormal baseline lab values|7
381172|NCT00246337|1215452|P9|Overall Study|Site Terminated|2
381173|NCT00246337|1215453|P8|Overall Study|Site Terminated|6
381174|NCT00246337|1215454|P7|Overall Study|Site Terminated|1
381175|NCT00246337|1215455|P6|Overall Study|Site Terminated|7
381176|NCT00246337|1215456|P5|Overall Study|Site Terminated|0
381177|NCT00246337|1215457|P4|Overall Study|Site Terminated|0
381178|NCT00246337|1215458|P3|Overall Study|Site Terminated|0
381179|NCT00246337|1215459|P2|Overall Study|Site Terminated|0
381180|NCT00246337|1215460|P1|Overall Study|Site Terminated|10
381181|NCT00246337|1215452|P9|Overall Study|Lack of Qualifying Event|5
381182|NCT00246337|1215453|P8|Overall Study|Lack of Qualifying Event|2
381183|NCT00246337|1215454|P7|Overall Study|Lack of Qualifying Event|3
381184|NCT00246337|1215455|P6|Overall Study|Lack of Qualifying Event|3
381185|NCT00246337|1215456|P5|Overall Study|Lack of Qualifying Event|1
381186|NCT00246337|1215457|P4|Overall Study|Lack of Qualifying Event|1
381187|NCT00246337|1215458|P3|Overall Study|Lack of Qualifying Event|1
381188|NCT00246337|1215459|P2|Overall Study|Lack of Qualifying Event|2
381189|NCT00246337|1215460|P1|Overall Study|Lack of Qualifying Event|8
381190|NCT00246337|1215452|P9|Overall Study|Withdrawal by Subject|0
381191|NCT00246337|1215453|P8|Overall Study|Withdrawal by Subject|1
381192|NCT00246337|1215454|P7|Overall Study|Withdrawal by Subject|1
381193|NCT00246337|1215455|P6|Overall Study|Withdrawal by Subject|0
381194|NCT00246337|1215456|P5|Overall Study|Withdrawal by Subject|0
381195|NCT00246337|1215457|P4|Overall Study|Withdrawal by Subject|0
381196|NCT00246337|1215458|P3|Overall Study|Withdrawal by Subject|0
381197|NCT00246337|1215459|P2|Overall Study|Withdrawal by Subject|0
381198|NCT00246337|1215460|P1|Overall Study|Withdrawal by Subject|2
381199|NCT00246337|1215452|P9|Overall Study|Protocol Violation|0
381200|NCT00246337|1215453|P8|Overall Study|Protocol Violation|1
381201|NCT00246337|1215454|P7|Overall Study|Protocol Violation|1
381202|NCT00246337|1215455|P6|Overall Study|Protocol Violation|0
381203|NCT00246337|1215456|P5|Overall Study|Protocol Violation|1
381204|NCT00246337|1215457|P4|Overall Study|Protocol Violation|0
381205|NCT00246337|1215458|P3|Overall Study|Protocol Violation|0
381206|NCT00246337|1215459|P2|Overall Study|Protocol Violation|0
381207|NCT00246337|1215460|P1|Overall Study|Protocol Violation|1
381208|NCT00246337|1215452|P9|Overall Study|Lost to Follow-up|0
381209|NCT00246337|1215453|P8|Overall Study|Lost to Follow-up|2
381210|NCT00246337|1215454|P7|Overall Study|Lost to Follow-up|1
381211|NCT00246337|1215455|P6|Overall Study|Lost to Follow-up|2
381212|NCT00246337|1215456|P5|Overall Study|Lost to Follow-up|2
381213|NCT00246337|1215457|P4|Overall Study|Lost to Follow-up|0
381214|NCT00246337|1215458|P3|Overall Study|Lost to Follow-up|0
381215|NCT00246337|1215459|P2|Overall Study|Lost to Follow-up|0
381216|NCT00246337|1215460|P1|Overall Study|Lost to Follow-up|3
381217|NCT00246324|1215507|P1|Overall Study|Withdrawal by Subject|1
381218|NCT00246259|1215514|P2|Overall Study|randomly assigned, not eligible for ITT|6
381219|NCT00246259|1215515|P1|Overall Study|randomly assigned, not eligible for ITT|2
381220|NCT00246259|1215514|P2|Overall Study|Withdrawal by Subject|1
381221|NCT00246259|1215515|P1|Overall Study|Withdrawal by Subject|5
381222|NCT00246259|1215514|P2|Overall Study|Lost to Follow-up|4
381223|NCT00246259|1215515|P1|Overall Study|Lost to Follow-up|3
381224|NCT00246259|1215514|P2|Overall Study|Adverse Event|0
381225|NCT00246259|1215515|P1|Overall Study|Adverse Event|5
381226|NCT00246259|1215514|P2|Overall Study|Investigator withdrew participant|0
381227|NCT00246259|1215515|P1|Overall Study|Investigator withdrew participant|2
381228|NCT00246259|1215514|P2|Overall Study|Lack of Efficacy|2
381229|NCT00246259|1215515|P1|Overall Study|Lack of Efficacy|2
381230|NCT00246259|1215514|P2|Overall Study|Participant non-compliant|9
381231|NCT00246259|1215515|P1|Overall Study|Participant non-compliant|4
381232|NCT00246259|1215514|P2|Overall Study|Not stable by Week 18|1
381233|NCT00246259|1215515|P1|Overall Study|Not stable by Week 18|2
381234|NCT00246259|1215514|P2|Overall Study|Unspecified|3
381235|NCT00246259|1215515|P1|Overall Study|Unspecified|3
381236|NCT00246090|1215549|P1|Overall Study|Not Otherwise Specified|10
381237|NCT00246090|1215549|P1|Overall Study|Physician Decision|11
381238|NCT00246090|1215549|P1|Overall Study|Clinical Progression|30
381239|NCT00246090|1215549|P1|Overall Study|Progressive Disease|212
381240|NCT00246090|1215549|P1|Overall Study|Withdrawal by Subject|7
381241|NCT00246090|1215549|P1|Overall Study|Adverse Event|25
381242|NCT00246025|1215558|P4|Overall Study|unsuitable medical history was found|1
381243|NCT00246025|1215559|P3|Overall Study|unsuitable medical history was found|0
381244|NCT00246025|1215560|P2|Overall Study|unsuitable medical history was found|0
381245|NCT00246025|1215561|P1|Overall Study|unsuitable medical history was found|0
381246|NCT00246025|1215558|P4|Overall Study|Withdrawal by Subject|2
381247|NCT00246025|1215559|P3|Overall Study|Withdrawal by Subject|1
381248|NCT00246025|1215560|P2|Overall Study|Withdrawal by Subject|0
381249|NCT00246025|1215561|P1|Overall Study|Withdrawal by Subject|3
381250|NCT00246025|1215558|P4|Overall Study|Adverse Event|10
381251|NCT00246025|1215559|P3|Overall Study|Adverse Event|9
381252|NCT00246025|1215560|P2|Overall Study|Adverse Event|9
381253|NCT00246025|1215561|P1|Overall Study|Adverse Event|7
381254|NCT00246012|1215620|P9|Overall Study|Randomly assigned but not treated|0
381255|NCT00246012|1215621|P8|Overall Study|Randomly assigned but not treated|0
381256|NCT00246012|1215622|P7|Overall Study|Randomly assigned but not treated|1
381257|NCT00246012|1215623|P6|Overall Study|Randomly assigned but not treated|1
381258|NCT00246012|1215624|P5|Overall Study|Randomly assigned but not treated|0
381259|NCT00246012|1215625|P4|Overall Study|Randomly assigned but not treated|0
381260|NCT00246012|1215626|P3|Overall Study|Randomly assigned but not treated|0
381261|NCT00246012|1215627|P2|Overall Study|Randomly assigned but not treated|0
381262|NCT00246012|1215628|P1|Overall Study|Randomly assigned but not treated|0
381263|NCT00246012|1215620|P9|Overall Study|unspecified|0
381264|NCT00246012|1215621|P8|Overall Study|unspecified|1
381265|NCT00246012|1215622|P7|Overall Study|unspecified|0
381266|NCT00246012|1215623|P6|Overall Study|unspecified|0
381267|NCT00246012|1215624|P5|Overall Study|unspecified|0
381268|NCT00246012|1215625|P4|Overall Study|unspecified|0
381269|NCT00246012|1215626|P3|Overall Study|unspecified|0
381270|NCT00246012|1215627|P2|Overall Study|unspecified|0
381271|NCT00246012|1215628|P1|Overall Study|unspecified|0
381272|NCT00246012|1215620|P9|Overall Study|Disease progression|26
381273|NCT00246012|1215621|P8|Overall Study|Disease progression|27
381274|NCT00246012|1215622|P7|Overall Study|Disease progression|30
381275|NCT00246012|1215623|P6|Overall Study|Disease progression|25
381276|NCT00246012|1215624|P5|Overall Study|Disease progression|3
381277|NCT00246012|1215625|P4|Overall Study|Disease progression|3
381278|NCT00246012|1215626|P3|Overall Study|Disease progression|2
381279|NCT00246012|1215627|P2|Overall Study|Disease progression|1
381280|NCT00246012|1215628|P1|Overall Study|Disease progression|3
381281|NCT00246012|1215620|P9|Overall Study|Withdrawal by Subject|0
381282|NCT00246012|1215621|P8|Overall Study|Withdrawal by Subject|0
381283|NCT00246012|1215622|P7|Overall Study|Withdrawal by Subject|0
381284|NCT00246012|1215623|P6|Overall Study|Withdrawal by Subject|1
381285|NCT00246012|1215624|P5|Overall Study|Withdrawal by Subject|0
381286|NCT00246012|1215625|P4|Overall Study|Withdrawal by Subject|0
381287|NCT00246012|1215626|P3|Overall Study|Withdrawal by Subject|0
381288|NCT00246012|1215627|P2|Overall Study|Withdrawal by Subject|0
381289|NCT00246012|1215628|P1|Overall Study|Withdrawal by Subject|0
381290|NCT00246012|1215620|P9|Overall Study|Adverse Event|2
381291|NCT00246012|1215621|P8|Overall Study|Adverse Event|0
381292|NCT00246012|1215622|P7|Overall Study|Adverse Event|0
381293|NCT00246012|1215623|P6|Overall Study|Adverse Event|1
381294|NCT00246012|1215624|P5|Overall Study|Adverse Event|0
381295|NCT00246012|1215625|P4|Overall Study|Adverse Event|0
381296|NCT00246012|1215626|P3|Overall Study|Adverse Event|0
381297|NCT00246012|1215627|P2|Overall Study|Adverse Event|0
381298|NCT00246012|1215628|P1|Overall Study|Adverse Event|0
381299|NCT00245960|1215723|P2|Overall Study|Lack of Efficacy|6
381300|NCT00245960|1215724|P1|Overall Study|Lack of Efficacy|4
381301|NCT00245960|1215723|P2|Overall Study|Withdrawal by Subject|7
381302|NCT00245960|1215724|P1|Overall Study|Withdrawal by Subject|5
381303|NCT00245960|1215723|P2|Overall Study|Protocol Violation|3
381304|NCT00245960|1215724|P1|Overall Study|Protocol Violation|4
381305|NCT00245960|1215723|P2|Overall Study|Lost to Follow-up|2
381306|NCT00245960|1215724|P1|Overall Study|Lost to Follow-up|2
381307|NCT00245960|1215723|P2|Overall Study|Adverse Event|10
381308|NCT00245960|1215724|P1|Overall Study|Adverse Event|14
381309|NCT00245856|1215732|P2|Period Two|Withdrawal by Subject|1
381310|NCT00245856|1215733|P1|Period Two|Withdrawal by Subject|0
381311|NCT00245102|1215746|P6|Overall Study|Clinical progression|0
381312|NCT00245102|1215747|P5|Overall Study|Clinical progression|0
381313|NCT00245102|1215748|P4|Overall Study|Clinical progression|0
381314|NCT00245102|1215749|P3|Overall Study|Clinical progression|0
381315|NCT00245102|1215750|P2|Overall Study|Clinical progression|0
381316|NCT00245102|1215751|P1|Overall Study|Clinical progression|1
381317|NCT00245102|1215746|P6|Overall Study|Participant needed surgery|0
381318|NCT00245102|1215747|P5|Overall Study|Participant needed surgery|0
381319|NCT00245102|1215748|P4|Overall Study|Participant needed surgery|0
381320|NCT00245102|1215749|P3|Overall Study|Participant needed surgery|1
381321|NCT00245102|1215750|P2|Overall Study|Participant needed surgery|0
381322|NCT00245102|1215751|P1|Overall Study|Participant needed surgery|0
381323|NCT00245102|1215746|P6|Overall Study|Decline in performance|2
381324|NCT00245102|1215747|P5|Overall Study|Decline in performance|0
381325|NCT00245102|1215748|P4|Overall Study|Decline in performance|1
381326|NCT00245102|1215749|P3|Overall Study|Decline in performance|0
381327|NCT00245102|1215750|P2|Overall Study|Decline in performance|2
381328|NCT00245102|1215751|P1|Overall Study|Decline in performance|0
381329|NCT00245102|1215746|P6|Overall Study|Adverse Event|2
381330|NCT00245102|1215747|P5|Overall Study|Adverse Event|0
381331|NCT00245102|1215748|P4|Overall Study|Adverse Event|1
381332|NCT00245102|1215749|P3|Overall Study|Adverse Event|5
381333|NCT00245102|1215750|P2|Overall Study|Adverse Event|2
381334|NCT00245102|1215751|P1|Overall Study|Adverse Event|4
381335|NCT00245102|1215746|P6|Overall Study|Death|0
381336|NCT00245102|1215747|P5|Overall Study|Death|0
381337|NCT00245102|1215748|P4|Overall Study|Death|1
381338|NCT00245102|1215749|P3|Overall Study|Death|0
381339|NCT00245102|1215750|P2|Overall Study|Death|0
381340|NCT00245102|1215751|P1|Overall Study|Death|0
381341|NCT00245102|1215746|P6|Overall Study|Protocol Violation|0
381342|NCT00245102|1215747|P5|Overall Study|Protocol Violation|0
381343|NCT00245102|1215748|P4|Overall Study|Protocol Violation|0
381344|NCT00245102|1215749|P3|Overall Study|Protocol Violation|0
381345|NCT00245102|1215750|P2|Overall Study|Protocol Violation|0
381346|NCT00245102|1215751|P1|Overall Study|Protocol Violation|1
381347|NCT00245102|1215746|P6|Overall Study|Not Treated|0
381348|NCT00245102|1215747|P5|Overall Study|Not Treated|0
381349|NCT00245102|1215748|P4|Overall Study|Not Treated|0
381350|NCT00245102|1215749|P3|Overall Study|Not Treated|1
381351|NCT00245102|1215750|P2|Overall Study|Not Treated|0
381352|NCT00245102|1215751|P1|Overall Study|Not Treated|1
381353|NCT00245063|1215767|P2|Overall Study|Death|0
381354|NCT00245063|1215768|P1|Overall Study|Death|1
381355|NCT00245063|1215767|P2|Overall Study|Adverse Event|5
381356|NCT00245063|1215768|P1|Overall Study|Adverse Event|6
381357|NCT00245050|1215776|P2|Overall Study|Adverse Event|2
381358|NCT00245050|1215777|P1|Overall Study|Adverse Event|3
381359|NCT00245011|1215785|P1|Overall Study|Lack of Efficacy|1
381360|NCT00244933|1215789|P1|Overall Study|Not response evaluable|2
381361|NCT00244881|1215793|P1|Overall Study|Withdrawal by Subject|3
381362|NCT00244855|1215801|P2|Overall Study|Withdrawal by Subject|1
381363|NCT00244855|1215802|P1|Overall Study|Withdrawal by Subject|0
381364|NCT00245570|1215819|P6|Washout Between Periods III and IV|Adverse Event|0
381365|NCT00245570|1215820|P5|Washout Between Periods III and IV|Adverse Event|0
381366|NCT00245570|1215821|P4|Washout Between Periods III and IV|Adverse Event|0
381367|NCT00245570|1215822|P3|Washout Between Periods III and IV|Adverse Event|0
381368|NCT00245570|1215823|P2|Washout Between Periods III and IV|Adverse Event|1
381369|NCT00245570|1215824|P1|Washout Between Periods III and IV|Adverse Event|0
381370|NCT00245466|1215885|P3|Overall Study|Administrative reasons|0
381371|NCT00245466|1215886|P2|Overall Study|Administrative reasons|1
381372|NCT00245466|1215887|P1|Overall Study|Administrative reasons|0
381373|NCT00245466|1215885|P3|Overall Study|Death|0
381374|NCT00245466|1215886|P2|Overall Study|Death|2
381375|NCT00245466|1215887|P1|Overall Study|Death|0
381376|NCT00245466|1215885|P3|Overall Study|Protocol Violation|2
381377|NCT00245466|1215886|P2|Overall Study|Protocol Violation|2
381378|NCT00245466|1215887|P1|Overall Study|Protocol Violation|1
381379|NCT00245466|1215885|P3|Overall Study|Disease progression|1
381380|NCT00245466|1215886|P2|Overall Study|Disease progression|3
381381|NCT00245466|1215887|P1|Overall Study|Disease progression|0
381382|NCT00245466|1215885|P3|Overall Study|Lost to Follow-up|0
381383|NCT00245466|1215886|P2|Overall Study|Lost to Follow-up|0
381384|NCT00245466|1215887|P1|Overall Study|Lost to Follow-up|3
381385|NCT00245466|1215885|P3|Overall Study|Withdrawal by Subject|1
381386|NCT00245466|1215886|P2|Overall Study|Withdrawal by Subject|2
381387|NCT00245466|1215887|P1|Overall Study|Withdrawal by Subject|2
381388|NCT00245466|1215885|P3|Overall Study|Insufficient PSA and testosterone suppr|3
381389|NCT00245466|1215886|P2|Overall Study|Insufficient PSA and testosterone suppr|0
381390|NCT00245466|1215887|P1|Overall Study|Insufficient PSA and testosterone suppr|0
381391|NCT00245466|1215885|P3|Overall Study|Insufficient testosterone suppr|21
381392|NCT00245466|1215886|P2|Overall Study|Insufficient testosterone suppr|12
381393|NCT00245466|1215887|P1|Overall Study|Insufficient testosterone suppr|12
381394|NCT00245466|1215885|P3|Overall Study|Low prostate specific antigen suppr|5
381395|NCT00245466|1215886|P2|Overall Study|Low prostate specific antigen suppr|14
381396|NCT00245466|1215887|P1|Overall Study|Low prostate specific antigen suppr|16
381397|NCT00245466|1215885|P3|Overall Study|Adverse Event|4
381398|NCT00245466|1215886|P2|Overall Study|Adverse Event|8
381399|NCT00245466|1215887|P1|Overall Study|Adverse Event|2
381400|NCT00244764|1215924|P1|Overall Study|Developed Secondary Malignancy|1
381401|NCT00244764|1215924|P1|Overall Study|Sponsor Terminated Study|2
381402|NCT00244764|1215924|P1|Overall Study|Primary Investigator Discretion|2
381403|NCT00244764|1215924|P1|Overall Study|Participant was Hospitalized until Death|1
381404|NCT00244764|1215924|P1|Overall Study|Declining Performance Status|1
381405|NCT00244764|1215924|P1|Overall Study|Off Study Medication for >21 Days|1
381406|NCT00244764|1215924|P1|Overall Study|Death|1
381407|NCT00244764|1215924|P1|Overall Study|Protocol Violation|2
381408|NCT00244764|1215924|P1|Overall Study|Disease Progression|13
381409|NCT00244764|1215924|P1|Overall Study|Withdrawal by Subject|12
381410|NCT00244764|1215924|P1|Overall Study|Lost to Follow-up|23
381411|NCT00244764|1215924|P1|Overall Study|Adverse Event|37
381412|NCT00244725|1215935|P4|Overall Study|Failed to follow-up|1
381413|NCT00244725|1215936|P3|Overall Study|Failed to follow-up|1
381414|NCT00244725|1215937|P2|Overall Study|Failed to follow-up|0
381415|NCT00244725|1215938|P1|Overall Study|Failed to follow-up|0
381416|NCT00244725|1215935|P4|Overall Study|Vomit|0
381417|NCT00244725|1215936|P3|Overall Study|Vomit|1
381418|NCT00244725|1215937|P2|Overall Study|Vomit|0
381419|NCT00244725|1215938|P1|Overall Study|Vomit|0
381420|NCT00244725|1215935|P4|Overall Study|Administrative reason|0
381421|NCT00244725|1215936|P3|Overall Study|Administrative reason|1
381422|NCT00244725|1215937|P2|Overall Study|Administrative reason|0
381423|NCT00244725|1215938|P1|Overall Study|Administrative reason|0
381424|NCT00244725|1215935|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
381425|NCT00244725|1215936|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
381426|NCT00244725|1215937|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
381427|NCT00244725|1215938|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
381428|NCT00244725|1215935|P4|Overall Study|Received prohibited medication|1
381429|NCT00244725|1215936|P3|Overall Study|Received prohibited medication|0
381430|NCT00244725|1215937|P2|Overall Study|Received prohibited medication|1
381431|NCT00244725|1215938|P1|Overall Study|Received prohibited medication|0
381432|NCT00244725|1215935|P4|Overall Study|Headache|0
381433|NCT00244725|1215936|P3|Overall Study|Headache|0
381434|NCT00244725|1215937|P2|Overall Study|Headache|1
381435|NCT00244725|1215938|P1|Overall Study|Headache|0
381436|NCT00244725|1215935|P4|Overall Study|Rehab Refused to allow participantion|0
381437|NCT00244725|1215936|P3|Overall Study|Rehab Refused to allow participantion|0
381438|NCT00244725|1215937|P2|Overall Study|Rehab Refused to allow participantion|1
381439|NCT00244725|1215938|P1|Overall Study|Rehab Refused to allow participantion|0
381440|NCT00244725|1215935|P4|Overall Study|Mediciation Error|0
381441|NCT00244725|1215936|P3|Overall Study|Mediciation Error|0
381442|NCT00244725|1215937|P2|Overall Study|Mediciation Error|1
381443|NCT00244725|1215938|P1|Overall Study|Mediciation Error|0
381444|NCT00244725|1215935|P4|Overall Study|Sponsor withdrew the participant|1
381445|NCT00244725|1215936|P3|Overall Study|Sponsor withdrew the participant|0
381446|NCT00244725|1215937|P2|Overall Study|Sponsor withdrew the participant|0
381447|NCT00244725|1215938|P1|Overall Study|Sponsor withdrew the participant|1
381448|NCT00244725|1215935|P4|Overall Study|Liver function test abnormality|1
381449|NCT00244725|1215936|P3|Overall Study|Liver function test abnormality|0
381450|NCT00244725|1215937|P2|Overall Study|Liver function test abnormality|0
381451|NCT00244725|1215938|P1|Overall Study|Liver function test abnormality|2
381452|NCT00244725|1215935|P4|Overall Study|Withdrwal by participant|1
381453|NCT00244725|1215936|P3|Overall Study|Withdrwal by participant|0
381454|NCT00244725|1215937|P2|Overall Study|Withdrwal by participant|0
381455|NCT00244725|1215938|P1|Overall Study|Withdrwal by participant|1
381456|NCT00244725|1215935|P4|Overall Study|Adverse Events|4
381457|NCT00244725|1215936|P3|Overall Study|Adverse Events|4
381458|NCT00244725|1215937|P2|Overall Study|Adverse Events|1
381459|NCT00244725|1215938|P1|Overall Study|Adverse Events|3
381460|NCT00244725|1215935|P4|Overall Study|Physician Decision|2
381461|NCT00244725|1215936|P3|Overall Study|Physician Decision|1
381462|NCT00244725|1215937|P2|Overall Study|Physician Decision|0
381463|NCT00244725|1215938|P1|Overall Study|Physician Decision|3
381464|NCT00244725|1215935|P4|Overall Study|Not meet treatment eligibility criteria|0
381465|NCT00244725|1215936|P3|Overall Study|Not meet treatment eligibility criteria|0
381466|NCT00244725|1215937|P2|Overall Study|Not meet treatment eligibility criteria|2
381467|NCT00244725|1215938|P1|Overall Study|Not meet treatment eligibility criteria|1
381468|NCT00244725|1215935|P4|Overall Study|Withdrawal by Subject|8
381469|NCT00244725|1215936|P3|Overall Study|Withdrawal by Subject|7
381470|NCT00244725|1215937|P2|Overall Study|Withdrawal by Subject|7
381471|NCT00244725|1215938|P1|Overall Study|Withdrawal by Subject|9
381472|NCT00244725|1215935|P4|Overall Study|Lost to Follow-up|2
381473|NCT00244725|1215936|P3|Overall Study|Lost to Follow-up|9
381474|NCT00244725|1215937|P2|Overall Study|Lost to Follow-up|4
381475|NCT00244725|1215938|P1|Overall Study|Lost to Follow-up|3
381476|NCT00244712|1215994|P2|Overall Study|Protocol Violation, disease progression|11
381477|NCT00244712|1215995|P1|Overall Study|Protocol Violation, disease progression|13
381478|NCT00244712|1215994|P2|Overall Study|Withdrawal by Subject|23
381479|NCT00244712|1215995|P1|Overall Study|Withdrawal by Subject|13
381480|NCT00244712|1215994|P2|Overall Study|Lost to Follow-up|52
381481|NCT00244712|1215995|P1|Overall Study|Lost to Follow-up|45
381482|NCT00244712|1215994|P2|Overall Study|Lack of Compliance|11
381483|NCT00244712|1215995|P1|Overall Study|Lack of Compliance|10
381484|NCT00244712|1215994|P2|Overall Study|Protocol-Defined Virologic Failure|6
381485|NCT00244712|1215995|P1|Overall Study|Protocol-Defined Virologic Failure|8
381486|NCT00244712|1215994|P2|Overall Study|Adverse Event|21
381487|NCT00244712|1215995|P1|Overall Study|Adverse Event|20
381488|NCT00244621|1216030|P3|Open-label Treatment Period|Moved abroad|1
381489|NCT00244621|1216031|P2|Open-label Treatment Period|Moved abroad|0
381490|NCT00244621|1216032|P1|Open-label Treatment Period|Moved abroad|0
381491|NCT00244621|1216030|P3|Open-label Treatment Period|Adverse Event|1
381492|NCT00244621|1216031|P2|Open-label Treatment Period|Adverse Event|0
381493|NCT00244621|1216032|P1|Open-label Treatment Period|Adverse Event|0
381494|NCT00244621|1216030|P3|Open-label Treatment Period|Withdrawal by Subject|0
381495|NCT00244621|1216031|P2|Open-label Treatment Period|Withdrawal by Subject|0
381496|NCT00244621|1216032|P1|Open-label Treatment Period|Withdrawal by Subject|1
381497|NCT00244621|1216030|P3|Open-label Treatment Period|Lost to Follow-up|0
381498|NCT00244621|1216031|P2|Open-label Treatment Period|Lost to Follow-up|1
381499|NCT00244621|1216032|P1|Open-label Treatment Period|Lost to Follow-up|0
381500|NCT00244621|1216030|P3|Double-blind Treatment Period|Multiple Reasons|1
381501|NCT00244621|1216031|P2|Double-blind Treatment Period|Multiple Reasons|1
381502|NCT00244621|1216032|P1|Double-blind Treatment Period|Multiple Reasons|2
381503|NCT00244621|1216030|P3|Double-blind Treatment Period|Lack of Efficacy|0
381504|NCT00244621|1216031|P2|Double-blind Treatment Period|Lack of Efficacy|1
381505|NCT00244621|1216032|P1|Double-blind Treatment Period|Lack of Efficacy|0
381506|NCT00244621|1216030|P3|Double-blind Treatment Period|Withdrawal by Subject|0
381507|NCT00244621|1216031|P2|Double-blind Treatment Period|Withdrawal by Subject|1
381508|NCT00244621|1216032|P1|Double-blind Treatment Period|Withdrawal by Subject|0
381509|NCT00244621|1216030|P3|Double-blind Treatment Period|Lost to Follow-up|1
381510|NCT00244621|1216031|P2|Double-blind Treatment Period|Lost to Follow-up|0
381511|NCT00244621|1216032|P1|Double-blind Treatment Period|Lost to Follow-up|0
381512|NCT00244374|1216049|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
381513|NCT00244374|1216050|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
381514|NCT00244374|1216051|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
381515|NCT00244374|1216052|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
381516|NCT00244374|1216053|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
381517|NCT00244374|1216049|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
381518|NCT00244374|1216050|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
381519|NCT00244374|1216051|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
381520|NCT00244374|1216052|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
381521|NCT00244374|1216053|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
381522|NCT00244374|1216049|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
381523|NCT00244374|1216050|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
381524|NCT00244374|1216051|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
381525|NCT00244374|1216052|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
381526|NCT00244374|1216053|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
381527|NCT00244374|1216049|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
381528|NCT00244374|1216050|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
381529|NCT00244374|1216051|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
381530|NCT00244374|1216052|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
381531|NCT00244374|1216053|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
381532|NCT00244374|1216049|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
381533|NCT00244374|1216050|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
381534|NCT00244374|1216051|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
381535|NCT00244374|1216052|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
381536|NCT00244374|1216053|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
381537|NCT00244374|1216049|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
381538|NCT00244374|1216050|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
381539|NCT00244374|1216051|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
381540|NCT00244374|1216052|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
381541|NCT00244374|1216053|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
381542|NCT00244374|1216049|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
381620|NCT00243347|1216287|P1|Overall Study|Condition worsened|7
381543|NCT00244374|1216050|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
381544|NCT00244374|1216051|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
381545|NCT00244374|1216052|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
381546|NCT00244374|1216053|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
381547|NCT00244374|1216049|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
381548|NCT00244374|1216050|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
381549|NCT00244374|1216051|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
381550|NCT00244374|1216052|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
381551|NCT00244374|1216053|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
381552|NCT00244374|1216049|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
381553|NCT00244374|1216050|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
381554|NCT00244374|1216051|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
381555|NCT00244374|1216052|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
381556|NCT00244374|1216053|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
381557|NCT00243932|1216109|P3|Stage 1: Dose Selection|Lost to Follow-up|0
381558|NCT00243932|1216110|P2|Stage 1: Dose Selection|Lost to Follow-up|0
381559|NCT00243932|1216111|P1|Stage 1: Dose Selection|Lost to Follow-up|2
381560|NCT00243919|1216122|P3|Overall Study|Physician Decision|0
381561|NCT00243919|1216123|P2|Overall Study|Physician Decision|1
381562|NCT00243919|1216124|P1|Overall Study|Physician Decision|1
381563|NCT00243919|1216122|P3|Overall Study|Administrative Error|0
381564|NCT00243919|1216123|P2|Overall Study|Administrative Error|0
381565|NCT00243919|1216124|P1|Overall Study|Administrative Error|1
381566|NCT00243919|1216122|P3|Overall Study|Lost to Follow-up|3
381567|NCT00243919|1216123|P2|Overall Study|Lost to Follow-up|7
381568|NCT00243919|1216124|P1|Overall Study|Lost to Follow-up|6
381569|NCT00243919|1216122|P3|Overall Study|Withdrawal by Subject|2
381570|NCT00243919|1216123|P2|Overall Study|Withdrawal by Subject|6
381571|NCT00243919|1216124|P1|Overall Study|Withdrawal by Subject|6
381572|NCT00243919|1216122|P3|Overall Study|Death|6
381573|NCT00243919|1216123|P2|Overall Study|Death|4
381574|NCT00243919|1216124|P1|Overall Study|Death|3
381575|NCT00243659|1216167|P2|Overall Study|Protocol Violation|2
381576|NCT00243659|1216168|P1|Overall Study|Protocol Violation|1
381577|NCT00243659|1216167|P2|Overall Study|Withdrawal by Subject|1
381578|NCT00243659|1216168|P1|Overall Study|Withdrawal by Subject|1
381579|NCT00243503|1216176|P1|Overall Study|Unspecified|1
381580|NCT00243503|1216176|P1|Overall Study|Death|1
381581|NCT00243503|1216176|P1|Overall Study|Lack of Efficacy|44
381582|NCT00243503|1216176|P1|Overall Study|Withdrawal by Subject|1
381583|NCT00243503|1216176|P1|Overall Study|Adverse Event|11
381584|NCT00243412|1216193|P2|Overall Study|not specified|1
381585|NCT00243412|1216194|P1|Overall Study|not specified|1
381586|NCT00243412|1216193|P2|Overall Study|Withdrawal by Subject|5
381587|NCT00243412|1216194|P1|Overall Study|Withdrawal by Subject|4
381588|NCT00243412|1216193|P2|Overall Study|Physician Decision|1
381589|NCT00243412|1216194|P1|Overall Study|Physician Decision|1
381590|NCT00243412|1216193|P2|Overall Study|Lost to Follow-up|1
381591|NCT00243412|1216194|P1|Overall Study|Lost to Follow-up|0
381592|NCT00243412|1216193|P2|Overall Study|Adverse Event|2
381593|NCT00243412|1216194|P1|Overall Study|Adverse Event|4
381594|NCT00243412|1216193|P2|Overall Study|Death|1
381595|NCT00243412|1216194|P1|Overall Study|Death|0
381596|NCT00243386|1216220|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
381597|NCT00243386|1216221|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
381598|NCT00243386|1216222|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
381599|NCT00243386|1216220|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
381600|NCT00243386|1216221|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
381601|NCT00243386|1216222|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
381602|NCT00243386|1216220|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
381603|NCT00243386|1216221|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
381604|NCT00243386|1216222|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
381605|NCT00243386|1216220|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
381606|NCT00243386|1216221|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
381607|NCT00243386|1216222|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
381608|NCT00243386|1216220|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
381609|NCT00243386|1216221|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
381610|NCT00243386|1216222|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
381611|NCT00243386|1216220|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
381612|NCT00243386|1216221|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
381613|NCT00243386|1216222|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
381614|NCT00243386|1216220|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
381615|NCT00243386|1216221|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
381616|NCT00243386|1216222|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
381617|NCT00243386|1216220|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
381618|NCT00243386|1216221|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
381619|NCT00243386|1216222|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
381621|NCT00243347|1216287|P1|Overall Study|Withdrawal by Subject|5
381622|NCT00243347|1216287|P1|Overall Study|Death|1
381623|NCT00243347|1216287|P1|Overall Study|Adverse Event|2
381624|NCT00243347|1216287|P1|Overall Study|Lack of Efficacy|4
381625|NCT00243269|1216296|P4|Overall Study|Lost to Follow-up|3
381626|NCT00243269|1216297|P3|Overall Study|Lost to Follow-up|1
381627|NCT00243269|1216298|P2|Overall Study|Lost to Follow-up|0
381628|NCT00243269|1216299|P1|Overall Study|Lost to Follow-up|1
381629|NCT00243269|1216296|P4|Overall Study|Protocol Violation|1
381630|NCT00243269|1216297|P3|Overall Study|Protocol Violation|0
381631|NCT00243269|1216298|P2|Overall Study|Protocol Violation|1
381632|NCT00243269|1216299|P1|Overall Study|Protocol Violation|2
381633|NCT00243074|1216326|P1|Overall Study|Did not receive any treatment|1
381634|NCT00243074|1216326|P1|Overall Study|not protocol specified|1
381635|NCT00243074|1216326|P1|Overall Study|Death|2
381636|NCT00243074|1216326|P1|Overall Study|Lack of Efficacy|36
381637|NCT00243074|1216326|P1|Overall Study|Withdrawal by Subject|2
381638|NCT00243074|1216326|P1|Overall Study|Adverse Event|6
381639|NCT00243074|1216326|P1|Overall Study|Ineligible|6
381640|NCT00243022|1216346|P2|Overall Study|Difficult Travel Distance|1
381641|NCT00243022|1216347|P1|Overall Study|Difficult Travel Distance|0
381642|NCT00243022|1216346|P2|Overall Study|Death|0
381643|NCT00243022|1216347|P1|Overall Study|Death|1
381644|NCT00243022|1216346|P2|Overall Study|Withdrawal by Subject|0
381645|NCT00243022|1216347|P1|Overall Study|Withdrawal by Subject|1
381646|NCT00242710|1216369|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
381647|NCT00242710|1216370|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
381648|NCT00242710|1216371|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
381649|NCT00242710|1216372|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
381650|NCT00242710|1216369|P4|Study Extension (up to Year 2)|Protocol Violation|1
381651|NCT00242710|1216370|P3|Study Extension (up to Year 2)|Protocol Violation|0
381652|NCT00242710|1216371|P2|Study Extension (up to Year 2)|Protocol Violation|2
381653|NCT00242710|1216372|P1|Study Extension (up to Year 2)|Protocol Violation|0
381654|NCT00242710|1216369|P4|Study Extension (up to Year 2)|Unspecified|3
381655|NCT00242710|1216370|P3|Study Extension (up to Year 2)|Unspecified|4
381656|NCT00242710|1216371|P2|Study Extension (up to Year 2)|Unspecified|5
381657|NCT00242710|1216372|P1|Study Extension (up to Year 2)|Unspecified|3
381658|NCT00242710|1216369|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
381659|NCT00242710|1216370|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
381660|NCT00242710|1216371|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
381661|NCT00242710|1216372|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
381662|NCT00242710|1216369|P4|Study Extension (up to Year 2)|Death|1
381663|NCT00242710|1216370|P3|Study Extension (up to Year 2)|Death|0
381664|NCT00242710|1216371|P2|Study Extension (up to Year 2)|Death|0
381665|NCT00242710|1216372|P1|Study Extension (up to Year 2)|Death|0
381666|NCT00242710|1216369|P4|Study Extension (up to Year 2)|Adverse Event|4
381667|NCT00242710|1216370|P3|Study Extension (up to Year 2)|Adverse Event|2
381668|NCT00242710|1216371|P2|Study Extension (up to Year 2)|Adverse Event|9
381669|NCT00242710|1216372|P1|Study Extension (up to Year 2)|Adverse Event|7
381670|NCT00242710|1216369|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
381671|NCT00242710|1216370|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
381672|NCT00242710|1216371|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
381673|NCT00242710|1216372|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
381674|NCT00242710|1216369|P4|Period Between Core Study and Extension|Protocol Violation|1
381675|NCT00242710|1216370|P3|Period Between Core Study and Extension|Protocol Violation|2
381676|NCT00242710|1216371|P2|Period Between Core Study and Extension|Protocol Violation|0
381677|NCT00242710|1216372|P1|Period Between Core Study and Extension|Protocol Violation|0
381678|NCT00242710|1216369|P4|Period Between Core Study and Extension|Extension not Available|7
381679|NCT00242710|1216370|P3|Period Between Core Study and Extension|Extension not Available|8
381680|NCT00242710|1216371|P2|Period Between Core Study and Extension|Extension not Available|21
381681|NCT00242710|1216372|P1|Period Between Core Study and Extension|Extension not Available|17
381682|NCT00242710|1216369|P4|Period Between Core Study and Extension|Unspecified|11
381683|NCT00242710|1216370|P3|Period Between Core Study and Extension|Unspecified|9
381684|NCT00242710|1216371|P2|Period Between Core Study and Extension|Unspecified|24
381685|NCT00242710|1216372|P1|Period Between Core Study and Extension|Unspecified|24
381686|NCT00242710|1216369|P4|Period Between Core Study and Extension|Physician Decision|0
381687|NCT00242710|1216370|P3|Period Between Core Study and Extension|Physician Decision|0
381771|NCT00242216|1216537|P1|Overall Study|Lack of Efficacy|1
381688|NCT00242710|1216371|P2|Period Between Core Study and Extension|Physician Decision|1
381689|NCT00242710|1216372|P1|Period Between Core Study and Extension|Physician Decision|1
381690|NCT00242710|1216369|P4|Period Between Core Study and Extension|Adverse Event|2
381691|NCT00242710|1216370|P3|Period Between Core Study and Extension|Adverse Event|5
381692|NCT00242710|1216371|P2|Period Between Core Study and Extension|Adverse Event|3
381693|NCT00242710|1216372|P1|Period Between Core Study and Extension|Adverse Event|2
381694|NCT00242710|1216369|P4|Core Study (up to Year 1)|Randomized but not Treated|2
381695|NCT00242710|1216370|P3|Core Study (up to Year 1)|Randomized but not Treated|4
381696|NCT00242710|1216371|P2|Core Study (up to Year 1)|Randomized but not Treated|4
381697|NCT00242710|1216372|P1|Core Study (up to Year 1)|Randomized but not Treated|12
381698|NCT00242710|1216369|P4|Core Study (up to Year 1)|Lack of Efficacy|0
381699|NCT00242710|1216370|P3|Core Study (up to Year 1)|Lack of Efficacy|0
381700|NCT00242710|1216371|P2|Core Study (up to Year 1)|Lack of Efficacy|0
381701|NCT00242710|1216372|P1|Core Study (up to Year 1)|Lack of Efficacy|1
381702|NCT00242710|1216369|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
381703|NCT00242710|1216370|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
381704|NCT00242710|1216371|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
381705|NCT00242710|1216372|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
381706|NCT00242710|1216369|P4|Core Study (up to Year 1)|Protocol Violation|3
381707|NCT00242710|1216370|P3|Core Study (up to Year 1)|Protocol Violation|1
381708|NCT00242710|1216371|P2|Core Study (up to Year 1)|Protocol Violation|9
381709|NCT00242710|1216372|P1|Core Study (up to Year 1)|Protocol Violation|2
381710|NCT00242710|1216369|P4|Core Study (up to Year 1)|Unspecified|2
381711|NCT00242710|1216370|P3|Core Study (up to Year 1)|Unspecified|0
381712|NCT00242710|1216371|P2|Core Study (up to Year 1)|Unspecified|1
381713|NCT00242710|1216372|P1|Core Study (up to Year 1)|Unspecified|6
381714|NCT00242710|1216369|P4|Core Study (up to Year 1)|Lost to Follow-up|3
381715|NCT00242710|1216370|P3|Core Study (up to Year 1)|Lost to Follow-up|7
381716|NCT00242710|1216371|P2|Core Study (up to Year 1)|Lost to Follow-up|8
381717|NCT00242710|1216372|P1|Core Study (up to Year 1)|Lost to Follow-up|8
381718|NCT00242710|1216369|P4|Core Study (up to Year 1)|Physician Decision|1
381719|NCT00242710|1216370|P3|Core Study (up to Year 1)|Physician Decision|0
381720|NCT00242710|1216371|P2|Core Study (up to Year 1)|Physician Decision|1
381721|NCT00242710|1216372|P1|Core Study (up to Year 1)|Physician Decision|0
381722|NCT00242710|1216369|P4|Core Study (up to Year 1)|Death|0
381723|NCT00242710|1216370|P3|Core Study (up to Year 1)|Death|1
381724|NCT00242710|1216371|P2|Core Study (up to Year 1)|Death|0
381725|NCT00242710|1216372|P1|Core Study (up to Year 1)|Death|0
381726|NCT00242710|1216369|P4|Core Study (up to Year 1)|Adverse Event|14
381727|NCT00242710|1216370|P3|Core Study (up to Year 1)|Adverse Event|23
381728|NCT00242710|1216371|P2|Core Study (up to Year 1)|Adverse Event|25
381729|NCT00242710|1216372|P1|Core Study (up to Year 1)|Adverse Event|30
381730|NCT00242658|1216429|P2|Overall Study|Lost to Follow-up|19
381731|NCT00242658|1216430|P1|Overall Study|Lost to Follow-up|22
381732|NCT00242580|1216461|P3|Overall Study|Death|1
381733|NCT00242580|1216462|P2|Overall Study|Death|2
381734|NCT00242580|1216463|P1|Overall Study|Death|1
381735|NCT00242580|1216461|P3|Overall Study|Lost to Follow-up|0
381736|NCT00242580|1216462|P2|Overall Study|Lost to Follow-up|3
381737|NCT00242580|1216463|P1|Overall Study|Lost to Follow-up|0
381738|NCT00242580|1216461|P3|Overall Study|Subject withdrew consent|5
381739|NCT00242580|1216462|P2|Overall Study|Subject withdrew consent|2
381740|NCT00242580|1216463|P1|Overall Study|Subject withdrew consent|2
381741|NCT00242580|1216461|P3|Overall Study|Protocol Violation|1
381742|NCT00242580|1216462|P2|Overall Study|Protocol Violation|0
381743|NCT00242580|1216463|P1|Overall Study|Protocol Violation|0
381744|NCT00242580|1216461|P3|Overall Study|Unsatisfactory therapeutic effect|5
381745|NCT00242580|1216462|P2|Overall Study|Unsatisfactory therapeutic effect|5
381746|NCT00242580|1216463|P1|Overall Study|Unsatisfactory therapeutic effect|4
381747|NCT00242580|1216461|P3|Overall Study|Adverse Event|2
381748|NCT00242580|1216462|P2|Overall Study|Adverse Event|0
381749|NCT00242580|1216463|P1|Overall Study|Adverse Event|3
381750|NCT00242567|1216488|P2|Overall Study|Other|9
381751|NCT00242567|1216489|P1|Overall Study|Other|14
381752|NCT00242567|1216488|P2|Overall Study|Use of an inhibitor of bone resorption|2
381753|NCT00242567|1216489|P1|Overall Study|Use of an inhibitor of bone resorption|0
381754|NCT00242567|1216488|P2|Overall Study|Protocol Violation|12
381755|NCT00242567|1216489|P1|Overall Study|Protocol Violation|12
381756|NCT00242567|1216488|P2|Overall Study|Withdrawal by Subject|28
381757|NCT00242567|1216489|P1|Overall Study|Withdrawal by Subject|33
381758|NCT00242567|1216488|P2|Overall Study|Lost to Follow-up|19
381759|NCT00242567|1216489|P1|Overall Study|Lost to Follow-up|9
381760|NCT00242567|1216488|P2|Overall Study|Lack of Efficacy|2
381761|NCT00242567|1216489|P1|Overall Study|Lack of Efficacy|2
381762|NCT00242567|1216488|P2|Overall Study|Symptomatic deterioration|3
381763|NCT00242567|1216489|P1|Overall Study|Symptomatic deterioration|9
381764|NCT00242567|1216488|P2|Overall Study|Disease Progression|22
381765|NCT00242567|1216489|P1|Overall Study|Disease Progression|17
381766|NCT00242567|1216488|P2|Overall Study|Adverse Event|43
381767|NCT00242567|1216489|P1|Overall Study|Adverse Event|70
381768|NCT00242216|1216536|P2|Overall Study|no medicaiton dispensed|1
381769|NCT00242216|1216537|P1|Overall Study|no medicaiton dispensed|1
381770|NCT00242216|1216536|P2|Overall Study|Lack of Efficacy|2
381772|NCT00242216|1216536|P2|Overall Study|Death|2
381773|NCT00242216|1216537|P1|Overall Study|Death|4
381774|NCT00242216|1216536|P2|Overall Study|Lost to Follow-up|17
381775|NCT00242216|1216537|P1|Overall Study|Lost to Follow-up|12
381776|NCT00241839|1216547|P2|Overall Study|Adverse Event|1
381777|NCT00241839|1216548|P1|Overall Study|Adverse Event|1
381778|NCT00241839|1216547|P2|Overall Study|Withdrawal by Subject|17
381779|NCT00241839|1216548|P1|Overall Study|Withdrawal by Subject|18
381780|NCT00241644|1216564|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
381781|NCT00241644|1216565|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
381782|NCT00241644|1216566|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
381783|NCT00241644|1216567|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
381862|NCT00241280|1216688|P1|Overall Study|Lost to Follow-up|5
381784|NCT00241644|1216564|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
381785|NCT00241644|1216565|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
381786|NCT00241644|1216566|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
381787|NCT00241644|1216567|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
381788|NCT00241644|1216564|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
381789|NCT00241644|1216565|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
381790|NCT00241644|1216566|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
381791|NCT00241644|1216567|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
381792|NCT00241644|1216564|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
381793|NCT00241644|1216565|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
381794|NCT00241644|1216566|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
381795|NCT00241644|1216567|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
381796|NCT00241644|1216564|P4|Second Efficacy Period (Year 2)|Adverse Event|20
381797|NCT00241644|1216565|P3|Second Efficacy Period (Year 2)|Adverse Event|12
381798|NCT00241644|1216566|P2|Second Efficacy Period (Year 2)|Adverse Event|9
381799|NCT00241644|1216567|P1|Second Efficacy Period (Year 2)|Adverse Event|11
381800|NCT00241644|1216564|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
381801|NCT00241644|1216565|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
381802|NCT00241644|1216566|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
381803|NCT00241644|1216567|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
381804|NCT00241644|1216564|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
381805|NCT00241644|1216565|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
381806|NCT00241644|1216566|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
381807|NCT00241644|1216567|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
381808|NCT00241644|1216564|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
381809|NCT00241644|1216565|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
381810|NCT00241644|1216566|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
381811|NCT00241644|1216567|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
381812|NCT00241644|1216564|P4|First Efficacy Period (Year 1)|Non-compliance|3
381813|NCT00241644|1216565|P3|First Efficacy Period (Year 1)|Non-compliance|2
381814|NCT00241644|1216566|P2|First Efficacy Period (Year 1)|Non-compliance|1
381815|NCT00241644|1216567|P1|First Efficacy Period (Year 1)|Non-compliance|2
381816|NCT00241644|1216564|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
381817|NCT00241644|1216565|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
381818|NCT00241644|1216566|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
381819|NCT00241644|1216567|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
381820|NCT00241644|1216564|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
381821|NCT00241644|1216565|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
381822|NCT00241644|1216566|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
381823|NCT00241644|1216567|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
381824|NCT00241644|1216564|P4|First Efficacy Period (Year 1)|Protocol Violation|8
381825|NCT00241644|1216565|P3|First Efficacy Period (Year 1)|Protocol Violation|4
381826|NCT00241644|1216566|P2|First Efficacy Period (Year 1)|Protocol Violation|5
381827|NCT00241644|1216567|P1|First Efficacy Period (Year 1)|Protocol Violation|3
381828|NCT00241644|1216564|P4|First Efficacy Period (Year 1)|Adverse Event|91
381829|NCT00241644|1216565|P3|First Efficacy Period (Year 1)|Adverse Event|45
381830|NCT00241644|1216566|P2|First Efficacy Period (Year 1)|Adverse Event|45
381831|NCT00241644|1216567|P1|First Efficacy Period (Year 1)|Adverse Event|46
381832|NCT00241358|1216652|P3|Overall Study|Determined to be not ineligible|1
381833|NCT00241358|1216653|P2|Overall Study|Determined to be not ineligible|1
381834|NCT00241358|1216654|P1|Overall Study|Determined to be not ineligible|0
381835|NCT00241280|1216687|P2|Overall Study|Excessive Dryness|1
381836|NCT00241280|1216688|P1|Overall Study|Excessive Dryness|0
381837|NCT00241280|1216687|P2|Overall Study|Coating on Lens|0
381838|NCT00241280|1216688|P1|Overall Study|Coating on Lens|1
381839|NCT00241280|1216687|P2|Overall Study|History of Ocular Surgery|1
381840|NCT00241280|1216688|P1|Overall Study|History of Ocular Surgery|0
381841|NCT00241280|1216687|P2|Overall Study|Scheduling Conflict|2
381842|NCT00241280|1216688|P1|Overall Study|Scheduling Conflict|0
381843|NCT00241280|1216687|P2|Overall Study|Unacceptable Fit|1
381844|NCT00241280|1216688|P1|Overall Study|Unacceptable Fit|0
381845|NCT00241280|1216687|P2|Overall Study|Dispensed incorrect test article|2
381846|NCT00241280|1216688|P1|Overall Study|Dispensed incorrect test article|1
381847|NCT00241280|1216687|P2|Overall Study|Subject Ineligible/Dispensed|6
381848|NCT00241280|1216688|P1|Overall Study|Subject Ineligible/Dispensed|9
381849|NCT00241280|1216687|P2|Overall Study|Diabetic|0
381850|NCT00241280|1216688|P1|Overall Study|Diabetic|1
381851|NCT00241280|1216687|P2|Overall Study|Unsatisfactory Visual Response|1
381852|NCT00241280|1216688|P1|Overall Study|Unsatisfactory Visual Response|1
381853|NCT00241280|1216687|P2|Overall Study|Unsatisfactory Physiological Response|1
381854|NCT00241280|1216688|P1|Overall Study|Unsatisfactory Physiological Response|1
381855|NCT00241280|1216687|P2|Overall Study|Relocation|4
381856|NCT00241280|1216688|P1|Overall Study|Relocation|4
381857|NCT00241280|1216687|P2|Overall Study|Protocol Violation|10
381858|NCT00241280|1216688|P1|Overall Study|Protocol Violation|4
381859|NCT00241280|1216687|P2|Overall Study|Withdrawal by Subject|4
381860|NCT00241280|1216688|P1|Overall Study|Withdrawal by Subject|7
381861|NCT00241280|1216687|P2|Overall Study|Lost to Follow-up|8
381863|NCT00241280|1216687|P2|Overall Study|Pregnancy|5
381864|NCT00241280|1216688|P1|Overall Study|Pregnancy|1
381865|NCT00241280|1216687|P2|Overall Study|Discomfort|16
381866|NCT00241280|1216688|P1|Overall Study|Discomfort|11
381867|NCT00241280|1216687|P2|Overall Study|Adverse Event|6
381868|NCT00241280|1216688|P1|Overall Study|Adverse Event|2
381869|NCT00240994|1216703|P1|Overall Study|Graft failure|1
381870|NCT00240994|1216703|P1|Overall Study|Protocol Violation|1
381871|NCT00240994|1216703|P1|Overall Study|Lost to Follow-up|1
381872|NCT00240331|1216838|P2|Overall Study|Option selected by investigator|2
381873|NCT00240331|1216839|P1|Overall Study|Option selected by investigator|1
381874|NCT00240331|1216838|P2|Overall Study|Withdrawal by Subject|132
381875|NCT00240331|1216839|P1|Overall Study|Withdrawal by Subject|125
381876|NCT00240110|1216872|P2|Overall Study|Lost to Follow-up|7
381877|NCT00240110|1216873|P1|Overall Study|Lost to Follow-up|6
381878|NCT00240097|1216881|P1|Part II|did not continue from Part I|23
381879|NCT00240097|1216881|P1|Part I|unevaluable|1
381880|NCT00240097|1216881|P1|Part I|histology|1
381881|NCT00240097|1216881|P1|Part I|Death|1
381882|NCT00240097|1216881|P1|Part I|Adverse Event|1
381883|NCT00240071|1216891|P1|Overall Study|Withdrawal by Subject|3
381884|NCT00239928|1216895|P1|Overall Study|Withdrawal by Subject|2
381885|NCT00239928|1216895|P1|Overall Study|Not need to continue study|3
381886|NCT00239928|1216895|P1|Overall Study|Adverse Event|4
381887|NCT00239928|1216895|P1|Overall Study|Lack of Efficacy|1
381888|NCT00239837|1216907|P2|Overall Study|Lost to Follow-up|7
381889|NCT00239837|1216908|P1|Overall Study|Lost to Follow-up|3
381890|NCT00239720|1216935|P2|Overall Study|Lost to Follow-up|1
381891|NCT00239720|1216936|P1|Overall Study|Lost to Follow-up|0
381892|NCT00239720|1216935|P2|Overall Study|Adverse Event|0
381893|NCT00239720|1216936|P1|Overall Study|Adverse Event|1
381894|NCT00239681|1216944|P2|Overall Study|No information chacked on CaseReportForm|84
381895|NCT00239681|1216945|P1|Overall Study|No information chacked on CaseReportForm|90
381896|NCT00239681|1216944|P2|Overall Study|Physician Decision|17
381897|NCT00239681|1216945|P1|Overall Study|Physician Decision|13
381898|NCT00239681|1216944|P2|Overall Study|Protocol Violation|4
381899|NCT00239681|1216945|P1|Overall Study|Protocol Violation|4
381900|NCT00239681|1216944|P2|Overall Study|Lost to Follow-up|22
381901|NCT00239681|1216945|P1|Overall Study|Lost to Follow-up|28
381902|NCT00239681|1216944|P2|Overall Study|Withdrawal by Subject|489
381903|NCT00239681|1216945|P1|Overall Study|Withdrawal by Subject|458
381904|NCT00239681|1216944|P2|Overall Study|Adverse Event|99
381905|NCT00239681|1216945|P1|Overall Study|Adverse Event|100
381906|NCT00239356|1217000|P2|Overall Study|Drug available on market|2
381907|NCT00239356|1217001|P1|Overall Study|Drug available on market|11
381908|NCT00239356|1217000|P2|Overall Study|Administrative reason|1
381909|NCT00239356|1217001|P1|Overall Study|Administrative reason|0
381910|NCT00239356|1217000|P2|Overall Study|Pregnancy|0
381911|NCT00239356|1217001|P1|Overall Study|Pregnancy|1
381912|NCT00239356|1217000|P2|Overall Study|poor/non-compliance|0
381913|NCT00239356|1217001|P1|Overall Study|poor/non-compliance|2
381914|NCT00239356|1217000|P2|Overall Study|Lost to Follow-up|0
381915|NCT00239356|1217001|P1|Overall Study|Lost to Follow-up|3
381916|NCT00239356|1217000|P2|Overall Study|Withdrawal by Subject|6
381917|NCT00239356|1217001|P1|Overall Study|Withdrawal by Subject|15
381918|NCT00239356|1217000|P2|Overall Study|Adverse Event|0
381919|NCT00239356|1217001|P1|Overall Study|Adverse Event|6
381920|NCT00239356|1217000|P2|Overall Study|Lack of Efficacy|0
381921|NCT00239356|1217001|P1|Overall Study|Lack of Efficacy|1
381922|NCT00239226|1217023|P4|Overall Study|Lost to Follow-up|0
381923|NCT00239226|1217024|P3|Overall Study|Lost to Follow-up|1
381924|NCT00239226|1217025|P2|Overall Study|Lost to Follow-up|0
381925|NCT00239226|1217026|P1|Overall Study|Lost to Follow-up|1
381926|NCT00239226|1217023|P4|Overall Study|permAF during stabilization period|3
381927|NCT00239226|1217024|P3|Overall Study|permAF during stabilization period|0
381928|NCT00239226|1217025|P2|Overall Study|permAF during stabilization period|0
381929|NCT00239226|1217026|P1|Overall Study|permAF during stabilization period|0
381930|NCT00239005|1217038|P2|Overall Study|Lost to Follow-up|1
381931|NCT00239005|1217039|P1|Overall Study|Lost to Follow-up|0
381932|NCT00239005|1217038|P2|Overall Study|Subj. cond. no longer needs study drug|1
381933|NCT00239005|1217039|P1|Overall Study|Subj. cond. no longer needs study drug|0
381934|NCT00239005|1217038|P2|Overall Study|Protocol Violation|0
381935|NCT00239005|1217039|P1|Overall Study|Protocol Violation|1
381936|NCT00239005|1217038|P2|Overall Study|Unsatisfactory Therapeutic effect|0
381937|NCT00239005|1217039|P1|Overall Study|Unsatisfactory Therapeutic effect|2
381938|NCT00239005|1217038|P2|Overall Study|Withdrawal by Subject|4
381939|NCT00239005|1217039|P1|Overall Study|Withdrawal by Subject|3
381940|NCT00239005|1217038|P2|Overall Study|Adverse Event|6
381941|NCT00239005|1217039|P1|Overall Study|Adverse Event|6
381942|NCT00238433|1217055|P1|Overall Study|Death|1
381943|NCT00238433|1217055|P1|Overall Study|Lost to Follow-up|1
381944|NCT00238433|1217055|P1|Overall Study|Screen failure|1
381945|NCT00238420|1217062|P2|Overall Study|Protocol Violation|1
381946|NCT00238420|1217063|P1|Overall Study|Protocol Violation|1
381947|NCT00238303|1217080|P3|Overall Study|Adverse Event|3
381948|NCT00238303|1217081|P2|Overall Study|Adverse Event|1
381949|NCT00238303|1217082|P1|Overall Study|Adverse Event|0
381950|NCT00238303|1217080|P3|Overall Study|Poor tolerance of study treatment|1
381951|NCT00238303|1217081|P2|Overall Study|Poor tolerance of study treatment|0
381952|NCT00238303|1217082|P1|Overall Study|Poor tolerance of study treatment|1
381953|NCT00238303|1217080|P3|Overall Study|Other Medical Problems|2
381954|NCT00238303|1217081|P2|Overall Study|Other Medical Problems|0
381955|NCT00238303|1217082|P1|Overall Study|Other Medical Problems|2
381956|NCT00238303|1217080|P3|Overall Study|Death|1
381957|NCT00238303|1217081|P2|Overall Study|Death|0
381958|NCT00238303|1217082|P1|Overall Study|Death|1
381959|NCT00238303|1217080|P3|Overall Study|Withdrawal by Subject|2
381960|NCT00238303|1217081|P2|Overall Study|Withdrawal by Subject|1
381961|NCT00238303|1217082|P1|Overall Study|Withdrawal by Subject|11
381962|NCT00238264|1217099|P1|Overall Study|Ineligible|7
381963|NCT00238264|1217099|P1|Overall Study|Withdrawal by Subject|4
381964|NCT00238264|1217099|P1|Overall Study|Lost to Follow-up|18
381965|NCT00238264|1217099|P1|Overall Study|Death|7
381966|NCT00238238|1217112|P3|Overall Study|Withdrawal by Subject|0
381967|NCT00238238|1217113|P2|Overall Study|Withdrawal by Subject|3
381968|NCT00238238|1217114|P1|Overall Study|Withdrawal by Subject|0
381969|NCT00238121|1217127|P2|Overall Study|Adverse Event|1
381970|NCT00238121|1217128|P1|Overall Study|Adverse Event|2
381971|NCT00238121|1217127|P2|Overall Study|Withdrawal by Subject|1
381972|NCT00238121|1217128|P1|Overall Study|Withdrawal by Subject|1
381973|NCT00237809|1217152|P4|Overall Study|Lost to Follow-up|9
381974|NCT00237809|1217153|P3|Overall Study|Lost to Follow-up|9
381975|NCT00237809|1217154|P2|Overall Study|Lost to Follow-up|10
381976|NCT00237809|1217155|P1|Overall Study|Lost to Follow-up|11
381977|NCT00237796|1217191|P2|Overall Study|Baseline and one other ILSS required|5
381978|NCT00237796|1217192|P1|Overall Study|Baseline and one other ILSS required|10
381979|NCT00237744|1217226|P3|Overall Study|Withdrawal by Subject|0
381980|NCT00237744|1217227|P2|Overall Study|Withdrawal by Subject|1
381981|NCT00237744|1217228|P1|Overall Study|Withdrawal by Subject|3
381982|NCT00237692|1217254|P4|Overall Study|Withdrawal by Subject|4
381983|NCT00237692|1217255|P3|Overall Study|Withdrawal by Subject|10
381984|NCT00237692|1217256|P2|Overall Study|Withdrawal by Subject|6
381985|NCT00237692|1217257|P1|Overall Study|Withdrawal by Subject|4
381986|NCT00237692|1217254|P4|Overall Study|Excluded - did not meet criteria|9
381987|NCT00237692|1217255|P3|Overall Study|Excluded - did not meet criteria|5
381988|NCT00237692|1217256|P2|Overall Study|Excluded - did not meet criteria|3
381989|NCT00237692|1217257|P1|Overall Study|Excluded - did not meet criteria|4
381990|NCT00237692|1217254|P4|Overall Study|Death|3
381991|NCT00237692|1217255|P3|Overall Study|Death|2
381992|NCT00237692|1217256|P2|Overall Study|Death|2
381993|NCT00237692|1217257|P1|Overall Study|Death|1
381994|NCT00237692|1217254|P4|Overall Study|Lost to Follow-up|3
381995|NCT00237692|1217255|P3|Overall Study|Lost to Follow-up|5
381996|NCT00237692|1217256|P2|Overall Study|Lost to Follow-up|3
381997|NCT00237692|1217257|P1|Overall Study|Lost to Follow-up|9
381998|NCT00237458|1217297|P1|Overall Study|Withdrawal by Subject|1
381999|NCT00237458|1217297|P1|Overall Study|Adverse Event|1
382000|NCT00237458|1217297|P1|Overall Study|Lack of Efficacy|1
382001|NCT00237185|1217315|P2|Extension|Death|1
382002|NCT00237185|1217316|P1|Extension|Death|1
382003|NCT00237185|1217315|P2|Extension|Administrative problems|0
382004|NCT00237185|1217316|P1|Extension|Administrative problems|1
382005|NCT00237185|1217315|P2|Extension|Lost to Follow-up|0
382006|NCT00237185|1217316|P1|Extension|Lost to Follow-up|1
382007|NCT00237185|1217315|P2|Extension|Withdrawal by Subject|2
382008|NCT00237185|1217316|P1|Extension|Withdrawal by Subject|3
382009|NCT00237185|1217315|P2|Extension|Condition no longer required study drug|1
382010|NCT00237185|1217316|P1|Extension|Condition no longer required study drug|0
382011|NCT00237185|1217315|P2|Extension|Lack of Efficacy|14
382012|NCT00237185|1217316|P1|Extension|Lack of Efficacy|9
382013|NCT00237185|1217315|P2|Extension|Abnormal laboratory value|1
382014|NCT00237185|1217316|P1|Extension|Abnormal laboratory value|0
382015|NCT00237185|1217315|P2|Extension|Adverse Event|0
382016|NCT00237185|1217316|P1|Extension|Adverse Event|1
382017|NCT00237185|1217315|P2|Core|Determined ineligible post randomization|0
382018|NCT00237185|1217316|P1|Core|Determined ineligible post randomization|1
382019|NCT00237185|1217315|P2|Core|Death|0
382020|NCT00237185|1217316|P1|Core|Death|4
382021|NCT00237185|1217315|P2|Core|Administrative problems|1
382022|NCT00237185|1217316|P1|Core|Administrative problems|0
382023|NCT00237185|1217315|P2|Core|Withdrawal by Subject|4
382024|NCT00237185|1217316|P1|Core|Withdrawal by Subject|4
382025|NCT00237185|1217315|P2|Core|Protocol Violation|1
382026|NCT00237185|1217316|P1|Core|Protocol Violation|1
382027|NCT00237185|1217315|P2|Core|Lack of Efficacy|23
382028|NCT00237185|1217316|P1|Core|Lack of Efficacy|30
382029|NCT00237185|1217315|P2|Core|Abnormal test procedure results|0
382030|NCT00237185|1217316|P1|Core|Abnormal test procedure results|1
382031|NCT00237185|1217315|P2|Core|Abnormal laboratory value|4
382032|NCT00237185|1217316|P1|Core|Abnormal laboratory value|0
382033|NCT00237185|1217315|P2|Core|Adverse Event|4
382034|NCT00237185|1217316|P1|Core|Adverse Event|3
382035|NCT00237042|1217347|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
382036|NCT00237042|1217348|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
382037|NCT00237042|1217349|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
382038|NCT00237042|1217347|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
382039|NCT00237042|1217348|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
382040|NCT00237042|1217349|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
382041|NCT00237042|1217347|P3|Treatment|Completed no treatment|21
382042|NCT00237042|1217348|P2|Treatment|Completed no treatment|5
382043|NCT00237042|1217349|P1|Treatment|Completed no treatment|5
382044|NCT00237042|1217347|P3|Treatment|Moved out of state|1
382045|NCT00237042|1217348|P2|Treatment|Moved out of state|1
382046|NCT00237042|1217349|P1|Treatment|Moved out of state|1
382047|NCT00237042|1217347|P3|Treatment|Became ineligible post-randomization|16
382048|NCT00237042|1217348|P2|Treatment|Became ineligible post-randomization|1
382049|NCT00237042|1217349|P1|Treatment|Became ineligible post-randomization|0
382050|NCT00236899|1217423|P4|Overall Study|Lack of Efficacy|23
382051|NCT00236899|1217424|P3|Overall Study|Lack of Efficacy|25
382052|NCT00236899|1217425|P2|Overall Study|Lack of Efficacy|18
382053|NCT00236899|1217426|P1|Overall Study|Lack of Efficacy|18
382054|NCT00236899|1217423|P4|Overall Study|Satisfactory Response|1
382055|NCT00236899|1217424|P3|Overall Study|Satisfactory Response|0
382056|NCT00236899|1217425|P2|Overall Study|Satisfactory Response|0
382057|NCT00236899|1217426|P1|Overall Study|Satisfactory Response|2
382058|NCT00236899|1217423|P4|Overall Study|Physician Decision|6
382059|NCT00236899|1217424|P3|Overall Study|Physician Decision|7
382060|NCT00236899|1217425|P2|Overall Study|Physician Decision|8
382061|NCT00236899|1217426|P1|Overall Study|Physician Decision|7
382062|NCT00236899|1217423|P4|Overall Study|Withdrawal by Subject|2
382063|NCT00236899|1217424|P3|Overall Study|Withdrawal by Subject|5
382064|NCT00236899|1217425|P2|Overall Study|Withdrawal by Subject|4
382065|NCT00236899|1217426|P1|Overall Study|Withdrawal by Subject|6
382066|NCT00236899|1217423|P4|Overall Study|Protocol Violation|0
382067|NCT00236899|1217424|P3|Overall Study|Protocol Violation|0
382068|NCT00236899|1217425|P2|Overall Study|Protocol Violation|0
382069|NCT00236899|1217426|P1|Overall Study|Protocol Violation|1
382070|NCT00236899|1217423|P4|Overall Study|Entry Criteria Exclusion|0
382071|NCT00236899|1217424|P3|Overall Study|Entry Criteria Exclusion|1
382072|NCT00236899|1217425|P2|Overall Study|Entry Criteria Exclusion|1
382073|NCT00236899|1217426|P1|Overall Study|Entry Criteria Exclusion|0
382074|NCT00236899|1217423|P4|Overall Study|Lost to Follow-up|0
382075|NCT00236899|1217424|P3|Overall Study|Lost to Follow-up|0
382076|NCT00236899|1217425|P2|Overall Study|Lost to Follow-up|1
382077|NCT00236899|1217426|P1|Overall Study|Lost to Follow-up|0
382078|NCT00236899|1217423|P4|Overall Study|Death (Study Drug Toxicity)|0
382079|NCT00236899|1217424|P3|Overall Study|Death (Study Drug Toxicity)|0
382080|NCT00236899|1217425|P2|Overall Study|Death (Study Drug Toxicity)|0
382081|NCT00236899|1217426|P1|Overall Study|Death (Study Drug Toxicity)|1
382082|NCT00236899|1217423|P4|Overall Study|Death (Not Study Related)|0
382083|NCT00236899|1217424|P3|Overall Study|Death (Not Study Related)|0
382084|NCT00236899|1217425|P2|Overall Study|Death (Not Study Related)|0
382085|NCT00236899|1217426|P1|Overall Study|Death (Not Study Related)|2
382086|NCT00236899|1217423|P4|Overall Study|Death (Study Disease)|0
382087|NCT00236899|1217424|P3|Overall Study|Death (Study Disease)|0
382088|NCT00236899|1217425|P2|Overall Study|Death (Study Disease)|4
382089|NCT00236899|1217426|P1|Overall Study|Death (Study Disease)|1
382090|NCT00236899|1217423|P4|Overall Study|Adverse Event (Not Study Related)|7
382091|NCT00236899|1217424|P3|Overall Study|Adverse Event (Not Study Related)|4
382092|NCT00236899|1217425|P2|Overall Study|Adverse Event (Not Study Related)|3
382093|NCT00236899|1217426|P1|Overall Study|Adverse Event (Not Study Related)|3
382094|NCT00236899|1217423|P4|Overall Study|Adverse Event (Study Related)|1
382095|NCT00236899|1217424|P3|Overall Study|Adverse Event (Study Related)|2
382096|NCT00236899|1217425|P2|Overall Study|Adverse Event (Study Related)|1
382097|NCT00236899|1217426|P1|Overall Study|Adverse Event (Study Related)|1
382098|NCT00236197|1217458|P2|Overall Study|Other|2
382099|NCT00236197|1217459|P1|Overall Study|Other|0
382100|NCT00236197|1217458|P2|Overall Study|Medication non-compliance|2
382101|NCT00236197|1217459|P1|Overall Study|Medication non-compliance|1
382102|NCT00236197|1217458|P2|Overall Study|Protocol Violation|3
382103|NCT00236197|1217459|P1|Overall Study|Protocol Violation|0
382104|NCT00236197|1217458|P2|Overall Study|Lost to Follow-up|5
382105|NCT00236197|1217459|P1|Overall Study|Lost to Follow-up|1
382106|NCT00236197|1217458|P2|Overall Study|Withdrawal by Subject|2
382107|NCT00236197|1217459|P1|Overall Study|Withdrawal by Subject|3
382108|NCT00236184|1217467|P2|Overall Study|other|2
382109|NCT00236184|1217468|P1|Overall Study|other|1
382110|NCT00236184|1217467|P2|Overall Study|non-compliance with study drug|1
382111|NCT00236184|1217468|P1|Overall Study|non-compliance with study drug|2
382112|NCT00236184|1217467|P2|Overall Study|Protocol Violation|0
382113|NCT00236184|1217468|P1|Overall Study|Protocol Violation|3
382114|NCT00236184|1217467|P2|Overall Study|Withdrawal by Subject|0
382115|NCT00236184|1217468|P1|Overall Study|Withdrawal by Subject|3
382116|NCT00236184|1217467|P2|Overall Study|Physician Decision|1
382117|NCT00236184|1217468|P1|Overall Study|Physician Decision|1
382118|NCT00236184|1217467|P2|Overall Study|Lost to Follow-up|4
382119|NCT00236184|1217468|P1|Overall Study|Lost to Follow-up|3
382120|NCT00236184|1217467|P2|Overall Study|Lack of Efficacy|1
382121|NCT00236184|1217468|P1|Overall Study|Lack of Efficacy|0
382122|NCT00236184|1217467|P2|Overall Study|Adverse Event|2
382123|NCT00236184|1217468|P1|Overall Study|Adverse Event|5
382124|NCT00236080|1217479|P5|Overall Study|Miscellaneous|0
382125|NCT00236080|1217480|P4|Overall Study|Miscellaneous|0
382126|NCT00236080|1217481|P3|Overall Study|Miscellaneous|1
382127|NCT00236080|1217482|P2|Overall Study|Miscellaneous|0
382128|NCT00236080|1217483|P1|Overall Study|Miscellaneous|0
382129|NCT00236080|1217479|P5|Overall Study|Withdrawal by Subject|0
382130|NCT00236080|1217480|P4|Overall Study|Withdrawal by Subject|0
382131|NCT00236080|1217481|P3|Overall Study|Withdrawal by Subject|0
382132|NCT00236080|1217482|P2|Overall Study|Withdrawal by Subject|0
382133|NCT00236080|1217483|P1|Overall Study|Withdrawal by Subject|1
382134|NCT00236080|1217479|P5|Overall Study|Physician Decision|1
382135|NCT00236080|1217480|P4|Overall Study|Physician Decision|1
382136|NCT00236080|1217481|P3|Overall Study|Physician Decision|1
382137|NCT00236080|1217482|P2|Overall Study|Physician Decision|0
382138|NCT00236080|1217483|P1|Overall Study|Physician Decision|1
382139|NCT00236080|1217479|P5|Overall Study|Lost to Follow-up|0
382140|NCT00236080|1217480|P4|Overall Study|Lost to Follow-up|0
382141|NCT00236080|1217481|P3|Overall Study|Lost to Follow-up|0
382142|NCT00236080|1217482|P2|Overall Study|Lost to Follow-up|1
382143|NCT00236080|1217483|P1|Overall Study|Lost to Follow-up|0
382144|NCT00236080|1217479|P5|Overall Study|Adverse Event|0
382145|NCT00236080|1217480|P4|Overall Study|Adverse Event|1
382146|NCT00236080|1217481|P3|Overall Study|Adverse Event|3
382147|NCT00236080|1217482|P2|Overall Study|Adverse Event|0
382148|NCT00236080|1217483|P1|Overall Study|Adverse Event|0
382149|NCT00235989|1217504|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
382150|NCT00235989|1217505|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
382151|NCT00235989|1217506|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
382152|NCT00235989|1217507|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
382153|NCT00235989|1217508|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
382154|NCT00235989|1217509|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
382155|NCT00235989|1217504|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
382156|NCT00235989|1217505|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
382157|NCT00235989|1217506|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
382158|NCT00235989|1217507|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
382159|NCT00235989|1217508|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
382160|NCT00235989|1217509|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
382161|NCT00235989|1217504|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
382162|NCT00235989|1217505|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
382163|NCT00235989|1217506|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
382164|NCT00235989|1217507|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
382165|NCT00235989|1217508|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
382166|NCT00235989|1217509|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
382167|NCT00235989|1217504|P6|Extension Treatment Period (ET)|Adverse Event|0
382168|NCT00235989|1217505|P5|Extension Treatment Period (ET)|Adverse Event|0
382169|NCT00235989|1217506|P4|Extension Treatment Period (ET)|Adverse Event|0
382170|NCT00235989|1217507|P3|Extension Treatment Period (ET)|Adverse Event|2
382171|NCT00235989|1217508|P2|Extension Treatment Period (ET)|Adverse Event|0
382172|NCT00235989|1217509|P1|Extension Treatment Period (ET)|Adverse Event|3
382173|NCT00235989|1217504|P6|Core Treatment Period (CT)|Lost to Follow-up|2
382174|NCT00235989|1217505|P5|Core Treatment Period (CT)|Lost to Follow-up|0
382175|NCT00235989|1217506|P4|Core Treatment Period (CT)|Lost to Follow-up|0
382176|NCT00235989|1217507|P3|Core Treatment Period (CT)|Lost to Follow-up|0
382177|NCT00235989|1217508|P2|Core Treatment Period (CT)|Lost to Follow-up|0
382178|NCT00235989|1217509|P1|Core Treatment Period (CT)|Lost to Follow-up|0
382179|NCT00235872|1217523|P1|Overall Study|Administrative reason|61
382180|NCT00235872|1217523|P1|Overall Study|Withdrawal by Subject|50
382181|NCT00235872|1217523|P1|Overall Study|Lost to Follow-up|1
382182|NCT00235872|1217523|P1|Overall Study|Death|1
382183|NCT00235872|1217523|P1|Overall Study|Adverse Event|34
382184|NCT00235755|1217554|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
382185|NCT00235755|1217555|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
382186|NCT00235755|1217556|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
382187|NCT00235755|1217554|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
382188|NCT00235755|1217555|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
382189|NCT00235755|1217556|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
382190|NCT00235755|1217554|P3|12-Week Maintenance Phase|Protocol Violation|2
382191|NCT00235755|1217555|P2|12-Week Maintenance Phase|Protocol Violation|4
382192|NCT00235755|1217556|P1|12-Week Maintenance Phase|Protocol Violation|0
382193|NCT00235755|1217554|P3|12-Week Maintenance Phase|Lack of Efficacy|0
382194|NCT00235755|1217555|P2|12-Week Maintenance Phase|Lack of Efficacy|0
382195|NCT00235755|1217556|P1|12-Week Maintenance Phase|Lack of Efficacy|5
382196|NCT00235755|1217554|P3|12-Week Maintenance Phase|Lost to Follow-up|0
382197|NCT00235755|1217555|P2|12-Week Maintenance Phase|Lost to Follow-up|3
382198|NCT00235755|1217556|P1|12-Week Maintenance Phase|Lost to Follow-up|2
382199|NCT00235755|1217554|P3|12-Week Maintenance Phase|Adverse Event|26
382200|NCT00235755|1217555|P2|12-Week Maintenance Phase|Adverse Event|12
382201|NCT00235755|1217556|P1|12-Week Maintenance Phase|Adverse Event|8
382202|NCT00235755|1217554|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
382203|NCT00235755|1217555|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
382204|NCT00235755|1217556|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
382205|NCT00235755|1217554|P3|4-Week Titration Phase|Randomization Occurred in Error|0
382206|NCT00235755|1217555|P2|4-Week Titration Phase|Randomization Occurred in Error|0
382207|NCT00235755|1217556|P1|4-Week Titration Phase|Randomization Occurred in Error|1
382208|NCT00235755|1217554|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
382209|NCT00235755|1217555|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
382210|NCT00235755|1217556|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
382211|NCT00235755|1217554|P3|4-Week Titration Phase|Withdrawal by Subject|3
382212|NCT00235755|1217555|P2|4-Week Titration Phase|Withdrawal by Subject|2
382213|NCT00235755|1217556|P1|4-Week Titration Phase|Withdrawal by Subject|1
382214|NCT00235755|1217554|P3|4-Week Titration Phase|Protocol Violation|1
382215|NCT00235755|1217555|P2|4-Week Titration Phase|Protocol Violation|2
382216|NCT00235755|1217556|P1|4-Week Titration Phase|Protocol Violation|2
382217|NCT00235755|1217554|P3|4-Week Titration Phase|Lost to Follow-up|1
382218|NCT00235755|1217555|P2|4-Week Titration Phase|Lost to Follow-up|1
382219|NCT00235755|1217556|P1|4-Week Titration Phase|Lost to Follow-up|0
382220|NCT00235755|1217554|P3|4-Week Titration Phase|Adverse Event|20
382221|NCT00235755|1217555|P2|4-Week Titration Phase|Adverse Event|14
382222|NCT00235755|1217556|P1|4-Week Titration Phase|Adverse Event|6
382223|NCT00235716|1217634|P4|Overall Study|Physician Decision|3
382224|NCT00235716|1217635|P3|Overall Study|Physician Decision|1
382225|NCT00235716|1217636|P2|Overall Study|Physician Decision|1
382226|NCT00235716|1217637|P1|Overall Study|Physician Decision|0
382227|NCT00235716|1217634|P4|Overall Study|Adverse Event|0
382228|NCT00235716|1217635|P3|Overall Study|Adverse Event|1
382229|NCT00235716|1217636|P2|Overall Study|Adverse Event|1
382230|NCT00235716|1217637|P1|Overall Study|Adverse Event|1
382231|NCT00235716|1217634|P4|Overall Study|Lost to Follow-up|10
382232|NCT00235716|1217635|P3|Overall Study|Lost to Follow-up|14
382233|NCT00235716|1217636|P2|Overall Study|Lost to Follow-up|7
382234|NCT00235716|1217637|P1|Overall Study|Lost to Follow-up|12
382235|NCT00235716|1217634|P4|Overall Study|Withdrawal by Subject|18
382236|NCT00235716|1217635|P3|Overall Study|Withdrawal by Subject|17
382237|NCT00235716|1217636|P2|Overall Study|Withdrawal by Subject|19
382238|NCT00235716|1217637|P1|Overall Study|Withdrawal by Subject|23
382239|NCT00235716|1217634|P4|Overall Study|Death|31
382240|NCT00235716|1217635|P3|Overall Study|Death|32
382241|NCT00235716|1217636|P2|Overall Study|Death|39
382242|NCT00235716|1217637|P1|Overall Study|Death|26
382243|NCT00235443|1217700|P6|Overall Study|Other reasons for premature termination|6
382244|NCT00235443|1217701|P5|Overall Study|Other reasons for premature termination|3
382245|NCT00235443|1217702|P4|Overall Study|Other reasons for premature termination|7
382246|NCT00235443|1217703|P3|Overall Study|Other reasons for premature termination|6
382247|NCT00235443|1217704|P2|Overall Study|Other reasons for premature termination|6
382248|NCT00235443|1217705|P1|Overall Study|Other reasons for premature termination|1
382249|NCT00235443|1217700|P6|Overall Study|Unsatisfactory compliance|0
382250|NCT00235443|1217701|P5|Overall Study|Unsatisfactory compliance|1
382251|NCT00235443|1217702|P4|Overall Study|Unsatisfactory compliance|4
382252|NCT00235443|1217703|P3|Overall Study|Unsatisfactory compliance|3
382253|NCT00235443|1217704|P2|Overall Study|Unsatisfactory compliance|2
382254|NCT00235443|1217705|P1|Overall Study|Unsatisfactory compliance|0
382255|NCT00235443|1217700|P6|Overall Study|Lost to Follow-up|3
382256|NCT00235443|1217701|P5|Overall Study|Lost to Follow-up|4
382257|NCT00235443|1217702|P4|Overall Study|Lost to Follow-up|6
382258|NCT00235443|1217703|P3|Overall Study|Lost to Follow-up|6
382259|NCT00235443|1217704|P2|Overall Study|Lost to Follow-up|8
382260|NCT00235443|1217705|P1|Overall Study|Lost to Follow-up|0
382261|NCT00235443|1217700|P6|Overall Study|Withdrawal by Subject|12
382262|NCT00235443|1217701|P5|Overall Study|Withdrawal by Subject|10
382263|NCT00235443|1217702|P4|Overall Study|Withdrawal by Subject|24
382264|NCT00235443|1217703|P3|Overall Study|Withdrawal by Subject|25
382265|NCT00235443|1217704|P2|Overall Study|Withdrawal by Subject|9
382266|NCT00235443|1217705|P1|Overall Study|Withdrawal by Subject|3
382267|NCT00235443|1217700|P6|Overall Study|Lack of Efficacy|9
382268|NCT00235443|1217701|P5|Overall Study|Lack of Efficacy|2
382269|NCT00235443|1217702|P4|Overall Study|Lack of Efficacy|12
382270|NCT00235443|1217703|P3|Overall Study|Lack of Efficacy|5
382271|NCT00235443|1217704|P2|Overall Study|Lack of Efficacy|1
382272|NCT00235443|1217705|P1|Overall Study|Lack of Efficacy|0
382273|NCT00235443|1217700|P6|Overall Study|Adverse Event|15
382274|NCT00235443|1217701|P5|Overall Study|Adverse Event|10
382275|NCT00235443|1217702|P4|Overall Study|Adverse Event|44
382276|NCT00235443|1217703|P3|Overall Study|Adverse Event|17
382277|NCT00235443|1217704|P2|Overall Study|Adverse Event|12
382278|NCT00235443|1217705|P1|Overall Study|Adverse Event|4
382279|NCT00235391|1217846|P6|Overall Study|Death|0
382280|NCT00235391|1217847|P5|Overall Study|Death|0
382281|NCT00235391|1217848|P4|Overall Study|Death|4
382282|NCT00235391|1217849|P3|Overall Study|Death|1
382283|NCT00235391|1217850|P2|Overall Study|Death|0
382284|NCT00235391|1217851|P1|Overall Study|Death|0
382285|NCT00235391|1217846|P6|Overall Study|Administrative problems|0
382286|NCT00235391|1217847|P5|Overall Study|Administrative problems|0
382287|NCT00235391|1217848|P4|Overall Study|Administrative problems|1
382288|NCT00235391|1217849|P3|Overall Study|Administrative problems|0
382289|NCT00235391|1217850|P2|Overall Study|Administrative problems|0
382290|NCT00235391|1217851|P1|Overall Study|Administrative problems|0
382291|NCT00235391|1217846|P6|Overall Study|Lost to Follow-up|0
382292|NCT00235391|1217847|P5|Overall Study|Lost to Follow-up|0
382293|NCT00235391|1217848|P4|Overall Study|Lost to Follow-up|16
382294|NCT00235391|1217849|P3|Overall Study|Lost to Follow-up|3
382295|NCT00235391|1217850|P2|Overall Study|Lost to Follow-up|3
382296|NCT00235391|1217851|P1|Overall Study|Lost to Follow-up|0
382297|NCT00235391|1217846|P6|Overall Study|Withdrawal by Subject|0
382298|NCT00235391|1217847|P5|Overall Study|Withdrawal by Subject|5
382299|NCT00235391|1217848|P4|Overall Study|Withdrawal by Subject|61
382300|NCT00235391|1217849|P3|Overall Study|Withdrawal by Subject|3
382301|NCT00235391|1217850|P2|Overall Study|Withdrawal by Subject|3
382302|NCT00235391|1217851|P1|Overall Study|Withdrawal by Subject|2
382303|NCT00235391|1217846|P6|Overall Study|Protocol deviation|0
382304|NCT00235391|1217847|P5|Overall Study|Protocol deviation|0
382305|NCT00235391|1217848|P4|Overall Study|Protocol deviation|11
382306|NCT00235391|1217849|P3|Overall Study|Protocol deviation|1
382307|NCT00235391|1217850|P2|Overall Study|Protocol deviation|0
382308|NCT00235391|1217851|P1|Overall Study|Protocol deviation|0
382309|NCT00235391|1217846|P6|Overall Study|Condition no longer requires treatment|0
382310|NCT00235391|1217847|P5|Overall Study|Condition no longer requires treatment|1
382311|NCT00235391|1217848|P4|Overall Study|Condition no longer requires treatment|11
382312|NCT00235391|1217849|P3|Overall Study|Condition no longer requires treatment|0
382313|NCT00235391|1217850|P2|Overall Study|Condition no longer requires treatment|0
382314|NCT00235391|1217851|P1|Overall Study|Condition no longer requires treatment|3
382315|NCT00235391|1217846|P6|Overall Study|Unsatisfactory therapeutic effect|0
382316|NCT00235391|1217847|P5|Overall Study|Unsatisfactory therapeutic effect|0
382317|NCT00235391|1217848|P4|Overall Study|Unsatisfactory therapeutic effect|17
382318|NCT00235391|1217849|P3|Overall Study|Unsatisfactory therapeutic effect|2
382319|NCT00235391|1217850|P2|Overall Study|Unsatisfactory therapeutic effect|2
382320|NCT00235391|1217851|P1|Overall Study|Unsatisfactory therapeutic effect|0
382321|NCT00235391|1217846|P6|Overall Study|Abnormal laboratory value(s)|2
382322|NCT00235391|1217847|P5|Overall Study|Abnormal laboratory value(s)|1
382323|NCT00235391|1217848|P4|Overall Study|Abnormal laboratory value(s)|27
382324|NCT00235391|1217849|P3|Overall Study|Abnormal laboratory value(s)|4
382325|NCT00235391|1217850|P2|Overall Study|Abnormal laboratory value(s)|5
382326|NCT00235391|1217851|P1|Overall Study|Abnormal laboratory value(s)|3
382327|NCT00235391|1217846|P6|Overall Study|Adverse Event|2
382328|NCT00235391|1217847|P5|Overall Study|Adverse Event|5
382329|NCT00235391|1217848|P4|Overall Study|Adverse Event|72
382330|NCT00235391|1217849|P3|Overall Study|Adverse Event|10
382331|NCT00235391|1217850|P2|Overall Study|Adverse Event|5
382332|NCT00235391|1217851|P1|Overall Study|Adverse Event|4
382333|NCT00235326|1217868|P2|Overall Study|Lost to Follow-up|1400
382334|NCT00235326|1217869|P1|Overall Study|Lost to Follow-up|746
382335|NCT00234494|1217909|P1|Overall Study|Protocol Violation|2
382336|NCT00233454|1217925|P1|Overall Study|Death|6
382337|NCT00233402|1217932|P2|Overall Study|Lost to follow up etc|21
382338|NCT00233402|1217933|P1|Overall Study|Lost to follow up etc|3
382339|NCT00233402|1217932|P2|Overall Study|No Ta/T1|94
382340|NCT00233402|1217933|P1|Overall Study|No Ta/T1|89
382341|NCT00233402|1217932|P2|Overall Study|No pathology data|9
382342|NCT00233402|1217933|P1|Overall Study|No pathology data|12
382343|NCT00234104|1217983|P4|Overall Study|Physician Decision|2
382344|NCT00234104|1217984|P3|Overall Study|Physician Decision|2
382345|NCT00234104|1217985|P2|Overall Study|Physician Decision|1
382346|NCT00234104|1217986|P1|Overall Study|Physician Decision|0
382347|NCT00234104|1217983|P4|Overall Study|Protocol Violation|1
382348|NCT00234104|1217984|P3|Overall Study|Protocol Violation|0
382349|NCT00234104|1217985|P2|Overall Study|Protocol Violation|0
382350|NCT00234104|1217986|P1|Overall Study|Protocol Violation|0
382351|NCT00234104|1217983|P4|Overall Study|Adverse Event|5
382352|NCT00234104|1217984|P3|Overall Study|Adverse Event|3
382353|NCT00234104|1217985|P2|Overall Study|Adverse Event|0
382354|NCT00234104|1217986|P1|Overall Study|Adverse Event|4
382355|NCT00234065|1218027|P2|Overall Study|Not Classified|112
382356|NCT00234065|1218028|P1|Overall Study|Not Classified|111
382357|NCT00234065|1218027|P2|Overall Study|Physician Decision|22
382358|NCT00234065|1218028|P1|Overall Study|Physician Decision|23
382359|NCT00234065|1218027|P2|Overall Study|Withdrawal by Subject|56
382360|NCT00234065|1218028|P1|Overall Study|Withdrawal by Subject|73
382361|NCT00234065|1218027|P2|Overall Study|Adverse Event|166
382362|NCT00234065|1218028|P1|Overall Study|Adverse Event|268
382363|NCT00234039|1218044|P1|Overall Study|No Protocol Treatment Received|2
382364|NCT00234039|1218044|P1|Overall Study|Ineligible|9
382365|NCT00234039|1218044|P1|Overall Study|Other - Not Protocol Specified|3
382366|NCT00234039|1218044|P1|Overall Study|Progression/relapse|34
382367|NCT00234039|1218044|P1|Overall Study|Adverse Event|2
382368|NCT00233987|1218051|P1|Overall Study|Ineligible|4
382369|NCT00233987|1218051|P1|Overall Study|Eligible but No Treatment Received|2
382370|NCT00233987|1218051|P1|Overall Study|Other - Not Protocol Specified|5
382371|NCT00233987|1218051|P1|Overall Study|Reason Under Review|1
382372|NCT00233987|1218051|P1|Overall Study|Lack of Efficacy|2
382373|NCT00233987|1218051|P1|Overall Study|Withdrawal by Subject|1
382374|NCT00233948|1218060|P6|Overall Study|Adverse Event|0
382375|NCT00233948|1218061|P5|Overall Study|Adverse Event|0
382376|NCT00233948|1218062|P4|Overall Study|Adverse Event|0
382377|NCT00233948|1218063|P3|Overall Study|Adverse Event|0
382378|NCT00233948|1218064|P2|Overall Study|Adverse Event|0
382379|NCT00233948|1218065|P1|Overall Study|Adverse Event|1
382380|NCT00233324|1218084|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
382381|NCT00233324|1218085|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
382382|NCT00233324|1218086|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
382383|NCT00233324|1218087|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
382384|NCT00233324|1218084|P4|Follow up at 18-22 Months Corrected Age|Death|4
382385|NCT00233324|1218085|P3|Follow up at 18-22 Months Corrected Age|Death|5
382386|NCT00233324|1218086|P2|Follow up at 18-22 Months Corrected Age|Death|7
382387|NCT00233324|1218087|P1|Follow up at 18-22 Months Corrected Age|Death|5
382388|NCT00233324|1218084|P4|Main Study|Death|47
382389|NCT00233324|1218085|P3|Main Study|Death|62
382390|NCT00233324|1218086|P2|Main Study|Death|60
382391|NCT00233324|1218087|P1|Main Study|Death|68
382392|NCT00233064|1218141|P2|Overall Study|Moved to Dom. Republic|0
382393|NCT00233064|1218142|P1|Overall Study|Moved to Dom. Republic|1
382394|NCT00233064|1218141|P2|Overall Study|Protocol Violation|0
382395|NCT00233064|1218142|P1|Overall Study|Protocol Violation|1
382396|NCT00233064|1218141|P2|Overall Study|Relocation|1
382397|NCT00233064|1218142|P1|Overall Study|Relocation|0
382398|NCT00233064|1218141|P2|Overall Study|Death|1
382399|NCT00233064|1218142|P1|Overall Study|Death|0
382400|NCT00233064|1218141|P2|Overall Study|Withdrawal by Subject|3
382401|NCT00233064|1218142|P1|Overall Study|Withdrawal by Subject|5
382402|NCT00233064|1218141|P2|Overall Study|Lost to Follow-up|7
382403|NCT00233064|1218142|P1|Overall Study|Lost to Follow-up|7
382404|NCT00232596|1218168|P2|12-Week Maintenance Phase|Other|3
382405|NCT00232596|1218169|P1|12-Week Maintenance Phase|Other|1
382406|NCT00232596|1218168|P2|12-Week Maintenance Phase|Protocol Violation|1
382407|NCT00232596|1218169|P1|12-Week Maintenance Phase|Protocol Violation|3
382408|NCT00232596|1218168|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
382409|NCT00232596|1218169|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
382410|NCT00232596|1218168|P2|12-Week Maintenance Phase|Adverse Event|22
382411|NCT00232596|1218169|P1|12-Week Maintenance Phase|Adverse Event|7
382412|NCT00232596|1218168|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
382413|NCT00232596|1218169|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
382414|NCT00232596|1218168|P2|6-Week Titration Phase|Other|3
382415|NCT00232596|1218169|P1|6-Week Titration Phase|Other|3
382416|NCT00232596|1218168|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
382417|NCT00232596|1218169|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
382418|NCT00232596|1218168|P2|6-Week Titration Phase|Protocol Violation|3
382419|NCT00232596|1218169|P1|6-Week Titration Phase|Protocol Violation|1
382420|NCT00232596|1218168|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
382421|NCT00232596|1218169|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
382422|NCT00232596|1218168|P2|6-Week Titration Phase|Failed to Return|1
382423|NCT00232596|1218169|P1|6-Week Titration Phase|Failed to Return|2
382424|NCT00232596|1218168|P2|6-Week Titration Phase|Adverse Event|19
382425|NCT00232596|1218169|P1|6-Week Titration Phase|Adverse Event|6
382426|NCT00232557|1218230|P2|Overall Study|Lost to Follow-up|5
382427|NCT00232557|1218231|P1|Overall Study|Lost to Follow-up|3
382428|NCT00232544|1218241|P2|Overall Study|Lost to Follow-up|15
382429|NCT00232544|1218242|P1|Overall Study|Lost to Follow-up|20
382430|NCT00232180|1218257|P3|Open Label Phase|Randomized but not treated|1
382431|NCT00232180|1218258|P2|Open Label Phase|Randomized but not treated|0
382432|NCT00232180|1218259|P1|Open Label Phase|Randomized but not treated|0
382433|NCT00232180|1218257|P3|Open Label Phase|Laboratory abnormality|10
382434|NCT00232180|1218258|P2|Open Label Phase|Laboratory abnormality|0
382435|NCT00232180|1218259|P1|Open Label Phase|Laboratory abnormality|0
382436|NCT00232180|1218257|P3|Open Label Phase|Adverse Event|25
382437|NCT00232180|1218258|P2|Open Label Phase|Adverse Event|0
382438|NCT00232180|1218259|P1|Open Label Phase|Adverse Event|0
382439|NCT00232180|1218257|P3|Open Label Phase|Unspecified|16
382440|NCT00232180|1218258|P2|Open Label Phase|Unspecified|0
382441|NCT00232180|1218259|P1|Open Label Phase|Unspecified|0
382442|NCT00232180|1218257|P3|Open Label Phase|Withdrawal by Subject|37
382443|NCT00232180|1218258|P2|Open Label Phase|Withdrawal by Subject|0
382444|NCT00232180|1218259|P1|Open Label Phase|Withdrawal by Subject|0
382445|NCT00232180|1218257|P3|Open Label Phase|Study terminated by sponsor|3
382446|NCT00232180|1218258|P2|Open Label Phase|Study terminated by sponsor|0
382447|NCT00232180|1218259|P1|Open Label Phase|Study terminated by sponsor|0
382448|NCT00232180|1218257|P3|Open Label Phase|Protocol Violation|3
382449|NCT00232180|1218258|P2|Open Label Phase|Protocol Violation|0
382450|NCT00232180|1218259|P1|Open Label Phase|Protocol Violation|0
382451|NCT00232180|1218257|P3|Open Label Phase|Lost to Follow-up|5
382452|NCT00232180|1218258|P2|Open Label Phase|Lost to Follow-up|0
382453|NCT00232180|1218259|P1|Open Label Phase|Lost to Follow-up|0
382454|NCT00232180|1218257|P3|Open Label Phase|Death|48
382455|NCT00232180|1218258|P2|Open Label Phase|Death|0
382456|NCT00232180|1218259|P1|Open Label Phase|Death|0
382457|NCT00232180|1218257|P3|Double-blind (DB) Phase|Laboratory abnormality|0
382458|NCT00232180|1218258|P2|Double-blind (DB) Phase|Laboratory abnormality|7
382459|NCT00232180|1218259|P1|Double-blind (DB) Phase|Laboratory abnormality|6
382460|NCT00232180|1218257|P3|Double-blind (DB) Phase|Randomized but not treated|0
382461|NCT00232180|1218258|P2|Double-blind (DB) Phase|Randomized but not treated|4
382462|NCT00232180|1218259|P1|Double-blind (DB) Phase|Randomized but not treated|3
382463|NCT00232180|1218257|P3|Double-blind (DB) Phase|Unspecified|0
382464|NCT00232180|1218258|P2|Double-blind (DB) Phase|Unspecified|75
382465|NCT00232180|1218259|P1|Double-blind (DB) Phase|Unspecified|70
382466|NCT00232180|1218257|P3|Double-blind (DB) Phase|Adverse Event|0
382467|NCT00232180|1218258|P2|Double-blind (DB) Phase|Adverse Event|100
382468|NCT00232180|1218259|P1|Double-blind (DB) Phase|Adverse Event|83
382469|NCT00232180|1218257|P3|Double-blind (DB) Phase|Protocol Violation|0
382470|NCT00232180|1218258|P2|Double-blind (DB) Phase|Protocol Violation|21
382471|NCT00232180|1218259|P1|Double-blind (DB) Phase|Protocol Violation|28
382472|NCT00232180|1218257|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
382473|NCT00232180|1218258|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
382474|NCT00232180|1218259|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
382475|NCT00232180|1218257|P3|Double-blind (DB) Phase|Lost to Follow-up|0
382476|NCT00232180|1218258|P2|Double-blind (DB) Phase|Lost to Follow-up|28
382477|NCT00232180|1218259|P1|Double-blind (DB) Phase|Lost to Follow-up|34
382478|NCT00232180|1218257|P3|Double-blind (DB) Phase|Death|0
382479|NCT00232180|1218258|P2|Double-blind (DB) Phase|Death|222
382480|NCT00232180|1218259|P1|Double-blind (DB) Phase|Death|186
382481|NCT00232141|1218304|P2|Overall Study|Withdrawal by Subject|3
382482|NCT00232141|1218305|P1|Overall Study|Withdrawal by Subject|5
382483|NCT00232141|1218304|P2|Overall Study|Other|10
382484|NCT00232141|1218305|P1|Overall Study|Other|8
382485|NCT00232141|1218304|P2|Overall Study|Lost to Follow-up|6
382486|NCT00232141|1218305|P1|Overall Study|Lost to Follow-up|9
382487|NCT00232141|1218304|P2|Overall Study|Lack of Efficacy|3
382488|NCT00232141|1218305|P1|Overall Study|Lack of Efficacy|0
382489|NCT00232141|1218304|P2|Overall Study|Adverse Event|4
382490|NCT00232141|1218305|P1|Overall Study|Adverse Event|9
382491|NCT00231816|1218375|P2|Overall Study|Not Specified|1
382492|NCT00231816|1218376|P1|Overall Study|Not Specified|2
382493|NCT00231816|1218375|P2|Overall Study|Withdrawal by Subject|3
382494|NCT00231816|1218376|P1|Overall Study|Withdrawal by Subject|3
382495|NCT00231816|1218375|P2|Overall Study|Protocol Violation|3
382496|NCT00231816|1218376|P1|Overall Study|Protocol Violation|2
382497|NCT00231816|1218375|P2|Overall Study|Lost to Follow-up|5
382498|NCT00231816|1218376|P1|Overall Study|Lost to Follow-up|8
382499|NCT00231816|1218375|P2|Overall Study|Adverse Event|0
382500|NCT00231816|1218376|P1|Overall Study|Adverse Event|1
382501|NCT00231777|1218391|P2|Overall Study|Unspecified|2
382502|NCT00231777|1218392|P1|Overall Study|Unspecified|3
382503|NCT00231777|1218391|P2|Overall Study|Lost to Follow-up|0
382504|NCT00231777|1218392|P1|Overall Study|Lost to Follow-up|3
382505|NCT00231478|1218406|P2|Overall Study|Administrative|2
382506|NCT00231478|1218407|P1|Overall Study|Administrative|3
382507|NCT00231478|1218406|P2|Overall Study|Adverse Event|1
382508|NCT00231478|1218407|P1|Overall Study|Adverse Event|0
382509|NCT00231478|1218406|P2|Overall Study|Withdrawal by Subject|0
382510|NCT00231478|1218407|P1|Overall Study|Withdrawal by Subject|1
382511|NCT00231478|1218406|P2|Overall Study|Refused Treatment|1
382512|NCT00231478|1218407|P1|Overall Study|Refused Treatment|1
382513|NCT00231478|1218406|P2|Overall Study|Protocol Violation|2
382514|NCT00231478|1218407|P1|Overall Study|Protocol Violation|3
382515|NCT00231465|1218419|P1|Overall Study|Did not have follow up CT scans|1
382516|NCT00231465|1218419|P1|Overall Study|Completed only one cycle|1
382517|NCT00231179|1218439|P2|Overall Study|Withdrawal by Subject|3
382518|NCT00231179|1218440|P1|Overall Study|Withdrawal by Subject|3
382519|NCT00231179|1218439|P2|Overall Study|Lost to Follow-up|21
382520|NCT00231179|1218440|P1|Overall Study|Lost to Follow-up|21
382521|NCT00231114|1218467|P2|Post-Treatment Period|Withdrawal by Subject|0
382522|NCT00231114|1218468|P1|Post-Treatment Period|Withdrawal by Subject|1
382523|NCT00231114|1218467|P2|Post-Treatment Period|Physician Decision|0
382524|NCT00231114|1218468|P1|Post-Treatment Period|Physician Decision|1
382525|NCT00231114|1218467|P2|Post-Treatment Period|Lost to Follow-up|1
382526|NCT00231114|1218468|P1|Post-Treatment Period|Lost to Follow-up|6
382527|NCT00231114|1218467|P2|Treatment Period|Death: Motor Vehicle Accident|0
382528|NCT00231114|1218468|P1|Treatment Period|Death: Motor Vehicle Accident|1
382529|NCT00231114|1218467|P2|Randomized|Withdrawal by Subject|3
382530|NCT00231114|1218468|P1|Randomized|Withdrawal by Subject|6
382531|NCT00231062|1218504|P1|Overall Study|Physician Decision|6
382532|NCT00230971|1218512|P2|Baseline Participants|Reintervention|0
382533|NCT00230971|1218513|P1|Baseline Participants|Reintervention|1
382534|NCT00230971|1218512|P2|Baseline Participants|Failure to return|1
382535|NCT00230971|1218513|P1|Baseline Participants|Failure to return|1
382536|NCT00230971|1218512|P2|Baseline Participants|No bacteria observed|0
382537|NCT00230971|1218513|P1|Baseline Participants|No bacteria observed|1
382538|NCT00230971|1218512|P2|Baseline Participants|Adverse Event|0
382539|NCT00230971|1218513|P1|Baseline Participants|Adverse Event|1
382540|NCT00230971|1218512|P2|Baseline Participants|Withdrawal by Subject|1
382541|NCT00230971|1218513|P1|Baseline Participants|Withdrawal by Subject|7
382542|NCT00230971|1218512|P2|Baseline Participants|Death|5
382543|NCT00230971|1218513|P1|Baseline Participants|Death|6
382544|NCT00230971|1218512|P2|Baseline Participants|Lost to Follow-up|12
382545|NCT00230971|1218513|P1|Baseline Participants|Lost to Follow-up|5
382546|NCT00230971|1218512|P2|Randomization|No study drug administered|3
382547|NCT00230971|1218513|P1|Randomization|No study drug administered|3
382548|NCT00230282|1218551|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
382549|NCT00230282|1218551|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
382550|NCT00230282|1218551|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
382551|NCT00230282|1218551|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
382552|NCT00228813|1218556|P1|Overall Study|Death|4
382553|NCT00230178|1218565|P3|Overall Study|Various other reasons|4
382554|NCT00230178|1218566|P2|Overall Study|Various other reasons|2
382555|NCT00230178|1218567|P1|Overall Study|Various other reasons|3
382556|NCT00230178|1218565|P3|Overall Study|Withdrawal by Subject|1
382557|NCT00230178|1218566|P2|Overall Study|Withdrawal by Subject|0
382558|NCT00230178|1218567|P1|Overall Study|Withdrawal by Subject|0
382559|NCT00230178|1218565|P3|Overall Study|Adverse Event|2
382560|NCT00230178|1218566|P2|Overall Study|Adverse Event|5
382561|NCT00230178|1218567|P1|Overall Study|Adverse Event|1
382562|NCT00230048|1218619|P2|Overall Study|Lost to Follow-up|18
382563|NCT00230048|1218620|P1|Overall Study|Lost to Follow-up|13
382564|NCT00229723|1218683|P7|Maintenance Phase|Unspecified|1
382565|NCT00229723|1218684|P6|Maintenance Phase|Unspecified|3
382566|NCT00229723|1218685|P5|Maintenance Phase|Unspecified|3
382567|NCT00229723|1218686|P4|Maintenance Phase|Unspecified|2
382568|NCT00229723|1218687|P3|Maintenance Phase|Unspecified|1
382569|NCT00229723|1218688|P2|Maintenance Phase|Unspecified|4
382570|NCT00229723|1218689|P1|Maintenance Phase|Unspecified|5
382571|NCT00229723|1218683|P7|Maintenance Phase|Severe non-compliance|0
382572|NCT00229723|1218684|P6|Maintenance Phase|Severe non-compliance|0
382573|NCT00229723|1218685|P5|Maintenance Phase|Severe non-compliance|1
382574|NCT00229723|1218686|P4|Maintenance Phase|Severe non-compliance|0
382575|NCT00229723|1218687|P3|Maintenance Phase|Severe non-compliance|0
382576|NCT00229723|1218688|P2|Maintenance Phase|Severe non-compliance|1
382577|NCT00229723|1218689|P1|Maintenance Phase|Severe non-compliance|3
382578|NCT00229723|1218683|P7|Maintenance Phase|Informed consent withdrawn|0
382579|NCT00229723|1218684|P6|Maintenance Phase|Informed consent withdrawn|1
382580|NCT00229723|1218685|P5|Maintenance Phase|Informed consent withdrawn|1
382581|NCT00229723|1218686|P4|Maintenance Phase|Informed consent withdrawn|1
382582|NCT00229723|1218687|P3|Maintenance Phase|Informed consent withdrawn|0
382583|NCT00229723|1218688|P2|Maintenance Phase|Informed consent withdrawn|0
382584|NCT00229723|1218689|P1|Maintenance Phase|Informed consent withdrawn|1
382585|NCT00229723|1218683|P7|Maintenance Phase|Lost to Follow-up|1
382586|NCT00229723|1218684|P6|Maintenance Phase|Lost to Follow-up|0
382587|NCT00229723|1218685|P5|Maintenance Phase|Lost to Follow-up|0
382588|NCT00229723|1218686|P4|Maintenance Phase|Lost to Follow-up|2
382589|NCT00229723|1218687|P3|Maintenance Phase|Lost to Follow-up|2
382590|NCT00229723|1218688|P2|Maintenance Phase|Lost to Follow-up|1
382591|NCT00229723|1218689|P1|Maintenance Phase|Lost to Follow-up|0
382592|NCT00229723|1218683|P7|Maintenance Phase|Clinical progression|1
382593|NCT00229723|1218684|P6|Maintenance Phase|Clinical progression|1
382594|NCT00229723|1218685|P5|Maintenance Phase|Clinical progression|1
382595|NCT00229723|1218686|P4|Maintenance Phase|Clinical progression|2
382596|NCT00229723|1218687|P3|Maintenance Phase|Clinical progression|2
382597|NCT00229723|1218688|P2|Maintenance Phase|Clinical progression|1
382598|NCT00229723|1218689|P1|Maintenance Phase|Clinical progression|4
382599|NCT00229723|1218683|P7|Maintenance Phase|Objective disease progression|5
382600|NCT00229723|1218684|P6|Maintenance Phase|Objective disease progression|9
382601|NCT00229723|1218685|P5|Maintenance Phase|Objective disease progression|2
382602|NCT00229723|1218686|P4|Maintenance Phase|Objective disease progression|6
382603|NCT00229723|1218687|P3|Maintenance Phase|Objective disease progression|3
382604|NCT00229723|1218688|P2|Maintenance Phase|Objective disease progression|5
382605|NCT00229723|1218689|P1|Maintenance Phase|Objective disease progression|5
382606|NCT00229723|1218683|P7|Maintenance Phase|Adverse Event|2
382607|NCT00229723|1218684|P6|Maintenance Phase|Adverse Event|5
382608|NCT00229723|1218685|P5|Maintenance Phase|Adverse Event|7
382609|NCT00229723|1218686|P4|Maintenance Phase|Adverse Event|4
382610|NCT00229723|1218687|P3|Maintenance Phase|Adverse Event|1
382611|NCT00229723|1218688|P2|Maintenance Phase|Adverse Event|2
382612|NCT00229723|1218689|P1|Maintenance Phase|Adverse Event|7
382613|NCT00229723|1218683|P7|Concomitant Phase|Unspecified|0
382614|NCT00229723|1218684|P6|Concomitant Phase|Unspecified|2
382615|NCT00229723|1218685|P5|Concomitant Phase|Unspecified|0
382616|NCT00229723|1218686|P4|Concomitant Phase|Unspecified|1
382617|NCT00229723|1218687|P3|Concomitant Phase|Unspecified|1
382618|NCT00229723|1218688|P2|Concomitant Phase|Unspecified|0
382619|NCT00229723|1218689|P1|Concomitant Phase|Unspecified|3
382620|NCT00229723|1218683|P7|Concomitant Phase|Severe non-compliance|0
382621|NCT00229723|1218684|P6|Concomitant Phase|Severe non-compliance|0
382622|NCT00229723|1218685|P5|Concomitant Phase|Severe non-compliance|1
382623|NCT00229723|1218686|P4|Concomitant Phase|Severe non-compliance|0
382624|NCT00229723|1218687|P3|Concomitant Phase|Severe non-compliance|0
382625|NCT00229723|1218688|P2|Concomitant Phase|Severe non-compliance|1
382626|NCT00229723|1218689|P1|Concomitant Phase|Severe non-compliance|0
382627|NCT00229723|1218683|P7|Concomitant Phase|Informed consent withdrawn|0
382628|NCT00229723|1218684|P6|Concomitant Phase|Informed consent withdrawn|0
382629|NCT00229723|1218685|P5|Concomitant Phase|Informed consent withdrawn|0
382630|NCT00229723|1218686|P4|Concomitant Phase|Informed consent withdrawn|2
382631|NCT00229723|1218687|P3|Concomitant Phase|Informed consent withdrawn|0
382632|NCT00229723|1218688|P2|Concomitant Phase|Informed consent withdrawn|2
382633|NCT00229723|1218689|P1|Concomitant Phase|Informed consent withdrawn|3
382634|NCT00229723|1218683|P7|Concomitant Phase|Lost to Follow-up|0
382635|NCT00229723|1218684|P6|Concomitant Phase|Lost to Follow-up|0
382636|NCT00229723|1218685|P5|Concomitant Phase|Lost to Follow-up|1
382637|NCT00229723|1218686|P4|Concomitant Phase|Lost to Follow-up|0
382638|NCT00229723|1218687|P3|Concomitant Phase|Lost to Follow-up|0
382639|NCT00229723|1218688|P2|Concomitant Phase|Lost to Follow-up|0
382640|NCT00229723|1218689|P1|Concomitant Phase|Lost to Follow-up|0
382641|NCT00229723|1218683|P7|Concomitant Phase|Clinical progression|1
382642|NCT00229723|1218684|P6|Concomitant Phase|Clinical progression|0
382643|NCT00229723|1218685|P5|Concomitant Phase|Clinical progression|0
382644|NCT00229723|1218686|P4|Concomitant Phase|Clinical progression|0
382645|NCT00229723|1218687|P3|Concomitant Phase|Clinical progression|0
382646|NCT00229723|1218688|P2|Concomitant Phase|Clinical progression|0
382647|NCT00229723|1218689|P1|Concomitant Phase|Clinical progression|0
382648|NCT00229723|1218683|P7|Concomitant Phase|Objective disease progression|0
382649|NCT00229723|1218684|P6|Concomitant Phase|Objective disease progression|0
382650|NCT00229723|1218685|P5|Concomitant Phase|Objective disease progression|0
382651|NCT00229723|1218686|P4|Concomitant Phase|Objective disease progression|0
382652|NCT00229723|1218687|P3|Concomitant Phase|Objective disease progression|0
382653|NCT00229723|1218688|P2|Concomitant Phase|Objective disease progression|0
382654|NCT00229723|1218689|P1|Concomitant Phase|Objective disease progression|0
382655|NCT00229723|1218683|P7|Concomitant Phase|Adverse Event|2
382656|NCT00229723|1218684|P6|Concomitant Phase|Adverse Event|1
382657|NCT00229723|1218685|P5|Concomitant Phase|Adverse Event|0
382658|NCT00229723|1218686|P4|Concomitant Phase|Adverse Event|2
382659|NCT00229723|1218687|P3|Concomitant Phase|Adverse Event|5
382660|NCT00229723|1218688|P2|Concomitant Phase|Adverse Event|2
382661|NCT00229723|1218689|P1|Concomitant Phase|Adverse Event|4
382662|NCT00229658|1218742|P2|Overall Study|Withdrawal of consent|39
382663|NCT00229658|1218743|P1|Overall Study|Withdrawal of consent|46
382664|NCT00229658|1218742|P2|Overall Study|Serious Adverse Event|2
382665|NCT00229658|1218743|P1|Overall Study|Serious Adverse Event|2
382666|NCT00229658|1218742|P2|Overall Study|Lost to Follow-up|55
382667|NCT00229658|1218743|P1|Overall Study|Lost to Follow-up|82
382668|NCT00229658|1218742|P2|Overall Study|Other|60
382669|NCT00229658|1218743|P1|Overall Study|Other|80
382670|NCT00229658|1218742|P2|Overall Study|Investigator decision|10
382671|NCT00229658|1218743|P1|Overall Study|Investigator decision|13
382672|NCT00229658|1218742|P2|Overall Study|Administrative|1
382673|NCT00229658|1218743|P1|Overall Study|Administrative|2
382674|NCT00228566|1218775|P1|Overall Study|Miscellaneous|1
382675|NCT00228566|1218775|P1|Overall Study|Withdrawal by Subject|4
382676|NCT00228566|1218775|P1|Overall Study|Physician Decision|5
382677|NCT00228566|1218775|P1|Overall Study|Lost to Follow-up|16
382678|NCT00228566|1218775|P1|Overall Study|Lack of Efficacy|14
382679|NCT00228566|1218775|P1|Overall Study|Adverse Event|31
382680|NCT00228553|1218779|P1|Overall Study|Miscellaneous|46
382681|NCT00228553|1218779|P1|Overall Study|Pregnancy|2
382682|NCT00228553|1218779|P1|Overall Study|Withdrawal by Subject|115
382683|NCT00228553|1218779|P1|Overall Study|Protocol Violation|6
382684|NCT00228553|1218779|P1|Overall Study|Physician Decision|48
382685|NCT00228553|1218779|P1|Overall Study|Lost to Follow-up|67
382686|NCT00228553|1218779|P1|Overall Study|Lack of Efficacy|34
382687|NCT00228553|1218779|P1|Overall Study|Adverse Event|112
382688|NCT00229203|1218785|P2|Overall Study|Withdrawal by Subject|4
382689|NCT00229203|1218786|P1|Overall Study|Withdrawal by Subject|1
382690|NCT00229203|1218785|P2|Overall Study|Other|3
382691|NCT00229203|1218786|P1|Overall Study|Other|3
382692|NCT00229203|1218785|P2|Overall Study|Death|2
382693|NCT00229203|1218786|P1|Overall Study|Death|4
382694|NCT00229203|1218785|P2|Overall Study|Toxicity|1
382695|NCT00229203|1218786|P1|Overall Study|Toxicity|6
382696|NCT00229203|1218785|P2|Overall Study|Progressive disease|9
382697|NCT00229203|1218786|P1|Overall Study|Progressive disease|18
382698|NCT00228917|1218810|P4|Overall Study|Migrated/moved from study area|0
382699|NCT00228917|1218811|P3|Overall Study|Migrated/moved from study area|0
382700|NCT00228917|1218812|P2|Overall Study|Migrated/moved from study area|3
382701|NCT00228917|1218813|P1|Overall Study|Migrated/moved from study area|0
382702|NCT00228917|1218810|P4|Overall Study|Lost to Follow-up|0
382703|NCT00228917|1218811|P3|Overall Study|Lost to Follow-up|0
382704|NCT00228917|1218812|P2|Overall Study|Lost to Follow-up|0
382705|NCT00228917|1218813|P1|Overall Study|Lost to Follow-up|1
382706|NCT00228384|1218841|P2|Overall Study|Physician Decision|1
382707|NCT00228384|1218842|P1|Overall Study|Physician Decision|0
382708|NCT00228384|1218841|P2|Overall Study|Withdrawal by Subject|10
382709|NCT00228384|1218842|P1|Overall Study|Withdrawal by Subject|9
382710|NCT00228384|1218841|P2|Overall Study|Surgical Intervention (bypass)|5
382711|NCT00228384|1218842|P1|Overall Study|Surgical Intervention (bypass)|5
382712|NCT00228384|1218841|P2|Overall Study|Lost to Follow-up|10
382713|NCT00228384|1218842|P1|Overall Study|Lost to Follow-up|6
382714|NCT00228384|1218841|P2|Overall Study|Death|3
382715|NCT00228384|1218842|P1|Overall Study|Death|9
382716|NCT00227903|1218893|P2|Overall Study|Miscarriage|0
382717|NCT00227903|1218894|P1|Overall Study|Miscarriage|1
382718|NCT00227903|1218893|P2|Overall Study|Lost to Follow-up|3
382719|NCT00227903|1218894|P1|Overall Study|Lost to Follow-up|1
382720|NCT00227903|1218893|P2|Overall Study|Subject moved out of area|2
382721|NCT00227903|1218894|P1|Overall Study|Subject moved out of area|1
382722|NCT00227903|1218893|P2|Overall Study|Withdrawal by Subject|5
382723|NCT00227903|1218894|P1|Overall Study|Withdrawal by Subject|2
382724|NCT00227721|1218960|P1|Overall Study|On study, but never treated.|1
382725|NCT00227591|1218964|P1|Overall Study|Withdrawal by Subject|1
382726|NCT00227539|1218968|P1|Overall Study|Protocol Violation|1
382727|NCT00227370|1218976|P2|Overall Study|Other reasons|1
382728|NCT00227370|1218977|P1|Overall Study|Other reasons|2
382729|NCT00227370|1218976|P2|Overall Study|Physician Decision|6
382730|NCT00227370|1218977|P1|Overall Study|Physician Decision|9
382731|NCT00227370|1218976|P2|Overall Study|Adverse Event|11
382732|NCT00227370|1218977|P1|Overall Study|Adverse Event|6
382733|NCT00227370|1218976|P2|Overall Study|Death|4
382734|NCT00227370|1218977|P1|Overall Study|Death|3
382735|NCT00227370|1218976|P2|Overall Study|Withdrawal by Subject|2
382736|NCT00227370|1218977|P1|Overall Study|Withdrawal by Subject|1
382737|NCT00227344|1218997|P2|Overall Study|study terminated early|5
382738|NCT00227344|1218998|P1|Overall Study|study terminated early|12
382739|NCT00227305|1219018|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
382740|NCT00227305|1219018|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
382741|NCT00227305|1219018|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
382742|NCT00227305|1219018|P1|Overall Study|Physician Decision|3
382743|NCT00227305|1219018|P1|Overall Study|Lack of Efficacy|7
382744|NCT00227305|1219018|P1|Overall Study|MOVED OUT OF AREA|3
382745|NCT00227305|1219018|P1|Overall Study|Study specific discontinuation|13
382746|NCT00227305|1219018|P1|Overall Study|Lost to Follow-up|33
382747|NCT00227305|1219018|P1|Overall Study|Withdrawal by Subject|42
382748|NCT00227305|1219018|P1|Overall Study|Adverse Event|40
382749|NCT00227266|1219035|P3|Overall Study|Excessive weight gain|2
382750|NCT00227266|1219036|P2|Overall Study|Excessive weight gain|0
382751|NCT00227266|1219037|P1|Overall Study|Excessive weight gain|0
382752|NCT00227266|1219035|P3|Overall Study|Protocol Violation|1
382753|NCT00227266|1219036|P2|Overall Study|Protocol Violation|0
382754|NCT00227266|1219037|P1|Overall Study|Protocol Violation|1
382755|NCT00227266|1219035|P3|Overall Study|Withdrawal by Subject|1
382756|NCT00227266|1219036|P2|Overall Study|Withdrawal by Subject|0
382757|NCT00227266|1219037|P1|Overall Study|Withdrawal by Subject|0
382758|NCT00226811|1219063|P1|Overall Study|Withdrawal by Subject|2
382759|NCT00226811|1219063|P1|Overall Study|Lack of Efficacy|55
382760|NCT00226811|1219063|P1|Overall Study|Adverse Event|11
382761|NCT00226811|1219063|P1|Overall Study|Death|8
382762|NCT00226655|1219073|P1|Overall Study|Clinical deterioration|10
382763|NCT00226655|1219073|P1|Overall Study|Physician Decision|6
382764|NCT00226655|1219073|P1|Overall Study|Adverse Event|35
382765|NCT00226655|1219073|P1|Overall Study|Withdrawal by Subject|15
382766|NCT00226655|1219073|P1|Overall Study|Death|13
382767|NCT00225277|1219127|P2|Overall Study|Other|9
382768|NCT00225277|1219128|P1|Overall Study|Other|7
382769|NCT00225277|1219127|P2|Overall Study|Withdrawal by Subject|34
382770|NCT00225277|1219128|P1|Overall Study|Withdrawal by Subject|40
382771|NCT00225277|1219127|P2|Overall Study|Protocol Violation|3
382772|NCT00225277|1219128|P1|Overall Study|Protocol Violation|6
382773|NCT00225277|1219127|P2|Overall Study|Physician Decision|8
382774|NCT00225277|1219128|P1|Overall Study|Physician Decision|6
382775|NCT00225277|1219127|P2|Overall Study|Lost to Follow-up|6
382776|NCT00225277|1219128|P1|Overall Study|Lost to Follow-up|4
382777|NCT00225277|1219127|P2|Overall Study|Lack of Efficacy|1
382778|NCT00225277|1219128|P1|Overall Study|Lack of Efficacy|4
382779|NCT00225277|1219127|P2|Overall Study|Adverse Event|34
382780|NCT00225277|1219128|P1|Overall Study|Adverse Event|30
382781|NCT00225251|1219146|P2|Overall Study|Withdrawal by Subject|1
382782|NCT00225251|1219147|P1|Overall Study|Withdrawal by Subject|1
382783|NCT00225212|1219161|P1|Overall Study|Intercurrent illness|1
382784|NCT00225212|1219161|P1|Overall Study|Adverse Event|2
382785|NCT00225212|1219161|P1|Overall Study|Death|1
382786|NCT00225212|1219161|P1|Overall Study|Disease progression|2
382787|NCT00225147|1219170|P4|Open-label Phase|Withdrawal by Subject|6
382788|NCT00225147|1219171|P3|Open-label Phase|Withdrawal by Subject|0
382789|NCT00225147|1219172|P2|Open-label Phase|Withdrawal by Subject|0
382790|NCT00225147|1219173|P1|Open-label Phase|Withdrawal by Subject|0
382791|NCT00225147|1219170|P4|Open-label Phase|Lost to Follow-up|4
382792|NCT00225147|1219171|P3|Open-label Phase|Lost to Follow-up|0
382793|NCT00225147|1219172|P2|Open-label Phase|Lost to Follow-up|0
382794|NCT00225147|1219173|P1|Open-label Phase|Lost to Follow-up|0
382795|NCT00224874|1219204|P4|Overall Study|Withdrawal by Subject|0
382796|NCT00224874|1219205|P3|Overall Study|Withdrawal by Subject|1
382797|NCT00224874|1219206|P2|Overall Study|Withdrawal by Subject|0
382798|NCT00224874|1219207|P1|Overall Study|Withdrawal by Subject|0
382799|NCT00224770|1219252|P3|Overall Study|Lost to Follow-up|0
382800|NCT00224770|1219253|P2|Overall Study|Lost to Follow-up|2
382801|NCT00224770|1219254|P1|Overall Study|Lost to Follow-up|4
382802|NCT00224484|1219289|P3|Overall Study|Reaon not specified|2
382803|NCT00224484|1219290|P2|Overall Study|Reaon not specified|4
382804|NCT00224484|1219291|P1|Overall Study|Reaon not specified|5
382805|NCT00224484|1219289|P3|Overall Study|Lost to Follow-up|36
382806|NCT00224484|1219290|P2|Overall Study|Lost to Follow-up|28
382807|NCT00224484|1219291|P1|Overall Study|Lost to Follow-up|66
382808|NCT00224484|1219289|P3|Overall Study|Migrated/moved from study area|5
382809|NCT00224484|1219290|P2|Overall Study|Migrated/moved from study area|5
382810|NCT00224484|1219291|P1|Overall Study|Migrated/moved from study area|18
382811|NCT00224484|1219289|P3|Overall Study|Withdrawal by Subject|16
382812|NCT00224484|1219290|P2|Overall Study|Withdrawal by Subject|18
382813|NCT00224484|1219291|P1|Overall Study|Withdrawal by Subject|49
382814|NCT00224484|1219289|P3|Overall Study|Protocol Violation|0
382815|NCT00224484|1219290|P2|Overall Study|Protocol Violation|2
382816|NCT00224484|1219291|P1|Overall Study|Protocol Violation|2
382817|NCT00224484|1219289|P3|Overall Study|Non-Serious Adverse Event|3
382818|NCT00224484|1219290|P2|Overall Study|Non-Serious Adverse Event|7
382819|NCT00224484|1219291|P1|Overall Study|Non-Serious Adverse Event|5
382820|NCT00224484|1219289|P3|Overall Study|Serious Adverse Event|0
382821|NCT00224484|1219290|P2|Overall Study|Serious Adverse Event|1
382822|NCT00224484|1219291|P1|Overall Study|Serious Adverse Event|1
382823|NCT00224133|1219355|P1|Overall Study|Not specified|14
382824|NCT00224133|1219355|P1|Overall Study|Physician Decision|1
382825|NCT00224133|1219355|P1|Overall Study|Lost to Follow-up|21
382826|NCT00224133|1219355|P1|Overall Study|Lack of Efficacy|58
382827|NCT00224133|1219355|P1|Overall Study|Withdrawal by Subject|33
382828|NCT00224133|1219355|P1|Overall Study|Protocol Violation|6
382829|NCT00224133|1219355|P1|Overall Study|Adverse Event|93
382830|NCT00224120|1219361|P2|Overall Study|Not specified|5
382831|NCT00224120|1219362|P1|Overall Study|Not specified|4
382832|NCT00224120|1219361|P2|Overall Study|Lost to Follow-up|3
382833|NCT00224120|1219362|P1|Overall Study|Lost to Follow-up|2
382834|NCT00224120|1219361|P2|Overall Study|Lack of Efficacy|2
382835|NCT00224120|1219362|P1|Overall Study|Lack of Efficacy|0
382836|NCT00224120|1219361|P2|Overall Study|Withdrawal by Subject|10
382837|NCT00224120|1219362|P1|Overall Study|Withdrawal by Subject|5
382838|NCT00224120|1219361|P2|Overall Study|Protocol Violation|0
382839|NCT00224120|1219362|P1|Overall Study|Protocol Violation|1
382840|NCT00224120|1219361|P2|Overall Study|Adverse Event|4
382841|NCT00224120|1219362|P1|Overall Study|Adverse Event|10
382842|NCT00224107|1219372|P2|Overall Study|Not specified|1
382843|NCT00224107|1219373|P1|Overall Study|Not specified|1
382844|NCT00224107|1219372|P2|Overall Study|Physician Decision|0
382845|NCT00224107|1219373|P1|Overall Study|Physician Decision|1
382846|NCT00224107|1219372|P2|Overall Study|Lost to Follow-up|0
382847|NCT00224107|1219373|P1|Overall Study|Lost to Follow-up|4
382848|NCT00224107|1219372|P2|Overall Study|Lack of Efficacy|0
382849|NCT00224107|1219373|P1|Overall Study|Lack of Efficacy|2
382850|NCT00224107|1219372|P2|Overall Study|Withdrawal by Subject|4
382851|NCT00224107|1219373|P1|Overall Study|Withdrawal by Subject|1
382852|NCT00224107|1219372|P2|Overall Study|Protocol Violation|3
382853|NCT00224107|1219373|P1|Overall Study|Protocol Violation|2
382854|NCT00224107|1219372|P2|Overall Study|Adverse Event|6
382855|NCT00224107|1219373|P1|Overall Study|Adverse Event|20
382856|NCT00224055|1219383|P2|Overall Study|Not Specified|0
382857|NCT00224055|1219384|P1|Overall Study|Not Specified|1
382858|NCT00224055|1219383|P2|Overall Study|Withdrawal by Subject|2
382859|NCT00224055|1219384|P1|Overall Study|Withdrawal by Subject|0
382860|NCT00224055|1219383|P2|Overall Study|Inclusion Violation|6
382861|NCT00224055|1219384|P1|Overall Study|Inclusion Violation|3
382862|NCT00224055|1219383|P2|Overall Study|Protocol Violation|1
382863|NCT00224055|1219384|P1|Overall Study|Protocol Violation|1
382864|NCT00224055|1219383|P2|Overall Study|Lost to Follow-up|2
382865|NCT00224055|1219384|P1|Overall Study|Lost to Follow-up|1
382866|NCT00224055|1219383|P2|Overall Study|Adverse Event|3
382867|NCT00224055|1219384|P1|Overall Study|Adverse Event|9
382868|NCT00224042|1219394|P2|Overall Study|Not specified|0
382869|NCT00224042|1219395|P1|Overall Study|Not specified|2
382870|NCT00224042|1219394|P2|Overall Study|Did not meet lab incusion criteria|3
382871|NCT00224042|1219395|P1|Overall Study|Did not meet lab incusion criteria|2
382872|NCT00224042|1219394|P2|Overall Study|Physician Decision|1
382873|NCT00224042|1219395|P1|Overall Study|Physician Decision|0
382874|NCT00224042|1219394|P2|Overall Study|Protocol Violation|1
382875|NCT00224042|1219395|P1|Overall Study|Protocol Violation|0
382876|NCT00224042|1219394|P2|Overall Study|Adverse Event|1
382877|NCT00224042|1219395|P1|Overall Study|Adverse Event|2
382878|NCT00224029|1219407|P1|Overall Study|Other|1
382879|NCT00224029|1219407|P1|Overall Study|Withdrawal by Subject|4
382880|NCT00224029|1219407|P1|Overall Study|Lost to Follow-up|1
382881|NCT00224016|1219413|P2|Maintenance Period|Lost to Follow-up|1
382882|NCT00224016|1219414|P1|Maintenance Period|Lost to Follow-up|0
382883|NCT00224016|1219413|P2|Maintenance Period|Withdrawal by Subject|0
382884|NCT00224016|1219414|P1|Maintenance Period|Withdrawal by Subject|2
382885|NCT00224016|1219413|P2|Titration Period|Lost to Follow-up|0
382886|NCT00224016|1219414|P1|Titration Period|Lost to Follow-up|1
382887|NCT00224016|1219413|P2|Titration Period|Withdrawal by Subject|1
382888|NCT00224016|1219414|P1|Titration Period|Withdrawal by Subject|0
382889|NCT00224003|1219422|P1|Overall Study|unk|3
382890|NCT00224003|1219422|P1|Overall Study|Withdrawal by Subject|1
382891|NCT00224003|1219422|P1|Overall Study|Protocol Violation|2
382892|NCT00224003|1219422|P1|Overall Study|Adverse Event|1
382893|NCT00223977|1219429|P3|Overall Study|not specified|0
382894|NCT00223977|1219430|P2|Overall Study|not specified|0
382895|NCT00223977|1219431|P1|Overall Study|not specified|1
382896|NCT00223977|1219429|P3|Overall Study|Withdrawal by Subject|2
382897|NCT00223977|1219430|P2|Overall Study|Withdrawal by Subject|1
382898|NCT00223977|1219431|P1|Overall Study|Withdrawal by Subject|1
382899|NCT00223977|1219429|P3|Overall Study|Protocol Violation|1
382900|NCT00223977|1219430|P2|Overall Study|Protocol Violation|0
382901|NCT00223977|1219431|P1|Overall Study|Protocol Violation|0
382902|NCT00223977|1219429|P3|Overall Study|Adverse Event|0
382903|NCT00223977|1219430|P2|Overall Study|Adverse Event|10
382904|NCT00223977|1219431|P1|Overall Study|Adverse Event|7
382905|NCT00223808|1219465|P3|Overall Study|<5 hrs therapy before discharge|5
382906|NCT00223808|1219466|P2|Overall Study|<5 hrs therapy before discharge|5
382907|NCT00223808|1219467|P1|Overall Study|<5 hrs therapy before discharge|3
382908|NCT00223795|1219484|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
382909|NCT00223795|1219485|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
382910|NCT00223795|1219484|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
382911|NCT00223795|1219485|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
382912|NCT00223496|1219545|P1|Overall Study|Physician Decision|2
382913|NCT00223496|1219545|P1|Overall Study|Withdrawal by Subject|1
382914|NCT00223496|1219545|P1|Overall Study|Lack of Efficacy|6
382915|NCT00223496|1219545|P1|Overall Study|Lost to Follow-up|4
382916|NCT00223496|1219545|P1|Overall Study|screen failure|9
382917|NCT00222729|1219564|P1|Overall Study|Adverse Event|3
382918|NCT00222105|1219571|P1|Overall Study|Death|2
382919|NCT00222105|1219571|P1|Overall Study|Treatment delays|2
382920|NCT00222105|1219571|P1|Overall Study|Adverse Event|8
382921|NCT00222105|1219571|P1|Overall Study|Withdrawal by Subject|1
382922|NCT00222105|1219571|P1|Overall Study|Removed due to wrong diagnosis|1
382923|NCT00221195|1219592|P2|Overall Study|Lost to Follow-up|1
382924|NCT00221195|1219593|P1|Overall Study|Lost to Follow-up|0
382925|NCT00221195|1219592|P2|Overall Study|Death|1
382926|NCT00221195|1219593|P1|Overall Study|Death|1
382927|NCT00221195|1219592|P2|Overall Study|Withdrawal by Subject|1
382928|NCT00221195|1219593|P1|Overall Study|Withdrawal by Subject|4
382929|NCT00220805|1219619|P2|Overall Study|Develop. of choroidal neovascularization|8
382930|NCT00220805|1219620|P1|Overall Study|Develop. of choroidal neovascularization|3
382931|NCT00220805|1219619|P2|Overall Study|Lack of Efficacy|0
382932|NCT00220805|1219620|P1|Overall Study|Lack of Efficacy|1
382933|NCT00220805|1219619|P2|Overall Study|Withdrawal by Subject|0
382934|NCT00220805|1219620|P1|Overall Study|Withdrawal by Subject|3
382935|NCT00220805|1219619|P2|Overall Study|Adverse Event|3
382936|NCT00220805|1219620|P1|Overall Study|Adverse Event|1
382937|NCT00220779|1219641|P3|Overall Study|Lack of Efficacy|1
382938|NCT00220779|1219642|P2|Overall Study|Lack of Efficacy|0
382939|NCT00220779|1219643|P1|Overall Study|Lack of Efficacy|3
382940|NCT00220779|1219641|P3|Overall Study|Pregnancy|2
382941|NCT00220779|1219642|P2|Overall Study|Pregnancy|0
382942|NCT00220779|1219643|P1|Overall Study|Pregnancy|0
382943|NCT00220779|1219641|P3|Overall Study|Too time consuming|0
382944|NCT00220779|1219642|P2|Overall Study|Too time consuming|0
382945|NCT00220779|1219643|P1|Overall Study|Too time consuming|1
382946|NCT00220779|1219641|P3|Overall Study|Non-compliance|0
382947|NCT00220779|1219642|P2|Overall Study|Non-compliance|0
382948|NCT00220779|1219643|P1|Overall Study|Non-compliance|1
382949|NCT00220779|1219641|P3|Overall Study|Withdrawal by Subject|1
382950|NCT00220779|1219642|P2|Overall Study|Withdrawal by Subject|4
382951|NCT00220779|1219643|P1|Overall Study|Withdrawal by Subject|1
382952|NCT00220779|1219641|P3|Overall Study|Adverse Event|0
382953|NCT00220779|1219642|P2|Overall Study|Adverse Event|0
382954|NCT00220779|1219643|P1|Overall Study|Adverse Event|1
382955|NCT00220740|1219653|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
382956|NCT00220740|1219654|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
382957|NCT00220740|1219653|P2|Efficacy Period|Protocol Violation|0
382958|NCT00220740|1219654|P1|Efficacy Period|Protocol Violation|1
382959|NCT00220740|1219653|P2|Efficacy Period|Withdrawal by Subject|0
382960|NCT00220740|1219654|P1|Efficacy Period|Withdrawal by Subject|1
382961|NCT00220740|1219653|P2|Efficacy Period|Adverse Event|1
382962|NCT00220740|1219654|P1|Efficacy Period|Adverse Event|1
382963|NCT00220740|1219653|P2|Efficacy Period|Entered rescue treatment with placebo|0
382964|NCT00220740|1219654|P1|Efficacy Period|Entered rescue treatment with placebo|23
382965|NCT00220727|1219668|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
382966|NCT00220727|1219669|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
382967|NCT00220701|1219685|P2|Overall Study|Lost to Follow-up|4
382968|NCT00220701|1219686|P1|Overall Study|Lost to Follow-up|5
382969|NCT00220636|1219702|P1|Overall Study|Withdrawal by Subject|4
382970|NCT00219557|1219712|P3|Phase 2|Treatment not received|3
382971|NCT00219557|1219713|P2|Phase 2|Treatment not received|1
382972|NCT00219557|1219714|P1|Phase 2|Treatment not received|0
382973|NCT00219557|1219712|P3|Phase 2|Withdrawal by Subject|5
382974|NCT00219557|1219713|P2|Phase 2|Withdrawal by Subject|9
382975|NCT00219557|1219714|P1|Phase 2|Withdrawal by Subject|0
382976|NCT00219557|1219712|P3|Phase 2|Unspecified|6
382977|NCT00219557|1219713|P2|Phase 2|Unspecified|8
382978|NCT00219557|1219714|P1|Phase 2|Unspecified|0
382979|NCT00219557|1219712|P3|Phase 2|Death|2
382980|NCT00219557|1219713|P2|Phase 2|Death|8
382981|NCT00219557|1219714|P1|Phase 2|Death|0
382982|NCT00219557|1219712|P3|Phase 2|Adverse Event|2
382983|NCT00219557|1219713|P2|Phase 2|Adverse Event|22
382984|NCT00219557|1219714|P1|Phase 2|Adverse Event|0
382985|NCT00219557|1219712|P3|Phase 2|Lack of Efficacy|15
382986|NCT00219557|1219713|P2|Phase 2|Lack of Efficacy|21
382987|NCT00219557|1219714|P1|Phase 2|Lack of Efficacy|0
382988|NCT00219557|1219712|P3|Phase 1|Started chemotherapy at other institute|0
382989|NCT00219557|1219713|P2|Phase 1|Started chemotherapy at other institute|0
382990|NCT00219557|1219714|P1|Phase 1|Started chemotherapy at other institute|1
382991|NCT00219557|1219712|P3|Phase 1|Withdrawal by Subject|0
382992|NCT00219557|1219713|P2|Phase 1|Withdrawal by Subject|0
382993|NCT00219557|1219714|P1|Phase 1|Withdrawal by Subject|1
382994|NCT00219557|1219712|P3|Phase 1|Adverse Event|0
382995|NCT00219557|1219713|P2|Phase 1|Adverse Event|0
382996|NCT00219557|1219714|P1|Phase 1|Adverse Event|2
382997|NCT00219557|1219712|P3|Phase 1|Lack of Efficacy|0
382998|NCT00219557|1219713|P2|Phase 1|Lack of Efficacy|0
382999|NCT00219557|1219714|P1|Phase 1|Lack of Efficacy|3
383000|NCT00219544|1219742|P2|Single Blind Treatment Period|Withdrawal by Subject|0
383001|NCT00219544|1219743|P1|Single Blind Treatment Period|Withdrawal by Subject|1
383002|NCT00219544|1219742|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
383003|NCT00219544|1219743|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
383004|NCT00219544|1219742|P2|Single Blind Treatment Period|Lost to Follow-up|0
383005|NCT00219544|1219743|P1|Single Blind Treatment Period|Lost to Follow-up|2
383006|NCT00219544|1219742|P2|Single Blind Treatment Period|Protocol Violation|0
383007|NCT00219544|1219743|P1|Single Blind Treatment Period|Protocol Violation|4
383008|NCT00219544|1219742|P2|Single Blind Treatment Period|Adverse Event|0
383009|NCT00219544|1219743|P1|Single Blind Treatment Period|Adverse Event|9
383010|NCT00219544|1219742|P2|Single Blind Treatment Period|Lack of Efficacy|0
383011|NCT00219544|1219743|P1|Single Blind Treatment Period|Lack of Efficacy|5
383012|NCT00219349|1219781|P1|Escitalopram Phase|Physician Decision|7
383013|NCT00219349|1219781|P1|Escitalopram Phase|Withdrawal by Subject|4
383014|NCT00219349|1219781|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
383015|NCT00219349|1219781|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
383016|NCT00219349|1219781|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
383017|NCT00219284|1219787|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
383018|NCT00219284|1219788|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
383019|NCT00219284|1219787|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
383020|NCT00219284|1219788|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
383021|NCT00219284|1219787|P2|Extension Phase - 8 Weeks|Adverse Event|3
383022|NCT00219284|1219788|P1|Extension Phase - 8 Weeks|Adverse Event|2
383023|NCT00219284|1219787|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
383024|NCT00219284|1219788|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
383025|NCT00219284|1219787|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
383026|NCT00219284|1219788|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
383027|NCT00219284|1219787|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
383028|NCT00219284|1219788|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
383029|NCT00219284|1219787|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
383030|NCT00219284|1219788|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
383031|NCT00219284|1219787|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
383032|NCT00219284|1219788|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
383033|NCT00219284|1219787|P2|Treatment Phase - 16 Weeks|Adverse Event|24
383034|NCT00219284|1219788|P1|Treatment Phase - 16 Weeks|Adverse Event|26
383035|NCT00219141|1219813|P3|Overall Study|Condition no longer requires study drug|0
383036|NCT00219141|1219814|P2|Overall Study|Condition no longer requires study drug|0
383037|NCT00219141|1219815|P1|Overall Study|Condition no longer requires study drug|1
383038|NCT00219141|1219813|P3|Overall Study|Withdrawal by Subject|5
383039|NCT00219141|1219814|P2|Overall Study|Withdrawal by Subject|3
383040|NCT00219141|1219815|P1|Overall Study|Withdrawal by Subject|1
383041|NCT00219141|1219813|P3|Overall Study|Protocol Violation|1
383042|NCT00219141|1219814|P2|Overall Study|Protocol Violation|1
383043|NCT00219141|1219815|P1|Overall Study|Protocol Violation|3
383044|NCT00219141|1219813|P3|Overall Study|Lost to Follow-up|1
383045|NCT00219141|1219814|P2|Overall Study|Lost to Follow-up|4
383046|NCT00219141|1219815|P1|Overall Study|Lost to Follow-up|2
383047|NCT00219141|1219813|P3|Overall Study|Administrative problems|0
383048|NCT00219141|1219814|P2|Overall Study|Administrative problems|1
383049|NCT00219141|1219815|P1|Overall Study|Administrative problems|0
383050|NCT00219141|1219813|P3|Overall Study|Lack of Efficacy|0
383051|NCT00219141|1219814|P2|Overall Study|Lack of Efficacy|2
383052|NCT00219141|1219815|P1|Overall Study|Lack of Efficacy|3
383053|NCT00219141|1219813|P3|Overall Study|Adverse Event|5
383054|NCT00219141|1219814|P2|Overall Study|Adverse Event|10
383055|NCT00219141|1219815|P1|Overall Study|Adverse Event|4
383056|NCT00218634|1219861|P2|Overall Study|Lost to Follow-up|15
383057|NCT00218634|1219862|P1|Overall Study|Lost to Follow-up|8
383058|NCT00218543|1219882|P1|Overall Study|Adverse Event|2
383059|NCT00218543|1219882|P1|Overall Study|Physician Decision|3
383060|NCT00218543|1219882|P1|Overall Study|Withdrawal by Subject|1
383061|NCT00218543|1219882|P1|Overall Study|relocated|1
383062|NCT00218543|1219882|P1|Overall Study|Lost to Follow-up|8
383063|NCT00218296|1219988|P2|Overall Study|Randomized but did not enter treatment|67
383064|NCT00218296|1219989|P1|Overall Study|Randomized but did not enter treatment|66
383065|NCT00218296|1219988|P2|Overall Study|Withdrawal by Subject|47
383066|NCT00218296|1219989|P1|Overall Study|Withdrawal by Subject|36
383067|NCT00218296|1219988|P2|Overall Study|Lost to Follow-up|7
383068|NCT00218296|1219989|P1|Overall Study|Lost to Follow-up|9
383069|NCT00217971|1220028|P2|Overall Study|non compliant|0
383070|NCT00217971|1220029|P1|Overall Study|non compliant|1
383071|NCT00217971|1220028|P2|Overall Study|Withdrawal by Subject|12
383072|NCT00217971|1220029|P1|Overall Study|Withdrawal by Subject|7
383073|NCT00217971|1220028|P2|Overall Study|Physician Decision|1
383074|NCT00217971|1220029|P1|Overall Study|Physician Decision|0
383075|NCT00217971|1220028|P2|Overall Study|Lost to Follow-up|19
383076|NCT00217971|1220029|P1|Overall Study|Lost to Follow-up|15
383077|NCT00217971|1220028|P2|Overall Study|Adverse Event|1
383078|NCT00217971|1220029|P1|Overall Study|Adverse Event|1
383079|NCT00217672|1220044|P2|Follow-up|Lost to Follow-up|0
383080|NCT00217672|1220045|P1|Follow-up|Lost to Follow-up|1
383081|NCT00217672|1220044|P2|Follow-up|Withdrawal by Subject|0
383082|NCT00217672|1220045|P1|Follow-up|Withdrawal by Subject|4
383083|NCT00217672|1220044|P2|Treatment|secondary malignancy|0
383084|NCT00217672|1220045|P1|Treatment|secondary malignancy|1
383085|NCT00217672|1220044|P2|Treatment|Death|0
383086|NCT00217672|1220045|P1|Treatment|Death|2
383087|NCT00217672|1220044|P2|Treatment|insurance issues|1
383088|NCT00217672|1220045|P1|Treatment|insurance issues|1
383089|NCT00217672|1220044|P2|Treatment|Physician Decision|0
383090|NCT00217672|1220045|P1|Treatment|Physician Decision|6
383091|NCT00217672|1220044|P2|Treatment|reqd treatment not permitted by protocol|0
383092|NCT00217672|1220045|P1|Treatment|reqd treatment not permitted by protocol|6
383093|NCT00217672|1220044|P2|Treatment|Adverse Event|2
383094|NCT00217672|1220045|P1|Treatment|Adverse Event|18
383095|NCT00217672|1220044|P2|Treatment|disease progression|4
383096|NCT00217672|1220045|P1|Treatment|disease progression|33
383097|NCT00217672|1220044|P2|Allocation|Ineligible|0
383098|NCT00217672|1220045|P1|Allocation|Ineligible|2
383099|NCT00217620|1220051|P1|Overall Study|Never received treatment|1
383100|NCT00217620|1220051|P1|Overall Study|Ineligible|13
383101|NCT00217620|1220051|P1|Overall Study|Not Protocol Specified|4
383102|NCT00217620|1220051|P1|Overall Study|Progression|31
383103|NCT00217620|1220051|P1|Overall Study|Adverse Event|2
383104|NCT00217581|1220062|P1|Overall Study|Withdrawal by Subject|1
383105|NCT00217464|1220087|P1|Overall Study|not specified|2
383106|NCT00217464|1220087|P1|Overall Study|Progression|15
383107|NCT00217425|1220103|P1|Overall Study|Other|4
383108|NCT00217425|1220103|P1|Overall Study|Other complicating disease|1
383109|NCT00217425|1220103|P1|Overall Study|Withdrawal by Subject|4
383110|NCT00217425|1220103|P1|Overall Study|Adverse Event|8
383111|NCT00217425|1220103|P1|Overall Study|Lack of Efficacy|13
383112|NCT00217425|1220103|P1|Overall Study|Patient ineligible|5
383113|NCT00217425|1220103|P1|Overall Study|Never started treatment|2
383114|NCT00217087|1220117|P2|Overall Study|completed less than 12 months return|18
383115|NCT00217087|1220118|P1|Overall Study|completed less than 12 months return|10
383116|NCT00217087|1220117|P2|Overall Study|decided to have esophagectomy|2
383117|NCT00217087|1220118|P1|Overall Study|decided to have esophagectomy|1
383118|NCT00216086|1220141|P1|Overall Study|Social Reasons|2
383119|NCT00216086|1220141|P1|Overall Study|Diagnosis of Metastatic Disease|1
383120|NCT00216086|1220141|P1|Overall Study|Protocol Violation|1
383121|NCT00215943|1220173|P2|Overall Study|Other complications|1
383122|NCT00215943|1220174|P1|Overall Study|Other complications|3
383123|NCT00215943|1220173|P2|Overall Study|Other disease|1
383124|NCT00215943|1220174|P1|Overall Study|Other disease|0
383125|NCT00215943|1220173|P2|Overall Study|Adverse Event|6
383126|NCT00215943|1220174|P1|Overall Study|Adverse Event|3
383127|NCT00215943|1220173|P2|Overall Study|Alternate therapy|1
383128|NCT00215943|1220174|P1|Overall Study|Alternate therapy|0
383129|NCT00215943|1220173|P2|Overall Study|Disease Progression|5
383130|NCT00215943|1220174|P1|Overall Study|Disease Progression|3
383131|NCT00217022|1220194|P2|Overall Study|Withdrawal by Subject|1
383132|NCT00217022|1220195|P1|Overall Study|Withdrawal by Subject|1
383133|NCT00216736|1220205|P2|Overall Study|Lost to Follow-up|1
383134|NCT00216736|1220206|P1|Overall Study|Lost to Follow-up|1
383135|NCT00216671|1220220|P2|Overall Study|Insufficient Response Adverse Event|1
383136|NCT00216671|1220221|P1|Overall Study|Insufficient Response Adverse Event|2
383137|NCT00216671|1220220|P2|Overall Study|Ineligible, no efficacy data|2
383138|NCT00216671|1220221|P1|Overall Study|Ineligible, no efficacy data|2
383139|NCT00216671|1220220|P2|Overall Study|Patient Moved|1
383140|NCT00216671|1220221|P1|Overall Study|Patient Moved|0
383141|NCT00216671|1220220|P2|Overall Study|Investigator Illness|1
383142|NCT00216671|1220221|P1|Overall Study|Investigator Illness|0
383143|NCT00216671|1220220|P2|Overall Study|Relapse|0
383144|NCT00216671|1220221|P1|Overall Study|Relapse|1
383145|NCT00216671|1220220|P2|Overall Study|Protocol Violation|5
383146|NCT00216671|1220221|P1|Overall Study|Protocol Violation|3
383147|NCT00216671|1220220|P2|Overall Study|Physician Decision|1
383148|NCT00216671|1220221|P1|Overall Study|Physician Decision|1
383149|NCT00216671|1220220|P2|Overall Study|Ineligible|2
383150|NCT00216671|1220221|P1|Overall Study|Ineligible|0
383151|NCT00216671|1220220|P2|Overall Study|Non compliant|2
383152|NCT00216671|1220221|P1|Overall Study|Non compliant|2
383153|NCT00216671|1220220|P2|Overall Study|Lost to Follow-up|5
383154|NCT00216671|1220221|P1|Overall Study|Lost to Follow-up|3
383155|NCT00216671|1220220|P2|Overall Study|Insufficient Response|4
383156|NCT00216671|1220221|P1|Overall Study|Insufficient Response|9
383157|NCT00216671|1220220|P2|Overall Study|No Need to Continue Medication|1
383158|NCT00216671|1220221|P1|Overall Study|No Need to Continue Medication|1
383159|NCT00216671|1220220|P2|Overall Study|Refused Injections|13
383160|NCT00216671|1220221|P1|Overall Study|Refused Injections|3
383161|NCT00216671|1220220|P2|Overall Study|Withdrawal by Subject|2
383162|NCT00216671|1220221|P1|Overall Study|Withdrawal by Subject|4
383163|NCT00216671|1220220|P2|Overall Study|Pregnancy|1
383164|NCT00216671|1220221|P1|Overall Study|Pregnancy|0
383165|NCT00216671|1220220|P2|Overall Study|Adverse Event|9
383166|NCT00216671|1220221|P1|Overall Study|Adverse Event|4
383167|NCT00216476|1220239|P3|Overall Study|Patient Moved|0
383168|NCT00216476|1220240|P2|Overall Study|Patient Moved|2
383169|NCT00216476|1220241|P1|Overall Study|Patient Moved|2
383170|NCT00216476|1220239|P3|Overall Study|Protocol Deviation|0
383171|NCT00216476|1220240|P2|Overall Study|Protocol Deviation|1
383172|NCT00216476|1220241|P1|Overall Study|Protocol Deviation|5
383173|NCT00216476|1220239|P3|Overall Study|Administrative Reasons|0
383174|NCT00216476|1220240|P2|Overall Study|Administrative Reasons|1
383175|NCT00216476|1220241|P1|Overall Study|Administrative Reasons|1
383176|NCT00216476|1220239|P3|Overall Study|Higher dose/Extra Medication Required|2
383177|NCT00216476|1220240|P2|Overall Study|Higher dose/Extra Medication Required|0
383178|NCT00216476|1220241|P1|Overall Study|Higher dose/Extra Medication Required|2
383179|NCT00216476|1220239|P3|Overall Study|Non-compliance|1
383180|NCT00216476|1220240|P2|Overall Study|Non-compliance|4
383181|NCT00216476|1220241|P1|Overall Study|Non-compliance|0
383182|NCT00216476|1220239|P3|Overall Study|No Further Need for Treatment|1
383183|NCT00216476|1220240|P2|Overall Study|No Further Need for Treatment|4
383184|NCT00216476|1220241|P1|Overall Study|No Further Need for Treatment|3
383185|NCT00216476|1220239|P3|Overall Study|Refuses Injection|0
383186|NCT00216476|1220240|P2|Overall Study|Refuses Injection|0
383187|NCT00216476|1220241|P1|Overall Study|Refuses Injection|11
383188|NCT00216476|1220239|P3|Overall Study|Other|1
383189|NCT00216476|1220240|P2|Overall Study|Other|0
383190|NCT00216476|1220241|P1|Overall Study|Other|0
383191|NCT00216476|1220239|P3|Overall Study|Pregnancy|1
383192|NCT00216476|1220240|P2|Overall Study|Pregnancy|1
383193|NCT00216476|1220241|P1|Overall Study|Pregnancy|0
383194|NCT00216476|1220239|P3|Overall Study|Death|0
383195|NCT00216476|1220240|P2|Overall Study|Death|0
383196|NCT00216476|1220241|P1|Overall Study|Death|2
383197|NCT00216476|1220239|P3|Overall Study|Lack of Efficacy|0
383198|NCT00216476|1220240|P2|Overall Study|Lack of Efficacy|3
383199|NCT00216476|1220241|P1|Overall Study|Lack of Efficacy|4
383200|NCT00216476|1220239|P3|Overall Study|Adverse Event|1
383201|NCT00216476|1220240|P2|Overall Study|Adverse Event|10
383202|NCT00216476|1220241|P1|Overall Study|Adverse Event|6
383203|NCT00216476|1220239|P3|Overall Study|Lost to Follow-up|1
383204|NCT00216476|1220240|P2|Overall Study|Lost to Follow-up|9
383205|NCT00216476|1220241|P1|Overall Study|Lost to Follow-up|10
383206|NCT00216476|1220239|P3|Overall Study|Withdrawal by Subject|9
383207|NCT00216476|1220240|P2|Overall Study|Withdrawal by Subject|72
383208|NCT00216476|1220241|P1|Overall Study|Withdrawal by Subject|59
383209|NCT00216203|1220278|P1|Overall Study|Withdrawal by Subject|2
383210|NCT00215683|1220304|P3|Overall Study|Intermittent therapy required|0
383211|NCT00215683|1220305|P2|Overall Study|Intermittent therapy required|1
383212|NCT00215683|1220306|P1|Overall Study|Intermittent therapy required|0
383213|NCT00215683|1220304|P3|Overall Study|No study drug available|0
383214|NCT00215683|1220305|P2|Overall Study|No study drug available|1
383215|NCT00215683|1220306|P1|Overall Study|No study drug available|0
383216|NCT00215683|1220304|P3|Overall Study|Difficult to attend visits|0
383217|NCT00215683|1220305|P2|Overall Study|Difficult to attend visits|1
383218|NCT00215683|1220306|P1|Overall Study|Difficult to attend visits|0
383219|NCT00215683|1220304|P3|Overall Study|Physician Decision|1
383220|NCT00215683|1220305|P2|Overall Study|Physician Decision|0
383221|NCT00215683|1220306|P1|Overall Study|Physician Decision|0
383222|NCT00215683|1220304|P3|Overall Study|Withdrawal by Subject|13
383223|NCT00215683|1220305|P2|Overall Study|Withdrawal by Subject|4
383224|NCT00215683|1220306|P1|Overall Study|Withdrawal by Subject|9
383225|NCT00215683|1220304|P3|Overall Study|Lost to Follow-up|1
383226|NCT00215683|1220305|P2|Overall Study|Lost to Follow-up|2
383227|NCT00215683|1220306|P1|Overall Study|Lost to Follow-up|0
383228|NCT00215683|1220304|P3|Overall Study|Lack of Efficacy|2
383229|NCT00215683|1220305|P2|Overall Study|Lack of Efficacy|1
383230|NCT00215683|1220306|P1|Overall Study|Lack of Efficacy|5
383231|NCT00215683|1220304|P3|Overall Study|Adverse Event|15
383232|NCT00215683|1220305|P2|Overall Study|Adverse Event|16
383233|NCT00215683|1220306|P1|Overall Study|Adverse Event|15
383234|NCT00215657|1220325|P8|Overall Study|Not specified|1
383235|NCT00215657|1220326|P7|Overall Study|Not specified|6
383236|NCT00215657|1220327|P6|Overall Study|Not specified|4
383237|NCT00215657|1220328|P5|Overall Study|Not specified|5
383238|NCT00215657|1220329|P4|Overall Study|Not specified|3
383239|NCT00215657|1220330|P3|Overall Study|Not specified|2
383240|NCT00215657|1220331|P2|Overall Study|Not specified|1
383241|NCT00215657|1220332|P1|Overall Study|Not specified|3
383242|NCT00215657|1220325|P8|Overall Study|Insufficient testosterone response|7
383243|NCT00215657|1220326|P7|Overall Study|Insufficient testosterone response|4
383244|NCT00215657|1220327|P6|Overall Study|Insufficient testosterone response|12
383245|NCT00215657|1220328|P5|Overall Study|Insufficient testosterone response|8
383246|NCT00215657|1220329|P4|Overall Study|Insufficient testosterone response|12
383247|NCT00215657|1220330|P3|Overall Study|Insufficient testosterone response|1
383248|NCT00215657|1220331|P2|Overall Study|Insufficient testosterone response|4
383249|NCT00215657|1220332|P1|Overall Study|Insufficient testosterone response|5
383250|NCT00215657|1220325|P8|Overall Study|Insuff prostate specific antigen resp|2
383251|NCT00215657|1220326|P7|Overall Study|Insuff prostate specific antigen resp|3
383252|NCT00215657|1220327|P6|Overall Study|Insuff prostate specific antigen resp|2
383253|NCT00215657|1220328|P5|Overall Study|Insuff prostate specific antigen resp|1
383254|NCT00215657|1220329|P4|Overall Study|Insuff prostate specific antigen resp|2
383255|NCT00215657|1220330|P3|Overall Study|Insuff prostate specific antigen resp|2
383256|NCT00215657|1220331|P2|Overall Study|Insuff prostate specific antigen resp|2
383257|NCT00215657|1220332|P1|Overall Study|Insuff prostate specific antigen resp|3
383258|NCT00215657|1220325|P8|Overall Study|Withdrawal by Subject|3
383259|NCT00215657|1220326|P7|Overall Study|Withdrawal by Subject|10
383260|NCT00215657|1220327|P6|Overall Study|Withdrawal by Subject|1
383261|NCT00215657|1220328|P5|Overall Study|Withdrawal by Subject|6
383262|NCT00215657|1220329|P4|Overall Study|Withdrawal by Subject|1
383263|NCT00215657|1220330|P3|Overall Study|Withdrawal by Subject|3
383264|NCT00215657|1220331|P2|Overall Study|Withdrawal by Subject|3
383265|NCT00215657|1220332|P1|Overall Study|Withdrawal by Subject|6
383266|NCT00215657|1220325|P8|Overall Study|Adverse Event|3
383267|NCT00215657|1220326|P7|Overall Study|Adverse Event|0
383268|NCT00215657|1220327|P6|Overall Study|Adverse Event|1
383269|NCT00215657|1220328|P5|Overall Study|Adverse Event|3
383270|NCT00215657|1220329|P4|Overall Study|Adverse Event|0
383271|NCT00215657|1220330|P3|Overall Study|Adverse Event|3
383272|NCT00215657|1220331|P2|Overall Study|Adverse Event|1
383273|NCT00215657|1220332|P1|Overall Study|Adverse Event|5
383274|NCT00215540|1220404|P3|Overall Study|Withdrew from study medication|0
383275|NCT00215540|1220405|P2|Overall Study|Withdrew from study medication|0
383276|NCT00215540|1220406|P1|Overall Study|Withdrew from study medication|1
383277|NCT00215150|1220441|P1|Randomization Phase Placebo|Withdrawal by Subject|1
383278|NCT00215150|1220441|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
383279|NCT00215150|1220441|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
383280|NCT00215150|1220441|P1|Open Label Phase|Did not meet randomization criteria|9
383281|NCT00215150|1220441|P1|Open Label Phase|Did not complete a post base visit|13
383282|NCT00215150|1220441|P1|Open Label Phase|Withdrawal by Subject|1
383283|NCT00215150|1220441|P1|Open Label Phase|Lost to Follow-up|7
383284|NCT00215137|1220449|P3|Randomization Period|Withdrawal by Subject|0
383285|NCT00215137|1220450|P2|Randomization Period|Withdrawal by Subject|1
383286|NCT00215137|1220451|P1|Randomization Period|Withdrawal by Subject|0
383287|NCT00215137|1220449|P3|Randomization Period|Lost to Follow-up|0
383288|NCT00215137|1220450|P2|Randomization Period|Lost to Follow-up|1
383289|NCT00215137|1220451|P1|Randomization Period|Lost to Follow-up|0
383290|NCT00215137|1220449|P3|Open Label Escitalopram|Lack of Efficacy|0
383291|NCT00215137|1220450|P2|Open Label Escitalopram|Lack of Efficacy|0
383292|NCT00215137|1220451|P1|Open Label Escitalopram|Lack of Efficacy|1
383293|NCT00214461|1220562|P4|Overall Study|Withdrawal by Subject|0
383294|NCT00214461|1220563|P3|Overall Study|Withdrawal by Subject|1
383295|NCT00214461|1220564|P2|Overall Study|Withdrawal by Subject|0
383296|NCT00214461|1220565|P1|Overall Study|Withdrawal by Subject|0
383297|NCT00214461|1220562|P4|Overall Study|Adverse Event|1
383298|NCT00214461|1220563|P3|Overall Study|Adverse Event|1
383299|NCT00214461|1220564|P2|Overall Study|Adverse Event|0
383300|NCT00214461|1220565|P1|Overall Study|Adverse Event|0
383301|NCT00214383|1220581|P2|Overall Study|Lost to Follow-up|26
383302|NCT00214383|1220582|P1|Overall Study|Lost to Follow-up|16
383303|NCT00214201|1220594|P2|Overall Study|Death|2
383304|NCT00214201|1220595|P1|Overall Study|Death|0
383305|NCT00214201|1220594|P2|Overall Study|Withdrawal by Subject|0
383306|NCT00214201|1220595|P1|Overall Study|Withdrawal by Subject|2
383307|NCT00214019|1220605|P1|Overall Study|Screen failed|17
383308|NCT00214019|1220605|P1|Overall Study|Withdrawal by Subject|2
383309|NCT00214019|1220605|P1|Overall Study|Lost to Follow-up|11
383310|NCT00213135|1220615|P3|Overall Study|Unspecified|15
383311|NCT00213135|1220616|P2|Overall Study|Unspecified|12
383312|NCT00213135|1220617|P1|Overall Study|Unspecified|21
383313|NCT00213135|1220615|P3|Overall Study|Disease progression|21
383314|NCT00213135|1220616|P2|Overall Study|Disease progression|5
383315|NCT00213135|1220617|P1|Overall Study|Disease progression|4
383316|NCT00213135|1220615|P3|Overall Study|Death|2
383317|NCT00213135|1220616|P2|Overall Study|Death|1
383318|NCT00213135|1220617|P1|Overall Study|Death|1
383319|NCT00213135|1220615|P3|Overall Study|Protocol Violation|10
383320|NCT00213135|1220616|P2|Overall Study|Protocol Violation|4
383321|NCT00213135|1220617|P1|Overall Study|Protocol Violation|4
383322|NCT00213135|1220615|P3|Overall Study|Lost to Follow-up|4
383323|NCT00213135|1220616|P2|Overall Study|Lost to Follow-up|8
383324|NCT00213135|1220617|P1|Overall Study|Lost to Follow-up|11
383325|NCT00213135|1220615|P3|Overall Study|Adverse Event|5
383326|NCT00213135|1220616|P2|Overall Study|Adverse Event|5
383327|NCT00213135|1220617|P1|Overall Study|Adverse Event|9
383328|NCT00210639|1220636|P2|Overall Study|Not specified|12
383329|NCT00210639|1220637|P1|Overall Study|Not specified|18
383330|NCT00210639|1220636|P2|Overall Study|Withdrawal by Subject|1
383331|NCT00210639|1220637|P1|Overall Study|Withdrawal by Subject|8
383332|NCT00210639|1220636|P2|Overall Study|Lost to Follow-up|29
383333|NCT00210639|1220637|P1|Overall Study|Lost to Follow-up|37
383334|NCT00210626|1220645|P2|Overall Study|Not Specified|5
383335|NCT00210626|1220646|P1|Overall Study|Not Specified|4
383336|NCT00210626|1220645|P2|Overall Study|Sponser Request|0
383337|NCT00210626|1220646|P1|Overall Study|Sponser Request|1
383338|NCT00210626|1220645|P2|Overall Study|Physician Decision|2
383339|NCT00210626|1220646|P1|Overall Study|Physician Decision|0
383340|NCT00210626|1220645|P2|Overall Study|Withdrawal by Subject|20
383341|NCT00210626|1220646|P1|Overall Study|Withdrawal by Subject|29
383342|NCT00210626|1220645|P2|Overall Study|Death|0
383343|NCT00210626|1220646|P1|Overall Study|Death|1
383344|NCT00210626|1220645|P2|Overall Study|Lost to Follow-up|11
383345|NCT00210626|1220646|P1|Overall Study|Lost to Follow-up|11
383346|NCT00210626|1220645|P2|Overall Study|Protocol Violation|5
383347|NCT00210626|1220646|P1|Overall Study|Protocol Violation|1
383348|NCT00210626|1220645|P2|Overall Study|Adverse Event|2
383349|NCT00210626|1220646|P1|Overall Study|Adverse Event|1
383350|NCT00212758|1220654|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
383351|NCT00212758|1220655|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
383352|NCT00212758|1220654|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
383353|NCT00212758|1220655|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
383354|NCT00212355|1220661|P1|Overall Study|A change of address|1
383355|NCT00212355|1220661|P1|Overall Study|Withdrawal by Subject|1
383356|NCT00212355|1220661|P1|Overall Study|Adverse Event|1
383357|NCT00211887|1220704|P3|Overall Study|Side effects|5
383358|NCT00211887|1220705|P2|Overall Study|Side effects|13
383359|NCT00211887|1220706|P1|Overall Study|Side effects|19
383360|NCT00211887|1220704|P3|Overall Study|Other medical reason|7
383361|NCT00211887|1220705|P2|Overall Study|Other medical reason|11
383362|NCT00211887|1220706|P1|Overall Study|Other medical reason|15
383363|NCT00211887|1220704|P3|Overall Study|Non-medical reason|8
383364|NCT00211887|1220705|P2|Overall Study|Non-medical reason|14
383365|NCT00211887|1220706|P1|Overall Study|Non-medical reason|31
383366|NCT00211887|1220704|P3|Overall Study|Lost to Follow-up|9
383367|NCT00211887|1220705|P2|Overall Study|Lost to Follow-up|13
383368|NCT00211887|1220706|P1|Overall Study|Lost to Follow-up|28
383369|NCT00211887|1220704|P3|Overall Study|Death|1
383370|NCT00211887|1220705|P2|Overall Study|Death|1
383371|NCT00211887|1220706|P1|Overall Study|Death|1
383372|NCT00211887|1220704|P3|Overall Study|Adverse Event|6
383373|NCT00211887|1220705|P2|Overall Study|Adverse Event|4
383374|NCT00211887|1220706|P1|Overall Study|Adverse Event|8
383375|NCT00211809|1220723|P1|Overall Study|side effects|2
383376|NCT00211809|1220723|P1|Overall Study|Pregnancy|1
383377|NCT00211809|1220723|P1|Overall Study|Lost to Follow-up|2
383378|NCT00211809|1220723|P1|Overall Study|Lack of Efficacy|1
383379|NCT00211536|1220750|P2|Overall Study|Adverse Event|0
383380|NCT00211536|1220751|P1|Overall Study|Adverse Event|2
383381|NCT00211536|1220750|P2|Overall Study|Physician Decision|5
383382|NCT00211536|1220751|P1|Overall Study|Physician Decision|0
383383|NCT00211536|1220750|P2|Overall Study|Withdrawal by Subject|2
383384|NCT00211536|1220751|P1|Overall Study|Withdrawal by Subject|2
383385|NCT00211510|1220767|P2|Overall Study|Withdrawal by Subject|1
383386|NCT00211510|1220768|P1|Overall Study|Withdrawal by Subject|3
383387|NCT00211510|1220767|P2|Overall Study|Physician Decision|1
383388|NCT00211510|1220768|P1|Overall Study|Physician Decision|3
383389|NCT00211237|1220786|P2|Overall Study|Physician Decision|2
383390|NCT00211237|1220787|P1|Overall Study|Physician Decision|0
383391|NCT00211237|1220786|P2|Overall Study|Withdrawal by Subject|14
383392|NCT00211237|1220787|P1|Overall Study|Withdrawal by Subject|5
383393|NCT00211237|1220786|P2|Overall Study|Lost to Follow-up|2
383394|NCT00211237|1220787|P1|Overall Study|Lost to Follow-up|2
383395|NCT00211237|1220786|P2|Overall Study|Death|12
383396|NCT00211237|1220787|P1|Overall Study|Death|23
383397|NCT00211172|1220795|P2|Overall Study|Died or lost health plan eligibility|32
383398|NCT00211172|1220796|P1|Overall Study|Died or lost health plan eligibility|39
383399|NCT00211081|1220802|P1|Overall Study|Withdrawal by Subject|2
383400|NCT00210470|1220806|P1|Overall Study|Subject did not continue to surgery|1
383401|NCT00209560|1220812|P2|Overall Study|Lack of Efficacy|0
383402|NCT00209560|1220813|P1|Overall Study|Lack of Efficacy|1
383403|NCT00209339|1220832|P1|At 5 Years Follow-up|Death|1
383404|NCT00209339|1220832|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
383405|NCT00209339|1220832|P1|At 5 Years Follow-up|Withdrawal by Subject|2
383406|NCT00209339|1220832|P1|At 4 Years Follow-up|Death|1
383407|NCT00209339|1220832|P1|At 4 Years Follow-up|Withdrawal by Subject|4
383408|NCT00209339|1220832|P1|At 3 Years Follow-up|Withdrawal by Subject|1
383409|NCT00209339|1220832|P1|At 24 Months Follow-up|Death|1
383410|NCT00209339|1220832|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
383411|NCT00209339|1220832|P1|At 24 Months Follow-up|Withdrawal by Subject|4
383412|NCT00209339|1220832|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
383413|NCT00209339|1220832|P1|At 12 Months Follow-up|Death|1
383414|NCT00209339|1220832|P1|At 12 Months Follow-up|Withdrawal by Subject|8
383415|NCT00209170|1220916|P2|Overall Study|Lack of Efficacy|1
383416|NCT00209170|1220917|P1|Overall Study|Lack of Efficacy|0
383417|NCT00209170|1220916|P2|Overall Study|Withdrawal by Subject|1
383418|NCT00209170|1220917|P1|Overall Study|Withdrawal by Subject|2
383419|NCT00209170|1220916|P2|Overall Study|Adverse Event|1
383420|NCT00209170|1220917|P1|Overall Study|Adverse Event|0
383421|NCT00209131|1220925|P2|Overall Study|Lack of personnel due to turnovers.|11
383422|NCT00209131|1220926|P1|Overall Study|Lack of personnel due to turnovers.|15
383423|NCT00209092|1220936|P2|Overall Study|Withdrawal by Subject|0
383424|NCT00209092|1220937|P1|Overall Study|Withdrawal by Subject|1
383425|NCT00209092|1220936|P2|Overall Study|Adverse Event|1
383426|NCT00209092|1220937|P1|Overall Study|Adverse Event|0
383427|NCT00209092|1220936|P2|Overall Study|Progression of disease|1
383428|NCT00209092|1220937|P1|Overall Study|Progression of disease|7
383429|NCT00209027|1220947|P2|Overall Study|study terminated|0
383430|NCT00209027|1220948|P1|Overall Study|study terminated|10
383431|NCT00208767|1220972|P2|Overall Study|Lost to Follow-up|3
383432|NCT00208767|1220973|P1|Overall Study|Lost to Follow-up|3
383433|NCT00208767|1220972|P2|Overall Study|Death|0
383434|NCT00208767|1220973|P1|Overall Study|Death|1
383435|NCT00208767|1220972|P2|Overall Study|Withdrawal by Subject|3
383436|NCT00208767|1220973|P1|Overall Study|Withdrawal by Subject|14
383437|NCT00208767|1220972|P2|Overall Study|Adverse Event|1
383438|NCT00208767|1220973|P1|Overall Study|Adverse Event|9
383439|NCT00208325|1221001|P4|Overall Study|Mis-Randomized|0
383440|NCT00208325|1221002|P3|Overall Study|Mis-Randomized|0
383441|NCT00208325|1221003|P2|Overall Study|Mis-Randomized|20
383442|NCT00208325|1221004|P1|Overall Study|Mis-Randomized|17
383443|NCT00208325|1221001|P4|Overall Study|Other|0
383444|NCT00208325|1221002|P3|Overall Study|Other|1
383445|NCT00208325|1221003|P2|Overall Study|Other|1
383446|NCT00208325|1221004|P1|Overall Study|Other|2
383447|NCT00208325|1221001|P4|Overall Study|Does not wish to Continue in Study|2
383448|NCT00208325|1221002|P3|Overall Study|Does not wish to Continue in Study|3
383449|NCT00208325|1221003|P2|Overall Study|Does not wish to Continue in Study|8
383450|NCT00208325|1221004|P1|Overall Study|Does not wish to Continue in Study|5
383451|NCT00208325|1221001|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
383452|NCT00208325|1221002|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
383453|NCT00208325|1221003|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
383454|NCT00208325|1221004|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
383455|NCT00208325|1221001|P4|Overall Study|Lost to Follow-up|0
383456|NCT00208325|1221002|P3|Overall Study|Lost to Follow-up|2
383457|NCT00208325|1221003|P2|Overall Study|Lost to Follow-up|0
383458|NCT00208325|1221004|P1|Overall Study|Lost to Follow-up|1
383459|NCT00208325|1221001|P4|Overall Study|Revision|4
383460|NCT00208325|1221002|P3|Overall Study|Revision|0
383461|NCT00208325|1221003|P2|Overall Study|Revision|1
383462|NCT00208325|1221004|P1|Overall Study|Revision|4
383463|NCT00208325|1221001|P4|Overall Study|Withdrawal by Subject|0
383464|NCT00208325|1221002|P3|Overall Study|Withdrawal by Subject|0
383465|NCT00208325|1221003|P2|Overall Study|Withdrawal by Subject|1
383466|NCT00208325|1221004|P1|Overall Study|Withdrawal by Subject|0
383467|NCT00208325|1221001|P4|Overall Study|Death|5
383468|NCT00208325|1221002|P3|Overall Study|Death|7
383469|NCT00208325|1221003|P2|Overall Study|Death|19
383470|NCT00208325|1221004|P1|Overall Study|Death|18
383471|NCT00207740|1221139|P4|Overall Study|Not Specified|5
383472|NCT00207740|1221140|P3|Overall Study|Not Specified|7
383473|NCT00207740|1221141|P2|Overall Study|Not Specified|10
383474|NCT00207740|1221142|P1|Overall Study|Not Specified|2
383475|NCT00207740|1221139|P4|Overall Study|Sponsor Directive|21
383476|NCT00207740|1221140|P3|Overall Study|Sponsor Directive|16
383477|NCT00207740|1221141|P2|Overall Study|Sponsor Directive|15
383478|NCT00207740|1221142|P1|Overall Study|Sponsor Directive|22
383479|NCT00207740|1221139|P4|Overall Study|Death|1
383480|NCT00207740|1221140|P3|Overall Study|Death|0
383481|NCT00207740|1221141|P2|Overall Study|Death|0
383482|NCT00207740|1221142|P1|Overall Study|Death|0
383483|NCT00207740|1221139|P4|Overall Study|Lost to Follow-up|1
383484|NCT00207740|1221140|P3|Overall Study|Lost to Follow-up|1
383485|NCT00207740|1221141|P2|Overall Study|Lost to Follow-up|2
383486|NCT00207740|1221142|P1|Overall Study|Lost to Follow-up|0
383487|NCT00207740|1221139|P4|Overall Study|Unsatisfactory therapeutic effect|4
383488|NCT00207740|1221140|P3|Overall Study|Unsatisfactory therapeutic effect|2
383489|NCT00207740|1221141|P2|Overall Study|Unsatisfactory therapeutic effect|0
383490|NCT00207740|1221142|P1|Overall Study|Unsatisfactory therapeutic effect|1
383491|NCT00207740|1221139|P4|Overall Study|Adverse Event|11
383492|NCT00207740|1221140|P3|Overall Study|Adverse Event|14
383493|NCT00207740|1221141|P2|Overall Study|Adverse Event|14
383494|NCT00207740|1221142|P1|Overall Study|Adverse Event|4
383495|NCT00207727|1221188|P5|Overall Study|Not specified|33
383496|NCT00207727|1221189|P4|Overall Study|Not specified|37
383497|NCT00207727|1221190|P3|Overall Study|Not specified|41
383498|NCT00207727|1221191|P2|Overall Study|Not specified|41
383499|NCT00207727|1221192|P1|Overall Study|Not specified|38
383500|NCT00207727|1221188|P5|Overall Study|Lost to Follow-up|0
383501|NCT00207727|1221189|P4|Overall Study|Lost to Follow-up|0
383502|NCT00207727|1221190|P3|Overall Study|Lost to Follow-up|0
383503|NCT00207727|1221191|P2|Overall Study|Lost to Follow-up|1
383504|NCT00207727|1221192|P1|Overall Study|Lost to Follow-up|0
383505|NCT00207727|1221188|P5|Overall Study|Withdrawal by Subject|1
383506|NCT00207727|1221189|P4|Overall Study|Withdrawal by Subject|0
383507|NCT00207727|1221190|P3|Overall Study|Withdrawal by Subject|0
383508|NCT00207727|1221191|P2|Overall Study|Withdrawal by Subject|0
383509|NCT00207727|1221192|P1|Overall Study|Withdrawal by Subject|0
383510|NCT00207714|1221219|P5|Overall Study|Unspecified|0
383511|NCT00207714|1221220|P4|Overall Study|Unspecified|1
383512|NCT00207714|1221221|P3|Overall Study|Unspecified|5
383513|NCT00207714|1221222|P2|Overall Study|Unspecified|2
383514|NCT00207714|1221223|P1|Overall Study|Unspecified|3
383515|NCT00207714|1221219|P5|Overall Study|Unsatisfactory therapeutic effect|4
383516|NCT00207714|1221220|P4|Overall Study|Unsatisfactory therapeutic effect|4
383517|NCT00207714|1221221|P3|Overall Study|Unsatisfactory therapeutic effect|1
383518|NCT00207714|1221222|P2|Overall Study|Unsatisfactory therapeutic effect|3
383519|NCT00207714|1221223|P1|Overall Study|Unsatisfactory therapeutic effect|5
383520|NCT00207714|1221219|P5|Overall Study|Adverse Event|1
383521|NCT00207714|1221220|P4|Overall Study|Adverse Event|3
383522|NCT00207714|1221221|P3|Overall Study|Adverse Event|4
383523|NCT00207714|1221222|P2|Overall Study|Adverse Event|2
383524|NCT00207714|1221223|P1|Overall Study|Adverse Event|6
383525|NCT00207142|1221245|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
383526|NCT00207142|1221246|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
383527|NCT00207142|1221247|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
383528|NCT00207142|1221248|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
383529|NCT00207142|1221245|P4|Maintenance Phase/Rescue Phase|Death|1
383530|NCT00207142|1221246|P3|Maintenance Phase/Rescue Phase|Death|0
383531|NCT00207142|1221247|P2|Maintenance Phase/Rescue Phase|Death|0
383532|NCT00207142|1221248|P1|Maintenance Phase/Rescue Phase|Death|0
383533|NCT00207142|1221245|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
383534|NCT00207142|1221246|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
383535|NCT00207142|1221247|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
383536|NCT00207142|1221248|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
383537|NCT00207142|1221245|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
383538|NCT00207142|1221246|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
383539|NCT00207142|1221247|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
383540|NCT00207142|1221248|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
383541|NCT00207142|1221245|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
383542|NCT00207142|1221246|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
383543|NCT00207142|1221247|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
383544|NCT00207142|1221248|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
383545|NCT00207142|1221245|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
383546|NCT00207142|1221246|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
383547|NCT00207142|1221247|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
383548|NCT00207142|1221248|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
383549|NCT00207142|1221245|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
383550|NCT00207142|1221246|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
383551|NCT00207142|1221247|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
383552|NCT00207142|1221248|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
383553|NCT00207142|1221245|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
383554|NCT00207142|1221246|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
383555|NCT00207142|1221247|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
383556|NCT00207142|1221248|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
383557|NCT00207142|1221245|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
383558|NCT00207142|1221246|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
383559|NCT00207142|1221247|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
383560|NCT00207142|1221248|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
383561|NCT00207142|1221245|P4|Induction Phase|Missing lab data|0
383562|NCT00207142|1221246|P3|Induction Phase|Missing lab data|0
383563|NCT00207142|1221247|P2|Induction Phase|Missing lab data|0
383564|NCT00207142|1221248|P1|Induction Phase|Missing lab data|1
383565|NCT00207142|1221245|P4|Induction Phase|Incarceration|0
383566|NCT00207142|1221246|P3|Induction Phase|Incarceration|0
383567|NCT00207142|1221247|P2|Induction Phase|Incarceration|0
383568|NCT00207142|1221248|P1|Induction Phase|Incarceration|1
383569|NCT00207142|1221245|P4|Induction Phase|Withdrawal by Subject|0
383570|NCT00207142|1221246|P3|Induction Phase|Withdrawal by Subject|0
383571|NCT00207142|1221247|P2|Induction Phase|Withdrawal by Subject|0
383572|NCT00207142|1221248|P1|Induction Phase|Withdrawal by Subject|4
383573|NCT00207142|1221245|P4|Induction Phase|Subject no longer meets study criteria|0
383574|NCT00207142|1221246|P3|Induction Phase|Subject no longer meets study criteria|0
383575|NCT00207142|1221247|P2|Induction Phase|Subject no longer meets study criteria|0
383576|NCT00207142|1221248|P1|Induction Phase|Subject no longer meets study criteria|3
383577|NCT00207142|1221245|P4|Induction Phase|Pregnancy|0
383578|NCT00207142|1221246|P3|Induction Phase|Pregnancy|0
383579|NCT00207142|1221247|P2|Induction Phase|Pregnancy|0
383580|NCT00207142|1221248|P1|Induction Phase|Pregnancy|1
383581|NCT00207142|1221245|P4|Induction Phase|Poor/noncompliance|0
383582|NCT00207142|1221246|P3|Induction Phase|Poor/noncompliance|0
383583|NCT00207142|1221247|P2|Induction Phase|Poor/noncompliance|0
383584|NCT00207142|1221248|P1|Induction Phase|Poor/noncompliance|2
383585|NCT00207142|1221245|P4|Induction Phase|Physician Decision|0
383586|NCT00207142|1221246|P3|Induction Phase|Physician Decision|0
383587|NCT00207142|1221247|P2|Induction Phase|Physician Decision|0
383588|NCT00207142|1221248|P1|Induction Phase|Physician Decision|2
383589|NCT00207142|1221245|P4|Induction Phase|Lost to Follow-up|0
383590|NCT00207142|1221246|P3|Induction Phase|Lost to Follow-up|0
383591|NCT00207142|1221247|P2|Induction Phase|Lost to Follow-up|0
383592|NCT00207142|1221248|P1|Induction Phase|Lost to Follow-up|5
383593|NCT00207142|1221245|P4|Induction Phase|Lack of Efficacy|0
383594|NCT00207142|1221246|P3|Induction Phase|Lack of Efficacy|0
383595|NCT00207142|1221247|P2|Induction Phase|Lack of Efficacy|0
383596|NCT00207142|1221248|P1|Induction Phase|Lack of Efficacy|1
383597|NCT00207142|1221245|P4|Induction Phase|Death|0
383598|NCT00207142|1221246|P3|Induction Phase|Death|0
383599|NCT00207142|1221247|P2|Induction Phase|Death|0
383600|NCT00207142|1221248|P1|Induction Phase|Death|1
383601|NCT00207142|1221245|P4|Induction Phase|Adverse Event|0
383602|NCT00207142|1221246|P3|Induction Phase|Adverse Event|0
383603|NCT00207142|1221247|P2|Induction Phase|Adverse Event|0
383604|NCT00207142|1221248|P1|Induction Phase|Adverse Event|9
383605|NCT00207090|1221285|P1|Overall Study|Physician Decision|1
383606|NCT00207090|1221285|P1|Overall Study|Disease progression/relapse|2
383607|NCT00207090|1221285|P1|Overall Study|Chest wall mass larger|1
383608|NCT00207090|1221285|P1|Overall Study|Study drug toxicity|3
383609|NCT00206726|1221314|P1|Overall Study|Withdrawal by Subject|8
383610|NCT00206726|1221314|P1|Overall Study|Protocol Violation|1
383611|NCT00206726|1221314|P1|Overall Study|Death|4
383612|NCT00206726|1221314|P1|Overall Study|Adverse Event|17
383613|NCT00206726|1221314|P1|Overall Study|Bone marrow transplant|1
383614|NCT00206726|1221314|P1|Overall Study|Placed on new protocol|1
383615|NCT00206726|1221314|P1|Overall Study|Progressive disease or relapsed disease|18
383616|NCT00206726|1221314|P1|Overall Study|Delayed recovery of blood counts|1
383617|NCT00206518|1221325|P2|Overall Study|Protocol Violation|1
383618|NCT00206518|1221326|P1|Overall Study|Protocol Violation|1
383619|NCT00206518|1221325|P2|Overall Study|Physician Decision|0
383620|NCT00206518|1221326|P1|Overall Study|Physician Decision|1
383621|NCT00206518|1221325|P2|Overall Study|Adverse Event|1
383622|NCT00206518|1221326|P1|Overall Study|Adverse Event|2
383623|NCT00206518|1221325|P2|Overall Study|Lack of Efficacy|4
383624|NCT00206518|1221326|P1|Overall Study|Lack of Efficacy|6
383625|NCT00206440|1221338|P2|Overall Study|Adverse Event|2
383626|NCT00206440|1221339|P1|Overall Study|Adverse Event|4
383627|NCT00206440|1221338|P2|Overall Study|Protocol Violation|2
383628|NCT00206440|1221339|P1|Overall Study|Protocol Violation|1
383629|NCT00206427|1221345|P1|Overall Study|Adverse Event|2
383630|NCT00206102|1221351|P2|Overall Study|None of those categories|36
383631|NCT00206102|1221352|P1|Overall Study|None of those categories|42
383632|NCT00206102|1221351|P2|Overall Study|Study-specific discontinuation criteria|17
383633|NCT00206102|1221352|P1|Overall Study|Study-specific discontinuation criteria|18
383634|NCT00206102|1221351|P2|Overall Study|Withdrawal by Subject|101
383635|NCT00206102|1221352|P1|Overall Study|Withdrawal by Subject|118
383636|NCT00206102|1221351|P2|Overall Study|Lost to Follow-up|66
383637|NCT00206102|1221352|P1|Overall Study|Lost to Follow-up|95
383638|NCT00206102|1221351|P2|Overall Study|Lack of therapeutic response|11
383639|NCT00206102|1221352|P1|Overall Study|Lack of therapeutic response|16
383640|NCT00206102|1221351|P2|Overall Study|Protocol Violation|2
383641|NCT00206102|1221352|P1|Overall Study|Protocol Violation|0
383642|NCT00206102|1221351|P2|Overall Study|Adverse Event|82
383643|NCT00206102|1221352|P1|Overall Study|Adverse Event|119
383644|NCT00206076|1221388|P2|Overall Study|Withdrawal by Subject|1
383645|NCT00206076|1221389|P1|Overall Study|Withdrawal by Subject|1
383646|NCT00206076|1221388|P2|Overall Study|Physician Decision|0
383647|NCT00206076|1221389|P1|Overall Study|Physician Decision|2
383648|NCT00205881|1221399|P1|Overall Study|Withdrawal by Subject|16
383649|NCT00205855|1221404|P1|Overall Study|Withdrawal by Subject|5
383650|NCT00205855|1221404|P1|Overall Study|Only received temporary implants|16
383651|NCT00205803|1221410|P2|Toddler Dose|Lost to Follow-up|3
383652|NCT00205803|1221411|P1|Toddler Dose|Lost to Follow-up|2
383653|NCT00205803|1221410|P2|After Infant Series|Unspecified|4
383654|NCT00205803|1221411|P1|After Infant Series|Unspecified|10
383655|NCT00205803|1221410|P2|After Infant Series|Withdrawal by Subject|4
383656|NCT00205803|1221411|P1|After Infant Series|Withdrawal by Subject|1
383657|NCT00205803|1221410|P2|After Infant Series|Physician Decision|2
383658|NCT00205803|1221411|P1|After Infant Series|Physician Decision|3
383659|NCT00205803|1221410|P2|After Infant Series|Lost to Follow-up|1
383660|NCT00205803|1221411|P1|After Infant Series|Lost to Follow-up|2
383661|NCT00205803|1221410|P2|After Infant Series|Protocol Violation|1
383662|NCT00205803|1221411|P1|After Infant Series|Protocol Violation|1
383663|NCT00205803|1221410|P2|After Infant Series|Adverse Event|1
383664|NCT00205803|1221411|P1|After Infant Series|Adverse Event|1
383665|NCT00205803|1221410|P2|Infant Series|Sponsor request|0
383666|NCT00205803|1221411|P1|Infant Series|Sponsor request|1
383667|NCT00205803|1221410|P2|Infant Series|Non-compliant|0
383668|NCT00205803|1221411|P1|Infant Series|Non-compliant|1
383669|NCT00205803|1221410|P2|Infant Series|Lost Kaiser coverage|1
383670|NCT00205803|1221411|P1|Infant Series|Lost Kaiser coverage|0
383671|NCT00205803|1221410|P2|Infant Series|Protocol Violation|0
383672|NCT00205803|1221411|P1|Infant Series|Protocol Violation|1
383673|NCT00205803|1221410|P2|Infant Series|Physician Decision|1
383674|NCT00205803|1221411|P1|Infant Series|Physician Decision|3
383675|NCT00205803|1221410|P2|Infant Series|Withdrawal by Subject|5
383676|NCT00205803|1221411|P1|Infant Series|Withdrawal by Subject|2
383677|NCT00205803|1221410|P2|Infant Series|Lost to Follow-up|4
383678|NCT00205803|1221411|P1|Infant Series|Lost to Follow-up|10
383679|NCT00205777|1221467|P6|Study Extension II|Enrolled but not treated|131
383680|NCT00205777|1221468|P5|Study Extension II|Enrolled but not treated|0
383681|NCT00205777|1221469|P4|Study Extension II|Enrolled but not treated|71
383682|NCT00205777|1221470|P3|Study Extension II|Enrolled but not treated|0
383683|NCT00205777|1221471|P2|Study Extension II|Enrolled but not treated|0
383684|NCT00205777|1221472|P1|Study Extension II|Enrolled but not treated|0
383685|NCT00205777|1221467|P6|Study Extension II|Other Event|20
383686|NCT00205777|1221468|P5|Study Extension II|Other Event|0
383687|NCT00205777|1221469|P4|Study Extension II|Other Event|12
383688|NCT00205777|1221470|P3|Study Extension II|Other Event|0
383689|NCT00205777|1221471|P2|Study Extension II|Other Event|0
383690|NCT00205777|1221472|P1|Study Extension II|Other Event|0
383691|NCT00205777|1221467|P6|Study Extension II|Failed to return|26
383692|NCT00205777|1221468|P5|Study Extension II|Failed to return|0
383693|NCT00205777|1221469|P4|Study Extension II|Failed to return|14
383694|NCT00205777|1221470|P3|Study Extension II|Failed to return|0
383695|NCT00205777|1221471|P2|Study Extension II|Failed to return|0
383696|NCT00205777|1221472|P1|Study Extension II|Failed to return|0
383697|NCT00205777|1221467|P6|Study Extension II|Lack of Efficacy|1
383698|NCT00205777|1221468|P5|Study Extension II|Lack of Efficacy|0
383699|NCT00205777|1221469|P4|Study Extension II|Lack of Efficacy|0
383700|NCT00205777|1221470|P3|Study Extension II|Lack of Efficacy|0
383701|NCT00205777|1221471|P2|Study Extension II|Lack of Efficacy|0
383702|NCT00205777|1221472|P1|Study Extension II|Lack of Efficacy|0
383703|NCT00205777|1221467|P6|Study Extension II|Protocol Violation|10
383704|NCT00205777|1221468|P5|Study Extension II|Protocol Violation|0
383705|NCT00205777|1221469|P4|Study Extension II|Protocol Violation|1
383706|NCT00205777|1221470|P3|Study Extension II|Protocol Violation|0
383707|NCT00205777|1221471|P2|Study Extension II|Protocol Violation|0
383708|NCT00205777|1221472|P1|Study Extension II|Protocol Violation|0
383709|NCT00205777|1221467|P6|Study Extension II|Withdrawal by Subject|59
383710|NCT00205777|1221468|P5|Study Extension II|Withdrawal by Subject|0
383711|NCT00205777|1221469|P4|Study Extension II|Withdrawal by Subject|35
383712|NCT00205777|1221470|P3|Study Extension II|Withdrawal by Subject|0
383713|NCT00205777|1221471|P2|Study Extension II|Withdrawal by Subject|0
383714|NCT00205777|1221472|P1|Study Extension II|Withdrawal by Subject|0
383715|NCT00205777|1221467|P6|Study Extension II|Death|5
383716|NCT00205777|1221468|P5|Study Extension II|Death|0
383717|NCT00205777|1221469|P4|Study Extension II|Death|2
383718|NCT00205777|1221470|P3|Study Extension II|Death|0
383719|NCT00205777|1221471|P2|Study Extension II|Death|0
383720|NCT00205777|1221472|P1|Study Extension II|Death|0
383721|NCT00205777|1221467|P6|Study Extension II|Adverse Event|30
383722|NCT00205777|1221468|P5|Study Extension II|Adverse Event|0
383723|NCT00205777|1221469|P4|Study Extension II|Adverse Event|14
383724|NCT00205777|1221470|P3|Study Extension II|Adverse Event|0
383725|NCT00205777|1221471|P2|Study Extension II|Adverse Event|0
383726|NCT00205777|1221472|P1|Study Extension II|Adverse Event|0
383727|NCT00205777|1221467|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
383728|NCT00205777|1221468|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
383729|NCT00205777|1221469|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
383730|NCT00205777|1221470|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
383731|NCT00205777|1221471|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
383732|NCT00205777|1221472|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
383733|NCT00205777|1221467|P6|Study Extension I|Withdrawn as per protocol|0
383734|NCT00205777|1221468|P5|Study Extension I|Withdrawn as per protocol|0
383735|NCT00205777|1221469|P4|Study Extension I|Withdrawn as per protocol|0
383736|NCT00205777|1221470|P3|Study Extension I|Withdrawn as per protocol|1070
383737|NCT00205777|1221471|P2|Study Extension I|Withdrawn as per protocol|0
383738|NCT00205777|1221472|P1|Study Extension I|Withdrawn as per protocol|0
383739|NCT00205777|1221467|P6|Study Extension I|Other Event|0
383740|NCT00205777|1221468|P5|Study Extension I|Other Event|29
383741|NCT00205777|1221469|P4|Study Extension I|Other Event|34
383742|NCT00205777|1221470|P3|Study Extension I|Other Event|0
383743|NCT00205777|1221471|P2|Study Extension I|Other Event|0
383744|NCT00205777|1221472|P1|Study Extension I|Other Event|34
383745|NCT00205777|1221467|P6|Study Extension I|Failed to return|0
383746|NCT00205777|1221468|P5|Study Extension I|Failed to return|13
383747|NCT00205777|1221469|P4|Study Extension I|Failed to return|17
383748|NCT00205777|1221470|P3|Study Extension I|Failed to return|0
383749|NCT00205777|1221471|P2|Study Extension I|Failed to return|0
383750|NCT00205777|1221472|P1|Study Extension I|Failed to return|15
383751|NCT00205777|1221467|P6|Study Extension I|Lack of Efficacy|0
383752|NCT00205777|1221468|P5|Study Extension I|Lack of Efficacy|2
383753|NCT00205777|1221469|P4|Study Extension I|Lack of Efficacy|1
383754|NCT00205777|1221470|P3|Study Extension I|Lack of Efficacy|0
383755|NCT00205777|1221471|P2|Study Extension I|Lack of Efficacy|0
383756|NCT00205777|1221472|P1|Study Extension I|Lack of Efficacy|0
383757|NCT00205777|1221467|P6|Study Extension I|Protocol Violation|0
383758|NCT00205777|1221468|P5|Study Extension I|Protocol Violation|8
383759|NCT00205777|1221469|P4|Study Extension I|Protocol Violation|8
383760|NCT00205777|1221470|P3|Study Extension I|Protocol Violation|0
383761|NCT00205777|1221471|P2|Study Extension I|Protocol Violation|0
383762|NCT00205777|1221472|P1|Study Extension I|Protocol Violation|4
383763|NCT00205777|1221467|P6|Study Extension I|Withdrawal by Subject|0
383764|NCT00205777|1221468|P5|Study Extension I|Withdrawal by Subject|89
383765|NCT00205777|1221469|P4|Study Extension I|Withdrawal by Subject|106
383766|NCT00205777|1221470|P3|Study Extension I|Withdrawal by Subject|0
383767|NCT00205777|1221471|P2|Study Extension I|Withdrawal by Subject|0
383768|NCT00205777|1221472|P1|Study Extension I|Withdrawal by Subject|99
383769|NCT00205777|1221467|P6|Study Extension I|Death|0
383770|NCT00205777|1221468|P5|Study Extension I|Death|2
383771|NCT00205777|1221469|P4|Study Extension I|Death|1
383772|NCT00205777|1221470|P3|Study Extension I|Death|0
383773|NCT00205777|1221471|P2|Study Extension I|Death|0
383774|NCT00205777|1221472|P1|Study Extension I|Death|5
383775|NCT00205777|1221467|P6|Study Extension I|Adverse Event|0
383776|NCT00205777|1221468|P5|Study Extension I|Adverse Event|58
383777|NCT00205777|1221469|P4|Study Extension I|Adverse Event|61
383778|NCT00205777|1221470|P3|Study Extension I|Adverse Event|0
383779|NCT00205777|1221471|P2|Study Extension I|Adverse Event|0
383780|NCT00205777|1221472|P1|Study Extension I|Adverse Event|57
383781|NCT00205777|1221467|P6|Completed Core Study, Entered SE I|Other Event|0
383782|NCT00205777|1221468|P5|Completed Core Study, Entered SE I|Other Event|0
383783|NCT00205777|1221469|P4|Completed Core Study, Entered SE I|Other Event|50
383784|NCT00205777|1221470|P3|Completed Core Study, Entered SE I|Other Event|47
383785|NCT00205777|1221471|P2|Completed Core Study, Entered SE I|Other Event|46
383786|NCT00205777|1221472|P1|Completed Core Study, Entered SE I|Other Event|52
383787|NCT00205777|1221467|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
383788|NCT00205777|1221468|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
383789|NCT00205777|1221469|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
383790|NCT00205777|1221470|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
383791|NCT00205777|1221471|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
383792|NCT00205777|1221472|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
383793|NCT00205777|1221467|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
383794|NCT00205777|1221468|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
383795|NCT00205777|1221469|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
383796|NCT00205777|1221470|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
383797|NCT00205777|1221471|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
383798|NCT00205777|1221472|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
383799|NCT00205777|1221467|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
383800|NCT00205777|1221468|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
383801|NCT00205777|1221469|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
383802|NCT00205777|1221470|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
383803|NCT00205777|1221471|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
383804|NCT00205777|1221472|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
383805|NCT00205777|1221467|P6|Core Study (Up to 3 Years)|Protocol Violation|0
383806|NCT00205777|1221468|P5|Core Study (Up to 3 Years)|Protocol Violation|0
383807|NCT00205777|1221469|P4|Core Study (Up to 3 Years)|Protocol Violation|42
383808|NCT00205777|1221470|P3|Core Study (Up to 3 Years)|Protocol Violation|50
383809|NCT00205777|1221471|P2|Core Study (Up to 3 Years)|Protocol Violation|55
383810|NCT00205777|1221472|P1|Core Study (Up to 3 Years)|Protocol Violation|53
383811|NCT00205777|1221467|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
383812|NCT00205777|1221468|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
383813|NCT00205777|1221469|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
383814|NCT00205777|1221470|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
383815|NCT00205777|1221471|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
383816|NCT00205777|1221472|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
383817|NCT00205777|1221467|P6|Core Study (Up to 3 Years)|Other Event|0
383818|NCT00205777|1221468|P5|Core Study (Up to 3 Years)|Other Event|0
383819|NCT00205777|1221469|P4|Core Study (Up to 3 Years)|Other Event|58
383820|NCT00205777|1221470|P3|Core Study (Up to 3 Years)|Other Event|41
383821|NCT00205777|1221471|P2|Core Study (Up to 3 Years)|Other Event|52
383822|NCT00205777|1221472|P1|Core Study (Up to 3 Years)|Other Event|49
383823|NCT00205777|1221467|P6|Core Study (Up to 3 Years)|Failed to return|0
383824|NCT00205777|1221468|P5|Core Study (Up to 3 Years)|Failed to return|0
383825|NCT00205777|1221469|P4|Core Study (Up to 3 Years)|Failed to return|27
383826|NCT00205777|1221470|P3|Core Study (Up to 3 Years)|Failed to return|27
383827|NCT00205777|1221471|P2|Core Study (Up to 3 Years)|Failed to return|25
383828|NCT00205777|1221472|P1|Core Study (Up to 3 Years)|Failed to return|40
383829|NCT00205777|1221467|P6|Core Study (Up to 3 Years)|Death|0
383830|NCT00205777|1221468|P5|Core Study (Up to 3 Years)|Death|0
383831|NCT00205777|1221469|P4|Core Study (Up to 3 Years)|Death|7
383832|NCT00205777|1221470|P3|Core Study (Up to 3 Years)|Death|14
383833|NCT00205777|1221471|P2|Core Study (Up to 3 Years)|Death|7
383834|NCT00205777|1221472|P1|Core Study (Up to 3 Years)|Death|9
383835|NCT00205777|1221467|P6|Core Study (Up to 3 Years)|Adverse Event|0
383836|NCT00205777|1221468|P5|Core Study (Up to 3 Years)|Adverse Event|0
383837|NCT00205777|1221469|P4|Core Study (Up to 3 Years)|Adverse Event|232
383838|NCT00205777|1221470|P3|Core Study (Up to 3 Years)|Adverse Event|252
383839|NCT00205777|1221471|P2|Core Study (Up to 3 Years)|Adverse Event|267
383840|NCT00205777|1221472|P1|Core Study (Up to 3 Years)|Adverse Event|260
383841|NCT00205712|1221681|P2|Overall Study|Lost to Follow-up|1
383842|NCT00205712|1221682|P1|Overall Study|Lost to Follow-up|0
383843|NCT00203996|1221748|P10|Overall Study|Scheduling issue|0
383844|NCT00203996|1221749|P9|Overall Study|Scheduling issue|0
383845|NCT00203996|1221750|P8|Overall Study|Scheduling issue|2
383846|NCT00203996|1221751|P7|Overall Study|Scheduling issue|0
383847|NCT00203996|1221752|P6|Overall Study|Scheduling issue|0
383848|NCT00203996|1221753|P5|Overall Study|Scheduling issue|0
383849|NCT00203996|1221754|P4|Overall Study|Scheduling issue|0
383850|NCT00203996|1221755|P3|Overall Study|Scheduling issue|0
383851|NCT00203996|1221756|P2|Overall Study|Scheduling issue|0
383852|NCT00203996|1221757|P1|Overall Study|Scheduling issue|0
383853|NCT00203996|1221748|P10|Overall Study|CPAP machine malfunction|0
383854|NCT00203996|1221749|P9|Overall Study|CPAP machine malfunction|0
383855|NCT00203996|1221750|P8|Overall Study|CPAP machine malfunction|0
383856|NCT00203996|1221751|P7|Overall Study|CPAP machine malfunction|0
383857|NCT00203996|1221752|P6|Overall Study|CPAP machine malfunction|0
383858|NCT00203996|1221753|P5|Overall Study|CPAP machine malfunction|0
383859|NCT00203996|1221754|P4|Overall Study|CPAP machine malfunction|1
383860|NCT00203996|1221755|P3|Overall Study|CPAP machine malfunction|0
383861|NCT00203996|1221756|P2|Overall Study|CPAP machine malfunction|0
383862|NCT00203996|1221757|P1|Overall Study|CPAP machine malfunction|0
383863|NCT00203996|1221748|P10|Overall Study|Physician Decision|1
383864|NCT00203996|1221749|P9|Overall Study|Physician Decision|0
383865|NCT00203996|1221750|P8|Overall Study|Physician Decision|0
383866|NCT00203996|1221751|P7|Overall Study|Physician Decision|0
383867|NCT00203996|1221752|P6|Overall Study|Physician Decision|0
383868|NCT00203996|1221753|P5|Overall Study|Physician Decision|0
383869|NCT00203996|1221754|P4|Overall Study|Physician Decision|2
383870|NCT00203996|1221755|P3|Overall Study|Physician Decision|0
383871|NCT00203996|1221756|P2|Overall Study|Physician Decision|0
383872|NCT00203996|1221757|P1|Overall Study|Physician Decision|0
383873|NCT00203996|1221748|P10|Overall Study|Protocol Violation|0
383874|NCT00203996|1221749|P9|Overall Study|Protocol Violation|0
383875|NCT00203996|1221750|P8|Overall Study|Protocol Violation|0
383876|NCT00203996|1221751|P7|Overall Study|Protocol Violation|0
383877|NCT00203996|1221752|P6|Overall Study|Protocol Violation|0
383878|NCT00203996|1221753|P5|Overall Study|Protocol Violation|1
383879|NCT00203996|1221754|P4|Overall Study|Protocol Violation|6
383880|NCT00203996|1221755|P3|Overall Study|Protocol Violation|0
383881|NCT00203996|1221756|P2|Overall Study|Protocol Violation|0
383882|NCT00203996|1221757|P1|Overall Study|Protocol Violation|0
383883|NCT00203996|1221748|P10|Overall Study|Lost to Follow-up|0
383884|NCT00203996|1221749|P9|Overall Study|Lost to Follow-up|0
383885|NCT00203996|1221750|P8|Overall Study|Lost to Follow-up|0
383886|NCT00203996|1221751|P7|Overall Study|Lost to Follow-up|0
383887|NCT00203996|1221752|P6|Overall Study|Lost to Follow-up|0
383888|NCT00203996|1221753|P5|Overall Study|Lost to Follow-up|0
383889|NCT00203996|1221754|P4|Overall Study|Lost to Follow-up|1
383890|NCT00203996|1221755|P3|Overall Study|Lost to Follow-up|0
383891|NCT00203996|1221756|P2|Overall Study|Lost to Follow-up|0
383892|NCT00203996|1221757|P1|Overall Study|Lost to Follow-up|0
383893|NCT00203892|1221824|P3|Overall Study|Death|0
383894|NCT00203892|1221825|P2|Overall Study|Death|0
383895|NCT00203892|1221826|P1|Overall Study|Death|1
383896|NCT00203892|1221824|P3|Overall Study|Physician Decision|0
383897|NCT00203892|1221825|P2|Overall Study|Physician Decision|2
383898|NCT00203892|1221826|P1|Overall Study|Physician Decision|1
383899|NCT00203502|1221837|P1|Overall Study|Death|1
383900|NCT00203476|1221848|P3|Overall Study|Withdrawal by Subject|0
383901|NCT00203476|1221849|P2|Overall Study|Withdrawal by Subject|1
383902|NCT00203476|1221850|P1|Overall Study|Withdrawal by Subject|0
383903|NCT00203476|1221848|P3|Overall Study|Lost to Follow-up|0
383904|NCT00203476|1221849|P2|Overall Study|Lost to Follow-up|0
383905|NCT00203476|1221850|P1|Overall Study|Lost to Follow-up|1
383906|NCT00203424|1221867|P1|Follow-up Period|Lost to Follow-up|1
383907|NCT00203424|1221867|P1|Follow-up Period|progressive disease|4
383908|NCT00203424|1221867|P1|Follow-up Period|Withdrawal by Subject|1
383909|NCT00203424|1221867|P1|Treatment Period|progressive disease|2
383910|NCT00203424|1221867|P1|Treatment Period|Adverse Event|5
383911|NCT00203424|1221867|P1|Treatment Period|Withdrawal by Subject|4
383912|NCT00203411|1221874|P1|Follow-up|Progressive Disease|4
383913|NCT00203307|1221883|P2|First Intervention|Adverse Event|0
383914|NCT00203307|1221884|P1|First Intervention|Adverse Event|2
383915|NCT00203294|1221892|P2|Overall Study|Withdrawal by Subject|13
383916|NCT00203294|1221893|P1|Overall Study|Withdrawal by Subject|8
383917|NCT00203268|1221899|P1|Early Treatment|Withdrawal by Subject|1
383918|NCT00203268|1221899|P1|Early Treatment|Lost to Follow-up|1
383919|NCT00203268|1221899|P1|Early Treatment|only treated one headache|2
383920|NCT00203242|1221905|P1|Overall Study|Lost to Follow-up|1
383921|NCT00203047|1221957|P2|Overall Study|Not specified|5
383922|NCT00203047|1221958|P1|Overall Study|Not specified|5
383923|NCT00203047|1221957|P2|Overall Study|Pregnancy|0
383924|NCT00203047|1221958|P1|Overall Study|Pregnancy|3
383925|NCT00203047|1221957|P2|Overall Study|Death|2
383926|NCT00203047|1221958|P1|Overall Study|Death|1
383927|NCT00203047|1221957|P2|Overall Study|Adverse Event|18
383928|NCT00203047|1221958|P1|Overall Study|Adverse Event|8
383929|NCT00203047|1221957|P2|Overall Study|Lost to Follow-up|5
383930|NCT00203047|1221958|P1|Overall Study|Lost to Follow-up|11
383931|NCT00203047|1221957|P2|Overall Study|Protocol Violation|0
383932|NCT00203047|1221958|P1|Overall Study|Protocol Violation|1
383933|NCT00203047|1221957|P2|Overall Study|Non-compliance|8
383934|NCT00203047|1221958|P1|Overall Study|Non-compliance|4
383935|NCT00203047|1221957|P2|Overall Study|Physician Decision|7
383936|NCT00203047|1221958|P1|Overall Study|Physician Decision|8
383937|NCT00203047|1221957|P2|Overall Study|Teva requested participant withdrawal|1
383938|NCT00203047|1221958|P1|Overall Study|Teva requested participant withdrawal|1
383939|NCT00203047|1221957|P2|Overall Study|Withdrawal by Subject|47
383940|NCT00203047|1221958|P1|Overall Study|Withdrawal by Subject|13
383941|NCT00203047|1221957|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
383942|NCT00203047|1221958|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
383943|NCT00203047|1221957|P2|Overall Study|Ongoing: in database - January 29, 2009|109
383944|NCT00203047|1221958|P1|Overall Study|Ongoing: in database - January 29, 2009|131
383945|NCT00202878|1221972|P2|Overall Study|Withdrawal by Subject|808
383946|NCT00202878|1221973|P1|Overall Study|Withdrawal by Subject|795
383947|NCT00202878|1221972|P2|Overall Study|Site Closure|36
383948|NCT00202878|1221973|P1|Overall Study|Site Closure|39
383949|NCT00202878|1221972|P2|Overall Study|Lost to Follow-up|49
383950|NCT00202878|1221973|P1|Overall Study|Lost to Follow-up|44
383951|NCT00202878|1221972|P2|Overall Study|Only Vital Status Known|356
383952|NCT00202878|1221973|P1|Overall Study|Only Vital Status Known|357
383953|NCT00202878|1221972|P2|Overall Study|Death|968
383954|NCT00202878|1221973|P1|Overall Study|Death|964
383955|NCT00202839|1221987|P2|Overall Study|Lost to Follow-up|2
383956|NCT00202839|1221988|P1|Overall Study|Lost to Follow-up|3
383957|NCT00202839|1221987|P2|Overall Study|Protocol Violation|1
383958|NCT00202839|1221988|P1|Overall Study|Protocol Violation|2
383959|NCT00202839|1221987|P2|Overall Study|Withdrawal by Subject|2
383960|NCT00202839|1221988|P1|Overall Study|Withdrawal by Subject|6
383961|NCT00202839|1221987|P2|Overall Study|Physician Decision|0
383962|NCT00202839|1221988|P1|Overall Study|Physician Decision|12
383963|NCT00202839|1221987|P2|Overall Study|Adverse Event|5
383964|NCT00202839|1221988|P1|Overall Study|Adverse Event|1
383965|NCT00201851|1222037|P3|Overall Study|Ineligible post enrollment|1
383966|NCT00201851|1222038|P2|Overall Study|Ineligible post enrollment|1
383967|NCT00201851|1222039|P1|Overall Study|Ineligible post enrollment|6
383968|NCT00201851|1222037|P3|Overall Study|Lost to Follow-up|0
383969|NCT00201851|1222038|P2|Overall Study|Lost to Follow-up|1
383970|NCT00201851|1222039|P1|Overall Study|Lost to Follow-up|2
383971|NCT00201643|1222098|P2|Overall Study|Withdrawal by Subject|4
383972|NCT00201643|1222099|P1|Overall Study|Withdrawal by Subject|5
383973|NCT00201201|1222163|P2|Overall Study|Withdrawal by Subject|5
383974|NCT00201201|1222164|P1|Overall Study|Withdrawal by Subject|5
383975|NCT00201201|1222163|P2|Overall Study|Death|2
383976|NCT00201201|1222164|P1|Overall Study|Death|0
383977|NCT00201006|1222202|P3|Overall Study|Adverse Event|1
383978|NCT00201006|1222203|P2|Overall Study|Adverse Event|0
383979|NCT00201006|1222204|P1|Overall Study|Adverse Event|1
383980|NCT00201006|1222202|P3|Overall Study|Withdrawal by Subject|3
383981|NCT00201006|1222203|P2|Overall Study|Withdrawal by Subject|2
383982|NCT00201006|1222204|P1|Overall Study|Withdrawal by Subject|7
383983|NCT00200967|1222214|P2|Run-out Period|Lost to Follow-up|0
383984|NCT00200967|1222215|P1|Run-out Period|Lost to Follow-up|1
383985|NCT00200967|1222214|P2|Second Treatment Period|Withdrawal by Subject|2
383986|NCT00200967|1222215|P1|Second Treatment Period|Withdrawal by Subject|1
383987|NCT00200967|1222214|P2|Wash-out Period|Lost to Follow-up|1
383988|NCT00200967|1222215|P1|Wash-out Period|Lost to Follow-up|0
383989|NCT00200967|1222214|P2|First Treatment Period|Pregnancy|0
383990|NCT00200967|1222215|P1|First Treatment Period|Pregnancy|1
383991|NCT00200967|1222214|P2|First Treatment Period|Withdrawal by Subject|1
383992|NCT00200967|1222215|P1|First Treatment Period|Withdrawal by Subject|5
383993|NCT00200356|1222256|P2|Overall Study|Nontreatment|0
383994|NCT00200356|1222257|P1|Overall Study|Nontreatment|1
383995|NCT00200356|1222256|P2|Overall Study|Protocol Violation|4
383996|NCT00200356|1222257|P1|Overall Study|Protocol Violation|4
383997|NCT00200356|1222256|P2|Overall Study|Lack of Efficacy|3
383998|NCT00200356|1222257|P1|Overall Study|Lack of Efficacy|3
383999|NCT00200057|1222309|P1|Overall Study|Death|1
384000|NCT00200057|1222309|P1|Overall Study|Infection|1
384001|NCT00200057|1222309|P1|Overall Study|Change in medical condition|1
384002|NCT00200057|1222309|P1|Overall Study|Withdrawal by Subject|1
384003|NCT00200057|1222309|P1|Overall Study|Exited due to terminal illness of PI|2
384004|NCT00200057|1222309|P1|Overall Study|Lack of Efficacy|3
384005|NCT00199381|1222328|P1|Overall Study|Study termination by Sponsor|323
384006|NCT00199381|1222328|P1|Overall Study|Not including due to early termination|37
384007|NCT00199381|1222328|P1|Overall Study|Lack of Efficacy|27
384008|NCT00199381|1222328|P1|Overall Study|Protocol Violation|6
384009|NCT00199381|1222328|P1|Overall Study|Adverse Event|73
384010|NCT00199381|1222328|P1|Overall Study|Withdrawal by Subject|38
384011|NCT00198822|1222335|P3|Overall Study|Lost to Follow-up|21
384012|NCT00198822|1222336|P2|Overall Study|Lost to Follow-up|20
384013|NCT00198822|1222337|P1|Overall Study|Lost to Follow-up|14
384014|NCT00198133|1222369|P2|Overall Study|Physician Decision|0
384015|NCT00198133|1222370|P1|Overall Study|Physician Decision|1
384016|NCT00198133|1222369|P2|Overall Study|Withdrawal by Subject|0
384017|NCT00198133|1222370|P1|Overall Study|Withdrawal by Subject|1
384018|NCT00198133|1222369|P2|Overall Study|Adverse Event|3
384019|NCT00198133|1222370|P1|Overall Study|Adverse Event|1
384020|NCT00198133|1222369|P2|Overall Study|Disease progression|5
384021|NCT00198133|1222370|P1|Overall Study|Disease progression|2
384022|NCT00198029|1222413|P1|Overall Study|Withdrawal by Subject|4
384023|NCT00197106|1222420|P3|Overall Treatment Period|Withdrawal by Subject|2
384024|NCT00197106|1222421|P2|Overall Treatment Period|Withdrawal by Subject|0
384025|NCT00197106|1222422|P1|Overall Treatment Period|Withdrawal by Subject|0
384026|NCT00197106|1222420|P3|Overall Treatment Period|Protocol Violation|2
384027|NCT00197106|1222421|P2|Overall Treatment Period|Protocol Violation|0
384028|NCT00197106|1222422|P1|Overall Treatment Period|Protocol Violation|0
384029|NCT00197106|1222420|P3|Overall Treatment Period|Lost to Follow-up|2
384030|NCT00197106|1222421|P2|Overall Treatment Period|Lost to Follow-up|0
384031|NCT00197106|1222422|P1|Overall Treatment Period|Lost to Follow-up|0
384032|NCT00197106|1222420|P3|Overall Treatment Period|Lack of Efficacy|0
384033|NCT00197106|1222421|P2|Overall Treatment Period|Lack of Efficacy|1
384034|NCT00197106|1222422|P1|Overall Treatment Period|Lack of Efficacy|0
384035|NCT00197106|1222420|P3|4-Week Run-In Period|Did not meet entry criteria|0
384036|NCT00197106|1222421|P2|4-Week Run-In Period|Did not meet entry criteria|0
384037|NCT00197106|1222422|P1|4-Week Run-In Period|Did not meet entry criteria|99
384038|NCT00197028|1222458|P2|Overall Study|Unspecified|6
384039|NCT00197028|1222459|P1|Overall Study|Unspecified|3
384040|NCT00197028|1222458|P2|Overall Study|Lost to Follow-up|0
384041|NCT00197028|1222459|P1|Overall Study|Lost to Follow-up|1
384042|NCT00197028|1222458|P2|Overall Study|Withdrawal by Subject|12
384043|NCT00197028|1222459|P1|Overall Study|Withdrawal by Subject|8
384044|NCT00197028|1222458|P2|Overall Study|Protocol Violation|1
384045|NCT00197028|1222459|P1|Overall Study|Protocol Violation|2
384046|NCT00197028|1222458|P2|Overall Study|Adverse Event|2
384047|NCT00197028|1222459|P1|Overall Study|Adverse Event|2
384048|NCT00197015|1222502|P3|Overall Study|Other|2
384049|NCT00197015|1222503|P2|Overall Study|Other|3
384050|NCT00197015|1222504|P1|Overall Study|Other|2
384051|NCT00197015|1222502|P3|Overall Study|Lost to Follow-up|37
384052|NCT00197015|1222503|P2|Overall Study|Lost to Follow-up|46
384053|NCT00197015|1222504|P1|Overall Study|Lost to Follow-up|28
384054|NCT00197015|1222502|P3|Overall Study|Withdrawal by Subject|34
384055|NCT00197015|1222503|P2|Overall Study|Withdrawal by Subject|37
384056|NCT00197015|1222504|P1|Overall Study|Withdrawal by Subject|17
384057|NCT00197015|1222502|P3|Overall Study|Protocol Violation|3
384058|NCT00197015|1222503|P2|Overall Study|Protocol Violation|3
384059|NCT00197015|1222504|P1|Overall Study|Protocol Violation|0
384060|NCT00197015|1222502|P3|Overall Study|Adverse Event|1
384061|NCT00197015|1222503|P2|Overall Study|Adverse Event|0
384062|NCT00197015|1222504|P1|Overall Study|Adverse Event|3
384063|NCT00197002|1222563|P3|Overall Study|Others|1
384064|NCT00197002|1222564|P2|Overall Study|Others|1
384065|NCT00197002|1222565|P1|Overall Study|Others|3
384066|NCT00197002|1222563|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
384067|NCT00197002|1222564|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
384068|NCT00197002|1222565|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
384069|NCT00197002|1222563|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
384070|NCT00197002|1222564|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
384071|NCT00197002|1222565|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
384072|NCT00197002|1222563|P3|Overall Study|Migrated/moved from study area|1
384073|NCT00197002|1222564|P2|Overall Study|Migrated/moved from study area|5
384074|NCT00197002|1222565|P1|Overall Study|Migrated/moved from study area|3
384075|NCT00197002|1222563|P3|Overall Study|Withdrawal by Subject|7
384076|NCT00197002|1222564|P2|Overall Study|Withdrawal by Subject|5
384077|NCT00197002|1222565|P1|Overall Study|Withdrawal by Subject|9
384078|NCT00197002|1222563|P3|Overall Study|Protocol Violation|2
384079|NCT00197002|1222564|P2|Overall Study|Protocol Violation|0
384080|NCT00197002|1222565|P1|Overall Study|Protocol Violation|1
384081|NCT00197002|1222563|P3|Overall Study|Adverse Event|0
384082|NCT00197002|1222564|P2|Overall Study|Adverse Event|1
384083|NCT00197002|1222565|P1|Overall Study|Adverse Event|0
384084|NCT00196976|1222616|P14|Booster Study|Lost to Follow-up|0
384085|NCT00196976|1222617|P13|Booster Study|Lost to Follow-up|0
384086|NCT00196976|1222618|P12|Booster Study|Lost to Follow-up|2
384087|NCT00196976|1222619|P11|Booster Study|Lost to Follow-up|1
384088|NCT00196976|1222620|P10|Booster Study|Lost to Follow-up|0
384089|NCT00196976|1222621|P9|Booster Study|Lost to Follow-up|0
384090|NCT00196976|1222622|P8|Booster Study|Lost to Follow-up|0
384091|NCT00196976|1222623|P7|Booster Study|Lost to Follow-up|0
384092|NCT00196976|1222624|P6|Booster Study|Lost to Follow-up|0
384093|NCT00196976|1222625|P5|Booster Study|Lost to Follow-up|0
384094|NCT00196976|1222626|P4|Booster Study|Lost to Follow-up|0
384095|NCT00196976|1222627|P3|Booster Study|Lost to Follow-up|0
384096|NCT00196976|1222628|P2|Booster Study|Lost to Follow-up|0
384097|NCT00196976|1222629|P1|Booster Study|Lost to Follow-up|0
384098|NCT00196976|1222616|P14|Booster Study|Withdrawal by Subject|0
384099|NCT00196976|1222617|P13|Booster Study|Withdrawal by Subject|0
384100|NCT00196976|1222618|P12|Booster Study|Withdrawal by Subject|0
384101|NCT00196976|1222619|P11|Booster Study|Withdrawal by Subject|1
384102|NCT00196976|1222620|P10|Booster Study|Withdrawal by Subject|0
384103|NCT00196976|1222621|P9|Booster Study|Withdrawal by Subject|0
384104|NCT00196976|1222622|P8|Booster Study|Withdrawal by Subject|0
384105|NCT00196976|1222623|P7|Booster Study|Withdrawal by Subject|0
384106|NCT00196976|1222624|P6|Booster Study|Withdrawal by Subject|0
384107|NCT00196976|1222625|P5|Booster Study|Withdrawal by Subject|0
384108|NCT00196976|1222626|P4|Booster Study|Withdrawal by Subject|0
384109|NCT00196976|1222627|P3|Booster Study|Withdrawal by Subject|0
384110|NCT00196976|1222628|P2|Booster Study|Withdrawal by Subject|0
384111|NCT00196976|1222629|P1|Booster Study|Withdrawal by Subject|0
384112|NCT00196976|1222616|P14|Primary Study|Unspecified|0
384113|NCT00196976|1222617|P13|Primary Study|Unspecified|0
384114|NCT00196976|1222618|P12|Primary Study|Unspecified|0
384115|NCT00196976|1222619|P11|Primary Study|Unspecified|0
384116|NCT00196976|1222620|P10|Primary Study|Unspecified|0
384117|NCT00196976|1222621|P9|Primary Study|Unspecified|0
384118|NCT00196976|1222622|P8|Primary Study|Unspecified|0
384119|NCT00196976|1222623|P7|Primary Study|Unspecified|0
384120|NCT00196976|1222624|P6|Primary Study|Unspecified|0
384121|NCT00196976|1222625|P5|Primary Study|Unspecified|0
384122|NCT00196976|1222626|P4|Primary Study|Unspecified|0
384123|NCT00196976|1222627|P3|Primary Study|Unspecified|2
384124|NCT00196976|1222628|P2|Primary Study|Unspecified|0
384125|NCT00196976|1222629|P1|Primary Study|Unspecified|0
384126|NCT00196976|1222616|P14|Primary Study|Lost to Follow-up|0
384127|NCT00196976|1222617|P13|Primary Study|Lost to Follow-up|0
384128|NCT00196976|1222618|P12|Primary Study|Lost to Follow-up|0
384129|NCT00196976|1222619|P11|Primary Study|Lost to Follow-up|0
384130|NCT00196976|1222620|P10|Primary Study|Lost to Follow-up|0
384131|NCT00196976|1222621|P9|Primary Study|Lost to Follow-up|0
384132|NCT00196976|1222622|P8|Primary Study|Lost to Follow-up|2
384133|NCT00196976|1222623|P7|Primary Study|Lost to Follow-up|0
384134|NCT00196976|1222624|P6|Primary Study|Lost to Follow-up|1
384135|NCT00196976|1222625|P5|Primary Study|Lost to Follow-up|1
384136|NCT00196976|1222626|P4|Primary Study|Lost to Follow-up|0
384137|NCT00196976|1222627|P3|Primary Study|Lost to Follow-up|0
384138|NCT00196976|1222628|P2|Primary Study|Lost to Follow-up|0
384139|NCT00196976|1222629|P1|Primary Study|Lost to Follow-up|0
384140|NCT00196976|1222616|P14|Primary Study|Withdrawal by Subject|0
384141|NCT00196976|1222617|P13|Primary Study|Withdrawal by Subject|0
384142|NCT00196976|1222618|P12|Primary Study|Withdrawal by Subject|0
384143|NCT00196976|1222619|P11|Primary Study|Withdrawal by Subject|0
384144|NCT00196976|1222620|P10|Primary Study|Withdrawal by Subject|1
384145|NCT00196976|1222621|P9|Primary Study|Withdrawal by Subject|0
384146|NCT00196976|1222622|P8|Primary Study|Withdrawal by Subject|0
384147|NCT00196976|1222623|P7|Primary Study|Withdrawal by Subject|0
384148|NCT00196976|1222624|P6|Primary Study|Withdrawal by Subject|1
384149|NCT00196976|1222625|P5|Primary Study|Withdrawal by Subject|2
384150|NCT00196976|1222626|P4|Primary Study|Withdrawal by Subject|1
384151|NCT00196976|1222627|P3|Primary Study|Withdrawal by Subject|1
384152|NCT00196976|1222628|P2|Primary Study|Withdrawal by Subject|0
384153|NCT00196976|1222629|P1|Primary Study|Withdrawal by Subject|1
384154|NCT00196976|1222616|P14|Primary Study|Protocol Violation|0
384155|NCT00196976|1222617|P13|Primary Study|Protocol Violation|0
384156|NCT00196976|1222618|P12|Primary Study|Protocol Violation|0
384157|NCT00196976|1222619|P11|Primary Study|Protocol Violation|0
384158|NCT00196976|1222620|P10|Primary Study|Protocol Violation|0
384159|NCT00196976|1222621|P9|Primary Study|Protocol Violation|0
384160|NCT00196976|1222622|P8|Primary Study|Protocol Violation|0
384161|NCT00196976|1222623|P7|Primary Study|Protocol Violation|0
384162|NCT00196976|1222624|P6|Primary Study|Protocol Violation|0
384163|NCT00196976|1222625|P5|Primary Study|Protocol Violation|0
384164|NCT00196976|1222626|P4|Primary Study|Protocol Violation|0
384165|NCT00196976|1222627|P3|Primary Study|Protocol Violation|1
384166|NCT00196976|1222628|P2|Primary Study|Protocol Violation|1
384167|NCT00196976|1222629|P1|Primary Study|Protocol Violation|0
384168|NCT00196976|1222616|P14|Primary Study|Migrated from study area|0
384169|NCT00196976|1222617|P13|Primary Study|Migrated from study area|0
384170|NCT00196976|1222618|P12|Primary Study|Migrated from study area|0
384171|NCT00196976|1222619|P11|Primary Study|Migrated from study area|0
384172|NCT00196976|1222620|P10|Primary Study|Migrated from study area|0
384173|NCT00196976|1222621|P9|Primary Study|Migrated from study area|0
384174|NCT00196976|1222622|P8|Primary Study|Migrated from study area|1
384175|NCT00196976|1222623|P7|Primary Study|Migrated from study area|0
384176|NCT00196976|1222624|P6|Primary Study|Migrated from study area|0
384177|NCT00196976|1222625|P5|Primary Study|Migrated from study area|0
384178|NCT00196976|1222626|P4|Primary Study|Migrated from study area|0
384179|NCT00196976|1222627|P3|Primary Study|Migrated from study area|0
384180|NCT00196976|1222628|P2|Primary Study|Migrated from study area|0
384181|NCT00196976|1222629|P1|Primary Study|Migrated from study area|0
384182|NCT00196937|1222825|P3|Overall Study|Withdrawal by Subject|3
384183|NCT00196937|1222826|P2|Overall Study|Withdrawal by Subject|0
384184|NCT00196937|1222827|P1|Overall Study|Withdrawal by Subject|0
384185|NCT00196937|1222825|P3|Overall Study|Lost to Follow-up|3
384186|NCT00196937|1222826|P2|Overall Study|Lost to Follow-up|3
384187|NCT00196937|1222827|P1|Overall Study|Lost to Follow-up|4
384188|NCT00196937|1222825|P3|Overall Study|Subject did not come due to holidays|0
384189|NCT00196937|1222826|P2|Overall Study|Subject did not come due to holidays|1
384190|NCT00196937|1222827|P1|Overall Study|Subject did not come due to holidays|3
384191|NCT00196937|1222825|P3|Overall Study|Adverse Event|1
384192|NCT00196937|1222826|P2|Overall Study|Adverse Event|1
384193|NCT00196937|1222827|P1|Overall Study|Adverse Event|2
384194|NCT00197496|1222867|P2|Follow-up|Lost to Follow-up|1
384195|NCT00197496|1222868|P1|Follow-up|Lost to Follow-up|2
384196|NCT00197496|1222867|P2|Baseline to Discharge|Protocol Violation|1
384197|NCT00197496|1222868|P1|Baseline to Discharge|Protocol Violation|0
384198|NCT00197496|1222867|P2|Baseline to Discharge|Physician Decision|1
384199|NCT00197496|1222868|P1|Baseline to Discharge|Physician Decision|0
384200|NCT00197496|1222867|P2|Baseline to Discharge|MRSA|0
384201|NCT00197496|1222868|P1|Baseline to Discharge|MRSA|1
384202|NCT00197496|1222867|P2|Baseline to Discharge|not interested|0
384203|NCT00197496|1222868|P1|Baseline to Discharge|not interested|1
384204|NCT00197236|1222916|P3|Overall Study|Returned out of specified time window|1
384205|NCT00197236|1222917|P2|Overall Study|Returned out of specified time window|0
384206|NCT00197236|1222918|P1|Overall Study|Returned out of specified time window|0
384207|NCT00197236|1222916|P3|Overall Study|Study drug/medication expiration|3
384208|NCT00197236|1222917|P2|Overall Study|Study drug/medication expiration|0
384209|NCT00197236|1222918|P1|Overall Study|Study drug/medication expiration|1
384210|NCT00197236|1222916|P3|Overall Study|Withdrawal by Subject|11
384211|NCT00197236|1222917|P2|Overall Study|Withdrawal by Subject|3
384212|NCT00197236|1222918|P1|Overall Study|Withdrawal by Subject|7
384213|NCT00197236|1222916|P3|Overall Study|Protocol Violation|1
384214|NCT00197236|1222917|P2|Overall Study|Protocol Violation|0
384215|NCT00197236|1222918|P1|Overall Study|Protocol Violation|0
384216|NCT00197236|1222916|P3|Overall Study|Lost to Follow-up|6
384217|NCT00197236|1222917|P2|Overall Study|Lost to Follow-up|14
384218|NCT00197236|1222918|P1|Overall Study|Lost to Follow-up|5
384219|NCT00197236|1222916|P3|Overall Study|Adverse Event|1
384220|NCT00197236|1222917|P2|Overall Study|Adverse Event|0
384221|NCT00197236|1222918|P1|Overall Study|Adverse Event|1
384222|NCT00196326|1223000|P1|Overall Study|Not specified|22
384223|NCT00196326|1223000|P1|Overall Study|Lost to Follow-up|304
384224|NCT00196326|1223000|P1|Overall Study|Pregnancy|34
384225|NCT00196326|1223000|P1|Overall Study|Adverse Event|253
384226|NCT00196326|1223000|P1|Overall Study|Withdrawal by Subject|225
384227|NCT00196326|1223000|P1|Overall Study|Physician Decision|3
384228|NCT00196326|1223000|P1|Overall Study|Non-compliance with the protocol|81
384229|NCT00196326|1223000|P1|Overall Study|Did not meet protocol requirements|64
384230|NCT00196313|1223008|P2|Overall Study|Lost to Follow-up|2
384231|NCT00196313|1223009|P1|Overall Study|Lost to Follow-up|2
384232|NCT00196313|1223008|P2|Overall Study|Subject Pregnant|1
384233|NCT00196313|1223009|P1|Overall Study|Subject Pregnant|1
384234|NCT00196313|1223008|P2|Overall Study|Adverse Event|1
384235|NCT00196313|1223009|P1|Overall Study|Adverse Event|3
384236|NCT00196313|1223008|P2|Overall Study|Withdrawal by Subject|1
384237|NCT00196313|1223009|P1|Overall Study|Withdrawal by Subject|3
384238|NCT00196313|1223008|P2|Overall Study|Protocol Violation|3
384239|NCT00196313|1223009|P1|Overall Study|Protocol Violation|2
384240|NCT00196196|1223023|P1|Overall Study|Did not have required condition (hydroce|5
384241|NCT00196196|1223023|P1|Overall Study|Withdrawal by Subject|2
384242|NCT00196105|1223031|P3|Overall Study|Lost to Follow-up|7
384243|NCT00196105|1223032|P2|Overall Study|Lost to Follow-up|5
384244|NCT00196105|1223033|P1|Overall Study|Lost to Follow-up|4
384245|NCT00195819|1223053|P2|Open-label|Withdrawal by Subject|5
384246|NCT00195819|1223054|P1|Open-label|Withdrawal by Subject|0
384247|NCT00195819|1223053|P2|Open-label|Moved|1
384248|NCT00195819|1223054|P1|Open-label|Moved|0
384249|NCT00195819|1223053|P2|Open-label|Protocol Violation|2
384250|NCT00195819|1223054|P1|Open-label|Protocol Violation|0
384251|NCT00195819|1223053|P2|Open-label|Pregnancy|1
384252|NCT00195819|1223054|P1|Open-label|Pregnancy|0
384253|NCT00195819|1223053|P2|Open-label|Lack of Efficacy|2
384254|NCT00195819|1223054|P1|Open-label|Lack of Efficacy|0
384255|NCT00195819|1223053|P2|Open-label|Adverse Event|9
384256|NCT00195819|1223054|P1|Open-label|Adverse Event|0
384257|NCT00195819|1223053|P2|Double-Blind|Moved|0
384258|NCT00195819|1223054|P1|Double-Blind|Moved|1
384259|NCT00195819|1223053|P2|Double-Blind|Withdrawal by Subject|0
384260|NCT00195819|1223054|P1|Double-Blind|Withdrawal by Subject|1
384261|NCT00195715|1223104|P1|Overall Study|Sponsor discretion - trial ended early|1
384262|NCT00195715|1223104|P1|Overall Study|Sponsor discontinued trial|1
384263|NCT00195715|1223104|P1|Overall Study|Colonic stricture|1
384264|NCT00195715|1223104|P1|Overall Study|Ineligible|1
384265|NCT00195715|1223104|P1|Overall Study|Increased infection rate|1
384266|NCT00195715|1223104|P1|Overall Study|Planned surgery|2
384267|NCT00195715|1223104|P1|Overall Study|Use of prohibited medication|2
384268|NCT00195715|1223104|P1|Overall Study|Subject wants to get pregnant|4
384269|NCT00195715|1223104|P1|Overall Study|Investigator's decision|2
384270|NCT00195715|1223104|P1|Overall Study|Administrative reasons|2
384271|NCT00195715|1223104|P1|Overall Study|Sponsor stopped study|1
384272|NCT00195715|1223104|P1|Overall Study|Loss of response/no improvement|3
384273|NCT00195715|1223104|P1|Overall Study|Subject choice|3
384274|NCT00195715|1223104|P1|Overall Study|Subject started commercial Humira|5
384275|NCT00195715|1223104|P1|Overall Study|Subject non-compliance|6
384276|NCT00195715|1223104|P1|Overall Study|Subject moved/relocated|7
384277|NCT00195715|1223104|P1|Overall Study|Investigative site closure|8
384278|NCT00195715|1223104|P1|Overall Study|Pregnancy|14
384279|NCT00195715|1223104|P1|Overall Study|Lack of Efficacy|93
384280|NCT00195715|1223104|P1|Overall Study|Protocol Violation|13
384281|NCT00195715|1223104|P1|Overall Study|Lost to Follow-up|27
384282|NCT00195715|1223104|P1|Overall Study|Withdrawal by Subject|58
384283|NCT00195715|1223104|P1|Overall Study|Adverse Event|122
384284|NCT00195676|1223204|P1|Period R - Retreatment 16 Weeks|Other reasons|6
384285|NCT00195676|1223204|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
384286|NCT00195676|1223204|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
384287|NCT00195676|1223204|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
384288|NCT00195676|1223204|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
384289|NCT00195676|1223204|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
384290|NCT00195676|1223204|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
384291|NCT00195676|1223204|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
384292|NCT00195676|1223204|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
384293|NCT00195676|1223204|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
384294|NCT00195676|1223204|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
384295|NCT00195676|1223204|P1|Period W (Withdrawal) - No Treatment|Death|2
384296|NCT00195676|1223204|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
384297|NCT00195676|1223204|P1|Period O - Open-label Treatment|Other reasons|68
384298|NCT00195676|1223204|P1|Period O - Open-label Treatment|Administrative reasons|2
384299|NCT00195676|1223204|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
384300|NCT00195676|1223204|P1|Period O - Open-label Treatment|Protocol Violation|12
384301|NCT00195676|1223204|P1|Period O - Open-label Treatment|Lost to Follow-up|91
384302|NCT00195676|1223204|P1|Period O - Open-label Treatment|Lack of Efficacy|198
384303|NCT00195676|1223204|P1|Period O - Open-label Treatment|Death|6
384304|NCT00195676|1223204|P1|Period O - Open-label Treatment|Adverse Event|82
384305|NCT00195663|1223218|P3|Open-Label Extension Period|Administrative reasons|13
384306|NCT00195663|1223219|P2|Open-Label Extension Period|Administrative reasons|11
384307|NCT00195663|1223220|P1|Open-Label Extension Period|Administrative reasons|11
384308|NCT00195663|1223218|P3|Open-Label Extension Period|Lack of Efficacy|12
384309|NCT00195663|1223219|P2|Open-Label Extension Period|Lack of Efficacy|6
384310|NCT00195663|1223220|P1|Open-Label Extension Period|Lack of Efficacy|14
384311|NCT00195663|1223218|P3|Open-Label Extension Period|Withdrawal by Subject|22
384312|NCT00195663|1223219|P2|Open-Label Extension Period|Withdrawal by Subject|15
384313|NCT00195663|1223220|P1|Open-Label Extension Period|Withdrawal by Subject|16
384314|NCT00195663|1223218|P3|Open-Label Extension Period|Death|2
384315|NCT00195663|1223219|P2|Open-Label Extension Period|Death|2
384316|NCT00195663|1223220|P1|Open-Label Extension Period|Death|2
384317|NCT00195663|1223218|P3|Open-Label Extension Period|Protocol Violation|4
384318|NCT00195663|1223219|P2|Open-Label Extension Period|Protocol Violation|4
384319|NCT00195663|1223220|P1|Open-Label Extension Period|Protocol Violation|3
384320|NCT00195663|1223218|P3|Open-Label Extension Period|Recovery|2
384321|NCT00195663|1223219|P2|Open-Label Extension Period|Recovery|2
384322|NCT00195663|1223220|P1|Open-Label Extension Period|Recovery|0
384323|NCT00195663|1223218|P3|Open-Label Extension Period|Lost to Follow-up|6
384324|NCT00195663|1223219|P2|Open-Label Extension Period|Lost to Follow-up|2
384325|NCT00195663|1223220|P1|Open-Label Extension Period|Lost to Follow-up|9
384326|NCT00195663|1223218|P3|Open-Label Extension Period|Adverse Event|36
384327|NCT00195663|1223219|P2|Open-Label Extension Period|Adverse Event|32
384328|NCT00195663|1223220|P1|Open-Label Extension Period|Adverse Event|21
384329|NCT00195663|1223218|P3|2-year Double-blind Treatment Period|Administrative reasons|9
384330|NCT00195663|1223219|P2|2-year Double-blind Treatment Period|Administrative reasons|2
384331|NCT00195663|1223220|P1|2-year Double-blind Treatment Period|Administrative reasons|3
384332|NCT00195663|1223218|P3|2-year Double-blind Treatment Period|Recovery|1
384333|NCT00195663|1223219|P2|2-year Double-blind Treatment Period|Recovery|0
384334|NCT00195663|1223220|P1|2-year Double-blind Treatment Period|Recovery|1
384335|NCT00195663|1223218|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
384336|NCT00195663|1223219|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
384337|NCT00195663|1223220|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
384338|NCT00195663|1223218|P3|2-year Double-blind Treatment Period|Protocol Violation|4
384339|NCT00195663|1223219|P2|2-year Double-blind Treatment Period|Protocol Violation|6
384340|NCT00195663|1223220|P1|2-year Double-blind Treatment Period|Protocol Violation|6
384341|NCT00195663|1223218|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
384342|NCT00195663|1223219|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
384343|NCT00195663|1223220|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
384344|NCT00195663|1223218|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
384345|NCT00195663|1223219|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
384346|NCT00195663|1223220|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
384347|NCT00195663|1223218|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
384348|NCT00195663|1223219|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
384349|NCT00195663|1223220|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
384350|NCT00195663|1223218|P3|2-year Double-blind Treatment Period|Death|0
384351|NCT00195663|1223219|P2|2-year Double-blind Treatment Period|Death|2
384352|NCT00195663|1223220|P1|2-year Double-blind Treatment Period|Death|0
384353|NCT00195663|1223218|P3|2-year Double-blind Treatment Period|Adverse Event|32
384354|NCT00195663|1223219|P2|2-year Double-blind Treatment Period|Adverse Event|27
384355|NCT00195663|1223220|P1|2-year Double-blind Treatment Period|Adverse Event|21
384356|NCT00195650|1223314|P1|Overall Study|Administrative reasons|83
384357|NCT00195650|1223314|P1|Overall Study|Protocol Violation|15
384358|NCT00195650|1223314|P1|Overall Study|Death|23
384359|NCT00195650|1223314|P1|Overall Study|Lost to Follow-up|44
384360|NCT00195650|1223314|P1|Overall Study|Withdrawal by Subject|67
384361|NCT00195650|1223314|P1|Overall Study|Lack of Efficacy|99
384362|NCT00195650|1223314|P1|Overall Study|Adverse Event|194
384363|NCT00195507|1223330|P2|Overall Study|Protocol Deviation|3
384364|NCT00195507|1223331|P1|Overall Study|Protocol Deviation|6
384365|NCT00195507|1223330|P2|Overall Study|Withdrawal by Subject|23
384366|NCT00195507|1223331|P1|Overall Study|Withdrawal by Subject|16
384367|NCT00195507|1223330|P2|Overall Study|Lack of Efficacy|67
384368|NCT00195507|1223331|P1|Overall Study|Lack of Efficacy|40
384369|NCT00195507|1223330|P2|Overall Study|Protocol Violation|4
384370|NCT00195507|1223331|P1|Overall Study|Protocol Violation|5
384371|NCT00195507|1223330|P2|Overall Study|Lost to Follow-up|2
384372|NCT00195507|1223331|P1|Overall Study|Lost to Follow-up|3
384373|NCT00195507|1223330|P2|Overall Study|Physician Decision|2
384374|NCT00195507|1223331|P1|Overall Study|Physician Decision|1
384375|NCT00195507|1223330|P2|Overall Study|Failed to Return|3
384376|NCT00195507|1223331|P1|Overall Study|Failed to Return|4
384377|NCT00195507|1223330|P2|Overall Study|Death|1
384378|NCT00195507|1223331|P1|Overall Study|Death|0
384379|NCT00195507|1223330|P2|Overall Study|Adverse Event|13
384380|NCT00195507|1223331|P1|Overall Study|Adverse Event|24
384381|NCT00195494|1223345|P6|Year 2|System toxicity|0
384382|NCT00195494|1223346|P5|Year 2|System toxicity|0
384383|NCT00195494|1223347|P4|Year 2|System toxicity|1
384384|NCT00195494|1223348|P3|Year 2|System toxicity|0
384385|NCT00195494|1223349|P2|Year 2|System toxicity|0
384386|NCT00195494|1223350|P1|Year 2|System toxicity|0
384387|NCT00195494|1223345|P6|Year 2|Withdrawal by Subject|0
384388|NCT00195494|1223346|P5|Year 2|Withdrawal by Subject|0
384389|NCT00195494|1223347|P4|Year 2|Withdrawal by Subject|3
384390|NCT00195494|1223348|P3|Year 2|Withdrawal by Subject|4
384391|NCT00195494|1223349|P2|Year 2|Withdrawal by Subject|5
384392|NCT00195494|1223350|P1|Year 2|Withdrawal by Subject|1
384393|NCT00195494|1223345|P6|Year 2|Physician Decision|0
384394|NCT00195494|1223346|P5|Year 2|Physician Decision|0
384395|NCT00195494|1223347|P4|Year 2|Physician Decision|0
384396|NCT00195494|1223348|P3|Year 2|Physician Decision|0
384397|NCT00195494|1223349|P2|Year 2|Physician Decision|1
384398|NCT00195494|1223350|P1|Year 2|Physician Decision|1
384399|NCT00195494|1223345|P6|Year 2|Protocol deviation|0
384400|NCT00195494|1223346|P5|Year 2|Protocol deviation|0
384401|NCT00195494|1223347|P4|Year 2|Protocol deviation|0
384402|NCT00195494|1223348|P3|Year 2|Protocol deviation|0
384403|NCT00195494|1223349|P2|Year 2|Protocol deviation|1
384404|NCT00195494|1223350|P1|Year 2|Protocol deviation|0
384405|NCT00195494|1223345|P6|Year 2|Missed >4 consecutive doses|0
384406|NCT00195494|1223346|P5|Year 2|Missed >4 consecutive doses|0
384407|NCT00195494|1223347|P4|Year 2|Missed >4 consecutive doses|0
384408|NCT00195494|1223348|P3|Year 2|Missed >4 consecutive doses|1
384409|NCT00195494|1223349|P2|Year 2|Missed >4 consecutive doses|1
384410|NCT00195494|1223350|P1|Year 2|Missed >4 consecutive doses|1
384411|NCT00195494|1223345|P6|Year 2|Lost to Follow-up|0
384412|NCT00195494|1223346|P5|Year 2|Lost to Follow-up|0
384413|NCT00195494|1223347|P4|Year 2|Lost to Follow-up|1
384414|NCT00195494|1223348|P3|Year 2|Lost to Follow-up|1
384415|NCT00195494|1223349|P2|Year 2|Lost to Follow-up|0
384416|NCT00195494|1223350|P1|Year 2|Lost to Follow-up|0
384417|NCT00195494|1223345|P6|Year 2|Compliance|0
384418|NCT00195494|1223346|P5|Year 2|Compliance|0
384419|NCT00195494|1223347|P4|Year 2|Compliance|2
384420|NCT00195494|1223348|P3|Year 2|Compliance|0
384421|NCT00195494|1223349|P2|Year 2|Compliance|0
384422|NCT00195494|1223350|P1|Year 2|Compliance|1
384423|NCT00195494|1223345|P6|Year 2|Lack of Efficacy|0
384424|NCT00195494|1223346|P5|Year 2|Lack of Efficacy|0
384425|NCT00195494|1223347|P4|Year 2|Lack of Efficacy|7
384426|NCT00195494|1223348|P3|Year 2|Lack of Efficacy|7
384427|NCT00195494|1223349|P2|Year 2|Lack of Efficacy|1
384428|NCT00195494|1223350|P1|Year 2|Lack of Efficacy|0
384429|NCT00195494|1223345|P6|Year 2|Adverse Event|0
384430|NCT00195494|1223346|P5|Year 2|Adverse Event|0
384431|NCT00195494|1223347|P4|Year 2|Adverse Event|9
384432|NCT00195494|1223348|P3|Year 2|Adverse Event|5
384433|NCT00195494|1223349|P2|Year 2|Adverse Event|7
384434|NCT00195494|1223350|P1|Year 2|Adverse Event|3
384435|NCT00195494|1223345|P6|Year 1|Protocol Violation|1
384436|NCT00195494|1223346|P5|Year 1|Protocol Violation|1
384437|NCT00195494|1223347|P4|Year 1|Protocol Violation|0
384438|NCT00195494|1223348|P3|Year 1|Protocol Violation|0
384439|NCT00195494|1223349|P2|Year 1|Protocol Violation|0
384440|NCT00195494|1223350|P1|Year 1|Protocol Violation|0
384441|NCT00195494|1223345|P6|Year 1|Withdrawal by Subject|9
384442|NCT00195494|1223346|P5|Year 1|Withdrawal by Subject|8
384443|NCT00195494|1223347|P4|Year 1|Withdrawal by Subject|0
384444|NCT00195494|1223348|P3|Year 1|Withdrawal by Subject|0
384445|NCT00195494|1223349|P2|Year 1|Withdrawal by Subject|0
384446|NCT00195494|1223350|P1|Year 1|Withdrawal by Subject|0
384447|NCT00195494|1223345|P6|Year 1|Physician Decision|0
384448|NCT00195494|1223346|P5|Year 1|Physician Decision|1
384449|NCT00195494|1223347|P4|Year 1|Physician Decision|0
384450|NCT00195494|1223348|P3|Year 1|Physician Decision|0
384451|NCT00195494|1223349|P2|Year 1|Physician Decision|0
384452|NCT00195494|1223350|P1|Year 1|Physician Decision|0
384453|NCT00195494|1223345|P6|Year 1|Protocol deviation|3
384454|NCT00195494|1223346|P5|Year 1|Protocol deviation|2
384455|NCT00195494|1223347|P4|Year 1|Protocol deviation|0
384456|NCT00195494|1223348|P3|Year 1|Protocol deviation|0
384457|NCT00195494|1223349|P2|Year 1|Protocol deviation|0
384458|NCT00195494|1223350|P1|Year 1|Protocol deviation|0
384459|NCT00195494|1223345|P6|Year 1|Missed >4 consecutive doses|2
384460|NCT00195494|1223346|P5|Year 1|Missed >4 consecutive doses|3
384461|NCT00195494|1223347|P4|Year 1|Missed >4 consecutive doses|0
384462|NCT00195494|1223348|P3|Year 1|Missed >4 consecutive doses|0
384463|NCT00195494|1223349|P2|Year 1|Missed >4 consecutive doses|0
384464|NCT00195494|1223350|P1|Year 1|Missed >4 consecutive doses|0
384465|NCT00195494|1223345|P6|Year 1|Lost to Follow-up|0
384466|NCT00195494|1223346|P5|Year 1|Lost to Follow-up|1
384467|NCT00195494|1223347|P4|Year 1|Lost to Follow-up|0
384468|NCT00195494|1223348|P3|Year 1|Lost to Follow-up|0
384469|NCT00195494|1223349|P2|Year 1|Lost to Follow-up|0
384470|NCT00195494|1223350|P1|Year 1|Lost to Follow-up|0
384471|NCT00195494|1223345|P6|Year 1|Compliance|1
384472|NCT00195494|1223346|P5|Year 1|Compliance|5
384473|NCT00195494|1223347|P4|Year 1|Compliance|0
384474|NCT00195494|1223348|P3|Year 1|Compliance|0
384475|NCT00195494|1223349|P2|Year 1|Compliance|0
384476|NCT00195494|1223350|P1|Year 1|Compliance|0
384477|NCT00195494|1223345|P6|Year 1|Lack of Efficacy|9
384478|NCT00195494|1223346|P5|Year 1|Lack of Efficacy|24
384479|NCT00195494|1223347|P4|Year 1|Lack of Efficacy|0
384480|NCT00195494|1223348|P3|Year 1|Lack of Efficacy|0
384481|NCT00195494|1223349|P2|Year 1|Lack of Efficacy|0
384482|NCT00195494|1223350|P1|Year 1|Lack of Efficacy|0
384483|NCT00195494|1223345|P6|Year 1|System Toxicity|1
384484|NCT00195494|1223346|P5|Year 1|System Toxicity|0
384485|NCT00195494|1223347|P4|Year 1|System Toxicity|0
384486|NCT00195494|1223348|P3|Year 1|System Toxicity|0
384487|NCT00195494|1223349|P2|Year 1|System Toxicity|0
384488|NCT00195494|1223350|P1|Year 1|System Toxicity|0
384489|NCT00195494|1223345|P6|Year 1|Adverse Event|27
384490|NCT00195494|1223346|P5|Year 1|Adverse Event|34
384491|NCT00195494|1223347|P4|Year 1|Adverse Event|0
384492|NCT00195494|1223348|P3|Year 1|Adverse Event|0
384493|NCT00195494|1223349|P2|Year 1|Adverse Event|0
384494|NCT00195494|1223350|P1|Year 1|Adverse Event|0
384495|NCT00195442|1223368|P1|Overall Study|Other|14
384496|NCT00195442|1223368|P1|Overall Study|Poor cooperation|2
384497|NCT00195442|1223368|P1|Overall Study|No reason specified|4
384498|NCT00195442|1223368|P1|Overall Study|Death|7
384499|NCT00195442|1223368|P1|Overall Study|Intermittent product shortage|21
384500|NCT00195442|1223368|P1|Overall Study|Switch to other Factor VIII preparation|23
384501|NCT00195442|1223368|P1|Overall Study|Lost to Follow-up|27
384502|NCT00195442|1223368|P1|Overall Study|Less than expected therapeutic effect|38
384503|NCT00195429|1223387|P2|Overall Study|Lost to Follow-up|0
384504|NCT00195429|1223388|P1|Overall Study|Lost to Follow-up|1
384505|NCT00195429|1223387|P2|Overall Study|Lack of Efficacy|1
384506|NCT00195429|1223388|P1|Overall Study|Lack of Efficacy|2
384507|NCT00195429|1223387|P2|Overall Study|Adverse Event|4
384508|NCT00195429|1223388|P1|Overall Study|Adverse Event|2
384509|NCT00195351|1223404|P2|Overall Study|Lack of Efficacy|1
384510|NCT00195351|1223405|P1|Overall Study|Lack of Efficacy|0
384511|NCT00195351|1223404|P2|Overall Study|Death|1
384512|NCT00195351|1223405|P1|Overall Study|Death|3
384513|NCT00195351|1223404|P2|Overall Study|Protocol Deviation|2
384514|NCT00195351|1223405|P1|Overall Study|Protocol Deviation|3
384515|NCT00195351|1223404|P2|Overall Study|Withdrawal by Subject|3
384516|NCT00195351|1223405|P1|Overall Study|Withdrawal by Subject|6
384517|NCT00195351|1223404|P2|Overall Study|Lost to Follow-up|9
384518|NCT00195351|1223405|P1|Overall Study|Lost to Follow-up|9
384519|NCT00195338|1223415|P1|Overall Study|Early closure of the site|4
384520|NCT00195338|1223415|P1|Overall Study|Lack of Efficacy|1
384521|NCT00195338|1223415|P1|Overall Study|Adverse Event|5
384522|NCT00195338|1223415|P1|Overall Study|Lost to Follow-up|2
384523|NCT00195273|1223425|P2|Overall Study|Procedural complications|3
384524|NCT00195273|1223426|P1|Overall Study|Procedural complications|9
384525|NCT00195273|1223425|P2|Overall Study|Lack of Efficacy|1
384526|NCT00195273|1223426|P1|Overall Study|Lack of Efficacy|3
384527|NCT00195273|1223425|P2|Overall Study|Protocol deviation|1
384528|NCT00195273|1223426|P1|Overall Study|Protocol deviation|0
384529|NCT00195273|1223425|P2|Overall Study|Adverse Event|9
384530|NCT00195273|1223426|P1|Overall Study|Adverse Event|9
384531|NCT00195260|1223440|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|3
384532|NCT00195260|1223441|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|4
384692|NCT00192296|1223822|P2|Overall Study|Withdrawal by Subject|1
384533|NCT00195260|1223442|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|6
384534|NCT00195260|1223443|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
384535|NCT00195260|1223444|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
384536|NCT00195260|1223445|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
384537|NCT00195260|1223446|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
384538|NCT00195260|1223447|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
384539|NCT00195260|1223448|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
384540|NCT00195260|1223449|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
384541|NCT00195260|1223450|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
384542|NCT00195260|1223440|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
384543|NCT00195260|1223441|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
384544|NCT00195260|1223442|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
384545|NCT00195260|1223443|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
384546|NCT00195260|1223444|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
384547|NCT00195260|1223445|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
384548|NCT00195260|1223446|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
384549|NCT00195260|1223447|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
384550|NCT00195260|1223448|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
384551|NCT00195260|1223449|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
384552|NCT00195260|1223450|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
384553|NCT00195260|1223440|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
384554|NCT00195260|1223441|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
384555|NCT00195260|1223442|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
384556|NCT00195260|1223443|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
384557|NCT00195260|1223444|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
384558|NCT00195260|1223445|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
384559|NCT00195260|1223446|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
384560|NCT00195260|1223447|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
384561|NCT00195260|1223448|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
384562|NCT00195260|1223449|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
384563|NCT00195260|1223450|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
384564|NCT00195260|1223440|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
384565|NCT00195260|1223441|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
384566|NCT00195260|1223442|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
384567|NCT00195260|1223443|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
384568|NCT00195260|1223444|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
384569|NCT00195260|1223445|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
384570|NCT00195260|1223446|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
384571|NCT00195260|1223447|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
384572|NCT00195260|1223448|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
384573|NCT00195260|1223449|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
384574|NCT00195260|1223450|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
384575|NCT00195260|1223440|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
384576|NCT00195260|1223441|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
384577|NCT00195260|1223442|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
384578|NCT00195260|1223443|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
384579|NCT00195260|1223444|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
384580|NCT00195260|1223445|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
384581|NCT00195260|1223446|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
384582|NCT00195260|1223447|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
384583|NCT00195260|1223448|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
384584|NCT00195260|1223449|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
384585|NCT00195260|1223450|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
384586|NCT00195260|1223440|P11|Part 1: Dose Escalation|Disease Progression|0
384587|NCT00195260|1223441|P10|Part 1: Dose Escalation|Disease Progression|0
384588|NCT00195260|1223442|P9|Part 1: Dose Escalation|Disease Progression|0
384589|NCT00195260|1223443|P8|Part 1: Dose Escalation|Disease Progression|4
384590|NCT00195260|1223444|P7|Part 1: Dose Escalation|Disease Progression|7
384591|NCT00195260|1223445|P6|Part 1: Dose Escalation|Disease Progression|6
384592|NCT00195260|1223446|P5|Part 1: Dose Escalation|Disease Progression|4
384593|NCT00195260|1223447|P4|Part 1: Dose Escalation|Disease Progression|6
384594|NCT00195260|1223448|P3|Part 1: Dose Escalation|Disease Progression|5
384595|NCT00195260|1223449|P2|Part 1: Dose Escalation|Disease Progression|2
384596|NCT00195260|1223450|P1|Part 1: Dose Escalation|Disease Progression|3
384597|NCT00195260|1223440|P11|Part 1: Dose Escalation|Death|0
384598|NCT00195260|1223441|P10|Part 1: Dose Escalation|Death|0
384599|NCT00195260|1223442|P9|Part 1: Dose Escalation|Death|0
384600|NCT00195260|1223443|P8|Part 1: Dose Escalation|Death|1
384601|NCT00195260|1223444|P7|Part 1: Dose Escalation|Death|0
384602|NCT00195260|1223445|P6|Part 1: Dose Escalation|Death|0
384603|NCT00195260|1223446|P5|Part 1: Dose Escalation|Death|0
384604|NCT00195260|1223447|P4|Part 1: Dose Escalation|Death|0
384605|NCT00195260|1223448|P3|Part 1: Dose Escalation|Death|0
384606|NCT00195260|1223449|P2|Part 1: Dose Escalation|Death|0
384607|NCT00195260|1223450|P1|Part 1: Dose Escalation|Death|0
384608|NCT00195260|1223440|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
384609|NCT00195260|1223441|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
384610|NCT00195260|1223442|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
384611|NCT00195260|1223443|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
384612|NCT00195260|1223444|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
384613|NCT00195260|1223445|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
384614|NCT00195260|1223446|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
384615|NCT00195260|1223447|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
384616|NCT00195260|1223448|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
384617|NCT00195260|1223449|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
384618|NCT00195260|1223450|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
384619|NCT00195260|1223440|P11|Part 1: Dose Escalation|Adverse Event|0
384620|NCT00195260|1223441|P10|Part 1: Dose Escalation|Adverse Event|0
384621|NCT00195260|1223442|P9|Part 1: Dose Escalation|Adverse Event|0
384622|NCT00195260|1223443|P8|Part 1: Dose Escalation|Adverse Event|0
384623|NCT00195260|1223444|P7|Part 1: Dose Escalation|Adverse Event|3
384624|NCT00195260|1223445|P6|Part 1: Dose Escalation|Adverse Event|0
384625|NCT00195260|1223446|P5|Part 1: Dose Escalation|Adverse Event|1
384626|NCT00195260|1223447|P4|Part 1: Dose Escalation|Adverse Event|1
384627|NCT00195260|1223448|P3|Part 1: Dose Escalation|Adverse Event|0
384628|NCT00195260|1223449|P2|Part 1: Dose Escalation|Adverse Event|1
384629|NCT00195260|1223450|P1|Part 1: Dose Escalation|Adverse Event|0
384630|NCT00194792|1223617|P1|Overall Study|Withdrawal by Subject|1
384631|NCT00194675|1223629|P2|Overall Study|Death|0
384632|NCT00194675|1223630|P1|Overall Study|Death|1
384633|NCT00194675|1223629|P2|Overall Study|Protocol Violation|0
384634|NCT00194675|1223630|P1|Overall Study|Protocol Violation|1
384635|NCT00194675|1223629|P2|Overall Study|"withdrew due to edgy feeling"|0
384636|NCT00194675|1223630|P1|Overall Study|"withdrew due to edgy feeling"|1
384637|NCT00194675|1223629|P2|Overall Study|lack of interest|1
384638|NCT00194675|1223630|P1|Overall Study|lack of interest|1
384639|NCT00194675|1223629|P2|Overall Study|Lost to Follow-up|1
384640|NCT00194675|1223630|P1|Overall Study|Lost to Follow-up|1
384641|NCT00194077|1223677|P2|Overall Study|Withdrawal by Subject|1
384642|NCT00194077|1223678|P1|Overall Study|Withdrawal by Subject|1
384643|NCT00194077|1223677|P2|Overall Study|Study nonadherence|0
384644|NCT00194077|1223678|P1|Overall Study|Study nonadherence|1
384645|NCT00194077|1223677|P2|Overall Study|Lack of Efficacy|29
384646|NCT00194077|1223678|P1|Overall Study|Lack of Efficacy|22
384647|NCT00194025|1223684|P1|Overall Study|non-adherence with study medication|4
384648|NCT00194025|1223684|P1|Overall Study|Adverse Event|1
384649|NCT00194012|1223699|P2|Open Label Extension|Pregnancy|1
384650|NCT00194012|1223700|P1|Open Label Extension|Pregnancy|1
384651|NCT00194012|1223699|P2|Open Label Extension|Withdrawal by Subject|1
384652|NCT00194012|1223700|P1|Open Label Extension|Withdrawal by Subject|2
384653|NCT00194012|1223699|P2|Open Label Extension|Study nonadherence|4
384654|NCT00194012|1223700|P1|Open Label Extension|Study nonadherence|1
384655|NCT00194012|1223699|P2|Open Label Extension|Lack of Efficacy|1
384656|NCT00194012|1223700|P1|Open Label Extension|Lack of Efficacy|2
384657|NCT00194012|1223699|P2|Randomized Phase|Adverse Event|1
384658|NCT00194012|1223700|P1|Randomized Phase|Adverse Event|2
384659|NCT00194012|1223699|P2|Randomized Phase|Withdrawal by Subject|3
384660|NCT00194012|1223700|P1|Randomized Phase|Withdrawal by Subject|3
384661|NCT00194012|1223699|P2|Randomized Phase|Study nonadherence|1
384662|NCT00194012|1223700|P1|Randomized Phase|Study nonadherence|2
384663|NCT00194012|1223699|P2|Randomized Phase|Lack of Efficacy|18
384664|NCT00194012|1223700|P1|Randomized Phase|Lack of Efficacy|8
384665|NCT00193609|1223708|P1|Overall Study|Adverse Event|2
384666|NCT00193609|1223708|P1|Overall Study|Lack of Efficacy|2
384667|NCT00193479|1223735|P1|Induction Chemotherapy|Disease Progression|1
384668|NCT00193479|1223735|P1|Induction Chemotherapy|Adverse Event|2
384669|NCT00193206|1223776|P1|Postoperative Therapy|Protocol Violation|1
384670|NCT00193206|1223776|P1|Postoperative Therapy|Lack of Efficacy|1
384671|NCT00193206|1223776|P1|Postoperative Therapy|Intercurrent Illness|2
384672|NCT00193206|1223776|P1|Postoperative Therapy|Physician Decision|3
384673|NCT00193206|1223776|P1|Postoperative Therapy|Withdrawal by Subject|7
384674|NCT00193206|1223776|P1|Preoperative Therapy|False Positive Pregnancy Test|1
384675|NCT00193206|1223776|P1|Preoperative Therapy|Withdrawal by Subject|2
384676|NCT00193206|1223776|P1|Preoperative Therapy|Adverse Event|2
384677|NCT00193206|1223776|P1|Preoperative Therapy|Lack of Efficacy|2
384678|NCT00193180|1223780|P1|Overall Study|Protocol Violation|1
384679|NCT00193180|1223780|P1|Overall Study|Adverse Event|8
384680|NCT00193180|1223780|P1|Overall Study|Lack of Efficacy|1
384681|NCT00193063|1223795|P1|Overall Study|Adverse Event|1
384682|NCT00193063|1223795|P1|Overall Study|Lack of Efficacy|3
384683|NCT00193050|1223801|P1|Adjuvant|Lack of Efficacy|2
384684|NCT00193050|1223801|P1|Adjuvant|Intercurrent Hospitalization|3
384685|NCT00193050|1223801|P1|Adjuvant|Physician Decision|5
384686|NCT00193050|1223801|P1|Neoadjuvant Treatment|Adverse Event|2
384687|NCT00193050|1223801|P1|Neoadjuvant Treatment|Physician Decision|2
384688|NCT00193050|1223801|P1|Neoadjuvant Treatment|Intercurrent Illness|3
384689|NCT00193050|1223801|P1|Neoadjuvant Treatment|Lack of Efficacy|2
384690|NCT00192296|1223820|P4|Overall Study|Withdrawal by Subject|0
384691|NCT00192296|1223821|P3|Overall Study|Withdrawal by Subject|0
384693|NCT00192296|1223823|P1|Overall Study|Withdrawal by Subject|0
384694|NCT00192647|1223879|P2|Overall Study|Other/Administrative|3
384695|NCT00192647|1223880|P1|Overall Study|Other/Administrative|5
384696|NCT00192647|1223879|P2|Overall Study|Failure to Return|13
384697|NCT00192647|1223880|P1|Overall Study|Failure to Return|11
384698|NCT00192647|1223879|P2|Overall Study|Refused Treatment/Did not Cooperate|8
384699|NCT00192647|1223880|P1|Overall Study|Refused Treatment/Did not Cooperate|10
384700|NCT00192647|1223879|P2|Overall Study|Protocol Violation|1
384701|NCT00192647|1223880|P1|Overall Study|Protocol Violation|3
384702|NCT00192647|1223879|P2|Overall Study|Entry Criteria Violation|6
384703|NCT00192647|1223880|P1|Overall Study|Entry Criteria Violation|6
384704|NCT00192647|1223879|P2|Overall Study|Insufficient Therapeutic Response|83
384705|NCT00192647|1223880|P1|Overall Study|Insufficient Therapeutic Response|53
384706|NCT00192647|1223879|P2|Overall Study|Laboratory Test Abnormality|2
384707|NCT00192647|1223880|P1|Overall Study|Laboratory Test Abnormality|4
384708|NCT00192647|1223879|P2|Overall Study|Adverse Event|29
384709|NCT00192647|1223880|P1|Overall Study|Adverse Event|35
384710|NCT00192647|1223879|P2|Overall Study|Death|1
384711|NCT00192647|1223880|P1|Overall Study|Death|1
384712|NCT00192075|1223898|P2|Overall Study|Other|2
384713|NCT00192075|1223899|P1|Overall Study|Other|5
384714|NCT00192075|1223898|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
384715|NCT00192075|1223899|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
384716|NCT00192075|1223898|P2|Overall Study|Patient Non-Compliance|1
384717|NCT00192075|1223899|P1|Overall Study|Patient Non-Compliance|0
384718|NCT00192075|1223898|P2|Overall Study|Withdrawal by Subject|5
384719|NCT00192075|1223899|P1|Overall Study|Withdrawal by Subject|5
384720|NCT00192075|1223898|P2|Overall Study|Physician Decision|0
384721|NCT00192075|1223899|P1|Overall Study|Physician Decision|3
384722|NCT00192075|1223898|P2|Overall Study|Lack of Efficacy|0
384723|NCT00192075|1223899|P1|Overall Study|Lack of Efficacy|0
384724|NCT00192075|1223898|P2|Overall Study|Death|1
384725|NCT00192075|1223899|P1|Overall Study|Death|0
384726|NCT00192075|1223898|P2|Overall Study|Adverse Event|3
384727|NCT00192075|1223899|P1|Overall Study|Adverse Event|1
384728|NCT00192075|1223898|P2|Overall Study|Disease Progression|6
384729|NCT00192075|1223899|P1|Overall Study|Disease Progression|23
384730|NCT00192036|1223924|P1|Overall Study|Unknown or Not Specified|5
384731|NCT00192036|1223924|P1|Overall Study|Death|1
384732|NCT00192036|1223924|P1|Overall Study|Clinical Disease Progression|1
384733|NCT00192036|1223924|P1|Overall Study|Objective Tumor Progression|4
384734|NCT00192036|1223924|P1|Overall Study|Patient/Physician Perception|1
384735|NCT00192036|1223924|P1|Overall Study|Adverse Event|6
384736|NCT00192036|1223924|P1|Overall Study|Protocol Violation|3
384737|NCT00192023|1223934|P2|Period IV - Optional Open-Label|Physician Decision|0
384738|NCT00192023|1223935|P1|Period IV - Optional Open-Label|Physician Decision|9
384739|NCT00192023|1223934|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
384740|NCT00192023|1223935|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
384741|NCT00192023|1223934|P2|Period IV - Optional Open-Label|Protocol Violation|0
384742|NCT00192023|1223935|P1|Period IV - Optional Open-Label|Protocol Violation|1
384743|NCT00192023|1223934|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
384744|NCT00192023|1223935|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
384745|NCT00192023|1223934|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
384746|NCT00192023|1223935|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
384747|NCT00192023|1223934|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
384748|NCT00192023|1223935|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
384749|NCT00192023|1223934|P2|Period IV - Optional Open-Label|Adverse Event|0
384750|NCT00192023|1223935|P1|Period IV - Optional Open-Label|Adverse Event|6
384751|NCT00192023|1223934|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
384752|NCT00192023|1223935|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
384753|NCT00192023|1223934|P2|Period III - Double-Blind|Physician Decision|0
384754|NCT00192023|1223935|P1|Period III - Double-Blind|Physician Decision|2
384755|NCT00192023|1223934|P2|Period III - Double-Blind|Adverse Event|0
384756|NCT00192023|1223935|P1|Period III - Double-Blind|Adverse Event|3
384757|NCT00191984|1223957|P1|Overall Study|Physician Decision|4
384758|NCT00191984|1223957|P1|Overall Study|Withdrawal by Subject|7
384759|NCT00191984|1223957|P1|Overall Study|Entry Criteria Exclusion|1
384760|NCT00191984|1223957|P1|Overall Study|Death|2
384761|NCT00191984|1223957|P1|Overall Study|Adverse Event|4
384762|NCT00191984|1223957|P1|Overall Study|Disease Progression|21
384763|NCT00191945|1223967|P2|Double-Blind Acute Treatment|Physician Decision|2
384764|NCT00191945|1223968|P1|Double-Blind Acute Treatment|Physician Decision|0
384765|NCT00191945|1223967|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
384766|NCT00191945|1223968|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
384767|NCT00191945|1223967|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
384768|NCT00191945|1223968|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
384769|NCT00191945|1223967|P2|Double-Blind Acute Treatment|Parent's Decision|0
384770|NCT00191945|1223968|P1|Double-Blind Acute Treatment|Parent's Decision|3
384771|NCT00191906|1224004|P4|Study Period III|Lack of Efficacy|0
384772|NCT00191906|1224005|P3|Study Period III|Lack of Efficacy|0
384773|NCT00191906|1224006|P2|Study Period III|Lack of Efficacy|3
384774|NCT00191906|1224007|P1|Study Period III|Lack of Efficacy|3
384775|NCT00191906|1224004|P4|Study Period III|Parent/Caregiver Decision|0
384776|NCT00191906|1224005|P3|Study Period III|Parent/Caregiver Decision|0
384777|NCT00191906|1224006|P2|Study Period III|Parent/Caregiver Decision|0
384778|NCT00191906|1224007|P1|Study Period III|Parent/Caregiver Decision|1
384779|NCT00191906|1224004|P4|Study Period III|Lost to Follow-up|0
384780|NCT00191906|1224005|P3|Study Period III|Lost to Follow-up|0
384781|NCT00191906|1224006|P2|Study Period III|Lost to Follow-up|1
384782|NCT00191906|1224007|P1|Study Period III|Lost to Follow-up|0
384783|NCT00191906|1224004|P4|Study Period III|Adverse Event|0
384784|NCT00191906|1224005|P3|Study Period III|Adverse Event|0
384785|NCT00191906|1224006|P2|Study Period III|Adverse Event|0
384786|NCT00191906|1224007|P1|Study Period III|Adverse Event|1
384787|NCT00191906|1224004|P4|Study Period II|Entry Criteria Exclusion|0
384788|NCT00191906|1224005|P3|Study Period II|Entry Criteria Exclusion|1
384789|NCT00191906|1224006|P2|Study Period II|Entry Criteria Exclusion|0
384790|NCT00191906|1224007|P1|Study Period II|Entry Criteria Exclusion|0
384791|NCT00191906|1224004|P4|Study Period II|Parent/Caregiver Decision|0
384792|NCT00191906|1224005|P3|Study Period II|Parent/Caregiver Decision|0
384793|NCT00191906|1224006|P2|Study Period II|Parent/Caregiver Decision|1
384794|NCT00191906|1224007|P1|Study Period II|Parent/Caregiver Decision|0
384795|NCT00191906|1224004|P4|Study Period II|Withdrawal by Subject|0
384796|NCT00191906|1224005|P3|Study Period II|Withdrawal by Subject|0
384797|NCT00191906|1224006|P2|Study Period II|Withdrawal by Subject|3
384798|NCT00191906|1224007|P1|Study Period II|Withdrawal by Subject|0
384799|NCT00191906|1224004|P4|Study Period II|Adverse Event|0
384800|NCT00191906|1224005|P3|Study Period II|Adverse Event|0
384801|NCT00191906|1224006|P2|Study Period II|Adverse Event|1
384802|NCT00191906|1224007|P1|Study Period II|Adverse Event|0
384803|NCT00191854|1224050|P3|Overall Study|Screen Failure|1
384804|NCT00191854|1224051|P2|Overall Study|Screen Failure|0
384805|NCT00191854|1224052|P1|Overall Study|Screen Failure|0
384806|NCT00191854|1224050|P3|Overall Study|Sponsor Decision|1
384807|NCT00191854|1224051|P2|Overall Study|Sponsor Decision|0
384808|NCT00191854|1224052|P1|Overall Study|Sponsor Decision|0
384809|NCT00191854|1224050|P3|Overall Study|Withdrawal by Subject|3
384810|NCT00191854|1224051|P2|Overall Study|Withdrawal by Subject|2
384811|NCT00191854|1224052|P1|Overall Study|Withdrawal by Subject|4
384812|NCT00191854|1224050|P3|Overall Study|Lost to Follow-up|5
384813|NCT00191854|1224051|P2|Overall Study|Lost to Follow-up|5
384814|NCT00191854|1224052|P1|Overall Study|Lost to Follow-up|7
384815|NCT00191854|1224050|P3|Overall Study|Death|29
384816|NCT00191854|1224051|P2|Overall Study|Death|23
384817|NCT00191854|1224052|P1|Overall Study|Death|26
384818|NCT00191815|1224072|P1|Overall Study|Withdrawal by Subject|7
384819|NCT00191815|1224072|P1|Overall Study|Physician Decision|2
384820|NCT00191815|1224072|P1|Overall Study|Protocol Violation|3
384821|NCT00191815|1224072|P1|Overall Study|Death|2
384822|NCT00191815|1224072|P1|Overall Study|Disease progression or relapse|24
384823|NCT00191815|1224072|P1|Overall Study|Adverse Event|2
384824|NCT00191789|1224084|P1|Overall Study|Death - Not Study-Drug Related|1
384825|NCT00191789|1224084|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
384826|NCT00191789|1224084|P1|Overall Study|Death - Possibly Study Drug Related|4
384827|NCT00191789|1224084|P1|Overall Study|Withdrawal by Subject|4
384828|NCT00191789|1224084|P1|Overall Study|Patient/Physician: Satisfactory Response|4
384829|NCT00191789|1224084|P1|Overall Study|Patient: Satisfactory Response|5
384830|NCT00191789|1224084|P1|Overall Study|Adverse Event|5
384831|NCT00191724|1224101|P5|Overall Study|Withdrawal by Subject|0
384832|NCT00191724|1224102|P4|Overall Study|Withdrawal by Subject|1
384833|NCT00191724|1224103|P3|Overall Study|Withdrawal by Subject|0
384834|NCT00191724|1224104|P2|Overall Study|Withdrawal by Subject|0
384835|NCT00191724|1224105|P1|Overall Study|Withdrawal by Subject|0
384836|NCT00191724|1224101|P5|Overall Study|Lost to Follow-up|3
384837|NCT00191724|1224102|P4|Overall Study|Lost to Follow-up|2
384838|NCT00191724|1224103|P3|Overall Study|Lost to Follow-up|0
384839|NCT00191724|1224104|P2|Overall Study|Lost to Follow-up|1
384840|NCT00191724|1224105|P1|Overall Study|Lost to Follow-up|1
384841|NCT00191724|1224101|P5|Overall Study|Adverse Event|0
384842|NCT00191724|1224102|P4|Overall Study|Adverse Event|0
384843|NCT00191724|1224103|P3|Overall Study|Adverse Event|1
384844|NCT00191724|1224104|P2|Overall Study|Adverse Event|0
384845|NCT00191724|1224105|P1|Overall Study|Adverse Event|0
384846|NCT00191646|1224134|P2|Overall Study|Missing Data|11
384847|NCT00191646|1224135|P1|Overall Study|Missing Data|18
384848|NCT00191646|1224134|P2|Overall Study|Other|34
384849|NCT00191646|1224135|P1|Overall Study|Other|33
384850|NCT00191646|1224134|P2|Overall Study|Death|8
384851|NCT00191646|1224135|P1|Overall Study|Death|6
384852|NCT00191646|1224134|P2|Overall Study|Protocol Violation|7
384853|NCT00191646|1224135|P1|Overall Study|Protocol Violation|5
384854|NCT00191646|1224134|P2|Overall Study|Withdrawal by Subject|39
384855|NCT00191646|1224135|P1|Overall Study|Withdrawal by Subject|58
384856|NCT00191646|1224134|P2|Overall Study|Physician Decision|11
384857|NCT00191646|1224135|P1|Overall Study|Physician Decision|20
384858|NCT00191646|1224134|P2|Overall Study|Disease Progression|6
384859|NCT00191646|1224135|P1|Overall Study|Disease Progression|5
384860|NCT00191646|1224134|P2|Overall Study|Toxicity|37
384861|NCT00191646|1224135|P1|Overall Study|Toxicity|26
384862|NCT00191477|1224155|P2|Overall Study|Discontinued Prior to Instillation|14
384863|NCT00191477|1224156|P1|Overall Study|Discontinued Prior to Instillation|13
384864|NCT00191477|1224155|P2|Overall Study|Pathological Specimen Lost|0
384865|NCT00191477|1224156|P1|Overall Study|Pathological Specimen Lost|1
384866|NCT00191477|1224155|P2|Overall Study|Not Eligible|38
384867|NCT00191477|1224156|P1|Overall Study|Not Eligible|41
384868|NCT00191477|1224155|P2|Overall Study|Unspecified|0
384869|NCT00191477|1224156|P1|Overall Study|Unspecified|2
384870|NCT00191477|1224155|P2|Overall Study|Withdrawal by Subject|0
384871|NCT00191477|1224156|P1|Overall Study|Withdrawal by Subject|2
384872|NCT00191477|1224155|P2|Overall Study|Treatment Change|0
384873|NCT00191477|1224156|P1|Overall Study|Treatment Change|2
384874|NCT00191477|1224155|P2|Overall Study|Protocol Violation|1
384875|NCT00191477|1224156|P1|Overall Study|Protocol Violation|1
384876|NCT00191477|1224155|P2|Overall Study|Lost to Follow-up|21
384877|NCT00191477|1224156|P1|Overall Study|Lost to Follow-up|23
384878|NCT00191477|1224155|P2|Overall Study|Death, Other Cause|6
384879|NCT00191477|1224156|P1|Overall Study|Death, Other Cause|3
384880|NCT00191477|1224155|P2|Overall Study|Death, Study Disease|1
384881|NCT00191477|1224156|P1|Overall Study|Death, Study Disease|1
384882|NCT00191477|1224155|P2|Overall Study|Tumor Recurrence|48
384883|NCT00191477|1224156|P1|Overall Study|Tumor Recurrence|49
384884|NCT00191451|1224175|P3|Overall Study|Reason Not Specified|3
384885|NCT00191451|1224176|P2|Overall Study|Reason Not Specified|1
384886|NCT00191451|1224177|P1|Overall Study|Reason Not Specified|2
384887|NCT00191451|1224175|P3|Overall Study|Ineligible|0
384888|NCT00191451|1224176|P2|Overall Study|Ineligible|1
384889|NCT00191451|1224177|P1|Overall Study|Ineligible|0
384890|NCT00191451|1224175|P3|Overall Study|Sponsor Decision|0
384891|NCT00191451|1224176|P2|Overall Study|Sponsor Decision|0
384892|NCT00191451|1224177|P1|Overall Study|Sponsor Decision|1
384893|NCT00191451|1224175|P3|Overall Study|Physician Decision|6
384894|NCT00191451|1224176|P2|Overall Study|Physician Decision|9
384895|NCT00191451|1224177|P1|Overall Study|Physician Decision|2
384896|NCT00191451|1224175|P3|Overall Study|Withdrawal by Subject|5
384897|NCT00191451|1224176|P2|Overall Study|Withdrawal by Subject|3
384898|NCT00191451|1224177|P1|Overall Study|Withdrawal by Subject|2
384899|NCT00191386|1224197|P1|Overall Study|Lack of Efficacy|15
384900|NCT00191386|1224197|P1|Overall Study|Physician Decision|11
384901|NCT00191386|1224197|P1|Overall Study|Withdrawal by Subject|96
384902|NCT00191386|1224197|P1|Overall Study|Protocol Violation|18
384903|NCT00191386|1224197|P1|Overall Study|Entry Criteria Exclusion|3
384904|NCT00191386|1224197|P1|Overall Study|Lost to Follow-up|1
384905|NCT00191386|1224197|P1|Overall Study|Adverse Event|16
384906|NCT00191334|1224204|P1|Overall Study|Withdrawal by Subject|4
384907|NCT00191334|1224204|P1|Overall Study|Physician Decision|1
384908|NCT00191334|1224204|P1|Overall Study|Disease Progression or Relapse|8
384909|NCT00191334|1224204|P1|Overall Study|Adverse Event|4
384910|NCT00191308|1224212|P1|Overall Study|Adverse Event|1
384911|NCT00191282|1224222|P2|Overall Study|Lost to Follow-up|31
384912|NCT00191282|1224223|P1|Overall Study|Lost to Follow-up|24
384913|NCT00191282|1224222|P2|Overall Study|Sponsor's decision|2
384914|NCT00191282|1224223|P1|Overall Study|Sponsor's decision|2
384915|NCT00191282|1224222|P2|Overall Study|Severity of outcome|5
384916|NCT00191282|1224223|P1|Overall Study|Severity of outcome|2
384917|NCT00191282|1224222|P2|Overall Study|Protocol Violation|12
384918|NCT00191282|1224223|P1|Overall Study|Protocol Violation|9
384919|NCT00191282|1224222|P2|Overall Study|Protocol entry criteria not met|9
384920|NCT00191282|1224223|P1|Overall Study|Protocol entry criteria not met|14
384921|NCT00191282|1224222|P2|Overall Study|Physician Decision|15
384922|NCT00191282|1224223|P1|Overall Study|Physician Decision|18
384923|NCT00191282|1224222|P2|Overall Study|Withdrawal by Subject|44
384924|NCT00191282|1224223|P1|Overall Study|Withdrawal by Subject|59
384925|NCT00191282|1224222|P2|Overall Study|Patient moved|14
384926|NCT00191282|1224223|P1|Overall Study|Patient moved|11
384927|NCT00191282|1224222|P2|Overall Study|Noncompliance|17
384928|NCT00191282|1224223|P1|Overall Study|Noncompliance|14
384929|NCT00191282|1224222|P2|Overall Study|Lack of Efficacy|6
384930|NCT00191282|1224223|P1|Overall Study|Lack of Efficacy|11
384931|NCT00191282|1224222|P2|Overall Study|Death|51
384932|NCT00191282|1224223|P1|Overall Study|Death|51
384933|NCT00191282|1224222|P2|Overall Study|Adverse Event|6
384934|NCT00191282|1224223|P1|Overall Study|Adverse Event|5
384935|NCT00191269|1224283|P2|Overall Study|Physician Decision|3
384936|NCT00191269|1224284|P1|Overall Study|Physician Decision|0
384937|NCT00191269|1224283|P2|Overall Study|Pathologic Aggrevation|1
384938|NCT00191269|1224284|P1|Overall Study|Pathologic Aggrevation|0
384939|NCT00191269|1224283|P2|Overall Study|Withdrawal by Subject|1
384940|NCT00191269|1224284|P1|Overall Study|Withdrawal by Subject|0
384941|NCT00191269|1224283|P2|Overall Study|Lack of Efficacy|5
384942|NCT00191269|1224284|P1|Overall Study|Lack of Efficacy|1
384943|NCT00191269|1224283|P2|Overall Study|Progression of Disease|42
384944|NCT00191269|1224284|P1|Overall Study|Progression of Disease|4
384945|NCT00191269|1224283|P2|Overall Study|Adverse Event|4
384946|NCT00191269|1224284|P1|Overall Study|Adverse Event|1
384947|NCT00191269|1224283|P2|Overall Study|Protocol Violation|2
384948|NCT00191269|1224284|P1|Overall Study|Protocol Violation|0
384949|NCT00191191|1224300|P2|Overall Study|Good Clinical Practice Violation|1
384950|NCT00191191|1224301|P1|Overall Study|Good Clinical Practice Violation|0
384951|NCT00191191|1224300|P2|Overall Study|Physician Decision|2
384952|NCT00191191|1224301|P1|Overall Study|Physician Decision|3
384953|NCT00191191|1224300|P2|Overall Study|Lost to Follow-up|0
384954|NCT00191191|1224301|P1|Overall Study|Lost to Follow-up|1
384955|NCT00191191|1224300|P2|Overall Study|Family/Caregiver Decision|7
384956|NCT00191191|1224301|P1|Overall Study|Family/Caregiver Decision|5
384957|NCT00191191|1224300|P2|Overall Study|Toxicity After Dose Reduction|8
384958|NCT00191191|1224301|P1|Overall Study|Toxicity After Dose Reduction|7
384959|NCT00191191|1224300|P2|Overall Study|Progressive Disease|72
384960|NCT00191191|1224301|P1|Overall Study|Progressive Disease|84
384961|NCT00191191|1224300|P2|Overall Study|Adverse Event|21
384962|NCT00191191|1224301|P1|Overall Study|Adverse Event|11
384963|NCT00191191|1224300|P2|Overall Study|Treated with Another Systemic Agent|1
384964|NCT00191191|1224301|P1|Overall Study|Treated with Another Systemic Agent|1
384965|NCT00191191|1224300|P2|Overall Study|Entry Criteria Exclusion|0
384966|NCT00191191|1224301|P1|Overall Study|Entry Criteria Exclusion|2
384967|NCT00191165|1224317|P2|Overall Study|Participant Moved Away|1
384968|NCT00191165|1224318|P1|Overall Study|Participant Moved Away|0
384969|NCT00191165|1224317|P2|Overall Study|Protocol Violation|1
384970|NCT00191165|1224318|P1|Overall Study|Protocol Violation|0
384971|NCT00191165|1224317|P2|Overall Study|Adverse Event|0
384972|NCT00191165|1224318|P1|Overall Study|Adverse Event|2
384973|NCT00191152|1224330|P2|Crossover Treatment|Not Specified|3
384974|NCT00191152|1224331|P1|Crossover Treatment|Not Specified|4
384975|NCT00191152|1224330|P2|Crossover Treatment|Lost to Follow-up|1
384976|NCT00191152|1224331|P1|Crossover Treatment|Lost to Follow-up|2
384977|NCT00191152|1224330|P2|Crossover Treatment|Withdrawal by Subject|9
384978|NCT00191152|1224331|P1|Crossover Treatment|Withdrawal by Subject|6
384979|NCT00191152|1224330|P2|Crossover Treatment|Physician Decision|7
384980|NCT00191152|1224331|P1|Crossover Treatment|Physician Decision|7
384981|NCT00191152|1224330|P2|Crossover Treatment|Adverse Event|8
384982|NCT00191152|1224331|P1|Crossover Treatment|Adverse Event|8
384983|NCT00191152|1224330|P2|Initial Treatment|not specified|21
384984|NCT00191152|1224331|P1|Initial Treatment|not specified|18
384985|NCT00191152|1224330|P2|Initial Treatment|Lost to Follow-up|6
384986|NCT00191152|1224331|P1|Initial Treatment|Lost to Follow-up|0
384987|NCT00191152|1224330|P2|Initial Treatment|Withdrawal by Subject|28
384988|NCT00191152|1224331|P1|Initial Treatment|Withdrawal by Subject|40
384989|NCT00191152|1224330|P2|Initial Treatment|Physician Decision|31
384990|NCT00191152|1224331|P1|Initial Treatment|Physician Decision|40
384991|NCT00191152|1224330|P2|Initial Treatment|Adverse Event|67
384992|NCT00191152|1224331|P1|Initial Treatment|Adverse Event|43
384993|NCT00191139|1224363|P2|Overall Study|Other|2
384994|NCT00191139|1224364|P1|Overall Study|Other|1
384995|NCT00191139|1224363|P2|Overall Study|Disease Progression|1
384996|NCT00191139|1224364|P1|Overall Study|Disease Progression|0
384997|NCT00191139|1224363|P2|Overall Study|Withdrawal by Subject|3
384998|NCT00191139|1224364|P1|Overall Study|Withdrawal by Subject|0
384999|NCT00191139|1224363|P2|Overall Study|Death|0
385000|NCT00191139|1224364|P1|Overall Study|Death|2
385001|NCT00191139|1224363|P2|Overall Study|Adverse Event|6
385002|NCT00191139|1224364|P1|Overall Study|Adverse Event|2
385003|NCT00191113|1224380|P2|Core Study|Death|0
385004|NCT00191113|1224381|P1|Core Study|Death|1
385005|NCT00191113|1224380|P2|Core Study|Lack of Efficacy|2
385006|NCT00191113|1224381|P1|Core Study|Lack of Efficacy|0
385007|NCT00191113|1224380|P2|Core Study|Adverse Event|2
385008|NCT00191113|1224381|P1|Core Study|Adverse Event|0
385009|NCT00191113|1224380|P2|Core Study|Lost to Follow-up|0
385010|NCT00191113|1224381|P1|Core Study|Lost to Follow-up|3
385011|NCT00191113|1224380|P2|Core Study|Protocol Violation|2
385012|NCT00191113|1224381|P1|Core Study|Protocol Violation|6
385013|NCT00191113|1224380|P2|Core Study|Withdrawal by Subject|9
385014|NCT00191113|1224381|P1|Core Study|Withdrawal by Subject|25
385015|NCT00191100|1224423|P2|Overall Study|Reason Not Specified|1
385016|NCT00191100|1224424|P1|Overall Study|Reason Not Specified|0
385017|NCT00191100|1224423|P2|Overall Study|Death from Other Cause|0
385018|NCT00191100|1224424|P1|Overall Study|Death from Other Cause|1
385019|NCT00191100|1224423|P2|Overall Study|Protocol Violation|1
385020|NCT00191100|1224424|P1|Overall Study|Protocol Violation|1
385021|NCT00191100|1224423|P2|Overall Study|Death from Study Drug Toxicity|0
385022|NCT00191100|1224424|P1|Overall Study|Death from Study Drug Toxicity|2
385023|NCT00191100|1224423|P2|Overall Study|Physician Decision|1
385024|NCT00191100|1224424|P1|Overall Study|Physician Decision|3
385025|NCT00191100|1224423|P2|Overall Study|Lack of Efficacy, Stable Disease|0
385026|NCT00191100|1224424|P1|Overall Study|Lack of Efficacy, Stable Disease|1
385027|NCT00191100|1224423|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
385028|NCT00191100|1224424|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
385029|NCT00191100|1224423|P2|Overall Study|Clinical Relapse|1
385030|NCT00191100|1224424|P1|Overall Study|Clinical Relapse|2
385031|NCT00191100|1224423|P2|Overall Study|Protocol Entry Criteria Not Met|1
385032|NCT00191100|1224424|P1|Overall Study|Protocol Entry Criteria Not Met|2
385033|NCT00191100|1224423|P2|Overall Study|Withdrawal by Subject|3
385034|NCT00191100|1224424|P1|Overall Study|Withdrawal by Subject|9
385035|NCT00191100|1224423|P2|Overall Study|Patient Moved|1
385036|NCT00191100|1224424|P1|Overall Study|Patient Moved|0
385037|NCT00191100|1224423|P2|Overall Study|Lost to Follow-up|0
385038|NCT00191100|1224424|P1|Overall Study|Lost to Follow-up|2
385039|NCT00191100|1224423|P2|Overall Study|Adverse Event|1
385040|NCT00191100|1224424|P1|Overall Study|Adverse Event|18
385041|NCT00190983|1224440|P1|Overall Study|Inevaluable (never treated)|2
385042|NCT00190775|1224449|P2|Overall Study|Exclusion Criteria Met|3
385043|NCT00190775|1224450|P1|Overall Study|Exclusion Criteria Met|1
385044|NCT00190775|1224449|P2|Overall Study|Protocol Violation|1
385045|NCT00190775|1224450|P1|Overall Study|Protocol Violation|0
385046|NCT00190775|1224449|P2|Overall Study|Noncompliance|5
385047|NCT00190775|1224450|P1|Overall Study|Noncompliance|3
385048|NCT00190775|1224449|P2|Overall Study|Physician Decision|0
385049|NCT00190775|1224450|P1|Overall Study|Physician Decision|3
385050|NCT00190775|1224449|P2|Overall Study|Sponsor Decision|0
385051|NCT00190775|1224450|P1|Overall Study|Sponsor Decision|1
385052|NCT00190775|1224449|P2|Overall Study|Withdrawal by Subject|13
385053|NCT00190775|1224450|P1|Overall Study|Withdrawal by Subject|24
385054|NCT00190775|1224449|P2|Overall Study|Participant Moved|1
385055|NCT00190775|1224450|P1|Overall Study|Participant Moved|0
385056|NCT00190775|1224449|P2|Overall Study|Lost to Follow-up|23
385057|NCT00190775|1224450|P1|Overall Study|Lost to Follow-up|31
385058|NCT00190775|1224449|P2|Overall Study|Lack of Efficacy|32
385059|NCT00190775|1224450|P1|Overall Study|Lack of Efficacy|28
385060|NCT00190775|1224449|P2|Overall Study|Satisfactory Response|0
385061|NCT00190775|1224450|P1|Overall Study|Satisfactory Response|1
385062|NCT00190775|1224449|P2|Overall Study|Adverse Event|22
385063|NCT00190775|1224450|P1|Overall Study|Adverse Event|57
385064|NCT00190749|1224521|P2|Overall Study|Sponsor Decision|0
385065|NCT00190749|1224522|P1|Overall Study|Sponsor Decision|1
385066|NCT00190749|1224521|P2|Overall Study|Reason Not Specified|2
385067|NCT00190749|1224522|P1|Overall Study|Reason Not Specified|0
385068|NCT00190749|1224521|P2|Overall Study|Lack of Efficacy|3
385069|NCT00190749|1224522|P1|Overall Study|Lack of Efficacy|2
385070|NCT00190749|1224521|P2|Overall Study|Adverse Event|5
385071|NCT00190749|1224522|P1|Overall Study|Adverse Event|0
385072|NCT00190749|1224521|P2|Overall Study|Protocol Violation|4
385073|NCT00190749|1224522|P1|Overall Study|Protocol Violation|5
385074|NCT00190749|1224521|P2|Overall Study|Withdrawal by Subject|6
385075|NCT00190749|1224522|P1|Overall Study|Withdrawal by Subject|10
385076|NCT00190749|1224521|P2|Overall Study|Lost to Follow-up|11
385077|NCT00190749|1224522|P1|Overall Study|Lost to Follow-up|8
385078|NCT00190684|1224586|P1|Overall Study|Study Period V Completed|1
385079|NCT00190684|1224586|P1|Overall Study|Study Period III Completed|103
385080|NCT00190684|1224586|P1|Overall Study|Protocol Violation|123
385081|NCT00190684|1224586|P1|Overall Study|Physician Decision|84
385082|NCT00190684|1224586|P1|Overall Study|Sponsor's decision|17
385083|NCT00190684|1224586|P1|Overall Study|Clinical relapse|67
385084|NCT00190684|1224586|P1|Overall Study|Patient Decision|432
385085|NCT00190684|1224586|P1|Overall Study|Patient moved|60
385086|NCT00190684|1224586|P1|Overall Study|Lost to Follow-up|232
385087|NCT00190684|1224586|P1|Overall Study|Lack of efficacy|204
385088|NCT00190684|1224586|P1|Overall Study|Satisfactory response|80
385089|NCT00190684|1224586|P1|Overall Study|Adverse Event|86
385090|NCT00190671|1224607|P2|Overall Study|Withdrawal by Subject|2
385091|NCT00190671|1224608|P1|Overall Study|Withdrawal by Subject|0
385092|NCT00190671|1224607|P2|Overall Study|Protocol Violation|1
385093|NCT00190671|1224608|P1|Overall Study|Protocol Violation|0
385094|NCT00190671|1224607|P2|Overall Study|Death from Other Causes|2
385095|NCT00190671|1224608|P1|Overall Study|Death from Other Causes|0
385096|NCT00190671|1224607|P2|Overall Study|Death from Study-Drug Toxicity|2
385097|NCT00190671|1224608|P1|Overall Study|Death from Study-Drug Toxicity|0
385098|NCT00190671|1224607|P2|Overall Study|Clinical Relapse|1
385099|NCT00190671|1224608|P1|Overall Study|Clinical Relapse|0
385100|NCT00190671|1224607|P2|Overall Study|Adverse Event|2
385101|NCT00190671|1224608|P1|Overall Study|Adverse Event|3
385102|NCT00190671|1224607|P2|Overall Study|Death from Study Disease|1
385103|NCT00190671|1224608|P1|Overall Study|Death from Study Disease|1
385104|NCT00190671|1224607|P2|Overall Study|Lack of Efficacy|24
385105|NCT00190671|1224608|P1|Overall Study|Lack of Efficacy|19
385106|NCT00190671|1224607|P2|Overall Study|Satisfactory Response|7
385107|NCT00190671|1224608|P1|Overall Study|Satisfactory Response|4
385108|NCT00189540|1224628|P2|Overall Study|Death|1
385109|NCT00189540|1224629|P1|Overall Study|Death|4
385110|NCT00189540|1224628|P2|Overall Study|Withdrawal by Subject|0
385111|NCT00189540|1224629|P1|Overall Study|Withdrawal by Subject|3
385112|NCT00189488|1224647|P2|Overall Study|Other|0
385113|NCT00189488|1224648|P1|Overall Study|Other|1
385114|NCT00189488|1224647|P2|Overall Study|Death|8
385115|NCT00189488|1224648|P1|Overall Study|Death|5
385116|NCT00189488|1224647|P2|Overall Study|Administrative Decision|2
385117|NCT00189488|1224648|P1|Overall Study|Administrative Decision|0
385118|NCT00189488|1224647|P2|Overall Study|Disease progression|4
385119|NCT00189488|1224648|P1|Overall Study|Disease progression|2
385120|NCT00189488|1224647|P2|Overall Study|Withdrawal by Subject|6
385121|NCT00189488|1224648|P1|Overall Study|Withdrawal by Subject|2
385122|NCT00189488|1224647|P2|Overall Study|Adverse Event|1
385123|NCT00189488|1224648|P1|Overall Study|Adverse Event|2
385124|NCT00189488|1224647|P2|Overall Study|Protocol deviation|1
385125|NCT00189488|1224648|P1|Overall Study|Protocol deviation|2
385126|NCT00189488|1224647|P2|Overall Study|Ineligibility determined|0
385127|NCT00189488|1224648|P1|Overall Study|Ineligibility determined|1
385128|NCT00189462|1224679|P2|Overall Study|Lost to Follow-up|20
385129|NCT00189462|1224680|P1|Overall Study|Lost to Follow-up|18
385130|NCT00189462|1224679|P2|Overall Study|Lack of Efficacy|1
385131|NCT00189462|1224680|P1|Overall Study|Lack of Efficacy|5
385132|NCT00189423|1224697|P2|Overall Study|Lost to Follow-up|10
385133|NCT00189423|1224698|P1|Overall Study|Lost to Follow-up|10
385134|NCT00189423|1224697|P2|Overall Study|Withdrawal by Subject|9
385135|NCT00189423|1224698|P1|Overall Study|Withdrawal by Subject|9
385136|NCT00189423|1224697|P2|Overall Study|Death|747
385137|NCT00189423|1224698|P1|Overall Study|Death|746
385138|NCT00189306|1224718|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
385139|NCT00189306|1224718|P1|Long-Term Follow-up|Lost to Follow-up|9
385140|NCT00189306|1224718|P1|Long-Term Follow-up|Intercurrent disease|2
385141|NCT00189306|1224718|P1|Long-Term Follow-up|Withdrawal by Subject|1
385142|NCT00189306|1224718|P1|Long-Term Follow-up|Death|4
385143|NCT00189306|1224718|P1|Long-Term Follow-up|Adverse Event|2
385144|NCT00189306|1224718|P1|Posttreatment Period|Local skin reaction/sign|1
385145|NCT00189306|1224718|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
385146|NCT00189306|1224718|P1|Posttreatment Period|Protocol Violation|1
385147|NCT00189306|1224718|P1|Posttreatment Period|Target lesion excised|1
385148|NCT00189306|1224718|P1|Posttreatment Period|Noncompliance|1
385149|NCT00189306|1224718|P1|Posttreatment Period|Withdrawal by Subject|2
385150|NCT00189306|1224718|P1|Posttreatment Period|Death|1
385151|NCT00189306|1224718|P1|Treatment Period|Protocol Violation|1
385152|NCT00189306|1224718|P1|Treatment Period|Adverse Event|2
385153|NCT00189306|1224718|P1|Treatment Period|Withdrawal by Subject|2
385154|NCT00189202|1224723|P1|Overall Study|Physician Decision|5
385155|NCT00187889|1224764|P2|Overall Study|Withdrawal by Subject|4
385156|NCT00187889|1224765|P1|Overall Study|Withdrawal by Subject|6
385157|NCT00187486|1224807|P1|Overall Study|Protocol Violation|1
385158|NCT00187135|1224858|P6|Visit Three|Study Discontinued|6
385159|NCT00187135|1224859|P5|Visit Three|Study Discontinued|7
385160|NCT00187135|1224860|P4|Visit Three|Study Discontinued|7
385161|NCT00187135|1224861|P3|Visit Three|Study Discontinued|7
385162|NCT00187135|1224862|P2|Visit Three|Study Discontinued|6
385163|NCT00187135|1224863|P1|Visit Three|Study Discontinued|7
385164|NCT00187135|1224858|P6|Visit Three|Withdrawal by Subject|0
385165|NCT00187135|1224859|P5|Visit Three|Withdrawal by Subject|0
385166|NCT00187135|1224860|P4|Visit Three|Withdrawal by Subject|2
385167|NCT00187135|1224861|P3|Visit Three|Withdrawal by Subject|1
385168|NCT00187135|1224862|P2|Visit Three|Withdrawal by Subject|1
385169|NCT00187135|1224863|P1|Visit Three|Withdrawal by Subject|0
385170|NCT00187135|1224858|P6|Visit Three|Death|0
385171|NCT00187135|1224859|P5|Visit Three|Death|1
385172|NCT00187135|1224860|P4|Visit Three|Death|0
385173|NCT00187135|1224861|P3|Visit Three|Death|1
385174|NCT00187135|1224862|P2|Visit Three|Death|0
385175|NCT00187135|1224863|P1|Visit Three|Death|0
385176|NCT00187135|1224858|P6|Visit Two|Study Discontinued|6
385177|NCT00187135|1224859|P5|Visit Two|Study Discontinued|5
385178|NCT00187135|1224860|P4|Visit Two|Study Discontinued|7
385179|NCT00187135|1224861|P3|Visit Two|Study Discontinued|1
385180|NCT00187135|1224862|P2|Visit Two|Study Discontinued|2
385181|NCT00187135|1224863|P1|Visit Two|Study Discontinued|3
385182|NCT00187135|1224858|P6|Visit Two|Withdrawal by Subject|1
385183|NCT00187135|1224859|P5|Visit Two|Withdrawal by Subject|1
385184|NCT00187135|1224860|P4|Visit Two|Withdrawal by Subject|0
385185|NCT00187135|1224861|P3|Visit Two|Withdrawal by Subject|1
385186|NCT00187135|1224862|P2|Visit Two|Withdrawal by Subject|1
385187|NCT00187135|1224863|P1|Visit Two|Withdrawal by Subject|1
385188|NCT00187135|1224858|P6|Visit Two|Physician Decision|0
385189|NCT00187135|1224859|P5|Visit Two|Physician Decision|0
385190|NCT00187135|1224860|P4|Visit Two|Physician Decision|0
385191|NCT00187135|1224861|P3|Visit Two|Physician Decision|0
385192|NCT00187135|1224862|P2|Visit Two|Physician Decision|0
385193|NCT00187135|1224863|P1|Visit Two|Physician Decision|1
385194|NCT00187135|1224858|P6|Visit Two|Death|1
385195|NCT00187135|1224859|P5|Visit Two|Death|0
385196|NCT00187135|1224860|P4|Visit Two|Death|1
385197|NCT00187135|1224861|P3|Visit Two|Death|0
385198|NCT00187135|1224862|P2|Visit Two|Death|0
385199|NCT00187135|1224863|P1|Visit Two|Death|0
385200|NCT00187135|1224858|P6|Visit One|Physician Decision|1
385201|NCT00187135|1224859|P5|Visit One|Physician Decision|0
385202|NCT00187135|1224860|P4|Visit One|Physician Decision|0
385203|NCT00187135|1224861|P3|Visit One|Physician Decision|0
385204|NCT00187135|1224862|P2|Visit One|Physician Decision|1
385205|NCT00187135|1224863|P1|Visit One|Physician Decision|3
385206|NCT00187135|1224858|P6|Visit One|Withdrawal by Subject|1
385207|NCT00187135|1224859|P5|Visit One|Withdrawal by Subject|0
385208|NCT00187135|1224860|P4|Visit One|Withdrawal by Subject|0
385209|NCT00187135|1224861|P3|Visit One|Withdrawal by Subject|0
385210|NCT00187135|1224862|P2|Visit One|Withdrawal by Subject|0
385211|NCT00187135|1224863|P1|Visit One|Withdrawal by Subject|1
385212|NCT00187096|1224886|P3|Overall Study|unacceptable toxicity|1
385213|NCT00187096|1224887|P2|Overall Study|unacceptable toxicity|0
385214|NCT00187096|1224888|P1|Overall Study|unacceptable toxicity|0
385215|NCT00186901|1224926|P3|Overall Study|Bone Mineral Density > 0|149
385216|NCT00186901|1224927|P2|Overall Study|Bone Mineral Density > 0|0
385217|NCT00186901|1224928|P1|Overall Study|Bone Mineral Density > 0|0
385218|NCT00186901|1224926|P3|Overall Study|Limited adherence to study requirements|0
385219|NCT00186901|1224927|P2|Overall Study|Limited adherence to study requirements|23
385220|NCT00186901|1224928|P1|Overall Study|Limited adherence to study requirements|20
385221|NCT00186901|1224926|P3|Overall Study|Open label|0
385222|NCT00186901|1224927|P2|Overall Study|Open label|2
385223|NCT00186901|1224928|P1|Overall Study|Open label|3
385224|NCT00186901|1224926|P3|Overall Study|Withdrawal by Subject|0
385225|NCT00186901|1224927|P2|Overall Study|Withdrawal by Subject|5
385226|NCT00186901|1224928|P1|Overall Study|Withdrawal by Subject|4
385227|NCT00186901|1224926|P3|Overall Study|ALL relapse or second malignancy|0
385228|NCT00186901|1224927|P2|Overall Study|ALL relapse or second malignancy|2
385229|NCT00186901|1224928|P1|Overall Study|ALL relapse or second malignancy|1
385230|NCT00186901|1224926|P3|Overall Study|Bone Mineral Density dropped > 5%|0
385231|NCT00186901|1224927|P2|Overall Study|Bone Mineral Density dropped > 5%|7
385232|NCT00186901|1224928|P1|Overall Study|Bone Mineral Density dropped > 5%|9
385233|NCT00186901|1224926|P3|Overall Study|Lost to Follow-up|0
385234|NCT00186901|1224927|P2|Overall Study|Lost to Follow-up|3
385235|NCT00186901|1224928|P1|Overall Study|Lost to Follow-up|6
385236|NCT00186901|1224926|P3|Overall Study|Pregnancy|0
385237|NCT00186901|1224927|P2|Overall Study|Pregnancy|3
385238|NCT00186901|1224928|P1|Overall Study|Pregnancy|6
385239|NCT00186888|1224968|P3|Overall Study|Relapse or progression of disease|0
385240|NCT00186888|1224969|P2|Overall Study|Relapse or progression of disease|2
385241|NCT00186888|1224970|P1|Overall Study|Relapse or progression of disease|4
385242|NCT00186888|1224968|P3|Overall Study|Toxicity|0
385243|NCT00186888|1224969|P2|Overall Study|Toxicity|1
385244|NCT00186888|1224970|P1|Overall Study|Toxicity|0
385245|NCT00186537|1225046|P3|Overall Study|ALT > 1.5 x ULN|0
385246|NCT00186537|1225047|P2|Overall Study|ALT > 1.5 x ULN|0
385247|NCT00186537|1225048|P1|Overall Study|ALT > 1.5 x ULN|3
385248|NCT00186537|1225046|P3|Overall Study|Withdrawal by Subject|3
385249|NCT00186537|1225047|P2|Overall Study|Withdrawal by Subject|0
385250|NCT00186537|1225048|P1|Overall Study|Withdrawal by Subject|4
385251|NCT00186485|1225062|P1|Overall Study|Lost to Follow-up|3
385252|NCT00186186|1225074|P1|Overall Study|Not reported as to reason|2
385253|NCT00186186|1225074|P1|Overall Study|Withdrawal by Subject|3
385254|NCT00186186|1225074|P1|Overall Study|Lack of Efficacy|3
385255|NCT00185965|1225118|P2|Overall Study|Adverse Event|1
385256|NCT00185965|1225119|P1|Overall Study|Adverse Event|0
385257|NCT00185588|1225140|P4|Overall Study|Physician Decision|0
385258|NCT00185588|1225141|P3|Overall Study|Physician Decision|1
385259|NCT00185588|1225142|P2|Overall Study|Physician Decision|0
385260|NCT00185588|1225143|P1|Overall Study|Physician Decision|0
385261|NCT00185588|1225140|P4|Overall Study|Withdrawal by Subject|0
385262|NCT00185588|1225141|P3|Overall Study|Withdrawal by Subject|0
385263|NCT00185588|1225142|P2|Overall Study|Withdrawal by Subject|1
385264|NCT00185588|1225143|P1|Overall Study|Withdrawal by Subject|0
385265|NCT00185588|1225140|P4|Overall Study|Lost to Follow-up|2
385266|NCT00185588|1225141|P3|Overall Study|Lost to Follow-up|1
385267|NCT00185588|1225142|P2|Overall Study|Lost to Follow-up|0
385268|NCT00185588|1225143|P1|Overall Study|Lost to Follow-up|0
385269|NCT00185588|1225140|P4|Overall Study|Adverse Event|2
385270|NCT00185588|1225141|P3|Overall Study|Adverse Event|4
385271|NCT00185588|1225142|P2|Overall Study|Adverse Event|1
385272|NCT00185588|1225143|P1|Overall Study|Adverse Event|3
385273|NCT00185458|1225157|P1|HRT Phase|Withdrawal by Subject|3
385274|NCT00185458|1225157|P1|HRT Phase|Protocol Violation|2
385275|NCT00185458|1225157|P1|HRT Phase|Lost to Follow-up|4
385276|NCT00185458|1225157|P1|HRT Phase|Adverse Event|18
385277|NCT00185458|1225157|P1|Contraception Phase|Withdrawal by Subject|7
385278|NCT00185458|1225157|P1|Contraception Phase|Physician Decision|2
385279|NCT00185458|1225157|P1|Contraception Phase|Protocol Violation|2
385280|NCT00185458|1225157|P1|Contraception Phase|Lost to Follow-up|10
385281|NCT00185458|1225157|P1|Contraception Phase|Adverse Event|37
385282|NCT00185380|1225220|P3|Overall Study|personal reason|1
385283|NCT00185380|1225221|P2|Overall Study|personal reason|1
385284|NCT00185380|1225222|P1|Overall Study|personal reason|6
385285|NCT00185380|1225220|P3|Overall Study|Could not attend visits|4
385286|NCT00185380|1225221|P2|Overall Study|Could not attend visits|0
385287|NCT00185380|1225222|P1|Overall Study|Could not attend visits|2
385288|NCT00185380|1225220|P3|Overall Study|No need for contraception|3
385289|NCT00185380|1225221|P2|Overall Study|No need for contraception|3
385290|NCT00185380|1225222|P1|Overall Study|No need for contraception|3
385291|NCT00185380|1225220|P3|Overall Study|Planned pregnancy|12
385292|NCT00185380|1225221|P2|Overall Study|Planned pregnancy|12
385293|NCT00185380|1225222|P1|Overall Study|Planned pregnancy|9
385294|NCT00185380|1225220|P3|Overall Study|Failed insertion|2
385295|NCT00185380|1225221|P2|Overall Study|Failed insertion|1
385296|NCT00185380|1225222|P1|Overall Study|Failed insertion|1
385297|NCT00185380|1225220|P3|Overall Study|Withdrawal by Subject|0
385298|NCT00185380|1225221|P2|Overall Study|Withdrawal by Subject|2
385299|NCT00185380|1225222|P1|Overall Study|Withdrawal by Subject|1
385300|NCT00185380|1225220|P3|Overall Study|Protocol Violation|1
385301|NCT00185380|1225221|P2|Overall Study|Protocol Violation|2
385302|NCT00185380|1225222|P1|Overall Study|Protocol Violation|2
385303|NCT00185380|1225220|P3|Overall Study|Pregnancy|0
385304|NCT00185380|1225221|P2|Overall Study|Pregnancy|4
385305|NCT00185380|1225222|P1|Overall Study|Pregnancy|1
385306|NCT00185380|1225220|P3|Overall Study|Lost to Follow-up|3
385307|NCT00185380|1225221|P2|Overall Study|Lost to Follow-up|4
385308|NCT00185380|1225222|P1|Overall Study|Lost to Follow-up|0
385309|NCT00185380|1225220|P3|Overall Study|Adverse Event|48
385310|NCT00185380|1225221|P2|Overall Study|Adverse Event|43
385311|NCT00185380|1225222|P1|Overall Study|Adverse Event|41
385312|NCT00185211|1225250|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
385313|NCT00185211|1225251|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
385314|NCT00185211|1225250|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
385315|NCT00185211|1225251|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
385316|NCT00185211|1225250|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
385317|NCT00185211|1225251|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
385318|NCT00185211|1225250|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
385319|NCT00185211|1225251|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
385320|NCT00185211|1225250|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
385321|NCT00185211|1225251|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
385322|NCT00185211|1225250|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
385323|NCT00185211|1225251|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
385324|NCT00185211|1225250|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
385325|NCT00185211|1225251|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
385326|NCT00185211|1225250|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
385327|NCT00185211|1225251|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
385328|NCT00185211|1225250|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
385329|NCT00185211|1225251|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
385330|NCT00185211|1225250|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
385331|NCT00185211|1225251|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
385332|NCT00185211|1225250|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
385333|NCT00185211|1225251|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
385334|NCT00185211|1225250|P2|Placebo-controlled Study (92012)|Adverse Event|0
385335|NCT00185211|1225251|P1|Placebo-controlled Study (92012)|Adverse Event|8
385336|NCT00184600|1225324|P3|Overall Study|Unclassified|3
385337|NCT00184600|1225325|P2|Overall Study|Unclassified|5
385338|NCT00184600|1225326|P1|Overall Study|Unclassified|4
385339|NCT00184600|1225324|P3|Overall Study|Withdrawal by Subject|12
385340|NCT00184600|1225325|P2|Overall Study|Withdrawal by Subject|28
385341|NCT00184600|1225326|P1|Overall Study|Withdrawal by Subject|20
385342|NCT00184600|1225324|P3|Overall Study|Protocol Violation|3
385343|NCT00184600|1225325|P2|Overall Study|Protocol Violation|2
385344|NCT00184600|1225326|P1|Overall Study|Protocol Violation|2
385345|NCT00184600|1225324|P3|Overall Study|Lost to Follow-up|1
385346|NCT00184600|1225325|P2|Overall Study|Lost to Follow-up|6
385347|NCT00184600|1225326|P1|Overall Study|Lost to Follow-up|4
385348|NCT00184600|1225324|P3|Overall Study|Lack of Efficacy|3
385349|NCT00184600|1225325|P2|Overall Study|Lack of Efficacy|1
385350|NCT00184600|1225326|P1|Overall Study|Lack of Efficacy|3
385351|NCT00184600|1225324|P3|Overall Study|Death|7
385352|NCT00184600|1225325|P2|Overall Study|Death|9
385353|NCT00184600|1225326|P1|Overall Study|Death|3
385354|NCT00184600|1225324|P3|Overall Study|Adverse Event|5
385355|NCT00184600|1225325|P2|Overall Study|Adverse Event|0
385356|NCT00184600|1225326|P1|Overall Study|Adverse Event|9
385357|NCT00184054|1225417|P1|Overall Study|Adverse Event|1
385358|NCT00184028|1225422|P1|Overall Study|Non-compliance|2
385359|NCT00184028|1225422|P1|Overall Study|Withdrawal by Subject|1
385360|NCT00184028|1225422|P1|Overall Study|Adverse Event|2
385361|NCT00184028|1225422|P1|Overall Study|Lack of Efficacy|4
385362|NCT00184028|1225422|P1|Overall Study|Death|1
385363|NCT00183625|1225468|P4|Overall Study|Withdrawal by Subject|14
385364|NCT00183625|1225469|P3|Overall Study|Withdrawal by Subject|19
385365|NCT00183625|1225470|P2|Overall Study|Withdrawal by Subject|18
385366|NCT00183625|1225471|P1|Overall Study|Withdrawal by Subject|18
385367|NCT00183430|1225543|P2|Overall Study|Withdrawal by Subject|0
385368|NCT00183430|1225544|P1|Overall Study|Withdrawal by Subject|1
385369|NCT00183430|1225543|P2|Overall Study|did not meet inclusion criteria|0
385370|NCT00183430|1225544|P1|Overall Study|did not meet inclusion criteria|1
385371|NCT00183430|1225543|P2|Overall Study|Lost to Follow-up|0
385372|NCT00183430|1225544|P1|Overall Study|Lost to Follow-up|3
385373|NCT00183430|1225543|P2|Overall Study|Adverse Event|0
385374|NCT00183430|1225544|P1|Overall Study|Adverse Event|1
385375|NCT00183274|1225569|P6|Phase 3: Double-Blind|Relapsed|2
385376|NCT00183274|1225570|P5|Phase 3: Double-Blind|Relapsed|11
385377|NCT00183274|1225571|P4|Phase 3: Double-Blind|Relapsed|1
385378|NCT00183274|1225572|P3|Phase 3: Double-Blind|Relapsed|0
385379|NCT00183274|1225573|P2|Phase 3: Double-Blind|Relapsed|0
385380|NCT00183274|1225574|P1|Phase 3: Double-Blind|Relapsed|0
385381|NCT00183274|1225569|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
385382|NCT00183274|1225570|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
385383|NCT00183274|1225571|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
385384|NCT00183274|1225572|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
385385|NCT00183274|1225573|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
385386|NCT00183274|1225574|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
385387|NCT00183274|1225569|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
385388|NCT00183274|1225570|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
385389|NCT00183274|1225571|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
385390|NCT00183274|1225572|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
385391|NCT00183274|1225573|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
385392|NCT00183274|1225574|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
385393|NCT00183274|1225569|P6|Phase 2: Double-Blind|Relapsed|0
385394|NCT00183274|1225570|P5|Phase 2: Double-Blind|Relapsed|0
385395|NCT00183274|1225571|P4|Phase 2: Double-Blind|Relapsed|0
385396|NCT00183274|1225572|P3|Phase 2: Double-Blind|Relapsed|29
385397|NCT00183274|1225573|P2|Phase 2: Double-Blind|Relapsed|8
385398|NCT00183274|1225574|P1|Phase 2: Double-Blind|Relapsed|0
385399|NCT00183274|1225569|P6|Phase 1: Open-Label|Other|0
385400|NCT00183274|1225570|P5|Phase 1: Open-Label|Other|0
385401|NCT00183274|1225571|P4|Phase 1: Open-Label|Other|0
385402|NCT00183274|1225572|P3|Phase 1: Open-Label|Other|0
385403|NCT00183274|1225573|P2|Phase 1: Open-Label|Other|0
385404|NCT00183274|1225574|P1|Phase 1: Open-Label|Other|9
385405|NCT00183274|1225569|P6|Phase 1: Open-Label|Lost to Follow-up|0
385406|NCT00183274|1225570|P5|Phase 1: Open-Label|Lost to Follow-up|0
385407|NCT00183274|1225571|P4|Phase 1: Open-Label|Lost to Follow-up|0
385408|NCT00183274|1225572|P3|Phase 1: Open-Label|Lost to Follow-up|0
385409|NCT00183274|1225573|P2|Phase 1: Open-Label|Lost to Follow-up|0
385410|NCT00183274|1225574|P1|Phase 1: Open-Label|Lost to Follow-up|33
385411|NCT00183274|1225569|P6|Phase 1: Open-Label|Withdrawal by Subject|0
385412|NCT00183274|1225570|P5|Phase 1: Open-Label|Withdrawal by Subject|0
385413|NCT00183274|1225571|P4|Phase 1: Open-Label|Withdrawal by Subject|0
385414|NCT00183274|1225572|P3|Phase 1: Open-Label|Withdrawal by Subject|0
385415|NCT00183274|1225573|P2|Phase 1: Open-Label|Withdrawal by Subject|0
385416|NCT00183274|1225574|P1|Phase 1: Open-Label|Withdrawal by Subject|13
385417|NCT00183274|1225569|P6|Phase 1: Open-Label|Protocol Violation|0
385418|NCT00183274|1225570|P5|Phase 1: Open-Label|Protocol Violation|0
385419|NCT00183274|1225571|P4|Phase 1: Open-Label|Protocol Violation|0
385420|NCT00183274|1225572|P3|Phase 1: Open-Label|Protocol Violation|0
385421|NCT00183274|1225573|P2|Phase 1: Open-Label|Protocol Violation|0
385422|NCT00183274|1225574|P1|Phase 1: Open-Label|Protocol Violation|11
385423|NCT00183274|1225569|P6|Phase 1: Open-Label|Lack of Efficacy|0
385424|NCT00183274|1225570|P5|Phase 1: Open-Label|Lack of Efficacy|0
385425|NCT00183274|1225571|P4|Phase 1: Open-Label|Lack of Efficacy|0
385426|NCT00183274|1225572|P3|Phase 1: Open-Label|Lack of Efficacy|0
385427|NCT00183274|1225573|P2|Phase 1: Open-Label|Lack of Efficacy|0
385428|NCT00183274|1225574|P1|Phase 1: Open-Label|Lack of Efficacy|13
385429|NCT00183274|1225569|P6|Phase 1: Open-Label|Adverse Event|0
385430|NCT00183274|1225570|P5|Phase 1: Open-Label|Adverse Event|0
385431|NCT00183274|1225571|P4|Phase 1: Open-Label|Adverse Event|0
385432|NCT00183274|1225572|P3|Phase 1: Open-Label|Adverse Event|0
385433|NCT00183274|1225573|P2|Phase 1: Open-Label|Adverse Event|0
385434|NCT00183274|1225574|P1|Phase 1: Open-Label|Adverse Event|31
385435|NCT00183248|1225591|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
385436|NCT00183248|1225592|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
385437|NCT00183248|1225591|P2|Overall Study|Lost to Follow-up|1
385438|NCT00183248|1225592|P1|Overall Study|Lost to Follow-up|0
385439|NCT00183196|1225613|P3|Overall Study|Required more intensive care|2
385440|NCT00183196|1225614|P2|Overall Study|Required more intensive care|1
385441|NCT00183196|1225615|P1|Overall Study|Required more intensive care|0
385442|NCT00183196|1225613|P3|Overall Study|Legal event|1
385443|NCT00183196|1225614|P2|Overall Study|Legal event|1
385444|NCT00183196|1225615|P1|Overall Study|Legal event|1
385445|NCT00183196|1225613|P3|Overall Study|Adverse Event|2
385446|NCT00183196|1225614|P2|Overall Study|Adverse Event|2
385447|NCT00183196|1225615|P1|Overall Study|Adverse Event|1
385448|NCT00183196|1225613|P3|Overall Study|Withdrawal by Subject|13
385449|NCT00183196|1225614|P2|Overall Study|Withdrawal by Subject|11
385450|NCT00183196|1225615|P1|Overall Study|Withdrawal by Subject|18
385451|NCT00182689|1225698|P2|Overall Study|Never received treatment|0
385452|NCT00182689|1225699|P1|Overall Study|Never received treatment|1
385453|NCT00182689|1225698|P2|Overall Study|Ineligible|4
385454|NCT00182689|1225699|P1|Overall Study|Ineligible|1
385455|NCT00182689|1225698|P2|Overall Study|not protocol specified|3
385456|NCT00182689|1225699|P1|Overall Study|not protocol specified|0
385457|NCT00182689|1225698|P2|Overall Study|Death|0
385458|NCT00182689|1225699|P1|Overall Study|Death|1
385459|NCT00182689|1225698|P2|Overall Study|Progression|29
385460|NCT00182689|1225699|P1|Overall Study|Progression|27
385461|NCT00182689|1225698|P2|Overall Study|Withdrawal by Subject|2
385462|NCT00182689|1225699|P1|Overall Study|Withdrawal by Subject|2
385463|NCT00182689|1225698|P2|Overall Study|Adverse Event|11
385464|NCT00182689|1225699|P1|Overall Study|Adverse Event|8
385465|NCT00182637|1225709|P1|Overall Study|Disease Progression|1
385466|NCT00182637|1225709|P1|Overall Study|Adverse Event|2
385467|NCT00182091|1225719|P4|Overall Study|Withdrawal by Subject|0
385468|NCT00182091|1225720|P3|Overall Study|Withdrawal by Subject|0
385469|NCT00182091|1225721|P2|Overall Study|Withdrawal by Subject|0
385470|NCT00182091|1225722|P1|Overall Study|Withdrawal by Subject|1
385471|NCT00182078|1225738|P2|Overall Study|Withdrawal by Subject|0
385472|NCT00182078|1225739|P1|Overall Study|Withdrawal by Subject|1
385473|NCT00181883|1225758|P1|Overall Study|Lost to Follow-up|1
385474|NCT00181883|1225758|P1|Overall Study|Withdrawal by Subject|4
385475|NCT00181883|1225758|P1|Overall Study|Treatment Limiting AEs|3
385476|NCT00181883|1225758|P1|Overall Study|Lack of Efficacy|2
385564|NCT00179309|1226030|P2|Treatment|Allergy|0
385477|NCT00181844|1225762|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
385478|NCT00181844|1225762|P1|Exposed to Study Medication|Withdrawal by Subject|1
385479|NCT00181844|1225762|P1|Exposed to Study Medication|Non-compliance|2
385480|NCT00181844|1225762|P1|Exposed to Study Medication|Lack of Efficacy|2
385481|NCT00181844|1225762|P1|Exposed to Study Medication|Adverse Event|10
385482|NCT00181844|1225762|P1|Signed Consent|Did not meet entrance criteria|7
385483|NCT00181844|1225762|P1|Signed Consent|Withdrawal by Subject|5
385484|NCT00181766|1225766|P1|Overall Study|non-compliance|2
385485|NCT00181766|1225766|P1|Overall Study|Adverse Event|4
385486|NCT00181766|1225766|P1|Overall Study|Lost to Follow-up|6
385487|NCT00181155|1225792|P2|Overall Study|Withdrawal by Subject|0
385488|NCT00181155|1225793|P1|Overall Study|Withdrawal by Subject|1
385489|NCT00181155|1225792|P2|Overall Study|Physician Decision|0
385490|NCT00181155|1225793|P1|Overall Study|Physician Decision|1
385491|NCT00180479|1225832|P2|Overall Study|Informed consent not signed|1
385492|NCT00180479|1225833|P1|Overall Study|Informed consent not signed|0
385493|NCT00180479|1225832|P2|Overall Study|Withdrawal by Subject|3
385494|NCT00180479|1225833|P1|Overall Study|Withdrawal by Subject|3
385495|NCT00180479|1225832|P2|Overall Study|Lost to Follow-up|7
385496|NCT00180479|1225833|P1|Overall Study|Lost to Follow-up|9
385497|NCT00180479|1225832|P2|Overall Study|Death|2
385498|NCT00180479|1225833|P1|Overall Study|Death|4
385499|NCT00179959|1225943|P2|Overall Study|Withdrawal by Subject|2
385500|NCT00179959|1225944|P1|Overall Study|Withdrawal by Subject|3
385501|NCT00179959|1225943|P2|Overall Study|Lost to Follow-up|1
385502|NCT00179959|1225944|P1|Overall Study|Lost to Follow-up|3
385503|NCT00179673|1225950|P1|Overall Study|Other Observations and options|14
385504|NCT00179673|1225950|P1|Overall Study|Death|4
385505|NCT00179673|1225950|P1|Overall Study|Withdrawal by Subject|3
385506|NCT00179673|1225950|P1|Overall Study|Lack of Efficacy|15
385507|NCT00179673|1225950|P1|Overall Study|Adverse Event|7
385508|NCT00179660|1225958|P1|Overall Study|Other - Unspecified|9
385509|NCT00179660|1225958|P1|Overall Study|Death|3
385510|NCT00179660|1225958|P1|Overall Study|Lost to Follow-up|1
385511|NCT00179660|1225958|P1|Overall Study|Withdrawal by Subject|2
385512|NCT00179660|1225958|P1|Overall Study|Lack of therapeutic effect|28
385513|NCT00179660|1225958|P1|Overall Study|Adverse Event|7
385514|NCT00179647|1225967|P1|Overall Study|Not specified|960
385515|NCT00179647|1225967|P1|Overall Study|Death|94
385516|NCT00179647|1225967|P1|Overall Study|Lost to Follow-up|4
385517|NCT00179647|1225967|P1|Overall Study|Withdrawal by Subject|83
385518|NCT00179647|1225967|P1|Overall Study|Lack of Efficacy|478
385519|NCT00179647|1225967|P1|Overall Study|Adverse Event|294
385520|NCT00179621|1225974|P4|Open-Label Period|Unspecified|2
385521|NCT00179621|1225975|P3|Open-Label Period|Unspecified|1
385522|NCT00179621|1225976|P2|Open-Label Period|Unspecified|1
385523|NCT00179621|1225977|P1|Open-Label Period|Unspecified|0
385524|NCT00179621|1225974|P4|Open-Label Period|Death|2
385525|NCT00179621|1225975|P3|Open-Label Period|Death|1
385526|NCT00179621|1225976|P2|Open-Label Period|Death|0
385527|NCT00179621|1225977|P1|Open-Label Period|Death|0
385528|NCT00179621|1225974|P4|Open-Label Period|Withdrawal by Subject|2
385529|NCT00179621|1225975|P3|Open-Label Period|Withdrawal by Subject|2
385530|NCT00179621|1225976|P2|Open-Label Period|Withdrawal by Subject|2
385531|NCT00179621|1225977|P1|Open-Label Period|Withdrawal by Subject|0
385532|NCT00179621|1225974|P4|Open-Label Period|Adverse Event|6
385533|NCT00179621|1225975|P3|Open-Label Period|Adverse Event|5
385534|NCT00179621|1225976|P2|Open-Label Period|Adverse Event|6
385535|NCT00179621|1225977|P1|Open-Label Period|Adverse Event|0
385536|NCT00179621|1225974|P4|Open-Label Period|Lack of Therapeutic Effect|31
385537|NCT00179621|1225975|P3|Open-Label Period|Lack of Therapeutic Effect|19
385538|NCT00179621|1225976|P2|Open-Label Period|Lack of Therapeutic Effect|19
385539|NCT00179621|1225977|P1|Open-Label Period|Lack of Therapeutic Effect|0
385540|NCT00179621|1225974|P4|Double-Blind Period|Unspecified|0
385541|NCT00179621|1225975|P3|Double-Blind Period|Unspecified|2
385542|NCT00179621|1225976|P2|Double-Blind Period|Unspecified|2
385543|NCT00179621|1225977|P1|Double-Blind Period|Unspecified|0
385544|NCT00179621|1225974|P4|Double-Blind Period|Protocol Violation|0
385545|NCT00179621|1225975|P3|Double-Blind Period|Protocol Violation|0
385546|NCT00179621|1225976|P2|Double-Blind Period|Protocol Violation|0
385547|NCT00179621|1225977|P1|Double-Blind Period|Protocol Violation|1
385548|NCT00179621|1225974|P4|Double-Blind Period|Death|0
385549|NCT00179621|1225975|P3|Double-Blind Period|Death|2
385550|NCT00179621|1225976|P2|Double-Blind Period|Death|1
385551|NCT00179621|1225977|P1|Double-Blind Period|Death|0
385552|NCT00179621|1225974|P4|Double-Blind Period|Withdrawal by Subject|0
385553|NCT00179621|1225975|P3|Double-Blind Period|Withdrawal by Subject|3
385554|NCT00179621|1225976|P2|Double-Blind Period|Withdrawal by Subject|1
385555|NCT00179621|1225977|P1|Double-Blind Period|Withdrawal by Subject|2
385556|NCT00179621|1225974|P4|Double-Blind Period|Adverse Event|0
385557|NCT00179621|1225975|P3|Double-Blind Period|Adverse Event|4
385558|NCT00179621|1225976|P2|Double-Blind Period|Adverse Event|7
385559|NCT00179621|1225977|P1|Double-Blind Period|Adverse Event|2
385560|NCT00179621|1225974|P4|Double-Blind Period|Lack of Therapeutic Effect|0
385561|NCT00179621|1225975|P3|Double-Blind Period|Lack of Therapeutic Effect|19
385562|NCT00179621|1225976|P2|Double-Blind Period|Lack of Therapeutic Effect|35
385563|NCT00179621|1225977|P1|Double-Blind Period|Lack of Therapeutic Effect|59
385565|NCT00179309|1226031|P1|Treatment|Allergy|1
385566|NCT00179309|1226030|P2|Treatment|Withdrawal by Subject|2
385567|NCT00179309|1226031|P1|Treatment|Withdrawal by Subject|1
385568|NCT00179309|1226030|P2|Treatment|Toxicity|3
385569|NCT00179309|1226031|P1|Treatment|Toxicity|2
385570|NCT00178685|1226070|P3|Overall Study|Withdrawal by Subject|7
385571|NCT00178685|1226071|P2|Overall Study|Withdrawal by Subject|14
385572|NCT00178685|1226072|P1|Overall Study|Withdrawal by Subject|8
385573|NCT00178685|1226070|P3|Overall Study|Lost to Follow-up|183
385574|NCT00178685|1226071|P2|Overall Study|Lost to Follow-up|187
385575|NCT00178685|1226072|P1|Overall Study|Lost to Follow-up|100
385576|NCT00178685|1226070|P3|Overall Study|Death|6
385577|NCT00178685|1226071|P2|Overall Study|Death|3
385578|NCT00178685|1226072|P1|Overall Study|Death|3
385579|NCT00178633|1226083|P1|Overall Study|Lost to Follow-up|6
385580|NCT00178464|1226113|P1|Overall Study|Physician Decision|1
385581|NCT00178464|1226113|P1|Overall Study|Withdrawal by Subject|1
385582|NCT00177307|1226118|P1|Overall Study|Withdrawal by Subject|1
385583|NCT00177294|1226127|P2|Overall Study|Withdrawal by Subject|5
385584|NCT00177294|1226128|P1|Overall Study|Withdrawal by Subject|7
385585|NCT00177216|1226142|P3|Overall Study|Withdrawal by Subject|1
385586|NCT00177216|1226143|P2|Overall Study|Withdrawal by Subject|3
385587|NCT00177216|1226144|P1|Overall Study|Withdrawal by Subject|6
385588|NCT00177164|1226160|P2|Overall Study|Pregnancy|1
385589|NCT00177164|1226161|P1|Overall Study|Pregnancy|0
385590|NCT00177164|1226160|P2|Overall Study|Lack of Efficacy|1
385591|NCT00177164|1226161|P1|Overall Study|Lack of Efficacy|2
385592|NCT00177164|1226160|P2|Overall Study|discharge from hospital|0
385593|NCT00177164|1226161|P1|Overall Study|discharge from hospital|1
385594|NCT00177164|1226160|P2|Overall Study|Adverse Event|0
385595|NCT00177164|1226161|P1|Overall Study|Adverse Event|1
385596|NCT00177164|1226160|P2|Overall Study|increase in alcohol and drug use|2
385597|NCT00177164|1226161|P1|Overall Study|increase in alcohol and drug use|1
385598|NCT00177164|1226160|P2|Overall Study|Lost to Follow-up|5
385599|NCT00177164|1226161|P1|Overall Study|Lost to Follow-up|4
385600|NCT00177164|1226160|P2|Overall Study|Protocol Violation|7
385601|NCT00177164|1226161|P1|Overall Study|Protocol Violation|0
385602|NCT00178256|1226173|P4|Overall Study|Cancer progression|1
385603|NCT00178256|1226174|P3|Overall Study|Cancer progression|0
385604|NCT00178256|1226175|P2|Overall Study|Cancer progression|0
385605|NCT00178256|1226176|P1|Overall Study|Cancer progression|2
385606|NCT00178256|1226173|P4|Overall Study|Death|1
385607|NCT00178256|1226174|P3|Overall Study|Death|0
385608|NCT00178256|1226175|P2|Overall Study|Death|1
385609|NCT00178256|1226176|P1|Overall Study|Death|0
385610|NCT00178256|1226173|P4|Overall Study|Adverse Event|0
385611|NCT00178256|1226174|P3|Overall Study|Adverse Event|0
385612|NCT00178256|1226175|P2|Overall Study|Adverse Event|0
385613|NCT00178256|1226176|P1|Overall Study|Adverse Event|2
385614|NCT00178126|1226215|P2|Overall Study|did not receive intervention|6
385615|NCT00178126|1226216|P1|Overall Study|did not receive intervention|4
385616|NCT00178126|1226215|P2|Overall Study|Lost to Follow-up|21
385617|NCT00178126|1226216|P1|Overall Study|Lost to Follow-up|21
385618|NCT00177671|1226258|P2|Overall Study|Physician Decision|8
385619|NCT00177671|1226259|P1|Overall Study|Physician Decision|12
385620|NCT00177671|1226258|P2|Overall Study|Adverse Event|0
385621|NCT00177671|1226259|P1|Overall Study|Adverse Event|6
385622|NCT00177671|1226258|P2|Overall Study|medical complications|0
385623|NCT00177671|1226259|P1|Overall Study|medical complications|2
385624|NCT00177671|1226258|P2|Overall Study|Withdrawal by Subject|6
385625|NCT00177671|1226259|P1|Overall Study|Withdrawal by Subject|5
385626|NCT00176644|1226424|P1|Overall Study|Withdrawal by Subject|1
385627|NCT00176605|1226437|P1|Overall Study|Withdrawal by Subject|2
385628|NCT00176488|1226448|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
385629|NCT00176462|1226456|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
385630|NCT00176462|1226457|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
385631|NCT00176462|1226456|P2|Intensive Continuation (8X8-week Cycles)|Death|0
385632|NCT00176462|1226457|P1|Intensive Continuation (8X8-week Cycles)|Death|1
385633|NCT00176462|1226456|P2|Consolidation (12 Weeks)|Not documented|1
385634|NCT00176462|1226457|P1|Consolidation (12 Weeks)|Not documented|0
385635|NCT00176462|1226456|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
385636|NCT00176462|1226457|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
385637|NCT00176462|1226456|P2|Consolidation (12 Weeks)|Adverse Event|1
385638|NCT00176462|1226457|P1|Consolidation (12 Weeks)|Adverse Event|0
385639|NCT00176462|1226456|P2|Consolidation (12 Weeks)|Patient moved to another state|1
385640|NCT00176462|1226457|P1|Consolidation (12 Weeks)|Patient moved to another state|0
385641|NCT00176462|1226456|P2|Induction (4 Weeks)|Lack of Efficacy|1
385642|NCT00176462|1226457|P1|Induction (4 Weeks)|Lack of Efficacy|0
385643|NCT00176462|1226456|P2|Induction (4 Weeks)|Death|2
385644|NCT00176462|1226457|P1|Induction (4 Weeks)|Death|1
385645|NCT00176462|1226456|P2|Induction (4 Weeks)|Withdrawal by Subject|2
385646|NCT00176462|1226457|P1|Induction (4 Weeks)|Withdrawal by Subject|0
385647|NCT00176254|1226477|P1|Overall Study|Lost to Follow-up|1
385648|NCT00175877|1226505|P1|Overall Study|Withdrawal by subject & Other|1
385649|NCT00175877|1226505|P1|Overall Study|AE & Other|1
385650|NCT00175877|1226505|P1|Overall Study|Other Reason|20
385651|NCT00175877|1226505|P1|Overall Study|Protocol Violation|15
385652|NCT00175877|1226505|P1|Overall Study|Lack of Efficacy|26
385653|NCT00175877|1226505|P1|Overall Study|Lost to Follow-up|9
385654|NCT00175877|1226505|P1|Overall Study|Withdrawal by Subject|141
385655|NCT00175877|1226505|P1|Overall Study|Adverse Event|136
385656|NCT00175019|1226539|P3|Overall Study|Reason Not Specified|11
385657|NCT00175019|1226540|P2|Overall Study|Reason Not Specified|34
385658|NCT00175019|1226541|P1|Overall Study|Reason Not Specified|40
385659|NCT00175019|1226539|P3|Overall Study|Gout Flare|0
385660|NCT00175019|1226540|P2|Overall Study|Gout Flare|3
385661|NCT00175019|1226541|P1|Overall Study|Gout Flare|2
385662|NCT00175019|1226539|P3|Overall Study|Therapeutic Failure|22
385663|NCT00175019|1226540|P2|Overall Study|Therapeutic Failure|38
385664|NCT00175019|1226541|P1|Overall Study|Therapeutic Failure|10
385665|NCT00175019|1226539|P3|Overall Study|Personal Reason(s)|8
385666|NCT00175019|1226540|P2|Overall Study|Personal Reason(s)|31
385667|NCT00175019|1226541|P1|Overall Study|Personal Reason(s)|39
385668|NCT00175019|1226539|P3|Overall Study|Did not continue under Amendment 4|2
385669|NCT00175019|1226540|P2|Overall Study|Did not continue under Amendment 4|1
385670|NCT00175019|1226541|P1|Overall Study|Did not continue under Amendment 4|1
385671|NCT00175019|1226539|P3|Overall Study|Lost to Follow-up|9
385672|NCT00175019|1226540|P2|Overall Study|Lost to Follow-up|39
385673|NCT00175019|1226541|P1|Overall Study|Lost to Follow-up|42
385674|NCT00175019|1226539|P3|Overall Study|Protocol Violation|3
385675|NCT00175019|1226540|P2|Overall Study|Protocol Violation|3
385676|NCT00175019|1226541|P1|Overall Study|Protocol Violation|6
385677|NCT00175019|1226539|P3|Overall Study|Adverse Event|2
385678|NCT00175019|1226540|P2|Overall Study|Adverse Event|22
385679|NCT00175019|1226541|P1|Overall Study|Adverse Event|54
385680|NCT00174967|1226594|P4|Overall Study|Not Specified|0
385681|NCT00174967|1226595|P3|Overall Study|Not Specified|0
385682|NCT00174967|1226596|P2|Overall Study|Not Specified|1
385683|NCT00174967|1226597|P1|Overall Study|Not Specified|0
385684|NCT00174967|1226594|P4|Overall Study|Gout Flare|1
385685|NCT00174967|1226595|P3|Overall Study|Gout Flare|0
385686|NCT00174967|1226596|P2|Overall Study|Gout Flare|0
385687|NCT00174967|1226597|P1|Overall Study|Gout Flare|0
385688|NCT00174967|1226594|P4|Overall Study|Adverse Event|1
385689|NCT00174967|1226595|P3|Overall Study|Adverse Event|2
385690|NCT00174967|1226596|P2|Overall Study|Adverse Event|2
385691|NCT00174967|1226597|P1|Overall Study|Adverse Event|1
385692|NCT00174954|1226643|P1|Overall Study|Physician Decision|1
385693|NCT00174954|1226643|P1|Overall Study|No tophi found in MRI|1
385694|NCT00174954|1226643|P1|Overall Study|Adverse Event|2
385695|NCT00174941|1226651|P4|Overall Study|Reason Not Specified|9
385696|NCT00174941|1226652|P3|Overall Study|Reason Not Specified|2
385697|NCT00174941|1226653|P2|Overall Study|Reason Not Specified|6
385698|NCT00174941|1226654|P1|Overall Study|Reason Not Specified|1
385699|NCT00174941|1226651|P4|Overall Study|Gout Flare|8
385700|NCT00174941|1226652|P3|Overall Study|Gout Flare|4
385701|NCT00174941|1226653|P2|Overall Study|Gout Flare|4
385702|NCT00174941|1226654|P1|Overall Study|Gout Flare|0
385703|NCT00174941|1226651|P4|Overall Study|Personal Reason(s)|22
385704|NCT00174941|1226652|P3|Overall Study|Personal Reason(s)|8
385705|NCT00174941|1226653|P2|Overall Study|Personal Reason(s)|14
385706|NCT00174941|1226654|P1|Overall Study|Personal Reason(s)|0
385707|NCT00174941|1226651|P4|Overall Study|Lost to Follow-up|5
385708|NCT00174941|1226652|P3|Overall Study|Lost to Follow-up|2
385709|NCT00174941|1226653|P2|Overall Study|Lost to Follow-up|3
385710|NCT00174941|1226654|P1|Overall Study|Lost to Follow-up|0
385711|NCT00174941|1226651|P4|Overall Study|Protocol Violation|1
385712|NCT00174941|1226652|P3|Overall Study|Protocol Violation|0
385713|NCT00174941|1226653|P2|Overall Study|Protocol Violation|1
385714|NCT00174941|1226654|P1|Overall Study|Protocol Violation|0
385715|NCT00174941|1226651|P4|Overall Study|Adverse Event|13
385716|NCT00174941|1226652|P3|Overall Study|Adverse Event|2
385717|NCT00174941|1226653|P2|Overall Study|Adverse Event|10
385718|NCT00174941|1226654|P1|Overall Study|Adverse Event|1
385719|NCT00174915|1226729|P5|Overall Study|Therapeutic Failure|3
385720|NCT00174915|1226730|P4|Overall Study|Therapeutic Failure|1
385721|NCT00174915|1226731|P3|Overall Study|Therapeutic Failure|2
385722|NCT00174915|1226732|P2|Overall Study|Therapeutic Failure|3
385723|NCT00174915|1226733|P1|Overall Study|Therapeutic Failure|6
385724|NCT00174915|1226729|P5|Overall Study|Protocol Violation|3
385725|NCT00174915|1226730|P4|Overall Study|Protocol Violation|6
385726|NCT00174915|1226731|P3|Overall Study|Protocol Violation|3
385727|NCT00174915|1226732|P2|Overall Study|Protocol Violation|3
385728|NCT00174915|1226733|P1|Overall Study|Protocol Violation|6
385729|NCT00174915|1226729|P5|Overall Study|Gout Flare|0
385730|NCT00174915|1226730|P4|Overall Study|Gout Flare|1
385731|NCT00174915|1226731|P3|Overall Study|Gout Flare|8
385732|NCT00174915|1226732|P2|Overall Study|Gout Flare|6
385733|NCT00174915|1226733|P1|Overall Study|Gout Flare|13
385734|NCT00174915|1226729|P5|Overall Study|Other|3
385735|NCT00174915|1226730|P4|Overall Study|Other|5
385736|NCT00174915|1226731|P3|Overall Study|Other|6
385737|NCT00174915|1226732|P2|Overall Study|Other|8
385738|NCT00174915|1226733|P1|Overall Study|Other|15
385739|NCT00174915|1226729|P5|Overall Study|Personal Reason(s)|9
385740|NCT00174915|1226730|P4|Overall Study|Personal Reason(s)|9
385741|NCT00174915|1226731|P3|Overall Study|Personal Reason(s)|9
385742|NCT00174915|1226732|P2|Overall Study|Personal Reason(s)|16
385743|NCT00174915|1226733|P1|Overall Study|Personal Reason(s)|16
385744|NCT00174915|1226729|P5|Overall Study|Adverse Event|5
385745|NCT00174915|1226730|P4|Overall Study|Adverse Event|18
385746|NCT00174915|1226731|P3|Overall Study|Adverse Event|11
385747|NCT00174915|1226732|P2|Overall Study|Adverse Event|16
385748|NCT00174915|1226733|P1|Overall Study|Adverse Event|18
385749|NCT00174915|1226729|P5|Overall Study|Lost to Follow-up|10
385750|NCT00174915|1226730|P4|Overall Study|Lost to Follow-up|17
385751|NCT00174915|1226731|P3|Overall Study|Lost to Follow-up|9
385752|NCT00174915|1226732|P2|Overall Study|Lost to Follow-up|17
385753|NCT00174915|1226733|P1|Overall Study|Lost to Follow-up|19
385754|NCT00174785|1226792|P2|Overall Study|Not pre-specified/Not coded|70
385755|NCT00174785|1226793|P1|Overall Study|Not pre-specified/Not coded|56
385756|NCT00174785|1226792|P2|Overall Study|Family request|8
385757|NCT00174785|1226793|P1|Overall Study|Family request|6
385758|NCT00174785|1226792|P2|Overall Study|Other prohibited medication|3
385759|NCT00174785|1226793|P1|Overall Study|Other prohibited medication|5
385760|NCT00174785|1226792|P2|Overall Study|Prohibited antiarrhythmic medication|88
385761|NCT00174785|1226793|P1|Overall Study|Prohibited antiarrhythmic medication|39
385846|NCT00171340|1227047|P2|Overall Study|Administrative Problems|2
385762|NCT00174785|1226792|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
385763|NCT00174785|1226793|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
385764|NCT00174785|1226792|P2|Overall Study|Withdrawal by Subject|175
385765|NCT00174785|1226793|P1|Overall Study|Withdrawal by Subject|173
385766|NCT00174785|1226792|P2|Overall Study|Protocol Violation|14
385767|NCT00174785|1226793|P1|Overall Study|Protocol Violation|14
385768|NCT00174785|1226792|P2|Overall Study|Adverse Event|191
385769|NCT00174785|1226793|P1|Overall Study|Adverse Event|293
385770|NCT00174460|1226809|P2|Overall Study|Withdrawal by Subject|1
385771|NCT00174460|1226810|P1|Overall Study|Withdrawal by Subject|0
385772|NCT00174447|1226856|P1|Overall Study|Administrative reason/Other|2
385773|NCT00174447|1226856|P1|Overall Study|Lack of Efficacy|1
385774|NCT00174447|1226856|P1|Overall Study|Protocol Violation|1
385775|NCT00174447|1226856|P1|Overall Study|Withdrawal by Subject|15
385776|NCT00174447|1226856|P1|Overall Study|Adverse Event|19
385777|NCT00174382|1226865|P1|Overall Study|Lost to Follow-up|1
385778|NCT00174382|1226865|P1|Overall Study|Subject felt pill not effective enough|1
385779|NCT00174382|1226865|P1|Overall Study|Arrived early for last visit in error|1
385780|NCT00174382|1226865|P1|Overall Study|Protocol Violation|3
385781|NCT00174382|1226865|P1|Overall Study|Withdrawal by Subject|6
385782|NCT00174382|1226865|P1|Overall Study|Adverse Event|19
385783|NCT00174382|1226865|P1|Overall Study|Death|2
385784|NCT00174291|1226884|P2|Overall Study|Withdrawal by Subject|3
385785|NCT00174291|1226885|P1|Overall Study|Withdrawal by Subject|3
385786|NCT00174291|1226884|P2|Overall Study|Study terminated by sponsor|0
385787|NCT00174291|1226885|P1|Overall Study|Study terminated by sponsor|1
385788|NCT00174291|1226884|P2|Overall Study|Protocol Violation|2
385789|NCT00174291|1226885|P1|Overall Study|Protocol Violation|0
385790|NCT00174291|1226884|P2|Overall Study|Lost to Follow-up|1
385791|NCT00174291|1226885|P1|Overall Study|Lost to Follow-up|1
385792|NCT00174265|1226915|P2|Overall Study|Other (Not specified)|10
385793|NCT00174265|1226916|P1|Overall Study|Other (Not specified)|16
385794|NCT00174265|1226915|P2|Overall Study|Lost to Follow-up|0
385795|NCT00174265|1226916|P1|Overall Study|Lost to Follow-up|1
385796|NCT00174265|1226915|P2|Overall Study|Withdrawal by Subject|5
385797|NCT00174265|1226916|P1|Overall Study|Withdrawal by Subject|3
385798|NCT00174265|1226915|P2|Overall Study|Lack of Efficacy|2
385799|NCT00174265|1226916|P1|Overall Study|Lack of Efficacy|2
385800|NCT00174265|1226915|P2|Overall Study|Adverse Event|4
385801|NCT00174265|1226916|P1|Overall Study|Adverse Event|7
385802|NCT00174252|1226924|P1|Overall Study|Protocol Violation|2
385803|NCT00174187|1226959|P3|Period 2 (After 3 Years)|Unspecified|5
385804|NCT00174187|1226960|P2|Period 2 (After 3 Years)|Unspecified|0
385805|NCT00174187|1226961|P1|Period 2 (After 3 Years)|Unspecified|0
385806|NCT00174187|1226959|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
385807|NCT00174187|1226960|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
385808|NCT00174187|1226961|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
385809|NCT00174187|1226959|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
385810|NCT00174187|1226960|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
385811|NCT00174187|1226961|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
385812|NCT00174187|1226959|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
385813|NCT00174187|1226960|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
385814|NCT00174187|1226961|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
385815|NCT00174187|1226959|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
385816|NCT00174187|1226960|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
385817|NCT00174187|1226961|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
385818|NCT00174187|1226959|P3|Period 1 (up to 3 Years)|Unspecified|0
385819|NCT00174187|1226960|P2|Period 1 (up to 3 Years)|Unspecified|1
385820|NCT00174187|1226961|P1|Period 1 (up to 3 Years)|Unspecified|0
385821|NCT00174187|1226959|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
385822|NCT00174187|1226960|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
385823|NCT00174187|1226961|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
385824|NCT00174187|1226959|P3|Period 1 (up to 3 Years)|Non compliance|0
385825|NCT00174187|1226960|P2|Period 1 (up to 3 Years)|Non compliance|1
385826|NCT00174187|1226961|P1|Period 1 (up to 3 Years)|Non compliance|0
385827|NCT00174187|1226959|P3|Period 1 (up to 3 Years)|Serious adverse event|0
385828|NCT00174187|1226960|P2|Period 1 (up to 3 Years)|Serious adverse event|1
385829|NCT00174187|1226961|P1|Period 1 (up to 3 Years)|Serious adverse event|0
385830|NCT00171704|1227024|P2|Overall Study|Protocol Violation|1
385831|NCT00171704|1227025|P1|Overall Study|Protocol Violation|0
385832|NCT00171704|1227024|P2|Overall Study|Withdrawal by Subject|3
385833|NCT00171704|1227025|P1|Overall Study|Withdrawal by Subject|1
385834|NCT00171704|1227024|P2|Overall Study|Death|2
385835|NCT00171704|1227025|P1|Overall Study|Death|2
385836|NCT00171704|1227024|P2|Overall Study|Administrative Problems|1
385837|NCT00171704|1227025|P1|Overall Study|Administrative Problems|2
385838|NCT00171704|1227024|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
385839|NCT00171704|1227025|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
385840|NCT00171704|1227024|P2|Overall Study|Disease Progression|9
385841|NCT00171704|1227025|P1|Overall Study|Disease Progression|14
385842|NCT00171704|1227024|P2|Overall Study|Adverse Event|33
385843|NCT00171704|1227025|P1|Overall Study|Adverse Event|24
385844|NCT00171340|1227047|P2|Overall Study|Death|6
385845|NCT00171340|1227048|P1|Overall Study|Death|6
385847|NCT00171340|1227048|P1|Overall Study|Administrative Problems|5
385848|NCT00171340|1227047|P2|Overall Study|No Longer Required Study Drug|1
385849|NCT00171340|1227048|P1|Overall Study|No Longer Required Study Drug|1
385850|NCT00171340|1227047|P2|Overall Study|Abnormal Test Procedure Results|11
385851|NCT00171340|1227048|P1|Overall Study|Abnormal Test Procedure Results|6
385852|NCT00171340|1227047|P2|Overall Study|Abnormal Laboratory Results|0
385853|NCT00171340|1227048|P1|Overall Study|Abnormal Laboratory Results|2
385854|NCT00171340|1227047|P2|Overall Study|Lost to Follow-up|5
385855|NCT00171340|1227048|P1|Overall Study|Lost to Follow-up|0
385856|NCT00171340|1227047|P2|Overall Study|Withdrawal by Subject|19
385857|NCT00171340|1227048|P1|Overall Study|Withdrawal by Subject|22
385858|NCT00171340|1227047|P2|Overall Study|Protocol Violation|8
385859|NCT00171340|1227048|P1|Overall Study|Protocol Violation|7
385860|NCT00171340|1227047|P2|Overall Study|Lack of Efficacy|41
385861|NCT00171340|1227048|P1|Overall Study|Lack of Efficacy|29
385862|NCT00171340|1227047|P2|Overall Study|Adverse Event|42
385863|NCT00171340|1227048|P1|Overall Study|Adverse Event|46
385864|NCT00171314|1227064|P2|Overall Study|Death|1
385865|NCT00171314|1227065|P1|Overall Study|Death|2
385866|NCT00171314|1227064|P2|Overall Study|Lost to Follow-up|3
385867|NCT00171314|1227065|P1|Overall Study|Lost to Follow-up|1
385868|NCT00171314|1227064|P2|Overall Study|Administrative Problems|3
385869|NCT00171314|1227065|P1|Overall Study|Administrative Problems|4
385870|NCT00171314|1227064|P2|Overall Study|Protocol Violation|7
385871|NCT00171314|1227065|P1|Overall Study|Protocol Violation|3
385872|NCT00171314|1227064|P2|Overall Study|Abnormal Test Procedure Results|3
385873|NCT00171314|1227065|P1|Overall Study|Abnormal Test Procedure Results|9
385874|NCT00171314|1227064|P2|Overall Study|Withdrawal by Subject|6
385875|NCT00171314|1227065|P1|Overall Study|Withdrawal by Subject|9
385876|NCT00171314|1227064|P2|Overall Study|Lack of Efficacy|14
385877|NCT00171314|1227065|P1|Overall Study|Lack of Efficacy|19
385878|NCT00171314|1227064|P2|Overall Study|Adverse Event|41
385879|NCT00171314|1227065|P1|Overall Study|Adverse Event|44
385880|NCT00171301|1227081|P2|Overall Study|Withdrawal by Subject|1
385881|NCT00171301|1227082|P1|Overall Study|Withdrawal by Subject|0
385882|NCT00171301|1227081|P2|Overall Study|Protocol Violation|2
385883|NCT00171301|1227082|P1|Overall Study|Protocol Violation|0
385884|NCT00171301|1227081|P2|Overall Study|Lost to Follow-up|2
385885|NCT00171301|1227082|P1|Overall Study|Lost to Follow-up|6
385886|NCT00171301|1227081|P2|Overall Study|Adverse Event|2
385887|NCT00171301|1227082|P1|Overall Study|Adverse Event|1
385888|NCT00171301|1227081|P2|Overall Study|Death|2
385889|NCT00171301|1227082|P1|Overall Study|Death|1
385890|NCT00172185|1227097|P4|Overall Study|Withdrawal by Subject|0
385891|NCT00172185|1227098|P3|Overall Study|Withdrawal by Subject|1
385892|NCT00172185|1227099|P2|Overall Study|Withdrawal by Subject|0
385893|NCT00172185|1227100|P1|Overall Study|Withdrawal by Subject|0
385894|NCT00172185|1227097|P4|Overall Study|SPONSOR Decision|0
385895|NCT00172185|1227098|P3|Overall Study|SPONSOR Decision|0
385896|NCT00172185|1227099|P2|Overall Study|SPONSOR Decision|1
385897|NCT00172185|1227100|P1|Overall Study|SPONSOR Decision|0
385898|NCT00172185|1227097|P4|Overall Study|Physician Decision|0
385899|NCT00172185|1227098|P3|Overall Study|Physician Decision|1
385900|NCT00172185|1227099|P2|Overall Study|Physician Decision|0
385901|NCT00172185|1227100|P1|Overall Study|Physician Decision|0
385902|NCT00172185|1227097|P4|Overall Study|Adverse Event|4
385903|NCT00172185|1227098|P3|Overall Study|Adverse Event|3
385904|NCT00172185|1227099|P2|Overall Study|Adverse Event|1
385905|NCT00172185|1227100|P1|Overall Study|Adverse Event|0
385906|NCT00172042|1227116|P2|Overall Study|Death|42
385907|NCT00172042|1227117|P1|Overall Study|Death|42
385908|NCT00172042|1227116|P2|Overall Study|Administrative problems|10
385909|NCT00172042|1227117|P1|Overall Study|Administrative problems|13
385910|NCT00172042|1227116|P2|Overall Study|Lost to Follow-up|5
385911|NCT00172042|1227117|P1|Overall Study|Lost to Follow-up|3
385912|NCT00172042|1227116|P2|Overall Study|Withdrawal by Subject|25
385913|NCT00172042|1227117|P1|Overall Study|Withdrawal by Subject|37
385914|NCT00172042|1227116|P2|Overall Study|Protocol Violation|7
385915|NCT00172042|1227117|P1|Overall Study|Protocol Violation|8
385916|NCT00172042|1227116|P2|Overall Study|Patient no longer requires study drug|8
385917|NCT00172042|1227117|P1|Overall Study|Patient no longer requires study drug|10
385918|NCT00172042|1227116|P2|Overall Study|Unsatisfactory therapeutic effect|11
385919|NCT00172042|1227117|P1|Overall Study|Unsatisfactory therapeutic effect|13
385920|NCT00172042|1227116|P2|Overall Study|Abnormal test procedure(s)|3
385921|NCT00172042|1227117|P1|Overall Study|Abnormal test procedure(s)|0
385922|NCT00172042|1227116|P2|Overall Study|Abnormal laboratory value(s)|1
385923|NCT00172042|1227117|P1|Overall Study|Abnormal laboratory value(s)|5
385924|NCT00172042|1227116|P2|Overall Study|Adverse Event|13
385925|NCT00172042|1227117|P1|Overall Study|Adverse Event|27
385926|NCT00171925|1227139|P2|Overall Study|Death|2
385927|NCT00171925|1227140|P1|Overall Study|Death|1
385928|NCT00171925|1227139|P2|Overall Study|Administrative problems|11
385929|NCT00171925|1227140|P1|Overall Study|Administrative problems|10
385930|NCT00171925|1227139|P2|Overall Study|Lost to Follow-up|2
385931|NCT00171925|1227140|P1|Overall Study|Lost to Follow-up|2
385932|NCT00171925|1227139|P2|Overall Study|Withdrawal by Subject|9
385933|NCT00171925|1227140|P1|Overall Study|Withdrawal by Subject|6
385934|NCT00171925|1227139|P2|Overall Study|Protocol Violation|1
385935|NCT00171925|1227140|P1|Overall Study|Protocol Violation|1
385936|NCT00171925|1227139|P2|Overall Study|Adverse Event|6
385937|NCT00171925|1227140|P1|Overall Study|Adverse Event|10
385938|NCT00171873|1227152|P2|Overall Study|Switched to Octreotide|1
385939|NCT00171873|1227153|P1|Overall Study|Switched to Octreotide|0
385940|NCT00171873|1227152|P2|Overall Study|Adverse Event|0
385941|NCT00171873|1227153|P1|Overall Study|Adverse Event|5
385942|NCT00171873|1227152|P2|Overall Study|Withdrawal by Subject|2
385943|NCT00171873|1227153|P1|Overall Study|Withdrawal by Subject|4
385944|NCT00171834|1227166|P7|Overall Study|Treatment Duration Completed|0
385945|NCT00171834|1227167|P6|Overall Study|Treatment Duration Completed|1
385946|NCT00171834|1227168|P5|Overall Study|Treatment Duration Completed|2
385947|NCT00171834|1227169|P4|Overall Study|Treatment Duration Completed|0
385948|NCT00171834|1227170|P3|Overall Study|Treatment Duration Completed|1
385949|NCT00171834|1227171|P2|Overall Study|Treatment Duration Completed|0
385950|NCT00171834|1227172|P1|Overall Study|Treatment Duration Completed|0
385951|NCT00171834|1227166|P7|Overall Study|Disease Progression|3
385952|NCT00171834|1227167|P6|Overall Study|Disease Progression|18
385953|NCT00171834|1227168|P5|Overall Study|Disease Progression|2
385954|NCT00171834|1227169|P4|Overall Study|Disease Progression|9
385955|NCT00171834|1227170|P3|Overall Study|Disease Progression|8
385956|NCT00171834|1227171|P2|Overall Study|Disease Progression|8
385957|NCT00171834|1227172|P1|Overall Study|Disease Progression|4
385958|NCT00171834|1227166|P7|Overall Study|Death from study indication|0
385959|NCT00171834|1227167|P6|Overall Study|Death from study indication|0
385960|NCT00171834|1227168|P5|Overall Study|Death from study indication|1
385961|NCT00171834|1227169|P4|Overall Study|Death from study indication|0
385962|NCT00171834|1227170|P3|Overall Study|Death from study indication|0
385963|NCT00171834|1227171|P2|Overall Study|Death from study indication|1
385964|NCT00171834|1227172|P1|Overall Study|Death from study indication|0
385965|NCT00171834|1227166|P7|Overall Study|Withdrawal by Subject|0
385966|NCT00171834|1227167|P6|Overall Study|Withdrawal by Subject|1
385967|NCT00171834|1227168|P5|Overall Study|Withdrawal by Subject|1
385968|NCT00171834|1227169|P4|Overall Study|Withdrawal by Subject|1
385969|NCT00171834|1227170|P3|Overall Study|Withdrawal by Subject|0
385970|NCT00171834|1227171|P2|Overall Study|Withdrawal by Subject|2
385971|NCT00171834|1227172|P1|Overall Study|Withdrawal by Subject|0
385972|NCT00171834|1227166|P7|Overall Study|Adverse Event|1
385973|NCT00171834|1227167|P6|Overall Study|Adverse Event|15
385974|NCT00171834|1227168|P5|Overall Study|Adverse Event|2
385975|NCT00171834|1227169|P4|Overall Study|Adverse Event|2
385976|NCT00171834|1227170|P3|Overall Study|Adverse Event|3
385977|NCT00171834|1227171|P2|Overall Study|Adverse Event|1
385978|NCT00171834|1227172|P1|Overall Study|Adverse Event|2
385979|NCT00171210|1227212|P2|Overall Study|Stopped at end of extension 1|1
385980|NCT00171210|1227213|P1|Overall Study|Stopped at end of extension 1|0
385981|NCT00171210|1227212|P2|Overall Study|Stopped at end of core|32
385982|NCT00171210|1227213|P1|Overall Study|Stopped at end of core|0
385983|NCT00171210|1227212|P2|Overall Study|Death|3
385984|NCT00171210|1227213|P1|Overall Study|Death|2
385985|NCT00171210|1227212|P2|Overall Study|Administrative problems|1
385986|NCT00171210|1227213|P1|Overall Study|Administrative problems|1
385987|NCT00171210|1227212|P2|Overall Study|Lost to Follow-up|0
385988|NCT00171210|1227213|P1|Overall Study|Lost to Follow-up|1
385989|NCT00171210|1227212|P2|Overall Study|Withdrawal by Subject|30
385990|NCT00171210|1227213|P1|Overall Study|Withdrawal by Subject|32
385991|NCT00171210|1227212|P2|Overall Study|Protocol Violation|2
385992|NCT00171210|1227213|P1|Overall Study|Protocol Violation|0
385993|NCT00171210|1227212|P2|Overall Study|Unsatisfactory therapeutic effect|15
385994|NCT00171210|1227213|P1|Overall Study|Unsatisfactory therapeutic effect|11
385995|NCT00171210|1227212|P2|Overall Study|Abnormal test procedure result(s)|1
385996|NCT00171210|1227213|P1|Overall Study|Abnormal test procedure result(s)|0
385997|NCT00171210|1227212|P2|Overall Study|Abnormal laboratory value(s)|3
385998|NCT00171210|1227213|P1|Overall Study|Abnormal laboratory value(s)|6
385999|NCT00171210|1227212|P2|Overall Study|Adverse Event|27
386000|NCT00171210|1227213|P1|Overall Study|Adverse Event|16
386001|NCT00171054|1227243|P2|Overall Study|Condition no longer required study drug|1
386002|NCT00171054|1227244|P1|Overall Study|Condition no longer required study drug|0
386003|NCT00171054|1227243|P2|Overall Study|Adverse Event|8
386004|NCT00171054|1227244|P1|Overall Study|Adverse Event|8
386005|NCT00171054|1227243|P2|Overall Study|Lost to Follow-up|1
386006|NCT00171054|1227244|P1|Overall Study|Lost to Follow-up|0
386007|NCT00171054|1227243|P2|Overall Study|Patient withdrew consent|0
386008|NCT00171054|1227244|P1|Overall Study|Patient withdrew consent|1
386009|NCT00171054|1227243|P2|Overall Study|Protocol Violation|2
386010|NCT00171054|1227244|P1|Overall Study|Protocol Violation|1
386011|NCT00170950|1227276|P2|Overall Study|Termination Data Not Recorded|22
386012|NCT00170950|1227277|P1|Overall Study|Termination Data Not Recorded|17
386013|NCT00170950|1227276|P2|Overall Study|Missing|1
386014|NCT00170950|1227277|P1|Overall Study|Missing|2
386015|NCT00170950|1227276|P2|Overall Study|Lost to Follow-up|115
386016|NCT00170950|1227277|P1|Overall Study|Lost to Follow-up|134
386017|NCT00170950|1227276|P2|Overall Study|Withdrawal by Subject|498
386018|NCT00170950|1227277|P1|Overall Study|Withdrawal by Subject|496
386019|NCT00170950|1227276|P2|Overall Study|Death|274
386020|NCT00170950|1227277|P1|Overall Study|Death|236
386021|NCT00170846|1227290|P3|Overall Study|Reason Missing|0
386022|NCT00170846|1227291|P2|Overall Study|Reason Missing|1
386023|NCT00170846|1227292|P1|Overall Study|Reason Missing|0
386024|NCT00170846|1227290|P3|Overall Study|Death|3
386025|NCT00170846|1227291|P2|Overall Study|Death|3
386026|NCT00170846|1227292|P1|Overall Study|Death|0
386027|NCT00170846|1227290|P3|Overall Study|Lost to Follow-up|2
386028|NCT00170846|1227291|P2|Overall Study|Lost to Follow-up|3
386029|NCT00170846|1227292|P1|Overall Study|Lost to Follow-up|6
386030|NCT00170846|1227290|P3|Overall Study|Subject withdrew Informed Consent|8
386031|NCT00170846|1227291|P2|Overall Study|Subject withdrew Informed Consent|12
386032|NCT00170846|1227292|P1|Overall Study|Subject withdrew Informed Consent|5
386033|NCT00169442|1227324|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
386034|NCT00169442|1227325|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
386035|NCT00169442|1227326|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
386036|NCT00169442|1227327|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
386037|NCT00169442|1227328|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
386038|NCT00169442|1227329|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
386039|NCT00169442|1227324|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
386040|NCT00169442|1227325|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
386041|NCT00169442|1227326|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
386042|NCT00169442|1227327|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
386043|NCT00169442|1227328|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
386044|NCT00169442|1227329|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
386045|NCT00169442|1227324|P6|Overall Study|Migrated/moved from study area|2
386046|NCT00169442|1227325|P5|Overall Study|Migrated/moved from study area|0
386047|NCT00169442|1227326|P4|Overall Study|Migrated/moved from study area|0
386048|NCT00169442|1227327|P3|Overall Study|Migrated/moved from study area|0
386049|NCT00169442|1227328|P2|Overall Study|Migrated/moved from study area|0
386050|NCT00169442|1227329|P1|Overall Study|Migrated/moved from study area|0
386051|NCT00169442|1227324|P6|Overall Study|Withdrawal by Subject|0
386052|NCT00169442|1227325|P5|Overall Study|Withdrawal by Subject|0
386053|NCT00169442|1227326|P4|Overall Study|Withdrawal by Subject|0
386054|NCT00169442|1227327|P3|Overall Study|Withdrawal by Subject|1
386055|NCT00169442|1227328|P2|Overall Study|Withdrawal by Subject|0
386056|NCT00169442|1227329|P1|Overall Study|Withdrawal by Subject|0
386057|NCT00168844|1227439|P3|Overall Study|Other|9
386058|NCT00168844|1227440|P2|Overall Study|Other|7
386059|NCT00168844|1227441|P1|Overall Study|Other|6
386060|NCT00168844|1227439|P3|Overall Study|Protocol Violation|4
386061|NCT00168844|1227440|P2|Overall Study|Protocol Violation|2
386062|NCT00168844|1227441|P1|Overall Study|Protocol Violation|2
386063|NCT00168844|1227439|P3|Overall Study|Withdrawal by Subject|19
386064|NCT00168844|1227440|P2|Overall Study|Withdrawal by Subject|9
386065|NCT00168844|1227441|P1|Overall Study|Withdrawal by Subject|12
386066|NCT00168844|1227439|P3|Overall Study|Lost to Follow-up|11
386067|NCT00168844|1227440|P2|Overall Study|Lost to Follow-up|5
386068|NCT00168844|1227441|P1|Overall Study|Lost to Follow-up|4
386069|NCT00168844|1227439|P3|Overall Study|Adverse Event|48
386070|NCT00168844|1227440|P2|Overall Study|Adverse Event|32
386071|NCT00168844|1227441|P1|Overall Study|Adverse Event|31
386072|NCT00168831|1227623|P3|Overall Study|Other|6
386073|NCT00168831|1227624|P2|Overall Study|Other|3
386074|NCT00168831|1227625|P1|Overall Study|Other|6
386075|NCT00168831|1227623|P3|Overall Study|Protocol Violation|11
386076|NCT00168831|1227624|P2|Overall Study|Protocol Violation|11
386077|NCT00168831|1227625|P1|Overall Study|Protocol Violation|6
386078|NCT00168831|1227623|P3|Overall Study|Withdrawal by Subject|19
386079|NCT00168831|1227624|P2|Overall Study|Withdrawal by Subject|14
386080|NCT00168831|1227625|P1|Overall Study|Withdrawal by Subject|7
386081|NCT00168831|1227623|P3|Overall Study|Lost to Follow-up|4
386082|NCT00168831|1227624|P2|Overall Study|Lost to Follow-up|6
386083|NCT00168831|1227625|P1|Overall Study|Lost to Follow-up|5
386084|NCT00168831|1227623|P3|Overall Study|Adverse Event|74
386085|NCT00168831|1227624|P2|Overall Study|Adverse Event|47
386086|NCT00168831|1227625|P1|Overall Study|Adverse Event|36
386087|NCT00168818|1227807|P3|Treatment|not specified|31
386088|NCT00168818|1227808|P2|Treatment|not specified|29
386089|NCT00168818|1227809|P1|Treatment|not specified|23
386090|NCT00168818|1227807|P3|Treatment|Withdrawal by Subject|22
386091|NCT00168818|1227808|P2|Treatment|Withdrawal by Subject|20
386092|NCT00168818|1227809|P1|Treatment|Withdrawal by Subject|25
386093|NCT00168818|1227807|P3|Treatment|Lost to Follow-up|1
386094|NCT00168818|1227808|P2|Treatment|Lost to Follow-up|2
386095|NCT00168818|1227809|P1|Treatment|Lost to Follow-up|0
386096|NCT00168818|1227807|P3|Treatment|Protocol Violation|11
386097|NCT00168818|1227808|P2|Treatment|Protocol Violation|11
386098|NCT00168818|1227809|P1|Treatment|Protocol Violation|8
386099|NCT00168818|1227807|P3|Treatment|Adverse Event|68
386100|NCT00168818|1227808|P2|Treatment|Adverse Event|89
386101|NCT00168818|1227809|P1|Treatment|Adverse Event|77
386102|NCT00168818|1227807|P3|Overall Study|not specified|30
386103|NCT00168818|1227808|P2|Overall Study|not specified|24
386104|NCT00168818|1227809|P1|Overall Study|not specified|22
386105|NCT00168818|1227807|P3|Overall Study|Withdrawal by Subject|37
386106|NCT00168818|1227808|P2|Overall Study|Withdrawal by Subject|41
386107|NCT00168818|1227809|P1|Overall Study|Withdrawal by Subject|43
386108|NCT00168818|1227807|P3|Overall Study|Lost to Follow-up|15
386109|NCT00168818|1227808|P2|Overall Study|Lost to Follow-up|4
386110|NCT00168818|1227809|P1|Overall Study|Lost to Follow-up|13
386111|NCT00168818|1227807|P3|Overall Study|Protocol Violation|11
386112|NCT00168818|1227808|P2|Overall Study|Protocol Violation|11
386113|NCT00168818|1227809|P1|Overall Study|Protocol Violation|16
386114|NCT00168818|1227807|P3|Overall Study|Adverse Event|31
386115|NCT00168818|1227808|P2|Overall Study|Adverse Event|29
386116|NCT00168818|1227809|P1|Overall Study|Adverse Event|23
386117|NCT00168805|1227853|P3|Treatment|not specified|17
386118|NCT00168805|1227854|P2|Treatment|not specified|18
386119|NCT00168805|1227855|P1|Treatment|not specified|18
386120|NCT00168805|1227853|P3|Treatment|Withdrawal by Subject|8
386121|NCT00168805|1227854|P2|Treatment|Withdrawal by Subject|7
386122|NCT00168805|1227855|P1|Treatment|Withdrawal by Subject|3
386123|NCT00168805|1227853|P3|Treatment|Protocol Violation|5
386124|NCT00168805|1227854|P2|Treatment|Protocol Violation|5
386125|NCT00168805|1227855|P1|Treatment|Protocol Violation|3
386126|NCT00168805|1227853|P3|Treatment|Adverse Event|32
386127|NCT00168805|1227854|P2|Treatment|Adverse Event|26
386128|NCT00168805|1227855|P1|Treatment|Adverse Event|25
386129|NCT00168805|1227853|P3|Overall Study|not specified|22
386130|NCT00168805|1227854|P2|Overall Study|not specified|21
386131|NCT00168805|1227855|P1|Overall Study|not specified|24
386132|NCT00168805|1227853|P3|Overall Study|Withdrawal by Subject|21
386133|NCT00168805|1227854|P2|Overall Study|Withdrawal by Subject|18
386134|NCT00168805|1227855|P1|Overall Study|Withdrawal by Subject|16
386135|NCT00168805|1227853|P3|Overall Study|Lost to Follow-up|11
386136|NCT00168805|1227854|P2|Overall Study|Lost to Follow-up|17
386137|NCT00168805|1227855|P1|Overall Study|Lost to Follow-up|12
386138|NCT00168805|1227853|P3|Overall Study|Protocol Violation|8
386139|NCT00168805|1227854|P2|Overall Study|Protocol Violation|11
386140|NCT00168805|1227855|P1|Overall Study|Protocol Violation|12
386141|NCT00168805|1227853|P3|Overall Study|Adverse Event|16
386142|NCT00168805|1227854|P2|Overall Study|Adverse Event|11
386143|NCT00168805|1227855|P1|Overall Study|Adverse Event|7
386144|NCT00167310|1227972|P2|Overall Study|Withdrawal by Subject|7
386145|NCT00167310|1227973|P1|Overall Study|Withdrawal by Subject|3
386146|NCT00167310|1227972|P2|Overall Study|Protocol Violation|3
386147|NCT00167310|1227973|P1|Overall Study|Protocol Violation|5
386148|NCT00167245|1227983|P2|Overall Study|Drowsy|0
386149|NCT00167245|1227984|P1|Overall Study|Drowsy|1
386150|NCT00167245|1227983|P2|Overall Study|Incarcerated|2
386151|NCT00167245|1227984|P1|Overall Study|Incarcerated|3
386152|NCT00167245|1227983|P2|Overall Study|Withdrawal by Subject|8
386153|NCT00167245|1227984|P1|Overall Study|Withdrawal by Subject|5
386154|NCT00167245|1227983|P2|Overall Study|Lost to Follow-up|31
386155|NCT00167245|1227984|P1|Overall Study|Lost to Follow-up|20
386156|NCT00168103|1228147|P4|Overall Study|Lost to Follow-up|0
386157|NCT00168103|1228148|P3|Overall Study|Lost to Follow-up|0
386158|NCT00168103|1228149|P2|Overall Study|Lost to Follow-up|3
386159|NCT00168103|1228150|P1|Overall Study|Lost to Follow-up|1
386160|NCT00168103|1228147|P4|Overall Study|Withdrawal by Subject|0
386161|NCT00168103|1228148|P3|Overall Study|Withdrawal by Subject|1
386162|NCT00168103|1228149|P2|Overall Study|Withdrawal by Subject|2
386163|NCT00168103|1228150|P1|Overall Study|Withdrawal by Subject|1
386164|NCT00168064|1228172|P2|Overall Study|Various|3
386165|NCT00168064|1228173|P1|Overall Study|Various|4
386166|NCT00168064|1228172|P2|Overall Study|Subject's Best interest|2
386167|NCT00168064|1228173|P1|Overall Study|Subject's Best interest|2
386168|NCT00168064|1228172|P2|Overall Study|Concurrent Illness|3
386169|NCT00168064|1228173|P1|Overall Study|Concurrent Illness|4
386170|NCT00168064|1228172|P2|Overall Study|Non-compliance|3
386171|NCT00168064|1228173|P1|Overall Study|Non-compliance|2
386172|NCT00168064|1228172|P2|Overall Study|Lost to Follow-up|3
386173|NCT00168064|1228173|P1|Overall Study|Lost to Follow-up|4
386174|NCT00168064|1228172|P2|Overall Study|Lack of Efficacy|4
386175|NCT00168064|1228173|P1|Overall Study|Lack of Efficacy|4
386176|NCT00168064|1228172|P2|Overall Study|Withdrawal by Subject|4
386177|NCT00168064|1228173|P1|Overall Study|Withdrawal by Subject|3
386178|NCT00168064|1228172|P2|Overall Study|Adverse Event|22
386179|NCT00168064|1228173|P1|Overall Study|Adverse Event|26
386180|NCT00168038|1228181|P1|Overall Study|Therapy failure|1
386181|NCT00168038|1228181|P1|Overall Study|Adverse Event|1
386182|NCT00167778|1228193|P1|Overall Study|Withdrawal by Subject|1
386183|NCT00166712|1228261|P2|Overall Study|Physician Decision|2
386184|NCT00166712|1228262|P1|Overall Study|Physician Decision|0
386185|NCT00166712|1228261|P2|Overall Study|Withdrawal by Subject|2
386186|NCT00166712|1228262|P1|Overall Study|Withdrawal by Subject|1
386187|NCT00166712|1228261|P2|Overall Study|Adverse Event|0
386188|NCT00166712|1228262|P1|Overall Study|Adverse Event|1
386189|NCT00166712|1228261|P2|Overall Study|Death|1
386190|NCT00166712|1228262|P1|Overall Study|Death|0
386191|NCT00166517|1228279|P2|Overall Study|Withdrawal by Subject|1
386192|NCT00166517|1228280|P1|Overall Study|Withdrawal by Subject|0
386193|NCT00166517|1228279|P2|Overall Study|Protocol Violation|1
386194|NCT00166517|1228280|P1|Overall Study|Protocol Violation|4
386195|NCT00166517|1228279|P2|Overall Study|Lost to Follow-up|0
386196|NCT00166517|1228280|P1|Overall Study|Lost to Follow-up|1
386197|NCT00166504|1228290|P2|Overall Study|Withdrawal by Subject|0
386198|NCT00166504|1228291|P1|Overall Study|Withdrawal by Subject|1
386199|NCT00166504|1228290|P2|Overall Study|Lost to Follow-up|1
386200|NCT00166504|1228291|P1|Overall Study|Lost to Follow-up|1
386201|NCT00166504|1228290|P2|Overall Study|Adverse Event|3
386202|NCT00166504|1228291|P1|Overall Study|Adverse Event|3
386203|NCT00166296|1228308|P2|Overall Study|Lost to Follow-up|2
386204|NCT00166296|1228309|P1|Overall Study|Lost to Follow-up|4
386205|NCT00166296|1228308|P2|Overall Study|Adverse Event|4
386206|NCT00166296|1228309|P1|Overall Study|Adverse Event|2
386207|NCT00166296|1228308|P2|Overall Study|Withdrawal by Subject|3
386208|NCT00166296|1228309|P1|Overall Study|Withdrawal by Subject|1
386209|NCT00166114|1228361|P2|Overall Study|Adverse Event|1
386210|NCT00166114|1228362|P1|Overall Study|Adverse Event|2
386211|NCT00166114|1228361|P2|Overall Study|Withdrawal by Subject|4
386212|NCT00166114|1228362|P1|Overall Study|Withdrawal by Subject|10
386213|NCT00166114|1228361|P2|Overall Study|Protocol Violation|1
386214|NCT00166114|1228362|P1|Overall Study|Protocol Violation|2
386215|NCT00165984|1228368|P1|Overall Study|Death|15
386216|NCT00165841|1228386|P2|Overall Study|Medication Noncompliance|1
386217|NCT00165841|1228387|P1|Overall Study|Medication Noncompliance|1
386218|NCT00165841|1228386|P2|Overall Study|Other|5
386219|NCT00165841|1228387|P1|Overall Study|Other|3
386220|NCT00165841|1228386|P2|Overall Study|Protocol Violation|8
386221|NCT00165841|1228387|P1|Overall Study|Protocol Violation|6
386222|NCT00165841|1228386|P2|Overall Study|Physician Decision|0
386223|NCT00165841|1228387|P1|Overall Study|Physician Decision|1
386224|NCT00165841|1228386|P2|Overall Study|Withdrawal by Subject|8
386225|NCT00165841|1228387|P1|Overall Study|Withdrawal by Subject|7
386226|NCT00165841|1228386|P2|Overall Study|Lost to Follow-up|4
386227|NCT00165841|1228387|P1|Overall Study|Lost to Follow-up|4
386228|NCT00165841|1228386|P2|Overall Study|Lack of Efficacy|33
386229|NCT00165841|1228387|P1|Overall Study|Lack of Efficacy|6
386230|NCT00165841|1228386|P2|Overall Study|Adverse Event|3
386231|NCT00165841|1228387|P1|Overall Study|Adverse Event|2
386232|NCT00165789|1228397|P4|Overall Study|Withdrawal by Subject|2
386233|NCT00165789|1228398|P3|Overall Study|Withdrawal by Subject|1
386234|NCT00165789|1228399|P2|Overall Study|Withdrawal by Subject|1
386235|NCT00165789|1228400|P1|Overall Study|Withdrawal by Subject|0
386236|NCT00165789|1228397|P4|Overall Study|Adverse Event|12
386237|NCT00165789|1228398|P3|Overall Study|Adverse Event|0
386238|NCT00165789|1228399|P2|Overall Study|Adverse Event|3
386239|NCT00165789|1228400|P1|Overall Study|Adverse Event|0
386240|NCT00165776|1228454|P4|Overall Study|Worsening of Cervical Dystonia|1
386241|NCT00165776|1228455|P3|Overall Study|Worsening of Cervical Dystonia|0
386242|NCT00165776|1228456|P2|Overall Study|Worsening of Cervical Dystonia|0
386243|NCT00165776|1228457|P1|Overall Study|Worsening of Cervical Dystonia|0
386244|NCT00165776|1228454|P4|Overall Study|Withdrawal by Subject|0
386245|NCT00165776|1228455|P3|Overall Study|Withdrawal by Subject|2
386246|NCT00165776|1228456|P2|Overall Study|Withdrawal by Subject|1
386247|NCT00165776|1228457|P1|Overall Study|Withdrawal by Subject|4
386248|NCT00165776|1228454|P4|Overall Study|Lack of Efficacy|1
386249|NCT00165776|1228455|P3|Overall Study|Lack of Efficacy|0
386250|NCT00165776|1228456|P2|Overall Study|Lack of Efficacy|0
386251|NCT00165776|1228457|P1|Overall Study|Lack of Efficacy|0
386252|NCT00165698|1228493|P2|Overall Study|Not Taken/Lost the medicine|2
386253|NCT00165698|1228494|P1|Overall Study|Not Taken/Lost the medicine|1
386254|NCT00165698|1228493|P2|Overall Study|Protocol Violation|0
386255|NCT00165698|1228494|P1|Overall Study|Protocol Violation|1
386256|NCT00165698|1228493|P2|Overall Study|Withdrawal by Subject|1
386257|NCT00165698|1228494|P1|Overall Study|Withdrawal by Subject|2
386258|NCT00165698|1228493|P2|Overall Study|Lost to Follow-up|2
386259|NCT00165698|1228494|P1|Overall Study|Lost to Follow-up|2
386260|NCT00165698|1228493|P2|Overall Study|Adverse Event|10
386261|NCT00165698|1228494|P1|Overall Study|Adverse Event|2
386262|NCT00165672|1228520|P2|Overall Study|Adverse Event|1
386263|NCT00165672|1228521|P1|Overall Study|Adverse Event|0
386264|NCT00165646|1228530|P3|Overall Study|Protocol Violation|0
386265|NCT00165646|1228531|P2|Overall Study|Protocol Violation|0
386266|NCT00165646|1228532|P1|Overall Study|Protocol Violation|1
386267|NCT00165646|1228530|P3|Overall Study|Physician Decision|2
386268|NCT00165646|1228531|P2|Overall Study|Physician Decision|0
386269|NCT00165646|1228532|P1|Overall Study|Physician Decision|2
386270|NCT00165646|1228530|P3|Overall Study|Withdrawal by Subject|1
386271|NCT00165646|1228531|P2|Overall Study|Withdrawal by Subject|2
386272|NCT00165646|1228532|P1|Overall Study|Withdrawal by Subject|0
386273|NCT00165646|1228530|P3|Overall Study|Lack of Efficacy|0
386274|NCT00165646|1228531|P2|Overall Study|Lack of Efficacy|2
386275|NCT00165646|1228532|P1|Overall Study|Lack of Efficacy|1
386276|NCT00165646|1228530|P3|Overall Study|Adverse Event|1
386277|NCT00165646|1228531|P2|Overall Study|Adverse Event|1
386278|NCT00165646|1228532|P1|Overall Study|Adverse Event|1
386279|NCT00165503|1228540|P1|Overall Study|Unresectable|3
386280|NCT00165503|1228540|P1|Overall Study|Lost to Follow-up|12
386281|NCT00165503|1228540|P1|Overall Study|Death|1
386282|NCT00163657|1228547|P3|Overall Study|Other reason|3
386283|NCT00163657|1228548|P2|Overall Study|Other reason|1
386284|NCT00163657|1228549|P1|Overall Study|Other reason|0
386285|NCT00163657|1228547|P3|Overall Study|Lost to Follow-up|10
386286|NCT00163657|1228548|P2|Overall Study|Lost to Follow-up|3
386287|NCT00163657|1228549|P1|Overall Study|Lost to Follow-up|1
386288|NCT00163657|1228547|P3|Overall Study|Non Compliance|0
386289|NCT00163657|1228548|P2|Overall Study|Non Compliance|0
386290|NCT00163657|1228549|P1|Overall Study|Non Compliance|1
386291|NCT00163657|1228547|P3|Overall Study|Physician Decision|1
386292|NCT00163657|1228548|P2|Overall Study|Physician Decision|1
386293|NCT00163657|1228549|P1|Overall Study|Physician Decision|0
386294|NCT00163657|1228547|P3|Overall Study|Withdrawal by Subject|2
386295|NCT00163657|1228548|P2|Overall Study|Withdrawal by Subject|3
386296|NCT00163657|1228549|P1|Overall Study|Withdrawal by Subject|2
386297|NCT00163657|1228547|P3|Overall Study|graft loss|2
386298|NCT00163657|1228548|P2|Overall Study|graft loss|1
386299|NCT00163657|1228549|P1|Overall Study|graft loss|4
386300|NCT00163657|1228547|P3|Overall Study|Death|19
386301|NCT00163657|1228548|P2|Overall Study|Death|14
386302|NCT00163657|1228549|P1|Overall Study|Death|12
386303|NCT00163215|1228639|P1|Overall Study|Unspecified|7
386304|NCT00163215|1228639|P1|Overall Study|Withdrawal by Subject|5
386305|NCT00163215|1228639|P1|Overall Study|Lack of Efficacy|3
386306|NCT00163189|1228659|P1|Overall Study|Did not meet continuation criterion|16
386307|NCT00163189|1228659|P1|Overall Study|Withdrawal by Subject|11
386308|NCT00163189|1228659|P1|Overall Study|Study terminated by sponsor|11
386309|NCT00163189|1228659|P1|Overall Study|Lack of Efficacy|7
386310|NCT00163189|1228659|P1|Overall Study|Adverse Event|6
386311|NCT00163189|1228659|P1|Overall Study|Death|3
386312|NCT00163189|1228659|P1|Overall Study|Protocol Violation|2
386313|NCT00163189|1228659|P1|Overall Study|Lost to Follow-up|1
386314|NCT00163189|1228659|P1|Overall Study|Unspecified|6
386315|NCT00163020|1228683|P2|Overall Study|Lost to Follow-up|2
386316|NCT00163020|1228684|P1|Overall Study|Lost to Follow-up|0
386317|NCT00162981|1228724|P2|Overall Study|Physician Decision|0
386318|NCT00162981|1228725|P1|Overall Study|Physician Decision|1
386319|NCT00162981|1228724|P2|Overall Study|Withdrawal by Subject|1
386320|NCT00162981|1228725|P1|Overall Study|Withdrawal by Subject|1
386321|NCT00162981|1228724|P2|Overall Study|Adverse Event|5
386322|NCT00162981|1228725|P1|Overall Study|Adverse Event|2
386323|NCT00162942|1228741|P2|Overall Study|2 or more consecutive treatments missed|0
386324|NCT00162942|1228742|P1|Overall Study|2 or more consecutive treatments missed|1
386325|NCT00162942|1228741|P2|Overall Study|Flare During Active Treatment|3
386326|NCT00162942|1228742|P1|Overall Study|Flare During Active Treatment|7
386327|NCT00162942|1228741|P2|Overall Study|Lack of Efficacy|0
386328|NCT00162942|1228742|P1|Overall Study|Lack of Efficacy|1
386329|NCT00162942|1228741|P2|Overall Study|Alternate Therapy|2
386330|NCT00162942|1228742|P1|Overall Study|Alternate Therapy|6
386331|NCT00162942|1228741|P2|Overall Study|Enter Open-Label Study|35
386332|NCT00162942|1228742|P1|Overall Study|Enter Open-Label Study|76
386333|NCT00162942|1228741|P2|Overall Study|Physician Decision|0
386334|NCT00162942|1228742|P1|Overall Study|Physician Decision|1
386335|NCT00162942|1228741|P2|Overall Study|Withdrawal by Subject|6
386336|NCT00162942|1228742|P1|Overall Study|Withdrawal by Subject|3
386337|NCT00162942|1228741|P2|Overall Study|Death|0
386338|NCT00162942|1228742|P1|Overall Study|Death|1
386339|NCT00162942|1228741|P2|Overall Study|Adverse Event|6
386340|NCT00162942|1228742|P1|Overall Study|Adverse Event|10
386341|NCT00162370|1228790|P1|Efficacy Population|Lost to Follow-up|51
386342|NCT00162266|1228798|P4|Open-Label Period|Other Reasons|15
386343|NCT00162266|1228799|P3|Open-Label Period|Other Reasons|0
386344|NCT00162266|1228800|P2|Open-Label Period|Other Reasons|0
386345|NCT00162266|1228801|P1|Open-Label Period|Other Reasons|0
386346|NCT00162266|1228798|P4|Open-Label Period|Administrative Reason By Sponsor|9
386347|NCT00162266|1228799|P3|Open-Label Period|Administrative Reason By Sponsor|0
386348|NCT00162266|1228800|P2|Open-Label Period|Administrative Reason By Sponsor|0
386349|NCT00162266|1228801|P1|Open-Label Period|Administrative Reason By Sponsor|0
386350|NCT00162266|1228798|P4|Open-Label Period|Withdrawal by Subject|31
386351|NCT00162266|1228799|P3|Open-Label Period|Withdrawal by Subject|0
386352|NCT00162266|1228800|P2|Open-Label Period|Withdrawal by Subject|0
386353|NCT00162266|1228801|P1|Open-Label Period|Withdrawal by Subject|0
386354|NCT00162266|1228798|P4|Open-Label Period|Lost to Follow-up|3
386355|NCT00162266|1228799|P3|Open-Label Period|Lost to Follow-up|0
386356|NCT00162266|1228800|P2|Open-Label Period|Lost to Follow-up|0
386357|NCT00162266|1228801|P1|Open-Label Period|Lost to Follow-up|0
386358|NCT00162266|1228798|P4|Open-Label Period|Lack of Efficacy|26
386359|NCT00162266|1228799|P3|Open-Label Period|Lack of Efficacy|0
386360|NCT00162266|1228800|P2|Open-Label Period|Lack of Efficacy|0
386361|NCT00162266|1228801|P1|Open-Label Period|Lack of Efficacy|0
386362|NCT00162266|1228798|P4|Open-Label Period|Adverse Event|46
386363|NCT00162266|1228799|P3|Open-Label Period|Adverse Event|0
386364|NCT00162266|1228800|P2|Open-Label Period|Adverse Event|0
386365|NCT00162266|1228801|P1|Open-Label Period|Adverse Event|0
386366|NCT00162266|1228798|P4|Open-Label Period|Death|7
386367|NCT00162266|1228799|P3|Open-Label Period|Death|0
386368|NCT00162266|1228800|P2|Open-Label Period|Death|0
386369|NCT00162266|1228801|P1|Open-Label Period|Death|0
386370|NCT00162266|1228798|P4|Double-Blind Period|Withdrawal by Subject|0
386371|NCT00162266|1228799|P3|Double-Blind Period|Withdrawal by Subject|6
386372|NCT00162266|1228800|P2|Double-Blind Period|Withdrawal by Subject|2
386373|NCT00162266|1228801|P1|Double-Blind Period|Withdrawal by Subject|5
386374|NCT00162266|1228798|P4|Double-Blind Period|Lack of Efficacy|0
386375|NCT00162266|1228799|P3|Double-Blind Period|Lack of Efficacy|30
386376|NCT00162266|1228800|P2|Double-Blind Period|Lack of Efficacy|17
386377|NCT00162266|1228801|P1|Double-Blind Period|Lack of Efficacy|13
386378|NCT00162266|1228798|P4|Double-Blind Period|Other Reason|0
386379|NCT00162266|1228799|P3|Double-Blind Period|Other Reason|1
386380|NCT00162266|1228800|P2|Double-Blind Period|Other Reason|0
386381|NCT00162266|1228801|P1|Double-Blind Period|Other Reason|1
386382|NCT00162266|1228798|P4|Double-Blind Period|Lost to Follow-up|0
386383|NCT00162266|1228799|P3|Double-Blind Period|Lost to Follow-up|0
386384|NCT00162266|1228800|P2|Double-Blind Period|Lost to Follow-up|2
386385|NCT00162266|1228801|P1|Double-Blind Period|Lost to Follow-up|1
386386|NCT00162266|1228798|P4|Double-Blind Period|Death|0
386387|NCT00162266|1228799|P3|Double-Blind Period|Death|0
386388|NCT00162266|1228800|P2|Double-Blind Period|Death|1
386389|NCT00162266|1228801|P1|Double-Blind Period|Death|0
386390|NCT00162266|1228798|P4|Double-Blind Period|Adverse Event|0
386391|NCT00162266|1228799|P3|Double-Blind Period|Adverse Event|11
386392|NCT00162266|1228800|P2|Double-Blind Period|Adverse Event|9
386393|NCT00162266|1228801|P1|Double-Blind Period|Adverse Event|5
386394|NCT00162136|1229002|P1|Overall Study|Withdrawal by Subject|1
386395|NCT00162136|1229002|P1|Overall Study|Study Drug Toxicity|4
386396|NCT00162136|1229002|P1|Overall Study|Investigator Request|5
386397|NCT00162136|1229002|P1|Overall Study|Disease Progression/Relapse|23
386398|NCT00162136|1229002|P1|Overall Study|Death|1
386399|NCT00162136|1229002|P1|Overall Study|Adverse Event|1
386400|NCT00162123|1229034|P8|Overall Study|Follow-up only (not treated or assessed)|57
386401|NCT00162123|1229035|P7|Overall Study|Follow-up only (not treated or assessed)|0
386402|NCT00162123|1229036|P6|Overall Study|Follow-up only (not treated or assessed)|0
386403|NCT00162123|1229037|P5|Overall Study|Follow-up only (not treated or assessed)|0
386404|NCT00162123|1229038|P4|Overall Study|Follow-up only (not treated or assessed)|0
386405|NCT00162123|1229039|P3|Overall Study|Follow-up only (not treated or assessed)|0
386406|NCT00162123|1229040|P2|Overall Study|Follow-up only (not treated or assessed)|0
386407|NCT00162123|1229041|P1|Overall Study|Follow-up only (not treated or assessed)|0
386408|NCT00162123|1229034|P8|Overall Study|Tumor assessment only (not treated)|1
386409|NCT00162123|1229035|P7|Overall Study|Tumor assessment only (not treated)|0
386410|NCT00162123|1229036|P6|Overall Study|Tumor assessment only (not treated)|0
386411|NCT00162123|1229037|P5|Overall Study|Tumor assessment only (not treated)|0
386412|NCT00162123|1229038|P4|Overall Study|Tumor assessment only (not treated)|0
386413|NCT00162123|1229039|P3|Overall Study|Tumor assessment only (not treated)|0
386414|NCT00162123|1229040|P2|Overall Study|Tumor assessment only (not treated)|0
386415|NCT00162123|1229041|P1|Overall Study|Tumor assessment only (not treated)|0
386416|NCT00162123|1229034|P8|Overall Study|Physician Decision|0
386417|NCT00162123|1229035|P7|Overall Study|Physician Decision|1
386418|NCT00162123|1229036|P6|Overall Study|Physician Decision|1
386419|NCT00162123|1229037|P5|Overall Study|Physician Decision|0
386420|NCT00162123|1229038|P4|Overall Study|Physician Decision|0
386421|NCT00162123|1229039|P3|Overall Study|Physician Decision|0
386422|NCT00162123|1229040|P2|Overall Study|Physician Decision|2
386423|NCT00162123|1229041|P1|Overall Study|Physician Decision|1
386424|NCT00162123|1229034|P8|Overall Study|Not specified (after start of treatment)|0
386425|NCT00162123|1229035|P7|Overall Study|Not specified (after start of treatment)|0
386426|NCT00162123|1229036|P6|Overall Study|Not specified (after start of treatment)|0
386427|NCT00162123|1229037|P5|Overall Study|Not specified (after start of treatment)|3
386428|NCT00162123|1229038|P4|Overall Study|Not specified (after start of treatment)|0
386429|NCT00162123|1229039|P3|Overall Study|Not specified (after start of treatment)|0
386430|NCT00162123|1229040|P2|Overall Study|Not specified (after start of treatment)|0
386431|NCT00162123|1229041|P1|Overall Study|Not specified (after start of treatment)|0
386432|NCT00162123|1229034|P8|Overall Study|Not specified (before treatment)|0
386433|NCT00162123|1229035|P7|Overall Study|Not specified (before treatment)|0
386434|NCT00162123|1229036|P6|Overall Study|Not specified (before treatment)|1
386435|NCT00162123|1229037|P5|Overall Study|Not specified (before treatment)|12
386436|NCT00162123|1229038|P4|Overall Study|Not specified (before treatment)|0
386437|NCT00162123|1229039|P3|Overall Study|Not specified (before treatment)|0
386438|NCT00162123|1229040|P2|Overall Study|Not specified (before treatment)|0
386439|NCT00162123|1229041|P1|Overall Study|Not specified (before treatment)|2
386440|NCT00162123|1229034|P8|Overall Study|Adverse Event|0
386441|NCT00162123|1229035|P7|Overall Study|Adverse Event|0
386442|NCT00162123|1229036|P6|Overall Study|Adverse Event|0
386443|NCT00162123|1229037|P5|Overall Study|Adverse Event|1
386444|NCT00162123|1229038|P4|Overall Study|Adverse Event|2
386445|NCT00162123|1229039|P3|Overall Study|Adverse Event|0
386446|NCT00162123|1229040|P2|Overall Study|Adverse Event|2
386447|NCT00162123|1229041|P1|Overall Study|Adverse Event|1
386448|NCT00162123|1229034|P8|Overall Study|Deterioration without progression|0
386449|NCT00162123|1229035|P7|Overall Study|Deterioration without progression|0
386450|NCT00162123|1229036|P6|Overall Study|Deterioration without progression|0
386451|NCT00162123|1229037|P5|Overall Study|Deterioration without progression|1
386452|NCT00162123|1229038|P4|Overall Study|Deterioration without progression|0
386453|NCT00162123|1229039|P3|Overall Study|Deterioration without progression|3
386454|NCT00162123|1229040|P2|Overall Study|Deterioration without progression|2
386455|NCT00162123|1229041|P1|Overall Study|Deterioration without progression|2
386456|NCT00162123|1229034|P8|Overall Study|Withdrawal by Subject|0
386457|NCT00162123|1229035|P7|Overall Study|Withdrawal by Subject|1
386458|NCT00162123|1229036|P6|Overall Study|Withdrawal by Subject|2
386459|NCT00162123|1229037|P5|Overall Study|Withdrawal by Subject|1
386460|NCT00162123|1229038|P4|Overall Study|Withdrawal by Subject|1
386461|NCT00162123|1229039|P3|Overall Study|Withdrawal by Subject|2
386462|NCT00162123|1229040|P2|Overall Study|Withdrawal by Subject|0
386463|NCT00162123|1229041|P1|Overall Study|Withdrawal by Subject|2
386464|NCT00162123|1229034|P8|Overall Study|Death|0
386465|NCT00162123|1229035|P7|Overall Study|Death|0
386466|NCT00162123|1229036|P6|Overall Study|Death|1
386467|NCT00162123|1229037|P5|Overall Study|Death|1
386468|NCT00162123|1229038|P4|Overall Study|Death|1
386469|NCT00162123|1229039|P3|Overall Study|Death|1
386470|NCT00162123|1229040|P2|Overall Study|Death|3
386471|NCT00162123|1229041|P1|Overall Study|Death|3
386472|NCT00162123|1229034|P8|Overall Study|Study drug toxicity|0
386473|NCT00162123|1229035|P7|Overall Study|Study drug toxicity|1
386474|NCT00162123|1229036|P6|Overall Study|Study drug toxicity|1
386475|NCT00162123|1229037|P5|Overall Study|Study drug toxicity|4
386476|NCT00162123|1229038|P4|Overall Study|Study drug toxicity|0
386477|NCT00162123|1229039|P3|Overall Study|Study drug toxicity|5
386478|NCT00162123|1229040|P2|Overall Study|Study drug toxicity|1
386479|NCT00162123|1229041|P1|Overall Study|Study drug toxicity|6
386480|NCT00162123|1229034|P8|Overall Study|Disease progression|0
386481|NCT00162123|1229035|P7|Overall Study|Disease progression|1
386482|NCT00162123|1229036|P6|Overall Study|Disease progression|3
386483|NCT00162123|1229037|P5|Overall Study|Disease progression|8
386484|NCT00162123|1229038|P4|Overall Study|Disease progression|4
386485|NCT00162123|1229039|P3|Overall Study|Disease progression|10
386486|NCT00162123|1229040|P2|Overall Study|Disease progression|19
386487|NCT00162123|1229041|P1|Overall Study|Disease progression|27
386488|NCT00162097|1229074|P4|Overall Study|Participant no longer met study criteria|1
386489|NCT00162097|1229075|P3|Overall Study|Participant no longer met study criteria|0
386490|NCT00162097|1229076|P2|Overall Study|Participant no longer met study criteria|0
386491|NCT00162097|1229077|P1|Overall Study|Participant no longer met study criteria|0
386492|NCT00162032|1229139|P2|Overall Study|Reason not specified|0
386493|NCT00162032|1229140|P1|Overall Study|Reason not specified|1
386494|NCT00162032|1229139|P2|Overall Study|Lost to Follow-up|2
386495|NCT00162032|1229140|P1|Overall Study|Lost to Follow-up|4
386496|NCT00161616|1229150|P2|Overall Study|Protocol deviation|0
386497|NCT00161616|1229151|P1|Overall Study|Protocol deviation|1
386498|NCT00161616|1229150|P2|Overall Study|Lost to Follow-up|13
386499|NCT00161616|1229151|P1|Overall Study|Lost to Follow-up|17
386500|NCT00161616|1229150|P2|Overall Study|Death|1
386501|NCT00161616|1229151|P1|Overall Study|Death|1
386502|NCT00161616|1229150|P2|Overall Study|Physician Decision|0
386503|NCT00161616|1229151|P1|Overall Study|Physician Decision|1
386504|NCT00161616|1229150|P2|Overall Study|Withdrawal by Subject|5
386505|NCT00161616|1229151|P1|Overall Study|Withdrawal by Subject|6
386506|NCT00161213|1229183|P1|Overall Study|Evaluable for toxicity but not response|1
386507|NCT00161213|1229183|P1|Overall Study|Withdrawal by Subject|1
386508|NCT00160706|1229190|P1|Overall Study|Other Reason|11
386509|NCT00160706|1229190|P1|Overall Study|Lack of Efficacy and Other|1
386510|NCT00160706|1229190|P1|Overall Study|Lack of Efficacy|42
386511|NCT00160706|1229190|P1|Overall Study|Lost to Follow-up and Other|1
386512|NCT00160706|1229190|P1|Overall Study|Lost to Follow-up|4
386513|NCT00160706|1229190|P1|Overall Study|Physician Decision and Other|3
386514|NCT00160706|1229190|P1|Overall Study|Physician Decision|10
386515|NCT00160706|1229190|P1|Overall Study|Withdrawal by Subject and Other|12
386516|NCT00160706|1229190|P1|Overall Study|Withdrawal by Subject|41
386517|NCT00160706|1229190|P1|Overall Study|Protocol Violation|3
386518|NCT00160706|1229190|P1|Overall Study|Adverse Event and Other Reason|105
386519|NCT00160706|1229190|P1|Overall Study|Adverse Event|53
386520|NCT00160693|1229202|P1|Overall Study|Study terminated by sponsor|15
386521|NCT00160693|1229202|P1|Overall Study|Withdrawal by Subject|54
386522|NCT00160693|1229202|P1|Overall Study|Lost to Follow-up|15
386523|NCT00160693|1229202|P1|Overall Study|Protocol Violation|24
386524|NCT00160693|1229202|P1|Overall Study|Lack of Efficacy|30
386525|NCT00160693|1229202|P1|Overall Study|Adverse Event|97
386526|NCT00160641|1229219|P1|Overall Study|Unspecified|9
386527|NCT00160641|1229219|P1|Overall Study|Protocol Violation|3
386528|NCT00160641|1229219|P1|Overall Study|Lack of Efficacy|12
386529|NCT00160641|1229219|P1|Overall Study|Lost to Follow-up|8
386530|NCT00160641|1229219|P1|Overall Study|Withdrawal by Subject|87
386531|NCT00160641|1229219|P1|Overall Study|Adverse Event|102
386532|NCT00160563|1229253|P3|Overall Study|Missing reason|0
386533|NCT00160563|1229254|P2|Overall Study|Missing reason|1
386534|NCT00160563|1229255|P1|Overall Study|Missing reason|0
386535|NCT00160563|1229253|P3|Overall Study|Other (listed in the study report)|81
386536|NCT00160563|1229254|P2|Overall Study|Other (listed in the study report)|40
386537|NCT00160563|1229255|P1|Overall Study|Other (listed in the study report)|48
386538|NCT00160563|1229253|P3|Overall Study|Withdrawal by Subject|3
386539|NCT00160563|1229254|P2|Overall Study|Withdrawal by Subject|2
386540|NCT00160563|1229255|P1|Overall Study|Withdrawal by Subject|1
386541|NCT00160563|1229253|P3|Overall Study|Protocol Violation|3
386542|NCT00160563|1229254|P2|Overall Study|Protocol Violation|0
386543|NCT00160563|1229255|P1|Overall Study|Protocol Violation|0
386544|NCT00160563|1229253|P3|Overall Study|Lost to Follow-up|2
386545|NCT00160563|1229254|P2|Overall Study|Lost to Follow-up|1
386546|NCT00160563|1229255|P1|Overall Study|Lost to Follow-up|1
386547|NCT00160563|1229253|P3|Overall Study|Adverse Event|1
386548|NCT00160563|1229254|P2|Overall Study|Adverse Event|1
386549|NCT00160563|1229255|P1|Overall Study|Adverse Event|1
386550|NCT00160524|1229267|P1|Overall Study|Other|20
386551|NCT00160524|1229267|P1|Overall Study|Lack of Efficacy and Other|1
386552|NCT00160524|1229267|P1|Overall Study|Lack of Efficacy|21
386553|NCT00160524|1229267|P1|Overall Study|Lost to Follow-up and Other|1
386554|NCT00160524|1229267|P1|Overall Study|Lost to Follow-up|13
386555|NCT00160524|1229267|P1|Overall Study|Physician Decision and Other|6
386556|NCT00160524|1229267|P1|Overall Study|Physician Decision|27
386557|NCT00160524|1229267|P1|Overall Study|Withdrawal by Subject and Other|17
386558|NCT00160524|1229267|P1|Overall Study|Withdrawal by Subject|141
386559|NCT00160524|1229267|P1|Overall Study|Protocol Violation and Other|2
386560|NCT00160524|1229267|P1|Overall Study|Protocol Violation|16
386561|NCT00160524|1229267|P1|Overall Study|Adverse Event and Other|94
386562|NCT00160524|1229267|P1|Overall Study|Adverse Event|119
386563|NCT00160251|1229284|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
386564|NCT00160251|1229285|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
386565|NCT00160251|1229286|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
386566|NCT00160251|1229287|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
386567|NCT00160251|1229288|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
386568|NCT00160251|1229289|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
386569|NCT00160251|1229290|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
386570|NCT00160251|1229291|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
386571|NCT00160251|1229284|P8|Post-amendment 2|Lack of Efficacy|24
386572|NCT00160251|1229285|P7|Post-amendment 2|Lack of Efficacy|0
386573|NCT00160251|1229286|P6|Post-amendment 2|Lack of Efficacy|0
386574|NCT00160251|1229287|P5|Post-amendment 2|Lack of Efficacy|0
386575|NCT00160251|1229288|P4|Post-amendment 2|Lack of Efficacy|0
386576|NCT00160251|1229289|P3|Post-amendment 2|Lack of Efficacy|0
386577|NCT00160251|1229290|P2|Post-amendment 2|Lack of Efficacy|0
386578|NCT00160251|1229291|P1|Post-amendment 2|Lack of Efficacy|0
386579|NCT00160251|1229284|P8|Post-amendment 2|Adverse Event|20
386580|NCT00160251|1229285|P7|Post-amendment 2|Adverse Event|0
386581|NCT00160251|1229286|P6|Post-amendment 2|Adverse Event|0
386582|NCT00160251|1229287|P5|Post-amendment 2|Adverse Event|0
386583|NCT00160251|1229288|P4|Post-amendment 2|Adverse Event|0
386584|NCT00160251|1229289|P3|Post-amendment 2|Adverse Event|0
386585|NCT00160251|1229290|P2|Post-amendment 2|Adverse Event|0
386586|NCT00160251|1229291|P1|Post-amendment 2|Adverse Event|0
386587|NCT00160251|1229284|P8|Prior to Amendment 2|Completed Treatment Phase|0
386588|NCT00160251|1229285|P7|Prior to Amendment 2|Completed Treatment Phase|0
386589|NCT00160251|1229286|P6|Prior to Amendment 2|Completed Treatment Phase|23
386590|NCT00160251|1229287|P5|Prior to Amendment 2|Completed Treatment Phase|0
386591|NCT00160251|1229288|P4|Prior to Amendment 2|Completed Treatment Phase|0
386592|NCT00160251|1229289|P3|Prior to Amendment 2|Completed Treatment Phase|0
386593|NCT00160251|1229290|P2|Prior to Amendment 2|Completed Treatment Phase|0
386594|NCT00160251|1229291|P1|Prior to Amendment 2|Completed Treatment Phase|3
386595|NCT00160251|1229284|P8|Prior to Amendment 2|Noncompliance with protocol|0
386596|NCT00160251|1229285|P7|Prior to Amendment 2|Noncompliance with protocol|0
386597|NCT00160251|1229286|P6|Prior to Amendment 2|Noncompliance with protocol|0
386598|NCT00160251|1229287|P5|Prior to Amendment 2|Noncompliance with protocol|0
386599|NCT00160251|1229288|P4|Prior to Amendment 2|Noncompliance with protocol|0
386600|NCT00160251|1229289|P3|Prior to Amendment 2|Noncompliance with protocol|0
386601|NCT00160251|1229290|P2|Prior to Amendment 2|Noncompliance with protocol|0
386602|NCT00160251|1229291|P1|Prior to Amendment 2|Noncompliance with protocol|1
386603|NCT00160251|1229284|P8|Prior to Amendment 2|Withdrawal by Subject|0
386604|NCT00160251|1229285|P7|Prior to Amendment 2|Withdrawal by Subject|3
386605|NCT00160251|1229286|P6|Prior to Amendment 2|Withdrawal by Subject|3
386606|NCT00160251|1229287|P5|Prior to Amendment 2|Withdrawal by Subject|2
386607|NCT00160251|1229288|P4|Prior to Amendment 2|Withdrawal by Subject|4
386608|NCT00160251|1229289|P3|Prior to Amendment 2|Withdrawal by Subject|3
386609|NCT00160251|1229290|P2|Prior to Amendment 2|Withdrawal by Subject|1
386610|NCT00160251|1229291|P1|Prior to Amendment 2|Withdrawal by Subject|3
386611|NCT00160251|1229284|P8|Prior to Amendment 2|Lost to Follow-up|0
386612|NCT00160251|1229285|P7|Prior to Amendment 2|Lost to Follow-up|0
386613|NCT00160251|1229286|P6|Prior to Amendment 2|Lost to Follow-up|1
386614|NCT00160251|1229287|P5|Prior to Amendment 2|Lost to Follow-up|1
386615|NCT00160251|1229288|P4|Prior to Amendment 2|Lost to Follow-up|0
386616|NCT00160251|1229289|P3|Prior to Amendment 2|Lost to Follow-up|1
386617|NCT00160251|1229290|P2|Prior to Amendment 2|Lost to Follow-up|0
386618|NCT00160251|1229291|P1|Prior to Amendment 2|Lost to Follow-up|0
386619|NCT00160251|1229284|P8|Prior to Amendment 2|Lack of Efficacy|0
386620|NCT00160251|1229285|P7|Prior to Amendment 2|Lack of Efficacy|0
386621|NCT00160251|1229286|P6|Prior to Amendment 2|Lack of Efficacy|55
386622|NCT00160251|1229287|P5|Prior to Amendment 2|Lack of Efficacy|24
386623|NCT00160251|1229288|P4|Prior to Amendment 2|Lack of Efficacy|35
386624|NCT00160251|1229289|P3|Prior to Amendment 2|Lack of Efficacy|37
386625|NCT00160251|1229290|P2|Prior to Amendment 2|Lack of Efficacy|4
386626|NCT00160251|1229291|P1|Prior to Amendment 2|Lack of Efficacy|0
386627|NCT00160251|1229284|P8|Prior to Amendment 2|Adverse Event|0
386628|NCT00160251|1229285|P7|Prior to Amendment 2|Adverse Event|1
386629|NCT00160251|1229286|P6|Prior to Amendment 2|Adverse Event|1
386630|NCT00160251|1229287|P5|Prior to Amendment 2|Adverse Event|1
386631|NCT00160251|1229288|P4|Prior to Amendment 2|Adverse Event|1
386632|NCT00160251|1229289|P3|Prior to Amendment 2|Adverse Event|3
386633|NCT00160251|1229290|P2|Prior to Amendment 2|Adverse Event|1
386634|NCT00160251|1229291|P1|Prior to Amendment 2|Adverse Event|2
386635|NCT00160199|1229367|P2|Overall Study|Protocol Violation|8
386636|NCT00160199|1229368|P1|Overall Study|Protocol Violation|8
386637|NCT00160199|1229367|P2|Overall Study|Administrative|1
386638|NCT00160199|1229368|P1|Overall Study|Administrative|0
386639|NCT00160199|1229367|P2|Overall Study|Withdrawal by Subject|6
386640|NCT00160199|1229368|P1|Overall Study|Withdrawal by Subject|4
386641|NCT00160199|1229367|P2|Overall Study|Lost to Follow-up|7
386642|NCT00160199|1229368|P1|Overall Study|Lost to Follow-up|7
386643|NCT00160199|1229367|P2|Overall Study|Lack of Efficacy|1
386644|NCT00160199|1229368|P1|Overall Study|Lack of Efficacy|0
386645|NCT00160199|1229367|P2|Overall Study|Adverse Event|14
386646|NCT00160199|1229368|P1|Overall Study|Adverse Event|5
386647|NCT00159913|1229425|P4|Overall Study|Protocol Violation|0
386648|NCT00159913|1229426|P3|Overall Study|Protocol Violation|1
386649|NCT00159913|1229427|P2|Overall Study|Protocol Violation|0
386650|NCT00159913|1229428|P1|Overall Study|Protocol Violation|1
386651|NCT00159913|1229425|P4|Overall Study|Lost to Follow-up|1
386652|NCT00159913|1229426|P3|Overall Study|Lost to Follow-up|0
386653|NCT00159913|1229427|P2|Overall Study|Lost to Follow-up|0
386654|NCT00159913|1229428|P1|Overall Study|Lost to Follow-up|0
386655|NCT00159913|1229425|P4|Overall Study|Withdrawal by Subject|1
386656|NCT00159913|1229426|P3|Overall Study|Withdrawal by Subject|0
386657|NCT00159913|1229427|P2|Overall Study|Withdrawal by Subject|0
386658|NCT00159913|1229428|P1|Overall Study|Withdrawal by Subject|0
386659|NCT00159913|1229425|P4|Overall Study|Adverse Event|0
386660|NCT00159913|1229426|P3|Overall Study|Adverse Event|1
386661|NCT00159913|1229427|P2|Overall Study|Adverse Event|0
386662|NCT00159913|1229428|P1|Overall Study|Adverse Event|1
386663|NCT00159874|1229502|P7|Overall Study|Pregnancy|0
386664|NCT00159874|1229503|P6|Overall Study|Pregnancy|0
386665|NCT00159874|1229504|P5|Overall Study|Pregnancy|0
386666|NCT00159874|1229505|P4|Overall Study|Pregnancy|0
386667|NCT00159874|1229506|P3|Overall Study|Pregnancy|0
386668|NCT00159874|1229507|P2|Overall Study|Pregnancy|1
386669|NCT00159874|1229508|P1|Overall Study|Pregnancy|1
386670|NCT00159874|1229502|P7|Overall Study|Withdrawal by Subject|1
386671|NCT00159874|1229503|P6|Overall Study|Withdrawal by Subject|2
386672|NCT00159874|1229504|P5|Overall Study|Withdrawal by Subject|3
386673|NCT00159874|1229505|P4|Overall Study|Withdrawal by Subject|4
386674|NCT00159874|1229506|P3|Overall Study|Withdrawal by Subject|8
386675|NCT00159874|1229507|P2|Overall Study|Withdrawal by Subject|6
386676|NCT00159874|1229508|P1|Overall Study|Withdrawal by Subject|2
386677|NCT00159874|1229502|P7|Overall Study|Death|0
386678|NCT00159874|1229503|P6|Overall Study|Death|2
386679|NCT00159874|1229504|P5|Overall Study|Death|1
386680|NCT00159874|1229505|P4|Overall Study|Death|0
386681|NCT00159874|1229506|P3|Overall Study|Death|15
386682|NCT00159874|1229507|P2|Overall Study|Death|8
386683|NCT00159874|1229508|P1|Overall Study|Death|3
386684|NCT00159874|1229502|P7|Overall Study|Protocol Violation|0
386685|NCT00159874|1229503|P6|Overall Study|Protocol Violation|0
386686|NCT00159874|1229504|P5|Overall Study|Protocol Violation|0
386687|NCT00159874|1229505|P4|Overall Study|Protocol Violation|0
386688|NCT00159874|1229506|P3|Overall Study|Protocol Violation|2
386689|NCT00159874|1229507|P2|Overall Study|Protocol Violation|5
386690|NCT00159874|1229508|P1|Overall Study|Protocol Violation|0
386691|NCT00159874|1229502|P7|Overall Study|Not specified|3
386692|NCT00159874|1229503|P6|Overall Study|Not specified|1
386693|NCT00159874|1229504|P5|Overall Study|Not specified|2
386694|NCT00159874|1229505|P4|Overall Study|Not specified|0
386695|NCT00159874|1229506|P3|Overall Study|Not specified|8
386696|NCT00159874|1229507|P2|Overall Study|Not specified|8
386697|NCT00159874|1229508|P1|Overall Study|Not specified|8
386698|NCT00159874|1229502|P7|Overall Study|Lost to Follow-up|1
386699|NCT00159874|1229503|P6|Overall Study|Lost to Follow-up|2
386700|NCT00159874|1229504|P5|Overall Study|Lost to Follow-up|1
386701|NCT00159874|1229505|P4|Overall Study|Lost to Follow-up|0
386702|NCT00159874|1229506|P3|Overall Study|Lost to Follow-up|3
386703|NCT00159874|1229507|P2|Overall Study|Lost to Follow-up|0
386704|NCT00159874|1229508|P1|Overall Study|Lost to Follow-up|1
386705|NCT00159874|1229502|P7|Overall Study|Lack of Efficacy|0
386706|NCT00159874|1229503|P6|Overall Study|Lack of Efficacy|3
386707|NCT00159874|1229504|P5|Overall Study|Lack of Efficacy|0
386708|NCT00159874|1229505|P4|Overall Study|Lack of Efficacy|1
386709|NCT00159874|1229506|P3|Overall Study|Lack of Efficacy|1
386710|NCT00159874|1229507|P2|Overall Study|Lack of Efficacy|0
386711|NCT00159874|1229508|P1|Overall Study|Lack of Efficacy|2
386712|NCT00159874|1229502|P7|Overall Study|Does Not Meet Entrance Criteria|0
386713|NCT00159874|1229503|P6|Overall Study|Does Not Meet Entrance Criteria|0
386714|NCT00159874|1229504|P5|Overall Study|Does Not Meet Entrance Criteria|0
386715|NCT00159874|1229505|P4|Overall Study|Does Not Meet Entrance Criteria|0
386716|NCT00159874|1229506|P3|Overall Study|Does Not Meet Entrance Criteria|1
386717|NCT00159874|1229507|P2|Overall Study|Does Not Meet Entrance Criteria|0
386718|NCT00159874|1229508|P1|Overall Study|Does Not Meet Entrance Criteria|1
386719|NCT00159874|1229502|P7|Overall Study|Adverse Event|0
386720|NCT00159874|1229503|P6|Overall Study|Adverse Event|2
386721|NCT00159874|1229504|P5|Overall Study|Adverse Event|1
386722|NCT00159874|1229505|P4|Overall Study|Adverse Event|1
386723|NCT00159874|1229506|P3|Overall Study|Adverse Event|5
386724|NCT00159874|1229507|P2|Overall Study|Adverse Event|2
386725|NCT00159874|1229508|P1|Overall Study|Adverse Event|2
386726|NCT00159861|1229678|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
386727|NCT00159861|1229679|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
386728|NCT00159861|1229678|P2|Extension Study - up to 3 Years|Reason Unspecified|19
386729|NCT00159861|1229679|P1|Extension Study - up to 3 Years|Reason Unspecified|12
386730|NCT00159861|1229678|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
386731|NCT00159861|1229679|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
386732|NCT00159861|1229678|P2|Extension Study - up to 3 Years|Adverse Event|14
386733|NCT00159861|1229679|P1|Extension Study - up to 3 Years|Adverse Event|14
386734|NCT00159861|1229678|P2|Extension Study - up to 3 Years|Death|28
386735|NCT00159861|1229679|P1|Extension Study - up to 3 Years|Death|24
386736|NCT00159861|1229678|P2|Core Study - 16 Weeks|Randomized but not Treated|0
386737|NCT00159861|1229679|P1|Core Study - 16 Weeks|Randomized but not Treated|2
386738|NCT00159861|1229678|P2|Core Study - 16 Weeks|Subject Defaulted|0
386739|NCT00159861|1229679|P1|Core Study - 16 Weeks|Subject Defaulted|1
386740|NCT00159861|1229678|P2|Core Study - 16 Weeks|Reason Unspecified|3
386741|NCT00159861|1229679|P1|Core Study - 16 Weeks|Reason Unspecified|5
386742|NCT00159861|1229678|P2|Core Study - 16 Weeks|Lack of Efficacy|3
386743|NCT00159861|1229679|P1|Core Study - 16 Weeks|Lack of Efficacy|2
386744|NCT00159861|1229678|P2|Core Study - 16 Weeks|Adverse Event|6
386745|NCT00159861|1229679|P1|Core Study - 16 Weeks|Adverse Event|12
386746|NCT00159861|1229678|P2|Core Study - 16 Weeks|Death|0
386747|NCT00159861|1229679|P1|Core Study - 16 Weeks|Death|3
386748|NCT00159822|1229700|P1|Post-treatment Follow-up Period|Reason unspecified|1
386749|NCT00159822|1229700|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
386750|NCT00159822|1229700|P1|Post-treatment Follow-up Period|Death|1
386751|NCT00159822|1229700|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
386752|NCT00159822|1229700|P1|Voriconazole Treatment Period|Lost to Follow-up|2
386753|NCT00159822|1229700|P1|Voriconazole Treatment Period|Protocol Violation|2
386754|NCT00159822|1229700|P1|Voriconazole Treatment Period|Death|4
386755|NCT00159822|1229700|P1|Voriconazole Treatment Period|Adverse Event|9
386756|NCT00159822|1229700|P1|Voriconazole Treatment Period|Lack of Efficacy|3
386757|NCT00159783|1229718|P3|Overall Study|not specified|4
386758|NCT00159783|1229719|P2|Overall Study|not specified|2
386759|NCT00159783|1229720|P1|Overall Study|not specified|0
386760|NCT00159783|1229718|P3|Overall Study|Lost to Follow-up|11
386761|NCT00159783|1229719|P2|Overall Study|Lost to Follow-up|5
386762|NCT00159783|1229720|P1|Overall Study|Lost to Follow-up|6
386763|NCT00159783|1229718|P3|Overall Study|Withdrawal by Subject|12
386764|NCT00159783|1229719|P2|Overall Study|Withdrawal by Subject|11
386765|NCT00159783|1229720|P1|Overall Study|Withdrawal by Subject|7
386766|NCT00159783|1229718|P3|Overall Study|Lack of Efficacy|3
386767|NCT00159783|1229719|P2|Overall Study|Lack of Efficacy|2
386768|NCT00159783|1229720|P1|Overall Study|Lack of Efficacy|1
386769|NCT00159783|1229718|P3|Overall Study|Adverse Event|9
386770|NCT00159783|1229719|P2|Overall Study|Adverse Event|7
386771|NCT00159783|1229720|P1|Overall Study|Adverse Event|5
386772|NCT00159432|1229750|P1|Overall Study|Lack of Efficacy|8
386773|NCT00159432|1229750|P1|Overall Study|Death|1
386774|NCT00159432|1229750|P1|Overall Study|Adverse Event|1
386775|NCT00158600|1229783|P2|Overall Study|Withdrawal by Subject|2
386776|NCT00158600|1229784|P1|Overall Study|Withdrawal by Subject|2
386777|NCT00158600|1229783|P2|Overall Study|Death|0
386778|NCT00158600|1229784|P1|Overall Study|Death|1
386779|NCT00158600|1229783|P2|Overall Study|Adverse Event|1
386780|NCT00158600|1229784|P1|Overall Study|Adverse Event|2
386781|NCT00158600|1229783|P2|Overall Study|unable to commit time to study|1
386782|NCT00158600|1229784|P1|Overall Study|unable to commit time to study|0
386783|NCT00158262|1229809|P2|Overall Study|Lost to Follow-up|1
386784|NCT00158262|1229810|P1|Overall Study|Lost to Follow-up|1
386785|NCT00158054|1229871|P2|Overall Study|Unavailable for follow up|3
386786|NCT00158054|1229872|P1|Overall Study|Unavailable for follow up|7
386787|NCT00158054|1229871|P2|Overall Study|Refused to continue|0
386788|NCT00158054|1229872|P1|Overall Study|Refused to continue|3
386789|NCT00157950|1229886|P2|Overall Study|Death|0
386790|NCT00157950|1229887|P1|Overall Study|Death|1
386791|NCT00157820|1229904|P3|2nd 8 Months|Premature cross-over|9
386792|NCT00157820|1229905|P2|2nd 8 Months|Premature cross-over|7
386793|NCT00157820|1229906|P1|2nd 8 Months|Premature cross-over|1
386794|NCT00157820|1229904|P3|2nd 8 Months|Lost to Follow-up|2
386795|NCT00157820|1229905|P2|2nd 8 Months|Lost to Follow-up|5
386796|NCT00157820|1229906|P1|2nd 8 Months|Lost to Follow-up|1
386797|NCT00157820|1229904|P3|2nd 8 Months|Death|3
386798|NCT00157820|1229905|P2|2nd 8 Months|Death|1
386799|NCT00157820|1229906|P1|2nd 8 Months|Death|3
386800|NCT00157820|1229904|P3|1st 8 Month|Premature cross-over|2
386801|NCT00157820|1229905|P2|1st 8 Month|Premature cross-over|2
386802|NCT00157820|1229906|P1|1st 8 Month|Premature cross-over|0
386803|NCT00157820|1229904|P3|1st 8 Month|Lost to Follow-up|1
386804|NCT00157820|1229905|P2|1st 8 Month|Lost to Follow-up|2
386805|NCT00157820|1229906|P1|1st 8 Month|Lost to Follow-up|1
386806|NCT00157820|1229904|P3|1st 8 Month|Death|3
386807|NCT00157820|1229905|P2|1st 8 Month|Death|8
386808|NCT00157820|1229906|P1|1st 8 Month|Death|7
386809|NCT00157820|1229904|P3|Randomized|Protocol Violation|2
386810|NCT00157820|1229905|P2|Randomized|Protocol Violation|1
386811|NCT00157820|1229906|P1|Randomized|Protocol Violation|2
386812|NCT00157820|1229904|P3|Randomized|Withdrawal by Subject|3
386813|NCT00157820|1229905|P2|Randomized|Withdrawal by Subject|2
386814|NCT00157820|1229906|P1|Randomized|Withdrawal by Subject|1
386815|NCT00157820|1229904|P3|Randomized|Physician Decision|3
386816|NCT00157820|1229905|P2|Randomized|Physician Decision|2
386817|NCT00157820|1229906|P1|Randomized|Physician Decision|4
386818|NCT00157755|1229919|P6|Overall Study|Study completion|2
386819|NCT00157755|1229920|P5|Overall Study|Study completion|1
386820|NCT00157755|1229921|P4|Overall Study|Study completion|0
386821|NCT00157755|1229922|P3|Overall Study|Study completion|0
386822|NCT00157755|1229923|P2|Overall Study|Study completion|0
386823|NCT00157755|1229924|P1|Overall Study|Study completion|0
386824|NCT00157755|1229919|P6|Overall Study|Subject non-compliance|1
386825|NCT00157755|1229920|P5|Overall Study|Subject non-compliance|0
386826|NCT00157755|1229921|P4|Overall Study|Subject non-compliance|0
386827|NCT00157755|1229922|P3|Overall Study|Subject non-compliance|0
386828|NCT00157755|1229923|P2|Overall Study|Subject non-compliance|0
386829|NCT00157755|1229924|P1|Overall Study|Subject non-compliance|0
386830|NCT00157755|1229919|P6|Overall Study|Study site closure|0
386831|NCT00157755|1229920|P5|Overall Study|Study site closure|0
386832|NCT00157755|1229921|P4|Overall Study|Study site closure|0
386833|NCT00157755|1229922|P3|Overall Study|Study site closure|0
386834|NCT00157755|1229923|P2|Overall Study|Study site closure|1
386835|NCT00157755|1229924|P1|Overall Study|Study site closure|0
386836|NCT00157755|1229919|P6|Overall Study|Medical reason|0
386837|NCT00157755|1229920|P5|Overall Study|Medical reason|0
386838|NCT00157755|1229921|P4|Overall Study|Medical reason|1
386839|NCT00157755|1229922|P3|Overall Study|Medical reason|1
386840|NCT00157755|1229923|P2|Overall Study|Medical reason|0
386841|NCT00157755|1229924|P1|Overall Study|Medical reason|0
386842|NCT00157755|1229919|P6|Overall Study|Explant due to infection|0
386843|NCT00157755|1229920|P5|Overall Study|Explant due to infection|0
386844|NCT00157755|1229921|P4|Overall Study|Explant due to infection|0
386845|NCT00157755|1229922|P3|Overall Study|Explant due to infection|1
386846|NCT00157755|1229923|P2|Overall Study|Explant due to infection|0
386847|NCT00157755|1229924|P1|Overall Study|Explant due to infection|0
386848|NCT00157755|1229919|P6|Overall Study|Withdrawal by Subject|2
386849|NCT00157755|1229920|P5|Overall Study|Withdrawal by Subject|1
386850|NCT00157755|1229921|P4|Overall Study|Withdrawal by Subject|1
386851|NCT00157755|1229922|P3|Overall Study|Withdrawal by Subject|1
386852|NCT00157755|1229923|P2|Overall Study|Withdrawal by Subject|0
386853|NCT00157755|1229924|P1|Overall Study|Withdrawal by Subject|0
386854|NCT00157755|1229919|P6|Overall Study|Lost to Follow-up|0
386855|NCT00157755|1229920|P5|Overall Study|Lost to Follow-up|0
386856|NCT00157755|1229921|P4|Overall Study|Lost to Follow-up|0
386857|NCT00157755|1229922|P3|Overall Study|Lost to Follow-up|1
386858|NCT00157755|1229923|P2|Overall Study|Lost to Follow-up|0
386859|NCT00157755|1229924|P1|Overall Study|Lost to Follow-up|0
386860|NCT00157755|1229919|P6|Overall Study|Death|0
386861|NCT00157755|1229920|P5|Overall Study|Death|0
386862|NCT00157755|1229921|P4|Overall Study|Death|2
386863|NCT00157755|1229922|P3|Overall Study|Death|3
386864|NCT00157755|1229923|P2|Overall Study|Death|3
386865|NCT00157755|1229924|P1|Overall Study|Death|2
386866|NCT00157248|1229960|P4|Overall Study|site closures, subject moving|9
386867|NCT00157248|1229961|P3|Overall Study|site closures, subject moving|3
386868|NCT00157248|1229962|P2|Overall Study|site closures, subject moving|7
386869|NCT00157248|1229963|P1|Overall Study|site closures, subject moving|7
386870|NCT00157248|1229960|P4|Overall Study|Withdrawal by Subject|3
386871|NCT00157248|1229961|P3|Overall Study|Withdrawal by Subject|3
386872|NCT00157248|1229962|P2|Overall Study|Withdrawal by Subject|4
386873|NCT00157248|1229963|P1|Overall Study|Withdrawal by Subject|1
386874|NCT00157248|1229960|P4|Overall Study|Lost to Follow-up|0
386875|NCT00157248|1229961|P3|Overall Study|Lost to Follow-up|0
386876|NCT00157248|1229962|P2|Overall Study|Lost to Follow-up|1
386877|NCT00157248|1229963|P1|Overall Study|Lost to Follow-up|0
386878|NCT00157248|1229960|P4|Overall Study|Protocol Violation|2
386879|NCT00157248|1229961|P3|Overall Study|Protocol Violation|2
386880|NCT00157248|1229962|P2|Overall Study|Protocol Violation|0
386881|NCT00157248|1229963|P1|Overall Study|Protocol Violation|4
386882|NCT00157248|1229960|P4|Overall Study|Adverse Event|33
386883|NCT00157248|1229961|P3|Overall Study|Adverse Event|13
386884|NCT00157248|1229962|P2|Overall Study|Adverse Event|25
386885|NCT00157248|1229963|P1|Overall Study|Adverse Event|36
386886|NCT00157209|1230069|P2|Overall Study|Ongoing at data cut-off|0
386887|NCT00157209|1230070|P1|Overall Study|Ongoing at data cut-off|10
386888|NCT00157196|1230084|P1|Overall Study|Ongoing at data cut-off|9
386889|NCT00157157|1230090|P1|Overall Study|Inclusion not met- baseline FVIII value|1
386890|NCT00157157|1230090|P1|Overall Study|Met exclusion criteria|1
386891|NCT00157157|1230090|P1|Overall Study|Enrolled in another study|1
386892|NCT00157157|1230090|P1|Overall Study|Lost to Follow-up|1
386893|NCT00157157|1230090|P1|Overall Study|Physician Decision|1
386894|NCT00157157|1230090|P1|Overall Study|Withdrawal by Subject|6
386895|NCT00157014|1230117|P4|Overall Study|Withdrawal by Subject|0
386896|NCT00157014|1230118|P3|Overall Study|Withdrawal by Subject|0
386897|NCT00157014|1230119|P2|Overall Study|Withdrawal by Subject|0
386898|NCT00157014|1230120|P1|Overall Study|Withdrawal by Subject|1
386899|NCT00157014|1230117|P4|Overall Study|Patient would not receive transplant|0
386900|NCT00157014|1230118|P3|Overall Study|Patient would not receive transplant|0
386901|NCT00157014|1230119|P2|Overall Study|Patient would not receive transplant|1
386902|NCT00157014|1230120|P1|Overall Study|Patient would not receive transplant|0
386903|NCT00157014|1230117|P4|Overall Study|Patient unable to return in nursing home|0
386904|NCT00157014|1230118|P3|Overall Study|Patient unable to return in nursing home|0
386905|NCT00157014|1230119|P2|Overall Study|Patient unable to return in nursing home|0
386906|NCT00157014|1230120|P1|Overall Study|Patient unable to return in nursing home|1
386907|NCT00157014|1230117|P4|Overall Study|Patient withdrawn by investigator|0
386908|NCT00157014|1230118|P3|Overall Study|Patient withdrawn by investigator|0
386909|NCT00157014|1230119|P2|Overall Study|Patient withdrawn by investigator|0
386910|NCT00157014|1230120|P1|Overall Study|Patient withdrawn by investigator|1
386911|NCT00157014|1230117|P4|Overall Study|Medications withdrawn on family request|0
386912|NCT00157014|1230118|P3|Overall Study|Medications withdrawn on family request|0
386913|NCT00157014|1230119|P2|Overall Study|Medications withdrawn on family request|1
386914|NCT00157014|1230120|P1|Overall Study|Medications withdrawn on family request|0
386915|NCT00157014|1230117|P4|Overall Study|Physician Decision|0
386916|NCT00157014|1230118|P3|Overall Study|Physician Decision|0
386917|NCT00157014|1230119|P2|Overall Study|Physician Decision|1
386918|NCT00157014|1230120|P1|Overall Study|Physician Decision|0
386919|NCT00157014|1230117|P4|Overall Study|Death|1
386920|NCT00157014|1230118|P3|Overall Study|Death|1
386921|NCT00157014|1230119|P2|Overall Study|Death|2
386922|NCT00157014|1230120|P1|Overall Study|Death|4
386923|NCT00156819|1230236|P3|Overall Study|Lost to Follow-up|3
386924|NCT00156819|1230237|P2|Overall Study|Lost to Follow-up|1
386925|NCT00156819|1230238|P1|Overall Study|Lost to Follow-up|1
386926|NCT00156533|1230255|P4|Overall Study|Failed Screening|1
386927|NCT00156533|1230256|P3|Overall Study|Failed Screening|1
386928|NCT00156533|1230257|P2|Overall Study|Failed Screening|0
386929|NCT00156533|1230258|P1|Overall Study|Failed Screening|1
386930|NCT00156533|1230255|P4|Overall Study|Withdrawal by Subject|1
386931|NCT00156533|1230256|P3|Overall Study|Withdrawal by Subject|0
386932|NCT00156533|1230257|P2|Overall Study|Withdrawal by Subject|0
386933|NCT00156533|1230258|P1|Overall Study|Withdrawal by Subject|1
386934|NCT00156533|1230255|P4|Overall Study|Withdrawn - Medication Expiration|0
386935|NCT00156533|1230256|P3|Overall Study|Withdrawn - Medication Expiration|1
386936|NCT00156533|1230257|P2|Overall Study|Withdrawn - Medication Expiration|2
386937|NCT00156533|1230258|P1|Overall Study|Withdrawn - Medication Expiration|0
386938|NCT00156065|1230290|P3|Overall Study|Unspecified|3
386939|NCT00156065|1230291|P2|Overall Study|Unspecified|9
386940|NCT00156065|1230292|P1|Overall Study|Unspecified|2
386941|NCT00156065|1230290|P3|Overall Study|Lost to Follow-up|1
386942|NCT00156065|1230291|P2|Overall Study|Lost to Follow-up|7
386943|NCT00156065|1230292|P1|Overall Study|Lost to Follow-up|5
386944|NCT00156065|1230290|P3|Overall Study|Withdrawal by Subject|16
386945|NCT00156065|1230291|P2|Overall Study|Withdrawal by Subject|26
386946|NCT00156065|1230292|P1|Overall Study|Withdrawal by Subject|13
386947|NCT00156065|1230290|P3|Overall Study|Lack of Efficacy|3
386948|NCT00156065|1230291|P2|Overall Study|Lack of Efficacy|9
386949|NCT00156065|1230292|P1|Overall Study|Lack of Efficacy|2
386950|NCT00156065|1230290|P3|Overall Study|Adverse Event|4
386951|NCT00156065|1230291|P2|Overall Study|Adverse Event|11
386952|NCT00156065|1230292|P1|Overall Study|Adverse Event|8
386953|NCT00156065|1230290|P3|Overall Study|Enrolled But Never Received Treatment|0
386954|NCT00156065|1230291|P2|Overall Study|Enrolled But Never Received Treatment|1
386955|NCT00156065|1230292|P1|Overall Study|Enrolled But Never Received Treatment|1
386956|NCT00154375|1230324|P2|Overall Study|Suspected progression of disease|30
386957|NCT00154375|1230325|P1|Overall Study|Suspected progression of disease|44
386958|NCT00154375|1230324|P2|Overall Study|Protocol Violation|1
386959|NCT00154375|1230325|P1|Overall Study|Protocol Violation|0
386960|NCT00154375|1230324|P2|Overall Study|Abnormal laboratory value(s)|2
386961|NCT00154375|1230325|P1|Overall Study|Abnormal laboratory value(s)|0
386962|NCT00154375|1230324|P2|Overall Study|Lost to Follow-up|1
386963|NCT00154375|1230325|P1|Overall Study|Lost to Follow-up|2
386964|NCT00154375|1230324|P2|Overall Study|Study drug no longer required|3
386965|NCT00154375|1230325|P1|Overall Study|Study drug no longer required|5
386966|NCT00154375|1230324|P2|Overall Study|Death|13
386967|NCT00154375|1230325|P1|Overall Study|Death|5
386968|NCT00154375|1230324|P2|Overall Study|Withdrawal by Subject|10
386969|NCT00154375|1230325|P1|Overall Study|Withdrawal by Subject|14
386970|NCT00154375|1230324|P2|Overall Study|Adverse Event|20
386971|NCT00154375|1230325|P1|Overall Study|Adverse Event|18
386972|NCT00154375|1230324|P2|Overall Study|Unsatisfactory therapeutic effect|26
386973|NCT00154375|1230325|P1|Overall Study|Unsatisfactory therapeutic effect|25
386974|NCT00154310|1230336|P2|Overall Study|Death|1
386975|NCT00154310|1230337|P1|Overall Study|Death|0
386976|NCT00154310|1230336|P2|Overall Study|Administrative problems|1
386977|NCT00154310|1230337|P1|Overall Study|Administrative problems|0
386978|NCT00154310|1230336|P2|Overall Study|Lost to Follow-up|8
386979|NCT00154310|1230337|P1|Overall Study|Lost to Follow-up|0
386980|NCT00154310|1230336|P2|Overall Study|Withdrawal by Subject|3
386981|NCT00154310|1230337|P1|Overall Study|Withdrawal by Subject|9
386982|NCT00154310|1230336|P2|Overall Study|Protocol Violation|2
386983|NCT00154310|1230337|P1|Overall Study|Protocol Violation|4
386984|NCT00154310|1230336|P2|Overall Study|Lack of Efficacy|4
386985|NCT00154310|1230337|P1|Overall Study|Lack of Efficacy|5
386986|NCT00154310|1230336|P2|Overall Study|Adverse Event|9
386987|NCT00154310|1230337|P1|Overall Study|Adverse Event|19
386988|NCT00154297|1230353|P2|Overall Study|Lost to Follow-up|0
386989|NCT00154297|1230354|P1|Overall Study|Lost to Follow-up|3
386990|NCT00154297|1230353|P2|Overall Study|Withdrawal by Subject|5
386991|NCT00154297|1230354|P1|Overall Study|Withdrawal by Subject|0
386992|NCT00154297|1230353|P2|Overall Study|Death|2
386993|NCT00154297|1230354|P1|Overall Study|Death|5
386994|NCT00154284|1230372|P2|Overall Study|Protocol Violation|1
386995|NCT00154284|1230373|P1|Overall Study|Protocol Violation|0
386996|NCT00154284|1230372|P2|Overall Study|Lack of Efficacy|2
386997|NCT00154284|1230373|P1|Overall Study|Lack of Efficacy|1
386998|NCT00154284|1230372|P2|Overall Study|Abnormal laboratory value(s)|1
386999|NCT00154284|1230373|P1|Overall Study|Abnormal laboratory value(s)|0
387000|NCT00154284|1230372|P2|Overall Study|Adverse Event|9
387001|NCT00154284|1230373|P1|Overall Study|Adverse Event|6
387002|NCT00154102|1230387|P2|Overall Study|investigational study phase ongoing|2
387003|NCT00154102|1230388|P1|Overall Study|investigational study phase ongoing|7
387004|NCT00154063|1230424|P2|Overall Study|Not specified|3
387005|NCT00154063|1230425|P1|Overall Study|Not specified|3
387006|NCT00154063|1230424|P2|Overall Study|Withdrawal by Subject|9
387007|NCT00154063|1230425|P1|Overall Study|Withdrawal by Subject|4
387008|NCT00154063|1230424|P2|Overall Study|Investigator or Sponsor Request|1
387009|NCT00154063|1230425|P1|Overall Study|Investigator or Sponsor Request|0
387010|NCT00154063|1230424|P2|Overall Study|Protocol Violation|1
387011|NCT00154063|1230425|P1|Overall Study|Protocol Violation|1
387012|NCT00154063|1230424|P2|Overall Study|Adverse Event|8
387013|NCT00154063|1230425|P1|Overall Study|Adverse Event|4
387014|NCT00153920|1230487|P1|Overall Study|Progressive Disease before Trt|1
387015|NCT00153920|1230487|P1|Overall Study|Withdrawal of Consent before Trt|1
387016|NCT00153920|1230487|P1|Overall Study|Non-Protocol Therapy|1
387017|NCT00153920|1230487|P1|Overall Study|Withdrawal by Subject|1
387018|NCT00153920|1230487|P1|Overall Study|Death|2
387019|NCT00153920|1230487|P1|Overall Study|Lack of Response|3
387020|NCT00153920|1230487|P1|Overall Study|Physician Decision|3
387021|NCT00153920|1230487|P1|Overall Study|Progressive Disease|9
387022|NCT00153920|1230487|P1|Overall Study|Adverse Event|9
387023|NCT00153816|1230502|P6|Overall Study|Follow-up exam done, histology missing|2
387024|NCT00153816|1230503|P5|Overall Study|Follow-up exam done, histology missing|1
387025|NCT00153816|1230504|P4|Overall Study|Follow-up exam done, histology missing|3
387026|NCT00153816|1230505|P3|Overall Study|Follow-up exam done, histology missing|3
387027|NCT00153816|1230506|P2|Overall Study|Follow-up exam done, histology missing|3
387028|NCT00153816|1230507|P1|Overall Study|Follow-up exam done, histology missing|2
387029|NCT00153816|1230502|P6|Overall Study|Follow-up exam not done|9
387030|NCT00153816|1230503|P5|Overall Study|Follow-up exam not done|8
387031|NCT00153816|1230504|P4|Overall Study|Follow-up exam not done|10
387032|NCT00153816|1230505|P3|Overall Study|Follow-up exam not done|11
387033|NCT00153816|1230506|P2|Overall Study|Follow-up exam not done|7
387034|NCT00153816|1230507|P1|Overall Study|Follow-up exam not done|8
387035|NCT00153816|1230502|P6|Overall Study|Withdrawal by Subject|5
387036|NCT00153816|1230503|P5|Overall Study|Withdrawal by Subject|1
387037|NCT00153816|1230504|P4|Overall Study|Withdrawal by Subject|4
387038|NCT00153816|1230505|P3|Overall Study|Withdrawal by Subject|9
387039|NCT00153816|1230506|P2|Overall Study|Withdrawal by Subject|9
387040|NCT00153816|1230507|P1|Overall Study|Withdrawal by Subject|9
387041|NCT00153816|1230502|P6|Overall Study|Lost to Follow-up|9
387042|NCT00153816|1230503|P5|Overall Study|Lost to Follow-up|7
387043|NCT00153816|1230504|P4|Overall Study|Lost to Follow-up|8
387044|NCT00153816|1230505|P3|Overall Study|Lost to Follow-up|5
387045|NCT00153816|1230506|P2|Overall Study|Lost to Follow-up|8
387046|NCT00153816|1230507|P1|Overall Study|Lost to Follow-up|7
387047|NCT00153816|1230502|P6|Overall Study|Death|2
387048|NCT00153816|1230503|P5|Overall Study|Death|0
387049|NCT00153816|1230504|P4|Overall Study|Death|6
387050|NCT00153816|1230505|P3|Overall Study|Death|4
387051|NCT00153816|1230506|P2|Overall Study|Death|5
387052|NCT00153816|1230507|P1|Overall Study|Death|6
387053|NCT00153101|1230562|P5|Overall Study|Withdrawal by Subject|5
387054|NCT00153101|1230563|P4|Overall Study|Withdrawal by Subject|3
387055|NCT00153101|1230564|P3|Overall Study|Withdrawal by Subject|3
387056|NCT00153101|1230565|P2|Overall Study|Withdrawal by Subject|4
387057|NCT00153101|1230566|P1|Overall Study|Withdrawal by Subject|3
387058|NCT00153101|1230562|P5|Overall Study|Lost to Follow-up|5
387059|NCT00153101|1230563|P4|Overall Study|Lost to Follow-up|5
387060|NCT00153101|1230564|P3|Overall Study|Lost to Follow-up|12
387061|NCT00153101|1230565|P2|Overall Study|Lost to Follow-up|14
387062|NCT00153101|1230566|P1|Overall Study|Lost to Follow-up|14
387063|NCT00153062|1230674|P4|Overall Study|Other|0
387064|NCT00153062|1230675|P3|Overall Study|Other|1
387065|NCT00153062|1230676|P2|Overall Study|Other|0
387066|NCT00153062|1230677|P1|Overall Study|Other|0
387067|NCT00153062|1230674|P4|Overall Study|No disposition data available|1
387068|NCT00153062|1230675|P3|Overall Study|No disposition data available|1
387069|NCT00153062|1230676|P2|Overall Study|No disposition data available|1
387070|NCT00153062|1230677|P1|Overall Study|No disposition data available|1
387071|NCT00153062|1230674|P4|Overall Study|Protocol Violation|1
387072|NCT00153062|1230675|P3|Overall Study|Protocol Violation|1
387073|NCT00153062|1230676|P2|Overall Study|Protocol Violation|2
387074|NCT00153062|1230677|P1|Overall Study|Protocol Violation|0
387075|NCT00153062|1230674|P4|Overall Study|Adverse Event|0
387076|NCT00153062|1230675|P3|Overall Study|Adverse Event|1
387077|NCT00153062|1230676|P2|Overall Study|Adverse Event|1
387078|NCT00153062|1230677|P1|Overall Study|Adverse Event|0
387079|NCT00153062|1230674|P4|Overall Study|Lost to Follow-up|16
387080|NCT00153062|1230675|P3|Overall Study|Lost to Follow-up|15
387081|NCT00153062|1230676|P2|Overall Study|Lost to Follow-up|20
387082|NCT00153062|1230677|P1|Overall Study|Lost to Follow-up|12
387083|NCT00153062|1230674|P4|Overall Study|Withdrawal by Subject|28
387084|NCT00153062|1230675|P3|Overall Study|Withdrawal by Subject|27
387085|NCT00153062|1230676|P2|Overall Study|Withdrawal by Subject|30
387086|NCT00153062|1230677|P1|Overall Study|Withdrawal by Subject|14
387087|NCT00153062|1230674|P4|Overall Study|Death|365
387088|NCT00153062|1230675|P3|Overall Study|Death|369
387089|NCT00153062|1230676|P2|Overall Study|Death|352
387090|NCT00153062|1230677|P1|Overall Study|Death|360
387091|NCT00152971|1230696|P3|Treatment|not specified|10
387092|NCT00152971|1230697|P2|Treatment|not specified|11
387093|NCT00152971|1230698|P1|Treatment|not specified|9
387094|NCT00152971|1230696|P3|Treatment|Withdrawal by Subject|5
387095|NCT00152971|1230697|P2|Treatment|Withdrawal by Subject|4
387096|NCT00152971|1230698|P1|Treatment|Withdrawal by Subject|4
387097|NCT00152971|1230696|P3|Treatment|Lost to Follow-up|1
387098|NCT00152971|1230697|P2|Treatment|Lost to Follow-up|2
387099|NCT00152971|1230698|P1|Treatment|Lost to Follow-up|1
387100|NCT00152971|1230696|P3|Treatment|Protocol Violation|10
387101|NCT00152971|1230697|P2|Treatment|Protocol Violation|6
387102|NCT00152971|1230698|P1|Treatment|Protocol Violation|8
387103|NCT00152971|1230696|P3|Treatment|Adverse Event|54
387104|NCT00152971|1230697|P2|Treatment|Adverse Event|40
387105|NCT00152971|1230698|P1|Treatment|Adverse Event|49
387106|NCT00152971|1230696|P3|Overall Study|not specified|5
387107|NCT00152971|1230697|P2|Overall Study|not specified|5
387108|NCT00152971|1230698|P1|Overall Study|not specified|3
387109|NCT00152971|1230696|P3|Overall Study|Withdrawal by Subject|14
387110|NCT00152971|1230697|P2|Overall Study|Withdrawal by Subject|8
387111|NCT00152971|1230698|P1|Overall Study|Withdrawal by Subject|9
387112|NCT00152971|1230696|P3|Overall Study|Lost to Follow-up|13
387113|NCT00152971|1230697|P2|Overall Study|Lost to Follow-up|14
387114|NCT00152971|1230698|P1|Overall Study|Lost to Follow-up|17
387115|NCT00152971|1230696|P3|Overall Study|Protocol Violation|8
387116|NCT00152971|1230697|P2|Overall Study|Protocol Violation|11
387117|NCT00152971|1230698|P1|Overall Study|Protocol Violation|10
387118|NCT00152971|1230696|P3|Overall Study|Adverse Event|9
387119|NCT00152971|1230697|P2|Overall Study|Adverse Event|10
387120|NCT00152971|1230698|P1|Overall Study|Adverse Event|12
387121|NCT00152763|1230734|P4|Overall Study|Lost to Follow-up|13
387122|NCT00152763|1230735|P3|Overall Study|Lost to Follow-up|2
387123|NCT00152763|1230736|P2|Overall Study|Lost to Follow-up|4
387124|NCT00152763|1230737|P1|Overall Study|Lost to Follow-up|6
387125|NCT00152763|1230734|P4|Overall Study|Death|1
387126|NCT00152763|1230735|P3|Overall Study|Death|2
387127|NCT00152763|1230736|P2|Overall Study|Death|1
387128|NCT00152763|1230737|P1|Overall Study|Death|4
387129|NCT00152516|1230853|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
387130|NCT00152516|1230853|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
387131|NCT00152516|1230853|P1|Overall Study|Other: Moved Out Of State|1
387132|NCT00152516|1230853|P1|Overall Study|Other: Primary Care Physician's Decision|1
387133|NCT00152516|1230853|P1|Overall Study|Other: Non-Compliance|2
387134|NCT00152516|1230853|P1|Overall Study|Other: Parents Withdrew Consent|2
387135|NCT00152516|1230853|P1|Overall Study|Other: Given Commercial Drug in Error|2
387136|NCT00152516|1230853|P1|Overall Study|Other: Mother Refused To Cooperate|1
387137|NCT00152516|1230853|P1|Overall Study|Protocol Violation|3
387138|NCT00152516|1230853|P1|Overall Study|Withdrawal by Subject|8
387139|NCT00152516|1230853|P1|Overall Study|Lost to Follow-up|5
387140|NCT00152516|1230853|P1|Overall Study|Lack and Loss of Efficacy|30
387141|NCT00152516|1230853|P1|Overall Study|Adverse Event|18
387142|NCT00152009|1230881|P4|Overall Study|Sponsor's decision|3
387143|NCT00152009|1230882|P3|Overall Study|Sponsor's decision|1
387144|NCT00152009|1230883|P2|Overall Study|Sponsor's decision|3
387145|NCT00152009|1230884|P1|Overall Study|Sponsor's decision|3
387146|NCT00152009|1230881|P4|Overall Study|ECG abnormalities|1
387147|NCT00152009|1230882|P3|Overall Study|ECG abnormalities|2
387148|NCT00152009|1230883|P2|Overall Study|ECG abnormalities|2
387149|NCT00152009|1230884|P1|Overall Study|ECG abnormalities|2
387150|NCT00152009|1230881|P4|Overall Study|Lack of Efficacy|15
387151|NCT00152009|1230882|P3|Overall Study|Lack of Efficacy|7
387152|NCT00152009|1230883|P2|Overall Study|Lack of Efficacy|6
387153|NCT00152009|1230884|P1|Overall Study|Lack of Efficacy|8
387154|NCT00152009|1230881|P4|Overall Study|Lost to Follow-up|3
387155|NCT00152009|1230882|P3|Overall Study|Lost to Follow-up|3
387156|NCT00152009|1230883|P2|Overall Study|Lost to Follow-up|4
387157|NCT00152009|1230884|P1|Overall Study|Lost to Follow-up|2
387158|NCT00152009|1230881|P4|Overall Study|Withdrawal by Subject|9
387159|NCT00152009|1230882|P3|Overall Study|Withdrawal by Subject|4
387160|NCT00152009|1230883|P2|Overall Study|Withdrawal by Subject|3
387161|NCT00152009|1230884|P1|Overall Study|Withdrawal by Subject|2
387162|NCT00152009|1230881|P4|Overall Study|Protocol Violation|1
387163|NCT00152009|1230882|P3|Overall Study|Protocol Violation|0
387164|NCT00152009|1230883|P2|Overall Study|Protocol Violation|0
387165|NCT00152009|1230884|P1|Overall Study|Protocol Violation|3
387166|NCT00152009|1230881|P4|Overall Study|Adverse Event|1
387167|NCT00152009|1230882|P3|Overall Study|Adverse Event|20
387168|NCT00152009|1230883|P2|Overall Study|Adverse Event|13
387169|NCT00152009|1230884|P1|Overall Study|Adverse Event|9
387170|NCT00151996|1230916|P2|Overall Study|Sponsor's decision|2
387171|NCT00151996|1230917|P1|Overall Study|Sponsor's decision|0
387172|NCT00151996|1230916|P2|Overall Study|Protocol Violation|2
387173|NCT00151996|1230917|P1|Overall Study|Protocol Violation|1
387174|NCT00151996|1230916|P2|Overall Study|Withdrawal by Subject|1
387175|NCT00151996|1230917|P1|Overall Study|Withdrawal by Subject|1
387176|NCT00151996|1230916|P2|Overall Study|Adverse Event|2
387177|NCT00151996|1230917|P1|Overall Study|Adverse Event|3
387178|NCT00151892|1230933|P2|Overall Study|Lack of study medication at center|1
387179|NCT00151892|1230934|P1|Overall Study|Lack of study medication at center|0
387180|NCT00151892|1230933|P2|Overall Study|Used prohibited corticosteroids|0
387181|NCT00151892|1230934|P1|Overall Study|Used prohibited corticosteroids|1
387182|NCT00151892|1230933|P2|Overall Study|Did not return for a visit|0
387183|NCT00151892|1230934|P1|Overall Study|Did not return for a visit|1
387184|NCT00151892|1230933|P2|Overall Study|Pregnancy|1
387185|NCT00151892|1230934|P1|Overall Study|Pregnancy|0
387186|NCT00151892|1230933|P2|Overall Study|Non-compliance|1
387187|NCT00151892|1230934|P1|Overall Study|Non-compliance|0
387188|NCT00151892|1230933|P2|Overall Study|Protocol Violation|3
387189|NCT00151892|1230934|P1|Overall Study|Protocol Violation|3
387190|NCT00151892|1230933|P2|Overall Study|Adverse Event|3
387191|NCT00151892|1230934|P1|Overall Study|Adverse Event|6
387192|NCT00151892|1230933|P2|Overall Study|Lost to Follow-up|10
387193|NCT00151892|1230934|P1|Overall Study|Lost to Follow-up|5
387194|NCT00151892|1230933|P2|Overall Study|Patient request|7
387195|NCT00151892|1230934|P1|Overall Study|Patient request|10
387196|NCT00151892|1230933|P2|Overall Study|Lack of Efficacy|57
387197|NCT00151892|1230934|P1|Overall Study|Lack of Efficacy|50
387198|NCT00151775|1230979|P12|Period 4: Open Label|Protocol Violation|0
387199|NCT00151775|1230980|P11|Period 4: Open Label|Protocol Violation|0
387200|NCT00151775|1230981|P10|Period 4: Open Label|Protocol Violation|0
387201|NCT00151775|1230982|P9|Period 4: Open Label|Protocol Violation|0
387202|NCT00151775|1230983|P8|Period 4: Open Label|Protocol Violation|0
387203|NCT00151775|1230984|P7|Period 4: Open Label|Protocol Violation|0
387204|NCT00151775|1230985|P6|Period 4: Open Label|Protocol Violation|0
387205|NCT00151775|1230986|P5|Period 4: Open Label|Protocol Violation|1
387206|NCT00151775|1230987|P4|Period 4: Open Label|Protocol Violation|0
387207|NCT00151775|1230988|P3|Period 4: Open Label|Protocol Violation|0
387208|NCT00151775|1230989|P2|Period 4: Open Label|Protocol Violation|0
387209|NCT00151775|1230990|P1|Period 4: Open Label|Protocol Violation|0
387210|NCT00151775|1230979|P12|Period 4: Open Label|Physician Decision|0
387211|NCT00151775|1230980|P11|Period 4: Open Label|Physician Decision|0
387212|NCT00151775|1230981|P10|Period 4: Open Label|Physician Decision|2
387213|NCT00151775|1230982|P9|Period 4: Open Label|Physician Decision|0
387214|NCT00151775|1230983|P8|Period 4: Open Label|Physician Decision|0
387215|NCT00151775|1230984|P7|Period 4: Open Label|Physician Decision|0
387216|NCT00151775|1230985|P6|Period 4: Open Label|Physician Decision|0
387217|NCT00151775|1230986|P5|Period 4: Open Label|Physician Decision|0
387218|NCT00151775|1230987|P4|Period 4: Open Label|Physician Decision|0
387219|NCT00151775|1230988|P3|Period 4: Open Label|Physician Decision|0
387220|NCT00151775|1230989|P2|Period 4: Open Label|Physician Decision|0
387221|NCT00151775|1230990|P1|Period 4: Open Label|Physician Decision|0
387222|NCT00151775|1230979|P12|Period 4: Open Label|Other|0
387223|NCT00151775|1230980|P11|Period 4: Open Label|Other|0
387224|NCT00151775|1230981|P10|Period 4: Open Label|Other|3
387225|NCT00151775|1230982|P9|Period 4: Open Label|Other|0
387226|NCT00151775|1230983|P8|Period 4: Open Label|Other|0
387227|NCT00151775|1230984|P7|Period 4: Open Label|Other|0
387228|NCT00151775|1230985|P6|Period 4: Open Label|Other|0
387229|NCT00151775|1230986|P5|Period 4: Open Label|Other|1
387230|NCT00151775|1230987|P4|Period 4: Open Label|Other|0
387231|NCT00151775|1230988|P3|Period 4: Open Label|Other|0
387232|NCT00151775|1230989|P2|Period 4: Open Label|Other|0
387233|NCT00151775|1230990|P1|Period 4: Open Label|Other|0
387234|NCT00151775|1230979|P12|Period 4: Open Label|Non-compliance with protocol|0
387235|NCT00151775|1230980|P11|Period 4: Open Label|Non-compliance with protocol|0
387236|NCT00151775|1230981|P10|Period 4: Open Label|Non-compliance with protocol|4
387237|NCT00151775|1230982|P9|Period 4: Open Label|Non-compliance with protocol|0
387238|NCT00151775|1230983|P8|Period 4: Open Label|Non-compliance with protocol|0
387239|NCT00151775|1230984|P7|Period 4: Open Label|Non-compliance with protocol|0
387240|NCT00151775|1230985|P6|Period 4: Open Label|Non-compliance with protocol|0
387241|NCT00151775|1230986|P5|Period 4: Open Label|Non-compliance with protocol|4
387242|NCT00151775|1230987|P4|Period 4: Open Label|Non-compliance with protocol|0
387243|NCT00151775|1230988|P3|Period 4: Open Label|Non-compliance with protocol|0
387244|NCT00151775|1230989|P2|Period 4: Open Label|Non-compliance with protocol|0
387245|NCT00151775|1230990|P1|Period 4: Open Label|Non-compliance with protocol|0
387246|NCT00151775|1230979|P12|Period 4: Open Label|Lost to Follow-up|0
387247|NCT00151775|1230980|P11|Period 4: Open Label|Lost to Follow-up|0
387248|NCT00151775|1230981|P10|Period 4: Open Label|Lost to Follow-up|7
387249|NCT00151775|1230982|P9|Period 4: Open Label|Lost to Follow-up|0
387250|NCT00151775|1230983|P8|Period 4: Open Label|Lost to Follow-up|0
387251|NCT00151775|1230984|P7|Period 4: Open Label|Lost to Follow-up|0
387252|NCT00151775|1230985|P6|Period 4: Open Label|Lost to Follow-up|0
387253|NCT00151775|1230986|P5|Period 4: Open Label|Lost to Follow-up|17
387254|NCT00151775|1230987|P4|Period 4: Open Label|Lost to Follow-up|0
387255|NCT00151775|1230988|P3|Period 4: Open Label|Lost to Follow-up|0
387256|NCT00151775|1230989|P2|Period 4: Open Label|Lost to Follow-up|0
387257|NCT00151775|1230990|P1|Period 4: Open Label|Lost to Follow-up|0
387258|NCT00151775|1230979|P12|Period 4: Open Label|Adverse Event|0
387259|NCT00151775|1230980|P11|Period 4: Open Label|Adverse Event|0
387260|NCT00151775|1230981|P10|Period 4: Open Label|Adverse Event|2
387261|NCT00151775|1230982|P9|Period 4: Open Label|Adverse Event|0
387262|NCT00151775|1230983|P8|Period 4: Open Label|Adverse Event|0
387263|NCT00151775|1230984|P7|Period 4: Open Label|Adverse Event|0
387264|NCT00151775|1230985|P6|Period 4: Open Label|Adverse Event|0
387265|NCT00151775|1230986|P5|Period 4: Open Label|Adverse Event|1
387266|NCT00151775|1230987|P4|Period 4: Open Label|Adverse Event|0
387267|NCT00151775|1230988|P3|Period 4: Open Label|Adverse Event|0
387268|NCT00151775|1230989|P2|Period 4: Open Label|Adverse Event|0
387269|NCT00151775|1230990|P1|Period 4: Open Label|Adverse Event|0
387270|NCT00151775|1230979|P12|Period 4: Open Label|Withdrawal by Subject|0
387271|NCT00151775|1230980|P11|Period 4: Open Label|Withdrawal by Subject|0
387272|NCT00151775|1230981|P10|Period 4: Open Label|Withdrawal by Subject|2
387273|NCT00151775|1230982|P9|Period 4: Open Label|Withdrawal by Subject|0
387274|NCT00151775|1230983|P8|Period 4: Open Label|Withdrawal by Subject|0
387275|NCT00151775|1230984|P7|Period 4: Open Label|Withdrawal by Subject|0
387276|NCT00151775|1230985|P6|Period 4: Open Label|Withdrawal by Subject|0
387277|NCT00151775|1230986|P5|Period 4: Open Label|Withdrawal by Subject|5
387278|NCT00151775|1230987|P4|Period 4: Open Label|Withdrawal by Subject|0
387279|NCT00151775|1230988|P3|Period 4: Open Label|Withdrawal by Subject|0
387280|NCT00151775|1230989|P2|Period 4: Open Label|Withdrawal by Subject|0
387281|NCT00151775|1230990|P1|Period 4: Open Label|Withdrawal by Subject|0
387282|NCT00151775|1230979|P12|Period 4: Open Label|Increased blood pressure|0
387283|NCT00151775|1230980|P11|Period 4: Open Label|Increased blood pressure|0
387284|NCT00151775|1230981|P10|Period 4: Open Label|Increased blood pressure|1
387285|NCT00151775|1230982|P9|Period 4: Open Label|Increased blood pressure|0
387286|NCT00151775|1230983|P8|Period 4: Open Label|Increased blood pressure|0
387287|NCT00151775|1230984|P7|Period 4: Open Label|Increased blood pressure|0
387288|NCT00151775|1230985|P6|Period 4: Open Label|Increased blood pressure|0
387289|NCT00151775|1230986|P5|Period 4: Open Label|Increased blood pressure|1
387290|NCT00151775|1230987|P4|Period 4: Open Label|Increased blood pressure|0
387291|NCT00151775|1230988|P3|Period 4: Open Label|Increased blood pressure|0
387292|NCT00151775|1230989|P2|Period 4: Open Label|Increased blood pressure|0
387293|NCT00151775|1230990|P1|Period 4: Open Label|Increased blood pressure|0
387294|NCT00151775|1230979|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
387295|NCT00151775|1230980|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387296|NCT00151775|1230981|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387297|NCT00151775|1230982|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387298|NCT00151775|1230983|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387299|NCT00151775|1230984|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387300|NCT00151775|1230985|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387301|NCT00151775|1230986|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387302|NCT00151775|1230987|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387303|NCT00151775|1230988|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387304|NCT00151775|1230989|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387305|NCT00151775|1230990|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
387306|NCT00151775|1230979|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387307|NCT00151775|1230980|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387452|NCT00151476|1231034|P2|FAP Analyzed Subjects|Lost to Follow-up|2
387308|NCT00151775|1230981|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387309|NCT00151775|1230982|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387310|NCT00151775|1230983|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387311|NCT00151775|1230984|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387312|NCT00151775|1230985|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387313|NCT00151775|1230986|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387314|NCT00151775|1230987|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387315|NCT00151775|1230988|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
387316|NCT00151775|1230989|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387317|NCT00151775|1230990|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
387318|NCT00151775|1230979|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
387319|NCT00151775|1230980|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
387320|NCT00151775|1230981|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
387321|NCT00151775|1230982|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
387322|NCT00151775|1230983|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
387323|NCT00151775|1230984|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
387324|NCT00151775|1230985|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
387325|NCT00151775|1230986|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
387326|NCT00151775|1230987|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
387327|NCT00151775|1230988|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
387328|NCT00151775|1230989|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
387329|NCT00151775|1230990|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
387330|NCT00151775|1230979|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387331|NCT00151775|1230980|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387332|NCT00151775|1230981|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387333|NCT00151775|1230982|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387334|NCT00151775|1230983|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387335|NCT00151775|1230984|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
387336|NCT00151775|1230985|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387337|NCT00151775|1230986|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387338|NCT00151775|1230987|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387339|NCT00151775|1230988|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387340|NCT00151775|1230989|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387341|NCT00151775|1230990|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
387342|NCT00151775|1230979|P12|Period 3: Double-blind, Withdrawal|Other|0
387343|NCT00151775|1230980|P11|Period 3: Double-blind, Withdrawal|Other|0
387344|NCT00151775|1230981|P10|Period 3: Double-blind, Withdrawal|Other|0
387345|NCT00151775|1230982|P9|Period 3: Double-blind, Withdrawal|Other|0
387346|NCT00151775|1230983|P8|Period 3: Double-blind, Withdrawal|Other|1
387347|NCT00151775|1230984|P7|Period 3: Double-blind, Withdrawal|Other|0
387348|NCT00151775|1230985|P6|Period 3: Double-blind, Withdrawal|Other|0
387349|NCT00151775|1230986|P5|Period 3: Double-blind, Withdrawal|Other|0
387350|NCT00151775|1230987|P4|Period 3: Double-blind, Withdrawal|Other|0
387351|NCT00151775|1230988|P3|Period 3: Double-blind, Withdrawal|Other|1
387352|NCT00151775|1230989|P2|Period 3: Double-blind, Withdrawal|Other|0
387353|NCT00151775|1230990|P1|Period 3: Double-blind, Withdrawal|Other|0
387354|NCT00151775|1230979|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387355|NCT00151775|1230980|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387356|NCT00151775|1230981|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387357|NCT00151775|1230982|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387358|NCT00151775|1230983|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387359|NCT00151775|1230984|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387360|NCT00151775|1230985|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
387361|NCT00151775|1230986|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387362|NCT00151775|1230987|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387363|NCT00151775|1230988|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387364|NCT00151775|1230989|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387365|NCT00151775|1230990|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
387366|NCT00151775|1230979|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387367|NCT00151775|1230980|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387368|NCT00151775|1230981|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387369|NCT00151775|1230982|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387370|NCT00151775|1230983|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387371|NCT00151775|1230984|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
387372|NCT00151775|1230985|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387373|NCT00151775|1230986|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387374|NCT00151775|1230987|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387375|NCT00151775|1230988|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387376|NCT00151775|1230989|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387377|NCT00151775|1230990|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
387378|NCT00151775|1230979|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
387379|NCT00151775|1230980|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
387380|NCT00151775|1230981|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
387381|NCT00151775|1230982|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
387382|NCT00151775|1230983|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
387383|NCT00151775|1230984|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
387384|NCT00151775|1230985|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
387385|NCT00151775|1230986|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
387386|NCT00151775|1230987|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
387387|NCT00151775|1230988|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
387388|NCT00151775|1230989|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
387389|NCT00151775|1230990|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
387390|NCT00151775|1230979|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
387391|NCT00151775|1230980|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
387392|NCT00151775|1230981|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
387470|NCT00151372|1231101|P2|Overall Study|Death|11
387393|NCT00151775|1230982|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
387394|NCT00151775|1230983|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
387395|NCT00151775|1230984|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
387396|NCT00151775|1230985|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
387397|NCT00151775|1230986|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
387398|NCT00151775|1230987|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
387399|NCT00151775|1230988|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
387400|NCT00151775|1230989|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
387401|NCT00151775|1230990|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
387402|NCT00151775|1230979|P12|Period 2 - Double-Blind Dose Response|Other|0
387403|NCT00151775|1230980|P11|Period 2 - Double-Blind Dose Response|Other|0
387404|NCT00151775|1230981|P10|Period 2 - Double-Blind Dose Response|Other|0
387405|NCT00151775|1230982|P9|Period 2 - Double-Blind Dose Response|Other|0
387406|NCT00151775|1230983|P8|Period 2 - Double-Blind Dose Response|Other|0
387407|NCT00151775|1230984|P7|Period 2 - Double-Blind Dose Response|Other|1
387408|NCT00151775|1230985|P6|Period 2 - Double-Blind Dose Response|Other|0
387409|NCT00151775|1230986|P5|Period 2 - Double-Blind Dose Response|Other|0
387410|NCT00151775|1230987|P4|Period 2 - Double-Blind Dose Response|Other|0
387411|NCT00151775|1230988|P3|Period 2 - Double-Blind Dose Response|Other|0
387412|NCT00151775|1230989|P2|Period 2 - Double-Blind Dose Response|Other|0
387413|NCT00151775|1230990|P1|Period 2 - Double-Blind Dose Response|Other|0
387414|NCT00151775|1230979|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387415|NCT00151775|1230980|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387416|NCT00151775|1230981|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387417|NCT00151775|1230982|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387418|NCT00151775|1230983|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387419|NCT00151775|1230984|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387420|NCT00151775|1230985|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387421|NCT00151775|1230986|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387422|NCT00151775|1230987|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387423|NCT00151775|1230988|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387424|NCT00151775|1230989|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
387425|NCT00151775|1230990|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
387426|NCT00151775|1230979|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
387427|NCT00151775|1230980|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
387428|NCT00151775|1230981|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
387429|NCT00151775|1230982|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
387430|NCT00151775|1230983|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
387431|NCT00151775|1230984|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
387432|NCT00151775|1230985|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
387433|NCT00151775|1230986|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
387434|NCT00151775|1230987|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
387435|NCT00151775|1230988|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
387436|NCT00151775|1230989|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
387437|NCT00151775|1230990|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
387438|NCT00151775|1230979|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
387439|NCT00151775|1230980|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
387440|NCT00151775|1230981|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
387441|NCT00151775|1230982|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
387442|NCT00151775|1230983|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
387443|NCT00151775|1230984|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
387444|NCT00151775|1230985|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
387445|NCT00151775|1230986|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
387446|NCT00151775|1230987|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
387447|NCT00151775|1230988|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
387448|NCT00151775|1230989|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
387449|NCT00151775|1230990|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
387450|NCT00151476|1231034|P2|FAP Analyzed Subjects|Other study participation|1
387451|NCT00151476|1231035|P1|FAP Analyzed Subjects|Other study participation|0
387453|NCT00151476|1231035|P1|FAP Analyzed Subjects|Lost to Follow-up|0
387454|NCT00151476|1231034|P2|FAP Identified Subjects|Protocol Violation|1
387455|NCT00151476|1231035|P1|FAP Identified Subjects|Protocol Violation|0
387456|NCT00151411|1231092|P2|Overall Study|Pregnancy|4
387457|NCT00151411|1231093|P1|Overall Study|Pregnancy|0
387458|NCT00151411|1231092|P2|Overall Study|Adverse Event|0
387459|NCT00151411|1231093|P1|Overall Study|Adverse Event|6
387460|NCT00151411|1231092|P2|Overall Study|Withdrawal by Subject|20
387461|NCT00151411|1231093|P1|Overall Study|Withdrawal by Subject|12
387462|NCT00151411|1231092|P2|Overall Study|Lost to Follow-up|19
387463|NCT00151411|1231093|P1|Overall Study|Lost to Follow-up|15
387464|NCT00151372|1231101|P2|Overall Study|Withdrawal by Subject|7
387465|NCT00151372|1231102|P1|Overall Study|Withdrawal by Subject|7
387466|NCT00151372|1231101|P2|Overall Study|Too sick medically to continue|6
387467|NCT00151372|1231102|P1|Overall Study|Too sick medically to continue|5
387468|NCT00151372|1231101|P2|Overall Study|Lost to Follow-up|5
387469|NCT00151372|1231102|P1|Overall Study|Lost to Follow-up|5
387471|NCT00151372|1231102|P1|Overall Study|Death|12
387472|NCT00150969|1231119|P2|24-48 Month Extension|Other Reason|91
387473|NCT00150969|1231120|P1|24-48 Month Extension|Other Reason|81
387474|NCT00150969|1231119|P2|24-48 Month Extension|Adverse Event|3
387475|NCT00150969|1231120|P1|24-48 Month Extension|Adverse Event|1
387476|NCT00150969|1231119|P2|24-48 Month Extension|Lack of Efficacy|1
387477|NCT00150969|1231120|P1|24-48 Month Extension|Lack of Efficacy|0
387478|NCT00150969|1231119|P2|24-48 Month Extension|Withdrawal by Subject|5
387479|NCT00150969|1231120|P1|24-48 Month Extension|Withdrawal by Subject|6
387480|NCT00150969|1231119|P2|24 Month Main Study|Withdrawal by Subject|4
387481|NCT00150969|1231120|P1|24 Month Main Study|Withdrawal by Subject|7
387482|NCT00150969|1231119|P2|24 Month Main Study|Protocol Violation|2
387483|NCT00150969|1231120|P1|24 Month Main Study|Protocol Violation|4
387484|NCT00150969|1231119|P2|24 Month Main Study|Lost to Follow-up|2
387485|NCT00150969|1231120|P1|24 Month Main Study|Lost to Follow-up|3
387486|NCT00150969|1231119|P2|24 Month Main Study|Lack of Efficacy|8
387487|NCT00150969|1231120|P1|24 Month Main Study|Lack of Efficacy|1
387488|NCT00150969|1231119|P2|24 Month Main Study|Death|1
387489|NCT00150969|1231120|P1|24 Month Main Study|Death|1
387490|NCT00150969|1231119|P2|24 Month Main Study|Adverse Event|4
387491|NCT00150969|1231120|P1|24 Month Main Study|Adverse Event|3
387492|NCT00150618|1231157|P5|Overall Study|Sponsor's decision|0
387493|NCT00150618|1231158|P4|Overall Study|Sponsor's decision|1
387494|NCT00150618|1231159|P3|Overall Study|Sponsor's decision|0
387495|NCT00150618|1231160|P2|Overall Study|Sponsor's decision|0
387496|NCT00150618|1231161|P1|Overall Study|Sponsor's decision|0
387497|NCT00150618|1231157|P5|Overall Study|Abnormal ECG|0
387498|NCT00150618|1231158|P4|Overall Study|Abnormal ECG|0
387499|NCT00150618|1231159|P3|Overall Study|Abnormal ECG|0
387500|NCT00150618|1231160|P2|Overall Study|Abnormal ECG|0
387501|NCT00150618|1231161|P1|Overall Study|Abnormal ECG|1
387502|NCT00150618|1231157|P5|Overall Study|Lack of compliance|1
387503|NCT00150618|1231158|P4|Overall Study|Lack of compliance|0
387504|NCT00150618|1231159|P3|Overall Study|Lack of compliance|1
387505|NCT00150618|1231160|P2|Overall Study|Lack of compliance|1
387506|NCT00150618|1231161|P1|Overall Study|Lack of compliance|2
387507|NCT00150618|1231157|P5|Overall Study|Physician Decision|1
387508|NCT00150618|1231158|P4|Overall Study|Physician Decision|0
387509|NCT00150618|1231159|P3|Overall Study|Physician Decision|0
387510|NCT00150618|1231160|P2|Overall Study|Physician Decision|2
387511|NCT00150618|1231161|P1|Overall Study|Physician Decision|0
387512|NCT00150618|1231157|P5|Overall Study|No study meds|2
387513|NCT00150618|1231158|P4|Overall Study|No study meds|0
387514|NCT00150618|1231159|P3|Overall Study|No study meds|0
387515|NCT00150618|1231160|P2|Overall Study|No study meds|0
387516|NCT00150618|1231161|P1|Overall Study|No study meds|0
387517|NCT00150618|1231157|P5|Overall Study|Lack of Efficacy|6
387518|NCT00150618|1231158|P4|Overall Study|Lack of Efficacy|4
387519|NCT00150618|1231159|P3|Overall Study|Lack of Efficacy|7
387520|NCT00150618|1231160|P2|Overall Study|Lack of Efficacy|4
387521|NCT00150618|1231161|P1|Overall Study|Lack of Efficacy|1
387522|NCT00150618|1231157|P5|Overall Study|Protocol Violation|1
387523|NCT00150618|1231158|P4|Overall Study|Protocol Violation|0
387524|NCT00150618|1231159|P3|Overall Study|Protocol Violation|0
387525|NCT00150618|1231160|P2|Overall Study|Protocol Violation|0
387526|NCT00150618|1231161|P1|Overall Study|Protocol Violation|1
387527|NCT00150618|1231157|P5|Overall Study|Lost to Follow-up|4
387528|NCT00150618|1231158|P4|Overall Study|Lost to Follow-up|8
387529|NCT00150618|1231159|P3|Overall Study|Lost to Follow-up|5
387530|NCT00150618|1231160|P2|Overall Study|Lost to Follow-up|1
387531|NCT00150618|1231161|P1|Overall Study|Lost to Follow-up|4
387532|NCT00150618|1231157|P5|Overall Study|Withdrawal by Subject|5
387533|NCT00150618|1231158|P4|Overall Study|Withdrawal by Subject|4
387534|NCT00150618|1231159|P3|Overall Study|Withdrawal by Subject|8
387535|NCT00150618|1231160|P2|Overall Study|Withdrawal by Subject|8
387536|NCT00150618|1231161|P1|Overall Study|Withdrawal by Subject|6
387537|NCT00150618|1231157|P5|Overall Study|Adverse Event|5
387538|NCT00150618|1231158|P4|Overall Study|Adverse Event|9
387539|NCT00150618|1231159|P3|Overall Study|Adverse Event|6
387540|NCT00150618|1231160|P2|Overall Study|Adverse Event|2
387541|NCT00150618|1231161|P1|Overall Study|Adverse Event|2
387542|NCT00150592|1231195|P2|Overall Study|Non-compliance|0
387543|NCT00150592|1231196|P1|Overall Study|Non-compliance|1
387544|NCT00150592|1231195|P2|Overall Study|Withdrawal by Subject|2
387545|NCT00150592|1231196|P1|Overall Study|Withdrawal by Subject|1
387546|NCT00150592|1231195|P2|Overall Study|Protocol Violation|0
387547|NCT00150592|1231196|P1|Overall Study|Protocol Violation|1
387548|NCT00150592|1231195|P2|Overall Study|Adverse Event|1
387549|NCT00150592|1231196|P1|Overall Study|Adverse Event|4
387550|NCT00150462|1231227|P11|Overall Study|Other|1
387551|NCT00150462|1231228|P10|Overall Study|Other|1
387552|NCT00150462|1231229|P9|Overall Study|Other|0
387553|NCT00150462|1231230|P8|Overall Study|Other|0
387554|NCT00150462|1231231|P7|Overall Study|Other|0
387555|NCT00150462|1231232|P6|Overall Study|Other|0
387556|NCT00150462|1231233|P5|Overall Study|Other|0
387557|NCT00150462|1231234|P4|Overall Study|Other|0
387558|NCT00150462|1231235|P3|Overall Study|Other|0
387559|NCT00150462|1231236|P2|Overall Study|Other|0
387560|NCT00150462|1231237|P1|Overall Study|Other|0
387561|NCT00150462|1231227|P11|Overall Study|Physician Decision|0
387562|NCT00150462|1231228|P10|Overall Study|Physician Decision|0
387563|NCT00150462|1231229|P9|Overall Study|Physician Decision|0
387564|NCT00150462|1231230|P8|Overall Study|Physician Decision|0
387565|NCT00150462|1231231|P7|Overall Study|Physician Decision|0
387566|NCT00150462|1231232|P6|Overall Study|Physician Decision|0
387567|NCT00150462|1231233|P5|Overall Study|Physician Decision|0
387568|NCT00150462|1231234|P4|Overall Study|Physician Decision|1
387569|NCT00150462|1231235|P3|Overall Study|Physician Decision|1
387570|NCT00150462|1231236|P2|Overall Study|Physician Decision|0
387571|NCT00150462|1231237|P1|Overall Study|Physician Decision|0
387572|NCT00150462|1231227|P11|Overall Study|Adverse Event|0
387573|NCT00150462|1231228|P10|Overall Study|Adverse Event|1
387574|NCT00150462|1231229|P9|Overall Study|Adverse Event|0
387575|NCT00150462|1231230|P8|Overall Study|Adverse Event|2
387576|NCT00150462|1231231|P7|Overall Study|Adverse Event|0
387577|NCT00150462|1231232|P6|Overall Study|Adverse Event|0
387578|NCT00150462|1231233|P5|Overall Study|Adverse Event|0
387579|NCT00150462|1231234|P4|Overall Study|Adverse Event|1
387580|NCT00150462|1231235|P3|Overall Study|Adverse Event|0
387581|NCT00150462|1231236|P2|Overall Study|Adverse Event|0
387582|NCT00150462|1231237|P1|Overall Study|Adverse Event|0
387583|NCT00150462|1231227|P11|Overall Study|Death|0
387584|NCT00150462|1231228|P10|Overall Study|Death|0
387585|NCT00150462|1231229|P9|Overall Study|Death|1
387586|NCT00150462|1231230|P8|Overall Study|Death|0
387587|NCT00150462|1231231|P7|Overall Study|Death|0
387588|NCT00150462|1231232|P6|Overall Study|Death|0
387589|NCT00150462|1231233|P5|Overall Study|Death|0
387590|NCT00150462|1231234|P4|Overall Study|Death|0
387591|NCT00150462|1231235|P3|Overall Study|Death|0
387592|NCT00150462|1231236|P2|Overall Study|Death|1
387593|NCT00150462|1231237|P1|Overall Study|Death|0
387594|NCT00150462|1231227|P11|Overall Study|Withdrawal by Subject|0
387595|NCT00150462|1231228|P10|Overall Study|Withdrawal by Subject|1
387596|NCT00150462|1231229|P9|Overall Study|Withdrawal by Subject|0
387597|NCT00150462|1231230|P8|Overall Study|Withdrawal by Subject|1
387598|NCT00150462|1231231|P7|Overall Study|Withdrawal by Subject|0
387599|NCT00150462|1231232|P6|Overall Study|Withdrawal by Subject|2
387600|NCT00150462|1231233|P5|Overall Study|Withdrawal by Subject|1
387601|NCT00150462|1231234|P4|Overall Study|Withdrawal by Subject|0
387602|NCT00150462|1231235|P3|Overall Study|Withdrawal by Subject|1
387603|NCT00150462|1231236|P2|Overall Study|Withdrawal by Subject|1
387604|NCT00150462|1231237|P1|Overall Study|Withdrawal by Subject|0
387605|NCT00150462|1231227|P11|Overall Study|Disease Progression or Relapse|2
387606|NCT00150462|1231228|P10|Overall Study|Disease Progression or Relapse|3
387607|NCT00150462|1231229|P9|Overall Study|Disease Progression or Relapse|5
387608|NCT00150462|1231230|P8|Overall Study|Disease Progression or Relapse|5
387609|NCT00150462|1231231|P7|Overall Study|Disease Progression or Relapse|3
387610|NCT00150462|1231232|P6|Overall Study|Disease Progression or Relapse|2
387611|NCT00150462|1231233|P5|Overall Study|Disease Progression or Relapse|2
387612|NCT00150462|1231234|P4|Overall Study|Disease Progression or Relapse|1
387613|NCT00150462|1231235|P3|Overall Study|Disease Progression or Relapse|2
387614|NCT00150462|1231236|P2|Overall Study|Disease Progression or Relapse|1
387615|NCT00150462|1231237|P1|Overall Study|Disease Progression or Relapse|3
387616|NCT00150345|1231347|P2|Overall Study|Unspecified|14
387617|NCT00150345|1231348|P1|Overall Study|Unspecified|12
387618|NCT00150345|1231347|P2|Overall Study|Laboratory abnormality|2
387619|NCT00150345|1231348|P1|Overall Study|Laboratory abnormality|1
387620|NCT00150345|1231347|P2|Overall Study|Withdrawal by Subject|4
387621|NCT00150345|1231348|P1|Overall Study|Withdrawal by Subject|3
387622|NCT00150345|1231347|P2|Overall Study|Lack of Efficacy|4
387623|NCT00150345|1231348|P1|Overall Study|Lack of Efficacy|5
387624|NCT00150345|1231347|P2|Overall Study|Adverse Event|6
387625|NCT00150345|1231348|P1|Overall Study|Adverse Event|8
387626|NCT00150345|1231347|P2|Overall Study|Death|2
387627|NCT00150345|1231348|P1|Overall Study|Death|5
387628|NCT00150176|1231412|P2|Overall Study|OTHER|13
387629|NCT00150176|1231413|P1|Overall Study|OTHER|11
387630|NCT00150176|1231412|P2|Overall Study|Lost to Follow-up|3
387631|NCT00150176|1231413|P1|Overall Study|Lost to Follow-up|3
387632|NCT00150176|1231412|P2|Overall Study|Withdrawal by Subject|12
387633|NCT00150176|1231413|P1|Overall Study|Withdrawal by Subject|19
387634|NCT00150176|1231412|P2|Overall Study|Relapse/Impending relapse, non-AE|39
387635|NCT00150176|1231413|P1|Overall Study|Relapse/Impending relapse, non-AE|10
387636|NCT00150176|1231412|P2|Overall Study|Adverse Event|53
387637|NCT00150176|1231413|P1|Overall Study|Adverse Event|16
387638|NCT00149994|1231424|P2|Overall Study|Protocol Violation|1
387639|NCT00149994|1231425|P1|Overall Study|Protocol Violation|0
387640|NCT00149994|1231424|P2|Overall Study|Administrative problems:|0
387641|NCT00149994|1231425|P1|Overall Study|Administrative problems:|1
387642|NCT00149890|1231433|P2|Overall Study|Graft Loss|1
387643|NCT00149890|1231434|P1|Overall Study|Graft Loss|2
387644|NCT00149890|1231433|P2|Overall Study|Lost to Follow-up|0
387645|NCT00149890|1231434|P1|Overall Study|Lost to Follow-up|1
387646|NCT00149890|1231433|P2|Overall Study|Protocol Violation|0
387647|NCT00149890|1231434|P1|Overall Study|Protocol Violation|1
387648|NCT00149890|1231433|P2|Overall Study|Lack of Efficacy|9
387649|NCT00149890|1231434|P1|Overall Study|Lack of Efficacy|8
387650|NCT00149890|1231433|P2|Overall Study|Adverse Event|8
387651|NCT00149890|1231434|P1|Overall Study|Adverse Event|1
387652|NCT00149825|1231454|P2|Overall Study|Other|0
387653|NCT00149825|1231455|P1|Overall Study|Other|1
387654|NCT00149825|1231454|P2|Overall Study|Not liking insomnia therapy|0
387655|NCT00149825|1231455|P1|Overall Study|Not liking insomnia therapy|1
387656|NCT00149825|1231454|P2|Overall Study|Time commitments|1
387657|NCT00149825|1231455|P1|Overall Study|Time commitments|2
387658|NCT00149825|1231454|P2|Overall Study|Intolerance to medication side effects|2
387659|NCT00149825|1231455|P1|Overall Study|Intolerance to medication side effects|1
387660|NCT00149747|1231477|P2|Overall Study|Withdrawal by Subject|3
387661|NCT00149747|1231478|P1|Overall Study|Withdrawal by Subject|3
387662|NCT00149747|1231477|P2|Overall Study|Death|0
387663|NCT00149747|1231478|P1|Overall Study|Death|1
387664|NCT00149630|1231503|P2|Overall Study|Adverse Event|0
387665|NCT00149630|1231504|P1|Overall Study|Adverse Event|2
387666|NCT00149630|1231503|P2|Overall Study|Treatment Programs|5
387667|NCT00149630|1231504|P1|Overall Study|Treatment Programs|4
387668|NCT00149630|1231503|P2|Overall Study|Incarceration|0
387669|NCT00149630|1231504|P1|Overall Study|Incarceration|2
387670|NCT00149214|1231543|P2|Overall Study|Progressive Disease|3
387671|NCT00149214|1231544|P1|Overall Study|Progressive Disease|7
387672|NCT00149214|1231543|P2|Overall Study|Sponsor Decision|1
387673|NCT00149214|1231544|P1|Overall Study|Sponsor Decision|0
387674|NCT00149214|1231543|P2|Overall Study|Physician Decision|3
387675|NCT00149214|1231544|P1|Overall Study|Physician Decision|3
387676|NCT00149214|1231543|P2|Overall Study|Withdrawal by Subject|1
387677|NCT00149214|1231544|P1|Overall Study|Withdrawal by Subject|4
387678|NCT00149214|1231543|P2|Overall Study|Adverse Event|9
387679|NCT00149214|1231544|P1|Overall Study|Adverse Event|12
387680|NCT00147238|1231586|P1|Overall Study|Inevaluable|8
387681|NCT00147225|1231596|P6|Overall Study|Chemotherapy Changed|1
387682|NCT00147225|1231597|P5|Overall Study|Chemotherapy Changed|0
387683|NCT00147225|1231598|P4|Overall Study|Chemotherapy Changed|0
387684|NCT00147225|1231599|P3|Overall Study|Chemotherapy Changed|0
387685|NCT00147225|1231600|P2|Overall Study|Chemotherapy Changed|0
387686|NCT00147225|1231601|P1|Overall Study|Chemotherapy Changed|0
387687|NCT00147225|1231596|P6|Overall Study|Screen Failure|0
387688|NCT00147225|1231597|P5|Overall Study|Screen Failure|1
387689|NCT00147225|1231598|P4|Overall Study|Screen Failure|0
387690|NCT00147225|1231599|P3|Overall Study|Screen Failure|0
387691|NCT00147225|1231600|P2|Overall Study|Screen Failure|0
387692|NCT00147225|1231601|P1|Overall Study|Screen Failure|0
387693|NCT00147225|1231596|P6|Overall Study|Adverse Event|0
387694|NCT00147225|1231597|P5|Overall Study|Adverse Event|0
387695|NCT00147225|1231598|P4|Overall Study|Adverse Event|1
387696|NCT00147225|1231599|P3|Overall Study|Adverse Event|1
387697|NCT00147225|1231600|P2|Overall Study|Adverse Event|0
387698|NCT00147225|1231601|P1|Overall Study|Adverse Event|0
387699|NCT00147225|1231596|P6|Overall Study|Withdrawal by Subject|1
387700|NCT00147225|1231597|P5|Overall Study|Withdrawal by Subject|0
387701|NCT00147225|1231598|P4|Overall Study|Withdrawal by Subject|0
387702|NCT00147225|1231599|P3|Overall Study|Withdrawal by Subject|1
387703|NCT00147225|1231600|P2|Overall Study|Withdrawal by Subject|0
387704|NCT00147225|1231601|P1|Overall Study|Withdrawal by Subject|1
387705|NCT00148759|1231675|P2|Overall Study|Lost to Follow-up|0
387706|NCT00148759|1231676|P1|Overall Study|Lost to Follow-up|1
387707|NCT00148759|1231675|P2|Overall Study|Withdrawal by Subject|1
387708|NCT00148759|1231676|P1|Overall Study|Withdrawal by Subject|1
387709|NCT00148122|1231702|P1|Overall Study|Withdrawal by Subject|2
387710|NCT00148109|1231710|P2|Overall Study|Withdrawal by Subject|0
387711|NCT00148109|1231711|P1|Overall Study|Withdrawal by Subject|2
387712|NCT00148109|1231710|P2|Overall Study|Adverse Event|2
387713|NCT00148109|1231711|P1|Overall Study|Adverse Event|0
387714|NCT00148109|1231710|P2|Overall Study|Lack of Efficacy|18
387715|NCT00148109|1231711|P1|Overall Study|Lack of Efficacy|10
387716|NCT00147823|1231778|P2|Overall Study|Did not receive vitoss due to infection|2
387717|NCT00147823|1231779|P1|Overall Study|Did not receive vitoss due to infection|6
387718|NCT00147823|1231778|P2|Overall Study|Withdrawal by Subject|1
387719|NCT00147823|1231779|P1|Overall Study|Withdrawal by Subject|0
387720|NCT00147823|1231778|P2|Overall Study|Physician Decision|0
387721|NCT00147823|1231779|P1|Overall Study|Physician Decision|1
387722|NCT00147823|1231778|P2|Overall Study|Lost to Follow-up|12
387723|NCT00147823|1231779|P1|Overall Study|Lost to Follow-up|6
387724|NCT00147745|1231810|P3|Overall Study|Withdrawal by Subject|0
387725|NCT00147745|1231811|P2|Overall Study|Withdrawal by Subject|0
387726|NCT00147745|1231812|P1|Overall Study|Withdrawal by Subject|1
387727|NCT00147537|1231834|P11|Phase 2|Randomized but not treated|1
387728|NCT00147537|1231835|P10|Phase 2|Randomized but not treated|1
387729|NCT00147537|1231836|P9|Phase 2|Randomized but not treated|0
387730|NCT00147537|1231837|P8|Phase 2|Randomized but not treated|0
387731|NCT00147537|1231838|P7|Phase 2|Randomized but not treated|0
387732|NCT00147537|1231839|P6|Phase 2|Randomized but not treated|0
387733|NCT00147537|1231840|P5|Phase 2|Randomized but not treated|0
387734|NCT00147537|1231841|P4|Phase 2|Randomized but not treated|0
387735|NCT00147537|1231842|P3|Phase 2|Randomized but not treated|0
387736|NCT00147537|1231843|P2|Phase 2|Randomized but not treated|0
387737|NCT00147537|1231844|P1|Phase 2|Randomized but not treated|0
387738|NCT00147537|1231834|P11|Phase 2|Withdrawal by Subject|4
387739|NCT00147537|1231835|P10|Phase 2|Withdrawal by Subject|16
387740|NCT00147537|1231836|P9|Phase 2|Withdrawal by Subject|0
387741|NCT00147537|1231837|P8|Phase 2|Withdrawal by Subject|0
387742|NCT00147537|1231838|P7|Phase 2|Withdrawal by Subject|0
387743|NCT00147537|1231839|P6|Phase 2|Withdrawal by Subject|0
387744|NCT00147537|1231840|P5|Phase 2|Withdrawal by Subject|0
387745|NCT00147537|1231841|P4|Phase 2|Withdrawal by Subject|0
387746|NCT00147537|1231842|P3|Phase 2|Withdrawal by Subject|0
387747|NCT00147537|1231843|P2|Phase 2|Withdrawal by Subject|0
387748|NCT00147537|1231844|P1|Phase 2|Withdrawal by Subject|0
387749|NCT00147537|1231834|P11|Phase 2|unspecified|12
387750|NCT00147537|1231835|P10|Phase 2|unspecified|47
387751|NCT00147537|1231836|P9|Phase 2|unspecified|0
387752|NCT00147537|1231837|P8|Phase 2|unspecified|0
387753|NCT00147537|1231838|P7|Phase 2|unspecified|0
387754|NCT00147537|1231839|P6|Phase 2|unspecified|0
387755|NCT00147537|1231840|P5|Phase 2|unspecified|0
387756|NCT00147537|1231841|P4|Phase 2|unspecified|0
387757|NCT00147537|1231842|P3|Phase 2|unspecified|0
387758|NCT00147537|1231843|P2|Phase 2|unspecified|0
387759|NCT00147537|1231844|P1|Phase 2|unspecified|0
387760|NCT00147537|1231834|P11|Phase 2|Lost to Follow-up|4
387761|NCT00147537|1231835|P10|Phase 2|Lost to Follow-up|12
387762|NCT00147537|1231836|P9|Phase 2|Lost to Follow-up|0
387763|NCT00147537|1231837|P8|Phase 2|Lost to Follow-up|0
387764|NCT00147537|1231838|P7|Phase 2|Lost to Follow-up|0
387765|NCT00147537|1231839|P6|Phase 2|Lost to Follow-up|0
387766|NCT00147537|1231840|P5|Phase 2|Lost to Follow-up|0
387767|NCT00147537|1231841|P4|Phase 2|Lost to Follow-up|0
387768|NCT00147537|1231842|P3|Phase 2|Lost to Follow-up|0
387769|NCT00147537|1231843|P2|Phase 2|Lost to Follow-up|0
387770|NCT00147537|1231844|P1|Phase 2|Lost to Follow-up|0
387771|NCT00147537|1231834|P11|Phase 2|Death|31
387772|NCT00147537|1231835|P10|Phase 2|Death|85
387773|NCT00147537|1231836|P9|Phase 2|Death|0
387774|NCT00147537|1231837|P8|Phase 2|Death|0
387775|NCT00147537|1231838|P7|Phase 2|Death|0
387776|NCT00147537|1231839|P6|Phase 2|Death|0
387777|NCT00147537|1231840|P5|Phase 2|Death|0
387778|NCT00147537|1231841|P4|Phase 2|Death|0
387779|NCT00147537|1231842|P3|Phase 2|Death|0
387780|NCT00147537|1231843|P2|Phase 2|Death|0
387781|NCT00147537|1231844|P1|Phase 2|Death|0
387782|NCT00147537|1231834|P11|Phase 1b|Randomized but not treated|0
387783|NCT00147537|1231835|P10|Phase 1b|Randomized but not treated|0
387784|NCT00147537|1231836|P9|Phase 1b|Randomized but not treated|1
387785|NCT00147537|1231837|P8|Phase 1b|Randomized but not treated|0
387786|NCT00147537|1231838|P7|Phase 1b|Randomized but not treated|1
387787|NCT00147537|1231839|P6|Phase 1b|Randomized but not treated|0
387788|NCT00147537|1231840|P5|Phase 1b|Randomized but not treated|0
387789|NCT00147537|1231841|P4|Phase 1b|Randomized but not treated|0
387790|NCT00147537|1231842|P3|Phase 1b|Randomized but not treated|0
387791|NCT00147537|1231843|P2|Phase 1b|Randomized but not treated|0
387792|NCT00147537|1231844|P1|Phase 1b|Randomized but not treated|0
387793|NCT00147537|1231834|P11|Phase 1b|Withdrawal by Subject|0
387794|NCT00147537|1231835|P10|Phase 1b|Withdrawal by Subject|0
387795|NCT00147537|1231836|P9|Phase 1b|Withdrawal by Subject|2
387796|NCT00147537|1231837|P8|Phase 1b|Withdrawal by Subject|0
387797|NCT00147537|1231838|P7|Phase 1b|Withdrawal by Subject|0
387798|NCT00147537|1231839|P6|Phase 1b|Withdrawal by Subject|0
387799|NCT00147537|1231840|P5|Phase 1b|Withdrawal by Subject|0
387800|NCT00147537|1231841|P4|Phase 1b|Withdrawal by Subject|0
387801|NCT00147537|1231842|P3|Phase 1b|Withdrawal by Subject|0
387802|NCT00147537|1231843|P2|Phase 1b|Withdrawal by Subject|0
387803|NCT00147537|1231844|P1|Phase 1b|Withdrawal by Subject|0
387804|NCT00147537|1231834|P11|Phase 1b|unspecified|0
387805|NCT00147537|1231835|P10|Phase 1b|unspecified|0
387806|NCT00147537|1231836|P9|Phase 1b|unspecified|4
387807|NCT00147537|1231837|P8|Phase 1b|unspecified|4
387808|NCT00147537|1231838|P7|Phase 1b|unspecified|14
387809|NCT00147537|1231839|P6|Phase 1b|unspecified|1
387810|NCT00147537|1231840|P5|Phase 1b|unspecified|1
387811|NCT00147537|1231841|P4|Phase 1b|unspecified|1
387812|NCT00147537|1231842|P3|Phase 1b|unspecified|2
387813|NCT00147537|1231843|P2|Phase 1b|unspecified|0
387814|NCT00147537|1231844|P1|Phase 1b|unspecified|0
387815|NCT00147537|1231834|P11|Phase 1b|Lost to Follow-up|0
387816|NCT00147537|1231835|P10|Phase 1b|Lost to Follow-up|0
387817|NCT00147537|1231836|P9|Phase 1b|Lost to Follow-up|1
387818|NCT00147537|1231837|P8|Phase 1b|Lost to Follow-up|0
387819|NCT00147537|1231838|P7|Phase 1b|Lost to Follow-up|2
387820|NCT00147537|1231839|P6|Phase 1b|Lost to Follow-up|0
387821|NCT00147537|1231840|P5|Phase 1b|Lost to Follow-up|0
387822|NCT00147537|1231841|P4|Phase 1b|Lost to Follow-up|0
387823|NCT00147537|1231842|P3|Phase 1b|Lost to Follow-up|0
387824|NCT00147537|1231843|P2|Phase 1b|Lost to Follow-up|1
387825|NCT00147537|1231844|P1|Phase 1b|Lost to Follow-up|2
387826|NCT00147537|1231834|P11|Phase 1b|Death|0
387827|NCT00147537|1231835|P10|Phase 1b|Death|0
387828|NCT00147537|1231836|P9|Phase 1b|Death|9
387829|NCT00147537|1231837|P8|Phase 1b|Death|3
387830|NCT00147537|1231838|P7|Phase 1b|Death|1
387831|NCT00147537|1231839|P6|Phase 1b|Death|2
387832|NCT00147537|1231840|P5|Phase 1b|Death|2
387833|NCT00147537|1231841|P4|Phase 1b|Death|1
387834|NCT00147537|1231842|P3|Phase 1b|Death|2
387835|NCT00147537|1231843|P2|Phase 1b|Death|1
387836|NCT00147537|1231844|P1|Phase 1b|Death|0
387837|NCT00147498|1232027|P4|Overall Study|Unspecified|3
387838|NCT00147498|1232028|P3|Overall Study|Unspecified|3
387839|NCT00147498|1232029|P2|Overall Study|Unspecified|1
387840|NCT00147498|1232030|P1|Overall Study|Unspecified|1
387841|NCT00147498|1232027|P4|Overall Study|Participant defaulted|3
387842|NCT00147498|1232028|P3|Overall Study|Participant defaulted|4
387843|NCT00147498|1232029|P2|Overall Study|Participant defaulted|1
387844|NCT00147498|1232030|P1|Overall Study|Participant defaulted|0
387845|NCT00147498|1232027|P4|Overall Study|Laboratory abnormality|0
387846|NCT00147498|1232028|P3|Overall Study|Laboratory abnormality|2
387847|NCT00147498|1232029|P2|Overall Study|Laboratory abnormality|0
387848|NCT00147498|1232030|P1|Overall Study|Laboratory abnormality|0
387849|NCT00147498|1232027|P4|Overall Study|Lack of Efficacy|8
387850|NCT00147498|1232028|P3|Overall Study|Lack of Efficacy|1
387851|NCT00147498|1232029|P2|Overall Study|Lack of Efficacy|1
387852|NCT00147498|1232030|P1|Overall Study|Lack of Efficacy|1
387853|NCT00147498|1232027|P4|Overall Study|Adverse Event|3
387854|NCT00147498|1232028|P3|Overall Study|Adverse Event|7
387855|NCT00147498|1232029|P2|Overall Study|Adverse Event|6
387856|NCT00147498|1232030|P1|Overall Study|Adverse Event|1
387857|NCT00146848|1232138|P3|Post-randomization|Withdrawn|27
387858|NCT00146848|1232139|P2|Post-randomization|Withdrawn|32
387859|NCT00146848|1232140|P1|Post-randomization|Withdrawn|26
387860|NCT00146848|1232138|P3|Post-randomization|Lost to Follow-up|12
387861|NCT00146848|1232139|P2|Post-randomization|Lost to Follow-up|15
387862|NCT00146848|1232140|P1|Post-randomization|Lost to Follow-up|12
387863|NCT00146848|1232138|P3|Pre-randomization|Withdrawal by Subject|0
387864|NCT00146848|1232139|P2|Pre-randomization|Withdrawal by Subject|0
387865|NCT00146848|1232140|P1|Pre-randomization|Withdrawal by Subject|40
387866|NCT00146848|1232138|P3|Pre-randomization|Protocol Violation|0
387867|NCT00146848|1232139|P2|Pre-randomization|Protocol Violation|0
387868|NCT00146848|1232140|P1|Pre-randomization|Protocol Violation|172
387869|NCT00146848|1232138|P3|Pre-randomization|Physician Decision|0
387870|NCT00146848|1232139|P2|Pre-randomization|Physician Decision|0
387871|NCT00146848|1232140|P1|Pre-randomization|Physician Decision|8
387872|NCT00146848|1232138|P3|Pre-randomization|Lost to Follow-up|0
387873|NCT00146848|1232139|P2|Pre-randomization|Lost to Follow-up|0
387874|NCT00146848|1232140|P1|Pre-randomization|Lost to Follow-up|70
387875|NCT00146848|1232138|P3|Pre-randomization|Death|0
387876|NCT00146848|1232139|P2|Pre-randomization|Death|0
387877|NCT00146848|1232140|P1|Pre-randomization|Death|19
387878|NCT00146770|1232156|P2|Overall Study|Withdrawal by Subject|0
387879|NCT00146770|1232157|P1|Overall Study|Withdrawal by Subject|2
387880|NCT00146770|1232156|P2|Overall Study|Pregnancy|0
387881|NCT00146770|1232157|P1|Overall Study|Pregnancy|1
387882|NCT00146770|1232156|P2|Overall Study|Adverse Event|0
387883|NCT00146770|1232157|P1|Overall Study|Adverse Event|2
387884|NCT00146757|1232175|P2|Overall Study|Adverse Event|0
387885|NCT00146757|1232176|P1|Overall Study|Adverse Event|1
387886|NCT00146757|1232175|P2|Overall Study|Death|0
387887|NCT00146757|1232176|P1|Overall Study|Death|1
387888|NCT00146328|1232196|P3|Overall Study|Interaction with other medication|1
387889|NCT00146328|1232197|P2|Overall Study|Interaction with other medication|0
387890|NCT00146328|1232198|P1|Overall Study|Interaction with other medication|2
387891|NCT00146328|1232196|P3|Overall Study|Moved|0
387892|NCT00146328|1232197|P2|Overall Study|Moved|0
387893|NCT00146328|1232198|P1|Overall Study|Moved|2
387894|NCT00146328|1232196|P3|Overall Study|Death|1
387895|NCT00146328|1232197|P2|Overall Study|Death|1
387896|NCT00146328|1232198|P1|Overall Study|Death|0
387897|NCT00146328|1232196|P3|Overall Study|Enroll into other trial|2
387898|NCT00146328|1232197|P2|Overall Study|Enroll into other trial|4
387899|NCT00146328|1232198|P1|Overall Study|Enroll into other trial|2
387900|NCT00146328|1232196|P3|Overall Study|Patient decision to end|6
387901|NCT00146328|1232197|P2|Overall Study|Patient decision to end|1
387902|NCT00146328|1232198|P1|Overall Study|Patient decision to end|0
387903|NCT00146328|1232196|P3|Overall Study|Trial ended/site closed|19
387904|NCT00146328|1232197|P2|Overall Study|Trial ended/site closed|2
387905|NCT00146328|1232198|P1|Overall Study|Trial ended/site closed|8
387906|NCT00146328|1232196|P3|Overall Study|Virologic Failure/lack of efficacy|142
387907|NCT00146328|1232197|P2|Overall Study|Virologic Failure/lack of efficacy|72
387908|NCT00146328|1232198|P1|Overall Study|Virologic Failure/lack of efficacy|54
387909|NCT00146328|1232196|P3|Overall Study|Withdrawal by Subject|22
387910|NCT00146328|1232197|P2|Overall Study|Withdrawal by Subject|16
387911|NCT00146328|1232198|P1|Overall Study|Withdrawal by Subject|16
387912|NCT00146328|1232196|P3|Overall Study|Lost to Follow-up|7
387913|NCT00146328|1232197|P2|Overall Study|Lost to Follow-up|4
387914|NCT00146328|1232198|P1|Overall Study|Lost to Follow-up|7
387915|NCT00146328|1232196|P3|Overall Study|Protocol Violation|12
387916|NCT00146328|1232197|P2|Overall Study|Protocol Violation|6
387917|NCT00146328|1232198|P1|Overall Study|Protocol Violation|11
387918|NCT00146328|1232196|P3|Overall Study|Adverse Event|79
387919|NCT00146328|1232197|P2|Overall Study|Adverse Event|48
387920|NCT00146328|1232198|P1|Overall Study|Adverse Event|39
387921|NCT00145795|1232283|P2|Overall Study|Adverse Event|0
387922|NCT00145795|1232284|P1|Overall Study|Adverse Event|1
387923|NCT00145626|1232319|P1|Overall Study|Withdrawal by Subject|1
387924|NCT00145626|1232319|P1|Overall Study|Death|1
387925|NCT00145626|1232319|P1|Overall Study|Turned 2 years old before treatment|1
387926|NCT00145626|1232319|P1|Overall Study|Did not have NK infusions|2
387927|NCT00145600|1232351|P4|Overall Study|Withdrawal by Subject|1
387928|NCT00145600|1232352|P3|Overall Study|Withdrawal by Subject|0
387929|NCT00145600|1232353|P2|Overall Study|Withdrawal by Subject|2
387930|NCT00145600|1232354|P1|Overall Study|Withdrawal by Subject|1
387931|NCT00145600|1232351|P4|Overall Study|Noncompliance|0
387932|NCT00145600|1232352|P3|Overall Study|Noncompliance|0
387933|NCT00145600|1232353|P2|Overall Study|Noncompliance|0
387934|NCT00145600|1232354|P1|Overall Study|Noncompliance|1
387935|NCT00145600|1232351|P4|Overall Study|Lost to Follow-up|4
387936|NCT00145600|1232352|P3|Overall Study|Lost to Follow-up|2
387937|NCT00145600|1232353|P2|Overall Study|Lost to Follow-up|6
387938|NCT00145600|1232354|P1|Overall Study|Lost to Follow-up|2
387939|NCT00145600|1232351|P4|Overall Study|Ineligible|5
387940|NCT00145600|1232352|P3|Overall Study|Ineligible|1
387941|NCT00145600|1232353|P2|Overall Study|Ineligible|0
387942|NCT00145600|1232354|P1|Overall Study|Ineligible|3
387943|NCT00145600|1232351|P4|Overall Study|Death|6
387944|NCT00145600|1232352|P3|Overall Study|Death|2
387945|NCT00145600|1232353|P2|Overall Study|Death|2
387946|NCT00145600|1232354|P1|Overall Study|Death|1
387947|NCT00145574|1232478|P3|Open Label Long-term Extension|required restricted medicine|1
387948|NCT00145574|1232479|P2|Open Label Long-term Extension|required restricted medicine|0
387949|NCT00145574|1232480|P1|Open Label Long-term Extension|required restricted medicine|0
387950|NCT00145574|1232478|P3|Open Label Long-term Extension|Withdrawal by Subject|4
387951|NCT00145574|1232479|P2|Open Label Long-term Extension|Withdrawal by Subject|0
387952|NCT00145574|1232480|P1|Open Label Long-term Extension|Withdrawal by Subject|0
387953|NCT00145574|1232478|P3|Open Label Long-term Extension|Lost to Follow-up|1
387954|NCT00145574|1232479|P2|Open Label Long-term Extension|Lost to Follow-up|0
387955|NCT00145574|1232480|P1|Open Label Long-term Extension|Lost to Follow-up|0
387956|NCT00145574|1232478|P3|Open Label Long-term Extension|Adverse Event|5
387957|NCT00145574|1232479|P2|Open Label Long-term Extension|Adverse Event|0
387958|NCT00145574|1232480|P1|Open Label Long-term Extension|Adverse Event|0
387959|NCT00145574|1232478|P3|Double Blind|required restricted medicine|0
387960|NCT00145574|1232479|P2|Double Blind|required restricted medicine|1
387961|NCT00145574|1232480|P1|Double Blind|required restricted medicine|0
387962|NCT00145574|1232478|P3|Double Blind|Withdrawal by Subject|1
387963|NCT00145574|1232479|P2|Double Blind|Withdrawal by Subject|1
387964|NCT00145574|1232480|P1|Double Blind|Withdrawal by Subject|1
387965|NCT00145574|1232478|P3|Double Blind|Adverse Event|1
387966|NCT00145574|1232479|P2|Double Blind|Adverse Event|3
387967|NCT00145574|1232480|P1|Double Blind|Adverse Event|0
387968|NCT00145509|1232537|P2|Overall Study|Reason not provided|1
387969|NCT00145509|1232538|P1|Overall Study|Reason not provided|2
387970|NCT00145509|1232537|P2|Overall Study|Withdrew Consent|7
387971|NCT00145509|1232538|P1|Overall Study|Withdrew Consent|2
387972|NCT00145509|1232537|P2|Overall Study|Lost to Follow-up|9
387973|NCT00145509|1232538|P1|Overall Study|Lost to Follow-up|5
387974|NCT00145509|1232537|P2|Overall Study|Lack of Efficacy|1
387975|NCT00145509|1232538|P1|Overall Study|Lack of Efficacy|3
387976|NCT00145509|1232537|P2|Overall Study|Adverse Event|3
387977|NCT00145509|1232538|P1|Overall Study|Adverse Event|10
387978|NCT00145496|1232552|P2|Overall Study|Other|13
387979|NCT00145496|1232553|P1|Overall Study|Other|25
387980|NCT00145496|1232552|P2|Overall Study|Lost to Follow-up|5
387981|NCT00145496|1232553|P1|Overall Study|Lost to Follow-up|12
387982|NCT00145496|1232552|P2|Overall Study|Withdrawal by Subject|26
387983|NCT00145496|1232553|P1|Overall Study|Withdrawal by Subject|32
387984|NCT00145496|1232552|P2|Overall Study|Lack of Efficacy|7
387985|NCT00145496|1232553|P1|Overall Study|Lack of Efficacy|12
387986|NCT00145496|1232552|P2|Overall Study|Adverse Event|30
387987|NCT00145496|1232553|P1|Overall Study|Adverse Event|42
387988|NCT00145327|1232573|P3|Overall Study|Missing – not stated|1
387989|NCT00145327|1232574|P2|Overall Study|Missing – not stated|0
387990|NCT00145327|1232575|P1|Overall Study|Missing – not stated|1
387991|NCT00145327|1232573|P3|Overall Study|Abnormal laboratory value(s)|2
387992|NCT00145327|1232574|P2|Overall Study|Abnormal laboratory value(s)|0
387993|NCT00145327|1232575|P1|Overall Study|Abnormal laboratory value(s)|1
387994|NCT00145327|1232573|P3|Overall Study|Protocol Violation|2
387995|NCT00145327|1232574|P2|Overall Study|Protocol Violation|0
387996|NCT00145327|1232575|P1|Overall Study|Protocol Violation|2
387997|NCT00145327|1232573|P3|Overall Study|Administrative problems|13
387998|NCT00145327|1232574|P2|Overall Study|Administrative problems|9
387999|NCT00145327|1232575|P1|Overall Study|Administrative problems|12
388000|NCT00145327|1232573|P3|Overall Study|Lost to Follow-up|14
388001|NCT00145327|1232574|P2|Overall Study|Lost to Follow-up|14
388002|NCT00145327|1232575|P1|Overall Study|Lost to Follow-up|9
388003|NCT00145327|1232573|P3|Overall Study|Adverse Event|22
388004|NCT00145327|1232574|P2|Overall Study|Adverse Event|11
388005|NCT00145327|1232575|P1|Overall Study|Adverse Event|14
388006|NCT00145327|1232573|P3|Overall Study|Death|30
388007|NCT00145327|1232574|P2|Overall Study|Death|18
388008|NCT00145327|1232575|P1|Overall Study|Death|26
388009|NCT00145327|1232573|P3|Overall Study|Withdrawal by Subject|164
388010|NCT00145327|1232574|P2|Overall Study|Withdrawal by Subject|72
388011|NCT00145327|1232575|P1|Overall Study|Withdrawal by Subject|77
388012|NCT00145119|1232674|P1|Overall Study|Death|45
388013|NCT00144339|1232680|P2|Overall Study|Other|60
388014|NCT00144339|1232681|P1|Overall Study|Other|58
388015|NCT00144339|1232680|P2|Overall Study|Lost to Follow-up|64
388016|NCT00144339|1232681|P1|Overall Study|Lost to Follow-up|76
388017|NCT00144339|1232680|P2|Overall Study|Withdrawal by Subject|300
388018|NCT00144339|1232681|P1|Overall Study|Withdrawal by Subject|403
388019|NCT00144339|1232680|P2|Overall Study|Protocol Violation|48
388020|NCT00144339|1232681|P1|Overall Study|Protocol Violation|75
388021|NCT00144339|1232680|P2|Overall Study|Adverse Event|627
388022|NCT00144339|1232681|P1|Overall Study|Adverse Event|746
388023|NCT00144300|1232889|P2|Overall Study|Other reason (not specified)|3
388024|NCT00144300|1232890|P1|Overall Study|Other reason (not specified)|1
388025|NCT00144300|1232889|P2|Overall Study|Withdrawal by Subject|6
388026|NCT00144300|1232890|P1|Overall Study|Withdrawal by Subject|6
388027|NCT00144300|1232889|P2|Overall Study|Lost to Follow-up|0
388028|NCT00144300|1232890|P1|Overall Study|Lost to Follow-up|3
388029|NCT00144300|1232889|P2|Overall Study|Protocol Violation|3
388030|NCT00144300|1232890|P1|Overall Study|Protocol Violation|1
388031|NCT00144300|1232889|P2|Overall Study|Adverse Event|16
388032|NCT00144300|1232890|P1|Overall Study|Adverse Event|18
388033|NCT00144781|1232950|P4|Overall Study|Non-compliant|0
388034|NCT00144781|1232951|P3|Overall Study|Non-compliant|0
388035|NCT00144781|1232952|P2|Overall Study|Non-compliant|1
388036|NCT00144781|1232953|P1|Overall Study|Non-compliant|0
388037|NCT00144781|1232950|P4|Overall Study|Adverse Event|0
388038|NCT00144781|1232951|P3|Overall Study|Adverse Event|0
388039|NCT00144781|1232952|P2|Overall Study|Adverse Event|1
388040|NCT00144781|1232953|P1|Overall Study|Adverse Event|0
388041|NCT00144170|1232973|P2|Overall Study|Other reason not defined above|316
388042|NCT00144170|1232974|P1|Overall Study|Other reason not defined above|211
388043|NCT00144170|1232973|P2|Overall Study|Withdrawal by Subject|13
388044|NCT00144170|1232974|P1|Overall Study|Withdrawal by Subject|29
388045|NCT00144170|1232973|P2|Overall Study|Lost to Follow-up|10
388046|NCT00144170|1232974|P1|Overall Study|Lost to Follow-up|5
388047|NCT00144170|1232973|P2|Overall Study|Protocol Violation|16
388048|NCT00144170|1232974|P1|Overall Study|Protocol Violation|23
388049|NCT00144170|1232973|P2|Overall Study|Adverse Event|41
388050|NCT00144170|1232974|P1|Overall Study|Adverse Event|84
388051|NCT00144027|1233164|P2|Overall Study|did not complete baseline assessment|6
388052|NCT00144027|1233165|P1|Overall Study|did not complete baseline assessment|0
388053|NCT00144027|1233164|P2|Overall Study|Withdrawal by Subject|2
388054|NCT00144027|1233165|P1|Overall Study|Withdrawal by Subject|2
388055|NCT00144027|1233164|P2|Overall Study|Lost to Follow-up|3
388056|NCT00144027|1233165|P1|Overall Study|Lost to Follow-up|1
388057|NCT00143598|1233195|P2|Overall Study|Death|36
388058|NCT00143598|1233196|P1|Overall Study|Death|36
388059|NCT00143598|1233195|P2|Overall Study|Withdrawal by Subject|37
388060|NCT00143598|1233196|P1|Overall Study|Withdrawal by Subject|33
388061|NCT00143598|1233195|P2|Overall Study|Lost to Follow-up|21
388062|NCT00143598|1233196|P1|Overall Study|Lost to Follow-up|23
388063|NCT00143507|1233210|P2|Overall Study|Withdrawn by sponsor's decision|3
388064|NCT00143507|1233211|P1|Overall Study|Withdrawn by sponsor's decision|0
388065|NCT00143507|1233210|P2|Overall Study|Lost to Follow-up|0
388066|NCT00143507|1233211|P1|Overall Study|Lost to Follow-up|1
388067|NCT00143507|1233210|P2|Overall Study|Withdrawal by Subject|102
388068|NCT00143507|1233211|P1|Overall Study|Withdrawal by Subject|114
388069|NCT00143507|1233210|P2|Overall Study|Death|547
388070|NCT00143507|1233211|P1|Overall Study|Death|572
388071|NCT00143455|1233245|P4|Cohort 2|Randomized But Not Treated|1
388072|NCT00143455|1233246|P3|Cohort 2|Randomized But Not Treated|1
388073|NCT00143455|1233247|P2|Cohort 2|Randomized But Not Treated|0
388074|NCT00143455|1233248|P1|Cohort 2|Randomized But Not Treated|0
388075|NCT00143455|1233245|P4|Cohort 2|Unspecified|6
388076|NCT00143455|1233246|P3|Cohort 2|Unspecified|7
388077|NCT00143455|1233247|P2|Cohort 2|Unspecified|0
388078|NCT00143455|1233248|P1|Cohort 2|Unspecified|0
388079|NCT00143455|1233245|P4|Cohort 2|Withdrawal by Subject|12
388080|NCT00143455|1233246|P3|Cohort 2|Withdrawal by Subject|13
388081|NCT00143455|1233247|P2|Cohort 2|Withdrawal by Subject|0
388082|NCT00143455|1233248|P1|Cohort 2|Withdrawal by Subject|0
388083|NCT00143455|1233245|P4|Cohort 2|Progressive Disease|27
388084|NCT00143455|1233246|P3|Cohort 2|Progressive Disease|20
388085|NCT00143455|1233247|P2|Cohort 2|Progressive Disease|0
388086|NCT00143455|1233248|P1|Cohort 2|Progressive Disease|0
388087|NCT00143455|1233245|P4|Cohort 2|Death|12
388088|NCT00143455|1233246|P3|Cohort 2|Death|20
388089|NCT00143455|1233247|P2|Cohort 2|Death|0
388090|NCT00143455|1233248|P1|Cohort 2|Death|0
388091|NCT00143455|1233245|P4|Cohort 2|Lost to Follow-up|4
388092|NCT00143455|1233246|P3|Cohort 2|Lost to Follow-up|1
388093|NCT00143455|1233247|P2|Cohort 2|Lost to Follow-up|0
388094|NCT00143455|1233248|P1|Cohort 2|Lost to Follow-up|0
388095|NCT00143455|1233245|P4|Cohort 2|Protocol Violation|1
388096|NCT00143455|1233246|P3|Cohort 2|Protocol Violation|1
388097|NCT00143455|1233247|P2|Cohort 2|Protocol Violation|0
388098|NCT00143455|1233248|P1|Cohort 2|Protocol Violation|0
388099|NCT00143455|1233245|P4|Cohort 2|No Longer Required Study Treatment|0
388100|NCT00143455|1233246|P3|Cohort 2|No Longer Required Study Treatment|1
388101|NCT00143455|1233247|P2|Cohort 2|No Longer Required Study Treatment|0
388102|NCT00143455|1233248|P1|Cohort 2|No Longer Required Study Treatment|0
388103|NCT00143455|1233245|P4|Cohort 2|Adverse Event|30
388104|NCT00143455|1233246|P3|Cohort 2|Adverse Event|42
388105|NCT00143455|1233247|P2|Cohort 2|Adverse Event|0
388106|NCT00143455|1233248|P1|Cohort 2|Adverse Event|0
388107|NCT00143455|1233245|P4|Cohort 1|Randomized But Not Treated|0
388108|NCT00143455|1233246|P3|Cohort 1|Randomized But Not Treated|0
388109|NCT00143455|1233247|P2|Cohort 1|Randomized But Not Treated|1
388110|NCT00143455|1233248|P1|Cohort 1|Randomized But Not Treated|0
388111|NCT00143455|1233245|P4|Cohort 1|Withdrawal by Subject|0
388112|NCT00143455|1233246|P3|Cohort 1|Withdrawal by Subject|0
388113|NCT00143455|1233247|P2|Cohort 1|Withdrawal by Subject|4
388114|NCT00143455|1233248|P1|Cohort 1|Withdrawal by Subject|1
388115|NCT00143455|1233245|P4|Cohort 1|Progressive Disease|0
388116|NCT00143455|1233246|P3|Cohort 1|Progressive Disease|0
388117|NCT00143455|1233247|P2|Cohort 1|Progressive Disease|6
388118|NCT00143455|1233248|P1|Cohort 1|Progressive Disease|0
388119|NCT00143455|1233245|P4|Cohort 1|Death|0
388120|NCT00143455|1233246|P3|Cohort 1|Death|0
388121|NCT00143455|1233247|P2|Cohort 1|Death|2
388122|NCT00143455|1233248|P1|Cohort 1|Death|5
388123|NCT00143455|1233245|P4|Cohort 1|Adverse Event|0
388124|NCT00143455|1233246|P3|Cohort 1|Adverse Event|0
388125|NCT00143455|1233247|P2|Cohort 1|Adverse Event|4
388126|NCT00143455|1233248|P1|Cohort 1|Adverse Event|8
388127|NCT00142415|1233286|P6|Overall Study|Physician Decision|2
388128|NCT00142415|1233287|P5|Overall Study|Physician Decision|1
388129|NCT00142415|1233288|P4|Overall Study|Physician Decision|0
388130|NCT00142415|1233289|P3|Overall Study|Physician Decision|0
388131|NCT00142415|1233290|P2|Overall Study|Physician Decision|0
388132|NCT00142415|1233291|P1|Overall Study|Physician Decision|0
388133|NCT00142298|1233329|P10|Overall Study|Treatment Failure|0
388134|NCT00142298|1233330|P9|Overall Study|Treatment Failure|0
388135|NCT00142298|1233331|P8|Overall Study|Treatment Failure|0
388136|NCT00142298|1233332|P7|Overall Study|Treatment Failure|2
388137|NCT00142298|1233333|P6|Overall Study|Treatment Failure|2
388138|NCT00142298|1233334|P5|Overall Study|Treatment Failure|0
388139|NCT00142298|1233335|P4|Overall Study|Treatment Failure|0
388140|NCT00142298|1233336|P3|Overall Study|Treatment Failure|0
388141|NCT00142298|1233337|P2|Overall Study|Treatment Failure|0
388142|NCT00142298|1233338|P1|Overall Study|Treatment Failure|0
388143|NCT00142298|1233329|P10|Overall Study|Lost to Follow-up|0
388144|NCT00142298|1233330|P9|Overall Study|Lost to Follow-up|0
388145|NCT00142298|1233331|P8|Overall Study|Lost to Follow-up|0
388146|NCT00142298|1233332|P7|Overall Study|Lost to Follow-up|2
388147|NCT00142298|1233333|P6|Overall Study|Lost to Follow-up|0
388148|NCT00142298|1233334|P5|Overall Study|Lost to Follow-up|0
388149|NCT00142298|1233335|P4|Overall Study|Lost to Follow-up|0
388150|NCT00142298|1233336|P3|Overall Study|Lost to Follow-up|0
388151|NCT00142298|1233337|P2|Overall Study|Lost to Follow-up|0
388152|NCT00142298|1233338|P1|Overall Study|Lost to Follow-up|0
388153|NCT00142298|1233329|P10|Overall Study|Other- not specified|0
388154|NCT00142298|1233330|P9|Overall Study|Other- not specified|0
388155|NCT00142298|1233331|P8|Overall Study|Other- not specified|0
388156|NCT00142298|1233332|P7|Overall Study|Other- not specified|0
388157|NCT00142298|1233333|P6|Overall Study|Other- not specified|0
388158|NCT00142298|1233334|P5|Overall Study|Other- not specified|0
388159|NCT00142298|1233335|P4|Overall Study|Other- not specified|1
388160|NCT00142298|1233336|P3|Overall Study|Other- not specified|0
388161|NCT00142298|1233337|P2|Overall Study|Other- not specified|3
388162|NCT00142298|1233338|P1|Overall Study|Other- not specified|0
388163|NCT00142298|1233329|P10|Overall Study|Virologic breakthrough|0
388164|NCT00142298|1233330|P9|Overall Study|Virologic breakthrough|0
388165|NCT00142298|1233331|P8|Overall Study|Virologic breakthrough|0
388166|NCT00142298|1233332|P7|Overall Study|Virologic breakthrough|3
388167|NCT00142298|1233333|P6|Overall Study|Virologic breakthrough|3
388168|NCT00142298|1233334|P5|Overall Study|Virologic breakthrough|2
388169|NCT00142298|1233335|P4|Overall Study|Virologic breakthrough|7
388170|NCT00142298|1233336|P3|Overall Study|Virologic breakthrough|9
388171|NCT00142298|1233337|P2|Overall Study|Virologic breakthrough|23
388172|NCT00142298|1233338|P1|Overall Study|Virologic breakthrough|19
388173|NCT00142298|1233329|P10|Overall Study|Pregnancy|0
388174|NCT00142298|1233330|P9|Overall Study|Pregnancy|1
388175|NCT00142298|1233331|P8|Overall Study|Pregnancy|0
388176|NCT00142298|1233332|P7|Overall Study|Pregnancy|0
388177|NCT00142298|1233333|P6|Overall Study|Pregnancy|0
388178|NCT00142298|1233334|P5|Overall Study|Pregnancy|0
388179|NCT00142298|1233335|P4|Overall Study|Pregnancy|3
388180|NCT00142298|1233336|P3|Overall Study|Pregnancy|2
388181|NCT00142298|1233337|P2|Overall Study|Pregnancy|4
388182|NCT00142298|1233338|P1|Overall Study|Pregnancy|4
388183|NCT00142298|1233329|P10|Overall Study|Patient, Investigator,or Sponsor request|0
388184|NCT00142298|1233330|P9|Overall Study|Patient, Investigator,or Sponsor request|1
388185|NCT00142298|1233331|P8|Overall Study|Patient, Investigator,or Sponsor request|4
388186|NCT00142298|1233332|P7|Overall Study|Patient, Investigator,or Sponsor request|1
388187|NCT00142298|1233333|P6|Overall Study|Patient, Investigator,or Sponsor request|3
388188|NCT00142298|1233334|P5|Overall Study|Patient, Investigator,or Sponsor request|4
388189|NCT00142298|1233335|P4|Overall Study|Patient, Investigator,or Sponsor request|51
388190|NCT00142298|1233336|P3|Overall Study|Patient, Investigator,or Sponsor request|11
388191|NCT00142298|1233337|P2|Overall Study|Patient, Investigator,or Sponsor request|60
388192|NCT00142298|1233338|P1|Overall Study|Patient, Investigator,or Sponsor request|66
388193|NCT00142298|1233329|P10|Overall Study|Non-compliance|0
388194|NCT00142298|1233330|P9|Overall Study|Non-compliance|3
388195|NCT00142298|1233331|P8|Overall Study|Non-compliance|3
388196|NCT00142298|1233332|P7|Overall Study|Non-compliance|0
388197|NCT00142298|1233333|P6|Overall Study|Non-compliance|0
388198|NCT00142298|1233334|P5|Overall Study|Non-compliance|1
388199|NCT00142298|1233335|P4|Overall Study|Non-compliance|6
388200|NCT00142298|1233336|P3|Overall Study|Non-compliance|0
388201|NCT00142298|1233337|P2|Overall Study|Non-compliance|13
388202|NCT00142298|1233338|P1|Overall Study|Non-compliance|15
388203|NCT00142298|1233329|P10|Overall Study|Lack of Efficacy|0
388204|NCT00142298|1233330|P9|Overall Study|Lack of Efficacy|0
388205|NCT00142298|1233331|P8|Overall Study|Lack of Efficacy|1
388206|NCT00142298|1233332|P7|Overall Study|Lack of Efficacy|0
388207|NCT00142298|1233333|P6|Overall Study|Lack of Efficacy|0
388208|NCT00142298|1233334|P5|Overall Study|Lack of Efficacy|1
388209|NCT00142298|1233335|P4|Overall Study|Lack of Efficacy|12
388210|NCT00142298|1233336|P3|Overall Study|Lack of Efficacy|9
388211|NCT00142298|1233337|P2|Overall Study|Lack of Efficacy|62
388212|NCT00142298|1233338|P1|Overall Study|Lack of Efficacy|44
388213|NCT00142298|1233329|P10|Overall Study|Death|0
388214|NCT00142298|1233330|P9|Overall Study|Death|0
388215|NCT00142298|1233331|P8|Overall Study|Death|0
388216|NCT00142298|1233332|P7|Overall Study|Death|0
388217|NCT00142298|1233333|P6|Overall Study|Death|6
388218|NCT00142298|1233334|P5|Overall Study|Death|0
388219|NCT00142298|1233335|P4|Overall Study|Death|0
388220|NCT00142298|1233336|P3|Overall Study|Death|1
388221|NCT00142298|1233337|P2|Overall Study|Death|1
388222|NCT00142298|1233338|P1|Overall Study|Death|1
388223|NCT00142298|1233329|P10|Overall Study|Clinical disease progression|0
388224|NCT00142298|1233330|P9|Overall Study|Clinical disease progression|0
388225|NCT00142298|1233331|P8|Overall Study|Clinical disease progression|0
388226|NCT00142298|1233332|P7|Overall Study|Clinical disease progression|0
388227|NCT00142298|1233333|P6|Overall Study|Clinical disease progression|0
388228|NCT00142298|1233334|P5|Overall Study|Clinical disease progression|0
388229|NCT00142298|1233335|P4|Overall Study|Clinical disease progression|0
388230|NCT00142298|1233336|P3|Overall Study|Clinical disease progression|0
388231|NCT00142298|1233337|P2|Overall Study|Clinical disease progression|0
388232|NCT00142298|1233338|P1|Overall Study|Clinical disease progression|1
388233|NCT00142298|1233329|P10|Overall Study|Adverse Event|0
388234|NCT00142298|1233330|P9|Overall Study|Adverse Event|0
388235|NCT00142298|1233331|P8|Overall Study|Adverse Event|0
388236|NCT00142298|1233332|P7|Overall Study|Adverse Event|0
388237|NCT00142298|1233333|P6|Overall Study|Adverse Event|2
388238|NCT00142298|1233334|P5|Overall Study|Adverse Event|2
388239|NCT00142298|1233335|P4|Overall Study|Adverse Event|5
388240|NCT00142298|1233336|P3|Overall Study|Adverse Event|1
388241|NCT00142298|1233337|P2|Overall Study|Adverse Event|10
388242|NCT00142298|1233338|P1|Overall Study|Adverse Event|10
388243|NCT00143403|1233362|P2|Overall Study|Randomized Not Treated|8
388244|NCT00143403|1233363|P1|Overall Study|Randomized Not Treated|7
388245|NCT00143403|1233362|P2|Overall Study|specified by site|9
388246|NCT00143403|1233363|P1|Overall Study|specified by site|4
388247|NCT00143403|1233362|P2|Overall Study|Protocol Violation|2
388248|NCT00143403|1233363|P1|Overall Study|Protocol Violation|2
388249|NCT00143403|1233362|P2|Overall Study|Relapse|7
388250|NCT00143403|1233363|P1|Overall Study|Relapse|15
388251|NCT00143403|1233362|P2|Overall Study|Withdrawal by Subject|12
388252|NCT00143403|1233363|P1|Overall Study|Withdrawal by Subject|3
388253|NCT00143403|1233362|P2|Overall Study|Death|0
388254|NCT00143403|1233363|P1|Overall Study|Death|1
388255|NCT00143403|1233362|P2|Overall Study|Adverse Event|8
388256|NCT00143403|1233363|P1|Overall Study|Adverse Event|3
388257|NCT00143390|1233373|P2|Overall Study|Other|2
388258|NCT00143390|1233374|P1|Overall Study|Other|1
388259|NCT00143390|1233373|P2|Overall Study|Adverse Event|8
388260|NCT00143390|1233374|P1|Overall Study|Adverse Event|9
388261|NCT00143390|1233373|P2|Overall Study|Study termination|15
388262|NCT00143390|1233374|P1|Overall Study|Study termination|10
388263|NCT00143390|1233373|P2|Overall Study|Protocol Violation|0
388264|NCT00143390|1233374|P1|Overall Study|Protocol Violation|2
388265|NCT00143390|1233373|P2|Overall Study|Progressive disease|115
388266|NCT00143390|1233374|P1|Overall Study|Progressive disease|119
388267|NCT00143390|1233373|P2|Overall Study|Withdrawal by Subject|4
388268|NCT00143390|1233374|P1|Overall Study|Withdrawal by Subject|4
388269|NCT00143390|1233373|P2|Overall Study|Not meeting entry criteria|5
388270|NCT00143390|1233374|P1|Overall Study|Not meeting entry criteria|2
388271|NCT00143390|1233373|P2|Overall Study|Death|0
388272|NCT00143390|1233374|P1|Overall Study|Death|2
388273|NCT00143312|1233390|P1|Overall Study|Withdrawal by Subject|1
388274|NCT00143312|1233390|P1|Overall Study|Other|1
388275|NCT00143312|1233390|P1|Overall Study|Lost to Follow-up|1
388276|NCT00143312|1233390|P1|Overall Study|Adverse Event|2
388277|NCT00143312|1233390|P1|Overall Study|Death|11
388278|NCT00143247|1233400|P1|Overall Study|Other|12
388279|NCT00143247|1233400|P1|Overall Study|following inaccurate lab adverse event|1
388280|NCT00143247|1233400|P1|Overall Study|Lost to Follow-up|12
388281|NCT00143247|1233400|P1|Overall Study|Protocol Violation|15
388282|NCT00143247|1233400|P1|Overall Study|Study terminated by sponsor|31
388283|NCT00143247|1233400|P1|Overall Study|Withdrawal by Subject|55
388284|NCT00143247|1233400|P1|Overall Study|Lack of Efficacy|3
388285|NCT00143247|1233400|P1|Overall Study|Adverse Event|19
388286|NCT00143247|1233400|P1|Overall Study|Death|8
388287|NCT00142935|1233417|P3|Overall Study|Death|1
388288|NCT00142935|1233418|P2|Overall Study|Death|2
388289|NCT00142935|1233419|P1|Overall Study|Death|0
388290|NCT00142935|1233417|P3|Overall Study|Lost to Follow-up|5
388291|NCT00142935|1233418|P2|Overall Study|Lost to Follow-up|5
388292|NCT00142935|1233419|P1|Overall Study|Lost to Follow-up|2
388293|NCT00142935|1233417|P3|Overall Study|Other reason|1
388294|NCT00142935|1233418|P2|Overall Study|Other reason|1
388295|NCT00142935|1233419|P1|Overall Study|Other reason|1
388296|NCT00142909|1233444|P2|Medications Begin|Withdrawal by Subject|0
388297|NCT00142909|1233445|P1|Medications Begin|Withdrawal by Subject|2
388298|NCT00142909|1233444|P2|Medications Begin|Withdrawal by Subject|3
388299|NCT00142909|1233445|P1|Medications Begin|Withdrawal by Subject|5
388300|NCT00142909|1233444|P2|Medications Begin|Protocol Violation|0
388301|NCT00142909|1233445|P1|Medications Begin|Protocol Violation|2
388302|NCT00142909|1233444|P2|Randomization|Various Reasons|10
388303|NCT00142909|1233445|P1|Randomization|Various Reasons|7
388315|NCT00141817|1233525|P4|Overall Study|Parent request|0
388316|NCT00141817|1233526|P3|Overall Study|Parent request|0
388317|NCT00141817|1233527|P2|Overall Study|Parent request|0
388318|NCT00141817|1233528|P1|Overall Study|Parent request|1
388319|NCT00141817|1233525|P4|Overall Study|Protocol Violation|0
388320|NCT00141817|1233526|P3|Overall Study|Protocol Violation|1
388321|NCT00141817|1233527|P2|Overall Study|Protocol Violation|0
388322|NCT00141817|1233528|P1|Overall Study|Protocol Violation|0
388323|NCT00141778|1233569|P3|Started Study Medication|Chest Discomfort|1
388324|NCT00141778|1233570|P2|Started Study Medication|Chest Discomfort|0
388325|NCT00141778|1233571|P1|Started Study Medication|Chest Discomfort|0
388326|NCT00141778|1233569|P3|Started Study Medication|Difficulty Swallowing|0
388327|NCT00141778|1233570|P2|Started Study Medication|Difficulty Swallowing|1
388328|NCT00141778|1233571|P1|Started Study Medication|Difficulty Swallowing|0
388329|NCT00141778|1233569|P3|Started Study Medication|Withdrawal by Subject|0
388330|NCT00141778|1233570|P2|Started Study Medication|Withdrawal by Subject|2
388331|NCT00141778|1233571|P1|Started Study Medication|Withdrawal by Subject|0
388332|NCT00141778|1233569|P3|Started Study Medication|Met safety criteria for discontinuation|3
388333|NCT00141778|1233570|P2|Started Study Medication|Met safety criteria for discontinuation|4
388334|NCT00141778|1233571|P1|Started Study Medication|Met safety criteria for discontinuation|2
388335|NCT00141778|1233569|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
388336|NCT00141778|1233570|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
388337|NCT00141778|1233571|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
388338|NCT00141726|1233624|P1|Overall Study|Completed <50% Scheduled Dosing|3
388339|NCT00141518|1233632|P3|Overall Study|Lack of Efficacy|0
388340|NCT00141518|1233633|P2|Overall Study|Lack of Efficacy|0
388341|NCT00141518|1233634|P1|Overall Study|Lack of Efficacy|5
388342|NCT00141518|1233632|P3|Overall Study|Protocol Violation|2
388343|NCT00141518|1233633|P2|Overall Study|Protocol Violation|1
388344|NCT00141518|1233634|P1|Overall Study|Protocol Violation|1
388345|NCT00141518|1233632|P3|Overall Study|Withdrawal by Subject|2
388346|NCT00141518|1233633|P2|Overall Study|Withdrawal by Subject|0
388347|NCT00141518|1233634|P1|Overall Study|Withdrawal by Subject|2
388348|NCT00141518|1233632|P3|Overall Study|Adverse Event|2
388349|NCT00141518|1233633|P2|Overall Study|Adverse Event|5
388350|NCT00141518|1233634|P1|Overall Study|Adverse Event|7
388351|NCT00141518|1233632|P3|Overall Study|Withdrew Consent Prior to Treatment|0
388352|NCT00141518|1233633|P2|Overall Study|Withdrew Consent Prior to Treatment|0
388353|NCT00141518|1233634|P1|Overall Study|Withdrew Consent Prior to Treatment|1
388354|NCT00141453|1233823|P2|Overall Study|Protocol Violation|5
388355|NCT00141453|1233824|P1|Overall Study|Protocol Violation|6
388356|NCT00141297|1233838|P10|Overall Study|Transitioned|0
388357|NCT00141297|1233839|P9|Overall Study|Transitioned|0
388358|NCT00141297|1233840|P8|Overall Study|Transitioned|0
388359|NCT00141297|1233841|P7|Overall Study|Transitioned|0
388360|NCT00141297|1233842|P6|Overall Study|Transitioned|0
388361|NCT00141297|1233843|P5|Overall Study|Transitioned|1
388362|NCT00141297|1233844|P4|Overall Study|Transitioned|0
388363|NCT00141297|1233845|P3|Overall Study|Transitioned|0
388364|NCT00141297|1233846|P2|Overall Study|Transitioned|0
388365|NCT00141297|1233847|P1|Overall Study|Transitioned|0
388366|NCT00141297|1233838|P10|Overall Study|Progressive Disease|6
388367|NCT00141297|1233839|P9|Overall Study|Progressive Disease|15
388368|NCT00141297|1233840|P8|Overall Study|Progressive Disease|3
388369|NCT00141297|1233841|P7|Overall Study|Progressive Disease|3
388370|NCT00141297|1233842|P6|Overall Study|Progressive Disease|2
388371|NCT00141297|1233843|P5|Overall Study|Progressive Disease|15
388372|NCT00141297|1233844|P4|Overall Study|Progressive Disease|2
388373|NCT00141297|1233845|P3|Overall Study|Progressive Disease|6
388374|NCT00141297|1233846|P2|Overall Study|Progressive Disease|3
388375|NCT00141297|1233847|P1|Overall Study|Progressive Disease|2
388376|NCT00141297|1233838|P10|Overall Study|Unspecified|0
388377|NCT00141297|1233839|P9|Overall Study|Unspecified|2
388378|NCT00141297|1233840|P8|Overall Study|Unspecified|0
388379|NCT00141297|1233841|P7|Overall Study|Unspecified|0
388380|NCT00141297|1233842|P6|Overall Study|Unspecified|0
388381|NCT00141297|1233843|P5|Overall Study|Unspecified|5
388382|NCT00141297|1233844|P4|Overall Study|Unspecified|1
388383|NCT00141297|1233845|P3|Overall Study|Unspecified|0
388384|NCT00141297|1233846|P2|Overall Study|Unspecified|0
388385|NCT00141297|1233847|P1|Overall Study|Unspecified|0
388386|NCT00141297|1233838|P10|Overall Study|Withdrawal by Subject|0
388387|NCT00141297|1233839|P9|Overall Study|Withdrawal by Subject|1
388388|NCT00141297|1233840|P8|Overall Study|Withdrawal by Subject|0
388389|NCT00141297|1233841|P7|Overall Study|Withdrawal by Subject|0
388390|NCT00141297|1233842|P6|Overall Study|Withdrawal by Subject|0
388391|NCT00141297|1233843|P5|Overall Study|Withdrawal by Subject|0
388392|NCT00141297|1233844|P4|Overall Study|Withdrawal by Subject|0
388393|NCT00141297|1233845|P3|Overall Study|Withdrawal by Subject|0
388394|NCT00141297|1233846|P2|Overall Study|Withdrawal by Subject|0
388395|NCT00141297|1233847|P1|Overall Study|Withdrawal by Subject|0
388396|NCT00141297|1233838|P10|Overall Study|Death|0
388397|NCT00141297|1233839|P9|Overall Study|Death|1
388398|NCT00141297|1233840|P8|Overall Study|Death|0
388399|NCT00141297|1233841|P7|Overall Study|Death|0
388400|NCT00141297|1233842|P6|Overall Study|Death|0
388401|NCT00141297|1233843|P5|Overall Study|Death|0
388402|NCT00141297|1233844|P4|Overall Study|Death|0
388403|NCT00141297|1233845|P3|Overall Study|Death|0
388404|NCT00141297|1233846|P2|Overall Study|Death|0
388405|NCT00141297|1233847|P1|Overall Study|Death|1
388406|NCT00141297|1233838|P10|Overall Study|Adverse Event|0
388407|NCT00141297|1233839|P9|Overall Study|Adverse Event|1
388408|NCT00141297|1233840|P8|Overall Study|Adverse Event|1
388409|NCT00141297|1233841|P7|Overall Study|Adverse Event|0
388410|NCT00141297|1233842|P6|Overall Study|Adverse Event|1
388411|NCT00141297|1233843|P5|Overall Study|Adverse Event|1
388412|NCT00141297|1233844|P4|Overall Study|Adverse Event|0
388413|NCT00141297|1233845|P3|Overall Study|Adverse Event|1
388414|NCT00141297|1233846|P2|Overall Study|Adverse Event|0
388415|NCT00141297|1233847|P1|Overall Study|Adverse Event|0
388416|NCT00141271|1234125|P3|Overall Study|Other|5
388417|NCT00141271|1234126|P2|Overall Study|Other|12
388418|NCT00141271|1234127|P1|Overall Study|Other|11
388419|NCT00141271|1234125|P3|Overall Study|Withdrawal by Subject|10
388420|NCT00141271|1234126|P2|Overall Study|Withdrawal by Subject|9
388421|NCT00141271|1234127|P1|Overall Study|Withdrawal by Subject|14
388422|NCT00141271|1234125|P3|Overall Study|Lost to Follow-up|21
388423|NCT00141271|1234126|P2|Overall Study|Lost to Follow-up|15
388424|NCT00141271|1234127|P1|Overall Study|Lost to Follow-up|15
388425|NCT00141271|1234125|P3|Overall Study|Lack of Efficacy|3
388426|NCT00141271|1234126|P2|Overall Study|Lack of Efficacy|7
388427|NCT00141271|1234127|P1|Overall Study|Lack of Efficacy|7
388428|NCT00141271|1234125|P3|Overall Study|Laboratory Abnormality|1
388429|NCT00141271|1234126|P2|Overall Study|Laboratory Abnormality|1
388430|NCT00141271|1234127|P1|Overall Study|Laboratory Abnormality|2
388431|NCT00141271|1234125|P3|Overall Study|Adverse Event|17
388432|NCT00141271|1234126|P2|Overall Study|Adverse Event|19
388433|NCT00141271|1234127|P1|Overall Study|Adverse Event|31
388434|NCT00141219|1234248|P2|Overall Study|Withdrawal by Subject|2
388435|NCT00141219|1234249|P1|Overall Study|Withdrawal by Subject|6
388436|NCT00141219|1234248|P2|Overall Study|Lack of Efficacy|4
388437|NCT00141219|1234249|P1|Overall Study|Lack of Efficacy|5
388438|NCT00141219|1234248|P2|Overall Study|Adverse Event|6
388439|NCT00141219|1234249|P1|Overall Study|Adverse Event|8
388440|NCT00141219|1234248|P2|Overall Study|Protocol violations|4
388441|NCT00141219|1234249|P1|Overall Study|Protocol violations|5
388442|NCT00141102|1234301|P2|Overall Study|Death|2
388443|NCT00141102|1234302|P1|Overall Study|Death|2
388444|NCT00141102|1234301|P2|Overall Study|Randomized But Did Not Receive Treatment|9
388445|NCT00141102|1234302|P1|Overall Study|Randomized But Did Not Receive Treatment|15
388446|NCT00141102|1234301|P2|Overall Study|Withdrawal by Subject|142
388447|NCT00141102|1234302|P1|Overall Study|Withdrawal by Subject|112
388448|NCT00141102|1234301|P2|Overall Study|Unspecified|76
388449|NCT00141102|1234302|P1|Overall Study|Unspecified|87
388450|NCT00141102|1234301|P2|Overall Study|Lost to Follow-up|32
388451|NCT00141102|1234302|P1|Overall Study|Lost to Follow-up|29
388452|NCT00141102|1234301|P2|Overall Study|Lack of Efficacy|26
388453|NCT00141102|1234302|P1|Overall Study|Lack of Efficacy|21
388454|NCT00141102|1234301|P2|Overall Study|Laboratory Abnormality|33
388455|NCT00141102|1234302|P1|Overall Study|Laboratory Abnormality|9
388456|NCT00141102|1234301|P2|Overall Study|Adverse Event|305
388457|NCT00141102|1234302|P1|Overall Study|Adverse Event|233
388458|NCT00141037|1234342|P2|Overall Study|Graft Failure|4
388459|NCT00141037|1234343|P1|Overall Study|Graft Failure|3
388460|NCT00141037|1234342|P2|Overall Study|Moved from area|7
388461|NCT00141037|1234343|P1|Overall Study|Moved from area|1
388462|NCT00141037|1234342|P2|Overall Study|Other|1
388463|NCT00141037|1234343|P1|Overall Study|Other|0
388464|NCT00141037|1234342|P2|Overall Study|Withdrawal by Subject|1
388465|NCT00141037|1234343|P1|Overall Study|Withdrawal by Subject|2
388466|NCT00141037|1234342|P2|Overall Study|Protocol Violation|2
388467|NCT00141037|1234343|P1|Overall Study|Protocol Violation|0
388468|NCT00141037|1234342|P2|Overall Study|Lost to Follow-up|1
388469|NCT00141037|1234343|P1|Overall Study|Lost to Follow-up|3
388470|NCT00141037|1234342|P2|Overall Study|Physician Decision|2
388471|NCT00141037|1234343|P1|Overall Study|Physician Decision|1
388472|NCT00140426|1234378|P2|Overall Study|Withdrawal by Subject|3
388473|NCT00140426|1234379|P1|Overall Study|Withdrawal by Subject|0
388474|NCT00140413|1234412|P2|Overall Study|Withdrawal by Subject|0
388475|NCT00140413|1234413|P1|Overall Study|Withdrawal by Subject|2
388476|NCT00140413|1234412|P2|Overall Study|Lost to Follow-up|0
388477|NCT00140413|1234413|P1|Overall Study|Lost to Follow-up|1
388478|NCT00140140|1234473|P3|Overall Study|Physician Decision|0
388479|NCT00140140|1234474|P2|Overall Study|Physician Decision|1
388480|NCT00140140|1234475|P1|Overall Study|Physician Decision|1
388481|NCT00140140|1234473|P3|Overall Study|Unacceptable toxicity|2
388482|NCT00140140|1234474|P2|Overall Study|Unacceptable toxicity|1
388483|NCT00140140|1234475|P1|Overall Study|Unacceptable toxicity|1
388484|NCT00139776|1234525|P4|Period III|Withdrawal by Subject|21
388485|NCT00139776|1234526|P3|Period III|Withdrawal by Subject|16
388486|NCT00139776|1234527|P2|Period III|Withdrawal by Subject|0
388487|NCT00139776|1234528|P1|Period III|Withdrawal by Subject|0
388488|NCT00139776|1234525|P4|Period III|Lost to Follow-up|4
388489|NCT00139776|1234526|P3|Period III|Lost to Follow-up|5
388490|NCT00139776|1234527|P2|Period III|Lost to Follow-up|0
388491|NCT00139776|1234528|P1|Period III|Lost to Follow-up|0
388492|NCT00139776|1234525|P4|Period III|Lack of Efficacy|24
388493|NCT00139776|1234526|P3|Period III|Lack of Efficacy|10
388494|NCT00139776|1234527|P2|Period III|Lack of Efficacy|0
388495|NCT00139776|1234528|P1|Period III|Lack of Efficacy|0
388496|NCT00139776|1234525|P4|Period III|Other|34
388497|NCT00139776|1234526|P3|Period III|Other|23
388498|NCT00139776|1234527|P2|Period III|Other|0
388499|NCT00139776|1234528|P1|Period III|Other|0
388500|NCT00139776|1234525|P4|Period III|Adverse Event|23
388501|NCT00139776|1234526|P3|Period III|Adverse Event|22
388502|NCT00139776|1234527|P2|Period III|Adverse Event|0
388503|NCT00139776|1234528|P1|Period III|Adverse Event|0
388504|NCT00139776|1234525|P4|Period II|Not Randomized into Period III|0
388505|NCT00139776|1234526|P3|Period II|Not Randomized into Period III|0
388506|NCT00139776|1234527|P2|Period II|Not Randomized into Period III|322
388507|NCT00139776|1234528|P1|Period II|Not Randomized into Period III|0
388508|NCT00139776|1234525|P4|Period I|Did not enter Period II|0
388509|NCT00139776|1234526|P3|Period I|Did not enter Period II|0
388510|NCT00139776|1234527|P2|Period I|Did not enter Period II|0
388511|NCT00139776|1234528|P1|Period I|Did not enter Period II|575
388512|NCT00139737|1234563|P1|Overall Study|Screened, Not Treated|13
388513|NCT00139737|1234563|P1|Overall Study|Did Not Meet Entrance Criteria|1
388514|NCT00139737|1234563|P1|Overall Study|Withdrew During Screening Phase|8
388515|NCT00139737|1234563|P1|Overall Study|Protocol Violation|18
388516|NCT00139737|1234563|P1|Overall Study|Laboratory Abnormality|2
388517|NCT00139737|1234563|P1|Overall Study|Death|3
388518|NCT00139737|1234563|P1|Overall Study|Lost to Follow-up|8
388519|NCT00139737|1234563|P1|Overall Study|Lack of Efficacy|40
388520|NCT00139737|1234563|P1|Overall Study|Adverse Event|58
388521|NCT00139737|1234563|P1|Overall Study|Withdrawal by Subject|190
388522|NCT00139659|1234569|P2|Overall Study|Withdrawal by Subject|10
388523|NCT00139659|1234570|P1|Overall Study|Withdrawal by Subject|14
388524|NCT00139659|1234569|P2|Overall Study|Reason not Specified|3
388525|NCT00139659|1234570|P1|Overall Study|Reason not Specified|6
388526|NCT00139659|1234569|P2|Overall Study|Lost to Follow-up|3
388527|NCT00139659|1234570|P1|Overall Study|Lost to Follow-up|7
388528|NCT00139659|1234569|P2|Overall Study|Lack of Efficacy|1
388529|NCT00139659|1234570|P1|Overall Study|Lack of Efficacy|1
388530|NCT00139659|1234569|P2|Overall Study|Adverse Event|1
388531|NCT00139659|1234570|P1|Overall Study|Adverse Event|12
388532|NCT00139477|1234648|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
388533|NCT00139477|1234649|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
388534|NCT00139477|1234648|P2|Second Intervention -6Months to 12Months|Relocation|0
388535|NCT00139477|1234649|P1|Second Intervention -6Months to 12Months|Relocation|1
388536|NCT00139477|1234648|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
388537|NCT00139477|1234649|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
388538|NCT00139477|1234648|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
388539|NCT00139477|1234649|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
388540|NCT00139477|1234648|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
388541|NCT00139477|1234649|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
388542|NCT00139477|1234648|P2|First Intervention -Baseline to 6Months|Relocation|2
388543|NCT00139477|1234649|P1|First Intervention -Baseline to 6Months|Relocation|1
388544|NCT00139477|1234648|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
388545|NCT00139477|1234649|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
388546|NCT00138671|1234671|P2|Overall Study|Other|3
388547|NCT00138671|1234672|P1|Overall Study|Other|3
388548|NCT00138671|1234671|P2|Overall Study|Withdrawal by Subject|5
388549|NCT00138671|1234672|P1|Overall Study|Withdrawal by Subject|3
388550|NCT00138671|1234671|P2|Overall Study|Lost to Follow-up|2
388551|NCT00138671|1234672|P1|Overall Study|Lost to Follow-up|1
388552|NCT00138671|1234671|P2|Overall Study|Adverse Event|3
388553|NCT00138671|1234672|P1|Overall Study|Adverse Event|6
388554|NCT00138671|1234671|P2|Overall Study|Death|3
388555|NCT00138671|1234672|P1|Overall Study|Death|0
388556|NCT00138658|1234722|P1|Overall Study|Withdrawal by Subject|5
388557|NCT00138658|1234722|P1|Overall Study|Physician Decision|11
388558|NCT00138658|1234722|P1|Overall Study|Disease Progression|21
388559|NCT00138658|1234722|P1|Overall Study|Death|1
388560|NCT00138658|1234722|P1|Overall Study|Adverse Event|23
388561|NCT00138424|1234745|P4|Overall Study|Physician Decision|0
388562|NCT00138424|1234746|P3|Overall Study|Physician Decision|0
388563|NCT00138424|1234747|P2|Overall Study|Physician Decision|1
388564|NCT00138424|1234748|P1|Overall Study|Physician Decision|0
388565|NCT00138151|1234830|P1|Overall Study|Physician Decision|1
388566|NCT00138151|1234830|P1|Overall Study|Withdrawal by Subject|3
388567|NCT00138073|1234840|P1|Overall Study|lack of resources|55
388568|NCT00137631|1234881|P2|Overall Study|Lost to Follow-up|41
388569|NCT00137631|1234882|P1|Overall Study|Lost to Follow-up|37
388570|NCT00137449|1234898|P2|Overall Study|Withdrawal by Subject|1
388571|NCT00137449|1234899|P1|Overall Study|Withdrawal by Subject|1
388572|NCT00137449|1234898|P2|Overall Study|Adverse Event|1
388573|NCT00137449|1234899|P1|Overall Study|Adverse Event|3
388574|NCT00137449|1234898|P2|Overall Study|Death|3
388575|NCT00137449|1234899|P1|Overall Study|Death|4
388576|NCT00137449|1234898|P2|Overall Study|Disease Progression|13
388577|NCT00137449|1234899|P1|Overall Study|Disease Progression|8
388578|NCT00137436|1234936|P1|Overall Study|Unspecified|5
388579|NCT00137436|1234936|P1|Overall Study|Withdrawal by Subject|6
388580|NCT00137436|1234936|P1|Overall Study|Lack of Efficacy|17
388581|NCT00137436|1234936|P1|Overall Study|Death|2
388582|NCT00137436|1234936|P1|Overall Study|Adverse Event|13
388583|NCT00137423|1234955|P2|Overall Study|Death|1
388584|NCT00137423|1234956|P1|Overall Study|Death|0
388585|NCT00137423|1234955|P2|Overall Study|Lack of Efficacy|33
388586|NCT00137423|1234956|P1|Overall Study|Lack of Efficacy|31
388587|NCT00137423|1234955|P2|Overall Study|consent withdrawn|1
388588|NCT00137423|1234956|P1|Overall Study|consent withdrawn|1
388589|NCT00137423|1234955|P2|Overall Study|Adverse Event|9
388590|NCT00137423|1234956|P1|Overall Study|Adverse Event|7
388591|NCT00137267|1234993|P2|Overall Study|Lost to Follow-up|21
388592|NCT00137267|1234994|P1|Overall Study|Lost to Follow-up|15
388593|NCT00137111|1235006|P4|Total Therapy|Non Compliance|0
388594|NCT00137111|1235007|P3|Total Therapy|Non Compliance|0
388595|NCT00137111|1235008|P2|Total Therapy|Non Compliance|0
388596|NCT00137111|1235009|P1|Total Therapy|Non Compliance|5
388597|NCT00137111|1235006|P4|Total Therapy|Death|0
388598|NCT00137111|1235007|P3|Total Therapy|Death|0
388599|NCT00137111|1235008|P2|Total Therapy|Death|0
388600|NCT00137111|1235009|P1|Total Therapy|Death|35
388601|NCT00137046|1235023|P2|Overall Study|Withdrew prior to study treatment|1
388602|NCT00137046|1235024|P1|Overall Study|Withdrew prior to study treatment|1
388603|NCT00137046|1235023|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
388604|NCT00137046|1235024|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
388605|NCT00137046|1235023|P2|Overall Study|Withdrawal by Subject|42
388606|NCT00137046|1235024|P1|Overall Study|Withdrawal by Subject|33
388607|NCT00137046|1235023|P2|Overall Study|Unspecified|19
388608|NCT00137046|1235024|P1|Overall Study|Unspecified|23
388609|NCT00137046|1235023|P2|Overall Study|Lost to Follow-up|24
388610|NCT00137046|1235024|P1|Overall Study|Lost to Follow-up|8
388611|NCT00137046|1235023|P2|Overall Study|Lack of Efficacy|1
388612|NCT00137046|1235024|P1|Overall Study|Lack of Efficacy|13
388613|NCT00137046|1235023|P2|Overall Study|Laboratory Abnormality|0
388614|NCT00137046|1235024|P1|Overall Study|Laboratory Abnormality|2
388615|NCT00137046|1235023|P2|Overall Study|Adverse Event|5
388616|NCT00137046|1235024|P1|Overall Study|Adverse Event|16
388617|NCT00137046|1235023|P2|Overall Study|Death|1
388618|NCT00137046|1235024|P1|Overall Study|Death|2
388619|NCT00136955|1235072|P1|Overall Study|Incl. prog. disease, protocol violation|12
388620|NCT00136955|1235072|P1|Overall Study|Withdrawal by Subject|2
388621|NCT00136955|1235072|P1|Overall Study|Lost to Follow-up|1
388622|NCT00136955|1235072|P1|Overall Study|Adverse Event|8
388623|NCT00136916|1235081|P2|Overall Study|Discontinued in follow up period|0
388624|NCT00136916|1235082|P1|Overall Study|Discontinued in follow up period|3
388625|NCT00136916|1235081|P2|Overall Study|Unspecified|24
388626|NCT00136916|1235082|P1|Overall Study|Unspecified|22
388627|NCT00136916|1235081|P2|Overall Study|Withdrawal by Subject|46
388628|NCT00136916|1235082|P1|Overall Study|Withdrawal by Subject|44
388629|NCT00136916|1235081|P2|Overall Study|Lost to Follow-up|14
388630|NCT00136916|1235082|P1|Overall Study|Lost to Follow-up|12
388631|NCT00136916|1235081|P2|Overall Study|Lack of Efficacy|3
388632|NCT00136916|1235082|P1|Overall Study|Lack of Efficacy|13
388633|NCT00136916|1235081|P2|Overall Study|Laboratory abnormality|1
388634|NCT00136916|1235082|P1|Overall Study|Laboratory abnormality|0
388635|NCT00136916|1235081|P2|Overall Study|Adverse Event|8
388636|NCT00136916|1235082|P1|Overall Study|Adverse Event|27
388637|NCT00136916|1235081|P2|Overall Study|Death|3
388638|NCT00136916|1235082|P1|Overall Study|Death|1
388639|NCT00136916|1235081|P2|Overall Study|Never received study treatment|5
388640|NCT00136916|1235082|P1|Overall Study|Never received study treatment|3
388641|NCT00136357|1235186|P2|Overall Study|Withdrawal by Subject|2
388642|NCT00136357|1235187|P1|Overall Study|Withdrawal by Subject|3
388643|NCT00136318|1235195|P2|Overall Study|Withdrawal by Subject|2
388644|NCT00136318|1235196|P1|Overall Study|Withdrawal by Subject|2
388645|NCT00136318|1235195|P2|Overall Study|Adverse Event|5
388646|NCT00136318|1235196|P1|Overall Study|Adverse Event|5
388647|NCT00136084|1235212|P2|Overall Study|Withdrawal by Subject|1
388648|NCT00136084|1235213|P1|Overall Study|Withdrawal by Subject|5
388649|NCT00136084|1235212|P2|Overall Study|No Response|2
388650|NCT00136084|1235213|P1|Overall Study|No Response|1
388651|NCT00136084|1235212|P2|Overall Study|Lost to Follow-up|0
388652|NCT00136084|1235213|P1|Overall Study|Lost to Follow-up|2
388653|NCT00136084|1235212|P2|Overall Study|Relapse|23
388654|NCT00136084|1235213|P1|Overall Study|Relapse|20
388655|NCT00136084|1235212|P2|Overall Study|Unacceptable toxicity|11
388656|NCT00136084|1235213|P1|Overall Study|Unacceptable toxicity|8
388657|NCT00136084|1235212|P2|Overall Study|Death|5
388658|NCT00136084|1235213|P1|Overall Study|Death|12
388659|NCT00135694|1235250|P3|Overall Study|Ineligible for Random assignment|0
388660|NCT00135694|1235251|P2|Overall Study|Ineligible for Random assignment|0
388661|NCT00135694|1235252|P1|Overall Study|Ineligible for Random assignment|42
388662|NCT00135694|1235250|P3|Overall Study|Hepatitis C related reasons|0
388663|NCT00135694|1235251|P2|Overall Study|Hepatitis C related reasons|1
388664|NCT00135694|1235252|P1|Overall Study|Hepatitis C related reasons|39
388665|NCT00135694|1235250|P3|Overall Study|Protocol Violation|0
388666|NCT00135694|1235251|P2|Overall Study|Protocol Violation|1
388667|NCT00135694|1235252|P1|Overall Study|Protocol Violation|19
388668|NCT00135694|1235250|P3|Overall Study|Withdrawal by Subject|4
388669|NCT00135694|1235251|P2|Overall Study|Withdrawal by Subject|7
388670|NCT00135694|1235252|P1|Overall Study|Withdrawal by Subject|41
388671|NCT00135694|1235250|P3|Overall Study|Lost to Follow-up|1
388672|NCT00135694|1235251|P2|Overall Study|Lost to Follow-up|7
388673|NCT00135694|1235252|P1|Overall Study|Lost to Follow-up|8
388674|NCT00135694|1235250|P3|Overall Study|Death|2
388675|NCT00135694|1235251|P2|Overall Study|Death|1
388676|NCT00135694|1235252|P1|Overall Study|Death|14
388677|NCT00135694|1235250|P3|Overall Study|Adverse Event|0
388678|NCT00135694|1235251|P2|Overall Study|Adverse Event|4
388679|NCT00135694|1235252|P1|Overall Study|Adverse Event|17
388680|NCT00135356|1235272|P2|Overall Study|Withdrawal by Subject|4
388681|NCT00135356|1235273|P1|Overall Study|Withdrawal by Subject|2
388682|NCT00135356|1235272|P2|Overall Study|No longer meets study criteria|0
388683|NCT00135356|1235273|P1|Overall Study|No longer meets study criteria|2
388684|NCT00135356|1235272|P2|Overall Study|Poor/noncompliance|1
388685|NCT00135356|1235273|P1|Overall Study|Poor/noncompliance|1
388686|NCT00135356|1235272|P2|Overall Study|Change in antiviral regimen|1
388687|NCT00135356|1235273|P1|Overall Study|Change in antiviral regimen|0
388688|NCT00135356|1235272|P2|Overall Study|Surgery for abdominal fat|0
388689|NCT00135356|1235273|P1|Overall Study|Surgery for abdominal fat|1
388690|NCT00135356|1235272|P2|Overall Study|Lost to Follow-up|1
388691|NCT00135356|1235273|P1|Overall Study|Lost to Follow-up|3
388692|NCT00135356|1235272|P2|Overall Study|Lack of Efficacy|0
388693|NCT00135356|1235273|P1|Overall Study|Lack of Efficacy|2
388694|NCT00135356|1235272|P2|Overall Study|Adverse Event|2
388695|NCT00135356|1235273|P1|Overall Study|Adverse Event|6
388696|NCT00135330|1235316|P3|Overall Study|Sponsor Decision|0
388697|NCT00135330|1235317|P2|Overall Study|Sponsor Decision|1
388698|NCT00135330|1235318|P1|Overall Study|Sponsor Decision|0
388699|NCT00135330|1235316|P3|Overall Study|Patient Decision|4
388700|NCT00135330|1235317|P2|Overall Study|Patient Decision|1
388701|NCT00135330|1235318|P1|Overall Study|Patient Decision|5
388702|NCT00135330|1235316|P3|Overall Study|Protocol Violation|3
388703|NCT00135330|1235317|P2|Overall Study|Protocol Violation|3
388704|NCT00135330|1235318|P1|Overall Study|Protocol Violation|4
388705|NCT00135330|1235316|P3|Overall Study|Physician Decision|0
388706|NCT00135330|1235317|P2|Overall Study|Physician Decision|1
388707|NCT00135330|1235318|P1|Overall Study|Physician Decision|1
388708|NCT00135330|1235316|P3|Overall Study|Lost to Follow-up|3
388709|NCT00135330|1235317|P2|Overall Study|Lost to Follow-up|2
388710|NCT00135330|1235318|P1|Overall Study|Lost to Follow-up|0
388711|NCT00135330|1235316|P3|Overall Study|Adverse Event|1
388712|NCT00135330|1235317|P2|Overall Study|Adverse Event|5
388713|NCT00135330|1235318|P1|Overall Study|Adverse Event|2
388714|NCT00134901|1235417|P2|Overall Study|discontinued intervention|10
388715|NCT00134901|1235418|P1|Overall Study|discontinued intervention|12
388716|NCT00134901|1235417|P2|Overall Study|Lost to Follow-up|5
388717|NCT00134901|1235418|P1|Overall Study|Lost to Follow-up|5
388718|NCT00134784|1235430|P4|Overall Study|Withdrawal by Subject|1
388719|NCT00134784|1235431|P3|Overall Study|Withdrawal by Subject|2
388720|NCT00134784|1235432|P2|Overall Study|Withdrawal by Subject|2
388721|NCT00134784|1235433|P1|Overall Study|Withdrawal by Subject|2
388722|NCT00134719|1235443|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
388723|NCT00134719|1235444|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
388724|NCT00134719|1235445|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
388725|NCT00134719|1235443|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
388726|NCT00134719|1235444|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
388727|NCT00134719|1235445|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
388728|NCT00134719|1235443|P3|Primary Vaccination Phase|Lost to Follow-up|3
388729|NCT00134719|1235444|P2|Primary Vaccination Phase|Lost to Follow-up|3
388730|NCT00134719|1235445|P1|Primary Vaccination Phase|Lost to Follow-up|7
388731|NCT00134719|1235443|P3|Primary Vaccination Phase|Withdrawal by Subject|2
388732|NCT00134719|1235444|P2|Primary Vaccination Phase|Withdrawal by Subject|3
388733|NCT00134719|1235445|P1|Primary Vaccination Phase|Withdrawal by Subject|2
388734|NCT00134719|1235443|P3|Primary Vaccination Phase|Protocol Violation|0
388735|NCT00134719|1235444|P2|Primary Vaccination Phase|Protocol Violation|0
388736|NCT00134719|1235445|P1|Primary Vaccination Phase|Protocol Violation|1
388737|NCT00134719|1235443|P3|Primary Vaccination Phase|Adverse Event|0
388738|NCT00134719|1235444|P2|Primary Vaccination Phase|Adverse Event|0
388739|NCT00134719|1235445|P1|Primary Vaccination Phase|Adverse Event|4
388740|NCT00134563|1235576|P3|Overall Study|Reason other than above|5
388741|NCT00134563|1235577|P2|Overall Study|Reason other than above|2
388742|NCT00134563|1235578|P1|Overall Study|Reason other than above|0
388743|NCT00134563|1235576|P3|Overall Study|did not wish to continue|26
388744|NCT00134563|1235577|P2|Overall Study|did not wish to continue|32
388745|NCT00134563|1235578|P1|Overall Study|did not wish to continue|33
388746|NCT00134563|1235576|P3|Overall Study|progressive disease|2
388747|NCT00134563|1235577|P2|Overall Study|progressive disease|4
388748|NCT00134563|1235578|P1|Overall Study|progressive disease|11
388749|NCT00134563|1235576|P3|Overall Study|Lost to Follow-up|2
388750|NCT00134563|1235577|P2|Overall Study|Lost to Follow-up|0
388751|NCT00134563|1235578|P1|Overall Study|Lost to Follow-up|4
388752|NCT00134563|1235576|P3|Overall Study|Protocol Violation|5
388753|NCT00134563|1235577|P2|Overall Study|Protocol Violation|2
388754|NCT00134563|1235578|P1|Overall Study|Protocol Violation|3
388755|NCT00134563|1235576|P3|Overall Study|Lack of Efficacy|17
388756|NCT00134563|1235577|P2|Overall Study|Lack of Efficacy|14
388757|NCT00134563|1235578|P1|Overall Study|Lack of Efficacy|24
388758|NCT00134563|1235576|P3|Overall Study|Adverse Event|38
388759|NCT00134563|1235577|P2|Overall Study|Adverse Event|37
388760|NCT00134563|1235578|P1|Overall Study|Adverse Event|29
388761|NCT00134563|1235576|P3|Overall Study|Not treated due to protocol violation|1
388762|NCT00134563|1235577|P2|Overall Study|Not treated due to protocol violation|1
388763|NCT00134563|1235578|P1|Overall Study|Not treated due to protocol violation|0
388764|NCT00134056|1235603|P2|Eligible for Protocol Assigned Treatment|Not specified|56
388765|NCT00134056|1235604|P1|Eligible for Protocol Assigned Treatment|Not specified|55
388766|NCT00134056|1235603|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
388767|NCT00134056|1235604|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
388768|NCT00134056|1235603|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
388769|NCT00134056|1235604|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
388770|NCT00134056|1235603|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
388771|NCT00134056|1235604|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
388772|NCT00134056|1235603|P2|Randomization|Not eligible for assigned treatment|20
388773|NCT00134056|1235604|P1|Randomization|Not eligible for assigned treatment|22
388774|NCT00133952|1235671|P2|Overall Study|Sponsor Decision|1
388775|NCT00133952|1235672|P1|Overall Study|Sponsor Decision|0
388776|NCT00133952|1235671|P2|Overall Study|Physician Decision|3
388777|NCT00133952|1235672|P1|Overall Study|Physician Decision|4
388778|NCT00133952|1235671|P2|Overall Study|Withdrawal by Subject|4
388779|NCT00133952|1235672|P1|Overall Study|Withdrawal by Subject|20
388780|NCT00133952|1235671|P2|Overall Study|Protocol Violation|1
388781|NCT00133952|1235672|P1|Overall Study|Protocol Violation|1
388782|NCT00133952|1235671|P2|Overall Study|Protocol Entry Criteria Exclusion|1
388783|NCT00133952|1235672|P1|Overall Study|Protocol Entry Criteria Exclusion|4
388784|NCT00133952|1235671|P2|Overall Study|Lost to Follow-up|14
388785|NCT00133952|1235672|P1|Overall Study|Lost to Follow-up|9
388786|NCT00133952|1235671|P2|Overall Study|Death|2
388787|NCT00133952|1235672|P1|Overall Study|Death|3
388788|NCT00133952|1235671|P2|Overall Study|Adverse Event|2
388789|NCT00133952|1235672|P1|Overall Study|Adverse Event|1
388790|NCT00133705|1235703|P2|Overall Study|Withdrawal by Subject|3
388791|NCT00133705|1235704|P1|Overall Study|Withdrawal by Subject|2
388792|NCT00132873|1235830|P1|Overall Study|Planned Pregnancy|1
388793|NCT00132873|1235830|P1|Overall Study|Withdrawal by Subject|3
388794|NCT00132873|1235830|P1|Overall Study|Lack of Efficacy|1
388795|NCT00132873|1235830|P1|Overall Study|Lost to Follow-up|1
388796|NCT00132873|1235830|P1|Overall Study|Adverse Event|3
388797|NCT00132808|1235838|P3|Stratum II|Withdrawal by Subject|6
388798|NCT00132808|1235839|P2|Stratum II|Withdrawal by Subject|9
388799|NCT00132808|1235840|P1|Stratum II|Withdrawal by Subject|4
388800|NCT00132808|1235838|P3|Stratum II|Protocol Violation|1
388801|NCT00132808|1235839|P2|Stratum II|Protocol Violation|2
388802|NCT00132808|1235840|P1|Stratum II|Protocol Violation|0
388803|NCT00132808|1235838|P3|Stratum II|Lost to Follow-up|1
388804|NCT00132808|1235839|P2|Stratum II|Lost to Follow-up|2
388805|NCT00132808|1235840|P1|Stratum II|Lost to Follow-up|2
388806|NCT00132808|1235838|P3|Stratum II|Death|0
388807|NCT00132808|1235839|P2|Stratum II|Death|0
388808|NCT00132808|1235840|P1|Stratum II|Death|1
388809|NCT00132808|1235838|P3|Stratum II|Adverse Event|1
388810|NCT00132808|1235839|P2|Stratum II|Adverse Event|2
388811|NCT00132808|1235840|P1|Stratum II|Adverse Event|1
388812|NCT00132808|1235838|P3|Stratum I|Abnormal test procedure result (s)|1
388813|NCT00132808|1235839|P2|Stratum I|Abnormal test procedure result (s)|0
388814|NCT00132808|1235840|P1|Stratum I|Abnormal test procedure result (s)|0
388815|NCT00132808|1235838|P3|Stratum I|Withdrawal by Subject|3
388816|NCT00132808|1235839|P2|Stratum I|Withdrawal by Subject|7
388817|NCT00132808|1235840|P1|Stratum I|Withdrawal by Subject|4
388818|NCT00132808|1235838|P3|Stratum I|Lost to Follow-up|1
388819|NCT00132808|1235839|P2|Stratum I|Lost to Follow-up|4
388820|NCT00132808|1235840|P1|Stratum I|Lost to Follow-up|3
388821|NCT00132808|1235838|P3|Stratum I|Adverse Event|0
388822|NCT00132808|1235839|P2|Stratum I|Adverse Event|1
388823|NCT00132808|1235840|P1|Stratum I|Adverse Event|2
388824|NCT00132769|1235865|P2|Overall Study|Protocol Violation|1
388825|NCT00132769|1235866|P1|Overall Study|Protocol Violation|1
388826|NCT00132769|1235865|P2|Overall Study|Adverse Event|1
388827|NCT00132769|1235866|P1|Overall Study|Adverse Event|2
388828|NCT00132769|1235865|P2|Overall Study|Lack of Efficacy|6
388829|NCT00132769|1235866|P1|Overall Study|Lack of Efficacy|7
388830|NCT00132769|1235865|P2|Overall Study|Withdrawal by Subject|3
388831|NCT00132769|1235866|P1|Overall Study|Withdrawal by Subject|1
388832|NCT00132730|1235892|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
388833|NCT00132730|1235893|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
388834|NCT00132730|1235894|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
388835|NCT00132730|1235895|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
388836|NCT00132730|1235896|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
388837|NCT00132730|1235897|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
388838|NCT00132730|1235892|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
388839|NCT00132730|1235893|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
388840|NCT00132730|1235894|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
388841|NCT00132730|1235895|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
388842|NCT00132730|1235896|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
388843|NCT00132730|1235897|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
388844|NCT00132730|1235892|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
388845|NCT00132730|1235893|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
388846|NCT00132730|1235894|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
388847|NCT00132730|1235895|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
388848|NCT00132730|1235896|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
388849|NCT00132730|1235897|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
388850|NCT00132730|1235892|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
388851|NCT00132730|1235893|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
388852|NCT00132730|1235894|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
388853|NCT00132730|1235895|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
388854|NCT00132730|1235896|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
388855|NCT00132730|1235897|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
388856|NCT00132730|1235892|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
388857|NCT00132730|1235893|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
388858|NCT00132730|1235894|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
388859|NCT00132730|1235895|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
388860|NCT00132730|1235896|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
388861|NCT00132730|1235897|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
388862|NCT00132730|1235892|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
388863|NCT00132730|1235893|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
388864|NCT00132730|1235894|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
388865|NCT00132730|1235895|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
388866|NCT00132730|1235896|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
388867|NCT00132730|1235897|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
388868|NCT00132730|1235892|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
388869|NCT00132730|1235893|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
388870|NCT00132730|1235894|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
388871|NCT00132730|1235895|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
388872|NCT00132730|1235896|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
388873|NCT00132730|1235897|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
388874|NCT00132730|1235892|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
388875|NCT00132730|1235893|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
388876|NCT00132730|1235894|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
388877|NCT00132730|1235895|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
388878|NCT00132730|1235896|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
388879|NCT00132730|1235897|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
388880|NCT00132730|1235892|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
388881|NCT00132730|1235893|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
388882|NCT00132730|1235894|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
388883|NCT00132730|1235895|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
388884|NCT00132730|1235896|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
388885|NCT00132730|1235897|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
388886|NCT00132730|1235892|P6|Period II - 12-week Treatment (Base)|Other reasons|0
389110|NCT00130832|1236299|P2|Overall Study|Protocol Violation|8
388887|NCT00132730|1235893|P5|Period II - 12-week Treatment (Base)|Other reasons|0
388888|NCT00132730|1235894|P4|Period II - 12-week Treatment (Base)|Other reasons|13
388889|NCT00132730|1235895|P3|Period II - 12-week Treatment (Base)|Other reasons|9
388890|NCT00132730|1235896|P2|Period II - 12-week Treatment (Base)|Other reasons|10
388891|NCT00132730|1235897|P1|Period II - 12-week Treatment (Base)|Other reasons|11
388892|NCT00132730|1235892|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
388893|NCT00132730|1235893|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
388894|NCT00132730|1235894|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
388895|NCT00132730|1235895|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
388896|NCT00132730|1235896|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
388897|NCT00132730|1235897|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
388898|NCT00132730|1235892|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
388899|NCT00132730|1235893|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
388900|NCT00132730|1235894|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
388901|NCT00132730|1235895|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
388902|NCT00132730|1235896|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
388903|NCT00132730|1235897|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
388904|NCT00132691|1235941|P2|Overall Study|Death|0
388905|NCT00132691|1235942|P1|Overall Study|Death|2
388906|NCT00132691|1235941|P2|Overall Study|Missed 2-year visit|4
388907|NCT00132691|1235942|P1|Overall Study|Missed 2-year visit|4
388908|NCT00132691|1235941|P2|Overall Study|Lost to Follow-up|8
388909|NCT00132691|1235942|P1|Overall Study|Lost to Follow-up|5
388910|NCT00132678|1235982|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
388911|NCT00132678|1235983|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
388912|NCT00132678|1235984|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
388913|NCT00132678|1235982|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
388914|NCT00132678|1235983|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
388915|NCT00132678|1235984|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
388916|NCT00132678|1235982|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
388917|NCT00132678|1235983|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
388918|NCT00132678|1235984|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
388919|NCT00132678|1235982|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
388920|NCT00132678|1235983|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
388921|NCT00132678|1235984|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
388922|NCT00132678|1235982|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
388923|NCT00132678|1235983|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
388924|NCT00132678|1235984|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
388925|NCT00132678|1235982|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
388926|NCT00132678|1235983|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
388927|NCT00132678|1235984|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
388928|NCT00132678|1235982|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
388929|NCT00132678|1235983|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
388930|NCT00132678|1235984|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
388931|NCT00132678|1235982|P3|Period III (Open-Label Stabilization)|Pregnancy|0
388932|NCT00132678|1235983|P2|Period III (Open-Label Stabilization)|Pregnancy|0
388933|NCT00132678|1235984|P1|Period III (Open-Label Stabilization)|Pregnancy|2
388934|NCT00132678|1235982|P3|Period III (Open-Label Stabilization)|Physician Decision|0
388935|NCT00132678|1235983|P2|Period III (Open-Label Stabilization)|Physician Decision|0
388936|NCT00132678|1235984|P1|Period III (Open-Label Stabilization)|Physician Decision|1
388937|NCT00132678|1235982|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
388938|NCT00132678|1235983|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
388939|NCT00132678|1235984|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
388940|NCT00132678|1235982|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
388941|NCT00132678|1235983|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
388942|NCT00132678|1235984|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
388943|NCT00132678|1235982|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
388944|NCT00132678|1235983|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
388945|NCT00132678|1235984|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
388946|NCT00132678|1235982|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
388947|NCT00132678|1235983|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
388948|NCT00132678|1235984|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
388949|NCT00132678|1235982|P3|Period III (Open-Label Stabilization)|Non responder|0
388950|NCT00132678|1235983|P2|Period III (Open-Label Stabilization)|Non responder|0
388951|NCT00132678|1235984|P1|Period III (Open-Label Stabilization)|Non responder|107
388952|NCT00132678|1235982|P3|Period III (Open-Label Stabilization)|Adverse Event|0
388953|NCT00132678|1235983|P2|Period III (Open-Label Stabilization)|Adverse Event|0
388954|NCT00132678|1235984|P1|Period III (Open-Label Stabilization)|Adverse Event|12
388955|NCT00132678|1235982|P3|Period III (Open-Label Stabilization)|Death|0
388956|NCT00132678|1235983|P2|Period III (Open-Label Stabilization)|Death|0
388957|NCT00132678|1235984|P1|Period III (Open-Label Stabilization)|Death|2
388958|NCT00132678|1235982|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
389111|NCT00130832|1236300|P1|Overall Study|Protocol Violation|6
388959|NCT00132678|1235983|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
388960|NCT00132678|1235984|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
388961|NCT00132678|1235982|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
388962|NCT00132678|1235983|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
388963|NCT00132678|1235984|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
388964|NCT00132678|1235982|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
388965|NCT00132678|1235983|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
388966|NCT00132678|1235984|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
388967|NCT00132678|1235982|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
388968|NCT00132678|1235983|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
388969|NCT00132678|1235984|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
388970|NCT00132678|1235982|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
388971|NCT00132678|1235983|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
388972|NCT00132678|1235984|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
388973|NCT00132678|1235982|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
388974|NCT00132678|1235983|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
388975|NCT00132678|1235984|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
388976|NCT00132678|1235982|P3|Period II (Open-Label Oral Risperidone)|Death|1
388977|NCT00132678|1235983|P2|Period II (Open-Label Oral Risperidone)|Death|0
388978|NCT00132678|1235984|P1|Period II (Open-Label Oral Risperidone)|Death|0
388979|NCT00132496|1235998|P2|Overall Study|Physician Decision|0
388980|NCT00132496|1235999|P1|Overall Study|Physician Decision|1
388981|NCT00132496|1235998|P2|Overall Study|Withdrawal by Subject|2
388982|NCT00132496|1235999|P1|Overall Study|Withdrawal by Subject|1
388983|NCT00132314|1236007|P2|Overall Study|Refused intervention at baseline|7
388984|NCT00132314|1236008|P1|Overall Study|Refused intervention at baseline|2
388985|NCT00132314|1236007|P2|Overall Study|Lacked SSN|3
388986|NCT00132314|1236008|P1|Overall Study|Lacked SSN|1
388987|NCT00132314|1236007|P2|Overall Study|Lost to Follow-up|62
388988|NCT00132314|1236008|P1|Overall Study|Lost to Follow-up|70
388989|NCT00132132|1236018|P2|Overall Study|Lost to Follow-up|2
388990|NCT00132132|1236019|P1|Overall Study|Lost to Follow-up|7
388991|NCT00132028|1236027|P1|Overall Study|Physician Decision|3
388992|NCT00132028|1236027|P1|Overall Study|not eligible|2
388993|NCT00132028|1236027|P1|Overall Study|Withdrawal by Subject|2
388994|NCT00132028|1236027|P1|Overall Study|Lack of Efficacy|11
388995|NCT00132028|1236027|P1|Overall Study|Death|2
388996|NCT00132028|1236027|P1|Overall Study|Adverse Event|7
388997|NCT00131937|1236039|P1|Overall Study|Alternative therapy|1
388998|NCT00131937|1236039|P1|Overall Study|Disease Progression|7
388999|NCT00131937|1236039|P1|Overall Study|Physician Decision|1
389000|NCT00131937|1236039|P1|Overall Study|Withdrawal by Subject|2
389001|NCT00131937|1236039|P1|Overall Study|Adverse Event|3
389002|NCT00131911|1236047|P2|Overall Study|Withdrawal by Subject|0
389003|NCT00131911|1236048|P1|Overall Study|Withdrawal by Subject|1
389004|NCT00131664|1236118|P6|Second Period (Additional Drug Added)|Administrative reasons|0
389005|NCT00131664|1236119|P5|Second Period (Additional Drug Added)|Administrative reasons|1
389006|NCT00131664|1236120|P4|Second Period (Additional Drug Added)|Administrative reasons|0
389007|NCT00131664|1236121|P3|Second Period (Additional Drug Added)|Administrative reasons|0
389008|NCT00131664|1236122|P2|Second Period (Additional Drug Added)|Administrative reasons|2
389009|NCT00131664|1236123|P1|Second Period (Additional Drug Added)|Administrative reasons|4
389010|NCT00131664|1236118|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
389011|NCT00131664|1236119|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
389012|NCT00131664|1236120|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
389013|NCT00131664|1236121|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
389014|NCT00131664|1236122|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
389015|NCT00131664|1236123|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
389016|NCT00131664|1236118|P6|Second Period (Additional Drug Added)|Adverse Event|1
389017|NCT00131664|1236119|P5|Second Period (Additional Drug Added)|Adverse Event|0
389018|NCT00131664|1236120|P4|Second Period (Additional Drug Added)|Adverse Event|0
389019|NCT00131664|1236121|P3|Second Period (Additional Drug Added)|Adverse Event|0
389020|NCT00131664|1236122|P2|Second Period (Additional Drug Added)|Adverse Event|1
389021|NCT00131664|1236123|P1|Second Period (Additional Drug Added)|Adverse Event|0
389022|NCT00131664|1236118|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
389023|NCT00131664|1236119|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
389024|NCT00131664|1236120|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
389025|NCT00131664|1236121|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
389026|NCT00131664|1236122|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
389027|NCT00131664|1236123|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
389028|NCT00131664|1236118|P6|Second Period (Additional Drug Added)|Protocol Violation|0
389029|NCT00131664|1236119|P5|Second Period (Additional Drug Added)|Protocol Violation|0
389030|NCT00131664|1236120|P4|Second Period (Additional Drug Added)|Protocol Violation|0
389031|NCT00131664|1236121|P3|Second Period (Additional Drug Added)|Protocol Violation|1
389032|NCT00131664|1236122|P2|Second Period (Additional Drug Added)|Protocol Violation|1
389033|NCT00131664|1236123|P1|Second Period (Additional Drug Added)|Protocol Violation|0
389034|NCT00131664|1236118|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
389035|NCT00131664|1236119|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
389036|NCT00131664|1236120|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
389037|NCT00131664|1236121|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
389118|NCT00130793|1236312|P2|Overall Study|Lost to Follow-up|4
389038|NCT00131664|1236122|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
389039|NCT00131664|1236123|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
389040|NCT00131664|1236118|P6|First Period (First 6 Months)|Administrative reasons|0
389041|NCT00131664|1236119|P5|First Period (First 6 Months)|Administrative reasons|0
389042|NCT00131664|1236120|P4|First Period (First 6 Months)|Administrative reasons|0
389043|NCT00131664|1236121|P3|First Period (First 6 Months)|Administrative reasons|5
389044|NCT00131664|1236122|P2|First Period (First 6 Months)|Administrative reasons|0
389045|NCT00131664|1236123|P1|First Period (First 6 Months)|Administrative reasons|2
389046|NCT00131664|1236118|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
389047|NCT00131664|1236119|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
389048|NCT00131664|1236120|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
389049|NCT00131664|1236121|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
389050|NCT00131664|1236122|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
389051|NCT00131664|1236123|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
389052|NCT00131664|1236118|P6|First Period (First 6 Months)|Adverse Event|0
389053|NCT00131664|1236119|P5|First Period (First 6 Months)|Adverse Event|0
389054|NCT00131664|1236120|P4|First Period (First 6 Months)|Adverse Event|0
389055|NCT00131664|1236121|P3|First Period (First 6 Months)|Adverse Event|5
389056|NCT00131664|1236122|P2|First Period (First 6 Months)|Adverse Event|4
389057|NCT00131664|1236123|P1|First Period (First 6 Months)|Adverse Event|9
389058|NCT00131664|1236118|P6|First Period (First 6 Months)|Withdrawal by Subject|0
389059|NCT00131664|1236119|P5|First Period (First 6 Months)|Withdrawal by Subject|0
389060|NCT00131664|1236120|P4|First Period (First 6 Months)|Withdrawal by Subject|0
389061|NCT00131664|1236121|P3|First Period (First 6 Months)|Withdrawal by Subject|2
389062|NCT00131664|1236122|P2|First Period (First 6 Months)|Withdrawal by Subject|6
389063|NCT00131664|1236123|P1|First Period (First 6 Months)|Withdrawal by Subject|4
389064|NCT00131664|1236118|P6|First Period (First 6 Months)|Protocol Violation|0
389065|NCT00131664|1236119|P5|First Period (First 6 Months)|Protocol Violation|0
389066|NCT00131664|1236120|P4|First Period (First 6 Months)|Protocol Violation|0
389067|NCT00131664|1236121|P3|First Period (First 6 Months)|Protocol Violation|1
389068|NCT00131664|1236122|P2|First Period (First 6 Months)|Protocol Violation|2
389069|NCT00131664|1236123|P1|First Period (First 6 Months)|Protocol Violation|2
389070|NCT00131664|1236118|P6|First Period (First 6 Months)|Death|0
389071|NCT00131664|1236119|P5|First Period (First 6 Months)|Death|0
389072|NCT00131664|1236120|P4|First Period (First 6 Months)|Death|0
389073|NCT00131664|1236121|P3|First Period (First 6 Months)|Death|0
389074|NCT00131664|1236122|P2|First Period (First 6 Months)|Death|1
389075|NCT00131664|1236123|P1|First Period (First 6 Months)|Death|0
389076|NCT00131664|1236118|P6|First Period (First 6 Months)|Lost to Follow-up|0
389077|NCT00131664|1236119|P5|First Period (First 6 Months)|Lost to Follow-up|0
389078|NCT00131664|1236120|P4|First Period (First 6 Months)|Lost to Follow-up|0
389079|NCT00131664|1236121|P3|First Period (First 6 Months)|Lost to Follow-up|3
389080|NCT00131664|1236122|P2|First Period (First 6 Months)|Lost to Follow-up|3
389081|NCT00131664|1236123|P1|First Period (First 6 Months)|Lost to Follow-up|7
389082|NCT00131508|1236195|P2|Overall Study|Withdrawal by Subject|2
389083|NCT00131508|1236196|P1|Overall Study|Withdrawal by Subject|1
389084|NCT00131508|1236195|P2|Overall Study|Non-Compliance|4
389085|NCT00131508|1236196|P1|Overall Study|Non-Compliance|2
389086|NCT00131508|1236195|P2|Overall Study|Disease progression|2
389087|NCT00131508|1236196|P1|Overall Study|Disease progression|0
389088|NCT00131352|1236258|P2|Repeat Treatment Period|Unspecified|0
389089|NCT00131352|1236259|P1|Repeat Treatment Period|Unspecified|1
389090|NCT00131352|1236258|P2|Repeat Treatment Period|Adverse Event|0
389091|NCT00131352|1236259|P1|Repeat Treatment Period|Adverse Event|1
389092|NCT00131352|1236258|P2|Initial Treatment Period|Unspecified|2
389093|NCT00131352|1236259|P1|Initial Treatment Period|Unspecified|0
389094|NCT00131352|1236258|P2|Initial Treatment Period|Lack of Efficacy|4
389095|NCT00131352|1236259|P1|Initial Treatment Period|Lack of Efficacy|6
389096|NCT00131352|1236258|P2|Initial Treatment Period|Withdrawal by Subject|1
389097|NCT00131352|1236259|P1|Initial Treatment Period|Withdrawal by Subject|1
389098|NCT00131352|1236258|P2|Initial Treatment Period|Non-compliant|2
389099|NCT00131352|1236259|P1|Initial Treatment Period|Non-compliant|1
389100|NCT00131352|1236258|P2|Initial Treatment Period|Adverse Event|3
389101|NCT00131352|1236259|P1|Initial Treatment Period|Adverse Event|1
389102|NCT00131248|1236281|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
389103|NCT00131248|1236282|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
389104|NCT00130832|1236299|P2|Overall Study|Unspecified|3
389105|NCT00130832|1236300|P1|Overall Study|Unspecified|0
389106|NCT00130832|1236299|P2|Overall Study|Moved|2
389107|NCT00130832|1236300|P1|Overall Study|Moved|2
389108|NCT00130832|1236299|P2|Overall Study|Withdrawal by Subject|1
389109|NCT00130832|1236300|P1|Overall Study|Withdrawal by Subject|6
389112|NCT00130832|1236299|P2|Overall Study|Lost to Follow-up|2
389113|NCT00130832|1236300|P1|Overall Study|Lost to Follow-up|1
389114|NCT00130832|1236299|P2|Overall Study|Adverse Event|1
389115|NCT00130832|1236300|P1|Overall Study|Adverse Event|1
389116|NCT00130793|1236312|P2|Overall Study|Withdrew consent|0
389117|NCT00130793|1236313|P1|Overall Study|Withdrew consent|2
389119|NCT00130793|1236313|P1|Overall Study|Lost to Follow-up|1
389120|NCT00130728|1236334|P2|Overall Study|Withdrawal by Subject|2
389121|NCT00130728|1236335|P1|Overall Study|Withdrawal by Subject|0
389122|NCT00130728|1236334|P2|Overall Study|Lost to Follow-up|0
389123|NCT00130728|1236335|P1|Overall Study|Lost to Follow-up|4
389124|NCT00130728|1236334|P2|Overall Study|Death|211
389125|NCT00130728|1236335|P1|Overall Study|Death|207
389126|NCT00130689|1236347|P1|Overall Study|Ineligible|6
389127|NCT00130689|1236347|P1|Overall Study|Withdrawal by Subject|3
389128|NCT00130689|1236347|P1|Overall Study|Clinical Deterioration|4
389129|NCT00130689|1236347|P1|Overall Study|Death|1
389130|NCT00130689|1236347|P1|Overall Study|Progressive Disease|29
389131|NCT00130637|1236351|P1|Overall Study|Withdrawal by Subject|1
389132|NCT00130637|1236351|P1|Overall Study|Adverse Event|2
389133|NCT00130520|1236356|P1|Overall Study|Did not meet re-treatment criteria|1
389134|NCT00130520|1236356|P1|Overall Study|Protocol non-compliance|1
389135|NCT00130520|1236356|P1|Overall Study|Disease Progression|23
389136|NCT00130520|1236356|P1|Overall Study|Withdrawal by Subject|1
389137|NCT00130520|1236356|P1|Overall Study|Physician Decision|1
389138|NCT00130520|1236356|P1|Overall Study|Death|1
389139|NCT00130520|1236356|P1|Overall Study|Adverse Event|11
389140|NCT00130286|1236366|P4|Overall Study|Missing lab specimens|0
389141|NCT00130286|1236367|P3|Overall Study|Missing lab specimens|0
389142|NCT00130286|1236368|P2|Overall Study|Missing lab specimens|2
389143|NCT00130286|1236369|P1|Overall Study|Missing lab specimens|0
389144|NCT00130286|1236366|P4|Overall Study|Adverse Event|0
389145|NCT00130286|1236367|P3|Overall Study|Adverse Event|2
389146|NCT00130286|1236368|P2|Overall Study|Adverse Event|0
389147|NCT00130286|1236369|P1|Overall Study|Adverse Event|0
389148|NCT00130286|1236366|P4|Overall Study|Withdrawal by Subject|2
389149|NCT00130286|1236367|P3|Overall Study|Withdrawal by Subject|2
389150|NCT00130286|1236368|P2|Overall Study|Withdrawal by Subject|1
389151|NCT00130286|1236369|P1|Overall Study|Withdrawal by Subject|0
389152|NCT00130247|1236389|P2|Overall Study|Not compliant with DOT|2
389153|NCT00130247|1236390|P1|Overall Study|Not compliant with DOT|0
389154|NCT00130247|1236389|P2|Overall Study|Post-randomization exclusion|2
389155|NCT00130247|1236390|P1|Overall Study|Post-randomization exclusion|1
389156|NCT00130247|1236389|P2|Overall Study|Pregnancy|0
389157|NCT00130247|1236390|P1|Overall Study|Pregnancy|1
389158|NCT00130039|1236432|P2|Overall Study|clinical events without follow up MRI|4
389159|NCT00130039|1236433|P1|Overall Study|clinical events without follow up MRI|5
389160|NCT00130039|1236432|P2|Overall Study|Physician Decision|0
389161|NCT00130039|1236433|P1|Overall Study|Physician Decision|3
389162|NCT00130039|1236432|P2|Overall Study|Adverse Event|2
389163|NCT00130039|1236433|P1|Overall Study|Adverse Event|4
389164|NCT00130039|1236432|P2|Overall Study|Lost to Follow-up|1
389165|NCT00130039|1236433|P1|Overall Study|Lost to Follow-up|3
389166|NCT00130039|1236432|P2|Overall Study|Withdrawal by Subject|11
389167|NCT00130039|1236433|P1|Overall Study|Withdrawal by Subject|15
389168|NCT00129974|1236449|P1|Overall Study|Other|1
389169|NCT00129961|1236456|P2|Overall Study|Missing Record|1
389170|NCT00129961|1236457|P1|Overall Study|Missing Record|0
389171|NCT00129961|1236456|P2|Overall Study|Withdrawal by Subject|1
389172|NCT00129961|1236457|P1|Overall Study|Withdrawal by Subject|2
389173|NCT00129961|1236456|P2|Overall Study|Physician Decision|0
389174|NCT00129961|1236457|P1|Overall Study|Physician Decision|1
389175|NCT00129961|1236456|P2|Overall Study|Withdrawal by Sponsor|20
389176|NCT00129961|1236457|P1|Overall Study|Withdrawal by Sponsor|14
389177|NCT00129961|1236456|P2|Overall Study|Death|1
389178|NCT00129961|1236457|P1|Overall Study|Death|1
389179|NCT00129961|1236456|P2|Overall Study|Adverse Event|0
389180|NCT00129961|1236457|P1|Overall Study|Adverse Event|1
389181|NCT00129766|1236493|P2|Overall Study|Lost to Follow-up|21
389182|NCT00129766|1236494|P1|Overall Study|Lost to Follow-up|26
389183|NCT00129766|1236493|P2|Overall Study|Withdrawal of consent|30
389184|NCT00129766|1236494|P1|Overall Study|Withdrawal of consent|31
389185|NCT00129766|1236493|P2|Overall Study|Death|8
389186|NCT00129766|1236494|P1|Overall Study|Death|3
389187|NCT00129623|1236540|P2|Overall Study|Uncertainty to return|1
389188|NCT00129623|1236541|P1|Overall Study|Uncertainty to return|0
389189|NCT00129623|1236540|P2|Overall Study|Relocated job out of state|0
389190|NCT00129623|1236541|P1|Overall Study|Relocated job out of state|1
389191|NCT00129623|1236540|P2|Overall Study|Failure to Return|1
389192|NCT00129623|1236541|P1|Overall Study|Failure to Return|1
389193|NCT00129623|1236540|P2|Overall Study|Refused Treatment|3
389194|NCT00129623|1236541|P1|Overall Study|Refused Treatment|5
389195|NCT00129623|1236540|P2|Overall Study|Adverse Event|7
389196|NCT00129623|1236541|P1|Overall Study|Adverse Event|3
389197|NCT00129545|1236566|P3|Overall Study|Device not implanted|0
389198|NCT00129545|1236567|P2|Overall Study|Device not implanted|61
389199|NCT00129545|1236568|P1|Overall Study|Device not implanted|16
389200|NCT00129545|1236566|P3|Overall Study|Physician Decision|10
389201|NCT00129545|1236567|P2|Overall Study|Physician Decision|3
389202|NCT00129545|1236568|P1|Overall Study|Physician Decision|0
389203|NCT00129545|1236566|P3|Overall Study|Lost to Follow-up|13
389204|NCT00129545|1236567|P2|Overall Study|Lost to Follow-up|22
389205|NCT00129545|1236568|P1|Overall Study|Lost to Follow-up|2
389206|NCT00129545|1236566|P3|Overall Study|Withdrawal by Subject|44
389207|NCT00129545|1236567|P2|Overall Study|Withdrawal by Subject|18
389208|NCT00129545|1236568|P1|Overall Study|Withdrawal by Subject|3
389209|NCT00129545|1236566|P3|Overall Study|Death|44
389210|NCT00129545|1236567|P2|Overall Study|Death|60
389211|NCT00129545|1236568|P1|Overall Study|Death|5
389212|NCT00129467|1236589|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
389213|NCT00129467|1236590|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
389214|NCT00129467|1236589|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
389215|NCT00129467|1236590|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
389216|NCT00129467|1236589|P2|Received Intervention|Dizzyness, fatigue|1
389217|NCT00129467|1236590|P1|Received Intervention|Dizzyness, fatigue|0
389218|NCT00129467|1236589|P2|Received Intervention|Intolerance to citalopram|1
389219|NCT00129467|1236590|P1|Received Intervention|Intolerance to citalopram|0
389220|NCT00129467|1236589|P2|Received Intervention|Nausea|0
389221|NCT00129467|1236590|P1|Received Intervention|Nausea|1
389222|NCT00129467|1236589|P2|Received Intervention|Withdrawal by Subject|0
389223|NCT00129467|1236590|P1|Received Intervention|Withdrawal by Subject|1
389224|NCT00129467|1236589|P2|Received Intervention|Delirium|0
389225|NCT00129467|1236590|P1|Received Intervention|Delirium|2
389226|NCT00129467|1236589|P2|Received Intervention|Cardiac SAE (hypertension)|1
389227|NCT00129467|1236590|P1|Received Intervention|Cardiac SAE (hypertension)|1
389228|NCT00129467|1236589|P2|Received Intervention|Death|1
389229|NCT00129467|1236590|P1|Received Intervention|Death|1
389230|NCT00129402|1236621|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
389231|NCT00129402|1236622|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
389232|NCT00129402|1236623|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
389233|NCT00129402|1236624|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
389234|NCT00129402|1236625|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
389235|NCT00129402|1236626|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
389236|NCT00129402|1236627|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
389237|NCT00129402|1236621|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
389238|NCT00129402|1236622|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
389239|NCT00129402|1236623|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
389240|NCT00129402|1236624|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
389241|NCT00129402|1236625|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
389242|NCT00129402|1236626|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
389243|NCT00129402|1236627|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
389244|NCT00129402|1236621|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
389245|NCT00129402|1236622|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
389246|NCT00129402|1236623|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
389247|NCT00129402|1236624|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
389248|NCT00129402|1236625|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
389249|NCT00129402|1236626|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
389250|NCT00129402|1236627|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
389251|NCT00129402|1236621|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
389252|NCT00129402|1236622|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
389253|NCT00129402|1236623|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
389254|NCT00129402|1236624|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
389255|NCT00129402|1236625|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
389256|NCT00129402|1236626|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
389257|NCT00129402|1236627|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
389258|NCT00129402|1236621|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
389259|NCT00129402|1236622|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
389260|NCT00129402|1236623|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
389261|NCT00129402|1236624|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
389262|NCT00129402|1236625|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
389263|NCT00129402|1236626|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
389264|NCT00129402|1236627|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
389265|NCT00129402|1236621|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
389266|NCT00129402|1236622|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
389267|NCT00129402|1236623|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
389268|NCT00129402|1236624|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
389269|NCT00129402|1236625|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
389270|NCT00129402|1236626|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
389271|NCT00129402|1236627|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
389272|NCT00129402|1236621|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
389273|NCT00129402|1236622|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
389274|NCT00129402|1236623|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
389275|NCT00129402|1236624|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
389276|NCT00129402|1236625|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
389277|NCT00129402|1236626|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
389278|NCT00129402|1236627|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
389279|NCT00129402|1236621|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
389280|NCT00129402|1236622|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
389281|NCT00129402|1236623|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
389282|NCT00129402|1236624|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
389283|NCT00129402|1236625|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
389284|NCT00129402|1236626|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
389285|NCT00129402|1236627|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
389286|NCT00129402|1236621|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
389287|NCT00129402|1236622|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
389288|NCT00129402|1236623|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
389289|NCT00129402|1236624|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
389290|NCT00129402|1236625|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
389291|NCT00129402|1236626|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
389292|NCT00129402|1236627|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
389293|NCT00129402|1236621|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
389294|NCT00129402|1236622|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
389295|NCT00129402|1236623|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
389296|NCT00129402|1236624|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
389297|NCT00129402|1236625|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
389298|NCT00129402|1236626|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
389299|NCT00129402|1236627|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
389300|NCT00129402|1236621|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
389301|NCT00129402|1236622|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
389302|NCT00129402|1236623|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
389303|NCT00129402|1236624|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
389304|NCT00129402|1236625|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
389305|NCT00129402|1236626|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
389306|NCT00129402|1236627|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
389307|NCT00129402|1236621|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
389308|NCT00129402|1236622|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
389309|NCT00129402|1236623|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
389310|NCT00129402|1236624|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
389311|NCT00129402|1236625|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
389312|NCT00129402|1236626|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
389313|NCT00129402|1236627|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
389314|NCT00129402|1236621|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
389315|NCT00129402|1236622|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
389316|NCT00129402|1236623|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
389317|NCT00129402|1236624|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
389318|NCT00129402|1236625|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
389319|NCT00129402|1236626|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
389320|NCT00129402|1236627|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
389321|NCT00129311|1236646|P2|Overall Study|Withdrawal by Subject|19
389322|NCT00129311|1236647|P1|Overall Study|Withdrawal by Subject|12
389323|NCT00129272|1236657|P2|Overall Study|Withdrawal by Subject|11
389324|NCT00129272|1236658|P1|Overall Study|Withdrawal by Subject|5
389325|NCT00129272|1236657|P2|Overall Study|Lost to Follow-up|11
389326|NCT00129272|1236658|P1|Overall Study|Lost to Follow-up|12
389327|NCT00129259|1236668|P2|Overall Study|Only available minimal phone assessments|1
389328|NCT00129259|1236669|P1|Overall Study|Only available minimal phone assessments|0
389329|NCT00129259|1236668|P2|Overall Study|Withdrawal by Subject|1
389330|NCT00129259|1236669|P1|Overall Study|Withdrawal by Subject|2
389331|NCT00129259|1236668|P2|Overall Study|Lost to Follow-up|1
389332|NCT00129259|1236669|P1|Overall Study|Lost to Follow-up|1
389333|NCT00129220|1236697|P3|Study Period III|Reason Not Specified|2
389334|NCT00129220|1236698|P2|Study Period III|Reason Not Specified|0
389335|NCT00129220|1236699|P1|Study Period III|Reason Not Specified|9
389336|NCT00129220|1236697|P3|Study Period III|Sponsor Decision|0
389337|NCT00129220|1236698|P2|Study Period III|Sponsor Decision|0
389338|NCT00129220|1236699|P1|Study Period III|Sponsor Decision|1
389339|NCT00129220|1236697|P3|Study Period III|Withdrawal by Subject|3
389340|NCT00129220|1236698|P2|Study Period III|Withdrawal by Subject|0
389341|NCT00129220|1236699|P1|Study Period III|Withdrawal by Subject|1
389342|NCT00129220|1236697|P3|Study Period III|Protocol Violation|2
389343|NCT00129220|1236698|P2|Study Period III|Protocol Violation|1
389344|NCT00129220|1236699|P1|Study Period III|Protocol Violation|1
389345|NCT00129220|1236697|P3|Study Period III|Adverse Event|3
389346|NCT00129220|1236698|P2|Study Period III|Adverse Event|0
389347|NCT00129220|1236699|P1|Study Period III|Adverse Event|1
389348|NCT00129220|1236697|P3|Study Period II|Reason Not Specified|5
389349|NCT00129220|1236698|P2|Study Period II|Reason Not Specified|0
389350|NCT00129220|1236699|P1|Study Period II|Reason Not Specified|2
389351|NCT00129220|1236697|P3|Study Period II|Withdrawal by Subject|4
389352|NCT00129220|1236698|P2|Study Period II|Withdrawal by Subject|3
389353|NCT00129220|1236699|P1|Study Period II|Withdrawal by Subject|1
389354|NCT00129220|1236697|P3|Study Period II|Physician Decision|0
389355|NCT00129220|1236698|P2|Study Period II|Physician Decision|1
389356|NCT00129220|1236699|P1|Study Period II|Physician Decision|0
389357|NCT00129220|1236697|P3|Study Period II|Protocol Violation|1
389358|NCT00129220|1236698|P2|Study Period II|Protocol Violation|2
389359|NCT00129220|1236699|P1|Study Period II|Protocol Violation|4
389360|NCT00129220|1236697|P3|Study Period II|Entry Criteria Not Met|2
389361|NCT00129220|1236698|P2|Study Period II|Entry Criteria Not Met|0
389362|NCT00129220|1236699|P1|Study Period II|Entry Criteria Not Met|2
389363|NCT00129220|1236697|P3|Study Period II|Lack of Efficacy|28
389364|NCT00129220|1236698|P2|Study Period II|Lack of Efficacy|1
389365|NCT00129220|1236699|P1|Study Period II|Lack of Efficacy|15
389366|NCT00129220|1236697|P3|Study Period II|Adverse Event|7
389367|NCT00129220|1236698|P2|Study Period II|Adverse Event|5
389368|NCT00129220|1236699|P1|Study Period II|Adverse Event|9
389369|NCT00129129|1236739|P5|Fourth Dose Phase|Protocol Violation|0
389370|NCT00129129|1236740|P4|Fourth Dose Phase|Protocol Violation|1
389371|NCT00129129|1236741|P3|Fourth Dose Phase|Protocol Violation|0
389372|NCT00129129|1236742|P2|Fourth Dose Phase|Protocol Violation|0
389373|NCT00129129|1236743|P1|Fourth Dose Phase|Protocol Violation|0
389374|NCT00129129|1236739|P5|Fourth Dose Phase|Unspecified|1
389375|NCT00129129|1236740|P4|Fourth Dose Phase|Unspecified|1
389376|NCT00129129|1236741|P3|Fourth Dose Phase|Unspecified|0
389377|NCT00129129|1236742|P2|Fourth Dose Phase|Unspecified|0
389378|NCT00129129|1236743|P1|Fourth Dose Phase|Unspecified|0
389379|NCT00129129|1236739|P5|Fourth Dose Phase|Migration from study area|2
389380|NCT00129129|1236740|P4|Fourth Dose Phase|Migration from study area|0
389381|NCT00129129|1236741|P3|Fourth Dose Phase|Migration from study area|0
389382|NCT00129129|1236742|P2|Fourth Dose Phase|Migration from study area|0
389383|NCT00129129|1236743|P1|Fourth Dose Phase|Migration from study area|0
389384|NCT00129129|1236739|P5|Fourth Dose Phase|Withdrawal by Subject|1
389385|NCT00129129|1236740|P4|Fourth Dose Phase|Withdrawal by Subject|0
389386|NCT00129129|1236741|P3|Fourth Dose Phase|Withdrawal by Subject|0
389387|NCT00129129|1236742|P2|Fourth Dose Phase|Withdrawal by Subject|0
389388|NCT00129129|1236743|P1|Fourth Dose Phase|Withdrawal by Subject|0
389389|NCT00129129|1236739|P5|Fourth Dose Phase|Lost to Follow-up|2
389390|NCT00129129|1236740|P4|Fourth Dose Phase|Lost to Follow-up|2
389391|NCT00129129|1236741|P3|Fourth Dose Phase|Lost to Follow-up|0
389392|NCT00129129|1236742|P2|Fourth Dose Phase|Lost to Follow-up|0
389393|NCT00129129|1236743|P1|Fourth Dose Phase|Lost to Follow-up|4
389394|NCT00129129|1236739|P5|Primary Phase|Unspecified|0
389395|NCT00129129|1236740|P4|Primary Phase|Unspecified|0
389396|NCT00129129|1236741|P3|Primary Phase|Unspecified|0
389397|NCT00129129|1236742|P2|Primary Phase|Unspecified|5
389398|NCT00129129|1236743|P1|Primary Phase|Unspecified|2
389399|NCT00129129|1236739|P5|Primary Phase|Lost to Follow-up|0
389400|NCT00129129|1236740|P4|Primary Phase|Lost to Follow-up|0
389401|NCT00129129|1236741|P3|Primary Phase|Lost to Follow-up|0
389402|NCT00129129|1236742|P2|Primary Phase|Lost to Follow-up|6
389403|NCT00129129|1236743|P1|Primary Phase|Lost to Follow-up|8
389404|NCT00129129|1236739|P5|Primary Phase|Migration from study area|0
389405|NCT00129129|1236740|P4|Primary Phase|Migration from study area|0
389406|NCT00129129|1236741|P3|Primary Phase|Migration from study area|0
389407|NCT00129129|1236742|P2|Primary Phase|Migration from study area|3
389408|NCT00129129|1236743|P1|Primary Phase|Migration from study area|1
389409|NCT00129129|1236739|P5|Primary Phase|Withdrawal by Subject|0
389410|NCT00129129|1236740|P4|Primary Phase|Withdrawal by Subject|0
389411|NCT00129129|1236741|P3|Primary Phase|Withdrawal by Subject|0
389412|NCT00129129|1236742|P2|Primary Phase|Withdrawal by Subject|10
389413|NCT00129129|1236743|P1|Primary Phase|Withdrawal by Subject|12
389414|NCT00129129|1236739|P5|Primary Phase|Adverse Event|0
389415|NCT00129129|1236740|P4|Primary Phase|Adverse Event|0
389416|NCT00129129|1236741|P3|Primary Phase|Adverse Event|0
389417|NCT00129129|1236742|P2|Primary Phase|Adverse Event|1
389418|NCT00129129|1236743|P1|Primary Phase|Adverse Event|2
389419|NCT00129116|1236950|P5|Booster Phase|Lost to Follow-up|1
389420|NCT00129116|1236951|P4|Booster Phase|Lost to Follow-up|0
389421|NCT00129116|1236952|P3|Booster Phase|Lost to Follow-up|0
389422|NCT00129116|1236953|P2|Booster Phase|Lost to Follow-up|0
389423|NCT00129116|1236954|P1|Booster Phase|Lost to Follow-up|2
389424|NCT00129116|1236950|P5|Primary Phase|Unspecified|0
389425|NCT00129116|1236951|P4|Primary Phase|Unspecified|0
389426|NCT00129116|1236952|P3|Primary Phase|Unspecified|1
389427|NCT00129116|1236953|P2|Primary Phase|Unspecified|0
389428|NCT00129116|1236954|P1|Primary Phase|Unspecified|0
389429|NCT00129116|1236950|P5|Primary Phase|Withdrawal by Subject|0
389430|NCT00129116|1236951|P4|Primary Phase|Withdrawal by Subject|0
389431|NCT00129116|1236952|P3|Primary Phase|Withdrawal by Subject|0
389432|NCT00129116|1236953|P2|Primary Phase|Withdrawal by Subject|1
389433|NCT00129116|1236954|P1|Primary Phase|Withdrawal by Subject|0
389434|NCT00129116|1236950|P5|Primary Phase|Adverse Event|0
389435|NCT00129116|1236951|P4|Primary Phase|Adverse Event|0
389436|NCT00129116|1236952|P3|Primary Phase|Adverse Event|0
389437|NCT00129116|1236953|P2|Primary Phase|Adverse Event|1
389438|NCT00129116|1236954|P1|Primary Phase|Adverse Event|1
389439|NCT00129116|1236950|P5|Primary Phase|Protocol Violation|0
389440|NCT00129116|1236951|P4|Primary Phase|Protocol Violation|0
389441|NCT00129116|1236952|P3|Primary Phase|Protocol Violation|0
389442|NCT00129116|1236953|P2|Primary Phase|Protocol Violation|1
389443|NCT00129116|1236954|P1|Primary Phase|Protocol Violation|0
389444|NCT00129116|1236950|P5|Primary Phase|Lost to Follow-up|1
389445|NCT00129116|1236951|P4|Primary Phase|Lost to Follow-up|1
389446|NCT00129116|1236952|P3|Primary Phase|Lost to Follow-up|0
389447|NCT00129116|1236953|P2|Primary Phase|Lost to Follow-up|1
389448|NCT00129116|1236954|P1|Primary Phase|Lost to Follow-up|1
389449|NCT00128830|1237238|P1|Overall Study|Unspecified|9
389450|NCT00128830|1237238|P1|Overall Study|Discontinued or ineligible for study|2
389451|NCT00128830|1237238|P1|Overall Study|Non-compliant|4
389452|NCT00128830|1237238|P1|Overall Study|Reached a virologic endpoint|29
389453|NCT00128830|1237238|P1|Overall Study|Lost to Follow-up|4
389454|NCT00128830|1237238|P1|Overall Study|Withdrawal by Subject|14
389455|NCT00128830|1237238|P1|Overall Study|Adverse Event|10
389456|NCT00128661|1237280|P2|Overall Study|Unspecified|8
389457|NCT00128661|1237281|P1|Overall Study|Unspecified|7
389458|NCT00128661|1237280|P2|Overall Study|Withdrawal by Subject|232
389459|NCT00128661|1237281|P1|Overall Study|Withdrawal by Subject|243
389460|NCT00128661|1237280|P2|Overall Study|Lost to Follow-up|7
389461|NCT00128661|1237281|P1|Overall Study|Lost to Follow-up|10
389462|NCT00128661|1237280|P2|Overall Study|Adverse Event|11
389463|NCT00128661|1237281|P1|Overall Study|Adverse Event|14
389464|NCT00128492|1237327|P2|Overall Study|Pregnancy|1
389465|NCT00128492|1237328|P1|Overall Study|Pregnancy|0
389466|NCT00128492|1237327|P2|Overall Study|Withdrawal by Subject|5
389467|NCT00128492|1237328|P1|Overall Study|Withdrawal by Subject|3
389468|NCT00128492|1237327|P2|Overall Study|Personal or administrative|22
389469|NCT00128492|1237328|P1|Overall Study|Personal or administrative|10
389470|NCT00128492|1237327|P2|Overall Study|Noncompliance|5
389471|NCT00128492|1237328|P1|Overall Study|Noncompliance|0
389472|NCT00128492|1237327|P2|Overall Study|Lost to Follow-up|5
389473|NCT00128492|1237328|P1|Overall Study|Lost to Follow-up|1
389474|NCT00128492|1237327|P2|Overall Study|Death|0
389475|NCT00128492|1237328|P1|Overall Study|Death|1
389476|NCT00128492|1237327|P2|Overall Study|AE related to study|4
389477|NCT00128492|1237328|P1|Overall Study|AE related to study|1
389478|NCT00128492|1237327|P2|Overall Study|Study drug intolerance (AE)|8
389479|NCT00128492|1237328|P1|Overall Study|Study drug intolerance (AE)|2
389480|NCT00128492|1237327|P2|Overall Study|AE unrelated to study|9
389481|NCT00128492|1237328|P1|Overall Study|AE unrelated to study|2
389482|NCT00128206|1237485|P2|Overall Study|Adverse Event|2
389483|NCT00128206|1237486|P1|Overall Study|Adverse Event|0
389484|NCT00128206|1237485|P2|Overall Study|Lost to Follow-up|118
389485|NCT00128206|1237486|P1|Overall Study|Lost to Follow-up|137
389486|NCT00127933|1237778|P2|Overall Study|Randomized but not dosed|0
389487|NCT00127933|1237779|P1|Overall Study|Randomized but not dosed|1
389488|NCT00127855|1237800|P5|Primary Vaccination Course|Unspecified|1
389489|NCT00127855|1237801|P4|Primary Vaccination Course|Unspecified|0
389490|NCT00127855|1237802|P3|Primary Vaccination Course|Unspecified|0
389491|NCT00127855|1237803|P2|Primary Vaccination Course|Unspecified|0
389492|NCT00127855|1237804|P1|Primary Vaccination Course|Unspecified|0
389493|NCT00127855|1237800|P5|Primary Vaccination Course|Lost to Follow-up|2
389494|NCT00127855|1237801|P4|Primary Vaccination Course|Lost to Follow-up|0
389495|NCT00127855|1237802|P3|Primary Vaccination Course|Lost to Follow-up|1
389496|NCT00127855|1237803|P2|Primary Vaccination Course|Lost to Follow-up|1
389497|NCT00127855|1237804|P1|Primary Vaccination Course|Lost to Follow-up|1
389498|NCT00127855|1237800|P5|Primary Vaccination Course|Withdrawal by Subject|1
389499|NCT00127855|1237801|P4|Primary Vaccination Course|Withdrawal by Subject|0
389500|NCT00127855|1237802|P3|Primary Vaccination Course|Withdrawal by Subject|0
389501|NCT00127855|1237803|P2|Primary Vaccination Course|Withdrawal by Subject|0
389502|NCT00127855|1237804|P1|Primary Vaccination Course|Withdrawal by Subject|1
389503|NCT00127855|1237800|P5|Primary Vaccination Course|Adverse Event|0
389504|NCT00127855|1237801|P4|Primary Vaccination Course|Adverse Event|0
389505|NCT00127855|1237802|P3|Primary Vaccination Course|Adverse Event|1
389506|NCT00127855|1237803|P2|Primary Vaccination Course|Adverse Event|0
389507|NCT00127855|1237804|P1|Primary Vaccination Course|Adverse Event|0
389508|NCT00127842|1237986|P1|Overall Study|Other|5
389509|NCT00127842|1237986|P1|Overall Study|Protocol Violation|1
389510|NCT00127842|1237986|P1|Overall Study|Noncompliance|2
389511|NCT00127842|1237986|P1|Overall Study|Lack of Efficacy|12
389512|NCT00127842|1237986|P1|Overall Study|Lost to Follow-up|1
389513|NCT00127842|1237986|P1|Overall Study|Withdrawal by Subject|3
389514|NCT00127842|1237986|P1|Overall Study|Adverse Event|15
389515|NCT00127803|1238004|P4|Overall Study|Lost to Follow-up|1
389516|NCT00127803|1238005|P3|Overall Study|Lost to Follow-up|0
389517|NCT00127803|1238006|P2|Overall Study|Lost to Follow-up|0
389518|NCT00127803|1238007|P1|Overall Study|Lost to Follow-up|0
389519|NCT00127803|1238004|P4|Overall Study|Withdrawal by Subject|0
389520|NCT00127803|1238005|P3|Overall Study|Withdrawal by Subject|0
389521|NCT00127803|1238006|P2|Overall Study|Withdrawal by Subject|0
389522|NCT00127803|1238007|P1|Overall Study|Withdrawal by Subject|1
389523|NCT00127803|1238004|P4|Overall Study|Adverse Event|0
389524|NCT00127803|1238005|P3|Overall Study|Adverse Event|0
389525|NCT00127803|1238006|P2|Overall Study|Adverse Event|0
389526|NCT00127803|1238007|P1|Overall Study|Adverse Event|2
389527|NCT00127712|1238056|P2|Overall Study|Lack of GI access to continue|0
389528|NCT00127712|1238057|P1|Overall Study|Lack of GI access to continue|2
389529|NCT00127712|1238056|P2|Overall Study|Adverse Event|0
389530|NCT00127712|1238057|P1|Overall Study|Adverse Event|3
389531|NCT00127413|1238082|P4|Overall Study|Lost to Follow-up|2
389532|NCT00127413|1238083|P3|Overall Study|Lost to Follow-up|8
389533|NCT00127413|1238084|P2|Overall Study|Lost to Follow-up|4
389534|NCT00127413|1238085|P1|Overall Study|Lost to Follow-up|6
389535|NCT00127192|1238109|P5|Overall Study|Adverse event in pre-treatment period|0
389536|NCT00127192|1238110|P4|Overall Study|Adverse event in pre-treatment period|0
389537|NCT00127192|1238111|P3|Overall Study|Adverse event in pre-treatment period|0
389538|NCT00127192|1238112|P2|Overall Study|Adverse event in pre-treatment period|0
389539|NCT00127192|1238113|P1|Overall Study|Adverse event in pre-treatment period|1
389540|NCT00127192|1238109|P5|Overall Study|Withdrawal by Subject|3
389541|NCT00127192|1238110|P4|Overall Study|Withdrawal by Subject|0
389542|NCT00127192|1238111|P3|Overall Study|Withdrawal by Subject|1
389543|NCT00127192|1238112|P2|Overall Study|Withdrawal by Subject|0
389544|NCT00127192|1238113|P1|Overall Study|Withdrawal by Subject|0
389545|NCT00127192|1238109|P5|Overall Study|Lack of Efficacy|2
389546|NCT00127192|1238110|P4|Overall Study|Lack of Efficacy|0
389547|NCT00127192|1238111|P3|Overall Study|Lack of Efficacy|0
389548|NCT00127192|1238112|P2|Overall Study|Lack of Efficacy|0
389549|NCT00127192|1238113|P1|Overall Study|Lack of Efficacy|2
389550|NCT00127192|1238109|P5|Overall Study|Adverse Event|0
389551|NCT00127192|1238110|P4|Overall Study|Adverse Event|1
389552|NCT00127192|1238111|P3|Overall Study|Adverse Event|1
389553|NCT00127192|1238112|P2|Overall Study|Adverse Event|1
389554|NCT00127192|1238113|P1|Overall Study|Adverse Event|0
389555|NCT00127166|1238137|P2|Period II|Patient did not perform Visit 6 exercise|0
389556|NCT00127166|1238138|P1|Period II|Patient did not perform Visit 6 exercise|1
389557|NCT00127166|1238137|P2|Period II|Withdrawal by Subject|0
389558|NCT00127166|1238138|P1|Period II|Withdrawal by Subject|2
389559|NCT00127166|1238137|P2|Washout Period|Patient did not meet inclusion criteria|1
389560|NCT00127166|1238138|P1|Washout Period|Patient did not meet inclusion criteria|0
389561|NCT00127166|1238137|P2|Period I|Patient did not meet inclusion criteria|0
389562|NCT00127166|1238138|P1|Period I|Patient did not meet inclusion criteria|1
389563|NCT00127166|1238137|P2|Period I|Withdrawal by Subject|0
389564|NCT00127166|1238138|P1|Period I|Withdrawal by Subject|2
389565|NCT00127166|1238137|P2|Period I|Protocol Violation|2
389566|NCT00127166|1238138|P1|Period I|Protocol Violation|0
389567|NCT00127101|1238158|P6|Continuation Phase|Withdrawal by Subject|1
389568|NCT00127101|1238159|P5|Continuation Phase|Withdrawal by Subject|2
389569|NCT00127101|1238160|P4|Continuation Phase|Withdrawal by Subject|0
389570|NCT00127101|1238161|P3|Continuation Phase|Withdrawal by Subject|1
389571|NCT00127101|1238162|P2|Continuation Phase|Withdrawal by Subject|0
389572|NCT00127101|1238163|P1|Continuation Phase|Withdrawal by Subject|0
389573|NCT00127101|1238158|P6|Continuation Phase|Lack of Efficacy|1
389574|NCT00127101|1238159|P5|Continuation Phase|Lack of Efficacy|0
389575|NCT00127101|1238160|P4|Continuation Phase|Lack of Efficacy|0
389576|NCT00127101|1238161|P3|Continuation Phase|Lack of Efficacy|0
389577|NCT00127101|1238162|P2|Continuation Phase|Lack of Efficacy|0
389578|NCT00127101|1238163|P1|Continuation Phase|Lack of Efficacy|0
389579|NCT00127101|1238158|P6|Continuation Phase|Adverse Event|1
389580|NCT00127101|1238159|P5|Continuation Phase|Adverse Event|1
389581|NCT00127101|1238160|P4|Continuation Phase|Adverse Event|0
389582|NCT00127101|1238161|P3|Continuation Phase|Adverse Event|0
389583|NCT00127101|1238162|P2|Continuation Phase|Adverse Event|0
389584|NCT00127101|1238163|P1|Continuation Phase|Adverse Event|0
389585|NCT00127101|1238158|P6|Base Protocol|Withdrawal by Subject|1
389586|NCT00127101|1238159|P5|Base Protocol|Withdrawal by Subject|0
389587|NCT00127101|1238160|P4|Base Protocol|Withdrawal by Subject|0
389588|NCT00127101|1238161|P3|Base Protocol|Withdrawal by Subject|1
389589|NCT00127101|1238162|P2|Base Protocol|Withdrawal by Subject|2
389590|NCT00127101|1238163|P1|Base Protocol|Withdrawal by Subject|1
389591|NCT00127101|1238158|P6|Base Protocol|Lack of Efficacy|0
389592|NCT00127101|1238159|P5|Base Protocol|Lack of Efficacy|2
389593|NCT00127101|1238160|P4|Base Protocol|Lack of Efficacy|0
389594|NCT00127101|1238161|P3|Base Protocol|Lack of Efficacy|0
389595|NCT00127101|1238162|P2|Base Protocol|Lack of Efficacy|0
389596|NCT00127101|1238163|P1|Base Protocol|Lack of Efficacy|1
389597|NCT00127101|1238158|P6|Base Protocol|Adverse Event|0
389598|NCT00127101|1238159|P5|Base Protocol|Adverse Event|0
389599|NCT00127101|1238160|P4|Base Protocol|Adverse Event|0
389600|NCT00127101|1238161|P3|Base Protocol|Adverse Event|1
389601|NCT00127101|1238162|P2|Base Protocol|Adverse Event|2
389602|NCT00127101|1238163|P1|Base Protocol|Adverse Event|0
389603|NCT00127036|1238185|P2|Overall Study|Screen Failure|0
389604|NCT00127036|1238186|P1|Overall Study|Screen Failure|2
389605|NCT00127036|1238185|P2|Overall Study|Insufficient Data for Analysis|11
389606|NCT00127036|1238186|P1|Overall Study|Insufficient Data for Analysis|6
389607|NCT00126776|1238198|P2|Overall Study|follow up complete on all patients|0
389608|NCT00126776|1238199|P1|Overall Study|follow up complete on all patients|0
389609|NCT00126659|1238248|P3|Overall Study|Adverse Event|2
389610|NCT00126659|1238249|P2|Overall Study|Adverse Event|0
389611|NCT00126659|1238250|P1|Overall Study|Adverse Event|0
389612|NCT00126594|1238258|P2|Overall Study|Disease Progression|24
389613|NCT00126594|1238259|P1|Overall Study|Disease Progression|29
389614|NCT00126594|1238258|P2|Overall Study|Non-compliance|1
389615|NCT00126594|1238259|P1|Overall Study|Non-compliance|0
389616|NCT00126594|1238258|P2|Overall Study|Adverse Event|5
389617|NCT00126594|1238259|P1|Overall Study|Adverse Event|7
389618|NCT00126594|1238258|P2|Overall Study|Physician Decision|3
389619|NCT00126594|1238259|P1|Overall Study|Physician Decision|1
389620|NCT00126594|1238258|P2|Overall Study|Withdrawal by Subject|4
389621|NCT00126594|1238259|P1|Overall Study|Withdrawal by Subject|0
389622|NCT00126594|1238258|P2|Overall Study|Ineligible|0
389623|NCT00126594|1238259|P1|Overall Study|Ineligible|2
389624|NCT00126581|1238276|P2|Overall Study|Other illness/MD discretion|4
389625|NCT00126581|1238277|P1|Overall Study|Other illness/MD discretion|3
389626|NCT00126581|1238276|P2|Overall Study|Alternative therapy|3
389627|NCT00126581|1238277|P1|Overall Study|Alternative therapy|3
389628|NCT00126581|1238276|P2|Overall Study|Withdrawal by Subject|4
389629|NCT00126581|1238277|P1|Overall Study|Withdrawal by Subject|1
389630|NCT00126581|1238276|P2|Overall Study|Death|2
389631|NCT00126581|1238277|P1|Overall Study|Death|3
389632|NCT00126581|1238276|P2|Overall Study|Adverse Event|7
389633|NCT00126581|1238277|P1|Overall Study|Adverse Event|3
389634|NCT00126568|1238297|P1|Overall Study|Death|2
389635|NCT00126555|1238303|P1|Overall Study|Progressive Disease|3
389636|NCT00126555|1238303|P1|Overall Study|Adverse Event|2
389637|NCT00126555|1238303|P1|Overall Study|Withdrawal by Subject|1
389638|NCT00126503|1238319|P2|Overall Study|Physician Decision|1
389639|NCT00126503|1238320|P1|Overall Study|Physician Decision|2
389640|NCT00126503|1238319|P2|Overall Study|non-compliant|0
389641|NCT00126503|1238320|P1|Overall Study|non-compliant|1
389642|NCT00126503|1238319|P2|Overall Study|Adverse Event|3
389643|NCT00126503|1238320|P1|Overall Study|Adverse Event|13
389644|NCT00126503|1238319|P2|Overall Study|Death|0
389645|NCT00126503|1238320|P1|Overall Study|Death|3
389646|NCT00126503|1238319|P2|Overall Study|other complicating disease|1
389647|NCT00126503|1238320|P1|Overall Study|other complicating disease|4
389648|NCT00126503|1238319|P2|Overall Study|alternative therapy|1
389649|NCT00126503|1238320|P1|Overall Study|alternative therapy|1
389650|NCT00126503|1238319|P2|Overall Study|Withdrawal by Subject|1
389651|NCT00126503|1238320|P1|Overall Study|Withdrawal by Subject|0
389652|NCT00126503|1238319|P2|Overall Study|disease progression|14
389653|NCT00126503|1238320|P1|Overall Study|disease progression|23
389654|NCT00126490|1238332|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
389655|NCT00126438|1238342|P2|Overall Study|Withdrawal by Subject|2
389656|NCT00126438|1238343|P1|Overall Study|Withdrawal by Subject|3
389657|NCT00126438|1238342|P2|Overall Study|Protocol Violation|8
389658|NCT00126438|1238343|P1|Overall Study|Protocol Violation|8
389659|NCT00126438|1238342|P2|Overall Study|Lost to Follow-up|0
389660|NCT00126438|1238343|P1|Overall Study|Lost to Follow-up|22
389661|NCT00126438|1238342|P2|Overall Study|Withdrawal due to adverse event|0
389662|NCT00126438|1238343|P1|Overall Study|Withdrawal due to adverse event|1
389663|NCT00126425|1238351|P2|Overall Study|Unspecified|0
389664|NCT00126425|1238352|P1|Overall Study|Unspecified|5
389665|NCT00126425|1238351|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
389666|NCT00126425|1238352|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
389667|NCT00126425|1238351|P2|Overall Study|Adverse Event|0
389668|NCT00126425|1238352|P1|Overall Study|Adverse Event|1
389669|NCT00126425|1238351|P2|Overall Study|Protocol Violation|6
389670|NCT00126425|1238352|P1|Overall Study|Protocol Violation|9
389671|NCT00126425|1238351|P2|Overall Study|Lost to Follow-up|4
389672|NCT00126425|1238352|P1|Overall Study|Lost to Follow-up|8
389673|NCT00126425|1238351|P2|Overall Study|Withdrawal by Subject|1
389674|NCT00126425|1238352|P1|Overall Study|Withdrawal by Subject|17
389675|NCT00126191|1238360|P2|Overall Study|Death|1
389676|NCT00126191|1238361|P1|Overall Study|Death|0
389677|NCT00126191|1238360|P2|Overall Study|Physician Decision|1
389678|NCT00126191|1238361|P1|Overall Study|Physician Decision|0
389679|NCT00126126|1238371|P2|Overall Study|Lost to Follow-up|2
389680|NCT00126126|1238372|P1|Overall Study|Lost to Follow-up|0
389681|NCT00125268|1238479|P2|Overall Study|Withdrawal by Subject|1
389682|NCT00125268|1238480|P1|Overall Study|Withdrawal by Subject|1
389683|NCT00125242|1238492|P2|Overall Study|did not qualify|2
389684|NCT00125242|1238493|P1|Overall Study|did not qualify|7
389685|NCT00125190|1238498|P1|Overall Study|Non-compliance|2
389686|NCT00125190|1238498|P1|Overall Study|other|1
389687|NCT00125190|1238498|P1|Overall Study|Patient/Parent Decision|7
389688|NCT00125190|1238498|P1|Overall Study|Lost to Follow-up|4
389689|NCT00125190|1238498|P1|Overall Study|Adverse Event|1
389690|NCT00125164|1238516|P4|Overall Study|Withdrawal by Subject|1
389691|NCT00125164|1238517|P3|Overall Study|Withdrawal by Subject|1
389692|NCT00125164|1238518|P2|Overall Study|Withdrawal by Subject|0
389693|NCT00125164|1238519|P1|Overall Study|Withdrawal by Subject|2
389694|NCT00125164|1238516|P4|Overall Study|Lost to Follow-up|1
389695|NCT00125164|1238517|P3|Overall Study|Lost to Follow-up|1
389696|NCT00125164|1238518|P2|Overall Study|Lost to Follow-up|0
389697|NCT00125164|1238519|P1|Overall Study|Lost to Follow-up|0
389698|NCT00125164|1238516|P4|Overall Study|Adverse Event|4
389699|NCT00125164|1238517|P3|Overall Study|Adverse Event|2
389700|NCT00125164|1238518|P2|Overall Study|Adverse Event|0
389701|NCT00125164|1238519|P1|Overall Study|Adverse Event|0
389702|NCT00125138|1238573|P4|Overall Study|Sponsor decision-pt moved to assist care|1
389703|NCT00125138|1238574|P3|Overall Study|Sponsor decision-pt moved to assist care|0
389704|NCT00125138|1238575|P2|Overall Study|Sponsor decision-pt moved to assist care|0
389705|NCT00125138|1238576|P1|Overall Study|Sponsor decision-pt moved to assist care|0
389706|NCT00125138|1238573|P4|Overall Study|Lack of Efficacy|1
389707|NCT00125138|1238574|P3|Overall Study|Lack of Efficacy|0
389708|NCT00125138|1238575|P2|Overall Study|Lack of Efficacy|0
389709|NCT00125138|1238576|P1|Overall Study|Lack of Efficacy|0
389710|NCT00125138|1238573|P4|Overall Study|Withdrawal by Subject|1
389711|NCT00125138|1238574|P3|Overall Study|Withdrawal by Subject|1
389712|NCT00125138|1238575|P2|Overall Study|Withdrawal by Subject|3
389713|NCT00125138|1238576|P1|Overall Study|Withdrawal by Subject|2
389714|NCT00125138|1238573|P4|Overall Study|Adverse Event|2
389715|NCT00125138|1238574|P3|Overall Study|Adverse Event|3
389716|NCT00125138|1238575|P2|Overall Study|Adverse Event|0
389717|NCT00125138|1238576|P1|Overall Study|Adverse Event|1
389718|NCT00124982|1238625|P3|Long-term Period|Neurologist Recommendation|1
389719|NCT00124982|1238626|P2|Long-term Period|Neurologist Recommendation|0
389720|NCT00124982|1238627|P1|Long-term Period|Neurologist Recommendation|0
389721|NCT00124982|1238625|P3|Long-term Period|Administrative Reason by Sponsor|1
389722|NCT00124982|1238626|P2|Long-term Period|Administrative Reason by Sponsor|0
389723|NCT00124982|1238627|P1|Long-term Period|Administrative Reason by Sponsor|0
389724|NCT00124982|1238625|P3|Long-term Period|Poor/Non-compliance|2
389725|NCT00124982|1238626|P2|Long-term Period|Poor/Non-compliance|0
389726|NCT00124982|1238627|P1|Long-term Period|Poor/Non-compliance|0
389727|NCT00124982|1238625|P3|Long-term Period|Pregnancy|1
389728|NCT00124982|1238626|P2|Long-term Period|Pregnancy|0
389729|NCT00124982|1238627|P1|Long-term Period|Pregnancy|0
389730|NCT00124982|1238625|P3|Long-term Period|Withdrawal by Subject|16
389731|NCT00124982|1238626|P2|Long-term Period|Withdrawal by Subject|0
389732|NCT00124982|1238627|P1|Long-term Period|Withdrawal by Subject|0
389733|NCT00124982|1238625|P3|Long-term Period|Lost to Follow-up|4
389734|NCT00124982|1238626|P2|Long-term Period|Lost to Follow-up|0
389735|NCT00124982|1238627|P1|Long-term Period|Lost to Follow-up|0
389736|NCT00124982|1238625|P3|Long-term Period|Lack of Efficacy|46
389737|NCT00124982|1238626|P2|Long-term Period|Lack of Efficacy|0
389738|NCT00124982|1238627|P1|Long-term Period|Lack of Efficacy|0
389739|NCT00124982|1238625|P3|Long-term Period|Adverse Event|17
389740|NCT00124982|1238626|P2|Long-term Period|Adverse Event|0
389741|NCT00124982|1238627|P1|Long-term Period|Adverse Event|0
389742|NCT00124982|1238625|P3|Long-term Period|Death|1
389743|NCT00124982|1238626|P2|Long-term Period|Death|0
389744|NCT00124982|1238627|P1|Long-term Period|Death|0
389745|NCT00124982|1238625|P3|Short-term Period|Participant Had Lymphopenia|0
389746|NCT00124982|1238626|P2|Short-term Period|Participant Had Lymphopenia|0
389747|NCT00124982|1238627|P1|Short-term Period|Participant Had Lymphopenia|1
389748|NCT00124982|1238625|P3|Short-term Period|Investigator Decision-No Specific AE|0
389749|NCT00124982|1238626|P2|Short-term Period|Investigator Decision-No Specific AE|0
389750|NCT00124982|1238627|P1|Short-term Period|Investigator Decision-No Specific AE|1
389751|NCT00124982|1238625|P3|Short-term Period|Participant Chose Own Doctor|0
389752|NCT00124982|1238626|P2|Short-term Period|Participant Chose Own Doctor|1
389753|NCT00124982|1238627|P1|Short-term Period|Participant Chose Own Doctor|0
389754|NCT00124982|1238625|P3|Short-term Period|Participant Decision|0
389755|NCT00124982|1238626|P2|Short-term Period|Participant Decision|0
389756|NCT00124982|1238627|P1|Short-term Period|Participant Decision|1
389757|NCT00124982|1238625|P3|Short-term Period|No Longer Meets Study Criteria|0
389758|NCT00124982|1238626|P2|Short-term Period|No Longer Meets Study Criteria|2
389759|NCT00124982|1238627|P1|Short-term Period|No Longer Meets Study Criteria|1
389760|NCT00124982|1238625|P3|Short-term Period|Poor/Non-compliance|0
389761|NCT00124982|1238626|P2|Short-term Period|Poor/Non-compliance|1
389762|NCT00124982|1238627|P1|Short-term Period|Poor/Non-compliance|3
389763|NCT00124982|1238625|P3|Short-term Period|Withdrawal of Consent|0
389764|NCT00124982|1238626|P2|Short-term Period|Withdrawal of Consent|9
389765|NCT00124982|1238627|P1|Short-term Period|Withdrawal of Consent|7
389766|NCT00124982|1238625|P3|Short-term Period|Lost to Follow-up|0
389767|NCT00124982|1238626|P2|Short-term Period|Lost to Follow-up|5
389768|NCT00124982|1238627|P1|Short-term Period|Lost to Follow-up|8
389769|NCT00124982|1238625|P3|Short-term Period|Lack of Efficacy|0
389770|NCT00124982|1238626|P2|Short-term Period|Lack of Efficacy|73
389771|NCT00124982|1238627|P1|Short-term Period|Lack of Efficacy|32
389772|NCT00124982|1238625|P3|Short-term Period|Adverse Event|0
389773|NCT00124982|1238626|P2|Short-term Period|Adverse Event|22
389774|NCT00124982|1238627|P1|Short-term Period|Adverse Event|17
389775|NCT00124982|1238625|P3|Short-term Period|Death|0
389776|NCT00124982|1238626|P2|Short-term Period|Death|1
389777|NCT00124982|1238627|P1|Short-term Period|Death|1
389778|NCT00124943|1238709|P4|Phase II|Withdrawal by Subject|2
389779|NCT00124943|1238710|P3|Phase II|Withdrawal by Subject|0
389780|NCT00124943|1238711|P2|Phase II|Withdrawal by Subject|0
389781|NCT00124943|1238712|P1|Phase II|Withdrawal by Subject|0
389782|NCT00124943|1238709|P4|Phase II|Lost to Follow-up|1
389783|NCT00124943|1238710|P3|Phase II|Lost to Follow-up|0
389784|NCT00124943|1238711|P2|Phase II|Lost to Follow-up|0
389785|NCT00124943|1238712|P1|Phase II|Lost to Follow-up|0
389786|NCT00124943|1238709|P4|Phase II|Protocol Violation|1
389787|NCT00124943|1238710|P3|Phase II|Protocol Violation|0
389788|NCT00124943|1238711|P2|Phase II|Protocol Violation|0
389789|NCT00124943|1238712|P1|Phase II|Protocol Violation|0
389790|NCT00124943|1238709|P4|Phase II|Adverse Event|1
389791|NCT00124943|1238710|P3|Phase II|Adverse Event|0
389792|NCT00124943|1238711|P2|Phase II|Adverse Event|2
389793|NCT00124943|1238712|P1|Phase II|Adverse Event|0
389794|NCT00124748|1238752|P2|Overall Study|Death|3
389795|NCT00124748|1238753|P1|Overall Study|Death|1
389877|NCT00124020|1239000|P2|Overall Study|Other|1
389796|NCT00124748|1238752|P2|Overall Study|Administrative Problem(Study Terminated)|174
389797|NCT00124748|1238753|P1|Overall Study|Administrative Problem(Study Terminated)|101
389798|NCT00124748|1238752|P2|Overall Study|Lost to Follow-up|7
389799|NCT00124748|1238753|P1|Overall Study|Lost to Follow-up|2
389800|NCT00124748|1238752|P2|Overall Study|Withdrawal by Subject|15
389801|NCT00124748|1238753|P1|Overall Study|Withdrawal by Subject|5
389802|NCT00124748|1238752|P2|Overall Study|Protocol Violation|1
389803|NCT00124748|1238753|P1|Overall Study|Protocol Violation|3
389804|NCT00124748|1238752|P2|Overall Study|No longer requires study drug|1
389805|NCT00124748|1238753|P1|Overall Study|No longer requires study drug|1
389806|NCT00124748|1238752|P2|Overall Study|Lack of Efficacy|41
389807|NCT00124748|1238753|P1|Overall Study|Lack of Efficacy|20
389808|NCT00124748|1238752|P2|Overall Study|Abnormal Procedure|1
389809|NCT00124748|1238753|P1|Overall Study|Abnormal Procedure|0
389810|NCT00124748|1238752|P2|Overall Study|Abnormal laboratory Value|2
389811|NCT00124748|1238753|P1|Overall Study|Abnormal laboratory Value|2
389812|NCT00124748|1238752|P2|Overall Study|Adverse Event|39
389813|NCT00124748|1238753|P1|Overall Study|Adverse Event|8
389814|NCT00124709|1238860|P2|Overall Study|Lost to Follow-up|120
389815|NCT00124709|1238861|P1|Overall Study|Lost to Follow-up|114
389816|NCT00124709|1238860|P2|Overall Study|Withdrawal by Subject|136
389817|NCT00124709|1238861|P1|Overall Study|Withdrawal by Subject|127
389818|NCT00124709|1238860|P2|Overall Study|Protocol Violation|5
389819|NCT00124709|1238861|P1|Overall Study|Protocol Violation|3
389820|NCT00124709|1238860|P2|Overall Study|Lack of Efficacy|10
389821|NCT00124709|1238861|P1|Overall Study|Lack of Efficacy|5
389822|NCT00124709|1238860|P2|Overall Study|Adverse Event|0
389823|NCT00124709|1238861|P1|Overall Study|Adverse Event|3
389824|NCT00124709|1238860|P2|Overall Study|Randomized but did not take medication|1
389825|NCT00124709|1238861|P1|Overall Study|Randomized but did not take medication|3
389826|NCT00124657|1238878|P3|Overall Study|Intercurrent illness|0
389827|NCT00124657|1238879|P2|Overall Study|Intercurrent illness|0
389828|NCT00124657|1238880|P1|Overall Study|Intercurrent illness|1
389829|NCT00124657|1238878|P3|Overall Study|Progressive disease|27
389830|NCT00124657|1238879|P2|Overall Study|Progressive disease|5
389831|NCT00124657|1238880|P1|Overall Study|Progressive disease|14
389832|NCT00124657|1238878|P3|Overall Study|Non-compliance|4
389833|NCT00124657|1238879|P2|Overall Study|Non-compliance|0
389834|NCT00124657|1238880|P1|Overall Study|Non-compliance|1
389835|NCT00124657|1238878|P3|Overall Study|Toxicity|1
389836|NCT00124657|1238879|P2|Overall Study|Toxicity|0
389837|NCT00124657|1238880|P1|Overall Study|Toxicity|0
389838|NCT00124618|1238915|P1|Overall Study|Ineligible|1
389839|NCT00124449|1238930|P2|18-Month Untreated Observation Period|Relocated|0
389840|NCT00124449|1238931|P1|18-Month Untreated Observation Period|Relocated|1
389841|NCT00124449|1238930|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
389842|NCT00124449|1238931|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
389843|NCT00124449|1238930|P2|18-Month Untreated Observation Period|Pregnancy|0
389844|NCT00124449|1238931|P1|18-Month Untreated Observation Period|Pregnancy|1
389845|NCT00124449|1238930|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
389846|NCT00124449|1238931|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
389847|NCT00124449|1238930|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
389848|NCT00124449|1238931|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
389849|NCT00124449|1238930|P2|18-Month Untreated Observation Period|Adverse Event|1
389850|NCT00124449|1238931|P1|18-Month Untreated Observation Period|Adverse Event|0
389851|NCT00124449|1238930|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
389852|NCT00124449|1238931|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
389853|NCT00124449|1238930|P2|6-month Double-Blind Treatment Period|Sponsor request|1
389854|NCT00124449|1238931|P1|6-month Double-Blind Treatment Period|Sponsor request|0
389855|NCT00124449|1238930|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
389856|NCT00124449|1238931|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
389857|NCT00124449|1238930|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
389858|NCT00124449|1238931|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
389859|NCT00124449|1238930|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
389860|NCT00124449|1238931|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
389861|NCT00124449|1238930|P2|6-month Double-Blind Treatment Period|Adverse Event|0
389862|NCT00124449|1238931|P1|6-month Double-Blind Treatment Period|Adverse Event|1
389863|NCT00124072|1238985|P4|Overall Study|Death|480
389864|NCT00124072|1238986|P3|Overall Study|Death|471
389865|NCT00124072|1238987|P2|Overall Study|Death|484
389866|NCT00124072|1238988|P1|Overall Study|Death|499
389867|NCT00124072|1238985|P4|Overall Study|Lost to Follow-up for Morbidity|18
389868|NCT00124072|1238986|P3|Overall Study|Lost to Follow-up for Morbidity|19
389869|NCT00124072|1238987|P2|Overall Study|Lost to Follow-up for Morbidity|25
389870|NCT00124072|1238988|P1|Overall Study|Lost to Follow-up for Morbidity|15
389871|NCT00124072|1238985|P4|Overall Study|Lost to Follow-up for Mortality|2
389872|NCT00124072|1238986|P3|Overall Study|Lost to Follow-up for Mortality|2
389873|NCT00124072|1238987|P2|Overall Study|Lost to Follow-up for Mortality|3
389874|NCT00124072|1238988|P1|Overall Study|Lost to Follow-up for Mortality|0
389875|NCT00124020|1239000|P2|Overall Study|Transfer to another hospital|0
389876|NCT00124020|1239001|P1|Overall Study|Transfer to another hospital|2
389878|NCT00124020|1239001|P1|Overall Study|Other|1
389879|NCT00124020|1239000|P2|Overall Study|Lost to Follow-up|8
389880|NCT00124020|1239001|P1|Overall Study|Lost to Follow-up|5
389881|NCT00124020|1239000|P2|Overall Study|Withdrawal by Subject|11
389882|NCT00124020|1239001|P1|Overall Study|Withdrawal by Subject|13
389883|NCT00124020|1239000|P2|Overall Study|Death|71
389884|NCT00124020|1239001|P1|Overall Study|Death|67
389885|NCT00123955|1239009|P2|Overall Study|Death|1
389886|NCT00123955|1239010|P1|Overall Study|Death|0
389887|NCT00123955|1239009|P2|Overall Study|Withdrawal by Subject|3
389888|NCT00123955|1239010|P1|Overall Study|Withdrawal by Subject|4
389889|NCT00123955|1239009|P2|Overall Study|Adverse Event|0
389890|NCT00123955|1239010|P1|Overall Study|Adverse Event|1
389891|NCT00123734|1239016|P1|Overall Study|Withdrawal by Subject|1
389892|NCT00123734|1239016|P1|Overall Study|Dropout|1
389893|NCT00123734|1239016|P1|Overall Study|Lost to Follow-up|3
389894|NCT00123734|1239016|P1|Overall Study|Death|3
389895|NCT00123487|1239101|P2|Treated With Study Drug|Unknown (case report form lost)|1
389896|NCT00123487|1239102|P1|Treated With Study Drug|Unknown (case report form lost)|0
389897|NCT00123487|1239101|P2|Treated With Study Drug|Withdrawal by Subject|13
389898|NCT00123487|1239102|P1|Treated With Study Drug|Withdrawal by Subject|11
389899|NCT00123487|1239101|P2|Treated With Study Drug|Study Drug Toxicity|80
389900|NCT00123487|1239102|P1|Treated With Study Drug|Study Drug Toxicity|62
389901|NCT00123487|1239101|P2|Treated With Study Drug|Not Specified|58
389902|NCT00123487|1239102|P1|Treated With Study Drug|Not Specified|59
389903|NCT00123487|1239101|P2|Treated With Study Drug|Physician Decision|9
389904|NCT00123487|1239102|P1|Treated With Study Drug|Physician Decision|8
389905|NCT00123487|1239101|P2|Treated With Study Drug|Disease Progression|122
389906|NCT00123487|1239102|P1|Treated With Study Drug|Disease Progression|141
389907|NCT00123487|1239101|P2|Treated With Study Drug|Adverse Event|22
389908|NCT00123487|1239102|P1|Treated With Study Drug|Adverse Event|23
389909|NCT00123487|1239101|P2|Randomized|SAE prior to starting treatment|0
389910|NCT00123487|1239102|P1|Randomized|SAE prior to starting treatment|1
389911|NCT00123487|1239101|P2|Randomized|Death prior to starting treatment|1
389912|NCT00123487|1239102|P1|Randomized|Death prior to starting treatment|0
389913|NCT00123474|1239146|P4|As Treated at Study Closure|Withdrawal by Subject|16
389914|NCT00123474|1239147|P3|As Treated at Study Closure|Withdrawal by Subject|18
389915|NCT00123474|1239148|P2|As Treated at Study Closure|Withdrawal by Subject|19
389916|NCT00123474|1239149|P1|As Treated at Study Closure|Withdrawal by Subject|14
389917|NCT00123474|1239146|P4|As Treated at Study Closure|Study Drug Toxicity|51
389918|NCT00123474|1239147|P3|As Treated at Study Closure|Study Drug Toxicity|45
389919|NCT00123474|1239148|P2|As Treated at Study Closure|Study Drug Toxicity|45
389920|NCT00123474|1239149|P1|As Treated at Study Closure|Study Drug Toxicity|39
389921|NCT00123474|1239146|P4|As Treated at Study Closure|non-specified|60
389922|NCT00123474|1239147|P3|As Treated at Study Closure|non-specified|57
389923|NCT00123474|1239148|P2|As Treated at Study Closure|non-specified|47
389924|NCT00123474|1239149|P1|As Treated at Study Closure|non-specified|54
389925|NCT00123474|1239146|P4|As Treated at Study Closure|Investigator Request|5
389926|NCT00123474|1239147|P3|As Treated at Study Closure|Investigator Request|7
389927|NCT00123474|1239148|P2|As Treated at Study Closure|Investigator Request|6
389928|NCT00123474|1239149|P1|As Treated at Study Closure|Investigator Request|12
389929|NCT00123474|1239146|P4|As Treated at Study Closure|Disease Progression|27
389930|NCT00123474|1239147|P3|As Treated at Study Closure|Disease Progression|29
389931|NCT00123474|1239148|P2|As Treated at Study Closure|Disease Progression|42
389932|NCT00123474|1239149|P1|As Treated at Study Closure|Disease Progression|35
389933|NCT00123474|1239146|P4|As Treated at Study Closure|Adverse Event|8
389934|NCT00123474|1239147|P3|As Treated at Study Closure|Adverse Event|10
389935|NCT00123474|1239148|P2|As Treated at Study Closure|Adverse Event|4
389936|NCT00123474|1239149|P1|As Treated at Study Closure|Adverse Event|10
389937|NCT00123474|1239146|P4|As Treated at Study Closure|not reported when site closed|0
389938|NCT00123474|1239147|P3|As Treated at Study Closure|not reported when site closed|1
389939|NCT00123474|1239148|P2|As Treated at Study Closure|not reported when site closed|0
389940|NCT00123474|1239149|P1|As Treated at Study Closure|not reported when site closed|1
389941|NCT00123474|1239146|P4|Randomized to Treatment|Randomized, never treated|1
389942|NCT00123474|1239147|P3|Randomized to Treatment|Randomized, never treated|2
389943|NCT00123474|1239148|P2|Randomized to Treatment|Randomized, never treated|4
389944|NCT00123474|1239149|P1|Randomized to Treatment|Randomized, never treated|1
389945|NCT00123422|1239243|P3|Overall Study|Lost to Follow-up|2
389946|NCT00123422|1239244|P2|Overall Study|Lost to Follow-up|2
389947|NCT00123422|1239245|P1|Overall Study|Lost to Follow-up|1
389948|NCT00123422|1239243|P3|Overall Study|Withdrawal by Subject|2
389949|NCT00123422|1239244|P2|Overall Study|Withdrawal by Subject|2
389950|NCT00123422|1239245|P1|Overall Study|Withdrawal by Subject|1
389951|NCT00123422|1239243|P3|Overall Study|Physician Decision|6
389952|NCT00123422|1239244|P2|Overall Study|Physician Decision|2
389953|NCT00123422|1239245|P1|Overall Study|Physician Decision|2
389954|NCT00122980|1239296|P2|Overall Study|Study termination|35
389955|NCT00122980|1239297|P1|Overall Study|Study termination|27
389956|NCT00122980|1239296|P2|Overall Study|Adjudicated stroke (study endpoint)|0
389957|NCT00122980|1239297|P1|Overall Study|Adjudicated stroke (study endpoint)|7
389958|NCT00122980|1239296|P2|Overall Study|Withdrawal by Subject|3
389959|NCT00122980|1239297|P1|Overall Study|Withdrawal by Subject|2
389960|NCT00122980|1239296|P2|Overall Study|Protocol Violation|1
389961|NCT00122980|1239297|P1|Overall Study|Protocol Violation|5
389962|NCT00122980|1239296|P2|Overall Study|Physician Decision|0
389963|NCT00122980|1239297|P1|Overall Study|Physician Decision|2
389964|NCT00122980|1239296|P2|Overall Study|Death|1
389965|NCT00122980|1239297|P1|Overall Study|Death|0
389966|NCT00122954|1239321|P2|Overall Study|Protocol Violation|1
389967|NCT00122954|1239322|P1|Overall Study|Protocol Violation|0
389968|NCT00122954|1239321|P2|Overall Study|Withdrawal by Subject|2
389969|NCT00122954|1239322|P1|Overall Study|Withdrawal by Subject|2
389970|NCT00122681|1239332|P2|Overall Study|Personal reasons|147
389971|NCT00122681|1239333|P1|Overall Study|Personal reasons|150
389972|NCT00122681|1239332|P2|Overall Study|Withdrawal by Subject|251
389973|NCT00122681|1239333|P1|Overall Study|Withdrawal by Subject|257
389974|NCT00122681|1239332|P2|Overall Study|Protocol Violation|10
389975|NCT00122681|1239333|P1|Overall Study|Protocol Violation|7
389976|NCT00122681|1239332|P2|Overall Study|Lost to Follow-up|1097
389977|NCT00122681|1239333|P1|Overall Study|Lost to Follow-up|1080
389978|NCT00122681|1239332|P2|Overall Study|Adverse Event|16
389979|NCT00122681|1239333|P1|Overall Study|Adverse Event|20
389980|NCT00122460|1239399|P2|Overall Study|investigational study phase ongoing|1
389981|NCT00122460|1239400|P1|Overall Study|investigational study phase ongoing|7
389982|NCT00122382|1239449|P3|Open-Label Study|Withdrawal of Consent|4
389983|NCT00122382|1239450|P2|Open-Label Study|Withdrawal of Consent|0
389984|NCT00122382|1239451|P1|Open-Label Study|Withdrawal of Consent|0
389985|NCT00122382|1239449|P3|Open-Label Study|Poor/Non-Compliance|1
389986|NCT00122382|1239450|P2|Open-Label Study|Poor/Non-Compliance|0
389987|NCT00122382|1239451|P1|Open-Label Study|Poor/Non-Compliance|0
389988|NCT00122382|1239449|P3|Open-Label Study|Pregnancy|2
389989|NCT00122382|1239450|P2|Open-Label Study|Pregnancy|0
389990|NCT00122382|1239451|P1|Open-Label Study|Pregnancy|0
389991|NCT00122382|1239449|P3|Open-Label Study|Lost to Follow-up|3
389992|NCT00122382|1239450|P2|Open-Label Study|Lost to Follow-up|0
389993|NCT00122382|1239451|P1|Open-Label Study|Lost to Follow-up|0
389994|NCT00122382|1239449|P3|Open-Label Study|Lack of Efficacy|3
389995|NCT00122382|1239450|P2|Open-Label Study|Lack of Efficacy|0
389996|NCT00122382|1239451|P1|Open-Label Study|Lack of Efficacy|0
389997|NCT00122382|1239449|P3|Open-Label Study|Death|2
389998|NCT00122382|1239450|P2|Open-Label Study|Death|0
389999|NCT00122382|1239451|P1|Open-Label Study|Death|0
390000|NCT00122382|1239449|P3|Open-Label Study|Adverse Event|11
390001|NCT00122382|1239450|P2|Open-Label Study|Adverse Event|0
390002|NCT00122382|1239451|P1|Open-Label Study|Adverse Event|0
390003|NCT00122382|1239449|P3|Double-Blind Study|Randomized but not treated|0
390004|NCT00122382|1239450|P2|Double-Blind Study|Randomized but not treated|2
390005|NCT00122382|1239451|P1|Double-Blind Study|Randomized but not treated|0
390006|NCT00122382|1239449|P3|Double-Blind Study|Methotrexate Discontinued|0
390007|NCT00122382|1239450|P2|Double-Blind Study|Methotrexate Discontinued|1
390008|NCT00122382|1239451|P1|Double-Blind Study|Methotrexate Discontinued|0
390009|NCT00122382|1239449|P3|Double-Blind Study|Protocol Violation|0
390010|NCT00122382|1239450|P2|Double-Blind Study|Protocol Violation|0
390011|NCT00122382|1239451|P1|Double-Blind Study|Protocol Violation|1
390012|NCT00122382|1239449|P3|Double-Blind Study|Withdrawal of Consent|0
390013|NCT00122382|1239450|P2|Double-Blind Study|Withdrawal of Consent|3
390014|NCT00122382|1239451|P1|Double-Blind Study|Withdrawal of Consent|7
390015|NCT00122382|1239449|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
390016|NCT00122382|1239450|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
390017|NCT00122382|1239451|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
390018|NCT00122382|1239449|P3|Double-Blind Study|Pregnancy|0
390019|NCT00122382|1239450|P2|Double-Blind Study|Pregnancy|0
390020|NCT00122382|1239451|P1|Double-Blind Study|Pregnancy|2
390021|NCT00122382|1239449|P3|Double-Blind Study|Lost to Follow-up|0
390022|NCT00122382|1239450|P2|Double-Blind Study|Lost to Follow-up|1
390023|NCT00122382|1239451|P1|Double-Blind Study|Lost to Follow-up|2
390024|NCT00122382|1239449|P3|Double-Blind Study|Lack of Efficacy|0
390025|NCT00122382|1239450|P2|Double-Blind Study|Lack of Efficacy|8
390026|NCT00122382|1239451|P1|Double-Blind Study|Lack of Efficacy|0
390027|NCT00122382|1239449|P3|Double-Blind Study|Death|0
390028|NCT00122382|1239450|P2|Double-Blind Study|Death|2
390029|NCT00122382|1239451|P1|Double-Blind Study|Death|2
390030|NCT00122382|1239449|P3|Double-Blind Study|Adverse Event|0
390031|NCT00122382|1239450|P2|Double-Blind Study|Adverse Event|11
390032|NCT00122382|1239451|P1|Double-Blind Study|Adverse Event|9
390033|NCT00122317|1239595|P1|Overall Study|Withdrawal by Subject|1
390034|NCT00122317|1239595|P1|Overall Study|patient non-compliance|1
390035|NCT00122317|1239595|P1|Overall Study|Physician Decision|2
390036|NCT00122317|1239595|P1|Overall Study|Adverse Event|4
390037|NCT00122317|1239595|P1|Overall Study|Death|3
390038|NCT00122187|1239601|P2|Overall Study|Withdrew because of resource limitations|2
390039|NCT00122187|1239602|P1|Overall Study|Withdrew because of resource limitations|2
390040|NCT00122135|1239616|P2|Overall Study|Withdrawal by Subject|0
390041|NCT00122135|1239617|P1|Overall Study|Withdrawal by Subject|3
390042|NCT00122109|1239625|P2|Overall Study|Did not meet criteria|7
390043|NCT00122109|1239626|P1|Overall Study|Did not meet criteria|6
390044|NCT00121719|1239690|P14|Overall Study|Continuing/ongoing patients|0
390045|NCT00121719|1239691|P13|Overall Study|Continuing/ongoing patients|3
390046|NCT00121719|1239692|P12|Overall Study|Continuing/ongoing patients|1
390047|NCT00121719|1239693|P11|Overall Study|Continuing/ongoing patients|1
390048|NCT00121719|1239694|P10|Overall Study|Continuing/ongoing patients|0
390049|NCT00121719|1239695|P9|Overall Study|Continuing/ongoing patients|0
390050|NCT00121719|1239696|P8|Overall Study|Continuing/ongoing patients|1
390051|NCT00121719|1239697|P7|Overall Study|Continuing/ongoing patients|0
390052|NCT00121719|1239698|P6|Overall Study|Continuing/ongoing patients|0
390053|NCT00121719|1239699|P5|Overall Study|Continuing/ongoing patients|0
390054|NCT00121719|1239700|P4|Overall Study|Continuing/ongoing patients|0
390055|NCT00121719|1239701|P3|Overall Study|Continuing/ongoing patients|0
390056|NCT00121719|1239702|P2|Overall Study|Continuing/ongoing patients|0
390057|NCT00121719|1239703|P1|Overall Study|Continuing/ongoing patients|0
390058|NCT00121719|1239690|P14|Overall Study|Not specified|1
390059|NCT00121719|1239691|P13|Overall Study|Not specified|1
390060|NCT00121719|1239692|P12|Overall Study|Not specified|0
390061|NCT00121719|1239693|P11|Overall Study|Not specified|0
390062|NCT00121719|1239694|P10|Overall Study|Not specified|0
390063|NCT00121719|1239695|P9|Overall Study|Not specified|1
390064|NCT00121719|1239696|P8|Overall Study|Not specified|0
390065|NCT00121719|1239697|P7|Overall Study|Not specified|1
390066|NCT00121719|1239698|P6|Overall Study|Not specified|0
390067|NCT00121719|1239699|P5|Overall Study|Not specified|0
390068|NCT00121719|1239700|P4|Overall Study|Not specified|1
390069|NCT00121719|1239701|P3|Overall Study|Not specified|1
390070|NCT00121719|1239702|P2|Overall Study|Not specified|0
390071|NCT00121719|1239703|P1|Overall Study|Not specified|0
390072|NCT00121719|1239690|P14|Overall Study|Physician Decision|0
390073|NCT00121719|1239691|P13|Overall Study|Physician Decision|1
390074|NCT00121719|1239692|P12|Overall Study|Physician Decision|0
390075|NCT00121719|1239693|P11|Overall Study|Physician Decision|0
390076|NCT00121719|1239694|P10|Overall Study|Physician Decision|0
390077|NCT00121719|1239695|P9|Overall Study|Physician Decision|0
390078|NCT00121719|1239696|P8|Overall Study|Physician Decision|0
390079|NCT00121719|1239697|P7|Overall Study|Physician Decision|0
390080|NCT00121719|1239698|P6|Overall Study|Physician Decision|0
390081|NCT00121719|1239699|P5|Overall Study|Physician Decision|0
390082|NCT00121719|1239700|P4|Overall Study|Physician Decision|0
390083|NCT00121719|1239701|P3|Overall Study|Physician Decision|0
390084|NCT00121719|1239702|P2|Overall Study|Physician Decision|1
390085|NCT00121719|1239703|P1|Overall Study|Physician Decision|0
390086|NCT00121719|1239690|P14|Overall Study|Clinical deterioration|2
390087|NCT00121719|1239691|P13|Overall Study|Clinical deterioration|2
390088|NCT00121719|1239692|P12|Overall Study|Clinical deterioration|1
390089|NCT00121719|1239693|P11|Overall Study|Clinical deterioration|0
390090|NCT00121719|1239694|P10|Overall Study|Clinical deterioration|2
390091|NCT00121719|1239695|P9|Overall Study|Clinical deterioration|2
390092|NCT00121719|1239696|P8|Overall Study|Clinical deterioration|1
390093|NCT00121719|1239697|P7|Overall Study|Clinical deterioration|2
390094|NCT00121719|1239698|P6|Overall Study|Clinical deterioration|0
390095|NCT00121719|1239699|P5|Overall Study|Clinical deterioration|1
390096|NCT00121719|1239700|P4|Overall Study|Clinical deterioration|0
390097|NCT00121719|1239701|P3|Overall Study|Clinical deterioration|1
390098|NCT00121719|1239702|P2|Overall Study|Clinical deterioration|1
390099|NCT00121719|1239703|P1|Overall Study|Clinical deterioration|0
390100|NCT00121719|1239690|P14|Overall Study|Progressive disease|4
390101|NCT00121719|1239691|P13|Overall Study|Progressive disease|13
390102|NCT00121719|1239692|P12|Overall Study|Progressive disease|3
390103|NCT00121719|1239693|P11|Overall Study|Progressive disease|4
390104|NCT00121719|1239694|P10|Overall Study|Progressive disease|1
390105|NCT00121719|1239695|P9|Overall Study|Progressive disease|3
390106|NCT00121719|1239696|P8|Overall Study|Progressive disease|5
390107|NCT00121719|1239697|P7|Overall Study|Progressive disease|7
390108|NCT00121719|1239698|P6|Overall Study|Progressive disease|1
390109|NCT00121719|1239699|P5|Overall Study|Progressive disease|2
390110|NCT00121719|1239700|P4|Overall Study|Progressive disease|2
390111|NCT00121719|1239701|P3|Overall Study|Progressive disease|0
390112|NCT00121719|1239702|P2|Overall Study|Progressive disease|1
390113|NCT00121719|1239703|P1|Overall Study|Progressive disease|2
390114|NCT00121719|1239690|P14|Overall Study|Withdrawal by Subject|0
390115|NCT00121719|1239691|P13|Overall Study|Withdrawal by Subject|0
390116|NCT00121719|1239692|P12|Overall Study|Withdrawal by Subject|0
390117|NCT00121719|1239693|P11|Overall Study|Withdrawal by Subject|0
390118|NCT00121719|1239694|P10|Overall Study|Withdrawal by Subject|0
390119|NCT00121719|1239695|P9|Overall Study|Withdrawal by Subject|0
390120|NCT00121719|1239696|P8|Overall Study|Withdrawal by Subject|0
390121|NCT00121719|1239697|P7|Overall Study|Withdrawal by Subject|0
390122|NCT00121719|1239698|P6|Overall Study|Withdrawal by Subject|0
390123|NCT00121719|1239699|P5|Overall Study|Withdrawal by Subject|0
390124|NCT00121719|1239700|P4|Overall Study|Withdrawal by Subject|0
390125|NCT00121719|1239701|P3|Overall Study|Withdrawal by Subject|0
390126|NCT00121719|1239702|P2|Overall Study|Withdrawal by Subject|0
390127|NCT00121719|1239703|P1|Overall Study|Withdrawal by Subject|1
390128|NCT00121719|1239690|P14|Overall Study|Protocol deviation|0
390129|NCT00121719|1239691|P13|Overall Study|Protocol deviation|0
390130|NCT00121719|1239692|P12|Overall Study|Protocol deviation|0
390131|NCT00121719|1239693|P11|Overall Study|Protocol deviation|0
390132|NCT00121719|1239694|P10|Overall Study|Protocol deviation|0
390133|NCT00121719|1239695|P9|Overall Study|Protocol deviation|0
390134|NCT00121719|1239696|P8|Overall Study|Protocol deviation|0
390135|NCT00121719|1239697|P7|Overall Study|Protocol deviation|0
390136|NCT00121719|1239698|P6|Overall Study|Protocol deviation|0
390137|NCT00121719|1239699|P5|Overall Study|Protocol deviation|0
390138|NCT00121719|1239700|P4|Overall Study|Protocol deviation|0
390139|NCT00121719|1239701|P3|Overall Study|Protocol deviation|1
390140|NCT00121719|1239702|P2|Overall Study|Protocol deviation|0
390141|NCT00121719|1239703|P1|Overall Study|Protocol deviation|0
390142|NCT00121719|1239690|P14|Overall Study|Abnormal laboratory value|0
390143|NCT00121719|1239691|P13|Overall Study|Abnormal laboratory value|1
390144|NCT00121719|1239692|P12|Overall Study|Abnormal laboratory value|0
390145|NCT00121719|1239693|P11|Overall Study|Abnormal laboratory value|0
390146|NCT00121719|1239694|P10|Overall Study|Abnormal laboratory value|0
390147|NCT00121719|1239695|P9|Overall Study|Abnormal laboratory value|0
390148|NCT00121719|1239696|P8|Overall Study|Abnormal laboratory value|1
390149|NCT00121719|1239697|P7|Overall Study|Abnormal laboratory value|0
390150|NCT00121719|1239698|P6|Overall Study|Abnormal laboratory value|0
390151|NCT00121719|1239699|P5|Overall Study|Abnormal laboratory value|0
390152|NCT00121719|1239700|P4|Overall Study|Abnormal laboratory value|0
390153|NCT00121719|1239701|P3|Overall Study|Abnormal laboratory value|0
390154|NCT00121719|1239702|P2|Overall Study|Abnormal laboratory value|1
390155|NCT00121719|1239703|P1|Overall Study|Abnormal laboratory value|1
390156|NCT00121719|1239690|P14|Overall Study|Adverse Event|0
390157|NCT00121719|1239691|P13|Overall Study|Adverse Event|3
390158|NCT00121719|1239692|P12|Overall Study|Adverse Event|0
390159|NCT00121719|1239693|P11|Overall Study|Adverse Event|1
390160|NCT00121719|1239694|P10|Overall Study|Adverse Event|0
390161|NCT00121719|1239695|P9|Overall Study|Adverse Event|0
390162|NCT00121719|1239696|P8|Overall Study|Adverse Event|1
390163|NCT00121719|1239697|P7|Overall Study|Adverse Event|2
390164|NCT00121719|1239698|P6|Overall Study|Adverse Event|2
390165|NCT00121719|1239699|P5|Overall Study|Adverse Event|0
390166|NCT00121719|1239700|P4|Overall Study|Adverse Event|0
390167|NCT00121719|1239701|P3|Overall Study|Adverse Event|1
390168|NCT00121719|1239702|P2|Overall Study|Adverse Event|0
390169|NCT00121719|1239703|P1|Overall Study|Adverse Event|0
390170|NCT00121667|1239880|P4|Short Term (ST) + Long Term (LT) Period|Death|2
390171|NCT00121667|1239881|P3|Short Term (ST) + Long Term (LT) Period|Death|0
390172|NCT00121667|1239882|P2|Short Term (ST) + Long Term (LT) Period|Death|0
390173|NCT00121667|1239883|P1|Short Term (ST) + Long Term (LT) Period|Death|1
390174|NCT00121667|1239880|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
390175|NCT00121667|1239881|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
390176|NCT00121667|1239882|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
390177|NCT00121667|1239883|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
390178|NCT00121667|1239880|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
390179|NCT00121667|1239881|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
390180|NCT00121667|1239882|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
390181|NCT00121667|1239883|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
390182|NCT00121667|1239880|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
390183|NCT00121667|1239881|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
390184|NCT00121667|1239882|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
390185|NCT00121667|1239883|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
390186|NCT00121667|1239880|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
390187|NCT00121667|1239881|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
390188|NCT00121667|1239882|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
390189|NCT00121667|1239883|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
390190|NCT00121667|1239880|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
390191|NCT00121667|1239881|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
390192|NCT00121667|1239882|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
390193|NCT00121667|1239883|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
390194|NCT00121667|1239880|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
390195|NCT00121667|1239881|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
390196|NCT00121667|1239882|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
390197|NCT00121667|1239883|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
390198|NCT00121667|1239880|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
390199|NCT00121667|1239881|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
390200|NCT00121667|1239882|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
390201|NCT00121667|1239883|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
390202|NCT00121667|1239880|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
390203|NCT00121667|1239881|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
390204|NCT00121667|1239882|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
390205|NCT00121667|1239883|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
390206|NCT00121667|1239880|P4|Short Term (ST) Period|Pregnancy|1
390207|NCT00121667|1239881|P3|Short Term (ST) Period|Pregnancy|0
390208|NCT00121667|1239882|P2|Short Term (ST) Period|Pregnancy|0
390209|NCT00121667|1239883|P1|Short Term (ST) Period|Pregnancy|0
390210|NCT00121667|1239880|P4|Short Term (ST) Period|Death|1
390211|NCT00121667|1239881|P3|Short Term (ST) Period|Death|0
390212|NCT00121667|1239882|P2|Short Term (ST) Period|Death|0
390213|NCT00121667|1239883|P1|Short Term (ST) Period|Death|0
390214|NCT00121667|1239880|P4|Short Term (ST) Period|Other Reason|0
390215|NCT00121667|1239881|P3|Short Term (ST) Period|Other Reason|0
390216|NCT00121667|1239882|P2|Short Term (ST) Period|Other Reason|0
390217|NCT00121667|1239883|P1|Short Term (ST) Period|Other Reason|3
390218|NCT00121667|1239880|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
390219|NCT00121667|1239881|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
390220|NCT00121667|1239882|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
390221|NCT00121667|1239883|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
390222|NCT00121667|1239880|P4|Short Term (ST) Period|Poor / Non-compliance|2
390223|NCT00121667|1239881|P3|Short Term (ST) Period|Poor / Non-compliance|1
390224|NCT00121667|1239882|P2|Short Term (ST) Period|Poor / Non-compliance|1
390225|NCT00121667|1239883|P1|Short Term (ST) Period|Poor / Non-compliance|0
390226|NCT00121667|1239880|P4|Short Term (ST) Period|Lost to Follow-up|3
390227|NCT00121667|1239881|P3|Short Term (ST) Period|Lost to Follow-up|4
390228|NCT00121667|1239882|P2|Short Term (ST) Period|Lost to Follow-up|4
390229|NCT00121667|1239883|P1|Short Term (ST) Period|Lost to Follow-up|3
390230|NCT00121667|1239880|P4|Short Term (ST) Period|Adverse Event|3
390231|NCT00121667|1239881|P3|Short Term (ST) Period|Adverse Event|5
390232|NCT00121667|1239882|P2|Short Term (ST) Period|Adverse Event|6
390233|NCT00121667|1239883|P1|Short Term (ST) Period|Adverse Event|5
390234|NCT00121667|1239880|P4|Short Term (ST) Period|Subject Withdrew Consent|11
390235|NCT00121667|1239881|P3|Short Term (ST) Period|Subject Withdrew Consent|4
390236|NCT00121667|1239882|P2|Short Term (ST) Period|Subject Withdrew Consent|13
390237|NCT00121667|1239883|P1|Short Term (ST) Period|Subject Withdrew Consent|8
390238|NCT00121667|1239880|P4|Short Term (ST) Period|Lack of Efficacy|44
390239|NCT00121667|1239881|P3|Short Term (ST) Period|Lack of Efficacy|27
390240|NCT00121667|1239882|P2|Short Term (ST) Period|Lack of Efficacy|22
390241|NCT00121667|1239883|P1|Short Term (ST) Period|Lack of Efficacy|25
390242|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Other Reason|1
390243|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Other Reason|0
390244|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Other Reason|2
390245|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Other Reason|3
390246|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Other Reason|5
390247|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Missing|0
390248|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Missing|0
390249|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Missing|1
390250|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Missing|0
390251|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Missing|0
390252|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Death|0
390253|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Death|1
390254|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Death|0
390255|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Death|0
390256|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Death|0
390257|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
390258|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
390259|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
390260|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
390261|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
390262|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Pregnancy|0
390263|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Pregnancy|1
390264|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Pregnancy|0
390265|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Pregnancy|1
390266|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Pregnancy|0
390267|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
390268|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
390269|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
390270|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
390271|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
390272|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
390273|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
390274|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
390275|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
390276|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
390277|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
390278|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
390279|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
390280|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
390281|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
390282|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Adverse Event|5
390283|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Adverse Event|5
390284|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Adverse Event|10
390285|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Adverse Event|10
390286|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Adverse Event|9
390287|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
390288|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
390289|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
390290|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
390291|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
390292|NCT00121641|1239981|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
390293|NCT00121641|1239982|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
390294|NCT00121641|1239983|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
390295|NCT00121641|1239984|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
390296|NCT00121641|1239985|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
390297|NCT00121641|1239981|P5|24-week Short-term Treatment Period|Other Reason|0
390298|NCT00121641|1239982|P4|24-week Short-term Treatment Period|Other Reason|0
390299|NCT00121641|1239983|P3|24-week Short-term Treatment Period|Other Reason|0
390300|NCT00121641|1239984|P2|24-week Short-term Treatment Period|Other Reason|0
390301|NCT00121641|1239985|P1|24-week Short-term Treatment Period|Other Reason|1
390302|NCT00121641|1239981|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
390303|NCT00121641|1239982|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
390304|NCT00121641|1239983|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
390305|NCT00121641|1239984|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
390306|NCT00121641|1239985|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
390307|NCT00121641|1239981|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
390308|NCT00121641|1239982|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
390309|NCT00121641|1239983|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
390310|NCT00121641|1239984|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
390311|NCT00121641|1239985|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
390312|NCT00121641|1239981|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
390313|NCT00121641|1239982|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
390314|NCT00121641|1239983|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
390315|NCT00121641|1239984|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
390316|NCT00121641|1239985|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
390317|NCT00121641|1239981|P5|24-week Short-term Treatment Period|Adverse Event|2
390318|NCT00121641|1239982|P4|24-week Short-term Treatment Period|Adverse Event|0
390319|NCT00121641|1239983|P3|24-week Short-term Treatment Period|Adverse Event|4
390320|NCT00121641|1239984|P2|24-week Short-term Treatment Period|Adverse Event|3
390321|NCT00121641|1239985|P1|24-week Short-term Treatment Period|Adverse Event|3
390322|NCT00121641|1239981|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
390323|NCT00121641|1239982|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
390324|NCT00121641|1239983|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
390325|NCT00121641|1239984|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
390326|NCT00121641|1239985|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
390327|NCT00121641|1239981|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
390328|NCT00121641|1239982|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
390329|NCT00121641|1239983|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
390330|NCT00121641|1239984|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
390331|NCT00121641|1239985|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
390332|NCT00121485|1240098|P2|Overall Study|Crossover|2
390333|NCT00121485|1240099|P1|Overall Study|Crossover|0
390334|NCT00121485|1240098|P2|Overall Study|Not implanted|5
390335|NCT00121485|1240099|P1|Overall Study|Not implanted|1
390336|NCT00121238|1240144|P1|Overall Study|Protocol Violation|2
390337|NCT00121238|1240144|P1|Overall Study|disease progression before intervention|1
390338|NCT00121199|1240156|P1|Overall Study|Ineligible|9
390339|NCT00121199|1240156|P1|Overall Study|Other - Not Protocol Specified|3
390340|NCT00121199|1240156|P1|Overall Study|Death|3
390341|NCT00121199|1240156|P1|Overall Study|Progression/Relapse|1
390342|NCT00121199|1240156|P1|Overall Study|Refusal Unrelated to Adverse Event|1
390343|NCT00121199|1240156|P1|Overall Study|Adverse Event|11
390344|NCT00121134|1240172|P4|Overall Study|Patient Personal Reasons|0
390345|NCT00121134|1240173|P3|Overall Study|Patient Personal Reasons|0
390346|NCT00121134|1240174|P2|Overall Study|Patient Personal Reasons|1
390347|NCT00121134|1240175|P1|Overall Study|Patient Personal Reasons|0
390348|NCT00121134|1240172|P4|Overall Study|Intercurrent Illness|1
390349|NCT00121134|1240173|P3|Overall Study|Intercurrent Illness|0
390350|NCT00121134|1240174|P2|Overall Study|Intercurrent Illness|0
390351|NCT00121134|1240175|P1|Overall Study|Intercurrent Illness|0
390352|NCT00121134|1240172|P4|Overall Study|Treatment Delay|0
390353|NCT00121134|1240173|P3|Overall Study|Treatment Delay|0
390354|NCT00121134|1240174|P2|Overall Study|Treatment Delay|0
390355|NCT00121134|1240175|P1|Overall Study|Treatment Delay|1
390356|NCT00121134|1240172|P4|Overall Study|Physician Decision|1
390357|NCT00121134|1240173|P3|Overall Study|Physician Decision|4
390358|NCT00121134|1240174|P2|Overall Study|Physician Decision|4
390359|NCT00121134|1240175|P1|Overall Study|Physician Decision|6
390360|NCT00121134|1240172|P4|Overall Study|Toxicity|5
390361|NCT00121134|1240173|P3|Overall Study|Toxicity|13
390362|NCT00121134|1240174|P2|Overall Study|Toxicity|7
390363|NCT00121134|1240175|P1|Overall Study|Toxicity|4
390364|NCT00121134|1240172|P4|Overall Study|Progression of Disease|2
390365|NCT00121134|1240173|P3|Overall Study|Progression of Disease|4
390366|NCT00121134|1240174|P2|Overall Study|Progression of Disease|3
390367|NCT00121134|1240175|P1|Overall Study|Progression of Disease|5
390368|NCT00120874|1240187|P2|Overall Study|Death|1
390369|NCT00120874|1240188|P1|Overall Study|Death|0
390370|NCT00120627|1240226|P2|Overall Study|Withdrawal by Subject|5
390371|NCT00120627|1240227|P1|Overall Study|Withdrawal by Subject|5
390372|NCT00120406|1240278|P2|Overall Study|patient moved but has not withdrawn|1
390373|NCT00120406|1240279|P1|Overall Study|patient moved but has not withdrawn|0
390374|NCT00120406|1240278|P2|Overall Study|received non-study stent|2
390375|NCT00120406|1240279|P1|Overall Study|received non-study stent|0
390376|NCT00120406|1240278|P2|Overall Study|Lost to Follow-up|2
390377|NCT00120406|1240279|P1|Overall Study|Lost to Follow-up|5
390378|NCT00120406|1240278|P2|Overall Study|Withdrawal by Subject|7
390379|NCT00120406|1240279|P1|Overall Study|Withdrawal by Subject|5
390380|NCT00120406|1240278|P2|Overall Study|Death|4
390381|NCT00120406|1240279|P1|Overall Study|Death|9
390382|NCT00120289|1240289|P2|Overall Study|Withdrawal by Subject|13
390383|NCT00120289|1240290|P1|Overall Study|Withdrawal by Subject|14
390384|NCT00120289|1240289|P2|Overall Study|Lost to Follow-up|14
390385|NCT00120289|1240290|P1|Overall Study|Lost to Follow-up|11
390386|NCT00120289|1240289|P2|Overall Study|Death|82
390387|NCT00120289|1240290|P1|Overall Study|Death|96
390388|NCT00120250|1240302|P2|Overall Study|Protocol Violation|1
390389|NCT00120250|1240303|P1|Overall Study|Protocol Violation|0
390390|NCT00120250|1240302|P2|Overall Study|Lost to Follow-up|1
390391|NCT00120250|1240303|P1|Overall Study|Lost to Follow-up|1
390392|NCT00120042|1240319|P3|Overall Study|all completed protocl|0
390393|NCT00120042|1240320|P2|Overall Study|all completed protocl|0
390394|NCT00120042|1240321|P1|Overall Study|all completed protocl|0
390395|NCT00119678|1240331|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
390396|NCT00119678|1240332|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
390397|NCT00119678|1240331|P2|Open-label Treatment Period|Pregnancy|0
390398|NCT00119678|1240332|P1|Open-label Treatment Period|Pregnancy|1
390399|NCT00119678|1240331|P2|Open-label Treatment Period|Participants not meeting study criteria|0
390400|NCT00119678|1240332|P1|Open-label Treatment Period|Participants not meeting study criteria|2
390401|NCT00119678|1240331|P2|Open-label Treatment Period|Participant withdrew consent|0
390402|NCT00119678|1240332|P1|Open-label Treatment Period|Participant withdrew consent|4
390403|NCT00119678|1240331|P2|Open-label Treatment Period|Lost to Follow-up|0
390404|NCT00119678|1240332|P1|Open-label Treatment Period|Lost to Follow-up|3
390405|NCT00119678|1240331|P2|Open-label Treatment Period|Lack of Efficacy|0
390406|NCT00119678|1240332|P1|Open-label Treatment Period|Lack of Efficacy|9
390407|NCT00119678|1240331|P2|Open-label Treatment Period|Adverse Event|0
390408|NCT00119678|1240332|P1|Open-label Treatment Period|Adverse Event|3
390409|NCT00119678|1240331|P2|Open-label Treatment Period|Death|0
390410|NCT00119678|1240332|P1|Open-label Treatment Period|Death|1
390411|NCT00119678|1240331|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
390412|NCT00119678|1240332|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
390413|NCT00119678|1240331|P2|Double-blind Treatment Period|Not treated|2
390414|NCT00119678|1240332|P1|Double-blind Treatment Period|Not treated|1
390415|NCT00119678|1240331|P2|Double-blind Treatment Period|Pregnancy|2
390416|NCT00119678|1240332|P1|Double-blind Treatment Period|Pregnancy|0
390417|NCT00119678|1240331|P2|Double-blind Treatment Period|Poor/Non-compliance|0
390418|NCT00119678|1240332|P1|Double-blind Treatment Period|Poor/Non-compliance|3
390419|NCT00119678|1240331|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
390420|NCT00119678|1240332|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
390421|NCT00119678|1240331|P2|Double-blind Treatment Period|Participant withdrew consent|4
390422|NCT00119678|1240332|P1|Double-blind Treatment Period|Participant withdrew consent|4
390423|NCT00119678|1240331|P2|Double-blind Treatment Period|Lost to Follow-up|2
390424|NCT00119678|1240332|P1|Double-blind Treatment Period|Lost to Follow-up|1
390425|NCT00119678|1240331|P2|Double-blind Treatment Period|Lack of Efficacy|12
390426|NCT00119678|1240332|P1|Double-blind Treatment Period|Lack of Efficacy|21
390427|NCT00119678|1240331|P2|Double-blind Treatment Period|Adverse Event|1
390428|NCT00119678|1240332|P1|Double-blind Treatment Period|Adverse Event|7
390429|NCT00119678|1240331|P2|Double-blind Treatment Period|Death|0
390430|NCT00119678|1240332|P1|Double-blind Treatment Period|Death|1
390431|NCT00119405|1240378|P1|Overall Study|Withdrawal by Subject|1
390432|NCT00119379|1240392|P2|Overall Study|Adverse Event|1
390433|NCT00119379|1240393|P1|Overall Study|Adverse Event|4
390434|NCT00119262|1240411|P2|Overall Study|others|5
390435|NCT00119262|1240412|P1|Overall Study|others|0
390436|NCT00119262|1240411|P2|Overall Study|ineligble|2
390437|NCT00119262|1240412|P1|Overall Study|ineligble|1
390438|NCT00119262|1240411|P2|Overall Study|other disease|2
390439|NCT00119262|1240412|P1|Overall Study|other disease|0
390440|NCT00119262|1240411|P2|Overall Study|Adverse Event|35
390441|NCT00119262|1240412|P1|Overall Study|Adverse Event|33
390442|NCT00119262|1240411|P2|Overall Study|Withdrawal by Subject|11
390443|NCT00119262|1240412|P1|Overall Study|Withdrawal by Subject|12
390444|NCT00119262|1240411|P2|Overall Study|Lack of Efficacy|3
390445|NCT00119262|1240412|P1|Overall Study|Lack of Efficacy|0
390446|NCT00119015|1240449|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
390447|NCT00119015|1240450|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
390448|NCT00119015|1240451|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
390449|NCT00118911|1240467|P2|Overall Study|Withdrawal by Subject|5
390450|NCT00118911|1240468|P1|Overall Study|Withdrawal by Subject|2
390451|NCT00118898|1240480|P4|Overall Study|Not able to get to clinic|40
390452|NCT00118898|1240481|P3|Overall Study|Not able to get to clinic|31
390453|NCT00118898|1240482|P2|Overall Study|Not able to get to clinic|43
390454|NCT00118898|1240483|P1|Overall Study|Not able to get to clinic|34
390455|NCT00118898|1240480|P4|Overall Study|Not compliant with requirements|11
390456|NCT00118898|1240481|P3|Overall Study|Not compliant with requirements|11
390457|NCT00118898|1240482|P2|Overall Study|Not compliant with requirements|13
390458|NCT00118898|1240483|P1|Overall Study|Not compliant with requirements|11
390459|NCT00118898|1240480|P4|Overall Study|Severe debilitation|4
390460|NCT00118898|1240481|P3|Overall Study|Severe debilitation|6
390461|NCT00118898|1240482|P2|Overall Study|Severe debilitation|4
390462|NCT00118898|1240483|P1|Overall Study|Severe debilitation|1
390463|NCT00118898|1240480|P4|Overall Study|Site Closure|37
390464|NCT00118898|1240481|P3|Overall Study|Site Closure|28
390465|NCT00118898|1240482|P2|Overall Study|Site Closure|31
390466|NCT00118898|1240483|P1|Overall Study|Site Closure|33
390467|NCT00118898|1240480|P4|Overall Study|Withdrawal by Subject|8
390468|NCT00118898|1240481|P3|Overall Study|Withdrawal by Subject|8
390469|NCT00118898|1240482|P2|Overall Study|Withdrawal by Subject|5
390470|NCT00118898|1240483|P1|Overall Study|Withdrawal by Subject|10
390471|NCT00118898|1240480|P4|Overall Study|Lost to Follow-up|33
390472|NCT00118898|1240481|P3|Overall Study|Lost to Follow-up|33
390473|NCT00118898|1240482|P2|Overall Study|Lost to Follow-up|34
390474|NCT00118898|1240483|P1|Overall Study|Lost to Follow-up|26
390475|NCT00118898|1240480|P4|Overall Study|Death|8
390476|NCT00118898|1240481|P3|Overall Study|Death|6
390477|NCT00118898|1240482|P2|Overall Study|Death|11
390478|NCT00118898|1240483|P1|Overall Study|Death|6
390479|NCT00118703|1240609|P2|Overall Study|Lost to Follow-up|2
390480|NCT00118703|1240610|P1|Overall Study|Lost to Follow-up|1
390481|NCT00118703|1240609|P2|Overall Study|Withdrawal by Subject|5
390482|NCT00118703|1240610|P1|Overall Study|Withdrawal by Subject|2
390483|NCT00118703|1240609|P2|Overall Study|Participant took two different treatment|1
390484|NCT00118703|1240610|P1|Overall Study|Participant took two different treatment|0
390485|NCT00118703|1240609|P2|Overall Study|Adverse Event|1
390486|NCT00118703|1240610|P1|Overall Study|Adverse Event|1
390487|NCT00118703|1240609|P2|Overall Study|Protocol Violation|0
390488|NCT00118703|1240610|P1|Overall Study|Protocol Violation|1
390489|NCT00118430|1240708|P3|Overall Study|Lost to Follow-up|28
390490|NCT00118430|1240709|P2|Overall Study|Lost to Follow-up|22
390491|NCT00118430|1240710|P1|Overall Study|Lost to Follow-up|15
390492|NCT00118430|1240708|P3|Overall Study|Withdrawal by Subject|0
390493|NCT00118430|1240709|P2|Overall Study|Withdrawal by Subject|2
390494|NCT00118430|1240710|P1|Overall Study|Withdrawal by Subject|6
390495|NCT00118417|1240725|P2|Phase II (Weeks 6 to 12)|Remission|2
390496|NCT00118417|1240726|P1|Phase II (Weeks 6 to 12)|Remission|1
390497|NCT00118417|1240725|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
390498|NCT00118417|1240726|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
390499|NCT00118417|1240725|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
390500|NCT00118417|1240726|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
390501|NCT00118417|1240725|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
390502|NCT00118417|1240726|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
390503|NCT00118417|1240725|P2|Phase I (Weeks 0 to 6)|Remission|0
390504|NCT00118417|1240726|P1|Phase I (Weeks 0 to 6)|Remission|8
390505|NCT00118287|1240870|P1|Overall Study|Muscle pain|1
390506|NCT00118287|1240870|P1|Overall Study|Intracranial haemorrhage|1
390507|NCT00118157|1240890|P1|Overall Study|Withdrawal by Subject|2
390508|NCT00118157|1240890|P1|Overall Study|Death|8
390509|NCT00118157|1240890|P1|Overall Study|Adverse Event|2
390510|NCT00118092|1240907|P1|Overall Study|Protocol Violation|1
390511|NCT00118092|1240907|P1|Overall Study|Withdrawal by Subject|1
390512|NCT00118040|1240925|P3|Overall Study|Other|1
390513|NCT00118040|1240926|P2|Overall Study|Other|0
390514|NCT00118040|1240927|P1|Overall Study|Other|0
390515|NCT00118040|1240925|P3|Overall Study|Non-Compliant Participant|2
390516|NCT00118040|1240926|P2|Overall Study|Non-Compliant Participant|1
390517|NCT00118040|1240927|P1|Overall Study|Non-Compliant Participant|1
390518|NCT00118040|1240925|P3|Overall Study|Medical Contraindication|1
390519|NCT00118040|1240926|P2|Overall Study|Medical Contraindication|0
390520|NCT00118040|1240927|P1|Overall Study|Medical Contraindication|0
390521|NCT00118040|1240925|P3|Overall Study|Withdrawal by Subject|2
390522|NCT00118040|1240926|P2|Overall Study|Withdrawal by Subject|0
390523|NCT00118040|1240927|P1|Overall Study|Withdrawal by Subject|0
390524|NCT00118040|1240925|P3|Overall Study|Adverse Event|0
390525|NCT00118040|1240926|P2|Overall Study|Adverse Event|1
390526|NCT00118040|1240927|P1|Overall Study|Adverse Event|0
390527|NCT00117988|1240988|P1|Overall Study|Adverse Event|1
390528|NCT00117988|1240988|P1|Overall Study|Death|3
390529|NCT00117949|1241011|P4|Overall Study|Hepatic abnormalities|1
390530|NCT00117949|1241012|P3|Overall Study|Hepatic abnormalities|0
390531|NCT00117949|1241013|P2|Overall Study|Hepatic abnormalities|1
390532|NCT00117949|1241014|P1|Overall Study|Hepatic abnormalities|0
390533|NCT00117949|1241011|P4|Overall Study|PSA reduction <=50%|4
390534|NCT00117949|1241012|P3|Overall Study|PSA reduction <=50%|2
390535|NCT00117949|1241013|P2|Overall Study|PSA reduction <=50%|2
390536|NCT00117949|1241014|P1|Overall Study|PSA reduction <=50%|0
390537|NCT00117949|1241011|P4|Overall Study|PSA increase >=10ng/mL|0
390538|NCT00117949|1241012|P3|Overall Study|PSA increase >=10ng/mL|1
390539|NCT00117949|1241013|P2|Overall Study|PSA increase >=10ng/mL|1
390540|NCT00117949|1241014|P1|Overall Study|PSA increase >=10ng/mL|0
390541|NCT00117949|1241011|P4|Overall Study|Prostate-specific antigen increase >=25%|2
390542|NCT00117949|1241012|P3|Overall Study|Prostate-specific antigen increase >=25%|1
390543|NCT00117949|1241013|P2|Overall Study|Prostate-specific antigen increase >=25%|1
390544|NCT00117949|1241014|P1|Overall Study|Prostate-specific antigen increase >=25%|0
390545|NCT00117949|1241011|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
390546|NCT00117949|1241012|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
390547|NCT00117949|1241013|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
390548|NCT00117949|1241014|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
390549|NCT00117949|1241011|P4|Overall Study|Testosterone >1.0 ng/mL|15
390550|NCT00117949|1241012|P3|Overall Study|Testosterone >1.0 ng/mL|17
390551|NCT00117949|1241013|P2|Overall Study|Testosterone >1.0 ng/mL|18
390552|NCT00117949|1241014|P1|Overall Study|Testosterone >1.0 ng/mL|10
390553|NCT00117845|1241048|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
390554|NCT00117793|1241066|P1|Overall Study|Withdrawal by Subject|12
390555|NCT00117676|1241083|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
390556|NCT00117676|1241084|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
390557|NCT00117676|1241083|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
390558|NCT00117676|1241084|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
390559|NCT00117676|1241083|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
390560|NCT00117676|1241084|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
390561|NCT00117676|1241083|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
390562|NCT00117676|1241084|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
390563|NCT00117676|1241083|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
390564|NCT00117676|1241084|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
390565|NCT00117676|1241083|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
390566|NCT00117676|1241084|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
390567|NCT00117676|1241083|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
390568|NCT00117676|1241084|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
390569|NCT00117676|1241083|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
390570|NCT00117676|1241084|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
390571|NCT00117676|1241083|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
390572|NCT00117676|1241084|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
390573|NCT00117676|1241083|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
390574|NCT00117676|1241084|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
390575|NCT00117676|1241083|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
390576|NCT00117676|1241084|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
390577|NCT00117676|1241083|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
390578|NCT00117676|1241084|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
390579|NCT00117676|1241083|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
390580|NCT00117676|1241084|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
390581|NCT00117676|1241083|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
390582|NCT00117676|1241084|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
390583|NCT00117676|1241083|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
390584|NCT00117676|1241084|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
390585|NCT00117676|1241083|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
390586|NCT00117676|1241084|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
390587|NCT00117676|1241083|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
390588|NCT00117676|1241084|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
390589|NCT00117676|1241083|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
390590|NCT00117676|1241084|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
390591|NCT00117676|1241083|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
390592|NCT00117676|1241084|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
390593|NCT00117676|1241083|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
390594|NCT00117676|1241084|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
390595|NCT00117676|1241083|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
390596|NCT00117676|1241084|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
390597|NCT00117676|1241083|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
390598|NCT00117676|1241084|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
390599|NCT00117676|1241083|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
390600|NCT00117676|1241084|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
390601|NCT00117676|1241083|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
390602|NCT00117676|1241084|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
390603|NCT00117676|1241083|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
390604|NCT00117676|1241084|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
390605|NCT00117676|1241083|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
390606|NCT00117676|1241084|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
390607|NCT00117676|1241083|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
390608|NCT00117676|1241084|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
390609|NCT00117676|1241083|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
390610|NCT00117676|1241084|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
390611|NCT00117676|1241083|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
390612|NCT00117676|1241084|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
390613|NCT00117676|1241083|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
390614|NCT00117676|1241084|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
390615|NCT00117676|1241083|P2|Double-blind Period Through Week 48|Withdrew Consent|1
390616|NCT00117676|1241084|P1|Double-blind Period Through Week 48|Withdrew Consent|0
390617|NCT00117676|1241083|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
390618|NCT00117676|1241084|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
390619|NCT00117676|1241083|P2|Double-blind Period Through Week 48|Protocol Violation|1
390620|NCT00117676|1241084|P1|Double-blind Period Through Week 48|Protocol Violation|0
390621|NCT00117676|1241083|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
390622|NCT00117676|1241084|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
390623|NCT00117676|1241083|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
390624|NCT00117676|1241084|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
390625|NCT00117637|1241173|P2|Second Intervention (Period 2)|reason not reported|0
390626|NCT00117637|1241174|P1|Second Intervention (Period 2)|reason not reported|1
390627|NCT00117637|1241173|P2|Second Intervention (Period 2)|non compliant with study medication|1
390628|NCT00117637|1241174|P1|Second Intervention (Period 2)|non compliant with study medication|1
390629|NCT00117637|1241173|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
390630|NCT00117637|1241174|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
390631|NCT00117637|1241173|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
390632|NCT00117637|1241174|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
390633|NCT00117637|1241173|P2|Second Intervention (Period 2)|Protocol Violation|0
390634|NCT00117637|1241174|P1|Second Intervention (Period 2)|Protocol Violation|1
390635|NCT00117637|1241173|P2|Second Intervention (Period 2)|Lost to Follow-up|0
390636|NCT00117637|1241174|P1|Second Intervention (Period 2)|Lost to Follow-up|1
390637|NCT00117637|1241173|P2|Second Intervention (Period 2)|Adverse Event|9
390638|NCT00117637|1241174|P1|Second Intervention (Period 2)|Adverse Event|0
390639|NCT00117637|1241173|P2|First Intervention (Period 1)|reason not reported|1
390640|NCT00117637|1241174|P1|First Intervention (Period 1)|reason not reported|0
390641|NCT00117637|1241173|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
390642|NCT00117637|1241174|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
390643|NCT00117637|1241173|P2|First Intervention (Period 1)|protocol driven decision point|0
390644|NCT00117637|1241174|P1|First Intervention (Period 1)|protocol driven decision point|1
390645|NCT00117637|1241173|P2|First Intervention (Period 1)|study terminated by the sponsor|1
390646|NCT00117637|1241174|P1|First Intervention (Period 1)|study terminated by the sponsor|3
390647|NCT00117637|1241173|P2|First Intervention (Period 1)|Withdrawal by Subject|4
390648|NCT00117637|1241174|P1|First Intervention (Period 1)|Withdrawal by Subject|2
390649|NCT00117637|1241173|P2|First Intervention (Period 1)|Protocol Violation|0
390650|NCT00117637|1241174|P1|First Intervention (Period 1)|Protocol Violation|1
390651|NCT00117637|1241173|P2|First Intervention (Period 1)|Lost to Follow-up|2
390652|NCT00117637|1241174|P1|First Intervention (Period 1)|Lost to Follow-up|0
390653|NCT00117637|1241173|P2|First Intervention (Period 1)|Adverse Event|16
390654|NCT00117637|1241174|P1|First Intervention (Period 1)|Adverse Event|11
390655|NCT00117598|1241249|P5|After Treament Cross Over|Unspecified|2
390656|NCT00117598|1241250|P4|After Treament Cross Over|Unspecified|1
390657|NCT00117598|1241251|P3|After Treament Cross Over|Unspecified|0
390658|NCT00117598|1241252|P2|After Treament Cross Over|Unspecified|0
390659|NCT00117598|1241253|P1|After Treament Cross Over|Unspecified|0
390660|NCT00117598|1241249|P5|After Treament Cross Over|Withdrawal by Subject|0
390661|NCT00117598|1241250|P4|After Treament Cross Over|Withdrawal by Subject|1
390662|NCT00117598|1241251|P3|After Treament Cross Over|Withdrawal by Subject|0
390663|NCT00117598|1241252|P2|After Treament Cross Over|Withdrawal by Subject|0
390664|NCT00117598|1241253|P1|After Treament Cross Over|Withdrawal by Subject|0
390665|NCT00117598|1241249|P5|After Treament Cross Over|Death|2
390666|NCT00117598|1241250|P4|After Treament Cross Over|Death|1
390667|NCT00117598|1241251|P3|After Treament Cross Over|Death|0
390668|NCT00117598|1241252|P2|After Treament Cross Over|Death|0
390669|NCT00117598|1241253|P1|After Treament Cross Over|Death|0
390670|NCT00117598|1241249|P5|Prior to Treatment Cross Over|Unspecified|0
390671|NCT00117598|1241250|P4|Prior to Treatment Cross Over|Unspecified|0
390672|NCT00117598|1241251|P3|Prior to Treatment Cross Over|Unspecified|9
390673|NCT00117598|1241252|P2|Prior to Treatment Cross Over|Unspecified|9
390674|NCT00117598|1241253|P1|Prior to Treatment Cross Over|Unspecified|15
390675|NCT00117598|1241249|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
390676|NCT00117598|1241250|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
390677|NCT00117598|1241251|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
390678|NCT00117598|1241252|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
390679|NCT00117598|1241253|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
390680|NCT00117598|1241249|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
390681|NCT00117598|1241250|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
390682|NCT00117598|1241251|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
390683|NCT00117598|1241252|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
390684|NCT00117598|1241253|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
390685|NCT00117598|1241249|P5|Prior to Treatment Cross Over|Death|0
390686|NCT00117598|1241250|P4|Prior to Treatment Cross Over|Death|0
390687|NCT00117598|1241251|P3|Prior to Treatment Cross Over|Death|37
390688|NCT00117598|1241252|P2|Prior to Treatment Cross Over|Death|41
390689|NCT00117598|1241253|P1|Prior to Treatment Cross Over|Death|40
390690|NCT00117338|1241296|P2|Overall Study|Lack of Efficacy|1
390691|NCT00117338|1241297|P1|Overall Study|Lack of Efficacy|0
390692|NCT00117338|1241296|P2|Overall Study|Did not meet Inclusion Criteria|0
390693|NCT00117338|1241297|P1|Overall Study|Did not meet Inclusion Criteria|1
390694|NCT00117338|1241296|P2|Overall Study|Withdrawal by Subject|0
390695|NCT00117338|1241297|P1|Overall Study|Withdrawal by Subject|1
390696|NCT00117338|1241296|P2|Overall Study|Protocol Violation|2
390697|NCT00117338|1241297|P1|Overall Study|Protocol Violation|3
390698|NCT00117338|1241296|P2|Overall Study|Adverse Event|1
390699|NCT00117338|1241297|P1|Overall Study|Adverse Event|0
390700|NCT00117312|1241319|P4|Overall Study|Withdrawal by Subject|0
390701|NCT00117312|1241320|P3|Overall Study|Withdrawal by Subject|0
390702|NCT00117312|1241321|P2|Overall Study|Withdrawal by Subject|2
390703|NCT00117312|1241322|P1|Overall Study|Withdrawal by Subject|0
390704|NCT00117312|1241319|P4|Overall Study|Hepatic abnormality|1
390705|NCT00117312|1241320|P3|Overall Study|Hepatic abnormality|0
390706|NCT00117312|1241321|P2|Overall Study|Hepatic abnormality|1
390707|NCT00117312|1241322|P1|Overall Study|Hepatic abnormality|0
390708|NCT00117312|1241319|P4|Overall Study|PSA increase >= 10ng/mL|0
390709|NCT00117312|1241320|P3|Overall Study|PSA increase >= 10ng/mL|1
390710|NCT00117312|1241321|P2|Overall Study|PSA increase >= 10ng/mL|1
390711|NCT00117312|1241322|P1|Overall Study|PSA increase >= 10ng/mL|0
390712|NCT00117312|1241319|P4|Overall Study|PSA decrease <=50%|4
390713|NCT00117312|1241320|P3|Overall Study|PSA decrease <=50%|2
390714|NCT00117312|1241321|P2|Overall Study|PSA decrease <=50%|2
390715|NCT00117312|1241322|P1|Overall Study|PSA decrease <=50%|0
390716|NCT00117312|1241319|P4|Overall Study|Protocol Violation|0
390717|NCT00117312|1241320|P3|Overall Study|Protocol Violation|3
390718|NCT00117312|1241321|P2|Overall Study|Protocol Violation|1
390719|NCT00117312|1241322|P1|Overall Study|Protocol Violation|0
390720|NCT00117312|1241319|P4|Overall Study|Adverse Event|0
390721|NCT00117312|1241320|P3|Overall Study|Adverse Event|0
390722|NCT00117312|1241321|P2|Overall Study|Adverse Event|2
390723|NCT00117312|1241322|P1|Overall Study|Adverse Event|0
390724|NCT00117312|1241319|P4|Overall Study|Patient choice|1
390725|NCT00117312|1241320|P3|Overall Study|Patient choice|2
390726|NCT00117312|1241321|P2|Overall Study|Patient choice|0
390727|NCT00117312|1241322|P1|Overall Study|Patient choice|0
390728|NCT00117312|1241319|P4|Overall Study|Not specified|1
390729|NCT00117312|1241320|P3|Overall Study|Not specified|3
390730|NCT00117312|1241321|P2|Overall Study|Not specified|1
390731|NCT00117312|1241322|P1|Overall Study|Not specified|0
390732|NCT00117312|1241319|P4|Overall Study|Prostate-specific antigen increase >=25%|3
390733|NCT00117312|1241320|P3|Overall Study|Prostate-specific antigen increase >=25%|5
390734|NCT00117312|1241321|P2|Overall Study|Prostate-specific antigen increase >=25%|1
390735|NCT00117312|1241322|P1|Overall Study|Prostate-specific antigen increase >=25%|0
390736|NCT00117312|1241319|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
390737|NCT00117312|1241320|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
390738|NCT00117312|1241321|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
390739|NCT00117312|1241322|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
390740|NCT00117312|1241319|P4|Overall Study|Testosterone >1.0 ng/mL|9
390741|NCT00117312|1241320|P3|Overall Study|Testosterone >1.0 ng/mL|5
390742|NCT00117312|1241321|P2|Overall Study|Testosterone >1.0 ng/mL|9
390743|NCT00117312|1241322|P1|Overall Study|Testosterone >1.0 ng/mL|9
390744|NCT00117286|1241338|P2|Overall Study|Research site closing|2
390745|NCT00117286|1241339|P1|Overall Study|Research site closing|0
390746|NCT00117286|1241338|P2|Overall Study|Lack of Efficacy|1
390747|NCT00117286|1241339|P1|Overall Study|Lack of Efficacy|2
390748|NCT00117286|1241338|P2|Overall Study|Physician Decision|7
390749|NCT00117286|1241339|P1|Overall Study|Physician Decision|3
390750|NCT00117286|1241338|P2|Overall Study|Withdrawal by Subject|2
390751|NCT00117286|1241339|P1|Overall Study|Withdrawal by Subject|6
390752|NCT00117286|1241338|P2|Overall Study|Protocol Violation|3
390753|NCT00117286|1241339|P1|Overall Study|Protocol Violation|3
390754|NCT00117286|1241338|P2|Overall Study|Lost to Follow-up|0
390755|NCT00117286|1241339|P1|Overall Study|Lost to Follow-up|2
390756|NCT00117286|1241338|P2|Overall Study|Adverse Event|6
390757|NCT00117286|1241339|P1|Overall Study|Adverse Event|12
390758|NCT00117156|1241347|P1|Overall Study|Trt for Pre-Exist Second Primary|1
390759|NCT00117156|1241347|P1|Overall Study|Physician Decision|1
390760|NCT00117156|1241347|P1|Overall Study|Adverse Event|9
390761|NCT00116831|1241366|P2|Overall Study|Missing data for participant|0
390762|NCT00116831|1241367|P1|Overall Study|Missing data for participant|1
390763|NCT00116831|1241366|P2|Overall Study|Insufficient therapeutic effect|1
390764|NCT00116831|1241367|P1|Overall Study|Insufficient therapeutic effect|0
390765|NCT00116831|1241366|P2|Overall Study|Withdrawal by Subject|32
390766|NCT00116831|1241367|P1|Overall Study|Withdrawal by Subject|32
390767|NCT00116831|1241366|P2|Overall Study|Withdrawn investigational product|0
390768|NCT00116831|1241367|P1|Overall Study|Withdrawn investigational product|1
390769|NCT00116831|1241366|P2|Overall Study|Low haemoglobin on screening|0
390770|NCT00116831|1241367|P1|Overall Study|Low haemoglobin on screening|1
390771|NCT00116831|1241366|P2|Overall Study|Hypoglycaemic events|0
390772|NCT00116831|1241367|P1|Overall Study|Hypoglycaemic events|1
390773|NCT00116831|1241366|P2|Overall Study|Protocol Violation|6
390774|NCT00116831|1241367|P1|Overall Study|Protocol Violation|3
390775|NCT00116831|1241366|P2|Overall Study|Lost to Follow-up|6
390776|NCT00116831|1241367|P1|Overall Study|Lost to Follow-up|8
390777|NCT00116831|1241366|P2|Overall Study|Baseline IVUS determined unevaluable|11
390778|NCT00116831|1241367|P1|Overall Study|Baseline IVUS determined unevaluable|12
390779|NCT00116831|1241366|P2|Overall Study|Adverse Event|16
390780|NCT00116831|1241367|P1|Overall Study|Adverse Event|14
390781|NCT00116805|1241445|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
390782|NCT00116805|1241446|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
390783|NCT00116805|1241445|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
390784|NCT00116805|1241446|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
390785|NCT00116805|1241445|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
390786|NCT00116805|1241446|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
390787|NCT00116805|1241445|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
390788|NCT00116805|1241446|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
390789|NCT00116805|1241445|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
390790|NCT00116805|1241446|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
390791|NCT00116805|1241445|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
390792|NCT00116805|1241446|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
390793|NCT00116805|1241445|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
390794|NCT00116805|1241446|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
390795|NCT00116805|1241445|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
390796|NCT00116805|1241446|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
390797|NCT00116805|1241445|P2|Open-label Period Weeks 337 - 384|Completed Study|0
390798|NCT00116805|1241446|P1|Open-label Period Weeks 337 - 384|Completed Study|1
390799|NCT00116805|1241445|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
390800|NCT00116805|1241446|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
390801|NCT00116805|1241445|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
390802|NCT00116805|1241446|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
390803|NCT00116805|1241445|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
390804|NCT00116805|1241446|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
390805|NCT00116805|1241445|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
390806|NCT00116805|1241446|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
390807|NCT00116805|1241445|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
390808|NCT00116805|1241446|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
390809|NCT00116805|1241445|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
390810|NCT00116805|1241446|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
390811|NCT00116805|1241445|P2|Open-label Period Weeks 289 - 336|Completed Study|1
390812|NCT00116805|1241446|P1|Open-label Period Weeks 289 - 336|Completed Study|0
390813|NCT00116805|1241445|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
390814|NCT00116805|1241446|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
390815|NCT00116805|1241445|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
390816|NCT00116805|1241446|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
390817|NCT00116805|1241445|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
390818|NCT00116805|1241446|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
390819|NCT00116805|1241445|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
390820|NCT00116805|1241446|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
390821|NCT00116805|1241445|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
390822|NCT00116805|1241446|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
390823|NCT00116805|1241445|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
390824|NCT00116805|1241446|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
390825|NCT00116805|1241445|P2|Open-label Period Weeks 193 - 240|Completed Study|1
390826|NCT00116805|1241446|P1|Open-label Period Weeks 193 - 240|Completed Study|0
390827|NCT00116805|1241445|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
390828|NCT00116805|1241446|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
390829|NCT00116805|1241445|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
390830|NCT00116805|1241446|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
390831|NCT00116805|1241445|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
390832|NCT00116805|1241446|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
390833|NCT00116805|1241445|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
390834|NCT00116805|1241446|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
390835|NCT00116805|1241445|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
390836|NCT00116805|1241446|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
390837|NCT00116805|1241445|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
390838|NCT00116805|1241446|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
390839|NCT00116805|1241445|P2|Open-label Period Weeks 145 - 192|Completed Study|1
390840|NCT00116805|1241446|P1|Open-label Period Weeks 145 - 192|Completed Study|1
390841|NCT00116805|1241445|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
390842|NCT00116805|1241446|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
390843|NCT00116805|1241445|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
390844|NCT00116805|1241446|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
390845|NCT00116805|1241445|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
390846|NCT00116805|1241446|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
390847|NCT00116805|1241445|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
390848|NCT00116805|1241446|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
390849|NCT00116805|1241445|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
390850|NCT00116805|1241446|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
390851|NCT00116805|1241445|P2|Open-label Period Weeks 97 - 144|Completed Study|0
390852|NCT00116805|1241446|P1|Open-label Period Weeks 97 - 144|Completed Study|1
390853|NCT00116805|1241445|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
390854|NCT00116805|1241446|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
390855|NCT00116805|1241445|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
390856|NCT00116805|1241446|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
390857|NCT00116805|1241445|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
390858|NCT00116805|1241446|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
390859|NCT00116805|1241445|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
390860|NCT00116805|1241446|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
390861|NCT00116805|1241445|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
390862|NCT00116805|1241446|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
390863|NCT00116805|1241445|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
390864|NCT00116805|1241446|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
390865|NCT00116805|1241445|P2|Double-blind Period Through Week 48|Withdrew Consent|2
390866|NCT00116805|1241446|P1|Double-blind Period Through Week 48|Withdrew Consent|4
390867|NCT00116805|1241445|P2|Double-blind Period Through Week 48|Protocol Violation|1
390868|NCT00116805|1241446|P1|Double-blind Period Through Week 48|Protocol Violation|1
390869|NCT00116805|1241445|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
390870|NCT00116805|1241446|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
390871|NCT00116779|1241539|P2|Overall Study|Elevated PSA levels|2
390872|NCT00116779|1241540|P1|Overall Study|Elevated PSA levels|2
390873|NCT00116779|1241539|P2|Overall Study|Physician Decision|1
390874|NCT00116779|1241540|P1|Overall Study|Physician Decision|3
390875|NCT00116779|1241539|P2|Overall Study|Inadequate testosterone suppression|9
390876|NCT00116779|1241540|P1|Overall Study|Inadequate testosterone suppression|7
390877|NCT00116779|1241539|P2|Overall Study|Withdrawal by Subject|1
390878|NCT00116779|1241540|P1|Overall Study|Withdrawal by Subject|4
390879|NCT00116779|1241539|P2|Overall Study|Protocol Violation|4
390880|NCT00116779|1241540|P1|Overall Study|Protocol Violation|1
390881|NCT00116779|1241539|P2|Overall Study|Adverse Event|2
390882|NCT00116779|1241540|P1|Overall Study|Adverse Event|4
390883|NCT00116753|1241573|P3|Overall Study|Dosing Error|0
390884|NCT00116753|1241574|P2|Overall Study|Dosing Error|1
390885|NCT00116753|1241575|P1|Overall Study|Dosing Error|0
390886|NCT00116753|1241573|P3|Overall Study|Progressive Parkinson's Disease|0
390887|NCT00116753|1241574|P2|Overall Study|Progressive Parkinson's Disease|0
390888|NCT00116753|1241575|P1|Overall Study|Progressive Parkinson's Disease|1
390889|NCT00116753|1241573|P3|Overall Study|Abnormal Echocardiogram|1
390890|NCT00116753|1241574|P2|Overall Study|Abnormal Echocardiogram|0
390891|NCT00116753|1241575|P1|Overall Study|Abnormal Echocardiogram|0
390892|NCT00116753|1241573|P3|Overall Study|Disease Progression|3
390893|NCT00116753|1241574|P2|Overall Study|Disease Progression|4
390894|NCT00116753|1241575|P1|Overall Study|Disease Progression|3
390895|NCT00116753|1241573|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
390896|NCT00116753|1241574|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
390897|NCT00116753|1241575|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
390898|NCT00116753|1241573|P3|Overall Study|Protocol Violation|1
390899|NCT00116753|1241574|P2|Overall Study|Protocol Violation|0
390900|NCT00116753|1241575|P1|Overall Study|Protocol Violation|0
390901|NCT00116753|1241573|P3|Overall Study|Lost to Follow-up|1
390902|NCT00116753|1241574|P2|Overall Study|Lost to Follow-up|2
390903|NCT00116753|1241575|P1|Overall Study|Lost to Follow-up|0
390904|NCT00116753|1241573|P3|Overall Study|Withdrawal by Subject|8
390905|NCT00116753|1241574|P2|Overall Study|Withdrawal by Subject|12
390906|NCT00116753|1241575|P1|Overall Study|Withdrawal by Subject|11
390907|NCT00116753|1241573|P3|Overall Study|Adverse Event|7
390908|NCT00116753|1241574|P2|Overall Study|Adverse Event|10
390909|NCT00116753|1241575|P1|Overall Study|Adverse Event|16
390910|NCT00116688|1241597|P2|Overall Study|Other|0
390911|NCT00116688|1241598|P1|Overall Study|Other|11
390912|NCT00116688|1241597|P2|Overall Study|Pregnancy|0
390913|NCT00116688|1241598|P1|Overall Study|Pregnancy|1
390914|NCT00116688|1241597|P2|Overall Study|Protocol-specified criteria|0
390915|NCT00116688|1241598|P1|Overall Study|Protocol-specified criteria|3
390916|NCT00116688|1241597|P2|Overall Study|Death|0
390917|NCT00116688|1241598|P1|Overall Study|Death|15
390918|NCT00116688|1241597|P2|Overall Study|Lost to Follow-up|0
390919|NCT00116688|1241598|P1|Overall Study|Lost to Follow-up|3
390920|NCT00116688|1241597|P2|Overall Study|Physician Decision|0
390921|NCT00116688|1241598|P1|Overall Study|Physician Decision|7
390922|NCT00116688|1241597|P2|Overall Study|Requirement for alternative therapy|1
391013|NCT00113763|1242127|P1|Overall Study|Disease Progression|28
390923|NCT00116688|1241598|P1|Overall Study|Requirement for alternative therapy|11
390924|NCT00116688|1241597|P2|Overall Study|Withdrawal by Subject|2
390925|NCT00116688|1241598|P1|Overall Study|Withdrawal by Subject|26
390926|NCT00116688|1241597|P2|Overall Study|Adverse Event|0
390927|NCT00116688|1241598|P1|Overall Study|Adverse Event|11
390928|NCT00116688|1241597|P2|Overall Study|Noncompliance|1
390929|NCT00116688|1241598|P1|Overall Study|Noncompliance|3
390930|NCT00116688|1241597|P2|Overall Study|Protocol deviation|0
390931|NCT00116688|1241598|P1|Overall Study|Protocol deviation|1
390932|NCT00116649|1241613|P1|Overall Study|Protocol Specified|7
390933|NCT00116649|1241613|P1|Overall Study|Various Reasons|18
390934|NCT00116649|1241613|P1|Overall Study|Local Skin Reaction|9
390935|NCT00116649|1241613|P1|Overall Study|Withdrawal by Subject|68
390936|NCT00116649|1241613|P1|Overall Study|Lost to Follow-up|32
390937|NCT00116649|1241613|P1|Overall Study|Lack of Efficacy|1
390938|NCT00116649|1241613|P1|Overall Study|Adverse Event|20
390939|NCT00116428|1241620|P2|Overall Study|Did not meet inclusion criteria|0
390940|NCT00116428|1241621|P1|Overall Study|Did not meet inclusion criteria|1
390941|NCT00116428|1241620|P2|Overall Study|Withdrawal by Subject|5
390942|NCT00116428|1241621|P1|Overall Study|Withdrawal by Subject|2
390943|NCT00116272|1241639|P2|Overall Study|Lost to Follow-up|6
390944|NCT00116272|1241640|P1|Overall Study|Lost to Follow-up|11
390945|NCT00116168|1241709|P4|Overall Study|Lost to Follow-up|0
390946|NCT00116168|1241710|P3|Overall Study|Lost to Follow-up|0
390947|NCT00116168|1241711|P2|Overall Study|Lost to Follow-up|5
390948|NCT00116168|1241712|P1|Overall Study|Lost to Follow-up|6
390949|NCT00115934|1241776|P2|Overall Study|Did not receive intervention|2
390950|NCT00115934|1241777|P1|Overall Study|Did not receive intervention|3
390951|NCT00115934|1241776|P2|Overall Study|Lost to Follow-up|0
390952|NCT00115934|1241777|P1|Overall Study|Lost to Follow-up|1
390953|NCT00115804|1241826|P1|Overall Study|Adverse Event|2
390954|NCT00115765|1241841|P4|Overall Study|Not specified|2
390955|NCT00115765|1241842|P3|Overall Study|Not specified|9
390956|NCT00115765|1241843|P2|Overall Study|Not specified|12
390957|NCT00115765|1241844|P1|Overall Study|Not specified|6
390958|NCT00115765|1241841|P4|Overall Study|Lost to Follow-up|1
390959|NCT00115765|1241842|P3|Overall Study|Lost to Follow-up|18
390960|NCT00115765|1241843|P2|Overall Study|Lost to Follow-up|20
390961|NCT00115765|1241844|P1|Overall Study|Lost to Follow-up|3
390962|NCT00115765|1241841|P4|Overall Study|Physician Decision|13
390963|NCT00115765|1241842|P3|Overall Study|Physician Decision|18
390964|NCT00115765|1241843|P2|Overall Study|Physician Decision|15
390965|NCT00115765|1241844|P1|Overall Study|Physician Decision|4
390966|NCT00115765|1241841|P4|Overall Study|Withdrawal by Subject|15
390967|NCT00115765|1241842|P3|Overall Study|Withdrawal by Subject|76
390968|NCT00115765|1241843|P2|Overall Study|Withdrawal by Subject|53
390969|NCT00115765|1241844|P1|Overall Study|Withdrawal by Subject|22
390970|NCT00115739|1241882|P1|Overall Study|Lost to Follow-up|3
390971|NCT00115349|1241891|P2|Overall Study|Study closed due to low enrollment.|9
390972|NCT00115349|1241892|P1|Overall Study|Study closed due to low enrollment.|11
390973|NCT00115063|1241913|P2|Overall Study|Death|0
390974|NCT00115063|1241914|P1|Overall Study|Death|1
390975|NCT00115063|1241913|P2|Overall Study|Lost to Follow-up|104
390976|NCT00115063|1241914|P1|Overall Study|Lost to Follow-up|98
390977|NCT00114972|1241932|P2|Overall Study|Lost to Follow-up|5
390978|NCT00114972|1241933|P1|Overall Study|Lost to Follow-up|8
390979|NCT00114972|1241932|P2|Overall Study|Withdrawal by Subject|7
390980|NCT00114972|1241933|P1|Overall Study|Withdrawal by Subject|40
390981|NCT00114959|1241953|P1|Overall Study|Death|1
390982|NCT00114959|1241953|P1|Overall Study|Physician Decision|1
390983|NCT00114959|1241953|P1|Overall Study|Lack of Efficacy|6
390984|NCT00114634|1241960|P1|Overall Study|failure to return forms|3
390985|NCT00114244|1242006|P2|Overall Study|Withdrawal by Subject|2
390986|NCT00114244|1242007|P1|Overall Study|Withdrawal by Subject|0
390987|NCT00114244|1242006|P2|Overall Study|Adverse Event|5
390988|NCT00114244|1242007|P1|Overall Study|Adverse Event|2
390989|NCT00114166|1242017|P1|Overall Study|Wrong primary|1
390990|NCT00114127|1242025|P2|Overall Study|Withdrawal by Subject|3
390991|NCT00114127|1242026|P1|Overall Study|Withdrawal by Subject|1
390992|NCT00114127|1242025|P2|Overall Study|Lost to Follow-up|0
390993|NCT00114127|1242026|P1|Overall Study|Lost to Follow-up|1
390994|NCT00114127|1242025|P2|Overall Study|Adverse Event|1
390995|NCT00114127|1242026|P1|Overall Study|Adverse Event|2
390996|NCT00113919|1242049|P1|Overall Study|Death|6
390997|NCT00113919|1242049|P1|Overall Study|Physician Decision|8
390998|NCT00113841|1242117|P2|Overall Study|Non-compliant|0
390999|NCT00113841|1242118|P1|Overall Study|Non-compliant|1
391000|NCT00113841|1242117|P2|Overall Study|Disease progression|2
391001|NCT00113841|1242118|P1|Overall Study|Disease progression|0
391002|NCT00113763|1242126|P2|Overall Study|Ongoing|0
391003|NCT00113763|1242127|P1|Overall Study|Ongoing|1
391004|NCT00113763|1242126|P2|Overall Study|Non-compliance|0
391005|NCT00113763|1242127|P1|Overall Study|Non-compliance|1
391006|NCT00113763|1242126|P2|Overall Study|Not specified|6
391007|NCT00113763|1242127|P1|Overall Study|Not specified|27
391008|NCT00113763|1242126|P2|Overall Study|Withdrawal by Subject|4
391009|NCT00113763|1242127|P1|Overall Study|Withdrawal by Subject|1
391010|NCT00113763|1242126|P2|Overall Study|Lost to Follow-up|0
391011|NCT00113763|1242127|P1|Overall Study|Lost to Follow-up|10
391012|NCT00113763|1242126|P2|Overall Study|Disease Progression|14
391014|NCT00113763|1242126|P2|Overall Study|Adverse Event|2
391015|NCT00113763|1242127|P1|Overall Study|Adverse Event|5
391016|NCT00113607|1242153|P2|Overall Study|Unspecified|32
391017|NCT00113607|1242154|P1|Overall Study|Unspecified|43
391018|NCT00113607|1242153|P2|Overall Study|Complete Response (Confirmed)|24
391019|NCT00113607|1242154|P1|Overall Study|Complete Response (Confirmed)|14
391020|NCT00113607|1242153|P2|Overall Study|Disease Progression|142
391021|NCT00113607|1242154|P1|Overall Study|Disease Progression|180
391022|NCT00113607|1242153|P2|Overall Study|Lost to Follow-up|2
391023|NCT00113607|1242154|P1|Overall Study|Lost to Follow-up|0
391024|NCT00113607|1242153|P2|Overall Study|Withdrawal by Subject|58
391025|NCT00113607|1242154|P1|Overall Study|Withdrawal by Subject|50
391026|NCT00113607|1242153|P2|Overall Study|Death|8
391027|NCT00113607|1242154|P1|Overall Study|Death|8
391028|NCT00113607|1242153|P2|Overall Study|Adverse Event|71
391029|NCT00113607|1242154|P1|Overall Study|Adverse Event|40
391030|NCT00113568|1242168|P1|Overall Study|Other|112
391031|NCT00113568|1242168|P1|Overall Study|Withdrawal by Subject|117
391032|NCT00113568|1242168|P1|Overall Study|Protocol Violation|32
391033|NCT00113568|1242168|P1|Overall Study|Lost to Follow-up|156
391034|NCT00113568|1242168|P1|Overall Study|Lack of Efficacy|30
391035|NCT00113568|1242168|P1|Overall Study|Death|1
391036|NCT00113568|1242168|P1|Overall Study|Adverse Event|97
391037|NCT00113529|1242180|P1|Overall Study|Withdrawal by Subject|4
391038|NCT00113529|1242180|P1|Overall Study|Decision of sponsor|6
391039|NCT00113529|1242180|P1|Overall Study|Lack of Efficacy|20
391040|NCT00113529|1242180|P1|Overall Study|Adverse Event|4
391041|NCT00113516|1242213|P2|Part 2|Ongoing|1
391042|NCT00113516|1242214|P1|Part 2|Ongoing|0
391043|NCT00113516|1242213|P2|Part 2|Laboratory Abnormality|1
391044|NCT00113516|1242214|P1|Part 2|Laboratory Abnormality|0
391045|NCT00113516|1242213|P2|Part 2|Unspecified|3
391046|NCT00113516|1242214|P1|Part 2|Unspecified|0
391047|NCT00113516|1242213|P2|Part 2|Withdrawal by Subject|3
391048|NCT00113516|1242214|P1|Part 2|Withdrawal by Subject|0
391049|NCT00113516|1242213|P2|Part 2|Lack of Efficacy|37
391050|NCT00113516|1242214|P1|Part 2|Lack of Efficacy|0
391051|NCT00113516|1242213|P2|Part 2|Death|5
391052|NCT00113516|1242214|P1|Part 2|Death|0
391053|NCT00113516|1242213|P2|Part 2|Adverse Event|16
391054|NCT00113516|1242214|P1|Part 2|Adverse Event|0
391055|NCT00113516|1242213|P2|Part 1|Missing|0
391056|NCT00113516|1242214|P1|Part 1|Missing|65
391057|NCT00113516|1242213|P2|Part 1|Ongoing|0
391058|NCT00113516|1242214|P1|Part 1|Ongoing|1
391059|NCT00113516|1242213|P2|Part 1|Laboratory Abnormality|0
391060|NCT00113516|1242214|P1|Part 1|Laboratory Abnormality|1
391061|NCT00113516|1242213|P2|Part 1|Did Not Meet Entrance Criteria|0
391062|NCT00113516|1242214|P1|Part 1|Did Not Meet Entrance Criteria|1
391063|NCT00113516|1242213|P2|Part 1|Lack of Efficacy|0
391064|NCT00113516|1242214|P1|Part 1|Lack of Efficacy|2
391065|NCT00113516|1242213|P2|Part 1|Withdrawal by Subject|0
391066|NCT00113516|1242214|P1|Part 1|Withdrawal by Subject|2
391067|NCT00113516|1242213|P2|Part 1|Unspecified|0
391068|NCT00113516|1242214|P1|Part 1|Unspecified|3
391069|NCT00113516|1242213|P2|Part 1|Death|0
391070|NCT00113516|1242214|P1|Part 1|Death|3
391071|NCT00113516|1242213|P2|Part 1|Adverse Event|0
391072|NCT00113516|1242214|P1|Part 1|Adverse Event|6
391073|NCT00113490|1242257|P2|Overall Study|Lost to Follow-up|0
391074|NCT00113490|1242258|P1|Overall Study|Lost to Follow-up|1
391075|NCT00113490|1242257|P2|Overall Study|Withdrawal by Subject|3
391076|NCT00113490|1242258|P1|Overall Study|Withdrawal by Subject|1
391077|NCT00113399|1242291|P2|Overall Study|Other|1
391078|NCT00113399|1242292|P1|Overall Study|Other|0
391079|NCT00113399|1242291|P2|Overall Study|Complete Response|1
391080|NCT00113399|1242292|P1|Overall Study|Complete Response|0
391081|NCT00113399|1242291|P2|Overall Study|Withdrawal by Subject|2
391082|NCT00113399|1242292|P1|Overall Study|Withdrawal by Subject|1
391083|NCT00113399|1242291|P2|Overall Study|Death|1
391084|NCT00113399|1242292|P1|Overall Study|Death|1
391085|NCT00113386|1242300|P2|Overall Study|Unknown - Lost to Follow-Up|1
391086|NCT00113386|1242301|P1|Overall Study|Unknown - Lost to Follow-Up|2
391087|NCT00113386|1242300|P2|Overall Study|Ineligible|2
391088|NCT00113386|1242301|P1|Overall Study|Ineligible|1
391089|NCT00113386|1242300|P2|Overall Study|Toxicity|0
391090|NCT00113386|1242301|P1|Overall Study|Toxicity|3
391091|NCT00113386|1242300|P2|Overall Study|Physician Decision|1
391092|NCT00113386|1242301|P1|Overall Study|Physician Decision|0
391093|NCT00113386|1242300|P2|Overall Study|Withdrawal by Subject|0
391094|NCT00113386|1242301|P1|Overall Study|Withdrawal by Subject|1
391095|NCT00113373|1242307|P1|Overall Study|Never Treated|1
391096|NCT00113373|1242307|P1|Overall Study|Ineligible: second primary|1
391097|NCT00113373|1242307|P1|Overall Study|Ineligible: wrong primary|1
391098|NCT00113360|1242313|P1|Overall Study|Did not meet eligibility criteria|3
391099|NCT00113360|1242313|P1|Overall Study|Subject required surgery|1
391100|NCT00113360|1242313|P1|Overall Study|Adverse Event|3
391101|NCT00113295|1242327|P2|Overall Study|Unrelated Medical Illness|0
391102|NCT00113295|1242328|P1|Overall Study|Unrelated Medical Illness|1
391103|NCT00113295|1242327|P2|Overall Study|Adverse Event|1
391104|NCT00113295|1242328|P1|Overall Study|Adverse Event|4
391105|NCT00113269|1242347|P4|Overall Study|Unable to return for follow up|0
391106|NCT00113269|1242348|P3|Overall Study|Unable to return for follow up|0
391107|NCT00113269|1242349|P2|Overall Study|Unable to return for follow up|1
391108|NCT00113269|1242350|P1|Overall Study|Unable to return for follow up|2
391109|NCT00113269|1242347|P4|Overall Study|Did not meet eligibility criteria|1
391110|NCT00113269|1242348|P3|Overall Study|Did not meet eligibility criteria|0
391111|NCT00113269|1242349|P2|Overall Study|Did not meet eligibility criteria|0
391112|NCT00113269|1242350|P1|Overall Study|Did not meet eligibility criteria|1
391113|NCT00113269|1242347|P4|Overall Study|Withdrew consent, Prednisone initiated|1
391114|NCT00113269|1242348|P3|Overall Study|Withdrew consent, Prednisone initiated|0
391115|NCT00113269|1242349|P2|Overall Study|Withdrew consent, Prednisone initiated|0
391116|NCT00113269|1242350|P1|Overall Study|Withdrew consent, Prednisone initiated|0
391117|NCT00113269|1242347|P4|Overall Study|Received pancreas transplant|2
391118|NCT00113269|1242348|P3|Overall Study|Received pancreas transplant|0
391119|NCT00113269|1242349|P2|Overall Study|Received pancreas transplant|0
391120|NCT00113269|1242350|P1|Overall Study|Received pancreas transplant|0
391121|NCT00113269|1242347|P4|Overall Study|Moved|3
391122|NCT00113269|1242348|P3|Overall Study|Moved|0
391123|NCT00113269|1242349|P2|Overall Study|Moved|1
391124|NCT00113269|1242350|P1|Overall Study|Moved|0
391125|NCT00113269|1242347|P4|Overall Study|Discontinued due to rejection|0
391126|NCT00113269|1242348|P3|Overall Study|Discontinued due to rejection|1
391127|NCT00113269|1242349|P2|Overall Study|Discontinued due to rejection|0
391128|NCT00113269|1242350|P1|Overall Study|Discontinued due to rejection|0
391129|NCT00113269|1242347|P4|Overall Study|Sponsor elected to discontinue patient|1
391130|NCT00113269|1242348|P3|Overall Study|Sponsor elected to discontinue patient|0
391131|NCT00113269|1242349|P2|Overall Study|Sponsor elected to discontinue patient|0
391132|NCT00113269|1242350|P1|Overall Study|Sponsor elected to discontinue patient|1
391133|NCT00113269|1242347|P4|Overall Study|Lost to Follow-up|3
391134|NCT00113269|1242348|P3|Overall Study|Lost to Follow-up|6
391135|NCT00113269|1242349|P2|Overall Study|Lost to Follow-up|3
391136|NCT00113269|1242350|P1|Overall Study|Lost to Follow-up|2
391137|NCT00113269|1242347|P4|Overall Study|Protocol Violation|2
391138|NCT00113269|1242348|P3|Overall Study|Protocol Violation|4
391139|NCT00113269|1242349|P2|Overall Study|Protocol Violation|0
391140|NCT00113269|1242350|P1|Overall Study|Protocol Violation|1
391141|NCT00113269|1242347|P4|Overall Study|Graft loss|9
391142|NCT00113269|1242348|P3|Overall Study|Graft loss|4
391143|NCT00113269|1242349|P2|Overall Study|Graft loss|6
391144|NCT00113269|1242350|P1|Overall Study|Graft loss|6
391145|NCT00113269|1242347|P4|Overall Study|Withdrawal by Subject|2
391146|NCT00113269|1242348|P3|Overall Study|Withdrawal by Subject|4
391147|NCT00113269|1242349|P2|Overall Study|Withdrawal by Subject|3
391148|NCT00113269|1242350|P1|Overall Study|Withdrawal by Subject|4
391149|NCT00113269|1242347|P4|Overall Study|Adverse Event|7
391150|NCT00113269|1242348|P3|Overall Study|Adverse Event|11
391151|NCT00113269|1242349|P2|Overall Study|Adverse Event|7
391152|NCT00113269|1242350|P1|Overall Study|Adverse Event|2
391153|NCT00113269|1242347|P4|Overall Study|Did not meet eligibility – pre-treatment|2
391154|NCT00113269|1242348|P3|Overall Study|Did not meet eligibility – pre-treatment|0
391155|NCT00113269|1242349|P2|Overall Study|Did not meet eligibility – pre-treatment|0
391156|NCT00113269|1242350|P1|Overall Study|Did not meet eligibility – pre-treatment|0
391157|NCT00113269|1242347|P4|Overall Study|Death in operating room|1
391158|NCT00113269|1242348|P3|Overall Study|Death in operating room|0
391159|NCT00113269|1242349|P2|Overall Study|Death in operating room|0
391160|NCT00113269|1242350|P1|Overall Study|Death in operating room|0
391161|NCT00113269|1242347|P4|Overall Study|Early graft loss, technical|0
391162|NCT00113269|1242348|P3|Overall Study|Early graft loss, technical|2
391163|NCT00113269|1242349|P2|Overall Study|Early graft loss, technical|0
391164|NCT00113269|1242350|P1|Overall Study|Early graft loss, technical|0
391165|NCT00113269|1242347|P4|Overall Study|Not transplanted, recipient issues|4
391166|NCT00113269|1242348|P3|Overall Study|Not transplanted, recipient issues|7
391167|NCT00113269|1242349|P2|Overall Study|Not transplanted, recipient issues|1
391168|NCT00113269|1242350|P1|Overall Study|Not transplanted, recipient issues|2
391169|NCT00113269|1242347|P4|Overall Study|Not transplanted, donor issues|2
391170|NCT00113269|1242348|P3|Overall Study|Not transplanted, donor issues|2
391171|NCT00113269|1242349|P2|Overall Study|Not transplanted, donor issues|0
391172|NCT00113269|1242350|P1|Overall Study|Not transplanted, donor issues|4
391173|NCT00113087|1242410|P2|Overall Study|Family or MD withdrew subject|5
391174|NCT00113087|1242411|P1|Overall Study|Family or MD withdrew subject|10
391175|NCT00113087|1242410|P2|Overall Study|Death or Transplant|16
391176|NCT00113087|1242411|P1|Overall Study|Death or Transplant|14
391177|NCT00112905|1242510|P1|Overall Study|performance status was deteiorating|1
391178|NCT00112905|1242510|P1|Overall Study|Alternative treatment|1
391179|NCT00112905|1242510|P1|Overall Study|Ineligibility|5
391180|NCT00112905|1242510|P1|Overall Study|Death|1
391181|NCT00112905|1242510|P1|Overall Study|Adverse Event|4
391182|NCT00112866|1242519|P2|Overall Study|did not start treatment post-op|2
391183|NCT00112866|1242520|P1|Overall Study|did not start treatment post-op|1
391184|NCT00112866|1242519|P2|Overall Study|Protocol Violation|0
391185|NCT00112866|1242520|P1|Overall Study|Protocol Violation|1
391186|NCT00112840|1242542|P3|Overall Study|Protocol Violation|5
391187|NCT00112840|1242543|P2|Overall Study|Protocol Violation|0
391188|NCT00112840|1242544|P1|Overall Study|Protocol Violation|0
391189|NCT00112840|1242542|P3|Overall Study|Withdrawal by Subject|1
391190|NCT00112840|1242543|P2|Overall Study|Withdrawal by Subject|0
391191|NCT00112840|1242544|P1|Overall Study|Withdrawal by Subject|1
391192|NCT00112840|1242542|P3|Overall Study|Physician Decision|0
391193|NCT00112840|1242543|P2|Overall Study|Physician Decision|0
391194|NCT00112840|1242544|P1|Overall Study|Physician Decision|1
391195|NCT00112736|1242563|P2|Overall Study|1 pt never had had RX due rapid decline|0
391196|NCT00112736|1242564|P1|Overall Study|1 pt never had had RX due rapid decline|1
391197|NCT00112489|1242619|P1|Overall Study|Ineligible|7
391198|NCT00112489|1242619|P1|Overall Study|Patient never treated|2
391199|NCT00112489|1242619|P1|Overall Study|Other, Not Specified|9
391200|NCT00112489|1242619|P1|Overall Study|Death|2
391201|NCT00112489|1242619|P1|Overall Study|Adverse Event|12
391202|NCT00112489|1242619|P1|Overall Study|Refused further treatment|8
391203|NCT00112463|1242623|P1|Overall Study|Never started treatment|2
391204|NCT00112463|1242623|P1|Overall Study|Withdrawal by Subject|2
391205|NCT00112463|1242623|P1|Overall Study|Toxicity|3
391206|NCT00112463|1242623|P1|Overall Study|Second Primary|1
391207|NCT00112463|1242623|P1|Overall Study|Progression|30
391208|NCT00112463|1242623|P1|Overall Study|Physician Decision|1
391209|NCT00112437|1242635|P15|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391210|NCT00112437|1242636|P14|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391211|NCT00112437|1242637|P13|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391212|NCT00112437|1242638|P12|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391213|NCT00112437|1242639|P11|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391214|NCT00112437|1242640|P10|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391215|NCT00112437|1242641|P9|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391216|NCT00112437|1242642|P8|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391217|NCT00112437|1242643|P7|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|1
391218|NCT00112437|1242644|P6|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|1
391219|NCT00112437|1242645|P5|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391220|NCT00112437|1242646|P4|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391221|NCT00112437|1242647|P3|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391222|NCT00112437|1242648|P2|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391223|NCT00112437|1242649|P1|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
391224|NCT00112437|1242635|P15|12 Month Extension (Year 3)|Withdrawal by Subject|0
391225|NCT00112437|1242636|P14|12 Month Extension (Year 3)|Withdrawal by Subject|0
391226|NCT00112437|1242637|P13|12 Month Extension (Year 3)|Withdrawal by Subject|0
391227|NCT00112437|1242638|P12|12 Month Extension (Year 3)|Withdrawal by Subject|0
391228|NCT00112437|1242639|P11|12 Month Extension (Year 3)|Withdrawal by Subject|0
391229|NCT00112437|1242640|P10|12 Month Extension (Year 3)|Withdrawal by Subject|1
391230|NCT00112437|1242641|P9|12 Month Extension (Year 3)|Withdrawal by Subject|0
391231|NCT00112437|1242642|P8|12 Month Extension (Year 3)|Withdrawal by Subject|0
391232|NCT00112437|1242643|P7|12 Month Extension (Year 3)|Withdrawal by Subject|3
391233|NCT00112437|1242644|P6|12 Month Extension (Year 3)|Withdrawal by Subject|0
391234|NCT00112437|1242645|P5|12 Month Extension (Year 3)|Withdrawal by Subject|0
391235|NCT00112437|1242646|P4|12 Month Extension (Year 3)|Withdrawal by Subject|0
391236|NCT00112437|1242647|P3|12 Month Extension (Year 3)|Withdrawal by Subject|0
391237|NCT00112437|1242648|P2|12 Month Extension (Year 3)|Withdrawal by Subject|0
391238|NCT00112437|1242649|P1|12 Month Extension (Year 3)|Withdrawal by Subject|0
391239|NCT00112437|1242635|P15|12 Month Extension (Year 3)|Protocol Violation|0
391240|NCT00112437|1242636|P14|12 Month Extension (Year 3)|Protocol Violation|0
391241|NCT00112437|1242637|P13|12 Month Extension (Year 3)|Protocol Violation|0
391242|NCT00112437|1242638|P12|12 Month Extension (Year 3)|Protocol Violation|0
391243|NCT00112437|1242639|P11|12 Month Extension (Year 3)|Protocol Violation|1
391244|NCT00112437|1242640|P10|12 Month Extension (Year 3)|Protocol Violation|0
391245|NCT00112437|1242641|P9|12 Month Extension (Year 3)|Protocol Violation|0
391246|NCT00112437|1242642|P8|12 Month Extension (Year 3)|Protocol Violation|0
391247|NCT00112437|1242643|P7|12 Month Extension (Year 3)|Protocol Violation|0
391248|NCT00112437|1242644|P6|12 Month Extension (Year 3)|Protocol Violation|0
391249|NCT00112437|1242645|P5|12 Month Extension (Year 3)|Protocol Violation|0
391250|NCT00112437|1242646|P4|12 Month Extension (Year 3)|Protocol Violation|0
391251|NCT00112437|1242647|P3|12 Month Extension (Year 3)|Protocol Violation|0
391252|NCT00112437|1242648|P2|12 Month Extension (Year 3)|Protocol Violation|0
391253|NCT00112437|1242649|P1|12 Month Extension (Year 3)|Protocol Violation|0
391254|NCT00112437|1242635|P15|12 Month Extension (Year 3)|Lost to Follow-up|0
391255|NCT00112437|1242636|P14|12 Month Extension (Year 3)|Lost to Follow-up|0
391256|NCT00112437|1242637|P13|12 Month Extension (Year 3)|Lost to Follow-up|0
391257|NCT00112437|1242638|P12|12 Month Extension (Year 3)|Lost to Follow-up|0
391258|NCT00112437|1242639|P11|12 Month Extension (Year 3)|Lost to Follow-up|1
391259|NCT00112437|1242640|P10|12 Month Extension (Year 3)|Lost to Follow-up|0
391260|NCT00112437|1242641|P9|12 Month Extension (Year 3)|Lost to Follow-up|0
391261|NCT00112437|1242642|P8|12 Month Extension (Year 3)|Lost to Follow-up|0
391262|NCT00112437|1242643|P7|12 Month Extension (Year 3)|Lost to Follow-up|0
391263|NCT00112437|1242644|P6|12 Month Extension (Year 3)|Lost to Follow-up|0
391264|NCT00112437|1242645|P5|12 Month Extension (Year 3)|Lost to Follow-up|0
391265|NCT00112437|1242646|P4|12 Month Extension (Year 3)|Lost to Follow-up|0
391266|NCT00112437|1242647|P3|12 Month Extension (Year 3)|Lost to Follow-up|0
391267|NCT00112437|1242648|P2|12 Month Extension (Year 3)|Lost to Follow-up|0
391268|NCT00112437|1242649|P1|12 Month Extension (Year 3)|Lost to Follow-up|0
391269|NCT00112437|1242635|P15|12 Month Extension (Year 3)|Lack of Efficacy|0
391270|NCT00112437|1242636|P14|12 Month Extension (Year 3)|Lack of Efficacy|2
391271|NCT00112437|1242637|P13|12 Month Extension (Year 3)|Lack of Efficacy|0
391272|NCT00112437|1242638|P12|12 Month Extension (Year 3)|Lack of Efficacy|0
391273|NCT00112437|1242639|P11|12 Month Extension (Year 3)|Lack of Efficacy|1
391274|NCT00112437|1242640|P10|12 Month Extension (Year 3)|Lack of Efficacy|0
391275|NCT00112437|1242641|P9|12 Month Extension (Year 3)|Lack of Efficacy|1
391276|NCT00112437|1242642|P8|12 Month Extension (Year 3)|Lack of Efficacy|0
391277|NCT00112437|1242643|P7|12 Month Extension (Year 3)|Lack of Efficacy|1
391278|NCT00112437|1242644|P6|12 Month Extension (Year 3)|Lack of Efficacy|0
391279|NCT00112437|1242645|P5|12 Month Extension (Year 3)|Lack of Efficacy|0
391280|NCT00112437|1242646|P4|12 Month Extension (Year 3)|Lack of Efficacy|0
391281|NCT00112437|1242647|P3|12 Month Extension (Year 3)|Lack of Efficacy|0
391282|NCT00112437|1242648|P2|12 Month Extension (Year 3)|Lack of Efficacy|0
391283|NCT00112437|1242649|P1|12 Month Extension (Year 3)|Lack of Efficacy|0
391284|NCT00112437|1242635|P15|12 Month Extension (Year 3)|Adverse Event|1
391285|NCT00112437|1242636|P14|12 Month Extension (Year 3)|Adverse Event|0
391286|NCT00112437|1242637|P13|12 Month Extension (Year 3)|Adverse Event|1
391287|NCT00112437|1242638|P12|12 Month Extension (Year 3)|Adverse Event|3
391288|NCT00112437|1242639|P11|12 Month Extension (Year 3)|Adverse Event|1
391289|NCT00112437|1242640|P10|12 Month Extension (Year 3)|Adverse Event|0
391290|NCT00112437|1242641|P9|12 Month Extension (Year 3)|Adverse Event|0
391291|NCT00112437|1242642|P8|12 Month Extension (Year 3)|Adverse Event|0
391292|NCT00112437|1242643|P7|12 Month Extension (Year 3)|Adverse Event|0
391293|NCT00112437|1242644|P6|12 Month Extension (Year 3)|Adverse Event|1
391294|NCT00112437|1242645|P5|12 Month Extension (Year 3)|Adverse Event|0
391295|NCT00112437|1242646|P4|12 Month Extension (Year 3)|Adverse Event|0
391296|NCT00112437|1242647|P3|12 Month Extension (Year 3)|Adverse Event|0
391297|NCT00112437|1242648|P2|12 Month Extension (Year 3)|Adverse Event|0
391298|NCT00112437|1242649|P1|12 Month Extension (Year 3)|Adverse Event|0
391299|NCT00112437|1242635|P15|12 Month Extension|Moved|0
391300|NCT00112437|1242636|P14|12 Month Extension|Moved|0
391301|NCT00112437|1242637|P13|12 Month Extension|Moved|0
391302|NCT00112437|1242638|P12|12 Month Extension|Moved|0
391303|NCT00112437|1242639|P11|12 Month Extension|Moved|0
391304|NCT00112437|1242640|P10|12 Month Extension|Moved|0
391305|NCT00112437|1242641|P9|12 Month Extension|Moved|0
391306|NCT00112437|1242642|P8|12 Month Extension|Moved|0
391307|NCT00112437|1242643|P7|12 Month Extension|Moved|0
391308|NCT00112437|1242644|P6|12 Month Extension|Moved|0
391309|NCT00112437|1242645|P5|12 Month Extension|Moved|1
391310|NCT00112437|1242646|P4|12 Month Extension|Moved|0
391311|NCT00112437|1242647|P3|12 Month Extension|Moved|0
391312|NCT00112437|1242648|P2|12 Month Extension|Moved|0
391313|NCT00112437|1242649|P1|12 Month Extension|Moved|0
391314|NCT00112437|1242635|P15|12 Month Extension|patient was out of windows|0
391315|NCT00112437|1242636|P14|12 Month Extension|patient was out of windows|0
391316|NCT00112437|1242637|P13|12 Month Extension|patient was out of windows|0
391317|NCT00112437|1242638|P12|12 Month Extension|patient was out of windows|0
391318|NCT00112437|1242639|P11|12 Month Extension|patient was out of windows|0
391319|NCT00112437|1242640|P10|12 Month Extension|patient was out of windows|0
391320|NCT00112437|1242641|P9|12 Month Extension|patient was out of windows|0
391321|NCT00112437|1242642|P8|12 Month Extension|patient was out of windows|0
391322|NCT00112437|1242643|P7|12 Month Extension|patient was out of windows|0
391323|NCT00112437|1242644|P6|12 Month Extension|patient was out of windows|0
391324|NCT00112437|1242645|P5|12 Month Extension|patient was out of windows|1
391325|NCT00112437|1242646|P4|12 Month Extension|patient was out of windows|0
391326|NCT00112437|1242647|P3|12 Month Extension|patient was out of windows|0
391327|NCT00112437|1242648|P2|12 Month Extension|patient was out of windows|0
391328|NCT00112437|1242649|P1|12 Month Extension|patient was out of windows|0
391329|NCT00112437|1242635|P15|12 Month Extension|Patient stopped taking medication|0
391330|NCT00112437|1242636|P14|12 Month Extension|Patient stopped taking medication|0
391331|NCT00112437|1242637|P13|12 Month Extension|Patient stopped taking medication|0
391332|NCT00112437|1242638|P12|12 Month Extension|Patient stopped taking medication|0
391333|NCT00112437|1242639|P11|12 Month Extension|Patient stopped taking medication|0
391334|NCT00112437|1242640|P10|12 Month Extension|Patient stopped taking medication|0
391335|NCT00112437|1242641|P9|12 Month Extension|Patient stopped taking medication|0
391336|NCT00112437|1242642|P8|12 Month Extension|Patient stopped taking medication|0
391337|NCT00112437|1242643|P7|12 Month Extension|Patient stopped taking medication|0
391338|NCT00112437|1242644|P6|12 Month Extension|Patient stopped taking medication|0
391339|NCT00112437|1242645|P5|12 Month Extension|Patient stopped taking medication|1
391340|NCT00112437|1242646|P4|12 Month Extension|Patient stopped taking medication|0
391341|NCT00112437|1242647|P3|12 Month Extension|Patient stopped taking medication|0
391342|NCT00112437|1242648|P2|12 Month Extension|Patient stopped taking medication|0
391343|NCT00112437|1242649|P1|12 Month Extension|Patient stopped taking medication|0
391344|NCT00112437|1242635|P15|12 Month Extension|Withdrawal by Subject|0
391345|NCT00112437|1242636|P14|12 Month Extension|Withdrawal by Subject|0
391346|NCT00112437|1242637|P13|12 Month Extension|Withdrawal by Subject|0
391347|NCT00112437|1242638|P12|12 Month Extension|Withdrawal by Subject|0
391348|NCT00112437|1242639|P11|12 Month Extension|Withdrawal by Subject|0
391349|NCT00112437|1242640|P10|12 Month Extension|Withdrawal by Subject|0
391350|NCT00112437|1242641|P9|12 Month Extension|Withdrawal by Subject|0
391351|NCT00112437|1242642|P8|12 Month Extension|Withdrawal by Subject|0
391352|NCT00112437|1242643|P7|12 Month Extension|Withdrawal by Subject|0
391353|NCT00112437|1242644|P6|12 Month Extension|Withdrawal by Subject|0
391354|NCT00112437|1242645|P5|12 Month Extension|Withdrawal by Subject|1
391355|NCT00112437|1242646|P4|12 Month Extension|Withdrawal by Subject|4
391356|NCT00112437|1242647|P3|12 Month Extension|Withdrawal by Subject|2
391357|NCT00112437|1242648|P2|12 Month Extension|Withdrawal by Subject|1
391358|NCT00112437|1242649|P1|12 Month Extension|Withdrawal by Subject|1
391359|NCT00112437|1242635|P15|12 Month Extension|Protocol Violation|0
391360|NCT00112437|1242636|P14|12 Month Extension|Protocol Violation|0
391361|NCT00112437|1242637|P13|12 Month Extension|Protocol Violation|0
391362|NCT00112437|1242638|P12|12 Month Extension|Protocol Violation|0
391363|NCT00112437|1242639|P11|12 Month Extension|Protocol Violation|0
391364|NCT00112437|1242640|P10|12 Month Extension|Protocol Violation|0
391365|NCT00112437|1242641|P9|12 Month Extension|Protocol Violation|0
391366|NCT00112437|1242642|P8|12 Month Extension|Protocol Violation|0
391367|NCT00112437|1242643|P7|12 Month Extension|Protocol Violation|0
391368|NCT00112437|1242644|P6|12 Month Extension|Protocol Violation|0
391369|NCT00112437|1242645|P5|12 Month Extension|Protocol Violation|0
391370|NCT00112437|1242646|P4|12 Month Extension|Protocol Violation|1
391371|NCT00112437|1242647|P3|12 Month Extension|Protocol Violation|0
391372|NCT00112437|1242648|P2|12 Month Extension|Protocol Violation|0
391373|NCT00112437|1242649|P1|12 Month Extension|Protocol Violation|0
391374|NCT00112437|1242635|P15|12 Month Extension|Lost to Follow-up|0
391375|NCT00112437|1242636|P14|12 Month Extension|Lost to Follow-up|0
391376|NCT00112437|1242637|P13|12 Month Extension|Lost to Follow-up|0
391377|NCT00112437|1242638|P12|12 Month Extension|Lost to Follow-up|0
391378|NCT00112437|1242639|P11|12 Month Extension|Lost to Follow-up|0
391379|NCT00112437|1242640|P10|12 Month Extension|Lost to Follow-up|0
391380|NCT00112437|1242641|P9|12 Month Extension|Lost to Follow-up|0
391381|NCT00112437|1242642|P8|12 Month Extension|Lost to Follow-up|0
391382|NCT00112437|1242643|P7|12 Month Extension|Lost to Follow-up|0
391383|NCT00112437|1242644|P6|12 Month Extension|Lost to Follow-up|0
391384|NCT00112437|1242645|P5|12 Month Extension|Lost to Follow-up|0
391385|NCT00112437|1242646|P4|12 Month Extension|Lost to Follow-up|1
391386|NCT00112437|1242647|P3|12 Month Extension|Lost to Follow-up|0
391387|NCT00112437|1242648|P2|12 Month Extension|Lost to Follow-up|0
391388|NCT00112437|1242649|P1|12 Month Extension|Lost to Follow-up|0
391389|NCT00112437|1242635|P15|12 Month Extension|Lack of Efficacy|0
391390|NCT00112437|1242636|P14|12 Month Extension|Lack of Efficacy|0
391391|NCT00112437|1242637|P13|12 Month Extension|Lack of Efficacy|0
391392|NCT00112437|1242638|P12|12 Month Extension|Lack of Efficacy|0
391393|NCT00112437|1242639|P11|12 Month Extension|Lack of Efficacy|0
391394|NCT00112437|1242640|P10|12 Month Extension|Lack of Efficacy|0
391395|NCT00112437|1242641|P9|12 Month Extension|Lack of Efficacy|0
391396|NCT00112437|1242642|P8|12 Month Extension|Lack of Efficacy|0
391397|NCT00112437|1242643|P7|12 Month Extension|Lack of Efficacy|0
391398|NCT00112437|1242644|P6|12 Month Extension|Lack of Efficacy|0
391399|NCT00112437|1242645|P5|12 Month Extension|Lack of Efficacy|2
391400|NCT00112437|1242646|P4|12 Month Extension|Lack of Efficacy|0
391401|NCT00112437|1242647|P3|12 Month Extension|Lack of Efficacy|0
391402|NCT00112437|1242648|P2|12 Month Extension|Lack of Efficacy|6
391403|NCT00112437|1242649|P1|12 Month Extension|Lack of Efficacy|1
391404|NCT00112437|1242635|P15|12 Month Extension|Adverse Event|0
391405|NCT00112437|1242636|P14|12 Month Extension|Adverse Event|0
391406|NCT00112437|1242637|P13|12 Month Extension|Adverse Event|0
391407|NCT00112437|1242638|P12|12 Month Extension|Adverse Event|0
391408|NCT00112437|1242639|P11|12 Month Extension|Adverse Event|0
391409|NCT00112437|1242640|P10|12 Month Extension|Adverse Event|0
391410|NCT00112437|1242641|P9|12 Month Extension|Adverse Event|0
391411|NCT00112437|1242642|P8|12 Month Extension|Adverse Event|0
391412|NCT00112437|1242643|P7|12 Month Extension|Adverse Event|0
391413|NCT00112437|1242644|P6|12 Month Extension|Adverse Event|0
391414|NCT00112437|1242645|P5|12 Month Extension|Adverse Event|7
391415|NCT00112437|1242646|P4|12 Month Extension|Adverse Event|1
391416|NCT00112437|1242647|P3|12 Month Extension|Adverse Event|6
391417|NCT00112437|1242648|P2|12 Month Extension|Adverse Event|2
391418|NCT00112437|1242649|P1|12 Month Extension|Adverse Event|1
391419|NCT00112437|1242635|P15|12 Month Base Study|DXA was lower by more than 8%|0
391420|NCT00112437|1242636|P14|12 Month Base Study|DXA was lower by more than 8%|0
391421|NCT00112437|1242637|P13|12 Month Base Study|DXA was lower by more than 8%|0
391422|NCT00112437|1242638|P12|12 Month Base Study|DXA was lower by more than 8%|0
391423|NCT00112437|1242639|P11|12 Month Base Study|DXA was lower by more than 8%|0
391424|NCT00112437|1242640|P10|12 Month Base Study|DXA was lower by more than 8%|0
391425|NCT00112437|1242641|P9|12 Month Base Study|DXA was lower by more than 8%|0
391426|NCT00112437|1242642|P8|12 Month Base Study|DXA was lower by more than 8%|0
391427|NCT00112437|1242643|P7|12 Month Base Study|DXA was lower by more than 8%|0
391428|NCT00112437|1242644|P6|12 Month Base Study|DXA was lower by more than 8%|0
391429|NCT00112437|1242645|P5|12 Month Base Study|DXA was lower by more than 8%|1
391430|NCT00112437|1242646|P4|12 Month Base Study|DXA was lower by more than 8%|0
391431|NCT00112437|1242647|P3|12 Month Base Study|DXA was lower by more than 8%|0
391432|NCT00112437|1242648|P2|12 Month Base Study|DXA was lower by more than 8%|0
391433|NCT00112437|1242649|P1|12 Month Base Study|DXA was lower by more than 8%|0
391434|NCT00112437|1242635|P15|12 Month Base Study|patient was unsure that they needed drug|0
391435|NCT00112437|1242636|P14|12 Month Base Study|patient was unsure that they needed drug|0
391436|NCT00112437|1242637|P13|12 Month Base Study|patient was unsure that they needed drug|0
391437|NCT00112437|1242638|P12|12 Month Base Study|patient was unsure that they needed drug|0
391438|NCT00112437|1242639|P11|12 Month Base Study|patient was unsure that they needed drug|0
391439|NCT00112437|1242640|P10|12 Month Base Study|patient was unsure that they needed drug|0
391440|NCT00112437|1242641|P9|12 Month Base Study|patient was unsure that they needed drug|0
391441|NCT00112437|1242642|P8|12 Month Base Study|patient was unsure that they needed drug|0
391442|NCT00112437|1242643|P7|12 Month Base Study|patient was unsure that they needed drug|0
391443|NCT00112437|1242644|P6|12 Month Base Study|patient was unsure that they needed drug|0
391444|NCT00112437|1242645|P5|12 Month Base Study|patient was unsure that they needed drug|0
391445|NCT00112437|1242646|P4|12 Month Base Study|patient was unsure that they needed drug|2
391446|NCT00112437|1242647|P3|12 Month Base Study|patient was unsure that they needed drug|0
391447|NCT00112437|1242648|P2|12 Month Base Study|patient was unsure that they needed drug|0
391448|NCT00112437|1242649|P1|12 Month Base Study|patient was unsure that they needed drug|0
391449|NCT00112437|1242635|P15|12 Month Base Study|moved|0
391450|NCT00112437|1242636|P14|12 Month Base Study|moved|0
391451|NCT00112437|1242637|P13|12 Month Base Study|moved|0
391452|NCT00112437|1242638|P12|12 Month Base Study|moved|0
391453|NCT00112437|1242639|P11|12 Month Base Study|moved|0
391454|NCT00112437|1242640|P10|12 Month Base Study|moved|0
391455|NCT00112437|1242641|P9|12 Month Base Study|moved|0
391456|NCT00112437|1242642|P8|12 Month Base Study|moved|0
391457|NCT00112437|1242643|P7|12 Month Base Study|moved|0
391458|NCT00112437|1242644|P6|12 Month Base Study|moved|0
391459|NCT00112437|1242645|P5|12 Month Base Study|moved|0
391460|NCT00112437|1242646|P4|12 Month Base Study|moved|0
391461|NCT00112437|1242647|P3|12 Month Base Study|moved|1
391462|NCT00112437|1242648|P2|12 Month Base Study|moved|1
391463|NCT00112437|1242649|P1|12 Month Base Study|moved|0
391464|NCT00112437|1242635|P15|12 Month Base Study|Withdrawal by Subject|0
391465|NCT00112437|1242636|P14|12 Month Base Study|Withdrawal by Subject|0
391466|NCT00112437|1242637|P13|12 Month Base Study|Withdrawal by Subject|0
391467|NCT00112437|1242638|P12|12 Month Base Study|Withdrawal by Subject|0
391468|NCT00112437|1242639|P11|12 Month Base Study|Withdrawal by Subject|0
391469|NCT00112437|1242640|P10|12 Month Base Study|Withdrawal by Subject|0
391470|NCT00112437|1242641|P9|12 Month Base Study|Withdrawal by Subject|0
391471|NCT00112437|1242642|P8|12 Month Base Study|Withdrawal by Subject|0
391472|NCT00112437|1242643|P7|12 Month Base Study|Withdrawal by Subject|0
391473|NCT00112437|1242644|P6|12 Month Base Study|Withdrawal by Subject|0
391474|NCT00112437|1242645|P5|12 Month Base Study|Withdrawal by Subject|7
391475|NCT00112437|1242646|P4|12 Month Base Study|Withdrawal by Subject|1
391476|NCT00112437|1242647|P3|12 Month Base Study|Withdrawal by Subject|2
391477|NCT00112437|1242648|P2|12 Month Base Study|Withdrawal by Subject|5
391478|NCT00112437|1242649|P1|12 Month Base Study|Withdrawal by Subject|5
391479|NCT00112437|1242635|P15|12 Month Base Study|Protocol Violation|0
391480|NCT00112437|1242636|P14|12 Month Base Study|Protocol Violation|0
391481|NCT00112437|1242637|P13|12 Month Base Study|Protocol Violation|0
391482|NCT00112437|1242638|P12|12 Month Base Study|Protocol Violation|0
391483|NCT00112437|1242639|P11|12 Month Base Study|Protocol Violation|0
391484|NCT00112437|1242640|P10|12 Month Base Study|Protocol Violation|0
391485|NCT00112437|1242641|P9|12 Month Base Study|Protocol Violation|0
391486|NCT00112437|1242642|P8|12 Month Base Study|Protocol Violation|0
391487|NCT00112437|1242643|P7|12 Month Base Study|Protocol Violation|0
391488|NCT00112437|1242644|P6|12 Month Base Study|Protocol Violation|0
391489|NCT00112437|1242645|P5|12 Month Base Study|Protocol Violation|1
391490|NCT00112437|1242646|P4|12 Month Base Study|Protocol Violation|1
391491|NCT00112437|1242647|P3|12 Month Base Study|Protocol Violation|3
391492|NCT00112437|1242648|P2|12 Month Base Study|Protocol Violation|0
391493|NCT00112437|1242649|P1|12 Month Base Study|Protocol Violation|1
391494|NCT00112437|1242635|P15|12 Month Base Study|Lost to Follow-up|0
391495|NCT00112437|1242636|P14|12 Month Base Study|Lost to Follow-up|0
391496|NCT00112437|1242637|P13|12 Month Base Study|Lost to Follow-up|0
391497|NCT00112437|1242638|P12|12 Month Base Study|Lost to Follow-up|0
391498|NCT00112437|1242639|P11|12 Month Base Study|Lost to Follow-up|0
391499|NCT00112437|1242640|P10|12 Month Base Study|Lost to Follow-up|0
391500|NCT00112437|1242641|P9|12 Month Base Study|Lost to Follow-up|0
391501|NCT00112437|1242642|P8|12 Month Base Study|Lost to Follow-up|0
391502|NCT00112437|1242643|P7|12 Month Base Study|Lost to Follow-up|0
391503|NCT00112437|1242644|P6|12 Month Base Study|Lost to Follow-up|0
391504|NCT00112437|1242645|P5|12 Month Base Study|Lost to Follow-up|0
391505|NCT00112437|1242646|P4|12 Month Base Study|Lost to Follow-up|0
391506|NCT00112437|1242647|P3|12 Month Base Study|Lost to Follow-up|0
391507|NCT00112437|1242648|P2|12 Month Base Study|Lost to Follow-up|1
391508|NCT00112437|1242649|P1|12 Month Base Study|Lost to Follow-up|0
391509|NCT00112437|1242635|P15|12 Month Base Study|Lack of Efficacy|0
391510|NCT00112437|1242636|P14|12 Month Base Study|Lack of Efficacy|0
391511|NCT00112437|1242637|P13|12 Month Base Study|Lack of Efficacy|0
391512|NCT00112437|1242638|P12|12 Month Base Study|Lack of Efficacy|0
391513|NCT00112437|1242639|P11|12 Month Base Study|Lack of Efficacy|0
391514|NCT00112437|1242640|P10|12 Month Base Study|Lack of Efficacy|0
391515|NCT00112437|1242641|P9|12 Month Base Study|Lack of Efficacy|0
391516|NCT00112437|1242642|P8|12 Month Base Study|Lack of Efficacy|0
391517|NCT00112437|1242643|P7|12 Month Base Study|Lack of Efficacy|0
391518|NCT00112437|1242644|P6|12 Month Base Study|Lack of Efficacy|0
391519|NCT00112437|1242645|P5|12 Month Base Study|Lack of Efficacy|0
391520|NCT00112437|1242646|P4|12 Month Base Study|Lack of Efficacy|0
391521|NCT00112437|1242647|P3|12 Month Base Study|Lack of Efficacy|0
391522|NCT00112437|1242648|P2|12 Month Base Study|Lack of Efficacy|1
391523|NCT00112437|1242649|P1|12 Month Base Study|Lack of Efficacy|0
391524|NCT00112437|1242635|P15|12 Month Base Study|Adverse Event|0
391525|NCT00112437|1242636|P14|12 Month Base Study|Adverse Event|0
391526|NCT00112437|1242637|P13|12 Month Base Study|Adverse Event|0
391527|NCT00112437|1242638|P12|12 Month Base Study|Adverse Event|0
391528|NCT00112437|1242639|P11|12 Month Base Study|Adverse Event|0
391529|NCT00112437|1242640|P10|12 Month Base Study|Adverse Event|0
391530|NCT00112437|1242641|P9|12 Month Base Study|Adverse Event|0
391531|NCT00112437|1242642|P8|12 Month Base Study|Adverse Event|0
391532|NCT00112437|1242643|P7|12 Month Base Study|Adverse Event|0
391533|NCT00112437|1242644|P6|12 Month Base Study|Adverse Event|0
391534|NCT00112437|1242645|P5|12 Month Base Study|Adverse Event|3
391535|NCT00112437|1242646|P4|12 Month Base Study|Adverse Event|4
391536|NCT00112437|1242647|P3|12 Month Base Study|Adverse Event|6
391537|NCT00112437|1242648|P2|12 Month Base Study|Adverse Event|10
391538|NCT00112437|1242649|P1|12 Month Base Study|Adverse Event|9
391539|NCT00112385|1242908|P2|Overall Study|Withdrawal by Subject|1
391540|NCT00112385|1242909|P1|Overall Study|Withdrawal by Subject|0
391541|NCT00112385|1242908|P2|Overall Study|Lost to Follow-up|0
391542|NCT00112385|1242909|P1|Overall Study|Lost to Follow-up|1
391543|NCT00112359|1242999|P2|Overall Study|Other|0
391544|NCT00112359|1243000|P1|Overall Study|Other|3
391545|NCT00112359|1242999|P2|Overall Study|Personal/administrative|1
391546|NCT00112359|1243000|P1|Overall Study|Personal/administrative|1
391547|NCT00112359|1242999|P2|Overall Study|Lost to Follow-up|1
391548|NCT00112359|1243000|P1|Overall Study|Lost to Follow-up|0
391549|NCT00112359|1242999|P2|Overall Study|Related adverse event|3
391550|NCT00112359|1243000|P1|Overall Study|Related adverse event|5
391551|NCT00112359|1242999|P2|Overall Study|Trial drug intolerance (adverse event)|0
391552|NCT00112359|1243000|P1|Overall Study|Trial drug intolerance (adverse event)|2
391553|NCT00112359|1242999|P2|Overall Study|Unrelated adverse event|8
391554|NCT00112359|1243000|P1|Overall Study|Unrelated adverse event|16
391555|NCT00112294|1243026|P2|Overall Study|Still on study|0
391556|NCT00112294|1243027|P1|Overall Study|Still on study|5
391557|NCT00112047|1243208|P2|Atripla Phase|Not specified|1
391558|NCT00112047|1243209|P1|Atripla Phase|Not specified|3
391559|NCT00112047|1243208|P2|Atripla Phase|Non-compliance|0
391560|NCT00112047|1243209|P1|Atripla Phase|Non-compliance|1
391561|NCT00112047|1243208|P2|Atripla Phase|Sub-optimal virological response|1
391562|NCT00112047|1243209|P1|Atripla Phase|Sub-optimal virological response|0
391563|NCT00112047|1243208|P2|Atripla Phase|Withdrew consent|7
391564|NCT00112047|1243209|P1|Atripla Phase|Withdrew consent|7
391565|NCT00112047|1243208|P2|Atripla Phase|Death|2
391566|NCT00112047|1243209|P1|Atripla Phase|Death|0
391567|NCT00112047|1243208|P2|Atripla Phase|Pregnancy|1
391568|NCT00112047|1243209|P1|Atripla Phase|Pregnancy|0
391569|NCT00112047|1243208|P2|Atripla Phase|Lost to Follow-up|7
391570|NCT00112047|1243209|P1|Atripla Phase|Lost to Follow-up|5
391571|NCT00112047|1243208|P2|Atripla Phase|Adverse Event|1
391572|NCT00112047|1243209|P1|Atripla Phase|Adverse Event|2
391573|NCT00112047|1243208|P2|Randomized Phase|High Hepatitis B DNA|1
391574|NCT00112047|1243209|P1|Randomized Phase|High Hepatitis B DNA|0
391575|NCT00112047|1243208|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
391576|NCT00112047|1243209|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
391577|NCT00112047|1243208|P2|Randomized Phase|Moved out of State|1
391578|NCT00112047|1243209|P1|Randomized Phase|Moved out of State|0
391579|NCT00112047|1243208|P2|Randomized Phase|Incarceration|2
391580|NCT00112047|1243209|P1|Randomized Phase|Incarceration|3
391581|NCT00112047|1243208|P2|Randomized Phase|Inability to swallow pills|1
391582|NCT00112047|1243209|P1|Randomized Phase|Inability to swallow pills|0
391583|NCT00112047|1243208|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
391584|NCT00112047|1243209|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
391585|NCT00112047|1243208|P2|Randomized Phase|Death|3
391586|NCT00112047|1243209|P1|Randomized Phase|Death|1
391587|NCT00112047|1243208|P2|Randomized Phase|Pregnancy|1
391588|NCT00112047|1243209|P1|Randomized Phase|Pregnancy|3
391589|NCT00112047|1243208|P2|Randomized Phase|Protocol Violation|0
391590|NCT00112047|1243209|P1|Randomized Phase|Protocol Violation|2
391591|NCT00112047|1243208|P2|Randomized Phase|Noncompliance|4
391592|NCT00112047|1243209|P1|Randomized Phase|Noncompliance|8
391593|NCT00112047|1243208|P2|Randomized Phase|Sub-optimal virological response|13
391594|NCT00112047|1243209|P1|Randomized Phase|Sub-optimal virological response|3
391595|NCT00112047|1243208|P2|Randomized Phase|Withrawal of consent|18
391596|NCT00112047|1243209|P1|Randomized Phase|Withrawal of consent|10
391597|NCT00112047|1243208|P2|Randomized Phase|Adverse Event|10
391598|NCT00112047|1243209|P1|Randomized Phase|Adverse Event|10
391599|NCT00112047|1243208|P2|Randomized Phase|Lost to Follow-up|33
391600|NCT00112047|1243209|P1|Randomized Phase|Lost to Follow-up|26
391601|NCT00111917|1243309|P2|Overall Study|Withdrawal by Subject|1
391602|NCT00111917|1243310|P1|Overall Study|Withdrawal by Subject|1
391603|NCT00111813|1243322|P6|Overall Study|Not specified|0
391604|NCT00111813|1243323|P5|Overall Study|Not specified|0
391605|NCT00111813|1243324|P4|Overall Study|Not specified|0
391606|NCT00111813|1243325|P3|Overall Study|Not specified|1
391607|NCT00111813|1243326|P2|Overall Study|Not specified|0
391608|NCT00111813|1243327|P1|Overall Study|Not specified|0
391609|NCT00111813|1243322|P6|Overall Study|Lack of Efficacy|1
391610|NCT00111813|1243323|P5|Overall Study|Lack of Efficacy|0
391611|NCT00111813|1243324|P4|Overall Study|Lack of Efficacy|0
391612|NCT00111813|1243325|P3|Overall Study|Lack of Efficacy|0
391613|NCT00111813|1243326|P2|Overall Study|Lack of Efficacy|0
391614|NCT00111813|1243327|P1|Overall Study|Lack of Efficacy|0
391615|NCT00111813|1243322|P6|Overall Study|Progressive disease|3
391616|NCT00111813|1243323|P5|Overall Study|Progressive disease|4
391617|NCT00111813|1243324|P4|Overall Study|Progressive disease|3
391618|NCT00111813|1243325|P3|Overall Study|Progressive disease|5
391619|NCT00111813|1243326|P2|Overall Study|Progressive disease|1
391620|NCT00111813|1243327|P1|Overall Study|Progressive disease|2
391621|NCT00111813|1243322|P6|Overall Study|Adverse Event|2
391622|NCT00111813|1243323|P5|Overall Study|Adverse Event|2
391623|NCT00111813|1243324|P4|Overall Study|Adverse Event|2
391624|NCT00111813|1243325|P3|Overall Study|Adverse Event|4
391625|NCT00111813|1243326|P2|Overall Study|Adverse Event|2
391626|NCT00111813|1243327|P1|Overall Study|Adverse Event|1
391627|NCT00111761|1243362|P2|Part 2|Other|0
391628|NCT00111761|1243363|P1|Part 2|Other|1
391629|NCT00111761|1243362|P2|Part 2|Protocol-specified criteria|0
391630|NCT00111761|1243363|P1|Part 2|Protocol-specified criteria|1
391631|NCT00111761|1243362|P2|Part 2|Disease progression|0
391632|NCT00111761|1243363|P1|Part 2|Disease progression|3
391633|NCT00111761|1243362|P2|Part 2|Death|0
391634|NCT00111761|1243363|P1|Part 2|Death|1
391635|NCT00111761|1243362|P2|Part 2|Physician Decision|0
391636|NCT00111761|1243363|P1|Part 2|Physician Decision|1
391637|NCT00111761|1243362|P2|Part 2|Adverse Event|0
391638|NCT00111761|1243363|P1|Part 2|Adverse Event|1
391639|NCT00111761|1243362|P2|Part 1|Withdrawal by Subject|1
391640|NCT00111761|1243363|P1|Part 1|Withdrawal by Subject|0
391641|NCT00111761|1243362|P2|Part 1|Other|1
391642|NCT00111761|1243363|P1|Part 1|Other|0
391643|NCT00111761|1243362|P2|Part 1|Death|2
391644|NCT00111761|1243363|P1|Part 1|Death|0
391645|NCT00111761|1243362|P2|Part 1|Physician Decision|1
391646|NCT00111761|1243363|P1|Part 1|Physician Decision|0
391647|NCT00111007|1243392|P2|Long Term Follow-up|Missing|3
391648|NCT00111007|1243393|P1|Long Term Follow-up|Missing|10
391649|NCT00111007|1243392|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
391650|NCT00111007|1243393|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
391651|NCT00111007|1243392|P2|Long Term Follow-up|Withdrawal by Subject|1
391652|NCT00111007|1243393|P1|Long Term Follow-up|Withdrawal by Subject|0
391653|NCT00111007|1243392|P2|Long Term Follow-up|Lost to Follow-up|1
391654|NCT00111007|1243393|P1|Long Term Follow-up|Lost to Follow-up|1
391655|NCT00111007|1243392|P2|Long Term Follow-up|Death|39
391656|NCT00111007|1243393|P1|Long Term Follow-up|Death|34
391657|NCT00111007|1243392|P2|Active Follow-up|Disease progression/recurrence/relapse|2
391658|NCT00111007|1243393|P1|Active Follow-up|Disease progression/recurrence/relapse|3
391659|NCT00111007|1243392|P2|Active Follow-up|Death|0
391660|NCT00111007|1243393|P1|Active Follow-up|Death|2
391661|NCT00111007|1243392|P2|Active Follow-up|Adverse Event|0
391662|NCT00111007|1243393|P1|Active Follow-up|Adverse Event|1
391663|NCT00111007|1243392|P2|Double-blind (DB) Treatment|Primary reason with other category|1
391664|NCT00111007|1243393|P1|Double-blind (DB) Treatment|Primary reason with other category|0
391665|NCT00111007|1243392|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
391666|NCT00111007|1243393|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
391667|NCT00111007|1243392|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
391668|NCT00111007|1243393|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
391669|NCT00111007|1243392|P2|Double-blind (DB) Treatment|Relapse|0
391670|NCT00111007|1243393|P1|Double-blind (DB) Treatment|Relapse|1
391671|NCT00111007|1243392|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
391672|NCT00111007|1243393|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
391673|NCT00111007|1243392|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
391674|NCT00111007|1243393|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
391675|NCT00111007|1243392|P2|Double-blind (DB) Treatment|Protocol Violation|1
391676|NCT00111007|1243393|P1|Double-blind (DB) Treatment|Protocol Violation|0
391677|NCT00111007|1243392|P2|Double-blind (DB) Treatment|Death|2
391678|NCT00111007|1243393|P1|Double-blind (DB) Treatment|Death|5
391679|NCT00111007|1243392|P2|Double-blind (DB) Treatment|Adverse Event|4
391680|NCT00111007|1243393|P1|Double-blind (DB) Treatment|Adverse Event|12
391681|NCT00110994|1243409|P2|Long Term Follow-up|Death|17
391682|NCT00110994|1243410|P1|Long Term Follow-up|Death|19
391683|NCT00110994|1243409|P2|Active Follow-up|Other reasons|2
391684|NCT00110994|1243410|P1|Active Follow-up|Other reasons|0
391685|NCT00110994|1243409|P2|Active Follow-up|Disease progression/recurrence/replace|0
391686|NCT00110994|1243410|P1|Active Follow-up|Disease progression/recurrence/replace|1
391687|NCT00110994|1243409|P2|Double-blind (DB) Treatment|other reasons|3
391688|NCT00110994|1243410|P1|Double-blind (DB) Treatment|other reasons|2
391689|NCT00110994|1243409|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
391690|NCT00110994|1243410|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
391691|NCT00110994|1243409|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
391692|NCT00110994|1243410|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
391693|NCT00110994|1243409|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
391694|NCT00110994|1243410|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
391695|NCT00110994|1243409|P2|Double-blind (DB) Treatment|Death|0
391696|NCT00110994|1243410|P1|Double-blind (DB) Treatment|Death|1
391697|NCT00110994|1243409|P2|Double-blind (DB) Treatment|Adverse Event|0
391698|NCT00110994|1243410|P1|Double-blind (DB) Treatment|Adverse Event|3
391699|NCT00110890|1243436|P2|Overall Study|Did not enter follow-up phase|4
391700|NCT00110890|1243437|P1|Overall Study|Did not enter follow-up phase|10
391701|NCT00110890|1243436|P2|Overall Study|Parathyroidectomy|1
391702|NCT00110890|1243437|P1|Overall Study|Parathyroidectomy|0
391703|NCT00110890|1243436|P2|Overall Study|Disease progression|1
391704|NCT00110890|1243437|P1|Overall Study|Disease progression|0
391705|NCT00110890|1243436|P2|Overall Study|Requirement for alternative therapy|1
391706|NCT00110890|1243437|P1|Overall Study|Requirement for alternative therapy|0
391707|NCT00110890|1243436|P2|Overall Study|Ineligibility determined|0
391708|NCT00110890|1243437|P1|Overall Study|Ineligibility determined|3
391709|NCT00110890|1243436|P2|Overall Study|Other|23
391710|NCT00110890|1243437|P1|Overall Study|Other|34
391711|NCT00110890|1243436|P2|Overall Study|Invest. Product Commercially Available|110
391712|NCT00110890|1243437|P1|Overall Study|Invest. Product Commercially Available|217
391713|NCT00110890|1243436|P2|Overall Study|Kidney Transplant|12
391714|NCT00110890|1243437|P1|Overall Study|Kidney Transplant|16
391715|NCT00110890|1243436|P2|Overall Study|Noncompliance|0
391716|NCT00110890|1243437|P1|Overall Study|Noncompliance|10
391717|NCT00110890|1243436|P2|Overall Study|Protocol Deviation|0
391718|NCT00110890|1243437|P1|Overall Study|Protocol Deviation|1
391719|NCT00110890|1243436|P2|Overall Study|Withdrawal by Subject|5
391720|NCT00110890|1243437|P1|Overall Study|Withdrawal by Subject|17
391721|NCT00110890|1243436|P2|Overall Study|Physician Decision|5
391722|NCT00110890|1243437|P1|Overall Study|Physician Decision|4
391723|NCT00110890|1243436|P2|Overall Study|Lost to Follow-up|1
391724|NCT00110890|1243437|P1|Overall Study|Lost to Follow-up|3
391725|NCT00110890|1243436|P2|Overall Study|Death|9
391726|NCT00110890|1243437|P1|Overall Study|Death|16
391727|NCT00110890|1243436|P2|Overall Study|Adverse Event|7
391728|NCT00110890|1243437|P1|Overall Study|Adverse Event|30
391729|NCT00110812|1243454|P3|Extended Follow-up|Lost to Follow-up|1
391730|NCT00110812|1243455|P2|Extended Follow-up|Lost to Follow-up|3
391731|NCT00110812|1243456|P1|Extended Follow-up|Lost to Follow-up|1
391732|NCT00110812|1243454|P3|Extended Follow-up|Withdrawal by Subject|0
391733|NCT00110812|1243455|P2|Extended Follow-up|Withdrawal by Subject|1
391734|NCT00110812|1243456|P1|Extended Follow-up|Withdrawal by Subject|0
391735|NCT00110812|1243454|P3|Extended Follow-up|Death|3
391736|NCT00110812|1243455|P2|Extended Follow-up|Death|0
391737|NCT00110812|1243456|P1|Extended Follow-up|Death|1
391738|NCT00110812|1243454|P3|Main Study|Lost to Follow-up|10
391739|NCT00110812|1243455|P2|Main Study|Lost to Follow-up|11
391740|NCT00110812|1243456|P1|Main Study|Lost to Follow-up|8
391741|NCT00110812|1243454|P3|Main Study|Withdrawal by Subject|1
391742|NCT00110812|1243455|P2|Main Study|Withdrawal by Subject|0
391743|NCT00110812|1243456|P1|Main Study|Withdrawal by Subject|0
391744|NCT00110812|1243454|P3|Main Study|Death|2
391745|NCT00110812|1243455|P2|Main Study|Death|0
391746|NCT00110812|1243456|P1|Main Study|Death|0
391747|NCT00110617|1243501|P2|Overall Study|Did not receive study drug|12
391748|NCT00110617|1243502|P1|Overall Study|Did not receive study drug|0
391749|NCT00110617|1243501|P2|Overall Study|Death|1
391750|NCT00110617|1243502|P1|Overall Study|Death|1
391751|NCT00110617|1243501|P2|Overall Study|Administrative problems|5
391752|NCT00110617|1243502|P1|Overall Study|Administrative problems|6
391753|NCT00110617|1243501|P2|Overall Study|Lost to Follow-up|1
391754|NCT00110617|1243502|P1|Overall Study|Lost to Follow-up|9
391755|NCT00110617|1243501|P2|Overall Study|Withdrawal by Subject|4
391756|NCT00110617|1243502|P1|Overall Study|Withdrawal by Subject|10
391757|NCT00110617|1243501|P2|Overall Study|Protocol Violation|0
391758|NCT00110617|1243502|P1|Overall Study|Protocol Violation|5
391759|NCT00110617|1243501|P2|Overall Study|Patient no longer requires study drug|0
391760|NCT00110617|1243502|P1|Overall Study|Patient no longer requires study drug|1
391761|NCT00110617|1243501|P2|Overall Study|Lack of Efficacy|0
391762|NCT00110617|1243502|P1|Overall Study|Lack of Efficacy|1
391763|NCT00110617|1243501|P2|Overall Study|Abnormal Laboratory Value|2
391764|NCT00110617|1243502|P1|Overall Study|Abnormal Laboratory Value|4
391765|NCT00110617|1243501|P2|Overall Study|Adverse Event|4
391766|NCT00110617|1243502|P1|Overall Study|Adverse Event|2
391767|NCT00110396|1243619|P1|Overall Study|Patient is to be administered copaxone|1
391768|NCT00110396|1243619|P1|Overall Study|The patient has refused to visit site|1
391769|NCT00110396|1243619|P1|Overall Study|The patient has refused|2
391770|NCT00110396|1243619|P1|Overall Study|Patient refused to come back|1
391771|NCT00110396|1243619|P1|Overall Study|Protocol Violation|2
391772|NCT00110396|1243619|P1|Overall Study|Pregnancy (Protocol violation)|2
391773|NCT00110396|1243619|P1|Overall Study|Pregnancy|1
391774|NCT00110396|1243619|P1|Overall Study|Participation in MS vaccine study|1
391775|NCT00110396|1243619|P1|Overall Study|Patient's decision|1
391776|NCT00110396|1243619|P1|Overall Study|Patient will|1
391777|NCT00110396|1243619|P1|Overall Study|Patient refused to participate|1
391778|NCT00110396|1243619|P1|Overall Study|Patient refused to continue|1
391779|NCT00110396|1243619|P1|Overall Study|Patient non-compliance|1
391780|NCT00110396|1243619|P1|Overall Study|Decided not to continue treatment|1
391781|NCT00110396|1243619|P1|Overall Study|Lack of Efficacy|1
391782|NCT00110396|1243619|P1|Overall Study|Initiated mitoxantrone therapy|1
391783|NCT00110396|1243619|P1|Overall Study|Administration of plasmapheresis|1
391784|NCT00110396|1243619|P1|Overall Study|Lost to Follow-up|1
391785|NCT00110396|1243619|P1|Overall Study|Adverse Event|15
391786|NCT00110357|1243627|P2|Overall Study|Withdrawal by Subject|1
391787|NCT00110357|1243628|P1|Overall Study|Withdrawal by Subject|3
391788|NCT00110357|1243627|P2|Overall Study|Study Drug Toxicity|3
391789|NCT00110357|1243628|P1|Overall Study|Study Drug Toxicity|1
391790|NCT00110357|1243627|P2|Overall Study|Study Closure|0
391791|NCT00110357|1243628|P1|Overall Study|Study Closure|1
391792|NCT00110357|1243627|P2|Overall Study|Disease progression/relapse|15
391793|NCT00110357|1243628|P1|Overall Study|Disease progression/relapse|20
391794|NCT00110357|1243627|P2|Overall Study|Deterioration without progression|0
391795|NCT00110357|1243628|P1|Overall Study|Deterioration without progression|2
391796|NCT00110305|1243716|P2|Overall Study|Unspecified|2
391797|NCT00110305|1243717|P1|Overall Study|Unspecified|8
391798|NCT00110305|1243716|P2|Overall Study|Lost to Follow-up|3
391799|NCT00110305|1243717|P1|Overall Study|Lost to Follow-up|20
391800|NCT00110305|1243716|P2|Overall Study|Withdrawal by Subject|7
391801|NCT00110305|1243717|P1|Overall Study|Withdrawal by Subject|7
391802|NCT00110305|1243716|P2|Overall Study|Protocol Violation|1
391803|NCT00110305|1243717|P1|Overall Study|Protocol Violation|0
391804|NCT00110305|1243716|P2|Overall Study|Subject Reached A Virologic Endpoint|3
391805|NCT00110305|1243717|P1|Overall Study|Subject Reached A Virologic Endpoint|21
391806|NCT00110305|1243716|P2|Overall Study|Subject Ineligible To Continue The Trial|1
391807|NCT00110305|1243717|P1|Overall Study|Subject Ineligible To Continue The Trial|2
391808|NCT00110305|1243716|P2|Overall Study|Subject Non-Compliant|2
391809|NCT00110305|1243717|P1|Overall Study|Subject Non-Compliant|9
391810|NCT00110305|1243716|P2|Overall Study|Sponsors Decision|0
391811|NCT00110305|1243717|P1|Overall Study|Sponsors Decision|1
391812|NCT00110305|1243716|P2|Overall Study|Adverse Event|13
391813|NCT00110305|1243717|P1|Overall Study|Adverse Event|46
391814|NCT00110214|1243770|P2|Overall Study|Other (not specified)|75
391815|NCT00110214|1243771|P1|Overall Study|Other (not specified)|61
391816|NCT00110214|1243770|P2|Overall Study|Refused further treatment|65
391817|NCT00110214|1243771|P1|Overall Study|Refused further treatment|52
391818|NCT00110214|1243770|P2|Overall Study|Adverse Event|192
391819|NCT00110214|1243771|P1|Overall Study|Adverse Event|115
391820|NCT00110214|1243770|P2|Overall Study|Disease progression or death|151
391821|NCT00110214|1243771|P1|Overall Study|Disease progression or death|260
391822|NCT00110214|1243770|P2|Overall Study|Never started treatment|20
391823|NCT00110214|1243771|P1|Overall Study|Never started treatment|21
391824|NCT00110084|1243792|P1|Overall Study|Other|2
391825|NCT00110084|1243792|P1|Overall Study|Intercurrent Illness|1
391826|NCT00110084|1243792|P1|Overall Study|Alternate Therapy|5
391827|NCT00110084|1243792|P1|Overall Study|Patient Refusal|10
391828|NCT00110084|1243792|P1|Overall Study|Death|1
391829|NCT00110084|1243792|P1|Overall Study|Adverse Event|9
391830|NCT00110019|1243801|P2|Overall Study|other reasons|30
391831|NCT00110019|1243802|P1|Overall Study|other reasons|22
391832|NCT00110019|1243801|P2|Overall Study|Not start protocol therapy|16
391833|NCT00110019|1243802|P1|Overall Study|Not start protocol therapy|17
391834|NCT00110019|1243801|P2|Overall Study|symptom deterioration|16
391835|NCT00110019|1243802|P1|Overall Study|symptom deterioration|13
391836|NCT00110019|1243801|P2|Overall Study|complicating disease|1
391837|NCT00110019|1243802|P1|Overall Study|complicating disease|1
391838|NCT00110019|1243801|P2|Overall Study|alternative therapy|1
391839|NCT00110019|1243802|P1|Overall Study|alternative therapy|5
391840|NCT00110019|1243801|P2|Overall Study|Withdrawal by Subject|9
391841|NCT00110019|1243802|P1|Overall Study|Withdrawal by Subject|21
391842|NCT00110019|1243801|P2|Overall Study|Death|15
391843|NCT00110019|1243802|P1|Overall Study|Death|13
391844|NCT00110019|1243801|P2|Overall Study|Adverse Event|40
391845|NCT00110019|1243802|P1|Overall Study|Adverse Event|61
391846|NCT00110019|1243801|P2|Overall Study|Lack of Efficacy|285
391847|NCT00110019|1243802|P1|Overall Study|Lack of Efficacy|253
391848|NCT00109967|1243814|P2|Overall Study|Death|2
391849|NCT00109967|1243815|P1|Overall Study|Death|0
391850|NCT00109967|1243814|P2|Overall Study|Physician Decision|3
391851|NCT00109967|1243815|P1|Overall Study|Physician Decision|1
391852|NCT00109967|1243814|P2|Overall Study|Withdrawal by Subject|0
391853|NCT00109967|1243815|P1|Overall Study|Withdrawal by Subject|5
391854|NCT00109967|1243814|P2|Overall Study|Adverse Event|1
391855|NCT00109967|1243815|P1|Overall Study|Adverse Event|12
391856|NCT00109967|1243814|P2|Overall Study|Cancel Prior to Treatment|0
391857|NCT00109967|1243815|P1|Overall Study|Cancel Prior to Treatment|2
391858|NCT00109928|1243829|P1|Overall Study|not eligible|1
391859|NCT00109928|1243829|P1|Overall Study|not protocol specified|2
391860|NCT00109928|1243829|P1|Overall Study|Death|2
391861|NCT00109928|1243829|P1|Overall Study|Progression|6
391862|NCT00109928|1243829|P1|Overall Study|Adverse Event|2
391863|NCT00109850|1243846|P1|Overall Study|Ineligible|1
391864|NCT00109850|1243846|P1|Overall Study|Death|2
391865|NCT00109850|1243846|P1|Overall Study|Adverse Event|1
391866|NCT00109837|1243853|P1|Overall Study|Ineligible|1
391867|NCT00109837|1243853|P1|Overall Study|Not treated|1
391868|NCT00109837|1243853|P1|Overall Study|BCR/ABL+ or Ph+|17
391869|NCT00109837|1243853|P1|Overall Study|Death|1
391870|NCT00109837|1243853|P1|Overall Study|Refusal unrelated to adverse effects|1
391871|NCT00109837|1243853|P1|Overall Study|Adverse Event|2
391872|NCT00109772|1243863|P2|Open-label Extension|not specified|10
391873|NCT00109772|1243864|P1|Open-label Extension|not specified|4
391874|NCT00109772|1243863|P2|Open-label Extension|Protocol Violation|2
391875|NCT00109772|1243864|P1|Open-label Extension|Protocol Violation|2
391876|NCT00109772|1243863|P2|Open-label Extension|Death|1
391877|NCT00109772|1243864|P1|Open-label Extension|Death|0
391878|NCT00109772|1243863|P2|Open-label Extension|Lost to Follow-up|0
391879|NCT00109772|1243864|P1|Open-label Extension|Lost to Follow-up|1
391880|NCT00109772|1243863|P2|Open-label Extension|Withdrawal by Subject|6
391881|NCT00109772|1243864|P1|Open-label Extension|Withdrawal by Subject|9
391882|NCT00109772|1243863|P2|Open-label Extension|Lack of Efficacy|11
391883|NCT00109772|1243864|P1|Open-label Extension|Lack of Efficacy|19
391884|NCT00109772|1243863|P2|Open-label Extension|Adverse Event|19
391885|NCT00109772|1243864|P1|Open-label Extension|Adverse Event|10
391886|NCT00109772|1243863|P2|Double-blind Treatment|Withdrew prior to treatment|1
391887|NCT00109772|1243864|P1|Double-blind Treatment|Withdrew prior to treatment|3
391888|NCT00109772|1243863|P2|Double-blind Treatment|not specified|4
391889|NCT00109772|1243864|P1|Double-blind Treatment|not specified|0
391890|NCT00109772|1243863|P2|Double-blind Treatment|Protocol Violation|1
391891|NCT00109772|1243864|P1|Double-blind Treatment|Protocol Violation|0
391892|NCT00109772|1243863|P2|Double-blind Treatment|Lost to Follow-up|3
391893|NCT00109772|1243864|P1|Double-blind Treatment|Lost to Follow-up|2
391894|NCT00109772|1243863|P2|Double-blind Treatment|Withdrawal by Subject|1
391895|NCT00109772|1243864|P1|Double-blind Treatment|Withdrawal by Subject|2
391896|NCT00109772|1243863|P2|Double-blind Treatment|Lack of Efficacy|0
391897|NCT00109772|1243864|P1|Double-blind Treatment|Lack of Efficacy|1
391898|NCT00109772|1243863|P2|Double-blind Treatment|Adverse Event|5
391899|NCT00109772|1243864|P1|Double-blind Treatment|Adverse Event|14
391900|NCT00109733|1243904|P2|Overall Study|Could not commit time for study|1
391901|NCT00109733|1243905|P1|Overall Study|Could not commit time for study|1
391902|NCT00109733|1243904|P2|Overall Study|Non-compliant|1
391903|NCT00109733|1243905|P1|Overall Study|Non-compliant|0
391904|NCT00109733|1243904|P2|Overall Study|Stopped taking study drug|1
391905|NCT00109733|1243905|P1|Overall Study|Stopped taking study drug|1
391906|NCT00109733|1243904|P2|Overall Study|Protocol Violation|1
391907|NCT00109733|1243905|P1|Overall Study|Protocol Violation|0
391908|NCT00109590|1243922|P3|Overall Study|Never Started Treatment|3
391909|NCT00109590|1243923|P2|Overall Study|Never Started Treatment|2
391910|NCT00109590|1243924|P1|Overall Study|Never Started Treatment|1
391911|NCT00109590|1243922|P3|Overall Study|Lost to Follow-up|1
391912|NCT00109590|1243923|P2|Overall Study|Lost to Follow-up|0
391913|NCT00109590|1243924|P1|Overall Study|Lost to Follow-up|1
391914|NCT00109577|1243966|P2|Overall Study|Withdrawal by Subject|3
391915|NCT00109577|1243967|P1|Overall Study|Withdrawal by Subject|3
391916|NCT00109343|1243998|P3|Overall Study|Unspecified|1
391917|NCT00109343|1243999|P2|Overall Study|Unspecified|2
391918|NCT00109343|1244000|P1|Overall Study|Unspecified|5
391919|NCT00109343|1243998|P3|Overall Study|Subject Moved|1
391920|NCT00109343|1243999|P2|Overall Study|Subject Moved|2
391921|NCT00109343|1244000|P1|Overall Study|Subject Moved|6
391922|NCT00109343|1243998|P3|Overall Study|Withdrawal by Subject|10
391923|NCT00109343|1243999|P2|Overall Study|Withdrawal by Subject|11
391924|NCT00109343|1244000|P1|Overall Study|Withdrawal by Subject|15
391925|NCT00109343|1243998|P3|Overall Study|Protocol Violation|2
391926|NCT00109343|1243999|P2|Overall Study|Protocol Violation|2
391927|NCT00109343|1244000|P1|Overall Study|Protocol Violation|1
391928|NCT00109343|1243998|P3|Overall Study|Lost to Follow-up|14
391929|NCT00109343|1243999|P2|Overall Study|Lost to Follow-up|20
391930|NCT00109343|1244000|P1|Overall Study|Lost to Follow-up|35
391931|NCT00109343|1243998|P3|Overall Study|Lack of Efficacy|0
391932|NCT00109343|1243999|P2|Overall Study|Lack of Efficacy|0
391933|NCT00109343|1244000|P1|Overall Study|Lack of Efficacy|1
391934|NCT00109343|1243998|P3|Overall Study|Adverse Event|2
391935|NCT00109343|1243999|P2|Overall Study|Adverse Event|0
391936|NCT00109343|1244000|P1|Overall Study|Adverse Event|1
391937|NCT00109031|1244045|P4|Overall Study|Protocol Violation|0
391938|NCT00109031|1244046|P3|Overall Study|Protocol Violation|1
391939|NCT00109031|1244047|P2|Overall Study|Protocol Violation|0
391940|NCT00109031|1244048|P1|Overall Study|Protocol Violation|0
391941|NCT00109031|1244045|P4|Overall Study|Physician Decision|0
391942|NCT00109031|1244046|P3|Overall Study|Physician Decision|0
391943|NCT00109031|1244047|P2|Overall Study|Physician Decision|1
391944|NCT00109031|1244048|P1|Overall Study|Physician Decision|0
391945|NCT00109031|1244045|P4|Overall Study|Withdrawal by Subject|0
391946|NCT00109031|1244046|P3|Overall Study|Withdrawal by Subject|0
391947|NCT00109031|1244047|P2|Overall Study|Withdrawal by Subject|1
391948|NCT00109031|1244048|P1|Overall Study|Withdrawal by Subject|0
391949|NCT00109031|1244045|P4|Overall Study|Adverse Event|0
391950|NCT00109031|1244046|P3|Overall Study|Adverse Event|1
391951|NCT00109031|1244047|P2|Overall Study|Adverse Event|0
391952|NCT00109031|1244048|P1|Overall Study|Adverse Event|0
391953|NCT00108953|1244099|P2|Follow-up|Study terminated by sponsor|6
391954|NCT00108953|1244100|P1|Follow-up|Study terminated by sponsor|10
391955|NCT00108953|1244099|P2|Follow-up|Lost to Follow-up|1
391956|NCT00108953|1244100|P1|Follow-up|Lost to Follow-up|1
391957|NCT00108953|1244099|P2|Follow-up|Death|26
391958|NCT00108953|1244100|P1|Follow-up|Death|18
391959|NCT00108862|1244122|P2|Overall Study|Lost to Follow-up|19
391960|NCT00108862|1244123|P1|Overall Study|Lost to Follow-up|27
391961|NCT00108862|1244122|P2|Overall Study|Withdrawal by Subject|6
391962|NCT00108862|1244123|P1|Overall Study|Withdrawal by Subject|10
391963|NCT00108862|1244122|P2|Overall Study|Death|37
391964|NCT00108862|1244123|P1|Overall Study|Death|31
391965|NCT00108732|1244151|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
391966|NCT00108732|1244151|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
391967|NCT00108732|1244151|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
391968|NCT00108732|1244151|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
391969|NCT00108732|1244151|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
391970|NCT00108732|1244151|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
391971|NCT00108732|1244151|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
391972|NCT00108628|1244160|P2|Overall Study|Death|0
391973|NCT00108628|1244161|P1|Overall Study|Death|1
391974|NCT00108628|1244160|P2|Overall Study|Lack of Efficacy|1
391975|NCT00108628|1244161|P1|Overall Study|Lack of Efficacy|2
391976|NCT00108628|1244160|P2|Overall Study|Withdrawal by Subject|9
391977|NCT00108628|1244161|P1|Overall Study|Withdrawal by Subject|17
391978|NCT00108485|1244211|P2|Overall Study|Lost to Follow-up|2
391979|NCT00108485|1244212|P1|Overall Study|Lost to Follow-up|0
391980|NCT00108485|1244211|P2|Overall Study|Withdrawal by Subject|0
391981|NCT00108485|1244212|P1|Overall Study|Withdrawal by Subject|3
391982|NCT00108433|1244220|P2|Overall Study|Unspecified|14
391983|NCT00108433|1244221|P1|Overall Study|Unspecified|14
391984|NCT00108433|1244220|P2|Overall Study|Adverse Event|1
391985|NCT00108433|1244221|P1|Overall Study|Adverse Event|3
391986|NCT00108433|1244220|P2|Overall Study|Death|0
391987|NCT00108433|1244221|P1|Overall Study|Death|3
391988|NCT00108433|1244220|P2|Overall Study|Lack of Efficacy|2
391989|NCT00108433|1244221|P1|Overall Study|Lack of Efficacy|1
391990|NCT00108355|1244237|P2|Overall Study|Loculated ascites, limiting paracentesis|1
391991|NCT00108355|1244238|P1|Overall Study|Loculated ascites, limiting paracentesis|1
391992|NCT00108355|1244237|P2|Overall Study|Peritonitis at index paracentesis|1
391993|NCT00108355|1244238|P1|Overall Study|Peritonitis at index paracentesis|1
391994|NCT00107172|1244287|P2|Overall Study|Other Reason|3
391995|NCT00107172|1244288|P1|Overall Study|Other Reason|4
391996|NCT00107172|1244287|P2|Overall Study|Death|2
391997|NCT00107172|1244288|P1|Overall Study|Death|0
391998|NCT00107172|1244287|P2|Overall Study|Withdrawal by Subject|0
391999|NCT00107172|1244288|P1|Overall Study|Withdrawal by Subject|1
392000|NCT00107120|1244318|P2|Overall Study|death of parent|1
392001|NCT00107120|1244319|P1|Overall Study|death of parent|0
392002|NCT00107120|1244318|P2|Overall Study|moving away from site|1
392003|NCT00107120|1244319|P1|Overall Study|moving away from site|1
392004|NCT00107120|1244318|P2|Overall Study|Pregnancy|1
392005|NCT00107120|1244319|P1|Overall Study|Pregnancy|0
392006|NCT00107120|1244318|P2|Overall Study|Lost to Follow-up|6
392007|NCT00107120|1244319|P1|Overall Study|Lost to Follow-up|8
392008|NCT00107120|1244318|P2|Overall Study|Withdrawal by Subject|9
392009|NCT00107120|1244319|P1|Overall Study|Withdrawal by Subject|8
392010|NCT00107120|1244318|P2|Overall Study|Protocol Violation|0
392011|NCT00107120|1244319|P1|Overall Study|Protocol Violation|3
392012|NCT00107120|1244318|P2|Overall Study|Lack of Efficacy|5
392013|NCT00107120|1244319|P1|Overall Study|Lack of Efficacy|5
392014|NCT00107120|1244318|P2|Overall Study|Adverse Event|1
392015|NCT00107120|1244319|P1|Overall Study|Adverse Event|4
392016|NCT00107042|1244331|P2|Overall Study|Disallowed medications|2
392017|NCT00107042|1244332|P1|Overall Study|Disallowed medications|0
392018|NCT00107042|1244331|P2|Overall Study|vaccinated outside window|1
392019|NCT00107042|1244332|P1|Overall Study|vaccinated outside window|1
392020|NCT00107042|1244331|P2|Overall Study|Inadvertent enrollment|1
392021|NCT00107042|1244332|P1|Overall Study|Inadvertent enrollment|0
392022|NCT00107042|1244331|P2|Overall Study|Pregnancy|1
392023|NCT00107042|1244332|P1|Overall Study|Pregnancy|1
392024|NCT00107042|1244331|P2|Overall Study|Moved out of area|3
392025|NCT00107042|1244332|P1|Overall Study|Moved out of area|5
392026|NCT00107042|1244331|P2|Overall Study|Withdrawal by Subject|1
392027|NCT00107042|1244332|P1|Overall Study|Withdrawal by Subject|6
392028|NCT00107042|1244331|P2|Overall Study|Lost to Follow-up|7
392029|NCT00107042|1244332|P1|Overall Study|Lost to Follow-up|9
392030|NCT00106964|1244398|P3|Overall Study|Required disallowed medication|0
392031|NCT00106964|1244399|P2|Overall Study|Required disallowed medication|1
392032|NCT00106964|1244400|P1|Overall Study|Required disallowed medication|0
392033|NCT00106964|1244398|P3|Overall Study|Did not meet eligibility criteria|2
392034|NCT00106964|1244399|P2|Overall Study|Did not meet eligibility criteria|2
392035|NCT00106964|1244400|P1|Overall Study|Did not meet eligibility criteria|0
392036|NCT00106964|1244398|P3|Overall Study|Failure to adhere|0
392037|NCT00106964|1244399|P2|Overall Study|Failure to adhere|0
392038|NCT00106964|1244400|P1|Overall Study|Failure to adhere|2
392039|NCT00106964|1244398|P3|Overall Study|Site Funding Terminated|1
392040|NCT00106964|1244399|P2|Overall Study|Site Funding Terminated|1
392041|NCT00106964|1244400|P1|Overall Study|Site Funding Terminated|0
392042|NCT00106964|1244398|P3|Overall Study|Incarceration|0
392043|NCT00106964|1244399|P2|Overall Study|Incarceration|1
392044|NCT00106964|1244400|P1|Overall Study|Incarceration|0
392045|NCT00106964|1244398|P3|Overall Study|Death|0
392046|NCT00106964|1244399|P2|Overall Study|Death|1
392047|NCT00106964|1244400|P1|Overall Study|Death|1
392048|NCT00106964|1244398|P3|Overall Study|Pregnancy|2
392049|NCT00106964|1244399|P2|Overall Study|Pregnancy|3
392050|NCT00106964|1244400|P1|Overall Study|Pregnancy|2
392051|NCT00106964|1244398|P3|Overall Study|Lost to Follow-up|2
392052|NCT00106964|1244399|P2|Overall Study|Lost to Follow-up|6
392053|NCT00106964|1244400|P1|Overall Study|Lost to Follow-up|8
392054|NCT00108160|1244473|P2|Overall Study|Protocol Violation|5
392055|NCT00108160|1244474|P1|Overall Study|Protocol Violation|9
392056|NCT00108160|1244473|P2|Overall Study|Withdrawal by Subject|2
392057|NCT00108160|1244474|P1|Overall Study|Withdrawal by Subject|4
392058|NCT00108160|1244473|P2|Overall Study|Death|2
392059|NCT00108160|1244474|P1|Overall Study|Death|1
392060|NCT00108160|1244473|P2|Overall Study|Lost to Follow-up|12
392061|NCT00108160|1244474|P1|Overall Study|Lost to Follow-up|25
392062|NCT00108082|1244487|P3|Overall Study|Blood Pressure Not Controlled|0
392063|NCT00108082|1244488|P2|Overall Study|Blood Pressure Not Controlled|0
392064|NCT00108082|1244489|P1|Overall Study|Blood Pressure Not Controlled|1
392065|NCT00108082|1244487|P3|Overall Study|Investigator Not at Site|0
392066|NCT00108082|1244488|P2|Overall Study|Investigator Not at Site|0
392067|NCT00108082|1244489|P1|Overall Study|Investigator Not at Site|1
392068|NCT00108082|1244487|P3|Overall Study|Subject Left Site Location|0
392069|NCT00108082|1244488|P2|Overall Study|Subject Left Site Location|0
392070|NCT00108082|1244489|P1|Overall Study|Subject Left Site Location|1
392071|NCT00108082|1244487|P3|Overall Study|Study Medication Not Tapered|0
392072|NCT00108082|1244488|P2|Overall Study|Study Medication Not Tapered|1
392073|NCT00108082|1244489|P1|Overall Study|Study Medication Not Tapered|0
392074|NCT00108082|1244487|P3|Overall Study|Protocol Amendment|0
392075|NCT00108082|1244488|P2|Overall Study|Protocol Amendment|1
392076|NCT00108082|1244489|P1|Overall Study|Protocol Amendment|0
392077|NCT00108082|1244487|P3|Overall Study|Site Closed Study|0
392078|NCT00108082|1244488|P2|Overall Study|Site Closed Study|2
392079|NCT00108082|1244489|P1|Overall Study|Site Closed Study|0
392080|NCT00108082|1244487|P3|Overall Study|Stopped Study Medication|1
392081|NCT00108082|1244488|P2|Overall Study|Stopped Study Medication|0
392082|NCT00108082|1244489|P1|Overall Study|Stopped Study Medication|0
392083|NCT00108082|1244487|P3|Overall Study|Non-compliance|2
392084|NCT00108082|1244488|P2|Overall Study|Non-compliance|0
392085|NCT00108082|1244489|P1|Overall Study|Non-compliance|1
392086|NCT00108082|1244487|P3|Overall Study|Incorrectly Randomized|2
392087|NCT00108082|1244488|P2|Overall Study|Incorrectly Randomized|0
392088|NCT00108082|1244489|P1|Overall Study|Incorrectly Randomized|0
392089|NCT00108082|1244487|P3|Overall Study|Woman of Child-bearing Potential|2
392090|NCT00108082|1244488|P2|Overall Study|Woman of Child-bearing Potential|0
392091|NCT00108082|1244489|P1|Overall Study|Woman of Child-bearing Potential|2
392092|NCT00108082|1244487|P3|Overall Study|Amendment 4: > Month 12|5
392093|NCT00108082|1244488|P2|Overall Study|Amendment 4: > Month 12|7
392094|NCT00108082|1244489|P1|Overall Study|Amendment 4: > Month 12|5
392095|NCT00108082|1244487|P3|Overall Study|Lack of Efficacy|2
392096|NCT00108082|1244488|P2|Overall Study|Lack of Efficacy|1
392097|NCT00108082|1244489|P1|Overall Study|Lack of Efficacy|3
392098|NCT00108082|1244487|P3|Overall Study|Protocol Violation|0
392099|NCT00108082|1244488|P2|Overall Study|Protocol Violation|2
392100|NCT00108082|1244489|P1|Overall Study|Protocol Violation|1
392101|NCT00108082|1244487|P3|Overall Study|Consent Withdrawn|5
392102|NCT00108082|1244488|P2|Overall Study|Consent Withdrawn|3
392103|NCT00108082|1244489|P1|Overall Study|Consent Withdrawn|3
392104|NCT00108082|1244487|P3|Overall Study|Lost to Follow-up|7
392105|NCT00108082|1244488|P2|Overall Study|Lost to Follow-up|3
392106|NCT00108082|1244489|P1|Overall Study|Lost to Follow-up|6
392107|NCT00108082|1244487|P3|Overall Study|Adverse Event|17
392108|NCT00108082|1244488|P2|Overall Study|Adverse Event|12
392109|NCT00108082|1244489|P1|Overall Study|Adverse Event|14
392110|NCT00108069|1244538|P2|Overall Study|Progessive disease|11
392111|NCT00108069|1244539|P1|Overall Study|Progessive disease|27
392112|NCT00108069|1244538|P2|Overall Study|Death|0
392113|NCT00108069|1244539|P1|Overall Study|Death|1
392114|NCT00108069|1244538|P2|Overall Study|Withdrawal by Subject|0
392115|NCT00108069|1244539|P1|Overall Study|Withdrawal by Subject|1
392116|NCT00108069|1244538|P2|Overall Study|Adverse Event|1
392117|NCT00108069|1244539|P1|Overall Study|Adverse Event|1
392118|NCT00108069|1244538|P2|Overall Study|Never rec'd study drug|1
392119|NCT00108069|1244539|P1|Overall Study|Never rec'd study drug|0
392120|NCT00107991|1244553|P1|18-Week Post Treatment Assessment|Adverse Event|2
392121|NCT00107991|1244553|P1|12 Week Treatment Period|Incarcerated|1
392122|NCT00107991|1244553|P1|12 Week Treatment Period|Protocol Violation|1
392123|NCT00107991|1244553|P1|12 Week Treatment Period|Adverse Event|1
392124|NCT00107991|1244553|P1|12 Week Treatment Period|Lack of Efficacy|2
392125|NCT00107991|1244553|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
392126|NCT00107991|1244553|P1|Eligibility Assessment|chronic uncontrolled asthma|1
392127|NCT00107991|1244553|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
392128|NCT00107991|1244553|P1|Eligibility Assessment|Abnormal labs|2
392129|NCT00107991|1244553|P1|Eligibility Assessment|Postive PPD|4
392130|NCT00107991|1244553|P1|Eligibility Assessment|Unwilling to participate|7
392131|NCT00107991|1244553|P1|Eligibility Assessment|Disease not severe enough|7
392132|NCT00107978|1244563|P2|Overall Study|Other|4
392133|NCT00107978|1244564|P1|Overall Study|Other|5
392134|NCT00107978|1244563|P2|Overall Study|Protocol Violation|1
392135|NCT00107978|1244564|P1|Overall Study|Protocol Violation|0
392136|NCT00107978|1244563|P2|Overall Study|Withdrawal by Subject|9
392137|NCT00107978|1244564|P1|Overall Study|Withdrawal by Subject|4
392138|NCT00107978|1244563|P2|Overall Study|Lost to Follow-up|28
392139|NCT00107978|1244564|P1|Overall Study|Lost to Follow-up|20
392140|NCT00107978|1244563|P2|Overall Study|Death|3
392141|NCT00107978|1244564|P1|Overall Study|Death|3
392142|NCT00107978|1244563|P2|Overall Study|Adverse Event|5
392143|NCT00107978|1244564|P1|Overall Study|Adverse Event|1
392144|NCT00107952|1244572|P2|Overall Study|Never received study treatment|6
392145|NCT00107952|1244573|P1|Overall Study|Never received study treatment|9
392146|NCT00107952|1244572|P2|Overall Study|Other|5
392147|NCT00107952|1244573|P1|Overall Study|Other|2
392148|NCT00107952|1244572|P2|Overall Study|Withdrawal by Subject|6
392149|NCT00107952|1244573|P1|Overall Study|Withdrawal by Subject|9
392150|NCT00107952|1244572|P2|Overall Study|Lost to Follow-up|3
392151|NCT00107952|1244573|P1|Overall Study|Lost to Follow-up|0
392152|NCT00107952|1244572|P2|Overall Study|Death|61
392153|NCT00107952|1244573|P1|Overall Study|Death|75
392154|NCT00107900|1244585|P6|Overall Study|Administrative Reasons|0
392155|NCT00107900|1244586|P5|Overall Study|Administrative Reasons|2
392156|NCT00107900|1244587|P4|Overall Study|Administrative Reasons|2
392157|NCT00107900|1244588|P3|Overall Study|Administrative Reasons|2
392158|NCT00107900|1244589|P2|Overall Study|Administrative Reasons|0
392159|NCT00107900|1244590|P1|Overall Study|Administrative Reasons|1
392160|NCT00107900|1244585|P6|Overall Study|Withdrawal by Subject|1
392161|NCT00107900|1244586|P5|Overall Study|Withdrawal by Subject|1
392162|NCT00107900|1244587|P4|Overall Study|Withdrawal by Subject|0
392163|NCT00107900|1244588|P3|Overall Study|Withdrawal by Subject|5
392164|NCT00107900|1244589|P2|Overall Study|Withdrawal by Subject|0
392165|NCT00107900|1244590|P1|Overall Study|Withdrawal by Subject|1
392166|NCT00107900|1244585|P6|Overall Study|Protocol Violation|0
392167|NCT00107900|1244586|P5|Overall Study|Protocol Violation|7
392168|NCT00107900|1244587|P4|Overall Study|Protocol Violation|5
392169|NCT00107900|1244588|P3|Overall Study|Protocol Violation|5
392170|NCT00107900|1244589|P2|Overall Study|Protocol Violation|0
392171|NCT00107900|1244590|P1|Overall Study|Protocol Violation|1
392172|NCT00107900|1244585|P6|Overall Study|Lost to Follow-up|5
392173|NCT00107900|1244586|P5|Overall Study|Lost to Follow-up|5
392174|NCT00107900|1244587|P4|Overall Study|Lost to Follow-up|2
392175|NCT00107900|1244588|P3|Overall Study|Lost to Follow-up|3
392176|NCT00107900|1244589|P2|Overall Study|Lost to Follow-up|1
392177|NCT00107900|1244590|P1|Overall Study|Lost to Follow-up|4
392178|NCT00107900|1244585|P6|Overall Study|Death|0
392179|NCT00107900|1244586|P5|Overall Study|Death|1
392180|NCT00107900|1244587|P4|Overall Study|Death|0
392181|NCT00107900|1244588|P3|Overall Study|Death|0
392182|NCT00107900|1244589|P2|Overall Study|Death|0
392183|NCT00107900|1244590|P1|Overall Study|Death|0
392184|NCT00107900|1244585|P6|Overall Study|Adverse Event|3
392185|NCT00107900|1244586|P5|Overall Study|Adverse Event|5
392186|NCT00107900|1244587|P4|Overall Study|Adverse Event|3
392187|NCT00107900|1244588|P3|Overall Study|Adverse Event|10
392188|NCT00107900|1244589|P2|Overall Study|Adverse Event|2
392189|NCT00107900|1244590|P1|Overall Study|Adverse Event|3
392190|NCT00107783|1244624|P2|Overall Study|Second hip replacement|1
392191|NCT00107783|1244625|P1|Overall Study|Second hip replacement|1
392192|NCT00107783|1244624|P2|Overall Study|Withdrawal by Subject|0
392193|NCT00107783|1244625|P1|Overall Study|Withdrawal by Subject|2
392194|NCT00107783|1244624|P2|Overall Study|Death|1
392195|NCT00107783|1244625|P1|Overall Study|Death|0
392196|NCT00107783|1244624|P2|Overall Study|Adverse Event|2
392197|NCT00107783|1244625|P1|Overall Study|Adverse Event|0
392198|NCT00107653|1244641|P2|Overall Study|Administrative Reasons|3
392199|NCT00107653|1244642|P1|Overall Study|Administrative Reasons|3
392200|NCT00107653|1244641|P2|Overall Study|Lost to Follow-up|5
392201|NCT00107653|1244642|P1|Overall Study|Lost to Follow-up|13
392202|NCT00107653|1244641|P2|Overall Study|Withdrawal by Subject|13
392203|NCT00107653|1244642|P1|Overall Study|Withdrawal by Subject|12
392204|NCT00107653|1244641|P2|Overall Study|Protocol Violation|0
392205|NCT00107653|1244642|P1|Overall Study|Protocol Violation|1
392206|NCT00107653|1244641|P2|Overall Study|Violation of Selection Criteria at Entry|1
392207|NCT00107653|1244642|P1|Overall Study|Violation of Selection Criteria at Entry|1
392208|NCT00107653|1244641|P2|Overall Study|Insufficient Therapeutic Response|11
392209|NCT00107653|1244642|P1|Overall Study|Insufficient Therapeutic Response|25
392210|NCT00107653|1244641|P2|Overall Study|Adverse Event|43
392211|NCT00107653|1244642|P1|Overall Study|Adverse Event|24
392212|NCT00107614|1244688|P1|Overall Study|Death|2
392213|NCT00107614|1244688|P1|Overall Study|Physician Decision|10
392214|NCT00107380|1244719|P1|Overall Study|Ineligible|2
392215|NCT00107380|1244719|P1|Overall Study|Other - not protocol specified|7
392216|NCT00107380|1244719|P1|Overall Study|Death|3
392217|NCT00107380|1244719|P1|Overall Study|Progression/relapse|4
392218|NCT00107380|1244719|P1|Overall Study|Refusal Unrelated to Adverse Event|7
392219|NCT00107380|1244719|P1|Overall Study|Adverse Event|7
392220|NCT00107315|1244725|P1|Overall Study|Withdrawal by Subject|2
392221|NCT00107315|1244725|P1|Overall Study|Adverse Event|4
392222|NCT00107315|1244725|P1|Overall Study|Disease Progression|9
392223|NCT00107276|1244732|P1|Overall Study|Ineligible|16
392224|NCT00107276|1244732|P1|Overall Study|Death|1
392225|NCT00107276|1244732|P1|Overall Study|Patient refusal|1
392226|NCT00107276|1244732|P1|Overall Study|M.D. decision|2
392227|NCT00107276|1244732|P1|Overall Study|Adverse Event|6
392228|NCT00107276|1244732|P1|Overall Study|Progression|46
392229|NCT00107198|1244738|P1|Overall Study|Ineligible|5
392230|NCT00107198|1244738|P1|Overall Study|Withdrawal by Subject|6
392231|NCT00107198|1244738|P1|Overall Study|Protocol Violation|1
392232|NCT00107198|1244738|P1|Overall Study|Lost to Follow-up|12
392233|NCT00107198|1244738|P1|Overall Study|Lack of Efficacy|28
392234|NCT00106704|1244748|P2|Overall Study|Laboratory test|1
392235|NCT00106704|1244749|P1|Overall Study|Laboratory test|1
392236|NCT00106704|1244748|P2|Overall Study|Unable to re-enter US|0
392237|NCT00106704|1244749|P1|Overall Study|Unable to re-enter US|1
392238|NCT00106704|1244748|P2|Overall Study|Patient Received Glycemic Medication|41
392239|NCT00106704|1244749|P1|Overall Study|Patient Received Glycemic Medication|22
392240|NCT00106704|1244748|P2|Overall Study|Planned major surgery|0
392241|NCT00106704|1244749|P1|Overall Study|Planned major surgery|1
392242|NCT00106704|1244748|P2|Overall Study|Site terminated|1
392243|NCT00106704|1244749|P1|Overall Study|Site terminated|0
392244|NCT00106704|1244748|P2|Overall Study|Patient moved|0
392245|NCT00106704|1244749|P1|Overall Study|Patient moved|1
392246|NCT00106704|1244748|P2|Overall Study|Withdrawal by Subject|21
392247|NCT00106704|1244749|P1|Overall Study|Withdrawal by Subject|14
392248|NCT00106704|1244748|P2|Overall Study|Protocol Violation|7
392249|NCT00106704|1244749|P1|Overall Study|Protocol Violation|4
392250|NCT00106704|1244748|P2|Overall Study|Pregnancy|0
392251|NCT00106704|1244749|P1|Overall Study|Pregnancy|1
392252|NCT00106704|1244748|P2|Overall Study|Lost to Follow-up|3
392253|NCT00106704|1244749|P1|Overall Study|Lost to Follow-up|7
392254|NCT00106704|1244748|P2|Overall Study|Lack of Efficacy|69
392255|NCT00106704|1244749|P1|Overall Study|Lack of Efficacy|67
392256|NCT00106704|1244748|P2|Overall Study|Death|1
392257|NCT00106704|1244749|P1|Overall Study|Death|2
392258|NCT00106704|1244748|P2|Overall Study|Adverse Event|7
392259|NCT00106704|1244749|P1|Overall Study|Adverse Event|10
392260|NCT00106639|1244760|P3|Overall Study|Participant defaulted|1
392261|NCT00106639|1244761|P2|Overall Study|Participant defaulted|1
392262|NCT00106639|1244762|P1|Overall Study|Participant defaulted|0
392263|NCT00106639|1244760|P3|Overall Study|Withdrawal by Subject|0
392264|NCT00106639|1244761|P2|Overall Study|Withdrawal by Subject|1
392265|NCT00106639|1244762|P1|Overall Study|Withdrawal by Subject|0
392266|NCT00106639|1244760|P3|Overall Study|Protocol Violation|0
392267|NCT00106639|1244761|P2|Overall Study|Protocol Violation|1
392268|NCT00106639|1244762|P1|Overall Study|Protocol Violation|0
392269|NCT00106639|1244760|P3|Overall Study|Adverse Event|1
392270|NCT00106639|1244761|P2|Overall Study|Adverse Event|4
392271|NCT00106639|1244762|P1|Overall Study|Adverse Event|3
392272|NCT00106626|1244889|P4|Overall Study|> 14 day delay in therapy start|0
392273|NCT00106626|1244890|P3|Overall Study|> 14 day delay in therapy start|0
392274|NCT00106626|1244891|P2|Overall Study|> 14 day delay in therapy start|1
392275|NCT00106626|1244892|P1|Overall Study|> 14 day delay in therapy start|0
392276|NCT00106626|1244889|P4|Overall Study|Received radiation on new therapy|0
392277|NCT00106626|1244890|P3|Overall Study|Received radiation on new therapy|0
392278|NCT00106626|1244891|P2|Overall Study|Received radiation on new therapy|0
392279|NCT00106626|1244892|P1|Overall Study|Received radiation on new therapy|1
392280|NCT00106626|1244889|P4|Overall Study|Progressive Disease|10
392281|NCT00106626|1244890|P3|Overall Study|Progressive Disease|9
392282|NCT00106626|1244891|P2|Overall Study|Progressive Disease|1
392283|NCT00106626|1244892|P1|Overall Study|Progressive Disease|4
392284|NCT00106626|1244889|P4|Overall Study|Adverse Event|3
392285|NCT00106626|1244890|P3|Overall Study|Adverse Event|3
392286|NCT00106626|1244891|P2|Overall Study|Adverse Event|4
392287|NCT00106626|1244892|P1|Overall Study|Adverse Event|5
392288|NCT00106353|1245237|P7|Part 2|Physician Decision|0
392289|NCT00106353|1245238|P6|Part 2|Physician Decision|1
392290|NCT00106353|1245239|P5|Part 2|Physician Decision|0
392291|NCT00106353|1245240|P4|Part 2|Physician Decision|0
392292|NCT00106353|1245241|P3|Part 2|Physician Decision|0
392293|NCT00106353|1245242|P2|Part 2|Physician Decision|0
392294|NCT00106353|1245243|P1|Part 2|Physician Decision|0
392295|NCT00106353|1245237|P7|Part 2|Withdrawal by Subject|0
392296|NCT00106353|1245238|P6|Part 2|Withdrawal by Subject|0
392297|NCT00106353|1245239|P5|Part 2|Withdrawal by Subject|1
392298|NCT00106353|1245240|P4|Part 2|Withdrawal by Subject|0
392299|NCT00106353|1245241|P3|Part 2|Withdrawal by Subject|0
392300|NCT00106353|1245242|P2|Part 2|Withdrawal by Subject|0
392301|NCT00106353|1245243|P1|Part 2|Withdrawal by Subject|0
392302|NCT00106353|1245237|P7|Part 2|Unspecified|1
392303|NCT00106353|1245238|P6|Part 2|Unspecified|1
392304|NCT00106353|1245239|P5|Part 2|Unspecified|1
392305|NCT00106353|1245240|P4|Part 2|Unspecified|0
392306|NCT00106353|1245241|P3|Part 2|Unspecified|0
392307|NCT00106353|1245242|P2|Part 2|Unspecified|0
392308|NCT00106353|1245243|P1|Part 2|Unspecified|0
392309|NCT00106353|1245237|P7|Part 2|Adverse Event|1
392310|NCT00106353|1245238|P6|Part 2|Adverse Event|2
392311|NCT00106353|1245239|P5|Part 2|Adverse Event|0
392312|NCT00106353|1245240|P4|Part 2|Adverse Event|0
392313|NCT00106353|1245241|P3|Part 2|Adverse Event|0
392314|NCT00106353|1245242|P2|Part 2|Adverse Event|0
392315|NCT00106353|1245243|P1|Part 2|Adverse Event|0
392316|NCT00106353|1245237|P7|Part 2|Symptomatic deterioration|0
392317|NCT00106353|1245238|P6|Part 2|Symptomatic deterioration|0
392318|NCT00106353|1245239|P5|Part 2|Symptomatic deterioration|3
392319|NCT00106353|1245240|P4|Part 2|Symptomatic deterioration|0
392320|NCT00106353|1245241|P3|Part 2|Symptomatic deterioration|0
392321|NCT00106353|1245242|P2|Part 2|Symptomatic deterioration|0
392322|NCT00106353|1245243|P1|Part 2|Symptomatic deterioration|0
392323|NCT00106353|1245237|P7|Part 2|Death|1
392324|NCT00106353|1245238|P6|Part 2|Death|0
392325|NCT00106353|1245239|P5|Part 2|Death|3
392326|NCT00106353|1245240|P4|Part 2|Death|0
392327|NCT00106353|1245241|P3|Part 2|Death|0
392328|NCT00106353|1245242|P2|Part 2|Death|0
392329|NCT00106353|1245243|P1|Part 2|Death|0
392330|NCT00106353|1245237|P7|Part 2|Disease progression|13
392331|NCT00106353|1245238|P6|Part 2|Disease progression|14
392332|NCT00106353|1245239|P5|Part 2|Disease progression|8
392333|NCT00106353|1245240|P4|Part 2|Disease progression|0
392334|NCT00106353|1245241|P3|Part 2|Disease progression|0
392335|NCT00106353|1245242|P2|Part 2|Disease progression|0
392336|NCT00106353|1245243|P1|Part 2|Disease progression|0
392337|NCT00106353|1245237|P7|Part 1|Adverse Event|0
392338|NCT00106353|1245238|P6|Part 1|Adverse Event|0
392339|NCT00106353|1245239|P5|Part 1|Adverse Event|0
392340|NCT00106353|1245240|P4|Part 1|Adverse Event|1
392341|NCT00106353|1245241|P3|Part 1|Adverse Event|0
392342|NCT00106353|1245242|P2|Part 1|Adverse Event|0
392343|NCT00106353|1245243|P1|Part 1|Adverse Event|0
392344|NCT00106353|1245237|P7|Part 1|Entered follow-up phase|0
392345|NCT00106353|1245238|P6|Part 1|Entered follow-up phase|0
392346|NCT00106353|1245239|P5|Part 1|Entered follow-up phase|0
392347|NCT00106353|1245240|P4|Part 1|Entered follow-up phase|1
392348|NCT00106353|1245241|P3|Part 1|Entered follow-up phase|0
392349|NCT00106353|1245242|P2|Part 1|Entered follow-up phase|1
392350|NCT00106353|1245243|P1|Part 1|Entered follow-up phase|1
392351|NCT00106353|1245237|P7|Part 1|Symptomatic deterioration|0
392352|NCT00106353|1245238|P6|Part 1|Symptomatic deterioration|0
392353|NCT00106353|1245239|P5|Part 1|Symptomatic deterioration|0
392354|NCT00106353|1245240|P4|Part 1|Symptomatic deterioration|0
392355|NCT00106353|1245241|P3|Part 1|Symptomatic deterioration|1
392356|NCT00106353|1245242|P2|Part 1|Symptomatic deterioration|0
392357|NCT00106353|1245243|P1|Part 1|Symptomatic deterioration|0
392358|NCT00106353|1245237|P7|Part 1|Withdrawal by Subject|0
392359|NCT00106353|1245238|P6|Part 1|Withdrawal by Subject|0
392360|NCT00106353|1245239|P5|Part 1|Withdrawal by Subject|0
392361|NCT00106353|1245240|P4|Part 1|Withdrawal by Subject|2
392362|NCT00106353|1245241|P3|Part 1|Withdrawal by Subject|1
392363|NCT00106353|1245242|P2|Part 1|Withdrawal by Subject|0
392364|NCT00106353|1245243|P1|Part 1|Withdrawal by Subject|0
392365|NCT00106353|1245237|P7|Part 1|Disease progression|0
392366|NCT00106353|1245238|P6|Part 1|Disease progression|0
392367|NCT00106353|1245239|P5|Part 1|Disease progression|0
392368|NCT00106353|1245240|P4|Part 1|Disease progression|3
392369|NCT00106353|1245241|P3|Part 1|Disease progression|1
392370|NCT00106353|1245242|P2|Part 1|Disease progression|4
392371|NCT00106353|1245243|P1|Part 1|Disease progression|3
392372|NCT00106249|1245370|P2|Overall Study|Lost to Follow-up|2
392373|NCT00106249|1245371|P1|Overall Study|Lost to Follow-up|3
392374|NCT00106184|1245383|P2|Overall Study|Withdrawal by Subject|2
392375|NCT00106184|1245384|P1|Overall Study|Withdrawal by Subject|3
392376|NCT00106080|1245426|P2|Overall Study|Withdrew/Loss to follow-up|27
392377|NCT00106080|1245427|P1|Overall Study|Withdrew/Loss to follow-up|43
392378|NCT00106028|1245437|P2|Overall Study|Lost to Follow-up|1
392379|NCT00106028|1245438|P1|Overall Study|Lost to Follow-up|0
392380|NCT00106028|1245437|P2|Overall Study|Withdrawal by Subject|8
392381|NCT00106028|1245438|P1|Overall Study|Withdrawal by Subject|2
392382|NCT00106028|1245437|P2|Overall Study|Protocol Violation|1
392383|NCT00106028|1245438|P1|Overall Study|Protocol Violation|1
392384|NCT00106028|1245437|P2|Overall Study|Adverse Event|2
392385|NCT00106028|1245438|P1|Overall Study|Adverse Event|3
392386|NCT00106002|1245532|P1|Overall Study|Ineligible after Registration|1
392387|NCT00106002|1245532|P1|Overall Study|Did not take any study drug|1
392388|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
392389|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
392390|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
392391|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
392392|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Death|0
392393|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Death|0
392394|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
392395|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
392396|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
392397|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
392398|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
392399|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
392400|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
392401|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
392402|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
392403|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
392404|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
392405|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
392406|NCT00105989|1245540|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
392407|NCT00105989|1245541|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
392408|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
392409|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
392410|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
392411|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
392412|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Death|0
392413|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Death|0
392414|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
392415|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
392416|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
392417|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
392418|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
392419|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
392420|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
392421|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
392422|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
392423|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
392424|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
392425|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
392426|NCT00105989|1245540|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
392427|NCT00105989|1245541|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
392428|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
392429|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
392430|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
392431|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
392432|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Death|0
392433|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Death|1
392434|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Physician Decision|0
392435|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Physician Decision|0
392436|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
392437|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
392438|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
392439|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
392440|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
392441|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
392442|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
392443|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
392444|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
392445|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
392446|NCT00105989|1245540|P2|Acute - Open Label: Week 0-10|Adverse Event|0
392447|NCT00105989|1245541|P1|Acute - Open Label: Week 0-10|Adverse Event|33
392448|NCT00105586|1245657|P2|Overall Study|Physician Decision|13
392449|NCT00105586|1245658|P1|Overall Study|Physician Decision|13
392450|NCT00105586|1245657|P2|Overall Study|Adverse Event|3
392451|NCT00105586|1245658|P1|Overall Study|Adverse Event|4
392452|NCT00105534|1245668|P2|Overall Study|Other Reason|2
392453|NCT00105534|1245669|P1|Overall Study|Other Reason|0
392454|NCT00105534|1245668|P2|Overall Study|Treatment unmasked|0
392455|NCT00105534|1245669|P1|Overall Study|Treatment unmasked|1
392456|NCT00105534|1245668|P2|Overall Study|Lack of Efficacy|15
392457|NCT00105534|1245669|P1|Overall Study|Lack of Efficacy|7
392458|NCT00105534|1245668|P2|Overall Study|Lost to Follow-up|1
392459|NCT00105534|1245669|P1|Overall Study|Lost to Follow-up|5
392460|NCT00105534|1245668|P2|Overall Study|Withdrawal by Subject|6
392461|NCT00105534|1245669|P1|Overall Study|Withdrawal by Subject|6
392462|NCT00105534|1245668|P2|Overall Study|Protocol Violation|4
392463|NCT00105534|1245669|P1|Overall Study|Protocol Violation|1
392464|NCT00105534|1245668|P2|Overall Study|Adverse Event|5
392465|NCT00105534|1245669|P1|Overall Study|Adverse Event|2
392466|NCT00105482|1245679|P2|Overall Study|Withdrawn by PI|1
392467|NCT00105482|1245680|P1|Overall Study|Withdrawn by PI|1
392468|NCT00105482|1245679|P2|Overall Study|Scheduling Conflict|3
392469|NCT00105482|1245680|P1|Overall Study|Scheduling Conflict|2
392470|NCT00105482|1245679|P2|Overall Study|Lost Interest|32
392471|NCT00105482|1245680|P1|Overall Study|Lost Interest|29
392472|NCT00105482|1245679|P2|Overall Study|Withdrawal by Subject|1
392473|NCT00105482|1245680|P1|Overall Study|Withdrawal by Subject|0
392474|NCT00105482|1245679|P2|Overall Study|Lost to Follow-up|17
392475|NCT00105482|1245680|P1|Overall Study|Lost to Follow-up|26
392476|NCT00105482|1245679|P2|Overall Study|Adverse Event|1
392477|NCT00105482|1245680|P1|Overall Study|Adverse Event|1
392478|NCT00105469|1245696|P2|Overall Study|Other Reason|0
392479|NCT00105469|1245697|P1|Overall Study|Other Reason|4
392480|NCT00105469|1245696|P2|Overall Study|Lack of Efficacy|0
392481|NCT00105469|1245697|P1|Overall Study|Lack of Efficacy|2
392482|NCT00105469|1245696|P2|Overall Study|Lost to Follow-up|0
392483|NCT00105469|1245697|P1|Overall Study|Lost to Follow-up|1
392484|NCT00105469|1245696|P2|Overall Study|Withdrawal by Subject|3
392485|NCT00105469|1245697|P1|Overall Study|Withdrawal by Subject|2
392486|NCT00105469|1245696|P2|Overall Study|Protocol Violation|0
392487|NCT00105469|1245697|P1|Overall Study|Protocol Violation|4
392488|NCT00105469|1245696|P2|Overall Study|Adverse Event|8
392489|NCT00105469|1245697|P1|Overall Study|Adverse Event|9
392490|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
392491|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
392492|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
392493|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
392494|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
392495|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
392496|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
392497|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
392498|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
392499|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
392500|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
392501|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
392502|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
392503|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
392504|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
392505|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
392506|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
392507|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
392508|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
392509|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
392510|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
392511|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
392512|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
392513|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
392514|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
392515|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
392516|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
392517|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
392518|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
392519|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
392520|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
392521|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
392522|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
392523|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
392524|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
392525|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
392526|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
392527|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
392528|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
392529|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
392530|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
392531|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
392532|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
392533|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
392534|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
392535|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
392536|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
392537|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
392538|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
392539|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
392540|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
392541|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
392542|NCT00105443|1245707|P4|Follow-up and/or Open Label Nexavar|Death|4
392543|NCT00105443|1245708|P3|Follow-up and/or Open Label Nexavar|Death|219
392544|NCT00105443|1245709|P2|Follow-up and/or Open Label Nexavar|Death|7
392545|NCT00105443|1245710|P1|Follow-up and/or Open Label Nexavar|Death|180
392546|NCT00105443|1245707|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
392547|NCT00105443|1245708|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
392548|NCT00105443|1245709|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
392549|NCT00105443|1245710|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
392550|NCT00105443|1245707|P4|Double-Blind Treatment|Physician Decision|0
392551|NCT00105443|1245708|P3|Double-Blind Treatment|Physician Decision|2
392552|NCT00105443|1245709|P2|Double-Blind Treatment|Physician Decision|0
392553|NCT00105443|1245710|P1|Double-Blind Treatment|Physician Decision|1
392554|NCT00105443|1245707|P4|Double-Blind Treatment|Withdrawal by Subject|0
392555|NCT00105443|1245708|P3|Double-Blind Treatment|Withdrawal by Subject|7
392556|NCT00105443|1245709|P2|Double-Blind Treatment|Withdrawal by Subject|0
392557|NCT00105443|1245710|P1|Double-Blind Treatment|Withdrawal by Subject|8
392558|NCT00105443|1245707|P4|Double-Blind Treatment|Lost to Follow-up|0
392559|NCT00105443|1245708|P3|Double-Blind Treatment|Lost to Follow-up|1
392560|NCT00105443|1245709|P2|Double-Blind Treatment|Lost to Follow-up|0
392561|NCT00105443|1245710|P1|Double-Blind Treatment|Lost to Follow-up|0
392562|NCT00105443|1245707|P4|Double-Blind Treatment|Adverse Event|0
392563|NCT00105443|1245708|P3|Double-Blind Treatment|Adverse Event|0
392564|NCT00105443|1245709|P2|Double-Blind Treatment|Adverse Event|0
392565|NCT00105443|1245710|P1|Double-Blind Treatment|Adverse Event|1
392566|NCT00105235|1245737|P1|Overall Study|Withdrawal by Subject|2
392567|NCT00105235|1245737|P1|Overall Study|Physician Decision|1
392568|NCT00105235|1245737|P1|Overall Study|Death|4
392569|NCT00105196|1245750|P2|Overall Study|Subject became unblinded|1
392570|NCT00105196|1245751|P1|Overall Study|Subject became unblinded|0
392571|NCT00105196|1245750|P2|Overall Study|marijuana use|1
392572|NCT00105196|1245751|P1|Overall Study|marijuana use|0
392573|NCT00105196|1245750|P2|Overall Study|pending surgery|1
392574|NCT00105196|1245751|P1|Overall Study|pending surgery|0
392575|NCT00105196|1245750|P2|Overall Study|Protocol Violation|2
392576|NCT00105196|1245751|P1|Overall Study|Protocol Violation|5
392577|NCT00105196|1245750|P2|Overall Study|Poor/noncompliance|4
392578|NCT00105196|1245751|P1|Overall Study|Poor/noncompliance|3
392579|NCT00105196|1245750|P2|Overall Study|Lost to Follow-up|2
392580|NCT00105196|1245751|P1|Overall Study|Lost to Follow-up|3
392581|NCT00105196|1245750|P2|Overall Study|Withdrawal by Subject|6
392582|NCT00105196|1245751|P1|Overall Study|Withdrawal by Subject|6
392583|NCT00105196|1245750|P2|Overall Study|Adverse Event|3
392584|NCT00105196|1245751|P1|Overall Study|Adverse Event|11
392585|NCT00105196|1245750|P2|Overall Study|Lack of Efficacy|3
392586|NCT00105196|1245751|P1|Overall Study|Lack of Efficacy|2
392587|NCT00105183|1245774|P3|Overall Study|Other reason|0
392588|NCT00105183|1245775|P2|Overall Study|Other reason|2
392589|NCT00105183|1245776|P1|Overall Study|Other reason|1
392590|NCT00105183|1245774|P3|Overall Study|Lost to Follow-up|1
392591|NCT00105183|1245775|P2|Overall Study|Lost to Follow-up|1
392592|NCT00105183|1245776|P1|Overall Study|Lost to Follow-up|0
392593|NCT00105183|1245774|P3|Overall Study|Physician Decision|3
392594|NCT00105183|1245775|P2|Overall Study|Physician Decision|2
392595|NCT00105183|1245776|P1|Overall Study|Physician Decision|1
392596|NCT00105183|1245774|P3|Overall Study|Withdrawal by Subject|4
392597|NCT00105183|1245775|P2|Overall Study|Withdrawal by Subject|1
392598|NCT00105183|1245776|P1|Overall Study|Withdrawal by Subject|1
392599|NCT00105183|1245774|P3|Overall Study|Death|15
392600|NCT00105183|1245775|P2|Overall Study|Death|13
392601|NCT00105183|1245776|P1|Overall Study|Death|19
392602|NCT00105157|1245812|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
392603|NCT00105157|1245813|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
392604|NCT00105157|1245814|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
392605|NCT00105157|1245815|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
392606|NCT00105157|1245812|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
392607|NCT00105157|1245813|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
392608|NCT00105157|1245814|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
392609|NCT00105157|1245815|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
392610|NCT00105157|1245812|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
392611|NCT00105157|1245813|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
392612|NCT00105157|1245814|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
392613|NCT00105157|1245815|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
392614|NCT00105157|1245812|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
392615|NCT00105157|1245813|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
392616|NCT00105157|1245814|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
392617|NCT00105157|1245815|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
392618|NCT00105157|1245812|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
392619|NCT00105157|1245813|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
392620|NCT00105157|1245814|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
392621|NCT00105157|1245815|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
392622|NCT00105157|1245812|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
392623|NCT00105157|1245813|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
392624|NCT00105157|1245814|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
392625|NCT00105157|1245815|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
392626|NCT00105157|1245812|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
392627|NCT00105157|1245813|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
392628|NCT00105157|1245814|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
392629|NCT00105157|1245815|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
392630|NCT00105157|1245812|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
392631|NCT00105157|1245813|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
392632|NCT00105157|1245814|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
392633|NCT00105157|1245815|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
392634|NCT00105157|1245812|P4|Open-Label Continuation of DB|Lost to Follow-up|0
392635|NCT00105157|1245813|P3|Open-Label Continuation of DB|Lost to Follow-up|1
392636|NCT00105157|1245814|P2|Open-Label Continuation of DB|Lost to Follow-up|1
392637|NCT00105157|1245815|P1|Open-Label Continuation of DB|Lost to Follow-up|1
392638|NCT00105157|1245812|P4|Open-Label Continuation of DB|Lack of Efficacy|1
392639|NCT00105157|1245813|P3|Open-Label Continuation of DB|Lack of Efficacy|3
392640|NCT00105157|1245814|P2|Open-Label Continuation of DB|Lack of Efficacy|4
392641|NCT00105157|1245815|P1|Open-Label Continuation of DB|Lack of Efficacy|1
392642|NCT00105157|1245812|P4|Open-Label Continuation of DB|Adverse Event|0
392643|NCT00105157|1245813|P3|Open-Label Continuation of DB|Adverse Event|0
392644|NCT00105157|1245814|P2|Open-Label Continuation of DB|Adverse Event|1
392645|NCT00105157|1245815|P1|Open-Label Continuation of DB|Adverse Event|3
392646|NCT00105157|1245812|P4|Double-Blind (DB)|Lack of Efficacy|38
392647|NCT00105157|1245813|P3|Double-Blind (DB)|Lack of Efficacy|11
392648|NCT00105157|1245814|P2|Double-Blind (DB)|Lack of Efficacy|14
392649|NCT00105157|1245815|P1|Double-Blind (DB)|Lack of Efficacy|11
392650|NCT00105157|1245812|P4|Double-Blind (DB)|Adverse Event|1
392651|NCT00105157|1245813|P3|Double-Blind (DB)|Adverse Event|1
392652|NCT00105157|1245814|P2|Double-Blind (DB)|Adverse Event|0
392653|NCT00105157|1245815|P1|Double-Blind (DB)|Adverse Event|2
392654|NCT00105157|1245812|P4|Double-Blind (DB)|Never Treated|0
392655|NCT00105157|1245813|P3|Double-Blind (DB)|Never Treated|0
392656|NCT00105157|1245814|P2|Double-Blind (DB)|Never Treated|0
392657|NCT00105157|1245815|P1|Double-Blind (DB)|Never Treated|1
392658|NCT00105079|1246009|P2|Overall Study|not specified|1
392659|NCT00105079|1246010|P1|Overall Study|not specified|3
392660|NCT00105079|1246009|P2|Overall Study|Protocol Violation|0
392661|NCT00105079|1246010|P1|Overall Study|Protocol Violation|1
392662|NCT00105079|1246009|P2|Overall Study|Violation of selection criteria at entry|2
392663|NCT00105079|1246010|P1|Overall Study|Violation of selection criteria at entry|0
392664|NCT00105079|1246009|P2|Overall Study|Refused treatment|4
392665|NCT00105079|1246010|P1|Overall Study|Refused treatment|6
392666|NCT00105079|1246009|P2|Overall Study|Lack of Efficacy|3
392667|NCT00105079|1246010|P1|Overall Study|Lack of Efficacy|9
392668|NCT00105079|1246009|P2|Overall Study|Lost to Follow-up|12
392669|NCT00105079|1246010|P1|Overall Study|Lost to Follow-up|12
392670|NCT00105079|1246009|P2|Overall Study|Death|1
392671|NCT00105079|1246010|P1|Overall Study|Death|3
392672|NCT00105079|1246009|P2|Overall Study|Adverse Event|12
392673|NCT00105079|1246010|P1|Overall Study|Adverse Event|5
392674|NCT00105066|1246028|P2|Overall Study|Adverse Event|5
392675|NCT00105066|1246029|P1|Overall Study|Adverse Event|2
392676|NCT00104884|1246089|P1|Overall Study|Disease progression|4
392677|NCT00104871|1246093|P1|Overall Study|Not evaluable|1
392678|NCT00104728|1246098|P1|Overall Study|screen failures|19
392679|NCT00104650|1246106|P3|Follow-up Period|Other|0
392680|NCT00104650|1246107|P2|Follow-up Period|Other|1
392681|NCT00104650|1246108|P1|Follow-up Period|Other|0
392682|NCT00104650|1246106|P3|Follow-up Period|Lost to Follow-up|2
392683|NCT00104650|1246107|P2|Follow-up Period|Lost to Follow-up|1
392684|NCT00104650|1246108|P1|Follow-up Period|Lost to Follow-up|0
392685|NCT00104650|1246106|P3|Follow-up Period|Disease progression|0
392686|NCT00104650|1246107|P2|Follow-up Period|Disease progression|1
392687|NCT00104650|1246108|P1|Follow-up Period|Disease progression|3
392688|NCT00104650|1246106|P3|Follow-up Period|Death|4
392689|NCT00104650|1246107|P2|Follow-up Period|Death|6
392690|NCT00104650|1246108|P1|Follow-up Period|Death|6
392691|NCT00104650|1246106|P3|Follow-up Period|Withdrawal by Subject|3
392692|NCT00104650|1246107|P2|Follow-up Period|Withdrawal by Subject|3
392693|NCT00104650|1246108|P1|Follow-up Period|Withdrawal by Subject|0
392694|NCT00104650|1246106|P3|Follow-up Period|Adverse Event|1
392695|NCT00104650|1246107|P2|Follow-up Period|Adverse Event|0
392696|NCT00104650|1246108|P1|Follow-up Period|Adverse Event|1
392697|NCT00104650|1246106|P3|Follow-up Period|Physician Decision|0
392698|NCT00104650|1246107|P2|Follow-up Period|Physician Decision|1
392699|NCT00104650|1246108|P1|Follow-up Period|Physician Decision|1
392700|NCT00104650|1246106|P3|Treatment Period (25 Weeks)|Protocol deviation|0
392701|NCT00104650|1246107|P2|Treatment Period (25 Weeks)|Protocol deviation|1
392702|NCT00104650|1246108|P1|Treatment Period (25 Weeks)|Protocol deviation|0
392703|NCT00104650|1246106|P3|Treatment Period (25 Weeks)|Other|0
392704|NCT00104650|1246107|P2|Treatment Period (25 Weeks)|Other|0
392705|NCT00104650|1246108|P1|Treatment Period (25 Weeks)|Other|1
392791|NCT00104416|1246204|P4|Double-Blind Phase|Adverse Event|0
392706|NCT00104650|1246106|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
392707|NCT00104650|1246107|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
392708|NCT00104650|1246108|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
392709|NCT00104650|1246106|P3|Treatment Period (25 Weeks)|Disease progression|2
392710|NCT00104650|1246107|P2|Treatment Period (25 Weeks)|Disease progression|3
392711|NCT00104650|1246108|P1|Treatment Period (25 Weeks)|Disease progression|2
392712|NCT00104650|1246106|P3|Treatment Period (25 Weeks)|Death|6
392713|NCT00104650|1246107|P2|Treatment Period (25 Weeks)|Death|5
392714|NCT00104650|1246108|P1|Treatment Period (25 Weeks)|Death|7
392715|NCT00104650|1246106|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
392716|NCT00104650|1246107|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
392717|NCT00104650|1246108|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
392718|NCT00104650|1246106|P3|Treatment Period (25 Weeks)|Physician Decision|1
392719|NCT00104650|1246107|P2|Treatment Period (25 Weeks)|Physician Decision|0
392720|NCT00104650|1246108|P1|Treatment Period (25 Weeks)|Physician Decision|0
392721|NCT00104637|1246140|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
392722|NCT00104637|1246141|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
392723|NCT00104572|1246170|P3|Overall Study|Withdrawal by Subject|0
392724|NCT00104572|1246171|P2|Overall Study|Withdrawal by Subject|3
392725|NCT00104572|1246172|P1|Overall Study|Withdrawal by Subject|3
392726|NCT00104520|1246182|P2|Overall Study|Other|5
392727|NCT00104520|1246183|P1|Overall Study|Other|1
392728|NCT00104520|1246182|P2|Overall Study|Personal/administrative|1
392729|NCT00104520|1246183|P1|Overall Study|Personal/administrative|1
392730|NCT00104520|1246182|P2|Overall Study|Noncompliance|2
392731|NCT00104520|1246183|P1|Overall Study|Noncompliance|0
392732|NCT00104520|1246182|P2|Overall Study|Lost to Follow-up|0
392733|NCT00104520|1246183|P1|Overall Study|Lost to Follow-up|1
392734|NCT00104520|1246182|P2|Overall Study|Related adverse event|15
392735|NCT00104520|1246183|P1|Overall Study|Related adverse event|13
392736|NCT00104520|1246182|P2|Overall Study|Study drug intolerance|1
392737|NCT00104520|1246183|P1|Overall Study|Study drug intolerance|0
392738|NCT00104520|1246182|P2|Overall Study|Unrelated adverse event|47
392739|NCT00104520|1246183|P1|Overall Study|Unrelated adverse event|34
392740|NCT00104416|1246203|P5|Continuation Phase|Non-compliance|1
392741|NCT00104416|1246204|P4|Continuation Phase|Non-compliance|0
392742|NCT00104416|1246205|P3|Continuation Phase|Non-compliance|0
392743|NCT00104416|1246206|P2|Continuation Phase|Non-compliance|0
392744|NCT00104416|1246207|P1|Continuation Phase|Non-compliance|0
392745|NCT00104416|1246203|P5|Continuation Phase|Pregnancy|0
392746|NCT00104416|1246204|P4|Continuation Phase|Pregnancy|1
392747|NCT00104416|1246205|P3|Continuation Phase|Pregnancy|1
392748|NCT00104416|1246206|P2|Continuation Phase|Pregnancy|0
392749|NCT00104416|1246207|P1|Continuation Phase|Pregnancy|0
392750|NCT00104416|1246203|P5|Continuation Phase|Withdrawal by Subject|1
392751|NCT00104416|1246204|P4|Continuation Phase|Withdrawal by Subject|1
392752|NCT00104416|1246205|P3|Continuation Phase|Withdrawal by Subject|2
392753|NCT00104416|1246206|P2|Continuation Phase|Withdrawal by Subject|0
392754|NCT00104416|1246207|P1|Continuation Phase|Withdrawal by Subject|0
392755|NCT00104416|1246203|P5|Continuation Phase|Lost to Follow-up|1
392756|NCT00104416|1246204|P4|Continuation Phase|Lost to Follow-up|0
392757|NCT00104416|1246205|P3|Continuation Phase|Lost to Follow-up|1
392758|NCT00104416|1246206|P2|Continuation Phase|Lost to Follow-up|0
392759|NCT00104416|1246207|P1|Continuation Phase|Lost to Follow-up|0
392760|NCT00104416|1246203|P5|Continuation Phase|Adverse Event|2
392761|NCT00104416|1246204|P4|Continuation Phase|Adverse Event|0
392762|NCT00104416|1246205|P3|Continuation Phase|Adverse Event|2
392763|NCT00104416|1246206|P2|Continuation Phase|Adverse Event|0
392764|NCT00104416|1246207|P1|Continuation Phase|Adverse Event|0
392765|NCT00104416|1246203|P5|Double-Blind Phase|Participant Did Not Take Drug|0
392766|NCT00104416|1246204|P4|Double-Blind Phase|Participant Did Not Take Drug|0
392767|NCT00104416|1246205|P3|Double-Blind Phase|Participant Did Not Take Drug|0
392768|NCT00104416|1246206|P2|Double-Blind Phase|Participant Did Not Take Drug|4
392769|NCT00104416|1246207|P1|Double-Blind Phase|Participant Did Not Take Drug|3
392770|NCT00104416|1246203|P5|Double-Blind Phase|Pregnancy|0
392771|NCT00104416|1246204|P4|Double-Blind Phase|Pregnancy|0
392772|NCT00104416|1246205|P3|Double-Blind Phase|Pregnancy|0
392773|NCT00104416|1246206|P2|Double-Blind Phase|Pregnancy|0
392774|NCT00104416|1246207|P1|Double-Blind Phase|Pregnancy|1
392775|NCT00104416|1246203|P5|Double-Blind Phase|Withdrawal by Subject|0
392776|NCT00104416|1246204|P4|Double-Blind Phase|Withdrawal by Subject|0
392777|NCT00104416|1246205|P3|Double-Blind Phase|Withdrawal by Subject|0
392778|NCT00104416|1246206|P2|Double-Blind Phase|Withdrawal by Subject|3
392779|NCT00104416|1246207|P1|Double-Blind Phase|Withdrawal by Subject|2
392780|NCT00104416|1246203|P5|Double-Blind Phase|Protocol Violation|0
392781|NCT00104416|1246204|P4|Double-Blind Phase|Protocol Violation|0
392782|NCT00104416|1246205|P3|Double-Blind Phase|Protocol Violation|0
392783|NCT00104416|1246206|P2|Double-Blind Phase|Protocol Violation|1
392784|NCT00104416|1246207|P1|Double-Blind Phase|Protocol Violation|0
392785|NCT00104416|1246203|P5|Double-Blind Phase|Lost to Follow-up|0
392786|NCT00104416|1246204|P4|Double-Blind Phase|Lost to Follow-up|0
392787|NCT00104416|1246205|P3|Double-Blind Phase|Lost to Follow-up|0
392788|NCT00104416|1246206|P2|Double-Blind Phase|Lost to Follow-up|1
392789|NCT00104416|1246207|P1|Double-Blind Phase|Lost to Follow-up|0
392790|NCT00104416|1246203|P5|Double-Blind Phase|Adverse Event|0
392792|NCT00104416|1246205|P3|Double-Blind Phase|Adverse Event|0
392793|NCT00104416|1246206|P2|Double-Blind Phase|Adverse Event|1
392794|NCT00104416|1246207|P1|Double-Blind Phase|Adverse Event|2
392795|NCT00104299|1246252|P2|Overall Study|To have renal transplant|0
392796|NCT00104299|1246253|P1|Overall Study|To have renal transplant|1
392797|NCT00104299|1246252|P2|Overall Study|Physician Decision|1
392798|NCT00104299|1246253|P1|Overall Study|Physician Decision|1
392799|NCT00104299|1246252|P2|Overall Study|Withdrawal by Subject|6
392800|NCT00104299|1246253|P1|Overall Study|Withdrawal by Subject|2
392801|NCT00104299|1246252|P2|Overall Study|Death|2
392802|NCT00104299|1246253|P1|Overall Study|Death|2
392803|NCT00104299|1246252|P2|Overall Study|Adverse Event|1
392804|NCT00104299|1246253|P1|Overall Study|Adverse Event|3
392805|NCT00104247|1246275|P2|Overall Study|Noncompliant with dosing|1
392806|NCT00104247|1246276|P1|Overall Study|Noncompliant with dosing|0
392807|NCT00104247|1246275|P2|Overall Study|Withdrawal by Subject|0
392808|NCT00104247|1246276|P1|Overall Study|Withdrawal by Subject|1
392809|NCT00104104|1246295|P2|Overall Study|Death|6
392810|NCT00104104|1246296|P1|Overall Study|Death|9
392811|NCT00104104|1246295|P2|Overall Study|Administrative problems|13
392812|NCT00104104|1246296|P1|Overall Study|Administrative problems|12
392813|NCT00104104|1246295|P2|Overall Study|Lost to Follow-up|7
392814|NCT00104104|1246296|P1|Overall Study|Lost to Follow-up|3
392815|NCT00104104|1246295|P2|Overall Study|Withdrawal by Subject|15
392816|NCT00104104|1246296|P1|Overall Study|Withdrawal by Subject|11
392817|NCT00104104|1246295|P2|Overall Study|Protocol Violation|2
392818|NCT00104104|1246296|P1|Overall Study|Protocol Violation|5
392819|NCT00104104|1246295|P2|Overall Study|Condition no longer requires study drug|4
392820|NCT00104104|1246296|P1|Overall Study|Condition no longer requires study drug|7
392821|NCT00104104|1246295|P2|Overall Study|Lack of Efficacy|3
392822|NCT00104104|1246296|P1|Overall Study|Lack of Efficacy|0
392823|NCT00104104|1246295|P2|Overall Study|Abnormal laboratory value(s)|14
392824|NCT00104104|1246296|P1|Overall Study|Abnormal laboratory value(s)|20
392825|NCT00104104|1246295|P2|Overall Study|Adverse Event|8
392826|NCT00104104|1246296|P1|Overall Study|Adverse Event|8
392827|NCT00104052|1246310|P1|Overall Study|Discontinuation unrelated to treatment|2
392828|NCT00104052|1246310|P1|Overall Study|Lack of Efficacy|26
392829|NCT00104052|1246310|P1|Overall Study|Adverse Event|1
392830|NCT00103857|1246321|P7|50-Week Extension Study|reason unspecified|0
392831|NCT00103857|1246322|P6|50-Week Extension Study|reason unspecified|0
392832|NCT00103857|1246323|P5|50-Week Extension Study|reason unspecified|1
392833|NCT00103857|1246324|P4|50-Week Extension Study|reason unspecified|0
392834|NCT00103857|1246325|P3|50-Week Extension Study|reason unspecified|0
392835|NCT00103857|1246326|P2|50-Week Extension Study|reason unspecified|0
392836|NCT00103857|1246327|P1|50-Week Extension Study|reason unspecified|0
392837|NCT00103857|1246321|P7|50-Week Extension Study|patient scheduled for elective surgery|0
392838|NCT00103857|1246322|P6|50-Week Extension Study|patient scheduled for elective surgery|0
392839|NCT00103857|1246323|P5|50-Week Extension Study|patient scheduled for elective surgery|0
392840|NCT00103857|1246324|P4|50-Week Extension Study|patient scheduled for elective surgery|0
392841|NCT00103857|1246325|P3|50-Week Extension Study|patient scheduled for elective surgery|1
392842|NCT00103857|1246326|P2|50-Week Extension Study|patient scheduled for elective surgery|0
392843|NCT00103857|1246327|P1|50-Week Extension Study|patient scheduled for elective surgery|0
392844|NCT00103857|1246321|P7|50-Week Extension Study|patient moved|0
392845|NCT00103857|1246322|P6|50-Week Extension Study|patient moved|0
392846|NCT00103857|1246323|P5|50-Week Extension Study|patient moved|0
392847|NCT00103857|1246324|P4|50-Week Extension Study|patient moved|2
392848|NCT00103857|1246325|P3|50-Week Extension Study|patient moved|1
392849|NCT00103857|1246326|P2|50-Week Extension Study|patient moved|0
392850|NCT00103857|1246327|P1|50-Week Extension Study|patient moved|0
392851|NCT00103857|1246321|P7|50-Week Extension Study|non-compliance with study procedures|0
392852|NCT00103857|1246322|P6|50-Week Extension Study|non-compliance with study procedures|0
392853|NCT00103857|1246323|P5|50-Week Extension Study|non-compliance with study procedures|1
392854|NCT00103857|1246324|P4|50-Week Extension Study|non-compliance with study procedures|1
392855|NCT00103857|1246325|P3|50-Week Extension Study|non-compliance with study procedures|0
392856|NCT00103857|1246326|P2|50-Week Extension Study|non-compliance with study procedures|0
392857|NCT00103857|1246327|P1|50-Week Extension Study|non-compliance with study procedures|1
392858|NCT00103857|1246321|P7|50-Week Extension Study|protocol discontinuation criteria|0
392859|NCT00103857|1246322|P6|50-Week Extension Study|protocol discontinuation criteria|3
392860|NCT00103857|1246323|P5|50-Week Extension Study|protocol discontinuation criteria|3
392861|NCT00103857|1246324|P4|50-Week Extension Study|protocol discontinuation criteria|2
392862|NCT00103857|1246325|P3|50-Week Extension Study|protocol discontinuation criteria|3
392863|NCT00103857|1246326|P2|50-Week Extension Study|protocol discontinuation criteria|2
392864|NCT00103857|1246327|P1|50-Week Extension Study|protocol discontinuation criteria|2
392865|NCT00103857|1246321|P7|50-Week Extension Study|Withdrawal by Subject|0
392866|NCT00103857|1246322|P6|50-Week Extension Study|Withdrawal by Subject|3
392867|NCT00103857|1246323|P5|50-Week Extension Study|Withdrawal by Subject|3
392868|NCT00103857|1246324|P4|50-Week Extension Study|Withdrawal by Subject|8
392869|NCT00103857|1246325|P3|50-Week Extension Study|Withdrawal by Subject|2
392870|NCT00103857|1246326|P2|50-Week Extension Study|Withdrawal by Subject|5
392871|NCT00103857|1246327|P1|50-Week Extension Study|Withdrawal by Subject|2
392872|NCT00103857|1246321|P7|50-Week Extension Study|Protocol Violation|0
392873|NCT00103857|1246322|P6|50-Week Extension Study|Protocol Violation|1
392874|NCT00103857|1246323|P5|50-Week Extension Study|Protocol Violation|0
392875|NCT00103857|1246324|P4|50-Week Extension Study|Protocol Violation|2
392876|NCT00103857|1246325|P3|50-Week Extension Study|Protocol Violation|1
392877|NCT00103857|1246326|P2|50-Week Extension Study|Protocol Violation|1
392878|NCT00103857|1246327|P1|50-Week Extension Study|Protocol Violation|1
392879|NCT00103857|1246321|P7|50-Week Extension Study|Pregnancy|0
392880|NCT00103857|1246322|P6|50-Week Extension Study|Pregnancy|0
392881|NCT00103857|1246323|P5|50-Week Extension Study|Pregnancy|1
392882|NCT00103857|1246324|P4|50-Week Extension Study|Pregnancy|0
392883|NCT00103857|1246325|P3|50-Week Extension Study|Pregnancy|1
392884|NCT00103857|1246326|P2|50-Week Extension Study|Pregnancy|0
392885|NCT00103857|1246327|P1|50-Week Extension Study|Pregnancy|0
392886|NCT00103857|1246321|P7|50-Week Extension Study|Physician Decision|0
392887|NCT00103857|1246322|P6|50-Week Extension Study|Physician Decision|0
392888|NCT00103857|1246323|P5|50-Week Extension Study|Physician Decision|0
392889|NCT00103857|1246324|P4|50-Week Extension Study|Physician Decision|0
392890|NCT00103857|1246325|P3|50-Week Extension Study|Physician Decision|1
392891|NCT00103857|1246326|P2|50-Week Extension Study|Physician Decision|1
392892|NCT00103857|1246327|P1|50-Week Extension Study|Physician Decision|0
392893|NCT00103857|1246321|P7|50-Week Extension Study|Lost to Follow-up|0
392894|NCT00103857|1246322|P6|50-Week Extension Study|Lost to Follow-up|3
392895|NCT00103857|1246323|P5|50-Week Extension Study|Lost to Follow-up|3
392896|NCT00103857|1246324|P4|50-Week Extension Study|Lost to Follow-up|4
392897|NCT00103857|1246325|P3|50-Week Extension Study|Lost to Follow-up|1
392898|NCT00103857|1246326|P2|50-Week Extension Study|Lost to Follow-up|0
392899|NCT00103857|1246327|P1|50-Week Extension Study|Lost to Follow-up|4
392900|NCT00103857|1246321|P7|50-Week Extension Study|Lack of Efficacy|0
392901|NCT00103857|1246322|P6|50-Week Extension Study|Lack of Efficacy|8
392902|NCT00103857|1246323|P5|50-Week Extension Study|Lack of Efficacy|8
392903|NCT00103857|1246324|P4|50-Week Extension Study|Lack of Efficacy|16
392904|NCT00103857|1246325|P3|50-Week Extension Study|Lack of Efficacy|13
392905|NCT00103857|1246326|P2|50-Week Extension Study|Lack of Efficacy|15
392906|NCT00103857|1246327|P1|50-Week Extension Study|Lack of Efficacy|26
392907|NCT00103857|1246321|P7|50-Week Extension Study|Death|0
392908|NCT00103857|1246322|P6|50-Week Extension Study|Death|1
392909|NCT00103857|1246323|P5|50-Week Extension Study|Death|0
392910|NCT00103857|1246324|P4|50-Week Extension Study|Death|1
392911|NCT00103857|1246325|P3|50-Week Extension Study|Death|0
392912|NCT00103857|1246326|P2|50-Week Extension Study|Death|0
392913|NCT00103857|1246327|P1|50-Week Extension Study|Death|0
392914|NCT00103857|1246321|P7|50-Week Extension Study|Adverse Event|0
392915|NCT00103857|1246322|P6|50-Week Extension Study|Adverse Event|1
392916|NCT00103857|1246323|P5|50-Week Extension Study|Adverse Event|1
392917|NCT00103857|1246324|P4|50-Week Extension Study|Adverse Event|0
392918|NCT00103857|1246325|P3|50-Week Extension Study|Adverse Event|2
392919|NCT00103857|1246326|P2|50-Week Extension Study|Adverse Event|3
392920|NCT00103857|1246327|P1|50-Week Extension Study|Adverse Event|2
392921|NCT00103857|1246321|P7|54-Week Base Study|patient intolerance to rescue therapy|0
392922|NCT00103857|1246322|P6|54-Week Base Study|patient intolerance to rescue therapy|0
392923|NCT00103857|1246323|P5|54-Week Base Study|patient intolerance to rescue therapy|0
392924|NCT00103857|1246324|P4|54-Week Base Study|patient intolerance to rescue therapy|0
392925|NCT00103857|1246325|P3|54-Week Base Study|patient intolerance to rescue therapy|0
392926|NCT00103857|1246326|P2|54-Week Base Study|patient intolerance to rescue therapy|0
392927|NCT00103857|1246327|P1|54-Week Base Study|patient intolerance to rescue therapy|1
392928|NCT00103857|1246321|P7|54-Week Base Study|site error|0
392929|NCT00103857|1246322|P6|54-Week Base Study|site error|1
392930|NCT00103857|1246323|P5|54-Week Base Study|site error|0
392931|NCT00103857|1246324|P4|54-Week Base Study|site error|0
392932|NCT00103857|1246325|P3|54-Week Base Study|site error|0
392933|NCT00103857|1246326|P2|54-Week Base Study|site error|0
392934|NCT00103857|1246327|P1|54-Week Base Study|site error|0
392935|NCT00103857|1246321|P7|54-Week Base Study|laboratory reporting error|0
392936|NCT00103857|1246322|P6|54-Week Base Study|laboratory reporting error|0
392937|NCT00103857|1246323|P5|54-Week Base Study|laboratory reporting error|1
392938|NCT00103857|1246324|P4|54-Week Base Study|laboratory reporting error|0
392939|NCT00103857|1246325|P3|54-Week Base Study|laboratory reporting error|0
392940|NCT00103857|1246326|P2|54-Week Base Study|laboratory reporting error|0
392941|NCT00103857|1246327|P1|54-Week Base Study|laboratory reporting error|0
392942|NCT00103857|1246321|P7|54-Week Base Study|patient incarcerated|0
392943|NCT00103857|1246322|P6|54-Week Base Study|patient incarcerated|1
392944|NCT00103857|1246323|P5|54-Week Base Study|patient incarcerated|1
392945|NCT00103857|1246324|P4|54-Week Base Study|patient incarcerated|0
392946|NCT00103857|1246325|P3|54-Week Base Study|patient incarcerated|0
392947|NCT00103857|1246326|P2|54-Week Base Study|patient incarcerated|0
392948|NCT00103857|1246327|P1|54-Week Base Study|patient incarcerated|0
392949|NCT00103857|1246321|P7|54-Week Base Study|non-compliance with study procedures|0
392950|NCT00103857|1246322|P6|54-Week Base Study|non-compliance with study procedures|2
392951|NCT00103857|1246323|P5|54-Week Base Study|non-compliance with study procedures|0
392952|NCT00103857|1246324|P4|54-Week Base Study|non-compliance with study procedures|0
392953|NCT00103857|1246325|P3|54-Week Base Study|non-compliance with study procedures|0
392954|NCT00103857|1246326|P2|54-Week Base Study|non-compliance with study procedures|2
392955|NCT00103857|1246327|P1|54-Week Base Study|non-compliance with study procedures|1
392956|NCT00103857|1246321|P7|54-Week Base Study|patient moved|0
392957|NCT00103857|1246322|P6|54-Week Base Study|patient moved|1
392958|NCT00103857|1246323|P5|54-Week Base Study|patient moved|3
392959|NCT00103857|1246324|P4|54-Week Base Study|patient moved|2
392960|NCT00103857|1246325|P3|54-Week Base Study|patient moved|1
392961|NCT00103857|1246326|P2|54-Week Base Study|patient moved|1
392962|NCT00103857|1246327|P1|54-Week Base Study|patient moved|0
392963|NCT00103857|1246321|P7|54-Week Base Study|protocol discontinuation criteria|5
392964|NCT00103857|1246322|P6|54-Week Base Study|protocol discontinuation criteria|3
392965|NCT00103857|1246323|P5|54-Week Base Study|protocol discontinuation criteria|5
392966|NCT00103857|1246324|P4|54-Week Base Study|protocol discontinuation criteria|6
392967|NCT00103857|1246325|P3|54-Week Base Study|protocol discontinuation criteria|2
392968|NCT00103857|1246326|P2|54-Week Base Study|protocol discontinuation criteria|5
392969|NCT00103857|1246327|P1|54-Week Base Study|protocol discontinuation criteria|2
392970|NCT00103857|1246321|P7|54-Week Base Study|Withdrawal by Subject|4
392971|NCT00103857|1246322|P6|54-Week Base Study|Withdrawal by Subject|15
392972|NCT00103857|1246323|P5|54-Week Base Study|Withdrawal by Subject|10
392973|NCT00103857|1246324|P4|54-Week Base Study|Withdrawal by Subject|15
392974|NCT00103857|1246325|P3|54-Week Base Study|Withdrawal by Subject|16
392975|NCT00103857|1246326|P2|54-Week Base Study|Withdrawal by Subject|16
392976|NCT00103857|1246327|P1|54-Week Base Study|Withdrawal by Subject|17
392977|NCT00103857|1246321|P7|54-Week Base Study|Protocol Violation|3
392978|NCT00103857|1246322|P6|54-Week Base Study|Protocol Violation|3
392979|NCT00103857|1246323|P5|54-Week Base Study|Protocol Violation|0
392980|NCT00103857|1246324|P4|54-Week Base Study|Protocol Violation|4
392981|NCT00103857|1246325|P3|54-Week Base Study|Protocol Violation|2
392982|NCT00103857|1246326|P2|54-Week Base Study|Protocol Violation|4
392983|NCT00103857|1246327|P1|54-Week Base Study|Protocol Violation|6
392984|NCT00103857|1246321|P7|54-Week Base Study|Pregnancy|1
392985|NCT00103857|1246322|P6|54-Week Base Study|Pregnancy|0
392986|NCT00103857|1246323|P5|54-Week Base Study|Pregnancy|1
392987|NCT00103857|1246324|P4|54-Week Base Study|Pregnancy|0
392988|NCT00103857|1246325|P3|54-Week Base Study|Pregnancy|0
392989|NCT00103857|1246326|P2|54-Week Base Study|Pregnancy|0
392990|NCT00103857|1246327|P1|54-Week Base Study|Pregnancy|1
392991|NCT00103857|1246321|P7|54-Week Base Study|Physician Decision|0
392992|NCT00103857|1246322|P6|54-Week Base Study|Physician Decision|0
392993|NCT00103857|1246323|P5|54-Week Base Study|Physician Decision|1
392994|NCT00103857|1246324|P4|54-Week Base Study|Physician Decision|0
392995|NCT00103857|1246325|P3|54-Week Base Study|Physician Decision|0
392996|NCT00103857|1246326|P2|54-Week Base Study|Physician Decision|1
392997|NCT00103857|1246327|P1|54-Week Base Study|Physician Decision|1
392998|NCT00103857|1246321|P7|54-Week Base Study|Lost to Follow-up|3
392999|NCT00103857|1246322|P6|54-Week Base Study|Lost to Follow-up|9
393000|NCT00103857|1246323|P5|54-Week Base Study|Lost to Follow-up|10
393001|NCT00103857|1246324|P4|54-Week Base Study|Lost to Follow-up|5
393002|NCT00103857|1246325|P3|54-Week Base Study|Lost to Follow-up|7
393003|NCT00103857|1246326|P2|54-Week Base Study|Lost to Follow-up|4
393004|NCT00103857|1246327|P1|54-Week Base Study|Lost to Follow-up|5
393005|NCT00103857|1246321|P7|54-Week Base Study|Lack of Efficacy|19
393006|NCT00103857|1246322|P6|54-Week Base Study|Lack of Efficacy|14
393007|NCT00103857|1246323|P5|54-Week Base Study|Lack of Efficacy|3
393008|NCT00103857|1246324|P4|54-Week Base Study|Lack of Efficacy|4
393009|NCT00103857|1246325|P3|54-Week Base Study|Lack of Efficacy|8
393010|NCT00103857|1246326|P2|54-Week Base Study|Lack of Efficacy|14
393011|NCT00103857|1246327|P1|54-Week Base Study|Lack of Efficacy|11
393012|NCT00103857|1246321|P7|54-Week Base Study|Death|0
393013|NCT00103857|1246322|P6|54-Week Base Study|Death|1
393014|NCT00103857|1246323|P5|54-Week Base Study|Death|1
393015|NCT00103857|1246324|P4|54-Week Base Study|Death|0
393016|NCT00103857|1246325|P3|54-Week Base Study|Death|0
393017|NCT00103857|1246326|P2|54-Week Base Study|Death|0
393018|NCT00103857|1246327|P1|54-Week Base Study|Death|0
393019|NCT00103857|1246321|P7|54-Week Base Study|Adverse Event|3
393020|NCT00103857|1246322|P6|54-Week Base Study|Adverse Event|11
393021|NCT00103857|1246323|P5|54-Week Base Study|Adverse Event|5
393022|NCT00103857|1246324|P4|54-Week Base Study|Adverse Event|6
393023|NCT00103857|1246325|P3|54-Week Base Study|Adverse Event|11
393024|NCT00103857|1246326|P2|54-Week Base Study|Adverse Event|9
393025|NCT00103857|1246327|P1|54-Week Base Study|Adverse Event|12
393026|NCT00103740|1246426|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
393027|NCT00103740|1246427|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
393028|NCT00103740|1246426|P2|Period 2 - Extended Observation Period|Death|2
393029|NCT00103740|1246427|P1|Period 2 - Extended Observation Period|Death|6
393030|NCT00103740|1246426|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
393031|NCT00103740|1246427|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
393032|NCT00103740|1246426|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
393033|NCT00103740|1246427|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
393034|NCT00103740|1246426|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
393035|NCT00103740|1246427|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
393036|NCT00103740|1246426|P2|Period 1 - Core|Patient withdrew consent|2
393037|NCT00103740|1246427|P1|Period 1 - Core|Patient withdrew consent|3
393038|NCT00103740|1246426|P2|Period 1 - Core|Protocol Violation|2
393039|NCT00103740|1246427|P1|Period 1 - Core|Protocol Violation|3
393040|NCT00103740|1246426|P2|Period 1 - Core|Adverse Event|0
393041|NCT00103740|1246427|P1|Period 1 - Core|Adverse Event|1
393042|NCT00103662|1246455|P2|Overall Study|Intercurrent illness|0
393043|NCT00103662|1246456|P1|Overall Study|Intercurrent illness|1
393044|NCT00103662|1246455|P2|Overall Study|Failed mobilization|4
393045|NCT00103662|1246456|P1|Overall Study|Failed mobilization|0
393046|NCT00103662|1246455|P2|Overall Study|Other|9
393047|NCT00103662|1246456|P1|Overall Study|Other|6
393048|NCT00103662|1246455|P2|Overall Study|Lost to Follow-up|1
393049|NCT00103662|1246456|P1|Overall Study|Lost to Follow-up|0
393050|NCT00103662|1246455|P2|Overall Study|Elective Withdrawal|5
393051|NCT00103662|1246456|P1|Overall Study|Elective Withdrawal|5
393052|NCT00103662|1246455|P2|Overall Study|Death|7
393053|NCT00103662|1246456|P1|Overall Study|Death|7
393054|NCT00103662|1246455|P2|Overall Study|Entered Rescue Procedure|7
393055|NCT00103662|1246456|P1|Overall Study|Entered Rescue Procedure|0
393056|NCT00103610|1246482|P2|Overall Study|Noncompliance|1
393057|NCT00103610|1246483|P1|Overall Study|Noncompliance|0
393058|NCT00103610|1246482|P2|Overall Study|Failed mobilization|5
393059|NCT00103610|1246483|P1|Overall Study|Failed mobilization|1
393060|NCT00103610|1246482|P2|Overall Study|Other|7
393061|NCT00103610|1246483|P1|Overall Study|Other|2
393062|NCT00103610|1246482|P2|Overall Study|Adverse Event|2
393063|NCT00103610|1246483|P1|Overall Study|Adverse Event|2
393064|NCT00103610|1246482|P2|Overall Study|Lost to Follow-up|1
393065|NCT00103610|1246483|P1|Overall Study|Lost to Follow-up|3
393066|NCT00103610|1246482|P2|Overall Study|Elective Withdrawal|0
393067|NCT00103610|1246483|P1|Overall Study|Elective Withdrawal|4
393068|NCT00103610|1246482|P2|Overall Study|Death|12
393069|NCT00103610|1246483|P1|Overall Study|Death|16
393070|NCT00103610|1246482|P2|Overall Study|Entered Rescue Procedure|52
393071|NCT00103610|1246483|P1|Overall Study|Entered Rescue Procedure|10
393072|NCT00103506|1246507|P2|Overall Study|Withdrawal by Subject|21
393073|NCT00103506|1246508|P1|Overall Study|Withdrawal by Subject|18
393074|NCT00103506|1246507|P2|Overall Study|Lost to Follow-up|13
393075|NCT00103506|1246508|P1|Overall Study|Lost to Follow-up|13
393076|NCT00103506|1246507|P2|Overall Study|Death|253
393077|NCT00103506|1246508|P1|Overall Study|Death|257
393078|NCT00103506|1246507|P2|Overall Study|Study closed by sponsor|37
393079|NCT00103506|1246508|P1|Overall Study|Study closed by sponsor|34
393080|NCT00103311|1246520|P2|Overall Study|Adverse Event|0
393081|NCT00103311|1246521|P1|Overall Study|Adverse Event|1
393082|NCT00103311|1246520|P2|Overall Study|Withdrawal by Subject|1
393083|NCT00103311|1246521|P1|Overall Study|Withdrawal by Subject|2
393084|NCT00103311|1246520|P2|Overall Study|Lost to Follow-up|0
393085|NCT00103311|1246521|P1|Overall Study|Lost to Follow-up|1
393086|NCT00103259|1246533|P2|Overall Study|ineligible/no protocol therapy|6
393087|NCT00103259|1246534|P1|Overall Study|ineligible/no protocol therapy|4
393088|NCT00103259|1246533|P2|Overall Study|other (reasons were not specified)|1
393089|NCT00103259|1246534|P1|Overall Study|other (reasons were not specified)|2
393090|NCT00103259|1246533|P2|Overall Study|alternative therapy|0
393091|NCT00103259|1246534|P1|Overall Study|alternative therapy|1
393092|NCT00103259|1246533|P2|Overall Study|Withdrawal by Subject|3
393093|NCT00103259|1246534|P1|Overall Study|Withdrawal by Subject|2
393094|NCT00103259|1246533|P2|Overall Study|Death|2
393095|NCT00103259|1246534|P1|Overall Study|Death|3
393096|NCT00103207|1246546|P1|Overall Study|Diagnosis of BAC not confirmed|27
393097|NCT00103207|1246546|P1|Overall Study|Ineligible|4
393098|NCT00103207|1246546|P1|Overall Study|Other complicating disease|1
393099|NCT00103207|1246546|P1|Overall Study|Withdrawal by Subject|2
393100|NCT00103207|1246546|P1|Overall Study|Death|1
393101|NCT00103207|1246546|P1|Overall Study|Adverse Event|3
393102|NCT00103142|1246565|P2|Overall Study|Progression of disease|1
393103|NCT00103142|1246566|P1|Overall Study|Progression of disease|2
393104|NCT00103142|1246565|P2|Overall Study|Adverse Event|0
393105|NCT00103142|1246566|P1|Overall Study|Adverse Event|1
393106|NCT00103012|1246582|P3|Overall Study|Subject non-compliant with medications|1
393107|NCT00103012|1246583|P2|Overall Study|Subject non-compliant with medications|0
393108|NCT00103012|1246584|P1|Overall Study|Subject non-compliant with medications|0
393109|NCT00103012|1246582|P3|Overall Study|Adverse Event|1
393110|NCT00103012|1246583|P2|Overall Study|Adverse Event|0
393111|NCT00103012|1246584|P1|Overall Study|Adverse Event|0
393112|NCT00103012|1246582|P3|Overall Study|Pregnancy|0
393113|NCT00103012|1246583|P2|Overall Study|Pregnancy|0
393114|NCT00103012|1246584|P1|Overall Study|Pregnancy|1
393115|NCT00103012|1246582|P3|Overall Study|Withdrawal by Subject|2
393116|NCT00103012|1246583|P2|Overall Study|Withdrawal by Subject|1
393117|NCT00103012|1246584|P1|Overall Study|Withdrawal by Subject|2
393118|NCT00102804|1246594|P2|Overall Study|Alive, Receiving Treatment|2
393119|NCT00102804|1246595|P1|Overall Study|Alive, Receiving Treatment|7
393120|NCT00102804|1246594|P2|Overall Study|Sponsor Decision|0
393121|NCT00102804|1246595|P1|Overall Study|Sponsor Decision|1
393122|NCT00102804|1246594|P2|Overall Study|Satisfactory Response|0
393123|NCT00102804|1246595|P1|Overall Study|Satisfactory Response|2
393124|NCT00102804|1246594|P2|Overall Study|Protocol Violation|1
393125|NCT00102804|1246595|P1|Overall Study|Protocol Violation|2
393126|NCT00102804|1246594|P2|Overall Study|Lost to Follow-up|1
393127|NCT00102804|1246595|P1|Overall Study|Lost to Follow-up|4
393128|NCT00102804|1246594|P2|Overall Study|Enrollment Criteria Not Met|0
393129|NCT00102804|1246595|P1|Overall Study|Enrollment Criteria Not Met|6
393130|NCT00102804|1246594|P2|Overall Study|Death|6
393131|NCT00102804|1246595|P1|Overall Study|Death|5
393132|NCT00102804|1246594|P2|Overall Study|Physician Decision|6
393133|NCT00102804|1246595|P1|Overall Study|Physician Decision|24
393134|NCT00102804|1246594|P2|Overall Study|Adverse Event|3
393135|NCT00102804|1246595|P1|Overall Study|Adverse Event|37
393136|NCT00102804|1246594|P2|Overall Study|Withdrawal by Subject|7
393137|NCT00102804|1246595|P1|Overall Study|Withdrawal by Subject|46
393138|NCT00102804|1246594|P2|Overall Study|Progressive Disease (PD)|196
393139|NCT00102804|1246595|P1|Overall Study|Progressive Disease (PD)|307
393140|NCT00102687|1246616|P5|Maintenance Period|Death|1
393141|NCT00102687|1246617|P4|Maintenance Period|Death|1
393142|NCT00102687|1246618|P3|Maintenance Period|Death|0
393143|NCT00102687|1246619|P2|Maintenance Period|Death|0
393144|NCT00102687|1246620|P1|Maintenance Period|Death|0
393145|NCT00102687|1246616|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
393146|NCT00102687|1246617|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
393147|NCT00102687|1246618|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
393148|NCT00102687|1246619|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
393149|NCT00102687|1246620|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
393150|NCT00102687|1246616|P5|Maintenance Period|Sponsor decision|0
393151|NCT00102687|1246617|P4|Maintenance Period|Sponsor decision|0
393152|NCT00102687|1246618|P3|Maintenance Period|Sponsor decision|0
393153|NCT00102687|1246619|P2|Maintenance Period|Sponsor decision|0
393154|NCT00102687|1246620|P1|Maintenance Period|Sponsor decision|0
393155|NCT00102687|1246616|P5|Maintenance Period|Physician Decision|4
393156|NCT00102687|1246617|P4|Maintenance Period|Physician Decision|0
393157|NCT00102687|1246618|P3|Maintenance Period|Physician Decision|3
393158|NCT00102687|1246619|P2|Maintenance Period|Physician Decision|2
393159|NCT00102687|1246620|P1|Maintenance Period|Physician Decision|1
393160|NCT00102687|1246616|P5|Maintenance Period|Protocol Violation|0
393161|NCT00102687|1246617|P4|Maintenance Period|Protocol Violation|0
393162|NCT00102687|1246618|P3|Maintenance Period|Protocol Violation|0
393163|NCT00102687|1246619|P2|Maintenance Period|Protocol Violation|0
393164|NCT00102687|1246620|P1|Maintenance Period|Protocol Violation|0
393165|NCT00102687|1246616|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
393166|NCT00102687|1246617|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
393167|NCT00102687|1246618|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
393168|NCT00102687|1246619|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
393169|NCT00102687|1246620|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
393170|NCT00102687|1246616|P5|Maintenance Period|Adverse Event|3
393171|NCT00102687|1246617|P4|Maintenance Period|Adverse Event|1
393172|NCT00102687|1246618|P3|Maintenance Period|Adverse Event|0
393173|NCT00102687|1246619|P2|Maintenance Period|Adverse Event|0
393174|NCT00102687|1246620|P1|Maintenance Period|Adverse Event|1
393175|NCT00102687|1246616|P5|Maintenance Period|Withdrawal by Subject|1
393176|NCT00102687|1246617|P4|Maintenance Period|Withdrawal by Subject|3
393177|NCT00102687|1246618|P3|Maintenance Period|Withdrawal by Subject|2
393178|NCT00102687|1246619|P2|Maintenance Period|Withdrawal by Subject|0
393179|NCT00102687|1246620|P1|Maintenance Period|Withdrawal by Subject|4
393180|NCT00102687|1246616|P5|Initial Period|Death|0
393181|NCT00102687|1246617|P4|Initial Period|Death|0
393182|NCT00102687|1246618|P3|Initial Period|Death|1
393183|NCT00102687|1246619|P2|Initial Period|Death|1
393184|NCT00102687|1246620|P1|Initial Period|Death|1
393185|NCT00102687|1246616|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
393186|NCT00102687|1246617|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
393187|NCT00102687|1246618|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
393188|NCT00102687|1246619|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
393189|NCT00102687|1246620|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
393190|NCT00102687|1246616|P5|Initial Period|Sponsor's decision|0
393191|NCT00102687|1246617|P4|Initial Period|Sponsor's decision|0
393192|NCT00102687|1246618|P3|Initial Period|Sponsor's decision|1
393193|NCT00102687|1246619|P2|Initial Period|Sponsor's decision|1
393194|NCT00102687|1246620|P1|Initial Period|Sponsor's decision|0
393195|NCT00102687|1246616|P5|Initial Period|Physician Decision|0
393196|NCT00102687|1246617|P4|Initial Period|Physician Decision|0
393197|NCT00102687|1246618|P3|Initial Period|Physician Decision|6
393198|NCT00102687|1246619|P2|Initial Period|Physician Decision|9
393199|NCT00102687|1246620|P1|Initial Period|Physician Decision|2
393200|NCT00102687|1246616|P5|Initial Period|Protocol Violation|0
393201|NCT00102687|1246617|P4|Initial Period|Protocol Violation|0
393202|NCT00102687|1246618|P3|Initial Period|Protocol Violation|2
393203|NCT00102687|1246619|P2|Initial Period|Protocol Violation|0
393204|NCT00102687|1246620|P1|Initial Period|Protocol Violation|0
393205|NCT00102687|1246616|P5|Initial Period|Transformation to AML (blast > 30%)|0
393206|NCT00102687|1246617|P4|Initial Period|Transformation to AML (blast > 30%)|0
393207|NCT00102687|1246618|P3|Initial Period|Transformation to AML (blast > 30%)|0
393208|NCT00102687|1246619|P2|Initial Period|Transformation to AML (blast > 30%)|3
393209|NCT00102687|1246620|P1|Initial Period|Transformation to AML (blast > 30%)|1
393210|NCT00102687|1246616|P5|Initial Period|Adverse Event|0
393211|NCT00102687|1246617|P4|Initial Period|Adverse Event|0
393212|NCT00102687|1246618|P3|Initial Period|Adverse Event|9
393213|NCT00102687|1246619|P2|Initial Period|Adverse Event|7
393214|NCT00102687|1246620|P1|Initial Period|Adverse Event|4
393215|NCT00102687|1246616|P5|Initial Period|Withdrawal by Subject|0
393216|NCT00102687|1246617|P4|Initial Period|Withdrawal by Subject|0
393217|NCT00102687|1246618|P3|Initial Period|Withdrawal by Subject|5
393218|NCT00102687|1246619|P2|Initial Period|Withdrawal by Subject|3
393219|NCT00102687|1246620|P1|Initial Period|Withdrawal by Subject|6
393220|NCT00102596|1246684|P2|Part A|Adverse Event|0
393221|NCT00102596|1246685|P1|Part A|Adverse Event|1
393222|NCT00102596|1246684|P2|Part A|Screen failures|0
393223|NCT00102596|1246685|P1|Part A|Screen failures|6
393224|NCT00102440|1246703|P3|Overall Study|Protocol Violation|1
393225|NCT00102440|1246704|P2|Overall Study|Protocol Violation|2
393226|NCT00102440|1246705|P1|Overall Study|Protocol Violation|7
393227|NCT00102440|1246703|P3|Overall Study|Other|14
393228|NCT00102440|1246704|P2|Overall Study|Other|14
393229|NCT00102440|1246705|P1|Overall Study|Other|11
393230|NCT00102440|1246703|P3|Overall Study|Personal Reason(s)|13
393231|NCT00102440|1246704|P2|Overall Study|Personal Reason(s)|13
393232|NCT00102440|1246705|P1|Overall Study|Personal Reason(s)|19
393233|NCT00102440|1246703|P3|Overall Study|Gout Flare|9
393234|NCT00102440|1246704|P2|Overall Study|Gout Flare|28
393235|NCT00102440|1246705|P1|Overall Study|Gout Flare|10
393236|NCT00102440|1246703|P3|Overall Study|Adverse Event|8
393237|NCT00102440|1246704|P2|Overall Study|Adverse Event|23
393238|NCT00102440|1246705|P1|Overall Study|Adverse Event|16
393239|NCT00102440|1246703|P3|Overall Study|Lost to Follow-up|21
393240|NCT00102440|1246704|P2|Overall Study|Lost to Follow-up|18
393241|NCT00102440|1246705|P1|Overall Study|Lost to Follow-up|25
393242|NCT00102063|1246755|P3|Overall Study|Protocol Violation|1
393243|NCT00102063|1246756|P2|Overall Study|Protocol Violation|1
393244|NCT00102063|1246757|P1|Overall Study|Protocol Violation|0
393245|NCT00102063|1246755|P3|Overall Study|Lost to Follow-up|1
393246|NCT00102063|1246756|P2|Overall Study|Lost to Follow-up|0
393247|NCT00102063|1246757|P1|Overall Study|Lost to Follow-up|0
393248|NCT00102063|1246755|P3|Overall Study|Withdrawal by Subject|5
393249|NCT00102063|1246756|P2|Overall Study|Withdrawal by Subject|12
393250|NCT00102063|1246757|P1|Overall Study|Withdrawal by Subject|4
393251|NCT00102063|1246755|P3|Overall Study|Adverse Event|2
393252|NCT00102063|1246756|P2|Overall Study|Adverse Event|4
393253|NCT00102063|1246757|P1|Overall Study|Adverse Event|7
393254|NCT00102063|1246755|P3|Overall Study|Lack of Efficacy|1
393255|NCT00102063|1246756|P2|Overall Study|Lack of Efficacy|1
393256|NCT00102063|1246757|P1|Overall Study|Lack of Efficacy|5
393257|NCT00101907|1246815|P6|Overall Study|Withdrawal by Subject|0
393258|NCT00101907|1246816|P5|Overall Study|Withdrawal by Subject|1
393259|NCT00101907|1246817|P4|Overall Study|Withdrawal by Subject|0
393260|NCT00101907|1246818|P3|Overall Study|Withdrawal by Subject|1
393261|NCT00101907|1246819|P2|Overall Study|Withdrawal by Subject|0
393262|NCT00101907|1246820|P1|Overall Study|Withdrawal by Subject|1
393263|NCT00101907|1246815|P6|Overall Study|Physician Decision|0
393264|NCT00101907|1246816|P5|Overall Study|Physician Decision|1
393265|NCT00101907|1246817|P4|Overall Study|Physician Decision|1
393266|NCT00101907|1246818|P3|Overall Study|Physician Decision|0
393267|NCT00101907|1246819|P2|Overall Study|Physician Decision|0
393268|NCT00101907|1246820|P1|Overall Study|Physician Decision|0
393269|NCT00101907|1246815|P6|Overall Study|Death|0
393270|NCT00101907|1246816|P5|Overall Study|Death|3
393271|NCT00101907|1246817|P4|Overall Study|Death|0
393272|NCT00101907|1246818|P3|Overall Study|Death|0
393273|NCT00101907|1246819|P2|Overall Study|Death|1
393274|NCT00101907|1246820|P1|Overall Study|Death|0
393275|NCT00101907|1246815|P6|Overall Study|Adverse Event|0
393276|NCT00101907|1246816|P5|Overall Study|Adverse Event|0
393277|NCT00101907|1246817|P4|Overall Study|Adverse Event|0
393278|NCT00101907|1246818|P3|Overall Study|Adverse Event|0
393279|NCT00101907|1246819|P2|Overall Study|Adverse Event|0
393280|NCT00101907|1246820|P1|Overall Study|Adverse Event|1
393281|NCT00101868|1246862|P2|Overall Study|Lost to Follow-up|13
393282|NCT00101868|1246863|P1|Overall Study|Lost to Follow-up|8
393283|NCT00101868|1246862|P2|Overall Study|Protocol Violation|0
393284|NCT00101868|1246863|P1|Overall Study|Protocol Violation|3
393285|NCT00101868|1246862|P2|Overall Study|Withdrawal by Subject|9
393286|NCT00101868|1246863|P1|Overall Study|Withdrawal by Subject|8
393287|NCT00101868|1246862|P2|Overall Study|Death|10
393288|NCT00101868|1246863|P1|Overall Study|Death|10
393289|NCT00101686|1246933|P10|Overall Study|Withdrawal by Subject|9
393290|NCT00101686|1246934|P9|Overall Study|Withdrawal by Subject|8
393291|NCT00101686|1246935|P8|Overall Study|Withdrawal by Subject|7
393292|NCT00101686|1246936|P7|Overall Study|Withdrawal by Subject|7
393293|NCT00101686|1246937|P6|Overall Study|Withdrawal by Subject|7
393294|NCT00101686|1246938|P5|Overall Study|Withdrawal by Subject|8
393295|NCT00101686|1246939|P4|Overall Study|Withdrawal by Subject|8
393296|NCT00101686|1246940|P3|Overall Study|Withdrawal by Subject|6
393297|NCT00101686|1246941|P2|Overall Study|Withdrawal by Subject|8
393298|NCT00101686|1246942|P1|Overall Study|Withdrawal by Subject|9
393299|NCT00101686|1246933|P10|Overall Study|Other|3
393300|NCT00101686|1246934|P9|Overall Study|Other|3
393301|NCT00101686|1246935|P8|Overall Study|Other|5
393302|NCT00101686|1246936|P7|Overall Study|Other|1
393303|NCT00101686|1246937|P6|Overall Study|Other|12
393304|NCT00101686|1246938|P5|Overall Study|Other|2
393305|NCT00101686|1246939|P4|Overall Study|Other|6
393306|NCT00101686|1246940|P3|Overall Study|Other|1
393307|NCT00101686|1246941|P2|Overall Study|Other|4
393308|NCT00101686|1246942|P1|Overall Study|Other|1
393309|NCT00101686|1246933|P10|Overall Study|Physician Decision|1
393310|NCT00101686|1246934|P9|Overall Study|Physician Decision|1
393311|NCT00101686|1246935|P8|Overall Study|Physician Decision|5
393312|NCT00101686|1246936|P7|Overall Study|Physician Decision|5
393313|NCT00101686|1246937|P6|Overall Study|Physician Decision|9
393314|NCT00101686|1246938|P5|Overall Study|Physician Decision|8
393315|NCT00101686|1246939|P4|Overall Study|Physician Decision|7
393316|NCT00101686|1246940|P3|Overall Study|Physician Decision|6
393317|NCT00101686|1246941|P2|Overall Study|Physician Decision|13
393318|NCT00101686|1246942|P1|Overall Study|Physician Decision|10
393319|NCT00101686|1246933|P10|Overall Study|intercurrent non-cancer related illness|1
393320|NCT00101686|1246934|P9|Overall Study|intercurrent non-cancer related illness|1
393321|NCT00101686|1246935|P8|Overall Study|intercurrent non-cancer related illness|0
393322|NCT00101686|1246936|P7|Overall Study|intercurrent non-cancer related illness|1
393323|NCT00101686|1246937|P6|Overall Study|intercurrent non-cancer related illness|3
393324|NCT00101686|1246938|P5|Overall Study|intercurrent non-cancer related illness|1
393325|NCT00101686|1246939|P4|Overall Study|intercurrent non-cancer related illness|0
393326|NCT00101686|1246940|P3|Overall Study|intercurrent non-cancer related illness|2
393327|NCT00101686|1246941|P2|Overall Study|intercurrent non-cancer related illness|0
393328|NCT00101686|1246942|P1|Overall Study|intercurrent non-cancer related illness|0
393329|NCT00101686|1246933|P10|Overall Study|Randomized but did not receive treament|1
393330|NCT00101686|1246934|P9|Overall Study|Randomized but did not receive treament|0
393331|NCT00101686|1246935|P8|Overall Study|Randomized but did not receive treament|1
393332|NCT00101686|1246936|P7|Overall Study|Randomized but did not receive treament|0
393333|NCT00101686|1246937|P6|Overall Study|Randomized but did not receive treament|2
393334|NCT00101686|1246938|P5|Overall Study|Randomized but did not receive treament|2
393335|NCT00101686|1246939|P4|Overall Study|Randomized but did not receive treament|2
393336|NCT00101686|1246940|P3|Overall Study|Randomized but did not receive treament|2
393337|NCT00101686|1246941|P2|Overall Study|Randomized but did not receive treament|6
393338|NCT00101686|1246942|P1|Overall Study|Randomized but did not receive treament|1
393339|NCT00101686|1246933|P10|Overall Study|unacceptable toxicity|4
393340|NCT00101686|1246934|P9|Overall Study|unacceptable toxicity|1
393341|NCT00101686|1246935|P8|Overall Study|unacceptable toxicity|2
393342|NCT00101686|1246936|P7|Overall Study|unacceptable toxicity|4
393343|NCT00101686|1246937|P6|Overall Study|unacceptable toxicity|10
393344|NCT00101686|1246938|P5|Overall Study|unacceptable toxicity|16
393345|NCT00101686|1246939|P4|Overall Study|unacceptable toxicity|6
393346|NCT00101686|1246940|P3|Overall Study|unacceptable toxicity|10
393347|NCT00101686|1246941|P2|Overall Study|unacceptable toxicity|9
393348|NCT00101686|1246942|P1|Overall Study|unacceptable toxicity|3
393349|NCT00101686|1246933|P10|Overall Study|>3 week delay treatment due toxicity|0
393350|NCT00101686|1246934|P9|Overall Study|>3 week delay treatment due toxicity|3
393351|NCT00101686|1246935|P8|Overall Study|>3 week delay treatment due toxicity|1
393352|NCT00101686|1246936|P7|Overall Study|>3 week delay treatment due toxicity|2
393353|NCT00101686|1246937|P6|Overall Study|>3 week delay treatment due toxicity|3
393354|NCT00101686|1246938|P5|Overall Study|>3 week delay treatment due toxicity|7
393355|NCT00101686|1246939|P4|Overall Study|>3 week delay treatment due toxicity|2
393356|NCT00101686|1246940|P3|Overall Study|>3 week delay treatment due toxicity|1
393357|NCT00101686|1246941|P2|Overall Study|>3 week delay treatment due toxicity|2
393358|NCT00101686|1246942|P1|Overall Study|>3 week delay treatment due toxicity|6
393359|NCT00101686|1246933|P10|Overall Study|initiation other anti-cancer treatment|3
393360|NCT00101686|1246934|P9|Overall Study|initiation other anti-cancer treatment|3
393361|NCT00101686|1246935|P8|Overall Study|initiation other anti-cancer treatment|2
393362|NCT00101686|1246936|P7|Overall Study|initiation other anti-cancer treatment|2
393363|NCT00101686|1246937|P6|Overall Study|initiation other anti-cancer treatment|1
393364|NCT00101686|1246938|P5|Overall Study|initiation other anti-cancer treatment|1
393365|NCT00101686|1246939|P4|Overall Study|initiation other anti-cancer treatment|3
393366|NCT00101686|1246940|P3|Overall Study|initiation other anti-cancer treatment|4
393367|NCT00101686|1246941|P2|Overall Study|initiation other anti-cancer treatment|3
393368|NCT00101686|1246942|P1|Overall Study|initiation other anti-cancer treatment|4
393369|NCT00101686|1246933|P10|Overall Study|Progressive Disease|8
393370|NCT00101686|1246934|P9|Overall Study|Progressive Disease|10
393371|NCT00101686|1246935|P8|Overall Study|Progressive Disease|7
393372|NCT00101686|1246936|P7|Overall Study|Progressive Disease|5
393373|NCT00101686|1246937|P6|Overall Study|Progressive Disease|25
393374|NCT00101686|1246938|P5|Overall Study|Progressive Disease|28
393375|NCT00101686|1246939|P4|Overall Study|Progressive Disease|38
393376|NCT00101686|1246940|P3|Overall Study|Progressive Disease|37
393377|NCT00101686|1246941|P2|Overall Study|Progressive Disease|28
393378|NCT00101686|1246942|P1|Overall Study|Progressive Disease|37
393379|NCT00101582|1247059|P2|Overall Study|Other|1
393380|NCT00101582|1247060|P1|Overall Study|Other|0
393381|NCT00101582|1247059|P2|Overall Study|Death|5
393382|NCT00101582|1247060|P1|Overall Study|Death|3
393383|NCT00101582|1247059|P2|Overall Study|Physician Decision|0
393384|NCT00101582|1247060|P1|Overall Study|Physician Decision|1
393385|NCT00101582|1247059|P2|Overall Study|Withdrawal by Subject|4
393386|NCT00101582|1247060|P1|Overall Study|Withdrawal by Subject|6
393387|NCT00101582|1247059|P2|Overall Study|Adverse Event|4
393388|NCT00101582|1247060|P1|Overall Study|Adverse Event|1
393389|NCT00101582|1247059|P2|Overall Study|Ineligibility determined|1
393390|NCT00101582|1247060|P1|Overall Study|Ineligibility determined|0
393391|NCT00101452|1247083|P3|Overall Study|Other|12
393392|NCT00101452|1247084|P2|Overall Study|Other|16
393393|NCT00101452|1247085|P1|Overall Study|Other|15
393394|NCT00101452|1247083|P3|Overall Study|Protocol Violation|3
393395|NCT00101452|1247084|P2|Overall Study|Protocol Violation|1
393396|NCT00101452|1247085|P1|Overall Study|Protocol Violation|2
393397|NCT00101452|1247083|P3|Overall Study|Physician Decision|2
393398|NCT00101452|1247084|P2|Overall Study|Physician Decision|3
393399|NCT00101452|1247085|P1|Overall Study|Physician Decision|0
393400|NCT00101452|1247083|P3|Overall Study|Baseline Fail|2
393401|NCT00101452|1247084|P2|Overall Study|Baseline Fail|1
393402|NCT00101452|1247085|P1|Overall Study|Baseline Fail|2
393403|NCT00101452|1247083|P3|Overall Study|Withdrawal by Subject|9
393404|NCT00101452|1247084|P2|Overall Study|Withdrawal by Subject|14
393405|NCT00101452|1247085|P1|Overall Study|Withdrawal by Subject|10
393406|NCT00101452|1247083|P3|Overall Study|Lost to Follow-up|14
393407|NCT00101452|1247084|P2|Overall Study|Lost to Follow-up|8
393408|NCT00101452|1247085|P1|Overall Study|Lost to Follow-up|13
393409|NCT00101452|1247083|P3|Overall Study|Adverse Event|1
393410|NCT00101452|1247084|P2|Overall Study|Adverse Event|0
393411|NCT00101452|1247085|P1|Overall Study|Adverse Event|2
393412|NCT00101439|1247099|P2|Period 2|Withdrawal by Subject|2
393413|NCT00101439|1247100|P1|Period 2|Withdrawal by Subject|0
393414|NCT00101400|1247116|P1|Survival Follow-Up|Alive|7
393415|NCT00101283|1247136|P2|Overall Study|Prostate Cancer Recurrence|1
393416|NCT00101283|1247137|P1|Overall Study|Prostate Cancer Recurrence|0
393417|NCT00101283|1247136|P2|Overall Study|Insurance Refusal|1
393418|NCT00101283|1247137|P1|Overall Study|Insurance Refusal|0
393419|NCT00101283|1247136|P2|Overall Study|Withdrawal by Subject|1
393420|NCT00101283|1247137|P1|Overall Study|Withdrawal by Subject|0
393421|NCT00101192|1247147|P1|Overall Study|Inevaluable|1
393422|NCT00101192|1247147|P1|Overall Study|Ineligible|6
393423|NCT00101166|1247151|P1|Overall Study|progressive disease|10
393424|NCT00101101|1247159|P1|Overall Study|never received vaccine|20
393425|NCT00100932|1247180|P2|Overall Study|Not specified|2
393426|NCT00100932|1247181|P1|Overall Study|Not specified|5
393427|NCT00100932|1247180|P2|Overall Study|Physician Decision|5
393428|NCT00100932|1247181|P1|Overall Study|Physician Decision|7
393429|NCT00100932|1247180|P2|Overall Study|Progressive Disease|18
393430|NCT00100932|1247181|P1|Overall Study|Progressive Disease|44
393431|NCT00100932|1247180|P2|Overall Study|Withdrawal by Subject|0
393432|NCT00100932|1247181|P1|Overall Study|Withdrawal by Subject|6
393433|NCT00100932|1247180|P2|Overall Study|Adverse Event|2
393434|NCT00100932|1247181|P1|Overall Study|Adverse Event|11
393435|NCT00100815|1247196|P1|Overall Study|not specified|3
393436|NCT00100815|1247196|P1|Overall Study|Death|4
393437|NCT00100815|1247196|P1|Overall Study|Adverse Event|18
393438|NCT00100815|1247196|P1|Overall Study|Progression|24
393439|NCT00100802|1247204|P1|Overall Study|Ineligible|12
393440|NCT00100802|1247204|P1|Overall Study|Withdrawal by Subject|5
393441|NCT00100802|1247204|P1|Overall Study|Protocol Violation|1
393442|NCT00100802|1247204|P1|Overall Study|Physician Decision|5
393443|NCT00100802|1247204|P1|Overall Study|Lack of Efficacy|47
393444|NCT00100802|1247204|P1|Overall Study|Death|1
393445|NCT00100802|1247204|P1|Overall Study|Adverse Event|9
393446|NCT00100789|1247209|P1|Overall Study|Never received treatment|1
393447|NCT00100789|1247209|P1|Overall Study|Ineligible|3
393448|NCT00100789|1247209|P1|Overall Study|Not protocol specified|5
393449|NCT00100789|1247209|P1|Overall Study|Death|2
393450|NCT00100789|1247209|P1|Overall Study|Progression/relapse|42
393451|NCT00100789|1247209|P1|Overall Study|Withdrawal by Subject|1
393452|NCT00100789|1247209|P1|Overall Study|Adverse Event|10
393453|NCT00100178|1247284|P3|Overall Study|Physician Decision|3
393454|NCT00100178|1247285|P2|Overall Study|Physician Decision|1
393455|NCT00100178|1247286|P1|Overall Study|Physician Decision|6
393456|NCT00100178|1247284|P3|Overall Study|Withdrawal by Subject|1
393457|NCT00100178|1247285|P2|Overall Study|Withdrawal by Subject|1
393458|NCT00100178|1247286|P1|Overall Study|Withdrawal by Subject|1
393459|NCT00100178|1247284|P3|Overall Study|Adverse Event|1
393460|NCT00100178|1247285|P2|Overall Study|Adverse Event|2
393461|NCT00100178|1247286|P1|Overall Study|Adverse Event|2
393462|NCT00100178|1247284|P3|Overall Study|Lost to Follow-up|5
393463|NCT00100178|1247285|P2|Overall Study|Lost to Follow-up|6
393464|NCT00100178|1247286|P1|Overall Study|Lost to Follow-up|0
393465|NCT00100048|1247299|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
393466|NCT00100048|1247300|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
393467|NCT00100048|1247301|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
393468|NCT00100048|1247302|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
393469|NCT00100048|1247303|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
393470|NCT00100048|1247304|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
393471|NCT00100048|1247299|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
393472|NCT00100048|1247300|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
393473|NCT00100048|1247301|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
393474|NCT00100048|1247302|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
393475|NCT00100048|1247303|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
393476|NCT00100048|1247304|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
393477|NCT00100048|1247299|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
393478|NCT00100048|1247300|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
393479|NCT00100048|1247301|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
393480|NCT00100048|1247302|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
393481|NCT00100048|1247303|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
393482|NCT00100048|1247304|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
393483|NCT00100048|1247299|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
393484|NCT00100048|1247300|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
393485|NCT00100048|1247301|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
393486|NCT00100048|1247302|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
393487|NCT00100048|1247303|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
393488|NCT00100048|1247304|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
393489|NCT00100048|1247299|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
393490|NCT00100048|1247300|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
393491|NCT00100048|1247301|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
393492|NCT00100048|1247302|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
393493|NCT00100048|1247303|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
393494|NCT00100048|1247304|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
393495|NCT00100048|1247299|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
393496|NCT00100048|1247300|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
393497|NCT00100048|1247301|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
393498|NCT00100048|1247302|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
393499|NCT00100048|1247303|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
393500|NCT00100048|1247304|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
393501|NCT00100048|1247299|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
393502|NCT00100048|1247300|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
393503|NCT00100048|1247301|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
393504|NCT00100048|1247302|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
393505|NCT00100048|1247303|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
393506|NCT00100048|1247304|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
393507|NCT00100048|1247299|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
393508|NCT00100048|1247300|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
393509|NCT00100048|1247301|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
393510|NCT00100048|1247302|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
393511|NCT00100048|1247303|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
393512|NCT00100048|1247304|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
393513|NCT00099983|1247413|P2|Overall Study|Other issue|0
393514|NCT00099983|1247414|P1|Overall Study|Other issue|1
393515|NCT00099983|1247413|P2|Overall Study|Intolerant of burden of visits|1
393516|NCT00099983|1247414|P1|Overall Study|Intolerant of burden of visits|0
393517|NCT00099983|1247413|P2|Overall Study|Incarcerated|1
393518|NCT00099983|1247414|P1|Overall Study|Incarcerated|0
393519|NCT00099983|1247413|P2|Overall Study|Other psychiatric problem|0
393520|NCT00099983|1247414|P1|Overall Study|Other psychiatric problem|1
393521|NCT00099983|1247413|P2|Overall Study|Moved|0
393522|NCT00099983|1247414|P1|Overall Study|Moved|1
393523|NCT00099983|1247413|P2|Overall Study|Unable to return for appointments|1
393524|NCT00099983|1247414|P1|Overall Study|Unable to return for appointments|1
393525|NCT00099983|1247413|P2|Overall Study|Lack of Efficacy|1
393526|NCT00099983|1247414|P1|Overall Study|Lack of Efficacy|0
393527|NCT00099983|1247413|P2|Overall Study|Adverse Event|1
393528|NCT00099983|1247414|P1|Overall Study|Adverse Event|1
393529|NCT00099983|1247413|P2|Overall Study|Withdrawal by Subject|2
393530|NCT00099983|1247414|P1|Overall Study|Withdrawal by Subject|3
393531|NCT00099983|1247413|P2|Overall Study|Missing Source Documents|15
393532|NCT00099983|1247414|P1|Overall Study|Missing Source Documents|14
393533|NCT00099983|1247413|P2|Overall Study|Lost to Follow-up|3
393534|NCT00099983|1247414|P1|Overall Study|Lost to Follow-up|2
393535|NCT00099632|1247426|P6|Overall Study|Protocol Violation|1
393536|NCT00099632|1247427|P5|Overall Study|Protocol Violation|0
393537|NCT00099632|1247428|P4|Overall Study|Protocol Violation|0
393538|NCT00099632|1247429|P3|Overall Study|Protocol Violation|0
393539|NCT00099632|1247430|P2|Overall Study|Protocol Violation|0
393540|NCT00099632|1247431|P1|Overall Study|Protocol Violation|0
393541|NCT00099632|1247426|P6|Overall Study|Withdrawal by Subject|1
393542|NCT00099632|1247427|P5|Overall Study|Withdrawal by Subject|0
393543|NCT00099632|1247428|P4|Overall Study|Withdrawal by Subject|0
393544|NCT00099632|1247429|P3|Overall Study|Withdrawal by Subject|0
393545|NCT00099632|1247430|P2|Overall Study|Withdrawal by Subject|1
393546|NCT00099632|1247431|P1|Overall Study|Withdrawal by Subject|0
393547|NCT00099632|1247426|P6|Overall Study|Lost to Follow-up|0
393548|NCT00099632|1247427|P5|Overall Study|Lost to Follow-up|1
393549|NCT00099632|1247428|P4|Overall Study|Lost to Follow-up|1
393550|NCT00099632|1247429|P3|Overall Study|Lost to Follow-up|3
393551|NCT00099632|1247430|P2|Overall Study|Lost to Follow-up|0
393552|NCT00099632|1247431|P1|Overall Study|Lost to Follow-up|1
393553|NCT00099437|1247471|P2|Overall Study|Ongoing in FU but not on treatment|45
393554|NCT00099437|1247472|P1|Overall Study|Ongoing in FU but not on treatment|37
393555|NCT00099437|1247471|P2|Overall Study|Withdrawal by Subject|10
393556|NCT00099437|1247472|P1|Overall Study|Withdrawal by Subject|6
393557|NCT00099437|1247471|P2|Overall Study|Death|261
393558|NCT00099437|1247472|P1|Overall Study|Death|293
393559|NCT00099437|1247471|P2|Overall Study|Lost to Follow-up|33
393560|NCT00099437|1247472|P1|Overall Study|Lost to Follow-up|30
393561|NCT00099359|1247495|P3|Overall Study|moved out of area|4
393562|NCT00099359|1247496|P2|Overall Study|moved out of area|7
393563|NCT00099359|1247497|P1|Overall Study|moved out of area|9
393564|NCT00099359|1247495|P3|Overall Study|Lost to Follow-up|24
393565|NCT00099359|1247496|P2|Overall Study|Lost to Follow-up|24
393566|NCT00099359|1247497|P1|Overall Study|Lost to Follow-up|15
393567|NCT00099359|1247495|P3|Overall Study|Withdrawal by Subject|23
393568|NCT00099359|1247496|P2|Overall Study|Withdrawal by Subject|19
393569|NCT00099359|1247497|P1|Overall Study|Withdrawal by Subject|19
393570|NCT00099359|1247495|P3|Overall Study|Death|17
393571|NCT00099359|1247496|P2|Overall Study|Death|15
393572|NCT00099359|1247497|P1|Overall Study|Death|11
393573|NCT00099268|1247520|P2|Overall Study|Death|1
393574|NCT00099268|1247521|P1|Overall Study|Death|3
393575|NCT00099268|1247520|P2|Overall Study|Administrative problems|4
393576|NCT00099268|1247521|P1|Overall Study|Administrative problems|4
393577|NCT00099268|1247520|P2|Overall Study|Lack of Efficacy|18
393578|NCT00099268|1247521|P1|Overall Study|Lack of Efficacy|5
393579|NCT00099268|1247520|P2|Overall Study|Lost to Follow-up|4
393580|NCT00099268|1247521|P1|Overall Study|Lost to Follow-up|6
393581|NCT00099268|1247520|P2|Overall Study|Protocol Violation|8
393582|NCT00099268|1247521|P1|Overall Study|Protocol Violation|9
393583|NCT00099268|1247520|P2|Overall Study|Adverse Event|19
393584|NCT00099268|1247521|P1|Overall Study|Adverse Event|19
393585|NCT00099268|1247520|P2|Overall Study|Withdrawal by Subject|28
393586|NCT00099268|1247521|P1|Overall Study|Withdrawal by Subject|46
393587|NCT00098865|1247557|P1|Overall Study|Alternative Therapy|1
393588|NCT00098865|1247557|P1|Overall Study|Adverse Event|2
393589|NCT00098865|1247557|P1|Overall Study|Progressive Disease|6
393590|NCT00098839|1247565|P2|Overall Study|Ineligible|0
393591|NCT00098839|1247566|P1|Overall Study|Ineligible|2
393592|NCT00098839|1247565|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
393593|NCT00098839|1247566|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
393594|NCT00098839|1247565|P2|Overall Study|Relapse|3
393595|NCT00098839|1247566|P1|Overall Study|Relapse|6
393596|NCT00098839|1247565|P2|Overall Study|Refusal of further protocol therapy|1
393597|NCT00098839|1247566|P1|Overall Study|Refusal of further protocol therapy|3
393598|NCT00098839|1247565|P2|Overall Study|Withdrawal by Subject|0
393599|NCT00098839|1247566|P1|Overall Study|Withdrawal by Subject|1
393600|NCT00098839|1247565|P2|Overall Study|Physician Decision|14
393601|NCT00098839|1247566|P1|Overall Study|Physician Decision|4
393602|NCT00098839|1247565|P2|Overall Study|Death|2
393603|NCT00098839|1247566|P1|Overall Study|Death|1
393604|NCT00098839|1247565|P2|Overall Study|Adverse Event|2
393605|NCT00098839|1247566|P1|Overall Study|Adverse Event|5
393606|NCT00098813|1247576|P1|Overall Study|Reversal of RAI resistance|1
393607|NCT00098813|1247576|P1|Overall Study|Other complicating disease|1
393608|NCT00098813|1247576|P1|Overall Study|Progression of Disease|1
393609|NCT00098813|1247576|P1|Overall Study|Withdrawal by Subject|7
393610|NCT00098813|1247576|P1|Overall Study|Protocol Violation|1
393611|NCT00098813|1247576|P1|Overall Study|Death|8
393612|NCT00098787|1247583|P3|Overall Study|Other|9
393613|NCT00098787|1247584|P2|Overall Study|Other|6
393614|NCT00098787|1247585|P1|Overall Study|Other|7
393615|NCT00098787|1247583|P3|Overall Study|Alternative therapy|13
393616|NCT00098787|1247584|P2|Overall Study|Alternative therapy|13
393617|NCT00098787|1247585|P1|Overall Study|Alternative therapy|8
393618|NCT00098787|1247583|P3|Overall Study|Withdrawal by Subject|6
393619|NCT00098787|1247584|P2|Overall Study|Withdrawal by Subject|12
393620|NCT00098787|1247585|P1|Overall Study|Withdrawal by Subject|4
393621|NCT00098787|1247583|P3|Overall Study|Death|0
393622|NCT00098787|1247584|P2|Overall Study|Death|1
393623|NCT00098787|1247585|P1|Overall Study|Death|6
393624|NCT00098787|1247583|P3|Overall Study|Adverse Event|8
393625|NCT00098787|1247584|P2|Overall Study|Adverse Event|17
393626|NCT00098787|1247585|P1|Overall Study|Adverse Event|8
393627|NCT00098787|1247583|P3|Overall Study|Disease progression|23
393628|NCT00098787|1247584|P2|Overall Study|Disease progression|17
393629|NCT00098787|1247585|P1|Overall Study|Disease progression|28
393630|NCT00098787|1247583|P3|Overall Study|Ineligible|3
393631|NCT00098787|1247584|P2|Overall Study|Ineligible|7
393632|NCT00098787|1247585|P1|Overall Study|Ineligible|9
393633|NCT00098787|1247583|P3|Overall Study|Never started treatment|1
393634|NCT00098787|1247584|P2|Overall Study|Never started treatment|2
393635|NCT00098787|1247585|P1|Overall Study|Never started treatment|3
393636|NCT00098774|1247599|P1|Overall Study|Physician Decision|2
393637|NCT00098774|1247599|P1|Overall Study|Failed (to respond) during induction|4
393638|NCT00098774|1247599|P1|Overall Study|Withdrawal by Subject|1
393639|NCT00098774|1247599|P1|Overall Study|Disease Progression|9
393640|NCT00098774|1247599|P1|Overall Study|Adverse Event|2
393641|NCT00098748|1247609|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
393642|NCT00098748|1247610|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
393643|NCT00098748|1247611|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
393644|NCT00098748|1247609|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
393645|NCT00098748|1247610|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
393646|NCT00098748|1247611|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
393647|NCT00098748|1247609|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
393648|NCT00098748|1247610|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
393649|NCT00098748|1247611|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
393650|NCT00098748|1247609|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
393651|NCT00098748|1247610|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
393652|NCT00098748|1247611|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
393653|NCT00098748|1247609|P3|Continued on Open-Label Treatment|Adverse Event|0
393654|NCT00098748|1247610|P2|Continued on Open-Label Treatment|Adverse Event|1
393655|NCT00098748|1247611|P1|Continued on Open-Label Treatment|Adverse Event|0
393656|NCT00098748|1247609|P3|Received Study Treatment|Subject defaulted|4
393657|NCT00098748|1247610|P2|Received Study Treatment|Subject defaulted|4
393658|NCT00098748|1247611|P1|Received Study Treatment|Subject defaulted|3
393659|NCT00098748|1247609|P3|Received Study Treatment|Unspecified|6
393660|NCT00098748|1247610|P2|Received Study Treatment|Unspecified|2
393661|NCT00098748|1247611|P1|Received Study Treatment|Unspecified|2
393662|NCT00098748|1247609|P3|Received Study Treatment|Lack of Efficacy|27
393663|NCT00098748|1247610|P2|Received Study Treatment|Lack of Efficacy|27
393664|NCT00098748|1247611|P1|Received Study Treatment|Lack of Efficacy|40
393665|NCT00098748|1247609|P3|Received Study Treatment|Adverse Event|5
393666|NCT00098748|1247610|P2|Received Study Treatment|Adverse Event|2
393667|NCT00098748|1247611|P1|Received Study Treatment|Adverse Event|1
393668|NCT00098748|1247609|P3|Received Study Treatment|Death|2
393669|NCT00098748|1247610|P2|Received Study Treatment|Death|1
393670|NCT00098748|1247611|P1|Received Study Treatment|Death|2
393671|NCT00098748|1247609|P3|Assigned to Study Treatment|Randomized, but not treated|2
393672|NCT00098748|1247610|P2|Assigned to Study Treatment|Randomized, but not treated|2
393673|NCT00098748|1247611|P1|Assigned to Study Treatment|Randomized, but not treated|0
393674|NCT00098722|1247667|P7|Observation Phase|Unspecified|10
393675|NCT00098722|1247668|P6|Observation Phase|Unspecified|21
393676|NCT00098722|1247669|P5|Observation Phase|Unspecified|0
393677|NCT00098722|1247670|P4|Observation Phase|Unspecified|0
393678|NCT00098722|1247671|P3|Observation Phase|Unspecified|0
393679|NCT00098722|1247672|P2|Observation Phase|Unspecified|0
393680|NCT00098722|1247673|P1|Observation Phase|Unspecified|0
393681|NCT00098722|1247667|P7|Observation Phase|Participant defaulted|4
393682|NCT00098722|1247668|P6|Observation Phase|Participant defaulted|17
393683|NCT00098722|1247669|P5|Observation Phase|Participant defaulted|0
393684|NCT00098722|1247670|P4|Observation Phase|Participant defaulted|0
393685|NCT00098722|1247671|P3|Observation Phase|Participant defaulted|0
393686|NCT00098722|1247672|P2|Observation Phase|Participant defaulted|0
393687|NCT00098722|1247673|P1|Observation Phase|Participant defaulted|0
393688|NCT00098722|1247667|P7|Observation Phase|Lack of Efficacy|0
393689|NCT00098722|1247668|P6|Observation Phase|Lack of Efficacy|2
393690|NCT00098722|1247669|P5|Observation Phase|Lack of Efficacy|0
393691|NCT00098722|1247670|P4|Observation Phase|Lack of Efficacy|0
393692|NCT00098722|1247671|P3|Observation Phase|Lack of Efficacy|0
393693|NCT00098722|1247672|P2|Observation Phase|Lack of Efficacy|0
393694|NCT00098722|1247673|P1|Observation Phase|Lack of Efficacy|0
393695|NCT00098722|1247667|P7|Observation Phase|Death|3
393696|NCT00098722|1247668|P6|Observation Phase|Death|5
393697|NCT00098722|1247669|P5|Observation Phase|Death|0
393698|NCT00098722|1247670|P4|Observation Phase|Death|0
393699|NCT00098722|1247671|P3|Observation Phase|Death|0
393700|NCT00098722|1247672|P2|Observation Phase|Death|0
393701|NCT00098722|1247673|P1|Observation Phase|Death|0
393702|NCT00098722|1247667|P7|Open Label Phase|Unspecified|0
393703|NCT00098722|1247668|P6|Open Label Phase|Unspecified|0
393704|NCT00098722|1247669|P5|Open Label Phase|Unspecified|0
393705|NCT00098722|1247670|P4|Open Label Phase|Unspecified|18
393706|NCT00098722|1247671|P3|Open Label Phase|Unspecified|0
393707|NCT00098722|1247672|P2|Open Label Phase|Unspecified|0
393708|NCT00098722|1247673|P1|Open Label Phase|Unspecified|0
393709|NCT00098722|1247667|P7|Open Label Phase|Ongoing at cut-off date|0
393710|NCT00098722|1247668|P6|Open Label Phase|Ongoing at cut-off date|0
393711|NCT00098722|1247669|P5|Open Label Phase|Ongoing at cut-off date|50
393712|NCT00098722|1247670|P4|Open Label Phase|Ongoing at cut-off date|220
393713|NCT00098722|1247671|P3|Open Label Phase|Ongoing at cut-off date|0
393714|NCT00098722|1247672|P2|Open Label Phase|Ongoing at cut-off date|0
393715|NCT00098722|1247673|P1|Open Label Phase|Ongoing at cut-off date|0
393716|NCT00098722|1247667|P7|Open Label Phase|Participant defaulted|0
393717|NCT00098722|1247668|P6|Open Label Phase|Participant defaulted|0
393718|NCT00098722|1247669|P5|Open Label Phase|Participant defaulted|0
393719|NCT00098722|1247670|P4|Open Label Phase|Participant defaulted|18
393720|NCT00098722|1247671|P3|Open Label Phase|Participant defaulted|0
393721|NCT00098722|1247672|P2|Open Label Phase|Participant defaulted|0
393722|NCT00098722|1247673|P1|Open Label Phase|Participant defaulted|0
393723|NCT00098722|1247667|P7|Open Label Phase|Pregnancy|0
393724|NCT00098722|1247668|P6|Open Label Phase|Pregnancy|0
393725|NCT00098722|1247669|P5|Open Label Phase|Pregnancy|0
393726|NCT00098722|1247670|P4|Open Label Phase|Pregnancy|1
393727|NCT00098722|1247671|P3|Open Label Phase|Pregnancy|0
393728|NCT00098722|1247672|P2|Open Label Phase|Pregnancy|0
393729|NCT00098722|1247673|P1|Open Label Phase|Pregnancy|0
393730|NCT00098722|1247667|P7|Open Label Phase|Lack of Efficacy|0
393731|NCT00098722|1247668|P6|Open Label Phase|Lack of Efficacy|0
393732|NCT00098722|1247669|P5|Open Label Phase|Lack of Efficacy|0
393733|NCT00098722|1247670|P4|Open Label Phase|Lack of Efficacy|8
393734|NCT00098722|1247671|P3|Open Label Phase|Lack of Efficacy|0
393735|NCT00098722|1247672|P2|Open Label Phase|Lack of Efficacy|0
393736|NCT00098722|1247673|P1|Open Label Phase|Lack of Efficacy|0
393737|NCT00098722|1247667|P7|Open Label Phase|Death|0
393738|NCT00098722|1247668|P6|Open Label Phase|Death|0
393739|NCT00098722|1247669|P5|Open Label Phase|Death|0
393740|NCT00098722|1247670|P4|Open Label Phase|Death|2
393741|NCT00098722|1247671|P3|Open Label Phase|Death|0
393742|NCT00098722|1247672|P2|Open Label Phase|Death|0
393743|NCT00098722|1247673|P1|Open Label Phase|Death|0
393744|NCT00098722|1247667|P7|Open Label Phase|Adverse Event|0
393745|NCT00098722|1247668|P6|Open Label Phase|Adverse Event|0
393746|NCT00098722|1247669|P5|Open Label Phase|Adverse Event|0
393747|NCT00098722|1247670|P4|Open Label Phase|Adverse Event|5
393748|NCT00098722|1247671|P3|Open Label Phase|Adverse Event|0
393749|NCT00098722|1247672|P2|Open Label Phase|Adverse Event|0
393750|NCT00098722|1247673|P1|Open Label Phase|Adverse Event|0
393751|NCT00098722|1247667|P7|Double Blind Phase|Unspecified|0
393752|NCT00098722|1247668|P6|Double Blind Phase|Unspecified|0
393753|NCT00098722|1247669|P5|Double Blind Phase|Unspecified|0
393754|NCT00098722|1247670|P4|Double Blind Phase|Unspecified|0
393755|NCT00098722|1247671|P3|Double Blind Phase|Unspecified|7
393756|NCT00098722|1247672|P2|Double Blind Phase|Unspecified|8
393757|NCT00098722|1247673|P1|Double Blind Phase|Unspecified|7
393758|NCT00098722|1247667|P7|Double Blind Phase|Ongoing at cut-off date|0
393759|NCT00098722|1247668|P6|Double Blind Phase|Ongoing at cut-off date|0
393760|NCT00098722|1247669|P5|Double Blind Phase|Ongoing at cut-off date|0
393761|NCT00098722|1247670|P4|Double Blind Phase|Ongoing at cut-off date|0
393762|NCT00098722|1247671|P3|Double Blind Phase|Ongoing at cut-off date|57
393763|NCT00098722|1247672|P2|Double Blind Phase|Ongoing at cut-off date|137
393764|NCT00098722|1247673|P1|Double Blind Phase|Ongoing at cut-off date|128
393765|NCT00098722|1247667|P7|Double Blind Phase|Randomized, not treated|0
393766|NCT00098722|1247668|P6|Double Blind Phase|Randomized, not treated|0
393767|NCT00098722|1247669|P5|Double Blind Phase|Randomized, not treated|0
393768|NCT00098722|1247670|P4|Double Blind Phase|Randomized, not treated|0
393769|NCT00098722|1247671|P3|Double Blind Phase|Randomized, not treated|3
393770|NCT00098722|1247672|P2|Double Blind Phase|Randomized, not treated|3
393771|NCT00098722|1247673|P1|Double Blind Phase|Randomized, not treated|4
393772|NCT00098722|1247667|P7|Double Blind Phase|Pregnancy|0
393773|NCT00098722|1247668|P6|Double Blind Phase|Pregnancy|0
393774|NCT00098722|1247669|P5|Double Blind Phase|Pregnancy|0
393775|NCT00098722|1247670|P4|Double Blind Phase|Pregnancy|0
393776|NCT00098722|1247671|P3|Double Blind Phase|Pregnancy|0
393777|NCT00098722|1247672|P2|Double Blind Phase|Pregnancy|0
393778|NCT00098722|1247673|P1|Double Blind Phase|Pregnancy|1
393779|NCT00098722|1247667|P7|Double Blind Phase|Participant defaulted|0
393780|NCT00098722|1247668|P6|Double Blind Phase|Participant defaulted|0
393781|NCT00098722|1247669|P5|Double Blind Phase|Participant defaulted|0
393782|NCT00098722|1247670|P4|Double Blind Phase|Participant defaulted|0
393783|NCT00098722|1247671|P3|Double Blind Phase|Participant defaulted|9
393784|NCT00098722|1247672|P2|Double Blind Phase|Participant defaulted|11
393785|NCT00098722|1247673|P1|Double Blind Phase|Participant defaulted|16
393786|NCT00098722|1247667|P7|Double Blind Phase|Lack of Efficacy|0
393787|NCT00098722|1247668|P6|Double Blind Phase|Lack of Efficacy|0
393788|NCT00098722|1247669|P5|Double Blind Phase|Lack of Efficacy|0
393789|NCT00098722|1247670|P4|Double Blind Phase|Lack of Efficacy|0
393790|NCT00098722|1247671|P3|Double Blind Phase|Lack of Efficacy|15
393791|NCT00098722|1247672|P2|Double Blind Phase|Lack of Efficacy|23
393792|NCT00098722|1247673|P1|Double Blind Phase|Lack of Efficacy|21
393793|NCT00098722|1247667|P7|Double Blind Phase|Death|0
393794|NCT00098722|1247668|P6|Double Blind Phase|Death|0
393795|NCT00098722|1247669|P5|Double Blind Phase|Death|0
393796|NCT00098722|1247670|P4|Double Blind Phase|Death|0
393797|NCT00098722|1247671|P3|Double Blind Phase|Death|0
393798|NCT00098722|1247672|P2|Double Blind Phase|Death|5
393799|NCT00098722|1247673|P1|Double Blind Phase|Death|2
393800|NCT00098722|1247667|P7|Double Blind Phase|Adverse Event|0
393801|NCT00098722|1247668|P6|Double Blind Phase|Adverse Event|0
393802|NCT00098722|1247669|P5|Double Blind Phase|Adverse Event|0
393803|NCT00098722|1247670|P4|Double Blind Phase|Adverse Event|0
393804|NCT00098722|1247671|P3|Double Blind Phase|Adverse Event|3
393805|NCT00098722|1247672|P2|Double Blind Phase|Adverse Event|7
393806|NCT00098722|1247673|P1|Double Blind Phase|Adverse Event|7
393807|NCT00098475|1247747|P4|Step 2|Never started treatment|0
393808|NCT00098475|1247748|P3|Step 2|Never started treatment|0
393809|NCT00098475|1247749|P2|Step 2|Never started treatment|1
393810|NCT00098475|1247750|P1|Step 2|Never started treatment|1
393811|NCT00098475|1247747|P4|Step 2|Alternative therapy|0
393812|NCT00098475|1247748|P3|Step 2|Alternative therapy|0
393813|NCT00098475|1247749|P2|Step 2|Alternative therapy|2
393814|NCT00098475|1247750|P1|Step 2|Alternative therapy|1
393815|NCT00098475|1247747|P4|Step 2|Physician Decision|0
393816|NCT00098475|1247748|P3|Step 2|Physician Decision|0
393817|NCT00098475|1247749|P2|Step 2|Physician Decision|1
393818|NCT00098475|1247750|P1|Step 2|Physician Decision|0
393819|NCT00098475|1247747|P4|Step 2|Withdrawal by Subject|0
393820|NCT00098475|1247748|P3|Step 2|Withdrawal by Subject|0
393821|NCT00098475|1247749|P2|Step 2|Withdrawal by Subject|2
393822|NCT00098475|1247750|P1|Step 2|Withdrawal by Subject|0
393823|NCT00098475|1247747|P4|Step 2|Adverse Event|0
393824|NCT00098475|1247748|P3|Step 2|Adverse Event|0
393825|NCT00098475|1247749|P2|Step 2|Adverse Event|0
393826|NCT00098475|1247750|P1|Step 2|Adverse Event|2
393827|NCT00098475|1247747|P4|Step 2|Disease progression|0
393828|NCT00098475|1247748|P3|Step 2|Disease progression|0
393829|NCT00098475|1247749|P2|Step 2|Disease progression|4
393830|NCT00098475|1247750|P1|Step 2|Disease progression|1
393831|NCT00098475|1247747|P4|Step 1|Not documented|0
393832|NCT00098475|1247748|P3|Step 1|Not documented|0
393833|NCT00098475|1247749|P2|Step 1|Not documented|1
393834|NCT00098475|1247750|P1|Step 1|Not documented|0
393835|NCT00098475|1247747|P4|Step 1|Patient fell with fracture|0
393836|NCT00098475|1247748|P3|Step 1|Patient fell with fracture|0
393837|NCT00098475|1247749|P2|Step 1|Patient fell with fracture|0
393838|NCT00098475|1247750|P1|Step 1|Patient fell with fracture|1
393839|NCT00098475|1247747|P4|Step 1|Misinterpretation of lab data|0
393840|NCT00098475|1247748|P3|Step 1|Misinterpretation of lab data|0
393841|NCT00098475|1247749|P2|Step 1|Misinterpretation of lab data|1
393842|NCT00098475|1247750|P1|Step 1|Misinterpretation of lab data|0
393843|NCT00098475|1247747|P4|Step 1|Criteria to continue treatment not met|0
393844|NCT00098475|1247748|P3|Step 1|Criteria to continue treatment not met|0
393845|NCT00098475|1247749|P2|Step 1|Criteria to continue treatment not met|1
393846|NCT00098475|1247750|P1|Step 1|Criteria to continue treatment not met|0
393847|NCT00098475|1247747|P4|Step 1|Referred to other physicians|0
393848|NCT00098475|1247748|P3|Step 1|Referred to other physicians|0
393849|NCT00098475|1247749|P2|Step 1|Referred to other physicians|1
393850|NCT00098475|1247750|P1|Step 1|Referred to other physicians|0
393851|NCT00098475|1247747|P4|Step 1|Rising paraprotein|0
393852|NCT00098475|1247748|P3|Step 1|Rising paraprotein|0
393853|NCT00098475|1247749|P2|Step 1|Rising paraprotein|1
393854|NCT00098475|1247750|P1|Step 1|Rising paraprotein|0
393855|NCT00098475|1247747|P4|Step 1|Insurance issue|0
393856|NCT00098475|1247748|P3|Step 1|Insurance issue|0
393857|NCT00098475|1247749|P2|Step 1|Insurance issue|1
393858|NCT00098475|1247750|P1|Step 1|Insurance issue|0
393859|NCT00098475|1247747|P4|Step 1|Declining performance status|0
393860|NCT00098475|1247748|P3|Step 1|Declining performance status|0
393861|NCT00098475|1247749|P2|Step 1|Declining performance status|1
393862|NCT00098475|1247750|P1|Step 1|Declining performance status|0
393863|NCT00098475|1247747|P4|Step 1|Off treatment for > specified timeframe|0
393864|NCT00098475|1247748|P3|Step 1|Off treatment for > specified timeframe|0
393865|NCT00098475|1247749|P2|Step 1|Off treatment for > specified timeframe|1
393866|NCT00098475|1247750|P1|Step 1|Off treatment for > specified timeframe|1
393867|NCT00098475|1247747|P4|Step 1|Incorrect disease assessment|0
393868|NCT00098475|1247748|P3|Step 1|Incorrect disease assessment|0
393869|NCT00098475|1247749|P2|Step 1|Incorrect disease assessment|0
393870|NCT00098475|1247750|P1|Step 1|Incorrect disease assessment|2
393871|NCT00098475|1247747|P4|Step 1|Both patient and physician's decision|0
393872|NCT00098475|1247748|P3|Step 1|Both patient and physician's decision|0
393873|NCT00098475|1247749|P2|Step 1|Both patient and physician's decision|1
393874|NCT00098475|1247750|P1|Step 1|Both patient and physician's decision|2
393875|NCT00098475|1247747|P4|Step 1|Cannot comply due to other tx|0
393876|NCT00098475|1247748|P3|Step 1|Cannot comply due to other tx|0
393877|NCT00098475|1247749|P2|Step 1|Cannot comply due to other tx|1
393878|NCT00098475|1247750|P1|Step 1|Cannot comply due to other tx|0
393879|NCT00098475|1247747|P4|Step 1|Complications|0
393880|NCT00098475|1247748|P3|Step 1|Complications|0
393881|NCT00098475|1247749|P2|Step 1|Complications|0
393882|NCT00098475|1247750|P1|Step 1|Complications|1
393883|NCT00098475|1247747|P4|Step 1|Knee surgery|0
393884|NCT00098475|1247748|P3|Step 1|Knee surgery|0
393885|NCT00098475|1247749|P2|Step 1|Knee surgery|0
393886|NCT00098475|1247750|P1|Step 1|Knee surgery|1
393887|NCT00098475|1247747|P4|Step 1|Still on treatment as of this analysis|0
393888|NCT00098475|1247748|P3|Step 1|Still on treatment as of this analysis|0
393889|NCT00098475|1247749|P2|Step 1|Still on treatment as of this analysis|27
393890|NCT00098475|1247750|P1|Step 1|Still on treatment as of this analysis|14
393891|NCT00098475|1247747|P4|Step 1|Never started treatment|0
393892|NCT00098475|1247748|P3|Step 1|Never started treatment|0
393893|NCT00098475|1247749|P2|Step 1|Never started treatment|2
393894|NCT00098475|1247750|P1|Step 1|Never started treatment|0
393895|NCT00098475|1247747|P4|Step 1|Other disease|0
393896|NCT00098475|1247748|P3|Step 1|Other disease|1
393897|NCT00098475|1247749|P2|Step 1|Other disease|1
393898|NCT00098475|1247750|P1|Step 1|Other disease|2
393899|NCT00098475|1247747|P4|Step 1|Alternative therapy|0
393900|NCT00098475|1247748|P3|Step 1|Alternative therapy|1
393901|NCT00098475|1247749|P2|Step 1|Alternative therapy|43
393902|NCT00098475|1247750|P1|Step 1|Alternative therapy|31
393903|NCT00098475|1247747|P4|Step 1|Physician Decision|0
393904|NCT00098475|1247748|P3|Step 1|Physician Decision|0
393905|NCT00098475|1247749|P2|Step 1|Physician Decision|2
393906|NCT00098475|1247750|P1|Step 1|Physician Decision|5
393907|NCT00098475|1247747|P4|Step 1|Withdrawal by Subject|0
393908|NCT00098475|1247748|P3|Step 1|Withdrawal by Subject|0
393909|NCT00098475|1247749|P2|Step 1|Withdrawal by Subject|11
393910|NCT00098475|1247750|P1|Step 1|Withdrawal by Subject|14
393911|NCT00098475|1247747|P4|Step 1|Death|1
393912|NCT00098475|1247748|P3|Step 1|Death|0
393913|NCT00098475|1247749|P2|Step 1|Death|5
393914|NCT00098475|1247750|P1|Step 1|Death|8
393915|NCT00098475|1247747|P4|Step 1|Adverse Event|1
393916|NCT00098475|1247748|P3|Step 1|Adverse Event|0
393917|NCT00098475|1247749|P2|Step 1|Adverse Event|37
393918|NCT00098475|1247750|P1|Step 1|Adverse Event|56
393919|NCT00098475|1247747|P4|Step 1|Progressive disease|1
393920|NCT00098475|1247748|P3|Step 1|Progressive disease|2
393921|NCT00098475|1247749|P2|Step 1|Progressive disease|35
393922|NCT00098475|1247750|P1|Step 1|Progressive disease|33
393923|NCT00098345|1247787|P1|Overall Study|progression|4
393924|NCT00098345|1247787|P1|Overall Study|Withdrawal by Subject|2
393925|NCT00098345|1247787|P1|Overall Study|Adverse Event|7
393926|NCT00098306|1247800|P7|Observational Phase|Un-specified|4
393927|NCT00098306|1247801|P6|Observational Phase|Un-specified|7
393928|NCT00098306|1247802|P5|Observational Phase|Un-specified|0
393929|NCT00098306|1247803|P4|Observational Phase|Un-specified|0
393930|NCT00098306|1247804|P3|Observational Phase|Un-specified|0
393931|NCT00098306|1247805|P2|Observational Phase|Un-specified|0
393932|NCT00098306|1247806|P1|Observational Phase|Un-specified|0
393933|NCT00098306|1247800|P7|Observational Phase|Participant defaulted|18
393934|NCT00098306|1247801|P6|Observational Phase|Participant defaulted|34
393935|NCT00098306|1247802|P5|Observational Phase|Participant defaulted|0
393936|NCT00098306|1247803|P4|Observational Phase|Participant defaulted|0
393937|NCT00098306|1247804|P3|Observational Phase|Participant defaulted|0
393938|NCT00098306|1247805|P2|Observational Phase|Participant defaulted|0
393939|NCT00098306|1247806|P1|Observational Phase|Participant defaulted|0
393940|NCT00098306|1247800|P7|Observational Phase|Death|4
393941|NCT00098306|1247801|P6|Observational Phase|Death|5
393942|NCT00098306|1247802|P5|Observational Phase|Death|0
393943|NCT00098306|1247803|P4|Observational Phase|Death|0
393944|NCT00098306|1247804|P3|Observational Phase|Death|0
393945|NCT00098306|1247805|P2|Observational Phase|Death|0
393946|NCT00098306|1247806|P1|Observational Phase|Death|0
393947|NCT00098306|1247800|P7|Open Label|Ongoing at cut-off date|0
393948|NCT00098306|1247801|P6|Open Label|Ongoing at cut-off date|0
393949|NCT00098306|1247802|P5|Open Label|Ongoing at cut-off date|62
393950|NCT00098306|1247803|P4|Open Label|Ongoing at cut-off date|269
393951|NCT00098306|1247804|P3|Open Label|Ongoing at cut-off date|0
393952|NCT00098306|1247805|P2|Open Label|Ongoing at cut-off date|0
393953|NCT00098306|1247806|P1|Open Label|Ongoing at cut-off date|0
393954|NCT00098306|1247800|P7|Open Label|Un-specified|0
393955|NCT00098306|1247801|P6|Open Label|Un-specified|0
393956|NCT00098306|1247802|P5|Open Label|Un-specified|0
393957|NCT00098306|1247803|P4|Open Label|Un-specified|15
393958|NCT00098306|1247804|P3|Open Label|Un-specified|0
393959|NCT00098306|1247805|P2|Open Label|Un-specified|0
393960|NCT00098306|1247806|P1|Open Label|Un-specified|0
393961|NCT00098306|1247800|P7|Open Label|Participant defaulted|0
393962|NCT00098306|1247801|P6|Open Label|Participant defaulted|0
393963|NCT00098306|1247802|P5|Open Label|Participant defaulted|0
393964|NCT00098306|1247803|P4|Open Label|Participant defaulted|24
393965|NCT00098306|1247804|P3|Open Label|Participant defaulted|0
393966|NCT00098306|1247805|P2|Open Label|Participant defaulted|0
393967|NCT00098306|1247806|P1|Open Label|Participant defaulted|0
393968|NCT00098306|1247800|P7|Open Label|Death|0
393969|NCT00098306|1247801|P6|Open Label|Death|0
393970|NCT00098306|1247802|P5|Open Label|Death|0
393971|NCT00098306|1247803|P4|Open Label|Death|4
393972|NCT00098306|1247804|P3|Open Label|Death|0
393973|NCT00098306|1247805|P2|Open Label|Death|0
393974|NCT00098306|1247806|P1|Open Label|Death|0
393975|NCT00098306|1247800|P7|Open Label|Adverse Event|0
393976|NCT00098306|1247801|P6|Open Label|Adverse Event|0
393977|NCT00098306|1247802|P5|Open Label|Adverse Event|0
393978|NCT00098306|1247803|P4|Open Label|Adverse Event|2
393979|NCT00098306|1247804|P3|Open Label|Adverse Event|0
393980|NCT00098306|1247805|P2|Open Label|Adverse Event|0
393981|NCT00098306|1247806|P1|Open Label|Adverse Event|0
393982|NCT00098306|1247800|P7|Open Label|Lack of Efficacy|0
393983|NCT00098306|1247801|P6|Open Label|Lack of Efficacy|0
393984|NCT00098306|1247802|P5|Open Label|Lack of Efficacy|0
393985|NCT00098306|1247803|P4|Open Label|Lack of Efficacy|13
393986|NCT00098306|1247804|P3|Open Label|Lack of Efficacy|0
393987|NCT00098306|1247805|P2|Open Label|Lack of Efficacy|0
393988|NCT00098306|1247806|P1|Open Label|Lack of Efficacy|0
393989|NCT00098306|1247800|P7|Double Blind|Un-specified|0
393990|NCT00098306|1247801|P6|Double Blind|Un-specified|0
393991|NCT00098306|1247802|P5|Double Blind|Un-specified|0
393992|NCT00098306|1247803|P4|Double Blind|Un-specified|0
393993|NCT00098306|1247804|P3|Double Blind|Un-specified|11
393994|NCT00098306|1247805|P2|Double Blind|Un-specified|3
393995|NCT00098306|1247806|P1|Double Blind|Un-specified|7
393996|NCT00098306|1247800|P7|Double Blind|Participant defaulted|0
393997|NCT00098306|1247801|P6|Double Blind|Participant defaulted|0
393998|NCT00098306|1247802|P5|Double Blind|Participant defaulted|0
393999|NCT00098306|1247803|P4|Double Blind|Participant defaulted|0
394000|NCT00098306|1247804|P3|Double Blind|Participant defaulted|11
394001|NCT00098306|1247805|P2|Double Blind|Participant defaulted|18
394002|NCT00098306|1247806|P1|Double Blind|Participant defaulted|19
394003|NCT00098306|1247800|P7|Double Blind|Death|0
394004|NCT00098306|1247801|P6|Double Blind|Death|0
394005|NCT00098306|1247802|P5|Double Blind|Death|0
394006|NCT00098306|1247803|P4|Double Blind|Death|0
394007|NCT00098306|1247804|P3|Double Blind|Death|1
394008|NCT00098306|1247805|P2|Double Blind|Death|4
394009|NCT00098306|1247806|P1|Double Blind|Death|1
394010|NCT00098306|1247800|P7|Double Blind|Lack of Efficacy|0
394011|NCT00098306|1247801|P6|Double Blind|Lack of Efficacy|0
394012|NCT00098306|1247802|P5|Double Blind|Lack of Efficacy|0
394013|NCT00098306|1247803|P4|Double Blind|Lack of Efficacy|0
394014|NCT00098306|1247804|P3|Double Blind|Lack of Efficacy|17
394015|NCT00098306|1247805|P2|Double Blind|Lack of Efficacy|34
394016|NCT00098306|1247806|P1|Double Blind|Lack of Efficacy|43
394017|NCT00098306|1247800|P7|Double Blind|Adverse Event|0
394018|NCT00098306|1247801|P6|Double Blind|Adverse Event|0
394019|NCT00098306|1247802|P5|Double Blind|Adverse Event|0
394020|NCT00098306|1247803|P4|Double Blind|Adverse Event|0
394021|NCT00098306|1247804|P3|Double Blind|Adverse Event|6
394022|NCT00098306|1247805|P2|Double Blind|Adverse Event|10
394023|NCT00098306|1247806|P1|Double Blind|Adverse Event|11
394024|NCT00098306|1247800|P7|Double Blind|Ongoing at cut-off date|0
394025|NCT00098306|1247801|P6|Double Blind|Ongoing at cut-off date|0
394026|NCT00098306|1247802|P5|Double Blind|Ongoing at cut-off date|0
394027|NCT00098306|1247803|P4|Double Blind|Ongoing at cut-off date|0
394028|NCT00098306|1247804|P3|Double Blind|Ongoing at cut-off date|72
394029|NCT00098306|1247805|P2|Double Blind|Ongoing at cut-off date|166
394030|NCT00098306|1247806|P1|Double Blind|Ongoing at cut-off date|151
394031|NCT00098306|1247800|P7|Double Blind|Randomized, not treated|0
394032|NCT00098306|1247801|P6|Double Blind|Randomized, not treated|0
394033|NCT00098306|1247802|P5|Double Blind|Randomized, not treated|0
394034|NCT00098306|1247803|P4|Double Blind|Randomized, not treated|0
394035|NCT00098306|1247804|P3|Double Blind|Randomized, not treated|2
394036|NCT00098306|1247805|P2|Double Blind|Randomized, not treated|5
394037|NCT00098306|1247806|P1|Double Blind|Randomized, not treated|9
394038|NCT00098293|1247872|P5|Supplemental Phase (SP)|Unspecified|22
394039|NCT00098293|1247873|P4|Supplemental Phase (SP)|Unspecified|0
394040|NCT00098293|1247874|P3|Supplemental Phase (SP)|Unspecified|0
394041|NCT00098293|1247875|P2|Supplemental Phase (SP)|Unspecified|0
394042|NCT00098293|1247876|P1|Supplemental Phase (SP)|Unspecified|0
394043|NCT00098293|1247872|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
394044|NCT00098293|1247873|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
394045|NCT00098293|1247874|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
394046|NCT00098293|1247875|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
394047|NCT00098293|1247876|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
394048|NCT00098293|1247872|P5|Supplemental Phase (SP)|Lost to Follow-up|2
394049|NCT00098293|1247873|P4|Supplemental Phase (SP)|Lost to Follow-up|0
394050|NCT00098293|1247874|P3|Supplemental Phase (SP)|Lost to Follow-up|0
394051|NCT00098293|1247875|P2|Supplemental Phase (SP)|Lost to Follow-up|0
394052|NCT00098293|1247876|P1|Supplemental Phase (SP)|Lost to Follow-up|0
394053|NCT00098293|1247872|P5|Supplemental Phase (SP)|Death|1
394054|NCT00098293|1247873|P4|Supplemental Phase (SP)|Death|0
394055|NCT00098293|1247874|P3|Supplemental Phase (SP)|Death|0
394056|NCT00098293|1247875|P2|Supplemental Phase (SP)|Death|0
394057|NCT00098293|1247876|P1|Supplemental Phase (SP)|Death|0
394058|NCT00098293|1247872|P5|Open-label (OL) Phase|Death|0
394059|NCT00098293|1247873|P4|Open-label (OL) Phase|Death|0
394060|NCT00098293|1247874|P3|Open-label (OL) Phase|Death|3
394061|NCT00098293|1247875|P2|Open-label (OL) Phase|Death|2
394062|NCT00098293|1247876|P1|Open-label (OL) Phase|Death|0
394063|NCT00098293|1247872|P5|Open-label (OL) Phase|Participant Defaulted|0
394064|NCT00098293|1247873|P4|Open-label (OL) Phase|Participant Defaulted|20
394065|NCT00098293|1247874|P3|Open-label (OL) Phase|Participant Defaulted|16
394066|NCT00098293|1247875|P2|Open-label (OL) Phase|Participant Defaulted|6
394067|NCT00098293|1247876|P1|Open-label (OL) Phase|Participant Defaulted|0
394068|NCT00098293|1247872|P5|Open-label (OL) Phase|Protocol Violation|0
394069|NCT00098293|1247873|P4|Open-label (OL) Phase|Protocol Violation|16
394070|NCT00098293|1247874|P3|Open-label (OL) Phase|Protocol Violation|13
394071|NCT00098293|1247875|P2|Open-label (OL) Phase|Protocol Violation|6
394072|NCT00098293|1247876|P1|Open-label (OL) Phase|Protocol Violation|0
394073|NCT00098293|1247872|P5|Open-label (OL) Phase|Pregnancy|0
394074|NCT00098293|1247873|P4|Open-label (OL) Phase|Pregnancy|3
394075|NCT00098293|1247874|P3|Open-label (OL) Phase|Pregnancy|0
394076|NCT00098293|1247875|P2|Open-label (OL) Phase|Pregnancy|1
394077|NCT00098293|1247876|P1|Open-label (OL) Phase|Pregnancy|0
394078|NCT00098293|1247872|P5|Open-label (OL) Phase|Lack of Efficacy|0
394079|NCT00098293|1247873|P4|Open-label (OL) Phase|Lack of Efficacy|20
394080|NCT00098293|1247874|P3|Open-label (OL) Phase|Lack of Efficacy|2
394081|NCT00098293|1247875|P2|Open-label (OL) Phase|Lack of Efficacy|7
394082|NCT00098293|1247876|P1|Open-label (OL) Phase|Lack of Efficacy|0
394083|NCT00098293|1247872|P5|Open-label (OL) Phase|Adverse Event|0
394084|NCT00098293|1247873|P4|Open-label (OL) Phase|Adverse Event|6
394085|NCT00098293|1247874|P3|Open-label (OL) Phase|Adverse Event|7
394086|NCT00098293|1247875|P2|Open-label (OL) Phase|Adverse Event|3
394087|NCT00098293|1247876|P1|Open-label (OL) Phase|Adverse Event|0
394088|NCT00098293|1247872|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
394089|NCT00098293|1247873|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
394090|NCT00098293|1247874|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
394091|NCT00098293|1247875|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
394092|NCT00098293|1247876|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
394093|NCT00098293|1247872|P5|Double-blind (DB) Phase|Terminated by sponsor|0
394094|NCT00098293|1247873|P4|Double-blind (DB) Phase|Terminated by sponsor|0
394095|NCT00098293|1247874|P3|Double-blind (DB) Phase|Terminated by sponsor|0
394096|NCT00098293|1247875|P2|Double-blind (DB) Phase|Terminated by sponsor|0
394097|NCT00098293|1247876|P1|Double-blind (DB) Phase|Terminated by sponsor|135
394098|NCT00098293|1247872|P5|Double-blind (DB) Phase|Protocol Violation|0
394099|NCT00098293|1247873|P4|Double-blind (DB) Phase|Protocol Violation|0
394100|NCT00098293|1247874|P3|Double-blind (DB) Phase|Protocol Violation|22
394101|NCT00098293|1247875|P2|Double-blind (DB) Phase|Protocol Violation|18
394102|NCT00098293|1247876|P1|Double-blind (DB) Phase|Protocol Violation|2
394103|NCT00098293|1247872|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
394104|NCT00098293|1247873|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
394105|NCT00098293|1247874|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
394106|NCT00098293|1247875|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
394107|NCT00098293|1247876|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
394108|NCT00098293|1247872|P5|Double-blind (DB) Phase|Death|0
394109|NCT00098293|1247873|P4|Double-blind (DB) Phase|Death|0
394110|NCT00098293|1247874|P3|Double-blind (DB) Phase|Death|2
394111|NCT00098293|1247875|P2|Double-blind (DB) Phase|Death|2
394112|NCT00098293|1247876|P1|Double-blind (DB) Phase|Death|1
394113|NCT00098293|1247872|P5|Double-blind (DB) Phase|Lack of Efficacy|0
394114|NCT00098293|1247873|P4|Double-blind (DB) Phase|Lack of Efficacy|0
394115|NCT00098293|1247874|P3|Double-blind (DB) Phase|Lack of Efficacy|30
394116|NCT00098293|1247875|P2|Double-blind (DB) Phase|Lack of Efficacy|64
394117|NCT00098293|1247876|P1|Double-blind (DB) Phase|Lack of Efficacy|11
394118|NCT00098293|1247872|P5|Double-blind (DB) Phase|Participant Defaulted|0
394119|NCT00098293|1247873|P4|Double-blind (DB) Phase|Participant Defaulted|0
394120|NCT00098293|1247874|P3|Double-blind (DB) Phase|Participant Defaulted|36
394121|NCT00098293|1247875|P2|Double-blind (DB) Phase|Participant Defaulted|40
394122|NCT00098293|1247876|P1|Double-blind (DB) Phase|Participant Defaulted|11
394123|NCT00098293|1247872|P5|Double-blind (DB) Phase|Pregnancy|0
394124|NCT00098293|1247873|P4|Double-blind (DB) Phase|Pregnancy|0
394125|NCT00098293|1247874|P3|Double-blind (DB) Phase|Pregnancy|9
394126|NCT00098293|1247875|P2|Double-blind (DB) Phase|Pregnancy|7
394127|NCT00098293|1247876|P1|Double-blind (DB) Phase|Pregnancy|0
394128|NCT00098293|1247872|P5|Double-blind (DB) Phase|Adverse Event|0
394129|NCT00098293|1247873|P4|Double-blind (DB) Phase|Adverse Event|0
394130|NCT00098293|1247874|P3|Double-blind (DB) Phase|Adverse Event|60
394131|NCT00098293|1247875|P2|Double-blind (DB) Phase|Adverse Event|27
394132|NCT00098293|1247876|P1|Double-blind (DB) Phase|Adverse Event|14
394133|NCT00098254|1247929|P1|Overall Study|Death|1
394134|NCT00098254|1247929|P1|Overall Study|Adverse Event|2
394135|NCT00097981|1247997|P2|Overall Study|Other|13
394136|NCT00097981|1247998|P1|Overall Study|Other|19
394137|NCT00097981|1247997|P2|Overall Study|Transplant planned|27
394138|NCT00097981|1247998|P1|Overall Study|Transplant planned|28
394139|NCT00097981|1247997|P2|Overall Study|Disease Progression|2
394140|NCT00097981|1247998|P1|Overall Study|Disease Progression|8
394141|NCT00097981|1247997|P2|Overall Study|Physician Decision|1
394142|NCT00097981|1247998|P1|Overall Study|Physician Decision|7
394143|NCT00097981|1247997|P2|Overall Study|Death|4
394144|NCT00097981|1247998|P1|Overall Study|Death|2
394145|NCT00097981|1247997|P2|Overall Study|Protocol Violation|1
394146|NCT00097981|1247998|P1|Overall Study|Protocol Violation|1
394147|NCT00097981|1247997|P2|Overall Study|Withdrawal by Subject|8
394148|NCT00097981|1247998|P1|Overall Study|Withdrawal by Subject|10
394149|NCT00097981|1247997|P2|Overall Study|Adverse Event|44
394150|NCT00097981|1247998|P1|Overall Study|Adverse Event|31
394151|NCT00097786|1248020|P4|Overall Study|lost to follow-up for all-cause death|310
394152|NCT00097786|1248021|P3|Overall Study|lost to follow-up for all-cause death|313
394153|NCT00097786|1248022|P2|Overall Study|lost to follow-up for all-cause death|292
394154|NCT00097786|1248023|P1|Overall Study|lost to follow-up for all-cause death|296
394155|NCT00097773|1248045|P4|Overall Study|Other|0
394156|NCT00097773|1248046|P3|Overall Study|Other|2
394157|NCT00097773|1248047|P2|Overall Study|Other|0
394158|NCT00097773|1248048|P1|Overall Study|Other|1
394159|NCT00097773|1248045|P4|Overall Study|Adverse Event|0
394160|NCT00097773|1248046|P3|Overall Study|Adverse Event|0
394161|NCT00097773|1248047|P2|Overall Study|Adverse Event|1
394162|NCT00097773|1248048|P1|Overall Study|Adverse Event|0
394163|NCT00097773|1248045|P4|Overall Study|Withdrawal by Subject|1
394164|NCT00097773|1248046|P3|Overall Study|Withdrawal by Subject|3
394165|NCT00097773|1248047|P2|Overall Study|Withdrawal by Subject|3
394166|NCT00097773|1248048|P1|Overall Study|Withdrawal by Subject|3
394167|NCT00097773|1248045|P4|Overall Study|Physician Decision|1
394168|NCT00097773|1248046|P3|Overall Study|Physician Decision|3
394169|NCT00097773|1248047|P2|Overall Study|Physician Decision|2
394170|NCT00097773|1248048|P1|Overall Study|Physician Decision|2
394171|NCT00097773|1248045|P4|Overall Study|Lost to Follow-up|1
394172|NCT00097773|1248046|P3|Overall Study|Lost to Follow-up|0
394173|NCT00097773|1248047|P2|Overall Study|Lost to Follow-up|2
394174|NCT00097773|1248048|P1|Overall Study|Lost to Follow-up|2
394175|NCT00097721|1248068|P2|Overall Study|Reason not given|1
394176|NCT00097721|1248069|P1|Overall Study|Reason not given|1
394177|NCT00097721|1248068|P2|Overall Study|Physician Decision|3
394178|NCT00097721|1248069|P1|Overall Study|Physician Decision|1
394179|NCT00097721|1248068|P2|Overall Study|Progressive Disease|27
394180|NCT00097721|1248069|P1|Overall Study|Progressive Disease|55
394181|NCT00097721|1248068|P2|Overall Study|Withdrawal by Subject|1
394182|NCT00097721|1248069|P1|Overall Study|Withdrawal by Subject|6
394183|NCT00097721|1248068|P2|Overall Study|Adverse Event|1
394184|NCT00097721|1248069|P1|Overall Study|Adverse Event|8
394185|NCT00097591|1248119|P2|Overall Study|Other|3
394186|NCT00097591|1248120|P1|Overall Study|Other|0
394187|NCT00097591|1248119|P2|Overall Study|Lost to follow up|10
394188|NCT00097591|1248120|P1|Overall Study|Lost to follow up|6
394189|NCT00097591|1248119|P2|Overall Study|Unable to attend termination visit|51
394190|NCT00097591|1248120|P1|Overall Study|Unable to attend termination visit|53
394191|NCT00097591|1248119|P2|Overall Study|Less than 6 months on study drug|7
394192|NCT00097591|1248120|P1|Overall Study|Less than 6 months on study drug|9
394193|NCT00097591|1248119|P2|Overall Study|Withdrawal of consent|323
394194|NCT00097591|1248120|P1|Overall Study|Withdrawal of consent|342
394195|NCT00097539|1248143|P7|Overall Study|Reason not Specified|2
394196|NCT00097539|1248144|P6|Overall Study|Reason not Specified|40
394197|NCT00097539|1248145|P5|Overall Study|Reason not Specified|11
394198|NCT00097539|1248146|P4|Overall Study|Reason not Specified|21
394199|NCT00097539|1248147|P3|Overall Study|Reason not Specified|53
394200|NCT00097539|1248148|P2|Overall Study|Reason not Specified|49
394201|NCT00097539|1248149|P1|Overall Study|Reason not Specified|111
394202|NCT00097539|1248143|P7|Overall Study|Reasons Other Than Above|34
394203|NCT00097539|1248144|P6|Overall Study|Reasons Other Than Above|1244
394204|NCT00097539|1248145|P5|Overall Study|Reasons Other Than Above|361
394205|NCT00097539|1248146|P4|Overall Study|Reasons Other Than Above|692
394206|NCT00097539|1248147|P3|Overall Study|Reasons Other Than Above|1757
394207|NCT00097539|1248148|P2|Overall Study|Reasons Other Than Above|1382
394208|NCT00097539|1248149|P1|Overall Study|Reasons Other Than Above|3602
394209|NCT00097539|1248143|P7|Overall Study|Death|0
394210|NCT00097539|1248144|P6|Overall Study|Death|3
394211|NCT00097539|1248145|P5|Overall Study|Death|1
394212|NCT00097539|1248146|P4|Overall Study|Death|0
394213|NCT00097539|1248147|P3|Overall Study|Death|0
394214|NCT00097539|1248148|P2|Overall Study|Death|7
394215|NCT00097539|1248149|P1|Overall Study|Death|2
394216|NCT00097539|1248143|P7|Overall Study|Adverse Event|1
394217|NCT00097539|1248144|P6|Overall Study|Adverse Event|59
394218|NCT00097539|1248145|P5|Overall Study|Adverse Event|30
394219|NCT00097539|1248146|P4|Overall Study|Adverse Event|27
394220|NCT00097539|1248147|P3|Overall Study|Adverse Event|37
394221|NCT00097539|1248148|P2|Overall Study|Adverse Event|133
394222|NCT00097539|1248149|P1|Overall Study|Adverse Event|78
394223|NCT00097539|1248143|P7|Overall Study|Lack of Efficacy|5
394224|NCT00097539|1248144|P6|Overall Study|Lack of Efficacy|228
394225|NCT00097539|1248145|P5|Overall Study|Lack of Efficacy|45
394226|NCT00097539|1248146|P4|Overall Study|Lack of Efficacy|105
394227|NCT00097539|1248147|P3|Overall Study|Lack of Efficacy|202
394228|NCT00097539|1248148|P2|Overall Study|Lack of Efficacy|122
394229|NCT00097539|1248149|P1|Overall Study|Lack of Efficacy|249
394230|NCT00097539|1248143|P7|Overall Study|Participant Non-compliant|18
394231|NCT00097539|1248144|P6|Overall Study|Participant Non-compliant|543
394232|NCT00097539|1248145|P5|Overall Study|Participant Non-compliant|136
394233|NCT00097539|1248146|P4|Overall Study|Participant Non-compliant|353
394234|NCT00097539|1248147|P3|Overall Study|Participant Non-compliant|1067
394235|NCT00097539|1248148|P2|Overall Study|Participant Non-compliant|567
394236|NCT00097539|1248149|P1|Overall Study|Participant Non-compliant|2140
394237|NCT00097539|1248143|P7|Overall Study|Withdrawal by Subject|3
394238|NCT00097539|1248144|P6|Overall Study|Withdrawal by Subject|229
394239|NCT00097539|1248145|P5|Overall Study|Withdrawal by Subject|68
394240|NCT00097539|1248146|P4|Overall Study|Withdrawal by Subject|217
394241|NCT00097539|1248147|P3|Overall Study|Withdrawal by Subject|346
394242|NCT00097539|1248148|P2|Overall Study|Withdrawal by Subject|323
394243|NCT00097539|1248149|P1|Overall Study|Withdrawal by Subject|925
394244|NCT00097539|1248143|P7|Overall Study|Status Unknown (Or no final evaluation)|108
394245|NCT00097539|1248144|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
394246|NCT00097539|1248145|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
394247|NCT00097539|1248146|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
394248|NCT00097539|1248147|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
394249|NCT00097539|1248148|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
394250|NCT00097539|1248149|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
394251|NCT00097500|1248195|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
394252|NCT00097500|1248196|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
394253|NCT00097500|1248195|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
394254|NCT00097500|1248196|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
394255|NCT00097500|1248195|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
394256|NCT00097500|1248196|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
394257|NCT00097500|1248195|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
394258|NCT00097500|1248196|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
394259|NCT00097500|1248195|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
394260|NCT00097500|1248196|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
394261|NCT00097500|1248195|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
394262|NCT00097500|1248196|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
394263|NCT00097500|1248195|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
394264|NCT00097500|1248196|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
394265|NCT00097370|1248227|P1|Stage 3|Lost to Follow-up|1
394266|NCT00097370|1248227|P1|Stage 3|Sponsor Terminated Study|52
394267|NCT00097370|1248227|P1|Stage 3|Lack of Efficacy|1
394268|NCT00097370|1248227|P1|Stage 3|Withdrawal by Subject|3
394269|NCT00097370|1248227|P1|Stage 3|Adverse Event|2
394270|NCT00097370|1248227|P1|Stage 2|Lost to Follow-up|1
394271|NCT00097370|1248227|P1|Stage 2|Sponsor Terminated Study|2
394272|NCT00097370|1248227|P1|Stage 2|Pregnancy|1
394273|NCT00097370|1248227|P1|Stage 2|Lack of Efficacy|3
394274|NCT00097370|1248227|P1|Stage 2|Withdrawal by Subject|1
394275|NCT00097370|1248227|P1|Stage 2|Adverse Event|5
394276|NCT00097370|1248227|P1|Stage 1|Lack of Efficacy|2
394277|NCT00097370|1248227|P1|Stage 1|Withdrawal by Subject|1
394278|NCT00097370|1248227|P1|Stage 1|Adverse Event|3
394279|NCT00096993|1248261|P2|Overall Study|Other unspecified|1
394280|NCT00096993|1248262|P1|Overall Study|Other unspecified|1
394281|NCT00096993|1248261|P2|Overall Study|Non-compliance|1
394282|NCT00096993|1248262|P1|Overall Study|Non-compliance|0
394283|NCT00096993|1248261|P2|Overall Study|Physician Decision|1
394284|NCT00096993|1248262|P1|Overall Study|Physician Decision|2
394285|NCT00096993|1248261|P2|Overall Study|Subject's decision|1
394286|NCT00096993|1248262|P1|Overall Study|Subject's decision|3
394287|NCT00096993|1248261|P2|Overall Study|Adverse Event|8
394288|NCT00096993|1248262|P1|Overall Study|Adverse Event|2
394289|NCT00096993|1248261|P2|Overall Study|Disease progression|53
394290|NCT00096993|1248262|P1|Overall Study|Disease progression|56
394291|NCT00096993|1248261|P2|Overall Study|Death|0
394292|NCT00096993|1248262|P1|Overall Study|Death|1
394293|NCT00096954|1248278|P2|Overall Study|Lost to Follow-up|5
394294|NCT00096954|1248279|P1|Overall Study|Lost to Follow-up|8
394295|NCT00096954|1248278|P2|Overall Study|Non-compliance|3
394296|NCT00096954|1248279|P1|Overall Study|Non-compliance|0
394297|NCT00096954|1248278|P2|Overall Study|Initiation of immunotherapy|0
394298|NCT00096954|1248279|P1|Overall Study|Initiation of immunotherapy|1
394299|NCT00096954|1248278|P2|Overall Study|Pregnancy|1
394300|NCT00096954|1248279|P1|Overall Study|Pregnancy|1
394301|NCT00096954|1248278|P2|Overall Study|Sponsors Decision|1
394302|NCT00096954|1248279|P1|Overall Study|Sponsors Decision|1
394303|NCT00096954|1248278|P2|Overall Study|Physician Decision|1
394304|NCT00096954|1248279|P1|Overall Study|Physician Decision|1
394305|NCT00096954|1248278|P2|Overall Study|Withdrawal by Subject|8
394306|NCT00096954|1248279|P1|Overall Study|Withdrawal by Subject|9
394307|NCT00096954|1248278|P2|Overall Study|Adverse Event|1
394308|NCT00096954|1248279|P1|Overall Study|Adverse Event|3
394309|NCT00096941|1248291|P1|Overall Study|disease progression|3
394310|NCT00096785|1248298|P2|Overall Study|Relocated|0
394311|NCT00096785|1248299|P1|Overall Study|Relocated|1
394312|NCT00096785|1248298|P2|Overall Study|Withdrawal by Subject|1
394313|NCT00096785|1248299|P1|Overall Study|Withdrawal by Subject|0
394314|NCT00096785|1248298|P2|Overall Study|Lost to Follow-up|0
394315|NCT00096785|1248299|P1|Overall Study|Lost to Follow-up|1
394316|NCT00095498|1248340|P3|Overall Study|Requirement for alternative therapy|2
394317|NCT00095498|1248341|P2|Overall Study|Requirement for alternative therapy|0
394318|NCT00095498|1248342|P1|Overall Study|Requirement for alternative therapy|1
394319|NCT00095498|1248340|P3|Overall Study|Protocol Violation|1
394320|NCT00095498|1248341|P2|Overall Study|Protocol Violation|0
394321|NCT00095498|1248342|P1|Overall Study|Protocol Violation|0
394322|NCT00095498|1248340|P3|Overall Study|Other|6
394323|NCT00095498|1248341|P2|Overall Study|Other|7
394324|NCT00095498|1248342|P1|Overall Study|Other|6
394325|NCT00095498|1248340|P3|Overall Study|Noncompliance|1
394326|NCT00095498|1248341|P2|Overall Study|Noncompliance|0
394327|NCT00095498|1248342|P1|Overall Study|Noncompliance|1
394328|NCT00095498|1248340|P3|Overall Study|Lost to Follow-up|2
394329|NCT00095498|1248341|P2|Overall Study|Lost to Follow-up|1
394330|NCT00095498|1248342|P1|Overall Study|Lost to Follow-up|1
394331|NCT00095498|1248340|P3|Overall Study|Ineligibility determined|2
394332|NCT00095498|1248341|P2|Overall Study|Ineligibility determined|0
394333|NCT00095498|1248342|P1|Overall Study|Ineligibility determined|3
394334|NCT00095498|1248340|P3|Overall Study|Disease progression|1
394335|NCT00095498|1248341|P2|Overall Study|Disease progression|1
394336|NCT00095498|1248342|P1|Overall Study|Disease progression|0
394337|NCT00095498|1248340|P3|Overall Study|Withdrawal by Subject|15
394338|NCT00095498|1248341|P2|Overall Study|Withdrawal by Subject|16
394339|NCT00095498|1248342|P1|Overall Study|Withdrawal by Subject|15
394340|NCT00095498|1248340|P3|Overall Study|Adverse Event|1
394341|NCT00095498|1248341|P2|Overall Study|Adverse Event|0
394342|NCT00095498|1248342|P1|Overall Study|Adverse Event|1
394343|NCT00095498|1248340|P3|Overall Study|Physician Decision|8
394344|NCT00095498|1248341|P2|Overall Study|Physician Decision|10
394345|NCT00095498|1248342|P1|Overall Study|Physician Decision|9
394346|NCT00095303|1248769|P2|Follow Up Study|Lost to Follow-up|58
394347|NCT00095303|1248770|P1|Follow Up Study|Lost to Follow-up|59
394348|NCT00095303|1248769|P2|Main Study|Lost to Follow-up|87
394349|NCT00095303|1248770|P1|Main Study|Lost to Follow-up|91
394350|NCT00096538|1248836|P1|Overall Study|Withdrawal by Subject|1
394351|NCT00096486|1248844|P4|Overall Study|Not Treated|1
394352|NCT00096486|1248845|P3|Overall Study|Not Treated|1
394353|NCT00096486|1248846|P2|Overall Study|Not Treated|0
394354|NCT00096486|1248847|P1|Overall Study|Not Treated|0
394355|NCT00096486|1248844|P4|Overall Study|Withdrawal by Subject|1
394356|NCT00096486|1248845|P3|Overall Study|Withdrawal by Subject|1
394357|NCT00096486|1248846|P2|Overall Study|Withdrawal by Subject|0
394358|NCT00096486|1248847|P1|Overall Study|Withdrawal by Subject|0
394359|NCT00096447|1248866|P1|Overall Study|Never treated|1
394360|NCT00096382|1248874|P2|Overall Study|Death during treatment|0
394361|NCT00096382|1248875|P1|Overall Study|Death during treatment|1
394362|NCT00096382|1248874|P2|Overall Study|Not treated|0
394363|NCT00096382|1248875|P1|Overall Study|Not treated|1
394364|NCT00096356|1248885|P2|Overall Study|multiple reasons|18
394365|NCT00096356|1248886|P1|Overall Study|multiple reasons|10
394366|NCT00096356|1248885|P2|Overall Study|Lack of Efficacy|0
394367|NCT00096356|1248886|P1|Overall Study|Lack of Efficacy|1
394368|NCT00096356|1248885|P2|Overall Study|Withdrawal by Subject|23
394369|NCT00096356|1248886|P1|Overall Study|Withdrawal by Subject|17
394370|NCT00096356|1248885|P2|Overall Study|Physician Decision|3
394371|NCT00096356|1248886|P1|Overall Study|Physician Decision|5
394372|NCT00096356|1248885|P2|Overall Study|Adverse Event|9
394373|NCT00096356|1248886|P1|Overall Study|Adverse Event|11
394374|NCT00096278|1248898|P2|Overall Study|Patient not at risk for primary endpoint|2
394375|NCT00096278|1248899|P1|Overall Study|Patient not at risk for primary endpoint|3
394376|NCT00096278|1248898|P2|Overall Study|No follow-up data|18
394377|NCT00096278|1248899|P1|Overall Study|No follow-up data|15
394378|NCT00096265|1248908|P3|Overall Study|Ineligible|0
394379|NCT00096265|1248909|P2|Overall Study|Ineligible|0
394380|NCT00096265|1248910|P1|Overall Study|Ineligible|1
394381|NCT00096226|1248918|P1|Overall Study|Surgery but inadequate nodal sampling|1
394382|NCT00096226|1248918|P1|Overall Study|Surgical restaging not performed|13
394383|NCT00096226|1248918|P1|Overall Study|Protocol treatment not started|1
394384|NCT00096226|1248918|P1|Overall Study|Ineligible|2
394385|NCT00096200|1248925|P3|Overall Study|Ineligible pathology|0
394386|NCT00096200|1248926|P2|Overall Study|Ineligible pathology|1
394387|NCT00096200|1248927|P1|Overall Study|Ineligible pathology|0
394388|NCT00096200|1248925|P3|Overall Study|Withdrawal by Subject|0
394389|NCT00096200|1248926|P2|Overall Study|Withdrawal by Subject|2
394390|NCT00096200|1248927|P1|Overall Study|Withdrawal by Subject|1
394391|NCT00096200|1248925|P3|Overall Study|Adverse Event|0
394392|NCT00096200|1248926|P2|Overall Study|Adverse Event|4
394393|NCT00096200|1248927|P1|Overall Study|Adverse Event|0
394394|NCT00096174|1248935|P1|Overall Study|other reason|8
394395|NCT00096174|1248935|P1|Overall Study|Ineligible|6
394396|NCT00096174|1248935|P1|Overall Study|Not started protocol therapy|3
394397|NCT00096174|1248935|P1|Overall Study|Withdrawal by Subject|15
394398|NCT00096174|1248935|P1|Overall Study|Death|6
394399|NCT00096174|1248935|P1|Overall Study|Adverse Event|15
394400|NCT00096174|1248935|P1|Overall Study|Lack of Efficacy|9
394401|NCT00096135|1248980|P2|Overall Study|Ineligible|0
394402|NCT00096135|1248981|P1|Overall Study|Ineligible|2
394403|NCT00096135|1248980|P2|Overall Study|Other, specify|3
394404|NCT00096135|1248981|P1|Overall Study|Other, specify|15
394405|NCT00096135|1248980|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
394406|NCT00096135|1248981|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
394407|NCT00096135|1248980|P2|Overall Study|Refusal of further protocol therapy|1
394408|NCT00096135|1248981|P1|Overall Study|Refusal of further protocol therapy|4
394409|NCT00096135|1248980|P2|Overall Study|Physician Decision|4
394410|NCT00096135|1248981|P1|Overall Study|Physician Decision|20
394411|NCT00096031|1248997|P1|Overall Study|Not protocol specified|5
394412|NCT00096031|1248997|P1|Overall Study|Ineligible|8
394413|NCT00096031|1248997|P1|Overall Study|Withdrawal by Subject|1
394414|NCT00096031|1248997|P1|Overall Study|Death|4
394415|NCT00096031|1248997|P1|Overall Study|Lack of Efficacy|42
394416|NCT00096031|1248997|P1|Overall Study|Adverse Event|3
394417|NCT00096018|1249005|P2|Overall Study|Miscellaneous|1
394418|NCT00096018|1249006|P1|Overall Study|Miscellaneous|2
394419|NCT00096018|1249005|P2|Overall Study|Withdrawal by Subject|2
394420|NCT00096018|1249006|P1|Overall Study|Withdrawal by Subject|0
394421|NCT00096018|1249005|P2|Overall Study|Death|1
394422|NCT00096018|1249006|P1|Overall Study|Death|0
394423|NCT00096018|1249005|P2|Overall Study|Adverse Event|5
394424|NCT00096018|1249006|P1|Overall Study|Adverse Event|0
394425|NCT00096018|1249005|P2|Overall Study|Miscellaneous (not treated)|2
394426|NCT00096018|1249006|P1|Overall Study|Miscellaneous (not treated)|0
394427|NCT00096018|1249005|P2|Overall Study|Became Ineligible (not treated)|3
394428|NCT00096018|1249006|P1|Overall Study|Became Ineligible (not treated)|0
394429|NCT00095979|1249014|P1|Overall Study|Ineligible: Second primary cancer site|2
394430|NCT00095940|1249027|P9|Lapatinib Continuation/Phase II|Adverse Event|0
394431|NCT00095940|1249028|P8|Lapatinib Continuation/Phase II|Adverse Event|1
394432|NCT00095940|1249029|P7|Lapatinib Continuation/Phase II|Adverse Event|0
394433|NCT00095940|1249030|P6|Lapatinib Continuation/Phase II|Adverse Event|0
394434|NCT00095940|1249031|P5|Lapatinib Continuation/Phase II|Adverse Event|0
394435|NCT00095940|1249032|P4|Lapatinib Continuation/Phase II|Adverse Event|0
394436|NCT00095940|1249033|P3|Lapatinib Continuation/Phase II|Adverse Event|0
394437|NCT00095940|1249034|P2|Lapatinib Continuation/Phase II|Adverse Event|0
394438|NCT00095940|1249035|P1|Lapatinib Continuation/Phase II|Adverse Event|0
394439|NCT00095940|1249027|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
394440|NCT00095940|1249028|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
394441|NCT00095940|1249029|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
394442|NCT00095940|1249030|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
394443|NCT00095940|1249031|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
394444|NCT00095940|1249032|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
394445|NCT00095940|1249033|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
394446|NCT00095940|1249034|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
394447|NCT00095940|1249035|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
394448|NCT00095940|1249027|P9|Lapatinib Continuation/Phase II|Disease Progression|12
394449|NCT00095940|1249028|P8|Lapatinib Continuation/Phase II|Disease Progression|1
394450|NCT00095940|1249029|P7|Lapatinib Continuation/Phase II|Disease Progression|2
394451|NCT00095940|1249030|P6|Lapatinib Continuation/Phase II|Disease Progression|13
394452|NCT00095940|1249031|P5|Lapatinib Continuation/Phase II|Disease Progression|0
394453|NCT00095940|1249032|P4|Lapatinib Continuation/Phase II|Disease Progression|0
394454|NCT00095940|1249033|P3|Lapatinib Continuation/Phase II|Disease Progression|15
394455|NCT00095940|1249034|P2|Lapatinib Continuation/Phase II|Disease Progression|1
394456|NCT00095940|1249035|P1|Lapatinib Continuation/Phase II|Disease Progression|1
394457|NCT00095836|1249068|P1|Overall Study|Death|2
394458|NCT00095836|1249068|P1|Overall Study|Adverse Event|1
394459|NCT00095836|1249068|P1|Overall Study|Lost to Follow-up|1
394460|NCT00095628|1249098|P1|Overall Study|Disease progression prior to treatment|1
394461|NCT00095576|1249109|P2|Overall Study|Subject moved|36
394462|NCT00095576|1249110|P1|Overall Study|Subject moved|30
394463|NCT00095576|1249109|P2|Overall Study|Site terminated|67
394464|NCT00095576|1249110|P1|Overall Study|Site terminated|75
394465|NCT00095576|1249109|P2|Overall Study|Option to switch to a rollover study|1099
394466|NCT00095576|1249110|P1|Overall Study|Option to switch to a rollover study|1097
394467|NCT00095576|1249109|P2|Overall Study|Withdrawal by Subject|47
394468|NCT00095576|1249110|P1|Overall Study|Withdrawal by Subject|34
394469|NCT00095576|1249109|P2|Overall Study|Protocol Violation|0
394470|NCT00095576|1249110|P1|Overall Study|Protocol Violation|1
394471|NCT00095576|1249109|P2|Overall Study|Lost to Follow-up|229
394472|NCT00095576|1249110|P1|Overall Study|Lost to Follow-up|233
394473|NCT00095576|1249109|P2|Overall Study|Adverse Event|3
394474|NCT00095576|1249110|P1|Overall Study|Adverse Event|5
394475|NCT00095238|1249124|P2|Overall Study|Other Reasons|88
394476|NCT00095238|1249125|P1|Overall Study|Other Reasons|87
394477|NCT00095238|1249124|P2|Overall Study|Missing|0
394478|NCT00095238|1249125|P1|Overall Study|Missing|1
394479|NCT00095238|1249124|P2|Overall Study|Study terminated by sponsor|1
394480|NCT00095238|1249125|P1|Overall Study|Study terminated by sponsor|0
394481|NCT00095238|1249124|P2|Overall Study|No longer met study criteria|5
394482|NCT00095238|1249125|P1|Overall Study|No longer met study criteria|4
394483|NCT00095238|1249124|P2|Overall Study|Noncompliance|45
394484|NCT00095238|1249125|P1|Overall Study|Noncompliance|44
394485|NCT00095238|1249124|P2|Overall Study|Lost to Follow-up|24
394486|NCT00095238|1249125|P1|Overall Study|Lost to Follow-up|19
394487|NCT00095238|1249124|P2|Overall Study|Death|170
394488|NCT00095238|1249125|P1|Overall Study|Death|154
394489|NCT00095238|1249124|P2|Overall Study|Subject Withdrew Consent|223
394490|NCT00095238|1249125|P1|Overall Study|Subject Withdrew Consent|208
394491|NCT00095238|1249124|P2|Overall Study|Adverse Event|287
394492|NCT00095238|1249125|P1|Overall Study|Adverse Event|331
394493|NCT00095238|1249124|P2|Overall Study|Lack of Efficacy|9
394494|NCT00095238|1249125|P1|Overall Study|Lack of Efficacy|9
394495|NCT00095212|1249187|P2|Overall Study|Withdrawal by Subject|3
394496|NCT00095212|1249188|P1|Overall Study|Withdrawal by Subject|1
394497|NCT00095199|1249218|P4|Overall Study|Data inadvertently lost by site|0
394498|NCT00095199|1249219|P3|Overall Study|Data inadvertently lost by site|0
394499|NCT00095199|1249220|P2|Overall Study|Data inadvertently lost by site|0
394500|NCT00095199|1249221|P1|Overall Study|Data inadvertently lost by site|1
394501|NCT00095199|1249218|P4|Overall Study|Primary tumor removed in other surgery|0
394502|NCT00095199|1249219|P3|Overall Study|Primary tumor removed in other surgery|0
394503|NCT00095199|1249220|P2|Overall Study|Primary tumor removed in other surgery|1
394504|NCT00095199|1249221|P1|Overall Study|Primary tumor removed in other surgery|0
394505|NCT00095199|1249218|P4|Overall Study|Started radiotherapy regimen|0
394506|NCT00095199|1249219|P3|Overall Study|Started radiotherapy regimen|0
394507|NCT00095199|1249220|P2|Overall Study|Started radiotherapy regimen|1
394508|NCT00095199|1249221|P1|Overall Study|Started radiotherapy regimen|0
394509|NCT00095199|1249218|P4|Overall Study|Started Palliative Radiotherapy|0
394510|NCT00095199|1249219|P3|Overall Study|Started Palliative Radiotherapy|0
394511|NCT00095199|1249220|P2|Overall Study|Started Palliative Radiotherapy|0
394512|NCT00095199|1249221|P1|Overall Study|Started Palliative Radiotherapy|1
394513|NCT00095199|1249218|P4|Overall Study|Not eligible|1
394514|NCT00095199|1249219|P3|Overall Study|Not eligible|0
394515|NCT00095199|1249220|P2|Overall Study|Not eligible|7
394516|NCT00095199|1249221|P1|Overall Study|Not eligible|1
394517|NCT00095199|1249218|P4|Overall Study|Physician Decision|1
394518|NCT00095199|1249219|P3|Overall Study|Physician Decision|1
394519|NCT00095199|1249220|P2|Overall Study|Physician Decision|6
394520|NCT00095199|1249221|P1|Overall Study|Physician Decision|5
394521|NCT00095199|1249218|P4|Overall Study|Surgery needed could not start in 7 days|0
394522|NCT00095199|1249219|P3|Overall Study|Surgery needed could not start in 7 days|1
394523|NCT00095199|1249220|P2|Overall Study|Surgery needed could not start in 7 days|0
394524|NCT00095199|1249221|P1|Overall Study|Surgery needed could not start in 7 days|0
394525|NCT00095199|1249218|P4|Overall Study|Liver function test results elevated|1
394526|NCT00095199|1249219|P3|Overall Study|Liver function test results elevated|1
394527|NCT00095199|1249220|P2|Overall Study|Liver function test results elevated|0
394528|NCT00095199|1249221|P1|Overall Study|Liver function test results elevated|0
394529|NCT00095199|1249218|P4|Overall Study|Protocol Violation|0
394530|NCT00095199|1249219|P3|Overall Study|Protocol Violation|2
394531|NCT00095199|1249220|P2|Overall Study|Protocol Violation|4
394532|NCT00095199|1249221|P1|Overall Study|Protocol Violation|4
394533|NCT00095199|1249218|P4|Overall Study|Withdrawal by Subject|22
394534|NCT00095199|1249219|P3|Overall Study|Withdrawal by Subject|13
394535|NCT00095199|1249220|P2|Overall Study|Withdrawal by Subject|16
394536|NCT00095199|1249221|P1|Overall Study|Withdrawal by Subject|21
394537|NCT00095199|1249218|P4|Overall Study|Death|9
394538|NCT00095199|1249219|P3|Overall Study|Death|11
394539|NCT00095199|1249220|P2|Overall Study|Death|6
394540|NCT00095199|1249221|P1|Overall Study|Death|10
394541|NCT00095199|1249218|P4|Overall Study|Progressive disease|98
394542|NCT00095199|1249219|P3|Overall Study|Progressive disease|105
394543|NCT00095199|1249220|P2|Overall Study|Progressive disease|179
394544|NCT00095199|1249221|P1|Overall Study|Progressive disease|213
394545|NCT00095199|1249218|P4|Overall Study|Adverse Event|11
394546|NCT00095199|1249219|P3|Overall Study|Adverse Event|26
394547|NCT00095199|1249220|P2|Overall Study|Adverse Event|22
394548|NCT00095199|1249221|P1|Overall Study|Adverse Event|40
394549|NCT00095173|1249259|P6|Open-Label Extension Phase (Period C)|Not Specified|8
394550|NCT00095173|1249260|P5|Open-Label Extension Phase (Period C)|Not Specified|6
394551|NCT00095173|1249261|P4|Open-Label Extension Phase (Period C)|Not Specified|4
394552|NCT00095173|1249262|P3|Open-Label Extension Phase (Period C)|Not Specified|0
394553|NCT00095173|1249263|P2|Open-Label Extension Phase (Period C)|Not Specified|0
394554|NCT00095173|1249264|P1|Open-Label Extension Phase (Period C)|Not Specified|0
394555|NCT00095173|1249259|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
394556|NCT00095173|1249260|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
394557|NCT00095173|1249261|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
394558|NCT00095173|1249262|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
394559|NCT00095173|1249263|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
394560|NCT00095173|1249264|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
394561|NCT00095173|1249259|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
394562|NCT00095173|1249260|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
394563|NCT00095173|1249261|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
394564|NCT00095173|1249262|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
394565|NCT00095173|1249263|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
394566|NCT00095173|1249264|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
394567|NCT00095173|1249259|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
394568|NCT00095173|1249260|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
394569|NCT00095173|1249261|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
394570|NCT00095173|1249262|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
394571|NCT00095173|1249263|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
394572|NCT00095173|1249264|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
394573|NCT00095173|1249259|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
394574|NCT00095173|1249260|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
394575|NCT00095173|1249261|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
394576|NCT00095173|1249262|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
394577|NCT00095173|1249263|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
394578|NCT00095173|1249264|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
394579|NCT00095173|1249259|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
394580|NCT00095173|1249260|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
394581|NCT00095173|1249261|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
394582|NCT00095173|1249262|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
394583|NCT00095173|1249263|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
394584|NCT00095173|1249264|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
394585|NCT00095173|1249259|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
394586|NCT00095173|1249260|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
394587|NCT00095173|1249261|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
394588|NCT00095173|1249262|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
394589|NCT00095173|1249263|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
394590|NCT00095173|1249264|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
394591|NCT00095173|1249259|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
394592|NCT00095173|1249260|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
394593|NCT00095173|1249261|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
394594|NCT00095173|1249262|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
394595|NCT00095173|1249263|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
394596|NCT00095173|1249264|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
394597|NCT00095173|1249259|P6|Open-Label Extension Phase (Period C)|Death|1
394598|NCT00095173|1249260|P5|Open-Label Extension Phase (Period C)|Death|0
394599|NCT00095173|1249261|P4|Open-Label Extension Phase (Period C)|Death|0
394600|NCT00095173|1249262|P3|Open-Label Extension Phase (Period C)|Death|0
394601|NCT00095173|1249263|P2|Open-Label Extension Phase (Period C)|Death|0
394602|NCT00095173|1249264|P1|Open-Label Extension Phase (Period C)|Death|0
394603|NCT00095173|1249259|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
394604|NCT00095173|1249260|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
394605|NCT00095173|1249261|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
394606|NCT00095173|1249262|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
394607|NCT00095173|1249263|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
394608|NCT00095173|1249264|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
394609|NCT00095173|1249259|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
394610|NCT00095173|1249260|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
394611|NCT00095173|1249261|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
394612|NCT00095173|1249262|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
394613|NCT00095173|1249263|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
394614|NCT00095173|1249264|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
394615|NCT00095173|1249259|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
394616|NCT00095173|1249260|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
394617|NCT00095173|1249261|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
394618|NCT00095173|1249262|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
394619|NCT00095173|1249263|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
394620|NCT00095173|1249264|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
394621|NCT00095173|1249259|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
394622|NCT00095173|1249260|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
394623|NCT00095173|1249261|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
394624|NCT00095173|1249262|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
394625|NCT00095173|1249263|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
394626|NCT00095173|1249264|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
394627|NCT00095173|1249259|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
394628|NCT00095173|1249260|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
394629|NCT00095173|1249261|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
394630|NCT00095173|1249262|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
394631|NCT00095173|1249263|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
394632|NCT00095173|1249264|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
394633|NCT00095173|1249259|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
394634|NCT00095173|1249260|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
394635|NCT00095173|1249261|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
394636|NCT00095173|1249262|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
394637|NCT00095173|1249263|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
394638|NCT00095173|1249264|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
394639|NCT00095147|1249302|P5|Long-term Extension Period|Leaving country|1
394640|NCT00095147|1249303|P4|Long-term Extension Period|Leaving country|0
394641|NCT00095147|1249304|P3|Long-term Extension Period|Leaving country|0
394642|NCT00095147|1249305|P2|Long-term Extension Period|Leaving country|0
394643|NCT00095147|1249306|P1|Long-term Extension Period|Leaving country|0
394644|NCT00095147|1249302|P5|Long-term Extension Period|Participant chose to use Revellex|1
394645|NCT00095147|1249303|P4|Long-term Extension Period|Participant chose to use Revellex|0
394646|NCT00095147|1249304|P3|Long-term Extension Period|Participant chose to use Revellex|0
394647|NCT00095147|1249305|P2|Long-term Extension Period|Participant chose to use Revellex|0
394648|NCT00095147|1249306|P1|Long-term Extension Period|Participant chose to use Revellex|0
394649|NCT00095147|1249302|P5|Long-term Extension Period|No longer meets study criteria|1
394650|NCT00095147|1249303|P4|Long-term Extension Period|No longer meets study criteria|0
394651|NCT00095147|1249304|P3|Long-term Extension Period|No longer meets study criteria|0
394652|NCT00095147|1249305|P2|Long-term Extension Period|No longer meets study criteria|0
394653|NCT00095147|1249306|P1|Long-term Extension Period|No longer meets study criteria|0
394654|NCT00095147|1249302|P5|Long-term Extension Period|Pregnancy|1
394655|NCT00095147|1249303|P4|Long-term Extension Period|Pregnancy|0
394656|NCT00095147|1249304|P3|Long-term Extension Period|Pregnancy|0
394657|NCT00095147|1249305|P2|Long-term Extension Period|Pregnancy|0
394658|NCT00095147|1249306|P1|Long-term Extension Period|Pregnancy|0
394659|NCT00095147|1249302|P5|Long-term Extension Period|Withdrawal of consent|12
394660|NCT00095147|1249303|P4|Long-term Extension Period|Withdrawal of consent|0
394661|NCT00095147|1249304|P3|Long-term Extension Period|Withdrawal of consent|0
394662|NCT00095147|1249305|P2|Long-term Extension Period|Withdrawal of consent|0
394663|NCT00095147|1249306|P1|Long-term Extension Period|Withdrawal of consent|0
394664|NCT00095147|1249302|P5|Long-term Extension Period|Lost to Follow-up|6
394665|NCT00095147|1249303|P4|Long-term Extension Period|Lost to Follow-up|0
394666|NCT00095147|1249304|P3|Long-term Extension Period|Lost to Follow-up|0
394667|NCT00095147|1249305|P2|Long-term Extension Period|Lost to Follow-up|0
394668|NCT00095147|1249306|P1|Long-term Extension Period|Lost to Follow-up|0
394669|NCT00095147|1249302|P5|Long-term Extension Period|Lack of Efficacy|9
394670|NCT00095147|1249303|P4|Long-term Extension Period|Lack of Efficacy|0
394671|NCT00095147|1249304|P3|Long-term Extension Period|Lack of Efficacy|0
394672|NCT00095147|1249305|P2|Long-term Extension Period|Lack of Efficacy|0
394673|NCT00095147|1249306|P1|Long-term Extension Period|Lack of Efficacy|0
394674|NCT00095147|1249302|P5|Long-term Extension Period|Adverse Event|11
394675|NCT00095147|1249303|P4|Long-term Extension Period|Adverse Event|0
394676|NCT00095147|1249304|P3|Long-term Extension Period|Adverse Event|0
394677|NCT00095147|1249305|P2|Long-term Extension Period|Adverse Event|0
394678|NCT00095147|1249306|P1|Long-term Extension Period|Adverse Event|0
394679|NCT00095147|1249302|P5|Long-term Extension Period|Death|3
394680|NCT00095147|1249303|P4|Long-term Extension Period|Death|0
394681|NCT00095147|1249304|P3|Long-term Extension Period|Death|0
394682|NCT00095147|1249305|P2|Long-term Extension Period|Death|0
394683|NCT00095147|1249306|P1|Long-term Extension Period|Death|0
394684|NCT00095147|1249302|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
394685|NCT00095147|1249303|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
394686|NCT00095147|1249304|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
394687|NCT00095147|1249305|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
394688|NCT00095147|1249306|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
394689|NCT00095147|1249302|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
394690|NCT00095147|1249303|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
394691|NCT00095147|1249304|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
394692|NCT00095147|1249305|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
394693|NCT00095147|1249306|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
394694|NCT00095147|1249302|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
394695|NCT00095147|1249303|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
394696|NCT00095147|1249304|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
394697|NCT00095147|1249305|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
394698|NCT00095147|1249306|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
394699|NCT00095147|1249302|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
394700|NCT00095147|1249303|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
394701|NCT00095147|1249304|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
394702|NCT00095147|1249305|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
394703|NCT00095147|1249306|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
394704|NCT00095147|1249302|P5|Double-blind Period 2 (Days 198-365)|Death|0
394705|NCT00095147|1249303|P4|Double-blind Period 2 (Days 198-365)|Death|1
394706|NCT00095147|1249304|P3|Double-blind Period 2 (Days 198-365)|Death|0
394707|NCT00095147|1249305|P2|Double-blind Period 2 (Days 198-365)|Death|1
394708|NCT00095147|1249306|P1|Double-blind Period 2 (Days 198-365)|Death|0
394709|NCT00095147|1249302|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
394710|NCT00095147|1249303|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
394711|NCT00095147|1249304|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
394712|NCT00095147|1249305|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
394713|NCT00095147|1249306|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
394714|NCT00095147|1249302|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
394715|NCT00095147|1249303|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
394716|NCT00095147|1249304|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
394717|NCT00095147|1249305|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
394718|NCT00095147|1249306|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
394719|NCT00095147|1249302|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
394720|NCT00095147|1249303|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
394721|NCT00095147|1249304|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
394722|NCT00095147|1249305|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
394723|NCT00095147|1249306|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
394724|NCT00095147|1249302|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
394725|NCT00095147|1249303|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
394726|NCT00095147|1249304|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
394727|NCT00095147|1249305|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
394728|NCT00095147|1249306|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
394729|NCT00095147|1249302|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
394730|NCT00095147|1249303|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
394731|NCT00095147|1249304|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
394732|NCT00095147|1249305|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
394733|NCT00095147|1249306|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
394734|NCT00095147|1249302|P5|Double-blind Period 1 (Days 1-197)|Death|0
394735|NCT00095147|1249303|P4|Double-blind Period 1 (Days 1-197)|Death|0
394736|NCT00095147|1249304|P3|Double-blind Period 1 (Days 1-197)|Death|0
394737|NCT00095147|1249305|P2|Double-blind Period 1 (Days 1-197)|Death|0
394738|NCT00095147|1249306|P1|Double-blind Period 1 (Days 1-197)|Death|1
394739|NCT00095121|1249501|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
394740|NCT00095121|1249502|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
394741|NCT00095121|1249501|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
394742|NCT00095121|1249502|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
394743|NCT00095056|1249548|P2|Phase B (Weeks 12-54)|Protocol Violation|1
394744|NCT00095056|1249549|P1|Phase B (Weeks 12-54)|Protocol Violation|0
394745|NCT00095056|1249548|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
394746|NCT00095056|1249549|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
394747|NCT00095056|1249548|P2|Phase B (Weeks 12-54)|Death|1
394748|NCT00095056|1249549|P1|Phase B (Weeks 12-54)|Death|3
394749|NCT00095056|1249548|P2|Phase B (Weeks 12-54)|Patient Moved|0
394750|NCT00095056|1249549|P1|Phase B (Weeks 12-54)|Patient Moved|1
394751|NCT00095056|1249548|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
394752|NCT00095056|1249549|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
394753|NCT00095056|1249548|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
394754|NCT00095056|1249549|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
394755|NCT00095056|1249548|P2|Phase B (Weeks 12-54)|Adverse Event|2
394756|NCT00095056|1249549|P1|Phase B (Weeks 12-54)|Adverse Event|2
394757|NCT00095056|1249548|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
394758|NCT00095056|1249549|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
394759|NCT00095056|1249548|P2|Phase A (Weeks 0-12)|Death|0
394760|NCT00095056|1249549|P1|Phase A (Weeks 0-12)|Death|1
394761|NCT00095056|1249548|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
394762|NCT00095056|1249549|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
394763|NCT00095056|1249548|P2|Phase A (Weeks 0-12)|Adverse Event|1
394764|NCT00095056|1249549|P1|Phase A (Weeks 0-12)|Adverse Event|1
394765|NCT00094887|1249659|P2|Overall Study|Physician Decision|2
394766|NCT00094887|1249660|P1|Overall Study|Physician Decision|2
394767|NCT00094887|1249659|P2|Overall Study|Family emergency, Subject noncompliance|4
394768|NCT00094887|1249660|P1|Overall Study|Family emergency, Subject noncompliance|3
394769|NCT00094861|1249668|P2|Overall Study|Other|0
394770|NCT00094861|1249669|P1|Overall Study|Other|3
394771|NCT00094861|1249668|P2|Overall Study|Death|2
394772|NCT00094861|1249669|P1|Overall Study|Death|4
394773|NCT00094861|1249668|P2|Overall Study|Lost to Follow-up|1
394774|NCT00094861|1249669|P1|Overall Study|Lost to Follow-up|0
394775|NCT00094861|1249668|P2|Overall Study|Physician Decision|1
394776|NCT00094861|1249669|P1|Overall Study|Physician Decision|1
394777|NCT00094861|1249668|P2|Overall Study|Withdrawal by Subject|3
394778|NCT00094861|1249669|P1|Overall Study|Withdrawal by Subject|5
394779|NCT00094861|1249668|P2|Overall Study|Adverse Event|2
394780|NCT00094861|1249669|P1|Overall Study|Adverse Event|5
394781|NCT00094835|1249696|P7|Overall Study|Other|0
394782|NCT00094835|1249697|P6|Overall Study|Other|0
394783|NCT00094835|1249698|P5|Overall Study|Other|0
394784|NCT00094835|1249699|P4|Overall Study|Other|1
394785|NCT00094835|1249700|P3|Overall Study|Other|1
394786|NCT00094835|1249701|P2|Overall Study|Other|1
394787|NCT00094835|1249702|P1|Overall Study|Other|1
394788|NCT00094835|1249696|P7|Overall Study|Non-compliance|1
394789|NCT00094835|1249697|P6|Overall Study|Non-compliance|2
394790|NCT00094835|1249698|P5|Overall Study|Non-compliance|2
394791|NCT00094835|1249699|P4|Overall Study|Non-compliance|0
394792|NCT00094835|1249700|P3|Overall Study|Non-compliance|2
394793|NCT00094835|1249701|P2|Overall Study|Non-compliance|2
394794|NCT00094835|1249702|P1|Overall Study|Non-compliance|1
394795|NCT00094835|1249696|P7|Overall Study|Death|0
394796|NCT00094835|1249697|P6|Overall Study|Death|0
394797|NCT00094835|1249698|P5|Overall Study|Death|1
394798|NCT00094835|1249699|P4|Overall Study|Death|0
394799|NCT00094835|1249700|P3|Overall Study|Death|0
394800|NCT00094835|1249701|P2|Overall Study|Death|0
394801|NCT00094835|1249702|P1|Overall Study|Death|1
394802|NCT00094835|1249696|P7|Overall Study|Lost to Follow-up|0
394803|NCT00094835|1249697|P6|Overall Study|Lost to Follow-up|0
394804|NCT00094835|1249698|P5|Overall Study|Lost to Follow-up|1
394805|NCT00094835|1249699|P4|Overall Study|Lost to Follow-up|0
394806|NCT00094835|1249700|P3|Overall Study|Lost to Follow-up|0
394807|NCT00094835|1249701|P2|Overall Study|Lost to Follow-up|0
394808|NCT00094835|1249702|P1|Overall Study|Lost to Follow-up|0
394809|NCT00094835|1249696|P7|Overall Study|Withdrawal by Subject|1
394810|NCT00094835|1249697|P6|Overall Study|Withdrawal by Subject|0
394811|NCT00094835|1249698|P5|Overall Study|Withdrawal by Subject|0
394812|NCT00094835|1249699|P4|Overall Study|Withdrawal by Subject|0
394813|NCT00094835|1249700|P3|Overall Study|Withdrawal by Subject|0
394814|NCT00094835|1249701|P2|Overall Study|Withdrawal by Subject|0
394815|NCT00094835|1249702|P1|Overall Study|Withdrawal by Subject|0
394816|NCT00094835|1249696|P7|Overall Study|Physician Decision|0
394817|NCT00094835|1249697|P6|Overall Study|Physician Decision|1
394818|NCT00094835|1249698|P5|Overall Study|Physician Decision|0
394819|NCT00094835|1249699|P4|Overall Study|Physician Decision|0
394820|NCT00094835|1249700|P3|Overall Study|Physician Decision|0
394821|NCT00094835|1249701|P2|Overall Study|Physician Decision|0
394822|NCT00094835|1249702|P1|Overall Study|Physician Decision|1
394823|NCT00094809|1249780|P2|Overall Study|Other|1
394824|NCT00094809|1249781|P1|Overall Study|Other|1
394825|NCT00094809|1249780|P2|Overall Study|Study drug not received|8
394826|NCT00094809|1249781|P1|Overall Study|Study drug not received|2
394827|NCT00094809|1249780|P2|Overall Study|Informed consent signed after treatment|0
394828|NCT00094809|1249781|P1|Overall Study|Informed consent signed after treatment|1
394829|NCT00094809|1249780|P2|Overall Study|Other|4
394830|NCT00094809|1249781|P1|Overall Study|Other|2
394831|NCT00094809|1249780|P2|Overall Study|Protocol-specified criteria|1
394832|NCT00094809|1249781|P1|Overall Study|Protocol-specified criteria|1
394833|NCT00094809|1249780|P2|Overall Study|Death|25
394834|NCT00094809|1249781|P1|Overall Study|Death|19
394835|NCT00094809|1249780|P2|Overall Study|Lost to Follow-up|6
394836|NCT00094809|1249781|P1|Overall Study|Lost to Follow-up|6
394837|NCT00094809|1249780|P2|Overall Study|Physician Decision|5
394838|NCT00094809|1249781|P1|Overall Study|Physician Decision|3
394839|NCT00094809|1249780|P2|Overall Study|Disease progression|3
394840|NCT00094809|1249781|P1|Overall Study|Disease progression|3
394841|NCT00094809|1249780|P2|Overall Study|Withdrawal by Subject|9
394842|NCT00094809|1249781|P1|Overall Study|Withdrawal by Subject|8
394843|NCT00094809|1249780|P2|Overall Study|Adverse Event|1
394844|NCT00094809|1249781|P1|Overall Study|Adverse Event|3
394845|NCT00094809|1249780|P2|Overall Study|Noncompliance|0
394846|NCT00094809|1249781|P1|Overall Study|Noncompliance|1
394847|NCT00094809|1249780|P2|Overall Study|Protocol deviation|2
394848|NCT00094809|1249781|P1|Overall Study|Protocol deviation|2
394849|NCT00094770|1249807|P2|Year 2 (Week 0 to Week 104)|Unspecified|23
394850|NCT00094770|1249808|P1|Year 2 (Week 0 to Week 104)|Unspecified|15
394851|NCT00094770|1249807|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
394852|NCT00094770|1249808|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
394853|NCT00094770|1249807|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
394854|NCT00094770|1249808|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
394855|NCT00094770|1249807|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
394856|NCT00094770|1249808|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
394857|NCT00094770|1249807|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
394858|NCT00094770|1249808|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
394859|NCT00094770|1249807|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
394860|NCT00094770|1249808|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
394861|NCT00094770|1249807|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
394862|NCT00094770|1249808|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
394863|NCT00094770|1249807|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
394864|NCT00094770|1249808|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
394865|NCT00094770|1249807|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
394866|NCT00094770|1249808|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
394867|NCT00094770|1249807|P2|Year 1 ( Week 0 to Week 52)|Unspecified|11
394868|NCT00094770|1249808|P1|Year 1 ( Week 0 to Week 52)|Unspecified|10
394869|NCT00094770|1249807|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
394870|NCT00094770|1249808|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
394871|NCT00094770|1249807|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
394872|NCT00094770|1249808|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
394873|NCT00094770|1249807|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
394874|NCT00094770|1249808|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
394875|NCT00094770|1249807|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
394876|NCT00094770|1249808|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
394877|NCT00094770|1249807|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
394878|NCT00094770|1249808|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
394879|NCT00094770|1249807|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
394880|NCT00094770|1249808|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
394881|NCT00094770|1249807|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
394882|NCT00094770|1249808|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
394883|NCT00094770|1249807|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
394884|NCT00094770|1249808|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
394885|NCT00094757|1249839|P3|Overall Study|Protocol specified discontinuation|0
394886|NCT00094757|1249840|P2|Overall Study|Protocol specified discontinuation|3
394887|NCT00094757|1249841|P1|Overall Study|Protocol specified discontinuation|1
394888|NCT00094757|1249839|P3|Overall Study|Unspecified|1
394889|NCT00094757|1249840|P2|Overall Study|Unspecified|3
394890|NCT00094757|1249841|P1|Overall Study|Unspecified|3
394891|NCT00094757|1249839|P3|Overall Study|Withdrawal by Subject|5
394892|NCT00094757|1249840|P2|Overall Study|Withdrawal by Subject|21
394893|NCT00094757|1249841|P1|Overall Study|Withdrawal by Subject|14
394894|NCT00094757|1249839|P3|Overall Study|Protocol Violation|3
394895|NCT00094757|1249840|P2|Overall Study|Protocol Violation|5
394896|NCT00094757|1249841|P1|Overall Study|Protocol Violation|8
394897|NCT00094757|1249839|P3|Overall Study|Patient Moved|1
394898|NCT00094757|1249840|P2|Overall Study|Patient Moved|1
394899|NCT00094757|1249841|P1|Overall Study|Patient Moved|2
394900|NCT00094757|1249839|P3|Overall Study|Lost to Follow-up|6
394901|NCT00094757|1249840|P2|Overall Study|Lost to Follow-up|5
394902|NCT00094757|1249841|P1|Overall Study|Lost to Follow-up|3
394903|NCT00094757|1249839|P3|Overall Study|Lack of Efficacy|8
394904|NCT00094757|1249840|P2|Overall Study|Lack of Efficacy|15
394905|NCT00094757|1249841|P1|Overall Study|Lack of Efficacy|11
394906|NCT00094757|1249839|P3|Overall Study|Adverse Event|6
394907|NCT00094757|1249840|P2|Overall Study|Adverse Event|9
394908|NCT00094757|1249841|P1|Overall Study|Adverse Event|11
394909|NCT00094653|1249861|P3|Overall Study|Protocol Violation|1
394910|NCT00094653|1249862|P2|Overall Study|Protocol Violation|0
394911|NCT00094653|1249863|P1|Overall Study|Protocol Violation|0
394912|NCT00094653|1249861|P3|Overall Study|Lost to Follow-up|1
394913|NCT00094653|1249862|P2|Overall Study|Lost to Follow-up|2
394914|NCT00094653|1249863|P1|Overall Study|Lost to Follow-up|3
394915|NCT00094653|1249861|P3|Overall Study|Not specified|2
394916|NCT00094653|1249862|P2|Overall Study|Not specified|2
394917|NCT00094653|1249863|P1|Overall Study|Not specified|2
394918|NCT00094653|1249861|P3|Overall Study|Subject Withdrew Consent|3
394919|NCT00094653|1249862|P2|Overall Study|Subject Withdrew Consent|2
394920|NCT00094653|1249863|P1|Overall Study|Subject Withdrew Consent|10
394921|NCT00094653|1249861|P3|Overall Study|Death|119
394922|NCT00094653|1249862|P2|Overall Study|Death|100
394923|NCT00094653|1249863|P1|Overall Study|Death|306
394924|NCT00094575|1249926|P2|Overall Study|Death|146
394925|NCT00094575|1249927|P1|Overall Study|Death|146
394926|NCT00094536|1249947|P1|Treatment and Follow-up|Unable to attend visits|1
394927|NCT00094536|1249947|P1|Treatment and Follow-up|Subject non-compliance|9
394928|NCT00094536|1249947|P1|Treatment and Follow-up|Withdrawal by Subject|1
394929|NCT00094536|1249947|P1|Treatment and Follow-up|Lost to Follow-up|7
394930|NCT00094536|1249947|P1|Treatment and Follow-up|Lack of Efficacy|9
394931|NCT00094536|1249947|P1|Treatment and Follow-up|Adverse Event|4
394932|NCT00094536|1249947|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
394933|NCT00094458|1249971|P6|OLE: Open-Label Extension|Patient decision|0
394934|NCT00094458|1249972|P5|OLE: Open-Label Extension|Patient decision|1
394935|NCT00094458|1249973|P4|OLE: Open-Label Extension|Patient decision|0
394936|NCT00094458|1249974|P3|OLE: Open-Label Extension|Patient decision|0
394937|NCT00094458|1249975|P2|OLE: Open-Label Extension|Patient decision|0
394938|NCT00094458|1249976|P1|OLE: Open-Label Extension|Patient decision|0
394939|NCT00094458|1249971|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
394940|NCT00094458|1249972|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
394941|NCT00094458|1249973|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
394942|NCT00094458|1249974|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
394943|NCT00094458|1249975|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
394944|NCT00094458|1249976|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
394945|NCT00094458|1249971|P6|OLE: Open-Label Extension|Adverse Event|4
394946|NCT00094458|1249972|P5|OLE: Open-Label Extension|Adverse Event|3
394947|NCT00094458|1249973|P4|OLE: Open-Label Extension|Adverse Event|0
394948|NCT00094458|1249974|P3|OLE: Open-Label Extension|Adverse Event|0
394949|NCT00094458|1249975|P2|OLE: Open-Label Extension|Adverse Event|0
394950|NCT00094458|1249976|P1|OLE: Open-Label Extension|Adverse Event|0
394951|NCT00094458|1249971|P6|Study Extension: Week 30 Through Week 50|Unspecified|0
394952|NCT00094458|1249972|P5|Study Extension: Week 30 Through Week 50|Unspecified|0
394953|NCT00094458|1249973|P4|Study Extension: Week 30 Through Week 50|Unspecified|0
394954|NCT00094458|1249974|P3|Study Extension: Week 30 Through Week 50|Unspecified|3
394955|NCT00094458|1249975|P2|Study Extension: Week 30 Through Week 50|Unspecified|2
394956|NCT00094458|1249976|P1|Study Extension: Week 30 Through Week 50|Unspecified|1
394957|NCT00094458|1249971|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
394958|NCT00094458|1249972|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
394959|NCT00094458|1249973|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
394960|NCT00094458|1249974|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
394961|NCT00094458|1249975|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
394962|NCT00094458|1249976|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
394963|NCT00094458|1249971|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
394964|NCT00094458|1249972|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
394965|NCT00094458|1249973|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
394966|NCT00094458|1249974|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
394967|NCT00094458|1249975|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
394968|NCT00094458|1249976|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
394969|NCT00094458|1249971|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
394970|NCT00094458|1249972|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
394971|NCT00094458|1249973|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
394972|NCT00094458|1249974|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
394973|NCT00094458|1249975|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
394974|NCT00094458|1249976|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
394975|NCT00094458|1249971|P6|Main Study: Through Week 30|Unspecified|0
394976|NCT00094458|1249972|P5|Main Study: Through Week 30|Unspecified|0
394977|NCT00094458|1249973|P4|Main Study: Through Week 30|Unspecified|0
394978|NCT00094458|1249974|P3|Main Study: Through Week 30|Unspecified|9
394979|NCT00094458|1249975|P2|Main Study: Through Week 30|Unspecified|16
394980|NCT00094458|1249976|P1|Main Study: Through Week 30|Unspecified|19
394981|NCT00094458|1249971|P6|Main Study: Through Week 30|Death|0
394982|NCT00094458|1249972|P5|Main Study: Through Week 30|Death|0
394983|NCT00094458|1249973|P4|Main Study: Through Week 30|Death|0
394984|NCT00094458|1249974|P3|Main Study: Through Week 30|Death|0
394985|NCT00094458|1249975|P2|Main Study: Through Week 30|Death|0
394986|NCT00094458|1249976|P1|Main Study: Through Week 30|Death|1
394987|NCT00094458|1249971|P6|Main Study: Through Week 30|Adverse Event|0
394988|NCT00094458|1249972|P5|Main Study: Through Week 30|Adverse Event|0
394989|NCT00094458|1249973|P4|Main Study: Through Week 30|Adverse Event|0
394990|NCT00094458|1249974|P3|Main Study: Through Week 30|Adverse Event|28
394991|NCT00094458|1249975|P2|Main Study: Through Week 30|Adverse Event|20
394992|NCT00094458|1249976|P1|Main Study: Through Week 30|Adverse Event|38
394993|NCT00094458|1249971|P6|Main Study: Through Week 30|Withdrawal by Subject|0
394994|NCT00094458|1249972|P5|Main Study: Through Week 30|Withdrawal by Subject|0
394995|NCT00094458|1249973|P4|Main Study: Through Week 30|Withdrawal by Subject|0
394996|NCT00094458|1249974|P3|Main Study: Through Week 30|Withdrawal by Subject|7
394997|NCT00094458|1249975|P2|Main Study: Through Week 30|Withdrawal by Subject|9
394998|NCT00094458|1249976|P1|Main Study: Through Week 30|Withdrawal by Subject|18
394999|NCT00094458|1249971|P6|Main Study: Through Week 30|Lost to Follow-up|0
395000|NCT00094458|1249972|P5|Main Study: Through Week 30|Lost to Follow-up|0
395001|NCT00094458|1249973|P4|Main Study: Through Week 30|Lost to Follow-up|0
395002|NCT00094458|1249974|P3|Main Study: Through Week 30|Lost to Follow-up|2
395003|NCT00094458|1249975|P2|Main Study: Through Week 30|Lost to Follow-up|5
395004|NCT00094458|1249976|P1|Main Study: Through Week 30|Lost to Follow-up|5
395005|NCT00094458|1249971|P6|Main Study: Through Week 30|Eligibility criteria not met|0
395006|NCT00094458|1249972|P5|Main Study: Through Week 30|Eligibility criteria not met|0
395007|NCT00094458|1249973|P4|Main Study: Through Week 30|Eligibility criteria not met|0
395008|NCT00094458|1249974|P3|Main Study: Through Week 30|Eligibility criteria not met|2
395009|NCT00094458|1249975|P2|Main Study: Through Week 30|Eligibility criteria not met|8
395010|NCT00094458|1249976|P1|Main Study: Through Week 30|Eligibility criteria not met|3
395011|NCT00094328|1250014|P1|Overall Study|Lost to Follow-up|1
395012|NCT00094302|1250024|P2|Overall Study|Death|246
395013|NCT00094302|1250025|P1|Overall Study|Death|266
395014|NCT00094302|1250024|P2|Overall Study|Withdrawal by Subject|111
395015|NCT00094302|1250025|P1|Overall Study|Withdrawal by Subject|103
395016|NCT00094302|1250024|P2|Overall Study|Physician Decision|8
395017|NCT00094302|1250025|P1|Overall Study|Physician Decision|5
395018|NCT00094302|1250024|P2|Overall Study|Lost to Follow-up|41
395019|NCT00094302|1250025|P1|Overall Study|Lost to Follow-up|43
395020|NCT00094172|1250081|P2|Overall Study|Started other MS therapy due to disease|0
395021|NCT00094172|1250082|P1|Overall Study|Started other MS therapy due to disease|1
395022|NCT00094172|1250081|P2|Overall Study|Primary endpoint met.|0
395023|NCT00094172|1250082|P1|Overall Study|Primary endpoint met.|1
395024|NCT00094172|1250081|P2|Overall Study|Withdrawal by Subject|5
395025|NCT00094172|1250082|P1|Overall Study|Withdrawal by Subject|10
395026|NCT00094172|1250081|P2|Overall Study|Protocol Violation|1
395027|NCT00094172|1250082|P1|Overall Study|Protocol Violation|0
395028|NCT00094172|1250081|P2|Overall Study|Lost to Follow-up|0
395029|NCT00094172|1250082|P1|Overall Study|Lost to Follow-up|2
395030|NCT00094172|1250081|P2|Overall Study|Adverse Event|1
395031|NCT00094172|1250082|P1|Overall Study|Adverse Event|0
395032|NCT00094107|1250092|P1|Overall Study|Withdrawal due to Disease Progression|1
395033|NCT00094107|1250092|P1|Overall Study|Adverse Event|3
395034|NCT00094107|1250092|P1|Overall Study|Death|5
395035|NCT00094107|1250092|P1|Overall Study|Lack of Efficacy|23
395036|NCT00094094|1250101|P1|Overall Study|Adverse Event|7
395037|NCT00094094|1250101|P1|Overall Study|Lack of Efficacy|23
395038|NCT00094094|1250101|P1|Overall Study|Death|2
395039|NCT00094055|1250110|P1|Overall Study|Withdrawal by Subject|9
395040|NCT00094055|1250110|P1|Overall Study|roll-over to another study|14
395041|NCT00094055|1250110|P1|Overall Study|clinical progression|1
395042|NCT00094055|1250110|P1|Overall Study|progressive disease|2
395043|NCT00094055|1250110|P1|Overall Study|Lost to Follow-up|2
395044|NCT00094055|1250110|P1|Overall Study|Lack of Efficacy|17
395045|NCT00094055|1250110|P1|Overall Study|Death|4
395046|NCT00094055|1250110|P1|Overall Study|Adverse Event|11
395047|NCT00093808|1250130|P1|Overall Study|Protocol Violation|1
395048|NCT00093808|1250130|P1|Overall Study|Cancel participation before receiving tx|1
395049|NCT00093496|1250157|P2|Overall Study|Protocol Violation|3
395050|NCT00093496|1250158|P1|Overall Study|Protocol Violation|1
395051|NCT00093470|1250171|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
395052|NCT00093470|1250172|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
395053|NCT00093470|1250171|P2|Overall Study|Never started treatment|0
395054|NCT00093470|1250172|P1|Overall Study|Never started treatment|1
395055|NCT00093470|1250171|P2|Overall Study|Physician Decision|0
395056|NCT00093470|1250172|P1|Overall Study|Physician Decision|2
395057|NCT00093470|1250171|P2|Overall Study|Other complicating disease|0
395058|NCT00093470|1250172|P1|Overall Study|Other complicating disease|3
395059|NCT00093470|1250171|P2|Overall Study|Alternative therapy|0
395060|NCT00093470|1250172|P1|Overall Study|Alternative therapy|2
395061|NCT00093470|1250171|P2|Overall Study|Withdrawal by Subject|0
395062|NCT00093470|1250172|P1|Overall Study|Withdrawal by Subject|8
395063|NCT00093470|1250171|P2|Overall Study|Death|0
395064|NCT00093470|1250172|P1|Overall Study|Death|2
395065|NCT00093470|1250171|P2|Overall Study|Adverse Event|0
395066|NCT00093470|1250172|P1|Overall Study|Adverse Event|15
395067|NCT00093470|1250171|P2|Overall Study|Disease progression|0
395068|NCT00093470|1250172|P1|Overall Study|Disease progression|39
395069|NCT00093145|1250186|P1|Overall Study|Other|1
395070|NCT00093145|1250186|P1|Overall Study|Withdrawal by Subject|9
395071|NCT00093145|1250186|P1|Overall Study|Physician Decision|5
395072|NCT00093145|1250186|P1|Overall Study|Unacceptable Toxicity Only|2
395073|NCT00093015|1250228|P2|Overall Study|Death|385
395074|NCT00093015|1250229|P1|Overall Study|Death|375
395075|NCT00093015|1250228|P2|Overall Study|Lost to Follow-up|108
395076|NCT00093015|1250229|P1|Overall Study|Lost to Follow-up|96
395077|NCT00093015|1250228|P2|Overall Study|Withdrawal by Subject|171
395078|NCT00093015|1250229|P1|Overall Study|Withdrawal by Subject|194
395079|NCT00091832|1250261|P6|Overall Study|Protocol Violation|1
395080|NCT00091832|1250262|P5|Overall Study|Protocol Violation|0
395081|NCT00091832|1250263|P4|Overall Study|Protocol Violation|0
395082|NCT00091832|1250264|P3|Overall Study|Protocol Violation|1
395083|NCT00091832|1250265|P2|Overall Study|Protocol Violation|0
395084|NCT00091832|1250266|P1|Overall Study|Protocol Violation|0
395085|NCT00091832|1250261|P6|Overall Study|Other|0
395086|NCT00091832|1250262|P5|Overall Study|Other|0
395087|NCT00091832|1250263|P4|Overall Study|Other|0
395088|NCT00091832|1250264|P3|Overall Study|Other|2
395089|NCT00091832|1250265|P2|Overall Study|Other|1
395090|NCT00091832|1250266|P1|Overall Study|Other|0
395091|NCT00091832|1250261|P6|Overall Study|Noncompliance|0
395092|NCT00091832|1250262|P5|Overall Study|Noncompliance|0
395093|NCT00091832|1250263|P4|Overall Study|Noncompliance|0
395094|NCT00091832|1250264|P3|Overall Study|Noncompliance|0
395095|NCT00091832|1250265|P2|Overall Study|Noncompliance|1
395096|NCT00091832|1250266|P1|Overall Study|Noncompliance|0
395097|NCT00091832|1250261|P6|Overall Study|Lost to Follow-up|1
395098|NCT00091832|1250262|P5|Overall Study|Lost to Follow-up|2
395099|NCT00091832|1250263|P4|Overall Study|Lost to Follow-up|3
395100|NCT00091832|1250264|P3|Overall Study|Lost to Follow-up|3
395101|NCT00091832|1250265|P2|Overall Study|Lost to Follow-up|0
395102|NCT00091832|1250266|P1|Overall Study|Lost to Follow-up|1
395103|NCT00091832|1250261|P6|Overall Study|Ineligibility Determined|0
395104|NCT00091832|1250262|P5|Overall Study|Ineligibility Determined|1
395105|NCT00091832|1250263|P4|Overall Study|Ineligibility Determined|0
395106|NCT00091832|1250264|P3|Overall Study|Ineligibility Determined|1
395107|NCT00091832|1250265|P2|Overall Study|Ineligibility Determined|0
395108|NCT00091832|1250266|P1|Overall Study|Ineligibility Determined|0
395109|NCT00091832|1250261|P6|Overall Study|Disease Progression|2
395110|NCT00091832|1250262|P5|Overall Study|Disease Progression|1
395111|NCT00091832|1250263|P4|Overall Study|Disease Progression|1
395112|NCT00091832|1250264|P3|Overall Study|Disease Progression|0
395113|NCT00091832|1250265|P2|Overall Study|Disease Progression|0
395114|NCT00091832|1250266|P1|Overall Study|Disease Progression|2
395115|NCT00091832|1250261|P6|Overall Study|Death|6
395116|NCT00091832|1250262|P5|Overall Study|Death|5
395117|NCT00091832|1250263|P4|Overall Study|Death|8
395118|NCT00091832|1250264|P3|Overall Study|Death|5
395119|NCT00091832|1250265|P2|Overall Study|Death|4
395120|NCT00091832|1250266|P1|Overall Study|Death|6
395121|NCT00091832|1250261|P6|Overall Study|Withdrawal by Subject|1
395122|NCT00091832|1250262|P5|Overall Study|Withdrawal by Subject|3
395123|NCT00091832|1250263|P4|Overall Study|Withdrawal by Subject|1
395124|NCT00091832|1250264|P3|Overall Study|Withdrawal by Subject|0
395125|NCT00091832|1250265|P2|Overall Study|Withdrawal by Subject|5
395126|NCT00091832|1250266|P1|Overall Study|Withdrawal by Subject|4
395127|NCT00091832|1250261|P6|Overall Study|Adverse Event|0
395128|NCT00091832|1250262|P5|Overall Study|Adverse Event|3
395129|NCT00091832|1250263|P4|Overall Study|Adverse Event|1
395130|NCT00091832|1250264|P3|Overall Study|Adverse Event|0
395131|NCT00091832|1250265|P2|Overall Study|Adverse Event|0
395132|NCT00091832|1250266|P1|Overall Study|Adverse Event|0
395133|NCT00091832|1250261|P6|Overall Study|Physician Decision|0
395134|NCT00091832|1250262|P5|Overall Study|Physician Decision|0
395135|NCT00091832|1250263|P4|Overall Study|Physician Decision|0
395136|NCT00091832|1250264|P3|Overall Study|Physician Decision|0
395137|NCT00091832|1250265|P2|Overall Study|Physician Decision|0
395138|NCT00091832|1250266|P1|Overall Study|Physician Decision|1
395139|NCT00091819|1250384|P2|Overall Study|Never received study treatment|4
395140|NCT00091819|1250385|P1|Overall Study|Never received study treatment|3
395141|NCT00091819|1250384|P2|Overall Study|Other|3
395142|NCT00091819|1250385|P1|Overall Study|Other|2
395143|NCT00091819|1250384|P2|Overall Study|Protocol Violation|2
395144|NCT00091819|1250385|P1|Overall Study|Protocol Violation|1
395145|NCT00091819|1250384|P2|Overall Study|Withdrawal by Subject|8
395146|NCT00091819|1250385|P1|Overall Study|Withdrawal by Subject|5
395147|NCT00091819|1250384|P2|Overall Study|Lost to Follow-up|23
395148|NCT00091819|1250385|P1|Overall Study|Lost to Follow-up|26
395149|NCT00091819|1250384|P2|Overall Study|Death|5
395150|NCT00091819|1250385|P1|Overall Study|Death|4
395151|NCT00091819|1250384|P2|Overall Study|Adverse Event|1
395152|NCT00091819|1250385|P1|Overall Study|Adverse Event|1
395153|NCT00091793|1250393|P2|Overall Study|Other|0
395154|NCT00091793|1250394|P1|Overall Study|Other|2
395155|NCT00091793|1250393|P2|Overall Study|Noncompliance|0
395156|NCT00091793|1250394|P1|Overall Study|Noncompliance|2
395157|NCT00091793|1250393|P2|Overall Study|Lost to Follow-up|5
395158|NCT00091793|1250394|P1|Overall Study|Lost to Follow-up|7
395159|NCT00091793|1250393|P2|Overall Study|Ineligibility determined|0
395160|NCT00091793|1250394|P1|Overall Study|Ineligibility determined|2
395161|NCT00091793|1250393|P2|Overall Study|Withdrawal by Subject|15
395162|NCT00091793|1250394|P1|Overall Study|Withdrawal by Subject|10
395163|NCT00091793|1250393|P2|Overall Study|Adverse Event|2
395164|NCT00091793|1250394|P1|Overall Study|Adverse Event|1
395165|NCT00092677|1250418|P2|Overall Study|Adminstrative|9
395166|NCT00092677|1250419|P1|Overall Study|Adminstrative|5
395167|NCT00092677|1250418|P2|Overall Study|Lost to Follow-up|2
395168|NCT00092677|1250419|P1|Overall Study|Lost to Follow-up|0
395169|NCT00092547|1250463|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
395170|NCT00092547|1250464|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
395171|NCT00092547|1250465|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
395172|NCT00092547|1250463|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
395173|NCT00092547|1250464|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
395174|NCT00092547|1250465|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
395175|NCT00092547|1250463|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
395176|NCT00092547|1250464|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
395177|NCT00092547|1250465|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
395178|NCT00092547|1250463|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
395179|NCT00092547|1250464|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
395180|NCT00092547|1250465|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
395181|NCT00092547|1250463|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
395182|NCT00092547|1250464|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
395183|NCT00092547|1250465|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
395184|NCT00092547|1250463|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
395185|NCT00092547|1250464|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
395186|NCT00092547|1250465|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
395187|NCT00092547|1250463|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
395188|NCT00092547|1250464|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
395189|NCT00092547|1250465|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
395190|NCT00092547|1250463|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
395191|NCT00092547|1250464|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
395192|NCT00092547|1250465|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
395193|NCT00092547|1250463|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
395194|NCT00092547|1250464|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
395195|NCT00092547|1250465|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
395196|NCT00092547|1250463|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
395197|NCT00092547|1250464|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
395198|NCT00092547|1250465|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
395199|NCT00092547|1250463|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
395200|NCT00092547|1250464|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
395201|NCT00092547|1250465|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
395202|NCT00092547|1250463|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
395203|NCT00092547|1250464|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
395204|NCT00092547|1250465|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
395205|NCT00092547|1250463|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
395206|NCT00092547|1250464|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
395207|NCT00092547|1250465|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
395208|NCT00092547|1250463|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
395209|NCT00092547|1250464|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
395210|NCT00092547|1250465|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
395211|NCT00092547|1250463|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
395212|NCT00092547|1250464|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
395213|NCT00092547|1250465|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
395214|NCT00092547|1250463|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
395215|NCT00092547|1250464|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
395216|NCT00092547|1250465|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
395217|NCT00092547|1250463|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
395218|NCT00092547|1250464|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
395219|NCT00092547|1250465|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
395220|NCT00092547|1250463|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
395221|NCT00092547|1250464|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
395222|NCT00092547|1250465|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
395223|NCT00092547|1250463|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
395224|NCT00092547|1250464|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
395225|NCT00092547|1250465|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
395226|NCT00092547|1250463|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
395227|NCT00092547|1250464|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
395228|NCT00092547|1250465|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
395229|NCT00092547|1250463|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
395230|NCT00092547|1250464|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
395231|NCT00092547|1250465|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
395232|NCT00092534|1250509|P3|Extension Study|Protocol Deviation|15
395233|NCT00092534|1250510|P2|Extension Study|Protocol Deviation|0
395234|NCT00092534|1250511|P1|Extension Study|Protocol Deviation|0
395235|NCT00092534|1250509|P3|Extension Study|Study Ended|29
395236|NCT00092534|1250510|P2|Extension Study|Study Ended|0
395237|NCT00092534|1250511|P1|Extension Study|Study Ended|0
395238|NCT00092534|1250509|P3|Extension Study|Site Closed|21
395239|NCT00092534|1250510|P2|Extension Study|Site Closed|0
395240|NCT00092534|1250511|P1|Extension Study|Site Closed|0
395241|NCT00092534|1250509|P3|Extension Study|Travel|2
395242|NCT00092534|1250510|P2|Extension Study|Travel|0
395243|NCT00092534|1250511|P1|Extension Study|Travel|0
395244|NCT00092534|1250509|P3|Extension Study|Moved|6
395245|NCT00092534|1250510|P2|Extension Study|Moved|0
395246|NCT00092534|1250511|P1|Extension Study|Moved|0
395247|NCT00092534|1250509|P3|Extension Study|Withdrawal by Subject|18
395248|NCT00092534|1250510|P2|Extension Study|Withdrawal by Subject|0
395249|NCT00092534|1250511|P1|Extension Study|Withdrawal by Subject|0
395250|NCT00092534|1250509|P3|Extension Study|Pregnancy|12
395251|NCT00092534|1250510|P2|Extension Study|Pregnancy|0
395252|NCT00092534|1250511|P1|Extension Study|Pregnancy|0
395253|NCT00092534|1250509|P3|Extension Study|Physician Decision|1
395254|NCT00092534|1250510|P2|Extension Study|Physician Decision|0
395255|NCT00092534|1250511|P1|Extension Study|Physician Decision|0
395256|NCT00092534|1250509|P3|Extension Study|Lost to Follow-up|41
395257|NCT00092534|1250510|P2|Extension Study|Lost to Follow-up|0
395258|NCT00092534|1250511|P1|Extension Study|Lost to Follow-up|0
395259|NCT00092534|1250509|P3|Base Study Follow Up Period|Subjects in extension|0
395260|NCT00092534|1250510|P2|Base Study Follow Up Period|Subjects in extension|371
395261|NCT00092534|1250511|P1|Base Study Follow Up Period|Subjects in extension|15
395262|NCT00092534|1250509|P3|Base Study Follow Up Period|Subjects continuing|0
395263|NCT00092534|1250510|P2|Base Study Follow Up Period|Subjects continuing|31
395264|NCT00092534|1250511|P1|Base Study Follow Up Period|Subjects continuing|27
395265|NCT00092534|1250509|P3|Base Study Follow Up Period|Site Closed|0
395266|NCT00092534|1250510|P2|Base Study Follow Up Period|Site Closed|2
395267|NCT00092534|1250511|P1|Base Study Follow Up Period|Site Closed|0
395268|NCT00092534|1250509|P3|Base Study Follow Up Period|Travel|0
395269|NCT00092534|1250510|P2|Base Study Follow Up Period|Travel|7
395270|NCT00092534|1250511|P1|Base Study Follow Up Period|Travel|10
395271|NCT00092534|1250509|P3|Base Study Follow Up Period|Moved|0
395272|NCT00092534|1250510|P2|Base Study Follow Up Period|Moved|58
395273|NCT00092534|1250511|P1|Base Study Follow Up Period|Moved|62
395274|NCT00092534|1250509|P3|Base Study Follow Up Period|Withdrawal by Subject|0
395275|NCT00092534|1250510|P2|Base Study Follow Up Period|Withdrawal by Subject|62
395276|NCT00092534|1250511|P1|Base Study Follow Up Period|Withdrawal by Subject|71
395277|NCT00092534|1250509|P3|Base Study Follow Up Period|Protocol Violation|0
395278|NCT00092534|1250510|P2|Base Study Follow Up Period|Protocol Violation|2
395279|NCT00092534|1250511|P1|Base Study Follow Up Period|Protocol Violation|1
395280|NCT00092534|1250509|P3|Base Study Follow Up Period|Pregnancy|0
395281|NCT00092534|1250510|P2|Base Study Follow Up Period|Pregnancy|10
395282|NCT00092534|1250511|P1|Base Study Follow Up Period|Pregnancy|6
395283|NCT00092534|1250509|P3|Base Study Follow Up Period|Lost to Follow-up|0
395284|NCT00092534|1250510|P2|Base Study Follow Up Period|Lost to Follow-up|146
395285|NCT00092534|1250511|P1|Base Study Follow Up Period|Lost to Follow-up|120
395286|NCT00092534|1250509|P3|Base Study Follow Up Period|Death|0
395287|NCT00092534|1250510|P2|Base Study Follow Up Period|Death|1
395288|NCT00092534|1250511|P1|Base Study Follow Up Period|Death|2
395289|NCT00092534|1250509|P3|Base Study Follow Up Period|Adverse Event|0
395290|NCT00092534|1250510|P2|Base Study Follow Up Period|Adverse Event|4
395291|NCT00092534|1250511|P1|Base Study Follow Up Period|Adverse Event|2
395292|NCT00092534|1250509|P3|Base Study Vaccination Period|Site Closed|0
395293|NCT00092534|1250510|P2|Base Study Vaccination Period|Site Closed|1
395294|NCT00092534|1250511|P1|Base Study Vaccination Period|Site Closed|0
395295|NCT00092534|1250509|P3|Base Study Vaccination Period|Travel|0
395296|NCT00092534|1250510|P2|Base Study Vaccination Period|Travel|0
395297|NCT00092534|1250511|P1|Base Study Vaccination Period|Travel|1
395298|NCT00092534|1250509|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
395299|NCT00092534|1250510|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
395300|NCT00092534|1250511|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
395301|NCT00092534|1250509|P3|Base Study Vaccination Period|Moved|0
395302|NCT00092534|1250510|P2|Base Study Vaccination Period|Moved|12
395303|NCT00092534|1250511|P1|Base Study Vaccination Period|Moved|14
395304|NCT00092534|1250509|P3|Base Study Vaccination Period|Withdrawal by Subject|0
395305|NCT00092534|1250510|P2|Base Study Vaccination Period|Withdrawal by Subject|58
395306|NCT00092534|1250511|P1|Base Study Vaccination Period|Withdrawal by Subject|85
395307|NCT00092534|1250509|P3|Base Study Vaccination Period|Protocol Violation|0
395308|NCT00092534|1250510|P2|Base Study Vaccination Period|Protocol Violation|1
395309|NCT00092534|1250511|P1|Base Study Vaccination Period|Protocol Violation|2
395310|NCT00092534|1250509|P3|Base Study Vaccination Period|Pregnancy|0
395311|NCT00092534|1250510|P2|Base Study Vaccination Period|Pregnancy|7
395312|NCT00092534|1250511|P1|Base Study Vaccination Period|Pregnancy|9
395313|NCT00092534|1250509|P3|Base Study Vaccination Period|Physician Decision|0
395314|NCT00092534|1250510|P2|Base Study Vaccination Period|Physician Decision|0
395315|NCT00092534|1250511|P1|Base Study Vaccination Period|Physician Decision|1
395316|NCT00092534|1250509|P3|Base Study Vaccination Period|Lost to Follow-up|0
395317|NCT00092534|1250510|P2|Base Study Vaccination Period|Lost to Follow-up|37
395318|NCT00092534|1250511|P1|Base Study Vaccination Period|Lost to Follow-up|41
395319|NCT00092534|1250509|P3|Base Study Vaccination Period|Death|0
395320|NCT00092534|1250510|P2|Base Study Vaccination Period|Death|4
395321|NCT00092534|1250511|P1|Base Study Vaccination Period|Death|5
395322|NCT00092534|1250509|P3|Base Study Vaccination Period|Adverse Event|0
395323|NCT00092534|1250510|P2|Base Study Vaccination Period|Adverse Event|1
395324|NCT00092534|1250511|P1|Base Study Vaccination Period|Adverse Event|3
395325|NCT00092534|1250509|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
395326|NCT00092534|1250510|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
395482|NCT00092495|1250549|P2|Base Study Vaccination Period|Unspecified|1
395327|NCT00092534|1250511|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
395328|NCT00092521|1250529|P4|Extension Study (Group 4)|Unable/unwilling to return|25
395329|NCT00092521|1250530|P3|Extension Study (Group 4)|Unable/unwilling to return|0
395330|NCT00092521|1250531|P2|Extension Study (Group 4)|Unable/unwilling to return|0
395331|NCT00092521|1250532|P1|Extension Study (Group 4)|Unable/unwilling to return|0
395332|NCT00092521|1250529|P4|Extension Study (Group 4)|Site Terminated|4
395333|NCT00092521|1250530|P3|Extension Study (Group 4)|Site Terminated|0
395334|NCT00092521|1250531|P2|Extension Study (Group 4)|Site Terminated|0
395335|NCT00092521|1250532|P1|Extension Study (Group 4)|Site Terminated|0
395336|NCT00092521|1250529|P4|Extension Study (Group 4)|Moved|16
395337|NCT00092521|1250530|P3|Extension Study (Group 4)|Moved|0
395338|NCT00092521|1250531|P2|Extension Study (Group 4)|Moved|0
395339|NCT00092521|1250532|P1|Extension Study (Group 4)|Moved|0
395340|NCT00092521|1250529|P4|Extension Study (Group 4)|Withdrawal by Subject|46
395341|NCT00092521|1250530|P3|Extension Study (Group 4)|Withdrawal by Subject|0
395342|NCT00092521|1250531|P2|Extension Study (Group 4)|Withdrawal by Subject|0
395343|NCT00092521|1250532|P1|Extension Study (Group 4)|Withdrawal by Subject|0
395344|NCT00092521|1250529|P4|Extension Study (Group 4)|Protocol Violation|2
395345|NCT00092521|1250530|P3|Extension Study (Group 4)|Protocol Violation|0
395346|NCT00092521|1250531|P2|Extension Study (Group 4)|Protocol Violation|0
395347|NCT00092521|1250532|P1|Extension Study (Group 4)|Protocol Violation|0
395348|NCT00092521|1250529|P4|Extension Study (Group 4)|Pregnancy|4
395349|NCT00092521|1250530|P3|Extension Study (Group 4)|Pregnancy|0
395350|NCT00092521|1250531|P2|Extension Study (Group 4)|Pregnancy|0
395351|NCT00092521|1250532|P1|Extension Study (Group 4)|Pregnancy|0
395352|NCT00092521|1250529|P4|Extension Study (Group 4)|Lost to Follow-up|87
395353|NCT00092521|1250530|P3|Extension Study (Group 4)|Lost to Follow-up|0
395354|NCT00092521|1250531|P2|Extension Study (Group 4)|Lost to Follow-up|0
395355|NCT00092521|1250532|P1|Extension Study (Group 4)|Lost to Follow-up|0
395356|NCT00092521|1250529|P4|Extension Study (Group 4)|Adverse Event|2
395357|NCT00092521|1250530|P3|Extension Study (Group 4)|Adverse Event|0
395358|NCT00092521|1250531|P2|Extension Study (Group 4)|Adverse Event|0
395359|NCT00092521|1250532|P1|Extension Study (Group 4)|Adverse Event|0
395360|NCT00092521|1250529|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
395361|NCT00092521|1250530|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
395362|NCT00092521|1250531|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
395363|NCT00092521|1250532|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
395364|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Visits Compressed|0
395365|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Visits Compressed|5
395366|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Visits Compressed|0
395367|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Visits Compressed|5
395368|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Travel|0
395369|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Travel|0
395370|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Travel|0
395371|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Travel|2
395372|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Site Terminated|0
395373|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Site Terminated|3
395374|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Site Terminated|0
395375|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Site Terminated|3
395376|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Moved|0
395377|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Moved|28
395378|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Moved|2
395379|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Moved|32
395380|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
395381|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
395382|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
395383|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
395384|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Protocol Violation|0
395385|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Protocol Violation|5
395386|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Protocol Violation|1
395387|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Protocol Violation|1
395388|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
395389|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
395390|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
395391|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
395392|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Death|0
395393|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Death|1
395394|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Death|0
395395|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Death|2
395396|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Adverse Event|0
395397|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Adverse Event|0
395398|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Adverse Event|0
395399|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Adverse Event|1
395400|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Subjects in Extension|0
395401|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Subjects in Extension|412
395402|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Subjects in Extension|109
395403|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Subjects in Extension|13
395404|NCT00092521|1250529|P4|Follow-Up (After Month 7)|Subjects Continuing|0
395405|NCT00092521|1250530|P3|Follow-Up (After Month 7)|Subjects Continuing|35
395406|NCT00092521|1250531|P2|Follow-Up (After Month 7)|Subjects Continuing|4
395407|NCT00092521|1250532|P1|Follow-Up (After Month 7)|Subjects Continuing|34
395408|NCT00092521|1250529|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
395409|NCT00092521|1250530|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
395410|NCT00092521|1250531|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
395411|NCT00092521|1250532|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
395412|NCT00092521|1250529|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
395413|NCT00092521|1250530|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
395414|NCT00092521|1250531|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
395415|NCT00092521|1250532|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
395416|NCT00092521|1250529|P4|Vaccination (Day 1 Through Month 7)|Moved|0
395417|NCT00092521|1250530|P3|Vaccination (Day 1 Through Month 7)|Moved|18
395418|NCT00092521|1250531|P2|Vaccination (Day 1 Through Month 7)|Moved|1
395419|NCT00092521|1250532|P1|Vaccination (Day 1 Through Month 7)|Moved|14
395420|NCT00092521|1250529|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
395421|NCT00092521|1250530|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
395422|NCT00092521|1250531|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
395423|NCT00092521|1250532|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
395424|NCT00092521|1250529|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
395425|NCT00092521|1250530|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
395426|NCT00092521|1250531|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
395427|NCT00092521|1250532|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
395428|NCT00092521|1250529|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
395429|NCT00092521|1250530|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
395430|NCT00092521|1250531|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
395431|NCT00092521|1250532|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
395432|NCT00092521|1250529|P4|Vaccination (Day 1 Through Month 7)|Death|0
395433|NCT00092521|1250530|P3|Vaccination (Day 1 Through Month 7)|Death|1
395434|NCT00092521|1250531|P2|Vaccination (Day 1 Through Month 7)|Death|0
395435|NCT00092521|1250532|P1|Vaccination (Day 1 Through Month 7)|Death|0
395436|NCT00092521|1250529|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
395437|NCT00092521|1250530|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
395438|NCT00092521|1250531|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
395439|NCT00092521|1250532|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
395440|NCT00092521|1250529|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
395441|NCT00092521|1250530|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
395442|NCT00092521|1250531|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
395443|NCT00092521|1250532|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
395444|NCT00092495|1250546|P5|Base Study Follow-up Period|Withdrawal by Subject|0
395445|NCT00092495|1250547|P4|Base Study Follow-up Period|Withdrawal by Subject|0
395446|NCT00092495|1250548|P3|Base Study Follow-up Period|Withdrawal by Subject|0
395447|NCT00092495|1250549|P2|Base Study Follow-up Period|Withdrawal by Subject|0
395448|NCT00092495|1250550|P1|Base Study Follow-up Period|Withdrawal by Subject|2
395449|NCT00092495|1250546|P5|Base Study Follow-up Period|Lost to Follow-up|0
395450|NCT00092495|1250547|P4|Base Study Follow-up Period|Lost to Follow-up|12
395451|NCT00092495|1250548|P3|Base Study Follow-up Period|Lost to Follow-up|3
395452|NCT00092495|1250549|P2|Base Study Follow-up Period|Lost to Follow-up|3
395453|NCT00092495|1250550|P1|Base Study Follow-up Period|Lost to Follow-up|1
395454|NCT00092495|1250546|P5|Base Study Follow-up Period|Extended|0
395455|NCT00092495|1250547|P4|Base Study Follow-up Period|Extended|2
395456|NCT00092495|1250548|P3|Base Study Follow-up Period|Extended|1
395457|NCT00092495|1250549|P2|Base Study Follow-up Period|Extended|0
395458|NCT00092495|1250550|P1|Base Study Follow-up Period|Extended|0
395459|NCT00092495|1250546|P5|Base Study Vaccination Period|Withdrawal by Subject|0
395460|NCT00092495|1250547|P4|Base Study Vaccination Period|Withdrawal by Subject|25
395461|NCT00092495|1250548|P3|Base Study Vaccination Period|Withdrawal by Subject|14
395462|NCT00092495|1250549|P2|Base Study Vaccination Period|Withdrawal by Subject|10
395463|NCT00092495|1250550|P1|Base Study Vaccination Period|Withdrawal by Subject|9
395464|NCT00092495|1250546|P5|Base Study Vaccination Period|Protocol Violation|0
395465|NCT00092495|1250547|P4|Base Study Vaccination Period|Protocol Violation|0
395466|NCT00092495|1250548|P3|Base Study Vaccination Period|Protocol Violation|0
395467|NCT00092495|1250549|P2|Base Study Vaccination Period|Protocol Violation|0
395468|NCT00092495|1250550|P1|Base Study Vaccination Period|Protocol Violation|1
395469|NCT00092495|1250546|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
395470|NCT00092495|1250547|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
395471|NCT00092495|1250548|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
395472|NCT00092495|1250549|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
395473|NCT00092495|1250550|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
395474|NCT00092495|1250546|P5|Base Study Vaccination Period|Pregnancy|0
395475|NCT00092495|1250547|P4|Base Study Vaccination Period|Pregnancy|0
395476|NCT00092495|1250548|P3|Base Study Vaccination Period|Pregnancy|0
395477|NCT00092495|1250549|P2|Base Study Vaccination Period|Pregnancy|0
395478|NCT00092495|1250550|P1|Base Study Vaccination Period|Pregnancy|2
395479|NCT00092495|1250546|P5|Base Study Vaccination Period|Unspecified|0
395480|NCT00092495|1250547|P4|Base Study Vaccination Period|Unspecified|2
395481|NCT00092495|1250548|P3|Base Study Vaccination Period|Unspecified|0
395483|NCT00092495|1250550|P1|Base Study Vaccination Period|Unspecified|1
395484|NCT00092495|1250546|P5|Base Study Vaccination Period|Moved|0
395485|NCT00092495|1250547|P4|Base Study Vaccination Period|Moved|2
395486|NCT00092495|1250548|P3|Base Study Vaccination Period|Moved|2
395487|NCT00092495|1250549|P2|Base Study Vaccination Period|Moved|1
395488|NCT00092495|1250550|P1|Base Study Vaccination Period|Moved|3
395489|NCT00092495|1250546|P5|Base Study Vaccination Period|Lost to Follow-up|0
395490|NCT00092495|1250547|P4|Base Study Vaccination Period|Lost to Follow-up|36
395491|NCT00092495|1250548|P3|Base Study Vaccination Period|Lost to Follow-up|11
395492|NCT00092495|1250549|P2|Base Study Vaccination Period|Lost to Follow-up|6
395493|NCT00092495|1250550|P1|Base Study Vaccination Period|Lost to Follow-up|16
395494|NCT00092495|1250546|P5|Base Study Vaccination Period|Adverse Event|0
395495|NCT00092495|1250547|P4|Base Study Vaccination Period|Adverse Event|3
395496|NCT00092495|1250548|P3|Base Study Vaccination Period|Adverse Event|0
395497|NCT00092495|1250549|P2|Base Study Vaccination Period|Adverse Event|0
395498|NCT00092495|1250550|P1|Base Study Vaccination Period|Adverse Event|1
395499|NCT00092495|1250546|P5|Base Study Vaccination Period|*Pregnancy|0
395500|NCT00092495|1250547|P4|Base Study Vaccination Period|*Pregnancy|7
395501|NCT00092495|1250548|P3|Base Study Vaccination Period|*Pregnancy|5
395502|NCT00092495|1250549|P2|Base Study Vaccination Period|*Pregnancy|2
395503|NCT00092495|1250550|P1|Base Study Vaccination Period|*Pregnancy|0
395504|NCT00092495|1250546|P5|Base Study Vaccination Period|*Other reasons|0
395505|NCT00092495|1250547|P4|Base Study Vaccination Period|*Other reasons|1
395506|NCT00092495|1250548|P3|Base Study Vaccination Period|*Other reasons|0
395507|NCT00092495|1250549|P2|Base Study Vaccination Period|*Other reasons|0
395508|NCT00092495|1250550|P1|Base Study Vaccination Period|*Other reasons|1
395509|NCT00092495|1250546|P5|Base Study Vaccination Period|*Clinical AE|0
395510|NCT00092495|1250547|P4|Base Study Vaccination Period|*Clinical AE|2
395511|NCT00092495|1250548|P3|Base Study Vaccination Period|*Clinical AE|1
395512|NCT00092495|1250549|P2|Base Study Vaccination Period|*Clinical AE|0
395513|NCT00092495|1250550|P1|Base Study Vaccination Period|*Clinical AE|1
395514|NCT00092495|1250546|P5|Base Study Vaccination Period|Extended|0
395515|NCT00092495|1250547|P4|Base Study Vaccination Period|Extended|1
395516|NCT00092495|1250548|P3|Base Study Vaccination Period|Extended|0
395517|NCT00092495|1250549|P2|Base Study Vaccination Period|Extended|0
395518|NCT00092495|1250550|P1|Base Study Vaccination Period|Extended|0
395519|NCT00092495|1250546|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
395520|NCT00092495|1250547|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
395521|NCT00092495|1250548|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
395522|NCT00092495|1250549|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
395523|NCT00092495|1250550|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
395524|NCT00092456|1250616|P4|Overall Study|Not Specified|0
395525|NCT00092456|1250617|P3|Overall Study|Not Specified|3
395526|NCT00092456|1250618|P2|Overall Study|Not Specified|2
395527|NCT00092456|1250619|P1|Overall Study|Not Specified|4
395528|NCT00092456|1250616|P4|Overall Study|Moved|1
395529|NCT00092456|1250617|P3|Overall Study|Moved|0
395530|NCT00092456|1250618|P2|Overall Study|Moved|1
395531|NCT00092456|1250619|P1|Overall Study|Moved|1
395532|NCT00092456|1250616|P4|Overall Study|Withdrawal by Subject|6
395533|NCT00092456|1250617|P3|Overall Study|Withdrawal by Subject|16
395534|NCT00092456|1250618|P2|Overall Study|Withdrawal by Subject|5
395535|NCT00092456|1250619|P1|Overall Study|Withdrawal by Subject|13
395536|NCT00092456|1250616|P4|Overall Study|Protocol Violation|6
395537|NCT00092456|1250617|P3|Overall Study|Protocol Violation|8
395538|NCT00092456|1250618|P2|Overall Study|Protocol Violation|7
395539|NCT00092456|1250619|P1|Overall Study|Protocol Violation|5
395540|NCT00092456|1250616|P4|Overall Study|Lost to Follow-up|2
395541|NCT00092456|1250617|P3|Overall Study|Lost to Follow-up|1
395542|NCT00092456|1250618|P2|Overall Study|Lost to Follow-up|2
395543|NCT00092456|1250619|P1|Overall Study|Lost to Follow-up|2
395544|NCT00092456|1250616|P4|Overall Study|Adverse Event|1
395545|NCT00092456|1250617|P3|Overall Study|Adverse Event|1
395546|NCT00092456|1250618|P2|Overall Study|Adverse Event|0
395547|NCT00092456|1250619|P1|Overall Study|Adverse Event|0
395548|NCT00092443|1250667|P2|Overall Study|Not Specified|13
395549|NCT00092443|1250668|P1|Overall Study|Not Specified|17
395550|NCT00092443|1250667|P2|Overall Study|Moved|5
395551|NCT00092443|1250668|P1|Overall Study|Moved|5
395552|NCT00092443|1250667|P2|Overall Study|Withdrawal by Subject|11
395553|NCT00092443|1250668|P1|Overall Study|Withdrawal by Subject|9
395554|NCT00092443|1250667|P2|Overall Study|Protocol Violation|9
395555|NCT00092443|1250668|P1|Overall Study|Protocol Violation|11
395556|NCT00092443|1250667|P2|Overall Study|Lost to Follow-up|3
395557|NCT00092443|1250668|P1|Overall Study|Lost to Follow-up|7
395558|NCT00092443|1250667|P2|Overall Study|Adverse Event|13
395559|NCT00092443|1250668|P1|Overall Study|Adverse Event|9
395560|NCT00092417|1250686|P2|Overall Study|Not Specified|0
395561|NCT00092417|1250687|P1|Overall Study|Not Specified|1
395562|NCT00092417|1250686|P2|Overall Study|Withdrawal by Subject|1
395563|NCT00092417|1250687|P1|Overall Study|Withdrawal by Subject|2
395564|NCT00092417|1250686|P2|Overall Study|Lost to Follow-up|0
395565|NCT00092417|1250687|P1|Overall Study|Lost to Follow-up|2
395566|NCT00092131|1250701|P2|Treatment Period II|Adverse Event|1
395567|NCT00092131|1250702|P1|Treatment Period II|Adverse Event|0
395568|NCT00092131|1250701|P2|Treatment Period I|Adverse Event|0
395569|NCT00092131|1250702|P1|Treatment Period I|Adverse Event|1
395570|NCT00092118|1250732|P2|Overall Study|Not Specified|5
395571|NCT00092118|1250733|P1|Overall Study|Not Specified|6
395572|NCT00092118|1250732|P2|Overall Study|Withdrawal by Subject|10
395573|NCT00092118|1250733|P1|Overall Study|Withdrawal by Subject|4
395574|NCT00092118|1250732|P2|Overall Study|Protocol Violation|25
395575|NCT00092118|1250733|P1|Overall Study|Protocol Violation|23
395576|NCT00092118|1250732|P2|Overall Study|Lost to Follow-up|3
395577|NCT00092118|1250733|P1|Overall Study|Lost to Follow-up|4
395578|NCT00092118|1250732|P2|Overall Study|Lack of Efficacy|14
395579|NCT00092118|1250733|P1|Overall Study|Lack of Efficacy|12
395580|NCT00092118|1250732|P2|Overall Study|Adverse Event|32
395581|NCT00092118|1250733|P1|Overall Study|Adverse Event|35
395582|NCT00091949|1250767|P2|Overall Study|Lost to Follow-up|41
395583|NCT00091949|1250768|P1|Overall Study|Lost to Follow-up|58
395584|NCT00091949|1250767|P2|Overall Study|Withdrawal by Subject|110
395585|NCT00091949|1250768|P1|Overall Study|Withdrawal by Subject|117
395586|NCT00091572|1250788|P2|Overall Study|Toxicity (Related AE)|9
395587|NCT00091572|1250789|P1|Overall Study|Toxicity (Related AE)|53
395588|NCT00091572|1250788|P2|Overall Study|Major Protocol Violation|0
395589|NCT00091572|1250789|P1|Overall Study|Major Protocol Violation|2
395590|NCT00091572|1250788|P2|Overall Study|Ongoing (still on treatment)|12
395591|NCT00091572|1250789|P1|Overall Study|Ongoing (still on treatment)|8
395592|NCT00091572|1250788|P2|Overall Study|Other Reason|13
395593|NCT00091572|1250789|P1|Overall Study|Other Reason|6
395594|NCT00091572|1250788|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
395595|NCT00091572|1250789|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
395596|NCT00091572|1250788|P2|Overall Study|Death not due to malignancy/toxicity|3
395597|NCT00091572|1250789|P1|Overall Study|Death not due to malignancy/toxicity|1
395598|NCT00091572|1250788|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
395599|NCT00091572|1250789|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
395600|NCT00091572|1250788|P2|Overall Study|Lost to Follow-up|1
395601|NCT00091572|1250789|P1|Overall Study|Lost to Follow-up|1
395602|NCT00091442|1250820|P2|Overall Study|Not Specified|6
395603|NCT00091442|1250821|P1|Overall Study|Not Specified|2
395604|NCT00091442|1250820|P2|Overall Study|Lost to Follow-up|3
395605|NCT00091442|1250821|P1|Overall Study|Lost to Follow-up|1
395606|NCT00091442|1250820|P2|Overall Study|Death|7
395607|NCT00091442|1250821|P1|Overall Study|Death|9
395608|NCT00091442|1250820|P2|Overall Study|2cycles therapy beyond Complete response|16
395609|NCT00091442|1250821|P1|Overall Study|2cycles therapy beyond Complete response|9
395610|NCT00091442|1250820|P2|Overall Study|Adverse Event|48
395611|NCT00091442|1250821|P1|Overall Study|Adverse Event|29
395612|NCT00091442|1250820|P2|Overall Study|Withdrawal by Subject|46
395613|NCT00091442|1250821|P1|Overall Study|Withdrawal by Subject|38
395614|NCT00091442|1250820|P2|Overall Study|Physician Decision|58
395615|NCT00091442|1250821|P1|Overall Study|Physician Decision|61
395616|NCT00091442|1250820|P2|Overall Study|Progressive Disease|189
395617|NCT00091442|1250821|P1|Overall Study|Progressive Disease|220
395618|NCT00091390|1250831|P1|Overall Study|Protocol Violation|2
395619|NCT00091390|1250831|P1|Overall Study|Withdrawal by Subject|2
395620|NCT00091169|1250849|P2|Overall Study|Not start protocol therapy|17
395621|NCT00091169|1250850|P1|Overall Study|Not start protocol therapy|26
395622|NCT00091169|1250849|P2|Overall Study|Other|4
395623|NCT00091169|1250850|P1|Overall Study|Other|3
395624|NCT00091169|1250849|P2|Overall Study|Withdrawal by Subject|13
395625|NCT00091169|1250850|P1|Overall Study|Withdrawal by Subject|10
395626|NCT00091169|1250849|P2|Overall Study|Death|1
395627|NCT00091169|1250850|P1|Overall Study|Death|4
395628|NCT00091169|1250849|P2|Overall Study|Adverse Event|17
395629|NCT00091169|1250850|P1|Overall Study|Adverse Event|11
395630|NCT00091169|1250849|P2|Overall Study|Disease progression|1
395631|NCT00091169|1250850|P1|Overall Study|Disease progression|3
395632|NCT00091026|1250868|P2|Overall Study|Unknown-never received treatment|1
395633|NCT00091026|1250869|P1|Overall Study|Unknown-never received treatment|0
395634|NCT00091026|1250868|P2|Overall Study|Patient withdrew and never received trea|2
395635|NCT00091026|1250869|P1|Overall Study|Patient withdrew and never received trea|0
395636|NCT00091026|1250868|P2|Overall Study|Patient deemed non eligible-never receiv|0
395637|NCT00091026|1250869|P1|Overall Study|Patient deemed non eligible-never receiv|1
395638|NCT00090987|1250879|P1|Overall Study|Incarcerated|1
395639|NCT00090987|1250879|P1|Overall Study|Non-compliance|4
395640|NCT00090987|1250879|P1|Overall Study|alternative therapy|1
395641|NCT00090987|1250879|P1|Overall Study|Withdrawal by Subject|3
395642|NCT00090987|1250879|P1|Overall Study|Lack of Efficacy|7
395643|NCT00090987|1250879|P1|Overall Study|Adverse Event|5
395644|NCT00090779|1250894|P2|Step 3|Off extended study due to study closure|3
395645|NCT00090779|1250895|P1|Step 3|Off extended study due to study closure|4
395646|NCT00090779|1250894|P2|Step 3|Initiation of ART and off extended study|2
395647|NCT00090779|1250895|P1|Step 3|Initiation of ART and off extended study|3
395648|NCT00090779|1250894|P2|Step 2|Non-compliance to study requirements|1
395649|NCT00090779|1250895|P1|Step 2|Non-compliance to study requirements|0
395650|NCT00090779|1250894|P2|Step 2|Subject relocated|1
395651|NCT00090779|1250895|P1|Step 2|Subject relocated|0
395652|NCT00090779|1250894|P2|Step 2|Off study per study closure|16
395653|NCT00090779|1250895|P1|Step 2|Off study per study closure|6
395654|NCT00090779|1250894|P2|Step 1|Subject relocated|8
395655|NCT00090779|1250895|P1|Step 1|Subject relocated|2
395656|NCT00090779|1250894|P2|Step 1|Non-compliance to study requirements|1
395657|NCT00090779|1250895|P1|Step 1|Non-compliance to study requirements|0
395658|NCT00090779|1250894|P2|Step 1|Pregnancy|0
395659|NCT00090779|1250895|P1|Step 1|Pregnancy|1
395660|NCT00090779|1250894|P2|Step 1|Physician Decision|0
395661|NCT00090779|1250895|P1|Step 1|Physician Decision|1
395662|NCT00090779|1250894|P2|Step 1|Death|2
395663|NCT00090779|1250895|P1|Step 1|Death|0
395664|NCT00090779|1250894|P2|Step 1|Lost to Follow-up|2
395665|NCT00090779|1250895|P1|Step 1|Lost to Follow-up|3
395666|NCT00090779|1250894|P2|Step 1|Withdrawal by Subject|2
395667|NCT00090779|1250895|P1|Step 1|Withdrawal by Subject|4
395668|NCT00090766|1250919|P3|Overall Study|Lost to Follow-up|2
395669|NCT00090766|1250920|P2|Overall Study|Lost to Follow-up|0
395670|NCT00090766|1250921|P1|Overall Study|Lost to Follow-up|2
395671|NCT00090766|1250919|P3|Overall Study|Admin|0
395672|NCT00090766|1250920|P2|Overall Study|Admin|2
395673|NCT00090766|1250921|P1|Overall Study|Admin|0
395674|NCT00090766|1250919|P3|Overall Study|Death|0
395675|NCT00090766|1250920|P2|Overall Study|Death|0
395676|NCT00090766|1250921|P1|Overall Study|Death|1
395677|NCT00090766|1250919|P3|Overall Study|Nephrectomy Planned|1
395678|NCT00090766|1250920|P2|Overall Study|Nephrectomy Planned|0
395679|NCT00090766|1250921|P1|Overall Study|Nephrectomy Planned|0
395680|NCT00090753|1250963|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
395681|NCT00090753|1250964|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
395682|NCT00090753|1250963|P2|Extended Treatment Period|Mircera Commercialization|93
395683|NCT00090753|1250964|P1|Extended Treatment Period|Mircera Commercialization|188
395684|NCT00090753|1250963|P2|Extended Treatment Period|Renal Transplant|12
395685|NCT00090753|1250964|P1|Extended Treatment Period|Renal Transplant|15
395686|NCT00090753|1250963|P2|Extended Treatment Period|Lost to Follow-up|1
395687|NCT00090753|1250964|P1|Extended Treatment Period|Lost to Follow-up|3
395688|NCT00090753|1250963|P2|Extended Treatment Period|Refused Treatment|12
395689|NCT00090753|1250964|P1|Extended Treatment Period|Refused Treatment|18
395690|NCT00090753|1250963|P2|Extended Treatment Period|Lack of Efficacy|0
395691|NCT00090753|1250964|P1|Extended Treatment Period|Lack of Efficacy|1
395692|NCT00090753|1250963|P2|Extended Treatment Period|Death|30
395693|NCT00090753|1250964|P1|Extended Treatment Period|Death|58
395694|NCT00090753|1250963|P2|Extended Treatment Period|Adverse Event|0
395695|NCT00090753|1250964|P1|Extended Treatment Period|Adverse Event|11
395696|NCT00090753|1250963|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
395697|NCT00090753|1250964|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
395698|NCT00090753|1250963|P2|First Treatment Period|Mircera Commercialization|0
395699|NCT00090753|1250964|P1|First Treatment Period|Mircera Commercialization|1
395700|NCT00090753|1250963|P2|First Treatment Period|Renal Transplant|50
395701|NCT00090753|1250964|P1|First Treatment Period|Renal Transplant|70
395702|NCT00090753|1250963|P2|First Treatment Period|Lost to Follow-up|4
395703|NCT00090753|1250964|P1|First Treatment Period|Lost to Follow-up|4
395704|NCT00090753|1250963|P2|First Treatment Period|Refused Treatment|25
395705|NCT00090753|1250964|P1|First Treatment Period|Refused Treatment|32
395706|NCT00090753|1250963|P2|First Treatment Period|Lack of Efficacy|1
395707|NCT00090753|1250964|P1|First Treatment Period|Lack of Efficacy|2
395708|NCT00090753|1250963|P2|First Treatment Period|Death|62
395709|NCT00090753|1250964|P1|First Treatment Period|Death|88
395710|NCT00090753|1250963|P2|First Treatment Period|Adverse Event|8
395711|NCT00090753|1250964|P1|First Treatment Period|Adverse Event|20
395712|NCT00090610|1250974|P2|Overall Study|Withdrawal by Subject|1
395713|NCT00090610|1250975|P1|Overall Study|Withdrawal by Subject|1
395714|NCT00090584|1250991|P2|Baseline to 8 Months|Lost to Follow-up|41
395715|NCT00090584|1250992|P1|Baseline to 8 Months|Lost to Follow-up|44
395716|NCT00090584|1250991|P2|Baseline to 10 Weeks|Lost to Follow-up|12
395717|NCT00090584|1250992|P1|Baseline to 10 Weeks|Lost to Follow-up|15
395718|NCT00090545|1251024|P2|Overall Study|Adverse Event|2
395719|NCT00090545|1251025|P1|Overall Study|Adverse Event|0
395720|NCT00090545|1251024|P2|Overall Study|Death|1
395721|NCT00090545|1251025|P1|Overall Study|Death|0
395722|NCT00090545|1251024|P2|Overall Study|Refused further treatment|4
395723|NCT00090545|1251025|P1|Overall Study|Refused further treatment|1
395724|NCT00090545|1251024|P2|Overall Study|Disease progression on study|17
395725|NCT00090545|1251025|P1|Overall Study|Disease progression on study|21
395726|NCT00090519|1251035|P2|Overall Study|Sponsor Decision|1
395727|NCT00090519|1251036|P1|Overall Study|Sponsor Decision|3
395728|NCT00090519|1251035|P2|Overall Study|Physician Decision|3
395729|NCT00090519|1251036|P1|Overall Study|Physician Decision|2
395730|NCT00090519|1251035|P2|Overall Study|Withdrawal by Subject|29
395731|NCT00090519|1251036|P1|Overall Study|Withdrawal by Subject|28
395732|NCT00090519|1251035|P2|Overall Study|Lost to Follow-up|29
395733|NCT00090519|1251036|P1|Overall Study|Lost to Follow-up|26
395734|NCT00090519|1251035|P2|Overall Study|Death|9
395735|NCT00090519|1251036|P1|Overall Study|Death|9
395736|NCT00090519|1251035|P2|Overall Study|Adverse Event|4
395737|NCT00090519|1251036|P1|Overall Study|Adverse Event|5
395738|NCT00090493|1251060|P1|Overall Study|Physician Decision|2
395739|NCT00090402|1251067|P3|Overall Study|stopped taking study medication|1
395740|NCT00090402|1251068|P2|Overall Study|stopped taking study medication|1
395741|NCT00090402|1251069|P1|Overall Study|stopped taking study medication|0
395742|NCT00090402|1251067|P3|Overall Study|subject moved|0
395743|NCT00090402|1251068|P2|Overall Study|subject moved|0
395744|NCT00090402|1251069|P1|Overall Study|subject moved|1
395745|NCT00090402|1251067|P3|Overall Study|Death|0
395746|NCT00090402|1251068|P2|Overall Study|Death|1
395747|NCT00090402|1251069|P1|Overall Study|Death|1
395748|NCT00090363|1251080|P3|Overall Study|Continuing on study off treatment|16
395749|NCT00090363|1251081|P2|Overall Study|Continuing on study off treatment|13
395750|NCT00090363|1251082|P1|Overall Study|Continuing on study off treatment|14
395751|NCT00090363|1251080|P3|Overall Study|Reasons not specified|1
395752|NCT00090363|1251081|P2|Overall Study|Reasons not specified|1
395753|NCT00090363|1251082|P1|Overall Study|Reasons not specified|2
395754|NCT00090363|1251080|P3|Overall Study|Consent expired|9
395755|NCT00090363|1251081|P2|Overall Study|Consent expired|10
395756|NCT00090363|1251082|P1|Overall Study|Consent expired|7
395757|NCT00090363|1251080|P3|Overall Study|Eligibility criteria not fulfilled|1
395758|NCT00090363|1251081|P2|Overall Study|Eligibility criteria not fulfilled|0
395759|NCT00090363|1251082|P1|Overall Study|Eligibility criteria not fulfilled|0
395760|NCT00090363|1251080|P3|Overall Study|Study-specific discontinuation criteria|62
395761|NCT00090363|1251081|P2|Overall Study|Study-specific discontinuation criteria|74
395762|NCT00090363|1251082|P1|Overall Study|Study-specific discontinuation criteria|75
395763|NCT00090363|1251080|P3|Overall Study|Withdrawal by Subject|6
395764|NCT00090363|1251081|P2|Overall Study|Withdrawal by Subject|7
395765|NCT00090363|1251082|P1|Overall Study|Withdrawal by Subject|7
395766|NCT00090363|1251080|P3|Overall Study|Lost to Follow-up|1
395767|NCT00090363|1251081|P2|Overall Study|Lost to Follow-up|2
395768|NCT00090363|1251082|P1|Overall Study|Lost to Follow-up|1
395769|NCT00090285|1251104|P4|Extension 1|Moved|0
395770|NCT00090285|1251105|P3|Extension 1|Moved|3
395771|NCT00090285|1251106|P2|Extension 1|Moved|0
395772|NCT00090285|1251107|P1|Extension 1|Moved|0
395773|NCT00090285|1251104|P4|Extension 1|Other Reason|0
395774|NCT00090285|1251105|P3|Extension 1|Other Reason|4
395775|NCT00090285|1251106|P2|Extension 1|Other Reason|0
395776|NCT00090285|1251107|P1|Extension 1|Other Reason|0
395777|NCT00090285|1251104|P4|Extension 1|Withdrawal by Subject|1
395778|NCT00090285|1251105|P3|Extension 1|Withdrawal by Subject|13
395779|NCT00090285|1251106|P2|Extension 1|Withdrawal by Subject|0
395780|NCT00090285|1251107|P1|Extension 1|Withdrawal by Subject|0
395781|NCT00090285|1251104|P4|Extension 1|Lost to Follow-up|0
395782|NCT00090285|1251105|P3|Extension 1|Lost to Follow-up|35
395783|NCT00090285|1251106|P2|Extension 1|Lost to Follow-up|0
395784|NCT00090285|1251107|P1|Extension 1|Lost to Follow-up|0
395785|NCT00090285|1251104|P4|Extension 1|Adverse Event|0
395786|NCT00090285|1251105|P3|Extension 1|Adverse Event|2
395787|NCT00090285|1251106|P2|Extension 1|Adverse Event|0
395788|NCT00090285|1251107|P1|Extension 1|Adverse Event|0
395789|NCT00090285|1251104|P4|Base Study Follow-up Period|Subject Incarcerated|0
395790|NCT00090285|1251105|P3|Base Study Follow-up Period|Subject Incarcerated|0
395791|NCT00090285|1251106|P2|Base Study Follow-up Period|Subject Incarcerated|2
395792|NCT00090285|1251107|P1|Base Study Follow-up Period|Subject Incarcerated|0
395793|NCT00090285|1251104|P4|Base Study Follow-up Period|Uncooperative|0
395794|NCT00090285|1251105|P3|Base Study Follow-up Period|Uncooperative|0
395795|NCT00090285|1251106|P2|Base Study Follow-up Period|Uncooperative|4
395796|NCT00090285|1251107|P1|Base Study Follow-up Period|Uncooperative|3
395797|NCT00090285|1251104|P4|Base Study Follow-up Period|Protocol Violation|0
395798|NCT00090285|1251105|P3|Base Study Follow-up Period|Protocol Violation|0
395799|NCT00090285|1251106|P2|Base Study Follow-up Period|Protocol Violation|0
395800|NCT00090285|1251107|P1|Base Study Follow-up Period|Protocol Violation|1
395801|NCT00090285|1251104|P4|Base Study Follow-up Period|Unspecified|0
395802|NCT00090285|1251105|P3|Base Study Follow-up Period|Unspecified|0
395803|NCT00090285|1251106|P2|Base Study Follow-up Period|Unspecified|0
395804|NCT00090285|1251107|P1|Base Study Follow-up Period|Unspecified|2
395805|NCT00090285|1251104|P4|Base Study Follow-up Period|Moved|0
395806|NCT00090285|1251105|P3|Base Study Follow-up Period|Moved|0
395807|NCT00090285|1251106|P2|Base Study Follow-up Period|Moved|36
395808|NCT00090285|1251107|P1|Base Study Follow-up Period|Moved|41
395809|NCT00090285|1251104|P4|Base Study Follow-up Period|Withdrawal by Subject|0
395810|NCT00090285|1251105|P3|Base Study Follow-up Period|Withdrawal by Subject|0
395811|NCT00090285|1251106|P2|Base Study Follow-up Period|Withdrawal by Subject|64
395812|NCT00090285|1251107|P1|Base Study Follow-up Period|Withdrawal by Subject|53
395813|NCT00090285|1251104|P4|Base Study Follow-up Period|Lost to Follow-up|0
395814|NCT00090285|1251105|P3|Base Study Follow-up Period|Lost to Follow-up|0
395815|NCT00090285|1251106|P2|Base Study Follow-up Period|Lost to Follow-up|226
395816|NCT00090285|1251107|P1|Base Study Follow-up Period|Lost to Follow-up|232
395817|NCT00090285|1251104|P4|Base Study Follow-up Period|Adverse Event|0
395818|NCT00090285|1251105|P3|Base Study Follow-up Period|Adverse Event|0
395819|NCT00090285|1251106|P2|Base Study Follow-up Period|Adverse Event|10
395820|NCT00090285|1251107|P1|Base Study Follow-up Period|Adverse Event|3
395821|NCT00090285|1251104|P4|Base Study Vaccination Period|HIV positive|0
395822|NCT00090285|1251105|P3|Base Study Vaccination Period|HIV positive|0
395823|NCT00090285|1251106|P2|Base Study Vaccination Period|HIV positive|1
395824|NCT00090285|1251107|P1|Base Study Vaccination Period|HIV positive|1
395825|NCT00090285|1251104|P4|Base Study Vaccination Period|Subject Incarcerated|0
395826|NCT00090285|1251105|P3|Base Study Vaccination Period|Subject Incarcerated|0
395827|NCT00090285|1251106|P2|Base Study Vaccination Period|Subject Incarcerated|2
395828|NCT00090285|1251107|P1|Base Study Vaccination Period|Subject Incarcerated|2
395829|NCT00090285|1251104|P4|Base Study Vaccination Period|Unspecified|0
395830|NCT00090285|1251105|P3|Base Study Vaccination Period|Unspecified|0
395831|NCT00090285|1251106|P2|Base Study Vaccination Period|Unspecified|2
395832|NCT00090285|1251107|P1|Base Study Vaccination Period|Unspecified|2
395833|NCT00090285|1251104|P4|Base Study Vaccination Period|Site Terminated|0
395834|NCT00090285|1251105|P3|Base Study Vaccination Period|Site Terminated|0
395835|NCT00090285|1251106|P2|Base Study Vaccination Period|Site Terminated|0
395836|NCT00090285|1251107|P1|Base Study Vaccination Period|Site Terminated|1
395837|NCT00090285|1251104|P4|Base Study Vaccination Period|Moved|0
395838|NCT00090285|1251105|P3|Base Study Vaccination Period|Moved|0
395839|NCT00090285|1251106|P2|Base Study Vaccination Period|Moved|21
395840|NCT00090285|1251107|P1|Base Study Vaccination Period|Moved|20
395841|NCT00090285|1251104|P4|Base Study Vaccination Period|Uncooperative|0
395842|NCT00090285|1251105|P3|Base Study Vaccination Period|Uncooperative|0
395843|NCT00090285|1251106|P2|Base Study Vaccination Period|Uncooperative|2
395844|NCT00090285|1251107|P1|Base Study Vaccination Period|Uncooperative|2
395845|NCT00090285|1251104|P4|Base Study Vaccination Period|Withdrawal by Subject|0
395846|NCT00090285|1251105|P3|Base Study Vaccination Period|Withdrawal by Subject|0
395847|NCT00090285|1251106|P2|Base Study Vaccination Period|Withdrawal by Subject|69
395848|NCT00090285|1251107|P1|Base Study Vaccination Period|Withdrawal by Subject|64
395849|NCT00090285|1251104|P4|Base Study Vaccination Period|Protocol Violation|0
395850|NCT00090285|1251105|P3|Base Study Vaccination Period|Protocol Violation|0
395851|NCT00090285|1251106|P2|Base Study Vaccination Period|Protocol Violation|3
395852|NCT00090285|1251107|P1|Base Study Vaccination Period|Protocol Violation|2
395853|NCT00090285|1251104|P4|Base Study Vaccination Period|Lost to Follow-up|0
395854|NCT00090285|1251105|P3|Base Study Vaccination Period|Lost to Follow-up|0
395855|NCT00090285|1251106|P2|Base Study Vaccination Period|Lost to Follow-up|112
395856|NCT00090285|1251107|P1|Base Study Vaccination Period|Lost to Follow-up|111
395857|NCT00090285|1251104|P4|Base Study Vaccination Period|Adverse Event|0
395858|NCT00090285|1251105|P3|Base Study Vaccination Period|Adverse Event|0
395859|NCT00090285|1251106|P2|Base Study Vaccination Period|Adverse Event|4
395860|NCT00090285|1251107|P1|Base Study Vaccination Period|Adverse Event|2
395861|NCT00090285|1251104|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
395862|NCT00090285|1251105|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
395863|NCT00090285|1251106|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
395864|NCT00090285|1251107|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
395865|NCT00090259|1251126|P2|Overall Study|Investigator site closed|7
395866|NCT00090259|1251127|P1|Overall Study|Investigator site closed|11
395867|NCT00090259|1251126|P2|Overall Study|Withdrawal by Subject|15
395868|NCT00090259|1251127|P1|Overall Study|Withdrawal by Subject|21
395869|NCT00090259|1251126|P2|Overall Study|Lost to Follow-up|26
395870|NCT00090259|1251127|P1|Overall Study|Lost to Follow-up|30
395871|NCT00090233|1251143|P2|Overall Study|Data not available at data cut-off point|1563
395872|NCT00090233|1251144|P1|Overall Study|Data not available at data cut-off point|1552
395873|NCT00090233|1251143|P2|Overall Study|Not Specified|1160
395874|NCT00090233|1251144|P1|Overall Study|Not Specified|1211
395875|NCT00090233|1251143|P2|Overall Study|Moved|189
395876|NCT00090233|1251144|P1|Overall Study|Moved|203
395877|NCT00090233|1251143|P2|Overall Study|Withdrawal by Subject|211
395878|NCT00090233|1251144|P1|Overall Study|Withdrawal by Subject|182
395879|NCT00090233|1251143|P2|Overall Study|Protocol Violation|1022
395880|NCT00090233|1251144|P1|Overall Study|Protocol Violation|960
395881|NCT00090233|1251143|P2|Overall Study|Lost to Follow-up|95
395882|NCT00090233|1251144|P1|Overall Study|Lost to Follow-up|68
395883|NCT00090233|1251143|P2|Overall Study|Adverse Event|198
395884|NCT00090233|1251144|P1|Overall Study|Adverse Event|214
395885|NCT00090233|1251143|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
395886|NCT00090233|1251144|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
395887|NCT00090220|1251168|P6|Long-term Follow-up (EXT2)|Other|0
395888|NCT00090220|1251169|P5|Long-term Follow-up (EXT2)|Other|1
395889|NCT00090220|1251170|P4|Long-term Follow-up (EXT2)|Other|0
395890|NCT00090220|1251171|P3|Long-term Follow-up (EXT2)|Other|0
395891|NCT00090220|1251172|P2|Long-term Follow-up (EXT2)|Other|0
395892|NCT00090220|1251173|P1|Long-term Follow-up (EXT2)|Other|0
395893|NCT00090220|1251168|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
395894|NCT00090220|1251169|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
395895|NCT00090220|1251170|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
395896|NCT00090220|1251171|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
395897|NCT00090220|1251172|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
395898|NCT00090220|1251173|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
395899|NCT00090220|1251168|P6|Long-term Follow-up (EXT2)|Death|1
395900|NCT00090220|1251169|P5|Long-term Follow-up (EXT2)|Death|1
395901|NCT00090220|1251170|P4|Long-term Follow-up (EXT2)|Death|0
395902|NCT00090220|1251171|P3|Long-term Follow-up (EXT2)|Death|0
395903|NCT00090220|1251172|P2|Long-term Follow-up (EXT2)|Death|0
395904|NCT00090220|1251173|P1|Long-term Follow-up (EXT2)|Death|0
395905|NCT00090220|1251168|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
395906|NCT00090220|1251169|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
395907|NCT00090220|1251170|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
395908|NCT00090220|1251171|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
395909|NCT00090220|1251172|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
395910|NCT00090220|1251173|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
395911|NCT00090220|1251168|P6|Extension 1 (EXT1)|Other reason|0
395912|NCT00090220|1251169|P5|Extension 1 (EXT1)|Other reason|0
395913|NCT00090220|1251170|P4|Extension 1 (EXT1)|Other reason|0
395914|NCT00090220|1251171|P3|Extension 1 (EXT1)|Other reason|2
395915|NCT00090220|1251172|P2|Extension 1 (EXT1)|Other reason|0
395916|NCT00090220|1251173|P1|Extension 1 (EXT1)|Other reason|0
395917|NCT00090220|1251168|P6|Extension 1 (EXT1)|Protocol Violation|0
395918|NCT00090220|1251169|P5|Extension 1 (EXT1)|Protocol Violation|0
395919|NCT00090220|1251170|P4|Extension 1 (EXT1)|Protocol Violation|1
395920|NCT00090220|1251171|P3|Extension 1 (EXT1)|Protocol Violation|0
395921|NCT00090220|1251172|P2|Extension 1 (EXT1)|Protocol Violation|0
395922|NCT00090220|1251173|P1|Extension 1 (EXT1)|Protocol Violation|0
395923|NCT00090220|1251168|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
395924|NCT00090220|1251169|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
395925|NCT00090220|1251170|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
395926|NCT00090220|1251171|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
395927|NCT00090220|1251172|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
395928|NCT00090220|1251173|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
395929|NCT00090220|1251168|P6|Extension 1 (EXT1)|Moved|0
395930|NCT00090220|1251169|P5|Extension 1 (EXT1)|Moved|0
395931|NCT00090220|1251170|P4|Extension 1 (EXT1)|Moved|1
395932|NCT00090220|1251171|P3|Extension 1 (EXT1)|Moved|2
395933|NCT00090220|1251172|P2|Extension 1 (EXT1)|Moved|0
395934|NCT00090220|1251173|P1|Extension 1 (EXT1)|Moved|0
395935|NCT00090220|1251168|P6|Extension 1 (EXT1)|Lost to Follow-up|0
395936|NCT00090220|1251169|P5|Extension 1 (EXT1)|Lost to Follow-up|0
395937|NCT00090220|1251170|P4|Extension 1 (EXT1)|Lost to Follow-up|0
395938|NCT00090220|1251171|P3|Extension 1 (EXT1)|Lost to Follow-up|22
395939|NCT00090220|1251172|P2|Extension 1 (EXT1)|Lost to Follow-up|0
395940|NCT00090220|1251173|P1|Extension 1 (EXT1)|Lost to Follow-up|0
395941|NCT00090220|1251168|P6|Extension 1 (EXT1)|Adverse Event|0
395942|NCT00090220|1251169|P5|Extension 1 (EXT1)|Adverse Event|0
395943|NCT00090220|1251170|P4|Extension 1 (EXT1)|Adverse Event|0
395944|NCT00090220|1251171|P3|Extension 1 (EXT1)|Adverse Event|4
395945|NCT00090220|1251172|P2|Extension 1 (EXT1)|Adverse Event|0
395946|NCT00090220|1251173|P1|Extension 1 (EXT1)|Adverse Event|0
395947|NCT00090220|1251168|P6|Base Study Follow-up Period|Unspecified|0
395948|NCT00090220|1251169|P5|Base Study Follow-up Period|Unspecified|0
395949|NCT00090220|1251170|P4|Base Study Follow-up Period|Unspecified|0
395950|NCT00090220|1251171|P3|Base Study Follow-up Period|Unspecified|0
395951|NCT00090220|1251172|P2|Base Study Follow-up Period|Unspecified|21
395952|NCT00090220|1251173|P1|Base Study Follow-up Period|Unspecified|19
395953|NCT00090220|1251168|P6|Base Study Follow-up Period|Patient Moved|0
395954|NCT00090220|1251169|P5|Base Study Follow-up Period|Patient Moved|0
395955|NCT00090220|1251170|P4|Base Study Follow-up Period|Patient Moved|0
395956|NCT00090220|1251171|P3|Base Study Follow-up Period|Patient Moved|0
395957|NCT00090220|1251172|P2|Base Study Follow-up Period|Patient Moved|28
395958|NCT00090220|1251173|P1|Base Study Follow-up Period|Patient Moved|20
395959|NCT00090220|1251168|P6|Base Study Follow-up Period|Withdrawal by Subject|0
395960|NCT00090220|1251169|P5|Base Study Follow-up Period|Withdrawal by Subject|0
395961|NCT00090220|1251170|P4|Base Study Follow-up Period|Withdrawal by Subject|0
395962|NCT00090220|1251171|P3|Base Study Follow-up Period|Withdrawal by Subject|0
395963|NCT00090220|1251172|P2|Base Study Follow-up Period|Withdrawal by Subject|36
395964|NCT00090220|1251173|P1|Base Study Follow-up Period|Withdrawal by Subject|27
395965|NCT00090220|1251168|P6|Base Study Follow-up Period|Lost to Follow-up|0
395966|NCT00090220|1251169|P5|Base Study Follow-up Period|Lost to Follow-up|0
395967|NCT00090220|1251170|P4|Base Study Follow-up Period|Lost to Follow-up|0
395968|NCT00090220|1251171|P3|Base Study Follow-up Period|Lost to Follow-up|0
395969|NCT00090220|1251172|P2|Base Study Follow-up Period|Lost to Follow-up|78
395970|NCT00090220|1251173|P1|Base Study Follow-up Period|Lost to Follow-up|88
395971|NCT00090220|1251168|P6|Base Study Follow-up Period|Adverse Event|0
395972|NCT00090220|1251169|P5|Base Study Follow-up Period|Adverse Event|0
395973|NCT00090220|1251170|P4|Base Study Follow-up Period|Adverse Event|0
395974|NCT00090220|1251171|P3|Base Study Follow-up Period|Adverse Event|0
395975|NCT00090220|1251172|P2|Base Study Follow-up Period|Adverse Event|1
395976|NCT00090220|1251173|P1|Base Study Follow-up Period|Adverse Event|6
395977|NCT00090220|1251168|P6|Base Study Vaccination Period|Unspecified|0
395978|NCT00090220|1251169|P5|Base Study Vaccination Period|Unspecified|0
395979|NCT00090220|1251170|P4|Base Study Vaccination Period|Unspecified|0
395980|NCT00090220|1251171|P3|Base Study Vaccination Period|Unspecified|0
395981|NCT00090220|1251172|P2|Base Study Vaccination Period|Unspecified|4
395982|NCT00090220|1251173|P1|Base Study Vaccination Period|Unspecified|4
395983|NCT00090220|1251168|P6|Base Study Vaccination Period|Patient Moved|0
395984|NCT00090220|1251169|P5|Base Study Vaccination Period|Patient Moved|0
395985|NCT00090220|1251170|P4|Base Study Vaccination Period|Patient Moved|0
395986|NCT00090220|1251171|P3|Base Study Vaccination Period|Patient Moved|0
395987|NCT00090220|1251172|P2|Base Study Vaccination Period|Patient Moved|2
395988|NCT00090220|1251173|P1|Base Study Vaccination Period|Patient Moved|6
395989|NCT00090220|1251168|P6|Base Study Vaccination Period|Withdrawal by Subject|0
395990|NCT00090220|1251169|P5|Base Study Vaccination Period|Withdrawal by Subject|0
395991|NCT00090220|1251170|P4|Base Study Vaccination Period|Withdrawal by Subject|0
395992|NCT00090220|1251171|P3|Base Study Vaccination Period|Withdrawal by Subject|0
395993|NCT00090220|1251172|P2|Base Study Vaccination Period|Withdrawal by Subject|27
395994|NCT00090220|1251173|P1|Base Study Vaccination Period|Withdrawal by Subject|23
395995|NCT00090220|1251168|P6|Base Study Vaccination Period|Lost to Follow-up|0
395996|NCT00090220|1251169|P5|Base Study Vaccination Period|Lost to Follow-up|0
395997|NCT00090220|1251170|P4|Base Study Vaccination Period|Lost to Follow-up|0
395998|NCT00090220|1251171|P3|Base Study Vaccination Period|Lost to Follow-up|0
395999|NCT00090220|1251172|P2|Base Study Vaccination Period|Lost to Follow-up|28
396000|NCT00090220|1251173|P1|Base Study Vaccination Period|Lost to Follow-up|24
396001|NCT00090220|1251168|P6|Base Study Vaccination Period|Adverse Event|0
396002|NCT00090220|1251169|P5|Base Study Vaccination Period|Adverse Event|0
396003|NCT00090220|1251170|P4|Base Study Vaccination Period|Adverse Event|0
396004|NCT00090220|1251171|P3|Base Study Vaccination Period|Adverse Event|0
396005|NCT00090220|1251172|P2|Base Study Vaccination Period|Adverse Event|1
396006|NCT00090220|1251173|P1|Base Study Vaccination Period|Adverse Event|6
396007|NCT00090220|1251168|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
396008|NCT00090220|1251169|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
396009|NCT00090220|1251170|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
396010|NCT00090220|1251171|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
396011|NCT00090220|1251172|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
396012|NCT00090220|1251173|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
396013|NCT00090142|1251265|P2|Treatment Period II|Not Specified|0
396014|NCT00090142|1251266|P1|Treatment Period II|Not Specified|1
396015|NCT00090142|1251265|P2|Treatment Period I|Not Specified|1
396016|NCT00090142|1251266|P1|Treatment Period I|Not Specified|0
396017|NCT00090142|1251265|P2|Treatment Period I|Withdrawal by Subject|0
396018|NCT00090142|1251266|P1|Treatment Period I|Withdrawal by Subject|2
396019|NCT00090142|1251265|P2|Treatment Period I|Protocol Violation|0
396020|NCT00090142|1251266|P1|Treatment Period I|Protocol Violation|2
396021|NCT00090142|1251265|P2|Treatment Period I|Lost to Follow-up|2
396022|NCT00090142|1251266|P1|Treatment Period I|Lost to Follow-up|1
396023|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Other|0
396024|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Other|1
396025|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Other|0
396026|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Jailed|0
396027|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Jailed|1
396028|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Jailed|0
396029|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
396030|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
396031|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
396032|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Depression|0
396033|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Depression|1
396034|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Depression|0
396035|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
396036|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
396037|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
396038|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
396039|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
396040|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
396041|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Back Pain|0
396042|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Back Pain|1
396043|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Back Pain|0
396044|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
396045|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
396046|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
396047|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
396048|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
396049|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
396050|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
396051|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
396052|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
396053|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Gyneomastia|0
396054|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Gyneomastia|0
396055|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Gyneomastia|1
396056|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Death|1
396057|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Death|0
396058|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Death|1
396059|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
396060|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
396061|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
396062|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Enrollment Error|2
396063|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Enrollment Error|0
396064|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Enrollment Error|1
396284|NCT00089791|1251510|P1|Overall Study|Other|20
396065|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Loss of Libido|0
396066|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Loss of Libido|0
396067|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Loss of Libido|1
396068|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
396069|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
396070|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
396071|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
396072|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
396073|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
396074|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
396075|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
396076|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
396077|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
396078|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
396079|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
396080|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Participant relocated|1
396081|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Participant relocated|3
396082|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Participant relocated|2
396083|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
396084|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
396085|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
396086|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Loss of Contact|2
396087|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Loss of Contact|0
396088|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Loss of Contact|4
396089|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
396090|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
396091|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
396092|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
396093|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
396094|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
396095|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Protocol Violation|17
396096|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Protocol Violation|18
396097|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Protocol Violation|18
396098|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
396099|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
396100|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
396101|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
396102|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
396103|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
396104|NCT00090103|1251297|P3|16-Week Safety Follow-up Period|Adverse Event|44
396105|NCT00090103|1251298|P2|16-Week Safety Follow-up Period|Adverse Event|39
396106|NCT00090103|1251299|P1|16-Week Safety Follow-up Period|Adverse Event|34
396107|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
396108|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
396109|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
396110|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
396111|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
396112|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
396113|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
396114|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
396115|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
396116|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
396117|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
396118|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
396119|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
396120|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
396121|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
396122|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
396123|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
396124|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
396125|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
396126|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
396127|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
396128|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
396129|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
396130|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
396131|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
396132|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
396285|NCT00089791|1251509|P2|Overall Study|Noncompliance|13
396133|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
396134|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
396135|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
396136|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
396137|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
396138|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
396139|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
396140|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
396141|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
396142|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
396143|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
396144|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
396145|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
396146|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
396147|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
396148|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
396149|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
396150|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
396151|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
396152|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
396153|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
396154|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
396155|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
396156|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
396157|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
396158|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
396159|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
396160|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
396161|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
396162|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
396163|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
396164|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
396165|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
396166|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
396167|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
396168|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
396169|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
396170|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
396171|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
396172|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
396173|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
396174|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
396175|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
396176|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
396177|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
396178|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
396179|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
396180|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
396181|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
396182|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
396183|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
396184|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
396185|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
396186|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
396187|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
396188|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
396189|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
396190|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
396191|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
396192|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
396193|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
396194|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
396195|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
396196|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
396197|NCT00090103|1251297|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
396198|NCT00090103|1251298|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
396199|NCT00090103|1251299|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
396200|NCT00089999|1251436|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
396201|NCT00089999|1251437|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
396202|NCT00089999|1251436|P2|Overall Study|Patient Underwent Surgery|0
396203|NCT00089999|1251437|P1|Overall Study|Patient Underwent Surgery|2
396204|NCT00089999|1251436|P2|Overall Study|Physician Decision|2
396205|NCT00089999|1251437|P1|Overall Study|Physician Decision|2
396206|NCT00089999|1251436|P2|Overall Study|Clinical Progression|2
396207|NCT00089999|1251437|P1|Overall Study|Clinical Progression|1
396208|NCT00089999|1251436|P2|Overall Study|Poor General Condition|0
396209|NCT00089999|1251437|P1|Overall Study|Poor General Condition|1
396210|NCT00089999|1251436|P2|Overall Study|Death|3
396211|NCT00089999|1251437|P1|Overall Study|Death|3
396212|NCT00089999|1251436|P2|Overall Study|Symptomatic Progression of Cancer|5
396213|NCT00089999|1251437|P1|Overall Study|Symptomatic Progression of Cancer|2
396214|NCT00089999|1251436|P2|Overall Study|Radiological Progression of Cancer|44
396215|NCT00089999|1251437|P1|Overall Study|Radiological Progression of Cancer|52
396216|NCT00089999|1251436|P2|Overall Study|Lost to Follow-up|1
396217|NCT00089999|1251437|P1|Overall Study|Lost to Follow-up|2
396218|NCT00089999|1251436|P2|Overall Study|Withdrawal by Subject|4
396219|NCT00089999|1251437|P1|Overall Study|Withdrawal by Subject|0
396220|NCT00089999|1251436|P2|Overall Study|Adverse Event|7
396221|NCT00089999|1251437|P1|Overall Study|Adverse Event|4
396222|NCT00089986|1251460|P3|Overall Study|Withdrawal by Subject|2
396223|NCT00089986|1251461|P2|Overall Study|Withdrawal by Subject|6
396224|NCT00089986|1251462|P1|Overall Study|Withdrawal by Subject|3
396225|NCT00089986|1251460|P3|Overall Study|Do not resuscitate (DNR)|1
396226|NCT00089986|1251461|P2|Overall Study|Do not resuscitate (DNR)|0
396227|NCT00089986|1251462|P1|Overall Study|Do not resuscitate (DNR)|0
396228|NCT00089986|1251460|P3|Overall Study|Family decision|0
396229|NCT00089986|1251461|P2|Overall Study|Family decision|1
396230|NCT00089986|1251462|P1|Overall Study|Family decision|0
396231|NCT00089986|1251460|P3|Overall Study|Enrollment in another study|0
396232|NCT00089986|1251461|P2|Overall Study|Enrollment in another study|1
396233|NCT00089986|1251462|P1|Overall Study|Enrollment in another study|0
396234|NCT00089986|1251460|P3|Overall Study|Investigator decision to withdrew|0
396235|NCT00089986|1251461|P2|Overall Study|Investigator decision to withdrew|1
396236|NCT00089986|1251462|P1|Overall Study|Investigator decision to withdrew|0
396237|NCT00089986|1251460|P3|Overall Study|Hemohlobin stopping rule|0
396238|NCT00089986|1251461|P2|Overall Study|Hemohlobin stopping rule|1
396239|NCT00089986|1251462|P1|Overall Study|Hemohlobin stopping rule|0
396240|NCT00089986|1251460|P3|Overall Study|Subject withdrew but agreed follow up|0
396241|NCT00089986|1251461|P2|Overall Study|Subject withdrew but agreed follow up|2
396242|NCT00089986|1251462|P1|Overall Study|Subject withdrew but agreed follow up|1
396243|NCT00089986|1251460|P3|Overall Study|Patient transferred to another hospital|0
396244|NCT00089986|1251461|P2|Overall Study|Patient transferred to another hospital|1
396245|NCT00089986|1251462|P1|Overall Study|Patient transferred to another hospital|2
396246|NCT00089986|1251460|P3|Overall Study|Protocol Violation|0
396247|NCT00089986|1251461|P2|Overall Study|Protocol Violation|1
396248|NCT00089986|1251462|P1|Overall Study|Protocol Violation|0
396249|NCT00089986|1251460|P3|Overall Study|Lost to Follow-up|1
396250|NCT00089986|1251461|P2|Overall Study|Lost to Follow-up|1
396251|NCT00089986|1251462|P1|Overall Study|Lost to Follow-up|3
396252|NCT00089986|1251460|P3|Overall Study|Adverse Event|6
396253|NCT00089986|1251461|P2|Overall Study|Adverse Event|9
396254|NCT00089986|1251462|P1|Overall Study|Adverse Event|6
396255|NCT00089895|1251481|P2|Overall Study|Missing|2
396256|NCT00089895|1251482|P1|Overall Study|Missing|4
396257|NCT00089895|1251481|P2|Overall Study|Not otherwise specified|8
396258|NCT00089895|1251482|P1|Overall Study|Not otherwise specified|4
396259|NCT00089895|1251481|P2|Overall Study|Exclusion criteria met|6
396260|NCT00089895|1251482|P1|Overall Study|Exclusion criteria met|6
396261|NCT00089895|1251481|P2|Overall Study|Physician Decision|7
396262|NCT00089895|1251482|P1|Overall Study|Physician Decision|3
396263|NCT00089895|1251481|P2|Overall Study|Bleeding|2
396264|NCT00089895|1251482|P1|Overall Study|Bleeding|0
396265|NCT00089895|1251481|P2|Overall Study|Surgery|1
396266|NCT00089895|1251482|P1|Overall Study|Surgery|0
396267|NCT00089895|1251481|P2|Overall Study|Technical reason|2
396268|NCT00089895|1251482|P1|Overall Study|Technical reason|7
396269|NCT00089895|1251481|P2|Overall Study|Consent Withdrawn|14
396270|NCT00089895|1251482|P1|Overall Study|Consent Withdrawn|11
396271|NCT00089843|1251494|P4|Overall Study|Physician Decision|1
396272|NCT00089843|1251495|P3|Overall Study|Physician Decision|0
396273|NCT00089843|1251496|P2|Overall Study|Physician Decision|0
396274|NCT00089843|1251497|P1|Overall Study|Physician Decision|1
396275|NCT00089843|1251494|P4|Overall Study|Withdrawal by Subject|6
396276|NCT00089843|1251495|P3|Overall Study|Withdrawal by Subject|5
396277|NCT00089843|1251496|P2|Overall Study|Withdrawal by Subject|4
396278|NCT00089843|1251497|P1|Overall Study|Withdrawal by Subject|1
396279|NCT00089791|1251509|P2|Overall Study|Requirement for alternative therapy|4
396280|NCT00089791|1251510|P1|Overall Study|Requirement for alternative therapy|7
396281|NCT00089791|1251509|P2|Overall Study|Protocol deviation|10
396282|NCT00089791|1251510|P1|Overall Study|Protocol deviation|12
396283|NCT00089791|1251509|P2|Overall Study|Other|32
396286|NCT00089791|1251510|P1|Overall Study|Noncompliance|17
396287|NCT00089791|1251509|P2|Overall Study|Lost to Follow-up|57
396288|NCT00089791|1251510|P1|Overall Study|Lost to Follow-up|57
396289|NCT00089791|1251509|P2|Overall Study|Ineligibility determined|9
396290|NCT00089791|1251510|P1|Overall Study|Ineligibility determined|12
396291|NCT00089791|1251509|P2|Overall Study|Disease progression|3
396292|NCT00089791|1251510|P1|Overall Study|Disease progression|7
396293|NCT00089791|1251509|P2|Overall Study|Death|62
396294|NCT00089791|1251510|P1|Overall Study|Death|78
396295|NCT00089791|1251509|P2|Overall Study|Withdrawal by Subject|344
396296|NCT00089791|1251510|P1|Overall Study|Withdrawal by Subject|403
396297|NCT00089791|1251509|P2|Overall Study|Adverse Event|93
396298|NCT00089791|1251510|P1|Overall Study|Adverse Event|81
396299|NCT00089791|1251509|P2|Overall Study|Physician Decision|3
396300|NCT00089791|1251510|P1|Overall Study|Physician Decision|6
396301|NCT00089778|1251523|P3|Overall Study|Protocol Violation|1
396302|NCT00089778|1251524|P2|Overall Study|Protocol Violation|0
396303|NCT00089778|1251525|P1|Overall Study|Protocol Violation|0
396304|NCT00089674|1251538|P2|Overall Study|Requirement for alternative therapy|4
396305|NCT00089674|1251539|P1|Overall Study|Requirement for alternative therapy|14
396306|NCT00089674|1251538|P2|Overall Study|Other|9
396307|NCT00089674|1251539|P1|Overall Study|Other|5
396308|NCT00089674|1251538|P2|Overall Study|Noncompliance|3
396309|NCT00089674|1251539|P1|Overall Study|Noncompliance|7
396310|NCT00089674|1251538|P2|Overall Study|Lost to Follow-up|17
396311|NCT00089674|1251539|P1|Overall Study|Lost to Follow-up|21
396312|NCT00089674|1251538|P2|Overall Study|Ineligibility determined|10
396313|NCT00089674|1251539|P1|Overall Study|Ineligibility determined|8
396314|NCT00089674|1251538|P2|Overall Study|Disease progression|23
396315|NCT00089674|1251539|P1|Overall Study|Disease progression|21
396316|NCT00089674|1251538|P2|Overall Study|Death|43
396317|NCT00089674|1251539|P1|Overall Study|Death|43
396318|NCT00089674|1251538|P2|Overall Study|Withdrawal by Subject|127
396319|NCT00089674|1251539|P1|Overall Study|Withdrawal by Subject|143
396320|NCT00089674|1251538|P2|Overall Study|Adverse Event|29
396321|NCT00089674|1251539|P1|Overall Study|Adverse Event|23
396322|NCT00089674|1251538|P2|Overall Study|Physician Decision|2
396323|NCT00089674|1251539|P1|Overall Study|Physician Decision|4
396324|NCT00089661|1251565|P2|Overall Study|Other|1
396325|NCT00089661|1251566|P1|Overall Study|Other|2
396326|NCT00089661|1251565|P2|Overall Study|Noncompliance|4
396327|NCT00089661|1251566|P1|Overall Study|Noncompliance|2
396328|NCT00089661|1251565|P2|Overall Study|Ineligibility determined|4
396329|NCT00089661|1251566|P1|Overall Study|Ineligibility determined|4
396330|NCT00089661|1251565|P2|Overall Study|Disease progression|3
396331|NCT00089661|1251566|P1|Overall Study|Disease progression|1
396332|NCT00089661|1251565|P2|Overall Study|Withdrawal by Subject|9
396333|NCT00089661|1251566|P1|Overall Study|Withdrawal by Subject|11
396334|NCT00089661|1251565|P2|Overall Study|Lost to Follow-up|3
396335|NCT00089661|1251566|P1|Overall Study|Lost to Follow-up|0
396336|NCT00089661|1251565|P2|Overall Study|Death|0
396337|NCT00089661|1251566|P1|Overall Study|Death|1
396338|NCT00089661|1251565|P2|Overall Study|Adverse Event|2
396339|NCT00089661|1251566|P1|Overall Study|Adverse Event|0
396340|NCT00089648|1251582|P1|Overall Study|Lack of Efficacy|33
396341|NCT00089648|1251582|P1|Overall Study|Withdrawal by Subject|1
396342|NCT00089648|1251582|P1|Overall Study|Adverse Event|7
396343|NCT00089635|1251598|P1|Overall Study|Not specified|2
396344|NCT00089635|1251598|P1|Overall Study|Ineligibility determined|1
396345|NCT00089635|1251598|P1|Overall Study|Withdrawal by Subject|6
396346|NCT00089635|1251598|P1|Overall Study|Lost to Follow-up|3
396347|NCT00089635|1251598|P1|Overall Study|Disease Progression|12
396348|NCT00089635|1251598|P1|Overall Study|Death|17
396349|NCT00089635|1251598|P1|Overall Study|Adverse Event|2
396350|NCT00089609|1251612|P2|Overall Study|Withdrawal by Subject|1
396351|NCT00089609|1251613|P1|Overall Study|Withdrawal by Subject|3
396352|NCT00089583|1251632|P2|Overall Study|Participant Incarcerated|1
396353|NCT00089583|1251633|P1|Overall Study|Participant Incarcerated|0
396354|NCT00089583|1251632|P2|Overall Study|Necessity to Use Prohibited Drug|0
396355|NCT00089583|1251633|P1|Overall Study|Necessity to Use Prohibited Drug|1
396356|NCT00089583|1251632|P2|Overall Study|Start of Disallowed Medication|1
396357|NCT00089583|1251633|P1|Overall Study|Start of Disallowed Medication|0
396358|NCT00089583|1251632|P2|Overall Study|Principal Investigator Decision|10
396359|NCT00089583|1251633|P1|Overall Study|Principal Investigator Decision|0
396360|NCT00089583|1251632|P2|Overall Study|Protocol Violation|3
396361|NCT00089583|1251633|P1|Overall Study|Protocol Violation|0
396362|NCT00089583|1251632|P2|Overall Study|Reason Not Provided|1
396363|NCT00089583|1251633|P1|Overall Study|Reason Not Provided|0
396364|NCT00089583|1251632|P2|Overall Study|Participant Management Criteria Met|1
396365|NCT00089583|1251633|P1|Overall Study|Participant Management Criteria Met|0
396366|NCT00089583|1251632|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
396367|NCT00089583|1251633|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
396368|NCT00089583|1251632|P2|Overall Study|Non-Compliance|4
396369|NCT00089583|1251633|P1|Overall Study|Non-Compliance|0
396370|NCT00089583|1251632|P2|Overall Study|Participant Refused Study Medication|2
396371|NCT00089583|1251633|P1|Overall Study|Participant Refused Study Medication|0
396372|NCT00089583|1251632|P2|Overall Study|Participant (Par) Didn't Take Medication|0
396373|NCT00089583|1251633|P1|Overall Study|Participant (Par) Didn't Take Medication|1
396374|NCT00089583|1251632|P2|Overall Study|Withdrawal by Subject|4
396375|NCT00089583|1251633|P1|Overall Study|Withdrawal by Subject|0
396376|NCT00089583|1251632|P2|Overall Study|Insufficient Viral Load Response|5
396377|NCT00089583|1251633|P1|Overall Study|Insufficient Viral Load Response|5
396378|NCT00089583|1251632|P2|Overall Study|Adverse Event|3
396379|NCT00089583|1251633|P1|Overall Study|Adverse Event|0
396380|NCT00089544|1251727|P2|Overall Study|Ineligible|0
396381|NCT00089544|1251728|P1|Overall Study|Ineligible|1
396382|NCT00089505|1251742|P4|Overall Study|Protocol Violation|0
396383|NCT00089505|1251743|P3|Overall Study|Protocol Violation|1
396384|NCT00089505|1251744|P2|Overall Study|Protocol Violation|0
396385|NCT00089505|1251745|P1|Overall Study|Protocol Violation|0
396386|NCT00089505|1251742|P4|Overall Study|Physician Decision|0
396387|NCT00089505|1251743|P3|Overall Study|Physician Decision|0
396388|NCT00089505|1251744|P2|Overall Study|Physician Decision|0
396389|NCT00089505|1251745|P1|Overall Study|Physician Decision|1
396390|NCT00089505|1251742|P4|Overall Study|Lost to Follow-up|7
396391|NCT00089505|1251743|P3|Overall Study|Lost to Follow-up|9
396392|NCT00089505|1251744|P2|Overall Study|Lost to Follow-up|1
396393|NCT00089505|1251745|P1|Overall Study|Lost to Follow-up|1
396394|NCT00089505|1251742|P4|Overall Study|Withdrawal by Subject|6
396395|NCT00089505|1251743|P3|Overall Study|Withdrawal by Subject|6
396396|NCT00089505|1251744|P2|Overall Study|Withdrawal by Subject|0
396397|NCT00089505|1251745|P1|Overall Study|Withdrawal by Subject|3
396398|NCT00089505|1251742|P4|Overall Study|Death|8
396399|NCT00089505|1251743|P3|Overall Study|Death|5
396400|NCT00089505|1251744|P2|Overall Study|Death|1
396401|NCT00089505|1251745|P1|Overall Study|Death|4
396402|NCT00089479|1251789|P2|Overall Study|Lost to Follow-up|107
396403|NCT00089479|1251790|P1|Overall Study|Lost to Follow-up|137
396404|NCT00089479|1251789|P2|Overall Study|Withdrawal by Subject|107
396405|NCT00089479|1251790|P1|Overall Study|Withdrawal by Subject|86
396406|NCT00089479|1251789|P2|Overall Study|Death|75
396407|NCT00089479|1251790|P1|Overall Study|Death|108
396408|NCT00089297|1251833|P1|Overall Study|Non-compliance|1
396409|NCT00089297|1251833|P1|Overall Study|IRB approval not ready|1
396410|NCT00089297|1251833|P1|Overall Study|Secondary malignancy|1
396411|NCT00089297|1251833|P1|Overall Study|Ineligible|11
396412|NCT00089297|1251833|P1|Overall Study|Disease progression|2
396413|NCT00089297|1251833|P1|Overall Study|Withdrawal by Subject|12
396414|NCT00089297|1251833|P1|Overall Study|Death|1
396415|NCT00089297|1251833|P1|Overall Study|Adverse Event|9
396416|NCT00089141|1251842|P2|Overall Study|Termination of trial|24
396417|NCT00089141|1251843|P1|Overall Study|Termination of trial|18
396418|NCT00089076|1251865|P1|Overall Study|Progression|7
396419|NCT00089076|1251865|P1|Overall Study|Withdrawal by Subject|2
396420|NCT00089076|1251865|P1|Overall Study|Alternate Therapy|1
396421|NCT00088907|1251914|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
396422|NCT00088907|1251915|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
396423|NCT00088907|1251914|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
396424|NCT00088907|1251915|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
396425|NCT00088907|1251914|P2|Single Gefitinib Treatment (Step 2)|Death|0
396426|NCT00088907|1251915|P1|Single Gefitinib Treatment (Step 2)|Death|1
396427|NCT00088907|1251914|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
396428|NCT00088907|1251915|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
396429|NCT00088907|1251914|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
396430|NCT00088907|1251915|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
396431|NCT00088907|1251914|P2|Randomized Study (Step 1)|unknown/not specify|13
396432|NCT00088907|1251915|P1|Randomized Study (Step 1)|unknown/not specify|24
396433|NCT00088907|1251914|P2|Randomized Study (Step 1)|complicating disease|1
396434|NCT00088907|1251915|P1|Randomized Study (Step 1)|complicating disease|3
396435|NCT00088907|1251914|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
396436|NCT00088907|1251915|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
396437|NCT00088907|1251914|P2|Randomized Study (Step 1)|Death|12
396438|NCT00088907|1251915|P1|Randomized Study (Step 1)|Death|11
396439|NCT00088907|1251914|P2|Randomized Study (Step 1)|Adverse Event|19
396440|NCT00088907|1251915|P1|Randomized Study (Step 1)|Adverse Event|14
396441|NCT00088907|1251914|P2|Randomized Study (Step 1)|Lack of Efficacy|62
396442|NCT00088907|1251915|P1|Randomized Study (Step 1)|Lack of Efficacy|55
396443|NCT00088881|1251926|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
396444|NCT00088881|1251926|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
396445|NCT00088881|1251926|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
396446|NCT00088881|1251926|P1|Step 1 - R-CHOP|Physician Decision|1
396447|NCT00088881|1251926|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
396448|NCT00088881|1251926|P1|Step 1 - R-CHOP|Adverse Event|1
396449|NCT00088881|1251926|P1|Step 1 - R-CHOP|Patient ineligible|9
396450|NCT00088595|1251954|P1|Overall Study|New Cancer Therapy|2
396451|NCT00088595|1251954|P1|Overall Study|Ongoing (After Core)|7
396452|NCT00088595|1251954|P1|Overall Study|Withdrawal by Subject|8
396453|NCT00088595|1251954|P1|Overall Study|Adverse Event|11
396454|NCT00088530|1251972|P2|Overall Study|Patient never treated|0
396455|NCT00088530|1251973|P1|Overall Study|Patient never treated|1
396456|NCT00088530|1251972|P2|Overall Study|Sponsor decision|1
396457|NCT00088530|1251973|P1|Overall Study|Sponsor decision|0
396458|NCT00088530|1251972|P2|Overall Study|Physician Decision|0
396459|NCT00088530|1251973|P1|Overall Study|Physician Decision|2
396460|NCT00088530|1251972|P2|Overall Study|Lost to Follow-up|0
396461|NCT00088530|1251973|P1|Overall Study|Lost to Follow-up|2
396462|NCT00088530|1251972|P2|Overall Study|Withdrawal by Subject|5
396463|NCT00088530|1251973|P1|Overall Study|Withdrawal by Subject|2
396464|NCT00088530|1251972|P2|Overall Study|Adverse Event|9
396465|NCT00088530|1251973|P1|Overall Study|Adverse Event|15
396466|NCT00088530|1251972|P2|Overall Study|Progressive/Relapsed Disease|39
396467|NCT00088530|1251973|P1|Overall Study|Progressive/Relapsed Disease|28
396468|NCT00088465|1251985|P1|Overall Study|Death|11
396469|NCT00088465|1251985|P1|Overall Study|Protocol Violation|17
396470|NCT00088465|1251985|P1|Overall Study|Lack of Efficacy|27
396471|NCT00088465|1251985|P1|Overall Study|Sponsor Decision|37
396472|NCT00088465|1251985|P1|Overall Study|Physician Decision|45
396473|NCT00088465|1251985|P1|Overall Study|Lost to Follow-up|57
396474|NCT00088465|1251985|P1|Overall Study|Adverse Event|77
396475|NCT00088465|1251985|P1|Overall Study|Withdrawal by Subject|290
396476|NCT00088374|1252008|P1|Overall Study|patient received <1 cycle only of 17AAG|1
396477|NCT00088374|1252008|P1|Overall Study|patient did not receive any 17AAG|1
396478|NCT00088166|1252028|P2|Overall Study|Withdrawal by Subject|5
396479|NCT00088166|1252029|P1|Overall Study|Withdrawal by Subject|5
396480|NCT00088166|1252028|P2|Overall Study|Patient deterioration|39
396481|NCT00088166|1252029|P1|Overall Study|Patient deterioration|29
396482|NCT00088166|1252028|P2|Overall Study|Protocol Violation|5
396483|NCT00088166|1252029|P1|Overall Study|Protocol Violation|1
396484|NCT00088166|1252028|P2|Overall Study|Physician Decision|1
396485|NCT00088166|1252029|P1|Overall Study|Physician Decision|4
396486|NCT00088166|1252028|P2|Overall Study|Lost to Follow-up|1
396487|NCT00088166|1252029|P1|Overall Study|Lost to Follow-up|0
396488|NCT00088166|1252028|P2|Overall Study|Death|1
396489|NCT00088166|1252029|P1|Overall Study|Death|3
396490|NCT00088166|1252028|P2|Overall Study|Adverse Event|9
396491|NCT00088166|1252029|P1|Overall Study|Adverse Event|11
396492|NCT00088153|1252053|P2|Overall Study|Lost to Follow-up|12
396493|NCT00088153|1252054|P1|Overall Study|Lost to Follow-up|11
396494|NCT00088153|1252053|P2|Overall Study|Withdrawal by Subject|10
396495|NCT00088153|1252054|P1|Overall Study|Withdrawal by Subject|10
396496|NCT00088153|1252053|P2|Overall Study|Physician Decision|3
396497|NCT00088153|1252054|P1|Overall Study|Physician Decision|3
396498|NCT00087698|1252064|P1|Overall Study|Protocol Violation|1
396499|NCT00087698|1252064|P1|Overall Study|Death from Study Drug Toxicity|2
396500|NCT00087698|1252064|P1|Overall Study|Death from Study Disease|2
396501|NCT00087698|1252064|P1|Overall Study|Clinical Relapse|1
396502|NCT00087698|1252064|P1|Overall Study|Protocol Entry Criteria Not Met|2
396503|NCT00087698|1252064|P1|Overall Study|Lack of Efficacy, Physician Perception|3
396504|NCT00087698|1252064|P1|Overall Study|Withdrawal by Subject|4
396505|NCT00087698|1252064|P1|Overall Study|Adverse Event|4
396506|NCT00087698|1252064|P1|Overall Study|Death from Other Causes|3
396507|NCT00087698|1252064|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
396508|NCT00087685|1252073|P1|Overall Study|Withdrawal by Subject|3
396509|NCT00087685|1252073|P1|Overall Study|Progressive Disease|5
396510|NCT00087685|1252073|P1|Overall Study|Non-Compliance|1
396511|NCT00087685|1252073|P1|Overall Study|Adverse Event|5
396512|NCT00087646|1252086|P4|Overall Study|Violation of Selection Criteria at Entry|1
396513|NCT00087646|1252087|P3|Overall Study|Violation of Selection Criteria at Entry|0
396514|NCT00087646|1252088|P2|Overall Study|Violation of Selection Criteria at Entry|0
396515|NCT00087646|1252089|P1|Overall Study|Violation of Selection Criteria at Entry|1
396516|NCT00087646|1252086|P4|Overall Study|Other Protocol Violation|0
396517|NCT00087646|1252087|P3|Overall Study|Other Protocol Violation|0
396518|NCT00087646|1252088|P2|Overall Study|Other Protocol Violation|1
396519|NCT00087646|1252089|P1|Overall Study|Other Protocol Violation|3
396520|NCT00087646|1252086|P4|Overall Study|Administrative/Other|2
396521|NCT00087646|1252087|P3|Overall Study|Administrative/Other|1
396522|NCT00087646|1252088|P2|Overall Study|Administrative/Other|1
396523|NCT00087646|1252089|P1|Overall Study|Administrative/Other|6
396524|NCT00087646|1252086|P4|Overall Study|Failure to Return|3
396525|NCT00087646|1252087|P3|Overall Study|Failure to Return|2
396526|NCT00087646|1252088|P2|Overall Study|Failure to Return|2
396527|NCT00087646|1252089|P1|Overall Study|Failure to Return|5
396528|NCT00087646|1252086|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
396529|NCT00087646|1252087|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
396530|NCT00087646|1252088|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
396531|NCT00087646|1252089|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
396532|NCT00087646|1252086|P4|Overall Study|Insufficient therapeutic response|51
396533|NCT00087646|1252087|P3|Overall Study|Insufficient therapeutic response|38
396534|NCT00087646|1252088|P2|Overall Study|Insufficient therapeutic response|24
396535|NCT00087646|1252089|P1|Overall Study|Insufficient therapeutic response|64
396536|NCT00087646|1252086|P4|Overall Study|Withdrawal by Subject|2
396537|NCT00087646|1252087|P3|Overall Study|Withdrawal by Subject|2
396538|NCT00087646|1252088|P2|Overall Study|Withdrawal by Subject|1
396539|NCT00087646|1252089|P1|Overall Study|Withdrawal by Subject|6
396540|NCT00087646|1252086|P4|Overall Study|Death|0
396541|NCT00087646|1252087|P3|Overall Study|Death|0
396542|NCT00087646|1252088|P2|Overall Study|Death|1
396543|NCT00087646|1252089|P1|Overall Study|Death|0
396544|NCT00087646|1252086|P4|Overall Study|Adverse Event|20
396545|NCT00087646|1252087|P3|Overall Study|Adverse Event|18
396546|NCT00087646|1252088|P2|Overall Study|Adverse Event|6
396547|NCT00087646|1252089|P1|Overall Study|Adverse Event|37
396548|NCT00087607|1252128|P2|Overall Study|Violation of Selection Criteria at Entry|1
396549|NCT00087607|1252129|P1|Overall Study|Violation of Selection Criteria at Entry|0
396550|NCT00087607|1252128|P2|Overall Study|Other Protocol Violation|2
396551|NCT00087607|1252129|P1|Overall Study|Other Protocol Violation|5
396552|NCT00087607|1252128|P2|Overall Study|Refused Treatment|7
396553|NCT00087607|1252129|P1|Overall Study|Refused Treatment|5
396554|NCT00087607|1252128|P2|Overall Study|Administrative|12
396555|NCT00087607|1252129|P1|Overall Study|Administrative|12
396556|NCT00087607|1252128|P2|Overall Study|Withdrew Consent|16
396557|NCT00087607|1252129|P1|Overall Study|Withdrew Consent|12
396558|NCT00087607|1252128|P2|Overall Study|Failure to return|17
396559|NCT00087607|1252129|P1|Overall Study|Failure to return|21
396560|NCT00087607|1252128|P2|Overall Study|Insufficient Therapeutic Response|42
396561|NCT00087607|1252129|P1|Overall Study|Insufficient Therapeutic Response|53
396562|NCT00087607|1252128|P2|Overall Study|Death|1
396563|NCT00087607|1252129|P1|Overall Study|Death|0
396564|NCT00087607|1252128|P2|Overall Study|Adverse Event|24
396565|NCT00087607|1252129|P1|Overall Study|Adverse Event|14
396566|NCT00087594|1252169|P2|Overall Study|Lack of Efficacy|5
396567|NCT00087594|1252170|P1|Overall Study|Lack of Efficacy|2
396568|NCT00087594|1252169|P2|Overall Study|Withdrawal by Subject|2
396569|NCT00087594|1252170|P1|Overall Study|Withdrawal by Subject|4
396570|NCT00087594|1252169|P2|Overall Study|Lost to Follow-up|2
396571|NCT00087594|1252170|P1|Overall Study|Lost to Follow-up|0
396572|NCT00087594|1252169|P2|Overall Study|Adverse Event|3
396573|NCT00087594|1252170|P1|Overall Study|Adverse Event|2
396574|NCT00087568|1252204|P2|Overall Study|Lack of Efficacy|1
396575|NCT00087568|1252205|P1|Overall Study|Lack of Efficacy|24
396576|NCT00087568|1252204|P2|Overall Study|Lost to Follow-up|0
396577|NCT00087568|1252205|P1|Overall Study|Lost to Follow-up|1
396578|NCT00087568|1252204|P2|Overall Study|Withdrawal by Subject|1
396579|NCT00087568|1252205|P1|Overall Study|Withdrawal by Subject|1
396580|NCT00087568|1252204|P2|Overall Study|Adverse Event|0
396581|NCT00087568|1252205|P1|Overall Study|Adverse Event|4
396582|NCT00087555|1252232|P3|Overall Study|Patient wanted to go back on Med|0
396583|NCT00087555|1252233|P2|Overall Study|Patient wanted to go back on Med|0
396584|NCT00087555|1252234|P1|Overall Study|Patient wanted to go back on Med|1
396585|NCT00087555|1252232|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
396586|NCT00087555|1252233|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
396587|NCT00087555|1252234|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
396588|NCT00087555|1252232|P3|Overall Study|Non Compliance|1
396589|NCT00087555|1252233|P2|Overall Study|Non Compliance|0
396590|NCT00087555|1252234|P1|Overall Study|Non Compliance|0
396591|NCT00087555|1252232|P3|Overall Study|Lack of Efficacy|1
396592|NCT00087555|1252233|P2|Overall Study|Lack of Efficacy|0
396593|NCT00087555|1252234|P1|Overall Study|Lack of Efficacy|2
396594|NCT00087555|1252232|P3|Overall Study|Withdrawal by Subject|1
396595|NCT00087555|1252233|P2|Overall Study|Withdrawal by Subject|2
396596|NCT00087555|1252234|P1|Overall Study|Withdrawal by Subject|3
396597|NCT00087555|1252232|P3|Overall Study|Pregnancy|1
396598|NCT00087555|1252233|P2|Overall Study|Pregnancy|1
396599|NCT00087555|1252234|P1|Overall Study|Pregnancy|0
396600|NCT00087555|1252232|P3|Overall Study|Screen Failure|0
396601|NCT00087555|1252233|P2|Overall Study|Screen Failure|1
396602|NCT00087555|1252234|P1|Overall Study|Screen Failure|1
396603|NCT00087555|1252232|P3|Overall Study|Protocol Violation|2
396604|NCT00087555|1252233|P2|Overall Study|Protocol Violation|0
396605|NCT00087555|1252234|P1|Overall Study|Protocol Violation|0
396606|NCT00087555|1252232|P3|Overall Study|Non - Compliance|0
396607|NCT00087555|1252233|P2|Overall Study|Non - Compliance|0
396608|NCT00087555|1252234|P1|Overall Study|Non - Compliance|1
396609|NCT00087555|1252232|P3|Overall Study|Lost to Follow-up|1
396610|NCT00087555|1252233|P2|Overall Study|Lost to Follow-up|1
396611|NCT00087555|1252234|P1|Overall Study|Lost to Follow-up|0
396612|NCT00087555|1252232|P3|Overall Study|Adverse Event|14
396613|NCT00087555|1252233|P2|Overall Study|Adverse Event|6
396614|NCT00087555|1252234|P1|Overall Study|Adverse Event|3
396615|NCT00087529|1252244|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
396616|NCT00087529|1252245|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
396617|NCT00087529|1252244|P2|Overall Study|Disease Progression|4
396618|NCT00087529|1252245|P1|Overall Study|Disease Progression|5
396619|NCT00087529|1252244|P2|Overall Study|Participant Noncompliance|1
396620|NCT00087529|1252245|P1|Overall Study|Participant Noncompliance|0
396621|NCT00087529|1252244|P2|Overall Study|Initiation of Excluded Therapy|1
396622|NCT00087529|1252245|P1|Overall Study|Initiation of Excluded Therapy|0
396623|NCT00087529|1252244|P2|Overall Study|Physician Decision|8
396624|NCT00087529|1252245|P1|Overall Study|Physician Decision|4
396625|NCT00087529|1252244|P2|Overall Study|Participant Decision|37
396626|NCT00087529|1252245|P1|Overall Study|Participant Decision|14
396627|NCT00087529|1252244|P2|Overall Study|Lost to Follow-up|3
396628|NCT00087529|1252245|P1|Overall Study|Lost to Follow-up|2
396629|NCT00087529|1252244|P2|Overall Study|Pregnancy|1
396630|NCT00087529|1252245|P1|Overall Study|Pregnancy|0
396631|NCT00087529|1252244|P2|Overall Study|Adverse Event|8
396632|NCT00087529|1252245|P1|Overall Study|Adverse Event|0
396633|NCT00087529|1252244|P2|Overall Study|Death|0
396634|NCT00087529|1252245|P1|Overall Study|Death|1
396635|NCT00087516|1252260|P4|Overall Study|Unspecified|0
396636|NCT00087516|1252261|P3|Overall Study|Unspecified|1
396637|NCT00087516|1252262|P2|Overall Study|Unspecified|0
396638|NCT00087516|1252263|P1|Overall Study|Unspecified|0
396639|NCT00087516|1252260|P4|Overall Study|Recommendation of Primary Care Physician|1
396640|NCT00087516|1252261|P3|Overall Study|Recommendation of Primary Care Physician|0
396641|NCT00087516|1252262|P2|Overall Study|Recommendation of Primary Care Physician|0
396642|NCT00087516|1252263|P1|Overall Study|Recommendation of Primary Care Physician|0
396643|NCT00087516|1252260|P4|Overall Study|Patient was non-compliant|0
396644|NCT00087516|1252261|P3|Overall Study|Patient was non-compliant|0
396645|NCT00087516|1252262|P2|Overall Study|Patient was non-compliant|1
396646|NCT00087516|1252263|P1|Overall Study|Patient was non-compliant|3
396647|NCT00087516|1252260|P4|Overall Study|Patient moved|0
396648|NCT00087516|1252261|P3|Overall Study|Patient moved|1
396649|NCT00087516|1252262|P2|Overall Study|Patient moved|2
396650|NCT00087516|1252263|P1|Overall Study|Patient moved|3
396651|NCT00087516|1252260|P4|Overall Study|Protocol specified discontinuation|26
396652|NCT00087516|1252261|P3|Overall Study|Protocol specified discontinuation|33
396653|NCT00087516|1252262|P2|Overall Study|Protocol specified discontinuation|33
396654|NCT00087516|1252263|P1|Overall Study|Protocol specified discontinuation|35
396655|NCT00087516|1252260|P4|Overall Study|Site terminated|0
396656|NCT00087516|1252261|P3|Overall Study|Site terminated|1
396657|NCT00087516|1252262|P2|Overall Study|Site terminated|2
396658|NCT00087516|1252263|P1|Overall Study|Site terminated|0
396659|NCT00087516|1252260|P4|Overall Study|Withdrawal by Subject|12
396660|NCT00087516|1252261|P3|Overall Study|Withdrawal by Subject|11
396661|NCT00087516|1252262|P2|Overall Study|Withdrawal by Subject|27
396662|NCT00087516|1252263|P1|Overall Study|Withdrawal by Subject|16
396663|NCT00087516|1252260|P4|Overall Study|Protocol Violation|6
396664|NCT00087516|1252261|P3|Overall Study|Protocol Violation|3
396665|NCT00087516|1252262|P2|Overall Study|Protocol Violation|8
396666|NCT00087516|1252263|P1|Overall Study|Protocol Violation|4
396667|NCT00087516|1252260|P4|Overall Study|Lost to Follow-up|5
396668|NCT00087516|1252261|P3|Overall Study|Lost to Follow-up|5
396669|NCT00087516|1252262|P2|Overall Study|Lost to Follow-up|6
396670|NCT00087516|1252263|P1|Overall Study|Lost to Follow-up|8
396671|NCT00087516|1252260|P4|Overall Study|Lack of Efficacy|29
396672|NCT00087516|1252261|P3|Overall Study|Lack of Efficacy|39
396673|NCT00087516|1252262|P2|Overall Study|Lack of Efficacy|80
396674|NCT00087516|1252263|P1|Overall Study|Lack of Efficacy|82
396675|NCT00087516|1252260|P4|Overall Study|Adverse Event|6
396676|NCT00087516|1252261|P3|Overall Study|Adverse Event|3
396677|NCT00087516|1252262|P2|Overall Study|Adverse Event|10
396678|NCT00087516|1252263|P1|Overall Study|Adverse Event|10
396679|NCT00087490|1252292|P2|Overall Study|Randomized but not treated|18
396680|NCT00087490|1252293|P1|Overall Study|Randomized but not treated|7
396681|NCT00087490|1252292|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
396682|NCT00087490|1252293|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
396683|NCT00087490|1252292|P2|Overall Study|Protocol Violation or (/) Unspecified|201
396684|NCT00087490|1252293|P1|Overall Study|Protocol Violation or (/) Unspecified|214
396685|NCT00087490|1252292|P2|Overall Study|Lack of Efficacy|2
396686|NCT00087490|1252293|P1|Overall Study|Lack of Efficacy|0
396687|NCT00087490|1252292|P2|Overall Study|Adverse Event|8
396688|NCT00087490|1252293|P1|Overall Study|Adverse Event|3
396689|NCT00087490|1252292|P2|Overall Study|Death|4
396690|NCT00087490|1252293|P1|Overall Study|Death|6
396691|NCT00087438|1252327|P1|Overall Study|Ineligible / No protocol treatment|4
396692|NCT00087152|1252331|P1|Overall Study|Ineligible|6
396693|NCT00087139|1252340|P3|Overall Study|Extradural disease|1
396694|NCT00087139|1252341|P2|Overall Study|Extradural disease|0
396695|NCT00087139|1252342|P1|Overall Study|Extradural disease|0
396696|NCT00087139|1252340|P3|Overall Study|Response achieved|0
396697|NCT00087139|1252341|P2|Overall Study|Response achieved|1
396698|NCT00087139|1252342|P1|Overall Study|Response achieved|0
396699|NCT00087139|1252340|P3|Overall Study|Use of coumadin|0
396700|NCT00087139|1252341|P2|Overall Study|Use of coumadin|0
396701|NCT00087139|1252342|P1|Overall Study|Use of coumadin|1
396702|NCT00087139|1252340|P3|Overall Study|Symptomatic deterioration|3
396703|NCT00087139|1252341|P2|Overall Study|Symptomatic deterioration|1
396704|NCT00087139|1252342|P1|Overall Study|Symptomatic deterioration|1
396705|NCT00087139|1252340|P3|Overall Study|Ineligible|4
396706|NCT00087139|1252341|P2|Overall Study|Ineligible|7
396707|NCT00087139|1252342|P1|Overall Study|Ineligible|4
396708|NCT00087139|1252340|P3|Overall Study|Disease progression|12
396709|NCT00087139|1252341|P2|Overall Study|Disease progression|19
396710|NCT00087139|1252342|P1|Overall Study|Disease progression|9
396711|NCT00087139|1252340|P3|Overall Study|Physician Decision|1
396712|NCT00087139|1252341|P2|Overall Study|Physician Decision|1
396713|NCT00087139|1252342|P1|Overall Study|Physician Decision|1
396714|NCT00087139|1252340|P3|Overall Study|Withdrawal by Subject|2
396715|NCT00087139|1252341|P2|Overall Study|Withdrawal by Subject|2
396716|NCT00087139|1252342|P1|Overall Study|Withdrawal by Subject|3
396717|NCT00087139|1252340|P3|Overall Study|Death|0
396718|NCT00087139|1252341|P2|Overall Study|Death|1
396719|NCT00087139|1252342|P1|Overall Study|Death|2
396720|NCT00087139|1252340|P3|Overall Study|Adverse Event|13
396721|NCT00087139|1252341|P2|Overall Study|Adverse Event|17
396722|NCT00087139|1252342|P1|Overall Study|Adverse Event|18
396723|NCT00086996|1252357|P1|Overall Study|not eligible|5
396724|NCT00086996|1252357|P1|Overall Study|not specified|6
396725|NCT00086996|1252357|P1|Overall Study|Withdrawal by Subject|13
396726|NCT00086996|1252357|P1|Overall Study|progression/relapse|7
396727|NCT00086996|1252357|P1|Overall Study|Death|4
396728|NCT00086996|1252357|P1|Overall Study|Adverse Event|29
396729|NCT00086684|1252379|P3|Overall Study|Not specified|3
396730|NCT00086684|1252380|P2|Overall Study|Not specified|2
396731|NCT00086684|1252381|P1|Overall Study|Not specified|4
396732|NCT00086684|1252379|P3|Overall Study|WITHDRAWAL OF CONSENT|5
396733|NCT00086684|1252380|P2|Overall Study|WITHDRAWAL OF CONSENT|7
396734|NCT00086684|1252381|P1|Overall Study|WITHDRAWAL OF CONSENT|5
396735|NCT00086684|1252379|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
396736|NCT00086684|1252380|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
396737|NCT00086684|1252381|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
396738|NCT00086684|1252379|P3|Overall Study|NONCOMPLIANCE|6
396739|NCT00086684|1252380|P2|Overall Study|NONCOMPLIANCE|7
396740|NCT00086684|1252381|P1|Overall Study|NONCOMPLIANCE|5
396741|NCT00086684|1252379|P3|Overall Study|Withdrawal by Subject|10
396742|NCT00086684|1252380|P2|Overall Study|Withdrawal by Subject|4
396743|NCT00086684|1252381|P1|Overall Study|Withdrawal by Subject|0
396744|NCT00086684|1252379|P3|Overall Study|Protocol Violation|0
396745|NCT00086684|1252380|P2|Overall Study|Protocol Violation|3
396746|NCT00086684|1252381|P1|Overall Study|Protocol Violation|8
396747|NCT00086684|1252379|P3|Overall Study|Lost to Follow-up|10
396748|NCT00086684|1252380|P2|Overall Study|Lost to Follow-up|8
396749|NCT00086684|1252381|P1|Overall Study|Lost to Follow-up|15
396750|NCT00086684|1252379|P3|Overall Study|Lack of Efficacy|5
396751|NCT00086684|1252380|P2|Overall Study|Lack of Efficacy|6
396752|NCT00086684|1252381|P1|Overall Study|Lack of Efficacy|6
396753|NCT00086684|1252379|P3|Overall Study|Adverse Event|14
396754|NCT00086684|1252380|P2|Overall Study|Adverse Event|17
396755|NCT00086684|1252381|P1|Overall Study|Adverse Event|12
396756|NCT00086619|1252394|P2|Overall Study|Protocol Violation|1
396757|NCT00086619|1252395|P1|Overall Study|Protocol Violation|1
396758|NCT00086619|1252394|P2|Overall Study|Adverse Event|10
396759|NCT00086619|1252395|P1|Overall Study|Adverse Event|8
396760|NCT00086619|1252394|P2|Overall Study|Withdrawal by Subject|6
396761|NCT00086619|1252395|P1|Overall Study|Withdrawal by Subject|6
396762|NCT00086580|1252405|P2|Observation Period|Not specified|7
396763|NCT00086580|1252406|P1|Observation Period|Not specified|8
396764|NCT00086580|1252405|P2|Observation Period|Death|55
396765|NCT00086580|1252406|P1|Observation Period|Death|33
396766|NCT00086580|1252405|P2|Observation Period|Withdrawal by Subject|2
396767|NCT00086580|1252406|P1|Observation Period|Withdrawal by Subject|4
396768|NCT00086580|1252405|P2|Observation Period|Unable to comply with protocol|1
396769|NCT00086580|1252406|P1|Observation Period|Unable to comply with protocol|1
396770|NCT00086580|1252405|P2|Follow-up Period|Not specified|6
396771|NCT00086580|1252406|P1|Follow-up Period|Not specified|7
396772|NCT00086580|1252405|P2|Follow-up Period|Death|7
396773|NCT00086580|1252406|P1|Follow-up Period|Death|13
396774|NCT00086580|1252405|P2|Follow-up Period|AE - not related|0
396775|NCT00086580|1252406|P1|Follow-up Period|AE - not related|1
396776|NCT00086580|1252405|P2|Follow-up Period|Physician Decision|1
396777|NCT00086580|1252406|P1|Follow-up Period|Physician Decision|0
396778|NCT00086580|1252405|P2|Follow-up Period|Withdrawal by Subject|6
396779|NCT00086580|1252406|P1|Follow-up Period|Withdrawal by Subject|6
396780|NCT00086580|1252405|P2|Follow-up Period|Unable to comply with protocol|0
396781|NCT00086580|1252406|P1|Follow-up Period|Unable to comply with protocol|5
396782|NCT00086580|1252405|P2|Follow-up Period|Disease progression|99
396783|NCT00086580|1252406|P1|Follow-up Period|Disease progression|72
396784|NCT00086580|1252405|P2|Treatment Period|Not specified|3
396785|NCT00086580|1252406|P1|Treatment Period|Not specified|5
396786|NCT00086580|1252405|P2|Treatment Period|Death|7
396787|NCT00086580|1252406|P1|Treatment Period|Death|5
396788|NCT00086580|1252405|P2|Treatment Period|Anemia or thrombocytopenia|4
396789|NCT00086580|1252406|P1|Treatment Period|Anemia or thrombocytopenia|1
396790|NCT00086580|1252405|P2|Treatment Period|Toxicity - treatment related|15
396791|NCT00086580|1252406|P1|Treatment Period|Toxicity - treatment related|15
396792|NCT00086580|1252405|P2|Treatment Period|AE - not treatment related|7
396793|NCT00086580|1252406|P1|Treatment Period|AE - not treatment related|7
396794|NCT00086580|1252405|P2|Treatment Period|Physician Decision|7
396795|NCT00086580|1252406|P1|Treatment Period|Physician Decision|13
396796|NCT00086580|1252405|P2|Treatment Period|Withdrawal by Subject|8
396797|NCT00086580|1252406|P1|Treatment Period|Withdrawal by Subject|7
396798|NCT00086580|1252405|P2|Treatment Period|Unable to comply with protocol|1
396799|NCT00086580|1252406|P1|Treatment Period|Unable to comply with protocol|3
396800|NCT00086580|1252405|P2|Treatment Period|Disease progression|8
396801|NCT00086580|1252406|P1|Treatment Period|Disease progression|9
396802|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Discontinued in error|0
396803|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Discontinued in error|1
396804|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
396805|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
396806|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
396807|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
396808|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Patient Died|1
396809|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Patient Died|3
396810|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
396811|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
396812|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
396813|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
396814|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Patient Moved|2
396815|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Patient Moved|2
396816|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
396817|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
396818|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Protocol Violation|0
396819|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Protocol Violation|1
396820|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Physician Decision|0
396821|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Physician Decision|3
396822|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
396823|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
396824|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
396825|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
396826|NCT00086515|1252452|P2|Phase B (Weeks 24-104)|Adverse Event|10
396827|NCT00086515|1252453|P1|Phase B (Weeks 24-104)|Adverse Event|16
396828|NCT00086515|1252452|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
396829|NCT00086515|1252453|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
396830|NCT00086515|1252452|P2|Phase A to Phase B Transition Period|Poor compliance|0
396831|NCT00086515|1252453|P1|Phase A to Phase B Transition Period|Poor compliance|1
396832|NCT00086515|1252452|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
396833|NCT00086515|1252453|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
396834|NCT00086515|1252452|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
396835|NCT00086515|1252453|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
396836|NCT00086515|1252452|P2|Phase A to Phase B Transition Period|Protocol Violation|1
396837|NCT00086515|1252453|P1|Phase A to Phase B Transition Period|Protocol Violation|0
396838|NCT00086515|1252452|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
396839|NCT00086515|1252453|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
396840|NCT00086515|1252452|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
396841|NCT00086515|1252453|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
396842|NCT00086515|1252452|P2|Phase A to Phase B Transition Period|Adverse Event|1
396843|NCT00086515|1252453|P1|Phase A to Phase B Transition Period|Adverse Event|2
396844|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
396845|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
396846|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
396847|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
396848|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Poor compliance|0
396849|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Poor compliance|1
396850|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
396851|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
396852|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Patient Moved|3
396853|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Patient Moved|2
396854|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
396855|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
396856|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Protocol Violation|1
396857|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Protocol Violation|3
396858|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
396859|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
396860|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
396861|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
396862|NCT00086515|1252452|P2|Phase A (Weeks 0-24)|Adverse Event|9
396863|NCT00086515|1252453|P1|Phase A (Weeks 0-24)|Adverse Event|17
396864|NCT00086502|1252465|P2|Overall Study|Patient Accidentally Unblinded|0
396865|NCT00086502|1252466|P1|Overall Study|Patient Accidentally Unblinded|1
396866|NCT00086502|1252465|P2|Overall Study|Protocol Discontinuation Criteria|3
396867|NCT00086502|1252466|P1|Overall Study|Protocol Discontinuation Criteria|1
396868|NCT00086502|1252465|P2|Overall Study|Patient Moved|1
396869|NCT00086502|1252466|P1|Overall Study|Patient Moved|1
396870|NCT00086502|1252465|P2|Overall Study|Withdrawal by Subject|6
396871|NCT00086502|1252466|P1|Overall Study|Withdrawal by Subject|5
396872|NCT00086502|1252465|P2|Overall Study|Protocol Violation|3
396873|NCT00086502|1252466|P1|Overall Study|Protocol Violation|3
396874|NCT00086502|1252465|P2|Overall Study|Pregnancy|1
396875|NCT00086502|1252466|P1|Overall Study|Pregnancy|0
396876|NCT00086502|1252465|P2|Overall Study|Physician Decision|1
396877|NCT00086502|1252466|P1|Overall Study|Physician Decision|1
396878|NCT00086502|1252465|P2|Overall Study|Lost to Follow-up|1
396879|NCT00086502|1252466|P1|Overall Study|Lost to Follow-up|3
396880|NCT00086502|1252465|P2|Overall Study|Lack of Efficacy|2
396881|NCT00086502|1252466|P1|Overall Study|Lack of Efficacy|0
396882|NCT00086502|1252465|P2|Overall Study|Adverse Event|2
396883|NCT00086502|1252466|P1|Overall Study|Adverse Event|11
396884|NCT00086411|1252493|P4|Overall Study|Lost to Follow-up|12
396885|NCT00086411|1252494|P3|Overall Study|Lost to Follow-up|13
396886|NCT00086411|1252495|P2|Overall Study|Lost to Follow-up|11
396887|NCT00086411|1252496|P1|Overall Study|Lost to Follow-up|11
396888|NCT00086385|1252510|P4|Overall Study|Death|1
396889|NCT00086385|1252511|P3|Overall Study|Death|1
396890|NCT00086385|1252512|P2|Overall Study|Death|2
396891|NCT00086385|1252513|P1|Overall Study|Death|2
396892|NCT00086346|1252525|P2|Patients Dosed With Test Article|Lack of Efficacy|0
396893|NCT00086346|1252526|P1|Patients Dosed With Test Article|Lack of Efficacy|11
396894|NCT00086346|1252525|P2|Patients Dosed With Test Article|Protocol Violation|3
396895|NCT00086346|1252526|P1|Patients Dosed With Test Article|Protocol Violation|11
396896|NCT00086346|1252525|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
396897|NCT00086346|1252526|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
396898|NCT00086346|1252525|P2|Patients Dosed With Test Article|Nonmedical event|3
396899|NCT00086346|1252526|P1|Patients Dosed With Test Article|Nonmedical event|7
396900|NCT00086346|1252525|P2|Patients Dosed With Test Article|Lost to Follow-up|3
396901|NCT00086346|1252526|P1|Patients Dosed With Test Article|Lost to Follow-up|1
396902|NCT00086346|1252525|P2|Patients Dosed With Test Article|Adverse Event|11
396903|NCT00086346|1252526|P1|Patients Dosed With Test Article|Adverse Event|94
396904|NCT00086346|1252525|P2|Randomization|Did not receive test article|4
396905|NCT00086346|1252526|P1|Randomization|Did not receive test article|4
396906|NCT00086307|1252541|P3|Overall Study|Withdrawal by Subject|2
396907|NCT00086307|1252542|P2|Overall Study|Withdrawal by Subject|0
396908|NCT00086307|1252543|P1|Overall Study|Withdrawal by Subject|0
396909|NCT00086307|1252541|P3|Overall Study|Fatigue and difficulty falling asleep|1
396910|NCT00086307|1252542|P2|Overall Study|Fatigue and difficulty falling asleep|0
396911|NCT00086307|1252543|P1|Overall Study|Fatigue and difficulty falling asleep|0
396912|NCT00086307|1252541|P3|Overall Study|Suicidal ideation|1
396913|NCT00086307|1252542|P2|Overall Study|Suicidal ideation|0
396914|NCT00086307|1252543|P1|Overall Study|Suicidal ideation|0
396915|NCT00086307|1252541|P3|Overall Study|Constipation and sleepiness|1
396916|NCT00086307|1252542|P2|Overall Study|Constipation and sleepiness|0
396917|NCT00086307|1252543|P1|Overall Study|Constipation and sleepiness|0
396918|NCT00086307|1252541|P3|Overall Study|Nausea and headaches|1
396919|NCT00086307|1252542|P2|Overall Study|Nausea and headaches|0
396920|NCT00086307|1252543|P1|Overall Study|Nausea and headaches|0
396921|NCT00086307|1252541|P3|Overall Study|Shortness of breath and muscle spasms|0
396922|NCT00086307|1252542|P2|Overall Study|Shortness of breath and muscle spasms|0
396923|NCT00086307|1252543|P1|Overall Study|Shortness of breath and muscle spasms|1
396924|NCT00086307|1252541|P3|Overall Study|Lack of Efficacy|2
396925|NCT00086307|1252542|P2|Overall Study|Lack of Efficacy|1
396926|NCT00086307|1252543|P1|Overall Study|Lack of Efficacy|1
396927|NCT00086281|1252566|P15|Phase 2|Adverse Event|0
396928|NCT00086281|1252567|P14|Phase 2|Adverse Event|1
396929|NCT00086281|1252568|P13|Phase 2|Adverse Event|1
396930|NCT00086281|1252569|P12|Phase 2|Adverse Event|0
396931|NCT00086281|1252570|P11|Phase 2|Adverse Event|0
396932|NCT00086281|1252571|P10|Phase 2|Adverse Event|0
396933|NCT00086281|1252572|P9|Phase 2|Adverse Event|0
396934|NCT00086281|1252573|P8|Phase 2|Adverse Event|0
396935|NCT00086281|1252574|P7|Phase 2|Adverse Event|0
396936|NCT00086281|1252575|P6|Phase 2|Adverse Event|0
396937|NCT00086281|1252576|P5|Phase 2|Adverse Event|0
396938|NCT00086281|1252577|P4|Phase 2|Adverse Event|0
396939|NCT00086281|1252578|P3|Phase 2|Adverse Event|0
396940|NCT00086281|1252579|P2|Phase 2|Adverse Event|0
396941|NCT00086281|1252580|P1|Phase 2|Adverse Event|0
396942|NCT00086281|1252566|P15|Phase 1|Serious Adverse Event|1
396943|NCT00086281|1252567|P14|Phase 1|Serious Adverse Event|0
396944|NCT00086281|1252568|P13|Phase 1|Serious Adverse Event|0
396945|NCT00086281|1252569|P12|Phase 1|Serious Adverse Event|0
396946|NCT00086281|1252570|P11|Phase 1|Serious Adverse Event|0
396947|NCT00086281|1252571|P10|Phase 1|Serious Adverse Event|0
396948|NCT00086281|1252572|P9|Phase 1|Serious Adverse Event|0
396949|NCT00086281|1252573|P8|Phase 1|Serious Adverse Event|0
396950|NCT00086281|1252574|P7|Phase 1|Serious Adverse Event|0
396951|NCT00086281|1252575|P6|Phase 1|Serious Adverse Event|0
396952|NCT00086281|1252576|P5|Phase 1|Serious Adverse Event|0
396953|NCT00086281|1252577|P4|Phase 1|Serious Adverse Event|0
396954|NCT00086281|1252578|P3|Phase 1|Serious Adverse Event|0
396955|NCT00086281|1252579|P2|Phase 1|Serious Adverse Event|0
396956|NCT00086281|1252580|P1|Phase 1|Serious Adverse Event|0
396957|NCT00086281|1252566|P15|Phase 1|Protocol Violation|0
396958|NCT00086281|1252567|P14|Phase 1|Protocol Violation|0
396959|NCT00086281|1252568|P13|Phase 1|Protocol Violation|0
396960|NCT00086281|1252569|P12|Phase 1|Protocol Violation|0
396961|NCT00086281|1252570|P11|Phase 1|Protocol Violation|1
396962|NCT00086281|1252571|P10|Phase 1|Protocol Violation|0
396963|NCT00086281|1252572|P9|Phase 1|Protocol Violation|0
396964|NCT00086281|1252573|P8|Phase 1|Protocol Violation|0
396965|NCT00086281|1252574|P7|Phase 1|Protocol Violation|0
396966|NCT00086281|1252575|P6|Phase 1|Protocol Violation|0
396967|NCT00086281|1252576|P5|Phase 1|Protocol Violation|0
396968|NCT00086281|1252577|P4|Phase 1|Protocol Violation|0
396969|NCT00086281|1252578|P3|Phase 1|Protocol Violation|0
396970|NCT00086281|1252579|P2|Phase 1|Protocol Violation|0
396971|NCT00086281|1252580|P1|Phase 1|Protocol Violation|0
396972|NCT00086281|1252566|P15|Phase 1|Adverse Event|2
396973|NCT00086281|1252567|P14|Phase 1|Adverse Event|1
396974|NCT00086281|1252568|P13|Phase 1|Adverse Event|1
396975|NCT00086281|1252569|P12|Phase 1|Adverse Event|1
396976|NCT00086281|1252570|P11|Phase 1|Adverse Event|2
396977|NCT00086281|1252571|P10|Phase 1|Adverse Event|1
396978|NCT00086281|1252572|P9|Phase 1|Adverse Event|0
396979|NCT00086281|1252573|P8|Phase 1|Adverse Event|0
396980|NCT00086281|1252574|P7|Phase 1|Adverse Event|0
396981|NCT00086281|1252575|P6|Phase 1|Adverse Event|0
396982|NCT00086281|1252576|P5|Phase 1|Adverse Event|0
396983|NCT00086281|1252577|P4|Phase 1|Adverse Event|0
396984|NCT00086281|1252578|P3|Phase 1|Adverse Event|0
396985|NCT00086281|1252579|P2|Phase 1|Adverse Event|0
396986|NCT00086281|1252580|P1|Phase 1|Adverse Event|0
396987|NCT00086190|1252593|P3|Overall Study|Worsening depression|2
396988|NCT00086190|1252594|P2|Overall Study|Worsening depression|0
396989|NCT00086190|1252595|P1|Overall Study|Worsening depression|0
396990|NCT00086190|1252593|P3|Overall Study|Moved|0
396991|NCT00086190|1252594|P2|Overall Study|Moved|0
396992|NCT00086190|1252595|P1|Overall Study|Moved|1
396993|NCT00086190|1252593|P3|Overall Study|Protocol Violation|0
396994|NCT00086190|1252594|P2|Overall Study|Protocol Violation|0
396995|NCT00086190|1252595|P1|Overall Study|Protocol Violation|1
396996|NCT00086190|1252593|P3|Overall Study|Withdrawal by Subject|2
396997|NCT00086190|1252594|P2|Overall Study|Withdrawal by Subject|2
396998|NCT00086190|1252595|P1|Overall Study|Withdrawal by Subject|0
396999|NCT00086190|1252593|P3|Overall Study|Adverse Event|2
397000|NCT00086190|1252594|P2|Overall Study|Adverse Event|2
397001|NCT00086190|1252595|P1|Overall Study|Adverse Event|6
397002|NCT00086047|1252664|P2|Overall Study|Physician Decision|1
397003|NCT00086047|1252665|P1|Overall Study|Physician Decision|0
397004|NCT00086047|1252664|P2|Overall Study|Lost to Follow-up|6
397005|NCT00086047|1252665|P1|Overall Study|Lost to Follow-up|7
397006|NCT00085917|1252673|P2|Overall Study|Adverse Event|3
397007|NCT00085917|1252674|P1|Overall Study|Adverse Event|4
397008|NCT00085735|1252703|P6|Overall Study|Pt transferred to inst w/out study open|0
397009|NCT00085735|1252704|P5|Overall Study|Pt transferred to inst w/out study open|0
397010|NCT00085735|1252705|P4|Overall Study|Pt transferred to inst w/out study open|0
397011|NCT00085735|1252706|P3|Overall Study|Pt transferred to inst w/out study open|0
397012|NCT00085735|1252707|P2|Overall Study|Pt transferred to inst w/out study open|0
397013|NCT00085735|1252708|P1|Overall Study|Pt transferred to inst w/out study open|1
397014|NCT00085735|1252703|P6|Overall Study|Reason not documented|0
397015|NCT00085735|1252704|P5|Overall Study|Reason not documented|1
397016|NCT00085735|1252705|P4|Overall Study|Reason not documented|0
397017|NCT00085735|1252706|P3|Overall Study|Reason not documented|1
397018|NCT00085735|1252707|P2|Overall Study|Reason not documented|0
397019|NCT00085735|1252708|P1|Overall Study|Reason not documented|1
397020|NCT00085735|1252703|P6|Overall Study|Excess residual disease|4
397021|NCT00085735|1252704|P5|Overall Study|Excess residual disease|1
397022|NCT00085735|1252705|P4|Overall Study|Excess residual disease|1
397023|NCT00085735|1252706|P3|Overall Study|Excess residual disease|1
397024|NCT00085735|1252707|P2|Overall Study|Excess residual disease|2
397025|NCT00085735|1252708|P1|Overall Study|Excess residual disease|2
397026|NCT00085735|1252703|P6|Overall Study|Patient ineligible|8
397027|NCT00085735|1252704|P5|Overall Study|Patient ineligible|17
397028|NCT00085735|1252705|P4|Overall Study|Patient ineligible|7
397029|NCT00085735|1252706|P3|Overall Study|Patient ineligible|3
397030|NCT00085735|1252707|P2|Overall Study|Patient ineligible|0
397031|NCT00085735|1252708|P1|Overall Study|Patient ineligible|1
397032|NCT00085735|1252703|P6|Overall Study|Withdrawal by Subject|8
397033|NCT00085735|1252704|P5|Overall Study|Withdrawal by Subject|7
397034|NCT00085735|1252705|P4|Overall Study|Withdrawal by Subject|5
397035|NCT00085735|1252706|P3|Overall Study|Withdrawal by Subject|4
397036|NCT00085735|1252707|P2|Overall Study|Withdrawal by Subject|0
397037|NCT00085735|1252708|P1|Overall Study|Withdrawal by Subject|1
397038|NCT00085735|1252703|P6|Overall Study|Protocol Violation|0
397039|NCT00085735|1252704|P5|Overall Study|Protocol Violation|0
397040|NCT00085735|1252705|P4|Overall Study|Protocol Violation|0
397041|NCT00085735|1252706|P3|Overall Study|Protocol Violation|0
397042|NCT00085735|1252707|P2|Overall Study|Protocol Violation|0
397043|NCT00085735|1252708|P1|Overall Study|Protocol Violation|1
397044|NCT00085735|1252703|P6|Overall Study|Physician Decision|8
397045|NCT00085735|1252704|P5|Overall Study|Physician Decision|11
397046|NCT00085735|1252705|P4|Overall Study|Physician Decision|3
397047|NCT00085735|1252706|P3|Overall Study|Physician Decision|2
397048|NCT00085735|1252707|P2|Overall Study|Physician Decision|3
397049|NCT00085735|1252708|P1|Overall Study|Physician Decision|2
397050|NCT00085735|1252703|P6|Overall Study|Lost to Follow-up|0
397051|NCT00085735|1252704|P5|Overall Study|Lost to Follow-up|1
397052|NCT00085735|1252705|P4|Overall Study|Lost to Follow-up|0
397053|NCT00085735|1252706|P3|Overall Study|Lost to Follow-up|0
397054|NCT00085735|1252707|P2|Overall Study|Lost to Follow-up|1
397055|NCT00085735|1252708|P1|Overall Study|Lost to Follow-up|0
397056|NCT00085735|1252703|P6|Overall Study|Lack of Efficacy|3
397057|NCT00085735|1252704|P5|Overall Study|Lack of Efficacy|4
397058|NCT00085735|1252705|P4|Overall Study|Lack of Efficacy|3
397059|NCT00085735|1252706|P3|Overall Study|Lack of Efficacy|6
397060|NCT00085735|1252707|P2|Overall Study|Lack of Efficacy|4
397061|NCT00085735|1252708|P1|Overall Study|Lack of Efficacy|2
397062|NCT00085735|1252703|P6|Overall Study|Adverse Event|0
397063|NCT00085735|1252704|P5|Overall Study|Adverse Event|0
397064|NCT00085735|1252705|P4|Overall Study|Adverse Event|0
397065|NCT00085735|1252706|P3|Overall Study|Adverse Event|0
397066|NCT00085735|1252707|P2|Overall Study|Adverse Event|0
397067|NCT00085735|1252708|P1|Overall Study|Adverse Event|1
397068|NCT00085709|1252736|P2|Overall Study|Withdrawal by Subject|1
397069|NCT00085709|1252737|P1|Overall Study|Withdrawal by Subject|2
397070|NCT00085709|1252736|P2|Overall Study|Not eligible|19
397071|NCT00085709|1252737|P1|Overall Study|Not eligible|19
397072|NCT00085709|1252736|P2|Overall Study|Not protocol specified|22
397073|NCT00085709|1252737|P1|Overall Study|Not protocol specified|12
397074|NCT00085709|1252736|P2|Overall Study|Progression|4
397075|NCT00085709|1252737|P1|Overall Study|Progression|3
397076|NCT00085709|1252736|P2|Overall Study|Refusal unrelated to adverse events|2
397077|NCT00085709|1252737|P1|Overall Study|Refusal unrelated to adverse events|1
397078|NCT00085709|1252736|P2|Overall Study|Death|2
397079|NCT00085709|1252737|P1|Overall Study|Death|8
397080|NCT00085709|1252736|P2|Overall Study|Adverse Event|0
397081|NCT00085709|1252737|P1|Overall Study|Adverse Event|8
397082|NCT00085644|1252753|P3|Open-Label Period|Personal reason|4
397083|NCT00085644|1252754|P2|Open-Label Period|Personal reason|0
397084|NCT00085644|1252755|P1|Open-Label Period|Personal reason|0
397085|NCT00085644|1252753|P3|Open-Label Period|Protocol Violation|4
397086|NCT00085644|1252754|P2|Open-Label Period|Protocol Violation|0
397087|NCT00085644|1252755|P1|Open-Label Period|Protocol Violation|0
397088|NCT00085644|1252753|P3|Open-Label Period|Contemplating pregnancy|3
397089|NCT00085644|1252754|P2|Open-Label Period|Contemplating pregnancy|0
397090|NCT00085644|1252755|P1|Open-Label Period|Contemplating pregnancy|0
397091|NCT00085644|1252753|P3|Open-Label Period|Pregnancy|3
397092|NCT00085644|1252754|P2|Open-Label Period|Pregnancy|0
397093|NCT00085644|1252755|P1|Open-Label Period|Pregnancy|0
397094|NCT00085644|1252753|P3|Open-Label Period|Lack of Efficacy|15
397095|NCT00085644|1252754|P2|Open-Label Period|Lack of Efficacy|0
397096|NCT00085644|1252755|P1|Open-Label Period|Lack of Efficacy|0
397097|NCT00085644|1252753|P3|Open-Label Period|Lost to Follow-up|13
397098|NCT00085644|1252754|P2|Open-Label Period|Lost to Follow-up|0
397099|NCT00085644|1252755|P1|Open-Label Period|Lost to Follow-up|0
397100|NCT00085644|1252753|P3|Open-Label Period|Withdrawal by Subject|29
397101|NCT00085644|1252754|P2|Open-Label Period|Withdrawal by Subject|0
397102|NCT00085644|1252755|P1|Open-Label Period|Withdrawal by Subject|0
397103|NCT00085644|1252753|P3|Open-Label Period|Adverse Event|38
397104|NCT00085644|1252754|P2|Open-Label Period|Adverse Event|0
397105|NCT00085644|1252755|P1|Open-Label Period|Adverse Event|0
397106|NCT00085644|1252753|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
397107|NCT00085644|1252754|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
397108|NCT00085644|1252755|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
397109|NCT00085644|1252753|P3|Double-Blind Period|Contemplating pregnancy|0
397110|NCT00085644|1252754|P2|Double-Blind Period|Contemplating pregnancy|0
397111|NCT00085644|1252755|P1|Double-Blind Period|Contemplating pregnancy|1
397112|NCT00085644|1252753|P3|Double-Blind Period|Lack/loss of efficacy|0
397113|NCT00085644|1252754|P2|Double-Blind Period|Lack/loss of efficacy|2
397114|NCT00085644|1252755|P1|Double-Blind Period|Lack/loss of efficacy|2
397115|NCT00085644|1252753|P3|Double-Blind Period|Lost to Follow-up|0
397116|NCT00085644|1252754|P2|Double-Blind Period|Lost to Follow-up|1
397117|NCT00085644|1252755|P1|Double-Blind Period|Lost to Follow-up|2
397118|NCT00085644|1252753|P3|Double-Blind Period|Withdrawal by Subject|0
397119|NCT00085644|1252754|P2|Double-Blind Period|Withdrawal by Subject|0
397120|NCT00085644|1252755|P1|Double-Blind Period|Withdrawal by Subject|3
397121|NCT00085644|1252753|P3|Double-Blind Period|Adverse Event|0
397122|NCT00085644|1252754|P2|Double-Blind Period|Adverse Event|2
397123|NCT00085644|1252755|P1|Double-Blind Period|Adverse Event|5
397124|NCT00085631|1252796|P3|Overall Study|Missing Data|7
397125|NCT00085631|1252797|P2|Overall Study|Missing Data|11
397126|NCT00085631|1252798|P1|Overall Study|Missing Data|4
397127|NCT00085566|1252808|P3|Overall Study|Clinical progression|1
397128|NCT00085566|1252809|P2|Overall Study|Clinical progression|0
397129|NCT00085566|1252810|P1|Overall Study|Clinical progression|0
397130|NCT00085566|1252808|P3|Overall Study|Patient Not treated|3
397131|NCT00085566|1252809|P2|Overall Study|Patient Not treated|0
397132|NCT00085566|1252810|P1|Overall Study|Patient Not treated|0
397133|NCT00085566|1252808|P3|Overall Study|Adverse Event|10
397134|NCT00085566|1252809|P2|Overall Study|Adverse Event|0
397135|NCT00085566|1252810|P1|Overall Study|Adverse Event|0
397136|NCT00085540|1252820|P2|Overall Study|Protocol Violation|1
397137|NCT00085540|1252821|P1|Overall Study|Protocol Violation|0
397138|NCT00085540|1252820|P2|Overall Study|Withdrawal by Subject|1
397139|NCT00085540|1252821|P1|Overall Study|Withdrawal by Subject|0
397140|NCT00085423|1252832|P1|Overall Study|screen failure|1
397141|NCT00085423|1252832|P1|Overall Study|Withdrawal by Subject|1
397142|NCT00085202|1252878|P2|Overall Study|Progressive disease|11
397143|NCT00085202|1252879|P1|Overall Study|Progressive disease|1
397144|NCT00085202|1252878|P2|Overall Study|Physician Decision|1
397145|NCT00085202|1252879|P1|Overall Study|Physician Decision|4
397146|NCT00085202|1252878|P2|Overall Study|Withdrawal by Subject|1
397147|NCT00085202|1252879|P1|Overall Study|Withdrawal by Subject|2
397148|NCT00085202|1252878|P2|Overall Study|Non-specified|5
397149|NCT00085202|1252879|P1|Overall Study|Non-specified|3
397150|NCT00085202|1252878|P2|Overall Study|Excessive toxicity|5
397151|NCT00085202|1252879|P1|Overall Study|Excessive toxicity|6
397152|NCT00085202|1252878|P2|Overall Study|Bone involvement confirmed by bone scan|1
397153|NCT00085202|1252879|P1|Overall Study|Bone involvement confirmed by bone scan|0
397154|NCT00085202|1252878|P2|Overall Study|Still on therapy|0
397155|NCT00085202|1252879|P1|Overall Study|Still on therapy|2
397156|NCT00085098|1252892|P2|Overall Study|Ineligible|1
397157|NCT00085098|1252893|P1|Overall Study|Ineligible|1
397158|NCT00085098|1252892|P2|Overall Study|Withdrawal by Subject|1
397159|NCT00085098|1252893|P1|Overall Study|Withdrawal by Subject|0
397160|NCT00084864|1252903|P4|Overall Study|Adverse Event|0
397161|NCT00084864|1252904|P3|Overall Study|Adverse Event|0
397162|NCT00084864|1252905|P2|Overall Study|Adverse Event|0
397163|NCT00084864|1252906|P1|Overall Study|Adverse Event|1
397164|NCT00084838|1252932|P1|Overall Study|Ineligible|4
397165|NCT00084838|1252932|P1|Overall Study|Pt Non-Compliance|1
397166|NCT00084838|1252932|P1|Overall Study|Progressive Disease|4
397167|NCT00084838|1252932|P1|Overall Study|Withdrawal by Subject|1
397168|NCT00084838|1252932|P1|Overall Study|Adverse Event|2
397169|NCT00084838|1252932|P1|Overall Study|Death|1
397170|NCT00084747|1252954|P1|Overall Study|Withdrawal by Subject|2
397171|NCT00084747|1252954|P1|Overall Study|Death|3
397172|NCT00084747|1252954|P1|Overall Study|Relapsed|8
397173|NCT00084682|1252959|P1|Overall Study|Withdrawal by Subject|1
397174|NCT00084617|1252963|P1|Overall Study|Protocol Violation|1
397175|NCT00084617|1252963|P1|Overall Study|Lack of Efficacy|1
397176|NCT00084617|1252963|P1|Overall Study|Withdrawal by Subject|7
397177|NCT00084487|1252969|P1|Overall Study|Death|1
397178|NCT00084318|1253015|P2|Overall Study|No protocol treatment|0
397179|NCT00084318|1253016|P1|Overall Study|No protocol treatment|2
397180|NCT00084318|1253015|P2|Overall Study|Protocol Violation|11
397181|NCT00084318|1253016|P1|Overall Study|Protocol Violation|15
397182|NCT00084318|1253015|P2|Overall Study|Withdrawal by Subject|2
397183|NCT00084318|1253016|P1|Overall Study|Withdrawal by Subject|5
397184|NCT00084266|1253034|P2|Overall Study|Randomized not treated|20
397185|NCT00084266|1253035|P1|Overall Study|Randomized not treated|21
397186|NCT00084266|1253034|P2|Overall Study|Unspecified|344
397187|NCT00084266|1253035|P1|Overall Study|Unspecified|360
397188|NCT00084266|1253034|P2|Overall Study|Participant not willing to participate|8
397189|NCT00084266|1253035|P1|Overall Study|Participant not willing to participate|3
397190|NCT00084266|1253034|P2|Overall Study|Lost to Follow-up|3
397191|NCT00084266|1253035|P1|Overall Study|Lost to Follow-up|5
397192|NCT00084266|1253034|P2|Overall Study|Lack of Efficacy|4
397193|NCT00084266|1253035|P1|Overall Study|Lack of Efficacy|2
397194|NCT00084266|1253034|P2|Overall Study|Adverse Event|5
397195|NCT00084266|1253035|P1|Overall Study|Adverse Event|8
397196|NCT00084266|1253034|P2|Overall Study|Death|39
397197|NCT00084266|1253035|P1|Overall Study|Death|42
397198|NCT00084136|1253072|P3|NRTI Comparison|Not reason above|0
397199|NCT00084136|1253073|P2|NRTI Comparison|Not reason above|0
397200|NCT00084136|1253074|P1|NRTI Comparison|Not reason above|1
397201|NCT00084136|1253072|P3|NRTI Comparison|Clinic site closed|14
397202|NCT00084136|1253073|P2|NRTI Comparison|Clinic site closed|0
397203|NCT00084136|1253074|P1|NRTI Comparison|Clinic site closed|12
397204|NCT00084136|1253072|P3|NRTI Comparison|Withdrawal by Subject|38
397205|NCT00084136|1253073|P2|NRTI Comparison|Withdrawal by Subject|0
397206|NCT00084136|1253074|P1|NRTI Comparison|Withdrawal by Subject|54
397207|NCT00084136|1253072|P3|NRTI Comparison|Lost to Follow-up|12
397208|NCT00084136|1253073|P2|NRTI Comparison|Lost to Follow-up|0
397209|NCT00084136|1253074|P1|NRTI Comparison|Lost to Follow-up|14
397210|NCT00084136|1253072|P3|NRTI Comparison|Death|18
397211|NCT00084136|1253073|P2|NRTI Comparison|Death|0
397212|NCT00084136|1253074|P1|NRTI Comparison|Death|20
397213|NCT00084136|1253072|P3|PI Comparison|Clinic site closed|0
397214|NCT00084136|1253073|P2|PI Comparison|Clinic site closed|0
397215|NCT00084136|1253074|P1|PI Comparison|Clinic site closed|1
397216|NCT00084136|1253072|P3|PI Comparison|Withdrawal by Subject|0
397217|NCT00084136|1253073|P2|PI Comparison|Withdrawal by Subject|30
397218|NCT00084136|1253074|P1|PI Comparison|Withdrawal by Subject|33
397219|NCT00084136|1253072|P3|PI Comparison|Lost to Follow-up|0
397220|NCT00084136|1253073|P2|PI Comparison|Lost to Follow-up|8
397221|NCT00084136|1253074|P1|PI Comparison|Lost to Follow-up|11
397222|NCT00084136|1253072|P3|PI Comparison|Death|0
397223|NCT00084136|1253073|P2|PI Comparison|Death|9
397224|NCT00084136|1253074|P1|PI Comparison|Death|10
397225|NCT00084084|1253133|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
397226|NCT00084084|1253133|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
397227|NCT00083915|1253143|P2|Overall Study|Insurance issues|1
397228|NCT00083915|1253144|P1|Overall Study|Insurance issues|1
397229|NCT00083915|1253143|P2|Overall Study|No response|1
397230|NCT00083915|1253144|P1|Overall Study|No response|3
397231|NCT00083915|1253143|P2|Overall Study|Failure to collect|0
397232|NCT00083915|1253144|P1|Overall Study|Failure to collect|3
397233|NCT00083915|1253143|P2|Overall Study|disease progression|23
397234|NCT00083915|1253144|P1|Overall Study|disease progression|18
397235|NCT00083915|1253143|P2|Overall Study|Withdrawal by Subject|3
397236|NCT00083915|1253144|P1|Overall Study|Withdrawal by Subject|8
397237|NCT00083915|1253143|P2|Overall Study|Physician Decision|6
397238|NCT00083915|1253144|P1|Overall Study|Physician Decision|11
397239|NCT00083915|1253143|P2|Overall Study|Death|3
397240|NCT00083915|1253144|P1|Overall Study|Death|6
397241|NCT00083889|1253152|P2|Overall Study|Crossover to SU011248|25
397242|NCT00083889|1253153|P1|Overall Study|Crossover to SU011248|0
397243|NCT00083889|1253152|P2|Overall Study|Completed on marketed sunitinub|0
397244|NCT00083889|1253153|P1|Overall Study|Completed on marketed sunitinub|3
397245|NCT00083889|1253152|P2|Overall Study|Randomized: did not take study drug|15
397246|NCT00083889|1253153|P1|Overall Study|Randomized: did not take study drug|0
397247|NCT00083889|1253152|P2|Overall Study|Decision of sponsor|4
397248|NCT00083889|1253153|P1|Overall Study|Decision of sponsor|32
397249|NCT00083889|1253152|P2|Overall Study|Lack of Efficacy|219
397250|NCT00083889|1253153|P1|Overall Study|Lack of Efficacy|240
397251|NCT00083889|1253152|P2|Overall Study|Withdrawal by Subject|24
397252|NCT00083889|1253153|P1|Overall Study|Withdrawal by Subject|22
397253|NCT00083889|1253152|P2|Overall Study|Protocol Violation|2
397254|NCT00083889|1253153|P1|Overall Study|Protocol Violation|2
397255|NCT00083889|1253152|P2|Overall Study|Adverse Event|86
397256|NCT00083889|1253153|P1|Overall Study|Adverse Event|76
397257|NCT00083759|1253204|P2|Overall Study|Other|13
397258|NCT00083759|1253205|P1|Overall Study|Other|14
397259|NCT00083759|1253204|P2|Overall Study|Sponsor's Discretion|29
397260|NCT00083759|1253205|P1|Overall Study|Sponsor's Discretion|28
397261|NCT00083759|1253204|P2|Overall Study|Non-Compliance|0
397262|NCT00083759|1253205|P1|Overall Study|Non-Compliance|1
397263|NCT00083759|1253204|P2|Overall Study|Subject Withdrew Consent|2
397264|NCT00083759|1253205|P1|Overall Study|Subject Withdrew Consent|2
397265|NCT00083759|1253204|P2|Overall Study|Inadequate Therapeutic Response|35
397266|NCT00083759|1253205|P1|Overall Study|Inadequate Therapeutic Response|32
397267|NCT00083759|1253204|P2|Overall Study|Death|1
397268|NCT00083759|1253205|P1|Overall Study|Death|1
397269|NCT00083759|1253204|P2|Overall Study|Lost to Follow-up|0
397270|NCT00083759|1253205|P1|Overall Study|Lost to Follow-up|1
397271|NCT00083759|1253204|P2|Overall Study|Adverse Event|3
397272|NCT00083759|1253205|P1|Overall Study|Adverse Event|5
397273|NCT00083616|1253223|P1|Overall Study|Other|6
397274|NCT00083616|1253223|P1|Overall Study|Non-compliance|1
397275|NCT00083616|1253223|P1|Overall Study|Ineligibility determined|2
397276|NCT00083616|1253223|P1|Overall Study|Withdrawal by Subject|3
397277|NCT00083616|1253223|P1|Overall Study|Physician Decision|2
397278|NCT00083616|1253223|P1|Overall Study|Lost to Follow-up|1
397279|NCT00083616|1253223|P1|Overall Study|Disease Progression|16
397280|NCT00083226|1253248|P1|Overall Study|ineligible or not receiving treatment|4
397281|NCT00083226|1253248|P1|Overall Study|Other|2
397282|NCT00083226|1253248|P1|Overall Study|Withdrawal by Subject|4
397283|NCT00083226|1253248|P1|Overall Study|Death|4
397284|NCT00083226|1253248|P1|Overall Study|Adverse Event|9
397285|NCT00083226|1253248|P1|Overall Study|Lack of Efficacy|19
397286|NCT00082888|1253287|P1|Overall Study|Still receiving treatment|4
397287|NCT00082888|1253287|P1|Overall Study|Other Medical Problems|2
397288|NCT00082888|1253287|P1|Overall Study|Alternate Treatment|1
397289|NCT00082888|1253287|P1|Overall Study|Withdrawal by Subject|9
397290|NCT00082888|1253287|P1|Overall Study|Adverse Event|4
397291|NCT00082888|1253287|P1|Overall Study|Death|2
397292|NCT00082810|1253291|P1|Overall Study|Withdrawal by Subject|4
397293|NCT00082810|1253291|P1|Overall Study|Progressive disease|24
397294|NCT00082810|1253291|P1|Overall Study|Adverse Event|3
397295|NCT00082758|1253301|P3|Overall Study|Protocol Violation|0
397296|NCT00082758|1253302|P2|Overall Study|Protocol Violation|1
397297|NCT00082758|1253303|P1|Overall Study|Protocol Violation|0
397298|NCT00082758|1253301|P3|Overall Study|Withdrawal by Subject|0
397299|NCT00082758|1253302|P2|Overall Study|Withdrawal by Subject|0
397300|NCT00082758|1253303|P1|Overall Study|Withdrawal by Subject|3
397301|NCT00082758|1253301|P3|Overall Study|Physician Decision|0
397302|NCT00082758|1253302|P2|Overall Study|Physician Decision|1
397303|NCT00082758|1253303|P1|Overall Study|Physician Decision|0
397304|NCT00082758|1253301|P3|Overall Study|Lack of Efficacy|0
397305|NCT00082758|1253302|P2|Overall Study|Lack of Efficacy|13
397306|NCT00082758|1253303|P1|Overall Study|Lack of Efficacy|12
397307|NCT00082758|1253301|P3|Overall Study|Adverse Event|0
397308|NCT00082758|1253302|P2|Overall Study|Adverse Event|2
397309|NCT00082758|1253303|P1|Overall Study|Adverse Event|0
397310|NCT00082433|1253313|P2|Overall Study|Impending surgery|1
397311|NCT00082433|1253314|P1|Overall Study|Impending surgery|0
397312|NCT00082433|1253313|P2|Overall Study|New primary cancer|0
397313|NCT00082433|1253314|P1|Overall Study|New primary cancer|1
397314|NCT00082433|1253313|P2|Overall Study|Noncompliance|1
397315|NCT00082433|1253314|P1|Overall Study|Noncompliance|2
397316|NCT00082433|1253313|P2|Overall Study|Ineligible|1
397317|NCT00082433|1253314|P1|Overall Study|Ineligible|2
397318|NCT00082433|1253313|P2|Overall Study|Not Treated|11
397319|NCT00082433|1253314|P1|Overall Study|Not Treated|12
397320|NCT00082433|1253313|P2|Overall Study|Still On Treatment|1
397321|NCT00082433|1253314|P1|Overall Study|Still On Treatment|2
397322|NCT00082433|1253313|P2|Overall Study|Withdrawal by Subject|30
397323|NCT00082433|1253314|P1|Overall Study|Withdrawal by Subject|55
397324|NCT00082433|1253313|P2|Overall Study|Study Drug Toxicity|66
397325|NCT00082433|1253314|P1|Overall Study|Study Drug Toxicity|179
397326|NCT00082433|1253313|P2|Overall Study|Lost to Follow-up|2
397327|NCT00082433|1253314|P1|Overall Study|Lost to Follow-up|1
397328|NCT00082433|1253313|P2|Overall Study|Physician Decision|61
397329|NCT00082433|1253314|P1|Overall Study|Physician Decision|50
397330|NCT00082433|1253313|P2|Overall Study|Disease Progression/Relapse|388
397331|NCT00082433|1253314|P1|Overall Study|Disease Progression/Relapse|270
397332|NCT00082433|1253313|P2|Overall Study|Death|18
397333|NCT00082433|1253314|P1|Overall Study|Death|8
397334|NCT00082433|1253313|P2|Overall Study|Adverse Event|17
397335|NCT00082433|1253314|P1|Overall Study|Adverse Event|12
397336|NCT00082407|1253334|P2|Overall Study|Lost to Follow-up|3
397337|NCT00082407|1253335|P1|Overall Study|Lost to Follow-up|0
397338|NCT00082407|1253334|P2|Overall Study|Death|1
397339|NCT00082407|1253335|P1|Overall Study|Death|2
397340|NCT00082407|1253334|P2|Overall Study|Loss of Glucose Control|2
397341|NCT00082407|1253335|P1|Overall Study|Loss of Glucose Control|2
397342|NCT00082407|1253334|P2|Overall Study|Physician Decision|3
397343|NCT00082407|1253335|P1|Overall Study|Physician Decision|5
397344|NCT00082407|1253334|P2|Overall Study|Patient Decision|6
397345|NCT00082407|1253335|P1|Overall Study|Patient Decision|13
397346|NCT00082407|1253334|P2|Overall Study|Protocol Violation|12
397347|NCT00082407|1253335|P1|Overall Study|Protocol Violation|14
397348|NCT00082407|1253334|P2|Overall Study|Adverse Event|0
397349|NCT00082407|1253335|P1|Overall Study|Adverse Event|20
397350|NCT00082381|1253355|P2|Overall Study|Loss of Glucose Control|0
397351|NCT00082381|1253356|P1|Overall Study|Loss of Glucose Control|4
397352|NCT00082381|1253355|P2|Overall Study|Protocol Violation|11
397353|NCT00082381|1253356|P1|Overall Study|Protocol Violation|10
397354|NCT00082381|1253355|P2|Overall Study|Physician Decision|2
397355|NCT00082381|1253356|P1|Overall Study|Physician Decision|1
397356|NCT00082381|1253355|P2|Overall Study|Patient Decision|4
397357|NCT00082381|1253356|P1|Overall Study|Patient Decision|8
397358|NCT00082381|1253355|P2|Overall Study|Lost to Follow-up|7
397359|NCT00082381|1253356|P1|Overall Study|Lost to Follow-up|5
397360|NCT00082381|1253355|P2|Overall Study|Adverse Event|2
397361|NCT00082381|1253356|P1|Overall Study|Adverse Event|27
397362|NCT00082368|1253374|P1|Overall Study|Not treated-pt had poor IV access|1
397363|NCT00082355|1253379|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
397364|NCT00082355|1253379|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
397365|NCT00082355|1253379|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
397366|NCT00082173|1253413|P2|Overall Study|Culture negative or resistant at baselin|6
397367|NCT00082173|1253414|P1|Overall Study|Culture negative or resistant at baselin|5
397368|NCT00082173|1253413|P2|Overall Study|Adverse Event|0
397369|NCT00082173|1253414|P1|Overall Study|Adverse Event|1
397370|NCT00082173|1253413|P2|Overall Study|Lost to Follow-up|0
397371|NCT00082173|1253414|P1|Overall Study|Lost to Follow-up|1
397372|NCT00082173|1253413|P2|Overall Study|Withdrawal by Subject|5
397373|NCT00082173|1253414|P1|Overall Study|Withdrawal by Subject|3
397374|NCT00081770|1253450|P3|Overall Study|Not Specified|8
397375|NCT00081770|1253451|P2|Overall Study|Not Specified|7
397376|NCT00081770|1253452|P1|Overall Study|Not Specified|2
397377|NCT00081770|1253450|P3|Overall Study|Administrative|1
397378|NCT00081770|1253451|P2|Overall Study|Administrative|0
397379|NCT00081770|1253452|P1|Overall Study|Administrative|1
397380|NCT00081770|1253450|P3|Overall Study|Did not meet protocol eligibility|3
397381|NCT00081770|1253451|P2|Overall Study|Did not meet protocol eligibility|0
397382|NCT00081770|1253452|P1|Overall Study|Did not meet protocol eligibility|2
397383|NCT00081770|1253450|P3|Overall Study|Withdrawal by Subject|42
397384|NCT00081770|1253451|P2|Overall Study|Withdrawal by Subject|40
397385|NCT00081770|1253452|P1|Overall Study|Withdrawal by Subject|45
397386|NCT00081770|1253450|P3|Overall Study|Protocol Violation|10
397387|NCT00081770|1253451|P2|Overall Study|Protocol Violation|10
397388|NCT00081770|1253452|P1|Overall Study|Protocol Violation|15
397389|NCT00081770|1253450|P3|Overall Study|Lost to Follow-up|45
397390|NCT00081770|1253451|P2|Overall Study|Lost to Follow-up|34
397391|NCT00081770|1253452|P1|Overall Study|Lost to Follow-up|45
397392|NCT00081770|1253450|P3|Overall Study|Lack of Efficacy|211
397393|NCT00081770|1253451|P2|Overall Study|Lack of Efficacy|357
397394|NCT00081770|1253452|P1|Overall Study|Lack of Efficacy|262
397395|NCT00081770|1253450|P3|Overall Study|Adverse Event|136
397396|NCT00081770|1253451|P2|Overall Study|Adverse Event|98
397397|NCT00081770|1253452|P1|Overall Study|Adverse Event|130
397398|NCT00081731|1253471|P2|Overall Study|scientific integrity issue|8
397399|NCT00081731|1253472|P1|Overall Study|scientific integrity issue|8
397400|NCT00081653|1253492|P2|Overall Study|Loss of bone mass|2
397401|NCT00081653|1253493|P1|Overall Study|Loss of bone mass|0
397402|NCT00081653|1253492|P2|Overall Study|Participant leaving country|0
397403|NCT00081653|1253493|P1|Overall Study|Participant leaving country|1
397404|NCT00081653|1253492|P2|Overall Study|Bone loss|0
397405|NCT00081653|1253493|P1|Overall Study|Bone loss|2
397406|NCT00081653|1253492|P2|Overall Study|Low bone mineral density|0
397407|NCT00081653|1253493|P1|Overall Study|Low bone mineral density|1
397408|NCT00081653|1253492|P2|Overall Study|Refused Treatment|14
397409|NCT00081653|1253493|P1|Overall Study|Refused Treatment|18
397410|NCT00081653|1253492|P2|Overall Study|Lost to Follow-up|4
397411|NCT00081653|1253493|P1|Overall Study|Lost to Follow-up|2
397412|NCT00081653|1253492|P2|Overall Study|Adverse Event|17
397413|NCT00081653|1253493|P1|Overall Study|Adverse Event|23
397414|NCT00081497|1253511|P2|Overall Study|Non-compliance|1
397415|NCT00081497|1253512|P1|Overall Study|Non-compliance|0
397416|NCT00081497|1253511|P2|Overall Study|Withdrawal by Subject|0
397417|NCT00081497|1253512|P1|Overall Study|Withdrawal by Subject|1
397418|NCT00081497|1253511|P2|Overall Study|Death|1
397419|NCT00081497|1253512|P1|Overall Study|Death|0
397420|NCT00081497|1253511|P2|Overall Study|Adverse Event|0
397421|NCT00081497|1253512|P1|Overall Study|Adverse Event|2
397422|NCT00081458|1253530|P3|Overall Study|Randomized but not dosed|1
397423|NCT00081458|1253531|P2|Overall Study|Randomized but not dosed|0
397424|NCT00081458|1253532|P1|Overall Study|Randomized but not dosed|0
397425|NCT00081458|1253530|P3|Overall Study|Withdrawal by Subject|1
397426|NCT00081458|1253531|P2|Overall Study|Withdrawal by Subject|3
397427|NCT00081458|1253532|P1|Overall Study|Withdrawal by Subject|0
397428|NCT00081458|1253530|P3|Overall Study|Adverse Event|2
397429|NCT00081458|1253531|P2|Overall Study|Adverse Event|5
397430|NCT00081458|1253532|P1|Overall Study|Adverse Event|1
397431|NCT00081289|1253588|P2|Overall Study|Ineligible / no protocol treatment|4
397432|NCT00081289|1253589|P1|Overall Study|Ineligible / no protocol treatment|3
397433|NCT00081289|1253588|P2|Overall Study|Accrued prior to chemotherapy amendment|17
397434|NCT00081289|1253589|P1|Overall Study|Accrued prior to chemotherapy amendment|18
397435|NCT00081159|1253597|P2|Overall Study|Lost to Follow-up|1
397436|NCT00081159|1253598|P1|Overall Study|Lost to Follow-up|2
397437|NCT00081159|1253597|P2|Overall Study|Myelosuppression prior to treatment|1
397438|NCT00081159|1253598|P1|Overall Study|Myelosuppression prior to treatment|0
397439|NCT00081159|1253597|P2|Overall Study|Withdrawal by Subject|3
397440|NCT00081159|1253598|P1|Overall Study|Withdrawal by Subject|0
397441|NCT00080938|1253608|P1|Overall Study|Ineligible|4
397442|NCT00080938|1253608|P1|Overall Study|Not started protocol therapy|1
397443|NCT00080938|1253608|P1|Overall Study|other disease|1
397444|NCT00080938|1253608|P1|Overall Study|Lack of Efficacy|7
397445|NCT00080938|1253608|P1|Overall Study|Death|2
397446|NCT00080938|1253608|P1|Overall Study|Withdrawal by Subject|6
397447|NCT00080938|1253608|P1|Overall Study|Adverse Event|3
397448|NCT00080899|1253624|P1|Overall Study|Adverse Event|1
397449|NCT00080483|1253636|P2|Overall Study|Physician Decision|1
397450|NCT00080483|1253637|P1|Overall Study|Physician Decision|1
397451|NCT00080483|1253636|P2|Overall Study|Lost to Follow-up|1
397452|NCT00080483|1253637|P1|Overall Study|Lost to Follow-up|1
397453|NCT00080301|1253656|P2|Overall Study|Still on Treatment as of CSR date|1
397454|NCT00080301|1253657|P1|Overall Study|Still on Treatment as of CSR date|0
397455|NCT00080301|1253656|P2|Overall Study|Randomized but Never Treated|10
397456|NCT00080301|1253657|P1|Overall Study|Randomized but Never Treated|5
397457|NCT00080288|1253677|P2|Overall Study|Miscellaneous|11
397458|NCT00080288|1253678|P1|Overall Study|Miscellaneous|11
397459|NCT00080288|1253677|P2|Overall Study|Withdrawal by Subject|16
397460|NCT00080288|1253678|P1|Overall Study|Withdrawal by Subject|3
397461|NCT00080288|1253677|P2|Overall Study|Physician Decision|2
397462|NCT00080288|1253678|P1|Overall Study|Physician Decision|6
397463|NCT00080288|1253677|P2|Overall Study|Lost to Follow-up|5
397464|NCT00080288|1253678|P1|Overall Study|Lost to Follow-up|3
397465|NCT00080288|1253677|P2|Overall Study|Adverse Event|4
397466|NCT00080288|1253678|P1|Overall Study|Adverse Event|7
397467|NCT00080223|1253686|P1|Overall Study|Physician Decision|1
397468|NCT00080223|1253686|P1|Overall Study|Participant unwilling to continue|2
397469|NCT00080223|1253686|P1|Overall Study|Non-compliance With Study Treatment|7
397470|NCT00080223|1253686|P1|Overall Study|Lung Transplantation|9
397471|NCT00080223|1253686|P1|Overall Study|Withdrawal by Subject|13
397472|NCT00080223|1253686|P1|Overall Study|Death|21
397473|NCT00080223|1253686|P1|Overall Study|Adverse Event|23
397474|NCT00080119|1253698|P4|Overall Study|Lost to Follow-up|14
397475|NCT00080119|1253699|P3|Overall Study|Lost to Follow-up|19
397476|NCT00080119|1253700|P2|Overall Study|Lost to Follow-up|19
397477|NCT00080119|1253701|P1|Overall Study|Lost to Follow-up|16
397478|NCT00080119|1253698|P4|Overall Study|Unwilling to adhere to study requirement|1
397479|NCT00080119|1253699|P3|Overall Study|Unwilling to adhere to study requirement|5
397480|NCT00080119|1253700|P2|Overall Study|Unwilling to adhere to study requirement|2
397481|NCT00080119|1253701|P1|Overall Study|Unwilling to adhere to study requirement|3
397482|NCT00080119|1253698|P4|Overall Study|Consent withdrawn|6
397483|NCT00080119|1253699|P3|Overall Study|Consent withdrawn|4
397484|NCT00080119|1253700|P2|Overall Study|Consent withdrawn|17
397485|NCT00080119|1253701|P1|Overall Study|Consent withdrawn|13
397486|NCT00080119|1253698|P4|Overall Study|Unable to get to clinic|1
397487|NCT00080119|1253699|P3|Overall Study|Unable to get to clinic|7
397488|NCT00080119|1253700|P2|Overall Study|Unable to get to clinic|24
397489|NCT00080119|1253701|P1|Overall Study|Unable to get to clinic|24
397490|NCT00080119|1253698|P4|Overall Study|Discontinued because of study closure|141
397491|NCT00080119|1253699|P3|Overall Study|Discontinued because of study closure|130
397492|NCT00080119|1253700|P2|Overall Study|Discontinued because of study closure|0
397493|NCT00080119|1253701|P1|Overall Study|Discontinued because of study closure|0
397494|NCT00079937|1253735|P2|Overall Study|Administrative problems|11
397495|NCT00079937|1253736|P1|Overall Study|Administrative problems|22
397496|NCT00079937|1253735|P2|Overall Study|Lost to Follow-up|5
397497|NCT00079937|1253736|P1|Overall Study|Lost to Follow-up|12
397498|NCT00079937|1253735|P2|Overall Study|Withdrawal by Subject|7
397499|NCT00079937|1253736|P1|Overall Study|Withdrawal by Subject|21
397500|NCT00079937|1253735|P2|Overall Study|Protocol Violation|6
397501|NCT00079937|1253736|P1|Overall Study|Protocol Violation|8
397502|NCT00079937|1253735|P2|Overall Study|Subject no longer requires study drug|0
397503|NCT00079937|1253736|P1|Overall Study|Subject no longer requires study drug|3
397504|NCT00079937|1253735|P2|Overall Study|Unsatisfactory therapeutic effect|2
397505|NCT00079937|1253736|P1|Overall Study|Unsatisfactory therapeutic effect|1
397506|NCT00079937|1253735|P2|Overall Study|Adverse Event|1
397507|NCT00079937|1253736|P1|Overall Study|Adverse Event|2
397508|NCT00079781|1253755|P3|Follow-up Period|Death|1
397509|NCT00079781|1253756|P2|Follow-up Period|Death|0
397510|NCT00079781|1253757|P1|Follow-up Period|Death|0
397511|NCT00079781|1253755|P3|Follow-up Period|Lost to Follow-up|0
397512|NCT00079781|1253756|P2|Follow-up Period|Lost to Follow-up|0
397513|NCT00079781|1253757|P1|Follow-up Period|Lost to Follow-up|1
397514|NCT00079781|1253755|P3|Follow-up Period|Withdrawal by Subject|1
397515|NCT00079781|1253756|P2|Follow-up Period|Withdrawal by Subject|0
397516|NCT00079781|1253757|P1|Follow-up Period|Withdrawal by Subject|3
397517|NCT00079781|1253755|P3|Pre-implant Period|Did not meet I/E criteria|1
397518|NCT00079781|1253756|P2|Pre-implant Period|Did not meet I/E criteria|1
397519|NCT00079781|1253757|P1|Pre-implant Period|Did not meet I/E criteria|1
397520|NCT00079781|1253755|P3|Pre-implant Period|Withdrawal by Subject|0
397521|NCT00079781|1253756|P2|Pre-implant Period|Withdrawal by Subject|0
397522|NCT00079781|1253757|P1|Pre-implant Period|Withdrawal by Subject|2
397523|NCT00079677|1253766|P2|Overall Study|Miscellaneous|0
397524|NCT00079677|1253767|P1|Overall Study|Miscellaneous|2
397525|NCT00079677|1253766|P2|Overall Study|Withdrawal by Subject|3
397526|NCT00079677|1253767|P1|Overall Study|Withdrawal by Subject|5
397527|NCT00079677|1253766|P2|Overall Study|Protocol Violation|3
397528|NCT00079677|1253767|P1|Overall Study|Protocol Violation|2
397529|NCT00079677|1253766|P2|Overall Study|Physician Decision|0
397530|NCT00079677|1253767|P1|Overall Study|Physician Decision|3
397531|NCT00079677|1253766|P2|Overall Study|Lost to Follow-up|2
397532|NCT00079677|1253767|P1|Overall Study|Lost to Follow-up|2
397533|NCT00079677|1253766|P2|Overall Study|Lack of Efficacy|0
397534|NCT00079677|1253767|P1|Overall Study|Lack of Efficacy|1
397535|NCT00079677|1253766|P2|Overall Study|Adverse Event|6
397536|NCT00079677|1253767|P1|Overall Study|Adverse Event|5
397537|NCT00079417|1253775|P1|Overall Study|ineligible|1
397538|NCT00079417|1253775|P1|Overall Study|Tumor requires non-protocol radiotherapy|2
397539|NCT00079417|1253775|P1|Overall Study|Tumor requires non-protocol chemotherapy|1
397540|NCT00079417|1253775|P1|Overall Study|Physician Decision|5
397541|NCT00079391|1253779|P1|Overall Study|Withdrawal by Subject|1
397542|NCT00079339|1253791|P3|Overall Study|Disease progression|2
397543|NCT00079339|1253792|P2|Overall Study|Disease progression|28
397544|NCT00079339|1253793|P1|Overall Study|Disease progression|3
397545|NCT00079339|1253791|P3|Overall Study|Withdrawal by Subject|1
397546|NCT00079339|1253792|P2|Overall Study|Withdrawal by Subject|4
397547|NCT00079339|1253793|P1|Overall Study|Withdrawal by Subject|0
397548|NCT00079339|1253791|P3|Overall Study|Non-compliance|1
397549|NCT00079339|1253792|P2|Overall Study|Non-compliance|0
397550|NCT00079339|1253793|P1|Overall Study|Non-compliance|0
397551|NCT00079339|1253791|P3|Overall Study|Death|0
397552|NCT00079339|1253792|P2|Overall Study|Death|0
397553|NCT00079339|1253793|P1|Overall Study|Death|1
397554|NCT00079339|1253791|P3|Overall Study|Adverse Event|2
397555|NCT00079339|1253792|P2|Overall Study|Adverse Event|7
397556|NCT00079339|1253793|P1|Overall Study|Adverse Event|1
397557|NCT00079274|1253824|P7|Overall Study|Not Specified|0
397558|NCT00079274|1253825|P6|Overall Study|Not Specified|2
397559|NCT00079274|1253826|P5|Overall Study|Not Specified|1
397560|NCT00079274|1253827|P4|Overall Study|Not Specified|55
397561|NCT00079274|1253828|P3|Overall Study|Not Specified|5
397562|NCT00079274|1253829|P2|Overall Study|Not Specified|7
397563|NCT00079274|1253830|P1|Overall Study|Not Specified|43
397564|NCT00079274|1253824|P7|Overall Study|Cytogenetic resistance|0
397565|NCT00079274|1253825|P6|Overall Study|Cytogenetic resistance|0
397566|NCT00079274|1253826|P5|Overall Study|Cytogenetic resistance|0
397567|NCT00079274|1253827|P4|Overall Study|Cytogenetic resistance|2
397568|NCT00079274|1253828|P3|Overall Study|Cytogenetic resistance|0
397569|NCT00079274|1253829|P2|Overall Study|Cytogenetic resistance|0
397570|NCT00079274|1253830|P1|Overall Study|Cytogenetic resistance|0
397571|NCT00079274|1253824|P7|Overall Study|Death|0
397572|NCT00079274|1253825|P6|Overall Study|Death|0
397573|NCT00079274|1253826|P5|Overall Study|Death|0
397574|NCT00079274|1253827|P4|Overall Study|Death|15
397575|NCT00079274|1253828|P3|Overall Study|Death|1
397576|NCT00079274|1253829|P2|Overall Study|Death|0
397577|NCT00079274|1253830|P1|Overall Study|Death|4
397578|NCT00079274|1253824|P7|Overall Study|Other Medical Problems|0
397579|NCT00079274|1253825|P6|Overall Study|Other Medical Problems|0
397580|NCT00079274|1253826|P5|Overall Study|Other Medical Problems|0
397581|NCT00079274|1253827|P4|Overall Study|Other Medical Problems|7
397582|NCT00079274|1253828|P3|Overall Study|Other Medical Problems|0
397583|NCT00079274|1253829|P2|Overall Study|Other Medical Problems|1
397584|NCT00079274|1253830|P1|Overall Study|Other Medical Problems|6
397585|NCT00079274|1253824|P7|Overall Study|Alternate Treatment|0
397586|NCT00079274|1253825|P6|Overall Study|Alternate Treatment|0
397587|NCT00079274|1253826|P5|Overall Study|Alternate Treatment|0
397588|NCT00079274|1253827|P4|Overall Study|Alternate Treatment|3
397589|NCT00079274|1253828|P3|Overall Study|Alternate Treatment|0
397590|NCT00079274|1253829|P2|Overall Study|Alternate Treatment|1
397591|NCT00079274|1253830|P1|Overall Study|Alternate Treatment|6
397592|NCT00079274|1253824|P7|Overall Study|Recurrence|0
397593|NCT00079274|1253825|P6|Overall Study|Recurrence|2
397594|NCT00079274|1253826|P5|Overall Study|Recurrence|0
397595|NCT00079274|1253827|P4|Overall Study|Recurrence|15
397596|NCT00079274|1253828|P3|Overall Study|Recurrence|1
397597|NCT00079274|1253829|P2|Overall Study|Recurrence|0
397598|NCT00079274|1253830|P1|Overall Study|Recurrence|21
397599|NCT00079274|1253824|P7|Overall Study|Adverse Event|0
397600|NCT00079274|1253825|P6|Overall Study|Adverse Event|8
397601|NCT00079274|1253826|P5|Overall Study|Adverse Event|7
397602|NCT00079274|1253827|P4|Overall Study|Adverse Event|184
397603|NCT00079274|1253828|P3|Overall Study|Adverse Event|8
397604|NCT00079274|1253829|P2|Overall Study|Adverse Event|8
397605|NCT00079274|1253830|P1|Overall Study|Adverse Event|130
397606|NCT00079274|1253824|P7|Overall Study|Withdrawal by Subject|0
397607|NCT00079274|1253825|P6|Overall Study|Withdrawal by Subject|8
397608|NCT00079274|1253826|P5|Overall Study|Withdrawal by Subject|7
397609|NCT00079274|1253827|P4|Overall Study|Withdrawal by Subject|163
397610|NCT00079274|1253828|P3|Overall Study|Withdrawal by Subject|12
397611|NCT00079274|1253829|P2|Overall Study|Withdrawal by Subject|10
397612|NCT00079274|1253830|P1|Overall Study|Withdrawal by Subject|111
397613|NCT00079183|1253843|P1|Overall Study|Specimen collection non-compliance|1
397614|NCT00079183|1253843|P1|Overall Study|Study medication non-compliance|2
397615|NCT00079183|1253843|P1|Overall Study|Withdrawal by Subject|4
397616|NCT00079040|1253858|P1|Overall Study|Ineligible|1
397617|NCT00079040|1253858|P1|Overall Study|Withdrew before treatment|1
397618|NCT00078949|1253881|P4|Maintenance|No treated|3
397619|NCT00078949|1253882|P3|Maintenance|No treated|3
397620|NCT00078949|1253883|P2|Maintenance|No treated|0
397621|NCT00078949|1253884|P1|Maintenance|No treated|0
397622|NCT00078949|1253881|P4|Salvage|No treated|0
397623|NCT00078949|1253882|P3|Salvage|No treated|0
397624|NCT00078949|1253883|P2|Salvage|No treated|5
397625|NCT00078949|1253884|P1|Salvage|No treated|4
397626|NCT00078767|1253898|P2|Overall Study|Withdrawal by Subject|1
397627|NCT00078767|1253899|P1|Overall Study|Withdrawal by Subject|1
397628|NCT00078377|1254033|P3|Overall Study|Miscellaneous|1
397629|NCT00078377|1254034|P2|Overall Study|Miscellaneous|6
397630|NCT00078377|1254035|P1|Overall Study|Miscellaneous|2
397631|NCT00078377|1254033|P3|Overall Study|Withdrawal by Subject|4
397632|NCT00078377|1254034|P2|Overall Study|Withdrawal by Subject|4
397633|NCT00078377|1254035|P1|Overall Study|Withdrawal by Subject|3
397634|NCT00078377|1254033|P3|Overall Study|Physician Decision|0
397635|NCT00078377|1254034|P2|Overall Study|Physician Decision|0
397636|NCT00078377|1254035|P1|Overall Study|Physician Decision|2
397637|NCT00078377|1254033|P3|Overall Study|Lost to Follow-up|1
397638|NCT00078377|1254034|P2|Overall Study|Lost to Follow-up|1
397639|NCT00078377|1254035|P1|Overall Study|Lost to Follow-up|0
397640|NCT00078377|1254033|P3|Overall Study|Lack of Efficacy|2
397641|NCT00078377|1254034|P2|Overall Study|Lack of Efficacy|0
397642|NCT00078377|1254035|P1|Overall Study|Lack of Efficacy|2
397643|NCT00078377|1254033|P3|Overall Study|Adverse Event|1
397644|NCT00078377|1254034|P2|Overall Study|Adverse Event|5
397645|NCT00078377|1254035|P1|Overall Study|Adverse Event|2
397646|NCT00078325|1254051|P3|Overall Study|Miscellaneous|1
397647|NCT00078325|1254052|P2|Overall Study|Miscellaneous|1
397648|NCT00078325|1254053|P1|Overall Study|Miscellaneous|1
397649|NCT00078325|1254051|P3|Overall Study|Physician Decision|1
397650|NCT00078325|1254052|P2|Overall Study|Physician Decision|0
397651|NCT00078325|1254053|P1|Overall Study|Physician Decision|2
397652|NCT00078325|1254051|P3|Overall Study|Lost to Follow-up|1
397653|NCT00078325|1254052|P2|Overall Study|Lost to Follow-up|1
397654|NCT00078325|1254053|P1|Overall Study|Lost to Follow-up|0
397655|NCT00078325|1254051|P3|Overall Study|Withdrawal by Subject|3
397656|NCT00078325|1254052|P2|Overall Study|Withdrawal by Subject|5
397657|NCT00078325|1254053|P1|Overall Study|Withdrawal by Subject|1
397658|NCT00078325|1254051|P3|Overall Study|Protocol Violation|0
397659|NCT00078325|1254052|P2|Overall Study|Protocol Violation|2
397660|NCT00078325|1254053|P1|Overall Study|Protocol Violation|2
397661|NCT00078325|1254051|P3|Overall Study|Adverse Event|5
397662|NCT00078325|1254052|P2|Overall Study|Adverse Event|10
397663|NCT00078325|1254053|P1|Overall Study|Adverse Event|15
397664|NCT00078312|1254064|P1|Overall Study|Miscellaneous|33
397665|NCT00078312|1254064|P1|Overall Study|Withdrawal by Subject|33
397666|NCT00078312|1254064|P1|Overall Study|Protocol Violation|3
397667|NCT00078312|1254064|P1|Overall Study|Physician Decision|9
397668|NCT00078312|1254064|P1|Overall Study|Lost to Follow-up|41
397669|NCT00078312|1254064|P1|Overall Study|Lack of Efficacy|15
397670|NCT00078312|1254064|P1|Overall Study|Adverse Event|43
397671|NCT00077974|1254079|P1|Overall Study|Decision of Sponsor|2
397672|NCT00077974|1254079|P1|Overall Study|Lack of Efficacy|76
397673|NCT00077974|1254079|P1|Overall Study|Withdrawal by Subject|3
397674|NCT00077974|1254079|P1|Overall Study|Protocol Violation|1
397675|NCT00077974|1254079|P1|Overall Study|Adverse Event|22
397676|NCT00077857|1254101|P2|Overall Study|Other|13
397677|NCT00077857|1254102|P1|Overall Study|Other|15
397678|NCT00077857|1254101|P2|Overall Study|Failure to return|5
397679|NCT00077857|1254102|P1|Overall Study|Failure to return|5
397680|NCT00077857|1254101|P2|Overall Study|Refused treatment|21
397681|NCT00077857|1254102|P1|Overall Study|Refused treatment|29
397682|NCT00077857|1254101|P2|Overall Study|Other protocol violation|1
397683|NCT00077857|1254102|P1|Overall Study|Other protocol violation|0
397684|NCT00077857|1254101|P2|Overall Study|Violation of selection criteria at entry|1
397685|NCT00077857|1254102|P1|Overall Study|Violation of selection criteria at entry|3
397686|NCT00077857|1254101|P2|Overall Study|Insufficient therapeutic response|128
397687|NCT00077857|1254102|P1|Overall Study|Insufficient therapeutic response|112
397688|NCT00077857|1254101|P2|Overall Study|Death|3
397689|NCT00077857|1254102|P1|Overall Study|Death|7
397690|NCT00077857|1254101|P2|Overall Study|Adverse Event|32
397691|NCT00077857|1254102|P1|Overall Study|Adverse Event|30
397692|NCT00077766|1254122|P2|Overall Study|Participants Vacation|1
397693|NCT00077766|1254123|P1|Overall Study|Participants Vacation|2
397694|NCT00077766|1254122|P2|Overall Study|Stop Dialysis|1
397695|NCT00077766|1254123|P1|Overall Study|Stop Dialysis|0
397696|NCT00077766|1254122|P2|Overall Study|Started Nocturnal Dialysis|1
397697|NCT00077766|1254123|P1|Overall Study|Started Nocturnal Dialysis|0
397698|NCT00077766|1254122|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
397699|NCT00077766|1254123|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
397700|NCT00077766|1254122|P2|Overall Study|Dialysis|1
397701|NCT00077766|1254123|P1|Overall Study|Dialysis|0
397702|NCT00077766|1254122|P2|Overall Study|Dialysis Discontinued|0
397703|NCT00077766|1254123|P1|Overall Study|Dialysis Discontinued|1
397704|NCT00077766|1254122|P2|Overall Study|Participant's decision|0
397705|NCT00077766|1254123|P1|Overall Study|Participant's decision|1
397706|NCT00077766|1254122|P2|Overall Study|Investigators Discretion|0
397707|NCT00077766|1254123|P1|Overall Study|Investigators Discretion|1
397708|NCT00077766|1254122|P2|Overall Study|Transplantation|1
397709|NCT00077766|1254123|P1|Overall Study|Transplantation|5
397710|NCT00077766|1254122|P2|Overall Study|Kidney Transplantation|5
397711|NCT00077766|1254123|P1|Overall Study|Kidney Transplantation|9
397712|NCT00077766|1254122|P2|Overall Study|Protocol Violation|0
397713|NCT00077766|1254123|P1|Overall Study|Protocol Violation|1
397714|NCT00077766|1254122|P2|Overall Study|Lost to Follow-up|0
397715|NCT00077766|1254123|P1|Overall Study|Lost to Follow-up|2
397716|NCT00077766|1254122|P2|Overall Study|Death|10
397717|NCT00077766|1254123|P1|Overall Study|Death|12
397718|NCT00077766|1254122|P2|Overall Study|Withdrawal by Subject|3
397719|NCT00077766|1254123|P1|Overall Study|Withdrawal by Subject|4
397720|NCT00077766|1254122|P2|Overall Study|Adverse Event|1
397721|NCT00077766|1254123|P1|Overall Study|Adverse Event|1
397722|NCT00077675|1254143|P2|Overall Study|Never received study treatment|3
397723|NCT00077675|1254144|P1|Overall Study|Never received study treatment|3
397724|NCT00077675|1254143|P2|Overall Study|Other|1
397725|NCT00077675|1254144|P1|Overall Study|Other|0
397726|NCT00077675|1254143|P2|Overall Study|Withdrawal by Subject|0
397727|NCT00077675|1254144|P1|Overall Study|Withdrawal by Subject|1
397728|NCT00077675|1254143|P2|Overall Study|Lost to Follow-up|3
397729|NCT00077675|1254144|P1|Overall Study|Lost to Follow-up|6
397730|NCT00077675|1254143|P2|Overall Study|Adverse Event|2
397731|NCT00077675|1254144|P1|Overall Study|Adverse Event|1
397732|NCT00077649|1254154|P4|Overall Study|Randomized but never dosed|0
397733|NCT00077649|1254155|P3|Overall Study|Randomized but never dosed|0
397734|NCT00077649|1254156|P2|Overall Study|Randomized but never dosed|0
397735|NCT00077649|1254157|P1|Overall Study|Randomized but never dosed|1
397736|NCT00077649|1254154|P4|Overall Study|Abnormality of Laboratory Test|2
397737|NCT00077649|1254155|P3|Overall Study|Abnormality of Laboratory Test|1
397738|NCT00077649|1254156|P2|Overall Study|Abnormality of Laboratory Test|2
397739|NCT00077649|1254157|P1|Overall Study|Abnormality of Laboratory Test|1
397740|NCT00077649|1254154|P4|Overall Study|Lost to Follow-up|2
397741|NCT00077649|1254155|P3|Overall Study|Lost to Follow-up|3
397742|NCT00077649|1254156|P2|Overall Study|Lost to Follow-up|2
397743|NCT00077649|1254157|P1|Overall Study|Lost to Follow-up|2
397744|NCT00077649|1254154|P4|Overall Study|Withdrawal by Subject|2
397745|NCT00077649|1254155|P3|Overall Study|Withdrawal by Subject|1
397746|NCT00077649|1254156|P2|Overall Study|Withdrawal by Subject|1
397747|NCT00077649|1254157|P1|Overall Study|Withdrawal by Subject|0
397748|NCT00077649|1254154|P4|Overall Study|Lack of Efficacy|2
397749|NCT00077649|1254155|P3|Overall Study|Lack of Efficacy|3
397750|NCT00077649|1254156|P2|Overall Study|Lack of Efficacy|3
397751|NCT00077649|1254157|P1|Overall Study|Lack of Efficacy|5
397752|NCT00077649|1254154|P4|Overall Study|Adverse Event|9
397753|NCT00077649|1254155|P3|Overall Study|Adverse Event|7
397754|NCT00077649|1254156|P2|Overall Study|Adverse Event|1
397755|NCT00077649|1254157|P1|Overall Study|Adverse Event|5
397756|NCT00077636|1254205|P2|Overall Study|Abnormality Of Laboratory Test|2
397757|NCT00077636|1254206|P1|Overall Study|Abnormality Of Laboratory Test|3
397758|NCT00077636|1254205|P2|Overall Study|Lost to Follow-up|18
397759|NCT00077636|1254206|P1|Overall Study|Lost to Follow-up|10
397760|NCT00077636|1254205|P2|Overall Study|Protocol Violation|2
397761|NCT00077636|1254206|P1|Overall Study|Protocol Violation|0
397762|NCT00077636|1254205|P2|Overall Study|Adverse Event|34
397763|NCT00077636|1254206|P1|Overall Study|Adverse Event|17
397764|NCT00077636|1254205|P2|Overall Study|Withdrawal by Subject|2
397765|NCT00077636|1254206|P1|Overall Study|Withdrawal by Subject|2
397766|NCT00077636|1254205|P2|Overall Study|Admin|3
397767|NCT00077636|1254206|P1|Overall Study|Admin|3
397768|NCT00077636|1254205|P2|Overall Study|Refused Treatment|31
397769|NCT00077636|1254206|P1|Overall Study|Refused Treatment|9
397770|NCT00077623|1254227|P3|Overall Study|Failure to return|0
397771|NCT00077623|1254228|P2|Overall Study|Failure to return|0
397772|NCT00077623|1254229|P1|Overall Study|Failure to return|1
397773|NCT00077623|1254227|P3|Overall Study|Death|11
397774|NCT00077623|1254228|P2|Overall Study|Death|18
397775|NCT00077623|1254229|P1|Overall Study|Death|12
397776|NCT00077623|1254227|P3|Overall Study|Insufficient therapeutic response|0
397777|NCT00077623|1254228|P2|Overall Study|Insufficient therapeutic response|0
397778|NCT00077623|1254229|P1|Overall Study|Insufficient therapeutic response|2
397779|NCT00077623|1254227|P3|Overall Study|Other-Non safety reason|19
397780|NCT00077623|1254228|P2|Overall Study|Other-Non safety reason|15
397781|NCT00077623|1254229|P1|Overall Study|Other-Non safety reason|18
397782|NCT00077623|1254227|P3|Overall Study|Withdrawal by Subject|1
397783|NCT00077623|1254228|P2|Overall Study|Withdrawal by Subject|10
397784|NCT00077623|1254229|P1|Overall Study|Withdrawal by Subject|2
397785|NCT00077623|1254227|P3|Overall Study|Adverse Event|1
397786|NCT00077623|1254228|P2|Overall Study|Adverse Event|0
397787|NCT00077623|1254229|P1|Overall Study|Adverse Event|1
397788|NCT00077610|1254264|P3|Overall Study|Sponsors decision to withdraw|1
397789|NCT00077610|1254265|P2|Overall Study|Sponsors decision to withdraw|0
397790|NCT00077610|1254266|P1|Overall Study|Sponsors decision to withdraw|0
397791|NCT00077610|1254264|P3|Overall Study|Financial issues|0
397792|NCT00077610|1254265|P2|Overall Study|Financial issues|1
397793|NCT00077610|1254266|P1|Overall Study|Financial issues|0
397794|NCT00077610|1254264|P3|Overall Study|Relocation|5
397795|NCT00077610|1254265|P2|Overall Study|Relocation|8
397796|NCT00077610|1254266|P1|Overall Study|Relocation|0
397797|NCT00077610|1254264|P3|Overall Study|Change in dialysis modality|0
397798|NCT00077610|1254265|P2|Overall Study|Change in dialysis modality|0
397799|NCT00077610|1254266|P1|Overall Study|Change in dialysis modality|1
397800|NCT00077610|1254264|P3|Overall Study|Transfer to other center for surgery|0
397801|NCT00077610|1254265|P2|Overall Study|Transfer to other center for surgery|0
397802|NCT00077610|1254266|P1|Overall Study|Transfer to other center for surgery|1
397803|NCT00077610|1254264|P3|Overall Study|Transfer to satellite unit|0
397804|NCT00077610|1254265|P2|Overall Study|Transfer to satellite unit|0
397805|NCT00077610|1254266|P1|Overall Study|Transfer to satellite unit|1
397806|NCT00077610|1254264|P3|Overall Study|Transferred to nursing home|1
397807|NCT00077610|1254265|P2|Overall Study|Transferred to nursing home|0
397808|NCT00077610|1254266|P1|Overall Study|Transferred to nursing home|0
397809|NCT00077610|1254264|P3|Overall Study|Transferred to other unit|1
397810|NCT00077610|1254265|P2|Overall Study|Transferred to other unit|0
397811|NCT00077610|1254266|P1|Overall Study|Transferred to other unit|0
397812|NCT00077610|1254264|P3|Overall Study|Given Epogen in hospital|0
397813|NCT00077610|1254265|P2|Overall Study|Given Epogen in hospital|0
397814|NCT00077610|1254266|P1|Overall Study|Given Epogen in hospital|1
397815|NCT00077610|1254264|P3|Overall Study|Worsening of health condition|0
397816|NCT00077610|1254265|P2|Overall Study|Worsening of health condition|1
397817|NCT00077610|1254266|P1|Overall Study|Worsening of health condition|1
397818|NCT00077610|1254264|P3|Overall Study|Principal Investigator's decision|1
397819|NCT00077610|1254265|P2|Overall Study|Principal Investigator's decision|0
397820|NCT00077610|1254266|P1|Overall Study|Principal Investigator's decision|1
397821|NCT00077610|1254264|P3|Overall Study|Multiple blood transfusions|1
397822|NCT00077610|1254265|P2|Overall Study|Multiple blood transfusions|0
397823|NCT00077610|1254266|P1|Overall Study|Multiple blood transfusions|0
397824|NCT00077610|1254264|P3|Overall Study|Insufficient Therapeutic Response|0
397825|NCT00077610|1254265|P2|Overall Study|Insufficient Therapeutic Response|0
397826|NCT00077610|1254266|P1|Overall Study|Insufficient Therapeutic Response|1
397827|NCT00077610|1254264|P3|Overall Study|Withdrew from dialysis care|3
397828|NCT00077610|1254265|P2|Overall Study|Withdrew from dialysis care|0
397829|NCT00077610|1254266|P1|Overall Study|Withdrew from dialysis care|5
397830|NCT00077610|1254264|P3|Overall Study|Renal transplant|11
397831|NCT00077610|1254265|P2|Overall Study|Renal transplant|15
397832|NCT00077610|1254266|P1|Overall Study|Renal transplant|12
397833|NCT00077610|1254264|P3|Overall Study|Death|13
397834|NCT00077610|1254265|P2|Overall Study|Death|13
397835|NCT00077610|1254266|P1|Overall Study|Death|17
397836|NCT00077610|1254264|P3|Overall Study|Withdrawal by Subject|6
397837|NCT00077610|1254265|P2|Overall Study|Withdrawal by Subject|10
397838|NCT00077610|1254266|P1|Overall Study|Withdrawal by Subject|4
397839|NCT00077610|1254264|P3|Overall Study|Lost to Follow-up|2
397840|NCT00077610|1254265|P2|Overall Study|Lost to Follow-up|1
397841|NCT00077610|1254266|P1|Overall Study|Lost to Follow-up|0
397842|NCT00077610|1254264|P3|Overall Study|Adverse Event|1
397843|NCT00077610|1254265|P2|Overall Study|Adverse Event|7
397844|NCT00077610|1254266|P1|Overall Study|Adverse Event|9
397845|NCT00077376|1254295|P1|Overall Study|Insurance ran out|1
397846|NCT00077376|1254295|P1|Overall Study|Surgery|1
397847|NCT00077376|1254295|P1|Overall Study|Symptomatic deterioration|1
397848|NCT00077376|1254295|P1|Overall Study|Still on treatment|1
397849|NCT00077376|1254295|P1|Overall Study|Complicating disease|1
397850|NCT00077376|1254295|P1|Overall Study|Alternative therapy|5
397851|NCT00077376|1254295|P1|Overall Study|Physician Decision|1
397852|NCT00077376|1254295|P1|Overall Study|Death|1
397853|NCT00077376|1254295|P1|Overall Study|Withdrawal by Subject|2
397854|NCT00077376|1254295|P1|Overall Study|Adverse Event|8
397855|NCT00077207|1254306|P1|Overall Study|Ineligible|1
397856|NCT00077207|1254306|P1|Overall Study|Withdrawal by Subject|6
397857|NCT00077207|1254306|P1|Overall Study|Physician Decision|6
397858|NCT00077207|1254306|P1|Overall Study|Lack of Efficacy|12
397859|NCT00077207|1254306|P1|Overall Study|Adverse Event|5
397860|NCT00076999|1254315|P5|Overall Study|Other reason (not specified)|13
397861|NCT00076999|1254316|P4|Overall Study|Other reason (not specified)|1
397862|NCT00076999|1254317|P3|Overall Study|Other reason (not specified)|4
397863|NCT00076999|1254318|P2|Overall Study|Other reason (not specified)|8
397864|NCT00076999|1254319|P1|Overall Study|Other reason (not specified)|8
397865|NCT00076999|1254315|P5|Overall Study|Withdrawal by Subject|1
397866|NCT00076999|1254316|P4|Overall Study|Withdrawal by Subject|0
397867|NCT00076999|1254317|P3|Overall Study|Withdrawal by Subject|3
397868|NCT00076999|1254318|P2|Overall Study|Withdrawal by Subject|4
397869|NCT00076999|1254319|P1|Overall Study|Withdrawal by Subject|0
397870|NCT00076999|1254315|P5|Overall Study|Lost to Follow-up|0
397871|NCT00076999|1254316|P4|Overall Study|Lost to Follow-up|0
397872|NCT00076999|1254317|P3|Overall Study|Lost to Follow-up|0
397873|NCT00076999|1254318|P2|Overall Study|Lost to Follow-up|1
397874|NCT00076999|1254319|P1|Overall Study|Lost to Follow-up|2
397875|NCT00076999|1254315|P5|Overall Study|Protocol Violation|9
397876|NCT00076999|1254316|P4|Overall Study|Protocol Violation|0
397877|NCT00076999|1254317|P3|Overall Study|Protocol Violation|4
397878|NCT00076999|1254318|P2|Overall Study|Protocol Violation|3
397879|NCT00076999|1254319|P1|Overall Study|Protocol Violation|0
397880|NCT00076999|1254315|P5|Overall Study|Adverse Event|2
397881|NCT00076999|1254316|P4|Overall Study|Adverse Event|0
397882|NCT00076999|1254317|P3|Overall Study|Adverse Event|6
397883|NCT00076999|1254318|P2|Overall Study|Adverse Event|8
397884|NCT00076999|1254319|P1|Overall Study|Adverse Event|2
397885|NCT00076804|1254438|P2|Overall Study|Early study Closure|32
397886|NCT00076804|1254439|P1|Overall Study|Early study Closure|32
397887|NCT00076804|1254438|P2|Overall Study|Withdrawal by Subject|8
397888|NCT00076804|1254439|P1|Overall Study|Withdrawal by Subject|10
397889|NCT00076804|1254438|P2|Overall Study|Lost to Follow-up|9
397890|NCT00076804|1254439|P1|Overall Study|Lost to Follow-up|9
397891|NCT00076804|1254438|P2|Overall Study|Death|20
397892|NCT00076804|1254439|P1|Overall Study|Death|9
397893|NCT00076752|1254451|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
397894|NCT00076752|1254451|P1|Overall Study|Death|2
397895|NCT00076570|1254494|P2|Overall Study|Drug intolerance|8
397896|NCT00076570|1254495|P1|Overall Study|Drug intolerance|8
397897|NCT00076336|1254505|P2|Overall Study|Treatment failure|5
397898|NCT00076336|1254506|P1|Overall Study|Treatment failure|4
397899|NCT00076336|1254505|P2|Overall Study|Virologic Breakthrough|16
397900|NCT00076336|1254506|P1|Overall Study|Virologic Breakthrough|14
397901|NCT00076336|1254505|P2|Overall Study|Liver Transplantation|3
397902|NCT00076336|1254506|P1|Overall Study|Liver Transplantation|3
397903|NCT00076336|1254505|P2|Overall Study|Patient, Investigator, Sponsor request|6
397904|NCT00076336|1254506|P1|Overall Study|Patient, Investigator, Sponsor request|8
397905|NCT00076336|1254505|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
397906|NCT00076336|1254506|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
397907|NCT00076336|1254505|P2|Overall Study|Non-Compliance|0
397908|NCT00076336|1254506|P1|Overall Study|Non-Compliance|2
397909|NCT00076336|1254505|P2|Overall Study|Lost to Follow-up|4
397910|NCT00076336|1254506|P1|Overall Study|Lost to Follow-up|4
397911|NCT00076336|1254505|P2|Overall Study|Adverse Event|4
397912|NCT00076336|1254506|P1|Overall Study|Adverse Event|4
397913|NCT00076336|1254505|P2|Overall Study|Death|17
397914|NCT00076336|1254506|P1|Overall Study|Death|13
397915|NCT00076024|1254580|P4|Phase 2, Open-label|Unspecified|2
397916|NCT00076024|1254581|P3|Phase 2, Open-label|Unspecified|0
397917|NCT00076024|1254582|P2|Phase 2, Open-label|Unspecified|0
397918|NCT00076024|1254583|P1|Phase 2, Open-label|Unspecified|0
397919|NCT00076024|1254580|P4|Phase 2, Open-label|Withdrawal by Subject|1
397920|NCT00076024|1254581|P3|Phase 2, Open-label|Withdrawal by Subject|0
397921|NCT00076024|1254582|P2|Phase 2, Open-label|Withdrawal by Subject|0
397922|NCT00076024|1254583|P1|Phase 2, Open-label|Withdrawal by Subject|0
397923|NCT00076024|1254580|P4|Phase 2, Open-label|Lack of Efficacy|11
397924|NCT00076024|1254581|P3|Phase 2, Open-label|Lack of Efficacy|0
397925|NCT00076024|1254582|P2|Phase 2, Open-label|Lack of Efficacy|0
397926|NCT00076024|1254583|P1|Phase 2, Open-label|Lack of Efficacy|0
397927|NCT00076024|1254580|P4|Phase 2, Open-label|Adverse Event|2
397928|NCT00076024|1254581|P3|Phase 2, Open-label|Adverse Event|0
397929|NCT00076024|1254582|P2|Phase 2, Open-label|Adverse Event|0
397930|NCT00076024|1254583|P1|Phase 2, Open-label|Adverse Event|0
397931|NCT00076024|1254580|P4|Phase 2, Double-blind|Randomized but not treated|0
397932|NCT00076024|1254581|P3|Phase 2, Double-blind|Randomized but not treated|0
397933|NCT00076024|1254582|P2|Phase 2, Double-blind|Randomized but not treated|1
397934|NCT00076024|1254583|P1|Phase 2, Double-blind|Randomized but not treated|0
397935|NCT00076024|1254580|P4|Phase 2, Double-blind|Un-specified|0
397936|NCT00076024|1254581|P3|Phase 2, Double-blind|Un-specified|6
397937|NCT00076024|1254582|P2|Phase 2, Double-blind|Un-specified|14
397938|NCT00076024|1254583|P1|Phase 2, Double-blind|Un-specified|0
397939|NCT00076024|1254580|P4|Phase 2, Double-blind|Adverse Event|0
397940|NCT00076024|1254581|P3|Phase 2, Double-blind|Adverse Event|6
397941|NCT00076024|1254582|P2|Phase 2, Double-blind|Adverse Event|25
397942|NCT00076024|1254583|P1|Phase 2, Double-blind|Adverse Event|0
397943|NCT00076024|1254580|P4|Phase 2, Double-blind|Withdrawal by Subject|0
397944|NCT00076024|1254581|P3|Phase 2, Double-blind|Withdrawal by Subject|4
397945|NCT00076024|1254582|P2|Phase 2, Double-blind|Withdrawal by Subject|13
397946|NCT00076024|1254583|P1|Phase 2, Double-blind|Withdrawal by Subject|0
397947|NCT00076024|1254580|P4|Phase 2, Double-blind|Lack of Efficacy|0
397948|NCT00076024|1254581|P3|Phase 2, Double-blind|Lack of Efficacy|40
397949|NCT00076024|1254582|P2|Phase 2, Double-blind|Lack of Efficacy|59
397950|NCT00076024|1254583|P1|Phase 2, Double-blind|Lack of Efficacy|0
397951|NCT00076024|1254580|P4|Phase 1, Lead-in|Clinical progression|0
397952|NCT00076024|1254581|P3|Phase 1, Lead-in|Clinical progression|0
397953|NCT00076024|1254582|P2|Phase 1, Lead-in|Clinical progression|0
397954|NCT00076024|1254583|P1|Phase 1, Lead-in|Clinical progression|1
397955|NCT00076024|1254580|P4|Phase 1, Lead-in|Adverse Event|0
397956|NCT00076024|1254581|P3|Phase 1, Lead-in|Adverse Event|0
397957|NCT00076024|1254582|P2|Phase 1, Lead-in|Adverse Event|0
397958|NCT00076024|1254583|P1|Phase 1, Lead-in|Adverse Event|1
397959|NCT00076024|1254580|P4|Phase 1, Lead-in|Lack of Efficacy|0
397960|NCT00076024|1254581|P3|Phase 1, Lead-in|Lack of Efficacy|0
397961|NCT00076024|1254582|P2|Phase 1, Lead-in|Lack of Efficacy|0
397962|NCT00076024|1254583|P1|Phase 1, Lead-in|Lack of Efficacy|4
397963|NCT00076011|1254597|P1|Overall Study|Ongoing|1
397964|NCT00076011|1254597|P1|Overall Study|Unspecified|11
397965|NCT00076011|1254597|P1|Overall Study|Study terminated by sponsor|3
397966|NCT00076011|1254597|P1|Overall Study|Withdrawal by Subject|1
397967|NCT00076011|1254597|P1|Overall Study|Lack of Efficacy|25
397968|NCT00076011|1254597|P1|Overall Study|Adverse Event|10
397969|NCT00076011|1254597|P1|Overall Study|Death|1
397970|NCT00075946|1254609|P5|Overall Study|Other|0
397971|NCT00075946|1254610|P4|Overall Study|Other|2
397972|NCT00075946|1254611|P3|Overall Study|Other|0
397973|NCT00075946|1254612|P2|Overall Study|Other|13
397974|NCT00075946|1254613|P1|Overall Study|Other|5
397975|NCT00075946|1254609|P5|Overall Study|Time to progression less than 6 months|0
397976|NCT00075946|1254610|P4|Overall Study|Time to progression less than 6 months|3
397977|NCT00075946|1254611|P3|Overall Study|Time to progression less than 6 months|8
397978|NCT00075946|1254612|P2|Overall Study|Time to progression less than 6 months|30
397979|NCT00075946|1254613|P1|Overall Study|Time to progression less than 6 months|15
397980|NCT00075946|1254609|P5|Overall Study|No response to retreatment|0
397981|NCT00075946|1254610|P4|Overall Study|No response to retreatment|0
397982|NCT00075946|1254611|P3|Overall Study|No response to retreatment|2
397983|NCT00075946|1254612|P2|Overall Study|No response to retreatment|0
397984|NCT00075946|1254613|P1|Overall Study|No response to retreatment|23
397985|NCT00075946|1254609|P5|Overall Study|Other complicating disease|0
397986|NCT00075946|1254610|P4|Overall Study|Other complicating disease|4
397987|NCT00075946|1254611|P3|Overall Study|Other complicating disease|1
397988|NCT00075946|1254612|P2|Overall Study|Other complicating disease|13
397989|NCT00075946|1254613|P1|Overall Study|Other complicating disease|7
397990|NCT00075946|1254609|P5|Overall Study|Alternative therapy|0
397991|NCT00075946|1254610|P4|Overall Study|Alternative therapy|0
397992|NCT00075946|1254611|P3|Overall Study|Alternative therapy|5
397993|NCT00075946|1254612|P2|Overall Study|Alternative therapy|2
397994|NCT00075946|1254613|P1|Overall Study|Alternative therapy|16
397995|NCT00075946|1254609|P5|Overall Study|Withdrawal by Subject|0
397996|NCT00075946|1254610|P4|Overall Study|Withdrawal by Subject|9
397997|NCT00075946|1254611|P3|Overall Study|Withdrawal by Subject|4
397998|NCT00075946|1254612|P2|Overall Study|Withdrawal by Subject|58
397999|NCT00075946|1254613|P1|Overall Study|Withdrawal by Subject|23
398000|NCT00075946|1254609|P5|Overall Study|Death|0
398001|NCT00075946|1254610|P4|Overall Study|Death|0
398002|NCT00075946|1254611|P3|Overall Study|Death|0
398003|NCT00075946|1254612|P2|Overall Study|Death|1
398004|NCT00075946|1254613|P1|Overall Study|Death|0
398005|NCT00075946|1254609|P5|Overall Study|Adverse Event|0
398006|NCT00075946|1254610|P4|Overall Study|Adverse Event|2
398007|NCT00075946|1254611|P3|Overall Study|Adverse Event|0
398008|NCT00075946|1254612|P2|Overall Study|Adverse Event|10
398009|NCT00075946|1254613|P1|Overall Study|Adverse Event|2
398010|NCT00075946|1254609|P5|Overall Study|Still on treatment at time of analysis|0
398011|NCT00075946|1254610|P4|Overall Study|Still on treatment at time of analysis|9
398012|NCT00075946|1254611|P3|Overall Study|Still on treatment at time of analysis|3
398013|NCT00075946|1254612|P2|Overall Study|Still on treatment at time of analysis|19
398014|NCT00075946|1254613|P1|Overall Study|Still on treatment at time of analysis|52
398015|NCT00075946|1254609|P5|Overall Study|Incorrectly randomized (no response)|0
398016|NCT00075946|1254610|P4|Overall Study|Incorrectly randomized (no response)|1
398017|NCT00075946|1254611|P3|Overall Study|Incorrectly randomized (no response)|5
398018|NCT00075946|1254612|P2|Overall Study|Incorrectly randomized (no response)|5
398019|NCT00075946|1254613|P1|Overall Study|Incorrectly randomized (no response)|5
398020|NCT00075946|1254609|P5|Overall Study|Did not achieve response after induction|182
398021|NCT00075946|1254610|P4|Overall Study|Did not achieve response after induction|0
398022|NCT00075946|1254611|P3|Overall Study|Did not achieve response after induction|0
398023|NCT00075946|1254612|P2|Overall Study|Did not achieve response after induction|0
398024|NCT00075946|1254613|P1|Overall Study|Did not achieve response after induction|0
398025|NCT00075946|1254609|P5|Overall Study|Path ineligible: undetermined histology|6
398026|NCT00075946|1254610|P4|Overall Study|Path ineligible: undetermined histology|0
398027|NCT00075946|1254611|P3|Overall Study|Path ineligible: undetermined histology|0
398028|NCT00075946|1254612|P2|Overall Study|Path ineligible: undetermined histology|0
398029|NCT00075946|1254613|P1|Overall Study|Path ineligible: undetermined histology|0
398030|NCT00075881|1254628|P1|Overall Study|never start protocol therapy|1
398031|NCT00075881|1254628|P1|Overall Study|Ineligible|1
398032|NCT00075881|1254628|P1|Overall Study|missing data|2
398033|NCT00075881|1254628|P1|Overall Study|other|4
398034|NCT00075881|1254628|P1|Overall Study|other complicating disease|3
398035|NCT00075881|1254628|P1|Overall Study|Protocol Violation|4
398036|NCT00075881|1254628|P1|Overall Study|Withdrawal by Subject|2
398037|NCT00075881|1254628|P1|Overall Study|Death|1
398038|NCT00075881|1254628|P1|Overall Study|Adverse Event|7
398039|NCT00075881|1254628|P1|Overall Study|Lack of Efficacy|18
398040|NCT00075816|1254672|P2|Overall Study|Did not undergo transplantation|11
398041|NCT00075816|1254673|P1|Overall Study|Did not undergo transplantation|14
398042|NCT00075764|1254742|P2|Overall Study|Under review|1
398043|NCT00075764|1254743|P1|Overall Study|Under review|0
398044|NCT00075764|1254742|P2|Overall Study|Not protocol specified|19
398045|NCT00075764|1254743|P1|Overall Study|Not protocol specified|27
398046|NCT00075764|1254742|P2|Overall Study|Delinquent|2
398047|NCT00075764|1254743|P1|Overall Study|Delinquent|4
398048|NCT00075764|1254742|P2|Overall Study|Still on treatment|15
398049|NCT00075764|1254743|P1|Overall Study|Still on treatment|8
398050|NCT00075764|1254742|P2|Overall Study|Progression|274
398051|NCT00075764|1254743|P1|Overall Study|Progression|269
398052|NCT00075764|1254742|P2|Overall Study|Withdrawal by Subject|18
398053|NCT00075764|1254743|P1|Overall Study|Withdrawal by Subject|28
398054|NCT00075764|1254742|P2|Overall Study|Death|8
398055|NCT00075764|1254743|P1|Overall Study|Death|4
398056|NCT00075764|1254742|P2|Overall Study|Adverse Event|12
398057|NCT00075764|1254743|P1|Overall Study|Adverse Event|5
398058|NCT00075725|1254767|P12|Overall Study|Pt incarcerated|0
398059|NCT00075725|1254768|P11|Overall Study|Pt incarcerated|0
398060|NCT00075725|1254769|P10|Overall Study|Pt incarcerated|0
398061|NCT00075725|1254770|P9|Overall Study|Pt incarcerated|0
398062|NCT00075725|1254771|P8|Overall Study|Pt incarcerated|1
398063|NCT00075725|1254772|P7|Overall Study|Pt incarcerated|0
398064|NCT00075725|1254773|P6|Overall Study|Pt incarcerated|0
398065|NCT00075725|1254774|P5|Overall Study|Pt incarcerated|0
398066|NCT00075725|1254775|P4|Overall Study|Pt incarcerated|0
398067|NCT00075725|1254776|P3|Overall Study|Pt incarcerated|0
398068|NCT00075725|1254777|P2|Overall Study|Pt incarcerated|0
398069|NCT00075725|1254778|P1|Overall Study|Pt incarcerated|0
398070|NCT00075725|1254767|P12|Overall Study|Pt care terminated due to pt behavior|0
398071|NCT00075725|1254768|P11|Overall Study|Pt care terminated due to pt behavior|0
398072|NCT00075725|1254769|P10|Overall Study|Pt care terminated due to pt behavior|0
398073|NCT00075725|1254770|P9|Overall Study|Pt care terminated due to pt behavior|0
398074|NCT00075725|1254771|P8|Overall Study|Pt care terminated due to pt behavior|1
398075|NCT00075725|1254772|P7|Overall Study|Pt care terminated due to pt behavior|0
398076|NCT00075725|1254773|P6|Overall Study|Pt care terminated due to pt behavior|0
398077|NCT00075725|1254774|P5|Overall Study|Pt care terminated due to pt behavior|0
398078|NCT00075725|1254775|P4|Overall Study|Pt care terminated due to pt behavior|0
398079|NCT00075725|1254776|P3|Overall Study|Pt care terminated due to pt behavior|0
398080|NCT00075725|1254777|P2|Overall Study|Pt care terminated due to pt behavior|0
398081|NCT00075725|1254778|P1|Overall Study|Pt care terminated due to pt behavior|0
398082|NCT00075725|1254767|P12|Overall Study|Other complications|0
398083|NCT00075725|1254768|P11|Overall Study|Other complications|0
398084|NCT00075725|1254769|P10|Overall Study|Other complications|0
398085|NCT00075725|1254770|P9|Overall Study|Other complications|0
398086|NCT00075725|1254771|P8|Overall Study|Other complications|0
398087|NCT00075725|1254772|P7|Overall Study|Other complications|0
398088|NCT00075725|1254773|P6|Overall Study|Other complications|1
398089|NCT00075725|1254774|P5|Overall Study|Other complications|0
398090|NCT00075725|1254775|P4|Overall Study|Other complications|0
398091|NCT00075725|1254776|P3|Overall Study|Other complications|0
398092|NCT00075725|1254777|P2|Overall Study|Other complications|0
398093|NCT00075725|1254778|P1|Overall Study|Other complications|0
398094|NCT00075725|1254767|P12|Overall Study|Study Closure|0
398095|NCT00075725|1254768|P11|Overall Study|Study Closure|0
398096|NCT00075725|1254769|P10|Overall Study|Study Closure|0
398097|NCT00075725|1254770|P9|Overall Study|Study Closure|0
398098|NCT00075725|1254771|P8|Overall Study|Study Closure|1
398099|NCT00075725|1254772|P7|Overall Study|Study Closure|0
398100|NCT00075725|1254773|P6|Overall Study|Study Closure|3
398101|NCT00075725|1254774|P5|Overall Study|Study Closure|1
398102|NCT00075725|1254775|P4|Overall Study|Study Closure|0
398103|NCT00075725|1254776|P3|Overall Study|Study Closure|0
398104|NCT00075725|1254777|P2|Overall Study|Study Closure|0
398105|NCT00075725|1254778|P1|Overall Study|Study Closure|1
398106|NCT00075725|1254767|P12|Overall Study|Institution Terminated|0
398107|NCT00075725|1254768|P11|Overall Study|Institution Terminated|0
398108|NCT00075725|1254769|P10|Overall Study|Institution Terminated|0
398109|NCT00075725|1254770|P9|Overall Study|Institution Terminated|0
398110|NCT00075725|1254771|P8|Overall Study|Institution Terminated|3
398111|NCT00075725|1254772|P7|Overall Study|Institution Terminated|0
398112|NCT00075725|1254773|P6|Overall Study|Institution Terminated|0
398113|NCT00075725|1254774|P5|Overall Study|Institution Terminated|1
398114|NCT00075725|1254775|P4|Overall Study|Institution Terminated|0
398115|NCT00075725|1254776|P3|Overall Study|Institution Terminated|0
398116|NCT00075725|1254777|P2|Overall Study|Institution Terminated|0
398117|NCT00075725|1254778|P1|Overall Study|Institution Terminated|0
398118|NCT00075725|1254767|P12|Overall Study|Pt relocated|0
398119|NCT00075725|1254768|P11|Overall Study|Pt relocated|0
398120|NCT00075725|1254769|P10|Overall Study|Pt relocated|0
398121|NCT00075725|1254770|P9|Overall Study|Pt relocated|1
398122|NCT00075725|1254771|P8|Overall Study|Pt relocated|2
398123|NCT00075725|1254772|P7|Overall Study|Pt relocated|1
398124|NCT00075725|1254773|P6|Overall Study|Pt relocated|1
398125|NCT00075725|1254774|P5|Overall Study|Pt relocated|0
398126|NCT00075725|1254775|P4|Overall Study|Pt relocated|2
398127|NCT00075725|1254776|P3|Overall Study|Pt relocated|0
398128|NCT00075725|1254777|P2|Overall Study|Pt relocated|0
398129|NCT00075725|1254778|P1|Overall Study|Pt relocated|0
398130|NCT00075725|1254767|P12|Overall Study|Pt received additional steroids|0
398131|NCT00075725|1254768|P11|Overall Study|Pt received additional steroids|0
398132|NCT00075725|1254769|P10|Overall Study|Pt received additional steroids|0
398133|NCT00075725|1254770|P9|Overall Study|Pt received additional steroids|0
398134|NCT00075725|1254771|P8|Overall Study|Pt received additional steroids|0
398135|NCT00075725|1254772|P7|Overall Study|Pt received additional steroids|0
398136|NCT00075725|1254773|P6|Overall Study|Pt received additional steroids|0
398137|NCT00075725|1254774|P5|Overall Study|Pt received additional steroids|0
398138|NCT00075725|1254775|P4|Overall Study|Pt received additional steroids|1
398139|NCT00075725|1254776|P3|Overall Study|Pt received additional steroids|0
398140|NCT00075725|1254777|P2|Overall Study|Pt received additional steroids|0
398141|NCT00075725|1254778|P1|Overall Study|Pt received additional steroids|0
398142|NCT00075725|1254767|P12|Overall Study|Pt went to transplant|0
398143|NCT00075725|1254768|P11|Overall Study|Pt went to transplant|0
398144|NCT00075725|1254769|P10|Overall Study|Pt went to transplant|0
398145|NCT00075725|1254770|P9|Overall Study|Pt went to transplant|0
398146|NCT00075725|1254771|P8|Overall Study|Pt went to transplant|0
398147|NCT00075725|1254772|P7|Overall Study|Pt went to transplant|0
398148|NCT00075725|1254773|P6|Overall Study|Pt went to transplant|1
398149|NCT00075725|1254774|P5|Overall Study|Pt went to transplant|0
398150|NCT00075725|1254775|P4|Overall Study|Pt went to transplant|1
398151|NCT00075725|1254776|P3|Overall Study|Pt went to transplant|0
398152|NCT00075725|1254777|P2|Overall Study|Pt went to transplant|0
398153|NCT00075725|1254778|P1|Overall Study|Pt went to transplant|0
398154|NCT00075725|1254767|P12|Overall Study|specimen(s) not submitted|0
398155|NCT00075725|1254768|P11|Overall Study|specimen(s) not submitted|0
398156|NCT00075725|1254769|P10|Overall Study|specimen(s) not submitted|0
398157|NCT00075725|1254770|P9|Overall Study|specimen(s) not submitted|0
398158|NCT00075725|1254771|P8|Overall Study|specimen(s) not submitted|0
398159|NCT00075725|1254772|P7|Overall Study|specimen(s) not submitted|0
398160|NCT00075725|1254773|P6|Overall Study|specimen(s) not submitted|0
398161|NCT00075725|1254774|P5|Overall Study|specimen(s) not submitted|0
398162|NCT00075725|1254775|P4|Overall Study|specimen(s) not submitted|0
398163|NCT00075725|1254776|P3|Overall Study|specimen(s) not submitted|2
398164|NCT00075725|1254777|P2|Overall Study|specimen(s) not submitted|0
398165|NCT00075725|1254778|P1|Overall Study|specimen(s) not submitted|0
398166|NCT00075725|1254767|P12|Overall Study|Unsuccessful institutional transfer|0
398167|NCT00075725|1254768|P11|Overall Study|Unsuccessful institutional transfer|0
398168|NCT00075725|1254769|P10|Overall Study|Unsuccessful institutional transfer|1
398169|NCT00075725|1254770|P9|Overall Study|Unsuccessful institutional transfer|0
398170|NCT00075725|1254771|P8|Overall Study|Unsuccessful institutional transfer|0
398171|NCT00075725|1254772|P7|Overall Study|Unsuccessful institutional transfer|0
398172|NCT00075725|1254773|P6|Overall Study|Unsuccessful institutional transfer|0
398173|NCT00075725|1254774|P5|Overall Study|Unsuccessful institutional transfer|0
398174|NCT00075725|1254775|P4|Overall Study|Unsuccessful institutional transfer|0
398175|NCT00075725|1254776|P3|Overall Study|Unsuccessful institutional transfer|2
398176|NCT00075725|1254777|P2|Overall Study|Unsuccessful institutional transfer|0
398177|NCT00075725|1254778|P1|Overall Study|Unsuccessful institutional transfer|0
398178|NCT00075725|1254767|P12|Overall Study|Clinic chart lost unable to recreate|0
398179|NCT00075725|1254768|P11|Overall Study|Clinic chart lost unable to recreate|0
398180|NCT00075725|1254769|P10|Overall Study|Clinic chart lost unable to recreate|0
398181|NCT00075725|1254770|P9|Overall Study|Clinic chart lost unable to recreate|0
398182|NCT00075725|1254771|P8|Overall Study|Clinic chart lost unable to recreate|0
398183|NCT00075725|1254772|P7|Overall Study|Clinic chart lost unable to recreate|0
398184|NCT00075725|1254773|P6|Overall Study|Clinic chart lost unable to recreate|0
398185|NCT00075725|1254774|P5|Overall Study|Clinic chart lost unable to recreate|0
398186|NCT00075725|1254775|P4|Overall Study|Clinic chart lost unable to recreate|0
398187|NCT00075725|1254776|P3|Overall Study|Clinic chart lost unable to recreate|1
398188|NCT00075725|1254777|P2|Overall Study|Clinic chart lost unable to recreate|0
398189|NCT00075725|1254778|P1|Overall Study|Clinic chart lost unable to recreate|0
398190|NCT00075725|1254767|P12|Overall Study|Pt trying to find a BM donor|0
398191|NCT00075725|1254768|P11|Overall Study|Pt trying to find a BM donor|0
398192|NCT00075725|1254769|P10|Overall Study|Pt trying to find a BM donor|0
398193|NCT00075725|1254770|P9|Overall Study|Pt trying to find a BM donor|0
398194|NCT00075725|1254771|P8|Overall Study|Pt trying to find a BM donor|0
398195|NCT00075725|1254772|P7|Overall Study|Pt trying to find a BM donor|0
398196|NCT00075725|1254773|P6|Overall Study|Pt trying to find a BM donor|0
398197|NCT00075725|1254774|P5|Overall Study|Pt trying to find a BM donor|0
398198|NCT00075725|1254775|P4|Overall Study|Pt trying to find a BM donor|0
398199|NCT00075725|1254776|P3|Overall Study|Pt trying to find a BM donor|0
398200|NCT00075725|1254777|P2|Overall Study|Pt trying to find a BM donor|1
398201|NCT00075725|1254778|P1|Overall Study|Pt trying to find a BM donor|0
398202|NCT00075725|1254767|P12|Overall Study|Other|3
398203|NCT00075725|1254768|P11|Overall Study|Other|0
398204|NCT00075725|1254769|P10|Overall Study|Other|1
398205|NCT00075725|1254770|P9|Overall Study|Other|2
398206|NCT00075725|1254771|P8|Overall Study|Other|9
398207|NCT00075725|1254772|P7|Overall Study|Other|2
398208|NCT00075725|1254773|P6|Overall Study|Other|4
398209|NCT00075725|1254774|P5|Overall Study|Other|1
398210|NCT00075725|1254775|P4|Overall Study|Other|1
398211|NCT00075725|1254776|P3|Overall Study|Other|1
398212|NCT00075725|1254777|P2|Overall Study|Other|2
398213|NCT00075725|1254778|P1|Overall Study|Other|4
398214|NCT00075725|1254767|P12|Overall Study|Inevaluable|0
398215|NCT00075725|1254768|P11|Overall Study|Inevaluable|1
398216|NCT00075725|1254769|P10|Overall Study|Inevaluable|0
398217|NCT00075725|1254770|P9|Overall Study|Inevaluable|2
398218|NCT00075725|1254771|P8|Overall Study|Inevaluable|11
398219|NCT00075725|1254772|P7|Overall Study|Inevaluable|1
398220|NCT00075725|1254773|P6|Overall Study|Inevaluable|9
398221|NCT00075725|1254774|P5|Overall Study|Inevaluable|2
398222|NCT00075725|1254775|P4|Overall Study|Inevaluable|2
398223|NCT00075725|1254776|P3|Overall Study|Inevaluable|4
398224|NCT00075725|1254777|P2|Overall Study|Inevaluable|1
398225|NCT00075725|1254778|P1|Overall Study|Inevaluable|1
398226|NCT00075725|1254767|P12|Overall Study|Pt has very high risk ALL characteristic|3
398227|NCT00075725|1254768|P11|Overall Study|Pt has very high risk ALL characteristic|0
398228|NCT00075725|1254769|P10|Overall Study|Pt has very high risk ALL characteristic|1
398229|NCT00075725|1254770|P9|Overall Study|Pt has very high risk ALL characteristic|29
398230|NCT00075725|1254771|P8|Overall Study|Pt has very high risk ALL characteristic|74
398231|NCT00075725|1254772|P7|Overall Study|Pt has very high risk ALL characteristic|23
398232|NCT00075725|1254773|P6|Overall Study|Pt has very high risk ALL characteristic|75
398233|NCT00075725|1254774|P5|Overall Study|Pt has very high risk ALL characteristic|11
398234|NCT00075725|1254775|P4|Overall Study|Pt has very high risk ALL characteristic|18
398235|NCT00075725|1254776|P3|Overall Study|Pt has very high risk ALL characteristic|26
398236|NCT00075725|1254777|P2|Overall Study|Pt has very high risk ALL characteristic|11
398237|NCT00075725|1254778|P1|Overall Study|Pt has very high risk ALL characteristic|15
398238|NCT00075725|1254767|P12|Overall Study|MRD positive after extended ind|0
398239|NCT00075725|1254768|P11|Overall Study|MRD positive after extended ind|0
398240|NCT00075725|1254769|P10|Overall Study|MRD positive after extended ind|0
398241|NCT00075725|1254770|P9|Overall Study|MRD positive after extended ind|0
398242|NCT00075725|1254771|P8|Overall Study|MRD positive after extended ind|1
398243|NCT00075725|1254772|P7|Overall Study|MRD positive after extended ind|0
398244|NCT00075725|1254773|P6|Overall Study|MRD positive after extended ind|2
398245|NCT00075725|1254774|P5|Overall Study|MRD positive after extended ind|1
398246|NCT00075725|1254775|P4|Overall Study|MRD positive after extended ind|0
398247|NCT00075725|1254776|P3|Overall Study|MRD positive after extended ind|1
398248|NCT00075725|1254777|P2|Overall Study|MRD positive after extended ind|1
398249|NCT00075725|1254778|P1|Overall Study|MRD positive after extended ind|0
398250|NCT00075725|1254767|P12|Overall Study|Insurance issues|0
398251|NCT00075725|1254768|P11|Overall Study|Insurance issues|0
398252|NCT00075725|1254769|P10|Overall Study|Insurance issues|0
398253|NCT00075725|1254770|P9|Overall Study|Insurance issues|0
398254|NCT00075725|1254771|P8|Overall Study|Insurance issues|1
398255|NCT00075725|1254772|P7|Overall Study|Insurance issues|0
398256|NCT00075725|1254773|P6|Overall Study|Insurance issues|1
398257|NCT00075725|1254774|P5|Overall Study|Insurance issues|1
398258|NCT00075725|1254775|P4|Overall Study|Insurance issues|1
398259|NCT00075725|1254776|P3|Overall Study|Insurance issues|0
398260|NCT00075725|1254777|P2|Overall Study|Insurance issues|1
398261|NCT00075725|1254778|P1|Overall Study|Insurance issues|0
398262|NCT00075725|1254767|P12|Overall Study|Pt age out of range for treatment|0
398263|NCT00075725|1254768|P11|Overall Study|Pt age out of range for treatment|0
398264|NCT00075725|1254769|P10|Overall Study|Pt age out of range for treatment|0
398265|NCT00075725|1254770|P9|Overall Study|Pt age out of range for treatment|0
398266|NCT00075725|1254771|P8|Overall Study|Pt age out of range for treatment|1
398267|NCT00075725|1254772|P7|Overall Study|Pt age out of range for treatment|0
398268|NCT00075725|1254773|P6|Overall Study|Pt age out of range for treatment|1
398269|NCT00075725|1254774|P5|Overall Study|Pt age out of range for treatment|0
398270|NCT00075725|1254775|P4|Overall Study|Pt age out of range for treatment|0
398271|NCT00075725|1254776|P3|Overall Study|Pt age out of range for treatment|0
398272|NCT00075725|1254777|P2|Overall Study|Pt age out of range for treatment|1
398273|NCT00075725|1254778|P1|Overall Study|Pt age out of range for treatment|0
398274|NCT00075725|1254767|P12|Overall Study|Pt non compliant with therapy|0
398275|NCT00075725|1254768|P11|Overall Study|Pt non compliant with therapy|0
398276|NCT00075725|1254769|P10|Overall Study|Pt non compliant with therapy|0
398277|NCT00075725|1254770|P9|Overall Study|Pt non compliant with therapy|3
398278|NCT00075725|1254771|P8|Overall Study|Pt non compliant with therapy|5
398279|NCT00075725|1254772|P7|Overall Study|Pt non compliant with therapy|2
398280|NCT00075725|1254773|P6|Overall Study|Pt non compliant with therapy|14
398281|NCT00075725|1254774|P5|Overall Study|Pt non compliant with therapy|2
398282|NCT00075725|1254775|P4|Overall Study|Pt non compliant with therapy|0
398283|NCT00075725|1254776|P3|Overall Study|Pt non compliant with therapy|1
398284|NCT00075725|1254777|P2|Overall Study|Pt non compliant with therapy|1
398285|NCT00075725|1254778|P1|Overall Study|Pt non compliant with therapy|2
398286|NCT00075725|1254767|P12|Overall Study|Pt/Guardian refused RT therapy|0
398287|NCT00075725|1254768|P11|Overall Study|Pt/Guardian refused RT therapy|0
398288|NCT00075725|1254769|P10|Overall Study|Pt/Guardian refused RT therapy|0
398289|NCT00075725|1254770|P9|Overall Study|Pt/Guardian refused RT therapy|0
398290|NCT00075725|1254771|P8|Overall Study|Pt/Guardian refused RT therapy|0
398291|NCT00075725|1254772|P7|Overall Study|Pt/Guardian refused RT therapy|0
398292|NCT00075725|1254773|P6|Overall Study|Pt/Guardian refused RT therapy|0
398293|NCT00075725|1254774|P5|Overall Study|Pt/Guardian refused RT therapy|1
398294|NCT00075725|1254775|P4|Overall Study|Pt/Guardian refused RT therapy|2
398295|NCT00075725|1254776|P3|Overall Study|Pt/Guardian refused RT therapy|1
398296|NCT00075725|1254777|P2|Overall Study|Pt/Guardian refused RT therapy|0
398297|NCT00075725|1254778|P1|Overall Study|Pt/Guardian refused RT therapy|1
398298|NCT00075725|1254767|P12|Overall Study|Ineligible or wrong diagnosis|4
398299|NCT00075725|1254768|P11|Overall Study|Ineligible or wrong diagnosis|2
398300|NCT00075725|1254769|P10|Overall Study|Ineligible or wrong diagnosis|1
398301|NCT00075725|1254770|P9|Overall Study|Ineligible or wrong diagnosis|10
398302|NCT00075725|1254771|P8|Overall Study|Ineligible or wrong diagnosis|9
398303|NCT00075725|1254772|P7|Overall Study|Ineligible or wrong diagnosis|6
398304|NCT00075725|1254773|P6|Overall Study|Ineligible or wrong diagnosis|17
398305|NCT00075725|1254774|P5|Overall Study|Ineligible or wrong diagnosis|3
398306|NCT00075725|1254775|P4|Overall Study|Ineligible or wrong diagnosis|10
398307|NCT00075725|1254776|P3|Overall Study|Ineligible or wrong diagnosis|3
398308|NCT00075725|1254777|P2|Overall Study|Ineligible or wrong diagnosis|3
398309|NCT00075725|1254778|P1|Overall Study|Ineligible or wrong diagnosis|8
398310|NCT00075725|1254767|P12|Overall Study|Patient off treatment|0
398311|NCT00075725|1254768|P11|Overall Study|Patient off treatment|0
398312|NCT00075725|1254769|P10|Overall Study|Patient off treatment|0
398313|NCT00075725|1254770|P9|Overall Study|Patient off treatment|1
398314|NCT00075725|1254771|P8|Overall Study|Patient off treatment|2
398315|NCT00075725|1254772|P7|Overall Study|Patient off treatment|0
398316|NCT00075725|1254773|P6|Overall Study|Patient off treatment|0
398317|NCT00075725|1254774|P5|Overall Study|Patient off treatment|1
398318|NCT00075725|1254775|P4|Overall Study|Patient off treatment|2
398319|NCT00075725|1254776|P3|Overall Study|Patient off treatment|1
398320|NCT00075725|1254777|P2|Overall Study|Patient off treatment|0
398321|NCT00075725|1254778|P1|Overall Study|Patient off treatment|0
398322|NCT00075725|1254767|P12|Overall Study|Disease Progression, all other reasons|5
398323|NCT00075725|1254768|P11|Overall Study|Disease Progression, all other reasons|0
398324|NCT00075725|1254769|P10|Overall Study|Disease Progression, all other reasons|4
398325|NCT00075725|1254770|P9|Overall Study|Disease Progression, all other reasons|21
398326|NCT00075725|1254771|P8|Overall Study|Disease Progression, all other reasons|46
398327|NCT00075725|1254772|P7|Overall Study|Disease Progression, all other reasons|20
398328|NCT00075725|1254773|P6|Overall Study|Disease Progression, all other reasons|59
398329|NCT00075725|1254774|P5|Overall Study|Disease Progression, all other reasons|21
398330|NCT00075725|1254775|P4|Overall Study|Disease Progression, all other reasons|6
398331|NCT00075725|1254776|P3|Overall Study|Disease Progression, all other reasons|33
398332|NCT00075725|1254777|P2|Overall Study|Disease Progression, all other reasons|5
398333|NCT00075725|1254778|P1|Overall Study|Disease Progression, all other reasons|17
398334|NCT00075725|1254767|P12|Overall Study|Withdrawal by Subject|0
398335|NCT00075725|1254768|P11|Overall Study|Withdrawal by Subject|0
398336|NCT00075725|1254769|P10|Overall Study|Withdrawal by Subject|2
398337|NCT00075725|1254770|P9|Overall Study|Withdrawal by Subject|10
398338|NCT00075725|1254771|P8|Overall Study|Withdrawal by Subject|31
398339|NCT00075725|1254772|P7|Overall Study|Withdrawal by Subject|7
398340|NCT00075725|1254773|P6|Overall Study|Withdrawal by Subject|27
398341|NCT00075725|1254774|P5|Overall Study|Withdrawal by Subject|6
398342|NCT00075725|1254775|P4|Overall Study|Withdrawal by Subject|10
398343|NCT00075725|1254776|P3|Overall Study|Withdrawal by Subject|6
398344|NCT00075725|1254777|P2|Overall Study|Withdrawal by Subject|3
398345|NCT00075725|1254778|P1|Overall Study|Withdrawal by Subject|12
398346|NCT00075725|1254767|P12|Overall Study|Protocol Violation|1
398347|NCT00075725|1254768|P11|Overall Study|Protocol Violation|0
398348|NCT00075725|1254769|P10|Overall Study|Protocol Violation|0
398349|NCT00075725|1254770|P9|Overall Study|Protocol Violation|3
398350|NCT00075725|1254771|P8|Overall Study|Protocol Violation|2
398351|NCT00075725|1254772|P7|Overall Study|Protocol Violation|1
398352|NCT00075725|1254773|P6|Overall Study|Protocol Violation|2
398353|NCT00075725|1254774|P5|Overall Study|Protocol Violation|3
398354|NCT00075725|1254775|P4|Overall Study|Protocol Violation|3
398355|NCT00075725|1254776|P3|Overall Study|Protocol Violation|0
398356|NCT00075725|1254777|P2|Overall Study|Protocol Violation|1
398357|NCT00075725|1254778|P1|Overall Study|Protocol Violation|1
398358|NCT00075725|1254767|P12|Overall Study|Pregnancy|0
398359|NCT00075725|1254768|P11|Overall Study|Pregnancy|0
398360|NCT00075725|1254769|P10|Overall Study|Pregnancy|0
398361|NCT00075725|1254770|P9|Overall Study|Pregnancy|0
398362|NCT00075725|1254771|P8|Overall Study|Pregnancy|1
398363|NCT00075725|1254772|P7|Overall Study|Pregnancy|0
398364|NCT00075725|1254773|P6|Overall Study|Pregnancy|1
398365|NCT00075725|1254774|P5|Overall Study|Pregnancy|0
398366|NCT00075725|1254775|P4|Overall Study|Pregnancy|0
398367|NCT00075725|1254776|P3|Overall Study|Pregnancy|0
398368|NCT00075725|1254777|P2|Overall Study|Pregnancy|0
398369|NCT00075725|1254778|P1|Overall Study|Pregnancy|0
398370|NCT00075725|1254767|P12|Overall Study|Physician Decision|0
398371|NCT00075725|1254768|P11|Overall Study|Physician Decision|1
398372|NCT00075725|1254769|P10|Overall Study|Physician Decision|0
398373|NCT00075725|1254770|P9|Overall Study|Physician Decision|5
398374|NCT00075725|1254771|P8|Overall Study|Physician Decision|17
398375|NCT00075725|1254772|P7|Overall Study|Physician Decision|3
398376|NCT00075725|1254773|P6|Overall Study|Physician Decision|19
398377|NCT00075725|1254774|P5|Overall Study|Physician Decision|4
398378|NCT00075725|1254775|P4|Overall Study|Physician Decision|8
398379|NCT00075725|1254776|P3|Overall Study|Physician Decision|5
398380|NCT00075725|1254777|P2|Overall Study|Physician Decision|6
398381|NCT00075725|1254778|P1|Overall Study|Physician Decision|2
398382|NCT00075725|1254767|P12|Overall Study|Lost to Follow-up|0
398383|NCT00075725|1254768|P11|Overall Study|Lost to Follow-up|0
398384|NCT00075725|1254769|P10|Overall Study|Lost to Follow-up|0
398385|NCT00075725|1254770|P9|Overall Study|Lost to Follow-up|1
398386|NCT00075725|1254771|P8|Overall Study|Lost to Follow-up|4
398387|NCT00075725|1254772|P7|Overall Study|Lost to Follow-up|2
398388|NCT00075725|1254773|P6|Overall Study|Lost to Follow-up|13
398389|NCT00075725|1254774|P5|Overall Study|Lost to Follow-up|0
398390|NCT00075725|1254775|P4|Overall Study|Lost to Follow-up|1
398391|NCT00075725|1254776|P3|Overall Study|Lost to Follow-up|4
398392|NCT00075725|1254777|P2|Overall Study|Lost to Follow-up|1
398393|NCT00075725|1254778|P1|Overall Study|Lost to Follow-up|1
398394|NCT00075725|1254767|P12|Overall Study|Death|0
398395|NCT00075725|1254768|P11|Overall Study|Death|3
398396|NCT00075725|1254769|P10|Overall Study|Death|4
398397|NCT00075725|1254770|P9|Overall Study|Death|14
398398|NCT00075725|1254771|P8|Overall Study|Death|22
398399|NCT00075725|1254772|P7|Overall Study|Death|4
398400|NCT00075725|1254773|P6|Overall Study|Death|25
398401|NCT00075725|1254774|P5|Overall Study|Death|3
398402|NCT00075725|1254775|P4|Overall Study|Death|2
398403|NCT00075725|1254776|P3|Overall Study|Death|10
398404|NCT00075725|1254777|P2|Overall Study|Death|5
398405|NCT00075725|1254778|P1|Overall Study|Death|3
398406|NCT00075725|1254767|P12|Overall Study|Adverse Event|2
398407|NCT00075725|1254768|P11|Overall Study|Adverse Event|2
398408|NCT00075725|1254769|P10|Overall Study|Adverse Event|4
398409|NCT00075725|1254770|P9|Overall Study|Adverse Event|15
398410|NCT00075725|1254771|P8|Overall Study|Adverse Event|51
398411|NCT00075725|1254772|P7|Overall Study|Adverse Event|3
398412|NCT00075725|1254773|P6|Overall Study|Adverse Event|38
398413|NCT00075725|1254774|P5|Overall Study|Adverse Event|4
398414|NCT00075725|1254775|P4|Overall Study|Adverse Event|8
398415|NCT00075725|1254776|P3|Overall Study|Adverse Event|20
398416|NCT00075725|1254777|P2|Overall Study|Adverse Event|6
398417|NCT00075725|1254778|P1|Overall Study|Adverse Event|6
398418|NCT00075582|1254875|P2|Overall Study|Ineligible for study|16
398419|NCT00075582|1254876|P1|Overall Study|Ineligible for study|36
398420|NCT00075582|1254875|P2|Overall Study|Withdrawal by Subject|2
398421|NCT00075582|1254876|P1|Overall Study|Withdrawal by Subject|2
398422|NCT00075582|1254875|P2|Overall Study|Physician Decision|8
398423|NCT00075582|1254876|P1|Overall Study|Physician Decision|5
398424|NCT00075582|1254875|P2|Overall Study|Lack of Efficacy|8
398425|NCT00075582|1254876|P1|Overall Study|Lack of Efficacy|4
398426|NCT00075582|1254875|P2|Overall Study|Adverse Event|1
398427|NCT00075582|1254876|P1|Overall Study|Adverse Event|3
398428|NCT00075504|1254886|P2|Overall Study|Withdrawal by Subject|7
398429|NCT00075504|1254887|P1|Overall Study|Withdrawal by Subject|9
398430|NCT00075478|1254899|P2|Overall Study|Physician Decision|1
398431|NCT00075478|1254900|P1|Overall Study|Physician Decision|0
398432|NCT00075478|1254899|P2|Overall Study|not eligible|0
398433|NCT00075478|1254900|P1|Overall Study|not eligible|1
398434|NCT00075400|1254920|P1|Overall Study|Never treated|2
398435|NCT00075400|1254920|P1|Overall Study|Ineligible: wrong primary|1
398436|NCT00075270|1254928|P2|Overall Study|Missing|13
398437|NCT00075270|1254929|P1|Overall Study|Missing|26
398438|NCT00075270|1254928|P2|Overall Study|Other/Unknown|5
398439|NCT00075270|1254929|P1|Overall Study|Other/Unknown|9
398440|NCT00075270|1254928|P2|Overall Study|Death|215
398441|NCT00075270|1254929|P1|Overall Study|Death|198
398442|NCT00075270|1254928|P2|Overall Study|Protocol Violation|2
398443|NCT00075270|1254929|P1|Overall Study|Protocol Violation|0
398444|NCT00075270|1254928|P2|Overall Study|Lost to Follow-up|28
398445|NCT00075270|1254929|P1|Overall Study|Lost to Follow-up|25
398446|NCT00075270|1254928|P2|Overall Study|Withdrawal by Subject|21
398447|NCT00075270|1254929|P1|Overall Study|Withdrawal by Subject|28
398448|NCT00075218|1254975|P3|Open-Label Treatment|enrolled in a separate continuation|9
398449|NCT00075218|1254976|P2|Open-Label Treatment|enrolled in a separate continuation|0
398450|NCT00075218|1254977|P1|Open-Label Treatment|enrolled in a separate continuation|0
398451|NCT00075218|1254975|P3|Open-Label Treatment|Protocol Violation|1
398452|NCT00075218|1254976|P2|Open-Label Treatment|Protocol Violation|0
398453|NCT00075218|1254977|P1|Open-Label Treatment|Protocol Violation|0
398454|NCT00075218|1254975|P3|Open-Label Treatment|Decision of Sponsor|8
398455|NCT00075218|1254976|P2|Open-Label Treatment|Decision of Sponsor|0
398456|NCT00075218|1254977|P1|Open-Label Treatment|Decision of Sponsor|0
398457|NCT00075218|1254975|P3|Open-Label Treatment|Withdrawal by Subject|12
398458|NCT00075218|1254976|P2|Open-Label Treatment|Withdrawal by Subject|0
398459|NCT00075218|1254977|P1|Open-Label Treatment|Withdrawal by Subject|0
398460|NCT00075218|1254975|P3|Open-Label Treatment|Adverse Event|51
398461|NCT00075218|1254976|P2|Open-Label Treatment|Adverse Event|0
398462|NCT00075218|1254977|P1|Open-Label Treatment|Adverse Event|0
398463|NCT00075218|1254975|P3|Open-Label Treatment|Lack of Efficacy|174
398464|NCT00075218|1254976|P2|Open-Label Treatment|Lack of Efficacy|0
398465|NCT00075218|1254977|P1|Open-Label Treatment|Lack of Efficacy|0
398466|NCT00075218|1254975|P3|Double-Blind Treatment|No study medication taken|0
398467|NCT00075218|1254976|P2|Double-Blind Treatment|No study medication taken|0
398468|NCT00075218|1254977|P1|Double-Blind Treatment|No study medication taken|2
398469|NCT00075218|1254975|P3|Double-Blind Treatment|Decision of Sponsor|0
398470|NCT00075218|1254976|P2|Double-Blind Treatment|Decision of Sponsor|1
398471|NCT00075218|1254977|P1|Double-Blind Treatment|Decision of Sponsor|0
398472|NCT00075218|1254975|P3|Double-Blind Treatment|Lack of Efficacy|0
398473|NCT00075218|1254976|P2|Double-Blind Treatment|Lack of Efficacy|6
398474|NCT00075218|1254977|P1|Double-Blind Treatment|Lack of Efficacy|58
398475|NCT00075218|1254975|P3|Double-Blind Treatment|Lost to Follow-up|0
398476|NCT00075218|1254976|P2|Double-Blind Treatment|Lost to Follow-up|0
398477|NCT00075218|1254977|P1|Double-Blind Treatment|Lost to Follow-up|1
398478|NCT00075218|1254975|P3|Double-Blind Treatment|Withdrawal by Subject|0
398479|NCT00075218|1254976|P2|Double-Blind Treatment|Withdrawal by Subject|4
398480|NCT00075218|1254977|P1|Double-Blind Treatment|Withdrawal by Subject|7
398481|NCT00075218|1254975|P3|Double-Blind Treatment|Adverse Event|0
398482|NCT00075218|1254976|P2|Double-Blind Treatment|Adverse Event|4
398483|NCT00075218|1254977|P1|Double-Blind Treatment|Adverse Event|23
398484|NCT00075023|1255026|P2|Pilot Study|Withdrawal by Subject|0
398485|NCT00075023|1255027|P1|Pilot Study|Withdrawal by Subject|1
398486|NCT00075023|1255026|P2|Pilot Study|Physician Decision|2
398487|NCT00075023|1255027|P1|Pilot Study|Physician Decision|1
398488|NCT00074984|1255036|P2|Overall Study|Patient Withdrawn Per Protocol|3
398489|NCT00074984|1255037|P1|Overall Study|Patient Withdrawn Per Protocol|0
398490|NCT00074984|1255036|P2|Overall Study|Withdrawal by Subject|3
398491|NCT00074984|1255037|P1|Overall Study|Withdrawal by Subject|2
398492|NCT00074984|1255036|P2|Overall Study|Death|2
398493|NCT00074984|1255037|P1|Overall Study|Death|1
398494|NCT00074958|1255052|P1|Overall Study|Adverse Event|1
398495|NCT00074711|1255093|P2|Overall Study|Participant stopped study drug|6
398496|NCT00074711|1255094|P1|Overall Study|Participant stopped study drug|4
398497|NCT00074711|1255093|P2|Overall Study|Lost to Follow-up|8
398498|NCT00074711|1255094|P1|Overall Study|Lost to Follow-up|10
398499|NCT00074711|1255093|P2|Overall Study|Withdrawal by Subject|1
398500|NCT00074711|1255094|P1|Overall Study|Withdrawal by Subject|1
398501|NCT00074581|1255112|P2|Overall Study|Other|19
398502|NCT00074581|1255113|P1|Overall Study|Other|14
398503|NCT00074581|1255112|P2|Overall Study|Ended relationship w. index participant|106
398504|NCT00074581|1255113|P1|Overall Study|Ended relationship w. index participant|117
398505|NCT00074581|1255112|P2|Overall Study|Lost to Follow-up|11
398506|NCT00074581|1255113|P1|Overall Study|Lost to Follow-up|16
398507|NCT00074581|1255112|P2|Overall Study|Were withdrawn by investigator|2
398508|NCT00074581|1255113|P1|Overall Study|Were withdrawn by investigator|5
398509|NCT00074581|1255112|P2|Overall Study|Relocated|9
398510|NCT00074581|1255113|P1|Overall Study|Relocated|14
398511|NCT00074581|1255112|P2|Overall Study|Unable to adhere to visit schedule|14
398512|NCT00074581|1255113|P1|Overall Study|Unable to adhere to visit schedule|13
398513|NCT00074581|1255112|P2|Overall Study|Withdrawal by Subject|49
398514|NCT00074581|1255113|P1|Overall Study|Withdrawal by Subject|50
398515|NCT00074581|1255112|P2|Overall Study|Death|16
398516|NCT00074581|1255113|P1|Overall Study|Death|15
398517|NCT00074412|1255123|P2|Overall Study|Lost to Follow-up|58
398518|NCT00074412|1255124|P1|Overall Study|Lost to Follow-up|52
398519|NCT00074412|1255123|P2|Overall Study|Death|26
398520|NCT00074412|1255124|P1|Overall Study|Death|30
398521|NCT00074152|1255149|P2|Overall Study|Lack of Efficacy|24
398522|NCT00074152|1255150|P1|Overall Study|Lack of Efficacy|34
398523|NCT00074152|1255149|P2|Overall Study|Death|9
398524|NCT00074152|1255150|P1|Overall Study|Death|21
398525|NCT00073983|1255167|P1|Overall Study|not evaluable|1
398526|NCT00073918|1255182|P1|Overall Study|Eligibility requirement not met-low CD20|1
398527|NCT00073918|1255182|P1|Overall Study|Rapid disease progression|2
398528|NCT00073918|1255182|P1|Overall Study|Eligibility requirement not met - HAMA+|1
398529|NCT00073528|1255189|P2|Overall Study|Ongoing|344
398530|NCT00073528|1255190|P1|Overall Study|Ongoing|349
398531|NCT00073528|1255189|P2|Overall Study|Non-compliance|1
398532|NCT00073528|1255190|P1|Overall Study|Non-compliance|0
398533|NCT00073528|1255189|P2|Overall Study|Enrolled in Error|1
398534|NCT00073528|1255190|P1|Overall Study|Enrolled in Error|0
398535|NCT00073528|1255189|P2|Overall Study|Participant Was Unblinded|1
398536|NCT00073528|1255190|P1|Overall Study|Participant Was Unblinded|0
398537|NCT00073528|1255189|P2|Overall Study|Progressive Disease|1
398538|NCT00073528|1255190|P1|Overall Study|Progressive Disease|0
398539|NCT00073528|1255189|P2|Overall Study|Randomized in Error; Not Treated|0
398540|NCT00073528|1255190|P1|Overall Study|Randomized in Error; Not Treated|2
398541|NCT00073528|1255189|P2|Overall Study|Mastectomy Intervention|0
398542|NCT00073528|1255190|P1|Overall Study|Mastectomy Intervention|1
398543|NCT00073528|1255189|P2|Overall Study|Death|238
398544|NCT00073528|1255190|P1|Overall Study|Death|229
398545|NCT00073528|1255189|P2|Overall Study|Protocol Violation|5
398546|NCT00073528|1255190|P1|Overall Study|Protocol Violation|3
398547|NCT00073528|1255189|P2|Overall Study|Lost to Follow-up|22
398548|NCT00073528|1255190|P1|Overall Study|Lost to Follow-up|26
398549|NCT00073528|1255189|P2|Overall Study|Withdrawal by Subject|29
398550|NCT00073528|1255190|P1|Overall Study|Withdrawal by Subject|34
398551|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
398552|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
398553|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
398554|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
398555|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
398556|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
398557|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
398558|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
398559|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
398560|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
398561|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
398562|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
398563|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
398564|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
398565|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
398566|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
398567|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
398568|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
398569|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
398570|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
398571|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
398572|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
398573|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
398574|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
398575|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
398576|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
398577|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
398578|NCT00073307|1255279|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
398579|NCT00073307|1255280|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
398580|NCT00073307|1255281|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
398581|NCT00073307|1255279|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
398582|NCT00073307|1255280|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
398583|NCT00073307|1255281|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
398584|NCT00073307|1255279|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
398585|NCT00073307|1255280|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
398586|NCT00073307|1255281|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
398587|NCT00073307|1255279|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
398588|NCT00073307|1255280|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
398589|NCT00073307|1255281|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
398590|NCT00073307|1255279|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
398591|NCT00073307|1255280|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
398592|NCT00073307|1255281|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
398593|NCT00073307|1255279|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
398594|NCT00073307|1255280|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
398595|NCT00073307|1255281|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
398596|NCT00073307|1255279|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
398597|NCT00073307|1255280|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
398598|NCT00073307|1255281|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
398599|NCT00073307|1255279|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
398600|NCT00073307|1255280|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
398601|NCT00073307|1255281|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
398602|NCT00073307|1255279|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
398603|NCT00073307|1255280|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
398604|NCT00073307|1255281|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
398605|NCT00073307|1255279|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
398606|NCT00073307|1255280|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
398607|NCT00073307|1255281|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
398608|NCT00073021|1255312|P2|Overall Study|Lack of Efficacy|5
398609|NCT00073021|1255313|P1|Overall Study|Lack of Efficacy|11
398610|NCT00073021|1255312|P2|Overall Study|Physician Decision|1
398611|NCT00073021|1255313|P1|Overall Study|Physician Decision|3
398612|NCT00073021|1255312|P2|Overall Study|Withdrawal by Subject|5
398613|NCT00073021|1255313|P1|Overall Study|Withdrawal by Subject|6
398614|NCT00073021|1255312|P2|Overall Study|Adverse Event|4
398615|NCT00073021|1255313|P1|Overall Study|Adverse Event|4
398616|NCT00073021|1255312|P2|Overall Study|Protocol Violation|1
398617|NCT00073021|1255313|P1|Overall Study|Protocol Violation|2
398618|NCT00073008|1255343|P2|Overall Study|"Other selected on Case Report Form"|5
398619|NCT00073008|1255344|P1|Overall Study|"Other selected on Case Report Form"|7
398620|NCT00073008|1255343|P2|Overall Study|Death|47
398621|NCT00073008|1255344|P1|Overall Study|Death|46
398622|NCT00073008|1255343|P2|Overall Study|Lost to Follow-up|3
398623|NCT00073008|1255344|P1|Overall Study|Lost to Follow-up|1
398624|NCT00073008|1255343|P2|Overall Study|Withdrawal by Subject|2
398625|NCT00073008|1255344|P1|Overall Study|Withdrawal by Subject|2
398626|NCT00073008|1255343|P2|Overall Study|Missing|6
398627|NCT00073008|1255344|P1|Overall Study|Missing|6
398628|NCT00072475|1255389|P1|Overall Study|Patient/Investigator Decision|4
398629|NCT00072475|1255389|P1|Overall Study|Withdrawal by Subject|46
398630|NCT00072475|1255389|P1|Overall Study|Death|3
398631|NCT00072475|1255389|P1|Overall Study|Adverse Event|44
398632|NCT00072293|1255406|P2|Overall Study|Withdrawal by Subject|1
398633|NCT00072293|1255407|P1|Overall Study|Withdrawal by Subject|0
398634|NCT00072293|1255406|P2|Overall Study|Lost to Follow-up|1
398635|NCT00072293|1255407|P1|Overall Study|Lost to Follow-up|1
398636|NCT00072280|1255419|P2|Follow-up|Early termination of study|2
398637|NCT00072280|1255420|P1|Follow-up|Early termination of study|2
398638|NCT00072280|1255419|P2|Treatment|Found ineligible|2
398639|NCT00072280|1255420|P1|Treatment|Found ineligible|1
398640|NCT00072189|1255425|P1|Overall Study|Withdrawal by Subject|1
398641|NCT00072176|1255433|P2|Overall Study|Protocol Violation|1
398642|NCT00072176|1255434|P1|Overall Study|Protocol Violation|0
398643|NCT00072176|1255433|P2|Overall Study|Withdrawal by Subject|0
398644|NCT00072176|1255434|P1|Overall Study|Withdrawal by Subject|1
398645|NCT00071981|1255446|P4|Overall Study|others (not specified in the study)|0
398646|NCT00071981|1255447|P3|Overall Study|others (not specified in the study)|2
398647|NCT00071981|1255448|P2|Overall Study|others (not specified in the study)|2
398648|NCT00071981|1255449|P1|Overall Study|others (not specified in the study)|0
398649|NCT00071981|1255446|P4|Overall Study|No protocol therapy|0
398650|NCT00071981|1255447|P3|Overall Study|No protocol therapy|1
398651|NCT00071981|1255448|P2|Overall Study|No protocol therapy|5
398652|NCT00071981|1255449|P1|Overall Study|No protocol therapy|2
398653|NCT00071981|1255446|P4|Overall Study|Withdrawal by Subject|0
398654|NCT00071981|1255447|P3|Overall Study|Withdrawal by Subject|0
398655|NCT00071981|1255448|P2|Overall Study|Withdrawal by Subject|1
398656|NCT00071981|1255449|P1|Overall Study|Withdrawal by Subject|3
398657|NCT00071981|1255446|P4|Overall Study|Death|1
398658|NCT00071981|1255447|P3|Overall Study|Death|1
398659|NCT00071981|1255448|P2|Overall Study|Death|0
398660|NCT00071981|1255449|P1|Overall Study|Death|0
398661|NCT00071981|1255446|P4|Overall Study|Adverse Event|1
398662|NCT00071981|1255447|P3|Overall Study|Adverse Event|3
398663|NCT00071981|1255448|P2|Overall Study|Adverse Event|4
398664|NCT00071981|1255449|P1|Overall Study|Adverse Event|4
398665|NCT00071981|1255446|P4|Overall Study|Lack of Efficacy|43
398666|NCT00071981|1255447|P3|Overall Study|Lack of Efficacy|30
398667|NCT00071981|1255448|P2|Overall Study|Lack of Efficacy|29
398668|NCT00071981|1255449|P1|Overall Study|Lack of Efficacy|37
398669|NCT00071812|1255492|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
398670|NCT00071812|1255493|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
398671|NCT00071812|1255494|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
398672|NCT00071812|1255495|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
398673|NCT00071812|1255492|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
398674|NCT00071812|1255493|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
398675|NCT00071812|1255494|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
398676|NCT00071812|1255495|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
398677|NCT00071812|1255492|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
398678|NCT00071812|1255493|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
398679|NCT00071812|1255494|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
398680|NCT00071812|1255495|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
398681|NCT00071812|1255492|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
398682|NCT00071812|1255493|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
398683|NCT00071812|1255494|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
398684|NCT00071812|1255495|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
398685|NCT00071812|1255492|P4|24-Week Open-Label Extension Period|Adverse Event|7
398686|NCT00071812|1255493|P3|24-Week Open-Label Extension Period|Adverse Event|0
398687|NCT00071812|1255494|P2|24-Week Open-Label Extension Period|Adverse Event|0
398688|NCT00071812|1255495|P1|24-Week Open-Label Extension Period|Adverse Event|0
398689|NCT00071812|1255492|P4|24-Week Double-Blind Period|Protocol Violation|1
398690|NCT00071812|1255493|P3|24-Week Double-Blind Period|Protocol Violation|0
398691|NCT00071812|1255494|P2|24-Week Double-Blind Period|Protocol Violation|0
398692|NCT00071812|1255495|P1|24-Week Double-Blind Period|Protocol Violation|0
398693|NCT00071812|1255492|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
398694|NCT00071812|1255493|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
398695|NCT00071812|1255494|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
398696|NCT00071812|1255495|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
398697|NCT00071812|1255492|P4|24-Week Double-Blind Period|Lost to Follow-up|0
398698|NCT00071812|1255493|P3|24-Week Double-Blind Period|Lost to Follow-up|1
398699|NCT00071812|1255494|P2|24-Week Double-Blind Period|Lost to Follow-up|1
398700|NCT00071812|1255495|P1|24-Week Double-Blind Period|Lost to Follow-up|0
398701|NCT00071812|1255492|P4|24-Week Double-Blind Period|Lack of Efficacy|1
398702|NCT00071812|1255493|P3|24-Week Double-Blind Period|Lack of Efficacy|2
398703|NCT00071812|1255494|P2|24-Week Double-Blind Period|Lack of Efficacy|1
398704|NCT00071812|1255495|P1|24-Week Double-Blind Period|Lack of Efficacy|3
398705|NCT00071812|1255492|P4|24-Week Double-Blind Period|Adverse Event|4
398706|NCT00071812|1255493|P3|24-Week Double-Blind Period|Adverse Event|4
398707|NCT00071812|1255494|P2|24-Week Double-Blind Period|Adverse Event|3
398708|NCT00071812|1255495|P1|24-Week Double-Blind Period|Adverse Event|2
398709|NCT00071799|1255537|P2|Overall Study|Not Documented|2
398710|NCT00071799|1255538|P1|Overall Study|Not Documented|0
398711|NCT00071799|1255537|P2|Overall Study|Different Central+Local Pathology Review|1
398712|NCT00071799|1255538|P1|Overall Study|Different Central+Local Pathology Review|0
398713|NCT00071799|1255537|P2|Overall Study|Disease Progression|20
398714|NCT00071799|1255538|P1|Overall Study|Disease Progression|23
398715|NCT00071799|1255537|P2|Overall Study|Lack of Efficacy|18
398716|NCT00071799|1255538|P1|Overall Study|Lack of Efficacy|11
398717|NCT00071799|1255537|P2|Overall Study|Physician Decision|2
398718|NCT00071799|1255538|P1|Overall Study|Physician Decision|0
398719|NCT00071799|1255537|P2|Overall Study|Withdrawal by Subject|37
398720|NCT00071799|1255538|P1|Overall Study|Withdrawal by Subject|15
398721|NCT00071799|1255537|P2|Overall Study|Lost to Follow-up|1
398722|NCT00071799|1255538|P1|Overall Study|Lost to Follow-up|1
398723|NCT00071799|1255537|P2|Overall Study|Protocol Violation|7
398724|NCT00071799|1255538|P1|Overall Study|Protocol Violation|1
398725|NCT00071799|1255537|P2|Overall Study|Adverse Event|10
398726|NCT00071799|1255538|P1|Overall Study|Adverse Event|19
398727|NCT00071760|1255578|P1|Overall Study|Ongoing|25
398728|NCT00071760|1255578|P1|Overall Study|Study Team Rec./Resistance|1
398729|NCT00071760|1255578|P1|Overall Study|Investigator's Recommendation (Rec.)|4
398730|NCT00071760|1255578|P1|Overall Study|Relocation|1
398731|NCT00071760|1255578|P1|Overall Study|Unavailability of RTV|8
398732|NCT00071760|1255578|P1|Overall Study|Pulmonary Tuberculosis|1
398733|NCT00071760|1255578|P1|Overall Study|Insufficient Viral Load Response|3
398734|NCT00071760|1255578|P1|Overall Study|Withdrawal by Subject|3
398735|NCT00071760|1255578|P1|Overall Study|Protocol Violation|1
398736|NCT00071760|1255578|P1|Overall Study|Lost to Follow-up|4
398737|NCT00071760|1255578|P1|Overall Study|Adverse Event|3
398738|NCT00071513|1255658|P2|Follow-up Assessment|Withdrawal by Subject|6
398739|NCT00071513|1255659|P1|Follow-up Assessment|Withdrawal by Subject|6
398740|NCT00071513|1255658|P2|Intervention Component|Withdrawal by Subject|3
398741|NCT00071513|1255659|P1|Intervention Component|Withdrawal by Subject|2
398742|NCT00071487|1255671|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
398743|NCT00071487|1255672|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
398744|NCT00071487|1255673|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
398745|NCT00071487|1255674|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
398746|NCT00071487|1255671|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
398747|NCT00071487|1255672|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
398748|NCT00071487|1255673|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
398749|NCT00071487|1255674|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
398750|NCT00071487|1255671|P4|24-Week Open-Label Extension Period|Pregnancy|1
398751|NCT00071487|1255672|P3|24-Week Open-Label Extension Period|Pregnancy|0
398752|NCT00071487|1255673|P2|24-Week Open-Label Extension Period|Pregnancy|0
398753|NCT00071487|1255674|P1|24-Week Open-Label Extension Period|Pregnancy|0
398754|NCT00071487|1255671|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
398755|NCT00071487|1255672|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
398756|NCT00071487|1255673|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
398757|NCT00071487|1255674|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
398758|NCT00071487|1255671|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
398759|NCT00071487|1255672|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
398760|NCT00071487|1255673|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
398761|NCT00071487|1255674|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
398762|NCT00071487|1255671|P4|24-Week Open-Label Extension Period|Adverse Event|6
398763|NCT00071487|1255672|P3|24-Week Open-Label Extension Period|Adverse Event|1
398764|NCT00071487|1255673|P2|24-Week Open-Label Extension Period|Adverse Event|0
398765|NCT00071487|1255674|P1|24-Week Open-Label Extension Period|Adverse Event|0
398766|NCT00071487|1255671|P4|52-Week Double-Blind Period|Lack of Compliance|3
398767|NCT00071487|1255672|P3|52-Week Double-Blind Period|Lack of Compliance|3
398768|NCT00071487|1255673|P2|52-Week Double-Blind Period|Lack of Compliance|3
398769|NCT00071487|1255674|P1|52-Week Double-Blind Period|Lack of Compliance|6
398770|NCT00071487|1255671|P4|52-Week Double-Blind Period|Death|0
398771|NCT00071487|1255672|P3|52-Week Double-Blind Period|Death|0
398772|NCT00071487|1255673|P2|52-Week Double-Blind Period|Death|1
398773|NCT00071487|1255674|P1|52-Week Double-Blind Period|Death|0
398774|NCT00071487|1255671|P4|52-Week Double-Blind Period|Protocol Violation|0
398775|NCT00071487|1255672|P3|52-Week Double-Blind Period|Protocol Violation|1
398776|NCT00071487|1255673|P2|52-Week Double-Blind Period|Protocol Violation|1
398777|NCT00071487|1255674|P1|52-Week Double-Blind Period|Protocol Violation|0
398778|NCT00071487|1255671|P4|52-Week Double-Blind Period|Pregnancy|0
398779|NCT00071487|1255672|P3|52-Week Double-Blind Period|Pregnancy|0
398780|NCT00071487|1255673|P2|52-Week Double-Blind Period|Pregnancy|1
398781|NCT00071487|1255674|P1|52-Week Double-Blind Period|Pregnancy|0
398782|NCT00071487|1255671|P4|52-Week Double-Blind Period|Lost to Follow-up|2
398783|NCT00071487|1255672|P3|52-Week Double-Blind Period|Lost to Follow-up|2
398784|NCT00071487|1255673|P2|52-Week Double-Blind Period|Lost to Follow-up|0
398785|NCT00071487|1255674|P1|52-Week Double-Blind Period|Lost to Follow-up|0
398786|NCT00071487|1255671|P4|52-Week Double-Blind Period|Physician Decision|0
398787|NCT00071487|1255672|P3|52-Week Double-Blind Period|Physician Decision|0
398788|NCT00071487|1255673|P2|52-Week Double-Blind Period|Physician Decision|0
398789|NCT00071487|1255674|P1|52-Week Double-Blind Period|Physician Decision|1
398790|NCT00071487|1255671|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
398791|NCT00071487|1255672|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
398792|NCT00071487|1255673|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
398793|NCT00071487|1255674|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
398794|NCT00071487|1255671|P4|52-Week Double-Blind Period|Lack of Efficacy|1
398795|NCT00071487|1255672|P3|52-Week Double-Blind Period|Lack of Efficacy|0
398796|NCT00071487|1255673|P2|52-Week Double-Blind Period|Lack of Efficacy|2
398797|NCT00071487|1255674|P1|52-Week Double-Blind Period|Lack of Efficacy|1
398798|NCT00071487|1255671|P4|52-Week Double-Blind Period|Adverse Event|8
398799|NCT00071487|1255672|P3|52-Week Double-Blind Period|Adverse Event|4
398800|NCT00071487|1255673|P2|52-Week Double-Blind Period|Adverse Event|8
398801|NCT00071487|1255674|P1|52-Week Double-Blind Period|Adverse Event|5
398802|NCT00071396|1255718|P1|Overall Study|Physician Decision|2
398803|NCT00071396|1255718|P1|Overall Study|Withdrawal by Subject|1
398804|NCT00071110|1255724|P2|Overall Study|Protocol Violation|4
398805|NCT00071110|1255725|P1|Overall Study|Protocol Violation|0
398806|NCT00071058|1255737|P1|Overall Study|brain tumor-removed from study|1
398807|NCT00071032|1255744|P2|Overall Study|Missing Primary Outcome|1
398808|NCT00071032|1255745|P1|Overall Study|Missing Primary Outcome|0
398809|NCT00071032|1255744|P2|Overall Study|Withdrawal by Subject|6
398810|NCT00071032|1255745|P1|Overall Study|Withdrawal by Subject|8
398811|NCT00071032|1255744|P2|Overall Study|Lost to Follow-up|1
398812|NCT00071032|1255745|P1|Overall Study|Lost to Follow-up|1
398813|NCT00071006|1255753|P1|Overall Study|Unspecified|3
398814|NCT00071006|1255753|P1|Overall Study|Withdrawal by Subject|1
398815|NCT00071006|1255753|P1|Overall Study|Adverse Event|1
398816|NCT00071006|1255753|P1|Overall Study|Lack of Efficacy|7
398817|NCT00070941|1255766|P3|Overall Study|Adverse Event|4
398818|NCT00070941|1255767|P2|Overall Study|Adverse Event|8
398819|NCT00070941|1255768|P1|Overall Study|Adverse Event|10
398820|NCT00070564|1255780|P6|Overall Study|Not reported|0
398821|NCT00070564|1255781|P5|Overall Study|Not reported|1
398822|NCT00070564|1255782|P4|Overall Study|Not reported|0
398823|NCT00070564|1255783|P3|Overall Study|Not reported|0
398824|NCT00070564|1255784|P2|Overall Study|Not reported|0
398825|NCT00070564|1255785|P1|Overall Study|Not reported|0
398826|NCT00070564|1255780|P6|Overall Study|Withdrawal by Subject|8
398827|NCT00070564|1255781|P5|Overall Study|Withdrawal by Subject|8
398828|NCT00070564|1255782|P4|Overall Study|Withdrawal by Subject|30
398829|NCT00070564|1255783|P3|Overall Study|Withdrawal by Subject|23
398830|NCT00070564|1255784|P2|Overall Study|Withdrawal by Subject|37
398831|NCT00070564|1255785|P1|Overall Study|Withdrawal by Subject|26
398832|NCT00070564|1255780|P6|Overall Study|Other, not protocol specified|7
398833|NCT00070564|1255781|P5|Overall Study|Other, not protocol specified|6
398834|NCT00070564|1255782|P4|Overall Study|Other, not protocol specified|19
398835|NCT00070564|1255783|P3|Overall Study|Other, not protocol specified|14
398836|NCT00070564|1255784|P2|Overall Study|Other, not protocol specified|15
398837|NCT00070564|1255785|P1|Overall Study|Other, not protocol specified|17
398838|NCT00070564|1255780|P6|Overall Study|Death|1
398839|NCT00070564|1255781|P5|Overall Study|Death|0
398840|NCT00070564|1255782|P4|Overall Study|Death|3
398841|NCT00070564|1255783|P3|Overall Study|Death|5
398842|NCT00070564|1255784|P2|Overall Study|Death|1
398843|NCT00070564|1255785|P1|Overall Study|Death|4
398844|NCT00070564|1255780|P6|Overall Study|Adverse Event|36
398845|NCT00070564|1255781|P5|Overall Study|Adverse Event|63
398846|NCT00070564|1255782|P4|Overall Study|Adverse Event|108
398847|NCT00070564|1255783|P3|Overall Study|Adverse Event|120
398848|NCT00070564|1255784|P2|Overall Study|Adverse Event|142
398849|NCT00070564|1255785|P1|Overall Study|Adverse Event|150
398850|NCT00070564|1255780|P6|Overall Study|Delinquent|0
398851|NCT00070564|1255781|P5|Overall Study|Delinquent|0
398852|NCT00070564|1255782|P4|Overall Study|Delinquent|0
398853|NCT00070564|1255783|P3|Overall Study|Delinquent|2
398854|NCT00070564|1255784|P2|Overall Study|Delinquent|4
398855|NCT00070564|1255785|P1|Overall Study|Delinquent|1
398856|NCT00070564|1255780|P6|Overall Study|Progression|0
398857|NCT00070564|1255781|P5|Overall Study|Progression|1
398858|NCT00070564|1255782|P4|Overall Study|Progression|7
398859|NCT00070564|1255783|P3|Overall Study|Progression|7
398860|NCT00070564|1255784|P2|Overall Study|Progression|4
398861|NCT00070564|1255785|P1|Overall Study|Progression|2
398862|NCT00070499|1255831|P4|Overall Study|Not eligible|2
398863|NCT00070499|1255832|P3|Overall Study|Not eligible|3
398864|NCT00070499|1255833|P2|Overall Study|Not eligible|5
398865|NCT00070499|1255834|P1|Overall Study|Not eligible|2
398866|NCT00070499|1255831|P4|Overall Study|Did not start treatment|2
398867|NCT00070499|1255832|P3|Overall Study|Did not start treatment|0
398868|NCT00070499|1255833|P2|Overall Study|Did not start treatment|0
398869|NCT00070499|1255834|P1|Overall Study|Did not start treatment|1
398870|NCT00070499|1255831|P4|Overall Study|Still on protocol treatment|57
398871|NCT00070499|1255832|P3|Overall Study|Still on protocol treatment|79
398872|NCT00070499|1255833|P2|Overall Study|Still on protocol treatment|4
398873|NCT00070499|1255834|P1|Overall Study|Still on protocol treatment|10
398874|NCT00070499|1255831|P4|Overall Study|Other - not protocol specified|20
398875|NCT00070499|1255832|P3|Overall Study|Other - not protocol specified|12
398876|NCT00070499|1255833|P2|Overall Study|Other - not protocol specified|3
398877|NCT00070499|1255834|P1|Overall Study|Other - not protocol specified|7
398878|NCT00070499|1255831|P4|Overall Study|Death|2
398879|NCT00070499|1255832|P3|Overall Study|Death|1
398880|NCT00070499|1255833|P2|Overall Study|Death|1
398881|NCT00070499|1255834|P1|Overall Study|Death|1
398882|NCT00070499|1255831|P4|Overall Study|Progression/relapse|4
398883|NCT00070499|1255832|P3|Overall Study|Progression/relapse|1
398884|NCT00070499|1255833|P2|Overall Study|Progression/relapse|2
398885|NCT00070499|1255834|P1|Overall Study|Progression/relapse|4
398886|NCT00070499|1255831|P4|Overall Study|Refusal unrelated to adverse effects|8
398887|NCT00070499|1255832|P3|Overall Study|Refusal unrelated to adverse effects|5
398888|NCT00070499|1255833|P2|Overall Study|Refusal unrelated to adverse effects|5
398889|NCT00070499|1255834|P1|Overall Study|Refusal unrelated to adverse effects|7
398890|NCT00070499|1255831|P4|Overall Study|Adverse Event|15
398891|NCT00070499|1255832|P3|Overall Study|Adverse Event|19
398892|NCT00070499|1255833|P2|Overall Study|Adverse Event|6
398893|NCT00070499|1255834|P1|Overall Study|Adverse Event|6
398894|NCT00070291|1255860|P1|Step 2|Adverse Event|1
398895|NCT00070291|1255860|P1|Step 1|Adverse Event|1
398896|NCT00070291|1255860|P1|Step 1|Withdrawal by Subject|1
398897|NCT00070109|1255876|P5|Overall Study|removed from prot thpy prior to chemo|0
398898|NCT00070109|1255877|P4|Overall Study|removed from prot thpy prior to chemo|1
398899|NCT00070109|1255878|P3|Overall Study|removed from prot thpy prior to chemo|0
398900|NCT00070109|1255879|P2|Overall Study|removed from prot thpy prior to chemo|0
398901|NCT00070109|1255880|P1|Overall Study|removed from prot thpy prior to chemo|0
398902|NCT00070109|1255876|P5|Overall Study|Adverse Event|2
398903|NCT00070109|1255877|P4|Overall Study|Adverse Event|4
398904|NCT00070109|1255878|P3|Overall Study|Adverse Event|2
398905|NCT00070109|1255879|P2|Overall Study|Adverse Event|0
398906|NCT00070109|1255880|P1|Overall Study|Adverse Event|0
398907|NCT00070109|1255876|P5|Overall Study|Withdrawal by Subject|0
398908|NCT00070109|1255877|P4|Overall Study|Withdrawal by Subject|0
398909|NCT00070109|1255878|P3|Overall Study|Withdrawal by Subject|1
398910|NCT00070109|1255879|P2|Overall Study|Withdrawal by Subject|1
398911|NCT00070109|1255880|P1|Overall Study|Withdrawal by Subject|0
398912|NCT00070109|1255876|P5|Overall Study|Physician Decision|0
398913|NCT00070109|1255877|P4|Overall Study|Physician Decision|0
398914|NCT00070109|1255878|P3|Overall Study|Physician Decision|0
398915|NCT00070109|1255879|P2|Overall Study|Physician Decision|0
398916|NCT00070109|1255880|P1|Overall Study|Physician Decision|1
398917|NCT00070109|1255876|P5|Overall Study|Lack of Efficacy|5
398918|NCT00070109|1255877|P4|Overall Study|Lack of Efficacy|15
398919|NCT00070109|1255878|P3|Overall Study|Lack of Efficacy|5
398920|NCT00070109|1255879|P2|Overall Study|Lack of Efficacy|4
398921|NCT00070109|1255880|P1|Overall Study|Lack of Efficacy|6
398922|NCT00070109|1255876|P5|Overall Study|Death|1
398923|NCT00070109|1255877|P4|Overall Study|Death|0
398924|NCT00070109|1255878|P3|Overall Study|Death|0
398925|NCT00070109|1255879|P2|Overall Study|Death|1
398926|NCT00070109|1255880|P1|Overall Study|Death|1
398927|NCT00070018|1255893|P1|Overall Study|Withdrawal by Subject|1
398928|NCT00070018|1255893|P1|Overall Study|Lack of Efficacy|1
398929|NCT00070018|1255893|P1|Overall Study|Adverse Event|2
398930|NCT00069953|1255897|P1|Overall Study|Protocol Violation|2
398931|NCT00069823|1255903|P2|Overall Study|Did not have follow-up diary cards|3
398932|NCT00069823|1255904|P1|Overall Study|Did not have follow-up diary cards|6
398933|NCT00069784|1255946|P2|Overall Study|Other|0
398934|NCT00069784|1255947|P1|Overall Study|Other|17
398935|NCT00069784|1255946|P2|Overall Study|Withdrawal by Subject|0
398936|NCT00069784|1255947|P1|Overall Study|Withdrawal by Subject|1090
398937|NCT00069784|1255946|P2|Overall Study|Adverse Event|0
398938|NCT00069784|1255947|P1|Overall Study|Adverse Event|105
398939|NCT00069641|1255968|P3|Overall Study|Death|1
398940|NCT00069641|1255969|P2|Overall Study|Death|0
398941|NCT00069641|1255970|P1|Overall Study|Death|1
398942|NCT00069277|1256019|P1|Overall Study|Physician Decision|2
398943|NCT00069277|1256019|P1|Overall Study|Progressive Disease|15
398944|NCT00069277|1256019|P1|Overall Study|Withdrawal by Subject|1
398945|NCT00069277|1256019|P1|Overall Study|Adverse Event|3
398946|NCT00069264|1256023|P1|Overall Study|Discon Therapy|3
398947|NCT00069264|1256023|P1|Overall Study|Withdrawal by Subject|3
398948|NCT00069264|1256023|P1|Overall Study|Progressive Disease|23
398949|NCT00069264|1256023|P1|Overall Study|Adverse Event|3
398950|NCT00069238|1256027|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
398951|NCT00069238|1256028|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
398952|NCT00069238|1256029|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
398953|NCT00069238|1256027|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
398954|NCT00069238|1256028|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
398955|NCT00069238|1256029|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
398956|NCT00069238|1256027|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
398957|NCT00069238|1256028|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
398958|NCT00069238|1256029|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
398959|NCT00069121|1256052|P2|Overall Study|Lost to Follow-up|57
398960|NCT00069121|1256053|P1|Overall Study|Lost to Follow-up|57
398961|NCT00069121|1256052|P2|Overall Study|Withdrawal by Subject|22
398962|NCT00069121|1256053|P1|Overall Study|Withdrawal by Subject|20
398963|NCT00069121|1256052|P2|Overall Study|Death|197
398964|NCT00069121|1256053|P1|Overall Study|Death|225
398965|NCT00069108|1256075|P2|Overall Study|Refused treatment|10
398966|NCT00069108|1256076|P1|Overall Study|Refused treatment|5
398967|NCT00069108|1256075|P2|Overall Study|Violation criteria|4
398968|NCT00069108|1256076|P1|Overall Study|Violation criteria|1
398969|NCT00069108|1256075|P2|Overall Study|Insufficient therapy|144
398970|NCT00069108|1256076|P1|Overall Study|Insufficient therapy|117
398971|NCT00069108|1256075|P2|Overall Study|Administration|4
398972|NCT00069108|1256076|P1|Overall Study|Administration|15
398973|NCT00069108|1256075|P2|Overall Study|Death|6
398974|NCT00069108|1256076|P1|Overall Study|Death|6
398975|NCT00069108|1256075|P2|Overall Study|Adverse Event|42
398976|NCT00069108|1256076|P1|Overall Study|Adverse Event|64
398977|NCT00069108|1256075|P2|Overall Study|Withdrawal by Subject|9
398978|NCT00069108|1256076|P1|Overall Study|Withdrawal by Subject|5
398979|NCT00069095|1256108|P6|Follow-up Phase|Death|101
398980|NCT00069095|1256109|P5|Follow-up Phase|Death|92
398981|NCT00069095|1256110|P4|Follow-up Phase|Death|112
398982|NCT00069095|1256111|P3|Follow-up Phase|Death|120
398983|NCT00069095|1256112|P2|Follow-up Phase|Death|206
398984|NCT00069095|1256113|P1|Follow-up Phase|Death|174
398985|NCT00069095|1256108|P6|Post-study Treatment Phase|Investigator decision|1
398986|NCT00069095|1256109|P5|Post-study Treatment Phase|Investigator decision|0
398987|NCT00069095|1256110|P4|Post-study Treatment Phase|Investigator decision|0
398988|NCT00069095|1256111|P3|Post-study Treatment Phase|Investigator decision|0
398989|NCT00069095|1256112|P2|Post-study Treatment Phase|Investigator decision|0
398990|NCT00069095|1256113|P1|Post-study Treatment Phase|Investigator decision|0
398991|NCT00069095|1256108|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
398992|NCT00069095|1256109|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
398993|NCT00069095|1256110|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
398994|NCT00069095|1256111|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
398995|NCT00069095|1256112|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
398996|NCT00069095|1256113|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
398997|NCT00069095|1256108|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
398998|NCT00069095|1256109|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
398999|NCT00069095|1256110|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
399000|NCT00069095|1256111|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
399001|NCT00069095|1256112|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
399002|NCT00069095|1256113|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
399003|NCT00069095|1256108|P6|Post-study Treatment Phase|Participant had progressive disease|0
399004|NCT00069095|1256109|P5|Post-study Treatment Phase|Participant had progressive disease|1
399005|NCT00069095|1256110|P4|Post-study Treatment Phase|Participant had progressive disease|0
399006|NCT00069095|1256111|P3|Post-study Treatment Phase|Participant had progressive disease|0
399007|NCT00069095|1256112|P2|Post-study Treatment Phase|Participant had progressive disease|0
399008|NCT00069095|1256113|P1|Post-study Treatment Phase|Participant had progressive disease|0
399009|NCT00069095|1256108|P6|Post-study Treatment Phase|Death|0
399010|NCT00069095|1256109|P5|Post-study Treatment Phase|Death|1
399011|NCT00069095|1256110|P4|Post-study Treatment Phase|Death|0
399012|NCT00069095|1256111|P3|Post-study Treatment Phase|Death|0
399013|NCT00069095|1256112|P2|Post-study Treatment Phase|Death|0
399014|NCT00069095|1256113|P1|Post-study Treatment Phase|Death|0
399015|NCT00069095|1256108|P6|Post-study Treatment Phase|Surgery|0
399016|NCT00069095|1256109|P5|Post-study Treatment Phase|Surgery|1
399017|NCT00069095|1256110|P4|Post-study Treatment Phase|Surgery|1
399018|NCT00069095|1256111|P3|Post-study Treatment Phase|Surgery|0
399019|NCT00069095|1256112|P2|Post-study Treatment Phase|Surgery|0
399020|NCT00069095|1256113|P1|Post-study Treatment Phase|Surgery|0
399021|NCT00069095|1256108|P6|Post-study Treatment Phase|Participant completed treatment|0
399022|NCT00069095|1256109|P5|Post-study Treatment Phase|Participant completed treatment|0
399023|NCT00069095|1256110|P4|Post-study Treatment Phase|Participant completed treatment|1
399024|NCT00069095|1256111|P3|Post-study Treatment Phase|Participant completed treatment|0
399025|NCT00069095|1256112|P2|Post-study Treatment Phase|Participant completed treatment|0
399026|NCT00069095|1256113|P1|Post-study Treatment Phase|Participant completed treatment|0
399027|NCT00069095|1256108|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
399028|NCT00069095|1256109|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
399029|NCT00069095|1256110|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
399030|NCT00069095|1256111|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
399031|NCT00069095|1256112|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
399032|NCT00069095|1256113|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
399106|NCT00069095|1256109|P5|Primary Treatment Phase|Withdrew|4
399033|NCT00069095|1256108|P6|Post-study Treatment Phase|Participant will start new treatment|0
399034|NCT00069095|1256109|P5|Post-study Treatment Phase|Participant will start new treatment|0
399035|NCT00069095|1256110|P4|Post-study Treatment Phase|Participant will start new treatment|0
399036|NCT00069095|1256111|P3|Post-study Treatment Phase|Participant will start new treatment|1
399037|NCT00069095|1256112|P2|Post-study Treatment Phase|Participant will start new treatment|0
399038|NCT00069095|1256113|P1|Post-study Treatment Phase|Participant will start new treatment|0
399039|NCT00069095|1256108|P6|Post-study Treatment Phase|Participant withdrew consent|0
399040|NCT00069095|1256109|P5|Post-study Treatment Phase|Participant withdrew consent|0
399041|NCT00069095|1256110|P4|Post-study Treatment Phase|Participant withdrew consent|0
399042|NCT00069095|1256111|P3|Post-study Treatment Phase|Participant withdrew consent|1
399043|NCT00069095|1256112|P2|Post-study Treatment Phase|Participant withdrew consent|0
399044|NCT00069095|1256113|P1|Post-study Treatment Phase|Participant withdrew consent|0
399045|NCT00069095|1256108|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
399046|NCT00069095|1256109|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
399047|NCT00069095|1256110|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
399048|NCT00069095|1256111|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
399049|NCT00069095|1256112|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
399050|NCT00069095|1256113|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
399051|NCT00069095|1256108|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
399052|NCT00069095|1256109|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
399053|NCT00069095|1256110|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
399054|NCT00069095|1256111|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
399055|NCT00069095|1256112|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
399056|NCT00069095|1256113|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
399057|NCT00069095|1256108|P6|Post-study Treatment Phase|Participant had complete response|0
399058|NCT00069095|1256109|P5|Post-study Treatment Phase|Participant had complete response|0
399059|NCT00069095|1256110|P4|Post-study Treatment Phase|Participant had complete response|0
399060|NCT00069095|1256111|P3|Post-study Treatment Phase|Participant had complete response|0
399061|NCT00069095|1256112|P2|Post-study Treatment Phase|Participant had complete response|1
399062|NCT00069095|1256113|P1|Post-study Treatment Phase|Participant had complete response|1
399063|NCT00069095|1256108|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
399064|NCT00069095|1256109|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
399065|NCT00069095|1256110|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
399066|NCT00069095|1256111|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
399067|NCT00069095|1256112|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
399068|NCT00069095|1256113|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
399069|NCT00069095|1256108|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
399070|NCT00069095|1256109|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
399071|NCT00069095|1256110|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
399072|NCT00069095|1256111|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
399073|NCT00069095|1256112|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
399074|NCT00069095|1256113|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
399075|NCT00069095|1256108|P6|Post-study Treatment Phase|Eligible for surgery|0
399076|NCT00069095|1256109|P5|Post-study Treatment Phase|Eligible for surgery|0
399077|NCT00069095|1256110|P4|Post-study Treatment Phase|Eligible for surgery|0
399078|NCT00069095|1256111|P3|Post-study Treatment Phase|Eligible for surgery|0
399079|NCT00069095|1256112|P2|Post-study Treatment Phase|Eligible for surgery|0
399080|NCT00069095|1256113|P1|Post-study Treatment Phase|Eligible for surgery|2
399081|NCT00069095|1256108|P6|Post-study Treatment Phase|Adverse Event|1
399082|NCT00069095|1256109|P5|Post-study Treatment Phase|Adverse Event|5
399083|NCT00069095|1256110|P4|Post-study Treatment Phase|Adverse Event|0
399084|NCT00069095|1256111|P3|Post-study Treatment Phase|Adverse Event|1
399085|NCT00069095|1256112|P2|Post-study Treatment Phase|Adverse Event|3
399086|NCT00069095|1256113|P1|Post-study Treatment Phase|Adverse Event|2
399087|NCT00069095|1256108|P6|Post-study Treatment Phase|Missing reason|17
399088|NCT00069095|1256109|P5|Post-study Treatment Phase|Missing reason|18
399089|NCT00069095|1256110|P4|Post-study Treatment Phase|Missing reason|8
399090|NCT00069095|1256111|P3|Post-study Treatment Phase|Missing reason|12
399091|NCT00069095|1256112|P2|Post-study Treatment Phase|Missing reason|3
399092|NCT00069095|1256113|P1|Post-study Treatment Phase|Missing reason|1
399093|NCT00069095|1256108|P6|Primary Treatment Phase|Violation criteria|5
399094|NCT00069095|1256109|P5|Primary Treatment Phase|Violation criteria|1
399095|NCT00069095|1256110|P4|Primary Treatment Phase|Violation criteria|3
399096|NCT00069095|1256111|P3|Primary Treatment Phase|Violation criteria|4
399097|NCT00069095|1256112|P2|Primary Treatment Phase|Violation criteria|2
399098|NCT00069095|1256113|P1|Primary Treatment Phase|Violation criteria|0
399099|NCT00069095|1256108|P6|Primary Treatment Phase|Other Violation|1
399100|NCT00069095|1256109|P5|Primary Treatment Phase|Other Violation|0
399101|NCT00069095|1256110|P4|Primary Treatment Phase|Other Violation|1
399102|NCT00069095|1256111|P3|Primary Treatment Phase|Other Violation|1
399103|NCT00069095|1256112|P2|Primary Treatment Phase|Other Violation|1
399104|NCT00069095|1256113|P1|Primary Treatment Phase|Other Violation|0
399105|NCT00069095|1256108|P6|Primary Treatment Phase|Withdrew|9
399107|NCT00069095|1256110|P4|Primary Treatment Phase|Withdrew|2
399108|NCT00069095|1256111|P3|Primary Treatment Phase|Withdrew|8
399109|NCT00069095|1256112|P2|Primary Treatment Phase|Withdrew|3
399110|NCT00069095|1256113|P1|Primary Treatment Phase|Withdrew|2
399111|NCT00069095|1256108|P6|Primary Treatment Phase|Refused treatment|27
399112|NCT00069095|1256109|P5|Primary Treatment Phase|Refused treatment|24
399113|NCT00069095|1256110|P4|Primary Treatment Phase|Refused treatment|31
399114|NCT00069095|1256111|P3|Primary Treatment Phase|Refused treatment|17
399115|NCT00069095|1256112|P2|Primary Treatment Phase|Refused treatment|26
399116|NCT00069095|1256113|P1|Primary Treatment Phase|Refused treatment|15
399117|NCT00069095|1256108|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
399118|NCT00069095|1256109|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
399119|NCT00069095|1256110|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
399120|NCT00069095|1256111|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
399121|NCT00069095|1256112|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
399122|NCT00069095|1256113|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
399123|NCT00069095|1256108|P6|Primary Treatment Phase|Failure to return|2
399124|NCT00069095|1256109|P5|Primary Treatment Phase|Failure to return|0
399125|NCT00069095|1256110|P4|Primary Treatment Phase|Failure to return|0
399126|NCT00069095|1256111|P3|Primary Treatment Phase|Failure to return|0
399127|NCT00069095|1256112|P2|Primary Treatment Phase|Failure to return|5
399128|NCT00069095|1256113|P1|Primary Treatment Phase|Failure to return|5
399129|NCT00069095|1256108|P6|Primary Treatment Phase|Death|8
399130|NCT00069095|1256109|P5|Primary Treatment Phase|Death|8
399131|NCT00069095|1256110|P4|Primary Treatment Phase|Death|5
399132|NCT00069095|1256111|P3|Primary Treatment Phase|Death|2
399133|NCT00069095|1256112|P2|Primary Treatment Phase|Death|8
399134|NCT00069095|1256113|P1|Primary Treatment Phase|Death|14
399135|NCT00069095|1256108|P6|Primary Treatment Phase|Adverse Event|101
399136|NCT00069095|1256109|P5|Primary Treatment Phase|Adverse Event|109
399137|NCT00069095|1256110|P4|Primary Treatment Phase|Adverse Event|72
399138|NCT00069095|1256111|P3|Primary Treatment Phase|Adverse Event|71
399139|NCT00069095|1256112|P2|Primary Treatment Phase|Adverse Event|92
399140|NCT00069095|1256113|P1|Primary Treatment Phase|Adverse Event|99
399141|NCT00069095|1256108|P6|Primary Treatment Phase|Admin/Other|42
399142|NCT00069095|1256109|P5|Primary Treatment Phase|Admin/Other|48
399143|NCT00069095|1256110|P4|Primary Treatment Phase|Admin/Other|45
399144|NCT00069095|1256111|P3|Primary Treatment Phase|Admin/Other|31
399145|NCT00069095|1256112|P2|Primary Treatment Phase|Admin/Other|38
399146|NCT00069095|1256113|P1|Primary Treatment Phase|Admin/Other|29
399147|NCT00069095|1256108|P6|Primary Treatment Phase|Ongoing|4
399148|NCT00069095|1256109|P5|Primary Treatment Phase|Ongoing|7
399149|NCT00069095|1256110|P4|Primary Treatment Phase|Ongoing|7
399150|NCT00069095|1256111|P3|Primary Treatment Phase|Ongoing|5
399151|NCT00069095|1256112|P2|Primary Treatment Phase|Ongoing|0
399152|NCT00069095|1256113|P1|Primary Treatment Phase|Ongoing|0
399153|NCT00068822|1256167|P2|First Randomized Intervention|Lost to Follow-up|2
399154|NCT00068822|1256168|P1|First Randomized Intervention|Lost to Follow-up|1
399155|NCT00068601|1256201|P2|Overall Study|Missing primary outcome data|34
399156|NCT00068601|1256202|P1|Overall Study|Missing primary outcome data|30
399157|NCT00068601|1256201|P2|Overall Study|Lost to Follow-up|2
399158|NCT00068601|1256202|P1|Overall Study|Lost to Follow-up|3
399159|NCT00068601|1256201|P2|Overall Study|Death|3
399160|NCT00068601|1256202|P1|Overall Study|Death|11
399161|NCT00068601|1256201|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
399162|NCT00068601|1256202|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
399163|NCT00068601|1256201|P2|Overall Study|Not evaluable: withdrew consent|4
399164|NCT00068601|1256202|P1|Overall Study|Not evaluable: withdrew consent|5
399165|NCT00068601|1256201|P2|Overall Study|Ineligible|13
399166|NCT00068601|1256202|P1|Overall Study|Ineligible|11
399167|NCT00068588|1256215|P3|Overall Study|Poor KPS|1
399168|NCT00068588|1256216|P2|Overall Study|Poor KPS|0
399169|NCT00068588|1256217|P1|Overall Study|Poor KPS|0
399170|NCT00068588|1256215|P3|Overall Study|Withdrawal by Subject|1
399171|NCT00068588|1256216|P2|Overall Study|Withdrawal by Subject|0
399172|NCT00068588|1256217|P1|Overall Study|Withdrawal by Subject|0
399173|NCT00068588|1256215|P3|Overall Study|Adverse Event|2
399174|NCT00068588|1256216|P2|Overall Study|Adverse Event|0
399175|NCT00068588|1256217|P1|Overall Study|Adverse Event|0
399176|NCT00068419|1256231|P1|Overall Study|Ineligible|11
399177|NCT00068419|1256231|P1|Overall Study|Withdrawal by Subject|14
399178|NCT00068419|1256231|P1|Overall Study|Physician Decision|7
399179|NCT00068419|1256231|P1|Overall Study|Lost to Follow-up|1
399180|NCT00068419|1256231|P1|Overall Study|Lack of Efficacy|24
399181|NCT00068419|1256231|P1|Overall Study|Adverse Event|3
399182|NCT00068393|1256235|P1|Overall Study|Quality of life worsening|1
399183|NCT00068393|1256235|P1|Overall Study|Alternative treatment|1
399184|NCT00068393|1256235|P1|Overall Study|Withdrawal by Subject|3
399185|NCT00068393|1256235|P1|Overall Study|Death|3
399186|NCT00068393|1256235|P1|Overall Study|Adverse Event|2
399187|NCT00068380|1256241|P1|Overall Study|Adverse Event|2
399188|NCT00068380|1256241|P1|Overall Study|Withdrawal by Subject|3
399189|NCT00068237|1256271|P1|Overall Study|No protocol treatment received|2
399190|NCT00068237|1256271|P1|Overall Study|Ineligible|3
399191|NCT00068107|1256275|P1|Overall Study|Withdrawal by Subject|1
399192|NCT00068107|1256275|P1|Overall Study|Death|2
399193|NCT00068107|1256275|P1|Overall Study|end-stage renal disease|6
399194|NCT00067470|1256301|P2|Overall Study|Withdrawal by Subject|1
399195|NCT00067470|1256302|P1|Overall Study|Withdrawal by Subject|0
399196|NCT00066807|1256336|P2|Overall Study|Study was terminated early|15
399197|NCT00066807|1256337|P1|Overall Study|Study was terminated early|14
399198|NCT00066742|1256362|P1|Consolidation Chemotherapy|Ineligible|2
399199|NCT00066742|1256362|P1|Consolidation Chemotherapy|not protocol specified|1
399200|NCT00066742|1256362|P1|Induction Chemoradiotherapy|Ineligible|3
399201|NCT00066742|1256362|P1|Induction Chemoradiotherapy|not protocol specified|2
399202|NCT00066742|1256362|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
399203|NCT00066742|1256362|P1|Induction Chemoradiotherapy|Adverse Event|21
399204|NCT00066742|1256362|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
399205|NCT00066703|1256371|P2|Overall Study|Treatment ongoing|311
399206|NCT00066703|1256372|P1|Overall Study|Treatment ongoing|346
399207|NCT00066703|1256371|P2|Overall Study|Withdrawal by Subject|63
399208|NCT00066703|1256372|P1|Overall Study|Withdrawal by Subject|38
399209|NCT00066703|1256371|P2|Overall Study|Lost to Follow-up|28
399210|NCT00066703|1256372|P1|Overall Study|Lost to Follow-up|31
399211|NCT00066703|1256371|P2|Overall Study|Lack of Efficacy|69
399212|NCT00066703|1256372|P1|Overall Study|Lack of Efficacy|114
399213|NCT00066703|1256371|P2|Overall Study|Death|0
399214|NCT00066703|1256372|P1|Overall Study|Death|3
399215|NCT00066703|1256371|P2|Overall Study|Adverse Event|111
399216|NCT00066703|1256372|P1|Overall Study|Adverse Event|80
399217|NCT00066690|1256385|P3|Overall Study|Treatment Ongoing|282
399218|NCT00066690|1256386|P2|Overall Study|Treatment Ongoing|278
399219|NCT00066690|1256387|P1|Overall Study|Treatment Ongoing|246
399220|NCT00066690|1256385|P3|Overall Study|Withdrawal by Subject|49
399221|NCT00066690|1256386|P2|Overall Study|Withdrawal by Subject|55
399222|NCT00066690|1256387|P1|Overall Study|Withdrawal by Subject|50
399223|NCT00066690|1256385|P3|Overall Study|Lost to Follow-up|29
399224|NCT00066690|1256386|P2|Overall Study|Lost to Follow-up|21
399225|NCT00066690|1256387|P1|Overall Study|Lost to Follow-up|40
399226|NCT00066690|1256385|P3|Overall Study|Lack of Efficacy|76
399227|NCT00066690|1256386|P2|Overall Study|Lack of Efficacy|110
399228|NCT00066690|1256387|P1|Overall Study|Lack of Efficacy|114
399229|NCT00066690|1256385|P3|Overall Study|Death|2
399230|NCT00066690|1256386|P2|Overall Study|Death|0
399231|NCT00066690|1256387|P1|Overall Study|Death|3
399232|NCT00066690|1256385|P3|Overall Study|Adverse Event|126
399233|NCT00066690|1256386|P2|Overall Study|Adverse Event|58
399234|NCT00066690|1256387|P1|Overall Study|Adverse Event|145
399235|NCT00066573|1256403|P2|Overall Study|Did not received protocol treatment|28
399236|NCT00066573|1256404|P1|Overall Study|Did not received protocol treatment|28
399237|NCT00066469|1256410|P1|Overall Study|ineligible|1
399238|NCT00066469|1256410|P1|Overall Study|Withdrawal by Subject|1
399239|NCT00066469|1256410|P1|Overall Study|Physician Decision|1
399240|NCT00066469|1256410|P1|Overall Study|Lost to Follow-up|1
399241|NCT00066469|1256410|P1|Overall Study|Lack of Efficacy|9
399242|NCT00066469|1256410|P1|Overall Study|Death|3
399243|NCT00066365|1256416|P2|Overall Study|Ineligible|2
399244|NCT00066365|1256417|P1|Overall Study|Ineligible|4
399245|NCT00066365|1256416|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
399246|NCT00066365|1256417|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
399247|NCT00066365|1256416|P2|Overall Study|Physician Decision|0
399248|NCT00066365|1256417|P1|Overall Study|Physician Decision|1
399249|NCT00066365|1256416|P2|Overall Study|Lack of Efficacy|12
399250|NCT00066365|1256417|P1|Overall Study|Lack of Efficacy|15
399251|NCT00066365|1256416|P2|Overall Study|Adverse Event|0
399252|NCT00066365|1256417|P1|Overall Study|Adverse Event|1
399253|NCT00066222|1256445|P1|Overall Study|No protocol treatment received|1
399254|NCT00066170|1256453|P4|Overall Study|Other|0
399255|NCT00066170|1256454|P3|Overall Study|Other|2
399256|NCT00066170|1256455|P2|Overall Study|Other|5
399257|NCT00066170|1256456|P1|Overall Study|Other|1
399258|NCT00066170|1256453|P4|Overall Study|Protocol Violation|0
399259|NCT00066170|1256454|P3|Overall Study|Protocol Violation|0
399260|NCT00066170|1256455|P2|Overall Study|Protocol Violation|0
399261|NCT00066170|1256456|P1|Overall Study|Protocol Violation|3
399262|NCT00066170|1256453|P4|Overall Study|Non-Compliance with Trial Medicine|1
399263|NCT00066170|1256454|P3|Overall Study|Non-Compliance with Trial Medicine|0
399264|NCT00066170|1256455|P2|Overall Study|Non-Compliance with Trial Medicine|0
399265|NCT00066170|1256456|P1|Overall Study|Non-Compliance with Trial Medicine|1
399266|NCT00066170|1256453|P4|Overall Study|Lost to Follow-up|0
399267|NCT00066170|1256454|P3|Overall Study|Lost to Follow-up|0
399268|NCT00066170|1256455|P2|Overall Study|Lost to Follow-up|1
399269|NCT00066170|1256456|P1|Overall Study|Lost to Follow-up|0
399270|NCT00066170|1256453|P4|Overall Study|Serious Adverse Event|1
399271|NCT00066170|1256454|P3|Overall Study|Serious Adverse Event|1
399272|NCT00066170|1256455|P2|Overall Study|Serious Adverse Event|0
399273|NCT00066170|1256456|P1|Overall Study|Serious Adverse Event|0
399274|NCT00066170|1256453|P4|Overall Study|Adverse Event|7
399275|NCT00066170|1256454|P3|Overall Study|Adverse Event|1
399276|NCT00066170|1256455|P2|Overall Study|Adverse Event|4
399277|NCT00066170|1256456|P1|Overall Study|Adverse Event|2
399278|NCT00066066|1256469|P6|Overall Study|Lost to Follow-up|5
399279|NCT00066066|1256470|P5|Overall Study|Lost to Follow-up|3
399280|NCT00066066|1256471|P4|Overall Study|Lost to Follow-up|4
399281|NCT00066066|1256472|P3|Overall Study|Lost to Follow-up|7
399282|NCT00066066|1256473|P2|Overall Study|Lost to Follow-up|4
399283|NCT00066066|1256474|P1|Overall Study|Lost to Follow-up|6
399284|NCT00065507|1256548|P2|Overall Study|Subject No Longer Meets Study Criteria|0
399285|NCT00065507|1256549|P1|Overall Study|Subject No Longer Meets Study Criteria|1
399286|NCT00065507|1256548|P2|Overall Study|Subject Withdrew Consent|1
399287|NCT00065507|1256549|P1|Overall Study|Subject Withdrew Consent|2
399288|NCT00065507|1256548|P2|Overall Study|Lost to Follow-up|0
399289|NCT00065507|1256549|P1|Overall Study|Lost to Follow-up|3
399290|NCT00065507|1256548|P2|Overall Study|Poor/Non-compliance|2
399291|NCT00065507|1256549|P1|Overall Study|Poor/Non-compliance|3
399292|NCT00065507|1256548|P2|Overall Study|Lack of Efficacy|6
399293|NCT00065507|1256549|P1|Overall Study|Lack of Efficacy|0
399294|NCT00065507|1256548|P2|Overall Study|Adverse Event|3
399295|NCT00065507|1256549|P1|Overall Study|Adverse Event|4
399296|NCT00065507|1256548|P2|Overall Study|Death|17
399297|NCT00065507|1256549|P1|Overall Study|Death|16
399298|NCT00065468|1256614|P3|Overall Study|Unspecified|18
399299|NCT00065468|1256615|P2|Overall Study|Unspecified|24
399300|NCT00065468|1256616|P1|Overall Study|Unspecified|14
399301|NCT00065468|1256614|P3|Overall Study|Disease progression|1
399302|NCT00065468|1256615|P2|Overall Study|Disease progression|0
399303|NCT00065468|1256616|P1|Overall Study|Disease progression|0
399304|NCT00065468|1256614|P3|Overall Study|Discontinuation of study by Sponsor|13
399305|NCT00065468|1256615|P2|Overall Study|Discontinuation of study by Sponsor|9
399306|NCT00065468|1256616|P1|Overall Study|Discontinuation of study by Sponsor|13
399307|NCT00065468|1256614|P3|Overall Study|Lost to Follow-up|2
399308|NCT00065468|1256615|P2|Overall Study|Lost to Follow-up|3
399309|NCT00065468|1256616|P1|Overall Study|Lost to Follow-up|5
399310|NCT00065468|1256614|P3|Overall Study|Withdrawal by Subject|5
399311|NCT00065468|1256615|P2|Overall Study|Withdrawal by Subject|4
399312|NCT00065468|1256616|P1|Overall Study|Withdrawal by Subject|3
399313|NCT00065468|1256614|P3|Overall Study|Death|171
399314|NCT00065468|1256615|P2|Overall Study|Death|169
399315|NCT00065468|1256616|P1|Overall Study|Death|172
399316|NCT00065442|1256647|P2|Overall Study|Withdrawal by Subject|9
399317|NCT00065442|1256648|P1|Overall Study|Withdrawal by Subject|3
399318|NCT00065442|1256647|P2|Overall Study|Death|210
399319|NCT00065442|1256648|P1|Overall Study|Death|121
399320|NCT00065442|1256647|P2|Overall Study|Lost to Follow-up|1
399321|NCT00065442|1256648|P1|Overall Study|Lost to Follow-up|1
399322|NCT00065429|1256663|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
399323|NCT00065429|1256664|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
399324|NCT00065429|1256665|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
399325|NCT00065429|1256666|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
399326|NCT00065429|1256667|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
399327|NCT00065429|1256668|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
399328|NCT00065429|1256669|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
399329|NCT00065429|1256663|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
399330|NCT00065429|1256664|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
399331|NCT00065429|1256665|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
399332|NCT00065429|1256666|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
399333|NCT00065429|1256667|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
399334|NCT00065429|1256668|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
399335|NCT00065429|1256669|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
399336|NCT00065429|1256663|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
399337|NCT00065429|1256664|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
399338|NCT00065429|1256665|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
399339|NCT00065429|1256666|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
399340|NCT00065429|1256667|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
399341|NCT00065429|1256668|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
399342|NCT00065429|1256669|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
399343|NCT00065429|1256663|P7|Phase I - May 2001 - Oct 2002|Death|0
399344|NCT00065429|1256664|P6|Phase I - May 2001 - Oct 2002|Death|0
399345|NCT00065429|1256665|P5|Phase I - May 2001 - Oct 2002|Death|1
399346|NCT00065429|1256666|P4|Phase I - May 2001 - Oct 2002|Death|0
399347|NCT00065429|1256667|P3|Phase I - May 2001 - Oct 2002|Death|0
399348|NCT00065429|1256668|P2|Phase I - May 2001 - Oct 2002|Death|0
399349|NCT00065429|1256669|P1|Phase I - May 2001 - Oct 2002|Death|0
399350|NCT00065429|1256663|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
399351|NCT00065429|1256664|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
399352|NCT00065429|1256665|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
399353|NCT00065429|1256666|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
399354|NCT00065429|1256667|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
399355|NCT00065429|1256668|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
399356|NCT00065429|1256669|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
399357|NCT00065429|1256663|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
399358|NCT00065429|1256664|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
399359|NCT00065429|1256665|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
399360|NCT00065429|1256666|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
399361|NCT00065429|1256667|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
399362|NCT00065429|1256668|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
399363|NCT00065429|1256669|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
399364|NCT00065429|1256663|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
399365|NCT00065429|1256664|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
399366|NCT00065429|1256665|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
399367|NCT00065429|1256666|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
399368|NCT00065429|1256667|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
399369|NCT00065429|1256668|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
399370|NCT00065429|1256669|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
399371|NCT00065260|1256683|P2|Overall Study|Death|1
399372|NCT00065260|1256684|P1|Overall Study|Death|0
399373|NCT00065156|1256690|P1|Overall Study|Secondary Malign Disease|1
399374|NCT00065156|1256690|P1|Overall Study|Loss of Response|1
399375|NCT00065156|1256690|P1|Overall Study|Non-Compliance|2
399376|NCT00065156|1256690|P1|Overall Study|Investigator Decision|2
399377|NCT00065156|1256690|P1|Overall Study|Disease Progression|7
399378|NCT00065156|1256690|P1|Overall Study|Study Closed by Sponsor|2
399379|NCT00065156|1256690|P1|Overall Study|Death|11
399380|NCT00065156|1256690|P1|Overall Study|Lost to Follow-up|1
399381|NCT00065156|1256690|P1|Overall Study|Withdrawal by Subject|8
399382|NCT00065156|1256690|P1|Overall Study|Lack of Efficacy|52
399383|NCT00065156|1256690|P1|Overall Study|Adverse Event|37
399384|NCT00065065|1256707|P2|Overall Study|Other|2
399385|NCT00065065|1256708|P1|Overall Study|Other|2
399386|NCT00065065|1256707|P2|Overall Study|Lack of Efficacy|11
399387|NCT00065065|1256708|P1|Overall Study|Lack of Efficacy|4
399388|NCT00065065|1256707|P2|Overall Study|Withdrawal by Subject|5
399389|NCT00065065|1256708|P1|Overall Study|Withdrawal by Subject|1
399390|NCT00065065|1256707|P2|Overall Study|Adverse Event|2
399391|NCT00065065|1256708|P1|Overall Study|Adverse Event|3
399392|NCT00064259|1256716|P4|Overall Study|Adverse Event|1
399393|NCT00064259|1256717|P3|Overall Study|Adverse Event|0
399394|NCT00064259|1256718|P2|Overall Study|Adverse Event|0
399395|NCT00064259|1256719|P1|Overall Study|Adverse Event|1
399396|NCT00064792|1256736|P2|Overall Study|Adverse Event|0
399397|NCT00064792|1256737|P1|Overall Study|Adverse Event|3
399398|NCT00064792|1256736|P2|Overall Study|Withdrawal by Subject|0
399399|NCT00064792|1256737|P1|Overall Study|Withdrawal by Subject|2
399400|NCT00064753|1256747|P2|Overall Study|Lost to Follow-up|235
399401|NCT00064753|1256748|P1|Overall Study|Lost to Follow-up|225
399402|NCT00064753|1256747|P2|Overall Study|Withdrawal by Subject|171
399403|NCT00064753|1256748|P1|Overall Study|Withdrawal by Subject|198
399404|NCT00064753|1256747|P2|Overall Study|Death|242
399405|NCT00064753|1256748|P1|Overall Study|Death|251
399406|NCT00064701|1256779|P3|Clinical Continuation Phase|Patient opted out|1
399407|NCT00064701|1256780|P2|Clinical Continuation Phase|Patient opted out|0
399408|NCT00064701|1256781|P1|Clinical Continuation Phase|Patient opted out|0
399409|NCT00064701|1256779|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
399410|NCT00064701|1256780|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
399411|NCT00064701|1256781|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
399412|NCT00064701|1256779|P3|Clinical Continuation Phase|Discharged to nursing home|0
399413|NCT00064701|1256780|P2|Clinical Continuation Phase|Discharged to nursing home|1
399414|NCT00064701|1256781|P1|Clinical Continuation Phase|Discharged to nursing home|0
399415|NCT00064701|1256779|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
399416|NCT00064701|1256780|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
399417|NCT00064701|1256781|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
399418|NCT00064701|1256779|P3|Clinical Continuation Phase|Pancreas transplant|0
399419|NCT00064701|1256780|P2|Clinical Continuation Phase|Pancreas transplant|0
399420|NCT00064701|1256781|P1|Clinical Continuation Phase|Pancreas transplant|1
399421|NCT00064701|1256779|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
399422|NCT00064701|1256780|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
399423|NCT00064701|1256781|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
399424|NCT00064701|1256779|P3|Clinical Continuation Phase|Physician Decision|0
399425|NCT00064701|1256780|P2|Clinical Continuation Phase|Physician Decision|3
399426|NCT00064701|1256781|P1|Clinical Continuation Phase|Physician Decision|1
399427|NCT00064701|1256779|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
399428|NCT00064701|1256780|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
399429|NCT00064701|1256781|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
399430|NCT00064701|1256779|P3|Clinical Continuation Phase|Sponsor discontinued study|79
399431|NCT00064701|1256780|P2|Clinical Continuation Phase|Sponsor discontinued study|129
399432|NCT00064701|1256781|P1|Clinical Continuation Phase|Sponsor discontinued study|113
399433|NCT00064701|1256779|P3|Clinical Continuation Phase|Rejection|2
399434|NCT00064701|1256780|P2|Clinical Continuation Phase|Rejection|2
399435|NCT00064701|1256781|P1|Clinical Continuation Phase|Rejection|1
399436|NCT00064701|1256779|P3|Clinical Continuation Phase|Graft Failure|2
399437|NCT00064701|1256780|P2|Clinical Continuation Phase|Graft Failure|5
399438|NCT00064701|1256781|P1|Clinical Continuation Phase|Graft Failure|5
399439|NCT00064701|1256779|P3|Clinical Continuation Phase|Lost to Follow-up|6
399440|NCT00064701|1256780|P2|Clinical Continuation Phase|Lost to Follow-up|3
399441|NCT00064701|1256781|P1|Clinical Continuation Phase|Lost to Follow-up|6
399442|NCT00064701|1256779|P3|Clinical Continuation Phase|Withdrawal by Subject|22
399443|NCT00064701|1256780|P2|Clinical Continuation Phase|Withdrawal by Subject|3
399444|NCT00064701|1256781|P1|Clinical Continuation Phase|Withdrawal by Subject|22
399445|NCT00064701|1256779|P3|Clinical Continuation Phase|Non-compliance|7
399446|NCT00064701|1256780|P2|Clinical Continuation Phase|Non-compliance|6
399447|NCT00064701|1256781|P1|Clinical Continuation Phase|Non-compliance|8
399448|NCT00064701|1256779|P3|Clinical Continuation Phase|Adverse Event|14
399449|NCT00064701|1256780|P2|Clinical Continuation Phase|Adverse Event|21
399450|NCT00064701|1256781|P1|Clinical Continuation Phase|Adverse Event|12
399451|NCT00064701|1256779|P3|One Year Post-transplant|Pancreas transplant|1
399452|NCT00064701|1256780|P2|One Year Post-transplant|Pancreas transplant|0
399453|NCT00064701|1256781|P1|One Year Post-transplant|Pancreas transplant|0
399454|NCT00064701|1256779|P3|One Year Post-transplant|Poor absorption|0
399455|NCT00064701|1256780|P2|One Year Post-transplant|Poor absorption|1
399456|NCT00064701|1256781|P1|One Year Post-transplant|Poor absorption|0
399457|NCT00064701|1256779|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
399458|NCT00064701|1256780|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
399459|NCT00064701|1256781|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
399460|NCT00064701|1256779|P3|One Year Post-transplant|Incorrect study drug dispensed|0
399461|NCT00064701|1256780|P2|One Year Post-transplant|Incorrect study drug dispensed|1
399462|NCT00064701|1256781|P1|One Year Post-transplant|Incorrect study drug dispensed|0
399463|NCT00064701|1256779|P3|One Year Post-transplant|Acute tubular necrosis|0
399464|NCT00064701|1256780|P2|One Year Post-transplant|Acute tubular necrosis|0
399465|NCT00064701|1256781|P1|One Year Post-transplant|Acute tubular necrosis|1
399466|NCT00064701|1256779|P3|One Year Post-transplant|Converted to rapamycin|0
399467|NCT00064701|1256780|P2|One Year Post-transplant|Converted to rapamycin|0
399468|NCT00064701|1256781|P1|One Year Post-transplant|Converted to rapamycin|1
399469|NCT00064701|1256779|P3|One Year Post-transplant|Lost to Follow-up|0
399470|NCT00064701|1256780|P2|One Year Post-transplant|Lost to Follow-up|0
399471|NCT00064701|1256781|P1|One Year Post-transplant|Lost to Follow-up|1
399472|NCT00064701|1256779|P3|One Year Post-transplant|Withdrawal by Subject|1
399473|NCT00064701|1256780|P2|One Year Post-transplant|Withdrawal by Subject|4
399474|NCT00064701|1256781|P1|One Year Post-transplant|Withdrawal by Subject|0
399475|NCT00064701|1256779|P3|One Year Post-transplant|Graft Failure|1
399476|NCT00064701|1256780|P2|One Year Post-transplant|Graft Failure|2
399477|NCT00064701|1256781|P1|One Year Post-transplant|Graft Failure|3
399478|NCT00064701|1256779|P3|One Year Post-transplant|Non-compliance|5
399479|NCT00064701|1256780|P2|One Year Post-transplant|Non-compliance|2
399480|NCT00064701|1256781|P1|One Year Post-transplant|Non-compliance|4
399481|NCT00064701|1256779|P3|One Year Post-transplant|Rejection|16
399482|NCT00064701|1256780|P2|One Year Post-transplant|Rejection|1
399483|NCT00064701|1256781|P1|One Year Post-transplant|Rejection|0
399484|NCT00064701|1256779|P3|One Year Post-transplant|Adverse Event|37
399485|NCT00064701|1256780|P2|One Year Post-transplant|Adverse Event|19
399486|NCT00064701|1256781|P1|One Year Post-transplant|Adverse Event|23
399487|NCT00064701|1256779|P3|One Year Post-transplant|Did not receive study drug|11
399488|NCT00064701|1256780|P2|One Year Post-transplant|Did not receive study drug|12
399489|NCT00064701|1256781|P1|One Year Post-transplant|Did not receive study drug|7
399490|NCT00064662|1256833|P2|Overall Study|Administratively withdrawn|2
399491|NCT00064662|1256834|P1|Overall Study|Administratively withdrawn|2
399492|NCT00064662|1256833|P2|Overall Study|Withdrawal by Subject|14
399493|NCT00064662|1256834|P1|Overall Study|Withdrawal by Subject|14
399494|NCT00064662|1256833|P2|Overall Study|Lost to Follow-up|44
399495|NCT00064662|1256834|P1|Overall Study|Lost to Follow-up|57
399496|NCT00064662|1256833|P2|Overall Study|Death|1
399497|NCT00064662|1256834|P1|Overall Study|Death|1
399498|NCT00064350|1256845|P3|Cross-Over|Other|0
399499|NCT00064350|1256846|P2|Cross-Over|Other|2
399500|NCT00064350|1256847|P1|Cross-Over|Other|0
399501|NCT00064350|1256845|P3|Cross-Over|Ineligible or never started treatment|0
399502|NCT00064350|1256846|P2|Cross-Over|Ineligible or never started treatment|6
399503|NCT00064350|1256847|P1|Cross-Over|Ineligible or never started treatment|3
399504|NCT00064350|1256845|P3|Cross-Over|Withdrawal by Subject|0
399505|NCT00064350|1256846|P2|Cross-Over|Withdrawal by Subject|2
399506|NCT00064350|1256847|P1|Cross-Over|Withdrawal by Subject|2
399507|NCT00064350|1256845|P3|Cross-Over|Death|0
399508|NCT00064350|1256846|P2|Cross-Over|Death|3
399509|NCT00064350|1256847|P1|Cross-Over|Death|1
399510|NCT00064350|1256845|P3|Cross-Over|Adverse Event|0
399511|NCT00064350|1256846|P2|Cross-Over|Adverse Event|1
399512|NCT00064350|1256847|P1|Cross-Over|Adverse Event|0
399513|NCT00064350|1256845|P3|Randomization|Other|0
399514|NCT00064350|1256846|P2|Randomization|Other|0
399515|NCT00064350|1256847|P1|Randomization|Other|5
399516|NCT00064350|1256845|P3|Randomization|Ineligible or never started treatment|0
399517|NCT00064350|1256846|P2|Randomization|Ineligible or never started treatment|15
399518|NCT00064350|1256847|P1|Randomization|Ineligible or never started treatment|9
399519|NCT00064350|1256845|P3|Randomization|Withdrawal by Subject|0
399520|NCT00064350|1256846|P2|Randomization|Withdrawal by Subject|0
399521|NCT00064350|1256847|P1|Randomization|Withdrawal by Subject|1
399522|NCT00064350|1256845|P3|Randomization|Death|0
399523|NCT00064350|1256846|P2|Randomization|Death|0
399524|NCT00064350|1256847|P1|Randomization|Death|3
399525|NCT00064350|1256845|P3|Randomization|Adverse Event|0
399526|NCT00064350|1256846|P2|Randomization|Adverse Event|3
399527|NCT00064350|1256847|P1|Randomization|Adverse Event|8
399528|NCT00064350|1256845|P3|Induction Treatment|Other|13
399529|NCT00064350|1256846|P2|Induction Treatment|Other|0
399530|NCT00064350|1256847|P1|Induction Treatment|Other|0
399531|NCT00064350|1256845|P3|Induction Treatment|Ineligible or never started treatment|34
399532|NCT00064350|1256846|P2|Induction Treatment|Ineligible or never started treatment|6
399533|NCT00064350|1256847|P1|Induction Treatment|Ineligible or never started treatment|3
399534|NCT00064350|1256845|P3|Induction Treatment|Withdrawal by Subject|21
399535|NCT00064350|1256846|P2|Induction Treatment|Withdrawal by Subject|0
399536|NCT00064350|1256847|P1|Induction Treatment|Withdrawal by Subject|0
399537|NCT00064350|1256845|P3|Induction Treatment|Death|9
399538|NCT00064350|1256846|P2|Induction Treatment|Death|0
399539|NCT00064350|1256847|P1|Induction Treatment|Death|0
399540|NCT00064350|1256845|P3|Induction Treatment|Adverse Event|49
399541|NCT00064350|1256846|P2|Induction Treatment|Adverse Event|2
399542|NCT00064350|1256847|P1|Induction Treatment|Adverse Event|0
399543|NCT00064350|1256845|P3|Induction Treatment|Disease Progression|110
399544|NCT00064350|1256846|P2|Induction Treatment|Disease Progression|1
399545|NCT00064350|1256847|P1|Induction Treatment|Disease Progression|5
399546|NCT00064025|1256876|P1|Overall Study|Inevaluable|3
399547|NCT00064025|1256876|P1|Overall Study|Ineligible|4
399548|NCT00063986|1256883|P1|Overall Study|Intra-operatively ineligible|4
399549|NCT00063986|1256883|P1|Overall Study|Ineligible|1
399550|NCT00063986|1256883|P1|Overall Study|Withdrawal by Subject|1
399551|NCT00063934|1256895|P1|Overall Study|Ineligible|1
399552|NCT00063258|1257000|P2|Overall Study|Lack of Efficacy|0
399553|NCT00063258|1257001|P1|Overall Study|Lack of Efficacy|2
399554|NCT00063258|1257000|P2|Overall Study|Physician Decision|0
399555|NCT00063258|1257001|P1|Overall Study|Physician Decision|2
399556|NCT00063154|1257013|P1|Overall Study|Did not receive treatment|8
399557|NCT00063154|1257013|P1|Overall Study|Reason unspecified|1
399558|NCT00063154|1257013|P1|Overall Study|Death|3
399559|NCT00063154|1257013|P1|Overall Study|Physician Decision|10
399560|NCT00063154|1257013|P1|Overall Study|Adverse Event|2
399561|NCT00063154|1257013|P1|Overall Study|Disease progression|27
399562|NCT00062751|1257033|P5|Overall Study|Death|0
399563|NCT00062751|1257034|P4|Overall Study|Death|0
399564|NCT00062751|1257035|P3|Overall Study|Death|1
399565|NCT00062751|1257036|P2|Overall Study|Death|0
399566|NCT00062751|1257037|P1|Overall Study|Death|1
399567|NCT00062751|1257033|P5|Overall Study|Symptomatic deterioration|1
399568|NCT00062751|1257034|P4|Overall Study|Symptomatic deterioration|0
399569|NCT00062751|1257035|P3|Overall Study|Symptomatic deterioration|0
399570|NCT00062751|1257036|P2|Overall Study|Symptomatic deterioration|1
399571|NCT00062751|1257037|P1|Overall Study|Symptomatic deterioration|1
399572|NCT00062751|1257033|P5|Overall Study|Withdrawal by Subject|0
399573|NCT00062751|1257034|P4|Overall Study|Withdrawal by Subject|1
399574|NCT00062751|1257035|P3|Overall Study|Withdrawal by Subject|2
399575|NCT00062751|1257036|P2|Overall Study|Withdrawal by Subject|2
399576|NCT00062751|1257037|P1|Overall Study|Withdrawal by Subject|1
399577|NCT00062751|1257033|P5|Overall Study|Unspecified|1
399578|NCT00062751|1257034|P4|Overall Study|Unspecified|0
399579|NCT00062751|1257035|P3|Overall Study|Unspecified|1
399580|NCT00062751|1257036|P2|Overall Study|Unspecified|3
399581|NCT00062751|1257037|P1|Overall Study|Unspecified|2
399582|NCT00062751|1257033|P5|Overall Study|Adverse Event|2
399583|NCT00062751|1257034|P4|Overall Study|Adverse Event|2
399584|NCT00062751|1257035|P3|Overall Study|Adverse Event|2
399585|NCT00062751|1257036|P2|Overall Study|Adverse Event|7
399586|NCT00062751|1257037|P1|Overall Study|Adverse Event|4
399587|NCT00062751|1257033|P5|Overall Study|Disease progression|2
399588|NCT00062751|1257034|P4|Overall Study|Disease progression|2
399589|NCT00062751|1257035|P3|Overall Study|Disease progression|24
399590|NCT00062751|1257036|P2|Overall Study|Disease progression|17
399591|NCT00062751|1257037|P1|Overall Study|Disease progression|24
399592|NCT00062647|1257123|P2|Overall Study|Never received study treatment|1
399593|NCT00062647|1257124|P1|Overall Study|Never received study treatment|1
399594|NCT00062647|1257123|P2|Overall Study|Other|4
399595|NCT00062647|1257124|P1|Overall Study|Other|4
399596|NCT00062647|1257123|P2|Overall Study|Failed continuation criteria|2
399597|NCT00062647|1257124|P1|Overall Study|Failed continuation criteria|4
399598|NCT00062647|1257123|P2|Overall Study|Lost to Follow-up|2
399599|NCT00062647|1257124|P1|Overall Study|Lost to Follow-up|1
399600|NCT00062647|1257123|P2|Overall Study|Protocol Violation|0
399601|NCT00062647|1257124|P1|Overall Study|Protocol Violation|1
399602|NCT00062647|1257123|P2|Overall Study|Withdrawal by Subject|1
399603|NCT00062647|1257124|P1|Overall Study|Withdrawal by Subject|2
399604|NCT00062647|1257123|P2|Overall Study|Adverse Event|1
399605|NCT00062647|1257124|P1|Overall Study|Adverse Event|1
399606|NCT00062647|1257123|P2|Overall Study|Death|2
399607|NCT00062647|1257124|P1|Overall Study|Death|2
399608|NCT00062439|1257130|P1|Consolidation Chemotherapy|Adverse Event|2
399609|NCT00062439|1257130|P1|Surgery|Adverse Event|2
399610|NCT00062439|1257130|P1|Surgery|Death|1
399611|NCT00062439|1257130|P1|Surgery|Physician Decision|4
399612|NCT00062439|1257130|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
399613|NCT00062439|1257130|P1|Post Chemoradiation Assessment|Physician Decision|1
399614|NCT00062439|1257130|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
399615|NCT00062439|1257130|P1|Post Chemoradiation Assessment|Disease progression|2
399616|NCT00062439|1257130|P1|Post Chemoradiation Assessment|Death|1
399617|NCT00062439|1257130|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
399618|NCT00062439|1257130|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
399619|NCT00062439|1257130|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
399620|NCT00062439|1257130|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
399621|NCT00062010|1257142|P1|Overall Study|Ineligible|3
399622|NCT00061945|1257150|P2|Course IV: Alemtuzumab|Early exits|15
399623|NCT00061945|1257151|P1|Course IV: Alemtuzumab|Early exits|6
399624|NCT00061945|1257150|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
399625|NCT00061945|1257151|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
399626|NCT00061945|1257150|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
399627|NCT00061945|1257151|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
399628|NCT00061945|1257150|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
399629|NCT00061945|1257151|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
399630|NCT00061932|1257161|P2|Overall Study|Withdrawal by Subject|4
399631|NCT00061932|1257162|P1|Overall Study|Withdrawal by Subject|13
399632|NCT00061633|1257175|P2|Overall Study|Never received study treatment|2
399633|NCT00061633|1257176|P1|Overall Study|Never received study treatment|0
399634|NCT00061633|1257175|P2|Overall Study|Other|1
399635|NCT00061633|1257176|P1|Overall Study|Other|1
399636|NCT00061633|1257175|P2|Overall Study|Lost to Follow-up|4
399637|NCT00061633|1257176|P1|Overall Study|Lost to Follow-up|1
399638|NCT00061633|1257175|P2|Overall Study|Withdrawal by Subject|2
399639|NCT00061633|1257176|P1|Overall Study|Withdrawal by Subject|2
399640|NCT00061633|1257175|P2|Overall Study|Adverse Event|2
399641|NCT00061633|1257176|P1|Overall Study|Adverse Event|1
399642|NCT00061048|1257201|P1|Overall Study|disease progression|20
399643|NCT00061048|1257201|P1|Overall Study|Adverse Event|2
399644|NCT00060944|1257211|P2|Overall Study|randomized but not treated|4
399645|NCT00060944|1257212|P1|Overall Study|randomized but not treated|6
399646|NCT00060944|1257211|P2|Overall Study|Not specified|4
399647|NCT00060944|1257212|P1|Overall Study|Not specified|2
399648|NCT00060944|1257211|P2|Overall Study|Treatment Switch|13
399649|NCT00060944|1257212|P1|Overall Study|Treatment Switch|0
399650|NCT00060944|1257211|P2|Overall Study|Subject Ineligible To Continue|1
399651|NCT00060944|1257212|P1|Overall Study|Subject Ineligible To Continue|2
399652|NCT00060944|1257211|P2|Overall Study|Lost to Follow-up|0
399653|NCT00060944|1257212|P1|Overall Study|Lost to Follow-up|1
399654|NCT00060944|1257211|P2|Overall Study|Disease Progression|94
399655|NCT00060944|1257212|P1|Overall Study|Disease Progression|93
399656|NCT00060944|1257211|P2|Overall Study|Withdrawal by Subject|5
399657|NCT00060944|1257212|P1|Overall Study|Withdrawal by Subject|18
399658|NCT00060944|1257211|P2|Overall Study|Death|3
399659|NCT00060944|1257212|P1|Overall Study|Death|2
399660|NCT00060944|1257211|P2|Overall Study|Adverse Event|10
399661|NCT00060944|1257212|P1|Overall Study|Adverse Event|12
399662|NCT00060840|1257228|P2|Overall Study|Other|0
399663|NCT00060840|1257229|P1|Overall Study|Other|1
399664|NCT00060840|1257228|P2|Overall Study|Physician Decision|0
399665|NCT00060840|1257229|P1|Overall Study|Physician Decision|1
399666|NCT00060840|1257228|P2|Overall Study|Subinvestigator unavailable|1
399667|NCT00060840|1257229|P1|Overall Study|Subinvestigator unavailable|0
399668|NCT00060840|1257228|P2|Overall Study|Withdrawal by Subject|1
399669|NCT00060840|1257229|P1|Overall Study|Withdrawal by Subject|0
399670|NCT00060840|1257228|P2|Overall Study|Death|1
399671|NCT00060840|1257229|P1|Overall Study|Death|0
399672|NCT00060840|1257228|P2|Overall Study|Change in surgical plan|6
399673|NCT00060840|1257229|P1|Overall Study|Change in surgical plan|2
399674|NCT00059839|1257274|P2|Overall Study|Ineligible|3
399675|NCT00059839|1257275|P1|Overall Study|Ineligible|1
399676|NCT00059839|1257274|P2|Overall Study|Withdrawal by Subject|6
399677|NCT00059839|1257275|P1|Overall Study|Withdrawal by Subject|1
399678|NCT00059839|1257274|P2|Overall Study|Physician Decision|2
399679|NCT00059839|1257275|P1|Overall Study|Physician Decision|1
399680|NCT00059839|1257274|P2|Overall Study|Lost to Follow-up|0
399681|NCT00059839|1257275|P1|Overall Study|Lost to Follow-up|2
399682|NCT00059839|1257274|P2|Overall Study|Lack of Efficacy|5
399683|NCT00059839|1257275|P1|Overall Study|Lack of Efficacy|6
399684|NCT00059839|1257274|P2|Overall Study|Death|1
399685|NCT00059839|1257275|P1|Overall Study|Death|1
399686|NCT00059787|1257281|P1|Overall Study|Other|4
399687|NCT00059787|1257281|P1|Overall Study|ineligible|1
399688|NCT00059787|1257281|P1|Overall Study|disease progression|2
399689|NCT00059787|1257281|P1|Overall Study|Adverse Event|13
399690|NCT00059332|1257332|P2|Overall Study|Lost to Follow-up|1
399691|NCT00059332|1257333|P1|Overall Study|Lost to Follow-up|1
399692|NCT00059332|1257332|P2|Overall Study|Withdrawal by Subject|1
399693|NCT00059332|1257333|P1|Overall Study|Withdrawal by Subject|2
399694|NCT00059215|1257359|P4|Overall Study|Physician Decision|1
399695|NCT00059215|1257360|P3|Overall Study|Physician Decision|1
399696|NCT00059215|1257361|P2|Overall Study|Physician Decision|2
399697|NCT00059215|1257362|P1|Overall Study|Physician Decision|1
399698|NCT00059215|1257359|P4|Overall Study|Protocol entry criteria not met|2
399699|NCT00059215|1257360|P3|Overall Study|Protocol entry criteria not met|0
399700|NCT00059215|1257361|P2|Overall Study|Protocol entry criteria not met|1
399701|NCT00059215|1257362|P1|Overall Study|Protocol entry criteria not met|1
399702|NCT00059215|1257359|P4|Overall Study|Protocol Violation|0
399703|NCT00059215|1257360|P3|Overall Study|Protocol Violation|1
399704|NCT00059215|1257361|P2|Overall Study|Protocol Violation|0
399705|NCT00059215|1257362|P1|Overall Study|Protocol Violation|1
399706|NCT00059215|1257359|P4|Overall Study|Withdrawal by Subject|3
399707|NCT00059215|1257360|P3|Overall Study|Withdrawal by Subject|1
399708|NCT00059215|1257361|P2|Overall Study|Withdrawal by Subject|4
399709|NCT00059215|1257362|P1|Overall Study|Withdrawal by Subject|4
399710|NCT00059215|1257359|P4|Overall Study|Lost to Follow-up|0
399711|NCT00059215|1257360|P3|Overall Study|Lost to Follow-up|0
399712|NCT00059215|1257361|P2|Overall Study|Lost to Follow-up|2
399713|NCT00059215|1257362|P1|Overall Study|Lost to Follow-up|1
399714|NCT00059215|1257359|P4|Overall Study|Death|0
399715|NCT00059215|1257360|P3|Overall Study|Death|3
399716|NCT00059215|1257361|P2|Overall Study|Death|0
399717|NCT00059215|1257362|P1|Overall Study|Death|0
399718|NCT00059215|1257359|P4|Overall Study|Adverse Event|9
399719|NCT00059215|1257360|P3|Overall Study|Adverse Event|9
399720|NCT00059215|1257361|P2|Overall Study|Adverse Event|5
399721|NCT00059215|1257362|P1|Overall Study|Adverse Event|5
399722|NCT00058825|1257388|P1|Overall Study|Death|3
399723|NCT00058825|1257388|P1|Overall Study|Graft Failure|5
399724|NCT00058825|1257388|P1|Overall Study|Progressive Disease|5
399725|NCT00058825|1257388|P1|Overall Study|Relapse|9
399726|NCT00058552|1257404|P2|Overall Study|Clinical disease progression|4
399727|NCT00058552|1257405|P1|Overall Study|Clinical disease progression|0
399728|NCT00058552|1257404|P2|Overall Study|Physician Decision|5
399729|NCT00058552|1257405|P1|Overall Study|Physician Decision|2
399730|NCT00058552|1257404|P2|Overall Study|Withdrawal by Subject|5
399731|NCT00058552|1257405|P1|Overall Study|Withdrawal by Subject|3
399732|NCT00058552|1257404|P2|Overall Study|Adverse Event|2
399733|NCT00058552|1257405|P1|Overall Study|Adverse Event|4
399734|NCT00058552|1257404|P2|Overall Study|Disease progression|44
399735|NCT00058552|1257405|P1|Overall Study|Disease progression|52
399736|NCT00058552|1257404|P2|Overall Study|Died prior to receiving treatment|2
399737|NCT00058552|1257405|P1|Overall Study|Died prior to receiving treatment|4
399738|NCT00058539|1257423|P1|Overall Study|Death|1
399739|NCT00058539|1257423|P1|Overall Study|Physician Decision|9
399740|NCT00058539|1257423|P1|Overall Study|Withdrawal by Subject|5
399741|NCT00058539|1257423|P1|Overall Study|Adverse Event|3
399742|NCT00058539|1257423|P1|Overall Study|Disease progression|24
399743|NCT00058214|1257450|P1|Overall Study|Adverse Event|1
399744|NCT00057954|1257471|P1|Overall Study|Disease progression|1
399745|NCT00057954|1257471|P1|Overall Study|Death|1
399746|NCT00057941|1257479|P2|Overall Study|Ineligible|5
399747|NCT00057941|1257480|P1|Overall Study|Ineligible|2
399748|NCT00057941|1257479|P2|Overall Study|insurance, symptomatic deterioration|3
399749|NCT00057941|1257480|P1|Overall Study|insurance, symptomatic deterioration|1
399750|NCT00057941|1257479|P2|Overall Study|still on treatment|1
399751|NCT00057941|1257480|P1|Overall Study|still on treatment|3
399752|NCT00057941|1257479|P2|Overall Study|Withdrawal by Subject|1
399753|NCT00057941|1257480|P1|Overall Study|Withdrawal by Subject|6
399754|NCT00057941|1257479|P2|Overall Study|Lack of Efficacy|53
399755|NCT00057941|1257480|P1|Overall Study|Lack of Efficacy|54
399756|NCT00057941|1257479|P2|Overall Study|Adverse Event|9
399757|NCT00057941|1257480|P1|Overall Study|Adverse Event|7
399758|NCT00057941|1257479|P2|Overall Study|Death|2
399759|NCT00057941|1257480|P1|Overall Study|Death|1
399760|NCT00057876|1257488|P2|Overall Study|other complicating disease|0
399761|NCT00057876|1257489|P1|Overall Study|other complicating disease|1
399762|NCT00057876|1257488|P2|Overall Study|other reason|2
399763|NCT00057876|1257489|P1|Overall Study|other reason|2
399764|NCT00057876|1257488|P2|Overall Study|Ineligible|2
399765|NCT00057876|1257489|P1|Overall Study|Ineligible|1
399766|NCT00057876|1257488|P2|Overall Study|Lack of Efficacy|8
399767|NCT00057876|1257489|P1|Overall Study|Lack of Efficacy|10
399768|NCT00057876|1257488|P2|Overall Study|Withdrawal by Subject|6
399769|NCT00057876|1257489|P1|Overall Study|Withdrawal by Subject|5
399770|NCT00057876|1257488|P2|Overall Study|Death|1
399771|NCT00057876|1257489|P1|Overall Study|Death|2
399772|NCT00057876|1257488|P2|Overall Study|Adverse Event|8
399773|NCT00057876|1257489|P1|Overall Study|Adverse Event|8
399774|NCT00057863|1257499|P1|Overall Study|Withdrawal by Subject|2
399775|NCT00057863|1257499|P1|Overall Study|Death|1
399776|NCT00057837|1257508|P2|Overall Study|Never started treatment|1
399777|NCT00057837|1257509|P1|Overall Study|Never started treatment|1
399778|NCT00057837|1257508|P2|Overall Study|Ineligible|3
399779|NCT00057837|1257509|P1|Overall Study|Ineligible|3
399780|NCT00057837|1257508|P2|Overall Study|Physician Decision|0
399781|NCT00057837|1257509|P1|Overall Study|Physician Decision|1
399782|NCT00057837|1257508|P2|Overall Study|Other complicating disease|1
399783|NCT00057837|1257509|P1|Overall Study|Other complicating disease|2
399784|NCT00057837|1257508|P2|Overall Study|Alternative therapy|1
399785|NCT00057837|1257509|P1|Overall Study|Alternative therapy|0
399786|NCT00057837|1257508|P2|Overall Study|Withdrawal by Subject|3
399787|NCT00057837|1257509|P1|Overall Study|Withdrawal by Subject|5
399788|NCT00057837|1257508|P2|Overall Study|Death|4
399789|NCT00057837|1257509|P1|Overall Study|Death|5
399790|NCT00057837|1257508|P2|Overall Study|Adverse Event|12
399791|NCT00057837|1257509|P1|Overall Study|Adverse Event|2
399792|NCT00057837|1257508|P2|Overall Study|Progression/relapse|14
399793|NCT00057837|1257509|P1|Overall Study|Progression/relapse|12
399794|NCT00057811|1257521|P2|Overall Study|Inevaluable|2
399795|NCT00057811|1257522|P1|Overall Study|Inevaluable|1
399796|NCT00057811|1257521|P2|Overall Study|Ineligible|2
399797|NCT00057811|1257522|P1|Overall Study|Ineligible|4
399798|NCT00057811|1257521|P2|Overall Study|Withdrawal by Subject|4
399799|NCT00057811|1257522|P1|Overall Study|Withdrawal by Subject|3
399800|NCT00057811|1257521|P2|Overall Study|Physician Decision|0
399801|NCT00057811|1257522|P1|Overall Study|Physician Decision|1
399802|NCT00057811|1257521|P2|Overall Study|Lack of Efficacy|4
399803|NCT00057811|1257522|P1|Overall Study|Lack of Efficacy|1
399804|NCT00057746|1257541|P3|Overall Study|Withdrawal by Subject|1
399805|NCT00057746|1257542|P2|Overall Study|Withdrawal by Subject|0
399806|NCT00057746|1257543|P1|Overall Study|Withdrawal by Subject|0
399807|NCT00057330|1257602|P2|Overall Study|Unspecified|206
399808|NCT00057330|1257603|P1|Overall Study|Unspecified|260
399809|NCT00057330|1257602|P2|Overall Study|Physician Decision|0
399810|NCT00057330|1257603|P1|Overall Study|Physician Decision|1
399811|NCT00057330|1257602|P2|Overall Study|Lost to Follow-up|617
399812|NCT00057330|1257603|P1|Overall Study|Lost to Follow-up|745
399813|NCT00057330|1257602|P2|Overall Study|Withdrawal by Subject|84
399814|NCT00057330|1257603|P1|Overall Study|Withdrawal by Subject|115
399815|NCT00057330|1257602|P2|Overall Study|Protocol Violation|1
399816|NCT00057330|1257603|P1|Overall Study|Protocol Violation|1
399817|NCT00057330|1257602|P2|Overall Study|Death|0
399818|NCT00057330|1257603|P1|Overall Study|Death|1
399819|NCT00057330|1257602|P2|Overall Study|Adverse Event|12
399820|NCT00057330|1257603|P1|Overall Study|Adverse Event|9
399821|NCT00056862|1257633|P2|Overall Study|Protocol Violation|0
399822|NCT00056862|1257634|P1|Overall Study|Protocol Violation|1
399823|NCT00056407|1257688|P2|Overall Study|Missing|34
399824|NCT00056407|1257689|P1|Overall Study|Missing|25
399825|NCT00056407|1257688|P2|Overall Study|"Listed as Other on Case Report Form"|60
399826|NCT00056407|1257689|P1|Overall Study|"Listed as Other on Case Report Form"|98
399827|NCT00056407|1257688|P2|Overall Study|Diagnosed with Prostate Cancer|166
399828|NCT00056407|1257689|P1|Overall Study|Diagnosed with Prostate Cancer|202
399829|NCT00056407|1257688|P2|Overall Study|Protocol Violation|95
399830|NCT00056407|1257689|P1|Overall Study|Protocol Violation|104
399831|NCT00056407|1257688|P2|Overall Study|Lost to Follow-up|113
399832|NCT00056407|1257689|P1|Overall Study|Lost to Follow-up|123
399833|NCT00056407|1257688|P2|Overall Study|Withdrawal by Subject|361
399834|NCT00056407|1257689|P1|Overall Study|Withdrawal by Subject|377
399835|NCT00056407|1257688|P2|Overall Study|Adverse Event|364
399836|NCT00056407|1257689|P1|Overall Study|Adverse Event|282
399837|NCT00056316|1257747|P2|Overall Study|Death/NH placement of pt|1
399838|NCT00056316|1257748|P1|Overall Study|Death/NH placement of pt|1
399839|NCT00056316|1257747|P2|Overall Study|Withdrawal by Subject|2
399840|NCT00056316|1257748|P1|Overall Study|Withdrawal by Subject|2
399841|NCT00056160|1257762|P2|Final Follow-up|Adverse Event|0
399842|NCT00056160|1257763|P1|Final Follow-up|Adverse Event|1
399843|NCT00056160|1257762|P2|Final Follow-up|Transferred into RevAssist Program|0
399844|NCT00056160|1257763|P1|Final Follow-up|Transferred into RevAssist Program|2
399845|NCT00056160|1257762|P2|Final Follow-up|Transferred into expanded access study.|0
399846|NCT00056160|1257763|P1|Final Follow-up|Transferred into expanded access study.|3
399847|NCT00056160|1257762|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
399848|NCT00056160|1257763|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
399849|NCT00056160|1257762|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
399850|NCT00056160|1257763|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
399851|NCT00056160|1257762|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
399852|NCT00056160|1257763|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
399853|NCT00056160|1257762|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
399854|NCT00056160|1257763|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
399855|NCT00056160|1257762|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
399856|NCT00056160|1257763|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
399857|NCT00056160|1257762|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
399858|NCT00056160|1257763|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
399859|NCT00056160|1257762|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
399860|NCT00056160|1257763|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
399861|NCT00056160|1257762|P2|Up to Unblinding (07 Jun 2005)|Death|1
399862|NCT00056160|1257763|P1|Up to Unblinding (07 Jun 2005)|Death|2
399863|NCT00056160|1257762|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
399864|NCT00056160|1257763|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
399865|NCT00056160|1257762|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
399866|NCT00056160|1257763|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
399867|NCT00056160|1257762|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
399868|NCT00056160|1257763|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
399869|NCT00056160|1257762|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
399870|NCT00056160|1257763|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
399871|NCT00055601|1257786|P2|Overall Study|No protocol treatment received|1
399872|NCT00055601|1257787|P1|Overall Study|No protocol treatment received|1
399873|NCT00055601|1257786|P2|Overall Study|Protocol Violation|1
399874|NCT00055601|1257787|P1|Overall Study|Protocol Violation|1
399875|NCT00055497|1257801|P4|Overall Study|Other|11
399876|NCT00055497|1257802|P3|Overall Study|Other|0
399877|NCT00055497|1257803|P2|Overall Study|Other|0
399878|NCT00055497|1257804|P1|Overall Study|Other|0
399879|NCT00055497|1257801|P4|Overall Study|Administrative Reasons|1
399880|NCT00055497|1257802|P3|Overall Study|Administrative Reasons|0
399881|NCT00055497|1257803|P2|Overall Study|Administrative Reasons|0
399882|NCT00055497|1257804|P1|Overall Study|Administrative Reasons|0
399883|NCT00055497|1257801|P4|Overall Study|Lack of Efficacy|27
399884|NCT00055497|1257802|P3|Overall Study|Lack of Efficacy|0
399885|NCT00055497|1257803|P2|Overall Study|Lack of Efficacy|0
399886|NCT00055497|1257804|P1|Overall Study|Lack of Efficacy|1
399887|NCT00055497|1257801|P4|Overall Study|Protocol Violation|3
399888|NCT00055497|1257802|P3|Overall Study|Protocol Violation|0
399889|NCT00055497|1257803|P2|Overall Study|Protocol Violation|0
399890|NCT00055497|1257804|P1|Overall Study|Protocol Violation|0
399891|NCT00055497|1257801|P4|Overall Study|Lost to Follow-up|5
399892|NCT00055497|1257802|P3|Overall Study|Lost to Follow-up|0
399893|NCT00055497|1257803|P2|Overall Study|Lost to Follow-up|1
399894|NCT00055497|1257804|P1|Overall Study|Lost to Follow-up|0
399895|NCT00055497|1257801|P4|Overall Study|Withdrawal by Subject|15
399896|NCT00055497|1257802|P3|Overall Study|Withdrawal by Subject|1
399897|NCT00055497|1257803|P2|Overall Study|Withdrawal by Subject|1
399898|NCT00055497|1257804|P1|Overall Study|Withdrawal by Subject|3
399899|NCT00055497|1257801|P4|Overall Study|Adverse Event|28
399900|NCT00055497|1257802|P3|Overall Study|Adverse Event|1
399901|NCT00055497|1257803|P2|Overall Study|Adverse Event|1
399902|NCT00055497|1257804|P1|Overall Study|Adverse Event|1
399903|NCT00055471|1257849|P3|Period 1: Dose Escalation Period|Disease progression|0
399904|NCT00055471|1257850|P2|Period 1: Dose Escalation Period|Disease progression|1
399905|NCT00055471|1257851|P1|Period 1: Dose Escalation Period|Disease progression|0
399906|NCT00055471|1257849|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
399907|NCT00055471|1257850|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
399908|NCT00055471|1257851|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
399909|NCT00055471|1257849|P3|Period 1: Dose Escalation Period|Adverse Event|2
399910|NCT00055471|1257850|P2|Period 1: Dose Escalation Period|Adverse Event|1
399911|NCT00055471|1257851|P1|Period 1: Dose Escalation Period|Adverse Event|0
399912|NCT00054717|1257902|P2|Overall Study|Other reason not defined above|217
399913|NCT00054717|1257903|P1|Overall Study|Other reason not defined above|117
399914|NCT00054717|1257902|P2|Overall Study|Withdrawal by Subject|20
399915|NCT00054717|1257903|P1|Overall Study|Withdrawal by Subject|32
399916|NCT00054717|1257902|P2|Overall Study|Lost to Follow-up|13
399917|NCT00054717|1257903|P1|Overall Study|Lost to Follow-up|23
399918|NCT00054717|1257902|P2|Overall Study|Protocol Violation|19
399919|NCT00054717|1257903|P1|Overall Study|Protocol Violation|18
399920|NCT00054717|1257902|P2|Overall Study|Adverse Event|22
399921|NCT00054717|1257903|P1|Overall Study|Adverse Event|70
399922|NCT00054717|1257902|P2|Overall Study|Randomized but not treated|8
399923|NCT00054717|1257903|P1|Overall Study|Randomized but not treated|2
399924|NCT00054704|1258091|P2|Overall Study|Lost to Follow-up|0
399925|NCT00054704|1258092|P1|Overall Study|Lost to Follow-up|1
399926|NCT00054704|1258091|P2|Overall Study|Adverse Event|2
399927|NCT00054704|1258092|P1|Overall Study|Adverse Event|3
399928|NCT00054704|1258091|P2|Overall Study|Lack of Efficacy|3
399929|NCT00054704|1258092|P1|Overall Study|Lack of Efficacy|1
399930|NCT00054691|1258098|P1|Overall Study|Noncompliant|1
399931|NCT00054691|1258098|P1|Overall Study|Unmeasurable Disease|2
399932|NCT00054639|1258112|P1|Overall Study|Physician Decision|1
399933|NCT00054639|1258112|P1|Overall Study|Lack of Efficacy|1
399934|NCT00054327|1258122|P6|Overall Study|Engraftment failure|0
399935|NCT00054327|1258123|P5|Overall Study|Engraftment failure|0
399936|NCT00054327|1258124|P4|Overall Study|Engraftment failure|0
399937|NCT00054327|1258125|P3|Overall Study|Engraftment failure|0
399938|NCT00054327|1258126|P2|Overall Study|Engraftment failure|0
399939|NCT00054327|1258127|P1|Overall Study|Engraftment failure|1
399940|NCT00054275|1258165|P1|Overall Study|Physician Decision|1
399941|NCT00054275|1258165|P1|Overall Study|Progressive disease in cycle 1|1
399942|NCT00054275|1258165|P1|Overall Study|Adverse Event|5
399943|NCT00054275|1258165|P1|Overall Study|Withdrawal by Subject|4
399944|NCT00053846|1258181|P2|Overall Study|Pills too large|1
399945|NCT00053846|1258182|P1|Overall Study|Pills too large|0
399946|NCT00053846|1258181|P2|Overall Study|Quit due to side effects|3
399947|NCT00053846|1258182|P1|Overall Study|Quit due to side effects|1
399948|NCT00053846|1258181|P2|Overall Study|Did not return data|2
399949|NCT00053846|1258182|P1|Overall Study|Did not return data|1
399950|NCT00053846|1258181|P2|Overall Study|Became ineligible|1
399951|NCT00053846|1258182|P1|Overall Study|Became ineligible|3
399952|NCT00053846|1258181|P2|Overall Study|Expired|0
399953|NCT00053846|1258182|P1|Overall Study|Expired|5
399954|NCT00053846|1258181|P2|Overall Study|Became too ill|7
399955|NCT00053846|1258182|P1|Overall Study|Became too ill|8
399956|NCT00053846|1258181|P2|Overall Study|Changed mind|13
399957|NCT00053846|1258182|P1|Overall Study|Changed mind|8
399958|NCT00053417|1258332|P4|Overall Study|Lost to Follow-up|0
399959|NCT00053417|1258333|P3|Overall Study|Lost to Follow-up|0
399960|NCT00053417|1258334|P2|Overall Study|Lost to Follow-up|1
399961|NCT00053417|1258335|P1|Overall Study|Lost to Follow-up|1
399962|NCT00053417|1258332|P4|Overall Study|Withdrawal by Subject|0
399963|NCT00053417|1258333|P3|Overall Study|Withdrawal by Subject|0
399964|NCT00053417|1258334|P2|Overall Study|Withdrawal by Subject|1
399965|NCT00053417|1258335|P1|Overall Study|Withdrawal by Subject|0
399966|NCT00053417|1258332|P4|Overall Study|Non-Compliance|1
399967|NCT00053417|1258333|P3|Overall Study|Non-Compliance|0
399968|NCT00053417|1258334|P2|Overall Study|Non-Compliance|0
399969|NCT00053417|1258335|P1|Overall Study|Non-Compliance|0
399970|NCT00053417|1258332|P4|Overall Study|Adverse Event|5
399971|NCT00053417|1258333|P3|Overall Study|Adverse Event|1
399972|NCT00053417|1258334|P2|Overall Study|Adverse Event|0
399973|NCT00053417|1258335|P1|Overall Study|Adverse Event|1
399974|NCT00053365|1258345|P1|Overall Study|Never treated|4
399975|NCT00053365|1258345|P1|Overall Study|Platinum-sensitive interval >12 months|1
399976|NCT00053365|1258345|P1|Overall Study|Incorrect cell type|1
399977|NCT00052962|1258357|P2|Overall Study|Not randomized/not evaluable|0
399978|NCT00052962|1258358|P1|Overall Study|Not randomized/not evaluable|1
399979|NCT00052962|1258357|P2|Overall Study|Not evaluable|2
399980|NCT00052962|1258358|P1|Overall Study|Not evaluable|0
399981|NCT00052715|1258366|P1|Overall Study|wrong histology|1
399982|NCT00051636|1258397|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
399983|NCT00051636|1258398|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
399984|NCT00051636|1258397|P2|Period 2- Extended Observation Period|Death|5
399985|NCT00051636|1258398|P1|Period 2- Extended Observation Period|Death|4
399986|NCT00051636|1258397|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
399987|NCT00051636|1258398|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
399988|NCT00051636|1258397|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
399989|NCT00051636|1258398|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
399990|NCT00051636|1258397|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
399991|NCT00051636|1258398|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
399992|NCT00051636|1258397|P2|Period 1 - Core|Lost to Follow-up|2
399993|NCT00051636|1258398|P1|Period 1 - Core|Lost to Follow-up|0
399994|NCT00051636|1258397|P2|Period 1 - Core|Withdrawal by Subject|2
399995|NCT00051636|1258398|P1|Period 1 - Core|Withdrawal by Subject|1
399996|NCT00051636|1258397|P2|Period 1 - Core|Protocol Violation|0
399997|NCT00051636|1258398|P1|Period 1 - Core|Protocol Violation|1
399998|NCT00051636|1258397|P2|Period 1 - Core|Adverse Event|2
399999|NCT00051636|1258398|P1|Period 1 - Core|Adverse Event|2
400000|NCT00051558|1258426|P2|Overall Study|Physician Decision|0
400001|NCT00051558|1258427|P1|Overall Study|Physician Decision|5
400002|NCT00051558|1258426|P2|Overall Study|Significant Lab Value|0
400003|NCT00051558|1258427|P1|Overall Study|Significant Lab Value|2
400004|NCT00051558|1258426|P2|Overall Study|Unspecified|1
400005|NCT00051558|1258427|P1|Overall Study|Unspecified|2
400006|NCT00051558|1258426|P2|Overall Study|Sponsor Decision|1
400007|NCT00051558|1258427|P1|Overall Study|Sponsor Decision|6
400008|NCT00051558|1258426|P2|Overall Study|Protocol Entry Criteria Unmet|2
400009|NCT00051558|1258427|P1|Overall Study|Protocol Entry Criteria Unmet|1
400010|NCT00051558|1258426|P2|Overall Study|Protocol Violation|4
400011|NCT00051558|1258427|P1|Overall Study|Protocol Violation|3
400012|NCT00051558|1258426|P2|Overall Study|Lost to Follow-up|13
400013|NCT00051558|1258427|P1|Overall Study|Lost to Follow-up|4
400014|NCT00051558|1258426|P2|Overall Study|Death|15
400015|NCT00051558|1258427|P1|Overall Study|Death|9
400016|NCT00051558|1258426|P2|Overall Study|Withdrawal by Subject|42
400017|NCT00051558|1258427|P1|Overall Study|Withdrawal by Subject|29
400018|NCT00051558|1258426|P2|Overall Study|Adverse Event|18
400019|NCT00051558|1258427|P1|Overall Study|Adverse Event|30
400020|NCT00051363|1258463|P2|Overall Study|Excluded Pre-Randomization|5
400021|NCT00051363|1258464|P1|Overall Study|Excluded Pre-Randomization|2
400022|NCT00051363|1258463|P2|Overall Study|Death|2
400023|NCT00051363|1258464|P1|Overall Study|Death|2
400024|NCT00051363|1258463|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
400025|NCT00051363|1258464|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
400026|NCT00051363|1258463|P2|Overall Study|Dropped Post-Rand for Any Reason|126
400027|NCT00051363|1258464|P1|Overall Study|Dropped Post-Rand for Any Reason|102
400028|NCT00050778|1258501|P3|Overall Study|Familial and personal reasons|0
400029|NCT00050778|1258502|P2|Overall Study|Familial and personal reasons|0
400030|NCT00050778|1258503|P1|Overall Study|Familial and personal reasons|1
400031|NCT00050778|1258501|P3|Overall Study|Randomized but not treated|2
400032|NCT00050778|1258502|P2|Overall Study|Randomized but not treated|5
400033|NCT00050778|1258503|P1|Overall Study|Randomized but not treated|4
400034|NCT00050778|1258501|P3|Overall Study|Withdrawal by Subject|4
400035|NCT00050778|1258502|P2|Overall Study|Withdrawal by Subject|8
400036|NCT00050778|1258503|P1|Overall Study|Withdrawal by Subject|6
400037|NCT00050778|1258501|P3|Overall Study|Protocol Violation|1
400038|NCT00050778|1258502|P2|Overall Study|Protocol Violation|0
400039|NCT00050778|1258503|P1|Overall Study|Protocol Violation|2
400040|NCT00050778|1258501|P3|Overall Study|Physician Decision|2
400041|NCT00050778|1258502|P2|Overall Study|Physician Decision|0
400042|NCT00050778|1258503|P1|Overall Study|Physician Decision|3
400043|NCT00050778|1258501|P3|Overall Study|Lost to Follow-up|4
400044|NCT00050778|1258502|P2|Overall Study|Lost to Follow-up|2
400045|NCT00050778|1258503|P1|Overall Study|Lost to Follow-up|0
400046|NCT00050778|1258501|P3|Overall Study|Lack of Efficacy|2
400047|NCT00050778|1258502|P2|Overall Study|Lack of Efficacy|2
400048|NCT00050778|1258503|P1|Overall Study|Lack of Efficacy|16
400049|NCT00050778|1258501|P3|Overall Study|Death|1
400050|NCT00050778|1258502|P2|Overall Study|Death|1
400051|NCT00050778|1258503|P1|Overall Study|Death|0
400052|NCT00050778|1258501|P3|Overall Study|Adverse Event|2
400053|NCT00050778|1258502|P2|Overall Study|Adverse Event|3
400054|NCT00050778|1258503|P1|Overall Study|Adverse Event|13
400055|NCT00050622|1258529|P1|Overall Study|Adverse Event|1
400056|NCT00051025|1258571|P2|Overall Study|Death|1
400057|NCT00051025|1258572|P1|Overall Study|Death|0
400058|NCT00051025|1258571|P2|Overall Study|Withdrawal by Subject|1
400059|NCT00051025|1258572|P1|Overall Study|Withdrawal by Subject|0
400060|NCT00051025|1258571|P2|Overall Study|Adverse Event|1
400061|NCT00051025|1258572|P1|Overall Study|Adverse Event|1
400062|NCT00051025|1258571|P2|Overall Study|Progressive Disease|1
400063|NCT00051025|1258572|P1|Overall Study|Progressive Disease|1
400064|NCT00050960|1258586|P2|Overall Study|Death|15
400065|NCT00050960|1258587|P1|Overall Study|Death|13
400066|NCT00050960|1258586|P2|Overall Study|Non-compliance|1
400067|NCT00050960|1258587|P1|Overall Study|Non-compliance|3
400068|NCT00050960|1258586|P2|Overall Study|Administrative|46
400069|NCT00050960|1258587|P1|Overall Study|Administrative|31
400070|NCT00050960|1258586|P2|Overall Study|Withdrawal by Subject|18
400071|NCT00050960|1258587|P1|Overall Study|Withdrawal by Subject|23
400072|NCT00050960|1258586|P2|Overall Study|Lost to Follow-up|1
400073|NCT00050960|1258587|P1|Overall Study|Lost to Follow-up|0
400074|NCT00050960|1258586|P2|Overall Study|Adverse Event|61
400075|NCT00050960|1258587|P1|Overall Study|Adverse Event|62
400076|NCT00050960|1258586|P2|Overall Study|Complete Response|2
400077|NCT00050960|1258587|P1|Overall Study|Complete Response|0
400078|NCT00050960|1258586|P2|Overall Study|Partial Response|19
400079|NCT00050960|1258587|P1|Overall Study|Partial Response|14
400080|NCT00050960|1258586|P2|Overall Study|Stable Disease|48
400081|NCT00050960|1258587|P1|Overall Study|Stable Disease|19
400082|NCT00050960|1258586|P2|Overall Study|Progressive Disease|93
400083|NCT00050960|1258587|P1|Overall Study|Progressive Disease|137
400084|NCT00050167|1258595|P2|Overall Study|not eligible not invasive|1
400085|NCT00050167|1258596|P1|Overall Study|not eligible not invasive|1
400086|NCT00050011|1258629|P2|Overall Study|Unknown - Reason is missing|2
400087|NCT00050011|1258630|P1|Overall Study|Unknown - Reason is missing|0
400088|NCT00050011|1258629|P2|Overall Study|Death|4
400089|NCT00050011|1258630|P1|Overall Study|Death|7
400090|NCT00050011|1258629|P2|Overall Study|Administrative problems|6
400091|NCT00050011|1258630|P1|Overall Study|Administrative problems|10
400092|NCT00050011|1258629|P2|Overall Study|Lost to Follow-up|9
400093|NCT00050011|1258630|P1|Overall Study|Lost to Follow-up|7
400094|NCT00050011|1258629|P2|Overall Study|Withdrawal by Subject|26
400095|NCT00050011|1258630|P1|Overall Study|Withdrawal by Subject|34
400096|NCT00050011|1258629|P2|Overall Study|Protocol Violation|10
400097|NCT00050011|1258630|P1|Overall Study|Protocol Violation|4
400098|NCT00050011|1258629|P2|Overall Study|Participant condition no longer required|0
400099|NCT00050011|1258630|P1|Overall Study|Participant condition no longer required|1
400100|NCT00050011|1258629|P2|Overall Study|Lack of Efficacy|21
400101|NCT00050011|1258630|P1|Overall Study|Lack of Efficacy|16
400102|NCT00050011|1258629|P2|Overall Study|Abnormal test procedure results|1
400103|NCT00050011|1258630|P1|Overall Study|Abnormal test procedure results|0
400104|NCT00050011|1258629|P2|Overall Study|Abnormal laboratory value(s)|1
400105|NCT00050011|1258630|P1|Overall Study|Abnormal laboratory value(s)|1
400106|NCT00050011|1258629|P2|Overall Study|Adverse Event|46
400107|NCT00050011|1258630|P1|Overall Study|Adverse Event|41
400108|NCT00049842|1258652|P2|Follow-up Phase|Not specified|4
400109|NCT00049842|1258653|P1|Follow-up Phase|Not specified|1
400110|NCT00049842|1258652|P2|Follow-up Phase|Adverse Event|1
400111|NCT00049842|1258653|P1|Follow-up Phase|Adverse Event|6
400112|NCT00049842|1258652|P2|Treatment Phase|Did not meet protocol eligibility|1
400113|NCT00049842|1258653|P1|Treatment Phase|Did not meet protocol eligibility|0
400114|NCT00049842|1258652|P2|Treatment Phase|Administrative|3
400115|NCT00049842|1258653|P1|Treatment Phase|Administrative|0
400116|NCT00049842|1258652|P2|Treatment Phase|Lost to Follow-up|8
400117|NCT00049842|1258653|P1|Treatment Phase|Lost to Follow-up|4
400118|NCT00049842|1258652|P2|Treatment Phase|Non-compliance with protocol|8
400119|NCT00049842|1258653|P1|Treatment Phase|Non-compliance with protocol|7
400120|NCT00049842|1258652|P2|Treatment Phase|Withdrawal by Subject|46
400121|NCT00049842|1258653|P1|Treatment Phase|Withdrawal by Subject|35
400122|NCT00049842|1258652|P2|Treatment Phase|Adverse Event|12
400123|NCT00049842|1258653|P1|Treatment Phase|Adverse Event|47
400124|NCT00049543|1258671|P2|Overall Study|still on treatment|9
400125|NCT00049543|1258672|P1|Overall Study|still on treatment|2
400126|NCT00049530|1258682|P1|Overall Study|ineligible|3
400127|NCT00049530|1258682|P1|Overall Study|symptomatic deterioration|1
400128|NCT00049530|1258682|P1|Overall Study|Death|1
400129|NCT00049530|1258682|P1|Overall Study|Adverse Event|2
400130|NCT00049530|1258682|P1|Overall Study|Lack of Efficacy|25
400131|NCT00049517|1258691|P6|Conditioning/Transplant|Reasons not reported|5
400132|NCT00049517|1258692|P5|Conditioning/Transplant|Reasons not reported|5
400133|NCT00049517|1258693|P4|Conditioning/Transplant|Reasons not reported|15
400134|NCT00049517|1258694|P3|Conditioning/Transplant|Reasons not reported|18
400135|NCT00049517|1258695|P2|Conditioning/Transplant|Reasons not reported|31
400136|NCT00049517|1258696|P1|Conditioning/Transplant|Reasons not reported|25
400137|NCT00049517|1258691|P6|Conditioning/Transplant|Other complicating disease|1
400138|NCT00049517|1258692|P5|Conditioning/Transplant|Other complicating disease|0
400139|NCT00049517|1258693|P4|Conditioning/Transplant|Other complicating disease|4
400140|NCT00049517|1258694|P3|Conditioning/Transplant|Other complicating disease|0
400141|NCT00049517|1258695|P2|Conditioning/Transplant|Other complicating disease|0
400142|NCT00049517|1258696|P1|Conditioning/Transplant|Other complicating disease|2
400143|NCT00049517|1258691|P6|Conditioning/Transplant|Alternative therapy|0
400144|NCT00049517|1258692|P5|Conditioning/Transplant|Alternative therapy|1
400145|NCT00049517|1258693|P4|Conditioning/Transplant|Alternative therapy|1
400146|NCT00049517|1258694|P3|Conditioning/Transplant|Alternative therapy|2
400147|NCT00049517|1258695|P2|Conditioning/Transplant|Alternative therapy|4
400148|NCT00049517|1258696|P1|Conditioning/Transplant|Alternative therapy|4
400149|NCT00049517|1258691|P6|Conditioning/Transplant|Withdrawal by Subject|0
400150|NCT00049517|1258692|P5|Conditioning/Transplant|Withdrawal by Subject|0
400151|NCT00049517|1258693|P4|Conditioning/Transplant|Withdrawal by Subject|7
400152|NCT00049517|1258694|P3|Conditioning/Transplant|Withdrawal by Subject|4
400153|NCT00049517|1258695|P2|Conditioning/Transplant|Withdrawal by Subject|8
400154|NCT00049517|1258696|P1|Conditioning/Transplant|Withdrawal by Subject|4
400155|NCT00049517|1258691|P6|Conditioning/Transplant|Death|0
400156|NCT00049517|1258692|P5|Conditioning/Transplant|Death|0
400157|NCT00049517|1258693|P4|Conditioning/Transplant|Death|2
400158|NCT00049517|1258694|P3|Conditioning/Transplant|Death|0
400159|NCT00049517|1258695|P2|Conditioning/Transplant|Death|0
400160|NCT00049517|1258696|P1|Conditioning/Transplant|Death|1
400161|NCT00049517|1258691|P6|Conditioning/Transplant|Adverse Event|0
400162|NCT00049517|1258692|P5|Conditioning/Transplant|Adverse Event|0
400163|NCT00049517|1258693|P4|Conditioning/Transplant|Adverse Event|8
400164|NCT00049517|1258694|P3|Conditioning/Transplant|Adverse Event|4
400165|NCT00049517|1258695|P2|Conditioning/Transplant|Adverse Event|1
400166|NCT00049517|1258696|P1|Conditioning/Transplant|Adverse Event|2
400167|NCT00049517|1258691|P6|Conditioning/Transplant|Disease progression|0
400168|NCT00049517|1258692|P5|Conditioning/Transplant|Disease progression|0
400169|NCT00049517|1258693|P4|Conditioning/Transplant|Disease progression|6
400170|NCT00049517|1258694|P3|Conditioning/Transplant|Disease progression|10
400171|NCT00049517|1258695|P2|Conditioning/Transplant|Disease progression|6
400172|NCT00049517|1258696|P1|Conditioning/Transplant|Disease progression|14
400173|NCT00049517|1258691|P6|Induction|Reasons not reported|25
400174|NCT00049517|1258692|P5|Induction|Reasons not reported|22
400175|NCT00049517|1258693|P4|Induction|Reasons not reported|0
400176|NCT00049517|1258694|P3|Induction|Reasons not reported|0
400177|NCT00049517|1258695|P2|Induction|Reasons not reported|0
400178|NCT00049517|1258696|P1|Induction|Reasons not reported|0
400179|NCT00049517|1258691|P6|Induction|Other complicating disease|0
400180|NCT00049517|1258692|P5|Induction|Other complicating disease|3
400181|NCT00049517|1258693|P4|Induction|Other complicating disease|0
400182|NCT00049517|1258694|P3|Induction|Other complicating disease|0
400183|NCT00049517|1258695|P2|Induction|Other complicating disease|0
400184|NCT00049517|1258696|P1|Induction|Other complicating disease|0
400185|NCT00049517|1258691|P6|Induction|Alternative therapy|2
400186|NCT00049517|1258692|P5|Induction|Alternative therapy|2
400187|NCT00049517|1258693|P4|Induction|Alternative therapy|0
400188|NCT00049517|1258694|P3|Induction|Alternative therapy|0
400189|NCT00049517|1258695|P2|Induction|Alternative therapy|0
400190|NCT00049517|1258696|P1|Induction|Alternative therapy|0
400191|NCT00049517|1258691|P6|Induction|Withdrawal by Subject|3
400192|NCT00049517|1258692|P5|Induction|Withdrawal by Subject|1
400193|NCT00049517|1258693|P4|Induction|Withdrawal by Subject|0
400194|NCT00049517|1258694|P3|Induction|Withdrawal by Subject|0
400195|NCT00049517|1258695|P2|Induction|Withdrawal by Subject|0
400196|NCT00049517|1258696|P1|Induction|Withdrawal by Subject|0
400197|NCT00049517|1258691|P6|Induction|Death|6
400198|NCT00049517|1258692|P5|Induction|Death|9
400199|NCT00049517|1258693|P4|Induction|Death|0
400200|NCT00049517|1258694|P3|Induction|Death|0
400201|NCT00049517|1258695|P2|Induction|Death|0
400202|NCT00049517|1258696|P1|Induction|Death|0
400203|NCT00049517|1258691|P6|Induction|Adverse Event|7
400204|NCT00049517|1258692|P5|Induction|Adverse Event|5
400205|NCT00049517|1258693|P4|Induction|Adverse Event|0
400206|NCT00049517|1258694|P3|Induction|Adverse Event|0
400207|NCT00049517|1258695|P2|Induction|Adverse Event|0
400208|NCT00049517|1258696|P1|Induction|Adverse Event|0
400209|NCT00049517|1258691|P6|Induction|Disease progression|11
400210|NCT00049517|1258692|P5|Induction|Disease progression|18
400211|NCT00049517|1258693|P4|Induction|Disease progression|0
400212|NCT00049517|1258694|P3|Induction|Disease progression|0
400213|NCT00049517|1258695|P2|Induction|Disease progression|0
400214|NCT00049517|1258696|P1|Induction|Disease progression|0
400215|NCT00049322|1258714|P2|Overall Study|refused angio|3
400216|NCT00049322|1258715|P1|Overall Study|refused angio|0
400217|NCT00049322|1258714|P2|Overall Study|Adverse Event|0
400218|NCT00049322|1258715|P1|Overall Study|Adverse Event|1
400219|NCT00049322|1258714|P2|Overall Study|disease burden|3
400220|NCT00049322|1258715|P1|Overall Study|disease burden|0
400221|NCT00049257|1258727|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
400222|NCT00049257|1258727|P1|Carboplatin, Paclitaxel|Death|2
400223|NCT00049257|1258727|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
400224|NCT00049257|1258727|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
400225|NCT00049127|1258739|P5|Overall Study|Withdrawal by Subject|0
400226|NCT00049127|1258740|P4|Overall Study|Withdrawal by Subject|0
400227|NCT00049127|1258741|P3|Overall Study|Withdrawal by Subject|1
400228|NCT00049127|1258742|P2|Overall Study|Withdrawal by Subject|0
400229|NCT00049127|1258743|P1|Overall Study|Withdrawal by Subject|0
400230|NCT00048997|1258781|P2|Overall Study|Withdrawal by Subject|1
400231|NCT00048997|1258782|P1|Overall Study|Withdrawal by Subject|6
400232|NCT00048997|1258781|P2|Overall Study|Protocol Violation|2
400233|NCT00048997|1258782|P1|Overall Study|Protocol Violation|7
400234|NCT00048932|1258789|P3|Open Label Period (OL)|Participant Surgery|1
400235|NCT00048932|1258790|P2|Open Label Period (OL)|Participant Surgery|0
400236|NCT00048932|1258791|P1|Open Label Period (OL)|Participant Surgery|0
400237|NCT00048932|1258789|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
400238|NCT00048932|1258790|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
400239|NCT00048932|1258791|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
400240|NCT00048932|1258789|P3|Open Label Period (OL)|Site Staff Issues|2
400241|NCT00048932|1258790|P2|Open Label Period (OL)|Site Staff Issues|0
400242|NCT00048932|1258791|P1|Open Label Period (OL)|Site Staff Issues|0
400243|NCT00048932|1258789|P3|Open Label Period (OL)|Investigator Decision|4
400244|NCT00048932|1258790|P2|Open Label Period (OL)|Investigator Decision|0
400245|NCT00048932|1258791|P1|Open Label Period (OL)|Investigator Decision|0
400246|NCT00048932|1258789|P3|Open Label Period (OL)|Medication Lost Efficacy|1
400247|NCT00048932|1258790|P2|Open Label Period (OL)|Medication Lost Efficacy|0
400248|NCT00048932|1258791|P1|Open Label Period (OL)|Medication Lost Efficacy|0
400249|NCT00048932|1258789|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
400250|NCT00048932|1258790|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
400251|NCT00048932|1258791|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
400252|NCT00048932|1258789|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
400253|NCT00048932|1258790|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
400254|NCT00048932|1258791|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
400255|NCT00048932|1258789|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
400256|NCT00048932|1258790|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
400257|NCT00048932|1258791|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
400258|NCT00048932|1258789|P3|Open Label Period (OL)|Patient Decision|4
400259|NCT00048932|1258790|P2|Open Label Period (OL)|Patient Decision|0
400260|NCT00048932|1258791|P1|Open Label Period (OL)|Patient Decision|0
400261|NCT00048932|1258789|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
400262|NCT00048932|1258790|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
400263|NCT00048932|1258791|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
400264|NCT00048932|1258789|P3|Open Label Period (OL)|Trial Terminated|1
400265|NCT00048932|1258790|P2|Open Label Period (OL)|Trial Terminated|0
400266|NCT00048932|1258791|P1|Open Label Period (OL)|Trial Terminated|0
400267|NCT00048932|1258789|P3|Open Label Period (OL)|Site Closure|3
400268|NCT00048932|1258790|P2|Open Label Period (OL)|Site Closure|0
400269|NCT00048932|1258791|P1|Open Label Period (OL)|Site Closure|0
400270|NCT00048932|1258789|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
400271|NCT00048932|1258790|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
400272|NCT00048932|1258791|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
400273|NCT00048932|1258789|P3|Open Label Period (OL)|Participant Relocated|6
400274|NCT00048932|1258790|P2|Open Label Period (OL)|Participant Relocated|0
400275|NCT00048932|1258791|P1|Open Label Period (OL)|Participant Relocated|0
400276|NCT00048932|1258789|P3|Open Label Period (OL)|Participant Transportation Issues|1
400277|NCT00048932|1258790|P2|Open Label Period (OL)|Participant Transportation Issues|0
400278|NCT00048932|1258791|P1|Open Label Period (OL)|Participant Transportation Issues|0
400279|NCT00048932|1258789|P3|Open Label Period (OL)|Investigator Retiring|2
400280|NCT00048932|1258790|P2|Open Label Period (OL)|Investigator Retiring|0
400281|NCT00048932|1258791|P1|Open Label Period (OL)|Investigator Retiring|0
400282|NCT00048932|1258789|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
400283|NCT00048932|1258790|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
400284|NCT00048932|1258791|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
400285|NCT00048932|1258789|P3|Open Label Period (OL)|Pregnancy|6
400286|NCT00048932|1258790|P2|Open Label Period (OL)|Pregnancy|0
400287|NCT00048932|1258791|P1|Open Label Period (OL)|Pregnancy|0
400288|NCT00048932|1258789|P3|Open Label Period (OL)|Poor/Non-Compliance|13
400289|NCT00048932|1258790|P2|Open Label Period (OL)|Poor/Non-Compliance|0
400290|NCT00048932|1258791|P1|Open Label Period (OL)|Poor/Non-Compliance|0
400291|NCT00048932|1258789|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
400292|NCT00048932|1258790|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
400293|NCT00048932|1258791|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
400294|NCT00048932|1258789|P3|Open Label Period (OL)|Withdrawal by Subject|117
400295|NCT00048932|1258790|P2|Open Label Period (OL)|Withdrawal by Subject|0
400296|NCT00048932|1258791|P1|Open Label Period (OL)|Withdrawal by Subject|0
400297|NCT00048932|1258789|P3|Open Label Period (OL)|Lost to Follow-up|27
400298|NCT00048932|1258790|P2|Open Label Period (OL)|Lost to Follow-up|0
400299|NCT00048932|1258791|P1|Open Label Period (OL)|Lost to Follow-up|0
400300|NCT00048932|1258789|P3|Open Label Period (OL)|Lack of Efficacy|81
400301|NCT00048932|1258790|P2|Open Label Period (OL)|Lack of Efficacy|0
400302|NCT00048932|1258791|P1|Open Label Period (OL)|Lack of Efficacy|0
400303|NCT00048932|1258789|P3|Open Label Period (OL)|Adverse Event|103
400304|NCT00048932|1258790|P2|Open Label Period (OL)|Adverse Event|0
400305|NCT00048932|1258791|P1|Open Label Period (OL)|Adverse Event|0
400306|NCT00048932|1258789|P3|Open Label Period (OL)|Death|25
400307|NCT00048932|1258790|P2|Open Label Period (OL)|Death|0
400308|NCT00048932|1258791|P1|Open Label Period (OL)|Death|0
400309|NCT00048932|1258789|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
400310|NCT00048932|1258790|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
400311|NCT00048932|1258791|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
400312|NCT00048932|1258789|P3|Double Blind Period (DB)|Withdrawal by Subject|0
400313|NCT00048932|1258790|P2|Double Blind Period (DB)|Withdrawal by Subject|10
400314|NCT00048932|1258791|P1|Double Blind Period (DB)|Withdrawal by Subject|24
400315|NCT00048932|1258789|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
400316|NCT00048932|1258790|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
400317|NCT00048932|1258791|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
400318|NCT00048932|1258789|P3|Double Blind Period (DB)|Pregnancy|0
400319|NCT00048932|1258790|P2|Double Blind Period (DB)|Pregnancy|0
400320|NCT00048932|1258791|P1|Double Blind Period (DB)|Pregnancy|1
400321|NCT00048932|1258789|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
400322|NCT00048932|1258790|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
400323|NCT00048932|1258791|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
400324|NCT00048932|1258789|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
400325|NCT00048932|1258790|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
400326|NCT00048932|1258791|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
400327|NCT00048932|1258789|P3|Double Blind Period (DB)|Relocation|0
400328|NCT00048932|1258790|P2|Double Blind Period (DB)|Relocation|0
400329|NCT00048932|1258791|P1|Double Blind Period (DB)|Relocation|1
400330|NCT00048932|1258789|P3|Double Blind Period (DB)|Lost to Follow-up|0
400331|NCT00048932|1258790|P2|Double Blind Period (DB)|Lost to Follow-up|4
400332|NCT00048932|1258791|P1|Double Blind Period (DB)|Lost to Follow-up|3
400333|NCT00048932|1258789|P3|Double Blind Period (DB)|Lack of Efficacy|0
400334|NCT00048932|1258790|P2|Double Blind Period (DB)|Lack of Efficacy|44
400335|NCT00048932|1258791|P1|Double Blind Period (DB)|Lack of Efficacy|26
400336|NCT00048932|1258789|P3|Double Blind Period (DB)|Death|0
400337|NCT00048932|1258790|P2|Double Blind Period (DB)|Death|3
400338|NCT00048932|1258791|P1|Double Blind Period (DB)|Death|5
400339|NCT00048932|1258789|P3|Double Blind Period (DB)|Adverse Event|0
400340|NCT00048932|1258790|P2|Double Blind Period (DB)|Adverse Event|19
400341|NCT00048932|1258791|P1|Double Blind Period (DB)|Adverse Event|51
400342|NCT00048932|1258789|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
400343|NCT00048932|1258790|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
400344|NCT00048932|1258791|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
400345|NCT00048724|1258832|P2|Overall Study|Administrative|1
400346|NCT00048724|1258833|P1|Overall Study|Administrative|1
400347|NCT00048724|1258832|P2|Overall Study|Did Not Meet Protocol Eligibility|2
400348|NCT00048724|1258833|P1|Overall Study|Did Not Meet Protocol Eligibility|2
400349|NCT00048724|1258832|P2|Overall Study|Noncompliance With Protocol|12
400350|NCT00048724|1258833|P1|Overall Study|Noncompliance With Protocol|4
400351|NCT00048724|1258832|P2|Overall Study|Protocol-defined Clinical Event|32
400352|NCT00048724|1258833|P1|Overall Study|Protocol-defined Clinical Event|17
400353|NCT00048724|1258832|P2|Overall Study|Lost to Follow-up|5
400354|NCT00048724|1258833|P1|Overall Study|Lost to Follow-up|5
400355|NCT00048724|1258832|P2|Overall Study|Withdrawal by Subject|54
400356|NCT00048724|1258833|P1|Overall Study|Withdrawal by Subject|34
400357|NCT00048724|1258832|P2|Overall Study|Adverse Event|12
400358|NCT00048724|1258833|P1|Overall Study|Adverse Event|53
400359|NCT00048581|1258843|P3|Open-Label Period|Study Ended By Sponsor|1
400360|NCT00048581|1258844|P2|Open-Label Period|Study Ended By Sponsor|0
400361|NCT00048581|1258845|P1|Open-Label Period|Study Ended By Sponsor|0
400362|NCT00048581|1258843|P3|Open-Label Period|Primary Investigator Retired|2
400363|NCT00048581|1258844|P2|Open-Label Period|Primary Investigator Retired|0
400364|NCT00048581|1258845|P1|Open-Label Period|Primary Investigator Retired|0
400365|NCT00048581|1258843|P3|Open-Label Period|Problem With Transportation To Site|1
400366|NCT00048581|1258844|P2|Open-Label Period|Problem With Transportation To Site|0
400367|NCT00048581|1258845|P1|Open-Label Period|Problem With Transportation To Site|0
400368|NCT00048581|1258843|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
400369|NCT00048581|1258844|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
400370|NCT00048581|1258845|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
400371|NCT00048581|1258843|P3|Open-Label Period|Study Site Closure|2
400372|NCT00048581|1258844|P2|Open-Label Period|Study Site Closure|0
400373|NCT00048581|1258845|P1|Open-Label Period|Study Site Closure|0
400374|NCT00048581|1258843|P3|Open-Label Period|Pregnancy|7
400375|NCT00048581|1258844|P2|Open-Label Period|Pregnancy|0
400376|NCT00048581|1258845|P1|Open-Label Period|Pregnancy|0
400377|NCT00048581|1258843|P3|Open-Label Period|Poor/Non-compliance|5
400378|NCT00048581|1258844|P2|Open-Label Period|Poor/Non-compliance|0
400379|NCT00048581|1258845|P1|Open-Label Period|Poor/Non-compliance|0
400380|NCT00048581|1258843|P3|Open-Label Period|No Longer Meets Study Criteria|2
400381|NCT00048581|1258844|P2|Open-Label Period|No Longer Meets Study Criteria|0
400382|NCT00048581|1258845|P1|Open-Label Period|No Longer Meets Study Criteria|0
400383|NCT00048581|1258843|P3|Open-Label Period|Withdrawal by Subject|20
400384|NCT00048581|1258844|P2|Open-Label Period|Withdrawal by Subject|0
400385|NCT00048581|1258845|P1|Open-Label Period|Withdrawal by Subject|0
400386|NCT00048581|1258843|P3|Open-Label Period|Lost to Follow-up|14
400387|NCT00048581|1258844|P2|Open-Label Period|Lost to Follow-up|0
400388|NCT00048581|1258845|P1|Open-Label Period|Lost to Follow-up|0
400389|NCT00048581|1258843|P3|Open-Label Period|Lack of Efficacy|69
400390|NCT00048581|1258844|P2|Open-Label Period|Lack of Efficacy|0
400391|NCT00048581|1258845|P1|Open-Label Period|Lack of Efficacy|0
400392|NCT00048581|1258843|P3|Open-Label Period|Adverse Event|37
400393|NCT00048581|1258844|P2|Open-Label Period|Adverse Event|0
400394|NCT00048581|1258845|P1|Open-Label Period|Adverse Event|0
400395|NCT00048581|1258843|P3|Open-Label Period|Death|4
400396|NCT00048581|1258844|P2|Open-Label Period|Death|0
400397|NCT00048581|1258845|P1|Open-Label Period|Death|0
400398|NCT00048581|1258843|P3|Double-Blind Period|Investigator Decision|0
400399|NCT00048581|1258844|P2|Double-Blind Period|Investigator Decision|0
400400|NCT00048581|1258845|P1|Double-Blind Period|Investigator Decision|1
400401|NCT00048581|1258843|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
400402|NCT00048581|1258844|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
400403|NCT00048581|1258845|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
400404|NCT00048581|1258843|P3|Double-Blind Period|Withdrawal by Subject|0
400405|NCT00048581|1258844|P2|Double-Blind Period|Withdrawal by Subject|2
400406|NCT00048581|1258845|P1|Double-Blind Period|Withdrawal by Subject|5
400407|NCT00048581|1258843|P3|Double-Blind Period|Lost to Follow-up|0
400408|NCT00048581|1258844|P2|Double-Blind Period|Lost to Follow-up|0
400409|NCT00048581|1258845|P1|Double-Blind Period|Lost to Follow-up|5
400410|NCT00048581|1258843|P3|Double-Blind Period|Lack of Efficacy|0
400411|NCT00048581|1258844|P2|Double-Blind Period|Lack of Efficacy|27
400412|NCT00048581|1258845|P1|Double-Blind Period|Lack of Efficacy|14
400413|NCT00048581|1258843|P3|Double-Blind Period|Adverse Event|0
400414|NCT00048581|1258844|P2|Double-Blind Period|Adverse Event|5
400415|NCT00048581|1258845|P1|Double-Blind Period|Adverse Event|9
400416|NCT00048568|1259012|P3|Open-Label Period|Lost to Follow-up|7
400417|NCT00048568|1259013|P2|Open-Label Period|Lost to Follow-up|0
400418|NCT00048568|1259014|P1|Open-Label Period|Lost to Follow-up|0
400419|NCT00048568|1259012|P3|Open-Label Period|Unknown Reasons|25
400420|NCT00048568|1259013|P2|Open-Label Period|Unknown Reasons|0
400421|NCT00048568|1259014|P1|Open-Label Period|Unknown Reasons|0
400422|NCT00048568|1259012|P3|Open-Label Period|Administrative Decision By Sponsor|1
400423|NCT00048568|1259013|P2|Open-Label Period|Administrative Decision By Sponsor|0
400424|NCT00048568|1259014|P1|Open-Label Period|Administrative Decision By Sponsor|0
400425|NCT00048568|1259012|P3|Open-Label Period|No Longer Met Study Criteria|2
400426|NCT00048568|1259013|P2|Open-Label Period|No Longer Met Study Criteria|0
400427|NCT00048568|1259014|P1|Open-Label Period|No Longer Met Study Criteria|0
400428|NCT00048568|1259012|P3|Open-Label Period|Pregnancy|5
400429|NCT00048568|1259013|P2|Open-Label Period|Pregnancy|0
400430|NCT00048568|1259014|P1|Open-Label Period|Pregnancy|0
400431|NCT00048568|1259012|P3|Open-Label Period|Withdrawal by Subject|26
400432|NCT00048568|1259013|P2|Open-Label Period|Withdrawal by Subject|0
400433|NCT00048568|1259014|P1|Open-Label Period|Withdrawal by Subject|0
400434|NCT00048568|1259012|P3|Open-Label Period|Lack of Efficacy|32
400435|NCT00048568|1259013|P2|Open-Label Period|Lack of Efficacy|0
400436|NCT00048568|1259014|P1|Open-Label Period|Lack of Efficacy|0
400437|NCT00048568|1259012|P3|Open-Label Period|Adverse Event|49
400438|NCT00048568|1259013|P2|Open-Label Period|Adverse Event|0
400439|NCT00048568|1259014|P1|Open-Label Period|Adverse Event|0
400440|NCT00048568|1259012|P3|Open-Label Period|Death|13
400441|NCT00048568|1259013|P2|Open-Label Period|Death|0
400442|NCT00048568|1259014|P1|Open-Label Period|Death|0
400443|NCT00048568|1259012|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
400444|NCT00048568|1259013|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
400445|NCT00048568|1259014|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
400446|NCT00048568|1259012|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
400447|NCT00048568|1259013|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
400448|NCT00048568|1259014|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
400449|NCT00048568|1259012|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
400450|NCT00048568|1259013|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
400451|NCT00048568|1259014|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
400452|NCT00048568|1259012|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
400453|NCT00048568|1259013|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
400454|NCT00048568|1259014|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
400455|NCT00048568|1259012|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
400456|NCT00048568|1259013|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
400457|NCT00048568|1259014|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
400458|NCT00048568|1259012|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
400459|NCT00048568|1259013|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
400460|NCT00048568|1259014|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
400461|NCT00048568|1259012|P3|Double-Blind Period Days 170 to 365|Death|0
400462|NCT00048568|1259013|P2|Double-Blind Period Days 170 to 365|Death|1
400463|NCT00048568|1259014|P1|Double-Blind Period Days 170 to 365|Death|1
400464|NCT00048568|1259012|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
400465|NCT00048568|1259013|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
400466|NCT00048568|1259014|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
400467|NCT00048568|1259012|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
400468|NCT00048568|1259013|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
400469|NCT00048568|1259014|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
400470|NCT00048568|1259012|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
400471|NCT00048568|1259013|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
400472|NCT00048568|1259014|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
400473|NCT00048568|1259012|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
400474|NCT00048568|1259013|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
400475|NCT00048568|1259014|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
400476|NCT00048568|1259012|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
400477|NCT00048568|1259013|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
400478|NCT00048568|1259014|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
400479|NCT00048542|1259306|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
400480|NCT00048542|1259307|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
400481|NCT00048542|1259308|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
400482|NCT00048542|1259309|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
400483|NCT00048542|1259310|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
400484|NCT00048542|1259311|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
400485|NCT00048542|1259312|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
400486|NCT00048542|1259313|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
400487|NCT00048542|1259306|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
400488|NCT00048542|1259307|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
400489|NCT00048542|1259308|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
400490|NCT00048542|1259309|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
400491|NCT00048542|1259310|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
400492|NCT00048542|1259311|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
400493|NCT00048542|1259312|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
400494|NCT00048542|1259313|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
400495|NCT00048542|1259306|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
400496|NCT00048542|1259307|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
400497|NCT00048542|1259308|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
400498|NCT00048542|1259309|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
400499|NCT00048542|1259310|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
400500|NCT00048542|1259311|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
400501|NCT00048542|1259312|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
400502|NCT00048542|1259313|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
400503|NCT00048542|1259306|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
400504|NCT00048542|1259307|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
400505|NCT00048542|1259308|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
400506|NCT00048542|1259309|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
400507|NCT00048542|1259310|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
400508|NCT00048542|1259311|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
400509|NCT00048542|1259312|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
400510|NCT00048542|1259313|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
400511|NCT00048542|1259306|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
400512|NCT00048542|1259307|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
400513|NCT00048542|1259308|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
400514|NCT00048542|1259309|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
400515|NCT00048542|1259310|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
400516|NCT00048542|1259311|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
400517|NCT00048542|1259312|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
400518|NCT00048542|1259313|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
400519|NCT00048542|1259306|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
400520|NCT00048542|1259307|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
400521|NCT00048542|1259308|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
400522|NCT00048542|1259309|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
400523|NCT00048542|1259310|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
400524|NCT00048542|1259311|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
400525|NCT00048542|1259312|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
400526|NCT00048542|1259313|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
400527|NCT00048542|1259306|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
400528|NCT00048542|1259307|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
400529|NCT00048542|1259308|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
400530|NCT00048542|1259309|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
400531|NCT00048542|1259310|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
400532|NCT00048542|1259311|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
400533|NCT00048542|1259312|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
400534|NCT00048542|1259313|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
400535|NCT00048542|1259306|P8|Open-Label Extension BSA Phase|Adverse Event|0
400536|NCT00048542|1259307|P7|Open-Label Extension BSA Phase|Adverse Event|0
400537|NCT00048542|1259308|P6|Open-Label Extension BSA Phase|Adverse Event|1
400538|NCT00048542|1259309|P5|Open-Label Extension BSA Phase|Adverse Event|1
400539|NCT00048542|1259310|P4|Open-Label Extension BSA Phase|Adverse Event|0
400540|NCT00048542|1259311|P3|Open-Label Extension BSA Phase|Adverse Event|0
400541|NCT00048542|1259312|P2|Open-Label Extension BSA Phase|Adverse Event|0
400542|NCT00048542|1259313|P1|Open-Label Extension BSA Phase|Adverse Event|0
400543|NCT00048542|1259306|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
400544|NCT00048542|1259307|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
400545|NCT00048542|1259308|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
400546|NCT00048542|1259309|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
400547|NCT00048542|1259310|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
400548|NCT00048542|1259311|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
400549|NCT00048542|1259312|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
400550|NCT00048542|1259313|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
400551|NCT00048542|1259306|P8|Open-Label Extension BSA Phase|Protocol Violation|0
400552|NCT00048542|1259307|P7|Open-Label Extension BSA Phase|Protocol Violation|0
400553|NCT00048542|1259308|P6|Open-Label Extension BSA Phase|Protocol Violation|1
400554|NCT00048542|1259309|P5|Open-Label Extension BSA Phase|Protocol Violation|0
400555|NCT00048542|1259310|P4|Open-Label Extension BSA Phase|Protocol Violation|0
400556|NCT00048542|1259311|P3|Open-Label Extension BSA Phase|Protocol Violation|0
400557|NCT00048542|1259312|P2|Open-Label Extension BSA Phase|Protocol Violation|0
400558|NCT00048542|1259313|P1|Open-Label Extension BSA Phase|Protocol Violation|0
400559|NCT00048542|1259306|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
400560|NCT00048542|1259307|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
400561|NCT00048542|1259308|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
400562|NCT00048542|1259309|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
400563|NCT00048542|1259310|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
400564|NCT00048542|1259311|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
400565|NCT00048542|1259312|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
400566|NCT00048542|1259313|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
400567|NCT00048542|1259306|P8|Double-Blind Phase|Randomized in error|0
400568|NCT00048542|1259307|P7|Double-Blind Phase|Randomized in error|0
400569|NCT00048542|1259308|P6|Double-Blind Phase|Randomized in error|0
400570|NCT00048542|1259309|P5|Double-Blind Phase|Randomized in error|0
400571|NCT00048542|1259310|P4|Double-Blind Phase|Randomized in error|0
400572|NCT00048542|1259311|P3|Double-Blind Phase|Randomized in error|0
400573|NCT00048542|1259312|P2|Double-Blind Phase|Randomized in error|0
400574|NCT00048542|1259313|P1|Double-Blind Phase|Randomized in error|1
400575|NCT00048542|1259306|P8|Double-Blind Phase|Sponsor request or decision|0
400576|NCT00048542|1259307|P7|Double-Blind Phase|Sponsor request or decision|0
400577|NCT00048542|1259308|P6|Double-Blind Phase|Sponsor request or decision|0
400578|NCT00048542|1259309|P5|Double-Blind Phase|Sponsor request or decision|0
400579|NCT00048542|1259310|P4|Double-Blind Phase|Sponsor request or decision|0
400580|NCT00048542|1259311|P3|Double-Blind Phase|Sponsor request or decision|0
400581|NCT00048542|1259312|P2|Double-Blind Phase|Sponsor request or decision|0
400582|NCT00048542|1259313|P1|Double-Blind Phase|Sponsor request or decision|2
400583|NCT00048542|1259306|P8|Double-Blind Phase|Protocol Violation|0
400584|NCT00048542|1259307|P7|Double-Blind Phase|Protocol Violation|0
400585|NCT00048542|1259308|P6|Double-Blind Phase|Protocol Violation|0
400586|NCT00048542|1259309|P5|Double-Blind Phase|Protocol Violation|0
400587|NCT00048542|1259310|P4|Double-Blind Phase|Protocol Violation|0
400588|NCT00048542|1259311|P3|Double-Blind Phase|Protocol Violation|1
400589|NCT00048542|1259312|P2|Double-Blind Phase|Protocol Violation|0
400590|NCT00048542|1259313|P1|Double-Blind Phase|Protocol Violation|0
400591|NCT00048542|1259306|P8|Double-Blind Phase|Withdrawal by Subject|0
400592|NCT00048542|1259307|P7|Double-Blind Phase|Withdrawal by Subject|0
400593|NCT00048542|1259308|P6|Double-Blind Phase|Withdrawal by Subject|0
400594|NCT00048542|1259309|P5|Double-Blind Phase|Withdrawal by Subject|0
400595|NCT00048542|1259310|P4|Double-Blind Phase|Withdrawal by Subject|0
400596|NCT00048542|1259311|P3|Double-Blind Phase|Withdrawal by Subject|0
400597|NCT00048542|1259312|P2|Double-Blind Phase|Withdrawal by Subject|1
400598|NCT00048542|1259313|P1|Double-Blind Phase|Withdrawal by Subject|0
400599|NCT00048347|1259379|P1|Overall Study|Screen failure|2
400600|NCT00048165|1259385|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
400601|NCT00048165|1259386|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
400602|NCT00048165|1259385|P2|Completed 12 Months Study|Death|1
400603|NCT00048165|1259386|P1|Completed 12 Months Study|Death|2
400604|NCT00048165|1259385|P2|Completed 12 Months Study|Administration/Other|2
400605|NCT00048165|1259386|P1|Completed 12 Months Study|Administration/Other|0
400606|NCT00048165|1259385|P2|Completed 6 Months Study|Did not receive study drug|6
400607|NCT00048165|1259386|P1|Completed 6 Months Study|Did not receive study drug|6
400608|NCT00048165|1259385|P2|Completed 6 Months Study|Violation criteria|2
400609|NCT00048165|1259386|P1|Completed 6 Months Study|Violation criteria|0
400610|NCT00048165|1259385|P2|Completed 6 Months Study|Refused treatment|5
400611|NCT00048165|1259386|P1|Completed 6 Months Study|Refused treatment|5
400612|NCT00048165|1259385|P2|Completed 6 Months Study|Other violation|6
400613|NCT00048165|1259386|P1|Completed 6 Months Study|Other violation|4
400614|NCT00048165|1259385|P2|Completed 6 Months Study|Insufficient therapy|4
400615|NCT00048165|1259386|P1|Completed 6 Months Study|Insufficient therapy|1
400616|NCT00048165|1259385|P2|Completed 6 Months Study|Death|6
400617|NCT00048165|1259386|P1|Completed 6 Months Study|Death|12
400618|NCT00048165|1259385|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
400619|NCT00048165|1259386|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
400620|NCT00048165|1259385|P2|Completed 6 Months Study|Abnormality of laboratory test|0
400621|NCT00048165|1259386|P1|Completed 6 Months Study|Abnormality of laboratory test|1
400622|NCT00048165|1259385|P2|Completed 6 Months Study|Administration/Other|8
400623|NCT00048165|1259386|P1|Completed 6 Months Study|Administration/Other|8
400624|NCT00048074|1259421|P3|Overall Study|Social reasons|0
400625|NCT00048074|1259422|P2|Overall Study|Social reasons|0
400626|NCT00048074|1259423|P1|Overall Study|Social reasons|1
400627|NCT00048074|1259421|P3|Overall Study|Out of station|1
400628|NCT00048074|1259422|P2|Overall Study|Out of station|1
400629|NCT00048074|1259423|P1|Overall Study|Out of station|0
400630|NCT00048074|1259421|P3|Overall Study|Poor compliance|0
400631|NCT00048074|1259422|P2|Overall Study|Poor compliance|1
400632|NCT00048074|1259423|P1|Overall Study|Poor compliance|0
400633|NCT00048074|1259421|P3|Overall Study|Husband ill|0
400634|NCT00048074|1259422|P2|Overall Study|Husband ill|1
400635|NCT00048074|1259423|P1|Overall Study|Husband ill|0
400636|NCT00048074|1259421|P3|Overall Study|Study participation was terminated|0
400637|NCT00048074|1259422|P2|Overall Study|Study participation was terminated|1
400638|NCT00048074|1259423|P1|Overall Study|Study participation was terminated|0
400639|NCT00048074|1259421|P3|Overall Study|Protocol Violation|0
400640|NCT00048074|1259422|P2|Overall Study|Protocol Violation|3
400641|NCT00048074|1259423|P1|Overall Study|Protocol Violation|1
400642|NCT00048074|1259421|P3|Overall Study|Withdrawal by Subject|35
400643|NCT00048074|1259422|P2|Overall Study|Withdrawal by Subject|30
400644|NCT00048074|1259423|P1|Overall Study|Withdrawal by Subject|28
400645|NCT00048074|1259421|P3|Overall Study|Lost to Follow-up|6
400646|NCT00048074|1259422|P2|Overall Study|Lost to Follow-up|6
400647|NCT00048074|1259423|P1|Overall Study|Lost to Follow-up|2
400648|NCT00048074|1259421|P3|Overall Study|Death|2
400649|NCT00048074|1259422|P2|Overall Study|Death|3
400650|NCT00048074|1259423|P1|Overall Study|Death|3
400651|NCT00048074|1259421|P3|Overall Study|Adverse Event|53
400652|NCT00048074|1259422|P2|Overall Study|Adverse Event|41
400653|NCT00048074|1259423|P1|Overall Study|Adverse Event|46
400654|NCT00048061|1259480|P4|Overall Study|Early improvement|0
400655|NCT00048061|1259481|P3|Overall Study|Early improvement|3
400656|NCT00048061|1259482|P2|Overall Study|Early improvement|5
400657|NCT00048061|1259483|P1|Overall Study|Early improvement|6
400658|NCT00048061|1259480|P4|Overall Study|Did not follow-up|5
400659|NCT00048061|1259481|P3|Overall Study|Did not follow-up|4
400660|NCT00048061|1259482|P2|Overall Study|Did not follow-up|5
400661|NCT00048061|1259483|P1|Overall Study|Did not follow-up|5
400662|NCT00048061|1259480|P4|Overall Study|Withdrawal by Subject|32
400663|NCT00048061|1259481|P3|Overall Study|Withdrawal by Subject|29
400664|NCT00048061|1259482|P2|Overall Study|Withdrawal by Subject|29
400665|NCT00048061|1259483|P1|Overall Study|Withdrawal by Subject|20
400666|NCT00048061|1259480|P4|Overall Study|Lost to Follow-up|5
400667|NCT00048061|1259481|P3|Overall Study|Lost to Follow-up|4
400668|NCT00048061|1259482|P2|Overall Study|Lost to Follow-up|2
400669|NCT00048061|1259483|P1|Overall Study|Lost to Follow-up|3
400670|NCT00048061|1259480|P4|Overall Study|Adverse Event|37
400671|NCT00048061|1259481|P3|Overall Study|Adverse Event|44
400672|NCT00048061|1259482|P2|Overall Study|Adverse Event|32
400673|NCT00048061|1259483|P1|Overall Study|Adverse Event|41
400674|NCT00048035|1259559|P8|Extension Year 2|Early Withdrawals|3
400675|NCT00048035|1259560|P7|Extension Year 2|Early Withdrawals|3
400676|NCT00048035|1259561|P6|Extension Year 2|Early Withdrawals|0
400677|NCT00048035|1259562|P5|Extension Year 2|Early Withdrawals|0
400678|NCT00048035|1259563|P4|Extension Year 2|Early Withdrawals|0
400679|NCT00048035|1259564|P3|Extension Year 2|Early Withdrawals|0
400680|NCT00048035|1259565|P2|Extension Year 2|Early Withdrawals|0
400681|NCT00048035|1259566|P1|Extension Year 2|Early Withdrawals|0
400682|NCT00048035|1259559|P8|Extension Year 1|Early Withdrawals|11
400683|NCT00048035|1259560|P7|Extension Year 1|Early Withdrawals|11
400684|NCT00048035|1259561|P6|Extension Year 1|Early Withdrawals|0
400685|NCT00048035|1259562|P5|Extension Year 1|Early Withdrawals|0
400686|NCT00048035|1259563|P4|Extension Year 1|Early Withdrawals|0
400687|NCT00048035|1259564|P3|Extension Year 1|Early Withdrawals|0
400688|NCT00048035|1259565|P2|Extension Year 1|Early Withdrawals|0
400689|NCT00048035|1259566|P1|Extension Year 1|Early Withdrawals|0
400690|NCT00048035|1259559|P8|Core Period|Early Withdrawals|0
400691|NCT00048035|1259560|P7|Core Period|Early Withdrawals|0
400692|NCT00048035|1259561|P6|Core Period|Early Withdrawals|1
400693|NCT00048035|1259562|P5|Core Period|Early Withdrawals|1
400694|NCT00048035|1259563|P4|Core Period|Early Withdrawals|1
400695|NCT00048035|1259564|P3|Core Period|Early Withdrawals|1
400696|NCT00048035|1259565|P2|Core Period|Early Withdrawals|2
400697|NCT00048035|1259566|P1|Core Period|Early Withdrawals|4
400698|NCT00047879|1259604|P2|Overall Study|Progressive disease|3
400699|NCT00047879|1259605|P1|Overall Study|Progressive disease|4
400700|NCT00047463|1259668|P2|Overall Study|Withdrawal by Subject|3
400701|NCT00047463|1259669|P1|Overall Study|Withdrawal by Subject|0
400702|NCT00047385|1259680|P2|Overall Study|Eligible for screening but had no screen|492
400703|NCT00047385|1259681|P1|Overall Study|Eligible for screening but had no screen|260
400704|NCT00047385|1259680|P2|Overall Study|Lung Cancer diagnosed before screening|3
400705|NCT00047385|1259681|P1|Overall Study|Lung Cancer diagnosed before screening|5
400706|NCT00047385|1259680|P2|Overall Study|Death before any screening|5
400707|NCT00047385|1259681|P1|Overall Study|Death before any screening|2
400708|NCT00047320|1259699|P1|Overall Study|Ineligible|3
400709|NCT00047320|1259699|P1|Overall Study|Withdrawal by Subject|6
400710|NCT00047320|1259699|P1|Overall Study|Physician Decision|8
400711|NCT00047320|1259699|P1|Overall Study|Lost to Follow-up|1
400712|NCT00047320|1259699|P1|Overall Study|Lack of Efficacy|10
400713|NCT00047008|1259705|P2|Overall Study|Ineligible|8
400714|NCT00047008|1259706|P1|Overall Study|Ineligible|9
400715|NCT00047008|1259705|P2|Overall Study|Withdrawn consent|3
400716|NCT00047008|1259706|P1|Overall Study|Withdrawn consent|2
400717|NCT00046930|1259714|P2|Overall Study|Ineligible|4
400718|NCT00046930|1259715|P1|Overall Study|Ineligible|12
400719|NCT00046891|1259730|P2|Overall Study|Adverse Event|5
400720|NCT00046891|1259731|P1|Overall Study|Adverse Event|5
400721|NCT00046891|1259730|P2|Overall Study|Withdrawal by Subject|15
400722|NCT00046891|1259731|P1|Overall Study|Withdrawal by Subject|18
400723|NCT00046891|1259730|P2|Overall Study|Ineligible|1
400724|NCT00046891|1259731|P1|Overall Study|Ineligible|1
400725|NCT00046891|1259730|P2|Overall Study|Cancels|9
400726|NCT00046891|1259731|P1|Overall Study|Cancels|5
400727|NCT00046839|1259751|P2|Overall Study|Withdrawal of consent|0
400728|NCT00046839|1259752|P1|Overall Study|Withdrawal of consent|1
400729|NCT00046839|1259751|P2|Overall Study|Ineligible / No protocol treatment|2
400730|NCT00046839|1259752|P1|Overall Study|Ineligible / No protocol treatment|0
400731|NCT00045734|1259799|P1|Overall Study|Protocol Violation|1
400732|NCT00045708|1259814|P3|Phase 1|early progressive disease|0
400733|NCT00045708|1259815|P2|Phase 1|early progressive disease|1
400734|NCT00045708|1259816|P1|Phase 1|early progressive disease|0
400735|NCT00045630|1259839|P1|Overall Study|Ineligible|2
400736|NCT00045630|1259839|P1|Overall Study|Death|1
400737|NCT00045630|1259839|P1|Overall Study|Progression/relapse|1
400738|NCT00045630|1259839|P1|Overall Study|Refusal unrelated to adverse event|1
400739|NCT00045630|1259839|P1|Overall Study|Adverse Event|1
400740|NCT00045305|1259858|P1|Overall Study|site error|2
400741|NCT00045305|1259858|P1|Overall Study|Death|3
400742|NCT00045305|1259858|P1|Overall Study|Adverse Event|3
400743|NCT00045305|1259858|P1|Overall Study|Lack of Efficacy|6
400744|NCT00045162|1259869|P2|Overall Study|Not specified|16
400745|NCT00045162|1259870|P1|Overall Study|Not specified|21
400746|NCT00045162|1259869|P2|Overall Study|Withdrawal by Subject|3
400747|NCT00045162|1259870|P1|Overall Study|Withdrawal by Subject|5
400748|NCT00045162|1259869|P2|Overall Study|Death|10
400749|NCT00045162|1259870|P1|Overall Study|Death|10
400750|NCT00045162|1259869|P2|Overall Study|Lack of Efficacy|29
400751|NCT00045162|1259870|P1|Overall Study|Lack of Efficacy|32
400752|NCT00045162|1259869|P2|Overall Study|Adverse Event|50
400753|NCT00045162|1259870|P1|Overall Study|Adverse Event|55
400754|NCT00045162|1259869|P2|Overall Study|Not treated|2
400755|NCT00045162|1259870|P1|Overall Study|Not treated|7
400756|NCT00045162|1259869|P2|Overall Study|Ineligible|8
400757|NCT00045162|1259870|P1|Overall Study|Ineligible|12
400758|NCT00045032|1259885|P3|Overall Study|Not Specified|105
400759|NCT00045032|1259886|P2|Overall Study|Not Specified|84
400760|NCT00045032|1259887|P1|Overall Study|Not Specified|93
400761|NCT00045032|1259885|P3|Overall Study|Failure to Return|61
400762|NCT00045032|1259886|P2|Overall Study|Failure to Return|62
400763|NCT00045032|1259887|P1|Overall Study|Failure to Return|57
400764|NCT00045032|1259885|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
400765|NCT00045032|1259886|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
400766|NCT00045032|1259887|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
400767|NCT00045032|1259885|P3|Overall Study|Other Protocol Violation|1
400768|NCT00045032|1259886|P2|Overall Study|Other Protocol Violation|0
400769|NCT00045032|1259887|P1|Overall Study|Other Protocol Violation|2
400770|NCT00045032|1259885|P3|Overall Study|Violation of Selection Criteria at Entry|6
400771|NCT00045032|1259886|P2|Overall Study|Violation of Selection Criteria at Entry|6
400772|NCT00045032|1259887|P1|Overall Study|Violation of Selection Criteria at Entry|3
400773|NCT00045032|1259885|P3|Overall Study|Insufficient Therapeutic Response|445
400774|NCT00045032|1259886|P2|Overall Study|Insufficient Therapeutic Response|437
400775|NCT00045032|1259887|P1|Overall Study|Insufficient Therapeutic Response|542
400776|NCT00045032|1259885|P3|Overall Study|Death|17
400777|NCT00045032|1259886|P2|Overall Study|Death|24
400778|NCT00045032|1259887|P1|Overall Study|Death|22
400779|NCT00045032|1259885|P3|Overall Study|Adverse Event/Intercurrent Illness|7
400780|NCT00045032|1259886|P2|Overall Study|Adverse Event/Intercurrent Illness|2
400781|NCT00045032|1259887|P1|Overall Study|Adverse Event/Intercurrent Illness|2
400782|NCT00043186|1260023|P9|Overall Study|Other|0
400783|NCT00043186|1260024|P8|Overall Study|Other|0
400784|NCT00043186|1260025|P7|Overall Study|Other|0
400785|NCT00043186|1260026|P6|Overall Study|Other|0
400786|NCT00043186|1260027|P5|Overall Study|Other|0
400787|NCT00043186|1260028|P4|Overall Study|Other|1
400788|NCT00043186|1260029|P3|Overall Study|Other|1
400789|NCT00043186|1260030|P2|Overall Study|Other|0
400790|NCT00043186|1260031|P1|Overall Study|Other|0
400791|NCT00043186|1260023|P9|Overall Study|Noncompliance|0
400792|NCT00043186|1260024|P8|Overall Study|Noncompliance|0
400793|NCT00043186|1260025|P7|Overall Study|Noncompliance|0
400794|NCT00043186|1260026|P6|Overall Study|Noncompliance|0
400795|NCT00043186|1260027|P5|Overall Study|Noncompliance|0
400796|NCT00043186|1260028|P4|Overall Study|Noncompliance|1
400797|NCT00043186|1260029|P3|Overall Study|Noncompliance|1
400798|NCT00043186|1260030|P2|Overall Study|Noncompliance|0
400799|NCT00043186|1260031|P1|Overall Study|Noncompliance|0
400800|NCT00043186|1260023|P9|Overall Study|Lost to Follow-up|2
400801|NCT00043186|1260024|P8|Overall Study|Lost to Follow-up|1
400802|NCT00043186|1260025|P7|Overall Study|Lost to Follow-up|1
400803|NCT00043186|1260026|P6|Overall Study|Lost to Follow-up|1
400804|NCT00043186|1260027|P5|Overall Study|Lost to Follow-up|1
400805|NCT00043186|1260028|P4|Overall Study|Lost to Follow-up|1
400806|NCT00043186|1260029|P3|Overall Study|Lost to Follow-up|1
400807|NCT00043186|1260030|P2|Overall Study|Lost to Follow-up|5
400808|NCT00043186|1260031|P1|Overall Study|Lost to Follow-up|3
400809|NCT00043186|1260023|P9|Overall Study|Ineligibility determined|1
400810|NCT00043186|1260024|P8|Overall Study|Ineligibility determined|0
400811|NCT00043186|1260025|P7|Overall Study|Ineligibility determined|0
400812|NCT00043186|1260026|P6|Overall Study|Ineligibility determined|0
400813|NCT00043186|1260027|P5|Overall Study|Ineligibility determined|0
400814|NCT00043186|1260028|P4|Overall Study|Ineligibility determined|0
400815|NCT00043186|1260029|P3|Overall Study|Ineligibility determined|0
400816|NCT00043186|1260030|P2|Overall Study|Ineligibility determined|0
400817|NCT00043186|1260031|P1|Overall Study|Ineligibility determined|0
400818|NCT00043186|1260023|P9|Overall Study|Disease progression|0
400819|NCT00043186|1260024|P8|Overall Study|Disease progression|4
400820|NCT00043186|1260025|P7|Overall Study|Disease progression|0
400821|NCT00043186|1260026|P6|Overall Study|Disease progression|0
400822|NCT00043186|1260027|P5|Overall Study|Disease progression|0
400823|NCT00043186|1260028|P4|Overall Study|Disease progression|3
400824|NCT00043186|1260029|P3|Overall Study|Disease progression|0
400825|NCT00043186|1260030|P2|Overall Study|Disease progression|0
400826|NCT00043186|1260031|P1|Overall Study|Disease progression|1
400827|NCT00043186|1260023|P9|Overall Study|Death|0
400828|NCT00043186|1260024|P8|Overall Study|Death|0
400829|NCT00043186|1260025|P7|Overall Study|Death|2
400830|NCT00043186|1260026|P6|Overall Study|Death|0
400831|NCT00043186|1260027|P5|Overall Study|Death|0
400832|NCT00043186|1260028|P4|Overall Study|Death|0
400833|NCT00043186|1260029|P3|Overall Study|Death|1
400834|NCT00043186|1260030|P2|Overall Study|Death|0
400835|NCT00043186|1260031|P1|Overall Study|Death|0
400836|NCT00043186|1260023|P9|Overall Study|Withdrawal by Subject|10
400837|NCT00043186|1260024|P8|Overall Study|Withdrawal by Subject|9
400838|NCT00043186|1260025|P7|Overall Study|Withdrawal by Subject|12
400839|NCT00043186|1260026|P6|Overall Study|Withdrawal by Subject|6
400840|NCT00043186|1260027|P5|Overall Study|Withdrawal by Subject|14
400841|NCT00043186|1260028|P4|Overall Study|Withdrawal by Subject|13
400842|NCT00043186|1260029|P3|Overall Study|Withdrawal by Subject|11
400843|NCT00043186|1260030|P2|Overall Study|Withdrawal by Subject|8
400844|NCT00043186|1260031|P1|Overall Study|Withdrawal by Subject|11
400845|NCT00043186|1260023|P9|Overall Study|Adverse Event|3
400846|NCT00043186|1260024|P8|Overall Study|Adverse Event|1
400847|NCT00043186|1260025|P7|Overall Study|Adverse Event|2
400848|NCT00043186|1260026|P6|Overall Study|Adverse Event|1
400849|NCT00043186|1260027|P5|Overall Study|Adverse Event|2
400850|NCT00043186|1260028|P4|Overall Study|Adverse Event|3
400851|NCT00043186|1260029|P3|Overall Study|Adverse Event|2
400852|NCT00043186|1260030|P2|Overall Study|Adverse Event|2
400853|NCT00043186|1260031|P1|Overall Study|Adverse Event|2
400854|NCT00043186|1260023|P9|Overall Study|Physician Decision|1
400855|NCT00043186|1260024|P8|Overall Study|Physician Decision|1
400856|NCT00043186|1260025|P7|Overall Study|Physician Decision|0
400857|NCT00043186|1260026|P6|Overall Study|Physician Decision|0
400858|NCT00043186|1260027|P5|Overall Study|Physician Decision|1
400859|NCT00043186|1260028|P4|Overall Study|Physician Decision|0
400860|NCT00043186|1260029|P3|Overall Study|Physician Decision|3
400861|NCT00043186|1260030|P2|Overall Study|Physician Decision|0
400862|NCT00043186|1260031|P1|Overall Study|Physician Decision|0
400863|NCT00044512|1260366|P1|Follow Up|Lost to Follow-up|2
400864|NCT00042991|1260384|P7|Overall Study|Alternative Therapy|0
400865|NCT00042991|1260385|P6|Overall Study|Alternative Therapy|0
400866|NCT00042991|1260386|P5|Overall Study|Alternative Therapy|1
400867|NCT00042991|1260387|P4|Overall Study|Alternative Therapy|0
400868|NCT00042991|1260388|P3|Overall Study|Alternative Therapy|0
400869|NCT00042991|1260389|P2|Overall Study|Alternative Therapy|0
400870|NCT00042991|1260390|P1|Overall Study|Alternative Therapy|0
400871|NCT00042991|1260384|P7|Overall Study|Disease Progression|2
400872|NCT00042991|1260385|P6|Overall Study|Disease Progression|4
400873|NCT00042991|1260386|P5|Overall Study|Disease Progression|1
400874|NCT00042991|1260387|P4|Overall Study|Disease Progression|2
400875|NCT00042991|1260388|P3|Overall Study|Disease Progression|2
400876|NCT00042991|1260389|P2|Overall Study|Disease Progression|29
400877|NCT00042991|1260390|P1|Overall Study|Disease Progression|5
400878|NCT00042991|1260384|P7|Overall Study|Withdrawal by Subject|0
400879|NCT00042991|1260385|P6|Overall Study|Withdrawal by Subject|0
400880|NCT00042991|1260386|P5|Overall Study|Withdrawal by Subject|1
400881|NCT00042991|1260387|P4|Overall Study|Withdrawal by Subject|0
400882|NCT00042991|1260388|P3|Overall Study|Withdrawal by Subject|2
400883|NCT00042991|1260389|P2|Overall Study|Withdrawal by Subject|7
400884|NCT00042991|1260390|P1|Overall Study|Withdrawal by Subject|0
400885|NCT00042991|1260384|P7|Overall Study|Adverse Event|0
400886|NCT00042991|1260385|P6|Overall Study|Adverse Event|1
400887|NCT00042991|1260386|P5|Overall Study|Adverse Event|0
400888|NCT00042991|1260387|P4|Overall Study|Adverse Event|0
400889|NCT00042991|1260388|P3|Overall Study|Adverse Event|2
400890|NCT00042991|1260389|P2|Overall Study|Adverse Event|4
400891|NCT00042991|1260390|P1|Overall Study|Adverse Event|1
400892|NCT00042939|1260433|P2|Overall Study|Did not start treatment|1
400893|NCT00042939|1260434|P1|Overall Study|Did not start treatment|2
400894|NCT00042939|1260433|P2|Overall Study|Treatment break > 4 weeks|1
400895|NCT00042939|1260434|P1|Overall Study|Treatment break > 4 weeks|0
400896|NCT00042939|1260433|P2|Overall Study|Still on treatment|0
400897|NCT00042939|1260434|P1|Overall Study|Still on treatment|1
400898|NCT00042939|1260433|P2|Overall Study|Patient non-compliance|0
400899|NCT00042939|1260434|P1|Overall Study|Patient non-compliance|1
400900|NCT00042939|1260433|P2|Overall Study|Rising ca 19-9|0
400901|NCT00042939|1260434|P1|Overall Study|Rising ca 19-9|1
400902|NCT00042939|1260433|P2|Overall Study|QOL diminished|0
400903|NCT00042939|1260434|P1|Overall Study|QOL diminished|1
400904|NCT00042939|1260433|P2|Overall Study|Deterioration of health|4
400905|NCT00042939|1260434|P1|Overall Study|Deterioration of health|3
400906|NCT00042939|1260433|P2|Overall Study|Ineligible|2
400907|NCT00042939|1260434|P1|Overall Study|Ineligible|2
400908|NCT00042939|1260433|P2|Overall Study|Other disease|0
400909|NCT00042939|1260434|P1|Overall Study|Other disease|1
400910|NCT00042939|1260433|P2|Overall Study|Withdrawal by Subject|4
400911|NCT00042939|1260434|P1|Overall Study|Withdrawal by Subject|3
400912|NCT00042939|1260433|P2|Overall Study|Death|2
400913|NCT00042939|1260434|P1|Overall Study|Death|3
400914|NCT00042939|1260433|P2|Overall Study|Adverse Event|7
400915|NCT00042939|1260434|P1|Overall Study|Adverse Event|6
400916|NCT00044213|1260452|P4|Overall Study|Lost to Follow-up|4
400917|NCT00044213|1260453|P3|Overall Study|Lost to Follow-up|5
400918|NCT00044213|1260454|P2|Overall Study|Lost to Follow-up|5
400919|NCT00044213|1260455|P1|Overall Study|Lost to Follow-up|8
400920|NCT00044213|1260452|P4|Overall Study|Death|49
400921|NCT00044213|1260453|P3|Overall Study|Death|42
400922|NCT00044213|1260454|P2|Overall Study|Death|42
400923|NCT00044213|1260455|P1|Overall Study|Death|42
400924|NCT00044213|1260452|P4|Overall Study|Withdrawal by Subject|83
400925|NCT00044213|1260453|P3|Overall Study|Withdrawal by Subject|91
400926|NCT00044213|1260454|P2|Overall Study|Withdrawal by Subject|65
400927|NCT00044213|1260455|P1|Overall Study|Withdrawal by Subject|50
400928|NCT00043979|1260520|P3|Period 1|recipient with progressive disease|3
400929|NCT00043979|1260521|P2|Period 1|recipient with progressive disease|4
400930|NCT00043979|1260522|P1|Period 1|recipient with progressive disease|7
400931|NCT00043550|1260543|P3|Overall Study|Withdrawal by Subject|20
400932|NCT00043550|1260544|P2|Overall Study|Withdrawal by Subject|12
400933|NCT00043550|1260545|P1|Overall Study|Withdrawal by Subject|22
400934|NCT00042432|1260555|P2|Overall Study|Other|0
400935|NCT00042432|1260556|P1|Overall Study|Other|2
400936|NCT00042432|1260555|P2|Overall Study|Initiation of maintenance dialysis|1
400937|NCT00042432|1260556|P1|Overall Study|Initiation of maintenance dialysis|1
400938|NCT00042432|1260555|P2|Overall Study|Ineligibility determined|0
400939|NCT00042432|1260556|P1|Overall Study|Ineligibility determined|1
400940|NCT00042432|1260555|P2|Overall Study|Death|2
400941|NCT00042432|1260556|P1|Overall Study|Death|0
400942|NCT00042432|1260555|P2|Overall Study|Withdrawal by Subject|3
400943|NCT00042432|1260556|P1|Overall Study|Withdrawal by Subject|1
400944|NCT00042432|1260555|P2|Overall Study|Adverse Event|1
400945|NCT00042432|1260556|P1|Overall Study|Adverse Event|4
400946|NCT00040365|1260564|P1|Overall Study|Lost to Follow-up|3
400947|NCT00040365|1260564|P1|Overall Study|Progressive disease|7
400948|NCT00040365|1260564|P1|Overall Study|Death|1
400949|NCT00041756|1260618|P5|Overall Study|Data Monitoring Committee Recommendation|21
400950|NCT00041756|1260619|P4|Overall Study|Data Monitoring Committee Recommendation|0
400951|NCT00041756|1260620|P3|Overall Study|Data Monitoring Committee Recommendation|0
400952|NCT00041756|1260621|P2|Overall Study|Data Monitoring Committee Recommendation|0
400953|NCT00041756|1260622|P1|Overall Study|Data Monitoring Committee Recommendation|0
400954|NCT00041756|1260618|P5|Overall Study|Unable to meet protocol criteria|1
400955|NCT00041756|1260619|P4|Overall Study|Unable to meet protocol criteria|0
400956|NCT00041756|1260620|P3|Overall Study|Unable to meet protocol criteria|1
400957|NCT00041756|1260621|P2|Overall Study|Unable to meet protocol criteria|0
400958|NCT00041756|1260622|P1|Overall Study|Unable to meet protocol criteria|0
400959|NCT00041756|1260618|P5|Overall Study|Lost to Follow-up|0
400960|NCT00041756|1260619|P4|Overall Study|Lost to Follow-up|1
400961|NCT00041756|1260620|P3|Overall Study|Lost to Follow-up|0
400962|NCT00041756|1260621|P2|Overall Study|Lost to Follow-up|1
400963|NCT00041756|1260622|P1|Overall Study|Lost to Follow-up|0
400964|NCT00041756|1260618|P5|Overall Study|Withdrawal by Subject|3
400965|NCT00041756|1260619|P4|Overall Study|Withdrawal by Subject|2
400966|NCT00041756|1260620|P3|Overall Study|Withdrawal by Subject|4
400967|NCT00041756|1260621|P2|Overall Study|Withdrawal by Subject|3
400968|NCT00041756|1260622|P1|Overall Study|Withdrawal by Subject|3
400969|NCT00041756|1260618|P5|Overall Study|Protocol Violation|1
400970|NCT00041756|1260619|P4|Overall Study|Protocol Violation|2
400971|NCT00041756|1260620|P3|Overall Study|Protocol Violation|2
400972|NCT00041756|1260621|P2|Overall Study|Protocol Violation|1
400973|NCT00041756|1260622|P1|Overall Study|Protocol Violation|1
400974|NCT00041756|1260618|P5|Overall Study|Adverse Event|34
400975|NCT00041756|1260619|P4|Overall Study|Adverse Event|11
400976|NCT00041756|1260620|P3|Overall Study|Adverse Event|6
400977|NCT00041756|1260621|P2|Overall Study|Adverse Event|10
400978|NCT00041756|1260622|P1|Overall Study|Adverse Event|4
400979|NCT00039871|1260650|P1|Overall Study|Never entered follow-up|7
400980|NCT00039871|1260650|P1|Overall Study|Discontinued at Week 12 per protocol|1061
400981|NCT00039871|1260650|P1|Overall Study|Administrative|1
400982|NCT00039871|1260650|P1|Overall Study|Did not meet eligibility criteria|11
400983|NCT00039871|1260650|P1|Overall Study|Withdrawal by Subject|97
400984|NCT00039871|1260650|P1|Overall Study|Protocol Violation|24
400985|NCT00039871|1260650|P1|Overall Study|Lost to Follow-up|18
400986|NCT00039871|1260650|P1|Overall Study|Adverse Event|165
400987|NCT00041470|1260656|P1|Overall Study|Loss of Funding|40
400988|NCT00041132|1260670|P1|Overall Study|Physician Decision|2
400989|NCT00041132|1260670|P1|Overall Study|Withdrawal by Subject|1
400990|NCT00041132|1260670|P1|Overall Study|Not Eligible|7
400991|NCT00041132|1260670|P1|Overall Study|Death|1
400992|NCT00041132|1260670|P1|Overall Study|Adverse Event|19
400993|NCT00041080|1260705|P2|Overall Study|Ineligible|0
400994|NCT00041080|1260706|P1|Overall Study|Ineligible|1
400995|NCT00041080|1260705|P2|Overall Study|Did not start therapy|1
400996|NCT00041080|1260706|P1|Overall Study|Did not start therapy|1
400997|NCT00041080|1260705|P2|Overall Study|Concommitant Illness/Other|2
400998|NCT00041080|1260706|P1|Overall Study|Concommitant Illness/Other|1
400999|NCT00041080|1260705|P2|Overall Study|Withdrawal by Subject|6
401000|NCT00041080|1260706|P1|Overall Study|Withdrawal by Subject|6
401001|NCT00041080|1260705|P2|Overall Study|Adverse Event|1
401002|NCT00041080|1260706|P1|Overall Study|Adverse Event|21
401003|NCT00041067|1260712|P1|Overall Study|Ineligible|2
401004|NCT00041067|1260712|P1|Overall Study|Other reasons|23
401005|NCT00041067|1260712|P1|Overall Study|Patient refusal|12
401006|NCT00041067|1260712|P1|Overall Study|Progression|19
401007|NCT00041067|1260712|P1|Overall Study|Adverse Event|20
401008|NCT00040742|1260779|P4|Overall Study|Other medical|5
401009|NCT00040742|1260780|P3|Overall Study|Other medical|5
401010|NCT00040742|1260781|P2|Overall Study|Other medical|5
401011|NCT00040742|1260782|P1|Overall Study|Other medical|7
401012|NCT00040742|1260779|P4|Overall Study|Incomplete Forms|5
401013|NCT00040742|1260780|P3|Overall Study|Incomplete Forms|4
401014|NCT00040742|1260781|P2|Overall Study|Incomplete Forms|10
401015|NCT00040742|1260782|P1|Overall Study|Incomplete Forms|6
401016|NCT00040742|1260779|P4|Overall Study|Chemotoxicity|2
401017|NCT00040742|1260780|P3|Overall Study|Chemotoxicity|5
401018|NCT00040742|1260781|P2|Overall Study|Chemotoxicity|3
401019|NCT00040742|1260782|P1|Overall Study|Chemotoxicity|4
401020|NCT00040742|1260779|P4|Overall Study|Withdrawal by Subject|13
401021|NCT00040742|1260780|P3|Overall Study|Withdrawal by Subject|10
401022|NCT00040742|1260781|P2|Overall Study|Withdrawal by Subject|15
401023|NCT00040742|1260782|P1|Overall Study|Withdrawal by Subject|7
401024|NCT00040742|1260779|P4|Overall Study|Adverse Event|9
401025|NCT00040742|1260780|P3|Overall Study|Adverse Event|21
401026|NCT00040742|1260781|P2|Overall Study|Adverse Event|16
401027|NCT00040742|1260782|P1|Overall Study|Adverse Event|15
401028|NCT00040742|1260779|P4|Overall Study|Death|0
401029|NCT00040742|1260780|P3|Overall Study|Death|1
401030|NCT00040742|1260781|P2|Overall Study|Death|0
401031|NCT00040742|1260782|P1|Overall Study|Death|0
401032|NCT00040664|1260796|P4|Overall Study|Non-viability of oral suspension|0
401033|NCT00040664|1260797|P3|Overall Study|Non-viability of oral suspension|1
401034|NCT00040664|1260798|P2|Overall Study|Non-viability of oral suspension|0
401035|NCT00040664|1260799|P1|Overall Study|Non-viability of oral suspension|1
401036|NCT00040664|1260796|P4|Overall Study|Change of formulation|0
401037|NCT00040664|1260797|P3|Overall Study|Change of formulation|0
401038|NCT00040664|1260798|P2|Overall Study|Change of formulation|2
401039|NCT00040664|1260799|P1|Overall Study|Change of formulation|2
401040|NCT00040664|1260796|P4|Overall Study|Pharmacokinetic target not achieved|1
401041|NCT00040664|1260797|P3|Overall Study|Pharmacokinetic target not achieved|0
401042|NCT00040664|1260798|P2|Overall Study|Pharmacokinetic target not achieved|1
401043|NCT00040664|1260799|P1|Overall Study|Pharmacokinetic target not achieved|2
401044|NCT00040664|1260796|P4|Overall Study|Poor taste|0
401045|NCT00040664|1260797|P3|Overall Study|Poor taste|2
401046|NCT00040664|1260798|P2|Overall Study|Poor taste|0
401047|NCT00040664|1260799|P1|Overall Study|Poor taste|2
401048|NCT00040664|1260796|P4|Overall Study|Medication adherence/compliance problems|5
401049|NCT00040664|1260797|P3|Overall Study|Medication adherence/compliance problems|1
401050|NCT00040664|1260798|P2|Overall Study|Medication adherence/compliance problems|2
401051|NCT00040664|1260799|P1|Overall Study|Medication adherence/compliance problems|8
401052|NCT00040664|1260796|P4|Overall Study|Pregnancy|3
401053|NCT00040664|1260797|P3|Overall Study|Pregnancy|0
401054|NCT00040664|1260798|P2|Overall Study|Pregnancy|0
401055|NCT00040664|1260799|P1|Overall Study|Pregnancy|3
401056|NCT00040664|1260796|P4|Overall Study|Withdrawal by Subject|4
401057|NCT00040664|1260797|P3|Overall Study|Withdrawal by Subject|3
401058|NCT00040664|1260798|P2|Overall Study|Withdrawal by Subject|0
401059|NCT00040664|1260799|P1|Overall Study|Withdrawal by Subject|7
401060|NCT00040664|1260796|P4|Overall Study|Protocol Violation|1
401061|NCT00040664|1260797|P3|Overall Study|Protocol Violation|0
401062|NCT00040664|1260798|P2|Overall Study|Protocol Violation|1
401063|NCT00040664|1260799|P1|Overall Study|Protocol Violation|2
401064|NCT00040664|1260796|P4|Overall Study|Lost to Follow-up|2
401065|NCT00040664|1260797|P3|Overall Study|Lost to Follow-up|0
401066|NCT00040664|1260798|P2|Overall Study|Lost to Follow-up|2
401067|NCT00040664|1260799|P1|Overall Study|Lost to Follow-up|4
401068|NCT00040664|1260796|P4|Overall Study|Insufficient CD4 response|0
401069|NCT00040664|1260797|P3|Overall Study|Insufficient CD4 response|1
401070|NCT00040664|1260798|P2|Overall Study|Insufficient CD4 response|0
401071|NCT00040664|1260799|P1|Overall Study|Insufficient CD4 response|1
401072|NCT00040664|1260796|P4|Overall Study|Lack of Efficacy|4
401073|NCT00040664|1260797|P3|Overall Study|Lack of Efficacy|3
401074|NCT00040664|1260798|P2|Overall Study|Lack of Efficacy|2
401075|NCT00040664|1260799|P1|Overall Study|Lack of Efficacy|9
401076|NCT00040664|1260796|P4|Overall Study|Adverse Event|7
401077|NCT00040664|1260797|P3|Overall Study|Adverse Event|2
401078|NCT00040664|1260798|P2|Overall Study|Adverse Event|3
401079|NCT00040664|1260799|P1|Overall Study|Adverse Event|12
401080|NCT00039741|1260851|P4|Overall Study|Missed final visit|2
401081|NCT00039741|1260852|P3|Overall Study|Missed final visit|2
401082|NCT00039741|1260853|P2|Overall Study|Missed final visit|1
401083|NCT00039741|1260854|P1|Overall Study|Missed final visit|2
401084|NCT00039741|1260851|P4|Overall Study|Withdrew consent|1
401085|NCT00039741|1260852|P3|Overall Study|Withdrew consent|0
401086|NCT00039741|1260853|P2|Overall Study|Withdrew consent|5
401087|NCT00039741|1260854|P1|Overall Study|Withdrew consent|0
401088|NCT00039741|1260851|P4|Overall Study|Non-compliance with protocol|0
401089|NCT00039741|1260852|P3|Overall Study|Non-compliance with protocol|1
401090|NCT00039741|1260853|P2|Overall Study|Non-compliance with protocol|0
401091|NCT00039741|1260854|P1|Overall Study|Non-compliance with protocol|1
401092|NCT00039741|1260851|P4|Overall Study|Moved|6
401093|NCT00039741|1260852|P3|Overall Study|Moved|3
401094|NCT00039741|1260853|P2|Overall Study|Moved|2
401095|NCT00039741|1260854|P1|Overall Study|Moved|3
401096|NCT00039741|1260851|P4|Overall Study|Not able to get to clinic|3
401097|NCT00039741|1260852|P3|Overall Study|Not able to get to clinic|0
401098|NCT00039741|1260853|P2|Overall Study|Not able to get to clinic|2
401099|NCT00039741|1260854|P1|Overall Study|Not able to get to clinic|5
401100|NCT00039741|1260851|P4|Overall Study|Confounding medical condition|0
401101|NCT00039741|1260852|P3|Overall Study|Confounding medical condition|0
401102|NCT00039741|1260853|P2|Overall Study|Confounding medical condition|0
401103|NCT00039741|1260854|P1|Overall Study|Confounding medical condition|1
401104|NCT00039741|1260851|P4|Overall Study|Lost to Follow-up|2
401105|NCT00039741|1260852|P3|Overall Study|Lost to Follow-up|5
401106|NCT00039741|1260853|P2|Overall Study|Lost to Follow-up|1
401107|NCT00039741|1260854|P1|Overall Study|Lost to Follow-up|3
401108|NCT00039741|1260851|P4|Overall Study|Death|0
401109|NCT00039741|1260852|P3|Overall Study|Death|0
401110|NCT00039741|1260853|P2|Overall Study|Death|1
401111|NCT00039741|1260854|P1|Overall Study|Death|0
401112|NCT00039377|1260896|P4|Initial Registration|Withdrawal by Subject|0
401113|NCT00039377|1260897|P3|Initial Registration|Withdrawal by Subject|0
401114|NCT00039377|1260898|P2|Initial Registration|Withdrawal by Subject|0
401115|NCT00039377|1260899|P1|Initial Registration|Withdrawal by Subject|3
401116|NCT00039377|1260896|P4|Initial Registration|Received non-protocol therapy|0
401117|NCT00039377|1260897|P3|Initial Registration|Received non-protocol therapy|0
401118|NCT00039377|1260898|P2|Initial Registration|Received non-protocol therapy|0
401119|NCT00039377|1260899|P1|Initial Registration|Received non-protocol therapy|11
401120|NCT00039377|1260896|P4|Initial Registration|Relapsed|0
401121|NCT00039377|1260897|P3|Initial Registration|Relapsed|0
401122|NCT00039377|1260898|P2|Initial Registration|Relapsed|0
401123|NCT00039377|1260899|P1|Initial Registration|Relapsed|6
401124|NCT00039377|1260896|P4|Initial Registration|Adverse Event|0
401125|NCT00039377|1260897|P3|Initial Registration|Adverse Event|0
401126|NCT00039377|1260898|P2|Initial Registration|Adverse Event|0
401127|NCT00039377|1260899|P1|Initial Registration|Adverse Event|2
401128|NCT00039130|1260915|P1|Overall Study|Physician Decision|3
401129|NCT00039130|1260915|P1|Overall Study|Subsequent treatment|2
401130|NCT00039130|1260915|P1|Overall Study|Progression|2
401131|NCT00039130|1260915|P1|Overall Study|Withdrawal by Subject|3
401132|NCT00039130|1260915|P1|Overall Study|Death|9
401133|NCT00039130|1260915|P1|Overall Study|Adverse Event|11
401134|NCT00038948|1260923|P2|Overall Study|Lack of Efficacy|6
401135|NCT00038948|1260924|P1|Overall Study|Lack of Efficacy|3
401136|NCT00038948|1260923|P2|Overall Study|Protocol Violation|7
401137|NCT00038948|1260924|P1|Overall Study|Protocol Violation|3
401138|NCT00038948|1260923|P2|Overall Study|Withdrawal by Subject|10
401139|NCT00038948|1260924|P1|Overall Study|Withdrawal by Subject|23
401140|NCT00038948|1260923|P2|Overall Study|Nonmedical event|7
401141|NCT00038948|1260924|P1|Overall Study|Nonmedical event|5
401142|NCT00038948|1260923|P2|Overall Study|Lost to Follow-up|4
401143|NCT00038948|1260924|P1|Overall Study|Lost to Follow-up|4
401144|NCT00038948|1260923|P2|Overall Study|Adverse Event|43
401145|NCT00038948|1260924|P1|Overall Study|Adverse Event|131
401146|NCT00038467|1260948|P2|Overall Study|Unspecified|28
401147|NCT00038467|1260949|P1|Overall Study|Unspecified|26
401148|NCT00038467|1260948|P2|Overall Study|Randomized, but not treated|35
401149|NCT00038467|1260949|P1|Overall Study|Randomized, but not treated|31
401150|NCT00038467|1260948|P2|Overall Study|Recurrence|179
401151|NCT00038467|1260949|P1|Overall Study|Recurrence|109
401152|NCT00038467|1260948|P2|Overall Study|Lost to Follow-up|10
401153|NCT00038467|1260949|P1|Overall Study|Lost to Follow-up|15
401154|NCT00038467|1260948|P2|Overall Study|Death|16
401155|NCT00038467|1260949|P1|Overall Study|Death|22
401156|NCT00038467|1260948|P2|Overall Study|Protocol Violation|22
401157|NCT00038467|1260949|P1|Overall Study|Protocol Violation|19
401158|NCT00038467|1260948|P2|Overall Study|Withdrawal by Subject|107
401159|NCT00038467|1260949|P1|Overall Study|Withdrawal by Subject|150
401160|NCT00038467|1260948|P2|Overall Study|Adverse Event|145
401161|NCT00038467|1260949|P1|Overall Study|Adverse Event|170
401162|NCT00038103|1261011|P2|Overall Study|Randomized/never treated|0
401163|NCT00038103|1261012|P1|Overall Study|Randomized/never treated|2
401164|NCT00038103|1261011|P2|Overall Study|Sponsor Decision|1
401165|NCT00038103|1261012|P1|Overall Study|Sponsor Decision|0
401166|NCT00038103|1261011|P2|Overall Study|Protocol Violation|2
401167|NCT00038103|1261012|P1|Overall Study|Protocol Violation|0
401168|NCT00038103|1261011|P2|Overall Study|Lost to Follow-up|3
401169|NCT00038103|1261012|P1|Overall Study|Lost to Follow-up|0
401170|NCT00038103|1261011|P2|Overall Study|Withdrawal by Subject|3
401171|NCT00038103|1261012|P1|Overall Study|Withdrawal by Subject|0
401172|NCT00038103|1261011|P2|Overall Study|Lack of Efficacy|41
401173|NCT00038103|1261012|P1|Overall Study|Lack of Efficacy|48
401174|NCT00038103|1261011|P2|Overall Study|Adverse Event|6
401175|NCT00038103|1261012|P1|Overall Study|Adverse Event|5
401176|NCT00037830|1261035|P3|Overall Study|Unrelated Medical Problem|0
401177|NCT00037830|1261036|P2|Overall Study|Unrelated Medical Problem|0
401178|NCT00037830|1261037|P1|Overall Study|Unrelated Medical Problem|2
401179|NCT00037830|1261035|P3|Overall Study|Protocol Violation|0
401180|NCT00037830|1261036|P2|Overall Study|Protocol Violation|2
401181|NCT00037830|1261037|P1|Overall Study|Protocol Violation|2
401182|NCT00037830|1261035|P3|Overall Study|Withdrawal by Subject|1
401183|NCT00037830|1261036|P2|Overall Study|Withdrawal by Subject|5
401184|NCT00037830|1261037|P1|Overall Study|Withdrawal by Subject|4
401185|NCT00037830|1261035|P3|Overall Study|Adverse Event|0
401186|NCT00037830|1261036|P2|Overall Study|Adverse Event|0
401187|NCT00037830|1261037|P1|Overall Study|Adverse Event|2
401188|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
401189|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
401190|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|Too early switch|103
401191|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|Too early switch|0
401192|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
401193|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
401194|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|Protocol Violation|91
401195|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|Protocol Violation|23
401196|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
401197|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
401198|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|Treatment refusal|208
401199|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|Treatment refusal|113
401200|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|Unspecified|288
401201|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|Unspecified|277
401202|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|Adverse Event|782
401203|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|Adverse Event|501
401204|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
401205|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
401206|NCT00036270|1261069|P2|Study Treatment to 5 Year Report|Ongoing|736
401207|NCT00036270|1261070|P1|Study Treatment to 5 Year Report|Ongoing|1081
401208|NCT00036270|1261069|P2|Randomized to Study Treatment|Withdrawal by Subject|7
401209|NCT00036270|1261070|P1|Randomized to Study Treatment|Withdrawal by Subject|6
401210|NCT00035932|1261089|P3|Overall Study|Lack of Efficacy|28
401211|NCT00035932|1261090|P2|Overall Study|Lack of Efficacy|33
401212|NCT00035932|1261091|P1|Overall Study|Lack of Efficacy|33
401213|NCT00035932|1261089|P3|Overall Study|Study Termination by Sponsor|0
401214|NCT00035932|1261090|P2|Overall Study|Study Termination by Sponsor|0
401215|NCT00035932|1261091|P1|Overall Study|Study Termination by Sponsor|1
401216|NCT00035932|1261089|P3|Overall Study|Withdrawal by Subject|0
401217|NCT00035932|1261090|P2|Overall Study|Withdrawal by Subject|5
401218|NCT00035932|1261091|P1|Overall Study|Withdrawal by Subject|1
401219|NCT00035932|1261089|P3|Overall Study|Protocol Violation While on Study|2
401220|NCT00035932|1261090|P2|Overall Study|Protocol Violation While on Study|1
401221|NCT00035932|1261091|P1|Overall Study|Protocol Violation While on Study|0
401222|NCT00035932|1261089|P3|Overall Study|Noncompliance|6
401223|NCT00035932|1261090|P2|Overall Study|Noncompliance|7
401224|NCT00035932|1261091|P1|Overall Study|Noncompliance|6
401225|NCT00035932|1261089|P3|Overall Study|Lost to Follow-up|3
401226|NCT00035932|1261090|P2|Overall Study|Lost to Follow-up|4
401227|NCT00035932|1261091|P1|Overall Study|Lost to Follow-up|4
401228|NCT00035932|1261089|P3|Overall Study|Disease Progression / Relapse|0
401229|NCT00035932|1261090|P2|Overall Study|Disease Progression / Relapse|1
401230|NCT00035932|1261091|P1|Overall Study|Disease Progression / Relapse|1
401231|NCT00035932|1261089|P3|Overall Study|Death|1
401232|NCT00035932|1261090|P2|Overall Study|Death|0
401233|NCT00035932|1261091|P1|Overall Study|Death|0
401234|NCT00035932|1261089|P3|Overall Study|Adverse Event|9
401235|NCT00035932|1261090|P2|Overall Study|Adverse Event|9
401236|NCT00035932|1261091|P1|Overall Study|Adverse Event|10
401237|NCT00035815|1261217|P2|Overall Study|Withdrawal by Subject|11
401238|NCT00035815|1261218|P1|Overall Study|Withdrawal by Subject|17
401239|NCT00035555|1261231|P3|Overall Study|Received cyclosporin in error|1
401240|NCT00035555|1261232|P2|Overall Study|Received cyclosporin in error|0
401241|NCT00035555|1261233|P1|Overall Study|Received cyclosporin in error|0
401242|NCT00035555|1261231|P3|Overall Study|Investigator deemed not a good candidate|1
401243|NCT00035555|1261232|P2|Overall Study|Investigator deemed not a good candidate|0
401244|NCT00035555|1261233|P1|Overall Study|Investigator deemed not a good candidate|0
401245|NCT00035555|1261231|P3|Overall Study|Withdrawal by Subject|2
401246|NCT00035555|1261232|P2|Overall Study|Withdrawal by Subject|0
401247|NCT00035555|1261233|P1|Overall Study|Withdrawal by Subject|2
401248|NCT00035555|1261231|P3|Overall Study|Treatment failure/lack of efficacy|3
401249|NCT00035555|1261232|P2|Overall Study|Treatment failure/lack of efficacy|5
401250|NCT00035555|1261233|P1|Overall Study|Treatment failure/lack of efficacy|7
401251|NCT00035555|1261231|P3|Overall Study|Prohibited medication|0
401252|NCT00035555|1261232|P2|Overall Study|Prohibited medication|1
401253|NCT00035555|1261233|P1|Overall Study|Prohibited medication|1
401254|NCT00035555|1261231|P3|Overall Study|Noncompliance|1
401255|NCT00035555|1261232|P2|Overall Study|Noncompliance|1
401256|NCT00035555|1261233|P1|Overall Study|Noncompliance|0
401257|NCT00035555|1261231|P3|Overall Study|Lost to Follow-up|1
401258|NCT00035555|1261232|P2|Overall Study|Lost to Follow-up|0
401259|NCT00035555|1261233|P1|Overall Study|Lost to Follow-up|0
401260|NCT00035555|1261231|P3|Overall Study|Death|2
401261|NCT00035555|1261232|P2|Overall Study|Death|0
401262|NCT00035555|1261233|P1|Overall Study|Death|0
401263|NCT00035555|1261231|P3|Overall Study|Allograft loss|2
401264|NCT00035555|1261232|P2|Overall Study|Allograft loss|1
401265|NCT00035555|1261233|P1|Overall Study|Allograft loss|1
401266|NCT00035555|1261231|P3|Overall Study|Adverse Event|9
401267|NCT00035555|1261232|P2|Overall Study|Adverse Event|8
401268|NCT00035555|1261233|P1|Overall Study|Adverse Event|5
401269|NCT00033657|1261289|P2|Adjuvant Chemotherapy|Other|2
401270|NCT00033657|1261290|P1|Adjuvant Chemotherapy|Other|0
401271|NCT00033657|1261289|P2|Adjuvant Chemotherapy|alternative therapy|0
401272|NCT00033657|1261290|P1|Adjuvant Chemotherapy|alternative therapy|1
401273|NCT00033657|1261289|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
401274|NCT00033657|1261290|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
401275|NCT00033657|1261289|P2|Adjuvant Chemotherapy|Death|1
401276|NCT00033657|1261290|P1|Adjuvant Chemotherapy|Death|2
401277|NCT00033657|1261289|P2|Adjuvant Chemotherapy|Adverse Event|10
401278|NCT00033657|1261290|P1|Adjuvant Chemotherapy|Adverse Event|7
401279|NCT00033657|1261289|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
401280|NCT00033657|1261290|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
401281|NCT00033657|1261289|P2|Surgical Resection|not complete resection|3
401282|NCT00033657|1261290|P1|Surgical Resection|not complete resection|0
401283|NCT00033657|1261289|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
401284|NCT00033657|1261290|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
401285|NCT00033657|1261289|P2|Neoadjuvant Chemotherapy|Ineligible|4
401286|NCT00033657|1261290|P1|Neoadjuvant Chemotherapy|Ineligible|8
401287|NCT00033657|1261289|P2|Neoadjuvant Chemotherapy|other complicating disease|1
401288|NCT00033657|1261290|P1|Neoadjuvant Chemotherapy|other complicating disease|0
401289|NCT00033657|1261289|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
401290|NCT00033657|1261290|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
401291|NCT00033657|1261289|P2|Neoadjuvant Chemotherapy|Death|1
401292|NCT00033657|1261290|P1|Neoadjuvant Chemotherapy|Death|1
401293|NCT00033657|1261289|P2|Neoadjuvant Chemotherapy|Adverse Event|2
401294|NCT00033657|1261290|P1|Neoadjuvant Chemotherapy|Adverse Event|0
401295|NCT00033657|1261289|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
401296|NCT00033657|1261290|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
401297|NCT00033631|1261304|P2|Overall Study|Withdrawal by Subject|4
401298|NCT00033631|1261305|P1|Overall Study|Withdrawal by Subject|4
401299|NCT00033631|1261304|P2|Overall Study|Protocol Violation|11
401300|NCT00033631|1261305|P1|Overall Study|Protocol Violation|14
401301|NCT00033540|1261323|P1|Overall Study|Never received treatment|2
401302|NCT00033540|1261323|P1|Overall Study|Ineligible|3
401303|NCT00033540|1261323|P1|Overall Study|Not specified|5
401304|NCT00033540|1261323|P1|Overall Study|Withdrawal by Subject|6
401305|NCT00033540|1261323|P1|Overall Study|Progression|26
401306|NCT00033540|1261323|P1|Overall Study|Death|1
401307|NCT00033540|1261323|P1|Overall Study|Adverse Event|14
401308|NCT00033514|1261333|P2|Overall Study|Withdrawal by Subject|3
401309|NCT00033514|1261334|P1|Overall Study|Withdrawal by Subject|0
401310|NCT00033514|1261333|P2|Overall Study|Lost to Follow-up|1
401311|NCT00033514|1261334|P1|Overall Study|Lost to Follow-up|1
401312|NCT00033371|1261344|P2|Overall Study|Disease Progression|1
401313|NCT00033371|1261345|P1|Overall Study|Disease Progression|0
401314|NCT00033371|1261344|P2|Overall Study|Withdrawal by Subject|3
401315|NCT00033371|1261345|P1|Overall Study|Withdrawal by Subject|3
401316|NCT00033371|1261344|P2|Overall Study|Lost to Follow-up|1
401317|NCT00033371|1261345|P1|Overall Study|Lost to Follow-up|2
401318|NCT00033371|1261344|P2|Overall Study|Adverse Event|5
401319|NCT00033371|1261345|P1|Overall Study|Adverse Event|1
401320|NCT00033293|1261353|P2|Overall Study|Treatment refused|6
401321|NCT00033293|1261354|P1|Overall Study|Treatment refused|0
401322|NCT00033293|1261353|P2|Overall Study|Could not be weaned from steroid therapy|1
401323|NCT00033293|1261354|P1|Overall Study|Could not be weaned from steroid therapy|1
401324|NCT00033293|1261353|P2|Overall Study|Withdrawal by Subject|0
401325|NCT00033293|1261354|P1|Overall Study|Withdrawal by Subject|1
401326|NCT00033293|1261353|P2|Overall Study|Physician Decision|1
401327|NCT00033293|1261354|P1|Overall Study|Physician Decision|3
401328|NCT00033293|1261353|P2|Overall Study|Lost to Follow-up|1
401329|NCT00033293|1261354|P1|Overall Study|Lost to Follow-up|0
401330|NCT00033293|1261353|P2|Overall Study|Lack of Efficacy|8
401331|NCT00033293|1261354|P1|Overall Study|Lack of Efficacy|5
401332|NCT00033293|1261353|P2|Overall Study|Death|1
401333|NCT00033293|1261354|P1|Overall Study|Death|0
401334|NCT00032487|1261402|P2|Overall Study|Had other reason|12
401335|NCT00032487|1261403|P1|Overall Study|Had other reason|12
401336|NCT00032487|1261402|P2|Overall Study|Lost to Follow-up|58
401337|NCT00032487|1261403|P1|Overall Study|Lost to Follow-up|57
401338|NCT00032487|1261402|P2|Overall Study|Adverse Event|7
401339|NCT00032487|1261403|P1|Overall Study|Adverse Event|3
401340|NCT00032487|1261402|P2|Overall Study|Withdrawal by Subject|43
401341|NCT00032487|1261403|P1|Overall Study|Withdrawal by Subject|67
401342|NCT00031694|1261411|P1|Overall Study|Withdrawal by Subject|5
401343|NCT00031694|1261411|P1|Overall Study|Death|2
401344|NCT00031694|1261411|P1|Overall Study|Adverse Event|12
401345|NCT00031551|1261417|P2|Overall Study|Withdrew due to chemotherapy effects|0
401346|NCT00031551|1261418|P1|Overall Study|Withdrew due to chemotherapy effects|2
401347|NCT00031486|1261430|P2|Overall Study|Unspecified|1
401348|NCT00031486|1261431|P1|Overall Study|Unspecified|1
401349|NCT00031486|1261430|P2|Overall Study|Did not meet eligibility requirement|1
401350|NCT00031486|1261431|P1|Overall Study|Did not meet eligibility requirement|2
401351|NCT00031486|1261430|P2|Overall Study|Non-compliant|4
401352|NCT00031486|1261431|P1|Overall Study|Non-compliant|0
401353|NCT00031486|1261430|P2|Overall Study|Death|3
401354|NCT00031486|1261431|P1|Overall Study|Death|0
401355|NCT00031486|1261430|P2|Overall Study|Withdrawal by Subject|2
401356|NCT00031486|1261431|P1|Overall Study|Withdrawal by Subject|3
401357|NCT00031486|1261430|P2|Overall Study|Lost to Follow-up|1
401358|NCT00031486|1261431|P1|Overall Study|Lost to Follow-up|0
401359|NCT00031486|1261430|P2|Overall Study|Adverse Event|0
401360|NCT00031486|1261431|P1|Overall Study|Adverse Event|1
401361|NCT00031460|1261457|P2|Overall Study|Confirmed unevaluable|1
401362|NCT00031460|1261458|P1|Overall Study|Confirmed unevaluable|0
401363|NCT00031460|1261457|P2|Overall Study|Disruption of blinded drug supply|0
401364|NCT00031460|1261458|P1|Overall Study|Disruption of blinded drug supply|2
401365|NCT00031460|1261457|P2|Overall Study|Reactivation of Disease|9
401366|NCT00031460|1261458|P1|Overall Study|Reactivation of Disease|5
401367|NCT00031460|1261457|P2|Overall Study|Death|1
401368|NCT00031460|1261458|P1|Overall Study|Death|0
401369|NCT00031460|1261457|P2|Overall Study|Non-Compliant|1
401370|NCT00031460|1261458|P1|Overall Study|Non-Compliant|1
401371|NCT00031460|1261457|P2|Overall Study|Withdrawal by Subject|1
401372|NCT00031460|1261458|P1|Overall Study|Withdrawal by Subject|1
401373|NCT00031460|1261457|P2|Overall Study|Lost to Follow-up|1
401374|NCT00031460|1261458|P1|Overall Study|Lost to Follow-up|0
401375|NCT00031447|1261472|P2|Overall Study|Disruption of blinded study drug supply|4
401376|NCT00031447|1261473|P1|Overall Study|Disruption of blinded study drug supply|7
401377|NCT00031447|1261472|P2|Overall Study|Re-activation of Disease|1
401378|NCT00031447|1261473|P1|Overall Study|Re-activation of Disease|2
401379|NCT00031447|1261472|P2|Overall Study|Non-compliant|1
401380|NCT00031447|1261473|P1|Overall Study|Non-compliant|1
401381|NCT00031447|1261472|P2|Overall Study|Lost to Follow-up|1
401382|NCT00031447|1261473|P1|Overall Study|Lost to Follow-up|0
401383|NCT00030901|1261492|P3|Randomization|Ineligible|14
401384|NCT00030901|1261493|P2|Randomization|Ineligible|15
401385|NCT00030901|1261494|P1|Randomization|Ineligible|0
401386|NCT00030901|1261492|P3|Randomization|Other|33
401387|NCT00030901|1261493|P2|Randomization|Other|36
401388|NCT00030901|1261494|P1|Randomization|Other|0
401389|NCT00030901|1261492|P3|Randomization|Death|3
401390|NCT00030901|1261493|P2|Randomization|Death|1
401391|NCT00030901|1261494|P1|Randomization|Death|0
401392|NCT00030901|1261492|P3|Randomization|Progression/Relapse|21
401393|NCT00030901|1261493|P2|Randomization|Progression/Relapse|22
401394|NCT00030901|1261494|P1|Randomization|Progression/Relapse|0
401395|NCT00030901|1261492|P3|Randomization|Refusal Unrelated to Adverse Event|10
401396|NCT00030901|1261493|P2|Randomization|Refusal Unrelated to Adverse Event|16
401397|NCT00030901|1261494|P1|Randomization|Refusal Unrelated to Adverse Event|0
401398|NCT00030901|1261492|P3|Randomization|Adverse Event|7
401399|NCT00030901|1261493|P2|Randomization|Adverse Event|11
401400|NCT00030901|1261494|P1|Randomization|Adverse Event|0
401401|NCT00030901|1261492|P3|Initial Registration|Ineligible|0
401402|NCT00030901|1261493|P2|Initial Registration|Ineligible|0
401403|NCT00030901|1261494|P1|Initial Registration|Ineligible|167
401404|NCT00030823|1261502|P1|Overall Study|Withdrawal by Subject|1
401405|NCT00029146|1261564|P2|Overall Study|Lost to Follow-up|1
401406|NCT00029146|1261565|P1|Overall Study|Lost to Follow-up|2
401407|NCT00028769|1261601|P1|Overall Study|Not Analyzable|1
401408|NCT00028769|1261601|P1|Overall Study|Ineligible|5
401409|NCT00028769|1261601|P1|Overall Study|Other - Not Protocol Specified|1
401410|NCT00028769|1261601|P1|Overall Study|Progression or Death|31
401411|NCT00028769|1261601|P1|Overall Study|Refusal Unrelated to Adverse Events|1
401412|NCT00028769|1261601|P1|Overall Study|Adverse Event|2
401413|NCT00028002|1261620|P1|Overall Study|Ineligible|8
401414|NCT00028002|1261620|P1|Overall Study|Withdrawal by Subject|3
401415|NCT00027846|1261627|P3|Overall Study|Neuraxis dissemination during/after ther|5
401416|NCT00027846|1261628|P2|Overall Study|Neuraxis dissemination during/after ther|2
401417|NCT00027846|1261629|P1|Overall Study|Neuraxis dissemination during/after ther|0
401418|NCT00027846|1261627|P3|Overall Study|Entry into another COG therapeutic study|2
401419|NCT00027846|1261628|P2|Overall Study|Entry into another COG therapeutic study|5
401420|NCT00027846|1261629|P1|Overall Study|Entry into another COG therapeutic study|0
401421|NCT00027846|1261627|P3|Overall Study|Ineligible for study|14
401422|NCT00027846|1261628|P2|Overall Study|Ineligible for study|6
401423|NCT00027846|1261629|P1|Overall Study|Ineligible for study|2
401424|NCT00027846|1261627|P3|Overall Study|Withdrawal by Subject|7
401425|NCT00027846|1261628|P2|Overall Study|Withdrawal by Subject|14
401426|NCT00027846|1261629|P1|Overall Study|Withdrawal by Subject|0
401427|NCT00027846|1261627|P3|Overall Study|Lost to Follow-up|9
401428|NCT00027846|1261628|P2|Overall Study|Lost to Follow-up|41
401429|NCT00027846|1261629|P1|Overall Study|Lost to Follow-up|0
401430|NCT00027560|1261647|P1|Overall Study|Withdrawal by Subject|1
401431|NCT00027378|1261658|P2|Overall Study|Physician Decision|3
401432|NCT00027378|1261659|P1|Overall Study|Physician Decision|0
401433|NCT00027027|1261672|P5|Overall Study|Withdrawal by Subject|1
401434|NCT00027027|1261673|P4|Overall Study|Withdrawal by Subject|0
401435|NCT00027027|1261674|P3|Overall Study|Withdrawal by Subject|0
401436|NCT00027027|1261675|P2|Overall Study|Withdrawal by Subject|0
401437|NCT00027027|1261676|P1|Overall Study|Withdrawal by Subject|0
401438|NCT00027027|1261672|P5|Overall Study|Physician Decision Due To PD|5
401439|NCT00027027|1261673|P4|Overall Study|Physician Decision Due To PD|3
401440|NCT00027027|1261674|P3|Overall Study|Physician Decision Due To PD|2
401441|NCT00027027|1261675|P2|Overall Study|Physician Decision Due To PD|3
401442|NCT00027027|1261676|P1|Overall Study|Physician Decision Due To PD|2
401443|NCT00027027|1261672|P5|Overall Study|PD Requiring Surgery|0
401444|NCT00027027|1261673|P4|Overall Study|PD Requiring Surgery|0
401445|NCT00027027|1261674|P3|Overall Study|PD Requiring Surgery|1
401446|NCT00027027|1261675|P2|Overall Study|PD Requiring Surgery|0
401447|NCT00027027|1261676|P1|Overall Study|PD Requiring Surgery|0
401448|NCT00027027|1261672|P5|Overall Study|Clinical Symptoms Progression not PD|0
401449|NCT00027027|1261673|P4|Overall Study|Clinical Symptoms Progression not PD|0
401450|NCT00027027|1261674|P3|Overall Study|Clinical Symptoms Progression not PD|0
401451|NCT00027027|1261675|P2|Overall Study|Clinical Symptoms Progression not PD|0
401452|NCT00027027|1261676|P1|Overall Study|Clinical Symptoms Progression not PD|1
401453|NCT00027027|1261672|P5|Overall Study|Admitted for Signs of PD|1
401454|NCT00027027|1261673|P4|Overall Study|Admitted for Signs of PD|0
401455|NCT00027027|1261674|P3|Overall Study|Admitted for Signs of PD|0
401456|NCT00027027|1261675|P2|Overall Study|Admitted for Signs of PD|0
401457|NCT00027027|1261676|P1|Overall Study|Admitted for Signs of PD|0
401458|NCT00027027|1261672|P5|Overall Study|Adverse Event|1
401459|NCT00027027|1261673|P4|Overall Study|Adverse Event|0
401460|NCT00027027|1261674|P3|Overall Study|Adverse Event|1
401461|NCT00027027|1261675|P2|Overall Study|Adverse Event|0
401462|NCT00027027|1261676|P1|Overall Study|Adverse Event|0
401463|NCT00026494|1261725|P4|Overall Study|Clinical progression|0
401464|NCT00026494|1261726|P3|Overall Study|Clinical progression|3
401465|NCT00026494|1261727|P2|Overall Study|Clinical progression|0
401466|NCT00026494|1261728|P1|Overall Study|Clinical progression|0
401467|NCT00026494|1261725|P4|Overall Study|Patient not treated|0
401468|NCT00026494|1261726|P3|Overall Study|Patient not treated|2
401469|NCT00026494|1261727|P2|Overall Study|Patient not treated|0
401470|NCT00026494|1261728|P1|Overall Study|Patient not treated|0
401471|NCT00026494|1261725|P4|Overall Study|Patient non-compliance|0
401472|NCT00026494|1261726|P3|Overall Study|Patient non-compliance|0
401473|NCT00026494|1261727|P2|Overall Study|Patient non-compliance|0
401474|NCT00026494|1261728|P1|Overall Study|Patient non-compliance|1
401475|NCT00026494|1261725|P4|Overall Study|Withdrawal by Subject|0
401476|NCT00026494|1261726|P3|Overall Study|Withdrawal by Subject|1
401477|NCT00026494|1261727|P2|Overall Study|Withdrawal by Subject|0
401478|NCT00026494|1261728|P1|Overall Study|Withdrawal by Subject|1
401479|NCT00026312|1261740|P2|Overall Study|Refusal by patient/parent/guardian|59
401480|NCT00026312|1261741|P1|Overall Study|Refusal by patient/parent/guardian|8
401481|NCT00026312|1261740|P2|Overall Study|Entry onto another COG study|1
401482|NCT00026312|1261741|P1|Overall Study|Entry onto another COG study|0
401483|NCT00026312|1261740|P2|Overall Study|Ineligible|5
401484|NCT00026312|1261741|P1|Overall Study|Ineligible|4
401485|NCT00026312|1261740|P2|Overall Study|Withdrawal by Subject|6
401486|NCT00026312|1261741|P1|Overall Study|Withdrawal by Subject|1
401487|NCT00026312|1261740|P2|Overall Study|Protocol Violation|3
401488|NCT00026312|1261741|P1|Overall Study|Protocol Violation|0
401489|NCT00026312|1261740|P2|Overall Study|Physician Decision|37
401490|NCT00026312|1261741|P1|Overall Study|Physician Decision|1
401491|NCT00026312|1261740|P2|Overall Study|Lost to Follow-up|5
401492|NCT00026312|1261741|P1|Overall Study|Lost to Follow-up|0
401493|NCT00026312|1261740|P2|Overall Study|Lack of Efficacy|114
401494|NCT00026312|1261741|P1|Overall Study|Lack of Efficacy|19
401495|NCT00026312|1261740|P2|Overall Study|Death|7
401496|NCT00026312|1261741|P1|Overall Study|Death|1
401497|NCT00026312|1261740|P2|Overall Study|Adverse Event|32
401498|NCT00026312|1261741|P1|Overall Study|Adverse Event|0
401499|NCT00025883|1261780|P1|Overall Study|didn't reach 6 months of Metreleptin|10
401500|NCT00025883|1261780|P1|Overall Study|Adverse Event|1
401501|NCT00025883|1261780|P1|Overall Study|Death|1
401502|NCT00025883|1261780|P1|Overall Study|no baseline data|1
401503|NCT00025883|1261780|P1|Overall Study|had atypical progeriod lipodystrophy|4
401504|NCT00025662|1261787|P1|Overall Study|Technical failure of manipulation|1
401505|NCT00025662|1261787|P1|Overall Study|Withdrawal by Subject|2
401506|NCT00025506|1261795|P1|Overall Study|Never Treated|2
401507|NCT00025506|1261795|P1|Overall Study|Ineligible: inadequate pathology|2
401508|NCT00025506|1261795|P1|Overall Study|Ineligible: wrong cell type|5
401509|NCT00025506|1261795|P1|Overall Study|Ineligible: clerical error|1
401510|NCT00025259|1261808|P7|Overall Study|Adverse Event|0
401511|NCT00025259|1261809|P6|Overall Study|Adverse Event|0
401512|NCT00025259|1261810|P5|Overall Study|Adverse Event|0
401513|NCT00025259|1261811|P4|Overall Study|Adverse Event|0
401514|NCT00025259|1261812|P3|Overall Study|Adverse Event|0
401515|NCT00025259|1261813|P2|Overall Study|Adverse Event|0
401516|NCT00025259|1261814|P1|Overall Study|Adverse Event|1
401517|NCT00025259|1261808|P7|Overall Study|Randomization error|2
401518|NCT00025259|1261809|P6|Overall Study|Randomization error|7
401519|NCT00025259|1261810|P5|Overall Study|Randomization error|1
401520|NCT00025259|1261811|P4|Overall Study|Randomization error|0
401521|NCT00025259|1261812|P3|Overall Study|Randomization error|0
401522|NCT00025259|1261813|P2|Overall Study|Randomization error|0
401523|NCT00025259|1261814|P1|Overall Study|Randomization error|1
401524|NCT00025259|1261808|P7|Overall Study|Ineligible|1
401525|NCT00025259|1261809|P6|Overall Study|Ineligible|0
401526|NCT00025259|1261810|P5|Overall Study|Ineligible|6
401527|NCT00025259|1261811|P4|Overall Study|Ineligible|0
401528|NCT00025259|1261812|P3|Overall Study|Ineligible|0
401529|NCT00025259|1261813|P2|Overall Study|Ineligible|1
401530|NCT00025259|1261814|P1|Overall Study|Ineligible|14
401531|NCT00025259|1261808|P7|Overall Study|Withdrawal by Subject|3
401532|NCT00025259|1261809|P6|Overall Study|Withdrawal by Subject|8
401533|NCT00025259|1261810|P5|Overall Study|Withdrawal by Subject|11
401534|NCT00025259|1261811|P4|Overall Study|Withdrawal by Subject|14
401535|NCT00025259|1261812|P3|Overall Study|Withdrawal by Subject|6
401536|NCT00025259|1261813|P2|Overall Study|Withdrawal by Subject|27
401537|NCT00025259|1261814|P1|Overall Study|Withdrawal by Subject|9
401538|NCT00025259|1261808|P7|Overall Study|Protocol Violation|3
401539|NCT00025259|1261809|P6|Overall Study|Protocol Violation|1
401540|NCT00025259|1261810|P5|Overall Study|Protocol Violation|2
401541|NCT00025259|1261811|P4|Overall Study|Protocol Violation|1
401542|NCT00025259|1261812|P3|Overall Study|Protocol Violation|2
401543|NCT00025259|1261813|P2|Overall Study|Protocol Violation|2
401544|NCT00025259|1261814|P1|Overall Study|Protocol Violation|3
401545|NCT00025259|1261808|P7|Overall Study|Physician Decision|1
401546|NCT00025259|1261809|P6|Overall Study|Physician Decision|2
401547|NCT00025259|1261810|P5|Overall Study|Physician Decision|4
401548|NCT00025259|1261811|P4|Overall Study|Physician Decision|5
401549|NCT00025259|1261812|P3|Overall Study|Physician Decision|0
401550|NCT00025259|1261813|P2|Overall Study|Physician Decision|1
401551|NCT00025259|1261814|P1|Overall Study|Physician Decision|12
401552|NCT00025259|1261808|P7|Overall Study|Lost to Follow-up|1
401553|NCT00025259|1261809|P6|Overall Study|Lost to Follow-up|3
401554|NCT00025259|1261810|P5|Overall Study|Lost to Follow-up|1
401555|NCT00025259|1261811|P4|Overall Study|Lost to Follow-up|13
401556|NCT00025259|1261812|P3|Overall Study|Lost to Follow-up|13
401557|NCT00025259|1261813|P2|Overall Study|Lost to Follow-up|9
401558|NCT00025259|1261814|P1|Overall Study|Lost to Follow-up|2
401559|NCT00025259|1261808|P7|Overall Study|Lack of Efficacy|38
401560|NCT00025259|1261809|P6|Overall Study|Lack of Efficacy|30
401561|NCT00025259|1261810|P5|Overall Study|Lack of Efficacy|11
401562|NCT00025259|1261811|P4|Overall Study|Lack of Efficacy|78
401563|NCT00025259|1261812|P3|Overall Study|Lack of Efficacy|60
401564|NCT00025259|1261813|P2|Overall Study|Lack of Efficacy|46
401565|NCT00025259|1261814|P1|Overall Study|Lack of Efficacy|2
401566|NCT00025259|1261808|P7|Overall Study|Death|2
401567|NCT00025259|1261809|P6|Overall Study|Death|1
401568|NCT00025259|1261810|P5|Overall Study|Death|0
401569|NCT00025259|1261811|P4|Overall Study|Death|3
401570|NCT00025259|1261812|P3|Overall Study|Death|0
401571|NCT00025259|1261813|P2|Overall Study|Death|3
401572|NCT00025259|1261814|P1|Overall Study|Death|1
401573|NCT00025233|1261850|P1|Overall Study|Never treated|1
401574|NCT00025233|1261850|P1|Overall Study|Ineligible: improper prior treatment|1
401575|NCT00025233|1261850|P1|Overall Study|Ineligible: wrong primary|1
401576|NCT00025233|1261850|P1|Overall Study|Ineligible: wrong cell type|1
401577|NCT00025155|1261856|P1|Overall Study|Ineligible: Second primary cancer site|1
401578|NCT00025155|1261856|P1|Overall Study|Ineligible: Wrong primary cancer site|1
401579|NCT00024258|1261862|P1|Overall Study|Disease Progression|8
401580|NCT00024258|1261862|P1|Overall Study|Withdrawal by Subject|1
401581|NCT00024167|1261869|P2|Overall Study|Death|47
401582|NCT00024167|1261870|P1|Overall Study|Death|53
401583|NCT00023764|1261894|P1|Overall Study|delay in obtaining staging images|1
401584|NCT00023764|1261894|P1|Overall Study|patient received other treatment|1
401585|NCT00023764|1261894|P1|Overall Study|Progression of disease|6
401586|NCT00023764|1261894|P1|Overall Study|Withdrawal by Subject|1
401587|NCT00023764|1261894|P1|Overall Study|Adverse Event|4
401588|NCT00023764|1261894|P1|Overall Study|Other|1
401589|NCT00023712|1261901|P2|Overall Study|Never treated|1
401590|NCT00023712|1261902|P1|Overall Study|Never treated|1
401591|NCT00023712|1261901|P2|Overall Study|Not platinum sensitive|0
401592|NCT00023712|1261902|P1|Overall Study|Not platinum sensitive|1
401593|NCT00023673|1261917|P4|Overall Study|Patient withdrew consent|1
401594|NCT00023673|1261918|P3|Overall Study|Patient withdrew consent|0
401595|NCT00023673|1261919|P2|Overall Study|Patient withdrew consent|0
401596|NCT00023673|1261920|P1|Overall Study|Patient withdrew consent|0
401597|NCT00023673|1261917|P4|Overall Study|Ineligible / no protocol treatment|1
401598|NCT00023673|1261918|P3|Overall Study|Ineligible / no protocol treatment|0
401599|NCT00023673|1261919|P2|Overall Study|Ineligible / no protocol treatment|0
401600|NCT00023673|1261920|P1|Overall Study|Ineligible / no protocol treatment|0
401601|NCT00023452|1261929|P2|Overall Study|Other|69
401602|NCT00023452|1261930|P1|Overall Study|Other|204
401603|NCT00023452|1261929|P2|Overall Study|Pregnant|20
401604|NCT00023452|1261930|P1|Overall Study|Pregnant|53
401605|NCT00023452|1261929|P2|Overall Study|Refused Treatment (continued follow-up)|224
401606|NCT00023452|1261930|P1|Overall Study|Refused Treatment (continued follow-up)|225
401607|NCT00023452|1261929|P2|Overall Study|Physician Decision|21
401608|NCT00023452|1261930|P1|Overall Study|Physician Decision|49
401609|NCT00023452|1261929|P2|Overall Study|Lost to Follow-up|60
401610|NCT00023452|1261930|P1|Overall Study|Lost to Follow-up|293
401611|NCT00023452|1261929|P2|Overall Study|Adverse Event|196
401612|NCT00023452|1261930|P1|Overall Study|Adverse Event|139
401613|NCT00023452|1261929|P2|Overall Study|Withdrawal by Subject|54
401614|NCT00023452|1261930|P1|Overall Study|Withdrawal by Subject|66
401615|NCT00023452|1261929|P2|Overall Study|Death|0
401616|NCT00023452|1261930|P1|Overall Study|Death|2
401617|NCT00023452|1261929|P2|Overall Study|Out of Window|69
401618|NCT00023452|1261930|P1|Overall Study|Out of Window|129
401619|NCT00023452|1261929|P2|Overall Study|Ineligible for Study|159
401620|NCT00023452|1261930|P1|Overall Study|Ineligible for Study|163
401621|NCT00023322|1261954|P1|Overall Study|Lost to Follow-up|1
401622|NCT00022763|1261978|P2|Overall Study|Admin|2
401623|NCT00022763|1261979|P1|Overall Study|Admin|3
401624|NCT00022763|1261978|P2|Overall Study|Insufficient Therapy|0
401625|NCT00022763|1261979|P1|Overall Study|Insufficient Therapy|1
401626|NCT00022763|1261978|P2|Overall Study|Withdrawal by Subject|7
401627|NCT00022763|1261979|P1|Overall Study|Withdrawal by Subject|4
401628|NCT00022763|1261978|P2|Overall Study|Lost to Follow-up|3
401629|NCT00022763|1261979|P1|Overall Study|Lost to Follow-up|0
401630|NCT00022763|1261978|P2|Overall Study|Death|1
401631|NCT00022763|1261979|P1|Overall Study|Death|0
401632|NCT00022763|1261978|P2|Overall Study|Injection Site Reactions|2
401633|NCT00022763|1261979|P1|Overall Study|Injection Site Reactions|0
401634|NCT00022763|1261978|P2|Overall Study|Adverse Event|2
401635|NCT00022763|1261979|P1|Overall Study|Adverse Event|1
401636|NCT00022698|1262004|P2|Overall Study|Administrative /other|7
401637|NCT00022698|1262005|P1|Overall Study|Administrative /other|1
401638|NCT00022698|1262004|P2|Overall Study|Insufficient therapeutic response|14
401639|NCT00022698|1262005|P1|Overall Study|Insufficient therapeutic response|2
401640|NCT00022698|1262004|P2|Overall Study|Refused treatment|2
401641|NCT00022698|1262005|P1|Overall Study|Refused treatment|0
401642|NCT00022698|1262004|P2|Overall Study|Failure to return|1
401643|NCT00022698|1262005|P1|Overall Study|Failure to return|0
401644|NCT00022698|1262004|P2|Overall Study|Death|2
401645|NCT00022698|1262005|P1|Overall Study|Death|0
401646|NCT00022698|1262004|P2|Overall Study|Adverse Event|9
401647|NCT00022698|1262005|P1|Overall Study|Adverse Event|5
401648|NCT00022672|1262030|P2|Extension Phase|Other|1
401649|NCT00022672|1262031|P1|Extension Phase|Other|1
401650|NCT00022672|1262030|P2|Extension Phase|Refused Treatment|2
401651|NCT00022672|1262031|P1|Extension Phase|Refused Treatment|0
401652|NCT00022672|1262030|P2|Extension Phase|Insufficient Therapeutic Response|44
401653|NCT00022672|1262031|P1|Extension Phase|Insufficient Therapeutic Response|1
401654|NCT00022672|1262030|P2|Extension Phase|Death|1
401655|NCT00022672|1262031|P1|Extension Phase|Death|0
401656|NCT00022672|1262030|P2|Extension Phase|Adverse Event|3
401657|NCT00022672|1262031|P1|Extension Phase|Adverse Event|1
401658|NCT00022672|1262030|P2|Main Phase: 24 Months|Other|0
401659|NCT00022672|1262031|P1|Main Phase: 24 Months|Other|1
401660|NCT00022672|1262030|P2|Main Phase: 24 Months|Failure to Return|1
401661|NCT00022672|1262031|P1|Main Phase: 24 Months|Failure to Return|1
401662|NCT00022672|1262030|P2|Main Phase: 24 Months|Refused Treatment|4
401663|NCT00022672|1262031|P1|Main Phase: 24 Months|Refused Treatment|3
401664|NCT00022672|1262030|P2|Main Phase: 24 Months|Other Protocol Violation|0
401665|NCT00022672|1262031|P1|Main Phase: 24 Months|Other Protocol Violation|1
401666|NCT00022672|1262030|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
401667|NCT00022672|1262031|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
401668|NCT00022672|1262030|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
401669|NCT00022672|1262031|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
401670|NCT00022672|1262030|P2|Main Phase: 24 Months|Death|3
401671|NCT00022672|1262031|P1|Main Phase: 24 Months|Death|0
401672|NCT00022672|1262030|P2|Main Phase: 24 Months|Adverse Event|0
401673|NCT00022672|1262031|P1|Main Phase: 24 Months|Adverse Event|6
401674|NCT00022659|1262064|P1|Overall Study|Never treated|1
401675|NCT00022659|1262064|P1|Overall Study|Ineligible: wrong primary|1
401676|NCT00022633|1262072|P2|Overall Study|Ineligible|0
401677|NCT00022633|1262073|P1|Overall Study|Ineligible|4
401678|NCT00022633|1262072|P2|Overall Study|Other - not protocol specified|2
401679|NCT00022633|1262073|P1|Overall Study|Other - not protocol specified|3
401680|NCT00022633|1262072|P2|Overall Study|Death|0
401681|NCT00022633|1262073|P1|Overall Study|Death|4
401682|NCT00022633|1262072|P2|Overall Study|Progression/relapse|2
401683|NCT00022633|1262073|P1|Overall Study|Progression/relapse|9
401684|NCT00022633|1262072|P2|Overall Study|Refusal unrelated to adverse event|0
401685|NCT00022633|1262073|P1|Overall Study|Refusal unrelated to adverse event|1
401686|NCT00022633|1262072|P2|Overall Study|Adverse Event|1
401687|NCT00022633|1262073|P1|Overall Study|Adverse Event|11
401688|NCT00022516|1262086|P2|Overall Study|Incomplete documentation|27
401689|NCT00022516|1262087|P1|Overall Study|Incomplete documentation|0
401690|NCT00022516|1262086|P2|Overall Study|Withdrawal by Subject|113
401691|NCT00022516|1262087|P1|Overall Study|Withdrawal by Subject|2
401692|NCT00022516|1262086|P2|Overall Study|Protocol Violation|3
401693|NCT00022516|1262087|P1|Overall Study|Protocol Violation|1
401694|NCT00022516|1262086|P2|Overall Study|Physician Decision|1
401695|NCT00022516|1262087|P1|Overall Study|Physician Decision|0
401696|NCT00022516|1262086|P2|Overall Study|Lack of Efficacy|27
401697|NCT00022516|1262087|P1|Overall Study|Lack of Efficacy|0
401698|NCT00022516|1262086|P2|Overall Study|Adverse Event|59
401699|NCT00022516|1262087|P1|Overall Study|Adverse Event|0
401700|NCT00021541|1262105|P2|Period 2-crossover|Pts that did not progress|3
401701|NCT00021541|1262106|P1|Period 2-crossover|Pts that did not progress|2
401702|NCT00021541|1262105|P2|Period 2-crossover|non-adherence|0
401703|NCT00021541|1262106|P1|Period 2-crossover|non-adherence|1
401704|NCT00021541|1262105|P2|Period 2-crossover|Adverse Event|2
401705|NCT00021541|1262106|P1|Period 2-crossover|Adverse Event|2
401706|NCT00021541|1262105|P2|Period 2-crossover|Withdrawal by Subject|4
401707|NCT00021541|1262106|P1|Period 2-crossover|Withdrawal by Subject|3
401708|NCT00021541|1262105|P2|Period 2-crossover|refused phase B|2
401709|NCT00021541|1262106|P1|Period 2-crossover|refused phase B|2
401710|NCT00021541|1262105|P2|Period 1-First Treatment|Ineligible|2
401711|NCT00021541|1262106|P1|Period 1-First Treatment|Ineligible|0
401712|NCT00021541|1262105|P2|Period 1-First Treatment|Pts that did not progress|2
401713|NCT00021541|1262106|P1|Period 1-First Treatment|Pts that did not progress|2
401714|NCT00021541|1262105|P2|Period 1-First Treatment|Death|0
401715|NCT00021541|1262106|P1|Period 1-First Treatment|Death|1
401716|NCT00021541|1262105|P2|Period 1-First Treatment|non-adherence|0
401717|NCT00021541|1262106|P1|Period 1-First Treatment|non-adherence|3
401718|NCT00021541|1262105|P2|Period 1-First Treatment|Adverse Event|1
401719|NCT00021541|1262106|P1|Period 1-First Treatment|Adverse Event|2
401720|NCT00021541|1262105|P2|Period 1-First Treatment|Withdrawal by Subject|3
401721|NCT00021541|1262106|P1|Period 1-First Treatment|Withdrawal by Subject|3
401722|NCT00021255|1262115|P3|Overall Study|Randomized but not treated|18
401723|NCT00021255|1262116|P2|Overall Study|Randomized but not treated|2
401724|NCT00021255|1262117|P1|Overall Study|Randomized but not treated|28
401725|NCT00021255|1262115|P3|Overall Study|Missing|13
401726|NCT00021255|1262116|P2|Overall Study|Missing|27
401727|NCT00021255|1262117|P1|Overall Study|Missing|0
401728|NCT00021255|1262115|P3|Overall Study|Other than specified above|19
401729|NCT00021255|1262116|P2|Overall Study|Other than specified above|38
401730|NCT00021255|1262117|P1|Overall Study|Other than specified above|0
401731|NCT00021255|1262115|P3|Overall Study|Protocol Violation|0
401732|NCT00021255|1262116|P2|Overall Study|Protocol Violation|2
401733|NCT00021255|1262117|P1|Overall Study|Protocol Violation|0
401734|NCT00021255|1262115|P3|Overall Study|Adverse Event|18
401735|NCT00021255|1262116|P2|Overall Study|Adverse Event|30
401736|NCT00021255|1262117|P1|Overall Study|Adverse Event|46
401737|NCT00021255|1262115|P3|Overall Study|Herceptin toxicity|6
401738|NCT00021255|1262116|P2|Overall Study|Herceptin toxicity|22
401739|NCT00021255|1262117|P1|Overall Study|Herceptin toxicity|0
401740|NCT00021255|1262115|P3|Overall Study|Cardiac toxicity|32
401741|NCT00021255|1262116|P2|Overall Study|Cardiac toxicity|61
401742|NCT00021255|1262117|P1|Overall Study|Cardiac toxicity|0
401743|NCT00021255|1262115|P3|Overall Study|Lost to Follow-up|3
401744|NCT00021255|1262116|P2|Overall Study|Lost to Follow-up|2
401745|NCT00021255|1262117|P1|Overall Study|Lost to Follow-up|0
401746|NCT00021255|1262115|P3|Overall Study|Withdrawal by Subject|26
401747|NCT00021255|1262116|P2|Overall Study|Withdrawal by Subject|64
401748|NCT00021255|1262117|P1|Overall Study|Withdrawal by Subject|41
401749|NCT00021255|1262115|P3|Overall Study|Second primary malignancy|1
401750|NCT00021255|1262116|P2|Overall Study|Second primary malignancy|4
401751|NCT00021255|1262117|P1|Overall Study|Second primary malignancy|0
401752|NCT00021255|1262115|P3|Overall Study|Breast cancer relapse|11
401753|NCT00021255|1262116|P2|Overall Study|Breast cancer relapse|18
401754|NCT00021255|1262117|P1|Overall Study|Breast cancer relapse|5
401755|NCT00021255|1262115|P3|Overall Study|Death|2
401756|NCT00021255|1262116|P2|Overall Study|Death|0
401757|NCT00021255|1262117|P1|Overall Study|Death|1
401758|NCT00021229|1262134|P3|Overall Study|Punctate hemmorrhage post RT|0
401759|NCT00021229|1262135|P2|Overall Study|Punctate hemmorrhage post RT|0
401760|NCT00021229|1262136|P1|Overall Study|Punctate hemmorrhage post RT|2
401761|NCT00021229|1262134|P3|Overall Study|Physician Decision|1
401762|NCT00021229|1262135|P2|Overall Study|Physician Decision|0
401763|NCT00021229|1262136|P1|Overall Study|Physician Decision|0
401764|NCT00021229|1262134|P3|Overall Study|Protocol Violation|0
401765|NCT00021229|1262135|P2|Overall Study|Protocol Violation|1
401766|NCT00021229|1262136|P1|Overall Study|Protocol Violation|1
401767|NCT00021229|1262134|P3|Overall Study|Progressive Disease|12
401768|NCT00021229|1262135|P2|Overall Study|Progressive Disease|19
401769|NCT00021229|1262136|P1|Overall Study|Progressive Disease|15
401770|NCT00021229|1262134|P3|Overall Study|Withdrawal by Subject|1
401771|NCT00021229|1262135|P2|Overall Study|Withdrawal by Subject|7
401772|NCT00021229|1262136|P1|Overall Study|Withdrawal by Subject|7
401773|NCT00021229|1262134|P3|Overall Study|Death|0
401774|NCT00021229|1262135|P2|Overall Study|Death|1
401775|NCT00021229|1262136|P1|Overall Study|Death|0
401776|NCT00021229|1262134|P3|Overall Study|Adverse Event|2
401777|NCT00021229|1262135|P2|Overall Study|Adverse Event|5
401778|NCT00021229|1262136|P1|Overall Study|Adverse Event|10
401779|NCT00019604|1262176|P1|Overall Study|Details for other not available|4
401780|NCT00019604|1262176|P1|Overall Study|Unable to evaluate|1
401781|NCT00019604|1262176|P1|Overall Study|Too much disease|1
401782|NCT00019604|1262176|P1|Overall Study|Pt going to immunotherapy study|1
401783|NCT00019604|1262176|P1|Overall Study|Started new chemo regimen|1
401784|NCT00019604|1262176|P1|Overall Study|Resectable disease|1
401785|NCT00019604|1262176|P1|Overall Study|Non compliant|1
401786|NCT00019604|1262176|P1|Overall Study|Non compliant on systemic CH|1
401787|NCT00019604|1262176|P1|Overall Study|Move to a different study|1
401788|NCT00019604|1262176|P1|Overall Study|Going to have liver transplant|1
401789|NCT00019604|1262176|P1|Overall Study|Carcinoid tumor, not treatable|1
401790|NCT00019604|1262176|P1|Overall Study|Refused treatment|1
401791|NCT00019604|1262176|P1|Overall Study|Progressive disease|23
401792|NCT00019604|1262176|P1|Overall Study|Death|1
401793|NCT00016354|1262203|P8|Overall Study|Lack of Efficacy|1
401794|NCT00016354|1262204|P7|Overall Study|Lack of Efficacy|0
401795|NCT00016354|1262205|P6|Overall Study|Lack of Efficacy|0
401796|NCT00016354|1262206|P5|Overall Study|Lack of Efficacy|0
401797|NCT00016354|1262207|P4|Overall Study|Lack of Efficacy|0
401798|NCT00016354|1262208|P3|Overall Study|Lack of Efficacy|0
401799|NCT00016354|1262209|P2|Overall Study|Lack of Efficacy|0
401800|NCT00016354|1262210|P1|Overall Study|Lack of Efficacy|0
401801|NCT00015457|1262220|P2|Second Intervention|Withdrawal by Subject|0
401802|NCT00015457|1262221|P1|Second Intervention|Withdrawal by Subject|1
401803|NCT00015457|1262220|P2|First Intervention|Lack of Efficacy|1
401804|NCT00015457|1262221|P1|First Intervention|Lack of Efficacy|0
401805|NCT00015457|1262220|P2|First Intervention|Adverse Event|2
401806|NCT00015457|1262221|P1|First Intervention|Adverse Event|0
401807|NCT00014911|1262229|P1|Overall Study|Immunosuppression-related Side Effects|1
401808|NCT00014911|1262229|P1|Overall Study|Unknown Reasons|2
401809|NCT00014911|1262229|P1|Overall Study|Withdrawal by Subject|6
401810|NCT00014911|1262229|P1|Overall Study|Lost to Follow-up|1
401811|NCT00014911|1262229|P1|Overall Study|Adverse Event|1
401812|NCT00014495|1262246|P4|Overall Study|Clinical deterioration|1
401813|NCT00014495|1262247|P3|Overall Study|Clinical deterioration|0
401814|NCT00014495|1262248|P2|Overall Study|Clinical deterioration|0
401815|NCT00014495|1262249|P1|Overall Study|Clinical deterioration|0
401816|NCT00014495|1262246|P4|Overall Study|Death|0
401817|NCT00014495|1262247|P3|Overall Study|Death|1
401818|NCT00014495|1262248|P2|Overall Study|Death|0
401819|NCT00014495|1262249|P1|Overall Study|Death|0
401820|NCT00013611|1262258|P2|Overall Study|Lost to Follow-up|100
401821|NCT00013611|1262259|P1|Overall Study|Lost to Follow-up|91
401822|NCT00012012|1262312|P2|Overall Study|Withdrawal by Subject|2
401823|NCT00012012|1262313|P1|Overall Study|Withdrawal by Subject|0
401824|NCT00012012|1262312|P2|Overall Study|Protocol Violation|1
401825|NCT00012012|1262313|P1|Overall Study|Protocol Violation|1
401826|NCT00010803|1262342|P2|Overall Study|Withdrawal by Subject|98
401827|NCT00010803|1262343|P1|Overall Study|Withdrawal by Subject|97
401828|NCT00010257|1262360|P2|Overall Study|Withdrawal by Subject|0
401829|NCT00010257|1262361|P1|Overall Study|Withdrawal by Subject|1
401830|NCT00009737|1262371|P2|Overall Study|Administrative/Other Reasons|1
401831|NCT00009737|1262372|P1|Overall Study|Administrative/Other Reasons|7
401832|NCT00009737|1262371|P2|Overall Study|Lost to Follow-up|1
401833|NCT00009737|1262372|P1|Overall Study|Lost to Follow-up|1
401834|NCT00009737|1262371|P2|Overall Study|Refused Treatment|16
401835|NCT00009737|1262372|P1|Overall Study|Refused Treatment|15
401836|NCT00009737|1262371|P2|Overall Study|Other Protocol Violation|0
401837|NCT00009737|1262372|P1|Overall Study|Other Protocol Violation|1
401838|NCT00009737|1262371|P2|Overall Study|Violation of Selection Criteria at Entry|9
401839|NCT00009737|1262372|P1|Overall Study|Violation of Selection Criteria at Entry|13
401840|NCT00009737|1262371|P2|Overall Study|Lack of Efficacy|15
401841|NCT00009737|1262372|P1|Overall Study|Lack of Efficacy|17
401842|NCT00009737|1262371|P2|Overall Study|Death|6
401843|NCT00009737|1262372|P1|Overall Study|Death|4
401844|NCT00009737|1262371|P2|Overall Study|Adverse Event|75
401845|NCT00009737|1262372|P1|Overall Study|Adverse Event|112
401846|NCT00008385|1262390|P2|Overall Study|Not start protocol therapy|175
401847|NCT00008385|1262391|P1|Overall Study|Not start protocol therapy|44
401848|NCT00008385|1262390|P2|Overall Study|Not specified|212
401849|NCT00008385|1262391|P1|Overall Study|Not specified|105
401850|NCT00008385|1262390|P2|Overall Study|Maximum dose reached|2
401851|NCT00008385|1262391|P1|Overall Study|Maximum dose reached|0
401852|NCT00008385|1262390|P2|Overall Study|Other complicating disease|30
401853|NCT00008385|1262391|P1|Overall Study|Other complicating disease|17
401854|NCT00008385|1262390|P2|Overall Study|Start non-protocol therapy|1
401855|NCT00008385|1262391|P1|Overall Study|Start non-protocol therapy|3
401856|NCT00008385|1262390|P2|Overall Study|Withdrawal by Subject|157
401857|NCT00008385|1262391|P1|Overall Study|Withdrawal by Subject|67
401858|NCT00008385|1262390|P2|Overall Study|Death|18
401859|NCT00008385|1262391|P1|Overall Study|Death|12
401860|NCT00008385|1262390|P2|Overall Study|Adverse Event|20
401861|NCT00008385|1262391|P1|Overall Study|Adverse Event|8
401862|NCT00008385|1262390|P2|Overall Study|Progressive disease|117
401863|NCT00008385|1262391|P1|Overall Study|Progressive disease|52
401864|NCT00008385|1262390|P2|Overall Study|Off treatment reasons not reported|70
401865|NCT00008385|1262391|P1|Overall Study|Off treatment reasons not reported|79
401866|NCT00008138|1262401|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
401867|NCT00008138|1262401|P1|Post-Cytoreduction Chemotherapy|Progression|1
401868|NCT00008138|1262401|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
401869|NCT00008138|1262401|P1|Interval Debulking|Withdrawal by Subject|2
401870|NCT00008138|1262401|P1|Neoadjuvant Chemotherapy|not protocol specified|8
401871|NCT00008138|1262401|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
401872|NCT00008138|1262401|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
401873|NCT00008138|1262401|P1|Neoadjuvant Chemotherapy|Adverse Event|3
401874|NCT00007475|1262419|P4|Overall Study|Adverse Event|0
401875|NCT00007475|1262420|P3|Overall Study|Adverse Event|0
401876|NCT00007475|1262421|P2|Overall Study|Adverse Event|0
401877|NCT00007475|1262422|P1|Overall Study|Adverse Event|3
401878|NCT00007475|1262419|P4|Overall Study|Withdrawal by Subject|0
401879|NCT00007475|1262420|P3|Overall Study|Withdrawal by Subject|0
401880|NCT00007475|1262421|P2|Overall Study|Withdrawal by Subject|0
401881|NCT00007475|1262422|P1|Overall Study|Withdrawal by Subject|1
401882|NCT00007345|1262444|P2|Overall Study|Death on study|1
401883|NCT00007345|1262445|P1|Overall Study|Death on study|1
401884|NCT00007345|1262444|P2|Overall Study|Intercurrent illness|0
401885|NCT00007345|1262445|P1|Overall Study|Intercurrent illness|1
401886|NCT00007345|1262444|P2|Overall Study|Switched to alternative treatment|3
401887|NCT00007345|1262445|P1|Overall Study|Switched to alternative treatment|0
401888|NCT00007345|1262444|P2|Overall Study|Refused further treatment|7
401889|NCT00007345|1262445|P1|Overall Study|Refused further treatment|0
401890|NCT00006916|1262463|P1|Overall Study|Complication of device insertion|1
401891|NCT00006916|1262463|P1|Overall Study|Device not inserted|4
401892|NCT00006903|1262469|P3|Overall Study|Ineligible|2
401893|NCT00006903|1262470|P2|Overall Study|Ineligible|1
401894|NCT00006903|1262471|P1|Overall Study|Ineligible|10
401895|NCT00006903|1262469|P3|Overall Study|Patient never treated|1
401896|NCT00006903|1262470|P2|Overall Study|Patient never treated|0
401897|NCT00006903|1262471|P1|Overall Study|Patient never treated|0
401898|NCT00006903|1262469|P3|Overall Study|Death|0
401899|NCT00006903|1262470|P2|Overall Study|Death|1
401900|NCT00006903|1262471|P1|Overall Study|Death|0
401901|NCT00006903|1262469|P3|Overall Study|Adverse Event|1
401902|NCT00006903|1262470|P2|Overall Study|Adverse Event|0
401903|NCT00006903|1262471|P1|Overall Study|Adverse Event|0
401904|NCT00006903|1262469|P3|Overall Study|Refused further treatment|1
401905|NCT00006903|1262470|P2|Overall Study|Refused further treatment|2
401906|NCT00006903|1262471|P1|Overall Study|Refused further treatment|0
401907|NCT00006903|1262469|P3|Overall Study|Still receiving treatment|1
401908|NCT00006903|1262470|P2|Overall Study|Still receiving treatment|0
401909|NCT00006903|1262471|P1|Overall Study|Still receiving treatment|0
401910|NCT00006721|1262479|P3|Overall Study|Eligible but no Treatment Received|0
401911|NCT00006721|1262480|P2|Overall Study|Eligible but no Treatment Received|0
401912|NCT00006721|1262481|P1|Overall Study|Eligible but no Treatment Received|1
401913|NCT00006721|1262479|P3|Overall Study|Ineligible|10
401914|NCT00006721|1262480|P2|Overall Study|Ineligible|12
401915|NCT00006721|1262481|P1|Overall Study|Ineligible|2
401916|NCT00006721|1262479|P3|Overall Study|Other - Not Protocol Specified|7
401917|NCT00006721|1262480|P2|Overall Study|Other - Not Protocol Specified|7
401918|NCT00006721|1262481|P1|Overall Study|Other - Not Protocol Specified|0
401919|NCT00006721|1262479|P3|Overall Study|Death|2
401920|NCT00006721|1262480|P2|Overall Study|Death|1
401921|NCT00006721|1262481|P1|Overall Study|Death|0
401922|NCT00006721|1262479|P3|Overall Study|Progression/Relapse|2
401923|NCT00006721|1262480|P2|Overall Study|Progression/Relapse|1
401924|NCT00006721|1262481|P1|Overall Study|Progression/Relapse|0
401925|NCT00006721|1262479|P3|Overall Study|Refusal Unrelated to Adverse Event|8
401926|NCT00006721|1262480|P2|Overall Study|Refusal Unrelated to Adverse Event|0
401927|NCT00006721|1262481|P1|Overall Study|Refusal Unrelated to Adverse Event|1
401928|NCT00006721|1262479|P3|Overall Study|Adverse Event|4
401929|NCT00006721|1262480|P2|Overall Study|Adverse Event|4
401930|NCT00006721|1262481|P1|Overall Study|Adverse Event|0
401931|NCT00006604|1262506|P17|Overall Study|Other Reason|0
401932|NCT00006604|1262507|P16|Overall Study|Other Reason|0
401933|NCT00006604|1262508|P15|Overall Study|Other Reason|0
401934|NCT00006604|1262509|P14|Overall Study|Other Reason|0
401935|NCT00006604|1262510|P13|Overall Study|Other Reason|0
401936|NCT00006604|1262511|P12|Overall Study|Other Reason|0
401937|NCT00006604|1262512|P11|Overall Study|Other Reason|0
401938|NCT00006604|1262513|P10|Overall Study|Other Reason|1
401939|NCT00006604|1262514|P9|Overall Study|Other Reason|0
401940|NCT00006604|1262515|P8|Overall Study|Other Reason|0
401941|NCT00006604|1262516|P7|Overall Study|Other Reason|0
401942|NCT00006604|1262517|P6|Overall Study|Other Reason|1
401943|NCT00006604|1262518|P5|Overall Study|Other Reason|0
401944|NCT00006604|1262519|P4|Overall Study|Other Reason|0
401945|NCT00006604|1262520|P3|Overall Study|Other Reason|0
401946|NCT00006604|1262521|P2|Overall Study|Other Reason|0
401947|NCT00006604|1262522|P1|Overall Study|Other Reason|0
401948|NCT00006604|1262506|P17|Overall Study|Lost to Follow-up|3
401949|NCT00006604|1262507|P16|Overall Study|Lost to Follow-up|1
401950|NCT00006604|1262508|P15|Overall Study|Lost to Follow-up|0
401951|NCT00006604|1262509|P14|Overall Study|Lost to Follow-up|0
401952|NCT00006604|1262510|P13|Overall Study|Lost to Follow-up|0
401953|NCT00006604|1262511|P12|Overall Study|Lost to Follow-up|0
401954|NCT00006604|1262512|P11|Overall Study|Lost to Follow-up|0
401955|NCT00006604|1262513|P10|Overall Study|Lost to Follow-up|2
401956|NCT00006604|1262514|P9|Overall Study|Lost to Follow-up|0
401957|NCT00006604|1262515|P8|Overall Study|Lost to Follow-up|1
401958|NCT00006604|1262516|P7|Overall Study|Lost to Follow-up|0
401959|NCT00006604|1262517|P6|Overall Study|Lost to Follow-up|0
401960|NCT00006604|1262518|P5|Overall Study|Lost to Follow-up|0
401961|NCT00006604|1262519|P4|Overall Study|Lost to Follow-up|0
401962|NCT00006604|1262520|P3|Overall Study|Lost to Follow-up|0
401963|NCT00006604|1262521|P2|Overall Study|Lost to Follow-up|0
401964|NCT00006604|1262522|P1|Overall Study|Lost to Follow-up|0
401965|NCT00006604|1262506|P17|Overall Study|Subj/parent not willing to adhere to req|4
401966|NCT00006604|1262507|P16|Overall Study|Subj/parent not willing to adhere to req|3
401967|NCT00006604|1262508|P15|Overall Study|Subj/parent not willing to adhere to req|3
401968|NCT00006604|1262509|P14|Overall Study|Subj/parent not willing to adhere to req|2
401969|NCT00006604|1262510|P13|Overall Study|Subj/parent not willing to adhere to req|0
401970|NCT00006604|1262511|P12|Overall Study|Subj/parent not willing to adhere to req|0
401971|NCT00006604|1262512|P11|Overall Study|Subj/parent not willing to adhere to req|3
401972|NCT00006604|1262513|P10|Overall Study|Subj/parent not willing to adhere to req|6
401973|NCT00006604|1262514|P9|Overall Study|Subj/parent not willing to adhere to req|0
401974|NCT00006604|1262515|P8|Overall Study|Subj/parent not willing to adhere to req|1
401975|NCT00006604|1262516|P7|Overall Study|Subj/parent not willing to adhere to req|3
401976|NCT00006604|1262517|P6|Overall Study|Subj/parent not willing to adhere to req|0
401977|NCT00006604|1262518|P5|Overall Study|Subj/parent not willing to adhere to req|0
401978|NCT00006604|1262519|P4|Overall Study|Subj/parent not willing to adhere to req|3
401979|NCT00006604|1262520|P3|Overall Study|Subj/parent not willing to adhere to req|1
401980|NCT00006604|1262521|P2|Overall Study|Subj/parent not willing to adhere to req|0
401981|NCT00006604|1262522|P1|Overall Study|Subj/parent not willing to adhere to req|0
401982|NCT00006604|1262506|P17|Overall Study|Withdrawal by Subject|1
401983|NCT00006604|1262507|P16|Overall Study|Withdrawal by Subject|0
401984|NCT00006604|1262508|P15|Overall Study|Withdrawal by Subject|1
401985|NCT00006604|1262509|P14|Overall Study|Withdrawal by Subject|2
401986|NCT00006604|1262510|P13|Overall Study|Withdrawal by Subject|1
401987|NCT00006604|1262511|P12|Overall Study|Withdrawal by Subject|0
401988|NCT00006604|1262512|P11|Overall Study|Withdrawal by Subject|2
401989|NCT00006604|1262513|P10|Overall Study|Withdrawal by Subject|3
401990|NCT00006604|1262514|P9|Overall Study|Withdrawal by Subject|1
401991|NCT00006604|1262515|P8|Overall Study|Withdrawal by Subject|0
401992|NCT00006604|1262516|P7|Overall Study|Withdrawal by Subject|2
401993|NCT00006604|1262517|P6|Overall Study|Withdrawal by Subject|2
401994|NCT00006604|1262518|P5|Overall Study|Withdrawal by Subject|1
401995|NCT00006604|1262519|P4|Overall Study|Withdrawal by Subject|0
401996|NCT00006604|1262520|P3|Overall Study|Withdrawal by Subject|2
401997|NCT00006604|1262521|P2|Overall Study|Withdrawal by Subject|0
401998|NCT00006604|1262522|P1|Overall Study|Withdrawal by Subject|1
401999|NCT00006604|1262506|P17|Overall Study|Site closing|1
402000|NCT00006604|1262507|P16|Overall Study|Site closing|0
402001|NCT00006604|1262508|P15|Overall Study|Site closing|0
402002|NCT00006604|1262509|P14|Overall Study|Site closing|1
402003|NCT00006604|1262510|P13|Overall Study|Site closing|1
402004|NCT00006604|1262511|P12|Overall Study|Site closing|1
402005|NCT00006604|1262512|P11|Overall Study|Site closing|0
402006|NCT00006604|1262513|P10|Overall Study|Site closing|0
402007|NCT00006604|1262514|P9|Overall Study|Site closing|0
402008|NCT00006604|1262515|P8|Overall Study|Site closing|1
402009|NCT00006604|1262516|P7|Overall Study|Site closing|0
402010|NCT00006604|1262517|P6|Overall Study|Site closing|0
402011|NCT00006604|1262518|P5|Overall Study|Site closing|0
402012|NCT00006604|1262519|P4|Overall Study|Site closing|1
402013|NCT00006604|1262520|P3|Overall Study|Site closing|1
402014|NCT00006604|1262521|P2|Overall Study|Site closing|0
402015|NCT00006604|1262522|P1|Overall Study|Site closing|0
402016|NCT00006604|1262506|P17|Overall Study|Subj/Parent not able to get to clinic|0
402017|NCT00006604|1262507|P16|Overall Study|Subj/Parent not able to get to clinic|0
402018|NCT00006604|1262508|P15|Overall Study|Subj/Parent not able to get to clinic|3
402019|NCT00006604|1262509|P14|Overall Study|Subj/Parent not able to get to clinic|1
402020|NCT00006604|1262510|P13|Overall Study|Subj/Parent not able to get to clinic|1
402021|NCT00006604|1262511|P12|Overall Study|Subj/Parent not able to get to clinic|1
402022|NCT00006604|1262512|P11|Overall Study|Subj/Parent not able to get to clinic|2
402023|NCT00006604|1262513|P10|Overall Study|Subj/Parent not able to get to clinic|1
402024|NCT00006604|1262514|P9|Overall Study|Subj/Parent not able to get to clinic|0
402025|NCT00006604|1262515|P8|Overall Study|Subj/Parent not able to get to clinic|0
402026|NCT00006604|1262516|P7|Overall Study|Subj/Parent not able to get to clinic|1
402027|NCT00006604|1262517|P6|Overall Study|Subj/Parent not able to get to clinic|0
402028|NCT00006604|1262518|P5|Overall Study|Subj/Parent not able to get to clinic|1
402029|NCT00006604|1262519|P4|Overall Study|Subj/Parent not able to get to clinic|1
402030|NCT00006604|1262520|P3|Overall Study|Subj/Parent not able to get to clinic|0
402031|NCT00006604|1262521|P2|Overall Study|Subj/Parent not able to get to clinic|0
402032|NCT00006604|1262522|P1|Overall Study|Subj/Parent not able to get to clinic|0
402033|NCT00006604|1262506|P17|Overall Study|Severe debilitation, unable to continue|0
402034|NCT00006604|1262507|P16|Overall Study|Severe debilitation, unable to continue|0
402035|NCT00006604|1262508|P15|Overall Study|Severe debilitation, unable to continue|2
402036|NCT00006604|1262509|P14|Overall Study|Severe debilitation, unable to continue|0
402037|NCT00006604|1262510|P13|Overall Study|Severe debilitation, unable to continue|1
402038|NCT00006604|1262511|P12|Overall Study|Severe debilitation, unable to continue|2
402039|NCT00006604|1262512|P11|Overall Study|Severe debilitation, unable to continue|0
402040|NCT00006604|1262513|P10|Overall Study|Severe debilitation, unable to continue|5
402041|NCT00006604|1262514|P9|Overall Study|Severe debilitation, unable to continue|0
402042|NCT00006604|1262515|P8|Overall Study|Severe debilitation, unable to continue|0
402043|NCT00006604|1262516|P7|Overall Study|Severe debilitation, unable to continue|3
402044|NCT00006604|1262517|P6|Overall Study|Severe debilitation, unable to continue|0
402045|NCT00006604|1262518|P5|Overall Study|Severe debilitation, unable to continue|0
402046|NCT00006604|1262519|P4|Overall Study|Severe debilitation, unable to continue|0
402047|NCT00006604|1262520|P3|Overall Study|Severe debilitation, unable to continue|0
402048|NCT00006604|1262521|P2|Overall Study|Severe debilitation, unable to continue|0
402049|NCT00006604|1262522|P1|Overall Study|Severe debilitation, unable to continue|0
402050|NCT00006604|1262506|P17|Overall Study|Death|0
402051|NCT00006604|1262507|P16|Overall Study|Death|0
402052|NCT00006604|1262508|P15|Overall Study|Death|0
402053|NCT00006604|1262509|P14|Overall Study|Death|0
402054|NCT00006604|1262510|P13|Overall Study|Death|0
402055|NCT00006604|1262511|P12|Overall Study|Death|1
402056|NCT00006604|1262512|P11|Overall Study|Death|1
402057|NCT00006604|1262513|P10|Overall Study|Death|1
402058|NCT00006604|1262514|P9|Overall Study|Death|0
402059|NCT00006604|1262515|P8|Overall Study|Death|0
402060|NCT00006604|1262516|P7|Overall Study|Death|0
402061|NCT00006604|1262517|P6|Overall Study|Death|0
402062|NCT00006604|1262518|P5|Overall Study|Death|0
402063|NCT00006604|1262519|P4|Overall Study|Death|0
402064|NCT00006604|1262520|P3|Overall Study|Death|0
402065|NCT00006604|1262521|P2|Overall Study|Death|0
402066|NCT00006604|1262522|P1|Overall Study|Death|0
402067|NCT00006604|1262506|P17|Overall Study|Randomization entry error-no RX, no FU|0
402068|NCT00006604|1262507|P16|Overall Study|Randomization entry error-no RX, no FU|0
402069|NCT00006604|1262508|P15|Overall Study|Randomization entry error-no RX, no FU|0
402070|NCT00006604|1262509|P14|Overall Study|Randomization entry error-no RX, no FU|0
402071|NCT00006604|1262510|P13|Overall Study|Randomization entry error-no RX, no FU|0
402072|NCT00006604|1262511|P12|Overall Study|Randomization entry error-no RX, no FU|1
402073|NCT00006604|1262512|P11|Overall Study|Randomization entry error-no RX, no FU|0
402074|NCT00006604|1262513|P10|Overall Study|Randomization entry error-no RX, no FU|0
402075|NCT00006604|1262514|P9|Overall Study|Randomization entry error-no RX, no FU|0
402076|NCT00006604|1262515|P8|Overall Study|Randomization entry error-no RX, no FU|0
402077|NCT00006604|1262516|P7|Overall Study|Randomization entry error-no RX, no FU|0
402078|NCT00006604|1262517|P6|Overall Study|Randomization entry error-no RX, no FU|0
402079|NCT00006604|1262518|P5|Overall Study|Randomization entry error-no RX, no FU|0
402080|NCT00006604|1262519|P4|Overall Study|Randomization entry error-no RX, no FU|0
402081|NCT00006604|1262520|P3|Overall Study|Randomization entry error-no RX, no FU|0
402082|NCT00006604|1262521|P2|Overall Study|Randomization entry error-no RX, no FU|0
402083|NCT00006604|1262522|P1|Overall Study|Randomization entry error-no RX, no FU|0
402084|NCT00006604|1262506|P17|Overall Study|Met study objective - no further FU|0
402085|NCT00006604|1262507|P16|Overall Study|Met study objective - no further FU|1
402086|NCT00006604|1262508|P15|Overall Study|Met study objective - no further FU|1
402087|NCT00006604|1262509|P14|Overall Study|Met study objective - no further FU|0
402088|NCT00006604|1262510|P13|Overall Study|Met study objective - no further FU|0
402089|NCT00006604|1262511|P12|Overall Study|Met study objective - no further FU|0
402090|NCT00006604|1262512|P11|Overall Study|Met study objective - no further FU|0
402091|NCT00006604|1262513|P10|Overall Study|Met study objective - no further FU|0
402092|NCT00006604|1262514|P9|Overall Study|Met study objective - no further FU|0
402093|NCT00006604|1262515|P8|Overall Study|Met study objective - no further FU|0
402094|NCT00006604|1262516|P7|Overall Study|Met study objective - no further FU|0
402095|NCT00006604|1262517|P6|Overall Study|Met study objective - no further FU|0
402096|NCT00006604|1262518|P5|Overall Study|Met study objective - no further FU|0
402097|NCT00006604|1262519|P4|Overall Study|Met study objective - no further FU|0
402098|NCT00006604|1262520|P3|Overall Study|Met study objective - no further FU|0
402099|NCT00006604|1262521|P2|Overall Study|Met study objective - no further FU|0
402100|NCT00006604|1262522|P1|Overall Study|Met study objective - no further FU|1
402101|NCT00006489|1262640|P4|Overall Study|Death|1
402102|NCT00006489|1262641|P3|Overall Study|Death|0
402103|NCT00006489|1262642|P2|Overall Study|Death|0
402104|NCT00006489|1262643|P1|Overall Study|Death|0
402105|NCT00006489|1262640|P4|Overall Study|Scheduling Conflict|1
402106|NCT00006489|1262641|P3|Overall Study|Scheduling Conflict|2
402107|NCT00006489|1262642|P2|Overall Study|Scheduling Conflict|3
402108|NCT00006489|1262643|P1|Overall Study|Scheduling Conflict|0
402109|NCT00006489|1262640|P4|Overall Study|Withdrawal by Subject|6
402110|NCT00006489|1262641|P3|Overall Study|Withdrawal by Subject|9
402111|NCT00006489|1262642|P2|Overall Study|Withdrawal by Subject|9
402112|NCT00006489|1262643|P1|Overall Study|Withdrawal by Subject|10
402113|NCT00006489|1262640|P4|Overall Study|Adverse Event|3
402114|NCT00006489|1262641|P3|Overall Study|Adverse Event|4
402115|NCT00006489|1262642|P2|Overall Study|Adverse Event|2
402116|NCT00006489|1262643|P1|Overall Study|Adverse Event|3
402117|NCT00006478|1262661|P1|Overall Study|Physician Decision|6
402118|NCT00006478|1262661|P1|Overall Study|Vaccine could not be produced|1
402119|NCT00006409|1262671|P6|Post-3 Year Intervention|Protocol Violation|62
402120|NCT00006409|1262672|P5|Post-3 Year Intervention|Protocol Violation|62
402121|NCT00006409|1262673|P4|Post-3 Year Intervention|Protocol Violation|0
402122|NCT00006409|1262674|P3|Post-3 Year Intervention|Protocol Violation|0
402123|NCT00006409|1262675|P2|Post-3 Year Intervention|Protocol Violation|0
402124|NCT00006409|1262676|P1|Post-3 Year Intervention|Protocol Violation|0
402125|NCT00006409|1262671|P6|Post-2 Year Intervention|Protocol Violation|0
402126|NCT00006409|1262672|P5|Post-2 Year Intervention|Protocol Violation|0
402127|NCT00006409|1262673|P4|Post-2 Year Intervention|Protocol Violation|168
402128|NCT00006409|1262674|P3|Post-2 Year Intervention|Protocol Violation|251
402129|NCT00006409|1262675|P2|Post-2 Year Intervention|Protocol Violation|0
402130|NCT00006409|1262676|P1|Post-2 Year Intervention|Protocol Violation|0
402131|NCT00006409|1262671|P6|Baseline|Protocol Violation|0
402132|NCT00006409|1262672|P5|Baseline|Protocol Violation|0
402133|NCT00006409|1262673|P4|Baseline|Protocol Violation|0
402134|NCT00006409|1262674|P3|Baseline|Protocol Violation|0
402135|NCT00006409|1262675|P2|Baseline|Protocol Violation|70
402136|NCT00006409|1262676|P1|Baseline|Protocol Violation|48
402137|NCT00006392|1262700|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
402138|NCT00006392|1262701|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
402139|NCT00006392|1262702|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
402140|NCT00006392|1262703|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
402141|NCT00006392|1262700|P4|Overall Study|Ineligible|5
402142|NCT00006392|1262701|P3|Overall Study|Ineligible|5
402143|NCT00006392|1262702|P2|Overall Study|Ineligible|3
402144|NCT00006392|1262703|P1|Overall Study|Ineligible|11
402145|NCT00006389|1262733|P1|Overall Study|Adverse Event|1
402146|NCT00006305|1262743|P4|Overall Study|Withdrawal by Subject|14
402147|NCT00006305|1262744|P3|Overall Study|Withdrawal by Subject|15
402148|NCT00006305|1262745|P2|Overall Study|Withdrawal by Subject|10
402149|NCT00006305|1262746|P1|Overall Study|Withdrawal by Subject|17
402150|NCT00006289|1262762|P2|Second Intervention (5 Weeks)|Protocol Violation|1
402151|NCT00006289|1262763|P1|Second Intervention (5 Weeks)|Protocol Violation|1
402152|NCT00006289|1262762|P2|First Intervention (5 Weeks)|Adverse Event|0
402153|NCT00006289|1262763|P1|First Intervention (5 Weeks)|Adverse Event|1
402154|NCT00006237|1262790|P2|Overall Study|Not protocol specified|5
402155|NCT00006237|1262791|P1|Overall Study|Not protocol specified|14
402156|NCT00006237|1262790|P2|Overall Study|Withdrawal by Subject|1
402157|NCT00006237|1262791|P1|Overall Study|Withdrawal by Subject|0
402158|NCT00006237|1262790|P2|Overall Study|Not eligible|20
402159|NCT00006237|1262791|P1|Overall Study|Not eligible|9
402160|NCT00006237|1262790|P2|Overall Study|Progression/relapse|2
402161|NCT00006237|1262791|P1|Overall Study|Progression/relapse|54
402162|NCT00006237|1262790|P2|Overall Study|Refusal unrelated to adverse effects|4
402163|NCT00006237|1262791|P1|Overall Study|Refusal unrelated to adverse effects|8
402164|NCT00006237|1262790|P2|Overall Study|Death|0
402165|NCT00006237|1262791|P1|Overall Study|Death|1
402166|NCT00006237|1262790|P2|Overall Study|Adverse Event|29
402167|NCT00006237|1262791|P1|Overall Study|Adverse Event|39
402168|NCT00006184|1262803|P2|Overall Study|Death|0
402169|NCT00006184|1262804|P1|Overall Study|Death|1
402170|NCT00006164|1262845|P2|Overall Study|Withdrew or lost to follow-up|81
402171|NCT00006164|1262846|P1|Overall Study|Withdrew or lost to follow-up|70
402172|NCT00006011|1262892|P3|Overall Study|Ineligible|9
402173|NCT00006011|1262893|P2|Overall Study|Ineligible|16
402174|NCT00006011|1262894|P1|Overall Study|Ineligible|18
402175|NCT00006011|1262892|P3|Overall Study|Not specified|5
402176|NCT00006011|1262893|P2|Overall Study|Not specified|2
402177|NCT00006011|1262894|P1|Overall Study|Not specified|4
402178|NCT00006011|1262892|P3|Overall Study|Death|2
402179|NCT00006011|1262893|P2|Overall Study|Death|1
402180|NCT00006011|1262894|P1|Overall Study|Death|0
402181|NCT00006011|1262892|P3|Overall Study|Adverse Event|5
402182|NCT00006011|1262893|P2|Overall Study|Adverse Event|39
402183|NCT00006011|1262894|P1|Overall Study|Adverse Event|15
402184|NCT00006011|1262892|P3|Overall Study|Refused further treatment|26
402185|NCT00006011|1262893|P2|Overall Study|Refused further treatment|13
402186|NCT00006011|1262894|P1|Overall Study|Refused further treatment|15
402187|NCT00006011|1262892|P3|Overall Study|Disease progression|26
402188|NCT00006011|1262893|P2|Overall Study|Disease progression|6
402189|NCT00006011|1262894|P1|Overall Study|Disease progression|13
402190|NCT00005957|1262902|P2|Overall Study|Crossover to the other arm|19
402191|NCT00005957|1262903|P1|Overall Study|Crossover to the other arm|5
402192|NCT00005957|1262902|P2|Overall Study|No treated|9
402193|NCT00005957|1262903|P1|Overall Study|No treated|3
402194|NCT00005947|1262913|P2|Overall Study|Site Closure|0
402195|NCT00005947|1262914|P1|Overall Study|Site Closure|1
402196|NCT00005947|1262913|P2|Overall Study|Patient Refused to Continue|1
402197|NCT00005947|1262914|P1|Overall Study|Patient Refused to Continue|2
402198|NCT00005947|1262913|P2|Overall Study|Death|40
402199|NCT00005947|1262914|P1|Overall Study|Death|54
402200|NCT00005937|1262922|P1|Overall Study|Lack of Efficacy|5
402201|NCT00005908|1262926|P2|Overall Study|Withdrawal by Subject|0
402202|NCT00005908|1262927|P1|Overall Study|Withdrawal by Subject|1
402203|NCT00005906|1262936|P1|Overall Study|Lack of Efficacy|3
402204|NCT00005879|1262963|P2|Overall Study|Withdrawal by Subject|10
402205|NCT00005879|1262964|P1|Overall Study|Withdrawal by Subject|8
402206|NCT00005047|1262993|P4|Overall Study|Lack of Efficacy|0
402207|NCT00005047|1262994|P3|Overall Study|Lack of Efficacy|0
402208|NCT00005047|1262995|P2|Overall Study|Lack of Efficacy|0
402209|NCT00005047|1262996|P1|Overall Study|Lack of Efficacy|1
402210|NCT00005047|1262993|P4|Overall Study|Lost to Follow-up|0
402211|NCT00005047|1262994|P3|Overall Study|Lost to Follow-up|0
402212|NCT00005047|1262995|P2|Overall Study|Lost to Follow-up|0
402213|NCT00005047|1262996|P1|Overall Study|Lost to Follow-up|1
402214|NCT00005047|1262993|P4|Overall Study|Adverse Event|0
402215|NCT00005047|1262994|P3|Overall Study|Adverse Event|0
402216|NCT00005047|1262995|P2|Overall Study|Adverse Event|0
402217|NCT00005047|1262996|P1|Overall Study|Adverse Event|5
402218|NCT00005047|1262993|P4|Overall Study|Withdrawal by Subject|0
402219|NCT00005047|1262994|P3|Overall Study|Withdrawal by Subject|0
402220|NCT00005047|1262995|P2|Overall Study|Withdrawal by Subject|0
402221|NCT00005047|1262996|P1|Overall Study|Withdrawal by Subject|12
402222|NCT00004980|1263012|P2|Overall Study|Physician Decision|1
402223|NCT00004980|1263013|P1|Overall Study|Physician Decision|0
402224|NCT00004980|1263012|P2|Overall Study|memory difficulties|1
402225|NCT00004980|1263013|P1|Overall Study|memory difficulties|1
402226|NCT00004980|1263012|P2|Overall Study|Withdrawal by Subject|0
402227|NCT00004980|1263013|P1|Overall Study|Withdrawal by Subject|1
402228|NCT00004978|1263027|P2|Overall Study|site closure - not in analysis cohort|20
402229|NCT00004978|1263028|P1|Overall Study|site closure - not in analysis cohort|19
402230|NCT00004978|1263027|P2|Overall Study|Withdrawal by Subject|26
402231|NCT00004978|1263028|P1|Overall Study|Withdrawal by Subject|17
402232|NCT00004978|1263027|P2|Overall Study|Lost to Follow-up|108
402233|NCT00004978|1263028|P1|Overall Study|Lost to Follow-up|101
402234|NCT00004978|1263027|P2|Overall Study|Death|116
402235|NCT00004978|1263028|P1|Overall Study|Death|107
402236|NCT00004888|1263054|P2|Overall Study|Toxic death|0
402237|NCT00004888|1263055|P1|Overall Study|Toxic death|1
402238|NCT00004888|1263054|P2|Overall Study|Death without progressive disease|1
402239|NCT00004888|1263055|P1|Overall Study|Death without progressive disease|0
402240|NCT00004888|1263054|P2|Overall Study|Progressive Disease|9
402241|NCT00004888|1263055|P1|Overall Study|Progressive Disease|4
402242|NCT00004888|1263054|P2|Overall Study|Physician Decision|1
402243|NCT00004888|1263055|P1|Overall Study|Physician Decision|1
402244|NCT00004888|1263054|P2|Overall Study|Withdrawal by Subject|3
402245|NCT00004888|1263055|P1|Overall Study|Withdrawal by Subject|0
402246|NCT00004888|1263054|P2|Overall Study|Adverse Event|10
402247|NCT00004888|1263055|P1|Overall Study|Adverse Event|5
402248|NCT00004859|1263073|P2|Overall Study|Not specified|21
402249|NCT00004859|1263074|P1|Overall Study|Not specified|13
402250|NCT00004859|1263073|P2|Overall Study|missing data|11
402251|NCT00004859|1263074|P1|Overall Study|missing data|14
402252|NCT00004859|1263073|P2|Overall Study|error|1
402253|NCT00004859|1263074|P1|Overall Study|error|3
402254|NCT00004859|1263073|P2|Overall Study|other disease|3
402255|NCT00004859|1263074|P1|Overall Study|other disease|0
402256|NCT00004859|1263073|P2|Overall Study|Protocol Violation|2
402257|NCT00004859|1263074|P1|Overall Study|Protocol Violation|2
402258|NCT00004859|1263073|P2|Overall Study|Withdrawal by Subject|33
402259|NCT00004859|1263074|P1|Overall Study|Withdrawal by Subject|7
402260|NCT00004859|1263073|P2|Overall Study|Death|5
402261|NCT00004859|1263074|P1|Overall Study|Death|5
402262|NCT00004859|1263073|P2|Overall Study|Adverse Event|93
402263|NCT00004859|1263074|P1|Overall Study|Adverse Event|31
402264|NCT00004859|1263073|P2|Overall Study|Lack of Efficacy|113
402265|NCT00004859|1263074|P1|Overall Study|Lack of Efficacy|43
402266|NCT00004732|1263086|P2|Overall Study|Lost to Follow-up|47
402267|NCT00004732|1263087|P1|Overall Study|Lost to Follow-up|33
402268|NCT00004732|1263086|P2|Overall Study|Withdrawal by Subject|64
402269|NCT00004732|1263087|P1|Overall Study|Withdrawal by Subject|36
402270|NCT00004635|1263097|P2|Period Two|discrepancy in data entry|1
402271|NCT00004635|1263098|P1|Period Two|discrepancy in data entry|0
402272|NCT00004635|1263097|P2|Period Two|Lost to Follow-up|0
402273|NCT00004635|1263098|P1|Period Two|Lost to Follow-up|1
402274|NCT00004635|1263097|P2|Period Two|secondary malignancy|1
402275|NCT00004635|1263098|P1|Period Two|secondary malignancy|1
402276|NCT00004635|1263097|P2|Period Two|travel issues|1
402277|NCT00004635|1263098|P1|Period Two|travel issues|0
402278|NCT00004635|1263097|P2|Period Two|health problem|1
402279|NCT00004635|1263098|P1|Period Two|health problem|1
402280|NCT00004635|1263097|P2|Period Two|refused|2
402281|NCT00004635|1263098|P1|Period Two|refused|0
402282|NCT00004635|1263097|P2|Period Two|Adverse Event|0
402283|NCT00004635|1263098|P1|Period Two|Adverse Event|1
402284|NCT00004635|1263097|P2|Period Two|progression|3
402285|NCT00004635|1263098|P1|Period Two|progression|2
402286|NCT00004635|1263097|P2|Period One|discrepancy in data entry|1
402287|NCT00004635|1263098|P1|Period One|discrepancy in data entry|0
402288|NCT00004635|1263097|P2|Period One|health problem|1
402289|NCT00004635|1263098|P1|Period One|health problem|0
402290|NCT00004635|1263097|P2|Period One|progressed|2
402291|NCT00004635|1263098|P1|Period One|progressed|0
402292|NCT00004635|1263097|P2|Period One|second malignancy|0
402293|NCT00004635|1263098|P1|Period One|second malignancy|1
402294|NCT00004635|1263097|P2|Period One|PSA did not go <5 ng/mL|0
402295|NCT00004635|1263098|P1|Period One|PSA did not go <5 ng/mL|1
402296|NCT00004635|1263097|P2|Period One|Protocol Violation|0
402297|NCT00004635|1263098|P1|Period One|Protocol Violation|1
402298|NCT00004635|1263097|P2|Period One|Withdrawal by Subject|1
402299|NCT00004635|1263098|P1|Period One|Withdrawal by Subject|1
402300|NCT00004635|1263097|P2|Period One|refused|1
402301|NCT00004635|1263098|P1|Period One|refused|2
402302|NCT00004563|1263110|P2|Overall Study|Death|3
402303|NCT00004563|1263111|P1|Overall Study|Death|2
402304|NCT00004563|1263110|P2|Overall Study|Lack of Efficacy|5
402305|NCT00004563|1263111|P1|Overall Study|Lack of Efficacy|3
402306|NCT00004563|1263110|P2|Overall Study|Withdrawal by Subject|16
402307|NCT00004563|1263111|P1|Overall Study|Withdrawal by Subject|20
402308|NCT00004562|1263123|P2|Overall Study|Lost to Follow-up|91
402309|NCT00004562|1263124|P1|Overall Study|Lost to Follow-up|102
402310|NCT00004412|1263171|P3|Randomized Period|Moved to Crossover Period|0
402311|NCT00004412|1263172|P2|Randomized Period|Moved to Crossover Period|0
402312|NCT00004412|1263173|P1|Randomized Period|Moved to Crossover Period|3
402313|NCT00004228|1263188|P7|Overall Study|ineligible|5
402314|NCT00004228|1263189|P6|Overall Study|ineligible|2
402315|NCT00004228|1263190|P5|Overall Study|ineligible|1
402316|NCT00004228|1263191|P4|Overall Study|ineligible|1
402317|NCT00004228|1263192|P3|Overall Study|ineligible|4
402318|NCT00004228|1263193|P2|Overall Study|ineligible|2
402319|NCT00004228|1263194|P1|Overall Study|ineligible|4
402320|NCT00004228|1263188|P7|Overall Study|Other|0
402321|NCT00004228|1263189|P6|Overall Study|Other|0
402322|NCT00004228|1263190|P5|Overall Study|Other|0
402323|NCT00004228|1263191|P4|Overall Study|Other|0
402324|NCT00004228|1263192|P3|Overall Study|Other|1
402325|NCT00004228|1263193|P2|Overall Study|Other|0
402326|NCT00004228|1263194|P1|Overall Study|Other|0
402327|NCT00004228|1263188|P7|Overall Study|Withdrawal by Subject|2
402328|NCT00004228|1263189|P6|Overall Study|Withdrawal by Subject|1
402329|NCT00004228|1263190|P5|Overall Study|Withdrawal by Subject|2
402330|NCT00004228|1263191|P4|Overall Study|Withdrawal by Subject|0
402331|NCT00004228|1263192|P3|Overall Study|Withdrawal by Subject|1
402332|NCT00004228|1263193|P2|Overall Study|Withdrawal by Subject|0
402333|NCT00004228|1263194|P1|Overall Study|Withdrawal by Subject|3
402334|NCT00004228|1263188|P7|Overall Study|Protocol Violation|0
402335|NCT00004228|1263189|P6|Overall Study|Protocol Violation|2
402336|NCT00004228|1263190|P5|Overall Study|Protocol Violation|1
402337|NCT00004228|1263191|P4|Overall Study|Protocol Violation|1
402338|NCT00004228|1263192|P3|Overall Study|Protocol Violation|2
402339|NCT00004228|1263193|P2|Overall Study|Protocol Violation|5
402340|NCT00004228|1263194|P1|Overall Study|Protocol Violation|0
402341|NCT00004228|1263188|P7|Overall Study|Physician Decision|1
402342|NCT00004228|1263189|P6|Overall Study|Physician Decision|1
402343|NCT00004228|1263190|P5|Overall Study|Physician Decision|1
402344|NCT00004228|1263191|P4|Overall Study|Physician Decision|2
402345|NCT00004228|1263192|P3|Overall Study|Physician Decision|3
402346|NCT00004228|1263193|P2|Overall Study|Physician Decision|0
402347|NCT00004228|1263194|P1|Overall Study|Physician Decision|1
402348|NCT00004228|1263188|P7|Overall Study|Lost to Follow-up|0
402349|NCT00004228|1263189|P6|Overall Study|Lost to Follow-up|0
402350|NCT00004228|1263190|P5|Overall Study|Lost to Follow-up|0
402351|NCT00004228|1263191|P4|Overall Study|Lost to Follow-up|0
402352|NCT00004228|1263192|P3|Overall Study|Lost to Follow-up|1
402353|NCT00004228|1263193|P2|Overall Study|Lost to Follow-up|0
402354|NCT00004228|1263194|P1|Overall Study|Lost to Follow-up|0
402355|NCT00004228|1263188|P7|Overall Study|Lack of Efficacy|4
402356|NCT00004228|1263189|P6|Overall Study|Lack of Efficacy|8
402357|NCT00004228|1263190|P5|Overall Study|Lack of Efficacy|9
402358|NCT00004228|1263191|P4|Overall Study|Lack of Efficacy|3
402359|NCT00004228|1263192|P3|Overall Study|Lack of Efficacy|5
402360|NCT00004228|1263193|P2|Overall Study|Lack of Efficacy|6
402361|NCT00004228|1263194|P1|Overall Study|Lack of Efficacy|1
402362|NCT00004228|1263188|P7|Overall Study|Death|0
402363|NCT00004228|1263189|P6|Overall Study|Death|0
402364|NCT00004228|1263190|P5|Overall Study|Death|1
402365|NCT00004228|1263191|P4|Overall Study|Death|0
402366|NCT00004228|1263192|P3|Overall Study|Death|2
402367|NCT00004228|1263193|P2|Overall Study|Death|1
402368|NCT00004228|1263194|P1|Overall Study|Death|0
402369|NCT00004228|1263188|P7|Overall Study|Adverse Event|0
402370|NCT00004228|1263189|P6|Overall Study|Adverse Event|0
402371|NCT00004228|1263190|P5|Overall Study|Adverse Event|1
402372|NCT00004228|1263191|P4|Overall Study|Adverse Event|0
402373|NCT00004228|1263192|P3|Overall Study|Adverse Event|0
402374|NCT00004228|1263193|P2|Overall Study|Adverse Event|1
402375|NCT00004228|1263194|P1|Overall Study|Adverse Event|0
402376|NCT00003907|1263261|P2|Overall Study|ineligible or not treated|2
402377|NCT00003907|1263262|P1|Overall Study|ineligible or not treated|2
402378|NCT00003907|1263261|P2|Overall Study|Not specified|3
402379|NCT00003907|1263262|P1|Overall Study|Not specified|1
402380|NCT00003907|1263261|P2|Overall Study|Complicating disease|0
402381|NCT00003907|1263262|P1|Overall Study|Complicating disease|1
402382|NCT00003907|1263261|P2|Overall Study|Progressive disease|4
402383|NCT00003907|1263262|P1|Overall Study|Progressive disease|4
402384|NCT00003907|1263261|P2|Overall Study|Withdrawal by Subject|3
402385|NCT00003907|1263262|P1|Overall Study|Withdrawal by Subject|1
402386|NCT00003907|1263261|P2|Overall Study|Death|0
402387|NCT00003907|1263262|P1|Overall Study|Death|2
402388|NCT00003907|1263261|P2|Overall Study|Adverse Event|11
402389|NCT00003907|1263262|P1|Overall Study|Adverse Event|2
402390|NCT00003901|1263272|P1|Overall Study|Medical problems|6
402391|NCT00003901|1263272|P1|Overall Study|Chest X-Ray not done prior registration|1
402392|NCT00003901|1263272|P1|Overall Study|CT Scan not within protocol requirement|2
402393|NCT00003901|1263272|P1|Overall Study|Ineligible|6
402394|NCT00003901|1263272|P1|Overall Study|Withdrawal by Subject|1
402395|NCT00003901|1263272|P1|Overall Study|Adverse Event|1
402396|NCT00003896|1263283|P1|Overall Study|ineligible|5
402397|NCT00003896|1263283|P1|Overall Study|not protocol specified|3
402398|NCT00003896|1263283|P1|Overall Study|Death|3
402399|NCT00003896|1263283|P1|Overall Study|Lack of Efficacy|1
402400|NCT00003896|1263283|P1|Overall Study|Withdrawal by Subject|1
402401|NCT00003896|1263283|P1|Overall Study|Adverse Event|16
402402|NCT00003895|1263291|P2|Overall Study|Withdrawal by Subject|3
402403|NCT00003895|1263292|P1|Overall Study|Withdrawal by Subject|0
402404|NCT00003895|1263291|P2|Overall Study|Patient Vacation|0
402405|NCT00003895|1263292|P1|Overall Study|Patient Vacation|2
402406|NCT00003895|1263291|P2|Overall Study|Lack of Efficacy|1
402407|NCT00003895|1263292|P1|Overall Study|Lack of Efficacy|1
402408|NCT00003895|1263291|P2|Overall Study|Adverse Event|0
402409|NCT00003895|1263292|P1|Overall Study|Adverse Event|4
402410|NCT00003875|1263298|P1|Overall Study|Screen Failed|1
402411|NCT00003869|1263307|P2|Overall Study|Alternative treatmnt, medical problems|4
402412|NCT00003869|1263308|P1|Overall Study|Alternative treatmnt, medical problems|5
402413|NCT00003869|1263307|P2|Overall Study|Death|2
402414|NCT00003869|1263308|P1|Overall Study|Death|1
402415|NCT00003869|1263307|P2|Overall Study|Withdrawal by Subject|3
402416|NCT00003869|1263308|P1|Overall Study|Withdrawal by Subject|21
402417|NCT00003869|1263307|P2|Overall Study|Adverse Event|3
402418|NCT00003869|1263308|P1|Overall Study|Adverse Event|14
402419|NCT00003782|1263334|P3|Overall Study|No follow up data|26
402420|NCT00003782|1263335|P2|Overall Study|No follow up data|31
402421|NCT00003782|1263336|P1|Overall Study|No follow up data|30
402422|NCT00003659|1263348|P1|Overall Study|Withdrawal by Subject|3
402423|NCT00003641|1263356|P2|Overall Study|Never started interferon|12
402424|NCT00003641|1263357|P1|Overall Study|Never started interferon|567
402425|NCT00003641|1263356|P2|Overall Study|Should not receive interferon therapy|0
402426|NCT00003641|1263357|P1|Overall Study|Should not receive interferon therapy|2
402427|NCT00003641|1263356|P2|Overall Study|Unknown/missing|22
402428|NCT00003641|1263357|P1|Overall Study|Unknown/missing|0
402429|NCT00003641|1263356|P2|Overall Study|Disease progression|2
402430|NCT00003641|1263357|P1|Overall Study|Disease progression|0
402431|NCT00003641|1263356|P2|Overall Study|Adverse Event|38
402432|NCT00003641|1263357|P1|Overall Study|Adverse Event|0
402433|NCT00003641|1263356|P2|Overall Study|Withdrawal by Subject|100
402434|NCT00003641|1263357|P1|Overall Study|Withdrawal by Subject|0
402435|NCT00003631|1263368|P3|Overall Study|Evaluable for toxicity only|2
402436|NCT00003631|1263369|P2|Overall Study|Evaluable for toxicity only|0
402437|NCT00003631|1263370|P1|Overall Study|Evaluable for toxicity only|0
402438|NCT00003631|1263368|P3|Overall Study|Death|1
402439|NCT00003631|1263369|P2|Overall Study|Death|0
402440|NCT00003631|1263370|P1|Overall Study|Death|0
402441|NCT00003631|1263368|P3|Overall Study|Adverse Event|5
402442|NCT00003631|1263369|P2|Overall Study|Adverse Event|1
402443|NCT00003631|1263370|P1|Overall Study|Adverse Event|1
402444|NCT00003631|1263368|P3|Overall Study|Protocol Violation|0
402445|NCT00003631|1263369|P2|Overall Study|Protocol Violation|0
402446|NCT00003631|1263370|P1|Overall Study|Protocol Violation|1
402447|NCT00003631|1263368|P3|Overall Study|Patient not treated|1
402448|NCT00003631|1263369|P2|Overall Study|Patient not treated|0
402449|NCT00003631|1263370|P1|Overall Study|Patient not treated|1
402450|NCT00003590|1263378|P1|Overall Study|Physician Decision|1
402451|NCT00003590|1263378|P1|Overall Study|Death|1
402452|NCT00003590|1263378|P1|Overall Study|Lack of Efficacy|11
402453|NCT00003590|1263378|P1|Overall Study|Withdrawal by Subject|1
402454|NCT00003590|1263378|P1|Overall Study|Adverse Event|7
402455|NCT00003590|1263378|P1|Overall Study|Ineligible Patient|1
402456|NCT00003537|1263383|P1|Overall Study|Not evalauable|1
402457|NCT00003483|1263388|P1|Overall Study|Not evaluable|1
402458|NCT00003479|1263393|P1|Overall Study|Not evaluable|3
402459|NCT00003477|1263398|P1|Overall Study|Not evalauable|4
402460|NCT00003476|1263403|P1|Overall Study|Not evaluable|1
402461|NCT00003475|1263408|P1|Overall Study|Not evaluable|13
402462|NCT00003473|1263413|P1|Overall Study|Three patients were not evaluable.|3
402463|NCT00003470|1263418|P1|Overall Study|Not evaluable|6
402464|NCT00003458|1263443|P1|Overall Study|Not evaluable|4
402465|NCT00003457|1263448|P1|Overall Study|Not evaluable|9
402466|NCT00003389|1263455|P2|Overall Study|Ineligible|27
402467|NCT00003389|1263456|P1|Overall Study|Ineligible|33
402468|NCT00003389|1263455|P2|Overall Study|Off-treatment reason missing|21
402469|NCT00003389|1263456|P1|Overall Study|Off-treatment reason missing|31
402470|NCT00003389|1263455|P2|Overall Study|Complicating disease|0
402471|NCT00003389|1263456|P1|Overall Study|Complicating disease|1
402472|NCT00003389|1263455|P2|Overall Study|Alternative therapy|1
402473|NCT00003389|1263456|P1|Overall Study|Alternative therapy|2
402474|NCT00003389|1263455|P2|Overall Study|Withdrawal by Subject|5
402475|NCT00003389|1263456|P1|Overall Study|Withdrawal by Subject|12
402476|NCT00003389|1263455|P2|Overall Study|Death|3
402477|NCT00003389|1263456|P1|Overall Study|Death|0
402478|NCT00003389|1263455|P2|Overall Study|Adverse Event|2
402479|NCT00003389|1263456|P1|Overall Study|Adverse Event|13
402480|NCT00003389|1263455|P2|Overall Study|Disease progression|1
402481|NCT00003389|1263456|P1|Overall Study|Disease progression|6
402482|NCT00003377|1263471|P5|Period II|Ureteral stent complications|1
402483|NCT00003377|1263472|P4|Period II|Ureteral stent complications|0
402484|NCT00003377|1263473|P3|Period II|Ureteral stent complications|0
402485|NCT00003377|1263474|P2|Period II|Ureteral stent complications|0
402486|NCT00003377|1263475|P1|Period II|Ureteral stent complications|0
402487|NCT00003377|1263471|P5|Period I|Dose Limiting Toxicity(DLT)|0
402488|NCT00003377|1263472|P4|Period I|Dose Limiting Toxicity(DLT)|1
402489|NCT00003377|1263473|P3|Period I|Dose Limiting Toxicity(DLT)|1
402490|NCT00003377|1263474|P2|Period I|Dose Limiting Toxicity(DLT)|0
402491|NCT00003377|1263475|P1|Period I|Dose Limiting Toxicity(DLT)|0
402492|NCT00003298|1263489|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
402493|NCT00003298|1263489|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
402494|NCT00003298|1263489|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
402495|NCT00003298|1263489|P1|Step 2 (Adjuvant Therapy)|Death|1
402496|NCT00003298|1263489|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
402497|NCT00003298|1263489|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
402498|NCT00003298|1263489|P1|Re-register to Step 2 After Surgery|Reason unknown|1
402499|NCT00003298|1263489|P1|Re-register to Step 2 After Surgery|Other complications|2
402500|NCT00003298|1263489|P1|Re-register to Step 2 After Surgery|Positive margins|5
402501|NCT00003298|1263489|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
402502|NCT00003298|1263489|P1|Surgery|Unevaluable and off study|2
402503|NCT00003298|1263489|P1|Surgery|Progression before surgery|2
402504|NCT00003298|1263489|P1|Surgery|Unresectable at surgery|3
402505|NCT00003298|1263489|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
402506|NCT00003298|1263489|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
402507|NCT00003222|1263528|P2|Overall Study|Physician Decision|1
402508|NCT00003222|1263529|P1|Overall Study|Physician Decision|0
402509|NCT00003199|1263539|P1|Overall Study|Screen fail|15
402510|NCT00003199|1263539|P1|Overall Study|Lack of insurance clearance|2
402511|NCT00003199|1263539|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
402512|NCT00003138|1263547|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
402513|NCT00003138|1263548|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
402514|NCT00003138|1263547|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
402515|NCT00003138|1263548|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
402516|NCT00003138|1263547|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
402517|NCT00003138|1263548|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
402518|NCT00003138|1263547|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
402519|NCT00003138|1263548|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
402520|NCT00003138|1263547|P2|Step 1|Never started treatment|0
402521|NCT00003138|1263548|P1|Step 1|Never started treatment|1
402522|NCT00003138|1263547|P2|Step 1|Reasons off treatment not documented|57
402523|NCT00003138|1263548|P1|Step 1|Reasons off treatment not documented|60
402524|NCT00002931|1263565|P1|Overall Study|rapidly progressing disease during|2
402525|NCT00002850|1263574|P3|Overall Study|Withdrawal by Subject|0
402526|NCT00002850|1263575|P2|Overall Study|Withdrawal by Subject|1
402527|NCT00002850|1263576|P1|Overall Study|Withdrawal by Subject|0
402528|NCT00002850|1263574|P3|Overall Study|Protocol Violation|1
402529|NCT00002850|1263575|P2|Overall Study|Protocol Violation|0
402530|NCT00002850|1263576|P1|Overall Study|Protocol Violation|1
402531|NCT00002850|1263574|P3|Overall Study|Death|3
402532|NCT00002850|1263575|P2|Overall Study|Death|1
402533|NCT00002850|1263576|P1|Overall Study|Death|4
402534|NCT00002842|1263584|P1|Overall Study|ineligible for surgical resection|27
402535|NCT00002766|1263590|P2|Overall Study|Protocol Violation|0
402536|NCT00002766|1263591|P1|Overall Study|Protocol Violation|1
402537|NCT00002766|1263590|P2|Overall Study|Adverse Event|1
402538|NCT00002766|1263591|P1|Overall Study|Adverse Event|1
402539|NCT00002766|1263590|P2|Overall Study|Patient Not Treated|2
402540|NCT00002766|1263591|P1|Overall Study|Patient Not Treated|1
402541|NCT00002766|1263590|P2|Overall Study|Withdrawal by Subject|1
402542|NCT00002766|1263591|P1|Overall Study|Withdrawal by Subject|0
402543|NCT00002651|1263599|P3|Consolidation and Randomization|not eligible|112
402544|NCT00002651|1263600|P2|Consolidation and Randomization|not eligible|102
402545|NCT00002651|1263601|P1|Consolidation and Randomization|not eligible|0
402546|NCT00002651|1263599|P3|Consolidation and Randomization|not specified|313
402547|NCT00002651|1263600|P2|Consolidation and Randomization|not specified|314
402548|NCT00002651|1263601|P1|Consolidation and Randomization|not specified|0
402549|NCT00002651|1263599|P3|Consolidation and Randomization|Death|48
402550|NCT00002651|1263600|P2|Consolidation and Randomization|Death|38
402551|NCT00002651|1263601|P1|Consolidation and Randomization|Death|0
402552|NCT00002651|1263599|P3|Consolidation and Randomization|Progression/relapse|298
402553|NCT00002651|1263600|P2|Consolidation and Randomization|Progression/relapse|295
402554|NCT00002651|1263601|P1|Consolidation and Randomization|Progression/relapse|0
402555|NCT00002651|1263599|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
402556|NCT00002651|1263600|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
402557|NCT00002651|1263601|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
402558|NCT00002651|1263599|P3|Consolidation and Randomization|Adverse Event|14
402559|NCT00002651|1263600|P2|Consolidation and Randomization|Adverse Event|36
402560|NCT00002651|1263601|P1|Consolidation and Randomization|Adverse Event|0
402561|NCT00002651|1263599|P3|Induction|not eligible|0
402562|NCT00002651|1263600|P2|Induction|not eligible|0
402563|NCT00002651|1263601|P1|Induction|not eligible|90
402564|NCT00002651|1263599|P3|Induction|not specified|0
402565|NCT00002651|1263600|P2|Induction|not specified|0
402566|NCT00002651|1263601|P1|Induction|not specified|823
402567|NCT00002651|1263599|P3|Induction|Death|0
402568|NCT00002651|1263600|P2|Induction|Death|0
402569|NCT00002651|1263601|P1|Induction|Death|62
402570|NCT00002651|1263599|P3|Induction|Progression/relapse|0
402571|NCT00002651|1263600|P2|Induction|Progression/relapse|0
402572|NCT00002651|1263601|P1|Induction|Progression/relapse|274
402573|NCT00002651|1263599|P3|Induction|Refusal unrelated to adverse event|0
402574|NCT00002651|1263600|P2|Induction|Refusal unrelated to adverse event|0
402575|NCT00002651|1263601|P1|Induction|Refusal unrelated to adverse event|50
402576|NCT00002651|1263599|P3|Induction|Adverse Event|0
402577|NCT00002651|1263600|P2|Induction|Adverse Event|0
402578|NCT00002651|1263601|P1|Induction|Adverse Event|44
402579|NCT00002597|1263627|P2|Overall Study|Withdrawal by Subject|6
402580|NCT00002597|1263628|P1|Overall Study|Withdrawal by Subject|7
402581|NCT00002597|1263627|P2|Overall Study|Protocol Violation|17
402582|NCT00002597|1263628|P1|Overall Study|Protocol Violation|19
402583|NCT00002558|1263652|P2|Overall Study|Withdrawal by Subject|1
402584|NCT00002558|1263653|P1|Overall Study|Withdrawal by Subject|0
402585|NCT00002540|1263661|P2|Overall Study|Refused Screen (Prostate Screening)|2433
402586|NCT00002540|1263662|P1|Overall Study|Refused Screen (Prostate Screening)|0
402587|NCT00002540|1263661|P2|Overall Study|Refused ASU (Control)|0
402588|NCT00002540|1263662|P1|Overall Study|Refused ASU (Control)|597
402589|NCT00002540|1263661|P2|Overall Study|Died Before ASU (Control)|0
402590|NCT00002540|1263662|P1|Overall Study|Died Before ASU (Control)|202
402591|NCT00002540|1263661|P2|Overall Study|Died Before Randomization|6
402592|NCT00002540|1263662|P1|Overall Study|Died Before Randomization|2
402593|NCT00002540|1263661|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
402594|NCT00002540|1263662|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
402595|NCT00002525|1263690|P2|Overall Study|Never start protocol therapy|0
402596|NCT00002525|1263691|P1|Overall Study|Never start protocol therapy|8
402597|NCT00002525|1263690|P2|Overall Study|Other|0
402598|NCT00002525|1263691|P1|Overall Study|Other|26
402599|NCT00002525|1263690|P2|Overall Study|Error|0
402600|NCT00002525|1263691|P1|Overall Study|Error|6
402601|NCT00002525|1263690|P2|Overall Study|Duke's A, B1, D disease|0
402602|NCT00002525|1263691|P1|Overall Study|Duke's A, B1, D disease|92
402603|NCT00002525|1263690|P2|Overall Study|Other complicating disease|0
402604|NCT00002525|1263691|P1|Overall Study|Other complicating disease|1
402605|NCT00002525|1263690|P2|Overall Study|Start non-protocol therapy|0
402606|NCT00002525|1263691|P1|Overall Study|Start non-protocol therapy|1
402607|NCT00002525|1263690|P2|Overall Study|Withdrawal by Subject|0
402608|NCT00002525|1263691|P1|Overall Study|Withdrawal by Subject|11
402609|NCT00002525|1263690|P2|Overall Study|Death|0
402610|NCT00002525|1263691|P1|Overall Study|Death|5
402611|NCT00002525|1263690|P2|Overall Study|Adverse Event|0
402612|NCT00002525|1263691|P1|Overall Study|Adverse Event|36
402613|NCT00001962|1263715|P1|Overall Study|Adverse Event|1
402614|NCT00001962|1263715|P1|Overall Study|Lost to Follow-up|2
402615|NCT00001962|1263715|P1|Overall Study|Death|1
402616|NCT00001962|1263715|P1|Overall Study|Lack of Accrual|6
402617|NCT00001962|1263715|P1|Overall Study|Lack of Efficacy|18
402618|NCT00001959|1263719|P1|Overall Study|non-compliance|1
402619|NCT00001959|1263719|P1|Overall Study|disabling sedation|1
402620|NCT00001959|1263719|P1|Overall Study|newly diagnosed colon cancer|1
402621|NCT00001941|1263725|P5|Overall Study|not treated- rapidly progressing disease|1
402622|NCT00001941|1263726|P4|Overall Study|not treated- rapidly progressing disease|0
402623|NCT00001941|1263727|P3|Overall Study|not treated- rapidly progressing disease|0
402624|NCT00001941|1263728|P2|Overall Study|not treated- rapidly progressing disease|0
402625|NCT00001941|1263729|P1|Overall Study|not treated- rapidly progressing disease|0
402626|NCT00001832|1263750|P15|Treatment Period|Not treated|0
402627|NCT00001832|1263751|P14|Treatment Period|Not treated|0
402628|NCT00001832|1263752|P13|Treatment Period|Not treated|0
402629|NCT00001832|1263753|P12|Treatment Period|Not treated|0
402630|NCT00001832|1263754|P11|Treatment Period|Not treated|0
402631|NCT00001832|1263755|P10|Treatment Period|Not treated|0
402632|NCT00001832|1263756|P9|Treatment Period|Not treated|0
402633|NCT00001832|1263757|P8|Treatment Period|Not treated|1
402634|NCT00001832|1263758|P7|Treatment Period|Not treated|0
402635|NCT00001832|1263759|P6|Treatment Period|Not treated|0
402636|NCT00001832|1263760|P5|Treatment Period|Not treated|0
402637|NCT00001832|1263761|P4|Treatment Period|Not treated|0
402638|NCT00001832|1263762|P3|Treatment Period|Not treated|0
402639|NCT00001832|1263763|P2|Treatment Period|Not treated|0
402640|NCT00001832|1263764|P1|Treatment Period|Not treated|0
402641|NCT00001832|1263750|P15|Treatment Period|Death during treatment|0
402642|NCT00001832|1263751|P14|Treatment Period|Death during treatment|0
402643|NCT00001832|1263752|P13|Treatment Period|Death during treatment|0
402644|NCT00001832|1263753|P12|Treatment Period|Death during treatment|0
402645|NCT00001832|1263754|P11|Treatment Period|Death during treatment|0
402646|NCT00001832|1263755|P10|Treatment Period|Death during treatment|0
402647|NCT00001832|1263756|P9|Treatment Period|Death during treatment|0
402648|NCT00001832|1263757|P8|Treatment Period|Death during treatment|0
402649|NCT00001832|1263758|P7|Treatment Period|Death during treatment|0
402650|NCT00001832|1263759|P6|Treatment Period|Death during treatment|1
402651|NCT00001832|1263760|P5|Treatment Period|Death during treatment|0
402652|NCT00001832|1263761|P4|Treatment Period|Death during treatment|0
402653|NCT00001832|1263762|P3|Treatment Period|Death during treatment|0
402654|NCT00001832|1263763|P2|Treatment Period|Death during treatment|0
402655|NCT00001832|1263764|P1|Treatment Period|Death during treatment|0
402656|NCT00001832|1263750|P15|Apheresis Period|not able to manufacture treatment cells|0
402657|NCT00001832|1263751|P14|Apheresis Period|not able to manufacture treatment cells|0
402658|NCT00001832|1263752|P13|Apheresis Period|not able to manufacture treatment cells|0
402659|NCT00001832|1263753|P12|Apheresis Period|not able to manufacture treatment cells|0
402660|NCT00001832|1263754|P11|Apheresis Period|not able to manufacture treatment cells|0
402661|NCT00001832|1263755|P10|Apheresis Period|not able to manufacture treatment cells|0
402662|NCT00001832|1263756|P9|Apheresis Period|not able to manufacture treatment cells|0
402663|NCT00001832|1263757|P8|Apheresis Period|not able to manufacture treatment cells|0
402664|NCT00001832|1263758|P7|Apheresis Period|not able to manufacture treatment cells|0
402665|NCT00001832|1263759|P6|Apheresis Period|not able to manufacture treatment cells|0
402666|NCT00001832|1263760|P5|Apheresis Period|not able to manufacture treatment cells|0
402667|NCT00001832|1263761|P4|Apheresis Period|not able to manufacture treatment cells|0
402668|NCT00001832|1263762|P3|Apheresis Period|not able to manufacture treatment cells|0
402669|NCT00001832|1263763|P2|Apheresis Period|not able to manufacture treatment cells|0
402670|NCT00001832|1263764|P1|Apheresis Period|not able to manufacture treatment cells|60
402671|NCT00001723|1263810|P2|Overall Study|medication intolerance|2
402672|NCT00001723|1263811|P1|Overall Study|medication intolerance|1
402673|NCT00001723|1263810|P2|Overall Study|Lost to Follow-up|2
402674|NCT00001723|1263811|P1|Overall Study|Lost to Follow-up|2
402675|NCT00001723|1263810|P2|Overall Study|Lack of family interest|5
402676|NCT00001723|1263811|P1|Overall Study|Lack of family interest|4
402677|NCT00001723|1263810|P2|Overall Study|Lack of Efficacy|7
402678|NCT00001723|1263811|P1|Overall Study|Lack of Efficacy|6
402679|NCT00001703|1263827|P1|Overall Study|recurrent disease|2
402680|NCT00001703|1263827|P1|Overall Study|No evidence of disease|1
402681|NCT00001703|1263827|P1|Overall Study|progressed disease|2
402682|NCT00001596|1263865|P2|Overall Study|Adverse Event|0
402683|NCT00001596|1263866|P1|Overall Study|Adverse Event|1
402684|NCT00001596|1263865|P2|Overall Study|Study Termination|9
402685|NCT00001596|1263866|P1|Overall Study|Study Termination|12
402686|NCT00001596|1263865|P2|Overall Study|Withdrawal by Subject|1
402687|NCT00001596|1263866|P1|Overall Study|Withdrawal by Subject|3
402688|NCT00001596|1263865|P2|Overall Study|Death|0
402689|NCT00001596|1263866|P1|Overall Study|Death|1
402690|NCT00001575|1263897|P1|Overall Study|Withdrawn/deaths|23
402691|NCT00001575|1263897|P1|Overall Study|Screening failures-Ph I portion|22
402692|NCT00001566|1263903|P1|Overall Study|unable to complete initial apheresis|1
402693|NCT00001566|1263903|P1|Overall Study|Lost to Follow-up|1
402694|NCT00001566|1263903|P1|Overall Study|Death|13
402695|NCT00001566|1263903|P1|Overall Study|stopped after C3 due to symptomatic PD|1
402696|NCT00001566|1263903|P1|Overall Study|patients' choice to discontinue protocol|3
402697|NCT00001262|1263939|P3|Overall Study|Withdrawal by Subject|0
402698|NCT00001262|1263940|P2|Overall Study|Withdrawal by Subject|3
402699|NCT00001262|1263941|P1|Overall Study|Withdrawal by Subject|0
402700|NCT00001262|1263939|P3|Overall Study|Death|0
402701|NCT00001262|1263940|P2|Overall Study|Death|11
402702|NCT00001262|1263941|P1|Overall Study|Death|10
402703|NCT00001213|1263967|P1|Overall Study|Death|18
402704|NCT00000620|1263978|P8|Overall Study|missed closeout visit|16
402705|NCT00000620|1263979|P7|Overall Study|missed closeout visit|13
402706|NCT00000620|1263980|P6|Overall Study|missed closeout visit|28
402707|NCT00000620|1263981|P5|Overall Study|missed closeout visit|26
402708|NCT00000620|1263982|P4|Overall Study|missed closeout visit|11
402709|NCT00000620|1263983|P3|Overall Study|missed closeout visit|16
402710|NCT00000620|1263984|P2|Overall Study|missed closeout visit|28
402711|NCT00000620|1263985|P1|Overall Study|missed closeout visit|22
402712|NCT00000620|1263978|P8|Overall Study|Withdrawal by Subject|21
402713|NCT00000620|1263979|P7|Overall Study|Withdrawal by Subject|32
402714|NCT00000620|1263980|P6|Overall Study|Withdrawal by Subject|32
402715|NCT00000620|1263981|P5|Overall Study|Withdrawal by Subject|30
402716|NCT00000620|1263982|P4|Overall Study|Withdrawal by Subject|27
402717|NCT00000620|1263983|P3|Overall Study|Withdrawal by Subject|28
402718|NCT00000620|1263984|P2|Overall Study|Withdrawal by Subject|27
402719|NCT00000620|1263985|P1|Overall Study|Withdrawal by Subject|40
402720|NCT00000620|1263978|P8|Overall Study|Lost to Follow-up|14
402721|NCT00000620|1263979|P7|Overall Study|Lost to Follow-up|13
402722|NCT00000620|1263980|P6|Overall Study|Lost to Follow-up|15
402723|NCT00000620|1263981|P5|Overall Study|Lost to Follow-up|15
402724|NCT00000620|1263982|P4|Overall Study|Lost to Follow-up|14
402725|NCT00000620|1263983|P3|Overall Study|Lost to Follow-up|14
402726|NCT00000620|1263984|P2|Overall Study|Lost to Follow-up|14
402727|NCT00000620|1263985|P1|Overall Study|Lost to Follow-up|14
402728|NCT00000620|1263978|P8|Overall Study|Death|95
402729|NCT00000620|1263979|P7|Overall Study|Death|91
402730|NCT00000620|1263980|P6|Overall Study|Death|77
402731|NCT00000620|1263981|P5|Overall Study|Death|64
402732|NCT00000620|1263982|P4|Overall Study|Death|126
402733|NCT00000620|1263983|P3|Overall Study|Death|112
402734|NCT00000620|1263984|P2|Overall Study|Death|67
402735|NCT00000620|1263985|P1|Overall Study|Death|86
402736|NCT00000378|1264066|P2|Overall Study|Lack of Efficacy|14
402737|NCT00000378|1264067|P1|Overall Study|Lack of Efficacy|16
402738|NCT00000135|1264115|P2|Overall Study|Death|14
402739|NCT00000135|1264116|P1|Overall Study|Death|27
402764|NCT02388191|1264178|P2|Overall Study|Patient did not receive IUD|0
402765|NCT02388191|1264179|P1|Overall Study|Patient did not receive IUD|1
402766|NCT02357342|1264195|P2|First 6 Months|Death|0
402767|NCT02357342|1264196|P1|First 6 Months|Death|2
402768|NCT01851720|1264224|P2|Overall Study|Lost to Follow-up|1
402769|NCT01851720|1264225|P1|Overall Study|Lost to Follow-up|0
402770|NCT01849458|1264231|P1|Overall Study|Lost to Follow-up|4
402771|NCT01762761|1264243|P2|Overall Study|Physician Decision|1
402772|NCT01762761|1264244|P1|Overall Study|Physician Decision|0
402773|NCT01762761|1264243|P2|Overall Study|Protocol Violation|1
402774|NCT01762761|1264244|P1|Overall Study|Protocol Violation|0
402775|NCT01762761|1264243|P2|Overall Study|Lack of Efficacy|0
402776|NCT01762761|1264244|P1|Overall Study|Lack of Efficacy|1
402777|NCT01762761|1264243|P2|Overall Study|Adverse Event|2
402778|NCT01762761|1264244|P1|Overall Study|Adverse Event|1
402779|NCT01253317|1264296|P1|Overall Study|Adverse Event|2
402780|NCT01233687|1264304|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
402781|NCT01233687|1264304|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
402782|NCT01233687|1264304|P1|Phase II AMG 102 + Erlotinib|Death|1
402808|NCT00610857|1264346|P1|Overall Study|Not evaluable for response|2
402809|NCT00483327|1264353|P1|Overall Study|Patient Non Compliance|2
402810|NCT00483327|1264353|P1|Overall Study|Lost to Follow-up|4
402811|NCT00483327|1264353|P1|Overall Study|Withdrawal by Subject|3
402812|NCT00483327|1264353|P1|Overall Study|Adverse Event|1
402901|NCT01894230|1264441|P2|Overall Study|Death|0
402902|NCT01894230|1264442|P1|Overall Study|Death|1
402903|NCT01894230|1264441|P2|Overall Study|Non-adherent|1
402904|NCT01894230|1264442|P1|Overall Study|Non-adherent|0
402905|NCT01894230|1264441|P2|Overall Study|Withdrawal by Subject|4
402906|NCT01894230|1264442|P1|Overall Study|Withdrawal by Subject|4
402907|NCT01894230|1264441|P2|Overall Study|Lost to Follow-up|2
402908|NCT01894230|1264442|P1|Overall Study|Lost to Follow-up|2
402976|NCT01012999|1264661|P1|Overall Study|Protocol Violation|1
402977|NCT00390455|1264667|P2|Overall Study|Other Medical Reasons|11
402978|NCT00390455|1264668|P1|Overall Study|Other Medical Reasons|7
402979|NCT00390455|1264667|P2|Overall Study|Alternate Treatment|1
402980|NCT00390455|1264668|P1|Overall Study|Alternate Treatment|0
402981|NCT00390455|1264667|P2|Overall Study|Withdrawal by Subject|8
402982|NCT00390455|1264668|P1|Overall Study|Withdrawal by Subject|8
402983|NCT00390455|1264667|P2|Overall Study|Adverse Event|3
402984|NCT00390455|1264668|P1|Overall Study|Adverse Event|17
403047|NCT00141921|1264725|P1|Overall Study|Other|8
403048|NCT00141921|1264725|P1|Overall Study|Ineligibility Determined|2
403049|NCT00141921|1264725|P1|Overall Study|Pregnancy|4
403050|NCT00141921|1264725|P1|Overall Study|Administrative Decision|2
403051|NCT00141921|1264725|P1|Overall Study|Adverse Event|5
403052|NCT00141921|1264725|P1|Overall Study|Protocol Deviation|7
403053|NCT00141921|1264725|P1|Overall Study|Disease Progression|7
403054|NCT00141921|1264725|P1|Overall Study|Noncompliance|17
403055|NCT00141921|1264725|P1|Overall Study|Lost to Follow-up|19
403056|NCT00141921|1264725|P1|Overall Study|Withdrawal by Subject|42
403057|NCT00141921|1264725|P1|Overall Study|Remain on Study|28
403058|NCT02482428|1264773|P5|Overall Study|subject/guardian decision|2
403059|NCT02482428|1264774|P4|Overall Study|subject/guardian decision|0
403060|NCT02482428|1264775|P3|Overall Study|subject/guardian decision|0
403061|NCT02482428|1264776|P2|Overall Study|subject/guardian decision|2
403062|NCT02482428|1264777|P1|Overall Study|subject/guardian decision|4
403063|NCT02482428|1264773|P5|Overall Study|protocol deviation|0
403064|NCT02482428|1264774|P4|Overall Study|protocol deviation|0
403065|NCT02482428|1264775|P3|Overall Study|protocol deviation|0
403066|NCT02482428|1264776|P2|Overall Study|protocol deviation|1
403067|NCT02482428|1264777|P1|Overall Study|protocol deviation|1
403068|NCT02482428|1264773|P5|Overall Study|Physician Decision|1
403069|NCT02482428|1264774|P4|Overall Study|Physician Decision|0
403070|NCT02482428|1264775|P3|Overall Study|Physician Decision|0
403071|NCT02482428|1264776|P2|Overall Study|Physician Decision|0
403072|NCT02482428|1264777|P1|Overall Study|Physician Decision|0
403073|NCT02482428|1264773|P5|Overall Study|Lost to Follow-up|4
403074|NCT02482428|1264774|P4|Overall Study|Lost to Follow-up|2
403075|NCT02482428|1264775|P3|Overall Study|Lost to Follow-up|1
403076|NCT02482428|1264776|P2|Overall Study|Lost to Follow-up|9
403077|NCT02482428|1264777|P1|Overall Study|Lost to Follow-up|4
403078|NCT01639469|1264799|P2|Overall Study|Lost to Follow-up|1
403079|NCT01639469|1264800|P1|Overall Study|Lost to Follow-up|1
403080|NCT01639469|1264799|P2|Overall Study|Death|2
403081|NCT01639469|1264800|P1|Overall Study|Death|4
403082|NCT01261325|1264809|P3|Overall Study|AE, serious fatal|2
403083|NCT01261325|1264810|P2|Overall Study|AE, serious fatal|0
403084|NCT01261325|1264811|P1|Overall Study|AE, serious fatal|0
403085|NCT01261325|1264809|P3|Overall Study|Lost to Follow-up|3
403086|NCT01261325|1264810|P2|Overall Study|Lost to Follow-up|1
403087|NCT01261325|1264811|P1|Overall Study|Lost to Follow-up|0
403088|NCT01261325|1264809|P3|Overall Study|Protocol Violation|1
403089|NCT01261325|1264810|P2|Overall Study|Protocol Violation|3
403090|NCT01261325|1264811|P1|Overall Study|Protocol Violation|0
403091|NCT01261325|1264809|P3|Overall Study|Randomized in Error|1
403092|NCT01261325|1264810|P2|Overall Study|Randomized in Error|0
403093|NCT01261325|1264811|P1|Overall Study|Randomized in Error|0
403094|NCT01261325|1264809|P3|Overall Study|Screen Failure|0
403095|NCT01261325|1264810|P2|Overall Study|Screen Failure|0
403096|NCT01261325|1264811|P1|Overall Study|Screen Failure|1
403097|NCT01261325|1264809|P3|Overall Study|Erroneously Randomized|0
403098|NCT01261325|1264810|P2|Overall Study|Erroneously Randomized|0
403099|NCT01261325|1264811|P1|Overall Study|Erroneously Randomized|1
403100|NCT01261325|1264809|P3|Overall Study|Patient Randomized by Mistake|0
403101|NCT01261325|1264810|P2|Overall Study|Patient Randomized by Mistake|1
403102|NCT01261325|1264811|P1|Overall Study|Patient Randomized by Mistake|0
403103|NCT01261325|1264809|P3|Overall Study|Non Compliance|0
403104|NCT01261325|1264810|P2|Overall Study|Non Compliance|0
403105|NCT01261325|1264811|P1|Overall Study|Non Compliance|2
403106|NCT01261325|1264809|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
403107|NCT01261325|1264810|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
403108|NCT01261325|1264811|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
403109|NCT01261325|1264809|P3|Overall Study|AE, non-serious non-fatal|13
403110|NCT01261325|1264810|P2|Overall Study|AE, non-serious non-fatal|15
403111|NCT01261325|1264811|P1|Overall Study|AE, non-serious non-fatal|9
403112|NCT01261325|1264809|P3|Overall Study|SAE, non-fatal|1
403113|NCT01261325|1264810|P2|Overall Study|SAE, non-fatal|5
403114|NCT01261325|1264811|P1|Overall Study|SAE, non-fatal|1
403115|NCT01261325|1264809|P3|Overall Study|Withdrawal by Subject|4
403116|NCT01261325|1264810|P2|Overall Study|Withdrawal by Subject|2
403117|NCT01261325|1264811|P1|Overall Study|Withdrawal by Subject|2
403118|NCT01261325|1264809|P3|Overall Study|Lack of Efficacy|0
403119|NCT01261325|1264810|P2|Overall Study|Lack of Efficacy|1
403120|NCT01261325|1264811|P1|Overall Study|Lack of Efficacy|1
403121|NCT01134614|1264855|P2|Overall Study|Patient in hospice care|1
403122|NCT01134614|1264856|P1|Overall Study|Patient in hospice care|0
403123|NCT01134614|1264855|P2|Overall Study|Symptomatic deterioration|1
403124|NCT01134614|1264856|P1|Overall Study|Symptomatic deterioration|0
403125|NCT01134614|1264855|P2|Overall Study|Pt received tx not allowed on study|1
403126|NCT01134614|1264856|P1|Overall Study|Pt received tx not allowed on study|0
403127|NCT01134614|1264855|P2|Overall Study|Never started treatment|1
403128|NCT01134614|1264856|P1|Overall Study|Never started treatment|4
403129|NCT01134614|1264855|P2|Overall Study|Physician's decision|1
403130|NCT01134614|1264856|P1|Overall Study|Physician's decision|0
403131|NCT01134614|1264855|P2|Overall Study|Complicating disease|1
403132|NCT01134614|1264856|P1|Overall Study|Complicating disease|2
403133|NCT01134614|1264855|P2|Overall Study|Alternative therapy|0
403134|NCT01134614|1264856|P1|Overall Study|Alternative therapy|2
403135|NCT01134614|1264855|P2|Overall Study|Withdrawal by Subject|2
403136|NCT01134614|1264856|P1|Overall Study|Withdrawal by Subject|3
403137|NCT01134614|1264855|P2|Overall Study|Death|8
403138|NCT01134614|1264856|P1|Overall Study|Death|5
403139|NCT01134614|1264855|P2|Overall Study|Adverse Event|39
403140|NCT01134614|1264856|P1|Overall Study|Adverse Event|26
403141|NCT01134614|1264855|P2|Overall Study|Progressive disease|54
403142|NCT01134614|1264856|P1|Overall Study|Progressive disease|60
403143|NCT01134614|1264855|P2|Overall Study|Still on treatment as of March 2013|13
403144|NCT01134614|1264856|P1|Overall Study|Still on treatment as of March 2013|21
403145|NCT00378703|1264870|P4|Overall Study|Other|3
403146|NCT00378703|1264871|P3|Overall Study|Other|2
403147|NCT00378703|1264872|P2|Overall Study|Other|1
403148|NCT00378703|1264873|P1|Overall Study|Other|1
403149|NCT00378703|1264870|P4|Overall Study|Never started treatment|0
403150|NCT00378703|1264871|P3|Overall Study|Never started treatment|0
403151|NCT00378703|1264872|P2|Overall Study|Never started treatment|4
403152|NCT00378703|1264873|P1|Overall Study|Never started treatment|1
403153|NCT00378703|1264870|P4|Overall Study|Ineligible|7
403154|NCT00378703|1264871|P3|Overall Study|Ineligible|7
403155|NCT00378703|1264872|P2|Overall Study|Ineligible|7
403156|NCT00378703|1264873|P1|Overall Study|Ineligible|4
403157|NCT00378703|1264870|P4|Overall Study|Relocation|0
403158|NCT00378703|1264871|P3|Overall Study|Relocation|1
403159|NCT00378703|1264872|P2|Overall Study|Relocation|0
403160|NCT00378703|1264873|P1|Overall Study|Relocation|0
403161|NCT00378703|1264870|P4|Overall Study|Adverse events and progressive disease|1
403162|NCT00378703|1264871|P3|Overall Study|Adverse events and progressive disease|0
403163|NCT00378703|1264872|P2|Overall Study|Adverse events and progressive disease|0
403164|NCT00378703|1264873|P1|Overall Study|Adverse events and progressive disease|0
403165|NCT00378703|1264870|P4|Overall Study|Joint decision of physician and patient|0
403166|NCT00378703|1264871|P3|Overall Study|Joint decision of physician and patient|0
403167|NCT00378703|1264872|P2|Overall Study|Joint decision of physician and patient|0
403168|NCT00378703|1264873|P1|Overall Study|Joint decision of physician and patient|1
403169|NCT00378703|1264870|P4|Overall Study|Surgery|1
403170|NCT00378703|1264871|P3|Overall Study|Surgery|0
403171|NCT00378703|1264872|P2|Overall Study|Surgery|0
403172|NCT00378703|1264873|P1|Overall Study|Surgery|1
403173|NCT00378703|1264870|P4|Overall Study|Symptomatic deterioration|2
403174|NCT00378703|1264871|P3|Overall Study|Symptomatic deterioration|0
403175|NCT00378703|1264872|P2|Overall Study|Symptomatic deterioration|1
403176|NCT00378703|1264873|P1|Overall Study|Symptomatic deterioration|0
403177|NCT00378703|1264870|P4|Overall Study|Other complicated disease|0
403178|NCT00378703|1264871|P3|Overall Study|Other complicated disease|2
403179|NCT00378703|1264872|P2|Overall Study|Other complicated disease|2
403180|NCT00378703|1264873|P1|Overall Study|Other complicated disease|0
403181|NCT00378703|1264870|P4|Overall Study|Alternative therapy|0
403182|NCT00378703|1264871|P3|Overall Study|Alternative therapy|0
403183|NCT00378703|1264872|P2|Overall Study|Alternative therapy|2
403184|NCT00378703|1264873|P1|Overall Study|Alternative therapy|4
403185|NCT00378703|1264870|P4|Overall Study|Physician Decision|0
403186|NCT00378703|1264871|P3|Overall Study|Physician Decision|1
403187|NCT00378703|1264872|P2|Overall Study|Physician Decision|4
403188|NCT00378703|1264873|P1|Overall Study|Physician Decision|1
403189|NCT00378703|1264870|P4|Overall Study|Withdrawal by Subject|7
403190|NCT00378703|1264871|P3|Overall Study|Withdrawal by Subject|5
403191|NCT00378703|1264872|P2|Overall Study|Withdrawal by Subject|8
403192|NCT00378703|1264873|P1|Overall Study|Withdrawal by Subject|4
403193|NCT00378703|1264870|P4|Overall Study|Death|3
403194|NCT00378703|1264871|P3|Overall Study|Death|4
403195|NCT00378703|1264872|P2|Overall Study|Death|2
403196|NCT00378703|1264873|P1|Overall Study|Death|2
403197|NCT00378703|1264870|P4|Overall Study|Adverse Event|18
403198|NCT00378703|1264871|P3|Overall Study|Adverse Event|20
403199|NCT00378703|1264872|P2|Overall Study|Adverse Event|17
403200|NCT00378703|1264873|P1|Overall Study|Adverse Event|11
403201|NCT00378703|1264870|P4|Overall Study|Disease progression|49
403202|NCT00378703|1264871|P3|Overall Study|Disease progression|48
403203|NCT00378703|1264872|P2|Overall Study|Disease progression|43
403204|NCT00378703|1264873|P1|Overall Study|Disease progression|59
403205|NCT00280748|1264895|P1|Overall Study|Extra-cranial disease progression|1
403206|NCT00280748|1264895|P1|Overall Study|Decline in performance|3
403207|NCT02234362|1264905|P1|Overall Study|Withdrawal by Subject|3
403208|NCT02234362|1264905|P1|Overall Study|Lost to Follow-up|6
403209|NCT02234362|1264905|P1|Overall Study|Not eligible after first screening visit|17
403210|NCT01681849|1264925|P3|Overall Study|Lost to Follow-up|6
403211|NCT01681849|1264926|P2|Overall Study|Lost to Follow-up|2
403212|NCT01681849|1264927|P1|Overall Study|Lost to Follow-up|3
403213|NCT01681849|1264925|P3|Overall Study|Withdrawal by Subject|33
403214|NCT01681849|1264926|P2|Overall Study|Withdrawal by Subject|5
403215|NCT01681849|1264927|P1|Overall Study|Withdrawal by Subject|3
403216|NCT01681849|1264925|P3|Overall Study|Protocol Violation|0
403217|NCT01681849|1264926|P2|Overall Study|Protocol Violation|0
403218|NCT01681849|1264927|P1|Overall Study|Protocol Violation|2
403219|NCT01188681|1264981|P4|Overall Study|Withdrawal by Subject|1
403220|NCT01188681|1264982|P3|Overall Study|Withdrawal by Subject|0
403221|NCT01188681|1264983|P2|Overall Study|Withdrawal by Subject|0
403222|NCT01188681|1264984|P1|Overall Study|Withdrawal by Subject|0
403223|NCT01188681|1264981|P4|Overall Study|bladder cancer|0
403224|NCT01188681|1264982|P3|Overall Study|bladder cancer|1
403225|NCT01188681|1264983|P2|Overall Study|bladder cancer|0
403226|NCT01188681|1264984|P1|Overall Study|bladder cancer|0
403227|NCT01153815|1265000|P2|Overall Study|Withdrawal by Subject|4
403228|NCT01153815|1265001|P1|Overall Study|Withdrawal by Subject|6
403229|NCT01153815|1265000|P2|Overall Study|Adverse Event|1
403230|NCT01153815|1265001|P1|Overall Study|Adverse Event|3
403231|NCT01061736|1265038|P10|Overall Study|Other than specified above|21
403232|NCT01061736|1265039|P9|Overall Study|Other than specified above|15
403233|NCT01061736|1265040|P8|Overall Study|Other than specified above|18
403234|NCT01061736|1265041|P7|Overall Study|Other than specified above|0
403235|NCT01061736|1265042|P6|Overall Study|Other than specified above|0
403236|NCT01061736|1265043|P5|Overall Study|Other than specified above|1
403237|NCT01061736|1265044|P4|Overall Study|Other than specified above|0
403238|NCT01061736|1265045|P3|Overall Study|Other than specified above|2
403239|NCT01061736|1265046|P2|Overall Study|Other than specified above|1
403240|NCT01061736|1265047|P1|Overall Study|Other than specified above|0
403241|NCT01061736|1265038|P10|Overall Study|Not treated|0
403242|NCT01061736|1265039|P9|Overall Study|Not treated|1
403243|NCT01061736|1265040|P8|Overall Study|Not treated|2
403244|NCT01061736|1265041|P7|Overall Study|Not treated|0
403245|NCT01061736|1265042|P6|Overall Study|Not treated|0
403246|NCT01061736|1265043|P5|Overall Study|Not treated|1
403247|NCT01061736|1265044|P4|Overall Study|Not treated|0
403248|NCT01061736|1265045|P3|Overall Study|Not treated|0
403249|NCT01061736|1265046|P2|Overall Study|Not treated|0
403250|NCT01061736|1265047|P1|Overall Study|Not treated|0
403251|NCT01061736|1265038|P10|Overall Study|Poor compliance to protocol|9
403252|NCT01061736|1265039|P9|Overall Study|Poor compliance to protocol|5
403253|NCT01061736|1265040|P8|Overall Study|Poor compliance to protocol|2
403254|NCT01061736|1265041|P7|Overall Study|Poor compliance to protocol|0
403255|NCT01061736|1265042|P6|Overall Study|Poor compliance to protocol|0
403256|NCT01061736|1265043|P5|Overall Study|Poor compliance to protocol|0
403257|NCT01061736|1265044|P4|Overall Study|Poor compliance to protocol|0
403258|NCT01061736|1265045|P3|Overall Study|Poor compliance to protocol|0
403259|NCT01061736|1265046|P2|Overall Study|Poor compliance to protocol|0
403260|NCT01061736|1265047|P1|Overall Study|Poor compliance to protocol|0
403261|NCT01061736|1265038|P10|Overall Study|Lack of Efficacy|10
403262|NCT01061736|1265039|P9|Overall Study|Lack of Efficacy|9
403263|NCT01061736|1265040|P8|Overall Study|Lack of Efficacy|9
403264|NCT01061736|1265041|P7|Overall Study|Lack of Efficacy|1
403265|NCT01061736|1265042|P6|Overall Study|Lack of Efficacy|2
403266|NCT01061736|1265043|P5|Overall Study|Lack of Efficacy|1
403267|NCT01061736|1265044|P4|Overall Study|Lack of Efficacy|1
403268|NCT01061736|1265045|P3|Overall Study|Lack of Efficacy|1
403269|NCT01061736|1265046|P2|Overall Study|Lack of Efficacy|2
403270|NCT01061736|1265047|P1|Overall Study|Lack of Efficacy|0
403271|NCT01061736|1265038|P10|Overall Study|Adverse Event|34
403272|NCT01061736|1265039|P9|Overall Study|Adverse Event|67
403273|NCT01061736|1265040|P8|Overall Study|Adverse Event|63
403274|NCT01061736|1265041|P7|Overall Study|Adverse Event|4
403275|NCT01061736|1265042|P6|Overall Study|Adverse Event|1
403276|NCT01061736|1265043|P5|Overall Study|Adverse Event|4
403277|NCT01061736|1265044|P4|Overall Study|Adverse Event|2
403278|NCT01061736|1265045|P3|Overall Study|Adverse Event|3
403279|NCT01061736|1265046|P2|Overall Study|Adverse Event|1
403280|NCT01061736|1265047|P1|Overall Study|Adverse Event|13
403281|NCT01061736|1265038|P10|Overall Study|Dose regimen not selected|0
403282|NCT01061736|1265039|P9|Overall Study|Dose regimen not selected|0
403283|NCT01061736|1265040|P8|Overall Study|Dose regimen not selected|0
403284|NCT01061736|1265041|P7|Overall Study|Dose regimen not selected|79
403285|NCT01061736|1265042|P6|Overall Study|Dose regimen not selected|0
403286|NCT01061736|1265043|P5|Overall Study|Dose regimen not selected|0
403287|NCT01061736|1265044|P4|Overall Study|Dose regimen not selected|0
403288|NCT01061736|1265045|P3|Overall Study|Dose regimen not selected|0
403289|NCT01061736|1265046|P2|Overall Study|Dose regimen not selected|0
403290|NCT01061736|1265047|P1|Overall Study|Dose regimen not selected|0
